id|nct_id|result_group_id|ctgov_group_code|title|period|description|count
2190965|NCT04204200|5377710|P3|NOT COMPLETED|Overall Study||0
2190966|NCT04204200|5377711|P2|NOT COMPLETED|Overall Study||0
2190967|NCT04204200|5377712|P1|NOT COMPLETED|Overall Study||0
2190968|NCT04204200|5377710|P3|COMPLETED|Overall Study||22
2190969|NCT04204200|5377711|P2|COMPLETED|Overall Study||22
2190970|NCT04204200|5377712|P1|COMPLETED|Overall Study||22
2190971|NCT04204200|5377710|P3|STARTED|Overall Study||22
2190972|NCT04204200|5377711|P2|STARTED|Overall Study||22
2190973|NCT04204200|5377712|P1|STARTED|Overall Study||22
2190974|NCT04182217|5377729|P1|NOT COMPLETED|Overall Study||0
2190975|NCT04182217|5377729|P1|COMPLETED|Overall Study||91
2190976|NCT04182217|5377729|P1|STARTED|Overall Study||91
2190977|NCT04144088|5377743|P3|NOT COMPLETED|Overall Study||7
2190978|NCT04144088|5377744|P2|NOT COMPLETED|Overall Study||5
2190979|NCT04144088|5377745|P1|NOT COMPLETED|Overall Study||6
2190980|NCT04144088|5377743|P3|COMPLETED|Overall Study||13
2190981|NCT04144088|5377744|P2|COMPLETED|Overall Study||15
2190982|NCT04144088|5377745|P1|COMPLETED|Overall Study||14
2190983|NCT04144088|5377743|P3|STARTED|Overall Study||20
2190984|NCT04144088|5377744|P2|STARTED|Overall Study||20
2190985|NCT04144088|5377745|P1|STARTED|Overall Study||20
2190986|NCT04137627|5377755|P2|NOT COMPLETED|Overall Study||13
2190987|NCT04137627|5377756|P1|NOT COMPLETED|Overall Study||12
2190988|NCT04137627|5377755|P2|COMPLETED|Overall Study||12
2190989|NCT04137627|5377756|P1|COMPLETED|Overall Study||13
2190990|NCT04137627|5377755|P2|STARTED|Overall Study||25
2190991|NCT04137627|5377756|P1|STARTED|Overall Study||25
2190992|NCT04123665|5377772|P2|NOT COMPLETED|Overall Study||0
2190993|NCT04123665|5377773|P1|NOT COMPLETED|Overall Study||8
2190994|NCT04123665|5377772|P2|COMPLETED|Overall Study||48
2190995|NCT04123665|5377773|P1|COMPLETED|Overall Study||42
2190996|NCT04123665|5377772|P2|STARTED|Overall Study||48
2190997|NCT04123665|5377773|P1|STARTED|Overall Study||50
2190998|NCT04113785|5377795|P1|NOT COMPLETED|Overall Study||0
2190999|NCT04113785|5377795|P1|COMPLETED|Overall Study||21
2191000|NCT04113785|5377795|P1|STARTED|Overall Study||21
2191001|NCT04112069|5377802|P2|NOT COMPLETED|Overall Study||0
2191002|NCT04112069|5377803|P1|NOT COMPLETED|Overall Study||0
2191003|NCT04112069|5377802|P2|COMPLETED|Overall Study||10
2191004|NCT04112069|5377803|P1|COMPLETED|Overall Study||10
2191005|NCT04112069|5377802|P2|STARTED|Overall Study||10
2191006|NCT04112069|5377803|P1|STARTED|Overall Study||10
2191007|NCT04109703|5377825|P2|NOT COMPLETED|Overall Study||0
2191008|NCT04109703|5377826|P1|NOT COMPLETED|Overall Study||0
2191009|NCT04109703|5377825|P2|COMPLETED|Overall Study||51
2191010|NCT04109703|5377826|P1|COMPLETED|Overall Study||49
2191011|NCT04109703|5377825|P2|STARTED|Overall Study||51
2191012|NCT04109703|5377826|P1|STARTED|Overall Study||49
2191013|NCT04106817|5377837|P3|NOT COMPLETED|Overall Study||0
2191014|NCT04106817|5377838|P2|NOT COMPLETED|Overall Study||0
2191015|NCT04106817|5377839|P1|NOT COMPLETED|Overall Study||1
2191016|NCT04106817|5377837|P3|COMPLETED|Overall Study||12
2191017|NCT04106817|5377838|P2|COMPLETED|Overall Study||11
2191018|NCT04106817|5377839|P1|COMPLETED|Overall Study||11
2191019|NCT04106817|5377837|P3|STARTED|Overall Study||12
2191020|NCT04106817|5377838|P2|STARTED|Overall Study||11
2191021|NCT04106817|5377839|P1|STARTED|Overall Study||12
2191022|NCT04098809|5377855|P2|NOT COMPLETED|Overall Study||4
2191023|NCT04098809|5377856|P1|NOT COMPLETED|Overall Study||3
2191024|NCT04098809|5377855|P2|COMPLETED|Overall Study||21
2191025|NCT04098809|5377856|P1|COMPLETED|Overall Study||24
2191026|NCT04098809|5377855|P2|STARTED|Overall Study||25
2191027|NCT04098809|5377856|P1|STARTED|Overall Study||27
2191028|NCT04091659|5377884|P2|NOT COMPLETED|Overall Study||1
2191029|NCT04091659|5377885|P1|NOT COMPLETED|Overall Study||3
2191030|NCT04091659|5377884|P2|COMPLETED|Overall Study||57
2191031|NCT04091659|5377885|P1|COMPLETED|Overall Study||37
2191032|NCT04091659|5377884|P2|STARTED|Overall Study||58
2191033|NCT04091659|5377885|P1|STARTED|Overall Study||40
2191034|NCT04083404|5377893|P1|NOT COMPLETED|Overall Study||0
2191035|NCT04083404|5377893|P1|COMPLETED|Overall Study||202
2191036|NCT04083404|5377893|P1|STARTED|Overall Study||202
2191037|NCT04081961|5377901|P3|NOT COMPLETED|Overall Study||0
2191038|NCT04081961|5377902|P2|NOT COMPLETED|Overall Study||0
2191039|NCT04081961|5377903|P1|NOT COMPLETED|Overall Study||0
2191040|NCT04081961|5377901|P3|COMPLETED|Overall Study||9
2191041|NCT04081961|5377902|P2|COMPLETED|Overall Study||9
2191042|NCT04081961|5377903|P1|COMPLETED|Overall Study||9
2191043|NCT04081961|5377901|P3|STARTED|Overall Study||9
2191044|NCT04081961|5377902|P2|STARTED|Overall Study||9
2191045|NCT04081961|5377903|P1|STARTED|Overall Study||9
2191046|NCT04076787|5377920|P3|NOT COMPLETED|Overall Study||0
2191047|NCT04076787|5377921|P2|NOT COMPLETED|Overall Study||0
2191048|NCT04076787|5377922|P1|NOT COMPLETED|Overall Study||0
2191049|NCT04076787|5377920|P3|COMPLETED|Overall Study||420
2191050|NCT04076787|5377921|P2|COMPLETED|Overall Study||1031
2191051|NCT04076787|5377922|P1|COMPLETED|Overall Study||318
2191052|NCT04076787|5377920|P3|STARTED|Overall Study||420
2191053|NCT04076787|5377921|P2|STARTED|Overall Study||1031
2191054|NCT04076787|5377922|P1|STARTED|Overall Study||318
2191055|NCT04071392|5377947|P2|NOT COMPLETED|Overall Study||2
2191056|NCT04071392|5377948|P1|NOT COMPLETED|Overall Study||2
2191057|NCT04071392|5377947|P2|COMPLETED|Overall Study||10
2191058|NCT04071392|5377948|P1|COMPLETED|Overall Study||10
2191059|NCT04071392|5377947|P2|STARTED|Overall Study||12
2191060|NCT04071392|5377948|P1|STARTED|Overall Study||12
2191061|NCT04069221|5377958|P4|NOT COMPLETED|Overall Study||0
2191062|NCT04069221|5377959|P3|NOT COMPLETED|Overall Study||0
2191063|NCT04069221|5377960|P2|NOT COMPLETED|Overall Study||0
2191064|NCT04069221|5377961|P1|NOT COMPLETED|Overall Study||0
2191065|NCT04069221|5377958|P4|COMPLETED|Overall Study||6
2191066|NCT04069221|5377959|P3|COMPLETED|Overall Study||6
2191067|NCT04069221|5377960|P2|COMPLETED|Overall Study||6
2191068|NCT04069221|5377961|P1|COMPLETED|Overall Study||8
2191069|NCT04069221|5377958|P4|STARTED|Overall Study||6
2191070|NCT04069221|5377959|P3|STARTED|Overall Study||6
2191071|NCT04069221|5377960|P2|STARTED|Overall Study||6
2191072|NCT04069221|5377961|P1|STARTED|Overall Study||8
2191073|NCT04053270|5377982|P2|NOT COMPLETED|Overall Study||5
2191074|NCT04053270|5377983|P1|NOT COMPLETED|Overall Study||2
2191075|NCT04053270|5377982|P2|COMPLETED|Overall Study||46
2191076|NCT04053270|5377983|P1|COMPLETED|Overall Study||47
2191077|NCT04053270|5377982|P2|STARTED|Overall Study||51
2191078|NCT04053270|5377983|P1|STARTED|Overall Study||49
2191079|NCT04051684|5378001|P2|NOT COMPLETED|Overall Study||0
2191080|NCT04051684|5378002|P1|NOT COMPLETED|Overall Study||0
2191081|NCT04051684|5378001|P2|COMPLETED|Overall Study||11
2191082|NCT04051684|5378002|P1|COMPLETED|Overall Study||12
2191083|NCT04051684|5378001|P2|STARTED|Overall Study||11
2191084|NCT04051684|5378002|P1|STARTED|Overall Study||12
2191085|NCT04048681|5378014|P5|NOT COMPLETED|Overall Study||0
2191086|NCT04048681|5378015|P4|NOT COMPLETED|Overall Study||1
2191087|NCT04048681|5378016|P3|NOT COMPLETED|Overall Study||0
2191088|NCT04048681|5378017|P2|NOT COMPLETED|Overall Study||0
2191089|NCT04048681|5378018|P1|NOT COMPLETED|Overall Study||0
2191090|NCT04048681|5378014|P5|COMPLETED|Overall Study||1
2191091|NCT04048681|5378015|P4|COMPLETED|Overall Study||0
2191092|NCT04048681|5378016|P3|COMPLETED|Overall Study||1
2191093|NCT04048681|5378017|P2|COMPLETED|Overall Study||1
2191094|NCT04048681|5378018|P1|COMPLETED|Overall Study||1
2191095|NCT04048681|5378014|P5|STARTED|Overall Study||1
2191096|NCT04048681|5378015|P4|STARTED|Overall Study||1
2191097|NCT04048681|5378016|P3|STARTED|Overall Study||1
2191098|NCT04048681|5378017|P2|STARTED|Overall Study||1
2191099|NCT04048681|5378018|P1|STARTED|Overall Study||1
2191100|NCT04045964|5378031|P2|NOT COMPLETED|Overall Study||1
2191101|NCT04045964|5378032|P1|NOT COMPLETED|Overall Study||1
2191102|NCT04045964|5378031|P2|COMPLETED|Overall Study||15
2191103|NCT04045964|5378032|P1|COMPLETED|Overall Study||15
2191104|NCT04045964|5378031|P2|Follow up Visit 2|Overall Study||15
2191105|NCT04045964|5378032|P1|Follow up Visit 2|Overall Study||15
2191106|NCT04045964|5378031|P2|Follow up Visit 1|Overall Study||15
2191107|NCT04045964|5378032|P1|Follow up Visit 1|Overall Study||15
2191108|NCT04045964|5378031|P2|Intervention Visit(s)|Overall Study||16
2191109|NCT04045964|5378032|P1|Intervention Visit(s)|Overall Study||15
2191110|NCT04045964|5378031|P2|STARTED|Overall Study||16
2191111|NCT04045964|5378032|P1|STARTED|Overall Study||16
2191112|NCT04039867|5378061|P1|NOT COMPLETED|Overall Study||0
2191113|NCT04039867|5378061|P1|COMPLETED|Overall Study||17
2191114|NCT04039867|5378061|P1|STARTED|Overall Study||17
2191115|NCT04039412|5378070|P3|NOT COMPLETED|Overall Study||2
2191116|NCT04039412|5378071|P2|NOT COMPLETED|Overall Study||3
2191117|NCT04039412|5378072|P1|NOT COMPLETED|Overall Study||1
2191118|NCT04039412|5378070|P3|COMPLETED|Overall Study||108
2191119|NCT04039412|5378071|P2|COMPLETED|Overall Study||107
2191120|NCT04039412|5378072|P1|COMPLETED|Overall Study||109
2191121|NCT04039412|5378070|P3|STARTED|Overall Study||110
2191122|NCT04039412|5378071|P2|STARTED|Overall Study||110
2191123|NCT04039412|5378072|P1|STARTED|Overall Study||110
2191124|NCT04036838|5378086|P1|NOT COMPLETED|Overall Study||91
2191125|NCT04036838|5378086|P1|COMPLETED|Overall Study||324
2191126|NCT04036838|5378086|P1|STARTED|Overall Study||415
2191127|NCT04034043|5378090|P1|NOT COMPLETED|Overall Study||0
2191128|NCT04034043|5378090|P1|COMPLETED|Overall Study||68
2191129|NCT04034043|5378090|P1|STARTED|Overall Study||68
2191130|NCT04032652|5378099|P2|NOT COMPLETED|Overall Study||1
2191131|NCT04032652|5378100|P1|NOT COMPLETED|Overall Study||1
2191132|NCT04032652|5378099|P2|COMPLETED|Overall Study||0
2191133|NCT04032652|5378100|P1|COMPLETED|Overall Study||0
2191134|NCT04032652|5378099|P2|STARTED|Overall Study||1
2191135|NCT04032652|5378100|P1|STARTED|Overall Study||1
2191136|NCT04027218|5378114|P6|NOT COMPLETED|Overall Study||0
2191137|NCT04027218|5378115|P5|NOT COMPLETED|Overall Study||0
2191138|NCT04027218|5378116|P4|NOT COMPLETED|Overall Study||0
2191139|NCT04027218|5378117|P3|NOT COMPLETED|Overall Study||0
2191140|NCT04027218|5378118|P2|NOT COMPLETED|Overall Study||3
2191141|NCT04027218|5378119|P1|NOT COMPLETED|Overall Study||0
2191142|NCT04027218|5378114|P6|COMPLETED|Overall Study||11
2191143|NCT04027218|5378115|P5|COMPLETED|Overall Study||10
2191144|NCT04027218|5378116|P4|COMPLETED|Overall Study||11
2191145|NCT04027218|5378117|P3|COMPLETED|Overall Study||9
2191146|NCT04027218|5378118|P2|COMPLETED|Overall Study||8
2191147|NCT04027218|5378119|P1|COMPLETED|Overall Study||10
2191148|NCT04027218|5378114|P6|STARTED|Overall Study||11
2191149|NCT04027218|5378115|P5|STARTED|Overall Study||10
2191150|NCT04027218|5378116|P4|STARTED|Overall Study||11
2191151|NCT04027218|5378117|P3|STARTED|Overall Study||9
2191152|NCT04027218|5378118|P2|STARTED|Overall Study||11
2191153|NCT04027218|5378119|P1|STARTED|Overall Study||10
2191154|NCT04023695|5378151|P2|NOT COMPLETED|Overall Study||0
2191155|NCT04023695|5378152|P1|NOT COMPLETED|Overall Study||0
2191156|NCT04023695|5378151|P2|COMPLETED|Overall Study||53
2191157|NCT04023695|5378152|P1|COMPLETED|Overall Study||57
2191158|NCT04023695|5378151|P2|STARTED|Overall Study||53
2191159|NCT04023695|5378152|P1|STARTED|Overall Study||57
2191166|NCT04015232|5378170|P2|NOT COMPLETED|Overall Study||7
2191167|NCT04015232|5378171|P1|NOT COMPLETED|Overall Study||11
2191168|NCT04015232|5378170|P2|COMPLETED|Overall Study||93
2191169|NCT04015232|5378171|P1|COMPLETED|Overall Study||89
2191170|NCT04015232|5378170|P2|STARTED|Overall Study||100
2191171|NCT04015232|5378171|P1|STARTED|Overall Study||100
2191172|NCT04014062|5378243|P2|NOT COMPLETED|Period II: Crossover Dosing||0
2191173|NCT04014062|5378244|P1|NOT COMPLETED|Period II: Crossover Dosing||0
2191174|NCT04014062|5378243|P2|COMPLETED|Period II: Crossover Dosing||65
2191175|NCT04014062|5378244|P1|COMPLETED|Period II: Crossover Dosing||64
2191176|NCT04014062|5378243|P2|STARTED|Period II: Crossover Dosing||65
2191177|NCT04014062|5378244|P1|STARTED|Period II: Crossover Dosing||64
2191178|NCT04014062|5378243|P2|NOT COMPLETED|Period I: Dosing||6
2191179|NCT04014062|5378244|P1|NOT COMPLETED|Period I: Dosing||7
2191180|NCT04014062|5378243|P2|COMPLETED|Period I: Dosing|Period I: Dosing, includes a washout period of 42 days before starting Period II: Crossover Dosing|65
2191181|NCT04014062|5378244|P1|COMPLETED|Period I: Dosing|Period I: Dosing, includes a washout period of 42 days before starting Period II: Crossover Dosing|64
2191182|NCT04014062|5378243|P2|STARTED|Period I: Dosing||71
2191183|NCT04014062|5378244|P1|STARTED|Period I: Dosing||71
2191184|NCT04012970|5378284|P2|NOT COMPLETED|Control Session, 30 Minutes||0
2191185|NCT04012970|5378285|P1|NOT COMPLETED|Control Session, 30 Minutes||0
2191186|NCT04012970|5378284|P2|COMPLETED|Control Session, 30 Minutes||14
2191187|NCT04012970|5378285|P1|COMPLETED|Control Session, 30 Minutes||26
2191188|NCT04012970|5378284|P2|STARTED|Control Session, 30 Minutes||14
2191189|NCT04012970|5378285|P1|STARTED|Control Session, 30 Minutes||26
2191190|NCT04012970|5378284|P2|NOT COMPLETED|Intervention Session, 30 Minutes||0
2191191|NCT04012970|5378285|P1|NOT COMPLETED|Intervention Session, 30 Minutes||0
2191192|NCT04012970|5378284|P2|COMPLETED|Intervention Session, 30 Minutes||14
2191193|NCT04012970|5378285|P1|COMPLETED|Intervention Session, 30 Minutes||26
2191194|NCT04012970|5378284|P2|STARTED|Intervention Session, 30 Minutes||14
2191195|NCT04012970|5378285|P1|STARTED|Intervention Session, 30 Minutes||26
2191202|NCT03991715|5378308|P1|NOT COMPLETED|Overall Study||0
2191203|NCT03991715|5378308|P1|COMPLETED|Overall Study||5
2191204|NCT03991715|5378308|P1|STARTED|Overall Study||5
2191205|NCT03982433|5378317|P1|NOT COMPLETED|Overall Study||1
2191206|NCT03982433|5378317|P1|COMPLETED|Overall Study||7
2191207|NCT03982433|5378317|P1|STARTED|Overall Study||8
2191208|NCT03975790|5378331|P3|NOT COMPLETED|Overall Study||0
2191209|NCT03975790|5378332|P2|NOT COMPLETED|Overall Study||0
2191210|NCT03975790|5378333|P1|NOT COMPLETED|Overall Study||0
2191211|NCT03975790|5378331|P3|COMPLETED|Overall Study||48
2191212|NCT03975790|5378332|P2|COMPLETED|Overall Study||94
2191213|NCT03975790|5378333|P1|COMPLETED|Overall Study||337
2191214|NCT03975790|5378331|P3|STARTED|Overall Study||48
2191215|NCT03975790|5378332|P2|STARTED|Overall Study||94
2191216|NCT03975790|5378333|P1|STARTED|Overall Study||337
2191217|NCT03972813|5378564|P18|NOT COMPLETED|Overall Study||2
2191218|NCT03972813|5378565|P17|NOT COMPLETED|Overall Study||3
2191219|NCT03972813|5378566|P16|NOT COMPLETED|Overall Study||6
2191220|NCT03972813|5378567|P15|NOT COMPLETED|Overall Study||2
2191221|NCT03972813|5378568|P14|NOT COMPLETED|Overall Study||3
2191222|NCT03972813|5378569|P13|NOT COMPLETED|Overall Study||3
2191223|NCT03972813|5378570|P12|NOT COMPLETED|Overall Study||4
2191224|NCT03972813|5378571|P11|NOT COMPLETED|Overall Study||5
2191225|NCT03972813|5378572|P10|NOT COMPLETED|Overall Study||2
2191226|NCT03972813|5378573|P9|NOT COMPLETED|Overall Study||5
2191227|NCT03972813|5378574|P8|NOT COMPLETED|Overall Study||3
2191228|NCT03972813|5378575|P7|NOT COMPLETED|Overall Study||4
2191229|NCT03972813|5378576|P6|NOT COMPLETED|Overall Study||2
2191230|NCT03972813|5378577|P5|NOT COMPLETED|Overall Study||4
2191231|NCT03972813|5378578|P4|NOT COMPLETED|Overall Study||4
2191232|NCT03972813|5378579|P3|NOT COMPLETED|Overall Study||6
2191233|NCT03972813|5378580|P2|NOT COMPLETED|Overall Study||4
2191234|NCT03972813|5378581|P1|NOT COMPLETED|Overall Study||6
2191235|NCT03972813|5378564|P18|COMPLETED|Overall Study||48
2191236|NCT03972813|5378565|P17|COMPLETED|Overall Study||48
2191237|NCT03972813|5378566|P16|COMPLETED|Overall Study||50
2191238|NCT03972813|5378567|P15|COMPLETED|Overall Study||56
2191239|NCT03972813|5378568|P14|COMPLETED|Overall Study||52
2191240|NCT03972813|5378569|P13|COMPLETED|Overall Study||55
2191241|NCT03972813|5378570|P12|COMPLETED|Overall Study||51
2191242|NCT03972813|5378571|P11|COMPLETED|Overall Study||57
2191243|NCT03972813|5378572|P10|COMPLETED|Overall Study||58
2191244|NCT03972813|5378573|P9|COMPLETED|Overall Study||53
2191245|NCT03972813|5378574|P8|COMPLETED|Overall Study||52
2191246|NCT03972813|5378575|P7|COMPLETED|Overall Study||49
2191247|NCT03972813|5378576|P6|COMPLETED|Overall Study||49
2191248|NCT03972813|5378577|P5|COMPLETED|Overall Study||48
2191249|NCT03972813|5378578|P4|COMPLETED|Overall Study||51
2191250|NCT03972813|5378579|P3|COMPLETED|Overall Study||52
2191251|NCT03972813|5378580|P2|COMPLETED|Overall Study||45
2191252|NCT03972813|5378581|P1|COMPLETED|Overall Study||79
2191253|NCT03972813|5378564|P18|STARTED|Overall Study||50
2191254|NCT03972813|5378565|P17|STARTED|Overall Study||51
2191255|NCT03972813|5378566|P16|STARTED|Overall Study||56
2191256|NCT03972813|5378567|P15|STARTED|Overall Study||58
2191257|NCT03972813|5378568|P14|STARTED|Overall Study||55
2191258|NCT03972813|5378569|P13|STARTED|Overall Study||58
2191259|NCT03972813|5378570|P12|STARTED|Overall Study||55
2191260|NCT03972813|5378571|P11|STARTED|Overall Study||62
2191261|NCT03972813|5378572|P10|STARTED|Overall Study||60
2191262|NCT03972813|5378573|P9|STARTED|Overall Study||58
2191263|NCT03972813|5378574|P8|STARTED|Overall Study||55
2191264|NCT03972813|5378575|P7|STARTED|Overall Study||53
2191265|NCT03972813|5378576|P6|STARTED|Overall Study||51
2191266|NCT03972813|5378577|P5|STARTED|Overall Study||52
2191267|NCT03972813|5378578|P4|STARTED|Overall Study||55
2191268|NCT03972813|5378579|P3|STARTED|Overall Study||58
2191269|NCT03972813|5378580|P2|STARTED|Overall Study||49
2191270|NCT03972813|5378581|P1|STARTED|Overall Study||85
2191271|NCT03966365|5378621|P2|NOT COMPLETED|Overall Study||0
2191272|NCT03966365|5378622|P1|NOT COMPLETED|Overall Study||1
2191273|NCT03966365|5378621|P2|COMPLETED|Overall Study||12
2191274|NCT03966365|5378622|P1|COMPLETED|Overall Study||11
2191275|NCT03966365|5378621|P2|STARTED|Overall Study||12
2191276|NCT03966365|5378622|P1|STARTED|Overall Study||12
2191280|NCT03965052|5378653|P2|NOT COMPLETED|Overall Study||0
2191281|NCT03965052|5378654|P1|NOT COMPLETED|Overall Study||1
2191282|NCT03965052|5378653|P2|COMPLETED|Overall Study||12
2191283|NCT03965052|5378654|P1|COMPLETED|Overall Study||11
2191284|NCT03965052|5378653|P2|STARTED|Overall Study||12
2191285|NCT03965052|5378654|P1|STARTED|Overall Study||12
2191286|NCT03961308|5378674|P2|NOT COMPLETED|Overall Study||2
2191287|NCT03961308|5378675|P1|NOT COMPLETED|Overall Study||2
2191288|NCT03961308|5378674|P2|COMPLETED|Overall Study||100
2191289|NCT03961308|5378675|P1|COMPLETED|Overall Study||100
2191290|NCT03961308|5378674|P2|STARTED|Overall Study||102
2191291|NCT03961308|5378675|P1|STARTED|Overall Study||102
2191292|NCT03961295|5378687|P2|NOT COMPLETED|Overall Study||0
2191293|NCT03961295|5378688|P1|NOT COMPLETED|Overall Study||0
2191294|NCT03961295|5378687|P2|COMPLETED|Overall Study||12
2191295|NCT03961295|5378688|P1|COMPLETED|Overall Study||12
2191296|NCT03961295|5378687|P2|STARTED|Overall Study||12
2191297|NCT03961295|5378688|P1|STARTED|Overall Study||12
2191298|NCT03949621|5378700|P2|NOT COMPLETED|Overall Study||0
2191299|NCT03949621|5378701|P1|NOT COMPLETED|Overall Study||0
2191300|NCT03949621|5378700|P2|COMPLETED|Overall Study||12
2191301|NCT03949621|5378701|P1|COMPLETED|Overall Study||12
2191302|NCT03949621|5378700|P2|STARTED|Overall Study||12
2191303|NCT03949621|5378701|P1|STARTED|Overall Study||12
2191304|NCT03948581|5378713|P2|NOT COMPLETED|Overall Study||1
2191305|NCT03948581|5378714|P1|NOT COMPLETED|Overall Study||0
2191306|NCT03948581|5378713|P2|COMPLETED|Overall Study||50
2191307|NCT03948581|5378714|P1|COMPLETED|Overall Study||51
2191308|NCT03948581|5378713|P2|STARTED|Overall Study||51
2191309|NCT03948581|5378714|P1|STARTED|Overall Study||51
2191310|NCT03946124|5378724|P1|NOT COMPLETED|Overall Study||19
2191311|NCT03946124|5378724|P1|COMPLETED|Overall Study||55
2191312|NCT03946124|5378724|P1|STARTED|Overall Study||74
2191313|NCT03933618|5378734|P6|NOT COMPLETED|Week 16 to Week 24||0
2191314|NCT03933618|5378735|P5|NOT COMPLETED|Week 16 to Week 24||0
2191315|NCT03933618|5378736|P4|NOT COMPLETED|Week 16 to Week 24||0
2191316|NCT03933618|5378737|P3|NOT COMPLETED|Week 16 to Week 24||0
2191317|NCT03933618|5378738|P2|NOT COMPLETED|Week 16 to Week 24||0
2191318|NCT03933618|5378739|P1|NOT COMPLETED|Week 16 to Week 24||0
2191319|NCT03933618|5378734|P6|COMPLETED|Week 16 to Week 24||4
2191320|NCT03933618|5378735|P5|COMPLETED|Week 16 to Week 24||4
2191321|NCT03933618|5378736|P4|COMPLETED|Week 16 to Week 24||4
2191322|NCT03933618|5378737|P3|COMPLETED|Week 16 to Week 24||4
2191323|NCT03933618|5378738|P2|COMPLETED|Week 16 to Week 24||4
2191324|NCT03933618|5378739|P1|COMPLETED|Week 16 to Week 24||4
2191325|NCT03933618|5378734|P6|STARTED|Week 16 to Week 24||4
2191326|NCT03933618|5378735|P5|STARTED|Week 16 to Week 24||4
2191327|NCT03933618|5378736|P4|STARTED|Week 16 to Week 24||4
2191328|NCT03933618|5378737|P3|STARTED|Week 16 to Week 24||4
2191329|NCT03933618|5378738|P2|STARTED|Week 16 to Week 24||4
2191330|NCT03933618|5378739|P1|STARTED|Week 16 to Week 24||4
2191331|NCT03933618|5378734|P6|NOT COMPLETED|Week 8 to Week 16||0
2191332|NCT03933618|5378735|P5|NOT COMPLETED|Week 8 to Week 16||0
2191333|NCT03933618|5378736|P4|NOT COMPLETED|Week 8 to Week 16||0
2191334|NCT03933618|5378737|P3|NOT COMPLETED|Week 8 to Week 16||0
2191335|NCT03933618|5378738|P2|NOT COMPLETED|Week 8 to Week 16||0
2191336|NCT03933618|5378739|P1|NOT COMPLETED|Week 8 to Week 16||0
2191337|NCT03933618|5378734|P6|COMPLETED|Week 8 to Week 16||4
2191338|NCT03933618|5378735|P5|COMPLETED|Week 8 to Week 16||4
2191339|NCT03933618|5378736|P4|COMPLETED|Week 8 to Week 16||4
2191340|NCT03933618|5378737|P3|COMPLETED|Week 8 to Week 16||4
2191341|NCT03933618|5378738|P2|COMPLETED|Week 8 to Week 16||4
2191342|NCT03933618|5378739|P1|COMPLETED|Week 8 to Week 16||4
2191343|NCT03933618|5378734|P6|STARTED|Week 8 to Week 16||4
2191344|NCT03933618|5378735|P5|STARTED|Week 8 to Week 16||4
2191345|NCT03933618|5378736|P4|STARTED|Week 8 to Week 16||4
2191346|NCT03933618|5378737|P3|STARTED|Week 8 to Week 16||4
2191347|NCT03933618|5378738|P2|STARTED|Week 8 to Week 16||4
2191348|NCT03933618|5378739|P1|STARTED|Week 8 to Week 16||4
2191349|NCT03933618|5378734|P6|NOT COMPLETED|Baseline to Week 8||0
2191350|NCT03933618|5378735|P5|NOT COMPLETED|Baseline to Week 8||0
2191351|NCT03933618|5378736|P4|NOT COMPLETED|Baseline to Week 8||0
2191352|NCT03933618|5378737|P3|NOT COMPLETED|Baseline to Week 8||0
2191353|NCT03933618|5378738|P2|NOT COMPLETED|Baseline to Week 8||0
2191354|NCT03933618|5378739|P1|NOT COMPLETED|Baseline to Week 8||0
2191355|NCT03933618|5378734|P6|COMPLETED|Baseline to Week 8||4
2191356|NCT03933618|5378735|P5|COMPLETED|Baseline to Week 8||4
2191357|NCT03933618|5378736|P4|COMPLETED|Baseline to Week 8||4
2191358|NCT03933618|5378737|P3|COMPLETED|Baseline to Week 8||4
2191359|NCT03933618|5378738|P2|COMPLETED|Baseline to Week 8||4
2191360|NCT03933618|5378739|P1|COMPLETED|Baseline to Week 8||4
2191361|NCT03933618|5378734|P6|STARTED|Baseline to Week 8||4
2191362|NCT03933618|5378735|P5|STARTED|Baseline to Week 8||4
2191363|NCT03933618|5378736|P4|STARTED|Baseline to Week 8||4
2191364|NCT03933618|5378737|P3|STARTED|Baseline to Week 8||4
2191365|NCT03933618|5378738|P2|STARTED|Baseline to Week 8||4
2191366|NCT03933618|5378739|P1|STARTED|Baseline to Week 8||4
2191367|NCT03933618|5378734|P6|NOT COMPLETED|Baseline||0
2191368|NCT03933618|5378735|P5|NOT COMPLETED|Baseline||0
2191369|NCT03933618|5378736|P4|NOT COMPLETED|Baseline||0
2191370|NCT03933618|5378737|P3|NOT COMPLETED|Baseline||0
2191371|NCT03933618|5378738|P2|NOT COMPLETED|Baseline||0
2191372|NCT03933618|5378739|P1|NOT COMPLETED|Baseline||0
2191373|NCT03933618|5378734|P6|COMPLETED|Baseline||4
2191374|NCT03933618|5378735|P5|COMPLETED|Baseline||4
2191375|NCT03933618|5378736|P4|COMPLETED|Baseline||4
2191376|NCT03933618|5378737|P3|COMPLETED|Baseline||4
2191377|NCT03933618|5378738|P2|COMPLETED|Baseline||4
2191378|NCT03933618|5378739|P1|COMPLETED|Baseline||4
2191379|NCT03933618|5378734|P6|STARTED|Baseline||4
2191380|NCT03933618|5378735|P5|STARTED|Baseline||4
2191381|NCT03933618|5378736|P4|STARTED|Baseline||4
2191382|NCT03933618|5378737|P3|STARTED|Baseline||4
2191383|NCT03933618|5378738|P2|STARTED|Baseline||4
2191384|NCT03933618|5378739|P1|STARTED|Baseline||4
2191385|NCT03927950|5378987|P1|NOT COMPLETED|Overall Study||9
2191386|NCT03927950|5378987|P1|COMPLETED|Overall Study||126
2191387|NCT03927950|5378987|P1|STARTED|Overall Study||135
2191388|NCT03911752|5378995|P3|NOT COMPLETED|Overall Study||0
2191389|NCT03911752|5378996|P2|NOT COMPLETED|Overall Study||0
2191390|NCT03911752|5378997|P1|NOT COMPLETED|Overall Study||0
2191391|NCT03911752|5378995|P3|COMPLETED|Overall Study||2
2191392|NCT03911752|5378996|P2|COMPLETED|Overall Study||2
2191393|NCT03911752|5378997|P1|COMPLETED|Overall Study||8
2191394|NCT03911752|5378995|P3|STARTED|Overall Study||2
2191395|NCT03911752|5378996|P2|STARTED|Overall Study||2
2191396|NCT03911752|5378997|P1|STARTED|Overall Study||8
2191397|NCT03905642|5379014|P1|NOT COMPLETED|Overall Study||8
2191398|NCT03905642|5379014|P1|COMPLETED|Overall Study||41
2191399|NCT03905642|5379014|P1|STARTED|Overall Study||49
2191400|NCT03902392|5379025|P2|NOT COMPLETED|Overall Study||7
2191401|NCT03902392|5379026|P1|NOT COMPLETED|Overall Study||7
2191402|NCT03902392|5379025|P2|COMPLETED|Overall Study||18
2191403|NCT03902392|5379026|P1|COMPLETED|Overall Study||18
2191404|NCT03902392|5379025|P2|STARTED|Overall Study||25
2191405|NCT03902392|5379026|P1|STARTED|Overall Study||25
2191406|NCT03900299|5379036|P2|NOT COMPLETED|Overall Study||0
2191407|NCT03900299|5379037|P1|NOT COMPLETED|Overall Study||0
2191408|NCT03900299|5379036|P2|COMPLETED|Overall Study||59
2191409|NCT03900299|5379037|P1|COMPLETED|Overall Study||66
2191410|NCT03900299|5379036|P2|STARTED|Overall Study||59
2191411|NCT03900299|5379037|P1|STARTED|Overall Study||66
2191412|NCT03898349|5379046|P2|NOT COMPLETED|Overall Study||610
2191413|NCT03898349|5379047|P1|NOT COMPLETED|Overall Study||110
2191414|NCT03898349|5379046|P2|COMPLETED|Overall Study||15
2191415|NCT03898349|5379047|P1|COMPLETED|Overall Study||15
2191416|NCT03898349|5379046|P2|STARTED|Overall Study||625
2191417|NCT03898349|5379047|P1|STARTED|Overall Study||125
2191418|NCT03894449|5379058|P5|NOT COMPLETED|Overall Study||0
2191419|NCT03894449|5379059|P4|NOT COMPLETED|Overall Study||0
2191420|NCT03894449|5379060|P3|NOT COMPLETED|Overall Study||0
2191421|NCT03894449|5379061|P2|NOT COMPLETED|Overall Study||0
2191422|NCT03894449|5379062|P1|NOT COMPLETED|Overall Study||0
2191423|NCT03894449|5379058|P5|COMPLETED|Overall Study||15
2191424|NCT03894449|5379059|P4|COMPLETED|Overall Study||15
2191425|NCT03894449|5379060|P3|COMPLETED|Overall Study||15
2191426|NCT03894449|5379061|P2|COMPLETED|Overall Study||15
2191427|NCT03894449|5379062|P1|COMPLETED|Overall Study||15
2191428|NCT03894449|5379058|P5|STARTED|Overall Study||15
2191429|NCT03894449|5379059|P4|STARTED|Overall Study||15
2191430|NCT03894449|5379060|P3|STARTED|Overall Study||15
2191431|NCT03894449|5379061|P2|STARTED|Overall Study||15
2191432|NCT03894449|5379062|P1|STARTED|Overall Study||15
2191433|NCT03892564|5379174|P1|NOT COMPLETED|Overall Study||2
2191434|NCT03892564|5379174|P1|COMPLETED|Overall Study||33
2191435|NCT03892564|5379174|P1|Control Site|Overall Study||35
2191436|NCT03892564|5379174|P1|MC2-01 Vehicle + Non-irridiation|Overall Study||35
2191437|NCT03892564|5379174|P1|MC2-01 Vehicle + Irridiation|Overall Study||35
2191438|NCT03892564|5379174|P1|MC2-01 Cream + Non-irridiation|Overall Study||35
2191439|NCT03892564|5379174|P1|MC2-01 Cream + Irridiation|Overall Study||35
2191440|NCT03892564|5379174|P1|STARTED|Overall Study||35
2191441|NCT03888755|5379180|P1|NOT COMPLETED|Overall Study||0
2191442|NCT03888755|5379180|P1|COMPLETED|Overall Study||8
2191443|NCT03888755|5379180|P1|STARTED|Overall Study||8
2191444|NCT03888391|5379201|P1|NOT COMPLETED|Overall Study||15
2191445|NCT03888391|5379201|P1|COMPLETED|Overall Study||3
2191446|NCT03888391|5379201|P1|STARTED|Overall Study||18
2191447|NCT03882047|5379214|P3|NOT COMPLETED|Overall Study||16
2191448|NCT03882047|5379215|P2|NOT COMPLETED|Overall Study||10
2191449|NCT03882047|5379216|P1|NOT COMPLETED|Overall Study||6
2191450|NCT03882047|5379214|P3|COMPLETED|Overall Study||88
2191451|NCT03882047|5379215|P2|COMPLETED|Overall Study||95
2191452|NCT03882047|5379216|P1|COMPLETED|Overall Study||98
2191453|NCT03882047|5379214|P3|Treated|Overall Study||103
2191454|NCT03882047|5379215|P2|Treated|Overall Study||104
2191455|NCT03882047|5379216|P1|Treated|Overall Study||104
2191456|NCT03882047|5379214|P3|STARTED|Overall Study||104
2191457|NCT03882047|5379215|P2|STARTED|Overall Study||105
2191458|NCT03882047|5379216|P1|STARTED|Overall Study||104
2191469|NCT03879772|5379272|P5|NOT COMPLETED|Overall Study||8
2191470|NCT03879772|5379273|P4|NOT COMPLETED|Overall Study||8
2191471|NCT03879772|5379274|P3|NOT COMPLETED|Overall Study||10
2191472|NCT03879772|5379275|P2|NOT COMPLETED|Overall Study||3
2191473|NCT03879772|5379276|P1|NOT COMPLETED|Overall Study||4
2191474|NCT03879772|5379272|P5|COMPLETED|Overall Study||128
2191475|NCT03879772|5379273|P4|COMPLETED|Overall Study||130
2191476|NCT03879772|5379274|P3|COMPLETED|Overall Study||123
2191477|NCT03879772|5379275|P2|COMPLETED|Overall Study||132
2191478|NCT03879772|5379276|P1|COMPLETED|Overall Study||133
2191479|NCT03879772|5379272|P5|STARTED|Overall Study||136
2191480|NCT03879772|5379273|P4|STARTED|Overall Study||138
2191481|NCT03879772|5379274|P3|STARTED|Overall Study||133
2191482|NCT03879772|5379275|P2|STARTED|Overall Study||135
2191483|NCT03879772|5379276|P1|STARTED|Overall Study||137
2191484|NCT03870737|5379313|P1|NOT COMPLETED|Overall Study||2
2191485|NCT03870737|5379313|P1|COMPLETED|Overall Study||20
2191486|NCT03870737|5379313|P1|STARTED|Overall Study||22
2191487|NCT03861559|5379325|P2|NOT COMPLETED|Overall Study||5
2191488|NCT03861559|5379326|P1|NOT COMPLETED|Overall Study||2
2191489|NCT03861559|5379325|P2|COMPLETED|Overall Study||95
2191490|NCT03861559|5379326|P1|COMPLETED|Overall Study||99
2191491|NCT03861559|5379325|P2|STARTED|Overall Study||100
2191492|NCT03861559|5379326|P1|STARTED|Overall Study||101
2191493|NCT03859622|5379372|P1|NOT COMPLETED|Overall Study||0
2191494|NCT03859622|5379372|P1|COMPLETED|Overall Study||289
2191495|NCT03859622|5379372|P1|STARTED|Overall Study||289
2191496|NCT03857243|5379382|P2|NOT COMPLETED|Overall Study||0
2191497|NCT03857243|5379383|P1|NOT COMPLETED|Overall Study||0
2191498|NCT03857243|5379382|P2|COMPLETED|Overall Study||1
2191499|NCT03857243|5379383|P1|COMPLETED|Overall Study||1
2191500|NCT03857243|5379382|P2|STARTED|Overall Study||1
2191501|NCT03857243|5379383|P1|STARTED|Overall Study||1
2191502|NCT03857230|5379395|P2|NOT COMPLETED|Period 2 (Gonal-F-Primapur)||0
2191503|NCT03857230|5379396|P1|NOT COMPLETED|Period 2 (Gonal-F-Primapur)||0
2191504|NCT03857230|5379395|P2|COMPLETED|Period 2 (Gonal-F-Primapur)||12
2191505|NCT03857230|5379396|P1|COMPLETED|Period 2 (Gonal-F-Primapur)||12
2191506|NCT03857230|5379395|P2|STARTED|Period 2 (Gonal-F-Primapur)||12
2191507|NCT03857230|5379396|P1|STARTED|Period 2 (Gonal-F-Primapur)||12
2191508|NCT03857230|5379395|P2|NOT COMPLETED|Period 1 (Primapur-Gonal-F)||0
2191509|NCT03857230|5379396|P1|NOT COMPLETED|Period 1 (Primapur-Gonal-F)||0
2191510|NCT03857230|5379395|P2|COMPLETED|Period 1 (Primapur-Gonal-F)||12
2191511|NCT03857230|5379396|P1|COMPLETED|Period 1 (Primapur-Gonal-F)||12
2191512|NCT03857230|5379395|P2|STARTED|Period 1 (Primapur-Gonal-F)||12
2191513|NCT03857230|5379396|P1|STARTED|Period 1 (Primapur-Gonal-F)||12
2191514|NCT03855228|5379414|P4|NOT COMPLETED|Overall Study||19
2191515|NCT03855228|5379415|P3|NOT COMPLETED|Overall Study||8
2191516|NCT03855228|5379416|P2|NOT COMPLETED|Overall Study||9
2191517|NCT03855228|5379417|P1|NOT COMPLETED|Overall Study||3
2191518|NCT03855228|5379414|P4|COMPLETED|Overall Study||158
2191519|NCT03855228|5379415|P3|COMPLETED|Overall Study||174
2191520|NCT03855228|5379416|P2|COMPLETED|Overall Study||167
2191521|NCT03855228|5379417|P1|COMPLETED|Overall Study||166
2191522|NCT03855228|5379414|P4|Treated|Overall Study|1 participant immediately dropped out prior to starting study intervention.|176
2191523|NCT03855228|5379415|P3|Treated|Overall Study|1 participant immediately dropped out prior to starting study intervention.|181
2191524|NCT03855228|5379416|P2|Treated|Overall Study||176
2191525|NCT03855228|5379417|P1|Treated|Overall Study||169
2191526|NCT03855228|5379414|P4|STARTED|Overall Study||177
2191527|NCT03855228|5379415|P3|STARTED|Overall Study||182
2191528|NCT03855228|5379416|P2|STARTED|Overall Study||176
2191529|NCT03855228|5379417|P1|STARTED|Overall Study||169
2191530|NCT03855189|5379466|P3|NOT COMPLETED|Overall Study||6
2191531|NCT03855189|5379467|P2|NOT COMPLETED|Overall Study||7
2191532|NCT03855189|5379468|P1|NOT COMPLETED|Overall Study||10
2191533|NCT03855189|5379466|P3|COMPLETED|Overall Study||110
2191534|NCT03855189|5379467|P2|COMPLETED|Overall Study||109
2191535|NCT03855189|5379468|P1|COMPLETED|Overall Study||103
2191536|NCT03855189|5379466|P3|Treated|Overall Study||116
2191537|NCT03855189|5379467|P2|Treated|Overall Study||116
2191538|NCT03855189|5379468|P1|Treated|Overall Study|Does not include 1 participant who received first dose but was excluded from safety analysis.|112
2191539|NCT03855189|5379466|P3|STARTED|Overall Study||116
2191540|NCT03855189|5379467|P2|STARTED|Overall Study||116
2191541|NCT03855189|5379468|P1|STARTED|Overall Study||113
2191542|NCT03854253|5379559|P2|NOT COMPLETED|Overall Study||0
2191543|NCT03854253|5379560|P1|NOT COMPLETED|Overall Study||1
2191544|NCT03854253|5379559|P2|COMPLETED|Overall Study||50
2191545|NCT03854253|5379560|P1|COMPLETED|Overall Study||49
2191546|NCT03854253|5379559|P2|STARTED|Overall Study||50
2191547|NCT03854253|5379560|P1|STARTED|Overall Study||50
2191548|NCT03850496|5379587|P3|NOT COMPLETED|Overall Study||4
2191549|NCT03850496|5379588|P2|NOT COMPLETED|Overall Study||1
2191550|NCT03850496|5379589|P1|NOT COMPLETED|Overall Study||1
2191551|NCT03850496|5379587|P3|COMPLETED|Overall Study||21
2191552|NCT03850496|5379588|P2|COMPLETED|Overall Study||24
2191553|NCT03850496|5379589|P1|COMPLETED|Overall Study||25
2191554|NCT03850496|5379587|P3|STARTED|Overall Study||25
2191555|NCT03850496|5379588|P2|STARTED|Overall Study||25
2191556|NCT03850496|5379589|P1|STARTED|Overall Study||26
2191557|NCT03850444|5379599|P2|NOT COMPLETED|Overall Study||134
2191558|NCT03850444|5379600|P1|NOT COMPLETED|Overall Study||128
2191559|NCT03850444|5379599|P2|COMPLETED|Overall Study||0
2191560|NCT03850444|5379600|P1|COMPLETED|Overall Study||0
2191561|NCT03850444|5379599|P2|STARTED|Overall Study||134
2191562|NCT03850444|5379600|P1|STARTED|Overall Study||128
2191563|NCT03850093|5379629|P3|NOT COMPLETED|Overall Study||2
2191564|NCT03850093|5379630|P2|NOT COMPLETED|Overall Study||0
2191565|NCT03850093|5379631|P1|NOT COMPLETED|Overall Study||1
2191566|NCT03850093|5379629|P3|COMPLETED|Overall Study||17
2191567|NCT03850093|5379630|P2|COMPLETED|Overall Study||22
2191568|NCT03850093|5379631|P1|COMPLETED|Overall Study||21
2191569|NCT03850093|5379629|P3|STARTED|Overall Study||19
2191570|NCT03850093|5379630|P2|STARTED|Overall Study||22
2191571|NCT03850093|5379631|P1|STARTED|Overall Study||22
2191572|NCT03848910|5379666|P1|NOT COMPLETED|Overall Study||0
2191573|NCT03848910|5379666|P1|COMPLETED|Overall Study||11
2191574|NCT03848910|5379666|P1|STARTED|Overall Study||11
2191575|NCT03848455|5379686|P3|NOT COMPLETED|Overall Study||0
2191576|NCT03848455|5379687|P2|NOT COMPLETED|Overall Study||0
2191577|NCT03848455|5379688|P1|NOT COMPLETED|Overall Study||0
2191578|NCT03848455|5379686|P3|COMPLETED|Overall Study||23
2191579|NCT03848455|5379687|P2|COMPLETED|Overall Study||125
2191580|NCT03848455|5379688|P1|COMPLETED|Overall Study||90
2191581|NCT03848455|5379686|P3|STARTED|Overall Study||23
2191582|NCT03848455|5379687|P2|STARTED|Overall Study||125
2191583|NCT03848455|5379688|P1|STARTED|Overall Study||90
2191584|NCT03845933|5379704|P2|NOT COMPLETED|Overall Study||0
2191585|NCT03845933|5379705|P1|NOT COMPLETED|Overall Study||0
2191586|NCT03845933|5379704|P2|COMPLETED|Overall Study||131
2191587|NCT03845933|5379705|P1|COMPLETED|Overall Study||131
2191588|NCT03845933|5379704|P2|STARTED|Overall Study||131
2191589|NCT03845933|5379705|P1|STARTED|Overall Study||131
2191590|NCT03842683|5379711|P1|NOT COMPLETED|Overall Study||0
2191591|NCT03842683|5379711|P1|COMPLETED|Overall Study||472
2191592|NCT03842683|5379711|P1|STARTED|Overall Study||472
2191593|NCT03840278|5379716|P2|NOT COMPLETED|Overall Study||0
2191594|NCT03840278|5379717|P1|NOT COMPLETED|Overall Study||0
2191595|NCT03840278|5379716|P2|COMPLETED|Overall Study||5
2191596|NCT03840278|5379717|P1|COMPLETED|Overall Study||5
2191597|NCT03840278|5379716|P2|STARTED|Overall Study||5
2191598|NCT03840278|5379717|P1|STARTED|Overall Study||5
2191599|NCT03836664|5379737|P2|NOT COMPLETED|Overall Study||3
2191600|NCT03836664|5379738|P1|NOT COMPLETED|Overall Study||3
2191601|NCT03836664|5379737|P2|COMPLETED|Overall Study||8
2191602|NCT03836664|5379738|P1|COMPLETED|Overall Study||11
2191603|NCT03836664|5379737|P2|STARTED|Overall Study||11
2191604|NCT03836664|5379738|P1|STARTED|Overall Study||14
2191605|NCT03832387|5379750|P2|NOT COMPLETED|Overall Study||7
2191606|NCT03832387|5379751|P1|NOT COMPLETED|Overall Study||5
2191607|NCT03832387|5379750|P2|COMPLETED|Overall Study||32
2191608|NCT03832387|5379751|P1|COMPLETED|Overall Study||33
2191609|NCT03832387|5379750|P2|STARTED|Overall Study||39
2191610|NCT03832387|5379751|P1|STARTED|Overall Study||38
2191611|NCT03832322|5379781|P2|NOT COMPLETED|Overall Study||1
2191612|NCT03832322|5379782|P1|NOT COMPLETED|Overall Study||3
2191613|NCT03832322|5379781|P2|COMPLETED|Overall Study||86
2191614|NCT03832322|5379782|P1|COMPLETED|Overall Study||86
2191615|NCT03832322|5379781|P2|STARTED|Overall Study||87
2191616|NCT03832322|5379782|P1|STARTED|Overall Study||89
2191617|NCT03831451|5379792|P2|NOT COMPLETED|Overall Study||0
2191618|NCT03831451|5379793|P1|NOT COMPLETED|Overall Study||0
2191619|NCT03831451|5379792|P2|COMPLETED|Overall Study||55
2191620|NCT03831451|5379793|P1|COMPLETED|Overall Study||74
2191621|NCT03831451|5379792|P2|STARTED|Overall Study||55
2191622|NCT03831451|5379793|P1|STARTED|Overall Study||74
2191626|NCT03828149|5379805|P2|NOT COMPLETED|Second Intervention (Single Dose)||0
2191627|NCT03828149|5379806|P1|NOT COMPLETED|Second Intervention (Single Dose)||0
2191628|NCT03828149|5379805|P2|COMPLETED|Second Intervention (Single Dose)||8
2191629|NCT03828149|5379806|P1|COMPLETED|Second Intervention (Single Dose)||9
2191630|NCT03828149|5379805|P2|STARTED|Second Intervention (Single Dose)||8
2191631|NCT03828149|5379806|P1|STARTED|Second Intervention (Single Dose)||9
2191632|NCT03828149|5379805|P2|NOT COMPLETED|Washout (6 Days)||0
2191633|NCT03828149|5379806|P1|NOT COMPLETED|Washout (6 Days)||0
2191634|NCT03828149|5379805|P2|COMPLETED|Washout (6 Days)||8
2191635|NCT03828149|5379806|P1|COMPLETED|Washout (6 Days)||9
2191636|NCT03828149|5379805|P2|STARTED|Washout (6 Days)||8
2191637|NCT03828149|5379806|P1|STARTED|Washout (6 Days)||9
2191638|NCT03828149|5379805|P2|NOT COMPLETED|First Intervention (Single Dose)||0
2191639|NCT03828149|5379806|P1|NOT COMPLETED|First Intervention (Single Dose)||0
2191640|NCT03828149|5379805|P2|COMPLETED|First Intervention (Single Dose)||8
2191641|NCT03828149|5379806|P1|COMPLETED|First Intervention (Single Dose)||9
2191642|NCT03828149|5379805|P2|STARTED|First Intervention (Single Dose)||8
2191643|NCT03828149|5379806|P1|STARTED|First Intervention (Single Dose)||9
2191644|NCT03824912|5379815|P3|NOT COMPLETED|Overall Study||68
2191645|NCT03824912|5379816|P2|NOT COMPLETED|Overall Study||134
2191646|NCT03824912|5379817|P1|NOT COMPLETED|Overall Study||140
2191647|NCT03824912|5379815|P3|COMPLETED|Overall Study||96
2191648|NCT03824912|5379816|P2|COMPLETED|Overall Study||201
2191649|NCT03824912|5379817|P1|COMPLETED|Overall Study||192
2191650|NCT03824912|5379815|P3|STARTED|Overall Study||164
2191651|NCT03824912|5379816|P2|STARTED|Overall Study||335
2191652|NCT03824912|5379817|P1|STARTED|Overall Study||332
2191653|NCT03822884|5379843|P6|NOT COMPLETED|Overall Study||0
2191654|NCT03822884|5379844|P5|NOT COMPLETED|Overall Study||1
2191655|NCT03822884|5379845|P4|NOT COMPLETED|Overall Study||0
2191656|NCT03822884|5379846|P3|NOT COMPLETED|Overall Study||0
2191657|NCT03822884|5379847|P2|NOT COMPLETED|Overall Study||0
2191658|NCT03822884|5379848|P1|NOT COMPLETED|Overall Study||0
2191659|NCT03822884|5379843|P6|COMPLETED|Overall Study||4
2191660|NCT03822884|5379844|P5|COMPLETED|Overall Study||3
2191661|NCT03822884|5379845|P4|COMPLETED|Overall Study||4
2191662|NCT03822884|5379846|P3|COMPLETED|Overall Study||4
2191663|NCT03822884|5379847|P2|COMPLETED|Overall Study||4
2191664|NCT03822884|5379848|P1|COMPLETED|Overall Study||4
2191665|NCT03822884|5379843|P6|STARTED|Overall Study||4
2191666|NCT03822884|5379844|P5|STARTED|Overall Study||4
2191667|NCT03822884|5379845|P4|STARTED|Overall Study||4
2191668|NCT03822884|5379846|P3|STARTED|Overall Study||4
2191669|NCT03822884|5379847|P2|STARTED|Overall Study||4
2191670|NCT03822884|5379848|P1|STARTED|Overall Study||4
2191671|NCT03822078|5379883|P6|NOT COMPLETED|Overall Study||0
2191672|NCT03822078|5379884|P5|NOT COMPLETED|Overall Study||1
2191673|NCT03822078|5379885|P4|NOT COMPLETED|Overall Study||2
2191674|NCT03822078|5379886|P3|NOT COMPLETED|Overall Study||0
2191675|NCT03822078|5379887|P2|NOT COMPLETED|Overall Study||0
2191676|NCT03822078|5379888|P1|NOT COMPLETED|Overall Study||2
2191677|NCT03822078|5379883|P6|COMPLETED|Overall Study||6
2191678|NCT03822078|5379884|P5|COMPLETED|Overall Study||6
2191679|NCT03822078|5379885|P4|COMPLETED|Overall Study||6
2191680|NCT03822078|5379886|P3|COMPLETED|Overall Study||6
2191681|NCT03822078|5379887|P2|COMPLETED|Overall Study||6
2191682|NCT03822078|5379888|P1|COMPLETED|Overall Study||10
2191683|NCT03822078|5379883|P6|Received Study Drug|Overall Study||6
2191684|NCT03822078|5379884|P5|Received Study Drug|Overall Study||6
2191685|NCT03822078|5379885|P4|Received Study Drug|Overall Study||6
2191686|NCT03822078|5379886|P3|Received Study Drug|Overall Study||6
2191687|NCT03822078|5379887|P2|Received Study Drug|Overall Study||6
2191688|NCT03822078|5379888|P1|Received Study Drug|Overall Study||10
2191689|NCT03822078|5379883|P6|STARTED|Overall Study||6
2191690|NCT03822078|5379884|P5|STARTED|Overall Study||7
2191691|NCT03822078|5379885|P4|STARTED|Overall Study||8
2191692|NCT03822078|5379886|P3|STARTED|Overall Study||6
2191693|NCT03822078|5379887|P2|STARTED|Overall Study||6
2191694|NCT03822078|5379888|P1|STARTED|Overall Study||12
2191695|NCT03820544|5379948|P2|NOT COMPLETED|Overall Study||0
2191696|NCT03820544|5379949|P1|NOT COMPLETED|Overall Study||0
2191697|NCT03820544|5379948|P2|COMPLETED|Overall Study||2
2191698|NCT03820544|5379949|P1|COMPLETED|Overall Study||2
2191699|NCT03820544|5379948|P2|STARTED|Overall Study||2
2191700|NCT03820544|5379949|P1|STARTED|Overall Study||2
2191701|NCT03819491|5379959|P2|NOT COMPLETED|After Randomization||0
2191702|NCT03819491|5379960|P1|NOT COMPLETED|After Randomization||0
2191703|NCT03819491|5379959|P2|COMPLETED|After Randomization||12
2191704|NCT03819491|5379960|P1|COMPLETED|After Randomization||12
2191705|NCT03819491|5379959|P2|STARTED|After Randomization||12
2191706|NCT03819491|5379960|P1|STARTED|After Randomization||12
2191707|NCT03819491|5379959|P2|NOT COMPLETED|Before Randomization||0
2191708|NCT03819491|5379960|P1|NOT COMPLETED|Before Randomization||0
2191709|NCT03819491|5379959|P2|COMPLETED|Before Randomization||0
2191710|NCT03819491|5379960|P1|COMPLETED|Before Randomization||24
2191711|NCT03819491|5379959|P2|STARTED|Before Randomization||0
2191712|NCT03819491|5379960|P1|STARTED|Before Randomization||24
2191713|NCT03817879|5379973|P2|NOT COMPLETED|Overall Study||13
2191714|NCT03817879|5379974|P1|NOT COMPLETED|Overall Study||5
2191715|NCT03817879|5379973|P2|COMPLETED|Overall Study||22
2191716|NCT03817879|5379974|P1|COMPLETED|Overall Study||30
2191717|NCT03817879|5379973|P2|STARTED|Overall Study||35
2191718|NCT03817879|5379974|P1|STARTED|Overall Study||35
2191719|NCT03817775|5379982|P2|NOT COMPLETED|Overall Study||0
2191720|NCT03817775|5379983|P1|NOT COMPLETED|Overall Study||0
2191721|NCT03817775|5379982|P2|COMPLETED|Overall Study||54
2191722|NCT03817775|5379983|P1|COMPLETED|Overall Study||22
2191723|NCT03817775|5379982|P2|STARTED|Overall Study||54
2191724|NCT03817775|5379983|P1|STARTED|Overall Study||22
2191725|NCT03811093|5380009|P2|NOT COMPLETED|Overall Study||4
2191726|NCT03811093|5380010|P1|NOT COMPLETED|Overall Study||2
2191727|NCT03811093|5380009|P2|COMPLETED|Overall Study||15
2191728|NCT03811093|5380010|P1|COMPLETED|Overall Study||18
2191729|NCT03811093|5380009|P2|STARTED|Overall Study||19
2191730|NCT03811093|5380010|P1|STARTED|Overall Study||20
2191731|NCT03809104|5380020|P1|NOT COMPLETED|Overall Study||3
2191732|NCT03809104|5380020|P1|COMPLETED|Overall Study||40
2191733|NCT03809104|5380020|P1|STARTED|Overall Study||43
2191734|NCT03807089|5380031|P2|NOT COMPLETED|Overall Study||0
2191735|NCT03807089|5380032|P1|NOT COMPLETED|Overall Study||0
2191736|NCT03807089|5380031|P2|COMPLETED|Overall Study||93
2191737|NCT03807089|5380032|P1|COMPLETED|Overall Study||101
2191738|NCT03807089|5380031|P2|STARTED|Overall Study||93
2191739|NCT03807089|5380032|P1|STARTED|Overall Study||101
2191740|NCT03806270|5380049|P3|NOT COMPLETED|Overall Study||0
2191741|NCT03806270|5380050|P2|NOT COMPLETED|Overall Study||0
2191742|NCT03806270|5380051|P1|NOT COMPLETED|Overall Study||0
2191743|NCT03806270|5380049|P3|COMPLETED|Overall Study||15
2191744|NCT03806270|5380050|P2|COMPLETED|Overall Study||15
2191745|NCT03806270|5380051|P1|COMPLETED|Overall Study||15
2191746|NCT03806270|5380049|P3|STARTED|Overall Study||15
2191747|NCT03806270|5380050|P2|STARTED|Overall Study||15
2191748|NCT03806270|5380051|P1|STARTED|Overall Study||15
2191749|NCT03805672|5380079|P2|NOT COMPLETED|Overall Study||0
2191750|NCT03805672|5380080|P1|NOT COMPLETED|Overall Study||0
2191751|NCT03805672|5380079|P2|COMPLETED|Overall Study||2
2191752|NCT03805672|5380080|P1|COMPLETED|Overall Study||2
2191753|NCT03805672|5380079|P2|STARTED|Overall Study||2
2191754|NCT03805672|5380080|P1|STARTED|Overall Study||2
2191755|NCT03796182|5380086|P2|NOT COMPLETED|Period 2||0
2191756|NCT03796182|5380087|P1|NOT COMPLETED|Period 2||0
2191757|NCT03796182|5380086|P2|COMPLETED|Period 2||6
2191758|NCT03796182|5380087|P1|COMPLETED|Period 2||6
2191759|NCT03796182|5380086|P2|STARTED|Period 2||6
2191760|NCT03796182|5380087|P1|STARTED|Period 2||6
2191761|NCT03796182|5380086|P2|NOT COMPLETED|Washout Period||0
2191762|NCT03796182|5380087|P1|NOT COMPLETED|Washout Period||0
2191763|NCT03796182|5380086|P2|COMPLETED|Washout Period||6
2191764|NCT03796182|5380087|P1|COMPLETED|Washout Period||6
2191765|NCT03796182|5380086|P2|STARTED|Washout Period||6
2191766|NCT03796182|5380087|P1|STARTED|Washout Period||6
2191767|NCT03796182|5380086|P2|NOT COMPLETED|Period 1||0
2191768|NCT03796182|5380087|P1|NOT COMPLETED|Period 1||0
2191769|NCT03796182|5380086|P2|COMPLETED|Period 1||6
2191770|NCT03796182|5380087|P1|COMPLETED|Period 1||6
2191771|NCT03796182|5380086|P2|STARTED|Period 1||6
2191772|NCT03796182|5380087|P1|STARTED|Period 1||6
2191773|NCT03787212|5380119|P2|NOT COMPLETED|Period 1||2
2191774|NCT03787212|5380120|P1|NOT COMPLETED|Period 1||2
2191775|NCT03787212|5380119|P2|COMPLETED|Period 1||0
2191776|NCT03787212|5380120|P1|COMPLETED|Period 1||0
2191777|NCT03787212|5380119|P2|STARTED|Period 1||2
2191778|NCT03787212|5380120|P1|STARTED|Period 1||2
2191779|NCT03787212|5380119|P2|NOT COMPLETED|Period 1||0
2191780|NCT03787212|5380120|P1|NOT COMPLETED|Period 1||0
2191781|NCT03787212|5380119|P2|COMPLETED|Period 1||2
2191782|NCT03787212|5380120|P1|COMPLETED|Period 1||2
2191783|NCT03787212|5380119|P2|STARTED|Period 1||2
2191784|NCT03787212|5380120|P1|STARTED|Period 1||2
2191785|NCT03783780|5380126|P1|NOT COMPLETED|Overall Study||1
2191786|NCT03783780|5380126|P1|COMPLETED|Overall Study||20
2191787|NCT03783780|5380126|P1|STARTED|Overall Study||21
2191788|NCT03782181|5380133|P2|NOT COMPLETED|Overall Study||0
2191789|NCT03782181|5380134|P1|NOT COMPLETED|Overall Study||0
2191790|NCT03782181|5380133|P2|COMPLETED|Overall Study||20
2191791|NCT03782181|5380134|P1|COMPLETED|Overall Study||20
2191792|NCT03782181|5380133|P2|STARTED|Overall Study||20
2191793|NCT03782181|5380134|P1|STARTED|Overall Study||20
2191794|NCT03781375|5380160|P2|NOT COMPLETED|Open-label Phase||3
2191795|NCT03781375|5380161|P1|NOT COMPLETED|Open-label Phase||3
2191796|NCT03781375|5380160|P2|COMPLETED|Open-label Phase||6
2191797|NCT03781375|5380161|P1|COMPLETED|Open-label Phase||8
2191798|NCT03781375|5380160|P2|Received Study Drug|Open-label Phase||9
2191799|NCT03781375|5380161|P1|Received Study Drug|Open-label Phase||10
2191800|NCT03781375|5380160|P2|STARTED|Open-label Phase||9
2191801|NCT03781375|5380161|P1|STARTED|Open-label Phase||11
2191802|NCT03781375|5380160|P2|NOT COMPLETED|Double-blind Phase||6
2191803|NCT03781375|5380161|P1|NOT COMPLETED|Double-blind Phase||7
2191804|NCT03781375|5380160|P2|COMPLETED|Double-blind Phase||7
2191805|NCT03781375|5380161|P1|COMPLETED|Double-blind Phase||5
2191806|NCT03781375|5380160|P2|Received Study Drug|Double-blind Phase||13
2191807|NCT03781375|5380161|P1|Received Study Drug|Double-blind Phase||12
2191808|NCT03781375|5380160|P2|STARTED|Double-blind Phase||13
2191809|NCT03781375|5380161|P1|STARTED|Double-blind Phase||12
2191810|NCT03780959|5380175|P3|NOT COMPLETED|Part 2||6
2191811|NCT03780959|5380176|P2|NOT COMPLETED|Part 2||19
2191812|NCT03780959|5380177|P1|NOT COMPLETED|Part 2||0
2191813|NCT03780959|5380175|P3|COMPLETED|Part 2||19
2191814|NCT03780959|5380176|P2|COMPLETED|Part 2||7
2191815|NCT03780959|5380177|P1|COMPLETED|Part 2||0
2191816|NCT03780959|5380175|P3|STARTED|Part 2||25
2191817|NCT03780959|5380176|P2|STARTED|Part 2||26
2191818|NCT03780959|5380177|P1|STARTED|Part 2||0
2191819|NCT03780959|5380175|P3|NOT COMPLETED|Part 1||0
2191820|NCT03780959|5380176|P2|NOT COMPLETED|Part 1||0
2191821|NCT03780959|5380177|P1|NOT COMPLETED|Part 1||5
2191822|NCT03780959|5380175|P3|COMPLETED|Part 1||0
2191823|NCT03780959|5380176|P2|COMPLETED|Part 1||0
2191824|NCT03780959|5380177|P1|COMPLETED|Part 1||64
2191825|NCT03780959|5380175|P3|STARTED|Part 1||0
2191826|NCT03780959|5380176|P2|STARTED|Part 1||0
2191827|NCT03780959|5380177|P1|STARTED|Part 1||69
2191828|NCT03780010|5380191|P2|NOT COMPLETED|Overall Study||0
2191829|NCT03780010|5380192|P1|NOT COMPLETED|Overall Study||0
2191830|NCT03780010|5380191|P2|COMPLETED|Overall Study||12
2191831|NCT03780010|5380192|P1|COMPLETED|Overall Study||3
2191832|NCT03780010|5380191|P2|STARTED|Overall Study||12
2191833|NCT03780010|5380192|P1|STARTED|Overall Study||3
2191834|NCT03779724|5380219|P2|NOT COMPLETED|Overall Study||4
2191835|NCT03779724|5380220|P1|NOT COMPLETED|Overall Study||6
2191836|NCT03779724|5380219|P2|COMPLETED|Overall Study||21
2191837|NCT03779724|5380220|P1|COMPLETED|Overall Study||19
2191838|NCT03779724|5380219|P2|STARTED|Overall Study||25
2191839|NCT03779724|5380220|P1|STARTED|Overall Study||25
2191840|NCT03774745|5380246|P2|NOT COMPLETED|Overall Study||4
2191841|NCT03774745|5380247|P1|NOT COMPLETED|Overall Study||2
2191842|NCT03774745|5380246|P2|COMPLETED|Overall Study||2
2191843|NCT03774745|5380247|P1|COMPLETED|Overall Study||4
2191844|NCT03774745|5380246|P2|Follow-up 2|Overall Study||2
2191845|NCT03774745|5380247|P1|Follow-up 2|Overall Study||4
2191846|NCT03774745|5380246|P2|Follow-Up 1|Overall Study||6
2191847|NCT03774745|5380247|P1|Follow-Up 1|Overall Study||5
2191848|NCT03774745|5380246|P2|STARTED|Overall Study||6
2191849|NCT03774745|5380247|P1|STARTED|Overall Study||6
2191850|NCT03772327|5380263|P2|NOT COMPLETED|Overall Study||7
2191851|NCT03772327|5380264|P1|NOT COMPLETED|Overall Study||5
2191852|NCT03772327|5380263|P2|COMPLETED|Overall Study||26
2191853|NCT03772327|5380264|P1|COMPLETED|Overall Study||25
2191854|NCT03772327|5380263|P2|Week 0 Visit|Overall Study||33
2191855|NCT03772327|5380264|P1|Week 0 Visit|Overall Study|2 participants were lost to follow up after randomization prior to any study interventions.|28
2191856|NCT03772327|5380263|P2|STARTED|Overall Study||33
2191857|NCT03772327|5380264|P1|STARTED|Overall Study||30
2191858|NCT03771560|5380280|P1|NOT COMPLETED|Overall Study||6
2191859|NCT03771560|5380280|P1|COMPLETED|Overall Study||12
2191860|NCT03771560|5380280|P1|STARTED|Overall Study||18
2191861|NCT03767062|5380290|P2|NOT COMPLETED|Overall Study||4
2191862|NCT03767062|5380291|P1|NOT COMPLETED|Overall Study||8
2191863|NCT03767062|5380290|P2|COMPLETED|Overall Study||41
2191864|NCT03767062|5380291|P1|COMPLETED|Overall Study||37
2191865|NCT03767062|5380290|P2|STARTED|Overall Study||45
2191866|NCT03767062|5380291|P1|STARTED|Overall Study||45
2191867|NCT03766373|5380301|P2|NOT COMPLETED|Overall Study||0
2191868|NCT03766373|5380302|P1|NOT COMPLETED|Overall Study||0
2191869|NCT03766373|5380301|P2|COMPLETED|Overall Study||12
2191870|NCT03766373|5380302|P1|COMPLETED|Overall Study||12
2191871|NCT03766373|5380301|P2|STARTED|Overall Study||12
2191872|NCT03766373|5380302|P1|STARTED|Overall Study||12
2191873|NCT03765138|5380308|P1|NOT COMPLETED|Overall Study||1
2191874|NCT03765138|5380308|P1|COMPLETED|Overall Study||0
2191875|NCT03765138|5380308|P1|STARTED|Overall Study||1
2191882|NCT03763058|5380407|P1|NOT COMPLETED|Overall Study||2
2191883|NCT03763058|5380407|P1|COMPLETED|Overall Study||18
2191884|NCT03763058|5380407|P1|STARTED|Overall Study||20
2191885|NCT03762668|5380417|P2|NOT COMPLETED|Period 2, Second Week of Wear||0
2191886|NCT03762668|5380418|P1|NOT COMPLETED|Period 2, Second Week of Wear||0
2191887|NCT03762668|5380417|P2|COMPLETED|Period 2, Second Week of Wear||29
2191888|NCT03762668|5380418|P1|COMPLETED|Period 2, Second Week of Wear||30
2191889|NCT03762668|5380417|P2|STARTED|Period 2, Second Week of Wear||29
2191890|NCT03762668|5380418|P1|STARTED|Period 2, Second Week of Wear||30
2191891|NCT03762668|5380417|P2|NOT COMPLETED|Period 1, First Week of Wear||1
2191892|NCT03762668|5380418|P1|NOT COMPLETED|Period 1, First Week of Wear||0
2191893|NCT03762668|5380417|P2|COMPLETED|Period 1, First Week of Wear||29
2191894|NCT03762668|5380418|P1|COMPLETED|Period 1, First Week of Wear||30
2191895|NCT03762668|5380417|P2|STARTED|Period 1, First Week of Wear||30
2191896|NCT03762668|5380418|P1|STARTED|Period 1, First Week of Wear||30
2191897|NCT03760510|5380426|P2|NOT COMPLETED|Overall Study||97
2191898|NCT03760510|5380427|P1|NOT COMPLETED|Overall Study||105
2191899|NCT03760510|5380426|P2|COMPLETED|Overall Study||153
2191900|NCT03760510|5380427|P1|COMPLETED|Overall Study||145
2191901|NCT03760510|5380426|P2|STARTED|Overall Study||250
2191902|NCT03760510|5380427|P1|STARTED|Overall Study||250
2191903|NCT03758365|5380439|P1|NOT COMPLETED|Overall Study||0
2191904|NCT03758365|5380439|P1|COMPLETED|Overall Study||36
2191905|NCT03758365|5380439|P1|Vehicle Cream|Overall Study||36
2191906|NCT03758365|5380439|P1|Desonide 0.05% Cream|Overall Study||36
2191907|NCT03758365|5380439|P1|Hydrocortisone Butyrate 0.1% Cream|Overall Study||36
2191908|NCT03758365|5380439|P1|Triamcinolone Acetonide 0,1% Cream|Overall Study||36
2191909|NCT03758365|5380439|P1|Betamethasone Dipropionate 0.05% Cream|Overall Study||36
2191910|NCT03758365|5380439|P1|Clobetasol Propionate 0.05% Lotion|Overall Study||36
2191911|NCT03758365|5380439|P1|MC2-01 Cream|Overall Study||36
2191912|NCT03758365|5380439|P1|STARTED|Overall Study||36
2191913|NCT03755882|5380450|P2|NOT COMPLETED|Period 2||0
2191914|NCT03755882|5380451|P1|NOT COMPLETED|Period 2||0
2191915|NCT03755882|5380450|P2|COMPLETED|Period 2||22
2191916|NCT03755882|5380451|P1|COMPLETED|Period 2||19
2191917|NCT03755882|5380450|P2|STARTED|Period 2||22
2191918|NCT03755882|5380451|P1|STARTED|Period 2||19
2191919|NCT03755882|5380450|P2|NOT COMPLETED|Period 1||0
2191920|NCT03755882|5380451|P1|NOT COMPLETED|Period 1||4
2191921|NCT03755882|5380450|P2|COMPLETED|Period 1||22
2191922|NCT03755882|5380451|P1|COMPLETED|Period 1||19
2191923|NCT03755882|5380450|P2|STARTED|Period 1||22
2191924|NCT03755882|5380451|P1|STARTED|Period 1||23
2191925|NCT03752567|5380457|P1|NOT COMPLETED|Overall Study||0
2191926|NCT03752567|5380457|P1|COMPLETED|Overall Study||40
2191927|NCT03752567|5380457|P1|STARTED|Overall Study||40
2191937|NCT03744780|5380523|P1|NOT COMPLETED|Overall Study||0
2191938|NCT03744780|5380523|P1|COMPLETED|Overall Study||32
2191939|NCT03744780|5380523|P1|STARTED|Overall Study||32
2191940|NCT03741725|5380544|P3|NOT COMPLETED|Overall Study||0
2191941|NCT03741725|5380545|P2|NOT COMPLETED|Overall Study||0
2191942|NCT03741725|5380546|P1|NOT COMPLETED|Overall Study||0
2191943|NCT03741725|5380544|P3|COMPLETED|Overall Study||100
2191944|NCT03741725|5380545|P2|COMPLETED|Overall Study||100
2191945|NCT03741725|5380546|P1|COMPLETED|Overall Study||101
2191946|NCT03741725|5380544|P3|STARTED|Overall Study||100
2191947|NCT03741725|5380545|P2|STARTED|Overall Study||100
2191948|NCT03741725|5380546|P1|STARTED|Overall Study||101
2191949|NCT03739242|5380556|P2|NOT COMPLETED|Overall Study||2
2191950|NCT03739242|5380557|P1|NOT COMPLETED|Overall Study||1
2191951|NCT03739242|5380556|P2|COMPLETED|Overall Study||42
2191952|NCT03739242|5380557|P1|COMPLETED|Overall Study||43
2191953|NCT03739242|5380556|P2|STARTED|Overall Study||44
2191954|NCT03739242|5380557|P1|STARTED|Overall Study||44
2191955|NCT03738020|5380593|P1|NOT COMPLETED|Overall Study||1
2191956|NCT03738020|5380593|P1|COMPLETED|Overall Study||57
2191957|NCT03738020|5380593|P1|STARTED|Overall Study||58
2191958|NCT03735862|5380600|P1|NOT COMPLETED|Overall Study||0
2191959|NCT03735862|5380600|P1|COMPLETED|Overall Study||73
2191960|NCT03735862|5380600|P1|STARTED|Overall Study||73
2191961|NCT03734822|5380608|P1|NOT COMPLETED|Overall Study||0
2191962|NCT03734822|5380608|P1|COMPLETED|Overall Study||47
2191963|NCT03734822|5380608|P1|STARTED|Overall Study||47
2191964|NCT03733899|5380612|P6|NOT COMPLETED|Period 3||0
2191965|NCT03733899|5380613|P5|NOT COMPLETED|Period 3||0
2191966|NCT03733899|5380614|P4|NOT COMPLETED|Period 3||0
2191967|NCT03733899|5380615|P3|NOT COMPLETED|Period 3||0
2191968|NCT03733899|5380616|P2|NOT COMPLETED|Period 3||0
2191969|NCT03733899|5380617|P1|NOT COMPLETED|Period 3||1
2191970|NCT03733899|5380612|P6|COMPLETED|Period 3||2
2191971|NCT03733899|5380613|P5|COMPLETED|Period 3||4
2191972|NCT03733899|5380614|P4|COMPLETED|Period 3||4
2191973|NCT03733899|5380615|P3|COMPLETED|Period 3||3
2191974|NCT03733899|5380616|P2|COMPLETED|Period 3||2
2191975|NCT03733899|5380617|P1|COMPLETED|Period 3||2
2191976|NCT03733899|5380612|P6|STARTED|Period 3||2
2191977|NCT03733899|5380613|P5|STARTED|Period 3||4
2191978|NCT03733899|5380614|P4|STARTED|Period 3||4
2191979|NCT03733899|5380615|P3|STARTED|Period 3||3
2191980|NCT03733899|5380616|P2|STARTED|Period 3||2
2191981|NCT03733899|5380617|P1|STARTED|Period 3||3
2191982|NCT03733899|5380612|P6|NOT COMPLETED|Period 2||0
2191983|NCT03733899|5380613|P5|NOT COMPLETED|Period 2||0
2191984|NCT03733899|5380614|P4|NOT COMPLETED|Period 2||0
2191985|NCT03733899|5380615|P3|NOT COMPLETED|Period 2||0
2191986|NCT03733899|5380616|P2|NOT COMPLETED|Period 2||1
2191987|NCT03733899|5380617|P1|NOT COMPLETED|Period 2||0
2191988|NCT03733899|5380612|P6|COMPLETED|Period 2||2
2191989|NCT03733899|5380613|P5|COMPLETED|Period 2||4
2191990|NCT03733899|5380614|P4|COMPLETED|Period 2||4
2191991|NCT03733899|5380615|P3|COMPLETED|Period 2||3
2191992|NCT03733899|5380616|P2|COMPLETED|Period 2||2
2191993|NCT03733899|5380617|P1|COMPLETED|Period 2||3
2191994|NCT03733899|5380612|P6|STARTED|Period 2||2
2191995|NCT03733899|5380613|P5|STARTED|Period 2||4
2191996|NCT03733899|5380614|P4|STARTED|Period 2||4
2191997|NCT03733899|5380615|P3|STARTED|Period 2||3
2191998|NCT03733899|5380616|P2|STARTED|Period 2||3
2191999|NCT03733899|5380617|P1|STARTED|Period 2||3
2192000|NCT03733899|5380612|P6|NOT COMPLETED|Period 1||1
2192001|NCT03733899|5380613|P5|NOT COMPLETED|Period 1||0
2192002|NCT03733899|5380614|P4|NOT COMPLETED|Period 1||0
2192003|NCT03733899|5380615|P3|NOT COMPLETED|Period 1||0
2192004|NCT03733899|5380616|P2|NOT COMPLETED|Period 1||0
2192005|NCT03733899|5380617|P1|NOT COMPLETED|Period 1||0
2192006|NCT03733899|5380612|P6|COMPLETED|Period 1||2
2192007|NCT03733899|5380613|P5|COMPLETED|Period 1||4
2192008|NCT03733899|5380614|P4|COMPLETED|Period 1||4
2192009|NCT03733899|5380615|P3|COMPLETED|Period 1||3
2192010|NCT03733899|5380616|P2|COMPLETED|Period 1||3
2192011|NCT03733899|5380617|P1|COMPLETED|Period 1||3
2192012|NCT03733899|5380612|P6|STARTED|Period 1||3
2192013|NCT03733899|5380613|P5|STARTED|Period 1||4
2192014|NCT03733899|5380614|P4|STARTED|Period 1||4
2192015|NCT03733899|5380615|P3|STARTED|Period 1||3
2192016|NCT03733899|5380616|P2|STARTED|Period 1||3
2192017|NCT03733899|5380617|P1|STARTED|Period 1||3
2192018|NCT03733470|5380645|P2|NOT COMPLETED|Overall Study||1
2192019|NCT03733470|5380646|P1|NOT COMPLETED|Overall Study||1
2192020|NCT03733470|5380645|P2|COMPLETED|Overall Study||10
2192021|NCT03733470|5380646|P1|COMPLETED|Overall Study||7
2192022|NCT03733470|5380645|P2|STARTED|Overall Study||11
2192023|NCT03733470|5380646|P1|STARTED|Overall Study||8
2192024|NCT03728140|5380654|P2|NOT COMPLETED|Overall Study||7
2192025|NCT03728140|5380655|P1|NOT COMPLETED|Overall Study||10
2192026|NCT03728140|5380654|P2|COMPLETED|Overall Study||168
2192027|NCT03728140|5380655|P1|COMPLETED|Overall Study||150
2192028|NCT03728140|5380654|P2|STARTED|Overall Study|embryo transfer with new culture medium|175
2192029|NCT03728140|5380655|P1|STARTED|Overall Study|embryo transfer with self-spent culture medium|160
2192030|NCT03725098|5380665|P2|NOT COMPLETED|Overall Study||0
2192031|NCT03725098|5380666|P1|NOT COMPLETED|Overall Study||0
2192032|NCT03725098|5380665|P2|COMPLETED|Overall Study||52
2192033|NCT03725098|5380666|P1|COMPLETED|Overall Study||53
2192034|NCT03725098|5380665|P2|STARTED|Overall Study||52
2192035|NCT03725098|5380666|P1|STARTED|Overall Study||53
2192036|NCT03725085|5380674|P1|NOT COMPLETED|Overall Study||2
2192037|NCT03725085|5380674|P1|COMPLETED|Overall Study||550
2192038|NCT03725085|5380674|P1|STARTED|Overall Study||552
2192039|NCT03724877|5380684|P2|NOT COMPLETED|Overall Study||0
2192040|NCT03724877|5380685|P1|NOT COMPLETED|Overall Study||0
2192041|NCT03724877|5380684|P2|COMPLETED|Overall Study||1932
2192042|NCT03724877|5380685|P1|COMPLETED|Overall Study||6921
2192043|NCT03724877|5380684|P2|STARTED|Overall Study||1932
2192044|NCT03724877|5380685|P1|STARTED|Overall Study||6921
2192045|NCT03723980|5380699|P2|NOT COMPLETED|Overall Study||5
2192046|NCT03723980|5380700|P1|NOT COMPLETED|Overall Study||7
2192047|NCT03723980|5380699|P2|COMPLETED|Overall Study||35
2192048|NCT03723980|5380700|P1|COMPLETED|Overall Study||33
2192049|NCT03723980|5380699|P2|STARTED|Overall Study||40
2192050|NCT03723980|5380700|P1|STARTED|Overall Study||40
2192054|NCT03721549|5380728|P2|NOT COMPLETED|Overall Study||0
2192055|NCT03721549|5380729|P1|NOT COMPLETED|Overall Study||1
2192056|NCT03721549|5380728|P2|COMPLETED|Overall Study||8
2192057|NCT03721549|5380729|P1|COMPLETED|Overall Study||7
2192058|NCT03721549|5380728|P2|STARTED|Overall Study||8
2192059|NCT03721549|5380729|P1|STARTED|Overall Study||8
2192060|NCT03720847|5380737|P2|NOT COMPLETED|Condition 2||0
2192061|NCT03720847|5380738|P1|NOT COMPLETED|Condition 2||0
2192062|NCT03720847|5380737|P2|COMPLETED|Condition 2||13
2192063|NCT03720847|5380738|P1|COMPLETED|Condition 2||14
2192064|NCT03720847|5380737|P2|STARTED|Condition 2||13
2192065|NCT03720847|5380738|P1|STARTED|Condition 2||14
2192066|NCT03720847|5380737|P2|NOT COMPLETED|Washout||2
2192067|NCT03720847|5380738|P1|NOT COMPLETED|Washout||1
2192068|NCT03720847|5380737|P2|COMPLETED|Washout||13
2192069|NCT03720847|5380738|P1|COMPLETED|Washout||14
2192070|NCT03720847|5380737|P2|STARTED|Washout||15
2192071|NCT03720847|5380738|P1|STARTED|Washout||15
2192072|NCT03720847|5380737|P2|NOT COMPLETED|Condition 1||0
2192073|NCT03720847|5380738|P1|NOT COMPLETED|Condition 1||0
2192074|NCT03720847|5380737|P2|COMPLETED|Condition 1||15
2192075|NCT03720847|5380738|P1|COMPLETED|Condition 1||15
2192076|NCT03720847|5380737|P2|STARTED|Condition 1||15
2192077|NCT03720847|5380738|P1|STARTED|Condition 1||15
2192078|NCT03720119|5380756|P1|NOT COMPLETED|Overall Study||9
2192079|NCT03720119|5380756|P1|COMPLETED|Overall Study||69
2192080|NCT03720119|5380756|P1|STARTED|Overall Study||78
2192081|NCT03718000|5380764|P2|NOT COMPLETED|Overall Study||5
2192082|NCT03718000|5380765|P1|NOT COMPLETED|Overall Study||2
2192083|NCT03718000|5380764|P2|COMPLETED|Overall Study||51
2192084|NCT03718000|5380765|P1|COMPLETED|Overall Study||53
2192085|NCT03718000|5380764|P2|STARTED|Overall Study||56
2192086|NCT03718000|5380765|P1|STARTED|Overall Study||55
2192087|NCT03717064|5380787|P1|NOT COMPLETED|Period 2||1
2192088|NCT03717064|5380787|P1|COMPLETED|Period 2||17
2192089|NCT03717064|5380787|P1|STARTED|Period 2||18
2192090|NCT03717064|5380787|P1|NOT COMPLETED|Period 1||0
2192091|NCT03717064|5380787|P1|COMPLETED|Period 1||18
2192092|NCT03717064|5380787|P1|STARTED|Period 1||18
2192093|NCT03716050|5380819|P8|NOT COMPLETED|Overall Study||2
2192094|NCT03716050|5380820|P7|NOT COMPLETED|Overall Study||0
2192095|NCT03716050|5380821|P6|NOT COMPLETED|Overall Study||0
2192096|NCT03716050|5380822|P5|NOT COMPLETED|Overall Study||0
2192097|NCT03716050|5380823|P4|NOT COMPLETED|Overall Study||2
2192098|NCT03716050|5380824|P3|NOT COMPLETED|Overall Study||1
2192099|NCT03716050|5380825|P2|NOT COMPLETED|Overall Study||0
2192100|NCT03716050|5380826|P1|NOT COMPLETED|Overall Study||0
2192101|NCT03716050|5380819|P8|COMPLETED|Overall Study||0
2192102|NCT03716050|5380820|P7|COMPLETED|Overall Study||4
2192103|NCT03716050|5380821|P6|COMPLETED|Overall Study||0
2192104|NCT03716050|5380822|P5|COMPLETED|Overall Study||1
2192105|NCT03716050|5380823|P4|COMPLETED|Overall Study||1
2192106|NCT03716050|5380824|P3|COMPLETED|Overall Study||0
2192107|NCT03716050|5380825|P2|COMPLETED|Overall Study||4
2192108|NCT03716050|5380826|P1|COMPLETED|Overall Study||2
2192109|NCT03716050|5380819|P8|STARTED|Overall Study||2
2192110|NCT03716050|5380820|P7|STARTED|Overall Study||4
2192111|NCT03716050|5380821|P6|STARTED|Overall Study||0
2192112|NCT03716050|5380822|P5|STARTED|Overall Study||1
2192113|NCT03716050|5380823|P4|STARTED|Overall Study||3
2192114|NCT03716050|5380824|P3|STARTED|Overall Study||1
2192115|NCT03716050|5380825|P2|STARTED|Overall Study||4
2192116|NCT03716050|5380826|P1|STARTED|Overall Study||2
2192117|NCT03715530|5380881|P3|NOT COMPLETED|Overall Study||2
2192118|NCT03715530|5380882|P2|NOT COMPLETED|Overall Study||1
2192119|NCT03715530|5380883|P1|NOT COMPLETED|Overall Study||3
2192120|NCT03715530|5380881|P3|COMPLETED|Overall Study||85
2192121|NCT03715530|5380882|P2|COMPLETED|Overall Study||41
2192122|NCT03715530|5380883|P1|COMPLETED|Overall Study||30
2192123|NCT03715530|5380881|P3|STARTED|Overall Study||87
2192124|NCT03715530|5380882|P2|STARTED|Overall Study||42
2192125|NCT03715530|5380883|P1|STARTED|Overall Study||33
2192126|NCT03715426|5380893|P2|NOT COMPLETED|Overall Study||25
2192127|NCT03715426|5380894|P1|NOT COMPLETED|Overall Study||21
2192128|NCT03715426|5380893|P2|COMPLETED|Overall Study||92
2192129|NCT03715426|5380894|P1|COMPLETED|Overall Study||112
2192130|NCT03715426|5380893|P2|4-Month Follow-Up Survey|Overall Study||92
2192131|NCT03715426|5380894|P1|4-Month Follow-Up Survey|Overall Study||112
2192132|NCT03715426|5380893|P2|1-Month Follow-Up Survey|Overall Study||97
2192133|NCT03715426|5380894|P1|1-Month Follow-Up Survey|Overall Study||113
2192134|NCT03715426|5380893|P2|STARTED|Overall Study||117
2192135|NCT03715426|5380894|P1|STARTED|Overall Study||133
2192136|NCT03714672|5380938|P4|NOT COMPLETED|Overall Study||1
2192137|NCT03714672|5380939|P3|NOT COMPLETED|Overall Study||4
2192138|NCT03714672|5380940|P2|NOT COMPLETED|Overall Study||4
2192139|NCT03714672|5380941|P1|NOT COMPLETED|Overall Study||2
2192140|NCT03714672|5380938|P4|COMPLETED|Overall Study||207
2192141|NCT03714672|5380939|P3|COMPLETED|Overall Study||202
2192142|NCT03714672|5380940|P2|COMPLETED|Overall Study||202
2192143|NCT03714672|5380941|P1|COMPLETED|Overall Study||207
2192144|NCT03714672|5380938|P4|Safety Set|Overall Study||207
2192145|NCT03714672|5380939|P3|Safety Set|Overall Study||206
2192146|NCT03714672|5380940|P2|Safety Set|Overall Study||205
2192147|NCT03714672|5380941|P1|Safety Set|Overall Study||208
2192148|NCT03714672|5380938|P4|STARTED|Overall Study||208
2192149|NCT03714672|5380939|P3|STARTED|Overall Study||206
2192150|NCT03714672|5380940|P2|STARTED|Overall Study||206
2192151|NCT03714672|5380941|P1|STARTED|Overall Study||209
2192152|NCT03714659|5380987|P1|NOT COMPLETED|Overall Study||1
2192153|NCT03714659|5380987|P1|COMPLETED|Overall Study||19
2192154|NCT03714659|5380987|P1|STARTED|Overall Study||20
2192155|NCT03712917|5380995|P3|NOT COMPLETED|Overall Study||9
2192156|NCT03712917|5380996|P2|NOT COMPLETED|Overall Study||8
2192157|NCT03712917|5380997|P1|NOT COMPLETED|Overall Study||9
2192158|NCT03712917|5380995|P3|COMPLETED|Overall Study||31
2192159|NCT03712917|5380996|P2|COMPLETED|Overall Study||32
2192160|NCT03712917|5380997|P1|COMPLETED|Overall Study||31
2192161|NCT03712917|5380995|P3|STARTED|Overall Study||40
2192162|NCT03712917|5380996|P2|STARTED|Overall Study||40
2192163|NCT03712917|5380997|P1|STARTED|Overall Study||40
2192164|NCT03708770|5381008|P1|NOT COMPLETED|Overall Study||10
2192165|NCT03708770|5381008|P1|COMPLETED|Overall Study||22
2192166|NCT03708770|5381008|P1|STARTED|Overall Study||32
2192167|NCT03708744|5381019|P4|NOT COMPLETED|Overall Study||0
2192168|NCT03708744|5381020|P3|NOT COMPLETED|Overall Study||1
2192169|NCT03708744|5381021|P2|NOT COMPLETED|Overall Study||0
2192170|NCT03708744|5381022|P1|NOT COMPLETED|Overall Study||0
2192171|NCT03708744|5381019|P4|COMPLETED|Overall Study||6
2192172|NCT03708744|5381020|P3|COMPLETED|Overall Study||4
2192173|NCT03708744|5381021|P2|COMPLETED|Overall Study||6
2192174|NCT03708744|5381022|P1|COMPLETED|Overall Study||7
2192175|NCT03708744|5381019|P4|STARTED|Overall Study||6
2192176|NCT03708744|5381020|P3|STARTED|Overall Study||5
2192177|NCT03708744|5381021|P2|STARTED|Overall Study||6
2192178|NCT03708744|5381022|P1|STARTED|Overall Study||7
2192179|NCT03708562|5381040|P1|NOT COMPLETED|Overall Study||12
2192180|NCT03708562|5381040|P1|COMPLETED|Overall Study||12
2192181|NCT03708562|5381040|P1|STARTED|Overall Study||24
2192182|NCT03707821|5381056|P2|NOT COMPLETED|Overall Study||1
2192183|NCT03707821|5381057|P1|NOT COMPLETED|Overall Study||2
2192184|NCT03707821|5381056|P2|COMPLETED|Overall Study||125
2192185|NCT03707821|5381057|P1|COMPLETED|Overall Study||123
2192186|NCT03707821|5381056|P2|STARTED|Overall Study||126
2192187|NCT03707821|5381057|P1|STARTED|Overall Study||125
2192188|NCT03707522|5381079|P4|NOT COMPLETED|Overall Study||36
2192189|NCT03707522|5381080|P3|NOT COMPLETED|Overall Study||41
2192190|NCT03707522|5381081|P2|NOT COMPLETED|Overall Study||27
2192191|NCT03707522|5381082|P1|NOT COMPLETED|Overall Study||24
2192192|NCT03707522|5381079|P4|COMPLETED|Overall Study||7
2192193|NCT03707522|5381080|P3|COMPLETED|Overall Study||11
2192194|NCT03707522|5381081|P2|COMPLETED|Overall Study||9
2192195|NCT03707522|5381082|P1|COMPLETED|Overall Study||7
2192196|NCT03707522|5381079|P4|STARTED|Overall Study||43
2192197|NCT03707522|5381080|P3|STARTED|Overall Study||52
2192198|NCT03707522|5381081|P2|STARTED|Overall Study||36
2192199|NCT03707522|5381082|P1|STARTED|Overall Study||31
2192200|NCT03706469|5381112|P4|NOT COMPLETED|Overall Study||0
2192201|NCT03706469|5381113|P3|NOT COMPLETED|Overall Study||0
2192202|NCT03706469|5381114|P2|NOT COMPLETED|Overall Study||0
2192203|NCT03706469|5381115|P1|NOT COMPLETED|Overall Study||0
2192204|NCT03706469|5381112|P4|COMPLETED|Overall Study||4
2192205|NCT03706469|5381113|P3|COMPLETED|Overall Study||4
2192206|NCT03706469|5381114|P2|COMPLETED|Overall Study||4
2192207|NCT03706469|5381115|P1|COMPLETED|Overall Study||4
2192208|NCT03706469|5381112|P4|STARTED|Overall Study||4
2192209|NCT03706469|5381113|P3|STARTED|Overall Study||4
2192210|NCT03706469|5381114|P2|STARTED|Overall Study||4
2192211|NCT03706469|5381115|P1|STARTED|Overall Study||4
2192212|NCT03705481|5381142|P1|NOT COMPLETED|Overall Study||0
2192213|NCT03705481|5381142|P1|COMPLETED|Overall Study||5
2192214|NCT03705481|5381142|P1|STARTED|Overall Study||5
2192215|NCT03704376|5381151|P2|NOT COMPLETED|Overall Study||4
2192216|NCT03704376|5381152|P1|NOT COMPLETED|Overall Study||4
2192217|NCT03704376|5381151|P2|COMPLETED|Overall Study||40
2192218|NCT03704376|5381152|P1|COMPLETED|Overall Study||38
2192219|NCT03704376|5381151|P2|STARTED|Overall Study||44
2192220|NCT03704376|5381152|P1|STARTED|Overall Study||42
2192227|NCT03698591|5381211|P2|NOT COMPLETED|Overall Study||5
2192228|NCT03698591|5381212|P1|NOT COMPLETED|Overall Study||5
2192229|NCT03698591|5381211|P2|COMPLETED|Overall Study||15
2192230|NCT03698591|5381212|P1|COMPLETED|Overall Study||15
2192231|NCT03698591|5381211|P2|STARTED|Overall Study||20
2192232|NCT03698591|5381212|P1|STARTED|Overall Study||20
2192233|NCT03697083|5381227|P3|NOT COMPLETED|Overall Study||0
2192234|NCT03697083|5381228|P2|NOT COMPLETED|Overall Study||10
2192235|NCT03697083|5381229|P1|NOT COMPLETED|Overall Study||0
2192236|NCT03697083|5381227|P3|COMPLETED|Overall Study||255
2192237|NCT03697083|5381228|P2|COMPLETED|Overall Study||250
2192238|NCT03697083|5381229|P1|COMPLETED|Overall Study||262
2192239|NCT03697083|5381227|P3|STARTED|Overall Study||255
2192240|NCT03697083|5381228|P2|STARTED|Overall Study||260
2192241|NCT03697083|5381229|P1|STARTED|Overall Study||262
2192251|NCT03693989|5381273|P2|NOT COMPLETED|Overall Study||4
2192252|NCT03693989|5381274|P1|NOT COMPLETED|Overall Study||3
2192253|NCT03693989|5381273|P2|COMPLETED|Overall Study||86
2192254|NCT03693989|5381274|P1|COMPLETED|Overall Study||85
2192255|NCT03693989|5381273|P2|STARTED|Overall Study||90
2192256|NCT03693989|5381274|P1|STARTED|Overall Study||88
2192257|NCT03693950|5381298|P2|NOT COMPLETED|Overall Study||0
2192258|NCT03693950|5381299|P1|NOT COMPLETED|Overall Study||1
2192259|NCT03693950|5381298|P2|COMPLETED|Overall Study||28
2192260|NCT03693950|5381299|P1|COMPLETED|Overall Study||28
2192261|NCT03693950|5381298|P2|STARTED|Overall Study||28
2192262|NCT03693950|5381299|P1|STARTED|Overall Study||29
2192263|NCT03693937|5381317|P1|NOT COMPLETED|Overall Study||0
2192264|NCT03693937|5381317|P1|COMPLETED|Overall Study||776
2192265|NCT03693937|5381317|P1|STARTED|Overall Study||776
2192266|NCT03685968|5381324|P3|NOT COMPLETED|Overall Study||0
2192267|NCT03685968|5381325|P2|NOT COMPLETED|Overall Study||0
2192268|NCT03685968|5381326|P1|NOT COMPLETED|Overall Study||0
2192269|NCT03685968|5381324|P3|COMPLETED|Overall Study||75
2192270|NCT03685968|5381325|P2|COMPLETED|Overall Study||75
2192271|NCT03685968|5381326|P1|COMPLETED|Overall Study||75
2192272|NCT03685968|5381324|P3|STARTED|Overall Study||75
2192273|NCT03685968|5381325|P2|STARTED|Overall Study||75
2192274|NCT03685968|5381326|P1|STARTED|Overall Study||75
2192275|NCT03685396|5381342|P2|NOT COMPLETED|Overall Study||0
2192276|NCT03685396|5381343|P1|NOT COMPLETED|Overall Study||0
2192277|NCT03685396|5381342|P2|COMPLETED|Overall Study||21
2192278|NCT03685396|5381343|P1|COMPLETED|Overall Study||21
2192279|NCT03685396|5381342|P2|STARTED|Overall Study||21
2192280|NCT03685396|5381343|P1|STARTED|Overall Study||21
2192281|NCT03684265|5381357|P2|NOT COMPLETED|Treatment Period 2||0
2192282|NCT03684265|5381358|P1|NOT COMPLETED|Treatment Period 2||0
2192283|NCT03684265|5381357|P2|COMPLETED|Treatment Period 2||13
2192284|NCT03684265|5381358|P1|COMPLETED|Treatment Period 2||13
2192285|NCT03684265|5381357|P2|STARTED|Treatment Period 2||13
2192286|NCT03684265|5381358|P1|STARTED|Treatment Period 2||13
2192287|NCT03684265|5381357|P2|NOT COMPLETED|Washout Period of 1 Week||0
2192288|NCT03684265|5381358|P1|NOT COMPLETED|Washout Period of 1 Week||0
2192289|NCT03684265|5381357|P2|COMPLETED|Washout Period of 1 Week||13
2192290|NCT03684265|5381358|P1|COMPLETED|Washout Period of 1 Week||13
2192291|NCT03684265|5381357|P2|STARTED|Washout Period of 1 Week||13
2192292|NCT03684265|5381358|P1|STARTED|Washout Period of 1 Week||13
2192293|NCT03684265|5381357|P2|NOT COMPLETED|Treatment Period 1||0
2192294|NCT03684265|5381358|P1|NOT COMPLETED|Treatment Period 1||0
2192295|NCT03684265|5381357|P2|COMPLETED|Treatment Period 1||13
2192296|NCT03684265|5381358|P1|COMPLETED|Treatment Period 1||13
2192297|NCT03684265|5381357|P2|STARTED|Treatment Period 1||13
2192298|NCT03684265|5381358|P1|STARTED|Treatment Period 1||13
2192299|NCT03683901|5381368|P1|NOT COMPLETED|Overall Study||0
2192300|NCT03683901|5381368|P1|COMPLETED|Overall Study||10
2192301|NCT03683901|5381368|P1|STARTED|Overall Study||10
2192302|NCT03683758|5381379|P2|NOT COMPLETED|Overall Study||3
2192303|NCT03683758|5381380|P1|NOT COMPLETED|Overall Study||3
2192304|NCT03683758|5381379|P2|COMPLETED|Overall Study||7
2192305|NCT03683758|5381380|P1|COMPLETED|Overall Study||8
2192306|NCT03683758|5381379|P2|STARTED|Overall Study||10
2192307|NCT03683758|5381380|P1|STARTED|Overall Study||11
2192308|NCT03679741|5381392|P2|NOT COMPLETED|Period 3||0
2192309|NCT03679741|5381393|P1|NOT COMPLETED|Period 3||0
2192310|NCT03679741|5381392|P2|COMPLETED|Period 3||56
2192311|NCT03679741|5381393|P1|COMPLETED|Period 3||54
2192312|NCT03679741|5381392|P2|STARTED|Period 3||56
2192313|NCT03679741|5381393|P1|STARTED|Period 3||54
2192314|NCT03679741|5381392|P2|NOT COMPLETED|Period 2||2
2192315|NCT03679741|5381393|P1|NOT COMPLETED|Period 2||3
2192316|NCT03679741|5381392|P2|COMPLETED|Period 2||56
2192317|NCT03679741|5381393|P1|COMPLETED|Period 2||54
2192318|NCT03679741|5381392|P2|STARTED|Period 2||58
2192319|NCT03679741|5381393|P1|STARTED|Period 2||57
2192320|NCT03679741|5381392|P2|NOT COMPLETED|Period 1||3
2192321|NCT03679741|5381393|P1|NOT COMPLETED|Period 1||2
2192322|NCT03679741|5381392|P2|COMPLETED|Period 1||58
2192323|NCT03679741|5381393|P1|COMPLETED|Period 1||57
2192324|NCT03679741|5381392|P2|STARTED|Period 1||61
2192325|NCT03679741|5381393|P1|STARTED|Period 1||59
2192338|NCT03677375|5381449|P1|NOT COMPLETED|Overall Study||12
2192339|NCT03677375|5381449|P1|COMPLETED|Overall Study||81
2192340|NCT03677375|5381449|P1|STARTED|Overall Study||93
2192341|NCT03676803|5381455|P2|NOT COMPLETED|Overall Study||0
2192342|NCT03676803|5381456|P1|NOT COMPLETED|Overall Study||0
2192343|NCT03676803|5381455|P2|COMPLETED|Overall Study||16
2192344|NCT03676803|5381456|P1|COMPLETED|Overall Study||15
2192345|NCT03676803|5381455|P2|STARTED|Overall Study||16
2192346|NCT03676803|5381456|P1|STARTED|Overall Study||15
2192347|NCT03673670|5381470|P6|NOT COMPLETED|Treatment Period 3 (3 Days)||0
2192348|NCT03673670|5381471|P5|NOT COMPLETED|Treatment Period 3 (3 Days)||1
2192349|NCT03673670|5381472|P4|NOT COMPLETED|Treatment Period 3 (3 Days)||0
2192350|NCT03673670|5381473|P3|NOT COMPLETED|Treatment Period 3 (3 Days)||0
2192351|NCT03673670|5381474|P2|NOT COMPLETED|Treatment Period 3 (3 Days)||0
2192352|NCT03673670|5381475|P1|NOT COMPLETED|Treatment Period 3 (3 Days)||0
2192353|NCT03673670|5381470|P6|COMPLETED|Treatment Period 3 (3 Days)||11
2192354|NCT03673670|5381471|P5|COMPLETED|Treatment Period 3 (3 Days)||10
2192355|NCT03673670|5381472|P4|COMPLETED|Treatment Period 3 (3 Days)||12
2192356|NCT03673670|5381473|P3|COMPLETED|Treatment Period 3 (3 Days)||11
2192357|NCT03673670|5381474|P2|COMPLETED|Treatment Period 3 (3 Days)||14
2192358|NCT03673670|5381475|P1|COMPLETED|Treatment Period 3 (3 Days)||13
2192359|NCT03673670|5381470|P6|STARTED|Treatment Period 3 (3 Days)||11
2192360|NCT03673670|5381471|P5|STARTED|Treatment Period 3 (3 Days)||11
2192361|NCT03673670|5381472|P4|STARTED|Treatment Period 3 (3 Days)||12
2192362|NCT03673670|5381473|P3|STARTED|Treatment Period 3 (3 Days)||11
2192363|NCT03673670|5381474|P2|STARTED|Treatment Period 3 (3 Days)||14
2192364|NCT03673670|5381475|P1|STARTED|Treatment Period 3 (3 Days)||13
2192365|NCT03673670|5381470|P6|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
2192366|NCT03673670|5381471|P5|NOT COMPLETED|Washout Period 2 (7-14 Days)||1
2192367|NCT03673670|5381472|P4|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
2192368|NCT03673670|5381473|P3|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
2192369|NCT03673670|5381474|P2|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
2192370|NCT03673670|5381475|P1|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
2192371|NCT03673670|5381470|P6|COMPLETED|Washout Period 2 (7-14 Days)||11
2192372|NCT03673670|5381471|P5|COMPLETED|Washout Period 2 (7-14 Days)||11
2192373|NCT03673670|5381472|P4|COMPLETED|Washout Period 2 (7-14 Days)||12
2192374|NCT03673670|5381473|P3|COMPLETED|Washout Period 2 (7-14 Days)||11
2192375|NCT03673670|5381474|P2|COMPLETED|Washout Period 2 (7-14 Days)||14
2192376|NCT03673670|5381475|P1|COMPLETED|Washout Period 2 (7-14 Days)||13
2192377|NCT03673670|5381470|P6|STARTED|Washout Period 2 (7-14 Days)||11
2192378|NCT03673670|5381471|P5|STARTED|Washout Period 2 (7-14 Days)||12
2192379|NCT03673670|5381472|P4|STARTED|Washout Period 2 (7-14 Days)||12
2192380|NCT03673670|5381473|P3|STARTED|Washout Period 2 (7-14 Days)||11
2192381|NCT03673670|5381474|P2|STARTED|Washout Period 2 (7-14 Days)||14
2192382|NCT03673670|5381475|P1|STARTED|Washout Period 2 (7-14 Days)||13
2192383|NCT03673670|5381470|P6|NOT COMPLETED|Treatment Period 2 (3 Days)||0
2192384|NCT03673670|5381471|P5|NOT COMPLETED|Treatment Period 2 (3 Days)||1
2192385|NCT03673670|5381472|P4|NOT COMPLETED|Treatment Period 2 (3 Days)||0
2192386|NCT03673670|5381473|P3|NOT COMPLETED|Treatment Period 2 (3 Days)||1
2192387|NCT03673670|5381474|P2|NOT COMPLETED|Treatment Period 2 (3 Days)||0
2192388|NCT03673670|5381475|P1|NOT COMPLETED|Treatment Period 2 (3 Days)||0
2192389|NCT03673670|5381470|P6|COMPLETED|Treatment Period 2 (3 Days)||11
2192390|NCT03673670|5381471|P5|COMPLETED|Treatment Period 2 (3 Days)||12
2192391|NCT03673670|5381472|P4|COMPLETED|Treatment Period 2 (3 Days)||12
2192392|NCT03673670|5381473|P3|COMPLETED|Treatment Period 2 (3 Days)||11
2192393|NCT03673670|5381474|P2|COMPLETED|Treatment Period 2 (3 Days)||14
2192394|NCT03673670|5381475|P1|COMPLETED|Treatment Period 2 (3 Days)||13
2192395|NCT03673670|5381470|P6|STARTED|Treatment Period 2 (3 Days)||11
2192396|NCT03673670|5381471|P5|STARTED|Treatment Period 2 (3 Days)||13
2192397|NCT03673670|5381472|P4|STARTED|Treatment Period 2 (3 Days)||12
2192398|NCT03673670|5381473|P3|STARTED|Treatment Period 2 (3 Days)||12
2192399|NCT03673670|5381474|P2|STARTED|Treatment Period 2 (3 Days)||14
2192400|NCT03673670|5381475|P1|STARTED|Treatment Period 2 (3 Days)||13
2192401|NCT03673670|5381470|P6|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
2192402|NCT03673670|5381471|P5|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
2192403|NCT03673670|5381472|P4|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
2192404|NCT03673670|5381473|P3|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
2192405|NCT03673670|5381474|P2|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
2192406|NCT03673670|5381475|P1|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
2192407|NCT03673670|5381470|P6|COMPLETED|Washout Period 1 (7-14 Days)||11
2192408|NCT03673670|5381471|P5|COMPLETED|Washout Period 1 (7-14 Days)||13
2192409|NCT03673670|5381472|P4|COMPLETED|Washout Period 1 (7-14 Days)||12
2192410|NCT03673670|5381473|P3|COMPLETED|Washout Period 1 (7-14 Days)||12
2192411|NCT03673670|5381474|P2|COMPLETED|Washout Period 1 (7-14 Days)||14
2192412|NCT03673670|5381475|P1|COMPLETED|Washout Period 1 (7-14 Days)||13
2192413|NCT03673670|5381470|P6|STARTED|Washout Period 1 (7-14 Days)||11
2192414|NCT03673670|5381471|P5|STARTED|Washout Period 1 (7-14 Days)||13
2192415|NCT03673670|5381472|P4|STARTED|Washout Period 1 (7-14 Days)||12
2192416|NCT03673670|5381473|P3|STARTED|Washout Period 1 (7-14 Days)||12
2192417|NCT03673670|5381474|P2|STARTED|Washout Period 1 (7-14 Days)||14
2192418|NCT03673670|5381475|P1|STARTED|Washout Period 1 (7-14 Days)||13
2192419|NCT03673670|5381470|P6|NOT COMPLETED|Treatment Period 1 (3 Days)||2
2192420|NCT03673670|5381471|P5|NOT COMPLETED|Treatment Period 1 (3 Days)||0
2192421|NCT03673670|5381472|P4|NOT COMPLETED|Treatment Period 1 (3 Days)||0
2192422|NCT03673670|5381473|P3|NOT COMPLETED|Treatment Period 1 (3 Days)||1
2192423|NCT03673670|5381474|P2|NOT COMPLETED|Treatment Period 1 (3 Days)||0
2192424|NCT03673670|5381475|P1|NOT COMPLETED|Treatment Period 1 (3 Days)||1
2192425|NCT03673670|5381470|P6|COMPLETED|Treatment Period 1 (3 Days)||11
2192426|NCT03673670|5381471|P5|COMPLETED|Treatment Period 1 (3 Days)||13
2192427|NCT03673670|5381472|P4|COMPLETED|Treatment Period 1 (3 Days)||12
2192428|NCT03673670|5381473|P3|COMPLETED|Treatment Period 1 (3 Days)||12
2192429|NCT03673670|5381474|P2|COMPLETED|Treatment Period 1 (3 Days)||14
2192430|NCT03673670|5381475|P1|COMPLETED|Treatment Period 1 (3 Days)||13
2192431|NCT03673670|5381470|P6|STARTED|Treatment Period 1 (3 Days)||13
2192432|NCT03673670|5381471|P5|STARTED|Treatment Period 1 (3 Days)||13
2192433|NCT03673670|5381472|P4|STARTED|Treatment Period 1 (3 Days)||12
2192434|NCT03673670|5381473|P3|STARTED|Treatment Period 1 (3 Days)||13
2192435|NCT03673670|5381474|P2|STARTED|Treatment Period 1 (3 Days)||14
2192436|NCT03673670|5381475|P1|STARTED|Treatment Period 1 (3 Days)||14
2192437|NCT03670537|5381522|P1|NOT COMPLETED|Overall Study||1
2192438|NCT03670537|5381522|P1|COMPLETED|Overall Study||101
2192439|NCT03670537|5381522|P1|STARTED|Overall Study||102
2192440|NCT03669081|5381528|P2|NOT COMPLETED|Overall Study||1
2192441|NCT03669081|5381529|P1|NOT COMPLETED|Overall Study||1
2192442|NCT03669081|5381528|P2|COMPLETED|Overall Study||29
2192443|NCT03669081|5381529|P1|COMPLETED|Overall Study||33
2192444|NCT03669081|5381528|P2|STARTED|Overall Study||30
2192445|NCT03669081|5381529|P1|STARTED|Overall Study||34
2192446|NCT03667547|5381545|P1|NOT COMPLETED|Overall Study||0
2192447|NCT03667547|5381545|P1|COMPLETED|Overall Study||12
2192448|NCT03667547|5381545|P1|STARTED|Overall Study||12
2192449|NCT03663179|5381561|P2|NOT COMPLETED|Overall Study||1
2192450|NCT03663179|5381562|P1|NOT COMPLETED|Overall Study||4
2192451|NCT03663179|5381561|P2|COMPLETED|Overall Study||13
2192452|NCT03663179|5381562|P1|COMPLETED|Overall Study||14
2192453|NCT03663179|5381561|P2|STARTED|Overall Study||14
2192454|NCT03663179|5381562|P1|STARTED|Overall Study||18
2192455|NCT03662334|5381572|P2|NOT COMPLETED|Part 3: Treatment Period 2||0
2192456|NCT03662334|5381573|P1|NOT COMPLETED|Part 3: Treatment Period 2||0
2192457|NCT03662334|5381572|P2|COMPLETED|Part 3: Treatment Period 2||0
2192458|NCT03662334|5381573|P1|COMPLETED|Part 3: Treatment Period 2||0
2192459|NCT03662334|5381572|P2|STARTED|Part 3: Treatment Period 2||0
2192460|NCT03662334|5381573|P1|STARTED|Part 3: Treatment Period 2||0
2192461|NCT03662334|5381572|P2|NOT COMPLETED|Part 3: Treatment Period 1||0
2192462|NCT03662334|5381573|P1|NOT COMPLETED|Part 3: Treatment Period 1||0
2192463|NCT03662334|5381572|P2|COMPLETED|Part 3: Treatment Period 1||0
2192464|NCT03662334|5381573|P1|COMPLETED|Part 3: Treatment Period 1||0
2192465|NCT03662334|5381572|P2|STARTED|Part 3: Treatment Period 1|Part 3 of the study was not conducted. No participants were enrolled in this part of the study.|0
2192554|NCT03650842|5381774|P1|NOT COMPLETED|Overall Study||0
2192555|NCT03650842|5381774|P1|COMPLETED|Overall Study||25
2192466|NCT03662334|5381573|P1|STARTED|Part 3: Treatment Period 1|Part 3 of the study was not conducted. No participants were enrolled in this part of the study.|0
2192467|NCT03662334|5381572|P2|NOT COMPLETED|Part 2: Treatment Period 2 (2 Days)||0
2192468|NCT03662334|5381573|P1|NOT COMPLETED|Part 2: Treatment Period 2 (2 Days)||1
2192469|NCT03662334|5381572|P2|COMPLETED|Part 2: Treatment Period 2 (2 Days)||7
2192470|NCT03662334|5381573|P1|COMPLETED|Part 2: Treatment Period 2 (2 Days)||6
2192471|NCT03662334|5381572|P2|STARTED|Part 2: Treatment Period 2 (2 Days)||7
2192472|NCT03662334|5381573|P1|STARTED|Part 2: Treatment Period 2 (2 Days)||7
2192473|NCT03662334|5381572|P2|NOT COMPLETED|Part 2: Treatment Period 1 (2 Days)||0
2192474|NCT03662334|5381573|P1|NOT COMPLETED|Part 2: Treatment Period 1 (2 Days)||0
2192475|NCT03662334|5381572|P2|COMPLETED|Part 2: Treatment Period 1 (2 Days)||7
2192476|NCT03662334|5381573|P1|COMPLETED|Part 2: Treatment Period 1 (2 Days)||7
2192477|NCT03662334|5381572|P2|STARTED|Part 2: Treatment Period 1 (2 Days)|Part 1 of the study was not conducted. Participants were enrolled starting with Part 2.|7
2192478|NCT03662334|5381573|P1|STARTED|Part 2: Treatment Period 1 (2 Days)|Part 1 of the study was not conducted. Participants were enrolled starting with Part 2.|7
2192479|NCT03662334|5381572|P2|NOT COMPLETED|Part 1: Treatment Period 2||0
2192480|NCT03662334|5381573|P1|NOT COMPLETED|Part 1: Treatment Period 2||0
2192481|NCT03662334|5381572|P2|COMPLETED|Part 1: Treatment Period 2||0
2192482|NCT03662334|5381573|P1|COMPLETED|Part 1: Treatment Period 2||0
2192483|NCT03662334|5381572|P2|STARTED|Part 1: Treatment Period 2||0
2192484|NCT03662334|5381573|P1|STARTED|Part 1: Treatment Period 2||0
2192485|NCT03662334|5381572|P2|NOT COMPLETED|Part 1: Treatment Period 1||0
2192486|NCT03662334|5381573|P1|NOT COMPLETED|Part 1: Treatment Period 1||0
2192487|NCT03662334|5381572|P2|COMPLETED|Part 1: Treatment Period 1||0
2192488|NCT03662334|5381573|P1|COMPLETED|Part 1: Treatment Period 1||0
2192489|NCT03662334|5381572|P2|STARTED|Part 1: Treatment Period 1||0
2192490|NCT03662334|5381573|P1|STARTED|Part 1: Treatment Period 1||0
2192491|NCT03662139|5381611|P2|NOT COMPLETED|Overall Study||0
2192492|NCT03662139|5381612|P1|NOT COMPLETED|Overall Study||0
2192493|NCT03662139|5381611|P2|COMPLETED|Overall Study||16
2192494|NCT03662139|5381612|P1|COMPLETED|Overall Study||16
2192495|NCT03662139|5381611|P2|STARTED|Overall Study||16
2192496|NCT03662139|5381612|P1|STARTED|Overall Study||16
2192497|NCT03660787|5381628|P4|NOT COMPLETED|Overall Study||0
2192498|NCT03660787|5381629|P3|NOT COMPLETED|Overall Study||1
2192499|NCT03660787|5381630|P2|NOT COMPLETED|Overall Study||1
2192500|NCT03660787|5381631|P1|NOT COMPLETED|Overall Study||1
2192501|NCT03660787|5381628|P4|COMPLETED|Overall Study||26
2192502|NCT03660787|5381629|P3|COMPLETED|Overall Study||25
2192503|NCT03660787|5381630|P2|COMPLETED|Overall Study||25
2192504|NCT03660787|5381631|P1|COMPLETED|Overall Study||25
2192505|NCT03660787|5381628|P4|STARTED|Overall Study||26
2192506|NCT03660787|5381629|P3|STARTED|Overall Study||26
2192507|NCT03660787|5381630|P2|STARTED|Overall Study||26
2192508|NCT03660787|5381631|P1|STARTED|Overall Study||26
2192509|NCT03658876|5381667|P2|NOT COMPLETED|Overall Study||12
2192510|NCT03658876|5381668|P1|NOT COMPLETED|Overall Study||12
2192511|NCT03658876|5381667|P2|COMPLETED|Overall Study||84
2192512|NCT03658876|5381668|P1|COMPLETED|Overall Study||76
2192513|NCT03658876|5381667|P2|STARTED|Overall Study||96
2192514|NCT03658876|5381668|P1|STARTED|Overall Study||88
2192515|NCT03658811|5381674|P1|NOT COMPLETED|Overall Study||3
2192516|NCT03658811|5381674|P1|COMPLETED|Overall Study||16
2192517|NCT03658811|5381674|P1|STARTED|Overall Study||19
2192518|NCT03657407|5381683|P2|NOT COMPLETED|Overall Study||0
2192519|NCT03657407|5381684|P1|NOT COMPLETED|Overall Study||0
2192520|NCT03657407|5381683|P2|COMPLETED|Overall Study||27
2192521|NCT03657407|5381684|P1|COMPLETED|Overall Study||29
2192522|NCT03657407|5381683|P2|STARTED|Overall Study||27
2192523|NCT03657407|5381684|P1|STARTED|Overall Study||29
2192524|NCT03657264|5381700|P4|NOT COMPLETED|Overall Study||0
2192525|NCT03657264|5381701|P3|NOT COMPLETED|Overall Study||0
2192526|NCT03657264|5381702|P2|NOT COMPLETED|Overall Study||0
2192527|NCT03657264|5381703|P1|NOT COMPLETED|Overall Study||0
2192528|NCT03657264|5381700|P4|COMPLETED|Overall Study||12
2192529|NCT03657264|5381701|P3|COMPLETED|Overall Study||12
2192530|NCT03657264|5381702|P2|COMPLETED|Overall Study||12
2192531|NCT03657264|5381703|P1|COMPLETED|Overall Study||12
2192532|NCT03657264|5381700|P4|STARTED|Overall Study||12
2192533|NCT03657264|5381701|P3|STARTED|Overall Study||12
2192534|NCT03657264|5381702|P2|STARTED|Overall Study||12
2192535|NCT03657264|5381703|P1|STARTED|Overall Study||12
2192536|NCT03655301|5381716|P1|NOT COMPLETED|Overall Study||0
2192537|NCT03655301|5381716|P1|COMPLETED|Overall Study||13
2192538|NCT03655301|5381716|P1|STARTED|Overall Study||13
2192539|NCT03654417|5381728|P2|NOT COMPLETED|Overall Study||0
2192540|NCT03654417|5381729|P1|NOT COMPLETED|Overall Study||0
2192541|NCT03654417|5381728|P2|COMPLETED|Overall Study||18
2192542|NCT03654417|5381729|P1|COMPLETED|Overall Study||19
2192543|NCT03654417|5381728|P2|STARTED|Overall Study||18
2192544|NCT03654417|5381729|P1|STARTED|Overall Study||19
2192545|NCT03651856|5381751|P1|NOT COMPLETED|Overall Study||0
2192546|NCT03651856|5381751|P1|COMPLETED|Overall Study||10
2192547|NCT03651856|5381751|P1|STARTED|Overall Study||10
2192548|NCT03651479|5381757|P2|NOT COMPLETED|Overall Study||0
2192549|NCT03651479|5381758|P1|NOT COMPLETED|Overall Study||0
2192550|NCT03651479|5381757|P2|COMPLETED|Overall Study||20
2192551|NCT03651479|5381758|P1|COMPLETED|Overall Study||20
2192552|NCT03651479|5381757|P2|STARTED|Overall Study||20
2192553|NCT03651479|5381758|P1|STARTED|Overall Study||20
2192556|NCT03650842|5381774|P1|STARTED|Overall Study||25
2192557|NCT03649867|5381781|P1|NOT COMPLETED|Overall Study||0
2192558|NCT03649867|5381781|P1|COMPLETED|Overall Study||13
2192559|NCT03649867|5381781|P1|STARTED|Overall Study||13
2192560|NCT03649750|5381785|P2|NOT COMPLETED|Period 2||0
2192561|NCT03649750|5381786|P1|NOT COMPLETED|Period 2||0
2192562|NCT03649750|5381785|P2|COMPLETED|Period 2||24
2192563|NCT03649750|5381786|P1|COMPLETED|Period 2||12
2192564|NCT03649750|5381785|P2|STARTED|Period 2||24
2192565|NCT03649750|5381786|P1|STARTED|Period 2||12
2192566|NCT03649750|5381785|P2|NOT COMPLETED|Washout: 7 Days||0
2192567|NCT03649750|5381786|P1|NOT COMPLETED|Washout: 7 Days||0
2192568|NCT03649750|5381785|P2|COMPLETED|Washout: 7 Days||24
2192569|NCT03649750|5381786|P1|COMPLETED|Washout: 7 Days||12
2192570|NCT03649750|5381785|P2|STARTED|Washout: 7 Days||24
2192571|NCT03649750|5381786|P1|STARTED|Washout: 7 Days||12
2192572|NCT03649750|5381785|P2|NOT COMPLETED|Period 1||0
2192573|NCT03649750|5381786|P1|NOT COMPLETED|Period 1||0
2192574|NCT03649750|5381785|P2|COMPLETED|Period 1||24
2192575|NCT03649750|5381786|P1|COMPLETED|Period 1||12
2192576|NCT03649750|5381785|P2|STARTED|Period 1||24
2192577|NCT03649750|5381786|P1|STARTED|Period 1||12
2192578|NCT03648983|5381805|P1|NOT COMPLETED|Overall Study||95
2192579|NCT03648983|5381805|P1|COMPLETED|Overall Study||0
2192580|NCT03648983|5381805|P1|STARTED|Overall Study||95
2192581|NCT03647033|5381813|P2|NOT COMPLETED|Overall Study||0
2192582|NCT03647033|5381814|P1|NOT COMPLETED|Overall Study||0
2192583|NCT03647033|5381813|P2|COMPLETED|Overall Study||16
2192584|NCT03647033|5381814|P1|COMPLETED|Overall Study||16
2192585|NCT03647033|5381813|P2|STARTED|Overall Study||16
2192586|NCT03647033|5381814|P1|STARTED|Overall Study||16
2192587|NCT03645421|5381826|P4|NOT COMPLETED|Overall Study||4
2192588|NCT03645421|5381827|P3|NOT COMPLETED|Overall Study||5
2192589|NCT03645421|5381828|P2|NOT COMPLETED|Overall Study||0
2192590|NCT03645421|5381829|P1|NOT COMPLETED|Overall Study||0
2192591|NCT03645421|5381826|P4|COMPLETED|Overall Study||11
2192592|NCT03645421|5381827|P3|COMPLETED|Overall Study||10
2192593|NCT03645421|5381828|P2|COMPLETED|Overall Study||15
2192594|NCT03645421|5381829|P1|COMPLETED|Overall Study||16
2192595|NCT03645421|5381826|P4|Received Investigational Product (IP)|Overall Study||15
2192596|NCT03645421|5381827|P3|Received Investigational Product (IP)|Overall Study||15
2192597|NCT03645421|5381828|P2|Received Investigational Product (IP)|Overall Study||15
2192598|NCT03645421|5381829|P1|Received Investigational Product (IP)|Overall Study||16
2192599|NCT03645421|5381826|P4|STARTED|Overall Study||15
2192600|NCT03645421|5381827|P3|STARTED|Overall Study||15
2192601|NCT03645421|5381828|P2|STARTED|Overall Study||15
2192602|NCT03645421|5381829|P1|STARTED|Overall Study||16
2192603|NCT03644212|5381895|P2|NOT COMPLETED|Overall Study||0
2192604|NCT03644212|5381896|P1|NOT COMPLETED|Overall Study||0
2192605|NCT03644212|5381895|P2|COMPLETED|Overall Study||16
2192606|NCT03644212|5381896|P1|COMPLETED|Overall Study||63
2192607|NCT03644212|5381895|P2|STARTED|Overall Study||16
2192608|NCT03644212|5381896|P1|STARTED|Overall Study||63
2192609|NCT03644108|5381902|P1|NOT COMPLETED|Overall Study||0
2192610|NCT03644108|5381902|P1|COMPLETED|Overall Study||30
2192611|NCT03644108|5381902|P1|STARTED|Overall Study||30
2192612|NCT03644095|5381913|P2|NOT COMPLETED|Period 2||0
2192613|NCT03644095|5381914|P1|NOT COMPLETED|Period 2||0
2192614|NCT03644095|5381913|P2|COMPLETED|Period 2||15
2192615|NCT03644095|5381914|P1|COMPLETED|Period 2||15
2192616|NCT03644095|5381913|P2|STARTED|Period 2||15
2192617|NCT03644095|5381914|P1|STARTED|Period 2||15
2192618|NCT03644095|5381913|P2|NOT COMPLETED|Washout (7 Days)||0
2192619|NCT03644095|5381914|P1|NOT COMPLETED|Washout (7 Days)||0
2192620|NCT03644095|5381913|P2|COMPLETED|Washout (7 Days)||15
2192621|NCT03644095|5381914|P1|COMPLETED|Washout (7 Days)||15
2192622|NCT03644095|5381913|P2|STARTED|Washout (7 Days)||15
2192623|NCT03644095|5381914|P1|STARTED|Washout (7 Days)||15
2192624|NCT03644095|5381913|P2|NOT COMPLETED|Period 1||0
2192625|NCT03644095|5381914|P1|NOT COMPLETED|Period 1||0
2192626|NCT03644095|5381913|P2|COMPLETED|Period 1||15
2192627|NCT03644095|5381914|P1|COMPLETED|Period 1||15
2192628|NCT03644095|5381913|P2|STARTED|Period 1||15
2192629|NCT03644095|5381914|P1|STARTED|Period 1||15
2192630|NCT03643575|5381934|P6|NOT COMPLETED|Period 3||0
2192631|NCT03643575|5381935|P5|NOT COMPLETED|Period 3||0
2192632|NCT03643575|5381936|P4|NOT COMPLETED|Period 3||0
2192633|NCT03643575|5381937|P3|NOT COMPLETED|Period 3||0
2192634|NCT03643575|5381938|P2|NOT COMPLETED|Period 3||0
2192635|NCT03643575|5381939|P1|NOT COMPLETED|Period 3||0
2192636|NCT03643575|5381934|P6|COMPLETED|Period 3||5
2192637|NCT03643575|5381935|P5|COMPLETED|Period 3||5
2192638|NCT03643575|5381936|P4|COMPLETED|Period 3||4
2192639|NCT03643575|5381937|P3|COMPLETED|Period 3||5
2192640|NCT03643575|5381938|P2|COMPLETED|Period 3||4
2192641|NCT03643575|5381939|P1|COMPLETED|Period 3||4
2192642|NCT03643575|5381934|P6|STARTED|Period 3||5
2192643|NCT03643575|5381935|P5|STARTED|Period 3||5
2192644|NCT03643575|5381936|P4|STARTED|Period 3||4
2192645|NCT03643575|5381937|P3|STARTED|Period 3||5
2192646|NCT03643575|5381938|P2|STARTED|Period 3||4
2192647|NCT03643575|5381939|P1|STARTED|Period 3||4
2192648|NCT03643575|5381934|P6|NOT COMPLETED|Washout: 7 Days||0
2192649|NCT03643575|5381935|P5|NOT COMPLETED|Washout: 7 Days||0
2192650|NCT03643575|5381936|P4|NOT COMPLETED|Washout: 7 Days||0
2192651|NCT03643575|5381937|P3|NOT COMPLETED|Washout: 7 Days||0
2192652|NCT03643575|5381938|P2|NOT COMPLETED|Washout: 7 Days||1
2192653|NCT03643575|5381939|P1|NOT COMPLETED|Washout: 7 Days||0
2192654|NCT03643575|5381934|P6|COMPLETED|Washout: 7 Days||5
2192655|NCT03643575|5381935|P5|COMPLETED|Washout: 7 Days||5
2192656|NCT03643575|5381936|P4|COMPLETED|Washout: 7 Days||4
2192657|NCT03643575|5381937|P3|COMPLETED|Washout: 7 Days||5
2192658|NCT03643575|5381938|P2|COMPLETED|Washout: 7 Days||4
2192659|NCT03643575|5381939|P1|COMPLETED|Washout: 7 Days||4
2192660|NCT03643575|5381934|P6|STARTED|Washout: 7 Days||5
2192661|NCT03643575|5381935|P5|STARTED|Washout: 7 Days||5
2192662|NCT03643575|5381936|P4|STARTED|Washout: 7 Days||4
2192663|NCT03643575|5381937|P3|STARTED|Washout: 7 Days||5
2192664|NCT03643575|5381938|P2|STARTED|Washout: 7 Days||5
2192665|NCT03643575|5381939|P1|STARTED|Washout: 7 Days||4
2192666|NCT03643575|5381934|P6|NOT COMPLETED|Period 2||0
2192667|NCT03643575|5381935|P5|NOT COMPLETED|Period 2||0
2192668|NCT03643575|5381936|P4|NOT COMPLETED|Period 2||0
2192669|NCT03643575|5381937|P3|NOT COMPLETED|Period 2||0
2192670|NCT03643575|5381938|P2|NOT COMPLETED|Period 2||0
2192671|NCT03643575|5381939|P1|NOT COMPLETED|Period 2||0
2192672|NCT03643575|5381934|P6|COMPLETED|Period 2||5
2192673|NCT03643575|5381935|P5|COMPLETED|Period 2||5
2192674|NCT03643575|5381936|P4|COMPLETED|Period 2||4
2192675|NCT03643575|5381937|P3|COMPLETED|Period 2||5
2192676|NCT03643575|5381938|P2|COMPLETED|Period 2||5
2192677|NCT03643575|5381939|P1|COMPLETED|Period 2||4
2192678|NCT03643575|5381934|P6|STARTED|Period 2||5
2192679|NCT03643575|5381935|P5|STARTED|Period 2||5
2192680|NCT03643575|5381936|P4|STARTED|Period 2||4
2192681|NCT03643575|5381937|P3|STARTED|Period 2||5
2192682|NCT03643575|5381938|P2|STARTED|Period 2||5
2192683|NCT03643575|5381939|P1|STARTED|Period 2||4
2192684|NCT03643575|5381934|P6|NOT COMPLETED|Washout: 7 Days||0
2192685|NCT03643575|5381935|P5|NOT COMPLETED|Washout: 7 Days||0
2192686|NCT03643575|5381936|P4|NOT COMPLETED|Washout: 7 Days||1
2192687|NCT03643575|5381937|P3|NOT COMPLETED|Washout: 7 Days||0
2192688|NCT03643575|5381938|P2|NOT COMPLETED|Washout: 7 Days||0
2192689|NCT03643575|5381939|P1|NOT COMPLETED|Washout: 7 Days||1
2192690|NCT03643575|5381934|P6|COMPLETED|Washout: 7 Days||5
2192691|NCT03643575|5381935|P5|COMPLETED|Washout: 7 Days||5
2192692|NCT03643575|5381936|P4|COMPLETED|Washout: 7 Days||4
2192693|NCT03643575|5381937|P3|COMPLETED|Washout: 7 Days||5
2192694|NCT03643575|5381938|P2|COMPLETED|Washout: 7 Days||5
2192695|NCT03643575|5381939|P1|COMPLETED|Washout: 7 Days||4
2192696|NCT03643575|5381934|P6|STARTED|Washout: 7 Days||5
2192697|NCT03643575|5381935|P5|STARTED|Washout: 7 Days||5
2192698|NCT03643575|5381936|P4|STARTED|Washout: 7 Days||5
2192699|NCT03643575|5381937|P3|STARTED|Washout: 7 Days||5
2192700|NCT03643575|5381938|P2|STARTED|Washout: 7 Days||5
2192701|NCT03643575|5381939|P1|STARTED|Washout: 7 Days||5
2192702|NCT03643575|5381934|P6|NOT COMPLETED|Period 1||0
2192703|NCT03643575|5381935|P5|NOT COMPLETED|Period 1||0
2192704|NCT03643575|5381936|P4|NOT COMPLETED|Period 1||0
2192705|NCT03643575|5381937|P3|NOT COMPLETED|Period 1||0
2192706|NCT03643575|5381938|P2|NOT COMPLETED|Period 1||0
2192707|NCT03643575|5381939|P1|NOT COMPLETED|Period 1||0
2192708|NCT03643575|5381934|P6|COMPLETED|Period 1||5
2192709|NCT03643575|5381935|P5|COMPLETED|Period 1||5
2192710|NCT03643575|5381936|P4|COMPLETED|Period 1||5
2192711|NCT03643575|5381937|P3|COMPLETED|Period 1||5
2192712|NCT03643575|5381938|P2|COMPLETED|Period 1||5
2192713|NCT03643575|5381939|P1|COMPLETED|Period 1||5
2192714|NCT03643575|5381934|P6|STARTED|Period 1||5
2192715|NCT03643575|5381935|P5|STARTED|Period 1||5
2192716|NCT03643575|5381936|P4|STARTED|Period 1||5
2192717|NCT03643575|5381937|P3|STARTED|Period 1||5
2192718|NCT03643575|5381938|P2|STARTED|Period 1||5
2192719|NCT03643575|5381939|P1|STARTED|Period 1||5
2192720|NCT03643159|5381997|P1|NOT COMPLETED|Overall Study||2
2192721|NCT03643159|5381997|P1|COMPLETED|Overall Study||0
2192722|NCT03643159|5381997|P1|Received At Least 1 Dose Of Study Drug|Overall Study||2
2192723|NCT03643159|5381997|P1|STARTED|Overall Study||2
2192724|NCT03642873|5382004|P6|NOT COMPLETED|Third Intervention (1 Day)||0
2192725|NCT03642873|5382005|P5|NOT COMPLETED|Third Intervention (1 Day)||1
2192726|NCT03642873|5382006|P4|NOT COMPLETED|Third Intervention (1 Day)||0
2192727|NCT03642873|5382007|P3|NOT COMPLETED|Third Intervention (1 Day)||0
2192728|NCT03642873|5382008|P2|NOT COMPLETED|Third Intervention (1 Day)||0
2192729|NCT03642873|5382009|P1|NOT COMPLETED|Third Intervention (1 Day)||0
2192730|NCT03642873|5382004|P6|COMPLETED|Third Intervention (1 Day)||4
2192731|NCT03642873|5382005|P5|COMPLETED|Third Intervention (1 Day)||3
2192732|NCT03642873|5382006|P4|COMPLETED|Third Intervention (1 Day)||4
2192733|NCT03642873|5382007|P3|COMPLETED|Third Intervention (1 Day)||4
2192734|NCT03642873|5382008|P2|COMPLETED|Third Intervention (1 Day)||4
2192735|NCT03642873|5382009|P1|COMPLETED|Third Intervention (1 Day)||4
2192736|NCT03642873|5382004|P6|STARTED|Third Intervention (1 Day)||4
2192737|NCT03642873|5382005|P5|STARTED|Third Intervention (1 Day)||4
2192738|NCT03642873|5382006|P4|STARTED|Third Intervention (1 Day)||4
2192739|NCT03642873|5382007|P3|STARTED|Third Intervention (1 Day)||4
2192740|NCT03642873|5382008|P2|STARTED|Third Intervention (1 Day)||4
2192741|NCT03642873|5382009|P1|STARTED|Third Intervention (1 Day)||4
2192742|NCT03642873|5382004|P6|NOT COMPLETED|Washout (7 Days)||0
2192743|NCT03642873|5382005|P5|NOT COMPLETED|Washout (7 Days)||0
2192744|NCT03642873|5382006|P4|NOT COMPLETED|Washout (7 Days)||0
2192745|NCT03642873|5382007|P3|NOT COMPLETED|Washout (7 Days)||0
2192746|NCT03642873|5382008|P2|NOT COMPLETED|Washout (7 Days)||0
2192747|NCT03642873|5382009|P1|NOT COMPLETED|Washout (7 Days)||0
2192748|NCT03642873|5382004|P6|COMPLETED|Washout (7 Days)||4
2192749|NCT03642873|5382005|P5|COMPLETED|Washout (7 Days)||4
2192750|NCT03642873|5382006|P4|COMPLETED|Washout (7 Days)||4
2192751|NCT03642873|5382007|P3|COMPLETED|Washout (7 Days)||4
2192752|NCT03642873|5382008|P2|COMPLETED|Washout (7 Days)||4
2192753|NCT03642873|5382009|P1|COMPLETED|Washout (7 Days)||4
2192754|NCT03642873|5382004|P6|STARTED|Washout (7 Days)||4
2192755|NCT03642873|5382005|P5|STARTED|Washout (7 Days)||4
2192756|NCT03642873|5382006|P4|STARTED|Washout (7 Days)||4
2192757|NCT03642873|5382007|P3|STARTED|Washout (7 Days)||4
2192758|NCT03642873|5382008|P2|STARTED|Washout (7 Days)||4
2192759|NCT03642873|5382009|P1|STARTED|Washout (7 Days)||4
2192760|NCT03642873|5382004|P6|NOT COMPLETED|Second Intervention (1 Day)||0
2192761|NCT03642873|5382005|P5|NOT COMPLETED|Second Intervention (1 Day)||0
2192762|NCT03642873|5382006|P4|NOT COMPLETED|Second Intervention (1 Day)||0
2192763|NCT03642873|5382007|P3|NOT COMPLETED|Second Intervention (1 Day)||0
2192764|NCT03642873|5382008|P2|NOT COMPLETED|Second Intervention (1 Day)||0
2192765|NCT03642873|5382009|P1|NOT COMPLETED|Second Intervention (1 Day)||0
2192766|NCT03642873|5382004|P6|COMPLETED|Second Intervention (1 Day)||4
2192767|NCT03642873|5382005|P5|COMPLETED|Second Intervention (1 Day)||4
2192768|NCT03642873|5382006|P4|COMPLETED|Second Intervention (1 Day)||4
2192769|NCT03642873|5382007|P3|COMPLETED|Second Intervention (1 Day)||4
2192770|NCT03642873|5382008|P2|COMPLETED|Second Intervention (1 Day)||4
2192771|NCT03642873|5382009|P1|COMPLETED|Second Intervention (1 Day)||4
2192772|NCT03642873|5382004|P6|STARTED|Second Intervention (1 Day)||4
2192773|NCT03642873|5382005|P5|STARTED|Second Intervention (1 Day)||4
2192774|NCT03642873|5382006|P4|STARTED|Second Intervention (1 Day)||4
2192775|NCT03642873|5382007|P3|STARTED|Second Intervention (1 Day)||4
2192776|NCT03642873|5382008|P2|STARTED|Second Intervention (1 Day)||4
2192777|NCT03642873|5382009|P1|STARTED|Second Intervention (1 Day)||4
2192778|NCT03642873|5382004|P6|NOT COMPLETED|Washout (7 Days)||0
2192779|NCT03642873|5382005|P5|NOT COMPLETED|Washout (7 Days)||0
2192780|NCT03642873|5382006|P4|NOT COMPLETED|Washout (7 Days)||0
2192781|NCT03642873|5382007|P3|NOT COMPLETED|Washout (7 Days)||0
2192782|NCT03642873|5382008|P2|NOT COMPLETED|Washout (7 Days)||0
2192783|NCT03642873|5382009|P1|NOT COMPLETED|Washout (7 Days)||0
2192784|NCT03642873|5382004|P6|COMPLETED|Washout (7 Days)||4
2192785|NCT03642873|5382005|P5|COMPLETED|Washout (7 Days)||4
2192786|NCT03642873|5382006|P4|COMPLETED|Washout (7 Days)||4
2192787|NCT03642873|5382007|P3|COMPLETED|Washout (7 Days)||4
2192788|NCT03642873|5382008|P2|COMPLETED|Washout (7 Days)||4
2192789|NCT03642873|5382009|P1|COMPLETED|Washout (7 Days)||4
2192790|NCT03642873|5382004|P6|STARTED|Washout (7 Days)||4
2192791|NCT03642873|5382005|P5|STARTED|Washout (7 Days)||4
2192792|NCT03642873|5382006|P4|STARTED|Washout (7 Days)||4
2192793|NCT03642873|5382007|P3|STARTED|Washout (7 Days)||4
2192794|NCT03642873|5382008|P2|STARTED|Washout (7 Days)||4
2192795|NCT03642873|5382009|P1|STARTED|Washout (7 Days)||4
2192796|NCT03642873|5382004|P6|NOT COMPLETED|First Intervention (1 Day)||0
2192797|NCT03642873|5382005|P5|NOT COMPLETED|First Intervention (1 Day)||0
2192798|NCT03642873|5382006|P4|NOT COMPLETED|First Intervention (1 Day)||0
2192799|NCT03642873|5382007|P3|NOT COMPLETED|First Intervention (1 Day)||0
2192800|NCT03642873|5382008|P2|NOT COMPLETED|First Intervention (1 Day)||0
2192801|NCT03642873|5382009|P1|NOT COMPLETED|First Intervention (1 Day)||0
2192802|NCT03642873|5382004|P6|COMPLETED|First Intervention (1 Day)||4
2192803|NCT03642873|5382005|P5|COMPLETED|First Intervention (1 Day)||4
2192804|NCT03642873|5382006|P4|COMPLETED|First Intervention (1 Day)||4
2192805|NCT03642873|5382007|P3|COMPLETED|First Intervention (1 Day)||4
2192806|NCT03642873|5382008|P2|COMPLETED|First Intervention (1 Day)||4
2192807|NCT03642873|5382009|P1|COMPLETED|First Intervention (1 Day)||4
2192808|NCT03642873|5382004|P6|STARTED|First Intervention (1 Day)||4
2192809|NCT03642873|5382005|P5|STARTED|First Intervention (1 Day)||4
2192810|NCT03642873|5382006|P4|STARTED|First Intervention (1 Day)||4
2192811|NCT03642873|5382007|P3|STARTED|First Intervention (1 Day)||4
2192812|NCT03642873|5382008|P2|STARTED|First Intervention (1 Day)||4
2192813|NCT03642873|5382009|P1|STARTED|First Intervention (1 Day)||4
2192814|NCT03642262|5382041|P2|NOT COMPLETED|Period 2||0
2192815|NCT03642262|5382042|P1|NOT COMPLETED|Period 2||0
2192816|NCT03642262|5382041|P2|COMPLETED|Period 2||16
2192817|NCT03642262|5382042|P1|COMPLETED|Period 2||11
2192818|NCT03642262|5382041|P2|STARTED|Period 2||16
2192819|NCT03642262|5382042|P1|STARTED|Period 2||11
2192820|NCT03642262|5382041|P2|NOT COMPLETED|Washout: 7 Days||0
2192821|NCT03642262|5382042|P1|NOT COMPLETED|Washout: 7 Days||0
2192822|NCT03642262|5382041|P2|COMPLETED|Washout: 7 Days||16
2192823|NCT03642262|5382042|P1|COMPLETED|Washout: 7 Days||11
2192824|NCT03642262|5382041|P2|STARTED|Washout: 7 Days||16
2192825|NCT03642262|5382042|P1|STARTED|Washout: 7 Days||11
2192826|NCT03642262|5382041|P2|NOT COMPLETED|Period 1||2
2192827|NCT03642262|5382042|P1|NOT COMPLETED|Period 1||1
2192828|NCT03642262|5382041|P2|COMPLETED|Period 1||16
2192829|NCT03642262|5382042|P1|COMPLETED|Period 1||11
2192830|NCT03642262|5382041|P2|STARTED|Period 1||18
2192831|NCT03642262|5382042|P1|STARTED|Period 1||12
2192832|NCT03641508|5382063|P2|NOT COMPLETED|Follow-up/Second Injection||0
2192833|NCT03641508|5382064|P1|NOT COMPLETED|Follow-up/Second Injection||0
2192834|NCT03641508|5382063|P2|COMPLETED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|10
2192835|NCT03641508|5382064|P1|COMPLETED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|2
2192836|NCT03641508|5382063|P2|STARTED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|10
2192837|NCT03641508|5382064|P1|STARTED|Follow-up/Second Injection||2
2192838|NCT03641508|5382063|P2|NOT COMPLETED|First Injection||0
2192839|NCT03641508|5382064|P1|NOT COMPLETED|First Injection||2
2192840|NCT03641508|5382063|P2|COMPLETED|First Injection||32
2192841|NCT03641508|5382064|P1|COMPLETED|First Injection||35
2192842|NCT03641508|5382063|P2|STARTED|First Injection||32
2192843|NCT03641508|5382064|P1|STARTED|First Injection||37
2192844|NCT03640832|5382076|P2|NOT COMPLETED|Overall Study||0
2192845|NCT03640832|5382077|P1|NOT COMPLETED|Overall Study||0
2192846|NCT03640832|5382076|P2|COMPLETED|Overall Study||46
2192847|NCT03640832|5382077|P1|COMPLETED|Overall Study||44
2192848|NCT03640832|5382076|P2|STARTED|Overall Study||46
2192849|NCT03640832|5382077|P1|STARTED|Overall Study||44
2192850|NCT03640559|5382091|P2|NOT COMPLETED|Overall Study||1
2192851|NCT03640559|5382092|P1|NOT COMPLETED|Overall Study||2
2192852|NCT03640559|5382091|P2|COMPLETED|Overall Study||24
2192853|NCT03640559|5382092|P1|COMPLETED|Overall Study||23
2192854|NCT03640559|5382091|P2|STARTED|Overall Study||25
2192855|NCT03640559|5382092|P1|STARTED|Overall Study||25
2192875|NCT03638908|5382124|P1|NOT COMPLETED|Overall Study||1
2192876|NCT03638908|5382124|P1|COMPLETED|Overall Study||7
2192877|NCT03638908|5382124|P1|STARTED|Overall Study||8
2192878|NCT03638635|5382141|P2|NOT COMPLETED|Follow-Up (30 Days After Discharge)||22
2192879|NCT03638635|5382142|P1|NOT COMPLETED|Follow-Up (30 Days After Discharge)||39
2192880|NCT03638635|5382141|P2|COMPLETED|Follow-Up (30 Days After Discharge)||0
2192881|NCT03638635|5382142|P1|COMPLETED|Follow-Up (30 Days After Discharge)||0
2192882|NCT03638635|5382141|P2|STARTED|Follow-Up (30 Days After Discharge)||22
2192883|NCT03638635|5382142|P1|STARTED|Follow-Up (30 Days After Discharge)||39
2192884|NCT03638635|5382141|P2|NOT COMPLETED|Initial Hospitalization||2
2192885|NCT03638635|5382142|P1|NOT COMPLETED|Initial Hospitalization||0
2192886|NCT03638635|5382141|P2|COMPLETED|Initial Hospitalization||22
2192887|NCT03638635|5382142|P1|COMPLETED|Initial Hospitalization||39
2192888|NCT03638635|5382141|P2|STARTED|Initial Hospitalization||24
2192889|NCT03638635|5382142|P1|STARTED|Initial Hospitalization||39
2192890|NCT03638323|5382172|P1|NOT COMPLETED|Overall Study||1
2192891|NCT03638323|5382172|P1|COMPLETED|Overall Study||37
2192892|NCT03638323|5382172|P1|STARTED|Overall Study||38
2192893|NCT03634306|5382196|P3|NOT COMPLETED|Overall Study||0
2192894|NCT03634306|5382197|P2|NOT COMPLETED|Overall Study||0
2192895|NCT03634306|5382198|P1|NOT COMPLETED|Overall Study||0
2192896|NCT03634306|5382196|P3|COMPLETED|Overall Study||5
2192897|NCT03634306|5382197|P2|COMPLETED|Overall Study||15
2192898|NCT03634306|5382198|P1|COMPLETED|Overall Study||15
2192899|NCT03634306|5382196|P3|STARTED|Overall Study||5
2192900|NCT03634306|5382197|P2|STARTED|Overall Study||15
2192901|NCT03634306|5382198|P1|STARTED|Overall Study||15
2192902|NCT03633825|5382211|P2|NOT COMPLETED|Analysis||0
2192903|NCT03633825|5382212|P1|NOT COMPLETED|Analysis||0
2192904|NCT03633825|5382211|P2|COMPLETED|Analysis||325
2192905|NCT03633825|5382212|P1|COMPLETED|Analysis||327
2192906|NCT03633825|5382211|P2|STARTED|Analysis||325
2192907|NCT03633825|5382212|P1|STARTED|Analysis||327
2192908|NCT03633825|5382211|P2|NOT COMPLETED|Follow up||450
2192909|NCT03633825|5382212|P1|NOT COMPLETED|Follow up||478
2192910|NCT03633825|5382211|P2|COMPLETED|Follow up||325
2192911|NCT03633825|5382212|P1|COMPLETED|Follow up||327
2192912|NCT03633825|5382211|P2|STARTED|Follow up||775
2192913|NCT03633825|5382212|P1|STARTED|Follow up||805
2192914|NCT03633825|5382211|P2|NOT COMPLETED|Allocation||0
2192915|NCT03633825|5382212|P1|NOT COMPLETED|Allocation||0
2192916|NCT03633825|5382211|P2|COMPLETED|Allocation||775
2192917|NCT03633825|5382212|P1|COMPLETED|Allocation||805
2192918|NCT03633825|5382211|P2|STARTED|Allocation||775
2192919|NCT03633825|5382212|P1|STARTED|Allocation||805
2192920|NCT03633825|5382211|P2|NOT COMPLETED|Enrollment||18837
2192921|NCT03633825|5382212|P1|NOT COMPLETED|Enrollment||19033
2192922|NCT03633825|5382211|P2|COMPLETED|Enrollment||775
2192923|NCT03633825|5382212|P1|COMPLETED|Enrollment||805
2192924|NCT03633825|5382211|P2|STARTED|Enrollment||19612
2192925|NCT03633825|5382212|P1|STARTED|Enrollment||19838
2192926|NCT03633526|5382220|P1|NOT COMPLETED|Overall Study||0
2192927|NCT03633526|5382220|P1|COMPLETED|Overall Study||16
2192928|NCT03633526|5382220|P1|STARTED|Overall Study||16
2192929|NCT03633487|5382230|P1|NOT COMPLETED|Overall Study||0
2192930|NCT03633487|5382230|P1|COMPLETED|Overall Study||24
2192931|NCT03633487|5382230|P1|STARTED|Overall Study||24
2192932|NCT03633448|5382244|P2|NOT COMPLETED|Period 2 (1 Day)||0
2192933|NCT03633448|5382245|P1|NOT COMPLETED|Period 2 (1 Day)||0
2192934|NCT03633448|5382244|P2|COMPLETED|Period 2 (1 Day)||12
2192935|NCT03633448|5382245|P1|COMPLETED|Period 2 (1 Day)||12
2192936|NCT03633448|5382244|P2|STARTED|Period 2 (1 Day)||12
2192937|NCT03633448|5382245|P1|STARTED|Period 2 (1 Day)||12
2192938|NCT03633448|5382244|P2|NOT COMPLETED|Washout (7 Days)||0
2192939|NCT03633448|5382245|P1|NOT COMPLETED|Washout (7 Days)||0
2192940|NCT03633448|5382244|P2|COMPLETED|Washout (7 Days)||12
2192941|NCT03633448|5382245|P1|COMPLETED|Washout (7 Days)||12
2192942|NCT03633448|5382244|P2|STARTED|Washout (7 Days)||12
2192943|NCT03633448|5382245|P1|STARTED|Washout (7 Days)||12
2192944|NCT03633448|5382244|P2|NOT COMPLETED|Period 1 (1 Day)||0
2192945|NCT03633448|5382245|P1|NOT COMPLETED|Period 1 (1 Day)||0
2192946|NCT03633448|5382244|P2|COMPLETED|Period 1 (1 Day)||12
2192947|NCT03633448|5382245|P1|COMPLETED|Period 1 (1 Day)||12
2192948|NCT03633448|5382244|P2|STARTED|Period 1 (1 Day)||12
2192949|NCT03633448|5382245|P1|STARTED|Period 1 (1 Day)||12
2192950|NCT03633344|5382285|P2|NOT COMPLETED|Overall Study||0
2192951|NCT03633344|5382286|P1|NOT COMPLETED|Overall Study||0
2192952|NCT03633344|5382285|P2|COMPLETED|Overall Study||24
2192953|NCT03633344|5382286|P1|COMPLETED|Overall Study||120
2192954|NCT03633344|5382285|P2|STARTED|Overall Study||24
2192955|NCT03633344|5382286|P1|STARTED|Overall Study||120
2192968|NCT03630016|5382345|P1|NOT COMPLETED|Overall Study||1
2192969|NCT03630016|5382345|P1|COMPLETED|Overall Study||10
2192970|NCT03630016|5382345|P1|STARTED|Overall Study||11
2192991|NCT03629041|5382376|P4|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
2192992|NCT03629041|5382377|P3|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
2192993|NCT03629041|5382378|P2|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||1
2192994|NCT03629041|5382379|P1|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
2192995|NCT03629041|5382376|P4|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
2192996|NCT03629041|5382377|P3|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
2192997|NCT03629041|5382378|P2|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||3
2192998|NCT03629041|5382379|P1|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
2192999|NCT03629041|5382376|P4|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
2193000|NCT03629041|5382377|P3|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
2193001|NCT03629041|5382378|P2|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
2193002|NCT03629041|5382379|P1|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
2193003|NCT03629041|5382376|P4|NOT COMPLETED|Visit 1||0
2193004|NCT03629041|5382377|P3|NOT COMPLETED|Visit 1||0
2193005|NCT03629041|5382378|P2|NOT COMPLETED|Visit 1||0
2193006|NCT03629041|5382379|P1|NOT COMPLETED|Visit 1||0
2193007|NCT03629041|5382376|P4|COMPLETED|Visit 1||4
2193008|NCT03629041|5382377|P3|COMPLETED|Visit 1||4
2193009|NCT03629041|5382378|P2|COMPLETED|Visit 1||4
2193010|NCT03629041|5382379|P1|COMPLETED|Visit 1||4
2193011|NCT03629041|5382376|P4|STARTED|Visit 1||4
2193012|NCT03629041|5382377|P3|STARTED|Visit 1||4
2193013|NCT03629041|5382378|P2|STARTED|Visit 1||4
2193014|NCT03629041|5382379|P1|STARTED|Visit 1||4
2193015|NCT03628885|5382408|P3|NOT COMPLETED|Overall Study||60
2193016|NCT03628885|5382409|P2|NOT COMPLETED|Overall Study||47
2193017|NCT03628885|5382410|P1|NOT COMPLETED|Overall Study||39
2193018|NCT03628885|5382408|P3|COMPLETED|Overall Study||243
2193019|NCT03628885|5382409|P2|COMPLETED|Overall Study||252
2193020|NCT03628885|5382410|P1|COMPLETED|Overall Study||267
2193021|NCT03628885|5382408|P3|STARTED|Overall Study||303
2193022|NCT03628885|5382409|P2|STARTED|Overall Study||299
2193023|NCT03628885|5382410|P1|STARTED|Overall Study||306
2193024|NCT03628599|5382420|P2|NOT COMPLETED|Overall Study||1
2193025|NCT03628599|5382421|P1|NOT COMPLETED|Overall Study||0
2193026|NCT03628599|5382420|P2|COMPLETED|Overall Study||18
2193027|NCT03628599|5382421|P1|COMPLETED|Overall Study||18
2193028|NCT03628599|5382420|P2|STARTED|Overall Study||19
2193029|NCT03628599|5382421|P1|STARTED|Overall Study||18
2193030|NCT03628456|5382431|P1|NOT COMPLETED|Overall Study||0
2193031|NCT03628456|5382431|P1|COMPLETED|Overall Study||10
2193032|NCT03628456|5382431|P1|STARTED|Overall Study||10
2193033|NCT03628417|5382451|P2|NOT COMPLETED|Overall Study||1
2193034|NCT03628417|5382452|P1|NOT COMPLETED|Overall Study||1
2193035|NCT03628417|5382451|P2|COMPLETED|Overall Study|One patient died before the one-year closing visit,this is why decreased the number of metastases|6
2193036|NCT03628417|5382452|P1|COMPLETED|Overall Study|One patient died and 3 more Ca electroporated lesions were removed before the one-year closing visit|6
2193037|NCT03628417|5382451|P2|Day 180|Overall Study||7
2193038|NCT03628417|5382452|P1|Day 180|Overall Study||7
2193039|NCT03628417|5382451|P2|Day 90|Overall Study||7
2193040|NCT03628417|5382452|P1|Day 90|Overall Study||7
2193041|NCT03628417|5382451|P2|Day 60|Overall Study||7
2193042|NCT03628417|5382452|P1|Day 60|Overall Study||7
2193043|NCT03628417|5382451|P2|Day 30|Overall Study||7
2193044|NCT03628417|5382452|P1|Day 30|Overall Study||7
2193045|NCT03628417|5382451|P2|Day 15|Overall Study||7
2193046|NCT03628417|5382452|P1|Day 15|Overall Study||7
2193047|NCT03628417|5382451|P2|Day 7|Overall Study||7
2193048|NCT03628417|5382452|P1|Day 7|Overall Study||7
2193049|NCT03628417|5382451|P2|Day 0|Overall Study||7
2193050|NCT03628417|5382452|P1|Day 0|Overall Study||7
2193051|NCT03628417|5382451|P2|STARTED|Overall Study||7
2193052|NCT03628417|5382452|P1|STARTED|Overall Study||7
2193053|NCT03626714|5382462|P1|NOT COMPLETED|Overall Study||0
2193054|NCT03626714|5382462|P1|COMPLETED|Overall Study||8
2193055|NCT03626714|5382462|P1|STARTED|Overall Study||8
2193056|NCT03623035|5382471|P1|NOT COMPLETED|Overall Study||0
2193057|NCT03623035|5382471|P1|COMPLETED|Overall Study||10
2193058|NCT03623035|5382471|P1|STARTED|Overall Study||10
2193059|NCT03621878|5382480|P3|NOT COMPLETED|Overall Study||0
2193060|NCT03621878|5382481|P2|NOT COMPLETED|Overall Study||0
2193061|NCT03621878|5382482|P1|NOT COMPLETED|Overall Study||0
2193062|NCT03621878|5382480|P3|COMPLETED|Overall Study||17
2193063|NCT03621878|5382481|P2|COMPLETED|Overall Study||17
2193064|NCT03621878|5382482|P1|COMPLETED|Overall Study||17
2193065|NCT03621878|5382480|P3|STARTED|Overall Study||17
2193066|NCT03621878|5382481|P2|STARTED|Overall Study||17
2193067|NCT03621878|5382482|P1|STARTED|Overall Study||17
2193068|NCT03620708|5382505|P3|NOT COMPLETED|Overall Study||3
2193069|NCT03620708|5382506|P2|NOT COMPLETED|Overall Study||1
2193070|NCT03620708|5382507|P1|NOT COMPLETED|Overall Study||1
2193071|NCT03620708|5382505|P3|COMPLETED|Overall Study||17
2193072|NCT03620708|5382506|P2|COMPLETED|Overall Study||18
2193073|NCT03620708|5382507|P1|COMPLETED|Overall Study||18
2193074|NCT03620708|5382505|P3|STARTED|Overall Study||20
2193075|NCT03620708|5382506|P2|STARTED|Overall Study||19
2193076|NCT03620708|5382507|P1|STARTED|Overall Study||19
2193077|NCT03620383|5382529|P2|NOT COMPLETED|Overall Study||0
2193078|NCT03620383|5382530|P1|NOT COMPLETED|Overall Study||0
2193079|NCT03620383|5382529|P2|COMPLETED|Overall Study||15
2193080|NCT03620383|5382530|P1|COMPLETED|Overall Study||30
2193081|NCT03620383|5382529|P2|STARTED|Overall Study||15
2193082|NCT03620383|5382530|P1|STARTED|Overall Study||30
2193083|NCT03619889|5382538|P2|NOT COMPLETED|Overall Study||0
2193084|NCT03619889|5382539|P1|NOT COMPLETED|Overall Study||2
2193085|NCT03619889|5382538|P2|COMPLETED|Overall Study||37
2193086|NCT03619889|5382539|P1|COMPLETED|Overall Study||35
2193087|NCT03619889|5382538|P2|STARTED|Overall Study||37
2193088|NCT03619889|5382539|P1|STARTED|Overall Study||37
2193089|NCT03619590|5382569|P1|NOT COMPLETED|Overall Study||0
2193090|NCT03619590|5382569|P1|COMPLETED|Overall Study||103
2193091|NCT03619590|5382569|P1|STARTED|Overall Study||103
2193092|NCT03619135|5382579|P2|NOT COMPLETED|Overall Study||0
2193093|NCT03619135|5382580|P1|NOT COMPLETED|Overall Study||0
2193094|NCT03619135|5382579|P2|COMPLETED|Overall Study||50
2193095|NCT03619135|5382580|P1|COMPLETED|Overall Study||50
2193096|NCT03619135|5382579|P2|STARTED|Overall Study||50
2193097|NCT03619135|5382580|P1|STARTED|Overall Study||50
2193098|NCT03618628|5382588|P1|NOT COMPLETED|Overall Study||2
2193099|NCT03618628|5382588|P1|COMPLETED|Overall Study||1
2193100|NCT03618628|5382588|P1|STARTED|Overall Study||3
2193101|NCT03618147|5382592|P1|NOT COMPLETED|Overall Study||0
2193102|NCT03618147|5382592|P1|COMPLETED|Overall Study||314
2193103|NCT03618147|5382592|P1|STARTED|Overall Study||314
2193104|NCT03617523|5382602|P5|NOT COMPLETED|Overall Study||0
2193105|NCT03617523|5382603|P4|NOT COMPLETED|Overall Study||0
2193106|NCT03617523|5382604|P3|NOT COMPLETED|Overall Study||0
2193107|NCT03617523|5382605|P2|NOT COMPLETED|Overall Study||0
2193108|NCT03617523|5382606|P1|NOT COMPLETED|Overall Study||0
2193109|NCT03617523|5382602|P5|COMPLETED|Overall Study||60
2193110|NCT03617523|5382603|P4|COMPLETED|Overall Study||59
2193111|NCT03617523|5382604|P3|COMPLETED|Overall Study||61
2193112|NCT03617523|5382605|P2|COMPLETED|Overall Study||30
2193113|NCT03617523|5382606|P1|COMPLETED|Overall Study||30
2193114|NCT03617523|5382602|P5|STARTED|Overall Study||60
2193115|NCT03617523|5382603|P4|STARTED|Overall Study||59
2193116|NCT03617523|5382604|P3|STARTED|Overall Study||61
2193117|NCT03617523|5382605|P2|STARTED|Overall Study||30
2193118|NCT03617523|5382606|P1|STARTED|Overall Study||30
2193119|NCT03617419|5382638|P1|NOT COMPLETED|Part 2||0
2193120|NCT03617419|5382638|P1|COMPLETED|Part 2||14
2193121|NCT03617419|5382638|P1|STARTED|Part 2||14
2193122|NCT03617419|5382638|P1|NOT COMPLETED|Part 1||0
2193123|NCT03617419|5382638|P1|COMPLETED|Part 1||2
2193124|NCT03617419|5382638|P1|STARTED|Part 1||2
2193125|NCT03616171|5382648|P2|NOT COMPLETED|Overall Study||0
2193126|NCT03616171|5382649|P1|NOT COMPLETED|Overall Study||0
2193127|NCT03616171|5382648|P2|COMPLETED|Overall Study||2
2193128|NCT03616171|5382649|P1|COMPLETED|Overall Study||4
2193129|NCT03616171|5382648|P2|STARTED|Overall Study||2
2193130|NCT03616171|5382649|P1|STARTED|Overall Study||4
2193131|NCT03615534|5382666|P4|NOT COMPLETED|Overall Study||1
2193132|NCT03615534|5382667|P3|NOT COMPLETED|Overall Study||0
2193133|NCT03615534|5382668|P2|NOT COMPLETED|Overall Study||0
2193134|NCT03615534|5382669|P1|NOT COMPLETED|Overall Study||2
2193135|NCT03615534|5382666|P4|COMPLETED|Overall Study||13
2193136|NCT03615534|5382667|P3|COMPLETED|Overall Study||14
2193137|NCT03615534|5382668|P2|COMPLETED|Overall Study||15
2193138|NCT03615534|5382669|P1|COMPLETED|Overall Study||12
2193139|NCT03615534|5382666|P4|STARTED|Overall Study||14
2193140|NCT03615534|5382667|P3|STARTED|Overall Study||14
2193141|NCT03615534|5382668|P2|STARTED|Overall Study||15
2193142|NCT03615534|5382669|P1|STARTED|Overall Study||14
2193143|NCT03614975|5382713|P2|NOT COMPLETED|Overall Study||8
2193144|NCT03614975|5382714|P1|NOT COMPLETED|Overall Study||10
2193145|NCT03614975|5382713|P2|COMPLETED|Overall Study||73
2193146|NCT03614975|5382714|P1|COMPLETED|Overall Study||75
2193147|NCT03614975|5382713|P2|STARTED|Overall Study||81
2193148|NCT03614975|5382714|P1|STARTED|Overall Study||85
2193149|NCT03613493|5382728|P4|NOT COMPLETED|Overall Study||7
2193150|NCT03613493|5382729|P3|NOT COMPLETED|Overall Study||0
2193151|NCT03613493|5382730|P2|NOT COMPLETED|Overall Study||2
2193152|NCT03613493|5382731|P1|NOT COMPLETED|Overall Study||0
2193153|NCT03613493|5382728|P4|COMPLETED|Overall Study||83
2193154|NCT03613493|5382729|P3|COMPLETED|Overall Study||0
2193155|NCT03613493|5382730|P2|COMPLETED|Overall Study||73
2193156|NCT03613493|5382731|P1|COMPLETED|Overall Study||10
2193157|NCT03613493|5382728|P4|Enrollment Criteria Met|Overall Study||89
2193158|NCT03613493|5382729|P3|Enrollment Criteria Met|Overall Study||0
2193159|NCT03613493|5382730|P2|Enrollment Criteria Met|Overall Study||74
2193160|NCT03613493|5382731|P1|Enrollment Criteria Met|Overall Study||10
2193161|NCT03613493|5382728|P4|STARTED|Overall Study||90
2193162|NCT03613493|5382729|P3|STARTED|Overall Study||0
2193163|NCT03613493|5382730|P2|STARTED|Overall Study||75
2193164|NCT03613493|5382731|P1|STARTED|Overall Study||10
2193165|NCT03611829|5382742|P2|NOT COMPLETED|Overall Study||25
2193166|NCT03611829|5382743|P1|NOT COMPLETED|Overall Study||22
2193167|NCT03611829|5382742|P2|COMPLETED|Overall Study||19
2193168|NCT03611829|5382743|P1|COMPLETED|Overall Study||21
2193169|NCT03611829|5382742|P2|STARTED|Overall Study||44
2193170|NCT03611829|5382743|P1|STARTED|Overall Study||43
2193171|NCT03610633|5382776|P2|NOT COMPLETED|Overall Study||1
2193172|NCT03610633|5382777|P1|NOT COMPLETED|Overall Study||0
2193173|NCT03610633|5382776|P2|COMPLETED|Overall Study||5
2193174|NCT03610633|5382777|P1|COMPLETED|Overall Study||5
2193175|NCT03610633|5382776|P2|STARTED|Overall Study||6
2193176|NCT03610633|5382777|P1|STARTED|Overall Study||5
2193177|NCT03610464|5382783|P1|NOT COMPLETED|Overall Study||0
2193178|NCT03610464|5382783|P1|COMPLETED|Overall Study||5
2193179|NCT03610464|5382783|P1|STARTED|Overall Study||5
2193180|NCT03610269|5382788|P1|NOT COMPLETED|Overall Study||16
2193181|NCT03610269|5382788|P1|COMPLETED|Overall Study||127
2193182|NCT03610269|5382788|P1|STARTED|Overall Study||143
2193183|NCT03609619|5382794|P2|NOT COMPLETED|Overall Study||6
2193184|NCT03609619|5382795|P1|NOT COMPLETED|Overall Study||10
2193185|NCT03609619|5382794|P2|COMPLETED|Overall Study||49
2193186|NCT03609619|5382795|P1|COMPLETED|Overall Study||44
2193187|NCT03609619|5382794|P2|STARTED|Overall Study||55
2193188|NCT03609619|5382795|P1|STARTED|Overall Study||54
2193189|NCT03608839|5382806|P3|NOT COMPLETED|Overall Study||0
2193190|NCT03608839|5382807|P2|NOT COMPLETED|Overall Study||0
2193191|NCT03608839|5382808|P1|NOT COMPLETED|Overall Study||0
2193192|NCT03608839|5382806|P3|COMPLETED|Overall Study||9
2193193|NCT03608839|5382807|P2|COMPLETED|Overall Study||9
2193194|NCT03608839|5382808|P1|COMPLETED|Overall Study||9
2193195|NCT03608839|5382806|P3|STARTED|Overall Study||9
2193196|NCT03608839|5382807|P2|STARTED|Overall Study||9
2193197|NCT03608839|5382808|P1|STARTED|Overall Study||9
2193198|NCT03605303|5382831|P2|NOT COMPLETED|Period 2||0
2193199|NCT03605303|5382832|P1|NOT COMPLETED|Period 2||0
2193200|NCT03605303|5382831|P2|COMPLETED|Period 2||0
2193201|NCT03605303|5382832|P1|COMPLETED|Period 2||0
2193202|NCT03605303|5382831|P2|STARTED|Period 2||0
2193203|NCT03605303|5382832|P1|STARTED|Period 2||0
2193204|NCT03605303|5382831|P2|NOT COMPLETED|Period 1||1
2193205|NCT03605303|5382832|P1|NOT COMPLETED|Period 1||2
2193206|NCT03605303|5382831|P2|COMPLETED|Period 1||0
2193207|NCT03605303|5382832|P1|COMPLETED|Period 1||0
2193208|NCT03605303|5382831|P2|STARTED|Period 1||1
2193209|NCT03605303|5382832|P1|STARTED|Period 1||2
2193210|NCT03603106|5382851|P11|NOT COMPLETED|Overall Study||0
2193211|NCT03603106|5382852|P10|NOT COMPLETED|Overall Study||0
2193212|NCT03603106|5382853|P9|NOT COMPLETED|Overall Study||0
2193213|NCT03603106|5382854|P8|NOT COMPLETED|Overall Study||0
2193214|NCT03603106|5382855|P7|NOT COMPLETED|Overall Study||0
2193215|NCT03603106|5382856|P6|NOT COMPLETED|Overall Study||0
2193216|NCT03603106|5382857|P5|NOT COMPLETED|Overall Study||0
2193217|NCT03603106|5382858|P4|NOT COMPLETED|Overall Study||0
2193218|NCT03603106|5382859|P3|NOT COMPLETED|Overall Study||0
2193219|NCT03603106|5382860|P2|NOT COMPLETED|Overall Study||0
2193220|NCT03603106|5382861|P1|NOT COMPLETED|Overall Study||0
2193221|NCT03603106|5382851|P11|COMPLETED|Overall Study||3
2193222|NCT03603106|5382852|P10|COMPLETED|Overall Study||3
2193223|NCT03603106|5382853|P9|COMPLETED|Overall Study||3
2193224|NCT03603106|5382854|P8|COMPLETED|Overall Study||3
2193225|NCT03603106|5382855|P7|COMPLETED|Overall Study||18
2193226|NCT03603106|5382856|P6|COMPLETED|Overall Study||6
2193227|NCT03603106|5382857|P5|COMPLETED|Overall Study||6
2193228|NCT03603106|5382858|P4|COMPLETED|Overall Study||6
2193229|NCT03603106|5382859|P3|COMPLETED|Overall Study||6
2193230|NCT03603106|5382860|P2|COMPLETED|Overall Study||6
2193231|NCT03603106|5382861|P1|COMPLETED|Overall Study||6
2193232|NCT03603106|5382851|P11|STARTED|Overall Study||3
2193233|NCT03603106|5382852|P10|STARTED|Overall Study||3
2193234|NCT03603106|5382853|P9|STARTED|Overall Study||3
2193235|NCT03603106|5382854|P8|STARTED|Overall Study||3
2193236|NCT03603106|5382855|P7|STARTED|Overall Study||18
2193237|NCT03603106|5382856|P6|STARTED|Overall Study||6
2193238|NCT03603106|5382857|P5|STARTED|Overall Study||6
2193239|NCT03603106|5382858|P4|STARTED|Overall Study||6
2193240|NCT03603106|5382859|P3|STARTED|Overall Study||6
2193241|NCT03603106|5382860|P2|STARTED|Overall Study||6
2193242|NCT03603106|5382861|P1|STARTED|Overall Study||6
2193243|NCT03603028|5382914|P1|NOT COMPLETED|Overall Study||1
2193244|NCT03603028|5382914|P1|COMPLETED|Overall Study||12
2193245|NCT03603028|5382914|P1|STARTED|Overall Study||13
2193246|NCT03601715|5382922|P3|NOT COMPLETED|Third Intervention||0
2193247|NCT03601715|5382923|P2|NOT COMPLETED|Third Intervention||0
2193248|NCT03601715|5382924|P1|NOT COMPLETED|Third Intervention||0
2193249|NCT03601715|5382922|P3|COMPLETED|Third Intervention||6
2193250|NCT03601715|5382923|P2|COMPLETED|Third Intervention||6
2193251|NCT03601715|5382924|P1|COMPLETED|Third Intervention||6
2193252|NCT03601715|5382922|P3|STARTED|Third Intervention||6
2193253|NCT03601715|5382923|P2|STARTED|Third Intervention||6
2193254|NCT03601715|5382924|P1|STARTED|Third Intervention||6
2193255|NCT03601715|5382922|P3|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
2193256|NCT03601715|5382923|P2|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
2193257|NCT03601715|5382924|P1|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
2193258|NCT03601715|5382922|P3|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
2193259|NCT03601715|5382923|P2|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
2193260|NCT03601715|5382924|P1|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
2193261|NCT03601715|5382922|P3|STARTED|Wash Out 2 (at Least 24 Hours)||6
2193262|NCT03601715|5382923|P2|STARTED|Wash Out 2 (at Least 24 Hours)||6
2193263|NCT03601715|5382924|P1|STARTED|Wash Out 2 (at Least 24 Hours)||6
2193264|NCT03601715|5382922|P3|NOT COMPLETED|Second Intervention||0
2193265|NCT03601715|5382923|P2|NOT COMPLETED|Second Intervention||1
2193266|NCT03601715|5382924|P1|NOT COMPLETED|Second Intervention||1
2193267|NCT03601715|5382922|P3|COMPLETED|Second Intervention||6
2193268|NCT03601715|5382923|P2|COMPLETED|Second Intervention||6
2193269|NCT03601715|5382924|P1|COMPLETED|Second Intervention||6
2193270|NCT03601715|5382922|P3|STARTED|Second Intervention||6
2193271|NCT03601715|5382923|P2|STARTED|Second Intervention||7
2193272|NCT03601715|5382924|P1|STARTED|Second Intervention||7
2193273|NCT03601715|5382922|P3|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
2193274|NCT03601715|5382923|P2|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
2193275|NCT03601715|5382924|P1|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
2193276|NCT03601715|5382922|P3|COMPLETED|Washout 1 (at Least 24 Hours)||6
2193277|NCT03601715|5382923|P2|COMPLETED|Washout 1 (at Least 24 Hours)||7
2193278|NCT03601715|5382924|P1|COMPLETED|Washout 1 (at Least 24 Hours)||7
2193279|NCT03601715|5382922|P3|STARTED|Washout 1 (at Least 24 Hours)||6
2193280|NCT03601715|5382923|P2|STARTED|Washout 1 (at Least 24 Hours)||7
2193281|NCT03601715|5382924|P1|STARTED|Washout 1 (at Least 24 Hours)||7
2193282|NCT03601715|5382922|P3|NOT COMPLETED|First Intervention||0
2193283|NCT03601715|5382923|P2|NOT COMPLETED|First Intervention||0
2193284|NCT03601715|5382924|P1|NOT COMPLETED|First Intervention||0
2193285|NCT03601715|5382922|P3|COMPLETED|First Intervention||6
2193286|NCT03601715|5382923|P2|COMPLETED|First Intervention||7
2193287|NCT03601715|5382924|P1|COMPLETED|First Intervention||7
2193288|NCT03601715|5382922|P3|STARTED|First Intervention||6
2193289|NCT03601715|5382923|P2|STARTED|First Intervention||7
2193290|NCT03601715|5382924|P1|STARTED|First Intervention||7
2193291|NCT03599349|5382938|P1|NOT COMPLETED|Overall Study||1
2193292|NCT03599349|5382938|P1|COMPLETED|Overall Study||19
2193293|NCT03599349|5382938|P1|Treated|Overall Study||20
2193294|NCT03599349|5382938|P1|STARTED|Overall Study||20
2193295|NCT03597178|5382950|P1|NOT COMPLETED|Overall Study||0
2193296|NCT03597178|5382950|P1|COMPLETED|Overall Study||14
2193297|NCT03597178|5382950|P1|STARTED|Overall Study||14
2193298|NCT03595215|5382954|P1|NOT COMPLETED|Overall Study||8
2193299|NCT03595215|5382954|P1|COMPLETED|Overall Study||10
2193300|NCT03595215|5382954|P1|STARTED|Overall Study||18
2193301|NCT03591458|5382960|P2|NOT COMPLETED|Overall Study||0
2193302|NCT03591458|5382961|P1|NOT COMPLETED|Overall Study||0
2193303|NCT03591458|5382960|P2|COMPLETED|Overall Study||1
2193304|NCT03591458|5382961|P1|COMPLETED|Overall Study||1
2193305|NCT03591458|5382960|P2|STARTED|Overall Study||1
2193306|NCT03591458|5382961|P1|STARTED|Overall Study||1
2193307|NCT03590613|5382989|P4|NOT COMPLETED|Period 4, 4 Days||0
2193308|NCT03590613|5382990|P3|NOT COMPLETED|Period 4, 4 Days||0
2193309|NCT03590613|5382991|P2|NOT COMPLETED|Period 4, 4 Days||0
2193310|NCT03590613|5382992|P1|NOT COMPLETED|Period 4, 4 Days||0
2193311|NCT03590613|5382989|P4|COMPLETED|Period 4, 4 Days||3
2193312|NCT03590613|5382990|P3|COMPLETED|Period 4, 4 Days||3
2193313|NCT03590613|5382991|P2|COMPLETED|Period 4, 4 Days||3
2193314|NCT03590613|5382992|P1|COMPLETED|Period 4, 4 Days||3
2193315|NCT03590613|5382989|P4|STARTED|Period 4, 4 Days||3
2193316|NCT03590613|5382990|P3|STARTED|Period 4, 4 Days||3
2193317|NCT03590613|5382991|P2|STARTED|Period 4, 4 Days||3
2193318|NCT03590613|5382992|P1|STARTED|Period 4, 4 Days||3
2193319|NCT03590613|5382989|P4|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
2193320|NCT03590613|5382990|P3|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
2193321|NCT03590613|5382991|P2|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
2193322|NCT03590613|5382992|P1|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
2193323|NCT03590613|5382989|P4|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
2193324|NCT03590613|5382990|P3|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
2193325|NCT03590613|5382991|P2|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
2193326|NCT03590613|5382992|P1|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
2193327|NCT03590613|5382989|P4|STARTED|Period 3,Wash-out, at Least 3 Days||3
2193328|NCT03590613|5382990|P3|STARTED|Period 3,Wash-out, at Least 3 Days||3
2193329|NCT03590613|5382991|P2|STARTED|Period 3,Wash-out, at Least 3 Days||3
2193330|NCT03590613|5382992|P1|STARTED|Period 3,Wash-out, at Least 3 Days||3
2193331|NCT03590613|5382989|P4|NOT COMPLETED|Period 3, 4 Days||0
2193332|NCT03590613|5382990|P3|NOT COMPLETED|Period 3, 4 Days||0
2193333|NCT03590613|5382991|P2|NOT COMPLETED|Period 3, 4 Days||0
2193334|NCT03590613|5382992|P1|NOT COMPLETED|Period 3, 4 Days||0
2193335|NCT03590613|5382989|P4|COMPLETED|Period 3, 4 Days||3
2193336|NCT03590613|5382990|P3|COMPLETED|Period 3, 4 Days||3
2193337|NCT03590613|5382991|P2|COMPLETED|Period 3, 4 Days||3
2193338|NCT03590613|5382992|P1|COMPLETED|Period 3, 4 Days||3
2193339|NCT03590613|5382989|P4|STARTED|Period 3, 4 Days||3
2193340|NCT03590613|5382990|P3|STARTED|Period 3, 4 Days||3
2193341|NCT03590613|5382991|P2|STARTED|Period 3, 4 Days||3
2193342|NCT03590613|5382992|P1|STARTED|Period 3, 4 Days||3
2193343|NCT03590613|5382989|P4|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
2193344|NCT03590613|5382990|P3|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
2193345|NCT03590613|5382991|P2|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
2193346|NCT03590613|5382992|P1|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
2193347|NCT03590613|5382989|P4|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
2193348|NCT03590613|5382990|P3|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
2193349|NCT03590613|5382991|P2|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
2193350|NCT03590613|5382992|P1|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
2193351|NCT03590613|5382989|P4|STARTED|Period 2, Wash-out, at Least 3 Days||3
2193352|NCT03590613|5382990|P3|STARTED|Period 2, Wash-out, at Least 3 Days||3
2193353|NCT03590613|5382991|P2|STARTED|Period 2, Wash-out, at Least 3 Days||3
2193354|NCT03590613|5382992|P1|STARTED|Period 2, Wash-out, at Least 3 Days||3
2193355|NCT03590613|5382989|P4|NOT COMPLETED|Period 2, 4 Days||1
2193356|NCT03590613|5382990|P3|NOT COMPLETED|Period 2, 4 Days||0
2193357|NCT03590613|5382991|P2|NOT COMPLETED|Period 2, 4 Days||0
2193358|NCT03590613|5382992|P1|NOT COMPLETED|Period 2, 4 Days||0
2193359|NCT03590613|5382989|P4|COMPLETED|Period 2, 4 Days||3
2193360|NCT03590613|5382990|P3|COMPLETED|Period 2, 4 Days||3
2193361|NCT03590613|5382991|P2|COMPLETED|Period 2, 4 Days||3
2193362|NCT03590613|5382992|P1|COMPLETED|Period 2, 4 Days||3
2193363|NCT03590613|5382989|P4|STARTED|Period 2, 4 Days|One additional participant was enrolled in Period 2.|4
2193364|NCT03590613|5382990|P3|STARTED|Period 2, 4 Days||3
2193365|NCT03590613|5382991|P2|STARTED|Period 2, 4 Days||3
2193366|NCT03590613|5382992|P1|STARTED|Period 2, 4 Days||3
2193367|NCT03590613|5382989|P4|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
2193368|NCT03590613|5382990|P3|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
2193369|NCT03590613|5382991|P2|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
2193370|NCT03590613|5382992|P1|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
2193371|NCT03590613|5382989|P4|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
2193372|NCT03590613|5382990|P3|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
2193373|NCT03590613|5382991|P2|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
2193374|NCT03590613|5382992|P1|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
2193375|NCT03590613|5382989|P4|STARTED|Period 1, Wash-out, at Least 3 Days||3
2193376|NCT03590613|5382990|P3|STARTED|Period 1, Wash-out, at Least 3 Days||3
2193377|NCT03590613|5382991|P2|STARTED|Period 1, Wash-out, at Least 3 Days||3
2193378|NCT03590613|5382992|P1|STARTED|Period 1, Wash-out, at Least 3 Days||3
2193379|NCT03590613|5382989|P4|NOT COMPLETED|Period 1, 4 Days||0
2193380|NCT03590613|5382990|P3|NOT COMPLETED|Period 1, 4 Days||0
2193381|NCT03590613|5382991|P2|NOT COMPLETED|Period 1, 4 Days||0
2193382|NCT03590613|5382992|P1|NOT COMPLETED|Period 1, 4 Days||0
2193383|NCT03590613|5382989|P4|COMPLETED|Period 1, 4 Days||3
2193384|NCT03590613|5382990|P3|COMPLETED|Period 1, 4 Days||3
2193385|NCT03590613|5382991|P2|COMPLETED|Period 1, 4 Days||3
2193386|NCT03590613|5382992|P1|COMPLETED|Period 1, 4 Days||3
2193387|NCT03590613|5382989|P4|STARTED|Period 1, 4 Days||3
2193388|NCT03590613|5382990|P3|STARTED|Period 1, 4 Days||3
2193389|NCT03590613|5382991|P2|STARTED|Period 1, 4 Days||3
2193390|NCT03590613|5382992|P1|STARTED|Period 1, 4 Days||3
2193391|NCT03588572|5383112|P2|NOT COMPLETED|Visitation 3||2
2193392|NCT03588572|5383113|P1|NOT COMPLETED|Visitation 3||3
2193393|NCT03588572|5383112|P2|COMPLETED|Visitation 3||16
2193394|NCT03588572|5383113|P1|COMPLETED|Visitation 3||16
2193395|NCT03588572|5383112|P2|STARTED|Visitation 3||18
2193396|NCT03588572|5383113|P1|STARTED|Visitation 3||19
2193397|NCT03588572|5383112|P2|NOT COMPLETED|Visitation 2||2
2193398|NCT03588572|5383113|P1|NOT COMPLETED|Visitation 2||2
2193399|NCT03588572|5383112|P2|COMPLETED|Visitation 2||18
2193400|NCT03588572|5383113|P1|COMPLETED|Visitation 2||19
2193401|NCT03588572|5383112|P2|STARTED|Visitation 2||20
2193402|NCT03588572|5383113|P1|STARTED|Visitation 2||21
2193403|NCT03588572|5383112|P2|NOT COMPLETED|Visitation 1||1
2193404|NCT03588572|5383113|P1|NOT COMPLETED|Visitation 1||1
2193405|NCT03588572|5383112|P2|COMPLETED|Visitation 1||20
2193406|NCT03588572|5383113|P1|COMPLETED|Visitation 1||21
2193407|NCT03588572|5383112|P2|STARTED|Visitation 1||21
2193408|NCT03588572|5383113|P1|STARTED|Visitation 1||22
2193409|NCT03587428|5383129|P6|NOT COMPLETED|Period 3||0
2193410|NCT03587428|5383130|P5|NOT COMPLETED|Period 3||0
2193411|NCT03587428|5383131|P4|NOT COMPLETED|Period 3||0
2193412|NCT03587428|5383132|P3|NOT COMPLETED|Period 3||0
2193413|NCT03587428|5383133|P2|NOT COMPLETED|Period 3||0
2193414|NCT03587428|5383134|P1|NOT COMPLETED|Period 3||0
2193415|NCT03587428|5383129|P6|COMPLETED|Period 3||2
2193416|NCT03587428|5383130|P5|COMPLETED|Period 3||2
2193417|NCT03587428|5383131|P4|COMPLETED|Period 3||3
2193418|NCT03587428|5383132|P3|COMPLETED|Period 3||3
2193419|NCT03587428|5383133|P2|COMPLETED|Period 3||2
2193420|NCT03587428|5383134|P1|COMPLETED|Period 3||3
2193421|NCT03587428|5383129|P6|STARTED|Period 3||2
2193422|NCT03587428|5383130|P5|STARTED|Period 3||2
2193423|NCT03587428|5383131|P4|STARTED|Period 3||3
2193424|NCT03587428|5383132|P3|STARTED|Period 3||3
2193425|NCT03587428|5383133|P2|STARTED|Period 3||2
2193426|NCT03587428|5383134|P1|STARTED|Period 3||3
2193427|NCT03587428|5383129|P6|NOT COMPLETED|Period 2||0
2193428|NCT03587428|5383130|P5|NOT COMPLETED|Period 2||0
2193429|NCT03587428|5383131|P4|NOT COMPLETED|Period 2||0
2193430|NCT03587428|5383132|P3|NOT COMPLETED|Period 2||0
2193431|NCT03587428|5383133|P2|NOT COMPLETED|Period 2||0
2193432|NCT03587428|5383134|P1|NOT COMPLETED|Period 2||0
2193433|NCT03587428|5383129|P6|COMPLETED|Period 2||2
2193434|NCT03587428|5383130|P5|COMPLETED|Period 2||2
2193435|NCT03587428|5383131|P4|COMPLETED|Period 2||3
2193436|NCT03587428|5383132|P3|COMPLETED|Period 2||3
2193437|NCT03587428|5383133|P2|COMPLETED|Period 2||2
2193438|NCT03587428|5383134|P1|COMPLETED|Period 2||3
2193439|NCT03587428|5383129|P6|STARTED|Period 2||2
2193440|NCT03587428|5383130|P5|STARTED|Period 2||2
2193441|NCT03587428|5383131|P4|STARTED|Period 2||3
2193442|NCT03587428|5383132|P3|STARTED|Period 2||3
2193443|NCT03587428|5383133|P2|STARTED|Period 2||2
2193444|NCT03587428|5383134|P1|STARTED|Period 2||3
2193445|NCT03587428|5383129|P6|NOT COMPLETED|Period 1||0
2193446|NCT03587428|5383130|P5|NOT COMPLETED|Period 1||0
2193447|NCT03587428|5383131|P4|NOT COMPLETED|Period 1||0
2193448|NCT03587428|5383132|P3|NOT COMPLETED|Period 1||0
2193449|NCT03587428|5383133|P2|NOT COMPLETED|Period 1||0
2193450|NCT03587428|5383134|P1|NOT COMPLETED|Period 1||0
2193451|NCT03587428|5383129|P6|COMPLETED|Period 1||2
2193452|NCT03587428|5383130|P5|COMPLETED|Period 1||2
2193453|NCT03587428|5383131|P4|COMPLETED|Period 1||3
2193454|NCT03587428|5383132|P3|COMPLETED|Period 1||3
2193455|NCT03587428|5383133|P2|COMPLETED|Period 1||2
2193456|NCT03587428|5383134|P1|COMPLETED|Period 1||3
2193457|NCT03587428|5383129|P6|STARTED|Period 1||2
2193458|NCT03587428|5383130|P5|STARTED|Period 1||2
2193459|NCT03587428|5383131|P4|STARTED|Period 1||3
2193460|NCT03587428|5383132|P3|STARTED|Period 1||3
2193461|NCT03587428|5383133|P2|STARTED|Period 1||2
2193462|NCT03587428|5383134|P1|STARTED|Period 1||3
2193463|NCT03587207|5383156|P5|NOT COMPLETED|Overall Study||0
2193464|NCT03587207|5383157|P4|NOT COMPLETED|Overall Study||0
2193465|NCT03587207|5383158|P3|NOT COMPLETED|Overall Study||0
2193466|NCT03587207|5383159|P2|NOT COMPLETED|Overall Study||0
2193467|NCT03587207|5383160|P1|NOT COMPLETED|Overall Study||0
2193468|NCT03587207|5383156|P5|COMPLETED|Overall Study||102
2193469|NCT03587207|5383157|P4|COMPLETED|Overall Study||94
2193470|NCT03587207|5383158|P3|COMPLETED|Overall Study||100
2193471|NCT03587207|5383159|P2|COMPLETED|Overall Study||104
2193472|NCT03587207|5383160|P1|COMPLETED|Overall Study||100
2193473|NCT03587207|5383156|P5|STARTED|Overall Study||102
2193474|NCT03587207|5383157|P4|STARTED|Overall Study||94
2193475|NCT03587207|5383158|P3|STARTED|Overall Study||100
2193476|NCT03587207|5383159|P2|STARTED|Overall Study||104
2193477|NCT03587207|5383160|P1|STARTED|Overall Study||100
2193478|NCT03586830|5383235|P4|NOT COMPLETED|Overall Study||5
2193479|NCT03586830|5383236|P3|NOT COMPLETED|Overall Study||8
2193480|NCT03586830|5383237|P2|NOT COMPLETED|Overall Study||6
2193481|NCT03586830|5383238|P1|NOT COMPLETED|Overall Study||2
2193482|NCT03586830|5383235|P4|COMPLETED|Overall Study||44
2193483|NCT03586830|5383236|P3|COMPLETED|Overall Study||41
2193484|NCT03586830|5383237|P2|COMPLETED|Overall Study||42
2193485|NCT03586830|5383238|P1|COMPLETED|Overall Study||48
2193486|NCT03586830|5383235|P4|Treated|Overall Study||49
2193487|NCT03586830|5383236|P3|Treated|Overall Study||49
2193488|NCT03586830|5383237|P2|Treated|Overall Study||48
2193489|NCT03586830|5383238|P1|Treated|Overall Study||49
2193490|NCT03586830|5383235|P4|STARTED|Overall Study||49
2193491|NCT03586830|5383236|P3|STARTED|Overall Study||49
2193492|NCT03586830|5383237|P2|STARTED|Overall Study||48
2193493|NCT03586830|5383238|P1|STARTED|Overall Study||50
2193494|NCT03586726|5383260|P1|NOT COMPLETED|Overall Study||1
2193495|NCT03586726|5383260|P1|COMPLETED|Overall Study||15
2193496|NCT03586726|5383260|P1|STARTED|Overall Study||16
2193497|NCT03585790|5383279|P2|NOT COMPLETED|Second Intervention (1 Week)||0
2193498|NCT03585790|5383280|P1|NOT COMPLETED|Second Intervention (1 Week)||0
2193499|NCT03585790|5383279|P2|COMPLETED|Second Intervention (1 Week)||22
2193500|NCT03585790|5383280|P1|COMPLETED|Second Intervention (1 Week)||23
2193501|NCT03585790|5383279|P2|STARTED|Second Intervention (1 Week)||22
2193502|NCT03585790|5383280|P1|STARTED|Second Intervention (1 Week)||23
2193503|NCT03585790|5383279|P2|NOT COMPLETED|First Intervention (1 Week)||0
2193504|NCT03585790|5383280|P1|NOT COMPLETED|First Intervention (1 Week)||0
2193505|NCT03585790|5383279|P2|COMPLETED|First Intervention (1 Week)||22
2193506|NCT03585790|5383280|P1|COMPLETED|First Intervention (1 Week)||23
2193507|NCT03585790|5383279|P2|STARTED|First Intervention (1 Week)||22
2193508|NCT03585790|5383280|P1|STARTED|First Intervention (1 Week)||23
2193509|NCT03585504|5383289|P2|NOT COMPLETED|Overall Study||29
2193510|NCT03585504|5383290|P1|NOT COMPLETED|Overall Study||26
2193511|NCT03585504|5383289|P2|COMPLETED|Overall Study||11
2193512|NCT03585504|5383290|P1|COMPLETED|Overall Study||15
2193513|NCT03585504|5383289|P2|STARTED|Overall Study||40
2193514|NCT03585504|5383290|P1|STARTED|Overall Study||41
2193518|NCT03583385|5383304|P2|NOT COMPLETED|Treatment Period 2||0
2193519|NCT03583385|5383305|P1|NOT COMPLETED|Treatment Period 2||1
2193520|NCT03583385|5383304|P2|COMPLETED|Treatment Period 2||23
2193521|NCT03583385|5383305|P1|COMPLETED|Treatment Period 2||21
2193522|NCT03583385|5383304|P2|STARTED|Treatment Period 2||23
2193523|NCT03583385|5383305|P1|STARTED|Treatment Period 2|Of 46 participants who completed period 1, 45 entered period2 & 1 participant didn’t attend period2.|22
2193524|NCT03583385|5383304|P2|NOT COMPLETED|Treatment Period 1||1
2193525|NCT03583385|5383305|P1|NOT COMPLETED|Treatment Period 1||1
2193526|NCT03583385|5383304|P2|COMPLETED|Treatment Period 1||23
2193527|NCT03583385|5383305|P1|COMPLETED|Treatment Period 1||23
2193528|NCT03583385|5383304|P2|STARTED|Treatment Period 1||24
2193529|NCT03583385|5383305|P1|STARTED|Treatment Period 1||24
2193530|NCT03582943|5383323|P2|NOT COMPLETED|Analyzed||1
2193531|NCT03582943|5383324|P1|NOT COMPLETED|Analyzed||4
2193532|NCT03582943|5383323|P2|COMPLETED|Analyzed||36
2193533|NCT03582943|5383324|P1|COMPLETED|Analyzed||33
2193534|NCT03582943|5383323|P2|STARTED|Analyzed||37
2193535|NCT03582943|5383324|P1|STARTED|Analyzed||37
2193536|NCT03582943|5383323|P2|NOT COMPLETED|Intervention and Follow up||2
2193537|NCT03582943|5383324|P1|NOT COMPLETED|Intervention and Follow up||4
2193538|NCT03582943|5383323|P2|COMPLETED|Intervention and Follow up||37
2193539|NCT03582943|5383324|P1|COMPLETED|Intervention and Follow up||37
2193540|NCT03582943|5383323|P2|STARTED|Intervention and Follow up||39
2193541|NCT03582943|5383324|P1|STARTED|Intervention and Follow up||41
2193542|NCT03582943|5383323|P2|NOT COMPLETED|Allocated to Groups||1
2193543|NCT03582943|5383324|P1|NOT COMPLETED|Allocated to Groups||1
2193544|NCT03582943|5383323|P2|COMPLETED|Allocated to Groups||39
2193545|NCT03582943|5383324|P1|COMPLETED|Allocated to Groups||41
2193546|NCT03582943|5383323|P2|STARTED|Allocated to Groups||40
2193547|NCT03582943|5383324|P1|STARTED|Allocated to Groups||42
2193548|NCT03582553|5383336|P6|NOT COMPLETED|Intervention 3/Visit 3||0
2193549|NCT03582553|5383337|P5|NOT COMPLETED|Intervention 3/Visit 3||0
2193550|NCT03582553|5383338|P4|NOT COMPLETED|Intervention 3/Visit 3||0
2193551|NCT03582553|5383339|P3|NOT COMPLETED|Intervention 3/Visit 3||0
2193552|NCT03582553|5383340|P2|NOT COMPLETED|Intervention 3/Visit 3||0
2193553|NCT03582553|5383341|P1|NOT COMPLETED|Intervention 3/Visit 3||0
2193554|NCT03582553|5383336|P6|COMPLETED|Intervention 3/Visit 3||3
2193555|NCT03582553|5383337|P5|COMPLETED|Intervention 3/Visit 3||3
2193556|NCT03582553|5383338|P4|COMPLETED|Intervention 3/Visit 3||3
2193557|NCT03582553|5383339|P3|COMPLETED|Intervention 3/Visit 3||3
2193558|NCT03582553|5383340|P2|COMPLETED|Intervention 3/Visit 3||3
2193559|NCT03582553|5383341|P1|COMPLETED|Intervention 3/Visit 3||3
2193560|NCT03582553|5383336|P6|STARTED|Intervention 3/Visit 3||3
2193561|NCT03582553|5383337|P5|STARTED|Intervention 3/Visit 3||3
2193562|NCT03582553|5383338|P4|STARTED|Intervention 3/Visit 3||3
2193563|NCT03582553|5383339|P3|STARTED|Intervention 3/Visit 3||3
2193564|NCT03582553|5383340|P2|STARTED|Intervention 3/Visit 3||3
2193565|NCT03582553|5383341|P1|STARTED|Intervention 3/Visit 3||3
2193566|NCT03582553|5383336|P6|NOT COMPLETED|Washout Period (At Least 1 Week)||0
2193567|NCT03582553|5383337|P5|NOT COMPLETED|Washout Period (At Least 1 Week)||0
2193568|NCT03582553|5383338|P4|NOT COMPLETED|Washout Period (At Least 1 Week)||0
2193569|NCT03582553|5383339|P3|NOT COMPLETED|Washout Period (At Least 1 Week)||0
2193570|NCT03582553|5383340|P2|NOT COMPLETED|Washout Period (At Least 1 Week)||0
2193571|NCT03582553|5383341|P1|NOT COMPLETED|Washout Period (At Least 1 Week)||0
2193572|NCT03582553|5383336|P6|COMPLETED|Washout Period (At Least 1 Week)||3
2193573|NCT03582553|5383337|P5|COMPLETED|Washout Period (At Least 1 Week)||3
2193574|NCT03582553|5383338|P4|COMPLETED|Washout Period (At Least 1 Week)||3
2193575|NCT03582553|5383339|P3|COMPLETED|Washout Period (At Least 1 Week)||3
2193576|NCT03582553|5383340|P2|COMPLETED|Washout Period (At Least 1 Week)||3
2193577|NCT03582553|5383341|P1|COMPLETED|Washout Period (At Least 1 Week)||3
2193578|NCT03582553|5383336|P6|STARTED|Washout Period (At Least 1 Week)||3
2193579|NCT03582553|5383337|P5|STARTED|Washout Period (At Least 1 Week)||3
2193580|NCT03582553|5383338|P4|STARTED|Washout Period (At Least 1 Week)||3
2193581|NCT03582553|5383339|P3|STARTED|Washout Period (At Least 1 Week)||3
2193582|NCT03582553|5383340|P2|STARTED|Washout Period (At Least 1 Week)||3
2193583|NCT03582553|5383341|P1|STARTED|Washout Period (At Least 1 Week)||3
2193584|NCT03582553|5383336|P6|NOT COMPLETED|Intervention 2/Visit 2||0
2193585|NCT03582553|5383337|P5|NOT COMPLETED|Intervention 2/Visit 2||0
2193586|NCT03582553|5383338|P4|NOT COMPLETED|Intervention 2/Visit 2||0
2193587|NCT03582553|5383339|P3|NOT COMPLETED|Intervention 2/Visit 2||0
2193588|NCT03582553|5383340|P2|NOT COMPLETED|Intervention 2/Visit 2||0
2193589|NCT03582553|5383341|P1|NOT COMPLETED|Intervention 2/Visit 2||0
2193590|NCT03582553|5383336|P6|COMPLETED|Intervention 2/Visit 2||3
2193591|NCT03582553|5383337|P5|COMPLETED|Intervention 2/Visit 2||3
2193592|NCT03582553|5383338|P4|COMPLETED|Intervention 2/Visit 2||3
2193593|NCT03582553|5383339|P3|COMPLETED|Intervention 2/Visit 2||3
2193594|NCT03582553|5383340|P2|COMPLETED|Intervention 2/Visit 2||3
2193595|NCT03582553|5383341|P1|COMPLETED|Intervention 2/Visit 2||3
2193596|NCT03582553|5383336|P6|STARTED|Intervention 2/Visit 2||3
2193597|NCT03582553|5383337|P5|STARTED|Intervention 2/Visit 2||3
2193598|NCT03582553|5383338|P4|STARTED|Intervention 2/Visit 2||3
2193599|NCT03582553|5383339|P3|STARTED|Intervention 2/Visit 2||3
2193600|NCT03582553|5383340|P2|STARTED|Intervention 2/Visit 2||3
2193601|NCT03582553|5383341|P1|STARTED|Intervention 2/Visit 2||3
2193602|NCT03582553|5383336|P6|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
2193603|NCT03582553|5383337|P5|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
2193604|NCT03582553|5383338|P4|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
2193605|NCT03582553|5383339|P3|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
2193606|NCT03582553|5383340|P2|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
2193607|NCT03582553|5383341|P1|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
2193608|NCT03582553|5383336|P6|COMPLETED|Washout Period ( At Least 1 Week)||3
2193609|NCT03582553|5383337|P5|COMPLETED|Washout Period ( At Least 1 Week)||3
2193610|NCT03582553|5383338|P4|COMPLETED|Washout Period ( At Least 1 Week)||3
2193611|NCT03582553|5383339|P3|COMPLETED|Washout Period ( At Least 1 Week)||3
2193612|NCT03582553|5383340|P2|COMPLETED|Washout Period ( At Least 1 Week)||3
2193613|NCT03582553|5383341|P1|COMPLETED|Washout Period ( At Least 1 Week)||3
2193614|NCT03582553|5383336|P6|STARTED|Washout Period ( At Least 1 Week)||3
2193615|NCT03582553|5383337|P5|STARTED|Washout Period ( At Least 1 Week)||3
2193616|NCT03582553|5383338|P4|STARTED|Washout Period ( At Least 1 Week)||3
2193617|NCT03582553|5383339|P3|STARTED|Washout Period ( At Least 1 Week)||3
2193618|NCT03582553|5383340|P2|STARTED|Washout Period ( At Least 1 Week)||3
2193619|NCT03582553|5383341|P1|STARTED|Washout Period ( At Least 1 Week)||3
2193620|NCT03582553|5383336|P6|NOT COMPLETED|Intervention 1/Visit 1||0
2193621|NCT03582553|5383337|P5|NOT COMPLETED|Intervention 1/Visit 1||0
2193622|NCT03582553|5383338|P4|NOT COMPLETED|Intervention 1/Visit 1||0
2193623|NCT03582553|5383339|P3|NOT COMPLETED|Intervention 1/Visit 1||0
2193624|NCT03582553|5383340|P2|NOT COMPLETED|Intervention 1/Visit 1||0
2193625|NCT03582553|5383341|P1|NOT COMPLETED|Intervention 1/Visit 1||0
2193626|NCT03582553|5383336|P6|COMPLETED|Intervention 1/Visit 1||3
2193627|NCT03582553|5383337|P5|COMPLETED|Intervention 1/Visit 1||3
2193628|NCT03582553|5383338|P4|COMPLETED|Intervention 1/Visit 1||3
2193629|NCT03582553|5383339|P3|COMPLETED|Intervention 1/Visit 1||3
2193630|NCT03582553|5383340|P2|COMPLETED|Intervention 1/Visit 1||3
2193631|NCT03582553|5383341|P1|COMPLETED|Intervention 1/Visit 1||3
2193632|NCT03582553|5383336|P6|STARTED|Intervention 1/Visit 1||3
2193633|NCT03582553|5383337|P5|STARTED|Intervention 1/Visit 1||3
2193634|NCT03582553|5383338|P4|STARTED|Intervention 1/Visit 1||3
2193635|NCT03582553|5383339|P3|STARTED|Intervention 1/Visit 1||3
2193636|NCT03582553|5383340|P2|STARTED|Intervention 1/Visit 1||3
2193637|NCT03582553|5383341|P1|STARTED|Intervention 1/Visit 1||3
2193638|NCT03581474|5383371|P1|NOT COMPLETED|Overall Study||0
2193639|NCT03581474|5383371|P1|COMPLETED|Overall Study||12
2193640|NCT03581474|5383371|P1|STARTED|Overall Study||12
2193641|NCT03581097|5383377|P2|NOT COMPLETED|Overall Study||0
2193642|NCT03581097|5383378|P1|NOT COMPLETED|Overall Study||0
2193643|NCT03581097|5383377|P2|COMPLETED|Overall Study||47
2193644|NCT03581097|5383378|P1|COMPLETED|Overall Study||46
2193645|NCT03581097|5383377|P2|STARTED|Overall Study||47
2193646|NCT03581097|5383378|P1|STARTED|Overall Study||46
2193647|NCT03579940|5383409|P11|NOT COMPLETED|Period 3||0
2193648|NCT03579940|5383410|P10|NOT COMPLETED|Period 3||0
2193649|NCT03579940|5383411|P9|NOT COMPLETED|Period 3||0
2193650|NCT03579940|5383412|P8|NOT COMPLETED|Period 3||0
2193651|NCT03579940|5383413|P7|NOT COMPLETED|Period 3||0
2193652|NCT03579940|5383414|P6|NOT COMPLETED|Period 3||0
2193653|NCT03579940|5383415|P5|NOT COMPLETED|Period 3||0
2193654|NCT03579940|5383416|P4|NOT COMPLETED|Period 3||0
2193655|NCT03579940|5383417|P3|NOT COMPLETED|Period 3||0
2193656|NCT03579940|5383418|P2|NOT COMPLETED|Period 3||0
2193657|NCT03579940|5383419|P1|NOT COMPLETED|Period 3||0
2193658|NCT03579940|5383409|P11|COMPLETED|Period 3||3
2193659|NCT03579940|5383410|P10|COMPLETED|Period 3||2
2193660|NCT03579940|5383411|P9|COMPLETED|Period 3||3
2193661|NCT03579940|5383412|P8|COMPLETED|Period 3||3
2193662|NCT03579940|5383413|P7|COMPLETED|Period 3||3
2193663|NCT03579940|5383414|P6|COMPLETED|Period 3||2
2193664|NCT03579940|5383415|P5|COMPLETED|Period 3||2
2193665|NCT03579940|5383416|P4|COMPLETED|Period 3||2
2193666|NCT03579940|5383417|P3|COMPLETED|Period 3||1
2193667|NCT03579940|5383418|P2|COMPLETED|Period 3||2
2193668|NCT03579940|5383419|P1|COMPLETED|Period 3||3
2193669|NCT03579940|5383409|P11|STARTED|Period 3||3
2193670|NCT03579940|5383410|P10|STARTED|Period 3||2
2193671|NCT03579940|5383411|P9|STARTED|Period 3||3
2193672|NCT03579940|5383412|P8|STARTED|Period 3||3
2193673|NCT03579940|5383413|P7|STARTED|Period 3||3
2193674|NCT03579940|5383414|P6|STARTED|Period 3||2
2193675|NCT03579940|5383415|P5|STARTED|Period 3||2
2193676|NCT03579940|5383416|P4|STARTED|Period 3||2
2193677|NCT03579940|5383417|P3|STARTED|Period 3||1
2193678|NCT03579940|5383418|P2|STARTED|Period 3||2
2193679|NCT03579940|5383419|P1|STARTED|Period 3||3
2193680|NCT03579940|5383409|P11|NOT COMPLETED|Period 2||0
2193681|NCT03579940|5383410|P10|NOT COMPLETED|Period 2||0
2193682|NCT03579940|5383411|P9|NOT COMPLETED|Period 2||0
2193683|NCT03579940|5383412|P8|NOT COMPLETED|Period 2||0
2193684|NCT03579940|5383413|P7|NOT COMPLETED|Period 2||0
2193685|NCT03579940|5383414|P6|NOT COMPLETED|Period 2||0
2193686|NCT03579940|5383415|P5|NOT COMPLETED|Period 2||0
2193687|NCT03579940|5383416|P4|NOT COMPLETED|Period 2||0
2193688|NCT03579940|5383417|P3|NOT COMPLETED|Period 2||1
2193689|NCT03579940|5383418|P2|NOT COMPLETED|Period 2||0
2193690|NCT03579940|5383419|P1|NOT COMPLETED|Period 2||0
2193691|NCT03579940|5383409|P11|COMPLETED|Period 2||3
2193692|NCT03579940|5383410|P10|COMPLETED|Period 2||2
2193693|NCT03579940|5383411|P9|COMPLETED|Period 2||3
2193694|NCT03579940|5383412|P8|COMPLETED|Period 2||3
2193695|NCT03579940|5383413|P7|COMPLETED|Period 2||3
2193696|NCT03579940|5383414|P6|COMPLETED|Period 2||2
2193697|NCT03579940|5383415|P5|COMPLETED|Period 2||2
2193698|NCT03579940|5383416|P4|COMPLETED|Period 2||2
2193699|NCT03579940|5383417|P3|COMPLETED|Period 2||1
2193700|NCT03579940|5383418|P2|COMPLETED|Period 2||2
2193701|NCT03579940|5383419|P1|COMPLETED|Period 2||3
2193702|NCT03579940|5383409|P11|STARTED|Period 2||3
2193703|NCT03579940|5383410|P10|STARTED|Period 2||2
2193704|NCT03579940|5383411|P9|STARTED|Period 2||3
2193705|NCT03579940|5383412|P8|STARTED|Period 2||3
2193706|NCT03579940|5383413|P7|STARTED|Period 2||3
2193707|NCT03579940|5383414|P6|STARTED|Period 2||2
2193708|NCT03579940|5383415|P5|STARTED|Period 2||2
2193709|NCT03579940|5383416|P4|STARTED|Period 2||2
2193710|NCT03579940|5383417|P3|STARTED|Period 2||2
2193711|NCT03579940|5383418|P2|STARTED|Period 2||2
2193712|NCT03579940|5383419|P1|STARTED|Period 2||3
2193713|NCT03579940|5383409|P11|NOT COMPLETED|Period 1||0
2193714|NCT03579940|5383410|P10|NOT COMPLETED|Period 1||0
2193715|NCT03579940|5383411|P9|NOT COMPLETED|Period 1||0
2193716|NCT03579940|5383412|P8|NOT COMPLETED|Period 1||0
2193717|NCT03579940|5383413|P7|NOT COMPLETED|Period 1||0
2193718|NCT03579940|5383414|P6|NOT COMPLETED|Period 1||0
2193719|NCT03579940|5383415|P5|NOT COMPLETED|Period 1||0
2193720|NCT03579940|5383416|P4|NOT COMPLETED|Period 1||0
2193721|NCT03579940|5383417|P3|NOT COMPLETED|Period 1||0
2193722|NCT03579940|5383418|P2|NOT COMPLETED|Period 1||0
2193723|NCT03579940|5383419|P1|NOT COMPLETED|Period 1||0
2193724|NCT03579940|5383409|P11|COMPLETED|Period 1||3
2193725|NCT03579940|5383410|P10|COMPLETED|Period 1||2
2193726|NCT03579940|5383411|P9|COMPLETED|Period 1||3
2193727|NCT03579940|5383412|P8|COMPLETED|Period 1||3
2193728|NCT03579940|5383413|P7|COMPLETED|Period 1||3
2193729|NCT03579940|5383414|P6|COMPLETED|Period 1||2
2193730|NCT03579940|5383415|P5|COMPLETED|Period 1||2
2193731|NCT03579940|5383416|P4|COMPLETED|Period 1||2
2193732|NCT03579940|5383417|P3|COMPLETED|Period 1||2
2193733|NCT03579940|5383418|P2|COMPLETED|Period 1||2
2193734|NCT03579940|5383419|P1|COMPLETED|Period 1||3
2193735|NCT03579940|5383409|P11|Received at Least 1 Dose of Study Drug|Period 1||3
2193736|NCT03579940|5383410|P10|Received at Least 1 Dose of Study Drug|Period 1||2
2193737|NCT03579940|5383411|P9|Received at Least 1 Dose of Study Drug|Period 1||3
2193738|NCT03579940|5383412|P8|Received at Least 1 Dose of Study Drug|Period 1||3
2193739|NCT03579940|5383413|P7|Received at Least 1 Dose of Study Drug|Period 1||3
2193740|NCT03579940|5383414|P6|Received at Least 1 Dose of Study Drug|Period 1||2
2193741|NCT03579940|5383415|P5|Received at Least 1 Dose of Study Drug|Period 1||2
2193742|NCT03579940|5383416|P4|Received at Least 1 Dose of Study Drug|Period 1||2
2193743|NCT03579940|5383417|P3|Received at Least 1 Dose of Study Drug|Period 1||2
2193744|NCT03579940|5383418|P2|Received at Least 1 Dose of Study Drug|Period 1||2
2193745|NCT03579940|5383419|P1|Received at Least 1 Dose of Study Drug|Period 1||3
2193746|NCT03579940|5383409|P11|STARTED|Period 1||3
2193747|NCT03579940|5383410|P10|STARTED|Period 1||2
2193748|NCT03579940|5383411|P9|STARTED|Period 1||3
2193749|NCT03579940|5383412|P8|STARTED|Period 1||3
2193750|NCT03579940|5383413|P7|STARTED|Period 1||3
2193751|NCT03579940|5383414|P6|STARTED|Period 1||2
2193752|NCT03579940|5383415|P5|STARTED|Period 1||2
2193753|NCT03579940|5383416|P4|STARTED|Period 1||2
2193754|NCT03579940|5383417|P3|STARTED|Period 1||2
2193755|NCT03579940|5383418|P2|STARTED|Period 1||2
2193756|NCT03579940|5383419|P1|STARTED|Period 1||3
2193757|NCT03579719|5383459|P1|NOT COMPLETED|Overall Study||1
2193758|NCT03579719|5383459|P1|COMPLETED|Overall Study||14
2193759|NCT03579719|5383459|P1|STARTED|Overall Study||15
2193760|NCT03578926|5383476|P2|NOT COMPLETED|Second Intervention||0
2193761|NCT03578926|5383477|P1|NOT COMPLETED|Second Intervention||0
2193762|NCT03578926|5383476|P2|COMPLETED|Second Intervention||21
2193763|NCT03578926|5383477|P1|COMPLETED|Second Intervention||23
2193764|NCT03578926|5383476|P2|STARTED|Second Intervention||21
2193765|NCT03578926|5383477|P1|STARTED|Second Intervention||23
2193766|NCT03578926|5383476|P2|NOT COMPLETED|First Intervention||0
2193767|NCT03578926|5383477|P1|NOT COMPLETED|First Intervention||0
2193768|NCT03578926|5383476|P2|COMPLETED|First Intervention||23
2193769|NCT03578926|5383477|P1|COMPLETED|First Intervention||21
2193770|NCT03578926|5383476|P2|STARTED|First Intervention||23
2193771|NCT03578926|5383477|P1|STARTED|First Intervention||21
2193772|NCT03578146|5383503|P6|NOT COMPLETED|Overall Study||3
2193773|NCT03578146|5383504|P5|NOT COMPLETED|Overall Study||0
2193774|NCT03578146|5383505|P4|NOT COMPLETED|Overall Study||0
2193775|NCT03578146|5383506|P3|NOT COMPLETED|Overall Study||1
2193776|NCT03578146|5383507|P2|NOT COMPLETED|Overall Study||1
2193777|NCT03578146|5383508|P1|NOT COMPLETED|Overall Study||1
2193778|NCT03578146|5383503|P6|COMPLETED|Overall Study||5
2193779|NCT03578146|5383504|P5|COMPLETED|Overall Study||6
2193780|NCT03578146|5383505|P4|COMPLETED|Overall Study||6
2193781|NCT03578146|5383506|P3|COMPLETED|Overall Study||5
2193782|NCT03578146|5383507|P2|COMPLETED|Overall Study||5
2193783|NCT03578146|5383508|P1|COMPLETED|Overall Study||15
2193784|NCT03578146|5383503|P6|STARTED|Overall Study||8
2193785|NCT03578146|5383504|P5|STARTED|Overall Study||6
2193786|NCT03578146|5383505|P4|STARTED|Overall Study||6
2193787|NCT03578146|5383506|P3|STARTED|Overall Study||6
2193788|NCT03578146|5383507|P2|STARTED|Overall Study||6
2193789|NCT03578146|5383508|P1|STARTED|Overall Study||16
2193790|NCT03577275|5383570|P1|NOT COMPLETED|Overall Study||0
2193791|NCT03577275|5383570|P1|COMPLETED|Overall Study||32
2193792|NCT03577275|5383570|P1|NST-4016 2000mg|Overall Study||32
2193793|NCT03577275|5383570|P1|NST-4016 600mg|Overall Study||32
2193794|NCT03577275|5383570|P1|Moxifloxacin 400mg|Overall Study||32
2193795|NCT03577275|5383570|P1|Placebo|Overall Study||32
2193796|NCT03577275|5383570|P1|STARTED|Overall Study|All participants received all of the 4 interventions|32
2193797|NCT03575962|5383596|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
2193798|NCT03575962|5383597|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
2193799|NCT03575962|5383596|P2|COMPLETED|Treatment Period 2 (4 Days)||7
2193800|NCT03575962|5383597|P1|COMPLETED|Treatment Period 2 (4 Days)||7
2193801|NCT03575962|5383596|P2|STARTED|Treatment Period 2 (4 Days)||7
2193802|NCT03575962|5383597|P1|STARTED|Treatment Period 2 (4 Days)||7
2193803|NCT03575962|5383596|P2|NOT COMPLETED|Washout Period (7 Days)||0
2193804|NCT03575962|5383597|P1|NOT COMPLETED|Washout Period (7 Days)||0
2193805|NCT03575962|5383596|P2|COMPLETED|Washout Period (7 Days)||7
2193806|NCT03575962|5383597|P1|COMPLETED|Washout Period (7 Days)||7
2193807|NCT03575962|5383596|P2|STARTED|Washout Period (7 Days)||7
2193808|NCT03575962|5383597|P1|STARTED|Washout Period (7 Days)||7
2193809|NCT03575962|5383596|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
2193810|NCT03575962|5383597|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
2193811|NCT03575962|5383596|P2|COMPLETED|Treatment Period 1 (4 Days)||7
2193812|NCT03575962|5383597|P1|COMPLETED|Treatment Period 1 (4 Days)||7
2193813|NCT03575962|5383596|P2|STARTED|Treatment Period 1 (4 Days)||7
2193814|NCT03575962|5383597|P1|STARTED|Treatment Period 1 (4 Days)||7
2193815|NCT03575702|5383639|P2|NOT COMPLETED|Overall Study||4
2193816|NCT03575702|5383640|P1|NOT COMPLETED|Overall Study||6
2193817|NCT03575702|5383639|P2|COMPLETED|Overall Study||146
2193818|NCT03575702|5383640|P1|COMPLETED|Overall Study||143
2193819|NCT03575702|5383639|P2|STARTED|Overall Study||150
2193820|NCT03575702|5383640|P1|STARTED|Overall Study||149
2193824|NCT03574441|5383681|P3|NOT COMPLETED|Overall Study||0
2193825|NCT03574441|5383682|P2|NOT COMPLETED|Overall Study||0
2193826|NCT03574441|5383683|P1|NOT COMPLETED|Overall Study||0
2193827|NCT03574441|5383681|P3|COMPLETED|Overall Study||30
2193828|NCT03574441|5383682|P2|COMPLETED|Overall Study||30
2193829|NCT03574441|5383683|P1|COMPLETED|Overall Study||31
2193830|NCT03574441|5383681|P3|STARTED|Overall Study||30
2193831|NCT03574441|5383682|P2|STARTED|Overall Study||30
2193832|NCT03574441|5383683|P1|STARTED|Overall Study||31
2193833|NCT03573817|5383696|P2|NOT COMPLETED|Overall Study||4
2193834|NCT03573817|5383697|P1|NOT COMPLETED|Overall Study||1
2193835|NCT03573817|5383696|P2|COMPLETED|Overall Study||55
2193836|NCT03573817|5383697|P1|COMPLETED|Overall Study||62
2193837|NCT03573817|5383696|P2|Randomized and Treated With Study Drug|Overall Study||59
2193838|NCT03573817|5383697|P1|Randomized and Treated With Study Drug|Overall Study||63
2193839|NCT03573817|5383696|P2|STARTED|Overall Study||59
2193840|NCT03573817|5383697|P1|STARTED|Overall Study||63
2193841|NCT03573206|5383723|P1|NOT COMPLETED|Overall Study||0
2193842|NCT03573206|5383723|P1|COMPLETED|Overall Study||168
2193843|NCT03573206|5383723|P1|STARTED|Overall Study||168
2193844|NCT03572972|5383738|P5|NOT COMPLETED|Overall Study||0
2193845|NCT03572972|5383739|P4|NOT COMPLETED|Overall Study||0
2193846|NCT03572972|5383740|P3|NOT COMPLETED|Overall Study||0
2193847|NCT03572972|5383741|P2|NOT COMPLETED|Overall Study||0
2193848|NCT03572972|5383742|P1|NOT COMPLETED|Overall Study||0
2193849|NCT03572972|5383738|P5|COMPLETED|Overall Study||16295
2193850|NCT03572972|5383739|P4|COMPLETED|Overall Study||8648
2193851|NCT03572972|5383740|P3|COMPLETED|Overall Study||17779
2193852|NCT03572972|5383741|P2|COMPLETED|Overall Study||11414
2193853|NCT03572972|5383742|P1|COMPLETED|Overall Study||10548
2193854|NCT03572972|5383738|P5|STARTED|Overall Study||16295
2193855|NCT03572972|5383739|P4|STARTED|Overall Study||8648
2193856|NCT03572972|5383740|P3|STARTED|Overall Study||17779
2193857|NCT03572972|5383741|P2|STARTED|Overall Study||11414
2193858|NCT03572972|5383742|P1|STARTED|Overall Study||10548
2193870|NCT03570047|5383871|P5|NOT COMPLETED|Overall Study||0
2193871|NCT03570047|5383872|P4|NOT COMPLETED|Overall Study||0
2193872|NCT03570047|5383873|P3|NOT COMPLETED|Overall Study||0
2193873|NCT03570047|5383874|P2|NOT COMPLETED|Overall Study||0
2193874|NCT03570047|5383875|P1|NOT COMPLETED|Overall Study||0
2193875|NCT03570047|5383871|P5|COMPLETED|Overall Study||12262
2193876|NCT03570047|5383872|P4|COMPLETED|Overall Study||16564
2193877|NCT03570047|5383873|P3|COMPLETED|Overall Study||6925
2193878|NCT03570047|5383874|P2|COMPLETED|Overall Study||22336
2193879|NCT03570047|5383875|P1|COMPLETED|Overall Study||15902
2193880|NCT03570047|5383871|P5|STARTED|Overall Study||12262
2193881|NCT03570047|5383872|P4|STARTED|Overall Study||16564
2193882|NCT03570047|5383873|P3|STARTED|Overall Study||6925
2193883|NCT03570047|5383874|P2|STARTED|Overall Study||22336
2193884|NCT03570047|5383875|P1|STARTED|Overall Study||15902
2193885|NCT03569202|5383934|P2|NOT COMPLETED|Part 3||1
2193886|NCT03569202|5383935|P1|NOT COMPLETED|Part 3||2
2193887|NCT03569202|5383934|P2|COMPLETED|Part 3|Per-protocol (PP) dataset. 'Not Completed' participants are included in safety and ITT datasets.|25
2193888|NCT03569202|5383935|P1|COMPLETED|Part 3|Per-protocol (PP) dataset. 'Not Completed' participants are included in safety and ITT datasets.|24
2193889|NCT03569202|5383934|P2|STARTED|Part 3|Control Eye Drops were used on both eyes. Participants were different from Parts 1 and 2.|26
2193890|NCT03569202|5383935|P1|STARTED|Part 3|Emulsion Eye Drops were used on both eyes. Participants were different from Parts 1 and 2.|26
2193891|NCT03569202|5383934|P2|NOT COMPLETED|Part 2||0
2193892|NCT03569202|5383935|P1|NOT COMPLETED|Part 2||0
2193893|NCT03569202|5383934|P2|COMPLETED|Part 2|No participant completing Part 2 was allowed to continue to Part 3.|9
2193894|NCT03569202|5383935|P1|COMPLETED|Part 2|No participant completing Part 2 was allowed to continue to Part 3.|9
2193895|NCT03569202|5383934|P2|STARTED|Part 2|Control Eye Drops were used on contralateral eye. Participants were different from Part 1.|9
2193896|NCT03569202|5383935|P1|STARTED|Part 2|Emulsion Eye Drops were used on one randomized eye. Participants were different from Part 1.|9
2193897|NCT03569202|5383934|P2|NOT COMPLETED|Part 1||0
2193898|NCT03569202|5383935|P1|NOT COMPLETED|Part 1||0
2193899|NCT03569202|5383934|P2|COMPLETED|Part 1||0
2193900|NCT03569202|5383935|P1|COMPLETED|Part 1|No participant completing Part 1 was allowed to continue to Parts 2 or 3.|3
2193901|NCT03569202|5383934|P2|STARTED|Part 1|Control Eye Drops were not used for Part 1.|0
2193902|NCT03569202|5383935|P1|STARTED|Part 1|Emulsion Eye Drops were used on one eye only.|3
2193903|NCT03569033|5383967|P2|NOT COMPLETED|Overall Study||0
2193904|NCT03569033|5383968|P1|NOT COMPLETED|Overall Study||0
2193905|NCT03569033|5383967|P2|COMPLETED|Overall Study||23
2193906|NCT03569033|5383968|P1|COMPLETED|Overall Study||23
2193907|NCT03569033|5383967|P2|STARTED|Overall Study||23
2193908|NCT03569033|5383968|P1|STARTED|Overall Study||23
2193909|NCT03568942|5383984|P1|NOT COMPLETED|Overall Study||2
2193910|NCT03568942|5383984|P1|COMPLETED|Overall Study||20
2193911|NCT03568942|5383984|P1|STARTED|Overall Study||22
2193912|NCT03567005|5384019|P2|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
2193913|NCT03567005|5384020|P1|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
2193914|NCT03567005|5384019|P2|COMPLETED|Period 2, Second 7 Days of Wear||31
2193915|NCT03567005|5384020|P1|COMPLETED|Period 2, Second 7 Days of Wear||29
2193916|NCT03567005|5384019|P2|STARTED|Period 2, Second 7 Days of Wear||31
2193917|NCT03567005|5384020|P1|STARTED|Period 2, Second 7 Days of Wear||29
2193918|NCT03567005|5384019|P2|NOT COMPLETED|Period 1, First 7 Days of Wear||0
2193919|NCT03567005|5384020|P1|NOT COMPLETED|Period 1, First 7 Days of Wear||0
2193920|NCT03567005|5384019|P2|COMPLETED|Period 1, First 7 Days of Wear||31
2193921|NCT03567005|5384020|P1|COMPLETED|Period 1, First 7 Days of Wear||29
2193922|NCT03567005|5384019|P2|STARTED|Period 1, First 7 Days of Wear||31
2193923|NCT03567005|5384020|P1|STARTED|Period 1, First 7 Days of Wear||29
2193924|NCT03566810|5384032|P4|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
2193925|NCT03566810|5384033|P3|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
2193926|NCT03566810|5384034|P2|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
2193927|NCT03566810|5384035|P1|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
2193928|NCT03566810|5384032|P4|COMPLETED|Treatment Period 2 (Day 8- Day 10)||8
2193929|NCT03566810|5384033|P3|COMPLETED|Treatment Period 2 (Day 8- Day 10)||8
2193930|NCT03566810|5384034|P2|COMPLETED|Treatment Period 2 (Day 8- Day 10)||18
2193931|NCT03566810|5384035|P1|COMPLETED|Treatment Period 2 (Day 8- Day 10)||19
2193932|NCT03566810|5384032|P4|STARTED|Treatment Period 2 (Day 8- Day 10)||8
2193933|NCT03566810|5384033|P3|STARTED|Treatment Period 2 (Day 8- Day 10)||8
2193934|NCT03566810|5384034|P2|STARTED|Treatment Period 2 (Day 8- Day 10)||18
2193935|NCT03566810|5384035|P1|STARTED|Treatment Period 2 (Day 8- Day 10)||19
2193936|NCT03566810|5384032|P4|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
2193937|NCT03566810|5384033|P3|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
2193938|NCT03566810|5384034|P2|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||1
2193939|NCT03566810|5384035|P1|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
2193940|NCT03566810|5384032|P4|COMPLETED|Treatment Period 1 (Day 1-Day 3)||8
2193941|NCT03566810|5384033|P3|COMPLETED|Treatment Period 1 (Day 1-Day 3)||8
2193942|NCT03566810|5384034|P2|COMPLETED|Treatment Period 1 (Day 1-Day 3)||18
2193943|NCT03566810|5384035|P1|COMPLETED|Treatment Period 1 (Day 1-Day 3)||19
2193944|NCT03566810|5384032|P4|Treated|Treatment Period 1 (Day 1-Day 3)||8
2193945|NCT03566810|5384033|P3|Treated|Treatment Period 1 (Day 1-Day 3)||8
2193946|NCT03566810|5384034|P2|Treated|Treatment Period 1 (Day 1-Day 3)||18
2193947|NCT03566810|5384035|P1|Treated|Treatment Period 1 (Day 1-Day 3)||19
2193948|NCT03566810|5384032|P4|STARTED|Treatment Period 1 (Day 1-Day 3)||8
2193949|NCT03566810|5384033|P3|STARTED|Treatment Period 1 (Day 1-Day 3)||8
2193950|NCT03566810|5384034|P2|STARTED|Treatment Period 1 (Day 1-Day 3)||19
2193951|NCT03566810|5384035|P1|STARTED|Treatment Period 1 (Day 1-Day 3)||19
2193952|NCT03565874|5384097|P1|NOT COMPLETED|Overall Study||2
2193953|NCT03565874|5384097|P1|COMPLETED|Overall Study||4
2193954|NCT03565874|5384097|P1|STARTED|Overall Study||6
2193955|NCT03565679|5384110|P1|NOT COMPLETED|Overall Study||0
2193956|NCT03565679|5384110|P1|COMPLETED|Overall Study||10
2193957|NCT03565679|5384110|P1|STARTED|Overall Study||10
2193958|NCT03565666|5384117|P3|NOT COMPLETED|Overall Study||1
2193959|NCT03565666|5384118|P2|NOT COMPLETED|Overall Study||0
2193960|NCT03565666|5384119|P1|NOT COMPLETED|Overall Study||0
2193961|NCT03565666|5384117|P3|COMPLETED|Overall Study||11
2193962|NCT03565666|5384118|P2|COMPLETED|Overall Study||12
2193963|NCT03565666|5384119|P1|COMPLETED|Overall Study||12
2193964|NCT03565666|5384117|P3|STARTED|Overall Study||12
2193965|NCT03565666|5384118|P2|STARTED|Overall Study||12
2193966|NCT03565666|5384119|P1|STARTED|Overall Study||12
2193967|NCT03564444|5384158|P2|NOT COMPLETED|Overall Study||0
2193968|NCT03564444|5384159|P1|NOT COMPLETED|Overall Study||0
2193969|NCT03564444|5384158|P2|COMPLETED|Overall Study||240
2193970|NCT03564444|5384159|P1|COMPLETED|Overall Study||60
2193971|NCT03564444|5384158|P2|STARTED|Overall Study||240
2193972|NCT03564444|5384159|P1|STARTED|Overall Study||60
2193973|NCT03563209|5384175|P1|NOT COMPLETED|Overall Study||0
2193974|NCT03563209|5384175|P1|COMPLETED|Overall Study||60
2193975|NCT03563209|5384175|P1|STARTED|Overall Study||60
2193976|NCT03562559|5384181|P1|NOT COMPLETED|Overall Study||0
2193977|NCT03562559|5384181|P1|COMPLETED|Overall Study||40
2193978|NCT03562559|5384181|P1|STARTED|Overall Study||40
2193979|NCT03562117|5384188|P3|NOT COMPLETED|Part 2, Up to 3 Days||0
2193980|NCT03562117|5384189|P2|NOT COMPLETED|Part 2, Up to 3 Days||0
2193981|NCT03562117|5384190|P1|NOT COMPLETED|Part 2, Up to 3 Days||0
2193982|NCT03562117|5384188|P3|COMPLETED|Part 2, Up to 3 Days||8
2193983|NCT03562117|5384189|P2|COMPLETED|Part 2, Up to 3 Days||0
2193984|NCT03562117|5384190|P1|COMPLETED|Part 2, Up to 3 Days||8
2193985|NCT03562117|5384188|P3|STARTED|Part 2, Up to 3 Days||8
2193986|NCT03562117|5384189|P2|STARTED|Part 2, Up to 3 Days||0
2193987|NCT03562117|5384190|P1|STARTED|Part 2, Up to 3 Days|Only 1 additional participant with normal hepatic function enrolled in Part 2 received dosing|8
2193988|NCT03562117|5384188|P3|NOT COMPLETED|Part 1, Up to 3 Days||0
2193989|NCT03562117|5384189|P2|NOT COMPLETED|Part 1, Up to 3 Days||0
2193990|NCT03562117|5384190|P1|NOT COMPLETED|Part 1, Up to 3 Days||1
2193991|NCT03562117|5384188|P3|COMPLETED|Part 1, Up to 3 Days||0
2193992|NCT03562117|5384189|P2|COMPLETED|Part 1, Up to 3 Days||8
2193993|NCT03562117|5384190|P1|COMPLETED|Part 1, Up to 3 Days||7
2193994|NCT03562117|5384188|P3|STARTED|Part 1, Up to 3 Days||0
2193995|NCT03562117|5384189|P2|STARTED|Part 1, Up to 3 Days||8
2193996|NCT03562117|5384190|P1|STARTED|Part 1, Up to 3 Days||8
2193997|NCT03560128|5384278|P2|NOT COMPLETED|Overall Study||8
2193998|NCT03560128|5384279|P1|NOT COMPLETED|Overall Study||12
2193999|NCT03560128|5384278|P2|COMPLETED|Overall Study||298
2194000|NCT03560128|5384279|P1|COMPLETED|Overall Study||294
2194001|NCT03560128|5384278|P2|STARTED|Overall Study||306
2194002|NCT03560128|5384279|P1|STARTED|Overall Study||306
2194003|NCT03559829|5384299|P1|NOT COMPLETED|Overall Study||0
2194004|NCT03559829|5384299|P1|COMPLETED|Overall Study||20
2194005|NCT03559829|5384299|P1|STARTED|Overall Study||20
2194006|NCT03559062|5384315|P3|NOT COMPLETED|Overall Study||0
2194007|NCT03559062|5384316|P2|NOT COMPLETED|Overall Study||1
2194008|NCT03559062|5384317|P1|NOT COMPLETED|Overall Study||0
2194009|NCT03559062|5384315|P3|COMPLETED|Overall Study||3
2194010|NCT03559062|5384316|P2|COMPLETED|Overall Study||53
2194011|NCT03559062|5384317|P1|COMPLETED|Overall Study||10
2194012|NCT03559062|5384315|P3|STARTED|Overall Study||3
2194013|NCT03559062|5384316|P2|STARTED|Overall Study||54
2194014|NCT03559062|5384317|P1|STARTED|Overall Study||10
2194015|NCT03558555|5384330|P2|NOT COMPLETED|Overall Study||1
2194016|NCT03558555|5384331|P1|NOT COMPLETED|Overall Study||2
2194017|NCT03558555|5384330|P2|COMPLETED|Overall Study||44
2194018|NCT03558555|5384331|P1|COMPLETED|Overall Study||56
2194019|NCT03558555|5384330|P2|STARTED|Overall Study||45
2194020|NCT03558555|5384331|P1|STARTED|Overall Study||58
2194021|NCT03558230|5384349|P2|NOT COMPLETED|Overall Study||0
2194022|NCT03558230|5384350|P1|NOT COMPLETED|Overall Study||0
2194023|NCT03558230|5384349|P2|COMPLETED|Overall Study||6
2194024|NCT03558230|5384350|P1|COMPLETED|Overall Study||7
2194025|NCT03558230|5384349|P2|STARTED|Overall Study||6
2194026|NCT03558230|5384350|P1|STARTED|Overall Study||7
2194027|NCT03557801|5384359|P3|NOT COMPLETED|Overall Study||3
2194028|NCT03557801|5384360|P2|NOT COMPLETED|Overall Study||1
2194029|NCT03557801|5384361|P1|NOT COMPLETED|Overall Study||2
2194030|NCT03557801|5384359|P3|COMPLETED|Overall Study||30
2194031|NCT03557801|5384360|P2|COMPLETED|Overall Study||32
2194032|NCT03557801|5384361|P1|COMPLETED|Overall Study||32
2194033|NCT03557801|5384359|P3|STARTED|Overall Study||33
2194034|NCT03557801|5384360|P2|STARTED|Overall Study||33
2194035|NCT03557801|5384361|P1|STARTED|Overall Study||34
2194036|NCT03557476|5384377|P2|NOT COMPLETED|Overall Study||0
2194037|NCT03557476|5384378|P1|NOT COMPLETED|Overall Study||0
2194038|NCT03557476|5384377|P2|COMPLETED|Overall Study||13
2194039|NCT03557476|5384378|P1|COMPLETED|Overall Study||13
2194040|NCT03557476|5384377|P2|STARTED|Overall Study||13
2194041|NCT03557476|5384378|P1|STARTED|Overall Study||13
2194042|NCT03556579|5384396|P4|NOT COMPLETED|Visit 2||0
2194043|NCT03556579|5384397|P3|NOT COMPLETED|Visit 2||0
2194044|NCT03556579|5384398|P2|NOT COMPLETED|Visit 2||0
2194045|NCT03556579|5384399|P1|NOT COMPLETED|Visit 2||0
2194046|NCT03556579|5384396|P4|COMPLETED|Visit 2||16
2194047|NCT03556579|5384397|P3|COMPLETED|Visit 2||14
2194048|NCT03556579|5384398|P2|COMPLETED|Visit 2||14
2194049|NCT03556579|5384399|P1|COMPLETED|Visit 2||16
2194050|NCT03556579|5384396|P4|STARTED|Visit 2||16
2194051|NCT03556579|5384397|P3|STARTED|Visit 2||14
2194052|NCT03556579|5384398|P2|STARTED|Visit 2||14
2194053|NCT03556579|5384399|P1|STARTED|Visit 2||16
2194054|NCT03556579|5384396|P4|NOT COMPLETED|Visit 1||0
2194055|NCT03556579|5384397|P3|NOT COMPLETED|Visit 1||0
2194056|NCT03556579|5384398|P2|NOT COMPLETED|Visit 1||0
2194057|NCT03556579|5384399|P1|NOT COMPLETED|Visit 1||0
2194058|NCT03556579|5384396|P4|COMPLETED|Visit 1||16
2194059|NCT03556579|5384397|P3|COMPLETED|Visit 1||14
2194060|NCT03556579|5384398|P2|COMPLETED|Visit 1||14
2194061|NCT03556579|5384399|P1|COMPLETED|Visit 1||16
2194062|NCT03556579|5384396|P4|STARTED|Visit 1||16
2194063|NCT03556579|5384397|P3|STARTED|Visit 1||14
2194064|NCT03556579|5384398|P2|STARTED|Visit 1||14
2194065|NCT03556579|5384399|P1|STARTED|Visit 1||16
2194066|NCT03555890|5384427|P4|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
2194067|NCT03555890|5384428|P3|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
2194068|NCT03555890|5384429|P2|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
2194069|NCT03555890|5384430|P1|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
2194070|NCT03555890|5384427|P4|COMPLETED|Part 2:Treatment Period 2 (10 Days)||23
2194071|NCT03555890|5384428|P3|COMPLETED|Part 2:Treatment Period 2 (10 Days)||24
2194072|NCT03555890|5384429|P2|COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
2194073|NCT03555890|5384430|P1|COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
2194074|NCT03555890|5384427|P4|STARTED|Part 2:Treatment Period 2 (10 Days)||23
2194075|NCT03555890|5384428|P3|STARTED|Part 2:Treatment Period 2 (10 Days)||24
2194076|NCT03555890|5384429|P2|STARTED|Part 2:Treatment Period 2 (10 Days)||0
2194077|NCT03555890|5384430|P1|STARTED|Part 2:Treatment Period 2 (10 Days)||0
2194078|NCT03555890|5384427|P4|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||1
2194079|NCT03555890|5384428|P3|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
2194080|NCT03555890|5384429|P2|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
2194081|NCT03555890|5384430|P1|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
2194082|NCT03555890|5384427|P4|COMPLETED|Part 2:Washout Period (at Least 5 Days)||23
2194083|NCT03555890|5384428|P3|COMPLETED|Part 2:Washout Period (at Least 5 Days)||24
2194084|NCT03555890|5384429|P2|COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
2194085|NCT03555890|5384430|P1|COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
2194086|NCT03555890|5384427|P4|STARTED|Part 2:Washout Period (at Least 5 Days)||24
2194087|NCT03555890|5384428|P3|STARTED|Part 2:Washout Period (at Least 5 Days)||24
2194088|NCT03555890|5384429|P2|STARTED|Part 2:Washout Period (at Least 5 Days)||0
2194089|NCT03555890|5384430|P1|STARTED|Part 2:Washout Period (at Least 5 Days)||0
2194090|NCT03555890|5384427|P4|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
2194091|NCT03555890|5384428|P3|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
2194092|NCT03555890|5384429|P2|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
2194093|NCT03555890|5384430|P1|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
2194094|NCT03555890|5384427|P4|COMPLETED|Part 2:Treatment Period 1 (3 Days)||24
2194095|NCT03555890|5384428|P3|COMPLETED|Part 2:Treatment Period 1 (3 Days)||24
2194096|NCT03555890|5384429|P2|COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
2194097|NCT03555890|5384430|P1|COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
2194098|NCT03555890|5384427|P4|STARTED|Part 2:Treatment Period 1 (3 Days)||24
2194099|NCT03555890|5384428|P3|STARTED|Part 2:Treatment Period 1 (3 Days)||24
2194100|NCT03555890|5384429|P2|STARTED|Part 2:Treatment Period 1 (3 Days)||0
2194101|NCT03555890|5384430|P1|STARTED|Part 2:Treatment Period 1 (3 Days)||0
2194102|NCT03555890|5384427|P4|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
2194103|NCT03555890|5384428|P3|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
2194104|NCT03555890|5384429|P2|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
2194105|NCT03555890|5384430|P1|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
2194106|NCT03555890|5384427|P4|COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
2194107|NCT03555890|5384428|P3|COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
2194108|NCT03555890|5384429|P2|COMPLETED|Part 1:Treatment Period 2 (10 Days)||12
2194109|NCT03555890|5384430|P1|COMPLETED|Part 1:Treatment Period 2 (10 Days)||12
2194110|NCT03555890|5384427|P4|STARTED|Part 1:Treatment Period 2 (10 Days)||0
2194111|NCT03555890|5384428|P3|STARTED|Part 1:Treatment Period 2 (10 Days)||0
2194112|NCT03555890|5384429|P2|STARTED|Part 1:Treatment Period 2 (10 Days)||12
2194113|NCT03555890|5384430|P1|STARTED|Part 1:Treatment Period 2 (10 Days)||12
2194114|NCT03555890|5384427|P4|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
2194115|NCT03555890|5384428|P3|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
2194116|NCT03555890|5384429|P2|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
2194117|NCT03555890|5384430|P1|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
2194118|NCT03555890|5384427|P4|COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
2194119|NCT03555890|5384428|P3|COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
2194120|NCT03555890|5384429|P2|COMPLETED|Part 1:Washout Period (at Least 5 Days)||12
2194121|NCT03555890|5384430|P1|COMPLETED|Part 1:Washout Period (at Least 5 Days)||12
2194122|NCT03555890|5384427|P4|STARTED|Part 1:Washout Period (at Least 5 Days)||0
2194123|NCT03555890|5384428|P3|STARTED|Part 1:Washout Period (at Least 5 Days)||0
2194124|NCT03555890|5384429|P2|STARTED|Part 1:Washout Period (at Least 5 Days)||12
2194125|NCT03555890|5384430|P1|STARTED|Part 1:Washout Period (at Least 5 Days)||12
2194126|NCT03555890|5384427|P4|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
2194127|NCT03555890|5384428|P3|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
2194128|NCT03555890|5384429|P2|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
2194129|NCT03555890|5384430|P1|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
2194130|NCT03555890|5384427|P4|COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
2194131|NCT03555890|5384428|P3|COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
2194132|NCT03555890|5384429|P2|COMPLETED|Part 1:Treatment Period 1 (3 Days)||12
2194133|NCT03555890|5384430|P1|COMPLETED|Part 1:Treatment Period 1 (3 Days)||12
2194134|NCT03555890|5384427|P4|STARTED|Part 1:Treatment Period 1 (3 Days)||0
2194135|NCT03555890|5384428|P3|STARTED|Part 1:Treatment Period 1 (3 Days)||0
2194136|NCT03555890|5384429|P2|STARTED|Part 1:Treatment Period 1 (3 Days)||12
2194137|NCT03555890|5384430|P1|STARTED|Part 1:Treatment Period 1 (3 Days)||12
2194138|NCT03554746|5384566|P2|NOT COMPLETED|Overall Study||0
2194139|NCT03554746|5384567|P1|NOT COMPLETED|Overall Study||0
2194140|NCT03554746|5384566|P2|COMPLETED|Overall Study||24
2194141|NCT03554746|5384567|P1|COMPLETED|Overall Study||24
2194142|NCT03554746|5384566|P2|STARTED|Overall Study||24
2194143|NCT03554746|5384567|P1|STARTED|Overall Study||24
2194144|NCT03554005|5384589|P6|NOT COMPLETED|Overall Study||11
2194145|NCT03554005|5384590|P5|NOT COMPLETED|Overall Study||6
2194146|NCT03554005|5384591|P4|NOT COMPLETED|Overall Study||1
2194147|NCT03554005|5384592|P3|NOT COMPLETED|Overall Study||1
2194148|NCT03554005|5384593|P2|NOT COMPLETED|Overall Study||1
2194149|NCT03554005|5384594|P1|NOT COMPLETED|Overall Study||1
2194150|NCT03554005|5384589|P6|COMPLETED|Overall Study||0
2194151|NCT03554005|5384590|P5|COMPLETED|Overall Study||5
2194152|NCT03554005|5384591|P4|COMPLETED|Overall Study||1
2194153|NCT03554005|5384592|P3|COMPLETED|Overall Study||1
2194154|NCT03554005|5384593|P2|COMPLETED|Overall Study||1
2194155|NCT03554005|5384594|P1|COMPLETED|Overall Study||0
2194156|NCT03554005|5384589|P6|STARTED|Overall Study||11
2194157|NCT03554005|5384590|P5|STARTED|Overall Study||11
2194158|NCT03554005|5384591|P4|STARTED|Overall Study||2
2194159|NCT03554005|5384592|P3|STARTED|Overall Study||2
2194160|NCT03554005|5384593|P2|STARTED|Overall Study||2
2194161|NCT03554005|5384594|P1|STARTED|Overall Study||1
2194162|NCT03552549|5384622|P2|NOT COMPLETED|Overall Study||52
2194163|NCT03552549|5384623|P1|NOT COMPLETED|Overall Study||53
2194164|NCT03552549|5384622|P2|COMPLETED|Overall Study||11
2194165|NCT03552549|5384623|P1|COMPLETED|Overall Study||10
2194166|NCT03552549|5384622|P2|Treated|Overall Study||62
2194167|NCT03552549|5384623|P1|Treated|Overall Study||62
2194168|NCT03552549|5384622|P2|STARTED|Overall Study||63
2194169|NCT03552549|5384623|P1|STARTED|Overall Study||63
2194170|NCT03552523|5384631|P2|NOT COMPLETED|Overall Study||1
2194171|NCT03552523|5384632|P1|NOT COMPLETED|Overall Study||1
2194172|NCT03552523|5384631|P2|COMPLETED|Overall Study||1
2194173|NCT03552523|5384632|P1|COMPLETED|Overall Study||4
2194174|NCT03552523|5384631|P2|STARTED|Overall Study||2
2194175|NCT03552523|5384632|P1|STARTED|Overall Study||5
2194176|NCT03551821|5384640|P1|NOT COMPLETED|Overall Study||0
2194177|NCT03551821|5384640|P1|COMPLETED|Overall Study||1
2194178|NCT03551821|5384640|P1|STARTED|Overall Study||1
2194179|NCT03551743|5384649|P4|NOT COMPLETED|Overall Study||0
2194180|NCT03551743|5384650|P3|NOT COMPLETED|Overall Study||0
2194181|NCT03551743|5384651|P2|NOT COMPLETED|Overall Study||0
2194182|NCT03551743|5384652|P1|NOT COMPLETED|Overall Study||2
2194183|NCT03551743|5384649|P4|COMPLETED|Overall Study||6
2194184|NCT03551743|5384650|P3|COMPLETED|Overall Study||6
2194185|NCT03551743|5384651|P2|COMPLETED|Overall Study||6
2194186|NCT03551743|5384652|P1|COMPLETED|Overall Study||8
2194187|NCT03551743|5384649|P4|STARTED|Overall Study||6
2194188|NCT03551743|5384650|P3|STARTED|Overall Study||6
2194189|NCT03551743|5384651|P2|STARTED|Overall Study||6
2194190|NCT03551743|5384652|P1|STARTED|Overall Study||10
2194191|NCT03551730|5384698|P4|NOT COMPLETED|Overall Study||0
2194192|NCT03551730|5384699|P3|NOT COMPLETED|Overall Study||0
2194193|NCT03551730|5384700|P2|NOT COMPLETED|Overall Study||0
2194194|NCT03551730|5384701|P1|NOT COMPLETED|Overall Study||1
2194195|NCT03551730|5384698|P4|COMPLETED|Overall Study||6
2194196|NCT03551730|5384699|P3|COMPLETED|Overall Study||6
2194197|NCT03551730|5384700|P2|COMPLETED|Overall Study||6
2194198|NCT03551730|5384701|P1|COMPLETED|Overall Study||8
2194199|NCT03551730|5384698|P4|STARTED|Overall Study||6
2194200|NCT03551730|5384699|P3|STARTED|Overall Study||6
2194201|NCT03551730|5384700|P2|STARTED|Overall Study||6
2194202|NCT03551730|5384701|P1|STARTED|Overall Study||9
2194203|NCT03550989|5384743|P4|NOT COMPLETED|Overall Study||0
2194204|NCT03550989|5384744|P3|NOT COMPLETED|Overall Study||1
2194205|NCT03550989|5384745|P2|NOT COMPLETED|Overall Study||1
2194206|NCT03550989|5384746|P1|NOT COMPLETED|Overall Study||2
2194207|NCT03550989|5384743|P4|COMPLETED|Overall Study||60
2194208|NCT03550989|5384744|P3|COMPLETED|Overall Study||76
2194209|NCT03550989|5384745|P2|COMPLETED|Overall Study||73
2194210|NCT03550989|5384746|P1|COMPLETED|Overall Study||188
2194211|NCT03550989|5384743|P4|STARTED|Overall Study||60
2194212|NCT03550989|5384744|P3|STARTED|Overall Study||77
2194213|NCT03550989|5384745|P2|STARTED|Overall Study||74
2194214|NCT03550989|5384746|P1|STARTED|Overall Study||190
2194215|NCT03550066|5384823|P2|NOT COMPLETED|Overall Study||0
2194216|NCT03550066|5384824|P1|NOT COMPLETED|Overall Study||0
2194217|NCT03550066|5384823|P2|COMPLETED|Overall Study||41
2194218|NCT03550066|5384824|P1|COMPLETED|Overall Study||49
2194219|NCT03550066|5384823|P2|STARTED|Overall Study||41
2194220|NCT03550066|5384824|P1|STARTED|Overall Study||49
2194221|NCT03549429|5384836|P2|NOT COMPLETED|Overall Study||3
2194222|NCT03549429|5384837|P1|NOT COMPLETED|Overall Study||5
2194223|NCT03549429|5384836|P2|COMPLETED|Overall Study||75
2194224|NCT03549429|5384837|P1|COMPLETED|Overall Study||76
2194225|NCT03549429|5384836|P2|STARTED|Overall Study||78
2194226|NCT03549429|5384837|P1|STARTED|Overall Study||81
2194227|NCT03549338|5384850|P3|NOT COMPLETED|Overall Study||0
2194228|NCT03549338|5384851|P2|NOT COMPLETED|Overall Study||1
2194229|NCT03549338|5384852|P1|NOT COMPLETED|Overall Study||1
2194230|NCT03549338|5384850|P3|COMPLETED|Overall Study||0
2194231|NCT03549338|5384851|P2|COMPLETED|Overall Study|Patient crossed-over to Sym004 at the EOC1 per Sponsor decision following trial termination.|0
2194232|NCT03549338|5384852|P1|COMPLETED|Overall Study||0
2194233|NCT03549338|5384850|P3|STARTED|Overall Study||0
2194234|NCT03549338|5384851|P2|STARTED|Overall Study||1
2194235|NCT03549338|5384852|P1|STARTED|Overall Study||1
2194236|NCT03549130|5384860|P2|NOT COMPLETED|Overall Study||2
2194237|NCT03549130|5384861|P1|NOT COMPLETED|Overall Study||0
2194238|NCT03549130|5384860|P2|COMPLETED|Overall Study||64
2194239|NCT03549130|5384861|P1|COMPLETED|Overall Study||64
2194240|NCT03549130|5384860|P2|STARTED|Overall Study||66
2194241|NCT03549130|5384861|P1|STARTED|Overall Study||64
2194242|NCT03549117|5384879|P2|NOT COMPLETED|Overall Study||0
2194243|NCT03549117|5384880|P1|NOT COMPLETED|Overall Study||1
2194244|NCT03549117|5384879|P2|COMPLETED|Overall Study||70
2194245|NCT03549117|5384880|P1|COMPLETED|Overall Study||69
2194246|NCT03549117|5384879|P2|STARTED|Overall Study||70
2194247|NCT03549117|5384880|P1|STARTED|Overall Study||70
2194248|NCT03547531|5384908|P2|NOT COMPLETED|Overall Study||4
2194249|NCT03547531|5384909|P1|NOT COMPLETED|Overall Study||2
2194250|NCT03547531|5384908|P2|COMPLETED|Overall Study||58
2194251|NCT03547531|5384909|P1|COMPLETED|Overall Study||60
2194252|NCT03547531|5384908|P2|STARTED|Overall Study||62
2194253|NCT03547531|5384909|P1|STARTED|Overall Study||62
2194254|NCT03547154|5384923|P2|NOT COMPLETED|Overall Study||116
2194255|NCT03547154|5384924|P1|NOT COMPLETED|Overall Study||123
2194256|NCT03547154|5384923|P2|COMPLETED|Overall Study||55
2194257|NCT03547154|5384924|P1|COMPLETED|Overall Study||50
2194258|NCT03547154|5384923|P2|STARTED|Overall Study||171
2194259|NCT03547154|5384924|P1|STARTED|Overall Study||173
2194266|NCT03546621|5384949|P4|NOT COMPLETED|Overall Study||3
2194267|NCT03546621|5384950|P3|NOT COMPLETED|Overall Study||2
2194268|NCT03546621|5384951|P2|NOT COMPLETED|Overall Study||3
2194269|NCT03546621|5384952|P1|NOT COMPLETED|Overall Study||0
2194270|NCT03546621|5384949|P4|COMPLETED|Overall Study||25
2194271|NCT03546621|5384950|P3|COMPLETED|Overall Study||28
2194272|NCT03546621|5384951|P2|COMPLETED|Overall Study||29
2194273|NCT03546621|5384952|P1|COMPLETED|Overall Study||28
2194274|NCT03546621|5384949|P4|STARTED|Overall Study|2 patients from Tenofovir only group withdrew from the study before treatment.|28
2194275|NCT03546621|5384950|P3|STARTED|Overall Study||30
2194276|NCT03546621|5384951|P2|STARTED|Overall Study||32
2194277|NCT03546621|5384952|P1|STARTED|Overall Study||28
2194278|NCT03546491|5384990|P1|NOT COMPLETED|Overall Study||2
2194279|NCT03546491|5384990|P1|COMPLETED|Overall Study||30
2194280|NCT03546491|5384990|P1|Received Test Product 2|Overall Study||32
2194281|NCT03546491|5384990|P1|Recieved Test Product 1|Overall Study||32
2194282|NCT03546491|5384990|P1|STARTED|Overall Study||32
2194283|NCT03546270|5385004|P2|NOT COMPLETED|Overall Study||0
2194284|NCT03546270|5385005|P1|NOT COMPLETED|Overall Study||0
2194285|NCT03546270|5385004|P2|COMPLETED|Overall Study||48
2194286|NCT03546270|5385005|P1|COMPLETED|Overall Study||52
2194287|NCT03546270|5385004|P2|STARTED|Overall Study||48
2194288|NCT03546270|5385005|P1|STARTED|Overall Study||52
2194289|NCT03546192|5385023|P2|NOT COMPLETED|Overall Study||0
2194290|NCT03546192|5385024|P1|NOT COMPLETED|Overall Study||0
2194291|NCT03546192|5385023|P2|COMPLETED|Overall Study||60
2194292|NCT03546192|5385024|P1|COMPLETED|Overall Study||60
2194293|NCT03546192|5385023|P2|STARTED|Overall Study||60
2194294|NCT03546192|5385024|P1|STARTED|Overall Study||60
2194295|NCT03545984|5385042|P2|NOT COMPLETED|Overall Study||9
2194296|NCT03545984|5385043|P1|NOT COMPLETED|Overall Study||11
2194297|NCT03545984|5385042|P2|COMPLETED|Overall Study||15
2194298|NCT03545984|5385043|P1|COMPLETED|Overall Study||13
2194299|NCT03545984|5385042|P2|STARTED|Overall Study||24
2194300|NCT03545984|5385043|P1|STARTED|Overall Study||24
2194301|NCT03545412|5385049|P1|NOT COMPLETED|Overall Study||0
2194302|NCT03545412|5385049|P1|COMPLETED|Overall Study||25
2194303|NCT03545412|5385049|P1|STARTED|Overall Study||25
2194304|NCT03544879|5385061|P2|NOT COMPLETED|Overall Study||1
2194305|NCT03544879|5385062|P1|NOT COMPLETED|Overall Study||0
2194306|NCT03544879|5385061|P2|COMPLETED|Overall Study||23
2194307|NCT03544879|5385062|P1|COMPLETED|Overall Study||22
2194308|NCT03544879|5385061|P2|Completed Follow-up Physical Assessment|Overall Study||21
2194309|NCT03544879|5385062|P1|Completed Follow-up Physical Assessment|Overall Study||20
2194310|NCT03544879|5385061|P2|STARTED|Overall Study||24
2194311|NCT03544879|5385062|P1|STARTED|Overall Study||22
2194312|NCT03544307|5385090|P2|NOT COMPLETED|Overall Study||0
2194313|NCT03544307|5385091|P1|NOT COMPLETED|Overall Study||0
2194314|NCT03544307|5385090|P2|COMPLETED|Overall Study||10
2194315|NCT03544307|5385091|P1|COMPLETED|Overall Study||10
2194316|NCT03544307|5385090|P2|STARTED|Overall Study||10
2194317|NCT03544307|5385091|P1|STARTED|Overall Study||10
2194318|NCT03544216|5385111|P2|NOT COMPLETED|Overall Study||0
2194319|NCT03544216|5385112|P1|NOT COMPLETED|Overall Study||0
2194320|NCT03544216|5385111|P2|COMPLETED|Overall Study||42
2194321|NCT03544216|5385112|P1|COMPLETED|Overall Study||42
2194322|NCT03544216|5385111|P2|STARTED|Overall Study||42
2194323|NCT03544216|5385112|P1|STARTED|Overall Study||42
2194324|NCT03543137|5385119|P2|NOT COMPLETED|Study Period 2: Up to Day 8||1
2194325|NCT03543137|5385120|P1|NOT COMPLETED|Study Period 2: Up to Day 8||2
2194326|NCT03543137|5385119|P2|COMPLETED|Study Period 2: Up to Day 8||18
2194327|NCT03543137|5385120|P1|COMPLETED|Study Period 2: Up to Day 8||16
2194328|NCT03543137|5385119|P2|Treated|Study Period 2: Up to Day 8||18
2194329|NCT03543137|5385120|P1|Treated|Study Period 2: Up to Day 8||16
2194330|NCT03543137|5385119|P2|STARTED|Study Period 2: Up to Day 8||19
2194331|NCT03543137|5385120|P1|STARTED|Study Period 2: Up to Day 8||18
2194332|NCT03543137|5385119|P2|NOT COMPLETED|Washout Period: 5 to 7 Days||0
2194333|NCT03543137|5385120|P1|NOT COMPLETED|Washout Period: 5 to 7 Days||0
2194334|NCT03543137|5385119|P2|COMPLETED|Washout Period: 5 to 7 Days||19
2194335|NCT03543137|5385120|P1|COMPLETED|Washout Period: 5 to 7 Days||18
2194336|NCT03543137|5385119|P2|STARTED|Washout Period: 5 to 7 Days||19
2194337|NCT03543137|5385120|P1|STARTED|Washout Period: 5 to 7 Days||18
2194338|NCT03543137|5385119|P2|NOT COMPLETED|Study Period 1: Up to Day 1||0
2194339|NCT03543137|5385120|P1|NOT COMPLETED|Study Period 1: Up to Day 1||0
2194340|NCT03543137|5385119|P2|COMPLETED|Study Period 1: Up to Day 1||19
2194341|NCT03543137|5385120|P1|COMPLETED|Study Period 1: Up to Day 1||18
2194342|NCT03543137|5385119|P2|STARTED|Study Period 1: Up to Day 1||19
2194343|NCT03543137|5385120|P1|STARTED|Study Period 1: Up to Day 1||18
2194344|NCT03537404|5385143|P2|NOT COMPLETED|Third Intervention (A or B or C)||0
2194345|NCT03537404|5385144|P1|NOT COMPLETED|Third Intervention (A or B or C)||0
2194346|NCT03537404|5385143|P2|COMPLETED|Third Intervention (A or B or C)||18
2194347|NCT03537404|5385144|P1|COMPLETED|Third Intervention (A or B or C)||18
2194348|NCT03537404|5385143|P2|STARTED|Third Intervention (A or B or C)||18
2194349|NCT03537404|5385144|P1|STARTED|Third Intervention (A or B or C)||18
2194350|NCT03537404|5385143|P2|NOT COMPLETED|Second Washout Period (8 Days)||0
2194351|NCT03537404|5385144|P1|NOT COMPLETED|Second Washout Period (8 Days)||0
2194352|NCT03537404|5385143|P2|COMPLETED|Second Washout Period (8 Days)||18
2194353|NCT03537404|5385144|P1|COMPLETED|Second Washout Period (8 Days)||18
2194354|NCT03537404|5385143|P2|STARTED|Second Washout Period (8 Days)||18
2194355|NCT03537404|5385144|P1|STARTED|Second Washout Period (8 Days)||18
2194356|NCT03537404|5385143|P2|NOT COMPLETED|Second Intervention (A or B or C)||0
2194357|NCT03537404|5385144|P1|NOT COMPLETED|Second Intervention (A or B or C)||0
2194358|NCT03537404|5385143|P2|COMPLETED|Second Intervention (A or B or C)||18
2194359|NCT03537404|5385144|P1|COMPLETED|Second Intervention (A or B or C)||18
2194360|NCT03537404|5385143|P2|STARTED|Second Intervention (A or B or C)||18
2194361|NCT03537404|5385144|P1|STARTED|Second Intervention (A or B or C)||18
2194362|NCT03537404|5385143|P2|NOT COMPLETED|First Washout Period (8 Days)||0
2194363|NCT03537404|5385144|P1|NOT COMPLETED|First Washout Period (8 Days)||0
2194364|NCT03537404|5385143|P2|COMPLETED|First Washout Period (8 Days)||18
2194365|NCT03537404|5385144|P1|COMPLETED|First Washout Period (8 Days)||18
2194366|NCT03537404|5385143|P2|STARTED|First Washout Period (8 Days)||18
2194367|NCT03537404|5385144|P1|STARTED|First Washout Period (8 Days)||18
2194368|NCT03537404|5385143|P2|NOT COMPLETED|First Intervention (A or B or C)||0
2194369|NCT03537404|5385144|P1|NOT COMPLETED|First Intervention (A or B or C)||0
2194370|NCT03537404|5385143|P2|COMPLETED|First Intervention (A or B or C)||18
2194371|NCT03537404|5385144|P1|COMPLETED|First Intervention (A or B or C)||18
2194372|NCT03537404|5385143|P2|STARTED|First Intervention (A or B or C)||18
2194373|NCT03537404|5385144|P1|STARTED|First Intervention (A or B or C)||18
2194374|NCT03537274|5385190|P4|NOT COMPLETED|Overall Study||76
2194375|NCT03537274|5385191|P3|NOT COMPLETED|Overall Study||76
2194376|NCT03537274|5385192|P2|NOT COMPLETED|Overall Study||69
2194377|NCT03537274|5385193|P1|NOT COMPLETED|Overall Study||60
2194378|NCT03537274|5385190|P4|COMPLETED|Overall Study||231
2194379|NCT03537274|5385191|P3|COMPLETED|Overall Study||228
2194380|NCT03537274|5385192|P2|COMPLETED|Overall Study||229
2194381|NCT03537274|5385193|P1|COMPLETED|Overall Study||255
2194382|NCT03537274|5385190|P4|Treated|Overall Study||303
2194383|NCT03537274|5385191|P3|Treated|Overall Study||304
2194384|NCT03537274|5385192|P2|Treated|Overall Study||297
2194385|NCT03537274|5385193|P1|Treated|Overall Study||315
2194386|NCT03537274|5385190|P4|STARTED|Overall Study||307
2194387|NCT03537274|5385191|P3|STARTED|Overall Study||304
2194388|NCT03537274|5385192|P2|STARTED|Overall Study||298
2194389|NCT03537274|5385193|P1|STARTED|Overall Study||315
2194390|NCT03537092|5385207|P1|NOT COMPLETED|Overall Study||0
2194391|NCT03537092|5385207|P1|COMPLETED|Overall Study||64
2194392|NCT03537092|5385207|P1|STARTED|Overall Study||64
2194393|NCT03536923|5385214|P1|NOT COMPLETED|Overall Study||0
2194394|NCT03536923|5385214|P1|COMPLETED|Overall Study||23
2194395|NCT03536923|5385214|P1|STARTED|Overall Study||23
2194396|NCT03535649|5385221|P1|NOT COMPLETED|Overall Study||0
2194397|NCT03535649|5385221|P1|COMPLETED|Overall Study||105
2194398|NCT03535649|5385221|P1|STARTED|Overall Study||105
2194399|NCT03535571|5385230|P1|NOT COMPLETED|Overall Study||1
2194400|NCT03535571|5385230|P1|COMPLETED|Overall Study||19
2194401|NCT03535571|5385230|P1|STARTED|Overall Study||20
2194402|NCT03534986|5385262|P3|NOT COMPLETED|Overall Study||2
2194403|NCT03534986|5385263|P2|NOT COMPLETED|Overall Study||0
2194404|NCT03534986|5385264|P1|NOT COMPLETED|Overall Study||0
2194405|NCT03534986|5385262|P3|COMPLETED|Overall Study||10
2194406|NCT03534986|5385263|P2|COMPLETED|Overall Study||10
2194407|NCT03534986|5385264|P1|COMPLETED|Overall Study||10
2194408|NCT03534986|5385262|P3|STARTED|Overall Study||12
2194409|NCT03534986|5385263|P2|STARTED|Overall Study||10
2194410|NCT03534986|5385264|P1|STARTED|Overall Study||10
2194411|NCT03534427|5385286|P2|NOT COMPLETED|Overall Study||0
2194412|NCT03534427|5385287|P1|NOT COMPLETED|Overall Study||0
2194413|NCT03534427|5385286|P2|COMPLETED|Overall Study||20
2194414|NCT03534427|5385287|P1|COMPLETED|Overall Study||20
2194415|NCT03534427|5385286|P2|STARTED|Overall Study||20
2194416|NCT03534427|5385287|P1|STARTED|Overall Study||20
2194417|NCT03533829|5385316|P3|NOT COMPLETED|Overall Study||0
2194418|NCT03533829|5385317|P2|NOT COMPLETED|Overall Study||0
2194419|NCT03533829|5385318|P1|NOT COMPLETED|Overall Study||0
2194420|NCT03533829|5385316|P3|COMPLETED|Overall Study||10
2194421|NCT03533829|5385317|P2|COMPLETED|Overall Study||10
2194422|NCT03533829|5385318|P1|COMPLETED|Overall Study||10
2194423|NCT03533829|5385316|P3|STARTED|Overall Study||10
2194424|NCT03533829|5385317|P2|STARTED|Overall Study||10
2194425|NCT03533829|5385318|P1|STARTED|Overall Study||10
2194426|NCT03533036|5385418|P2|NOT COMPLETED|Overall Study||0
2194427|NCT03533036|5385419|P1|NOT COMPLETED|Overall Study||0
2194428|NCT03533036|5385418|P2|COMPLETED|Overall Study||15
2194429|NCT03533036|5385419|P1|COMPLETED|Overall Study||15
2194430|NCT03533036|5385418|P2|STARTED|Overall Study||15
2194431|NCT03533036|5385419|P1|STARTED|Overall Study||15
2194432|NCT03530631|5385426|P1|NOT COMPLETED|Placebo/Deception||0
2194433|NCT03530631|5385426|P1|COMPLETED|Placebo/Deception||4
2194434|NCT03530631|5385426|P1|STARTED|Placebo/Deception||4
2194435|NCT03530631|5385426|P1|NOT COMPLETED|Adderall/Deception||0
2194436|NCT03530631|5385426|P1|COMPLETED|Adderall/Deception||4
2194437|NCT03530631|5385426|P1|STARTED|Adderall/Deception||4
2194438|NCT03530631|5385426|P1|NOT COMPLETED|Placebo/Truth||0
2194439|NCT03530631|5385426|P1|COMPLETED|Placebo/Truth||4
2194440|NCT03530631|5385426|P1|STARTED|Placebo/Truth||4
2194441|NCT03530631|5385426|P1|NOT COMPLETED|Adderall/Truth||0
2194442|NCT03530631|5385426|P1|COMPLETED|Adderall/Truth||4
2194443|NCT03530631|5385426|P1|STARTED|Adderall/Truth||4
2194444|NCT03529461|5385438|P2|NOT COMPLETED|Overall Study||0
2194445|NCT03529461|5385439|P1|NOT COMPLETED|Overall Study||0
2194446|NCT03529461|5385438|P2|COMPLETED|Overall Study||28
2194447|NCT03529461|5385439|P1|COMPLETED|Overall Study||28
2194448|NCT03529461|5385438|P2|STARTED|Overall Study||28
2194449|NCT03529461|5385439|P1|STARTED|Overall Study||28
2194450|NCT03528369|5385451|P3|NOT COMPLETED|Overall Study||0
2194451|NCT03528369|5385452|P2|NOT COMPLETED|Overall Study||1
2194452|NCT03528369|5385453|P1|NOT COMPLETED|Overall Study||3
2194453|NCT03528369|5385451|P3|COMPLETED|Overall Study||40
2194454|NCT03528369|5385452|P2|COMPLETED|Overall Study||41
2194455|NCT03528369|5385453|P1|COMPLETED|Overall Study||37
2194456|NCT03528369|5385451|P3|STARTED|Overall Study||40
2194457|NCT03528369|5385452|P2|STARTED|Overall Study||42
2194458|NCT03528369|5385453|P1|STARTED|Overall Study||40
2194459|NCT03528174|5385482|P1|NOT COMPLETED|Overall Study||2
2194460|NCT03528174|5385482|P1|COMPLETED|Overall Study||8
2194461|NCT03528174|5385482|P1|STARTED|Overall Study||10
2194462|NCT03527966|5385502|P2|NOT COMPLETED|Overall Study||0
2194463|NCT03527966|5385503|P1|NOT COMPLETED|Overall Study||3
2194464|NCT03527966|5385502|P2|COMPLETED|Overall Study||0
2194465|NCT03527966|5385503|P1|COMPLETED|Overall Study||0
2194466|NCT03527966|5385502|P2|STARTED|Overall Study||0
2194467|NCT03527966|5385503|P1|STARTED|Overall Study||3
2194468|NCT03526055|5385515|P2|NOT COMPLETED|Second Program||0
2194469|NCT03526055|5385516|P1|NOT COMPLETED|Second Program||0
2194470|NCT03526055|5385515|P2|COMPLETED|Second Program||5
2194471|NCT03526055|5385516|P1|COMPLETED|Second Program||5
2194472|NCT03526055|5385515|P2|STARTED|Second Program||5
2194473|NCT03526055|5385516|P1|STARTED|Second Program||5
2194474|NCT03526055|5385515|P2|NOT COMPLETED|Initial Program||0
2194475|NCT03526055|5385516|P1|NOT COMPLETED|Initial Program||0
2194476|NCT03526055|5385515|P2|COMPLETED|Initial Program||5
2194477|NCT03526055|5385516|P1|COMPLETED|Initial Program||5
2194478|NCT03526055|5385515|P2|STARTED|Initial Program||5
2194479|NCT03526055|5385516|P1|STARTED|Initial Program||5
2194480|NCT03525548|5385532|P2|NOT COMPLETED|Overall Study||0
2194481|NCT03525548|5385533|P1|NOT COMPLETED|Overall Study||0
2194482|NCT03525548|5385532|P2|COMPLETED|Overall Study||55
2194483|NCT03525548|5385533|P1|COMPLETED|Overall Study||52
2194484|NCT03525548|5385532|P2|STARTED|Overall Study||55
2194485|NCT03525548|5385533|P1|STARTED|Overall Study||52
2194486|NCT03524157|5385550|P3|NOT COMPLETED|Overall Study||1
2194487|NCT03524157|5385551|P2|NOT COMPLETED|Overall Study||0
2194488|NCT03524157|5385552|P1|NOT COMPLETED|Overall Study||0
2194489|NCT03524157|5385550|P3|COMPLETED|Overall Study||9
2194490|NCT03524157|5385551|P2|COMPLETED|Overall Study||10
2194491|NCT03524157|5385552|P1|COMPLETED|Overall Study||10
2194492|NCT03524157|5385550|P3|STARTED|Overall Study||10
2194493|NCT03524157|5385551|P2|STARTED|Overall Study||10
2194494|NCT03524157|5385552|P1|STARTED|Overall Study||10
2194495|NCT03523988|5385590|P3|NOT COMPLETED|Overall Study||18
2194496|NCT03523988|5385591|P2|NOT COMPLETED|Overall Study||16
2194497|NCT03523988|5385592|P1|NOT COMPLETED|Overall Study||17
2194498|NCT03523988|5385590|P3|COMPLETED|Overall Study||7
2194499|NCT03523988|5385591|P2|COMPLETED|Overall Study||8
2194500|NCT03523988|5385592|P1|COMPLETED|Overall Study||7
2194501|NCT03523988|5385590|P3|STARTED|Overall Study||25
2194502|NCT03523988|5385591|P2|STARTED|Overall Study||24
2194503|NCT03523988|5385592|P1|STARTED|Overall Study||24
2194504|NCT03522675|5385606|P1|NOT COMPLETED|Overall Study||2
2194505|NCT03522675|5385606|P1|COMPLETED|Overall Study||20
2194506|NCT03522675|5385606|P1|STARTED|Overall Study||22
2194507|NCT03522506|5385624|P4|NOT COMPLETED|Treatment Period 4 (2 Days)||0
2194508|NCT03522506|5385625|P3|NOT COMPLETED|Treatment Period 4 (2 Days)||0
2194509|NCT03522506|5385626|P2|NOT COMPLETED|Treatment Period 4 (2 Days)||0
2194510|NCT03522506|5385627|P1|NOT COMPLETED|Treatment Period 4 (2 Days)||0
2194511|NCT03522506|5385624|P4|COMPLETED|Treatment Period 4 (2 Days)||3
2194512|NCT03522506|5385625|P3|COMPLETED|Treatment Period 4 (2 Days)||5
2194513|NCT03522506|5385626|P2|COMPLETED|Treatment Period 4 (2 Days)||5
2194514|NCT03522506|5385627|P1|COMPLETED|Treatment Period 4 (2 Days)||5
2194515|NCT03522506|5385624|P4|STARTED|Treatment Period 4 (2 Days)||3
2194516|NCT03522506|5385625|P3|STARTED|Treatment Period 4 (2 Days)||5
2194517|NCT03522506|5385626|P2|STARTED|Treatment Period 4 (2 Days)||5
2194518|NCT03522506|5385627|P1|STARTED|Treatment Period 4 (2 Days)||5
2194519|NCT03522506|5385624|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
2194520|NCT03522506|5385625|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
2194521|NCT03522506|5385626|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
2194522|NCT03522506|5385627|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
2194523|NCT03522506|5385624|P4|COMPLETED|Washout Period 3 (7 Days)||3
2194524|NCT03522506|5385625|P3|COMPLETED|Washout Period 3 (7 Days)||5
2194525|NCT03522506|5385626|P2|COMPLETED|Washout Period 3 (7 Days)||5
2194526|NCT03522506|5385627|P1|COMPLETED|Washout Period 3 (7 Days)||5
2194527|NCT03522506|5385624|P4|STARTED|Washout Period 3 (7 Days)||3
2194528|NCT03522506|5385625|P3|STARTED|Washout Period 3 (7 Days)||5
2194529|NCT03522506|5385626|P2|STARTED|Washout Period 3 (7 Days)||5
2194530|NCT03522506|5385627|P1|STARTED|Washout Period 3 (7 Days)||5
2194531|NCT03522506|5385624|P4|NOT COMPLETED|Treatment Period 3 (2 Days)||0
2194532|NCT03522506|5385625|P3|NOT COMPLETED|Treatment Period 3 (2 Days)||0
2194533|NCT03522506|5385626|P2|NOT COMPLETED|Treatment Period 3 (2 Days)||0
2194534|NCT03522506|5385627|P1|NOT COMPLETED|Treatment Period 3 (2 Days)||0
2194535|NCT03522506|5385624|P4|COMPLETED|Treatment Period 3 (2 Days)||3
2194536|NCT03522506|5385625|P3|COMPLETED|Treatment Period 3 (2 Days)||5
2194537|NCT03522506|5385626|P2|COMPLETED|Treatment Period 3 (2 Days)||5
2194538|NCT03522506|5385627|P1|COMPLETED|Treatment Period 3 (2 Days)||5
2194539|NCT03522506|5385624|P4|STARTED|Treatment Period 3 (2 Days)||3
2194540|NCT03522506|5385625|P3|STARTED|Treatment Period 3 (2 Days)||5
2194541|NCT03522506|5385626|P2|STARTED|Treatment Period 3 (2 Days)||5
2194542|NCT03522506|5385627|P1|STARTED|Treatment Period 3 (2 Days)||5
2194543|NCT03522506|5385624|P4|NOT COMPLETED|Washout Period 2 (7 Days)||1
2194544|NCT03522506|5385625|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
2194545|NCT03522506|5385626|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
2194546|NCT03522506|5385627|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
2194547|NCT03522506|5385624|P4|COMPLETED|Washout Period 2 (7 Days)||3
2194548|NCT03522506|5385625|P3|COMPLETED|Washout Period 2 (7 Days)||5
2194549|NCT03522506|5385626|P2|COMPLETED|Washout Period 2 (7 Days)||5
2194550|NCT03522506|5385627|P1|COMPLETED|Washout Period 2 (7 Days)||5
2194551|NCT03522506|5385624|P4|STARTED|Washout Period 2 (7 Days)||4
2194552|NCT03522506|5385625|P3|STARTED|Washout Period 2 (7 Days)||5
2194553|NCT03522506|5385626|P2|STARTED|Washout Period 2 (7 Days)||5
2194554|NCT03522506|5385627|P1|STARTED|Washout Period 2 (7 Days)||5
2194555|NCT03522506|5385624|P4|NOT COMPLETED|Treatment Period 2 (2 Days)||0
2194556|NCT03522506|5385625|P3|NOT COMPLETED|Treatment Period 2 (2 Days)||0
2194557|NCT03522506|5385626|P2|NOT COMPLETED|Treatment Period 2 (2 Days)||0
2194558|NCT03522506|5385627|P1|NOT COMPLETED|Treatment Period 2 (2 Days)||0
2194559|NCT03522506|5385624|P4|COMPLETED|Treatment Period 2 (2 Days)||4
2194560|NCT03522506|5385625|P3|COMPLETED|Treatment Period 2 (2 Days)||5
2194561|NCT03522506|5385626|P2|COMPLETED|Treatment Period 2 (2 Days)||5
2194562|NCT03522506|5385627|P1|COMPLETED|Treatment Period 2 (2 Days)||5
2194563|NCT03522506|5385624|P4|STARTED|Treatment Period 2 (2 Days)||4
2194564|NCT03522506|5385625|P3|STARTED|Treatment Period 2 (2 Days)||5
2194565|NCT03522506|5385626|P2|STARTED|Treatment Period 2 (2 Days)||5
2194566|NCT03522506|5385627|P1|STARTED|Treatment Period 2 (2 Days)||5
2194567|NCT03522506|5385624|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
2194568|NCT03522506|5385625|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
2194569|NCT03522506|5385626|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
2194570|NCT03522506|5385627|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
2194571|NCT03522506|5385624|P4|COMPLETED|Washout Period 1 (7 Days)||4
2194572|NCT03522506|5385625|P3|COMPLETED|Washout Period 1 (7 Days)||5
2194573|NCT03522506|5385626|P2|COMPLETED|Washout Period 1 (7 Days)||5
2194574|NCT03522506|5385627|P1|COMPLETED|Washout Period 1 (7 Days)||5
2194575|NCT03522506|5385624|P4|STARTED|Washout Period 1 (7 Days)||5
2194576|NCT03522506|5385625|P3|STARTED|Washout Period 1 (7 Days)||5
2194577|NCT03522506|5385626|P2|STARTED|Washout Period 1 (7 Days)||5
2194578|NCT03522506|5385627|P1|STARTED|Washout Period 1 (7 Days)||5
2194579|NCT03522506|5385624|P4|NOT COMPLETED|Treatment Period 1 (2 Days)||0
2194580|NCT03522506|5385625|P3|NOT COMPLETED|Treatment Period 1 (2 Days)||0
2194581|NCT03522506|5385626|P2|NOT COMPLETED|Treatment Period 1 (2 Days)||0
2194582|NCT03522506|5385627|P1|NOT COMPLETED|Treatment Period 1 (2 Days)||0
2194583|NCT03522506|5385624|P4|COMPLETED|Treatment Period 1 (2 Days)||5
2194584|NCT03522506|5385625|P3|COMPLETED|Treatment Period 1 (2 Days)||5
2194585|NCT03522506|5385626|P2|COMPLETED|Treatment Period 1 (2 Days)||5
2194586|NCT03522506|5385627|P1|COMPLETED|Treatment Period 1 (2 Days)||5
2194587|NCT03522506|5385624|P4|STARTED|Treatment Period 1 (2 Days)||5
2194588|NCT03522506|5385625|P3|STARTED|Treatment Period 1 (2 Days)||5
2194589|NCT03522506|5385626|P2|STARTED|Treatment Period 1 (2 Days)||5
2194590|NCT03522506|5385627|P1|STARTED|Treatment Period 1 (2 Days)||5
2194591|NCT03522350|5385675|P2|NOT COMPLETED|Overall Study||0
2194592|NCT03522350|5385676|P1|NOT COMPLETED|Overall Study||0
2194593|NCT03522350|5385675|P2|COMPLETED|Overall Study||18
2194594|NCT03522350|5385676|P1|COMPLETED|Overall Study||18
2194595|NCT03522350|5385675|P2|STARTED|Overall Study||18
2194596|NCT03522350|5385676|P1|STARTED|Overall Study||18
2194597|NCT03521791|5385689|P2|NOT COMPLETED|Overall Study||17
2194598|NCT03521791|5385690|P1|NOT COMPLETED|Overall Study||7
2194599|NCT03521791|5385689|P2|COMPLETED|Overall Study||73
2194600|NCT03521791|5385690|P1|COMPLETED|Overall Study||69
2194601|NCT03521791|5385689|P2|STARTED|Overall Study||90
2194602|NCT03521791|5385690|P1|STARTED|Overall Study||76
2194603|NCT03520348|5385716|P2|NOT COMPLETED|Overall Study||0
2194604|NCT03520348|5385717|P1|NOT COMPLETED|Overall Study||0
2194605|NCT03520348|5385716|P2|COMPLETED|Overall Study||12
2194606|NCT03520348|5385717|P1|COMPLETED|Overall Study||12
2194607|NCT03520348|5385716|P2|STARTED|Overall Study||12
2194608|NCT03520348|5385717|P1|STARTED|Overall Study||12
2194609|NCT03519932|5385741|P2|NOT COMPLETED|Second Intervention||0
2194610|NCT03519932|5385742|P1|NOT COMPLETED|Second Intervention||0
2194611|NCT03519932|5385741|P2|COMPLETED|Second Intervention||23
2194612|NCT03519932|5385742|P1|COMPLETED|Second Intervention||22
2194613|NCT03519932|5385741|P2|STARTED|Second Intervention|Subjects who wore comfilcon A toric at 1st intervention wear Samfilcon A toric at 2nd intervention|23
2194614|NCT03519932|5385742|P1|STARTED|Second Intervention|Subjects who wore samfilcon A toric at 1st intervention wear comfilcon A toric at 2nd intervention|22
2194615|NCT03519932|5385741|P2|NOT COMPLETED|First Intervention||3
2194616|NCT03519932|5385742|P1|NOT COMPLETED|First Intervention||1
2194617|NCT03519932|5385741|P2|COMPLETED|First Intervention|3 subjects had non-significant adverse events and data not included in analysis.|22
2194618|NCT03519932|5385742|P1|COMPLETED|First Intervention|One subject had non-significant adverse event and data not included in the analysis|23
2194619|NCT03519932|5385741|P2|STARTED|First Intervention||25
2194620|NCT03519932|5385742|P1|STARTED|First Intervention||24
2194621|NCT03519919|5385768|P1|NOT COMPLETED|Overall Study||3
2194622|NCT03519919|5385768|P1|COMPLETED|Overall Study||48
2194623|NCT03519919|5385768|P1|STARTED|Overall Study||51
2194624|NCT03519867|5385820|P10|NOT COMPLETED|Overall Study||0
2194625|NCT03519867|5385821|P9|NOT COMPLETED|Overall Study||1
2194626|NCT03519867|5385822|P8|NOT COMPLETED|Overall Study||1
2194627|NCT03519867|5385823|P7|NOT COMPLETED|Overall Study||1
2194628|NCT03519867|5385824|P6|NOT COMPLETED|Overall Study||3
2194629|NCT03519867|5385825|P5|NOT COMPLETED|Overall Study||0
2194630|NCT03519867|5385826|P4|NOT COMPLETED|Overall Study||1
2194631|NCT03519867|5385827|P3|NOT COMPLETED|Overall Study||1
2194632|NCT03519867|5385828|P2|NOT COMPLETED|Overall Study||3
2194633|NCT03519867|5385829|P1|NOT COMPLETED|Overall Study||3
2194634|NCT03519867|5385820|P10|COMPLETED|Overall Study||4
2194635|NCT03519867|5385821|P9|COMPLETED|Overall Study||3
2194636|NCT03519867|5385822|P8|COMPLETED|Overall Study||4
2194637|NCT03519867|5385823|P7|COMPLETED|Overall Study||3
2194638|NCT03519867|5385824|P6|COMPLETED|Overall Study||2
2194639|NCT03519867|5385825|P5|COMPLETED|Overall Study||5
2194640|NCT03519867|5385826|P4|COMPLETED|Overall Study||3
2194641|NCT03519867|5385827|P3|COMPLETED|Overall Study||5
2194642|NCT03519867|5385828|P2|COMPLETED|Overall Study||4
2194643|NCT03519867|5385829|P1|COMPLETED|Overall Study||3
2194644|NCT03519867|5385820|P10|Treated|Overall Study||4
2194645|NCT03519867|5385821|P9|Treated|Overall Study||3
2194646|NCT03519867|5385822|P8|Treated|Overall Study||4
2194647|NCT03519867|5385823|P7|Treated|Overall Study||4
2194648|NCT03519867|5385824|P6|Treated|Overall Study||4
2194649|NCT03519867|5385825|P5|Treated|Overall Study||5
2194650|NCT03519867|5385826|P4|Treated|Overall Study||3
2194651|NCT03519867|5385827|P3|Treated|Overall Study||5
2194652|NCT03519867|5385828|P2|Treated|Overall Study||6
2194653|NCT03519867|5385829|P1|Treated|Overall Study||5
2194654|NCT03519867|5385820|P10|STARTED|Overall Study||4
2194655|NCT03519867|5385821|P9|STARTED|Overall Study||4
2194656|NCT03519867|5385822|P8|STARTED|Overall Study||5
2194657|NCT03519867|5385823|P7|STARTED|Overall Study||4
2194658|NCT03519867|5385824|P6|STARTED|Overall Study||5
2194659|NCT03519867|5385825|P5|STARTED|Overall Study||5
2194660|NCT03519867|5385826|P4|STARTED|Overall Study||4
2194661|NCT03519867|5385827|P3|STARTED|Overall Study||6
2194662|NCT03519867|5385828|P2|STARTED|Overall Study|One participant randomized to receive MK-8616 8.0 mg/kg received MK-8616 0.8 mg/kg.|7
2194663|NCT03519867|5385829|P1|STARTED|Overall Study||6
2194664|NCT03519854|5385879|P18|NOT COMPLETED|Overall Study||0
2194665|NCT03519854|5385880|P17|NOT COMPLETED|Overall Study||0
2194666|NCT03519854|5385881|P16|NOT COMPLETED|Overall Study||0
2194667|NCT03519854|5385882|P15|NOT COMPLETED|Overall Study||0
2194668|NCT03519854|5385883|P14|NOT COMPLETED|Overall Study||0
2194669|NCT03519854|5385884|P13|NOT COMPLETED|Overall Study||0
2194670|NCT03519854|5385885|P12|NOT COMPLETED|Overall Study||0
2194671|NCT03519854|5385886|P11|NOT COMPLETED|Overall Study||0
2194672|NCT03519854|5385887|P10|NOT COMPLETED|Overall Study||0
2194673|NCT03519854|5385888|P9|NOT COMPLETED|Overall Study||0
2194674|NCT03519854|5385889|P8|NOT COMPLETED|Overall Study||0
2194675|NCT03519854|5385890|P7|NOT COMPLETED|Overall Study||0
2194676|NCT03519854|5385891|P6|NOT COMPLETED|Overall Study||0
2194677|NCT03519854|5385892|P5|NOT COMPLETED|Overall Study||0
2194678|NCT03519854|5385893|P4|NOT COMPLETED|Overall Study||0
2194679|NCT03519854|5385894|P3|NOT COMPLETED|Overall Study||1
2194680|NCT03519854|5385895|P2|NOT COMPLETED|Overall Study||0
2194681|NCT03519854|5385896|P1|NOT COMPLETED|Overall Study||0
2194682|NCT03519854|5385879|P18|COMPLETED|Overall Study||6
2194683|NCT03519854|5385880|P17|COMPLETED|Overall Study||6
2194684|NCT03519854|5385881|P16|COMPLETED|Overall Study||6
2194685|NCT03519854|5385882|P15|COMPLETED|Overall Study||6
2194686|NCT03519854|5385883|P14|COMPLETED|Overall Study||6
2194687|NCT03519854|5385884|P13|COMPLETED|Overall Study||3
2194688|NCT03519854|5385885|P12|COMPLETED|Overall Study||6
2194689|NCT03519854|5385886|P11|COMPLETED|Overall Study||6
2194690|NCT03519854|5385887|P10|COMPLETED|Overall Study||6
2194691|NCT03519854|5385888|P9|COMPLETED|Overall Study||6
2194692|NCT03519854|5385889|P8|COMPLETED|Overall Study||6
2194693|NCT03519854|5385890|P7|COMPLETED|Overall Study||3
2194694|NCT03519854|5385891|P6|COMPLETED|Overall Study||6
2194695|NCT03519854|5385892|P5|COMPLETED|Overall Study||6
2194696|NCT03519854|5385893|P4|COMPLETED|Overall Study||6
2194697|NCT03519854|5385894|P3|COMPLETED|Overall Study||4
2194698|NCT03519854|5385895|P2|COMPLETED|Overall Study||6
2194699|NCT03519854|5385896|P1|COMPLETED|Overall Study||4
2194700|NCT03519854|5385879|P18|Treated|Overall Study||6
2194701|NCT03519854|5385880|P17|Treated|Overall Study||6
2194702|NCT03519854|5385881|P16|Treated|Overall Study||6
2194703|NCT03519854|5385882|P15|Treated|Overall Study||6
2194704|NCT03519854|5385883|P14|Treated|Overall Study||6
2194705|NCT03519854|5385884|P13|Treated|Overall Study||3
2194706|NCT03519854|5385885|P12|Treated|Overall Study||6
2194707|NCT03519854|5385886|P11|Treated|Overall Study||6
2194708|NCT03519854|5385887|P10|Treated|Overall Study||6
2194709|NCT03519854|5385888|P9|Treated|Overall Study||6
2194710|NCT03519854|5385889|P8|Treated|Overall Study||6
2194711|NCT03519854|5385890|P7|Treated|Overall Study||3
2194712|NCT03519854|5385891|P6|Treated|Overall Study||6
2194713|NCT03519854|5385892|P5|Treated|Overall Study||6
2194714|NCT03519854|5385893|P4|Treated|Overall Study||6
2194715|NCT03519854|5385894|P3|Treated|Overall Study||4
2194716|NCT03519854|5385895|P2|Treated|Overall Study||6
2194717|NCT03519854|5385896|P1|Treated|Overall Study|N=1 (randomized to Arm C) received placebo, 3 min after 1.2 mg/kg Esmeron®|4
2194718|NCT03519854|5385879|P18|STARTED|Overall Study||6
2194719|NCT03519854|5385880|P17|STARTED|Overall Study||6
2194720|NCT03519854|5385881|P16|STARTED|Overall Study||6
2194721|NCT03519854|5385882|P15|STARTED|Overall Study||6
2194722|NCT03519854|5385883|P14|STARTED|Overall Study||6
2194723|NCT03519854|5385884|P13|STARTED|Overall Study||3
2194724|NCT03519854|5385885|P12|STARTED|Overall Study||6
2194725|NCT03519854|5385886|P11|STARTED|Overall Study||6
2194726|NCT03519854|5385887|P10|STARTED|Overall Study||6
2194727|NCT03519854|5385888|P9|STARTED|Overall Study||6
2194728|NCT03519854|5385889|P8|STARTED|Overall Study||6
2194729|NCT03519854|5385890|P7|STARTED|Overall Study||3
2194730|NCT03519854|5385891|P6|STARTED|Overall Study||6
2194731|NCT03519854|5385892|P5|STARTED|Overall Study||6
2194732|NCT03519854|5385893|P4|STARTED|Overall Study||6
2194733|NCT03519854|5385894|P3|STARTED|Overall Study||5
2194734|NCT03519854|5385895|P2|STARTED|Overall Study||6
2194735|NCT03519854|5385896|P1|STARTED|Overall Study|N=3 randomized to Arm A. An additional N=1 (randomized to Arm C) is counted as Started in Arm A|4
2194736|NCT03519516|5386062|P2|NOT COMPLETED|Overall Study||1
2194737|NCT03519516|5386063|P1|NOT COMPLETED|Overall Study||0
2194738|NCT03519516|5386062|P2|COMPLETED|Overall Study||14
2194739|NCT03519516|5386063|P1|COMPLETED|Overall Study||15
2194740|NCT03519516|5386062|P2|STARTED|Overall Study||15
2194741|NCT03519516|5386063|P1|STARTED|Overall Study||15
2194742|NCT03519243|5386090|P4|NOT COMPLETED|Overall Study||1
2194743|NCT03519243|5386091|P3|NOT COMPLETED|Overall Study||0
2194744|NCT03519243|5386092|P2|NOT COMPLETED|Overall Study||4
2194745|NCT03519243|5386093|P1|NOT COMPLETED|Overall Study||5
2194746|NCT03519243|5386090|P4|COMPLETED|Overall Study||24
2194747|NCT03519243|5386091|P3|COMPLETED|Overall Study||0
2194748|NCT03519243|5386092|P2|COMPLETED|Overall Study||21
2194749|NCT03519243|5386093|P1|COMPLETED|Overall Study||20
2194750|NCT03519243|5386090|P4|STARTED|Overall Study||25
2194751|NCT03519243|5386091|P3|STARTED|Overall Study|The dose level was not studied due to the dose level l.7 µg/kg demonstrated the sufficient PD effect|0
2194752|NCT03519243|5386092|P2|STARTED|Overall Study||25
2194753|NCT03519243|5386093|P1|STARTED|Overall Study||25
2194754|NCT03519204|5386124|P2|NOT COMPLETED|Overall Study||15
2194755|NCT03519204|5386125|P1|NOT COMPLETED|Overall Study||13
2194756|NCT03519204|5386124|P2|COMPLETED|Overall Study||118
2194757|NCT03519204|5386125|P1|COMPLETED|Overall Study||30
2194758|NCT03519204|5386124|P2|Safety Population|Overall Study||136
2194759|NCT03519204|5386125|P1|Safety Population|Overall Study||40
2194760|NCT03519204|5386124|P2|mITT Population|Overall Study||130
2194761|NCT03519204|5386125|P1|mITT Population|Overall Study||33
2194762|NCT03519204|5386124|P2|STARTED|Overall Study||133
2194763|NCT03519204|5386125|P1|STARTED|Overall Study|3 control participants were treated in error; 29 participants received treatment after 3 months.|43
2194764|NCT03518008|5386142|P2|NOT COMPLETED|Period 2, Second Week of Wear||1
2194765|NCT03518008|5386143|P1|NOT COMPLETED|Period 2, Second Week of Wear||0
2194766|NCT03518008|5386142|P2|COMPLETED|Period 2, Second Week of Wear||10
2194767|NCT03518008|5386143|P1|COMPLETED|Period 2, Second Week of Wear||11
2194768|NCT03518008|5386142|P2|STARTED|Period 2, Second Week of Wear||11
2194769|NCT03518008|5386143|P1|STARTED|Period 2, Second Week of Wear||11
2194770|NCT03518008|5386142|P2|NOT COMPLETED|Period 1, First Week of Wear||0
2194771|NCT03518008|5386143|P1|NOT COMPLETED|Period 1, First Week of Wear||0
2194772|NCT03518008|5386142|P2|COMPLETED|Period 1, First Week of Wear||11
2194773|NCT03518008|5386143|P1|COMPLETED|Period 1, First Week of Wear||11
2194774|NCT03518008|5386142|P2|STARTED|Period 1, First Week of Wear||11
2194775|NCT03518008|5386143|P1|STARTED|Period 1, First Week of Wear||11
2194776|NCT03516227|5386151|P2|NOT COMPLETED|Overall Study||4
2194777|NCT03516227|5386152|P1|NOT COMPLETED|Overall Study||1
2194778|NCT03516227|5386151|P2|COMPLETED|Overall Study||16
2194779|NCT03516227|5386152|P1|COMPLETED|Overall Study||19
2194780|NCT03516227|5386151|P2|STARTED|Overall Study||20
2194781|NCT03516227|5386152|P1|STARTED|Overall Study||20
2194782|NCT03514966|5386168|P2|NOT COMPLETED|Overall Study||0
2194783|NCT03514966|5386169|P1|NOT COMPLETED|Overall Study||0
2194784|NCT03514966|5386168|P2|COMPLETED|Overall Study||43
2194785|NCT03514966|5386169|P1|COMPLETED|Overall Study||40
2194786|NCT03514966|5386168|P2|STARTED|Overall Study||43
2194787|NCT03514966|5386169|P1|STARTED|Overall Study||40
2194788|NCT03513848|5386181|P2|NOT COMPLETED|Overall Study||0
2194789|NCT03513848|5386182|P1|NOT COMPLETED|Overall Study||0
2194790|NCT03513848|5386181|P2|COMPLETED|Overall Study||6
2194791|NCT03513848|5386182|P1|COMPLETED|Overall Study||9
2194792|NCT03513848|5386181|P2|STARTED|Overall Study||6
2194793|NCT03513848|5386182|P1|STARTED|Overall Study||9
2194800|NCT03512457|5386225|P2|NOT COMPLETED|Overall Study||40
2194801|NCT03512457|5386226|P1|NOT COMPLETED|Overall Study||34
2194802|NCT03512457|5386225|P2|COMPLETED|Overall Study||185
2194803|NCT03512457|5386226|P1|COMPLETED|Overall Study||161
2194804|NCT03512457|5386225|P2|STARTED|Overall Study||225
2194805|NCT03512457|5386226|P1|STARTED|Overall Study||195
2194806|NCT03512067|5386234|P1|NOT COMPLETED|Overall Study||0
2194807|NCT03512067|5386234|P1|COMPLETED|Overall Study||1
2194808|NCT03512067|5386234|P1|STARTED|Overall Study||1
2194809|NCT03512041|5386243|P4|NOT COMPLETED|Overall Study||0
2194810|NCT03512041|5386244|P3|NOT COMPLETED|Overall Study||0
2194811|NCT03512041|5386245|P2|NOT COMPLETED|Overall Study||0
2194812|NCT03512041|5386246|P1|NOT COMPLETED|Overall Study||0
2194813|NCT03512041|5386243|P4|COMPLETED|Overall Study||9
2194814|NCT03512041|5386244|P3|COMPLETED|Overall Study||11
2194815|NCT03512041|5386245|P2|COMPLETED|Overall Study||10
2194816|NCT03512041|5386246|P1|COMPLETED|Overall Study||10
2194817|NCT03512041|5386243|P4|STARTED|Overall Study||9
2194818|NCT03512041|5386244|P3|STARTED|Overall Study||11
2194819|NCT03512041|5386245|P2|STARTED|Overall Study||10
2194820|NCT03512041|5386246|P1|STARTED|Overall Study||10
2194821|NCT03512028|5386266|P2|NOT COMPLETED|Overall Study||0
2194822|NCT03512028|5386267|P1|NOT COMPLETED|Overall Study||4
2194823|NCT03512028|5386266|P2|COMPLETED|Overall Study||15
2194824|NCT03512028|5386267|P1|COMPLETED|Overall Study||15
2194825|NCT03512028|5386266|P2|STARTED|Overall Study||15
2194826|NCT03512028|5386267|P1|STARTED|Overall Study||19
2194827|NCT03511105|5386275|P2|NOT COMPLETED|Overall Study||0
2194828|NCT03511105|5386276|P1|NOT COMPLETED|Overall Study||2
2194829|NCT03511105|5386275|P2|COMPLETED|Overall Study||22
2194830|NCT03511105|5386276|P1|COMPLETED|Overall Study||23
2194831|NCT03511105|5386275|P2|STARTED|Overall Study||22
2194832|NCT03511105|5386276|P1|STARTED|Overall Study||25
2194833|NCT03509948|5386330|P2|NOT COMPLETED|Overall Study||1
2194834|NCT03509948|5386331|P1|NOT COMPLETED|Overall Study||0
2194835|NCT03509948|5386330|P2|COMPLETED|Overall Study||6
2194836|NCT03509948|5386331|P1|COMPLETED|Overall Study||6
2194837|NCT03509948|5386330|P2|STARTED|Overall Study||7
2194838|NCT03509948|5386331|P1|STARTED|Overall Study||6
2194839|NCT03509883|5386355|P2|NOT COMPLETED|Cross-over and Treatment||0
2194840|NCT03509883|5386356|P1|NOT COMPLETED|Cross-over and Treatment||0
2194841|NCT03509883|5386355|P2|COMPLETED|Cross-over and Treatment||15
2194842|NCT03509883|5386356|P1|COMPLETED|Cross-over and Treatment||15
2194843|NCT03509883|5386355|P2|STARTED|Cross-over and Treatment||15
2194844|NCT03509883|5386356|P1|STARTED|Cross-over and Treatment||15
2194845|NCT03509883|5386355|P2|NOT COMPLETED|Initial Treatment Washout||0
2194846|NCT03509883|5386356|P1|NOT COMPLETED|Initial Treatment Washout||0
2194847|NCT03509883|5386355|P2|COMPLETED|Initial Treatment Washout||15
2194848|NCT03509883|5386356|P1|COMPLETED|Initial Treatment Washout||15
2194849|NCT03509883|5386355|P2|STARTED|Initial Treatment Washout||15
2194850|NCT03509883|5386356|P1|STARTED|Initial Treatment Washout||15
2194851|NCT03509883|5386355|P2|NOT COMPLETED|Initial Treatment||0
2194852|NCT03509883|5386356|P1|NOT COMPLETED|Initial Treatment||0
2194853|NCT03509883|5386355|P2|COMPLETED|Initial Treatment||15
2194854|NCT03509883|5386356|P1|COMPLETED|Initial Treatment||15
2194855|NCT03509883|5386355|P2|STARTED|Initial Treatment||15
2194856|NCT03509883|5386356|P1|STARTED|Initial Treatment||15
2194857|NCT03509766|5386391|P1|NOT COMPLETED|Overall Study||0
2194858|NCT03509766|5386391|P1|COMPLETED|Overall Study||24
2194859|NCT03509766|5386391|P1|STARTED|Overall Study||24
2194860|NCT03508843|5386397|P1|NOT COMPLETED|Overall Study||3
2194861|NCT03508843|5386397|P1|COMPLETED|Overall Study||147
2194862|NCT03508843|5386397|P1|STARTED|Overall Study||150
2194863|NCT03508661|5386403|P1|NOT COMPLETED|Overall Study||0
2194864|NCT03508661|5386403|P1|COMPLETED|Overall Study||10
2194865|NCT03508661|5386403|P1|STARTED|Overall Study||10
2194866|NCT03507569|5386421|P4|NOT COMPLETED|Overall Study||0
2194867|NCT03507569|5386422|P3|NOT COMPLETED|Overall Study||0
2194868|NCT03507569|5386423|P2|NOT COMPLETED|Overall Study||0
2194869|NCT03507569|5386424|P1|NOT COMPLETED|Overall Study||0
2194870|NCT03507569|5386421|P4|COMPLETED|Overall Study||1
2194871|NCT03507569|5386422|P3|COMPLETED|Overall Study||2
2194872|NCT03507569|5386423|P2|COMPLETED|Overall Study||1
2194873|NCT03507569|5386424|P1|COMPLETED|Overall Study||2
2194874|NCT03507569|5386421|P4|STARTED|Overall Study||1
2194875|NCT03507569|5386422|P3|STARTED|Overall Study||2
2194876|NCT03507569|5386423|P2|STARTED|Overall Study||1
2194877|NCT03507569|5386424|P1|STARTED|Overall Study||2
2194878|NCT03506425|5386445|P3|NOT COMPLETED|Overall Study||1
2194879|NCT03506425|5386446|P2|NOT COMPLETED|Overall Study||3
2194880|NCT03506425|5386447|P1|NOT COMPLETED|Overall Study||2
2194881|NCT03506425|5386445|P3|COMPLETED|Overall Study||4
2194882|NCT03506425|5386446|P2|COMPLETED|Overall Study||2
2194883|NCT03506425|5386447|P1|COMPLETED|Overall Study||3
2194884|NCT03506425|5386445|P3|STARTED|Overall Study||5
2194885|NCT03506425|5386446|P2|STARTED|Overall Study||5
2194886|NCT03506425|5386447|P1|STARTED|Overall Study||5
2194887|NCT03506347|5386460|P2|NOT COMPLETED|Overall Study||0
2194888|NCT03506347|5386461|P1|NOT COMPLETED|Overall Study||0
2194889|NCT03506347|5386460|P2|COMPLETED|Overall Study||12
2194890|NCT03506347|5386461|P1|COMPLETED|Overall Study||12
2194891|NCT03506347|5386460|P2|STARTED|Overall Study||12
2194892|NCT03506347|5386461|P1|STARTED|Overall Study||12
2194893|NCT03506295|5386469|P1|NOT COMPLETED|Overall Study||0
2194894|NCT03506295|5386469|P1|COMPLETED|Overall Study||10
2194895|NCT03506295|5386469|P1|STARTED|Overall Study||10
2194896|NCT03505372|5386482|P1|NOT COMPLETED|Overall Study||0
2194897|NCT03505372|5386482|P1|COMPLETED|Overall Study||5
2194898|NCT03505372|5386482|P1|STARTED|Overall Study||5
2194902|NCT03503578|5386496|P1|NOT COMPLETED|Overall Study||0
2194903|NCT03503578|5386496|P1|COMPLETED|Overall Study||12
2194904|NCT03503578|5386496|P1|STARTED|Overall Study||12
2194905|NCT03503188|5386502|P2|NOT COMPLETED|Overall Study||1
2194906|NCT03503188|5386503|P1|NOT COMPLETED|Overall Study||0
2194907|NCT03503188|5386502|P2|COMPLETED|Overall Study||145
2194908|NCT03503188|5386503|P1|COMPLETED|Overall Study||128
2194909|NCT03503188|5386502|P2|Sub-study|Overall Study||44
2194910|NCT03503188|5386503|P1|Sub-study|Overall Study||29
2194911|NCT03503188|5386502|P2|Main Study|Overall Study||101
2194912|NCT03503188|5386503|P1|Main Study|Overall Study||99
2194913|NCT03503188|5386502|P2|Entered in the Entire Study|Overall Study||145
2194914|NCT03503188|5386503|P1|Entered in the Entire Study|Overall Study||128
2194915|NCT03503188|5386502|P2|STARTED|Overall Study||146
2194916|NCT03503188|5386503|P1|STARTED|Overall Study||128
2194917|NCT03502915|5386521|P2|NOT COMPLETED|Overall Study||0
2194918|NCT03502915|5386522|P1|NOT COMPLETED|Overall Study||0
2194919|NCT03502915|5386521|P2|COMPLETED|Overall Study||24
2194920|NCT03502915|5386522|P1|COMPLETED|Overall Study||24
2194921|NCT03502915|5386521|P2|STARTED|Overall Study||24
2194922|NCT03502915|5386522|P1|STARTED|Overall Study||24
2194923|NCT03501277|5386540|P4|NOT COMPLETED|Intervention Period 4 (4 Days)||0
2194924|NCT03501277|5386541|P3|NOT COMPLETED|Intervention Period 4 (4 Days)||0
2194925|NCT03501277|5386542|P2|NOT COMPLETED|Intervention Period 4 (4 Days)||0
2194926|NCT03501277|5386543|P1|NOT COMPLETED|Intervention Period 4 (4 Days)||0
2194927|NCT03501277|5386540|P4|COMPLETED|Intervention Period 4 (4 Days)||15
2194928|NCT03501277|5386541|P3|COMPLETED|Intervention Period 4 (4 Days)||17
2194929|NCT03501277|5386542|P2|COMPLETED|Intervention Period 4 (4 Days)||18
2194930|NCT03501277|5386543|P1|COMPLETED|Intervention Period 4 (4 Days)||18
2194931|NCT03501277|5386540|P4|STARTED|Intervention Period 4 (4 Days)||15
2194932|NCT03501277|5386541|P3|STARTED|Intervention Period 4 (4 Days)||17
2194933|NCT03501277|5386542|P2|STARTED|Intervention Period 4 (4 Days)||18
2194934|NCT03501277|5386543|P1|STARTED|Intervention Period 4 (4 Days)||18
2194935|NCT03501277|5386540|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
2194936|NCT03501277|5386541|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
2194937|NCT03501277|5386542|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
2194938|NCT03501277|5386543|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
2194939|NCT03501277|5386540|P4|COMPLETED|Washout Period 3 (7 Days)||15
2194940|NCT03501277|5386541|P3|COMPLETED|Washout Period 3 (7 Days)||17
2194941|NCT03501277|5386542|P2|COMPLETED|Washout Period 3 (7 Days)||18
2194942|NCT03501277|5386543|P1|COMPLETED|Washout Period 3 (7 Days)||18
2194943|NCT03501277|5386540|P4|STARTED|Washout Period 3 (7 Days)||15
2194944|NCT03501277|5386541|P3|STARTED|Washout Period 3 (7 Days)||17
2194945|NCT03501277|5386542|P2|STARTED|Washout Period 3 (7 Days)||18
2194946|NCT03501277|5386543|P1|STARTED|Washout Period 3 (7 Days)||18
2194947|NCT03501277|5386540|P4|NOT COMPLETED|Intervention Period 3 (4 Days)||1
2194948|NCT03501277|5386541|P3|NOT COMPLETED|Intervention Period 3 (4 Days)||0
2194949|NCT03501277|5386542|P2|NOT COMPLETED|Intervention Period 3 (4 Days)||0
2194950|NCT03501277|5386543|P1|NOT COMPLETED|Intervention Period 3 (4 Days)||0
2194951|NCT03501277|5386540|P4|COMPLETED|Intervention Period 3 (4 Days)||15
2194952|NCT03501277|5386541|P3|COMPLETED|Intervention Period 3 (4 Days)||17
2194953|NCT03501277|5386542|P2|COMPLETED|Intervention Period 3 (4 Days)||18
2194954|NCT03501277|5386543|P1|COMPLETED|Intervention Period 3 (4 Days)||18
2194955|NCT03501277|5386540|P4|STARTED|Intervention Period 3 (4 Days)||16
2194956|NCT03501277|5386541|P3|STARTED|Intervention Period 3 (4 Days)||17
2194957|NCT03501277|5386542|P2|STARTED|Intervention Period 3 (4 Days)||18
2194958|NCT03501277|5386543|P1|STARTED|Intervention Period 3 (4 Days)||18
2194959|NCT03501277|5386540|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
2194960|NCT03501277|5386541|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
2194961|NCT03501277|5386542|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
2194962|NCT03501277|5386543|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
2194963|NCT03501277|5386540|P4|COMPLETED|Washout Period 2 (7 Days)||16
2194964|NCT03501277|5386541|P3|COMPLETED|Washout Period 2 (7 Days)||17
2194965|NCT03501277|5386542|P2|COMPLETED|Washout Period 2 (7 Days)||18
2194966|NCT03501277|5386543|P1|COMPLETED|Washout Period 2 (7 Days)||18
2194967|NCT03501277|5386540|P4|STARTED|Washout Period 2 (7 Days)||16
2194968|NCT03501277|5386541|P3|STARTED|Washout Period 2 (7 Days)||17
2194969|NCT03501277|5386542|P2|STARTED|Washout Period 2 (7 Days)||18
2194970|NCT03501277|5386543|P1|STARTED|Washout Period 2 (7 Days)||18
2194971|NCT03501277|5386540|P4|NOT COMPLETED|Intervention Period 2 (4 Days)||1
2194972|NCT03501277|5386541|P3|NOT COMPLETED|Intervention Period 2 (4 Days)||0
2194973|NCT03501277|5386542|P2|NOT COMPLETED|Intervention Period 2 (4 Days)||0
2194974|NCT03501277|5386543|P1|NOT COMPLETED|Intervention Period 2 (4 Days)||0
2194975|NCT03501277|5386540|P4|COMPLETED|Intervention Period 2 (4 Days)||16
2194976|NCT03501277|5386541|P3|COMPLETED|Intervention Period 2 (4 Days)||17
2194977|NCT03501277|5386542|P2|COMPLETED|Intervention Period 2 (4 Days)||18
2194978|NCT03501277|5386543|P1|COMPLETED|Intervention Period 2 (4 Days)||18
2194979|NCT03501277|5386540|P4|STARTED|Intervention Period 2 (4 Days)||17
2194980|NCT03501277|5386541|P3|STARTED|Intervention Period 2 (4 Days)||17
2194981|NCT03501277|5386542|P2|STARTED|Intervention Period 2 (4 Days)||18
2194982|NCT03501277|5386543|P1|STARTED|Intervention Period 2 (4 Days)||18
2194983|NCT03501277|5386540|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
2194984|NCT03501277|5386541|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
2194985|NCT03501277|5386542|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
2194986|NCT03501277|5386543|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
2194987|NCT03501277|5386540|P4|COMPLETED|Washout Period 1 (7 Days)||17
2194988|NCT03501277|5386541|P3|COMPLETED|Washout Period 1 (7 Days)||17
2194989|NCT03501277|5386542|P2|COMPLETED|Washout Period 1 (7 Days)||18
2194990|NCT03501277|5386543|P1|COMPLETED|Washout Period 1 (7 Days)||18
2194991|NCT03501277|5386540|P4|STARTED|Washout Period 1 (7 Days)||17
2194992|NCT03501277|5386541|P3|STARTED|Washout Period 1 (7 Days)||17
2194993|NCT03501277|5386542|P2|STARTED|Washout Period 1 (7 Days)||18
2194994|NCT03501277|5386543|P1|STARTED|Washout Period 1 (7 Days)||18
2194995|NCT03501277|5386540|P4|NOT COMPLETED|Intervention Period 1 (4 Days)||1
2194996|NCT03501277|5386541|P3|NOT COMPLETED|Intervention Period 1 (4 Days)||1
2194997|NCT03501277|5386542|P2|NOT COMPLETED|Intervention Period 1 (4 Days)||0
2194998|NCT03501277|5386543|P1|NOT COMPLETED|Intervention Period 1 (4 Days)||0
2194999|NCT03501277|5386540|P4|COMPLETED|Intervention Period 1 (4 Days)||17
2195000|NCT03501277|5386541|P3|COMPLETED|Intervention Period 1 (4 Days)||17
2195001|NCT03501277|5386542|P2|COMPLETED|Intervention Period 1 (4 Days)||18
2195002|NCT03501277|5386543|P1|COMPLETED|Intervention Period 1 (4 Days)||18
2195003|NCT03501277|5386540|P4|Safety Analysis Set|Intervention Period 1 (4 Days)||17
2195004|NCT03501277|5386541|P3|Safety Analysis Set|Intervention Period 1 (4 Days)||17
2195005|NCT03501277|5386542|P2|Safety Analysis Set|Intervention Period 1 (4 Days)||18
2195006|NCT03501277|5386543|P1|Safety Analysis Set|Intervention Period 1 (4 Days)||18
2195007|NCT03501277|5386540|P4|STARTED|Intervention Period 1 (4 Days)||18
2195008|NCT03501277|5386541|P3|STARTED|Intervention Period 1 (4 Days)||18
2195009|NCT03501277|5386542|P2|STARTED|Intervention Period 1 (4 Days)||18
2195010|NCT03501277|5386543|P1|STARTED|Intervention Period 1 (4 Days)||18
2195011|NCT03501264|5386559|P2|NOT COMPLETED|Overall Study||0
2195012|NCT03501264|5386560|P1|NOT COMPLETED|Overall Study||0
2195013|NCT03501264|5386559|P2|COMPLETED|Overall Study||120
2195014|NCT03501264|5386560|P1|COMPLETED|Overall Study||120
2195015|NCT03501264|5386559|P2|STARTED|Overall Study||120
2195016|NCT03501264|5386560|P1|STARTED|Overall Study||120
2195017|NCT03500679|5386568|P2|NOT COMPLETED|Overall Study||3
2195018|NCT03500679|5386569|P1|NOT COMPLETED|Overall Study||9
2195019|NCT03500679|5386568|P2|COMPLETED|Overall Study||22
2195020|NCT03500679|5386569|P1|COMPLETED|Overall Study||66
2195021|NCT03500679|5386568|P2|STARTED|Overall Study||25
2195022|NCT03500679|5386569|P1|STARTED|Overall Study||75
2195023|NCT03500406|5386617|P2|NOT COMPLETED|Overall Study||0
2195024|NCT03500406|5386618|P1|NOT COMPLETED|Overall Study||0
2195025|NCT03500406|5386617|P2|COMPLETED|Overall Study||20
2195026|NCT03500406|5386618|P1|COMPLETED|Overall Study||4
2195027|NCT03500406|5386617|P2|STARTED|Overall Study||20
2195028|NCT03500406|5386618|P1|STARTED|Overall Study||4
2195029|NCT03500224|5386636|P1|NOT COMPLETED|Overall Study||2
2195030|NCT03500224|5386636|P1|COMPLETED|Overall Study||4
2195031|NCT03500224|5386636|P1|STARTED|Overall Study||6
2195032|NCT03500159|5386675|P2|NOT COMPLETED|Overall Study||1
2195033|NCT03500159|5386676|P1|NOT COMPLETED|Overall Study||2
2195034|NCT03500159|5386675|P2|COMPLETED|Overall Study||0
2195035|NCT03500159|5386676|P1|COMPLETED|Overall Study||0
2195036|NCT03500159|5386675|P2|STARTED|Overall Study||1
2195037|NCT03500159|5386676|P1|STARTED|Overall Study||2
2195046|NCT03496987|5386699|P2|NOT COMPLETED|Overall Study||0
2195047|NCT03496987|5386700|P1|NOT COMPLETED|Overall Study||0
2195048|NCT03496987|5386699|P2|COMPLETED|Overall Study||51
2195049|NCT03496987|5386700|P1|COMPLETED|Overall Study||49
2195050|NCT03496987|5386699|P2|STARTED|Overall Study||51
2195051|NCT03496987|5386700|P1|STARTED|Overall Study||49
2195052|NCT03496974|5386720|P2|NOT COMPLETED|Overall Study||8
2195053|NCT03496974|5386721|P1|NOT COMPLETED|Overall Study||1
2195054|NCT03496974|5386720|P2|COMPLETED|Overall Study||20
2195055|NCT03496974|5386721|P1|COMPLETED|Overall Study||9
2195056|NCT03496974|5386720|P2|STARTED|Overall Study||28
2195057|NCT03496974|5386721|P1|STARTED|Overall Study||10
2195058|NCT03496428|5386755|P1|NOT COMPLETED|Overall Study||0
2195059|NCT03496428|5386755|P1|COMPLETED|Overall Study|304 locations distributed for the analyzed teeth 108 locations distributed for the implant spots|6
2195060|NCT03496428|5386755|P1|STARTED|Overall Study|304 locations distributed for the analyzed teeth 108 locations distributed for the implant spots|6
2195061|NCT03496324|5386760|P4|NOT COMPLETED|Period 7: Period 4||0
2195062|NCT03496324|5386761|P3|NOT COMPLETED|Period 7: Period 4||0
2195063|NCT03496324|5386762|P2|NOT COMPLETED|Period 7: Period 4||0
2195064|NCT03496324|5386763|P1|NOT COMPLETED|Period 7: Period 4||0
2195065|NCT03496324|5386760|P4|COMPLETED|Period 7: Period 4||6
2195066|NCT03496324|5386761|P3|COMPLETED|Period 7: Period 4||6
2195067|NCT03496324|5386762|P2|COMPLETED|Period 7: Period 4||6
2195068|NCT03496324|5386763|P1|COMPLETED|Period 7: Period 4||6
2195069|NCT03496324|5386760|P4|STARTED|Period 7: Period 4||6
2195070|NCT03496324|5386761|P3|STARTED|Period 7: Period 4||6
2195071|NCT03496324|5386762|P2|STARTED|Period 7: Period 4||6
2195072|NCT03496324|5386763|P1|STARTED|Period 7: Period 4||6
2195073|NCT03496324|5386760|P4|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
2195074|NCT03496324|5386761|P3|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
2195075|NCT03496324|5386762|P2|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
2195076|NCT03496324|5386763|P1|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
2195077|NCT03496324|5386760|P4|COMPLETED|Period 3: Washout (3 to 7 Days)||6
2195078|NCT03496324|5386761|P3|COMPLETED|Period 3: Washout (3 to 7 Days)||6
2195079|NCT03496324|5386762|P2|COMPLETED|Period 3: Washout (3 to 7 Days)||6
2195080|NCT03496324|5386763|P1|COMPLETED|Period 3: Washout (3 to 7 Days)||6
2195081|NCT03496324|5386760|P4|STARTED|Period 3: Washout (3 to 7 Days)||6
2195082|NCT03496324|5386761|P3|STARTED|Period 3: Washout (3 to 7 Days)||6
2195083|NCT03496324|5386762|P2|STARTED|Period 3: Washout (3 to 7 Days)||6
2195084|NCT03496324|5386763|P1|STARTED|Period 3: Washout (3 to 7 Days)||6
2195085|NCT03496324|5386760|P4|NOT COMPLETED|Period 3||0
2195086|NCT03496324|5386761|P3|NOT COMPLETED|Period 3||0
2195087|NCT03496324|5386762|P2|NOT COMPLETED|Period 3||0
2195088|NCT03496324|5386763|P1|NOT COMPLETED|Period 3||0
2195089|NCT03496324|5386760|P4|COMPLETED|Period 3||6
2195090|NCT03496324|5386761|P3|COMPLETED|Period 3||6
2195091|NCT03496324|5386762|P2|COMPLETED|Period 3||6
2195092|NCT03496324|5386763|P1|COMPLETED|Period 3||6
2195093|NCT03496324|5386760|P4|STARTED|Period 3||6
2195094|NCT03496324|5386761|P3|STARTED|Period 3||6
2195095|NCT03496324|5386762|P2|STARTED|Period 3||6
2195096|NCT03496324|5386763|P1|STARTED|Period 3||6
2195097|NCT03496324|5386760|P4|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
2195098|NCT03496324|5386761|P3|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
2195099|NCT03496324|5386762|P2|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
2195100|NCT03496324|5386763|P1|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
2195101|NCT03496324|5386760|P4|COMPLETED|Period 2: Washout (3 to 7 Days)||6
2195102|NCT03496324|5386761|P3|COMPLETED|Period 2: Washout (3 to 7 Days)||6
2195103|NCT03496324|5386762|P2|COMPLETED|Period 2: Washout (3 to 7 Days)||6
2195104|NCT03496324|5386763|P1|COMPLETED|Period 2: Washout (3 to 7 Days)||6
2195105|NCT03496324|5386760|P4|STARTED|Period 2: Washout (3 to 7 Days)||6
2195106|NCT03496324|5386761|P3|STARTED|Period 2: Washout (3 to 7 Days)||6
2195107|NCT03496324|5386762|P2|STARTED|Period 2: Washout (3 to 7 Days)||6
2195108|NCT03496324|5386763|P1|STARTED|Period 2: Washout (3 to 7 Days)||6
2195109|NCT03496324|5386760|P4|NOT COMPLETED|Period 2||0
2195110|NCT03496324|5386761|P3|NOT COMPLETED|Period 2||0
2195111|NCT03496324|5386762|P2|NOT COMPLETED|Period 2||0
2195112|NCT03496324|5386763|P1|NOT COMPLETED|Period 2||0
2195113|NCT03496324|5386760|P4|COMPLETED|Period 2||6
2195114|NCT03496324|5386761|P3|COMPLETED|Period 2||6
2195115|NCT03496324|5386762|P2|COMPLETED|Period 2||6
2195116|NCT03496324|5386763|P1|COMPLETED|Period 2||6
2195117|NCT03496324|5386760|P4|STARTED|Period 2||6
2195118|NCT03496324|5386761|P3|STARTED|Period 2||6
2195119|NCT03496324|5386762|P2|STARTED|Period 2||6
2195120|NCT03496324|5386763|P1|STARTED|Period 2||6
2195121|NCT03496324|5386760|P4|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
2195122|NCT03496324|5386761|P3|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
2195123|NCT03496324|5386762|P2|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
2195124|NCT03496324|5386763|P1|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
2195125|NCT03496324|5386760|P4|COMPLETED|Period 1: Washout (3 to 7 Days)||6
2195126|NCT03496324|5386761|P3|COMPLETED|Period 1: Washout (3 to 7 Days)||6
2195127|NCT03496324|5386762|P2|COMPLETED|Period 1: Washout (3 to 7 Days)||6
2195128|NCT03496324|5386763|P1|COMPLETED|Period 1: Washout (3 to 7 Days)||6
2195129|NCT03496324|5386760|P4|STARTED|Period 1: Washout (3 to 7 Days)||6
2195130|NCT03496324|5386761|P3|STARTED|Period 1: Washout (3 to 7 Days)||6
2195131|NCT03496324|5386762|P2|STARTED|Period 1: Washout (3 to 7 Days)||6
2195132|NCT03496324|5386763|P1|STARTED|Period 1: Washout (3 to 7 Days)||6
2195133|NCT03496324|5386760|P4|NOT COMPLETED|Period 1||0
2195134|NCT03496324|5386761|P3|NOT COMPLETED|Period 1||0
2195135|NCT03496324|5386762|P2|NOT COMPLETED|Period 1||0
2195136|NCT03496324|5386763|P1|NOT COMPLETED|Period 1||0
2195137|NCT03496324|5386760|P4|COMPLETED|Period 1||6
2195138|NCT03496324|5386761|P3|COMPLETED|Period 1||6
2195139|NCT03496324|5386762|P2|COMPLETED|Period 1||6
2195140|NCT03496324|5386763|P1|COMPLETED|Period 1||6
2195141|NCT03496324|5386760|P4|STARTED|Period 1||6
2195142|NCT03496324|5386761|P3|STARTED|Period 1||6
2195143|NCT03496324|5386762|P2|STARTED|Period 1||6
2195144|NCT03496324|5386763|P1|STARTED|Period 1||6
2195145|NCT03495856|5386801|P1|NOT COMPLETED|Overall Study||1
2195146|NCT03495856|5386801|P1|COMPLETED|Overall Study||22
2195147|NCT03495856|5386801|P1|STARTED|Overall Study||23
2195148|NCT03494985|5386823|P4|NOT COMPLETED|Overall Study||5
2195149|NCT03494985|5386824|P3|NOT COMPLETED|Overall Study||6
2195150|NCT03494985|5386825|P2|NOT COMPLETED|Overall Study||6
2195151|NCT03494985|5386826|P1|NOT COMPLETED|Overall Study||5
2195152|NCT03494985|5386823|P4|COMPLETED|Overall Study||94
2195153|NCT03494985|5386824|P3|COMPLETED|Overall Study||92
2195154|NCT03494985|5386825|P2|COMPLETED|Overall Study||92
2195155|NCT03494985|5386826|P1|COMPLETED|Overall Study||96
2195156|NCT03494985|5386823|P4|STARTED|Overall Study||99
2195157|NCT03494985|5386824|P3|STARTED|Overall Study||98
2195158|NCT03494985|5386825|P2|STARTED|Overall Study||98
2195159|NCT03494985|5386826|P1|STARTED|Overall Study||101
2195160|NCT03493828|5386863|P3|NOT COMPLETED|Overall Study||0
2195161|NCT03493828|5386864|P2|NOT COMPLETED|Overall Study||0
2195162|NCT03493828|5386865|P1|NOT COMPLETED|Overall Study||0
2195163|NCT03493828|5386863|P3|COMPLETED|Overall Study||20
2195164|NCT03493828|5386864|P2|COMPLETED|Overall Study||20
2195165|NCT03493828|5386865|P1|COMPLETED|Overall Study||20
2195166|NCT03493828|5386863|P3|STARTED|Overall Study||20
2195167|NCT03493828|5386864|P2|STARTED|Overall Study||20
2195168|NCT03493828|5386865|P1|STARTED|Overall Study||20
2195169|NCT03493386|5386875|P4|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
2195170|NCT03493386|5386876|P3|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
2195171|NCT03493386|5386877|P2|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
2195172|NCT03493386|5386878|P1|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
2195173|NCT03493386|5386875|P4|COMPLETED|Part 2, Intervention Period 2 (2 Days)||6
2195174|NCT03493386|5386876|P3|COMPLETED|Part 2, Intervention Period 2 (2 Days)||6
2195175|NCT03493386|5386877|P2|COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
2195176|NCT03493386|5386878|P1|COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
2195177|NCT03493386|5386875|P4|STARTED|Part 2, Intervention Period 2 (2 Days)||6
2195178|NCT03493386|5386876|P3|STARTED|Part 2, Intervention Period 2 (2 Days)||6
2195179|NCT03493386|5386877|P2|STARTED|Part 2, Intervention Period 2 (2 Days)||0
2195180|NCT03493386|5386878|P1|STARTED|Part 2, Intervention Period 2 (2 Days)||0
2195181|NCT03493386|5386875|P4|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
2195182|NCT03493386|5386876|P3|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
2195183|NCT03493386|5386877|P2|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
2195184|NCT03493386|5386878|P1|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
2195185|NCT03493386|5386875|P4|COMPLETED|Part 2, Washout Period (at Least 5 Days)||6
2195186|NCT03493386|5386876|P3|COMPLETED|Part 2, Washout Period (at Least 5 Days)||6
2195187|NCT03493386|5386877|P2|COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
2195188|NCT03493386|5386878|P1|COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
2195189|NCT03493386|5386875|P4|STARTED|Part 2, Washout Period (at Least 5 Days)||6
2195190|NCT03493386|5386876|P3|STARTED|Part 2, Washout Period (at Least 5 Days)||6
2195191|NCT03493386|5386877|P2|STARTED|Part 2, Washout Period (at Least 5 Days)||0
2195192|NCT03493386|5386878|P1|STARTED|Part 2, Washout Period (at Least 5 Days)||0
2195193|NCT03493386|5386875|P4|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
2195194|NCT03493386|5386876|P3|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
2195195|NCT03493386|5386877|P2|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
2195196|NCT03493386|5386878|P1|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
2195197|NCT03493386|5386875|P4|COMPLETED|Part 2, Intervention Period 1 (2 Days)||6
2195198|NCT03493386|5386876|P3|COMPLETED|Part 2, Intervention Period 1 (2 Days)||6
2195199|NCT03493386|5386877|P2|COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
2195200|NCT03493386|5386878|P1|COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
2195201|NCT03493386|5386875|P4|STARTED|Part 2, Intervention Period 1 (2 Days)||6
2195202|NCT03493386|5386876|P3|STARTED|Part 2, Intervention Period 1 (2 Days)||6
2195203|NCT03493386|5386877|P2|STARTED|Part 2, Intervention Period 1 (2 Days)||0
2195204|NCT03493386|5386878|P1|STARTED|Part 2, Intervention Period 1 (2 Days)||0
2195205|NCT03493386|5386875|P4|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
2195206|NCT03493386|5386876|P3|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
2195207|NCT03493386|5386877|P2|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
2195208|NCT03493386|5386878|P1|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
2195209|NCT03493386|5386875|P4|COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
2195210|NCT03493386|5386876|P3|COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
2195211|NCT03493386|5386877|P2|COMPLETED|Part 1, Intervention Period 2 (2 Days)||25
2195212|NCT03493386|5386878|P1|COMPLETED|Part 1, Intervention Period 2 (2 Days)||26
2195213|NCT03493386|5386875|P4|STARTED|Part 1, Intervention Period 2 (2 Days)||0
2195214|NCT03493386|5386876|P3|STARTED|Part 1, Intervention Period 2 (2 Days)||0
2195215|NCT03493386|5386877|P2|STARTED|Part 1, Intervention Period 2 (2 Days)||25
2195216|NCT03493386|5386878|P1|STARTED|Part 1, Intervention Period 2 (2 Days)||26
2195217|NCT03493386|5386875|P4|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
2195218|NCT03493386|5386876|P3|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
2195219|NCT03493386|5386877|P2|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||1
2195220|NCT03493386|5386878|P1|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
2195221|NCT03493386|5386875|P4|COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
2195222|NCT03493386|5386876|P3|COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
2195223|NCT03493386|5386877|P2|COMPLETED|Part 1, Washout Period (at Least 5 Days)||25
2195224|NCT03493386|5386878|P1|COMPLETED|Part 1, Washout Period (at Least 5 Days)||26
2195225|NCT03493386|5386875|P4|STARTED|Part 1, Washout Period (at Least 5 Days)||0
2195226|NCT03493386|5386876|P3|STARTED|Part 1, Washout Period (at Least 5 Days)||0
2195227|NCT03493386|5386877|P2|STARTED|Part 1, Washout Period (at Least 5 Days)||26
2195228|NCT03493386|5386878|P1|STARTED|Part 1, Washout Period (at Least 5 Days)||26
2195229|NCT03493386|5386875|P4|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
2195230|NCT03493386|5386876|P3|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
2195231|NCT03493386|5386877|P2|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
2195232|NCT03493386|5386878|P1|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
2195233|NCT03493386|5386875|P4|COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
2195234|NCT03493386|5386876|P3|COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
2195235|NCT03493386|5386877|P2|COMPLETED|Part 1, Intervention Period 1 (2 Days)||26
2195236|NCT03493386|5386878|P1|COMPLETED|Part 1, Intervention Period 1 (2 Days)||26
2195237|NCT03493386|5386875|P4|STARTED|Part 1, Intervention Period 1 (2 Days)||0
2195238|NCT03493386|5386876|P3|STARTED|Part 1, Intervention Period 1 (2 Days)||0
2195239|NCT03493386|5386877|P2|STARTED|Part 1, Intervention Period 1 (2 Days)||26
2195240|NCT03493386|5386878|P1|STARTED|Part 1, Intervention Period 1 (2 Days)||26
2195241|NCT03492554|5386998|P2|NOT COMPLETED|Overall Study||14
2195242|NCT03492554|5386999|P1|NOT COMPLETED|Overall Study||0
2195243|NCT03492554|5386998|P2|COMPLETED|Overall Study||287
2195244|NCT03492554|5386999|P1|COMPLETED|Overall Study||301
2195245|NCT03492554|5386998|P2|STARTED|Overall Study||301
2195246|NCT03492554|5386999|P1|STARTED|Overall Study||301
2195247|NCT03491891|5387013|P2|NOT COMPLETED|Overall Study||380
2195248|NCT03491891|5387014|P1|NOT COMPLETED|Overall Study||853
2195249|NCT03491891|5387013|P2|COMPLETED|Overall Study||2058
2195250|NCT03491891|5387014|P1|COMPLETED|Overall Study||5185
2195251|NCT03491891|5387013|P2|STARTED|Overall Study||2438
2195252|NCT03491891|5387014|P1|STARTED|Overall Study||6038
2195253|NCT03491228|5387020|P1|NOT COMPLETED|Overall Study||0
2195254|NCT03491228|5387020|P1|COMPLETED|Overall Study||107
2195255|NCT03491228|5387020|P1|STARTED|Overall Study||107
2195256|NCT03490916|5387028|P2|NOT COMPLETED|Overall Study||0
2195257|NCT03490916|5387029|P1|NOT COMPLETED|Overall Study||0
2195258|NCT03490916|5387028|P2|COMPLETED|Overall Study||0
2195259|NCT03490916|5387029|P1|COMPLETED|Overall Study||0
2195260|NCT03490916|5387028|P2|STARTED|Overall Study||0
2195261|NCT03490916|5387029|P1|STARTED|Overall Study||0
2195262|NCT03489551|5387037|P1|NOT COMPLETED|Overall Study||2
2195263|NCT03489551|5387037|P1|COMPLETED|Overall Study||15
2195264|NCT03489551|5387037|P1|STARTED|Overall Study||17
2195265|NCT03489304|5387041|P1|NOT COMPLETED|Overall Study||4
2195266|NCT03489304|5387041|P1|COMPLETED|Overall Study||16
2195267|NCT03489304|5387041|P1|STARTED|Overall Study||20
2195268|NCT03487588|5387047|P1|NOT COMPLETED|Overall Study||0
2195269|NCT03487588|5387047|P1|COMPLETED|Overall Study||41
2195270|NCT03487588|5387047|P1|STARTED|Overall Study||41
2195271|NCT03486392|5387058|P5|NOT COMPLETED|Overall Study||4
2195272|NCT03486392|5387059|P4|NOT COMPLETED|Overall Study||9
2195273|NCT03486392|5387060|P3|NOT COMPLETED|Overall Study||14
2195274|NCT03486392|5387061|P2|NOT COMPLETED|Overall Study||0
2195275|NCT03486392|5387062|P1|NOT COMPLETED|Overall Study||3
2195276|NCT03486392|5387058|P5|COMPLETED|Overall Study||115
2195277|NCT03486392|5387059|P4|COMPLETED|Overall Study||109
2195278|NCT03486392|5387060|P3|COMPLETED|Overall Study||104
2195279|NCT03486392|5387061|P2|COMPLETED|Overall Study||59
2195280|NCT03486392|5387062|P1|COMPLETED|Overall Study||57
2195281|NCT03486392|5387058|P5|STARTED|Overall Study||119
2195282|NCT03486392|5387059|P4|STARTED|Overall Study||118
2195283|NCT03486392|5387060|P3|STARTED|Overall Study||118
2195284|NCT03486392|5387061|P2|STARTED|Overall Study||59
2195285|NCT03486392|5387062|P1|STARTED|Overall Study||60
2195286|NCT03483896|5387096|P2|NOT COMPLETED|Overall Study||4
2195287|NCT03483896|5387097|P1|NOT COMPLETED|Overall Study||2
2195288|NCT03483896|5387096|P2|COMPLETED|Overall Study||46
2195289|NCT03483896|5387097|P1|COMPLETED|Overall Study||31
2195290|NCT03483896|5387096|P2|STARTED|Overall Study||50
2195291|NCT03483896|5387097|P1|STARTED|Overall Study||33
2195292|NCT03482713|5387107|P2|NOT COMPLETED|Overall Study||0
2195293|NCT03482713|5387108|P1|NOT COMPLETED|Overall Study||0
2195294|NCT03482713|5387107|P2|COMPLETED|Overall Study||12
2195295|NCT03482713|5387108|P1|COMPLETED|Overall Study||11
2195296|NCT03482713|5387107|P2|STARTED|Overall Study||12
2195297|NCT03482713|5387108|P1|STARTED|Overall Study||11
2195298|NCT03482453|5387132|P12|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
2195299|NCT03482453|5387133|P11|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
2195300|NCT03482453|5387134|P10|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
2195301|NCT03482453|5387135|P9|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
2195302|NCT03482453|5387136|P8|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
2195303|NCT03482453|5387137|P7|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
2195304|NCT03482453|5387138|P6|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
2195305|NCT03482453|5387139|P5|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
2195306|NCT03482453|5387140|P4|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
2195307|NCT03482453|5387141|P3|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
2195308|NCT03482453|5387142|P2|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
2195309|NCT03482453|5387143|P1|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
2195310|NCT03482453|5387132|P12|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||6
2195311|NCT03482453|5387133|P11|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||6
2195312|NCT03482453|5387134|P10|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||5
2195313|NCT03482453|5387135|P9|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||5
2195314|NCT03482453|5387136|P8|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||3
2195315|NCT03482453|5387137|P7|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||3
2195316|NCT03482453|5387138|P6|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
2195317|NCT03482453|5387139|P5|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
2195318|NCT03482453|5387140|P4|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
2195319|NCT03482453|5387141|P3|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
2195320|NCT03482453|5387142|P2|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
2195321|NCT03482453|5387143|P1|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
2195322|NCT03482453|5387132|P12|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||6
2195323|NCT03482453|5387133|P11|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||6
2195324|NCT03482453|5387134|P10|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||5
2195325|NCT03482453|5387135|P9|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||5
2195326|NCT03482453|5387136|P8|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||3
2195327|NCT03482453|5387137|P7|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||3
2195328|NCT03482453|5387138|P6|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
2195329|NCT03482453|5387139|P5|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
2195330|NCT03482453|5387140|P4|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
2195331|NCT03482453|5387141|P3|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
2195332|NCT03482453|5387142|P2|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
2195333|NCT03482453|5387143|P1|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
2195334|NCT03482453|5387132|P12|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
2195335|NCT03482453|5387133|P11|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
2195336|NCT03482453|5387134|P10|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
2195337|NCT03482453|5387135|P9|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
2195338|NCT03482453|5387136|P8|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
2195339|NCT03482453|5387137|P7|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
2195340|NCT03482453|5387138|P6|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
2195341|NCT03482453|5387139|P5|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
2195342|NCT03482453|5387140|P4|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
2195343|NCT03482453|5387141|P3|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
2195344|NCT03482453|5387142|P2|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
2195345|NCT03482453|5387143|P1|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
2195346|NCT03482453|5387132|P12|COMPLETED|Parts 2, 3 Washout Period (7 Days)||6
2195347|NCT03482453|5387133|P11|COMPLETED|Parts 2, 3 Washout Period (7 Days)||6
2195348|NCT03482453|5387134|P10|COMPLETED|Parts 2, 3 Washout Period (7 Days)||5
2195349|NCT03482453|5387135|P9|COMPLETED|Parts 2, 3 Washout Period (7 Days)||5
2195350|NCT03482453|5387136|P8|COMPLETED|Parts 2, 3 Washout Period (7 Days)||3
2195351|NCT03482453|5387137|P7|COMPLETED|Parts 2, 3 Washout Period (7 Days)||3
2195352|NCT03482453|5387138|P6|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
2195353|NCT03482453|5387139|P5|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
2195354|NCT03482453|5387140|P4|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
2195355|NCT03482453|5387141|P3|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
2195356|NCT03482453|5387142|P2|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
2195357|NCT03482453|5387143|P1|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
2195358|NCT03482453|5387132|P12|STARTED|Parts 2, 3 Washout Period (7 Days)||6
2195359|NCT03482453|5387133|P11|STARTED|Parts 2, 3 Washout Period (7 Days)||6
2195360|NCT03482453|5387134|P10|STARTED|Parts 2, 3 Washout Period (7 Days)||5
2195361|NCT03482453|5387135|P9|STARTED|Parts 2, 3 Washout Period (7 Days)||5
2195362|NCT03482453|5387136|P8|STARTED|Parts 2, 3 Washout Period (7 Days)||3
2195363|NCT03482453|5387137|P7|STARTED|Parts 2, 3 Washout Period (7 Days)||3
2195364|NCT03482453|5387138|P6|STARTED|Parts 2, 3 Washout Period (7 Days)||0
2195365|NCT03482453|5387139|P5|STARTED|Parts 2, 3 Washout Period (7 Days)||0
2195366|NCT03482453|5387140|P4|STARTED|Parts 2, 3 Washout Period (7 Days)||0
2195367|NCT03482453|5387141|P3|STARTED|Parts 2, 3 Washout Period (7 Days)||0
2195368|NCT03482453|5387142|P2|STARTED|Parts 2, 3 Washout Period (7 Days)||0
2195369|NCT03482453|5387143|P1|STARTED|Parts 2, 3 Washout Period (7 Days)||0
2195370|NCT03482453|5387132|P12|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
2195371|NCT03482453|5387133|P11|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||1
2195372|NCT03482453|5387134|P10|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
2195373|NCT03482453|5387135|P9|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
2195374|NCT03482453|5387136|P8|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
2195375|NCT03482453|5387137|P7|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
2195376|NCT03482453|5387138|P6|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
2195377|NCT03482453|5387139|P5|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
2195378|NCT03482453|5387140|P4|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
2195379|NCT03482453|5387141|P3|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
2195380|NCT03482453|5387142|P2|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
2195381|NCT03482453|5387143|P1|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
2195382|NCT03482453|5387132|P12|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||6
2195383|NCT03482453|5387133|P11|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||6
2195384|NCT03482453|5387134|P10|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||5
2195385|NCT03482453|5387135|P9|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||5
2195386|NCT03482453|5387136|P8|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||3
2195387|NCT03482453|5387137|P7|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||3
2195388|NCT03482453|5387138|P6|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
2195389|NCT03482453|5387139|P5|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
2195390|NCT03482453|5387140|P4|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
2195391|NCT03482453|5387141|P3|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
2195392|NCT03482453|5387142|P2|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
2195393|NCT03482453|5387143|P1|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
2195394|NCT03482453|5387132|P12|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||6
2195395|NCT03482453|5387133|P11|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||7
2195396|NCT03482453|5387134|P10|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||5
2195397|NCT03482453|5387135|P9|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||5
2195398|NCT03482453|5387136|P8|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||3
2195399|NCT03482453|5387137|P7|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||3
2195400|NCT03482453|5387138|P6|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
2195401|NCT03482453|5387139|P5|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
2195402|NCT03482453|5387140|P4|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
2195403|NCT03482453|5387141|P3|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
2195404|NCT03482453|5387142|P2|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
2195405|NCT03482453|5387143|P1|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
2195406|NCT03482453|5387132|P12|NOT COMPLETED|Part 1 (1 Day)||0
2195407|NCT03482453|5387133|P11|NOT COMPLETED|Part 1 (1 Day)||0
2195408|NCT03482453|5387134|P10|NOT COMPLETED|Part 1 (1 Day)||0
2195409|NCT03482453|5387135|P9|NOT COMPLETED|Part 1 (1 Day)||0
2195410|NCT03482453|5387136|P8|NOT COMPLETED|Part 1 (1 Day)||0
2195411|NCT03482453|5387137|P7|NOT COMPLETED|Part 1 (1 Day)||0
2195412|NCT03482453|5387138|P6|NOT COMPLETED|Part 1 (1 Day)||0
2195413|NCT03482453|5387139|P5|NOT COMPLETED|Part 1 (1 Day)||0
2195414|NCT03482453|5387140|P4|NOT COMPLETED|Part 1 (1 Day)||0
2195415|NCT03482453|5387141|P3|NOT COMPLETED|Part 1 (1 Day)||0
2195416|NCT03482453|5387142|P2|NOT COMPLETED|Part 1 (1 Day)||0
2195417|NCT03482453|5387143|P1|NOT COMPLETED|Part 1 (1 Day)||0
2195418|NCT03482453|5387132|P12|COMPLETED|Part 1 (1 Day)||0
2195419|NCT03482453|5387133|P11|COMPLETED|Part 1 (1 Day)||0
2195420|NCT03482453|5387134|P10|COMPLETED|Part 1 (1 Day)||0
2195421|NCT03482453|5387135|P9|COMPLETED|Part 1 (1 Day)||0
2195422|NCT03482453|5387136|P8|COMPLETED|Part 1 (1 Day)||0
2195423|NCT03482453|5387137|P7|COMPLETED|Part 1 (1 Day)||0
2195424|NCT03482453|5387138|P6|COMPLETED|Part 1 (1 Day)||6
2195425|NCT03482453|5387139|P5|COMPLETED|Part 1 (1 Day)||6
2195426|NCT03482453|5387140|P4|COMPLETED|Part 1 (1 Day)||6
2195427|NCT03482453|5387141|P3|COMPLETED|Part 1 (1 Day)||6
2195428|NCT03482453|5387142|P2|COMPLETED|Part 1 (1 Day)||6
2195429|NCT03482453|5387143|P1|COMPLETED|Part 1 (1 Day)||10
2195430|NCT03482453|5387132|P12|STARTED|Part 1 (1 Day)||0
2195431|NCT03482453|5387133|P11|STARTED|Part 1 (1 Day)||0
2195432|NCT03482453|5387134|P10|STARTED|Part 1 (1 Day)||0
2195433|NCT03482453|5387135|P9|STARTED|Part 1 (1 Day)||0
2195434|NCT03482453|5387136|P8|STARTED|Part 1 (1 Day)||0
2195435|NCT03482453|5387137|P7|STARTED|Part 1 (1 Day)||0
2195436|NCT03482453|5387138|P6|STARTED|Part 1 (1 Day)||6
2195437|NCT03482453|5387139|P5|STARTED|Part 1 (1 Day)||6
2195438|NCT03482453|5387140|P4|STARTED|Part 1 (1 Day)||6
2195439|NCT03482453|5387141|P3|STARTED|Part 1 (1 Day)||6
2195440|NCT03482453|5387142|P2|STARTED|Part 1 (1 Day)||6
2195441|NCT03482453|5387143|P1|STARTED|Part 1 (1 Day)||10
2195442|NCT03481309|5387266|P6|NOT COMPLETED|Third Intervention (1 Day)||0
2195443|NCT03481309|5387267|P5|NOT COMPLETED|Third Intervention (1 Day)||0
2195444|NCT03481309|5387268|P4|NOT COMPLETED|Third Intervention (1 Day)||0
2195445|NCT03481309|5387269|P3|NOT COMPLETED|Third Intervention (1 Day)||0
2195446|NCT03481309|5387270|P2|NOT COMPLETED|Third Intervention (1 Day)||0
2195447|NCT03481309|5387271|P1|NOT COMPLETED|Third Intervention (1 Day)||0
2195448|NCT03481309|5387266|P6|COMPLETED|Third Intervention (1 Day)||3
2195449|NCT03481309|5387267|P5|COMPLETED|Third Intervention (1 Day)||3
2195450|NCT03481309|5387268|P4|COMPLETED|Third Intervention (1 Day)||3
2195451|NCT03481309|5387269|P3|COMPLETED|Third Intervention (1 Day)||3
2195452|NCT03481309|5387270|P2|COMPLETED|Third Intervention (1 Day)||3
2195453|NCT03481309|5387271|P1|COMPLETED|Third Intervention (1 Day)||3
2195454|NCT03481309|5387266|P6|STARTED|Third Intervention (1 Day)||3
2195455|NCT03481309|5387267|P5|STARTED|Third Intervention (1 Day)||3
2195456|NCT03481309|5387268|P4|STARTED|Third Intervention (1 Day)||3
2195457|NCT03481309|5387269|P3|STARTED|Third Intervention (1 Day)||3
2195458|NCT03481309|5387270|P2|STARTED|Third Intervention (1 Day)||3
2195459|NCT03481309|5387271|P1|STARTED|Third Intervention (1 Day)||3
2195460|NCT03481309|5387266|P6|NOT COMPLETED|Washout (at Least 3 Days)||0
2195461|NCT03481309|5387267|P5|NOT COMPLETED|Washout (at Least 3 Days)||0
2195462|NCT03481309|5387268|P4|NOT COMPLETED|Washout (at Least 3 Days)||0
2195463|NCT03481309|5387269|P3|NOT COMPLETED|Washout (at Least 3 Days)||0
2195464|NCT03481309|5387270|P2|NOT COMPLETED|Washout (at Least 3 Days)||0
2195465|NCT03481309|5387271|P1|NOT COMPLETED|Washout (at Least 3 Days)||0
2195466|NCT03481309|5387266|P6|COMPLETED|Washout (at Least 3 Days)||3
2195467|NCT03481309|5387267|P5|COMPLETED|Washout (at Least 3 Days)||3
2195468|NCT03481309|5387268|P4|COMPLETED|Washout (at Least 3 Days)||3
2195469|NCT03481309|5387269|P3|COMPLETED|Washout (at Least 3 Days)||3
2195470|NCT03481309|5387270|P2|COMPLETED|Washout (at Least 3 Days)||3
2195471|NCT03481309|5387271|P1|COMPLETED|Washout (at Least 3 Days)||3
2195472|NCT03481309|5387266|P6|STARTED|Washout (at Least 3 Days)||3
2195473|NCT03481309|5387267|P5|STARTED|Washout (at Least 3 Days)||3
2195474|NCT03481309|5387268|P4|STARTED|Washout (at Least 3 Days)||3
2195475|NCT03481309|5387269|P3|STARTED|Washout (at Least 3 Days)||3
2195476|NCT03481309|5387270|P2|STARTED|Washout (at Least 3 Days)||3
2195477|NCT03481309|5387271|P1|STARTED|Washout (at Least 3 Days)||3
2195478|NCT03481309|5387266|P6|NOT COMPLETED|Second Intervention (1 Day)||0
2195479|NCT03481309|5387267|P5|NOT COMPLETED|Second Intervention (1 Day)||0
2195480|NCT03481309|5387268|P4|NOT COMPLETED|Second Intervention (1 Day)||0
2195481|NCT03481309|5387269|P3|NOT COMPLETED|Second Intervention (1 Day)||0
2195482|NCT03481309|5387270|P2|NOT COMPLETED|Second Intervention (1 Day)||0
2195483|NCT03481309|5387271|P1|NOT COMPLETED|Second Intervention (1 Day)||0
2195484|NCT03481309|5387266|P6|COMPLETED|Second Intervention (1 Day)||3
2195485|NCT03481309|5387267|P5|COMPLETED|Second Intervention (1 Day)||3
2195486|NCT03481309|5387268|P4|COMPLETED|Second Intervention (1 Day)||3
2195487|NCT03481309|5387269|P3|COMPLETED|Second Intervention (1 Day)||3
2195488|NCT03481309|5387270|P2|COMPLETED|Second Intervention (1 Day)||3
2195489|NCT03481309|5387271|P1|COMPLETED|Second Intervention (1 Day)||3
2195490|NCT03481309|5387266|P6|STARTED|Second Intervention (1 Day)||3
2195491|NCT03481309|5387267|P5|STARTED|Second Intervention (1 Day)||3
2195492|NCT03481309|5387268|P4|STARTED|Second Intervention (1 Day)||3
2195493|NCT03481309|5387269|P3|STARTED|Second Intervention (1 Day)||3
2195494|NCT03481309|5387270|P2|STARTED|Second Intervention (1 Day)||3
2195495|NCT03481309|5387271|P1|STARTED|Second Intervention (1 Day)||3
2195496|NCT03481309|5387266|P6|NOT COMPLETED|Washout (at Least 3 Days)||0
2195497|NCT03481309|5387267|P5|NOT COMPLETED|Washout (at Least 3 Days)||0
2195498|NCT03481309|5387268|P4|NOT COMPLETED|Washout (at Least 3 Days)||0
2195499|NCT03481309|5387269|P3|NOT COMPLETED|Washout (at Least 3 Days)||0
2195500|NCT03481309|5387270|P2|NOT COMPLETED|Washout (at Least 3 Days)||0
2195501|NCT03481309|5387271|P1|NOT COMPLETED|Washout (at Least 3 Days)||1
2195502|NCT03481309|5387266|P6|COMPLETED|Washout (at Least 3 Days)||3
2195503|NCT03481309|5387267|P5|COMPLETED|Washout (at Least 3 Days)||3
2195504|NCT03481309|5387268|P4|COMPLETED|Washout (at Least 3 Days)||3
2195505|NCT03481309|5387269|P3|COMPLETED|Washout (at Least 3 Days)||3
2195506|NCT03481309|5387270|P2|COMPLETED|Washout (at Least 3 Days)||3
2195507|NCT03481309|5387271|P1|COMPLETED|Washout (at Least 3 Days)||3
2195508|NCT03481309|5387266|P6|STARTED|Washout (at Least 3 Days)||3
2195509|NCT03481309|5387267|P5|STARTED|Washout (at Least 3 Days)||3
2195510|NCT03481309|5387268|P4|STARTED|Washout (at Least 3 Days)||3
2195511|NCT03481309|5387269|P3|STARTED|Washout (at Least 3 Days)||3
2195512|NCT03481309|5387270|P2|STARTED|Washout (at Least 3 Days)||3
2195513|NCT03481309|5387271|P1|STARTED|Washout (at Least 3 Days)||4
2195514|NCT03481309|5387266|P6|NOT COMPLETED|First Intervention (1 Day)||0
2195515|NCT03481309|5387267|P5|NOT COMPLETED|First Intervention (1 Day)||0
2195516|NCT03481309|5387268|P4|NOT COMPLETED|First Intervention (1 Day)||0
2195517|NCT03481309|5387269|P3|NOT COMPLETED|First Intervention (1 Day)||0
2195518|NCT03481309|5387270|P2|NOT COMPLETED|First Intervention (1 Day)||0
2195519|NCT03481309|5387271|P1|NOT COMPLETED|First Intervention (1 Day)||0
2195520|NCT03481309|5387266|P6|COMPLETED|First Intervention (1 Day)||3
2195521|NCT03481309|5387267|P5|COMPLETED|First Intervention (1 Day)||3
2195522|NCT03481309|5387268|P4|COMPLETED|First Intervention (1 Day)||3
2195523|NCT03481309|5387269|P3|COMPLETED|First Intervention (1 Day)||3
2195524|NCT03481309|5387270|P2|COMPLETED|First Intervention (1 Day)||3
2195525|NCT03481309|5387271|P1|COMPLETED|First Intervention (1 Day)||4
2195526|NCT03481309|5387266|P6|STARTED|First Intervention (1 Day)||3
2195527|NCT03481309|5387267|P5|STARTED|First Intervention (1 Day)||3
2195528|NCT03481309|5387268|P4|STARTED|First Intervention (1 Day)||3
2195529|NCT03481309|5387269|P3|STARTED|First Intervention (1 Day)||3
2195530|NCT03481309|5387270|P2|STARTED|First Intervention (1 Day)||3
2195531|NCT03481309|5387271|P1|STARTED|First Intervention (1 Day)||4
2195532|NCT03481270|5387287|P2|NOT COMPLETED|Overall Study||0
2195533|NCT03481270|5387288|P1|NOT COMPLETED|Overall Study||0
2195534|NCT03481270|5387287|P2|COMPLETED|Overall Study||313
2195535|NCT03481270|5387288|P1|COMPLETED|Overall Study||324
2195536|NCT03481270|5387287|P2|STARTED|Overall Study||313
2195537|NCT03481270|5387288|P1|STARTED|Overall Study||324
2195538|NCT03480919|5387297|P3|NOT COMPLETED|Overall Study||0
2195539|NCT03480919|5387298|P2|NOT COMPLETED|Overall Study||0
2195540|NCT03480919|5387299|P1|NOT COMPLETED|Overall Study||0
2195541|NCT03480919|5387297|P3|COMPLETED|Overall Study||1
2195542|NCT03480919|5387298|P2|COMPLETED|Overall Study||2
2195543|NCT03480919|5387299|P1|COMPLETED|Overall Study||1
2195544|NCT03480919|5387297|P3|STARTED|Overall Study||1
2195545|NCT03480919|5387298|P2|STARTED|Overall Study||2
2195546|NCT03480919|5387299|P1|STARTED|Overall Study||1
2195547|NCT03480841|5387313|P1|NOT COMPLETED|Overall Study||2
2195548|NCT03480841|5387313|P1|COMPLETED|Overall Study||8
2195549|NCT03480841|5387313|P1|Time 2 Data Collection (T2)|Overall Study||8
2195550|NCT03480841|5387313|P1|LENA Time 5|Overall Study||8
2195551|NCT03480841|5387313|P1|LENA Time 4|Overall Study||9
2195552|NCT03480841|5387313|P1|LENA Time 3|Overall Study||10
2195553|NCT03480841|5387313|P1|LENA Time 2|Overall Study||10
2195554|NCT03480841|5387313|P1|LENA Time 1|Overall Study||10
2195555|NCT03480841|5387313|P1|LENA Baseline|Overall Study||10
2195556|NCT03480841|5387313|P1|Time 1 Data Collection (T1)|Overall Study||10
2195557|NCT03480841|5387313|P1|STARTED|Overall Study||10
2195558|NCT03480048|5387324|P2|NOT COMPLETED|Overall Study||8
2195559|NCT03480048|5387325|P1|NOT COMPLETED|Overall Study||10
2195560|NCT03480048|5387324|P2|COMPLETED|Overall Study||17
2195561|NCT03480048|5387325|P1|COMPLETED|Overall Study||18
2195562|NCT03480048|5387324|P2|STARTED|Overall Study||25
2195563|NCT03480048|5387325|P1|STARTED|Overall Study||28
2195564|NCT03479944|5387333|P1|NOT COMPLETED|Overall Study||0
2195565|NCT03479944|5387333|P1|COMPLETED|Overall Study||55
2195566|NCT03479944|5387333|P1|Full Analysis Set|Overall Study||53
2195567|NCT03479944|5387333|P1|Conventional|Overall Study||55
2195568|NCT03479944|5387333|P1|FLACS|Overall Study||55
2195569|NCT03479944|5387333|P1|STARTED|Overall Study||55
2195570|NCT03479216|5387346|P2|NOT COMPLETED|Overall Study||5
2195571|NCT03479216|5387347|P1|NOT COMPLETED|Overall Study||5
2195572|NCT03479216|5387346|P2|COMPLETED|Overall Study||26
2195573|NCT03479216|5387347|P1|COMPLETED|Overall Study||26
2195574|NCT03479216|5387346|P2|STARTED|Overall Study||31
2195575|NCT03479216|5387347|P1|STARTED|Overall Study||31
2195576|NCT03478891|5387368|P3|NOT COMPLETED|Overall Study||3
2195577|NCT03478891|5387369|P2|NOT COMPLETED|Overall Study||0
2195578|NCT03478891|5387370|P1|NOT COMPLETED|Overall Study||1
2195579|NCT03478891|5387368|P3|COMPLETED|Overall Study||8
2195580|NCT03478891|5387369|P2|COMPLETED|Overall Study||5
2195581|NCT03478891|5387370|P1|COMPLETED|Overall Study||2
2195582|NCT03478891|5387368|P3|Received MAb114|Overall Study|A Group 3 subject discontinued prior to MAb114 infusion due to suboptimal IV access|10
2195583|NCT03478891|5387369|P2|Received MAb114|Overall Study||5
2195584|NCT03478891|5387370|P1|Received MAb114|Overall Study||3
2195585|NCT03478891|5387368|P3|STARTED|Overall Study||11
2195586|NCT03478891|5387369|P2|STARTED|Overall Study||5
2195587|NCT03478891|5387370|P1|STARTED|Overall Study||3
2195588|NCT03478696|5387421|P2|NOT COMPLETED|Overall Study||12
2195589|NCT03478696|5387422|P1|NOT COMPLETED|Overall Study||17
2195590|NCT03478696|5387421|P2|COMPLETED|Overall Study||354
2195591|NCT03478696|5387422|P1|COMPLETED|Overall Study||349
2195592|NCT03478696|5387421|P2|STARTED|Overall Study||366
2195593|NCT03478696|5387422|P1|STARTED|Overall Study||366
2195594|NCT03478683|5387436|P2|NOT COMPLETED|Overall Study||18
2195595|NCT03478683|5387437|P1|NOT COMPLETED|Overall Study||13
2195596|NCT03478683|5387436|P2|COMPLETED|Overall Study||347
2195597|NCT03478683|5387437|P1|COMPLETED|Overall Study||350
2195598|NCT03478683|5387436|P2|STARTED|Overall Study||365
2195599|NCT03478683|5387437|P1|STARTED|Overall Study||363
2195600|NCT03478657|5387451|P2|NOT COMPLETED|Overall Study||1
2195601|NCT03478657|5387452|P1|NOT COMPLETED|Overall Study||0
2195602|NCT03478657|5387451|P2|COMPLETED|Overall Study||133
2195603|NCT03478657|5387452|P1|COMPLETED|Overall Study||88
2195604|NCT03478657|5387451|P2|STARTED|Overall Study||134
2195605|NCT03478657|5387452|P1|STARTED|Overall Study||88
2195606|NCT03478644|5387467|P2|NOT COMPLETED|Phase 2||1
2195607|NCT03478644|5387468|P1|NOT COMPLETED|Phase 2||3
2195608|NCT03478644|5387467|P2|COMPLETED|Phase 2||75
2195609|NCT03478644|5387468|P1|COMPLETED|Phase 2||73
2195610|NCT03478644|5387467|P2|STARTED|Phase 2||76
2195611|NCT03478644|5387468|P1|STARTED|Phase 2||76
2195612|NCT03478644|5387467|P2|NOT COMPLETED|Phase 1||0
2195613|NCT03478644|5387468|P1|NOT COMPLETED|Phase 1||0
2195614|NCT03478644|5387467|P2|COMPLETED|Phase 1||0
2195615|NCT03478644|5387468|P1|COMPLETED|Phase 1|In Phase 1, only the wipe treatment was administered to eligible participants.|31
2195616|NCT03478644|5387467|P2|STARTED|Phase 1||0
2195617|NCT03478644|5387468|P1|STARTED|Phase 1|In Phase 1, only the wipe treatment was administered to eligible participants.|31
2195618|NCT03478371|5387480|P1|NOT COMPLETED|Overall Study||5
2195619|NCT03478371|5387480|P1|COMPLETED|Overall Study||89
2195620|NCT03478371|5387480|P1|Received Tampon V|Overall Study||91
2195621|NCT03478371|5387480|P1|Recived Tampon T|Overall Study||90
2195622|NCT03478371|5387480|P1|Received Tampon M|Overall Study||92
2195623|NCT03478371|5387480|P1|Received Tampon D|Overall Study||91
2195624|NCT03478371|5387480|P1|STARTED|Overall Study||94
2195625|NCT03477903|5387502|P1|NOT COMPLETED|Overall Study||1
2195626|NCT03477903|5387502|P1|COMPLETED|Overall Study||0
2195627|NCT03477903|5387502|P1|STARTED|Overall Study||1
2195628|NCT03476278|5387513|P1|NOT COMPLETED|Overall Study||0
2195629|NCT03476278|5387513|P1|COMPLETED|Overall Study||300
2195630|NCT03476278|5387513|P1|STARTED|Overall Study||300
2195631|NCT03475875|5387559|P2|NOT COMPLETED|Period 3||0
2195632|NCT03475875|5387560|P1|NOT COMPLETED|Period 3||0
2195633|NCT03475875|5387559|P2|COMPLETED|Period 3||43
2195634|NCT03475875|5387560|P1|COMPLETED|Period 3||40
2195635|NCT03475875|5387559|P2|STARTED|Period 3||43
2195636|NCT03475875|5387560|P1|STARTED|Period 3||40
2195637|NCT03475875|5387559|P2|NOT COMPLETED|Period 2||1
2195638|NCT03475875|5387560|P1|NOT COMPLETED|Period 2||3
2195639|NCT03475875|5387559|P2|COMPLETED|Period 2||43
2195640|NCT03475875|5387560|P1|COMPLETED|Period 2||40
2195641|NCT03475875|5387559|P2|STARTED|Period 2||44
2195642|NCT03475875|5387560|P1|STARTED|Period 2||43
2195643|NCT03475875|5387559|P2|NOT COMPLETED|Period 1||1
2195644|NCT03475875|5387560|P1|NOT COMPLETED|Period 1||3
2195645|NCT03475875|5387559|P2|COMPLETED|Period 1||44
2195646|NCT03475875|5387560|P1|COMPLETED|Period 1||43
2195647|NCT03475875|5387559|P2|STARTED|Period 1||45
2195648|NCT03475875|5387560|P1|STARTED|Period 1||46
2195649|NCT03474874|5387568|P1|NOT COMPLETED|Overall Study||14
2195650|NCT03474874|5387568|P1|COMPLETED|Overall Study||54
2195651|NCT03474874|5387568|P1|STARTED|Overall Study||68
2195652|NCT03473808|5387577|P1|NOT COMPLETED|Overall Study||1
2195653|NCT03473808|5387577|P1|COMPLETED|Overall Study||4
2195654|NCT03473808|5387577|P1|STARTED|Overall Study||5
2195685|NCT03473197|5387723|P1|NOT COMPLETED|Overall Study||10
2195686|NCT03473197|5387723|P1|COMPLETED|Overall Study||51
2195687|NCT03473197|5387723|P1|Untreated Irradiated|Overall Study||51
2195688|NCT03473197|5387723|P1|Vehicle Ointment Non-irradiated|Overall Study||51
2195689|NCT03473197|5387723|P1|Diacerein 1% Ointment Non-irradiated|Overall Study||51
2195690|NCT03473197|5387723|P1|Vehicle Ointment Irradiated|Overall Study||51
2195691|NCT03473197|5387723|P1|Diacerein 1% Ointment Irradiated|Overall Study||51
2195692|NCT03473197|5387723|P1|STARTED|Overall Study||61
2195693|NCT03473184|5387727|P1|NOT COMPLETED|Overall Study||0
2195694|NCT03473184|5387727|P1|COMPLETED|Overall Study||34
2195695|NCT03473184|5387727|P1|Untreated Irradiated|Overall Study||34
2195696|NCT03473184|5387727|P1|Vehicle Ointment Non-irradiated|Overall Study||34
2195697|NCT03473184|5387727|P1|Diacerein 1% Ointment Non-irradiated|Overall Study||34
2195698|NCT03473184|5387727|P1|Vehicle Ointment Irradiated|Overall Study||34
2195699|NCT03473184|5387727|P1|Diacerein 1% Ointment Irradiated|Overall Study||34
2195700|NCT03473184|5387727|P1|STARTED|Overall Study||34
2195701|NCT03472547|5387731|P1|NOT COMPLETED|Overall Study||30
2195702|NCT03472547|5387731|P1|COMPLETED|Overall Study||204
2195703|NCT03472547|5387731|P1|STARTED|Overall Study||234
2195704|NCT03472534|5387735|P1|NOT COMPLETED|Overall Study||11
2195705|NCT03472534|5387735|P1|COMPLETED|Overall Study||35
2195706|NCT03472534|5387735|P1|0.9% Saline|Overall Study||46
2195707|NCT03472534|5387735|P1|0.2% Sodium Lauryl Sulfate (SLS)|Overall Study||46
2195708|NCT03472534|5387735|P1|Vehicle Ointment|Overall Study||46
2195709|NCT03472534|5387735|P1|Diacerein 1% Ointment|Overall Study||46
2195710|NCT03472534|5387735|P1|STARTED|Overall Study|Each participant receives all 4 unit interventions.|46
2195711|NCT03472287|5387741|P2|NOT COMPLETED|Overall Study||0
2195712|NCT03472287|5387742|P1|NOT COMPLETED|Overall Study||0
2195713|NCT03472287|5387741|P2|COMPLETED|Overall Study||3
2195714|NCT03472287|5387742|P1|COMPLETED|Overall Study||8
2195715|NCT03472287|5387741|P2|STARTED|Overall Study||3
2195716|NCT03472287|5387742|P1|STARTED|Overall Study||8
2195717|NCT03471975|5387750|P2|NOT COMPLETED|Overall Study||0
2195718|NCT03471975|5387751|P1|NOT COMPLETED|Overall Study||0
2195719|NCT03471975|5387750|P2|COMPLETED|Overall Study||20
2195720|NCT03471975|5387751|P1|COMPLETED|Overall Study||17
2195721|NCT03471975|5387750|P2|STARTED|Overall Study||20
2195722|NCT03471975|5387751|P1|STARTED|Overall Study||17
2195818|NCT03471832|5387794|P2|NOT COMPLETED|Overall Study||0
2195819|NCT03471832|5387795|P1|NOT COMPLETED|Overall Study||0
2195820|NCT03471832|5387794|P2|COMPLETED|Overall Study||40
2195821|NCT03471832|5387795|P1|COMPLETED|Overall Study||40
2195822|NCT03471832|5387794|P2|STARTED|Overall Study||40
2195823|NCT03471832|5387795|P1|STARTED|Overall Study||40
2195824|NCT03470740|5387854|P2|NOT COMPLETED|Overall Study||6
2195825|NCT03470740|5387855|P1|NOT COMPLETED|Overall Study||4
2195826|NCT03470740|5387854|P2|COMPLETED|Overall Study||106
2195827|NCT03470740|5387855|P1|COMPLETED|Overall Study||108
2195828|NCT03470740|5387854|P2|STARTED|Overall Study||112
2195829|NCT03470740|5387855|P1|STARTED|Overall Study||112
2195830|NCT03468920|5387875|P2|NOT COMPLETED|Overall Study||0
2195831|NCT03468920|5387876|P1|NOT COMPLETED|Overall Study||0
2195832|NCT03468920|5387875|P2|COMPLETED|Overall Study||60
2195833|NCT03468920|5387876|P1|COMPLETED|Overall Study||60
2195834|NCT03468920|5387875|P2|STARTED|Overall Study||60
2195835|NCT03468920|5387876|P1|STARTED|Overall Study||60
2195836|NCT03468543|5387893|P1|NOT COMPLETED|Overall Study||3
2195837|NCT03468543|5387893|P1|COMPLETED|Overall Study||0
2195838|NCT03468543|5387893|P1|STARTED|Overall Study||3
2195839|NCT03468179|5387897|P1|NOT COMPLETED|Overall Study||0
2195840|NCT03468179|5387897|P1|COMPLETED|Overall Study||10
2195841|NCT03468179|5387897|P1|STARTED|Overall Study||10
2195842|NCT03467971|5387905|P2|NOT COMPLETED|Treatment Period 2||1
2195843|NCT03467971|5387906|P1|NOT COMPLETED|Treatment Period 2||0
2195844|NCT03467971|5387905|P2|COMPLETED|Treatment Period 2||10
2195845|NCT03467971|5387906|P1|COMPLETED|Treatment Period 2||10
2195846|NCT03467971|5387905|P2|STARTED|Treatment Period 2||11
2195847|NCT03467971|5387906|P1|STARTED|Treatment Period 2||10
2195848|NCT03467971|5387905|P2|NOT COMPLETED|Treatment Period 1||0
2195849|NCT03467971|5387906|P1|NOT COMPLETED|Treatment Period 1||0
2195850|NCT03467971|5387905|P2|COMPLETED|Treatment Period 1||11
2195851|NCT03467971|5387906|P1|COMPLETED|Treatment Period 1||10
2195852|NCT03467971|5387905|P2|STARTED|Treatment Period 1||11
2195853|NCT03467971|5387906|P1|STARTED|Treatment Period 1||10
2195854|NCT03467945|5387930|P4|NOT COMPLETED|Treatment Period 4||0
2195855|NCT03467945|5387931|P3|NOT COMPLETED|Treatment Period 4||0
2195856|NCT03467945|5387932|P2|NOT COMPLETED|Treatment Period 4||0
2195857|NCT03467945|5387933|P1|NOT COMPLETED|Treatment Period 4||0
2195858|NCT03467945|5387930|P4|COMPLETED|Treatment Period 4||9
2195859|NCT03467945|5387931|P3|COMPLETED|Treatment Period 4||8
2195860|NCT03467945|5387932|P2|COMPLETED|Treatment Period 4||9
2195861|NCT03467945|5387933|P1|COMPLETED|Treatment Period 4||9
2195862|NCT03467945|5387930|P4|STARTED|Treatment Period 4||9
2195863|NCT03467945|5387931|P3|STARTED|Treatment Period 4||8
2195864|NCT03467945|5387932|P2|STARTED|Treatment Period 4||9
2195865|NCT03467945|5387933|P1|STARTED|Treatment Period 4||9
2195866|NCT03467945|5387930|P4|NOT COMPLETED|Treatment Period 3||1
2195867|NCT03467945|5387931|P3|NOT COMPLETED|Treatment Period 3||2
2195868|NCT03467945|5387932|P2|NOT COMPLETED|Treatment Period 3||0
2195869|NCT03467945|5387933|P1|NOT COMPLETED|Treatment Period 3||1
2195870|NCT03467945|5387930|P4|COMPLETED|Treatment Period 3||9
2195871|NCT03467945|5387931|P3|COMPLETED|Treatment Period 3||8
2195872|NCT03467945|5387932|P2|COMPLETED|Treatment Period 3||9
2195873|NCT03467945|5387933|P1|COMPLETED|Treatment Period 3||9
2195874|NCT03467945|5387930|P4|STARTED|Treatment Period 3||10
2195875|NCT03467945|5387931|P3|STARTED|Treatment Period 3||10
2195876|NCT03467945|5387932|P2|STARTED|Treatment Period 3||9
2195877|NCT03467945|5387933|P1|STARTED|Treatment Period 3||10
2195878|NCT03467945|5387930|P4|NOT COMPLETED|Treatment Period 2||0
2195879|NCT03467945|5387931|P3|NOT COMPLETED|Treatment Period 2||0
2195880|NCT03467945|5387932|P2|NOT COMPLETED|Treatment Period 2||1
2195881|NCT03467945|5387933|P1|NOT COMPLETED|Treatment Period 2||0
2195882|NCT03467945|5387930|P4|COMPLETED|Treatment Period 2||10
2195883|NCT03467945|5387931|P3|COMPLETED|Treatment Period 2||10
2195884|NCT03467945|5387932|P2|COMPLETED|Treatment Period 2||9
2195885|NCT03467945|5387933|P1|COMPLETED|Treatment Period 2||10
2195886|NCT03467945|5387930|P4|STARTED|Treatment Period 2||10
2195887|NCT03467945|5387931|P3|STARTED|Treatment Period 2||10
2195888|NCT03467945|5387932|P2|STARTED|Treatment Period 2||10
2195889|NCT03467945|5387933|P1|STARTED|Treatment Period 2||10
2195890|NCT03467945|5387930|P4|NOT COMPLETED|Treatment Period 1||0
2195891|NCT03467945|5387931|P3|NOT COMPLETED|Treatment Period 1||0
2195892|NCT03467945|5387932|P2|NOT COMPLETED|Treatment Period 1||0
2195893|NCT03467945|5387933|P1|NOT COMPLETED|Treatment Period 1||0
2195894|NCT03467945|5387930|P4|COMPLETED|Treatment Period 1||10
2195895|NCT03467945|5387931|P3|COMPLETED|Treatment Period 1||10
2195896|NCT03467945|5387932|P2|COMPLETED|Treatment Period 1||10
2195897|NCT03467945|5387933|P1|COMPLETED|Treatment Period 1||10
2195898|NCT03467945|5387930|P4|STARTED|Treatment Period 1||10
2195899|NCT03467945|5387931|P3|STARTED|Treatment Period 1||10
2195900|NCT03467945|5387932|P2|STARTED|Treatment Period 1||10
2195901|NCT03467945|5387933|P1|STARTED|Treatment Period 1||10
2195902|NCT03466658|5387985|P1|NOT COMPLETED|Overall Study||3
2195903|NCT03466658|5387985|P1|COMPLETED|Overall Study||14
2195904|NCT03466658|5387985|P1|STARTED|Overall Study||17
2195905|NCT03466086|5387991|P2|NOT COMPLETED|Period 2||0
2195906|NCT03466086|5387992|P1|NOT COMPLETED|Period 2||0
2195907|NCT03466086|5387991|P2|COMPLETED|Period 2||27
2195908|NCT03466086|5387992|P1|COMPLETED|Period 2||26
2195909|NCT03466086|5387991|P2|STARTED|Period 2||27
2195910|NCT03466086|5387992|P1|STARTED|Period 2||26
2195911|NCT03466086|5387991|P2|NOT COMPLETED|Period 1||0
2195912|NCT03466086|5387992|P1|NOT COMPLETED|Period 1||2
2195913|NCT03466086|5387991|P2|COMPLETED|Period 1||27
2195914|NCT03466086|5387992|P1|COMPLETED|Period 1||26
2195915|NCT03466086|5387991|P2|STARTED|Period 1||27
2195916|NCT03466086|5387992|P1|STARTED|Period 1||28
2195917|NCT03466073|5388006|P6|NOT COMPLETED|Overall Study||1
2195918|NCT03466073|5388007|P5|NOT COMPLETED|Overall Study||0
2195919|NCT03466073|5388008|P4|NOT COMPLETED|Overall Study||0
2195920|NCT03466073|5388009|P3|NOT COMPLETED|Overall Study||0
2195921|NCT03466073|5388010|P2|NOT COMPLETED|Overall Study||0
2195922|NCT03466073|5388011|P1|NOT COMPLETED|Overall Study||1
2195923|NCT03466073|5388006|P6|COMPLETED|Overall Study||6
2195924|NCT03466073|5388007|P5|COMPLETED|Overall Study||6
2195925|NCT03466073|5388008|P4|COMPLETED|Overall Study||6
2195926|NCT03466073|5388009|P3|COMPLETED|Overall Study||6
2195927|NCT03466073|5388010|P2|COMPLETED|Overall Study||2
2195928|NCT03466073|5388011|P1|COMPLETED|Overall Study||5
2195929|NCT03466073|5388006|P6|STARTED|Overall Study||7
2195930|NCT03466073|5388007|P5|STARTED|Overall Study||6
2195931|NCT03466073|5388008|P4|STARTED|Overall Study||6
2195932|NCT03466073|5388009|P3|STARTED|Overall Study||6
2195933|NCT03466073|5388010|P2|STARTED|Overall Study||2
2195934|NCT03466073|5388011|P1|STARTED|Overall Study||6
2195935|NCT03466060|5388044|P6|NOT COMPLETED|Period 2||0
2195936|NCT03466060|5388045|P5|NOT COMPLETED|Period 2||0
2195937|NCT03466060|5388046|P4|NOT COMPLETED|Period 2||0
2195938|NCT03466060|5388047|P3|NOT COMPLETED|Period 2||1
2195939|NCT03466060|5388048|P2|NOT COMPLETED|Period 2||0
2195940|NCT03466060|5388049|P1|NOT COMPLETED|Period 2||0
2195941|NCT03466060|5388044|P6|COMPLETED|Period 2||18
2195942|NCT03466060|5388045|P5|COMPLETED|Period 2||20
2195943|NCT03466060|5388046|P4|COMPLETED|Period 2||17
2195944|NCT03466060|5388047|P3|COMPLETED|Period 2||16
2195945|NCT03466060|5388048|P2|COMPLETED|Period 2||16
2195946|NCT03466060|5388049|P1|COMPLETED|Period 2||19
2195947|NCT03466060|5388044|P6|STARTED|Period 2||18
2195948|NCT03466060|5388045|P5|STARTED|Period 2||20
2195949|NCT03466060|5388046|P4|STARTED|Period 2||17
2195950|NCT03466060|5388047|P3|STARTED|Period 2||17
2195951|NCT03466060|5388048|P2|STARTED|Period 2||16
2195952|NCT03466060|5388049|P1|STARTED|Period 2||19
2195953|NCT03466060|5388044|P6|NOT COMPLETED|Period 1||0
2195954|NCT03466060|5388045|P5|NOT COMPLETED|Period 1||0
2195955|NCT03466060|5388046|P4|NOT COMPLETED|Period 1||1
2195956|NCT03466060|5388047|P3|NOT COMPLETED|Period 1||3
2195957|NCT03466060|5388048|P2|NOT COMPLETED|Period 1||2
2195958|NCT03466060|5388049|P1|NOT COMPLETED|Period 1||0
2195959|NCT03466060|5388044|P6|COMPLETED|Period 1||18
2195960|NCT03466060|5388045|P5|COMPLETED|Period 1||20
2195961|NCT03466060|5388046|P4|COMPLETED|Period 1||17
2195962|NCT03466060|5388047|P3|COMPLETED|Period 1||17
2195963|NCT03466060|5388048|P2|COMPLETED|Period 1||16
2195964|NCT03466060|5388049|P1|COMPLETED|Period 1||19
2195965|NCT03466060|5388044|P6|STARTED|Period 1||18
2195966|NCT03466060|5388045|P5|STARTED|Period 1||20
2195967|NCT03466060|5388046|P4|STARTED|Period 1||18
2195968|NCT03466060|5388047|P3|STARTED|Period 1||20
2195969|NCT03466060|5388048|P2|STARTED|Period 1||18
2195970|NCT03466060|5388049|P1|STARTED|Period 1||19
2195971|NCT03465904|5388065|P2|NOT COMPLETED|Overall Study||66
2195972|NCT03465904|5388066|P1|NOT COMPLETED|Overall Study||89
2195973|NCT03465904|5388065|P2|COMPLETED|Overall Study||237
2195974|NCT03465904|5388066|P1|COMPLETED|Overall Study||209
2195975|NCT03465904|5388065|P2|STARTED|Overall Study||303
2195976|NCT03465904|5388066|P1|STARTED|Overall Study||298
2195977|NCT03465436|5388088|P4|NOT COMPLETED|Period 4||0
2195978|NCT03465436|5388089|P3|NOT COMPLETED|Period 4||1
2195979|NCT03465436|5388090|P2|NOT COMPLETED|Period 4||0
2195980|NCT03465436|5388091|P1|NOT COMPLETED|Period 4||0
2195981|NCT03465436|5388088|P4|COMPLETED|Period 4||14
2195982|NCT03465436|5388089|P3|COMPLETED|Period 4||12
2195983|NCT03465436|5388090|P2|COMPLETED|Period 4||12
2195984|NCT03465436|5388091|P1|COMPLETED|Period 4||13
2195985|NCT03465436|5388088|P4|Received at Least 1 Dose of Study Drug|Period 4||14
2195986|NCT03465436|5388089|P3|Received at Least 1 Dose of Study Drug|Period 4||13
2195987|NCT03465436|5388090|P2|Received at Least 1 Dose of Study Drug|Period 4||12
2195988|NCT03465436|5388091|P1|Received at Least 1 Dose of Study Drug|Period 4||13
2195989|NCT03465436|5388088|P4|STARTED|Period 4||14
2195990|NCT03465436|5388089|P3|STARTED|Period 4||13
2195991|NCT03465436|5388090|P2|STARTED|Period 4||12
2195992|NCT03465436|5388091|P1|STARTED|Period 4||13
2195993|NCT03465436|5388088|P4|NOT COMPLETED|Period 3||0
2195994|NCT03465436|5388089|P3|NOT COMPLETED|Period 3||0
2195995|NCT03465436|5388090|P2|NOT COMPLETED|Period 3||1
2195996|NCT03465436|5388091|P1|NOT COMPLETED|Period 3||1
2195997|NCT03465436|5388088|P4|COMPLETED|Period 3||14
2195998|NCT03465436|5388089|P3|COMPLETED|Period 3||13
2195999|NCT03465436|5388090|P2|COMPLETED|Period 3||12
2196000|NCT03465436|5388091|P1|COMPLETED|Period 3||13
2196001|NCT03465436|5388088|P4|Received at Least One Dose of Study Drug|Period 3||14
2196002|NCT03465436|5388089|P3|Received at Least One Dose of Study Drug|Period 3||13
2196003|NCT03465436|5388090|P2|Received at Least One Dose of Study Drug|Period 3||12
2196004|NCT03465436|5388091|P1|Received at Least One Dose of Study Drug|Period 3||13
2196005|NCT03465436|5388088|P4|STARTED|Period 3||14
2196006|NCT03465436|5388089|P3|STARTED|Period 3||13
2196007|NCT03465436|5388090|P2|STARTED|Period 3||13
2196008|NCT03465436|5388091|P1|STARTED|Period 3||14
2196009|NCT03465436|5388088|P4|NOT COMPLETED|Period 2||0
2196010|NCT03465436|5388089|P3|NOT COMPLETED|Period 2||0
2196011|NCT03465436|5388090|P2|NOT COMPLETED|Period 2||1
2196012|NCT03465436|5388091|P1|NOT COMPLETED|Period 2||0
2196013|NCT03465436|5388088|P4|COMPLETED|Period 2||14
2196014|NCT03465436|5388089|P3|COMPLETED|Period 2||13
2196015|NCT03465436|5388090|P2|COMPLETED|Period 2||13
2196016|NCT03465436|5388091|P1|COMPLETED|Period 2||14
2196017|NCT03465436|5388088|P4|Received at Least 1 Dose of Study Drug|Period 2||14
2196018|NCT03465436|5388089|P3|Received at Least 1 Dose of Study Drug|Period 2||13
2196019|NCT03465436|5388090|P2|Received at Least 1 Dose of Study Drug|Period 2||13
2196020|NCT03465436|5388091|P1|Received at Least 1 Dose of Study Drug|Period 2||14
2196021|NCT03465436|5388088|P4|STARTED|Period 2||14
2196022|NCT03465436|5388089|P3|STARTED|Period 2||13
2196023|NCT03465436|5388090|P2|STARTED|Period 2||14
2196024|NCT03465436|5388091|P1|STARTED|Period 2||14
2196025|NCT03465436|5388088|P4|NOT COMPLETED|Period 1||0
2196026|NCT03465436|5388089|P3|NOT COMPLETED|Period 1||1
2196027|NCT03465436|5388090|P2|NOT COMPLETED|Period 1||0
2196028|NCT03465436|5388091|P1|NOT COMPLETED|Period 1||0
2196029|NCT03465436|5388088|P4|COMPLETED|Period 1||14
2196030|NCT03465436|5388089|P3|COMPLETED|Period 1||13
2196031|NCT03465436|5388090|P2|COMPLETED|Period 1||14
2196032|NCT03465436|5388091|P1|COMPLETED|Period 1||14
2196033|NCT03465436|5388088|P4|Received at Least 1 Dose of Study Drug|Period 1||14
2196034|NCT03465436|5388089|P3|Received at Least 1 Dose of Study Drug|Period 1||14
2196035|NCT03465436|5388090|P2|Received at Least 1 Dose of Study Drug|Period 1||14
2196036|NCT03465436|5388091|P1|Received at Least 1 Dose of Study Drug|Period 1||14
2196037|NCT03465436|5388088|P4|STARTED|Period 1||14
2196038|NCT03465436|5388089|P3|STARTED|Period 1||14
2196039|NCT03465436|5388090|P2|STARTED|Period 1||14
2196040|NCT03465436|5388091|P1|STARTED|Period 1||14
2196041|NCT03463512|5388127|P2|NOT COMPLETED|Overall Study||0
2196042|NCT03463512|5388128|P1|NOT COMPLETED|Overall Study||0
2196043|NCT03463512|5388127|P2|COMPLETED|Overall Study||62
2196044|NCT03463512|5388128|P1|COMPLETED|Overall Study||62
2196045|NCT03463512|5388127|P2|STARTED|Overall Study||62
2196046|NCT03463512|5388128|P1|STARTED|Overall Study||62
2196047|NCT03463161|5388138|P1|NOT COMPLETED|Overall Study||0
2196048|NCT03463161|5388138|P1|COMPLETED|Overall Study||2
2196049|NCT03463161|5388138|P1|STARTED|Overall Study||2
2196050|NCT03463031|5388147|P2|NOT COMPLETED|Overall Study||5
2196051|NCT03463031|5388148|P1|NOT COMPLETED|Overall Study||10
2196052|NCT03463031|5388147|P2|COMPLETED|Overall Study||216
2196053|NCT03463031|5388148|P1|COMPLETED|Overall Study||215
2196054|NCT03463031|5388147|P2|STARTED|Overall Study||221
2196055|NCT03463031|5388148|P1|STARTED|Overall Study||225
2196056|NCT03462927|5388162|P2|NOT COMPLETED|Overall Study||2
2196057|NCT03462927|5388163|P1|NOT COMPLETED|Overall Study||6
2196058|NCT03462927|5388162|P2|COMPLETED|Overall Study||29
2196059|NCT03462927|5388163|P1|COMPLETED|Overall Study||26
2196060|NCT03462927|5388162|P2|STARTED|Overall Study||31
2196061|NCT03462927|5388163|P1|STARTED|Overall Study||32
2196062|NCT03462745|5388189|P2|NOT COMPLETED|Overall Study||0
2196063|NCT03462745|5388190|P1|NOT COMPLETED|Overall Study||0
2196064|NCT03462745|5388189|P2|COMPLETED|Overall Study||92
2196065|NCT03462745|5388190|P1|COMPLETED|Overall Study||92
2196066|NCT03462745|5388189|P2|STARTED|Overall Study||92
2196067|NCT03462745|5388190|P1|STARTED|Overall Study||92
2196068|NCT03461705|5388196|P1|NOT COMPLETED|Overall Study||0
2196069|NCT03461705|5388196|P1|COMPLETED|Overall Study||5
2196070|NCT03461705|5388196|P1|STARTED|Overall Study||5
2196071|NCT03460990|5388209|P2|NOT COMPLETED|Overall Study||0
2196072|NCT03460990|5388210|P1|NOT COMPLETED|Overall Study||0
2196073|NCT03460990|5388209|P2|COMPLETED|Overall Study||54
2196074|NCT03460990|5388210|P1|COMPLETED|Overall Study||57
2196075|NCT03460990|5388209|P2|STARTED|Overall Study||54
2196076|NCT03460990|5388210|P1|STARTED|Overall Study||57
2196077|NCT03460899|5388224|P1|NOT COMPLETED|Hyperinsulinaemic/Hypoglycaemic Clamp||0
2196078|NCT03460899|5388224|P1|COMPLETED|Hyperinsulinaemic/Hypoglycaemic Clamp|Last Hyperinsulinaemic/Hypoglycaemic Clamp completed: 05. June 2018|14
2196079|NCT03460899|5388224|P1|STARTED|Hyperinsulinaemic/Hypoglycaemic Clamp|First Hyperinsulinaemic/Hypoglycaemic Clamp completed: 15. March 2018|14
2196080|NCT03460899|5388224|P1|NOT COMPLETED|Euglycaemic Clamp||0
2196081|NCT03460899|5388224|P1|COMPLETED|Euglycaemic Clamp|Last Euglycaemic clamp completed: 23. May 2018|14
2196082|NCT03460899|5388224|P1|STARTED|Euglycaemic Clamp|First Euglycaemic Clamp completed: 05. March 2018|14
2196083|NCT03459794|5388233|P2|NOT COMPLETED|Overall Study||0
2196084|NCT03459794|5388234|P1|NOT COMPLETED|Overall Study||0
2196085|NCT03459794|5388233|P2|COMPLETED|Overall Study||4
2196086|NCT03459794|5388234|P1|COMPLETED|Overall Study||8
2196087|NCT03459794|5388233|P2|STARTED|Overall Study||4
2196088|NCT03459794|5388234|P1|STARTED|Overall Study||8
2196089|NCT03459612|5388254|P4|NOT COMPLETED|Period 4||0
2196090|NCT03459612|5388255|P3|NOT COMPLETED|Period 4||0
2196091|NCT03459612|5388256|P2|NOT COMPLETED|Period 4||0
2196092|NCT03459612|5388257|P1|NOT COMPLETED|Period 4||0
2196093|NCT03459612|5388254|P4|COMPLETED|Period 4||17
2196094|NCT03459612|5388255|P3|COMPLETED|Period 4||16
2196095|NCT03459612|5388256|P2|COMPLETED|Period 4||17
2196096|NCT03459612|5388257|P1|COMPLETED|Period 4||17
2196097|NCT03459612|5388254|P4|Received at Least 1 Dose of Study Drug|Period 4||17
2196098|NCT03459612|5388255|P3|Received at Least 1 Dose of Study Drug|Period 4||16
2196099|NCT03459612|5388256|P2|Received at Least 1 Dose of Study Drug|Period 4||17
2196100|NCT03459612|5388257|P1|Received at Least 1 Dose of Study Drug|Period 4||17
2196101|NCT03459612|5388254|P4|STARTED|Period 4||17
2196102|NCT03459612|5388255|P3|STARTED|Period 4|One participant completed period 3 and withdrew for personal reasons prior to Period 4.|16
2196103|NCT03459612|5388256|P2|STARTED|Period 4||17
2196104|NCT03459612|5388257|P1|STARTED|Period 4||17
2196105|NCT03459612|5388254|P4|NOT COMPLETED|Period 3||0
2196106|NCT03459612|5388255|P3|NOT COMPLETED|Period 3||0
2196107|NCT03459612|5388256|P2|NOT COMPLETED|Period 3||0
2196108|NCT03459612|5388257|P1|NOT COMPLETED|Period 3||0
2196109|NCT03459612|5388254|P4|COMPLETED|Period 3||17
2196110|NCT03459612|5388255|P3|COMPLETED|Period 3||17
2196111|NCT03459612|5388256|P2|COMPLETED|Period 3||17
2196112|NCT03459612|5388257|P1|COMPLETED|Period 3||17
2196113|NCT03459612|5388254|P4|Received at Least 1 Dose of Study Drug|Period 3||17
2196114|NCT03459612|5388255|P3|Received at Least 1 Dose of Study Drug|Period 3||17
2196115|NCT03459612|5388256|P2|Received at Least 1 Dose of Study Drug|Period 3||17
2196116|NCT03459612|5388257|P1|Received at Least 1 Dose of Study Drug|Period 3||17
2196117|NCT03459612|5388254|P4|STARTED|Period 3||17
2196118|NCT03459612|5388255|P3|STARTED|Period 3||17
2196119|NCT03459612|5388256|P2|STARTED|Period 3||17
2196120|NCT03459612|5388257|P1|STARTED|Period 3||17
2196121|NCT03459612|5388254|P4|NOT COMPLETED|Period 2||0
2196122|NCT03459612|5388255|P3|NOT COMPLETED|Period 2||0
2196123|NCT03459612|5388256|P2|NOT COMPLETED|Period 2||0
2196124|NCT03459612|5388257|P1|NOT COMPLETED|Period 2||0
2196125|NCT03459612|5388254|P4|COMPLETED|Period 2||17
2196126|NCT03459612|5388255|P3|COMPLETED|Period 2||17
2196127|NCT03459612|5388256|P2|COMPLETED|Period 2||17
2196128|NCT03459612|5388257|P1|COMPLETED|Period 2||17
2196129|NCT03459612|5388254|P4|Received at Least 1 Dose of Study Drug|Period 2||17
2196130|NCT03459612|5388255|P3|Received at Least 1 Dose of Study Drug|Period 2||17
2196131|NCT03459612|5388256|P2|Received at Least 1 Dose of Study Drug|Period 2||17
2196132|NCT03459612|5388257|P1|Received at Least 1 Dose of Study Drug|Period 2||17
2196133|NCT03459612|5388254|P4|STARTED|Period 2||17
2196134|NCT03459612|5388255|P3|STARTED|Period 2||17
2196135|NCT03459612|5388256|P2|STARTED|Period 2||17
2196136|NCT03459612|5388257|P1|STARTED|Period 2||17
2196137|NCT03459612|5388254|P4|NOT COMPLETED|Period 1||0
2196138|NCT03459612|5388255|P3|NOT COMPLETED|Period 1||0
2196139|NCT03459612|5388256|P2|NOT COMPLETED|Period 1||0
2196140|NCT03459612|5388257|P1|NOT COMPLETED|Period 1||0
2196141|NCT03459612|5388254|P4|COMPLETED|Period 1||17
2196142|NCT03459612|5388255|P3|COMPLETED|Period 1||17
2196143|NCT03459612|5388256|P2|COMPLETED|Period 1||17
2196144|NCT03459612|5388257|P1|COMPLETED|Period 1||17
2196145|NCT03459612|5388254|P4|Received at Least 1 Dose of Study Drug|Period 1||17
2196146|NCT03459612|5388255|P3|Received at Least 1 Dose of Study Drug|Period 1||17
2196147|NCT03459612|5388256|P2|Received at Least 1 Dose of Study Drug|Period 1||17
2196148|NCT03459612|5388257|P1|Received at Least 1 Dose of Study Drug|Period 1||17
2196149|NCT03459612|5388254|P4|STARTED|Period 1||17
2196150|NCT03459612|5388255|P3|STARTED|Period 1||17
2196151|NCT03459612|5388256|P2|STARTED|Period 1||17
2196152|NCT03459612|5388257|P1|STARTED|Period 1||17
2196153|NCT03459196|5388315|P1|NOT COMPLETED|Overall Study||2
2196154|NCT03459196|5388315|P1|COMPLETED|Overall Study||52
2196155|NCT03459196|5388315|P1|STARTED|Overall Study||54
2196156|NCT03459131|5388320|P2|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
2196157|NCT03459131|5388321|P1|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
2196158|NCT03459131|5388320|P2|COMPLETED|Period 2, Second 7 Days of Wear||8
2196159|NCT03459131|5388321|P1|COMPLETED|Period 2, Second 7 Days of Wear||7
2196160|NCT03459131|5388320|P2|STARTED|Period 2, Second 7 Days of Wear||8
2196161|NCT03459131|5388321|P1|STARTED|Period 2, Second 7 Days of Wear||7
2196162|NCT03459131|5388320|P2|NOT COMPLETED|Period 1, First 7 Days of Wear||0
2196163|NCT03459131|5388321|P1|NOT COMPLETED|Period 1, First 7 Days of Wear||0
2196164|NCT03459131|5388320|P2|COMPLETED|Period 1, First 7 Days of Wear||8
2196165|NCT03459131|5388321|P1|COMPLETED|Period 1, First 7 Days of Wear||7
2196166|NCT03459131|5388320|P2|STARTED|Period 1, First 7 Days of Wear||8
2196167|NCT03459131|5388321|P1|STARTED|Period 1, First 7 Days of Wear||7
2196168|NCT03458702|5388329|P2|NOT COMPLETED|Picture Rating/Body Composition||0
2196169|NCT03458702|5388330|P1|NOT COMPLETED|Picture Rating/Body Composition||0
2196170|NCT03458702|5388329|P2|COMPLETED|Picture Rating/Body Composition||20
2196171|NCT03458702|5388330|P1|COMPLETED|Picture Rating/Body Composition||20
2196172|NCT03458702|5388329|P2|STARTED|Picture Rating/Body Composition||20
2196173|NCT03458702|5388330|P1|STARTED|Picture Rating/Body Composition||20
2196174|NCT03458702|5388329|P2|NOT COMPLETED|Study Condition B (Yoga or Rest)||2
2196175|NCT03458702|5388330|P1|NOT COMPLETED|Study Condition B (Yoga or Rest)||4
2196176|NCT03458702|5388329|P2|COMPLETED|Study Condition B (Yoga or Rest)||20
2196177|NCT03458702|5388330|P1|COMPLETED|Study Condition B (Yoga or Rest)||20
2196178|NCT03458702|5388329|P2|STARTED|Study Condition B (Yoga or Rest)||22
2196179|NCT03458702|5388330|P1|STARTED|Study Condition B (Yoga or Rest)||24
2196180|NCT03458702|5388329|P2|NOT COMPLETED|Study Condition A (Yoga or Rest)||6
2196181|NCT03458702|5388330|P1|NOT COMPLETED|Study Condition A (Yoga or Rest)||4
2196182|NCT03458702|5388329|P2|COMPLETED|Study Condition A (Yoga or Rest)||22
2196183|NCT03458702|5388330|P1|COMPLETED|Study Condition A (Yoga or Rest)||24
2196184|NCT03458702|5388329|P2|STARTED|Study Condition A (Yoga or Rest)||28
2196185|NCT03458702|5388330|P1|STARTED|Study Condition A (Yoga or Rest)||28
2196186|NCT03457909|5388346|P1|NOT COMPLETED|Overall Study||0
2196187|NCT03457909|5388346|P1|COMPLETED|Overall Study||25
2196188|NCT03457909|5388346|P1|STARTED|Overall Study||25
2196189|NCT03457727|5388359|P4|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
2196190|NCT03457727|5388360|P3|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
2196191|NCT03457727|5388361|P2|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
2196192|NCT03457727|5388362|P1|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
2196193|NCT03457727|5388359|P4|COMPLETED|Part 2, Period 4 (1 Day)||0
2196194|NCT03457727|5388360|P3|COMPLETED|Part 2, Period 4 (1 Day)||12
2196195|NCT03457727|5388361|P2|COMPLETED|Part 2, Period 4 (1 Day)||0
2196196|NCT03457727|5388362|P1|COMPLETED|Part 2, Period 4 (1 Day)||0
2196197|NCT03457727|5388359|P4|STARTED|Part 2, Period 4 (1 Day)||0
2196198|NCT03457727|5388360|P3|STARTED|Part 2, Period 4 (1 Day)||12
2196199|NCT03457727|5388361|P2|STARTED|Part 2, Period 4 (1 Day)||0
2196200|NCT03457727|5388362|P1|STARTED|Part 2, Period 4 (1 Day)||0
2196201|NCT03457727|5388359|P4|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
2196202|NCT03457727|5388360|P3|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
2196203|NCT03457727|5388361|P2|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
2196204|NCT03457727|5388362|P1|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
2196205|NCT03457727|5388359|P4|COMPLETED|Part 2, Washout Period 3 (5 Days)||11
2196206|NCT03457727|5388360|P3|COMPLETED|Part 2, Washout Period 3 (5 Days)||12
2196207|NCT03457727|5388361|P2|COMPLETED|Part 2, Washout Period 3 (5 Days)||0
2196208|NCT03457727|5388362|P1|COMPLETED|Part 2, Washout Period 3 (5 Days)||0
2196209|NCT03457727|5388359|P4|STARTED|Part 2, Washout Period 3 (5 Days)||11
2196210|NCT03457727|5388360|P3|STARTED|Part 2, Washout Period 3 (5 Days)||12
2196211|NCT03457727|5388361|P2|STARTED|Part 2, Washout Period 3 (5 Days)||0
2196212|NCT03457727|5388362|P1|STARTED|Part 2, Washout Period 3 (5 Days)||0
2196213|NCT03457727|5388359|P4|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
2196214|NCT03457727|5388360|P3|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
2196215|NCT03457727|5388361|P2|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
2196216|NCT03457727|5388362|P1|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
2196217|NCT03457727|5388359|P4|COMPLETED|Part 2, Period 3 (1 Day)||11
2196218|NCT03457727|5388360|P3|COMPLETED|Part 2, Period 3 (1 Day)||12
2196219|NCT03457727|5388361|P2|COMPLETED|Part 2, Period 3 (1 Day)||0
2196220|NCT03457727|5388362|P1|COMPLETED|Part 2, Period 3 (1 Day)||0
2196221|NCT03457727|5388359|P4|STARTED|Part 2, Period 3 (1 Day)||11
2196222|NCT03457727|5388360|P3|STARTED|Part 2, Period 3 (1 Day)||12
2196223|NCT03457727|5388361|P2|STARTED|Part 2, Period 3 (1 Day)||0
2196224|NCT03457727|5388362|P1|STARTED|Part 2, Period 3 (1 Day)||0
2196225|NCT03457727|5388359|P4|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
2196226|NCT03457727|5388360|P3|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
2196227|NCT03457727|5388361|P2|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
2196228|NCT03457727|5388362|P1|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
2196229|NCT03457727|5388359|P4|COMPLETED|Part 2, Washout Period 2 (5 Days)||11
2196230|NCT03457727|5388360|P3|COMPLETED|Part 2, Washout Period 2 (5 Days)||12
2196231|NCT03457727|5388361|P2|COMPLETED|Part 2, Washout Period 2 (5 Days)||0
2196232|NCT03457727|5388362|P1|COMPLETED|Part 2, Washout Period 2 (5 Days)||0
2196233|NCT03457727|5388359|P4|STARTED|Part 2, Washout Period 2 (5 Days)||11
2196234|NCT03457727|5388360|P3|STARTED|Part 2, Washout Period 2 (5 Days)||12
2196235|NCT03457727|5388361|P2|STARTED|Part 2, Washout Period 2 (5 Days)||0
2196236|NCT03457727|5388362|P1|STARTED|Part 2, Washout Period 2 (5 Days)||0
2196237|NCT03457727|5388359|P4|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
2196238|NCT03457727|5388360|P3|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
2196239|NCT03457727|5388361|P2|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
2196240|NCT03457727|5388362|P1|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
2196241|NCT03457727|5388359|P4|COMPLETED|Part 2, Period 2 (1 Day)||11
2196242|NCT03457727|5388360|P3|COMPLETED|Part 2, Period 2 (1 Day)||12
2196243|NCT03457727|5388361|P2|COMPLETED|Part 2, Period 2 (1 Day)||0
2196244|NCT03457727|5388362|P1|COMPLETED|Part 2, Period 2 (1 Day)||0
2196245|NCT03457727|5388359|P4|STARTED|Part 2, Period 2 (1 Day)||11
2196246|NCT03457727|5388360|P3|STARTED|Part 2, Period 2 (1 Day)||12
2196247|NCT03457727|5388361|P2|STARTED|Part 2, Period 2 (1 Day)||0
2196248|NCT03457727|5388362|P1|STARTED|Part 2, Period 2 (1 Day)||0
2196249|NCT03457727|5388359|P4|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||1
2196250|NCT03457727|5388360|P3|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
2196251|NCT03457727|5388361|P2|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
2196252|NCT03457727|5388362|P1|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
2196253|NCT03457727|5388359|P4|COMPLETED|Part 2, Washout Period 1 (5 Days)||11
2196254|NCT03457727|5388360|P3|COMPLETED|Part 2, Washout Period 1 (5 Days)||12
2196255|NCT03457727|5388361|P2|COMPLETED|Part 2, Washout Period 1 (5 Days)||0
2196256|NCT03457727|5388362|P1|COMPLETED|Part 2, Washout Period 1 (5 Days)||0
2196257|NCT03457727|5388359|P4|STARTED|Part 2, Washout Period 1 (5 Days)||12
2196258|NCT03457727|5388360|P3|STARTED|Part 2, Washout Period 1 (5 Days)||12
2196259|NCT03457727|5388361|P2|STARTED|Part 2, Washout Period 1 (5 Days)||0
2196260|NCT03457727|5388362|P1|STARTED|Part 2, Washout Period 1 (5 Days)||0
2196261|NCT03457727|5388359|P4|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
2196262|NCT03457727|5388360|P3|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
2196263|NCT03457727|5388361|P2|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
2196264|NCT03457727|5388362|P1|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
2196265|NCT03457727|5388359|P4|COMPLETED|Part 2, Period 1 (1 Day)||12
2196266|NCT03457727|5388360|P3|COMPLETED|Part 2, Period 1 (1 Day)||12
2196267|NCT03457727|5388361|P2|COMPLETED|Part 2, Period 1 (1 Day)||0
2196268|NCT03457727|5388362|P1|COMPLETED|Part 2, Period 1 (1 Day)||0
2196269|NCT03457727|5388359|P4|STARTED|Part 2, Period 1 (1 Day)||12
2196270|NCT03457727|5388360|P3|STARTED|Part 2, Period 1 (1 Day)||12
2196271|NCT03457727|5388361|P2|STARTED|Part 2, Period 1 (1 Day)||0
2196272|NCT03457727|5388362|P1|STARTED|Part 2, Period 1 (1 Day)||0
2196273|NCT03457727|5388359|P4|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
2196274|NCT03457727|5388360|P3|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
2196275|NCT03457727|5388361|P2|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
2196276|NCT03457727|5388362|P1|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
2196277|NCT03457727|5388359|P4|COMPLETED|Part 1, Period 4 (1 Day)||0
2196278|NCT03457727|5388360|P3|COMPLETED|Part 1, Period 4 (1 Day)||0
2196279|NCT03457727|5388361|P2|COMPLETED|Part 1, Period 4 (1 Day)||8
2196280|NCT03457727|5388362|P1|COMPLETED|Part 1, Period 4 (1 Day)||8
2196281|NCT03457727|5388359|P4|STARTED|Part 1, Period 4 (1 Day)||0
2196282|NCT03457727|5388360|P3|STARTED|Part 1, Period 4 (1 Day)||0
2196283|NCT03457727|5388361|P2|STARTED|Part 1, Period 4 (1 Day)||8
2196284|NCT03457727|5388362|P1|STARTED|Part 1, Period 4 (1 Day)||8
2196285|NCT03457727|5388359|P4|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
2196286|NCT03457727|5388360|P3|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
2196287|NCT03457727|5388361|P2|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
2196288|NCT03457727|5388362|P1|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
2196289|NCT03457727|5388359|P4|COMPLETED|Part 1, Washout Period 3 (5 Days)||0
2196290|NCT03457727|5388360|P3|COMPLETED|Part 1, Washout Period 3 (5 Days)||0
2196291|NCT03457727|5388361|P2|COMPLETED|Part 1, Washout Period 3 (5 Days)||8
2196292|NCT03457727|5388362|P1|COMPLETED|Part 1, Washout Period 3 (5 Days)||8
2196293|NCT03457727|5388359|P4|STARTED|Part 1, Washout Period 3 (5 Days)||0
2196294|NCT03457727|5388360|P3|STARTED|Part 1, Washout Period 3 (5 Days)||0
2196295|NCT03457727|5388361|P2|STARTED|Part 1, Washout Period 3 (5 Days)||8
2196296|NCT03457727|5388362|P1|STARTED|Part 1, Washout Period 3 (5 Days)||8
2196297|NCT03457727|5388359|P4|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
2196298|NCT03457727|5388360|P3|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
2196299|NCT03457727|5388361|P2|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
2196300|NCT03457727|5388362|P1|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
2196301|NCT03457727|5388359|P4|COMPLETED|Part 1, Period 3 (1 Day)||0
2196302|NCT03457727|5388360|P3|COMPLETED|Part 1, Period 3 (1 Day)||0
2196303|NCT03457727|5388361|P2|COMPLETED|Part 1, Period 3 (1 Day)||8
2196304|NCT03457727|5388362|P1|COMPLETED|Part 1, Period 3 (1 Day)||8
2196305|NCT03457727|5388359|P4|STARTED|Part 1, Period 3 (1 Day)||0
2196306|NCT03457727|5388360|P3|STARTED|Part 1, Period 3 (1 Day)||0
2196307|NCT03457727|5388361|P2|STARTED|Part 1, Period 3 (1 Day)||8
2196308|NCT03457727|5388362|P1|STARTED|Part 1, Period 3 (1 Day)||8
2196309|NCT03457727|5388359|P4|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
2196310|NCT03457727|5388360|P3|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
2196311|NCT03457727|5388361|P2|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
2196312|NCT03457727|5388362|P1|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
2196313|NCT03457727|5388359|P4|COMPLETED|Part 1, Washout Period 2 (5 Days)||0
2196314|NCT03457727|5388360|P3|COMPLETED|Part 1, Washout Period 2 (5 Days)||0
2196315|NCT03457727|5388361|P2|COMPLETED|Part 1, Washout Period 2 (5 Days)||8
2196316|NCT03457727|5388362|P1|COMPLETED|Part 1, Washout Period 2 (5 Days)||8
2196317|NCT03457727|5388359|P4|STARTED|Part 1, Washout Period 2 (5 Days)||0
2196318|NCT03457727|5388360|P3|STARTED|Part 1, Washout Period 2 (5 Days)||0
2196319|NCT03457727|5388361|P2|STARTED|Part 1, Washout Period 2 (5 Days)||8
2196320|NCT03457727|5388362|P1|STARTED|Part 1, Washout Period 2 (5 Days)||8
2196321|NCT03457727|5388359|P4|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
2196322|NCT03457727|5388360|P3|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
2196323|NCT03457727|5388361|P2|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
2196324|NCT03457727|5388362|P1|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
2196325|NCT03457727|5388359|P4|COMPLETED|Part 1, Period 2 (1 Day)||0
2196326|NCT03457727|5388360|P3|COMPLETED|Part 1, Period 2 (1 Day)||0
2196327|NCT03457727|5388361|P2|COMPLETED|Part 1, Period 2 (1 Day)||8
2196328|NCT03457727|5388362|P1|COMPLETED|Part 1, Period 2 (1 Day)||8
2196329|NCT03457727|5388359|P4|STARTED|Part 1, Period 2 (1 Day)||0
2196330|NCT03457727|5388360|P3|STARTED|Part 1, Period 2 (1 Day)||0
2196331|NCT03457727|5388361|P2|STARTED|Part 1, Period 2 (1 Day)||8
2196332|NCT03457727|5388362|P1|STARTED|Part 1, Period 2 (1 Day)||8
2196333|NCT03457727|5388359|P4|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
2196334|NCT03457727|5388360|P3|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
2196335|NCT03457727|5388361|P2|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
2196336|NCT03457727|5388362|P1|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
2196337|NCT03457727|5388359|P4|COMPLETED|Part 1, Washout Period 1 (5 Days)||0
2196338|NCT03457727|5388360|P3|COMPLETED|Part 1, Washout Period 1 (5 Days)||0
2196339|NCT03457727|5388361|P2|COMPLETED|Part 1, Washout Period 1 (5 Days)||8
2196340|NCT03457727|5388362|P1|COMPLETED|Part 1, Washout Period 1 (5 Days)||8
2196341|NCT03457727|5388359|P4|STARTED|Part 1, Washout Period 1 (5 Days)||0
2196342|NCT03457727|5388360|P3|STARTED|Part 1, Washout Period 1 (5 Days)||0
2196343|NCT03457727|5388361|P2|STARTED|Part 1, Washout Period 1 (5 Days)||8
2196344|NCT03457727|5388362|P1|STARTED|Part 1, Washout Period 1 (5 Days)||8
2196345|NCT03457727|5388359|P4|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
2196346|NCT03457727|5388360|P3|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
2196347|NCT03457727|5388361|P2|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
2196348|NCT03457727|5388362|P1|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
2196349|NCT03457727|5388359|P4|COMPLETED|Part 1, Period 1 (1 Day)||0
2196350|NCT03457727|5388360|P3|COMPLETED|Part 1, Period 1 (1 Day)||0
2196351|NCT03457727|5388361|P2|COMPLETED|Part 1, Period 1 (1 Day)||8
2196352|NCT03457727|5388362|P1|COMPLETED|Part 1, Period 1 (1 Day)||8
2196353|NCT03457727|5388359|P4|STARTED|Part 1, Period 1 (1 Day)||0
2196354|NCT03457727|5388360|P3|STARTED|Part 1, Period 1 (1 Day)||0
2196355|NCT03457727|5388361|P2|STARTED|Part 1, Period 1 (1 Day)||8
2196356|NCT03457727|5388362|P1|STARTED|Part 1, Period 1 (1 Day)||8
2196357|NCT03457636|5388559|P1|NOT COMPLETED|Overall Study||2
2196358|NCT03457636|5388559|P1|COMPLETED|Overall Study||20
2196359|NCT03457636|5388559|P1|STARTED|Overall Study||22
2196360|NCT03456960|5388572|P6|NOT COMPLETED|Period 2 (1 Day)||0
2196361|NCT03456960|5388573|P5|NOT COMPLETED|Period 2 (1 Day)||0
2196362|NCT03456960|5388574|P4|NOT COMPLETED|Period 2 (1 Day)||1
2196363|NCT03456960|5388575|P3|NOT COMPLETED|Period 2 (1 Day)||0
2196364|NCT03456960|5388576|P2|NOT COMPLETED|Period 2 (1 Day)||0
2196365|NCT03456960|5388577|P1|NOT COMPLETED|Period 2 (1 Day)||1
2196366|NCT03456960|5388572|P6|COMPLETED|Period 2 (1 Day)||6
2196367|NCT03456960|5388573|P5|COMPLETED|Period 2 (1 Day)||6
2196368|NCT03456960|5388574|P4|COMPLETED|Period 2 (1 Day)||117
2196369|NCT03456960|5388575|P3|COMPLETED|Period 2 (1 Day)||119
2196370|NCT03456960|5388576|P2|COMPLETED|Period 2 (1 Day)||12
2196371|NCT03456960|5388577|P1|COMPLETED|Period 2 (1 Day)||11
2196372|NCT03456960|5388572|P6|STARTED|Period 2 (1 Day)||6
2196373|NCT03456960|5388573|P5|STARTED|Period 2 (1 Day)||6
2196374|NCT03456960|5388574|P4|STARTED|Period 2 (1 Day)||118
2196375|NCT03456960|5388575|P3|STARTED|Period 2 (1 Day)||119
2196376|NCT03456960|5388576|P2|STARTED|Period 2 (1 Day)||12
2196377|NCT03456960|5388577|P1|STARTED|Period 2 (1 Day)||12
2196378|NCT03456960|5388572|P6|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2196379|NCT03456960|5388573|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2196380|NCT03456960|5388574|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||2
2196381|NCT03456960|5388575|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||1
2196382|NCT03456960|5388576|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2196383|NCT03456960|5388577|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2196384|NCT03456960|5388572|P6|COMPLETED|Washout Period (at Least 14 Days)||6
2196385|NCT03456960|5388573|P5|COMPLETED|Washout Period (at Least 14 Days)||6
2196386|NCT03456960|5388574|P4|COMPLETED|Washout Period (at Least 14 Days)||118
2196387|NCT03456960|5388575|P3|COMPLETED|Washout Period (at Least 14 Days)||119
2196388|NCT03456960|5388576|P2|COMPLETED|Washout Period (at Least 14 Days)||12
2196389|NCT03456960|5388577|P1|COMPLETED|Washout Period (at Least 14 Days)||12
2196390|NCT03456960|5388572|P6|STARTED|Washout Period (at Least 14 Days)||6
2196391|NCT03456960|5388573|P5|STARTED|Washout Period (at Least 14 Days)||6
2196392|NCT03456960|5388574|P4|STARTED|Washout Period (at Least 14 Days)||120
2196393|NCT03456960|5388575|P3|STARTED|Washout Period (at Least 14 Days)||120
2196394|NCT03456960|5388576|P2|STARTED|Washout Period (at Least 14 Days)||12
2196395|NCT03456960|5388577|P1|STARTED|Washout Period (at Least 14 Days)||12
2196396|NCT03456960|5388572|P6|NOT COMPLETED|Period 1 (1 Day)||0
2196397|NCT03456960|5388573|P5|NOT COMPLETED|Period 1 (1 Day)||0
2196398|NCT03456960|5388574|P4|NOT COMPLETED|Period 1 (1 Day)||0
2196399|NCT03456960|5388575|P3|NOT COMPLETED|Period 1 (1 Day)||0
2196400|NCT03456960|5388576|P2|NOT COMPLETED|Period 1 (1 Day)||0
2196401|NCT03456960|5388577|P1|NOT COMPLETED|Period 1 (1 Day)||0
2196402|NCT03456960|5388572|P6|COMPLETED|Period 1 (1 Day)||6
2196403|NCT03456960|5388573|P5|COMPLETED|Period 1 (1 Day)||6
2196404|NCT03456960|5388574|P4|COMPLETED|Period 1 (1 Day)||120
2196405|NCT03456960|5388575|P3|COMPLETED|Period 1 (1 Day)||120
2196406|NCT03456960|5388576|P2|COMPLETED|Period 1 (1 Day)||12
2196407|NCT03456960|5388577|P1|COMPLETED|Period 1 (1 Day)||12
2196408|NCT03456960|5388572|P6|STARTED|Period 1 (1 Day)||6
2196409|NCT03456960|5388573|P5|STARTED|Period 1 (1 Day)||6
2196410|NCT03456960|5388574|P4|STARTED|Period 1 (1 Day)||120
2196411|NCT03456960|5388575|P3|STARTED|Period 1 (1 Day)||120
2196412|NCT03456960|5388576|P2|STARTED|Period 1 (1 Day)||12
2196413|NCT03456960|5388577|P1|STARTED|Period 1 (1 Day)||12
2196414|NCT03456427|5388669|P1|NOT COMPLETED|Overall Study||3
2196415|NCT03456427|5388669|P1|COMPLETED|Overall Study||33
2196416|NCT03456427|5388669|P1|STARTED|Overall Study||36
2196420|NCT03455491|5388685|P3|NOT COMPLETED|Overall Study||0
2196421|NCT03455491|5388686|P2|NOT COMPLETED|Overall Study||0
2196422|NCT03455491|5388687|P1|NOT COMPLETED|Overall Study||0
2196423|NCT03455491|5388685|P3|COMPLETED|Overall Study||40
2196424|NCT03455491|5388686|P2|COMPLETED|Overall Study||40
2196425|NCT03455491|5388687|P1|COMPLETED|Overall Study||40
2196426|NCT03455491|5388685|P3|STARTED|Overall Study||40
2196427|NCT03455491|5388686|P2|STARTED|Overall Study||40
2196428|NCT03455491|5388687|P1|STARTED|Overall Study||40
2196429|NCT03454581|5388707|P3|NOT COMPLETED|Overall Study||3
2196430|NCT03454581|5388708|P2|NOT COMPLETED|Overall Study||3
2196431|NCT03454581|5388709|P1|NOT COMPLETED|Overall Study||4
2196432|NCT03454581|5388707|P3|COMPLETED|Overall Study||14
2196433|NCT03454581|5388708|P2|COMPLETED|Overall Study||13
2196434|NCT03454581|5388709|P1|COMPLETED|Overall Study||14
2196435|NCT03454581|5388707|P3|STARTED|Overall Study||17
2196436|NCT03454581|5388708|P2|STARTED|Overall Study||16
2196437|NCT03454581|5388709|P1|STARTED|Overall Study||18
2196438|NCT03453060|5388743|P5|NOT COMPLETED|Overall Study||0
2196439|NCT03453060|5388744|P4|NOT COMPLETED|Overall Study||0
2196440|NCT03453060|5388745|P3|NOT COMPLETED|Overall Study||0
2196441|NCT03453060|5388746|P2|NOT COMPLETED|Overall Study||0
2196442|NCT03453060|5388747|P1|NOT COMPLETED|Overall Study||0
2196443|NCT03453060|5388743|P5|COMPLETED|Overall Study||5
2196444|NCT03453060|5388744|P4|COMPLETED|Overall Study||4
2196445|NCT03453060|5388745|P3|COMPLETED|Overall Study||4
2196446|NCT03453060|5388746|P2|COMPLETED|Overall Study||4
2196447|NCT03453060|5388747|P1|COMPLETED|Overall Study||4
2196448|NCT03453060|5388743|P5|STARTED|Overall Study||5
2196449|NCT03453060|5388744|P4|STARTED|Overall Study||4
2196450|NCT03453060|5388745|P3|STARTED|Overall Study||4
2196451|NCT03453060|5388746|P2|STARTED|Overall Study||4
2196452|NCT03453060|5388747|P1|STARTED|Overall Study||4
2196453|NCT03450070|5388964|P1|NOT COMPLETED|Overall Study||8
2196454|NCT03450070|5388964|P1|COMPLETED|Overall Study||110
2196455|NCT03450070|5388964|P1|STARTED|Overall Study||118
2196456|NCT03448536|5388970|P2|NOT COMPLETED|Overall Study||4
2196457|NCT03448536|5388971|P1|NOT COMPLETED|Overall Study||12
2196458|NCT03448536|5388970|P2|COMPLETED|Overall Study||97
2196459|NCT03448536|5388971|P1|COMPLETED|Overall Study||88
2196460|NCT03448536|5388970|P2|Completed Second Intervention|Overall Study||87
2196461|NCT03448536|5388971|P1|Completed Second Intervention|Overall Study||82
2196462|NCT03448536|5388970|P2|Completed First Intervention|Overall Study||97
2196463|NCT03448536|5388971|P1|Completed First Intervention|Overall Study||95
2196464|NCT03448536|5388970|P2|Completed First Intervention|Overall Study||78
2196465|NCT03448536|5388971|P1|Completed First Intervention|Overall Study||83
2196466|NCT03448536|5388970|P2|STARTED|Overall Study||101
2196467|NCT03448536|5388971|P1|STARTED|Overall Study||100
2196477|NCT03447639|5389025|P2|NOT COMPLETED|Overall Study||2
2196478|NCT03447639|5389026|P1|NOT COMPLETED|Overall Study||0
2196479|NCT03447639|5389025|P2|COMPLETED|Overall Study|2 patients were withdrawn because their catheters had to be re-inserted.|1
2196480|NCT03447639|5389026|P1|COMPLETED|Overall Study|No patients were randomized to the Povidone-Iodine irrigation arm|0
2196481|NCT03447639|5389025|P2|STARTED|Overall Study|3 patients were randomized to the Standard of Care arm.|3
2196482|NCT03447639|5389026|P1|STARTED|Overall Study|No patients were randomized to the Povidone-Iodine irrigation arm|0
2196483|NCT03447353|5389036|P1|NOT COMPLETED|Overall Study||10
2196484|NCT03447353|5389036|P1|COMPLETED|Overall Study||8
2196485|NCT03447353|5389036|P1|STARTED|Overall Study||18
2196486|NCT03447015|5389052|P2|NOT COMPLETED|Overall Study||44
2196487|NCT03447015|5389053|P1|NOT COMPLETED|Overall Study||45
2196488|NCT03447015|5389052|P2|COMPLETED|Overall Study||106
2196489|NCT03447015|5389053|P1|COMPLETED|Overall Study||95
2196490|NCT03447015|5389052|P2|STARTED|Overall Study||150
2196491|NCT03447015|5389053|P1|STARTED|Overall Study||140
2196492|NCT03446690|5389071|P2|NOT COMPLETED|Overall Study||0
2196493|NCT03446690|5389072|P1|NOT COMPLETED|Overall Study||7
2196494|NCT03446690|5389071|P2|COMPLETED|Overall Study||29
2196495|NCT03446690|5389072|P1|COMPLETED|Overall Study||26
2196496|NCT03446690|5389071|P2|STARTED|Overall Study||29
2196497|NCT03446690|5389072|P1|STARTED|Overall Study||33
2196498|NCT03445390|5389078|P2|NOT COMPLETED|Second Intervention||1
2196499|NCT03445390|5389079|P1|NOT COMPLETED|Second Intervention||2
2196500|NCT03445390|5389078|P2|COMPLETED|Second Intervention||10
2196501|NCT03445390|5389079|P1|COMPLETED|Second Intervention||10
2196502|NCT03445390|5389078|P2|STARTED|Second Intervention||11
2196503|NCT03445390|5389079|P1|STARTED|Second Intervention||12
2196504|NCT03445390|5389078|P2|NOT COMPLETED|First Intervention||2
2196505|NCT03445390|5389079|P1|NOT COMPLETED|First Intervention||2
2196506|NCT03445390|5389078|P2|COMPLETED|First Intervention||11
2196507|NCT03445390|5389079|P1|COMPLETED|First Intervention||12
2196508|NCT03445390|5389078|P2|STARTED|First Intervention||13
2196509|NCT03445390|5389079|P1|STARTED|First Intervention||14
2196510|NCT03445195|5389091|P2|NOT COMPLETED|Overall Study||0
2196511|NCT03445195|5389092|P1|NOT COMPLETED|Overall Study||2
2196512|NCT03445195|5389091|P2|COMPLETED|Overall Study||27
2196513|NCT03445195|5389092|P1|COMPLETED|Overall Study||51
2196514|NCT03445195|5389091|P2|STARTED|Overall Study||27
2196515|NCT03445195|5389092|P1|STARTED|Overall Study||53
2196516|NCT03445156|5389107|P3|NOT COMPLETED|Experiment Proper||0
2196517|NCT03445156|5389108|P2|NOT COMPLETED|Experiment Proper||0
2196518|NCT03445156|5389109|P1|NOT COMPLETED|Experiment Proper||0
2196519|NCT03445156|5389107|P3|COMPLETED|Experiment Proper||59
2196520|NCT03445156|5389108|P2|COMPLETED|Experiment Proper||115
2196521|NCT03445156|5389109|P1|COMPLETED|Experiment Proper||113
2196522|NCT03445156|5389107|P3|STARTED|Experiment Proper||59
2196523|NCT03445156|5389108|P2|STARTED|Experiment Proper||115
2196524|NCT03445156|5389109|P1|STARTED|Experiment Proper||113
2196525|NCT03445156|5389107|P3|NOT COMPLETED|Pilot Study||0
2196526|NCT03445156|5389108|P2|NOT COMPLETED|Pilot Study||0
2196527|NCT03445156|5389109|P1|NOT COMPLETED|Pilot Study||0
2196528|NCT03445156|5389107|P3|COMPLETED|Pilot Study||0
2196529|NCT03445156|5389108|P2|COMPLETED|Pilot Study||20
2196530|NCT03445156|5389109|P1|COMPLETED|Pilot Study||20
2196531|NCT03445156|5389107|P3|STARTED|Pilot Study||0
2196532|NCT03445156|5389108|P2|STARTED|Pilot Study||20
2196533|NCT03445156|5389109|P1|STARTED|Pilot Study||20
2196534|NCT03444584|5389128|P2|NOT COMPLETED|Overall Study||2
2196535|NCT03444584|5389129|P1|NOT COMPLETED|Overall Study||0
2196536|NCT03444584|5389128|P2|COMPLETED|Overall Study||23
2196537|NCT03444584|5389129|P1|COMPLETED|Overall Study||24
2196538|NCT03444584|5389128|P2|STARTED|Overall Study||25
2196539|NCT03444584|5389129|P1|STARTED|Overall Study||24
2196540|NCT03444090|5389187|P2|NOT COMPLETED|Overall Study||4
2196541|NCT03444090|5389188|P1|NOT COMPLETED|Overall Study||3
2196542|NCT03444090|5389187|P2|COMPLETED|Overall Study||210
2196543|NCT03444090|5389188|P1|COMPLETED|Overall Study||211
2196544|NCT03444090|5389187|P2|STARTED|Overall Study||214
2196545|NCT03444090|5389188|P1|STARTED|Overall Study||214
2196546|NCT03443414|5389201|P5|NOT COMPLETED|Overall Study||5
2196547|NCT03443414|5389202|P4|NOT COMPLETED|Overall Study||5
2196548|NCT03443414|5389203|P3|NOT COMPLETED|Overall Study||6
2196549|NCT03443414|5389204|P2|NOT COMPLETED|Overall Study||3
2196550|NCT03443414|5389205|P1|NOT COMPLETED|Overall Study||11
2196551|NCT03443414|5389201|P5|COMPLETED|Overall Study||75
2196552|NCT03443414|5389202|P4|COMPLETED|Overall Study||75
2196553|NCT03443414|5389203|P3|COMPLETED|Overall Study||76
2196554|NCT03443414|5389204|P2|COMPLETED|Overall Study||78
2196555|NCT03443414|5389205|P1|COMPLETED|Overall Study||71
2196556|NCT03443414|5389201|P5|Received Treatment|Overall Study||79
2196557|NCT03443414|5389202|P4|Received Treatment|Overall Study||80
2196558|NCT03443414|5389203|P3|Received Treatment|Overall Study||82
2196559|NCT03443414|5389204|P2|Received Treatment|Overall Study||81
2196560|NCT03443414|5389205|P1|Received Treatment|Overall Study||81
2196561|NCT03443414|5389201|P5|STARTED|Overall Study||80
2196562|NCT03443414|5389202|P4|STARTED|Overall Study||80
2196563|NCT03443414|5389203|P3|STARTED|Overall Study||82
2196564|NCT03443414|5389204|P2|STARTED|Overall Study||81
2196565|NCT03443414|5389205|P1|STARTED|Overall Study||82
2196566|NCT03443063|5389244|P2|NOT COMPLETED|Overall Study||0
2196567|NCT03443063|5389245|P1|NOT COMPLETED|Overall Study||0
2196568|NCT03443063|5389244|P2|COMPLETED|Overall Study||8
2196569|NCT03443063|5389245|P1|COMPLETED|Overall Study||8
2196570|NCT03443063|5389244|P2|STARTED|Overall Study||8
2196571|NCT03443063|5389245|P1|STARTED|Overall Study||8
2196572|NCT03442933|5389295|P2|NOT COMPLETED|Overall Study||0
2196573|NCT03442933|5389296|P1|NOT COMPLETED|Overall Study||0
2196574|NCT03442933|5389295|P2|COMPLETED|Overall Study||20
2196575|NCT03442933|5389296|P1|COMPLETED|Overall Study||20
2196576|NCT03442933|5389295|P2|STARTED|Overall Study||20
2196577|NCT03442933|5389296|P1|STARTED|Overall Study||20
2196578|NCT03442725|5389309|P2|NOT COMPLETED|Overall Study||0
2196579|NCT03442725|5389310|P1|NOT COMPLETED|Overall Study||0
2196580|NCT03442725|5389309|P2|COMPLETED|Overall Study||8
2196581|NCT03442725|5389310|P1|COMPLETED|Overall Study||8
2196582|NCT03442725|5389309|P2|STARTED|Overall Study||8
2196583|NCT03442725|5389310|P1|STARTED|Overall Study||8
2196584|NCT03442699|5389342|P1|NOT COMPLETED|Overall Study||0
2196585|NCT03442699|5389342|P1|COMPLETED|Overall Study||6
2196586|NCT03442699|5389342|P1|STARTED|Overall Study||6
2196587|NCT03441984|5389352|P12|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
2196588|NCT03441984|5389353|P11|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
2196589|NCT03441984|5389354|P10|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
2196590|NCT03441984|5389355|P9|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
2196591|NCT03441984|5389356|P8|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
2196592|NCT03441984|5389357|P7|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
2196593|NCT03441984|5389358|P6|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
2196594|NCT03441984|5389359|P5|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
2196595|NCT03441984|5389360|P4|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
2196596|NCT03441984|5389361|P3|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
2196597|NCT03441984|5389362|P2|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
2196598|NCT03441984|5389363|P1|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
2196599|NCT03441984|5389352|P12|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
2196600|NCT03441984|5389353|P11|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
2196601|NCT03441984|5389354|P10|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
2196602|NCT03441984|5389355|P9|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
2196603|NCT03441984|5389356|P8|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
2196604|NCT03441984|5389357|P7|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
2196605|NCT03441984|5389358|P6|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
2196606|NCT03441984|5389359|P5|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
2196607|NCT03441984|5389360|P4|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
2196608|NCT03441984|5389361|P3|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
2196609|NCT03441984|5389362|P2|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
2196610|NCT03441984|5389363|P1|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
2196611|NCT03441984|5389352|P12|STARTED|Part 2: Period 3 (Up to Day 4)||3
2196612|NCT03441984|5389353|P11|STARTED|Part 2: Period 3 (Up to Day 4)||3
2196613|NCT03441984|5389354|P10|STARTED|Part 2: Period 3 (Up to Day 4)||3
2196614|NCT03441984|5389355|P9|STARTED|Part 2: Period 3 (Up to Day 4)||3
2196615|NCT03441984|5389356|P8|STARTED|Part 2: Period 3 (Up to Day 4)||3
2196616|NCT03441984|5389357|P7|STARTED|Part 2: Period 3 (Up to Day 4)||3
2196617|NCT03441984|5389358|P6|STARTED|Part 2: Period 3 (Up to Day 4)||0
2196618|NCT03441984|5389359|P5|STARTED|Part 2: Period 3 (Up to Day 4)||0
2196619|NCT03441984|5389360|P4|STARTED|Part 2: Period 3 (Up to Day 4)||0
2196620|NCT03441984|5389361|P3|STARTED|Part 2: Period 3 (Up to Day 4)||0
2196621|NCT03441984|5389362|P2|STARTED|Part 2: Period 3 (Up to Day 4)||0
2196622|NCT03441984|5389363|P1|STARTED|Part 2: Period 3 (Up to Day 4)||0
2196623|NCT03441984|5389352|P12|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
2196624|NCT03441984|5389353|P11|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
2196625|NCT03441984|5389354|P10|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
2196626|NCT03441984|5389355|P9|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
2196627|NCT03441984|5389356|P8|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
2196628|NCT03441984|5389357|P7|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
2196629|NCT03441984|5389358|P6|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
2196630|NCT03441984|5389359|P5|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
2196631|NCT03441984|5389360|P4|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
2196632|NCT03441984|5389361|P3|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
2196633|NCT03441984|5389362|P2|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
2196634|NCT03441984|5389363|P1|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
2196635|NCT03441984|5389352|P12|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
2196636|NCT03441984|5389353|P11|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
2196637|NCT03441984|5389354|P10|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
2196638|NCT03441984|5389355|P9|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
2196639|NCT03441984|5389356|P8|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
2196640|NCT03441984|5389357|P7|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
2196641|NCT03441984|5389358|P6|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
2196642|NCT03441984|5389359|P5|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
2196643|NCT03441984|5389360|P4|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
2196644|NCT03441984|5389361|P3|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
2196645|NCT03441984|5389362|P2|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
2196646|NCT03441984|5389363|P1|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
2196647|NCT03441984|5389352|P12|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
2196648|NCT03441984|5389353|P11|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
2196649|NCT03441984|5389354|P10|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
2196650|NCT03441984|5389355|P9|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
2196651|NCT03441984|5389356|P8|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
2196652|NCT03441984|5389357|P7|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
2196653|NCT03441984|5389358|P6|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
2196654|NCT03441984|5389359|P5|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
2196655|NCT03441984|5389360|P4|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
2196656|NCT03441984|5389361|P3|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
2196657|NCT03441984|5389362|P2|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
2196658|NCT03441984|5389363|P1|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
2196659|NCT03441984|5389352|P12|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
2196660|NCT03441984|5389353|P11|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
2196661|NCT03441984|5389354|P10|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
2196662|NCT03441984|5389355|P9|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
2196663|NCT03441984|5389356|P8|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
2196664|NCT03441984|5389357|P7|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
2196665|NCT03441984|5389358|P6|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
2196666|NCT03441984|5389359|P5|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
2196667|NCT03441984|5389360|P4|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
2196668|NCT03441984|5389361|P3|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
2196669|NCT03441984|5389362|P2|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
2196670|NCT03441984|5389363|P1|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
2196671|NCT03441984|5389352|P12|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
2196672|NCT03441984|5389353|P11|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
2196673|NCT03441984|5389354|P10|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
2196674|NCT03441984|5389355|P9|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
2196675|NCT03441984|5389356|P8|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
2196676|NCT03441984|5389357|P7|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
2196677|NCT03441984|5389358|P6|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
2196678|NCT03441984|5389359|P5|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
2196679|NCT03441984|5389360|P4|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
2196680|NCT03441984|5389361|P3|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
2196681|NCT03441984|5389362|P2|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
2196682|NCT03441984|5389363|P1|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
2196683|NCT03441984|5389352|P12|STARTED|Part 2: Period 2 (Up to Day 4)||3
2196684|NCT03441984|5389353|P11|STARTED|Part 2: Period 2 (Up to Day 4)||3
2196685|NCT03441984|5389354|P10|STARTED|Part 2: Period 2 (Up to Day 4)||3
2196686|NCT03441984|5389355|P9|STARTED|Part 2: Period 2 (Up to Day 4)||3
2196687|NCT03441984|5389356|P8|STARTED|Part 2: Period 2 (Up to Day 4)||3
2196688|NCT03441984|5389357|P7|STARTED|Part 2: Period 2 (Up to Day 4)||3
2196689|NCT03441984|5389358|P6|STARTED|Part 2: Period 2 (Up to Day 4)||0
2196690|NCT03441984|5389359|P5|STARTED|Part 2: Period 2 (Up to Day 4)||0
2196691|NCT03441984|5389360|P4|STARTED|Part 2: Period 2 (Up to Day 4)||0
2196692|NCT03441984|5389361|P3|STARTED|Part 2: Period 2 (Up to Day 4)||0
2196693|NCT03441984|5389362|P2|STARTED|Part 2: Period 2 (Up to Day 4)||0
2196694|NCT03441984|5389363|P1|STARTED|Part 2: Period 2 (Up to Day 4)||0
2196695|NCT03441984|5389352|P12|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
2196696|NCT03441984|5389353|P11|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
2196697|NCT03441984|5389354|P10|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
2196698|NCT03441984|5389355|P9|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
2196699|NCT03441984|5389356|P8|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
2196700|NCT03441984|5389357|P7|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
2196701|NCT03441984|5389358|P6|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
2196702|NCT03441984|5389359|P5|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
2196703|NCT03441984|5389360|P4|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
2196704|NCT03441984|5389361|P3|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
2196705|NCT03441984|5389362|P2|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
2196706|NCT03441984|5389363|P1|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
2196707|NCT03441984|5389352|P12|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
2196708|NCT03441984|5389353|P11|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
2196709|NCT03441984|5389354|P10|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
2196710|NCT03441984|5389355|P9|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
2196711|NCT03441984|5389356|P8|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
2196712|NCT03441984|5389357|P7|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
2196713|NCT03441984|5389358|P6|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
2196714|NCT03441984|5389359|P5|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
2196715|NCT03441984|5389360|P4|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
2196716|NCT03441984|5389361|P3|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
2196717|NCT03441984|5389362|P2|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
2196718|NCT03441984|5389363|P1|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
2196719|NCT03441984|5389352|P12|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
2196720|NCT03441984|5389353|P11|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
2196721|NCT03441984|5389354|P10|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
2196722|NCT03441984|5389355|P9|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
2196723|NCT03441984|5389356|P8|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
2196724|NCT03441984|5389357|P7|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
2196725|NCT03441984|5389358|P6|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
2196726|NCT03441984|5389359|P5|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
2196727|NCT03441984|5389360|P4|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
2196728|NCT03441984|5389361|P3|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
2196729|NCT03441984|5389362|P2|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
2196730|NCT03441984|5389363|P1|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
2196731|NCT03441984|5389352|P12|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
2196732|NCT03441984|5389353|P11|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
2196733|NCT03441984|5389354|P10|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
2196734|NCT03441984|5389355|P9|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
2196735|NCT03441984|5389356|P8|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
2196736|NCT03441984|5389357|P7|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
2196737|NCT03441984|5389358|P6|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
2196738|NCT03441984|5389359|P5|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
2196739|NCT03441984|5389360|P4|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
2196740|NCT03441984|5389361|P3|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
2196741|NCT03441984|5389362|P2|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
2196742|NCT03441984|5389363|P1|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
2196743|NCT03441984|5389352|P12|COMPLETED|Part 2: Period 1(Up to Day 4)||3
2196744|NCT03441984|5389353|P11|COMPLETED|Part 2: Period 1(Up to Day 4)||3
2196745|NCT03441984|5389354|P10|COMPLETED|Part 2: Period 1(Up to Day 4)||3
2196746|NCT03441984|5389355|P9|COMPLETED|Part 2: Period 1(Up to Day 4)||3
2196747|NCT03441984|5389356|P8|COMPLETED|Part 2: Period 1(Up to Day 4)||3
2196748|NCT03441984|5389357|P7|COMPLETED|Part 2: Period 1(Up to Day 4)||3
2196749|NCT03441984|5389358|P6|COMPLETED|Part 2: Period 1(Up to Day 4)||0
2196750|NCT03441984|5389359|P5|COMPLETED|Part 2: Period 1(Up to Day 4)||0
2196751|NCT03441984|5389360|P4|COMPLETED|Part 2: Period 1(Up to Day 4)||0
2196752|NCT03441984|5389361|P3|COMPLETED|Part 2: Period 1(Up to Day 4)||0
2196753|NCT03441984|5389362|P2|COMPLETED|Part 2: Period 1(Up to Day 4)||0
2196754|NCT03441984|5389363|P1|COMPLETED|Part 2: Period 1(Up to Day 4)||0
2196755|NCT03441984|5389352|P12|STARTED|Part 2: Period 1(Up to Day 4)||3
2196756|NCT03441984|5389353|P11|STARTED|Part 2: Period 1(Up to Day 4)||3
2196757|NCT03441984|5389354|P10|STARTED|Part 2: Period 1(Up to Day 4)||3
2196758|NCT03441984|5389355|P9|STARTED|Part 2: Period 1(Up to Day 4)||3
2196759|NCT03441984|5389356|P8|STARTED|Part 2: Period 1(Up to Day 4)||3
2196760|NCT03441984|5389357|P7|STARTED|Part 2: Period 1(Up to Day 4)||3
2196761|NCT03441984|5389358|P6|STARTED|Part 2: Period 1(Up to Day 4)||0
2196762|NCT03441984|5389359|P5|STARTED|Part 2: Period 1(Up to Day 4)||0
2196763|NCT03441984|5389360|P4|STARTED|Part 2: Period 1(Up to Day 4)||0
2196764|NCT03441984|5389361|P3|STARTED|Part 2: Period 1(Up to Day 4)||0
2196765|NCT03441984|5389362|P2|STARTED|Part 2: Period 1(Up to Day 4)||0
2196766|NCT03441984|5389363|P1|STARTED|Part 2: Period 1(Up to Day 4)||0
2196767|NCT03441984|5389352|P12|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
2196768|NCT03441984|5389353|P11|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
2196769|NCT03441984|5389354|P10|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
2196770|NCT03441984|5389355|P9|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
2196771|NCT03441984|5389356|P8|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
2196772|NCT03441984|5389357|P7|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
2196773|NCT03441984|5389358|P6|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
2196774|NCT03441984|5389359|P5|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
2196775|NCT03441984|5389360|P4|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
2196776|NCT03441984|5389361|P3|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
2196777|NCT03441984|5389362|P2|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
2196778|NCT03441984|5389363|P1|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
2196779|NCT03441984|5389352|P12|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
2196780|NCT03441984|5389353|P11|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
2196781|NCT03441984|5389354|P10|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
2196782|NCT03441984|5389355|P9|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
2196783|NCT03441984|5389356|P8|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
2196784|NCT03441984|5389357|P7|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
2196785|NCT03441984|5389358|P6|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
2196786|NCT03441984|5389359|P5|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
2196787|NCT03441984|5389360|P4|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
2196788|NCT03441984|5389361|P3|COMPLETED|Part 1: Period 3 (Up to Day 4 )||2
2196789|NCT03441984|5389362|P2|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
2196790|NCT03441984|5389363|P1|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
2196791|NCT03441984|5389352|P12|STARTED|Part 1: Period 3 (Up to Day 4 )||0
2196792|NCT03441984|5389353|P11|STARTED|Part 1: Period 3 (Up to Day 4 )||0
2196793|NCT03441984|5389354|P10|STARTED|Part 1: Period 3 (Up to Day 4 )||0
2196794|NCT03441984|5389355|P9|STARTED|Part 1: Period 3 (Up to Day 4 )||0
2196795|NCT03441984|5389356|P8|STARTED|Part 1: Period 3 (Up to Day 4 )||0
2196796|NCT03441984|5389357|P7|STARTED|Part 1: Period 3 (Up to Day 4 )||0
2196797|NCT03441984|5389358|P6|STARTED|Part 1: Period 3 (Up to Day 4 )||3
2196798|NCT03441984|5389359|P5|STARTED|Part 1: Period 3 (Up to Day 4 )||3
2196799|NCT03441984|5389360|P4|STARTED|Part 1: Period 3 (Up to Day 4 )||3
2196800|NCT03441984|5389361|P3|STARTED|Part 1: Period 3 (Up to Day 4 )||2
2196801|NCT03441984|5389362|P2|STARTED|Part 1: Period 3 (Up to Day 4 )||3
2196802|NCT03441984|5389363|P1|STARTED|Part 1: Period 3 (Up to Day 4 )||3
2196803|NCT03441984|5389352|P12|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
2196804|NCT03441984|5389353|P11|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
2196805|NCT03441984|5389354|P10|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
2196806|NCT03441984|5389355|P9|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
2196807|NCT03441984|5389356|P8|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
2196808|NCT03441984|5389357|P7|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
2196809|NCT03441984|5389358|P6|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
2196810|NCT03441984|5389359|P5|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
2196811|NCT03441984|5389360|P4|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
2196812|NCT03441984|5389361|P3|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
2196813|NCT03441984|5389362|P2|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
2196814|NCT03441984|5389363|P1|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
2196815|NCT03441984|5389352|P12|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
2196816|NCT03441984|5389353|P11|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
2196817|NCT03441984|5389354|P10|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
2196818|NCT03441984|5389355|P9|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
2196819|NCT03441984|5389356|P8|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
2196820|NCT03441984|5389357|P7|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
2196821|NCT03441984|5389358|P6|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
2196822|NCT03441984|5389359|P5|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
2196823|NCT03441984|5389360|P4|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
2196824|NCT03441984|5389361|P3|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||2
2196825|NCT03441984|5389362|P2|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
2196826|NCT03441984|5389363|P1|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
2196827|NCT03441984|5389352|P12|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
2196828|NCT03441984|5389353|P11|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
2196829|NCT03441984|5389354|P10|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
2196830|NCT03441984|5389355|P9|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
2196831|NCT03441984|5389356|P8|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
2196832|NCT03441984|5389357|P7|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
2196833|NCT03441984|5389358|P6|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
2196834|NCT03441984|5389359|P5|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
2196835|NCT03441984|5389360|P4|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
2196836|NCT03441984|5389361|P3|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||2
2196837|NCT03441984|5389362|P2|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
2196838|NCT03441984|5389363|P1|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
2196839|NCT03441984|5389352|P12|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
2196840|NCT03441984|5389353|P11|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
2196841|NCT03441984|5389354|P10|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
2196842|NCT03441984|5389355|P9|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
2196843|NCT03441984|5389356|P8|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
2196844|NCT03441984|5389357|P7|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
2196845|NCT03441984|5389358|P6|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
2196846|NCT03441984|5389359|P5|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
2196847|NCT03441984|5389360|P4|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
2196848|NCT03441984|5389361|P3|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||1
2196849|NCT03441984|5389362|P2|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
2196850|NCT03441984|5389363|P1|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
2196851|NCT03441984|5389352|P12|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
2196852|NCT03441984|5389353|P11|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
2196853|NCT03441984|5389354|P10|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
2196854|NCT03441984|5389355|P9|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
2196855|NCT03441984|5389356|P8|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
2196856|NCT03441984|5389357|P7|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
2196857|NCT03441984|5389358|P6|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
2196858|NCT03441984|5389359|P5|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
2196859|NCT03441984|5389360|P4|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
2196860|NCT03441984|5389361|P3|COMPLETED|Part 1: Period 2 (Up to Day 4 )||2
2196861|NCT03441984|5389362|P2|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
2196862|NCT03441984|5389363|P1|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
2196863|NCT03441984|5389352|P12|STARTED|Part 1: Period 2 (Up to Day 4 )||0
2196864|NCT03441984|5389353|P11|STARTED|Part 1: Period 2 (Up to Day 4 )||0
2196865|NCT03441984|5389354|P10|STARTED|Part 1: Period 2 (Up to Day 4 )||0
2196866|NCT03441984|5389355|P9|STARTED|Part 1: Period 2 (Up to Day 4 )||0
2196867|NCT03441984|5389356|P8|STARTED|Part 1: Period 2 (Up to Day 4 )||0
2196868|NCT03441984|5389357|P7|STARTED|Part 1: Period 2 (Up to Day 4 )||0
2196869|NCT03441984|5389358|P6|STARTED|Part 1: Period 2 (Up to Day 4 )||3
2196870|NCT03441984|5389359|P5|STARTED|Part 1: Period 2 (Up to Day 4 )||3
2196871|NCT03441984|5389360|P4|STARTED|Part 1: Period 2 (Up to Day 4 )||3
2196872|NCT03441984|5389361|P3|STARTED|Part 1: Period 2 (Up to Day 4 )||3
2196873|NCT03441984|5389362|P2|STARTED|Part 1: Period 2 (Up to Day 4 )||3
2196874|NCT03441984|5389363|P1|STARTED|Part 1: Period 2 (Up to Day 4 )||3
2196875|NCT03441984|5389352|P12|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
2196876|NCT03441984|5389353|P11|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
2196877|NCT03441984|5389354|P10|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
2196878|NCT03441984|5389355|P9|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
2196879|NCT03441984|5389356|P8|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
2196880|NCT03441984|5389357|P7|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
2196881|NCT03441984|5389358|P6|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
2196882|NCT03441984|5389359|P5|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
2196883|NCT03441984|5389360|P4|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
2196884|NCT03441984|5389361|P3|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
2196885|NCT03441984|5389362|P2|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
2196886|NCT03441984|5389363|P1|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
2196887|NCT03441984|5389352|P12|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
2196888|NCT03441984|5389353|P11|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
2196889|NCT03441984|5389354|P10|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
2196890|NCT03441984|5389355|P9|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
2196891|NCT03441984|5389356|P8|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
2196892|NCT03441984|5389357|P7|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
2196893|NCT03441984|5389358|P6|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
2196894|NCT03441984|5389359|P5|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
2196895|NCT03441984|5389360|P4|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
2196896|NCT03441984|5389361|P3|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
2196897|NCT03441984|5389362|P2|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
2196898|NCT03441984|5389363|P1|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
2196899|NCT03441984|5389352|P12|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
2196900|NCT03441984|5389353|P11|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
2196901|NCT03441984|5389354|P10|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
2196902|NCT03441984|5389355|P9|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
2196903|NCT03441984|5389356|P8|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
2196904|NCT03441984|5389357|P7|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
2196905|NCT03441984|5389358|P6|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
2196906|NCT03441984|5389359|P5|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
2196907|NCT03441984|5389360|P4|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
2196908|NCT03441984|5389361|P3|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
2196909|NCT03441984|5389362|P2|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
2196910|NCT03441984|5389363|P1|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
2196911|NCT03441984|5389352|P12|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
2196912|NCT03441984|5389353|P11|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
2196913|NCT03441984|5389354|P10|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
2196914|NCT03441984|5389355|P9|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
2196915|NCT03441984|5389356|P8|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
2196916|NCT03441984|5389357|P7|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
2196917|NCT03441984|5389358|P6|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
2196918|NCT03441984|5389359|P5|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
2196919|NCT03441984|5389360|P4|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
2196920|NCT03441984|5389361|P3|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
2196921|NCT03441984|5389362|P2|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
2196922|NCT03441984|5389363|P1|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
2196923|NCT03441984|5389352|P12|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
2196924|NCT03441984|5389353|P11|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
2196925|NCT03441984|5389354|P10|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
2196926|NCT03441984|5389355|P9|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
2196927|NCT03441984|5389356|P8|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
2196928|NCT03441984|5389357|P7|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
2196929|NCT03441984|5389358|P6|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
2196930|NCT03441984|5389359|P5|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
2196931|NCT03441984|5389360|P4|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
2196932|NCT03441984|5389361|P3|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
2196933|NCT03441984|5389362|P2|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
2196934|NCT03441984|5389363|P1|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
2196935|NCT03441984|5389352|P12|STARTED|Part 1: Period 1 (Up to Day 4)||0
2196936|NCT03441984|5389353|P11|STARTED|Part 1: Period 1 (Up to Day 4)||0
2196937|NCT03441984|5389354|P10|STARTED|Part 1: Period 1 (Up to Day 4)||0
2196938|NCT03441984|5389355|P9|STARTED|Part 1: Period 1 (Up to Day 4)||0
2196939|NCT03441984|5389356|P8|STARTED|Part 1: Period 1 (Up to Day 4)||0
2196940|NCT03441984|5389357|P7|STARTED|Part 1: Period 1 (Up to Day 4)||0
2196941|NCT03441984|5389358|P6|STARTED|Part 1: Period 1 (Up to Day 4)||3
2196942|NCT03441984|5389359|P5|STARTED|Part 1: Period 1 (Up to Day 4)||3
2196943|NCT03441984|5389360|P4|STARTED|Part 1: Period 1 (Up to Day 4)||3
2196944|NCT03441984|5389361|P3|STARTED|Part 1: Period 1 (Up to Day 4)||3
2196945|NCT03441984|5389362|P2|STARTED|Part 1: Period 1 (Up to Day 4)||3
2196946|NCT03441984|5389363|P1|STARTED|Part 1: Period 1 (Up to Day 4)||3
2196947|NCT03441789|5389724|P2|NOT COMPLETED|Overall Study||4
2196948|NCT03441789|5389725|P1|NOT COMPLETED|Overall Study||1
2196949|NCT03441789|5389724|P2|COMPLETED|Overall Study||10
2196950|NCT03441789|5389725|P1|COMPLETED|Overall Study||13
2196951|NCT03441789|5389724|P2|STARTED|Overall Study||14
2196952|NCT03441789|5389725|P1|STARTED|Overall Study||14
2196953|NCT03441633|5389751|P10|NOT COMPLETED|Overall Study||0
2196954|NCT03441633|5389752|P9|NOT COMPLETED|Overall Study||0
2196955|NCT03441633|5389753|P8|NOT COMPLETED|Overall Study||0
2196956|NCT03441633|5389754|P7|NOT COMPLETED|Overall Study||0
2196957|NCT03441633|5389755|P6|NOT COMPLETED|Overall Study||0
2196958|NCT03441633|5389756|P5|NOT COMPLETED|Overall Study||0
2196959|NCT03441633|5389757|P4|NOT COMPLETED|Overall Study||0
2196960|NCT03441633|5389758|P3|NOT COMPLETED|Overall Study||0
2196961|NCT03441633|5389759|P2|NOT COMPLETED|Overall Study||0
2196962|NCT03441633|5389760|P1|NOT COMPLETED|Overall Study||0
2196963|NCT03441633|5389751|P10|COMPLETED|Overall Study||1562
2196964|NCT03441633|5389752|P9|COMPLETED|Overall Study||5132
2196965|NCT03441633|5389753|P8|COMPLETED|Overall Study||953
2196966|NCT03441633|5389754|P7|COMPLETED|Overall Study||2855
2196967|NCT03441633|5389755|P6|COMPLETED|Overall Study||363
2196968|NCT03441633|5389756|P5|COMPLETED|Overall Study||2286
2196969|NCT03441633|5389757|P4|COMPLETED|Overall Study||192
2196970|NCT03441633|5389758|P3|COMPLETED|Overall Study||32212
2196971|NCT03441633|5389759|P2|COMPLETED|Overall Study||1423
2196972|NCT03441633|5389760|P1|COMPLETED|Overall Study||4712
2196973|NCT03441633|5389751|P10|STARTED|Overall Study||1562
2196974|NCT03441633|5389752|P9|STARTED|Overall Study||5132
2196975|NCT03441633|5389753|P8|STARTED|Overall Study||953
2196976|NCT03441633|5389754|P7|STARTED|Overall Study||2855
2196977|NCT03441633|5389755|P6|STARTED|Overall Study||363
2196978|NCT03441633|5389756|P5|STARTED|Overall Study||2286
2196979|NCT03441633|5389757|P4|STARTED|Overall Study||192
2196980|NCT03441633|5389758|P3|STARTED|Overall Study||32212
2196981|NCT03441633|5389759|P2|STARTED|Overall Study||1423
2196982|NCT03441633|5389760|P1|STARTED|Overall Study||4712
2196983|NCT03441594|5389900|P1|NOT COMPLETED|Overall Study||0
2196984|NCT03441594|5389900|P1|COMPLETED|Overall Study||56
2196985|NCT03441594|5389900|P1|STARTED|Overall Study||56
2196986|NCT03440619|5389905|P1|NOT COMPLETED|Overall Study||0
2196987|NCT03440619|5389905|P1|COMPLETED|Overall Study||28
2196988|NCT03440619|5389905|P1|STARTED|Overall Study||28
2196989|NCT03440424|5389912|P3|NOT COMPLETED|Overall Study||0
2196990|NCT03440424|5389913|P2|NOT COMPLETED|Overall Study||0
2196991|NCT03440424|5389914|P1|NOT COMPLETED|Overall Study||0
2196992|NCT03440424|5389912|P3|COMPLETED|Overall Study||8
2196993|NCT03440424|5389913|P2|COMPLETED|Overall Study||8
2196994|NCT03440424|5389914|P1|COMPLETED|Overall Study||8
2196995|NCT03440424|5389912|P3|STARTED|Overall Study||8
2196996|NCT03440424|5389913|P2|STARTED|Overall Study||8
2196997|NCT03440424|5389914|P1|STARTED|Overall Study||8
2197004|NCT03438539|5390012|P6|NOT COMPLETED|Overall Study||8
2197005|NCT03438539|5390013|P5|NOT COMPLETED|Overall Study||3
2197006|NCT03438539|5390014|P4|NOT COMPLETED|Overall Study||9
2197007|NCT03438539|5390015|P3|NOT COMPLETED|Overall Study||10
2197008|NCT03438539|5390016|P2|NOT COMPLETED|Overall Study||4
2197009|NCT03438539|5390017|P1|NOT COMPLETED|Overall Study||8
2197010|NCT03438539|5390012|P6|COMPLETED|Overall Study||66
2197011|NCT03438539|5390013|P5|COMPLETED|Overall Study||70
2197012|NCT03438539|5390014|P4|COMPLETED|Overall Study||64
2197013|NCT03438539|5390015|P3|COMPLETED|Overall Study||66
2197014|NCT03438539|5390016|P2|COMPLETED|Overall Study||68
2197015|NCT03438539|5390017|P1|COMPLETED|Overall Study||68
2197016|NCT03438539|5390012|P6|STARTED|Overall Study||74
2197017|NCT03438539|5390013|P5|STARTED|Overall Study||73
2197018|NCT03438539|5390014|P4|STARTED|Overall Study||73
2197019|NCT03438539|5390015|P3|STARTED|Overall Study||76
2197020|NCT03438539|5390016|P2|STARTED|Overall Study||72
2197021|NCT03438539|5390017|P1|STARTED|Overall Study||76
2197022|NCT03438266|5390043|P1|NOT COMPLETED|Overall Study||0
2197023|NCT03438266|5390043|P1|COMPLETED|Overall Study||60
2197024|NCT03438266|5390043|P1|STARTED|Overall Study||60
2197025|NCT03437733|5390054|P2|NOT COMPLETED|Overall Study||3
2197026|NCT03437733|5390055|P1|NOT COMPLETED|Overall Study||0
2197027|NCT03437733|5390054|P2|COMPLETED|Overall Study||87
2197028|NCT03437733|5390055|P1|COMPLETED|Overall Study||8
2197029|NCT03437733|5390054|P2|Safety|Overall Study||87
2197030|NCT03437733|5390055|P1|Safety|Overall Study||8
2197031|NCT03437733|5390054|P2|STARTED|Overall Study||90
2197032|NCT03437733|5390055|P1|STARTED|Overall Study||8
2197033|NCT03437564|5390063|P2|NOT COMPLETED|Overall Study||0
2197034|NCT03437564|5390064|P1|NOT COMPLETED|Overall Study||0
2197035|NCT03437564|5390063|P2|COMPLETED|Overall Study||14
2197036|NCT03437564|5390064|P1|COMPLETED|Overall Study||14
2197037|NCT03437564|5390063|P2|STARTED|Overall Study||14
2197038|NCT03437564|5390064|P1|STARTED|Overall Study||14
2197039|NCT03437447|5390095|P3|NOT COMPLETED|Treatment Period 3||0
2197040|NCT03437447|5390096|P2|NOT COMPLETED|Treatment Period 3||0
2197041|NCT03437447|5390097|P1|NOT COMPLETED|Treatment Period 3||0
2197042|NCT03437447|5390095|P3|COMPLETED|Treatment Period 3||19
2197043|NCT03437447|5390096|P2|COMPLETED|Treatment Period 3||20
2197044|NCT03437447|5390097|P1|COMPLETED|Treatment Period 3||20
2197045|NCT03437447|5390095|P3|STARTED|Treatment Period 3||19
2197046|NCT03437447|5390096|P2|STARTED|Treatment Period 3||20
2197047|NCT03437447|5390097|P1|STARTED|Treatment Period 3||20
2197048|NCT03437447|5390095|P3|NOT COMPLETED|Treatment Period 2||0
2197049|NCT03437447|5390096|P2|NOT COMPLETED|Treatment Period 2||0
2197050|NCT03437447|5390097|P1|NOT COMPLETED|Treatment Period 2||0
2197051|NCT03437447|5390095|P3|COMPLETED|Treatment Period 2||19
2197052|NCT03437447|5390096|P2|COMPLETED|Treatment Period 2||20
2197053|NCT03437447|5390097|P1|COMPLETED|Treatment Period 2||20
2197054|NCT03437447|5390095|P3|STARTED|Treatment Period 2||19
2197055|NCT03437447|5390096|P2|STARTED|Treatment Period 2||20
2197056|NCT03437447|5390097|P1|STARTED|Treatment Period 2||20
2197057|NCT03437447|5390095|P3|NOT COMPLETED|Treatment Period 1||1
2197058|NCT03437447|5390096|P2|NOT COMPLETED|Treatment Period 1||0
2197059|NCT03437447|5390097|P1|NOT COMPLETED|Treatment Period 1||0
2197060|NCT03437447|5390095|P3|COMPLETED|Treatment Period 1||19
2197061|NCT03437447|5390096|P2|COMPLETED|Treatment Period 1||20
2197062|NCT03437447|5390097|P1|COMPLETED|Treatment Period 1||20
2197063|NCT03437447|5390095|P3|STARTED|Treatment Period 1||20
2197064|NCT03437447|5390096|P2|STARTED|Treatment Period 1||20
2197065|NCT03437447|5390097|P1|STARTED|Treatment Period 1||20
2197066|NCT03436732|5390152|P2|NOT COMPLETED|Overall Study||1
2197067|NCT03436732|5390153|P1|NOT COMPLETED|Overall Study||4
2197068|NCT03436732|5390152|P2|COMPLETED|Overall Study||0
2197069|NCT03436732|5390153|P1|COMPLETED|Overall Study||0
2197070|NCT03436732|5390152|P2|STARTED|Overall Study||1
2197071|NCT03436732|5390153|P1|STARTED|Overall Study||4
2197072|NCT03435783|5390168|P2|NOT COMPLETED|Overall Study||1
2197073|NCT03435783|5390169|P1|NOT COMPLETED|Overall Study||0
2197074|NCT03435783|5390168|P2|COMPLETED|Overall Study||19
2197075|NCT03435783|5390169|P1|COMPLETED|Overall Study||20
2197076|NCT03435783|5390168|P2|STARTED|Overall Study||20
2197077|NCT03435783|5390169|P1|STARTED|Overall Study||20
2197078|NCT03435185|5390185|P2|NOT COMPLETED|Overall Study||15
2197079|NCT03435185|5390186|P1|NOT COMPLETED|Overall Study||1
2197080|NCT03435185|5390185|P2|COMPLETED|Overall Study||28
2197081|NCT03435185|5390186|P1|COMPLETED|Overall Study||43
2197082|NCT03435185|5390185|P2|STARTED|Overall Study||43
2197083|NCT03435185|5390186|P1|STARTED|Overall Study||44
2197084|NCT03434977|5390196|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
2197085|NCT03434977|5390197|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
2197086|NCT03434977|5390196|P2|COMPLETED|Intervention Period 2 (6 Days)||5
2197087|NCT03434977|5390197|P1|COMPLETED|Intervention Period 2 (6 Days)||6
2197088|NCT03434977|5390196|P2|STARTED|Intervention Period 2 (6 Days)||5
2197089|NCT03434977|5390197|P1|STARTED|Intervention Period 2 (6 Days)||6
2197090|NCT03434977|5390196|P2|NOT COMPLETED|Washout Period (at Least 6 Days)||1
2197091|NCT03434977|5390197|P1|NOT COMPLETED|Washout Period (at Least 6 Days)||0
2197092|NCT03434977|5390196|P2|COMPLETED|Washout Period (at Least 6 Days)||5
2197093|NCT03434977|5390197|P1|COMPLETED|Washout Period (at Least 6 Days)||6
2197094|NCT03434977|5390196|P2|STARTED|Washout Period (at Least 6 Days)||6
2197095|NCT03434977|5390197|P1|STARTED|Washout Period (at Least 6 Days)||6
2197096|NCT03434977|5390196|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
2197097|NCT03434977|5390197|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
2197098|NCT03434977|5390196|P2|COMPLETED|Intervention Period 1 (6 Days)||6
2197099|NCT03434977|5390197|P1|COMPLETED|Intervention Period 1 (6 Days)||6
2197100|NCT03434977|5390196|P2|STARTED|Intervention Period 1 (6 Days)||6
2197101|NCT03434977|5390197|P1|STARTED|Intervention Period 1 (6 Days)||6
2197102|NCT03434249|5390233|P2|NOT COMPLETED|Overall Study||3
2197103|NCT03434249|5390234|P1|NOT COMPLETED|Overall Study||5
2197104|NCT03434249|5390233|P2|COMPLETED|Overall Study||37
2197105|NCT03434249|5390234|P1|COMPLETED|Overall Study||35
2197106|NCT03434249|5390233|P2|STARTED|Overall Study||40
2197107|NCT03434249|5390234|P1|STARTED|Overall Study||40
2197108|NCT03434119|5390268|P2|NOT COMPLETED|Overall Study||113
2197109|NCT03434119|5390269|P1|NOT COMPLETED|Overall Study||107
2197110|NCT03434119|5390268|P2|COMPLETED|Overall Study||12
2197111|NCT03434119|5390269|P1|COMPLETED|Overall Study||9
2197112|NCT03434119|5390268|P2|Treated|Overall Study||125
2197113|NCT03434119|5390269|P1|Treated|Overall Study||115
2197114|NCT03434119|5390268|P2|STARTED|Overall Study||125
2197115|NCT03434119|5390269|P1|STARTED|Overall Study||116
2197116|NCT03433703|5390287|P1|NOT COMPLETED|Overall Study||2
2197117|NCT03433703|5390287|P1|COMPLETED|Overall Study||0
2197118|NCT03433703|5390287|P1|STARTED|Overall Study||2
2197119|NCT03433677|5390296|P2|NOT COMPLETED|Period 2||1
2197120|NCT03433677|5390297|P1|NOT COMPLETED|Period 2||1
2197121|NCT03433677|5390296|P2|COMPLETED|Period 2||24
2197122|NCT03433677|5390297|P1|COMPLETED|Period 2||22
2197123|NCT03433677|5390296|P2|Received at Least 1 Dose of Study Drug|Period 2||25
2197124|NCT03433677|5390297|P1|Received at Least 1 Dose of Study Drug|Period 2||23
2197125|NCT03433677|5390296|P2|STARTED|Period 2||25
2197126|NCT03433677|5390297|P1|STARTED|Period 2||23
2197127|NCT03433677|5390296|P2|NOT COMPLETED|Period 1||0
2197128|NCT03433677|5390297|P1|NOT COMPLETED|Period 1||1
2197129|NCT03433677|5390296|P2|COMPLETED|Period 1||25
2197130|NCT03433677|5390297|P1|COMPLETED|Period 1||23
2197131|NCT03433677|5390296|P2|Received at Least 1 Dose of Study Drug|Period 1||25
2197132|NCT03433677|5390297|P1|Received at Least 1 Dose of Study Drug|Period 1||24
2197133|NCT03433677|5390296|P2|STARTED|Period 1||25
2197134|NCT03433677|5390297|P1|STARTED|Period 1||24
2197135|NCT03432390|5390317|P2|NOT COMPLETED|Recovery Period||0
2197136|NCT03432390|5390318|P1|NOT COMPLETED|Recovery Period||0
2197137|NCT03432390|5390317|P2|COMPLETED|Recovery Period||34
2197138|NCT03432390|5390318|P1|COMPLETED|Recovery Period||34
2197139|NCT03432390|5390317|P2|STARTED|Recovery Period||34
2197140|NCT03432390|5390318|P1|STARTED|Recovery Period||34
2197141|NCT03432390|5390317|P2|NOT COMPLETED|Apnea Period||2
2197142|NCT03432390|5390318|P1|NOT COMPLETED|Apnea Period||2
2197143|NCT03432390|5390317|P2|COMPLETED|Apnea Period||34
2197144|NCT03432390|5390318|P1|COMPLETED|Apnea Period||34
2197145|NCT03432390|5390317|P2|STARTED|Apnea Period||36
2197146|NCT03432390|5390318|P1|STARTED|Apnea Period||36
2197147|NCT03431441|5390328|P1|NOT COMPLETED|Overall Study||5
2197148|NCT03431441|5390328|P1|COMPLETED|Overall Study||19
2197149|NCT03431441|5390328|P1|STARTED|Overall Study||24
2197150|NCT03431012|5390336|P4|NOT COMPLETED|Overall Study||0
2197151|NCT03431012|5390337|P3|NOT COMPLETED|Overall Study||0
2197152|NCT03431012|5390338|P2|NOT COMPLETED|Overall Study||0
2197153|NCT03431012|5390339|P1|NOT COMPLETED|Overall Study||0
2197154|NCT03431012|5390336|P4|COMPLETED|Overall Study||53
2197155|NCT03431012|5390337|P3|COMPLETED|Overall Study||56
2197156|NCT03431012|5390338|P2|COMPLETED|Overall Study||60
2197157|NCT03431012|5390339|P1|COMPLETED|Overall Study||47
2197158|NCT03431012|5390336|P4|STARTED|Overall Study||53
2197159|NCT03431012|5390337|P3|STARTED|Overall Study||56
2197160|NCT03431012|5390338|P2|STARTED|Overall Study||60
2197161|NCT03431012|5390339|P1|STARTED|Overall Study||47
2197162|NCT03430245|5390361|P1|NOT COMPLETED|Overall Study||7
2197253|NCT03421730|5390614|P2|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
2197163|NCT03430245|5390361|P1|COMPLETED|Overall Study|6 subjects withdrew from study due to lengthy treatment. Treatment protocol amended.|9
2197164|NCT03430245|5390361|P1|STARTED|Overall Study||16
2197165|NCT03430050|5390370|P2|NOT COMPLETED|Overall Study||0
2197166|NCT03430050|5390371|P1|NOT COMPLETED|Overall Study||0
2197167|NCT03430050|5390370|P2|COMPLETED|Overall Study||5
2197168|NCT03430050|5390371|P1|COMPLETED|Overall Study||3
2197169|NCT03430050|5390370|P2|STARTED|Overall Study||5
2197170|NCT03430050|5390371|P1|STARTED|Overall Study||3
2197171|NCT03429712|5390379|P1|NOT COMPLETED|Overall Study||9
2197172|NCT03429712|5390379|P1|COMPLETED|Overall Study||10
2197173|NCT03429712|5390379|P1|STARTED|Overall Study||19
2197174|NCT03429556|5390387|P4|NOT COMPLETED|Overall Study||0
2197175|NCT03429556|5390388|P3|NOT COMPLETED|Overall Study||0
2197176|NCT03429556|5390389|P2|NOT COMPLETED|Overall Study||1
2197177|NCT03429556|5390390|P1|NOT COMPLETED|Overall Study||0
2197178|NCT03429556|5390387|P4|COMPLETED|Overall Study||3
2197179|NCT03429556|5390388|P3|COMPLETED|Overall Study||4
2197180|NCT03429556|5390389|P2|COMPLETED|Overall Study||3
2197181|NCT03429556|5390390|P1|COMPLETED|Overall Study||12
2197182|NCT03429556|5390387|P4|STARTED|Overall Study||3
2197183|NCT03429556|5390388|P3|STARTED|Overall Study||4
2197184|NCT03429556|5390389|P2|STARTED|Overall Study||4
2197185|NCT03429556|5390390|P1|STARTED|Overall Study||12
2197186|NCT03428997|5390436|P1|NOT COMPLETED|Overall Study||8
2197187|NCT03428997|5390436|P1|COMPLETED|Overall Study||16
2197188|NCT03428997|5390436|P1|STARTED|Overall Study||24
2197189|NCT03428152|5390444|P2|NOT COMPLETED|Overall Study||11
2197190|NCT03428152|5390445|P1|NOT COMPLETED|Overall Study||7
2197191|NCT03428152|5390444|P2|COMPLETED|Overall Study|exclusions: epidural / TAP / wound infiltration malignity retroperitone was opened age >65|30
2197192|NCT03428152|5390445|P1|COMPLETED|Overall Study||30
2197193|NCT03428152|5390444|P2|STARTED|Overall Study||41
2197194|NCT03428152|5390445|P1|STARTED|Overall Study||37
2197195|NCT03427892|5390461|P1|NOT COMPLETED|Overall Study||2
2197196|NCT03427892|5390461|P1|COMPLETED|Overall Study|Of the 21 recruited, 19 completed at least one post baseline visit, included in the analysis.|19
2197197|NCT03427892|5390461|P1|STARTED|Overall Study||21
2197198|NCT03427073|5390485|P8|NOT COMPLETED|Overall Study||4
2197199|NCT03427073|5390486|P7|NOT COMPLETED|Overall Study||3
2197200|NCT03427073|5390487|P6|NOT COMPLETED|Overall Study||4
2197201|NCT03427073|5390488|P5|NOT COMPLETED|Overall Study||3
2197202|NCT03427073|5390489|P4|NOT COMPLETED|Overall Study||3
2197203|NCT03427073|5390490|P3|NOT COMPLETED|Overall Study||1
2197204|NCT03427073|5390491|P2|NOT COMPLETED|Overall Study||1
2197205|NCT03427073|5390492|P1|NOT COMPLETED|Overall Study||1
2197206|NCT03427073|5390485|P8|COMPLETED|Overall Study||0
2197207|NCT03427073|5390486|P7|COMPLETED|Overall Study||0
2197208|NCT03427073|5390487|P6|COMPLETED|Overall Study||0
2197209|NCT03427073|5390488|P5|COMPLETED|Overall Study||0
2197210|NCT03427073|5390489|P4|COMPLETED|Overall Study||0
2197211|NCT03427073|5390490|P3|COMPLETED|Overall Study||0
2197212|NCT03427073|5390491|P2|COMPLETED|Overall Study||0
2197213|NCT03427073|5390492|P1|COMPLETED|Overall Study||0
2197214|NCT03427073|5390485|P8|STARTED|Overall Study||4
2197215|NCT03427073|5390486|P7|STARTED|Overall Study||3
2197216|NCT03427073|5390487|P6|STARTED|Overall Study||4
2197217|NCT03427073|5390488|P5|STARTED|Overall Study||3
2197218|NCT03427073|5390489|P4|STARTED|Overall Study||3
2197219|NCT03427073|5390490|P3|STARTED|Overall Study||1
2197220|NCT03427073|5390491|P2|STARTED|Overall Study||1
2197221|NCT03427073|5390492|P1|STARTED|Overall Study||1
2197222|NCT03426787|5390542|P1|NOT COMPLETED|Overall Study||14
2197223|NCT03426787|5390542|P1|COMPLETED|Overall Study||56
2197224|NCT03426787|5390542|P1|STARTED|Overall Study||70
2197231|NCT03426566|5390559|P1|NOT COMPLETED|Overall Study||0
2197232|NCT03426566|5390559|P1|COMPLETED|Overall Study||974
2197233|NCT03426566|5390559|P1|STARTED|Overall Study||974
2197234|NCT03426436|5390565|P1|NOT COMPLETED|Overall Study||19
2197235|NCT03426436|5390565|P1|COMPLETED|Overall Study||295
2197236|NCT03426436|5390565|P1|STARTED|Overall Study||314
2197237|NCT03423641|5390572|P2|NOT COMPLETED|Overall Study||8074
2197238|NCT03423641|5390573|P1|NOT COMPLETED|Overall Study||331
2197239|NCT03423641|5390572|P2|COMPLETED|Overall Study||10210
2197240|NCT03423641|5390573|P1|COMPLETED|Overall Study||15193
2197241|NCT03423641|5390572|P2|STARTED|Overall Study||18284
2197242|NCT03423641|5390573|P1|STARTED|Overall Study||15524
2197243|NCT03421730|5390604|P12|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
2197244|NCT03421730|5390605|P11|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
2197245|NCT03421730|5390606|P10|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
2197246|NCT03421730|5390607|P9|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
2197247|NCT03421730|5390608|P8|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
2197248|NCT03421730|5390609|P7|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
2197249|NCT03421730|5390610|P6|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
2197250|NCT03421730|5390611|P5|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
2197251|NCT03421730|5390612|P4|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
2197252|NCT03421730|5390613|P3|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
2197254|NCT03421730|5390615|P1|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
2197255|NCT03421730|5390604|P12|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
2197256|NCT03421730|5390605|P11|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
2197257|NCT03421730|5390606|P10|COMPLETED|Second Intervention (Day 8±3, Visit 3)||2
2197258|NCT03421730|5390607|P9|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
2197259|NCT03421730|5390608|P8|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
2197260|NCT03421730|5390609|P7|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
2197261|NCT03421730|5390610|P6|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
2197262|NCT03421730|5390611|P5|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
2197263|NCT03421730|5390612|P4|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
2197264|NCT03421730|5390613|P3|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
2197265|NCT03421730|5390614|P2|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
2197266|NCT03421730|5390615|P1|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
2197267|NCT03421730|5390604|P12|STARTED|Second Intervention (Day 8±3, Visit 3)||1
2197268|NCT03421730|5390605|P11|STARTED|Second Intervention (Day 8±3, Visit 3)||1
2197269|NCT03421730|5390606|P10|STARTED|Second Intervention (Day 8±3, Visit 3)||2
2197270|NCT03421730|5390607|P9|STARTED|Second Intervention (Day 8±3, Visit 3)||1
2197271|NCT03421730|5390608|P8|STARTED|Second Intervention (Day 8±3, Visit 3)||1
2197272|NCT03421730|5390609|P7|STARTED|Second Intervention (Day 8±3, Visit 3)||1
2197273|NCT03421730|5390610|P6|STARTED|Second Intervention (Day 8±3, Visit 3)||1
2197274|NCT03421730|5390611|P5|STARTED|Second Intervention (Day 8±3, Visit 3)||1
2197275|NCT03421730|5390612|P4|STARTED|Second Intervention (Day 8±3, Visit 3)||1
2197276|NCT03421730|5390613|P3|STARTED|Second Intervention (Day 8±3, Visit 3)||1
2197277|NCT03421730|5390614|P2|STARTED|Second Intervention (Day 8±3, Visit 3)||1
2197278|NCT03421730|5390615|P1|STARTED|Second Intervention (Day 8±3, Visit 3)||1
2197279|NCT03421730|5390604|P12|NOT COMPLETED|Washout (Days 4 to 10)||0
2197280|NCT03421730|5390605|P11|NOT COMPLETED|Washout (Days 4 to 10)||0
2197281|NCT03421730|5390606|P10|NOT COMPLETED|Washout (Days 4 to 10)||0
2197282|NCT03421730|5390607|P9|NOT COMPLETED|Washout (Days 4 to 10)||0
2197283|NCT03421730|5390608|P8|NOT COMPLETED|Washout (Days 4 to 10)||0
2197284|NCT03421730|5390609|P7|NOT COMPLETED|Washout (Days 4 to 10)||0
2197285|NCT03421730|5390610|P6|NOT COMPLETED|Washout (Days 4 to 10)||0
2197286|NCT03421730|5390611|P5|NOT COMPLETED|Washout (Days 4 to 10)||2
2197287|NCT03421730|5390612|P4|NOT COMPLETED|Washout (Days 4 to 10)||0
2197288|NCT03421730|5390613|P3|NOT COMPLETED|Washout (Days 4 to 10)||0
2197289|NCT03421730|5390614|P2|NOT COMPLETED|Washout (Days 4 to 10)||0
2197290|NCT03421730|5390615|P1|NOT COMPLETED|Washout (Days 4 to 10)||0
2197291|NCT03421730|5390604|P12|COMPLETED|Washout (Days 4 to 10)||1
2197292|NCT03421730|5390605|P11|COMPLETED|Washout (Days 4 to 10)||1
2197293|NCT03421730|5390606|P10|COMPLETED|Washout (Days 4 to 10)||2
2197294|NCT03421730|5390607|P9|COMPLETED|Washout (Days 4 to 10)||1
2197295|NCT03421730|5390608|P8|COMPLETED|Washout (Days 4 to 10)||1
2197296|NCT03421730|5390609|P7|COMPLETED|Washout (Days 4 to 10)||1
2197297|NCT03421730|5390610|P6|COMPLETED|Washout (Days 4 to 10)||1
2197298|NCT03421730|5390611|P5|COMPLETED|Washout (Days 4 to 10)|Two subjects withdrew after receiving treatment with B but before receiving treatment with C.|1
2197299|NCT03421730|5390612|P4|COMPLETED|Washout (Days 4 to 10)||1
2197300|NCT03421730|5390613|P3|COMPLETED|Washout (Days 4 to 10)||1
2197301|NCT03421730|5390614|P2|COMPLETED|Washout (Days 4 to 10)||1
2197302|NCT03421730|5390615|P1|COMPLETED|Washout (Days 4 to 10)||1
2197303|NCT03421730|5390604|P12|STARTED|Washout (Days 4 to 10)||1
2197304|NCT03421730|5390605|P11|STARTED|Washout (Days 4 to 10)||1
2197305|NCT03421730|5390606|P10|STARTED|Washout (Days 4 to 10)||2
2197306|NCT03421730|5390607|P9|STARTED|Washout (Days 4 to 10)||1
2197307|NCT03421730|5390608|P8|STARTED|Washout (Days 4 to 10)||1
2197308|NCT03421730|5390609|P7|STARTED|Washout (Days 4 to 10)||1
2197309|NCT03421730|5390610|P6|STARTED|Washout (Days 4 to 10)||1
2197310|NCT03421730|5390611|P5|STARTED|Washout (Days 4 to 10)||3
2197311|NCT03421730|5390612|P4|STARTED|Washout (Days 4 to 10)||1
2197312|NCT03421730|5390613|P3|STARTED|Washout (Days 4 to 10)||1
2197313|NCT03421730|5390614|P2|STARTED|Washout (Days 4 to 10)||1
2197314|NCT03421730|5390615|P1|STARTED|Washout (Days 4 to 10)||1
2197315|NCT03421730|5390604|P12|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
2197316|NCT03421730|5390605|P11|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
2197317|NCT03421730|5390606|P10|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
2197318|NCT03421730|5390607|P9|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
2197319|NCT03421730|5390608|P8|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
2197320|NCT03421730|5390609|P7|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
2197321|NCT03421730|5390610|P6|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
2197322|NCT03421730|5390611|P5|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
2197323|NCT03421730|5390612|P4|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
2197324|NCT03421730|5390613|P3|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
2197325|NCT03421730|5390614|P2|NOT COMPLETED|First Intervention (Day 1, Visit 2)||2
2197326|NCT03421730|5390615|P1|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
2197327|NCT03421730|5390604|P12|COMPLETED|First Intervention (Day 1, Visit 2)||1
2197328|NCT03421730|5390605|P11|COMPLETED|First Intervention (Day 1, Visit 2)||1
2197329|NCT03421730|5390606|P10|COMPLETED|First Intervention (Day 1, Visit 2)||2
2197330|NCT03421730|5390607|P9|COMPLETED|First Intervention (Day 1, Visit 2)||1
2197331|NCT03421730|5390608|P8|COMPLETED|First Intervention (Day 1, Visit 2)||1
2197332|NCT03421730|5390609|P7|COMPLETED|First Intervention (Day 1, Visit 2)||1
2197333|NCT03421730|5390610|P6|COMPLETED|First Intervention (Day 1, Visit 2)||1
2197334|NCT03421730|5390611|P5|COMPLETED|First Intervention (Day 1, Visit 2)||3
2197335|NCT03421730|5390612|P4|COMPLETED|First Intervention (Day 1, Visit 2)||1
2197336|NCT03421730|5390613|P3|COMPLETED|First Intervention (Day 1, Visit 2)||1
2197337|NCT03421730|5390614|P2|COMPLETED|First Intervention (Day 1, Visit 2)|Two subjects withdrew without receiving treatment with either A or C.|1
2197338|NCT03421730|5390615|P1|COMPLETED|First Intervention (Day 1, Visit 2)||1
2197339|NCT03421730|5390604|P12|STARTED|First Intervention (Day 1, Visit 2)||1
2197340|NCT03421730|5390605|P11|STARTED|First Intervention (Day 1, Visit 2)||1
2197341|NCT03421730|5390606|P10|STARTED|First Intervention (Day 1, Visit 2)||2
2197342|NCT03421730|5390607|P9|STARTED|First Intervention (Day 1, Visit 2)||1
2197343|NCT03421730|5390608|P8|STARTED|First Intervention (Day 1, Visit 2)||1
2197344|NCT03421730|5390609|P7|STARTED|First Intervention (Day 1, Visit 2)||1
2197345|NCT03421730|5390610|P6|STARTED|First Intervention (Day 1, Visit 2)||1
2197346|NCT03421730|5390611|P5|STARTED|First Intervention (Day 1, Visit 2)||3
2197347|NCT03421730|5390612|P4|STARTED|First Intervention (Day 1, Visit 2)||1
2197348|NCT03421730|5390613|P3|STARTED|First Intervention (Day 1, Visit 2)||1
2197349|NCT03421730|5390614|P2|STARTED|First Intervention (Day 1, Visit 2)||3
2197350|NCT03421730|5390615|P1|STARTED|First Intervention (Day 1, Visit 2)||1
2197351|NCT03421379|5390688|P2|NOT COMPLETED|Period 2||0
2197352|NCT03421379|5390689|P1|NOT COMPLETED|Period 2||0
2197353|NCT03421379|5390688|P2|COMPLETED|Period 2||37
2197354|NCT03421379|5390689|P1|COMPLETED|Period 2||32
2197355|NCT03421379|5390688|P2|STARTED|Period 2||37
2197356|NCT03421379|5390689|P1|STARTED|Period 2||32
2197357|NCT03421379|5390688|P2|NOT COMPLETED|Washout Period (3 to 14 Days)||0
2197358|NCT03421379|5390689|P1|NOT COMPLETED|Washout Period (3 to 14 Days)||0
2197359|NCT03421379|5390688|P2|COMPLETED|Washout Period (3 to 14 Days)||37
2197360|NCT03421379|5390689|P1|COMPLETED|Washout Period (3 to 14 Days)||32
2197361|NCT03421379|5390688|P2|STARTED|Washout Period (3 to 14 Days)||37
2197362|NCT03421379|5390689|P1|STARTED|Washout Period (3 to 14 Days)||32
2197363|NCT03421379|5390688|P2|NOT COMPLETED|Period 1||4
2197364|NCT03421379|5390689|P1|NOT COMPLETED|Period 1||2
2197365|NCT03421379|5390688|P2|COMPLETED|Period 1||37
2197366|NCT03421379|5390689|P1|COMPLETED|Period 1||32
2197367|NCT03421379|5390688|P2|Received at Least One Dose of Study Drug|Period 1||39
2197368|NCT03421379|5390689|P1|Received at Least One Dose of Study Drug|Period 1||33
2197369|NCT03421379|5390688|P2|STARTED|Period 1||41
2197370|NCT03421379|5390689|P1|STARTED|Period 1||34
2197371|NCT03420625|5390705|P1|NOT COMPLETED|Overall Study||0
2197372|NCT03420625|5390705|P1|COMPLETED|Overall Study||10
2197373|NCT03420625|5390705|P1|Calf NMES|Overall Study||10
2197374|NCT03420625|5390705|P1|Slow Calf IPC|Overall Study||10
2197375|NCT03420625|5390705|P1|Rapid Calf IPC|Overall Study||10
2197376|NCT03420625|5390705|P1|Foot IPC|Overall Study||10
2197377|NCT03420625|5390705|P1|Baseline|Overall Study||10
2197378|NCT03420625|5390705|P1|STARTED|Overall Study||10
2197379|NCT03419078|5390738|P3|NOT COMPLETED|Overall Study||0
2197380|NCT03419078|5390739|P2|NOT COMPLETED|Overall Study||0
2197381|NCT03419078|5390740|P1|NOT COMPLETED|Overall Study||0
2197382|NCT03419078|5390738|P3|COMPLETED|Overall Study||91
2197383|NCT03419078|5390739|P2|COMPLETED|Overall Study||148
2197384|NCT03419078|5390740|P1|COMPLETED|Overall Study||245
2197385|NCT03419078|5390738|P3|STARTED|Overall Study||91
2197386|NCT03419078|5390739|P2|STARTED|Overall Study||148
2197387|NCT03419078|5390740|P1|STARTED|Overall Study||245
2197388|NCT03418662|5390759|P2|NOT COMPLETED|Overall Study||4
2197389|NCT03418662|5390760|P1|NOT COMPLETED|Overall Study||3
2197390|NCT03418662|5390759|P2|COMPLETED|Overall Study||278
2197391|NCT03418662|5390760|P1|COMPLETED|Overall Study||284
2197392|NCT03418662|5390759|P2|STARTED|Overall Study||282
2197393|NCT03418662|5390760|P1|STARTED|Overall Study||287
2197394|NCT03418571|5390784|P2|NOT COMPLETED|Overall Study||0
2197395|NCT03418571|5390785|P1|NOT COMPLETED|Overall Study||1
2197396|NCT03418571|5390784|P2|COMPLETED|Overall Study||3
2197397|NCT03418571|5390785|P1|COMPLETED|Overall Study||11
2197398|NCT03418571|5390784|P2|STARTED|Overall Study||3
2197399|NCT03418571|5390785|P1|STARTED|Overall Study||12
2197400|NCT03418064|5390793|P2|NOT COMPLETED|Second Intervention (1 Month)||0
2197401|NCT03418064|5390794|P1|NOT COMPLETED|Second Intervention (1 Month)||0
2197402|NCT03418064|5390793|P2|COMPLETED|Second Intervention (1 Month)||21
2197403|NCT03418064|5390794|P1|COMPLETED|Second Intervention (1 Month)||21
2197404|NCT03418064|5390793|P2|STARTED|Second Intervention (1 Month)||21
2197405|NCT03418064|5390794|P1|STARTED|Second Intervention (1 Month)||21
2197406|NCT03418064|5390793|P2|NOT COMPLETED|First Intervention (1 Month)||0
2197407|NCT03418064|5390794|P1|NOT COMPLETED|First Intervention (1 Month)||0
2197408|NCT03418064|5390793|P2|COMPLETED|First Intervention (1 Month)||21
2197409|NCT03418064|5390794|P1|COMPLETED|First Intervention (1 Month)||21
2197410|NCT03418064|5390793|P2|STARTED|First Intervention (1 Month)||21
2197411|NCT03418064|5390794|P1|STARTED|First Intervention (1 Month)||21
2197412|NCT03417830|5390825|P2|NOT COMPLETED|Part B (up to 26 Days)||0
2197413|NCT03417830|5390826|P1|NOT COMPLETED|Part B (up to 26 Days)||0
2197414|NCT03417830|5390825|P2|COMPLETED|Part B (up to 26 Days)||0
2197415|NCT03417830|5390826|P1|COMPLETED|Part B (up to 26 Days)||0
2197416|NCT03417830|5390825|P2|STARTED|Part B (up to 26 Days)||0
2197417|NCT03417830|5390826|P1|STARTED|Part B (up to 26 Days)||0
2197418|NCT03417830|5390825|P2|NOT COMPLETED|Part A (up to 26 Days)||0
2197419|NCT03417830|5390826|P1|NOT COMPLETED|Part A (up to 26 Days)||1
2197420|NCT03417830|5390825|P2|COMPLETED|Part A (up to 26 Days)||0
2197421|NCT03417830|5390826|P1|COMPLETED|Part A (up to 26 Days)||1
2197422|NCT03417830|5390825|P2|STARTED|Part A (up to 26 Days)||0
2197423|NCT03417830|5390826|P1|STARTED|Part A (up to 26 Days)||2
2197424|NCT03417713|5390920|P1|NOT COMPLETED|Overall Study||3
2197425|NCT03417713|5390920|P1|COMPLETED|Overall Study||30
2197426|NCT03417713|5390920|P1|STARTED|Overall Study||33
2197427|NCT03417505|5390925|P2|NOT COMPLETED|Second Lens Type (30 Days)||0
2197428|NCT03417505|5390926|P1|NOT COMPLETED|Second Lens Type (30 Days)||0
2197429|NCT03417505|5390925|P2|COMPLETED|Second Lens Type (30 Days)||11
2197430|NCT03417505|5390926|P1|COMPLETED|Second Lens Type (30 Days)||8
2197431|NCT03417505|5390925|P2|STARTED|Second Lens Type (30 Days)||11
2197432|NCT03417505|5390926|P1|STARTED|Second Lens Type (30 Days)||8
2197433|NCT03417505|5390925|P2|NOT COMPLETED|Washout Period (7 Days)||0
2197434|NCT03417505|5390926|P1|NOT COMPLETED|Washout Period (7 Days)||0
2197435|NCT03417505|5390925|P2|COMPLETED|Washout Period (7 Days)||11
2197436|NCT03417505|5390926|P1|COMPLETED|Washout Period (7 Days)||8
2197437|NCT03417505|5390925|P2|STARTED|Washout Period (7 Days)||11
2197438|NCT03417505|5390926|P1|STARTED|Washout Period (7 Days)||8
2197439|NCT03417505|5390925|P2|NOT COMPLETED|First Lens Type (30 Days)||1
2197440|NCT03417505|5390926|P1|NOT COMPLETED|First Lens Type (30 Days)||1
2197441|NCT03417505|5390925|P2|COMPLETED|First Lens Type (30 Days)||11
2197442|NCT03417505|5390926|P1|COMPLETED|First Lens Type (30 Days)||8
2197443|NCT03417505|5390925|P2|STARTED|First Lens Type (30 Days)||12
2197444|NCT03417505|5390926|P1|STARTED|First Lens Type (30 Days)||9
2197445|NCT03417466|5390948|P1|NOT COMPLETED|Overall Study||0
2197446|NCT03417466|5390948|P1|COMPLETED|Overall Study||66
2197447|NCT03417466|5390948|P1|STARTED|Overall Study||66
2197448|NCT03417219|5390957|P2|NOT COMPLETED|Overall Study||3
2197449|NCT03417219|5390958|P1|NOT COMPLETED|Overall Study||0
2197450|NCT03417219|5390957|P2|COMPLETED|Overall Study||5
2197451|NCT03417219|5390958|P1|COMPLETED|Overall Study||8
2197452|NCT03417219|5390957|P2|STARTED|Overall Study||8
2197453|NCT03417219|5390958|P1|STARTED|Overall Study||8
2197454|NCT03417024|5390968|P1|NOT COMPLETED|Overall Study||13
2197455|NCT03417024|5390968|P1|COMPLETED|Overall Study||0
2197456|NCT03417024|5390968|P1|STARTED|Overall Study||13
2197457|NCT03416985|5390977|P3|NOT COMPLETED|Overall Study||6
2197458|NCT03416985|5390978|P2|NOT COMPLETED|Overall Study||0
2197459|NCT03416985|5390979|P1|NOT COMPLETED|Overall Study||2
2197460|NCT03416985|5390977|P3|COMPLETED|Overall Study||24
2197461|NCT03416985|5390978|P2|COMPLETED|Overall Study||30
2197462|NCT03416985|5390979|P1|COMPLETED|Overall Study||28
2197463|NCT03416985|5390977|P3|STARTED|Overall Study||30
2197464|NCT03416985|5390978|P2|STARTED|Overall Study||30
2197465|NCT03416985|5390979|P1|STARTED|Overall Study||30
2197466|NCT03415243|5390992|P2|NOT COMPLETED|Overall Study||0
2197467|NCT03415243|5390993|P1|NOT COMPLETED|Overall Study||0
2197468|NCT03415243|5390992|P2|COMPLETED|Overall Study||14
2197469|NCT03415243|5390993|P1|COMPLETED|Overall Study||14
2197470|NCT03415243|5390992|P2|STARTED|Overall Study||14
2197471|NCT03415243|5390993|P1|STARTED|Overall Study||14
2197472|NCT03415178|5391057|P2|NOT COMPLETED|Single Arm Period (up to Week 16)||1
2197473|NCT03415178|5391058|P1|NOT COMPLETED|Single Arm Period (up to Week 16)||0
2197474|NCT03415178|5391057|P2|COMPLETED|Single Arm Period (up to Week 16)||65
2197475|NCT03415178|5391058|P1|COMPLETED|Single Arm Period (up to Week 16)||0
2197476|NCT03415178|5391057|P2|STARTED|Single Arm Period (up to Week 16)|65 (participants completed period 1) + 1 (randomized to SYDNEY arm but not treated in period 1).|66
2197477|NCT03415178|5391058|P1|STARTED|Single Arm Period (up to Week 16)|Out of 34 participants from AI group, 33 participants entered entered in single arm period.|0
2197478|NCT03415178|5391057|P2|NOT COMPLETED|Parallel-Arm Period (up to Week 4)||2
2197479|NCT03415178|5391058|P1|NOT COMPLETED|Parallel-Arm Period (up to Week 4)||0
2197480|NCT03415178|5391057|P2|COMPLETED|Parallel-Arm Period (up to Week 4)|32 participants entered in single arm period & 1 participant decided not to enter single arm period.|33
2197481|NCT03415178|5391058|P1|COMPLETED|Parallel-Arm Period (up to Week 4)|33 participants entered in single arm period & 1 participant decided not to enter single arm period.|34
2197482|NCT03415178|5391057|P2|Treated|Parallel-Arm Period (up to Week 4)||33
2197483|NCT03415178|5391058|P1|Treated|Parallel-Arm Period (up to Week 4)||34
2197484|NCT03415178|5391057|P2|STARTED|Parallel-Arm Period (up to Week 4)|Randomized|35
2197485|NCT03415178|5391058|P1|STARTED|Parallel-Arm Period (up to Week 4)|Randomized|34
2197486|NCT03413618|5391095|P2|NOT COMPLETED|Overall Study||0
2197487|NCT03413618|5391096|P1|NOT COMPLETED|Overall Study||0
2197488|NCT03413618|5391095|P2|COMPLETED|Overall Study||45
2197489|NCT03413618|5391096|P1|COMPLETED|Overall Study||45
2197490|NCT03413618|5391095|P2|STARTED|Overall Study||45
2197491|NCT03413618|5391096|P1|STARTED|Overall Study||45
2197492|NCT03410628|5391122|P1|NOT COMPLETED|Overall Study||6
2197493|NCT03410628|5391122|P1|COMPLETED|Overall Study||15
2197494|NCT03410628|5391122|P1|STARTED|Overall Study||21
2197495|NCT03409731|5391127|P1|NOT COMPLETED|Overall Study||0
2197496|NCT03409731|5391127|P1|COMPLETED|Overall Study||135
2197497|NCT03409731|5391127|P1|STARTED|Overall Study||135
2197498|NCT03408639|5391161|P2|NOT COMPLETED|Overall Study||22
2197499|NCT03408639|5391162|P1|NOT COMPLETED|Overall Study||11
2197500|NCT03408639|5391161|P2|COMPLETED|Overall Study||56
2197501|NCT03408639|5391162|P1|COMPLETED|Overall Study||67
2197502|NCT03408639|5391161|P2|STARTED|Overall Study||78
2197503|NCT03408639|5391162|P1|STARTED|Overall Study||78
2197522|NCT03407612|5391245|P2|NOT COMPLETED|Overall Study||0
2197523|NCT03407612|5391246|P1|NOT COMPLETED|Overall Study||0
2197524|NCT03407612|5391245|P2|COMPLETED|Overall Study||23
2197525|NCT03407612|5391246|P1|COMPLETED|Overall Study||19
2197526|NCT03407612|5391245|P2|STARTED|Overall Study||23
2197527|NCT03407612|5391246|P1|STARTED|Overall Study||19
2197528|NCT03407430|5391258|P2|NOT COMPLETED|Second Intervention||0
2197529|NCT03407430|5391259|P1|NOT COMPLETED|Second Intervention||0
2197530|NCT03407430|5391258|P2|COMPLETED|Second Intervention||3
2197531|NCT03407430|5391259|P1|COMPLETED|Second Intervention||4
2197532|NCT03407430|5391258|P2|STARTED|Second Intervention||3
2197533|NCT03407430|5391259|P1|STARTED|Second Intervention||4
2197534|NCT03407430|5391258|P2|NOT COMPLETED|Washout||0
2197535|NCT03407430|5391259|P1|NOT COMPLETED|Washout||1
2197536|NCT03407430|5391258|P2|COMPLETED|Washout||3
2197537|NCT03407430|5391259|P1|COMPLETED|Washout||4
2197538|NCT03407430|5391258|P2|STARTED|Washout||3
2197539|NCT03407430|5391259|P1|STARTED|Washout||5
2197540|NCT03407430|5391258|P2|NOT COMPLETED|First Intervention||0
2197541|NCT03407430|5391259|P1|NOT COMPLETED|First Intervention||0
2197542|NCT03407430|5391258|P2|COMPLETED|First Intervention||3
2197543|NCT03407430|5391259|P1|COMPLETED|First Intervention||5
2197544|NCT03407430|5391258|P2|STARTED|First Intervention||3
2197545|NCT03407430|5391259|P1|STARTED|First Intervention||5
2197546|NCT03406260|5391297|P6|NOT COMPLETED|Period 3||0
2197547|NCT03406260|5391298|P5|NOT COMPLETED|Period 3||0
2197548|NCT03406260|5391299|P4|NOT COMPLETED|Period 3||0
2197549|NCT03406260|5391300|P3|NOT COMPLETED|Period 3||0
2197550|NCT03406260|5391301|P2|NOT COMPLETED|Period 3||0
2197551|NCT03406260|5391302|P1|NOT COMPLETED|Period 3||0
2197552|NCT03406260|5391297|P6|COMPLETED|Period 3||6
2197553|NCT03406260|5391298|P5|COMPLETED|Period 3||5
2197554|NCT03406260|5391299|P4|COMPLETED|Period 3||6
2197555|NCT03406260|5391300|P3|COMPLETED|Period 3||6
2197556|NCT03406260|5391301|P2|COMPLETED|Period 3||6
2197557|NCT03406260|5391302|P1|COMPLETED|Period 3||6
2197558|NCT03406260|5391297|P6|STARTED|Period 3||6
2197559|NCT03406260|5391298|P5|STARTED|Period 3||5
2197560|NCT03406260|5391299|P4|STARTED|Period 3||6
2197561|NCT03406260|5391300|P3|STARTED|Period 3||6
2197562|NCT03406260|5391301|P2|STARTED|Period 3||6
2197563|NCT03406260|5391302|P1|STARTED|Period 3||6
2197564|NCT03406260|5391297|P6|NOT COMPLETED|Period 2||0
2197565|NCT03406260|5391298|P5|NOT COMPLETED|Period 2||0
2197566|NCT03406260|5391299|P4|NOT COMPLETED|Period 2||0
2197567|NCT03406260|5391300|P3|NOT COMPLETED|Period 2||0
2197568|NCT03406260|5391301|P2|NOT COMPLETED|Period 2||0
2197569|NCT03406260|5391302|P1|NOT COMPLETED|Period 2||0
2197570|NCT03406260|5391297|P6|COMPLETED|Period 2||6
2197571|NCT03406260|5391298|P5|COMPLETED|Period 2||5
2197572|NCT03406260|5391299|P4|COMPLETED|Period 2||6
2197573|NCT03406260|5391300|P3|COMPLETED|Period 2||6
2197574|NCT03406260|5391301|P2|COMPLETED|Period 2||6
2197575|NCT03406260|5391302|P1|COMPLETED|Period 2||6
2197576|NCT03406260|5391297|P6|STARTED|Period 2||6
2197577|NCT03406260|5391298|P5|STARTED|Period 2||5
2197578|NCT03406260|5391299|P4|STARTED|Period 2||6
2197579|NCT03406260|5391300|P3|STARTED|Period 2||6
2197580|NCT03406260|5391301|P2|STARTED|Period 2||6
2197581|NCT03406260|5391302|P1|STARTED|Period 2||6
2197582|NCT03406260|5391297|P6|NOT COMPLETED|Period 1||0
2197583|NCT03406260|5391298|P5|NOT COMPLETED|Period 1||1
2197584|NCT03406260|5391299|P4|NOT COMPLETED|Period 1||0
2197585|NCT03406260|5391300|P3|NOT COMPLETED|Period 1||0
2197586|NCT03406260|5391301|P2|NOT COMPLETED|Period 1||0
2197587|NCT03406260|5391302|P1|NOT COMPLETED|Period 1||0
2197588|NCT03406260|5391297|P6|COMPLETED|Period 1||6
2197589|NCT03406260|5391298|P5|COMPLETED|Period 1||5
2197590|NCT03406260|5391299|P4|COMPLETED|Period 1||6
2197591|NCT03406260|5391300|P3|COMPLETED|Period 1||6
2197592|NCT03406260|5391301|P2|COMPLETED|Period 1||6
2197593|NCT03406260|5391302|P1|COMPLETED|Period 1||6
2197594|NCT03406260|5391297|P6|Received at Least 1 Dose of Study Drug|Period 1||6
2197595|NCT03406260|5391298|P5|Received at Least 1 Dose of Study Drug|Period 1||6
2197596|NCT03406260|5391299|P4|Received at Least 1 Dose of Study Drug|Period 1||6
2197597|NCT03406260|5391300|P3|Received at Least 1 Dose of Study Drug|Period 1||6
2197598|NCT03406260|5391301|P2|Received at Least 1 Dose of Study Drug|Period 1||6
2197599|NCT03406260|5391302|P1|Received at Least 1 Dose of Study Drug|Period 1||6
2197600|NCT03406260|5391297|P6|STARTED|Period 1||6
2197601|NCT03406260|5391298|P5|STARTED|Period 1||6
2197602|NCT03406260|5391299|P4|STARTED|Period 1||6
2197603|NCT03406260|5391300|P3|STARTED|Period 1||6
2197604|NCT03406260|5391301|P2|STARTED|Period 1||6
2197605|NCT03406260|5391302|P1|STARTED|Period 1||6
2197606|NCT03405935|5391314|P1|NOT COMPLETED|Overall Study||86
2197607|NCT03405935|5391314|P1|COMPLETED|Overall Study||0
2197608|NCT03405935|5391314|P1|STARTED|Overall Study||86
2197609|NCT03405818|5391325|P1|NOT COMPLETED|Overall Study||8
2197610|NCT03405818|5391325|P1|COMPLETED|Overall Study||47
2197611|NCT03405818|5391325|P1|STARTED|Overall Study||55
2197612|NCT03405259|5391368|P2|NOT COMPLETED|Overall Study||0
2197613|NCT03405259|5391369|P1|NOT COMPLETED|Overall Study||0
2197614|NCT03405259|5391368|P2|COMPLETED|Overall Study||11
2197615|NCT03405259|5391369|P1|COMPLETED|Overall Study||11
2197616|NCT03405259|5391368|P2|STARTED|Overall Study||11
2197617|NCT03405259|5391369|P1|STARTED|Overall Study||11
2197618|NCT03404206|5391380|P3|NOT COMPLETED|Overall Study||0
2197619|NCT03404206|5391381|P2|NOT COMPLETED|Overall Study||2
2197620|NCT03404206|5391382|P1|NOT COMPLETED|Overall Study||4
2197621|NCT03404206|5391380|P3|COMPLETED|Overall Study||55
2197622|NCT03404206|5391381|P2|COMPLETED|Overall Study||164
2197623|NCT03404206|5391382|P1|COMPLETED|Overall Study||162
2197624|NCT03404206|5391380|P3|STARTED|Overall Study||55
2197625|NCT03404206|5391381|P2|STARTED|Overall Study||166
2197626|NCT03404206|5391382|P1|STARTED|Overall Study||166
2197627|NCT03404167|5391396|P1|NOT COMPLETED|Overall Study||0
2197628|NCT03404167|5391396|P1|COMPLETED|Overall Study||8
2197629|NCT03404167|5391396|P1|STARTED|Overall Study||8
2197630|NCT03403504|5391433|P2|NOT COMPLETED|Period 2||0
2197631|NCT03403504|5391434|P1|NOT COMPLETED|Period 2||0
2197632|NCT03403504|5391433|P2|COMPLETED|Period 2||11
2197633|NCT03403504|5391434|P1|COMPLETED|Period 2||12
2197634|NCT03403504|5391433|P2|STARTED|Period 2||11
2197635|NCT03403504|5391434|P1|STARTED|Period 2||12
2197636|NCT03403504|5391433|P2|NOT COMPLETED|Period 1||1
2197637|NCT03403504|5391434|P1|NOT COMPLETED|Period 1||0
2197638|NCT03403504|5391433|P2|COMPLETED|Period 1||11
2197639|NCT03403504|5391434|P1|COMPLETED|Period 1||12
2197640|NCT03403504|5391433|P2|STARTED|Period 1||12
2197641|NCT03403504|5391434|P1|STARTED|Period 1||12
2197642|NCT03403036|5391454|P1|NOT COMPLETED|Overall Study||5
2197643|NCT03403036|5391454|P1|COMPLETED|Overall Study||34
2197644|NCT03403036|5391454|P1|STARTED|Overall Study||39
2197645|NCT03402932|5391464|P4|NOT COMPLETED|Overall Study||0
2197646|NCT03402932|5391465|P3|NOT COMPLETED|Overall Study||0
2197647|NCT03402932|5391466|P2|NOT COMPLETED|Overall Study||0
2197648|NCT03402932|5391467|P1|NOT COMPLETED|Overall Study||0
2197649|NCT03402932|5391464|P4|COMPLETED|Overall Study||8
2197650|NCT03402932|5391465|P3|COMPLETED|Overall Study||8
2197651|NCT03402932|5391466|P2|COMPLETED|Overall Study||8
2197652|NCT03402932|5391467|P1|COMPLETED|Overall Study||13
2197653|NCT03402932|5391464|P4|STARTED|Overall Study||8
2197654|NCT03402932|5391465|P3|STARTED|Overall Study||8
2197655|NCT03402932|5391466|P2|STARTED|Overall Study||8
2197656|NCT03402932|5391467|P1|STARTED|Overall Study||13
2197657|NCT03402893|5391481|P1|NOT COMPLETED|Overall Study||1
2197658|NCT03402893|5391481|P1|COMPLETED|Overall Study||20
2197659|NCT03402893|5391481|P1|STARTED|Overall Study||21
2197660|NCT03402750|5391492|P2|NOT COMPLETED|Overall Study||1
2197661|NCT03402750|5391493|P1|NOT COMPLETED|Overall Study||2
2197662|NCT03402750|5391492|P2|COMPLETED|Overall Study||19
2197663|NCT03402750|5391493|P1|COMPLETED|Overall Study||18
2197664|NCT03402750|5391492|P2|STARTED|Overall Study||20
2197665|NCT03402750|5391493|P1|STARTED|Overall Study||20
2197666|NCT03401671|5391509|P2|NOT COMPLETED|Overall Study||0
2197667|NCT03401671|5391510|P1|NOT COMPLETED|Overall Study||0
2197668|NCT03401671|5391509|P2|COMPLETED|Overall Study||16
2197669|NCT03401671|5391510|P1|COMPLETED|Overall Study||16
2197670|NCT03401671|5391509|P2|STARTED|Overall Study||16
2197671|NCT03401671|5391510|P1|STARTED|Overall Study||16
2197672|NCT03400787|5391552|P2|NOT COMPLETED|Overall Study||8
2197673|NCT03400787|5391553|P1|NOT COMPLETED|Overall Study||2
2197674|NCT03400787|5391552|P2|COMPLETED|Overall Study||63
2197675|NCT03400787|5391553|P1|COMPLETED|Overall Study||64
2197676|NCT03400787|5391552|P2|3-Month Follow-up|Overall Study||63
2197677|NCT03400787|5391553|P1|3-Month Follow-up|Overall Study||64
2197678|NCT03400787|5391552|P2|STARTED|Overall Study||71
2197679|NCT03400787|5391553|P1|STARTED|Overall Study||66
2197680|NCT03400475|5391561|P2|NOT COMPLETED|Overall Study||0
2197681|NCT03400475|5391562|P1|NOT COMPLETED|Overall Study||0
2197682|NCT03400475|5391561|P2|COMPLETED|Overall Study||22
2197683|NCT03400475|5391562|P1|COMPLETED|Overall Study||24
2197684|NCT03400475|5391561|P2|STARTED|Overall Study||22
2197685|NCT03400475|5391562|P1|STARTED|Overall Study||24
2197686|NCT03400449|5391604|P2|NOT COMPLETED|Overall Study||0
2197687|NCT03400449|5391605|P1|NOT COMPLETED|Overall Study||1
2197688|NCT03400449|5391604|P2|COMPLETED|Overall Study||119
2197689|NCT03400449|5391605|P1|COMPLETED|Overall Study||120
2197690|NCT03400449|5391604|P2|STARTED|Overall Study||119
2197691|NCT03400449|5391605|P1|STARTED|Overall Study||121
2197704|NCT03398421|5391650|P2|NOT COMPLETED|Treatment Period 2 (Up to 11 Days)||0
2197705|NCT03398421|5391651|P1|NOT COMPLETED|Treatment Period 2 (Up to 11 Days)||0
2197706|NCT03398421|5391650|P2|COMPLETED|Treatment Period 2 (Up to 11 Days)||20
2197707|NCT03398421|5391651|P1|COMPLETED|Treatment Period 2 (Up to 11 Days)||0
2197708|NCT03398421|5391650|P2|STARTED|Treatment Period 2 (Up to 11 Days)||20
2197709|NCT03398421|5391651|P1|STARTED|Treatment Period 2 (Up to 11 Days)||0
2197710|NCT03398421|5391650|P2|NOT COMPLETED|Washout Period (Up to 14 Days)||0
2197711|NCT03398421|5391651|P1|NOT COMPLETED|Washout Period (Up to 14 Days)||0
2197712|NCT03398421|5391650|P2|COMPLETED|Washout Period (Up to 14 Days)||0
2197713|NCT03398421|5391651|P1|COMPLETED|Washout Period (Up to 14 Days)||20
2197714|NCT03398421|5391650|P2|STARTED|Washout Period (Up to 14 Days)||0
2197715|NCT03398421|5391651|P1|STARTED|Washout Period (Up to 14 Days)||20
2197716|NCT03398421|5391650|P2|NOT COMPLETED|Treatment Period 1 (Up to 6 Days)||0
2197717|NCT03398421|5391651|P1|NOT COMPLETED|Treatment Period 1 (Up to 6 Days)||0
2197718|NCT03398421|5391650|P2|COMPLETED|Treatment Period 1 (Up to 6 Days)||0
2197719|NCT03398421|5391651|P1|COMPLETED|Treatment Period 1 (Up to 6 Days)||20
2197720|NCT03398421|5391650|P2|STARTED|Treatment Period 1 (Up to 6 Days)||0
2197721|NCT03398421|5391651|P1|STARTED|Treatment Period 1 (Up to 6 Days)||20
2197722|NCT03398330|5391714|P2|NOT COMPLETED|Period 2||0
2197723|NCT03398330|5391715|P1|NOT COMPLETED|Period 2||1
2197724|NCT03398330|5391714|P2|COMPLETED|Period 2||17
2197725|NCT03398330|5391715|P1|COMPLETED|Period 2||19
2197726|NCT03398330|5391714|P2|STARTED|Period 2||17
2197727|NCT03398330|5391715|P1|STARTED|Period 2||20
2197728|NCT03398330|5391714|P2|NOT COMPLETED|Period 1||4
2197729|NCT03398330|5391715|P1|NOT COMPLETED|Period 1||1
2197730|NCT03398330|5391714|P2|COMPLETED|Period 1||17
2197731|NCT03398330|5391715|P1|COMPLETED|Period 1||20
2197732|NCT03398330|5391714|P2|STARTED|Period 1||21
2197733|NCT03398330|5391715|P1|STARTED|Period 1||21
2197734|NCT03398278|5391737|P2|NOT COMPLETED|Period 2||2
2197735|NCT03398278|5391738|P1|NOT COMPLETED|Period 2||2
2197736|NCT03398278|5391737|P2|COMPLETED|Period 2||17
2197737|NCT03398278|5391738|P1|COMPLETED|Period 2||16
2197738|NCT03398278|5391737|P2|STARTED|Period 2||19
2197739|NCT03398278|5391738|P1|STARTED|Period 2||18
2197740|NCT03398278|5391737|P2|NOT COMPLETED|Period 1||0
2197741|NCT03398278|5391738|P1|NOT COMPLETED|Period 1||1
2197742|NCT03398278|5391737|P2|COMPLETED|Period 1||19
2197743|NCT03398278|5391738|P1|COMPLETED|Period 1||18
2197744|NCT03398278|5391737|P2|STARTED|Period 1||19
2197745|NCT03398278|5391738|P1|STARTED|Period 1||19
2197746|NCT03396835|5391758|P1|NOT COMPLETED|Overall Study||2
2197747|NCT03396835|5391758|P1|COMPLETED|Overall Study||14
2197748|NCT03396835|5391758|P1|STARTED|Overall Study||16
2197749|NCT03395886|5391764|P2|NOT COMPLETED|Overall Study||38
2197750|NCT03395886|5391765|P1|NOT COMPLETED|Overall Study||52
2197751|NCT03395886|5391764|P2|COMPLETED|Overall Study||0
2197752|NCT03395886|5391765|P1|COMPLETED|Overall Study||0
2197753|NCT03395886|5391764|P2|STARTED|Overall Study||38
2197754|NCT03395886|5391765|P1|STARTED|Overall Study||52
2197755|NCT03394391|5391775|P2|NOT COMPLETED|Overall Study||2
2197756|NCT03394391|5391776|P1|NOT COMPLETED|Overall Study||1
2197757|NCT03394391|5391775|P2|COMPLETED|Overall Study||104
2197758|NCT03394391|5391776|P1|COMPLETED|Overall Study||105
2197759|NCT03394391|5391775|P2|STARTED|Overall Study||106
2197760|NCT03394391|5391776|P1|STARTED|Overall Study||106
2197761|NCT03393208|5391796|P4|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
2197762|NCT03393208|5391797|P3|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
2197763|NCT03393208|5391798|P2|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
2197764|NCT03393208|5391799|P1|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
2197765|NCT03393208|5391796|P4|COMPLETED|Treatment Period 2 (Day 8- Day 10)||9
2197766|NCT03393208|5391797|P3|COMPLETED|Treatment Period 2 (Day 8- Day 10)||9
2197767|NCT03393208|5391798|P2|COMPLETED|Treatment Period 2 (Day 8- Day 10)||13
2197768|NCT03393208|5391799|P1|COMPLETED|Treatment Period 2 (Day 8- Day 10)||13
2197769|NCT03393208|5391796|P4|STARTED|Treatment Period 2 (Day 8- Day 10)||9
2197770|NCT03393208|5391797|P3|STARTED|Treatment Period 2 (Day 8- Day 10)||9
2197771|NCT03393208|5391798|P2|STARTED|Treatment Period 2 (Day 8- Day 10)||13
2197772|NCT03393208|5391799|P1|STARTED|Treatment Period 2 (Day 8- Day 10)||13
2197773|NCT03393208|5391796|P4|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
2197774|NCT03393208|5391797|P3|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
2197775|NCT03393208|5391798|P2|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
2197776|NCT03393208|5391799|P1|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
2197777|NCT03393208|5391796|P4|COMPLETED|Treatment Period 1 (Day 1-Day 3)||9
2197778|NCT03393208|5391797|P3|COMPLETED|Treatment Period 1 (Day 1-Day 3)||9
2197779|NCT03393208|5391798|P2|COMPLETED|Treatment Period 1 (Day 1-Day 3)||13
2197780|NCT03393208|5391799|P1|COMPLETED|Treatment Period 1 (Day 1-Day 3)||13
2197781|NCT03393208|5391796|P4|STARTED|Treatment Period 1 (Day 1-Day 3)||9
2197782|NCT03393208|5391797|P3|STARTED|Treatment Period 1 (Day 1-Day 3)||9
2197783|NCT03393208|5391798|P2|STARTED|Treatment Period 1 (Day 1-Day 3)||13
2197784|NCT03393208|5391799|P1|STARTED|Treatment Period 1 (Day 1-Day 3)||13
2197785|NCT03392532|5391853|P2|NOT COMPLETED|Period 2, Second 30 Minutes of Wear||0
2197786|NCT03392532|5391854|P1|NOT COMPLETED|Period 2, Second 30 Minutes of Wear||0
2197787|NCT03392532|5391853|P2|COMPLETED|Period 2, Second 30 Minutes of Wear||18
2197788|NCT03392532|5391854|P1|COMPLETED|Period 2, Second 30 Minutes of Wear||18
2197789|NCT03392532|5391853|P2|STARTED|Period 2, Second 30 Minutes of Wear||18
2197790|NCT03392532|5391854|P1|STARTED|Period 2, Second 30 Minutes of Wear||18
2197791|NCT03392532|5391853|P2|NOT COMPLETED|Period 1, FIrst 30 Minutes of Wear||0
2197792|NCT03392532|5391854|P1|NOT COMPLETED|Period 1, FIrst 30 Minutes of Wear||0
2197793|NCT03392532|5391853|P2|COMPLETED|Period 1, FIrst 30 Minutes of Wear||18
2197794|NCT03392532|5391854|P1|COMPLETED|Period 1, FIrst 30 Minutes of Wear||18
2197795|NCT03392532|5391853|P2|STARTED|Period 1, FIrst 30 Minutes of Wear||18
2197796|NCT03392532|5391854|P1|STARTED|Period 1, FIrst 30 Minutes of Wear||18
2197797|NCT03392194|5391862|P2|NOT COMPLETED|Overall Study||2
2197798|NCT03392194|5391863|P1|NOT COMPLETED|Overall Study||2
2197799|NCT03392194|5391862|P2|COMPLETED|Overall Study||15
2197800|NCT03392194|5391863|P1|COMPLETED|Overall Study||14
2197801|NCT03392194|5391862|P2|STARTED|Overall Study||17
2197802|NCT03392194|5391863|P1|STARTED|Overall Study||16
2197803|NCT03391986|5391872|P3|NOT COMPLETED|Overall Study||0
2197804|NCT03391986|5391873|P2|NOT COMPLETED|Overall Study||0
2197805|NCT03391986|5391874|P1|NOT COMPLETED|Overall Study||0
2197806|NCT03391986|5391872|P3|COMPLETED|Overall Study||50
2197807|NCT03391986|5391873|P2|COMPLETED|Overall Study||50
2197808|NCT03391986|5391874|P1|COMPLETED|Overall Study||53
2197809|NCT03391986|5391872|P3|STARTED|Overall Study||50
2197810|NCT03391986|5391873|P2|STARTED|Overall Study||50
2197811|NCT03391986|5391874|P1|STARTED|Overall Study||53
2197812|NCT03391115|5391887|P2|NOT COMPLETED|Overall Study||0
2197813|NCT03391115|5391888|P1|NOT COMPLETED|Overall Study||0
2197814|NCT03391115|5391887|P2|COMPLETED|Overall Study|Two Nurse participants in the dyadic patient-nurse enrollment were not successfully recruited.|18
2197815|NCT03391115|5391888|P1|COMPLETED|Overall Study||20
2197816|NCT03391115|5391887|P2|STARTED|Overall Study||18
2197817|NCT03391115|5391888|P1|STARTED|Overall Study||20
2197818|NCT03390426|5391898|P2|NOT COMPLETED|Overall Study||1
2197819|NCT03390426|5391899|P1|NOT COMPLETED|Overall Study||0
2197820|NCT03390426|5391898|P2|COMPLETED|Overall Study||15
2197821|NCT03390426|5391899|P1|COMPLETED|Overall Study||15
2197822|NCT03390426|5391898|P2|STARTED|Overall Study||16
2197823|NCT03390426|5391899|P1|STARTED|Overall Study||15
2197829|NCT03387059|5391920|P2|NOT COMPLETED|Overall Study||4
2197830|NCT03387059|5391921|P1|NOT COMPLETED|Overall Study||5
2197831|NCT03387059|5391920|P2|COMPLETED|Overall Study||0
2197832|NCT03387059|5391921|P1|COMPLETED|Overall Study||0
2197833|NCT03387059|5391920|P2|STARTED|Overall Study||4
2197834|NCT03387059|5391921|P1|STARTED|Overall Study||5
2197835|NCT03387046|5391935|P2|NOT COMPLETED|Overall Study||1
2197836|NCT03387046|5391936|P1|NOT COMPLETED|Overall Study||1
2197837|NCT03387046|5391935|P2|COMPLETED|Overall Study||1
2197838|NCT03387046|5391936|P1|COMPLETED|Overall Study||4
2197839|NCT03387046|5391935|P2|STARTED|Overall Study||2
2197840|NCT03387046|5391936|P1|STARTED|Overall Study||5
2197841|NCT03386448|5391962|P2|NOT COMPLETED|Overall Study||2
2197842|NCT03386448|5391963|P1|NOT COMPLETED|Overall Study||0
2197843|NCT03386448|5391962|P2|COMPLETED|Overall Study||6
2197844|NCT03386448|5391963|P1|COMPLETED|Overall Study||6
2197845|NCT03386448|5391962|P2|STARTED|Overall Study||8
2197846|NCT03386448|5391963|P1|STARTED|Overall Study||6
2197847|NCT03386435|5391971|P2|NOT COMPLETED|Overall Study||7
2197848|NCT03386435|5391972|P1|NOT COMPLETED|Overall Study||5
2197849|NCT03386435|5391971|P2|COMPLETED|Overall Study||73
2197850|NCT03386435|5391972|P1|COMPLETED|Overall Study||75
2197851|NCT03386435|5391971|P2|STARTED|Overall Study||80
2197852|NCT03386435|5391972|P1|STARTED|Overall Study||80
2197853|NCT03384316|5391986|P2|NOT COMPLETED|Overall Study||1
2197854|NCT03384316|5391987|P1|NOT COMPLETED|Overall Study||0
2197855|NCT03384316|5391986|P2|COMPLETED|Overall Study||4
2197856|NCT03384316|5391987|P1|COMPLETED|Overall Study||6
2197857|NCT03384316|5391986|P2|STARTED|Overall Study||5
2197858|NCT03384316|5391987|P1|STARTED|Overall Study||6
2197865|NCT03383783|5392019|P1|NOT COMPLETED|Overall Study||2
2197866|NCT03383783|5392019|P1|COMPLETED|Overall Study||25
2197867|NCT03383783|5392019|P1|STARTED|Overall Study||27
2197868|NCT03383588|5392086|P3|NOT COMPLETED|Overall Study||0
2197869|NCT03383588|5392087|P2|NOT COMPLETED|Overall Study||0
2197870|NCT03383588|5392088|P1|NOT COMPLETED|Overall Study||0
2197871|NCT03383588|5392086|P3|COMPLETED|Overall Study||9
2197872|NCT03383588|5392087|P2|COMPLETED|Overall Study||9
2197873|NCT03383588|5392088|P1|COMPLETED|Overall Study||8
2197874|NCT03383588|5392086|P3|STARTED|Overall Study||9
2197875|NCT03383588|5392087|P2|STARTED|Overall Study||9
2197876|NCT03383588|5392088|P1|STARTED|Overall Study||8
2197877|NCT03382834|5392098|P2|NOT COMPLETED|Overall Study||1
2197878|NCT03382834|5392099|P1|NOT COMPLETED|Overall Study||1
2197879|NCT03382834|5392098|P2|COMPLETED|Overall Study||9
2197880|NCT03382834|5392099|P1|COMPLETED|Overall Study||20
2197881|NCT03382834|5392098|P2|STARTED|Overall Study||10
2197882|NCT03382834|5392099|P1|STARTED|Overall Study||21
2197883|NCT03382262|5392115|P4|NOT COMPLETED|Overall Study||1
2197884|NCT03382262|5392116|P3|NOT COMPLETED|Overall Study||1
2197885|NCT03382262|5392117|P2|NOT COMPLETED|Overall Study||0
2197886|NCT03382262|5392118|P1|NOT COMPLETED|Overall Study||0
2197887|NCT03382262|5392115|P4|COMPLETED|Overall Study||14
2197888|NCT03382262|5392116|P3|COMPLETED|Overall Study||14
2197889|NCT03382262|5392117|P2|COMPLETED|Overall Study||13
2197890|NCT03382262|5392118|P1|COMPLETED|Overall Study||12
2197891|NCT03382262|5392115|P4|STARTED|Overall Study||15
2197892|NCT03382262|5392116|P3|STARTED|Overall Study||15
2197893|NCT03382262|5392117|P2|STARTED|Overall Study||13
2197894|NCT03382262|5392118|P1|STARTED|Overall Study||12
2197895|NCT03381742|5392136|P4|NOT COMPLETED|Overall Study||0
2197896|NCT03381742|5392137|P3|NOT COMPLETED|Overall Study||0
2197897|NCT03381742|5392138|P2|NOT COMPLETED|Overall Study||0
2197898|NCT03381742|5392139|P1|NOT COMPLETED|Overall Study||0
2197899|NCT03381742|5392136|P4|COMPLETED|Overall Study||506
2197900|NCT03381742|5392137|P3|COMPLETED|Overall Study||1511
2197901|NCT03381742|5392138|P2|COMPLETED|Overall Study||501
2197902|NCT03381742|5392139|P1|COMPLETED|Overall Study||525
2197903|NCT03381742|5392136|P4|STARTED|Overall Study||506
2197904|NCT03381742|5392137|P3|STARTED|Overall Study||1511
2197905|NCT03381742|5392138|P2|STARTED|Overall Study||501
2197906|NCT03381742|5392139|P1|STARTED|Overall Study||525
2197907|NCT03380845|5392169|P1|NOT COMPLETED|Overall Study||0
2197908|NCT03380845|5392169|P1|COMPLETED|Overall Study||4
2197909|NCT03380845|5392169|P1|STARTED|Overall Study|Participants got bilateral face treatments with Fraxel on one side of face; Fractora on the other.|4
2197910|NCT03380780|5392179|P1|NOT COMPLETED|Overall Study||0
2197911|NCT03380780|5392179|P1|COMPLETED|Overall Study||16
2197912|NCT03380780|5392179|P1|STARTED|Overall Study||16
2197913|NCT03380572|5392248|P2|NOT COMPLETED|Overall Study||0
2197914|NCT03380572|5392249|P1|NOT COMPLETED|Overall Study||0
2197915|NCT03380572|5392248|P2|COMPLETED|Overall Study||20
2197916|NCT03380572|5392249|P1|COMPLETED|Overall Study||20
2197917|NCT03380572|5392248|P2|STARTED|Overall Study||20
2197918|NCT03380572|5392249|P1|STARTED|Overall Study||20
2197919|NCT03380429|5392262|P5|NOT COMPLETED|Overall Study||5
2197920|NCT03380429|5392263|P4|NOT COMPLETED|Overall Study||10
2197921|NCT03380429|5392264|P3|NOT COMPLETED|Overall Study||11
2197922|NCT03380429|5392265|P2|NOT COMPLETED|Overall Study||7
2197923|NCT03380429|5392266|P1|NOT COMPLETED|Overall Study||5
2197924|NCT03380429|5392262|P5|COMPLETED|Overall Study||81
2197925|NCT03380429|5392263|P4|COMPLETED|Overall Study||78
2197926|NCT03380429|5392264|P3|COMPLETED|Overall Study||77
2197927|NCT03380429|5392265|P2|COMPLETED|Overall Study||81
2197928|NCT03380429|5392266|P1|COMPLETED|Overall Study||82
2197929|NCT03380429|5392262|P5|STARTED|Overall Study||86
2197930|NCT03380429|5392263|P4|STARTED|Overall Study||88
2197931|NCT03380429|5392264|P3|STARTED|Overall Study||88
2197932|NCT03380429|5392265|P2|STARTED|Overall Study||88
2197933|NCT03380429|5392266|P1|STARTED|Overall Study||87
2197934|NCT03380390|5392319|P1|NOT COMPLETED|Overall Study||3
2197935|NCT03380390|5392319|P1|COMPLETED|Overall Study||43
2197936|NCT03380390|5392319|P1|STARTED|Overall Study||46
2197937|NCT03379740|5392327|P2|NOT COMPLETED|Overall Study||0
2197938|NCT03379740|5392328|P1|NOT COMPLETED|Overall Study||0
2197939|NCT03379740|5392327|P2|COMPLETED|Overall Study||7
2197940|NCT03379740|5392328|P1|COMPLETED|Overall Study||8
2197941|NCT03379740|5392327|P2|STARTED|Overall Study||7
2197942|NCT03379740|5392328|P1|STARTED|Overall Study||8
2197943|NCT03379376|5392406|P1|NOT COMPLETED|Overall Study||5
2197944|NCT03379376|5392406|P1|COMPLETED|Overall Study||5
2197945|NCT03379376|5392406|P1|STARTED|Overall Study||10
2197946|NCT03379233|5392416|P2|NOT COMPLETED|Overall Study||6
2197947|NCT03379233|5392417|P1|NOT COMPLETED|Overall Study||1
2197948|NCT03379233|5392416|P2|COMPLETED|Overall Study||0
2197949|NCT03379233|5392417|P1|COMPLETED|Overall Study||0
2197950|NCT03379233|5392416|P2|STARTED|Overall Study||6
2197951|NCT03379233|5392417|P1|STARTED|Overall Study||1
2197952|NCT03378076|5392431|P2|NOT COMPLETED|Overall Study||0
2197953|NCT03378076|5392432|P1|NOT COMPLETED|Overall Study||0
2197954|NCT03378076|5392431|P2|COMPLETED|Overall Study||12
2197955|NCT03378076|5392432|P1|COMPLETED|Overall Study||12
2197956|NCT03378076|5392431|P2|STARTED|Overall Study||12
2197957|NCT03378076|5392432|P1|STARTED|Overall Study||12
2197958|NCT03376516|5392440|P1|NOT COMPLETED|Overall Study||2
2197959|NCT03376516|5392440|P1|COMPLETED|Overall Study||9
2197960|NCT03376516|5392440|P1|SURG Population|Overall Study||2
2197961|NCT03376516|5392440|P1|PP Population|Overall Study||9
2197962|NCT03376516|5392440|P1|PK Population|Overall Study||10
2197963|NCT03376516|5392440|P1|FAS Population|Overall Study||10
2197964|NCT03376516|5392440|P1|SAF Population|Overall Study||10
2197965|NCT03376516|5392440|P1|Received Treatment|Overall Study||10
2197966|NCT03376516|5392440|P1|STARTED|Overall Study||11
2197967|NCT03376295|5392472|P2|NOT COMPLETED|Overall Study||0
2197968|NCT03376295|5392473|P1|NOT COMPLETED|Overall Study||0
2197969|NCT03376295|5392472|P2|COMPLETED|Overall Study||1977
2197970|NCT03376295|5392473|P1|COMPLETED|Overall Study||1977
2197971|NCT03376295|5392472|P2|STARTED|Overall Study||1977
2197972|NCT03376295|5392473|P1|STARTED|Overall Study||1977
2197973|NCT03376061|5392485|P2|NOT COMPLETED|Overall Study||0
2197974|NCT03376061|5392486|P1|NOT COMPLETED|Overall Study||0
2197975|NCT03376061|5392485|P2|COMPLETED|Overall Study||48
2197976|NCT03376061|5392486|P1|COMPLETED|Overall Study||49
2197977|NCT03376061|5392485|P2|STARTED|Overall Study||48
2197978|NCT03376061|5392486|P1|STARTED|Overall Study||49
2197985|NCT03374488|5392521|P2|NOT COMPLETED|Overall Study||37
2197986|NCT03374488|5392522|P1|NOT COMPLETED|Overall Study||41
2197987|NCT03374488|5392521|P2|COMPLETED|Overall Study||5
2197988|NCT03374488|5392522|P1|COMPLETED|Overall Study||1
2197989|NCT03374488|5392521|P2|All Participants as Treated (APaT)|Overall Study||41
2197990|NCT03374488|5392522|P1|All Participants as Treated (APaT)|Overall Study||42
2197991|NCT03374488|5392521|P2|Intention-to-Treat (ITT)|Overall Study||42
2197992|NCT03374488|5392522|P1|Intention-to-Treat (ITT)|Overall Study||42
2197993|NCT03374488|5392521|P2|STARTED|Overall Study||42
2197994|NCT03374488|5392522|P1|STARTED|Overall Study||42
2197995|NCT03374189|5392534|P2|NOT COMPLETED|Overall Study||0
2197996|NCT03374189|5392535|P1|NOT COMPLETED|Overall Study||1
2197997|NCT03374189|5392534|P2|COMPLETED|Overall Study||39
2197998|NCT03374189|5392535|P1|COMPLETED|Overall Study||39
2197999|NCT03374189|5392534|P2|STARTED|Overall Study||39
2198000|NCT03374189|5392535|P1|STARTED|Overall Study||40
2198001|NCT03373890|5392555|P2|NOT COMPLETED|Overall Study||0
2198002|NCT03373890|5392556|P1|NOT COMPLETED|Overall Study||0
2198003|NCT03373890|5392555|P2|COMPLETED|Overall Study||6
2198004|NCT03373890|5392556|P1|COMPLETED|Overall Study||6
2198005|NCT03373890|5392555|P2|STARTED|Overall Study||6
2198006|NCT03373890|5392556|P1|STARTED|Overall Study||6
2198007|NCT03373591|5392579|P3|NOT COMPLETED|Overall Study||0
2198008|NCT03373591|5392580|P2|NOT COMPLETED|Overall Study||0
2198009|NCT03373591|5392581|P1|NOT COMPLETED|Overall Study||0
2198010|NCT03373591|5392579|P3|COMPLETED|Overall Study||73
2198011|NCT03373591|5392580|P2|COMPLETED|Overall Study||71
2198012|NCT03373591|5392581|P1|COMPLETED|Overall Study||75
2198013|NCT03373591|5392579|P3|STARTED|Overall Study||73
2198014|NCT03373591|5392580|P2|STARTED|Overall Study||71
2198015|NCT03373591|5392581|P1|STARTED|Overall Study||75
2198016|NCT03373162|5392610|P1|NOT COMPLETED|Overall Study||0
2198017|NCT03373162|5392610|P1|COMPLETED|Overall Study||10
2198018|NCT03373162|5392610|P1|STARTED|Overall Study||10
2198019|NCT03372603|5392616|P2|NOT COMPLETED|Treatment Period 2 (Up to 7 Days)||0
2198020|NCT03372603|5392617|P1|NOT COMPLETED|Treatment Period 2 (Up to 7 Days)||1
2198021|NCT03372603|5392616|P2|COMPLETED|Treatment Period 2 (Up to 7 Days)||8
2198022|NCT03372603|5392617|P1|COMPLETED|Treatment Period 2 (Up to 7 Days)||7
2198023|NCT03372603|5392616|P2|STARTED|Treatment Period 2 (Up to 7 Days)||8
2198024|NCT03372603|5392617|P1|STARTED|Treatment Period 2 (Up to 7 Days)||8
2198025|NCT03372603|5392616|P2|NOT COMPLETED|Wash-out Period (14-21 Days)||0
2198026|NCT03372603|5392617|P1|NOT COMPLETED|Wash-out Period (14-21 Days)||1
2198027|NCT03372603|5392616|P2|COMPLETED|Wash-out Period (14-21 Days)||8
2198028|NCT03372603|5392617|P1|COMPLETED|Wash-out Period (14-21 Days)||8
2198029|NCT03372603|5392616|P2|STARTED|Wash-out Period (14-21 Days)||8
2198030|NCT03372603|5392617|P1|STARTED|Wash-out Period (14-21 Days)||9
2198031|NCT03372603|5392616|P2|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
2198032|NCT03372603|5392617|P1|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
2198033|NCT03372603|5392616|P2|COMPLETED|Treatment Period 1 (Up to 7 Days)||8
2198034|NCT03372603|5392617|P1|COMPLETED|Treatment Period 1 (Up to 7 Days)||9
2198035|NCT03372603|5392616|P2|STARTED|Treatment Period 1 (Up to 7 Days)||8
2198036|NCT03372603|5392617|P1|STARTED|Treatment Period 1 (Up to 7 Days)||9
2198037|NCT03372551|5392659|P2|NOT COMPLETED|Second Intervention (1 Week)||0
2198038|NCT03372551|5392660|P1|NOT COMPLETED|Second Intervention (1 Week)||0
2198039|NCT03372551|5392659|P2|COMPLETED|Second Intervention (1 Week)||16
2198040|NCT03372551|5392660|P1|COMPLETED|Second Intervention (1 Week)||16
2198041|NCT03372551|5392659|P2|STARTED|Second Intervention (1 Week)||16
2198042|NCT03372551|5392660|P1|STARTED|Second Intervention (1 Week)||16
2198043|NCT03372551|5392659|P2|NOT COMPLETED|First Intervention (1 Week)||0
2198044|NCT03372551|5392660|P1|NOT COMPLETED|First Intervention (1 Week)||1
2198045|NCT03372551|5392659|P2|COMPLETED|First Intervention (1 Week)||16
2198046|NCT03372551|5392660|P1|COMPLETED|First Intervention (1 Week)||16
2198047|NCT03372551|5392659|P2|STARTED|First Intervention (1 Week)||16
2198048|NCT03372551|5392660|P1|STARTED|First Intervention (1 Week)||17
2198049|NCT03372382|5392679|P2|NOT COMPLETED|Overall Study||4
2198050|NCT03372382|5392680|P1|NOT COMPLETED|Overall Study||9
2198051|NCT03372382|5392679|P2|COMPLETED|Overall Study||81
2198052|NCT03372382|5392680|P1|COMPLETED|Overall Study||76
2198053|NCT03372382|5392679|P2|STARTED|Overall Study||85
2198054|NCT03372382|5392680|P1|STARTED|Overall Study||85
2198055|NCT03372369|5392690|P2|NOT COMPLETED|Intervention and Follow-Up Period||3
2198056|NCT03372369|5392691|P1|NOT COMPLETED|Intervention and Follow-Up Period||3
2198057|NCT03372369|5392690|P2|COMPLETED|Intervention and Follow-Up Period||470
2198058|NCT03372369|5392691|P1|COMPLETED|Intervention and Follow-Up Period||466
2198059|NCT03372369|5392690|P2|STARTED|Intervention and Follow-Up Period||473
2198060|NCT03372369|5392691|P1|STARTED|Intervention and Follow-Up Period||469
2198061|NCT03372369|5392690|P2|NOT COMPLETED|Qualification Period||22
2198062|NCT03372369|5392691|P1|NOT COMPLETED|Qualification Period||26
2198063|NCT03372369|5392690|P2|COMPLETED|Qualification Period||473
2198064|NCT03372369|5392691|P1|COMPLETED|Qualification Period||469
2198065|NCT03372369|5392690|P2|STARTED|Qualification Period||495
2198066|NCT03372369|5392691|P1|STARTED|Qualification Period||495
2198067|NCT03371459|5392703|P2|NOT COMPLETED|Period 2||0
2198068|NCT03371459|5392704|P1|NOT COMPLETED|Period 2||0
2198069|NCT03371459|5392703|P2|COMPLETED|Period 2||22
2198070|NCT03371459|5392704|P1|COMPLETED|Period 2||23
2198071|NCT03371459|5392703|P2|STARTED|Period 2||22
2198072|NCT03371459|5392704|P1|STARTED|Period 2||23
2198073|NCT03371459|5392703|P2|NOT COMPLETED|Washout||1
2198074|NCT03371459|5392704|P1|NOT COMPLETED|Washout||0
2198075|NCT03371459|5392703|P2|COMPLETED|Washout||22
2198076|NCT03371459|5392704|P1|COMPLETED|Washout||23
2198077|NCT03371459|5392703|P2|STARTED|Washout||23
2198078|NCT03371459|5392704|P1|STARTED|Washout||23
2198079|NCT03371459|5392703|P2|NOT COMPLETED|Period 1||0
2198080|NCT03371459|5392704|P1|NOT COMPLETED|Period 1||0
2198081|NCT03371459|5392703|P2|COMPLETED|Period 1||23
2198082|NCT03371459|5392704|P1|COMPLETED|Period 1||23
2198083|NCT03371459|5392703|P2|STARTED|Period 1||23
2198084|NCT03371459|5392704|P1|STARTED|Period 1||23
2198085|NCT03371381|5392712|P1|NOT COMPLETED|Overall Study||12
2198086|NCT03371381|5392712|P1|COMPLETED|Overall Study||0
2198087|NCT03371381|5392712|P1|STARTED|Overall Study||12
2198088|NCT03370536|5392724|P1|NOT COMPLETED|Overall Study||1
2198089|NCT03370536|5392724|P1|COMPLETED|Overall Study||0
2198090|NCT03370536|5392724|P1|STARTED|Overall Study||1
2198091|NCT03370419|5392733|P1|NOT COMPLETED|Overall Study||16
2198092|NCT03370419|5392733|P1|COMPLETED|Overall Study||24
2198093|NCT03370419|5392733|P1|STARTED|Overall Study||40
2198094|NCT03370289|5392737|P1|NOT COMPLETED|Overall Study||5
2198095|NCT03370289|5392737|P1|COMPLETED|Overall Study||50
2198096|NCT03370289|5392737|P1|STARTED|Overall Study||55
2198097|NCT03369704|5392756|P2|NOT COMPLETED|Follow-up Epoch||0
2198098|NCT03369704|5392757|P1|NOT COMPLETED|Follow-up Epoch||1
2198099|NCT03369704|5392756|P2|COMPLETED|Follow-up Epoch||174
2198100|NCT03369704|5392757|P1|COMPLETED|Follow-up Epoch||160
2198101|NCT03369704|5392756|P2|STARTED|Follow-up Epoch||174
2198102|NCT03369704|5392757|P1|STARTED|Follow-up Epoch||161
2198103|NCT03369704|5392756|P2|NOT COMPLETED|Treatment Epoch||3
2198104|NCT03369704|5392757|P1|NOT COMPLETED|Treatment Epoch||4
2198105|NCT03369704|5392756|P2|COMPLETED|Treatment Epoch||172
2198106|NCT03369704|5392757|P1|COMPLETED|Treatment Epoch||158
2198107|NCT03369704|5392756|P2|STARTED|Treatment Epoch||175
2198108|NCT03369704|5392757|P1|STARTED|Treatment Epoch||162
2198109|NCT03369340|5392790|P6|NOT COMPLETED|Day 4||0
2198110|NCT03369340|5392791|P5|NOT COMPLETED|Day 4||0
2198111|NCT03369340|5392792|P4|NOT COMPLETED|Day 4||0
2198112|NCT03369340|5392793|P3|NOT COMPLETED|Day 4||0
2198113|NCT03369340|5392794|P2|NOT COMPLETED|Day 4||0
2198114|NCT03369340|5392795|P1|NOT COMPLETED|Day 4||0
2198115|NCT03369340|5392790|P6|COMPLETED|Day 4||3
2198116|NCT03369340|5392791|P5|COMPLETED|Day 4||3
2198117|NCT03369340|5392792|P4|COMPLETED|Day 4||3
2198118|NCT03369340|5392793|P3|COMPLETED|Day 4||3
2198119|NCT03369340|5392794|P2|COMPLETED|Day 4||3
2198120|NCT03369340|5392795|P1|COMPLETED|Day 4||3
2198121|NCT03369340|5392790|P6|STARTED|Day 4||3
2198122|NCT03369340|5392791|P5|STARTED|Day 4||3
2198123|NCT03369340|5392792|P4|STARTED|Day 4||3
2198124|NCT03369340|5392793|P3|STARTED|Day 4||3
2198125|NCT03369340|5392794|P2|STARTED|Day 4||3
2198126|NCT03369340|5392795|P1|STARTED|Day 4||3
2198127|NCT03369340|5392790|P6|NOT COMPLETED|Day 3||0
2198128|NCT03369340|5392791|P5|NOT COMPLETED|Day 3||0
2198129|NCT03369340|5392792|P4|NOT COMPLETED|Day 3||0
2198130|NCT03369340|5392793|P3|NOT COMPLETED|Day 3||0
2198131|NCT03369340|5392794|P2|NOT COMPLETED|Day 3||0
2198132|NCT03369340|5392795|P1|NOT COMPLETED|Day 3||0
2198133|NCT03369340|5392790|P6|COMPLETED|Day 3||3
2198134|NCT03369340|5392791|P5|COMPLETED|Day 3||3
2198135|NCT03369340|5392792|P4|COMPLETED|Day 3||3
2198136|NCT03369340|5392793|P3|COMPLETED|Day 3||3
2198137|NCT03369340|5392794|P2|COMPLETED|Day 3||3
2198138|NCT03369340|5392795|P1|COMPLETED|Day 3||3
2198139|NCT03369340|5392790|P6|STARTED|Day 3||3
2198140|NCT03369340|5392791|P5|STARTED|Day 3||3
2198141|NCT03369340|5392792|P4|STARTED|Day 3||3
2198142|NCT03369340|5392793|P3|STARTED|Day 3||3
2198143|NCT03369340|5392794|P2|STARTED|Day 3||3
2198144|NCT03369340|5392795|P1|STARTED|Day 3||3
2198145|NCT03369340|5392790|P6|NOT COMPLETED|Day 2||0
2198146|NCT03369340|5392791|P5|NOT COMPLETED|Day 2||0
2198147|NCT03369340|5392792|P4|NOT COMPLETED|Day 2||0
2198148|NCT03369340|5392793|P3|NOT COMPLETED|Day 2||0
2198149|NCT03369340|5392794|P2|NOT COMPLETED|Day 2||0
2198150|NCT03369340|5392795|P1|NOT COMPLETED|Day 2||0
2198151|NCT03369340|5392790|P6|COMPLETED|Day 2||3
2198152|NCT03369340|5392791|P5|COMPLETED|Day 2||3
2198153|NCT03369340|5392792|P4|COMPLETED|Day 2||3
2198154|NCT03369340|5392793|P3|COMPLETED|Day 2||3
2198155|NCT03369340|5392794|P2|COMPLETED|Day 2||3
2198156|NCT03369340|5392795|P1|COMPLETED|Day 2||3
2198157|NCT03369340|5392790|P6|STARTED|Day 2||3
2198158|NCT03369340|5392791|P5|STARTED|Day 2||3
2198159|NCT03369340|5392792|P4|STARTED|Day 2||3
2198160|NCT03369340|5392793|P3|STARTED|Day 2||3
2198161|NCT03369340|5392794|P2|STARTED|Day 2||3
2198162|NCT03369340|5392795|P1|STARTED|Day 2||3
2198163|NCT03368937|5392873|P1|NOT COMPLETED|Overall Study||0
2198164|NCT03368937|5392873|P1|COMPLETED|Overall Study||5
2198165|NCT03368937|5392873|P1|STARTED|Overall Study||5
2198166|NCT03368807|5392877|P1|NOT COMPLETED|Period 2 (Unblinded CGM)||0
2198167|NCT03368807|5392877|P1|COMPLETED|Period 2 (Unblinded CGM)||73
2198168|NCT03368807|5392877|P1|STARTED|Period 2 (Unblinded CGM)||73
2198169|NCT03368807|5392877|P1|NOT COMPLETED|Period 1 (Blinded CGM)||6
2198170|NCT03368807|5392877|P1|COMPLETED|Period 1 (Blinded CGM)||73
2198171|NCT03368807|5392877|P1|Received at Least 1 Dose of Study Drug|Period 1 (Blinded CGM)||78
2198172|NCT03368807|5392877|P1|STARTED|Period 1 (Blinded CGM)||79
2198173|NCT03368053|5392891|P1|NOT COMPLETED|Overall Study||0
2198174|NCT03368053|5392891|P1|COMPLETED|Overall Study||36
2198175|NCT03368053|5392891|P1|STARTED|Overall Study||36
2198176|NCT03366207|5392906|P1|NOT COMPLETED|Overall Study||8
2198177|NCT03366207|5392906|P1|COMPLETED|Overall Study||242
2198178|NCT03366207|5392906|P1|STARTED|Overall Study||250
2198179|NCT03365934|5392911|P1|NOT COMPLETED|Overall Study||2
2198180|NCT03365934|5392911|P1|COMPLETED|Overall Study||33
2198181|NCT03365934|5392911|P1|STARTED|Overall Study||35
2198182|NCT03365778|5393187|P3|NOT COMPLETED|Overall Study||0
2198183|NCT03365778|5393188|P2|NOT COMPLETED|Overall Study||0
2198184|NCT03365778|5393189|P1|NOT COMPLETED|Overall Study||0
2198185|NCT03365778|5393187|P3|COMPLETED|Overall Study||53
2198186|NCT03365778|5393188|P2|COMPLETED|Overall Study||17
2198187|NCT03365778|5393189|P1|COMPLETED|Overall Study||16
2198188|NCT03365778|5393187|P3|STARTED|Overall Study||53
2198189|NCT03365778|5393188|P2|STARTED|Overall Study||17
2198190|NCT03365778|5393189|P1|STARTED|Overall Study||16
2198191|NCT03365011|5393201|P2|NOT COMPLETED|Overall Study||2
2198192|NCT03365011|5393202|P1|NOT COMPLETED|Overall Study||1
2198193|NCT03365011|5393201|P2|COMPLETED|Overall Study||18
2198194|NCT03365011|5393202|P1|COMPLETED|Overall Study||19
2198195|NCT03365011|5393201|P2|STARTED|Overall Study||20
2198196|NCT03365011|5393202|P1|STARTED|Overall Study||20
2198197|NCT03364608|5393212|P1|NOT COMPLETED|Overall Study||8
2198198|NCT03364608|5393212|P1|COMPLETED|Overall Study||78
2198199|NCT03364608|5393212|P1|Proventil 180 µg|Overall Study||79
2198200|NCT03364608|5393212|P1|Proventil 90 µg|Overall Study||82
2198201|NCT03364608|5393212|P1|AS MDI 180 µg|Overall Study||81
2198202|NCT03364608|5393212|P1|AS MDI 90 µg|Overall Study||81
2198203|NCT03364608|5393212|P1|Placebo MDI|Overall Study||82
2198204|NCT03364608|5393212|P1|STARTED|Overall Study||86
2198205|NCT03364335|5393239|P5|NOT COMPLETED|Overall Study||11
2198206|NCT03364335|5393240|P4|NOT COMPLETED|Overall Study||13
2198207|NCT03364335|5393241|P3|NOT COMPLETED|Overall Study||11
2198208|NCT03364335|5393242|P2|NOT COMPLETED|Overall Study||11
2198209|NCT03364335|5393243|P1|NOT COMPLETED|Overall Study||10
2198210|NCT03364335|5393239|P5|COMPLETED|Overall Study||41
2198211|NCT03364335|5393240|P4|COMPLETED|Overall Study||37
2198212|NCT03364335|5393241|P3|COMPLETED|Overall Study||42
2198213|NCT03364335|5393242|P2|COMPLETED|Overall Study||40
2198214|NCT03364335|5393243|P1|COMPLETED|Overall Study||42
2198215|NCT03364335|5393239|P5|STARTED|Overall Study||52
2198216|NCT03364335|5393240|P4|STARTED|Overall Study||50
2198217|NCT03364335|5393241|P3|STARTED|Overall Study||53
2198218|NCT03364335|5393242|P2|STARTED|Overall Study||51
2198219|NCT03364335|5393243|P1|STARTED|Overall Study||52
2198220|NCT03363906|5393315|P2|NOT COMPLETED|Period 2 (Test or Reference)||1
2198221|NCT03363906|5393316|P1|NOT COMPLETED|Period 2 (Test or Reference)||4
2198222|NCT03363906|5393315|P2|COMPLETED|Period 2 (Test or Reference)||9
2198223|NCT03363906|5393316|P1|COMPLETED|Period 2 (Test or Reference)||10
2198224|NCT03363906|5393315|P2|Received at Least One Dose of Study Drug|Period 2 (Test or Reference)||9
2198225|NCT03363906|5393316|P1|Received at Least One Dose of Study Drug|Period 2 (Test or Reference)||12
2198226|NCT03363906|5393315|P2|STARTED|Period 2 (Test or Reference)||10
2198227|NCT03363906|5393316|P1|STARTED|Period 2 (Test or Reference)||14
2198228|NCT03363906|5393315|P2|NOT COMPLETED|Period 1 (Reference or Test)||2
2198229|NCT03363906|5393316|P1|NOT COMPLETED|Period 1 (Reference or Test)||1
2198230|NCT03363906|5393315|P2|COMPLETED|Period 1 (Reference or Test)||10
2198231|NCT03363906|5393316|P1|COMPLETED|Period 1 (Reference or Test)||14
2198232|NCT03363906|5393315|P2|Received at Least One Dose of Study Drug|Period 1 (Reference or Test)||11
2198233|NCT03363906|5393316|P1|Received at Least One Dose of Study Drug|Period 1 (Reference or Test)||15
2198234|NCT03363906|5393315|P2|STARTED|Period 1 (Reference or Test)||12
2198235|NCT03363906|5393316|P1|STARTED|Period 1 (Reference or Test)||15
2198236|NCT03363633|5393324|P1|NOT COMPLETED|Overall Study||12
2198237|NCT03363633|5393324|P1|COMPLETED|Overall Study|See note in Pre-Assignment Details|0
2198238|NCT03363633|5393324|P1|STARTED|Overall Study||12
2198239|NCT03362944|5393332|P2|NOT COMPLETED|Second Intervention||0
2198240|NCT03362944|5393333|P1|NOT COMPLETED|Second Intervention||0
2198241|NCT03362944|5393332|P2|COMPLETED|Second Intervention||8
2198242|NCT03362944|5393333|P1|COMPLETED|Second Intervention||8
2198243|NCT03362944|5393332|P2|STARTED|Second Intervention||8
2198244|NCT03362944|5393333|P1|STARTED|Second Intervention||8
2198245|NCT03362944|5393332|P2|NOT COMPLETED|Single Week Washout Period||0
2198246|NCT03362944|5393333|P1|NOT COMPLETED|Single Week Washout Period||0
2198247|NCT03362944|5393332|P2|COMPLETED|Single Week Washout Period||8
2198248|NCT03362944|5393333|P1|COMPLETED|Single Week Washout Period||8
2198249|NCT03362944|5393332|P2|STARTED|Single Week Washout Period||8
2198250|NCT03362944|5393333|P1|STARTED|Single Week Washout Period||8
2198251|NCT03362944|5393332|P2|NOT COMPLETED|First Intervention||0
2198252|NCT03362944|5393333|P1|NOT COMPLETED|First Intervention||0
2198253|NCT03362944|5393332|P2|COMPLETED|First Intervention||8
2198254|NCT03362944|5393333|P1|COMPLETED|First Intervention||8
2198255|NCT03362944|5393332|P2|STARTED|First Intervention||8
2198256|NCT03362944|5393333|P1|STARTED|First Intervention||8
2198257|NCT03362879|5393349|P1|NOT COMPLETED|Overall Study||0
2198258|NCT03362879|5393349|P1|COMPLETED|Overall Study||409
2198259|NCT03362879|5393349|P1|STARTED|Overall Study||409
2198260|NCT03361917|5393367|P2|NOT COMPLETED|Overall Study||0
2198261|NCT03361917|5393368|P1|NOT COMPLETED|Overall Study||0
2198262|NCT03361917|5393367|P2|COMPLETED|Overall Study||101
2198263|NCT03361917|5393368|P1|COMPLETED|Overall Study||99
2198264|NCT03361917|5393367|P2|STARTED|Overall Study||101
2198265|NCT03361917|5393368|P1|STARTED|Overall Study||99
2198266|NCT03361865|5393386|P2|NOT COMPLETED|Overall Study||49
2198267|NCT03361865|5393387|P1|NOT COMPLETED|Overall Study||43
2198268|NCT03361865|5393386|P2|COMPLETED|Overall Study||0
2198269|NCT03361865|5393387|P1|COMPLETED|Overall Study||1
2198270|NCT03361865|5393386|P2|All Participants as Treated (APaT)|Overall Study||49
2198271|NCT03361865|5393387|P1|All Participants as Treated (APaT)|Overall Study||43
2198272|NCT03361865|5393386|P2|Intention-to-Treat (ITT)|Overall Study||49
2198273|NCT03361865|5393387|P1|Intention-to-Treat (ITT)|Overall Study||44
2198274|NCT03361865|5393386|P2|STARTED|Overall Study||49
2198275|NCT03361865|5393387|P1|STARTED|Overall Study||44
2198276|NCT03361176|5393399|P2|NOT COMPLETED|Overall Study||5
2198277|NCT03361176|5393400|P1|NOT COMPLETED|Overall Study||1
2198278|NCT03361176|5393399|P2|COMPLETED|Overall Study||15
2198279|NCT03361176|5393400|P1|COMPLETED|Overall Study||9
2198280|NCT03361176|5393399|P2|STARTED|Overall Study||20
2198281|NCT03361176|5393400|P1|STARTED|Overall Study||10
2198282|NCT03360903|5393412|P2|NOT COMPLETED|Second Intervention||0
2198283|NCT03360903|5393413|P1|NOT COMPLETED|Second Intervention||0
2198284|NCT03360903|5393412|P2|COMPLETED|Second Intervention||4
2198285|NCT03360903|5393413|P1|COMPLETED|Second Intervention||4
2198286|NCT03360903|5393412|P2|STARTED|Second Intervention||4
2198287|NCT03360903|5393413|P1|STARTED|Second Intervention||4
2198288|NCT03360903|5393412|P2|NOT COMPLETED|Washout (2 Weeks)||0
2198289|NCT03360903|5393413|P1|NOT COMPLETED|Washout (2 Weeks)||0
2198290|NCT03360903|5393412|P2|COMPLETED|Washout (2 Weeks)||4
2198291|NCT03360903|5393413|P1|COMPLETED|Washout (2 Weeks)||4
2198292|NCT03360903|5393412|P2|STARTED|Washout (2 Weeks)||4
2198293|NCT03360903|5393413|P1|STARTED|Washout (2 Weeks)||4
2198294|NCT03360903|5393412|P2|NOT COMPLETED|First Intervention||0
2198295|NCT03360903|5393413|P1|NOT COMPLETED|First Intervention||0
2198296|NCT03360903|5393412|P2|COMPLETED|First Intervention||4
2198297|NCT03360903|5393413|P1|COMPLETED|First Intervention||4
2198298|NCT03360903|5393412|P2|STARTED|First Intervention||4
2198299|NCT03360903|5393413|P1|STARTED|First Intervention||4
2198300|NCT03360071|5393433|P2|NOT COMPLETED|Overall Study||0
2198301|NCT03360071|5393434|P1|NOT COMPLETED|Overall Study||1
2198302|NCT03360071|5393433|P2|COMPLETED|Overall Study||14
2198303|NCT03360071|5393434|P1|COMPLETED|Overall Study||16
2198304|NCT03360071|5393433|P2|STARTED|Overall Study||14
2198305|NCT03360071|5393434|P1|STARTED|Overall Study||17
2198306|NCT03359629|5393448|P2|NOT COMPLETED|Overall Study||0
2198307|NCT03359629|5393449|P1|NOT COMPLETED|Overall Study||0
2198308|NCT03359629|5393448|P2|COMPLETED|Overall Study||10
2198309|NCT03359629|5393449|P1|COMPLETED|Overall Study||200
2198310|NCT03359629|5393448|P2|STARTED|Overall Study||10
2198311|NCT03359629|5393449|P1|STARTED|Overall Study||200
2198312|NCT03358472|5393458|P3|NOT COMPLETED|Overall Study||16
2198313|NCT03358472|5393459|P2|NOT COMPLETED|Overall Study||10
2198314|NCT03358472|5393460|P1|NOT COMPLETED|Overall Study||15
2198315|NCT03358472|5393458|P3|COMPLETED|Overall Study||19
2198316|NCT03358472|5393459|P2|COMPLETED|Overall Study||9
2198317|NCT03358472|5393460|P1|COMPLETED|Overall Study||20
2198318|NCT03358472|5393458|P3|All Participants as Treated (APaT)|Overall Study||34
2198319|NCT03358472|5393459|P2|All Participants as Treated (APaT)|Overall Study||19
2198320|NCT03358472|5393460|P1|All Participants as Treated (APaT)|Overall Study||34
2198321|NCT03358472|5393458|P3|Intention-to-Treat (ITT)|Overall Study||35
2198322|NCT03358472|5393459|P2|Intention-to-Treat (ITT)|Overall Study||19
2198323|NCT03358472|5393460|P1|Intention-to-Treat (ITT)|Overall Study||35
2198324|NCT03358472|5393458|P3|STARTED|Overall Study||35
2198325|NCT03358472|5393459|P2|STARTED|Overall Study||19
2198326|NCT03358472|5393460|P1|STARTED|Overall Study||35
2198327|NCT03358329|5393474|P1|NOT COMPLETED|Overall Study||4
2198328|NCT03358329|5393474|P1|COMPLETED|Overall Study||46
2198329|NCT03358329|5393474|P1|STARTED|Overall Study||50
2198330|NCT03357952|5393482|P2|NOT COMPLETED|Overall Study||1
2198331|NCT03357952|5393483|P1|NOT COMPLETED|Overall Study||9
2198332|NCT03357952|5393482|P2|COMPLETED|Overall Study||0
2198333|NCT03357952|5393483|P1|COMPLETED|Overall Study||0
2198334|NCT03357952|5393482|P2|STARTED|Overall Study||1
2198335|NCT03357952|5393483|P1|STARTED|Overall Study||9
2198336|NCT03357471|5393492|P2|NOT COMPLETED|Overall Study||0
2198337|NCT03357471|5393493|P1|NOT COMPLETED|Overall Study||2
2198338|NCT03357471|5393492|P2|COMPLETED|Overall Study||32
2198339|NCT03357471|5393493|P1|COMPLETED|Overall Study||33
2198340|NCT03357471|5393492|P2|STARTED|Overall Study||32
2198341|NCT03357471|5393493|P1|STARTED|Overall Study||35
2198342|NCT03356977|5393517|P1|NOT COMPLETED|Overall Study||5
2198343|NCT03356977|5393517|P1|COMPLETED|Overall Study||132
2198344|NCT03356977|5393517|P1|STARTED|Overall Study||137
2198345|NCT03355820|5393529|P1|NOT COMPLETED|Overall Study||0
2198346|NCT03355820|5393529|P1|COMPLETED|Overall Study||227
2198347|NCT03355820|5393529|P1|STARTED|Overall Study||227
2198348|NCT03354754|5393542|P2|NOT COMPLETED|Overall Study||0
2198349|NCT03354754|5393543|P1|NOT COMPLETED|Overall Study||0
2198350|NCT03354754|5393542|P2|COMPLETED|Overall Study||1
2198351|NCT03354754|5393543|P1|COMPLETED|Overall Study||2
2198352|NCT03354754|5393542|P2|STARTED|Overall Study||1
2198353|NCT03354754|5393543|P1|STARTED|Overall Study||2
2198354|NCT03354663|5393565|P1|NOT COMPLETED|Completed 30-day Visit||2
2198355|NCT03354663|5393565|P1|COMPLETED|Completed 30-day Visit||149
2198356|NCT03354663|5393565|P1|STARTED|Completed 30-day Visit||151
2198357|NCT03354663|5393565|P1|NOT COMPLETED|Enrollment to Catheter Insertion||5
2198358|NCT03354663|5393565|P1|COMPLETED|Enrollment to Catheter Insertion||151
2198359|NCT03354663|5393565|P1|STARTED|Enrollment to Catheter Insertion||156
2198360|NCT03353246|5393581|P1|NOT COMPLETED|Overall Study||0
2198361|NCT03353246|5393581|P1|COMPLETED|Overall Study||500
2198362|NCT03353246|5393581|P1|STARTED|Overall Study||500
2198363|NCT03352882|5393598|P1|NOT COMPLETED|Overall Study||0
2198364|NCT03352882|5393598|P1|COMPLETED|Overall Study||1
2198365|NCT03352882|5393598|P1|STARTED|Overall Study||1
2198366|NCT03352713|5393606|P1|NOT COMPLETED|Overall Study||26
2198367|NCT03352713|5393606|P1|COMPLETED|Overall Study|Participants who completed at least 1 EMA for inclusion in data analysis|159
2198368|NCT03352713|5393606|P1|STARTED|Overall Study||185
2198369|NCT03352609|5393614|P2|NOT COMPLETED|Overall Study||0
2198370|NCT03352609|5393615|P1|NOT COMPLETED|Overall Study||0
2198371|NCT03352609|5393614|P2|COMPLETED|Overall Study||3
2198372|NCT03352609|5393615|P1|COMPLETED|Overall Study||2
2198373|NCT03352609|5393614|P2|STARTED|Overall Study||3
2198374|NCT03352609|5393615|P1|STARTED|Overall Study||2
2198375|NCT03351933|5393625|P1|NOT COMPLETED|Overall Study||2
2198376|NCT03351933|5393625|P1|COMPLETED|Overall Study||26
2198377|NCT03351933|5393625|P1|STARTED|Overall Study||28
2198378|NCT03351738|5393635|P6|NOT COMPLETED|Overall Study||0
2198379|NCT03351738|5393636|P5|NOT COMPLETED|Overall Study||0
2198380|NCT03351738|5393637|P4|NOT COMPLETED|Overall Study||1
2198381|NCT03351738|5393638|P3|NOT COMPLETED|Overall Study||0
2198382|NCT03351738|5393639|P2|NOT COMPLETED|Overall Study||1
2198383|NCT03351738|5393640|P1|NOT COMPLETED|Overall Study||0
2198384|NCT03351738|5393635|P6|COMPLETED|Overall Study||22
2198385|NCT03351738|5393636|P5|COMPLETED|Overall Study||21
2198386|NCT03351738|5393637|P4|COMPLETED|Overall Study||21
2198387|NCT03351738|5393638|P3|COMPLETED|Overall Study||24
2198388|NCT03351738|5393639|P2|COMPLETED|Overall Study||19
2198389|NCT03351738|5393640|P1|COMPLETED|Overall Study||23
2198390|NCT03351738|5393635|P6|STARTED|Overall Study||22
2198391|NCT03351738|5393636|P5|STARTED|Overall Study||21
2198392|NCT03351738|5393637|P4|STARTED|Overall Study||22
2198393|NCT03351738|5393638|P3|STARTED|Overall Study||24
2198394|NCT03351738|5393639|P2|STARTED|Overall Study||20
2198395|NCT03351738|5393640|P1|STARTED|Overall Study||23
2198396|NCT03351699|5393716|P5|NOT COMPLETED|Overall Study||0
2198397|NCT03351699|5393717|P4|NOT COMPLETED|Overall Study||0
2198398|NCT03351699|5393718|P3|NOT COMPLETED|Overall Study||0
2198399|NCT03351699|5393719|P2|NOT COMPLETED|Overall Study||0
2198400|NCT03351699|5393720|P1|NOT COMPLETED|Overall Study||0
2198401|NCT03351699|5393716|P5|COMPLETED|Overall Study|Panel F did not enroll, following evaluation of earlier Panel data.|0
2198402|NCT03351699|5393717|P4|COMPLETED|Overall Study||6
2198403|NCT03351699|5393718|P3|COMPLETED|Overall Study||6
2198404|NCT03351699|5393719|P2|COMPLETED|Overall Study||6
2198405|NCT03351699|5393720|P1|COMPLETED|Overall Study||6
2198406|NCT03351699|5393716|P5|STARTED|Overall Study|Panel F did not enroll, following evaluation of earlier Panel data.|0
2198407|NCT03351699|5393717|P4|STARTED|Overall Study||6
2198408|NCT03351699|5393718|P3|STARTED|Overall Study||6
2198409|NCT03351699|5393719|P2|STARTED|Overall Study||6
2198410|NCT03351699|5393720|P1|STARTED|Overall Study||6
2198411|NCT03351335|5393792|P3|NOT COMPLETED|Overall Study||4
2198412|NCT03351335|5393793|P2|NOT COMPLETED|Overall Study||0
2198413|NCT03351335|5393794|P1|NOT COMPLETED|Overall Study||0
2198414|NCT03351335|5393792|P3|COMPLETED|Overall Study||16
2198415|NCT03351335|5393793|P2|COMPLETED|Overall Study||19
2198416|NCT03351335|5393794|P1|COMPLETED|Overall Study||21
2198417|NCT03351335|5393792|P3|STARTED|Overall Study||20
2198418|NCT03351335|5393793|P2|STARTED|Overall Study||19
2198419|NCT03351335|5393794|P1|STARTED|Overall Study||21
2198420|NCT03351231|5393814|P1|NOT COMPLETED|Safety Follow-Up Period||3
2198421|NCT03351231|5393814|P1|COMPLETED|Safety Follow-Up Period|Completed = Finishing safety follow-up and continuing in study|0
2198422|NCT03351231|5393814|P1|STARTED|Safety Follow-Up Period|Started = Initiated Safety Follow-up|3
2198423|NCT03351231|5393814|P1|NOT COMPLETED|Combination Therapy Period||5
2198424|NCT03351231|5393814|P1|COMPLETED|Combination Therapy Period|Completed = finished combination therapy|0
2198425|NCT03351231|5393814|P1|STARTED|Combination Therapy Period|Started = initiated and completed monotherapy, then initiated combination therapy|5
2198426|NCT03350984|5393838|P2|NOT COMPLETED|Overall Study||8
2198427|NCT03350984|5393839|P1|NOT COMPLETED|Overall Study||8
2198428|NCT03350984|5393838|P2|COMPLETED|Overall Study||28
2198429|NCT03350984|5393839|P1|COMPLETED|Overall Study||31
2198430|NCT03350984|5393838|P2|STARTED|Overall Study||36
2198431|NCT03350984|5393839|P1|STARTED|Overall Study||39
2198432|NCT03350724|5393851|P2|NOT COMPLETED|Overall Study||0
2198433|NCT03350724|5393852|P1|NOT COMPLETED|Overall Study||0
2198434|NCT03350724|5393851|P2|COMPLETED|Overall Study||17
2198435|NCT03350724|5393852|P1|COMPLETED|Overall Study||17
2198436|NCT03350724|5393851|P2|STARTED|Overall Study||17
2198437|NCT03350724|5393852|P1|STARTED|Overall Study||17
2198438|NCT03350217|5393908|P2|NOT COMPLETED|Overall Study||0
2198439|NCT03350217|5393909|P1|NOT COMPLETED|Overall Study||2
2198440|NCT03350217|5393908|P2|COMPLETED|Overall Study||81
2198441|NCT03350217|5393909|P1|COMPLETED|Overall Study||77
2198442|NCT03350217|5393908|P2|STARTED|Overall Study||81
2198443|NCT03350217|5393909|P1|STARTED|Overall Study||79
2198444|NCT03349632|5393939|P6|NOT COMPLETED|Period 2, Second Week of Wear||0
2198445|NCT03349632|5393940|P5|NOT COMPLETED|Period 2, Second Week of Wear||0
2198446|NCT03349632|5393941|P4|NOT COMPLETED|Period 2, Second Week of Wear||0
2198447|NCT03349632|5393942|P3|NOT COMPLETED|Period 2, Second Week of Wear||0
2198448|NCT03349632|5393943|P2|NOT COMPLETED|Period 2, Second Week of Wear||0
2198449|NCT03349632|5393944|P1|NOT COMPLETED|Period 2, Second Week of Wear||0
2198450|NCT03349632|5393939|P6|COMPLETED|Period 2, Second Week of Wear||11
2198451|NCT03349632|5393940|P5|COMPLETED|Period 2, Second Week of Wear||11
2198452|NCT03349632|5393941|P4|COMPLETED|Period 2, Second Week of Wear||11
2198453|NCT03349632|5393942|P3|COMPLETED|Period 2, Second Week of Wear||11
2198454|NCT03349632|5393943|P2|COMPLETED|Period 2, Second Week of Wear||11
2198455|NCT03349632|5393944|P1|COMPLETED|Period 2, Second Week of Wear||11
2198456|NCT03349632|5393939|P6|STARTED|Period 2, Second Week of Wear||11
2198457|NCT03349632|5393940|P5|STARTED|Period 2, Second Week of Wear||11
2198458|NCT03349632|5393941|P4|STARTED|Period 2, Second Week of Wear||11
2198459|NCT03349632|5393942|P3|STARTED|Period 2, Second Week of Wear||11
2198460|NCT03349632|5393943|P2|STARTED|Period 2, Second Week of Wear||11
2198461|NCT03349632|5393944|P1|STARTED|Period 2, Second Week of Wear||11
2198462|NCT03349632|5393939|P6|NOT COMPLETED|Period 1, First Week of Wear||0
2198463|NCT03349632|5393940|P5|NOT COMPLETED|Period 1, First Week of Wear||0
2198464|NCT03349632|5393941|P4|NOT COMPLETED|Period 1, First Week of Wear||0
2198465|NCT03349632|5393942|P3|NOT COMPLETED|Period 1, First Week of Wear||0
2198466|NCT03349632|5393943|P2|NOT COMPLETED|Period 1, First Week of Wear||0
2198467|NCT03349632|5393944|P1|NOT COMPLETED|Period 1, First Week of Wear||0
2198468|NCT03349632|5393939|P6|COMPLETED|Period 1, First Week of Wear||11
2198469|NCT03349632|5393940|P5|COMPLETED|Period 1, First Week of Wear||11
2198470|NCT03349632|5393941|P4|COMPLETED|Period 1, First Week of Wear||11
2198471|NCT03349632|5393942|P3|COMPLETED|Period 1, First Week of Wear||11
2198472|NCT03349632|5393943|P2|COMPLETED|Period 1, First Week of Wear||11
2198473|NCT03349632|5393944|P1|COMPLETED|Period 1, First Week of Wear||11
2198474|NCT03349632|5393939|P6|STARTED|Period 1, First Week of Wear||11
2198475|NCT03349632|5393940|P5|STARTED|Period 1, First Week of Wear||11
2198476|NCT03349632|5393941|P4|STARTED|Period 1, First Week of Wear||11
2198477|NCT03349632|5393942|P3|STARTED|Period 1, First Week of Wear||11
2198478|NCT03349632|5393943|P2|STARTED|Period 1, First Week of Wear||11
2198479|NCT03349632|5393944|P1|STARTED|Period 1, First Week of Wear||11
2198480|NCT03349515|5393960|P2|NOT COMPLETED|Overall Study||1
2198481|NCT03349515|5393961|P1|NOT COMPLETED|Overall Study||5
2198482|NCT03349515|5393960|P2|COMPLETED|Overall Study||50
2198483|NCT03349515|5393961|P1|COMPLETED|Overall Study||50
2198484|NCT03349515|5393960|P2|STARTED|Overall Study||51
2198485|NCT03349515|5393961|P1|STARTED|Overall Study||55
2198486|NCT03349437|5393967|P3|NOT COMPLETED|Intervention||0
2198487|NCT03349437|5393968|P2|NOT COMPLETED|Intervention||0
2198488|NCT03349437|5393969|P1|NOT COMPLETED|Intervention||0
2198489|NCT03349437|5393967|P3|COMPLETED|Intervention||10
2198490|NCT03349437|5393968|P2|COMPLETED|Intervention||10
2198491|NCT03349437|5393969|P1|COMPLETED|Intervention||0
2198492|NCT03349437|5393967|P3|STARTED|Intervention||10
2198493|NCT03349437|5393968|P2|STARTED|Intervention||10
2198494|NCT03349437|5393969|P1|STARTED|Intervention||0
2198495|NCT03349437|5393967|P3|NOT COMPLETED|Screening||0
2198496|NCT03349437|5393968|P2|NOT COMPLETED|Screening||0
2198497|NCT03349437|5393969|P1|NOT COMPLETED|Screening||5
2198498|NCT03349437|5393967|P3|COMPLETED|Screening||0
2198499|NCT03349437|5393968|P2|COMPLETED|Screening||0
2198500|NCT03349437|5393969|P1|COMPLETED|Screening||20
2198501|NCT03349437|5393967|P3|STARTED|Screening||0
2198502|NCT03349437|5393968|P2|STARTED|Screening||0
2198503|NCT03349437|5393969|P1|STARTED|Screening||25
2198504|NCT03349333|5393976|P1|NOT COMPLETED|Overall Study||71
2198505|NCT03349333|5393976|P1|COMPLETED|Overall Study||0
2198506|NCT03349333|5393976|P1|STARTED|Overall Study||71
2198507|NCT03349099|5393999|P2|NOT COMPLETED|Overall Study||4
2198508|NCT03349099|5394000|P1|NOT COMPLETED|Overall Study||4
2198509|NCT03349099|5393999|P2|COMPLETED|Overall Study||43
2198510|NCT03349099|5394000|P1|COMPLETED|Overall Study||44
2198511|NCT03349099|5393999|P2|STARTED|Overall Study||47
2198512|NCT03349099|5394000|P1|STARTED|Overall Study||48
2198513|NCT03349060|5394013|P3|NOT COMPLETED|Overall Study||16
2198514|NCT03349060|5394014|P2|NOT COMPLETED|Overall Study||17
2198515|NCT03349060|5394015|P1|NOT COMPLETED|Overall Study||21
2198516|NCT03349060|5394013|P3|COMPLETED|Overall Study||61
2198517|NCT03349060|5394014|P2|COMPLETED|Overall Study||137
2198518|NCT03349060|5394015|P1|COMPLETED|Overall Study||135
2198519|NCT03349060|5394013|P3|STARTED|Overall Study||77
2198520|NCT03349060|5394014|P2|STARTED|Overall Study||154
2198521|NCT03349060|5394015|P1|STARTED|Overall Study||156
2198522|NCT03348904|5394157|P3|NOT COMPLETED|Overall Study||0
2198523|NCT03348904|5394158|P2|NOT COMPLETED|Overall Study||1
2198524|NCT03348904|5394159|P1|NOT COMPLETED|Overall Study||0
2198525|NCT03348904|5394157|P3|COMPLETED|Overall Study||0
2198526|NCT03348904|5394158|P2|COMPLETED|Overall Study||1
2198527|NCT03348904|5394159|P1|COMPLETED|Overall Study||0
2198528|NCT03348904|5394157|P3|STARTED|Overall Study||0
2198529|NCT03348904|5394158|P2|STARTED|Overall Study||2
2198530|NCT03348904|5394159|P1|STARTED|Overall Study||0
2198531|NCT03348683|5394178|P2|NOT COMPLETED|Overall Study||0
2198532|NCT03348683|5394179|P1|NOT COMPLETED|Overall Study||0
2198533|NCT03348683|5394178|P2|COMPLETED|Overall Study||119
2198534|NCT03348683|5394179|P1|COMPLETED|Overall Study||121
2198535|NCT03348683|5394178|P2|STARTED|Overall Study||119
2198536|NCT03348683|5394179|P1|STARTED|Overall Study||121
2198537|NCT03346902|5394203|P2|NOT COMPLETED|Overall Study||0
2198538|NCT03346902|5394204|P1|NOT COMPLETED|Overall Study||0
2198539|NCT03346902|5394203|P2|COMPLETED|Overall Study||8
2198540|NCT03346902|5394204|P1|COMPLETED|Overall Study||4
2198541|NCT03346902|5394203|P2|STARTED|Overall Study||8
2198542|NCT03346902|5394204|P1|STARTED|Overall Study||4
2198543|NCT03346759|5394212|P2|NOT COMPLETED|Third Menstrual Cycle||0
2198544|NCT03346759|5394213|P1|NOT COMPLETED|Third Menstrual Cycle||0
2198545|NCT03346759|5394212|P2|COMPLETED|Third Menstrual Cycle||10
2198546|NCT03346759|5394213|P1|COMPLETED|Third Menstrual Cycle||11
2198547|NCT03346759|5394212|P2|STARTED|Third Menstrual Cycle||10
2198548|NCT03346759|5394213|P1|STARTED|Third Menstrual Cycle||11
2198549|NCT03346759|5394212|P2|NOT COMPLETED|Second Menstrual Cycle||0
2198550|NCT03346759|5394213|P1|NOT COMPLETED|Second Menstrual Cycle||1
2198551|NCT03346759|5394212|P2|COMPLETED|Second Menstrual Cycle||10
2198552|NCT03346759|5394213|P1|COMPLETED|Second Menstrual Cycle||11
2198553|NCT03346759|5394212|P2|STARTED|Second Menstrual Cycle||10
2198554|NCT03346759|5394213|P1|STARTED|Second Menstrual Cycle||12
2198555|NCT03346759|5394212|P2|NOT COMPLETED|First Menstrual Cycle||0
2198556|NCT03346759|5394213|P1|NOT COMPLETED|First Menstrual Cycle||1
2198557|NCT03346759|5394212|P2|COMPLETED|First Menstrual Cycle||10
2198558|NCT03346759|5394213|P1|COMPLETED|First Menstrual Cycle||12
2198559|NCT03346759|5394212|P2|STARTED|First Menstrual Cycle||10
2198560|NCT03346759|5394213|P1|STARTED|First Menstrual Cycle||13
2198561|NCT03346759|5394212|P2|NOT COMPLETED|Enrollment to Baseline Data Collected||3
2198562|NCT03346759|5394213|P1|NOT COMPLETED|Enrollment to Baseline Data Collected||2
2198563|NCT03346759|5394212|P2|COMPLETED|Enrollment to Baseline Data Collected|Participants assigned to the Tampon B First arm who provided at least one vaginal microbiota sample.|10
2198564|NCT03346759|5394213|P1|COMPLETED|Enrollment to Baseline Data Collected|Participants assigned to the Tampon A First arm who provided at least one vaginal microbiota sample.|13
2198565|NCT03346759|5394212|P2|STARTED|Enrollment to Baseline Data Collected||13
2198566|NCT03346759|5394213|P1|STARTED|Enrollment to Baseline Data Collected||15
2198567|NCT03346161|5394224|P2|NOT COMPLETED|Overall Study||0
2198568|NCT03346161|5394225|P1|NOT COMPLETED|Overall Study||0
2198569|NCT03346161|5394224|P2|COMPLETED|Overall Study||60
2198570|NCT03346161|5394225|P1|COMPLETED|Overall Study||60
2198571|NCT03346161|5394224|P2|STARTED|Overall Study||60
2198572|NCT03346161|5394225|P1|STARTED|Overall Study||60
2198573|NCT03346070|5394258|P5|NOT COMPLETED|Overall Study||5
2198574|NCT03346070|5394259|P4|NOT COMPLETED|Overall Study||6
2198575|NCT03346070|5394260|P3|NOT COMPLETED|Overall Study||4
2198576|NCT03346070|5394261|P2|NOT COMPLETED|Overall Study||4
2198577|NCT03346070|5394262|P1|NOT COMPLETED|Overall Study||3
2198578|NCT03346070|5394258|P5|COMPLETED|Overall Study||37
2198579|NCT03346070|5394259|P4|COMPLETED|Overall Study||36
2198580|NCT03346070|5394260|P3|COMPLETED|Overall Study||37
2198581|NCT03346070|5394261|P2|COMPLETED|Overall Study||37
2198582|NCT03346070|5394262|P1|COMPLETED|Overall Study||38
2198583|NCT03346070|5394258|P5|Treated|Overall Study||38
2198584|NCT03346070|5394259|P4|Treated|Overall Study||36
2198585|NCT03346070|5394260|P3|Treated|Overall Study||38
2198586|NCT03346070|5394261|P2|Treated|Overall Study||38
2198587|NCT03346070|5394262|P1|Treated|Overall Study||38
2198588|NCT03346070|5394258|P5|STARTED|Overall Study||42
2198589|NCT03346070|5394259|P4|STARTED|Overall Study||42
2198590|NCT03346070|5394260|P3|STARTED|Overall Study||41
2198591|NCT03346070|5394261|P2|STARTED|Overall Study||41
2198592|NCT03346070|5394262|P1|STARTED|Overall Study||41
2198593|NCT03345407|5394353|P7|NOT COMPLETED|Overall Study||45
2198594|NCT03345407|5394354|P6|NOT COMPLETED|Overall Study||16
2198595|NCT03345407|5394355|P5|NOT COMPLETED|Overall Study||15
2198596|NCT03345407|5394356|P4|NOT COMPLETED|Overall Study||11
2198597|NCT03345407|5394357|P3|NOT COMPLETED|Overall Study||12
2198598|NCT03345407|5394358|P2|NOT COMPLETED|Overall Study||3
2198599|NCT03345407|5394359|P1|NOT COMPLETED|Overall Study||32
2198600|NCT03345407|5394353|P7|COMPLETED|Overall Study||233
2198601|NCT03345407|5394354|P6|COMPLETED|Overall Study||73
2198602|NCT03345407|5394355|P5|COMPLETED|Overall Study||75
2198603|NCT03345407|5394356|P4|COMPLETED|Overall Study||81
2198604|NCT03345407|5394357|P3|COMPLETED|Overall Study||79
2198605|NCT03345407|5394358|P2|COMPLETED|Overall Study||19
2198606|NCT03345407|5394359|P1|COMPLETED|Overall Study||244
2198607|NCT03345407|5394353|P7|STARTED|Overall Study||278
2198608|NCT03345407|5394354|P6|STARTED|Overall Study||89
2198609|NCT03345407|5394355|P5|STARTED|Overall Study||90
2198610|NCT03345407|5394356|P4|STARTED|Overall Study||92
2198611|NCT03345407|5394357|P3|STARTED|Overall Study||91
2198612|NCT03345407|5394358|P2|STARTED|Overall Study||22
2198613|NCT03345407|5394359|P1|STARTED|Overall Study||276
2198614|NCT03345108|5394544|P6|NOT COMPLETED|Period-3||0
2198615|NCT03345108|5394545|P5|NOT COMPLETED|Period-3||0
2198616|NCT03345108|5394546|P4|NOT COMPLETED|Period-3||0
2198617|NCT03345108|5394547|P3|NOT COMPLETED|Period-3||0
2198618|NCT03345108|5394548|P2|NOT COMPLETED|Period-3||0
2198619|NCT03345108|5394549|P1|NOT COMPLETED|Period-3||0
2198620|NCT03345108|5394544|P6|COMPLETED|Period-3||8
2198621|NCT03345108|5394545|P5|COMPLETED|Period-3||8
2198622|NCT03345108|5394546|P4|COMPLETED|Period-3||8
2198623|NCT03345108|5394547|P3|COMPLETED|Period-3||8
2198624|NCT03345108|5394548|P2|COMPLETED|Period-3||8
2198625|NCT03345108|5394549|P1|COMPLETED|Period-3||7
2198626|NCT03345108|5394544|P6|STARTED|Period-3||8
2198627|NCT03345108|5394545|P5|STARTED|Period-3||8
2198628|NCT03345108|5394546|P4|STARTED|Period-3||8
2198629|NCT03345108|5394547|P3|STARTED|Period-3||8
2198630|NCT03345108|5394548|P2|STARTED|Period-3||8
2198631|NCT03345108|5394549|P1|STARTED|Period-3||7
2198632|NCT03345108|5394544|P6|NOT COMPLETED|Period-2||0
2198633|NCT03345108|5394545|P5|NOT COMPLETED|Period-2||0
2198634|NCT03345108|5394546|P4|NOT COMPLETED|Period-2||0
2198635|NCT03345108|5394547|P3|NOT COMPLETED|Period-2||0
2198636|NCT03345108|5394548|P2|NOT COMPLETED|Period-2||0
2198637|NCT03345108|5394549|P1|NOT COMPLETED|Period-2||0
2198638|NCT03345108|5394544|P6|COMPLETED|Period-2||8
2198639|NCT03345108|5394545|P5|COMPLETED|Period-2||8
2198640|NCT03345108|5394546|P4|COMPLETED|Period-2||8
2198641|NCT03345108|5394547|P3|COMPLETED|Period-2||8
2198642|NCT03345108|5394548|P2|COMPLETED|Period-2||8
2198643|NCT03345108|5394549|P1|COMPLETED|Period-2||8
2198644|NCT03345108|5394544|P6|STARTED|Period-2||8
2198645|NCT03345108|5394545|P5|STARTED|Period-2||8
2198646|NCT03345108|5394546|P4|STARTED|Period-2||8
2198647|NCT03345108|5394547|P3|STARTED|Period-2||8
2198648|NCT03345108|5394548|P2|STARTED|Period-2||8
2198649|NCT03345108|5394549|P1|STARTED|Period-2||8
2198650|NCT03345108|5394544|P6|NOT COMPLETED|Period-1||0
2198651|NCT03345108|5394545|P5|NOT COMPLETED|Period-1||0
2198652|NCT03345108|5394546|P4|NOT COMPLETED|Period-1||0
2198653|NCT03345108|5394547|P3|NOT COMPLETED|Period-1||0
2198654|NCT03345108|5394548|P2|NOT COMPLETED|Period-1||0
2198655|NCT03345108|5394549|P1|NOT COMPLETED|Period-1||0
2198656|NCT03345108|5394544|P6|COMPLETED|Period-1||8
2198657|NCT03345108|5394545|P5|COMPLETED|Period-1||8
2198658|NCT03345108|5394546|P4|COMPLETED|Period-1||8
2198659|NCT03345108|5394547|P3|COMPLETED|Period-1||8
2198660|NCT03345108|5394548|P2|COMPLETED|Period-1||8
2198661|NCT03345108|5394549|P1|COMPLETED|Period-1||8
2198662|NCT03345108|5394544|P6|STARTED|Period-1||8
2198663|NCT03345108|5394545|P5|STARTED|Period-1||8
2198664|NCT03345108|5394546|P4|STARTED|Period-1||8
2198665|NCT03345108|5394547|P3|STARTED|Period-1||8
2198666|NCT03345108|5394548|P2|STARTED|Period-1||8
2198667|NCT03345108|5394549|P1|STARTED|Period-1||8
2198668|NCT03344861|5394557|P1|NOT COMPLETED|Overall Study||0
2198669|NCT03344861|5394557|P1|COMPLETED|Overall Study||10
2198670|NCT03344861|5394557|P1|STARTED|Overall Study||10
2198671|NCT03344510|5394586|P2|NOT COMPLETED|Second Injection (5 Minutes)||0
2198672|NCT03344510|5394587|P1|NOT COMPLETED|Second Injection (5 Minutes)||0
2198673|NCT03344510|5394586|P2|COMPLETED|Second Injection (5 Minutes)||26
2198674|NCT03344510|5394587|P1|COMPLETED|Second Injection (5 Minutes)||21
2198675|NCT03344510|5394586|P2|Received Injection|Second Injection (5 Minutes)||26
2198676|NCT03344510|5394587|P1|Received Injection|Second Injection (5 Minutes)||21
2198677|NCT03344510|5394586|P2|STARTED|Second Injection (5 Minutes)||26
2198678|NCT03344510|5394587|P1|STARTED|Second Injection (5 Minutes)||21
2198679|NCT03344510|5394586|P2|NOT COMPLETED|Wash Out (10 Minutes||0
2198680|NCT03344510|5394587|P1|NOT COMPLETED|Wash Out (10 Minutes||0
2198681|NCT03344510|5394586|P2|COMPLETED|Wash Out (10 Minutes||26
2198682|NCT03344510|5394587|P1|COMPLETED|Wash Out (10 Minutes||21
2198683|NCT03344510|5394586|P2|STARTED|Wash Out (10 Minutes||26
2198684|NCT03344510|5394587|P1|STARTED|Wash Out (10 Minutes||21
2198685|NCT03344510|5394586|P2|NOT COMPLETED|First Injection (5 Minutes)||0
2198686|NCT03344510|5394587|P1|NOT COMPLETED|First Injection (5 Minutes)||0
2198687|NCT03344510|5394586|P2|COMPLETED|First Injection (5 Minutes)||26
2198688|NCT03344510|5394587|P1|COMPLETED|First Injection (5 Minutes)||21
2198689|NCT03344510|5394586|P2|Received Injection|First Injection (5 Minutes)||26
2198690|NCT03344510|5394587|P1|Received Injection|First Injection (5 Minutes)||21
2198691|NCT03344510|5394586|P2|STARTED|First Injection (5 Minutes)||26
2198692|NCT03344510|5394587|P1|STARTED|First Injection (5 Minutes)||21
2198693|NCT03343639|5394596|P2|NOT COMPLETED|Overall Study||12
2198694|NCT03343639|5394597|P1|NOT COMPLETED|Overall Study||14
2198695|NCT03343639|5394596|P2|COMPLETED|Overall Study||90
2198696|NCT03343639|5394597|P1|COMPLETED|Overall Study||88
2198697|NCT03343639|5394596|P2|STARTED|Overall Study||102
2198698|NCT03343639|5394597|P1|STARTED|Overall Study||102
2198699|NCT03343080|5394611|P2|NOT COMPLETED|Overall Study||0
2198700|NCT03343080|5394612|P1|NOT COMPLETED|Overall Study||0
2198701|NCT03343080|5394611|P2|COMPLETED|Overall Study||18
2198702|NCT03343080|5394612|P1|COMPLETED|Overall Study||14
2198703|NCT03343080|5394611|P2|STARTED|Overall Study||18
2198704|NCT03343080|5394612|P1|STARTED|Overall Study||14
2198705|NCT03343067|5394625|P3|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||1
2198706|NCT03343067|5394626|P2|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||3
2198707|NCT03343067|5394627|P1|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||0
2198708|NCT03343067|5394625|P3|COMPLETED|Double Blind Period: Month 3 to Month 6||0
2198709|NCT03343067|5394626|P2|COMPLETED|Double Blind Period: Month 3 to Month 6||0
2198710|NCT03343067|5394627|P1|COMPLETED|Double Blind Period: Month 3 to Month 6||0
2198711|NCT03343067|5394625|P3|STARTED|Double Blind Period: Month 3 to Month 6||1
2198712|NCT03343067|5394626|P2|STARTED|Double Blind Period: Month 3 to Month 6||3
2198713|NCT03343067|5394627|P1|STARTED|Double Blind Period: Month 3 to Month 6||0
2198714|NCT03343067|5394625|P3|NOT COMPLETED|Open Label Period: Day 1 to Month 3||0
2198715|NCT03343067|5394626|P2|NOT COMPLETED|Open Label Period: Day 1 to Month 3||0
2198716|NCT03343067|5394627|P1|NOT COMPLETED|Open Label Period: Day 1 to Month 3||7
2198717|NCT03343067|5394625|P3|COMPLETED|Open Label Period: Day 1 to Month 3||1
2198718|NCT03343067|5394626|P2|COMPLETED|Open Label Period: Day 1 to Month 3||3
2198719|NCT03343067|5394627|P1|COMPLETED|Open Label Period: Day 1 to Month 3||0
2198720|NCT03343067|5394625|P3|STARTED|Open Label Period: Day 1 to Month 3||1
2198721|NCT03343067|5394626|P2|STARTED|Open Label Period: Day 1 to Month 3||3
2198722|NCT03343067|5394627|P1|STARTED|Open Label Period: Day 1 to Month 3||7
2198723|NCT03342560|5394752|P1|NOT COMPLETED|Overall Study||2
2198724|NCT03342560|5394752|P1|COMPLETED|Overall Study||28
2198725|NCT03342560|5394752|P1|STARTED|Overall Study||30
2198726|NCT03341923|5394760|P2|NOT COMPLETED|Period 2, Second 14 Days of Wear||1
2198727|NCT03341923|5394761|P1|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
2198728|NCT03341923|5394760|P2|COMPLETED|Period 2, Second 14 Days of Wear||65
2198729|NCT03341923|5394761|P1|COMPLETED|Period 2, Second 14 Days of Wear||67
2198730|NCT03341923|5394760|P2|STARTED|Period 2, Second 14 Days of Wear|Subject completed Period 1 but was discontinued before starting Period 2.|66
2198731|NCT03341923|5394761|P1|STARTED|Period 2, Second 14 Days of Wear||67
2198732|NCT03341923|5394760|P2|NOT COMPLETED|Period 1, First 14 Days of Wear||0
2198733|NCT03341923|5394761|P1|NOT COMPLETED|Period 1, First 14 Days of Wear||0
2198734|NCT03341923|5394760|P2|COMPLETED|Period 1, First 14 Days of Wear||67
2198735|NCT03341923|5394761|P1|COMPLETED|Period 1, First 14 Days of Wear||67
2198736|NCT03341923|5394760|P2|STARTED|Period 1, First 14 Days of Wear||67
2198737|NCT03341923|5394761|P1|STARTED|Period 1, First 14 Days of Wear||67
2198738|NCT03341728|5394769|P2|NOT COMPLETED|Session 2||0
2198739|NCT03341728|5394770|P1|NOT COMPLETED|Session 2||0
2198740|NCT03341728|5394769|P2|COMPLETED|Session 2||7
2198741|NCT03341728|5394770|P1|COMPLETED|Session 2||7
2198742|NCT03341728|5394769|P2|STARTED|Session 2||7
2198743|NCT03341728|5394770|P1|STARTED|Session 2||7
2198744|NCT03341728|5394769|P2|NOT COMPLETED|Washout (1 Week)||0
2198745|NCT03341728|5394770|P1|NOT COMPLETED|Washout (1 Week)||0
2198746|NCT03341728|5394769|P2|COMPLETED|Washout (1 Week)||7
2198747|NCT03341728|5394770|P1|COMPLETED|Washout (1 Week)||7
2198748|NCT03341728|5394769|P2|STARTED|Washout (1 Week)||7
2198749|NCT03341728|5394770|P1|STARTED|Washout (1 Week)||7
2198750|NCT03341728|5394769|P2|NOT COMPLETED|Session 1||0
2198751|NCT03341728|5394770|P1|NOT COMPLETED|Session 1||0
2198752|NCT03341728|5394769|P2|COMPLETED|Session 1||7
2198753|NCT03341728|5394770|P1|COMPLETED|Session 1||7
2198754|NCT03341728|5394769|P2|STARTED|Session 1||7
2198755|NCT03341728|5394770|P1|STARTED|Session 1||7
2198756|NCT03341637|5394788|P2|NOT COMPLETED|Overall Study||4
2198757|NCT03341637|5394789|P1|NOT COMPLETED|Overall Study||5
2198758|NCT03341637|5394788|P2|COMPLETED|Overall Study||296
2198759|NCT03341637|5394789|P1|COMPLETED|Overall Study||95
2198760|NCT03341637|5394788|P2|STARTED|Overall Study||300
2198761|NCT03341637|5394789|P1|STARTED|Overall Study||100
2198762|NCT03341546|5394811|P1|NOT COMPLETED|Overall Study||0
2198763|NCT03341546|5394811|P1|COMPLETED|Overall Study||20
2198764|NCT03341546|5394811|P1|STARTED|Overall Study||20
2198765|NCT03340805|5394817|P2|NOT COMPLETED|Overall Study||0
2198766|NCT03340805|5394818|P1|NOT COMPLETED|Overall Study||0
2198767|NCT03340805|5394817|P2|COMPLETED|Overall Study||26
2198768|NCT03340805|5394818|P1|COMPLETED|Overall Study|1 subject withdrew early from study fluid administration but stayed in trial for outcome assessment|24
2198769|NCT03340805|5394817|P2|STARTED|Overall Study||26
2198770|NCT03340805|5394818|P1|STARTED|Overall Study||24
2198771|NCT03340610|5394838|P1|NOT COMPLETED|Overall Study||3
2198772|NCT03340610|5394838|P1|COMPLETED|Overall Study||27
2198773|NCT03340610|5394838|P1|STARTED|Overall Study||30
2198774|NCT03339726|5394845|P3|NOT COMPLETED|Overall Study||0
2198775|NCT03339726|5394846|P2|NOT COMPLETED|Overall Study||1
2198776|NCT03339726|5394847|P1|NOT COMPLETED|Overall Study||1
2198777|NCT03339726|5394845|P3|COMPLETED|Overall Study||63
2198778|NCT03339726|5394846|P2|COMPLETED|Overall Study||65
2198779|NCT03339726|5394847|P1|COMPLETED|Overall Study||63
2198780|NCT03339726|5394845|P3|STARTED|Overall Study||63
2198781|NCT03339726|5394846|P2|STARTED|Overall Study||66
2198782|NCT03339726|5394847|P1|STARTED|Overall Study||64
2198783|NCT03339583|5394905|P2|NOT COMPLETED|Follow-up (14 Days)||3
2198784|NCT03339583|5394906|P1|NOT COMPLETED|Follow-up (14 Days)||6
2198785|NCT03339583|5394905|P2|COMPLETED|Follow-up (14 Days)||18
2198786|NCT03339583|5394906|P1|COMPLETED|Follow-up (14 Days)||12
2198787|NCT03339583|5394905|P2|STARTED|Follow-up (14 Days)||21
2198788|NCT03339583|5394906|P1|STARTED|Follow-up (14 Days)||18
2198789|NCT03339583|5394905|P2|NOT COMPLETED|Second Intervention (14 Days)||2
2198790|NCT03339583|5394906|P1|NOT COMPLETED|Second Intervention (14 Days)||0
2198791|NCT03339583|5394905|P2|COMPLETED|Second Intervention (14 Days)||21
2198792|NCT03339583|5394906|P1|COMPLETED|Second Intervention (14 Days)||18
2198793|NCT03339583|5394905|P2|STARTED|Second Intervention (14 Days)||23
2198794|NCT03339583|5394906|P1|STARTED|Second Intervention (14 Days)||18
2198795|NCT03339583|5394905|P2|NOT COMPLETED|Washout (14 Days)||0
2198796|NCT03339583|5394906|P1|NOT COMPLETED|Washout (14 Days)||0
2198797|NCT03339583|5394905|P2|COMPLETED|Washout (14 Days)||23
2198798|NCT03339583|5394906|P1|COMPLETED|Washout (14 Days)||18
2198799|NCT03339583|5394905|P2|STARTED|Washout (14 Days)||23
2198800|NCT03339583|5394906|P1|STARTED|Washout (14 Days)||18
2198801|NCT03339583|5394905|P2|NOT COMPLETED|First Intervention (14 Days)||0
2198802|NCT03339583|5394906|P1|NOT COMPLETED|First Intervention (14 Days)||1
2198803|NCT03339583|5394905|P2|COMPLETED|First Intervention (14 Days)||23
2198804|NCT03339583|5394906|P1|COMPLETED|First Intervention (14 Days)||18
2198805|NCT03339583|5394905|P2|STARTED|First Intervention (14 Days)||23
2198806|NCT03339583|5394906|P1|STARTED|First Intervention (14 Days)||19
2198807|NCT03339453|5394944|P2|NOT COMPLETED|Second Visit for Alternate Glucagon||0
2198808|NCT03339453|5394945|P1|NOT COMPLETED|Second Visit for Alternate Glucagon||0
2198809|NCT03339453|5394944|P2|COMPLETED|Second Visit for Alternate Glucagon||34
2198810|NCT03339453|5394945|P1|COMPLETED|Second Visit for Alternate Glucagon||35
2198811|NCT03339453|5394944|P2|STARTED|Second Visit for Alternate Glucagon||34
2198812|NCT03339453|5394945|P1|STARTED|Second Visit for Alternate Glucagon||35
2198813|NCT03339453|5394944|P2|NOT COMPLETED|First Visit of Glucagon Treatment||1
2198814|NCT03339453|5394945|P1|NOT COMPLETED|First Visit of Glucagon Treatment||0
2198815|NCT03339453|5394944|P2|COMPLETED|First Visit of Glucagon Treatment||34
2198816|NCT03339453|5394945|P1|COMPLETED|First Visit of Glucagon Treatment||35
2198817|NCT03339453|5394944|P2|Received at Least 1 Dose of Study Drug|First Visit of Glucagon Treatment||35
2198818|NCT03339453|5394945|P1|Received at Least 1 Dose of Study Drug|First Visit of Glucagon Treatment||35
2198819|NCT03339453|5394944|P2|STARTED|First Visit of Glucagon Treatment||35
2198820|NCT03339453|5394945|P1|STARTED|First Visit of Glucagon Treatment||35
2198821|NCT03338816|5394963|P2|NOT COMPLETED|Open-Label Extension Period||47
2198822|NCT03338816|5394964|P1|NOT COMPLETED|Open-Label Extension Period||46
2198823|NCT03338816|5394963|P2|COMPLETED|Open-Label Extension Period||0
2198824|NCT03338816|5394964|P1|COMPLETED|Open-Label Extension Period||0
2198825|NCT03338816|5394963|P2|STARTED|Open-Label Extension Period||47
2198826|NCT03338816|5394964|P1|STARTED|Open-Label Extension Period||46
2198827|NCT03338816|5394963|P2|NOT COMPLETED|6-Month Double-blind Period||1
2198828|NCT03338816|5394964|P1|NOT COMPLETED|6-Month Double-blind Period||0
2198829|NCT03338816|5394963|P2|COMPLETED|6-Month Double-blind Period|1 participant discontinued treatment during the 6-month DB period but completed the 6-month DB Visit|47
2198830|NCT03338816|5394964|P1|COMPLETED|6-Month Double-blind Period||46
2198831|NCT03338816|5394963|P2|STARTED|6-Month Double-blind Period||48
2198832|NCT03338816|5394964|P1|STARTED|6-Month Double-blind Period||46
2198833|NCT03338803|5394992|P1|NOT COMPLETED|Overall Study||0
2198834|NCT03338803|5394992|P1|COMPLETED|Overall Study||11001
2198835|NCT03338803|5394992|P1|STARTED|Overall Study||11001
2198836|NCT03338556|5395003|P4|NOT COMPLETED|Overall Study||2
2198837|NCT03338556|5395004|P3|NOT COMPLETED|Overall Study||2
2198838|NCT03338556|5395005|P2|NOT COMPLETED|Overall Study||4
2198839|NCT03338556|5395006|P1|NOT COMPLETED|Overall Study||2
2198840|NCT03338556|5395003|P4|COMPLETED|Overall Study||24
2198841|NCT03338556|5395004|P3|COMPLETED|Overall Study||22
2198842|NCT03338556|5395005|P2|COMPLETED|Overall Study||23
2198843|NCT03338556|5395006|P1|COMPLETED|Overall Study||23
2198844|NCT03338556|5395003|P4|STARTED|Overall Study||26
2198845|NCT03338556|5395004|P3|STARTED|Overall Study||24
2198846|NCT03338556|5395005|P2|STARTED|Overall Study||27
2198847|NCT03338556|5395006|P1|STARTED|Overall Study||25
2198848|NCT03338400|5395026|P2|NOT COMPLETED|Overall Study||2
2198849|NCT03338400|5395027|P1|NOT COMPLETED|Overall Study||1
2198850|NCT03338400|5395026|P2|COMPLETED|Overall Study||24
2198851|NCT03338400|5395027|P1|COMPLETED|Overall Study||24
2198852|NCT03338400|5395026|P2|STARTED|Overall Study||26
2198853|NCT03338400|5395027|P1|STARTED|Overall Study||25
2198854|NCT03337477|5395035|P2|NOT COMPLETED|Overall Study||13
2198855|NCT03337477|5395036|P1|NOT COMPLETED|Overall Study||11
2198856|NCT03337477|5395035|P2|COMPLETED|Overall Study||24
2198857|NCT03337477|5395036|P1|COMPLETED|Overall Study||22
2198858|NCT03337477|5395035|P2|STARTED|Overall Study||37
2198859|NCT03337477|5395036|P1|STARTED|Overall Study||33
2198860|NCT03336853|5395058|P2|NOT COMPLETED|Overall Study||0
2198861|NCT03336853|5395059|P1|NOT COMPLETED|Overall Study||0
2198862|NCT03336853|5395058|P2|COMPLETED|Overall Study||30
2198863|NCT03336853|5395059|P1|COMPLETED|Overall Study||30
2198864|NCT03336853|5395058|P2|STARTED|Overall Study||30
2198865|NCT03336853|5395059|P1|STARTED|Overall Study||30
2198866|NCT03336502|5395067|P2|NOT COMPLETED|Overall Study||9
2198867|NCT03336502|5395068|P1|NOT COMPLETED|Overall Study||4
2198868|NCT03336502|5395067|P2|COMPLETED|Overall Study||31
2198869|NCT03336502|5395068|P1|COMPLETED|Overall Study||26
2198870|NCT03336502|5395067|P2|STARTED|Overall Study||40
2198871|NCT03336502|5395068|P1|STARTED|Overall Study||30
2198872|NCT03335566|5395097|P2|NOT COMPLETED|Overall Study||3
2198873|NCT03335566|5395098|P1|NOT COMPLETED|Overall Study||4
2198874|NCT03335566|5395097|P2|COMPLETED|Overall Study||203
2198875|NCT03335566|5395098|P1|COMPLETED|Overall Study||214
2198876|NCT03335566|5395097|P2|STARTED|Overall Study||206
2198877|NCT03335566|5395098|P1|STARTED|Overall Study||218
2198878|NCT03335254|5395130|P20|NOT COMPLETED|Period 3, Day 26-30||0
2198879|NCT03335254|5395131|P19|NOT COMPLETED|Period 3, Day 26-30||0
2198880|NCT03335254|5395132|P18|NOT COMPLETED|Period 3, Day 26-30||0
2198881|NCT03335254|5395133|P17|NOT COMPLETED|Period 3, Day 26-30||0
2198882|NCT03335254|5395134|P16|NOT COMPLETED|Period 3, Day 26-30||0
2198883|NCT03335254|5395135|P15|NOT COMPLETED|Period 3, Day 26-30||0
2198884|NCT03335254|5395136|P14|NOT COMPLETED|Period 3, Day 26-30||0
2198885|NCT03335254|5395137|P13|NOT COMPLETED|Period 3, Day 26-30||0
2198886|NCT03335254|5395138|P12|NOT COMPLETED|Period 3, Day 26-30||0
2198887|NCT03335254|5395139|P11|NOT COMPLETED|Period 3, Day 26-30||0
2198888|NCT03335254|5395140|P10|NOT COMPLETED|Period 3, Day 26-30||0
2198889|NCT03335254|5395141|P9|NOT COMPLETED|Period 3, Day 26-30||0
2198890|NCT03335254|5395142|P8|NOT COMPLETED|Period 3, Day 26-30||0
2198891|NCT03335254|5395143|P7|NOT COMPLETED|Period 3, Day 26-30||0
2198892|NCT03335254|5395144|P6|NOT COMPLETED|Period 3, Day 26-30||0
2198893|NCT03335254|5395145|P5|NOT COMPLETED|Period 3, Day 26-30||0
2198894|NCT03335254|5395146|P4|NOT COMPLETED|Period 3, Day 26-30||0
2198895|NCT03335254|5395147|P3|NOT COMPLETED|Period 3, Day 26-30||0
2198896|NCT03335254|5395148|P2|NOT COMPLETED|Period 3, Day 26-30||0
2198897|NCT03335254|5395149|P1|NOT COMPLETED|Period 3, Day 26-30||0
2198898|NCT03335254|5395130|P20|COMPLETED|Period 3, Day 26-30||0
2198899|NCT03335254|5395131|P19|COMPLETED|Period 3, Day 26-30||0
2198900|NCT03335254|5395132|P18|COMPLETED|Period 3, Day 26-30||0
2198901|NCT03335254|5395133|P17|COMPLETED|Period 3, Day 26-30||0
2198902|NCT03335254|5395134|P16|COMPLETED|Period 3, Day 26-30||0
2198903|NCT03335254|5395135|P15|COMPLETED|Period 3, Day 26-30||0
2198904|NCT03335254|5395136|P14|COMPLETED|Period 3, Day 26-30||0
2198905|NCT03335254|5395137|P13|COMPLETED|Period 3, Day 26-30||0
2198906|NCT03335254|5395138|P12|COMPLETED|Period 3, Day 26-30||0
2198907|NCT03335254|5395139|P11|COMPLETED|Period 3, Day 26-30||0
2198908|NCT03335254|5395140|P10|COMPLETED|Period 3, Day 26-30||0
2198909|NCT03335254|5395141|P9|COMPLETED|Period 3, Day 26-30||0
2198910|NCT03335254|5395142|P8|COMPLETED|Period 3, Day 26-30||0
2198911|NCT03335254|5395143|P7|COMPLETED|Period 3, Day 26-30||0
2198912|NCT03335254|5395144|P6|COMPLETED|Period 3, Day 26-30||0
2198913|NCT03335254|5395145|P5|COMPLETED|Period 3, Day 26-30||0
2198914|NCT03335254|5395146|P4|COMPLETED|Period 3, Day 26-30||0
2198915|NCT03335254|5395147|P3|COMPLETED|Period 3, Day 26-30||0
2198916|NCT03335254|5395148|P2|COMPLETED|Period 3, Day 26-30||0
2198917|NCT03335254|5395149|P1|COMPLETED|Period 3, Day 26-30||9
2198918|NCT03335254|5395130|P20|STARTED|Period 3, Day 26-30||0
2198919|NCT03335254|5395131|P19|STARTED|Period 3, Day 26-30||0
2198920|NCT03335254|5395132|P18|STARTED|Period 3, Day 26-30||0
2198921|NCT03335254|5395133|P17|STARTED|Period 3, Day 26-30||0
2198922|NCT03335254|5395134|P16|STARTED|Period 3, Day 26-30||0
2198923|NCT03335254|5395135|P15|STARTED|Period 3, Day 26-30||0
2198924|NCT03335254|5395136|P14|STARTED|Period 3, Day 26-30||0
2198925|NCT03335254|5395137|P13|STARTED|Period 3, Day 26-30||0
2198926|NCT03335254|5395138|P12|STARTED|Period 3, Day 26-30||0
2198927|NCT03335254|5395139|P11|STARTED|Period 3, Day 26-30||0
2198928|NCT03335254|5395140|P10|STARTED|Period 3, Day 26-30||0
2198929|NCT03335254|5395141|P9|STARTED|Period 3, Day 26-30||0
2198930|NCT03335254|5395142|P8|STARTED|Period 3, Day 26-30||0
2198931|NCT03335254|5395143|P7|STARTED|Period 3, Day 26-30||0
2198932|NCT03335254|5395144|P6|STARTED|Period 3, Day 26-30||0
2198933|NCT03335254|5395145|P5|STARTED|Period 3, Day 26-30||0
2198934|NCT03335254|5395146|P4|STARTED|Period 3, Day 26-30||0
2198935|NCT03335254|5395147|P3|STARTED|Period 3, Day 26-30||0
2198936|NCT03335254|5395148|P2|STARTED|Period 3, Day 26-30||0
2198937|NCT03335254|5395149|P1|STARTED|Period 3, Day 26-30||9
2198938|NCT03335254|5395130|P20|NOT COMPLETED|Period 3, Day 16-25||0
2198939|NCT03335254|5395131|P19|NOT COMPLETED|Period 3, Day 16-25||0
2198940|NCT03335254|5395132|P18|NOT COMPLETED|Period 3, Day 16-25||0
2198941|NCT03335254|5395133|P17|NOT COMPLETED|Period 3, Day 16-25||0
2198942|NCT03335254|5395134|P16|NOT COMPLETED|Period 3, Day 16-25||0
2198943|NCT03335254|5395135|P15|NOT COMPLETED|Period 3, Day 16-25||0
2198944|NCT03335254|5395136|P14|NOT COMPLETED|Period 3, Day 16-25||0
2198945|NCT03335254|5395137|P13|NOT COMPLETED|Period 3, Day 16-25||0
2198946|NCT03335254|5395138|P12|NOT COMPLETED|Period 3, Day 16-25||0
2198947|NCT03335254|5395139|P11|NOT COMPLETED|Period 3, Day 16-25||0
2198948|NCT03335254|5395140|P10|NOT COMPLETED|Period 3, Day 16-25||0
2198949|NCT03335254|5395141|P9|NOT COMPLETED|Period 3, Day 16-25||0
2198950|NCT03335254|5395142|P8|NOT COMPLETED|Period 3, Day 16-25||0
2198951|NCT03335254|5395143|P7|NOT COMPLETED|Period 3, Day 16-25||0
2198952|NCT03335254|5395144|P6|NOT COMPLETED|Period 3, Day 16-25||0
2198953|NCT03335254|5395145|P5|NOT COMPLETED|Period 3, Day 16-25||0
2198954|NCT03335254|5395146|P4|NOT COMPLETED|Period 3, Day 16-25||0
2198955|NCT03335254|5395147|P3|NOT COMPLETED|Period 3, Day 16-25||0
2198956|NCT03335254|5395148|P2|NOT COMPLETED|Period 3, Day 16-25||0
2198957|NCT03335254|5395149|P1|NOT COMPLETED|Period 3, Day 16-25||0
2198958|NCT03335254|5395130|P20|COMPLETED|Period 3, Day 16-25||0
2198959|NCT03335254|5395131|P19|COMPLETED|Period 3, Day 16-25||0
2198960|NCT03335254|5395132|P18|COMPLETED|Period 3, Day 16-25||0
2198961|NCT03335254|5395133|P17|COMPLETED|Period 3, Day 16-25||0
2198962|NCT03335254|5395134|P16|COMPLETED|Period 3, Day 16-25||0
2198963|NCT03335254|5395135|P15|COMPLETED|Period 3, Day 16-25||0
2198964|NCT03335254|5395136|P14|COMPLETED|Period 3, Day 16-25||0
2198965|NCT03335254|5395137|P13|COMPLETED|Period 3, Day 16-25||0
2198966|NCT03335254|5395138|P12|COMPLETED|Period 3, Day 16-25||0
2198967|NCT03335254|5395139|P11|COMPLETED|Period 3, Day 16-25||0
2198968|NCT03335254|5395140|P10|COMPLETED|Period 3, Day 16-25||0
2198969|NCT03335254|5395141|P9|COMPLETED|Period 3, Day 16-25||0
2198970|NCT03335254|5395142|P8|COMPLETED|Period 3, Day 16-25||0
2198971|NCT03335254|5395143|P7|COMPLETED|Period 3, Day 16-25||0
2198972|NCT03335254|5395144|P6|COMPLETED|Period 3, Day 16-25||0
2198973|NCT03335254|5395145|P5|COMPLETED|Period 3, Day 16-25||0
2198974|NCT03335254|5395146|P4|COMPLETED|Period 3, Day 16-25||0
2198975|NCT03335254|5395147|P3|COMPLETED|Period 3, Day 16-25||0
2198976|NCT03335254|5395148|P2|COMPLETED|Period 3, Day 16-25||0
2198977|NCT03335254|5395149|P1|COMPLETED|Period 3, Day 16-25||9
2198978|NCT03335254|5395130|P20|STARTED|Period 3, Day 16-25||0
2198979|NCT03335254|5395131|P19|STARTED|Period 3, Day 16-25||0
2198980|NCT03335254|5395132|P18|STARTED|Period 3, Day 16-25||0
2198981|NCT03335254|5395133|P17|STARTED|Period 3, Day 16-25||0
2198982|NCT03335254|5395134|P16|STARTED|Period 3, Day 16-25||0
2198983|NCT03335254|5395135|P15|STARTED|Period 3, Day 16-25||0
2198984|NCT03335254|5395136|P14|STARTED|Period 3, Day 16-25||0
2198985|NCT03335254|5395137|P13|STARTED|Period 3, Day 16-25||0
2198986|NCT03335254|5395138|P12|STARTED|Period 3, Day 16-25||0
2198987|NCT03335254|5395139|P11|STARTED|Period 3, Day 16-25||0
2198988|NCT03335254|5395140|P10|STARTED|Period 3, Day 16-25||0
2198989|NCT03335254|5395141|P9|STARTED|Period 3, Day 16-25||0
2198990|NCT03335254|5395142|P8|STARTED|Period 3, Day 16-25||0
2198991|NCT03335254|5395143|P7|STARTED|Period 3, Day 16-25||0
2198992|NCT03335254|5395144|P6|STARTED|Period 3, Day 16-25||0
2198993|NCT03335254|5395145|P5|STARTED|Period 3, Day 16-25||0
2198994|NCT03335254|5395146|P4|STARTED|Period 3, Day 16-25||0
2198995|NCT03335254|5395147|P3|STARTED|Period 3, Day 16-25||0
2198996|NCT03335254|5395148|P2|STARTED|Period 3, Day 16-25||0
2198997|NCT03335254|5395149|P1|STARTED|Period 3, Day 16-25||9
2198998|NCT03335254|5395130|P20|NOT COMPLETED|Period 2, Day 1-15||0
2198999|NCT03335254|5395131|P19|NOT COMPLETED|Period 2, Day 1-15||0
2199000|NCT03335254|5395132|P18|NOT COMPLETED|Period 2, Day 1-15||0
2199001|NCT03335254|5395133|P17|NOT COMPLETED|Period 2, Day 1-15||0
2199002|NCT03335254|5395134|P16|NOT COMPLETED|Period 2, Day 1-15||0
2199003|NCT03335254|5395135|P15|NOT COMPLETED|Period 2, Day 1-15||0
2199004|NCT03335254|5395136|P14|NOT COMPLETED|Period 2, Day 1-15||0
2199005|NCT03335254|5395137|P13|NOT COMPLETED|Period 2, Day 1-15||0
2199006|NCT03335254|5395138|P12|NOT COMPLETED|Period 2, Day 1-15||0
2199007|NCT03335254|5395139|P11|NOT COMPLETED|Period 2, Day 1-15||0
2199008|NCT03335254|5395140|P10|NOT COMPLETED|Period 2, Day 1-15||0
2199009|NCT03335254|5395141|P9|NOT COMPLETED|Period 2, Day 1-15||0
2199010|NCT03335254|5395142|P8|NOT COMPLETED|Period 2, Day 1-15||0
2199011|NCT03335254|5395143|P7|NOT COMPLETED|Period 2, Day 1-15||0
2199012|NCT03335254|5395144|P6|NOT COMPLETED|Period 2, Day 1-15||0
2199013|NCT03335254|5395145|P5|NOT COMPLETED|Period 2, Day 1-15||0
2199014|NCT03335254|5395146|P4|NOT COMPLETED|Period 2, Day 1-15||0
2199015|NCT03335254|5395147|P3|NOT COMPLETED|Period 2, Day 1-15||0
2199016|NCT03335254|5395148|P2|NOT COMPLETED|Period 2, Day 1-15||0
2199017|NCT03335254|5395149|P1|NOT COMPLETED|Period 2, Day 1-15||0
2199018|NCT03335254|5395130|P20|COMPLETED|Period 2, Day 1-15||0
2199019|NCT03335254|5395131|P19|COMPLETED|Period 2, Day 1-15||0
2199020|NCT03335254|5395132|P18|COMPLETED|Period 2, Day 1-15||0
2199021|NCT03335254|5395133|P17|COMPLETED|Period 2, Day 1-15||0
2199022|NCT03335254|5395134|P16|COMPLETED|Period 2, Day 1-15||0
2199023|NCT03335254|5395135|P15|COMPLETED|Period 2, Day 1-15||0
2199024|NCT03335254|5395136|P14|COMPLETED|Period 2, Day 1-15||0
2199025|NCT03335254|5395137|P13|COMPLETED|Period 2, Day 1-15||0
2199026|NCT03335254|5395138|P12|COMPLETED|Period 2, Day 1-15||0
2199027|NCT03335254|5395139|P11|COMPLETED|Period 2, Day 1-15||0
2199028|NCT03335254|5395140|P10|COMPLETED|Period 2, Day 1-15||0
2199029|NCT03335254|5395141|P9|COMPLETED|Period 2, Day 1-15||0
2199030|NCT03335254|5395142|P8|COMPLETED|Period 2, Day 1-15||0
2199031|NCT03335254|5395143|P7|COMPLETED|Period 2, Day 1-15||0
2199032|NCT03335254|5395144|P6|COMPLETED|Period 2, Day 1-15||0
2199033|NCT03335254|5395145|P5|COMPLETED|Period 2, Day 1-15||0
2199034|NCT03335254|5395146|P4|COMPLETED|Period 2, Day 1-15||0
2199035|NCT03335254|5395147|P3|COMPLETED|Period 2, Day 1-15||0
2199036|NCT03335254|5395148|P2|COMPLETED|Period 2, Day 1-15||0
2199037|NCT03335254|5395149|P1|COMPLETED|Period 2, Day 1-15||9
2199038|NCT03335254|5395130|P20|STARTED|Period 2, Day 1-15||0
2199039|NCT03335254|5395131|P19|STARTED|Period 2, Day 1-15||0
2199040|NCT03335254|5395132|P18|STARTED|Period 2, Day 1-15||0
2199041|NCT03335254|5395133|P17|STARTED|Period 2, Day 1-15||0
2199042|NCT03335254|5395134|P16|STARTED|Period 2, Day 1-15||0
2199043|NCT03335254|5395135|P15|STARTED|Period 2, Day 1-15||0
2199044|NCT03335254|5395136|P14|STARTED|Period 2, Day 1-15||0
2199045|NCT03335254|5395137|P13|STARTED|Period 2, Day 1-15||0
2199046|NCT03335254|5395138|P12|STARTED|Period 2, Day 1-15||0
2199047|NCT03335254|5395139|P11|STARTED|Period 2, Day 1-15||0
2199048|NCT03335254|5395140|P10|STARTED|Period 2, Day 1-15||0
2199049|NCT03335254|5395141|P9|STARTED|Period 2, Day 1-15||0
2199050|NCT03335254|5395142|P8|STARTED|Period 2, Day 1-15||0
2199051|NCT03335254|5395143|P7|STARTED|Period 2, Day 1-15||0
2199052|NCT03335254|5395144|P6|STARTED|Period 2, Day 1-15||0
2199053|NCT03335254|5395145|P5|STARTED|Period 2, Day 1-15||0
2199054|NCT03335254|5395146|P4|STARTED|Period 2, Day 1-15||0
2199055|NCT03335254|5395147|P3|STARTED|Period 2, Day 1-15||0
2199056|NCT03335254|5395148|P2|STARTED|Period 2, Day 1-15||0
2199057|NCT03335254|5395149|P1|STARTED|Period 2, Day 1-15||9
2199058|NCT03335254|5395130|P20|NOT COMPLETED|Period 1||0
2199059|NCT03335254|5395131|P19|NOT COMPLETED|Period 1||0
2199060|NCT03335254|5395132|P18|NOT COMPLETED|Period 1||0
2199061|NCT03335254|5395133|P17|NOT COMPLETED|Period 1||0
2199062|NCT03335254|5395134|P16|NOT COMPLETED|Period 1||0
2199063|NCT03335254|5395135|P15|NOT COMPLETED|Period 1||0
2199064|NCT03335254|5395136|P14|NOT COMPLETED|Period 1||0
2199065|NCT03335254|5395137|P13|NOT COMPLETED|Period 1||0
2199066|NCT03335254|5395138|P12|NOT COMPLETED|Period 1||0
2199067|NCT03335254|5395139|P11|NOT COMPLETED|Period 1||0
2199068|NCT03335254|5395140|P10|NOT COMPLETED|Period 1||0
2199069|NCT03335254|5395141|P9|NOT COMPLETED|Period 1||0
2199070|NCT03335254|5395142|P8|NOT COMPLETED|Period 1||0
2199071|NCT03335254|5395143|P7|NOT COMPLETED|Period 1||0
2199072|NCT03335254|5395144|P6|NOT COMPLETED|Period 1||0
2199073|NCT03335254|5395145|P5|NOT COMPLETED|Period 1||0
2199074|NCT03335254|5395146|P4|NOT COMPLETED|Period 1||0
2199075|NCT03335254|5395147|P3|NOT COMPLETED|Period 1||0
2199076|NCT03335254|5395148|P2|NOT COMPLETED|Period 1||0
2199077|NCT03335254|5395149|P1|NOT COMPLETED|Period 1||0
2199078|NCT03335254|5395130|P20|COMPLETED|Period 1||0
2199079|NCT03335254|5395131|P19|COMPLETED|Period 1||0
2199080|NCT03335254|5395132|P18|COMPLETED|Period 1||0
2199081|NCT03335254|5395133|P17|COMPLETED|Period 1||0
2199082|NCT03335254|5395134|P16|COMPLETED|Period 1||0
2199083|NCT03335254|5395135|P15|COMPLETED|Period 1||0
2199084|NCT03335254|5395136|P14|COMPLETED|Period 1||0
2199085|NCT03335254|5395137|P13|COMPLETED|Period 1||0
2199086|NCT03335254|5395138|P12|COMPLETED|Period 1||0
2199087|NCT03335254|5395139|P11|COMPLETED|Period 1||0
2199088|NCT03335254|5395140|P10|COMPLETED|Period 1||0
2199089|NCT03335254|5395141|P9|COMPLETED|Period 1||0
2199090|NCT03335254|5395142|P8|COMPLETED|Period 1||0
2199091|NCT03335254|5395143|P7|COMPLETED|Period 1||0
2199092|NCT03335254|5395144|P6|COMPLETED|Period 1||0
2199093|NCT03335254|5395145|P5|COMPLETED|Period 1||0
2199094|NCT03335254|5395146|P4|COMPLETED|Period 1||0
2199095|NCT03335254|5395147|P3|COMPLETED|Period 1||0
2199096|NCT03335254|5395148|P2|COMPLETED|Period 1||0
2199097|NCT03335254|5395149|P1|COMPLETED|Period 1||9
2199098|NCT03335254|5395130|P20|STARTED|Period 1||0
2199099|NCT03335254|5395131|P19|STARTED|Period 1||0
2199100|NCT03335254|5395132|P18|STARTED|Period 1||0
2199101|NCT03335254|5395133|P17|STARTED|Period 1||0
2199102|NCT03335254|5395134|P16|STARTED|Period 1||0
2199103|NCT03335254|5395135|P15|STARTED|Period 1||0
2199104|NCT03335254|5395136|P14|STARTED|Period 1||0
2199105|NCT03335254|5395137|P13|STARTED|Period 1||0
2199106|NCT03335254|5395138|P12|STARTED|Period 1||0
2199107|NCT03335254|5395139|P11|STARTED|Period 1||0
2199108|NCT03335254|5395140|P10|STARTED|Period 1||0
2199109|NCT03335254|5395141|P9|STARTED|Period 1||0
2199110|NCT03335254|5395142|P8|STARTED|Period 1||0
2199111|NCT03335254|5395143|P7|STARTED|Period 1||0
2199112|NCT03335254|5395144|P6|STARTED|Period 1||0
2199113|NCT03335254|5395145|P5|STARTED|Period 1||0
2199114|NCT03335254|5395146|P4|STARTED|Period 1||0
2199115|NCT03335254|5395147|P3|STARTED|Period 1||0
2199116|NCT03335254|5395148|P2|STARTED|Period 1||0
2199117|NCT03335254|5395149|P1|STARTED|Period 1||9
2199118|NCT03334825|5395180|P2|NOT COMPLETED|Overall Study||4
2199119|NCT03334825|5395181|P1|NOT COMPLETED|Overall Study||7
2199120|NCT03334825|5395180|P2|COMPLETED|Overall Study||113
2199121|NCT03334825|5395181|P1|COMPLETED|Overall Study||112
2199122|NCT03334825|5395180|P2|STARTED|Overall Study||117
2199123|NCT03334825|5395181|P1|STARTED|Overall Study||119
2199124|NCT03334422|5395195|P4|NOT COMPLETED|Overall Study||6
2199125|NCT03334422|5395196|P3|NOT COMPLETED|Overall Study||10
2199126|NCT03334422|5395197|P2|NOT COMPLETED|Overall Study||10
2199127|NCT03334422|5395198|P1|NOT COMPLETED|Overall Study||19
2199128|NCT03334422|5395195|P4|COMPLETED|Overall Study||117
2199129|NCT03334422|5395196|P3|COMPLETED|Overall Study||113
2199130|NCT03334422|5395197|P2|COMPLETED|Overall Study||115
2199131|NCT03334422|5395198|P1|COMPLETED|Overall Study||225
2199132|NCT03334422|5395195|P4|Received at Least One Dose of Study Drug|Overall Study||123
2199133|NCT03334422|5395196|P3|Received at Least One Dose of Study Drug|Overall Study||123
2199134|NCT03334422|5395197|P2|Received at Least One Dose of Study Drug|Overall Study||124
2199135|NCT03334422|5395198|P1|Received at Least One Dose of Study Drug|Overall Study||244
2199136|NCT03334422|5395195|P4|STARTED|Overall Study||123
2199137|NCT03334422|5395196|P3|STARTED|Overall Study||123
2199138|NCT03334422|5395197|P2|STARTED|Overall Study||125
2199139|NCT03334422|5395198|P1|STARTED|Overall Study||244
2199140|NCT03334396|5395301|P4|NOT COMPLETED|Overall Study||5
2199141|NCT03334396|5395302|P3|NOT COMPLETED|Overall Study||10
2199142|NCT03334396|5395303|P2|NOT COMPLETED|Overall Study||11
2199143|NCT03334396|5395304|P1|NOT COMPLETED|Overall Study||23
2199144|NCT03334396|5395301|P4|COMPLETED|Overall Study||120
2199145|NCT03334396|5395302|P3|COMPLETED|Overall Study||113
2199146|NCT03334396|5395303|P2|COMPLETED|Overall Study||116
2199147|NCT03334396|5395304|P1|COMPLETED|Overall Study||226
2199148|NCT03334396|5395301|P4|Received at Least One Dose of Study Drug|Overall Study||125
2199149|NCT03334396|5395302|P3|Received at Least One Dose of Study Drug|Overall Study||123
2199150|NCT03334396|5395303|P2|Received at Least One Dose of Study Drug|Overall Study||127
2199151|NCT03334396|5395304|P1|Received at Least One Dose of Study Drug|Overall Study||249
2199152|NCT03334396|5395301|P4|STARTED|Overall Study||125
2199153|NCT03334396|5395302|P3|STARTED|Overall Study||123
2199154|NCT03334396|5395303|P2|STARTED|Overall Study||127
2199155|NCT03334396|5395304|P1|STARTED|Overall Study||249
2199156|NCT03334214|5395405|P2|NOT COMPLETED|Overall Study||2
2199157|NCT03334214|5395406|P1|NOT COMPLETED|Overall Study||1
2199158|NCT03334214|5395405|P2|COMPLETED|Overall Study||27
2199159|NCT03334214|5395406|P1|COMPLETED|Overall Study||14
2199160|NCT03334214|5395405|P2|STARTED|Overall Study||29
2199161|NCT03334214|5395406|P1|STARTED|Overall Study||15
2199162|NCT03333876|5395432|P1|NOT COMPLETED|Positional Therapy||0
2199163|NCT03333876|5395432|P1|COMPLETED|Positional Therapy||54
2199164|NCT03333876|5395432|P1|STARTED|Positional Therapy||54
2199165|NCT03333876|5395432|P1|NOT COMPLETED|Mandibular Advancement||4
2199166|NCT03333876|5395432|P1|COMPLETED|Mandibular Advancement||50
2199167|NCT03333876|5395432|P1|STARTED|Mandibular Advancement||54
2199168|NCT03333876|5395432|P1|NOT COMPLETED|Nasal Dilator||6
2199169|NCT03333876|5395432|P1|COMPLETED|Nasal Dilator||48
2199170|NCT03333876|5395432|P1|STARTED|Nasal Dilator||54
2199171|NCT03333876|5395432|P1|NOT COMPLETED|Screening Period||4
2199172|NCT03333876|5395432|P1|COMPLETED|Screening Period||54
2199173|NCT03333876|5395432|P1|STARTED|Screening Period||58
2199174|NCT03333746|5395453|P1|NOT COMPLETED|Overall Study||1
2199175|NCT03333746|5395453|P1|COMPLETED|Overall Study||0
2199176|NCT03333746|5395453|P1|STARTED|Overall Study||1
2199177|NCT03333577|5395464|P1|NOT COMPLETED|Overall Study||7
2199178|NCT03333577|5395464|P1|COMPLETED|Overall Study||25
2199179|NCT03333577|5395464|P1|STARTED|Overall Study||32
2199180|NCT03333317|5395472|P3|NOT COMPLETED|Overall Study||0
2199181|NCT03333317|5395473|P2|NOT COMPLETED|Overall Study||0
2199182|NCT03333317|5395474|P1|NOT COMPLETED|Overall Study||0
2199183|NCT03333317|5395472|P3|COMPLETED|Overall Study||3
2199184|NCT03333317|5395473|P2|COMPLETED|Overall Study||1
2199185|NCT03333317|5395474|P1|COMPLETED|Overall Study||3
2199186|NCT03333317|5395472|P3|STARTED|Overall Study||3
2199187|NCT03333317|5395473|P2|STARTED|Overall Study||1
2199188|NCT03333317|5395474|P1|STARTED|Overall Study||3
2199195|NCT03331315|5395629|P2|NOT COMPLETED|Overall Study||14
2199196|NCT03331315|5395630|P1|NOT COMPLETED|Overall Study||18
2199197|NCT03331315|5395629|P2|COMPLETED|Overall Study||68
2199198|NCT03331315|5395630|P1|COMPLETED|Overall Study||70
2199199|NCT03331315|5395629|P2|STARTED|Overall Study||82
2199200|NCT03331315|5395630|P1|STARTED|Overall Study||88
2199201|NCT03331042|5395654|P4|NOT COMPLETED|Overall Study||1
2199202|NCT03331042|5395655|P3|NOT COMPLETED|Overall Study||1
2199203|NCT03331042|5395656|P2|NOT COMPLETED|Overall Study||0
2199204|NCT03331042|5395657|P1|NOT COMPLETED|Overall Study||1
2199205|NCT03331042|5395654|P4|COMPLETED|Overall Study||20
2199206|NCT03331042|5395655|P3|COMPLETED|Overall Study||20
2199207|NCT03331042|5395656|P2|COMPLETED|Overall Study||21
2199208|NCT03331042|5395657|P1|COMPLETED|Overall Study||21
2199209|NCT03331042|5395654|P4|STARTED|Overall Study||21
2199210|NCT03331042|5395655|P3|STARTED|Overall Study||21
2199211|NCT03331042|5395656|P2|STARTED|Overall Study||21
2199212|NCT03331042|5395657|P1|STARTED|Overall Study||22
2199213|NCT03330275|5395703|P10|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
2199214|NCT03330275|5395704|P9|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
2199215|NCT03330275|5395705|P8|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
2199216|NCT03330275|5395706|P7|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
2199217|NCT03330275|5395707|P6|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
2199218|NCT03330275|5395708|P5|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
2199219|NCT03330275|5395709|P4|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
2199220|NCT03330275|5395710|P3|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
2199221|NCT03330275|5395711|P2|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
2199222|NCT03330275|5395712|P1|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
2199223|NCT03330275|5395703|P10|COMPLETED|Visits 2, 3 and 4 - Period 3||4
2199224|NCT03330275|5395704|P9|COMPLETED|Visits 2, 3 and 4 - Period 3||4
2199225|NCT03330275|5395705|P8|COMPLETED|Visits 2, 3 and 4 - Period 3||4
2199226|NCT03330275|5395706|P7|COMPLETED|Visits 2, 3 and 4 - Period 3||4
2199227|NCT03330275|5395707|P6|COMPLETED|Visits 2, 3 and 4 - Period 3||4
2199228|NCT03330275|5395708|P5|COMPLETED|Visits 2, 3 and 4 - Period 3||4
2199229|NCT03330275|5395709|P4|COMPLETED|Visits 2, 3 and 4 - Period 3||0
2199230|NCT03330275|5395710|P3|COMPLETED|Visits 2, 3 and 4 - Period 3||0
2199231|NCT03330275|5395711|P2|COMPLETED|Visits 2, 3 and 4 - Period 3||0
2199232|NCT03330275|5395712|P1|COMPLETED|Visits 2, 3 and 4 - Period 3||0
2199233|NCT03330275|5395703|P10|STARTED|Visits 2, 3 and 4 - Period 3||4
2199234|NCT03330275|5395704|P9|STARTED|Visits 2, 3 and 4 - Period 3||4
2199235|NCT03330275|5395705|P8|STARTED|Visits 2, 3 and 4 - Period 3||4
2199236|NCT03330275|5395706|P7|STARTED|Visits 2, 3 and 4 - Period 3||4
2199237|NCT03330275|5395707|P6|STARTED|Visits 2, 3 and 4 - Period 3||4
2199238|NCT03330275|5395708|P5|STARTED|Visits 2, 3 and 4 - Period 3||4
2199239|NCT03330275|5395709|P4|STARTED|Visits 2, 3 and 4 - Period 3||0
2199240|NCT03330275|5395710|P3|STARTED|Visits 2, 3 and 4 - Period 3||0
2199241|NCT03330275|5395711|P2|STARTED|Visits 2, 3 and 4 - Period 3||0
2199242|NCT03330275|5395712|P1|STARTED|Visits 2, 3 and 4 - Period 3||0
2199243|NCT03330275|5395703|P10|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
2199244|NCT03330275|5395704|P9|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
2199245|NCT03330275|5395705|P8|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
2199246|NCT03330275|5395706|P7|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
2199247|NCT03330275|5395707|P6|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
2199248|NCT03330275|5395708|P5|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
2199249|NCT03330275|5395709|P4|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
2199250|NCT03330275|5395710|P3|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
2199251|NCT03330275|5395711|P2|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
2199252|NCT03330275|5395712|P1|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
2199253|NCT03330275|5395703|P10|COMPLETED|Visits 2, 3 and 4 - Period 2||4
2199254|NCT03330275|5395704|P9|COMPLETED|Visits 2, 3 and 4 - Period 2||4
2199255|NCT03330275|5395705|P8|COMPLETED|Visits 2, 3 and 4 - Period 2||4
2199256|NCT03330275|5395706|P7|COMPLETED|Visits 2, 3 and 4 - Period 2||4
2199257|NCT03330275|5395707|P6|COMPLETED|Visits 2, 3 and 4 - Period 2||4
2199258|NCT03330275|5395708|P5|COMPLETED|Visits 2, 3 and 4 - Period 2||4
2199259|NCT03330275|5395709|P4|COMPLETED|Visits 2, 3 and 4 - Period 2||0
2199260|NCT03330275|5395710|P3|COMPLETED|Visits 2, 3 and 4 - Period 2||0
2199261|NCT03330275|5395711|P2|COMPLETED|Visits 2, 3 and 4 - Period 2||0
2199262|NCT03330275|5395712|P1|COMPLETED|Visits 2, 3 and 4 - Period 2||0
2199263|NCT03330275|5395703|P10|STARTED|Visits 2, 3 and 4 - Period 2||4
2199264|NCT03330275|5395704|P9|STARTED|Visits 2, 3 and 4 - Period 2||4
2199265|NCT03330275|5395705|P8|STARTED|Visits 2, 3 and 4 - Period 2||4
2199266|NCT03330275|5395706|P7|STARTED|Visits 2, 3 and 4 - Period 2||4
2199267|NCT03330275|5395707|P6|STARTED|Visits 2, 3 and 4 - Period 2||4
2199268|NCT03330275|5395708|P5|STARTED|Visits 2, 3 and 4 - Period 2||4
2199269|NCT03330275|5395709|P4|STARTED|Visits 2, 3 and 4 - Period 2||0
2199270|NCT03330275|5395710|P3|STARTED|Visits 2, 3 and 4 - Period 2||0
2199271|NCT03330275|5395711|P2|STARTED|Visits 2, 3 and 4 - Period 2||0
2199272|NCT03330275|5395712|P1|STARTED|Visits 2, 3 and 4 - Period 2||0
2199273|NCT03330275|5395703|P10|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
2199274|NCT03330275|5395704|P9|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
2199275|NCT03330275|5395705|P8|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
2199276|NCT03330275|5395706|P7|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
2199277|NCT03330275|5395707|P6|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
2199278|NCT03330275|5395708|P5|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
2199279|NCT03330275|5395709|P4|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
2199280|NCT03330275|5395710|P3|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
2199281|NCT03330275|5395711|P2|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
2199282|NCT03330275|5395712|P1|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
2199283|NCT03330275|5395703|P10|COMPLETED|Visits 2, 3 and 4 - Period 1||4
2199284|NCT03330275|5395704|P9|COMPLETED|Visits 2, 3 and 4 - Period 1||4
2199285|NCT03330275|5395705|P8|COMPLETED|Visits 2, 3 and 4 - Period 1||4
2199286|NCT03330275|5395706|P7|COMPLETED|Visits 2, 3 and 4 - Period 1||4
2199287|NCT03330275|5395707|P6|COMPLETED|Visits 2, 3 and 4 - Period 1||4
2199288|NCT03330275|5395708|P5|COMPLETED|Visits 2, 3 and 4 - Period 1||4
2199289|NCT03330275|5395709|P4|COMPLETED|Visits 2, 3 and 4 - Period 1||0
2199290|NCT03330275|5395710|P3|COMPLETED|Visits 2, 3 and 4 - Period 1||0
2199291|NCT03330275|5395711|P2|COMPLETED|Visits 2, 3 and 4 - Period 1||0
2199292|NCT03330275|5395712|P1|COMPLETED|Visits 2, 3 and 4 - Period 1||0
2199293|NCT03330275|5395703|P10|STARTED|Visits 2, 3 and 4 - Period 1||4
2199294|NCT03330275|5395704|P9|STARTED|Visits 2, 3 and 4 - Period 1||4
2199295|NCT03330275|5395705|P8|STARTED|Visits 2, 3 and 4 - Period 1||4
2199296|NCT03330275|5395706|P7|STARTED|Visits 2, 3 and 4 - Period 1||4
2199297|NCT03330275|5395707|P6|STARTED|Visits 2, 3 and 4 - Period 1||4
2199298|NCT03330275|5395708|P5|STARTED|Visits 2, 3 and 4 - Period 1||4
2199299|NCT03330275|5395709|P4|STARTED|Visits 2, 3 and 4 - Period 1||0
2199300|NCT03330275|5395710|P3|STARTED|Visits 2, 3 and 4 - Period 1||0
2199301|NCT03330275|5395711|P2|STARTED|Visits 2, 3 and 4 - Period 1||0
2199302|NCT03330275|5395712|P1|STARTED|Visits 2, 3 and 4 - Period 1||0
2199303|NCT03330275|5395703|P10|NOT COMPLETED|Visit 1 - Period 2||0
2199304|NCT03330275|5395704|P9|NOT COMPLETED|Visit 1 - Period 2||0
2199305|NCT03330275|5395705|P8|NOT COMPLETED|Visit 1 - Period 2||0
2199306|NCT03330275|5395706|P7|NOT COMPLETED|Visit 1 - Period 2||0
2199307|NCT03330275|5395707|P6|NOT COMPLETED|Visit 1 - Period 2||0
2199308|NCT03330275|5395708|P5|NOT COMPLETED|Visit 1 - Period 2||0
2199309|NCT03330275|5395709|P4|NOT COMPLETED|Visit 1 - Period 2||0
2199310|NCT03330275|5395710|P3|NOT COMPLETED|Visit 1 - Period 2||0
2199311|NCT03330275|5395711|P2|NOT COMPLETED|Visit 1 - Period 2||0
2199312|NCT03330275|5395712|P1|NOT COMPLETED|Visit 1 - Period 2||0
2199313|NCT03330275|5395703|P10|COMPLETED|Visit 1 - Period 2||0
2199314|NCT03330275|5395704|P9|COMPLETED|Visit 1 - Period 2||0
2199315|NCT03330275|5395705|P8|COMPLETED|Visit 1 - Period 2||0
2199316|NCT03330275|5395706|P7|COMPLETED|Visit 1 - Period 2||0
2199317|NCT03330275|5395707|P6|COMPLETED|Visit 1 - Period 2||0
2199318|NCT03330275|5395708|P5|COMPLETED|Visit 1 - Period 2||0
2199319|NCT03330275|5395709|P4|COMPLETED|Visit 1 - Period 2||6
2199320|NCT03330275|5395710|P3|COMPLETED|Visit 1 - Period 2||6
2199321|NCT03330275|5395711|P2|COMPLETED|Visit 1 - Period 2||6
2199322|NCT03330275|5395712|P1|COMPLETED|Visit 1 - Period 2||6
2199323|NCT03330275|5395703|P10|STARTED|Visit 1 - Period 2||0
2199324|NCT03330275|5395704|P9|STARTED|Visit 1 - Period 2||0
2199325|NCT03330275|5395705|P8|STARTED|Visit 1 - Period 2||0
2199326|NCT03330275|5395706|P7|STARTED|Visit 1 - Period 2||0
2199327|NCT03330275|5395707|P6|STARTED|Visit 1 - Period 2||0
2199328|NCT03330275|5395708|P5|STARTED|Visit 1 - Period 2||0
2199329|NCT03330275|5395709|P4|STARTED|Visit 1 - Period 2||6
2199330|NCT03330275|5395710|P3|STARTED|Visit 1 - Period 2||6
2199331|NCT03330275|5395711|P2|STARTED|Visit 1 - Period 2||6
2199332|NCT03330275|5395712|P1|STARTED|Visit 1 - Period 2||6
2199333|NCT03330275|5395703|P10|NOT COMPLETED|Visit 1 - Period 1||0
2199334|NCT03330275|5395704|P9|NOT COMPLETED|Visit 1 - Period 1||0
2199335|NCT03330275|5395705|P8|NOT COMPLETED|Visit 1 - Period 1||0
2199336|NCT03330275|5395706|P7|NOT COMPLETED|Visit 1 - Period 1||0
2199337|NCT03330275|5395707|P6|NOT COMPLETED|Visit 1 - Period 1||0
2199338|NCT03330275|5395708|P5|NOT COMPLETED|Visit 1 - Period 1||0
2199339|NCT03330275|5395709|P4|NOT COMPLETED|Visit 1 - Period 1||0
2199340|NCT03330275|5395710|P3|NOT COMPLETED|Visit 1 - Period 1||0
2199341|NCT03330275|5395711|P2|NOT COMPLETED|Visit 1 - Period 1||0
2199342|NCT03330275|5395712|P1|NOT COMPLETED|Visit 1 - Period 1||0
2199343|NCT03330275|5395703|P10|COMPLETED|Visit 1 - Period 1||0
2199344|NCT03330275|5395704|P9|COMPLETED|Visit 1 - Period 1||0
2199345|NCT03330275|5395705|P8|COMPLETED|Visit 1 - Period 1||0
2199346|NCT03330275|5395706|P7|COMPLETED|Visit 1 - Period 1||0
2199347|NCT03330275|5395707|P6|COMPLETED|Visit 1 - Period 1||0
2199348|NCT03330275|5395708|P5|COMPLETED|Visit 1 - Period 1||0
2199349|NCT03330275|5395709|P4|COMPLETED|Visit 1 - Period 1||6
2199350|NCT03330275|5395710|P3|COMPLETED|Visit 1 - Period 1||6
2199351|NCT03330275|5395711|P2|COMPLETED|Visit 1 - Period 1||6
2199352|NCT03330275|5395712|P1|COMPLETED|Visit 1 - Period 1||6
2199353|NCT03330275|5395703|P10|STARTED|Visit 1 - Period 1||0
2199354|NCT03330275|5395704|P9|STARTED|Visit 1 - Period 1||0
2199355|NCT03330275|5395705|P8|STARTED|Visit 1 - Period 1||0
2199356|NCT03330275|5395706|P7|STARTED|Visit 1 - Period 1||0
2199357|NCT03330275|5395707|P6|STARTED|Visit 1 - Period 1||0
2199358|NCT03330275|5395708|P5|STARTED|Visit 1 - Period 1||0
2199359|NCT03330275|5395709|P4|STARTED|Visit 1 - Period 1||6
2199360|NCT03330275|5395710|P3|STARTED|Visit 1 - Period 1||6
2199361|NCT03330275|5395711|P2|STARTED|Visit 1 - Period 1||6
2199362|NCT03330275|5395712|P1|STARTED|Visit 1 - Period 1||6
2199363|NCT03330041|5395738|P1|NOT COMPLETED|Overall Study||2
2199364|NCT03330041|5395738|P1|COMPLETED|Overall Study||48
2199365|NCT03330041|5395738|P1|STARTED|Overall Study||50
2199366|NCT03329885|5395754|P9|NOT COMPLETED|Overall Study||0
2199367|NCT03329885|5395755|P8|NOT COMPLETED|Overall Study||1
2199368|NCT03329885|5395756|P7|NOT COMPLETED|Overall Study||1
2199369|NCT03329885|5395757|P6|NOT COMPLETED|Overall Study||0
2199370|NCT03329885|5395758|P5|NOT COMPLETED|Overall Study||0
2199371|NCT03329885|5395759|P4|NOT COMPLETED|Overall Study||0
2199372|NCT03329885|5395760|P3|NOT COMPLETED|Overall Study||0
2199373|NCT03329885|5395761|P2|NOT COMPLETED|Overall Study||0
2199374|NCT03329885|5395762|P1|NOT COMPLETED|Overall Study||0
2199375|NCT03329885|5395754|P9|COMPLETED|Overall Study||0
2199376|NCT03329885|5395755|P8|COMPLETED|Overall Study||0
2199377|NCT03329885|5395756|P7|COMPLETED|Overall Study||0
2199378|NCT03329885|5395757|P6|COMPLETED|Overall Study||3
2199379|NCT03329885|5395758|P5|COMPLETED|Overall Study||6
2199380|NCT03329885|5395759|P4|COMPLETED|Overall Study||6
2199381|NCT03329885|5395760|P3|COMPLETED|Overall Study||6
2199382|NCT03329885|5395761|P2|COMPLETED|Overall Study||6
2199383|NCT03329885|5395762|P1|COMPLETED|Overall Study||9
2199384|NCT03329885|5395754|P9|STARTED|Overall Study|Due to early termination of study, Part C was cancelled and no patients were dosed|0
2199385|NCT03329885|5395755|P8|STARTED|Overall Study||1
2199386|NCT03329885|5395756|P7|STARTED|Overall Study||1
2199387|NCT03329885|5395757|P6|STARTED|Overall Study||3
2199388|NCT03329885|5395758|P5|STARTED|Overall Study||6
2199389|NCT03329885|5395759|P4|STARTED|Overall Study||6
2199390|NCT03329885|5395760|P3|STARTED|Overall Study||6
2199391|NCT03329885|5395761|P2|STARTED|Overall Study||6
2199392|NCT03329885|5395762|P1|STARTED|Overall Study||9
2199393|NCT03329573|5395930|P4|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||0
2199394|NCT03329573|5395931|P3|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||0
2199395|NCT03329573|5395932|P2|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||1
2199396|NCT03329573|5395933|P1|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||1
2199397|NCT03329573|5395930|P4|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||19
2199398|NCT03329573|5395931|P3|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||19
2199399|NCT03329573|5395932|P2|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||20
2199400|NCT03329573|5395933|P1|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||21
2199401|NCT03329573|5395930|P4|STARTED|Treatment Period 2 (Day 12 to Day 26)||19
2199402|NCT03329573|5395931|P3|STARTED|Treatment Period 2 (Day 12 to Day 26)||19
2199403|NCT03329573|5395932|P2|STARTED|Treatment Period 2 (Day 12 to Day 26)||21
2199404|NCT03329573|5395933|P1|STARTED|Treatment Period 2 (Day 12 to Day 26)||22
2199405|NCT03329573|5395930|P4|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
2199406|NCT03329573|5395931|P3|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
2199407|NCT03329573|5395932|P2|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
2199408|NCT03329573|5395933|P1|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
2199409|NCT03329573|5395930|P4|COMPLETED|Washout Period (Day 6 to Day 11)||19
2199410|NCT03329573|5395931|P3|COMPLETED|Washout Period (Day 6 to Day 11)||19
2199411|NCT03329573|5395932|P2|COMPLETED|Washout Period (Day 6 to Day 11)||21
2199412|NCT03329573|5395933|P1|COMPLETED|Washout Period (Day 6 to Day 11)||22
2199413|NCT03329573|5395930|P4|STARTED|Washout Period (Day 6 to Day 11)||19
2199414|NCT03329573|5395931|P3|STARTED|Washout Period (Day 6 to Day 11)||19
2199415|NCT03329573|5395932|P2|STARTED|Washout Period (Day 6 to Day 11)||21
2199416|NCT03329573|5395933|P1|STARTED|Washout Period (Day 6 to Day 11)||22
2199417|NCT03329573|5395930|P4|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||0
2199418|NCT03329573|5395931|P3|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||0
2199419|NCT03329573|5395932|P2|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||3
2199420|NCT03329573|5395933|P1|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||1
2199421|NCT03329573|5395930|P4|COMPLETED|Treatment Period 1 (Up to 5 Days)||19
2199422|NCT03329573|5395931|P3|COMPLETED|Treatment Period 1 (Up to 5 Days)||19
2199423|NCT03329573|5395932|P2|COMPLETED|Treatment Period 1 (Up to 5 Days)||21
2199424|NCT03329573|5395933|P1|COMPLETED|Treatment Period 1 (Up to 5 Days)||22
2199425|NCT03329573|5395930|P4|STARTED|Treatment Period 1 (Up to 5 Days)||19
2199426|NCT03329573|5395931|P3|STARTED|Treatment Period 1 (Up to 5 Days)||19
2199427|NCT03329573|5395932|P2|STARTED|Treatment Period 1 (Up to 5 Days)||24
2199428|NCT03329573|5395933|P1|STARTED|Treatment Period 1 (Up to 5 Days)||23
2199429|NCT03329209|5395999|P1|NOT COMPLETED|Overall Study||0
2199430|NCT03329209|5395999|P1|COMPLETED|Overall Study||16
2199431|NCT03329209|5395999|P1|STARTED|Overall Study||16
2199432|NCT03328949|5396007|P1|NOT COMPLETED|Overall Study||0
2199433|NCT03328949|5396007|P1|COMPLETED|Overall Study||120
2199434|NCT03328949|5396007|P1|STARTED|Overall Study||120
2199435|NCT03328624|5396014|P1|NOT COMPLETED|Overall Study||0
2199436|NCT03328624|5396014|P1|COMPLETED|Overall Study||36
2199437|NCT03328624|5396014|P1|STARTED|Overall Study||36
2199438|NCT03328182|5396018|P1|NOT COMPLETED|Overall Study||4
2199439|NCT03328182|5396018|P1|COMPLETED|Overall Study||30
2199440|NCT03328182|5396018|P1|STARTED|Overall Study||34
2199441|NCT03327402|5396023|P1|NOT COMPLETED|Overall Study||2
2199442|NCT03327402|5396023|P1|COMPLETED|Overall Study||22
2199443|NCT03327402|5396023|P1|Sparse PK Sampling Group|Overall Study||12
2199444|NCT03327402|5396023|P1|Rich PK Sampling Group|Overall Study||12
2199445|NCT03327402|5396023|P1|STARTED|Overall Study||24
2199446|NCT03327051|5396058|P2|NOT COMPLETED|Overall Study||5
2199447|NCT03327051|5396059|P1|NOT COMPLETED|Overall Study||5
2199448|NCT03327051|5396058|P2|COMPLETED|Overall Study||15
2199449|NCT03327051|5396059|P1|COMPLETED|Overall Study||14
2199450|NCT03327051|5396058|P2|Attended Visit 2 (Week 0)|Overall Study||15
2199451|NCT03327051|5396059|P1|Attended Visit 2 (Week 0)|Overall Study||15
2199452|NCT03327051|5396058|P2|Received Treatment|Overall Study||16
2199453|NCT03327051|5396059|P1|Received Treatment|Overall Study||16
2199454|NCT03327051|5396058|P2|STARTED|Overall Study||20
2199455|NCT03327051|5396059|P1|STARTED|Overall Study||19
2199456|NCT03326986|5396070|P3|NOT COMPLETED|Overall Study||0
2199457|NCT03326986|5396071|P2|NOT COMPLETED|Overall Study||0
2199458|NCT03326986|5396072|P1|NOT COMPLETED|Overall Study||0
2199459|NCT03326986|5396070|P3|COMPLETED|Overall Study||8
2199460|NCT03326986|5396071|P2|COMPLETED|Overall Study||8
2199461|NCT03326986|5396072|P1|COMPLETED|Overall Study||8
2199462|NCT03326986|5396070|P3|STARTED|Overall Study||8
2199463|NCT03326986|5396071|P2|STARTED|Overall Study||8
2199464|NCT03326986|5396072|P1|STARTED|Overall Study||8
2199465|NCT03326323|5396312|P1|NOT COMPLETED|Overall Study||3
2199466|NCT03326323|5396312|P1|COMPLETED|Overall Study||40
2199467|NCT03326323|5396312|P1|STARTED|Overall Study||43
2199468|NCT03325894|5396319|P2|NOT COMPLETED|Overall Study||77
2199469|NCT03325894|5396320|P1|NOT COMPLETED|Overall Study||64
2199470|NCT03325894|5396319|P2|COMPLETED|Overall Study||0
2199471|NCT03325894|5396320|P1|COMPLETED|Overall Study||0
2199472|NCT03325894|5396319|P2|STARTED|Overall Study||77
2199473|NCT03325894|5396320|P1|STARTED|Overall Study||64
2199474|NCT03325881|5396388|P2|NOT COMPLETED|Overall Study||3
2199475|NCT03325881|5396389|P1|NOT COMPLETED|Overall Study||3
2199476|NCT03325881|5396388|P2|COMPLETED|Overall Study||42
2199477|NCT03325881|5396389|P1|COMPLETED|Overall Study||41
2199478|NCT03325881|5396388|P2|Treated|Overall Study||45
2199479|NCT03325881|5396389|P1|Treated|Overall Study||43
2199480|NCT03325881|5396388|P2|STARTED|Overall Study||45
2199481|NCT03325881|5396389|P1|STARTED|Overall Study||44
2199482|NCT03325673|5396417|P2|NOT COMPLETED|Overall Study||0
2199483|NCT03325673|5396418|P1|NOT COMPLETED|Overall Study||4
2199484|NCT03325673|5396417|P2|COMPLETED|Overall Study||42
2199485|NCT03325673|5396418|P1|COMPLETED|Overall Study||38
2199486|NCT03325673|5396417|P2|STARTED|Overall Study||42
2199487|NCT03325673|5396418|P1|STARTED|Overall Study||42
2199488|NCT03323736|5396433|P3|NOT COMPLETED|Overall Study||2
2199489|NCT03323736|5396434|P2|NOT COMPLETED|Overall Study||12
2199490|NCT03323736|5396435|P1|NOT COMPLETED|Overall Study||19
2199491|NCT03323736|5396433|P3|COMPLETED|Overall Study||68
2199492|NCT03323736|5396434|P2|COMPLETED|Overall Study||47
2199493|NCT03323736|5396435|P1|COMPLETED|Overall Study||222
2199494|NCT03323736|5396433|P3|Treated|Overall Study||68
2199495|NCT03323736|5396434|P2|Treated|Overall Study||47
2199496|NCT03323736|5396435|P1|Treated|Overall Study||222
2199497|NCT03323736|5396433|P3|STARTED|Overall Study||70
2199498|NCT03323736|5396434|P2|STARTED|Overall Study||59
2199499|NCT03323736|5396435|P1|STARTED|Overall Study||241
2199500|NCT03323723|5396446|P1|NOT COMPLETED|Treatment Phase||9
2199501|NCT03323723|5396446|P1|COMPLETED|Treatment Phase||51
2199502|NCT03323723|5396446|P1|STARTED|Treatment Phase||60
2199503|NCT03323723|5396446|P1|NOT COMPLETED|Baseline Phase||4
2199504|NCT03323723|5396446|P1|COMPLETED|Baseline Phase||60
2199505|NCT03323723|5396446|P1|STARTED|Baseline Phase||64
2199506|NCT03323723|5396446|P1|NOT COMPLETED|Screening||9
2199507|NCT03323723|5396446|P1|COMPLETED|Screening||64
2199508|NCT03323723|5396446|P1|STARTED|Screening||73
2199509|NCT03323307|5396453|P1|NOT COMPLETED|Overall Study||0
2199510|NCT03323307|5396453|P1|COMPLETED|Overall Study||70
2199511|NCT03323307|5396453|P1|STARTED|Overall Study||70
2199512|NCT03323086|5396462|P2|NOT COMPLETED|Overall Study||2
2199513|NCT03323086|5396463|P1|NOT COMPLETED|Overall Study||3
2199514|NCT03323086|5396462|P2|COMPLETED|Overall Study||20
2199515|NCT03323086|5396463|P1|COMPLETED|Overall Study||23
2199516|NCT03323086|5396462|P2|STARTED|Overall Study||22
2199517|NCT03323086|5396463|P1|STARTED|Overall Study||26
2199518|NCT03322930|5396481|P2|NOT COMPLETED|Overall Study||0
2199519|NCT03322930|5396482|P1|NOT COMPLETED|Overall Study||0
2199520|NCT03322930|5396481|P2|COMPLETED|Overall Study||20
2199521|NCT03322930|5396482|P1|COMPLETED|Overall Study||20
2199522|NCT03322930|5396481|P2|STARTED|Overall Study|recruitment of 20 patients with macular degeneration|20
2199523|NCT03322930|5396482|P1|STARTED|Overall Study|recruitment of 20 patients with retinitis pigmentosa|20
2199524|NCT03322566|5396491|P3|NOT COMPLETED|Overall Study||55
2199525|NCT03322566|5396492|P2|NOT COMPLETED|Overall Study||87
2199526|NCT03322566|5396493|P1|NOT COMPLETED|Overall Study||91
2199527|NCT03322566|5396491|P3|COMPLETED|Overall Study||0
2199528|NCT03322566|5396492|P2|COMPLETED|Overall Study||0
2199529|NCT03322566|5396493|P1|COMPLETED|Overall Study||0
2199530|NCT03322566|5396491|P3|STARTED|Overall Study||55
2199531|NCT03322566|5396492|P2|STARTED|Overall Study||87
2199532|NCT03322566|5396493|P1|STARTED|Overall Study||91
2199533|NCT03322540|5396512|P2|NOT COMPLETED|Overall Study||77
2199534|NCT03322540|5396513|P1|NOT COMPLETED|Overall Study||77
2199535|NCT03322540|5396512|P2|COMPLETED|Overall Study||0
2199536|NCT03322540|5396513|P1|COMPLETED|Overall Study||0
2199537|NCT03322540|5396512|P2|STARTED|Overall Study||77
2199538|NCT03322540|5396513|P1|STARTED|Overall Study||77
2199539|NCT03322514|5396521|P2|NOT COMPLETED|Overall Study||1
2199540|NCT03322514|5396522|P1|NOT COMPLETED|Overall Study||1
2199541|NCT03322514|5396521|P2|COMPLETED|Overall Study||5
2199542|NCT03322514|5396522|P1|COMPLETED|Overall Study||5
2199543|NCT03322514|5396521|P2|STARTED|Overall Study||6
2199544|NCT03322514|5396522|P1|STARTED|Overall Study||6
2199545|NCT03322423|5396532|P2|NOT COMPLETED|Period 2||2
2199546|NCT03322423|5396533|P1|NOT COMPLETED|Period 2||1
2199547|NCT03322423|5396532|P2|COMPLETED|Period 2||36
2199548|NCT03322423|5396533|P1|COMPLETED|Period 2||35
2199549|NCT03322423|5396532|P2|STARTED|Period 2||38
2199550|NCT03322423|5396533|P1|STARTED|Period 2||36
2199551|NCT03322423|5396532|P2|NOT COMPLETED|Period 1||2
2199552|NCT03322423|5396533|P1|NOT COMPLETED|Period 1||2
2199553|NCT03322423|5396532|P2|COMPLETED|Period 1||38
2199554|NCT03322423|5396533|P1|COMPLETED|Period 1||36
2199555|NCT03322423|5396532|P2|STARTED|Period 1||40
2199556|NCT03322423|5396533|P1|STARTED|Period 1||38
2199557|NCT03322293|5396546|P3|NOT COMPLETED|Overall Study||1
2199558|NCT03322293|5396547|P2|NOT COMPLETED|Overall Study||0
2199559|NCT03322293|5396548|P1|NOT COMPLETED|Overall Study||0
2199560|NCT03322293|5396546|P3|COMPLETED|Overall Study||7
2199561|NCT03322293|5396547|P2|COMPLETED|Overall Study||8
2199562|NCT03322293|5396548|P1|COMPLETED|Overall Study||8
2199563|NCT03322293|5396546|P3|STARTED|Overall Study||8
2199564|NCT03322293|5396547|P2|STARTED|Overall Study||8
2199565|NCT03322293|5396548|P1|STARTED|Overall Study||8
2199566|NCT03321396|5396568|P1|NOT COMPLETED|Overall Study||1
2199567|NCT03321396|5396568|P1|COMPLETED|Overall Study||12
2199568|NCT03321396|5396568|P1|STARTED|Overall Study||13
2199569|NCT03321253|5396574|P1|NOT COMPLETED|Overall Study||0
2199570|NCT03321253|5396574|P1|COMPLETED|Overall Study||38
2199571|NCT03321253|5396574|P1|STARTED|Overall Study||38
2199572|NCT03320941|5396587|P5|NOT COMPLETED|Overall Study||0
2199573|NCT03320941|5396588|P4|NOT COMPLETED|Overall Study||1
2199574|NCT03320941|5396589|P3|NOT COMPLETED|Overall Study||0
2199575|NCT03320941|5396590|P2|NOT COMPLETED|Overall Study||0
2199576|NCT03320941|5396591|P1|NOT COMPLETED|Overall Study||0
2199577|NCT03320941|5396587|P5|COMPLETED|Overall Study||29
2199578|NCT03320941|5396588|P4|COMPLETED|Overall Study||30
2199579|NCT03320941|5396589|P3|COMPLETED|Overall Study||28
2199580|NCT03320941|5396590|P2|COMPLETED|Overall Study||19
2199581|NCT03320941|5396591|P1|COMPLETED|Overall Study||19
2199582|NCT03320941|5396587|P5|STARTED|Overall Study||29
2199583|NCT03320941|5396588|P4|STARTED|Overall Study||31
2199584|NCT03320941|5396589|P3|STARTED|Overall Study||28
2199585|NCT03320941|5396590|P2|STARTED|Overall Study||19
2199586|NCT03320941|5396591|P1|STARTED|Overall Study||19
2199587|NCT03320564|5396692|P1|NOT COMPLETED|Overall Study||1
2199588|NCT03320564|5396692|P1|COMPLETED|Overall Study||1
2199589|NCT03320564|5396692|P1|STARTED|Overall Study||2
2199590|NCT03320096|5396696|P1|NOT COMPLETED|Overall Study||0
2199591|NCT03320096|5396696|P1|COMPLETED|Overall Study||20
2199592|NCT03320096|5396696|P1|STARTED|Overall Study||20
2199593|NCT03319810|5396703|P1|NOT COMPLETED|Overall Study||0
2199594|NCT03319810|5396703|P1|COMPLETED|Overall Study||5
2199595|NCT03319810|5396703|P1|STARTED|Overall Study||5
2199596|NCT03319719|5396708|P1|NOT COMPLETED|Overall Study||1
2199597|NCT03319719|5396708|P1|COMPLETED|Overall Study||51
2199598|NCT03319719|5396708|P1|STARTED|Overall Study||52
2199599|NCT03319407|5396722|P1|NOT COMPLETED|Overall Study||21
2199600|NCT03319407|5396722|P1|COMPLETED|Overall Study||0
2199601|NCT03319407|5396722|P1|STARTED|Overall Study||21
2199602|NCT03319277|5396728|P2|NOT COMPLETED|Overall Study||0
2199603|NCT03319277|5396729|P1|NOT COMPLETED|Overall Study||0
2199604|NCT03319277|5396728|P2|COMPLETED|Overall Study||59
2199605|NCT03319277|5396729|P1|COMPLETED|Overall Study||59
2199606|NCT03319277|5396728|P2|STARTED|Overall Study||59
2199607|NCT03319277|5396729|P1|STARTED|Overall Study||59
2199608|NCT03319212|5396741|P2|NOT COMPLETED|Overall Study||5
2199609|NCT03319212|5396742|P1|NOT COMPLETED|Overall Study||3
2199610|NCT03319212|5396741|P2|COMPLETED|Overall Study||47
2199611|NCT03319212|5396742|P1|COMPLETED|Overall Study||26
2199612|NCT03319212|5396741|P2|STARTED|Overall Study||52
2199613|NCT03319212|5396742|P1|STARTED|Overall Study||29
2199614|NCT03319173|5396769|P2|NOT COMPLETED|Overall Study||0
2199615|NCT03319173|5396770|P1|NOT COMPLETED|Overall Study||0
2199616|NCT03319173|5396769|P2|COMPLETED|Overall Study||50
2199617|NCT03319173|5396770|P1|COMPLETED|Overall Study||48
2199618|NCT03319173|5396769|P2|STARTED|Overall Study||50
2199619|NCT03319173|5396770|P1|STARTED|Overall Study||48
2199620|NCT03318341|5396808|P2|NOT COMPLETED|Month 2||0
2199621|NCT03318341|5396809|P1|NOT COMPLETED|Month 2||0
2199622|NCT03318341|5396808|P2|COMPLETED|Month 2||12
2199623|NCT03318341|5396809|P1|COMPLETED|Month 2||13
2199624|NCT03318341|5396808|P2|STARTED|Month 2||12
2199625|NCT03318341|5396809|P1|STARTED|Month 2||13
2199626|NCT03318341|5396808|P2|NOT COMPLETED|Month 1||1
2199627|NCT03318341|5396809|P1|NOT COMPLETED|Month 1||0
2199628|NCT03318341|5396808|P2|COMPLETED|Month 1||12
2199629|NCT03318341|5396809|P1|COMPLETED|Month 1||13
2199630|NCT03318341|5396808|P2|STARTED|Month 1||13
2199631|NCT03318341|5396809|P1|STARTED|Month 1||13
2199632|NCT03317431|5396819|P1|NOT COMPLETED|Overall Study||0
2199633|NCT03317431|5396819|P1|COMPLETED|Overall Study||46
2199634|NCT03317431|5396819|P1|STARTED|Overall Study||46
2199635|NCT03316976|5396829|P2|NOT COMPLETED|Overall Study||0
2199636|NCT03316976|5396830|P1|NOT COMPLETED|Overall Study||0
2199637|NCT03316976|5396829|P2|COMPLETED|Overall Study||20
2199638|NCT03316976|5396830|P1|COMPLETED|Overall Study||20
2199639|NCT03316976|5396829|P2|STARTED|Overall Study||20
2199640|NCT03316976|5396830|P1|STARTED|Overall Study||20
2199641|NCT03316911|5396842|P2|NOT COMPLETED|Overall Study||29
2199642|NCT03316911|5396843|P1|NOT COMPLETED|Overall Study||33
2199643|NCT03316911|5396842|P2|COMPLETED|Overall Study||110
2199644|NCT03316911|5396843|P1|COMPLETED|Overall Study||89
2199645|NCT03316911|5396842|P2|5-Month Follow-up Survey|Overall Study||110
2199646|NCT03316911|5396843|P1|5-Month Follow-up Survey|Overall Study||89
2199647|NCT03316911|5396842|P2|3-Month Follow-up Survey|Overall Study||112
2199648|NCT03316911|5396843|P1|3-Month Follow-up Survey|Overall Study||93
2199649|NCT03316911|5396842|P2|STARTED|Overall Study|3 did not complete baseline survey|139
2199650|NCT03316911|5396843|P1|STARTED|Overall Study|2 did not complete baseline survey|122
2199651|NCT03316378|5396877|P2|NOT COMPLETED|Overall Study||0
2199652|NCT03316378|5396878|P1|NOT COMPLETED|Overall Study||0
2199653|NCT03316378|5396877|P2|COMPLETED|Overall Study||23
2199654|NCT03316378|5396878|P1|COMPLETED|Overall Study||23
2199655|NCT03316378|5396877|P2|STARTED|Overall Study||23
2199656|NCT03316378|5396878|P1|STARTED|Overall Study||23
2199657|NCT03316131|5396888|P2|NOT COMPLETED|Treatment Period 2||0
2199658|NCT03316131|5396889|P1|NOT COMPLETED|Treatment Period 2||1
2199659|NCT03316131|5396888|P2|COMPLETED|Treatment Period 2||18
2199660|NCT03316131|5396889|P1|COMPLETED|Treatment Period 2||17
2199661|NCT03316131|5396888|P2|STARTED|Treatment Period 2||18
2199662|NCT03316131|5396889|P1|STARTED|Treatment Period 2||18
2199663|NCT03316131|5396888|P2|NOT COMPLETED|Treatment Period 1||0
2199664|NCT03316131|5396889|P1|NOT COMPLETED|Treatment Period 1||0
2199665|NCT03316131|5396888|P2|COMPLETED|Treatment Period 1||18
2199666|NCT03316131|5396889|P1|COMPLETED|Treatment Period 1||18
2199667|NCT03316131|5396888|P2|STARTED|Treatment Period 1||18
2199668|NCT03316131|5396889|P1|STARTED|Treatment Period 1||18
2199669|NCT03316105|5396909|P2|NOT COMPLETED|Overall Study||0
2199670|NCT03316105|5396910|P1|NOT COMPLETED|Overall Study||0
2199671|NCT03316105|5396909|P2|COMPLETED|Overall Study||7
2199672|NCT03316105|5396910|P1|COMPLETED|Overall Study||9
2199673|NCT03316105|5396909|P2|STARTED|Overall Study||7
2199674|NCT03316105|5396910|P1|STARTED|Overall Study||9
2199675|NCT03315780|5396916|P2|NOT COMPLETED|Period 2||0
2199676|NCT03315780|5396917|P1|NOT COMPLETED|Period 2||0
2199677|NCT03315780|5396916|P2|COMPLETED|Period 2||6
2199678|NCT03315780|5396917|P1|COMPLETED|Period 2||6
2199679|NCT03315780|5396916|P2|STARTED|Period 2||6
2199680|NCT03315780|5396917|P1|STARTED|Period 2||6
2199681|NCT03315780|5396916|P2|NOT COMPLETED|Period 1||0
2199682|NCT03315780|5396917|P1|NOT COMPLETED|Period 1||0
2199683|NCT03315780|5396916|P2|COMPLETED|Period 1||6
2199684|NCT03315780|5396917|P1|COMPLETED|Period 1||6
2199685|NCT03315780|5396916|P2|Received One Dose of Study Drug|Period 1||6
2199686|NCT03315780|5396917|P1|Received One Dose of Study Drug|Period 1||6
2199687|NCT03315780|5396916|P2|STARTED|Period 1||6
2199688|NCT03315780|5396917|P1|STARTED|Period 1||6
2199689|NCT03315702|5396937|P1|NOT COMPLETED|Overall Study||0
2199690|NCT03315702|5396937|P1|COMPLETED|Overall Study||52
2199691|NCT03315702|5396937|P1|STARTED|Overall Study||52
2199692|NCT03315572|5396946|P2|NOT COMPLETED|Overall Study||0
2199693|NCT03315572|5396947|P1|NOT COMPLETED|Overall Study||0
2199694|NCT03315572|5396946|P2|COMPLETED|Overall Study||14
2199695|NCT03315572|5396947|P1|COMPLETED|Overall Study||14
2199696|NCT03315572|5396946|P2|STARTED|Overall Study||14
2199697|NCT03315572|5396947|P1|STARTED|Overall Study||14
2199698|NCT03315559|5396970|P1|NOT COMPLETED|Treatment Period 2 (15 Days)||0
2199699|NCT03315559|5396970|P1|COMPLETED|Treatment Period 2 (15 Days)||6
2199700|NCT03315559|5396970|P1|STARTED|Treatment Period 2 (15 Days)||6
2199701|NCT03315559|5396970|P1|NOT COMPLETED|Washout Period (14 Days)||0
2199702|NCT03315559|5396970|P1|COMPLETED|Washout Period (14 Days)||6
2199703|NCT03315559|5396970|P1|STARTED|Washout Period (14 Days)||6
2199704|NCT03315559|5396970|P1|NOT COMPLETED|Treatment Period 1 (8 Days)||0
2199705|NCT03315559|5396970|P1|COMPLETED|Treatment Period 1 (8 Days)||6
2199706|NCT03315559|5396970|P1|STARTED|Treatment Period 1 (8 Days)||6
2199707|NCT03315286|5397010|P2|NOT COMPLETED|Overall Study||4
2199708|NCT03315286|5397011|P1|NOT COMPLETED|Overall Study||1
2199709|NCT03315286|5397010|P2|COMPLETED|Overall Study||43
2199710|NCT03315286|5397011|P1|COMPLETED|Overall Study||49
2199711|NCT03315286|5397010|P2|STARTED|Overall Study||47
2199712|NCT03315286|5397011|P1|STARTED|Overall Study||50
2199713|NCT03314753|5397029|P2|NOT COMPLETED|Overall Study||0
2199714|NCT03314753|5397030|P1|NOT COMPLETED|Overall Study||0
2199715|NCT03314753|5397029|P2|COMPLETED|Overall Study||36
2199716|NCT03314753|5397030|P1|COMPLETED|Overall Study||53
2199717|NCT03314753|5397029|P2|STARTED|Overall Study||36
2199718|NCT03314753|5397030|P1|STARTED|Overall Study||53
2199719|NCT03314233|5397052|P1|NOT COMPLETED|Overall Study||1
2199720|NCT03314233|5397052|P1|COMPLETED|Overall Study|20 mothers who had provided informed consent met eligibility criteria at time of delivery.|20
2199721|NCT03314233|5397052|P1|STARTED|Overall Study|21 mothers provided informed consent for participation in the trial.|21
2199722|NCT03313037|5397065|P2|NOT COMPLETED|Overall Study||20
2199723|NCT03313037|5397066|P1|NOT COMPLETED|Overall Study||20
2199724|NCT03313037|5397065|P2|COMPLETED|Overall Study||202
2199725|NCT03313037|5397066|P1|COMPLETED|Overall Study||202
2199726|NCT03313037|5397065|P2|Evaluable Immunogenicity Population(EIP)|Overall Study||208
2199727|NCT03313037|5397066|P1|Evaluable Immunogenicity Population(EIP)|Overall Study||210
2199728|NCT03313037|5397065|P2|Safety Population|Overall Study||222
2199729|NCT03313037|5397066|P1|Safety Population|Overall Study||221
2199730|NCT03313037|5397065|P2|STARTED|Overall Study||222
2199731|NCT03313037|5397066|P1|STARTED|Overall Study||222
2199732|NCT03312933|5397088|P1|NOT COMPLETED|Overall Study||54
2199733|NCT03312933|5397088|P1|COMPLETED|Overall Study||46
2199734|NCT03312933|5397088|P1|STARTED|Overall Study||100
2199735|NCT03312543|5397094|P2|NOT COMPLETED|Regression (Week 12 to Week 24)||2
2199736|NCT03312543|5397095|P1|NOT COMPLETED|Regression (Week 12 to Week 24)||1
2199737|NCT03312543|5397094|P2|COMPLETED|Regression (Week 12 to Week 24)||52
2199738|NCT03312543|5397095|P1|COMPLETED|Regression (Week 12 to Week 24)||55
2199739|NCT03312543|5397094|P2|STARTED|Regression (Week 12 to Week 24)||54
2199740|NCT03312543|5397095|P1|STARTED|Regression (Week 12 to Week 24)||56
2199741|NCT03312543|5397094|P2|NOT COMPLETED|Treatment (Baseline to Week 12)||5
2199742|NCT03312543|5397095|P1|NOT COMPLETED|Treatment (Baseline to Week 12)||4
2199743|NCT03312543|5397094|P2|COMPLETED|Treatment (Baseline to Week 12)||54
2199744|NCT03312543|5397095|P1|COMPLETED|Treatment (Baseline to Week 12)||56
2199745|NCT03312543|5397094|P2|STARTED|Treatment (Baseline to Week 12)||59
2199746|NCT03312543|5397095|P1|STARTED|Treatment (Baseline to Week 12)||60
2199747|NCT03312543|5397094|P2|NOT COMPLETED|Before Treatment (Screening to Baseline)||4
2199748|NCT03312543|5397095|P1|NOT COMPLETED|Before Treatment (Screening to Baseline)||1
2199749|NCT03312543|5397094|P2|COMPLETED|Before Treatment (Screening to Baseline)||59
2199750|NCT03312543|5397095|P1|COMPLETED|Before Treatment (Screening to Baseline)||60
2199751|NCT03312543|5397094|P2|STARTED|Before Treatment (Screening to Baseline)||63
2199752|NCT03312543|5397095|P1|STARTED|Before Treatment (Screening to Baseline)||61
2199753|NCT03312517|5397169|P6|NOT COMPLETED|Overall Study||0
2199754|NCT03312517|5397170|P5|NOT COMPLETED|Overall Study||0
2199755|NCT03312517|5397171|P4|NOT COMPLETED|Overall Study||0
2199756|NCT03312517|5397172|P3|NOT COMPLETED|Overall Study||0
2199757|NCT03312517|5397173|P2|NOT COMPLETED|Overall Study||0
2199758|NCT03312517|5397174|P1|NOT COMPLETED|Overall Study||0
2199759|NCT03312517|5397169|P6|COMPLETED|Overall Study||2
2199760|NCT03312517|5397170|P5|COMPLETED|Overall Study||2
2199761|NCT03312517|5397171|P4|COMPLETED|Overall Study||2
2199762|NCT03312517|5397172|P3|COMPLETED|Overall Study||2
2199763|NCT03312517|5397173|P2|COMPLETED|Overall Study||2
2199764|NCT03312517|5397174|P1|COMPLETED|Overall Study||2
2199765|NCT03312517|5397169|P6|STARTED|Overall Study||2
2199766|NCT03312517|5397170|P5|STARTED|Overall Study||2
2199767|NCT03312517|5397171|P4|STARTED|Overall Study||2
2199768|NCT03312517|5397172|P3|STARTED|Overall Study||2
2199769|NCT03312517|5397173|P2|STARTED|Overall Study||2
2199770|NCT03312517|5397174|P1|STARTED|Overall Study||2
2199771|NCT03312348|5397182|P1|NOT COMPLETED|Overall Study||0
2199772|NCT03312348|5397182|P1|COMPLETED|Overall Study||30
2199773|NCT03312348|5397182|P1|STARTED|Overall Study||30
2199774|NCT03311841|5397191|P5|NOT COMPLETED|Period 2||0
2199775|NCT03311841|5397192|P4|NOT COMPLETED|Period 2||0
2199776|NCT03311841|5397193|P3|NOT COMPLETED|Period 2||0
2199777|NCT03311841|5397194|P2|NOT COMPLETED|Period 2||0
2199778|NCT03311841|5397195|P1|NOT COMPLETED|Period 2||0
2199779|NCT03311841|5397191|P5|COMPLETED|Period 2||6
2199780|NCT03311841|5397192|P4|COMPLETED|Period 2||6
2199781|NCT03311841|5397193|P3|COMPLETED|Period 2||6
2199782|NCT03311841|5397194|P2|COMPLETED|Period 2||6
2199783|NCT03311841|5397195|P1|COMPLETED|Period 2||6
2199784|NCT03311841|5397191|P5|STARTED|Period 2||6
2199785|NCT03311841|5397192|P4|STARTED|Period 2||6
2199786|NCT03311841|5397193|P3|STARTED|Period 2||6
2199787|NCT03311841|5397194|P2|STARTED|Period 2||6
2199788|NCT03311841|5397195|P1|STARTED|Period 2||6
2199789|NCT03311841|5397191|P5|NOT COMPLETED|14-day Wash-out||0
2199790|NCT03311841|5397192|P4|NOT COMPLETED|14-day Wash-out||1
2199791|NCT03311841|5397193|P3|NOT COMPLETED|14-day Wash-out||0
2199792|NCT03311841|5397194|P2|NOT COMPLETED|14-day Wash-out||1
2199793|NCT03311841|5397195|P1|NOT COMPLETED|14-day Wash-out||0
2199794|NCT03311841|5397191|P5|COMPLETED|14-day Wash-out||6
2199795|NCT03311841|5397192|P4|COMPLETED|14-day Wash-out||6
2199796|NCT03311841|5397193|P3|COMPLETED|14-day Wash-out||6
2199797|NCT03311841|5397194|P2|COMPLETED|14-day Wash-out||6
2199798|NCT03311841|5397195|P1|COMPLETED|14-day Wash-out||6
2199799|NCT03311841|5397191|P5|STARTED|14-day Wash-out||6
2199800|NCT03311841|5397192|P4|STARTED|14-day Wash-out||7
2199801|NCT03311841|5397193|P3|STARTED|14-day Wash-out||6
2199802|NCT03311841|5397194|P2|STARTED|14-day Wash-out||7
2199803|NCT03311841|5397195|P1|STARTED|14-day Wash-out||6
2199804|NCT03311841|5397191|P5|NOT COMPLETED|Period 1||0
2199805|NCT03311841|5397192|P4|NOT COMPLETED|Period 1||0
2199806|NCT03311841|5397193|P3|NOT COMPLETED|Period 1||0
2199807|NCT03311841|5397194|P2|NOT COMPLETED|Period 1||0
2199808|NCT03311841|5397195|P1|NOT COMPLETED|Period 1||0
2199809|NCT03311841|5397191|P5|COMPLETED|Period 1||6
2199810|NCT03311841|5397192|P4|COMPLETED|Period 1||7
2199811|NCT03311841|5397193|P3|COMPLETED|Period 1||6
2199812|NCT03311841|5397194|P2|COMPLETED|Period 1||7
2199813|NCT03311841|5397195|P1|COMPLETED|Period 1||6
2199814|NCT03311841|5397191|P5|STARTED|Period 1||6
2199815|NCT03311841|5397192|P4|STARTED|Period 1||7
2199816|NCT03311841|5397193|P3|STARTED|Period 1||6
2199817|NCT03311841|5397194|P2|STARTED|Period 1||7
2199818|NCT03311841|5397195|P1|STARTED|Period 1||6
2199819|NCT03311659|5397296|P1|NOT COMPLETED|Overall Study||1
2199820|NCT03311659|5397296|P1|COMPLETED|Overall Study||446
2199821|NCT03311659|5397296|P1|STARTED|Overall Study||447
2199822|NCT03311646|5397311|P1|NOT COMPLETED|Overall Study||15
2199823|NCT03311646|5397311|P1|COMPLETED|Overall Study|Completed VLNC Condition|16
2199824|NCT03311646|5397311|P1|STARTED|Overall Study|Number who were eligible and consented.|31
2199825|NCT03311230|5397322|P4|NOT COMPLETED|Overall Study||7
2199826|NCT03311230|5397323|P3|NOT COMPLETED|Overall Study||2
2199827|NCT03311230|5397324|P2|NOT COMPLETED|Overall Study||5
2199828|NCT03311230|5397325|P1|NOT COMPLETED|Overall Study||1
2199829|NCT03311230|5397322|P4|COMPLETED|Overall Study||143
2199830|NCT03311230|5397323|P3|COMPLETED|Overall Study||148
2199831|NCT03311230|5397324|P2|COMPLETED|Overall Study||146
2199832|NCT03311230|5397325|P1|COMPLETED|Overall Study||150
2199833|NCT03311230|5397322|P4|STARTED|Overall Study||150
2199834|NCT03311230|5397323|P3|STARTED|Overall Study||150
2199835|NCT03311230|5397324|P2|STARTED|Overall Study||151
2199836|NCT03311230|5397325|P1|STARTED|Overall Study||151
2199837|NCT03310580|5397350|P3|NOT COMPLETED|Overall Study||0
2199838|NCT03310580|5397351|P2|NOT COMPLETED|Overall Study||1
2199839|NCT03310580|5397352|P1|NOT COMPLETED|Overall Study||0
2199840|NCT03310580|5397350|P3|COMPLETED|Overall Study||12
2199841|NCT03310580|5397351|P2|COMPLETED|Overall Study||14
2199842|NCT03310580|5397352|P1|COMPLETED|Overall Study||15
2199843|NCT03310580|5397350|P3|STARTED|Overall Study||12
2199844|NCT03310580|5397351|P2|STARTED|Overall Study||15
2199845|NCT03310580|5397352|P1|STARTED|Overall Study||15
2199846|NCT03310450|5397366|P3|NOT COMPLETED|Overall Study||0
2199847|NCT03310450|5397367|P2|NOT COMPLETED|Overall Study||4
2199848|NCT03310450|5397368|P1|NOT COMPLETED|Overall Study||2
2199849|NCT03310450|5397366|P3|COMPLETED|Overall Study||28
2199850|NCT03310450|5397367|P2|COMPLETED|Overall Study||30
2199851|NCT03310450|5397368|P1|COMPLETED|Overall Study||30
2199852|NCT03310450|5397366|P3|STARTED|Overall Study||28
2199853|NCT03310450|5397367|P2|STARTED|Overall Study||34
2199854|NCT03310450|5397368|P1|STARTED|Overall Study||32
2199855|NCT03310411|5397385|P4|NOT COMPLETED|Period Title: Period 4||0
2199856|NCT03310411|5397386|P3|NOT COMPLETED|Period Title: Period 4||0
2199857|NCT03310411|5397387|P2|NOT COMPLETED|Period Title: Period 4||0
2199858|NCT03310411|5397388|P1|NOT COMPLETED|Period Title: Period 4||0
2199859|NCT03310411|5397385|P4|COMPLETED|Period Title: Period 4||9
2199860|NCT03310411|5397386|P3|COMPLETED|Period Title: Period 4||10
2199861|NCT03310411|5397387|P2|COMPLETED|Period Title: Period 4||10
2199862|NCT03310411|5397388|P1|COMPLETED|Period Title: Period 4||10
2199863|NCT03310411|5397385|P4|STARTED|Period Title: Period 4||9
2199864|NCT03310411|5397386|P3|STARTED|Period Title: Period 4||10
2199865|NCT03310411|5397387|P2|STARTED|Period Title: Period 4||10
2199866|NCT03310411|5397388|P1|STARTED|Period Title: Period 4||10
2199867|NCT03310411|5397385|P4|NOT COMPLETED|Period 3||0
2199868|NCT03310411|5397386|P3|NOT COMPLETED|Period 3||0
2199869|NCT03310411|5397387|P2|NOT COMPLETED|Period 3||0
2199870|NCT03310411|5397388|P1|NOT COMPLETED|Period 3||0
2199871|NCT03310411|5397385|P4|COMPLETED|Period 3||9
2199872|NCT03310411|5397386|P3|COMPLETED|Period 3||10
2199873|NCT03310411|5397387|P2|COMPLETED|Period 3||10
2199874|NCT03310411|5397388|P1|COMPLETED|Period 3||10
2199875|NCT03310411|5397385|P4|STARTED|Period 3||9
2199876|NCT03310411|5397386|P3|STARTED|Period 3||10
2199877|NCT03310411|5397387|P2|STARTED|Period 3||10
2199878|NCT03310411|5397388|P1|STARTED|Period 3||10
2199879|NCT03310411|5397385|P4|NOT COMPLETED|Period 2||0
2199880|NCT03310411|5397386|P3|NOT COMPLETED|Period 2||0
2199881|NCT03310411|5397387|P2|NOT COMPLETED|Period 2||0
2199882|NCT03310411|5397388|P1|NOT COMPLETED|Period 2||0
2199883|NCT03310411|5397385|P4|COMPLETED|Period 2||9
2199884|NCT03310411|5397386|P3|COMPLETED|Period 2||10
2199885|NCT03310411|5397387|P2|COMPLETED|Period 2||10
2199886|NCT03310411|5397388|P1|COMPLETED|Period 2||10
2199887|NCT03310411|5397385|P4|STARTED|Period 2||9
2199888|NCT03310411|5397386|P3|STARTED|Period 2||10
2199889|NCT03310411|5397387|P2|STARTED|Period 2||10
2199890|NCT03310411|5397388|P1|STARTED|Period 2||10
2199891|NCT03310411|5397385|P4|NOT COMPLETED|Period 1||1
2199892|NCT03310411|5397386|P3|NOT COMPLETED|Period 1||0
2199893|NCT03310411|5397387|P2|NOT COMPLETED|Period 1||0
2199894|NCT03310411|5397388|P1|NOT COMPLETED|Period 1||0
2199895|NCT03310411|5397385|P4|COMPLETED|Period 1||9
2199896|NCT03310411|5397386|P3|COMPLETED|Period 1||10
2199897|NCT03310411|5397387|P2|COMPLETED|Period 1||10
2199898|NCT03310411|5397388|P1|COMPLETED|Period 1||10
2199899|NCT03310411|5397385|P4|Received at Least 1 Dose of Study Drug|Period 1||10
2199900|NCT03310411|5397386|P3|Received at Least 1 Dose of Study Drug|Period 1||10
2199901|NCT03310411|5397387|P2|Received at Least 1 Dose of Study Drug|Period 1||10
2199902|NCT03310411|5397388|P1|Received at Least 1 Dose of Study Drug|Period 1||10
2199903|NCT03310411|5397385|P4|STARTED|Period 1||10
2199904|NCT03310411|5397386|P3|STARTED|Period 1||10
2199905|NCT03310411|5397387|P2|STARTED|Period 1||10
2199906|NCT03310411|5397388|P1|STARTED|Period 1||10
2199907|NCT03310268|5397409|P3|NOT COMPLETED|Overall Study||0
2199908|NCT03310268|5397410|P2|NOT COMPLETED|Overall Study||5
2199909|NCT03310268|5397411|P1|NOT COMPLETED|Overall Study||1
2199910|NCT03310268|5397409|P3|COMPLETED|Overall Study||61
2199911|NCT03310268|5397410|P2|COMPLETED|Overall Study||57
2199912|NCT03310268|5397411|P1|COMPLETED|Overall Study||61
2199913|NCT03310268|5397409|P3|STARTED|Overall Study||61
2199914|NCT03310268|5397410|P2|STARTED|Overall Study||62
2199915|NCT03310268|5397411|P1|STARTED|Overall Study||62
2199916|NCT03309202|5397426|P4|NOT COMPLETED|Overall Study||0
2199917|NCT03309202|5397427|P3|NOT COMPLETED|Overall Study||0
2199918|NCT03309202|5397428|P2|NOT COMPLETED|Overall Study||0
2199919|NCT03309202|5397429|P1|NOT COMPLETED|Overall Study||1
2199920|NCT03309202|5397426|P4|COMPLETED|Overall Study||6
2199921|NCT03309202|5397427|P3|COMPLETED|Overall Study||6
2199922|NCT03309202|5397428|P2|COMPLETED|Overall Study||6
2199923|NCT03309202|5397429|P1|COMPLETED|Overall Study||5
2199924|NCT03309202|5397426|P4|STARTED|Overall Study||6
2199925|NCT03309202|5397427|P3|STARTED|Overall Study||6
2199926|NCT03309202|5397428|P2|STARTED|Overall Study||6
2199927|NCT03309202|5397429|P1|STARTED|Overall Study||6
2199928|NCT03308968|5397514|P3|NOT COMPLETED|Open-Label Period (12 Weeks)||12
2199929|NCT03308968|5397515|P2|NOT COMPLETED|Open-Label Period (12 Weeks)||12
2199930|NCT03308968|5397516|P1|NOT COMPLETED|Open-Label Period (12 Weeks)||11
2199931|NCT03308968|5397514|P3|COMPLETED|Open-Label Period (12 Weeks)||260
2199932|NCT03308968|5397515|P2|COMPLETED|Open-Label Period (12 Weeks)||259
2199933|NCT03308968|5397516|P1|COMPLETED|Open-Label Period (12 Weeks)||253
2199934|NCT03308968|5397514|P3|OL mITT Analysis Set|Open-Label Period (12 Weeks)||272
2199935|NCT03308968|5397515|P2|OL mITT Analysis Set|Open-Label Period (12 Weeks)||271
2199936|NCT03308968|5397516|P1|OL mITT Analysis Set|Open-Label Period (12 Weeks)||263
2199937|NCT03308968|5397514|P3|STARTED|Open-Label Period (12 Weeks)||272
2199938|NCT03308968|5397515|P2|STARTED|Open-Label Period (12 Weeks)||271
2199939|NCT03308968|5397516|P1|STARTED|Open-Label Period (12 Weeks)||264
2199940|NCT03308968|5397514|P3|NOT COMPLETED|Double-Blind Period (12 Weeks)||11
2199941|NCT03308968|5397515|P2|NOT COMPLETED|Double-Blind Period (12 Weeks)||5
2199942|NCT03308968|5397516|P1|NOT COMPLETED|Double-Blind Period (12 Weeks)||15
2199943|NCT03308968|5397514|P3|COMPLETED|Double-Blind Period (12 Weeks)||272
2199944|NCT03308968|5397515|P2|COMPLETED|Double-Blind Period (12 Weeks)||271
2199945|NCT03308968|5397516|P1|COMPLETED|Double-Blind Period (12 Weeks)||264
2199946|NCT03308968|5397514|P3|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||283
2199947|NCT03308968|5397515|P2|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||276
2199948|NCT03308968|5397516|P1|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||278
2199949|NCT03308968|5397514|P3|DB Safety Analysis Set|Double-Blind Period (12 Weeks)|2 participants (1 with CM and 1 with EM) randomized to placebo but received Fremanezumab monthly.|285
2199950|NCT03308968|5397515|P2|DB Safety Analysis Set|Double-Blind Period (12 Weeks)||276
2199951|NCT03308968|5397516|P1|DB Safety Analysis Set|Double-Blind Period (12 Weeks)|2 participants (1 with CM and 1 with EM) randomized to placebo but received Fremanezumab monthly.|277
2199952|NCT03308968|5397514|P3|STARTED|Double-Blind Period (12 Weeks)||283
2199953|NCT03308968|5397515|P2|STARTED|Double-Blind Period (12 Weeks)||276
2199954|NCT03308968|5397516|P1|STARTED|Double-Blind Period (12 Weeks)||279
2199955|NCT03308825|5397594|P4|NOT COMPLETED|Overall Study||0
2199956|NCT03308825|5397595|P3|NOT COMPLETED|Overall Study||1
2199957|NCT03308825|5397596|P2|NOT COMPLETED|Overall Study||4
2199958|NCT03308825|5397597|P1|NOT COMPLETED|Overall Study||2
2199959|NCT03308825|5397594|P4|COMPLETED|Overall Study||60
2199960|NCT03308825|5397595|P3|COMPLETED|Overall Study||59
2199961|NCT03308825|5397596|P2|COMPLETED|Overall Study||57
2199962|NCT03308825|5397597|P1|COMPLETED|Overall Study||57
2199963|NCT03308825|5397594|P4|STARTED|Overall Study||60
2199964|NCT03308825|5397595|P3|STARTED|Overall Study||60
2199965|NCT03308825|5397596|P2|STARTED|Overall Study|1 child in Group 1 received a 0.5mL dose instead of a 0.25 mL dose and is included in Group 2.|61
2199966|NCT03308825|5397597|P1|STARTED|Overall Study|1 child in Group 1 received a 0.5mL dose instead of a 0.25 mL dose and is included in Group 2.|59
2199967|NCT03308799|5397626|P3|NOT COMPLETED|Overall Study||21
2199968|NCT03308799|5397627|P2|NOT COMPLETED|Overall Study||28
2199969|NCT03308799|5397628|P1|NOT COMPLETED|Overall Study||22
2199970|NCT03308799|5397626|P3|COMPLETED|Overall Study||94
2199971|NCT03308799|5397627|P2|COMPLETED|Overall Study||309
2199972|NCT03308799|5397628|P1|COMPLETED|Overall Study||320
2199973|NCT03308799|5397626|P3|STARTED|Overall Study||115
2199974|NCT03308799|5397627|P2|STARTED|Overall Study||337
2199975|NCT03308799|5397628|P1|STARTED|Overall Study||342
2199976|NCT03308669|5397644|P2|NOT COMPLETED|Overall Study||0
2199977|NCT03308669|5397645|P1|NOT COMPLETED|Overall Study||0
2199978|NCT03308669|5397644|P2|COMPLETED|Overall Study||20
2199979|NCT03308669|5397645|P1|COMPLETED|Overall Study||10
2200066|NCT03307252|5397695|P1|NOT COMPLETED|Part 3, Period 3||0
2199980|NCT03308669|5397644|P2|Received at Least One Dose of Study Drug|Overall Study||20
2199981|NCT03308669|5397645|P1|Received at Least One Dose of Study Drug|Overall Study||10
2199982|NCT03308669|5397644|P2|STARTED|Overall Study||20
2199983|NCT03308669|5397645|P1|STARTED|Overall Study||10
2199984|NCT03308058|5397667|P2|NOT COMPLETED|Overall Study||0
2199985|NCT03308058|5397668|P1|NOT COMPLETED|Overall Study||0
2199986|NCT03308058|5397667|P2|COMPLETED|Overall Study||23
2199987|NCT03308058|5397668|P1|COMPLETED|Overall Study||23
2199988|NCT03308058|5397667|P2|STARTED|Overall Study||23
2199989|NCT03308058|5397668|P1|STARTED|Overall Study||23
2199990|NCT03307252|5397685|P11|NOT COMPLETED|Part 3, Period 4||0
2199991|NCT03307252|5397686|P10|NOT COMPLETED|Part 3, Period 4||0
2199992|NCT03307252|5397687|P9|NOT COMPLETED|Part 3, Period 4||0
2199993|NCT03307252|5397688|P8|NOT COMPLETED|Part 3, Period 4||0
2199994|NCT03307252|5397689|P7|NOT COMPLETED|Part 3, Period 4||0
2199995|NCT03307252|5397690|P6|NOT COMPLETED|Part 3, Period 4||0
2199996|NCT03307252|5397691|P5|NOT COMPLETED|Part 3, Period 4||0
2199997|NCT03307252|5397692|P4|NOT COMPLETED|Part 3, Period 4||0
2199998|NCT03307252|5397693|P3|NOT COMPLETED|Part 3, Period 4||0
2199999|NCT03307252|5397694|P2|NOT COMPLETED|Part 3, Period 4||0
2200000|NCT03307252|5397695|P1|NOT COMPLETED|Part 3, Period 4||0
2200001|NCT03307252|5397685|P11|COMPLETED|Part 3, Period 4||3
2200002|NCT03307252|5397686|P10|COMPLETED|Part 3, Period 4||4
2200003|NCT03307252|5397687|P9|COMPLETED|Part 3, Period 4||4
2200004|NCT03307252|5397688|P8|COMPLETED|Part 3, Period 4||4
2200005|NCT03307252|5397689|P7|COMPLETED|Part 3, Period 4||0
2200006|NCT03307252|5397690|P6|COMPLETED|Part 3, Period 4||0
2200007|NCT03307252|5397691|P5|COMPLETED|Part 3, Period 4||0
2200008|NCT03307252|5397692|P4|COMPLETED|Part 3, Period 4||0
2200009|NCT03307252|5397693|P3|COMPLETED|Part 3, Period 4||0
2200010|NCT03307252|5397694|P2|COMPLETED|Part 3, Period 4||0
2200011|NCT03307252|5397695|P1|COMPLETED|Part 3, Period 4||0
2200012|NCT03307252|5397685|P11|STARTED|Part 3, Period 4||3
2200013|NCT03307252|5397686|P10|STARTED|Part 3, Period 4||4
2200014|NCT03307252|5397687|P9|STARTED|Part 3, Period 4||4
2200015|NCT03307252|5397688|P8|STARTED|Part 3, Period 4||4
2200016|NCT03307252|5397689|P7|STARTED|Part 3, Period 4||0
2200017|NCT03307252|5397690|P6|STARTED|Part 3, Period 4||0
2200018|NCT03307252|5397691|P5|STARTED|Part 3, Period 4||0
2200019|NCT03307252|5397692|P4|STARTED|Part 3, Period 4||0
2200020|NCT03307252|5397693|P3|STARTED|Part 3, Period 4||0
2200021|NCT03307252|5397694|P2|STARTED|Part 3, Period 4||0
2200022|NCT03307252|5397695|P1|STARTED|Part 3, Period 4||0
2200023|NCT03307252|5397685|P11|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||1
2200024|NCT03307252|5397686|P10|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
2200025|NCT03307252|5397687|P9|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
2200026|NCT03307252|5397688|P8|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
2200027|NCT03307252|5397689|P7|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
2200028|NCT03307252|5397690|P6|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
2200029|NCT03307252|5397691|P5|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
2200030|NCT03307252|5397692|P4|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
2200031|NCT03307252|5397693|P3|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
2200032|NCT03307252|5397694|P2|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
2200033|NCT03307252|5397695|P1|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
2200034|NCT03307252|5397685|P11|COMPLETED|Part 3, Washout Period 3 (7 Days)||3
2200035|NCT03307252|5397686|P10|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
2200036|NCT03307252|5397687|P9|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
2200037|NCT03307252|5397688|P8|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
2200038|NCT03307252|5397689|P7|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
2200039|NCT03307252|5397690|P6|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
2200040|NCT03307252|5397691|P5|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
2200041|NCT03307252|5397692|P4|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
2200042|NCT03307252|5397693|P3|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
2200043|NCT03307252|5397694|P2|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
2200044|NCT03307252|5397695|P1|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
2200045|NCT03307252|5397685|P11|STARTED|Part 3, Washout Period 3 (7 Days)||4
2200046|NCT03307252|5397686|P10|STARTED|Part 3, Washout Period 3 (7 Days)||4
2200047|NCT03307252|5397687|P9|STARTED|Part 3, Washout Period 3 (7 Days)||4
2200048|NCT03307252|5397688|P8|STARTED|Part 3, Washout Period 3 (7 Days)||4
2200049|NCT03307252|5397689|P7|STARTED|Part 3, Washout Period 3 (7 Days)||0
2200050|NCT03307252|5397690|P6|STARTED|Part 3, Washout Period 3 (7 Days)||0
2200051|NCT03307252|5397691|P5|STARTED|Part 3, Washout Period 3 (7 Days)||0
2200052|NCT03307252|5397692|P4|STARTED|Part 3, Washout Period 3 (7 Days)||0
2200053|NCT03307252|5397693|P3|STARTED|Part 3, Washout Period 3 (7 Days)||0
2200054|NCT03307252|5397694|P2|STARTED|Part 3, Washout Period 3 (7 Days)||0
2200055|NCT03307252|5397695|P1|STARTED|Part 3, Washout Period 3 (7 Days)||0
2200056|NCT03307252|5397685|P11|NOT COMPLETED|Part 3, Period 3||0
2200057|NCT03307252|5397686|P10|NOT COMPLETED|Part 3, Period 3||0
2200058|NCT03307252|5397687|P9|NOT COMPLETED|Part 3, Period 3||0
2200059|NCT03307252|5397688|P8|NOT COMPLETED|Part 3, Period 3||0
2200060|NCT03307252|5397689|P7|NOT COMPLETED|Part 3, Period 3||0
2200061|NCT03307252|5397690|P6|NOT COMPLETED|Part 3, Period 3||0
2200062|NCT03307252|5397691|P5|NOT COMPLETED|Part 3, Period 3||0
2200063|NCT03307252|5397692|P4|NOT COMPLETED|Part 3, Period 3||0
2200064|NCT03307252|5397693|P3|NOT COMPLETED|Part 3, Period 3||0
2200065|NCT03307252|5397694|P2|NOT COMPLETED|Part 3, Period 3||0
2200067|NCT03307252|5397685|P11|COMPLETED|Part 3, Period 3||4
2200068|NCT03307252|5397686|P10|COMPLETED|Part 3, Period 3||4
2200069|NCT03307252|5397687|P9|COMPLETED|Part 3, Period 3||4
2200070|NCT03307252|5397688|P8|COMPLETED|Part 3, Period 3||4
2200071|NCT03307252|5397689|P7|COMPLETED|Part 3, Period 3||0
2200072|NCT03307252|5397690|P6|COMPLETED|Part 3, Period 3||0
2200073|NCT03307252|5397691|P5|COMPLETED|Part 3, Period 3||0
2200074|NCT03307252|5397692|P4|COMPLETED|Part 3, Period 3||0
2200075|NCT03307252|5397693|P3|COMPLETED|Part 3, Period 3||0
2200076|NCT03307252|5397694|P2|COMPLETED|Part 3, Period 3||0
2200077|NCT03307252|5397695|P1|COMPLETED|Part 3, Period 3||0
2200078|NCT03307252|5397685|P11|STARTED|Part 3, Period 3||4
2200079|NCT03307252|5397686|P10|STARTED|Part 3, Period 3||4
2200080|NCT03307252|5397687|P9|STARTED|Part 3, Period 3||4
2200081|NCT03307252|5397688|P8|STARTED|Part 3, Period 3||4
2200082|NCT03307252|5397689|P7|STARTED|Part 3, Period 3||0
2200083|NCT03307252|5397690|P6|STARTED|Part 3, Period 3||0
2200084|NCT03307252|5397691|P5|STARTED|Part 3, Period 3||0
2200085|NCT03307252|5397692|P4|STARTED|Part 3, Period 3||0
2200086|NCT03307252|5397693|P3|STARTED|Part 3, Period 3||0
2200087|NCT03307252|5397694|P2|STARTED|Part 3, Period 3||0
2200088|NCT03307252|5397695|P1|STARTED|Part 3, Period 3||0
2200089|NCT03307252|5397685|P11|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
2200090|NCT03307252|5397686|P10|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
2200091|NCT03307252|5397687|P9|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
2200092|NCT03307252|5397688|P8|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
2200093|NCT03307252|5397689|P7|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
2200094|NCT03307252|5397690|P6|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
2200095|NCT03307252|5397691|P5|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
2200096|NCT03307252|5397692|P4|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
2200097|NCT03307252|5397693|P3|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
2200098|NCT03307252|5397694|P2|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
2200099|NCT03307252|5397695|P1|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
2200100|NCT03307252|5397685|P11|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
2200101|NCT03307252|5397686|P10|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
2200102|NCT03307252|5397687|P9|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
2200103|NCT03307252|5397688|P8|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
2200104|NCT03307252|5397689|P7|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
2200105|NCT03307252|5397690|P6|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
2200106|NCT03307252|5397691|P5|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
2200107|NCT03307252|5397692|P4|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
2200108|NCT03307252|5397693|P3|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
2200109|NCT03307252|5397694|P2|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
2200110|NCT03307252|5397695|P1|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
2200111|NCT03307252|5397685|P11|STARTED|Part 3, Washout Period 2 (7 Days)||4
2200112|NCT03307252|5397686|P10|STARTED|Part 3, Washout Period 2 (7 Days)||4
2200113|NCT03307252|5397687|P9|STARTED|Part 3, Washout Period 2 (7 Days)||4
2200114|NCT03307252|5397688|P8|STARTED|Part 3, Washout Period 2 (7 Days)||4
2200115|NCT03307252|5397689|P7|STARTED|Part 3, Washout Period 2 (7 Days)||0
2200116|NCT03307252|5397690|P6|STARTED|Part 3, Washout Period 2 (7 Days)||0
2200117|NCT03307252|5397691|P5|STARTED|Part 3, Washout Period 2 (7 Days)||0
2200118|NCT03307252|5397692|P4|STARTED|Part 3, Washout Period 2 (7 Days)||0
2200119|NCT03307252|5397693|P3|STARTED|Part 3, Washout Period 2 (7 Days)||0
2200120|NCT03307252|5397694|P2|STARTED|Part 3, Washout Period 2 (7 Days)||0
2200121|NCT03307252|5397695|P1|STARTED|Part 3, Washout Period 2 (7 Days)||0
2200122|NCT03307252|5397685|P11|NOT COMPLETED|Part 3, Period 2||0
2200123|NCT03307252|5397686|P10|NOT COMPLETED|Part 3, Period 2||0
2200124|NCT03307252|5397687|P9|NOT COMPLETED|Part 3, Period 2||0
2200125|NCT03307252|5397688|P8|NOT COMPLETED|Part 3, Period 2||0
2200126|NCT03307252|5397689|P7|NOT COMPLETED|Part 3, Period 2||0
2200127|NCT03307252|5397690|P6|NOT COMPLETED|Part 3, Period 2||0
2200128|NCT03307252|5397691|P5|NOT COMPLETED|Part 3, Period 2||0
2200129|NCT03307252|5397692|P4|NOT COMPLETED|Part 3, Period 2||0
2200130|NCT03307252|5397693|P3|NOT COMPLETED|Part 3, Period 2||0
2200131|NCT03307252|5397694|P2|NOT COMPLETED|Part 3, Period 2||0
2200132|NCT03307252|5397695|P1|NOT COMPLETED|Part 3, Period 2||0
2200133|NCT03307252|5397685|P11|COMPLETED|Part 3, Period 2||4
2200134|NCT03307252|5397686|P10|COMPLETED|Part 3, Period 2||4
2200135|NCT03307252|5397687|P9|COMPLETED|Part 3, Period 2||4
2200136|NCT03307252|5397688|P8|COMPLETED|Part 3, Period 2||4
2200137|NCT03307252|5397689|P7|COMPLETED|Part 3, Period 2||0
2200138|NCT03307252|5397690|P6|COMPLETED|Part 3, Period 2||0
2200139|NCT03307252|5397691|P5|COMPLETED|Part 3, Period 2||0
2200140|NCT03307252|5397692|P4|COMPLETED|Part 3, Period 2||0
2200141|NCT03307252|5397693|P3|COMPLETED|Part 3, Period 2||0
2200142|NCT03307252|5397694|P2|COMPLETED|Part 3, Period 2||0
2200143|NCT03307252|5397695|P1|COMPLETED|Part 3, Period 2||0
2200144|NCT03307252|5397685|P11|STARTED|Part 3, Period 2||4
2200145|NCT03307252|5397686|P10|STARTED|Part 3, Period 2||4
2200146|NCT03307252|5397687|P9|STARTED|Part 3, Period 2||4
2200147|NCT03307252|5397688|P8|STARTED|Part 3, Period 2||4
2200148|NCT03307252|5397689|P7|STARTED|Part 3, Period 2||0
2200149|NCT03307252|5397690|P6|STARTED|Part 3, Period 2||0
2200150|NCT03307252|5397691|P5|STARTED|Part 3, Period 2||0
2200151|NCT03307252|5397692|P4|STARTED|Part 3, Period 2||0
2200152|NCT03307252|5397693|P3|STARTED|Part 3, Period 2||0
2200153|NCT03307252|5397694|P2|STARTED|Part 3, Period 2||0
2200154|NCT03307252|5397695|P1|STARTED|Part 3, Period 2||0
2200155|NCT03307252|5397685|P11|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
2200156|NCT03307252|5397686|P10|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
2200157|NCT03307252|5397687|P9|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
2200158|NCT03307252|5397688|P8|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
2200159|NCT03307252|5397689|P7|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
2200160|NCT03307252|5397690|P6|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
2200161|NCT03307252|5397691|P5|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
2200162|NCT03307252|5397692|P4|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
2200163|NCT03307252|5397693|P3|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
2200164|NCT03307252|5397694|P2|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
2200165|NCT03307252|5397695|P1|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
2200166|NCT03307252|5397685|P11|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
2200167|NCT03307252|5397686|P10|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
2200168|NCT03307252|5397687|P9|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
2200169|NCT03307252|5397688|P8|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
2200170|NCT03307252|5397689|P7|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
2200171|NCT03307252|5397690|P6|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
2200172|NCT03307252|5397691|P5|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
2200173|NCT03307252|5397692|P4|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
2200174|NCT03307252|5397693|P3|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
2200175|NCT03307252|5397694|P2|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
2200176|NCT03307252|5397695|P1|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
2200177|NCT03307252|5397685|P11|STARTED|Part 3, Washout Period 1 (7 Days)||4
2200178|NCT03307252|5397686|P10|STARTED|Part 3, Washout Period 1 (7 Days)||4
2200179|NCT03307252|5397687|P9|STARTED|Part 3, Washout Period 1 (7 Days)||4
2200180|NCT03307252|5397688|P8|STARTED|Part 3, Washout Period 1 (7 Days)||4
2200181|NCT03307252|5397689|P7|STARTED|Part 3, Washout Period 1 (7 Days)||0
2200182|NCT03307252|5397690|P6|STARTED|Part 3, Washout Period 1 (7 Days)||0
2200183|NCT03307252|5397691|P5|STARTED|Part 3, Washout Period 1 (7 Days)||0
2200184|NCT03307252|5397692|P4|STARTED|Part 3, Washout Period 1 (7 Days)||0
2200185|NCT03307252|5397693|P3|STARTED|Part 3, Washout Period 1 (7 Days)||0
2200186|NCT03307252|5397694|P2|STARTED|Part 3, Washout Period 1 (7 Days)||0
2200187|NCT03307252|5397695|P1|STARTED|Part 3, Washout Period 1 (7 Days)||0
2200188|NCT03307252|5397685|P11|NOT COMPLETED|Part 3, Period 1||0
2200189|NCT03307252|5397686|P10|NOT COMPLETED|Part 3, Period 1||0
2200190|NCT03307252|5397687|P9|NOT COMPLETED|Part 3, Period 1||0
2200191|NCT03307252|5397688|P8|NOT COMPLETED|Part 3, Period 1||0
2200192|NCT03307252|5397689|P7|NOT COMPLETED|Part 3, Period 1||0
2200193|NCT03307252|5397690|P6|NOT COMPLETED|Part 3, Period 1||0
2200194|NCT03307252|5397691|P5|NOT COMPLETED|Part 3, Period 1||0
2200195|NCT03307252|5397692|P4|NOT COMPLETED|Part 3, Period 1||0
2200196|NCT03307252|5397693|P3|NOT COMPLETED|Part 3, Period 1||0
2200197|NCT03307252|5397694|P2|NOT COMPLETED|Part 3, Period 1||0
2200198|NCT03307252|5397695|P1|NOT COMPLETED|Part 3, Period 1||0
2200199|NCT03307252|5397685|P11|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
2200200|NCT03307252|5397686|P10|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
2200201|NCT03307252|5397687|P9|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
2200202|NCT03307252|5397688|P8|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
2200203|NCT03307252|5397689|P7|COMPLETED|Part 3, Period 1||0
2200204|NCT03307252|5397690|P6|COMPLETED|Part 3, Period 1||0
2200205|NCT03307252|5397691|P5|COMPLETED|Part 3, Period 1||0
2200206|NCT03307252|5397692|P4|COMPLETED|Part 3, Period 1||0
2200207|NCT03307252|5397693|P3|COMPLETED|Part 3, Period 1||0
2200208|NCT03307252|5397694|P2|COMPLETED|Part 3, Period 1||0
2200209|NCT03307252|5397695|P1|COMPLETED|Part 3, Period 1||0
2200210|NCT03307252|5397685|P11|STARTED|Part 3, Period 1||4
2200211|NCT03307252|5397686|P10|STARTED|Part 3, Period 1||4
2200212|NCT03307252|5397687|P9|STARTED|Part 3, Period 1||4
2200213|NCT03307252|5397688|P8|STARTED|Part 3, Period 1||4
2200214|NCT03307252|5397689|P7|STARTED|Part 3, Period 1||0
2200215|NCT03307252|5397690|P6|STARTED|Part 3, Period 1||0
2200216|NCT03307252|5397691|P5|STARTED|Part 3, Period 1||0
2200217|NCT03307252|5397692|P4|STARTED|Part 3, Period 1||0
2200218|NCT03307252|5397693|P3|STARTED|Part 3, Period 1||0
2200219|NCT03307252|5397694|P2|STARTED|Part 3, Period 1||0
2200220|NCT03307252|5397695|P1|STARTED|Part 3, Period 1||0
2200221|NCT03307252|5397685|P11|NOT COMPLETED|Part 2, Period 4||0
2200222|NCT03307252|5397686|P10|NOT COMPLETED|Part 2, Period 4||0
2200223|NCT03307252|5397687|P9|NOT COMPLETED|Part 2, Period 4||0
2200224|NCT03307252|5397688|P8|NOT COMPLETED|Part 2, Period 4||0
2200225|NCT03307252|5397689|P7|NOT COMPLETED|Part 2, Period 4||1
2200226|NCT03307252|5397690|P6|NOT COMPLETED|Part 2, Period 4||0
2200227|NCT03307252|5397691|P5|NOT COMPLETED|Part 2, Period 4||0
2200228|NCT03307252|5397692|P4|NOT COMPLETED|Part 2, Period 4||0
2200229|NCT03307252|5397693|P3|NOT COMPLETED|Part 2, Period 4||0
2200230|NCT03307252|5397694|P2|NOT COMPLETED|Part 2, Period 4||0
2200231|NCT03307252|5397695|P1|NOT COMPLETED|Part 2, Period 4||0
2200232|NCT03307252|5397685|P11|COMPLETED|Part 2, Period 4||0
2200233|NCT03307252|5397686|P10|COMPLETED|Part 2, Period 4||0
2200234|NCT03307252|5397687|P9|COMPLETED|Part 2, Period 4||0
2200235|NCT03307252|5397688|P8|COMPLETED|Part 2, Period 4||0
2200236|NCT03307252|5397689|P7|COMPLETED|Part 2, Period 4||4
2200237|NCT03307252|5397690|P6|COMPLETED|Part 2, Period 4||3
2200238|NCT03307252|5397691|P5|COMPLETED|Part 2, Period 4||3
2200239|NCT03307252|5397692|P4|COMPLETED|Part 2, Period 4||4
2200240|NCT03307252|5397693|P3|COMPLETED|Part 2, Period 4||0
2200241|NCT03307252|5397694|P2|COMPLETED|Part 2, Period 4||0
2200242|NCT03307252|5397695|P1|COMPLETED|Part 2, Period 4||0
2200243|NCT03307252|5397685|P11|STARTED|Part 2, Period 4||0
2200244|NCT03307252|5397686|P10|STARTED|Part 2, Period 4||0
2200245|NCT03307252|5397687|P9|STARTED|Part 2, Period 4||0
2200246|NCT03307252|5397688|P8|STARTED|Part 2, Period 4||0
2200247|NCT03307252|5397689|P7|STARTED|Part 2, Period 4||5
2200248|NCT03307252|5397690|P6|STARTED|Part 2, Period 4||3
2200249|NCT03307252|5397691|P5|STARTED|Part 2, Period 4||3
2200250|NCT03307252|5397692|P4|STARTED|Part 2, Period 4||4
2200251|NCT03307252|5397693|P3|STARTED|Part 2, Period 4||0
2200252|NCT03307252|5397694|P2|STARTED|Part 2, Period 4||0
2200253|NCT03307252|5397695|P1|STARTED|Part 2, Period 4||0
2200254|NCT03307252|5397685|P11|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
2200255|NCT03307252|5397686|P10|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
2200256|NCT03307252|5397687|P9|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
2200257|NCT03307252|5397688|P8|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
2200258|NCT03307252|5397689|P7|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||1
2200259|NCT03307252|5397690|P6|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
2200260|NCT03307252|5397691|P5|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
2200261|NCT03307252|5397692|P4|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
2200262|NCT03307252|5397693|P3|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
2200263|NCT03307252|5397694|P2|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
2200264|NCT03307252|5397695|P1|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
2200265|NCT03307252|5397685|P11|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
2200266|NCT03307252|5397686|P10|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
2200267|NCT03307252|5397687|P9|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
2200268|NCT03307252|5397688|P8|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
2200269|NCT03307252|5397689|P7|COMPLETED|Part 2, Washout Period 3 (7 Days)||4
2200270|NCT03307252|5397690|P6|COMPLETED|Part 2, Washout Period 3 (7 Days)||3
2200271|NCT03307252|5397691|P5|COMPLETED|Part 2, Washout Period 3 (7 Days)||3
2200272|NCT03307252|5397692|P4|COMPLETED|Part 2, Washout Period 3 (7 Days)||4
2200273|NCT03307252|5397693|P3|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
2200274|NCT03307252|5397694|P2|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
2200275|NCT03307252|5397695|P1|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
2200276|NCT03307252|5397685|P11|STARTED|Part 2, Washout Period 3 (7 Days)||0
2200277|NCT03307252|5397686|P10|STARTED|Part 2, Washout Period 3 (7 Days)||0
2200278|NCT03307252|5397687|P9|STARTED|Part 2, Washout Period 3 (7 Days)||0
2200279|NCT03307252|5397688|P8|STARTED|Part 2, Washout Period 3 (7 Days)||0
2200280|NCT03307252|5397689|P7|STARTED|Part 2, Washout Period 3 (7 Days)||5
2200281|NCT03307252|5397690|P6|STARTED|Part 2, Washout Period 3 (7 Days)||3
2200282|NCT03307252|5397691|P5|STARTED|Part 2, Washout Period 3 (7 Days)||3
2200283|NCT03307252|5397692|P4|STARTED|Part 2, Washout Period 3 (7 Days)||4
2200284|NCT03307252|5397693|P3|STARTED|Part 2, Washout Period 3 (7 Days)||0
2200285|NCT03307252|5397694|P2|STARTED|Part 2, Washout Period 3 (7 Days)||0
2200286|NCT03307252|5397695|P1|STARTED|Part 2, Washout Period 3 (7 Days)||0
2200287|NCT03307252|5397685|P11|NOT COMPLETED|Part 2, Period 3||0
2200288|NCT03307252|5397686|P10|NOT COMPLETED|Part 2, Period 3||0
2200289|NCT03307252|5397687|P9|NOT COMPLETED|Part 2, Period 3||0
2200290|NCT03307252|5397688|P8|NOT COMPLETED|Part 2, Period 3||0
2200291|NCT03307252|5397689|P7|NOT COMPLETED|Part 2, Period 3||0
2200292|NCT03307252|5397690|P6|NOT COMPLETED|Part 2, Period 3||0
2200293|NCT03307252|5397691|P5|NOT COMPLETED|Part 2, Period 3||1
2200294|NCT03307252|5397692|P4|NOT COMPLETED|Part 2, Period 3||0
2200295|NCT03307252|5397693|P3|NOT COMPLETED|Part 2, Period 3||0
2200296|NCT03307252|5397694|P2|NOT COMPLETED|Part 2, Period 3||0
2200297|NCT03307252|5397695|P1|NOT COMPLETED|Part 2, Period 3||0
2200298|NCT03307252|5397685|P11|COMPLETED|Part 2, Period 3||0
2200299|NCT03307252|5397686|P10|COMPLETED|Part 2, Period 3||0
2200300|NCT03307252|5397687|P9|COMPLETED|Part 2, Period 3||0
2200301|NCT03307252|5397688|P8|COMPLETED|Part 2, Period 3||0
2200302|NCT03307252|5397689|P7|COMPLETED|Part 2, Period 3||5
2200303|NCT03307252|5397690|P6|COMPLETED|Part 2, Period 3||3
2200304|NCT03307252|5397691|P5|COMPLETED|Part 2, Period 3||3
2200305|NCT03307252|5397692|P4|COMPLETED|Part 2, Period 3||4
2200306|NCT03307252|5397693|P3|COMPLETED|Part 2, Period 3||0
2200307|NCT03307252|5397694|P2|COMPLETED|Part 2, Period 3||0
2200308|NCT03307252|5397695|P1|COMPLETED|Part 2, Period 3||0
2200309|NCT03307252|5397685|P11|STARTED|Part 2, Period 3||0
2200310|NCT03307252|5397686|P10|STARTED|Part 2, Period 3||0
2200311|NCT03307252|5397687|P9|STARTED|Part 2, Period 3||0
2200312|NCT03307252|5397688|P8|STARTED|Part 2, Period 3||0
2200313|NCT03307252|5397689|P7|STARTED|Part 2, Period 3||5
2200314|NCT03307252|5397690|P6|STARTED|Part 2, Period 3||3
2200315|NCT03307252|5397691|P5|STARTED|Part 2, Period 3||4
2200316|NCT03307252|5397692|P4|STARTED|Part 2, Period 3||4
2200317|NCT03307252|5397693|P3|STARTED|Part 2, Period 3||0
2200318|NCT03307252|5397694|P2|STARTED|Part 2, Period 3||0
2200319|NCT03307252|5397695|P1|STARTED|Part 2, Period 3||0
2200320|NCT03307252|5397685|P11|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
2200321|NCT03307252|5397686|P10|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
2200322|NCT03307252|5397687|P9|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
2200323|NCT03307252|5397688|P8|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
2200324|NCT03307252|5397689|P7|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
2200325|NCT03307252|5397690|P6|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
2200326|NCT03307252|5397691|P5|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
2200327|NCT03307252|5397692|P4|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
2200328|NCT03307252|5397693|P3|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
2200329|NCT03307252|5397694|P2|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
2200330|NCT03307252|5397695|P1|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
2200331|NCT03307252|5397685|P11|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
2200332|NCT03307252|5397686|P10|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
2200333|NCT03307252|5397687|P9|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
2200334|NCT03307252|5397688|P8|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
2200335|NCT03307252|5397689|P7|COMPLETED|Part 2, Washout Period 2 (7 Days)||5
2200336|NCT03307252|5397690|P6|COMPLETED|Part 2, Washout Period 2 (7 Days)||3
2200337|NCT03307252|5397691|P5|COMPLETED|Part 2, Washout Period 2 (7 Days)||4
2200338|NCT03307252|5397692|P4|COMPLETED|Part 2, Washout Period 2 (7 Days)||4
2200339|NCT03307252|5397693|P3|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
2200340|NCT03307252|5397694|P2|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
2200341|NCT03307252|5397695|P1|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
2200342|NCT03307252|5397685|P11|STARTED|Part 2, Washout Period 2 (7 Days)||0
2200343|NCT03307252|5397686|P10|STARTED|Part 2, Washout Period 2 (7 Days)||0
2200344|NCT03307252|5397687|P9|STARTED|Part 2, Washout Period 2 (7 Days)||0
2200345|NCT03307252|5397688|P8|STARTED|Part 2, Washout Period 2 (7 Days)||0
2200346|NCT03307252|5397689|P7|STARTED|Part 2, Washout Period 2 (7 Days)||5
2200347|NCT03307252|5397690|P6|STARTED|Part 2, Washout Period 2 (7 Days)||3
2200348|NCT03307252|5397691|P5|STARTED|Part 2, Washout Period 2 (7 Days)||4
2200349|NCT03307252|5397692|P4|STARTED|Part 2, Washout Period 2 (7 Days)||4
2200350|NCT03307252|5397693|P3|STARTED|Part 2, Washout Period 2 (7 Days)||0
2200351|NCT03307252|5397694|P2|STARTED|Part 2, Washout Period 2 (7 Days)||0
2200352|NCT03307252|5397695|P1|STARTED|Part 2, Washout Period 2 (7 Days)||0
2200353|NCT03307252|5397685|P11|NOT COMPLETED|Part 2, Period 2||0
2200354|NCT03307252|5397686|P10|NOT COMPLETED|Part 2, Period 2||0
2200355|NCT03307252|5397687|P9|NOT COMPLETED|Part 2, Period 2||0
2200356|NCT03307252|5397688|P8|NOT COMPLETED|Part 2, Period 2||0
2200357|NCT03307252|5397689|P7|NOT COMPLETED|Part 2, Period 2||0
2200358|NCT03307252|5397690|P6|NOT COMPLETED|Part 2, Period 2||0
2200359|NCT03307252|5397691|P5|NOT COMPLETED|Part 2, Period 2||0
2200360|NCT03307252|5397692|P4|NOT COMPLETED|Part 2, Period 2||0
2200361|NCT03307252|5397693|P3|NOT COMPLETED|Part 2, Period 2||0
2200362|NCT03307252|5397694|P2|NOT COMPLETED|Part 2, Period 2||0
2200363|NCT03307252|5397695|P1|NOT COMPLETED|Part 2, Period 2||0
2200364|NCT03307252|5397685|P11|COMPLETED|Part 2, Period 2||0
2200365|NCT03307252|5397686|P10|COMPLETED|Part 2, Period 2||0
2200366|NCT03307252|5397687|P9|COMPLETED|Part 2, Period 2||0
2200367|NCT03307252|5397688|P8|COMPLETED|Part 2, Period 2||0
2200368|NCT03307252|5397689|P7|COMPLETED|Part 2, Period 2||5
2200369|NCT03307252|5397690|P6|COMPLETED|Part 2, Period 2||3
2200370|NCT03307252|5397691|P5|COMPLETED|Part 2, Period 2||4
2200371|NCT03307252|5397692|P4|COMPLETED|Part 2, Period 2||4
2200372|NCT03307252|5397693|P3|COMPLETED|Part 2, Period 2||0
2200373|NCT03307252|5397694|P2|COMPLETED|Part 2, Period 2||0
2200374|NCT03307252|5397695|P1|COMPLETED|Part 2, Period 2||0
2200375|NCT03307252|5397685|P11|STARTED|Part 2, Period 2||0
2200376|NCT03307252|5397686|P10|STARTED|Part 2, Period 2||0
2200377|NCT03307252|5397687|P9|STARTED|Part 2, Period 2||0
2200378|NCT03307252|5397688|P8|STARTED|Part 2, Period 2||0
2200379|NCT03307252|5397689|P7|STARTED|Part 2, Period 2||5
2200380|NCT03307252|5397690|P6|STARTED|Part 2, Period 2||3
2200381|NCT03307252|5397691|P5|STARTED|Part 2, Period 2||4
2200382|NCT03307252|5397692|P4|STARTED|Part 2, Period 2||4
2200383|NCT03307252|5397693|P3|STARTED|Part 2, Period 2||0
2200384|NCT03307252|5397694|P2|STARTED|Part 2, Period 2||0
2200385|NCT03307252|5397695|P1|STARTED|Part 2, Period 2||0
2200386|NCT03307252|5397685|P11|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
2200387|NCT03307252|5397686|P10|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
2200388|NCT03307252|5397687|P9|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
2200389|NCT03307252|5397688|P8|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
2200390|NCT03307252|5397689|P7|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
2200391|NCT03307252|5397690|P6|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
2200392|NCT03307252|5397691|P5|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
2200393|NCT03307252|5397692|P4|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
2200394|NCT03307252|5397693|P3|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
2200395|NCT03307252|5397694|P2|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
2200396|NCT03307252|5397695|P1|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
2200397|NCT03307252|5397685|P11|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
2200398|NCT03307252|5397686|P10|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
2200399|NCT03307252|5397687|P9|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
2200400|NCT03307252|5397688|P8|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
2200401|NCT03307252|5397689|P7|COMPLETED|Part 2, Washout Period 1 (7 Days)||5
2200402|NCT03307252|5397690|P6|COMPLETED|Part 2, Washout Period 1 (7 Days)||3
2200403|NCT03307252|5397691|P5|COMPLETED|Part 2, Washout Period 1 (7 Days)||4
2200404|NCT03307252|5397692|P4|COMPLETED|Part 2, Washout Period 1 (7 Days)||4
2200405|NCT03307252|5397693|P3|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
2200406|NCT03307252|5397694|P2|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
2200407|NCT03307252|5397695|P1|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
2200408|NCT03307252|5397685|P11|STARTED|Part 2, Washout Period 1 (7 Days)||0
2200409|NCT03307252|5397686|P10|STARTED|Part 2, Washout Period 1 (7 Days)||0
2200410|NCT03307252|5397687|P9|STARTED|Part 2, Washout Period 1 (7 Days)||0
2200411|NCT03307252|5397688|P8|STARTED|Part 2, Washout Period 1 (7 Days)||0
2200412|NCT03307252|5397689|P7|STARTED|Part 2, Washout Period 1 (7 Days)||5
2200413|NCT03307252|5397690|P6|STARTED|Part 2, Washout Period 1 (7 Days)||3
2200414|NCT03307252|5397691|P5|STARTED|Part 2, Washout Period 1 (7 Days)||4
2200415|NCT03307252|5397692|P4|STARTED|Part 2, Washout Period 1 (7 Days)||4
2200416|NCT03307252|5397693|P3|STARTED|Part 2, Washout Period 1 (7 Days)||0
2200417|NCT03307252|5397694|P2|STARTED|Part 2, Washout Period 1 (7 Days)||0
2200418|NCT03307252|5397695|P1|STARTED|Part 2, Washout Period 1 (7 Days)||0
2200419|NCT03307252|5397685|P11|NOT COMPLETED|Part 2, Period 1||0
2200420|NCT03307252|5397686|P10|NOT COMPLETED|Part 2, Period 1||0
2200421|NCT03307252|5397687|P9|NOT COMPLETED|Part 2, Period 1||0
2200422|NCT03307252|5397688|P8|NOT COMPLETED|Part 2, Period 1||0
2200423|NCT03307252|5397689|P7|NOT COMPLETED|Part 2, Period 1||0
2200424|NCT03307252|5397690|P6|NOT COMPLETED|Part 2, Period 1||1
2200425|NCT03307252|5397691|P5|NOT COMPLETED|Part 2, Period 1||0
2200426|NCT03307252|5397692|P4|NOT COMPLETED|Part 2, Period 1||0
2200427|NCT03307252|5397693|P3|NOT COMPLETED|Part 2, Period 1||0
2200428|NCT03307252|5397694|P2|NOT COMPLETED|Part 2, Period 1||0
2200429|NCT03307252|5397695|P1|NOT COMPLETED|Part 2, Period 1||0
2200430|NCT03307252|5397685|P11|COMPLETED|Part 2, Period 1||0
2200431|NCT03307252|5397686|P10|COMPLETED|Part 2, Period 1||0
2200432|NCT03307252|5397687|P9|COMPLETED|Part 2, Period 1||0
2200433|NCT03307252|5397688|P8|COMPLETED|Part 2, Period 1||0
2200434|NCT03307252|5397689|P7|COMPLETED|Part 2, Period 1||5
2200435|NCT03307252|5397690|P6|COMPLETED|Part 2, Period 1||3
2200436|NCT03307252|5397691|P5|COMPLETED|Part 2, Period 1||4
2200437|NCT03307252|5397692|P4|COMPLETED|Part 2, Period 1||4
2200438|NCT03307252|5397693|P3|COMPLETED|Part 2, Period 1||0
2200439|NCT03307252|5397694|P2|COMPLETED|Part 2, Period 1||0
2200440|NCT03307252|5397695|P1|COMPLETED|Part 2, Period 1||0
2200441|NCT03307252|5397685|P11|STARTED|Part 2, Period 1||0
2200442|NCT03307252|5397686|P10|STARTED|Part 2, Period 1||0
2200443|NCT03307252|5397687|P9|STARTED|Part 2, Period 1||0
2200444|NCT03307252|5397688|P8|STARTED|Part 2, Period 1||0
2200445|NCT03307252|5397689|P7|STARTED|Part 2, Period 1|Participants randomized in Part 2|5
2200446|NCT03307252|5397690|P6|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
2200447|NCT03307252|5397691|P5|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
2200448|NCT03307252|5397692|P4|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
2200449|NCT03307252|5397693|P3|STARTED|Part 2, Period 1||0
2200450|NCT03307252|5397694|P2|STARTED|Part 2, Period 1||0
2200451|NCT03307252|5397695|P1|STARTED|Part 2, Period 1||0
2200452|NCT03307252|5397685|P11|NOT COMPLETED|Part 1, Period 3||0
2200453|NCT03307252|5397686|P10|NOT COMPLETED|Part 1, Period 3||0
2200454|NCT03307252|5397687|P9|NOT COMPLETED|Part 1, Period 3||0
2200455|NCT03307252|5397688|P8|NOT COMPLETED|Part 1, Period 3||0
2200456|NCT03307252|5397689|P7|NOT COMPLETED|Part 1, Period 3||0
2200457|NCT03307252|5397690|P6|NOT COMPLETED|Part 1, Period 3||0
2200458|NCT03307252|5397691|P5|NOT COMPLETED|Part 1, Period 3||0
2200459|NCT03307252|5397692|P4|NOT COMPLETED|Part 1, Period 3||0
2200460|NCT03307252|5397693|P3|NOT COMPLETED|Part 1, Period 3||0
2200461|NCT03307252|5397694|P2|NOT COMPLETED|Part 1, Period 3||0
2200462|NCT03307252|5397695|P1|NOT COMPLETED|Part 1, Period 3||0
2200463|NCT03307252|5397685|P11|COMPLETED|Part 1, Period 3||0
2200464|NCT03307252|5397686|P10|COMPLETED|Part 1, Period 3||0
2200465|NCT03307252|5397687|P9|COMPLETED|Part 1, Period 3||0
2200466|NCT03307252|5397688|P8|COMPLETED|Part 1, Period 3||0
2200467|NCT03307252|5397689|P7|COMPLETED|Part 1, Period 3||0
2200468|NCT03307252|5397690|P6|COMPLETED|Part 1, Period 3||0
2200469|NCT03307252|5397691|P5|COMPLETED|Part 1, Period 3||0
2200470|NCT03307252|5397692|P4|COMPLETED|Part 1, Period 3||0
2200471|NCT03307252|5397693|P3|COMPLETED|Part 1, Period 3||4
2200472|NCT03307252|5397694|P2|COMPLETED|Part 1, Period 3||4
2200473|NCT03307252|5397695|P1|COMPLETED|Part 1, Period 3||4
2200474|NCT03307252|5397685|P11|STARTED|Part 1, Period 3||0
2200475|NCT03307252|5397686|P10|STARTED|Part 1, Period 3||0
2200476|NCT03307252|5397687|P9|STARTED|Part 1, Period 3||0
2200477|NCT03307252|5397688|P8|STARTED|Part 1, Period 3||0
2200478|NCT03307252|5397689|P7|STARTED|Part 1, Period 3||0
2200479|NCT03307252|5397690|P6|STARTED|Part 1, Period 3||0
2200480|NCT03307252|5397691|P5|STARTED|Part 1, Period 3||0
2200481|NCT03307252|5397692|P4|STARTED|Part 1, Period 3||0
2200482|NCT03307252|5397693|P3|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
2200483|NCT03307252|5397694|P2|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
2200484|NCT03307252|5397695|P1|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
2200485|NCT03307252|5397685|P11|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
2200486|NCT03307252|5397686|P10|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
2200487|NCT03307252|5397687|P9|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
2200488|NCT03307252|5397688|P8|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
2200489|NCT03307252|5397689|P7|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
2200490|NCT03307252|5397690|P6|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
2200491|NCT03307252|5397691|P5|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
2200492|NCT03307252|5397692|P4|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
2200493|NCT03307252|5397693|P3|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
2200494|NCT03307252|5397694|P2|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
2200495|NCT03307252|5397695|P1|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
2200496|NCT03307252|5397685|P11|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
2200497|NCT03307252|5397686|P10|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
2200498|NCT03307252|5397687|P9|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
2200499|NCT03307252|5397688|P8|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
2200500|NCT03307252|5397689|P7|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
2200501|NCT03307252|5397690|P6|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
2200502|NCT03307252|5397691|P5|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
2200503|NCT03307252|5397692|P4|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
2200504|NCT03307252|5397693|P3|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
2200505|NCT03307252|5397694|P2|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
2200506|NCT03307252|5397695|P1|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
2200507|NCT03307252|5397685|P11|STARTED|Part 1, Washout Period 2 (13 Days)||0
2200508|NCT03307252|5397686|P10|STARTED|Part 1, Washout Period 2 (13 Days)||0
2200509|NCT03307252|5397687|P9|STARTED|Part 1, Washout Period 2 (13 Days)||0
2200510|NCT03307252|5397688|P8|STARTED|Part 1, Washout Period 2 (13 Days)||0
2200511|NCT03307252|5397689|P7|STARTED|Part 1, Washout Period 2 (13 Days)||0
2200512|NCT03307252|5397690|P6|STARTED|Part 1, Washout Period 2 (13 Days)||0
2200513|NCT03307252|5397691|P5|STARTED|Part 1, Washout Period 2 (13 Days)||0
2200514|NCT03307252|5397692|P4|STARTED|Part 1, Washout Period 2 (13 Days)||0
2200515|NCT03307252|5397693|P3|STARTED|Part 1, Washout Period 2 (13 Days)||4
2200516|NCT03307252|5397694|P2|STARTED|Part 1, Washout Period 2 (13 Days)||4
2200517|NCT03307252|5397695|P1|STARTED|Part 1, Washout Period 2 (13 Days)||4
2200518|NCT03307252|5397685|P11|NOT COMPLETED|Part 1, Period 2||0
2200519|NCT03307252|5397686|P10|NOT COMPLETED|Part 1, Period 2||0
2200520|NCT03307252|5397687|P9|NOT COMPLETED|Part 1, Period 2||0
2200521|NCT03307252|5397688|P8|NOT COMPLETED|Part 1, Period 2||0
2200522|NCT03307252|5397689|P7|NOT COMPLETED|Part 1, Period 2||0
2200523|NCT03307252|5397690|P6|NOT COMPLETED|Part 1, Period 2||0
2200524|NCT03307252|5397691|P5|NOT COMPLETED|Part 1, Period 2||0
2200525|NCT03307252|5397692|P4|NOT COMPLETED|Part 1, Period 2||0
2200526|NCT03307252|5397693|P3|NOT COMPLETED|Part 1, Period 2||0
2200527|NCT03307252|5397694|P2|NOT COMPLETED|Part 1, Period 2||0
2200528|NCT03307252|5397695|P1|NOT COMPLETED|Part 1, Period 2||0
2200529|NCT03307252|5397685|P11|COMPLETED|Part 1, Period 2||0
2200530|NCT03307252|5397686|P10|COMPLETED|Part 1, Period 2||0
2200531|NCT03307252|5397687|P9|COMPLETED|Part 1, Period 2||0
2200532|NCT03307252|5397688|P8|COMPLETED|Part 1, Period 2||0
2200533|NCT03307252|5397689|P7|COMPLETED|Part 1, Period 2||0
2200534|NCT03307252|5397690|P6|COMPLETED|Part 1, Period 2||0
2200535|NCT03307252|5397691|P5|COMPLETED|Part 1, Period 2||0
2200536|NCT03307252|5397692|P4|COMPLETED|Part 1, Period 2||0
2200537|NCT03307252|5397693|P3|COMPLETED|Part 1, Period 2||4
2200538|NCT03307252|5397694|P2|COMPLETED|Part 1, Period 2||4
2200539|NCT03307252|5397695|P1|COMPLETED|Part 1, Period 2||4
2200540|NCT03307252|5397685|P11|STARTED|Part 1, Period 2||0
2200541|NCT03307252|5397686|P10|STARTED|Part 1, Period 2||0
2200542|NCT03307252|5397687|P9|STARTED|Part 1, Period 2||0
2200543|NCT03307252|5397688|P8|STARTED|Part 1, Period 2||0
2200544|NCT03307252|5397689|P7|STARTED|Part 1, Period 2||0
2200545|NCT03307252|5397690|P6|STARTED|Part 1, Period 2||0
2200546|NCT03307252|5397691|P5|STARTED|Part 1, Period 2||0
2200547|NCT03307252|5397692|P4|STARTED|Part 1, Period 2||0
2200548|NCT03307252|5397693|P3|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
2200549|NCT03307252|5397694|P2|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
2200550|NCT03307252|5397695|P1|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
2200551|NCT03307252|5397685|P11|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
2200552|NCT03307252|5397686|P10|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
2200553|NCT03307252|5397687|P9|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
2200554|NCT03307252|5397688|P8|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
2200555|NCT03307252|5397689|P7|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
2200556|NCT03307252|5397690|P6|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
2200557|NCT03307252|5397691|P5|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
2200558|NCT03307252|5397692|P4|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
2200559|NCT03307252|5397693|P3|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
2200560|NCT03307252|5397694|P2|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
2200561|NCT03307252|5397695|P1|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
2200562|NCT03307252|5397685|P11|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
2200563|NCT03307252|5397686|P10|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
2200564|NCT03307252|5397687|P9|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
2200565|NCT03307252|5397688|P8|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
2200566|NCT03307252|5397689|P7|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
2200567|NCT03307252|5397690|P6|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
2200568|NCT03307252|5397691|P5|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
2200569|NCT03307252|5397692|P4|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
2200570|NCT03307252|5397693|P3|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
2200571|NCT03307252|5397694|P2|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
2200572|NCT03307252|5397695|P1|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
2200573|NCT03307252|5397685|P11|STARTED|Part 1, Washout Period 1 (13 Days)||0
2200574|NCT03307252|5397686|P10|STARTED|Part 1, Washout Period 1 (13 Days)||0
2200575|NCT03307252|5397687|P9|STARTED|Part 1, Washout Period 1 (13 Days)||0
2200576|NCT03307252|5397688|P8|STARTED|Part 1, Washout Period 1 (13 Days)||0
2200577|NCT03307252|5397689|P7|STARTED|Part 1, Washout Period 1 (13 Days)||0
2200578|NCT03307252|5397690|P6|STARTED|Part 1, Washout Period 1 (13 Days)||0
2200579|NCT03307252|5397691|P5|STARTED|Part 1, Washout Period 1 (13 Days)||0
2200580|NCT03307252|5397692|P4|STARTED|Part 1, Washout Period 1 (13 Days)||0
2200581|NCT03307252|5397693|P3|STARTED|Part 1, Washout Period 1 (13 Days)||4
2200582|NCT03307252|5397694|P2|STARTED|Part 1, Washout Period 1 (13 Days)||4
2200583|NCT03307252|5397695|P1|STARTED|Part 1, Washout Period 1 (13 Days)||4
2200584|NCT03307252|5397685|P11|NOT COMPLETED|Part 1, Period 1||0
2200585|NCT03307252|5397686|P10|NOT COMPLETED|Part 1, Period 1||0
2200586|NCT03307252|5397687|P9|NOT COMPLETED|Part 1, Period 1||0
2200587|NCT03307252|5397688|P8|NOT COMPLETED|Part 1, Period 1||0
2200588|NCT03307252|5397689|P7|NOT COMPLETED|Part 1, Period 1||0
2200589|NCT03307252|5397690|P6|NOT COMPLETED|Part 1, Period 1||0
2200590|NCT03307252|5397691|P5|NOT COMPLETED|Part 1, Period 1||0
2200591|NCT03307252|5397692|P4|NOT COMPLETED|Part 1, Period 1||0
2200592|NCT03307252|5397693|P3|NOT COMPLETED|Part 1, Period 1||0
2200593|NCT03307252|5397694|P2|NOT COMPLETED|Part 1, Period 1||0
2200594|NCT03307252|5397695|P1|NOT COMPLETED|Part 1, Period 1||0
2200595|NCT03307252|5397685|P11|COMPLETED|Part 1, Period 1||0
2200596|NCT03307252|5397686|P10|COMPLETED|Part 1, Period 1||0
2200597|NCT03307252|5397687|P9|COMPLETED|Part 1, Period 1||0
2200598|NCT03307252|5397688|P8|COMPLETED|Part 1, Period 1||0
2200599|NCT03307252|5397689|P7|COMPLETED|Part 1, Period 1||0
2200600|NCT03307252|5397690|P6|COMPLETED|Part 1, Period 1||0
2200601|NCT03307252|5397691|P5|COMPLETED|Part 1, Period 1||0
2200602|NCT03307252|5397692|P4|COMPLETED|Part 1, Period 1||0
2200603|NCT03307252|5397693|P3|COMPLETED|Part 1, Period 1||4
2200604|NCT03307252|5397694|P2|COMPLETED|Part 1, Period 1||4
2200605|NCT03307252|5397695|P1|COMPLETED|Part 1, Period 1||4
2200606|NCT03307252|5397685|P11|STARTED|Part 1, Period 1||0
2200607|NCT03307252|5397686|P10|STARTED|Part 1, Period 1||0
2200608|NCT03307252|5397687|P9|STARTED|Part 1, Period 1||0
2200609|NCT03307252|5397688|P8|STARTED|Part 1, Period 1||0
2200610|NCT03307252|5397689|P7|STARTED|Part 1, Period 1||0
2200611|NCT03307252|5397690|P6|STARTED|Part 1, Period 1||0
2200612|NCT03307252|5397691|P5|STARTED|Part 1, Period 1||0
2200613|NCT03307252|5397692|P4|STARTED|Part 1, Period 1||0
2200614|NCT03307252|5397693|P3|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
2200615|NCT03307252|5397694|P2|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
2200616|NCT03307252|5397695|P1|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
2200617|NCT03307005|5397732|P2|NOT COMPLETED|Overall Study||0
2200618|NCT03307005|5397733|P1|NOT COMPLETED|Overall Study||0
2200619|NCT03307005|5397732|P2|COMPLETED|Overall Study||2
2200620|NCT03307005|5397733|P1|COMPLETED|Overall Study||3
2200621|NCT03307005|5397732|P2|STARTED|Overall Study||2
2200622|NCT03307005|5397733|P1|STARTED|Overall Study||3
2200623|NCT03306589|5397757|P6|NOT COMPLETED|Part 2 (69 Days)||0
2200624|NCT03306589|5397758|P5|NOT COMPLETED|Part 2 (69 Days)||0
2200625|NCT03306589|5397759|P4|NOT COMPLETED|Part 2 (69 Days)||0
2200626|NCT03306589|5397760|P3|NOT COMPLETED|Part 2 (69 Days)||0
2200627|NCT03306589|5397761|P2|NOT COMPLETED|Part 2 (69 Days)||0
2200628|NCT03306589|5397762|P1|NOT COMPLETED|Part 2 (69 Days)||0
2200629|NCT03306589|5397757|P6|COMPLETED|Part 2 (69 Days)||0
2200630|NCT03306589|5397758|P5|COMPLETED|Part 2 (69 Days)||0
2200631|NCT03306589|5397759|P4|COMPLETED|Part 2 (69 Days)||0
2200632|NCT03306589|5397760|P3|COMPLETED|Part 2 (69 Days)||0
2200633|NCT03306589|5397761|P2|COMPLETED|Part 2 (69 Days)||0
2200634|NCT03306589|5397762|P1|COMPLETED|Part 2 (69 Days)||0
2200635|NCT03306589|5397757|P6|STARTED|Part 2 (69 Days)||0
2200636|NCT03306589|5397758|P5|STARTED|Part 2 (69 Days)||0
2200637|NCT03306589|5397759|P4|STARTED|Part 2 (69 Days)||0
2200638|NCT03306589|5397760|P3|STARTED|Part 2 (69 Days)||0
2200639|NCT03306589|5397761|P2|STARTED|Part 2 (69 Days)||0
2200640|NCT03306589|5397762|P1|STARTED|Part 2 (69 Days)||0
2200641|NCT03306589|5397757|P6|NOT COMPLETED|Part 1 (69 Days)||0
2200642|NCT03306589|5397758|P5|NOT COMPLETED|Part 1 (69 Days)||0
2200643|NCT03306589|5397759|P4|NOT COMPLETED|Part 1 (69 Days)||0
2200644|NCT03306589|5397760|P3|NOT COMPLETED|Part 1 (69 Days)||0
2200645|NCT03306589|5397761|P2|NOT COMPLETED|Part 1 (69 Days)||0
2200646|NCT03306589|5397762|P1|NOT COMPLETED|Part 1 (69 Days)||0
2200647|NCT03306589|5397757|P6|COMPLETED|Part 1 (69 Days)||0
2200648|NCT03306589|5397758|P5|COMPLETED|Part 1 (69 Days)||0
2200649|NCT03306589|5397759|P4|COMPLETED|Part 1 (69 Days)||4
2200650|NCT03306589|5397760|P3|COMPLETED|Part 1 (69 Days)||2
2200651|NCT03306589|5397761|P2|COMPLETED|Part 1 (69 Days)||4
2200652|NCT03306589|5397762|P1|COMPLETED|Part 1 (69 Days)||2
2200653|NCT03306589|5397757|P6|STARTED|Part 1 (69 Days)||0
2200654|NCT03306589|5397758|P5|STARTED|Part 1 (69 Days)||0
2200655|NCT03306589|5397759|P4|STARTED|Part 1 (69 Days)||4
2200656|NCT03306589|5397760|P3|STARTED|Part 1 (69 Days)||2
2200657|NCT03306589|5397761|P2|STARTED|Part 1 (69 Days)||4
2200658|NCT03306589|5397762|P1|STARTED|Part 1 (69 Days)||2
2200659|NCT03306420|5397868|P5|NOT COMPLETED|Overall Study||0
2200660|NCT03306420|5397869|P4|NOT COMPLETED|Overall Study||0
2200661|NCT03306420|5397870|P3|NOT COMPLETED|Overall Study||0
2200662|NCT03306420|5397871|P2|NOT COMPLETED|Overall Study||0
2200663|NCT03306420|5397872|P1|NOT COMPLETED|Overall Study||0
2200664|NCT03306420|5397868|P5|COMPLETED|Overall Study||3
2200665|NCT03306420|5397869|P4|COMPLETED|Overall Study||3
2200666|NCT03306420|5397870|P3|COMPLETED|Overall Study||3
2200667|NCT03306420|5397871|P2|COMPLETED|Overall Study||3
2200668|NCT03306420|5397872|P1|COMPLETED|Overall Study||3
2200669|NCT03306420|5397868|P5|STARTED|Overall Study||3
2200670|NCT03306420|5397869|P4|STARTED|Overall Study||3
2200671|NCT03306420|5397870|P3|STARTED|Overall Study||3
2200672|NCT03306420|5397871|P2|STARTED|Overall Study||3
2200673|NCT03306420|5397872|P1|STARTED|Overall Study||3
2200674|NCT03306199|5397984|P1|NOT COMPLETED|Overall Study||15
2200675|NCT03306199|5397984|P1|COMPLETED|Overall Study||67
2200676|NCT03306199|5397984|P1|STARTED|Overall Study||82
2200677|NCT03305887|5397990|P2|NOT COMPLETED|Overall Study||10
2200678|NCT03305887|5397991|P1|NOT COMPLETED|Overall Study||11
2200679|NCT03305887|5397990|P2|COMPLETED|Overall Study||83
2200680|NCT03305887|5397991|P1|COMPLETED|Overall Study||80
2200681|NCT03305887|5397990|P2|STARTED|Overall Study||93
2200682|NCT03305887|5397991|P1|STARTED|Overall Study||91
2200683|NCT03305770|5397999|P2|NOT COMPLETED|Overall Study||1
2200684|NCT03305770|5398000|P1|NOT COMPLETED|Overall Study||1
2200685|NCT03305770|5397999|P2|COMPLETED|Overall Study||36
2200686|NCT03305770|5398000|P1|COMPLETED|Overall Study||69
2200687|NCT03305770|5397999|P2|Completed Analysis Set|Overall Study||36
2200688|NCT03305770|5398000|P1|Completed Analysis Set|Overall Study||69
2200689|NCT03305770|5397999|P2|Enrolled Dispensed Analysis Set|Overall Study||36
2200690|NCT03305770|5398000|P1|Enrolled Dispensed Analysis Set|Overall Study||70
2200691|NCT03305770|5397999|P2|STARTED|Overall Study||37
2200692|NCT03305770|5398000|P1|STARTED|Overall Study||70
2200698|NCT03305419|5398025|P8|NOT COMPLETED|Part B (14 Days)||0
2200699|NCT03305419|5398026|P7|NOT COMPLETED|Part B (14 Days)||5
2200700|NCT03305419|5398027|P6|NOT COMPLETED|Part B (14 Days)||10
2200701|NCT03305419|5398028|P5|NOT COMPLETED|Part B (14 Days)||3
2200702|NCT03305419|5398029|P4|NOT COMPLETED|Part B (14 Days)||0
2200703|NCT03305419|5398030|P3|NOT COMPLETED|Part B (14 Days)||0
2200704|NCT03305419|5398031|P2|NOT COMPLETED|Part B (14 Days)||0
2200705|NCT03305419|5398032|P1|NOT COMPLETED|Part B (14 Days)||0
2200706|NCT03305419|5398025|P8|COMPLETED|Part B (14 Days)||0
2200707|NCT03305419|5398026|P7|COMPLETED|Part B (14 Days)||8
2200708|NCT03305419|5398027|P6|COMPLETED|Part B (14 Days)||10
2200709|NCT03305419|5398028|P5|COMPLETED|Part B (14 Days)||11
2200710|NCT03305419|5398029|P4|COMPLETED|Part B (14 Days)||0
2200711|NCT03305419|5398030|P3|COMPLETED|Part B (14 Days)||0
2200712|NCT03305419|5398031|P2|COMPLETED|Part B (14 Days)||0
2200713|NCT03305419|5398032|P1|COMPLETED|Part B (14 Days)||0
2200714|NCT03305419|5398025|P8|STARTED|Part B (14 Days)||0
2200715|NCT03305419|5398026|P7|STARTED|Part B (14 Days)||13
2200716|NCT03305419|5398027|P6|STARTED|Part B (14 Days)||20
2200717|NCT03305419|5398028|P5|STARTED|Part B (14 Days)||14
2200718|NCT03305419|5398029|P4|STARTED|Part B (14 Days)||0
2200719|NCT03305419|5398030|P3|STARTED|Part B (14 Days)||0
2200720|NCT03305419|5398031|P2|STARTED|Part B (14 Days)||0
2200721|NCT03305419|5398032|P1|STARTED|Part B (14 Days)||0
2200722|NCT03305419|5398025|P8|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
2200723|NCT03305419|5398026|P7|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
2200724|NCT03305419|5398027|P6|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
2200725|NCT03305419|5398028|P5|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
2200726|NCT03305419|5398029|P4|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
2200727|NCT03305419|5398030|P3|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
2200728|NCT03305419|5398031|P2|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
2200729|NCT03305419|5398032|P1|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
2200730|NCT03305419|5398025|P8|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
2200731|NCT03305419|5398026|P7|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
2200732|NCT03305419|5398027|P6|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
2200733|NCT03305419|5398028|P5|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
2200734|NCT03305419|5398029|P4|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
2200735|NCT03305419|5398030|P3|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
2200736|NCT03305419|5398031|P2|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
2200737|NCT03305419|5398032|P1|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
2200738|NCT03305419|5398025|P8|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
2200739|NCT03305419|5398026|P7|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
2200740|NCT03305419|5398027|P6|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
2200741|NCT03305419|5398028|P5|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
2200742|NCT03305419|5398029|P4|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
2200743|NCT03305419|5398030|P3|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
2200744|NCT03305419|5398031|P2|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
2200745|NCT03305419|5398032|P1|STARTED|Part A Period 3 (1Day) + Washout (7days)|2 participants were added to GSK2982772 120 mg TID/240 mg TID/360 mg BID arm after Washout Period.|3
2200746|NCT03305419|5398025|P8|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
2200747|NCT03305419|5398026|P7|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
2200748|NCT03305419|5398027|P6|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
2200749|NCT03305419|5398028|P5|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
2200750|NCT03305419|5398029|P4|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
2200751|NCT03305419|5398030|P3|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
2200752|NCT03305419|5398031|P2|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
2200753|NCT03305419|5398032|P1|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||2
2200754|NCT03305419|5398025|P8|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
2200755|NCT03305419|5398026|P7|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
2200756|NCT03305419|5398027|P6|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
2200757|NCT03305419|5398028|P5|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
2200758|NCT03305419|5398029|P4|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
2200759|NCT03305419|5398030|P3|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
2200760|NCT03305419|5398031|P2|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
2200761|NCT03305419|5398032|P1|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||1
2200762|NCT03305419|5398025|P8|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
2200763|NCT03305419|5398026|P7|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
2200764|NCT03305419|5398027|P6|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
2200765|NCT03305419|5398028|P5|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
2200766|NCT03305419|5398029|P4|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
2200767|NCT03305419|5398030|P3|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
2200768|NCT03305419|5398031|P2|STARTED|Part A Period 2 (1Day) + Washout (7days)|1 participant was added to GSK2982772 120 mg TID/240 mg TID/Placebo arm|3
2200769|NCT03305419|5398032|P1|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
2200770|NCT03305419|5398025|P8|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
2200771|NCT03305419|5398026|P7|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
2200772|NCT03305419|5398027|P6|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
2200773|NCT03305419|5398028|P5|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
2200774|NCT03305419|5398029|P4|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
2200775|NCT03305419|5398030|P3|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
2200776|NCT03305419|5398031|P2|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||1
2200777|NCT03305419|5398032|P1|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
2200778|NCT03305419|5398025|P8|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
2200779|NCT03305419|5398026|P7|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
2200780|NCT03305419|5398027|P6|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
2200781|NCT03305419|5398028|P5|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
2200782|NCT03305419|5398029|P4|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
2200783|NCT03305419|5398030|P3|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
2200784|NCT03305419|5398031|P2|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||2
2200785|NCT03305419|5398032|P1|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
2200786|NCT03305419|5398025|P8|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
2200787|NCT03305419|5398026|P7|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
2200788|NCT03305419|5398027|P6|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
2200789|NCT03305419|5398028|P5|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
2200790|NCT03305419|5398029|P4|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
2200791|NCT03305419|5398030|P3|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
2200792|NCT03305419|5398031|P2|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
2200793|NCT03305419|5398032|P1|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
2200794|NCT03305159|5398164|P2|NOT COMPLETED|Overall Study||8
2200795|NCT03305159|5398165|P1|NOT COMPLETED|Overall Study||3
2200796|NCT03305159|5398164|P2|COMPLETED|Overall Study||60
2200797|NCT03305159|5398165|P1|COMPLETED|Overall Study||63
2200798|NCT03305159|5398164|P2|STARTED|Overall Study||68
2200799|NCT03305159|5398165|P1|STARTED|Overall Study||66
2200800|NCT03305055|5398173|P2|NOT COMPLETED|Overall Study||2
2200801|NCT03305055|5398174|P1|NOT COMPLETED|Overall Study||1
2200802|NCT03305055|5398173|P2|COMPLETED|Overall Study||0
2200803|NCT03305055|5398174|P1|COMPLETED|Overall Study||1
2200804|NCT03305055|5398173|P2|STARTED|Overall Study||2
2200805|NCT03305055|5398174|P1|STARTED|Overall Study||2
2200806|NCT03304119|5398192|P2|NOT COMPLETED|Overall Study||0
2200807|NCT03304119|5398193|P1|NOT COMPLETED|Overall Study||0
2200808|NCT03304119|5398192|P2|COMPLETED|Overall Study||55
2200809|NCT03304119|5398193|P1|COMPLETED|Overall Study||37
2200810|NCT03304119|5398192|P2|STARTED|Overall Study||55
2200811|NCT03304119|5398193|P1|STARTED|Overall Study||37
2200812|NCT03303911|5398205|P2|NOT COMPLETED|Overall Study||0
2200813|NCT03303911|5398206|P1|NOT COMPLETED|Overall Study||0
2200814|NCT03303911|5398205|P2|COMPLETED|Overall Study||13
2200815|NCT03303911|5398206|P1|COMPLETED|Overall Study||13
2200816|NCT03303911|5398205|P2|STARTED|Overall Study||13
2200817|NCT03303911|5398206|P1|STARTED|Overall Study||13
2200824|NCT03303417|5398273|P2|NOT COMPLETED|Overall Study||1
2200825|NCT03303417|5398274|P1|NOT COMPLETED|Overall Study||1
2200826|NCT03303417|5398273|P2|COMPLETED|Overall Study||7
2200827|NCT03303417|5398274|P1|COMPLETED|Overall Study||7
2200828|NCT03303417|5398273|P2|STARTED|Overall Study||8
2200829|NCT03303417|5398274|P1|STARTED|Overall Study||8
2200830|NCT03302975|5398288|P1|NOT COMPLETED|Overall Study||4
2200831|NCT03302975|5398288|P1|COMPLETED|Overall Study||12
2200832|NCT03302975|5398288|P1|STARTED|Overall Study||16
2200833|NCT03302936|5398296|P2|NOT COMPLETED|Overall Study||4
2200834|NCT03302936|5398297|P1|NOT COMPLETED|Overall Study||3
2200835|NCT03302936|5398296|P2|COMPLETED|Overall Study||45
2200836|NCT03302936|5398297|P1|COMPLETED|Overall Study||46
2200837|NCT03302936|5398296|P2|STARTED|Overall Study||49
2200838|NCT03302936|5398297|P1|STARTED|Overall Study||49
2200839|NCT03302793|5398307|P2|NOT COMPLETED|Overall Study||2
2200840|NCT03302793|5398308|P1|NOT COMPLETED|Overall Study||0
2200841|NCT03302793|5398307|P2|COMPLETED|Overall Study||4
2200842|NCT03302793|5398308|P1|COMPLETED|Overall Study||6
2200843|NCT03302793|5398307|P2|STARTED|Overall Study||6
2200844|NCT03302793|5398308|P1|STARTED|Overall Study||6
2200845|NCT03302559|5398318|P1|NOT COMPLETED|Overall Study||6
2200846|NCT03302559|5398318|P1|COMPLETED|Overall Study||23
2200847|NCT03302559|5398318|P1|STARTED|Overall Study||29
2200848|NCT03301844|5398334|P2|NOT COMPLETED|Overall Study||1
2200849|NCT03301844|5398335|P1|NOT COMPLETED|Overall Study||1
2200850|NCT03301844|5398334|P2|COMPLETED|Overall Study||18
2200851|NCT03301844|5398335|P1|COMPLETED|Overall Study||18
2200852|NCT03301844|5398334|P2|STARTED|Overall Study|Each patient apply the Blephapad Combo wipes to one eye and standard treatment to the other eye.|19
2200853|NCT03301844|5398335|P1|STARTED|Overall Study|Each patient apply the Blephapad Combo wipes to one eye and standard treatment to the other eye.|19
2200854|NCT03301649|5398352|P3|NOT COMPLETED|Overall Study||85
2200855|NCT03301649|5398353|P2|NOT COMPLETED|Overall Study||44
2200856|NCT03301649|5398354|P1|NOT COMPLETED|Overall Study||43
2200857|NCT03301649|5398352|P3|COMPLETED|Overall Study||27
2200858|NCT03301649|5398353|P2|COMPLETED|Overall Study||356
2200859|NCT03301649|5398354|P1|COMPLETED|Overall Study||356
2200860|NCT03301649|5398352|P3|Per-protocol (PP) Population|Overall Study||103
2200861|NCT03301649|5398353|P2|Per-protocol (PP) Population|Overall Study||354
2200862|NCT03301649|5398354|P1|Per-protocol (PP) Population|Overall Study||345
2200863|NCT03301649|5398352|P3|Modified Intent-to-treat(mITT)Population|Overall Study||111
2200864|NCT03301649|5398353|P2|Modified Intent-to-treat(mITT)Population|Overall Study||380
2200865|NCT03301649|5398354|P1|Modified Intent-to-treat(mITT)Population|Overall Study||372
2200866|NCT03301649|5398352|P3|Safety Population|Overall Study||112
2200867|NCT03301649|5398353|P2|Safety Population|Overall Study||400
2200868|NCT03301649|5398354|P1|Safety Population|Overall Study||399
2200869|NCT03301649|5398352|P3|STARTED|Overall Study||112
2200870|NCT03301649|5398353|P2|STARTED|Overall Study||400
2200871|NCT03301649|5398354|P1|STARTED|Overall Study||399
2200872|NCT03301298|5398376|P7|NOT COMPLETED|Fed Conditions||0
2200873|NCT03301298|5398377|P6|NOT COMPLETED|Fed Conditions||0
2200874|NCT03301298|5398378|P5|NOT COMPLETED|Fed Conditions||0
2200875|NCT03301298|5398379|P4|NOT COMPLETED|Fed Conditions||0
2200876|NCT03301298|5398380|P3|NOT COMPLETED|Fed Conditions||0
2200877|NCT03301298|5398381|P2|NOT COMPLETED|Fed Conditions||0
2200878|NCT03301298|5398382|P1|NOT COMPLETED|Fed Conditions||0
2200879|NCT03301298|5398376|P7|COMPLETED|Fed Conditions||2
2200880|NCT03301298|5398377|P6|COMPLETED|Fed Conditions||0
2200881|NCT03301298|5398378|P5|COMPLETED|Fed Conditions||5
2200882|NCT03301298|5398379|P4|COMPLETED|Fed Conditions||0
2200883|NCT03301298|5398380|P3|COMPLETED|Fed Conditions||0
2200884|NCT03301298|5398381|P2|COMPLETED|Fed Conditions||0
2200885|NCT03301298|5398382|P1|COMPLETED|Fed Conditions||0
2200886|NCT03301298|5398376|P7|STARTED|Fed Conditions||2
2200887|NCT03301298|5398377|P6|STARTED|Fed Conditions||0
2200888|NCT03301298|5398378|P5|STARTED|Fed Conditions||5
2200889|NCT03301298|5398379|P4|STARTED|Fed Conditions||0
2200890|NCT03301298|5398380|P3|STARTED|Fed Conditions||0
2200891|NCT03301298|5398381|P2|STARTED|Fed Conditions||0
2200892|NCT03301298|5398382|P1|STARTED|Fed Conditions||0
2200893|NCT03301298|5398376|P7|NOT COMPLETED|Unfed Conditions||0
2200894|NCT03301298|5398377|P6|NOT COMPLETED|Unfed Conditions||0
2200895|NCT03301298|5398378|P5|NOT COMPLETED|Unfed Conditions||0
2200896|NCT03301298|5398379|P4|NOT COMPLETED|Unfed Conditions||0
2200897|NCT03301298|5398380|P3|NOT COMPLETED|Unfed Conditions||0
2200898|NCT03301298|5398381|P2|NOT COMPLETED|Unfed Conditions||0
2200899|NCT03301298|5398382|P1|NOT COMPLETED|Unfed Conditions||0
2200900|NCT03301298|5398376|P7|COMPLETED|Unfed Conditions||12
2200901|NCT03301298|5398377|P6|COMPLETED|Unfed Conditions||6
2200902|NCT03301298|5398378|P5|COMPLETED|Unfed Conditions||6
2200903|NCT03301298|5398379|P4|COMPLETED|Unfed Conditions||6
2200904|NCT03301298|5398380|P3|COMPLETED|Unfed Conditions||6
2200905|NCT03301298|5398381|P2|COMPLETED|Unfed Conditions||6
2200906|NCT03301298|5398382|P1|COMPLETED|Unfed Conditions||6
2200907|NCT03301298|5398376|P7|STARTED|Unfed Conditions||12
2200908|NCT03301298|5398377|P6|STARTED|Unfed Conditions||6
2200909|NCT03301298|5398378|P5|STARTED|Unfed Conditions||6
2200910|NCT03301298|5398379|P4|STARTED|Unfed Conditions||6
2200911|NCT03301298|5398380|P3|STARTED|Unfed Conditions||6
2200912|NCT03301298|5398381|P2|STARTED|Unfed Conditions||6
2200913|NCT03301298|5398382|P1|STARTED|Unfed Conditions||6
2200914|NCT03300843|5398418|P1|NOT COMPLETED|Overall Study||0
2200915|NCT03300843|5398418|P1|COMPLETED|Overall Study||1
2200916|NCT03300843|5398418|P1|STARTED|Overall Study||1
2200917|NCT03300674|5398426|P2|NOT COMPLETED|Overall Study||0
2200918|NCT03300674|5398427|P1|NOT COMPLETED|Overall Study||0
2200919|NCT03300674|5398426|P2|COMPLETED|Overall Study||77
2200920|NCT03300674|5398427|P1|COMPLETED|Overall Study||77
2200921|NCT03300674|5398426|P2|STARTED|Overall Study||77
2200922|NCT03300674|5398427|P1|STARTED|Overall Study||77
2200923|NCT03300570|5398439|P2|NOT COMPLETED|Overall Study||1
2200924|NCT03300570|5398440|P1|NOT COMPLETED|Overall Study||2
2200925|NCT03300570|5398439|P2|COMPLETED|Overall Study||13
2200926|NCT03300570|5398440|P1|COMPLETED|Overall Study||11
2200927|NCT03300570|5398439|P2|STARTED|Overall Study||14
2200928|NCT03300570|5398440|P1|STARTED|Overall Study||13
2200929|NCT03300024|5398452|P2|NOT COMPLETED|Overall Study||6
2200930|NCT03300024|5398453|P1|NOT COMPLETED|Overall Study||4
2200931|NCT03300024|5398452|P2|COMPLETED|Overall Study||0
2200932|NCT03300024|5398453|P1|COMPLETED|Overall Study||0
2200933|NCT03300024|5398452|P2|STARTED|Overall Study||6
2200934|NCT03300024|5398453|P1|STARTED|Overall Study||4
2200935|NCT03298113|5398507|P2|NOT COMPLETED|Overall Study||0
2200936|NCT03298113|5398508|P1|NOT COMPLETED|Overall Study||0
2200937|NCT03298113|5398507|P2|COMPLETED|Overall Study||10
2200938|NCT03298113|5398508|P1|COMPLETED|Overall Study||10
2200939|NCT03298113|5398507|P2|IAD 2A|Overall Study||6
2200940|NCT03298113|5398508|P1|IAD 2A|Overall Study||7
2200941|NCT03298113|5398507|P2|IAD 1A|Overall Study||4
2200942|NCT03298113|5398508|P1|IAD 1A|Overall Study||3
2200943|NCT03298113|5398507|P2|STARTED|Overall Study|10 subjects were treated with IAD Hospital Standard Care. Study terminated due to low enrollment.|10
2200944|NCT03298113|5398508|P1|STARTED|Overall Study|10 subjects were treated w/ Cavilon Advanced Skin Protectant. Study terminated due to low enrollment|10
2200945|NCT03298035|5398546|P2|NOT COMPLETED|Overall Study||2
2200946|NCT03298035|5398547|P1|NOT COMPLETED|Overall Study||1
2200947|NCT03298035|5398546|P2|COMPLETED|Overall Study||7
2200948|NCT03298035|5398547|P1|COMPLETED|Overall Study||9
2200949|NCT03298035|5398546|P2|Received Intervention|Overall Study||7
2200950|NCT03298035|5398547|P1|Received Intervention|Overall Study||9
2200951|NCT03298035|5398546|P2|STARTED|Overall Study||9
2200952|NCT03298035|5398547|P1|STARTED|Overall Study||10
2200953|NCT03297944|5398569|P1|NOT COMPLETED|Overall Study||0
2200954|NCT03297944|5398569|P1|COMPLETED|Overall Study||15
2200955|NCT03297944|5398569|P1|PLC/ALP|Overall Study||15
2200956|NCT03297944|5398569|P1|PLC/PLC|Overall Study||15
2200957|NCT03297944|5398569|P1|ZOL/PLC|Overall Study||15
2200958|NCT03297944|5398569|P1|0.5ALP/PLC|Overall Study||15
2200959|NCT03297944|5398569|P1|1ALP/PLC|Overall Study||15
2200960|NCT03297944|5398569|P1|2ALP/PLC|Overall Study||15
2200961|NCT03297944|5398569|P1|STARTED|Overall Study||15
2200962|NCT03297112|5398578|P1|NOT COMPLETED|Overall Study||0
2200963|NCT03297112|5398578|P1|COMPLETED|Overall Study||12
2200964|NCT03297112|5398578|P1|STARTED|Overall Study||12
2200965|NCT03296072|5398583|P6|NOT COMPLETED|Treament Period 3||0
2200966|NCT03296072|5398584|P5|NOT COMPLETED|Treament Period 3||0
2200967|NCT03296072|5398585|P4|NOT COMPLETED|Treament Period 3||0
2200968|NCT03296072|5398586|P3|NOT COMPLETED|Treament Period 3||0
2200969|NCT03296072|5398587|P2|NOT COMPLETED|Treament Period 3||0
2200970|NCT03296072|5398588|P1|NOT COMPLETED|Treament Period 3||0
2200971|NCT03296072|5398583|P6|COMPLETED|Treament Period 3||11
2200972|NCT03296072|5398584|P5|COMPLETED|Treament Period 3||10
2200973|NCT03296072|5398585|P4|COMPLETED|Treament Period 3||10
2200974|NCT03296072|5398586|P3|COMPLETED|Treament Period 3||10
2200975|NCT03296072|5398587|P2|COMPLETED|Treament Period 3||11
2200976|NCT03296072|5398588|P1|COMPLETED|Treament Period 3||10
2200977|NCT03296072|5398583|P6|STARTED|Treament Period 3||11
2200978|NCT03296072|5398584|P5|STARTED|Treament Period 3||10
2200979|NCT03296072|5398585|P4|STARTED|Treament Period 3||10
2200980|NCT03296072|5398586|P3|STARTED|Treament Period 3||10
2200981|NCT03296072|5398587|P2|STARTED|Treament Period 3||11
2200982|NCT03296072|5398588|P1|STARTED|Treament Period 3||10
2200983|NCT03296072|5398583|P6|NOT COMPLETED|Treament Period 2: Wash Out Period||0
2200984|NCT03296072|5398584|P5|NOT COMPLETED|Treament Period 2: Wash Out Period||0
2200985|NCT03296072|5398585|P4|NOT COMPLETED|Treament Period 2: Wash Out Period||0
2200986|NCT03296072|5398586|P3|NOT COMPLETED|Treament Period 2: Wash Out Period||0
2200987|NCT03296072|5398587|P2|NOT COMPLETED|Treament Period 2: Wash Out Period||0
2200988|NCT03296072|5398588|P1|NOT COMPLETED|Treament Period 2: Wash Out Period||0
2200989|NCT03296072|5398583|P6|COMPLETED|Treament Period 2: Wash Out Period||11
2200990|NCT03296072|5398584|P5|COMPLETED|Treament Period 2: Wash Out Period||10
2200991|NCT03296072|5398585|P4|COMPLETED|Treament Period 2: Wash Out Period||10
2200992|NCT03296072|5398586|P3|COMPLETED|Treament Period 2: Wash Out Period||10
2200993|NCT03296072|5398587|P2|COMPLETED|Treament Period 2: Wash Out Period||11
2200994|NCT03296072|5398588|P1|COMPLETED|Treament Period 2: Wash Out Period||10
2200995|NCT03296072|5398583|P6|STARTED|Treament Period 2: Wash Out Period||11
2200996|NCT03296072|5398584|P5|STARTED|Treament Period 2: Wash Out Period||10
2200997|NCT03296072|5398585|P4|STARTED|Treament Period 2: Wash Out Period||10
2200998|NCT03296072|5398586|P3|STARTED|Treament Period 2: Wash Out Period||10
2200999|NCT03296072|5398587|P2|STARTED|Treament Period 2: Wash Out Period||11
2201000|NCT03296072|5398588|P1|STARTED|Treament Period 2: Wash Out Period||10
2201001|NCT03296072|5398583|P6|NOT COMPLETED|Treament Period 2||0
2201002|NCT03296072|5398584|P5|NOT COMPLETED|Treament Period 2||0
2201003|NCT03296072|5398585|P4|NOT COMPLETED|Treament Period 2||0
2201004|NCT03296072|5398586|P3|NOT COMPLETED|Treament Period 2||0
2201005|NCT03296072|5398587|P2|NOT COMPLETED|Treament Period 2||0
2201006|NCT03296072|5398588|P1|NOT COMPLETED|Treament Period 2||0
2201007|NCT03296072|5398583|P6|COMPLETED|Treament Period 2||11
2201008|NCT03296072|5398584|P5|COMPLETED|Treament Period 2||10
2201009|NCT03296072|5398585|P4|COMPLETED|Treament Period 2||10
2201010|NCT03296072|5398586|P3|COMPLETED|Treament Period 2||10
2201011|NCT03296072|5398587|P2|COMPLETED|Treament Period 2||11
2201012|NCT03296072|5398588|P1|COMPLETED|Treament Period 2||10
2201013|NCT03296072|5398583|P6|STARTED|Treament Period 2||11
2201014|NCT03296072|5398584|P5|STARTED|Treament Period 2||10
2201015|NCT03296072|5398585|P4|STARTED|Treament Period 2||10
2201016|NCT03296072|5398586|P3|STARTED|Treament Period 2||10
2201017|NCT03296072|5398587|P2|STARTED|Treament Period 2||11
2201018|NCT03296072|5398588|P1|STARTED|Treament Period 2||10
2201019|NCT03296072|5398583|P6|NOT COMPLETED|Treament Period 1: Wash Out Period||0
2201020|NCT03296072|5398584|P5|NOT COMPLETED|Treament Period 1: Wash Out Period||0
2201021|NCT03296072|5398585|P4|NOT COMPLETED|Treament Period 1: Wash Out Period||0
2201022|NCT03296072|5398586|P3|NOT COMPLETED|Treament Period 1: Wash Out Period||0
2201023|NCT03296072|5398587|P2|NOT COMPLETED|Treament Period 1: Wash Out Period||0
2201024|NCT03296072|5398588|P1|NOT COMPLETED|Treament Period 1: Wash Out Period||0
2201025|NCT03296072|5398583|P6|COMPLETED|Treament Period 1: Wash Out Period||11
2201026|NCT03296072|5398584|P5|COMPLETED|Treament Period 1: Wash Out Period||10
2201027|NCT03296072|5398585|P4|COMPLETED|Treament Period 1: Wash Out Period||10
2201028|NCT03296072|5398586|P3|COMPLETED|Treament Period 1: Wash Out Period||10
2201029|NCT03296072|5398587|P2|COMPLETED|Treament Period 1: Wash Out Period||11
2201030|NCT03296072|5398588|P1|COMPLETED|Treament Period 1: Wash Out Period||10
2201031|NCT03296072|5398583|P6|STARTED|Treament Period 1: Wash Out Period||11
2201032|NCT03296072|5398584|P5|STARTED|Treament Period 1: Wash Out Period||10
2201033|NCT03296072|5398585|P4|STARTED|Treament Period 1: Wash Out Period||10
2201034|NCT03296072|5398586|P3|STARTED|Treament Period 1: Wash Out Period||10
2201035|NCT03296072|5398587|P2|STARTED|Treament Period 1: Wash Out Period||11
2201036|NCT03296072|5398588|P1|STARTED|Treament Period 1: Wash Out Period||10
2201037|NCT03296072|5398583|P6|NOT COMPLETED|Treatment Period 1||0
2201038|NCT03296072|5398584|P5|NOT COMPLETED|Treatment Period 1||0
2201039|NCT03296072|5398585|P4|NOT COMPLETED|Treatment Period 1||0
2201040|NCT03296072|5398586|P3|NOT COMPLETED|Treatment Period 1||0
2201041|NCT03296072|5398587|P2|NOT COMPLETED|Treatment Period 1||0
2201042|NCT03296072|5398588|P1|NOT COMPLETED|Treatment Period 1||0
2201043|NCT03296072|5398583|P6|COMPLETED|Treatment Period 1||11
2201044|NCT03296072|5398584|P5|COMPLETED|Treatment Period 1||10
2201045|NCT03296072|5398585|P4|COMPLETED|Treatment Period 1||10
2201046|NCT03296072|5398586|P3|COMPLETED|Treatment Period 1||10
2201047|NCT03296072|5398587|P2|COMPLETED|Treatment Period 1||11
2201048|NCT03296072|5398588|P1|COMPLETED|Treatment Period 1||10
2201049|NCT03296072|5398583|P6|STARTED|Treatment Period 1||11
2201050|NCT03296072|5398584|P5|STARTED|Treatment Period 1||10
2201051|NCT03296072|5398585|P4|STARTED|Treatment Period 1||10
2201052|NCT03296072|5398586|P3|STARTED|Treatment Period 1||10
2201053|NCT03296072|5398587|P2|STARTED|Treatment Period 1||11
2201054|NCT03296072|5398588|P1|STARTED|Treatment Period 1||10
2201055|NCT03295630|5398605|P1|NOT COMPLETED|Overall Study||0
2201056|NCT03295630|5398605|P1|COMPLETED|Overall Study||20
2201057|NCT03295630|5398605|P1|STARTED|Overall Study||20
2201058|NCT03295266|5398612|P2|NOT COMPLETED|Overall Study||0
2201059|NCT03295266|5398613|P1|NOT COMPLETED|Overall Study||0
2201060|NCT03295266|5398612|P2|COMPLETED|Overall Study||4
2201061|NCT03295266|5398613|P1|COMPLETED|Overall Study||5
2201062|NCT03295266|5398612|P2|STARTED|Overall Study||4
2201063|NCT03295266|5398613|P1|STARTED|Overall Study||5
2201064|NCT03295201|5398643|P2|NOT COMPLETED|Overall Study||2
2201065|NCT03295201|5398644|P1|NOT COMPLETED|Overall Study||1
2201066|NCT03295201|5398643|P2|COMPLETED|Overall Study||9
2201067|NCT03295201|5398644|P1|COMPLETED|Overall Study||10
2201068|NCT03295201|5398643|P2|STARTED|Overall Study||11
2201069|NCT03295201|5398644|P1|STARTED|Overall Study||11
2201070|NCT03294629|5398698|P2|NOT COMPLETED|Second Intervention (2 Weeks)||2
2201071|NCT03294629|5398699|P1|NOT COMPLETED|Second Intervention (2 Weeks)||2
2201072|NCT03294629|5398698|P2|COMPLETED|Second Intervention (2 Weeks)||13
2201073|NCT03294629|5398699|P1|COMPLETED|Second Intervention (2 Weeks)||12
2201074|NCT03294629|5398698|P2|STARTED|Second Intervention (2 Weeks)||15
2201075|NCT03294629|5398699|P1|STARTED|Second Intervention (2 Weeks)||14
2201076|NCT03294629|5398698|P2|NOT COMPLETED|First Intervention (2 Weeks)||4
2201077|NCT03294629|5398699|P1|NOT COMPLETED|First Intervention (2 Weeks)||2
2201078|NCT03294629|5398698|P2|COMPLETED|First Intervention (2 Weeks)||15
2201079|NCT03294629|5398699|P1|COMPLETED|First Intervention (2 Weeks)||14
2201080|NCT03294629|5398698|P2|STARTED|First Intervention (2 Weeks)||19
2201081|NCT03294629|5398699|P1|STARTED|First Intervention (2 Weeks)||16
2201082|NCT03294538|5398730|P3|NOT COMPLETED|Overall Study||2
2201083|NCT03294538|5398731|P2|NOT COMPLETED|Overall Study||5
2201084|NCT03294538|5398732|P1|NOT COMPLETED|Overall Study||5
2201085|NCT03294538|5398730|P3|COMPLETED|Overall Study||131
2201086|NCT03294538|5398731|P2|COMPLETED|Overall Study||257
2201087|NCT03294538|5398732|P1|COMPLETED|Overall Study||263
2201088|NCT03294538|5398730|P3|PP Population|Overall Study||126
2201089|NCT03294538|5398731|P2|PP Population|Overall Study||227
2201090|NCT03294538|5398732|P1|PP Population|Overall Study||244
2201091|NCT03294538|5398730|P3|mITT Population|Overall Study||132
2201092|NCT03294538|5398731|P2|mITT Population|Overall Study||262
2201093|NCT03294538|5398732|P1|mITT Population|Overall Study||267
2201094|NCT03294538|5398730|P3|Safety Population|Overall Study||132
2201095|NCT03294538|5398731|P2|Safety Population|Overall Study||262
2201096|NCT03294538|5398732|P1|Safety Population|Overall Study||267
2201097|NCT03294538|5398730|P3|STARTED|Overall Study||133
2201098|NCT03294538|5398731|P2|STARTED|Overall Study||262
2201099|NCT03294538|5398732|P1|STARTED|Overall Study||268
2201100|NCT03293485|5398747|P1|NOT COMPLETED|Overall Study||5
2201101|NCT03293485|5398747|P1|COMPLETED|Overall Study||78
2201102|NCT03293485|5398747|P1|Treated|Overall Study||81
2201103|NCT03293485|5398747|P1|STARTED|Overall Study||83
2201104|NCT03293394|5398758|P2|NOT COMPLETED|Follow-up (6 Months)||2
2201105|NCT03293394|5398759|P1|NOT COMPLETED|Follow-up (6 Months)||4
2201106|NCT03293394|5398758|P2|COMPLETED|Follow-up (6 Months)||8
2201107|NCT03293394|5398759|P1|COMPLETED|Follow-up (6 Months)||16
2201108|NCT03293394|5398758|P2|STARTED|Follow-up (6 Months)||10
2201109|NCT03293394|5398759|P1|STARTED|Follow-up (6 Months)||20
2201110|NCT03293394|5398758|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
2201111|NCT03293394|5398759|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
2201112|NCT03293394|5398758|P2|COMPLETED|First Intervention (2 Weeks)||10
2201113|NCT03293394|5398759|P1|COMPLETED|First Intervention (2 Weeks)||20
2201114|NCT03293394|5398758|P2|STARTED|First Intervention (2 Weeks)||10
2201115|NCT03293394|5398759|P1|STARTED|First Intervention (2 Weeks)||20
2201116|NCT03293238|5398783|P4|NOT COMPLETED|Overall Study||0
2201117|NCT03293238|5398784|P3|NOT COMPLETED|Overall Study||0
2201118|NCT03293238|5398785|P2|NOT COMPLETED|Overall Study||0
2201119|NCT03293238|5398786|P1|NOT COMPLETED|Overall Study||0
2201120|NCT03293238|5398783|P4|COMPLETED|Overall Study||14
2201121|NCT03293238|5398784|P3|COMPLETED|Overall Study||14
2201122|NCT03293238|5398785|P2|COMPLETED|Overall Study||16
2201123|NCT03293238|5398786|P1|COMPLETED|Overall Study||19
2201124|NCT03293238|5398783|P4|STARTED|Overall Study||14
2201125|NCT03293238|5398784|P3|STARTED|Overall Study||14
2201126|NCT03293238|5398785|P2|STARTED|Overall Study||16
2201127|NCT03293238|5398786|P1|STARTED|Overall Study||19
2201128|NCT03292692|5398806|P2|NOT COMPLETED|Overall Study||38
2201129|NCT03292692|5398807|P1|NOT COMPLETED|Overall Study||38
2201130|NCT03292692|5398806|P2|COMPLETED|Overall Study||260
2201131|NCT03292692|5398807|P1|COMPLETED|Overall Study||264
2201132|NCT03292692|5398806|P2|STARTED|Overall Study||298
2201133|NCT03292692|5398807|P1|STARTED|Overall Study||302
2201134|NCT03292614|5398819|P1|NOT COMPLETED|Overall Study||0
2201135|NCT03292614|5398819|P1|COMPLETED|Overall Study||25
2201136|NCT03292614|5398819|P1|STARTED|Overall Study||25
2201137|NCT03291613|5398823|P1|NOT COMPLETED|Overall Study||1
2201138|NCT03291613|5398823|P1|COMPLETED|Overall Study||12
2201139|NCT03291613|5398823|P1|STARTED|Overall Study||13
2201140|NCT03291197|5398827|P1|NOT COMPLETED|Overall Study||0
2201141|NCT03291197|5398827|P1|COMPLETED|Overall Study||5
2201142|NCT03291197|5398827|P1|STARTED|Overall Study||5
2201143|NCT03290768|5398835|P1|NOT COMPLETED|Overall Study||165
2201144|NCT03290768|5398835|P1|COMPLETED|Overall Study||193
2201145|NCT03290768|5398835|P1|STARTED|Overall Study||358
2201146|NCT03290300|5398846|P1|NOT COMPLETED|Overall Study||3
2201147|NCT03290300|5398846|P1|COMPLETED|Overall Study||36
2201148|NCT03290300|5398846|P1|STARTED|Overall Study||39
2201155|NCT03289676|5398866|P2|NOT COMPLETED|Overall Study||1
2201156|NCT03289676|5398867|P1|NOT COMPLETED|Overall Study||4
2201157|NCT03289676|5398866|P2|COMPLETED|Overall Study|Received 80% of the allotted intervention|25
2201158|NCT03289676|5398867|P1|COMPLETED|Overall Study||23
2201159|NCT03289676|5398866|P2|STARTED|Overall Study||26
2201160|NCT03289676|5398867|P1|STARTED|Overall Study||27
2201161|NCT03289481|5398879|P2|NOT COMPLETED|Overall Study||2
2201162|NCT03289481|5398880|P1|NOT COMPLETED|Overall Study||2
2201163|NCT03289481|5398879|P2|COMPLETED|Overall Study||5
2201164|NCT03289481|5398880|P1|COMPLETED|Overall Study||4
2201165|NCT03289481|5398879|P2|STARTED|Overall Study||7
2201166|NCT03289481|5398880|P1|STARTED|Overall Study||6
2201167|NCT03288779|5398892|P1|NOT COMPLETED|Overall Study||3
2201168|NCT03288779|5398892|P1|COMPLETED|Overall Study||3
2201169|NCT03288779|5398892|P1|STARTED|Overall Study||6
2201170|NCT03287843|5398899|P2|NOT COMPLETED|Overall Study||8
2201171|NCT03287843|5398900|P1|NOT COMPLETED|Overall Study||15
2201172|NCT03287843|5398899|P2|COMPLETED|Overall Study||167
2201173|NCT03287843|5398900|P1|COMPLETED|Overall Study||160
2201174|NCT03287843|5398899|P2|Lost to Follow up|Overall Study||0
2201175|NCT03287843|5398900|P1|Lost to Follow up|Overall Study||3
2201176|NCT03287843|5398899|P2|Excluded|Overall Study|No surgery n=4 R2 resection n=2 Stage IV n=2|8
2201177|NCT03287843|5398900|P1|Excluded|Overall Study|No surgery n=5 R2 resection n=5 Stage IV n=2|12
2201178|NCT03287843|5398899|P2|STARTED|Overall Study||175
2201179|NCT03287843|5398900|P1|STARTED|Overall Study||175
2201180|NCT03287791|5398915|P3|NOT COMPLETED|Overall Study||36
2201181|NCT03287791|5398916|P2|NOT COMPLETED|Overall Study||36
2201182|NCT03287791|5398917|P1|NOT COMPLETED|Overall Study||32
2201183|NCT03287791|5398915|P3|COMPLETED|Overall Study||264
2201184|NCT03287791|5398916|P2|COMPLETED|Overall Study||276
2201185|NCT03287791|5398917|P1|COMPLETED|Overall Study||280
2201186|NCT03287791|5398915|P3|PP Population|Overall Study||245
2201187|NCT03287791|5398916|P2|PP Population|Overall Study||259
2201188|NCT03287791|5398917|P1|PP Population|Overall Study||262
2201189|NCT03287791|5398915|P3|mITT Population|Overall Study||283
2201190|NCT03287791|5398916|P2|mITT Population|Overall Study||291
2201191|NCT03287791|5398917|P1|mITT Population|Overall Study||291
2201192|NCT03287791|5398915|P3|Safety Population|Overall Study||291
2201193|NCT03287791|5398916|P2|Safety Population|Overall Study||297
2201194|NCT03287791|5398917|P1|Safety Population|Overall Study||306
2201195|NCT03287791|5398915|P3|STARTED|Overall Study||300
2201196|NCT03287791|5398916|P2|STARTED|Overall Study||312
2201197|NCT03287791|5398917|P1|STARTED|Overall Study||312
2201198|NCT03286283|5398928|P1|NOT COMPLETED|Overall Study||0
2201199|NCT03286283|5398928|P1|COMPLETED|Overall Study||55
2201200|NCT03286283|5398928|P1|STARTED|Overall Study||55
2201201|NCT03286218|5398944|P12|NOT COMPLETED|Treatment Phase Period 5||0
2201202|NCT03286218|5398945|P11|NOT COMPLETED|Treatment Phase Period 5||0
2201203|NCT03286218|5398946|P10|NOT COMPLETED|Treatment Phase Period 5||0
2201204|NCT03286218|5398947|P9|NOT COMPLETED|Treatment Phase Period 5||0
2201205|NCT03286218|5398948|P8|NOT COMPLETED|Treatment Phase Period 5||0
2201206|NCT03286218|5398949|P7|NOT COMPLETED|Treatment Phase Period 5||0
2201207|NCT03286218|5398950|P6|NOT COMPLETED|Treatment Phase Period 5||0
2201208|NCT03286218|5398951|P5|NOT COMPLETED|Treatment Phase Period 5||0
2201209|NCT03286218|5398952|P4|NOT COMPLETED|Treatment Phase Period 5||0
2201210|NCT03286218|5398953|P3|NOT COMPLETED|Treatment Phase Period 5||0
2201211|NCT03286218|5398954|P2|NOT COMPLETED|Treatment Phase Period 5||0
2201212|NCT03286218|5398955|P1|NOT COMPLETED|Treatment Phase Period 5||0
2201213|NCT03286218|5398944|P12|COMPLETED|Treatment Phase Period 5||4
2201214|NCT03286218|5398945|P11|COMPLETED|Treatment Phase Period 5||5
2201215|NCT03286218|5398946|P10|COMPLETED|Treatment Phase Period 5||6
2201216|NCT03286218|5398947|P9|COMPLETED|Treatment Phase Period 5||6
2201217|NCT03286218|5398948|P8|COMPLETED|Treatment Phase Period 5||6
2201218|NCT03286218|5398949|P7|COMPLETED|Treatment Phase Period 5||6
2201219|NCT03286218|5398950|P6|COMPLETED|Treatment Phase Period 5||5
2201220|NCT03286218|5398951|P5|COMPLETED|Treatment Phase Period 5||5
2201221|NCT03286218|5398952|P4|COMPLETED|Treatment Phase Period 5||5
2201222|NCT03286218|5398953|P3|COMPLETED|Treatment Phase Period 5||5
2201223|NCT03286218|5398954|P2|COMPLETED|Treatment Phase Period 5||0
2201224|NCT03286218|5398955|P1|COMPLETED|Treatment Phase Period 5||0
2201225|NCT03286218|5398944|P12|STARTED|Treatment Phase Period 5||4
2201226|NCT03286218|5398945|P11|STARTED|Treatment Phase Period 5||5
2201227|NCT03286218|5398946|P10|STARTED|Treatment Phase Period 5||6
2201228|NCT03286218|5398947|P9|STARTED|Treatment Phase Period 5||6
2201229|NCT03286218|5398948|P8|STARTED|Treatment Phase Period 5||6
2201230|NCT03286218|5398949|P7|STARTED|Treatment Phase Period 5||6
2201231|NCT03286218|5398950|P6|STARTED|Treatment Phase Period 5||5
2201232|NCT03286218|5398951|P5|STARTED|Treatment Phase Period 5||5
2201233|NCT03286218|5398952|P4|STARTED|Treatment Phase Period 5||5
2201234|NCT03286218|5398953|P3|STARTED|Treatment Phase Period 5||5
2201235|NCT03286218|5398954|P2|STARTED|Treatment Phase Period 5||0
2201236|NCT03286218|5398955|P1|STARTED|Treatment Phase Period 5||0
2201237|NCT03286218|5398944|P12|NOT COMPLETED|Treatment Phase Period 4||1
2201238|NCT03286218|5398945|P11|NOT COMPLETED|Treatment Phase Period 4||0
2201239|NCT03286218|5398946|P10|NOT COMPLETED|Treatment Phase Period 4||0
2201240|NCT03286218|5398947|P9|NOT COMPLETED|Treatment Phase Period 4||0
2201241|NCT03286218|5398948|P8|NOT COMPLETED|Treatment Phase Period 4||0
2201242|NCT03286218|5398949|P7|NOT COMPLETED|Treatment Phase Period 4||0
2201243|NCT03286218|5398950|P6|NOT COMPLETED|Treatment Phase Period 4||0
2201244|NCT03286218|5398951|P5|NOT COMPLETED|Treatment Phase Period 4||0
2201245|NCT03286218|5398952|P4|NOT COMPLETED|Treatment Phase Period 4||0
2201246|NCT03286218|5398953|P3|NOT COMPLETED|Treatment Phase Period 4||0
2201247|NCT03286218|5398954|P2|NOT COMPLETED|Treatment Phase Period 4||0
2201248|NCT03286218|5398955|P1|NOT COMPLETED|Treatment Phase Period 4||0
2201249|NCT03286218|5398944|P12|COMPLETED|Treatment Phase Period 4||4
2201250|NCT03286218|5398945|P11|COMPLETED|Treatment Phase Period 4||5
2201251|NCT03286218|5398946|P10|COMPLETED|Treatment Phase Period 4||6
2201252|NCT03286218|5398947|P9|COMPLETED|Treatment Phase Period 4||6
2201253|NCT03286218|5398948|P8|COMPLETED|Treatment Phase Period 4||6
2201254|NCT03286218|5398949|P7|COMPLETED|Treatment Phase Period 4||6
2201255|NCT03286218|5398950|P6|COMPLETED|Treatment Phase Period 4||5
2201256|NCT03286218|5398951|P5|COMPLETED|Treatment Phase Period 4||5
2201257|NCT03286218|5398952|P4|COMPLETED|Treatment Phase Period 4||5
2201258|NCT03286218|5398953|P3|COMPLETED|Treatment Phase Period 4||5
2201259|NCT03286218|5398954|P2|COMPLETED|Treatment Phase Period 4||0
2201260|NCT03286218|5398955|P1|COMPLETED|Treatment Phase Period 4||0
2201261|NCT03286218|5398944|P12|STARTED|Treatment Phase Period 4||5
2201262|NCT03286218|5398945|P11|STARTED|Treatment Phase Period 4||5
2201263|NCT03286218|5398946|P10|STARTED|Treatment Phase Period 4||6
2201264|NCT03286218|5398947|P9|STARTED|Treatment Phase Period 4||6
2201265|NCT03286218|5398948|P8|STARTED|Treatment Phase Period 4||6
2201266|NCT03286218|5398949|P7|STARTED|Treatment Phase Period 4||6
2201267|NCT03286218|5398950|P6|STARTED|Treatment Phase Period 4||5
2201268|NCT03286218|5398951|P5|STARTED|Treatment Phase Period 4||5
2201269|NCT03286218|5398952|P4|STARTED|Treatment Phase Period 4||5
2201270|NCT03286218|5398953|P3|STARTED|Treatment Phase Period 4||5
2201271|NCT03286218|5398954|P2|STARTED|Treatment Phase Period 4||0
2201272|NCT03286218|5398955|P1|STARTED|Treatment Phase Period 4||0
2201273|NCT03286218|5398944|P12|NOT COMPLETED|Treatment Phase Period 3||0
2201274|NCT03286218|5398945|P11|NOT COMPLETED|Treatment Phase Period 3||0
2201275|NCT03286218|5398946|P10|NOT COMPLETED|Treatment Phase Period 3||0
2201276|NCT03286218|5398947|P9|NOT COMPLETED|Treatment Phase Period 3||0
2201277|NCT03286218|5398948|P8|NOT COMPLETED|Treatment Phase Period 3||0
2201278|NCT03286218|5398949|P7|NOT COMPLETED|Treatment Phase Period 3||0
2201279|NCT03286218|5398950|P6|NOT COMPLETED|Treatment Phase Period 3||0
2201280|NCT03286218|5398951|P5|NOT COMPLETED|Treatment Phase Period 3||0
2201281|NCT03286218|5398952|P4|NOT COMPLETED|Treatment Phase Period 3||0
2201282|NCT03286218|5398953|P3|NOT COMPLETED|Treatment Phase Period 3||0
2201283|NCT03286218|5398954|P2|NOT COMPLETED|Treatment Phase Period 3||0
2201284|NCT03286218|5398955|P1|NOT COMPLETED|Treatment Phase Period 3||0
2201285|NCT03286218|5398944|P12|COMPLETED|Treatment Phase Period 3||5
2201286|NCT03286218|5398945|P11|COMPLETED|Treatment Phase Period 3||5
2201287|NCT03286218|5398946|P10|COMPLETED|Treatment Phase Period 3||6
2201288|NCT03286218|5398947|P9|COMPLETED|Treatment Phase Period 3||6
2201289|NCT03286218|5398948|P8|COMPLETED|Treatment Phase Period 3||6
2201290|NCT03286218|5398949|P7|COMPLETED|Treatment Phase Period 3||6
2201291|NCT03286218|5398950|P6|COMPLETED|Treatment Phase Period 3||5
2201292|NCT03286218|5398951|P5|COMPLETED|Treatment Phase Period 3||5
2201293|NCT03286218|5398952|P4|COMPLETED|Treatment Phase Period 3||5
2201294|NCT03286218|5398953|P3|COMPLETED|Treatment Phase Period 3||5
2201295|NCT03286218|5398954|P2|COMPLETED|Treatment Phase Period 3||0
2201296|NCT03286218|5398955|P1|COMPLETED|Treatment Phase Period 3||0
2201297|NCT03286218|5398944|P12|STARTED|Treatment Phase Period 3||5
2201298|NCT03286218|5398945|P11|STARTED|Treatment Phase Period 3||5
2201299|NCT03286218|5398946|P10|STARTED|Treatment Phase Period 3||6
2201300|NCT03286218|5398947|P9|STARTED|Treatment Phase Period 3||6
2201301|NCT03286218|5398948|P8|STARTED|Treatment Phase Period 3||6
2201302|NCT03286218|5398949|P7|STARTED|Treatment Phase Period 3||6
2201303|NCT03286218|5398950|P6|STARTED|Treatment Phase Period 3||5
2201304|NCT03286218|5398951|P5|STARTED|Treatment Phase Period 3||5
2201305|NCT03286218|5398952|P4|STARTED|Treatment Phase Period 3||5
2201306|NCT03286218|5398953|P3|STARTED|Treatment Phase Period 3||5
2201307|NCT03286218|5398954|P2|STARTED|Treatment Phase Period 3||0
2201308|NCT03286218|5398955|P1|STARTED|Treatment Phase Period 3||0
2201309|NCT03286218|5398944|P12|NOT COMPLETED|Treatment Phase Period 2||0
2201310|NCT03286218|5398945|P11|NOT COMPLETED|Treatment Phase Period 2||0
2201311|NCT03286218|5398946|P10|NOT COMPLETED|Treatment Phase Period 2||0
2201312|NCT03286218|5398947|P9|NOT COMPLETED|Treatment Phase Period 2||0
2201313|NCT03286218|5398948|P8|NOT COMPLETED|Treatment Phase Period 2||0
2201314|NCT03286218|5398949|P7|NOT COMPLETED|Treatment Phase Period 2||0
2201315|NCT03286218|5398950|P6|NOT COMPLETED|Treatment Phase Period 2||0
2201316|NCT03286218|5398951|P5|NOT COMPLETED|Treatment Phase Period 2||0
2201317|NCT03286218|5398952|P4|NOT COMPLETED|Treatment Phase Period 2||0
2201318|NCT03286218|5398953|P3|NOT COMPLETED|Treatment Phase Period 2||0
2201319|NCT03286218|5398954|P2|NOT COMPLETED|Treatment Phase Period 2||0
2201320|NCT03286218|5398955|P1|NOT COMPLETED|Treatment Phase Period 2||0
2201321|NCT03286218|5398944|P12|COMPLETED|Treatment Phase Period 2||5
2201322|NCT03286218|5398945|P11|COMPLETED|Treatment Phase Period 2||5
2201323|NCT03286218|5398946|P10|COMPLETED|Treatment Phase Period 2||6
2201324|NCT03286218|5398947|P9|COMPLETED|Treatment Phase Period 2||6
2201325|NCT03286218|5398948|P8|COMPLETED|Treatment Phase Period 2||6
2201326|NCT03286218|5398949|P7|COMPLETED|Treatment Phase Period 2||6
2201327|NCT03286218|5398950|P6|COMPLETED|Treatment Phase Period 2||5
2201328|NCT03286218|5398951|P5|COMPLETED|Treatment Phase Period 2||5
2201329|NCT03286218|5398952|P4|COMPLETED|Treatment Phase Period 2||5
2201330|NCT03286218|5398953|P3|COMPLETED|Treatment Phase Period 2||5
2201331|NCT03286218|5398954|P2|COMPLETED|Treatment Phase Period 2||0
2201332|NCT03286218|5398955|P1|COMPLETED|Treatment Phase Period 2||0
2201333|NCT03286218|5398944|P12|STARTED|Treatment Phase Period 2||5
2201334|NCT03286218|5398945|P11|STARTED|Treatment Phase Period 2||5
2201335|NCT03286218|5398946|P10|STARTED|Treatment Phase Period 2||6
2201336|NCT03286218|5398947|P9|STARTED|Treatment Phase Period 2||6
2201337|NCT03286218|5398948|P8|STARTED|Treatment Phase Period 2||6
2201338|NCT03286218|5398949|P7|STARTED|Treatment Phase Period 2||6
2201339|NCT03286218|5398950|P6|STARTED|Treatment Phase Period 2||5
2201340|NCT03286218|5398951|P5|STARTED|Treatment Phase Period 2||5
2201341|NCT03286218|5398952|P4|STARTED|Treatment Phase Period 2||5
2201342|NCT03286218|5398953|P3|STARTED|Treatment Phase Period 2||5
2201343|NCT03286218|5398954|P2|STARTED|Treatment Phase Period 2||0
2201344|NCT03286218|5398955|P1|STARTED|Treatment Phase Period 2||0
2201345|NCT03286218|5398944|P12|NOT COMPLETED|Treatment Phase Period 1||1
2201346|NCT03286218|5398945|P11|NOT COMPLETED|Treatment Phase Period 1||0
2201347|NCT03286218|5398946|P10|NOT COMPLETED|Treatment Phase Period 1||0
2201348|NCT03286218|5398947|P9|NOT COMPLETED|Treatment Phase Period 1||0
2201349|NCT03286218|5398948|P8|NOT COMPLETED|Treatment Phase Period 1||0
2201350|NCT03286218|5398949|P7|NOT COMPLETED|Treatment Phase Period 1||0
2201351|NCT03286218|5398950|P6|NOT COMPLETED|Treatment Phase Period 1||1
2201352|NCT03286218|5398951|P5|NOT COMPLETED|Treatment Phase Period 1||0
2201353|NCT03286218|5398952|P4|NOT COMPLETED|Treatment Phase Period 1||1
2201354|NCT03286218|5398953|P3|NOT COMPLETED|Treatment Phase Period 1||1
2201355|NCT03286218|5398954|P2|NOT COMPLETED|Treatment Phase Period 1||0
2201356|NCT03286218|5398955|P1|NOT COMPLETED|Treatment Phase Period 1||0
2201357|NCT03286218|5398944|P12|COMPLETED|Treatment Phase Period 1||5
2201358|NCT03286218|5398945|P11|COMPLETED|Treatment Phase Period 1||5
2201359|NCT03286218|5398946|P10|COMPLETED|Treatment Phase Period 1||6
2201360|NCT03286218|5398947|P9|COMPLETED|Treatment Phase Period 1||6
2201361|NCT03286218|5398948|P8|COMPLETED|Treatment Phase Period 1||6
2201362|NCT03286218|5398949|P7|COMPLETED|Treatment Phase Period 1||6
2201363|NCT03286218|5398950|P6|COMPLETED|Treatment Phase Period 1||5
2201364|NCT03286218|5398951|P5|COMPLETED|Treatment Phase Period 1||5
2201365|NCT03286218|5398952|P4|COMPLETED|Treatment Phase Period 1||5
2201366|NCT03286218|5398953|P3|COMPLETED|Treatment Phase Period 1||5
2201367|NCT03286218|5398954|P2|COMPLETED|Treatment Phase Period 1||0
2201368|NCT03286218|5398955|P1|COMPLETED|Treatment Phase Period 1||0
2201369|NCT03286218|5398944|P12|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
2201370|NCT03286218|5398945|P11|Received at Least One Dose of Study Drug|Treatment Phase Period 1||5
2201371|NCT03286218|5398946|P10|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
2201372|NCT03286218|5398947|P9|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
2201373|NCT03286218|5398948|P8|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
2201374|NCT03286218|5398949|P7|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
2201375|NCT03286218|5398950|P6|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
2201376|NCT03286218|5398951|P5|Received at Least One Dose of Study Drug|Treatment Phase Period 1||5
2201377|NCT03286218|5398952|P4|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
2201378|NCT03286218|5398953|P3|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
2201379|NCT03286218|5398954|P2|Received at Least One Dose of Study Drug|Treatment Phase Period 1||0
2201380|NCT03286218|5398955|P1|Received at Least One Dose of Study Drug|Treatment Phase Period 1||0
2201381|NCT03286218|5398944|P12|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
2201382|NCT03286218|5398945|P11|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|5
2201383|NCT03286218|5398946|P10|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
2201384|NCT03286218|5398947|P9|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
2201385|NCT03286218|5398948|P8|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
2201386|NCT03286218|5398949|P7|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
2201387|NCT03286218|5398950|P6|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
2201388|NCT03286218|5398951|P5|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|5
2201389|NCT03286218|5398952|P4|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
2201390|NCT03286218|5398953|P3|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
2201391|NCT03286218|5398954|P2|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase prior to entering the Treatment Phase.|0
2201392|NCT03286218|5398955|P1|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase prior to entering the Treatment Phase.|0
2201393|NCT03286218|5398944|P12|NOT COMPLETED|Qualification Phase Period 2||0
2201394|NCT03286218|5398945|P11|NOT COMPLETED|Qualification Phase Period 2||0
2201395|NCT03286218|5398946|P10|NOT COMPLETED|Qualification Phase Period 2||0
2201396|NCT03286218|5398947|P9|NOT COMPLETED|Qualification Phase Period 2||0
2201397|NCT03286218|5398948|P8|NOT COMPLETED|Qualification Phase Period 2||0
2201398|NCT03286218|5398949|P7|NOT COMPLETED|Qualification Phase Period 2||0
2201399|NCT03286218|5398950|P6|NOT COMPLETED|Qualification Phase Period 2||0
2201400|NCT03286218|5398951|P5|NOT COMPLETED|Qualification Phase Period 2||0
2201401|NCT03286218|5398952|P4|NOT COMPLETED|Qualification Phase Period 2||0
2201402|NCT03286218|5398953|P3|NOT COMPLETED|Qualification Phase Period 2||0
2201403|NCT03286218|5398954|P2|NOT COMPLETED|Qualification Phase Period 2||19
2201404|NCT03286218|5398955|P1|NOT COMPLETED|Qualification Phase Period 2||17
2201405|NCT03286218|5398944|P12|COMPLETED|Qualification Phase Period 2||0
2201406|NCT03286218|5398945|P11|COMPLETED|Qualification Phase Period 2||0
2201407|NCT03286218|5398946|P10|COMPLETED|Qualification Phase Period 2||0
2201408|NCT03286218|5398947|P9|COMPLETED|Qualification Phase Period 2||0
2201409|NCT03286218|5398948|P8|COMPLETED|Qualification Phase Period 2||0
2201410|NCT03286218|5398949|P7|COMPLETED|Qualification Phase Period 2||0
2201411|NCT03286218|5398950|P6|COMPLETED|Qualification Phase Period 2||0
2201412|NCT03286218|5398951|P5|COMPLETED|Qualification Phase Period 2||0
2201413|NCT03286218|5398952|P4|COMPLETED|Qualification Phase Period 2||0
2201414|NCT03286218|5398953|P3|COMPLETED|Qualification Phase Period 2||0
2201415|NCT03286218|5398954|P2|COMPLETED|Qualification Phase Period 2||28
2201416|NCT03286218|5398955|P1|COMPLETED|Qualification Phase Period 2||30
2201417|NCT03286218|5398944|P12|STARTED|Qualification Phase Period 2||0
2201418|NCT03286218|5398945|P11|STARTED|Qualification Phase Period 2||0
2201419|NCT03286218|5398946|P10|STARTED|Qualification Phase Period 2||0
2201420|NCT03286218|5398947|P9|STARTED|Qualification Phase Period 2||0
2201421|NCT03286218|5398948|P8|STARTED|Qualification Phase Period 2||0
2201422|NCT03286218|5398949|P7|STARTED|Qualification Phase Period 2||0
2201423|NCT03286218|5398950|P6|STARTED|Qualification Phase Period 2||0
2201424|NCT03286218|5398951|P5|STARTED|Qualification Phase Period 2||0
2201425|NCT03286218|5398952|P4|STARTED|Qualification Phase Period 2||0
2201426|NCT03286218|5398953|P3|STARTED|Qualification Phase Period 2||0
2201427|NCT03286218|5398954|P2|STARTED|Qualification Phase Period 2||47
2201428|NCT03286218|5398955|P1|STARTED|Qualification Phase Period 2||47
2201429|NCT03286218|5398944|P12|NOT COMPLETED|Qualification Phase Period 1||0
2201430|NCT03286218|5398945|P11|NOT COMPLETED|Qualification Phase Period 1||0
2201431|NCT03286218|5398946|P10|NOT COMPLETED|Qualification Phase Period 1||0
2201432|NCT03286218|5398947|P9|NOT COMPLETED|Qualification Phase Period 1||0
2201433|NCT03286218|5398948|P8|NOT COMPLETED|Qualification Phase Period 1||0
2201434|NCT03286218|5398949|P7|NOT COMPLETED|Qualification Phase Period 1||0
2201435|NCT03286218|5398950|P6|NOT COMPLETED|Qualification Phase Period 1||0
2201436|NCT03286218|5398951|P5|NOT COMPLETED|Qualification Phase Period 1||0
2201437|NCT03286218|5398952|P4|NOT COMPLETED|Qualification Phase Period 1||0
2201438|NCT03286218|5398953|P3|NOT COMPLETED|Qualification Phase Period 1||0
2201439|NCT03286218|5398954|P2|NOT COMPLETED|Qualification Phase Period 1||1
2201440|NCT03286218|5398955|P1|NOT COMPLETED|Qualification Phase Period 1||1
2201441|NCT03286218|5398944|P12|COMPLETED|Qualification Phase Period 1||0
2201442|NCT03286218|5398945|P11|COMPLETED|Qualification Phase Period 1||0
2201443|NCT03286218|5398946|P10|COMPLETED|Qualification Phase Period 1||0
2201444|NCT03286218|5398947|P9|COMPLETED|Qualification Phase Period 1||0
2201445|NCT03286218|5398948|P8|COMPLETED|Qualification Phase Period 1||0
2201446|NCT03286218|5398949|P7|COMPLETED|Qualification Phase Period 1||0
2201447|NCT03286218|5398950|P6|COMPLETED|Qualification Phase Period 1||0
2201448|NCT03286218|5398951|P5|COMPLETED|Qualification Phase Period 1||0
2201449|NCT03286218|5398952|P4|COMPLETED|Qualification Phase Period 1||0
2201450|NCT03286218|5398953|P3|COMPLETED|Qualification Phase Period 1||0
2201451|NCT03286218|5398954|P2|COMPLETED|Qualification Phase Period 1||47
2201452|NCT03286218|5398955|P1|COMPLETED|Qualification Phase Period 1||47
2201453|NCT03286218|5398944|P12|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
2201454|NCT03286218|5398945|P11|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
2201455|NCT03286218|5398946|P10|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
2201456|NCT03286218|5398947|P9|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
2201457|NCT03286218|5398948|P8|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
2201458|NCT03286218|5398949|P7|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
2201459|NCT03286218|5398950|P6|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
2201460|NCT03286218|5398951|P5|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
2201461|NCT03286218|5398952|P4|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
2201462|NCT03286218|5398953|P3|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
2201463|NCT03286218|5398954|P2|Received at Least One Dose of Study Drug|Qualification Phase Period 1||47
2201464|NCT03286218|5398955|P1|Received at Least One Dose of Study Drug|Qualification Phase Period 1||47
2201465|NCT03286218|5398944|P12|STARTED|Qualification Phase Period 1||0
2201466|NCT03286218|5398945|P11|STARTED|Qualification Phase Period 1||0
2201467|NCT03286218|5398946|P10|STARTED|Qualification Phase Period 1||0
2201468|NCT03286218|5398947|P9|STARTED|Qualification Phase Period 1||0
2201469|NCT03286218|5398948|P8|STARTED|Qualification Phase Period 1||0
2201470|NCT03286218|5398949|P7|STARTED|Qualification Phase Period 1||0
2201471|NCT03286218|5398950|P6|STARTED|Qualification Phase Period 1||0
2201472|NCT03286218|5398951|P5|STARTED|Qualification Phase Period 1||0
2201473|NCT03286218|5398952|P4|STARTED|Qualification Phase Period 1||0
2201474|NCT03286218|5398953|P3|STARTED|Qualification Phase Period 1||0
2201475|NCT03286218|5398954|P2|STARTED|Qualification Phase Period 1||48
2201476|NCT03286218|5398955|P1|STARTED|Qualification Phase Period 1||48
2201477|NCT03285984|5398997|P1|NOT COMPLETED|Overall Study||0
2201478|NCT03285984|5398997|P1|COMPLETED|Overall Study||56
2201479|NCT03285984|5398997|P1|Received Test Product 4|Overall Study||56
2201480|NCT03285984|5398997|P1|Received Test Product 3|Overall Study||56
2201481|NCT03285984|5398997|P1|Received Test Product 2|Overall Study||56
2201482|NCT03285984|5398997|P1|Received Test Product 1|Overall Study||56
2201483|NCT03285984|5398997|P1|STARTED|Overall Study||56
2201484|NCT03285724|5399009|P1|NOT COMPLETED|Overall Study||0
2201485|NCT03285724|5399009|P1|COMPLETED|Overall Study||1
2201486|NCT03285724|5399009|P1|STARTED|Overall Study||1
2201499|NCT03285295|5399069|P5|NOT COMPLETED|Alinity s Chagas Follow-Up||0
2201500|NCT03285295|5399070|P4|NOT COMPLETED|Alinity s Chagas Follow-Up||0
2201501|NCT03285295|5399071|P3|NOT COMPLETED|Alinity s Chagas Follow-Up||0
2201502|NCT03285295|5399072|P2|NOT COMPLETED|Alinity s Chagas Follow-Up||0
2201503|NCT03285295|5399073|P1|NOT COMPLETED|Alinity s Chagas Follow-Up||13
2201504|NCT03285295|5399069|P5|COMPLETED|Alinity s Chagas Follow-Up||0
2201505|NCT03285295|5399070|P4|COMPLETED|Alinity s Chagas Follow-Up||0
2201506|NCT03285295|5399071|P3|COMPLETED|Alinity s Chagas Follow-Up||0
2201507|NCT03285295|5399072|P2|COMPLETED|Alinity s Chagas Follow-Up||0
2201508|NCT03285295|5399073|P1|COMPLETED|Alinity s Chagas Follow-Up||1
2201509|NCT03285295|5399069|P5|STARTED|Alinity s Chagas Follow-Up||0
2201510|NCT03285295|5399070|P4|STARTED|Alinity s Chagas Follow-Up||0
2201511|NCT03285295|5399071|P3|STARTED|Alinity s Chagas Follow-Up||0
2201512|NCT03285295|5399072|P2|STARTED|Alinity s Chagas Follow-Up||0
2201513|NCT03285295|5399073|P1|STARTED|Alinity s Chagas Follow-Up||14
2201514|NCT03285295|5399069|P5|NOT COMPLETED|Alinity s Chagas||0
2201515|NCT03285295|5399070|P4|NOT COMPLETED|Alinity s Chagas||0
2201516|NCT03285295|5399071|P3|NOT COMPLETED|Alinity s Chagas||0
2201517|NCT03285295|5399072|P2|NOT COMPLETED|Alinity s Chagas||0
2201518|NCT03285295|5399073|P1|NOT COMPLETED|Alinity s Chagas||219
2201519|NCT03285295|5399069|P5|COMPLETED|Alinity s Chagas||0
2201520|NCT03285295|5399070|P4|COMPLETED|Alinity s Chagas||615
2201521|NCT03285295|5399071|P3|COMPLETED|Alinity s Chagas||0
2201522|NCT03285295|5399072|P2|COMPLETED|Alinity s Chagas||320
2201523|NCT03285295|5399073|P1|COMPLETED|Alinity s Chagas||15804
2201524|NCT03285295|5399069|P5|STARTED|Alinity s Chagas||0
2201525|NCT03285295|5399070|P4|STARTED|Alinity s Chagas||615
2201526|NCT03285295|5399071|P3|STARTED|Alinity s Chagas||0
2201527|NCT03285295|5399072|P2|STARTED|Alinity s Chagas||320
2201528|NCT03285295|5399073|P1|STARTED|Alinity s Chagas||16023
2201529|NCT03285295|5399069|P5|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
2201530|NCT03285295|5399070|P4|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
2201531|NCT03285295|5399071|P3|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
2201532|NCT03285295|5399072|P2|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
2201533|NCT03285295|5399073|P1|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||14
2201534|NCT03285295|5399069|P5|COMPLETED|Alinity s Anti-HBc Follow-Up||0
2201535|NCT03285295|5399070|P4|COMPLETED|Alinity s Anti-HBc Follow-Up||0
2201536|NCT03285295|5399071|P3|COMPLETED|Alinity s Anti-HBc Follow-Up||0
2201537|NCT03285295|5399072|P2|COMPLETED|Alinity s Anti-HBc Follow-Up||0
2201538|NCT03285295|5399073|P1|COMPLETED|Alinity s Anti-HBc Follow-Up||2
2201539|NCT03285295|5399069|P5|STARTED|Alinity s Anti-HBc Follow-Up||0
2201540|NCT03285295|5399070|P4|STARTED|Alinity s Anti-HBc Follow-Up||0
2201541|NCT03285295|5399071|P3|STARTED|Alinity s Anti-HBc Follow-Up||0
2201542|NCT03285295|5399072|P2|STARTED|Alinity s Anti-HBc Follow-Up||0
2201543|NCT03285295|5399073|P1|STARTED|Alinity s Anti-HBc Follow-Up||16
2201544|NCT03285295|5399069|P5|NOT COMPLETED|Alinity s Anti-HBc||0
2201545|NCT03285295|5399070|P4|NOT COMPLETED|Alinity s Anti-HBc||0
2201546|NCT03285295|5399071|P3|NOT COMPLETED|Alinity s Anti-HBc||0
2201547|NCT03285295|5399072|P2|NOT COMPLETED|Alinity s Anti-HBc||1
2201548|NCT03285295|5399073|P1|NOT COMPLETED|Alinity s Anti-HBc||91
2201549|NCT03285295|5399069|P5|COMPLETED|Alinity s Anti-HBc||0
2201550|NCT03285295|5399070|P4|COMPLETED|Alinity s Anti-HBc||0
2201551|NCT03285295|5399071|P3|COMPLETED|Alinity s Anti-HBc||403
2201552|NCT03285295|5399072|P2|COMPLETED|Alinity s Anti-HBc||404
2201553|NCT03285295|5399073|P1|COMPLETED|Alinity s Anti-HBc||15877
2201554|NCT03285295|5399069|P5|STARTED|Alinity s Anti-HBc||0
2201555|NCT03285295|5399070|P4|STARTED|Alinity s Anti-HBc||0
2201556|NCT03285295|5399071|P3|STARTED|Alinity s Anti-HBc||403
2201557|NCT03285295|5399072|P2|STARTED|Alinity s Anti-HBc||405
2201558|NCT03285295|5399073|P1|STARTED|Alinity s Anti-HBc||15968
2201559|NCT03285295|5399069|P5|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
2201560|NCT03285295|5399070|P4|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
2201561|NCT03285295|5399071|P3|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
2201562|NCT03285295|5399072|P2|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
2201563|NCT03285295|5399073|P1|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||11
2201564|NCT03285295|5399069|P5|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
2201565|NCT03285295|5399070|P4|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
2201566|NCT03285295|5399071|P3|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
2201567|NCT03285295|5399072|P2|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
2201568|NCT03285295|5399073|P1|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||4
2201569|NCT03285295|5399069|P5|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
2201570|NCT03285295|5399070|P4|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
2201571|NCT03285295|5399071|P3|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
2201572|NCT03285295|5399072|P2|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
2201573|NCT03285295|5399073|P1|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||15
2201574|NCT03285295|5399069|P5|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
2201575|NCT03285295|5399070|P4|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
2201576|NCT03285295|5399071|P3|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
2201577|NCT03285295|5399072|P2|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
2201578|NCT03285295|5399073|P1|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||99
2201579|NCT03285295|5399069|P5|COMPLETED|Alinity s HIV Ag/Ab Combo||0
2201580|NCT03285295|5399070|P4|COMPLETED|Alinity s HIV Ag/Ab Combo|Individuals at Increased Risk of HIV Infection from HIV-2 Endemic Areas|535
2201581|NCT03285295|5399071|P3|COMPLETED|Alinity s HIV Ag/Ab Combo||605
2201582|NCT03285295|5399072|P2|COMPLETED|Alinity s HIV Ag/Ab Combo||1336
2201583|NCT03285295|5399073|P1|COMPLETED|Alinity s HIV Ag/Ab Combo||16996
2201584|NCT03285295|5399069|P5|STARTED|Alinity s HIV Ag/Ab Combo||0
2201585|NCT03285295|5399070|P4|STARTED|Alinity s HIV Ag/Ab Combo|Individuals at Increased Risk of HIV Infection from HIV-2 Endemic Areas|535
2201586|NCT03285295|5399071|P3|STARTED|Alinity s HIV Ag/Ab Combo||605
2201587|NCT03285295|5399072|P2|STARTED|Alinity s HIV Ag/Ab Combo||1336
2201588|NCT03285295|5399073|P1|STARTED|Alinity s HIV Ag/Ab Combo||17095
2201589|NCT03285295|5399069|P5|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
2201590|NCT03285295|5399070|P4|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
2201591|NCT03285295|5399071|P3|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
2201592|NCT03285295|5399072|P2|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
2201593|NCT03285295|5399073|P1|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||18
2201594|NCT03285295|5399069|P5|COMPLETED|Alinity s Anti-HCV Follow-Up||0
2201595|NCT03285295|5399070|P4|COMPLETED|Alinity s Anti-HCV Follow-Up||0
2201596|NCT03285295|5399071|P3|COMPLETED|Alinity s Anti-HCV Follow-Up||0
2201597|NCT03285295|5399072|P2|COMPLETED|Alinity s Anti-HCV Follow-Up||0
2201598|NCT03285295|5399073|P1|COMPLETED|Alinity s Anti-HCV Follow-Up||2
2201599|NCT03285295|5399069|P5|STARTED|Alinity s Anti-HCV Follow-Up||0
2201600|NCT03285295|5399070|P4|STARTED|Alinity s Anti-HCV Follow-Up||0
2201601|NCT03285295|5399071|P3|STARTED|Alinity s Anti-HCV Follow-Up||0
2201602|NCT03285295|5399072|P2|STARTED|Alinity s Anti-HCV Follow-Up||0
2201603|NCT03285295|5399073|P1|STARTED|Alinity s Anti-HCV Follow-Up||20
2201604|NCT03285295|5399069|P5|NOT COMPLETED|Alinity s Anti-HCV||0
2201605|NCT03285295|5399070|P4|NOT COMPLETED|Alinity s Anti-HCV||0
2201606|NCT03285295|5399071|P3|NOT COMPLETED|Alinity s Anti-HCV||0
2201607|NCT03285295|5399072|P2|NOT COMPLETED|Alinity s Anti-HCV||0
2201608|NCT03285295|5399073|P1|NOT COMPLETED|Alinity s Anti-HCV||96
2201609|NCT03285295|5399069|P5|COMPLETED|Alinity s Anti-HCV||0
2201610|NCT03285295|5399070|P4|COMPLETED|Alinity s Anti-HCV||0
2201611|NCT03285295|5399071|P3|COMPLETED|Alinity s Anti-HCV||407
2201612|NCT03285295|5399072|P2|COMPLETED|Alinity s Anti-HCV||402
2201613|NCT03285295|5399073|P1|COMPLETED|Alinity s Anti-HCV||16999
2201614|NCT03285295|5399069|P5|STARTED|Alinity s Anti-HCV||0
2201615|NCT03285295|5399070|P4|STARTED|Alinity s Anti-HCV||0
2201616|NCT03285295|5399071|P3|STARTED|Alinity s Anti-HCV||407
2201617|NCT03285295|5399072|P2|STARTED|Alinity s Anti-HCV||402
2201618|NCT03285295|5399073|P1|STARTED|Alinity s Anti-HCV||17095
2201619|NCT03285295|5399069|P5|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
2201620|NCT03285295|5399070|P4|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
2201621|NCT03285295|5399071|P3|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
2201622|NCT03285295|5399072|P2|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
2201623|NCT03285295|5399073|P1|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||4
2201624|NCT03285295|5399069|P5|COMPLETED|Alinity s HTLV I/II Follow-Up||0
2201625|NCT03285295|5399070|P4|COMPLETED|Alinity s HTLV I/II Follow-Up||0
2201626|NCT03285295|5399071|P3|COMPLETED|Alinity s HTLV I/II Follow-Up||0
2201627|NCT03285295|5399072|P2|COMPLETED|Alinity s HTLV I/II Follow-Up||0
2201628|NCT03285295|5399073|P1|COMPLETED|Alinity s HTLV I/II Follow-Up||8
2201629|NCT03285295|5399069|P5|STARTED|Alinity s HTLV I/II Follow-Up||0
2201630|NCT03285295|5399070|P4|STARTED|Alinity s HTLV I/II Follow-Up||0
2201631|NCT03285295|5399071|P3|STARTED|Alinity s HTLV I/II Follow-Up||0
2201632|NCT03285295|5399072|P2|STARTED|Alinity s HTLV I/II Follow-Up||0
2201633|NCT03285295|5399073|P1|STARTED|Alinity s HTLV I/II Follow-Up||12
2201634|NCT03285295|5399069|P5|NOT COMPLETED|Alinity s HTLV I/II||0
2201635|NCT03285295|5399070|P4|NOT COMPLETED|Alinity s HTLV I/II||0
2201636|NCT03285295|5399071|P3|NOT COMPLETED|Alinity s HTLV I/II||0
2201637|NCT03285295|5399072|P2|NOT COMPLETED|Alinity s HTLV I/II||0
2201638|NCT03285295|5399073|P1|NOT COMPLETED|Alinity s HTLV I/II||91
2201639|NCT03285295|5399069|P5|COMPLETED|Alinity s HTLV I/II||0
2201640|NCT03285295|5399070|P4|COMPLETED|Alinity s HTLV I/II||509
2201641|NCT03285295|5399071|P3|COMPLETED|Alinity s HTLV I/II||502
2201642|NCT03285295|5399072|P2|COMPLETED|Alinity s HTLV I/II||706
2201643|NCT03285295|5399073|P1|COMPLETED|Alinity s HTLV I/II||15877
2201644|NCT03285295|5399069|P5|STARTED|Alinity s HTLV I/II||0
2201645|NCT03285295|5399070|P4|STARTED|Alinity s HTLV I/II||509
2201646|NCT03285295|5399071|P3|STARTED|Alinity s HTLV I/II||502
2201647|NCT03285295|5399072|P2|STARTED|Alinity s HTLV I/II||706
2201648|NCT03285295|5399073|P1|STARTED|Alinity s HTLV I/II||15968
2201649|NCT03285295|5399069|P5|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
2201650|NCT03285295|5399070|P4|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
2201651|NCT03285295|5399071|P3|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
2201652|NCT03285295|5399072|P2|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
2201653|NCT03285295|5399073|P1|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
2201654|NCT03285295|5399069|P5|COMPLETED|Alinity s HBsAg Follow-Up||0
2201655|NCT03285295|5399070|P4|COMPLETED|Alinity s HBsAg Follow-Up||0
2201656|NCT03285295|5399071|P3|COMPLETED|Alinity s HBsAg Follow-Up||0
2201657|NCT03285295|5399072|P2|COMPLETED|Alinity s HBsAg Follow-Up||0
2201658|NCT03285295|5399073|P1|COMPLETED|Alinity s HBsAg Follow-Up||0
2201659|NCT03285295|5399069|P5|STARTED|Alinity s HBsAg Follow-Up||0
2201660|NCT03285295|5399070|P4|STARTED|Alinity s HBsAg Follow-Up||0
2201661|NCT03285295|5399071|P3|STARTED|Alinity s HBsAg Follow-Up||0
2201662|NCT03285295|5399072|P2|STARTED|Alinity s HBsAg Follow-Up||0
2201663|NCT03285295|5399073|P1|STARTED|Alinity s HBsAg Follow-Up||0
2201664|NCT03285295|5399069|P5|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
2201665|NCT03285295|5399070|P4|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
2201666|NCT03285295|5399071|P3|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
2201667|NCT03285295|5399072|P2|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
2201668|NCT03285295|5399073|P1|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
2201669|NCT03285295|5399069|P5|COMPLETED|Alinity s HBsAg Confirmatory||0
2201670|NCT03285295|5399070|P4|COMPLETED|Alinity s HBsAg Confirmatory||0
2201671|NCT03285295|5399071|P3|COMPLETED|Alinity s HBsAg Confirmatory||3
2201672|NCT03285295|5399072|P2|COMPLETED|Alinity s HBsAg Confirmatory||432
2201673|NCT03285295|5399073|P1|COMPLETED|Alinity s HBsAg Confirmatory||8
2201674|NCT03285295|5399069|P5|STARTED|Alinity s HBsAg Confirmatory||0
2201675|NCT03285295|5399070|P4|STARTED|Alinity s HBsAg Confirmatory||0
2201676|NCT03285295|5399071|P3|STARTED|Alinity s HBsAg Confirmatory||3
2201677|NCT03285295|5399072|P2|STARTED|Alinity s HBsAg Confirmatory||432
2201678|NCT03285295|5399073|P1|STARTED|Alinity s HBsAg Confirmatory||8
2201679|NCT03285295|5399069|P5|NOT COMPLETED|Alinity s HBsAg||0
2201680|NCT03285295|5399070|P4|NOT COMPLETED|Alinity s HBsAg||0
2201681|NCT03285295|5399071|P3|NOT COMPLETED|Alinity s HBsAg||0
2201682|NCT03285295|5399072|P2|NOT COMPLETED|Alinity s HBsAg||6
2201683|NCT03285295|5399073|P1|NOT COMPLETED|Alinity s HBsAg||102
2201684|NCT03285295|5399069|P5|COMPLETED|Alinity s HBsAg||51
2201685|NCT03285295|5399070|P4|COMPLETED|Alinity s HBsAg||0
2201686|NCT03285295|5399071|P3|COMPLETED|Alinity s HBsAg||403
2201687|NCT03285295|5399072|P2|COMPLETED|Alinity s HBsAg||432
2201688|NCT03285295|5399073|P1|COMPLETED|Alinity s HBsAg||16993
2201689|NCT03285295|5399069|P5|STARTED|Alinity s HBsAg||51
2201690|NCT03285295|5399070|P4|STARTED|Alinity s HBsAg||0
2201691|NCT03285295|5399071|P3|STARTED|Alinity s HBsAg||403
2201692|NCT03285295|5399072|P2|STARTED|Alinity s HBsAg||438
2201693|NCT03285295|5399073|P1|STARTED|Alinity s HBsAg||17095
2201694|NCT03283319|5399108|P6|NOT COMPLETED|Overall Study||4
2201695|NCT03283319|5399109|P5|NOT COMPLETED|Overall Study||4
2201696|NCT03283319|5399110|P4|NOT COMPLETED|Overall Study||7
2201697|NCT03283319|5399111|P3|NOT COMPLETED|Overall Study||7
2201698|NCT03283319|5399112|P2|NOT COMPLETED|Overall Study||6
2201699|NCT03283319|5399113|P1|NOT COMPLETED|Overall Study||7
2201700|NCT03283319|5399108|P6|COMPLETED|Overall Study||57
2201701|NCT03283319|5399109|P5|COMPLETED|Overall Study||56
2201702|NCT03283319|5399110|P4|COMPLETED|Overall Study||54
2201703|NCT03283319|5399111|P3|COMPLETED|Overall Study||55
2201704|NCT03283319|5399112|P2|COMPLETED|Overall Study||54
2201705|NCT03283319|5399113|P1|COMPLETED|Overall Study||55
2201706|NCT03283319|5399108|P6|STARTED|Overall Study||61
2201707|NCT03283319|5399109|P5|STARTED|Overall Study||60
2201708|NCT03283319|5399110|P4|STARTED|Overall Study||61
2201709|NCT03283319|5399111|P3|STARTED|Overall Study||62
2201710|NCT03283319|5399112|P2|STARTED|Overall Study||60
2201711|NCT03283319|5399113|P1|STARTED|Overall Study||62
2201712|NCT03283098|5399255|P2|NOT COMPLETED|Overall Study||1
2201713|NCT03283098|5399256|P1|NOT COMPLETED|Overall Study||0
2201714|NCT03283098|5399255|P2|COMPLETED|Overall Study||24
2201715|NCT03283098|5399256|P1|COMPLETED|Overall Study||8
2201716|NCT03283098|5399255|P2|STARTED|Overall Study||25
2201717|NCT03283098|5399256|P1|STARTED|Overall Study||8
2201724|NCT03282240|5399312|P3|NOT COMPLETED|Overall Study||3
2201725|NCT03282240|5399313|P2|NOT COMPLETED|Overall Study||3
2201726|NCT03282240|5399314|P1|NOT COMPLETED|Overall Study||10
2201727|NCT03282240|5399312|P3|COMPLETED|Overall Study||447
2201728|NCT03282240|5399313|P2|COMPLETED|Overall Study||440
2201729|NCT03282240|5399314|P1|COMPLETED|Overall Study||1767
2201730|NCT03282240|5399312|P3|STARTED|Overall Study||450
2201731|NCT03282240|5399313|P2|STARTED|Overall Study||443
2201732|NCT03282240|5399314|P1|STARTED|Overall Study||1777
2201733|NCT03281668|5399366|P1|NOT COMPLETED|Overall Study||8
2201734|NCT03281668|5399366|P1|COMPLETED|Overall Study||21
2201735|NCT03281668|5399366|P1|STARTED|Overall Study||29
2201736|NCT03281200|5399390|P1|NOT COMPLETED|Overall Study||0
2201737|NCT03281200|5399390|P1|COMPLETED|Overall Study||172
2201738|NCT03281200|5399390|P1|STARTED|Overall Study||172
2201739|NCT03280615|5399414|P2|NOT COMPLETED|Overall Study||5
2201740|NCT03280615|5399415|P1|NOT COMPLETED|Overall Study||4
2201741|NCT03280615|5399414|P2|COMPLETED|Overall Study||45
2201742|NCT03280615|5399415|P1|COMPLETED|Overall Study||46
2201743|NCT03280615|5399414|P2|STARTED|Overall Study||50
2201744|NCT03280615|5399415|P1|STARTED|Overall Study||50
2201745|NCT03280381|5399427|P2|NOT COMPLETED|Overall Study||2
2201746|NCT03280381|5399428|P1|NOT COMPLETED|Overall Study||0
2201747|NCT03280381|5399427|P2|COMPLETED|Overall Study||97
2201748|NCT03280381|5399428|P1|COMPLETED|Overall Study||101
2201749|NCT03280381|5399427|P2|STARTED|Overall Study||99
2201750|NCT03280381|5399428|P1|STARTED|Overall Study||101
2201751|NCT03280108|5399438|P2|NOT COMPLETED|Overall Study||0
2201752|NCT03280108|5399439|P1|NOT COMPLETED|Overall Study||2
2201753|NCT03280108|5399438|P2|COMPLETED|Overall Study||114
2201754|NCT03280108|5399439|P1|COMPLETED|Overall Study||127
2201755|NCT03280108|5399438|P2|STARTED|Overall Study||114
2201756|NCT03280108|5399439|P1|STARTED|Overall Study||129
2201757|NCT03279458|5399470|P1|NOT COMPLETED|Overall Study||0
2201758|NCT03279458|5399470|P1|COMPLETED|Overall Study||40
2201759|NCT03279458|5399470|P1|STARTED|Overall Study||40
2201760|NCT03278106|5399476|P1|NOT COMPLETED|Overall Study||1
2201761|NCT03278106|5399476|P1|COMPLETED|Overall Study||27
2201762|NCT03278106|5399476|P1|STARTED|Overall Study||28
2201763|NCT03278067|5399487|P3|NOT COMPLETED|Overall Study||0
2201764|NCT03278067|5399488|P2|NOT COMPLETED|Overall Study||0
2201765|NCT03278067|5399489|P1|NOT COMPLETED|Overall Study||0
2201766|NCT03278067|5399487|P3|COMPLETED|Overall Study||4196
2201767|NCT03278067|5399488|P2|COMPLETED|Overall Study||3310
2201768|NCT03278067|5399489|P1|COMPLETED|Overall Study||16433
2201769|NCT03278067|5399487|P3|STARTED|Overall Study||4196
2201770|NCT03278067|5399488|P2|STARTED|Overall Study||3310
2201771|NCT03278067|5399489|P1|STARTED|Overall Study||16433
2201772|NCT03278028|5399892|P2|NOT COMPLETED|Overall Study||2
2201773|NCT03278028|5399893|P1|NOT COMPLETED|Overall Study||4
2201774|NCT03278028|5399892|P2|COMPLETED|Overall Study||76
2201775|NCT03278028|5399893|P1|COMPLETED|Overall Study||77
2201776|NCT03278028|5399892|P2|STARTED|Overall Study||78
2201777|NCT03278028|5399893|P1|STARTED|Overall Study||81
2201778|NCT03277846|5399901|P2|NOT COMPLETED|Overall Study||11
2201779|NCT03277846|5399902|P1|NOT COMPLETED|Overall Study||12
2201780|NCT03277846|5399901|P2|COMPLETED|Overall Study||40
2201781|NCT03277846|5399902|P1|COMPLETED|Overall Study||38
2201782|NCT03277846|5399901|P2|STARTED|Overall Study||51
2201783|NCT03277846|5399902|P1|STARTED|Overall Study||50
2201784|NCT03277274|5399911|P3|NOT COMPLETED|Overall Study||0
2201785|NCT03277274|5399912|P2|NOT COMPLETED|Overall Study||0
2201786|NCT03277274|5399913|P1|NOT COMPLETED|Overall Study||0
2201787|NCT03277274|5399911|P3|COMPLETED|Overall Study||7
2201788|NCT03277274|5399912|P2|COMPLETED|Overall Study||10
2201789|NCT03277274|5399913|P1|COMPLETED|Overall Study||8
2201790|NCT03277274|5399911|P3|STARTED|Overall Study||7
2201791|NCT03277274|5399912|P2|STARTED|Overall Study||10
2201792|NCT03277274|5399913|P1|STARTED|Overall Study||8
2201793|NCT03276494|5399942|P1|NOT COMPLETED|Overall Study||1
2201794|NCT03276494|5399942|P1|COMPLETED|Overall Study||5
2201795|NCT03276494|5399942|P1|STARTED|Overall Study||6
2201796|NCT03276078|5399947|P1|NOT COMPLETED|Overall Study||1
2201797|NCT03276078|5399947|P1|COMPLETED|Overall Study||19
2201798|NCT03276078|5399947|P1|STARTED|Overall Study||20
2201799|NCT03276026|5399976|P2|NOT COMPLETED|Overall Study||0
2201800|NCT03276026|5399977|P1|NOT COMPLETED|Overall Study||1
2201801|NCT03276026|5399976|P2|COMPLETED|Overall Study||33
2201802|NCT03276026|5399977|P1|COMPLETED|Overall Study||34
2201803|NCT03276026|5399976|P2|STARTED|Overall Study||33
2201804|NCT03276026|5399977|P1|STARTED|Overall Study||35
2201805|NCT03274518|5399989|P2|NOT COMPLETED|Second Intervention||0
2201806|NCT03274518|5399990|P1|NOT COMPLETED|Second Intervention||0
2201807|NCT03274518|5399989|P2|COMPLETED|Second Intervention||8
2201808|NCT03274518|5399990|P1|COMPLETED|Second Intervention||8
2201809|NCT03274518|5399989|P2|STARTED|Second Intervention|Second intervention: patients from this group underwent online hemodiafiltration for 30 days.|8
2201810|NCT03274518|5399990|P1|STARTED|Second Intervention||8
2201811|NCT03274518|5399989|P2|NOT COMPLETED|Washout Period||0
2201812|NCT03274518|5399990|P1|NOT COMPLETED|Washout Period||0
2201813|NCT03274518|5399989|P2|COMPLETED|Washout Period||8
2201814|NCT03274518|5399990|P1|COMPLETED|Washout Period||8
2201815|NCT03274518|5399989|P2|STARTED|Washout Period|Patients returned from expanded hemodialysis to conventional hemodialysis for 15 days.|8
2201816|NCT03274518|5399990|P1|STARTED|Washout Period||8
2201817|NCT03274518|5399989|P2|NOT COMPLETED|First Intervention||0
2201818|NCT03274518|5399990|P1|NOT COMPLETED|First Intervention||0
2201819|NCT03274518|5399989|P2|COMPLETED|First Intervention||8
2201820|NCT03274518|5399990|P1|COMPLETED|First Intervention||8
2201821|NCT03274518|5399989|P2|STARTED|First Intervention|First intervention: expanded hemodialysis, for 30 days.|8
2201822|NCT03274518|5399990|P1|STARTED|First Intervention||8
2201823|NCT03274453|5400006|P4|NOT COMPLETED|Overall Study||4
2201824|NCT03274453|5400007|P3|NOT COMPLETED|Overall Study||4
2201825|NCT03274453|5400008|P2|NOT COMPLETED|Overall Study||6
2201826|NCT03274453|5400009|P1|NOT COMPLETED|Overall Study||4
2201827|NCT03274453|5400006|P4|COMPLETED|Overall Study||25
2201828|NCT03274453|5400007|P3|COMPLETED|Overall Study||28
2201829|NCT03274453|5400008|P2|COMPLETED|Overall Study||24
2201830|NCT03274453|5400009|P1|COMPLETED|Overall Study||34
2201831|NCT03274453|5400006|P4|STARTED|Overall Study||29
2201832|NCT03274453|5400007|P3|STARTED|Overall Study||32
2201833|NCT03274453|5400008|P2|STARTED|Overall Study||30
2201834|NCT03274453|5400009|P1|STARTED|Overall Study||38
2201835|NCT03273946|5400019|P1|NOT COMPLETED|Overall Study||9
2201836|NCT03273946|5400019|P1|COMPLETED|Overall Study||149
2201837|NCT03273946|5400019|P1|STARTED|Overall Study||158
2201838|NCT03273387|5400027|P2|NOT COMPLETED|Overall Study||3
2201839|NCT03273387|5400028|P1|NOT COMPLETED|Overall Study||3
2201840|NCT03273387|5400027|P2|COMPLETED|Overall Study||10
2201841|NCT03273387|5400028|P1|COMPLETED|Overall Study||10
2201842|NCT03273387|5400027|P2|STARTED|Overall Study||13
2201843|NCT03273387|5400028|P1|STARTED|Overall Study||13
2201844|NCT03272711|5400040|P2|NOT COMPLETED|Overall Study||8
2201845|NCT03272711|5400041|P1|NOT COMPLETED|Overall Study||7
2201846|NCT03272711|5400040|P2|COMPLETED|Overall Study||41
2201847|NCT03272711|5400041|P1|COMPLETED|Overall Study||44
2201848|NCT03272711|5400040|P2|STARTED|Overall Study||49
2201849|NCT03272711|5400041|P1|STARTED|Overall Study||51
2201850|NCT03271424|5400054|P3|NOT COMPLETED|April-May 2016||0
2201851|NCT03271424|5400055|P2|NOT COMPLETED|April-May 2016||0
2201852|NCT03271424|5400056|P1|NOT COMPLETED|April-May 2016||0
2201853|NCT03271424|5400054|P3|COMPLETED|April-May 2016||40
2201854|NCT03271424|5400055|P2|COMPLETED|April-May 2016||0
2201855|NCT03271424|5400056|P1|COMPLETED|April-May 2016||0
2201856|NCT03271424|5400054|P3|STARTED|April-May 2016||40
2201857|NCT03271424|5400055|P2|STARTED|April-May 2016||0
2201858|NCT03271424|5400056|P1|STARTED|April-May 2016||0
2201859|NCT03271424|5400054|P3|NOT COMPLETED|December 2015||0
2201860|NCT03271424|5400055|P2|NOT COMPLETED|December 2015||0
2201861|NCT03271424|5400056|P1|NOT COMPLETED|December 2015||0
2201862|NCT03271424|5400054|P3|COMPLETED|December 2015||0
2201863|NCT03271424|5400055|P2|COMPLETED|December 2015||35
2201864|NCT03271424|5400056|P1|COMPLETED|December 2015||0
2201865|NCT03271424|5400054|P3|STARTED|December 2015||0
2201866|NCT03271424|5400055|P2|STARTED|December 2015||35
2201867|NCT03271424|5400056|P1|STARTED|December 2015||0
2201868|NCT03271424|5400054|P3|NOT COMPLETED|November 2015||0
2201869|NCT03271424|5400055|P2|NOT COMPLETED|November 2015||0
2201870|NCT03271424|5400056|P1|NOT COMPLETED|November 2015||0
2201871|NCT03271424|5400054|P3|COMPLETED|November 2015||0
2201872|NCT03271424|5400055|P2|COMPLETED|November 2015||0
2201873|NCT03271424|5400056|P1|COMPLETED|November 2015||20
2201874|NCT03271424|5400054|P3|STARTED|November 2015||0
2201875|NCT03271424|5400055|P2|STARTED|November 2015||0
2201876|NCT03271424|5400056|P1|STARTED|November 2015||20
2201883|NCT03270644|5400077|P1|NOT COMPLETED|Day 4 - 10 Propranolol Reference||1
2201884|NCT03270644|5400077|P1|COMPLETED|Day 4 - 10 Propranolol Reference||42
2201885|NCT03270644|5400077|P1|Day 9 Lasmiditan + Propranolol Test|Day 4 - 10 Propranolol Reference||42
2201886|NCT03270644|5400077|P1|Received at Least One Dose of Study Drug|Day 4 - 10 Propranolol Reference||43
2201887|NCT03270644|5400077|P1|STARTED|Day 4 - 10 Propranolol Reference||43
2201888|NCT03270644|5400077|P1|NOT COMPLETED|Day 1 Lasmiditan Reference||1
2201889|NCT03270644|5400077|P1|COMPLETED|Day 1 Lasmiditan Reference||43
2201890|NCT03270644|5400077|P1|Received at Least One Dose of Study Drug|Day 1 Lasmiditan Reference||44
2201891|NCT03270644|5400077|P1|STARTED|Day 1 Lasmiditan Reference||44
2201892|NCT03269552|5400098|P1|NOT COMPLETED|Overall Study||2
2201893|NCT03269552|5400098|P1|COMPLETED|Overall Study||2
2201894|NCT03269552|5400098|P1|STARTED|Overall Study||4
2201895|NCT03268941|5400109|P7|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
2201896|NCT03268941|5400110|P6|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
2201897|NCT03268941|5400111|P5|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
2201898|NCT03268941|5400112|P4|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
2201899|NCT03268941|5400113|P3|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
2201900|NCT03268941|5400114|P2|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
2201901|NCT03268941|5400115|P1|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
2201902|NCT03268941|5400109|P7|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
2201903|NCT03268941|5400110|P6|COMPLETED|Part 2: Period 2: Fasted (Day 25)||6
2201904|NCT03268941|5400111|P5|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
2201905|NCT03268941|5400112|P4|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
2201906|NCT03268941|5400113|P3|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
2201907|NCT03268941|5400114|P2|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
2201908|NCT03268941|5400115|P1|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
2201909|NCT03268941|5400109|P7|STARTED|Part 2: Period 2: Fasted (Day 25)||0
2201910|NCT03268941|5400110|P6|STARTED|Part 2: Period 2: Fasted (Day 25)||6
2201911|NCT03268941|5400111|P5|STARTED|Part 2: Period 2: Fasted (Day 25)||0
2201912|NCT03268941|5400112|P4|STARTED|Part 2: Period 2: Fasted (Day 25)||0
2201913|NCT03268941|5400113|P3|STARTED|Part 2: Period 2: Fasted (Day 25)||0
2201914|NCT03268941|5400114|P2|STARTED|Part 2: Period 2: Fasted (Day 25)||0
2201915|NCT03268941|5400115|P1|STARTED|Part 2: Period 2: Fasted (Day 25)||0
2201916|NCT03268941|5400109|P7|NOT COMPLETED|Part 2: Days 17 to 25||2
2201917|NCT03268941|5400110|P6|NOT COMPLETED|Part 2: Days 17 to 25||0
2201918|NCT03268941|5400111|P5|NOT COMPLETED|Part 2: Days 17 to 25||0
2201919|NCT03268941|5400112|P4|NOT COMPLETED|Part 2: Days 17 to 25||0
2201920|NCT03268941|5400113|P3|NOT COMPLETED|Part 2: Days 17 to 25||0
2201921|NCT03268941|5400114|P2|NOT COMPLETED|Part 2: Days 17 to 25||0
2201922|NCT03268941|5400115|P1|NOT COMPLETED|Part 2: Days 17 to 25||0
2201923|NCT03268941|5400109|P7|COMPLETED|Part 2: Days 17 to 25||13
2201924|NCT03268941|5400110|P6|COMPLETED|Part 2: Days 17 to 25||0
2201925|NCT03268941|5400111|P5|COMPLETED|Part 2: Days 17 to 25||6
2201926|NCT03268941|5400112|P4|COMPLETED|Part 2: Days 17 to 25||0
2201927|NCT03268941|5400113|P3|COMPLETED|Part 2: Days 17 to 25||0
2201928|NCT03268941|5400114|P2|COMPLETED|Part 2: Days 17 to 25||0
2201929|NCT03268941|5400115|P1|COMPLETED|Part 2: Days 17 to 25||0
2201930|NCT03268941|5400109|P7|Treated|Part 2: Days 17 to 25||13
2201931|NCT03268941|5400110|P6|Treated|Part 2: Days 17 to 25||0
2201932|NCT03268941|5400111|P5|Treated|Part 2: Days 17 to 25||6
2201933|NCT03268941|5400112|P4|Treated|Part 2: Days 17 to 25||0
2201934|NCT03268941|5400113|P3|Treated|Part 2: Days 17 to 25||0
2201935|NCT03268941|5400114|P2|Treated|Part 2: Days 17 to 25||0
2201936|NCT03268941|5400115|P1|Treated|Part 2: Days 17 to 25||0
2201937|NCT03268941|5400109|P7|STARTED|Part 2: Days 17 to 25||15
2201938|NCT03268941|5400110|P6|STARTED|Part 2: Days 17 to 25||0
2201939|NCT03268941|5400111|P5|STARTED|Part 2: Days 17 to 25||6
2201940|NCT03268941|5400112|P4|STARTED|Part 2: Days 17 to 25||0
2201941|NCT03268941|5400113|P3|STARTED|Part 2: Days 17 to 25||0
2201942|NCT03268941|5400114|P2|STARTED|Part 2: Days 17 to 25||0
2201943|NCT03268941|5400115|P1|STARTED|Part 2: Days 17 to 25||0
2201944|NCT03268941|5400109|P7|NOT COMPLETED|Part 1 (Days 1 to 9)||0
2201945|NCT03268941|5400110|P6|NOT COMPLETED|Part 1 (Days 1 to 9)||0
2201946|NCT03268941|5400111|P5|NOT COMPLETED|Part 1 (Days 1 to 9)||0
2201947|NCT03268941|5400112|P4|NOT COMPLETED|Part 1 (Days 1 to 9)||2
2201948|NCT03268941|5400113|P3|NOT COMPLETED|Part 1 (Days 1 to 9)||0
2201949|NCT03268941|5400114|P2|NOT COMPLETED|Part 1 (Days 1 to 9)||0
2201950|NCT03268941|5400115|P1|NOT COMPLETED|Part 1 (Days 1 to 9)||1
2201951|NCT03268941|5400109|P7|COMPLETED|Part 1 (Days 1 to 9)||0
2201952|NCT03268941|5400110|P6|COMPLETED|Part 1 (Days 1 to 9)||0
2201953|NCT03268941|5400111|P5|COMPLETED|Part 1 (Days 1 to 9)||0
2201954|NCT03268941|5400112|P4|COMPLETED|Part 1 (Days 1 to 9)||11
2201955|NCT03268941|5400113|P3|COMPLETED|Part 1 (Days 1 to 9)||12
2201956|NCT03268941|5400114|P2|COMPLETED|Part 1 (Days 1 to 9)||14
2201957|NCT03268941|5400115|P1|COMPLETED|Part 1 (Days 1 to 9)||11
2201958|NCT03268941|5400109|P7|STARTED|Part 1 (Days 1 to 9)||0
2201959|NCT03268941|5400110|P6|STARTED|Part 1 (Days 1 to 9)||0
2201960|NCT03268941|5400111|P5|STARTED|Part 1 (Days 1 to 9)||0
2201961|NCT03268941|5400112|P4|STARTED|Part 1 (Days 1 to 9)||13
2201962|NCT03268941|5400113|P3|STARTED|Part 1 (Days 1 to 9)||12
2201963|NCT03268941|5400114|P2|STARTED|Part 1 (Days 1 to 9)||14
2201964|NCT03268941|5400115|P1|STARTED|Part 1 (Days 1 to 9)||12
2201965|NCT03268746|5400177|P1|NOT COMPLETED|Overall Study||1
2201966|NCT03268746|5400177|P1|COMPLETED|Overall Study||44
2201967|NCT03268746|5400177|P1|STARTED|Overall Study||45
2201968|NCT03268590|5400199|P1|NOT COMPLETED|Overall Study||1
2201969|NCT03268590|5400199|P1|COMPLETED|Overall Study|One participant did not complete MRI due to a previously undiagnosed subdermal metal shard in scalp.|32
2201970|NCT03268590|5400199|P1|STARTED|Overall Study||33
2201971|NCT03268343|5400206|P2|NOT COMPLETED|Overall Study||0
2201972|NCT03268343|5400207|P1|NOT COMPLETED|Overall Study||0
2201973|NCT03268343|5400206|P2|COMPLETED|Overall Study||12
2201974|NCT03268343|5400207|P1|COMPLETED|Overall Study||12
2201975|NCT03268343|5400206|P2|STARTED|Overall Study||12
2201976|NCT03268343|5400207|P1|STARTED|Overall Study||12
2201977|NCT03267940|5400238|P6|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||10
2201978|NCT03267940|5400239|P5|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||10
2201979|NCT03267940|5400240|P4|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||22
2201980|NCT03267940|5400241|P3|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||21
2201981|NCT03267940|5400242|P2|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
2201982|NCT03267940|5400243|P1|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
2201983|NCT03267940|5400238|P6|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
2201984|NCT03267940|5400239|P5|COMPLETED|Expansion (Maximum Exposure: 421 Days)||1
2201985|NCT03267940|5400240|P4|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
2201986|NCT03267940|5400241|P3|COMPLETED|Expansion (Maximum Exposure: 421 Days)||3
2201987|NCT03267940|5400242|P2|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
2201988|NCT03267940|5400243|P1|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
2201989|NCT03267940|5400238|P6|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||10
2201990|NCT03267940|5400239|P5|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||11
2201991|NCT03267940|5400240|P4|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||22
2201992|NCT03267940|5400241|P3|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||24
2201993|NCT03267940|5400242|P2|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||0
2201994|NCT03267940|5400243|P1|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||0
2201995|NCT03267940|5400238|P6|STARTED|Expansion (Maximum Exposure: 421 Days)||10
2201996|NCT03267940|5400239|P5|STARTED|Expansion (Maximum Exposure: 421 Days)||11
2201997|NCT03267940|5400240|P4|STARTED|Expansion (Maximum Exposure: 421 Days)||22
2201998|NCT03267940|5400241|P3|STARTED|Expansion (Maximum Exposure: 421 Days)||24
2201999|NCT03267940|5400242|P2|STARTED|Expansion (Maximum Exposure: 421 Days)||0
2202000|NCT03267940|5400243|P1|STARTED|Expansion (Maximum Exposure: 421 Days)||0
2202001|NCT03267940|5400238|P6|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
2202002|NCT03267940|5400239|P5|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
2202003|NCT03267940|5400240|P4|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
2202004|NCT03267940|5400241|P3|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
2202005|NCT03267940|5400242|P2|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||7
2202006|NCT03267940|5400243|P1|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||8
2202007|NCT03267940|5400238|P6|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
2202008|NCT03267940|5400239|P5|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
2202009|NCT03267940|5400240|P4|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
2202010|NCT03267940|5400241|P3|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
2202011|NCT03267940|5400242|P2|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||2
2202012|NCT03267940|5400243|P1|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||1
2202013|NCT03267940|5400238|P6|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
2202014|NCT03267940|5400239|P5|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
2202015|NCT03267940|5400240|P4|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
2202016|NCT03267940|5400241|P3|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
2202017|NCT03267940|5400242|P2|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||9
2202018|NCT03267940|5400243|P1|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||9
2202019|NCT03267940|5400238|P6|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
2202020|NCT03267940|5400239|P5|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
2202021|NCT03267940|5400240|P4|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
2202022|NCT03267940|5400241|P3|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
2202023|NCT03267940|5400242|P2|STARTED|Run-in Portion (Max. Exposure: 508 Days)||9
2202024|NCT03267940|5400243|P1|STARTED|Run-in Portion (Max. Exposure: 508 Days)||9
2202025|NCT03267576|5400345|P2|NOT COMPLETED|Period 2: Day 44 to 71||2
2202026|NCT03267576|5400346|P1|NOT COMPLETED|Period 2: Day 44 to 71||1
2202027|NCT03267576|5400345|P2|COMPLETED|Period 2: Day 44 to 71||30
2202028|NCT03267576|5400346|P1|COMPLETED|Period 2: Day 44 to 71||30
2202029|NCT03267576|5400345|P2|STARTED|Period 2: Day 44 to 71||32
2202030|NCT03267576|5400346|P1|STARTED|Period 2: Day 44 to 71||31
2202031|NCT03267576|5400345|P2|NOT COMPLETED|Washout Period: 16 Days||0
2202032|NCT03267576|5400346|P1|NOT COMPLETED|Washout Period: 16 Days||0
2202033|NCT03267576|5400345|P2|COMPLETED|Washout Period: 16 Days||32
2202034|NCT03267576|5400346|P1|COMPLETED|Washout Period: 16 Days||31
2202035|NCT03267576|5400345|P2|STARTED|Washout Period: 16 Days||32
2202036|NCT03267576|5400346|P1|STARTED|Washout Period: 16 Days||31
2202037|NCT03267576|5400345|P2|NOT COMPLETED|Period 1: Day 0 to 27||0
2202038|NCT03267576|5400346|P1|NOT COMPLETED|Period 1: Day 0 to 27||0
2202039|NCT03267576|5400345|P2|COMPLETED|Period 1: Day 0 to 27||32
2202040|NCT03267576|5400346|P1|COMPLETED|Period 1: Day 0 to 27||31
2202041|NCT03267576|5400345|P2|STARTED|Period 1: Day 0 to 27||32
2202042|NCT03267576|5400346|P1|STARTED|Period 1: Day 0 to 27||31
2202043|NCT03267511|5400384|P4|NOT COMPLETED|Overall Study||1
2202044|NCT03267511|5400385|P3|NOT COMPLETED|Overall Study||0
2202045|NCT03267511|5400386|P2|NOT COMPLETED|Overall Study||0
2202046|NCT03267511|5400387|P1|NOT COMPLETED|Overall Study||0
2202047|NCT03267511|5400384|P4|COMPLETED|Overall Study||30
2202048|NCT03267511|5400385|P3|COMPLETED|Overall Study||30
2202049|NCT03267511|5400386|P2|COMPLETED|Overall Study||31
2202050|NCT03267511|5400387|P1|COMPLETED|Overall Study||31
2202051|NCT03267511|5400384|P4|STARTED|Overall Study||31
2202052|NCT03267511|5400385|P3|STARTED|Overall Study||30
2202053|NCT03267511|5400386|P2|STARTED|Overall Study||31
2202054|NCT03267511|5400387|P1|STARTED|Overall Study||31
2202055|NCT03267264|5400403|P4|NOT COMPLETED|Overall Study||4
2202056|NCT03267264|5400404|P3|NOT COMPLETED|Overall Study||2
2202057|NCT03267264|5400405|P2|NOT COMPLETED|Overall Study||0
2202058|NCT03267264|5400406|P1|NOT COMPLETED|Overall Study||1
2202059|NCT03267264|5400403|P4|COMPLETED|Overall Study||61
2202060|NCT03267264|5400404|P3|COMPLETED|Overall Study||66
2202061|NCT03267264|5400405|P2|COMPLETED|Overall Study||49
2202062|NCT03267264|5400406|P1|COMPLETED|Overall Study||65
2202063|NCT03267264|5400403|P4|Sequence B(Comparator)|Overall Study||32
2202064|NCT03267264|5400404|P3|Sequence B(Comparator)|Overall Study||33
2202065|NCT03267264|5400405|P2|Sequence B(Comparator)|Overall Study||24
2202066|NCT03267264|5400406|P1|Sequence B(Comparator)|Overall Study||32
2202067|NCT03267264|5400403|P4|Sequence A(Nucleus)|Overall Study||33
2202068|NCT03267264|5400404|P3|Sequence A(Nucleus)|Overall Study||33
2202069|NCT03267264|5400405|P2|Sequence A(Nucleus)|Overall Study||25
2202070|NCT03267264|5400406|P1|Sequence A(Nucleus)|Overall Study||34
2202071|NCT03267264|5400403|P4|STARTED|Overall Study||65
2202072|NCT03267264|5400404|P3|STARTED|Overall Study||68
2202073|NCT03267264|5400405|P2|STARTED|Overall Study||49
2202074|NCT03267264|5400406|P1|STARTED|Overall Study||66
2202075|NCT03266419|5400425|P2|NOT COMPLETED|Overall Study||0
2202076|NCT03266419|5400426|P1|NOT COMPLETED|Overall Study||0
2202077|NCT03266419|5400425|P2|COMPLETED|Overall Study||49
2202078|NCT03266419|5400426|P1|COMPLETED|Overall Study||51
2202079|NCT03266419|5400425|P2|STARTED|Overall Study||49
2202080|NCT03266419|5400426|P1|STARTED|Overall Study||51
2202081|NCT03266172|5400437|P3|NOT COMPLETED|Part C Period 6(2 Days)||0
2202082|NCT03266172|5400438|P2|NOT COMPLETED|Part C Period 6(2 Days)||0
2202083|NCT03266172|5400439|P1|NOT COMPLETED|Part C Period 6(2 Days)||0
2202084|NCT03266172|5400437|P3|COMPLETED|Part C Period 6(2 Days)||14
2202085|NCT03266172|5400438|P2|COMPLETED|Part C Period 6(2 Days)||0
2202086|NCT03266172|5400439|P1|COMPLETED|Part C Period 6(2 Days)||0
2202087|NCT03266172|5400437|P3|STARTED|Part C Period 6(2 Days)||14
2202088|NCT03266172|5400438|P2|STARTED|Part C Period 6(2 Days)||0
2202089|NCT03266172|5400439|P1|STARTED|Part C Period 6(2 Days)||0
2202090|NCT03266172|5400437|P3|NOT COMPLETED|Part C Washout Period (7 Days)||1
2202091|NCT03266172|5400438|P2|NOT COMPLETED|Part C Washout Period (7 Days)||0
2202092|NCT03266172|5400439|P1|NOT COMPLETED|Part C Washout Period (7 Days)||0
2202093|NCT03266172|5400437|P3|COMPLETED|Part C Washout Period (7 Days)||14
2202094|NCT03266172|5400438|P2|COMPLETED|Part C Washout Period (7 Days)||0
2202095|NCT03266172|5400439|P1|COMPLETED|Part C Washout Period (7 Days)||0
2202096|NCT03266172|5400437|P3|STARTED|Part C Washout Period (7 Days)||15
2202097|NCT03266172|5400438|P2|STARTED|Part C Washout Period (7 Days)||0
2202098|NCT03266172|5400439|P1|STARTED|Part C Washout Period (7 Days)||0
2202099|NCT03266172|5400437|P3|NOT COMPLETED|Part C Period 5(2 Days)||0
2202100|NCT03266172|5400438|P2|NOT COMPLETED|Part C Period 5(2 Days)||0
2202101|NCT03266172|5400439|P1|NOT COMPLETED|Part C Period 5(2 Days)||0
2202102|NCT03266172|5400437|P3|COMPLETED|Part C Period 5(2 Days)||15
2202103|NCT03266172|5400438|P2|COMPLETED|Part C Period 5(2 Days)||0
2202104|NCT03266172|5400439|P1|COMPLETED|Part C Period 5(2 Days)||0
2202105|NCT03266172|5400437|P3|STARTED|Part C Period 5(2 Days)||15
2202106|NCT03266172|5400438|P2|STARTED|Part C Period 5(2 Days)||0
2202107|NCT03266172|5400439|P1|STARTED|Part C Period 5(2 Days)||0
2202108|NCT03266172|5400437|P3|NOT COMPLETED|Part C Washout Period (7 Days)||1
2202109|NCT03266172|5400438|P2|NOT COMPLETED|Part C Washout Period (7 Days)||0
2202110|NCT03266172|5400439|P1|NOT COMPLETED|Part C Washout Period (7 Days)||0
2202111|NCT03266172|5400437|P3|COMPLETED|Part C Washout Period (7 Days)||15
2202112|NCT03266172|5400438|P2|COMPLETED|Part C Washout Period (7 Days)||0
2202113|NCT03266172|5400439|P1|COMPLETED|Part C Washout Period (7 Days)||0
2202114|NCT03266172|5400437|P3|STARTED|Part C Washout Period (7 Days)||16
2202115|NCT03266172|5400438|P2|STARTED|Part C Washout Period (7 Days)||0
2202116|NCT03266172|5400439|P1|STARTED|Part C Washout Period (7 Days)||0
2202117|NCT03266172|5400437|P3|NOT COMPLETED|Part C Period 4(2 Days)||0
2202118|NCT03266172|5400438|P2|NOT COMPLETED|Part C Period 4(2 Days)||0
2202119|NCT03266172|5400439|P1|NOT COMPLETED|Part C Period 4(2 Days)||0
2202120|NCT03266172|5400437|P3|COMPLETED|Part C Period 4(2 Days)||16
2202121|NCT03266172|5400438|P2|COMPLETED|Part C Period 4(2 Days)||0
2202122|NCT03266172|5400439|P1|COMPLETED|Part C Period 4(2 Days)||0
2202123|NCT03266172|5400437|P3|STARTED|Part C Period 4(2 Days)||16
2202124|NCT03266172|5400438|P2|STARTED|Part C Period 4(2 Days)||0
2202125|NCT03266172|5400439|P1|STARTED|Part C Period 4(2 Days)||0
2202126|NCT03266172|5400437|P3|NOT COMPLETED|Part C Washout Period (7 Days)||0
2202127|NCT03266172|5400438|P2|NOT COMPLETED|Part C Washout Period (7 Days)||0
2202128|NCT03266172|5400439|P1|NOT COMPLETED|Part C Washout Period (7 Days)||0
2202129|NCT03266172|5400437|P3|COMPLETED|Part C Washout Period (7 Days)||16
2202130|NCT03266172|5400438|P2|COMPLETED|Part C Washout Period (7 Days)||0
2202131|NCT03266172|5400439|P1|COMPLETED|Part C Washout Period (7 Days)||0
2202132|NCT03266172|5400437|P3|STARTED|Part C Washout Period (7 Days)||16
2202133|NCT03266172|5400438|P2|STARTED|Part C Washout Period (7 Days)||0
2202134|NCT03266172|5400439|P1|STARTED|Part C Washout Period (7 Days)||0
2202135|NCT03266172|5400437|P3|NOT COMPLETED|Part C Period 3(2 Days)||0
2202136|NCT03266172|5400438|P2|NOT COMPLETED|Part C Period 3(2 Days)||0
2202137|NCT03266172|5400439|P1|NOT COMPLETED|Part C Period 3(2 Days)||0
2202138|NCT03266172|5400437|P3|COMPLETED|Part C Period 3(2 Days)||16
2202139|NCT03266172|5400438|P2|COMPLETED|Part C Period 3(2 Days)||0
2202140|NCT03266172|5400439|P1|COMPLETED|Part C Period 3(2 Days)||0
2202141|NCT03266172|5400437|P3|STARTED|Part C Period 3(2 Days)|1 replacement participant enrolled|16
2202142|NCT03266172|5400438|P2|STARTED|Part C Period 3(2 Days)||0
2202143|NCT03266172|5400439|P1|STARTED|Part C Period 3(2 Days)||0
2202144|NCT03266172|5400437|P3|NOT COMPLETED|Part C Washout Period (7 Days)||0
2202145|NCT03266172|5400438|P2|NOT COMPLETED|Part C Washout Period (7 Days)||0
2202146|NCT03266172|5400439|P1|NOT COMPLETED|Part C Washout Period (7 Days)||0
2202147|NCT03266172|5400437|P3|COMPLETED|Part C Washout Period (7 Days)||15
2202148|NCT03266172|5400438|P2|COMPLETED|Part C Washout Period (7 Days)||0
2202149|NCT03266172|5400439|P1|COMPLETED|Part C Washout Period (7 Days)||0
2202150|NCT03266172|5400437|P3|STARTED|Part C Washout Period (7 Days)||15
2202151|NCT03266172|5400438|P2|STARTED|Part C Washout Period (7 Days)||0
2202152|NCT03266172|5400439|P1|STARTED|Part C Washout Period (7 Days)||0
2202153|NCT03266172|5400437|P3|NOT COMPLETED|Part C Period 2(2 Days)||0
2202154|NCT03266172|5400438|P2|NOT COMPLETED|Part C Period 2(2 Days)||0
2202155|NCT03266172|5400439|P1|NOT COMPLETED|Part C Period 2(2 Days)||0
2202156|NCT03266172|5400437|P3|COMPLETED|Part C Period 2(2 Days)||15
2202157|NCT03266172|5400438|P2|COMPLETED|Part C Period 2(2 Days)||0
2202158|NCT03266172|5400439|P1|COMPLETED|Part C Period 2(2 Days)||0
2202159|NCT03266172|5400437|P3|STARTED|Part C Period 2(2 Days)||15
2202160|NCT03266172|5400438|P2|STARTED|Part C Period 2(2 Days)||0
2202161|NCT03266172|5400439|P1|STARTED|Part C Period 2(2 Days)||0
2202162|NCT03266172|5400437|P3|NOT COMPLETED|Part C Washout Period (7 Days)||0
2202163|NCT03266172|5400438|P2|NOT COMPLETED|Part C Washout Period (7 Days)||0
2202164|NCT03266172|5400439|P1|NOT COMPLETED|Part C Washout Period (7 Days)||0
2202165|NCT03266172|5400437|P3|COMPLETED|Part C Washout Period (7 Days)||15
2202166|NCT03266172|5400438|P2|COMPLETED|Part C Washout Period (7 Days)||0
2202167|NCT03266172|5400439|P1|COMPLETED|Part C Washout Period (7 Days)||0
2202168|NCT03266172|5400437|P3|STARTED|Part C Washout Period (7 Days)||15
2202169|NCT03266172|5400438|P2|STARTED|Part C Washout Period (7 Days)||0
2202170|NCT03266172|5400439|P1|STARTED|Part C Washout Period (7 Days)||0
2202171|NCT03266172|5400437|P3|NOT COMPLETED|Part C: Period 1(2 Days)||0
2202172|NCT03266172|5400438|P2|NOT COMPLETED|Part C: Period 1(2 Days)||0
2202173|NCT03266172|5400439|P1|NOT COMPLETED|Part C: Period 1(2 Days)||0
2202174|NCT03266172|5400437|P3|COMPLETED|Part C: Period 1(2 Days)||15
2202175|NCT03266172|5400438|P2|COMPLETED|Part C: Period 1(2 Days)||0
2202176|NCT03266172|5400439|P1|COMPLETED|Part C: Period 1(2 Days)||0
2202177|NCT03266172|5400437|P3|STARTED|Part C: Period 1(2 Days)|New participants were enrolled in Part C of study|15
2202178|NCT03266172|5400438|P2|STARTED|Part C: Period 1(2 Days)|Participants from Part B did not enter Part C|0
2202179|NCT03266172|5400439|P1|STARTED|Part C: Period 1(2 Days)||0
2202180|NCT03266172|5400437|P3|NOT COMPLETED|Part B: Period 3 (4 Days)||0
2202181|NCT03266172|5400438|P2|NOT COMPLETED|Part B: Period 3 (4 Days)||0
2202182|NCT03266172|5400439|P1|NOT COMPLETED|Part B: Period 3 (4 Days)||0
2202183|NCT03266172|5400437|P3|COMPLETED|Part B: Period 3 (4 Days)||0
2202184|NCT03266172|5400438|P2|COMPLETED|Part B: Period 3 (4 Days)||6
2202185|NCT03266172|5400439|P1|COMPLETED|Part B: Period 3 (4 Days)||0
2202186|NCT03266172|5400437|P3|STARTED|Part B: Period 3 (4 Days)||0
2202187|NCT03266172|5400438|P2|STARTED|Part B: Period 3 (4 Days)|Two participants completed Washout Period but withdrew before the start of Period 3.|6
2202188|NCT03266172|5400439|P1|STARTED|Part B: Period 3 (4 Days)||0
2202189|NCT03266172|5400437|P3|NOT COMPLETED|Part B: Washout (7 Days)||0
2202190|NCT03266172|5400438|P2|NOT COMPLETED|Part B: Washout (7 Days)||2
2202191|NCT03266172|5400439|P1|NOT COMPLETED|Part B: Washout (7 Days)||0
2202192|NCT03266172|5400437|P3|COMPLETED|Part B: Washout (7 Days)||0
2202193|NCT03266172|5400438|P2|COMPLETED|Part B: Washout (7 Days)||8
2202194|NCT03266172|5400439|P1|COMPLETED|Part B: Washout (7 Days)||0
2202195|NCT03266172|5400437|P3|STARTED|Part B: Washout (7 Days)||0
2202196|NCT03266172|5400438|P2|STARTED|Part B: Washout (7 Days)||10
2202197|NCT03266172|5400439|P1|STARTED|Part B: Washout (7 Days)||0
2202198|NCT03266172|5400437|P3|NOT COMPLETED|Part B: Period 2 (4 Days)||0
2202199|NCT03266172|5400438|P2|NOT COMPLETED|Part B: Period 2 (4 Days)||0
2202200|NCT03266172|5400439|P1|NOT COMPLETED|Part B: Period 2 (4 Days)||0
2202201|NCT03266172|5400437|P3|COMPLETED|Part B: Period 2 (4 Days)||0
2202202|NCT03266172|5400438|P2|COMPLETED|Part B: Period 2 (4 Days)||10
2202203|NCT03266172|5400439|P1|COMPLETED|Part B: Period 2 (4 Days)||0
2202204|NCT03266172|5400437|P3|STARTED|Part B: Period 2 (4 Days)||0
2202205|NCT03266172|5400438|P2|STARTED|Part B: Period 2 (4 Days)||10
2202206|NCT03266172|5400439|P1|STARTED|Part B: Period 2 (4 Days)||0
2202207|NCT03266172|5400437|P3|NOT COMPLETED|Part B: Washout (7 Days)||0
2202208|NCT03266172|5400438|P2|NOT COMPLETED|Part B: Washout (7 Days)||0
2202209|NCT03266172|5400439|P1|NOT COMPLETED|Part B: Washout (7 Days)||0
2202210|NCT03266172|5400437|P3|COMPLETED|Part B: Washout (7 Days)||0
2202211|NCT03266172|5400438|P2|COMPLETED|Part B: Washout (7 Days)||10
2202212|NCT03266172|5400439|P1|COMPLETED|Part B: Washout (7 Days)||0
2202213|NCT03266172|5400437|P3|STARTED|Part B: Washout (7 Days)||0
2202214|NCT03266172|5400438|P2|STARTED|Part B: Washout (7 Days)||10
2202215|NCT03266172|5400439|P1|STARTED|Part B: Washout (7 Days)||0
2202216|NCT03266172|5400437|P3|NOT COMPLETED|Part B: Period 1 (4 Days)||0
2202217|NCT03266172|5400438|P2|NOT COMPLETED|Part B: Period 1 (4 Days)||0
2202218|NCT03266172|5400439|P1|NOT COMPLETED|Part B: Period 1 (4 Days)||0
2202219|NCT03266172|5400437|P3|COMPLETED|Part B: Period 1 (4 Days)||0
2202220|NCT03266172|5400438|P2|COMPLETED|Part B: Period 1 (4 Days)||10
2202221|NCT03266172|5400439|P1|COMPLETED|Part B: Period 1 (4 Days)||0
2202222|NCT03266172|5400437|P3|STARTED|Part B: Period 1 (4 Days)||0
2202223|NCT03266172|5400438|P2|STARTED|Part B: Period 1 (4 Days)|New participants were enrolled in Part B of study|10
2202224|NCT03266172|5400439|P1|STARTED|Part B: Period 1 (4 Days)|Participants from Part A did not enter Part B|0
2202225|NCT03266172|5400437|P3|NOT COMPLETED|Part A: Period 4 (2 Days)||0
2202226|NCT03266172|5400438|P2|NOT COMPLETED|Part A: Period 4 (2 Days)||0
2202227|NCT03266172|5400439|P1|NOT COMPLETED|Part A: Period 4 (2 Days)||0
2202228|NCT03266172|5400437|P3|COMPLETED|Part A: Period 4 (2 Days)||0
2202229|NCT03266172|5400438|P2|COMPLETED|Part A: Period 4 (2 Days)||0
2202230|NCT03266172|5400439|P1|COMPLETED|Part A: Period 4 (2 Days)||16
2202231|NCT03266172|5400437|P3|STARTED|Part A: Period 4 (2 Days)||0
2202232|NCT03266172|5400438|P2|STARTED|Part A: Period 4 (2 Days)||0
2202233|NCT03266172|5400439|P1|STARTED|Part A: Period 4 (2 Days)||16
2202234|NCT03266172|5400437|P3|NOT COMPLETED|Part A: Washout (7 Days)||0
2202235|NCT03266172|5400438|P2|NOT COMPLETED|Part A: Washout (7 Days)||0
2202236|NCT03266172|5400439|P1|NOT COMPLETED|Part A: Washout (7 Days)||0
2202237|NCT03266172|5400437|P3|COMPLETED|Part A: Washout (7 Days)||0
2202238|NCT03266172|5400438|P2|COMPLETED|Part A: Washout (7 Days)||0
2202239|NCT03266172|5400439|P1|COMPLETED|Part A: Washout (7 Days)||16
2202240|NCT03266172|5400437|P3|STARTED|Part A: Washout (7 Days)||0
2202241|NCT03266172|5400438|P2|STARTED|Part A: Washout (7 Days)||0
2202242|NCT03266172|5400439|P1|STARTED|Part A: Washout (7 Days)||16
2202243|NCT03266172|5400437|P3|NOT COMPLETED|Part A: Period 3 (2 Days)||0
2202244|NCT03266172|5400438|P2|NOT COMPLETED|Part A: Period 3 (2 Days)||0
2202245|NCT03266172|5400439|P1|NOT COMPLETED|Part A: Period 3 (2 Days)||0
2202246|NCT03266172|5400437|P3|COMPLETED|Part A: Period 3 (2 Days)||0
2202247|NCT03266172|5400438|P2|COMPLETED|Part A: Period 3 (2 Days)||0
2202248|NCT03266172|5400439|P1|COMPLETED|Part A: Period 3 (2 Days)||16
2202249|NCT03266172|5400437|P3|STARTED|Part A: Period 3 (2 Days)||0
2202250|NCT03266172|5400438|P2|STARTED|Part A: Period 3 (2 Days)||0
2202251|NCT03266172|5400439|P1|STARTED|Part A: Period 3 (2 Days)|3 replacement participants were enrolled|16
2202252|NCT03266172|5400437|P3|NOT COMPLETED|Part A: Washout (7 Days)||0
2202253|NCT03266172|5400438|P2|NOT COMPLETED|Part A: Washout (7 Days)||0
2202254|NCT03266172|5400439|P1|NOT COMPLETED|Part A: Washout (7 Days)||0
2202255|NCT03266172|5400437|P3|COMPLETED|Part A: Washout (7 Days)||0
2202256|NCT03266172|5400438|P2|COMPLETED|Part A: Washout (7 Days)||0
2202257|NCT03266172|5400439|P1|COMPLETED|Part A: Washout (7 Days)||13
2202258|NCT03266172|5400437|P3|STARTED|Part A: Washout (7 Days)||0
2202259|NCT03266172|5400438|P2|STARTED|Part A: Washout (7 Days)||0
2202260|NCT03266172|5400439|P1|STARTED|Part A: Washout (7 Days)||13
2202261|NCT03266172|5400437|P3|NOT COMPLETED|Part A: Period 2 (2 Days)||0
2202262|NCT03266172|5400438|P2|NOT COMPLETED|Part A: Period 2 (2 Days)||0
2202263|NCT03266172|5400439|P1|NOT COMPLETED|Part A: Period 2 (2 Days)||0
2202264|NCT03266172|5400437|P3|COMPLETED|Part A: Period 2 (2 Days)||0
2202265|NCT03266172|5400438|P2|COMPLETED|Part A: Period 2 (2 Days)||0
2202266|NCT03266172|5400439|P1|COMPLETED|Part A: Period 2 (2 Days)||13
2202267|NCT03266172|5400437|P3|STARTED|Part A: Period 2 (2 Days)||0
2202268|NCT03266172|5400438|P2|STARTED|Part A: Period 2 (2 Days)||0
2202269|NCT03266172|5400439|P1|STARTED|Part A: Period 2 (2 Days)||13
2202270|NCT03266172|5400437|P3|NOT COMPLETED|Part A: Washout Period (7 Days)||0
2202271|NCT03266172|5400438|P2|NOT COMPLETED|Part A: Washout Period (7 Days)||0
2202272|NCT03266172|5400439|P1|NOT COMPLETED|Part A: Washout Period (7 Days)||2
2202273|NCT03266172|5400437|P3|COMPLETED|Part A: Washout Period (7 Days)||0
2202274|NCT03266172|5400438|P2|COMPLETED|Part A: Washout Period (7 Days)||0
2202275|NCT03266172|5400439|P1|COMPLETED|Part A: Washout Period (7 Days)||13
2202276|NCT03266172|5400437|P3|STARTED|Part A: Washout Period (7 Days)||0
2202277|NCT03266172|5400438|P2|STARTED|Part A: Washout Period (7 Days)||0
2202278|NCT03266172|5400439|P1|STARTED|Part A: Washout Period (7 Days)||15
2202279|NCT03266172|5400437|P3|NOT COMPLETED|Part A: Period 1(2 Days)||0
2202280|NCT03266172|5400438|P2|NOT COMPLETED|Part A: Period 1(2 Days)||0
2202281|NCT03266172|5400439|P1|NOT COMPLETED|Part A: Period 1(2 Days)||1
2202282|NCT03266172|5400437|P3|COMPLETED|Part A: Period 1(2 Days)||0
2202283|NCT03266172|5400438|P2|COMPLETED|Part A: Period 1(2 Days)||0
2202284|NCT03266172|5400439|P1|COMPLETED|Part A: Period 1(2 Days)||15
2202285|NCT03266172|5400437|P3|STARTED|Part A: Period 1(2 Days)||0
2202286|NCT03266172|5400438|P2|STARTED|Part A: Period 1(2 Days)||0
2202287|NCT03266172|5400439|P1|STARTED|Part A: Period 1(2 Days)||16
2202288|NCT03265600|5400686|P2|NOT COMPLETED|Overall Study||12
2202289|NCT03265600|5400687|P1|NOT COMPLETED|Overall Study||24
2202290|NCT03265600|5400686|P2|COMPLETED|Overall Study|Completed 8 or 9 week Action Plan Initiation Survey|32
2202291|NCT03265600|5400687|P1|COMPLETED|Overall Study|Completed 8 or 9 week Action Plan Initiation Survey|68
2202292|NCT03265600|5400686|P2|STARTED|Overall Study||44
2202293|NCT03265600|5400687|P1|STARTED|Overall Study||92
2202294|NCT03265119|5400713|P2|NOT COMPLETED|Overall Study||7
2202295|NCT03265119|5400714|P1|NOT COMPLETED|Overall Study||10
2202296|NCT03265119|5400713|P2|COMPLETED|Overall Study||28
2202297|NCT03265119|5400714|P1|COMPLETED|Overall Study||24
2202298|NCT03265119|5400713|P2|STARTED|Overall Study||35
2202299|NCT03265119|5400714|P1|STARTED|Overall Study||34
2202300|NCT03264456|5400722|P1|NOT COMPLETED|Overall Study||4
2202301|NCT03264456|5400722|P1|COMPLETED|Overall Study||14
2202302|NCT03264456|5400722|P1|STARTED|Overall Study||18
2202303|NCT03264248|5400729|P1|NOT COMPLETED|Overall Study||0
2202304|NCT03264248|5400729|P1|COMPLETED|Overall Study||9
2202305|NCT03264248|5400729|P1|STARTED|Overall Study||9
2202312|NCT03263806|5400757|P2|NOT COMPLETED|Overall Study||7
2202313|NCT03263806|5400758|P1|NOT COMPLETED|Overall Study||6
2202314|NCT03263806|5400757|P2|COMPLETED|Overall Study|Study Terminated due to lack of enrollment|0
2202315|NCT03263806|5400758|P1|COMPLETED|Overall Study|Study Terminated due to lack of enrollment|0
2202316|NCT03263806|5400757|P2|STARTED|Overall Study||7
2202317|NCT03263806|5400758|P1|STARTED|Overall Study||6
2202318|NCT03262233|5400774|P4|NOT COMPLETED|Overall Study||29
2202319|NCT03262233|5400775|P3|NOT COMPLETED|Overall Study||25
2202320|NCT03262233|5400776|P2|NOT COMPLETED|Overall Study||21
2202321|NCT03262233|5400777|P1|NOT COMPLETED|Overall Study||18
2202322|NCT03262233|5400774|P4|COMPLETED|Overall Study||32
2202323|NCT03262233|5400775|P3|COMPLETED|Overall Study||34
2202324|NCT03262233|5400776|P2|COMPLETED|Overall Study||32
2202325|NCT03262233|5400777|P1|COMPLETED|Overall Study||35
2202326|NCT03262233|5400774|P4|STARTED|Overall Study||61
2202327|NCT03262233|5400775|P3|STARTED|Overall Study||59
2202328|NCT03262233|5400776|P2|STARTED|Overall Study||53
2202329|NCT03262233|5400777|P1|STARTED|Overall Study||53
2202330|NCT03261531|5400799|P1|NOT COMPLETED|Overall Study||4
2202331|NCT03261531|5400799|P1|COMPLETED|Overall Study||3
2202332|NCT03261531|5400799|P1|STARTED|Overall Study||7
2202333|NCT03261167|5400817|P2|NOT COMPLETED|Open-label(Treatment cycle4,Upto Week48)||0
2202334|NCT03261167|5400818|P1|NOT COMPLETED|Open-label(Treatment cycle4,Upto Week48)||0
2202335|NCT03261167|5400817|P2|COMPLETED|Open-label(Treatment cycle4,Upto Week48)||40
2202336|NCT03261167|5400818|P1|COMPLETED|Open-label(Treatment cycle4,Upto Week48)||43
2202337|NCT03261167|5400817|P2|STARTED|Open-label(Treatment cycle4,Upto Week48)||40
2202338|NCT03261167|5400818|P1|STARTED|Open-label(Treatment cycle4,Upto Week48)||43
2202339|NCT03261167|5400817|P2|NOT COMPLETED|Open-label(Treatment cycle3,Upto Week48)||1
2202340|NCT03261167|5400818|P1|NOT COMPLETED|Open-label(Treatment cycle3,Upto Week48)||1
2202341|NCT03261167|5400817|P2|COMPLETED|Open-label(Treatment cycle3,Upto Week48)||55
2202342|NCT03261167|5400818|P1|COMPLETED|Open-label(Treatment cycle3,Upto Week48)||54
2202343|NCT03261167|5400817|P2|STARTED|Open-label(Treatment cycle3,Upto Week48)||56
2202344|NCT03261167|5400818|P1|STARTED|Open-label(Treatment cycle3,Upto Week48)||55
2202345|NCT03261167|5400817|P2|NOT COMPLETED|Open-label(Treatment cycle2,Upto Week48)||0
2202346|NCT03261167|5400818|P1|NOT COMPLETED|Open-label(Treatment cycle2,Upto Week48)||2
2202347|NCT03261167|5400817|P2|COMPLETED|Open-label(Treatment cycle2,Upto Week48)||57
2202348|NCT03261167|5400818|P1|COMPLETED|Open-label(Treatment cycle2,Upto Week48)||58
2202349|NCT03261167|5400817|P2|STARTED|Open-label(Treatment cycle2,Upto Week48)||57
2202350|NCT03261167|5400818|P1|STARTED|Open-label(Treatment cycle2,Upto Week48)||60
2202351|NCT03261167|5400817|P2|NOT COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||4
2202352|NCT03261167|5400818|P1|NOT COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||3
2202353|NCT03261167|5400817|P2|COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||57
2202354|NCT03261167|5400818|P1|COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||60
2202355|NCT03261167|5400817|P2|STARTED|Double Blind(Treatment cyc1,Upto Week48)||61
2202356|NCT03261167|5400818|P1|STARTED|Double Blind(Treatment cyc1,Upto Week48)||63
2202357|NCT03260894|5400856|P2|NOT COMPLETED|Overall Study||50
2202358|NCT03260894|5400857|P1|NOT COMPLETED|Overall Study||46
2202359|NCT03260894|5400856|P2|COMPLETED|Overall Study||15
2202360|NCT03260894|5400857|P1|COMPLETED|Overall Study||18
2202361|NCT03260894|5400856|P2|All Subjects as Treated (ASaT)|Overall Study||63
2202362|NCT03260894|5400857|P1|All Subjects as Treated (ASaT)|Overall Study||64
2202363|NCT03260894|5400856|P2|Intention-to-Treat (ITT)|Overall Study||65
2202364|NCT03260894|5400857|P1|Intention-to-Treat (ITT)|Overall Study||64
2202365|NCT03260894|5400856|P2|STARTED|Overall Study||65
2202366|NCT03260894|5400857|P1|STARTED|Overall Study||64
2202367|NCT03260868|5400869|P2|NOT COMPLETED|Overall Study||3
2202368|NCT03260868|5400870|P1|NOT COMPLETED|Overall Study||3
2202369|NCT03260868|5400869|P2|COMPLETED|Overall Study||4
2202370|NCT03260868|5400870|P1|COMPLETED|Overall Study||5
2202371|NCT03260868|5400869|P2|Safety Population|Overall Study||6
2202372|NCT03260868|5400870|P1|Safety Population|Overall Study||8
2202373|NCT03260868|5400869|P2|STARTED|Overall Study||7
2202374|NCT03260868|5400870|P1|STARTED|Overall Study||8
2202375|NCT03260699|5400910|P2|NOT COMPLETED|Overall Study||2
2202376|NCT03260699|5400911|P1|NOT COMPLETED|Overall Study||0
2202377|NCT03260699|5400910|P2|COMPLETED|Overall Study||2
2202378|NCT03260699|5400911|P1|COMPLETED|Overall Study||5
2202379|NCT03260699|5400910|P2|STARTED|Overall Study||4
2202380|NCT03260699|5400911|P1|STARTED|Overall Study||5
2202381|NCT03260595|5400940|P3|NOT COMPLETED|Overall Study||0
2202382|NCT03260595|5400941|P2|NOT COMPLETED|Overall Study||0
2202383|NCT03260595|5400942|P1|NOT COMPLETED|Overall Study||0
2202384|NCT03260595|5400940|P3|COMPLETED|Overall Study||2
2202385|NCT03260595|5400941|P2|COMPLETED|Overall Study||10
2202386|NCT03260595|5400942|P1|COMPLETED|Overall Study||20
2202387|NCT03260595|5400940|P3|STARTED|Overall Study||2
2202388|NCT03260595|5400941|P2|STARTED|Overall Study||10
2202389|NCT03260595|5400942|P1|STARTED|Overall Study||20
2202390|NCT03260426|5400966|P2|NOT COMPLETED|Overall Study||0
2202391|NCT03260426|5400967|P1|NOT COMPLETED|Overall Study||0
2202392|NCT03260426|5400966|P2|COMPLETED|Overall Study||50
2202393|NCT03260426|5400967|P1|COMPLETED|Overall Study||50
2202394|NCT03260426|5400966|P2|STARTED|Overall Study||50
2202395|NCT03260426|5400967|P1|STARTED|Overall Study||50
2202396|NCT03260205|5400992|P5|NOT COMPLETED|Overall Study||14
2202397|NCT03260205|5400993|P4|NOT COMPLETED|Overall Study||7
2202398|NCT03260205|5400994|P3|NOT COMPLETED|Overall Study||11
2202399|NCT03260205|5400995|P2|NOT COMPLETED|Overall Study||8
2202400|NCT03260205|5400996|P1|NOT COMPLETED|Overall Study||9
2202401|NCT03260205|5400992|P5|COMPLETED|Overall Study||25
2202402|NCT03260205|5400993|P4|COMPLETED|Overall Study||30
2202403|NCT03260205|5400994|P3|COMPLETED|Overall Study||26
2202404|NCT03260205|5400995|P2|COMPLETED|Overall Study||32
2202405|NCT03260205|5400996|P1|COMPLETED|Overall Study||37
2202406|NCT03260205|5400992|P5|Received Treatment|Overall Study||38
2202407|NCT03260205|5400993|P4|Received Treatment|Overall Study||34
2202408|NCT03260205|5400994|P3|Received Treatment|Overall Study||35
2202409|NCT03260205|5400995|P2|Received Treatment|Overall Study||39
2202410|NCT03260205|5400996|P1|Received Treatment|Overall Study||45
2202411|NCT03260205|5400992|P5|STARTED|Overall Study||39
2202412|NCT03260205|5400993|P4|STARTED|Overall Study||37
2202413|NCT03260205|5400994|P3|STARTED|Overall Study||37
2202414|NCT03260205|5400995|P2|STARTED|Overall Study||40
2202415|NCT03260205|5400996|P1|STARTED|Overall Study||46
2202416|NCT03259555|5401059|P2|NOT COMPLETED|Overall Study||30
2202417|NCT03259555|5401060|P1|NOT COMPLETED|Overall Study||34
2202418|NCT03259555|5401059|P2|COMPLETED|Overall Study||134
2202419|NCT03259555|5401060|P1|COMPLETED|Overall Study||124
2202420|NCT03259555|5401059|P2|Received At Least 1 Dose of Study Drug|Overall Study||163
2202421|NCT03259555|5401060|P1|Received At Least 1 Dose of Study Drug|Overall Study||158
2202422|NCT03259555|5401059|P2|STARTED|Overall Study||164
2202423|NCT03259555|5401060|P1|STARTED|Overall Study||158
2202436|NCT03259425|5401093|P1|NOT COMPLETED|Overall Study||1
2202437|NCT03259425|5401093|P1|COMPLETED|Overall Study||6
2202438|NCT03259425|5401093|P1|Surgery|Overall Study||6
2202439|NCT03259425|5401093|P1|STARTED|Overall Study||7
2202440|NCT03259087|5401102|P5|NOT COMPLETED|Period 2 of Part 2||1
2202441|NCT03259087|5401103|P4|NOT COMPLETED|Period 2 of Part 2||0
2202442|NCT03259087|5401104|P3|NOT COMPLETED|Period 2 of Part 2||0
2202443|NCT03259087|5401105|P2|NOT COMPLETED|Period 2 of Part 2||0
2202444|NCT03259087|5401106|P1|NOT COMPLETED|Period 2 of Part 2||0
2202445|NCT03259087|5401102|P5|COMPLETED|Period 2 of Part 2||6
2202446|NCT03259087|5401103|P4|COMPLETED|Period 2 of Part 2||0
2202447|NCT03259087|5401104|P3|COMPLETED|Period 2 of Part 2||0
2202448|NCT03259087|5401105|P2|COMPLETED|Period 2 of Part 2||0
2202449|NCT03259087|5401106|P1|COMPLETED|Period 2 of Part 2||0
2202450|NCT03259087|5401102|P5|STARTED|Period 2 of Part 2||7
2202451|NCT03259087|5401103|P4|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
2202452|NCT03259087|5401104|P3|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
2202453|NCT03259087|5401105|P2|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
2202454|NCT03259087|5401106|P1|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
2202455|NCT03259087|5401102|P5|NOT COMPLETED|Part 1 and Period 1 of Part 2||1
2202456|NCT03259087|5401103|P4|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
2202457|NCT03259087|5401104|P3|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
2202458|NCT03259087|5401105|P2|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
2202459|NCT03259087|5401106|P1|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
2202460|NCT03259087|5401102|P5|COMPLETED|Part 1 and Period 1 of Part 2||7
2202461|NCT03259087|5401103|P4|COMPLETED|Part 1 and Period 1 of Part 2||10
2202462|NCT03259087|5401104|P3|COMPLETED|Part 1 and Period 1 of Part 2||8
2202463|NCT03259087|5401105|P2|COMPLETED|Part 1 and Period 1 of Part 2||8
2202464|NCT03259087|5401106|P1|COMPLETED|Part 1 and Period 1 of Part 2||8
2202465|NCT03259087|5401102|P5|STARTED|Part 1 and Period 1 of Part 2||8
2202466|NCT03259087|5401103|P4|STARTED|Part 1 and Period 1 of Part 2||10
2202467|NCT03259087|5401104|P3|STARTED|Part 1 and Period 1 of Part 2||8
2202468|NCT03259087|5401105|P2|STARTED|Part 1 and Period 1 of Part 2||8
2202469|NCT03259087|5401106|P1|STARTED|Part 1 and Period 1 of Part 2||8
2202470|NCT03258814|5401234|P3|NOT COMPLETED|Overall Study||10
2202471|NCT03258814|5401235|P2|NOT COMPLETED|Overall Study||3
2202472|NCT03258814|5401236|P1|NOT COMPLETED|Overall Study||4
2202473|NCT03258814|5401234|P3|COMPLETED|Overall Study||0
2202474|NCT03258814|5401235|P2|COMPLETED|Overall Study||0
2202475|NCT03258814|5401236|P1|COMPLETED|Overall Study||0
2202476|NCT03258814|5401234|P3|STARTED|Overall Study||10
2202477|NCT03258814|5401235|P2|STARTED|Overall Study||3
2202478|NCT03258814|5401236|P1|STARTED|Overall Study||4
2202479|NCT03258762|5401291|P2|NOT COMPLETED|Overall Study||1
2202480|NCT03258762|5401292|P1|NOT COMPLETED|Overall Study||0
2202481|NCT03258762|5401291|P2|COMPLETED|Overall Study||6
2202482|NCT03258762|5401292|P1|COMPLETED|Overall Study||7
2202483|NCT03258762|5401291|P2|STARTED|Overall Study||7
2202484|NCT03258762|5401292|P1|STARTED|Overall Study||7
2202485|NCT03258710|5401352|P1|NOT COMPLETED|Overall Study||2
2202486|NCT03258710|5401352|P1|COMPLETED|Overall Study||73
2202487|NCT03258710|5401352|P1|STARTED|Overall Study||75
2202488|NCT03257995|5401390|P6|NOT COMPLETED|Overall Study||2
2202489|NCT03257995|5401391|P5|NOT COMPLETED|Overall Study||0
2202490|NCT03257995|5401392|P4|NOT COMPLETED|Overall Study||0
2202491|NCT03257995|5401393|P3|NOT COMPLETED|Overall Study||0
2202492|NCT03257995|5401394|P2|NOT COMPLETED|Overall Study||1
2202493|NCT03257995|5401395|P1|NOT COMPLETED|Overall Study||0
2202494|NCT03257995|5401390|P6|COMPLETED|Overall Study||7
2202495|NCT03257995|5401391|P5|COMPLETED|Overall Study||9
2202496|NCT03257995|5401392|P4|COMPLETED|Overall Study||9
2202497|NCT03257995|5401393|P3|COMPLETED|Overall Study||9
2202498|NCT03257995|5401394|P2|COMPLETED|Overall Study||8
2202499|NCT03257995|5401395|P1|COMPLETED|Overall Study||9
2202500|NCT03257995|5401390|P6|STARTED|Overall Study||9
2202501|NCT03257995|5401391|P5|STARTED|Overall Study||9
2202502|NCT03257995|5401392|P4|STARTED|Overall Study||9
2202503|NCT03257995|5401393|P3|STARTED|Overall Study||9
2202504|NCT03257995|5401394|P2|STARTED|Overall Study||9
2202505|NCT03257995|5401395|P1|STARTED|Overall Study||9
2202506|NCT03257865|5401445|P2|NOT COMPLETED|Overall Study||35
2202507|NCT03257865|5401446|P1|NOT COMPLETED|Overall Study||35
2202508|NCT03257865|5401445|P2|COMPLETED|Overall Study||135
2202509|NCT03257865|5401446|P1|COMPLETED|Overall Study||128
2202510|NCT03257865|5401445|P2|Received at Least 1 Dose of Study Drug|Overall Study||170
2202511|NCT03257865|5401446|P1|Received at Least 1 Dose of Study Drug|Overall Study||162
2202512|NCT03257865|5401445|P2|STARTED|Overall Study||170
2202513|NCT03257865|5401446|P1|STARTED|Overall Study||163
2202514|NCT03257813|5401456|P2|NOT COMPLETED|Overall Study||3
2202515|NCT03257813|5401457|P1|NOT COMPLETED|Overall Study||6
2202516|NCT03257813|5401456|P2|COMPLETED|Overall Study||27
2202517|NCT03257813|5401457|P1|COMPLETED|Overall Study||24
2202518|NCT03257813|5401456|P2|STARTED|Overall Study||30
2202519|NCT03257813|5401457|P1|STARTED|Overall Study||30
2202520|NCT03257631|5401481|P4|NOT COMPLETED|Overall Study||10
2202521|NCT03257631|5401482|P3|NOT COMPLETED|Overall Study||23
2202522|NCT03257631|5401483|P2|NOT COMPLETED|Overall Study||9
2202523|NCT03257631|5401484|P1|NOT COMPLETED|Overall Study||11
2202524|NCT03257631|5401481|P4|COMPLETED|Overall Study||0
2202525|NCT03257631|5401482|P3|COMPLETED|Overall Study||0
2202526|NCT03257631|5401483|P2|COMPLETED|Overall Study||0
2202527|NCT03257631|5401484|P1|COMPLETED|Overall Study||0
2202528|NCT03257631|5401481|P4|Received Study Drug|Overall Study||10
2202529|NCT03257631|5401482|P3|Received Study Drug|Overall Study||22
2202530|NCT03257631|5401483|P2|Received Study Drug|Overall Study||9
2202531|NCT03257631|5401484|P1|Received Study Drug|Overall Study||11
2202532|NCT03257631|5401481|P4|STARTED|Overall Study||10
2202533|NCT03257631|5401482|P3|STARTED|Overall Study||23
2202534|NCT03257631|5401483|P2|STARTED|Overall Study||9
2202535|NCT03257631|5401484|P1|STARTED|Overall Study||11
2202536|NCT03257202|5401518|P1|NOT COMPLETED|Overall Study||0
2202537|NCT03257202|5401518|P1|COMPLETED|Overall Study||12
2202538|NCT03257202|5401518|P1|STARTED|Overall Study||12
2202539|NCT03257189|5401528|P1|NOT COMPLETED|Overall Study||0
2202540|NCT03257189|5401528|P1|COMPLETED|Overall Study||30
2202541|NCT03257189|5401528|P1|STARTED|Overall Study||30
2202542|NCT03256851|5401542|P2|NOT COMPLETED|Overall Study||0
2202543|NCT03256851|5401543|P1|NOT COMPLETED|Overall Study||1
2202544|NCT03256851|5401542|P2|COMPLETED|Overall Study||10
2202545|NCT03256851|5401543|P1|COMPLETED|Overall Study||9
2202546|NCT03256851|5401542|P2|STARTED|Overall Study||10
2202547|NCT03256851|5401543|P1|STARTED|Overall Study||10
2202548|NCT03256799|5401551|P1|NOT COMPLETED|Overall Study||0
2202549|NCT03256799|5401551|P1|COMPLETED|Overall Study||1
2202550|NCT03256799|5401551|P1|STARTED|Overall Study||1
2202551|NCT03256695|5401555|P1|NOT COMPLETED|Overall Study||39
2202552|NCT03256695|5401555|P1|COMPLETED|Overall Study||366
2202553|NCT03256695|5401555|P1|Used ABS eMDPI at Least Once|Overall Study||390
2202554|NCT03256695|5401555|P1|STARTED|Overall Study||405
2202555|NCT03256552|5401563|P1|NOT COMPLETED|Overall Study||5
2202556|NCT03256552|5401563|P1|COMPLETED|Overall Study||61
2202557|NCT03256552|5401563|P1|Placebo MDI|Overall Study||65
2202558|NCT03256552|5401563|P1|GP MDI 7.2 µg|Overall Study||62
2202559|NCT03256552|5401563|P1|GP MDI 14.4 µg|Overall Study||63
2202560|NCT03256552|5401563|P1|GP MDI 28.8 µg|Overall Study||61
2202561|NCT03256552|5401563|P1|STARTED|Overall Study||66
2202562|NCT03256526|5401588|P3|NOT COMPLETED|Overall Study||3
2202563|NCT03256526|5401589|P2|NOT COMPLETED|Overall Study||0
2202564|NCT03256526|5401590|P1|NOT COMPLETED|Overall Study||2
2202565|NCT03256526|5401588|P3|COMPLETED|Overall Study||14
2202566|NCT03256526|5401589|P2|COMPLETED|Overall Study||17
2202567|NCT03256526|5401590|P1|COMPLETED|Overall Study||17
2202568|NCT03256526|5401588|P3|STARTED|Overall Study||17
2202569|NCT03256526|5401589|P2|STARTED|Overall Study||17
2202570|NCT03256526|5401590|P1|STARTED|Overall Study||19
2202571|NCT03256162|5401612|P2|NOT COMPLETED|Overall Study||4
2202572|NCT03256162|5401613|P1|NOT COMPLETED|Overall Study||5
2202573|NCT03256162|5401612|P2|COMPLETED|Overall Study||8
2202574|NCT03256162|5401613|P1|COMPLETED|Overall Study||8
2202575|NCT03256162|5401612|P2|STARTED|Overall Study||12
2202576|NCT03256162|5401613|P1|STARTED|Overall Study||13
2202577|NCT03255902|5401631|P1|NOT COMPLETED|Overall Study||2
2202578|NCT03255902|5401631|P1|COMPLETED|Overall Study||5
2202579|NCT03255902|5401631|P1|STARTED|Overall Study||7
2202580|NCT03255733|5401636|P1|NOT COMPLETED|Overall Study||4
2202581|NCT03255733|5401636|P1|COMPLETED|Overall Study||25
2202582|NCT03255733|5401636|P1|STARTED|Overall Study||29
2202583|NCT03255655|5401643|P2|NOT COMPLETED|Overall Study||4
2202584|NCT03255655|5401644|P1|NOT COMPLETED|Overall Study||7
2202585|NCT03255655|5401643|P2|COMPLETED|Overall Study||8
2202586|NCT03255655|5401644|P1|COMPLETED|Overall Study||22
2202587|NCT03255655|5401643|P2|STARTED|Overall Study||12
2202588|NCT03255655|5401644|P1|STARTED|Overall Study||29
2202589|NCT03255382|5401654|P2|NOT COMPLETED|Overall Study||0
2202590|NCT03255382|5401655|P1|NOT COMPLETED|Overall Study||13
2202591|NCT03255382|5401654|P2|COMPLETED|Overall Study||60
2202592|NCT03255382|5401655|P1|COMPLETED|Overall Study||47
2202593|NCT03255382|5401654|P2|STARTED|Overall Study||60
2202594|NCT03255382|5401655|P1|STARTED|Overall Study||60
2202595|NCT03255291|5401829|P6|NOT COMPLETED|Overall Study||10
2202596|NCT03255291|5401830|P5|NOT COMPLETED|Overall Study||7
2202597|NCT03255291|5401831|P4|NOT COMPLETED|Overall Study||6
2202598|NCT03255291|5401832|P3|NOT COMPLETED|Overall Study||6
2202599|NCT03255291|5401833|P2|NOT COMPLETED|Overall Study||12
2202600|NCT03255291|5401834|P1|NOT COMPLETED|Overall Study||13
2202601|NCT03255291|5401829|P6|COMPLETED|Overall Study||85
2202602|NCT03255291|5401830|P5|COMPLETED|Overall Study||88
2202603|NCT03255291|5401831|P4|COMPLETED|Overall Study||84
2202604|NCT03255291|5401832|P3|COMPLETED|Overall Study||85
2202605|NCT03255291|5401833|P2|COMPLETED|Overall Study||78
2202606|NCT03255291|5401834|P1|COMPLETED|Overall Study||80
2202607|NCT03255291|5401829|P6|STARTED|Overall Study||95
2202608|NCT03255291|5401830|P5|STARTED|Overall Study||95
2202609|NCT03255291|5401831|P4|STARTED|Overall Study||90
2202610|NCT03255291|5401832|P3|STARTED|Overall Study||91
2202611|NCT03255291|5401833|P2|STARTED|Overall Study||90
2202612|NCT03255291|5401834|P1|STARTED|Overall Study||93
2202613|NCT03255187|5401867|P2|NOT COMPLETED|Period at Fourth Follow-up||0
2202614|NCT03255187|5401868|P1|NOT COMPLETED|Period at Fourth Follow-up||0
2202615|NCT03255187|5401867|P2|COMPLETED|Period at Fourth Follow-up||31
2202616|NCT03255187|5401868|P1|COMPLETED|Period at Fourth Follow-up||34
2202617|NCT03255187|5401867|P2|STARTED|Period at Fourth Follow-up||31
2202618|NCT03255187|5401868|P1|STARTED|Period at Fourth Follow-up||34
2202619|NCT03255187|5401867|P2|NOT COMPLETED|Period From Third to Fourth Follow-up||0
2202620|NCT03255187|5401868|P1|NOT COMPLETED|Period From Third to Fourth Follow-up||0
2202621|NCT03255187|5401867|P2|COMPLETED|Period From Third to Fourth Follow-up||31
2202622|NCT03255187|5401868|P1|COMPLETED|Period From Third to Fourth Follow-up||34
2202623|NCT03255187|5401867|P2|STARTED|Period From Third to Fourth Follow-up||31
2202624|NCT03255187|5401868|P1|STARTED|Period From Third to Fourth Follow-up||34
2202625|NCT03255187|5401867|P2|NOT COMPLETED|Period From Second to Third Follow-up||0
2202626|NCT03255187|5401868|P1|NOT COMPLETED|Period From Second to Third Follow-up||0
2202627|NCT03255187|5401867|P2|COMPLETED|Period From Second to Third Follow-up||31
2202628|NCT03255187|5401868|P1|COMPLETED|Period From Second to Third Follow-up||34
2202629|NCT03255187|5401867|P2|STARTED|Period From Second to Third Follow-up||31
2202630|NCT03255187|5401868|P1|STARTED|Period From Second to Third Follow-up||34
2202631|NCT03255187|5401867|P2|NOT COMPLETED|Period From First to Second Follow-up||1
2202632|NCT03255187|5401868|P1|NOT COMPLETED|Period From First to Second Follow-up||0
2202633|NCT03255187|5401867|P2|COMPLETED|Period From First to Second Follow-up||31
2202634|NCT03255187|5401868|P1|COMPLETED|Period From First to Second Follow-up||34
2202635|NCT03255187|5401867|P2|STARTED|Period From First to Second Follow-up||32
2202636|NCT03255187|5401868|P1|STARTED|Period From First to Second Follow-up||34
2202637|NCT03255187|5401867|P2|NOT COMPLETED|Periodfrom Enrollment to First Follow-up||3
2202638|NCT03255187|5401868|P1|NOT COMPLETED|Periodfrom Enrollment to First Follow-up||1
2202639|NCT03255187|5401867|P2|COMPLETED|Periodfrom Enrollment to First Follow-up||32
2202640|NCT03255187|5401868|P1|COMPLETED|Periodfrom Enrollment to First Follow-up||34
2202641|NCT03255187|5401867|P2|STARTED|Periodfrom Enrollment to First Follow-up||35
2202642|NCT03255187|5401868|P1|STARTED|Periodfrom Enrollment to First Follow-up||35
2202643|NCT03254602|5401908|P1|NOT COMPLETED|Overall Study||4
2202644|NCT03254602|5401908|P1|COMPLETED|Overall Study||29
2202645|NCT03254602|5401908|P1|STARTED|Overall Study||33
2202646|NCT03254459|5401916|P2|NOT COMPLETED|Overall Study||23
2202647|NCT03254459|5401917|P1|NOT COMPLETED|Overall Study||10
2202648|NCT03254459|5401916|P2|COMPLETED|Overall Study||27
2202649|NCT03254459|5401917|P1|COMPLETED|Overall Study||40
2202650|NCT03254459|5401916|P2|STARTED|Overall Study||50
2202651|NCT03254459|5401917|P1|STARTED|Overall Study||50
2202652|NCT03254147|5401935|P1|NOT COMPLETED|Overall Study||0
2202653|NCT03254147|5401935|P1|COMPLETED|Overall Study||53969
2202654|NCT03254147|5401935|P1|STARTED|Overall Study|The number of patients meeting the inclusion and exclusion criteria|53969
2202655|NCT03254134|5401942|P2|NOT COMPLETED|Overall Study||3630
2202656|NCT03254134|5401943|P1|NOT COMPLETED|Overall Study||599
2202657|NCT03254134|5401942|P2|COMPLETED|Overall Study||13115
2202658|NCT03254134|5401943|P1|COMPLETED|Overall Study||5146
2202659|NCT03254134|5401942|P2|STARTED|Overall Study||16745
2202660|NCT03254134|5401943|P1|STARTED|Overall Study||5745
2202661|NCT03252964|5401951|P1|NOT COMPLETED|Overall Study||32
2202662|NCT03252964|5401951|P1|COMPLETED|Overall Study||20
2202663|NCT03252964|5401951|P1|STARTED|Overall Study||52
2202664|NCT03252015|5401969|P4|NOT COMPLETED|Overall Study||1
2202665|NCT03252015|5401970|P3|NOT COMPLETED|Overall Study||1
2202666|NCT03252015|5401971|P2|NOT COMPLETED|Overall Study||1
2202667|NCT03252015|5401972|P1|NOT COMPLETED|Overall Study||1
2202668|NCT03252015|5401969|P4|COMPLETED|Overall Study||14
2202669|NCT03252015|5401970|P3|COMPLETED|Overall Study||14
2202670|NCT03252015|5401971|P2|COMPLETED|Overall Study||27
2202671|NCT03252015|5401972|P1|COMPLETED|Overall Study||11
2202672|NCT03252015|5401969|P4|Received at Least 1 Dose of Study Drug|Overall Study||15
2202673|NCT03252015|5401970|P3|Received at Least 1 Dose of Study Drug|Overall Study||15
2202674|NCT03252015|5401971|P2|Received at Least 1 Dose of Study Drug|Overall Study||28
2202675|NCT03252015|5401972|P1|Received at Least 1 Dose of Study Drug|Overall Study||12
2202676|NCT03252015|5401969|P4|STARTED|Overall Study||15
2202677|NCT03252015|5401970|P3|STARTED|Overall Study||15
2202678|NCT03252015|5401971|P2|STARTED|Overall Study||28
2202679|NCT03252015|5401972|P1|STARTED|Overall Study||12
2202680|NCT03251482|5402013|P5|NOT COMPLETED|Overall Study||0
2202681|NCT03251482|5402014|P4|NOT COMPLETED|Overall Study||0
2202682|NCT03251482|5402015|P3|NOT COMPLETED|Overall Study||0
2202683|NCT03251482|5402016|P2|NOT COMPLETED|Overall Study||1
2202684|NCT03251482|5402017|P1|NOT COMPLETED|Overall Study||0
2202685|NCT03251482|5402013|P5|COMPLETED|Overall Study||63
2202686|NCT03251482|5402014|P4|COMPLETED|Overall Study||122
2202687|NCT03251482|5402015|P3|COMPLETED|Overall Study||43
2202688|NCT03251482|5402016|P2|COMPLETED|Overall Study||40
2202689|NCT03251482|5402017|P1|COMPLETED|Overall Study||39
2202690|NCT03251482|5402013|P5|Treated|Overall Study||63
2202691|NCT03251482|5402014|P4|Treated|Overall Study||122
2202692|NCT03251482|5402015|P3|Treated|Overall Study||42
2202693|NCT03251482|5402016|P2|Treated|Overall Study||40
2202694|NCT03251482|5402017|P1|Treated|Overall Study||38
2202695|NCT03251482|5402013|P5|STARTED|Overall Study||63
2202696|NCT03251482|5402014|P4|STARTED|Overall Study||122
2202697|NCT03251482|5402015|P3|STARTED|Overall Study||43
2202698|NCT03251482|5402016|P2|STARTED|Overall Study||41
2202699|NCT03251482|5402017|P1|STARTED|Overall Study||39
2202700|NCT03250845|5402089|P1|NOT COMPLETED|Multigam 10% Infusion (3-4 Weeks Later)||0
2202701|NCT03250845|5402089|P1|COMPLETED|Multigam 10% Infusion (3-4 Weeks Later)||30
2202702|NCT03250845|5402089|P1|STARTED|Multigam 10% Infusion (3-4 Weeks Later)||30
2202703|NCT03250845|5402089|P1|NOT COMPLETED|Multigam 5% Infusion (Baseline)||0
2202704|NCT03250845|5402089|P1|COMPLETED|Multigam 5% Infusion (Baseline)||30
2202705|NCT03250845|5402089|P1|STARTED|Multigam 5% Infusion (Baseline)||30
2202706|NCT03250689|5402100|P2|NOT COMPLETED|Overall Study||0
2202707|NCT03250689|5402101|P1|NOT COMPLETED|Overall Study||0
2202708|NCT03250689|5402100|P2|COMPLETED|Overall Study||14
2202709|NCT03250689|5402101|P1|COMPLETED|Overall Study||5
2202710|NCT03250689|5402100|P2|STARTED|Overall Study||14
2202711|NCT03250689|5402101|P1|STARTED|Overall Study||5
2202712|NCT03249935|5402161|P1|NOT COMPLETED|Overall Study||45
2202713|NCT03249935|5402161|P1|COMPLETED|Overall Study||55
2202714|NCT03249935|5402161|P1|STARTED|Overall Study||100
2202715|NCT03249779|5402167|P1|NOT COMPLETED|Overall Study||0
2202716|NCT03249779|5402167|P1|COMPLETED|Overall Study||8
2202717|NCT03249779|5402167|P1|STARTED|Overall Study||8
2202718|NCT03249454|5402172|P11|NOT COMPLETED|Overall Study||1
2202719|NCT03249454|5402173|P10|NOT COMPLETED|Overall Study||1
2202720|NCT03249454|5402174|P9|NOT COMPLETED|Overall Study||0
2202721|NCT03249454|5402175|P8|NOT COMPLETED|Overall Study||0
2202722|NCT03249454|5402176|P7|NOT COMPLETED|Overall Study||0
2202723|NCT03249454|5402177|P6|NOT COMPLETED|Overall Study||0
2202724|NCT03249454|5402178|P5|NOT COMPLETED|Overall Study||0
2202725|NCT03249454|5402179|P4|NOT COMPLETED|Overall Study||0
2202726|NCT03249454|5402180|P3|NOT COMPLETED|Overall Study||0
2202727|NCT03249454|5402181|P2|NOT COMPLETED|Overall Study||0
2202728|NCT03249454|5402182|P1|NOT COMPLETED|Overall Study||0
2202729|NCT03249454|5402172|P11|COMPLETED|Overall Study||0
2202730|NCT03249454|5402173|P10|COMPLETED|Overall Study||0
2202731|NCT03249454|5402174|P9|COMPLETED|Overall Study||1
2202732|NCT03249454|5402175|P8|COMPLETED|Overall Study||1
2202733|NCT03249454|5402176|P7|COMPLETED|Overall Study||1
2202734|NCT03249454|5402177|P6|COMPLETED|Overall Study||2
2202735|NCT03249454|5402178|P5|COMPLETED|Overall Study||1
2202736|NCT03249454|5402179|P4|COMPLETED|Overall Study||1
2202737|NCT03249454|5402180|P3|COMPLETED|Overall Study||2
2202738|NCT03249454|5402181|P2|COMPLETED|Overall Study||1
2202739|NCT03249454|5402182|P1|COMPLETED|Overall Study||1
2202740|NCT03249454|5402172|P11|Fifth Intervention (1 Day)|Overall Study||0
2202741|NCT03249454|5402173|P10|Fifth Intervention (1 Day)|Overall Study||0
2202742|NCT03249454|5402174|P9|Fifth Intervention (1 Day)|Overall Study||1
2202743|NCT03249454|5402175|P8|Fifth Intervention (1 Day)|Overall Study||1
2202744|NCT03249454|5402176|P7|Fifth Intervention (1 Day)|Overall Study||1
2202745|NCT03249454|5402177|P6|Fifth Intervention (1 Day)|Overall Study||2
2202746|NCT03249454|5402178|P5|Fifth Intervention (1 Day)|Overall Study||1
2202747|NCT03249454|5402179|P4|Fifth Intervention (1 Day)|Overall Study||1
2202748|NCT03249454|5402180|P3|Fifth Intervention (1 Day)|Overall Study||2
2202749|NCT03249454|5402181|P2|Fifth Intervention (1 Day)|Overall Study||1
2202750|NCT03249454|5402182|P1|Fifth Intervention (1 Day)|Overall Study||1
2202751|NCT03249454|5402172|P11|Washout (1 Week)|Overall Study||0
2202752|NCT03249454|5402173|P10|Washout (1 Week)|Overall Study||0
2202753|NCT03249454|5402174|P9|Washout (1 Week)|Overall Study||1
2202754|NCT03249454|5402175|P8|Washout (1 Week)|Overall Study||1
2202755|NCT03249454|5402176|P7|Washout (1 Week)|Overall Study||1
2202756|NCT03249454|5402177|P6|Washout (1 Week)|Overall Study||2
2202757|NCT03249454|5402178|P5|Washout (1 Week)|Overall Study||1
2202758|NCT03249454|5402179|P4|Washout (1 Week)|Overall Study||1
2202759|NCT03249454|5402180|P3|Washout (1 Week)|Overall Study||2
2202760|NCT03249454|5402181|P2|Washout (1 Week)|Overall Study||1
2202761|NCT03249454|5402182|P1|Washout (1 Week)|Overall Study||1
2202762|NCT03249454|5402172|P11|Fourth Intervention (1 Day)|Overall Study||0
2202763|NCT03249454|5402173|P10|Fourth Intervention (1 Day)|Overall Study||0
2202764|NCT03249454|5402174|P9|Fourth Intervention (1 Day)|Overall Study||1
2202765|NCT03249454|5402175|P8|Fourth Intervention (1 Day)|Overall Study||1
2202766|NCT03249454|5402176|P7|Fourth Intervention (1 Day)|Overall Study||1
2202767|NCT03249454|5402177|P6|Fourth Intervention (1 Day)|Overall Study||2
2202768|NCT03249454|5402178|P5|Fourth Intervention (1 Day)|Overall Study||1
2202769|NCT03249454|5402179|P4|Fourth Intervention (1 Day)|Overall Study||1
2202770|NCT03249454|5402180|P3|Fourth Intervention (1 Day)|Overall Study||2
2202771|NCT03249454|5402181|P2|Fourth Intervention (1 Day)|Overall Study||1
2202772|NCT03249454|5402182|P1|Fourth Intervention (1 Day)|Overall Study||1
2202773|NCT03249454|5402172|P11|Washout (1 Week)|Overall Study||0
2202774|NCT03249454|5402173|P10|Washout (1 Week)|Overall Study||0
2202775|NCT03249454|5402174|P9|Washout (1 Week)|Overall Study||1
2202776|NCT03249454|5402175|P8|Washout (1 Week)|Overall Study||1
2202777|NCT03249454|5402176|P7|Washout (1 Week)|Overall Study||1
2202778|NCT03249454|5402177|P6|Washout (1 Week)|Overall Study||2
2202779|NCT03249454|5402178|P5|Washout (1 Week)|Overall Study||1
2202780|NCT03249454|5402179|P4|Washout (1 Week)|Overall Study||1
2202781|NCT03249454|5402180|P3|Washout (1 Week)|Overall Study||2
2202782|NCT03249454|5402181|P2|Washout (1 Week)|Overall Study||1
2202783|NCT03249454|5402182|P1|Washout (1 Week)|Overall Study||1
2202784|NCT03249454|5402172|P11|Third Intervention (1 Day)|Overall Study||0
2202785|NCT03249454|5402173|P10|Third Intervention (1 Day)|Overall Study||0
2202786|NCT03249454|5402174|P9|Third Intervention (1 Day)|Overall Study||1
2202787|NCT03249454|5402175|P8|Third Intervention (1 Day)|Overall Study||1
2202788|NCT03249454|5402176|P7|Third Intervention (1 Day)|Overall Study||1
2202789|NCT03249454|5402177|P6|Third Intervention (1 Day)|Overall Study||2
2202790|NCT03249454|5402178|P5|Third Intervention (1 Day)|Overall Study||1
2202791|NCT03249454|5402179|P4|Third Intervention (1 Day)|Overall Study||1
2202792|NCT03249454|5402180|P3|Third Intervention (1 Day)|Overall Study||2
2202793|NCT03249454|5402181|P2|Third Intervention (1 Day)|Overall Study||1
2202794|NCT03249454|5402182|P1|Third Intervention (1 Day)|Overall Study||1
2202795|NCT03249454|5402172|P11|Washout (1 Week)|Overall Study||0
2202796|NCT03249454|5402173|P10|Washout (1 Week)|Overall Study||0
2202797|NCT03249454|5402174|P9|Washout (1 Week)|Overall Study||1
2202798|NCT03249454|5402175|P8|Washout (1 Week)|Overall Study||1
2202799|NCT03249454|5402176|P7|Washout (1 Week)|Overall Study||1
2202800|NCT03249454|5402177|P6|Washout (1 Week)|Overall Study||2
2202801|NCT03249454|5402178|P5|Washout (1 Week)|Overall Study||1
2202802|NCT03249454|5402179|P4|Washout (1 Week)|Overall Study||1
2202803|NCT03249454|5402180|P3|Washout (1 Week)|Overall Study||2
2202804|NCT03249454|5402181|P2|Washout (1 Week)|Overall Study||1
2202805|NCT03249454|5402182|P1|Washout (1 Week)|Overall Study||1
2202806|NCT03249454|5402172|P11|Second Intervention (1 Day)|Overall Study||0
2202807|NCT03249454|5402173|P10|Second Intervention (1 Day)|Overall Study||0
2202808|NCT03249454|5402174|P9|Second Intervention (1 Day)|Overall Study||1
2202809|NCT03249454|5402175|P8|Second Intervention (1 Day)|Overall Study||1
2202810|NCT03249454|5402176|P7|Second Intervention (1 Day)|Overall Study||1
2202811|NCT03249454|5402177|P6|Second Intervention (1 Day)|Overall Study||2
2202812|NCT03249454|5402178|P5|Second Intervention (1 Day)|Overall Study||1
2202813|NCT03249454|5402179|P4|Second Intervention (1 Day)|Overall Study||1
2202814|NCT03249454|5402180|P3|Second Intervention (1 Day)|Overall Study||2
2202815|NCT03249454|5402181|P2|Second Intervention (1 Day)|Overall Study||1
2202816|NCT03249454|5402182|P1|Second Intervention (1 Day)|Overall Study||1
2202817|NCT03249454|5402172|P11|Washout (1 Week)|Overall Study||0
2202818|NCT03249454|5402173|P10|Washout (1 Week)|Overall Study||0
2202819|NCT03249454|5402174|P9|Washout (1 Week)|Overall Study||1
2202820|NCT03249454|5402175|P8|Washout (1 Week)|Overall Study||1
2202821|NCT03249454|5402176|P7|Washout (1 Week)|Overall Study||1
2202822|NCT03249454|5402177|P6|Washout (1 Week)|Overall Study||2
2202823|NCT03249454|5402178|P5|Washout (1 Week)|Overall Study||1
2202824|NCT03249454|5402179|P4|Washout (1 Week)|Overall Study||1
2202825|NCT03249454|5402180|P3|Washout (1 Week)|Overall Study||2
2202826|NCT03249454|5402181|P2|Washout (1 Week)|Overall Study||1
2202827|NCT03249454|5402182|P1|Washout (1 Week)|Overall Study||1
2202828|NCT03249454|5402172|P11|First Intervention (1 Day)|Overall Study||0
2202829|NCT03249454|5402173|P10|First Intervention (1 Day)|Overall Study||0
2202830|NCT03249454|5402174|P9|First Intervention (1 Day)|Overall Study||1
2202831|NCT03249454|5402175|P8|First Intervention (1 Day)|Overall Study||1
2202832|NCT03249454|5402176|P7|First Intervention (1 Day)|Overall Study||1
2202833|NCT03249454|5402177|P6|First Intervention (1 Day)|Overall Study||2
2202834|NCT03249454|5402178|P5|First Intervention (1 Day)|Overall Study||1
2202835|NCT03249454|5402179|P4|First Intervention (1 Day)|Overall Study||1
2202836|NCT03249454|5402180|P3|First Intervention (1 Day)|Overall Study||2
2202837|NCT03249454|5402181|P2|First Intervention (1 Day)|Overall Study||1
2202838|NCT03249454|5402182|P1|First Intervention (1 Day)|Overall Study||1
2202839|NCT03249454|5402172|P11|STARTED|Overall Study||1
2202840|NCT03249454|5402173|P10|STARTED|Overall Study||1
2202841|NCT03249454|5402174|P9|STARTED|Overall Study||1
2202842|NCT03249454|5402175|P8|STARTED|Overall Study||1
2202843|NCT03249454|5402176|P7|STARTED|Overall Study||1
2202844|NCT03249454|5402177|P6|STARTED|Overall Study||2
2202845|NCT03249454|5402178|P5|STARTED|Overall Study||1
2202846|NCT03249454|5402179|P4|STARTED|Overall Study||1
2202847|NCT03249454|5402180|P3|STARTED|Overall Study||2
2202848|NCT03249454|5402181|P2|STARTED|Overall Study||1
2202849|NCT03249454|5402182|P1|STARTED|Overall Study||1
2202865|NCT03248141|5402251|P2|NOT COMPLETED|Overall Study||0
2202866|NCT03248141|5402252|P1|NOT COMPLETED|Overall Study||0
2202867|NCT03248141|5402251|P2|COMPLETED|Overall Study||0
2202868|NCT03248141|5402252|P1|COMPLETED|Overall Study|Participants who were present in the study till termination were considered as completed.|11
2202869|NCT03248141|5402251|P2|STARTED|Overall Study|No enrollment occurred in this arm prior to study termination.|0
2202870|NCT03248141|5402252|P1|STARTED|Overall Study||11
2202871|NCT03247985|5402262|P2|NOT COMPLETED|Overall Study||0
2202872|NCT03247985|5402263|P1|NOT COMPLETED|Overall Study||0
2202873|NCT03247985|5402262|P2|COMPLETED|Overall Study||19
2202874|NCT03247985|5402263|P1|COMPLETED|Overall Study||19
2202875|NCT03247985|5402262|P2|STARTED|Overall Study||19
2202876|NCT03247985|5402263|P1|STARTED|Overall Study||19
2202877|NCT03247790|5402277|P1|NOT COMPLETED|Period 2: Inter-ictal Period||0
2202878|NCT03247790|5402277|P1|COMPLETED|Period 2: Inter-ictal Period||16
2202879|NCT03247790|5402277|P1|STARTED|Period 2: Inter-ictal Period||16
2202880|NCT03247790|5402277|P1|NOT COMPLETED|Period 1: Migraine Attack||0
2202881|NCT03247790|5402277|P1|COMPLETED|Period 1: Migraine Attack||16
2202882|NCT03247790|5402277|P1|Received at Least One Dose of Study Drug|Period 1: Migraine Attack||16
2202883|NCT03247790|5402277|P1|STARTED|Period 1: Migraine Attack||16
2202884|NCT03247738|5402291|P2|NOT COMPLETED|Overall Study||0
2202885|NCT03247738|5402292|P1|NOT COMPLETED|Overall Study||0
2202886|NCT03247738|5402291|P2|COMPLETED|Overall Study||25
2202887|NCT03247738|5402292|P1|COMPLETED|Overall Study||25
2202888|NCT03247738|5402291|P2|STARTED|Overall Study||25
2202889|NCT03247738|5402292|P1|STARTED|Overall Study||25
2202890|NCT03247673|5402303|P3|NOT COMPLETED|Overall Study||4
2202891|NCT03247673|5402304|P2|NOT COMPLETED|Overall Study||0
2202892|NCT03247673|5402305|P1|NOT COMPLETED|Overall Study||1
2202893|NCT03247673|5402303|P3|COMPLETED|Overall Study||44
2202894|NCT03247673|5402304|P2|COMPLETED|Overall Study||47
2202895|NCT03247673|5402305|P1|COMPLETED|Overall Study||45
2202896|NCT03247673|5402303|P3|STARTED|Overall Study||48
2202897|NCT03247673|5402304|P2|STARTED|Overall Study||47
2202898|NCT03247673|5402305|P1|STARTED|Overall Study||46
2202899|NCT03246672|5402325|P1|NOT COMPLETED|Overall Study||2
2202900|NCT03246672|5402325|P1|COMPLETED|Overall Study||28
2202901|NCT03246672|5402325|P1|Completed First Phone Call|Overall Study||29
2202902|NCT03246672|5402325|P1|STARTED|Overall Study||30
2202903|NCT03246152|5402331|P1|NOT COMPLETED|Overall Study||3
2202904|NCT03246152|5402331|P1|COMPLETED|Overall Study||28
2202905|NCT03246152|5402331|P1|STARTED|Overall Study||31
2202906|NCT03245762|5402339|P2|NOT COMPLETED|Overall Study||0
2202907|NCT03245762|5402340|P1|NOT COMPLETED|Overall Study||0
2202908|NCT03245762|5402339|P2|COMPLETED|Overall Study||5
2202909|NCT03245762|5402340|P1|COMPLETED|Overall Study||10
2202910|NCT03245762|5402339|P2|STARTED|Overall Study||5
2202911|NCT03245762|5402340|P1|STARTED|Overall Study||10
2202912|NCT03245619|5402363|P17|NOT COMPLETED|Part C (Up to 34 Days)||0
2202913|NCT03245619|5402364|P16|NOT COMPLETED|Part C (Up to 34 Days)||0
2202914|NCT03245619|5402365|P15|NOT COMPLETED|Part C (Up to 34 Days)||0
2202915|NCT03245619|5402366|P14|NOT COMPLETED|Part C (Up to 34 Days)||0
2202916|NCT03245619|5402367|P13|NOT COMPLETED|Part C (Up to 34 Days)||0
2202917|NCT03245619|5402368|P12|NOT COMPLETED|Part C (Up to 34 Days)||0
2202918|NCT03245619|5402369|P11|NOT COMPLETED|Part C (Up to 34 Days)||0
2202919|NCT03245619|5402370|P10|NOT COMPLETED|Part C (Up to 34 Days)||0
2202920|NCT03245619|5402371|P9|NOT COMPLETED|Part C (Up to 34 Days)||0
2202921|NCT03245619|5402372|P8|NOT COMPLETED|Part C (Up to 34 Days)||0
2202922|NCT03245619|5402373|P7|NOT COMPLETED|Part C (Up to 34 Days)||0
2202923|NCT03245619|5402374|P6|NOT COMPLETED|Part C (Up to 34 Days)||0
2202924|NCT03245619|5402375|P5|NOT COMPLETED|Part C (Up to 34 Days)||0
2202925|NCT03245619|5402376|P4|NOT COMPLETED|Part C (Up to 34 Days)||0
2202926|NCT03245619|5402377|P3|NOT COMPLETED|Part C (Up to 34 Days)||0
2202927|NCT03245619|5402378|P2|NOT COMPLETED|Part C (Up to 34 Days)||0
2202928|NCT03245619|5402379|P1|NOT COMPLETED|Part C (Up to 34 Days)||0
2202929|NCT03245619|5402363|P17|COMPLETED|Part C (Up to 34 Days)||0
2202930|NCT03245619|5402364|P16|COMPLETED|Part C (Up to 34 Days)||0
2202931|NCT03245619|5402365|P15|COMPLETED|Part C (Up to 34 Days)||0
2202932|NCT03245619|5402366|P14|COMPLETED|Part C (Up to 34 Days)||0
2202933|NCT03245619|5402367|P13|COMPLETED|Part C (Up to 34 Days)||0
2202934|NCT03245619|5402368|P12|COMPLETED|Part C (Up to 34 Days)||0
2202935|NCT03245619|5402369|P11|COMPLETED|Part C (Up to 34 Days)||0
2202936|NCT03245619|5402370|P10|COMPLETED|Part C (Up to 34 Days)||0
2202937|NCT03245619|5402371|P9|COMPLETED|Part C (Up to 34 Days)||0
2202938|NCT03245619|5402372|P8|COMPLETED|Part C (Up to 34 Days)||0
2202939|NCT03245619|5402373|P7|COMPLETED|Part C (Up to 34 Days)||0
2202940|NCT03245619|5402374|P6|COMPLETED|Part C (Up to 34 Days)||0
2202941|NCT03245619|5402375|P5|COMPLETED|Part C (Up to 34 Days)||0
2202942|NCT03245619|5402376|P4|COMPLETED|Part C (Up to 34 Days)||0
2202943|NCT03245619|5402377|P3|COMPLETED|Part C (Up to 34 Days)||0
2202944|NCT03245619|5402378|P2|COMPLETED|Part C (Up to 34 Days)||0
2202945|NCT03245619|5402379|P1|COMPLETED|Part C (Up to 34 Days)||0
2202946|NCT03245619|5402363|P17|STARTED|Part C (Up to 34 Days)||0
2202947|NCT03245619|5402364|P16|STARTED|Part C (Up to 34 Days)||0
2202948|NCT03245619|5402365|P15|STARTED|Part C (Up to 34 Days)||0
2202949|NCT03245619|5402366|P14|STARTED|Part C (Up to 34 Days)||0
2202950|NCT03245619|5402367|P13|STARTED|Part C (Up to 34 Days)||0
2202951|NCT03245619|5402368|P12|STARTED|Part C (Up to 34 Days)||0
2202952|NCT03245619|5402369|P11|STARTED|Part C (Up to 34 Days)||0
2202953|NCT03245619|5402370|P10|STARTED|Part C (Up to 34 Days)||0
2202954|NCT03245619|5402371|P9|STARTED|Part C (Up to 34 Days)||0
2202955|NCT03245619|5402372|P8|STARTED|Part C (Up to 34 Days)||0
2202956|NCT03245619|5402373|P7|STARTED|Part C (Up to 34 Days)||0
2202957|NCT03245619|5402374|P6|STARTED|Part C (Up to 34 Days)||0
2202958|NCT03245619|5402375|P5|STARTED|Part C (Up to 34 Days)||0
2202959|NCT03245619|5402376|P4|STARTED|Part C (Up to 34 Days)||0
2202960|NCT03245619|5402377|P3|STARTED|Part C (Up to 34 Days)||0
2202961|NCT03245619|5402378|P2|STARTED|Part C (Up to 34 Days)||0
2202962|NCT03245619|5402379|P1|STARTED|Part C (Up to 34 Days)||0
2202963|NCT03245619|5402363|P17|NOT COMPLETED|Part B (Up to 34 Days)||0
2202964|NCT03245619|5402364|P16|NOT COMPLETED|Part B (Up to 34 Days)||0
2202965|NCT03245619|5402365|P15|NOT COMPLETED|Part B (Up to 34 Days)||0
2202966|NCT03245619|5402366|P14|NOT COMPLETED|Part B (Up to 34 Days)||0
2202967|NCT03245619|5402367|P13|NOT COMPLETED|Part B (Up to 34 Days)||0
2202968|NCT03245619|5402368|P12|NOT COMPLETED|Part B (Up to 34 Days)||0
2202969|NCT03245619|5402369|P11|NOT COMPLETED|Part B (Up to 34 Days)||0
2202970|NCT03245619|5402370|P10|NOT COMPLETED|Part B (Up to 34 Days)||0
2202971|NCT03245619|5402371|P9|NOT COMPLETED|Part B (Up to 34 Days)||0
2202972|NCT03245619|5402372|P8|NOT COMPLETED|Part B (Up to 34 Days)||0
2202973|NCT03245619|5402373|P7|NOT COMPLETED|Part B (Up to 34 Days)||0
2202974|NCT03245619|5402374|P6|NOT COMPLETED|Part B (Up to 34 Days)||0
2202975|NCT03245619|5402375|P5|NOT COMPLETED|Part B (Up to 34 Days)||0
2202976|NCT03245619|5402376|P4|NOT COMPLETED|Part B (Up to 34 Days)||0
2202977|NCT03245619|5402377|P3|NOT COMPLETED|Part B (Up to 34 Days)||0
2202978|NCT03245619|5402378|P2|NOT COMPLETED|Part B (Up to 34 Days)||0
2202979|NCT03245619|5402379|P1|NOT COMPLETED|Part B (Up to 34 Days)||0
2202980|NCT03245619|5402363|P17|COMPLETED|Part B (Up to 34 Days)||0
2202981|NCT03245619|5402364|P16|COMPLETED|Part B (Up to 34 Days)||0
2202982|NCT03245619|5402365|P15|COMPLETED|Part B (Up to 34 Days)||0
2202983|NCT03245619|5402366|P14|COMPLETED|Part B (Up to 34 Days)||0
2202984|NCT03245619|5402367|P13|COMPLETED|Part B (Up to 34 Days)||0
2202985|NCT03245619|5402368|P12|COMPLETED|Part B (Up to 34 Days)||0
2202986|NCT03245619|5402369|P11|COMPLETED|Part B (Up to 34 Days)||0
2202987|NCT03245619|5402370|P10|COMPLETED|Part B (Up to 34 Days)||0
2202988|NCT03245619|5402371|P9|COMPLETED|Part B (Up to 34 Days)||0
2202989|NCT03245619|5402372|P8|COMPLETED|Part B (Up to 34 Days)||0
2202990|NCT03245619|5402373|P7|COMPLETED|Part B (Up to 34 Days)||0
2202991|NCT03245619|5402374|P6|COMPLETED|Part B (Up to 34 Days)||0
2202992|NCT03245619|5402375|P5|COMPLETED|Part B (Up to 34 Days)||0
2202993|NCT03245619|5402376|P4|COMPLETED|Part B (Up to 34 Days)||0
2202994|NCT03245619|5402377|P3|COMPLETED|Part B (Up to 34 Days)||0
2202995|NCT03245619|5402378|P2|COMPLETED|Part B (Up to 34 Days)||0
2202996|NCT03245619|5402379|P1|COMPLETED|Part B (Up to 34 Days)||0
2202997|NCT03245619|5402363|P17|STARTED|Part B (Up to 34 Days)||0
2202998|NCT03245619|5402364|P16|STARTED|Part B (Up to 34 Days)||0
2202999|NCT03245619|5402365|P15|STARTED|Part B (Up to 34 Days)||0
2203000|NCT03245619|5402366|P14|STARTED|Part B (Up to 34 Days)||0
2203001|NCT03245619|5402367|P13|STARTED|Part B (Up to 34 Days)||0
2203002|NCT03245619|5402368|P12|STARTED|Part B (Up to 34 Days)||0
2203003|NCT03245619|5402369|P11|STARTED|Part B (Up to 34 Days)||0
2203004|NCT03245619|5402370|P10|STARTED|Part B (Up to 34 Days)||0
2203005|NCT03245619|5402371|P9|STARTED|Part B (Up to 34 Days)||0
2203006|NCT03245619|5402372|P8|STARTED|Part B (Up to 34 Days)||0
2203007|NCT03245619|5402373|P7|STARTED|Part B (Up to 34 Days)||0
2203008|NCT03245619|5402374|P6|STARTED|Part B (Up to 34 Days)||0
2203009|NCT03245619|5402375|P5|STARTED|Part B (Up to 34 Days)||0
2203010|NCT03245619|5402376|P4|STARTED|Part B (Up to 34 Days)||0
2203011|NCT03245619|5402377|P3|STARTED|Part B (Up to 34 Days)||0
2203012|NCT03245619|5402378|P2|STARTED|Part B (Up to 34 Days)||0
2203013|NCT03245619|5402379|P1|STARTED|Part B (Up to 34 Days)||0
2203014|NCT03245619|5402363|P17|NOT COMPLETED|Part A (Up to Day 22)||0
2203015|NCT03245619|5402364|P16|NOT COMPLETED|Part A (Up to Day 22)||0
2203016|NCT03245619|5402365|P15|NOT COMPLETED|Part A (Up to Day 22)||0
2203017|NCT03245619|5402366|P14|NOT COMPLETED|Part A (Up to Day 22)||0
2203018|NCT03245619|5402367|P13|NOT COMPLETED|Part A (Up to Day 22)||0
2203019|NCT03245619|5402368|P12|NOT COMPLETED|Part A (Up to Day 22)||0
2203020|NCT03245619|5402369|P11|NOT COMPLETED|Part A (Up to Day 22)||0
2203021|NCT03245619|5402370|P10|NOT COMPLETED|Part A (Up to Day 22)||0
2203022|NCT03245619|5402371|P9|NOT COMPLETED|Part A (Up to Day 22)||0
2203023|NCT03245619|5402372|P8|NOT COMPLETED|Part A (Up to Day 22)||0
2203024|NCT03245619|5402373|P7|NOT COMPLETED|Part A (Up to Day 22)||0
2203025|NCT03245619|5402374|P6|NOT COMPLETED|Part A (Up to Day 22)||0
2203026|NCT03245619|5402375|P5|NOT COMPLETED|Part A (Up to Day 22)||0
2203027|NCT03245619|5402376|P4|NOT COMPLETED|Part A (Up to Day 22)||0
2203028|NCT03245619|5402377|P3|NOT COMPLETED|Part A (Up to Day 22)||6
2203029|NCT03245619|5402378|P2|NOT COMPLETED|Part A (Up to Day 22)||6
2203030|NCT03245619|5402379|P1|NOT COMPLETED|Part A (Up to Day 22)||4
2203031|NCT03245619|5402363|P17|COMPLETED|Part A (Up to Day 22)||0
2203032|NCT03245619|5402364|P16|COMPLETED|Part A (Up to Day 22)||0
2203033|NCT03245619|5402365|P15|COMPLETED|Part A (Up to Day 22)||0
2203034|NCT03245619|5402366|P14|COMPLETED|Part A (Up to Day 22)||0
2203035|NCT03245619|5402367|P13|COMPLETED|Part A (Up to Day 22)||0
2203036|NCT03245619|5402368|P12|COMPLETED|Part A (Up to Day 22)||0
2203037|NCT03245619|5402369|P11|COMPLETED|Part A (Up to Day 22)||0
2203038|NCT03245619|5402370|P10|COMPLETED|Part A (Up to Day 22)||0
2203039|NCT03245619|5402371|P9|COMPLETED|Part A (Up to Day 22)||0
2203040|NCT03245619|5402372|P8|COMPLETED|Part A (Up to Day 22)||0
2203041|NCT03245619|5402373|P7|COMPLETED|Part A (Up to Day 22)||0
2203042|NCT03245619|5402374|P6|COMPLETED|Part A (Up to Day 22)||0
2203043|NCT03245619|5402375|P5|COMPLETED|Part A (Up to Day 22)||0
2203044|NCT03245619|5402376|P4|COMPLETED|Part A (Up to Day 22)||1
2203045|NCT03245619|5402377|P3|COMPLETED|Part A (Up to Day 22)||0
2203046|NCT03245619|5402378|P2|COMPLETED|Part A (Up to Day 22)||0
2203047|NCT03245619|5402379|P1|COMPLETED|Part A (Up to Day 22)||1
2203048|NCT03245619|5402363|P17|STARTED|Part A (Up to Day 22)||0
2203049|NCT03245619|5402364|P16|STARTED|Part A (Up to Day 22)||0
2203050|NCT03245619|5402365|P15|STARTED|Part A (Up to Day 22)||0
2203051|NCT03245619|5402366|P14|STARTED|Part A (Up to Day 22)||0
2203052|NCT03245619|5402367|P13|STARTED|Part A (Up to Day 22)||0
2203053|NCT03245619|5402368|P12|STARTED|Part A (Up to Day 22)||0
2203054|NCT03245619|5402369|P11|STARTED|Part A (Up to Day 22)||0
2203055|NCT03245619|5402370|P10|STARTED|Part A (Up to Day 22)||0
2203056|NCT03245619|5402371|P9|STARTED|Part A (Up to Day 22)||0
2203057|NCT03245619|5402372|P8|STARTED|Part A (Up to Day 22)||0
2203058|NCT03245619|5402373|P7|STARTED|Part A (Up to Day 22)||0
2203059|NCT03245619|5402374|P6|STARTED|Part A (Up to Day 22)||0
2203060|NCT03245619|5402375|P5|STARTED|Part A (Up to Day 22)||0
2203061|NCT03245619|5402376|P4|STARTED|Part A (Up to Day 22)||1
2203062|NCT03245619|5402377|P3|STARTED|Part A (Up to Day 22)||6
2203063|NCT03245619|5402378|P2|STARTED|Part A (Up to Day 22)||6
2203064|NCT03245619|5402379|P1|STARTED|Part A (Up to Day 22)||5
2203065|NCT03245463|5402634|P2|NOT COMPLETED|Overall Study||0
2203066|NCT03245463|5402635|P1|NOT COMPLETED|Overall Study||0
2203067|NCT03245463|5402634|P2|COMPLETED|Overall Study||12
2203068|NCT03245463|5402635|P1|COMPLETED|Overall Study||12
2203069|NCT03245463|5402634|P2|STARTED|Overall Study||12
2203070|NCT03245463|5402635|P1|STARTED|Overall Study||12
2203071|NCT03245398|5402653|P2|NOT COMPLETED|Overall Study||0
2203072|NCT03245398|5402654|P1|NOT COMPLETED|Overall Study||1
2203073|NCT03245398|5402653|P2|COMPLETED|Overall Study||93
2203074|NCT03245398|5402654|P1|COMPLETED|Overall Study||92
2203075|NCT03245398|5402653|P2|STARTED|Overall Study||93
2203076|NCT03245398|5402654|P1|STARTED|Overall Study||93
2203077|NCT03244865|5402676|P1|NOT COMPLETED|Overall Study||0
2203078|NCT03244865|5402676|P1|COMPLETED|Overall Study||35
2203079|NCT03244865|5402676|P1|STARTED|Overall Study||35
2203080|NCT03244800|5402684|P4|NOT COMPLETED|Overall Study||2
2203081|NCT03244800|5402685|P3|NOT COMPLETED|Overall Study||0
2203082|NCT03244800|5402686|P2|NOT COMPLETED|Overall Study||1
2203083|NCT03244800|5402687|P1|NOT COMPLETED|Overall Study||0
2203084|NCT03244800|5402684|P4|COMPLETED|Overall Study||18
2203085|NCT03244800|5402685|P3|COMPLETED|Overall Study||6
2203086|NCT03244800|5402686|P2|COMPLETED|Overall Study||25
2203087|NCT03244800|5402687|P1|COMPLETED|Overall Study||13
2203088|NCT03244800|5402684|P4|STARTED|Overall Study||20
2203089|NCT03244800|5402685|P3|STARTED|Overall Study||6
2203090|NCT03244800|5402686|P2|STARTED|Overall Study||26
2203091|NCT03244800|5402687|P1|STARTED|Overall Study||13
2203092|NCT03243981|5402745|P1|NOT COMPLETED|Overall Study||0
2203093|NCT03243981|5402745|P1|COMPLETED|Overall Study||5
2203094|NCT03243981|5402745|P1|STARTED|Overall Study||5
2203095|NCT03243084|5402766|P2|NOT COMPLETED|Session 2||0
2203096|NCT03243084|5402767|P1|NOT COMPLETED|Session 2||0
2203097|NCT03243084|5402766|P2|COMPLETED|Session 2||10
2203098|NCT03243084|5402767|P1|COMPLETED|Session 2||10
2203099|NCT03243084|5402766|P2|STARTED|Session 2||10
2203100|NCT03243084|5402767|P1|STARTED|Session 2||10
2203101|NCT03243084|5402766|P2|NOT COMPLETED|Washout (1-3 Weeks)||0
2203102|NCT03243084|5402767|P1|NOT COMPLETED|Washout (1-3 Weeks)||1
2203103|NCT03243084|5402766|P2|COMPLETED|Washout (1-3 Weeks)||10
2203104|NCT03243084|5402767|P1|COMPLETED|Washout (1-3 Weeks)||10
2203105|NCT03243084|5402766|P2|STARTED|Washout (1-3 Weeks)||10
2203106|NCT03243084|5402767|P1|STARTED|Washout (1-3 Weeks)||11
2203107|NCT03243084|5402766|P2|NOT COMPLETED|Session 1||0
2203108|NCT03243084|5402767|P1|NOT COMPLETED|Session 1||0
2203109|NCT03243084|5402766|P2|COMPLETED|Session 1||10
2203110|NCT03243084|5402767|P1|COMPLETED|Session 1||11
2203111|NCT03243084|5402766|P2|STARTED|Session 1||10
2203112|NCT03243084|5402767|P1|STARTED|Session 1||11
2203113|NCT03242941|5402777|P1|NOT COMPLETED|Overall Study||2
2203114|NCT03242941|5402777|P1|COMPLETED|Overall Study||14
2203115|NCT03242941|5402777|P1|STARTED|Overall Study||16
2203116|NCT03242590|5402783|P1|NOT COMPLETED|Overall Study||0
2203117|NCT03242590|5402783|P1|COMPLETED|Overall Study||95
2203118|NCT03242590|5402783|P1|STARTED|Overall Study||95
2203119|NCT03242434|5402789|P2|NOT COMPLETED|Overall Study||2
2203120|NCT03242434|5402790|P1|NOT COMPLETED|Overall Study||0
2203121|NCT03242434|5402789|P2|COMPLETED|Overall Study||1
2203122|NCT03242434|5402790|P1|COMPLETED|Overall Study||15
2203123|NCT03242434|5402789|P2|STARTED|Overall Study||3
2203124|NCT03242434|5402790|P1|STARTED|Overall Study||15
2203125|NCT03242408|5402798|P1|NOT COMPLETED|Overall Study||2
2203126|NCT03242408|5402798|P1|COMPLETED|Overall Study||98
2203127|NCT03242408|5402798|P1|STARTED|Overall Study||100
2203128|NCT03239873|5402804|P2|NOT COMPLETED|Overall Study||27
2203129|NCT03239873|5402805|P1|NOT COMPLETED|Overall Study||32
2203130|NCT03239873|5402804|P2|COMPLETED|Overall Study||273
2203131|NCT03239873|5402805|P1|COMPLETED|Overall Study||268
2203132|NCT03239873|5402804|P2|Vaccination 2|Overall Study||282
2203133|NCT03239873|5402805|P1|Vaccination 2|Overall Study||276
2203134|NCT03239873|5402804|P2|Vaccination 1|Overall Study||300
2203135|NCT03239873|5402805|P1|Vaccination 1|Overall Study||299
2203136|NCT03239873|5402804|P2|STARTED|Overall Study||300
2203137|NCT03239873|5402805|P1|STARTED|Overall Study||300
2203138|NCT03239522|5402849|P1|NOT COMPLETED|Treatment Period 2 (Up to 15 Days)||0
2203139|NCT03239522|5402849|P1|COMPLETED|Treatment Period 2 (Up to 15 Days)||6
2203140|NCT03239522|5402849|P1|STARTED|Treatment Period 2 (Up to 15 Days)||6
2203141|NCT03239522|5402849|P1|NOT COMPLETED|Washout Period (Up to 7 Days)||0
2203142|NCT03239522|5402849|P1|COMPLETED|Washout Period (Up to 7 Days)||6
2203143|NCT03239522|5402849|P1|STARTED|Washout Period (Up to 7 Days)||6
2203144|NCT03239522|5402849|P1|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
2203145|NCT03239522|5402849|P1|COMPLETED|Treatment Period 1 (Up to 7 Days)||6
2203146|NCT03239522|5402849|P1|STARTED|Treatment Period 1 (Up to 7 Days)||6
2203147|NCT03239483|5402941|P2|NOT COMPLETED|Overall Study||0
2203148|NCT03239483|5402942|P1|NOT COMPLETED|Overall Study||2
2203149|NCT03239483|5402941|P2|COMPLETED|Overall Study||9
2203150|NCT03239483|5402942|P1|COMPLETED|Overall Study||17
2203151|NCT03239483|5402941|P2|STARTED|Overall Study||9
2203152|NCT03239483|5402942|P1|STARTED|Overall Study||19
2203153|NCT03238924|5402958|P2|NOT COMPLETED|Overall Study||2
2203154|NCT03238924|5402959|P1|NOT COMPLETED|Overall Study||2
2203155|NCT03238924|5402958|P2|COMPLETED|Overall Study||7
2203156|NCT03238924|5402959|P1|COMPLETED|Overall Study||6
2203157|NCT03238924|5402958|P2|STARTED|Overall Study||9
2203158|NCT03238924|5402959|P1|STARTED|Overall Study||8
2203167|NCT03238781|5403015|P3|NOT COMPLETED|Overall Study||20
2203168|NCT03238781|5403016|P2|NOT COMPLETED|Overall Study||17
2203169|NCT03238781|5403017|P1|NOT COMPLETED|Overall Study||26
2203170|NCT03238781|5403015|P3|COMPLETED|Overall Study||82
2203171|NCT03238781|5403016|P2|COMPLETED|Overall Study||87
2203172|NCT03238781|5403017|P1|COMPLETED|Overall Study||111
2203173|NCT03238781|5403015|P3|STARTED|Overall Study||102
2203174|NCT03238781|5403016|P2|STARTED|Overall Study||104
2203175|NCT03238781|5403017|P1|STARTED|Overall Study||137
2203176|NCT03238352|5403067|P3|NOT COMPLETED|Overall Study||1
2203177|NCT03238352|5403068|P2|NOT COMPLETED|Overall Study||3
2203178|NCT03238352|5403069|P1|NOT COMPLETED|Overall Study||0
2203179|NCT03238352|5403067|P3|COMPLETED|Overall Study||22
2203180|NCT03238352|5403068|P2|COMPLETED|Overall Study||20
2203181|NCT03238352|5403069|P1|COMPLETED|Overall Study||43
2203182|NCT03238352|5403067|P3|STARTED|Overall Study||23
2203183|NCT03238352|5403068|P2|STARTED|Overall Study||23
2203184|NCT03238352|5403069|P1|STARTED|Overall Study||43
2203185|NCT03238001|5403080|P1|NOT COMPLETED|Visit 2 (Secondary Endpoint Cohort)||29
2203186|NCT03238001|5403080|P1|COMPLETED|Visit 2 (Secondary Endpoint Cohort)||403
2203187|NCT03238001|5403080|P1|STARTED|Visit 2 (Secondary Endpoint Cohort)||432
2203188|NCT03238001|5403080|P1|NOT COMPLETED|Visit 1 (Primary Endpoint Cohort)||4
2203189|NCT03238001|5403080|P1|COMPLETED|Visit 1 (Primary Endpoint Cohort)||432
2203190|NCT03238001|5403080|P1|STARTED|Visit 1 (Primary Endpoint Cohort)||436
2203191|NCT03237871|5403103|P1|NOT COMPLETED|Overall Study||6
2203192|NCT03237871|5403103|P1|COMPLETED|Overall Study||11
2203193|NCT03237871|5403103|P1|STARTED|Overall Study||17
2203194|NCT03237156|5403113|P4|NOT COMPLETED|Overall Study||0
2203195|NCT03237156|5403114|P3|NOT COMPLETED|Overall Study||0
2203196|NCT03237156|5403115|P2|NOT COMPLETED|Overall Study||0
2203197|NCT03237156|5403116|P1|NOT COMPLETED|Overall Study||0
2203198|NCT03237156|5403113|P4|COMPLETED|Overall Study||6
2203199|NCT03237156|5403114|P3|COMPLETED|Overall Study||6
2203200|NCT03237156|5403115|P2|COMPLETED|Overall Study||6
2203201|NCT03237156|5403116|P1|COMPLETED|Overall Study||6
2203202|NCT03237156|5403113|P4|STARTED|Overall Study||6
2203203|NCT03237156|5403114|P3|STARTED|Overall Study||6
2203204|NCT03237156|5403115|P2|STARTED|Overall Study||6
2203205|NCT03237156|5403116|P1|STARTED|Overall Study||6
2203214|NCT03237013|5403253|P3|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||37
2203215|NCT03237013|5403254|P2|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||30
2203216|NCT03237013|5403255|P1|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||43
2203217|NCT03237013|5403253|P3|COMPLETED|Immediate Post-treatment to 1-mo F/u||36
2203218|NCT03237013|5403254|P2|COMPLETED|Immediate Post-treatment to 1-mo F/u||43
2203219|NCT03237013|5403255|P1|COMPLETED|Immediate Post-treatment to 1-mo F/u||30
2203220|NCT03237013|5403253|P3|STARTED|Immediate Post-treatment to 1-mo F/u||73
2203221|NCT03237013|5403254|P2|STARTED|Immediate Post-treatment to 1-mo F/u||73
2203222|NCT03237013|5403255|P1|STARTED|Immediate Post-treatment to 1-mo F/u||73
2203223|NCT03237013|5403253|P3|NOT COMPLETED|Baseline to Immediate Post-treatment||0
2203224|NCT03237013|5403254|P2|NOT COMPLETED|Baseline to Immediate Post-treatment||0
2203225|NCT03237013|5403255|P1|NOT COMPLETED|Baseline to Immediate Post-treatment||0
2203226|NCT03237013|5403253|P3|COMPLETED|Baseline to Immediate Post-treatment||73
2203227|NCT03237013|5403254|P2|COMPLETED|Baseline to Immediate Post-treatment||73
2203228|NCT03237013|5403255|P1|COMPLETED|Baseline to Immediate Post-treatment||73
2203229|NCT03237013|5403253|P3|STARTED|Baseline to Immediate Post-treatment||73
2203230|NCT03237013|5403254|P2|STARTED|Baseline to Immediate Post-treatment||73
2203231|NCT03237013|5403255|P1|STARTED|Baseline to Immediate Post-treatment||73
2203232|NCT03236311|5403304|P2|NOT COMPLETED|Overall Study||3
2203233|NCT03236311|5403305|P1|NOT COMPLETED|Overall Study||0
2203234|NCT03236311|5403304|P2|COMPLETED|Overall Study||2
2203235|NCT03236311|5403305|P1|COMPLETED|Overall Study||5
2203236|NCT03236311|5403304|P2|STARTED|Overall Study||5
2203237|NCT03236311|5403305|P1|STARTED|Overall Study||5
2203238|NCT03236168|5403315|P1|NOT COMPLETED|Overall Study||11
2203239|NCT03236168|5403315|P1|COMPLETED|Overall Study||107
2203240|NCT03236168|5403315|P1|STARTED|Overall Study||118
2203241|NCT03235817|5403322|P3|NOT COMPLETED|Overall Study||2
2203242|NCT03235817|5403323|P2|NOT COMPLETED|Overall Study||1
2203243|NCT03235817|5403324|P1|NOT COMPLETED|Overall Study||3
2203244|NCT03235817|5403322|P3|COMPLETED|Overall Study||11
2203245|NCT03235817|5403323|P2|COMPLETED|Overall Study||12
2203246|NCT03235817|5403324|P1|COMPLETED|Overall Study||10
2203247|NCT03235817|5403322|P3|STARTED|Overall Study||13
2203248|NCT03235817|5403323|P2|STARTED|Overall Study||13
2203249|NCT03235817|5403324|P1|STARTED|Overall Study||13
2203250|NCT03235726|5403349|P10|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
2203251|NCT03235726|5403350|P9|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
2203252|NCT03235726|5403351|P8|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
2203253|NCT03235726|5403352|P7|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
2203254|NCT03235726|5403353|P6|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
2203255|NCT03235726|5403354|P5|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
2203256|NCT03235726|5403355|P4|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
2203257|NCT03235726|5403356|P3|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
2203258|NCT03235726|5403357|P2|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
2203259|NCT03235726|5403358|P1|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
2203260|NCT03235726|5403349|P10|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||8
2203261|NCT03235726|5403350|P9|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
2203262|NCT03235726|5403351|P8|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
2203263|NCT03235726|5403352|P7|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
2203264|NCT03235726|5403353|P6|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
2203265|NCT03235726|5403354|P5|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
2203266|NCT03235726|5403355|P4|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
2203267|NCT03235726|5403356|P3|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
2203268|NCT03235726|5403357|P2|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
2203269|NCT03235726|5403358|P1|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
2203270|NCT03235726|5403349|P10|STARTED|Part 2 (Cohort B - Days 1 to 14)||8
2203271|NCT03235726|5403350|P9|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
2203272|NCT03235726|5403351|P8|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
2203273|NCT03235726|5403352|P7|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
2203274|NCT03235726|5403353|P6|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
2203275|NCT03235726|5403354|P5|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
2203276|NCT03235726|5403355|P4|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
2203277|NCT03235726|5403356|P3|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
2203278|NCT03235726|5403357|P2|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
2203279|NCT03235726|5403358|P1|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
2203280|NCT03235726|5403349|P10|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
2203281|NCT03235726|5403350|P9|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
2203282|NCT03235726|5403351|P8|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
2203283|NCT03235726|5403352|P7|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
2203284|NCT03235726|5403353|P6|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
2203285|NCT03235726|5403354|P5|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
2203286|NCT03235726|5403355|P4|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
2203287|NCT03235726|5403356|P3|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
2203288|NCT03235726|5403357|P2|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
2203289|NCT03235726|5403358|P1|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
2203290|NCT03235726|5403349|P10|COMPLETED|Part 2 (Cohort A - Day 1)||0
2203291|NCT03235726|5403350|P9|COMPLETED|Part 2 (Cohort A - Day 1)||2
2203292|NCT03235726|5403351|P8|COMPLETED|Part 2 (Cohort A - Day 1)||6
2203293|NCT03235726|5403352|P7|COMPLETED|Part 2 (Cohort A - Day 1)||0
2203294|NCT03235726|5403353|P6|COMPLETED|Part 2 (Cohort A - Day 1)||0
2203295|NCT03235726|5403354|P5|COMPLETED|Part 2 (Cohort A - Day 1)||0
2203296|NCT03235726|5403355|P4|COMPLETED|Part 2 (Cohort A - Day 1)||0
2203297|NCT03235726|5403356|P3|COMPLETED|Part 2 (Cohort A - Day 1)||0
2203298|NCT03235726|5403357|P2|COMPLETED|Part 2 (Cohort A - Day 1)||0
2203299|NCT03235726|5403358|P1|COMPLETED|Part 2 (Cohort A - Day 1)||0
2203300|NCT03235726|5403349|P10|STARTED|Part 2 (Cohort A - Day 1)||0
2203301|NCT03235726|5403350|P9|STARTED|Part 2 (Cohort A - Day 1)||2
2203302|NCT03235726|5403351|P8|STARTED|Part 2 (Cohort A - Day 1)||6
2203303|NCT03235726|5403352|P7|STARTED|Part 2 (Cohort A - Day 1)||0
2203304|NCT03235726|5403353|P6|STARTED|Part 2 (Cohort A - Day 1)||0
2203305|NCT03235726|5403354|P5|STARTED|Part 2 (Cohort A - Day 1)||0
2203306|NCT03235726|5403355|P4|STARTED|Part 2 (Cohort A - Day 1)||0
2203307|NCT03235726|5403356|P3|STARTED|Part 2 (Cohort A - Day 1)||0
2203308|NCT03235726|5403357|P2|STARTED|Part 2 (Cohort A - Day 1)||0
2203309|NCT03235726|5403358|P1|STARTED|Part 2 (Cohort A - Day 1)||0
2203310|NCT03235726|5403349|P10|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
2203311|NCT03235726|5403350|P9|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
2203312|NCT03235726|5403351|P8|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
2203313|NCT03235726|5403352|P7|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
2203314|NCT03235726|5403353|P6|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
2203315|NCT03235726|5403354|P5|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||2
2203316|NCT03235726|5403355|P4|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
2203317|NCT03235726|5403356|P3|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
2203318|NCT03235726|5403357|P2|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
2203319|NCT03235726|5403358|P1|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
2203320|NCT03235726|5403349|P10|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
2203321|NCT03235726|5403350|P9|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
2203322|NCT03235726|5403351|P8|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
2203323|NCT03235726|5403352|P7|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||14
2203324|NCT03235726|5403353|P6|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||2
2203325|NCT03235726|5403354|P5|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||10
2203326|NCT03235726|5403355|P4|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
2203327|NCT03235726|5403356|P3|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
2203328|NCT03235726|5403357|P2|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
2203329|NCT03235726|5403358|P1|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
2203330|NCT03235726|5403349|P10|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
2203331|NCT03235726|5403350|P9|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
2203332|NCT03235726|5403351|P8|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
2203333|NCT03235726|5403352|P7|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||14
2203334|NCT03235726|5403353|P6|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||2
2203335|NCT03235726|5403354|P5|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||12
2203336|NCT03235726|5403355|P4|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
2203337|NCT03235726|5403356|P3|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
2203338|NCT03235726|5403357|P2|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
2203339|NCT03235726|5403358|P1|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
2203340|NCT03235726|5403349|P10|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
2203341|NCT03235726|5403350|P9|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
2203342|NCT03235726|5403351|P8|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
2203343|NCT03235726|5403352|P7|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
2203344|NCT03235726|5403353|P6|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
2203345|NCT03235726|5403354|P5|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
2203346|NCT03235726|5403355|P4|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
2203347|NCT03235726|5403356|P3|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
2203348|NCT03235726|5403357|P2|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
2203349|NCT03235726|5403358|P1|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
2203350|NCT03235726|5403349|P10|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
2203351|NCT03235726|5403350|P9|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
2203352|NCT03235726|5403351|P8|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
2203353|NCT03235726|5403352|P7|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
2203354|NCT03235726|5403353|P6|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
2203355|NCT03235726|5403354|P5|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
2203356|NCT03235726|5403355|P4|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||2
2203357|NCT03235726|5403356|P3|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||6
2203358|NCT03235726|5403357|P2|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
2203359|NCT03235726|5403358|P1|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
2203360|NCT03235726|5403349|P10|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
2203361|NCT03235726|5403350|P9|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
2203362|NCT03235726|5403351|P8|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
2203363|NCT03235726|5403352|P7|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
2203364|NCT03235726|5403353|P6|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
2203365|NCT03235726|5403354|P5|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
2203366|NCT03235726|5403355|P4|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||2
2203367|NCT03235726|5403356|P3|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||6
2203368|NCT03235726|5403357|P2|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
2203369|NCT03235726|5403358|P1|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
2203370|NCT03235726|5403349|P10|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
2203371|NCT03235726|5403350|P9|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
2203372|NCT03235726|5403351|P8|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
2203373|NCT03235726|5403352|P7|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
2203374|NCT03235726|5403353|P6|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
2203375|NCT03235726|5403354|P5|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
2203376|NCT03235726|5403355|P4|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
2203377|NCT03235726|5403356|P3|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
2203378|NCT03235726|5403357|P2|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
2203379|NCT03235726|5403358|P1|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
2203380|NCT03235726|5403349|P10|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
2203381|NCT03235726|5403350|P9|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
2203382|NCT03235726|5403351|P8|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
2203383|NCT03235726|5403352|P7|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
2203384|NCT03235726|5403353|P6|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
2203385|NCT03235726|5403354|P5|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
2203386|NCT03235726|5403355|P4|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||2
2203387|NCT03235726|5403356|P3|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
2203388|NCT03235726|5403357|P2|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||6
2203389|NCT03235726|5403358|P1|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
2203390|NCT03235726|5403349|P10|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
2203391|NCT03235726|5403350|P9|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
2203392|NCT03235726|5403351|P8|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
2203393|NCT03235726|5403352|P7|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
2203394|NCT03235726|5403353|P6|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
2203395|NCT03235726|5403354|P5|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
2203396|NCT03235726|5403355|P4|STARTED|Part 1 (Cohort A 120 mg - Day 3)||2
2203397|NCT03235726|5403356|P3|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
2203398|NCT03235726|5403357|P2|STARTED|Part 1 (Cohort A 120 mg - Day 3)||6
2203399|NCT03235726|5403358|P1|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
2203400|NCT03235726|5403349|P10|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
2203401|NCT03235726|5403350|P9|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
2203402|NCT03235726|5403351|P8|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
2203403|NCT03235726|5403352|P7|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
2203404|NCT03235726|5403353|P6|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
2203405|NCT03235726|5403354|P5|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
2203406|NCT03235726|5403355|P4|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
2203407|NCT03235726|5403356|P3|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
2203408|NCT03235726|5403357|P2|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
2203409|NCT03235726|5403358|P1|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
2203410|NCT03235726|5403349|P10|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
2203411|NCT03235726|5403350|P9|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
2203412|NCT03235726|5403351|P8|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
2203413|NCT03235726|5403352|P7|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
2203414|NCT03235726|5403353|P6|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
2203415|NCT03235726|5403354|P5|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
2203416|NCT03235726|5403355|P4|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||2
2203417|NCT03235726|5403356|P3|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
2203418|NCT03235726|5403357|P2|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
2203419|NCT03235726|5403358|P1|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||6
2203420|NCT03235726|5403349|P10|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
2203421|NCT03235726|5403350|P9|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
2203422|NCT03235726|5403351|P8|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
2203423|NCT03235726|5403352|P7|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
2203424|NCT03235726|5403353|P6|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
2203425|NCT03235726|5403354|P5|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
2203426|NCT03235726|5403355|P4|STARTED|Part 1 (Cohort A 60 mg - Day 1)||2
2203427|NCT03235726|5403356|P3|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
2203428|NCT03235726|5403357|P2|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
2203429|NCT03235726|5403358|P1|STARTED|Part 1 (Cohort A 60 mg - Day 1)||6
2203430|NCT03235349|5403510|P1|NOT COMPLETED|Overall Study||2
2203431|NCT03235349|5403510|P1|COMPLETED|Overall Study||158
2203432|NCT03235349|5403510|P1|STARTED|Overall Study||160
2203433|NCT03235284|5403520|P3|NOT COMPLETED|Overall Study||1
2203434|NCT03235284|5403521|P2|NOT COMPLETED|Overall Study||2
2203435|NCT03235284|5403522|P1|NOT COMPLETED|Overall Study||1
2203436|NCT03235284|5403520|P3|COMPLETED|Overall Study||14
2203437|NCT03235284|5403521|P2|COMPLETED|Overall Study||13
2203438|NCT03235284|5403522|P1|COMPLETED|Overall Study||14
2203439|NCT03235284|5403520|P3|STARTED|Overall Study||15
2203440|NCT03235284|5403521|P2|STARTED|Overall Study||15
2203441|NCT03235284|5403522|P1|STARTED|Overall Study||15
2203442|NCT03235115|5403539|P6|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
2203443|NCT03235115|5403540|P5|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
2203444|NCT03235115|5403541|P4|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
2203445|NCT03235115|5403542|P3|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
2203446|NCT03235115|5403543|P2|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
2203447|NCT03235115|5403544|P1|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
2203448|NCT03235115|5403539|P6|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||5
2203449|NCT03235115|5403540|P5|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
2203450|NCT03235115|5403541|P4|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
2203451|NCT03235115|5403542|P3|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||7
2203452|NCT03235115|5403543|P2|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
2203453|NCT03235115|5403544|P1|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||9
2203454|NCT03235115|5403539|P6|STARTED|Third Intervention ( 1 Hour, Visit 6)||5
2203455|NCT03235115|5403540|P5|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
2203456|NCT03235115|5403541|P4|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
2203457|NCT03235115|5403542|P3|STARTED|Third Intervention ( 1 Hour, Visit 6)||7
2203458|NCT03235115|5403543|P2|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
2203459|NCT03235115|5403544|P1|STARTED|Third Intervention ( 1 Hour, Visit 6)||9
2203460|NCT03235115|5403539|P6|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
2203461|NCT03235115|5403540|P5|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
2203462|NCT03235115|5403541|P4|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
2203463|NCT03235115|5403542|P3|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
2203464|NCT03235115|5403543|P2|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
2203465|NCT03235115|5403544|P1|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
2203466|NCT03235115|5403539|P6|COMPLETED|Second Intervention (1 Hour, Visit 4)||5
2203467|NCT03235115|5403540|P5|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
2203468|NCT03235115|5403541|P4|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
2203469|NCT03235115|5403542|P3|COMPLETED|Second Intervention (1 Hour, Visit 4)||7
2203470|NCT03235115|5403543|P2|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
2203471|NCT03235115|5403544|P1|COMPLETED|Second Intervention (1 Hour, Visit 4)||9
2203472|NCT03235115|5403539|P6|STARTED|Second Intervention (1 Hour, Visit 4)||5
2203473|NCT03235115|5403540|P5|STARTED|Second Intervention (1 Hour, Visit 4)||6
2203474|NCT03235115|5403541|P4|STARTED|Second Intervention (1 Hour, Visit 4)||6
2203475|NCT03235115|5403542|P3|STARTED|Second Intervention (1 Hour, Visit 4)||7
2203476|NCT03235115|5403543|P2|STARTED|Second Intervention (1 Hour, Visit 4)||6
2203477|NCT03235115|5403544|P1|STARTED|Second Intervention (1 Hour, Visit 4)||9
2203478|NCT03235115|5403539|P6|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||1
2203479|NCT03235115|5403540|P5|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
2203480|NCT03235115|5403541|P4|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
2203481|NCT03235115|5403542|P3|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
2203482|NCT03235115|5403543|P2|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
2203483|NCT03235115|5403544|P1|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
2203484|NCT03235115|5403539|P6|COMPLETED|First Intervention (1 Hour, Visit 2)||5
2203485|NCT03235115|5403540|P5|COMPLETED|First Intervention (1 Hour, Visit 2)||6
2203486|NCT03235115|5403541|P4|COMPLETED|First Intervention (1 Hour, Visit 2)||6
2203487|NCT03235115|5403542|P3|COMPLETED|First Intervention (1 Hour, Visit 2)||7
2203488|NCT03235115|5403543|P2|COMPLETED|First Intervention (1 Hour, Visit 2)||6
2203489|NCT03235115|5403544|P1|COMPLETED|First Intervention (1 Hour, Visit 2)||9
2203490|NCT03235115|5403539|P6|STARTED|First Intervention (1 Hour, Visit 2)||6
2203491|NCT03235115|5403540|P5|STARTED|First Intervention (1 Hour, Visit 2)||6
2203492|NCT03235115|5403541|P4|STARTED|First Intervention (1 Hour, Visit 2)||6
2203493|NCT03235115|5403542|P3|STARTED|First Intervention (1 Hour, Visit 2)||7
2203494|NCT03235115|5403543|P2|STARTED|First Intervention (1 Hour, Visit 2)||6
2203495|NCT03235115|5403544|P1|STARTED|First Intervention (1 Hour, Visit 2)||9
2203496|NCT03234036|5403567|P4|NOT COMPLETED|Part 2 (Up to 25 Days)||0
2203497|NCT03234036|5403568|P3|NOT COMPLETED|Part 2 (Up to 25 Days)||0
2203498|NCT03234036|5403569|P2|NOT COMPLETED|Part 2 (Up to 25 Days)||0
2203499|NCT03234036|5403570|P1|NOT COMPLETED|Part 2 (Up to 25 Days)||0
2203500|NCT03234036|5403567|P4|COMPLETED|Part 2 (Up to 25 Days)||7
2203501|NCT03234036|5403568|P3|COMPLETED|Part 2 (Up to 25 Days)||3
2203502|NCT03234036|5403569|P2|COMPLETED|Part 2 (Up to 25 Days)||0
2203503|NCT03234036|5403570|P1|COMPLETED|Part 2 (Up to 25 Days)||0
2203504|NCT03234036|5403567|P4|STARTED|Part 2 (Up to 25 Days)||7
2203505|NCT03234036|5403568|P3|STARTED|Part 2 (Up to 25 Days)||3
2203506|NCT03234036|5403569|P2|STARTED|Part 2 (Up to 25 Days)||0
2203507|NCT03234036|5403570|P1|STARTED|Part 2 (Up to 25 Days)||0
2203508|NCT03234036|5403567|P4|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
2203509|NCT03234036|5403568|P3|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
2203510|NCT03234036|5403569|P2|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
2203511|NCT03234036|5403570|P1|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
2203512|NCT03234036|5403567|P4|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
2203513|NCT03234036|5403568|P3|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
2203514|NCT03234036|5403569|P2|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||7
2203515|NCT03234036|5403570|P1|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||7
2203516|NCT03234036|5403567|P4|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||0
2203517|NCT03234036|5403568|P3|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||0
2203518|NCT03234036|5403569|P2|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||7
2203519|NCT03234036|5403570|P1|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||7
2203520|NCT03234036|5403567|P4|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
2203521|NCT03234036|5403568|P3|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
2203522|NCT03234036|5403569|P2|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
2203523|NCT03234036|5403570|P1|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
2203524|NCT03234036|5403567|P4|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
2203525|NCT03234036|5403568|P3|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
2203526|NCT03234036|5403569|P2|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||7
2203527|NCT03234036|5403570|P1|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||7
2203528|NCT03234036|5403567|P4|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||0
2203529|NCT03234036|5403568|P3|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||0
2203530|NCT03234036|5403569|P2|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||7
2203531|NCT03234036|5403570|P1|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||7
2203532|NCT03234036|5403567|P4|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
2203533|NCT03234036|5403568|P3|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
2203534|NCT03234036|5403569|P2|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
2203535|NCT03234036|5403570|P1|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
2203536|NCT03234036|5403567|P4|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
2203537|NCT03234036|5403568|P3|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
2203538|NCT03234036|5403569|P2|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||7
2203539|NCT03234036|5403570|P1|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||7
2203540|NCT03234036|5403567|P4|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||0
2203541|NCT03234036|5403568|P3|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||0
2203542|NCT03234036|5403569|P2|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||7
2203543|NCT03234036|5403570|P1|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||7
2203544|NCT03234036|5403567|P4|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
2203545|NCT03234036|5403568|P3|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
2203546|NCT03234036|5403569|P2|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||1
2203547|NCT03234036|5403570|P1|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||1
2203548|NCT03234036|5403567|P4|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
2203549|NCT03234036|5403568|P3|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
2203550|NCT03234036|5403569|P2|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||7
2203551|NCT03234036|5403570|P1|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||7
2203552|NCT03234036|5403567|P4|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||0
2203553|NCT03234036|5403568|P3|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||0
2203554|NCT03234036|5403569|P2|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||8
2203555|NCT03234036|5403570|P1|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||8
2203556|NCT03234036|5403567|P4|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
2203557|NCT03234036|5403568|P3|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
2203558|NCT03234036|5403569|P2|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
2203559|NCT03234036|5403570|P1|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
2203560|NCT03234036|5403567|P4|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
2203561|NCT03234036|5403568|P3|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
2203562|NCT03234036|5403569|P2|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||8
2203563|NCT03234036|5403570|P1|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||8
2203564|NCT03234036|5403567|P4|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||0
2203565|NCT03234036|5403568|P3|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||0
2203566|NCT03234036|5403569|P2|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||8
2203567|NCT03234036|5403570|P1|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||8
2203568|NCT03233737|5403677|P5|NOT COMPLETED|Overall Study||0
2203569|NCT03233737|5403678|P4|NOT COMPLETED|Overall Study||0
2203570|NCT03233737|5403679|P3|NOT COMPLETED|Overall Study||0
2203571|NCT03233737|5403680|P2|NOT COMPLETED|Overall Study||0
2203572|NCT03233737|5403681|P1|NOT COMPLETED|Overall Study||0
2203573|NCT03233737|5403677|P5|COMPLETED|Overall Study||26
2203574|NCT03233737|5403678|P4|COMPLETED|Overall Study||24
2203575|NCT03233737|5403679|P3|COMPLETED|Overall Study||5
2203576|NCT03233737|5403680|P2|COMPLETED|Overall Study||10
2203577|NCT03233737|5403681|P1|COMPLETED|Overall Study||10
2203578|NCT03233737|5403677|P5|STARTED|Overall Study||26
2203579|NCT03233737|5403678|P4|STARTED|Overall Study||24
2203580|NCT03233737|5403679|P3|STARTED|Overall Study||5
2203581|NCT03233737|5403680|P2|STARTED|Overall Study||10
2203582|NCT03233737|5403681|P1|STARTED|Overall Study||10
2203583|NCT03233529|5403741|P1|NOT COMPLETED|Open-Label Period (Day 15 to Day 71)||1
2203584|NCT03233529|5403741|P1|COMPLETED|Open-Label Period (Day 15 to Day 71)||38
2203585|NCT03233529|5403741|P1|STARTED|Open-Label Period (Day 15 to Day 71)||39
2203586|NCT03233529|5403741|P1|NOT COMPLETED|Double-Blind Period (Day 1 to Day 15)||1
2203587|NCT03233529|5403741|P1|COMPLETED|Double-Blind Period (Day 1 to Day 15)||39
2203588|NCT03233529|5403741|P1|STARTED|Double-Blind Period (Day 1 to Day 15)||40
2203589|NCT03233438|5403785|P2|NOT COMPLETED|Overall Study||11
2203590|NCT03233438|5403786|P1|NOT COMPLETED|Overall Study||6
2203591|NCT03233438|5403785|P2|COMPLETED|Overall Study||32
2203592|NCT03233438|5403786|P1|COMPLETED|Overall Study||42
2203593|NCT03233438|5403785|P2|STARTED|Overall Study||43
2203594|NCT03233438|5403786|P1|STARTED|Overall Study||48
2203595|NCT03233308|5403852|P1|NOT COMPLETED|Overall Study||2
2203596|NCT03233308|5403852|P1|COMPLETED|Overall Study||18
2203597|NCT03233308|5403852|P1|STARTED|Overall Study||20
2203598|NCT03233217|5403869|P5|NOT COMPLETED|Overall Study||0
2203599|NCT03233217|5403870|P4|NOT COMPLETED|Overall Study||0
2203600|NCT03233217|5403871|P3|NOT COMPLETED|Overall Study||0
2203601|NCT03233217|5403872|P2|NOT COMPLETED|Overall Study||0
2203602|NCT03233217|5403873|P1|NOT COMPLETED|Overall Study||0
2203603|NCT03233217|5403869|P5|COMPLETED|Overall Study||55
2203604|NCT03233217|5403870|P4|COMPLETED|Overall Study||55
2203605|NCT03233217|5403871|P3|COMPLETED|Overall Study||55
2203606|NCT03233217|5403872|P2|COMPLETED|Overall Study||5
2203607|NCT03233217|5403873|P1|COMPLETED|Overall Study||5
2203608|NCT03233217|5403869|P5|Per-protocol Analysis Set (PPAS)|Overall Study||54
2203609|NCT03233217|5403870|P4|Per-protocol Analysis Set (PPAS)|Overall Study||55
2203610|NCT03233217|5403871|P3|Per-protocol Analysis Set (PPAS)|Overall Study||55
2203611|NCT03233217|5403872|P2|Per-protocol Analysis Set (PPAS)|Overall Study||5
2203612|NCT03233217|5403873|P1|Per-protocol Analysis Set (PPAS)|Overall Study||5
2203613|NCT03233217|5403869|P5|Safety Analysis Set (SafAS)|Overall Study||55
2203614|NCT03233217|5403870|P4|Safety Analysis Set (SafAS)|Overall Study||55
2203615|NCT03233217|5403871|P3|Safety Analysis Set (SafAS)|Overall Study||55
2203616|NCT03233217|5403872|P2|Safety Analysis Set (SafAS)|Overall Study||5
2203617|NCT03233217|5403873|P1|Safety Analysis Set (SafAS)|Overall Study||5
2203618|NCT03233217|5403869|P5|STARTED|Overall Study||55
2203619|NCT03233217|5403870|P4|STARTED|Overall Study||55
2203620|NCT03233217|5403871|P3|STARTED|Overall Study||55
2203621|NCT03233217|5403872|P2|STARTED|Overall Study||5
2203622|NCT03233217|5403873|P1|STARTED|Overall Study||5
2203623|NCT03233009|5403902|P1|NOT COMPLETED|Overall Study||1
2203624|NCT03233009|5403902|P1|COMPLETED|Overall Study||39
2203625|NCT03233009|5403902|P1|Reference Product|Overall Study||39
2203626|NCT03233009|5403902|P1|Test Product 4|Overall Study||39
2203627|NCT03233009|5403902|P1|Test Product 3|Overall Study||39
2203628|NCT03233009|5403902|P1|Test Product 2|Overall Study||39
2203629|NCT03233009|5403902|P1|Test Product 1|Overall Study||39
2203630|NCT03233009|5403902|P1|STARTED|Overall Study||40
2203631|NCT03232892|5403945|P1|NOT COMPLETED|Overall Study||0
2203632|NCT03232892|5403945|P1|COMPLETED|Overall Study||1
2203633|NCT03232892|5403945|P1|STARTED|Overall Study||1
2203634|NCT03232827|5403953|P1|NOT COMPLETED|Flavored-very Low Sweetened||0
2203635|NCT03232827|5403953|P1|COMPLETED|Flavored-very Low Sweetened||66
2203636|NCT03232827|5403953|P1|STARTED|Flavored-very Low Sweetened||66
2203637|NCT03232827|5403953|P1|NOT COMPLETED|Unflavored-very Low Sweetened (UU)||0
2203638|NCT03232827|5403953|P1|COMPLETED|Unflavored-very Low Sweetened (UU)||66
2203639|NCT03232827|5403953|P1|STARTED|Unflavored-very Low Sweetened (UU)||66
2203640|NCT03232827|5403953|P1|NOT COMPLETED|Unflavored-sweetened (US)||0
2203641|NCT03232827|5403953|P1|COMPLETED|Unflavored-sweetened (US)||86
2203642|NCT03232827|5403953|P1|STARTED|Unflavored-sweetened (US)||86
2203643|NCT03232827|5403953|P1|NOT COMPLETED|Flavored-sweetened (FS)||0
2203644|NCT03232827|5403953|P1|COMPLETED|Flavored-sweetened (FS)||80
2203645|NCT03232827|5403953|P1|STARTED|Flavored-sweetened (FS)||80
2203646|NCT03232580|5403967|P1|NOT COMPLETED|Overall Study||0
2203647|NCT03232580|5403967|P1|COMPLETED|Overall Study||5
2203648|NCT03232580|5403967|P1|STARTED|Overall Study||5
2203649|NCT03232567|5403976|P4|NOT COMPLETED|Overall Study||0
2203650|NCT03232567|5403977|P3|NOT COMPLETED|Overall Study||0
2203651|NCT03232567|5403978|P2|NOT COMPLETED|Overall Study||1
2203652|NCT03232567|5403979|P1|NOT COMPLETED|Overall Study||0
2203653|NCT03232567|5403976|P4|COMPLETED|Overall Study||15
2203654|NCT03232567|5403977|P3|COMPLETED|Overall Study||15
2203655|NCT03232567|5403978|P2|COMPLETED|Overall Study||14
2203656|NCT03232567|5403979|P1|COMPLETED|Overall Study||15
2203657|NCT03232567|5403976|P4|STARTED|Overall Study||15
2203658|NCT03232567|5403977|P3|STARTED|Overall Study||15
2203659|NCT03232567|5403978|P2|STARTED|Overall Study||15
2203660|NCT03232567|5403979|P1|STARTED|Overall Study||15
2203661|NCT03232333|5404001|P1|NOT COMPLETED|Overall Study||15
2203662|NCT03232333|5404001|P1|COMPLETED|Overall Study||38
2203663|NCT03232333|5404001|P1|STARTED|Overall Study||53
2203664|NCT03231943|5404018|P13|NOT COMPLETED|Part 2||0
2203665|NCT03231943|5404019|P12|NOT COMPLETED|Part 2||1
2203666|NCT03231943|5404020|P11|NOT COMPLETED|Part 2||1
2203667|NCT03231943|5404021|P10|NOT COMPLETED|Part 2||0
2203668|NCT03231943|5404022|P9|NOT COMPLETED|Part 2||0
2203669|NCT03231943|5404023|P8|NOT COMPLETED|Part 2||0
2203670|NCT03231943|5404024|P7|NOT COMPLETED|Part 2||0
2203671|NCT03231943|5404025|P6|NOT COMPLETED|Part 2||0
2203672|NCT03231943|5404026|P5|NOT COMPLETED|Part 2||0
2203673|NCT03231943|5404027|P4|NOT COMPLETED|Part 2||0
2203674|NCT03231943|5404028|P3|NOT COMPLETED|Part 2||0
2203675|NCT03231943|5404029|P2|NOT COMPLETED|Part 2||0
2203676|NCT03231943|5404030|P1|NOT COMPLETED|Part 2||0
2203677|NCT03231943|5404018|P13|COMPLETED|Part 2||14
2203678|NCT03231943|5404019|P12|COMPLETED|Part 2||6
2203679|NCT03231943|5404020|P11|COMPLETED|Part 2||24
2203680|NCT03231943|5404021|P10|COMPLETED|Part 2||6
2203681|NCT03231943|5404022|P9|COMPLETED|Part 2||6
2203682|NCT03231943|5404023|P8|COMPLETED|Part 2||0
2203683|NCT03231943|5404024|P7|COMPLETED|Part 2||0
2203684|NCT03231943|5404025|P6|COMPLETED|Part 2||0
2203685|NCT03231943|5404026|P5|COMPLETED|Part 2||0
2203686|NCT03231943|5404027|P4|COMPLETED|Part 2||0
2203687|NCT03231943|5404028|P3|COMPLETED|Part 2||0
2203688|NCT03231943|5404029|P2|COMPLETED|Part 2||0
2203689|NCT03231943|5404030|P1|COMPLETED|Part 2||0
2203690|NCT03231943|5404018|P13|STARTED|Part 2||14
2203691|NCT03231943|5404019|P12|STARTED|Part 2||7
2203692|NCT03231943|5404020|P11|STARTED|Part 2||25
2203693|NCT03231943|5404021|P10|STARTED|Part 2||6
2203694|NCT03231943|5404022|P9|STARTED|Part 2||6
2203695|NCT03231943|5404023|P8|STARTED|Part 2||0
2203696|NCT03231943|5404024|P7|STARTED|Part 2||0
2203697|NCT03231943|5404025|P6|STARTED|Part 2||0
2203698|NCT03231943|5404026|P5|STARTED|Part 2||0
2203699|NCT03231943|5404027|P4|STARTED|Part 2||0
2203700|NCT03231943|5404028|P3|STARTED|Part 2||0
2203701|NCT03231943|5404029|P2|STARTED|Part 2||0
2203702|NCT03231943|5404030|P1|STARTED|Part 2||0
2203703|NCT03231943|5404018|P13|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
2203704|NCT03231943|5404019|P12|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
2203705|NCT03231943|5404020|P11|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
2203706|NCT03231943|5404021|P10|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
2203707|NCT03231943|5404022|P9|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
2203708|NCT03231943|5404023|P8|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
2203709|NCT03231943|5404024|P7|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
2203710|NCT03231943|5404025|P6|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
2203711|NCT03231943|5404026|P5|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
2203712|NCT03231943|5404027|P4|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
2203713|NCT03231943|5404028|P3|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
2203714|NCT03231943|5404029|P2|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
2203715|NCT03231943|5404030|P1|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
2203716|NCT03231943|5404018|P13|COMPLETED|Part 1 Period 4 (up to Day 60)||0
2203717|NCT03231943|5404019|P12|COMPLETED|Part 1 Period 4 (up to Day 60)||0
2203718|NCT03231943|5404020|P11|COMPLETED|Part 1 Period 4 (up to Day 60)||0
2203719|NCT03231943|5404021|P10|COMPLETED|Part 1 Period 4 (up to Day 60)||0
2203720|NCT03231943|5404022|P9|COMPLETED|Part 1 Period 4 (up to Day 60)||0
2203721|NCT03231943|5404023|P8|COMPLETED|Part 1 Period 4 (up to Day 60)||2
2203722|NCT03231943|5404024|P7|COMPLETED|Part 1 Period 4 (up to Day 60)||2
2203723|NCT03231943|5404025|P6|COMPLETED|Part 1 Period 4 (up to Day 60)||2
2203724|NCT03231943|5404026|P5|COMPLETED|Part 1 Period 4 (up to Day 60)||2
2203725|NCT03231943|5404027|P4|COMPLETED|Part 1 Period 4 (up to Day 60)||2
2203726|NCT03231943|5404028|P3|COMPLETED|Part 1 Period 4 (up to Day 60)||2
2203727|NCT03231943|5404029|P2|COMPLETED|Part 1 Period 4 (up to Day 60)||2
2203728|NCT03231943|5404030|P1|COMPLETED|Part 1 Period 4 (up to Day 60)||2
2203729|NCT03231943|5404018|P13|STARTED|Part 1 Period 4 (up to Day 60)||0
2203730|NCT03231943|5404019|P12|STARTED|Part 1 Period 4 (up to Day 60)||0
2203731|NCT03231943|5404020|P11|STARTED|Part 1 Period 4 (up to Day 60)||0
2203732|NCT03231943|5404021|P10|STARTED|Part 1 Period 4 (up to Day 60)||0
2203733|NCT03231943|5404022|P9|STARTED|Part 1 Period 4 (up to Day 60)||0
2203734|NCT03231943|5404023|P8|STARTED|Part 1 Period 4 (up to Day 60)||2
2203735|NCT03231943|5404024|P7|STARTED|Part 1 Period 4 (up to Day 60)||2
2203736|NCT03231943|5404025|P6|STARTED|Part 1 Period 4 (up to Day 60)||2
2203737|NCT03231943|5404026|P5|STARTED|Part 1 Period 4 (up to Day 60)||2
2203738|NCT03231943|5404027|P4|STARTED|Part 1 Period 4 (up to Day 60)||2
2203739|NCT03231943|5404028|P3|STARTED|Part 1 Period 4 (up to Day 60)||2
2203740|NCT03231943|5404029|P2|STARTED|Part 1 Period 4 (up to Day 60)||2
2203741|NCT03231943|5404030|P1|STARTED|Part 1 Period 4 (up to Day 60)||2
2203742|NCT03231943|5404018|P13|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
2203743|NCT03231943|5404019|P12|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
2203744|NCT03231943|5404020|P11|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
2203745|NCT03231943|5404021|P10|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
2203746|NCT03231943|5404022|P9|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
2203747|NCT03231943|5404023|P8|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
2203748|NCT03231943|5404024|P7|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
2203749|NCT03231943|5404025|P6|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
2203750|NCT03231943|5404026|P5|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
2203751|NCT03231943|5404027|P4|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
2203752|NCT03231943|5404028|P3|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
2203753|NCT03231943|5404029|P2|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
2203754|NCT03231943|5404030|P1|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||1
2203755|NCT03231943|5404018|P13|COMPLETED|Part 1, Period 3 (up to Day 45)||0
2203756|NCT03231943|5404019|P12|COMPLETED|Part 1, Period 3 (up to Day 45)||0
2203757|NCT03231943|5404020|P11|COMPLETED|Part 1, Period 3 (up to Day 45)||0
2203758|NCT03231943|5404021|P10|COMPLETED|Part 1, Period 3 (up to Day 45)||0
2203759|NCT03231943|5404022|P9|COMPLETED|Part 1, Period 3 (up to Day 45)||0
2203760|NCT03231943|5404023|P8|COMPLETED|Part 1, Period 3 (up to Day 45)||2
2203761|NCT03231943|5404024|P7|COMPLETED|Part 1, Period 3 (up to Day 45)||2
2203762|NCT03231943|5404025|P6|COMPLETED|Part 1, Period 3 (up to Day 45)||2
2203763|NCT03231943|5404026|P5|COMPLETED|Part 1, Period 3 (up to Day 45)||2
2203764|NCT03231943|5404027|P4|COMPLETED|Part 1, Period 3 (up to Day 45)||2
2203765|NCT03231943|5404028|P3|COMPLETED|Part 1, Period 3 (up to Day 45)||2
2203766|NCT03231943|5404029|P2|COMPLETED|Part 1, Period 3 (up to Day 45)||2
2203767|NCT03231943|5404030|P1|COMPLETED|Part 1, Period 3 (up to Day 45)|One participant withdrawn was replaced|1
2203768|NCT03231943|5404018|P13|STARTED|Part 1, Period 3 (up to Day 45)||0
2203769|NCT03231943|5404019|P12|STARTED|Part 1, Period 3 (up to Day 45)||0
2203770|NCT03231943|5404020|P11|STARTED|Part 1, Period 3 (up to Day 45)||0
2203771|NCT03231943|5404021|P10|STARTED|Part 1, Period 3 (up to Day 45)||0
2203772|NCT03231943|5404022|P9|STARTED|Part 1, Period 3 (up to Day 45)||0
2203773|NCT03231943|5404023|P8|STARTED|Part 1, Period 3 (up to Day 45)||2
2203774|NCT03231943|5404024|P7|STARTED|Part 1, Period 3 (up to Day 45)||2
2203775|NCT03231943|5404025|P6|STARTED|Part 1, Period 3 (up to Day 45)||2
2203776|NCT03231943|5404026|P5|STARTED|Part 1, Period 3 (up to Day 45)||2
2203777|NCT03231943|5404027|P4|STARTED|Part 1, Period 3 (up to Day 45)||2
2203778|NCT03231943|5404028|P3|STARTED|Part 1, Period 3 (up to Day 45)||2
2203779|NCT03231943|5404029|P2|STARTED|Part 1, Period 3 (up to Day 45)||2
2203780|NCT03231943|5404030|P1|STARTED|Part 1, Period 3 (up to Day 45)||2
2203781|NCT03231943|5404018|P13|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
2203782|NCT03231943|5404019|P12|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
2203783|NCT03231943|5404020|P11|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
2203784|NCT03231943|5404021|P10|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
2203785|NCT03231943|5404022|P9|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
2203786|NCT03231943|5404023|P8|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
2203787|NCT03231943|5404024|P7|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
2203788|NCT03231943|5404025|P6|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
2203789|NCT03231943|5404026|P5|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
2203790|NCT03231943|5404027|P4|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
2203791|NCT03231943|5404028|P3|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||1
2203792|NCT03231943|5404029|P2|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||2
2203793|NCT03231943|5404030|P1|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
2203794|NCT03231943|5404018|P13|COMPLETED|Part 1, Period 2 (up to Day 30)||0
2203795|NCT03231943|5404019|P12|COMPLETED|Part 1, Period 2 (up to Day 30)||0
2203796|NCT03231943|5404020|P11|COMPLETED|Part 1, Period 2 (up to Day 30)||0
2203797|NCT03231943|5404021|P10|COMPLETED|Part 1, Period 2 (up to Day 30)||0
2203798|NCT03231943|5404022|P9|COMPLETED|Part 1, Period 2 (up to Day 30)||0
2203799|NCT03231943|5404023|P8|COMPLETED|Part 1, Period 2 (up to Day 30)||2
2203800|NCT03231943|5404024|P7|COMPLETED|Part 1, Period 2 (up to Day 30)||2
2203801|NCT03231943|5404025|P6|COMPLETED|Part 1, Period 2 (up to Day 30)||2
2203802|NCT03231943|5404026|P5|COMPLETED|Part 1, Period 2 (up to Day 30)||2
2203803|NCT03231943|5404027|P4|COMPLETED|Part 1, Period 2 (up to Day 30)||2
2203804|NCT03231943|5404028|P3|COMPLETED|Part 1, Period 2 (up to Day 30)|One participant withdrawn was replaced|1
2203805|NCT03231943|5404029|P2|COMPLETED|Part 1, Period 2 (up to Day 30)|Two participants withdrawn were replaced|0
2203806|NCT03231943|5404030|P1|COMPLETED|Part 1, Period 2 (up to Day 30)||2
2203807|NCT03231943|5404018|P13|STARTED|Part 1, Period 2 (up to Day 30)||0
2203808|NCT03231943|5404019|P12|STARTED|Part 1, Period 2 (up to Day 30)||0
2203809|NCT03231943|5404020|P11|STARTED|Part 1, Period 2 (up to Day 30)||0
2203810|NCT03231943|5404021|P10|STARTED|Part 1, Period 2 (up to Day 30)||0
2203811|NCT03231943|5404022|P9|STARTED|Part 1, Period 2 (up to Day 30)||0
2203812|NCT03231943|5404023|P8|STARTED|Part 1, Period 2 (up to Day 30)||2
2203813|NCT03231943|5404024|P7|STARTED|Part 1, Period 2 (up to Day 30)||2
2203814|NCT03231943|5404025|P6|STARTED|Part 1, Period 2 (up to Day 30)||2
2203815|NCT03231943|5404026|P5|STARTED|Part 1, Period 2 (up to Day 30)||2
2203816|NCT03231943|5404027|P4|STARTED|Part 1, Period 2 (up to Day 30)||2
2203817|NCT03231943|5404028|P3|STARTED|Part 1, Period 2 (up to Day 30)||2
2203818|NCT03231943|5404029|P2|STARTED|Part 1, Period 2 (up to Day 30)||2
2203819|NCT03231943|5404030|P1|STARTED|Part 1, Period 2 (up to Day 30)||2
2203820|NCT03231943|5404018|P13|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
2203821|NCT03231943|5404019|P12|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
2203822|NCT03231943|5404020|P11|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
2203823|NCT03231943|5404021|P10|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
2203824|NCT03231943|5404022|P9|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
2203825|NCT03231943|5404023|P8|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
2203826|NCT03231943|5404024|P7|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
2203827|NCT03231943|5404025|P6|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
2203828|NCT03231943|5404026|P5|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
2203829|NCT03231943|5404027|P4|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
2203830|NCT03231943|5404028|P3|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
2203831|NCT03231943|5404029|P2|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
2203832|NCT03231943|5404030|P1|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
2203833|NCT03231943|5404018|P13|COMPLETED|Part 1, Period 1 (up to Day 15)||0
2203834|NCT03231943|5404019|P12|COMPLETED|Part 1, Period 1 (up to Day 15)||0
2203835|NCT03231943|5404020|P11|COMPLETED|Part 1, Period 1 (up to Day 15)||0
2203836|NCT03231943|5404021|P10|COMPLETED|Part 1, Period 1 (up to Day 15)||0
2203837|NCT03231943|5404022|P9|COMPLETED|Part 1, Period 1 (up to Day 15)||0
2203838|NCT03231943|5404023|P8|COMPLETED|Part 1, Period 1 (up to Day 15)||2
2203839|NCT03231943|5404024|P7|COMPLETED|Part 1, Period 1 (up to Day 15)||2
2203840|NCT03231943|5404025|P6|COMPLETED|Part 1, Period 1 (up to Day 15)||2
2203841|NCT03231943|5404026|P5|COMPLETED|Part 1, Period 1 (up to Day 15)||2
2203842|NCT03231943|5404027|P4|COMPLETED|Part 1, Period 1 (up to Day 15)||2
2203843|NCT03231943|5404028|P3|COMPLETED|Part 1, Period 1 (up to Day 15)||2
2203844|NCT03231943|5404029|P2|COMPLETED|Part 1, Period 1 (up to Day 15)||2
2203845|NCT03231943|5404030|P1|COMPLETED|Part 1, Period 1 (up to Day 15)||2
2203846|NCT03231943|5404018|P13|STARTED|Part 1, Period 1 (up to Day 15)||0
2203847|NCT03231943|5404019|P12|STARTED|Part 1, Period 1 (up to Day 15)||0
2203848|NCT03231943|5404020|P11|STARTED|Part 1, Period 1 (up to Day 15)||0
2203849|NCT03231943|5404021|P10|STARTED|Part 1, Period 1 (up to Day 15)||0
2203850|NCT03231943|5404022|P9|STARTED|Part 1, Period 1 (up to Day 15)||0
2203851|NCT03231943|5404023|P8|STARTED|Part 1, Period 1 (up to Day 15)||2
2203852|NCT03231943|5404024|P7|STARTED|Part 1, Period 1 (up to Day 15)||2
2203853|NCT03231943|5404025|P6|STARTED|Part 1, Period 1 (up to Day 15)||2
2203854|NCT03231943|5404026|P5|STARTED|Part 1, Period 1 (up to Day 15)||2
2203855|NCT03231943|5404027|P4|STARTED|Part 1, Period 1 (up to Day 15)||2
2203856|NCT03231943|5404028|P3|STARTED|Part 1, Period 1 (up to Day 15)||2
2203857|NCT03231943|5404029|P2|STARTED|Part 1, Period 1 (up to Day 15)||2
2203858|NCT03231943|5404030|P1|STARTED|Part 1, Period 1 (up to Day 15)||2
2203859|NCT03231917|5404480|P2|NOT COMPLETED|Overall Study||0
2203860|NCT03231917|5404481|P1|NOT COMPLETED|Overall Study||0
2203861|NCT03231917|5404480|P2|COMPLETED|Overall Study||61
2203862|NCT03231917|5404481|P1|COMPLETED|Overall Study||60
2203863|NCT03231917|5404480|P2|STARTED|Overall Study||61
2203864|NCT03231917|5404481|P1|STARTED|Overall Study||60
2203865|NCT03231709|5404493|P2|NOT COMPLETED|Treatment Period 2||1
2203866|NCT03231709|5404494|P1|NOT COMPLETED|Treatment Period 2||0
2203867|NCT03231709|5404493|P2|COMPLETED|Treatment Period 2||28
2203868|NCT03231709|5404494|P1|COMPLETED|Treatment Period 2||30
2203869|NCT03231709|5404493|P2|STARTED|Treatment Period 2||29
2203870|NCT03231709|5404494|P1|STARTED|Treatment Period 2||30
2203871|NCT03231709|5404493|P2|NOT COMPLETED|Treatment Period 1||1
2203872|NCT03231709|5404494|P1|NOT COMPLETED|Treatment Period 1||0
2203873|NCT03231709|5404493|P2|COMPLETED|Treatment Period 1||29
2203874|NCT03231709|5404494|P1|COMPLETED|Treatment Period 1||30
2203875|NCT03231709|5404493|P2|STARTED|Treatment Period 1||30
2203876|NCT03231709|5404494|P1|STARTED|Treatment Period 1||30
2203877|NCT03231371|5404512|P1|NOT COMPLETED|Overall Study||13
2203878|NCT03231371|5404512|P1|COMPLETED|Overall Study||9
2203879|NCT03231371|5404512|P1|Optional and Age Limited (12 Yrs+) MRI|Overall Study||9
2203880|NCT03231371|5404512|P1|STARTED|Overall Study||22
2203881|NCT03231345|5404517|P1|NOT COMPLETED|Overall Study||0
2203882|NCT03231345|5404517|P1|COMPLETED|Overall Study||35
2203883|NCT03231345|5404517|P1|STARTED|Overall Study||35
2203884|NCT03230864|5404526|P4|NOT COMPLETED|Double Blind Treatment (DBT) Period||2
2203885|NCT03230864|5404527|P3|NOT COMPLETED|Double Blind Treatment (DBT) Period||8
2203886|NCT03230864|5404528|P2|NOT COMPLETED|Double Blind Treatment (DBT) Period||0
2203887|NCT03230864|5404529|P1|NOT COMPLETED|Double Blind Treatment (DBT) Period||0
2203888|NCT03230864|5404526|P4|COMPLETED|Double Blind Treatment (DBT) Period||31
2203889|NCT03230864|5404527|P3|COMPLETED|Double Blind Treatment (DBT) Period||27
2203890|NCT03230864|5404528|P2|COMPLETED|Double Blind Treatment (DBT) Period||0
2203891|NCT03230864|5404529|P1|COMPLETED|Double Blind Treatment (DBT) Period||0
2203892|NCT03230864|5404526|P4|STARTED|Double Blind Treatment (DBT) Period||33
2203893|NCT03230864|5404527|P3|STARTED|Double Blind Treatment (DBT) Period||35
2203894|NCT03230864|5404528|P2|STARTED|Double Blind Treatment (DBT) Period||0
2203895|NCT03230864|5404529|P1|STARTED|Double Blind Treatment (DBT) Period||0
2203896|NCT03230864|5404526|P4|NOT COMPLETED|Prospective Confirmation (PC) Period||0
2203897|NCT03230864|5404527|P3|NOT COMPLETED|Prospective Confirmation (PC) Period||0
2203898|NCT03230864|5404528|P2|NOT COMPLETED|Prospective Confirmation (PC) Period||19
2203899|NCT03230864|5404529|P1|NOT COMPLETED|Prospective Confirmation (PC) Period||32
2203900|NCT03230864|5404526|P4|COMPLETED|Prospective Confirmation (PC) Period||0
2203901|NCT03230864|5404527|P3|COMPLETED|Prospective Confirmation (PC) Period||0
2203902|NCT03230864|5404528|P2|COMPLETED|Prospective Confirmation (PC) Period||32
2203903|NCT03230864|5404529|P1|COMPLETED|Prospective Confirmation (PC) Period||36
2203904|NCT03230864|5404526|P4|STARTED|Prospective Confirmation (PC) Period||0
2203905|NCT03230864|5404527|P3|STARTED|Prospective Confirmation (PC) Period||0
2203906|NCT03230864|5404528|P2|STARTED|Prospective Confirmation (PC) Period||51
2203907|NCT03230864|5404529|P1|STARTED|Prospective Confirmation (PC) Period||68
2203908|NCT03229252|5404548|P3|NOT COMPLETED|Overall Study||6
2203909|NCT03229252|5404549|P2|NOT COMPLETED|Overall Study||0
2203910|NCT03229252|5404550|P1|NOT COMPLETED|Overall Study||2
2203911|NCT03229252|5404548|P3|COMPLETED|Overall Study||39
2203912|NCT03229252|5404549|P2|COMPLETED|Overall Study||15
2203913|NCT03229252|5404550|P1|COMPLETED|Overall Study||29
2203914|NCT03229252|5404548|P3|STARTED|Overall Study||45
2203915|NCT03229252|5404549|P2|STARTED|Overall Study||15
2203916|NCT03229252|5404550|P1|STARTED|Overall Study||31
2203917|NCT03229109|5404568|P4|NOT COMPLETED|Overall Study||1
2203918|NCT03229109|5404569|P3|NOT COMPLETED|Overall Study||0
2203919|NCT03229109|5404570|P2|NOT COMPLETED|Overall Study||0
2203920|NCT03229109|5404571|P1|NOT COMPLETED|Overall Study||0
2203921|NCT03229109|5404568|P4|COMPLETED|Overall Study||50
2203922|NCT03229109|5404569|P3|COMPLETED|Overall Study||50
2203923|NCT03229109|5404570|P2|COMPLETED|Overall Study||50
2203924|NCT03229109|5404571|P1|COMPLETED|Overall Study||50
2203925|NCT03229109|5404568|P4|STARTED|Overall Study||51
2203926|NCT03229109|5404569|P3|STARTED|Overall Study||50
2203927|NCT03229109|5404570|P2|STARTED|Overall Study||50
2203928|NCT03229109|5404571|P1|STARTED|Overall Study||50
2203929|NCT03228433|5404587|P6|NOT COMPLETED|Overall Study||0
2203930|NCT03228433|5404588|P5|NOT COMPLETED|Overall Study||0
2203931|NCT03228433|5404589|P4|NOT COMPLETED|Overall Study||1
2203932|NCT03228433|5404590|P3|NOT COMPLETED|Overall Study||0
2203933|NCT03228433|5404591|P2|NOT COMPLETED|Overall Study||0
2203934|NCT03228433|5404592|P1|NOT COMPLETED|Overall Study||1
2203935|NCT03228433|5404587|P6|COMPLETED|Overall Study||6
2203936|NCT03228433|5404588|P5|COMPLETED|Overall Study||6
2203937|NCT03228433|5404589|P4|COMPLETED|Overall Study||5
2203938|NCT03228433|5404590|P3|COMPLETED|Overall Study||6
2203939|NCT03228433|5404591|P2|COMPLETED|Overall Study||6
2203940|NCT03228433|5404592|P1|COMPLETED|Overall Study||9
2203941|NCT03228433|5404587|P6|STARTED|Overall Study||6
2203942|NCT03228433|5404588|P5|STARTED|Overall Study||6
2203943|NCT03228433|5404589|P4|STARTED|Overall Study||6
2203944|NCT03228433|5404590|P3|STARTED|Overall Study||6
2203945|NCT03228433|5404591|P2|STARTED|Overall Study||6
2203946|NCT03228433|5404592|P1|STARTED|Overall Study||10
2203947|NCT03228212|5404667|P2|NOT COMPLETED|Period 3||0
2203948|NCT03228212|5404668|P1|NOT COMPLETED|Period 3||0
2203949|NCT03228212|5404667|P2|COMPLETED|Period 3||64
2203950|NCT03228212|5404668|P1|COMPLETED|Period 3||63
2203951|NCT03228212|5404667|P2|STARTED|Period 3||64
2203952|NCT03228212|5404668|P1|STARTED|Period 3||63
2203953|NCT03228212|5404667|P2|NOT COMPLETED|Period 2||0
2203954|NCT03228212|5404668|P1|NOT COMPLETED|Period 2||1
2203955|NCT03228212|5404667|P2|COMPLETED|Period 2||64
2203956|NCT03228212|5404668|P1|COMPLETED|Period 2||63
2203957|NCT03228212|5404667|P2|STARTED|Period 2||64
2203958|NCT03228212|5404668|P1|STARTED|Period 2||64
2203959|NCT03228212|5404667|P2|NOT COMPLETED|Period 1||1
2203960|NCT03228212|5404668|P1|NOT COMPLETED|Period 1||1
2203961|NCT03228212|5404667|P2|COMPLETED|Period 1||64
2203962|NCT03228212|5404668|P1|COMPLETED|Period 1||64
2203963|NCT03228212|5404667|P2|STARTED|Period 1||65
2203964|NCT03228212|5404668|P1|STARTED|Period 1||65
2203965|NCT03227861|5404684|P1|NOT COMPLETED|Overall Study||12
2203966|NCT03227861|5404684|P1|COMPLETED|Overall Study||97
2203967|NCT03227861|5404684|P1|STARTED|Overall Study||109
2203968|NCT03227445|5404709|P4|NOT COMPLETED|Period 2 (28 Days)||3
2203969|NCT03227445|5404710|P3|NOT COMPLETED|Period 2 (28 Days)||2
2203970|NCT03227445|5404711|P2|NOT COMPLETED|Period 2 (28 Days)||1
2203971|NCT03227445|5404712|P1|NOT COMPLETED|Period 2 (28 Days)||1
2203972|NCT03227445|5404709|P4|COMPLETED|Period 2 (28 Days)||55
2203973|NCT03227445|5404710|P3|COMPLETED|Period 2 (28 Days)||57
2203974|NCT03227445|5404711|P2|COMPLETED|Period 2 (28 Days)||56
2203975|NCT03227445|5404712|P1|COMPLETED|Period 2 (28 Days)||57
2203976|NCT03227445|5404709|P4|STARTED|Period 2 (28 Days)||58
2203977|NCT03227445|5404710|P3|STARTED|Period 2 (28 Days)||59
2203978|NCT03227445|5404711|P2|STARTED|Period 2 (28 Days)||57
2203979|NCT03227445|5404712|P1|STARTED|Period 2 (28 Days)||58
2203980|NCT03227445|5404709|P4|NOT COMPLETED|Period 1 (28 Days)||2
2203981|NCT03227445|5404710|P3|NOT COMPLETED|Period 1 (28 Days)||1
2203982|NCT03227445|5404711|P2|NOT COMPLETED|Period 1 (28 Days)||2
2203983|NCT03227445|5404712|P1|NOT COMPLETED|Period 1 (28 Days)||2
2203984|NCT03227445|5404709|P4|COMPLETED|Period 1 (28 Days)||58
2203985|NCT03227445|5404710|P3|COMPLETED|Period 1 (28 Days)||59
2203986|NCT03227445|5404711|P2|COMPLETED|Period 1 (28 Days)||57
2203987|NCT03227445|5404712|P1|COMPLETED|Period 1 (28 Days)||58
2203988|NCT03227445|5404709|P4|STARTED|Period 1 (28 Days)||60
2203989|NCT03227445|5404710|P3|STARTED|Period 1 (28 Days)||60
2203990|NCT03227445|5404711|P2|STARTED|Period 1 (28 Days)||59
2203991|NCT03227445|5404712|P1|STARTED|Period 1 (28 Days)||60
2203992|NCT03226353|5404736|P1|NOT COMPLETED|Overall Study||6
2203993|NCT03226353|5404736|P1|COMPLETED|Overall Study|Study participants completed includes the Omafilcon A habitual wearers.|71
2203994|NCT03226353|5404736|P1|Other Habitual Lens Types|Overall Study||75
2203995|NCT03226353|5404736|P1|Habitual Wearers of Proclear 1 Day|Overall Study||2
2203996|NCT03226353|5404736|P1|STARTED|Overall Study||77
2203997|NCT03226275|5404760|P4|NOT COMPLETED|Treatment Period 2 (8 Days)||0
2203998|NCT03226275|5404761|P3|NOT COMPLETED|Treatment Period 2 (8 Days)||0
2203999|NCT03226275|5404762|P2|NOT COMPLETED|Treatment Period 2 (8 Days)||0
2204000|NCT03226275|5404763|P1|NOT COMPLETED|Treatment Period 2 (8 Days)||0
2204001|NCT03226275|5404760|P4|COMPLETED|Treatment Period 2 (8 Days)||7
2204002|NCT03226275|5404761|P3|COMPLETED|Treatment Period 2 (8 Days)||7
2204003|NCT03226275|5404762|P2|COMPLETED|Treatment Period 2 (8 Days)||8
2204004|NCT03226275|5404763|P1|COMPLETED|Treatment Period 2 (8 Days)||8
2204005|NCT03226275|5404760|P4|STARTED|Treatment Period 2 (8 Days)||7
2204006|NCT03226275|5404761|P3|STARTED|Treatment Period 2 (8 Days)||7
2204007|NCT03226275|5404762|P2|STARTED|Treatment Period 2 (8 Days)||8
2204008|NCT03226275|5404763|P1|STARTED|Treatment Period 2 (8 Days)||8
2204009|NCT03226275|5404760|P4|NOT COMPLETED|Treatment Period 1 (8 Days)||1
2204010|NCT03226275|5404761|P3|NOT COMPLETED|Treatment Period 1 (8 Days)||1
2204011|NCT03226275|5404762|P2|NOT COMPLETED|Treatment Period 1 (8 Days)||0
2204012|NCT03226275|5404763|P1|NOT COMPLETED|Treatment Period 1 (8 Days)||0
2204013|NCT03226275|5404760|P4|COMPLETED|Treatment Period 1 (8 Days)||7
2204014|NCT03226275|5404761|P3|COMPLETED|Treatment Period 1 (8 Days)||7
2204015|NCT03226275|5404762|P2|COMPLETED|Treatment Period 1 (8 Days)||8
2204016|NCT03226275|5404763|P1|COMPLETED|Treatment Period 1 (8 Days)||8
2204017|NCT03226275|5404760|P4|STARTED|Treatment Period 1 (8 Days)||8
2204018|NCT03226275|5404761|P3|STARTED|Treatment Period 1 (8 Days)||8
2204019|NCT03226275|5404762|P2|STARTED|Treatment Period 1 (8 Days)||8
2204020|NCT03226275|5404763|P1|STARTED|Treatment Period 1 (8 Days)||8
2204021|NCT03225599|5404809|P1|NOT COMPLETED|Overall Study||2
2204022|NCT03225599|5404809|P1|COMPLETED|Overall Study||7
2204023|NCT03225599|5404809|P1|STARTED|Overall Study||9
2204024|NCT03225573|5404813|P1|NOT COMPLETED|Overall Study||0
2204025|NCT03225573|5404813|P1|COMPLETED|Overall Study||60
2204026|NCT03225573|5404813|P1|STARTED|Overall Study||60
2204027|NCT03225313|5404820|P3|NOT COMPLETED|Overall Study||0
2204028|NCT03225313|5404821|P2|NOT COMPLETED|Overall Study||0
2204029|NCT03225313|5404822|P1|NOT COMPLETED|Overall Study||0
2204030|NCT03225313|5404820|P3|COMPLETED|Overall Study|25 Patients|25
2204031|NCT03225313|5404821|P2|COMPLETED|Overall Study|25 Patients|25
2204032|NCT03225313|5404822|P1|COMPLETED|Overall Study|25 Patients|25
2204033|NCT03225313|5404820|P3|STARTED|Overall Study|25 Patients|25
2204034|NCT03225313|5404821|P2|STARTED|Overall Study|25 Patients|25
2204035|NCT03225313|5404822|P1|STARTED|Overall Study|25 Patients|25
2204036|NCT03225001|5404854|P1|NOT COMPLETED|Overall Study||9
2204037|NCT03225001|5404854|P1|COMPLETED|Overall Study||188
2204038|NCT03225001|5404854|P1|Valve-Implanted|Overall Study||195
2204039|NCT03225001|5404854|P1|STARTED|Overall Study||197
2204040|NCT03224390|5404861|P2|NOT COMPLETED|Overall Study||35
2204041|NCT03224390|5404862|P1|NOT COMPLETED|Overall Study||27
2204042|NCT03224390|5404861|P2|COMPLETED|Overall Study||21
2204043|NCT03224390|5404862|P1|COMPLETED|Overall Study||29
2204044|NCT03224390|5404861|P2|STARTED|Overall Study||56
2204045|NCT03224390|5404862|P1|STARTED|Overall Study||56
2204046|NCT03224325|5404877|P7|NOT COMPLETED|Overall Study||1
2204047|NCT03224325|5404878|P6|NOT COMPLETED|Overall Study||0
2204048|NCT03224325|5404879|P5|NOT COMPLETED|Overall Study||0
2204049|NCT03224325|5404880|P4|NOT COMPLETED|Overall Study||1
2204050|NCT03224325|5404881|P3|NOT COMPLETED|Overall Study||0
2204051|NCT03224325|5404882|P2|NOT COMPLETED|Overall Study||0
2204052|NCT03224325|5404883|P1|NOT COMPLETED|Overall Study||1
2204053|NCT03224325|5404877|P7|COMPLETED|Overall Study||6
2204054|NCT03224325|5404878|P6|COMPLETED|Overall Study||6
2204055|NCT03224325|5404879|P5|COMPLETED|Overall Study||6
2204056|NCT03224325|5404880|P4|COMPLETED|Overall Study||5
2204057|NCT03224325|5404881|P3|COMPLETED|Overall Study||6
2204058|NCT03224325|5404882|P2|COMPLETED|Overall Study||6
2204059|NCT03224325|5404883|P1|COMPLETED|Overall Study||12
2204060|NCT03224325|5404877|P7|STARTED|Overall Study||7
2204061|NCT03224325|5404878|P6|STARTED|Overall Study||6
2204062|NCT03224325|5404879|P5|STARTED|Overall Study||6
2204063|NCT03224325|5404880|P4|STARTED|Overall Study||6
2204064|NCT03224325|5404881|P3|STARTED|Overall Study||6
2204065|NCT03224325|5404882|P2|STARTED|Overall Study||6
2204066|NCT03224325|5404883|P1|STARTED|Overall Study||13
2204067|NCT03224130|5404946|P2|NOT COMPLETED|Overall Study||1
2204068|NCT03224130|5404947|P1|NOT COMPLETED|Overall Study||0
2204069|NCT03224130|5404946|P2|COMPLETED|Overall Study||482
2204070|NCT03224130|5404947|P1|COMPLETED|Overall Study||483
2204071|NCT03224130|5404946|P2|STARTED|Overall Study||483
2204072|NCT03224130|5404947|P1|STARTED|Overall Study||483
2204073|NCT03223909|5404968|P3|NOT COMPLETED|Overall Study||16
2204074|NCT03223909|5404969|P2|NOT COMPLETED|Overall Study||45
2204075|NCT03223909|5404970|P1|NOT COMPLETED|Overall Study||48
2204076|NCT03223909|5404968|P3|COMPLETED|Overall Study||81
2204077|NCT03223909|5404969|P2|COMPLETED|Overall Study||64
2204078|NCT03223909|5404970|P1|COMPLETED|Overall Study||72
2204079|NCT03223909|5404968|P3|STARTED|Overall Study||97
2204080|NCT03223909|5404969|P2|STARTED|Overall Study||109
2204081|NCT03223909|5404970|P1|STARTED|Overall Study||120
2204082|NCT03223662|5404999|P1|NOT COMPLETED|Overall Study||2
2204083|NCT03223662|5404999|P1|COMPLETED|Overall Study||0
2204084|NCT03223662|5404999|P1|STARTED|Overall Study||2
2204085|NCT03223337|5405013|P4|NOT COMPLETED|Part 2 (Up to 16 Days)||0
2204086|NCT03223337|5405014|P3|NOT COMPLETED|Part 2 (Up to 16 Days)||0
2204087|NCT03223337|5405015|P2|NOT COMPLETED|Part 2 (Up to 16 Days)||0
2204088|NCT03223337|5405016|P1|NOT COMPLETED|Part 2 (Up to 16 Days)||0
2204089|NCT03223337|5405013|P4|COMPLETED|Part 2 (Up to 16 Days)||9
2204090|NCT03223337|5405014|P3|COMPLETED|Part 2 (Up to 16 Days)||12
2204091|NCT03223337|5405015|P2|COMPLETED|Part 2 (Up to 16 Days)||0
2204092|NCT03223337|5405016|P1|COMPLETED|Part 2 (Up to 16 Days)||0
2204093|NCT03223337|5405013|P4|STARTED|Part 2 (Up to 16 Days)||9
2204094|NCT03223337|5405014|P3|STARTED|Part 2 (Up to 16 Days)||12
2204095|NCT03223337|5405015|P2|STARTED|Part 2 (Up to 16 Days)||0
2204096|NCT03223337|5405016|P1|STARTED|Part 2 (Up to 16 Days)||0
2204097|NCT03223337|5405013|P4|NOT COMPLETED|Part 1 (Up to 16 Days)||0
2204098|NCT03223337|5405014|P3|NOT COMPLETED|Part 1 (Up to 16 Days)||0
2204099|NCT03223337|5405015|P2|NOT COMPLETED|Part 1 (Up to 16 Days)||0
2204100|NCT03223337|5405016|P1|NOT COMPLETED|Part 1 (Up to 16 Days)||0
2204101|NCT03223337|5405013|P4|COMPLETED|Part 1 (Up to 16 Days)||0
2204102|NCT03223337|5405014|P3|COMPLETED|Part 1 (Up to 16 Days)||0
2204103|NCT03223337|5405015|P2|COMPLETED|Part 1 (Up to 16 Days)||8
2204104|NCT03223337|5405016|P1|COMPLETED|Part 1 (Up to 16 Days)||8
2204105|NCT03223337|5405013|P4|STARTED|Part 1 (Up to 16 Days)||0
2204106|NCT03223337|5405014|P3|STARTED|Part 1 (Up to 16 Days)||0
2204107|NCT03223337|5405015|P2|STARTED|Part 1 (Up to 16 Days)||8
2204108|NCT03223337|5405016|P1|STARTED|Part 1 (Up to 16 Days)||8
2204109|NCT03222583|5405084|P2|NOT COMPLETED|Overall Study||6
2204110|NCT03222583|5405085|P1|NOT COMPLETED|Overall Study||5
2204111|NCT03222583|5405084|P2|COMPLETED|Overall Study||177
2204112|NCT03222583|5405085|P1|COMPLETED|Overall Study||358
2204113|NCT03222583|5405084|P2|Completed Open-label Period|Overall Study||181
2204114|NCT03222583|5405085|P1|Completed Open-label Period|Overall Study||0
2204115|NCT03222583|5405084|P2|Entered Open-label Period|Overall Study||182
2204116|NCT03222583|5405085|P1|Entered Open-label Period|Overall Study||0
2204117|NCT03222583|5405084|P2|Completed Double-blind Period|Overall Study||183
2204118|NCT03222583|5405085|P1|Completed Double-blind Period|Overall Study||360
2204119|NCT03222583|5405084|P2|Received Double-blind Treatment|Overall Study||183
2204120|NCT03222583|5405085|P1|Received Double-blind Treatment|Overall Study||362
2204121|NCT03222583|5405084|P2|STARTED|Overall Study||183
2204122|NCT03222583|5405085|P1|STARTED|Overall Study||363
2204123|NCT03222505|5405098|P2|NOT COMPLETED|Overall Study||0
2204124|NCT03222505|5405099|P1|NOT COMPLETED|Overall Study||0
2204125|NCT03222505|5405098|P2|COMPLETED|Overall Study||7
2204126|NCT03222505|5405099|P1|COMPLETED|Overall Study||5
2204127|NCT03222505|5405098|P2|STARTED|Overall Study||7
2204128|NCT03222505|5405099|P1|STARTED|Overall Study||5
2204129|NCT03222427|5405109|P1|NOT COMPLETED|Overall Study||0
2204130|NCT03222427|5405109|P1|COMPLETED|Overall Study||8
2204131|NCT03222427|5405109|P1|Received One Dose of Study Drug|Overall Study||8
2204132|NCT03222427|5405109|P1|STARTED|Overall Study||8
2204133|NCT03222414|5405118|P2|NOT COMPLETED|Overall Study||0
2204134|NCT03222414|5405119|P1|NOT COMPLETED|Overall Study||0
2204135|NCT03222414|5405118|P2|COMPLETED|Overall Study||1
2204136|NCT03222414|5405119|P1|COMPLETED|Overall Study||0
2204137|NCT03222414|5405118|P2|STARTED|Overall Study||1
2204138|NCT03222414|5405119|P1|STARTED|Overall Study||0
2204139|NCT03222141|5405135|P1|NOT COMPLETED|Overall Study||18
2204140|NCT03222141|5405135|P1|COMPLETED|Overall Study||565
2204141|NCT03222141|5405135|P1|STARTED|Overall Study||583
2204142|NCT03222128|5405141|P1|NOT COMPLETED|Overall Study||106
2204143|NCT03222128|5405141|P1|COMPLETED|Overall Study||968
2204144|NCT03222128|5405141|P1|Valve-Implanted|Overall Study||1069
2204145|NCT03222128|5405141|P1|STARTED|Overall Study||1074
2204146|NCT03222037|5405146|P2|NOT COMPLETED|Period 2||0
2204147|NCT03222037|5405147|P1|NOT COMPLETED|Period 2||0
2204148|NCT03222037|5405146|P2|COMPLETED|Period 2||22
2204149|NCT03222037|5405147|P1|COMPLETED|Period 2||21
2204150|NCT03222037|5405146|P2|STARTED|Period 2||22
2204151|NCT03222037|5405147|P1|STARTED|Period 2||21
2204152|NCT03222037|5405146|P2|NOT COMPLETED|Period 1||0
2204153|NCT03222037|5405147|P1|NOT COMPLETED|Period 1||0
2204154|NCT03222037|5405146|P2|COMPLETED|Period 1||22
2204155|NCT03222037|5405147|P1|COMPLETED|Period 1||21
2204156|NCT03222037|5405146|P2|STARTED|Period 1||22
2204157|NCT03222037|5405147|P1|STARTED|Period 1||21
2204158|NCT03221738|5405155|P1|NOT COMPLETED|Overall Study||0
2204159|NCT03221738|5405155|P1|COMPLETED|Overall Study||10
2204160|NCT03221738|5405155|P1|STARTED|Overall Study||10
2204161|NCT03221192|5405161|P1|NOT COMPLETED|Overall Study||0
2204162|NCT03221192|5405161|P1|COMPLETED|Overall Study||27
2204163|NCT03221192|5405161|P1|STARTED|Overall Study||27
2204164|NCT03220412|5405202|P2|NOT COMPLETED|Overall Study||0
2204165|NCT03220412|5405203|P1|NOT COMPLETED|Overall Study||0
2204166|NCT03220412|5405202|P2|COMPLETED|Overall Study||50
2204167|NCT03220412|5405203|P1|COMPLETED|Overall Study||54
2204168|NCT03220412|5405202|P2|STARTED|Overall Study||50
2204169|NCT03220412|5405203|P1|STARTED|Overall Study||54
2204170|NCT03220230|5405211|P1|NOT COMPLETED|Overall Study||0
2204171|NCT03220230|5405211|P1|COMPLETED|Overall Study||4240
2204172|NCT03220230|5405211|P1|STARTED|Overall Study||4240
2204173|NCT03220048|5405224|P3|NOT COMPLETED|Overall Study||1
2204174|NCT03220048|5405225|P2|NOT COMPLETED|Overall Study||2
2204175|NCT03220048|5405226|P1|NOT COMPLETED|Overall Study||0
2204176|NCT03220048|5405224|P3|COMPLETED|Overall Study||27
2204177|NCT03220048|5405225|P2|COMPLETED|Overall Study||25
2204178|NCT03220048|5405226|P1|COMPLETED|Overall Study||11
2204179|NCT03220048|5405224|P3|STARTED|Overall Study||28
2204180|NCT03220048|5405225|P2|STARTED|Overall Study||27
2204181|NCT03220048|5405226|P1|STARTED|Overall Study||11
2204182|NCT03219723|5405249|P1|NOT COMPLETED|Overall Study||10
2204183|NCT03219723|5405249|P1|COMPLETED|Overall Study||550
2204184|NCT03219723|5405249|P1|STARTED|Overall Study||560
2204185|NCT03219294|5405256|P2|NOT COMPLETED|Overall Study||0
2204186|NCT03219294|5405257|P1|NOT COMPLETED|Overall Study||0
2204187|NCT03219294|5405256|P2|COMPLETED|Overall Study||58
2204188|NCT03219294|5405257|P1|COMPLETED|Overall Study||58
2204189|NCT03219294|5405256|P2|STARTED|Overall Study||58
2204190|NCT03219294|5405257|P1|STARTED|Overall Study||58
2204191|NCT03218592|5405268|P3|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
2204192|NCT03218592|5405269|P2|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
2204193|NCT03218592|5405270|P1|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
2204194|NCT03218592|5405268|P3|COMPLETED|Phase 3: 3 Doses Per Week||4
2204195|NCT03218592|5405269|P2|COMPLETED|Phase 3: 3 Doses Per Week||4
2204196|NCT03218592|5405270|P1|COMPLETED|Phase 3: 3 Doses Per Week||4
2204197|NCT03218592|5405268|P3|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
2204198|NCT03218592|5405269|P2|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
2204199|NCT03218592|5405270|P1|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
2204200|NCT03218592|5405268|P3|STARTED|Phase 3: 3 Doses Per Week||4
2204201|NCT03218592|5405269|P2|STARTED|Phase 3: 3 Doses Per Week||4
2204202|NCT03218592|5405270|P1|STARTED|Phase 3: 3 Doses Per Week||4
2204203|NCT03218592|5405268|P3|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
2204204|NCT03218592|5405269|P2|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
2204205|NCT03218592|5405270|P1|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
2204206|NCT03218592|5405268|P3|COMPLETED|Phase 3: 1 Dose Per Period||4
2204207|NCT03218592|5405269|P2|COMPLETED|Phase 3: 1 Dose Per Period||4
2204208|NCT03218592|5405270|P1|COMPLETED|Phase 3: 1 Dose Per Period||4
2204209|NCT03218592|5405268|P3|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
2204210|NCT03218592|5405269|P2|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
2204211|NCT03218592|5405270|P1|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
2204212|NCT03218592|5405268|P3|STARTED|Phase 3: 1 Dose Per Period||4
2204213|NCT03218592|5405269|P2|STARTED|Phase 3: 1 Dose Per Period||4
2204214|NCT03218592|5405270|P1|STARTED|Phase 3: 1 Dose Per Period||4
2204215|NCT03218592|5405268|P3|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
2204216|NCT03218592|5405269|P2|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
2204217|NCT03218592|5405270|P1|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
2204218|NCT03218592|5405268|P3|COMPLETED|Phase 3: 0 Doses Per Week||4
2204219|NCT03218592|5405269|P2|COMPLETED|Phase 3: 0 Doses Per Week||4
2204220|NCT03218592|5405270|P1|COMPLETED|Phase 3: 0 Doses Per Week||4
2204221|NCT03218592|5405268|P3|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
2204222|NCT03218592|5405269|P2|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
2204223|NCT03218592|5405270|P1|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
2204224|NCT03218592|5405268|P3|STARTED|Phase 3: 0 Doses Per Week||4
2204225|NCT03218592|5405269|P2|STARTED|Phase 3: 0 Doses Per Week||4
2204226|NCT03218592|5405270|P1|STARTED|Phase 3: 0 Doses Per Week||4
2204227|NCT03218592|5405268|P3|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
2204228|NCT03218592|5405269|P2|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
2204229|NCT03218592|5405270|P1|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
2204230|NCT03218592|5405268|P3|COMPLETED|Phase 2: Daily Doses x 28 Days||12
2204231|NCT03218592|5405269|P2|COMPLETED|Phase 2: Daily Doses x 28 Days||12
2204232|NCT03218592|5405270|P1|COMPLETED|Phase 2: Daily Doses x 28 Days||12
2204233|NCT03218592|5405268|P3|STARTED|Phase 2: Daily Doses x 28 Days||12
2204234|NCT03218592|5405269|P2|STARTED|Phase 2: Daily Doses x 28 Days||12
2204235|NCT03218592|5405270|P1|STARTED|Phase 2: Daily Doses x 28 Days||12
2204236|NCT03218592|5405268|P3|NOT COMPLETED|Phase 1: 1 Dose||0
2204237|NCT03218592|5405269|P2|NOT COMPLETED|Phase 1: 1 Dose||0
2204238|NCT03218592|5405270|P1|NOT COMPLETED|Phase 1: 1 Dose||0
2204239|NCT03218592|5405268|P3|COMPLETED|Phase 1: 1 Dose||12
2204240|NCT03218592|5405269|P2|COMPLETED|Phase 1: 1 Dose||12
2204241|NCT03218592|5405270|P1|COMPLETED|Phase 1: 1 Dose||12
2204242|NCT03218592|5405268|P3|STARTED|Phase 1: 1 Dose||12
2204243|NCT03218592|5405269|P2|STARTED|Phase 1: 1 Dose||12
2204244|NCT03218592|5405270|P1|STARTED|Phase 1: 1 Dose||12
2204245|NCT03218397|5405292|P2|NOT COMPLETED|Overall Study||29
2204246|NCT03218397|5405293|P1|NOT COMPLETED|Overall Study||23
2204247|NCT03218397|5405292|P2|COMPLETED|Overall Study||222
2204248|NCT03218397|5405293|P1|COMPLETED|Overall Study||226
2204249|NCT03218397|5405292|P2|STARTED|Overall Study||251
2204250|NCT03218397|5405293|P1|STARTED|Overall Study||249
2204251|NCT03218163|5405321|P1|NOT COMPLETED|Overall Study||0
2204252|NCT03218163|5405321|P1|COMPLETED|Overall Study||0
2204253|NCT03218163|5405321|P1|STARTED|Overall Study||0
2204254|NCT03217968|5405325|P1|NOT COMPLETED|Overall Study||11
2204255|NCT03217968|5405325|P1|COMPLETED|Overall Study||48
2204256|NCT03217968|5405325|P1|STARTED|Overall Study||59
2204257|NCT03217175|5405334|P2|NOT COMPLETED|Overall Study||1
2204258|NCT03217175|5405335|P1|NOT COMPLETED|Overall Study||4
2204259|NCT03217175|5405334|P2|COMPLETED|Overall Study||0
2204260|NCT03217175|5405335|P1|COMPLETED|Overall Study||0
2204261|NCT03217175|5405334|P2|STARTED|Overall Study||1
2204262|NCT03217175|5405335|P1|STARTED|Overall Study||4
2204263|NCT03216850|5405349|P1|NOT COMPLETED|Overall Study||6
2204264|NCT03216850|5405349|P1|COMPLETED|Overall Study|6 patients did not complete the study because of the pre-analytical error.|9
2204265|NCT03216850|5405349|P1|STARTED|Overall Study||15
2204266|NCT03216512|5405355|P2|NOT COMPLETED|Overall Study||1
2204267|NCT03216512|5405356|P1|NOT COMPLETED|Overall Study||0
2204268|NCT03216512|5405355|P2|COMPLETED|Overall Study||13
2204269|NCT03216512|5405356|P1|COMPLETED|Overall Study||17
2204270|NCT03216512|5405355|P2|STARTED|Overall Study||14
2204271|NCT03216512|5405356|P1|STARTED|Overall Study||17
2204272|NCT03216265|5405377|P3|NOT COMPLETED|Overall Study||3
2204273|NCT03216265|5405378|P2|NOT COMPLETED|Overall Study||1
2204274|NCT03216265|5405379|P1|NOT COMPLETED|Overall Study||2
2204275|NCT03216265|5405377|P3|COMPLETED|Overall Study||19
2204276|NCT03216265|5405378|P2|COMPLETED|Overall Study||21
2204277|NCT03216265|5405379|P1|COMPLETED|Overall Study||20
2204278|NCT03216265|5405377|P3|STARTED|Overall Study||22
2204279|NCT03216265|5405378|P2|STARTED|Overall Study||22
2204280|NCT03216265|5405379|P1|STARTED|Overall Study||22
2204281|NCT03216200|5405429|P1|NOT COMPLETED|Overall Study||0
2204282|NCT03216200|5405429|P1|COMPLETED|Overall Study||5
2204283|NCT03216200|5405429|P1|STARTED|Overall Study||5
2204284|NCT03215758|5405436|P2|NOT COMPLETED|Overall Study||8
2204285|NCT03215758|5405437|P1|NOT COMPLETED|Overall Study||5
2204286|NCT03215758|5405436|P2|COMPLETED|Overall Study||328
2204287|NCT03215758|5405437|P1|COMPLETED|Overall Study||334
2204288|NCT03215758|5405436|P2|STARTED|Overall Study||336
2204289|NCT03215758|5405437|P1|STARTED|Overall Study||339
2204290|NCT03214952|5405449|P1|NOT COMPLETED|Overall Study||58
2204291|NCT03214952|5405449|P1|COMPLETED|Overall Study||3125
2204292|NCT03214952|5405449|P1|STARTED|Overall Study||3183
2204293|NCT03214588|5405464|P3|NOT COMPLETED|Overall Study||2
2204294|NCT03214588|5405465|P2|NOT COMPLETED|Overall Study||1
2204295|NCT03214588|5405466|P1|NOT COMPLETED|Overall Study||1
2204296|NCT03214588|5405464|P3|COMPLETED|Overall Study||24
2204297|NCT03214588|5405465|P2|COMPLETED|Overall Study||13
2204298|NCT03214588|5405466|P1|COMPLETED|Overall Study||26
2204299|NCT03214588|5405464|P3|STARTED|Overall Study||26
2204300|NCT03214588|5405465|P2|STARTED|Overall Study||14
2204301|NCT03214588|5405466|P1|STARTED|Overall Study||27
2204302|NCT03214406|5405533|P2|NOT COMPLETED|Overall Study||15
2204303|NCT03214406|5405534|P1|NOT COMPLETED|Overall Study||10
2204304|NCT03214406|5405533|P2|COMPLETED|Overall Study||78
2204305|NCT03214406|5405534|P1|COMPLETED|Overall Study||78
2204306|NCT03214406|5405533|P2|STARTED|Overall Study||93
2204307|NCT03214406|5405534|P1|STARTED|Overall Study||88
2204308|NCT03214224|5405547|P3|NOT COMPLETED|Longitudinal PFT Study||0
2204309|NCT03214224|5405548|P2|NOT COMPLETED|Longitudinal PFT Study||0
2204310|NCT03214224|5405549|P1|NOT COMPLETED|Longitudinal PFT Study||0
2204311|NCT03214224|5405547|P3|COMPLETED|Longitudinal PFT Study||0
2204312|NCT03214224|5405548|P2|COMPLETED|Longitudinal PFT Study||0
2204313|NCT03214224|5405549|P1|COMPLETED|Longitudinal PFT Study||0
2204314|NCT03214224|5405547|P3|STARTED|Longitudinal PFT Study||0
2204315|NCT03214224|5405548|P2|STARTED|Longitudinal PFT Study||0
2204316|NCT03214224|5405549|P1|STARTED|Longitudinal PFT Study||0
2204317|NCT03214224|5405547|P3|NOT COMPLETED|Validation Study||9
2204318|NCT03214224|5405548|P2|NOT COMPLETED|Validation Study||0
2204319|NCT03214224|5405549|P1|NOT COMPLETED|Validation Study||0
2204320|NCT03214224|5405547|P3|COMPLETED|Validation Study|3 therapists enrolled. 3 controls enrolled but not included in analysis set. 3 patients also.|40
2204321|NCT03214224|5405548|P2|COMPLETED|Validation Study||0
2204322|NCT03214224|5405549|P1|COMPLETED|Validation Study||0
2204323|NCT03214224|5405547|P3|STARTED|Validation Study|Subjects did both standard and remote assessments in the validation study. Total enrollment 49.|49
2204324|NCT03214224|5405548|P2|STARTED|Validation Study||0
2204325|NCT03214224|5405549|P1|STARTED|Validation Study||0
2204326|NCT03214081|5405558|P1|NOT COMPLETED|Overall Study||63
2204327|NCT03214081|5405558|P1|COMPLETED|Overall Study||1174
2204328|NCT03214081|5405558|P1|STARTED|Overall Study||1237
2204329|NCT03213509|5405575|P2|NOT COMPLETED|Overall Study||5
2204330|NCT03213509|5405576|P1|NOT COMPLETED|Overall Study||4
2204331|NCT03213509|5405575|P2|COMPLETED|Overall Study||85
2204332|NCT03213509|5405576|P1|COMPLETED|Overall Study||76
2204333|NCT03213509|5405575|P2|STARTED|Overall Study||90
2204334|NCT03213509|5405576|P1|STARTED|Overall Study||80
2204335|NCT03213366|5405589|P2|NOT COMPLETED|Overall Study||4
2204336|NCT03213366|5405590|P1|NOT COMPLETED|Overall Study||9
2204337|NCT03213366|5405589|P2|COMPLETED|Overall Study||67
2204338|NCT03213366|5405590|P1|COMPLETED|Overall Study||72
2204339|NCT03213366|5405589|P2|STARTED|Overall Study||71
2204340|NCT03213366|5405590|P1|STARTED|Overall Study||81
2204341|NCT03212638|5405618|P5|NOT COMPLETED|Period 5||0
2204342|NCT03212638|5405619|P4|NOT COMPLETED|Period 5||0
2204343|NCT03212638|5405620|P3|NOT COMPLETED|Period 5||0
2204344|NCT03212638|5405621|P2|NOT COMPLETED|Period 5||0
2204345|NCT03212638|5405622|P1|NOT COMPLETED|Period 5||0
2204346|NCT03212638|5405618|P5|COMPLETED|Period 5||9
2204347|NCT03212638|5405619|P4|COMPLETED|Period 5||9
2204348|NCT03212638|5405620|P3|COMPLETED|Period 5||0
2204349|NCT03212638|5405621|P2|COMPLETED|Period 5||0
2204350|NCT03212638|5405622|P1|COMPLETED|Period 5||0
2204351|NCT03212638|5405618|P5|Received at Least 1 Dose of Study Drug|Period 5||9
2204352|NCT03212638|5405619|P4|Received at Least 1 Dose of Study Drug|Period 5||9
2204353|NCT03212638|5405620|P3|Received at Least 1 Dose of Study Drug|Period 5||0
2204354|NCT03212638|5405621|P2|Received at Least 1 Dose of Study Drug|Period 5||0
2204355|NCT03212638|5405622|P1|Received at Least 1 Dose of Study Drug|Period 5||0
2204356|NCT03212638|5405618|P5|STARTED|Period 5||9
2204357|NCT03212638|5405619|P4|STARTED|Period 5||9
2204358|NCT03212638|5405620|P3|STARTED|Period 5||0
2204359|NCT03212638|5405621|P2|STARTED|Period 5||0
2204360|NCT03212638|5405622|P1|STARTED|Period 5||0
2204361|NCT03212638|5405618|P5|NOT COMPLETED|Period 4||0
2204362|NCT03212638|5405619|P4|NOT COMPLETED|Period 4||0
2204363|NCT03212638|5405620|P3|NOT COMPLETED|Period 4||0
2204364|NCT03212638|5405621|P2|NOT COMPLETED|Period 4||0
2204365|NCT03212638|5405622|P1|NOT COMPLETED|Period 4||0
2204366|NCT03212638|5405618|P5|COMPLETED|Period 4||9
2204367|NCT03212638|5405619|P4|COMPLETED|Period 4||9
2204368|NCT03212638|5405620|P3|COMPLETED|Period 4||0
2204369|NCT03212638|5405621|P2|COMPLETED|Period 4||0
2204370|NCT03212638|5405622|P1|COMPLETED|Period 4||0
2204371|NCT03212638|5405618|P5|Received at Least 1 Dose of Study Drug|Period 4||9
2204372|NCT03212638|5405619|P4|Received at Least 1 Dose of Study Drug|Period 4||9
2204373|NCT03212638|5405620|P3|Received at Least 1 Dose of Study Drug|Period 4||0
2204374|NCT03212638|5405621|P2|Received at Least 1 Dose of Study Drug|Period 4||0
2204375|NCT03212638|5405622|P1|Received at Least 1 Dose of Study Drug|Period 4||0
2204376|NCT03212638|5405618|P5|STARTED|Period 4|New Participants in Part B, no participants from Part A participated in Part B.|9
2204377|NCT03212638|5405619|P4|STARTED|Period 4|New Participants in Part B, no participants from Part A participated in Part B.|9
2204467|NCT03211117|5405693|P2|STARTED|Overall Study||3
2204378|NCT03212638|5405620|P3|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
2204379|NCT03212638|5405621|P2|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
2204380|NCT03212638|5405622|P1|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
2204381|NCT03212638|5405618|P5|NOT COMPLETED|Period 3||0
2204382|NCT03212638|5405619|P4|NOT COMPLETED|Period 3||0
2204383|NCT03212638|5405620|P3|NOT COMPLETED|Period 3||0
2204384|NCT03212638|5405621|P2|NOT COMPLETED|Period 3||0
2204385|NCT03212638|5405622|P1|NOT COMPLETED|Period 3||0
2204386|NCT03212638|5405618|P5|COMPLETED|Period 3||0
2204387|NCT03212638|5405619|P4|COMPLETED|Period 3||0
2204388|NCT03212638|5405620|P3|COMPLETED|Period 3||8
2204389|NCT03212638|5405621|P2|COMPLETED|Period 3||8
2204390|NCT03212638|5405622|P1|COMPLETED|Period 3||8
2204391|NCT03212638|5405618|P5|Received at Least 1 Dose of Study Drug|Period 3||0
2204392|NCT03212638|5405619|P4|Received at Least 1 Dose of Study Drug|Period 3||0
2204393|NCT03212638|5405620|P3|Received at Least 1 Dose of Study Drug|Period 3||8
2204394|NCT03212638|5405621|P2|Received at Least 1 Dose of Study Drug|Period 3||8
2204395|NCT03212638|5405622|P1|Received at Least 1 Dose of Study Drug|Period 3||8
2204396|NCT03212638|5405618|P5|STARTED|Period 3||0
2204397|NCT03212638|5405619|P4|STARTED|Period 3||0
2204398|NCT03212638|5405620|P3|STARTED|Period 3||8
2204399|NCT03212638|5405621|P2|STARTED|Period 3||8
2204400|NCT03212638|5405622|P1|STARTED|Period 3||8
2204401|NCT03212638|5405618|P5|NOT COMPLETED|Period 2||0
2204402|NCT03212638|5405619|P4|NOT COMPLETED|Period 2||0
2204403|NCT03212638|5405620|P3|NOT COMPLETED|Period 2||0
2204404|NCT03212638|5405621|P2|NOT COMPLETED|Period 2||0
2204405|NCT03212638|5405622|P1|NOT COMPLETED|Period 2||0
2204406|NCT03212638|5405618|P5|COMPLETED|Period 2||0
2204407|NCT03212638|5405619|P4|COMPLETED|Period 2||0
2204408|NCT03212638|5405620|P3|COMPLETED|Period 2||8
2204409|NCT03212638|5405621|P2|COMPLETED|Period 2||8
2204410|NCT03212638|5405622|P1|COMPLETED|Period 2||8
2204411|NCT03212638|5405618|P5|Received at Least 1 Dose of Study Drug|Period 2||0
2204412|NCT03212638|5405619|P4|Received at Least 1 Dose of Study Drug|Period 2||0
2204413|NCT03212638|5405620|P3|Received at Least 1 Dose of Study Drug|Period 2||8
2204414|NCT03212638|5405621|P2|Received at Least 1 Dose of Study Drug|Period 2||8
2204415|NCT03212638|5405622|P1|Received at Least 1 Dose of Study Drug|Period 2||8
2204416|NCT03212638|5405618|P5|STARTED|Period 2||0
2204417|NCT03212638|5405619|P4|STARTED|Period 2||0
2204418|NCT03212638|5405620|P3|STARTED|Period 2||8
2204419|NCT03212638|5405621|P2|STARTED|Period 2||8
2204420|NCT03212638|5405622|P1|STARTED|Period 2||8
2204421|NCT03212638|5405618|P5|NOT COMPLETED|Period 1||0
2204422|NCT03212638|5405619|P4|NOT COMPLETED|Period 1||0
2204423|NCT03212638|5405620|P3|NOT COMPLETED|Period 1||0
2204424|NCT03212638|5405621|P2|NOT COMPLETED|Period 1||0
2204425|NCT03212638|5405622|P1|NOT COMPLETED|Period 1||0
2204426|NCT03212638|5405618|P5|COMPLETED|Period 1||0
2204427|NCT03212638|5405619|P4|COMPLETED|Period 1||0
2204428|NCT03212638|5405620|P3|COMPLETED|Period 1||8
2204429|NCT03212638|5405621|P2|COMPLETED|Period 1||8
2204430|NCT03212638|5405622|P1|COMPLETED|Period 1||8
2204431|NCT03212638|5405618|P5|Received at Least 1 Dose of Study Drug|Period 1||0
2204432|NCT03212638|5405619|P4|Received at Least 1 Dose of Study Drug|Period 1||0
2204433|NCT03212638|5405620|P3|Received at Least 1 Dose of Study Drug|Period 1||8
2204434|NCT03212638|5405621|P2|Received at Least 1 Dose of Study Drug|Period 1||8
2204435|NCT03212638|5405622|P1|Received at Least 1 Dose of Study Drug|Period 1||8
2204436|NCT03212638|5405618|P5|STARTED|Period 1||0
2204437|NCT03212638|5405619|P4|STARTED|Period 1||0
2204438|NCT03212638|5405620|P3|STARTED|Period 1||8
2204439|NCT03212638|5405621|P2|STARTED|Period 1||8
2204440|NCT03212638|5405622|P1|STARTED|Period 1||8
2204441|NCT03212521|5405644|P1|NOT COMPLETED|Overall Study||7
2204442|NCT03212521|5405644|P1|COMPLETED|Overall Study||223
2204443|NCT03212521|5405644|P1|STARTED|Overall Study||230
2204444|NCT03212326|5405651|P1|NOT COMPLETED|Overall Study||4
2204445|NCT03212326|5405651|P1|COMPLETED|Overall Study||20
2204446|NCT03212326|5405651|P1|STARTED|Overall Study||24
2204447|NCT03212261|5405656|P1|NOT COMPLETED|Overall Study||16
2204448|NCT03212261|5405656|P1|COMPLETED|Overall Study||21
2204449|NCT03212261|5405656|P1|One Month Follow-up|Overall Study|Lost to follow up (n=1)|21
2204450|NCT03212261|5405656|P1|Post-intervention Survey|Overall Study|Lost to follow up (n=4)|22
2204451|NCT03212261|5405656|P1|Program Initiation|Overall Study|Lost patients: Tech trouble no first visit (n=1), Too busy/no time (n=2), LTFU (n=1)|26
2204452|NCT03212261|5405656|P1|Baseline Completion|Overall Study|Lost patients: Technology difficulties (n=2), Family Emergency (n=1), Too busy (n=3), LTFU (n=1)|30
2204453|NCT03212261|5405656|P1|Remained Eligible|Overall Study||35
2204454|NCT03212261|5405656|P1|STARTED|Overall Study|Enrolled: eligible at time of approach and signed a consent.|37
2204455|NCT03211858|5405664|P2|NOT COMPLETED|Overall Study||33
2204456|NCT03211858|5405665|P1|NOT COMPLETED|Overall Study||37
2204457|NCT03211858|5405664|P2|COMPLETED|Overall Study||263
2204458|NCT03211858|5405665|P1|COMPLETED|Overall Study||264
2204459|NCT03211858|5405664|P2|Treated|Overall Study||296
2204460|NCT03211858|5405665|P1|Treated|Overall Study||301
2204461|NCT03211858|5405664|P2|STARTED|Overall Study||296
2204462|NCT03211858|5405665|P1|STARTED|Overall Study||301
2204463|NCT03211117|5405693|P2|NOT COMPLETED|Overall Study||0
2204464|NCT03211117|5405694|P1|NOT COMPLETED|Overall Study||0
2204465|NCT03211117|5405693|P2|COMPLETED|Overall Study||3
2204466|NCT03211117|5405694|P1|COMPLETED|Overall Study||0
2204468|NCT03211117|5405694|P1|STARTED|Overall Study||0
2204469|NCT03210376|5405703|P2|NOT COMPLETED|Overall Study||0
2204470|NCT03210376|5405704|P1|NOT COMPLETED|Overall Study||0
2204471|NCT03210376|5405703|P2|COMPLETED|Overall Study||50
2204472|NCT03210376|5405704|P1|COMPLETED|Overall Study||50
2204473|NCT03210376|5405703|P2|STARTED|Overall Study||50
2204474|NCT03210376|5405704|P1|STARTED|Overall Study||50
2204475|NCT03210337|5405724|P2|NOT COMPLETED|Overall Study||5
2204476|NCT03210337|5405725|P1|NOT COMPLETED|Overall Study||8
2204477|NCT03210337|5405724|P2|COMPLETED|Overall Study||74
2204478|NCT03210337|5405725|P1|COMPLETED|Overall Study||70
2204479|NCT03210337|5405724|P2|STARTED|Overall Study||79
2204480|NCT03210337|5405725|P1|STARTED|Overall Study||78
2204481|NCT03210220|5405733|P2|NOT COMPLETED|Overall Study||0
2204482|NCT03210220|5405734|P1|NOT COMPLETED|Overall Study||1
2204483|NCT03210220|5405733|P2|COMPLETED|Overall Study||20
2204484|NCT03210220|5405734|P1|COMPLETED|Overall Study||19
2204485|NCT03210220|5405733|P2|STARTED|Overall Study||20
2204486|NCT03210220|5405734|P1|STARTED|Overall Study||20
2204487|NCT03209570|5405742|P2|NOT COMPLETED|Overall Study||13
2204488|NCT03209570|5405743|P1|NOT COMPLETED|Overall Study||10
2204489|NCT03209570|5405742|P2|COMPLETED|Overall Study||12
2204490|NCT03209570|5405743|P1|COMPLETED|Overall Study||14
2204491|NCT03209570|5405742|P2|STARTED|Overall Study||25
2204492|NCT03209570|5405743|P1|STARTED|Overall Study||24
2204493|NCT03209518|5405753|P1|NOT COMPLETED|Overall Study||2
2204494|NCT03209518|5405753|P1|COMPLETED|Overall Study||310
2204495|NCT03209518|5405753|P1|STARTED|Overall Study||312
2204496|NCT03209492|5405758|P1|NOT COMPLETED|Overall Study||5
2204497|NCT03209492|5405758|P1|COMPLETED|Overall Study||328
2204498|NCT03209492|5405758|P1|STARTED|Overall Study||333
2204499|NCT03208673|5405763|P1|NOT COMPLETED|Overall Study||0
2204500|NCT03208673|5405763|P1|COMPLETED|Overall Study||32
2204501|NCT03208673|5405763|P1|STARTED|Overall Study||32
2204502|NCT03208166|5405771|P2|NOT COMPLETED|Overall Study||0
2204503|NCT03208166|5405772|P1|NOT COMPLETED|Overall Study||0
2204504|NCT03208166|5405771|P2|COMPLETED|Overall Study||1
2204505|NCT03208166|5405772|P1|COMPLETED|Overall Study||1
2204506|NCT03208166|5405771|P2|STARTED|Overall Study||1
2204507|NCT03208166|5405772|P1|STARTED|Overall Study||1
2204508|NCT03207776|5405782|P2|NOT COMPLETED|Overall Study||0
2204509|NCT03207776|5405783|P1|NOT COMPLETED|Overall Study||0
2204510|NCT03207776|5405782|P2|COMPLETED|Overall Study||2353
2204511|NCT03207776|5405783|P1|COMPLETED|Overall Study||2479
2204512|NCT03207776|5405782|P2|STARTED|Overall Study||2353
2204513|NCT03207776|5405783|P1|STARTED|Overall Study||2479
2204514|NCT03207750|5405797|P2|NOT COMPLETED|Overall Study||66
2204515|NCT03207750|5405798|P1|NOT COMPLETED|Overall Study||58
2204516|NCT03207750|5405797|P2|COMPLETED|Overall Study||574
2204517|NCT03207750|5405798|P1|COMPLETED|Overall Study||574
2204518|NCT03207750|5405797|P2|STARTED|Overall Study||640
2204519|NCT03207750|5405798|P1|STARTED|Overall Study||632
2204520|NCT03207438|5405844|P4|NOT COMPLETED|Overall Study||112
2204521|NCT03207438|5405845|P3|NOT COMPLETED|Overall Study||232
2204522|NCT03207438|5405846|P2|NOT COMPLETED|Overall Study||21
2204523|NCT03207438|5405847|P1|NOT COMPLETED|Overall Study||19
2204524|NCT03207438|5405844|P4|COMPLETED|Overall Study||470
2204525|NCT03207438|5405845|P3|COMPLETED|Overall Study||643
2204526|NCT03207438|5405846|P2|COMPLETED|Overall Study||145
2204527|NCT03207438|5405847|P1|COMPLETED|Overall Study||148
2204528|NCT03207438|5405844|P4|STARTED|Overall Study||582
2204529|NCT03207438|5405845|P3|STARTED|Overall Study||875
2204530|NCT03207438|5405846|P2|STARTED|Overall Study||166
2204531|NCT03207438|5405847|P1|STARTED|Overall Study||167
2204532|NCT03207399|5405864|P1|NOT COMPLETED|Overall Study||0
2204533|NCT03207399|5405864|P1|COMPLETED|Overall Study||1
2204534|NCT03207399|5405864|P1|STARTED|Overall Study||1
2204535|NCT03206216|5405878|P2|NOT COMPLETED|Overall Study||1
2204536|NCT03206216|5405879|P1|NOT COMPLETED|Overall Study||0
2204537|NCT03206216|5405878|P2|COMPLETED|Overall Study||0
2204538|NCT03206216|5405879|P1|COMPLETED|Overall Study||0
2204539|NCT03206216|5405878|P2|STARTED|Overall Study||1
2204540|NCT03206216|5405879|P1|STARTED|Overall Study||0
2204541|NCT03205163|5405889|P2|NOT COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||0
2204542|NCT03205163|5405890|P1|NOT COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||0
2204543|NCT03205163|5405889|P2|COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||9
2204544|NCT03205163|5405890|P1|COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||6
2204545|NCT03205163|5405889|P2|Safety Population|BTP (LDC: 28 Days; HDC: 28 Days)||9
2204546|NCT03205163|5405890|P1|Safety Population|BTP (LDC: 28 Days; HDC: 28 Days)||6
2204547|NCT03205163|5405889|P2|STARTED|BTP (LDC: 28 Days; HDC: 28 Days)||9
2204548|NCT03205163|5405890|P1|STARTED|BTP (LDC: 28 Days; HDC: 28 Days)||6
2204549|NCT03205163|5405889|P2|NOT COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||0
2204550|NCT03205163|5405890|P1|NOT COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||1
2204551|NCT03205163|5405889|P2|COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||9
2204552|NCT03205163|5405890|P1|COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||6
2204553|NCT03205163|5405889|P2|Safety Population|ATP (LDC: 3 Days; HDC: 4 Days)||9
2204554|NCT03205163|5405890|P1|Safety Population|ATP (LDC: 3 Days; HDC: 4 Days)||7
2204555|NCT03205163|5405889|P2|STARTED|ATP (LDC: 3 Days; HDC: 4 Days)||9
2204556|NCT03205163|5405890|P1|STARTED|ATP (LDC: 3 Days; HDC: 4 Days)||7
2204557|NCT03204643|5405940|P2|NOT COMPLETED|Overall Study||0
2204558|NCT03204643|5405941|P1|NOT COMPLETED|Overall Study||0
2204559|NCT03204643|5405940|P2|COMPLETED|Overall Study||314
2204560|NCT03204643|5405941|P1|COMPLETED|Overall Study||323
2204561|NCT03204643|5405940|P2|STARTED|Overall Study||314
2204562|NCT03204643|5405941|P1|STARTED|Overall Study||323
2204563|NCT03203291|5405953|P1|NOT COMPLETED|Overall Study||1
2204564|NCT03203291|5405953|P1|COMPLETED|Overall Study||11
2204565|NCT03203291|5405953|P1|STARTED|Overall Study||12
2204573|NCT03200925|5405971|P2|NOT COMPLETED|Overall Study||0
2204574|NCT03200925|5405972|P1|NOT COMPLETED|Overall Study||0
2204575|NCT03200925|5405971|P2|COMPLETED|Overall Study||120
2204576|NCT03200925|5405972|P1|COMPLETED|Overall Study||120
2204577|NCT03200925|5405971|P2|STARTED|Overall Study||120
2204578|NCT03200925|5405972|P1|STARTED|Overall Study||120
2204579|NCT03200912|5405985|P3|NOT COMPLETED|Overall Study||4
2204580|NCT03200912|5405986|P2|NOT COMPLETED|Overall Study||3
2204581|NCT03200912|5405987|P1|NOT COMPLETED|Overall Study||4
2204582|NCT03200912|5405985|P3|COMPLETED|Overall Study||164
2204583|NCT03200912|5405986|P2|COMPLETED|Overall Study||166
2204584|NCT03200912|5405987|P1|COMPLETED|Overall Study||166
2204585|NCT03200912|5405985|P3|STARTED|Overall Study||168
2204586|NCT03200912|5405986|P2|STARTED|Overall Study||169
2204587|NCT03200912|5405987|P1|STARTED|Overall Study||170
2204594|NCT03200535|5406022|P4|NOT COMPLETED|Overall Study||0
2204595|NCT03200535|5406023|P3|NOT COMPLETED|Overall Study||0
2204596|NCT03200535|5406024|P2|NOT COMPLETED|Overall Study||0
2204597|NCT03200535|5406025|P1|NOT COMPLETED|Overall Study||0
2204598|NCT03200535|5406022|P4|COMPLETED|Overall Study||1000
2204599|NCT03200535|5406023|P3|COMPLETED|Overall Study||1862
2204600|NCT03200535|5406024|P2|COMPLETED|Overall Study||1863
2204601|NCT03200535|5406025|P1|COMPLETED|Overall Study||1863
2204602|NCT03200535|5406022|P4|STARTED|Overall Study||1000
2204603|NCT03200535|5406023|P3|STARTED|Overall Study||1862
2204604|NCT03200535|5406024|P2|STARTED|Overall Study||1863
2204605|NCT03200535|5406025|P1|STARTED|Overall Study||1863
2204606|NCT03198767|5406046|P7|NOT COMPLETED|Overall Study||0
2204607|NCT03198767|5406047|P6|NOT COMPLETED|Overall Study||0
2204608|NCT03198767|5406048|P5|NOT COMPLETED|Overall Study||0
2204609|NCT03198767|5406049|P4|NOT COMPLETED|Overall Study||6
2204610|NCT03198767|5406050|P3|NOT COMPLETED|Overall Study||0
2204611|NCT03198767|5406051|P2|NOT COMPLETED|Overall Study||0
2204612|NCT03198767|5406052|P1|NOT COMPLETED|Overall Study||0
2204613|NCT03198767|5406046|P7|COMPLETED|Overall Study||8
2204614|NCT03198767|5406047|P6|COMPLETED|Overall Study||8
2204615|NCT03198767|5406048|P5|COMPLETED|Overall Study||8
2204616|NCT03198767|5406049|P4|COMPLETED|Overall Study||0
2204617|NCT03198767|5406050|P3|COMPLETED|Overall Study||8
2204618|NCT03198767|5406051|P2|COMPLETED|Overall Study||8
2204619|NCT03198767|5406052|P1|COMPLETED|Overall Study||8
2204620|NCT03198767|5406046|P7|STARTED|Overall Study||8
2204621|NCT03198767|5406047|P6|STARTED|Overall Study||8
2204622|NCT03198767|5406048|P5|STARTED|Overall Study||8
2204623|NCT03198767|5406049|P4|STARTED|Overall Study||6
2204624|NCT03198767|5406050|P3|STARTED|Overall Study||8
2204625|NCT03198767|5406051|P2|STARTED|Overall Study||8
2204626|NCT03198767|5406052|P1|STARTED|Overall Study||8
2204627|NCT03198000|5406094|P3|NOT COMPLETED|Overall Study||0
2204628|NCT03198000|5406095|P2|NOT COMPLETED|Overall Study||0
2204629|NCT03198000|5406096|P1|NOT COMPLETED|Overall Study||0
2204630|NCT03198000|5406094|P3|COMPLETED|Overall Study||41
2204631|NCT03198000|5406095|P2|COMPLETED|Overall Study||38
2204632|NCT03198000|5406096|P1|COMPLETED|Overall Study||41
2204633|NCT03198000|5406094|P3|STARTED|Overall Study||41
2204634|NCT03198000|5406095|P2|STARTED|Overall Study||38
2204635|NCT03198000|5406096|P1|STARTED|Overall Study||41
2204636|NCT03197883|5406205|P2|NOT COMPLETED|Overall Study||6
2204637|NCT03197883|5406206|P1|NOT COMPLETED|Overall Study||3
2204638|NCT03197883|5406205|P2|COMPLETED|Overall Study||44
2204639|NCT03197883|5406206|P1|COMPLETED|Overall Study||47
2204640|NCT03197883|5406205|P2|STARTED|Overall Study||50
2204641|NCT03197883|5406206|P1|STARTED|Overall Study||50
2204642|NCT03197558|5406236|P1|NOT COMPLETED|Overall Study||1
2204643|NCT03197558|5406236|P1|COMPLETED|Overall Study||29
2204644|NCT03197558|5406236|P1|STARTED|Overall Study||30
2204645|NCT03197376|5406244|P4|NOT COMPLETED|Overall Study||25
2204646|NCT03197376|5406245|P3|NOT COMPLETED|Overall Study||20
2204647|NCT03197376|5406246|P2|NOT COMPLETED|Overall Study||13
2204648|NCT03197376|5406247|P1|NOT COMPLETED|Overall Study||15
2204649|NCT03197376|5406244|P4|COMPLETED|Overall Study||722
2204650|NCT03197376|5406245|P3|COMPLETED|Overall Study||480
2204651|NCT03197376|5406246|P2|COMPLETED|Overall Study||488
2204652|NCT03197376|5406247|P1|COMPLETED|Overall Study||487
2204653|NCT03197376|5406244|P4|Ongoing in Immune Persistence Phase|Overall Study||211
2204654|NCT03197376|5406245|P3|Ongoing in Immune Persistence Phase|Overall Study||138
2204655|NCT03197376|5406246|P2|Ongoing in Immune Persistence Phase|Overall Study||144
2204656|NCT03197376|5406247|P1|Ongoing in Immune Persistence Phase|Overall Study||144
2204657|NCT03197376|5406244|P4|Received Booster Vaccine|Overall Study||213
2204658|NCT03197376|5406245|P3|Received Booster Vaccine|Overall Study||139
2204659|NCT03197376|5406246|P2|Received Booster Vaccine|Overall Study||144
2204660|NCT03197376|5406247|P1|Received Booster Vaccine|Overall Study||145
2204661|NCT03197376|5406244|P4|Booster Cohort|Overall Study||224
2204662|NCT03197376|5406245|P3|Booster Cohort|Overall Study||150
2204663|NCT03197376|5406246|P2|Booster Cohort|Overall Study||151
2204664|NCT03197376|5406247|P1|Booster Cohort|Overall Study||150
2204665|NCT03197376|5406244|P4|Primary Reactogenicity Cohort|Overall Study||364
2204666|NCT03197376|5406245|P3|Primary Reactogenicity Cohort|Overall Study||257
2204667|NCT03197376|5406246|P2|Primary Reactogenicity Cohort|Overall Study||243
2204668|NCT03197376|5406247|P1|Primary Reactogenicity Cohort|Overall Study||251
2204669|NCT03197376|5406244|P4|Vaccinated-Dose 3|Overall Study||731
2204670|NCT03197376|5406245|P3|Vaccinated-Dose 3|Overall Study||490
2204671|NCT03197376|5406246|P2|Vaccinated-Dose 3|Overall Study||493
2204672|NCT03197376|5406247|P1|Vaccinated-Dose 3|Overall Study||492
2204673|NCT03197376|5406244|P4|Vaccinated-Dose 2|Overall Study||738
2204674|NCT03197376|5406245|P3|Vaccinated-Dose 2|Overall Study||491
2204675|NCT03197376|5406246|P2|Vaccinated-Dose 2|Overall Study||495
2204676|NCT03197376|5406247|P1|Vaccinated-Dose 2|Overall Study||495
2204677|NCT03197376|5406244|P4|Vaccinated-Dose 1|Overall Study||747
2204678|NCT03197376|5406245|P3|Vaccinated-Dose 1|Overall Study||500
2204679|NCT03197376|5406246|P2|Vaccinated-Dose 1|Overall Study||501
2204680|NCT03197376|5406247|P1|Vaccinated-Dose 1|Overall Study||502
2204681|NCT03197376|5406244|P4|STARTED|Overall Study||747
2204682|NCT03197376|5406245|P3|STARTED|Overall Study||500
2204683|NCT03197376|5406246|P2|STARTED|Overall Study||501
2204684|NCT03197376|5406247|P1|STARTED|Overall Study||502
2204685|NCT03197025|5406298|P1|NOT COMPLETED|Overall Study||0
2204686|NCT03197025|5406298|P1|COMPLETED|Overall Study||1
2204687|NCT03197025|5406298|P1|STARTED|Overall Study||1
2204688|NCT03196635|5406305|P1|NOT COMPLETED|Overall Study||1
2204689|NCT03196635|5406305|P1|COMPLETED|Overall Study||30
2204690|NCT03196635|5406305|P1|STARTED|Overall Study||31
2204691|NCT03196349|5406326|P3|NOT COMPLETED|Overall Study||13
2204692|NCT03196349|5406327|P2|NOT COMPLETED|Overall Study||14
2204693|NCT03196349|5406328|P1|NOT COMPLETED|Overall Study||17
2204694|NCT03196349|5406326|P3|COMPLETED|Overall Study||0
2204695|NCT03196349|5406327|P2|COMPLETED|Overall Study||0
2204696|NCT03196349|5406328|P1|COMPLETED|Overall Study||0
2204697|NCT03196349|5406326|P3|STARTED|Overall Study||13
2204698|NCT03196349|5406327|P2|STARTED|Overall Study||14
2204699|NCT03196349|5406328|P1|STARTED|Overall Study||17
2204700|NCT03195517|5406354|P1|NOT COMPLETED|Overall Study||0
2204701|NCT03195517|5406354|P1|COMPLETED|Overall Study||33
2204702|NCT03195517|5406354|P1|STARTED|Overall Study||33
2204703|NCT03195010|5406369|P2|NOT COMPLETED|Overall Study||0
2204704|NCT03195010|5406370|P1|NOT COMPLETED|Overall Study||0
2204705|NCT03195010|5406369|P2|COMPLETED|Overall Study||2
2204706|NCT03195010|5406370|P1|COMPLETED|Overall Study||2
2204707|NCT03195010|5406369|P2|STARTED|Overall Study||2
2204708|NCT03195010|5406370|P1|STARTED|Overall Study||2
2204709|NCT03194776|5406397|P2|NOT COMPLETED|Overall Study||0
2204710|NCT03194776|5406398|P1|NOT COMPLETED|Overall Study||0
2204711|NCT03194776|5406397|P2|COMPLETED|Overall Study||23
2204712|NCT03194776|5406398|P1|COMPLETED|Overall Study||23
2204713|NCT03194776|5406397|P2|STARTED|Overall Study||23
2204714|NCT03194776|5406398|P1|STARTED|Overall Study||23
2204715|NCT03194698|5406416|P2|NOT COMPLETED|Overall Study||0
2204716|NCT03194698|5406417|P1|NOT COMPLETED|Overall Study||0
2204717|NCT03194698|5406416|P2|COMPLETED|Overall Study||10
2204718|NCT03194698|5406417|P1|COMPLETED|Overall Study||10
2204719|NCT03194698|5406416|P2|STARTED|Overall Study||10
2204720|NCT03194698|5406417|P1|STARTED|Overall Study||10
2204721|NCT03194490|5406429|P2|NOT COMPLETED|Overall Study||3
2204722|NCT03194490|5406430|P1|NOT COMPLETED|Overall Study||2
2204723|NCT03194490|5406429|P2|COMPLETED|Overall Study||20
2204724|NCT03194490|5406430|P1|COMPLETED|Overall Study||18
2204725|NCT03194490|5406429|P2|STARTED|Overall Study||23
2204726|NCT03194490|5406430|P1|STARTED|Overall Study||20
2204727|NCT03194373|5406472|P1|NOT COMPLETED|Overall Study||2
2204728|NCT03194373|5406472|P1|COMPLETED|Overall Study||18
2204729|NCT03194373|5406472|P1|STARTED|Overall Study||20
2204730|NCT03194334|5406479|P3|NOT COMPLETED|3-6 Months||0
2204731|NCT03194334|5406480|P2|NOT COMPLETED|3-6 Months||0
2204732|NCT03194334|5406481|P1|NOT COMPLETED|3-6 Months||0
2204733|NCT03194334|5406479|P3|COMPLETED|3-6 Months||14
2204734|NCT03194334|5406480|P2|COMPLETED|3-6 Months||15
2204735|NCT03194334|5406481|P1|COMPLETED|3-6 Months||10
2204736|NCT03194334|5406479|P3|STARTED|3-6 Months||14
2204737|NCT03194334|5406480|P2|STARTED|3-6 Months||15
2204738|NCT03194334|5406481|P1|STARTED|3-6 Months||10
2204739|NCT03194334|5406479|P3|NOT COMPLETED|0-3 Months||1
2204740|NCT03194334|5406480|P2|NOT COMPLETED|0-3 Months||0
2204741|NCT03194334|5406481|P1|NOT COMPLETED|0-3 Months||0
2204742|NCT03194334|5406479|P3|COMPLETED|0-3 Months||14
2204743|NCT03194334|5406480|P2|COMPLETED|0-3 Months||15
2204744|NCT03194334|5406481|P1|COMPLETED|0-3 Months||10
2204745|NCT03194334|5406479|P3|STARTED|0-3 Months||15
2204746|NCT03194334|5406480|P2|STARTED|0-3 Months||15
2204747|NCT03194334|5406481|P1|STARTED|0-3 Months||10
2204748|NCT03193593|5406559|P7|NOT COMPLETED|Overall Study||4
2204749|NCT03193593|5406560|P6|NOT COMPLETED|Overall Study||3
2204750|NCT03193593|5406561|P5|NOT COMPLETED|Overall Study||1
2204751|NCT03193593|5406562|P4|NOT COMPLETED|Overall Study||0
2204752|NCT03193593|5406563|P3|NOT COMPLETED|Overall Study||1
2204753|NCT03193593|5406564|P2|NOT COMPLETED|Overall Study||1
2204754|NCT03193593|5406565|P1|NOT COMPLETED|Overall Study||4
2204755|NCT03193593|5406559|P7|COMPLETED|Overall Study||8
2204756|NCT03193593|5406560|P6|COMPLETED|Overall Study||13
2204757|NCT03193593|5406561|P5|COMPLETED|Overall Study||7
2204758|NCT03193593|5406562|P4|COMPLETED|Overall Study||4
2204759|NCT03193593|5406563|P3|COMPLETED|Overall Study||3
2204760|NCT03193593|5406564|P2|COMPLETED|Overall Study||3
2204761|NCT03193593|5406565|P1|COMPLETED|Overall Study||14
2204762|NCT03193593|5406559|P7|STARTED|Overall Study||12
2204763|NCT03193593|5406560|P6|STARTED|Overall Study||16
2204764|NCT03193593|5406561|P5|STARTED|Overall Study||8
2204765|NCT03193593|5406562|P4|STARTED|Overall Study||4
2204766|NCT03193593|5406563|P3|STARTED|Overall Study||4
2204767|NCT03193593|5406564|P2|STARTED|Overall Study||4
2204768|NCT03193593|5406565|P1|STARTED|Overall Study||18
2204769|NCT03193021|5406583|P2|NOT COMPLETED|Overall Study||1
2204770|NCT03193021|5406584|P1|NOT COMPLETED|Overall Study||1
2204771|NCT03193021|5406583|P2|COMPLETED|Overall Study||103
2204772|NCT03193021|5406584|P1|COMPLETED|Overall Study||99
2204773|NCT03193021|5406583|P2|STARTED|Overall Study||104
2204774|NCT03193021|5406584|P1|STARTED|Overall Study||100
2204775|NCT03192826|5406610|P3|NOT COMPLETED|Overall Study||0
2204776|NCT03192826|5406611|P2|NOT COMPLETED|Overall Study||0
2204777|NCT03192826|5406612|P1|NOT COMPLETED|Overall Study||0
2204778|NCT03192826|5406610|P3|COMPLETED|Overall Study||25
2204779|NCT03192826|5406611|P2|COMPLETED|Overall Study||27
2204780|NCT03192826|5406612|P1|COMPLETED|Overall Study||27
2204781|NCT03192826|5406610|P3|STARTED|Overall Study||25
2204782|NCT03192826|5406611|P2|STARTED|Overall Study||27
2204783|NCT03192826|5406612|P1|STARTED|Overall Study||27
2204784|NCT03192475|5406631|P2|NOT COMPLETED|Overall Study||9
2204785|NCT03192475|5406632|P1|NOT COMPLETED|Overall Study||13
2204786|NCT03192475|5406631|P2|COMPLETED|Overall Study||151
2204787|NCT03192475|5406632|P1|COMPLETED|Overall Study||149
2204788|NCT03192475|5406631|P2|STARTED|Overall Study||160
2204789|NCT03192475|5406632|P1|STARTED|Overall Study||162
2204790|NCT03192306|5406668|P2|NOT COMPLETED|Overall Study||145
2204791|NCT03192306|5406669|P1|NOT COMPLETED|Overall Study||152
2204792|NCT03192306|5406668|P2|COMPLETED|Overall Study||79
2204793|NCT03192306|5406669|P1|COMPLETED|Overall Study||75
2204794|NCT03192306|5406668|P2|Modified Intent to Treat (MITT)|Overall Study||80
2204795|NCT03192306|5406669|P1|Modified Intent to Treat (MITT)|Overall Study||76
2204796|NCT03192306|5406668|P2|STARTED|Overall Study||224
2204797|NCT03192306|5406669|P1|STARTED|Overall Study||227
2204798|NCT03191552|5406690|P3|NOT COMPLETED|Overall Study||0
2204799|NCT03191552|5406691|P2|NOT COMPLETED|Overall Study||1
2204800|NCT03191552|5406692|P1|NOT COMPLETED|Overall Study||1
2204801|NCT03191552|5406690|P3|COMPLETED|Overall Study||8
2204802|NCT03191552|5406691|P2|COMPLETED|Overall Study||8
2204803|NCT03191552|5406692|P1|COMPLETED|Overall Study||8
2204804|NCT03191552|5406690|P3|STARTED|Overall Study||8
2204805|NCT03191552|5406691|P2|STARTED|Overall Study||9
2204806|NCT03191552|5406692|P1|STARTED|Overall Study||9
2204807|NCT03191396|5406745|P2|NOT COMPLETED|Overall Study||5
2204808|NCT03191396|5406746|P1|NOT COMPLETED|Overall Study||3
2204809|NCT03191396|5406745|P2|COMPLETED|Overall Study||282
2204810|NCT03191396|5406746|P1|COMPLETED|Overall Study||287
2204811|NCT03191396|5406745|P2|STARTED|Overall Study||287
2204812|NCT03191396|5406746|P1|STARTED|Overall Study||290
2204813|NCT03190369|5406834|P2|NOT COMPLETED|Overall Study||8
2204814|NCT03190369|5406835|P1|NOT COMPLETED|Overall Study||1
2204815|NCT03190369|5406834|P2|COMPLETED|Overall Study||212
2204816|NCT03190369|5406835|P1|COMPLETED|Overall Study||219
2204817|NCT03190369|5406834|P2|Treated|Overall Study||218
2204818|NCT03190369|5406835|P1|Treated|Overall Study||220
2204819|NCT03190369|5406834|P2|STARTED|Overall Study||220
2204820|NCT03190369|5406835|P1|STARTED|Overall Study||220
2204821|NCT03190213|5406853|P1|NOT COMPLETED|Overall Study||0
2204822|NCT03190213|5406853|P1|COMPLETED|Overall Study||6
2204823|NCT03190213|5406853|P1|STARTED|Overall Study||6
2204824|NCT03190005|5406868|P7|NOT COMPLETED|Overall Study||0
2204825|NCT03190005|5406869|P6|NOT COMPLETED|Overall Study||0
2204826|NCT03190005|5406870|P5|NOT COMPLETED|Overall Study||0
2204827|NCT03190005|5406871|P4|NOT COMPLETED|Overall Study||0
2204828|NCT03190005|5406872|P3|NOT COMPLETED|Overall Study||0
2204829|NCT03190005|5406873|P2|NOT COMPLETED|Overall Study||0
2204830|NCT03190005|5406874|P1|NOT COMPLETED|Overall Study||0
2204831|NCT03190005|5406868|P7|COMPLETED|Overall Study||5
2204832|NCT03190005|5406869|P6|COMPLETED|Overall Study||5
2204833|NCT03190005|5406870|P5|COMPLETED|Overall Study||5
2204834|NCT03190005|5406871|P4|COMPLETED|Overall Study||5
2204835|NCT03190005|5406872|P3|COMPLETED|Overall Study||5
2204836|NCT03190005|5406873|P2|COMPLETED|Overall Study||5
2204837|NCT03190005|5406874|P1|COMPLETED|Overall Study||5
2204838|NCT03190005|5406868|P7|STARTED|Overall Study||5
2204839|NCT03190005|5406869|P6|STARTED|Overall Study||5
2204840|NCT03190005|5406870|P5|STARTED|Overall Study||5
2204841|NCT03190005|5406871|P4|STARTED|Overall Study||5
2204842|NCT03190005|5406872|P3|STARTED|Overall Study||5
2204843|NCT03190005|5406873|P2|STARTED|Overall Study||5
2204844|NCT03190005|5406874|P1|STARTED|Overall Study||5
2204845|NCT03189589|5406892|P2|NOT COMPLETED|Overall Study||0
2204846|NCT03189589|5406893|P1|NOT COMPLETED|Overall Study||0
2204847|NCT03189589|5406892|P2|COMPLETED|Overall Study||6
2204848|NCT03189589|5406893|P1|COMPLETED|Overall Study||6
2204849|NCT03189589|5406892|P2|STARTED|Overall Study||6
2204850|NCT03189589|5406893|P1|STARTED|Overall Study||6
2204851|NCT03188523|5406919|P4|NOT COMPLETED|Overall Study||0
2204852|NCT03188523|5406920|P3|NOT COMPLETED|Overall Study||0
2204853|NCT03188523|5406921|P2|NOT COMPLETED|Overall Study||0
2204854|NCT03188523|5406922|P1|NOT COMPLETED|Overall Study||0
2204855|NCT03188523|5406919|P4|COMPLETED|Overall Study||0
2204856|NCT03188523|5406920|P3|COMPLETED|Overall Study||0
2204857|NCT03188523|5406921|P2|COMPLETED|Overall Study||6
2204858|NCT03188523|5406922|P1|COMPLETED|Overall Study||6
2204859|NCT03188523|5406919|P4|STARTED|Overall Study||0
2204860|NCT03188523|5406920|P3|STARTED|Overall Study||0
2204861|NCT03188523|5406921|P2|STARTED|Overall Study||6
2204862|NCT03188523|5406922|P1|STARTED|Overall Study||6
2204863|NCT03188120|5406972|P1|NOT COMPLETED|Overall Study||47
2204864|NCT03188120|5406972|P1|COMPLETED|Overall Study||146
2204865|NCT03188120|5406972|P1|STARTED|Overall Study||193
2204866|NCT03187678|5406977|P1|NOT COMPLETED|Period 3 (Oral Selexipag)||0
2204867|NCT03187678|5406977|P1|COMPLETED|Period 3 (Oral Selexipag)||20
2204868|NCT03187678|5406977|P1|STARTED|Period 3 (Oral Selexipag)||20
2204869|NCT03187678|5406977|P1|NOT COMPLETED|Period 2 (Intravenous Selexipag)||0
2204870|NCT03187678|5406977|P1|COMPLETED|Period 2 (Intravenous Selexipag)||20
2204871|NCT03187678|5406977|P1|STARTED|Period 2 (Intravenous Selexipag)||20
2204872|NCT03187678|5406977|P1|NOT COMPLETED|Period 1 (Oral Selexipag)||0
2204873|NCT03187678|5406977|P1|COMPLETED|Period 1 (Oral Selexipag)||20
2204874|NCT03187678|5406977|P1|STARTED|Period 1 (Oral Selexipag)||20
2204887|NCT03185481|5407001|P1|NOT COMPLETED|Overall Study||5
2204888|NCT03185481|5407001|P1|COMPLETED|Overall Study||0
2204889|NCT03185481|5407001|P1|STARTED|Overall Study||5
2204890|NCT03185455|5407020|P2|NOT COMPLETED|Overall Study||0
2204891|NCT03185455|5407021|P1|NOT COMPLETED|Overall Study||0
2204892|NCT03185455|5407020|P2|COMPLETED|Overall Study||103
2204893|NCT03185455|5407021|P1|COMPLETED|Overall Study||103
2204894|NCT03185455|5407020|P2|STARTED|Overall Study||103
2204895|NCT03185455|5407021|P1|STARTED|Overall Study||103
2204896|NCT03185182|5407035|P1|NOT COMPLETED|Overall Study||0
2204897|NCT03185182|5407035|P1|COMPLETED|Overall Study||5
2204898|NCT03185182|5407035|P1|STARTED|Overall Study||5
2204899|NCT03184441|5407040|P1|NOT COMPLETED|Overall Study||1
2204900|NCT03184441|5407040|P1|COMPLETED|Overall Study|Last subject completed study|10
2204901|NCT03184441|5407040|P1|STARTED|Overall Study||11
2204902|NCT03184077|5407050|P2|NOT COMPLETED|Overall Study||21
2204903|NCT03184077|5407051|P1|NOT COMPLETED|Overall Study||21
2204904|NCT03184077|5407050|P2|COMPLETED|Overall Study||131
2204905|NCT03184077|5407051|P1|COMPLETED|Overall Study||145
2204906|NCT03184077|5407050|P2|STARTED|Overall Study||152
2204907|NCT03184077|5407051|P1|STARTED|Overall Study||166
2204908|NCT03183869|5407063|P2|NOT COMPLETED|Overall Study||5
2204909|NCT03183869|5407064|P1|NOT COMPLETED|Overall Study||4
2204910|NCT03183869|5407063|P2|COMPLETED|Overall Study||2
2204911|NCT03183869|5407064|P1|COMPLETED|Overall Study||0
2204912|NCT03183869|5407063|P2|STARTED|Overall Study||7
2204913|NCT03183869|5407064|P1|STARTED|Overall Study||4
2204914|NCT03183518|5407070|P1|NOT COMPLETED|Overall Study||3
2204915|NCT03183518|5407070|P1|COMPLETED|Overall Study||33
2204916|NCT03183518|5407070|P1|Negative Control|Overall Study||36
2204917|NCT03183518|5407070|P1|Test Product|Overall Study||36
2204918|NCT03183518|5407070|P1|STARTED|Overall Study||36
2204919|NCT03182933|5407103|P2|NOT COMPLETED|Overall Study||0
2204920|NCT03182933|5407104|P1|NOT COMPLETED|Overall Study||1
2204921|NCT03182933|5407103|P2|COMPLETED|Overall Study||32
2204922|NCT03182933|5407104|P1|COMPLETED|Overall Study||31
2204923|NCT03182933|5407103|P2|STARTED|Overall Study||32
2204924|NCT03182933|5407104|P1|STARTED|Overall Study||32
2204925|NCT03182920|5407120|P3|NOT COMPLETED|Period 2||0
2204926|NCT03182920|5407121|P2|NOT COMPLETED|Period 2||0
2204927|NCT03182920|5407122|P1|NOT COMPLETED|Period 2||0
2204928|NCT03182920|5407120|P3|COMPLETED|Period 2||0
2204929|NCT03182920|5407121|P2|COMPLETED|Period 2||9
2204930|NCT03182920|5407122|P1|COMPLETED|Period 2||9
2204931|NCT03182920|5407120|P3|STARTED|Period 2|Young participants on Lasmiditan did not move to study period 2.|0
2204932|NCT03182920|5407121|P2|STARTED|Period 2||9
2204933|NCT03182920|5407122|P1|STARTED|Period 2||9
2204934|NCT03182920|5407120|P3|NOT COMPLETED|Washout Period||0
2204935|NCT03182920|5407121|P2|NOT COMPLETED|Washout Period||0
2204936|NCT03182920|5407122|P1|NOT COMPLETED|Washout Period||0
2204937|NCT03182920|5407120|P3|COMPLETED|Washout Period||0
2204938|NCT03182920|5407121|P2|COMPLETED|Washout Period||9
2204939|NCT03182920|5407122|P1|COMPLETED|Washout Period||9
2204940|NCT03182920|5407120|P3|STARTED|Washout Period||0
2204941|NCT03182920|5407121|P2|STARTED|Washout Period||9
2204942|NCT03182920|5407122|P1|STARTED|Washout Period||9
2204943|NCT03182920|5407120|P3|NOT COMPLETED|Period 1||0
2204944|NCT03182920|5407121|P2|NOT COMPLETED|Period 1||0
2204945|NCT03182920|5407122|P1|NOT COMPLETED|Period 1||0
2204946|NCT03182920|5407120|P3|COMPLETED|Period 1||17
2204947|NCT03182920|5407121|P2|COMPLETED|Period 1||9
2204948|NCT03182920|5407122|P1|COMPLETED|Period 1||9
2204949|NCT03182920|5407120|P3|STARTED|Period 1||17
2204950|NCT03182920|5407121|P2|STARTED|Period 1||9
2204951|NCT03182920|5407122|P1|STARTED|Period 1||9
2204952|NCT03182738|5407133|P2|NOT COMPLETED|Overall Study||5
2204953|NCT03182738|5407134|P1|NOT COMPLETED|Overall Study||9
2204954|NCT03182738|5407133|P2|COMPLETED|Overall Study||45
2204955|NCT03182738|5407134|P1|COMPLETED|Overall Study||41
2204956|NCT03182738|5407133|P2|STARTED|Overall Study||50
2204957|NCT03182738|5407134|P1|STARTED|Overall Study||50
2204958|NCT03182582|5407148|P2|NOT COMPLETED|Treatment 2||0
2204959|NCT03182582|5407149|P1|NOT COMPLETED|Treatment 2||0
2204960|NCT03182582|5407148|P2|COMPLETED|Treatment 2||10
2204961|NCT03182582|5407149|P1|COMPLETED|Treatment 2||12
2204962|NCT03182582|5407148|P2|STARTED|Treatment 2||10
2204963|NCT03182582|5407149|P1|STARTED|Treatment 2||12
2204964|NCT03182582|5407148|P2|NOT COMPLETED|Treatment 1||0
2204965|NCT03182582|5407149|P1|NOT COMPLETED|Treatment 1||0
2204966|NCT03182582|5407148|P2|COMPLETED|Treatment 1||10
2204967|NCT03182582|5407149|P1|COMPLETED|Treatment 1||12
2204968|NCT03182582|5407148|P2|STARTED|Treatment 1||10
2204969|NCT03182582|5407149|P1|STARTED|Treatment 1||12
2204970|NCT03181724|5407166|P2|NOT COMPLETED|Overall Study||0
2204971|NCT03181724|5407167|P1|NOT COMPLETED|Overall Study||0
2204972|NCT03181724|5407166|P2|COMPLETED|Overall Study||45
2204973|NCT03181724|5407167|P1|COMPLETED|Overall Study||45
2204974|NCT03181724|5407166|P2|STARTED|Overall Study||45
2204975|NCT03181724|5407167|P1|STARTED|Overall Study||45
2204976|NCT03181594|5407183|P1|NOT COMPLETED|Overall Study||2
2204977|NCT03181594|5407183|P1|COMPLETED|Overall Study||98
2204978|NCT03181594|5407183|P1|90-day Follow-up|Overall Study||98
2204979|NCT03181594|5407183|P1|30-day Follow-up|Overall Study||99
2204980|NCT03181594|5407183|P1|STARTED|Overall Study||100
2204989|NCT03181009|5407230|P2|NOT COMPLETED|Overall Study||2
2204990|NCT03181009|5407231|P1|NOT COMPLETED|Overall Study||0
2204991|NCT03181009|5407230|P2|COMPLETED|Overall Study||28
2204992|NCT03181009|5407231|P1|COMPLETED|Overall Study||30
2204993|NCT03181009|5407230|P2|STARTED|Overall Study||30
2204994|NCT03181009|5407231|P1|STARTED|Overall Study||30
2204995|NCT03180801|5407240|P3|NOT COMPLETED|Overall Study||10
2204996|NCT03180801|5407241|P2|NOT COMPLETED|Overall Study||12
2204997|NCT03180801|5407242|P1|NOT COMPLETED|Overall Study||8
2204998|NCT03180801|5407240|P3|COMPLETED|Overall Study||41
2204999|NCT03180801|5407241|P2|COMPLETED|Overall Study||40
2205000|NCT03180801|5407242|P1|COMPLETED|Overall Study||42
2205001|NCT03180801|5407240|P3|Intention to Treat|Overall Study||41
2205002|NCT03180801|5407241|P2|Intention to Treat|Overall Study||40
2205003|NCT03180801|5407242|P1|Intention to Treat|Overall Study||42
2205004|NCT03180801|5407240|P3|Safety Population|Overall Study||51
2205005|NCT03180801|5407241|P2|Safety Population|Overall Study||52
2205006|NCT03180801|5407242|P1|Safety Population|Overall Study||50
2205007|NCT03180801|5407240|P3|STARTED|Overall Study||51
2205008|NCT03180801|5407241|P2|STARTED|Overall Study||52
2205009|NCT03180801|5407242|P1|STARTED|Overall Study||50
2205010|NCT03180645|5407283|P3|NOT COMPLETED|Overall Study||2
2205011|NCT03180645|5407284|P2|NOT COMPLETED|Overall Study||1
2205012|NCT03180645|5407285|P1|NOT COMPLETED|Overall Study||0
2205013|NCT03180645|5407283|P3|COMPLETED|Overall Study||22
2205014|NCT03180645|5407284|P2|COMPLETED|Overall Study||23
2205015|NCT03180645|5407285|P1|COMPLETED|Overall Study||24
2205016|NCT03180645|5407283|P3|STARTED|Overall Study||24
2205017|NCT03180645|5407284|P2|STARTED|Overall Study||24
2205018|NCT03180645|5407285|P1|STARTED|Overall Study||24
2205019|NCT03180515|5407324|P1|NOT COMPLETED|Aim 3||0
2205020|NCT03180515|5407324|P1|COMPLETED|Aim 3||1
2205021|NCT03180515|5407324|P1|STARTED|Aim 3||1
2205022|NCT03180515|5407324|P1|NOT COMPLETED|Aim 2||0
2205023|NCT03180515|5407324|P1|COMPLETED|Aim 2||12
2205024|NCT03180515|5407324|P1|STARTED|Aim 2||12
2205025|NCT03180515|5407324|P1|NOT COMPLETED|Aim 1||0
2205026|NCT03180515|5407324|P1|COMPLETED|Aim 1||12
2205027|NCT03180515|5407324|P1|STARTED|Aim 1||12
2205028|NCT03180489|5407369|P2|NOT COMPLETED|Overall Study||4
2205029|NCT03180489|5407370|P1|NOT COMPLETED|Overall Study||8
2205030|NCT03180489|5407369|P2|COMPLETED|Overall Study||25
2205031|NCT03180489|5407370|P1|COMPLETED|Overall Study||25
2205032|NCT03180489|5407369|P2|STARTED|Overall Study||29
2205033|NCT03180489|5407370|P1|STARTED|Overall Study||33
2205034|NCT03180385|5407402|P2|NOT COMPLETED|Overall Study||0
2205035|NCT03180385|5407403|P1|NOT COMPLETED|Overall Study||0
2205036|NCT03180385|5407402|P2|COMPLETED|Overall Study||2
2205037|NCT03180385|5407403|P1|COMPLETED|Overall Study||0
2205038|NCT03180385|5407402|P2|STARTED|Overall Study||2
2205039|NCT03180385|5407403|P1|STARTED|Overall Study||0
2205040|NCT03180138|5407430|P3|NOT COMPLETED|Overall Study||24
2205041|NCT03180138|5407431|P2|NOT COMPLETED|Overall Study||13
2205042|NCT03180138|5407432|P1|NOT COMPLETED|Overall Study||22
2205043|NCT03180138|5407430|P3|COMPLETED|Overall Study||179
2205044|NCT03180138|5407431|P2|COMPLETED|Overall Study||188
2205045|NCT03180138|5407432|P1|COMPLETED|Overall Study||182
2205046|NCT03180138|5407430|P3|STARTED|Overall Study||203
2205047|NCT03180138|5407431|P2|STARTED|Overall Study||201
2205048|NCT03180138|5407432|P1|STARTED|Overall Study||204
2205049|NCT03178942|5407445|P2|NOT COMPLETED|Overall Study||2
2205050|NCT03178942|5407446|P1|NOT COMPLETED|Overall Study||3
2205051|NCT03178942|5407445|P2|COMPLETED|Overall Study||123
2205052|NCT03178942|5407446|P1|COMPLETED|Overall Study||126
2205053|NCT03178942|5407445|P2|STARTED|Overall Study||125
2205054|NCT03178942|5407446|P1|STARTED|Overall Study||129
2205055|NCT03178344|5407458|P2|NOT COMPLETED|Second Session||0
2205056|NCT03178344|5407459|P1|NOT COMPLETED|Second Session||0
2205057|NCT03178344|5407458|P2|COMPLETED|Second Session||10
2205058|NCT03178344|5407459|P1|COMPLETED|Second Session||10
2205059|NCT03178344|5407458|P2|STARTED|Second Session||10
2205060|NCT03178344|5407459|P1|STARTED|Second Session||10
2205061|NCT03178344|5407458|P2|NOT COMPLETED|Washout Period (5-9 Days)||0
2205062|NCT03178344|5407459|P1|NOT COMPLETED|Washout Period (5-9 Days)||0
2205063|NCT03178344|5407458|P2|COMPLETED|Washout Period (5-9 Days)||10
2205064|NCT03178344|5407459|P1|COMPLETED|Washout Period (5-9 Days)||10
2205065|NCT03178344|5407458|P2|STARTED|Washout Period (5-9 Days)||10
2205066|NCT03178344|5407459|P1|STARTED|Washout Period (5-9 Days)||10
2205067|NCT03178344|5407458|P2|NOT COMPLETED|First Session||0
2205068|NCT03178344|5407459|P1|NOT COMPLETED|First Session||0
2205069|NCT03178344|5407458|P2|COMPLETED|First Session||10
2205070|NCT03178344|5407459|P1|COMPLETED|First Session||10
2205071|NCT03178344|5407458|P2|STARTED|First Session||10
2205072|NCT03178344|5407459|P1|STARTED|First Session||10
2205073|NCT03178266|5407475|P2|NOT COMPLETED|Overall Study||4
2205074|NCT03178266|5407476|P1|NOT COMPLETED|Overall Study||0
2205075|NCT03178266|5407475|P2|COMPLETED|Overall Study||16
2205076|NCT03178266|5407476|P1|COMPLETED|Overall Study||21
2205077|NCT03178266|5407475|P2|STARTED|Overall Study||20
2205078|NCT03178266|5407476|P1|STARTED|Overall Study||21
2205079|NCT03177798|5407486|P2|NOT COMPLETED|Overall Study||0
2205080|NCT03177798|5407487|P1|NOT COMPLETED|Overall Study||0
2205081|NCT03177798|5407486|P2|COMPLETED|Overall Study||6
2205082|NCT03177798|5407487|P1|COMPLETED|Overall Study||5
2205083|NCT03177798|5407486|P2|Intervention 2|Overall Study||6
2205084|NCT03177798|5407487|P1|Intervention 2|Overall Study||5
2205085|NCT03177798|5407486|P2|Washout|Overall Study||6
2205086|NCT03177798|5407487|P1|Washout|Overall Study||5
2205087|NCT03177798|5407486|P2|Intervention 1|Overall Study||6
2205088|NCT03177798|5407487|P1|Intervention 1|Overall Study||5
2205089|NCT03177798|5407486|P2|STARTED|Overall Study||6
2205090|NCT03177798|5407487|P1|STARTED|Overall Study||5
2205091|NCT03177395|5407499|P4|NOT COMPLETED|Overall Study||0
2205092|NCT03177395|5407500|P3|NOT COMPLETED|Overall Study||0
2205093|NCT03177395|5407501|P2|NOT COMPLETED|Overall Study||0
2205094|NCT03177395|5407502|P1|NOT COMPLETED|Overall Study||0
2205095|NCT03177395|5407499|P4|COMPLETED|Overall Study||6
2205096|NCT03177395|5407500|P3|COMPLETED|Overall Study||6
2205097|NCT03177395|5407501|P2|COMPLETED|Overall Study||6
2205098|NCT03177395|5407502|P1|COMPLETED|Overall Study||6
2205099|NCT03177395|5407499|P4|STARTED|Overall Study||6
2205100|NCT03177395|5407500|P3|STARTED|Overall Study||6
2205101|NCT03177395|5407501|P2|STARTED|Overall Study||6
2205102|NCT03177395|5407502|P1|STARTED|Overall Study||6
2205103|NCT03176654|5407606|P2|NOT COMPLETED|Overall Study||0
2205104|NCT03176654|5407607|P1|NOT COMPLETED|Overall Study||0
2205105|NCT03176654|5407606|P2|COMPLETED|Overall Study||15
2205106|NCT03176654|5407607|P1|COMPLETED|Overall Study||13
2205107|NCT03176654|5407606|P2|STARTED|Overall Study||15
2205108|NCT03176654|5407607|P1|STARTED|Overall Study||13
2205109|NCT03176407|5407627|P1|NOT COMPLETED|Overall Study||3
2205110|NCT03176407|5407627|P1|COMPLETED|Overall Study||27
2205111|NCT03176407|5407627|P1|STARTED|Overall Study||30
2205112|NCT03175562|5407635|P1|NOT COMPLETED|Overall Study||16
2205113|NCT03175562|5407635|P1|COMPLETED|Overall Study||224
2205114|NCT03175562|5407635|P1|Negative Control|Overall Study||240
2205115|NCT03175562|5407635|P1|Test Product|Overall Study||240
2205116|NCT03175562|5407635|P1|STARTED|Overall Study||240
2205117|NCT03175172|5407660|P1|NOT COMPLETED|Overall Study||10
2205118|NCT03175172|5407660|P1|COMPLETED|Overall Study||0
2205119|NCT03175172|5407660|P1|STARTED|Overall Study||10
2205120|NCT03174366|5407668|P1|NOT COMPLETED|Overall Study||0
2205121|NCT03174366|5407668|P1|COMPLETED|Overall Study||7
2205122|NCT03174366|5407668|P1|STARTED|Overall Study||7
2205123|NCT03174158|5407677|P4|NOT COMPLETED|Overall Study||1
2205124|NCT03174158|5407678|P3|NOT COMPLETED|Overall Study||2
2205125|NCT03174158|5407679|P2|NOT COMPLETED|Overall Study||2
2205126|NCT03174158|5407680|P1|NOT COMPLETED|Overall Study||4
2205127|NCT03174158|5407677|P4|COMPLETED|Overall Study||38
2205128|NCT03174158|5407678|P3|COMPLETED|Overall Study||34
2205129|NCT03174158|5407679|P2|COMPLETED|Overall Study||37
2205130|NCT03174158|5407680|P1|COMPLETED|Overall Study||35
2205131|NCT03174158|5407677|P4|STARTED|Overall Study||39
2205132|NCT03174158|5407678|P3|STARTED|Overall Study||36
2205133|NCT03174158|5407679|P2|STARTED|Overall Study||39
2205134|NCT03174158|5407680|P1|STARTED|Overall Study||39
2205135|NCT03174132|5407716|P1|NOT COMPLETED|Overall Study||0
2205136|NCT03174132|5407716|P1|COMPLETED|Overall Study||70
2205137|NCT03174132|5407716|P1|STARTED|Overall Study||70
2205138|NCT03173170|5407721|P1|NOT COMPLETED|Intervention Period 2 (9 Days)||0
2205139|NCT03173170|5407721|P1|COMPLETED|Intervention Period 2 (9 Days)||10
2205140|NCT03173170|5407721|P1|STARTED|Intervention Period 2 (9 Days)||10
2205141|NCT03173170|5407721|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2205142|NCT03173170|5407721|P1|COMPLETED|Washout Period (at Least 7 Days)||10
2205143|NCT03173170|5407721|P1|STARTED|Washout Period (at Least 7 Days)||10
2205144|NCT03173170|5407721|P1|NOT COMPLETED|First Intervention Period (6 Days)||0
2205145|NCT03173170|5407721|P1|COMPLETED|First Intervention Period (6 Days)||10
2205146|NCT03173170|5407721|P1|STARTED|First Intervention Period (6 Days)||10
2205147|NCT03172520|5407730|P1|NOT COMPLETED|Overall Study||10
2205148|NCT03172520|5407730|P1|COMPLETED|Overall Study||0
2205149|NCT03172520|5407730|P1|STARTED|Overall Study||10
2205150|NCT03172481|5407736|P2|NOT COMPLETED|Double-blind||0
2205151|NCT03172481|5407737|P1|NOT COMPLETED|Double-blind||1
2205152|NCT03172481|5407736|P2|COMPLETED|Double-blind||73
2205153|NCT03172481|5407737|P1|COMPLETED|Double-blind||74
2205154|NCT03172481|5407736|P2|STARTED|Double-blind|From 148 subjects who completed the Open-label period, 73 randomly received Placebo|73
2205155|NCT03172481|5407737|P1|STARTED|Double-blind||75
2205156|NCT03172481|5407736|P2|NOT COMPLETED|Open-label||0
2205157|NCT03172481|5407737|P1|NOT COMPLETED|Open-label||8
2205158|NCT03172481|5407736|P2|COMPLETED|Open-label||0
2205159|NCT03172481|5407737|P1|COMPLETED|Open-label||148
2205160|NCT03172481|5407736|P2|STARTED|Open-label||0
2205161|NCT03172481|5407737|P1|STARTED|Open-label||156
2205162|NCT03172364|5407745|P2|NOT COMPLETED|Overall Study||1
2205163|NCT03172364|5407746|P1|NOT COMPLETED|Overall Study||2
2205164|NCT03172364|5407745|P2|COMPLETED|Overall Study||57
2205165|NCT03172364|5407746|P1|COMPLETED|Overall Study||53
2205166|NCT03172364|5407745|P2|STARTED|Overall Study||58
2205167|NCT03172364|5407746|P1|STARTED|Overall Study||55
2205168|NCT03171415|5407767|P5|NOT COMPLETED|Overall Study||2
2205169|NCT03171415|5407768|P4|NOT COMPLETED|Overall Study||0
2205170|NCT03171415|5407769|P3|NOT COMPLETED|Overall Study||0
2205171|NCT03171415|5407770|P2|NOT COMPLETED|Overall Study||0
2205172|NCT03171415|5407771|P1|NOT COMPLETED|Overall Study||0
2205173|NCT03171415|5407767|P5|COMPLETED|Overall Study||7
2205174|NCT03171415|5407768|P4|COMPLETED|Overall Study||6
2205175|NCT03171415|5407769|P3|COMPLETED|Overall Study||6
2205176|NCT03171415|5407770|P2|COMPLETED|Overall Study||6
2205177|NCT03171415|5407771|P1|COMPLETED|Overall Study||6
2205178|NCT03171415|5407767|P5|STARTED|Overall Study||9
2205179|NCT03171415|5407768|P4|STARTED|Overall Study||6
2205180|NCT03171415|5407769|P3|STARTED|Overall Study||6
2205181|NCT03171415|5407770|P2|STARTED|Overall Study||6
2205182|NCT03171415|5407771|P1|STARTED|Overall Study||6
2205183|NCT03170609|5407839|P7|NOT COMPLETED|Overall Study||1
2205184|NCT03170609|5407840|P6|NOT COMPLETED|Overall Study||2
2205185|NCT03170609|5407841|P5|NOT COMPLETED|Overall Study||1
2205186|NCT03170609|5407842|P4|NOT COMPLETED|Overall Study||2
2205187|NCT03170609|5407843|P3|NOT COMPLETED|Overall Study||6
2205188|NCT03170609|5407844|P2|NOT COMPLETED|Overall Study||2
2205189|NCT03170609|5407845|P1|NOT COMPLETED|Overall Study||3
2205190|NCT03170609|5407839|P7|COMPLETED|Overall Study||51
2205191|NCT03170609|5407840|P6|COMPLETED|Overall Study||50
2205192|NCT03170609|5407841|P5|COMPLETED|Overall Study||51
2205193|NCT03170609|5407842|P4|COMPLETED|Overall Study||50
2205194|NCT03170609|5407843|P3|COMPLETED|Overall Study||46
2205195|NCT03170609|5407844|P2|COMPLETED|Overall Study||50
2205196|NCT03170609|5407845|P1|COMPLETED|Overall Study||50
2205197|NCT03170609|5407839|P7|Vaccinated|Overall Study||52
2205198|NCT03170609|5407840|P6|Vaccinated|Overall Study||52
2205199|NCT03170609|5407841|P5|Vaccinated|Overall Study||52
2205200|NCT03170609|5407842|P4|Vaccinated|Overall Study||52
2205201|NCT03170609|5407843|P3|Vaccinated|Overall Study||52
2205202|NCT03170609|5407844|P2|Vaccinated|Overall Study||52
2205203|NCT03170609|5407845|P1|Vaccinated|Overall Study||52
2205204|NCT03170609|5407839|P7|STARTED|Overall Study||52
2205205|NCT03170609|5407840|P6|STARTED|Overall Study||52
2205206|NCT03170609|5407841|P5|STARTED|Overall Study||52
2205207|NCT03170609|5407842|P4|STARTED|Overall Study||52
2205208|NCT03170609|5407843|P3|STARTED|Overall Study||52
2205209|NCT03170609|5407844|P2|STARTED|Overall Study||52
2205210|NCT03170609|5407845|P1|STARTED|Overall Study||53
2205211|NCT03170544|5407915|P12|NOT COMPLETED|Part 4||0
2205212|NCT03170544|5407916|P11|NOT COMPLETED|Part 4||0
2205213|NCT03170544|5407917|P10|NOT COMPLETED|Part 4||0
2205214|NCT03170544|5407918|P9|NOT COMPLETED|Part 4||0
2205215|NCT03170544|5407919|P8|NOT COMPLETED|Part 4||0
2205216|NCT03170544|5407920|P7|NOT COMPLETED|Part 4||0
2205217|NCT03170544|5407921|P6|NOT COMPLETED|Part 4||0
2205218|NCT03170544|5407922|P5|NOT COMPLETED|Part 4||0
2205219|NCT03170544|5407923|P4|NOT COMPLETED|Part 4||0
2205220|NCT03170544|5407924|P3|NOT COMPLETED|Part 4||0
2205221|NCT03170544|5407925|P2|NOT COMPLETED|Part 4||0
2205222|NCT03170544|5407926|P1|NOT COMPLETED|Part 4||0
2205223|NCT03170544|5407915|P12|COMPLETED|Part 4||6
2205224|NCT03170544|5407916|P11|COMPLETED|Part 4||3
2205225|NCT03170544|5407917|P10|COMPLETED|Part 4||0
2205226|NCT03170544|5407918|P9|COMPLETED|Part 4||0
2205227|NCT03170544|5407919|P8|COMPLETED|Part 4||0
2205228|NCT03170544|5407920|P7|COMPLETED|Part 4||0
2205229|NCT03170544|5407921|P6|COMPLETED|Part 4||0
2205230|NCT03170544|5407922|P5|COMPLETED|Part 4||0
2205231|NCT03170544|5407923|P4|COMPLETED|Part 4||0
2205232|NCT03170544|5407924|P3|COMPLETED|Part 4||0
2205233|NCT03170544|5407925|P2|COMPLETED|Part 4||0
2205234|NCT03170544|5407926|P1|COMPLETED|Part 4||0
2205235|NCT03170544|5407915|P12|STARTED|Part 4||6
2205236|NCT03170544|5407916|P11|STARTED|Part 4||3
2205237|NCT03170544|5407917|P10|STARTED|Part 4||0
2205238|NCT03170544|5407918|P9|STARTED|Part 4||0
2205239|NCT03170544|5407919|P8|STARTED|Part 4||0
2205240|NCT03170544|5407920|P7|STARTED|Part 4||0
2205241|NCT03170544|5407921|P6|STARTED|Part 4||0
2205242|NCT03170544|5407922|P5|STARTED|Part 4||0
2205243|NCT03170544|5407923|P4|STARTED|Part 4||0
2205244|NCT03170544|5407924|P3|STARTED|Part 4||0
2205245|NCT03170544|5407925|P2|STARTED|Part 4||0
2205246|NCT03170544|5407926|P1|STARTED|Part 4||0
2205247|NCT03170544|5407915|P12|NOT COMPLETED|Part 3||0
2205248|NCT03170544|5407916|P11|NOT COMPLETED|Part 3||0
2205249|NCT03170544|5407917|P10|NOT COMPLETED|Part 3||0
2205250|NCT03170544|5407918|P9|NOT COMPLETED|Part 3||0
2205251|NCT03170544|5407919|P8|NOT COMPLETED|Part 3||0
2205252|NCT03170544|5407920|P7|NOT COMPLETED|Part 3||0
2205253|NCT03170544|5407921|P6|NOT COMPLETED|Part 3||0
2205254|NCT03170544|5407922|P5|NOT COMPLETED|Part 3||0
2205255|NCT03170544|5407923|P4|NOT COMPLETED|Part 3||0
2205256|NCT03170544|5407924|P3|NOT COMPLETED|Part 3||0
2205257|NCT03170544|5407925|P2|NOT COMPLETED|Part 3||0
2205258|NCT03170544|5407926|P1|NOT COMPLETED|Part 3||0
2205259|NCT03170544|5407915|P12|COMPLETED|Part 3||0
2205260|NCT03170544|5407916|P11|COMPLETED|Part 3||0
2205261|NCT03170544|5407917|P10|COMPLETED|Part 3||6
2205262|NCT03170544|5407918|P9|COMPLETED|Part 3||6
2205263|NCT03170544|5407919|P8|COMPLETED|Part 3||4
2205264|NCT03170544|5407920|P7|COMPLETED|Part 3||0
2205265|NCT03170544|5407921|P6|COMPLETED|Part 3||0
2205266|NCT03170544|5407922|P5|COMPLETED|Part 3||0
2205267|NCT03170544|5407923|P4|COMPLETED|Part 3||0
2205268|NCT03170544|5407924|P3|COMPLETED|Part 3||0
2205269|NCT03170544|5407925|P2|COMPLETED|Part 3||0
2205270|NCT03170544|5407926|P1|COMPLETED|Part 3||0
2205271|NCT03170544|5407915|P12|STARTED|Part 3||0
2205272|NCT03170544|5407916|P11|STARTED|Part 3||0
2205273|NCT03170544|5407917|P10|STARTED|Part 3||6
2205274|NCT03170544|5407918|P9|STARTED|Part 3||6
2205275|NCT03170544|5407919|P8|STARTED|Part 3||4
2205276|NCT03170544|5407920|P7|STARTED|Part 3||0
2205277|NCT03170544|5407921|P6|STARTED|Part 3||0
2205278|NCT03170544|5407922|P5|STARTED|Part 3||0
2205279|NCT03170544|5407923|P4|STARTED|Part 3||0
2205280|NCT03170544|5407924|P3|STARTED|Part 3||0
2205281|NCT03170544|5407925|P2|STARTED|Part 3||0
2205282|NCT03170544|5407926|P1|STARTED|Part 3||0
2205283|NCT03170544|5407915|P12|NOT COMPLETED|Part 2||0
2205284|NCT03170544|5407916|P11|NOT COMPLETED|Part 2||0
2205285|NCT03170544|5407917|P10|NOT COMPLETED|Part 2||0
2205286|NCT03170544|5407918|P9|NOT COMPLETED|Part 2||0
2205287|NCT03170544|5407919|P8|NOT COMPLETED|Part 2||0
2205288|NCT03170544|5407920|P7|NOT COMPLETED|Part 2||0
2205289|NCT03170544|5407921|P6|NOT COMPLETED|Part 2||0
2205290|NCT03170544|5407922|P5|NOT COMPLETED|Part 2||0
2205291|NCT03170544|5407923|P4|NOT COMPLETED|Part 2||0
2205292|NCT03170544|5407924|P3|NOT COMPLETED|Part 2||0
2205293|NCT03170544|5407925|P2|NOT COMPLETED|Part 2||0
2205294|NCT03170544|5407926|P1|NOT COMPLETED|Part 2||0
2205295|NCT03170544|5407915|P12|COMPLETED|Part 2||0
2205296|NCT03170544|5407916|P11|COMPLETED|Part 2||0
2205297|NCT03170544|5407917|P10|COMPLETED|Part 2||0
2205298|NCT03170544|5407918|P9|COMPLETED|Part 2||0
2205299|NCT03170544|5407919|P8|COMPLETED|Part 2||0
2205300|NCT03170544|5407920|P7|COMPLETED|Part 2||4
2205301|NCT03170544|5407921|P6|COMPLETED|Part 2||0
2205302|NCT03170544|5407922|P5|COMPLETED|Part 2||0
2205303|NCT03170544|5407923|P4|COMPLETED|Part 2||0
2205304|NCT03170544|5407924|P3|COMPLETED|Part 2||0
2205305|NCT03170544|5407925|P2|COMPLETED|Part 2||0
2205306|NCT03170544|5407926|P1|COMPLETED|Part 2||0
2205307|NCT03170544|5407915|P12|STARTED|Part 2||0
2205308|NCT03170544|5407916|P11|STARTED|Part 2||0
2205309|NCT03170544|5407917|P10|STARTED|Part 2||0
2205310|NCT03170544|5407918|P9|STARTED|Part 2||0
2205311|NCT03170544|5407919|P8|STARTED|Part 2||0
2205312|NCT03170544|5407920|P7|STARTED|Part 2||4
2205313|NCT03170544|5407921|P6|STARTED|Part 2||0
2205314|NCT03170544|5407922|P5|STARTED|Part 2||0
2205315|NCT03170544|5407923|P4|STARTED|Part 2||0
2205316|NCT03170544|5407924|P3|STARTED|Part 2||0
2205317|NCT03170544|5407925|P2|STARTED|Part 2||0
2205318|NCT03170544|5407926|P1|STARTED|Part 2||0
2205319|NCT03170544|5407915|P12|NOT COMPLETED|Part 1||0
2205320|NCT03170544|5407916|P11|NOT COMPLETED|Part 1||0
2205321|NCT03170544|5407917|P10|NOT COMPLETED|Part 1||0
2205322|NCT03170544|5407918|P9|NOT COMPLETED|Part 1||0
2205323|NCT03170544|5407919|P8|NOT COMPLETED|Part 1||0
2205324|NCT03170544|5407920|P7|NOT COMPLETED|Part 1||0
2205325|NCT03170544|5407921|P6|NOT COMPLETED|Part 1||0
2205326|NCT03170544|5407922|P5|NOT COMPLETED|Part 1||0
2205327|NCT03170544|5407923|P4|NOT COMPLETED|Part 1||1
2205328|NCT03170544|5407924|P3|NOT COMPLETED|Part 1||0
2205329|NCT03170544|5407925|P2|NOT COMPLETED|Part 1||0
2205330|NCT03170544|5407926|P1|NOT COMPLETED|Part 1||1
2205331|NCT03170544|5407915|P12|COMPLETED|Part 1||0
2205332|NCT03170544|5407916|P11|COMPLETED|Part 1||0
2205333|NCT03170544|5407917|P10|COMPLETED|Part 1||0
2205334|NCT03170544|5407918|P9|COMPLETED|Part 1||0
2205335|NCT03170544|5407919|P8|COMPLETED|Part 1||0
2205336|NCT03170544|5407920|P7|COMPLETED|Part 1||0
2205337|NCT03170544|5407921|P6|COMPLETED|Part 1||6
2205338|NCT03170544|5407922|P5|COMPLETED|Part 1||6
2205339|NCT03170544|5407923|P4|COMPLETED|Part 1||6
2205340|NCT03170544|5407924|P3|COMPLETED|Part 1||6
2205341|NCT03170544|5407925|P2|COMPLETED|Part 1||6
2205342|NCT03170544|5407926|P1|COMPLETED|Part 1||9
2205343|NCT03170544|5407915|P12|STARTED|Part 1||0
2205344|NCT03170544|5407916|P11|STARTED|Part 1||0
2205345|NCT03170544|5407917|P10|STARTED|Part 1||0
2205346|NCT03170544|5407918|P9|STARTED|Part 1||0
2205347|NCT03170544|5407919|P8|STARTED|Part 1||0
2205348|NCT03170544|5407920|P7|STARTED|Part 1||0
2205349|NCT03170544|5407921|P6|STARTED|Part 1||6
2205350|NCT03170544|5407922|P5|STARTED|Part 1||6
2205351|NCT03170544|5407923|P4|STARTED|Part 1||7
2205352|NCT03170544|5407924|P3|STARTED|Part 1||6
2205353|NCT03170544|5407925|P2|STARTED|Part 1||6
2205354|NCT03170544|5407926|P1|STARTED|Part 1||10
2205355|NCT03170232|5408090|P2|NOT COMPLETED|Overall Study||27
2205356|NCT03170232|5408091|P1|NOT COMPLETED|Overall Study||27
2205357|NCT03170232|5408090|P2|COMPLETED|Overall Study||0
2205358|NCT03170232|5408091|P1|COMPLETED|Overall Study||0
2205359|NCT03170232|5408090|P2|STARTED|Overall Study||27
2205360|NCT03170232|5408091|P1|STARTED|Overall Study||27
2205361|NCT03170219|5408137|P2|NOT COMPLETED|Overall Study||0
2205362|NCT03170219|5408138|P1|NOT COMPLETED|Overall Study||0
2205363|NCT03170219|5408137|P2|COMPLETED|Overall Study||4
2205364|NCT03170219|5408138|P1|COMPLETED|Overall Study||7
2205365|NCT03170219|5408137|P2|STARTED|Overall Study||4
2205366|NCT03170219|5408138|P1|STARTED|Overall Study||7
2205367|NCT03170193|5408169|P7|NOT COMPLETED|Overall Study||0
2205368|NCT03170193|5408170|P6|NOT COMPLETED|Overall Study||0
2205369|NCT03170193|5408171|P5|NOT COMPLETED|Overall Study||0
2205370|NCT03170193|5408172|P4|NOT COMPLETED|Overall Study||1
2205371|NCT03170193|5408173|P3|NOT COMPLETED|Overall Study||0
2205372|NCT03170193|5408174|P2|NOT COMPLETED|Overall Study||1
2205373|NCT03170193|5408175|P1|NOT COMPLETED|Overall Study||1
2205374|NCT03170193|5408169|P7|COMPLETED|Overall Study||6
2205375|NCT03170193|5408170|P6|COMPLETED|Overall Study||6
2205376|NCT03170193|5408171|P5|COMPLETED|Overall Study||6
2205377|NCT03170193|5408172|P4|COMPLETED|Overall Study||5
2205378|NCT03170193|5408173|P3|COMPLETED|Overall Study||6
2205379|NCT03170193|5408174|P2|COMPLETED|Overall Study||5
2205380|NCT03170193|5408175|P1|COMPLETED|Overall Study||11
2205381|NCT03170193|5408169|P7|STARTED|Overall Study||6
2205382|NCT03170193|5408170|P6|STARTED|Overall Study||6
2205383|NCT03170193|5408171|P5|STARTED|Overall Study||6
2205384|NCT03170193|5408172|P4|STARTED|Overall Study||6
2205385|NCT03170193|5408173|P3|STARTED|Overall Study||6
2205386|NCT03170193|5408174|P2|STARTED|Overall Study||6
2205387|NCT03170193|5408175|P1|STARTED|Overall Study||12
2205388|NCT03169530|5408246|P2|NOT COMPLETED|Overall Study||17
2205389|NCT03169530|5408247|P1|NOT COMPLETED|Overall Study||15
2205390|NCT03169530|5408246|P2|COMPLETED|Overall Study||0
2205391|NCT03169530|5408247|P1|COMPLETED|Overall Study||0
2205392|NCT03169530|5408246|P2|STARTED|Overall Study||17
2205393|NCT03169530|5408247|P1|STARTED|Overall Study||15
2205394|NCT03169153|5408265|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
2205395|NCT03169153|5408266|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
2205396|NCT03169153|5408265|P2|COMPLETED|Period 2, Second 30 Days of Wear||32
2205397|NCT03169153|5408266|P1|COMPLETED|Period 2, Second 30 Days of Wear||37
2205398|NCT03169153|5408265|P2|STARTED|Period 2, Second 30 Days of Wear|One subject discontinued after completing Period 1 and was not exposed in Period 2.|34
2205399|NCT03169153|5408266|P1|STARTED|Period 2, Second 30 Days of Wear||39
2205400|NCT03169153|5408265|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||4
2205401|NCT03169153|5408266|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||3
2205402|NCT03169153|5408265|P2|COMPLETED|Period 1, First 30 Days of Wear||35
2205403|NCT03169153|5408266|P1|COMPLETED|Period 1, First 30 Days of Wear||39
2205404|NCT03169153|5408265|P2|STARTED|Period 1, First 30 Days of Wear||39
2205405|NCT03169153|5408266|P1|STARTED|Period 1, First 30 Days of Wear||42
2205406|NCT03169062|5408272|P1|NOT COMPLETED|Overall Study||0
2205407|NCT03169062|5408272|P1|COMPLETED|Overall Study||10
2205408|NCT03169062|5408272|P1|STARTED|Overall Study||10
2205409|NCT03168919|5408277|P1|NOT COMPLETED|Overall Study||2
2205410|NCT03168919|5408277|P1|COMPLETED|Overall Study||3
2205411|NCT03168919|5408277|P1|STARTED|Overall Study||5
2205412|NCT03168906|5408287|P2|NOT COMPLETED|Overall Study||6
2205413|NCT03168906|5408288|P1|NOT COMPLETED|Overall Study||6
2205414|NCT03168906|5408287|P2|COMPLETED|Overall Study|Study discontinued due to futile nature of drug|0
2205415|NCT03168906|5408288|P1|COMPLETED|Overall Study|Study discontinued due to futile nature of drug|0
2205416|NCT03168906|5408287|P2|STARTED|Overall Study||6
2205417|NCT03168906|5408288|P1|STARTED|Overall Study||6
2205418|NCT03168841|5408296|P1|NOT COMPLETED|Overall Study||4
2205419|NCT03168841|5408296|P1|COMPLETED|Overall Study||36
2205420|NCT03168841|5408296|P1|STARTED|Overall Study||40
2205421|NCT03168542|5408301|P3|NOT COMPLETED|Overall Study||0
2205422|NCT03168542|5408302|P2|NOT COMPLETED|Overall Study||0
2205423|NCT03168542|5408303|P1|NOT COMPLETED|Overall Study||0
2205424|NCT03168542|5408301|P3|COMPLETED|Overall Study||9
2205425|NCT03168542|5408302|P2|COMPLETED|Overall Study||5
2205426|NCT03168542|5408303|P1|COMPLETED|Overall Study||7
2205427|NCT03168542|5408301|P3|STARTED|Overall Study||9
2205428|NCT03168542|5408302|P2|STARTED|Overall Study||5
2205429|NCT03168542|5408303|P1|STARTED|Overall Study||7
2205430|NCT03168425|5408320|P2|NOT COMPLETED|Overall Study||11
2205431|NCT03168425|5408321|P1|NOT COMPLETED|Overall Study||7
2205432|NCT03168425|5408320|P2|COMPLETED|Overall Study||85
2205433|NCT03168425|5408321|P1|COMPLETED|Overall Study||87
2205434|NCT03168425|5408320|P2|STARTED|Overall Study||96
2205435|NCT03168425|5408321|P1|STARTED|Overall Study||94
2205442|NCT03168295|5408345|P5|NOT COMPLETED|Overall Study||0
2205443|NCT03168295|5408346|P4|NOT COMPLETED|Overall Study||0
2205444|NCT03168295|5408347|P3|NOT COMPLETED|Overall Study||0
2205445|NCT03168295|5408348|P2|NOT COMPLETED|Overall Study||0
2205446|NCT03168295|5408349|P1|NOT COMPLETED|Overall Study||0
2205447|NCT03168295|5408345|P5|COMPLETED|Overall Study||20
2205448|NCT03168295|5408346|P4|COMPLETED|Overall Study||4
2205449|NCT03168295|5408347|P3|COMPLETED|Overall Study||4
2205450|NCT03168295|5408348|P2|COMPLETED|Overall Study||3
2205451|NCT03168295|5408349|P1|COMPLETED|Overall Study||3
2205452|NCT03168295|5408345|P5|STARTED|Overall Study||20
2205453|NCT03168295|5408346|P4|STARTED|Overall Study||4
2205454|NCT03168295|5408347|P3|STARTED|Overall Study||4
2205455|NCT03168295|5408348|P2|STARTED|Overall Study||3
2205456|NCT03168295|5408349|P1|STARTED|Overall Study||3
2205457|NCT03168022|5408363|P2|NOT COMPLETED|Overall Study||1
2205458|NCT03168022|5408364|P1|NOT COMPLETED|Overall Study||0
2205459|NCT03168022|5408363|P2|COMPLETED|Overall Study||21
2205460|NCT03168022|5408364|P1|COMPLETED|Overall Study||21
2205461|NCT03168022|5408363|P2|STARTED|Overall Study||22
2205462|NCT03168022|5408364|P1|STARTED|Overall Study||21
2205463|NCT03167541|5408372|P2|NOT COMPLETED|Second Intervention||0
2205464|NCT03167541|5408373|P1|NOT COMPLETED|Second Intervention||0
2205465|NCT03167541|5408372|P2|COMPLETED|Second Intervention||9
2205466|NCT03167541|5408373|P1|COMPLETED|Second Intervention||9
2205467|NCT03167541|5408372|P2|STARTED|Second Intervention||9
2205468|NCT03167541|5408373|P1|STARTED|Second Intervention||9
2205469|NCT03167541|5408372|P2|NOT COMPLETED|Washout: 5-8 Days||0
2205470|NCT03167541|5408373|P1|NOT COMPLETED|Washout: 5-8 Days||0
2205471|NCT03167541|5408372|P2|COMPLETED|Washout: 5-8 Days||9
2205472|NCT03167541|5408373|P1|COMPLETED|Washout: 5-8 Days||9
2205473|NCT03167541|5408372|P2|STARTED|Washout: 5-8 Days||9
2205474|NCT03167541|5408373|P1|STARTED|Washout: 5-8 Days||9
2205475|NCT03167541|5408372|P2|NOT COMPLETED|First Intervention||0
2205476|NCT03167541|5408373|P1|NOT COMPLETED|First Intervention||0
2205477|NCT03167541|5408372|P2|COMPLETED|First Intervention||9
2205478|NCT03167541|5408373|P1|COMPLETED|First Intervention||9
2205479|NCT03167541|5408372|P2|STARTED|First Intervention||9
2205480|NCT03167541|5408373|P1|STARTED|First Intervention||9
2205481|NCT03166618|5408397|P2|NOT COMPLETED|Overall Study||1
2205482|NCT03166618|5408398|P1|NOT COMPLETED|Overall Study||0
2205483|NCT03166618|5408397|P2|COMPLETED|Overall Study||0
2205484|NCT03166618|5408398|P1|COMPLETED|Overall Study||0
2205485|NCT03166618|5408397|P2|STARTED|Overall Study||1
2205486|NCT03166618|5408398|P1|STARTED|Overall Study||0
2205487|NCT03166215|5408410|P3|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||2
2205488|NCT03166215|5408411|P2|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
2205489|NCT03166215|5408412|P1|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
2205490|NCT03166215|5408410|P3|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||14
2205491|NCT03166215|5408411|P2|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
2205492|NCT03166215|5408412|P1|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
2205493|NCT03166215|5408410|P3|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||16
2205494|NCT03166215|5408411|P2|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||0
2205495|NCT03166215|5408412|P1|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||0
2205496|NCT03166215|5408410|P3|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
2205497|NCT03166215|5408411|P2|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||2
2205498|NCT03166215|5408412|P1|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
2205499|NCT03166215|5408410|P3|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
2205500|NCT03166215|5408411|P2|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||12
2205501|NCT03166215|5408412|P1|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||4
2205502|NCT03166215|5408410|P3|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||0
2205503|NCT03166215|5408411|P2|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||14
2205504|NCT03166215|5408412|P1|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||4
2205505|NCT03165981|5408452|P2|NOT COMPLETED|Overall Study||4
2205506|NCT03165981|5408453|P1|NOT COMPLETED|Overall Study||11
2205507|NCT03165981|5408452|P2|COMPLETED|Overall Study||107
2205508|NCT03165981|5408453|P1|COMPLETED|Overall Study||99
2205509|NCT03165981|5408452|P2|Per Protocol Population|Overall Study||107
2205510|NCT03165981|5408453|P1|Per Protocol Population|Overall Study||99
2205511|NCT03165981|5408452|P2|STARTED|Overall Study||111
2205512|NCT03165981|5408453|P1|STARTED|Overall Study||110
2205513|NCT03165175|5408483|P2|NOT COMPLETED|Baseline to 3-month||0
2205514|NCT03165175|5408484|P1|NOT COMPLETED|Baseline to 3-month||4
2205515|NCT03165175|5408483|P2|COMPLETED|Baseline to 3-month||39
2205516|NCT03165175|5408484|P1|COMPLETED|Baseline to 3-month||31
2205517|NCT03165175|5408483|P2|STARTED|Baseline to 3-month||39
2205518|NCT03165175|5408484|P1|STARTED|Baseline to 3-month||35
2205519|NCT03165175|5408483|P2|NOT COMPLETED|1-month to 3-month||0
2205520|NCT03165175|5408484|P1|NOT COMPLETED|1-month to 3-month||6
2205521|NCT03165175|5408483|P2|COMPLETED|1-month to 3-month||39
2205522|NCT03165175|5408484|P1|COMPLETED|1-month to 3-month||35
2205523|NCT03165175|5408483|P2|STARTED|1-month to 3-month||39
2205524|NCT03165175|5408484|P1|STARTED|1-month to 3-month||41
2205525|NCT03165110|5408498|P1|NOT COMPLETED|Overall Study||1
2205526|NCT03165110|5408498|P1|COMPLETED|Overall Study||46
2205527|NCT03165110|5408498|P1|STARTED|Overall Study||47
2205528|NCT03164629|5408512|P2|NOT COMPLETED|Overall Study||0
2205529|NCT03164629|5408513|P1|NOT COMPLETED|Overall Study||0
2205530|NCT03164629|5408512|P2|COMPLETED|Overall Study||25
2205531|NCT03164629|5408513|P1|COMPLETED|Overall Study||25
2205532|NCT03164629|5408512|P2|STARTED|Overall Study||25
2205533|NCT03164629|5408513|P1|STARTED|Overall Study||25
2205534|NCT03163342|5408519|P1|NOT COMPLETED|Overall Study||0
2205535|NCT03163342|5408519|P1|COMPLETED|Overall Study||20
2205536|NCT03163342|5408519|P1|STARTED|Overall Study||20
2205537|NCT03163134|5408528|P2|NOT COMPLETED|Overall Study||0
2205538|NCT03163134|5408529|P1|NOT COMPLETED|Overall Study||0
2205539|NCT03163134|5408528|P2|COMPLETED|Overall Study||85
2205540|NCT03163134|5408529|P1|COMPLETED|Overall Study||85
2205541|NCT03163134|5408528|P2|STARTED|Overall Study||85
2205542|NCT03163134|5408529|P1|STARTED|Overall Study||85
2205543|NCT03163017|5408537|P1|NOT COMPLETED|Overall Study||0
2205544|NCT03163017|5408537|P1|COMPLETED|Overall Study||30
2205545|NCT03163017|5408537|P1|STARTED|Overall Study||30
2205546|NCT03162614|5408559|P6|NOT COMPLETED|Overall Study||0
2205547|NCT03162614|5408560|P5|NOT COMPLETED|Overall Study||5
2205548|NCT03162614|5408561|P4|NOT COMPLETED|Overall Study||7
2205549|NCT03162614|5408562|P3|NOT COMPLETED|Overall Study||4
2205550|NCT03162614|5408563|P2|NOT COMPLETED|Overall Study||5
2205551|NCT03162614|5408564|P1|NOT COMPLETED|Overall Study||6
2205552|NCT03162614|5408559|P6|COMPLETED|Overall Study||24
2205553|NCT03162614|5408560|P5|COMPLETED|Overall Study||21
2205554|NCT03162614|5408561|P4|COMPLETED|Overall Study||19
2205555|NCT03162614|5408562|P3|COMPLETED|Overall Study||22
2205556|NCT03162614|5408563|P2|COMPLETED|Overall Study||21
2205557|NCT03162614|5408564|P1|COMPLETED|Overall Study||20
2205558|NCT03162614|5408559|P6|STARTED|Overall Study||24
2205559|NCT03162614|5408560|P5|STARTED|Overall Study||26
2205560|NCT03162614|5408561|P4|STARTED|Overall Study||26
2205561|NCT03162614|5408562|P3|STARTED|Overall Study||26
2205562|NCT03162614|5408563|P2|STARTED|Overall Study||26
2205563|NCT03162614|5408564|P1|STARTED|Overall Study||26
2205564|NCT03162458|5408658|P2|NOT COMPLETED|Overall Study||0
2205565|NCT03162458|5408659|P1|NOT COMPLETED|Overall Study||0
2205566|NCT03162458|5408658|P2|COMPLETED|Overall Study||71
2205567|NCT03162458|5408659|P1|COMPLETED|Overall Study||71
2205568|NCT03162458|5408658|P2|STARTED|Overall Study||71
2205569|NCT03162458|5408659|P1|STARTED|Overall Study||71
2205570|NCT03162328|5408683|P3|NOT COMPLETED|Study Period||1
2205571|NCT03162328|5408684|P2|NOT COMPLETED|Study Period||0
2205572|NCT03162328|5408685|P1|NOT COMPLETED|Study Period||0
2205573|NCT03162328|5408683|P3|COMPLETED|Study Period||31
2205574|NCT03162328|5408684|P2|COMPLETED|Study Period||30
2205575|NCT03162328|5408685|P1|COMPLETED|Study Period||0
2205576|NCT03162328|5408683|P3|STARTED|Study Period||32
2205577|NCT03162328|5408684|P2|STARTED|Study Period||30
2205578|NCT03162328|5408685|P1|STARTED|Study Period||0
2205579|NCT03162328|5408683|P3|NOT COMPLETED|Screening Period||0
2205580|NCT03162328|5408684|P2|NOT COMPLETED|Screening Period||0
2205581|NCT03162328|5408685|P1|NOT COMPLETED|Screening Period||22
2205582|NCT03162328|5408683|P3|COMPLETED|Screening Period||0
2205583|NCT03162328|5408684|P2|COMPLETED|Screening Period||0
2205584|NCT03162328|5408685|P1|COMPLETED|Screening Period||62
2205585|NCT03162328|5408683|P3|STARTED|Screening Period||0
2205586|NCT03162328|5408684|P2|STARTED|Screening Period||0
2205587|NCT03162328|5408685|P1|STARTED|Screening Period||84
2205588|NCT03162055|5408714|P2|NOT COMPLETED|Overall Study||43
2205589|NCT03162055|5408715|P1|NOT COMPLETED|Overall Study||62
2205590|NCT03162055|5408714|P2|COMPLETED|Overall Study||517
2205591|NCT03162055|5408715|P1|COMPLETED|Overall Study||497
2205592|NCT03162055|5408714|P2|Per Protocol (PP) Analysis Set|Overall Study||510
2205593|NCT03162055|5408715|P1|Per Protocol (PP) Analysis Set|Overall Study||506
2205594|NCT03162055|5408714|P2|Full Analysis Set (FAS)|Overall Study||552
2205595|NCT03162055|5408715|P1|Full Analysis Set (FAS)|Overall Study||552
2205596|NCT03162055|5408714|P2|Safety Analysis Set|Overall Study||552
2205597|NCT03162055|5408715|P1|Safety Analysis Set|Overall Study||552
2205598|NCT03162055|5408714|P2|Received Treatment|Overall Study||560
2205599|NCT03162055|5408715|P1|Received Treatment|Overall Study||557
2205600|NCT03162055|5408714|P2|STARTED|Overall Study||560
2205601|NCT03162055|5408715|P1|STARTED|Overall Study||559
2205602|NCT03161405|5408739|P1|NOT COMPLETED|Second Intervention Period (6 Days)||1
2205603|NCT03161405|5408739|P1|COMPLETED|Second Intervention Period (6 Days)||11
2205604|NCT03161405|5408739|P1|STARTED|Second Intervention Period (6 Days)||12
2205605|NCT03161405|5408739|P1|NOT COMPLETED|Washout Period (at Least 4 Days)||0
2205606|NCT03161405|5408739|P1|COMPLETED|Washout Period (at Least 4 Days)||12
2205607|NCT03161405|5408739|P1|STARTED|Washout Period (at Least 4 Days)||12
2205608|NCT03161405|5408739|P1|NOT COMPLETED|First Intervention Period (3 Days)||0
2205609|NCT03161405|5408739|P1|COMPLETED|First Intervention Period (3 Days)||12
2205610|NCT03161405|5408739|P1|STARTED|First Intervention Period (3 Days)||12
2205611|NCT03161327|5408750|P1|NOT COMPLETED|Overall Study||0
2205612|NCT03161327|5408750|P1|COMPLETED|Overall Study||238
2205613|NCT03161327|5408750|P1|STARTED|Overall Study||238
2205614|NCT03160716|5408755|P1|NOT COMPLETED|Overall Study||1
2205615|NCT03160716|5408755|P1|COMPLETED|Overall Study||59
2205616|NCT03160716|5408755|P1|STARTED|Overall Study||60
2205617|NCT03160703|5408766|P4|NOT COMPLETED|Overall Study||1
2205618|NCT03160703|5408767|P3|NOT COMPLETED|Overall Study||0
2205619|NCT03160703|5408768|P2|NOT COMPLETED|Overall Study||0
2205620|NCT03160703|5408769|P1|NOT COMPLETED|Overall Study||0
2205621|NCT03160703|5408766|P4|COMPLETED|Overall Study||54
2205622|NCT03160703|5408767|P3|COMPLETED|Overall Study||55
2205623|NCT03160703|5408768|P2|COMPLETED|Overall Study||55
2205624|NCT03160703|5408769|P1|COMPLETED|Overall Study||55
2205625|NCT03160703|5408766|P4|STARTED|Overall Study||55
2205626|NCT03160703|5408767|P3|STARTED|Overall Study||55
2205627|NCT03160703|5408768|P2|STARTED|Overall Study||55
2205628|NCT03160703|5408769|P1|STARTED|Overall Study||55
2205629|NCT03160170|5408781|P2|NOT COMPLETED|Overall Study||0
2205630|NCT03160170|5408782|P1|NOT COMPLETED|Overall Study||0
2205631|NCT03160170|5408781|P2|COMPLETED|Overall Study||10
2205632|NCT03160170|5408782|P1|COMPLETED|Overall Study||10
2205633|NCT03160170|5408781|P2|STARTED|Overall Study||10
2205634|NCT03160170|5408782|P1|STARTED|Overall Study||10
2205635|NCT03160027|5408796|P4|NOT COMPLETED|Overall Study||0
2205636|NCT03160027|5408797|P3|NOT COMPLETED|Overall Study||0
2205637|NCT03160027|5408798|P2|NOT COMPLETED|Overall Study||0
2205638|NCT03160027|5408799|P1|NOT COMPLETED|Overall Study||0
2205639|NCT03160027|5408796|P4|COMPLETED|Overall Study||4
2205640|NCT03160027|5408797|P3|COMPLETED|Overall Study||6
2205641|NCT03160027|5408798|P2|COMPLETED|Overall Study||4
2205642|NCT03160027|5408799|P1|COMPLETED|Overall Study||6
2205643|NCT03160027|5408796|P4|STARTED|Overall Study||4
2205644|NCT03160027|5408797|P3|STARTED|Overall Study||6
2205645|NCT03160027|5408798|P2|STARTED|Overall Study||4
2205646|NCT03160027|5408799|P1|STARTED|Overall Study||6
2205647|NCT03159624|5408834|P2|NOT COMPLETED|Overall Study||1
2205648|NCT03159624|5408835|P1|NOT COMPLETED|Overall Study||0
2205649|NCT03159624|5408834|P2|COMPLETED|Overall Study||25
2205650|NCT03159624|5408835|P1|COMPLETED|Overall Study||21
2205651|NCT03159624|5408834|P2|STARTED|Overall Study||26
2205652|NCT03159624|5408835|P1|STARTED|Overall Study||21
2205653|NCT03159611|5408847|P2|NOT COMPLETED|Overall Study||15
2205654|NCT03159611|5408848|P1|NOT COMPLETED|Overall Study||23
2205655|NCT03159611|5408847|P2|COMPLETED|Overall Study||72
2205656|NCT03159611|5408848|P1|COMPLETED|Overall Study||72
2205657|NCT03159611|5408847|P2|STARTED|Overall Study||87
2205658|NCT03159611|5408848|P1|STARTED|Overall Study||95
2205659|NCT03159468|5408868|P6|NOT COMPLETED|Overall Study||0
2205660|NCT03159468|5408869|P5|NOT COMPLETED|Overall Study||0
2205661|NCT03159468|5408870|P4|NOT COMPLETED|Overall Study||0
2205662|NCT03159468|5408871|P3|NOT COMPLETED|Overall Study||3
2205663|NCT03159468|5408872|P2|NOT COMPLETED|Overall Study||0
2205664|NCT03159468|5408873|P1|NOT COMPLETED|Overall Study||0
2205665|NCT03159468|5408868|P6|COMPLETED|Overall Study||34
2205666|NCT03159468|5408869|P5|COMPLETED|Overall Study||34
2205667|NCT03159468|5408870|P4|COMPLETED|Overall Study||34
2205668|NCT03159468|5408871|P3|COMPLETED|Overall Study||34
2205669|NCT03159468|5408872|P2|COMPLETED|Overall Study||35
2205670|NCT03159468|5408873|P1|COMPLETED|Overall Study||35
2205671|NCT03159468|5408868|P6|STARTED|Overall Study||34
2205672|NCT03159468|5408869|P5|STARTED|Overall Study||34
2205673|NCT03159468|5408870|P4|STARTED|Overall Study||34
2205674|NCT03159468|5408871|P3|STARTED|Overall Study||37
2205675|NCT03159468|5408872|P2|STARTED|Overall Study||35
2205676|NCT03159468|5408873|P1|STARTED|Overall Study||35
2205677|NCT03159260|5408889|P2|NOT COMPLETED|Overall Study||4
2205678|NCT03159260|5408890|P1|NOT COMPLETED|Overall Study||3
2205679|NCT03159260|5408889|P2|COMPLETED|Overall Study||25
2205680|NCT03159260|5408890|P1|COMPLETED|Overall Study||25
2205681|NCT03159260|5408889|P2|STARTED|Overall Study||29
2205682|NCT03159260|5408890|P1|STARTED|Overall Study||28
2205683|NCT03159143|5408904|P1|NOT COMPLETED|Overall Study||0
2205684|NCT03159143|5408904|P1|COMPLETED|Overall Study||22
2205685|NCT03159143|5408904|P1|STARTED|Overall Study||22
2205686|NCT03158220|5408913|P2|NOT COMPLETED|Overall Study||16
2205687|NCT03158220|5408914|P1|NOT COMPLETED|Overall Study||17
2205688|NCT03158220|5408913|P2|COMPLETED|Overall Study||626
2205689|NCT03158220|5408914|P1|COMPLETED|Overall Study||553
2205690|NCT03158220|5408913|P2|Vaccination 3|Overall Study||629
2205691|NCT03158220|5408914|P1|Vaccination 3|Overall Study||556
2205692|NCT03158220|5408913|P2|Vaccination 2|Overall Study||635
2205693|NCT03158220|5408914|P1|Vaccination 2|Overall Study||563
2205694|NCT03158220|5408913|P2|Vaccination 1|Overall Study||640
2205695|NCT03158220|5408914|P1|Vaccination 1|Overall Study||570
2205696|NCT03158220|5408913|P2|STARTED|Overall Study||642
2205697|NCT03158220|5408914|P1|STARTED|Overall Study||570
2205698|NCT03158038|5408934|P2|NOT COMPLETED|Overall Study||0
2205699|NCT03158038|5408935|P1|NOT COMPLETED|Overall Study||0
2205700|NCT03158038|5408934|P2|COMPLETED|Overall Study||60
2205701|NCT03158038|5408935|P1|COMPLETED|Overall Study||240
2205702|NCT03158038|5408934|P2|STARTED|Overall Study||60
2205703|NCT03158038|5408935|P1|STARTED|Overall Study||240
2205704|NCT03158012|5408951|P2|NOT COMPLETED|Overall Study||1
2205705|NCT03158012|5408952|P1|NOT COMPLETED|Overall Study||0
2205706|NCT03158012|5408951|P2|COMPLETED|Overall Study||6
2205707|NCT03158012|5408952|P1|COMPLETED|Overall Study||8
2205708|NCT03158012|5408951|P2|STARTED|Overall Study||7
2205709|NCT03158012|5408952|P1|STARTED|Overall Study||8
2205710|NCT03157583|5408958|P1|NOT COMPLETED|Overall Study||1
2205711|NCT03157583|5408958|P1|COMPLETED|Overall Study||7
2205712|NCT03157583|5408958|P1|STARTED|Overall Study||8
2205713|NCT03157531|5408976|P1|NOT COMPLETED|Overall Study||6
2205714|NCT03157531|5408976|P1|COMPLETED|Overall Study||91
2205715|NCT03157531|5408976|P1|Analyzed at 30 Days For MAEs|Overall Study||93
2205716|NCT03157531|5408976|P1|STARTED|Overall Study||97
2205717|NCT03157232|5408991|P1|NOT COMPLETED|Overall Study||0
2205718|NCT03157232|5408991|P1|COMPLETED|Overall Study||18
2205719|NCT03157232|5408991|P1|STARTED|Overall Study||18
2205720|NCT03155269|5408997|P2|NOT COMPLETED|Overall Study||7
2205721|NCT03155269|5408998|P1|NOT COMPLETED|Overall Study||5
2205722|NCT03155269|5408997|P2|COMPLETED|Overall Study||50
2205723|NCT03155269|5408998|P1|COMPLETED|Overall Study||52
2205724|NCT03155269|5408997|P2|STARTED|Overall Study||57
2205725|NCT03155269|5408998|P1|STARTED|Overall Study||57
2205726|NCT03154333|5409042|P2|NOT COMPLETED|Overall Study||5
2205727|NCT03154333|5409043|P1|NOT COMPLETED|Overall Study||7
2205728|NCT03154333|5409042|P2|COMPLETED|Overall Study||21
2205729|NCT03154333|5409043|P1|COMPLETED|Overall Study||21
2205730|NCT03154333|5409042|P2|STARTED|Overall Study||26
2205731|NCT03154333|5409043|P1|STARTED|Overall Study||28
2205732|NCT03154086|5409066|P15|NOT COMPLETED|Part B (Up to 25 Days)||0
2205733|NCT03154086|5409067|P14|NOT COMPLETED|Part B (Up to 25 Days)||0
2205734|NCT03154086|5409068|P13|NOT COMPLETED|Part B (Up to 25 Days)||0
2205735|NCT03154086|5409069|P12|NOT COMPLETED|Part B (Up to 25 Days)||0
2205736|NCT03154086|5409070|P11|NOT COMPLETED|Part B (Up to 25 Days)||1
2205737|NCT03154086|5409071|P10|NOT COMPLETED|Part B (Up to 25 Days)||0
2205738|NCT03154086|5409072|P9|NOT COMPLETED|Part B (Up to 25 Days)||0
2205739|NCT03154086|5409073|P8|NOT COMPLETED|Part B (Up to 25 Days)||0
2205740|NCT03154086|5409074|P7|NOT COMPLETED|Part B (Up to 25 Days)||0
2205741|NCT03154086|5409075|P6|NOT COMPLETED|Part B (Up to 25 Days)||0
2205742|NCT03154086|5409076|P5|NOT COMPLETED|Part B (Up to 25 Days)||0
2205743|NCT03154086|5409077|P4|NOT COMPLETED|Part B (Up to 25 Days)||0
2205744|NCT03154086|5409078|P3|NOT COMPLETED|Part B (Up to 25 Days)||0
2205745|NCT03154086|5409079|P2|NOT COMPLETED|Part B (Up to 25 Days)||0
2205746|NCT03154086|5409080|P1|NOT COMPLETED|Part B (Up to 25 Days)||0
2205747|NCT03154086|5409066|P15|COMPLETED|Part B (Up to 25 Days)||6
2205748|NCT03154086|5409067|P14|COMPLETED|Part B (Up to 25 Days)||6
2205749|NCT03154086|5409068|P13|COMPLETED|Part B (Up to 25 Days)||6
2205750|NCT03154086|5409069|P12|COMPLETED|Part B (Up to 25 Days)||6
2205751|NCT03154086|5409070|P11|COMPLETED|Part B (Up to 25 Days)||5
2205752|NCT03154086|5409071|P10|COMPLETED|Part B (Up to 25 Days)||10
2205753|NCT03154086|5409072|P9|COMPLETED|Part B (Up to 25 Days)||0
2205754|NCT03154086|5409073|P8|COMPLETED|Part B (Up to 25 Days)||0
2205755|NCT03154086|5409074|P7|COMPLETED|Part B (Up to 25 Days)||0
2205756|NCT03154086|5409075|P6|COMPLETED|Part B (Up to 25 Days)||0
2205757|NCT03154086|5409076|P5|COMPLETED|Part B (Up to 25 Days)||0
2205758|NCT03154086|5409077|P4|COMPLETED|Part B (Up to 25 Days)||0
2205759|NCT03154086|5409078|P3|COMPLETED|Part B (Up to 25 Days)||0
2205760|NCT03154086|5409079|P2|COMPLETED|Part B (Up to 25 Days)||0
2205761|NCT03154086|5409080|P1|COMPLETED|Part B (Up to 25 Days)||0
2205762|NCT03154086|5409066|P15|STARTED|Part B (Up to 25 Days)||6
2205763|NCT03154086|5409067|P14|STARTED|Part B (Up to 25 Days)||6
2205764|NCT03154086|5409068|P13|STARTED|Part B (Up to 25 Days)||6
2205765|NCT03154086|5409069|P12|STARTED|Part B (Up to 25 Days)||6
2205766|NCT03154086|5409070|P11|STARTED|Part B (Up to 25 Days)||6
2205767|NCT03154086|5409071|P10|STARTED|Part B (Up to 25 Days)||10
2205768|NCT03154086|5409072|P9|STARTED|Part B (Up to 25 Days)||0
2205769|NCT03154086|5409073|P8|STARTED|Part B (Up to 25 Days)||0
2205770|NCT03154086|5409074|P7|STARTED|Part B (Up to 25 Days)||0
2205771|NCT03154086|5409075|P6|STARTED|Part B (Up to 25 Days)||0
2205772|NCT03154086|5409076|P5|STARTED|Part B (Up to 25 Days)||0
2205773|NCT03154086|5409077|P4|STARTED|Part B (Up to 25 Days)||0
2205774|NCT03154086|5409078|P3|STARTED|Part B (Up to 25 Days)||0
2205775|NCT03154086|5409079|P2|STARTED|Part B (Up to 25 Days)||0
2205776|NCT03154086|5409080|P1|STARTED|Part B (Up to 25 Days)||0
2205777|NCT03154086|5409066|P15|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205778|NCT03154086|5409067|P14|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205779|NCT03154086|5409068|P13|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205780|NCT03154086|5409069|P12|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205781|NCT03154086|5409070|P11|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205782|NCT03154086|5409071|P10|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205783|NCT03154086|5409072|P9|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
2205784|NCT03154086|5409073|P8|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
2205785|NCT03154086|5409074|P7|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205786|NCT03154086|5409075|P6|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205787|NCT03154086|5409076|P5|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205788|NCT03154086|5409077|P4|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205789|NCT03154086|5409078|P3|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205790|NCT03154086|5409079|P2|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205791|NCT03154086|5409080|P1|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205792|NCT03154086|5409066|P15|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205793|NCT03154086|5409067|P14|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205794|NCT03154086|5409068|P13|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205795|NCT03154086|5409069|P12|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205796|NCT03154086|5409070|P11|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205797|NCT03154086|5409071|P10|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205798|NCT03154086|5409072|P9|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||4
2205799|NCT03154086|5409073|P8|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
2205800|NCT03154086|5409074|P7|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||2
2205801|NCT03154086|5409075|P6|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205802|NCT03154086|5409076|P5|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205803|NCT03154086|5409077|P4|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205804|NCT03154086|5409078|P3|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205805|NCT03154086|5409079|P2|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205806|NCT03154086|5409080|P1|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205807|NCT03154086|5409066|P15|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205808|NCT03154086|5409067|P14|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205809|NCT03154086|5409068|P13|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205810|NCT03154086|5409069|P12|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205811|NCT03154086|5409070|P11|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205812|NCT03154086|5409071|P10|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205813|NCT03154086|5409072|P9|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)|1 par was unwell on Day-1 of Period 2 and discontinued; hence,1 replacement was enrolled and dosed|5
2205814|NCT03154086|5409073|P8|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||2
2205815|NCT03154086|5409074|P7|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||2
2205816|NCT03154086|5409075|P6|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205817|NCT03154086|5409076|P5|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205818|NCT03154086|5409077|P4|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205819|NCT03154086|5409078|P3|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205820|NCT03154086|5409079|P2|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205821|NCT03154086|5409080|P1|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
2205822|NCT03154086|5409066|P15|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205823|NCT03154086|5409067|P14|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205824|NCT03154086|5409068|P13|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205825|NCT03154086|5409069|P12|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205826|NCT03154086|5409070|P11|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205827|NCT03154086|5409071|P10|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205828|NCT03154086|5409072|P9|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205829|NCT03154086|5409073|P8|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205830|NCT03154086|5409074|P7|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205831|NCT03154086|5409075|P6|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205832|NCT03154086|5409076|P5|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205833|NCT03154086|5409077|P4|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205834|NCT03154086|5409078|P3|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205835|NCT03154086|5409079|P2|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205836|NCT03154086|5409080|P1|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205837|NCT03154086|5409066|P15|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205838|NCT03154086|5409067|P14|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205839|NCT03154086|5409068|P13|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205840|NCT03154086|5409069|P12|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205841|NCT03154086|5409070|P11|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205842|NCT03154086|5409071|P10|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205843|NCT03154086|5409072|P9|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||4
2205844|NCT03154086|5409073|P8|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
2205845|NCT03154086|5409074|P7|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
2205846|NCT03154086|5409075|P6|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205847|NCT03154086|5409076|P5|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205848|NCT03154086|5409077|P4|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205849|NCT03154086|5409078|P3|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205850|NCT03154086|5409079|P2|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205851|NCT03154086|5409080|P1|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205852|NCT03154086|5409066|P15|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205853|NCT03154086|5409067|P14|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205854|NCT03154086|5409068|P13|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205855|NCT03154086|5409069|P12|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205856|NCT03154086|5409070|P11|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205857|NCT03154086|5409071|P10|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205858|NCT03154086|5409072|P9|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||4
2205859|NCT03154086|5409073|P8|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
2205860|NCT03154086|5409074|P7|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
2205861|NCT03154086|5409075|P6|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205862|NCT03154086|5409076|P5|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205863|NCT03154086|5409077|P4|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205864|NCT03154086|5409078|P3|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205865|NCT03154086|5409079|P2|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205866|NCT03154086|5409080|P1|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
2205867|NCT03154086|5409066|P15|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205868|NCT03154086|5409067|P14|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205869|NCT03154086|5409068|P13|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205870|NCT03154086|5409069|P12|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205871|NCT03154086|5409070|P11|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205872|NCT03154086|5409071|P10|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205873|NCT03154086|5409072|P9|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205874|NCT03154086|5409073|P8|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205875|NCT03154086|5409074|P7|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205876|NCT03154086|5409075|P6|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205877|NCT03154086|5409076|P5|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205878|NCT03154086|5409077|P4|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205879|NCT03154086|5409078|P3|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205880|NCT03154086|5409079|P2|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205881|NCT03154086|5409080|P1|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205882|NCT03154086|5409066|P15|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205883|NCT03154086|5409067|P14|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205884|NCT03154086|5409068|P13|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205885|NCT03154086|5409069|P12|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205886|NCT03154086|5409070|P11|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205887|NCT03154086|5409071|P10|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205888|NCT03154086|5409072|P9|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||4
2205889|NCT03154086|5409073|P8|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||2
2205890|NCT03154086|5409074|P7|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||2
2205891|NCT03154086|5409075|P6|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205892|NCT03154086|5409076|P5|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205893|NCT03154086|5409077|P4|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205894|NCT03154086|5409078|P3|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205895|NCT03154086|5409079|P2|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205896|NCT03154086|5409080|P1|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205897|NCT03154086|5409066|P15|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205898|NCT03154086|5409067|P14|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205899|NCT03154086|5409068|P13|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205900|NCT03154086|5409069|P12|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205901|NCT03154086|5409070|P11|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205902|NCT03154086|5409071|P10|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205903|NCT03154086|5409072|P9|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||4
2205904|NCT03154086|5409073|P8|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||2
2205905|NCT03154086|5409074|P7|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||2
2205906|NCT03154086|5409075|P6|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205907|NCT03154086|5409076|P5|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205908|NCT03154086|5409077|P4|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205909|NCT03154086|5409078|P3|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205910|NCT03154086|5409079|P2|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205911|NCT03154086|5409080|P1|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
2205912|NCT03154086|5409066|P15|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205913|NCT03154086|5409067|P14|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205914|NCT03154086|5409068|P13|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205915|NCT03154086|5409069|P12|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205916|NCT03154086|5409070|P11|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205917|NCT03154086|5409071|P10|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205918|NCT03154086|5409072|P9|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205919|NCT03154086|5409073|P8|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205920|NCT03154086|5409074|P7|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205921|NCT03154086|5409075|P6|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205922|NCT03154086|5409076|P5|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205923|NCT03154086|5409077|P4|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205924|NCT03154086|5409078|P3|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205925|NCT03154086|5409079|P2|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205926|NCT03154086|5409080|P1|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205927|NCT03154086|5409066|P15|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205928|NCT03154086|5409067|P14|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205929|NCT03154086|5409068|P13|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205930|NCT03154086|5409069|P12|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205931|NCT03154086|5409070|P11|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205932|NCT03154086|5409071|P10|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205933|NCT03154086|5409072|P9|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205934|NCT03154086|5409073|P8|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205935|NCT03154086|5409074|P7|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205936|NCT03154086|5409075|P6|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||2
2205937|NCT03154086|5409076|P5|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||6
2205938|NCT03154086|5409077|P4|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205939|NCT03154086|5409078|P3|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205940|NCT03154086|5409079|P2|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205941|NCT03154086|5409080|P1|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205942|NCT03154086|5409066|P15|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205943|NCT03154086|5409067|P14|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205944|NCT03154086|5409068|P13|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205945|NCT03154086|5409069|P12|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205946|NCT03154086|5409070|P11|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205947|NCT03154086|5409071|P10|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205948|NCT03154086|5409072|P9|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205949|NCT03154086|5409073|P8|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205950|NCT03154086|5409074|P7|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205951|NCT03154086|5409075|P6|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||2
2205952|NCT03154086|5409076|P5|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||6
2205953|NCT03154086|5409077|P4|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205954|NCT03154086|5409078|P3|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205955|NCT03154086|5409079|P2|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205956|NCT03154086|5409080|P1|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
2205957|NCT03154086|5409066|P15|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205958|NCT03154086|5409067|P14|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205959|NCT03154086|5409068|P13|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205960|NCT03154086|5409069|P12|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205961|NCT03154086|5409070|P11|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205962|NCT03154086|5409071|P10|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205963|NCT03154086|5409072|P9|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205964|NCT03154086|5409073|P8|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205965|NCT03154086|5409074|P7|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205966|NCT03154086|5409075|P6|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205967|NCT03154086|5409076|P5|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205968|NCT03154086|5409077|P4|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205969|NCT03154086|5409078|P3|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205970|NCT03154086|5409079|P2|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205971|NCT03154086|5409080|P1|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205972|NCT03154086|5409066|P15|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205973|NCT03154086|5409067|P14|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205974|NCT03154086|5409068|P13|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205975|NCT03154086|5409069|P12|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205976|NCT03154086|5409070|P11|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205977|NCT03154086|5409071|P10|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205978|NCT03154086|5409072|P9|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205979|NCT03154086|5409073|P8|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205980|NCT03154086|5409074|P7|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205981|NCT03154086|5409075|P6|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||2
2205982|NCT03154086|5409076|P5|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||6
2205983|NCT03154086|5409077|P4|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205984|NCT03154086|5409078|P3|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205985|NCT03154086|5409079|P2|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205986|NCT03154086|5409080|P1|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205987|NCT03154086|5409066|P15|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205988|NCT03154086|5409067|P14|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205989|NCT03154086|5409068|P13|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205990|NCT03154086|5409069|P12|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205991|NCT03154086|5409070|P11|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205992|NCT03154086|5409071|P10|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205993|NCT03154086|5409072|P9|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205994|NCT03154086|5409073|P8|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205995|NCT03154086|5409074|P7|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205996|NCT03154086|5409075|P6|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||2
2205997|NCT03154086|5409076|P5|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||6
2205998|NCT03154086|5409077|P4|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2205999|NCT03154086|5409078|P3|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2206000|NCT03154086|5409079|P2|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2206001|NCT03154086|5409080|P1|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
2206002|NCT03154086|5409066|P15|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206003|NCT03154086|5409067|P14|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206004|NCT03154086|5409068|P13|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206005|NCT03154086|5409069|P12|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206006|NCT03154086|5409070|P11|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206007|NCT03154086|5409071|P10|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206008|NCT03154086|5409072|P9|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206009|NCT03154086|5409073|P8|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206010|NCT03154086|5409074|P7|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206011|NCT03154086|5409075|P6|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206012|NCT03154086|5409076|P5|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206013|NCT03154086|5409077|P4|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206014|NCT03154086|5409078|P3|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206015|NCT03154086|5409079|P2|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206016|NCT03154086|5409080|P1|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206017|NCT03154086|5409066|P15|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206018|NCT03154086|5409067|P14|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206019|NCT03154086|5409068|P13|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206020|NCT03154086|5409069|P12|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206021|NCT03154086|5409070|P11|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206022|NCT03154086|5409071|P10|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206023|NCT03154086|5409072|P9|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206024|NCT03154086|5409073|P8|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206025|NCT03154086|5409074|P7|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206026|NCT03154086|5409075|P6|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||2
2206027|NCT03154086|5409076|P5|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||6
2206028|NCT03154086|5409077|P4|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206029|NCT03154086|5409078|P3|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206030|NCT03154086|5409079|P2|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206031|NCT03154086|5409080|P1|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206032|NCT03154086|5409066|P15|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206033|NCT03154086|5409067|P14|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206034|NCT03154086|5409068|P13|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206035|NCT03154086|5409069|P12|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206036|NCT03154086|5409070|P11|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206037|NCT03154086|5409071|P10|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206038|NCT03154086|5409072|P9|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206039|NCT03154086|5409073|P8|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206040|NCT03154086|5409074|P7|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206041|NCT03154086|5409075|P6|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||2
2206042|NCT03154086|5409076|P5|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||6
2206043|NCT03154086|5409077|P4|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206044|NCT03154086|5409078|P3|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206045|NCT03154086|5409079|P2|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206046|NCT03154086|5409080|P1|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
2206047|NCT03154086|5409066|P15|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206048|NCT03154086|5409067|P14|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206049|NCT03154086|5409068|P13|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206050|NCT03154086|5409069|P12|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206051|NCT03154086|5409070|P11|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206052|NCT03154086|5409071|P10|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206053|NCT03154086|5409072|P9|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206054|NCT03154086|5409073|P8|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206055|NCT03154086|5409074|P7|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206056|NCT03154086|5409075|P6|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206057|NCT03154086|5409076|P5|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206058|NCT03154086|5409077|P4|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206059|NCT03154086|5409078|P3|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206060|NCT03154086|5409079|P2|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206061|NCT03154086|5409080|P1|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||1
2206062|NCT03154086|5409066|P15|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206063|NCT03154086|5409067|P14|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206064|NCT03154086|5409068|P13|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206065|NCT03154086|5409069|P12|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206066|NCT03154086|5409070|P11|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206067|NCT03154086|5409071|P10|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206068|NCT03154086|5409072|P9|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206069|NCT03154086|5409073|P8|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206070|NCT03154086|5409074|P7|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206071|NCT03154086|5409075|P6|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206072|NCT03154086|5409076|P5|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206073|NCT03154086|5409077|P4|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
2206074|NCT03154086|5409078|P3|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||1
2206075|NCT03154086|5409079|P2|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
2206076|NCT03154086|5409080|P1|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
2206077|NCT03154086|5409066|P15|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206078|NCT03154086|5409067|P14|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206079|NCT03154086|5409068|P13|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206080|NCT03154086|5409069|P12|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206081|NCT03154086|5409070|P11|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206082|NCT03154086|5409071|P10|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206083|NCT03154086|5409072|P9|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206084|NCT03154086|5409073|P8|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206085|NCT03154086|5409074|P7|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206086|NCT03154086|5409075|P6|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206087|NCT03154086|5409076|P5|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
2206088|NCT03154086|5409077|P4|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||2
2206089|NCT03154086|5409078|P3|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||1
2206090|NCT03154086|5409079|P2|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||2
2206091|NCT03154086|5409080|P1|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)|1 par was not dosed on day of dosing due to elevated lab; hence 1 replacement was enrolled and dosed|3
2206092|NCT03154086|5409066|P15|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206093|NCT03154086|5409067|P14|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206094|NCT03154086|5409068|P13|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206095|NCT03154086|5409069|P12|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206096|NCT03154086|5409070|P11|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206097|NCT03154086|5409071|P10|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206098|NCT03154086|5409072|P9|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206099|NCT03154086|5409073|P8|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206100|NCT03154086|5409074|P7|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206101|NCT03154086|5409075|P6|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206102|NCT03154086|5409076|P5|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206103|NCT03154086|5409077|P4|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206104|NCT03154086|5409078|P3|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||1
2206105|NCT03154086|5409079|P2|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206106|NCT03154086|5409080|P1|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206107|NCT03154086|5409066|P15|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206108|NCT03154086|5409067|P14|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206109|NCT03154086|5409068|P13|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206110|NCT03154086|5409069|P12|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206111|NCT03154086|5409070|P11|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206112|NCT03154086|5409071|P10|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206113|NCT03154086|5409072|P9|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206114|NCT03154086|5409073|P8|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206115|NCT03154086|5409074|P7|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206116|NCT03154086|5409075|P6|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206117|NCT03154086|5409076|P5|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206118|NCT03154086|5409077|P4|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
2206119|NCT03154086|5409078|P3|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||1
2206120|NCT03154086|5409079|P2|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
2206121|NCT03154086|5409080|P1|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
2206122|NCT03154086|5409066|P15|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206123|NCT03154086|5409067|P14|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206124|NCT03154086|5409068|P13|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206125|NCT03154086|5409069|P12|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206126|NCT03154086|5409070|P11|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206127|NCT03154086|5409071|P10|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206128|NCT03154086|5409072|P9|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206129|NCT03154086|5409073|P8|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206130|NCT03154086|5409074|P7|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206131|NCT03154086|5409075|P6|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206132|NCT03154086|5409076|P5|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
2206133|NCT03154086|5409077|P4|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
2206134|NCT03154086|5409078|P3|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
2206135|NCT03154086|5409079|P2|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
2206136|NCT03154086|5409080|P1|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
2206137|NCT03154086|5409066|P15|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206138|NCT03154086|5409067|P14|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206139|NCT03154086|5409068|P13|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206140|NCT03154086|5409069|P12|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206141|NCT03154086|5409070|P11|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206142|NCT03154086|5409071|P10|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206143|NCT03154086|5409072|P9|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206144|NCT03154086|5409073|P8|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206145|NCT03154086|5409074|P7|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206146|NCT03154086|5409075|P6|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206147|NCT03154086|5409076|P5|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206148|NCT03154086|5409077|P4|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206149|NCT03154086|5409078|P3|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206150|NCT03154086|5409079|P2|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206151|NCT03154086|5409080|P1|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206152|NCT03154086|5409066|P15|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206153|NCT03154086|5409067|P14|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206154|NCT03154086|5409068|P13|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206155|NCT03154086|5409069|P12|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206156|NCT03154086|5409070|P11|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206157|NCT03154086|5409071|P10|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206158|NCT03154086|5409072|P9|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206159|NCT03154086|5409073|P8|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206160|NCT03154086|5409074|P7|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206161|NCT03154086|5409075|P6|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206162|NCT03154086|5409076|P5|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206163|NCT03154086|5409077|P4|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
2206164|NCT03154086|5409078|P3|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
2206165|NCT03154086|5409079|P2|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
2206166|NCT03154086|5409080|P1|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
2206167|NCT03154086|5409066|P15|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206168|NCT03154086|5409067|P14|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206169|NCT03154086|5409068|P13|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206170|NCT03154086|5409069|P12|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206171|NCT03154086|5409070|P11|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206172|NCT03154086|5409071|P10|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206173|NCT03154086|5409072|P9|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206174|NCT03154086|5409073|P8|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206175|NCT03154086|5409074|P7|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206176|NCT03154086|5409075|P6|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206177|NCT03154086|5409076|P5|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
2206178|NCT03154086|5409077|P4|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
2206179|NCT03154086|5409078|P3|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
2206180|NCT03154086|5409079|P2|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)|One replacement par was enrolled and dosed|2
2206181|NCT03154086|5409080|P1|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
2206182|NCT03154086|5409066|P15|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206183|NCT03154086|5409067|P14|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206184|NCT03154086|5409068|P13|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206185|NCT03154086|5409069|P12|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206186|NCT03154086|5409070|P11|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206187|NCT03154086|5409071|P10|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206188|NCT03154086|5409072|P9|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206189|NCT03154086|5409073|P8|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206190|NCT03154086|5409074|P7|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206191|NCT03154086|5409075|P6|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206192|NCT03154086|5409076|P5|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206193|NCT03154086|5409077|P4|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206194|NCT03154086|5409078|P3|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206195|NCT03154086|5409079|P2|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||1
2206196|NCT03154086|5409080|P1|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206197|NCT03154086|5409066|P15|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206198|NCT03154086|5409067|P14|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206199|NCT03154086|5409068|P13|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206200|NCT03154086|5409069|P12|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206201|NCT03154086|5409070|P11|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206202|NCT03154086|5409071|P10|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206203|NCT03154086|5409072|P9|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206204|NCT03154086|5409073|P8|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206205|NCT03154086|5409074|P7|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206206|NCT03154086|5409075|P6|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206207|NCT03154086|5409076|P5|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206208|NCT03154086|5409077|P4|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
2206209|NCT03154086|5409078|P3|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
2206210|NCT03154086|5409079|P2|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||1
2206211|NCT03154086|5409080|P1|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
2206212|NCT03154086|5409066|P15|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206213|NCT03154086|5409067|P14|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206214|NCT03154086|5409068|P13|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206215|NCT03154086|5409069|P12|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206216|NCT03154086|5409070|P11|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206217|NCT03154086|5409071|P10|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206218|NCT03154086|5409072|P9|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206219|NCT03154086|5409073|P8|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206220|NCT03154086|5409074|P7|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206221|NCT03154086|5409075|P6|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206222|NCT03154086|5409076|P5|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
2206223|NCT03154086|5409077|P4|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
2206224|NCT03154086|5409078|P3|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
2206225|NCT03154086|5409079|P2|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
2206226|NCT03154086|5409080|P1|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
2206227|NCT03154086|5409066|P15|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206228|NCT03154086|5409067|P14|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206229|NCT03154086|5409068|P13|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206230|NCT03154086|5409069|P12|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206231|NCT03154086|5409070|P11|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206232|NCT03154086|5409071|P10|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206233|NCT03154086|5409072|P9|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206234|NCT03154086|5409073|P8|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206235|NCT03154086|5409074|P7|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206236|NCT03154086|5409075|P6|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206237|NCT03154086|5409076|P5|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206238|NCT03154086|5409077|P4|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206239|NCT03154086|5409078|P3|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206240|NCT03154086|5409079|P2|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206241|NCT03154086|5409080|P1|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206242|NCT03154086|5409066|P15|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206243|NCT03154086|5409067|P14|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206244|NCT03154086|5409068|P13|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206245|NCT03154086|5409069|P12|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206246|NCT03154086|5409070|P11|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206247|NCT03154086|5409071|P10|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206248|NCT03154086|5409072|P9|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206249|NCT03154086|5409073|P8|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206250|NCT03154086|5409074|P7|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206251|NCT03154086|5409075|P6|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206252|NCT03154086|5409076|P5|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206253|NCT03154086|5409077|P4|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
2206254|NCT03154086|5409078|P3|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
2206255|NCT03154086|5409079|P2|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
2206256|NCT03154086|5409080|P1|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
2206257|NCT03154086|5409066|P15|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206258|NCT03154086|5409067|P14|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206259|NCT03154086|5409068|P13|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206260|NCT03154086|5409069|P12|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206261|NCT03154086|5409070|P11|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206262|NCT03154086|5409071|P10|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206263|NCT03154086|5409072|P9|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206264|NCT03154086|5409073|P8|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206265|NCT03154086|5409074|P7|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206266|NCT03154086|5409075|P6|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206267|NCT03154086|5409076|P5|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
2206268|NCT03154086|5409077|P4|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)|One replacement participant (par) was enrolled and dosed|2
2206269|NCT03154086|5409078|P3|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
2206270|NCT03154086|5409079|P2|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
2206271|NCT03154086|5409080|P1|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
2206272|NCT03154086|5409066|P15|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206273|NCT03154086|5409067|P14|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206274|NCT03154086|5409068|P13|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206275|NCT03154086|5409069|P12|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206276|NCT03154086|5409070|P11|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206277|NCT03154086|5409071|P10|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206278|NCT03154086|5409072|P9|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206279|NCT03154086|5409073|P8|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206280|NCT03154086|5409074|P7|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206281|NCT03154086|5409075|P6|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206282|NCT03154086|5409076|P5|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206283|NCT03154086|5409077|P4|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||1
2206284|NCT03154086|5409078|P3|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206285|NCT03154086|5409079|P2|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206286|NCT03154086|5409080|P1|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206287|NCT03154086|5409066|P15|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206288|NCT03154086|5409067|P14|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206289|NCT03154086|5409068|P13|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206290|NCT03154086|5409069|P12|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206291|NCT03154086|5409070|P11|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206292|NCT03154086|5409071|P10|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206293|NCT03154086|5409072|P9|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206294|NCT03154086|5409073|P8|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206295|NCT03154086|5409074|P7|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206296|NCT03154086|5409075|P6|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206297|NCT03154086|5409076|P5|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206298|NCT03154086|5409077|P4|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||1
2206299|NCT03154086|5409078|P3|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
2206300|NCT03154086|5409079|P2|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
2206301|NCT03154086|5409080|P1|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
2206302|NCT03154086|5409066|P15|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206303|NCT03154086|5409067|P14|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206304|NCT03154086|5409068|P13|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206305|NCT03154086|5409069|P12|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206306|NCT03154086|5409070|P11|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206307|NCT03154086|5409071|P10|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206308|NCT03154086|5409072|P9|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206309|NCT03154086|5409073|P8|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206310|NCT03154086|5409074|P7|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206311|NCT03154086|5409075|P6|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206312|NCT03154086|5409076|P5|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
2206313|NCT03154086|5409077|P4|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
2206314|NCT03154086|5409078|P3|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
2206315|NCT03154086|5409079|P2|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
2206316|NCT03154086|5409080|P1|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
2206317|NCT03154086|5409066|P15|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206318|NCT03154086|5409067|P14|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206319|NCT03154086|5409068|P13|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206320|NCT03154086|5409069|P12|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206321|NCT03154086|5409070|P11|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206322|NCT03154086|5409071|P10|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206323|NCT03154086|5409072|P9|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206324|NCT03154086|5409073|P8|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206325|NCT03154086|5409074|P7|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206326|NCT03154086|5409075|P6|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206327|NCT03154086|5409076|P5|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206328|NCT03154086|5409077|P4|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206329|NCT03154086|5409078|P3|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206330|NCT03154086|5409079|P2|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206331|NCT03154086|5409080|P1|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206332|NCT03154086|5409066|P15|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206333|NCT03154086|5409067|P14|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206334|NCT03154086|5409068|P13|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206335|NCT03154086|5409069|P12|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206336|NCT03154086|5409070|P11|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206337|NCT03154086|5409071|P10|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206338|NCT03154086|5409072|P9|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206339|NCT03154086|5409073|P8|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206340|NCT03154086|5409074|P7|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206341|NCT03154086|5409075|P6|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206342|NCT03154086|5409076|P5|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206343|NCT03154086|5409077|P4|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
2206344|NCT03154086|5409078|P3|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
2206345|NCT03154086|5409079|P2|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
2206346|NCT03154086|5409080|P1|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
2206347|NCT03154086|5409066|P15|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206348|NCT03154086|5409067|P14|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206349|NCT03154086|5409068|P13|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206350|NCT03154086|5409069|P12|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206351|NCT03154086|5409070|P11|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206352|NCT03154086|5409071|P10|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206353|NCT03154086|5409072|P9|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206354|NCT03154086|5409073|P8|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206355|NCT03154086|5409074|P7|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206356|NCT03154086|5409075|P6|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206357|NCT03154086|5409076|P5|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
2206358|NCT03154086|5409077|P4|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
2206359|NCT03154086|5409078|P3|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
2206360|NCT03154086|5409079|P2|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
2206361|NCT03154086|5409080|P1|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
2206362|NCT03154047|5409480|P1|NOT COMPLETED|Overall Study||80
2206363|NCT03154047|5409480|P1|COMPLETED|Overall Study||0
2206364|NCT03154047|5409480|P1|Number of Patients Dosed|Overall Study||80
2206365|NCT03154047|5409480|P1|STARTED|Overall Study||80
2206366|NCT03152591|5409486|P2|NOT COMPLETED|Overall Study||0
2206367|NCT03152591|5409487|P1|NOT COMPLETED|Overall Study||0
2206368|NCT03152591|5409486|P2|COMPLETED|Overall Study||14
2206369|NCT03152591|5409487|P1|COMPLETED|Overall Study||15
2206370|NCT03152591|5409486|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||14
2206371|NCT03152591|5409487|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||15
2206372|NCT03152591|5409486|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||0
2206373|NCT03152591|5409487|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||14
2206374|NCT03152591|5409486|P2|STARTED|Overall Study||14
2206375|NCT03152591|5409487|P1|STARTED|Overall Study||15
2206376|NCT03152552|5409514|P5|NOT COMPLETED|Treatment Period 2 (24 Weeks)||11
2206377|NCT03152552|5409515|P4|NOT COMPLETED|Treatment Period 2 (24 Weeks)||9
2206378|NCT03152552|5409516|P3|NOT COMPLETED|Treatment Period 2 (24 Weeks)||9
2206379|NCT03152552|5409517|P2|NOT COMPLETED|Treatment Period 2 (24 Weeks)||5
2206380|NCT03152552|5409518|P1|NOT COMPLETED|Treatment Period 2 (24 Weeks)||6
2206381|NCT03152552|5409514|P5|COMPLETED|Treatment Period 2 (24 Weeks)||0
2206382|NCT03152552|5409515|P4|COMPLETED|Treatment Period 2 (24 Weeks)||0
2206383|NCT03152552|5409516|P3|COMPLETED|Treatment Period 2 (24 Weeks)||0
2206384|NCT03152552|5409517|P2|COMPLETED|Treatment Period 2 (24 Weeks)||0
2206385|NCT03152552|5409518|P1|COMPLETED|Treatment Period 2 (24 Weeks)||1
2206386|NCT03152552|5409514|P5|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|11
2206387|NCT03152552|5409515|P4|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|9
2206388|NCT03152552|5409516|P3|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|9
2206389|NCT03152552|5409517|P2|STARTED|Treatment Period 2 (24 Weeks)||5
2206390|NCT03152552|5409518|P1|STARTED|Treatment Period 2 (24 Weeks)||7
2206391|NCT03152552|5409514|P5|NOT COMPLETED|Treatment Period 1 (12 Weeks)||21
2206392|NCT03152552|5409515|P4|NOT COMPLETED|Treatment Period 1 (12 Weeks)||20
2206393|NCT03152552|5409516|P3|NOT COMPLETED|Treatment Period 1 (12 Weeks)||21
2206394|NCT03152552|5409517|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11
2206395|NCT03152552|5409518|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8
2206396|NCT03152552|5409514|P5|COMPLETED|Treatment Period 1 (12 Weeks)||12
2206397|NCT03152552|5409515|P4|COMPLETED|Treatment Period 1 (12 Weeks)||10
2206398|NCT03152552|5409516|P3|COMPLETED|Treatment Period 1 (12 Weeks)||10
2206399|NCT03152552|5409517|P2|COMPLETED|Treatment Period 1 (12 Weeks)||5
2206400|NCT03152552|5409518|P1|COMPLETED|Treatment Period 1 (12 Weeks)||7
2206401|NCT03152552|5409514|P5|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||33
2206402|NCT03152552|5409515|P4|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||30
2206403|NCT03152552|5409516|P3|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||30
2206404|NCT03152552|5409517|P2|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||16
2206405|NCT03152552|5409518|P1|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||15
2206406|NCT03152552|5409514|P5|STARTED|Treatment Period 1 (12 Weeks)||33
2206407|NCT03152552|5409515|P4|STARTED|Treatment Period 1 (12 Weeks)||30
2206408|NCT03152552|5409516|P3|STARTED|Treatment Period 1 (12 Weeks)||31
2206409|NCT03152552|5409517|P2|STARTED|Treatment Period 1 (12 Weeks)||16
2206410|NCT03152552|5409518|P1|STARTED|Treatment Period 1 (12 Weeks)||15
2206417|NCT03152136|5409663|P3|NOT COMPLETED|Overall Study||1
2206418|NCT03152136|5409664|P2|NOT COMPLETED|Overall Study||0
2206419|NCT03152136|5409665|P1|NOT COMPLETED|Overall Study||3
2206420|NCT03152136|5409663|P3|COMPLETED|Overall Study||14
2206421|NCT03152136|5409664|P2|COMPLETED|Overall Study||15
2206422|NCT03152136|5409665|P1|COMPLETED|Overall Study||29
2206423|NCT03152136|5409663|P3|STARTED|Overall Study||15
2206424|NCT03152136|5409664|P2|STARTED|Overall Study||15
2206425|NCT03152136|5409665|P1|STARTED|Overall Study||32
2206426|NCT03151551|5409674|P2|NOT COMPLETED|Overall Study||276
2206427|NCT03151551|5409675|P1|NOT COMPLETED|Overall Study||275
2206428|NCT03151551|5409674|P2|COMPLETED|Overall Study||7
2206429|NCT03151551|5409675|P1|COMPLETED|Overall Study||8
2206430|NCT03151551|5409674|P2|ADA 40 mg at Baseline, 40 mg Q2W|Overall Study||219
2206431|NCT03151551|5409675|P1|ADA 40 mg at Baseline, 40 mg Q2W|Overall Study|Row represents adalimumab data only.|0
2206432|NCT03151551|5409674|P2|ADA 80 mg at Baseline, 40 mg Q2W|Overall Study||64
2206433|NCT03151551|5409675|P1|ADA 80 mg at Baseline, 40 mg Q2W|Overall Study|Row represents adalimumab data only.|0
2206434|NCT03151551|5409674|P2|IXE 160 mg at Baseline, 80 mg Q4W|Overall Study|Row represents Ixekizumab data only.|0
2206435|NCT03151551|5409675|P1|IXE 160 mg at Baseline, 80 mg Q4W|Overall Study||218
2206436|NCT03151551|5409674|P2|IXE 160 mg at Baseline, 80 mg Q2W/Q4W|Overall Study|Row represents Ixekizumab data only.|0
2206437|NCT03151551|5409675|P1|IXE 160 mg at Baseline, 80 mg Q2W/Q4W|Overall Study||65
2206438|NCT03151551|5409674|P2|Received at Least One Dose of Study Drug|Overall Study||283
2206439|NCT03151551|5409675|P1|Received at Least One Dose of Study Drug|Overall Study||283
2206440|NCT03151551|5409674|P2|STARTED|Overall Study||283
2206441|NCT03151551|5409675|P1|STARTED|Overall Study||283
2206442|NCT03151265|5409687|P2|NOT COMPLETED|Overall Study||0
2206443|NCT03151265|5409688|P1|NOT COMPLETED|Overall Study||0
2206444|NCT03151265|5409687|P2|COMPLETED|Overall Study||20
2206445|NCT03151265|5409688|P1|COMPLETED|Overall Study||20
2206446|NCT03151265|5409687|P2|STARTED|Overall Study||20
2206447|NCT03151265|5409688|P1|STARTED|Overall Study||20
2206448|NCT03151226|5409710|P1|NOT COMPLETED|Overall Study||3
2206449|NCT03151226|5409710|P1|COMPLETED|Overall Study||0
2206450|NCT03151226|5409710|P1|STARTED|Overall Study||3
2206451|NCT03150758|5409714|P1|NOT COMPLETED|Overall Study||0
2206452|NCT03150758|5409714|P1|COMPLETED|Overall Study||6
2206453|NCT03150758|5409714|P1|STARTED|Overall Study||6
2206454|NCT03150719|5409720|P2|NOT COMPLETED|Overall Study||2
2206455|NCT03150719|5409721|P1|NOT COMPLETED|Overall Study||1
2206456|NCT03150719|5409720|P2|COMPLETED|Overall Study||48
2206457|NCT03150719|5409721|P1|COMPLETED|Overall Study||46
2206458|NCT03150719|5409720|P2|STARTED|Overall Study||50
2206459|NCT03150719|5409721|P1|STARTED|Overall Study||47
2206460|NCT03150485|5409737|P6|NOT COMPLETED|Overall Study||0
2206461|NCT03150485|5409738|P5|NOT COMPLETED|Overall Study||0
2206462|NCT03150485|5409739|P4|NOT COMPLETED|Overall Study||0
2206463|NCT03150485|5409740|P3|NOT COMPLETED|Overall Study||0
2206464|NCT03150485|5409741|P2|NOT COMPLETED|Overall Study||1
2206465|NCT03150485|5409742|P1|NOT COMPLETED|Overall Study||0
2206466|NCT03150485|5409737|P6|COMPLETED|Overall Study||1
2206467|NCT03150485|5409738|P5|COMPLETED|Overall Study||2
2206468|NCT03150485|5409739|P4|COMPLETED|Overall Study||5
2206469|NCT03150485|5409740|P3|COMPLETED|Overall Study||4
2206470|NCT03150485|5409741|P2|COMPLETED|Overall Study||8
2206471|NCT03150485|5409742|P1|COMPLETED|Overall Study||2
2206472|NCT03150485|5409737|P6|STARTED|Overall Study||1
2206473|NCT03150485|5409738|P5|STARTED|Overall Study||2
2206474|NCT03150485|5409739|P4|STARTED|Overall Study||5
2206475|NCT03150485|5409740|P3|STARTED|Overall Study||4
2206476|NCT03150485|5409741|P2|STARTED|Overall Study||9
2206477|NCT03150485|5409742|P1|STARTED|Overall Study||2
2206478|NCT03150160|5409759|P2|NOT COMPLETED|Overall Study||0
2206479|NCT03150160|5409760|P1|NOT COMPLETED|Overall Study||0
2206480|NCT03150160|5409759|P2|COMPLETED|Overall Study||1
2206481|NCT03150160|5409760|P1|COMPLETED|Overall Study||0
2206482|NCT03150160|5409759|P2|STARTED|Overall Study||1
2206483|NCT03150160|5409760|P1|STARTED|Overall Study||0
2206484|NCT03150108|5409776|P2|NOT COMPLETED|Overall Study||0
2206485|NCT03150108|5409777|P1|NOT COMPLETED|Overall Study||0
2206486|NCT03150108|5409776|P2|COMPLETED|Overall Study||12
2206487|NCT03150108|5409777|P1|COMPLETED|Overall Study||12
2206488|NCT03150108|5409776|P2|STARTED|Overall Study||12
2206489|NCT03150108|5409777|P1|STARTED|Overall Study||12
2206490|NCT03150082|5409867|P2|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
2206491|NCT03150082|5409868|P1|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
2206492|NCT03150082|5409867|P2|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||13
2206493|NCT03150082|5409868|P1|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||12
2206494|NCT03150082|5409867|P2|STARTED|Treatment Period 2 (Up to 4 Weeks)||13
2206495|NCT03150082|5409868|P1|STARTED|Treatment Period 2 (Up to 4 Weeks)||12
2206496|NCT03150082|5409867|P2|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
2206497|NCT03150082|5409868|P1|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
2206498|NCT03150082|5409867|P2|COMPLETED|Washout Period (Up to 4 Weeks)||13
2206499|NCT03150082|5409868|P1|COMPLETED|Washout Period (Up to 4 Weeks)||12
2206500|NCT03150082|5409867|P2|STARTED|Washout Period (Up to 4 Weeks)||13
2206501|NCT03150082|5409868|P1|STARTED|Washout Period (Up to 4 Weeks)||12
2206502|NCT03150082|5409867|P2|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||0
2206503|NCT03150082|5409868|P1|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||1
2206504|NCT03150082|5409867|P2|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||13
2206505|NCT03150082|5409868|P1|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||12
2206506|NCT03150082|5409867|P2|STARTED|Treatment Period 1 (Up to 4 Weeks)||13
2206507|NCT03150082|5409868|P1|STARTED|Treatment Period 1 (Up to 4 Weeks)||13
2206508|NCT03149887|5409924|P2|NOT COMPLETED|Overall Study||0
2206509|NCT03149887|5409925|P1|NOT COMPLETED|Overall Study||0
2206510|NCT03149887|5409924|P2|COMPLETED|Overall Study||27
2206511|NCT03149887|5409925|P1|COMPLETED|Overall Study||27
2206512|NCT03149887|5409924|P2|STARTED|Overall Study||27
2206513|NCT03149887|5409925|P1|STARTED|Overall Study||27
2206514|NCT03149848|5409945|P1|NOT COMPLETED|Period 2 (Day 15 to Day 28)||2
2206515|NCT03149848|5409945|P1|COMPLETED|Period 2 (Day 15 to Day 28)||12
2206516|NCT03149848|5409945|P1|STARTED|Period 2 (Day 15 to Day 28)||14
2206517|NCT03149848|5409945|P1|NOT COMPLETED|Period 1 (Day 1 to Day 14)||1
2206518|NCT03149848|5409945|P1|COMPLETED|Period 1 (Day 1 to Day 14)||14
2206519|NCT03149848|5409945|P1|STARTED|Period 1 (Day 1 to Day 14)||15
2206520|NCT03148756|5409984|P2|NOT COMPLETED|Overall Study||1
2206521|NCT03148756|5409985|P1|NOT COMPLETED|Overall Study||0
2206522|NCT03148756|5409984|P2|COMPLETED|Overall Study||1
2206523|NCT03148756|5409985|P1|COMPLETED|Overall Study||0
2206524|NCT03148756|5409984|P2|STARTED|Overall Study||2
2206525|NCT03148756|5409985|P1|STARTED|Overall Study||0
2206526|NCT03148691|5410018|P3|NOT COMPLETED|Overall Study||8
2206527|NCT03148691|5410019|P2|NOT COMPLETED|Overall Study||2
2206528|NCT03148691|5410020|P1|NOT COMPLETED|Overall Study||3
2206529|NCT03148691|5410018|P3|COMPLETED|Overall Study||92
2206530|NCT03148691|5410019|P2|COMPLETED|Overall Study||101
2206531|NCT03148691|5410020|P1|COMPLETED|Overall Study||47
2206532|NCT03148691|5410018|P3|STARTED|Overall Study||100
2206533|NCT03148691|5410019|P2|STARTED|Overall Study||103
2206534|NCT03148691|5410020|P1|STARTED|Overall Study||50
2206535|NCT03148262|5410030|P2|NOT COMPLETED|Overall Study||1
2206536|NCT03148262|5410031|P1|NOT COMPLETED|Overall Study||3
2206537|NCT03148262|5410030|P2|COMPLETED|Overall Study||31
2206538|NCT03148262|5410031|P1|COMPLETED|Overall Study||28
2206539|NCT03148262|5410030|P2|STARTED|Overall Study||32
2206540|NCT03148262|5410031|P1|STARTED|Overall Study||31
2206541|NCT03148236|5410039|P2|NOT COMPLETED|Overall Study||0
2206542|NCT03148236|5410040|P1|NOT COMPLETED|Overall Study||0
2206543|NCT03148236|5410039|P2|COMPLETED|Overall Study||10
2206544|NCT03148236|5410040|P1|COMPLETED|Overall Study||10
2206545|NCT03148236|5410039|P2|STARTED|Overall Study||10
2206546|NCT03148236|5410040|P1|STARTED|Overall Study||10
2206547|NCT03148067|5410066|P1|NOT COMPLETED|Overall Study||4
2206548|NCT03148067|5410066|P1|COMPLETED|Overall Study||221
2206549|NCT03148067|5410066|P1|STARTED|Overall Study||225
2206550|NCT03146403|5410073|P2|NOT COMPLETED|Overall Study||3
2206551|NCT03146403|5410074|P1|NOT COMPLETED|Overall Study||2
2206552|NCT03146403|5410073|P2|COMPLETED|Overall Study||14
2206553|NCT03146403|5410074|P1|COMPLETED|Overall Study||14
2206554|NCT03146403|5410073|P2|STARTED|Overall Study||17
2206555|NCT03146403|5410074|P1|STARTED|Overall Study||16
2206556|NCT03144635|5410088|P1|NOT COMPLETED|Overall Study||80
2206557|NCT03144635|5410088|P1|COMPLETED|Overall Study||0
2206558|NCT03144635|5410088|P1|STARTED|Overall Study||80
2206559|NCT03144518|5410100|P2|NOT COMPLETED|16 Week Post-Vaccination||2
2206560|NCT03144518|5410101|P1|NOT COMPLETED|16 Week Post-Vaccination||3
2206561|NCT03144518|5410100|P2|COMPLETED|16 Week Post-Vaccination||49
2206562|NCT03144518|5410101|P1|COMPLETED|16 Week Post-Vaccination||49
2206563|NCT03144518|5410100|P2|STARTED|16 Week Post-Vaccination||51
2206564|NCT03144518|5410101|P1|STARTED|16 Week Post-Vaccination||52
2206565|NCT03144518|5410100|P2|NOT COMPLETED|4 Weeks Post-Vaccination||0
2206566|NCT03144518|5410101|P1|NOT COMPLETED|4 Weeks Post-Vaccination||1
2206567|NCT03144518|5410100|P2|COMPLETED|4 Weeks Post-Vaccination||51
2206568|NCT03144518|5410101|P1|COMPLETED|4 Weeks Post-Vaccination||51
2206569|NCT03144518|5410100|P2|STARTED|4 Weeks Post-Vaccination||51
2206570|NCT03144518|5410101|P1|STARTED|4 Weeks Post-Vaccination||52
2206571|NCT03144518|5410100|P2|NOT COMPLETED|Primary Outcome (Mood)||0
2206572|NCT03144518|5410101|P1|NOT COMPLETED|Primary Outcome (Mood)||0
2206573|NCT03144518|5410100|P2|COMPLETED|Primary Outcome (Mood)||51
2206574|NCT03144518|5410101|P1|COMPLETED|Primary Outcome (Mood)||52
2206575|NCT03144518|5410100|P2|STARTED|Primary Outcome (Mood)||51
2206576|NCT03144518|5410101|P1|STARTED|Primary Outcome (Mood)||52
2206577|NCT03144180|5410118|P2|NOT COMPLETED|Overall Study||6
2206578|NCT03144180|5410119|P1|NOT COMPLETED|Overall Study||2
2206579|NCT03144180|5410118|P2|COMPLETED|Overall Study||10
2206580|NCT03144180|5410119|P1|COMPLETED|Overall Study||14
2206581|NCT03144180|5410118|P2|STARTED|Overall Study||16
2206582|NCT03144180|5410119|P1|STARTED|Overall Study||16
2206589|NCT03143166|5410154|P1|NOT COMPLETED|Period 2 (Washout of at Least 4 Days)||1
2206590|NCT03143166|5410154|P1|COMPLETED|Period 2 (Washout of at Least 4 Days)||35
2206591|NCT03143166|5410154|P1|STARTED|Period 2 (Washout of at Least 4 Days)||36
2206592|NCT03143166|5410154|P1|NOT COMPLETED|Period 1||0
2206593|NCT03143166|5410154|P1|COMPLETED|Period 1||36
2206594|NCT03143166|5410154|P1|STARTED|Period 1||36
2206595|NCT03143101|5410173|P3|NOT COMPLETED|Overall Study||0
2206596|NCT03143101|5410174|P2|NOT COMPLETED|Overall Study||3
2206597|NCT03143101|5410175|P1|NOT COMPLETED|Overall Study||2
2206598|NCT03143101|5410173|P3|COMPLETED|Overall Study||67
2206599|NCT03143101|5410174|P2|COMPLETED|Overall Study||63
2206600|NCT03143101|5410175|P1|COMPLETED|Overall Study||65
2206601|NCT03143101|5410173|P3|STARTED|Overall Study||67
2206602|NCT03143101|5410174|P2|STARTED|Overall Study||66
2206603|NCT03143101|5410175|P1|STARTED|Overall Study||67
2206604|NCT03142932|5410230|P2|NOT COMPLETED|Overall Study||11
2206605|NCT03142932|5410231|P1|NOT COMPLETED|Overall Study||2
2206606|NCT03142932|5410230|P2|COMPLETED|Overall Study||39
2206607|NCT03142932|5410231|P1|COMPLETED|Overall Study||50
2206608|NCT03142932|5410230|P2|STARTED|Overall Study||50
2206609|NCT03142932|5410231|P1|STARTED|Overall Study||52
2206610|NCT03142750|5410247|P2|NOT COMPLETED|Overall Study||1
2206611|NCT03142750|5410248|P1|NOT COMPLETED|Overall Study||4
2206612|NCT03142750|5410247|P2|COMPLETED|Overall Study||9
2206613|NCT03142750|5410248|P1|COMPLETED|Overall Study||10
2206614|NCT03142750|5410247|P2|STARTED|Overall Study||10
2206615|NCT03142750|5410248|P1|STARTED|Overall Study||14
2206616|NCT03141528|5410261|P2|NOT COMPLETED|Overall Study||41
2206617|NCT03141528|5410262|P1|NOT COMPLETED|Overall Study||47
2206618|NCT03141528|5410261|P2|COMPLETED|Overall Study||77
2206619|NCT03141528|5410262|P1|COMPLETED|Overall Study||75
2206620|NCT03141528|5410261|P2|STARTED|Overall Study||118
2206621|NCT03141528|5410262|P1|STARTED|Overall Study||122
2206622|NCT03141372|5410304|P2|NOT COMPLETED|Overall Study||2
2206623|NCT03141372|5410305|P1|NOT COMPLETED|Overall Study||0
2206624|NCT03141372|5410304|P2|COMPLETED|Overall Study||40
2206625|NCT03141372|5410305|P1|COMPLETED|Overall Study||42
2206626|NCT03141372|5410304|P2|STARTED|Overall Study||42
2206627|NCT03141372|5410305|P1|STARTED|Overall Study||42
2206628|NCT03141307|5410325|P2|NOT COMPLETED|Follow-Up||54
2206629|NCT03141307|5410326|P1|NOT COMPLETED|Follow-Up||97
2206630|NCT03141307|5410325|P2|COMPLETED|Follow-Up||184
2206631|NCT03141307|5410326|P1|COMPLETED|Follow-Up||370
2206632|NCT03141307|5410325|P2|STARTED|Follow-Up||238
2206633|NCT03141307|5410326|P1|STARTED|Follow-Up||467
2206634|NCT03141307|5410325|P2|NOT COMPLETED|In-Hospital||2
2206635|NCT03141307|5410326|P1|NOT COMPLETED|In-Hospital||4
2206636|NCT03141307|5410325|P2|COMPLETED|In-Hospital||238
2206637|NCT03141307|5410326|P1|COMPLETED|In-Hospital||467
2206638|NCT03141307|5410325|P2|STARTED|In-Hospital||240
2206639|NCT03141307|5410326|P1|STARTED|In-Hospital||471
2206640|NCT03141086|5410344|P2|NOT COMPLETED|Overall Study||5
2206641|NCT03141086|5410345|P1|NOT COMPLETED|Overall Study||1
2206642|NCT03141086|5410344|P2|COMPLETED|Overall Study||12
2206643|NCT03141086|5410345|P1|COMPLETED|Overall Study||6
2206644|NCT03141086|5410344|P2|STARTED|Overall Study||17
2206645|NCT03141086|5410345|P1|STARTED|Overall Study||7
2206646|NCT03140631|5410374|P2|NOT COMPLETED|Overall Study||0
2206647|NCT03140631|5410375|P1|NOT COMPLETED|Overall Study||0
2206648|NCT03140631|5410374|P2|COMPLETED|Overall Study||77
2206649|NCT03140631|5410375|P1|COMPLETED|Overall Study||73
2206650|NCT03140631|5410374|P2|STARTED|Overall Study||77
2206651|NCT03140631|5410375|P1|STARTED|Overall Study||73
2206652|NCT03139578|5410383|P4|NOT COMPLETED|Period 2||0
2206653|NCT03139578|5410384|P3|NOT COMPLETED|Period 2||0
2206654|NCT03139578|5410385|P2|NOT COMPLETED|Period 2||0
2206655|NCT03139578|5410386|P1|NOT COMPLETED|Period 2||0
2206656|NCT03139578|5410383|P4|COMPLETED|Period 2||13
2206657|NCT03139578|5410384|P3|COMPLETED|Period 2||12
2206658|NCT03139578|5410385|P2|COMPLETED|Period 2||13
2206659|NCT03139578|5410386|P1|COMPLETED|Period 2||12
2206660|NCT03139578|5410383|P4|Discontinued|Period 2||0
2206661|NCT03139578|5410384|P3|Discontinued|Period 2||0
2206662|NCT03139578|5410385|P2|Discontinued|Period 2||0
2206663|NCT03139578|5410386|P1|Discontinued|Period 2||0
2206664|NCT03139578|5410383|P4|STARTED|Period 2||13
2206665|NCT03139578|5410384|P3|STARTED|Period 2||12
2206666|NCT03139578|5410385|P2|STARTED|Period 2||13
2206667|NCT03139578|5410386|P1|STARTED|Period 2||12
2206668|NCT03139578|5410383|P4|NOT COMPLETED|Period 1||0
2206669|NCT03139578|5410384|P3|NOT COMPLETED|Period 1||0
2206670|NCT03139578|5410385|P2|NOT COMPLETED|Period 1||0
2206671|NCT03139578|5410386|P1|NOT COMPLETED|Period 1||0
2206672|NCT03139578|5410383|P4|COMPLETED|Period 1||13
2206673|NCT03139578|5410384|P3|COMPLETED|Period 1||12
2206674|NCT03139578|5410385|P2|COMPLETED|Period 1||13
2206675|NCT03139578|5410386|P1|COMPLETED|Period 1||12
2206676|NCT03139578|5410383|P4|Discontinued|Period 1||0
2206677|NCT03139578|5410384|P3|Discontinued|Period 1||0
2206678|NCT03139578|5410385|P2|Discontinued|Period 1||0
2206679|NCT03139578|5410386|P1|Discontinued|Period 1||0
2206680|NCT03139578|5410383|P4|STARTED|Period 1||13
2206681|NCT03139578|5410384|P3|STARTED|Period 1||12
2206682|NCT03139578|5410385|P2|STARTED|Period 1||13
2206683|NCT03139578|5410386|P1|STARTED|Period 1||12
2206684|NCT03139552|5410420|P1|NOT COMPLETED|Overall Study||3
2206685|NCT03139552|5410420|P1|COMPLETED|Overall Study||147
2206686|NCT03139552|5410420|P1|STARTED|Overall Study||150
2206687|NCT03139448|5410463|P2|NOT COMPLETED|Overall Study||26
2206688|NCT03139448|5410464|P1|NOT COMPLETED|Overall Study||12
2206689|NCT03139448|5410463|P2|COMPLETED|Overall Study||63
2206690|NCT03139448|5410464|P1|COMPLETED|Overall Study||73
2206691|NCT03139448|5410463|P2|Intervention Started|Overall Study||70
2206692|NCT03139448|5410464|P1|Intervention Started|Overall Study||79
2206693|NCT03139448|5410463|P2|STARTED|Overall Study||89
2206694|NCT03139448|5410464|P1|STARTED|Overall Study||85
2206695|NCT03139279|5410488|P2|NOT COMPLETED|Overall Study||6
2206696|NCT03139279|5410489|P1|NOT COMPLETED|Overall Study||7
2206697|NCT03139279|5410488|P2|COMPLETED|Overall Study||50
2206698|NCT03139279|5410489|P1|COMPLETED|Overall Study||51
2206699|NCT03139279|5410488|P2|STARTED|Overall Study||56
2206700|NCT03139279|5410489|P1|STARTED|Overall Study||58
2206701|NCT03139240|5410507|P4|NOT COMPLETED|Overall Study||0
2206702|NCT03139240|5410508|P3|NOT COMPLETED|Overall Study||1
2206703|NCT03139240|5410509|P2|NOT COMPLETED|Overall Study||1
2206704|NCT03139240|5410510|P1|NOT COMPLETED|Overall Study||0
2206705|NCT03139240|5410507|P4|COMPLETED|Overall Study||38
2206706|NCT03139240|5410508|P3|COMPLETED|Overall Study||37
2206707|NCT03139240|5410509|P2|COMPLETED|Overall Study||47
2206708|NCT03139240|5410510|P1|COMPLETED|Overall Study||48
2206709|NCT03139240|5410507|P4|STARTED|Overall Study||38
2206710|NCT03139240|5410508|P3|STARTED|Overall Study||38
2206711|NCT03139240|5410509|P2|STARTED|Overall Study||48
2206712|NCT03139240|5410510|P1|STARTED|Overall Study||48
2206713|NCT03138967|5410522|P2|NOT COMPLETED|Overall Study||4
2206714|NCT03138967|5410523|P1|NOT COMPLETED|Overall Study||1
2206715|NCT03138967|5410522|P2|COMPLETED|Overall Study||24
2206716|NCT03138967|5410523|P1|COMPLETED|Overall Study||25
2206717|NCT03138967|5410522|P2|Post-operative Day(POD) 7 Follow-up|Overall Study||24
2206718|NCT03138967|5410523|P1|Post-operative Day(POD) 7 Follow-up|Overall Study||25
2206719|NCT03138967|5410522|P2|Post-operative Day(POD) 1 Follow-up|Overall Study||25
2206720|NCT03138967|5410523|P1|Post-operative Day(POD) 1 Follow-up|Overall Study||25
2206721|NCT03138967|5410522|P2|STARTED|Overall Study||28
2206722|NCT03138967|5410523|P1|STARTED|Overall Study||26
2206723|NCT03138876|5410533|P1|NOT COMPLETED|Overall Study||0
2206724|NCT03138876|5410533|P1|COMPLETED|Overall Study||20
2206725|NCT03138876|5410533|P1|STARTED|Overall Study||20
2206726|NCT03138798|5410542|P2|NOT COMPLETED|Overall Study||4
2206727|NCT03138798|5410543|P1|NOT COMPLETED|Overall Study||6
2206728|NCT03138798|5410542|P2|COMPLETED|Overall Study||171
2206729|NCT03138798|5410543|P1|COMPLETED|Overall Study||167
2206730|NCT03138798|5410542|P2|Randomized But Did Not Meet Eligibility|Overall Study||4
2206731|NCT03138798|5410543|P1|Randomized But Did Not Meet Eligibility|Overall Study||6
2206732|NCT03138798|5410542|P2|STARTED|Overall Study||175
2206733|NCT03138798|5410543|P1|STARTED|Overall Study||173
2206734|NCT03138382|5410568|P2|NOT COMPLETED|Overall Study||0
2206735|NCT03138382|5410569|P1|NOT COMPLETED|Overall Study||0
2206736|NCT03138382|5410568|P2|COMPLETED|Overall Study||10
2206737|NCT03138382|5410569|P1|COMPLETED|Overall Study||10
2206738|NCT03138382|5410568|P2|STARTED|Overall Study||10
2206739|NCT03138382|5410569|P1|STARTED|Overall Study||10
2206740|NCT03137784|5410577|P6|NOT COMPLETED|Overall Study||0
2206741|NCT03137784|5410578|P5|NOT COMPLETED|Overall Study||1
2206742|NCT03137784|5410579|P4|NOT COMPLETED|Overall Study||0
2206743|NCT03137784|5410580|P3|NOT COMPLETED|Overall Study||0
2206744|NCT03137784|5410581|P2|NOT COMPLETED|Overall Study||1
2206745|NCT03137784|5410582|P1|NOT COMPLETED|Overall Study||2
2206746|NCT03137784|5410577|P6|COMPLETED|Overall Study||25
2206747|NCT03137784|5410578|P5|COMPLETED|Overall Study||24
2206748|NCT03137784|5410579|P4|COMPLETED|Overall Study||24
2206749|NCT03137784|5410580|P3|COMPLETED|Overall Study||25
2206750|NCT03137784|5410581|P2|COMPLETED|Overall Study||24
2206751|NCT03137784|5410582|P1|COMPLETED|Overall Study||22
2206752|NCT03137784|5410577|P6|STARTED|Overall Study||25
2206753|NCT03137784|5410578|P5|STARTED|Overall Study||25
2206754|NCT03137784|5410579|P4|STARTED|Overall Study||24
2206755|NCT03137784|5410580|P3|STARTED|Overall Study||25
2206756|NCT03137784|5410581|P2|STARTED|Overall Study||25
2206757|NCT03137784|5410582|P1|STARTED|Overall Study||24
2206758|NCT03137225|5410619|P2|NOT COMPLETED|Second 4 Hour Measurement Period||0
2206759|NCT03137225|5410620|P1|NOT COMPLETED|Second 4 Hour Measurement Period||0
2206760|NCT03137225|5410619|P2|COMPLETED|Second 4 Hour Measurement Period||0
2206761|NCT03137225|5410620|P1|COMPLETED|Second 4 Hour Measurement Period||1
2206762|NCT03137225|5410619|P2|STARTED|Second 4 Hour Measurement Period||0
2206763|NCT03137225|5410620|P1|STARTED|Second 4 Hour Measurement Period||1
2206764|NCT03137225|5410619|P2|NOT COMPLETED|First 4 Hour Measurement Period||0
2206765|NCT03137225|5410620|P1|NOT COMPLETED|First 4 Hour Measurement Period||0
2206766|NCT03137225|5410619|P2|COMPLETED|First 4 Hour Measurement Period||0
2206767|NCT03137225|5410620|P1|COMPLETED|First 4 Hour Measurement Period||1
2206768|NCT03137225|5410619|P2|STARTED|First 4 Hour Measurement Period||0
2206769|NCT03137225|5410620|P1|STARTED|First 4 Hour Measurement Period||1
2206812|NCT03136484|5410660|P2|NOT COMPLETED|Overall Study||22
2206813|NCT03136484|5410661|P1|NOT COMPLETED|Overall Study||27
2206814|NCT03136484|5410660|P2|COMPLETED|Overall Study||372
2206815|NCT03136484|5410661|P1|COMPLETED|Overall Study||367
2206816|NCT03136484|5410660|P2|Exposed|Overall Study||394
2206817|NCT03136484|5410661|P1|Exposed|Overall Study||392
2206818|NCT03136484|5410660|P2|STARTED|Overall Study||394
2206819|NCT03136484|5410661|P1|STARTED|Overall Study||394
2206820|NCT03136380|5410789|P5|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
2206821|NCT03136380|5410790|P4|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
2206822|NCT03136380|5410791|P3|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
2206823|NCT03136380|5410792|P2|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
2206824|NCT03136380|5410793|P1|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
2206825|NCT03136380|5410789|P5|COMPLETED|Part 2, Period 2 (3 Days)||8
2206826|NCT03136380|5410790|P4|COMPLETED|Part 2, Period 2 (3 Days)||8
2206827|NCT03136380|5410791|P3|COMPLETED|Part 2, Period 2 (3 Days)||0
2206828|NCT03136380|5410792|P2|COMPLETED|Part 2, Period 2 (3 Days)||0
2206829|NCT03136380|5410793|P1|COMPLETED|Part 2, Period 2 (3 Days)||0
2206830|NCT03136380|5410789|P5|STARTED|Part 2, Period 2 (3 Days)||8
2206831|NCT03136380|5410790|P4|STARTED|Part 2, Period 2 (3 Days)||8
2206832|NCT03136380|5410791|P3|STARTED|Part 2, Period 2 (3 Days)||0
2206833|NCT03136380|5410792|P2|STARTED|Part 2, Period 2 (3 Days)||0
2206834|NCT03136380|5410793|P1|STARTED|Part 2, Period 2 (3 Days)||0
2206835|NCT03136380|5410789|P5|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
2206836|NCT03136380|5410790|P4|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
2206837|NCT03136380|5410791|P3|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
2206838|NCT03136380|5410792|P2|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
2206839|NCT03136380|5410793|P1|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
2206840|NCT03136380|5410789|P5|COMPLETED|Part 2, Washout Period 1 (7 Days)||8
2206841|NCT03136380|5410790|P4|COMPLETED|Part 2, Washout Period 1 (7 Days)||8
2206842|NCT03136380|5410791|P3|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
2206843|NCT03136380|5410792|P2|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
2206844|NCT03136380|5410793|P1|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
2206845|NCT03136380|5410789|P5|STARTED|Part 2, Washout Period 1 (7 Days)||8
2206846|NCT03136380|5410790|P4|STARTED|Part 2, Washout Period 1 (7 Days)||8
2206847|NCT03136380|5410791|P3|STARTED|Part 2, Washout Period 1 (7 Days)||0
2206848|NCT03136380|5410792|P2|STARTED|Part 2, Washout Period 1 (7 Days)||0
2206849|NCT03136380|5410793|P1|STARTED|Part 2, Washout Period 1 (7 Days)||0
2206850|NCT03136380|5410789|P5|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
2206851|NCT03136380|5410790|P4|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
2206852|NCT03136380|5410791|P3|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
2206853|NCT03136380|5410792|P2|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
2206854|NCT03136380|5410793|P1|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
2206855|NCT03136380|5410789|P5|COMPLETED|Part 2, Period 1 (3 Days)||8
2206856|NCT03136380|5410790|P4|COMPLETED|Part 2, Period 1 (3 Days)||8
2206857|NCT03136380|5410791|P3|COMPLETED|Part 2, Period 1 (3 Days)||0
2206858|NCT03136380|5410792|P2|COMPLETED|Part 2, Period 1 (3 Days)||0
2206859|NCT03136380|5410793|P1|COMPLETED|Part 2, Period 1 (3 Days)||0
2206860|NCT03136380|5410789|P5|STARTED|Part 2, Period 1 (3 Days)||8
2206861|NCT03136380|5410790|P4|STARTED|Part 2, Period 1 (3 Days)||8
2206862|NCT03136380|5410791|P3|STARTED|Part 2, Period 1 (3 Days)||0
2206863|NCT03136380|5410792|P2|STARTED|Part 2, Period 1 (3 Days)||0
2206864|NCT03136380|5410793|P1|STARTED|Part 2, Period 1 (3 Days)||0
2206865|NCT03136380|5410789|P5|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
2206866|NCT03136380|5410790|P4|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
2206867|NCT03136380|5410791|P3|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
2206868|NCT03136380|5410792|P2|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
2206869|NCT03136380|5410793|P1|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
2206870|NCT03136380|5410789|P5|COMPLETED|Part 1, Period 3 (4 Days)||0
2206871|NCT03136380|5410790|P4|COMPLETED|Part 1, Period 3 (4 Days)||0
2206872|NCT03136380|5410791|P3|COMPLETED|Part 1, Period 3 (4 Days)||6
2206873|NCT03136380|5410792|P2|COMPLETED|Part 1, Period 3 (4 Days)||5
2206874|NCT03136380|5410793|P1|COMPLETED|Part 1, Period 3 (4 Days)||6
2206875|NCT03136380|5410789|P5|STARTED|Part 1, Period 3 (4 Days)||0
2206876|NCT03136380|5410790|P4|STARTED|Part 1, Period 3 (4 Days)||0
2206877|NCT03136380|5410791|P3|STARTED|Part 1, Period 3 (4 Days)||6
2206878|NCT03136380|5410792|P2|STARTED|Part 1, Period 3 (4 Days)||5
2206879|NCT03136380|5410793|P1|STARTED|Part 1, Period 3 (4 Days)||6
2206880|NCT03136380|5410789|P5|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2206881|NCT03136380|5410790|P4|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2206882|NCT03136380|5410791|P3|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2206883|NCT03136380|5410792|P2|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||1
2206884|NCT03136380|5410793|P1|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2206885|NCT03136380|5410789|P5|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2206886|NCT03136380|5410790|P4|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2206887|NCT03136380|5410791|P3|COMPLETED|Part 1, Washout Period 2 (7 Days)||6
2206888|NCT03136380|5410792|P2|COMPLETED|Part 1, Washout Period 2 (7 Days)||5
2206889|NCT03136380|5410793|P1|COMPLETED|Part 1, Washout Period 2 (7 Days)||6
2206890|NCT03136380|5410789|P5|STARTED|Part 1, Washout Period 2 (7 Days)||0
2206891|NCT03136380|5410790|P4|STARTED|Part 1, Washout Period 2 (7 Days)||0
2206892|NCT03136380|5410791|P3|STARTED|Part 1, Washout Period 2 (7 Days)||6
2206893|NCT03136380|5410792|P2|STARTED|Part 1, Washout Period 2 (7 Days)||6
2206894|NCT03136380|5410793|P1|STARTED|Part 1, Washout Period 2 (7 Days)||6
2206895|NCT03136380|5410789|P5|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
2206896|NCT03136380|5410790|P4|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
2206897|NCT03136380|5410791|P3|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
2206898|NCT03136380|5410792|P2|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
2206899|NCT03136380|5410793|P1|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
2206900|NCT03136380|5410789|P5|COMPLETED|Part 1, Period 2 (3 Days)||0
2206901|NCT03136380|5410790|P4|COMPLETED|Part 1, Period 2 (3 Days)||0
2206902|NCT03136380|5410791|P3|COMPLETED|Part 1, Period 2 (3 Days)||6
2206903|NCT03136380|5410792|P2|COMPLETED|Part 1, Period 2 (3 Days)||6
2206904|NCT03136380|5410793|P1|COMPLETED|Part 1, Period 2 (3 Days)||6
2206905|NCT03136380|5410789|P5|STARTED|Part 1, Period 2 (3 Days)||0
2206906|NCT03136380|5410790|P4|STARTED|Part 1, Period 2 (3 Days)||0
2206907|NCT03136380|5410791|P3|STARTED|Part 1, Period 2 (3 Days)||6
2206908|NCT03136380|5410792|P2|STARTED|Part 1, Period 2 (3 Days)||6
2206909|NCT03136380|5410793|P1|STARTED|Part 1, Period 2 (3 Days)||6
2206910|NCT03136380|5410789|P5|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2206911|NCT03136380|5410790|P4|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2206912|NCT03136380|5410791|P3|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2206913|NCT03136380|5410792|P2|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2206914|NCT03136380|5410793|P1|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2206915|NCT03136380|5410789|P5|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2206916|NCT03136380|5410790|P4|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2206917|NCT03136380|5410791|P3|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
2206918|NCT03136380|5410792|P2|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
2206919|NCT03136380|5410793|P1|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
2206920|NCT03136380|5410789|P5|STARTED|Part 1, Washout Period 1 (7 Days)||0
2206921|NCT03136380|5410790|P4|STARTED|Part 1, Washout Period 1 (7 Days)||0
2206922|NCT03136380|5410791|P3|STARTED|Part 1, Washout Period 1 (7 Days)||6
2206923|NCT03136380|5410792|P2|STARTED|Part 1, Washout Period 1 (7 Days)||6
2206924|NCT03136380|5410793|P1|STARTED|Part 1, Washout Period 1 (7 Days)||6
2206925|NCT03136380|5410789|P5|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
2206926|NCT03136380|5410790|P4|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
2206927|NCT03136380|5410791|P3|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
2206928|NCT03136380|5410792|P2|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
2206929|NCT03136380|5410793|P1|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
2206930|NCT03136380|5410789|P5|COMPLETED|Part 1, Period 1 (3 Days)||0
2206931|NCT03136380|5410790|P4|COMPLETED|Part 1, Period 1 (3 Days)||0
2206932|NCT03136380|5410791|P3|COMPLETED|Part 1, Period 1 (3 Days)||6
2206933|NCT03136380|5410792|P2|COMPLETED|Part 1, Period 1 (3 Days)||6
2206934|NCT03136380|5410793|P1|COMPLETED|Part 1, Period 1 (3 Days)||6
2206935|NCT03136380|5410789|P5|STARTED|Part 1, Period 1 (3 Days)||0
2206936|NCT03136380|5410790|P4|STARTED|Part 1, Period 1 (3 Days)||0
2206937|NCT03136380|5410791|P3|STARTED|Part 1, Period 1 (3 Days)||6
2206938|NCT03136380|5410792|P2|STARTED|Part 1, Period 1 (3 Days)||6
2206939|NCT03136380|5410793|P1|STARTED|Part 1, Period 1 (3 Days)||6
2206940|NCT03136328|5410966|P1|NOT COMPLETED|Overall Study||0
2206941|NCT03136328|5410966|P1|COMPLETED|Overall Study||11
2206942|NCT03136328|5410966|P1|STARTED|Overall Study||11
2206943|NCT03136107|5410972|P1|NOT COMPLETED|Overall Study||1
2206944|NCT03136107|5410972|P1|COMPLETED|Overall Study||25
2206945|NCT03136107|5410972|P1|Negative Control|Overall Study||26
2206946|NCT03136107|5410972|P1|Reference Product|Overall Study||26
2206947|NCT03136107|5410972|P1|Test Product|Overall Study||26
2206948|NCT03136107|5410972|P1|STARTED|Overall Study||26
2206949|NCT03136068|5410982|P2|NOT COMPLETED|Overall Study||1
2206950|NCT03136068|5410983|P1|NOT COMPLETED|Overall Study||2
2206951|NCT03136068|5410982|P2|COMPLETED|Overall Study||89
2206952|NCT03136068|5410983|P1|COMPLETED|Overall Study||86
2206953|NCT03136068|5410982|P2|STARTED|Overall Study||90
2206954|NCT03136068|5410983|P1|STARTED|Overall Study||88
2206955|NCT03135899|5411005|P8|NOT COMPLETED|Overall Study||0
2206956|NCT03135899|5411006|P7|NOT COMPLETED|Overall Study||1
2206957|NCT03135899|5411007|P6|NOT COMPLETED|Overall Study||2
2206958|NCT03135899|5411008|P5|NOT COMPLETED|Overall Study||0
2206959|NCT03135899|5411009|P4|NOT COMPLETED|Overall Study||0
2206960|NCT03135899|5411010|P3|NOT COMPLETED|Overall Study||0
2206961|NCT03135899|5411011|P2|NOT COMPLETED|Overall Study||0
2206962|NCT03135899|5411012|P1|NOT COMPLETED|Overall Study||0
2206963|NCT03135899|5411005|P8|COMPLETED|Overall Study||8
2206964|NCT03135899|5411006|P7|COMPLETED|Overall Study||7
2206965|NCT03135899|5411007|P6|COMPLETED|Overall Study||7
2206966|NCT03135899|5411008|P5|COMPLETED|Overall Study||8
2206967|NCT03135899|5411009|P4|COMPLETED|Overall Study||1
2206968|NCT03135899|5411010|P3|COMPLETED|Overall Study||1
2206969|NCT03135899|5411011|P2|COMPLETED|Overall Study||1
2206970|NCT03135899|5411012|P1|COMPLETED|Overall Study||1
2206971|NCT03135899|5411005|P8|STARTED|Overall Study||8
2206972|NCT03135899|5411006|P7|STARTED|Overall Study||8
2206973|NCT03135899|5411007|P6|STARTED|Overall Study||9
2206974|NCT03135899|5411008|P5|STARTED|Overall Study||8
2206975|NCT03135899|5411009|P4|STARTED|Overall Study||1
2206976|NCT03135899|5411010|P3|STARTED|Overall Study||1
2206977|NCT03135899|5411011|P2|STARTED|Overall Study||1
2206978|NCT03135899|5411012|P1|STARTED|Overall Study||1
2206979|NCT03135548|5411045|P3|NOT COMPLETED|Overall Study||3
2206980|NCT03135548|5411046|P2|NOT COMPLETED|Overall Study||4
2206981|NCT03135548|5411047|P1|NOT COMPLETED|Overall Study||5
2206982|NCT03135548|5411045|P3|COMPLETED|Overall Study||18
2206983|NCT03135548|5411046|P2|COMPLETED|Overall Study||15
2206984|NCT03135548|5411047|P1|COMPLETED|Overall Study||14
2206985|NCT03135548|5411045|P3|STARTED|Overall Study||21
2206986|NCT03135548|5411046|P2|STARTED|Overall Study||19
2206987|NCT03135548|5411047|P1|STARTED|Overall Study||19
2206988|NCT03135431|5411069|P2|NOT COMPLETED|Overall Study||0
2206989|NCT03135431|5411070|P1|NOT COMPLETED|Overall Study||2
2206990|NCT03135431|5411069|P2|COMPLETED|Overall Study||20
2206991|NCT03135431|5411070|P1|COMPLETED|Overall Study||18
2206992|NCT03135431|5411069|P2|STARTED|Overall Study||20
2206993|NCT03135431|5411070|P1|STARTED|Overall Study||20
2206994|NCT03135379|5411082|P2|NOT COMPLETED|Overall Study||3
2206995|NCT03135379|5411083|P1|NOT COMPLETED|Overall Study||1
2206996|NCT03135379|5411082|P2|COMPLETED|Overall Study||59
2206997|NCT03135379|5411083|P1|COMPLETED|Overall Study||61
2206998|NCT03135379|5411082|P2|STARTED|Overall Study||62
2206999|NCT03135379|5411083|P1|STARTED|Overall Study||62
2207000|NCT03134911|5411093|P1|NOT COMPLETED|Overall Study||34
2207001|NCT03134911|5411093|P1|COMPLETED|Overall Study||501
2207002|NCT03134911|5411093|P1|STARTED|Overall Study||535
2207003|NCT03134599|5411120|P6|NOT COMPLETED|Week 3||1
2207004|NCT03134599|5411121|P5|NOT COMPLETED|Week 3||0
2207005|NCT03134599|5411122|P4|NOT COMPLETED|Week 3||1
2207006|NCT03134599|5411123|P3|NOT COMPLETED|Week 3||0
2207007|NCT03134599|5411124|P2|NOT COMPLETED|Week 3||0
2207008|NCT03134599|5411125|P1|NOT COMPLETED|Week 3||0
2207009|NCT03134599|5411120|P6|COMPLETED|Week 3||8
2207010|NCT03134599|5411121|P5|COMPLETED|Week 3||8
2207011|NCT03134599|5411122|P4|COMPLETED|Week 3||9
2207012|NCT03134599|5411123|P3|COMPLETED|Week 3||10
2207013|NCT03134599|5411124|P2|COMPLETED|Week 3||10
2207014|NCT03134599|5411125|P1|COMPLETED|Week 3||9
2207015|NCT03134599|5411120|P6|STARTED|Week 3||9
2207016|NCT03134599|5411121|P5|STARTED|Week 3||8
2207017|NCT03134599|5411122|P4|STARTED|Week 3||10
2207018|NCT03134599|5411123|P3|STARTED|Week 3||10
2207019|NCT03134599|5411124|P2|STARTED|Week 3||10
2207020|NCT03134599|5411125|P1|STARTED|Week 3||9
2207021|NCT03134599|5411120|P6|NOT COMPLETED|Week 2||0
2207022|NCT03134599|5411121|P5|NOT COMPLETED|Week 2||1
2207023|NCT03134599|5411122|P4|NOT COMPLETED|Week 2||1
2207024|NCT03134599|5411123|P3|NOT COMPLETED|Week 2||0
2207025|NCT03134599|5411124|P2|NOT COMPLETED|Week 2||0
2207026|NCT03134599|5411125|P1|NOT COMPLETED|Week 2||1
2207027|NCT03134599|5411120|P6|COMPLETED|Week 2||9
2207028|NCT03134599|5411121|P5|COMPLETED|Week 2||8
2207029|NCT03134599|5411122|P4|COMPLETED|Week 2||10
2207030|NCT03134599|5411123|P3|COMPLETED|Week 2||10
2207031|NCT03134599|5411124|P2|COMPLETED|Week 2||10
2207032|NCT03134599|5411125|P1|COMPLETED|Week 2||9
2207033|NCT03134599|5411120|P6|STARTED|Week 2||9
2207034|NCT03134599|5411121|P5|STARTED|Week 2||9
2207035|NCT03134599|5411122|P4|STARTED|Week 2||11
2207036|NCT03134599|5411123|P3|STARTED|Week 2||10
2207037|NCT03134599|5411124|P2|STARTED|Week 2||10
2207038|NCT03134599|5411125|P1|STARTED|Week 2||10
2207039|NCT03134599|5411120|P6|NOT COMPLETED|Week 1||0
2207040|NCT03134599|5411121|P5|NOT COMPLETED|Week 1||1
2207041|NCT03134599|5411122|P4|NOT COMPLETED|Week 1||0
2207042|NCT03134599|5411123|P3|NOT COMPLETED|Week 1||0
2207043|NCT03134599|5411124|P2|NOT COMPLETED|Week 1||0
2207044|NCT03134599|5411125|P1|NOT COMPLETED|Week 1||0
2207045|NCT03134599|5411120|P6|COMPLETED|Week 1||9
2207046|NCT03134599|5411121|P5|COMPLETED|Week 1||9
2207047|NCT03134599|5411122|P4|COMPLETED|Week 1||11
2207048|NCT03134599|5411123|P3|COMPLETED|Week 1||10
2207049|NCT03134599|5411124|P2|COMPLETED|Week 1||10
2207050|NCT03134599|5411125|P1|COMPLETED|Week 1||10
2207051|NCT03134599|5411120|P6|STARTED|Week 1||9
2207052|NCT03134599|5411121|P5|STARTED|Week 1||10
2207053|NCT03134599|5411122|P4|STARTED|Week 1||11
2207054|NCT03134599|5411123|P3|STARTED|Week 1||10
2207055|NCT03134599|5411124|P2|STARTED|Week 1||10
2207056|NCT03134599|5411125|P1|STARTED|Week 1||10
2207057|NCT03134326|5411133|P1|NOT COMPLETED|Overall Study||0
2207058|NCT03134326|5411133|P1|COMPLETED|Overall Study||21
2207059|NCT03134326|5411133|P1|STARTED|Overall Study||21
2207060|NCT03134313|5411137|P1|NOT COMPLETED|Overall Study||0
2207061|NCT03134313|5411137|P1|COMPLETED|Overall Study||25
2207062|NCT03134313|5411137|P1|STARTED|Overall Study||25
2207063|NCT03134248|5411141|P6|NOT COMPLETED|Week 3||0
2207064|NCT03134248|5411142|P5|NOT COMPLETED|Week 3||0
2207065|NCT03134248|5411143|P4|NOT COMPLETED|Week 3||0
2207066|NCT03134248|5411144|P3|NOT COMPLETED|Week 3||0
2207067|NCT03134248|5411145|P2|NOT COMPLETED|Week 3||0
2207068|NCT03134248|5411146|P1|NOT COMPLETED|Week 3||0
2207069|NCT03134248|5411141|P6|COMPLETED|Week 3||9
2207070|NCT03134248|5411142|P5|COMPLETED|Week 3||9
2207071|NCT03134248|5411143|P4|COMPLETED|Week 3||7
2207072|NCT03134248|5411144|P3|COMPLETED|Week 3||9
2207073|NCT03134248|5411145|P2|COMPLETED|Week 3||8
2207074|NCT03134248|5411146|P1|COMPLETED|Week 3||7
2207075|NCT03134248|5411141|P6|STARTED|Week 3||9
2207076|NCT03134248|5411142|P5|STARTED|Week 3||9
2207077|NCT03134248|5411143|P4|STARTED|Week 3||7
2207078|NCT03134248|5411144|P3|STARTED|Week 3||9
2207079|NCT03134248|5411145|P2|STARTED|Week 3||8
2207080|NCT03134248|5411146|P1|STARTED|Week 3||7
2207081|NCT03134248|5411141|P6|NOT COMPLETED|Week 2||0
2207082|NCT03134248|5411142|P5|NOT COMPLETED|Week 2||0
2207083|NCT03134248|5411143|P4|NOT COMPLETED|Week 2||0
2207084|NCT03134248|5411144|P3|NOT COMPLETED|Week 2||0
2207085|NCT03134248|5411145|P2|NOT COMPLETED|Week 2||0
2207086|NCT03134248|5411146|P1|NOT COMPLETED|Week 2||0
2207087|NCT03134248|5411141|P6|COMPLETED|Week 2||9
2207088|NCT03134248|5411142|P5|COMPLETED|Week 2||9
2207089|NCT03134248|5411143|P4|COMPLETED|Week 2||7
2207090|NCT03134248|5411144|P3|COMPLETED|Week 2||9
2207091|NCT03134248|5411145|P2|COMPLETED|Week 2||8
2207092|NCT03134248|5411146|P1|COMPLETED|Week 2||7
2207093|NCT03134248|5411141|P6|STARTED|Week 2||9
2207094|NCT03134248|5411142|P5|STARTED|Week 2||9
2207095|NCT03134248|5411143|P4|STARTED|Week 2||7
2207096|NCT03134248|5411144|P3|STARTED|Week 2||9
2207097|NCT03134248|5411145|P2|STARTED|Week 2||8
2207098|NCT03134248|5411146|P1|STARTED|Week 2||7
2207099|NCT03134248|5411141|P6|NOT COMPLETED|Week 1||0
2207100|NCT03134248|5411142|P5|NOT COMPLETED|Week 1||0
2207101|NCT03134248|5411143|P4|NOT COMPLETED|Week 1||0
2207102|NCT03134248|5411144|P3|NOT COMPLETED|Week 1||0
2207103|NCT03134248|5411145|P2|NOT COMPLETED|Week 1||0
2207104|NCT03134248|5411146|P1|NOT COMPLETED|Week 1||0
2207105|NCT03134248|5411141|P6|COMPLETED|Week 1||9
2207106|NCT03134248|5411142|P5|COMPLETED|Week 1||9
2207107|NCT03134248|5411143|P4|COMPLETED|Week 1||7
2207108|NCT03134248|5411144|P3|COMPLETED|Week 1||9
2207109|NCT03134248|5411145|P2|COMPLETED|Week 1||8
2207110|NCT03134248|5411146|P1|COMPLETED|Week 1||7
2207111|NCT03134248|5411141|P6|STARTED|Week 1||9
2207112|NCT03134248|5411142|P5|STARTED|Week 1||9
2207113|NCT03134248|5411143|P4|STARTED|Week 1||7
2207114|NCT03134248|5411144|P3|STARTED|Week 1||9
2207115|NCT03134248|5411145|P2|STARTED|Week 1||8
2207116|NCT03134248|5411146|P1|STARTED|Week 1||7
2207117|NCT03134183|5411164|P2|NOT COMPLETED|Overall Study||1
2207118|NCT03134183|5411165|P1|NOT COMPLETED|Overall Study||1
2207119|NCT03134183|5411164|P2|COMPLETED|Overall Study||33
2207120|NCT03134183|5411165|P1|COMPLETED|Overall Study||35
2207121|NCT03134183|5411164|P2|STARTED|Overall Study||34
2207122|NCT03134183|5411165|P1|STARTED|Overall Study||36
2207123|NCT03133767|5411175|P2|NOT COMPLETED|Overall Study||25
2207124|NCT03133767|5411176|P1|NOT COMPLETED|Overall Study||38
2207125|NCT03133767|5411175|P2|COMPLETED|Overall Study||53
2207126|NCT03133767|5411176|P1|COMPLETED|Overall Study||41
2207127|NCT03133767|5411175|P2|STARTED|Overall Study||78
2207128|NCT03133767|5411176|P1|STARTED|Overall Study||79
2207129|NCT03133481|5411192|P2|NOT COMPLETED|Overall Study||4
2207130|NCT03133481|5411193|P1|NOT COMPLETED|Overall Study||0
2207131|NCT03133481|5411192|P2|COMPLETED|Overall Study||45
2207132|NCT03133481|5411193|P1|COMPLETED|Overall Study||45
2207133|NCT03133481|5411192|P2|STARTED|Overall Study||49
2207134|NCT03133481|5411193|P1|STARTED|Overall Study||45
2207135|NCT03132571|5411223|P2|NOT COMPLETED|Overall Study||0
2207136|NCT03132571|5411224|P1|NOT COMPLETED|Overall Study||0
2207137|NCT03132571|5411223|P2|COMPLETED|Overall Study||2
2207138|NCT03132571|5411224|P1|COMPLETED|Overall Study||3
2207139|NCT03132571|5411223|P2|STARTED|Overall Study||2
2207140|NCT03132571|5411224|P1|STARTED|Overall Study||3
2207141|NCT03132298|5411238|P2|NOT COMPLETED|Overall Study||13
2207142|NCT03132298|5411239|P1|NOT COMPLETED|Overall Study||12
2207143|NCT03132298|5411238|P2|COMPLETED|Overall Study||35
2207144|NCT03132298|5411239|P1|COMPLETED|Overall Study||36
2207145|NCT03132298|5411238|P2|STARTED|Overall Study||48
2207146|NCT03132298|5411239|P1|STARTED|Overall Study||48
2207147|NCT03132220|5411269|P2|NOT COMPLETED|Overall Study||12
2207148|NCT03132220|5411270|P1|NOT COMPLETED|Overall Study||18
2207149|NCT03132220|5411269|P2|COMPLETED|Overall Study||54
2207150|NCT03132220|5411270|P1|COMPLETED|Overall Study||47
2207151|NCT03132220|5411269|P2|Began Study Sessions|Overall Study|66 participants randomized to control arm;8 were lost to f/u prior to study start; 58 began sessions|58
2207152|NCT03132220|5411270|P1|Began Study Sessions|Overall Study|65 participants randomized to intervention arm;17 lost to f/u prior to study start;48 began sessions|48
2207153|NCT03132220|5411269|P2|STARTED|Overall Study||66
2207154|NCT03132220|5411270|P1|STARTED|Overall Study||65
2207155|NCT03131895|5411300|P4|NOT COMPLETED|Intervention Period 2 (2 Days)||0
2207156|NCT03131895|5411301|P3|NOT COMPLETED|Intervention Period 2 (2 Days)||0
2207157|NCT03131895|5411302|P2|NOT COMPLETED|Intervention Period 2 (2 Days)||1
2207158|NCT03131895|5411303|P1|NOT COMPLETED|Intervention Period 2 (2 Days)||1
2207159|NCT03131895|5411300|P4|COMPLETED|Intervention Period 2 (2 Days)||25
2207160|NCT03131895|5411301|P3|COMPLETED|Intervention Period 2 (2 Days)||26
2207161|NCT03131895|5411302|P2|COMPLETED|Intervention Period 2 (2 Days)||22
2207162|NCT03131895|5411303|P1|COMPLETED|Intervention Period 2 (2 Days)||26
2207163|NCT03131895|5411300|P4|STARTED|Intervention Period 2 (2 Days)||25
2207164|NCT03131895|5411301|P3|STARTED|Intervention Period 2 (2 Days)||26
2207165|NCT03131895|5411302|P2|STARTED|Intervention Period 2 (2 Days)||23
2207166|NCT03131895|5411303|P1|STARTED|Intervention Period 2 (2 Days)||27
2207167|NCT03131895|5411300|P4|NOT COMPLETED|Washout Period (at Least 5 Days)||5
2207168|NCT03131895|5411301|P3|NOT COMPLETED|Washout Period (at Least 5 Days)||4
2207169|NCT03131895|5411302|P2|NOT COMPLETED|Washout Period (at Least 5 Days)||5
2207170|NCT03131895|5411303|P1|NOT COMPLETED|Washout Period (at Least 5 Days)||1
2207171|NCT03131895|5411300|P4|COMPLETED|Washout Period (at Least 5 Days)||25
2207172|NCT03131895|5411301|P3|COMPLETED|Washout Period (at Least 5 Days)||26
2207173|NCT03131895|5411302|P2|COMPLETED|Washout Period (at Least 5 Days)||23
2207174|NCT03131895|5411303|P1|COMPLETED|Washout Period (at Least 5 Days)||27
2207175|NCT03131895|5411300|P4|STARTED|Washout Period (at Least 5 Days)||30
2207176|NCT03131895|5411301|P3|STARTED|Washout Period (at Least 5 Days)||30
2207177|NCT03131895|5411302|P2|STARTED|Washout Period (at Least 5 Days)||28
2207178|NCT03131895|5411303|P1|STARTED|Washout Period (at Least 5 Days)||28
2207179|NCT03131895|5411300|P4|NOT COMPLETED|Intervention Period 1 (2 Days)||0
2207180|NCT03131895|5411301|P3|NOT COMPLETED|Intervention Period 1 (2 Days)||0
2207181|NCT03131895|5411302|P2|NOT COMPLETED|Intervention Period 1 (2 Days)||0
2207182|NCT03131895|5411303|P1|NOT COMPLETED|Intervention Period 1 (2 Days)||0
2207183|NCT03131895|5411300|P4|COMPLETED|Intervention Period 1 (2 Days)||30
2207184|NCT03131895|5411301|P3|COMPLETED|Intervention Period 1 (2 Days)||30
2207185|NCT03131895|5411302|P2|COMPLETED|Intervention Period 1 (2 Days)||28
2207186|NCT03131895|5411303|P1|COMPLETED|Intervention Period 1 (2 Days)||28
2207187|NCT03131895|5411300|P4|STARTED|Intervention Period 1 (2 Days)||30
2207188|NCT03131895|5411301|P3|STARTED|Intervention Period 1 (2 Days)||30
2207189|NCT03131895|5411302|P2|STARTED|Intervention Period 1 (2 Days)||28
2207190|NCT03131895|5411303|P1|STARTED|Intervention Period 1 (2 Days)||28
2207191|NCT03131713|5411323|P2|NOT COMPLETED|Overall Study||0
2207192|NCT03131713|5411324|P1|NOT COMPLETED|Overall Study||5
2207193|NCT03131713|5411323|P2|COMPLETED|Overall Study||51
2207194|NCT03131713|5411324|P1|COMPLETED|Overall Study||45
2207195|NCT03131713|5411323|P2|STARTED|Overall Study|1 intervention subject was added on after the protocol was initiated.|51
2207196|NCT03131713|5411324|P1|STARTED|Overall Study||50
2207197|NCT03131687|5411348|P6|NOT COMPLETED|Overall Study||5
2207198|NCT03131687|5411349|P5|NOT COMPLETED|Overall Study||8
2207199|NCT03131687|5411350|P4|NOT COMPLETED|Overall Study||4
2207200|NCT03131687|5411351|P3|NOT COMPLETED|Overall Study||3
2207201|NCT03131687|5411352|P2|NOT COMPLETED|Overall Study||9
2207202|NCT03131687|5411353|P1|NOT COMPLETED|Overall Study||6
2207203|NCT03131687|5411348|P6|COMPLETED|Overall Study||49
2207204|NCT03131687|5411349|P5|COMPLETED|Overall Study||45
2207205|NCT03131687|5411350|P4|COMPLETED|Overall Study||48
2207206|NCT03131687|5411351|P3|COMPLETED|Overall Study||52
2207207|NCT03131687|5411352|P2|COMPLETED|Overall Study||44
2207208|NCT03131687|5411353|P1|COMPLETED|Overall Study||45
2207209|NCT03131687|5411348|P6|Received at Least One Dose of Study Drug|Overall Study||54
2207210|NCT03131687|5411349|P5|Received at Least One Dose of Study Drug|Overall Study||53
2207211|NCT03131687|5411350|P4|Received at Least One Dose of Study Drug|Overall Study||51
2207212|NCT03131687|5411351|P3|Received at Least One Dose of Study Drug|Overall Study||55
2207213|NCT03131687|5411352|P2|Received at Least One Dose of Study Drug|Overall Study||52
2207214|NCT03131687|5411353|P1|Received at Least One Dose of Study Drug|Overall Study||51
2207215|NCT03131687|5411348|P6|STARTED|Overall Study||54
2207216|NCT03131687|5411349|P5|STARTED|Overall Study||53
2207217|NCT03131687|5411350|P4|STARTED|Overall Study||52
2207218|NCT03131687|5411351|P3|STARTED|Overall Study||55
2207219|NCT03131687|5411352|P2|STARTED|Overall Study||53
2207220|NCT03131687|5411353|P1|STARTED|Overall Study||51
2207221|NCT03131596|5411463|P2|NOT COMPLETED|Overall Study||3
2207222|NCT03131596|5411464|P1|NOT COMPLETED|Overall Study||6
2207223|NCT03131596|5411463|P2|COMPLETED|Overall Study||97
2207224|NCT03131596|5411464|P1|COMPLETED|Overall Study||94
2207225|NCT03131596|5411463|P2|STARTED|Overall Study||100
2207226|NCT03131596|5411464|P1|STARTED|Overall Study||100
2207227|NCT03131479|5411481|P5|NOT COMPLETED|Overall Study||0
2207228|NCT03131479|5411482|P4|NOT COMPLETED|Overall Study||2
2207229|NCT03131479|5411483|P3|NOT COMPLETED|Overall Study||1
2207230|NCT03131479|5411484|P2|NOT COMPLETED|Overall Study||0
2207231|NCT03131479|5411485|P1|NOT COMPLETED|Overall Study||0
2207232|NCT03131479|5411481|P5|COMPLETED|Overall Study||10
2207233|NCT03131479|5411482|P4|COMPLETED|Overall Study||10
2207234|NCT03131479|5411483|P3|COMPLETED|Overall Study||10
2207235|NCT03131479|5411484|P2|COMPLETED|Overall Study||10
2207236|NCT03131479|5411485|P1|COMPLETED|Overall Study||10
2207237|NCT03131479|5411481|P5|Pharcodynamic Analysis Set (PD)|Overall Study||10
2207238|NCT03131479|5411482|P4|Pharcodynamic Analysis Set (PD)|Overall Study||12
2207239|NCT03131479|5411483|P3|Pharcodynamic Analysis Set (PD)|Overall Study||11
2207240|NCT03131479|5411484|P2|Pharcodynamic Analysis Set (PD)|Overall Study||10
2207241|NCT03131479|5411485|P1|Pharcodynamic Analysis Set (PD)|Overall Study||10
2207242|NCT03131479|5411481|P5|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
2207243|NCT03131479|5411482|P4|Pharmacokinetic Analysis Set (PAS)|Overall Study||12
2207244|NCT03131479|5411483|P3|Pharmacokinetic Analysis Set (PAS)|Overall Study||11
2207245|NCT03131479|5411484|P2|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
2207246|NCT03131479|5411485|P1|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
2207247|NCT03131479|5411481|P5|Safety Analysis Set (SS)|Overall Study||10
2207248|NCT03131479|5411482|P4|Safety Analysis Set (SS)|Overall Study||12
2207249|NCT03131479|5411483|P3|Safety Analysis Set (SS)|Overall Study||11
2207250|NCT03131479|5411484|P2|Safety Analysis Set (SS)|Overall Study||10
2207251|NCT03131479|5411485|P1|Safety Analysis Set (SS)|Overall Study||10
2207252|NCT03131479|5411481|P5|STARTED|Overall Study||10
2207253|NCT03131479|5411482|P4|STARTED|Overall Study||12
2207254|NCT03131479|5411483|P3|STARTED|Overall Study||11
2207255|NCT03131479|5411484|P2|STARTED|Overall Study||10
2207256|NCT03131479|5411485|P1|STARTED|Overall Study||10
2207257|NCT03131206|5411546|P4|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
2207258|NCT03131206|5411547|P3|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
2207259|NCT03131206|5411548|P2|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
2207260|NCT03131206|5411549|P1|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
2207261|NCT03131206|5411546|P4|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
2207262|NCT03131206|5411547|P3|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
2207263|NCT03131206|5411548|P2|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
2207264|NCT03131206|5411549|P1|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
2207265|NCT03131206|5411546|P4|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
2207266|NCT03131206|5411547|P3|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
2207267|NCT03131206|5411548|P2|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
2207268|NCT03131206|5411549|P1|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
2207269|NCT03131206|5411546|P4|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
2207270|NCT03131206|5411547|P3|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
2207271|NCT03131206|5411548|P2|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
2207272|NCT03131206|5411549|P1|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
2207273|NCT03131206|5411546|P4|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
2207274|NCT03131206|5411547|P3|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
2207275|NCT03131206|5411548|P2|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
2207276|NCT03131206|5411549|P1|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||5
2207277|NCT03131206|5411546|P4|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
2207278|NCT03131206|5411547|P3|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
2207279|NCT03131206|5411548|P2|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
2207280|NCT03131206|5411549|P1|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||5
2207281|NCT03131167|5411580|P13|NOT COMPLETED|Overall Study||0
2207282|NCT03131167|5411581|P12|NOT COMPLETED|Overall Study||0
2207283|NCT03131167|5411582|P11|NOT COMPLETED|Overall Study||0
2207284|NCT03131167|5411583|P10|NOT COMPLETED|Overall Study||0
2207285|NCT03131167|5411584|P9|NOT COMPLETED|Overall Study||0
2207286|NCT03131167|5411585|P8|NOT COMPLETED|Overall Study||0
2207287|NCT03131167|5411586|P7|NOT COMPLETED|Overall Study||0
2207288|NCT03131167|5411587|P6|NOT COMPLETED|Overall Study||1
2207289|NCT03131167|5411588|P5|NOT COMPLETED|Overall Study||0
2207290|NCT03131167|5411589|P4|NOT COMPLETED|Overall Study||0
2207291|NCT03131167|5411590|P3|NOT COMPLETED|Overall Study||0
2207292|NCT03131167|5411591|P2|NOT COMPLETED|Overall Study||0
2207293|NCT03131167|5411592|P1|NOT COMPLETED|Overall Study||0
2207294|NCT03131167|5411580|P13|COMPLETED|Overall Study||5
2207295|NCT03131167|5411581|P12|COMPLETED|Overall Study||5
2207296|NCT03131167|5411582|P11|COMPLETED|Overall Study||4
2207297|NCT03131167|5411583|P10|COMPLETED|Overall Study||5
2207298|NCT03131167|5411584|P9|COMPLETED|Overall Study||2
2207299|NCT03131167|5411585|P8|COMPLETED|Overall Study||5
2207300|NCT03131167|5411586|P7|COMPLETED|Overall Study||5
2207301|NCT03131167|5411587|P6|COMPLETED|Overall Study||4
2207302|NCT03131167|5411588|P5|COMPLETED|Overall Study||6
2207303|NCT03131167|5411589|P4|COMPLETED|Overall Study||5
2207304|NCT03131167|5411590|P3|COMPLETED|Overall Study||5
2207305|NCT03131167|5411591|P2|COMPLETED|Overall Study||5
2207306|NCT03131167|5411592|P1|COMPLETED|Overall Study||6
2207307|NCT03131167|5411580|P13|STARTED|Overall Study||5
2207308|NCT03131167|5411581|P12|STARTED|Overall Study||5
2207309|NCT03131167|5411582|P11|STARTED|Overall Study||4
2207310|NCT03131167|5411583|P10|STARTED|Overall Study||5
2207311|NCT03131167|5411584|P9|STARTED|Overall Study||2
2207312|NCT03131167|5411585|P8|STARTED|Overall Study||5
2207313|NCT03131167|5411586|P7|STARTED|Overall Study||5
2207314|NCT03131167|5411587|P6|STARTED|Overall Study||5
2207315|NCT03131167|5411588|P5|STARTED|Overall Study||6
2207316|NCT03131167|5411589|P4|STARTED|Overall Study||5
2207317|NCT03131167|5411590|P3|STARTED|Overall Study||5
2207318|NCT03131167|5411591|P2|STARTED|Overall Study||5
2207319|NCT03131167|5411592|P1|STARTED|Overall Study||6
2207320|NCT03129321|5411636|P3|NOT COMPLETED|Overall Study||55
2207321|NCT03129321|5411637|P2|NOT COMPLETED|Overall Study||109
2207322|NCT03129321|5411638|P1|NOT COMPLETED|Overall Study||98
2207323|NCT03129321|5411636|P3|COMPLETED|Overall Study||120
2207324|NCT03129321|5411637|P2|COMPLETED|Overall Study||241
2207325|NCT03129321|5411638|P1|COMPLETED|Overall Study||253
2207326|NCT03129321|5411636|P3|STARTED|Overall Study||175
2207327|NCT03129321|5411637|P2|STARTED|Overall Study||350
2207328|NCT03129321|5411638|P1|STARTED|Overall Study||351
2207329|NCT03129178|5411660|P2|NOT COMPLETED|Overall Study||2
2207330|NCT03129178|5411661|P1|NOT COMPLETED|Overall Study||1
2207331|NCT03129178|5411660|P2|COMPLETED|Overall Study||11
2207332|NCT03129178|5411661|P1|COMPLETED|Overall Study||12
2207333|NCT03129178|5411660|P2|STARTED|Overall Study||13
2207334|NCT03129178|5411661|P1|STARTED|Overall Study||13
2207335|NCT03128723|5411679|P1|NOT COMPLETED|Overall Study||2
2207336|NCT03128723|5411679|P1|COMPLETED|Overall Study||43
2207337|NCT03128723|5411679|P1|STARTED|Overall Study||45
2207338|NCT03128372|5411694|P1|NOT COMPLETED|Overall Study||0
2207339|NCT03128372|5411694|P1|COMPLETED|Overall Study||32
2207340|NCT03128372|5411694|P1|STARTED|Overall Study||32
2207341|NCT03128307|5411698|P1|NOT COMPLETED|Overall Study||34
2207342|NCT03128307|5411698|P1|COMPLETED|Overall Study||570
2207343|NCT03128307|5411698|P1|STARTED|Overall Study||604
2207347|NCT03127956|5411708|P1|NOT COMPLETED|Overall Study||317
2207348|NCT03127956|5411708|P1|COMPLETED|Overall Study||431
2207349|NCT03127956|5411708|P1|STARTED|Overall Study||748
2207350|NCT03127943|5411712|P2|NOT COMPLETED|Second Intervention||0
2207351|NCT03127943|5411713|P1|NOT COMPLETED|Second Intervention||0
2207352|NCT03127943|5411712|P2|COMPLETED|Second Intervention||12
2207353|NCT03127943|5411713|P1|COMPLETED|Second Intervention||12
2207354|NCT03127943|5411712|P2|STARTED|Second Intervention||12
2207355|NCT03127943|5411713|P1|STARTED|Second Intervention||12
2207356|NCT03127943|5411712|P2|NOT COMPLETED|Washout (1 Week)||0
2207357|NCT03127943|5411713|P1|NOT COMPLETED|Washout (1 Week)||0
2207358|NCT03127943|5411712|P2|COMPLETED|Washout (1 Week)||12
2207359|NCT03127943|5411713|P1|COMPLETED|Washout (1 Week)||12
2207360|NCT03127943|5411712|P2|STARTED|Washout (1 Week)||12
2207361|NCT03127943|5411713|P1|STARTED|Washout (1 Week)||12
2207362|NCT03127943|5411712|P2|NOT COMPLETED|First Intervention||0
2207363|NCT03127943|5411713|P1|NOT COMPLETED|First Intervention||0
2207364|NCT03127943|5411712|P2|COMPLETED|First Intervention||12
2207365|NCT03127943|5411713|P1|COMPLETED|First Intervention||12
2207366|NCT03127943|5411712|P2|STARTED|First Intervention||12
2207367|NCT03127943|5411713|P1|STARTED|First Intervention||12
2207368|NCT03127644|5411724|P3|NOT COMPLETED|Overall Study||2
2207369|NCT03127644|5411725|P2|NOT COMPLETED|Overall Study||0
2207370|NCT03127644|5411726|P1|NOT COMPLETED|Overall Study||0
2207371|NCT03127644|5411724|P3|COMPLETED|Overall Study||31
2207372|NCT03127644|5411725|P2|COMPLETED|Overall Study||36
2207373|NCT03127644|5411726|P1|COMPLETED|Overall Study||34
2207374|NCT03127644|5411724|P3|STARTED|Overall Study||33
2207375|NCT03127644|5411725|P2|STARTED|Overall Study||36
2207376|NCT03127644|5411726|P1|STARTED|Overall Study||34
2207377|NCT03127384|5411758|P1|NOT COMPLETED|Overall Study||6
2207378|NCT03127384|5411758|P1|COMPLETED|Overall Study||43
2207379|NCT03127384|5411758|P1|Completed 3 Month Visit|Overall Study||47
2207380|NCT03127384|5411758|P1|STARTED|Overall Study||49
2207381|NCT03127228|5411766|P2|NOT COMPLETED|Overall Study||0
2207382|NCT03127228|5411767|P1|NOT COMPLETED|Overall Study||0
2207383|NCT03127228|5411766|P2|COMPLETED|Overall Study||12
2207384|NCT03127228|5411767|P1|COMPLETED|Overall Study||12
2207385|NCT03127228|5411766|P2|STARTED|Overall Study||12
2207386|NCT03127228|5411767|P1|STARTED|Overall Study||12
2207387|NCT03126682|5411781|P2|NOT COMPLETED|Overall Study||0
2207388|NCT03126682|5411782|P1|NOT COMPLETED|Overall Study||0
2207389|NCT03126682|5411781|P2|COMPLETED|Overall Study||5
2207390|NCT03126682|5411782|P1|COMPLETED|Overall Study||5
2207391|NCT03126682|5411781|P2|STARTED|Overall Study||5
2207392|NCT03126682|5411782|P1|STARTED|Overall Study||5
2207408|NCT03125941|5411813|P2|NOT COMPLETED|Overall Study||2
2207409|NCT03125941|5411814|P1|NOT COMPLETED|Overall Study||1
2207410|NCT03125941|5411813|P2|COMPLETED|Overall Study||63
2207411|NCT03125941|5411814|P1|COMPLETED|Overall Study||64
2207412|NCT03125941|5411813|P2|Post-randomization Exclusion|Overall Study|procedure changed, did not receive intervention|2
2207413|NCT03125941|5411814|P1|Post-randomization Exclusion|Overall Study|procedure changed, did not receive intervention|1
2207414|NCT03125941|5411813|P2|STARTED|Overall Study||65
2207415|NCT03125941|5411814|P1|STARTED|Overall Study||65
2207416|NCT03125200|5411853|P7|NOT COMPLETED|Overall Study||3
2207417|NCT03125200|5411854|P6|NOT COMPLETED|Overall Study||3
2207418|NCT03125200|5411855|P5|NOT COMPLETED|Overall Study||4
2207419|NCT03125200|5411856|P4|NOT COMPLETED|Overall Study||5
2207420|NCT03125200|5411857|P3|NOT COMPLETED|Overall Study||2
2207421|NCT03125200|5411858|P2|NOT COMPLETED|Overall Study||2
2207422|NCT03125200|5411859|P1|NOT COMPLETED|Overall Study||2
2207423|NCT03125200|5411853|P7|COMPLETED|Overall Study||0
2207424|NCT03125200|5411854|P6|COMPLETED|Overall Study||0
2207425|NCT03125200|5411855|P5|COMPLETED|Overall Study||0
2207426|NCT03125200|5411856|P4|COMPLETED|Overall Study||0
2207427|NCT03125200|5411857|P3|COMPLETED|Overall Study||0
2207428|NCT03125200|5411858|P2|COMPLETED|Overall Study||0
2207429|NCT03125200|5411859|P1|COMPLETED|Overall Study||0
2207430|NCT03125200|5411853|P7|STARTED|Overall Study||3
2207431|NCT03125200|5411854|P6|STARTED|Overall Study||3
2207432|NCT03125200|5411855|P5|STARTED|Overall Study||4
2207433|NCT03125200|5411856|P4|STARTED|Overall Study||5
2207434|NCT03125200|5411857|P3|STARTED|Overall Study||2
2207435|NCT03125200|5411858|P2|STARTED|Overall Study||2
2207436|NCT03125200|5411859|P1|STARTED|Overall Study||2
2207437|NCT03125031|5412057|P2|NOT COMPLETED|Overall Study||0
2207438|NCT03125031|5412058|P1|NOT COMPLETED|Overall Study||0
2207439|NCT03125031|5412057|P2|COMPLETED|Overall Study||44
2207440|NCT03125031|5412058|P1|COMPLETED|Overall Study||44
2207441|NCT03125031|5412057|P2|STARTED|Overall Study||44
2207442|NCT03125031|5412058|P1|STARTED|Overall Study||44
2207443|NCT03125018|5412063|P1|NOT COMPLETED|Overall Study||0
2207444|NCT03125018|5412063|P1|COMPLETED|Overall Study||13
2207445|NCT03125018|5412063|P1|STARTED|Overall Study||13
2207446|NCT03125005|5412067|P1|NOT COMPLETED|Overall Study||0
2207447|NCT03125005|5412067|P1|COMPLETED|Overall Study||51
2207448|NCT03125005|5412067|P1|STARTED|Overall Study||51
2207449|NCT03124979|5412071|P1|NOT COMPLETED|Overall Study||0
2207450|NCT03124979|5412071|P1|COMPLETED|Overall Study||13
2207451|NCT03124979|5412071|P1|STARTED|Overall Study||13
2207452|NCT03124966|5412075|P1|NOT COMPLETED|Overall Study||0
2207453|NCT03124966|5412075|P1|COMPLETED|Overall Study||118
2207454|NCT03124966|5412075|P1|STARTED|Overall Study||118
2207455|NCT03124927|5412079|P1|NOT COMPLETED|Overall Study||0
2207456|NCT03124927|5412079|P1|COMPLETED|Overall Study||25
2207457|NCT03124927|5412079|P1|STARTED|Overall Study||25
2207458|NCT03124901|5412083|P1|NOT COMPLETED|Overall Study||0
2207459|NCT03124901|5412083|P1|COMPLETED|Overall Study||147
2207460|NCT03124901|5412083|P1|STARTED|Overall Study||147
2207461|NCT03124836|5412087|P1|NOT COMPLETED|Overall Study||0
2207462|NCT03124836|5412087|P1|COMPLETED|Overall Study||28
2207463|NCT03124836|5412087|P1|STARTED|Overall Study||28
2207464|NCT03124823|5412091|P1|NOT COMPLETED|Overall Study||0
2207465|NCT03124823|5412091|P1|COMPLETED|Overall Study||11
2207466|NCT03124823|5412091|P1|STARTED|Overall Study||11
2207467|NCT03124797|5412095|P1|NOT COMPLETED|Overall Study||0
2207468|NCT03124797|5412095|P1|COMPLETED|Overall Study||18
2207469|NCT03124797|5412095|P1|STARTED|Overall Study||18
2207470|NCT03124784|5412099|P1|NOT COMPLETED|Overall Study||2
2207471|NCT03124784|5412099|P1|COMPLETED|Overall Study||25
2207472|NCT03124784|5412099|P1|STARTED|Overall Study||27
2207473|NCT03124771|5412103|P1|NOT COMPLETED|Overall Study||0
2207474|NCT03124771|5412103|P1|COMPLETED|Overall Study||132
2207475|NCT03124771|5412103|P1|STARTED|Overall Study||132
2207476|NCT03124758|5412107|P1|NOT COMPLETED|Overall Study||0
2207477|NCT03124758|5412107|P1|COMPLETED|Overall Study||354
2207478|NCT03124758|5412107|P1|STARTED|Overall Study||354
2207479|NCT03124693|5412111|P1|NOT COMPLETED|Overall Study||0
2207480|NCT03124693|5412111|P1|COMPLETED|Overall Study||90
2207481|NCT03124693|5412111|P1|STARTED|Overall Study||90
2207482|NCT03124602|5412115|P1|NOT COMPLETED|Overall Study||10
2207483|NCT03124602|5412115|P1|COMPLETED|Overall Study||25
2207484|NCT03124602|5412115|P1|STARTED|Overall Study||35
2207485|NCT03124563|5412121|P2|NOT COMPLETED|Overall Study||2
2207486|NCT03124563|5412122|P1|NOT COMPLETED|Overall Study||2
2207487|NCT03124563|5412121|P2|COMPLETED|Overall Study||29
2207488|NCT03124563|5412122|P1|COMPLETED|Overall Study||30
2207489|NCT03124563|5412121|P2|Pre-test|Overall Study||30
2207490|NCT03124563|5412122|P1|Pre-test|Overall Study||30
2207491|NCT03124563|5412121|P2|STARTED|Overall Study||31
2207492|NCT03124563|5412122|P1|STARTED|Overall Study||32
2207493|NCT03124381|5412140|P2|NOT COMPLETED|Overall Study||6
2207494|NCT03124381|5412141|P1|NOT COMPLETED|Overall Study||9
2207495|NCT03124381|5412140|P2|COMPLETED|Overall Study||55
2207496|NCT03124381|5412141|P1|COMPLETED|Overall Study||56
2207497|NCT03124381|5412140|P2|STARTED|Overall Study||61
2207498|NCT03124381|5412141|P1|STARTED|Overall Study||65
2207499|NCT03124342|5412233|P2|NOT COMPLETED|Overall Study||0
2207500|NCT03124342|5412234|P1|NOT COMPLETED|Overall Study||0
2207501|NCT03124342|5412233|P2|COMPLETED|Overall Study||121
2207502|NCT03124342|5412234|P1|COMPLETED|Overall Study||111
2207503|NCT03124342|5412233|P2|STARTED|Overall Study||121
2207504|NCT03124342|5412234|P1|STARTED|Overall Study||111
2207505|NCT03124199|5412248|P1|NOT COMPLETED|Overall Study||4
2207506|NCT03124199|5412248|P1|COMPLETED|Overall Study||36
2207507|NCT03124199|5412248|P1|STARTED|Overall Study||40
2207508|NCT03124108|5412257|P3|NOT COMPLETED|Overall Study||0
2207509|NCT03124108|5412258|P2|NOT COMPLETED|Overall Study||1
2207510|NCT03124108|5412259|P1|NOT COMPLETED|Overall Study||0
2207511|NCT03124108|5412257|P3|COMPLETED|Overall Study||15
2207512|NCT03124108|5412258|P2|COMPLETED|Overall Study||14
2207513|NCT03124108|5412259|P1|COMPLETED|Overall Study||15
2207514|NCT03124108|5412257|P3|STARTED|Overall Study||15
2207515|NCT03124108|5412258|P2|STARTED|Overall Study||15
2207516|NCT03124108|5412259|P1|STARTED|Overall Study||15
2207517|NCT03123874|5412392|P2|NOT COMPLETED|Overall Study||0
2207518|NCT03123874|5412393|P1|NOT COMPLETED|Overall Study||0
2207519|NCT03123874|5412392|P2|COMPLETED|Overall Study||25
2207520|NCT03123874|5412393|P1|COMPLETED|Overall Study||27
2207521|NCT03123874|5412392|P2|STARTED|Overall Study||25
2207522|NCT03123874|5412393|P1|STARTED|Overall Study||27
2207523|NCT03123848|5412403|P1|NOT COMPLETED|Overall Study||0
2207524|NCT03123848|5412403|P1|COMPLETED|Overall Study||8
2207525|NCT03123848|5412403|P1|STARTED|Overall Study||8
2207526|NCT03123471|5412427|P2|NOT COMPLETED|Apremilast Extension Phase||25
2207527|NCT03123471|5412428|P1|NOT COMPLETED|Apremilast Extension Phase||8
2207528|NCT03123471|5412427|P2|COMPLETED|Apremilast Extension Phase||140
2207529|NCT03123471|5412428|P1|COMPLETED|Apremilast Extension Phase||76
2207530|NCT03123471|5412427|P2|Received at Least 1 Dose of Study Drug|Apremilast Extension Phase||163
2207531|NCT03123471|5412428|P1|Received at Least 1 Dose of Study Drug|Apremilast Extension Phase||84
2207532|NCT03123471|5412427|P2|STARTED|Apremilast Extension Phase|3 participants completed the first phase; did not enter in extension phase|165
2207533|NCT03123471|5412428|P1|STARTED|Apremilast Extension Phase||84
2207534|NCT03123471|5412427|P2|NOT COMPLETED|Placebo-controlled Phase||33
2207535|NCT03123471|5412428|P1|NOT COMPLETED|Placebo-controlled Phase||18
2207536|NCT03123471|5412427|P2|COMPLETED|Placebo-controlled Phase||168
2207537|NCT03123471|5412428|P1|COMPLETED|Placebo-controlled Phase||84
2207538|NCT03123471|5412427|P2|Received at Least 1 Dose of Study Drug|Placebo-controlled Phase||200
2207539|NCT03123471|5412428|P1|Received at Least 1 Dose of Study Drug|Placebo-controlled Phase||102
2207540|NCT03123471|5412427|P2|STARTED|Placebo-controlled Phase||201
2207541|NCT03123471|5412428|P1|STARTED|Placebo-controlled Phase||102
2207542|NCT03123354|5412453|P1|NOT COMPLETED|Overall Study||6
2207543|NCT03123354|5412453|P1|COMPLETED|Overall Study||38
2207544|NCT03123354|5412453|P1|STARTED|Overall Study||44
2207545|NCT03123263|5412457|P1|NOT COMPLETED|Overall Study||0
2207546|NCT03123263|5412457|P1|COMPLETED|Overall Study||60
2207547|NCT03123263|5412457|P1|STARTED|Overall Study||60
2207548|NCT03122548|5412464|P1|NOT COMPLETED|Overall Study||5
2207549|NCT03122548|5412464|P1|COMPLETED|Overall Study||0
2207550|NCT03122548|5412464|P1|STARTED|Overall Study||5
2207551|NCT03122184|5412474|P2|NOT COMPLETED|Overall Study||6
2207552|NCT03122184|5412475|P1|NOT COMPLETED|Overall Study||8
2207553|NCT03122184|5412474|P2|COMPLETED|Overall Study||17
2207554|NCT03122184|5412475|P1|COMPLETED|Overall Study||16
2207555|NCT03122184|5412474|P2|STARTED|Overall Study||23
2207556|NCT03122184|5412475|P1|STARTED|Overall Study||24
2207557|NCT03121950|5412514|P2|NOT COMPLETED|Overall Study||2
2207558|NCT03121950|5412515|P1|NOT COMPLETED|Overall Study||10
2207559|NCT03121950|5412514|P2|COMPLETED|Overall Study||1
2207560|NCT03121950|5412515|P1|COMPLETED|Overall Study||7
2207561|NCT03121950|5412514|P2|STARTED|Overall Study||3
2207562|NCT03121950|5412515|P1|STARTED|Overall Study||17
2207563|NCT03121820|5412527|P2|NOT COMPLETED|Second Period (After Washout)||0
2207564|NCT03121820|5412528|P1|NOT COMPLETED|Second Period (After Washout)||0
2207565|NCT03121820|5412527|P2|COMPLETED|Second Period (After Washout)||9
2207566|NCT03121820|5412528|P1|COMPLETED|Second Period (After Washout)||9
2207567|NCT03121820|5412527|P2|STARTED|Second Period (After Washout)||9
2207568|NCT03121820|5412528|P1|STARTED|Second Period (After Washout)||9
2207569|NCT03121820|5412527|P2|NOT COMPLETED|First Period||0
2207570|NCT03121820|5412528|P1|NOT COMPLETED|First Period||0
2207571|NCT03121820|5412527|P2|COMPLETED|First Period||9
2207572|NCT03121820|5412528|P1|COMPLETED|First Period||9
2207573|NCT03121820|5412527|P2|STARTED|First Period||9
2207574|NCT03121820|5412528|P1|STARTED|First Period||9
2207575|NCT03121612|5412538|P2|NOT COMPLETED|Overall Study||0
2207576|NCT03121612|5412539|P1|NOT COMPLETED|Overall Study||0
2207577|NCT03121612|5412538|P2|COMPLETED|Overall Study||25
2207578|NCT03121612|5412539|P1|COMPLETED|Overall Study||26
2207579|NCT03121612|5412538|P2|STARTED|Overall Study||25
2207580|NCT03121612|5412539|P1|STARTED|Overall Study||26
2207581|NCT03121365|5412583|P2|NOT COMPLETED|12 Months||8
2207582|NCT03121365|5412584|P1|NOT COMPLETED|12 Months||11
2207583|NCT03121365|5412583|P2|COMPLETED|12 Months||37
2207584|NCT03121365|5412584|P1|COMPLETED|12 Months||43
2207585|NCT03121365|5412583|P2|STARTED|12 Months||45
2207586|NCT03121365|5412584|P1|STARTED|12 Months||54
2207587|NCT03121365|5412583|P2|NOT COMPLETED|9 Months||1
2207588|NCT03121365|5412584|P1|NOT COMPLETED|9 Months||3
2207589|NCT03121365|5412583|P2|COMPLETED|9 Months||44
2207590|NCT03121365|5412584|P1|COMPLETED|9 Months||52
2207591|NCT03121365|5412583|P2|STARTED|9 Months||45
2207592|NCT03121365|5412584|P1|STARTED|9 Months||55
2207593|NCT03121365|5412583|P2|NOT COMPLETED|6 Months||1
2207594|NCT03121365|5412584|P1|NOT COMPLETED|6 Months||2
2207595|NCT03121365|5412583|P2|COMPLETED|6 Months||45
2207596|NCT03121365|5412584|P1|COMPLETED|6 Months||53
2207597|NCT03121365|5412583|P2|STARTED|6 Months||46
2207598|NCT03121365|5412584|P1|STARTED|6 Months||55
2207599|NCT03121365|5412583|P2|NOT COMPLETED|Baseline||1
2207600|NCT03121365|5412584|P1|NOT COMPLETED|Baseline||0
2207601|NCT03121365|5412583|P2|COMPLETED|Baseline||48
2207602|NCT03121365|5412584|P1|COMPLETED|Baseline||55
2207603|NCT03121365|5412583|P2|STARTED|Baseline||49
2207604|NCT03121365|5412584|P1|STARTED|Baseline||55
2207605|NCT03120676|5412592|P1|NOT COMPLETED|Overall Study||1
2207606|NCT03120676|5412592|P1|COMPLETED|Overall Study||2
2207607|NCT03120676|5412592|P1|STARTED|Overall Study||3
2207608|NCT03120520|5412600|P4|NOT COMPLETED|Overall Study||3
2207609|NCT03120520|5412601|P3|NOT COMPLETED|Overall Study||4
2207610|NCT03120520|5412602|P2|NOT COMPLETED|Overall Study||4
2207611|NCT03120520|5412603|P1|NOT COMPLETED|Overall Study||4
2207612|NCT03120520|5412600|P4|COMPLETED|Overall Study||29
2207613|NCT03120520|5412601|P3|COMPLETED|Overall Study||26
2207614|NCT03120520|5412602|P2|COMPLETED|Overall Study||27
2207615|NCT03120520|5412603|P1|COMPLETED|Overall Study||27
2207616|NCT03120520|5412600|P4|STARTED|Overall Study||32
2207617|NCT03120520|5412601|P3|STARTED|Overall Study||30
2207618|NCT03120520|5412602|P2|STARTED|Overall Study||31
2207619|NCT03120520|5412603|P1|STARTED|Overall Study||31
2207620|NCT03120013|5412625|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
2207621|NCT03120013|5412626|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
2207622|NCT03120013|5412625|P2|COMPLETED|Second Intervention (2 Weeks)||10
2207623|NCT03120013|5412626|P1|COMPLETED|Second Intervention (2 Weeks)||10
2207624|NCT03120013|5412625|P2|STARTED|Second Intervention (2 Weeks)||10
2207625|NCT03120013|5412626|P1|STARTED|Second Intervention (2 Weeks)||10
2207626|NCT03120013|5412625|P2|NOT COMPLETED|Washout (6 Months)||0
2207627|NCT03120013|5412626|P1|NOT COMPLETED|Washout (6 Months)||0
2207628|NCT03120013|5412625|P2|COMPLETED|Washout (6 Months)||10
2207629|NCT03120013|5412626|P1|COMPLETED|Washout (6 Months)||10
2207630|NCT03120013|5412625|P2|STARTED|Washout (6 Months)||10
2207631|NCT03120013|5412626|P1|STARTED|Washout (6 Months)||10
2207632|NCT03120013|5412625|P2|NOT COMPLETED|First Intervention (2 Weeks)||1
2207633|NCT03120013|5412626|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
2207634|NCT03120013|5412625|P2|COMPLETED|First Intervention (2 Weeks)||10
2207635|NCT03120013|5412626|P1|COMPLETED|First Intervention (2 Weeks)||10
2207636|NCT03120013|5412625|P2|Received Intervention|First Intervention (2 Weeks)||11
2207637|NCT03120013|5412626|P1|Received Intervention|First Intervention (2 Weeks)||10
2207638|NCT03120013|5412625|P2|STARTED|First Intervention (2 Weeks)||11
2207639|NCT03120013|5412626|P1|STARTED|First Intervention (2 Weeks)||10
2207640|NCT03119831|5412649|P3|NOT COMPLETED|Overall Study||0
2207641|NCT03119831|5412650|P2|NOT COMPLETED|Overall Study||0
2207642|NCT03119831|5412651|P1|NOT COMPLETED|Overall Study||0
2207643|NCT03119831|5412649|P3|COMPLETED|Overall Study||14
2207644|NCT03119831|5412650|P2|COMPLETED|Overall Study||14
2207645|NCT03119831|5412651|P1|COMPLETED|Overall Study||14
2207646|NCT03119831|5412649|P3|STARTED|Overall Study||14
2207647|NCT03119831|5412650|P2|STARTED|Overall Study||14
2207648|NCT03119831|5412651|P1|STARTED|Overall Study||14
2207649|NCT03119688|5412668|P1|NOT COMPLETED|Overall Study||4
2207650|NCT03119688|5412668|P1|COMPLETED|Overall Study||44
2207651|NCT03119688|5412668|P1|STARTED|Overall Study||48
2207652|NCT03119662|5412701|P2|NOT COMPLETED|Overall Study||1
2207653|NCT03119662|5412702|P1|NOT COMPLETED|Overall Study||0
2207654|NCT03119662|5412701|P2|COMPLETED|Overall Study||1
2207655|NCT03119662|5412702|P1|COMPLETED|Overall Study||2
2207656|NCT03119662|5412701|P2|STARTED|Overall Study||2
2207657|NCT03119662|5412702|P1|STARTED|Overall Study||2
2207658|NCT03119649|5412723|P5|NOT COMPLETED|Overall Study||0
2207659|NCT03119649|5412724|P4|NOT COMPLETED|Overall Study||0
2207660|NCT03119649|5412725|P3|NOT COMPLETED|Overall Study||0
2207661|NCT03119649|5412726|P2|NOT COMPLETED|Overall Study||0
2207662|NCT03119649|5412727|P1|NOT COMPLETED|Overall Study||0
2207663|NCT03119649|5412723|P5|COMPLETED|Overall Study||14
2207664|NCT03119649|5412724|P4|COMPLETED|Overall Study||14
2207665|NCT03119649|5412725|P3|COMPLETED|Overall Study||10
2207666|NCT03119649|5412726|P2|COMPLETED|Overall Study||10
2207667|NCT03119649|5412727|P1|COMPLETED|Overall Study||11
2207668|NCT03119649|5412723|P5|STARTED|Overall Study||14
2207669|NCT03119649|5412724|P4|STARTED|Overall Study||14
2207670|NCT03119649|5412725|P3|STARTED|Overall Study||10
2207671|NCT03119649|5412726|P2|STARTED|Overall Study||10
2207672|NCT03119649|5412727|P1|STARTED|Overall Study||11
2207673|NCT03119181|5412772|P2|NOT COMPLETED|Overall Study||0
2207674|NCT03119181|5412773|P1|NOT COMPLETED|Overall Study||0
2207675|NCT03119181|5412772|P2|COMPLETED|Overall Study||21
2207676|NCT03119181|5412773|P1|COMPLETED|Overall Study||19
2207677|NCT03119181|5412772|P2|STARTED|Overall Study||21
2207678|NCT03119181|5412773|P1|STARTED|Overall Study||19
2207679|NCT03119168|5412781|P2|NOT COMPLETED|Overall Study||0
2207680|NCT03119168|5412782|P1|NOT COMPLETED|Overall Study||0
2207681|NCT03119168|5412781|P2|COMPLETED|Overall Study||139
2207682|NCT03119168|5412782|P1|COMPLETED|Overall Study||129
2207683|NCT03119168|5412781|P2|STARTED|Overall Study||139
2207684|NCT03119168|5412782|P1|STARTED|Overall Study||129
2207685|NCT03119025|5412794|P1|NOT COMPLETED|Overall Study||0
2207686|NCT03119025|5412794|P1|COMPLETED|Overall Study||10
2207687|NCT03119025|5412794|P1|STARTED|Overall Study||10
2207688|NCT03118934|5412804|P6|NOT COMPLETED|Overall Study||2
2207689|NCT03118934|5412805|P5|NOT COMPLETED|Overall Study||2
2207690|NCT03118934|5412806|P4|NOT COMPLETED|Overall Study||1
2207691|NCT03118934|5412807|P3|NOT COMPLETED|Overall Study||1
2207692|NCT03118934|5412808|P2|NOT COMPLETED|Overall Study||1
2207693|NCT03118934|5412809|P1|NOT COMPLETED|Overall Study||0
2207694|NCT03118934|5412804|P6|COMPLETED|Overall Study||23
2207695|NCT03118934|5412805|P5|COMPLETED|Overall Study||27
2207696|NCT03118934|5412806|P4|COMPLETED|Overall Study||28
2207697|NCT03118934|5412807|P3|COMPLETED|Overall Study||33
2207698|NCT03118934|5412808|P2|COMPLETED|Overall Study||30
2207699|NCT03118934|5412809|P1|COMPLETED|Overall Study||34
2207700|NCT03118934|5412804|P6|Safety Analysis Set|Overall Study||25
2207701|NCT03118934|5412805|P5|Safety Analysis Set|Overall Study||26
2207702|NCT03118934|5412806|P4|Safety Analysis Set|Overall Study||29
2207703|NCT03118934|5412807|P3|Safety Analysis Set|Overall Study||34
2207704|NCT03118934|5412808|P2|Safety Analysis Set|Overall Study||29
2207705|NCT03118934|5412809|P1|Safety Analysis Set|Overall Study||34
2207706|NCT03118934|5412804|P6|STARTED|Overall Study||25
2207707|NCT03118934|5412805|P5|STARTED|Overall Study||29
2207708|NCT03118934|5412806|P4|STARTED|Overall Study||29
2207709|NCT03118934|5412807|P3|STARTED|Overall Study||34
2207710|NCT03118934|5412808|P2|STARTED|Overall Study||31
2207711|NCT03118934|5412809|P1|STARTED|Overall Study||34
2207712|NCT03118843|5412819|P1|NOT COMPLETED|Overall Study||0
2207713|NCT03118843|5412819|P1|COMPLETED|Overall Study||31
2207714|NCT03118843|5412819|P1|STARTED|Overall Study||31
2207715|NCT03118765|5412833|P5|NOT COMPLETED|Overall Study||2
2207716|NCT03118765|5412834|P4|NOT COMPLETED|Overall Study||3
2207717|NCT03118765|5412835|P3|NOT COMPLETED|Overall Study||5
2207718|NCT03118765|5412836|P2|NOT COMPLETED|Overall Study||2
2207719|NCT03118765|5412837|P1|NOT COMPLETED|Overall Study||4
2207720|NCT03118765|5412833|P5|COMPLETED|Overall Study||28
2207721|NCT03118765|5412834|P4|COMPLETED|Overall Study||29
2207722|NCT03118765|5412835|P3|COMPLETED|Overall Study||26
2207723|NCT03118765|5412836|P2|COMPLETED|Overall Study||30
2207724|NCT03118765|5412837|P1|COMPLETED|Overall Study||26
2207725|NCT03118765|5412833|P5|STARTED|Overall Study||30
2207726|NCT03118765|5412834|P4|STARTED|Overall Study||32
2207727|NCT03118765|5412835|P3|STARTED|Overall Study||31
2207728|NCT03118765|5412836|P2|STARTED|Overall Study||32
2207729|NCT03118765|5412837|P1|STARTED|Overall Study||30
2207730|NCT03118739|5412933|P2|NOT COMPLETED|Overall Study||4
2207731|NCT03118739|5412934|P1|NOT COMPLETED|Overall Study||7
2207732|NCT03118739|5412933|P2|COMPLETED|Overall Study||24
2207733|NCT03118739|5412934|P1|COMPLETED|Overall Study||25
2207734|NCT03118739|5412933|P2|Completed 24 Weeks of Treatment|Overall Study||25
2207735|NCT03118739|5412934|P1|Completed 24 Weeks of Treatment|Overall Study||24
2207736|NCT03118739|5412933|P2|Completed 12 Weeks of Treatment|Overall Study||25
2207737|NCT03118739|5412934|P1|Completed 12 Weeks of Treatment|Overall Study||26
2207738|NCT03118739|5412933|P2|STARTED|Overall Study||28
2207739|NCT03118739|5412934|P1|STARTED|Overall Study||32
2207740|NCT03118596|5413026|P2|NOT COMPLETED|Overall Study||4
2207741|NCT03118596|5413027|P1|NOT COMPLETED|Overall Study||0
2207742|NCT03118596|5413026|P2|COMPLETED|Overall Study||86
2207743|NCT03118596|5413027|P1|COMPLETED|Overall Study||90
2207744|NCT03118596|5413026|P2|Failed|Overall Study||4
2207745|NCT03118596|5413027|P1|Failed|Overall Study||0
2207746|NCT03118596|5413026|P2|Treated|Overall Study||0
2207747|NCT03118596|5413027|P1|Treated|Overall Study||2
2207748|NCT03118596|5413026|P2|STARTED|Overall Study||90
2207749|NCT03118596|5413027|P1|STARTED|Overall Study||90
2207750|NCT03118297|5413047|P2|NOT COMPLETED|Overall Study||2
2207751|NCT03118297|5413048|P1|NOT COMPLETED|Overall Study||0
2207752|NCT03118297|5413047|P2|COMPLETED|Overall Study||31
2207753|NCT03118297|5413048|P1|COMPLETED|Overall Study||32
2207754|NCT03118297|5413047|P2|STARTED|Overall Study||33
2207755|NCT03118297|5413048|P1|STARTED|Overall Study||32
2207756|NCT03117569|5413064|P2|NOT COMPLETED|Overall Study||12
2207757|NCT03117569|5413065|P1|NOT COMPLETED|Overall Study||4
2207758|NCT03117569|5413064|P2|COMPLETED|Overall Study||241
2207759|NCT03117569|5413065|P1|COMPLETED|Overall Study||123
2207760|NCT03117569|5413064|P2|STARTED|Overall Study||253
2207761|NCT03117569|5413065|P1|STARTED|Overall Study||127
2207762|NCT03117140|5413091|P4|NOT COMPLETED|Overall Study||0
2207763|NCT03117140|5413092|P3|NOT COMPLETED|Overall Study||0
2207764|NCT03117140|5413093|P2|NOT COMPLETED|Overall Study||0
2207765|NCT03117140|5413094|P1|NOT COMPLETED|Overall Study||0
2207766|NCT03117140|5413091|P4|COMPLETED|Overall Study||40
2207767|NCT03117140|5413092|P3|COMPLETED|Overall Study||40
2207768|NCT03117140|5413093|P2|COMPLETED|Overall Study||40
2207769|NCT03117140|5413094|P1|COMPLETED|Overall Study||40
2207770|NCT03117140|5413091|P4|STARTED|Overall Study||40
2207771|NCT03117140|5413092|P3|STARTED|Overall Study||40
2207772|NCT03117140|5413093|P2|STARTED|Overall Study||40
2207773|NCT03117140|5413094|P1|STARTED|Overall Study||40
2207774|NCT03116841|5413160|P1|NOT COMPLETED|Overall Study||0
2207775|NCT03116841|5413160|P1|COMPLETED|Overall Study||3
2207776|NCT03116841|5413160|P1|STARTED|Overall Study||3
2207777|NCT03116698|5413181|P4|NOT COMPLETED|Overall Study||2
2207778|NCT03116698|5413182|P3|NOT COMPLETED|Overall Study||8
2207779|NCT03116698|5413183|P2|NOT COMPLETED|Overall Study||6
2207780|NCT03116698|5413184|P1|NOT COMPLETED|Overall Study||6
2207781|NCT03116698|5413181|P4|COMPLETED|Overall Study||55
2207782|NCT03116698|5413182|P3|COMPLETED|Overall Study||54
2207783|NCT03116698|5413183|P2|COMPLETED|Overall Study||51
2207784|NCT03116698|5413184|P1|COMPLETED|Overall Study||56
2207785|NCT03116698|5413181|P4|STARTED|Overall Study||57
2207786|NCT03116698|5413182|P3|STARTED|Overall Study||62
2207787|NCT03116698|5413183|P2|STARTED|Overall Study||57
2207788|NCT03116698|5413184|P1|STARTED|Overall Study||62
2207789|NCT03115853|5413198|P1|NOT COMPLETED|Overall Study||0
2207790|NCT03115853|5413198|P1|COMPLETED|Overall Study||31
2207791|NCT03115853|5413198|P1|STARTED|Overall Study||31
2207792|NCT03115827|5413216|P1|NOT COMPLETED|Overall Study||3
2207793|NCT03115827|5413216|P1|COMPLETED|Overall Study||12
2207794|NCT03115827|5413216|P1|STARTED|Overall Study||15
2207795|NCT03115476|5413227|P3|NOT COMPLETED|LP0084-1369||162
2207796|NCT03115476|5413228|P2|NOT COMPLETED|LP0084-1369||210
2207797|NCT03115476|5413229|P1|NOT COMPLETED|LP0084-1369||191
2207798|NCT03115476|5413227|P3|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
2207799|NCT03115476|5413228|P2|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
2207800|NCT03115476|5413229|P1|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
2207801|NCT03115476|5413227|P3|STARTED|LP0084-1369||162
2207802|NCT03115476|5413228|P2|STARTED|LP0084-1369||210
2207803|NCT03115476|5413229|P1|STARTED|LP0084-1369||191
2207804|NCT03115476|5413227|P3|NOT COMPLETED|Main Trials (LP0084-119x)||0
2207805|NCT03115476|5413228|P2|NOT COMPLETED|Main Trials (LP0084-119x)||0
2207806|NCT03115476|5413229|P1|NOT COMPLETED|Main Trials (LP0084-119x)||0
2207807|NCT03115476|5413227|P3|COMPLETED|Main Trials (LP0084-119x)||409
2207808|NCT03115476|5413228|P2|COMPLETED|Main Trials (LP0084-119x)||418
2207809|NCT03115476|5413229|P1|COMPLETED|Main Trials (LP0084-119x)||407
2207810|NCT03115476|5413227|P3|STARTED|Main Trials (LP0084-119x)||409
2207811|NCT03115476|5413228|P2|STARTED|Main Trials (LP0084-119x)||418
2207812|NCT03115476|5413229|P1|STARTED|Main Trials (LP0084-119x)||407
2207813|NCT03115411|5413240|P1|NOT COMPLETED|Overall Study||0
2207814|NCT03115411|5413240|P1|COMPLETED|Overall Study||23
2207815|NCT03115411|5413240|P1|STARTED|Overall Study||23
2207816|NCT03115177|5413246|P2|NOT COMPLETED|Overall Study||0
2207817|NCT03115177|5413247|P1|NOT COMPLETED|Overall Study||0
2207818|NCT03115177|5413246|P2|COMPLETED|Overall Study||29
2207819|NCT03115177|5413247|P1|COMPLETED|Overall Study||27
2207820|NCT03115177|5413246|P2|STARTED|Overall Study||29
2207821|NCT03115177|5413247|P1|STARTED|Overall Study||27
2207822|NCT03114995|5413256|P3|NOT COMPLETED|Overall Study||0
2207823|NCT03114995|5413257|P2|NOT COMPLETED|Overall Study||1
2207824|NCT03114995|5413258|P1|NOT COMPLETED|Overall Study||1
2207825|NCT03114995|5413256|P3|COMPLETED|Overall Study||78
2207826|NCT03114995|5413257|P2|COMPLETED|Overall Study||30
2207827|NCT03114995|5413258|P1|COMPLETED|Overall Study||30
2207828|NCT03114995|5413256|P3|STARTED|Overall Study||78
2207829|NCT03114995|5413257|P2|STARTED|Overall Study||31
2207830|NCT03114995|5413258|P1|STARTED|Overall Study||31
2207831|NCT03114969|5413278|P9|NOT COMPLETED|Overall Study||2
2207832|NCT03114969|5413279|P8|NOT COMPLETED|Overall Study||0
2207833|NCT03114969|5413280|P7|NOT COMPLETED|Overall Study||1
2207834|NCT03114969|5413281|P6|NOT COMPLETED|Overall Study||1
2207835|NCT03114969|5413282|P5|NOT COMPLETED|Overall Study||0
2207836|NCT03114969|5413283|P4|NOT COMPLETED|Overall Study||2
2207837|NCT03114969|5413284|P3|NOT COMPLETED|Overall Study||4
2207838|NCT03114969|5413285|P2|NOT COMPLETED|Overall Study||0
2207839|NCT03114969|5413286|P1|NOT COMPLETED|Overall Study||0
2207840|NCT03114969|5413278|P9|COMPLETED|Overall Study||48
2207841|NCT03114969|5413279|P8|COMPLETED|Overall Study||50
2207842|NCT03114969|5413280|P7|COMPLETED|Overall Study||49
2207843|NCT03114969|5413281|P6|COMPLETED|Overall Study||48
2207844|NCT03114969|5413282|P5|COMPLETED|Overall Study||51
2207845|NCT03114969|5413283|P4|COMPLETED|Overall Study||48
2207846|NCT03114969|5413284|P3|COMPLETED|Overall Study||46
2207847|NCT03114969|5413285|P2|COMPLETED|Overall Study||50
2207848|NCT03114969|5413286|P1|COMPLETED|Overall Study||50
2207849|NCT03114969|5413278|P9|STARTED|Overall Study||50
2207850|NCT03114969|5413279|P8|STARTED|Overall Study||50
2207851|NCT03114969|5413280|P7|STARTED|Overall Study||50
2207852|NCT03114969|5413281|P6|STARTED|Overall Study||49
2207853|NCT03114969|5413282|P5|STARTED|Overall Study||51
2207854|NCT03114969|5413283|P4|STARTED|Overall Study||50
2207855|NCT03114969|5413284|P3|STARTED|Overall Study||50
2207856|NCT03114969|5413285|P2|STARTED|Overall Study||50
2207857|NCT03114969|5413286|P1|STARTED|Overall Study||50
2207858|NCT03114488|5413381|P2|NOT COMPLETED|Time Period 2||3
2207859|NCT03114488|5413382|P1|NOT COMPLETED|Time Period 2||1
2207860|NCT03114488|5413381|P2|COMPLETED|Time Period 2||19
2207861|NCT03114488|5413382|P1|COMPLETED|Time Period 2||18
2207862|NCT03114488|5413381|P2|STARTED|Time Period 2||22
2207863|NCT03114488|5413382|P1|STARTED|Time Period 2||19
2207864|NCT03114488|5413381|P2|NOT COMPLETED|Time Period 1||0
2207865|NCT03114488|5413382|P1|NOT COMPLETED|Time Period 1||0
2207866|NCT03114488|5413381|P2|COMPLETED|Time Period 1||22
2207867|NCT03114488|5413382|P1|COMPLETED|Time Period 1||19
2207868|NCT03114488|5413381|P2|STARTED|Time Period 1||22
2207869|NCT03114488|5413382|P1|STARTED|Time Period 1||19
2207870|NCT03113656|5413394|P2|NOT COMPLETED|Overall Study||0
2207871|NCT03113656|5413395|P1|NOT COMPLETED|Overall Study||0
2207872|NCT03113656|5413394|P2|COMPLETED|Overall Study||7
2207873|NCT03113656|5413395|P1|COMPLETED|Overall Study||9
2207874|NCT03113656|5413394|P2|STARTED|Overall Study||7
2207875|NCT03113656|5413395|P1|STARTED|Overall Study||9
2207876|NCT03112993|5413403|P2|NOT COMPLETED|Overall Study||0
2207877|NCT03112993|5413404|P1|NOT COMPLETED|Overall Study||0
2207878|NCT03112993|5413403|P2|COMPLETED|Overall Study||21
2207879|NCT03112993|5413404|P1|COMPLETED|Overall Study||19
2207880|NCT03112993|5413403|P2|STARTED|Overall Study||21
2207881|NCT03112993|5413404|P1|STARTED|Overall Study||19
2207882|NCT03111316|5413422|P4|NOT COMPLETED|Overall Study||0
2207883|NCT03111316|5413423|P3|NOT COMPLETED|Overall Study||0
2207884|NCT03111316|5413424|P2|NOT COMPLETED|Overall Study||0
2207885|NCT03111316|5413425|P1|NOT COMPLETED|Overall Study||0
2207886|NCT03111316|5413422|P4|COMPLETED|Overall Study||25
2207887|NCT03111316|5413423|P3|COMPLETED|Overall Study||25
2207888|NCT03111316|5413424|P2|COMPLETED|Overall Study||24
2207889|NCT03111316|5413425|P1|COMPLETED|Overall Study||26
2207890|NCT03111316|5413422|P4|STARTED|Overall Study||25
2207891|NCT03111316|5413423|P3|STARTED|Overall Study||25
2207892|NCT03111316|5413424|P2|STARTED|Overall Study||24
2207893|NCT03111316|5413425|P1|STARTED|Overall Study||26
2207894|NCT03111108|5413441|P2|NOT COMPLETED|Overall Study||1
2207895|NCT03111108|5413442|P1|NOT COMPLETED|Overall Study||1
2207896|NCT03111108|5413441|P2|COMPLETED|Overall Study||63
2207897|NCT03111108|5413442|P1|COMPLETED|Overall Study||52
2207898|NCT03111108|5413441|P2|STARTED|Overall Study||64
2207899|NCT03111108|5413442|P1|STARTED|Overall Study||53
2207900|NCT03110900|5413460|P2|NOT COMPLETED|Overall Study||1
2207901|NCT03110900|5413461|P1|NOT COMPLETED|Overall Study||1
2207902|NCT03110900|5413460|P2|COMPLETED|Overall Study||0
2207903|NCT03110900|5413461|P1|COMPLETED|Overall Study||0
2207904|NCT03110900|5413460|P2|STARTED|Overall Study||1
2207905|NCT03110900|5413461|P1|STARTED|Overall Study||1
2207906|NCT03110692|5413469|P2|NOT COMPLETED|Overall Study||0
2207907|NCT03110692|5413470|P1|NOT COMPLETED|Overall Study||0
2207908|NCT03110692|5413469|P2|COMPLETED|Overall Study||509
2207909|NCT03110692|5413470|P1|COMPLETED|Overall Study||679
2207910|NCT03110692|5413469|P2|STARTED|Overall Study||509
2207911|NCT03110692|5413470|P1|STARTED|Overall Study||679
2207912|NCT03110601|5413476|P1|NOT COMPLETED|Stimgenics SCS Parameters||3
2207913|NCT03110601|5413476|P1|COMPLETED|Stimgenics SCS Parameters||20
2207914|NCT03110601|5413476|P1|STARTED|Stimgenics SCS Parameters||23
2207915|NCT03110601|5413476|P1|NOT COMPLETED|Washout Period||1
2207916|NCT03110601|5413476|P1|COMPLETED|Washout Period||23
2207917|NCT03110601|5413476|P1|STARTED|Washout Period||24
2207918|NCT03110601|5413476|P1|NOT COMPLETED|Conventional SCS Parameters||1
2207919|NCT03110601|5413476|P1|COMPLETED|Conventional SCS Parameters||24
2207920|NCT03110601|5413476|P1|STARTED|Conventional SCS Parameters||25
2207921|NCT03110380|5413485|P2|NOT COMPLETED|Overall Study||283
2207922|NCT03110380|5413486|P1|NOT COMPLETED|Overall Study||284
2207923|NCT03110380|5413485|P2|COMPLETED|Overall Study||0
2207924|NCT03110380|5413486|P1|COMPLETED|Overall Study||0
2207925|NCT03110380|5413485|P2|STARTED|Overall Study||283
2207926|NCT03110380|5413486|P1|STARTED|Overall Study||284
2207927|NCT03110159|5413496|P1|NOT COMPLETED|Overall Study||1
2207928|NCT03110159|5413496|P1|COMPLETED|Overall Study||0
2207929|NCT03110159|5413496|P1|STARTED|Overall Study||1
2207930|NCT03110029|5413507|P2|NOT COMPLETED|Overall Study||1
2207931|NCT03110029|5413508|P1|NOT COMPLETED|Overall Study||1
2207932|NCT03110029|5413507|P2|COMPLETED|Overall Study||5
2207933|NCT03110029|5413508|P1|COMPLETED|Overall Study||6
2207934|NCT03110029|5413507|P2|STARTED|Overall Study||6
2207935|NCT03110029|5413508|P1|STARTED|Overall Study||7
2207936|NCT03110003|5413518|P2|NOT COMPLETED|Overall Study||0
2207937|NCT03110003|5413519|P1|NOT COMPLETED|Overall Study||0
2207938|NCT03110003|5413518|P2|COMPLETED|Overall Study||24
2207939|NCT03110003|5413519|P1|COMPLETED|Overall Study||21
2207940|NCT03110003|5413518|P2|STARTED|Overall Study||24
2207941|NCT03110003|5413519|P1|STARTED|Overall Study||21
2207942|NCT03109873|5413537|P2|NOT COMPLETED|Overall Study||0
2207943|NCT03109873|5413538|P1|NOT COMPLETED|Overall Study||0
2207944|NCT03109873|5413537|P2|COMPLETED|Overall Study||4
2207945|NCT03109873|5413538|P1|COMPLETED|Overall Study||5
2207946|NCT03109873|5413537|P2|STARTED|Overall Study||4
2207947|NCT03109873|5413538|P1|STARTED|Overall Study||5
2207948|NCT03109769|5413554|P2|NOT COMPLETED|Overall Study||0
2207949|NCT03109769|5413555|P1|NOT COMPLETED|Overall Study||0
2207950|NCT03109769|5413554|P2|COMPLETED|Overall Study||22
2207951|NCT03109769|5413555|P1|COMPLETED|Overall Study||22
2207952|NCT03109769|5413554|P2|STARTED|Overall Study||22
2207953|NCT03109769|5413555|P1|STARTED|Overall Study||22
2207954|NCT03109418|5413565|P2|NOT COMPLETED|Overall Study||1
2207955|NCT03109418|5413566|P1|NOT COMPLETED|Overall Study||0
2207956|NCT03109418|5413565|P2|COMPLETED|Overall Study||3
2207957|NCT03109418|5413566|P1|COMPLETED|Overall Study||2
2207958|NCT03109418|5413565|P2|STARTED|Overall Study||4
2207959|NCT03109418|5413566|P1|STARTED|Overall Study||2
2207960|NCT03109184|5413576|P2|NOT COMPLETED|Overall Study||7
2207961|NCT03109184|5413577|P1|NOT COMPLETED|Overall Study||7
2207962|NCT03109184|5413576|P2|COMPLETED|Overall Study||52
2207963|NCT03109184|5413577|P1|COMPLETED|Overall Study||53
2207964|NCT03109184|5413576|P2|STARTED|Overall Study||59
2207965|NCT03109184|5413577|P1|STARTED|Overall Study||60
2207966|NCT03108924|5413599|P4|NOT COMPLETED|Overall Study||0
2207967|NCT03108924|5413600|P3|NOT COMPLETED|Overall Study||0
2207968|NCT03108924|5413601|P2|NOT COMPLETED|Overall Study||0
2207969|NCT03108924|5413602|P1|NOT COMPLETED|Overall Study||0
2207970|NCT03108924|5413599|P4|COMPLETED|Overall Study||6
2207971|NCT03108924|5413600|P3|COMPLETED|Overall Study||6
2207972|NCT03108924|5413601|P2|COMPLETED|Overall Study||6
2207973|NCT03108924|5413602|P1|COMPLETED|Overall Study||6
2207974|NCT03108924|5413599|P4|STARTED|Overall Study||6
2207975|NCT03108924|5413600|P3|STARTED|Overall Study||6
2207976|NCT03108924|5413601|P2|STARTED|Overall Study||6
2207977|NCT03108924|5413602|P1|STARTED|Overall Study||6
2207978|NCT03108482|5413700|P4|NOT COMPLETED|Overall Study||3
2207979|NCT03108482|5413701|P3|NOT COMPLETED|Overall Study||2
2207980|NCT03108482|5413702|P2|NOT COMPLETED|Overall Study||4
2207981|NCT03108482|5413703|P1|NOT COMPLETED|Overall Study||0
2207982|NCT03108482|5413700|P4|COMPLETED|Overall Study||86
2207983|NCT03108482|5413701|P3|COMPLETED|Overall Study||180
2207984|NCT03108482|5413702|P2|COMPLETED|Overall Study||179
2207985|NCT03108482|5413703|P1|COMPLETED|Overall Study||183
2207986|NCT03108482|5413700|P4|STARTED|Overall Study||89
2207987|NCT03108482|5413701|P3|STARTED|Overall Study||182
2207988|NCT03108482|5413702|P2|STARTED|Overall Study||183
2207989|NCT03108482|5413703|P1|STARTED|Overall Study||183
2207990|NCT03108469|5413715|P2|NOT COMPLETED|Overall Study||4
2207991|NCT03108469|5413716|P1|NOT COMPLETED|Overall Study||4
2207992|NCT03108469|5413715|P2|COMPLETED|Overall Study||11
2207993|NCT03108469|5413716|P1|COMPLETED|Overall Study||11
2207994|NCT03108469|5413715|P2|STARTED|Overall Study||15
2207995|NCT03108469|5413716|P1|STARTED|Overall Study||15
2207996|NCT03108157|5413738|P2|NOT COMPLETED|Overall Study||4
2207997|NCT03108157|5413739|P1|NOT COMPLETED|Overall Study||15
2207998|NCT03108157|5413738|P2|COMPLETED|Overall Study||172
2207999|NCT03108157|5413739|P1|COMPLETED|Overall Study||161
2208000|NCT03108157|5413738|P2|STARTED|Overall Study||176
2208001|NCT03108157|5413739|P1|STARTED|Overall Study||176
2208002|NCT03108027|5413745|P6|NOT COMPLETED|Period 3||0
2208003|NCT03108027|5413746|P5|NOT COMPLETED|Period 3||0
2208004|NCT03108027|5413747|P4|NOT COMPLETED|Period 3||0
2208005|NCT03108027|5413748|P3|NOT COMPLETED|Period 3||0
2208006|NCT03108027|5413749|P2|NOT COMPLETED|Period 3||1
2208007|NCT03108027|5413750|P1|NOT COMPLETED|Period 3||0
2208008|NCT03108027|5413745|P6|COMPLETED|Period 3||6
2208009|NCT03108027|5413746|P5|COMPLETED|Period 3||6
2208010|NCT03108027|5413747|P4|COMPLETED|Period 3||4
2208011|NCT03108027|5413748|P3|COMPLETED|Period 3||6
2208012|NCT03108027|5413749|P2|COMPLETED|Period 3||5
2208013|NCT03108027|5413750|P1|COMPLETED|Period 3||7
2208014|NCT03108027|5413745|P6|STARTED|Period 3||6
2208015|NCT03108027|5413746|P5|STARTED|Period 3||6
2208016|NCT03108027|5413747|P4|STARTED|Period 3||4
2208017|NCT03108027|5413748|P3|STARTED|Period 3||6
2208018|NCT03108027|5413749|P2|STARTED|Period 3||6
2208019|NCT03108027|5413750|P1|STARTED|Period 3||7
2208020|NCT03108027|5413745|P6|NOT COMPLETED|Period 2||0
2208021|NCT03108027|5413746|P5|NOT COMPLETED|Period 2||0
2208022|NCT03108027|5413747|P4|NOT COMPLETED|Period 2||0
2208023|NCT03108027|5413748|P3|NOT COMPLETED|Period 2||0
2208024|NCT03108027|5413749|P2|NOT COMPLETED|Period 2||0
2208025|NCT03108027|5413750|P1|NOT COMPLETED|Period 2||0
2208026|NCT03108027|5413745|P6|COMPLETED|Period 2||6
2208027|NCT03108027|5413746|P5|COMPLETED|Period 2||6
2208028|NCT03108027|5413747|P4|COMPLETED|Period 2||4
2208029|NCT03108027|5413748|P3|COMPLETED|Period 2||6
2208030|NCT03108027|5413749|P2|COMPLETED|Period 2||6
2208031|NCT03108027|5413750|P1|COMPLETED|Period 2||7
2208032|NCT03108027|5413745|P6|STARTED|Period 2||6
2208033|NCT03108027|5413746|P5|STARTED|Period 2||6
2208034|NCT03108027|5413747|P4|STARTED|Period 2||4
2208035|NCT03108027|5413748|P3|STARTED|Period 2||6
2208036|NCT03108027|5413749|P2|STARTED|Period 2||6
2208037|NCT03108027|5413750|P1|STARTED|Period 2||7
2208038|NCT03108027|5413745|P6|NOT COMPLETED|Period 1||0
2208039|NCT03108027|5413746|P5|NOT COMPLETED|Period 1||0
2208040|NCT03108027|5413747|P4|NOT COMPLETED|Period 1||2
2208041|NCT03108027|5413748|P3|NOT COMPLETED|Period 1||0
2208042|NCT03108027|5413749|P2|NOT COMPLETED|Period 1||0
2208043|NCT03108027|5413750|P1|NOT COMPLETED|Period 1||0
2208044|NCT03108027|5413745|P6|COMPLETED|Period 1||6
2208045|NCT03108027|5413746|P5|COMPLETED|Period 1||6
2208046|NCT03108027|5413747|P4|COMPLETED|Period 1||4
2208047|NCT03108027|5413748|P3|COMPLETED|Period 1||6
2208048|NCT03108027|5413749|P2|COMPLETED|Period 1||6
2208049|NCT03108027|5413750|P1|COMPLETED|Period 1||7
2208050|NCT03108027|5413745|P6|STARTED|Period 1||6
2208051|NCT03108027|5413746|P5|STARTED|Period 1||6
2208052|NCT03108027|5413747|P4|STARTED|Period 1||6
2208053|NCT03108027|5413748|P3|STARTED|Period 1||6
2208054|NCT03108027|5413749|P2|STARTED|Period 1||6
2208055|NCT03108027|5413750|P1|STARTED|Period 1||7
2208056|NCT03106870|5413766|P2|NOT COMPLETED|Overall Study||0
2208057|NCT03106870|5413767|P1|NOT COMPLETED|Overall Study||0
2208058|NCT03106870|5413766|P2|COMPLETED|Overall Study||31
2208059|NCT03106870|5413767|P1|COMPLETED|Overall Study||31
2208060|NCT03106870|5413766|P2|STARTED|Overall Study||31
2208061|NCT03106870|5413767|P1|STARTED|Overall Study||31
2208062|NCT03106337|5413777|P1|NOT COMPLETED|Overall Study||0
2208063|NCT03106337|5413777|P1|COMPLETED|Overall Study||35
2208064|NCT03106337|5413777|P1|STARTED|Overall Study||35
2208065|NCT03105518|5413782|P1|NOT COMPLETED|Overall Study||0
2208066|NCT03105518|5413782|P1|COMPLETED|Overall Study||100
2208067|NCT03105518|5413782|P1|STARTED|Overall Study||100
2208068|NCT03105479|5413787|P7|NOT COMPLETED|Overall Study||0
2208069|NCT03105479|5413788|P6|NOT COMPLETED|Overall Study||0
2208070|NCT03105479|5413789|P5|NOT COMPLETED|Overall Study||0
2208071|NCT03105479|5413790|P4|NOT COMPLETED|Overall Study||0
2208072|NCT03105479|5413791|P3|NOT COMPLETED|Overall Study||0
2208073|NCT03105479|5413792|P2|NOT COMPLETED|Overall Study||0
2208074|NCT03105479|5413793|P1|NOT COMPLETED|Overall Study||0
2208075|NCT03105479|5413787|P7|COMPLETED|Overall Study||0
2208076|NCT03105479|5413788|P6|COMPLETED|Overall Study||0
2208077|NCT03105479|5413789|P5|COMPLETED|Overall Study||0
2208078|NCT03105479|5413790|P4|COMPLETED|Overall Study||0
2208079|NCT03105479|5413791|P3|COMPLETED|Overall Study||0
2208080|NCT03105479|5413792|P2|COMPLETED|Overall Study||0
2208081|NCT03105479|5413793|P1|COMPLETED|Overall Study||1
2208082|NCT03105479|5413787|P7|STARTED|Overall Study||0
2208083|NCT03105479|5413788|P6|STARTED|Overall Study||0
2208084|NCT03105479|5413789|P5|STARTED|Overall Study||0
2208085|NCT03105479|5413790|P4|STARTED|Overall Study||0
2208086|NCT03105479|5413791|P3|STARTED|Overall Study||0
2208087|NCT03105479|5413792|P2|STARTED|Overall Study||0
2208088|NCT03105479|5413793|P1|STARTED|Overall Study||1
2208095|NCT03105297|5413823|P1|NOT COMPLETED|Nasal Resistance Phase (Day 30, 31)||8
2208096|NCT03105297|5413823|P1|COMPLETED|Nasal Resistance Phase (Day 30, 31)||48
2208097|NCT03105297|5413823|P1|Treated|Nasal Resistance Phase (Day 30, 31)||55
2208098|NCT03105297|5413823|P1|STARTED|Nasal Resistance Phase (Day 30, 31)|14 participants withdrew from the study after the completion of active phase|56
2208099|NCT03105297|5413823|P1|NOT COMPLETED|Active Phase (Day 2-29)||0
2208100|NCT03105297|5413823|P1|COMPLETED|Active Phase (Day 2-29)||70
2208101|NCT03105297|5413823|P1|STARTED|Active Phase (Day 2-29)||70
2208102|NCT03105297|5413823|P1|NOT COMPLETED|Baseline Phase (Day 1)||21
2208103|NCT03105297|5413823|P1|COMPLETED|Baseline Phase (Day 1)||70
2208104|NCT03105297|5413823|P1|STARTED|Baseline Phase (Day 1)||91
2208105|NCT03104985|5413857|P2|NOT COMPLETED|Overall Study||0
2208106|NCT03104985|5413858|P1|NOT COMPLETED|Overall Study||0
2208107|NCT03104985|5413857|P2|COMPLETED|Overall Study||34
2208108|NCT03104985|5413858|P1|COMPLETED|Overall Study||34
2208109|NCT03104985|5413857|P2|STARTED|Overall Study||34
2208110|NCT03104985|5413858|P1|STARTED|Overall Study||34
2208111|NCT03104816|5413867|P3|NOT COMPLETED|Overall Study||2
2208112|NCT03104816|5413868|P2|NOT COMPLETED|Overall Study||2
2208113|NCT03104816|5413869|P1|NOT COMPLETED|Overall Study||2
2208114|NCT03104816|5413867|P3|COMPLETED|Overall Study||4
2208115|NCT03104816|5413868|P2|COMPLETED|Overall Study||9
2208116|NCT03104816|5413869|P1|COMPLETED|Overall Study||9
2208117|NCT03104816|5413867|P3|STARTED|Overall Study||6
2208118|NCT03104816|5413868|P2|STARTED|Overall Study||11
2208119|NCT03104816|5413869|P1|STARTED|Overall Study||11
2208120|NCT03104738|5413879|P2|NOT COMPLETED|Overall Study||0
2208121|NCT03104738|5413880|P1|NOT COMPLETED|Overall Study||0
2208122|NCT03104738|5413879|P2|COMPLETED|Overall Study||20
2208123|NCT03104738|5413880|P1|COMPLETED|Overall Study||20
2208124|NCT03104738|5413879|P2|STARTED|Overall Study||20
2208125|NCT03104738|5413880|P1|STARTED|Overall Study||20
2208126|NCT03104647|5413906|P1|NOT COMPLETED|Overall Study||0
2208127|NCT03104647|5413906|P1|COMPLETED|Overall Study||20
2208128|NCT03104647|5413906|P1|STARTED|Overall Study||20
2208129|NCT03104322|5413911|P1|NOT COMPLETED|Overall Study||1
2208130|NCT03104322|5413911|P1|COMPLETED|Overall Study||6
2208131|NCT03104322|5413911|P1|STARTED|Overall Study||7
2208132|NCT03103919|5413921|P2|NOT COMPLETED|Overall Study||2
2208133|NCT03103919|5413922|P1|NOT COMPLETED|Overall Study||2
2208134|NCT03103919|5413921|P2|COMPLETED|Overall Study||17
2208135|NCT03103919|5413922|P1|COMPLETED|Overall Study||18
2208136|NCT03103919|5413921|P2|STARTED|Overall Study||19
2208137|NCT03103919|5413922|P1|STARTED|Overall Study||20
2208138|NCT03103906|5413958|P2|NOT COMPLETED|Overall Study||3
2208139|NCT03103906|5413959|P1|NOT COMPLETED|Overall Study||4
2208140|NCT03103906|5413958|P2|COMPLETED|Overall Study||39
2208141|NCT03103906|5413959|P1|COMPLETED|Overall Study||36
2208142|NCT03103906|5413958|P2|STARTED|Overall Study||42
2208143|NCT03103906|5413959|P1|STARTED|Overall Study||40
2208144|NCT03103061|5413979|P1|NOT COMPLETED|Overall Study||0
2208145|NCT03103061|5413979|P1|COMPLETED|Overall Study||24
2208146|NCT03103061|5413979|P1|STARTED|Overall Study||24
2208147|NCT03102918|5413986|P2|NOT COMPLETED|Overall Study||0
2208148|NCT03102918|5413987|P1|NOT COMPLETED|Overall Study||1
2208149|NCT03102918|5413986|P2|COMPLETED|Overall Study||5
2208150|NCT03102918|5413987|P1|COMPLETED|Overall Study||4
2208151|NCT03102918|5413986|P2|STARTED|Overall Study||5
2208152|NCT03102918|5413987|P1|STARTED|Overall Study||5
2208153|NCT03102879|5413995|P2|NOT COMPLETED|Overall Study||0
2208154|NCT03102879|5413996|P1|NOT COMPLETED|Overall Study||0
2208155|NCT03102879|5413995|P2|COMPLETED|Overall Study||18
2208156|NCT03102879|5413996|P1|COMPLETED|Overall Study||18
2208157|NCT03102879|5413995|P2|STARTED|Overall Study||18
2208158|NCT03102879|5413996|P1|STARTED|Overall Study||18
2208159|NCT03102762|5414013|P2|NOT COMPLETED|Overall Study||0
2208160|NCT03102762|5414014|P1|NOT COMPLETED|Overall Study||1
2208161|NCT03102762|5414013|P2|COMPLETED|Overall Study||35
2208162|NCT03102762|5414014|P1|COMPLETED|Overall Study||34
2208163|NCT03102762|5414013|P2|STARTED|Overall Study||35
2208164|NCT03102762|5414014|P1|STARTED|Overall Study||35
2208165|NCT03102411|5414040|P1|NOT COMPLETED|Overall Study||163
2208166|NCT03102411|5414040|P1|COMPLETED|Overall Study||1718
2208167|NCT03102411|5414040|P1|STARTED|Overall Study||1881
2208168|NCT03102190|5414045|P1|NOT COMPLETED|Overall Study||0
2208169|NCT03102190|5414045|P1|COMPLETED|Overall Study||6
2208170|NCT03102190|5414045|P1|STARTED|Overall Study||6
2208171|NCT03102034|5414051|P2|NOT COMPLETED|Overall Study||0
2208172|NCT03102034|5414052|P1|NOT COMPLETED|Overall Study||1
2208173|NCT03102034|5414051|P2|COMPLETED|Overall Study||11
2208174|NCT03102034|5414052|P1|COMPLETED|Overall Study||20
2208175|NCT03102034|5414051|P2|STARTED|Overall Study||11
2208176|NCT03102034|5414052|P1|STARTED|Overall Study||21
2208177|NCT03101462|5414080|P2|NOT COMPLETED|Overall Study||1
2208178|NCT03101462|5414081|P1|NOT COMPLETED|Overall Study||1
2208179|NCT03101462|5414080|P2|COMPLETED|Overall Study||18
2208180|NCT03101462|5414081|P1|COMPLETED|Overall Study||18
2208181|NCT03101462|5414080|P2|STARTED|Overall Study||19
2208182|NCT03101462|5414081|P1|STARTED|Overall Study||19
2208189|NCT03101293|5414118|P2|NOT COMPLETED|Intervention Period 2||0
2208190|NCT03101293|5414119|P1|NOT COMPLETED|Intervention Period 2||0
2208191|NCT03101293|5414118|P2|COMPLETED|Intervention Period 2||8
2208192|NCT03101293|5414119|P1|COMPLETED|Intervention Period 2||6
2208193|NCT03101293|5414118|P2|STARTED|Intervention Period 2||8
2208194|NCT03101293|5414119|P1|STARTED|Intervention Period 2||6
2208195|NCT03101293|5414118|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2208196|NCT03101293|5414119|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||1
2208197|NCT03101293|5414118|P2|COMPLETED|Washout Period (at Least 7 Days)||8
2208198|NCT03101293|5414119|P1|COMPLETED|Washout Period (at Least 7 Days)||6
2208199|NCT03101293|5414118|P2|STARTED|Washout Period (at Least 7 Days)||8
2208200|NCT03101293|5414119|P1|STARTED|Washout Period (at Least 7 Days)||7
2208201|NCT03101293|5414118|P2|NOT COMPLETED|Intervention Period 1||0
2208202|NCT03101293|5414119|P1|NOT COMPLETED|Intervention Period 1||0
2208203|NCT03101293|5414118|P2|COMPLETED|Intervention Period 1||8
2208204|NCT03101293|5414119|P1|COMPLETED|Intervention Period 1||7
2208205|NCT03101293|5414118|P2|STARTED|Intervention Period 1||8
2208206|NCT03101293|5414119|P1|STARTED|Intervention Period 1||7
2208207|NCT03101150|5414133|P2|NOT COMPLETED|Overall Study||10
2208208|NCT03101150|5414134|P1|NOT COMPLETED|Overall Study||5
2208209|NCT03101150|5414133|P2|COMPLETED|Overall Study||83
2208210|NCT03101150|5414134|P1|COMPLETED|Overall Study||81
2208211|NCT03101150|5414133|P2|STARTED|Overall Study||93
2208212|NCT03101150|5414134|P1|STARTED|Overall Study||86
2208213|NCT03101033|5414146|P2|NOT COMPLETED|Overall Study||9
2208214|NCT03101033|5414147|P1|NOT COMPLETED|Overall Study||5
2208215|NCT03101033|5414146|P2|COMPLETED|Overall Study||51
2208216|NCT03101033|5414147|P1|COMPLETED|Overall Study||27
2208217|NCT03101033|5414146|P2|STARTED|Overall Study||60
2208218|NCT03101033|5414147|P1|STARTED|Overall Study||32
2208219|NCT03101020|5414169|P2|NOT COMPLETED|Overall Study||3
2208220|NCT03101020|5414170|P1|NOT COMPLETED|Overall Study||1
2208221|NCT03101020|5414169|P2|COMPLETED|Overall Study||7
2208222|NCT03101020|5414170|P1|COMPLETED|Overall Study||9
2208223|NCT03101020|5414169|P2|STARTED|Overall Study||10
2208224|NCT03101020|5414170|P1|STARTED|Overall Study||10
2208225|NCT03100968|5414184|P2|NOT COMPLETED|Overall Study||0
2208226|NCT03100968|5414185|P1|NOT COMPLETED|Overall Study||0
2208227|NCT03100968|5414184|P2|COMPLETED|Overall Study||75
2208228|NCT03100968|5414185|P1|COMPLETED|Overall Study||75
2208229|NCT03100968|5414184|P2|STARTED|Overall Study||75
2208230|NCT03100968|5414185|P1|STARTED|Overall Study||75
2208231|NCT03100942|5414205|P4|NOT COMPLETED|Overall Study||23
2208232|NCT03100942|5414206|P3|NOT COMPLETED|Overall Study||26
2208233|NCT03100942|5414207|P2|NOT COMPLETED|Overall Study||27
2208234|NCT03100942|5414208|P1|NOT COMPLETED|Overall Study||29
2208235|NCT03100942|5414205|P4|COMPLETED|Overall Study||14
2208236|NCT03100942|5414206|P3|COMPLETED|Overall Study||13
2208237|NCT03100942|5414207|P2|COMPLETED|Overall Study||11
2208238|NCT03100942|5414208|P1|COMPLETED|Overall Study||9
2208239|NCT03100942|5414205|P4|Study Completed up to Week 24|Overall Study|32 participants were rerandomized at Week 24.|32
2208240|NCT03100942|5414206|P3|Study Completed up to Week 24|Overall Study||37
2208241|NCT03100942|5414207|P2|Study Completed up to Week 24|Overall Study||30
2208242|NCT03100942|5414208|P1|Study Completed up to Week 24|Overall Study||35
2208243|NCT03100942|5414205|P4|STARTED|Overall Study||37
2208244|NCT03100942|5414206|P3|STARTED|Overall Study||39
2208245|NCT03100942|5414207|P2|STARTED|Overall Study||38
2208246|NCT03100942|5414208|P1|STARTED|Overall Study||38
2208247|NCT03100838|5414234|P4|NOT COMPLETED|Overall Study||1
2208248|NCT03100838|5414235|P3|NOT COMPLETED|Overall Study||2
2208249|NCT03100838|5414236|P2|NOT COMPLETED|Overall Study||2
2208250|NCT03100838|5414237|P1|NOT COMPLETED|Overall Study||2
2208251|NCT03100838|5414234|P4|COMPLETED|Overall Study||15
2208252|NCT03100838|5414235|P3|COMPLETED|Overall Study||14
2208253|NCT03100838|5414236|P2|COMPLETED|Overall Study||14
2208254|NCT03100838|5414237|P1|COMPLETED|Overall Study||14
2208255|NCT03100838|5414234|P4|STARTED|Overall Study||16
2208256|NCT03100838|5414235|P3|STARTED|Overall Study||16
2208257|NCT03100838|5414236|P2|STARTED|Overall Study||16
2208258|NCT03100838|5414237|P1|STARTED|Overall Study||16
2208259|NCT03100500|5414263|P1|NOT COMPLETED|Overall Study||0
2208260|NCT03100500|5414263|P1|COMPLETED|Overall Study||51
2208261|NCT03100500|5414263|P1|STARTED|Overall Study||51
2208262|NCT03100344|5414276|P4|NOT COMPLETED|Overall Study||12
2208263|NCT03100344|5414277|P3|NOT COMPLETED|Overall Study||7
2208264|NCT03100344|5414278|P2|NOT COMPLETED|Overall Study||11
2208265|NCT03100344|5414279|P1|NOT COMPLETED|Overall Study||14
2208266|NCT03100344|5414276|P4|COMPLETED|Overall Study||45
2208267|NCT03100344|5414277|P3|COMPLETED|Overall Study||50
2208268|NCT03100344|5414278|P2|COMPLETED|Overall Study||44
2208269|NCT03100344|5414279|P1|COMPLETED|Overall Study||43
2208270|NCT03100344|5414276|P4|STARTED|Overall Study||57
2208271|NCT03100344|5414277|P3|STARTED|Overall Study||57
2208272|NCT03100344|5414278|P2|STARTED|Overall Study||55
2208273|NCT03100344|5414279|P1|STARTED|Overall Study||57
2208274|NCT03100058|5414366|P13|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||4
2208275|NCT03100058|5414367|P12|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||3
2208276|NCT03100058|5414368|P11|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||15
2208277|NCT03100058|5414369|P10|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||5
2208278|NCT03100058|5414370|P9|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
2208279|NCT03100058|5414371|P8|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
2208280|NCT03100058|5414372|P7|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
2208281|NCT03100058|5414373|P6|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
2208282|NCT03100058|5414374|P5|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
2208283|NCT03100058|5414375|P4|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
2208284|NCT03100058|5414376|P3|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
2208285|NCT03100058|5414377|P2|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
2208286|NCT03100058|5414378|P1|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
2208287|NCT03100058|5414366|P13|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||30
2208288|NCT03100058|5414367|P12|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||36
2208289|NCT03100058|5414368|P11|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||148
2208290|NCT03100058|5414369|P10|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||153
2208291|NCT03100058|5414370|P9|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
2208292|NCT03100058|5414371|P8|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
2208293|NCT03100058|5414372|P7|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
2208294|NCT03100058|5414373|P6|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
2208295|NCT03100058|5414374|P5|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
2208296|NCT03100058|5414375|P4|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
2208297|NCT03100058|5414376|P3|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
2208298|NCT03100058|5414377|P2|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
2208299|NCT03100058|5414378|P1|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
2208300|NCT03100058|5414366|P13|STARTED|Epoch 4 (Last 24 Weeks of the Study)||34
2208301|NCT03100058|5414367|P12|STARTED|Epoch 4 (Last 24 Weeks of the Study)||39
2208302|NCT03100058|5414368|P11|STARTED|Epoch 4 (Last 24 Weeks of the Study)||163
2208303|NCT03100058|5414369|P10|STARTED|Epoch 4 (Last 24 Weeks of the Study)||158
2208304|NCT03100058|5414370|P9|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
2208305|NCT03100058|5414371|P8|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
2208306|NCT03100058|5414372|P7|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
2208307|NCT03100058|5414373|P6|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
2208308|NCT03100058|5414374|P5|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
2208309|NCT03100058|5414375|P4|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
2208310|NCT03100058|5414376|P3|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
2208311|NCT03100058|5414377|P2|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
2208312|NCT03100058|5414378|P1|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
2208313|NCT03100058|5414366|P13|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
2208314|NCT03100058|5414367|P12|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
2208315|NCT03100058|5414368|P11|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
2208316|NCT03100058|5414369|P10|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
2208317|NCT03100058|5414370|P9|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||5
2208318|NCT03100058|5414371|P8|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||16
2208319|NCT03100058|5414372|P7|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||8
2208320|NCT03100058|5414373|P6|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||2
2208321|NCT03100058|5414374|P5|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||2
2208322|NCT03100058|5414375|P4|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||14
2208323|NCT03100058|5414376|P3|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||9
2208324|NCT03100058|5414377|P2|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||7
2208325|NCT03100058|5414378|P1|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||3
2208326|NCT03100058|5414366|P13|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
2208327|NCT03100058|5414367|P12|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
2208328|NCT03100058|5414368|P11|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
2208329|NCT03100058|5414369|P10|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
2208330|NCT03100058|5414370|P9|COMPLETED|Epoch 3 (24 Weeks of Treatment)||73
2208331|NCT03100058|5414371|P8|COMPLETED|Epoch 3 (24 Weeks of Treatment)||60
2208332|NCT03100058|5414372|P7|COMPLETED|Epoch 3 (24 Weeks of Treatment)||30
2208333|NCT03100058|5414373|P6|COMPLETED|Epoch 3 (24 Weeks of Treatment)||37
2208334|NCT03100058|5414374|P5|COMPLETED|Epoch 3 (24 Weeks of Treatment)||36
2208335|NCT03100058|5414375|P4|COMPLETED|Epoch 3 (24 Weeks of Treatment)||63
2208336|NCT03100058|5414376|P3|COMPLETED|Epoch 3 (24 Weeks of Treatment)||29
2208337|NCT03100058|5414377|P2|COMPLETED|Epoch 3 (24 Weeks of Treatment)||31
2208338|NCT03100058|5414378|P1|COMPLETED|Epoch 3 (24 Weeks of Treatment)||35
2208339|NCT03100058|5414366|P13|STARTED|Epoch 3 (24 Weeks of Treatment)||0
2208340|NCT03100058|5414367|P12|STARTED|Epoch 3 (24 Weeks of Treatment)||0
2208341|NCT03100058|5414368|P11|STARTED|Epoch 3 (24 Weeks of Treatment)||0
2208342|NCT03100058|5414369|P10|STARTED|Epoch 3 (24 Weeks of Treatment)||0
2208343|NCT03100058|5414370|P9|STARTED|Epoch 3 (24 Weeks of Treatment)||78
2208344|NCT03100058|5414371|P8|STARTED|Epoch 3 (24 Weeks of Treatment)||76
2208345|NCT03100058|5414372|P7|STARTED|Epoch 3 (24 Weeks of Treatment)||38
2208346|NCT03100058|5414373|P6|STARTED|Epoch 3 (24 Weeks of Treatment)||39
2208347|NCT03100058|5414374|P5|STARTED|Epoch 3 (24 Weeks of Treatment)||38
2208348|NCT03100058|5414375|P4|STARTED|Epoch 3 (24 Weeks of Treatment)||77
2208349|NCT03100058|5414376|P3|STARTED|Epoch 3 (24 Weeks of Treatment)||38
2208350|NCT03100058|5414377|P2|STARTED|Epoch 3 (24 Weeks of Treatment)||38
2208351|NCT03100058|5414378|P1|STARTED|Epoch 3 (24 Weeks of Treatment)||38
2208352|NCT03099694|5414585|P2|NOT COMPLETED|Overall Study||18
2208353|NCT03099694|5414586|P1|NOT COMPLETED|Overall Study||20
2208354|NCT03099694|5414585|P2|COMPLETED|Overall Study||152
2208355|NCT03099694|5414586|P1|COMPLETED|Overall Study||150
2208356|NCT03099694|5414585|P2|STARTED|Overall Study||170
2208357|NCT03099694|5414586|P1|STARTED|Overall Study||170
2208358|NCT03099655|5414614|P1|NOT COMPLETED|Overall Study||61
2208359|NCT03099655|5414614|P1|COMPLETED|Overall Study|6-Month visit with original 4798 lead implanted|379
2208360|NCT03099655|5414614|P1|STARTED|Overall Study||440
2208361|NCT03099369|5414627|P2|NOT COMPLETED|Overall Study||4
2208362|NCT03099369|5414628|P1|NOT COMPLETED|Overall Study||6
2208363|NCT03099369|5414627|P2|COMPLETED|Overall Study||5
2208364|NCT03099369|5414628|P1|COMPLETED|Overall Study||5
2208365|NCT03099369|5414627|P2|STARTED|Overall Study||9
2208366|NCT03099369|5414628|P1|STARTED|Overall Study||11
2208373|NCT03099161|5414690|P3|NOT COMPLETED|Overall Study||3
2208374|NCT03099161|5414691|P2|NOT COMPLETED|Overall Study||4
2208375|NCT03099161|5414692|P1|NOT COMPLETED|Overall Study||3
2208376|NCT03099161|5414690|P3|COMPLETED|Overall Study||0
2208377|NCT03099161|5414691|P2|COMPLETED|Overall Study||0
2208378|NCT03099161|5414692|P1|COMPLETED|Overall Study||0
2208379|NCT03099161|5414690|P3|STARTED|Overall Study||3
2208380|NCT03099161|5414691|P2|STARTED|Overall Study||4
2208381|NCT03099161|5414692|P1|STARTED|Overall Study||3
2208382|NCT03099096|5414709|P1|NOT COMPLETED|Overall Study||2
2208383|NCT03099096|5414709|P1|COMPLETED|Overall Study||157
2208384|NCT03099096|5414709|P1|STARTED|Overall Study||159
2208385|NCT03098979|5414722|P6|NOT COMPLETED|Overall Study||4
2208386|NCT03098979|5414723|P5|NOT COMPLETED|Overall Study||9
2208387|NCT03098979|5414724|P4|NOT COMPLETED|Overall Study||5
2208388|NCT03098979|5414725|P3|NOT COMPLETED|Overall Study||4
2208389|NCT03098979|5414726|P2|NOT COMPLETED|Overall Study||2
2208390|NCT03098979|5414727|P1|NOT COMPLETED|Overall Study||6
2208391|NCT03098979|5414722|P6|COMPLETED|Overall Study||47
2208392|NCT03098979|5414723|P5|COMPLETED|Overall Study||41
2208393|NCT03098979|5414724|P4|COMPLETED|Overall Study||46
2208394|NCT03098979|5414725|P3|COMPLETED|Overall Study||46
2208395|NCT03098979|5414726|P2|COMPLETED|Overall Study||25
2208396|NCT03098979|5414727|P1|COMPLETED|Overall Study||70
2208397|NCT03098979|5414722|P6|STARTED|Overall Study||51
2208398|NCT03098979|5414723|P5|STARTED|Overall Study||50
2208399|NCT03098979|5414724|P4|STARTED|Overall Study||51
2208400|NCT03098979|5414725|P3|STARTED|Overall Study||50
2208401|NCT03098979|5414726|P2|STARTED|Overall Study||27
2208402|NCT03098979|5414727|P1|STARTED|Overall Study||76
2208403|NCT03098966|5414765|P1|NOT COMPLETED|Overall Study||0
2208404|NCT03098966|5414765|P1|COMPLETED|Overall Study||368
2208405|NCT03098966|5414765|P1|STARTED|Overall Study||368
2208406|NCT03098745|5414771|P6|NOT COMPLETED|Day 3||0
2208407|NCT03098745|5414772|P5|NOT COMPLETED|Day 3||0
2208408|NCT03098745|5414773|P4|NOT COMPLETED|Day 3||0
2208409|NCT03098745|5414774|P3|NOT COMPLETED|Day 3||0
2208410|NCT03098745|5414775|P2|NOT COMPLETED|Day 3||0
2208411|NCT03098745|5414776|P1|NOT COMPLETED|Day 3||0
2208412|NCT03098745|5414771|P6|COMPLETED|Day 3||4
2208413|NCT03098745|5414772|P5|COMPLETED|Day 3||10
2208414|NCT03098745|5414773|P4|COMPLETED|Day 3||8
2208415|NCT03098745|5414774|P3|COMPLETED|Day 3||8
2208416|NCT03098745|5414775|P2|COMPLETED|Day 3||3
2208417|NCT03098745|5414776|P1|COMPLETED|Day 3||7
2208418|NCT03098745|5414771|P6|STARTED|Day 3||4
2208419|NCT03098745|5414772|P5|STARTED|Day 3||10
2208420|NCT03098745|5414773|P4|STARTED|Day 3||8
2208421|NCT03098745|5414774|P3|STARTED|Day 3||8
2208422|NCT03098745|5414775|P2|STARTED|Day 3||3
2208423|NCT03098745|5414776|P1|STARTED|Day 3||7
2208424|NCT03098745|5414771|P6|NOT COMPLETED|Day 2||0
2208425|NCT03098745|5414772|P5|NOT COMPLETED|Day 2||0
2208426|NCT03098745|5414773|P4|NOT COMPLETED|Day 2||0
2208427|NCT03098745|5414774|P3|NOT COMPLETED|Day 2||0
2208428|NCT03098745|5414775|P2|NOT COMPLETED|Day 2||0
2208429|NCT03098745|5414776|P1|NOT COMPLETED|Day 2||0
2208430|NCT03098745|5414771|P6|COMPLETED|Day 2||4
2208431|NCT03098745|5414772|P5|COMPLETED|Day 2||10
2208432|NCT03098745|5414773|P4|COMPLETED|Day 2||8
2208433|NCT03098745|5414774|P3|COMPLETED|Day 2||8
2208434|NCT03098745|5414775|P2|COMPLETED|Day 2||3
2208435|NCT03098745|5414776|P1|COMPLETED|Day 2||7
2208436|NCT03098745|5414771|P6|STARTED|Day 2||4
2208437|NCT03098745|5414772|P5|STARTED|Day 2||10
2208438|NCT03098745|5414773|P4|STARTED|Day 2||8
2208439|NCT03098745|5414774|P3|STARTED|Day 2||8
2208440|NCT03098745|5414775|P2|STARTED|Day 2||3
2208441|NCT03098745|5414776|P1|STARTED|Day 2||7
2208442|NCT03098745|5414771|P6|NOT COMPLETED|Day 1||0
2208443|NCT03098745|5414772|P5|NOT COMPLETED|Day 1||0
2208444|NCT03098745|5414773|P4|NOT COMPLETED|Day 1||0
2208445|NCT03098745|5414774|P3|NOT COMPLETED|Day 1||0
2208446|NCT03098745|5414775|P2|NOT COMPLETED|Day 1||0
2208447|NCT03098745|5414776|P1|NOT COMPLETED|Day 1||0
2208448|NCT03098745|5414771|P6|COMPLETED|Day 1||4
2208449|NCT03098745|5414772|P5|COMPLETED|Day 1||10
2208450|NCT03098745|5414773|P4|COMPLETED|Day 1||8
2208451|NCT03098745|5414774|P3|COMPLETED|Day 1||8
2208452|NCT03098745|5414775|P2|COMPLETED|Day 1||3
2208453|NCT03098745|5414776|P1|COMPLETED|Day 1||7
2208454|NCT03098745|5414771|P6|STARTED|Day 1||4
2208455|NCT03098745|5414772|P5|STARTED|Day 1||10
2208456|NCT03098745|5414773|P4|STARTED|Day 1||8
2208457|NCT03098745|5414774|P3|STARTED|Day 1||8
2208458|NCT03098745|5414775|P2|STARTED|Day 1||3
2208459|NCT03098745|5414776|P1|STARTED|Day 1||7
2208460|NCT03098641|5414812|P1|NOT COMPLETED|Overall Study||52
2208461|NCT03098641|5414812|P1|COMPLETED|Overall Study||220
2208462|NCT03098641|5414812|P1|STARTED|Overall Study||272
2208463|NCT03098615|5414830|P1|NOT COMPLETED|Overall Study||2
2208464|NCT03098615|5414830|P1|COMPLETED|Overall Study||17
2208465|NCT03098615|5414830|P1|STARTED|Overall Study||19
2208466|NCT03098173|5414837|P2|NOT COMPLETED|Overall Study||2
2208467|NCT03098173|5414838|P1|NOT COMPLETED|Overall Study||1
2208468|NCT03098173|5414837|P2|COMPLETED|Overall Study||79
2208469|NCT03098173|5414838|P1|COMPLETED|Overall Study||80
2208470|NCT03098173|5414837|P2|STARTED|Overall Study||81
2208471|NCT03098173|5414838|P1|STARTED|Overall Study||81
2208472|NCT03097861|5414869|P3|NOT COMPLETED|Overall Study||9
2208473|NCT03097861|5414870|P2|NOT COMPLETED|Overall Study||22
2208474|NCT03097861|5414871|P1|NOT COMPLETED|Overall Study||7
2208475|NCT03097861|5414869|P3|COMPLETED|Overall Study||122
2208476|NCT03097861|5414870|P2|COMPLETED|Overall Study||254
2208477|NCT03097861|5414871|P1|COMPLETED|Overall Study||138
2208478|NCT03097861|5414869|P3|Per-protocol Population (PP)|Overall Study||113
2208479|NCT03097861|5414870|P2|Per-protocol Population (PP)|Overall Study||234
2208480|NCT03097861|5414871|P1|Per-protocol Population (PP)|Overall Study||126
2208481|NCT03097861|5414869|P3|Completers|Overall Study||121
2208482|NCT03097861|5414870|P2|Completers|Overall Study||255
2208483|NCT03097861|5414871|P1|Completers|Overall Study||129
2208484|NCT03097861|5414869|P3|Modified Intent to Treat|Overall Study||130
2208485|NCT03097861|5414870|P2|Modified Intent to Treat|Overall Study||275
2208486|NCT03097861|5414871|P1|Modified Intent to Treat|Overall Study||143
2208487|NCT03097861|5414869|P3|Safety Population|Overall Study||130
2208488|NCT03097861|5414870|P2|Safety Population|Overall Study||275
2208489|NCT03097861|5414871|P1|Safety Population|Overall Study||143
2208490|NCT03097861|5414869|P3|STARTED|Overall Study||131
2208491|NCT03097861|5414870|P2|STARTED|Overall Study||276
2208492|NCT03097861|5414871|P1|STARTED|Overall Study||145
2208493|NCT03097614|5414888|P1|NOT COMPLETED|Overall Study||3
2208494|NCT03097614|5414888|P1|COMPLETED|Overall Study||54
2208495|NCT03097614|5414888|P1|STARTED|Overall Study||57
2208496|NCT03097484|5414894|P2|NOT COMPLETED|Overall Study||0
2208497|NCT03097484|5414895|P1|NOT COMPLETED|Overall Study||0
2208498|NCT03097484|5414894|P2|COMPLETED|Overall Study||19
2208499|NCT03097484|5414895|P1|COMPLETED|Overall Study||19
2208500|NCT03097484|5414894|P2|STARTED|Overall Study||19
2208501|NCT03097484|5414895|P1|STARTED|Overall Study||19
2208502|NCT03097341|5414908|P5|NOT COMPLETED|Overall Study||0
2208503|NCT03097341|5414909|P4|NOT COMPLETED|Overall Study||0
2208504|NCT03097341|5414910|P3|NOT COMPLETED|Overall Study||0
2208505|NCT03097341|5414911|P2|NOT COMPLETED|Overall Study||0
2208506|NCT03097341|5414912|P1|NOT COMPLETED|Overall Study||0
2208507|NCT03097341|5414908|P5|COMPLETED|Overall Study||5
2208508|NCT03097341|5414909|P4|COMPLETED|Overall Study||4
2208509|NCT03097341|5414910|P3|COMPLETED|Overall Study||4
2208510|NCT03097341|5414911|P2|COMPLETED|Overall Study||4
2208511|NCT03097341|5414912|P1|COMPLETED|Overall Study||4
2208512|NCT03097341|5414908|P5|STARTED|Overall Study||5
2208513|NCT03097341|5414909|P4|STARTED|Overall Study||4
2208514|NCT03097341|5414910|P3|STARTED|Overall Study||4
2208515|NCT03097341|5414911|P2|STARTED|Overall Study||4
2208516|NCT03097341|5414912|P1|STARTED|Overall Study||4
2208517|NCT03097289|5414990|P1|NOT COMPLETED|Overall Study||6
2208518|NCT03097289|5414990|P1|COMPLETED|Overall Study||26
2208519|NCT03097289|5414990|P1|STARTED|Overall Study||32
2208520|NCT03096873|5414999|P2|NOT COMPLETED|Overall Study||0
2208521|NCT03096873|5415000|P1|NOT COMPLETED|Overall Study||0
2208522|NCT03096873|5414999|P2|COMPLETED|Overall Study||20
2208523|NCT03096873|5415000|P1|COMPLETED|Overall Study||20
2208524|NCT03096873|5414999|P2|STARTED|Overall Study||20
2208525|NCT03096873|5415000|P1|STARTED|Overall Study||20
2208526|NCT03096483|5415034|P1|NOT COMPLETED|Overall Study||1
2208527|NCT03096483|5415034|P1|COMPLETED|Overall Study||11
2208528|NCT03096483|5415034|P1|STARTED|Overall Study||12
2208529|NCT03096444|5415039|P1|NOT COMPLETED|Overall Study||0
2208530|NCT03096444|5415039|P1|COMPLETED|Overall Study||13
2208531|NCT03096444|5415039|P1|STARTED|Overall Study||13
2208532|NCT03096314|5415063|P2|NOT COMPLETED|Confirmed Vitamin D Deficient||12
2208533|NCT03096314|5415064|P1|NOT COMPLETED|Confirmed Vitamin D Deficient||7
2208534|NCT03096314|5415063|P2|COMPLETED|Confirmed Vitamin D Deficient||528
2208535|NCT03096314|5415064|P1|COMPLETED|Confirmed Vitamin D Deficient||531
2208536|NCT03096314|5415063|P2|STARTED|Confirmed Vitamin D Deficient|Confirmed deficient (a prior primary analysis subgroup) is a subgroup of the screened deficient.|540
2208537|NCT03096314|5415064|P1|STARTED|Confirmed Vitamin D Deficient|Confirmed deficient (a prior primary analysis subgroup) is a subgroup of the screened deficient.|538
2208538|NCT03096314|5415063|P2|NOT COMPLETED|Screened Vitamin D Deficient||12
2208539|NCT03096314|5415064|P1|NOT COMPLETED|Screened Vitamin D Deficient||9
2208540|NCT03096314|5415063|P2|COMPLETED|Screened Vitamin D Deficient||656
2208541|NCT03096314|5415064|P1|COMPLETED|Screened Vitamin D Deficient||681
2208542|NCT03096314|5415063|P2|STARTED|Screened Vitamin D Deficient|2 randomized but not included in analysis; 1 treated but inadequate consent and 1 withdrew.|668
2208543|NCT03096314|5415064|P1|STARTED|Screened Vitamin D Deficient||690
2208544|NCT03095651|5415120|P8|NOT COMPLETED|Overall Study||0
2208545|NCT03095651|5415121|P7|NOT COMPLETED|Overall Study||0
2208546|NCT03095651|5415122|P6|NOT COMPLETED|Overall Study||1
2208547|NCT03095651|5415123|P5|NOT COMPLETED|Overall Study||0
2208548|NCT03095651|5415124|P4|NOT COMPLETED|Overall Study||1
2208549|NCT03095651|5415125|P3|NOT COMPLETED|Overall Study||0
2208550|NCT03095651|5415126|P2|NOT COMPLETED|Overall Study||1
2208551|NCT03095651|5415127|P1|NOT COMPLETED|Overall Study||1
2208552|NCT03095651|5415120|P8|COMPLETED|Overall Study||4
2208553|NCT03095651|5415121|P7|COMPLETED|Overall Study||6
2208554|NCT03095651|5415122|P6|COMPLETED|Overall Study||6
2208555|NCT03095651|5415123|P5|COMPLETED|Overall Study||0
2208556|NCT03095651|5415124|P4|COMPLETED|Overall Study||3
2208557|NCT03095651|5415125|P3|COMPLETED|Overall Study||0
2208558|NCT03095651|5415126|P2|COMPLETED|Overall Study||5
2208559|NCT03095651|5415127|P1|COMPLETED|Overall Study||5
2208560|NCT03095651|5415120|P8|STARTED|Overall Study||4
2208561|NCT03095651|5415121|P7|STARTED|Overall Study||6
2208562|NCT03095651|5415122|P6|STARTED|Overall Study||7
2208563|NCT03095651|5415123|P5|STARTED|Overall Study||0
2208564|NCT03095651|5415124|P4|STARTED|Overall Study||4
2208565|NCT03095651|5415125|P3|STARTED|Overall Study||0
2208566|NCT03095651|5415126|P2|STARTED|Overall Study||6
2208567|NCT03095651|5415127|P1|STARTED|Overall Study||6
2208568|NCT03095638|5415251|P8|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
2208569|NCT03095638|5415252|P7|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
2208570|NCT03095638|5415253|P6|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
2208571|NCT03095638|5415254|P5|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
2208572|NCT03095638|5415255|P4|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
2208573|NCT03095638|5415256|P3|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
2208574|NCT03095638|5415257|P2|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
2208575|NCT03095638|5415258|P1|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
2208576|NCT03095638|5415251|P8|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
2208577|NCT03095638|5415252|P7|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
2208578|NCT03095638|5415253|P6|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
2208579|NCT03095638|5415254|P5|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
2208580|NCT03095638|5415255|P4|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
2208581|NCT03095638|5415256|P3|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
2208582|NCT03095638|5415257|P2|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
2208583|NCT03095638|5415258|P1|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
2208584|NCT03095638|5415251|P8|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
2208585|NCT03095638|5415252|P7|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
2208586|NCT03095638|5415253|P6|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
2208587|NCT03095638|5415254|P5|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
2208588|NCT03095638|5415255|P4|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
2208589|NCT03095638|5415256|P3|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
2208590|NCT03095638|5415257|P2|STARTED|P2: Period 3, Washout (7[-4 Hours])||0
2208591|NCT03095638|5415258|P1|STARTED|P2: Period 3, Washout (7[-4 Hours])||0
2208592|NCT03095638|5415251|P8|NOT COMPLETED|P2: Period 3 (4 Days)||0
2208593|NCT03095638|5415252|P7|NOT COMPLETED|P2: Period 3 (4 Days)||0
2208594|NCT03095638|5415253|P6|NOT COMPLETED|P2: Period 3 (4 Days)||0
2208595|NCT03095638|5415254|P5|NOT COMPLETED|P2: Period 3 (4 Days)||0
2208596|NCT03095638|5415255|P4|NOT COMPLETED|P2: Period 3 (4 Days)||0
2208597|NCT03095638|5415256|P3|NOT COMPLETED|P2: Period 3 (4 Days)||0
2208598|NCT03095638|5415257|P2|NOT COMPLETED|P2: Period 3 (4 Days)||0
2208599|NCT03095638|5415258|P1|NOT COMPLETED|P2: Period 3 (4 Days)||0
2208600|NCT03095638|5415251|P8|COMPLETED|P2: Period 3 (4 Days)||4
2208601|NCT03095638|5415252|P7|COMPLETED|P2: Period 3 (4 Days)||4
2208602|NCT03095638|5415253|P6|COMPLETED|P2: Period 3 (4 Days)||4
2208603|NCT03095638|5415254|P5|COMPLETED|P2: Period 3 (4 Days)||4
2208604|NCT03095638|5415255|P4|COMPLETED|P2: Period 3 (4 Days)||4
2208605|NCT03095638|5415256|P3|COMPLETED|P2: Period 3 (4 Days)||4
2208606|NCT03095638|5415257|P2|COMPLETED|P2: Period 3 (4 Days)||0
2208607|NCT03095638|5415258|P1|COMPLETED|P2: Period 3 (4 Days)||0
2208608|NCT03095638|5415251|P8|STARTED|P2: Period 3 (4 Days)||4
2208609|NCT03095638|5415252|P7|STARTED|P2: Period 3 (4 Days)||4
2208610|NCT03095638|5415253|P6|STARTED|P2: Period 3 (4 Days)||4
2208611|NCT03095638|5415254|P5|STARTED|P2: Period 3 (4 Days)||4
2208612|NCT03095638|5415255|P4|STARTED|P2: Period 3 (4 Days)||4
2208613|NCT03095638|5415256|P3|STARTED|P2: Period 3 (4 Days)||4
2208614|NCT03095638|5415257|P2|STARTED|P2: Period 3 (4 Days)||0
2208615|NCT03095638|5415258|P1|STARTED|P2: Period 3 (4 Days)||0
2208616|NCT03095638|5415251|P8|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
2208617|NCT03095638|5415252|P7|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
2208618|NCT03095638|5415253|P6|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
2208619|NCT03095638|5415254|P5|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
2208620|NCT03095638|5415255|P4|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
2208621|NCT03095638|5415256|P3|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
2208622|NCT03095638|5415257|P2|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
2208623|NCT03095638|5415258|P1|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
2208624|NCT03095638|5415251|P8|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
2208625|NCT03095638|5415252|P7|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
2208626|NCT03095638|5415253|P6|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
2208627|NCT03095638|5415254|P5|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
2208628|NCT03095638|5415255|P4|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
2208629|NCT03095638|5415256|P3|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
2208630|NCT03095638|5415257|P2|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
2208631|NCT03095638|5415258|P1|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
2208632|NCT03095638|5415251|P8|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
2208633|NCT03095638|5415252|P7|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
2208634|NCT03095638|5415253|P6|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
2208635|NCT03095638|5415254|P5|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
2208636|NCT03095638|5415255|P4|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
2208637|NCT03095638|5415256|P3|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
2208638|NCT03095638|5415257|P2|STARTED|P2: Period 2, Washout (7[-4 Hours])||0
2208639|NCT03095638|5415258|P1|STARTED|P2: Period 2, Washout (7[-4 Hours])||0
2208640|NCT03095638|5415251|P8|NOT COMPLETED|P2: Period 2 (4 Days)||0
2208641|NCT03095638|5415252|P7|NOT COMPLETED|P2: Period 2 (4 Days)||0
2208642|NCT03095638|5415253|P6|NOT COMPLETED|P2: Period 2 (4 Days)||0
2208643|NCT03095638|5415254|P5|NOT COMPLETED|P2: Period 2 (4 Days)||0
2208644|NCT03095638|5415255|P4|NOT COMPLETED|P2: Period 2 (4 Days)||0
2208645|NCT03095638|5415256|P3|NOT COMPLETED|P2: Period 2 (4 Days)||0
2208646|NCT03095638|5415257|P2|NOT COMPLETED|P2: Period 2 (4 Days)||0
2208647|NCT03095638|5415258|P1|NOT COMPLETED|P2: Period 2 (4 Days)||0
2208648|NCT03095638|5415251|P8|COMPLETED|P2: Period 2 (4 Days)||4
2208649|NCT03095638|5415252|P7|COMPLETED|P2: Period 2 (4 Days)||4
2208650|NCT03095638|5415253|P6|COMPLETED|P2: Period 2 (4 Days)||4
2208651|NCT03095638|5415254|P5|COMPLETED|P2: Period 2 (4 Days)||4
2208652|NCT03095638|5415255|P4|COMPLETED|P2: Period 2 (4 Days)||4
2208653|NCT03095638|5415256|P3|COMPLETED|P2: Period 2 (4 Days)||4
2208654|NCT03095638|5415257|P2|COMPLETED|P2: Period 2 (4 Days)||0
2208655|NCT03095638|5415258|P1|COMPLETED|P2: Period 2 (4 Days)||0
2208656|NCT03095638|5415251|P8|STARTED|P2: Period 2 (4 Days)||4
2208657|NCT03095638|5415252|P7|STARTED|P2: Period 2 (4 Days)||4
2208658|NCT03095638|5415253|P6|STARTED|P2: Period 2 (4 Days)||4
2208659|NCT03095638|5415254|P5|STARTED|P2: Period 2 (4 Days)||4
2208660|NCT03095638|5415255|P4|STARTED|P2: Period 2 (4 Days)||4
2208661|NCT03095638|5415256|P3|STARTED|P2: Period 2 (4 Days)||4
2208662|NCT03095638|5415257|P2|STARTED|P2: Period 2 (4 Days)||0
2208663|NCT03095638|5415258|P1|STARTED|P2: Period 2 (4 Days)||0
2208664|NCT03095638|5415251|P8|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
2208665|NCT03095638|5415252|P7|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
2208666|NCT03095638|5415253|P6|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
2208667|NCT03095638|5415254|P5|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
2208668|NCT03095638|5415255|P4|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
2208669|NCT03095638|5415256|P3|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
2208670|NCT03095638|5415257|P2|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
2208671|NCT03095638|5415258|P1|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
2208672|NCT03095638|5415251|P8|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
2208673|NCT03095638|5415252|P7|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
2208674|NCT03095638|5415253|P6|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
2208675|NCT03095638|5415254|P5|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
2208676|NCT03095638|5415255|P4|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
2208677|NCT03095638|5415256|P3|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
2208678|NCT03095638|5415257|P2|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
2208679|NCT03095638|5415258|P1|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
2208680|NCT03095638|5415251|P8|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
2208681|NCT03095638|5415252|P7|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
2208682|NCT03095638|5415253|P6|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
2208683|NCT03095638|5415254|P5|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
2208684|NCT03095638|5415255|P4|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
2208685|NCT03095638|5415256|P3|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
2208686|NCT03095638|5415257|P2|STARTED|P2: Period 1, Washout (7[-4 Hours])||0
2208687|NCT03095638|5415258|P1|STARTED|P2: Period 1, Washout (7[-4 Hours])||0
2208688|NCT03095638|5415251|P8|NOT COMPLETED|P2: Period 1 (4 Days)||0
2208689|NCT03095638|5415252|P7|NOT COMPLETED|P2: Period 1 (4 Days)||0
2208690|NCT03095638|5415253|P6|NOT COMPLETED|P2: Period 1 (4 Days)||0
2208691|NCT03095638|5415254|P5|NOT COMPLETED|P2: Period 1 (4 Days)||0
2208692|NCT03095638|5415255|P4|NOT COMPLETED|P2: Period 1 (4 Days)||0
2208693|NCT03095638|5415256|P3|NOT COMPLETED|P2: Period 1 (4 Days)||0
2208694|NCT03095638|5415257|P2|NOT COMPLETED|P2: Period 1 (4 Days)||0
2208695|NCT03095638|5415258|P1|NOT COMPLETED|P2: Period 1 (4 Days)||0
2208696|NCT03095638|5415251|P8|COMPLETED|P2: Period 1 (4 Days)||4
2208697|NCT03095638|5415252|P7|COMPLETED|P2: Period 1 (4 Days)||4
2208698|NCT03095638|5415253|P6|COMPLETED|P2: Period 1 (4 Days)||4
2208699|NCT03095638|5415254|P5|COMPLETED|P2: Period 1 (4 Days)||4
2208700|NCT03095638|5415255|P4|COMPLETED|P2: Period 1 (4 Days)||4
2208701|NCT03095638|5415256|P3|COMPLETED|P2: Period 1 (4 Days)||4
2208702|NCT03095638|5415257|P2|COMPLETED|P2: Period 1 (4 Days)||0
2208703|NCT03095638|5415258|P1|COMPLETED|P2: Period 1 (4 Days)||0
2208704|NCT03095638|5415251|P8|STARTED|P2: Period 1 (4 Days)||4
2208705|NCT03095638|5415252|P7|STARTED|P2: Period 1 (4 Days)||4
2208706|NCT03095638|5415253|P6|STARTED|P2: Period 1 (4 Days)||4
2208707|NCT03095638|5415254|P5|STARTED|P2: Period 1 (4 Days)||4
2208708|NCT03095638|5415255|P4|STARTED|P2: Period 1 (4 Days)||4
2208709|NCT03095638|5415256|P3|STARTED|P2: Period 1 (4 Days)||4
2208710|NCT03095638|5415257|P2|STARTED|P2: Period 1 (4 Days)||0
2208711|NCT03095638|5415258|P1|STARTED|P2: Period 1 (4 Days)||0
2208712|NCT03095638|5415251|P8|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
2208713|NCT03095638|5415252|P7|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
2208714|NCT03095638|5415253|P6|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
2208715|NCT03095638|5415254|P5|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
2208716|NCT03095638|5415255|P4|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
2208717|NCT03095638|5415256|P3|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
2208718|NCT03095638|5415257|P2|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
2208719|NCT03095638|5415258|P1|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
2208720|NCT03095638|5415251|P8|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
2208721|NCT03095638|5415252|P7|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
2208722|NCT03095638|5415253|P6|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
2208723|NCT03095638|5415254|P5|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
2208724|NCT03095638|5415255|P4|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
2208725|NCT03095638|5415256|P3|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
2208726|NCT03095638|5415257|P2|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||7
2208727|NCT03095638|5415258|P1|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||7
2208728|NCT03095638|5415251|P8|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
2208729|NCT03095638|5415252|P7|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
2208730|NCT03095638|5415253|P6|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
2208731|NCT03095638|5415254|P5|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
2208732|NCT03095638|5415255|P4|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
2208733|NCT03095638|5415256|P3|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
2208734|NCT03095638|5415257|P2|STARTED|P1: Period 2, Washout (7[-4 Hours])||7
2208735|NCT03095638|5415258|P1|STARTED|P1: Period 2, Washout (7[-4 Hours])||7
2208736|NCT03095638|5415251|P8|NOT COMPLETED|P1: Period 2 (4 Days)||0
2208737|NCT03095638|5415252|P7|NOT COMPLETED|P1: Period 2 (4 Days)||0
2208738|NCT03095638|5415253|P6|NOT COMPLETED|P1: Period 2 (4 Days)||0
2208739|NCT03095638|5415254|P5|NOT COMPLETED|P1: Period 2 (4 Days)||0
2208740|NCT03095638|5415255|P4|NOT COMPLETED|P1: Period 2 (4 Days)||0
2208741|NCT03095638|5415256|P3|NOT COMPLETED|P1: Period 2 (4 Days)||0
2208742|NCT03095638|5415257|P2|NOT COMPLETED|P1: Period 2 (4 Days)||0
2208743|NCT03095638|5415258|P1|NOT COMPLETED|P1: Period 2 (4 Days)||0
2208744|NCT03095638|5415251|P8|COMPLETED|P1: Period 2 (4 Days)||0
2208745|NCT03095638|5415252|P7|COMPLETED|P1: Period 2 (4 Days)||0
2208746|NCT03095638|5415253|P6|COMPLETED|P1: Period 2 (4 Days)||0
2208747|NCT03095638|5415254|P5|COMPLETED|P1: Period 2 (4 Days)||0
2208748|NCT03095638|5415255|P4|COMPLETED|P1: Period 2 (4 Days)||0
2208749|NCT03095638|5415256|P3|COMPLETED|P1: Period 2 (4 Days)||0
2208750|NCT03095638|5415257|P2|COMPLETED|P1: Period 2 (4 Days)||7
2208751|NCT03095638|5415258|P1|COMPLETED|P1: Period 2 (4 Days)||7
2208752|NCT03095638|5415251|P8|STARTED|P1: Period 2 (4 Days)||0
2208753|NCT03095638|5415252|P7|STARTED|P1: Period 2 (4 Days)||0
2208754|NCT03095638|5415253|P6|STARTED|P1: Period 2 (4 Days)||0
2208755|NCT03095638|5415254|P5|STARTED|P1: Period 2 (4 Days)||0
2208756|NCT03095638|5415255|P4|STARTED|P1: Period 2 (4 Days)||0
2208757|NCT03095638|5415256|P3|STARTED|P1: Period 2 (4 Days)||0
2208758|NCT03095638|5415257|P2|STARTED|P1: Period 2 (4 Days)||7
2208759|NCT03095638|5415258|P1|STARTED|P1: Period 2 (4 Days)||7
2208760|NCT03095638|5415251|P8|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
2208761|NCT03095638|5415252|P7|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
2208762|NCT03095638|5415253|P6|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
2208763|NCT03095638|5415254|P5|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
2208764|NCT03095638|5415255|P4|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
2208765|NCT03095638|5415256|P3|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
2208766|NCT03095638|5415257|P2|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
2208767|NCT03095638|5415258|P1|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
2208768|NCT03095638|5415251|P8|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
2208769|NCT03095638|5415252|P7|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
2208770|NCT03095638|5415253|P6|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
2208771|NCT03095638|5415254|P5|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
2208772|NCT03095638|5415255|P4|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
2208773|NCT03095638|5415256|P3|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
2208774|NCT03095638|5415257|P2|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||7
2208775|NCT03095638|5415258|P1|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||7
2208776|NCT03095638|5415251|P8|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
2208777|NCT03095638|5415252|P7|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
2208778|NCT03095638|5415253|P6|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
2208779|NCT03095638|5415254|P5|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
2208780|NCT03095638|5415255|P4|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
2208781|NCT03095638|5415256|P3|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
2208782|NCT03095638|5415257|P2|STARTED|P1: Period 1, Washout (7 [-4 Hours])||7
2208783|NCT03095638|5415258|P1|STARTED|P1: Period 1, Washout (7 [-4 Hours])||7
2208784|NCT03095638|5415251|P8|NOT COMPLETED|P1: Period 1 (4 Days)||0
2208785|NCT03095638|5415252|P7|NOT COMPLETED|P1: Period 1 (4 Days)||0
2208786|NCT03095638|5415253|P6|NOT COMPLETED|P1: Period 1 (4 Days)||0
2208787|NCT03095638|5415254|P5|NOT COMPLETED|P1: Period 1 (4 Days)||0
2208788|NCT03095638|5415255|P4|NOT COMPLETED|P1: Period 1 (4 Days)||0
2208789|NCT03095638|5415256|P3|NOT COMPLETED|P1: Period 1 (4 Days)||0
2208790|NCT03095638|5415257|P2|NOT COMPLETED|P1: Period 1 (4 Days)||0
2208791|NCT03095638|5415258|P1|NOT COMPLETED|P1: Period 1 (4 Days)||0
2208792|NCT03095638|5415251|P8|COMPLETED|P1: Period 1 (4 Days)||0
2208793|NCT03095638|5415252|P7|COMPLETED|P1: Period 1 (4 Days)||0
2208794|NCT03095638|5415253|P6|COMPLETED|P1: Period 1 (4 Days)||0
2208795|NCT03095638|5415254|P5|COMPLETED|P1: Period 1 (4 Days)||0
2208796|NCT03095638|5415255|P4|COMPLETED|P1: Period 1 (4 Days)||0
2208797|NCT03095638|5415256|P3|COMPLETED|P1: Period 1 (4 Days)||0
2208798|NCT03095638|5415257|P2|COMPLETED|P1: Period 1 (4 Days)||7
2208799|NCT03095638|5415258|P1|COMPLETED|P1: Period 1 (4 Days)||7
2208800|NCT03095638|5415251|P8|STARTED|P1: Period 1 (4 Days)||0
2208801|NCT03095638|5415252|P7|STARTED|P1: Period 1 (4 Days)||0
2208802|NCT03095638|5415253|P6|STARTED|P1: Period 1 (4 Days)||0
2208803|NCT03095638|5415254|P5|STARTED|P1: Period 1 (4 Days)||0
2208804|NCT03095638|5415255|P4|STARTED|P1: Period 1 (4 Days)||0
2208805|NCT03095638|5415256|P3|STARTED|P1: Period 1 (4 Days)||0
2208806|NCT03095638|5415257|P2|STARTED|P1: Period 1 (4 Days)||7
2208807|NCT03095638|5415258|P1|STARTED|P1: Period 1 (4 Days)||7
2208808|NCT03095599|5415406|P2|NOT COMPLETED|Overall Study||0
2208809|NCT03095599|5415407|P1|NOT COMPLETED|Overall Study||3
2208810|NCT03095599|5415406|P2|COMPLETED|Overall Study||148
2208811|NCT03095599|5415407|P1|COMPLETED|Overall Study||738
2208812|NCT03095599|5415406|P2|Vaccinated|Overall Study||148
2208813|NCT03095599|5415407|P1|Vaccinated|Overall Study||740
2208814|NCT03095599|5415406|P2|Withdrawal Before Vaccination|Overall Study||0
2208815|NCT03095599|5415407|P1|Withdrawal Before Vaccination|Overall Study||1
2208816|NCT03095599|5415406|P2|STARTED|Overall Study||148
2208817|NCT03095599|5415407|P1|STARTED|Overall Study||741
2208818|NCT03095521|5415443|P2|NOT COMPLETED|Overall Study||2
2208819|NCT03095521|5415444|P1|NOT COMPLETED|Overall Study||0
2208820|NCT03095521|5415443|P2|COMPLETED|Overall Study||111
2208821|NCT03095521|5415444|P1|COMPLETED|Overall Study||115
2208822|NCT03095521|5415443|P2|Safety Population|Overall Study||113
2208823|NCT03095521|5415444|P1|Safety Population|Overall Study||115
2208824|NCT03095521|5415443|P2|Per Protocol Population PP|Overall Study||107
2208825|NCT03095521|5415444|P1|Per Protocol Population PP|Overall Study||113
2208826|NCT03095521|5415443|P2|Intent to Treat Population ITT|Overall Study||113
2208827|NCT03095521|5415444|P1|Intent to Treat Population ITT|Overall Study||115
2208828|NCT03095521|5415443|P2|STARTED|Overall Study||113
2208829|NCT03095521|5415444|P1|STARTED|Overall Study||115
2208830|NCT03095508|5415462|P2|NOT COMPLETED|Overall Study||1
2208831|NCT03095508|5415463|P1|NOT COMPLETED|Overall Study||0
2208832|NCT03095508|5415462|P2|COMPLETED|Overall Study||114
2208833|NCT03095508|5415463|P1|COMPLETED|Overall Study||114
2208834|NCT03095508|5415462|P2|ITT Population|Overall Study||115
2208835|NCT03095508|5415463|P1|ITT Population|Overall Study||114
2208836|NCT03095508|5415462|P2|Safety Population|Overall Study||115
2208837|NCT03095508|5415463|P1|Safety Population|Overall Study||114
2208838|NCT03095508|5415462|P2|Per Protocol Population|Overall Study||111
2208839|NCT03095508|5415463|P1|Per Protocol Population|Overall Study||112
2208840|NCT03095508|5415462|P2|STARTED|Overall Study||115
2208841|NCT03095508|5415463|P1|STARTED|Overall Study||114
2208842|NCT03095456|5415481|P2|NOT COMPLETED|Overall Study||8
2208843|NCT03095456|5415482|P1|NOT COMPLETED|Overall Study||4
2208844|NCT03095456|5415481|P2|COMPLETED|Overall Study||96
2208845|NCT03095456|5415482|P1|COMPLETED|Overall Study||99
2208846|NCT03095456|5415481|P2|STARTED|Overall Study||104
2208847|NCT03095456|5415482|P1|STARTED|Overall Study||103
2208848|NCT03095053|5415500|P2|NOT COMPLETED|Overall Study||0
2208849|NCT03095053|5415501|P1|NOT COMPLETED|Overall Study||29
2208850|NCT03095053|5415500|P2|COMPLETED|Overall Study||111
2208851|NCT03095053|5415501|P1|COMPLETED|Overall Study|29 excluded as blastocyst was predicted to be aneuploid|80
2208852|NCT03095053|5415500|P2|STARTED|Overall Study|All blastocysts scored morphologically|111
2208853|NCT03095053|5415501|P1|STARTED|Overall Study|All blastocysts scored morphologically PGT-A of the single best blastocyst from the cohort|109
2208854|NCT03095027|5415511|P2|NOT COMPLETED|Period 2, Second Week of Wear||0
2208855|NCT03095027|5415512|P1|NOT COMPLETED|Period 2, Second Week of Wear||1
2208856|NCT03095027|5415511|P2|COMPLETED|Period 2, Second Week of Wear||24
2208857|NCT03095027|5415512|P1|COMPLETED|Period 2, Second Week of Wear||26
2208858|NCT03095027|5415511|P2|STARTED|Period 2, Second Week of Wear||24
2208859|NCT03095027|5415512|P1|STARTED|Period 2, Second Week of Wear||27
2208860|NCT03095027|5415511|P2|NOT COMPLETED|Period 1, First Week of Wear||0
2208861|NCT03095027|5415512|P1|NOT COMPLETED|Period 1, First Week of Wear||0
2208862|NCT03095027|5415511|P2|COMPLETED|Period 1, First Week of Wear||24
2208863|NCT03095027|5415512|P1|COMPLETED|Period 1, First Week of Wear||27
2208864|NCT03095027|5415511|P2|STARTED|Period 1, First Week of Wear||24
2208865|NCT03095027|5415512|P1|STARTED|Period 1, First Week of Wear||27
2208866|NCT03094806|5415520|P2|NOT COMPLETED|Overall Study||0
2208867|NCT03094806|5415521|P1|NOT COMPLETED|Overall Study||0
2208868|NCT03094806|5415520|P2|COMPLETED|Overall Study||47
2208869|NCT03094806|5415521|P1|COMPLETED|Overall Study||44
2208870|NCT03094806|5415520|P2|STARTED|Overall Study||47
2208871|NCT03094806|5415521|P1|STARTED|Overall Study||44
2208881|NCT03093025|5415573|P3|NOT COMPLETED|Overall Study||2
2208882|NCT03093025|5415574|P2|NOT COMPLETED|Overall Study||2
2208883|NCT03093025|5415575|P1|NOT COMPLETED|Overall Study||4
2208884|NCT03093025|5415573|P3|COMPLETED|Overall Study||16
2208885|NCT03093025|5415574|P2|COMPLETED|Overall Study||15
2208886|NCT03093025|5415575|P1|COMPLETED|Overall Study||12
2208887|NCT03093025|5415573|P3|STARTED|Overall Study||18
2208888|NCT03093025|5415574|P2|STARTED|Overall Study|One participant did not take any dose of investigational product after randomization.|17
2208889|NCT03093025|5415575|P1|STARTED|Overall Study||16
2208890|NCT03092791|5415606|P8|NOT COMPLETED|Overall Study||60
2208891|NCT03092791|5415607|P7|NOT COMPLETED|Overall Study||60
2208892|NCT03092791|5415608|P6|NOT COMPLETED|Overall Study||60
2208893|NCT03092791|5415609|P5|NOT COMPLETED|Overall Study||60
2208894|NCT03092791|5415610|P4|NOT COMPLETED|Overall Study||0
2208895|NCT03092791|5415611|P3|NOT COMPLETED|Overall Study||0
2208896|NCT03092791|5415612|P2|NOT COMPLETED|Overall Study||0
2208897|NCT03092791|5415613|P1|NOT COMPLETED|Overall Study||0
2208898|NCT03092791|5415606|P8|COMPLETED|Overall Study||0
2208899|NCT03092791|5415607|P7|COMPLETED|Overall Study||0
2208900|NCT03092791|5415608|P6|COMPLETED|Overall Study||0
2208901|NCT03092791|5415609|P5|COMPLETED|Overall Study||0
2208902|NCT03092791|5415610|P4|COMPLETED|Overall Study||30
2208903|NCT03092791|5415611|P3|COMPLETED|Overall Study||30
2208904|NCT03092791|5415612|P2|COMPLETED|Overall Study||20
2208905|NCT03092791|5415613|P1|COMPLETED|Overall Study||20
2208906|NCT03092791|5415606|P8|STARTED|Overall Study||60
2208907|NCT03092791|5415607|P7|STARTED|Overall Study||60
2208908|NCT03092791|5415608|P6|STARTED|Overall Study||60
2208909|NCT03092791|5415609|P5|STARTED|Overall Study||60
2208910|NCT03092791|5415610|P4|STARTED|Overall Study||30
2208911|NCT03092791|5415611|P3|STARTED|Overall Study||30
2208912|NCT03092791|5415612|P2|STARTED|Overall Study||20
2208913|NCT03092791|5415613|P1|STARTED|Overall Study||20
2208914|NCT03092752|5415728|P1|NOT COMPLETED|Overall Study||361469
2208915|NCT03092752|5415728|P1|COMPLETED|Overall Study||162116
2208916|NCT03092752|5415728|P1|STARTED|Overall Study||523585
2208917|NCT03092726|5415793|P2|NOT COMPLETED|Overall Study||14
2208918|NCT03092726|5415794|P1|NOT COMPLETED|Overall Study||9
2208919|NCT03092726|5415793|P2|COMPLETED|Overall Study||81
2208920|NCT03092726|5415794|P1|COMPLETED|Overall Study||79
2208921|NCT03092726|5415793|P2|Treated|Overall Study||95
2208922|NCT03092726|5415794|P1|Treated|Overall Study||88
2208923|NCT03092726|5415793|P2|STARTED|Overall Study||95
2208924|NCT03092726|5415794|P1|STARTED|Overall Study||88
2208937|NCT03091777|5415858|P3|NOT COMPLETED|Overall Study||37
2208938|NCT03091777|5415859|P2|NOT COMPLETED|Overall Study||33
2208939|NCT03091777|5415860|P1|NOT COMPLETED|Overall Study||32
2208940|NCT03091777|5415858|P3|COMPLETED|Overall Study||257
2208941|NCT03091777|5415859|P2|COMPLETED|Overall Study||255
2208942|NCT03091777|5415860|P1|COMPLETED|Overall Study||257
2208943|NCT03091777|5415858|P3|STARTED|Overall Study||294
2208944|NCT03091777|5415859|P2|STARTED|Overall Study||288
2208945|NCT03091777|5415860|P1|STARTED|Overall Study||289
2208946|NCT03091751|5415868|P1|NOT COMPLETED|Overall Study||0
2208947|NCT03091751|5415868|P1|COMPLETED|Overall Study||22
2208948|NCT03091751|5415868|P1|STARTED|Overall Study||22
2208949|NCT03091673|5415879|P2|NOT COMPLETED|Second Dose||0
2208950|NCT03091673|5415880|P1|NOT COMPLETED|Second Dose||0
2208951|NCT03091673|5415879|P2|COMPLETED|Second Dose||11
2208952|NCT03091673|5415880|P1|COMPLETED|Second Dose||0
2208953|NCT03091673|5415879|P2|STARTED|Second Dose|Only the 11 study subjects ages 12-<18 years were assigned the 1 mg dose during period 2.|11
2208954|NCT03091673|5415880|P1|STARTED|Second Dose|No subjects received the 0.5 mg dose during period 2.|0
2208955|NCT03091673|5415879|P2|NOT COMPLETED|First Dose||0
2208956|NCT03091673|5415880|P1|NOT COMPLETED|First Dose||0
2208957|NCT03091673|5415879|P2|COMPLETED|First Dose||0
2208958|NCT03091673|5415880|P1|COMPLETED|First Dose||31
2208959|NCT03091673|5415879|P2|STARTED|First Dose|All 31 subjects received the 0.5 mg dose during period 1.|0
2208960|NCT03091673|5415880|P1|STARTED|First Dose||31
2208961|NCT03091439|5415902|P2|NOT COMPLETED|Overall Study||0
2208962|NCT03091439|5415903|P1|NOT COMPLETED|Overall Study||1
2208963|NCT03091439|5415902|P2|COMPLETED|Overall Study||0
2208964|NCT03091439|5415903|P1|COMPLETED|Overall Study||0
2208965|NCT03091439|5415902|P2|STARTED|Overall Study||0
2208966|NCT03091439|5415903|P1|STARTED|Overall Study||1
2208967|NCT03091361|5415925|P1|NOT COMPLETED|Overall Study||0
2208968|NCT03091361|5415925|P1|COMPLETED|Overall Study||30
2208969|NCT03091361|5415925|P1|STARTED|Overall Study||30
2208970|NCT03091348|5415931|P2|NOT COMPLETED|Overall Study||1
2208971|NCT03091348|5415932|P1|NOT COMPLETED|Overall Study||2
2208972|NCT03091348|5415931|P2|COMPLETED|Overall Study||1
2208973|NCT03091348|5415932|P1|COMPLETED|Overall Study||0
2208974|NCT03091348|5415931|P2|STARTED|Overall Study||2
2208975|NCT03091348|5415932|P1|STARTED|Overall Study||2
2208976|NCT03091179|5415958|P2|NOT COMPLETED|Overall Study||0
2208977|NCT03091179|5415959|P1|NOT COMPLETED|Overall Study||0
2208978|NCT03091179|5415958|P2|COMPLETED|Overall Study||10
2208979|NCT03091179|5415959|P1|COMPLETED|Overall Study||10
2208980|NCT03091179|5415958|P2|STARTED|Overall Study||10
2208981|NCT03091179|5415959|P1|STARTED|Overall Study||10
2208982|NCT03090958|5415985|P1|NOT COMPLETED|Overall Study||0
2208983|NCT03090958|5415985|P1|COMPLETED|Overall Study||20
2208984|NCT03090958|5415985|P1|STARTED|Overall Study||20
2208985|NCT03090256|5415997|P1|NOT COMPLETED|Overall Study||0
2208986|NCT03090256|5415997|P1|COMPLETED|Overall Study||68
2208987|NCT03090256|5415997|P1|STARTED|Overall Study||68
2208988|NCT03090100|5416008|P2|NOT COMPLETED|Overall Study||48
2208989|NCT03090100|5416009|P1|NOT COMPLETED|Overall Study||27
2208990|NCT03090100|5416008|P2|COMPLETED|Overall Study||466
2208991|NCT03090100|5416009|P1|COMPLETED|Overall Study||507
2208992|NCT03090100|5416008|P2|Treated|Overall Study||511
2208993|NCT03090100|5416009|P1|Treated|Overall Study||534
2208994|NCT03090100|5416008|P2|STARTED|Overall Study||514
2208995|NCT03090100|5416009|P1|STARTED|Overall Study||534
2208996|NCT03089879|5416052|P3|NOT COMPLETED|Overall Study||0
2208997|NCT03089879|5416053|P2|NOT COMPLETED|Overall Study||0
2208998|NCT03089879|5416054|P1|NOT COMPLETED|Overall Study||0
2208999|NCT03089879|5416052|P3|COMPLETED|Overall Study||26
2209000|NCT03089879|5416053|P2|COMPLETED|Overall Study||2
2209001|NCT03089879|5416054|P1|COMPLETED|Overall Study||7
2209002|NCT03089879|5416052|P3|STARTED|Overall Study||26
2209003|NCT03089879|5416053|P2|STARTED|Overall Study||2
2209004|NCT03089879|5416054|P1|STARTED|Overall Study||7
2209005|NCT03089580|5416083|P1|NOT COMPLETED|Overall Study||2
2209006|NCT03089580|5416083|P1|COMPLETED|Overall Study||12
2209007|NCT03089580|5416083|P1|STARTED|Overall Study||14
2209008|NCT03089216|5416094|P4|NOT COMPLETED|Overall Study||1
2209009|NCT03089216|5416095|P3|NOT COMPLETED|Overall Study||0
2209010|NCT03089216|5416096|P2|NOT COMPLETED|Overall Study||0
2209011|NCT03089216|5416097|P1|NOT COMPLETED|Overall Study||0
2209012|NCT03089216|5416094|P4|COMPLETED|Overall Study||26
2209013|NCT03089216|5416095|P3|COMPLETED|Overall Study||27
2209014|NCT03089216|5416096|P2|COMPLETED|Overall Study||27
2209015|NCT03089216|5416097|P1|COMPLETED|Overall Study||27
2209016|NCT03089216|5416094|P4|STARTED|Overall Study||27
2209017|NCT03089216|5416095|P3|STARTED|Overall Study||27
2209018|NCT03089216|5416096|P2|STARTED|Overall Study||27
2209019|NCT03089216|5416097|P1|STARTED|Overall Study||27
2209020|NCT03088917|5416111|P1|NOT COMPLETED|Overall Study||96
2209021|NCT03088917|5416111|P1|COMPLETED|Overall Study||10
2209022|NCT03088917|5416111|P1|STARTED|Overall Study||106
2209023|NCT03088267|5416119|P2|NOT COMPLETED|Overall Study||0
2209024|NCT03088267|5416120|P1|NOT COMPLETED|Overall Study||0
2209025|NCT03088267|5416119|P2|COMPLETED|Overall Study||9
2209026|NCT03088267|5416120|P1|COMPLETED|Overall Study||9
2209027|NCT03088267|5416119|P2|STARTED|Overall Study||9
2209028|NCT03088267|5416120|P1|STARTED|Overall Study||9
2209029|NCT03088137|5416131|P2|NOT COMPLETED|Overall Study||0
2209030|NCT03088137|5416132|P1|NOT COMPLETED|Overall Study||0
2209031|NCT03088137|5416131|P2|COMPLETED|Overall Study||55
2209032|NCT03088137|5416132|P1|COMPLETED|Overall Study||55
2209033|NCT03088137|5416131|P2|STARTED|Overall Study||55
2209034|NCT03088137|5416132|P1|STARTED|Overall Study||55
2209035|NCT03087643|5416162|P2|NOT COMPLETED|Overall Study||6
2209036|NCT03087643|5416163|P1|NOT COMPLETED|Overall Study||4
2209037|NCT03087643|5416162|P2|COMPLETED|Overall Study||19
2209038|NCT03087643|5416163|P1|COMPLETED|Overall Study||22
2209039|NCT03087643|5416162|P2|STARTED|Overall Study||25
2209040|NCT03087643|5416163|P1|STARTED|Overall Study||26
2209041|NCT03087604|5416179|P2|NOT COMPLETED|Overall Study||0
2209042|NCT03087604|5416180|P1|NOT COMPLETED|Overall Study||0
2209043|NCT03087604|5416179|P2|COMPLETED|Overall Study||50
2209044|NCT03087604|5416180|P1|COMPLETED|Overall Study||50
2209045|NCT03087604|5416179|P2|STARTED|Overall Study||50
2209046|NCT03087604|5416180|P1|STARTED|Overall Study||50
2209047|NCT03086447|5416192|P2|NOT COMPLETED|Overall Study||20
2209048|NCT03086447|5416193|P1|NOT COMPLETED|Overall Study||11
2209049|NCT03086447|5416192|P2|COMPLETED|Overall Study||110
2209050|NCT03086447|5416193|P1|COMPLETED|Overall Study||121
2209051|NCT03086447|5416192|P2|STARTED|Overall Study||130
2209052|NCT03086447|5416193|P1|STARTED|Overall Study||132
2209053|NCT03086356|5416213|P1|NOT COMPLETED|Overall Study||0
2209054|NCT03086356|5416213|P1|COMPLETED|Overall Study||12
2209055|NCT03086356|5416213|P1|STARTED|Overall Study||12
2209056|NCT03086330|5416224|P2|NOT COMPLETED|Overall Study||4
2209057|NCT03086330|5416225|P1|NOT COMPLETED|Overall Study||4
2209058|NCT03086330|5416224|P2|COMPLETED|Overall Study||147
2209059|NCT03086330|5416225|P1|COMPLETED|Overall Study||147
2209060|NCT03086330|5416224|P2|Exposed|Overall Study||151
2209061|NCT03086330|5416225|P1|Exposed|Overall Study||150
2209062|NCT03086330|5416224|P2|STARTED|Overall Study||151
2209063|NCT03086330|5416225|P1|STARTED|Overall Study||151
2209064|NCT03086135|5416345|P1|NOT COMPLETED|Overall Study||3
2209065|NCT03086135|5416345|P1|COMPLETED|Overall Study||48
2209066|NCT03086135|5416345|P1|STARTED|Overall Study||51
2209067|NCT03086018|5416372|P1|NOT COMPLETED|Final Testing for End of Trial||2
2209068|NCT03086018|5416372|P1|COMPLETED|Final Testing for End of Trial||28
2209069|NCT03086018|5416372|P1|STARTED|Final Testing for End of Trial||30
2209070|NCT03086018|5416372|P1|NOT COMPLETED|Field Testing||0
2209071|NCT03086018|5416372|P1|COMPLETED|Field Testing||30
2209072|NCT03086018|5416372|P1|STARTED|Field Testing||30
2209073|NCT03085836|5416383|P3|NOT COMPLETED|Overall Study||0
2209074|NCT03085836|5416384|P2|NOT COMPLETED|Overall Study||0
2209075|NCT03085836|5416385|P1|NOT COMPLETED|Overall Study||0
2209076|NCT03085836|5416383|P3|COMPLETED|Overall Study||10
2209077|NCT03085836|5416384|P2|COMPLETED|Overall Study||11
2209078|NCT03085836|5416385|P1|COMPLETED|Overall Study||12
2209079|NCT03085836|5416383|P3|STARTED|Overall Study||10
2209080|NCT03085836|5416384|P2|STARTED|Overall Study||11
2209081|NCT03085836|5416385|P1|STARTED|Overall Study||12
2209082|NCT03085238|5416432|P1|NOT COMPLETED|Overall Study||4
2209083|NCT03085238|5416432|P1|COMPLETED|Overall Study||19
2209084|NCT03085238|5416432|P1|18 Months|Overall Study||7
2209085|NCT03085238|5416432|P1|15 Months|Overall Study||11
2209086|NCT03085238|5416432|P1|12 Months|Overall Study||14
2209087|NCT03085238|5416432|P1|9 Months|Overall Study||16
2209088|NCT03085238|5416432|P1|6 Months|Overall Study||19
2209089|NCT03085238|5416432|P1|3 Months|Overall Study||22
2209090|NCT03085238|5416432|P1|1 Month|Overall Study||23
2209091|NCT03085238|5416432|P1|STARTED|Overall Study||23
2209092|NCT03083769|5416459|P2|NOT COMPLETED|Overall Study||32
2209093|NCT03083769|5416460|P1|NOT COMPLETED|Overall Study||20
2209094|NCT03083769|5416459|P2|COMPLETED|Overall Study||631
2209095|NCT03083769|5416460|P1|COMPLETED|Overall Study||819
2209096|NCT03083769|5416459|P2|STARTED|Overall Study||663
2209097|NCT03083769|5416460|P1|STARTED|Overall Study||839
2209098|NCT03083639|5416472|P2|NOT COMPLETED|Intervention Period 2 (1 Day)||0
2209099|NCT03083639|5416473|P1|NOT COMPLETED|Intervention Period 2 (1 Day)||0
2209100|NCT03083639|5416472|P2|COMPLETED|Intervention Period 2 (1 Day)||25
2209101|NCT03083639|5416473|P1|COMPLETED|Intervention Period 2 (1 Day)||25
2209102|NCT03083639|5416472|P2|STARTED|Intervention Period 2 (1 Day)||25
2209103|NCT03083639|5416473|P1|STARTED|Intervention Period 2 (1 Day)||25
2209104|NCT03083639|5416472|P2|NOT COMPLETED|Washout Period (at Least 6 Days)||1
2209105|NCT03083639|5416473|P1|NOT COMPLETED|Washout Period (at Least 6 Days)||1
2209106|NCT03083639|5416472|P2|COMPLETED|Washout Period (at Least 6 Days)||25
2209107|NCT03083639|5416473|P1|COMPLETED|Washout Period (at Least 6 Days)||25
2209108|NCT03083639|5416472|P2|STARTED|Washout Period (at Least 6 Days)||26
2209109|NCT03083639|5416473|P1|STARTED|Washout Period (at Least 6 Days)||26
2209110|NCT03083639|5416472|P2|NOT COMPLETED|Intervention Period 1 (1 Day)||0
2209111|NCT03083639|5416473|P1|NOT COMPLETED|Intervention Period 1 (1 Day)||0
2209112|NCT03083639|5416472|P2|COMPLETED|Intervention Period 1 (1 Day)||26
2209113|NCT03083639|5416473|P1|COMPLETED|Intervention Period 1 (1 Day)||26
2209114|NCT03083639|5416472|P2|STARTED|Intervention Period 1 (1 Day)||26
2209115|NCT03083639|5416473|P1|STARTED|Intervention Period 1 (1 Day)||26
2209116|NCT03083483|5416486|P3|NOT COMPLETED|Overall Study||3
2209117|NCT03083483|5416487|P2|NOT COMPLETED|Overall Study||2
2209118|NCT03083483|5416488|P1|NOT COMPLETED|Overall Study||4
2209119|NCT03083483|5416486|P3|COMPLETED|Overall Study||20
2209120|NCT03083483|5416487|P2|COMPLETED|Overall Study||20
2209121|NCT03083483|5416488|P1|COMPLETED|Overall Study||20
2209122|NCT03083483|5416486|P3|STARTED|Overall Study||23
2209123|NCT03083483|5416487|P2|STARTED|Overall Study||22
2209124|NCT03083483|5416488|P1|STARTED|Overall Study||24
2209125|NCT03083470|5416507|P5|NOT COMPLETED|Overall Study||2
2209126|NCT03083470|5416508|P4|NOT COMPLETED|Overall Study||0
2209127|NCT03083470|5416509|P3|NOT COMPLETED|Overall Study||0
2209128|NCT03083470|5416510|P2|NOT COMPLETED|Overall Study||0
2209129|NCT03083470|5416511|P1|NOT COMPLETED|Overall Study||0
2209130|NCT03083470|5416507|P5|COMPLETED|Overall Study||7
2209131|NCT03083470|5416508|P4|COMPLETED|Overall Study||6
2209132|NCT03083470|5416509|P3|COMPLETED|Overall Study||6
2209133|NCT03083470|5416510|P2|COMPLETED|Overall Study||6
2209134|NCT03083470|5416511|P1|COMPLETED|Overall Study||6
2209135|NCT03083470|5416507|P5|STARTED|Overall Study||9
2209136|NCT03083470|5416508|P4|STARTED|Overall Study||6
2209137|NCT03083470|5416509|P3|STARTED|Overall Study||6
2209138|NCT03083470|5416510|P2|STARTED|Overall Study||6
2209139|NCT03083470|5416511|P1|STARTED|Overall Study||6
2209140|NCT03083379|5416550|P2|NOT COMPLETED|Overall Study||0
2209141|NCT03083379|5416551|P1|NOT COMPLETED|Overall Study||0
2209142|NCT03083379|5416550|P2|COMPLETED|Overall Study||15
2209143|NCT03083379|5416551|P1|COMPLETED|Overall Study||15
2209144|NCT03083379|5416550|P2|STARTED|Overall Study||15
2209145|NCT03083379|5416551|P1|STARTED|Overall Study||15
2209146|NCT03082599|5416559|P2|NOT COMPLETED|Overall Study||0
2209147|NCT03082599|5416560|P1|NOT COMPLETED|Overall Study||1
2209148|NCT03082599|5416559|P2|COMPLETED|Overall Study||39
2209149|NCT03082599|5416560|P1|COMPLETED|Overall Study||39
2209150|NCT03082599|5416559|P2|STARTED|Overall Study||39
2209151|NCT03082599|5416560|P1|STARTED|Overall Study||40
2209152|NCT03080961|5416586|P1|NOT COMPLETED|Overall Study||3
2209153|NCT03080961|5416586|P1|COMPLETED|Overall Study||43
2209154|NCT03080961|5416586|P1|STARTED|Overall Study||46
2209155|NCT03080454|5416595|P1|NOT COMPLETED|Anodal FU (7 Days)||4
2209156|NCT03080454|5416595|P1|COMPLETED|Anodal FU (7 Days)||19
2209157|NCT03080454|5416595|P1|STARTED|Anodal FU (7 Days)||23
2209158|NCT03080454|5416595|P1|NOT COMPLETED|Anodal Doublestim (5 Days)||1
2209159|NCT03080454|5416595|P1|COMPLETED|Anodal Doublestim (5 Days)||23
2209160|NCT03080454|5416595|P1|STARTED|Anodal Doublestim (5 Days)||24
2209161|NCT03080454|5416595|P1|NOT COMPLETED|Sham FU (7days)||0
2209162|NCT03080454|5416595|P1|COMPLETED|Sham FU (7days)||24
2209163|NCT03080454|5416595|P1|STARTED|Sham FU (7days)||24
2209164|NCT03080454|5416595|P1|NOT COMPLETED|Sham Doublestim (5days)||0
2209165|NCT03080454|5416595|P1|COMPLETED|Sham Doublestim (5days)||24
2209166|NCT03080454|5416595|P1|STARTED|Sham Doublestim (5days)||24
2209167|NCT03080454|5416595|P1|NOT COMPLETED|Baseline||2
2209168|NCT03080454|5416595|P1|COMPLETED|Baseline|Two participants (pts) dropped out after consent due to hospitalizations unrelated to the study.|24
2209169|NCT03080454|5416595|P1|STARTED|Baseline||26
2209170|NCT03079531|5416604|P1|NOT COMPLETED|Overall Study||7
2209171|NCT03079531|5416604|P1|COMPLETED|Overall Study||17
2209172|NCT03079531|5416604|P1|Attended ≥1 Post-baseline Visit|Overall Study||23
2209173|NCT03079531|5416604|P1|STARTED|Overall Study||24
2209174|NCT03079375|5416617|P3|NOT COMPLETED|Overall Study||21
2209175|NCT03079375|5416618|P2|NOT COMPLETED|Overall Study||6
2209176|NCT03079375|5416619|P1|NOT COMPLETED|Overall Study||5
2209177|NCT03079375|5416617|P3|COMPLETED|Overall Study||476
2209178|NCT03079375|5416618|P2|COMPLETED|Overall Study||493
2209179|NCT03079375|5416619|P1|COMPLETED|Overall Study||498
2209180|NCT03079375|5416617|P3|STARTED|Overall Study||497
2209181|NCT03079375|5416618|P2|STARTED|Overall Study||499
2209182|NCT03079375|5416619|P1|STARTED|Overall Study||503
2209183|NCT03078647|5416654|P3|NOT COMPLETED|Overall Study||0
2209184|NCT03078647|5416655|P2|NOT COMPLETED|Overall Study||1
2209185|NCT03078647|5416656|P1|NOT COMPLETED|Overall Study||0
2209186|NCT03078647|5416654|P3|COMPLETED|Overall Study||3
2209187|NCT03078647|5416655|P2|COMPLETED|Overall Study||10
2209188|NCT03078647|5416656|P1|COMPLETED|Overall Study||17
2209189|NCT03078647|5416654|P3|STARTED|Overall Study||3
2209190|NCT03078647|5416655|P2|STARTED|Overall Study||11
2209191|NCT03078647|5416656|P1|STARTED|Overall Study||17
2209192|NCT03078556|5416675|P4|NOT COMPLETED|Treatment Period 3 (4 Days)||0
2209193|NCT03078556|5416676|P3|NOT COMPLETED|Treatment Period 3 (4 Days)||0
2209194|NCT03078556|5416677|P2|NOT COMPLETED|Treatment Period 3 (4 Days)||0
2209195|NCT03078556|5416678|P1|NOT COMPLETED|Treatment Period 3 (4 Days)||0
2209196|NCT03078556|5416675|P4|COMPLETED|Treatment Period 3 (4 Days)||9
2209197|NCT03078556|5416676|P3|COMPLETED|Treatment Period 3 (4 Days)||7
2209198|NCT03078556|5416677|P2|COMPLETED|Treatment Period 3 (4 Days)||7
2209199|NCT03078556|5416678|P1|COMPLETED|Treatment Period 3 (4 Days)||9
2209200|NCT03078556|5416675|P4|STARTED|Treatment Period 3 (4 Days)||9
2209201|NCT03078556|5416676|P3|STARTED|Treatment Period 3 (4 Days)||7
2209202|NCT03078556|5416677|P2|STARTED|Treatment Period 3 (4 Days)||7
2209203|NCT03078556|5416678|P1|STARTED|Treatment Period 3 (4 Days)||9
2209204|NCT03078556|5416675|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
2209205|NCT03078556|5416676|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
2209206|NCT03078556|5416677|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
2209207|NCT03078556|5416678|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
2209208|NCT03078556|5416675|P4|COMPLETED|Washout Period 2 (7 Days)||9
2209209|NCT03078556|5416676|P3|COMPLETED|Washout Period 2 (7 Days)||7
2209210|NCT03078556|5416677|P2|COMPLETED|Washout Period 2 (7 Days)||7
2209211|NCT03078556|5416678|P1|COMPLETED|Washout Period 2 (7 Days)||9
2209212|NCT03078556|5416675|P4|STARTED|Washout Period 2 (7 Days)||9
2209213|NCT03078556|5416676|P3|STARTED|Washout Period 2 (7 Days)||7
2209214|NCT03078556|5416677|P2|STARTED|Washout Period 2 (7 Days)||7
2209215|NCT03078556|5416678|P1|STARTED|Washout Period 2 (7 Days)||9
2209216|NCT03078556|5416675|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
2209217|NCT03078556|5416676|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
2209218|NCT03078556|5416677|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
2209219|NCT03078556|5416678|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
2209220|NCT03078556|5416675|P4|COMPLETED|Treatment Period 2 (4 Days)||37
2209221|NCT03078556|5416676|P3|COMPLETED|Treatment Period 2 (4 Days)||37
2209222|NCT03078556|5416677|P2|COMPLETED|Treatment Period 2 (4 Days)||36
2209223|NCT03078556|5416678|P1|COMPLETED|Treatment Period 2 (4 Days)||37
2209224|NCT03078556|5416675|P4|STARTED|Treatment Period 2 (4 Days)||37
2209225|NCT03078556|5416676|P3|STARTED|Treatment Period 2 (4 Days)||37
2209226|NCT03078556|5416677|P2|STARTED|Treatment Period 2 (4 Days)||36
2209227|NCT03078556|5416678|P1|STARTED|Treatment Period 2 (4 Days)||37
2209228|NCT03078556|5416675|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
2209229|NCT03078556|5416676|P3|NOT COMPLETED|Washout Period 1 (7 Days)||1
2209230|NCT03078556|5416677|P2|NOT COMPLETED|Washout Period 1 (7 Days)||2
2209231|NCT03078556|5416678|P1|NOT COMPLETED|Washout Period 1 (7 Days)||2
2209232|NCT03078556|5416675|P4|COMPLETED|Washout Period 1 (7 Days)||37
2209233|NCT03078556|5416676|P3|COMPLETED|Washout Period 1 (7 Days)||37
2209234|NCT03078556|5416677|P2|COMPLETED|Washout Period 1 (7 Days)||36
2209235|NCT03078556|5416678|P1|COMPLETED|Washout Period 1 (7 Days)||37
2209236|NCT03078556|5416675|P4|STARTED|Washout Period 1 (7 Days)||38
2209237|NCT03078556|5416676|P3|STARTED|Washout Period 1 (7 Days)||38
2209238|NCT03078556|5416677|P2|STARTED|Washout Period 1 (7 Days)||38
2209239|NCT03078556|5416678|P1|STARTED|Washout Period 1 (7 Days)||39
2209240|NCT03078556|5416675|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
2209241|NCT03078556|5416676|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
2209242|NCT03078556|5416677|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||1
2209243|NCT03078556|5416678|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
2209244|NCT03078556|5416675|P4|COMPLETED|Treatment Period 1 (4 Days)||38
2209245|NCT03078556|5416676|P3|COMPLETED|Treatment Period 1 (4 Days)||38
2209246|NCT03078556|5416677|P2|COMPLETED|Treatment Period 1 (4 Days)||38
2209247|NCT03078556|5416678|P1|COMPLETED|Treatment Period 1 (4 Days)||39
2209248|NCT03078556|5416675|P4|STARTED|Treatment Period 1 (4 Days)||38
2209249|NCT03078556|5416676|P3|STARTED|Treatment Period 1 (4 Days)||38
2209250|NCT03078556|5416677|P2|STARTED|Treatment Period 1 (4 Days)||39
2209251|NCT03078556|5416678|P1|STARTED|Treatment Period 1 (4 Days)||39
2209252|NCT03078270|5416818|P2|NOT COMPLETED|Overall Study||0
2209253|NCT03078270|5416819|P1|NOT COMPLETED|Overall Study||4
2209254|NCT03078270|5416818|P2|COMPLETED|Overall Study||0
2209255|NCT03078270|5416819|P1|COMPLETED|Overall Study||0
2209256|NCT03078270|5416818|P2|STARTED|Overall Study||0
2209257|NCT03078270|5416819|P1|STARTED|Overall Study||4
2209258|NCT03078127|5416828|P3|NOT COMPLETED|Third Intervention||0
2209259|NCT03078127|5416829|P2|NOT COMPLETED|Third Intervention||0
2209260|NCT03078127|5416830|P1|NOT COMPLETED|Third Intervention||0
2209261|NCT03078127|5416828|P3|COMPLETED|Third Intervention||3
2209262|NCT03078127|5416829|P2|COMPLETED|Third Intervention||3
2209263|NCT03078127|5416830|P1|COMPLETED|Third Intervention||4
2209264|NCT03078127|5416828|P3|STARTED|Third Intervention||3
2209265|NCT03078127|5416829|P2|STARTED|Third Intervention||3
2209266|NCT03078127|5416830|P1|STARTED|Third Intervention||4
2209267|NCT03078127|5416828|P3|NOT COMPLETED|Washout (3-21 Days)||0
2209268|NCT03078127|5416829|P2|NOT COMPLETED|Washout (3-21 Days)||0
2209269|NCT03078127|5416830|P1|NOT COMPLETED|Washout (3-21 Days)||0
2209270|NCT03078127|5416828|P3|COMPLETED|Washout (3-21 Days)||3
2209271|NCT03078127|5416829|P2|COMPLETED|Washout (3-21 Days)||3
2209272|NCT03078127|5416830|P1|COMPLETED|Washout (3-21 Days)||4
2209273|NCT03078127|5416828|P3|STARTED|Washout (3-21 Days)||3
2209274|NCT03078127|5416829|P2|STARTED|Washout (3-21 Days)||3
2209275|NCT03078127|5416830|P1|STARTED|Washout (3-21 Days)||4
2209276|NCT03078127|5416828|P3|NOT COMPLETED|Second Intervention||0
2209277|NCT03078127|5416829|P2|NOT COMPLETED|Second Intervention||0
2209278|NCT03078127|5416830|P1|NOT COMPLETED|Second Intervention||0
2209279|NCT03078127|5416828|P3|COMPLETED|Second Intervention||3
2209280|NCT03078127|5416829|P2|COMPLETED|Second Intervention||3
2209281|NCT03078127|5416830|P1|COMPLETED|Second Intervention||4
2209282|NCT03078127|5416828|P3|STARTED|Second Intervention||3
2209283|NCT03078127|5416829|P2|STARTED|Second Intervention||3
2209284|NCT03078127|5416830|P1|STARTED|Second Intervention||4
2209285|NCT03078127|5416828|P3|NOT COMPLETED|Washout (3-21 Days)||0
2209286|NCT03078127|5416829|P2|NOT COMPLETED|Washout (3-21 Days)||0
2209287|NCT03078127|5416830|P1|NOT COMPLETED|Washout (3-21 Days)||0
2209288|NCT03078127|5416828|P3|COMPLETED|Washout (3-21 Days)||3
2209289|NCT03078127|5416829|P2|COMPLETED|Washout (3-21 Days)||3
2209290|NCT03078127|5416830|P1|COMPLETED|Washout (3-21 Days)||4
2209291|NCT03078127|5416828|P3|STARTED|Washout (3-21 Days)||3
2209292|NCT03078127|5416829|P2|STARTED|Washout (3-21 Days)||3
2209293|NCT03078127|5416830|P1|STARTED|Washout (3-21 Days)||4
2209294|NCT03078127|5416828|P3|NOT COMPLETED|First Intervention||0
2209295|NCT03078127|5416829|P2|NOT COMPLETED|First Intervention||0
2209296|NCT03078127|5416830|P1|NOT COMPLETED|First Intervention||0
2209297|NCT03078127|5416828|P3|COMPLETED|First Intervention||3
2209298|NCT03078127|5416829|P2|COMPLETED|First Intervention||3
2209299|NCT03078127|5416830|P1|COMPLETED|First Intervention||4
2209300|NCT03078127|5416828|P3|STARTED|First Intervention||3
2209301|NCT03078127|5416829|P2|STARTED|First Intervention||3
2209302|NCT03078127|5416830|P1|STARTED|First Intervention||4
2209303|NCT03077893|5416866|P2|NOT COMPLETED|Overall Study||3
2209304|NCT03077893|5416867|P1|NOT COMPLETED|Overall Study||4
2209305|NCT03077893|5416866|P2|COMPLETED|Overall Study||16
2209306|NCT03077893|5416867|P1|COMPLETED|Overall Study||14
2209307|NCT03077893|5416866|P2|STARTED|Overall Study||19
2209308|NCT03077893|5416867|P1|STARTED|Overall Study||18
2209309|NCT03077724|5416896|P2|NOT COMPLETED|Overall Study||2
2209310|NCT03077724|5416897|P1|NOT COMPLETED|Overall Study||8
2209311|NCT03077724|5416896|P2|COMPLETED|Overall Study||12
2209312|NCT03077724|5416897|P1|COMPLETED|Overall Study||6
2209313|NCT03077724|5416896|P2|STARTED|Overall Study||14
2209314|NCT03077724|5416897|P1|STARTED|Overall Study||14
2209315|NCT03077711|5416909|P2|NOT COMPLETED|Overall Study||2
2209316|NCT03077711|5416910|P1|NOT COMPLETED|Overall Study||4
2209317|NCT03077711|5416909|P2|COMPLETED|Overall Study||43
2209318|NCT03077711|5416910|P1|COMPLETED|Overall Study||43
2209319|NCT03077711|5416909|P2|STARTED|Overall Study||45
2209320|NCT03077711|5416910|P1|STARTED|Overall Study||47
2209321|NCT03077659|5416929|P3|NOT COMPLETED|Overall Study||1
2209322|NCT03077659|5416930|P2|NOT COMPLETED|Overall Study||0
2209323|NCT03077659|5416931|P1|NOT COMPLETED|Overall Study||0
2209324|NCT03077659|5416929|P3|COMPLETED|Overall Study||9
2209325|NCT03077659|5416930|P2|COMPLETED|Overall Study||3
2209326|NCT03077659|5416931|P1|COMPLETED|Overall Study||3
2209327|NCT03077659|5416929|P3|STARTED|Overall Study||10
2209328|NCT03077659|5416930|P2|STARTED|Overall Study||3
2209329|NCT03077659|5416931|P1|STARTED|Overall Study||3
2209330|NCT03077607|5416962|P2|NOT COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||2
2209331|NCT03077607|5416963|P1|NOT COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||3
2209332|NCT03077607|5416962|P2|COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
2209333|NCT03077607|5416963|P1|COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||14
2209334|NCT03077607|5416962|P2|Received Talazoparib|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
2209335|NCT03077607|5416963|P1|Received Talazoparib|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
2209336|NCT03077607|5416962|P2|Treated (With Any Study Drug)|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
2209337|NCT03077607|5416963|P1|Treated (With Any Study Drug)|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
2209338|NCT03077607|5416962|P2|STARTED|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
2209339|NCT03077607|5416963|P1|STARTED|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
2209340|NCT03077607|5416962|P2|NOT COMPLETED|Period 1 (15 Days)||0
2209341|NCT03077607|5416963|P1|NOT COMPLETED|Period 1 (15 Days)||2
2209342|NCT03077607|5416962|P2|COMPLETED|Period 1 (15 Days)||17
2209343|NCT03077607|5416963|P1|COMPLETED|Period 1 (15 Days)||17
2209344|NCT03077607|5416962|P2|Received Talazoparib|Period 1 (15 Days)||17
2209345|NCT03077607|5416963|P1|Received Talazoparib|Period 1 (15 Days)||19
2209346|NCT03077607|5416962|P2|Treated (With Any Study Drug)|Period 1 (15 Days)||17
2209347|NCT03077607|5416963|P1|Treated (With Any Study Drug)|Period 1 (15 Days)||19
2209348|NCT03077607|5416962|P2|STARTED|Period 1 (15 Days)||17
2209349|NCT03077607|5416963|P1|STARTED|Period 1 (15 Days)||19
2209350|NCT03076996|5417029|P1|NOT COMPLETED|Overall Study||6
2209351|NCT03076996|5417029|P1|COMPLETED|Overall Study||35
2209352|NCT03076996|5417029|P1|STARTED|Overall Study||41
2209353|NCT03076983|5417038|P2|NOT COMPLETED|Overall Study||0
2209354|NCT03076983|5417039|P1|NOT COMPLETED|Overall Study||0
2209355|NCT03076983|5417038|P2|COMPLETED|Overall Study||25
2209356|NCT03076983|5417039|P1|COMPLETED|Overall Study||55
2209357|NCT03076983|5417038|P2|STARTED|Overall Study||25
2209358|NCT03076983|5417039|P1|STARTED|Overall Study||55
2209359|NCT03076970|5417055|P6|NOT COMPLETED|Washout Period 3||0
2209360|NCT03076970|5417056|P5|NOT COMPLETED|Washout Period 3||0
2209361|NCT03076970|5417057|P4|NOT COMPLETED|Washout Period 3||0
2209362|NCT03076970|5417058|P3|NOT COMPLETED|Washout Period 3||0
2209363|NCT03076970|5417059|P2|NOT COMPLETED|Washout Period 3||0
2209364|NCT03076970|5417060|P1|NOT COMPLETED|Washout Period 3||0
2209365|NCT03076970|5417055|P6|COMPLETED|Washout Period 3||6
2209366|NCT03076970|5417056|P5|COMPLETED|Washout Period 3||5
2209367|NCT03076970|5417057|P4|COMPLETED|Washout Period 3||7
2209368|NCT03076970|5417058|P3|COMPLETED|Washout Period 3||7
2209369|NCT03076970|5417059|P2|COMPLETED|Washout Period 3||7
2209370|NCT03076970|5417060|P1|COMPLETED|Washout Period 3||7
2209371|NCT03076970|5417055|P6|STARTED|Washout Period 3||6
2209372|NCT03076970|5417056|P5|STARTED|Washout Period 3||5
2209373|NCT03076970|5417057|P4|STARTED|Washout Period 3||7
2209374|NCT03076970|5417058|P3|STARTED|Washout Period 3||7
2209375|NCT03076970|5417059|P2|STARTED|Washout Period 3||7
2209376|NCT03076970|5417060|P1|STARTED|Washout Period 3||7
2209377|NCT03076970|5417055|P6|NOT COMPLETED|Period 3||1
2209378|NCT03076970|5417056|P5|NOT COMPLETED|Period 3||1
2209379|NCT03076970|5417057|P4|NOT COMPLETED|Period 3||0
2209380|NCT03076970|5417058|P3|NOT COMPLETED|Period 3||0
2209381|NCT03076970|5417059|P2|NOT COMPLETED|Period 3||0
2209382|NCT03076970|5417060|P1|NOT COMPLETED|Period 3||0
2209383|NCT03076970|5417055|P6|COMPLETED|Period 3||6
2209384|NCT03076970|5417056|P5|COMPLETED|Period 3||5
2209385|NCT03076970|5417057|P4|COMPLETED|Period 3||7
2209386|NCT03076970|5417058|P3|COMPLETED|Period 3||7
2209387|NCT03076970|5417059|P2|COMPLETED|Period 3||7
2209388|NCT03076970|5417060|P1|COMPLETED|Period 3||7
2209389|NCT03076970|5417055|P6|STARTED|Period 3||7
2209390|NCT03076970|5417056|P5|STARTED|Period 3||6
2209391|NCT03076970|5417057|P4|STARTED|Period 3||7
2209392|NCT03076970|5417058|P3|STARTED|Period 3||7
2209393|NCT03076970|5417059|P2|STARTED|Period 3||7
2209394|NCT03076970|5417060|P1|STARTED|Period 3||7
2209395|NCT03076970|5417055|P6|NOT COMPLETED|Washout Period 2||0
2209396|NCT03076970|5417056|P5|NOT COMPLETED|Washout Period 2||1
2209397|NCT03076970|5417057|P4|NOT COMPLETED|Washout Period 2||0
2209398|NCT03076970|5417058|P3|NOT COMPLETED|Washout Period 2||0
2209399|NCT03076970|5417059|P2|NOT COMPLETED|Washout Period 2||0
2209400|NCT03076970|5417060|P1|NOT COMPLETED|Washout Period 2||0
2209401|NCT03076970|5417055|P6|COMPLETED|Washout Period 2||7
2209402|NCT03076970|5417056|P5|COMPLETED|Washout Period 2||6
2209403|NCT03076970|5417057|P4|COMPLETED|Washout Period 2||7
2209404|NCT03076970|5417058|P3|COMPLETED|Washout Period 2||7
2209405|NCT03076970|5417059|P2|COMPLETED|Washout Period 2||7
2209406|NCT03076970|5417060|P1|COMPLETED|Washout Period 2||7
2209407|NCT03076970|5417055|P6|STARTED|Washout Period 2||7
2209408|NCT03076970|5417056|P5|STARTED|Washout Period 2||7
2209409|NCT03076970|5417057|P4|STARTED|Washout Period 2||7
2209410|NCT03076970|5417058|P3|STARTED|Washout Period 2||7
2209411|NCT03076970|5417059|P2|STARTED|Washout Period 2||7
2209412|NCT03076970|5417060|P1|STARTED|Washout Period 2||7
2209413|NCT03076970|5417055|P6|NOT COMPLETED|Period 2||0
2209414|NCT03076970|5417056|P5|NOT COMPLETED|Period 2||0
2209415|NCT03076970|5417057|P4|NOT COMPLETED|Period 2||0
2209416|NCT03076970|5417058|P3|NOT COMPLETED|Period 2||0
2209417|NCT03076970|5417059|P2|NOT COMPLETED|Period 2||0
2209418|NCT03076970|5417060|P1|NOT COMPLETED|Period 2||0
2209419|NCT03076970|5417055|P6|COMPLETED|Period 2||7
2209420|NCT03076970|5417056|P5|COMPLETED|Period 2||7
2209421|NCT03076970|5417057|P4|COMPLETED|Period 2||7
2209422|NCT03076970|5417058|P3|COMPLETED|Period 2||7
2209423|NCT03076970|5417059|P2|COMPLETED|Period 2||7
2209424|NCT03076970|5417060|P1|COMPLETED|Period 2||7
2209425|NCT03076970|5417055|P6|STARTED|Period 2||7
2209426|NCT03076970|5417056|P5|STARTED|Period 2||7
2209427|NCT03076970|5417057|P4|STARTED|Period 2||7
2209428|NCT03076970|5417058|P3|STARTED|Period 2||7
2209429|NCT03076970|5417059|P2|STARTED|Period 2||7
2209430|NCT03076970|5417060|P1|STARTED|Period 2||7
2209431|NCT03076970|5417055|P6|NOT COMPLETED|Washout Period 1||0
2209432|NCT03076970|5417056|P5|NOT COMPLETED|Washout Period 1||0
2209433|NCT03076970|5417057|P4|NOT COMPLETED|Washout Period 1||0
2209434|NCT03076970|5417058|P3|NOT COMPLETED|Washout Period 1||0
2209435|NCT03076970|5417059|P2|NOT COMPLETED|Washout Period 1||0
2209436|NCT03076970|5417060|P1|NOT COMPLETED|Washout Period 1||0
2209437|NCT03076970|5417055|P6|COMPLETED|Washout Period 1||7
2209438|NCT03076970|5417056|P5|COMPLETED|Washout Period 1||7
2209439|NCT03076970|5417057|P4|COMPLETED|Washout Period 1||7
2209440|NCT03076970|5417058|P3|COMPLETED|Washout Period 1||7
2209441|NCT03076970|5417059|P2|COMPLETED|Washout Period 1||7
2209442|NCT03076970|5417060|P1|COMPLETED|Washout Period 1||7
2209443|NCT03076970|5417055|P6|STARTED|Washout Period 1||7
2209444|NCT03076970|5417056|P5|STARTED|Washout Period 1||7
2209445|NCT03076970|5417057|P4|STARTED|Washout Period 1||7
2209446|NCT03076970|5417058|P3|STARTED|Washout Period 1||7
2209447|NCT03076970|5417059|P2|STARTED|Washout Period 1||7
2209448|NCT03076970|5417060|P1|STARTED|Washout Period 1||7
2209449|NCT03076970|5417055|P6|NOT COMPLETED|Period 1||0
2209450|NCT03076970|5417056|P5|NOT COMPLETED|Period 1||0
2209451|NCT03076970|5417057|P4|NOT COMPLETED|Period 1||0
2209452|NCT03076970|5417058|P3|NOT COMPLETED|Period 1||0
2209453|NCT03076970|5417059|P2|NOT COMPLETED|Period 1||0
2209454|NCT03076970|5417060|P1|NOT COMPLETED|Period 1||0
2209455|NCT03076970|5417055|P6|COMPLETED|Period 1||7
2209456|NCT03076970|5417056|P5|COMPLETED|Period 1||7
2209457|NCT03076970|5417057|P4|COMPLETED|Period 1||7
2209458|NCT03076970|5417058|P3|COMPLETED|Period 1||7
2209459|NCT03076970|5417059|P2|COMPLETED|Period 1||7
2209460|NCT03076970|5417060|P1|COMPLETED|Period 1||7
2209461|NCT03076970|5417055|P6|Received at Least 1 Dose of Study Drug|Period 1||7
2209462|NCT03076970|5417056|P5|Received at Least 1 Dose of Study Drug|Period 1||7
2209463|NCT03076970|5417057|P4|Received at Least 1 Dose of Study Drug|Period 1||7
2209464|NCT03076970|5417058|P3|Received at Least 1 Dose of Study Drug|Period 1||7
2209465|NCT03076970|5417059|P2|Received at Least 1 Dose of Study Drug|Period 1||7
2209466|NCT03076970|5417060|P1|Received at Least 1 Dose of Study Drug|Period 1||7
2209467|NCT03076970|5417055|P6|STARTED|Period 1||7
2209468|NCT03076970|5417056|P5|STARTED|Period 1||7
2209469|NCT03076970|5417057|P4|STARTED|Period 1||7
2209470|NCT03076970|5417058|P3|STARTED|Period 1||7
2209471|NCT03076970|5417059|P2|STARTED|Period 1||7
2209472|NCT03076970|5417060|P1|STARTED|Period 1||7
2209473|NCT03075904|5417110|P1|NOT COMPLETED|Overall Study||4
2209474|NCT03075904|5417110|P1|COMPLETED|Overall Study||4
2209475|NCT03075904|5417110|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
2209476|NCT03075904|5417110|P1|STARTED|Overall Study||8
2209477|NCT03075891|5417120|P2|NOT COMPLETED|Overall Study||13
2209478|NCT03075891|5417121|P1|NOT COMPLETED|Overall Study||9
2209479|NCT03075891|5417120|P2|COMPLETED|Overall Study||125
2209480|NCT03075891|5417121|P1|COMPLETED|Overall Study||126
2209481|NCT03075891|5417120|P2|STARTED|Overall Study||138
2209482|NCT03075891|5417121|P1|STARTED|Overall Study||135
2209483|NCT03075527|5417127|P1|NOT COMPLETED|Overall Study||2
2209484|NCT03075527|5417127|P1|COMPLETED|Overall Study||17
2209485|NCT03075527|5417127|P1|STARTED|Overall Study||19
2209486|NCT03075410|5417140|P9|NOT COMPLETED|Part B (up to 28 Days)||0
2209487|NCT03075410|5417141|P8|NOT COMPLETED|Part B (up to 28 Days)||0
2209488|NCT03075410|5417142|P7|NOT COMPLETED|Part B (up to 28 Days)||0
2209489|NCT03075410|5417143|P6|NOT COMPLETED|Part B (up to 28 Days)||0
2209490|NCT03075410|5417144|P5|NOT COMPLETED|Part B (up to 28 Days)||0
2209491|NCT03075410|5417145|P4|NOT COMPLETED|Part B (up to 28 Days)||0
2209492|NCT03075410|5417146|P3|NOT COMPLETED|Part B (up to 28 Days)||0
2209493|NCT03075410|5417147|P2|NOT COMPLETED|Part B (up to 28 Days)||0
2209494|NCT03075410|5417148|P1|NOT COMPLETED|Part B (up to 28 Days)||0
2209495|NCT03075410|5417140|P9|COMPLETED|Part B (up to 28 Days)||8
2209496|NCT03075410|5417141|P8|COMPLETED|Part B (up to 28 Days)||7
2209497|NCT03075410|5417142|P7|COMPLETED|Part B (up to 28 Days)||4
2209498|NCT03075410|5417143|P6|COMPLETED|Part B (up to 28 Days)||0
2209499|NCT03075410|5417144|P5|COMPLETED|Part B (up to 28 Days)||0
2209500|NCT03075410|5417145|P4|COMPLETED|Part B (up to 28 Days)||0
2209501|NCT03075410|5417146|P3|COMPLETED|Part B (up to 28 Days)||0
2209502|NCT03075410|5417147|P2|COMPLETED|Part B (up to 28 Days)||0
2209503|NCT03075410|5417148|P1|COMPLETED|Part B (up to 28 Days)||0
2209504|NCT03075410|5417140|P9|STARTED|Part B (up to 28 Days)||8
2209505|NCT03075410|5417141|P8|STARTED|Part B (up to 28 Days)||7
2209506|NCT03075410|5417142|P7|STARTED|Part B (up to 28 Days)||4
2209507|NCT03075410|5417143|P6|STARTED|Part B (up to 28 Days)||0
2209508|NCT03075410|5417144|P5|STARTED|Part B (up to 28 Days)||0
2209509|NCT03075410|5417145|P4|STARTED|Part B (up to 28 Days)||0
2209510|NCT03075410|5417146|P3|STARTED|Part B (up to 28 Days)||0
2209511|NCT03075410|5417147|P2|STARTED|Part B (up to 28 Days)||0
2209512|NCT03075410|5417148|P1|STARTED|Part B (up to 28 Days)||0
2209513|NCT03075410|5417140|P9|NOT COMPLETED|Part A-Period 4 (14 Days)||0
2209514|NCT03075410|5417141|P8|NOT COMPLETED|Part A-Period 4 (14 Days)||0
2209515|NCT03075410|5417142|P7|NOT COMPLETED|Part A-Period 4 (14 Days)||0
2209516|NCT03075410|5417143|P6|NOT COMPLETED|Part A-Period 4 (14 Days)||0
2209517|NCT03075410|5417144|P5|NOT COMPLETED|Part A-Period 4 (14 Days)||0
2209518|NCT03075410|5417145|P4|NOT COMPLETED|Part A-Period 4 (14 Days)||0
2209519|NCT03075410|5417146|P3|NOT COMPLETED|Part A-Period 4 (14 Days)||0
2209520|NCT03075410|5417147|P2|NOT COMPLETED|Part A-Period 4 (14 Days)||0
2209521|NCT03075410|5417148|P1|NOT COMPLETED|Part A-Period 4 (14 Days)||0
2209522|NCT03075410|5417140|P9|COMPLETED|Part A-Period 4 (14 Days)||0
2209523|NCT03075410|5417141|P8|COMPLETED|Part A-Period 4 (14 Days)||0
2209524|NCT03075410|5417142|P7|COMPLETED|Part A-Period 4 (14 Days)||0
2209525|NCT03075410|5417143|P6|COMPLETED|Part A-Period 4 (14 Days)||1
2209526|NCT03075410|5417144|P5|COMPLETED|Part A-Period 4 (14 Days)||2
2209527|NCT03075410|5417145|P4|COMPLETED|Part A-Period 4 (14 Days)||1
2209528|NCT03075410|5417146|P3|COMPLETED|Part A-Period 4 (14 Days)||2
2209529|NCT03075410|5417147|P2|COMPLETED|Part A-Period 4 (14 Days)||1
2209530|NCT03075410|5417148|P1|COMPLETED|Part A-Period 4 (14 Days)||1
2209531|NCT03075410|5417140|P9|STARTED|Part A-Period 4 (14 Days)||0
2209532|NCT03075410|5417141|P8|STARTED|Part A-Period 4 (14 Days)||0
2209533|NCT03075410|5417142|P7|STARTED|Part A-Period 4 (14 Days)||0
2209534|NCT03075410|5417143|P6|STARTED|Part A-Period 4 (14 Days)||1
2209535|NCT03075410|5417144|P5|STARTED|Part A-Period 4 (14 Days)||2
2209536|NCT03075410|5417145|P4|STARTED|Part A-Period 4 (14 Days)||1
2209537|NCT03075410|5417146|P3|STARTED|Part A-Period 4 (14 Days)||2
2209538|NCT03075410|5417147|P2|STARTED|Part A-Period 4 (14 Days)||1
2209539|NCT03075410|5417148|P1|STARTED|Part A-Period 4 (14 Days)||1
2209540|NCT03075410|5417140|P9|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
2209541|NCT03075410|5417141|P8|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
2209542|NCT03075410|5417142|P7|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
2209543|NCT03075410|5417143|P6|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
2209544|NCT03075410|5417144|P5|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
2209545|NCT03075410|5417145|P4|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
2209546|NCT03075410|5417146|P3|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
2209547|NCT03075410|5417147|P2|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
2209548|NCT03075410|5417148|P1|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
2209549|NCT03075410|5417140|P9|COMPLETED|Part A-Washout Period 3 (14 Days)||0
2209550|NCT03075410|5417141|P8|COMPLETED|Part A-Washout Period 3 (14 Days)||0
2209551|NCT03075410|5417142|P7|COMPLETED|Part A-Washout Period 3 (14 Days)||0
2209552|NCT03075410|5417143|P6|COMPLETED|Part A-Washout Period 3 (14 Days)||1
2209553|NCT03075410|5417144|P5|COMPLETED|Part A-Washout Period 3 (14 Days)||2
2209554|NCT03075410|5417145|P4|COMPLETED|Part A-Washout Period 3 (14 Days)||1
2209555|NCT03075410|5417146|P3|COMPLETED|Part A-Washout Period 3 (14 Days)||2
2209556|NCT03075410|5417147|P2|COMPLETED|Part A-Washout Period 3 (14 Days)||1
2209557|NCT03075410|5417148|P1|COMPLETED|Part A-Washout Period 3 (14 Days)||1
2209558|NCT03075410|5417140|P9|STARTED|Part A-Washout Period 3 (14 Days)||0
2209559|NCT03075410|5417141|P8|STARTED|Part A-Washout Period 3 (14 Days)||0
2209560|NCT03075410|5417142|P7|STARTED|Part A-Washout Period 3 (14 Days)||0
2209561|NCT03075410|5417143|P6|STARTED|Part A-Washout Period 3 (14 Days)||1
2209562|NCT03075410|5417144|P5|STARTED|Part A-Washout Period 3 (14 Days)||2
2209563|NCT03075410|5417145|P4|STARTED|Part A-Washout Period 3 (14 Days)||1
2209564|NCT03075410|5417146|P3|STARTED|Part A-Washout Period 3 (14 Days)||2
2209565|NCT03075410|5417147|P2|STARTED|Part A-Washout Period 3 (14 Days)||1
2209566|NCT03075410|5417148|P1|STARTED|Part A-Washout Period 3 (14 Days)||1
2209567|NCT03075410|5417140|P9|NOT COMPLETED|Part A-Period 3 (14 Days)||0
2209568|NCT03075410|5417141|P8|NOT COMPLETED|Part A-Period 3 (14 Days)||0
2209569|NCT03075410|5417142|P7|NOT COMPLETED|Part A-Period 3 (14 Days)||0
2209570|NCT03075410|5417143|P6|NOT COMPLETED|Part A-Period 3 (14 Days)||0
2209571|NCT03075410|5417144|P5|NOT COMPLETED|Part A-Period 3 (14 Days)||0
2209572|NCT03075410|5417145|P4|NOT COMPLETED|Part A-Period 3 (14 Days)||0
2209573|NCT03075410|5417146|P3|NOT COMPLETED|Part A-Period 3 (14 Days)||0
2209574|NCT03075410|5417147|P2|NOT COMPLETED|Part A-Period 3 (14 Days)||0
2209575|NCT03075410|5417148|P1|NOT COMPLETED|Part A-Period 3 (14 Days)||1
2209576|NCT03075410|5417140|P9|COMPLETED|Part A-Period 3 (14 Days)||0
2209577|NCT03075410|5417141|P8|COMPLETED|Part A-Period 3 (14 Days)||0
2209578|NCT03075410|5417142|P7|COMPLETED|Part A-Period 3 (14 Days)||0
2209579|NCT03075410|5417143|P6|COMPLETED|Part A-Period 3 (14 Days)||1
2209580|NCT03075410|5417144|P5|COMPLETED|Part A-Period 3 (14 Days)||2
2209581|NCT03075410|5417145|P4|COMPLETED|Part A-Period 3 (14 Days)||1
2209582|NCT03075410|5417146|P3|COMPLETED|Part A-Period 3 (14 Days)||2
2209583|NCT03075410|5417147|P2|COMPLETED|Part A-Period 3 (14 Days)||1
2209584|NCT03075410|5417148|P1|COMPLETED|Part A-Period 3 (14 Days)||1
2209585|NCT03075410|5417140|P9|STARTED|Part A-Period 3 (14 Days)||0
2209586|NCT03075410|5417141|P8|STARTED|Part A-Period 3 (14 Days)||0
2209587|NCT03075410|5417142|P7|STARTED|Part A-Period 3 (14 Days)||0
2209588|NCT03075410|5417143|P6|STARTED|Part A-Period 3 (14 Days)||1
2209589|NCT03075410|5417144|P5|STARTED|Part A-Period 3 (14 Days)||2
2209590|NCT03075410|5417145|P4|STARTED|Part A-Period 3 (14 Days)||1
2209591|NCT03075410|5417146|P3|STARTED|Part A-Period 3 (14 Days)|Participants who withdrew in Period 2 were replaced (2 new participants entered Part A period 3).|2
2209592|NCT03075410|5417147|P2|STARTED|Part A-Period 3 (14 Days)||1
2209593|NCT03075410|5417148|P1|STARTED|Part A-Period 3 (14 Days)|Participants who withdrew in Period 2 were replaced (2 new participants entered Part A period 3).|2
2209594|NCT03075410|5417140|P9|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
2209595|NCT03075410|5417141|P8|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
2209596|NCT03075410|5417142|P7|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
2209597|NCT03075410|5417143|P6|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
2209598|NCT03075410|5417144|P5|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
2209599|NCT03075410|5417145|P4|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
2209600|NCT03075410|5417146|P3|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
2209601|NCT03075410|5417147|P2|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
2209602|NCT03075410|5417148|P1|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
2209603|NCT03075410|5417140|P9|COMPLETED|Part A-Washout Period 2 (14 Days)||0
2209604|NCT03075410|5417141|P8|COMPLETED|Part A-Washout Period 2 (14 Days)||0
2209605|NCT03075410|5417142|P7|COMPLETED|Part A-Washout Period 2 (14 Days)||0
2209606|NCT03075410|5417143|P6|COMPLETED|Part A-Washout Period 2 (14 Days)||1
2209607|NCT03075410|5417144|P5|COMPLETED|Part A-Washout Period 2 (14 Days)||2
2209608|NCT03075410|5417145|P4|COMPLETED|Part A-Washout Period 2 (14 Days)||1
2209609|NCT03075410|5417146|P3|COMPLETED|Part A-Washout Period 2 (14 Days)||1
2209610|NCT03075410|5417147|P2|COMPLETED|Part A-Washout Period 2 (14 Days)||1
2209611|NCT03075410|5417148|P1|COMPLETED|Part A-Washout Period 2 (14 Days)||1
2209612|NCT03075410|5417140|P9|STARTED|Part A-Washout Period 2 (14 Days)||0
2209613|NCT03075410|5417141|P8|STARTED|Part A-Washout Period 2 (14 Days)||0
2209614|NCT03075410|5417142|P7|STARTED|Part A-Washout Period 2 (14 Days)||0
2209615|NCT03075410|5417143|P6|STARTED|Part A-Washout Period 2 (14 Days)||1
2209616|NCT03075410|5417144|P5|STARTED|Part A-Washout Period 2 (14 Days)||2
2209617|NCT03075410|5417145|P4|STARTED|Part A-Washout Period 2 (14 Days)||1
2209618|NCT03075410|5417146|P3|STARTED|Part A-Washout Period 2 (14 Days)||1
2209619|NCT03075410|5417147|P2|STARTED|Part A-Washout Period 2 (14 Days)||1
2209620|NCT03075410|5417148|P1|STARTED|Part A-Washout Period 2 (14 Days)||1
2209621|NCT03075410|5417140|P9|NOT COMPLETED|Part A-Period 2 (14 Days)||0
2209622|NCT03075410|5417141|P8|NOT COMPLETED|Part A-Period 2 (14 Days)||0
2209623|NCT03075410|5417142|P7|NOT COMPLETED|Part A-Period 2 (14 Days)||0
2209624|NCT03075410|5417143|P6|NOT COMPLETED|Part A-Period 2 (14 Days)||0
2209625|NCT03075410|5417144|P5|NOT COMPLETED|Part A-Period 2 (14 Days)||0
2209626|NCT03075410|5417145|P4|NOT COMPLETED|Part A-Period 2 (14 Days)||0
2209627|NCT03075410|5417146|P3|NOT COMPLETED|Part A-Period 2 (14 Days)||1
2209628|NCT03075410|5417147|P2|NOT COMPLETED|Part A-Period 2 (14 Days)||0
2209629|NCT03075410|5417148|P1|NOT COMPLETED|Part A-Period 2 (14 Days)||1
2209630|NCT03075410|5417140|P9|COMPLETED|Part A-Period 2 (14 Days)||0
2209631|NCT03075410|5417141|P8|COMPLETED|Part A-Period 2 (14 Days)||0
2209632|NCT03075410|5417142|P7|COMPLETED|Part A-Period 2 (14 Days)||0
2209633|NCT03075410|5417143|P6|COMPLETED|Part A-Period 2 (14 Days)||1
2209634|NCT03075410|5417144|P5|COMPLETED|Part A-Period 2 (14 Days)||2
2209635|NCT03075410|5417145|P4|COMPLETED|Part A-Period 2 (14 Days)||1
2209636|NCT03075410|5417146|P3|COMPLETED|Part A-Period 2 (14 Days)||1
2209637|NCT03075410|5417147|P2|COMPLETED|Part A-Period 2 (14 Days)||1
2209638|NCT03075410|5417148|P1|COMPLETED|Part A-Period 2 (14 Days)||1
2209639|NCT03075410|5417140|P9|STARTED|Part A-Period 2 (14 Days)||0
2209640|NCT03075410|5417141|P8|STARTED|Part A-Period 2 (14 Days)||0
2209641|NCT03075410|5417142|P7|STARTED|Part A-Period 2 (14 Days)||0
2209642|NCT03075410|5417143|P6|STARTED|Part A-Period 2 (14 Days)||1
2209643|NCT03075410|5417144|P5|STARTED|Part A-Period 2 (14 Days)||2
2209644|NCT03075410|5417145|P4|STARTED|Part A-Period 2 (14 Days)||1
2209645|NCT03075410|5417146|P3|STARTED|Part A-Period 2 (14 Days)||2
2209646|NCT03075410|5417147|P2|STARTED|Part A-Period 2 (14 Days)||1
2209647|NCT03075410|5417148|P1|STARTED|Part A-Period 2 (14 Days)||2
2209648|NCT03075410|5417140|P9|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
2209649|NCT03075410|5417141|P8|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
2209650|NCT03075410|5417142|P7|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
2209651|NCT03075410|5417143|P6|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
2209652|NCT03075410|5417144|P5|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
2209653|NCT03075410|5417145|P4|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
2209654|NCT03075410|5417146|P3|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
2209655|NCT03075410|5417147|P2|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
2209656|NCT03075410|5417148|P1|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
2209657|NCT03075410|5417140|P9|COMPLETED|Part A-Washout Period 1 (14 Days)||0
2209658|NCT03075410|5417141|P8|COMPLETED|Part A-Washout Period 1 (14 Days)||0
2209659|NCT03075410|5417142|P7|COMPLETED|Part A-Washout Period 1 (14 Days)||0
2209660|NCT03075410|5417143|P6|COMPLETED|Part A-Washout Period 1 (14 Days)||1
2209661|NCT03075410|5417144|P5|COMPLETED|Part A-Washout Period 1 (14 Days)||2
2209662|NCT03075410|5417145|P4|COMPLETED|Part A-Washout Period 1 (14 Days)||1
2209663|NCT03075410|5417146|P3|COMPLETED|Part A-Washout Period 1 (14 Days)||2
2209664|NCT03075410|5417147|P2|COMPLETED|Part A-Washout Period 1 (14 Days)||1
2209665|NCT03075410|5417148|P1|COMPLETED|Part A-Washout Period 1 (14 Days)||2
2209666|NCT03075410|5417140|P9|STARTED|Part A-Washout Period 1 (14 Days)||0
2209667|NCT03075410|5417141|P8|STARTED|Part A-Washout Period 1 (14 Days)||0
2209668|NCT03075410|5417142|P7|STARTED|Part A-Washout Period 1 (14 Days)||0
2209669|NCT03075410|5417143|P6|STARTED|Part A-Washout Period 1 (14 Days)||1
2209670|NCT03075410|5417144|P5|STARTED|Part A-Washout Period 1 (14 Days)||2
2209671|NCT03075410|5417145|P4|STARTED|Part A-Washout Period 1 (14 Days)||1
2209672|NCT03075410|5417146|P3|STARTED|Part A-Washout Period 1 (14 Days)||2
2209673|NCT03075410|5417147|P2|STARTED|Part A-Washout Period 1 (14 Days)||1
2209674|NCT03075410|5417148|P1|STARTED|Part A-Washout Period 1 (14 Days)||2
2209675|NCT03075410|5417140|P9|NOT COMPLETED|Part A-Period 1 (14 Days)||0
2209676|NCT03075410|5417141|P8|NOT COMPLETED|Part A-Period 1 (14 Days)||0
2209677|NCT03075410|5417142|P7|NOT COMPLETED|Part A-Period 1 (14 Days)||0
2209678|NCT03075410|5417143|P6|NOT COMPLETED|Part A-Period 1 (14 Days)||0
2209679|NCT03075410|5417144|P5|NOT COMPLETED|Part A-Period 1 (14 Days)||0
2209680|NCT03075410|5417145|P4|NOT COMPLETED|Part A-Period 1 (14 Days)||0
2209681|NCT03075410|5417146|P3|NOT COMPLETED|Part A-Period 1 (14 Days)||0
2209682|NCT03075410|5417147|P2|NOT COMPLETED|Part A-Period 1 (14 Days)||0
2209683|NCT03075410|5417148|P1|NOT COMPLETED|Part A-Period 1 (14 Days)||0
2209684|NCT03075410|5417140|P9|COMPLETED|Part A-Period 1 (14 Days)||0
2209685|NCT03075410|5417141|P8|COMPLETED|Part A-Period 1 (14 Days)||0
2209686|NCT03075410|5417142|P7|COMPLETED|Part A-Period 1 (14 Days)||0
2209687|NCT03075410|5417143|P6|COMPLETED|Part A-Period 1 (14 Days)||1
2209688|NCT03075410|5417144|P5|COMPLETED|Part A-Period 1 (14 Days)||2
2209689|NCT03075410|5417145|P4|COMPLETED|Part A-Period 1 (14 Days)||1
2209690|NCT03075410|5417146|P3|COMPLETED|Part A-Period 1 (14 Days)||2
2209691|NCT03075410|5417147|P2|COMPLETED|Part A-Period 1 (14 Days)||1
2209692|NCT03075410|5417148|P1|COMPLETED|Part A-Period 1 (14 Days)||2
2209693|NCT03075410|5417140|P9|STARTED|Part A-Period 1 (14 Days)||0
2209694|NCT03075410|5417141|P8|STARTED|Part A-Period 1 (14 Days)||0
2209695|NCT03075410|5417142|P7|STARTED|Part A-Period 1 (14 Days)||0
2209696|NCT03075410|5417143|P6|STARTED|Part A-Period 1 (14 Days)||1
2209697|NCT03075410|5417144|P5|STARTED|Part A-Period 1 (14 Days)||2
2209698|NCT03075410|5417145|P4|STARTED|Part A-Period 1 (14 Days)||1
2209699|NCT03075410|5417146|P3|STARTED|Part A-Period 1 (14 Days)||2
2209700|NCT03075410|5417147|P2|STARTED|Part A-Period 1 (14 Days)||1
2209701|NCT03075410|5417148|P1|STARTED|Part A-Period 1 (14 Days)||2
2209702|NCT03075163|5417314|P2|NOT COMPLETED|Overall Study||138
2209703|NCT03075163|5417315|P1|NOT COMPLETED|Overall Study||138
2209704|NCT03075163|5417314|P2|COMPLETED|Overall Study||12
2209705|NCT03075163|5417315|P1|COMPLETED|Overall Study||12
2209706|NCT03075163|5417314|P2|STARTED|Overall Study||150
2209707|NCT03075163|5417315|P1|STARTED|Overall Study||150
2209708|NCT03074682|5417324|P3|NOT COMPLETED|Overall Study||0
2209709|NCT03074682|5417325|P2|NOT COMPLETED|Overall Study||0
2209710|NCT03074682|5417326|P1|NOT COMPLETED|Overall Study||0
2209711|NCT03074682|5417324|P3|COMPLETED|Overall Study||18
2209712|NCT03074682|5417325|P2|COMPLETED|Overall Study||18
2209713|NCT03074682|5417326|P1|COMPLETED|Overall Study||18
2209714|NCT03074682|5417324|P3|STARTED|Overall Study||18
2209715|NCT03074682|5417325|P2|STARTED|Overall Study||18
2209716|NCT03074682|5417326|P1|STARTED|Overall Study||18
2209717|NCT03074500|5417346|P3|NOT COMPLETED|Overall Study||1
2209718|NCT03074500|5417347|P2|NOT COMPLETED|Overall Study||1
2209719|NCT03074500|5417348|P1|NOT COMPLETED|Overall Study||1
2209720|NCT03074500|5417346|P3|COMPLETED|Overall Study||10
2209721|NCT03074500|5417347|P2|COMPLETED|Overall Study||10
2209722|NCT03074500|5417348|P1|COMPLETED|Overall Study||10
2209723|NCT03074500|5417346|P3|STARTED|Overall Study||11
2209724|NCT03074500|5417347|P2|STARTED|Overall Study||11
2209725|NCT03074500|5417348|P1|STARTED|Overall Study||11
2209726|NCT03074409|5417376|P2|NOT COMPLETED|Overall Study||4
2209727|NCT03074409|5417377|P1|NOT COMPLETED|Overall Study||4
2209728|NCT03074409|5417376|P2|COMPLETED|Overall Study||38
2209729|NCT03074409|5417377|P1|COMPLETED|Overall Study||37
2209730|NCT03074409|5417376|P2|STARTED|Overall Study||42
2209731|NCT03074409|5417377|P1|STARTED|Overall Study||41
2209732|NCT03074331|5417385|P1|NOT COMPLETED|Overall Study||7
2209733|NCT03074331|5417385|P1|COMPLETED|Overall Study||123
2209734|NCT03074331|5417385|P1|STARTED|Overall Study||130
2209735|NCT03074162|5417397|P6|NOT COMPLETED|Period 3||0
2209736|NCT03074162|5417398|P5|NOT COMPLETED|Period 3||1
2209737|NCT03074162|5417399|P4|NOT COMPLETED|Period 3||0
2209738|NCT03074162|5417400|P3|NOT COMPLETED|Period 3||0
2209739|NCT03074162|5417401|P2|NOT COMPLETED|Period 3||0
2209740|NCT03074162|5417402|P1|NOT COMPLETED|Period 3||1
2209741|NCT03074162|5417397|P6|COMPLETED|Period 3||7
2209742|NCT03074162|5417398|P5|COMPLETED|Period 3||7
2209743|NCT03074162|5417399|P4|COMPLETED|Period 3||8
2209744|NCT03074162|5417400|P3|COMPLETED|Period 3||6
2209745|NCT03074162|5417401|P2|COMPLETED|Period 3||8
2209746|NCT03074162|5417402|P1|COMPLETED|Period 3||7
2209747|NCT03074162|5417397|P6|STARTED|Period 3||7
2209748|NCT03074162|5417398|P5|STARTED|Period 3||8
2209749|NCT03074162|5417399|P4|STARTED|Period 3||8
2209750|NCT03074162|5417400|P3|STARTED|Period 3||6
2209751|NCT03074162|5417401|P2|STARTED|Period 3||8
2209752|NCT03074162|5417402|P1|STARTED|Period 3||8
2209753|NCT03074162|5417397|P6|NOT COMPLETED|Period 2 Including Washout 2||1
2209754|NCT03074162|5417398|P5|NOT COMPLETED|Period 2 Including Washout 2||0
2209755|NCT03074162|5417399|P4|NOT COMPLETED|Period 2 Including Washout 2||0
2209756|NCT03074162|5417400|P3|NOT COMPLETED|Period 2 Including Washout 2||1
2209757|NCT03074162|5417401|P2|NOT COMPLETED|Period 2 Including Washout 2||0
2209758|NCT03074162|5417402|P1|NOT COMPLETED|Period 2 Including Washout 2||0
2209759|NCT03074162|5417397|P6|COMPLETED|Period 2 Including Washout 2||7
2209760|NCT03074162|5417398|P5|COMPLETED|Period 2 Including Washout 2||8
2209761|NCT03074162|5417399|P4|COMPLETED|Period 2 Including Washout 2||8
2209762|NCT03074162|5417400|P3|COMPLETED|Period 2 Including Washout 2||6
2209763|NCT03074162|5417401|P2|COMPLETED|Period 2 Including Washout 2||8
2209764|NCT03074162|5417402|P1|COMPLETED|Period 2 Including Washout 2||8
2209765|NCT03074162|5417397|P6|STARTED|Period 2 Including Washout 2||8
2209766|NCT03074162|5417398|P5|STARTED|Period 2 Including Washout 2||8
2209767|NCT03074162|5417399|P4|STARTED|Period 2 Including Washout 2||8
2209768|NCT03074162|5417400|P3|STARTED|Period 2 Including Washout 2||7
2209769|NCT03074162|5417401|P2|STARTED|Period 2 Including Washout 2||8
2209770|NCT03074162|5417402|P1|STARTED|Period 2 Including Washout 2||8
2209771|NCT03074162|5417397|P6|NOT COMPLETED|Period 1 Including Washout 1||0
2209772|NCT03074162|5417398|P5|NOT COMPLETED|Period 1 Including Washout 1||0
2209773|NCT03074162|5417399|P4|NOT COMPLETED|Period 1 Including Washout 1||0
2209774|NCT03074162|5417400|P3|NOT COMPLETED|Period 1 Including Washout 1||1
2209775|NCT03074162|5417401|P2|NOT COMPLETED|Period 1 Including Washout 1||0
2209776|NCT03074162|5417402|P1|NOT COMPLETED|Period 1 Including Washout 1||0
2209777|NCT03074162|5417397|P6|COMPLETED|Period 1 Including Washout 1||8
2209778|NCT03074162|5417398|P5|COMPLETED|Period 1 Including Washout 1||8
2209779|NCT03074162|5417399|P4|COMPLETED|Period 1 Including Washout 1||8
2209780|NCT03074162|5417400|P3|COMPLETED|Period 1 Including Washout 1||7
2209781|NCT03074162|5417401|P2|COMPLETED|Period 1 Including Washout 1||8
2209782|NCT03074162|5417402|P1|COMPLETED|Period 1 Including Washout 1||8
2209783|NCT03074162|5417397|P6|STARTED|Period 1 Including Washout 1||8
2209784|NCT03074162|5417398|P5|STARTED|Period 1 Including Washout 1||8
2209785|NCT03074162|5417399|P4|STARTED|Period 1 Including Washout 1||8
2209786|NCT03074162|5417400|P3|STARTED|Period 1 Including Washout 1||8
2209787|NCT03074162|5417401|P2|STARTED|Period 1 Including Washout 1||8
2209788|NCT03074162|5417402|P1|STARTED|Period 1 Including Washout 1||8
2209795|NCT03073798|5417464|P1|NOT COMPLETED|Overall Study||2
2209796|NCT03073798|5417464|P1|COMPLETED|Overall Study||10
2209797|NCT03073798|5417464|P1|STARTED|Overall Study||12
2209798|NCT03073486|5417477|P2|NOT COMPLETED|Overall Study||44
2209799|NCT03073486|5417478|P1|NOT COMPLETED|Overall Study||88
2209800|NCT03073486|5417477|P2|COMPLETED|Overall Study||207
2209801|NCT03073486|5417478|P1|COMPLETED|Overall Study||405
2209802|NCT03073486|5417477|P2|STARTED|Overall Study||251
2209803|NCT03073486|5417478|P1|STARTED|Overall Study||493
2209804|NCT03072875|5417488|P1|NOT COMPLETED|Overall Study||1
2209805|NCT03072875|5417488|P1|COMPLETED|Overall Study||25
2209806|NCT03072875|5417488|P1|STARTED|Overall Study||26
2209807|NCT03072719|5417495|P2|NOT COMPLETED|Overall Study||1
2209808|NCT03072719|5417496|P1|NOT COMPLETED|Overall Study||1
2209809|NCT03072719|5417495|P2|COMPLETED|Overall Study||59
2209810|NCT03072719|5417496|P1|COMPLETED|Overall Study||59
2209811|NCT03072719|5417495|P2|STARTED|Overall Study||60
2209812|NCT03072719|5417496|P1|STARTED|Overall Study||60
2209813|NCT03072550|5417506|P1|NOT COMPLETED|Overall Study||2
2209814|NCT03072550|5417506|P1|COMPLETED|Overall Study||24
2209815|NCT03072550|5417506|P1|STARTED|Overall Study||26
2209816|NCT03071887|5417510|P1|NOT COMPLETED|Overall Study||6
2209817|NCT03071887|5417510|P1|COMPLETED|Overall Study||7
2209818|NCT03071887|5417510|P1|STARTED|Overall Study||13
2209819|NCT03071744|5417515|P1|NOT COMPLETED|Overall Study||2
2209820|NCT03071744|5417515|P1|COMPLETED|Overall Study||4
2209821|NCT03071744|5417515|P1|STARTED|Overall Study||6
2209822|NCT03071263|5417523|P2|NOT COMPLETED|Overall Study||7
2209823|NCT03071263|5417524|P1|NOT COMPLETED|Overall Study||3
2209824|NCT03071263|5417523|P2|COMPLETED|Overall Study||141
2209825|NCT03071263|5417524|P1|COMPLETED|Overall Study||144
2209826|NCT03071263|5417523|P2|STARTED|Overall Study||148
2209827|NCT03071263|5417524|P1|STARTED|Overall Study||147
2209828|NCT03070730|5417551|P3|NOT COMPLETED|Overall Study||0
2209829|NCT03070730|5417552|P2|NOT COMPLETED|Overall Study||0
2209830|NCT03070730|5417553|P1|NOT COMPLETED|Overall Study||0
2209831|NCT03070730|5417551|P3|COMPLETED|Overall Study||0
2209832|NCT03070730|5417552|P2|COMPLETED|Overall Study||0
2209833|NCT03070730|5417553|P1|COMPLETED|Overall Study||0
2209834|NCT03070730|5417551|P3|STARTED|Overall Study||0
2209835|NCT03070730|5417552|P2|STARTED|Overall Study||0
2209836|NCT03070730|5417553|P1|STARTED|Overall Study||0
2209837|NCT03070548|5417684|P1|NOT COMPLETED|Overall Study||0
2209838|NCT03070548|5417684|P1|COMPLETED|Overall Study||6
2209839|NCT03070548|5417684|P1|STARTED|Overall Study||6
2209840|NCT03070470|5417726|P6|NOT COMPLETED|Overall Study||2
2209841|NCT03070470|5417727|P5|NOT COMPLETED|Overall Study||0
2209842|NCT03070470|5417728|P4|NOT COMPLETED|Overall Study||0
2209843|NCT03070470|5417729|P3|NOT COMPLETED|Overall Study||0
2209844|NCT03070470|5417730|P2|NOT COMPLETED|Overall Study||1
2209845|NCT03070470|5417731|P1|NOT COMPLETED|Overall Study||0
2209846|NCT03070470|5417726|P6|COMPLETED|Overall Study||8
2209847|NCT03070470|5417727|P5|COMPLETED|Overall Study||10
2209848|NCT03070470|5417728|P4|COMPLETED|Overall Study||10
2209849|NCT03070470|5417729|P3|COMPLETED|Overall Study||10
2209850|NCT03070470|5417730|P2|COMPLETED|Overall Study||9
2209851|NCT03070470|5417731|P1|COMPLETED|Overall Study||10
2209852|NCT03070470|5417726|P6|STARTED|Overall Study||10
2209853|NCT03070470|5417727|P5|STARTED|Overall Study||10
2209854|NCT03070470|5417728|P4|STARTED|Overall Study||10
2209855|NCT03070470|5417729|P3|STARTED|Overall Study||10
2209856|NCT03070470|5417730|P2|STARTED|Overall Study||10
2209857|NCT03070470|5417731|P1|STARTED|Overall Study||10
2209858|NCT03070171|5417760|P2|NOT COMPLETED|Treatment Period 4 + Washout||1
2209859|NCT03070171|5417761|P1|NOT COMPLETED|Treatment Period 4 + Washout||0
2209860|NCT03070171|5417760|P2|COMPLETED|Treatment Period 4 + Washout||78
2209861|NCT03070171|5417761|P1|COMPLETED|Treatment Period 4 + Washout||80
2209862|NCT03070171|5417760|P2|STARTED|Treatment Period 4 + Washout||79
2209863|NCT03070171|5417761|P1|STARTED|Treatment Period 4 + Washout||80
2209864|NCT03070171|5417760|P2|NOT COMPLETED|Treatment Period 3 + Washout||0
2209865|NCT03070171|5417761|P1|NOT COMPLETED|Treatment Period 3 + Washout||0
2209866|NCT03070171|5417760|P2|COMPLETED|Treatment Period 3 + Washout||79
2209867|NCT03070171|5417761|P1|COMPLETED|Treatment Period 3 + Washout||80
2209868|NCT03070171|5417760|P2|STARTED|Treatment Period 3 + Washout||79
2209869|NCT03070171|5417761|P1|STARTED|Treatment Period 3 + Washout||80
2209870|NCT03070171|5417760|P2|NOT COMPLETED|Treatment Period 2 + Washout||1
2209871|NCT03070171|5417761|P1|NOT COMPLETED|Treatment Period 2 + Washout||0
2209872|NCT03070171|5417760|P2|COMPLETED|Treatment Period 2 + Washout||79
2209873|NCT03070171|5417761|P1|COMPLETED|Treatment Period 2 + Washout||80
2209874|NCT03070171|5417760|P2|STARTED|Treatment Period 2 + Washout||80
2209875|NCT03070171|5417761|P1|STARTED|Treatment Period 2 + Washout||80
2209876|NCT03070171|5417760|P2|NOT COMPLETED|Treatment Period 1 + Washout||0
2209877|NCT03070171|5417761|P1|NOT COMPLETED|Treatment Period 1 + Washout||0
2209878|NCT03070171|5417760|P2|COMPLETED|Treatment Period 1 + Washout||80
2209879|NCT03070171|5417761|P1|COMPLETED|Treatment Period 1 + Washout||80
2209880|NCT03070171|5417760|P2|STARTED|Treatment Period 1 + Washout||80
2209881|NCT03070171|5417761|P1|STARTED|Treatment Period 1 + Washout||80
2209882|NCT03070002|5417777|P1|NOT COMPLETED|Follow up for 2 Years||1
2209883|NCT03070002|5417777|P1|COMPLETED|Follow up for 2 Years||0
2209884|NCT03070002|5417777|P1|STARTED|Follow up for 2 Years||1
2209885|NCT03070002|5417777|P1|NOT COMPLETED|3 Cycles of Treatment||0
2209886|NCT03070002|5417777|P1|COMPLETED|3 Cycles of Treatment||1
2209887|NCT03070002|5417777|P1|STARTED|3 Cycles of Treatment||1
2209888|NCT03069989|5417785|P2|NOT COMPLETED|Dosing Period 2 (Up to 16 Days)||0
2209889|NCT03069989|5417786|P1|NOT COMPLETED|Dosing Period 2 (Up to 16 Days)||1
2209890|NCT03069989|5417785|P2|COMPLETED|Dosing Period 2 (Up to 16 Days)||5
2209891|NCT03069989|5417786|P1|COMPLETED|Dosing Period 2 (Up to 16 Days)||2
2209892|NCT03069989|5417785|P2|STARTED|Dosing Period 2 (Up to 16 Days)||5
2209893|NCT03069989|5417786|P1|STARTED|Dosing Period 2 (Up to 16 Days)||3
2209894|NCT03069989|5417785|P2|NOT COMPLETED|Wash Out Period (Up to 28 Days))||0
2209895|NCT03069989|5417786|P1|NOT COMPLETED|Wash Out Period (Up to 28 Days))||0
2209896|NCT03069989|5417785|P2|COMPLETED|Wash Out Period (Up to 28 Days))||5
2209897|NCT03069989|5417786|P1|COMPLETED|Wash Out Period (Up to 28 Days))||3
2209898|NCT03069989|5417785|P2|STARTED|Wash Out Period (Up to 28 Days))||5
2209899|NCT03069989|5417786|P1|STARTED|Wash Out Period (Up to 28 Days))||3
2209900|NCT03069989|5417785|P2|NOT COMPLETED|Dosing Period 1 (Up to 2 Days)||0
2209901|NCT03069989|5417786|P1|NOT COMPLETED|Dosing Period 1 (Up to 2 Days)||0
2209902|NCT03069989|5417785|P2|COMPLETED|Dosing Period 1 (Up to 2 Days)||5
2209903|NCT03069989|5417786|P1|COMPLETED|Dosing Period 1 (Up to 2 Days)||3
2209904|NCT03069989|5417785|P2|STARTED|Dosing Period 1 (Up to 2 Days)||5
2209905|NCT03069989|5417786|P1|STARTED|Dosing Period 1 (Up to 2 Days)||3
2209906|NCT03069677|5417874|P2|NOT COMPLETED|Overall Study||3
2209907|NCT03069677|5417875|P1|NOT COMPLETED|Overall Study||3
2209908|NCT03069677|5417874|P2|COMPLETED|Overall Study||77
2209909|NCT03069677|5417875|P1|COMPLETED|Overall Study||77
2209910|NCT03069677|5417874|P2|STARTED|Overall Study||80
2209911|NCT03069677|5417875|P1|STARTED|Overall Study||80
2209912|NCT03069365|5417891|P1|NOT COMPLETED|Overall Study||1
2209913|NCT03069365|5417891|P1|COMPLETED|Overall Study||100
2209914|NCT03069365|5417891|P1|STARTED|Overall Study||101
2209915|NCT03069313|5417897|P1|NOT COMPLETED|Overall Study||5
2209916|NCT03069313|5417897|P1|COMPLETED|Overall Study||36
2209917|NCT03069313|5417897|P1|STARTED|Overall Study||41
2209918|NCT03068767|5417906|P2|NOT COMPLETED|Overall Study||3
2209919|NCT03068767|5417907|P1|NOT COMPLETED|Overall Study||10
2209920|NCT03068767|5417906|P2|COMPLETED|Overall Study|December 2018|71
2209921|NCT03068767|5417907|P1|COMPLETED|Overall Study|December 2018|65
2209922|NCT03068767|5417906|P2|STARTED|Overall Study|from August 2017 to September 2018|74
2209923|NCT03068767|5417907|P1|STARTED|Overall Study|from August 2017 to September 2018|75
2209924|NCT03068611|5417917|P2|NOT COMPLETED|Overall Study||25
2209925|NCT03068611|5417918|P1|NOT COMPLETED|Overall Study||31
2209926|NCT03068611|5417917|P2|COMPLETED|Overall Study|This is the number of participants followed through 6 months from enrollment.|33
2209927|NCT03068611|5417918|P1|COMPLETED|Overall Study|This is the number of participants followed through 6 months from enrollment.|30
2209928|NCT03068611|5417917|P2|STARTED|Overall Study||58
2209929|NCT03068611|5417918|P1|STARTED|Overall Study||61
2209936|NCT03067948|5417939|P1|NOT COMPLETED|Overall Study||0
2209937|NCT03067948|5417939|P1|COMPLETED|Overall Study||32
2209938|NCT03067948|5417939|P1|STARTED|Overall Study||32
2209939|NCT03067506|5417944|P1|NOT COMPLETED|Overall Study||0
2209940|NCT03067506|5417944|P1|COMPLETED|Overall Study||30
2209941|NCT03067506|5417944|P1|STARTED|Overall Study||30
2209942|NCT03066999|5417953|P2|NOT COMPLETED|Overall Study||2
2209943|NCT03066999|5417954|P1|NOT COMPLETED|Overall Study||0
2209944|NCT03066999|5417953|P2|COMPLETED|Overall Study||1
2209945|NCT03066999|5417954|P1|COMPLETED|Overall Study||2
2209946|NCT03066999|5417953|P2|STARTED|Overall Study||3
2209947|NCT03066999|5417954|P1|STARTED|Overall Study||2
2209948|NCT03066622|5417974|P2|NOT COMPLETED|Overall Study||26
2209949|NCT03066622|5417975|P1|NOT COMPLETED|Overall Study||26
2209950|NCT03066622|5417974|P2|COMPLETED|Overall Study||35
2209951|NCT03066622|5417975|P1|COMPLETED|Overall Study||35
2209952|NCT03066622|5417974|P2|STARTED|Overall Study||61
2209953|NCT03066622|5417975|P1|STARTED|Overall Study||61
2209954|NCT03066609|5417988|P4|NOT COMPLETED|OVERALL STUDY||5
2209955|NCT03066609|5417989|P3|NOT COMPLETED|OVERALL STUDY||4
2209956|NCT03066609|5417990|P2|NOT COMPLETED|OVERALL STUDY||8
2209957|NCT03066609|5417991|P1|NOT COMPLETED|OVERALL STUDY||10
2209958|NCT03066609|5417988|P4|COMPLETED|OVERALL STUDY||124
2209959|NCT03066609|5417989|P3|COMPLETED|OVERALL STUDY||2
2209960|NCT03066609|5417990|P2|COMPLETED|OVERALL STUDY||264
2209961|NCT03066609|5417991|P1|COMPLETED|OVERALL STUDY||126
2209962|NCT03066609|5417988|P4|STARTED|OVERALL STUDY||129
2209963|NCT03066609|5417989|P3|STARTED|OVERALL STUDY||6
2209964|NCT03066609|5417990|P2|STARTED|OVERALL STUDY||272
2209965|NCT03066609|5417991|P1|STARTED|OVERALL STUDY||136
2209966|NCT03066609|5417988|P4|NOT COMPLETED|MAINTENANCE||3
2209967|NCT03066609|5417989|P3|NOT COMPLETED|MAINTENANCE||2
2209968|NCT03066609|5417990|P2|NOT COMPLETED|MAINTENANCE||4
2209969|NCT03066609|5417991|P1|NOT COMPLETED|MAINTENANCE||7
2209970|NCT03066609|5417988|P4|COMPLETED|MAINTENANCE||126
2209971|NCT03066609|5417989|P3|COMPLETED|MAINTENANCE||2
2209972|NCT03066609|5417990|P2|COMPLETED|MAINTENANCE||266
2209973|NCT03066609|5417991|P1|COMPLETED|MAINTENANCE||127
2209974|NCT03066609|5417988|P4|STARTED|MAINTENANCE||129
2209975|NCT03066609|5417989|P3|STARTED|MAINTENANCE||4
2209976|NCT03066609|5417990|P2|STARTED|MAINTENANCE||270
2209977|NCT03066609|5417991|P1|STARTED|MAINTENANCE||134
2209978|NCT03066609|5417988|P4|NOT COMPLETED|INDUCTION||0
2209979|NCT03066609|5417989|P3|NOT COMPLETED|INDUCTION||2
2209980|NCT03066609|5417990|P2|NOT COMPLETED|INDUCTION||2
2209981|NCT03066609|5417991|P1|NOT COMPLETED|INDUCTION||2
2209982|NCT03066609|5417988|P4|COMPLETED|INDUCTION||0
2209983|NCT03066609|5417989|P3|COMPLETED|INDUCTION||133
2209984|NCT03066609|5417990|P2|COMPLETED|INDUCTION||270
2209985|NCT03066609|5417991|P1|COMPLETED|INDUCTION||134
2209986|NCT03066609|5417988|P4|STARTED|INDUCTION||0
2209987|NCT03066609|5417989|P3|STARTED|INDUCTION||135
2209988|NCT03066609|5417990|P2|STARTED|INDUCTION||272
2209989|NCT03066609|5417991|P1|STARTED|INDUCTION||136
2209993|NCT03066102|5418025|P1|NOT COMPLETED|Overall Study||0
2209994|NCT03066102|5418025|P1|COMPLETED|Overall Study||30
2209995|NCT03066102|5418025|P1|STARTED|Overall Study||30
2209996|NCT03065933|5418034|P1|NOT COMPLETED|Overall Study||5
2209997|NCT03065933|5418034|P1|COMPLETED|Overall Study||0
2209998|NCT03065933|5418034|P1|STARTED|Overall Study||5
2209999|NCT03065530|5418042|P4|NOT COMPLETED|Overall Study||2
2210000|NCT03065530|5418043|P3|NOT COMPLETED|Overall Study||1
2210001|NCT03065530|5418044|P2|NOT COMPLETED|Overall Study||1
2210002|NCT03065530|5418045|P1|NOT COMPLETED|Overall Study||2
2210003|NCT03065530|5418042|P4|COMPLETED|Overall Study||28
2210004|NCT03065530|5418043|P3|COMPLETED|Overall Study||29
2210005|NCT03065530|5418044|P2|COMPLETED|Overall Study||29
2210006|NCT03065530|5418045|P1|COMPLETED|Overall Study||28
2210007|NCT03065530|5418042|P4|STARTED|Overall Study||30
2210008|NCT03065530|5418043|P3|STARTED|Overall Study||30
2210009|NCT03065530|5418044|P2|STARTED|Overall Study||30
2210010|NCT03065530|5418045|P1|STARTED|Overall Study||30
2210011|NCT03065205|5418122|P1|NOT COMPLETED|Overall Study||12
2210012|NCT03065205|5418122|P1|COMPLETED|Overall Study||53
2210013|NCT03065205|5418122|P1|STARTED|Overall Study||65
2210014|NCT03065075|5418131|P2|NOT COMPLETED|Overall Study||0
2210015|NCT03065075|5418132|P1|NOT COMPLETED|Overall Study||0
2210016|NCT03065075|5418131|P2|COMPLETED|Overall Study||76
2210017|NCT03065075|5418132|P1|COMPLETED|Overall Study||76
2210018|NCT03065075|5418131|P2|As-treated Analysis|Overall Study||77
2210019|NCT03065075|5418132|P1|As-treated Analysis|Overall Study||69
2210020|NCT03065075|5418131|P2|Intent-to-treat Analysis|Overall Study||74
2210021|NCT03065075|5418132|P1|Intent-to-treat Analysis|Overall Study||72
2210022|NCT03065075|5418131|P2|STARTED|Overall Study||76
2210023|NCT03065075|5418132|P1|STARTED|Overall Study||76
2210024|NCT03065023|5418144|P5|NOT COMPLETED|Overall Study||0
2210025|NCT03065023|5418145|P4|NOT COMPLETED|Overall Study||3
2210026|NCT03065023|5418146|P3|NOT COMPLETED|Overall Study||1
2210027|NCT03065023|5418147|P2|NOT COMPLETED|Overall Study||2
2210028|NCT03065023|5418148|P1|NOT COMPLETED|Overall Study||2
2210029|NCT03065023|5418144|P5|COMPLETED|Overall Study||0
2210030|NCT03065023|5418145|P4|COMPLETED|Overall Study||3
2210031|NCT03065023|5418146|P3|COMPLETED|Overall Study||2
2210032|NCT03065023|5418147|P2|COMPLETED|Overall Study||1
2210033|NCT03065023|5418148|P1|COMPLETED|Overall Study||1
2210034|NCT03065023|5418144|P5|STARTED|Overall Study|Group B not started for business reasons.|0
2210035|NCT03065023|5418145|P4|STARTED|Overall Study||6
2210036|NCT03065023|5418146|P3|STARTED|Overall Study||3
2210037|NCT03065023|5418147|P2|STARTED|Overall Study||3
2210038|NCT03065023|5418148|P1|STARTED|Overall Study||3
2210039|NCT03064841|5418214|P1|NOT COMPLETED|Overall Study||17
2210040|NCT03064841|5418214|P1|COMPLETED|Overall Study||1520
2210041|NCT03064841|5418214|P1|STARTED|Overall Study||1537
2210042|NCT03064113|5418233|P4|NOT COMPLETED|Washout (7 Days)||0
2210043|NCT03064113|5418234|P3|NOT COMPLETED|Washout (7 Days)||0
2210044|NCT03064113|5418235|P2|NOT COMPLETED|Washout (7 Days)||0
2210045|NCT03064113|5418236|P1|NOT COMPLETED|Washout (7 Days)||0
2210046|NCT03064113|5418233|P4|COMPLETED|Washout (7 Days)||8
2210047|NCT03064113|5418234|P3|COMPLETED|Washout (7 Days)||8
2210048|NCT03064113|5418235|P2|COMPLETED|Washout (7 Days)||8
2210049|NCT03064113|5418236|P1|COMPLETED|Washout (7 Days)||8
2210050|NCT03064113|5418233|P4|STARTED|Washout (7 Days)||8
2210051|NCT03064113|5418234|P3|STARTED|Washout (7 Days)||8
2210052|NCT03064113|5418235|P2|STARTED|Washout (7 Days)||8
2210053|NCT03064113|5418236|P1|STARTED|Washout (7 Days)||8
2210054|NCT03064113|5418233|P4|NOT COMPLETED|Intervention 4 (2 Days)||0
2210055|NCT03064113|5418234|P3|NOT COMPLETED|Intervention 4 (2 Days)||0
2210056|NCT03064113|5418235|P2|NOT COMPLETED|Intervention 4 (2 Days)||0
2210057|NCT03064113|5418236|P1|NOT COMPLETED|Intervention 4 (2 Days)||0
2210058|NCT03064113|5418233|P4|COMPLETED|Intervention 4 (2 Days)||8
2210059|NCT03064113|5418234|P3|COMPLETED|Intervention 4 (2 Days)||8
2210060|NCT03064113|5418235|P2|COMPLETED|Intervention 4 (2 Days)||8
2210061|NCT03064113|5418236|P1|COMPLETED|Intervention 4 (2 Days)||8
2210062|NCT03064113|5418233|P4|STARTED|Intervention 4 (2 Days)||8
2210063|NCT03064113|5418234|P3|STARTED|Intervention 4 (2 Days)||8
2210064|NCT03064113|5418235|P2|STARTED|Intervention 4 (2 Days)||8
2210065|NCT03064113|5418236|P1|STARTED|Intervention 4 (2 Days)||8
2210066|NCT03064113|5418233|P4|NOT COMPLETED|Washout (7 Days)||0
2210067|NCT03064113|5418234|P3|NOT COMPLETED|Washout (7 Days)||0
2210068|NCT03064113|5418235|P2|NOT COMPLETED|Washout (7 Days)||0
2210069|NCT03064113|5418236|P1|NOT COMPLETED|Washout (7 Days)||0
2210070|NCT03064113|5418233|P4|COMPLETED|Washout (7 Days)||8
2210071|NCT03064113|5418234|P3|COMPLETED|Washout (7 Days)||8
2210072|NCT03064113|5418235|P2|COMPLETED|Washout (7 Days)||8
2210073|NCT03064113|5418236|P1|COMPLETED|Washout (7 Days)||8
2210074|NCT03064113|5418233|P4|STARTED|Washout (7 Days)||8
2210075|NCT03064113|5418234|P3|STARTED|Washout (7 Days)||8
2210076|NCT03064113|5418235|P2|STARTED|Washout (7 Days)||8
2210077|NCT03064113|5418236|P1|STARTED|Washout (7 Days)||8
2210078|NCT03064113|5418233|P4|NOT COMPLETED|Intervention 3 (2 Days)||0
2210079|NCT03064113|5418234|P3|NOT COMPLETED|Intervention 3 (2 Days)||0
2210080|NCT03064113|5418235|P2|NOT COMPLETED|Intervention 3 (2 Days)||0
2210081|NCT03064113|5418236|P1|NOT COMPLETED|Intervention 3 (2 Days)||0
2210082|NCT03064113|5418233|P4|COMPLETED|Intervention 3 (2 Days)||8
2210083|NCT03064113|5418234|P3|COMPLETED|Intervention 3 (2 Days)||8
2210084|NCT03064113|5418235|P2|COMPLETED|Intervention 3 (2 Days)||8
2210085|NCT03064113|5418236|P1|COMPLETED|Intervention 3 (2 Days)||8
2210086|NCT03064113|5418233|P4|STARTED|Intervention 3 (2 Days)||8
2210087|NCT03064113|5418234|P3|STARTED|Intervention 3 (2 Days)||8
2210088|NCT03064113|5418235|P2|STARTED|Intervention 3 (2 Days)||8
2210089|NCT03064113|5418236|P1|STARTED|Intervention 3 (2 Days)||8
2210090|NCT03064113|5418233|P4|NOT COMPLETED|Washout (7 Days)||0
2210091|NCT03064113|5418234|P3|NOT COMPLETED|Washout (7 Days)||0
2210092|NCT03064113|5418235|P2|NOT COMPLETED|Washout (7 Days)||0
2210093|NCT03064113|5418236|P1|NOT COMPLETED|Washout (7 Days)||0
2210094|NCT03064113|5418233|P4|COMPLETED|Washout (7 Days)||8
2210095|NCT03064113|5418234|P3|COMPLETED|Washout (7 Days)||8
2210096|NCT03064113|5418235|P2|COMPLETED|Washout (7 Days)||8
2210097|NCT03064113|5418236|P1|COMPLETED|Washout (7 Days)||8
2210098|NCT03064113|5418233|P4|STARTED|Washout (7 Days)||8
2210099|NCT03064113|5418234|P3|STARTED|Washout (7 Days)||8
2210100|NCT03064113|5418235|P2|STARTED|Washout (7 Days)||8
2210101|NCT03064113|5418236|P1|STARTED|Washout (7 Days)||8
2210102|NCT03064113|5418233|P4|NOT COMPLETED|Intervention 2 (2 Days)||0
2210103|NCT03064113|5418234|P3|NOT COMPLETED|Intervention 2 (2 Days)||0
2210104|NCT03064113|5418235|P2|NOT COMPLETED|Intervention 2 (2 Days)||0
2210105|NCT03064113|5418236|P1|NOT COMPLETED|Intervention 2 (2 Days)||0
2210106|NCT03064113|5418233|P4|COMPLETED|Intervention 2 (2 Days)||8
2210107|NCT03064113|5418234|P3|COMPLETED|Intervention 2 (2 Days)||8
2210108|NCT03064113|5418235|P2|COMPLETED|Intervention 2 (2 Days)||8
2210109|NCT03064113|5418236|P1|COMPLETED|Intervention 2 (2 Days)||8
2210110|NCT03064113|5418233|P4|STARTED|Intervention 2 (2 Days)||8
2210111|NCT03064113|5418234|P3|STARTED|Intervention 2 (2 Days)||8
2210112|NCT03064113|5418235|P2|STARTED|Intervention 2 (2 Days)||8
2210113|NCT03064113|5418236|P1|STARTED|Intervention 2 (2 Days)||8
2210114|NCT03064113|5418233|P4|NOT COMPLETED|Washout (7 Days)||0
2210115|NCT03064113|5418234|P3|NOT COMPLETED|Washout (7 Days)||0
2210116|NCT03064113|5418235|P2|NOT COMPLETED|Washout (7 Days)||0
2210117|NCT03064113|5418236|P1|NOT COMPLETED|Washout (7 Days)||0
2210118|NCT03064113|5418233|P4|COMPLETED|Washout (7 Days)||8
2210119|NCT03064113|5418234|P3|COMPLETED|Washout (7 Days)||8
2210120|NCT03064113|5418235|P2|COMPLETED|Washout (7 Days)||8
2210121|NCT03064113|5418236|P1|COMPLETED|Washout (7 Days)||8
2210122|NCT03064113|5418233|P4|STARTED|Washout (7 Days)||8
2210123|NCT03064113|5418234|P3|STARTED|Washout (7 Days)||8
2210124|NCT03064113|5418235|P2|STARTED|Washout (7 Days)||8
2210125|NCT03064113|5418236|P1|STARTED|Washout (7 Days)||8
2210126|NCT03064113|5418233|P4|NOT COMPLETED|Intervention 1 (2 Days)||0
2210127|NCT03064113|5418234|P3|NOT COMPLETED|Intervention 1 (2 Days)||0
2210128|NCT03064113|5418235|P2|NOT COMPLETED|Intervention 1 (2 Days)||0
2210129|NCT03064113|5418236|P1|NOT COMPLETED|Intervention 1 (2 Days)||0
2210130|NCT03064113|5418233|P4|COMPLETED|Intervention 1 (2 Days)||8
2210131|NCT03064113|5418234|P3|COMPLETED|Intervention 1 (2 Days)||8
2210132|NCT03064113|5418235|P2|COMPLETED|Intervention 1 (2 Days)||8
2210133|NCT03064113|5418236|P1|COMPLETED|Intervention 1 (2 Days)||8
2210134|NCT03064113|5418233|P4|STARTED|Intervention 1 (2 Days)||8
2210135|NCT03064113|5418234|P3|STARTED|Intervention 1 (2 Days)||8
2210136|NCT03064113|5418235|P2|STARTED|Intervention 1 (2 Days)||8
2210137|NCT03064113|5418236|P1|STARTED|Intervention 1 (2 Days)||8
2210138|NCT03063476|5418270|P1|NOT COMPLETED|Overall Study||0
2210139|NCT03063476|5418270|P1|COMPLETED|Overall Study||2
2210140|NCT03063476|5418270|P1|STARTED|Overall Study||2
2210141|NCT03063437|5418277|P2|NOT COMPLETED|Overall Study||0
2210142|NCT03063437|5418278|P1|NOT COMPLETED|Overall Study||0
2210143|NCT03063437|5418277|P2|COMPLETED|Overall Study||5
2210144|NCT03063437|5418278|P1|COMPLETED|Overall Study||4
2210145|NCT03063437|5418277|P2|STARTED|Overall Study||5
2210146|NCT03063437|5418278|P1|STARTED|Overall Study||4
2210147|NCT03063385|5418288|P2|NOT COMPLETED|Overall Study||76
2210148|NCT03063385|5418289|P1|NOT COMPLETED|Overall Study||87
2210149|NCT03063385|5418288|P2|COMPLETED|Overall Study||254
2210150|NCT03063385|5418289|P1|COMPLETED|Overall Study||243
2210151|NCT03063385|5418288|P2|12-month Follow-up|Overall Study||254
2210152|NCT03063385|5418289|P1|12-month Follow-up|Overall Study||243
2210153|NCT03063385|5418288|P2|6-month Follow-up|Overall Study||259
2210154|NCT03063385|5418289|P1|6-month Follow-up|Overall Study||265
2210155|NCT03063385|5418288|P2|3-month Follow-up|Overall Study||259
2210156|NCT03063385|5418289|P1|3-month Follow-up|Overall Study||257
2210157|NCT03063385|5418288|P2|STARTED|Overall Study||330
2210158|NCT03063385|5418289|P1|STARTED|Overall Study||330
2210159|NCT03063086|5418299|P6|NOT COMPLETED|Overall Study||1
2210160|NCT03063086|5418300|P5|NOT COMPLETED|Overall Study||0
2210161|NCT03063086|5418301|P4|NOT COMPLETED|Overall Study||3
2210162|NCT03063086|5418302|P3|NOT COMPLETED|Overall Study||1
2210163|NCT03063086|5418303|P2|NOT COMPLETED|Overall Study||1
2210164|NCT03063086|5418304|P1|NOT COMPLETED|Overall Study||3
2210165|NCT03063086|5418299|P6|COMPLETED|Overall Study||18
2210166|NCT03063086|5418300|P5|COMPLETED|Overall Study||20
2210167|NCT03063086|5418301|P4|COMPLETED|Overall Study||17
2210168|NCT03063086|5418302|P3|COMPLETED|Overall Study||17
2210169|NCT03063086|5418303|P2|COMPLETED|Overall Study||19
2210170|NCT03063086|5418304|P1|COMPLETED|Overall Study||16
2210171|NCT03063086|5418299|P6|STARTED|Overall Study||19
2210172|NCT03063086|5418300|P5|STARTED|Overall Study||20
2210173|NCT03063086|5418301|P4|STARTED|Overall Study||20
2210174|NCT03063086|5418302|P3|STARTED|Overall Study||18
2210175|NCT03063086|5418303|P2|STARTED|Overall Study||20
2210176|NCT03063086|5418304|P1|STARTED|Overall Study||19
2210177|NCT03062917|5418332|P5|NOT COMPLETED|Overall Study||0
2210178|NCT03062917|5418333|P4|NOT COMPLETED|Overall Study||0
2210179|NCT03062917|5418334|P3|NOT COMPLETED|Overall Study||0
2210180|NCT03062917|5418335|P2|NOT COMPLETED|Overall Study||0
2210181|NCT03062917|5418336|P1|NOT COMPLETED|Overall Study||0
2210182|NCT03062917|5418332|P5|COMPLETED|Overall Study||0
2210183|NCT03062917|5418333|P4|COMPLETED|Overall Study||20
2210184|NCT03062917|5418334|P3|COMPLETED|Overall Study||49
2210185|NCT03062917|5418335|P2|COMPLETED|Overall Study||51
2210186|NCT03062917|5418336|P1|COMPLETED|Overall Study||32
2210187|NCT03062917|5418332|P5|STARTED|Overall Study||0
2210188|NCT03062917|5418333|P4|STARTED|Overall Study||20
2210189|NCT03062917|5418334|P3|STARTED|Overall Study||49
2210190|NCT03062917|5418335|P2|STARTED|Overall Study||51
2210191|NCT03062917|5418336|P1|STARTED|Overall Study||32
2210192|NCT03062605|5418350|P2|NOT COMPLETED|Overall Study||10
2210193|NCT03062605|5418351|P1|NOT COMPLETED|Overall Study||11
2210194|NCT03062605|5418350|P2|COMPLETED|Overall Study||13
2210195|NCT03062605|5418351|P1|COMPLETED|Overall Study||14
2210196|NCT03062605|5418350|P2|STARTED|Overall Study||23
2210197|NCT03062605|5418351|P1|STARTED|Overall Study||25
2210198|NCT03062488|5418360|P3|NOT COMPLETED|Overall Study||0
2210199|NCT03062488|5418361|P2|NOT COMPLETED|Overall Study||0
2210200|NCT03062488|5418362|P1|NOT COMPLETED|Overall Study||0
2210201|NCT03062488|5418360|P3|COMPLETED|Overall Study||41
2210202|NCT03062488|5418361|P2|COMPLETED|Overall Study||51
2210203|NCT03062488|5418362|P1|COMPLETED|Overall Study||51
2210204|NCT03062488|5418360|P3|STARTED|Overall Study||41
2210205|NCT03062488|5418361|P2|STARTED|Overall Study||51
2210206|NCT03062488|5418362|P1|STARTED|Overall Study||51
2210207|NCT03061513|5418378|P2|NOT COMPLETED|Overall Study||1
2210208|NCT03061513|5418379|P1|NOT COMPLETED|Overall Study||0
2210209|NCT03061513|5418378|P2|COMPLETED|Overall Study||4
2210210|NCT03061513|5418379|P1|COMPLETED|Overall Study||6
2210211|NCT03061513|5418378|P2|STARTED|Overall Study||5
2210212|NCT03061513|5418379|P1|STARTED|Overall Study||6
2210213|NCT03061331|5418389|P2|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
2210214|NCT03061331|5418390|P1|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
2210215|NCT03061331|5418389|P2|COMPLETED|Treatment Period 2 (8 Weeks)||9
2210216|NCT03061331|5418390|P1|COMPLETED|Treatment Period 2 (8 Weeks)||8
2210217|NCT03061331|5418389|P2|STARTED|Treatment Period 2 (8 Weeks)||9
2210218|NCT03061331|5418390|P1|STARTED|Treatment Period 2 (8 Weeks)||8
2210219|NCT03061331|5418389|P2|NOT COMPLETED|Washout Period (8 Weeks)||1
2210220|NCT03061331|5418390|P1|NOT COMPLETED|Washout Period (8 Weeks)||2
2210221|NCT03061331|5418389|P2|COMPLETED|Washout Period (8 Weeks)||9
2210222|NCT03061331|5418390|P1|COMPLETED|Washout Period (8 Weeks)||8
2210223|NCT03061331|5418389|P2|STARTED|Washout Period (8 Weeks)||10
2210224|NCT03061331|5418390|P1|STARTED|Washout Period (8 Weeks)||10
2210225|NCT03061331|5418389|P2|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
2210226|NCT03061331|5418390|P1|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
2210227|NCT03061331|5418389|P2|COMPLETED|Treatment Period 1 (8 Weeks)||10
2210228|NCT03061331|5418390|P1|COMPLETED|Treatment Period 1 (8 Weeks)||10
2210229|NCT03061331|5418389|P2|STARTED|Treatment Period 1 (8 Weeks)||10
2210230|NCT03061331|5418390|P1|STARTED|Treatment Period 1 (8 Weeks)||10
2210231|NCT03060512|5418398|P2|NOT COMPLETED|Overall Study||9
2210232|NCT03060512|5418399|P1|NOT COMPLETED|Overall Study||7
2210233|NCT03060512|5418398|P2|COMPLETED|Overall Study||130
2210234|NCT03060512|5418399|P1|COMPLETED|Overall Study||130
2210235|NCT03060512|5418398|P2|Treated With PEG 3350|Overall Study||138
2210236|NCT03060512|5418399|P1|Treated With PEG 3350|Overall Study||130
2210237|NCT03060512|5418398|P2|Treated With Movantik|Overall Study||135
2210238|NCT03060512|5418399|P1|Treated With Movantik|Overall Study||136
2210239|NCT03060512|5418398|P2|STARTED|Overall Study||139
2210240|NCT03060512|5418399|P1|STARTED|Overall Study||137
2210241|NCT03060486|5418416|P1|NOT COMPLETED|Overall Study||0
2210242|NCT03060486|5418416|P1|COMPLETED|Overall Study||15
2210243|NCT03060486|5418416|P1|STARTED|Overall Study||15
2210244|NCT03059901|5418422|P2|NOT COMPLETED|Overall Study||2
2210245|NCT03059901|5418423|P1|NOT COMPLETED|Overall Study||4
2210246|NCT03059901|5418422|P2|COMPLETED|Overall Study||28
2210247|NCT03059901|5418423|P1|COMPLETED|Overall Study||26
2210248|NCT03059901|5418422|P2|STARTED|Overall Study||30
2210249|NCT03059901|5418423|P1|STARTED|Overall Study||30
2210250|NCT03059810|5418429|P1|NOT COMPLETED|Overall Study||0
2210251|NCT03059810|5418429|P1|COMPLETED|Overall Study||63
2210252|NCT03059810|5418429|P1|STARTED|Overall Study||63
2210265|NCT03058705|5418464|P1|NOT COMPLETED|Overall Study||4
2210266|NCT03058705|5418464|P1|COMPLETED|Overall Study||6
2210267|NCT03058705|5418464|P1|STARTED|Overall Study||10
2210268|NCT03058692|5418470|P2|NOT COMPLETED|Overall Study||2
2210269|NCT03058692|5418471|P1|NOT COMPLETED|Overall Study||3
2210270|NCT03058692|5418470|P2|COMPLETED|Overall Study||57
2210271|NCT03058692|5418471|P1|COMPLETED|Overall Study||58
2210272|NCT03058692|5418470|P2|STARTED|Overall Study||59
2210273|NCT03058692|5418471|P1|STARTED|Overall Study||61
2210274|NCT03057704|5418589|P2|NOT COMPLETED|Overall Study||0
2210275|NCT03057704|5418590|P1|NOT COMPLETED|Overall Study||0
2210276|NCT03057704|5418589|P2|COMPLETED|Overall Study||25
2210277|NCT03057704|5418590|P1|COMPLETED|Overall Study||25
2210278|NCT03057704|5418589|P2|STARTED|Overall Study||25
2210279|NCT03057704|5418590|P1|STARTED|Overall Study||25
2210280|NCT03057366|5418600|P3|NOT COMPLETED|Part B||0
2210281|NCT03057366|5418601|P2|NOT COMPLETED|Part B||0
2210282|NCT03057366|5418602|P1|NOT COMPLETED|Part B||0
2210283|NCT03057366|5418600|P3|COMPLETED|Part B||2
2210284|NCT03057366|5418601|P2|COMPLETED|Part B||5
2210285|NCT03057366|5418602|P1|COMPLETED|Part B||0
2210286|NCT03057366|5418600|P3|STARTED|Part B|Participants completed Part A, met eligibility criteria, and provided consent for Part B.|2
2210287|NCT03057366|5418601|P2|STARTED|Part B|Participants completed Part A, met eligibility criteria, and provided consent for Part B.|5
2210288|NCT03057366|5418602|P1|STARTED|Part B||0
2210289|NCT03057366|5418600|P3|NOT COMPLETED|Part A||0
2210290|NCT03057366|5418601|P2|NOT COMPLETED|Part A||0
2210291|NCT03057366|5418602|P1|NOT COMPLETED|Part A||0
2210292|NCT03057366|5418600|P3|COMPLETED|Part A||0
2210293|NCT03057366|5418601|P2|COMPLETED|Part A||0
2210294|NCT03057366|5418602|P1|COMPLETED|Part A||8
2210295|NCT03057366|5418600|P3|STARTED|Part A||0
2210296|NCT03057366|5418601|P2|STARTED|Part A||0
2210297|NCT03057366|5418602|P1|STARTED|Part A||8
2210298|NCT03057132|5418625|P1|NOT COMPLETED|Overall Study||0
2210299|NCT03057132|5418625|P1|COMPLETED|Overall Study||1
2210300|NCT03057132|5418625|P1|STARTED|Overall Study||1
2210301|NCT03056352|5418630|P1|NOT COMPLETED|Overall Study||1
2210302|NCT03056352|5418630|P1|COMPLETED|Overall Study||20
2210303|NCT03056352|5418630|P1|STARTED|Overall Study||21
2210304|NCT03056300|5418636|P1|NOT COMPLETED|Overall Study||3
2210305|NCT03056300|5418636|P1|COMPLETED|Overall Study||47
2210306|NCT03056300|5418636|P1|STARTED|Overall Study||50
2210307|NCT03056144|5418641|P1|NOT COMPLETED|Overall Study||0
2210308|NCT03056144|5418641|P1|COMPLETED|Overall Study||1
2210309|NCT03056144|5418641|P1|STARTED|Overall Study||1
2210310|NCT03056040|5418653|P2|NOT COMPLETED|Extension Period||95
2210311|NCT03056040|5418654|P1|NOT COMPLETED|Extension Period||96
2210312|NCT03056040|5418653|P2|COMPLETED|Extension Period||0
2210313|NCT03056040|5418654|P1|COMPLETED|Extension Period||0
2210314|NCT03056040|5418653|P2|Received at Least 1 Dose of Ravulizumab|Extension Period||95
2210315|NCT03056040|5418654|P1|Received at Least 1 Dose of Ravulizumab|Extension Period||96
2210316|NCT03056040|5418653|P2|STARTED|Extension Period||95
2210317|NCT03056040|5418654|P1|STARTED|Extension Period||96
2210318|NCT03056040|5418653|P2|NOT COMPLETED|Primary Evaluation Period||3
2210319|NCT03056040|5418654|P1|NOT COMPLETED|Primary Evaluation Period||1
2210320|NCT03056040|5418653|P2|COMPLETED|Primary Evaluation Period||95
2210321|NCT03056040|5418654|P1|COMPLETED|Primary Evaluation Period||96
2210322|NCT03056040|5418653|P2|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||98
2210323|NCT03056040|5418654|P1|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||97
2210324|NCT03056040|5418653|P2|STARTED|Primary Evaluation Period||98
2210325|NCT03056040|5418654|P1|STARTED|Primary Evaluation Period||97
2210326|NCT03055988|5418668|P2|NOT COMPLETED|Period 2||2
2210327|NCT03055988|5418669|P1|NOT COMPLETED|Period 2||1
2210328|NCT03055988|5418668|P2|COMPLETED|Period 2||31
2210329|NCT03055988|5418669|P1|COMPLETED|Period 2||36
2210330|NCT03055988|5418668|P2|STARTED|Period 2||33
2210331|NCT03055988|5418669|P1|STARTED|Period 2||37
2210332|NCT03055988|5418668|P2|NOT COMPLETED|Period 1||5
2210333|NCT03055988|5418669|P1|NOT COMPLETED|Period 1||1
2210334|NCT03055988|5418668|P2|COMPLETED|Period 1||33
2210335|NCT03055988|5418669|P1|COMPLETED|Period 1||37
2210336|NCT03055988|5418668|P2|STARTED|Period 1||38
2210337|NCT03055988|5418669|P1|STARTED|Period 1||38
2210338|NCT03055832|5418693|P2|NOT COMPLETED|Week 4||0
2210339|NCT03055832|5418694|P1|NOT COMPLETED|Week 4||0
2210340|NCT03055832|5418693|P2|COMPLETED|Week 4||71
2210341|NCT03055832|5418694|P1|COMPLETED|Week 4||70
2210342|NCT03055832|5418693|P2|STARTED|Week 4||71
2210343|NCT03055832|5418694|P1|STARTED|Week 4||70
2210344|NCT03055832|5418693|P2|NOT COMPLETED|Week 2||0
2210345|NCT03055832|5418694|P1|NOT COMPLETED|Week 2||1
2210346|NCT03055832|5418693|P2|COMPLETED|Week 2||71
2210347|NCT03055832|5418694|P1|COMPLETED|Week 2||70
2210348|NCT03055832|5418693|P2|STARTED|Week 2||71
2210349|NCT03055832|5418694|P1|STARTED|Week 2||71
2210350|NCT03055832|5418693|P2|NOT COMPLETED|Day 1||0
2210351|NCT03055832|5418694|P1|NOT COMPLETED|Day 1||0
2210352|NCT03055832|5418693|P2|COMPLETED|Day 1||71
2210353|NCT03055832|5418694|P1|COMPLETED|Day 1||71
2210354|NCT03055832|5418693|P2|STARTED|Day 1||71
2210355|NCT03055832|5418694|P1|STARTED|Day 1||71
2210356|NCT03055832|5418693|P2|NOT COMPLETED|Immediately Post-Procedure (Hour 1)||0
2210357|NCT03055832|5418694|P1|NOT COMPLETED|Immediately Post-Procedure (Hour 1)||0
2210358|NCT03055832|5418693|P2|COMPLETED|Immediately Post-Procedure (Hour 1)||71
2210359|NCT03055832|5418694|P1|COMPLETED|Immediately Post-Procedure (Hour 1)||71
2210360|NCT03055832|5418693|P2|STARTED|Immediately Post-Procedure (Hour 1)||71
2210361|NCT03055832|5418694|P1|STARTED|Immediately Post-Procedure (Hour 1)||71
2210362|NCT03055832|5418693|P2|NOT COMPLETED|Baseline||0
2210363|NCT03055832|5418694|P1|NOT COMPLETED|Baseline||0
2210364|NCT03055832|5418693|P2|COMPLETED|Baseline||71
2210365|NCT03055832|5418694|P1|COMPLETED|Baseline||71
2210366|NCT03055832|5418693|P2|STARTED|Baseline||71
2210367|NCT03055832|5418694|P1|STARTED|Baseline||71
2210368|NCT03055806|5418754|P4|NOT COMPLETED|Overall Study||15
2210369|NCT03055806|5418755|P3|NOT COMPLETED|Overall Study||13
2210370|NCT03055806|5418756|P2|NOT COMPLETED|Overall Study||7
2210371|NCT03055806|5418757|P1|NOT COMPLETED|Overall Study||6
2210372|NCT03055806|5418754|P4|COMPLETED|Overall Study||57
2210373|NCT03055806|5418755|P3|COMPLETED|Overall Study||58
2210374|NCT03055806|5418756|P2|COMPLETED|Overall Study||41
2210375|NCT03055806|5418757|P1|COMPLETED|Overall Study||42
2210376|NCT03055806|5418754|P4|STARTED|Overall Study||72
2210377|NCT03055806|5418755|P3|STARTED|Overall Study||71
2210378|NCT03055806|5418756|P2|STARTED|Overall Study||48
2210379|NCT03055806|5418757|P1|STARTED|Overall Study||48
2210380|NCT03055338|5418802|P3|NOT COMPLETED|Overall Study||12
2210381|NCT03055338|5418803|P2|NOT COMPLETED|Overall Study||11
2210382|NCT03055338|5418804|P1|NOT COMPLETED|Overall Study||18
2210383|NCT03055338|5418802|P3|COMPLETED|Overall Study||77
2210384|NCT03055338|5418803|P2|COMPLETED|Overall Study||34
2210385|NCT03055338|5418804|P1|COMPLETED|Overall Study||72
2210386|NCT03055338|5418802|P3|STARTED|Overall Study||89
2210387|NCT03055338|5418803|P2|STARTED|Overall Study||45
2210388|NCT03055338|5418804|P1|STARTED|Overall Study||90
2210389|NCT03055221|5418821|P1|NOT COMPLETED|Overall Study||16
2210390|NCT03055221|5418821|P1|COMPLETED|Overall Study||0
2210391|NCT03055221|5418821|P1|STARTED|Overall Study||16
2210398|NCT03054857|5418883|P2|NOT COMPLETED|Overall Study||0
2210399|NCT03054857|5418884|P1|NOT COMPLETED|Overall Study||1
2210400|NCT03054857|5418883|P2|COMPLETED|Overall Study||50
2210401|NCT03054857|5418884|P1|COMPLETED|Overall Study||49
2210402|NCT03054857|5418883|P2|STARTED|Overall Study||50
2210403|NCT03054857|5418884|P1|STARTED|Overall Study||50
2210404|NCT03054844|5418900|P2|NOT COMPLETED|Overall Study||1
2210405|NCT03054844|5418901|P1|NOT COMPLETED|Overall Study||3
2210406|NCT03054844|5418900|P2|COMPLETED|Overall Study||26
2210407|NCT03054844|5418901|P1|COMPLETED|Overall Study||25
2210408|NCT03054844|5418900|P2|STARTED|Overall Study||27
2210409|NCT03054844|5418901|P1|STARTED|Overall Study||28
2210410|NCT03054805|5418920|P3|NOT COMPLETED|Overall Study||2
2210411|NCT03054805|5418921|P2|NOT COMPLETED|Overall Study||10
2210412|NCT03054805|5418922|P1|NOT COMPLETED|Overall Study||16
2210413|NCT03054805|5418920|P3|COMPLETED|Overall Study||42
2210414|NCT03054805|5418921|P2|COMPLETED|Overall Study||41
2210415|NCT03054805|5418922|P1|COMPLETED|Overall Study||42
2210416|NCT03054805|5418920|P3|STARTED|Overall Study||44
2210417|NCT03054805|5418921|P2|STARTED|Overall Study||51
2210418|NCT03054805|5418922|P1|STARTED|Overall Study||58
2210419|NCT03054740|5418932|P2|NOT COMPLETED|Overall Study||0
2210420|NCT03054740|5418933|P1|NOT COMPLETED|Overall Study||0
2210421|NCT03054740|5418932|P2|COMPLETED|Overall Study||15
2210422|NCT03054740|5418933|P1|COMPLETED|Overall Study||15
2210423|NCT03054740|5418932|P2|STARTED|Overall Study||15
2210424|NCT03054740|5418933|P1|STARTED|Overall Study||15
2210425|NCT03054506|5418950|P3|NOT COMPLETED|Overall Study||0
2210426|NCT03054506|5418951|P2|NOT COMPLETED|Overall Study||0
2210427|NCT03054506|5418952|P1|NOT COMPLETED|Overall Study||1
2210428|NCT03054506|5418950|P3|COMPLETED|Overall Study||9
2210429|NCT03054506|5418951|P2|COMPLETED|Overall Study||11
2210430|NCT03054506|5418952|P1|COMPLETED|Overall Study||19
2210431|NCT03054506|5418950|P3|STARTED|Overall Study||9
2210432|NCT03054506|5418951|P2|STARTED|Overall Study||11
2210433|NCT03054506|5418952|P1|STARTED|Overall Study||20
2210434|NCT03054428|5418996|P3|NOT COMPLETED|Overall Study||79
2210435|NCT03054428|5418997|P2|NOT COMPLETED|Overall Study||80
2210436|NCT03054428|5418998|P1|NOT COMPLETED|Overall Study||83
2210437|NCT03054428|5418996|P3|COMPLETED|Overall Study||3
2210438|NCT03054428|5418997|P2|COMPLETED|Overall Study||4
2210439|NCT03054428|5418998|P1|COMPLETED|Overall Study||2
2210440|NCT03054428|5418996|P3|Completed Week 28 (End of Study)|Overall Study||3
2210441|NCT03054428|5418997|P2|Completed Week 28 (End of Study)|Overall Study||4
2210442|NCT03054428|5418998|P1|Completed Week 28 (End of Study)|Overall Study||2
2210443|NCT03054428|5418996|P3|Completed Wk 16 End of Treatment (EOT)|Overall Study||79
2210444|NCT03054428|5418997|P2|Completed Wk 16 End of Treatment (EOT)|Overall Study||81
2210445|NCT03054428|5418998|P1|Completed Wk 16 End of Treatment (EOT)|Overall Study||80
2210446|NCT03054428|5418996|P3|STARTED|Overall Study||82
2210447|NCT03054428|5418997|P2|STARTED|Overall Study||84
2210448|NCT03054428|5418998|P1|STARTED|Overall Study||85
2210449|NCT03054103|5419066|P3|NOT COMPLETED|Overall Study||0
2210450|NCT03054103|5419067|P2|NOT COMPLETED|Overall Study||0
2210451|NCT03054103|5419068|P1|NOT COMPLETED|Overall Study||0
2210452|NCT03054103|5419066|P3|COMPLETED|Overall Study||35
2210453|NCT03054103|5419067|P2|COMPLETED|Overall Study||29
2210454|NCT03054103|5419068|P1|COMPLETED|Overall Study||41
2210455|NCT03054103|5419066|P3|STARTED|Overall Study||35
2210456|NCT03054103|5419067|P2|STARTED|Overall Study||29
2210457|NCT03054103|5419068|P1|STARTED|Overall Study||41
2210458|NCT03054077|5419087|P2|NOT COMPLETED|Overall Study||0
2210459|NCT03054077|5419088|P1|NOT COMPLETED|Overall Study||0
2210460|NCT03054077|5419087|P2|COMPLETED|Overall Study||12
2210461|NCT03054077|5419088|P1|COMPLETED|Overall Study||12
2210462|NCT03054077|5419087|P2|STARTED|Overall Study||12
2210463|NCT03054077|5419088|P1|STARTED|Overall Study||12
2210464|NCT03054051|5419096|P2|NOT COMPLETED|Overall Study||0
2210465|NCT03054051|5419097|P1|NOT COMPLETED|Overall Study||0
2210466|NCT03054051|5419096|P2|COMPLETED|Overall Study||30
2210467|NCT03054051|5419097|P1|COMPLETED|Overall Study||30
2210468|NCT03054051|5419096|P2|STARTED|Overall Study||30
2210469|NCT03054051|5419097|P1|STARTED|Overall Study||30
2210470|NCT03053960|5419126|P1|NOT COMPLETED|Overall Study||0
2210471|NCT03053960|5419126|P1|COMPLETED|Overall Study||8
2210472|NCT03053960|5419126|P1|STARTED|Overall Study||8
2210473|NCT03053427|5419133|P2|NOT COMPLETED|Overall Study||16
2210474|NCT03053427|5419134|P1|NOT COMPLETED|Overall Study||13
2210475|NCT03053427|5419133|P2|COMPLETED|Overall Study||173
2210476|NCT03053427|5419134|P1|COMPLETED|Overall Study||173
2210477|NCT03053427|5419133|P2|STARTED|Overall Study||189
2210478|NCT03053427|5419134|P1|STARTED|Overall Study||186
2210479|NCT03053180|5419156|P1|NOT COMPLETED|Overall Study||1
2210480|NCT03053180|5419156|P1|COMPLETED|Overall Study||59
2210481|NCT03053180|5419156|P1|STARTED|Overall Study||60
2210482|NCT03052764|5419167|P2|NOT COMPLETED|Open-Label Re-Treatment Period||0
2210483|NCT03052764|5419168|P1|NOT COMPLETED|Open-Label Re-Treatment Period||0
2210484|NCT03052764|5419167|P2|COMPLETED|Open-Label Re-Treatment Period||33
2210485|NCT03052764|5419168|P1|COMPLETED|Open-Label Re-Treatment Period||58
2210486|NCT03052764|5419167|P2|STARTED|Open-Label Re-Treatment Period||33
2210487|NCT03052764|5419168|P1|STARTED|Open-Label Re-Treatment Period||58
2210488|NCT03052764|5419167|P2|NOT COMPLETED|Double-Blind Treatment Period||3
2210489|NCT03052764|5419168|P1|NOT COMPLETED|Double-Blind Treatment Period||10
2210490|NCT03052764|5419167|P2|COMPLETED|Double-Blind Treatment Period||37
2210491|NCT03052764|5419168|P1|COMPLETED|Double-Blind Treatment Period||70
2210492|NCT03052764|5419167|P2|mITT|Double-Blind Treatment Period||39
2210493|NCT03052764|5419168|P1|mITT|Double-Blind Treatment Period||78
2210494|NCT03052764|5419167|P2|STARTED|Double-Blind Treatment Period||40
2210495|NCT03052764|5419168|P1|STARTED|Double-Blind Treatment Period||80
2210496|NCT03052725|5419188|P2|NOT COMPLETED|Overall Study||150
2210497|NCT03052725|5419189|P1|NOT COMPLETED|Overall Study||148
2210498|NCT03052725|5419188|P2|COMPLETED|Overall Study||47
2210499|NCT03052725|5419189|P1|COMPLETED|Overall Study||46
2210500|NCT03052725|5419188|P2|Safety Analysis Set|Overall Study||196
2210501|NCT03052725|5419189|P1|Safety Analysis Set|Overall Study||194
2210502|NCT03052725|5419188|P2|STARTED|Overall Study||197
2210503|NCT03052725|5419189|P1|STARTED|Overall Study||194
2210504|NCT03052530|5419226|P1|NOT COMPLETED|Overall Study||0
2210505|NCT03052530|5419226|P1|COMPLETED|Overall Study||61
2210506|NCT03052530|5419226|P1|STARTED|Overall Study||61
2210507|NCT03052426|5419236|P3|NOT COMPLETED|Overall Study||1
2210508|NCT03052426|5419237|P2|NOT COMPLETED|Overall Study||1
2210509|NCT03052426|5419238|P1|NOT COMPLETED|Overall Study||2
2210510|NCT03052426|5419236|P3|COMPLETED|Overall Study||5
2210511|NCT03052426|5419237|P2|COMPLETED|Overall Study||5
2210512|NCT03052426|5419238|P1|COMPLETED|Overall Study||4
2210513|NCT03052426|5419236|P3|STARTED|Overall Study||6
2210514|NCT03052426|5419237|P2|STARTED|Overall Study||6
2210515|NCT03052426|5419238|P1|STARTED|Overall Study||6
2210516|NCT03052322|5419253|P2|NOT COMPLETED|Overall Study||32
2210517|NCT03052322|5419254|P1|NOT COMPLETED|Overall Study||21
2210518|NCT03052322|5419253|P2|COMPLETED|Overall Study||113
2210519|NCT03052322|5419254|P1|COMPLETED|Overall Study||122
2210520|NCT03052322|5419253|P2|STARTED|Overall Study||145
2210521|NCT03052322|5419254|P1|STARTED|Overall Study||143
2210522|NCT03051646|5419306|P2|NOT COMPLETED|Overall Study||0
2210523|NCT03051646|5419307|P1|NOT COMPLETED|Overall Study||0
2210524|NCT03051646|5419306|P2|COMPLETED|Overall Study||6
2210525|NCT03051646|5419307|P1|COMPLETED|Overall Study||6
2210526|NCT03051646|5419306|P2|STARTED|Overall Study||6
2210527|NCT03051646|5419307|P1|STARTED|Overall Study||6
2210528|NCT03051607|5419315|P1|NOT COMPLETED|Overall Study||66
2210529|NCT03051607|5419315|P1|COMPLETED|Overall Study||0
2210530|NCT03051607|5419315|P1|STARTED|Overall Study||66
2210531|NCT03051217|5419325|P7|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||1
2210532|NCT03051217|5419326|P6|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||2
2210533|NCT03051217|5419327|P5|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||3
2210534|NCT03051217|5419328|P4|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||3
2210535|NCT03051217|5419329|P3|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
2210536|NCT03051217|5419330|P2|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
2210537|NCT03051217|5419331|P1|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
2210538|NCT03051217|5419325|P7|COMPLETED|Maintenance Period (Week 16 to Week 52)||19
2210539|NCT03051217|5419326|P6|COMPLETED|Maintenance Period (Week 16 to Week 52)||24
2210540|NCT03051217|5419327|P5|COMPLETED|Maintenance Period (Week 16 to Week 52)||48
2210541|NCT03051217|5419328|P4|COMPLETED|Maintenance Period (Week 16 to Week 52)||20
2210542|NCT03051217|5419329|P3|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
2210543|NCT03051217|5419330|P2|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
2210544|NCT03051217|5419331|P1|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
2210545|NCT03051217|5419325|P7|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||3
2210546|NCT03051217|5419326|P6|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||7
2210547|NCT03051217|5419327|P5|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||3
2210548|NCT03051217|5419328|P4|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||21
2210549|NCT03051217|5419329|P3|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
2210550|NCT03051217|5419330|P2|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
2210551|NCT03051217|5419331|P1|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
2210552|NCT03051217|5419325|P7|STARTED|Maintenance Period (Week 16 to Week 52)||20
2210553|NCT03051217|5419326|P6|STARTED|Maintenance Period (Week 16 to Week 52)||26
2210554|NCT03051217|5419327|P5|STARTED|Maintenance Period (Week 16 to Week 52)||51
2210555|NCT03051217|5419328|P4|STARTED|Maintenance Period (Week 16 to Week 52)||23
2210556|NCT03051217|5419329|P3|STARTED|Maintenance Period (Week 16 to Week 52)||0
2210557|NCT03051217|5419330|P2|STARTED|Maintenance Period (Week 16 to Week 52)||0
2210558|NCT03051217|5419331|P1|STARTED|Maintenance Period (Week 16 to Week 52)||0
2210559|NCT03051217|5419325|P7|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
2210560|NCT03051217|5419326|P6|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
2210561|NCT03051217|5419327|P5|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
2210562|NCT03051217|5419328|P4|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
2210563|NCT03051217|5419329|P3|NOT COMPLETED|Initial Period (Week 0 to Week 16)||2
2210564|NCT03051217|5419330|P2|NOT COMPLETED|Initial Period (Week 0 to Week 16)||2
2210565|NCT03051217|5419331|P1|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
2210566|NCT03051217|5419325|P7|COMPLETED|Initial Period (Week 0 to Week 16)||0
2210567|NCT03051217|5419326|P6|COMPLETED|Initial Period (Week 0 to Week 16)||0
2210568|NCT03051217|5419327|P5|COMPLETED|Initial Period (Week 0 to Week 16)||0
2210569|NCT03051217|5419328|P4|COMPLETED|Initial Period (Week 0 to Week 16)||0
2210570|NCT03051217|5419329|P3|COMPLETED|Initial Period (Week 0 to Week 16)||51
2210571|NCT03051217|5419330|P2|COMPLETED|Initial Period (Week 0 to Week 16)||46
2210572|NCT03051217|5419331|P1|COMPLETED|Initial Period (Week 0 to Week 16)||23
2210573|NCT03051217|5419325|P7|STARTED|Initial Period (Week 0 to Week 16)||0
2210574|NCT03051217|5419326|P6|STARTED|Initial Period (Week 0 to Week 16)||0
2210575|NCT03051217|5419327|P5|STARTED|Initial Period (Week 0 to Week 16)||0
2210576|NCT03051217|5419328|P4|STARTED|Initial Period (Week 0 to Week 16)||0
2210577|NCT03051217|5419329|P3|STARTED|Initial Period (Week 0 to Week 16)||53
2210578|NCT03051217|5419330|P2|STARTED|Initial Period (Week 0 to Week 16)||48
2210579|NCT03051217|5419331|P1|STARTED|Initial Period (Week 0 to Week 16)||26
2210580|NCT03051165|5419360|P1|NOT COMPLETED|Overall Study||13
2210581|NCT03051165|5419360|P1|COMPLETED|Overall Study||0
2210582|NCT03051165|5419360|P1|Completed Some Day 137 Assessments|Overall Study||0
2210583|NCT03051165|5419360|P1|Began HGNS Treatment Withdrawal|Overall Study||0
2210584|NCT03051165|5419360|P1|Completed Some Day 105 Assessments|Overall Study||1
2210585|NCT03051165|5419360|P1|Completed Some Baseline Assessments|Overall Study||1
2210586|NCT03051165|5419360|P1|STARTED|Overall Study||13
2210587|NCT03050918|5419374|P2|NOT COMPLETED|Overall Study||0
2210588|NCT03050918|5419375|P1|NOT COMPLETED|Overall Study||0
2210589|NCT03050918|5419374|P2|COMPLETED|Overall Study||1520
2210590|NCT03050918|5419375|P1|COMPLETED|Overall Study||1534
2210591|NCT03050918|5419374|P2|STARTED|Overall Study||1520
2210592|NCT03050918|5419375|P1|STARTED|Overall Study||1534
2210593|NCT03050775|5419397|P2|NOT COMPLETED|Overall Study||0
2210594|NCT03050775|5419398|P1|NOT COMPLETED|Overall Study||0
2210595|NCT03050775|5419397|P2|COMPLETED|Overall Study||35
2210596|NCT03050775|5419398|P1|COMPLETED|Overall Study||35
2210597|NCT03050775|5419397|P2|STARTED|Overall Study||35
2210598|NCT03050775|5419398|P1|STARTED|Overall Study||35
2210599|NCT03050619|5419422|P6|NOT COMPLETED|Overall Study||0
2210600|NCT03050619|5419423|P5|NOT COMPLETED|Overall Study||0
2210601|NCT03050619|5419424|P4|NOT COMPLETED|Overall Study||0
2210602|NCT03050619|5419425|P3|NOT COMPLETED|Overall Study||0
2210603|NCT03050619|5419426|P2|NOT COMPLETED|Overall Study||0
2210604|NCT03050619|5419427|P1|NOT COMPLETED|Overall Study||0
2210605|NCT03050619|5419422|P6|COMPLETED|Overall Study||1351
2210606|NCT03050619|5419423|P5|COMPLETED|Overall Study||6079
2210607|NCT03050619|5419424|P4|COMPLETED|Overall Study||14007
2210608|NCT03050619|5419425|P3|COMPLETED|Overall Study||6416
2210609|NCT03050619|5419426|P2|COMPLETED|Overall Study||3926
2210610|NCT03050619|5419427|P1|COMPLETED|Overall Study||129
2210611|NCT03050619|5419422|P6|STARTED|Overall Study||1351
2210612|NCT03050619|5419423|P5|STARTED|Overall Study||6079
2210613|NCT03050619|5419424|P4|STARTED|Overall Study||14007
2210614|NCT03050619|5419425|P3|STARTED|Overall Study||6416
2210615|NCT03050619|5419426|P2|STARTED|Overall Study||3926
2210616|NCT03050619|5419427|P1|STARTED|Overall Study||129
2210617|NCT03050541|5419564|P3|NOT COMPLETED|Overall Study||8
2210618|NCT03050541|5419565|P2|NOT COMPLETED|Overall Study||8
2210619|NCT03050541|5419566|P1|NOT COMPLETED|Overall Study||8
2210620|NCT03050541|5419564|P3|COMPLETED|Overall Study||20
2210621|NCT03050541|5419565|P2|COMPLETED|Overall Study||20
2210622|NCT03050541|5419566|P1|COMPLETED|Overall Study||20
2210623|NCT03050541|5419564|P3|STARTED|Overall Study||28
2210624|NCT03050541|5419565|P2|STARTED|Overall Study||28
2210625|NCT03050541|5419566|P1|STARTED|Overall Study||28
2210626|NCT03050372|5419577|P2|NOT COMPLETED|Second Intervention (Nights #4 and #5)||1
2210627|NCT03050372|5419578|P1|NOT COMPLETED|Second Intervention (Nights #4 and #5)||0
2210628|NCT03050372|5419577|P2|COMPLETED|Second Intervention (Nights #4 and #5)|N=1 subject (blind only broken after double-blind analysis) moved out off State; lost to study|5
2210629|NCT03050372|5419578|P1|COMPLETED|Second Intervention (Nights #4 and #5)||5
2210630|NCT03050372|5419577|P2|STARTED|Second Intervention (Nights #4 and #5)||6
2210631|NCT03050372|5419578|P1|STARTED|Second Intervention (Nights #4 and #5)||5
2210632|NCT03050372|5419577|P2|NOT COMPLETED|First Intervention (Nights #2 and #3)||0
2210633|NCT03050372|5419578|P1|NOT COMPLETED|First Intervention (Nights #2 and #3)||0
2210634|NCT03050372|5419577|P2|COMPLETED|First Intervention (Nights #2 and #3)||6
2210635|NCT03050372|5419578|P1|COMPLETED|First Intervention (Nights #2 and #3)||5
2210636|NCT03050372|5419577|P2|STARTED|First Intervention (Nights #2 and #3)||6
2210637|NCT03050372|5419578|P1|STARTED|First Intervention (Nights #2 and #3)||5
2210638|NCT03050372|5419577|P2|NOT COMPLETED|Adaptation Night (Night #1 PSG)||0
2210639|NCT03050372|5419578|P1|NOT COMPLETED|Adaptation Night (Night #1 PSG)||1
2210640|NCT03050372|5419577|P2|COMPLETED|Adaptation Night (Night #1 PSG)||6
2210641|NCT03050372|5419578|P1|COMPLETED|Adaptation Night (Night #1 PSG)|N=1 subject removed from study due to mild sleep apnea during adaptation night|5
2210642|NCT03050372|5419577|P2|STARTED|Adaptation Night (Night #1 PSG)||6
2210643|NCT03050372|5419578|P1|STARTED|Adaptation Night (Night #1 PSG)||6
2210644|NCT03050320|5419601|P2|NOT COMPLETED|Overall Study||1
2210645|NCT03050320|5419602|P1|NOT COMPLETED|Overall Study||1
2210646|NCT03050320|5419601|P2|COMPLETED|Overall Study||21
2210647|NCT03050320|5419602|P1|COMPLETED|Overall Study||20
2210648|NCT03050320|5419601|P2|STARTED|Overall Study||22
2210649|NCT03050320|5419602|P1|STARTED|Overall Study||21
2210650|NCT03050294|5419636|P4|NOT COMPLETED|Overall Study||0
2210651|NCT03050294|5419637|P3|NOT COMPLETED|Overall Study||0
2210652|NCT03050294|5419638|P2|NOT COMPLETED|Overall Study||0
2210653|NCT03050294|5419639|P1|NOT COMPLETED|Overall Study||0
2210654|NCT03050294|5419636|P4|COMPLETED|Overall Study||6
2210655|NCT03050294|5419637|P3|COMPLETED|Overall Study||6
2210656|NCT03050294|5419638|P2|COMPLETED|Overall Study||6
2210657|NCT03050294|5419639|P1|COMPLETED|Overall Study||6
2210658|NCT03050294|5419636|P4|STARTED|Overall Study||6
2210659|NCT03050294|5419637|P3|STARTED|Overall Study||6
2210660|NCT03050294|5419638|P2|STARTED|Overall Study||6
2210661|NCT03050294|5419639|P1|STARTED|Overall Study||6
2210662|NCT03050203|5419663|P2|NOT COMPLETED|Overall Study||0
2210663|NCT03050203|5419664|P1|NOT COMPLETED|Overall Study||0
2210664|NCT03050203|5419663|P2|COMPLETED|Overall Study||18
2210665|NCT03050203|5419664|P1|COMPLETED|Overall Study||19
2210666|NCT03050203|5419663|P2|STARTED|Overall Study||18
2210667|NCT03050203|5419664|P1|STARTED|Overall Study||19
2210677|NCT03049501|5419687|P2|NOT COMPLETED|Overall Study||29
2210678|NCT03049501|5419688|P1|NOT COMPLETED|Overall Study||22
2210679|NCT03049501|5419687|P2|COMPLETED|Overall Study||92
2210680|NCT03049501|5419688|P1|COMPLETED|Overall Study||101
2210681|NCT03049501|5419687|P2|12 Month Follow up|Overall Study||92
2210682|NCT03049501|5419688|P1|12 Month Follow up|Overall Study||101
2210683|NCT03049501|5419687|P2|6 Month Follow up|Overall Study||91
2210684|NCT03049501|5419688|P1|6 Month Follow up|Overall Study||107
2210685|NCT03049501|5419687|P2|STARTED|Overall Study||121
2210686|NCT03049501|5419688|P1|STARTED|Overall Study||123
2210687|NCT03048383|5419707|P3|NOT COMPLETED|Overall Study||12
2210688|NCT03048383|5419708|P2|NOT COMPLETED|Overall Study||8
2210689|NCT03048383|5419709|P1|NOT COMPLETED|Overall Study||13
2210690|NCT03048383|5419707|P3|COMPLETED|Overall Study||10
2210691|NCT03048383|5419708|P2|COMPLETED|Overall Study||13
2210692|NCT03048383|5419709|P1|COMPLETED|Overall Study||15
2210693|NCT03048383|5419707|P3|STARTED|Overall Study||22
2210694|NCT03048383|5419708|P2|STARTED|Overall Study||21
2210695|NCT03048383|5419709|P1|STARTED|Overall Study||28
2210696|NCT03048058|5419722|P2|NOT COMPLETED|Overall Study||4
2210697|NCT03048058|5419723|P1|NOT COMPLETED|Overall Study||4
2210698|NCT03048058|5419722|P2|COMPLETED|Overall Study||6
2210699|NCT03048058|5419723|P1|COMPLETED|Overall Study||6
2210700|NCT03048058|5419722|P2|STARTED|Overall Study||10
2210701|NCT03048058|5419723|P1|STARTED|Overall Study||10
2210702|NCT03048006|5419741|P1|NOT COMPLETED|Overall Study||0
2210703|NCT03048006|5419741|P1|COMPLETED|Overall Study||44456
2210704|NCT03048006|5419741|P1|STARTED|Overall Study||44456
2210705|NCT03047551|5419749|P2|NOT COMPLETED|Overall Study||3
2210706|NCT03047551|5419750|P1|NOT COMPLETED|Overall Study||2
2210707|NCT03047551|5419749|P2|COMPLETED|Overall Study||312
2210708|NCT03047551|5419750|P1|COMPLETED|Overall Study||317
2210709|NCT03047551|5419749|P2|STARTED|Overall Study||315
2210710|NCT03047551|5419750|P1|STARTED|Overall Study||319
2210711|NCT03047447|5419761|P3|NOT COMPLETED|Overall Study||0
2210712|NCT03047447|5419762|P2|NOT COMPLETED|Overall Study||0
2210713|NCT03047447|5419763|P1|NOT COMPLETED|Overall Study||0
2210714|NCT03047447|5419761|P3|COMPLETED|Overall Study||10
2210715|NCT03047447|5419762|P2|COMPLETED|Overall Study||10
2210716|NCT03047447|5419763|P1|COMPLETED|Overall Study||10
2210717|NCT03047447|5419761|P3|STARTED|Overall Study||10
2210718|NCT03047447|5419762|P2|STARTED|Overall Study||10
2210719|NCT03047447|5419763|P1|STARTED|Overall Study||10
2210720|NCT03046472|5419785|P2|NOT COMPLETED|Overall Study||0
2210721|NCT03046472|5419786|P1|NOT COMPLETED|Overall Study||0
2210722|NCT03046472|5419785|P2|COMPLETED|Overall Study||17
2210723|NCT03046472|5419786|P1|COMPLETED|Overall Study||33
2210724|NCT03046472|5419785|P2|STARTED|Overall Study||17
2210725|NCT03046472|5419786|P1|STARTED|Overall Study||33
2210726|NCT03046446|5419796|P1|NOT COMPLETED|Overall Study||59
2210727|NCT03046446|5419796|P1|COMPLETED|Overall Study||149
2210728|NCT03046446|5419796|P1|Completed at Week 52|Overall Study||133
2210729|NCT03046446|5419796|P1|Completed at Week 24|Overall Study||6
2210730|NCT03046446|5419796|P1|Completed at Week 12|Overall Study||10
2210731|NCT03046446|5419796|P1|Second Injection|Overall Study||179
2210732|NCT03046446|5419796|P1|STARTED|Overall Study||208
2210733|NCT03046225|5419806|P2|NOT COMPLETED|Overall Study||0
2210734|NCT03046225|5419807|P1|NOT COMPLETED|Overall Study||0
2210735|NCT03046225|5419806|P2|COMPLETED|Overall Study||13
2210736|NCT03046225|5419807|P1|COMPLETED|Overall Study||13
2210737|NCT03046225|5419806|P2|STARTED|Overall Study||13
2210738|NCT03046225|5419807|P1|STARTED|Overall Study||13
2210739|NCT03046212|5419819|P2|NOT COMPLETED|Overall Study||0
2210740|NCT03046212|5419820|P1|NOT COMPLETED|Overall Study||0
2210741|NCT03046212|5419819|P2|COMPLETED|Overall Study||15
2210742|NCT03046212|5419820|P1|COMPLETED|Overall Study||15
2210743|NCT03046212|5419819|P2|STARTED|Overall Study||15
2210744|NCT03046212|5419820|P1|STARTED|Overall Study||15
2210745|NCT03045926|5419830|P1|NOT COMPLETED|Overall Study||0
2210746|NCT03045926|5419830|P1|COMPLETED|Overall Study||35
2210747|NCT03045926|5419830|P1|STARTED|Overall Study||35
2210748|NCT03045887|5419859|P10|NOT COMPLETED|Part B (14 Days)||0
2210749|NCT03045887|5419860|P9|NOT COMPLETED|Part B (14 Days)||0
2210750|NCT03045887|5419861|P8|NOT COMPLETED|Part B (14 Days)||0
2210751|NCT03045887|5419862|P7|NOT COMPLETED|Part B (14 Days)||0
2210752|NCT03045887|5419863|P6|NOT COMPLETED|Part B (14 Days)||0
2210753|NCT03045887|5419864|P5|NOT COMPLETED|Part B (14 Days)||0
2210754|NCT03045887|5419865|P4|NOT COMPLETED|Part B (14 Days)||0
2210755|NCT03045887|5419866|P3|NOT COMPLETED|Part B (14 Days)||0
2210756|NCT03045887|5419867|P2|NOT COMPLETED|Part B (14 Days)||0
2210757|NCT03045887|5419868|P1|NOT COMPLETED|Part B (14 Days)||0
2210758|NCT03045887|5419859|P10|COMPLETED|Part B (14 Days)||9
2210759|NCT03045887|5419860|P9|COMPLETED|Part B (14 Days)||3
2210760|NCT03045887|5419861|P8|COMPLETED|Part B (14 Days)||0
2210761|NCT03045887|5419862|P7|COMPLETED|Part B (14 Days)||0
2210762|NCT03045887|5419863|P6|COMPLETED|Part B (14 Days)||0
2210763|NCT03045887|5419864|P5|COMPLETED|Part B (14 Days)||0
2210764|NCT03045887|5419865|P4|COMPLETED|Part B (14 Days)||0
2210765|NCT03045887|5419866|P3|COMPLETED|Part B (14 Days)||0
2210766|NCT03045887|5419867|P2|COMPLETED|Part B (14 Days)||0
2210767|NCT03045887|5419868|P1|COMPLETED|Part B (14 Days)||0
2210768|NCT03045887|5419859|P10|STARTED|Part B (14 Days)||9
2210769|NCT03045887|5419860|P9|STARTED|Part B (14 Days)||3
2210770|NCT03045887|5419861|P8|STARTED|Part B (14 Days)||0
2210771|NCT03045887|5419862|P7|STARTED|Part B (14 Days)||0
2210772|NCT03045887|5419863|P6|STARTED|Part B (14 Days)||0
2210773|NCT03045887|5419864|P5|STARTED|Part B (14 Days)||0
2210774|NCT03045887|5419865|P4|STARTED|Part B (14 Days)||0
2210775|NCT03045887|5419866|P3|STARTED|Part B (14 Days)||0
2210776|NCT03045887|5419867|P2|STARTED|Part B (14 Days)||0
2210777|NCT03045887|5419868|P1|STARTED|Part B (14 Days)||0
2210778|NCT03045887|5419859|P10|NOT COMPLETED|Part A, Period 3 (1 Day)||0
2210779|NCT03045887|5419860|P9|NOT COMPLETED|Part A, Period 3 (1 Day)||0
2210780|NCT03045887|5419861|P8|NOT COMPLETED|Part A, Period 3 (1 Day)||0
2210781|NCT03045887|5419862|P7|NOT COMPLETED|Part A, Period 3 (1 Day)||0
2210782|NCT03045887|5419863|P6|NOT COMPLETED|Part A, Period 3 (1 Day)||0
2210783|NCT03045887|5419864|P5|NOT COMPLETED|Part A, Period 3 (1 Day)||0
2210784|NCT03045887|5419865|P4|NOT COMPLETED|Part A, Period 3 (1 Day)||0
2210785|NCT03045887|5419866|P3|NOT COMPLETED|Part A, Period 3 (1 Day)||0
2210786|NCT03045887|5419867|P2|NOT COMPLETED|Part A, Period 3 (1 Day)||0
2210787|NCT03045887|5419868|P1|NOT COMPLETED|Part A, Period 3 (1 Day)||0
2210788|NCT03045887|5419859|P10|COMPLETED|Part A, Period 3 (1 Day)||0
2210789|NCT03045887|5419860|P9|COMPLETED|Part A, Period 3 (1 Day)||0
2210790|NCT03045887|5419861|P8|COMPLETED|Part A, Period 3 (1 Day)||4
2210791|NCT03045887|5419862|P7|COMPLETED|Part A, Period 3 (1 Day)||4
2210792|NCT03045887|5419863|P6|COMPLETED|Part A, Period 3 (1 Day)||4
2210793|NCT03045887|5419864|P5|COMPLETED|Part A, Period 3 (1 Day)||4
2210794|NCT03045887|5419865|P4|COMPLETED|Part A, Period 3 (1 Day)||2
2210795|NCT03045887|5419866|P3|COMPLETED|Part A, Period 3 (1 Day)||4
2210796|NCT03045887|5419867|P2|COMPLETED|Part A, Period 3 (1 Day)||4
2210797|NCT03045887|5419868|P1|COMPLETED|Part A, Period 3 (1 Day)||3
2210798|NCT03045887|5419859|P10|STARTED|Part A, Period 3 (1 Day)||0
2210799|NCT03045887|5419860|P9|STARTED|Part A, Period 3 (1 Day)||0
2210800|NCT03045887|5419861|P8|STARTED|Part A, Period 3 (1 Day)||4
2210801|NCT03045887|5419862|P7|STARTED|Part A, Period 3 (1 Day)||4
2210802|NCT03045887|5419863|P6|STARTED|Part A, Period 3 (1 Day)||4
2210803|NCT03045887|5419864|P5|STARTED|Part A, Period 3 (1 Day)||4
2210804|NCT03045887|5419865|P4|STARTED|Part A, Period 3 (1 Day)||2
2210805|NCT03045887|5419866|P3|STARTED|Part A, Period 3 (1 Day)||4
2210806|NCT03045887|5419867|P2|STARTED|Part A, Period 3 (1 Day)||4
2210807|NCT03045887|5419868|P1|STARTED|Part A, Period 3 (1 Day)||3
2210808|NCT03045887|5419859|P10|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
2210809|NCT03045887|5419860|P9|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
2210810|NCT03045887|5419861|P8|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
2210892|NCT03045887|5419863|P6|STARTED|Part A,Washout Period 1(4 Weeks)||4
2210811|NCT03045887|5419862|P7|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
2210812|NCT03045887|5419863|P6|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
2210813|NCT03045887|5419864|P5|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
2210814|NCT03045887|5419865|P4|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||2
2210815|NCT03045887|5419866|P3|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||1
2210816|NCT03045887|5419867|P2|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
2210817|NCT03045887|5419868|P1|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
2210818|NCT03045887|5419859|P10|COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
2210819|NCT03045887|5419860|P9|COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
2210820|NCT03045887|5419861|P8|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
2210821|NCT03045887|5419862|P7|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
2210822|NCT03045887|5419863|P6|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
2210823|NCT03045887|5419864|P5|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
2210824|NCT03045887|5419865|P4|COMPLETED|Part A,Washout Period 2 (4 Weeks)||2
2210825|NCT03045887|5419866|P3|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
2210826|NCT03045887|5419867|P2|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
2210827|NCT03045887|5419868|P1|COMPLETED|Part A,Washout Period 2 (4 Weeks)||3
2210828|NCT03045887|5419859|P10|STARTED|Part A,Washout Period 2 (4 Weeks)||0
2210829|NCT03045887|5419860|P9|STARTED|Part A,Washout Period 2 (4 Weeks)||0
2210830|NCT03045887|5419861|P8|STARTED|Part A,Washout Period 2 (4 Weeks)||4
2210831|NCT03045887|5419862|P7|STARTED|Part A,Washout Period 2 (4 Weeks)||4
2210832|NCT03045887|5419863|P6|STARTED|Part A,Washout Period 2 (4 Weeks)||4
2210833|NCT03045887|5419864|P5|STARTED|Part A,Washout Period 2 (4 Weeks)||4
2210834|NCT03045887|5419865|P4|STARTED|Part A,Washout Period 2 (4 Weeks)||4
2210835|NCT03045887|5419866|P3|STARTED|Part A,Washout Period 2 (4 Weeks)||5
2210836|NCT03045887|5419867|P2|STARTED|Part A,Washout Period 2 (4 Weeks)||4
2210837|NCT03045887|5419868|P1|STARTED|Part A,Washout Period 2 (4 Weeks)||3
2210838|NCT03045887|5419859|P10|NOT COMPLETED|Part A, Period 2 (1 Day)||0
2210839|NCT03045887|5419860|P9|NOT COMPLETED|Part A, Period 2 (1 Day)||0
2210840|NCT03045887|5419861|P8|NOT COMPLETED|Part A, Period 2 (1 Day)||0
2210841|NCT03045887|5419862|P7|NOT COMPLETED|Part A, Period 2 (1 Day)||0
2210842|NCT03045887|5419863|P6|NOT COMPLETED|Part A, Period 2 (1 Day)||0
2210843|NCT03045887|5419864|P5|NOT COMPLETED|Part A, Period 2 (1 Day)||0
2210844|NCT03045887|5419865|P4|NOT COMPLETED|Part A, Period 2 (1 Day)||0
2210845|NCT03045887|5419866|P3|NOT COMPLETED|Part A, Period 2 (1 Day)||0
2210846|NCT03045887|5419867|P2|NOT COMPLETED|Part A, Period 2 (1 Day)||0
2210847|NCT03045887|5419868|P1|NOT COMPLETED|Part A, Period 2 (1 Day)||1
2210848|NCT03045887|5419859|P10|COMPLETED|Part A, Period 2 (1 Day)||0
2210849|NCT03045887|5419860|P9|COMPLETED|Part A, Period 2 (1 Day)||0
2210850|NCT03045887|5419861|P8|COMPLETED|Part A, Period 2 (1 Day)||4
2210851|NCT03045887|5419862|P7|COMPLETED|Part A, Period 2 (1 Day)||4
2210852|NCT03045887|5419863|P6|COMPLETED|Part A, Period 2 (1 Day)||4
2210853|NCT03045887|5419864|P5|COMPLETED|Part A, Period 2 (1 Day)||4
2210854|NCT03045887|5419865|P4|COMPLETED|Part A, Period 2 (1 Day)||4
2210855|NCT03045887|5419866|P3|COMPLETED|Part A, Period 2 (1 Day)||5
2210856|NCT03045887|5419867|P2|COMPLETED|Part A, Period 2 (1 Day)||4
2210857|NCT03045887|5419868|P1|COMPLETED|Part A, Period 2 (1 Day)||3
2210858|NCT03045887|5419859|P10|STARTED|Part A, Period 2 (1 Day)||0
2210859|NCT03045887|5419860|P9|STARTED|Part A, Period 2 (1 Day)||0
2210860|NCT03045887|5419861|P8|STARTED|Part A, Period 2 (1 Day)||4
2210861|NCT03045887|5419862|P7|STARTED|Part A, Period 2 (1 Day)||4
2210862|NCT03045887|5419863|P6|STARTED|Part A, Period 2 (1 Day)||4
2210863|NCT03045887|5419864|P5|STARTED|Part A, Period 2 (1 Day)||4
2210864|NCT03045887|5419865|P4|STARTED|Part A, Period 2 (1 Day)||4
2210865|NCT03045887|5419866|P3|STARTED|Part A, Period 2 (1 Day)||5
2210866|NCT03045887|5419867|P2|STARTED|Part A, Period 2 (1 Day)||4
2210867|NCT03045887|5419868|P1|STARTED|Part A, Period 2 (1 Day)||4
2210868|NCT03045887|5419859|P10|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
2210869|NCT03045887|5419860|P9|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
2210870|NCT03045887|5419861|P8|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
2210871|NCT03045887|5419862|P7|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
2210872|NCT03045887|5419863|P6|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
2210873|NCT03045887|5419864|P5|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
2210874|NCT03045887|5419865|P4|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||1
2210875|NCT03045887|5419866|P3|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
2210876|NCT03045887|5419867|P2|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
2210877|NCT03045887|5419868|P1|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||3
2210878|NCT03045887|5419859|P10|COMPLETED|Part A,Washout Period 1(4 Weeks)||0
2210879|NCT03045887|5419860|P9|COMPLETED|Part A,Washout Period 1(4 Weeks)||0
2210880|NCT03045887|5419861|P8|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
2210881|NCT03045887|5419862|P7|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
2210882|NCT03045887|5419863|P6|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
2210883|NCT03045887|5419864|P5|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
2210884|NCT03045887|5419865|P4|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
2210885|NCT03045887|5419866|P3|COMPLETED|Part A,Washout Period 1(4 Weeks)||5
2210886|NCT03045887|5419867|P2|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
2210887|NCT03045887|5419868|P1|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
2210888|NCT03045887|5419859|P10|STARTED|Part A,Washout Period 1(4 Weeks)||0
2210889|NCT03045887|5419860|P9|STARTED|Part A,Washout Period 1(4 Weeks)||0
2210890|NCT03045887|5419861|P8|STARTED|Part A,Washout Period 1(4 Weeks)||4
2210891|NCT03045887|5419862|P7|STARTED|Part A,Washout Period 1(4 Weeks)||4
2210893|NCT03045887|5419864|P5|STARTED|Part A,Washout Period 1(4 Weeks)||4
2210894|NCT03045887|5419865|P4|STARTED|Part A,Washout Period 1(4 Weeks)||5
2210895|NCT03045887|5419866|P3|STARTED|Part A,Washout Period 1(4 Weeks)||5
2210896|NCT03045887|5419867|P2|STARTED|Part A,Washout Period 1(4 Weeks)||4
2210897|NCT03045887|5419868|P1|STARTED|Part A,Washout Period 1(4 Weeks)||7
2210898|NCT03045887|5419859|P10|NOT COMPLETED|Part A, Period (1 Day)||0
2210899|NCT03045887|5419860|P9|NOT COMPLETED|Part A, Period (1 Day)||0
2210900|NCT03045887|5419861|P8|NOT COMPLETED|Part A, Period (1 Day)||0
2210901|NCT03045887|5419862|P7|NOT COMPLETED|Part A, Period (1 Day)||0
2210902|NCT03045887|5419863|P6|NOT COMPLETED|Part A, Period (1 Day)||0
2210903|NCT03045887|5419864|P5|NOT COMPLETED|Part A, Period (1 Day)||0
2210904|NCT03045887|5419865|P4|NOT COMPLETED|Part A, Period (1 Day)||0
2210905|NCT03045887|5419866|P3|NOT COMPLETED|Part A, Period (1 Day)||0
2210906|NCT03045887|5419867|P2|NOT COMPLETED|Part A, Period (1 Day)||0
2210907|NCT03045887|5419868|P1|NOT COMPLETED|Part A, Period (1 Day)||0
2210908|NCT03045887|5419859|P10|COMPLETED|Part A, Period (1 Day)||0
2210909|NCT03045887|5419860|P9|COMPLETED|Part A, Period (1 Day)||0
2210910|NCT03045887|5419861|P8|COMPLETED|Part A, Period (1 Day)||4
2210911|NCT03045887|5419862|P7|COMPLETED|Part A, Period (1 Day)||4
2210912|NCT03045887|5419863|P6|COMPLETED|Part A, Period (1 Day)||4
2210913|NCT03045887|5419864|P5|COMPLETED|Part A, Period (1 Day)||4
2210914|NCT03045887|5419865|P4|COMPLETED|Part A, Period (1 Day)||5
2210915|NCT03045887|5419866|P3|COMPLETED|Part A, Period (1 Day)||5
2210916|NCT03045887|5419867|P2|COMPLETED|Part A, Period (1 Day)||4
2210917|NCT03045887|5419868|P1|COMPLETED|Part A, Period (1 Day)||7
2210918|NCT03045887|5419859|P10|STARTED|Part A, Period (1 Day)||0
2210919|NCT03045887|5419860|P9|STARTED|Part A, Period (1 Day)||0
2210920|NCT03045887|5419861|P8|STARTED|Part A, Period (1 Day)||4
2210921|NCT03045887|5419862|P7|STARTED|Part A, Period (1 Day)||4
2210922|NCT03045887|5419863|P6|STARTED|Part A, Period (1 Day)||4
2210923|NCT03045887|5419864|P5|STARTED|Part A, Period (1 Day)||4
2210924|NCT03045887|5419865|P4|STARTED|Part A, Period (1 Day)||5
2210925|NCT03045887|5419866|P3|STARTED|Part A, Period (1 Day)||5
2210926|NCT03045887|5419867|P2|STARTED|Part A, Period (1 Day)||4
2210927|NCT03045887|5419868|P1|STARTED|Part A, Period (1 Day)||7
2210928|NCT03045861|5420010|P4|NOT COMPLETED|Part B (Up to 10 Days)||0
2210929|NCT03045861|5420011|P3|NOT COMPLETED|Part B (Up to 10 Days)||0
2210930|NCT03045861|5420012|P2|NOT COMPLETED|Part B (Up to 10 Days)||0
2210931|NCT03045861|5420013|P1|NOT COMPLETED|Part B (Up to 10 Days)||0
2210932|NCT03045861|5420010|P4|COMPLETED|Part B (Up to 10 Days)||8
2210933|NCT03045861|5420011|P3|COMPLETED|Part B (Up to 10 Days)||0
2210934|NCT03045861|5420012|P2|COMPLETED|Part B (Up to 10 Days)||8
2210935|NCT03045861|5420013|P1|COMPLETED|Part B (Up to 10 Days)||7
2210936|NCT03045861|5420010|P4|STARTED|Part B (Up to 10 Days)||8
2210937|NCT03045861|5420011|P3|STARTED|Part B (Up to 10 Days)||0
2210938|NCT03045861|5420012|P2|STARTED|Part B (Up to 10 Days)||8
2210939|NCT03045861|5420013|P1|STARTED|Part B (Up to 10 Days)||7
2210940|NCT03045861|5420010|P4|NOT COMPLETED|Part A (Up to 10 Days)||0
2210941|NCT03045861|5420011|P3|NOT COMPLETED|Part A (Up to 10 Days)||0
2210942|NCT03045861|5420012|P2|NOT COMPLETED|Part A (Up to 10 Days)||0
2210943|NCT03045861|5420013|P1|NOT COMPLETED|Part A (Up to 10 Days)||0
2210944|NCT03045861|5420010|P4|COMPLETED|Part A (Up to 10 Days)||0
2210945|NCT03045861|5420011|P3|COMPLETED|Part A (Up to 10 Days)||10
2210946|NCT03045861|5420012|P2|COMPLETED|Part A (Up to 10 Days)||0
2210947|NCT03045861|5420013|P1|COMPLETED|Part A (Up to 10 Days)||0
2210948|NCT03045861|5420010|P4|STARTED|Part A (Up to 10 Days)||0
2210949|NCT03045861|5420011|P3|STARTED|Part A (Up to 10 Days)||10
2210950|NCT03045861|5420012|P2|STARTED|Part A (Up to 10 Days)||0
2210951|NCT03045861|5420013|P1|STARTED|Part A (Up to 10 Days)||0
2210952|NCT03045809|5420139|P1|NOT COMPLETED|Overall Study||0
2210953|NCT03045809|5420139|P1|COMPLETED|Overall Study||705
2210954|NCT03045809|5420139|P1|Attended an Additional Visit (if Needed)|Overall Study|(only if needed, for medical follow-up, to complete study procedures, or to report adverse events).|51
2210955|NCT03045809|5420139|P1|STARTED|Overall Study||705
2210956|NCT03045653|5420146|P1|NOT COMPLETED|Overall Study||0
2210957|NCT03045653|5420146|P1|COMPLETED|Overall Study||30
2210958|NCT03045653|5420146|P1|STARTED|Overall Study||30
2210959|NCT03045302|5420150|P1|NOT COMPLETED|Overall Study||1
2210960|NCT03045302|5420150|P1|COMPLETED|Overall Study||3
2210961|NCT03045302|5420150|P1|STARTED|Overall Study||4
2210962|NCT03045081|5420156|P2|NOT COMPLETED|Overall Study||11
2210963|NCT03045081|5420157|P1|NOT COMPLETED|Overall Study||6
2210964|NCT03045081|5420156|P2|COMPLETED|Overall Study||37
2210965|NCT03045081|5420157|P1|COMPLETED|Overall Study||45
2210966|NCT03045081|5420156|P2|STARTED|Overall Study||48
2210967|NCT03045081|5420157|P1|STARTED|Overall Study||51
2210968|NCT03044886|5420176|P3|NOT COMPLETED|Overall Study||12
2210969|NCT03044886|5420177|P2|NOT COMPLETED|Overall Study||10
2210970|NCT03044886|5420178|P1|NOT COMPLETED|Overall Study||15
2210971|NCT03044886|5420176|P3|COMPLETED|Overall Study||108
2210972|NCT03044886|5420177|P2|COMPLETED|Overall Study||110
2210973|NCT03044886|5420178|P1|COMPLETED|Overall Study||105
2210974|NCT03044886|5420176|P3|STARTED|Overall Study||120
2210975|NCT03044886|5420177|P2|STARTED|Overall Study||120
2210976|NCT03044886|5420178|P1|STARTED|Overall Study||120
2210977|NCT03044691|5420221|P2|NOT COMPLETED|Overall Study||0
2210978|NCT03044691|5420222|P1|NOT COMPLETED|Overall Study||0
2210979|NCT03044691|5420221|P2|COMPLETED|Overall Study||84
2210980|NCT03044691|5420222|P1|COMPLETED|Overall Study||0
2210981|NCT03044691|5420221|P2|STARTED|Overall Study||84
2210982|NCT03044691|5420222|P1|STARTED|Overall Study||0
2210983|NCT03044574|5420230|P2|NOT COMPLETED|Overall Study||45
2210984|NCT03044574|5420231|P1|NOT COMPLETED|Overall Study||37
2210985|NCT03044574|5420230|P2|COMPLETED|Overall Study||158
2210986|NCT03044574|5420231|P1|COMPLETED|Overall Study||167
2210987|NCT03044574|5420230|P2|180 Days After Surgery|Overall Study||158
2210988|NCT03044574|5420231|P1|180 Days After Surgery|Overall Study||167
2210989|NCT03044574|5420230|P2|30 Days After Surgery|Overall Study||194
2210990|NCT03044574|5420231|P1|30 Days After Surgery|Overall Study||193
2210991|NCT03044574|5420230|P2|Inpatient Period|Overall Study||203
2210992|NCT03044574|5420231|P1|Inpatient Period|Overall Study||204
2210993|NCT03044574|5420230|P2|STARTED|Overall Study||203
2210994|NCT03044574|5420231|P1|STARTED|Overall Study||204
2210995|NCT03044431|5420257|P1|NOT COMPLETED|Overall Study||59
2210996|NCT03044431|5420257|P1|COMPLETED|Overall Study||148
2210997|NCT03044431|5420257|P1|STARTED|Overall Study||207
2210998|NCT03044353|5420270|P3|NOT COMPLETED|Overall Study||0
2210999|NCT03044353|5420271|P2|NOT COMPLETED|Overall Study||1
2211000|NCT03044353|5420272|P1|NOT COMPLETED|Overall Study||0
2211001|NCT03044353|5420270|P3|COMPLETED|Overall Study||0
2211002|NCT03044353|5420271|P2|COMPLETED|Overall Study||0
2211003|NCT03044353|5420272|P1|COMPLETED|Overall Study||6
2211004|NCT03044353|5420270|P3|STARTED|Overall Study|No participant was enrolled in Group-3 due to early termination of the study.|0
2211005|NCT03044353|5420271|P2|STARTED|Overall Study||1
2211006|NCT03044353|5420272|P1|STARTED|Overall Study||6
2211007|NCT03044197|5420355|P2|NOT COMPLETED|Overall Study||1
2211008|NCT03044197|5420356|P1|NOT COMPLETED|Overall Study||3
2211009|NCT03044197|5420355|P2|COMPLETED|Overall Study||11
2211010|NCT03044197|5420356|P1|COMPLETED|Overall Study||9
2211011|NCT03044197|5420355|P2|STARTED|Overall Study||12
2211012|NCT03044197|5420356|P1|STARTED|Overall Study||12
2211013|NCT03044106|5420366|P2|NOT COMPLETED|Visit 2||0
2211014|NCT03044106|5420367|P1|NOT COMPLETED|Visit 2||0
2211015|NCT03044106|5420366|P2|COMPLETED|Visit 2||20
2211016|NCT03044106|5420367|P1|COMPLETED|Visit 2||22
2211017|NCT03044106|5420366|P2|STARTED|Visit 2||20
2211018|NCT03044106|5420367|P1|STARTED|Visit 2||22
2211019|NCT03044106|5420366|P2|NOT COMPLETED|Washout (1 Week)||2
2211020|NCT03044106|5420367|P1|NOT COMPLETED|Washout (1 Week)||0
2211021|NCT03044106|5420366|P2|COMPLETED|Washout (1 Week)||20
2211022|NCT03044106|5420367|P1|COMPLETED|Washout (1 Week)||22
2211023|NCT03044106|5420366|P2|STARTED|Washout (1 Week)||22
2211024|NCT03044106|5420367|P1|STARTED|Washout (1 Week)||22
2211025|NCT03044106|5420366|P2|NOT COMPLETED|Visit 1||0
2211026|NCT03044106|5420367|P1|NOT COMPLETED|Visit 1||0
2211027|NCT03044106|5420366|P2|COMPLETED|Visit 1||22
2211028|NCT03044106|5420367|P1|COMPLETED|Visit 1||22
2211029|NCT03044106|5420366|P2|STARTED|Visit 1||22
2211030|NCT03044106|5420367|P1|STARTED|Visit 1||22
2211031|NCT03043885|5420385|P4|NOT COMPLETED|Overall Study||0
2211032|NCT03043885|5420386|P3|NOT COMPLETED|Overall Study||0
2211033|NCT03043885|5420387|P2|NOT COMPLETED|Overall Study||0
2211034|NCT03043885|5420388|P1|NOT COMPLETED|Overall Study||0
2211035|NCT03043885|5420385|P4|COMPLETED|Overall Study||10
2211036|NCT03043885|5420386|P3|COMPLETED|Overall Study||10
2211037|NCT03043885|5420387|P2|COMPLETED|Overall Study||10
2211038|NCT03043885|5420388|P1|COMPLETED|Overall Study||10
2211039|NCT03043885|5420385|P4|STARTED|Overall Study||10
2211040|NCT03043885|5420386|P3|STARTED|Overall Study||10
2211041|NCT03043885|5420387|P2|STARTED|Overall Study||10
2211042|NCT03043885|5420388|P1|STARTED|Overall Study||10
2211043|NCT03043599|5420402|P1|NOT COMPLETED|Overall Study||0
2211044|NCT03043599|5420402|P1|COMPLETED|Overall Study||21
2211045|NCT03043599|5420402|P1|STARTED|Overall Study||21
2211046|NCT03043534|5420410|P2|NOT COMPLETED|Overall Study||0
2211047|NCT03043534|5420411|P1|NOT COMPLETED|Overall Study||0
2211048|NCT03043534|5420410|P2|COMPLETED|Overall Study||14
2211049|NCT03043534|5420411|P1|COMPLETED|Overall Study||15
2211050|NCT03043534|5420410|P2|STARTED|Overall Study||14
2211051|NCT03043534|5420411|P1|STARTED|Overall Study||15
2211052|NCT03042910|5420425|P1|NOT COMPLETED|Overall Study||7
2211053|NCT03042910|5420425|P1|COMPLETED|Overall Study||31
2211054|NCT03042910|5420425|P1|Treated|Overall Study||37
2211055|NCT03042910|5420425|P1|STARTED|Overall Study||38
2211056|NCT03042780|5420448|P1|NOT COMPLETED|Overall Study||0
2211057|NCT03042780|5420448|P1|COMPLETED|Overall Study||2
2211058|NCT03042780|5420448|P1|STARTED|Overall Study||2
2211059|NCT03042715|5420454|P1|NOT COMPLETED|Overall Study||1
2211060|NCT03042715|5420454|P1|COMPLETED|Overall Study||5
2211061|NCT03042715|5420454|P1|STARTED|Overall Study||6
2211062|NCT03042702|5420458|P1|NOT COMPLETED|Overall Study||0
2211063|NCT03042702|5420458|P1|COMPLETED|Overall Study||2
2211064|NCT03042702|5420458|P1|STARTED|Overall Study||2
2211065|NCT03042559|5420469|P2|NOT COMPLETED|Overall Study||1
2211066|NCT03042559|5420470|P1|NOT COMPLETED|Overall Study||1
2211067|NCT03042559|5420469|P2|COMPLETED|Overall Study||20
2211068|NCT03042559|5420470|P1|COMPLETED|Overall Study||21
2211069|NCT03042559|5420469|P2|STARTED|Overall Study||21
2211070|NCT03042559|5420470|P1|STARTED|Overall Study||22
2211071|NCT03042299|5420532|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
2211072|NCT03042299|5420533|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
2211073|NCT03042299|5420532|P2|COMPLETED|Intervention Period 2 (6 Days)||7
2211074|NCT03042299|5420533|P1|COMPLETED|Intervention Period 2 (6 Days)||7
2211075|NCT03042299|5420532|P2|STARTED|Intervention Period 2 (6 Days)||7
2211076|NCT03042299|5420533|P1|STARTED|Intervention Period 2 (6 Days)||7
2211077|NCT03042299|5420532|P2|NOT COMPLETED|Washout Period (at Least 6 Days)||0
2211078|NCT03042299|5420533|P1|NOT COMPLETED|Washout Period (at Least 6 Days)||0
2211079|NCT03042299|5420532|P2|COMPLETED|Washout Period (at Least 6 Days)||7
2211080|NCT03042299|5420533|P1|COMPLETED|Washout Period (at Least 6 Days)||7
2211081|NCT03042299|5420532|P2|STARTED|Washout Period (at Least 6 Days)||7
2211082|NCT03042299|5420533|P1|STARTED|Washout Period (at Least 6 Days)||7
2211083|NCT03042299|5420532|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
2211084|NCT03042299|5420533|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
2211085|NCT03042299|5420532|P2|COMPLETED|Intervention Period 1 (6 Days)||7
2211086|NCT03042299|5420533|P1|COMPLETED|Intervention Period 1 (6 Days)||7
2211087|NCT03042299|5420532|P2|STARTED|Intervention Period 1 (6 Days)||7
2211088|NCT03042299|5420533|P1|STARTED|Intervention Period 1 (6 Days)||7
2211089|NCT03041909|5420562|P3|NOT COMPLETED|Overall Study||0
2211090|NCT03041909|5420563|P2|NOT COMPLETED|Overall Study||0
2211091|NCT03041909|5420564|P1|NOT COMPLETED|Overall Study||0
2211092|NCT03041909|5420562|P3|COMPLETED|Overall Study||1
2211093|NCT03041909|5420563|P2|COMPLETED|Overall Study||1
2211094|NCT03041909|5420564|P1|COMPLETED|Overall Study||3
2211095|NCT03041909|5420562|P3|STARTED|Overall Study||1
2211096|NCT03041909|5420563|P2|STARTED|Overall Study||1
2211097|NCT03041909|5420564|P1|STARTED|Overall Study||3
2211098|NCT03041792|5420583|P2|NOT COMPLETED|Overall Study||3
2211099|NCT03041792|5420584|P1|NOT COMPLETED|Overall Study||4
2211100|NCT03041792|5420583|P2|COMPLETED|Overall Study||26
2211101|NCT03041792|5420584|P1|COMPLETED|Overall Study||28
2211102|NCT03041792|5420583|P2|Received Treatment|Overall Study||28
2211103|NCT03041792|5420584|P1|Received Treatment|Overall Study||32
2211104|NCT03041792|5420583|P2|STARTED|Overall Study||29
2211105|NCT03041792|5420584|P1|STARTED|Overall Study||32
2211106|NCT03041298|5420606|P1|NOT COMPLETED|Overall Study||0
2211107|NCT03041298|5420606|P1|COMPLETED|Overall Study||1537
2211108|NCT03041298|5420606|P1|STARTED|Overall Study||1537
2211109|NCT03041181|5420616|P2|NOT COMPLETED|Overall Study||2
2211110|NCT03041181|5420617|P1|NOT COMPLETED|Overall Study||1
2211111|NCT03041181|5420616|P2|COMPLETED|Overall Study||0
2211112|NCT03041181|5420617|P1|COMPLETED|Overall Study||0
2211113|NCT03041181|5420616|P2|STARTED|Overall Study||2
2211114|NCT03041181|5420617|P1|STARTED|Overall Study||1
2211115|NCT03041090|5420633|P2|NOT COMPLETED|Overall Study||3
2211116|NCT03041090|5420634|P1|NOT COMPLETED|Overall Study||0
2211117|NCT03041090|5420633|P2|COMPLETED|Overall Study|3 consented subjects in the dynamic arm were not included in analysis due to technical errors.|21
2211118|NCT03041090|5420634|P1|COMPLETED|Overall Study||109
2211119|NCT03041090|5420633|P2|STARTED|Overall Study||24
2211120|NCT03041090|5420634|P1|STARTED|Overall Study||109
2211121|NCT03040687|5420647|P3|NOT COMPLETED|Overall Study||0
2211122|NCT03040687|5420648|P2|NOT COMPLETED|Overall Study||0
2211123|NCT03040687|5420649|P1|NOT COMPLETED|Overall Study||1
2211124|NCT03040687|5420647|P3|COMPLETED|Overall Study||20
2211125|NCT03040687|5420648|P2|COMPLETED|Overall Study||20
2211126|NCT03040687|5420649|P1|COMPLETED|Overall Study||19
2211127|NCT03040687|5420647|P3|STARTED|Overall Study||20
2211128|NCT03040687|5420648|P2|STARTED|Overall Study||20
2211129|NCT03040687|5420649|P1|STARTED|Overall Study||20
2211130|NCT03040479|5420663|P3|NOT COMPLETED|Overall Study||0
2211131|NCT03040479|5420664|P2|NOT COMPLETED|Overall Study||0
2211132|NCT03040479|5420665|P1|NOT COMPLETED|Overall Study||0
2211133|NCT03040479|5420663|P3|COMPLETED|Overall Study||8
2211134|NCT03040479|5420664|P2|COMPLETED|Overall Study||8
2211135|NCT03040479|5420665|P1|COMPLETED|Overall Study||8
2211136|NCT03040479|5420663|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
2211137|NCT03040479|5420664|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
2211138|NCT03040479|5420665|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
2211139|NCT03040479|5420663|P3|STARTED|Overall Study||8
2211140|NCT03040479|5420664|P2|STARTED|Overall Study||8
2211141|NCT03040479|5420665|P1|STARTED|Overall Study||8
2211142|NCT03040362|5420691|P1|NOT COMPLETED|Overall Study||0
2211143|NCT03040362|5420691|P1|COMPLETED|Overall Study||8
2211144|NCT03040362|5420691|P1|Received at Least 1dose of Study Drug|Overall Study||8
2211145|NCT03040362|5420691|P1|STARTED|Overall Study||8
2211146|NCT03040323|5420705|P2|NOT COMPLETED|Overall Study||0
2211147|NCT03040323|5420706|P1|NOT COMPLETED|Overall Study||0
2211148|NCT03040323|5420705|P2|COMPLETED|Overall Study||0
2211149|NCT03040323|5420706|P1|COMPLETED|Overall Study||0
2211150|NCT03040323|5420705|P2|STARTED|Overall Study|No information available regarding how many participants Started and Completed the study in each arm|0
2211151|NCT03040323|5420706|P1|STARTED|Overall Study|No information available regarding how many participants Started and Completed the study in each arm|0
2211152|NCT03039738|5420716|P2|NOT COMPLETED|Overall Study||0
2211153|NCT03039738|5420717|P1|NOT COMPLETED|Overall Study||54
2211154|NCT03039738|5420716|P2|COMPLETED|Overall Study||0
2211155|NCT03039738|5420717|P1|COMPLETED|Overall Study||152
2211156|NCT03039738|5420716|P2|STARTED|Overall Study|This arm did not initiate. The study was terminated following the completion of the telemetry phase.|0
2211157|NCT03039738|5420717|P1|STARTED|Overall Study||206
2211158|NCT03039569|5420739|P2|NOT COMPLETED|Overall Study||4
2211159|NCT03039569|5420740|P1|NOT COMPLETED|Overall Study||5
2211160|NCT03039569|5420739|P2|COMPLETED|Overall Study||35
2211161|NCT03039569|5420740|P1|COMPLETED|Overall Study||35
2211162|NCT03039569|5420739|P2|STARTED|Overall Study||39
2211163|NCT03039569|5420740|P1|STARTED|Overall Study||40
2211164|NCT03039543|5420770|P2|NOT COMPLETED|Overall Study||3
2211165|NCT03039543|5420771|P1|NOT COMPLETED|Overall Study||1
2211166|NCT03039543|5420770|P2|COMPLETED|Overall Study||51
2211167|NCT03039543|5420771|P1|COMPLETED|Overall Study||53
2211168|NCT03039543|5420770|P2|STARTED|Overall Study||54
2211169|NCT03039543|5420771|P1|STARTED|Overall Study||54
2211170|NCT03039283|5420785|P1|NOT COMPLETED|Overall Study||2
2211171|NCT03039283|5420785|P1|COMPLETED|Overall Study||160
2211172|NCT03039283|5420785|P1|STARTED|Overall Study||162
2211173|NCT03039179|5420796|P2|NOT COMPLETED|Overall Study||0
2211174|NCT03039179|5420797|P1|NOT COMPLETED|Overall Study||0
2211175|NCT03039179|5420796|P2|COMPLETED|Overall Study||42
2211176|NCT03039179|5420797|P1|COMPLETED|Overall Study||38
2211177|NCT03039179|5420796|P2|STARTED|Overall Study||42
2211178|NCT03039179|5420797|P1|STARTED|Overall Study||38
2211179|NCT03039088|5420807|P2|NOT COMPLETED|Overall Study||0
2211180|NCT03039088|5420808|P1|NOT COMPLETED|Overall Study||0
2211181|NCT03039088|5420807|P2|COMPLETED|Overall Study||316
2211182|NCT03039088|5420808|P1|COMPLETED|Overall Study||192
2211183|NCT03039088|5420807|P2|STARTED|Overall Study||316
2211184|NCT03039088|5420808|P1|STARTED|Overall Study||192
2211185|NCT03038815|5420816|P2|NOT COMPLETED|Intervention 2, 1 Hour||0
2211186|NCT03038815|5420817|P1|NOT COMPLETED|Intervention 2, 1 Hour||0
2211187|NCT03038815|5420816|P2|COMPLETED|Intervention 2, 1 Hour||10
2211188|NCT03038815|5420817|P1|COMPLETED|Intervention 2, 1 Hour||10
2211189|NCT03038815|5420816|P2|STARTED|Intervention 2, 1 Hour||10
2211190|NCT03038815|5420817|P1|STARTED|Intervention 2, 1 Hour||10
2211191|NCT03038815|5420816|P2|NOT COMPLETED|Intervention 1, 1 Hour||0
2211192|NCT03038815|5420817|P1|NOT COMPLETED|Intervention 1, 1 Hour||0
2211193|NCT03038815|5420816|P2|COMPLETED|Intervention 1, 1 Hour||10
2211194|NCT03038815|5420817|P1|COMPLETED|Intervention 1, 1 Hour||10
2211195|NCT03038815|5420816|P2|STARTED|Intervention 1, 1 Hour||10
2211196|NCT03038815|5420817|P1|STARTED|Intervention 1, 1 Hour||10
2211197|NCT03038815|5420816|P2|NOT COMPLETED|Controll Condition, 1 Hour||0
2211198|NCT03038815|5420817|P1|NOT COMPLETED|Controll Condition, 1 Hour||0
2211199|NCT03038815|5420816|P2|COMPLETED|Controll Condition, 1 Hour||10
2211200|NCT03038815|5420817|P1|COMPLETED|Controll Condition, 1 Hour||10
2211201|NCT03038815|5420816|P2|STARTED|Controll Condition, 1 Hour||10
2211202|NCT03038815|5420817|P1|STARTED|Controll Condition, 1 Hour||10
2211203|NCT03037905|5420829|P2|NOT COMPLETED|Overall Study||0
2211204|NCT03037905|5420830|P1|NOT COMPLETED|Overall Study||0
2211205|NCT03037905|5420829|P2|COMPLETED|Overall Study||50
2211206|NCT03037905|5420830|P1|COMPLETED|Overall Study||50
2211207|NCT03037905|5420829|P2|STARTED|Overall Study||50
2211208|NCT03037905|5420830|P1|STARTED|Overall Study||50
2211209|NCT03037619|5420844|P2|NOT COMPLETED|Overall Study||1
2211210|NCT03037619|5420845|P1|NOT COMPLETED|Overall Study||0
2211211|NCT03037619|5420844|P2|COMPLETED|Overall Study|7 participants and 7 buddies|14
2211212|NCT03037619|5420845|P1|COMPLETED|Overall Study||8
2211213|NCT03037619|5420844|P2|STARTED|Overall Study|8 participants and 7 buddies|15
2211214|NCT03037619|5420845|P1|STARTED|Overall Study||8
2211215|NCT03037541|5420859|P2|NOT COMPLETED|Overall Study||0
2211216|NCT03037541|5420860|P1|NOT COMPLETED|Overall Study||0
2211217|NCT03037541|5420859|P2|COMPLETED|Overall Study||30
2211218|NCT03037541|5420860|P1|COMPLETED|Overall Study||30
2211219|NCT03037541|5420859|P2|STARTED|Overall Study||30
2211220|NCT03037541|5420860|P1|STARTED|Overall Study||30
2211221|NCT03037489|5420870|P2|NOT COMPLETED|Overall Study||0
2211222|NCT03037489|5420871|P1|NOT COMPLETED|Overall Study||7
2211223|NCT03037489|5420870|P2|COMPLETED|Overall Study||4
2211224|NCT03037489|5420871|P1|COMPLETED|Overall Study||39
2211225|NCT03037489|5420870|P2|STARTED|Overall Study||4
2211226|NCT03037489|5420871|P1|STARTED|Overall Study||46
2211227|NCT03037307|5420877|P6|NOT COMPLETED|Period 3||0
2211228|NCT03037307|5420878|P5|NOT COMPLETED|Period 3||0
2211229|NCT03037307|5420879|P4|NOT COMPLETED|Period 3||0
2211230|NCT03037307|5420880|P3|NOT COMPLETED|Period 3||0
2211231|NCT03037307|5420881|P2|NOT COMPLETED|Period 3||0
2211232|NCT03037307|5420882|P1|NOT COMPLETED|Period 3||0
2211233|NCT03037307|5420877|P6|COMPLETED|Period 3||8
2211234|NCT03037307|5420878|P5|COMPLETED|Period 3||7
2211235|NCT03037307|5420879|P4|COMPLETED|Period 3||6
2211236|NCT03037307|5420880|P3|COMPLETED|Period 3||8
2211237|NCT03037307|5420881|P2|COMPLETED|Period 3||7
2211238|NCT03037307|5420882|P1|COMPLETED|Period 3||7
2211239|NCT03037307|5420877|P6|STARTED|Period 3||8
2211240|NCT03037307|5420878|P5|STARTED|Period 3||7
2211241|NCT03037307|5420879|P4|STARTED|Period 3||6
2211242|NCT03037307|5420880|P3|STARTED|Period 3||8
2211243|NCT03037307|5420881|P2|STARTED|Period 3||7
2211244|NCT03037307|5420882|P1|STARTED|Period 3||7
2211245|NCT03037307|5420877|P6|NOT COMPLETED|Wash Out Period 2||0
2211246|NCT03037307|5420878|P5|NOT COMPLETED|Wash Out Period 2||0
2211247|NCT03037307|5420879|P4|NOT COMPLETED|Wash Out Period 2||0
2211248|NCT03037307|5420880|P3|NOT COMPLETED|Wash Out Period 2||0
2211249|NCT03037307|5420881|P2|NOT COMPLETED|Wash Out Period 2||0
2211250|NCT03037307|5420882|P1|NOT COMPLETED|Wash Out Period 2||0
2211251|NCT03037307|5420877|P6|COMPLETED|Wash Out Period 2||8
2211252|NCT03037307|5420878|P5|COMPLETED|Wash Out Period 2||7
2211253|NCT03037307|5420879|P4|COMPLETED|Wash Out Period 2||6
2211254|NCT03037307|5420880|P3|COMPLETED|Wash Out Period 2||8
2211255|NCT03037307|5420881|P2|COMPLETED|Wash Out Period 2||7
2211256|NCT03037307|5420882|P1|COMPLETED|Wash Out Period 2||7
2211257|NCT03037307|5420877|P6|STARTED|Wash Out Period 2||8
2211258|NCT03037307|5420878|P5|STARTED|Wash Out Period 2||7
2211259|NCT03037307|5420879|P4|STARTED|Wash Out Period 2||6
2211260|NCT03037307|5420880|P3|STARTED|Wash Out Period 2||8
2211261|NCT03037307|5420881|P2|STARTED|Wash Out Period 2||7
2211262|NCT03037307|5420882|P1|STARTED|Wash Out Period 2||7
2211263|NCT03037307|5420877|P6|NOT COMPLETED|Period 2||0
2211264|NCT03037307|5420878|P5|NOT COMPLETED|Period 2||0
2211265|NCT03037307|5420879|P4|NOT COMPLETED|Period 2||0
2211266|NCT03037307|5420880|P3|NOT COMPLETED|Period 2||0
2211267|NCT03037307|5420881|P2|NOT COMPLETED|Period 2||0
2211268|NCT03037307|5420882|P1|NOT COMPLETED|Period 2||0
2211269|NCT03037307|5420877|P6|COMPLETED|Period 2||8
2211270|NCT03037307|5420878|P5|COMPLETED|Period 2||7
2211271|NCT03037307|5420879|P4|COMPLETED|Period 2||6
2211272|NCT03037307|5420880|P3|COMPLETED|Period 2||8
2211273|NCT03037307|5420881|P2|COMPLETED|Period 2||7
2211274|NCT03037307|5420882|P1|COMPLETED|Period 2||7
2211275|NCT03037307|5420877|P6|STARTED|Period 2||8
2211276|NCT03037307|5420878|P5|STARTED|Period 2||7
2211277|NCT03037307|5420879|P4|STARTED|Period 2||6
2211278|NCT03037307|5420880|P3|STARTED|Period 2||8
2211279|NCT03037307|5420881|P2|STARTED|Period 2||7
2211280|NCT03037307|5420882|P1|STARTED|Period 2||7
2211281|NCT03037307|5420877|P6|NOT COMPLETED|Wash Out Period 1||0
2211282|NCT03037307|5420878|P5|NOT COMPLETED|Wash Out Period 1||0
2211283|NCT03037307|5420879|P4|NOT COMPLETED|Wash Out Period 1||0
2211284|NCT03037307|5420880|P3|NOT COMPLETED|Wash Out Period 1||0
2211285|NCT03037307|5420881|P2|NOT COMPLETED|Wash Out Period 1||0
2211286|NCT03037307|5420882|P1|NOT COMPLETED|Wash Out Period 1||0
2211287|NCT03037307|5420877|P6|COMPLETED|Wash Out Period 1||8
2211288|NCT03037307|5420878|P5|COMPLETED|Wash Out Period 1||7
2211289|NCT03037307|5420879|P4|COMPLETED|Wash Out Period 1||6
2211290|NCT03037307|5420880|P3|COMPLETED|Wash Out Period 1||8
2211291|NCT03037307|5420881|P2|COMPLETED|Wash Out Period 1||7
2211292|NCT03037307|5420882|P1|COMPLETED|Wash Out Period 1||7
2211293|NCT03037307|5420877|P6|STARTED|Wash Out Period 1||8
2211294|NCT03037307|5420878|P5|STARTED|Wash Out Period 1||7
2211295|NCT03037307|5420879|P4|STARTED|Wash Out Period 1||6
2211296|NCT03037307|5420880|P3|STARTED|Wash Out Period 1||8
2211297|NCT03037307|5420881|P2|STARTED|Wash Out Period 1||7
2211298|NCT03037307|5420882|P1|STARTED|Wash Out Period 1||7
2211299|NCT03037307|5420877|P6|NOT COMPLETED|Period 1||0
2211300|NCT03037307|5420878|P5|NOT COMPLETED|Period 1||0
2211301|NCT03037307|5420879|P4|NOT COMPLETED|Period 1||1
2211302|NCT03037307|5420880|P3|NOT COMPLETED|Period 1||0
2211303|NCT03037307|5420881|P2|NOT COMPLETED|Period 1||0
2211304|NCT03037307|5420882|P1|NOT COMPLETED|Period 1||0
2211305|NCT03037307|5420877|P6|COMPLETED|Period 1||8
2211306|NCT03037307|5420878|P5|COMPLETED|Period 1||7
2211307|NCT03037307|5420879|P4|COMPLETED|Period 1||6
2211308|NCT03037307|5420880|P3|COMPLETED|Period 1||8
2211309|NCT03037307|5420881|P2|COMPLETED|Period 1||7
2211310|NCT03037307|5420882|P1|COMPLETED|Period 1||7
2211311|NCT03037307|5420877|P6|STARTED|Period 1||8
2211312|NCT03037307|5420878|P5|STARTED|Period 1||7
2211313|NCT03037307|5420879|P4|STARTED|Period 1||7
2211314|NCT03037307|5420880|P3|STARTED|Period 1||8
2211315|NCT03037307|5420881|P2|STARTED|Period 1||7
2211316|NCT03037307|5420882|P1|STARTED|Period 1||7
2211317|NCT03037203|5420895|P3|NOT COMPLETED|Overall Study||1
2211318|NCT03037203|5420896|P2|NOT COMPLETED|Overall Study||2
2211319|NCT03037203|5420897|P1|NOT COMPLETED|Overall Study||1
2211320|NCT03037203|5420895|P3|COMPLETED|Overall Study||9
2211321|NCT03037203|5420896|P2|COMPLETED|Overall Study||26
2211322|NCT03037203|5420897|P1|COMPLETED|Overall Study||27
2211323|NCT03037203|5420895|P3|STARTED|Overall Study||10
2211324|NCT03037203|5420896|P2|STARTED|Overall Study||28
2211325|NCT03037203|5420897|P1|STARTED|Overall Study||28
2211326|NCT03036852|5420921|P1|NOT COMPLETED|Overall Study||6
2211327|NCT03036852|5420921|P1|COMPLETED|Overall Study||53
2211328|NCT03036852|5420921|P1|STARTED|Overall Study||59
2211329|NCT03036839|5420978|P3|NOT COMPLETED|Overall Study||5
2211330|NCT03036839|5420979|P2|NOT COMPLETED|Overall Study||0
2211331|NCT03036839|5420980|P1|NOT COMPLETED|Overall Study||3
2211332|NCT03036839|5420978|P3|COMPLETED|Overall Study||14
2211333|NCT03036839|5420979|P2|COMPLETED|Overall Study||31
2211334|NCT03036839|5420980|P1|COMPLETED|Overall Study||42
2211335|NCT03036839|5420978|P3|STARTED|Overall Study||19
2211336|NCT03036839|5420979|P2|STARTED|Overall Study||31
2211337|NCT03036839|5420980|P1|STARTED|Overall Study||45
2211338|NCT03036735|5421030|P1|NOT COMPLETED|Overall Study||10
2211339|NCT03036735|5421030|P1|COMPLETED|Overall Study||0
2211340|NCT03036735|5421030|P1|STARTED|Overall Study||10
2211341|NCT03036215|5421036|P2|NOT COMPLETED|Overall Study||3
2211342|NCT03036215|5421037|P1|NOT COMPLETED|Overall Study||2
2211343|NCT03036215|5421036|P2|COMPLETED|Overall Study||36
2211344|NCT03036215|5421037|P1|COMPLETED|Overall Study||39
2211345|NCT03036215|5421036|P2|STARTED|Overall Study||39
2211346|NCT03036215|5421037|P1|STARTED|Overall Study||41
2211347|NCT03035955|5421049|P2|NOT COMPLETED|Overall Study||1
2211348|NCT03035955|5421050|P1|NOT COMPLETED|Overall Study||1
2211349|NCT03035955|5421049|P2|COMPLETED|Overall Study||9
2211350|NCT03035955|5421050|P1|COMPLETED|Overall Study||9
2211351|NCT03035955|5421049|P2|STARTED|Overall Study||10
2211352|NCT03035955|5421050|P1|STARTED|Overall Study||10
2211353|NCT03035929|5421056|P1|NOT COMPLETED|Overall Study||0
2211354|NCT03035929|5421056|P1|COMPLETED|Overall Study||10
2211355|NCT03035929|5421056|P1|STARTED|Overall Study||10
2211356|NCT03035916|5421068|P3|NOT COMPLETED|Overall Study||0
2211357|NCT03035916|5421069|P2|NOT COMPLETED|Overall Study||2
2211358|NCT03035916|5421070|P1|NOT COMPLETED|Overall Study||0
2211359|NCT03035916|5421068|P3|COMPLETED|Overall Study||31
2211360|NCT03035916|5421069|P2|COMPLETED|Overall Study||28
2211361|NCT03035916|5421070|P1|COMPLETED|Overall Study||30
2211362|NCT03035916|5421068|P3|STARTED|Overall Study||31
2211363|NCT03035916|5421069|P2|STARTED|Overall Study||30
2211364|NCT03035916|5421070|P1|STARTED|Overall Study||30
2211365|NCT03035864|5421119|P2|NOT COMPLETED|Follow-up Period||4
2211366|NCT03035864|5421120|P1|NOT COMPLETED|Follow-up Period||11
2211367|NCT03035864|5421119|P2|COMPLETED|Follow-up Period||55
2211368|NCT03035864|5421120|P1|COMPLETED|Follow-up Period||105
2211369|NCT03035864|5421119|P2|STARTED|Follow-up Period||59
2211370|NCT03035864|5421120|P1|STARTED|Follow-up Period||116
2211371|NCT03035864|5421119|P2|NOT COMPLETED|Treatment Period||1
2211372|NCT03035864|5421120|P1|NOT COMPLETED|Treatment Period||4
2211373|NCT03035864|5421119|P2|COMPLETED|Treatment Period||59
2211374|NCT03035864|5421120|P1|COMPLETED|Treatment Period||116
2211375|NCT03035864|5421119|P2|STARTED|Treatment Period||60
2211376|NCT03035864|5421120|P1|STARTED|Treatment Period||120
2211377|NCT03035760|5421141|P5|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
2211378|NCT03035760|5421142|P4|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
2211379|NCT03035760|5421143|P3|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
2211380|NCT03035760|5421144|P2|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
2211381|NCT03035760|5421145|P1|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
2211382|NCT03035760|5421141|P5|COMPLETED|Second Intervention - 7 Days Follow-up||6
2211383|NCT03035760|5421142|P4|COMPLETED|Second Intervention - 7 Days Follow-up||6
2211384|NCT03035760|5421143|P3|COMPLETED|Second Intervention - 7 Days Follow-up||0
2211385|NCT03035760|5421144|P2|COMPLETED|Second Intervention - 7 Days Follow-up||0
2211386|NCT03035760|5421145|P1|COMPLETED|Second Intervention - 7 Days Follow-up||0
2211387|NCT03035760|5421141|P5|STARTED|Second Intervention - 7 Days Follow-up||6
2211388|NCT03035760|5421142|P4|STARTED|Second Intervention - 7 Days Follow-up||6
2211389|NCT03035760|5421143|P3|STARTED|Second Intervention - 7 Days Follow-up||0
2211390|NCT03035760|5421144|P2|STARTED|Second Intervention - 7 Days Follow-up||0
2211391|NCT03035760|5421145|P1|STARTED|Second Intervention - 7 Days Follow-up||0
2211392|NCT03035760|5421141|P5|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
2211393|NCT03035760|5421142|P4|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
2211394|NCT03035760|5421143|P3|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
2211395|NCT03035760|5421144|P2|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
2211396|NCT03035760|5421145|P1|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
2211397|NCT03035760|5421141|P5|COMPLETED|First Intervention - 10/7 Days Follow-up||6
2211398|NCT03035760|5421142|P4|COMPLETED|First Intervention - 10/7 Days Follow-up||6
2211399|NCT03035760|5421143|P3|COMPLETED|First Intervention - 10/7 Days Follow-up||8
2211400|NCT03035760|5421144|P2|COMPLETED|First Intervention - 10/7 Days Follow-up||8
2211401|NCT03035760|5421145|P1|COMPLETED|First Intervention - 10/7 Days Follow-up||8
2211402|NCT03035760|5421141|P5|STARTED|First Intervention - 10/7 Days Follow-up||6
2211403|NCT03035760|5421142|P4|STARTED|First Intervention - 10/7 Days Follow-up||6
2211404|NCT03035760|5421143|P3|STARTED|First Intervention - 10/7 Days Follow-up||8
2211405|NCT03035760|5421144|P2|STARTED|First Intervention - 10/7 Days Follow-up||8
2211406|NCT03035760|5421145|P1|STARTED|First Intervention - 10/7 Days Follow-up||8
2211407|NCT03035708|5421175|P2|NOT COMPLETED|Overall Study||11
2211408|NCT03035708|5421176|P1|NOT COMPLETED|Overall Study||4
2211409|NCT03035708|5421175|P2|COMPLETED|Overall Study||13
2211410|NCT03035708|5421176|P1|COMPLETED|Overall Study||19
2211411|NCT03035708|5421175|P2|STARTED|Overall Study||24
2211412|NCT03035708|5421176|P1|STARTED|Overall Study||23
2211413|NCT03035487|5421190|P1|NOT COMPLETED|Overall Study||0
2211414|NCT03035487|5421190|P1|COMPLETED|Overall Study||9
2211415|NCT03035487|5421190|P1|STARTED|Overall Study||9
2211416|NCT03034967|5421200|P6|NOT COMPLETED|Overall Study||15
2211417|NCT03034967|5421201|P5|NOT COMPLETED|Overall Study||14
2211418|NCT03034967|5421202|P4|NOT COMPLETED|Overall Study||11
2211419|NCT03034967|5421203|P3|NOT COMPLETED|Overall Study||13
2211420|NCT03034967|5421204|P2|NOT COMPLETED|Overall Study||5
2211421|NCT03034967|5421205|P1|NOT COMPLETED|Overall Study||14
2211422|NCT03034967|5421200|P6|COMPLETED|Overall Study||87
2211423|NCT03034967|5421201|P5|COMPLETED|Overall Study||88
2211424|NCT03034967|5421202|P4|COMPLETED|Overall Study||92
2211425|NCT03034967|5421203|P3|COMPLETED|Overall Study||90
2211426|NCT03034967|5421204|P2|COMPLETED|Overall Study||97
2211427|NCT03034967|5421205|P1|COMPLETED|Overall Study||88
2211428|NCT03034967|5421200|P6|STARTED|Overall Study||102
2211429|NCT03034967|5421201|P5|STARTED|Overall Study||102
2211430|NCT03034967|5421202|P4|STARTED|Overall Study||103
2211431|NCT03034967|5421203|P3|STARTED|Overall Study||103
2211432|NCT03034967|5421204|P2|STARTED|Overall Study||102
2211433|NCT03034967|5421205|P1|STARTED|Overall Study||102
2211434|NCT03034954|5421403|P2|NOT COMPLETED|Overall Study||0
2211435|NCT03034954|5421404|P1|NOT COMPLETED|Overall Study||1
2211436|NCT03034954|5421403|P2|COMPLETED|Overall Study||21
2211437|NCT03034954|5421404|P1|COMPLETED|Overall Study||20
2211438|NCT03034954|5421403|P2|STARTED|Overall Study||21
2211439|NCT03034954|5421404|P1|STARTED|Overall Study||21
2211476|NCT03034915|5421471|P3|NOT COMPLETED|Overall Study||126
2211477|NCT03034915|5421472|P2|NOT COMPLETED|Overall Study||154
2211478|NCT03034915|5421473|P1|NOT COMPLETED|Overall Study||95
2211479|NCT03034915|5421471|P3|COMPLETED|Overall Study||683
2211480|NCT03034915|5421472|P2|COMPLETED|Overall Study||650
2211481|NCT03034915|5421473|P1|COMPLETED|Overall Study||717
2211482|NCT03034915|5421471|P3|STARTED|Overall Study||809
2211483|NCT03034915|5421472|P2|STARTED|Overall Study||804
2211484|NCT03034915|5421473|P1|STARTED|Overall Study||812
2211485|NCT03034577|5421513|P2|NOT COMPLETED|Overall Study||35
2211486|NCT03034577|5421514|P1|NOT COMPLETED|Overall Study||31
2211487|NCT03034577|5421513|P2|COMPLETED|Overall Study||140
2211488|NCT03034577|5421514|P1|COMPLETED|Overall Study||144
2211489|NCT03034577|5421513|P2|STARTED|Overall Study||175
2211490|NCT03034577|5421514|P1|STARTED|Overall Study||175
2211491|NCT03034057|5421530|P1|NOT COMPLETED|Overall Study||55
2211492|NCT03034057|5421530|P1|COMPLETED|Overall Study||114
2211493|NCT03034057|5421530|P1|STARTED|Overall Study||169
2211494|NCT03034044|5421536|P1|NOT COMPLETED|Overall Study||1
2211495|NCT03034044|5421536|P1|COMPLETED|Overall Study||105
2211496|NCT03034044|5421536|P1|Received Xyntha|Overall Study||105
2211497|NCT03034044|5421536|P1|STARTED|Overall Study||106
2211498|NCT03033745|5421559|P3|NOT COMPLETED|Overall Study||2
2211499|NCT03033745|5421560|P2|NOT COMPLETED|Overall Study||1
2211500|NCT03033745|5421561|P1|NOT COMPLETED|Overall Study||1
2211501|NCT03033745|5421559|P3|COMPLETED|Overall Study||14
2211502|NCT03033745|5421560|P2|COMPLETED|Overall Study||17
2211503|NCT03033745|5421561|P1|COMPLETED|Overall Study||14
2211504|NCT03033745|5421559|P3|STARTED|Overall Study||16
2211505|NCT03033745|5421560|P2|STARTED|Overall Study||18
2211506|NCT03033745|5421561|P1|STARTED|Overall Study||15
2211507|NCT03033134|5421596|P2|NOT COMPLETED|Overall Study||12
2211508|NCT03033134|5421597|P1|NOT COMPLETED|Overall Study||42
2211509|NCT03033134|5421596|P2|COMPLETED|Overall Study||0
2211510|NCT03033134|5421597|P1|COMPLETED|Overall Study||0
2211511|NCT03033134|5421596|P2|6-month Primary Endpoints|Overall Study||12
2211512|NCT03033134|5421597|P1|6-month Primary Endpoints|Overall Study||42
2211513|NCT03033134|5421596|P2|STARTED|Overall Study||12
2211514|NCT03033134|5421597|P1|STARTED|Overall Study||42
2211515|NCT03032965|5421619|P2|NOT COMPLETED|Overall Study||0
2211516|NCT03032965|5421620|P1|NOT COMPLETED|Overall Study||0
2211517|NCT03032965|5421619|P2|COMPLETED|Overall Study||68
2211518|NCT03032965|5421620|P1|COMPLETED|Overall Study||61
2211519|NCT03032965|5421619|P2|STARTED|Overall Study||68
2211520|NCT03032965|5421620|P1|STARTED|Overall Study||61
2211521|NCT03032523|5421644|P2|NOT COMPLETED|Overall Study||2
2211522|NCT03032523|5421645|P1|NOT COMPLETED|Overall Study||3
2211523|NCT03032523|5421644|P2|COMPLETED|Overall Study||4
2211524|NCT03032523|5421645|P1|COMPLETED|Overall Study||12
2211525|NCT03032523|5421644|P2|STARTED|Overall Study||6
2211526|NCT03032523|5421645|P1|STARTED|Overall Study||15
2211527|NCT03032510|5421657|P2|NOT COMPLETED|Overall Study||18
2211528|NCT03032510|5421658|P1|NOT COMPLETED|Overall Study||27
2211529|NCT03032510|5421657|P2|COMPLETED|Overall Study||584
2211530|NCT03032510|5421658|P1|COMPLETED|Overall Study||576
2211531|NCT03032510|5421657|P2|STARTED|Overall Study||602
2211532|NCT03032510|5421658|P1|STARTED|Overall Study||603
2211533|NCT03032263|5421670|P2|NOT COMPLETED|Overall Study||0
2211534|NCT03032263|5421671|P1|NOT COMPLETED|Overall Study||0
2211535|NCT03032263|5421670|P2|COMPLETED|Overall Study||6
2211536|NCT03032263|5421671|P1|COMPLETED|Overall Study||6
2211537|NCT03032263|5421670|P2|STARTED|Overall Study||6
2211538|NCT03032263|5421671|P1|STARTED|Overall Study||6
2211539|NCT03031899|5421685|P1|NOT COMPLETED|Overall Study||2
2211540|NCT03031899|5421685|P1|COMPLETED|Overall Study||25
2211541|NCT03031899|5421685|P1|STARTED|Overall Study||27
2211542|NCT03031795|5421695|P2|NOT COMPLETED|Overall Study||1
2211543|NCT03031795|5421696|P1|NOT COMPLETED|Overall Study||0
2211544|NCT03031795|5421695|P2|COMPLETED|Overall Study||35
2211545|NCT03031795|5421696|P1|COMPLETED|Overall Study||35
2211546|NCT03031795|5421695|P2|STARTED|Overall Study||36
2211547|NCT03031795|5421696|P1|STARTED|Overall Study||35
2211548|NCT03031496|5421702|P2|NOT COMPLETED|Period 2||0
2211549|NCT03031496|5421703|P1|NOT COMPLETED|Period 2||0
2211550|NCT03031496|5421702|P2|COMPLETED|Period 2||19
2211551|NCT03031496|5421703|P1|COMPLETED|Period 2||19
2211552|NCT03031496|5421702|P2|STARTED|Period 2||19
2211553|NCT03031496|5421703|P1|STARTED|Period 2||19
2211554|NCT03031496|5421702|P2|NOT COMPLETED|Period 1||2
2211555|NCT03031496|5421703|P1|NOT COMPLETED|Period 1||2
2211556|NCT03031496|5421702|P2|COMPLETED|Period 1||19
2211557|NCT03031496|5421703|P1|COMPLETED|Period 1||19
2211558|NCT03031496|5421702|P2|STARTED|Period 1||21
2211559|NCT03031496|5421703|P1|STARTED|Period 1||21
2211560|NCT03031431|5421739|P1|NOT COMPLETED|Overall Study||1
2211561|NCT03031431|5421739|P1|COMPLETED|Overall Study||129
2211562|NCT03031431|5421739|P1|STARTED|Overall Study||130
2211563|NCT03031340|5421748|P2|NOT COMPLETED|Overall Study||1
2211564|NCT03031340|5421749|P1|NOT COMPLETED|Overall Study||2
2211565|NCT03031340|5421748|P2|COMPLETED|Overall Study||0
2211566|NCT03031340|5421749|P1|COMPLETED|Overall Study||0
2211567|NCT03031340|5421748|P2|STARTED|Overall Study||1
2211568|NCT03031340|5421749|P1|STARTED|Overall Study||2
2211569|NCT03030638|5421773|P8|NOT COMPLETED|Overall Study||0
2211570|NCT03030638|5421774|P7|NOT COMPLETED|Overall Study||0
2211571|NCT03030638|5421775|P6|NOT COMPLETED|Overall Study||0
2211572|NCT03030638|5421776|P5|NOT COMPLETED|Overall Study||0
2211573|NCT03030638|5421777|P4|NOT COMPLETED|Overall Study||0
2211574|NCT03030638|5421778|P3|NOT COMPLETED|Overall Study||0
2211575|NCT03030638|5421779|P2|NOT COMPLETED|Overall Study||0
2211576|NCT03030638|5421780|P1|NOT COMPLETED|Overall Study||0
2211577|NCT03030638|5421773|P8|COMPLETED|Overall Study||127
2211578|NCT03030638|5421774|P7|COMPLETED|Overall Study||364
2211579|NCT03030638|5421775|P6|COMPLETED|Overall Study||1592
2211580|NCT03030638|5421776|P5|COMPLETED|Overall Study||696
2211581|NCT03030638|5421777|P4|COMPLETED|Overall Study||6406
2211582|NCT03030638|5421778|P3|COMPLETED|Overall Study||1712
2211583|NCT03030638|5421779|P2|COMPLETED|Overall Study||1841
2211584|NCT03030638|5421780|P1|COMPLETED|Overall Study||1386
2211585|NCT03030638|5421773|P8|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
2211586|NCT03030638|5421774|P7|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
2211587|NCT03030638|5421775|P6|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
2211588|NCT03030638|5421776|P5|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
2211589|NCT03030638|5421777|P4|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
2211590|NCT03030638|5421778|P3|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
2211591|NCT03030638|5421779|P2|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||636
2211592|NCT03030638|5421780|P1|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||372
2211593|NCT03030638|5421773|P8|STARTED|Overall Study||127
2211594|NCT03030638|5421774|P7|STARTED|Overall Study||364
2211595|NCT03030638|5421775|P6|STARTED|Overall Study||1592
2211596|NCT03030638|5421776|P5|STARTED|Overall Study||696
2211597|NCT03030638|5421777|P4|STARTED|Overall Study||6406
2211598|NCT03030638|5421778|P3|STARTED|Overall Study||1712
2211599|NCT03030638|5421779|P2|STARTED|Overall Study||1841
2211600|NCT03030638|5421780|P1|STARTED|Overall Study||1386
2211601|NCT03029988|5421810|P1|NOT COMPLETED|Overall Study||0
2211602|NCT03029988|5421810|P1|COMPLETED|Overall Study||3
2211603|NCT03029988|5421810|P1|STARTED|Overall Study||3
2211604|NCT03029832|5421817|P2|NOT COMPLETED|Overall Study||1
2211605|NCT03029832|5421818|P1|NOT COMPLETED|Overall Study||4
2211606|NCT03029832|5421817|P2|COMPLETED|Overall Study||0
2211607|NCT03029832|5421818|P1|COMPLETED|Overall Study||0
2211608|NCT03029832|5421817|P2|STARTED|Overall Study||1
2211609|NCT03029832|5421818|P1|STARTED|Overall Study||4
2211610|NCT03029819|5421848|P2|NOT COMPLETED|Overall Study||6
2211611|NCT03029819|5421849|P1|NOT COMPLETED|Overall Study||3
2211612|NCT03029819|5421848|P2|COMPLETED|Overall Study||33
2211613|NCT03029819|5421849|P1|COMPLETED|Overall Study||30
2211614|NCT03029819|5421848|P2|STARTED|Overall Study||39
2211615|NCT03029819|5421849|P1|STARTED|Overall Study||33
2211616|NCT03029780|5421863|P2|NOT COMPLETED|Overall Study||11
2211617|NCT03029780|5421864|P1|NOT COMPLETED|Overall Study||6
2211618|NCT03029780|5421863|P2|COMPLETED|Overall Study||41
2211619|NCT03029780|5421864|P1|COMPLETED|Overall Study||46
2211620|NCT03029780|5421863|P2|STARTED|Overall Study||52
2211621|NCT03029780|5421864|P1|STARTED|Overall Study||52
2211622|NCT03029650|5421876|P2|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0
2211623|NCT03029650|5421877|P1|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0
2211624|NCT03029650|5421876|P2|COMPLETED|2nd Intervention (3 - 6 Days)||10
2211625|NCT03029650|5421877|P1|COMPLETED|2nd Intervention (3 - 6 Days)||13
2211626|NCT03029650|5421876|P2|STARTED|2nd Intervention (3 - 6 Days)||10
2211627|NCT03029650|5421877|P1|STARTED|2nd Intervention (3 - 6 Days)||13
2211628|NCT03029650|5421876|P2|NOT COMPLETED|Washout (1 Week)||2
2211629|NCT03029650|5421877|P1|NOT COMPLETED|Washout (1 Week)||1
2211630|NCT03029650|5421876|P2|COMPLETED|Washout (1 Week)||10
2211631|NCT03029650|5421877|P1|COMPLETED|Washout (1 Week)||13
2211632|NCT03029650|5421876|P2|STARTED|Washout (1 Week)||12
2211633|NCT03029650|5421877|P1|STARTED|Washout (1 Week)||14
2211634|NCT03029650|5421876|P2|NOT COMPLETED|First Intervention (3 - 6 Days)||0
2211635|NCT03029650|5421877|P1|NOT COMPLETED|First Intervention (3 - 6 Days)||0
2211636|NCT03029650|5421876|P2|COMPLETED|First Intervention (3 - 6 Days)||12
2211637|NCT03029650|5421877|P1|COMPLETED|First Intervention (3 - 6 Days)||14
2211638|NCT03029650|5421876|P2|STARTED|First Intervention (3 - 6 Days)||12
2211639|NCT03029650|5421877|P1|STARTED|First Intervention (3 - 6 Days)|More subjects not enrolled after consent in other group leaving uneven number.|14
2211640|NCT03029234|5421892|P1|NOT COMPLETED|Overall Study||67
2211641|NCT03029234|5421892|P1|COMPLETED|Overall Study||59
2211642|NCT03029234|5421892|P1|Received Carfilzomib|Overall Study||123
2211643|NCT03029234|5421892|P1|STARTED|Overall Study||126
2211644|NCT03029000|5421917|P1|NOT COMPLETED|Overall Study||0
2211645|NCT03029000|5421917|P1|COMPLETED|Overall Study||1
2211646|NCT03029000|5421917|P1|STARTED|Overall Study||1
2211647|NCT03028987|5421930|P2|NOT COMPLETED|Overall Study||0
2211648|NCT03028987|5421931|P1|NOT COMPLETED|Overall Study||0
2211649|NCT03028987|5421930|P2|COMPLETED|Overall Study||5
2211650|NCT03028987|5421931|P1|COMPLETED|Overall Study||5
2211651|NCT03028987|5421930|P2|STARTED|Overall Study||5
2211652|NCT03028987|5421931|P1|STARTED|Overall Study||5
2211653|NCT03028974|5421944|P7|NOT COMPLETED|2017-2018||0
2211654|NCT03028974|5421945|P6|NOT COMPLETED|2017-2018||0
2211655|NCT03028974|5421946|P5|NOT COMPLETED|2017-2018||0
2211656|NCT03028974|5421947|P4|NOT COMPLETED|2017-2018||0
2211657|NCT03028974|5421948|P3|NOT COMPLETED|2017-2018||0
2211658|NCT03028974|5421949|P2|NOT COMPLETED|2017-2018||0
2211659|NCT03028974|5421950|P1|NOT COMPLETED|2017-2018||0
2211660|NCT03028974|5421944|P7|COMPLETED|2017-2018||5
2211661|NCT03028974|5421945|P6|COMPLETED|2017-2018||0
2211662|NCT03028974|5421946|P5|COMPLETED|2017-2018||0
2211663|NCT03028974|5421947|P4|COMPLETED|2017-2018||5
2211664|NCT03028974|5421948|P3|COMPLETED|2017-2018||0
2211665|NCT03028974|5421949|P2|COMPLETED|2017-2018||0
2211666|NCT03028974|5421950|P1|COMPLETED|2017-2018||0
2211667|NCT03028974|5421944|P7|STARTED|2017-2018|5 new participants were enrolled.|5
2211668|NCT03028974|5421945|P6|STARTED|2017-2018||0
2211669|NCT03028974|5421946|P5|STARTED|2017-2018||0
2211670|NCT03028974|5421947|P4|STARTED|2017-2018||5
2211671|NCT03028974|5421948|P3|STARTED|2017-2018||0
2211672|NCT03028974|5421949|P2|STARTED|2017-2018||0
2211673|NCT03028974|5421950|P1|STARTED|2017-2018||0
2211674|NCT03028974|5421944|P7|NOT COMPLETED|2016-2017||0
2211675|NCT03028974|5421945|P6|NOT COMPLETED|2016-2017||0
2211676|NCT03028974|5421946|P5|NOT COMPLETED|2016-2017||0
2211677|NCT03028974|5421947|P4|NOT COMPLETED|2016-2017||0
2211678|NCT03028974|5421948|P3|NOT COMPLETED|2016-2017||0
2211679|NCT03028974|5421949|P2|NOT COMPLETED|2016-2017||0
2211680|NCT03028974|5421950|P1|NOT COMPLETED|2016-2017||0
2211681|NCT03028974|5421944|P7|COMPLETED|2016-2017|18 participants did not continue to the next period.|18
2211682|NCT03028974|5421945|P6|COMPLETED|2016-2017||0
2211683|NCT03028974|5421946|P5|COMPLETED|2016-2017|2 participants did not continue to the next period|2
2211684|NCT03028974|5421947|P4|COMPLETED|2016-2017||4
2211685|NCT03028974|5421948|P3|COMPLETED|2016-2017||0
2211686|NCT03028974|5421949|P2|COMPLETED|2016-2017||0
2211687|NCT03028974|5421950|P1|COMPLETED|2016-2017||0
2211688|NCT03028974|5421944|P7|STARTED|2016-2017|18 new participants were enrolled.|18
2211689|NCT03028974|5421945|P6|STARTED|2016-2017||0
2211690|NCT03028974|5421946|P5|STARTED|2016-2017|2 new participants were enrolled.|2
2211691|NCT03028974|5421947|P4|STARTED|2016-2017|1 new participant was enrolled.|4
2211692|NCT03028974|5421948|P3|STARTED|2016-2017||0
2211693|NCT03028974|5421949|P2|STARTED|2016-2017||0
2211694|NCT03028974|5421950|P1|STARTED|2016-2017||0
2211695|NCT03028974|5421944|P7|NOT COMPLETED|2015-2016||0
2211696|NCT03028974|5421945|P6|NOT COMPLETED|2015-2016||0
2211697|NCT03028974|5421946|P5|NOT COMPLETED|2015-2016||0
2211698|NCT03028974|5421947|P4|NOT COMPLETED|2015-2016||0
2211699|NCT03028974|5421948|P3|NOT COMPLETED|2015-2016||0
2211700|NCT03028974|5421949|P2|NOT COMPLETED|2015-2016||0
2211701|NCT03028974|5421950|P1|NOT COMPLETED|2015-2016||0
2211702|NCT03028974|5421944|P7|COMPLETED|2015-2016|20 participants did not continue to the next period.|20
2211703|NCT03028974|5421945|P6|COMPLETED|2015-2016|14 participants did not continue to the next period.|14
2211704|NCT03028974|5421946|P5|COMPLETED|2015-2016||0
2211705|NCT03028974|5421947|P4|COMPLETED|2015-2016|3 participants did not continue to the next period. 1 Participant returned in period 4 (2017-2018).|6
2211706|NCT03028974|5421948|P3|COMPLETED|2015-2016||0
2211707|NCT03028974|5421949|P2|COMPLETED|2015-2016||0
2211708|NCT03028974|5421950|P1|COMPLETED|2015-2016||0
2211709|NCT03028974|5421944|P7|STARTED|2015-2016|11 new participants were enrolled; 9 subjects switched from Group F.|20
2211710|NCT03028974|5421945|P6|STARTED|2015-2016|10 new participants were enrolled; 4 subjects switched from Group G.|14
2211711|NCT03028974|5421946|P5|STARTED|2015-2016||0
2211712|NCT03028974|5421947|P4|STARTED|2015-2016|One participant joined from Group A, 2 new were enrolled.|6
2211713|NCT03028974|5421948|P3|STARTED|2015-2016||0
2211714|NCT03028974|5421949|P2|STARTED|2015-2016||0
2211715|NCT03028974|5421950|P1|STARTED|2015-2016||0
2211716|NCT03028974|5421944|P7|NOT COMPLETED|2014-2015||0
2211717|NCT03028974|5421945|P6|NOT COMPLETED|2014-2015||0
2211718|NCT03028974|5421946|P5|NOT COMPLETED|2014-2015||0
2211719|NCT03028974|5421947|P4|NOT COMPLETED|2014-2015||0
2211720|NCT03028974|5421948|P3|NOT COMPLETED|2014-2015||0
2211721|NCT03028974|5421949|P2|NOT COMPLETED|2014-2015||0
2211722|NCT03028974|5421950|P1|NOT COMPLETED|2014-2015||0
2211723|NCT03028974|5421944|P7|COMPLETED|2014-2015|13 participants did not continue to the next period.|13
2211724|NCT03028974|5421945|P6|COMPLETED|2014-2015|2 participants did not continue to the next period.|11
2211725|NCT03028974|5421946|P5|COMPLETED|2014-2015||0
2211726|NCT03028974|5421947|P4|COMPLETED|2014-2015||3
2211727|NCT03028974|5421948|P3|COMPLETED|2014-2015||0
2211728|NCT03028974|5421949|P2|COMPLETED|2014-2015||0
2211729|NCT03028974|5421950|P1|COMPLETED|2014-2015||1
2211730|NCT03028974|5421944|P7|STARTED|2014-2015||13
2211731|NCT03028974|5421945|P6|STARTED|2014-2015||11
2211732|NCT03028974|5421946|P5|STARTED|2014-2015||0
2211733|NCT03028974|5421947|P4|STARTED|2014-2015||3
2211734|NCT03028974|5421948|P3|STARTED|2014-2015||0
2211735|NCT03028974|5421949|P2|STARTED|2014-2015||0
2211736|NCT03028974|5421950|P1|STARTED|2014-2015||1
2211737|NCT03028896|5421969|P2|NOT COMPLETED|Overall Study||0
2211738|NCT03028896|5421970|P1|NOT COMPLETED|Overall Study||3
2211739|NCT03028896|5421969|P2|COMPLETED|Overall Study||66
2211740|NCT03028896|5421970|P1|COMPLETED|Overall Study||63
2211741|NCT03028896|5421969|P2|STARTED|Overall Study||66
2211742|NCT03028896|5421970|P1|STARTED|Overall Study||66
2211743|NCT03028870|5421986|P4|NOT COMPLETED|Overall Study||9
2211744|NCT03028870|5421987|P3|NOT COMPLETED|Overall Study||16
2211745|NCT03028870|5421988|P2|NOT COMPLETED|Overall Study||10
2211746|NCT03028870|5421989|P1|NOT COMPLETED|Overall Study||17
2211747|NCT03028870|5421986|P4|COMPLETED|Overall Study||65
2211748|NCT03028870|5421987|P3|COMPLETED|Overall Study||60
2211749|NCT03028870|5421988|P2|COMPLETED|Overall Study||57
2211750|NCT03028870|5421989|P1|COMPLETED|Overall Study||57
2211751|NCT03028870|5421986|P4|STARTED|Overall Study||74
2211752|NCT03028870|5421987|P3|STARTED|Overall Study||76
2211753|NCT03028870|5421988|P2|STARTED|Overall Study||67
2211754|NCT03028870|5421989|P1|STARTED|Overall Study||74
2211755|NCT03028636|5422067|P1|NOT COMPLETED|Overall Study||6
2211756|NCT03028636|5422067|P1|COMPLETED|Overall Study||11
2211757|NCT03028636|5422067|P1|STARTED|Overall Study||17
2211758|NCT03028467|5422080|P4|NOT COMPLETED|Overall Study||0
2211759|NCT03028467|5422081|P3|NOT COMPLETED|Overall Study||0
2211760|NCT03028467|5422082|P2|NOT COMPLETED|Overall Study||0
2211761|NCT03028467|5422083|P1|NOT COMPLETED|Overall Study||0
2211762|NCT03028467|5422080|P4|COMPLETED|Overall Study||4
2211763|NCT03028467|5422081|P3|COMPLETED|Overall Study||4
2211764|NCT03028467|5422082|P2|COMPLETED|Overall Study||3
2211765|NCT03028467|5422083|P1|COMPLETED|Overall Study||4
2211766|NCT03028467|5422080|P4|STARTED|Overall Study||4
2211767|NCT03028467|5422081|P3|STARTED|Overall Study||4
2211768|NCT03028467|5422082|P2|STARTED|Overall Study||3
2211769|NCT03028467|5422083|P1|STARTED|Overall Study||4
2211770|NCT03028363|5422147|P2|NOT COMPLETED|Overall Study||33
2211771|NCT03028363|5422148|P1|NOT COMPLETED|Overall Study||78
2211772|NCT03028363|5422147|P2|COMPLETED|Overall Study||228
2211773|NCT03028363|5422148|P1|COMPLETED|Overall Study||420
2211774|NCT03028363|5422147|P2|STARTED|Overall Study||261
2211775|NCT03028363|5422148|P1|STARTED|Overall Study||498
2211776|NCT03028220|5422160|P2|NOT COMPLETED|Overall Study||0
2211777|NCT03028220|5422161|P1|NOT COMPLETED|Overall Study||0
2211778|NCT03028220|5422160|P2|COMPLETED|Overall Study||20
2211779|NCT03028220|5422161|P1|COMPLETED|Overall Study||20
2211780|NCT03028220|5422160|P2|STARTED|Overall Study||20
2211781|NCT03028220|5422161|P1|STARTED|Overall Study||20
2211782|NCT03028142|5422189|P6|NOT COMPLETED|Overall Study||1
2211783|NCT03028142|5422190|P5|NOT COMPLETED|Overall Study||1
2211784|NCT03028142|5422191|P4|NOT COMPLETED|Overall Study||0
2211785|NCT03028142|5422192|P3|NOT COMPLETED|Overall Study||0
2211786|NCT03028142|5422193|P2|NOT COMPLETED|Overall Study||1
2211787|NCT03028142|5422194|P1|NOT COMPLETED|Overall Study||1
2211788|NCT03028142|5422189|P6|COMPLETED|Overall Study||3
2211789|NCT03028142|5422190|P5|COMPLETED|Overall Study||5
2211790|NCT03028142|5422191|P4|COMPLETED|Overall Study||4
2211791|NCT03028142|5422192|P3|COMPLETED|Overall Study||6
2211792|NCT03028142|5422193|P2|COMPLETED|Overall Study||4
2211793|NCT03028142|5422194|P1|COMPLETED|Overall Study||4
2211794|NCT03028142|5422189|P6|STARTED|Overall Study||4
2211795|NCT03028142|5422190|P5|STARTED|Overall Study||6
2211796|NCT03028142|5422191|P4|STARTED|Overall Study||4
2211797|NCT03028142|5422192|P3|STARTED|Overall Study||6
2211798|NCT03028142|5422193|P2|STARTED|Overall Study||5
2211799|NCT03028142|5422194|P1|STARTED|Overall Study||5
2211800|NCT03028129|5422213|P2|NOT COMPLETED|Overall Study||87
2211801|NCT03028129|5422214|P1|NOT COMPLETED|Overall Study||126
2211802|NCT03028129|5422213|P2|COMPLETED|Overall Study||122
2211803|NCT03028129|5422214|P1|COMPLETED|Overall Study||132
2211804|NCT03028129|5422213|P2|STARTED|Overall Study||209
2211805|NCT03028129|5422214|P1|STARTED|Overall Study||258
2211806|NCT03028025|5422222|P2|NOT COMPLETED|Overall Study||1
2211807|NCT03028025|5422223|P1|NOT COMPLETED|Overall Study||3
2211808|NCT03028025|5422222|P2|COMPLETED|Overall Study||93
2211809|NCT03028025|5422223|P1|COMPLETED|Overall Study||87
2211810|NCT03028025|5422222|P2|STARTED|Overall Study||94
2211811|NCT03028025|5422223|P1|STARTED|Overall Study||90
2211812|NCT03027661|5422233|P2|NOT COMPLETED|Overall Study||0
2211813|NCT03027661|5422234|P1|NOT COMPLETED|Overall Study||0
2211814|NCT03027661|5422233|P2|COMPLETED|Overall Study||21
2211815|NCT03027661|5422234|P1|COMPLETED|Overall Study||20
2211816|NCT03027661|5422233|P2|STARTED|Overall Study||21
2211817|NCT03027661|5422234|P1|STARTED|Overall Study||20
2211818|NCT03026803|5422242|P1|NOT COMPLETED|Overall Study||0
2211819|NCT03026803|5422242|P1|COMPLETED|Overall Study||4
2211820|NCT03026803|5422242|P1|STARTED|Overall Study||4
2211821|NCT03026556|5422249|P3|NOT COMPLETED|Overall Study||0
2211822|NCT03026556|5422250|P2|NOT COMPLETED|Overall Study||0
2211823|NCT03026556|5422251|P1|NOT COMPLETED|Overall Study||0
2211824|NCT03026556|5422249|P3|COMPLETED|Overall Study||12594
2211825|NCT03026556|5422250|P2|COMPLETED|Overall Study||17177
2211826|NCT03026556|5422251|P1|COMPLETED|Overall Study||12763
2211827|NCT03026556|5422249|P3|STARTED|Overall Study||12594
2211828|NCT03026556|5422250|P2|STARTED|Overall Study||17177
2211829|NCT03026556|5422251|P1|STARTED|Overall Study||12763
2211830|NCT03026530|5422310|P2|NOT COMPLETED|Overall Study||29
2211831|NCT03026530|5422311|P1|NOT COMPLETED|Overall Study||21
2211832|NCT03026530|5422310|P2|COMPLETED|Overall Study||71
2211833|NCT03026530|5422311|P1|COMPLETED|Overall Study||79
2211834|NCT03026530|5422310|P2|STARTED|Overall Study||100
2211835|NCT03026530|5422311|P1|STARTED|Overall Study||100
2211836|NCT03026257|5422325|P6|NOT COMPLETED|Overall Study||0
2211837|NCT03026257|5422326|P5|NOT COMPLETED|Overall Study||1
2211838|NCT03026257|5422327|P4|NOT COMPLETED|Overall Study||1
2211839|NCT03026257|5422328|P3|NOT COMPLETED|Overall Study||0
2211840|NCT03026257|5422329|P2|NOT COMPLETED|Overall Study||1
2211841|NCT03026257|5422330|P1|NOT COMPLETED|Overall Study||6
2211842|NCT03026257|5422325|P6|COMPLETED|Overall Study||46
2211843|NCT03026257|5422326|P5|COMPLETED|Overall Study||22
2211844|NCT03026257|5422327|P4|COMPLETED|Overall Study||24
2211845|NCT03026257|5422328|P3|COMPLETED|Overall Study||34
2211846|NCT03026257|5422329|P2|COMPLETED|Overall Study||63
2211847|NCT03026257|5422330|P1|COMPLETED|Overall Study||54
2211848|NCT03026257|5422325|P6|Treated|Overall Study||47
2211849|NCT03026257|5422326|P5|Treated|Overall Study||23
2211850|NCT03026257|5422327|P4|Treated|Overall Study||24
2211851|NCT03026257|5422328|P3|Treated|Overall Study||35
2211852|NCT03026257|5422329|P2|Treated|Overall Study||65
2211853|NCT03026257|5422330|P1|Treated|Overall Study||58
2211854|NCT03026257|5422325|P6|STARTED|Overall Study||46
2211855|NCT03026257|5422326|P5|STARTED|Overall Study||23
2211856|NCT03026257|5422327|P4|STARTED|Overall Study||25
2211857|NCT03026257|5422328|P3|STARTED|Overall Study||34
2211858|NCT03026257|5422329|P2|STARTED|Overall Study||64
2211859|NCT03026257|5422330|P1|STARTED|Overall Study||60
2211860|NCT03026088|5422344|P1|NOT COMPLETED|Overall Study||20
2211861|NCT03026088|5422344|P1|COMPLETED|Overall Study||0
2211862|NCT03026088|5422344|P1|STARTED|Overall Study||20
2211863|NCT03026075|5422368|P1|NOT COMPLETED|Overall Study||1
2211864|NCT03026075|5422368|P1|COMPLETED|Overall Study||46
2211865|NCT03026075|5422368|P1|STARTED|Overall Study||47
2211866|NCT03025945|5422374|P2|NOT COMPLETED|Overall Study||0
2211867|NCT03025945|5422375|P1|NOT COMPLETED|Overall Study||0
2211868|NCT03025945|5422374|P2|COMPLETED|Overall Study||331
2211869|NCT03025945|5422375|P1|COMPLETED|Overall Study||331
2211870|NCT03025945|5422374|P2|STARTED|Overall Study||331
2211871|NCT03025945|5422375|P1|STARTED|Overall Study||331
2211872|NCT03025217|5422381|P1|NOT COMPLETED|Overall Study||4
2211873|NCT03025217|5422381|P1|COMPLETED|Overall Study||27
2211874|NCT03025217|5422381|P1|STARTED|Overall Study||31
2211875|NCT03024606|5422388|P2|NOT COMPLETED|Overall Study||10
2211876|NCT03024606|5422389|P1|NOT COMPLETED|Overall Study||9
2211877|NCT03024606|5422388|P2|COMPLETED|Overall Study||16
2211878|NCT03024606|5422389|P1|COMPLETED|Overall Study||14
2211879|NCT03024606|5422388|P2|STARTED|Overall Study||26
2211880|NCT03024606|5422389|P1|STARTED|Overall Study||23
2211881|NCT03024112|5422397|P2|NOT COMPLETED|Overall Study||0
2211882|NCT03024112|5422398|P1|NOT COMPLETED|Overall Study||7
2211883|NCT03024112|5422397|P2|COMPLETED|Overall Study||26
2211884|NCT03024112|5422398|P1|COMPLETED|Overall Study||18
2211885|NCT03024112|5422397|P2|STARTED|Overall Study||26
2211886|NCT03024112|5422398|P1|STARTED|Overall Study||25
2211887|NCT03023891|5422410|P1|NOT COMPLETED|Overall Study||0
2211888|NCT03023891|5422410|P1|COMPLETED|Overall Study||18
2211889|NCT03023891|5422410|P1|STARTED|Overall Study||18
2211890|NCT03023709|5422419|P2|NOT COMPLETED|Overall Study||0
2211891|NCT03023709|5422420|P1|NOT COMPLETED|Overall Study||0
2211892|NCT03023709|5422419|P2|COMPLETED|Overall Study||0
2211893|NCT03023709|5422420|P1|COMPLETED|Overall Study||3
2211894|NCT03023709|5422419|P2|STARTED|Overall Study||0
2211895|NCT03023709|5422420|P1|STARTED|Overall Study||3
2211896|NCT03023683|5422430|P2|NOT COMPLETED|Overall Study||1
2211897|NCT03023683|5422431|P1|NOT COMPLETED|Overall Study||0
2211898|NCT03023683|5422430|P2|COMPLETED|Overall Study||17
2211899|NCT03023683|5422431|P1|COMPLETED|Overall Study||0
2211900|NCT03023683|5422430|P2|STARTED|Overall Study||18
2211901|NCT03023683|5422431|P1|STARTED|Overall Study||0
2211902|NCT03023553|5422441|P2|NOT COMPLETED|Overall Study||1
2211903|NCT03023553|5422442|P1|NOT COMPLETED|Overall Study||0
2211904|NCT03023553|5422441|P2|COMPLETED|Overall Study||8
2211905|NCT03023553|5422442|P1|COMPLETED|Overall Study||4
2211906|NCT03023553|5422441|P2|STARTED|Overall Study||9
2211907|NCT03023553|5422442|P1|STARTED|Overall Study||4
2211908|NCT03023488|5422450|P1|NOT COMPLETED|Overall Study||0
2211909|NCT03023488|5422450|P1|COMPLETED|Overall Study||46
2211910|NCT03023488|5422450|P1|STARTED|Overall Study||46
2211911|NCT03023423|5422466|P3|NOT COMPLETED|Overall Study||46
2211912|NCT03023423|5422467|P2|NOT COMPLETED|Overall Study||46
2211913|NCT03023423|5422468|P1|NOT COMPLETED|Overall Study||7
2211914|NCT03023423|5422466|P3|COMPLETED|Overall Study||0
2211915|NCT03023423|5422467|P2|COMPLETED|Overall Study||0
2211916|NCT03023423|5422468|P1|COMPLETED|Overall Study||0
2211917|NCT03023423|5422466|P3|Crossover From Atezo to Dara + Atezo|Overall Study||0
2211918|NCT03023423|5422467|P2|Crossover From Atezo to Dara + Atezo|Overall Study|Participants who met crossover eligibility criteria entered to Dara + Atezo arm.|8
2211919|NCT03023423|5422468|P1|Crossover From Atezo to Dara + Atezo|Overall Study||0
2211920|NCT03023423|5422466|P3|Treated|Overall Study||44
2211921|NCT03023423|5422467|P2|Treated|Overall Study||44
2211922|NCT03023423|5422468|P1|Treated|Overall Study||7
2211923|NCT03023423|5422466|P3|STARTED|Overall Study||46
2211924|NCT03023423|5422467|P2|STARTED|Overall Study||46
2211925|NCT03023423|5422468|P1|STARTED|Overall Study||7
2211926|NCT03023176|5422498|P1|NOT COMPLETED|Overall Study||0
2211927|NCT03023176|5422498|P1|COMPLETED|Overall Study||20
2211928|NCT03023176|5422498|P1|STARTED|Overall Study||20
2211929|NCT03023137|5422505|P2|NOT COMPLETED|Overall Study||9
2211930|NCT03023137|5422506|P1|NOT COMPLETED|Overall Study||4
2211931|NCT03023137|5422505|P2|COMPLETED|Overall Study||162
2211932|NCT03023137|5422506|P1|COMPLETED|Overall Study||174
2211933|NCT03023137|5422505|P2|STARTED|Overall Study||171
2211934|NCT03023137|5422506|P1|STARTED|Overall Study||178
2211935|NCT03022916|5422532|P4|NOT COMPLETED|Overall Study||0
2211936|NCT03022916|5422533|P3|NOT COMPLETED|Overall Study||0
2211937|NCT03022916|5422534|P2|NOT COMPLETED|Overall Study||0
2211938|NCT03022916|5422535|P1|NOT COMPLETED|Overall Study||0
2211939|NCT03022916|5422532|P4|COMPLETED|Overall Study||5
2211940|NCT03022916|5422533|P3|COMPLETED|Overall Study||5
2211941|NCT03022916|5422534|P2|COMPLETED|Overall Study||5
2211942|NCT03022916|5422535|P1|COMPLETED|Overall Study||5
2211943|NCT03022916|5422532|P4|Nail Polish, Top Coat|Overall Study||5
2211944|NCT03022916|5422533|P3|Nail Polish, Top Coat|Overall Study||5
2211945|NCT03022916|5422534|P2|Nail Polish, Top Coat|Overall Study||5
2211946|NCT03022916|5422535|P1|Nail Polish, Top Coat|Overall Study||5
2211947|NCT03022916|5422532|P4|Nail Polish, Base Coat|Overall Study||5
2211948|NCT03022916|5422533|P3|Nail Polish, Base Coat|Overall Study||5
2211949|NCT03022916|5422534|P2|Nail Polish, Base Coat|Overall Study||5
2211950|NCT03022916|5422535|P1|Nail Polish, Base Coat|Overall Study||5
2211951|NCT03022916|5422532|P4|Nail Polish|Overall Study||5
2211952|NCT03022916|5422533|P3|Nail Polish|Overall Study||5
2211953|NCT03022916|5422534|P2|Nail Polish|Overall Study||5
2211954|NCT03022916|5422535|P1|Nail Polish|Overall Study||5
2211955|NCT03022916|5422532|P4|STARTED|Overall Study||5
2211956|NCT03022916|5422533|P3|STARTED|Overall Study||5
2211957|NCT03022916|5422534|P2|STARTED|Overall Study||5
2211958|NCT03022916|5422535|P1|STARTED|Overall Study||5
2211959|NCT03022630|5422544|P2|NOT COMPLETED|Overall Study||12
2211960|NCT03022630|5422545|P1|NOT COMPLETED|Overall Study||9
2211961|NCT03022630|5422544|P2|COMPLETED|Overall Study||20
2211962|NCT03022630|5422545|P1|COMPLETED|Overall Study||22
2211963|NCT03022630|5422544|P2|STARTED|Overall Study||32
2211964|NCT03022630|5422545|P1|STARTED|Overall Study||31
2211965|NCT03022435|5422598|P5|NOT COMPLETED|Overall Study||0
2211966|NCT03022435|5422599|P4|NOT COMPLETED|Overall Study||0
2211967|NCT03022435|5422600|P3|NOT COMPLETED|Overall Study||0
2211968|NCT03022435|5422601|P2|NOT COMPLETED|Overall Study||0
2211969|NCT03022435|5422602|P1|NOT COMPLETED|Overall Study||0
2211970|NCT03022435|5422598|P5|COMPLETED|Overall Study||3
2211971|NCT03022435|5422599|P4|COMPLETED|Overall Study||3
2211972|NCT03022435|5422600|P3|COMPLETED|Overall Study||6
2211973|NCT03022435|5422601|P2|COMPLETED|Overall Study||5
2211974|NCT03022435|5422602|P1|COMPLETED|Overall Study||5
2211975|NCT03022435|5422598|P5|STARTED|Overall Study||3
2211976|NCT03022435|5422599|P4|STARTED|Overall Study||3
2211977|NCT03022435|5422600|P3|STARTED|Overall Study||6
2211978|NCT03022435|5422601|P2|STARTED|Overall Study||5
2211979|NCT03022435|5422602|P1|STARTED|Overall Study||5
2211980|NCT03022422|5422625|P6|NOT COMPLETED|Overall Study||0
2211981|NCT03022422|5422626|P5|NOT COMPLETED|Overall Study||0
2211982|NCT03022422|5422627|P4|NOT COMPLETED|Overall Study||0
2211983|NCT03022422|5422628|P3|NOT COMPLETED|Overall Study||3
2211984|NCT03022422|5422629|P2|NOT COMPLETED|Overall Study||0
2211985|NCT03022422|5422630|P1|NOT COMPLETED|Overall Study||0
2211986|NCT03022422|5422625|P6|COMPLETED|Overall Study||5
2211987|NCT03022422|5422626|P5|COMPLETED|Overall Study||5
2211988|NCT03022422|5422627|P4|COMPLETED|Overall Study||12
2211989|NCT03022422|5422628|P3|COMPLETED|Overall Study||20
2211990|NCT03022422|5422629|P2|COMPLETED|Overall Study||10
2211991|NCT03022422|5422630|P1|COMPLETED|Overall Study||8
2211992|NCT03022422|5422625|P6|STARTED|Overall Study||5
2211993|NCT03022422|5422626|P5|STARTED|Overall Study||5
2211994|NCT03022422|5422627|P4|STARTED|Overall Study||12
2211995|NCT03022422|5422628|P3|STARTED|Overall Study||23
2211996|NCT03022422|5422629|P2|STARTED|Overall Study||10
2211997|NCT03022422|5422630|P1|STARTED|Overall Study||8
2211998|NCT03022396|5422656|P6|NOT COMPLETED|Overall Study||0
2211999|NCT03022396|5422657|P5|NOT COMPLETED|Overall Study||0
2212000|NCT03022396|5422658|P4|NOT COMPLETED|Overall Study||0
2212001|NCT03022396|5422659|P3|NOT COMPLETED|Overall Study||0
2212002|NCT03022396|5422660|P2|NOT COMPLETED|Overall Study||0
2212003|NCT03022396|5422661|P1|NOT COMPLETED|Overall Study||0
2212004|NCT03022396|5422656|P6|COMPLETED|Overall Study||8
2212005|NCT03022396|5422657|P5|COMPLETED|Overall Study||14
2212006|NCT03022396|5422658|P4|COMPLETED|Overall Study||20
2212007|NCT03022396|5422659|P3|COMPLETED|Overall Study||10
2212008|NCT03022396|5422660|P2|COMPLETED|Overall Study||14
2212009|NCT03022396|5422661|P1|COMPLETED|Overall Study||16
2212010|NCT03022396|5422656|P6|STARTED|Overall Study||8
2212011|NCT03022396|5422657|P5|STARTED|Overall Study||14
2212012|NCT03022396|5422658|P4|STARTED|Overall Study||20
2212013|NCT03022396|5422659|P3|STARTED|Overall Study||10
2212014|NCT03022396|5422660|P2|STARTED|Overall Study||14
2212015|NCT03022396|5422661|P1|STARTED|Overall Study||16
2212016|NCT03022045|5422683|P2|NOT COMPLETED|Overall Study||2
2212017|NCT03022045|5422684|P1|NOT COMPLETED|Overall Study||1
2212018|NCT03022045|5422683|P2|COMPLETED|Overall Study||6
2212019|NCT03022045|5422684|P1|COMPLETED|Overall Study||8
2212020|NCT03022045|5422683|P2|STARTED|Overall Study||8
2212021|NCT03022045|5422684|P1|STARTED|Overall Study||9
2212022|NCT03021759|5422701|P3|NOT COMPLETED|Overall Study||0
2212023|NCT03021759|5422702|P2|NOT COMPLETED|Overall Study||0
2212024|NCT03021759|5422703|P1|NOT COMPLETED|Overall Study||0
2212025|NCT03021759|5422701|P3|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1465
2212026|NCT03021759|5422702|P2|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1743
2212027|NCT03021759|5422703|P1|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1566
2212028|NCT03021759|5422701|P3|STARTED|Overall Study||1465
2212029|NCT03021759|5422702|P2|STARTED|Overall Study||1743
2212030|NCT03021759|5422703|P1|STARTED|Overall Study||1566
2212031|NCT03021668|5422713|P2|NOT COMPLETED|Overall Study||1
2212032|NCT03021668|5422714|P1|NOT COMPLETED|Overall Study||0
2212033|NCT03021668|5422713|P2|COMPLETED|Overall Study||61
2212034|NCT03021668|5422714|P1|COMPLETED|Overall Study||62
2212035|NCT03021668|5422713|P2|STARTED|Overall Study||62
2212036|NCT03021668|5422714|P1|STARTED|Overall Study||62
2212037|NCT03021642|5422726|P2|NOT COMPLETED|Treatment Period 2 (Day 22)||0
2212038|NCT03021642|5422727|P1|NOT COMPLETED|Treatment Period 2 (Day 22)||0
2212039|NCT03021642|5422726|P2|COMPLETED|Treatment Period 2 (Day 22)||11
2212040|NCT03021642|5422727|P1|COMPLETED|Treatment Period 2 (Day 22)||11
2212041|NCT03021642|5422726|P2|STARTED|Treatment Period 2 (Day 22)||11
2212042|NCT03021642|5422727|P1|STARTED|Treatment Period 2 (Day 22)||11
2212043|NCT03021642|5422726|P2|NOT COMPLETED|Washout Period (21 Days)||1
2212044|NCT03021642|5422727|P1|NOT COMPLETED|Washout Period (21 Days)||1
2212045|NCT03021642|5422726|P2|COMPLETED|Washout Period (21 Days)||11
2212046|NCT03021642|5422727|P1|COMPLETED|Washout Period (21 Days)||11
2212047|NCT03021642|5422726|P2|STARTED|Washout Period (21 Days)||12
2212048|NCT03021642|5422727|P1|STARTED|Washout Period (21 Days)||12
2212049|NCT03021642|5422726|P2|NOT COMPLETED|Treatment Period 1 (Day 1)||0
2212050|NCT03021642|5422727|P1|NOT COMPLETED|Treatment Period 1 (Day 1)||0
2212051|NCT03021642|5422726|P2|COMPLETED|Treatment Period 1 (Day 1)||12
2212052|NCT03021642|5422727|P1|COMPLETED|Treatment Period 1 (Day 1)||12
2212053|NCT03021642|5422726|P2|STARTED|Treatment Period 1 (Day 1)||12
2212054|NCT03021642|5422727|P1|STARTED|Treatment Period 1 (Day 1)||12
2212055|NCT03021343|5422767|P2|NOT COMPLETED|Overall Study||7
2212056|NCT03021343|5422768|P1|NOT COMPLETED|Overall Study||5
2212057|NCT03021343|5422767|P2|COMPLETED|Overall Study||174
2212058|NCT03021343|5422768|P1|COMPLETED|Overall Study||174
2212059|NCT03021343|5422767|P2|STARTED|Overall Study||181
2212060|NCT03021343|5422768|P1|STARTED|Overall Study||179
2212061|NCT03021304|5422776|P1|NOT COMPLETED|Overall Study||1
2212062|NCT03021304|5422776|P1|COMPLETED|Overall Study||55
2212063|NCT03021304|5422776|P1|STARTED|Overall Study||56
2212064|NCT03021187|5422785|P4|NOT COMPLETED|Overall Study||9
2212065|NCT03021187|5422786|P3|NOT COMPLETED|Overall Study||6
2212066|NCT03021187|5422787|P2|NOT COMPLETED|Overall Study||9
2212067|NCT03021187|5422788|P1|NOT COMPLETED|Overall Study||10
2212068|NCT03021187|5422785|P4|COMPLETED|Overall Study||175
2212069|NCT03021187|5422786|P3|COMPLETED|Overall Study||175
2212070|NCT03021187|5422787|P2|COMPLETED|Overall Study||173
2212071|NCT03021187|5422788|P1|COMPLETED|Overall Study||174
2212072|NCT03021187|5422785|P4|Safety Analysis Set (SAS)|Overall Study||184
2212073|NCT03021187|5422786|P3|Safety Analysis Set (SAS)|Overall Study||181
2212074|NCT03021187|5422787|P2|Safety Analysis Set (SAS)|Overall Study||181
2212075|NCT03021187|5422788|P1|Safety Analysis Set (SAS)|Overall Study||184
2212076|NCT03021187|5422785|P4|Full Analysis Set (FAS)|Overall Study||184
2212077|NCT03021187|5422786|P3|Full Analysis Set (FAS)|Overall Study||181
2212078|NCT03021187|5422787|P2|Full Analysis Set (FAS)|Overall Study||182
2212079|NCT03021187|5422788|P1|Full Analysis Set (FAS)|Overall Study||184
2212080|NCT03021187|5422785|P4|Exposed|Overall Study||184
2212081|NCT03021187|5422786|P3|Exposed|Overall Study||181
2212082|NCT03021187|5422787|P2|Exposed|Overall Study||181
2212083|NCT03021187|5422788|P1|Exposed|Overall Study||184
2212084|NCT03021187|5422785|P4|STARTED|Overall Study||184
2212085|NCT03021187|5422786|P3|STARTED|Overall Study||181
2212086|NCT03021187|5422787|P2|STARTED|Overall Study||182
2212087|NCT03021187|5422788|P1|STARTED|Overall Study||184
2212088|NCT03021018|5422944|P3|NOT COMPLETED|Overall Study||0
2212089|NCT03021018|5422945|P2|NOT COMPLETED|Overall Study||0
2212090|NCT03021018|5422946|P1|NOT COMPLETED|Overall Study||2
2212091|NCT03021018|5422944|P3|COMPLETED|Overall Study||15
2212092|NCT03021018|5422945|P2|COMPLETED|Overall Study||15
2212093|NCT03021018|5422946|P1|COMPLETED|Overall Study||14
2212094|NCT03021018|5422944|P3|STARTED|Overall Study||15
2212095|NCT03021018|5422945|P2|STARTED|Overall Study||15
2212096|NCT03021018|5422946|P1|STARTED|Overall Study||16
2212097|NCT03020745|5422983|P10|NOT COMPLETED|Part 2 (Up to 169 Days)||0
2212098|NCT03020745|5422984|P9|NOT COMPLETED|Part 2 (Up to 169 Days)||1
2212099|NCT03020745|5422985|P8|NOT COMPLETED|Part 2 (Up to 169 Days)||1
2212100|NCT03020745|5422986|P7|NOT COMPLETED|Part 2 (Up to 169 Days)||0
2212101|NCT03020745|5422987|P6|NOT COMPLETED|Part 2 (Up to 169 Days)||0
2212102|NCT03020745|5422988|P5|NOT COMPLETED|Part 2 (Up to 169 Days)||0
2212103|NCT03020745|5422989|P4|NOT COMPLETED|Part 2 (Up to 169 Days)||0
2212104|NCT03020745|5422990|P3|NOT COMPLETED|Part 2 (Up to 169 Days)||0
2212105|NCT03020745|5422991|P2|NOT COMPLETED|Part 2 (Up to 169 Days)||0
2212106|NCT03020745|5422992|P1|NOT COMPLETED|Part 2 (Up to 169 Days)||0
2212107|NCT03020745|5422983|P10|COMPLETED|Part 2 (Up to 169 Days)||15
2212108|NCT03020745|5422984|P9|COMPLETED|Part 2 (Up to 169 Days)||14
2212109|NCT03020745|5422985|P8|COMPLETED|Part 2 (Up to 169 Days)||19
2212110|NCT03020745|5422986|P7|COMPLETED|Part 2 (Up to 169 Days)||6
2212111|NCT03020745|5422987|P6|COMPLETED|Part 2 (Up to 169 Days)||10
2212112|NCT03020745|5422988|P5|COMPLETED|Part 2 (Up to 169 Days)||0
2212113|NCT03020745|5422989|P4|COMPLETED|Part 2 (Up to 169 Days)||0
2212114|NCT03020745|5422990|P3|COMPLETED|Part 2 (Up to 169 Days)||0
2212115|NCT03020745|5422991|P2|COMPLETED|Part 2 (Up to 169 Days)||0
2212116|NCT03020745|5422992|P1|COMPLETED|Part 2 (Up to 169 Days)||0
2212117|NCT03020745|5422983|P10|STARTED|Part 2 (Up to 169 Days)||15
2212118|NCT03020745|5422984|P9|STARTED|Part 2 (Up to 169 Days)||15
2212119|NCT03020745|5422985|P8|STARTED|Part 2 (Up to 169 Days)||20
2212120|NCT03020745|5422986|P7|STARTED|Part 2 (Up to 169 Days)||6
2212121|NCT03020745|5422987|P6|STARTED|Part 2 (Up to 169 Days)||10
2212122|NCT03020745|5422988|P5|STARTED|Part 2 (Up to 169 Days)||0
2212123|NCT03020745|5422989|P4|STARTED|Part 2 (Up to 169 Days)||0
2212124|NCT03020745|5422990|P3|STARTED|Part 2 (Up to 169 Days)||0
2212125|NCT03020745|5422991|P2|STARTED|Part 2 (Up to 169 Days)||0
2212126|NCT03020745|5422992|P1|STARTED|Part 2 (Up to 169 Days)||0
2212127|NCT03020745|5422983|P10|NOT COMPLETED|Part 1 (Up to 60 Days)||0
2212128|NCT03020745|5422984|P9|NOT COMPLETED|Part 1 (Up to 60 Days)||0
2212129|NCT03020745|5422985|P8|NOT COMPLETED|Part 1 (Up to 60 Days)||0
2212130|NCT03020745|5422986|P7|NOT COMPLETED|Part 1 (Up to 60 Days)||0
2212131|NCT03020745|5422987|P6|NOT COMPLETED|Part 1 (Up to 60 Days)||0
2212132|NCT03020745|5422988|P5|NOT COMPLETED|Part 1 (Up to 60 Days)||0
2212133|NCT03020745|5422989|P4|NOT COMPLETED|Part 1 (Up to 60 Days)||0
2212134|NCT03020745|5422990|P3|NOT COMPLETED|Part 1 (Up to 60 Days)||0
2212135|NCT03020745|5422991|P2|NOT COMPLETED|Part 1 (Up to 60 Days)||0
2212136|NCT03020745|5422992|P1|NOT COMPLETED|Part 1 (Up to 60 Days)||0
2212137|NCT03020745|5422983|P10|COMPLETED|Part 1 (Up to 60 Days)||0
2212138|NCT03020745|5422984|P9|COMPLETED|Part 1 (Up to 60 Days)||0
2212139|NCT03020745|5422985|P8|COMPLETED|Part 1 (Up to 60 Days)||0
2212140|NCT03020745|5422986|P7|COMPLETED|Part 1 (Up to 60 Days)||0
2212141|NCT03020745|5422987|P6|COMPLETED|Part 1 (Up to 60 Days)||0
2212142|NCT03020745|5422988|P5|COMPLETED|Part 1 (Up to 60 Days)||0
2212143|NCT03020745|5422989|P4|COMPLETED|Part 1 (Up to 60 Days)||6
2212144|NCT03020745|5422990|P3|COMPLETED|Part 1 (Up to 60 Days)||0
2212145|NCT03020745|5422991|P2|COMPLETED|Part 1 (Up to 60 Days)||3
2212146|NCT03020745|5422992|P1|COMPLETED|Part 1 (Up to 60 Days)||3
2212147|NCT03020745|5422983|P10|STARTED|Part 1 (Up to 60 Days)||0
2212148|NCT03020745|5422984|P9|STARTED|Part 1 (Up to 60 Days)||0
2212149|NCT03020745|5422985|P8|STARTED|Part 1 (Up to 60 Days)||0
2212150|NCT03020745|5422986|P7|STARTED|Part 1 (Up to 60 Days)||0
2212151|NCT03020745|5422987|P6|STARTED|Part 1 (Up to 60 Days)||0
2212152|NCT03020745|5422988|P5|STARTED|Part 1 (Up to 60 Days)|No participants were enrolled in this arm as per decision made by the dose escalation committee.|0
2212153|NCT03020745|5422989|P4|STARTED|Part 1 (Up to 60 Days)||6
2212154|NCT03020745|5422990|P3|STARTED|Part 1 (Up to 60 Days)|No participants were enrolled in this arm as per decision made by the dose escalation committee.|0
2212155|NCT03020745|5422991|P2|STARTED|Part 1 (Up to 60 Days)||3
2212156|NCT03020745|5422992|P1|STARTED|Part 1 (Up to 60 Days)||3
2212157|NCT03020719|5423232|P2|NOT COMPLETED|Overall Study||2
2212158|NCT03020719|5423233|P1|NOT COMPLETED|Overall Study||0
2212159|NCT03020719|5423232|P2|COMPLETED|Overall Study||28
2212160|NCT03020719|5423233|P1|COMPLETED|Overall Study||30
2212161|NCT03020719|5423232|P2|STARTED|Overall Study||30
2212162|NCT03020719|5423233|P1|STARTED|Overall Study||30
2212163|NCT03020576|5423253|P2|NOT COMPLETED|Overall Study||2
2212164|NCT03020576|5423254|P1|NOT COMPLETED|Overall Study||1
2212165|NCT03020576|5423253|P2|COMPLETED|Overall Study||14
2212166|NCT03020576|5423254|P1|COMPLETED|Overall Study||14
2212167|NCT03020576|5423253|P2|STARTED|Overall Study||16
2212168|NCT03020576|5423254|P1|STARTED|Overall Study||15
2212169|NCT03020537|5423276|P2|NOT COMPLETED|Overall Study||0
2212170|NCT03020537|5423277|P1|NOT COMPLETED|Overall Study||0
2212171|NCT03020537|5423276|P2|COMPLETED|Overall Study||7
2212172|NCT03020537|5423277|P1|COMPLETED|Overall Study||1
2212173|NCT03020537|5423276|P2|STARTED|Overall Study||7
2212174|NCT03020537|5423277|P1|STARTED|Overall Study||1
2212175|NCT03020498|5423288|P3|NOT COMPLETED|Overall Study||0
2212176|NCT03020498|5423289|P2|NOT COMPLETED|Overall Study||3
2212177|NCT03020498|5423290|P1|NOT COMPLETED|Overall Study||0
2212178|NCT03020498|5423288|P3|COMPLETED|Overall Study||36
2212179|NCT03020498|5423289|P2|COMPLETED|Overall Study||38
2212180|NCT03020498|5423290|P1|COMPLETED|Overall Study||14
2212181|NCT03020498|5423288|P3|STARTED|Overall Study||36
2212182|NCT03020498|5423289|P2|STARTED|Overall Study||41
2212183|NCT03020498|5423290|P1|STARTED|Overall Study||14
2212184|NCT03020472|5423301|P1|NOT COMPLETED|Overall Study||0
2212185|NCT03020472|5423301|P1|COMPLETED|Overall Study||6
2212186|NCT03020472|5423301|P1|STARTED|Overall Study||6
2212187|NCT03020160|5423309|P2|NOT COMPLETED|Overall Study||41
2212188|NCT03020160|5423310|P1|NOT COMPLETED|Overall Study||7
2212189|NCT03020160|5423309|P2|COMPLETED|Overall Study||0
2212190|NCT03020160|5423310|P1|COMPLETED|Overall Study||0
2212191|NCT03020160|5423309|P2|Completed 24 Weeks in the Study|Overall Study||41
2212192|NCT03020160|5423310|P1|Completed 24 Weeks in the Study|Overall Study||7
2212193|NCT03020160|5423309|P2|STARTED|Overall Study||41
2212194|NCT03020160|5423310|P1|STARTED|Overall Study||7
2212195|NCT03020004|5423363|P1|NOT COMPLETED|Overall Study||1
2212196|NCT03020004|5423363|P1|COMPLETED|Overall Study||69
2212197|NCT03020004|5423363|P1|STARTED|Overall Study||70
2212198|NCT03019783|5423369|P2|NOT COMPLETED|Overall Study||0
2212199|NCT03019783|5423370|P1|NOT COMPLETED|Overall Study||0
2212200|NCT03019783|5423369|P2|COMPLETED|Overall Study||31
2212201|NCT03019783|5423370|P1|COMPLETED|Overall Study||29
2212202|NCT03019783|5423369|P2|STARTED|Overall Study||31
2212203|NCT03019783|5423370|P1|STARTED|Overall Study||29
2212204|NCT03019744|5423380|P2|NOT COMPLETED|Overall Study||8
2212205|NCT03019744|5423381|P1|NOT COMPLETED|Overall Study||6
2212206|NCT03019744|5423380|P2|COMPLETED|Overall Study||36
2212207|NCT03019744|5423381|P1|COMPLETED|Overall Study||32
2212208|NCT03019744|5423380|P2|STARTED|Overall Study||44
2212209|NCT03019744|5423381|P1|STARTED|Overall Study||38
2212210|NCT03019627|5423397|P2|NOT COMPLETED|Overall Study||8
2212211|NCT03019627|5423398|P1|NOT COMPLETED|Overall Study||15
2212212|NCT03019627|5423397|P2|COMPLETED|Overall Study||42
2212213|NCT03019627|5423398|P1|COMPLETED|Overall Study||85
2212214|NCT03019627|5423397|P2|STARTED|Overall Study||50
2212215|NCT03019627|5423398|P1|STARTED|Overall Study||100
2212216|NCT03019549|5423414|P1|NOT COMPLETED|Period 2||5
2212217|NCT03019549|5423414|P1|COMPLETED|Period 2||26
2212218|NCT03019549|5423414|P1|Received at Least 1 Dose of Study Drug|Period 2||29
2212219|NCT03019549|5423414|P1|STARTED|Period 2||31
2212220|NCT03019549|5423414|P1|NOT COMPLETED|Washout||11
2212221|NCT03019549|5423414|P1|COMPLETED|Washout||31
2212222|NCT03019549|5423414|P1|STARTED|Washout||42
2212223|NCT03019549|5423414|P1|NOT COMPLETED|Period 1||0
2212224|NCT03019549|5423414|P1|COMPLETED|Period 1||42
2212225|NCT03019549|5423414|P1|Received 1 Dose of Study Drug|Period 1||42
2212226|NCT03019549|5423414|P1|STARTED|Period 1||42
2212227|NCT03018340|5423427|P2|NOT COMPLETED|Overall Study||30
2212228|NCT03018340|5423428|P1|NOT COMPLETED|Overall Study||8
2212229|NCT03018340|5423427|P2|COMPLETED|Overall Study||125
2212230|NCT03018340|5423428|P1|COMPLETED|Overall Study||44
2212231|NCT03018340|5423427|P2|STARTED|Overall Study||155
2212232|NCT03018340|5423428|P1|STARTED|Overall Study||52
2212233|NCT03018223|5423478|P1|NOT COMPLETED|Overall Study||0
2212234|NCT03018223|5423478|P1|COMPLETED|Overall Study||32
2212235|NCT03018223|5423478|P1|STARTED|Overall Study||32
2212236|NCT03018106|5423487|P2|NOT COMPLETED|Overall Study||1
2212237|NCT03018106|5423488|P1|NOT COMPLETED|Overall Study||0
2212238|NCT03018106|5423487|P2|COMPLETED|Overall Study||0
2212239|NCT03018106|5423488|P1|COMPLETED|Overall Study||0
2212240|NCT03018106|5423487|P2|STARTED|Overall Study||1
2212241|NCT03018106|5423488|P1|STARTED|Overall Study||0
2212242|NCT03018028|5423501|P5|NOT COMPLETED|Overall Study||0
2212243|NCT03018028|5423502|P4|NOT COMPLETED|Overall Study||2
2212244|NCT03018028|5423503|P3|NOT COMPLETED|Overall Study||1
2212245|NCT03018028|5423504|P2|NOT COMPLETED|Overall Study||0
2212246|NCT03018028|5423505|P1|NOT COMPLETED|Overall Study||3
2212247|NCT03018028|5423501|P5|COMPLETED|Overall Study||49
2212248|NCT03018028|5423502|P4|COMPLETED|Overall Study||46
2212249|NCT03018028|5423503|P3|COMPLETED|Overall Study||47
2212250|NCT03018028|5423504|P2|COMPLETED|Overall Study||49
2212251|NCT03018028|5423505|P1|COMPLETED|Overall Study||46
2212252|NCT03018028|5423501|P5|Safety Analysis Set (SAS)|Overall Study||49
2212253|NCT03018028|5423502|P4|Safety Analysis Set (SAS)|Overall Study||48
2212254|NCT03018028|5423503|P3|Safety Analysis Set (SAS)|Overall Study||48
2212255|NCT03018028|5423504|P2|Safety Analysis Set (SAS)|Overall Study||49
2212256|NCT03018028|5423505|P1|Safety Analysis Set (SAS)|Overall Study||49
2212257|NCT03018028|5423501|P5|Full Analysis Set (FAS)|Overall Study||49
2212258|NCT03018028|5423502|P4|Full Analysis Set (FAS)|Overall Study||48
2212259|NCT03018028|5423503|P3|Full Analysis Set (FAS)|Overall Study||48
2212260|NCT03018028|5423504|P2|Full Analysis Set (FAS)|Overall Study||49
2212261|NCT03018028|5423505|P1|Full Analysis Set (FAS)|Overall Study||49
2212262|NCT03018028|5423501|P5|STARTED|Overall Study||49
2212263|NCT03018028|5423502|P4|STARTED|Overall Study||48
2212264|NCT03018028|5423503|P3|STARTED|Overall Study||48
2212265|NCT03018028|5423504|P2|STARTED|Overall Study||49
2212266|NCT03018028|5423505|P1|STARTED|Overall Study||49
2212267|NCT03017846|5423750|P1|NOT COMPLETED|Overall Study||5
2212268|NCT03017846|5423750|P1|COMPLETED|Overall Study||25
2212269|NCT03017846|5423750|P1|STARTED|Overall Study||30
2212270|NCT03017612|5423758|P1|NOT COMPLETED|Overall Study||2
2212271|NCT03017612|5423758|P1|COMPLETED|Overall Study||11
2212272|NCT03017612|5423758|P1|STARTED|Overall Study||13
2212273|NCT03017235|5423768|P2|NOT COMPLETED|Overall Study||14
2212274|NCT03017235|5423769|P1|NOT COMPLETED|Overall Study||12
2212275|NCT03017235|5423768|P2|COMPLETED|Overall Study||447
2212276|NCT03017235|5423769|P1|COMPLETED|Overall Study||444
2212277|NCT03017235|5423768|P2|STARTED|Overall Study||461
2212278|NCT03017235|5423769|P1|STARTED|Overall Study||456
2212279|NCT03017040|5423819|P2|NOT COMPLETED|Overall Study||1
2212280|NCT03017040|5423820|P1|NOT COMPLETED|Overall Study||1
2212281|NCT03017040|5423819|P2|COMPLETED|Overall Study||0
2212282|NCT03017040|5423820|P1|COMPLETED|Overall Study||0
2212283|NCT03017040|5423819|P2|STARTED|Overall Study|Participants enroll one wrist into each group,thus, one participant flows into both groups.|1
2212284|NCT03017040|5423820|P1|STARTED|Overall Study|Participants enroll one wrist into each group,thus, one participant flows into both groups.|1
2212285|NCT03016078|5423830|P1|NOT COMPLETED|Overall Study||2
2212286|NCT03016078|5423830|P1|COMPLETED|Overall Study||19
2212287|NCT03016078|5423830|P1|STARTED|Overall Study||21
2212288|NCT03015220|5423845|P4|NOT COMPLETED|Overall Study||2
2212289|NCT03015220|5423846|P3|NOT COMPLETED|Overall Study||3
2212290|NCT03015220|5423847|P2|NOT COMPLETED|Overall Study||2
2212291|NCT03015220|5423848|P1|NOT COMPLETED|Overall Study||3
2212292|NCT03015220|5423845|P4|COMPLETED|Overall Study||63
2212293|NCT03015220|5423846|P3|COMPLETED|Overall Study||127
2212294|NCT03015220|5423847|P2|COMPLETED|Overall Study||130
2212295|NCT03015220|5423848|P1|COMPLETED|Overall Study||128
2212296|NCT03015220|5423845|P4|Safety Analysis Set (SAS)|Overall Study||65
2212297|NCT03015220|5423846|P3|Safety Analysis Set (SAS)|Overall Study||130
2212298|NCT03015220|5423847|P2|Safety Analysis Set (SAS)|Overall Study||132
2212299|NCT03015220|5423848|P1|Safety Analysis Set (SAS)|Overall Study||131
2212300|NCT03015220|5423845|P4|Full Analysis Set (FAS)|Overall Study||65
2212301|NCT03015220|5423846|P3|Full Analysis Set (FAS)|Overall Study||130
2212302|NCT03015220|5423847|P2|Full Analysis Set (FAS)|Overall Study||132
2212303|NCT03015220|5423848|P1|Full Analysis Set (FAS)|Overall Study||131
2212304|NCT03015220|5423845|P4|STARTED|Overall Study||65
2212305|NCT03015220|5423846|P3|STARTED|Overall Study||130
2212306|NCT03015220|5423847|P2|STARTED|Overall Study||132
2212307|NCT03015220|5423848|P1|STARTED|Overall Study||131
2212343|NCT03015142|5424110|P1|NOT COMPLETED|Overall Study||1
2212344|NCT03015142|5424110|P1|COMPLETED|Overall Study||20
2212345|NCT03015142|5424110|P1|STARTED|Overall Study||21
2212346|NCT03014700|5424125|P2|NOT COMPLETED|Overall Study||1
2212347|NCT03014700|5424126|P1|NOT COMPLETED|Overall Study||5
2212348|NCT03014700|5424125|P2|COMPLETED|Overall Study||29
2212349|NCT03014700|5424126|P1|COMPLETED|Overall Study||25
2212350|NCT03014700|5424125|P2|STARTED|Overall Study||30
2212351|NCT03014700|5424126|P1|STARTED|Overall Study||30
2212352|NCT03014674|5424145|P3|NOT COMPLETED|Overall Study||0
2212353|NCT03014674|5424146|P2|NOT COMPLETED|Overall Study||0
2212354|NCT03014674|5424147|P1|NOT COMPLETED|Overall Study||1
2212355|NCT03014674|5424145|P3|COMPLETED|Overall Study||80
2212356|NCT03014674|5424146|P2|COMPLETED|Overall Study||79
2212357|NCT03014674|5424147|P1|COMPLETED|Overall Study||84
2212358|NCT03014674|5424145|P3|STARTED|Overall Study||80
2212359|NCT03014674|5424146|P2|STARTED|Overall Study||79
2212360|NCT03014674|5424147|P1|STARTED|Overall Study||85
2212361|NCT03014479|5424211|P2|NOT COMPLETED|Overall Study||4
2212362|NCT03014479|5424212|P1|NOT COMPLETED|Overall Study||0
2212363|NCT03014479|5424211|P2|COMPLETED|Overall Study||105
2212364|NCT03014479|5424212|P1|COMPLETED|Overall Study||110
2212365|NCT03014479|5424211|P2|STARTED|Overall Study||109
2212366|NCT03014479|5424212|P1|STARTED|Overall Study||110
2212367|NCT03014206|5424258|P1|NOT COMPLETED|Overall Study||12
2212368|NCT03014206|5424258|P1|COMPLETED|Overall Study||684
2212369|NCT03014206|5424258|P1|STARTED|Overall Study||696
2212370|NCT03014180|5424262|P1|NOT COMPLETED|Overall Study||2
2212371|NCT03014180|5424262|P1|COMPLETED|Overall Study||58
2212372|NCT03014180|5424262|P1|STARTED|Overall Study||60
2212373|NCT03014011|5424271|P2|NOT COMPLETED|Second Intervention||0
2212374|NCT03014011|5424272|P1|NOT COMPLETED|Second Intervention||0
2212375|NCT03014011|5424271|P2|COMPLETED|Second Intervention||13
2212376|NCT03014011|5424272|P1|COMPLETED|Second Intervention||12
2212377|NCT03014011|5424271|P2|STARTED|Second Intervention||13
2212378|NCT03014011|5424272|P1|STARTED|Second Intervention||12
2212379|NCT03014011|5424271|P2|NOT COMPLETED|Washout||0
2212380|NCT03014011|5424272|P1|NOT COMPLETED|Washout||1
2212381|NCT03014011|5424271|P2|COMPLETED|Washout||13
2212382|NCT03014011|5424272|P1|COMPLETED|Washout||12
2212383|NCT03014011|5424271|P2|STARTED|Washout||13
2212384|NCT03014011|5424272|P1|STARTED|Washout||13
2212385|NCT03014011|5424271|P2|NOT COMPLETED|First Intervention||0
2212386|NCT03014011|5424272|P1|NOT COMPLETED|First Intervention||1
2212387|NCT03014011|5424271|P2|COMPLETED|First Intervention||13
2212388|NCT03014011|5424272|P1|COMPLETED|First Intervention||13
2212389|NCT03014011|5424271|P2|STARTED|First Intervention||13
2212390|NCT03014011|5424272|P1|STARTED|First Intervention||14
2212391|NCT03012828|5424284|P6|NOT COMPLETED|Overall Study||2
2212392|NCT03012828|5424285|P5|NOT COMPLETED|Overall Study||2
2212393|NCT03012828|5424286|P4|NOT COMPLETED|Overall Study||0
2212394|NCT03012828|5424287|P3|NOT COMPLETED|Overall Study||2
2212395|NCT03012828|5424288|P2|NOT COMPLETED|Overall Study||0
2212396|NCT03012828|5424289|P1|NOT COMPLETED|Overall Study||1
2212397|NCT03012828|5424284|P6|COMPLETED|Overall Study||8
2212398|NCT03012828|5424285|P5|COMPLETED|Overall Study||8
2212399|NCT03012828|5424286|P4|COMPLETED|Overall Study||10
2212400|NCT03012828|5424287|P3|COMPLETED|Overall Study||8
2212401|NCT03012828|5424288|P2|COMPLETED|Overall Study||10
2212402|NCT03012828|5424289|P1|COMPLETED|Overall Study||9
2212403|NCT03012828|5424284|P6|STARTED|Overall Study||10
2212404|NCT03012828|5424285|P5|STARTED|Overall Study||10
2212405|NCT03012828|5424286|P4|STARTED|Overall Study||10
2212406|NCT03012828|5424287|P3|STARTED|Overall Study||10
2212407|NCT03012828|5424288|P2|STARTED|Overall Study||10
2212408|NCT03012828|5424289|P1|STARTED|Overall Study||10
2212409|NCT03012334|5424332|P10|NOT COMPLETED|Period 5||0
2212410|NCT03012334|5424333|P9|NOT COMPLETED|Period 5||0
2212411|NCT03012334|5424334|P8|NOT COMPLETED|Period 5||0
2212412|NCT03012334|5424335|P7|NOT COMPLETED|Period 5||0
2212413|NCT03012334|5424336|P6|NOT COMPLETED|Period 5||0
2212414|NCT03012334|5424337|P5|NOT COMPLETED|Period 5||0
2212415|NCT03012334|5424338|P4|NOT COMPLETED|Period 5||0
2212416|NCT03012334|5424339|P3|NOT COMPLETED|Period 5||0
2212417|NCT03012334|5424340|P2|NOT COMPLETED|Period 5||0
2212418|NCT03012334|5424341|P1|NOT COMPLETED|Period 5||0
2212419|NCT03012334|5424332|P10|COMPLETED|Period 5||8
2212420|NCT03012334|5424333|P9|COMPLETED|Period 5||8
2212421|NCT03012334|5424334|P8|COMPLETED|Period 5||8
2212422|NCT03012334|5424335|P7|COMPLETED|Period 5||8
2212423|NCT03012334|5424336|P6|COMPLETED|Period 5||9
2212424|NCT03012334|5424337|P5|COMPLETED|Period 5||9
2212425|NCT03012334|5424338|P4|COMPLETED|Period 5||9
2212426|NCT03012334|5424339|P3|COMPLETED|Period 5||8
2212427|NCT03012334|5424340|P2|COMPLETED|Period 5||8
2212428|NCT03012334|5424341|P1|COMPLETED|Period 5||9
2212429|NCT03012334|5424332|P10|STARTED|Period 5||8
2212430|NCT03012334|5424333|P9|STARTED|Period 5||8
2212431|NCT03012334|5424334|P8|STARTED|Period 5||8
2212432|NCT03012334|5424335|P7|STARTED|Period 5||8
2212433|NCT03012334|5424336|P6|STARTED|Period 5||9
2212434|NCT03012334|5424337|P5|STARTED|Period 5||9
2212435|NCT03012334|5424338|P4|STARTED|Period 5||9
2212436|NCT03012334|5424339|P3|STARTED|Period 5||8
2212437|NCT03012334|5424340|P2|STARTED|Period 5||8
2212438|NCT03012334|5424341|P1|STARTED|Period 5||9
2212439|NCT03012334|5424332|P10|NOT COMPLETED|Period 4||0
2212440|NCT03012334|5424333|P9|NOT COMPLETED|Period 4||1
2212441|NCT03012334|5424334|P8|NOT COMPLETED|Period 4||0
2212442|NCT03012334|5424335|P7|NOT COMPLETED|Period 4||1
2212443|NCT03012334|5424336|P6|NOT COMPLETED|Period 4||0
2212444|NCT03012334|5424337|P5|NOT COMPLETED|Period 4||0
2212445|NCT03012334|5424338|P4|NOT COMPLETED|Period 4||0
2212446|NCT03012334|5424339|P3|NOT COMPLETED|Period 4||0
2212447|NCT03012334|5424340|P2|NOT COMPLETED|Period 4||0
2212448|NCT03012334|5424341|P1|NOT COMPLETED|Period 4||0
2212449|NCT03012334|5424332|P10|COMPLETED|Period 4||8
2212450|NCT03012334|5424333|P9|COMPLETED|Period 4||8
2212451|NCT03012334|5424334|P8|COMPLETED|Period 4||8
2212452|NCT03012334|5424335|P7|COMPLETED|Period 4||8
2212453|NCT03012334|5424336|P6|COMPLETED|Period 4||9
2212454|NCT03012334|5424337|P5|COMPLETED|Period 4||9
2212455|NCT03012334|5424338|P4|COMPLETED|Period 4||9
2212456|NCT03012334|5424339|P3|COMPLETED|Period 4||8
2212457|NCT03012334|5424340|P2|COMPLETED|Period 4||8
2212458|NCT03012334|5424341|P1|COMPLETED|Period 4||9
2212459|NCT03012334|5424332|P10|STARTED|Period 4||8
2212460|NCT03012334|5424333|P9|STARTED|Period 4||9
2212461|NCT03012334|5424334|P8|STARTED|Period 4||8
2212462|NCT03012334|5424335|P7|STARTED|Period 4||9
2212463|NCT03012334|5424336|P6|STARTED|Period 4||9
2212464|NCT03012334|5424337|P5|STARTED|Period 4||9
2212465|NCT03012334|5424338|P4|STARTED|Period 4||9
2212466|NCT03012334|5424339|P3|STARTED|Period 4||8
2212467|NCT03012334|5424340|P2|STARTED|Period 4||8
2212468|NCT03012334|5424341|P1|STARTED|Period 4||9
2212469|NCT03012334|5424332|P10|NOT COMPLETED|Period 3||0
2212470|NCT03012334|5424333|P9|NOT COMPLETED|Period 3||0
2212471|NCT03012334|5424334|P8|NOT COMPLETED|Period 3||0
2212472|NCT03012334|5424335|P7|NOT COMPLETED|Period 3||0
2212473|NCT03012334|5424336|P6|NOT COMPLETED|Period 3||0
2212474|NCT03012334|5424337|P5|NOT COMPLETED|Period 3||0
2212475|NCT03012334|5424338|P4|NOT COMPLETED|Period 3||0
2212476|NCT03012334|5424339|P3|NOT COMPLETED|Period 3||0
2212477|NCT03012334|5424340|P2|NOT COMPLETED|Period 3||0
2212478|NCT03012334|5424341|P1|NOT COMPLETED|Period 3||0
2212479|NCT03012334|5424332|P10|COMPLETED|Period 3||8
2212480|NCT03012334|5424333|P9|COMPLETED|Period 3||9
2212481|NCT03012334|5424334|P8|COMPLETED|Period 3||8
2212482|NCT03012334|5424335|P7|COMPLETED|Period 3||9
2212483|NCT03012334|5424336|P6|COMPLETED|Period 3||9
2212484|NCT03012334|5424337|P5|COMPLETED|Period 3||9
2212485|NCT03012334|5424338|P4|COMPLETED|Period 3||9
2212486|NCT03012334|5424339|P3|COMPLETED|Period 3||8
2212487|NCT03012334|5424340|P2|COMPLETED|Period 3||8
2212488|NCT03012334|5424341|P1|COMPLETED|Period 3||9
2212489|NCT03012334|5424332|P10|STARTED|Period 3||8
2212490|NCT03012334|5424333|P9|STARTED|Period 3||9
2212491|NCT03012334|5424334|P8|STARTED|Period 3||8
2212492|NCT03012334|5424335|P7|STARTED|Period 3||9
2212493|NCT03012334|5424336|P6|STARTED|Period 3||9
2212494|NCT03012334|5424337|P5|STARTED|Period 3||9
2212495|NCT03012334|5424338|P4|STARTED|Period 3||9
2212496|NCT03012334|5424339|P3|STARTED|Period 3||8
2212497|NCT03012334|5424340|P2|STARTED|Period 3||8
2212498|NCT03012334|5424341|P1|STARTED|Period 3||9
2212499|NCT03012334|5424332|P10|NOT COMPLETED|Period 2||0
2212500|NCT03012334|5424333|P9|NOT COMPLETED|Period 2||0
2212501|NCT03012334|5424334|P8|NOT COMPLETED|Period 2||1
2212502|NCT03012334|5424335|P7|NOT COMPLETED|Period 2||0
2212503|NCT03012334|5424336|P6|NOT COMPLETED|Period 2||0
2212504|NCT03012334|5424337|P5|NOT COMPLETED|Period 2||0
2212505|NCT03012334|5424338|P4|NOT COMPLETED|Period 2||0
2212506|NCT03012334|5424339|P3|NOT COMPLETED|Period 2||1
2212507|NCT03012334|5424340|P2|NOT COMPLETED|Period 2||1
2212508|NCT03012334|5424341|P1|NOT COMPLETED|Period 2||0
2212509|NCT03012334|5424332|P10|COMPLETED|Period 2||8
2212510|NCT03012334|5424333|P9|COMPLETED|Period 2||9
2212511|NCT03012334|5424334|P8|COMPLETED|Period 2||8
2212512|NCT03012334|5424335|P7|COMPLETED|Period 2||9
2212513|NCT03012334|5424336|P6|COMPLETED|Period 2||9
2212514|NCT03012334|5424337|P5|COMPLETED|Period 2||9
2212515|NCT03012334|5424338|P4|COMPLETED|Period 2||9
2212516|NCT03012334|5424339|P3|COMPLETED|Period 2||8
2212517|NCT03012334|5424340|P2|COMPLETED|Period 2||8
2212518|NCT03012334|5424341|P1|COMPLETED|Period 2||9
2212519|NCT03012334|5424332|P10|STARTED|Period 2||8
2212520|NCT03012334|5424333|P9|STARTED|Period 2||9
2212521|NCT03012334|5424334|P8|STARTED|Period 2||9
2212522|NCT03012334|5424335|P7|STARTED|Period 2||9
2212523|NCT03012334|5424336|P6|STARTED|Period 2||9
2212524|NCT03012334|5424337|P5|STARTED|Period 2||9
2212525|NCT03012334|5424338|P4|STARTED|Period 2||9
2212526|NCT03012334|5424339|P3|STARTED|Period 2||9
2212527|NCT03012334|5424340|P2|STARTED|Period 2||9
2212528|NCT03012334|5424341|P1|STARTED|Period 2||9
2212529|NCT03012334|5424332|P10|NOT COMPLETED|Period 1||1
2212530|NCT03012334|5424333|P9|NOT COMPLETED|Period 1||0
2212531|NCT03012334|5424334|P8|NOT COMPLETED|Period 1||0
2212532|NCT03012334|5424335|P7|NOT COMPLETED|Period 1||0
2212533|NCT03012334|5424336|P6|NOT COMPLETED|Period 1||0
2212534|NCT03012334|5424337|P5|NOT COMPLETED|Period 1||0
2212535|NCT03012334|5424338|P4|NOT COMPLETED|Period 1||0
2212536|NCT03012334|5424339|P3|NOT COMPLETED|Period 1||0
2212537|NCT03012334|5424340|P2|NOT COMPLETED|Period 1||0
2212538|NCT03012334|5424341|P1|NOT COMPLETED|Period 1||0
2212539|NCT03012334|5424332|P10|COMPLETED|Period 1||8
2212540|NCT03012334|5424333|P9|COMPLETED|Period 1||9
2212541|NCT03012334|5424334|P8|COMPLETED|Period 1||9
2212542|NCT03012334|5424335|P7|COMPLETED|Period 1||9
2212543|NCT03012334|5424336|P6|COMPLETED|Period 1||9
2212544|NCT03012334|5424337|P5|COMPLETED|Period 1||9
2212545|NCT03012334|5424338|P4|COMPLETED|Period 1||9
2212546|NCT03012334|5424339|P3|COMPLETED|Period 1||9
2212547|NCT03012334|5424340|P2|COMPLETED|Period 1||9
2212548|NCT03012334|5424341|P1|COMPLETED|Period 1||9
2212549|NCT03012334|5424332|P10|STARTED|Period 1||9
2212550|NCT03012334|5424333|P9|STARTED|Period 1||9
2212551|NCT03012334|5424334|P8|STARTED|Period 1||9
2212552|NCT03012334|5424335|P7|STARTED|Period 1||9
2212553|NCT03012334|5424336|P6|STARTED|Period 1||9
2212554|NCT03012334|5424337|P5|STARTED|Period 1||9
2212555|NCT03012334|5424338|P4|STARTED|Period 1||9
2212556|NCT03012334|5424339|P3|STARTED|Period 1||9
2212557|NCT03012334|5424340|P2|STARTED|Period 1||9
2212558|NCT03012334|5424341|P1|STARTED|Period 1||9
2212559|NCT03012191|5424391|P3|NOT COMPLETED|Overall Study||0
2212560|NCT03012191|5424392|P2|NOT COMPLETED|Overall Study||0
2212561|NCT03012191|5424393|P1|NOT COMPLETED|Overall Study||0
2212562|NCT03012191|5424391|P3|COMPLETED|Overall Study||2
2212563|NCT03012191|5424392|P2|COMPLETED|Overall Study||2
2212564|NCT03012191|5424393|P1|COMPLETED|Overall Study||2
2212565|NCT03012191|5424391|P3|STARTED|Overall Study||2
2212566|NCT03012191|5424392|P2|STARTED|Overall Study||2
2212567|NCT03012191|5424393|P1|STARTED|Overall Study||2
2212568|NCT03012061|5424411|P3|NOT COMPLETED|Overall Study||8
2212569|NCT03012061|5424412|P2|NOT COMPLETED|Overall Study||9
2212570|NCT03012061|5424413|P1|NOT COMPLETED|Overall Study||6
2212571|NCT03012061|5424411|P3|COMPLETED|Overall Study||131
2212572|NCT03012061|5424412|P2|COMPLETED|Overall Study||130
2212573|NCT03012061|5424413|P1|COMPLETED|Overall Study||137
2212574|NCT03012061|5424411|P3|STARTED|Overall Study||139
2212575|NCT03012061|5424412|P2|STARTED|Overall Study||139
2212576|NCT03012061|5424413|P1|STARTED|Overall Study||143
2212577|NCT03011840|5424438|P2|NOT COMPLETED|Overall Study||21
2212578|NCT03011840|5424439|P1|NOT COMPLETED|Overall Study||0
2212579|NCT03011840|5424438|P2|COMPLETED|Overall Study||196
2212580|NCT03011840|5424439|P1|COMPLETED|Overall Study||232
2212581|NCT03011840|5424438|P2|STARTED|Overall Study||217
2212582|NCT03011840|5424439|P1|STARTED|Overall Study||232
2212583|NCT03011099|5424449|P2|NOT COMPLETED|Overall Study||2
2212584|NCT03011099|5424450|P1|NOT COMPLETED|Overall Study||0
2212585|NCT03011099|5424449|P2|COMPLETED|Overall Study||3
2212586|NCT03011099|5424450|P1|COMPLETED|Overall Study||6
2212587|NCT03011099|5424449|P2|STARTED|Overall Study||5
2212588|NCT03011099|5424450|P1|STARTED|Overall Study||6
2212589|NCT03010800|5424476|P2|NOT COMPLETED|Cross Over||0
2212590|NCT03010800|5424477|P1|NOT COMPLETED|Cross Over||0
2212591|NCT03010800|5424476|P2|COMPLETED|Cross Over||4
2212592|NCT03010800|5424477|P1|COMPLETED|Cross Over||4
2212593|NCT03010800|5424476|P2|STARTED|Cross Over||4
2212594|NCT03010800|5424477|P1|STARTED|Cross Over||4
2212595|NCT03010800|5424476|P2|NOT COMPLETED|Initial Assignment||0
2212596|NCT03010800|5424477|P1|NOT COMPLETED|Initial Assignment||0
2212597|NCT03010800|5424476|P2|COMPLETED|Initial Assignment||4
2212598|NCT03010800|5424477|P1|COMPLETED|Initial Assignment||4
2212599|NCT03010800|5424476|P2|STARTED|Initial Assignment||4
2212600|NCT03010800|5424477|P1|STARTED|Initial Assignment||4
2212601|NCT03010501|5424483|P6|NOT COMPLETED|Study Week 3||0
2212602|NCT03010501|5424484|P5|NOT COMPLETED|Study Week 3||0
2212603|NCT03010501|5424485|P4|NOT COMPLETED|Study Week 3||1
2212604|NCT03010501|5424486|P3|NOT COMPLETED|Study Week 3||0
2212605|NCT03010501|5424487|P2|NOT COMPLETED|Study Week 3||0
2212606|NCT03010501|5424488|P1|NOT COMPLETED|Study Week 3||0
2212607|NCT03010501|5424483|P6|COMPLETED|Study Week 3||11
2212608|NCT03010501|5424484|P5|COMPLETED|Study Week 3||7
2212609|NCT03010501|5424485|P4|COMPLETED|Study Week 3||4
2212610|NCT03010501|5424486|P3|COMPLETED|Study Week 3||7
2212611|NCT03010501|5424487|P2|COMPLETED|Study Week 3||14
2212612|NCT03010501|5424488|P1|COMPLETED|Study Week 3||7
2212613|NCT03010501|5424483|P6|STARTED|Study Week 3||11
2212614|NCT03010501|5424484|P5|STARTED|Study Week 3||7
2212615|NCT03010501|5424485|P4|STARTED|Study Week 3||5
2212616|NCT03010501|5424486|P3|STARTED|Study Week 3||7
2212617|NCT03010501|5424487|P2|STARTED|Study Week 3||14
2212618|NCT03010501|5424488|P1|STARTED|Study Week 3||7
2212619|NCT03010501|5424483|P6|NOT COMPLETED|Study Week 2||0
2212620|NCT03010501|5424484|P5|NOT COMPLETED|Study Week 2||0
2212621|NCT03010501|5424485|P4|NOT COMPLETED|Study Week 2||0
2212622|NCT03010501|5424486|P3|NOT COMPLETED|Study Week 2||0
2212623|NCT03010501|5424487|P2|NOT COMPLETED|Study Week 2||0
2212624|NCT03010501|5424488|P1|NOT COMPLETED|Study Week 2||0
2212625|NCT03010501|5424483|P6|COMPLETED|Study Week 2||11
2212626|NCT03010501|5424484|P5|COMPLETED|Study Week 2||7
2212627|NCT03010501|5424485|P4|COMPLETED|Study Week 2||5
2212628|NCT03010501|5424486|P3|COMPLETED|Study Week 2||7
2212629|NCT03010501|5424487|P2|COMPLETED|Study Week 2||14
2212630|NCT03010501|5424488|P1|COMPLETED|Study Week 2||7
2212631|NCT03010501|5424483|P6|STARTED|Study Week 2||11
2212632|NCT03010501|5424484|P5|STARTED|Study Week 2||7
2212633|NCT03010501|5424485|P4|STARTED|Study Week 2||5
2212634|NCT03010501|5424486|P3|STARTED|Study Week 2||7
2212635|NCT03010501|5424487|P2|STARTED|Study Week 2||14
2212636|NCT03010501|5424488|P1|STARTED|Study Week 2||7
2212637|NCT03010501|5424483|P6|NOT COMPLETED|Study Week 1||0
2212638|NCT03010501|5424484|P5|NOT COMPLETED|Study Week 1||0
2212639|NCT03010501|5424485|P4|NOT COMPLETED|Study Week 1||2
2212640|NCT03010501|5424486|P3|NOT COMPLETED|Study Week 1||0
2212641|NCT03010501|5424487|P2|NOT COMPLETED|Study Week 1||1
2212642|NCT03010501|5424488|P1|NOT COMPLETED|Study Week 1||2
2212643|NCT03010501|5424483|P6|COMPLETED|Study Week 1||11
2212644|NCT03010501|5424484|P5|COMPLETED|Study Week 1||7
2212645|NCT03010501|5424485|P4|COMPLETED|Study Week 1||5
2212646|NCT03010501|5424486|P3|COMPLETED|Study Week 1||7
2212647|NCT03010501|5424487|P2|COMPLETED|Study Week 1||14
2212648|NCT03010501|5424488|P1|COMPLETED|Study Week 1||7
2212649|NCT03010501|5424483|P6|STARTED|Study Week 1||11
2212650|NCT03010501|5424484|P5|STARTED|Study Week 1||7
2212651|NCT03010501|5424485|P4|STARTED|Study Week 1||7
2212652|NCT03010501|5424486|P3|STARTED|Study Week 1||7
2212653|NCT03010501|5424487|P2|STARTED|Study Week 1||15
2212654|NCT03010501|5424488|P1|STARTED|Study Week 1||9
2212655|NCT03009162|5424504|P2|NOT COMPLETED|Overall Study||0
2212656|NCT03009162|5424505|P1|NOT COMPLETED|Overall Study||0
2212657|NCT03009162|5424504|P2|COMPLETED|Overall Study||8
2212658|NCT03009162|5424505|P1|COMPLETED|Overall Study||8
2212659|NCT03009162|5424504|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
2212660|NCT03009162|5424505|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
2212661|NCT03009162|5424504|P2|STARTED|Overall Study||8
2212662|NCT03009162|5424505|P1|STARTED|Overall Study||8
2212663|NCT03008707|5424527|P2|NOT COMPLETED|Overall Study||0
2212664|NCT03008707|5424528|P1|NOT COMPLETED|Overall Study||0
2212665|NCT03008707|5424527|P2|COMPLETED|Overall Study||38
2212666|NCT03008707|5424528|P1|COMPLETED|Overall Study||28
2212667|NCT03008707|5424527|P2|STARTED|Overall Study||38
2212668|NCT03008707|5424528|P1|STARTED|Overall Study||28
2212669|NCT03008213|5424548|P1|NOT COMPLETED|Overall Study||0
2212670|NCT03008213|5424548|P1|COMPLETED|Overall Study||1
2212671|NCT03008213|5424548|P1|STARTED|Overall Study||1
2212672|NCT03008174|5424554|P2|NOT COMPLETED|Overall Study||4
2212673|NCT03008174|5424555|P1|NOT COMPLETED|Overall Study||3
2212674|NCT03008174|5424554|P2|COMPLETED|Overall Study||6
2212675|NCT03008174|5424555|P1|COMPLETED|Overall Study||7
2212676|NCT03008174|5424554|P2|STARTED|Overall Study||10
2212677|NCT03008174|5424555|P1|STARTED|Overall Study||10
2212678|NCT03007966|5424583|P2|NOT COMPLETED|Overall Study||0
2212679|NCT03007966|5424584|P1|NOT COMPLETED|Overall Study||1
2212680|NCT03007966|5424583|P2|COMPLETED|Overall Study||30
2212681|NCT03007966|5424584|P1|COMPLETED|Overall Study||29
2212682|NCT03007966|5424583|P2|STARTED|Overall Study||30
2212683|NCT03007966|5424584|P1|STARTED|Overall Study||30
2212684|NCT03007719|5424616|P2|NOT COMPLETED|Overall Study||0
2212685|NCT03007719|5424617|P1|NOT COMPLETED|Overall Study||0
2212686|NCT03007719|5424616|P2|COMPLETED|Overall Study||4
2212687|NCT03007719|5424617|P1|COMPLETED|Overall Study||0
2212688|NCT03007719|5424616|P2|STARTED|Overall Study||4
2212689|NCT03007719|5424617|P1|STARTED|Overall Study||0
2212690|NCT03006341|5424629|P4|NOT COMPLETED|Overall Study||10685
2212691|NCT03006341|5424630|P3|NOT COMPLETED|Overall Study||30993
2212692|NCT03006341|5424631|P2|NOT COMPLETED|Overall Study||67505
2212693|NCT03006341|5424632|P1|NOT COMPLETED|Overall Study||25069
2212694|NCT03006341|5424629|P4|COMPLETED|Overall Study||637
2212695|NCT03006341|5424630|P3|COMPLETED|Overall Study||1602
2212696|NCT03006341|5424631|P2|COMPLETED|Overall Study||2566
2212697|NCT03006341|5424632|P1|COMPLETED|Overall Study||1130
2212698|NCT03006341|5424629|P4|STARTED|Overall Study||11322
2212699|NCT03006341|5424630|P3|STARTED|Overall Study||32595
2212700|NCT03006341|5424631|P2|STARTED|Overall Study||70071
2212701|NCT03006341|5424632|P1|STARTED|Overall Study||26199
2212702|NCT03005067|5424676|P2|NOT COMPLETED|Overall Study||7
2212703|NCT03005067|5424677|P1|NOT COMPLETED|Overall Study||10
2212704|NCT03005067|5424676|P2|COMPLETED|Overall Study||74
2212705|NCT03005067|5424677|P1|COMPLETED|Overall Study||80
2212706|NCT03005067|5424676|P2|STARTED|Overall Study||81
2212707|NCT03005067|5424677|P1|STARTED|Overall Study||90
2212708|NCT03005041|5424689|P2|NOT COMPLETED|Period 2||0
2212709|NCT03005041|5424690|P1|NOT COMPLETED|Period 2||0
2212710|NCT03005041|5424689|P2|COMPLETED|Period 2||27
2212711|NCT03005041|5424690|P1|COMPLETED|Period 2||28
2212712|NCT03005041|5424689|P2|STARTED|Period 2||27
2212713|NCT03005041|5424690|P1|STARTED|Period 2||28
2212714|NCT03005041|5424689|P2|NOT COMPLETED|Washout Period 1||0
2212715|NCT03005041|5424690|P1|NOT COMPLETED|Washout Period 1||0
2212716|NCT03005041|5424689|P2|COMPLETED|Washout Period 1||27
2212717|NCT03005041|5424690|P1|COMPLETED|Washout Period 1||28
2212718|NCT03005041|5424689|P2|STARTED|Washout Period 1||27
2212719|NCT03005041|5424690|P1|STARTED|Washout Period 1||28
2212720|NCT03005041|5424689|P2|NOT COMPLETED|Period 1||0
2212721|NCT03005041|5424690|P1|NOT COMPLETED|Period 1||0
2212722|NCT03005041|5424689|P2|COMPLETED|Period 1||27
2212723|NCT03005041|5424690|P1|COMPLETED|Period 1||28
2212724|NCT03005041|5424689|P2|STARTED|Period 1||27
2212725|NCT03005041|5424690|P1|STARTED|Period 1||28
2212726|NCT03004924|5424705|P3|NOT COMPLETED|Overall Study||28
2212727|NCT03004924|5424706|P2|NOT COMPLETED|Overall Study||14
2212728|NCT03004924|5424707|P1|NOT COMPLETED|Overall Study||27
2212729|NCT03004924|5424705|P3|COMPLETED|Overall Study||293
2212730|NCT03004924|5424706|P2|COMPLETED|Overall Study||94
2212731|NCT03004924|5424707|P1|COMPLETED|Overall Study||297
2212732|NCT03004924|5424705|P3|STARTED|Overall Study||321
2212733|NCT03004924|5424706|P2|STARTED|Overall Study||108
2212734|NCT03004924|5424707|P1|STARTED|Overall Study||324
2212735|NCT03004911|5424759|P2|NOT COMPLETED|Overall Study||3
2212736|NCT03004911|5424760|P1|NOT COMPLETED|Overall Study||1
2212737|NCT03004911|5424759|P2|COMPLETED|Overall Study||17
2212738|NCT03004911|5424760|P1|COMPLETED|Overall Study||19
2212739|NCT03004911|5424759|P2|STARTED|Overall Study||20
2212740|NCT03004911|5424760|P1|STARTED|Overall Study||20
2212741|NCT03004846|5424778|P3|NOT COMPLETED|Part B (Up to 14 Weeks)||0
2212742|NCT03004846|5424779|P2|NOT COMPLETED|Part B (Up to 14 Weeks)||0
2212743|NCT03004846|5424780|P1|NOT COMPLETED|Part B (Up to 14 Weeks)||0
2212744|NCT03004846|5424778|P3|COMPLETED|Part B (Up to 14 Weeks)||0
2212745|NCT03004846|5424779|P2|COMPLETED|Part B (Up to 14 Weeks)||0
2212746|NCT03004846|5424780|P1|COMPLETED|Part B (Up to 14 Weeks)||0
2212747|NCT03004846|5424778|P3|STARTED|Part B (Up to 14 Weeks)||0
2212748|NCT03004846|5424779|P2|STARTED|Part B (Up to 14 Weeks)||0
2212749|NCT03004846|5424780|P1|STARTED|Part B (Up to 14 Weeks)||0
2212750|NCT03004846|5424778|P3|NOT COMPLETED|Part A (Up to 14 Weeks)||0
2212751|NCT03004846|5424779|P2|NOT COMPLETED|Part A (Up to 14 Weeks)||0
2212752|NCT03004846|5424780|P1|NOT COMPLETED|Part A (Up to 14 Weeks)||0
2212753|NCT03004846|5424778|P3|COMPLETED|Part A (Up to 14 Weeks)||0
2212754|NCT03004846|5424779|P2|COMPLETED|Part A (Up to 14 Weeks)||0
2212755|NCT03004846|5424780|P1|COMPLETED|Part A (Up to 14 Weeks)||8
2212756|NCT03004846|5424778|P3|STARTED|Part A (Up to 14 Weeks)||0
2212757|NCT03004846|5424779|P2|STARTED|Part A (Up to 14 Weeks)||0
2212758|NCT03004846|5424780|P1|STARTED|Part A (Up to 14 Weeks)||8
2212759|NCT03004638|5424832|P6|NOT COMPLETED|Overall Study||0
2212760|NCT03004638|5424833|P5|NOT COMPLETED|Overall Study||0
2212761|NCT03004638|5424834|P4|NOT COMPLETED|Overall Study||0
2212762|NCT03004638|5424835|P3|NOT COMPLETED|Overall Study||0
2212763|NCT03004638|5424836|P2|NOT COMPLETED|Overall Study||0
2212764|NCT03004638|5424837|P1|NOT COMPLETED|Overall Study||0
2212765|NCT03004638|5424832|P6|COMPLETED|Overall Study||7
2212766|NCT03004638|5424833|P5|COMPLETED|Overall Study||1
2212767|NCT03004638|5424834|P4|COMPLETED|Overall Study||6
2212768|NCT03004638|5424835|P3|COMPLETED|Overall Study||6
2212769|NCT03004638|5424836|P2|COMPLETED|Overall Study||6
2212770|NCT03004638|5424837|P1|COMPLETED|Overall Study||6
2212771|NCT03004638|5424832|P6|STARTED|Overall Study||7
2212772|NCT03004638|5424833|P5|STARTED|Overall Study||1
2212773|NCT03004638|5424834|P4|STARTED|Overall Study||6
2212774|NCT03004638|5424835|P3|STARTED|Overall Study||6
2212775|NCT03004638|5424836|P2|STARTED|Overall Study||6
2212776|NCT03004638|5424837|P1|STARTED|Overall Study||6
2212777|NCT03004469|5424946|P3|NOT COMPLETED|Overall Study||25
2212778|NCT03004469|5424947|P2|NOT COMPLETED|Overall Study||49
2212779|NCT03004469|5424948|P1|NOT COMPLETED|Overall Study||61
2212780|NCT03004469|5424946|P3|COMPLETED|Overall Study||60
2212781|NCT03004469|5424947|P2|COMPLETED|Overall Study||135
2212782|NCT03004469|5424948|P1|COMPLETED|Overall Study||128
2212783|NCT03004469|5424946|P3|STARTED|Overall Study||85
2212784|NCT03004469|5424947|P2|STARTED|Overall Study||184
2212785|NCT03004469|5424948|P1|STARTED|Overall Study||189
2212786|NCT03003793|5424982|P2|NOT COMPLETED|Overall Study||0
2212787|NCT03003793|5424983|P1|NOT COMPLETED|Overall Study||0
2212788|NCT03003793|5424982|P2|COMPLETED|Overall Study||16
2212789|NCT03003793|5424983|P1|COMPLETED|Overall Study||16
2212790|NCT03003793|5424982|P2|STARTED|Overall Study||16
2212791|NCT03003793|5424983|P1|STARTED|Overall Study||16
2212792|NCT03003520|5424991|P2|NOT COMPLETED|Follow-up||3
2212793|NCT03003520|5424992|P1|NOT COMPLETED|Follow-up||14
2212794|NCT03003520|5424991|P2|COMPLETED|Follow-up||0
2212795|NCT03003520|5424992|P1|COMPLETED|Follow-up||0
2212796|NCT03003520|5424991|P2|STARTED|Follow-up||3
2212797|NCT03003520|5424992|P1|STARTED|Follow-up||14
2212798|NCT03003520|5424991|P2|NOT COMPLETED|Consolidation||1
2212799|NCT03003520|5424992|P1|NOT COMPLETED|Consolidation||24
2212800|NCT03003520|5424991|P2|COMPLETED|Consolidation||2
2212801|NCT03003520|5424992|P1|COMPLETED|Consolidation||1
2212802|NCT03003520|5424991|P2|STARTED|Consolidation||3
2212803|NCT03003520|5424992|P1|STARTED|Consolidation||25
2212804|NCT03003520|5424991|P2|NOT COMPLETED|Induction||0
2212805|NCT03003520|5424992|P1|NOT COMPLETED|Induction||13
2212806|NCT03003520|5424991|P2|COMPLETED|Induction||3
2212807|NCT03003520|5424992|P1|COMPLETED|Induction||30
2212808|NCT03003520|5424991|P2|Efficacy Evaluable Population|Induction||3
2212809|NCT03003520|5424992|P1|Efficacy Evaluable Population|Induction||37
2212810|NCT03003520|5424991|P2|Safety Population|Induction||3
2212811|NCT03003520|5424992|P1|Safety Population|Induction||43
2212812|NCT03003520|5424991|P2|STARTED|Induction||3
2212813|NCT03003520|5424992|P1|STARTED|Induction||43
2212814|NCT03003494|5425010|P1|NOT COMPLETED|Overall Study||28
2212815|NCT03003494|5425010|P1|COMPLETED|Overall Study||278
2212816|NCT03003494|5425010|P1|STARTED|Overall Study||306
2212817|NCT03003000|5425022|P3|NOT COMPLETED|Overall Study||5
2212818|NCT03003000|5425023|P2|NOT COMPLETED|Overall Study||4
2212819|NCT03003000|5425024|P1|NOT COMPLETED|Overall Study||5
2212820|NCT03003000|5425022|P3|COMPLETED|Overall Study||251
2212821|NCT03003000|5425023|P2|COMPLETED|Overall Study||249
2212822|NCT03003000|5425024|P1|COMPLETED|Overall Study||121
2212823|NCT03003000|5425022|P3|STARTED|Overall Study||256
2212824|NCT03003000|5425023|P2|STARTED|Overall Study||253
2212825|NCT03003000|5425024|P1|STARTED|Overall Study||126
2212826|NCT03002818|5425050|P1|NOT COMPLETED|Overall Study||1
2212827|NCT03002818|5425050|P1|COMPLETED|Overall Study||40
2212828|NCT03002818|5425050|P1|STARTED|Overall Study||41
2212829|NCT03002753|5425064|P3|NOT COMPLETED|Second Randomization (Re-randomization)||0
2212830|NCT03002753|5425065|P2|NOT COMPLETED|Second Randomization (Re-randomization)||1
2212831|NCT03002753|5425066|P1|NOT COMPLETED|Second Randomization (Re-randomization)||0
2212832|NCT03002753|5425064|P3|COMPLETED|Second Randomization (Re-randomization)||0
2212833|NCT03002753|5425065|P2|COMPLETED|Second Randomization (Re-randomization)||9
2212834|NCT03002753|5425066|P1|COMPLETED|Second Randomization (Re-randomization)||11
2212835|NCT03002753|5425064|P3|STARTED|Second Randomization (Re-randomization)||0
2212836|NCT03002753|5425065|P2|STARTED|Second Randomization (Re-randomization)||10
2212837|NCT03002753|5425066|P1|STARTED|Second Randomization (Re-randomization)||11
2212838|NCT03002753|5425064|P3|NOT COMPLETED|First Randomization||0
2212839|NCT03002753|5425065|P2|NOT COMPLETED|First Randomization||1
2212840|NCT03002753|5425066|P1|NOT COMPLETED|First Randomization||1
2212841|NCT03002753|5425064|P3|COMPLETED|First Randomization||21
2212842|NCT03002753|5425065|P2|COMPLETED|First Randomization||11
2212843|NCT03002753|5425066|P1|COMPLETED|First Randomization||9
2212844|NCT03002753|5425064|P3|STARTED|First Randomization||21
2212845|NCT03002753|5425065|P2|STARTED|First Randomization||12
2212846|NCT03002753|5425066|P1|STARTED|First Randomization||10
2212847|NCT03002623|5425076|P2|NOT COMPLETED|Overall Study||1
2212848|NCT03002623|5425077|P1|NOT COMPLETED|Overall Study||2
2212849|NCT03002623|5425076|P2|COMPLETED|Overall Study||2
2212850|NCT03002623|5425077|P1|COMPLETED|Overall Study||2
2212851|NCT03002623|5425076|P2|STARTED|Overall Study||3
2212852|NCT03002623|5425077|P1|STARTED|Overall Study||4
2212853|NCT03002610|5425094|P3|NOT COMPLETED|Overall Study||13
2212854|NCT03002610|5425095|P2|NOT COMPLETED|Overall Study||25
2212855|NCT03002610|5425096|P1|NOT COMPLETED|Overall Study||6
2212856|NCT03002610|5425094|P3|COMPLETED|Overall Study||21
2212857|NCT03002610|5425095|P2|COMPLETED|Overall Study||25
2212858|NCT03002610|5425096|P1|COMPLETED|Overall Study||18
2212859|NCT03002610|5425094|P3|STARTED|Overall Study||34
2212860|NCT03002610|5425095|P2|STARTED|Overall Study||50
2212861|NCT03002610|5425096|P1|STARTED|Overall Study||24
2212862|NCT03002454|5425113|P1|NOT COMPLETED|Overall Study||0
2212863|NCT03002454|5425113|P1|COMPLETED|Overall Study||4
2212864|NCT03002454|5425113|P1|STARTED|Overall Study||4
2212865|NCT03002012|5425120|P2|NOT COMPLETED|Overall Study||0
2212866|NCT03002012|5425121|P1|NOT COMPLETED|Overall Study||0
2212867|NCT03002012|5425120|P2|COMPLETED|Overall Study||11
2212868|NCT03002012|5425121|P1|COMPLETED|Overall Study||11
2212869|NCT03002012|5425120|P2|STARTED|Overall Study||11
2212870|NCT03002012|5425121|P1|STARTED|Overall Study||11
2212871|NCT03001778|5425143|P2|NOT COMPLETED|Overall Study||0
2212872|NCT03001778|5425144|P1|NOT COMPLETED|Overall Study||0
2212873|NCT03001778|5425143|P2|COMPLETED|Overall Study||46
2212874|NCT03001778|5425144|P1|COMPLETED|Overall Study||21
2212875|NCT03001778|5425143|P2|STARTED|Overall Study||46
2212876|NCT03001778|5425144|P1|STARTED|Overall Study||21
2212877|NCT03001674|5425152|P2|NOT COMPLETED|Overall Study||0
2212878|NCT03001674|5425153|P1|NOT COMPLETED|Overall Study||0
2212879|NCT03001674|5425152|P2|COMPLETED|Overall Study||5
2212880|NCT03001674|5425153|P1|COMPLETED|Overall Study||10
2212881|NCT03001674|5425152|P2|STARTED|Overall Study||5
2212882|NCT03001674|5425153|P1|STARTED|Overall Study||10
2212903|NCT03001453|5425437|P2|NOT COMPLETED|Overall Study||0
2212904|NCT03001453|5425438|P1|NOT COMPLETED|Overall Study||0
2212905|NCT03001453|5425437|P2|COMPLETED|Overall Study||57
2212906|NCT03001453|5425438|P1|COMPLETED|Overall Study||50
2212907|NCT03001453|5425437|P2|STARTED|Overall Study||57
2212908|NCT03001453|5425438|P1|STARTED|Overall Study||50
2212909|NCT03001258|5425455|P3|NOT COMPLETED|Overall Study||0
2212910|NCT03001258|5425456|P2|NOT COMPLETED|Overall Study||0
2212911|NCT03001258|5425457|P1|NOT COMPLETED|Overall Study||0
2212912|NCT03001258|5425455|P3|COMPLETED|Overall Study||485
2212913|NCT03001258|5425456|P2|COMPLETED|Overall Study||751
2212914|NCT03001258|5425457|P1|COMPLETED|Overall Study||765
2212915|NCT03001258|5425455|P3|STARTED|Overall Study||485
2212916|NCT03001258|5425456|P2|STARTED|Overall Study||751
2212917|NCT03001258|5425457|P1|STARTED|Overall Study||765
2212918|NCT03001219|5425467|P2|NOT COMPLETED|Extension Period Analysis||45
2212919|NCT03001219|5425468|P1|NOT COMPLETED|Extension Period Analysis||5
2212920|NCT03001219|5425467|P2|COMPLETED|Extension Period Analysis||52
2212921|NCT03001219|5425468|P1|COMPLETED|Extension Period Analysis||4
2212922|NCT03001219|5425467|P2|STARTED|Extension Period Analysis||97
2212923|NCT03001219|5425468|P1|STARTED|Extension Period Analysis||9
2212924|NCT03001219|5425467|P2|NOT COMPLETED|Proof of Concept||7
2212925|NCT03001219|5425468|P1|NOT COMPLETED|Proof of Concept||2
2212926|NCT03001219|5425467|P2|COMPLETED|Proof of Concept||65
2212927|NCT03001219|5425468|P1|COMPLETED|Proof of Concept||35
2212928|NCT03001219|5425467|P2|STARTED|Proof of Concept||72
2212929|NCT03001219|5425468|P1|STARTED|Proof of Concept||37
2212930|NCT03000686|5425529|P4|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
2212931|NCT03000686|5425530|P3|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
2212932|NCT03000686|5425531|P2|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
2212933|NCT03000686|5425532|P1|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
2212934|NCT03000686|5425529|P4|COMPLETED|Part 2, Period 2 (1 Day)||3
2212935|NCT03000686|5425530|P3|COMPLETED|Part 2, Period 2 (1 Day)||3
2212936|NCT03000686|5425531|P2|COMPLETED|Part 2, Period 2 (1 Day)||0
2212937|NCT03000686|5425532|P1|COMPLETED|Part 2, Period 2 (1 Day)||0
2212938|NCT03000686|5425529|P4|STARTED|Part 2, Period 2 (1 Day)||3
2212939|NCT03000686|5425530|P3|STARTED|Part 2, Period 2 (1 Day)||3
2212940|NCT03000686|5425531|P2|STARTED|Part 2, Period 2 (1 Day)||0
2212941|NCT03000686|5425532|P1|STARTED|Part 2, Period 2 (1 Day)||0
2212942|NCT03000686|5425529|P4|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
2212943|NCT03000686|5425530|P3|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
2212944|NCT03000686|5425531|P2|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
2212945|NCT03000686|5425532|P1|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
2212946|NCT03000686|5425529|P4|COMPLETED|Part 2, Wash-out (Up to 14 Days)||3
2212947|NCT03000686|5425530|P3|COMPLETED|Part 2, Wash-out (Up to 14 Days)||3
2212948|NCT03000686|5425531|P2|COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
2212949|NCT03000686|5425532|P1|COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
2212950|NCT03000686|5425529|P4|STARTED|Part 2, Wash-out (Up to 14 Days)||3
2212951|NCT03000686|5425530|P3|STARTED|Part 2, Wash-out (Up to 14 Days)||3
2212952|NCT03000686|5425531|P2|STARTED|Part 2, Wash-out (Up to 14 Days)||0
2212953|NCT03000686|5425532|P1|STARTED|Part 2, Wash-out (Up to 14 Days)||0
2212954|NCT03000686|5425529|P4|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
2212955|NCT03000686|5425530|P3|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
2212956|NCT03000686|5425531|P2|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
2212957|NCT03000686|5425532|P1|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
2212958|NCT03000686|5425529|P4|COMPLETED|Part 2, Period 1 (1 Day)||3
2212959|NCT03000686|5425530|P3|COMPLETED|Part 2, Period 1 (1 Day)||3
2212960|NCT03000686|5425531|P2|COMPLETED|Part 2, Period 1 (1 Day)||0
2212961|NCT03000686|5425532|P1|COMPLETED|Part 2, Period 1 (1 Day)||0
2212962|NCT03000686|5425529|P4|STARTED|Part 2, Period 1 (1 Day)||3
2212963|NCT03000686|5425530|P3|STARTED|Part 2, Period 1 (1 Day)||3
2212964|NCT03000686|5425531|P2|STARTED|Part 2, Period 1 (1 Day)||0
2212965|NCT03000686|5425532|P1|STARTED|Part 2, Period 1 (1 Day)||0
2212966|NCT03000686|5425529|P4|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
2212967|NCT03000686|5425530|P3|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
2212968|NCT03000686|5425531|P2|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
2212969|NCT03000686|5425532|P1|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
2212970|NCT03000686|5425529|P4|COMPLETED|Part 1, Period 2 (1 Day)||0
2212971|NCT03000686|5425530|P3|COMPLETED|Part 1, Period 2 (1 Day)||0
2212972|NCT03000686|5425531|P2|COMPLETED|Part 1, Period 2 (1 Day)||5
2212973|NCT03000686|5425532|P1|COMPLETED|Part 1, Period 2 (1 Day)||5
2212974|NCT03000686|5425529|P4|STARTED|Part 1, Period 2 (1 Day)||0
2212975|NCT03000686|5425530|P3|STARTED|Part 1, Period 2 (1 Day)||0
2212976|NCT03000686|5425531|P2|STARTED|Part 1, Period 2 (1 Day)||5
2212977|NCT03000686|5425532|P1|STARTED|Part 1, Period 2 (1 Day)||5
2212978|NCT03000686|5425529|P4|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
2212979|NCT03000686|5425530|P3|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
2212980|NCT03000686|5425531|P2|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
2212981|NCT03000686|5425532|P1|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
2212982|NCT03000686|5425529|P4|COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
2212983|NCT03000686|5425530|P3|COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
2212984|NCT03000686|5425531|P2|COMPLETED|Part 1, Wash-out (Up to 14 Days)||5
2212985|NCT03000686|5425532|P1|COMPLETED|Part 1, Wash-out (Up to 14 Days)||5
2212986|NCT03000686|5425529|P4|STARTED|Part 1, Wash-out (Up to 14 Days)||0
2212987|NCT03000686|5425530|P3|STARTED|Part 1, Wash-out (Up to 14 Days)||0
2212988|NCT03000686|5425531|P2|STARTED|Part 1, Wash-out (Up to 14 Days)||5
2212989|NCT03000686|5425532|P1|STARTED|Part 1, Wash-out (Up to 14 Days)||5
2212990|NCT03000686|5425529|P4|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
2212991|NCT03000686|5425530|P3|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
2212992|NCT03000686|5425531|P2|NOT COMPLETED|Part 1, Period 1 (1 Day)||1
2212993|NCT03000686|5425532|P1|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
2212994|NCT03000686|5425529|P4|COMPLETED|Part 1, Period 1 (1 Day)||0
2212995|NCT03000686|5425530|P3|COMPLETED|Part 1, Period 1 (1 Day)||0
2212996|NCT03000686|5425531|P2|COMPLETED|Part 1, Period 1 (1 Day)||5
2212997|NCT03000686|5425532|P1|COMPLETED|Part 1, Period 1 (1 Day)||5
2212998|NCT03000686|5425529|P4|STARTED|Part 1, Period 1 (1 Day)||0
2212999|NCT03000686|5425530|P3|STARTED|Part 1, Period 1 (1 Day)||0
2213000|NCT03000686|5425531|P2|STARTED|Part 1, Period 1 (1 Day)||6
2213001|NCT03000686|5425532|P1|STARTED|Part 1, Period 1 (1 Day)||5
2213002|NCT03000608|5425600|P2|NOT COMPLETED|Overall Study||4
2213003|NCT03000608|5425601|P1|NOT COMPLETED|Overall Study||6
2213004|NCT03000608|5425600|P2|COMPLETED|Overall Study||19
2213005|NCT03000608|5425601|P1|COMPLETED|Overall Study||40
2213006|NCT03000608|5425600|P2|STARTED|Overall Study||23
2213007|NCT03000608|5425601|P1|STARTED|Overall Study||46
2213008|NCT03000452|5425609|P1|NOT COMPLETED|Follow-Up Period||7
2213009|NCT03000452|5425609|P1|COMPLETED|Follow-Up Period||10
2213010|NCT03000452|5425609|P1|STARTED|Follow-Up Period|1 participant died in Cycle 1 due to PD prior to evaluation.|17
2213011|NCT03000452|5425609|P1|NOT COMPLETED|Treatment Period||18
2213012|NCT03000452|5425609|P1|COMPLETED|Treatment Period||0
2213013|NCT03000452|5425609|P1|STARTED|Treatment Period||18
2213014|NCT03000309|5425625|P1|NOT COMPLETED|Overall Study||1
2213015|NCT03000309|5425625|P1|COMPLETED|Overall Study||19
2213016|NCT03000309|5425625|P1|STARTED|Overall Study||20
2213017|NCT03000088|5425647|P2|NOT COMPLETED|Overall Study||0
2213018|NCT03000088|5425648|P1|NOT COMPLETED|Overall Study||0
2213019|NCT03000088|5425647|P2|COMPLETED|Overall Study||70
2213020|NCT03000088|5425648|P1|COMPLETED|Overall Study||70
2213021|NCT03000088|5425647|P2|STARTED|Overall Study||70
2213022|NCT03000088|5425648|P1|STARTED|Overall Study||70
2213023|NCT03000075|5425657|P7|NOT COMPLETED|Part B||1
2213024|NCT03000075|5425658|P6|NOT COMPLETED|Part B||2
2213025|NCT03000075|5425659|P5|NOT COMPLETED|Part B||1
2213026|NCT03000075|5425660|P4|NOT COMPLETED|Part B||0
2213027|NCT03000075|5425661|P3|NOT COMPLETED|Part B||0
2213028|NCT03000075|5425662|P2|NOT COMPLETED|Part B||0
2213029|NCT03000075|5425663|P1|NOT COMPLETED|Part B||0
2213030|NCT03000075|5425657|P7|COMPLETED|Part B||54
2213031|NCT03000075|5425658|P6|COMPLETED|Part B||56
2213032|NCT03000075|5425659|P5|COMPLETED|Part B||26
2213033|NCT03000075|5425660|P4|COMPLETED|Part B||27
2213034|NCT03000075|5425661|P3|COMPLETED|Part B||0
2213035|NCT03000075|5425662|P2|COMPLETED|Part B||0
2213036|NCT03000075|5425663|P1|COMPLETED|Part B||0
2213037|NCT03000075|5425657|P7|STARTED|Part B|Participants who received risankizumab 150 mg in Part A received risankizumab 150 mg in Part B|55
2213038|NCT03000075|5425658|P6|STARTED|Part B|Participants who received risankizumab 75 mg in Part A received risankizumab 75 mg in Part B|58
2213039|NCT03000075|5425659|P5|STARTED|Part B|Participants who received placebo in Part A received risankizumab 150 mg in Part B|27
2213040|NCT03000075|5425660|P4|STARTED|Part B|Participants who received placebo in Part A received risankizumab 75 mg in Part B|27
2213041|NCT03000075|5425661|P3|STARTED|Part B||0
2213042|NCT03000075|5425662|P2|STARTED|Part B||0
2213043|NCT03000075|5425663|P1|STARTED|Part B||0
2213044|NCT03000075|5425657|P7|NOT COMPLETED|Part A||0
2213045|NCT03000075|5425658|P6|NOT COMPLETED|Part A||0
2213046|NCT03000075|5425659|P5|NOT COMPLETED|Part A||0
2213047|NCT03000075|5425660|P4|NOT COMPLETED|Part A||0
2213048|NCT03000075|5425661|P3|NOT COMPLETED|Part A||0
2213049|NCT03000075|5425662|P2|NOT COMPLETED|Part A||0
2213050|NCT03000075|5425663|P1|NOT COMPLETED|Part A||4
2213051|NCT03000075|5425657|P7|COMPLETED|Part A||0
2213052|NCT03000075|5425658|P6|COMPLETED|Part A||0
2213053|NCT03000075|5425659|P5|COMPLETED|Part A||0
2213054|NCT03000075|5425660|P4|COMPLETED|Part A||0
2213055|NCT03000075|5425661|P3|COMPLETED|Part A||55
2213056|NCT03000075|5425662|P2|COMPLETED|Part A||58
2213057|NCT03000075|5425663|P1|COMPLETED|Part A||54
2213058|NCT03000075|5425657|P7|STARTED|Part A||0
2213059|NCT03000075|5425658|P6|STARTED|Part A||0
2213060|NCT03000075|5425659|P5|STARTED|Part A||0
2213061|NCT03000075|5425660|P4|STARTED|Part A||0
2213062|NCT03000075|5425661|P3|STARTED|Part A||55
2213063|NCT03000075|5425662|P2|STARTED|Part A||58
2213064|NCT03000075|5425663|P1|STARTED|Part A||58
2213065|NCT02999763|5425707|P1|NOT COMPLETED|Overall Study||12
2213066|NCT02999763|5425707|P1|COMPLETED|Overall Study||58
2213067|NCT02999763|5425707|P1|STARTED|Overall Study||70
2213068|NCT02999672|5425716|P2|NOT COMPLETED|Overall Study||7
2213069|NCT02999672|5425717|P1|NOT COMPLETED|Overall Study||13
2213070|NCT02999672|5425716|P2|COMPLETED|Overall Study||0
2213071|NCT02999672|5425717|P1|COMPLETED|Overall Study||0
2213072|NCT02999672|5425716|P2|STARTED|Overall Study||7
2213073|NCT02999672|5425717|P1|STARTED|Overall Study||13
2213074|NCT02999633|5425733|P1|NOT COMPLETED|Overall Study||14
2213075|NCT02999633|5425733|P1|COMPLETED|Overall Study||0
2213076|NCT02999633|5425733|P1|STARTED|Overall Study||14
2213077|NCT02998996|5425747|P6|NOT COMPLETED|Overall Study||0
2213078|NCT02998996|5425748|P5|NOT COMPLETED|Overall Study||1
2213079|NCT02998996|5425749|P4|NOT COMPLETED|Overall Study||0
2213080|NCT02998996|5425750|P3|NOT COMPLETED|Overall Study||1
2213081|NCT02998996|5425751|P2|NOT COMPLETED|Overall Study||1
2213082|NCT02998996|5425752|P1|NOT COMPLETED|Overall Study||0
2213083|NCT02998996|5425747|P6|COMPLETED|Overall Study||19
2213084|NCT02998996|5425748|P5|COMPLETED|Overall Study||17
2213085|NCT02998996|5425749|P4|COMPLETED|Overall Study||18
2213086|NCT02998996|5425750|P3|COMPLETED|Overall Study||35
2213087|NCT02998996|5425751|P2|COMPLETED|Overall Study||34
2213088|NCT02998996|5425752|P1|COMPLETED|Overall Study||36
2213089|NCT02998996|5425747|P6|STARTED|Overall Study||19
2213090|NCT02998996|5425748|P5|STARTED|Overall Study||18
2213091|NCT02998996|5425749|P4|STARTED|Overall Study||18
2213092|NCT02998996|5425750|P3|STARTED|Overall Study||36
2213093|NCT02998996|5425751|P2|STARTED|Overall Study||35
2213094|NCT02998996|5425752|P1|STARTED|Overall Study||36
2213095|NCT02998684|5425772|P2|NOT COMPLETED|Overall Study||1
2213096|NCT02998684|5425773|P1|NOT COMPLETED|Overall Study||3
2213097|NCT02998684|5425772|P2|COMPLETED|Overall Study||6
2213098|NCT02998684|5425773|P1|COMPLETED|Overall Study||4
2213099|NCT02998684|5425772|P2|STARTED|Overall Study||7
2213100|NCT02998684|5425773|P1|STARTED|Overall Study||7
2213101|NCT02998671|5425786|P5|NOT COMPLETED|Period 2||0
2213102|NCT02998671|5425787|P4|NOT COMPLETED|Period 2||4
2213103|NCT02998671|5425788|P3|NOT COMPLETED|Period 2||1
2213104|NCT02998671|5425789|P2|NOT COMPLETED|Period 2||7
2213105|NCT02998671|5425790|P1|NOT COMPLETED|Period 2||3
2213106|NCT02998671|5425786|P5|COMPLETED|Period 2||0
2213107|NCT02998671|5425787|P4|COMPLETED|Period 2||4
2213108|NCT02998671|5425788|P3|COMPLETED|Period 2||5
2213109|NCT02998671|5425789|P2|COMPLETED|Period 2||3
2213110|NCT02998671|5425790|P1|COMPLETED|Period 2||14
2213111|NCT02998671|5425786|P5|STARTED|Period 2||0
2213112|NCT02998671|5425787|P4|STARTED|Period 2||8
2213113|NCT02998671|5425788|P3|STARTED|Period 2||6
2213114|NCT02998671|5425789|P2|STARTED|Period 2||10
2213115|NCT02998671|5425790|P1|STARTED|Period 2||17
2213116|NCT02998671|5425786|P5|NOT COMPLETED|Period 1||4
2213117|NCT02998671|5425787|P4|NOT COMPLETED|Period 1||0
2213118|NCT02998671|5425788|P3|NOT COMPLETED|Period 1||0
2213119|NCT02998671|5425789|P2|NOT COMPLETED|Period 1||3
2213120|NCT02998671|5425790|P1|NOT COMPLETED|Period 1||4
2213121|NCT02998671|5425786|P5|COMPLETED|Period 1||0
2213122|NCT02998671|5425787|P4|COMPLETED|Period 1||8
2213123|NCT02998671|5425788|P3|COMPLETED|Period 1||6
2213124|NCT02998671|5425789|P2|COMPLETED|Period 1||10
2213125|NCT02998671|5425790|P1|COMPLETED|Period 1||17
2213126|NCT02998671|5425786|P5|STARTED|Period 1||4
2213127|NCT02998671|5425787|P4|STARTED|Period 1||8
2213128|NCT02998671|5425788|P3|STARTED|Period 1||6
2213129|NCT02998671|5425789|P2|STARTED|Period 1||13
2213130|NCT02998671|5425790|P1|STARTED|Period 1||21
2213131|NCT02998021|5425835|P2|NOT COMPLETED|Overall Study||2
2213132|NCT02998021|5425836|P1|NOT COMPLETED|Overall Study||3
2213133|NCT02998021|5425835|P2|COMPLETED|Overall Study||0
2213134|NCT02998021|5425836|P1|COMPLETED|Overall Study||5
2213135|NCT02998021|5425835|P2|STARTED|Overall Study||2
2213136|NCT02998021|5425836|P1|STARTED|Overall Study||8
2213137|NCT02997904|5425862|P2|NOT COMPLETED|Overall Study||0
2213138|NCT02997904|5425863|P1|NOT COMPLETED|Overall Study||0
2213139|NCT02997904|5425862|P2|COMPLETED|Overall Study||49
2213140|NCT02997904|5425863|P1|COMPLETED|Overall Study||51
2213141|NCT02997904|5425862|P2|STARTED|Overall Study||49
2213142|NCT02997904|5425863|P1|STARTED|Overall Study||51
2213143|NCT02997735|5425875|P2|NOT COMPLETED|Overall Study||0
2213144|NCT02997735|5425876|P1|NOT COMPLETED|Overall Study||0
2213145|NCT02997735|5425875|P2|COMPLETED|Overall Study||251
2213146|NCT02997735|5425876|P1|COMPLETED|Overall Study||233
2213147|NCT02997735|5425875|P2|STARTED|Overall Study||251
2213148|NCT02997735|5425876|P1|STARTED|Overall Study||233
2213161|NCT02996968|5426037|P2|NOT COMPLETED|Overall Study||0
2213162|NCT02996968|5426038|P1|NOT COMPLETED|Overall Study||1
2213163|NCT02996968|5426037|P2|COMPLETED|Overall Study||79
2213164|NCT02996968|5426038|P1|COMPLETED|Overall Study||78
2213165|NCT02996968|5426037|P2|STARTED|Overall Study||79
2213166|NCT02996968|5426038|P1|STARTED|Overall Study||79
2213167|NCT02996682|5426046|P2|NOT COMPLETED|Overall Study||3
2213168|NCT02996682|5426047|P1|NOT COMPLETED|Overall Study||0
2213169|NCT02996682|5426046|P2|COMPLETED|Overall Study||48
2213170|NCT02996682|5426047|P1|COMPLETED|Overall Study||51
2213171|NCT02996682|5426046|P2|STARTED|Overall Study||51
2213172|NCT02996682|5426047|P1|STARTED|Overall Study||51
2213173|NCT02996591|5426071|P2|NOT COMPLETED|Overall Study||0
2213174|NCT02996591|5426072|P1|NOT COMPLETED|Overall Study||0
2213175|NCT02996591|5426071|P2|COMPLETED|Overall Study||18
2213176|NCT02996591|5426072|P1|COMPLETED|Overall Study||18
2213177|NCT02996591|5426071|P2|STARTED|Overall Study||18
2213178|NCT02996591|5426072|P1|STARTED|Overall Study||18
2213179|NCT02996097|5426120|P2|NOT COMPLETED|Overall Study||11
2213180|NCT02996097|5426121|P1|NOT COMPLETED|Overall Study||11
2213181|NCT02996097|5426120|P2|COMPLETED|Overall Study||19
2213182|NCT02996097|5426121|P1|COMPLETED|Overall Study||19
2213183|NCT02996097|5426120|P2|Per Protocol Population|Overall Study||22
2213184|NCT02996097|5426121|P1|Per Protocol Population|Overall Study||22
2213185|NCT02996097|5426120|P2|STARTED|Overall Study||30
2213186|NCT02996097|5426121|P1|STARTED|Overall Study||30
2213187|NCT02995980|5426128|P1|NOT COMPLETED|Overall Study||14
2213188|NCT02995980|5426128|P1|COMPLETED|Overall Study||114
2213189|NCT02995980|5426128|P1|STARTED|Overall Study||128
2213190|NCT02995967|5426139|P2|NOT COMPLETED|Overall Study||0
2213191|NCT02995967|5426140|P1|NOT COMPLETED|Overall Study||0
2213192|NCT02995967|5426139|P2|COMPLETED|Overall Study||2
2213193|NCT02995967|5426140|P1|COMPLETED|Overall Study||1
2213194|NCT02995967|5426139|P2|STARTED|Overall Study||2
2213195|NCT02995967|5426140|P1|STARTED|Overall Study||1
2213196|NCT02994979|5426166|P2|NOT COMPLETED|Overall Study||0
2213197|NCT02994979|5426167|P1|NOT COMPLETED|Overall Study||0
2213198|NCT02994979|5426166|P2|COMPLETED|Overall Study||105
2213199|NCT02994979|5426167|P1|COMPLETED|Overall Study||114
2213200|NCT02994979|5426166|P2|STARTED|Overall Study||105
2213201|NCT02994979|5426167|P1|STARTED|Overall Study||114
2213202|NCT02994732|5426179|P1|NOT COMPLETED|Overall Study||0
2213203|NCT02994732|5426179|P1|COMPLETED|Overall Study|All subjects were discharged from the clinic by Jan 24, 2017|6
2213204|NCT02994732|5426179|P1|STARTED|Overall Study|All subjects entered clinic on January 11, 2017|6
2213205|NCT02994251|5426193|P1|NOT COMPLETED|Overall Study||0
2213206|NCT02994251|5426193|P1|COMPLETED|Overall Study||0
2213207|NCT02994251|5426193|P1|STARTED|Overall Study||0
2213208|NCT02994056|5426203|P1|NOT COMPLETED|Overall Study||9
2213209|NCT02994056|5426203|P1|COMPLETED|Overall Study||23
2213210|NCT02994056|5426203|P1|STARTED|Overall Study||32
2213211|NCT02993926|5426237|P3|NOT COMPLETED|Follow-Up Phase||0
2213212|NCT02993926|5426238|P2|NOT COMPLETED|Follow-Up Phase||0
2213213|NCT02993926|5426239|P1|NOT COMPLETED|Follow-Up Phase||0
2213214|NCT02993926|5426237|P3|COMPLETED|Follow-Up Phase||26
2213215|NCT02993926|5426238|P2|COMPLETED|Follow-Up Phase||44
2213216|NCT02993926|5426239|P1|COMPLETED|Follow-Up Phase||0
2213217|NCT02993926|5426237|P3|STARTED|Follow-Up Phase||26
2213218|NCT02993926|5426238|P2|STARTED|Follow-Up Phase||44
2213219|NCT02993926|5426239|P1|STARTED|Follow-Up Phase||0
2213220|NCT02993926|5426237|P3|NOT COMPLETED|Enantone Treatment Phase||0
2213221|NCT02993926|5426238|P2|NOT COMPLETED|Enantone Treatment Phase||0
2213222|NCT02993926|5426239|P1|NOT COMPLETED|Enantone Treatment Phase||32
2213223|NCT02993926|5426237|P3|COMPLETED|Enantone Treatment Phase||0
2213224|NCT02993926|5426238|P2|COMPLETED|Enantone Treatment Phase||0
2213225|NCT02993926|5426239|P1|COMPLETED|Enantone Treatment Phase||76
2213226|NCT02993926|5426237|P3|STARTED|Enantone Treatment Phase||0
2213227|NCT02993926|5426238|P2|STARTED|Enantone Treatment Phase||0
2213228|NCT02993926|5426239|P1|STARTED|Enantone Treatment Phase||108
2213229|NCT02993783|5426271|P2|NOT COMPLETED|Overall Study||9
2213230|NCT02993783|5426272|P1|NOT COMPLETED|Overall Study||6
2213231|NCT02993783|5426271|P2|COMPLETED|Overall Study||0
2213232|NCT02993783|5426272|P1|COMPLETED|Overall Study||2
2213233|NCT02993783|5426271|P2|STARTED|Overall Study||9
2213234|NCT02993783|5426272|P1|STARTED|Overall Study||8
2213235|NCT02993471|5426302|P1|NOT COMPLETED|Period 2 (Drug Cocktail + Ixekizumab)||2
2213236|NCT02993471|5426302|P1|COMPLETED|Period 2 (Drug Cocktail + Ixekizumab)||26
2213237|NCT02993471|5426302|P1|Received at Least 1 Dose of Study Drug|Period 2 (Drug Cocktail + Ixekizumab)||27
2213238|NCT02993471|5426302|P1|STARTED|Period 2 (Drug Cocktail + Ixekizumab)||28
2213239|NCT02993471|5426302|P1|NOT COMPLETED|Period 1 (Drug Cocktail)||0
2213240|NCT02993471|5426302|P1|COMPLETED|Period 1 (Drug Cocktail)||28
2213241|NCT02993471|5426302|P1|Received at Least 1 Dose of Study Drug|Period 1 (Drug Cocktail)||28
2213242|NCT02993471|5426302|P1|STARTED|Period 1 (Drug Cocktail)||28
2213249|NCT02993250|5426353|P2|NOT COMPLETED|Overall Study||1
2213250|NCT02993250|5426354|P1|NOT COMPLETED|Overall Study||0
2213251|NCT02993250|5426353|P2|COMPLETED|Overall Study||10
2213252|NCT02993250|5426354|P1|COMPLETED|Overall Study||22
2213253|NCT02993250|5426353|P2|STARTED|Overall Study||11
2213254|NCT02993250|5426354|P1|STARTED|Overall Study||22
2213255|NCT02992691|5426374|P1|NOT COMPLETED|Overall Study||3
2213256|NCT02992691|5426374|P1|COMPLETED|Overall Study||53
2213257|NCT02992691|5426374|P1|Received Negative Control|Overall Study||55
2213258|NCT02992691|5426374|P1|Received Positive Control|Overall Study||55
2213259|NCT02992691|5426374|P1|Received Test Product 3|Overall Study||52
2213260|NCT02992691|5426374|P1|Received Test Product 2|Overall Study||55
2213261|NCT02992691|5426374|P1|Received Test Product 1|Overall Study||55
2213262|NCT02992691|5426374|P1|STARTED|Overall Study||56
2213263|NCT02992288|5426397|P6|NOT COMPLETED|Overall Study||13
2213264|NCT02992288|5426398|P5|NOT COMPLETED|Overall Study||8
2213265|NCT02992288|5426399|P4|NOT COMPLETED|Overall Study||9
2213266|NCT02992288|5426400|P3|NOT COMPLETED|Overall Study||7
2213267|NCT02992288|5426401|P2|NOT COMPLETED|Overall Study||5
2213268|NCT02992288|5426402|P1|NOT COMPLETED|Overall Study||17
2213269|NCT02992288|5426397|P6|COMPLETED|Overall Study||59
2213270|NCT02992288|5426398|P5|COMPLETED|Overall Study||61
2213271|NCT02992288|5426399|P4|COMPLETED|Overall Study||64
2213272|NCT02992288|5426400|P3|COMPLETED|Overall Study||63
2213273|NCT02992288|5426401|P2|COMPLETED|Overall Study||32
2213274|NCT02992288|5426402|P1|COMPLETED|Overall Study||89
2213275|NCT02992288|5426397|P6|Treated|Overall Study||72
2213276|NCT02992288|5426398|P5|Treated|Overall Study||69
2213277|NCT02992288|5426399|P4|Treated|Overall Study||72
2213278|NCT02992288|5426400|P3|Treated|Overall Study||70
2213279|NCT02992288|5426401|P2|Treated|Overall Study||37
2213280|NCT02992288|5426402|P1|Treated|Overall Study||106
2213281|NCT02992288|5426397|P6|STARTED|Overall Study||72
2213282|NCT02992288|5426398|P5|STARTED|Overall Study||69
2213283|NCT02992288|5426399|P4|STARTED|Overall Study||73
2213284|NCT02992288|5426400|P3|STARTED|Overall Study||70
2213285|NCT02992288|5426401|P2|STARTED|Overall Study||37
2213286|NCT02992288|5426402|P1|STARTED|Overall Study||106
2213287|NCT02992236|5426460|P2|NOT COMPLETED|Overall Study||0
2213288|NCT02992236|5426461|P1|NOT COMPLETED|Overall Study||0
2213289|NCT02992236|5426460|P2|COMPLETED|Overall Study||8
2213290|NCT02992236|5426461|P1|COMPLETED|Overall Study||8
2213291|NCT02992236|5426460|P2|STARTED|Overall Study||8
2213292|NCT02992236|5426461|P1|STARTED|Overall Study||8
2213293|NCT02992132|5426474|P3|NOT COMPLETED|Overall Study||7
2213294|NCT02992132|5426475|P2|NOT COMPLETED|Overall Study||8
2213295|NCT02992132|5426476|P1|NOT COMPLETED|Overall Study||13
2213296|NCT02992132|5426474|P3|COMPLETED|Overall Study||29
2213297|NCT02992132|5426475|P2|COMPLETED|Overall Study||27
2213298|NCT02992132|5426476|P1|COMPLETED|Overall Study||27
2213299|NCT02992132|5426474|P3|STARTED|Overall Study||36
2213300|NCT02992132|5426475|P2|STARTED|Overall Study||35
2213301|NCT02992132|5426476|P1|STARTED|Overall Study||40
2213302|NCT02992119|5426494|P7|NOT COMPLETED|Overall Study||3
2213303|NCT02992119|5426495|P6|NOT COMPLETED|Overall Study||0
2213304|NCT02992119|5426496|P5|NOT COMPLETED|Overall Study||0
2213305|NCT02992119|5426497|P4|NOT COMPLETED|Overall Study||0
2213306|NCT02992119|5426498|P3|NOT COMPLETED|Overall Study||1
2213307|NCT02992119|5426499|P2|NOT COMPLETED|Overall Study||1
2213308|NCT02992119|5426500|P1|NOT COMPLETED|Overall Study||2
2213309|NCT02992119|5426494|P7|COMPLETED|Overall Study||28
2213310|NCT02992119|5426495|P6|COMPLETED|Overall Study||30
2213311|NCT02992119|5426496|P5|COMPLETED|Overall Study||30
2213312|NCT02992119|5426497|P4|COMPLETED|Overall Study||30
2213313|NCT02992119|5426498|P3|COMPLETED|Overall Study||29
2213314|NCT02992119|5426499|P2|COMPLETED|Overall Study||20
2213315|NCT02992119|5426500|P1|COMPLETED|Overall Study||19
2213316|NCT02992119|5426494|P7|STARTED|Overall Study||31
2213317|NCT02992119|5426495|P6|STARTED|Overall Study||30
2213318|NCT02992119|5426496|P5|STARTED|Overall Study||30
2213319|NCT02992119|5426497|P4|STARTED|Overall Study||30
2213320|NCT02992119|5426498|P3|STARTED|Overall Study||30
2213321|NCT02992119|5426499|P2|STARTED|Overall Study||21
2213322|NCT02992119|5426500|P1|STARTED|Overall Study||21
2213323|NCT02992067|5426551|P1|NOT COMPLETED|Overall Study||0
2213324|NCT02992067|5426551|P1|COMPLETED|Overall Study||359
2213325|NCT02992067|5426551|P1|STARTED|Overall Study||359
2213326|NCT02991820|5426557|P2|NOT COMPLETED|Overall Study||0
2213327|NCT02991820|5426558|P1|NOT COMPLETED|Overall Study||0
2213328|NCT02991820|5426557|P2|COMPLETED|Overall Study||31
2213329|NCT02991820|5426558|P1|COMPLETED|Overall Study||12
2213330|NCT02991820|5426557|P2|STARTED|Overall Study||31
2213331|NCT02991820|5426558|P1|STARTED|Overall Study||12
2213332|NCT02991729|5426568|P2|NOT COMPLETED|Overall Study||0
2213333|NCT02991729|5426569|P1|NOT COMPLETED|Overall Study||0
2213334|NCT02991729|5426568|P2|COMPLETED|Overall Study||92
2213335|NCT02991729|5426569|P1|COMPLETED|Overall Study||105
2213336|NCT02991729|5426568|P2|STARTED|Overall Study||92
2213337|NCT02991729|5426569|P1|STARTED|Overall Study||105
2213338|NCT02991599|5426583|P2|NOT COMPLETED|Overall Study||37
2213339|NCT02991599|5426584|P1|NOT COMPLETED|Overall Study||38
2213340|NCT02991599|5426583|P2|COMPLETED|Overall Study||61
2213341|NCT02991599|5426584|P1|COMPLETED|Overall Study||60
2213342|NCT02991599|5426583|P2|STARTED|Overall Study||98
2213343|NCT02991599|5426584|P1|STARTED|Overall Study||98
2213344|NCT02991430|5426607|P3|NOT COMPLETED|Post-treatment Observation Period||5
2213345|NCT02991430|5426608|P2|NOT COMPLETED|Post-treatment Observation Period||6
2213346|NCT02991430|5426609|P1|NOT COMPLETED|Post-treatment Observation Period||3
2213347|NCT02991430|5426607|P3|COMPLETED|Post-treatment Observation Period||5
2213348|NCT02991430|5426608|P2|COMPLETED|Post-treatment Observation Period||2
2213349|NCT02991430|5426609|P1|COMPLETED|Post-treatment Observation Period||4
2213350|NCT02991430|5426607|P3|STARTED|Post-treatment Observation Period||10
2213351|NCT02991430|5426608|P2|STARTED|Post-treatment Observation Period||8
2213352|NCT02991430|5426609|P1|STARTED|Post-treatment Observation Period||7
2213353|NCT02991430|5426607|P3|NOT COMPLETED|Treatment Period 2||4
2213354|NCT02991430|5426608|P2|NOT COMPLETED|Treatment Period 2||3
2213355|NCT02991430|5426609|P1|NOT COMPLETED|Treatment Period 2||6
2213356|NCT02991430|5426607|P3|COMPLETED|Treatment Period 2||10
2213357|NCT02991430|5426608|P2|COMPLETED|Treatment Period 2||8
2213358|NCT02991430|5426609|P1|COMPLETED|Treatment Period 2||7
2213359|NCT02991430|5426607|P3|STARTED|Treatment Period 2||14
2213360|NCT02991430|5426608|P2|STARTED|Treatment Period 2||11
2213361|NCT02991430|5426609|P1|STARTED|Treatment Period 2||13
2213362|NCT02991430|5426607|P3|NOT COMPLETED|Treatment Period 1||2
2213363|NCT02991430|5426608|P2|NOT COMPLETED|Treatment Period 1||4
2213364|NCT02991430|5426609|P1|NOT COMPLETED|Treatment Period 1||1
2213365|NCT02991430|5426607|P3|COMPLETED|Treatment Period 1||14
2213366|NCT02991430|5426608|P2|COMPLETED|Treatment Period 1||11
2213367|NCT02991430|5426609|P1|COMPLETED|Treatment Period 1||13
2213368|NCT02991430|5426607|P3|STARTED|Treatment Period 1||16
2213369|NCT02991430|5426608|P2|STARTED|Treatment Period 1||15
2213370|NCT02991430|5426609|P1|STARTED|Treatment Period 1||14
2213371|NCT02991040|5426644|P1|NOT COMPLETED|Overall Study||4
2213372|NCT02991040|5426644|P1|COMPLETED|Overall Study||96
2213373|NCT02991040|5426644|P1|STARTED|Overall Study||100
2213374|NCT02990910|5426659|P2|NOT COMPLETED|Overall Study||10
2213375|NCT02990910|5426660|P1|NOT COMPLETED|Overall Study||6
2213376|NCT02990910|5426659|P2|COMPLETED|Overall Study||130
2213377|NCT02990910|5426660|P1|COMPLETED|Overall Study||134
2213378|NCT02990910|5426659|P2|STARTED|Overall Study||140
2213379|NCT02990910|5426660|P1|STARTED|Overall Study||140
2213380|NCT02990338|5426670|P2|NOT COMPLETED|Overall Study||89
2213381|NCT02990338|5426671|P1|NOT COMPLETED|Overall Study||118
2213382|NCT02990338|5426670|P2|COMPLETED|Overall Study||65
2213383|NCT02990338|5426671|P1|COMPLETED|Overall Study||35
2213384|NCT02990338|5426670|P2|Ongoing|Overall Study||65
2213385|NCT02990338|5426671|P1|Ongoing|Overall Study||35
2213386|NCT02990338|5426670|P2|Treated|Overall Study||152
2213387|NCT02990338|5426671|P1|Treated|Overall Study||149
2213388|NCT02990338|5426670|P2|STARTED|Overall Study||154
2213389|NCT02990338|5426671|P1|STARTED|Overall Study||153
2213390|NCT02989727|5426721|P4|NOT COMPLETED|Overall Study||0
2213391|NCT02989727|5426722|P3|NOT COMPLETED|Overall Study||0
2213392|NCT02989727|5426723|P2|NOT COMPLETED|Overall Study||0
2213393|NCT02989727|5426724|P1|NOT COMPLETED|Overall Study||0
2213394|NCT02989727|5426721|P4|COMPLETED|Overall Study||30
2213395|NCT02989727|5426722|P3|COMPLETED|Overall Study||30
2213396|NCT02989727|5426723|P2|COMPLETED|Overall Study||44
2213397|NCT02989727|5426724|P1|COMPLETED|Overall Study||46
2213398|NCT02989727|5426721|P4|STARTED|Overall Study||30
2213399|NCT02989727|5426722|P3|STARTED|Overall Study||30
2213400|NCT02989727|5426723|P2|STARTED|Overall Study||44
2213401|NCT02989727|5426724|P1|STARTED|Overall Study||46
2213402|NCT02989649|5426800|P1|NOT COMPLETED|Overall Study||420
2213403|NCT02989649|5426800|P1|COMPLETED|Overall Study||173
2213404|NCT02989649|5426800|P1|Eligible to Enter Into Treatment Period|Overall Study||509
2213405|NCT02989649|5426800|P1|Started But Not Treated|Overall Study||84
2213406|NCT02989649|5426800|P1|STARTED|Overall Study||593
2213407|NCT02988882|5426814|P2|NOT COMPLETED|Overall Study||2
2213408|NCT02988882|5426815|P1|NOT COMPLETED|Overall Study||3
2213409|NCT02988882|5426814|P2|COMPLETED|Overall Study||40
2213410|NCT02988882|5426815|P1|COMPLETED|Overall Study||41
2213411|NCT02988882|5426814|P2|STARTED|Overall Study||42
2213412|NCT02988882|5426815|P1|STARTED|Overall Study||44
2213413|NCT02988622|5426825|P1|NOT COMPLETED|Overall Study||17
2213414|NCT02988622|5426825|P1|COMPLETED|Overall Study||83
2213415|NCT02988622|5426825|P1|STARTED|Overall Study||100
2213416|NCT02988349|5426849|P2|NOT COMPLETED|Overall Study||0
2213417|NCT02988349|5426850|P1|NOT COMPLETED|Overall Study||0
2213418|NCT02988349|5426849|P2|COMPLETED|Overall Study||21
2213419|NCT02988349|5426850|P1|COMPLETED|Overall Study||21
2213420|NCT02988349|5426849|P2|STARTED|Overall Study||21
2213421|NCT02988349|5426850|P1|STARTED|Overall Study||21
2213422|NCT02988219|5426860|P2|NOT COMPLETED|Overall Study||3
2213423|NCT02988219|5426861|P1|NOT COMPLETED|Overall Study||1
2213424|NCT02988219|5426860|P2|COMPLETED|Overall Study||22
2213425|NCT02988219|5426861|P1|COMPLETED|Overall Study||24
2213426|NCT02988219|5426860|P2|STARTED|Overall Study||25
2213427|NCT02988219|5426861|P1|STARTED|Overall Study||25
2213428|NCT02988193|5426871|P2|NOT COMPLETED|Overall Study||0
2213429|NCT02988193|5426872|P1|NOT COMPLETED|Overall Study||0
2213430|NCT02988193|5426871|P2|COMPLETED|Overall Study||16
2213431|NCT02988193|5426872|P1|COMPLETED|Overall Study||12
2213432|NCT02988193|5426871|P2|STARTED|Overall Study||16
2213433|NCT02988193|5426872|P1|STARTED|Overall Study||12
2213434|NCT02987972|5426881|P3|NOT COMPLETED|Overall Study||42
2213435|NCT02987972|5426882|P2|NOT COMPLETED|Overall Study||45
2213436|NCT02987972|5426883|P1|NOT COMPLETED|Overall Study||43
2213437|NCT02987972|5426881|P3|COMPLETED|Overall Study||308
2213438|NCT02987972|5426882|P2|COMPLETED|Overall Study||305
2213439|NCT02987972|5426883|P1|COMPLETED|Overall Study||308
2213440|NCT02987972|5426881|P3|Vaccination 4|Overall Study||311
2213441|NCT02987972|5426882|P2|Vaccination 4|Overall Study||306
2213442|NCT02987972|5426883|P1|Vaccination 4|Overall Study||310
2213443|NCT02987972|5426881|P3|Vaccination 3|Overall Study||332
2213444|NCT02987972|5426882|P2|Vaccination 3|Overall Study||331
2213445|NCT02987972|5426883|P1|Vaccination 3|Overall Study||330
2213446|NCT02987972|5426881|P3|Vaccination 2|Overall Study||335
2213447|NCT02987972|5426882|P2|Vaccination 2|Overall Study||335
2213448|NCT02987972|5426883|P1|Vaccination 2|Overall Study||333
2213449|NCT02987972|5426881|P3|Vaccination 1|Overall Study||347
2213450|NCT02987972|5426882|P2|Vaccination 1|Overall Study||347
2213451|NCT02987972|5426883|P1|Vaccination 1|Overall Study||350
2213452|NCT02987972|5426881|P3|STARTED|Overall Study||350
2213453|NCT02987972|5426882|P2|STARTED|Overall Study||350
2213454|NCT02987972|5426883|P1|STARTED|Overall Study||351
2213455|NCT02987868|5426912|P2|NOT COMPLETED|Second Intervention||0
2213456|NCT02987868|5426913|P1|NOT COMPLETED|Second Intervention||0
2213457|NCT02987868|5426912|P2|COMPLETED|Second Intervention||8
2213458|NCT02987868|5426913|P1|COMPLETED|Second Intervention||8
2213459|NCT02987868|5426912|P2|STARTED|Second Intervention||8
2213460|NCT02987868|5426913|P1|STARTED|Second Intervention||8
2213461|NCT02987868|5426912|P2|NOT COMPLETED|Wash Out Period 1 Week||0
2213462|NCT02987868|5426913|P1|NOT COMPLETED|Wash Out Period 1 Week||0
2213463|NCT02987868|5426912|P2|COMPLETED|Wash Out Period 1 Week||8
2213464|NCT02987868|5426913|P1|COMPLETED|Wash Out Period 1 Week||8
2213465|NCT02987868|5426912|P2|STARTED|Wash Out Period 1 Week||8
2213466|NCT02987868|5426913|P1|STARTED|Wash Out Period 1 Week||8
2213467|NCT02987868|5426912|P2|NOT COMPLETED|First Intervention||0
2213468|NCT02987868|5426913|P1|NOT COMPLETED|First Intervention||0
2213469|NCT02987868|5426912|P2|COMPLETED|First Intervention||8
2213470|NCT02987868|5426913|P1|COMPLETED|First Intervention||8
2213471|NCT02987868|5426912|P2|STARTED|First Intervention||8
2213472|NCT02987868|5426913|P1|STARTED|First Intervention||8
2213473|NCT02987660|5426921|P2|NOT COMPLETED|Overall Study||10
2213474|NCT02987660|5426922|P1|NOT COMPLETED|Overall Study||10
2213475|NCT02987660|5426921|P2|COMPLETED|Overall Study||0
2213476|NCT02987660|5426922|P1|COMPLETED|Overall Study||0
2213477|NCT02987660|5426921|P2|STARTED|Overall Study||10
2213478|NCT02987660|5426922|P1|STARTED|Overall Study||10
2213479|NCT02987621|5426932|P2|NOT COMPLETED|Overall Study||0
2213480|NCT02987621|5426933|P1|NOT COMPLETED|Overall Study||0
2213481|NCT02987621|5426932|P2|COMPLETED|Overall Study||7
2213482|NCT02987621|5426933|P1|COMPLETED|Overall Study||7
2213483|NCT02987621|5426932|P2|STARTED|Overall Study||7
2213484|NCT02987621|5426933|P1|STARTED|Overall Study||7
2213485|NCT02987374|5426940|P1|NOT COMPLETED|Overall Study||0
2213486|NCT02987374|5426940|P1|COMPLETED|Overall Study||10
2213487|NCT02987374|5426940|P1|STARTED|Overall Study||10
2213488|NCT02987231|5426947|P2|NOT COMPLETED|Overall Study||0
2213489|NCT02987231|5426948|P1|NOT COMPLETED|Overall Study||0
2213490|NCT02987231|5426947|P2|COMPLETED|Overall Study||30
2213491|NCT02987231|5426948|P1|COMPLETED|Overall Study||30
2213492|NCT02987231|5426947|P2|STARTED|Overall Study||30
2213493|NCT02987231|5426948|P1|STARTED|Overall Study||30
2213494|NCT02987205|5426956|P1|NOT COMPLETED|Overall Study||4
2213495|NCT02987205|5426956|P1|COMPLETED|Overall Study|Treatment is bilateral, subject lost to Restylane AE was lost to further Revanesse Ultra treatment|159
2213496|NCT02987205|5426956|P1|Treated - Bilateral NLF Injection|Overall Study||163
2213497|NCT02987205|5426956|P1|STARTED|Overall Study||163
2213498|NCT02986958|5426966|P2|NOT COMPLETED|Overall Study||0
2213499|NCT02986958|5426967|P1|NOT COMPLETED|Overall Study||0
2213500|NCT02986958|5426966|P2|COMPLETED|Overall Study||44
2213501|NCT02986958|5426967|P1|COMPLETED|Overall Study||49
2213502|NCT02986958|5426966|P2|STARTED|Overall Study||44
2213503|NCT02986958|5426967|P1|STARTED|Overall Study||49
2213504|NCT02986854|5426990|P3|NOT COMPLETED|Overall Study||3
2213505|NCT02986854|5426991|P2|NOT COMPLETED|Overall Study||12
2213506|NCT02986854|5426992|P1|NOT COMPLETED|Overall Study||3
2213507|NCT02986854|5426990|P3|COMPLETED|Overall Study||97
2213508|NCT02986854|5426991|P2|COMPLETED|Overall Study||288
2213509|NCT02986854|5426992|P1|COMPLETED|Overall Study||298
2213510|NCT02986854|5426990|P3|STARTED|Overall Study||100
2213511|NCT02986854|5426991|P2|STARTED|Overall Study||300
2213512|NCT02986854|5426992|P1|STARTED|Overall Study||301
2213513|NCT02986711|5427067|P2|NOT COMPLETED|Overall Study||10
2213514|NCT02986711|5427068|P1|NOT COMPLETED|Overall Study||8
2213515|NCT02986711|5427067|P2|COMPLETED|Overall Study||70
2213516|NCT02986711|5427068|P1|COMPLETED|Overall Study||70
2213517|NCT02986711|5427067|P2|STARTED|Overall Study||80
2213518|NCT02986711|5427068|P1|STARTED|Overall Study||78
2213519|NCT02986373|5427076|P1|NOT COMPLETED|Overall Study||39
2213520|NCT02986373|5427076|P1|COMPLETED|Overall Study||106
2213521|NCT02986373|5427076|P1|STARTED|Overall Study||145
2213522|NCT02986282|5427111|P1|NOT COMPLETED|Overall Study||16
2213523|NCT02986282|5427111|P1|COMPLETED|Overall Study||99
2213524|NCT02986282|5427111|P1|STARTED|Overall Study||115
2213525|NCT02986139|5427118|P2|NOT COMPLETED|Overall Study||4
2213526|NCT02986139|5427119|P1|NOT COMPLETED|Overall Study||1
2213527|NCT02986139|5427118|P2|COMPLETED|Overall Study||51
2213528|NCT02986139|5427119|P1|COMPLETED|Overall Study||55
2213529|NCT02986139|5427118|P2|Received Etanercept|Overall Study||53
2213530|NCT02986139|5427119|P1|Received Etanercept|Overall Study||56
2213531|NCT02986139|5427118|P2|STARTED|Overall Study||55
2213532|NCT02986139|5427119|P1|STARTED|Overall Study||56
2213533|NCT02985996|5427136|P5|NOT COMPLETED|Overall Study||0
2213534|NCT02985996|5427137|P4|NOT COMPLETED|Overall Study||0
2213535|NCT02985996|5427138|P3|NOT COMPLETED|Overall Study||1
2213536|NCT02985996|5427139|P2|NOT COMPLETED|Overall Study||1
2213537|NCT02985996|5427140|P1|NOT COMPLETED|Overall Study||0
2213538|NCT02985996|5427136|P5|COMPLETED|Overall Study||9
2213539|NCT02985996|5427137|P4|COMPLETED|Overall Study||7
2213540|NCT02985996|5427138|P3|COMPLETED|Overall Study||9
2213541|NCT02985996|5427139|P2|COMPLETED|Overall Study||7
2213542|NCT02985996|5427140|P1|COMPLETED|Overall Study||5
2213543|NCT02985996|5427136|P5|STARTED|Overall Study||9
2213544|NCT02985996|5427137|P4|STARTED|Overall Study||7
2213545|NCT02985996|5427138|P3|STARTED|Overall Study||10
2213546|NCT02985996|5427139|P2|STARTED|Overall Study||8
2213547|NCT02985996|5427140|P1|STARTED|Overall Study||5
2213548|NCT02985840|5427254|P2|NOT COMPLETED|Overall Study||0
2213549|NCT02985840|5427255|P1|NOT COMPLETED|Overall Study||0
2213550|NCT02985840|5427254|P2|COMPLETED|Overall Study||63
2213551|NCT02985840|5427255|P1|COMPLETED|Overall Study||64
2213552|NCT02985840|5427254|P2|STARTED|Overall Study||63
2213553|NCT02985840|5427255|P1|STARTED|Overall Study||64
2213554|NCT02985827|5427265|P2|NOT COMPLETED|Overall Study||0
2213555|NCT02985827|5427266|P1|NOT COMPLETED|Overall Study||0
2213556|NCT02985827|5427265|P2|COMPLETED|Overall Study||15
2213557|NCT02985827|5427266|P1|COMPLETED|Overall Study||33
2213558|NCT02985827|5427265|P2|STARTED|Overall Study||15
2213559|NCT02985827|5427266|P1|STARTED|Overall Study||33
2213560|NCT02985684|5427274|P1|NOT COMPLETED|6-Month Closure Success Evaluation||8
2213561|NCT02985684|5427274|P1|COMPLETED|6-Month Closure Success Evaluation||112
2213562|NCT02985684|5427274|P1|STARTED|6-Month Closure Success Evaluation||120
2213563|NCT02985684|5427274|P1|NOT COMPLETED|6-Month Clinical Success Evaluation||5
2213564|NCT02985684|5427274|P1|COMPLETED|6-Month Clinical Success Evaluation||120
2213565|NCT02985684|5427274|P1|STARTED|6-Month Clinical Success Evaluation||125
2213572|NCT02984982|5427335|P2|NOT COMPLETED|Overall Study||10
2213573|NCT02984982|5427336|P1|NOT COMPLETED|Overall Study||8
2213574|NCT02984982|5427335|P2|COMPLETED|Overall Study||94
2213575|NCT02984982|5427336|P1|COMPLETED|Overall Study||94
2213576|NCT02984982|5427335|P2|Treated|Overall Study||103
2213577|NCT02984982|5427336|P1|Treated|Overall Study||102
2213578|NCT02984982|5427335|P2|STARTED|Overall Study||104
2213579|NCT02984982|5427336|P1|STARTED|Overall Study||102
2213580|NCT02984878|5427390|P2|NOT COMPLETED|Overall Study||0
2213581|NCT02984878|5427391|P1|NOT COMPLETED|Overall Study||0
2213582|NCT02984878|5427390|P2|COMPLETED|Overall Study||41
2213583|NCT02984878|5427391|P1|COMPLETED|Overall Study||30
2213584|NCT02984878|5427390|P2|STARTED|Overall Study||41
2213585|NCT02984878|5427391|P1|STARTED|Overall Study||30
2213586|NCT02984709|5427403|P2|NOT COMPLETED|Overall Study||0
2213587|NCT02984709|5427404|P1|NOT COMPLETED|Overall Study||0
2213588|NCT02984709|5427403|P2|COMPLETED|Overall Study||24
2213589|NCT02984709|5427404|P1|COMPLETED|Overall Study||24
2213686|NCT02982018|5427718|P1|NOT COMPLETED|Overall Study||5
2213590|NCT02984709|5427403|P2|STARTED|Overall Study|We enrolled 24 adolescent-parent dyads.|24
2213591|NCT02984709|5427404|P1|STARTED|Overall Study|We enrolled 24 adolescent-parent dyads.|24
2213592|NCT02984644|5427428|P2|NOT COMPLETED|Overall Study||0
2213593|NCT02984644|5427429|P1|NOT COMPLETED|Overall Study||0
2213594|NCT02984644|5427428|P2|COMPLETED|Overall Study||10
2213595|NCT02984644|5427429|P1|COMPLETED|Overall Study||20
2213596|NCT02984644|5427428|P2|STARTED|Overall Study||10
2213597|NCT02984644|5427429|P1|STARTED|Overall Study||20
2213598|NCT02984267|5427459|P2|NOT COMPLETED|Overall Study||1
2213599|NCT02984267|5427460|P1|NOT COMPLETED|Overall Study||1
2213600|NCT02984267|5427459|P2|COMPLETED|Overall Study||9
2213601|NCT02984267|5427460|P1|COMPLETED|Overall Study||7
2213602|NCT02984267|5427459|P2|STARTED|Overall Study||10
2213603|NCT02984267|5427460|P1|STARTED|Overall Study||8
2213604|NCT02983981|5427484|P1|NOT COMPLETED|Overall Study||0
2213605|NCT02983981|5427484|P1|COMPLETED|Overall Study||20
2213606|NCT02983981|5427484|P1|STARTED|Overall Study||20
2213607|NCT02983877|5427491|P1|NOT COMPLETED|Overall Study||0
2213608|NCT02983877|5427491|P1|COMPLETED|Overall Study||38
2213609|NCT02983877|5427491|P1|STARTED|Overall Study||38
2213610|NCT02983604|5427502|P4|NOT COMPLETED|Overall Study||0
2213611|NCT02983604|5427503|P3|NOT COMPLETED|Overall Study||1
2213612|NCT02983604|5427504|P2|NOT COMPLETED|Overall Study||0
2213613|NCT02983604|5427505|P1|NOT COMPLETED|Overall Study||0
2213614|NCT02983604|5427502|P4|COMPLETED|Overall Study||3
2213615|NCT02983604|5427503|P3|COMPLETED|Overall Study||3
2213616|NCT02983604|5427504|P2|COMPLETED|Overall Study||3
2213617|NCT02983604|5427505|P1|COMPLETED|Overall Study||4
2213618|NCT02983604|5427502|P4|STARTED|Overall Study||3
2213619|NCT02983604|5427503|P3|STARTED|Overall Study||4
2213620|NCT02983604|5427504|P2|STARTED|Overall Study||3
2213621|NCT02983604|5427505|P1|STARTED|Overall Study||4
2213622|NCT02983448|5427543|P2|NOT COMPLETED|Overall Study||0
2213623|NCT02983448|5427544|P1|NOT COMPLETED|Overall Study||0
2213624|NCT02983448|5427543|P2|COMPLETED|Overall Study||12
2213625|NCT02983448|5427544|P1|COMPLETED|Overall Study||12
2213626|NCT02983448|5427543|P2|STARTED|Overall Study||12
2213627|NCT02983448|5427544|P1|STARTED|Overall Study||12
2213628|NCT02983305|5427554|P2|NOT COMPLETED|Overall Study||0
2213629|NCT02983305|5427555|P1|NOT COMPLETED|Overall Study||2
2213630|NCT02983305|5427554|P2|COMPLETED|Overall Study||10
2213631|NCT02983305|5427555|P1|COMPLETED|Overall Study||10
2213632|NCT02983305|5427554|P2|STARTED|Overall Study||10
2213633|NCT02983305|5427555|P1|STARTED|Overall Study||12
2213634|NCT02982928|5427563|P1|NOT COMPLETED|Overall Study||0
2213635|NCT02982928|5427563|P1|COMPLETED|Overall Study||11
2213636|NCT02982928|5427563|P1|STARTED|Overall Study||11
2213637|NCT02982863|5427572|P5|NOT COMPLETED|Overall Study||492
2213638|NCT02982863|5427573|P4|NOT COMPLETED|Overall Study||1400
2213639|NCT02982863|5427574|P3|NOT COMPLETED|Overall Study||1852
2213640|NCT02982863|5427575|P2|NOT COMPLETED|Overall Study||4261
2213641|NCT02982863|5427576|P1|NOT COMPLETED|Overall Study||809
2213642|NCT02982863|5427572|P5|COMPLETED|Overall Study||2268
2213643|NCT02982863|5427573|P4|COMPLETED|Overall Study||8758
2213644|NCT02982863|5427574|P3|COMPLETED|Overall Study||11386
2213645|NCT02982863|5427575|P2|COMPLETED|Overall Study||12484
2213646|NCT02982863|5427576|P1|COMPLETED|Overall Study||4936
2213647|NCT02982863|5427572|P5|STARTED|Overall Study||2760
2213648|NCT02982863|5427573|P4|STARTED|Overall Study||10158
2213649|NCT02982863|5427574|P3|STARTED|Overall Study||13238
2213650|NCT02982863|5427575|P2|STARTED|Overall Study||16745
2213651|NCT02982863|5427576|P1|STARTED|Overall Study||5745
2213652|NCT02982720|5427633|P1|NOT COMPLETED|Overall Study||4
2213653|NCT02982720|5427633|P1|COMPLETED|Overall Study||0
2213654|NCT02982720|5427633|P1|STARTED|Overall Study||4
2213655|NCT02982239|5427643|P2|NOT COMPLETED|Overall Study||2
2213656|NCT02982239|5427644|P1|NOT COMPLETED|Overall Study||3
2213657|NCT02982239|5427643|P2|COMPLETED|Overall Study||18
2213658|NCT02982239|5427644|P1|COMPLETED|Overall Study||17
2213659|NCT02982239|5427643|P2|STARTED|Overall Study||20
2213660|NCT02982239|5427644|P1|STARTED|Overall Study||20
2213661|NCT02982187|5427660|P8|NOT COMPLETED|Overall Study||0
2213662|NCT02982187|5427661|P7|NOT COMPLETED|Overall Study||1
2213663|NCT02982187|5427662|P6|NOT COMPLETED|Overall Study||0
2213664|NCT02982187|5427663|P5|NOT COMPLETED|Overall Study||0
2213665|NCT02982187|5427664|P4|NOT COMPLETED|Overall Study||0
2213666|NCT02982187|5427665|P3|NOT COMPLETED|Overall Study||0
2213667|NCT02982187|5427666|P2|NOT COMPLETED|Overall Study||0
2213668|NCT02982187|5427667|P1|NOT COMPLETED|Overall Study||0
2213669|NCT02982187|5427660|P8|COMPLETED|Overall Study||20
2213670|NCT02982187|5427661|P7|COMPLETED|Overall Study||19
2213671|NCT02982187|5427662|P6|COMPLETED|Overall Study||20
2213672|NCT02982187|5427663|P5|COMPLETED|Overall Study||20
2213673|NCT02982187|5427664|P4|COMPLETED|Overall Study||20
2213674|NCT02982187|5427665|P3|COMPLETED|Overall Study||20
2213675|NCT02982187|5427666|P2|COMPLETED|Overall Study||20
2213676|NCT02982187|5427667|P1|COMPLETED|Overall Study||20
2213677|NCT02982187|5427660|P8|STARTED|Overall Study||20
2213678|NCT02982187|5427661|P7|STARTED|Overall Study||20
2213679|NCT02982187|5427662|P6|STARTED|Overall Study||20
2213680|NCT02982187|5427663|P5|STARTED|Overall Study||20
2213681|NCT02982187|5427664|P4|STARTED|Overall Study||20
2213682|NCT02982187|5427665|P3|STARTED|Overall Study||20
2213683|NCT02982187|5427666|P2|STARTED|Overall Study||20
2213684|NCT02982187|5427667|P1|STARTED|Overall Study||20
2213685|NCT02982018|5427717|P2|NOT COMPLETED|Overall Study||3
2213687|NCT02982018|5427717|P2|COMPLETED|Overall Study||61
2213688|NCT02982018|5427718|P1|COMPLETED|Overall Study||62
2213689|NCT02982018|5427717|P2|STARTED|Overall Study||64
2213690|NCT02982018|5427718|P1|STARTED|Overall Study||67
2213691|NCT02981524|5427732|P1|NOT COMPLETED|Overall Study||17
2213692|NCT02981524|5427732|P1|COMPLETED|Overall Study||0
2213693|NCT02981524|5427732|P1|STARTED|Overall Study||17
2213694|NCT02981342|5427744|P4|NOT COMPLETED|Overall Study||14
2213695|NCT02981342|5427745|P3|NOT COMPLETED|Overall Study||13
2213696|NCT02981342|5427746|P2|NOT COMPLETED|Overall Study||11
2213697|NCT02981342|5427747|P1|NOT COMPLETED|Overall Study||0
2213698|NCT02981342|5427744|P4|COMPLETED|Overall Study||19
2213699|NCT02981342|5427745|P3|COMPLETED|Overall Study||20
2213700|NCT02981342|5427746|P2|COMPLETED|Overall Study||22
2213701|NCT02981342|5427747|P1|COMPLETED|Overall Study||7
2213702|NCT02981342|5427744|P4|Received at Least One Dose of Study Drug|Overall Study||26
2213703|NCT02981342|5427745|P3|Received at Least One Dose of Study Drug|Overall Study||33
2213704|NCT02981342|5427746|P2|Received at Least One Dose of Study Drug|Overall Study||32
2213705|NCT02981342|5427747|P1|Received at Least One Dose of Study Drug|Overall Study||7
2213706|NCT02981342|5427744|P4|STARTED|Overall Study||33
2213707|NCT02981342|5427745|P3|STARTED|Overall Study||33
2213708|NCT02981342|5427746|P2|STARTED|Overall Study||33
2213709|NCT02981342|5427747|P1|STARTED|Overall Study||7
2213710|NCT02980978|5427790|P2|NOT COMPLETED|Overall Study||8
2213711|NCT02980978|5427791|P1|NOT COMPLETED|Overall Study||6
2213712|NCT02980978|5427790|P2|COMPLETED|Overall Study||50
2213713|NCT02980978|5427791|P1|COMPLETED|Overall Study||54
2213714|NCT02980978|5427790|P2|STARTED|Overall Study||58
2213715|NCT02980978|5427791|P1|STARTED|Overall Study||60
2213716|NCT02980783|5427805|P1|NOT COMPLETED|Overall Study||1
2213717|NCT02980783|5427805|P1|COMPLETED|Overall Study||52
2213718|NCT02980783|5427805|P1|STARTED|Overall Study||53
2213719|NCT02980601|5427818|P2|NOT COMPLETED|Overall Study||3
2213720|NCT02980601|5427819|P1|NOT COMPLETED|Overall Study||5
2213721|NCT02980601|5427818|P2|COMPLETED|Overall Study||1
2213722|NCT02980601|5427819|P1|COMPLETED|Overall Study||1
2213723|NCT02980601|5427818|P2|STARTED|Overall Study||4
2213724|NCT02980601|5427819|P1|STARTED|Overall Study||6
2213725|NCT02980523|5427912|P5|NOT COMPLETED|Overall Study||10
2213726|NCT02980523|5427913|P4|NOT COMPLETED|Overall Study||9
2213727|NCT02980523|5427914|P3|NOT COMPLETED|Overall Study||6
2213728|NCT02980523|5427915|P2|NOT COMPLETED|Overall Study||11
2213729|NCT02980523|5427916|P1|NOT COMPLETED|Overall Study||3
2213730|NCT02980523|5427912|P5|COMPLETED|Overall Study||20
2213731|NCT02980523|5427913|P4|COMPLETED|Overall Study||21
2213732|NCT02980523|5427914|P3|COMPLETED|Overall Study||24
2213733|NCT02980523|5427915|P2|COMPLETED|Overall Study||19
2213734|NCT02980523|5427916|P1|COMPLETED|Overall Study||27
2213735|NCT02980523|5427912|P5|STARTED|Overall Study||30
2213736|NCT02980523|5427913|P4|STARTED|Overall Study||30
2213737|NCT02980523|5427914|P3|STARTED|Overall Study||30
2213738|NCT02980523|5427915|P2|STARTED|Overall Study||30
2213739|NCT02980523|5427916|P1|STARTED|Overall Study||30
2213740|NCT02980224|5427960|P2|NOT COMPLETED|Overall Study||3
2213741|NCT02980224|5427961|P1|NOT COMPLETED|Overall Study||4
2213742|NCT02980224|5427960|P2|COMPLETED|Overall Study||88
2213743|NCT02980224|5427961|P1|COMPLETED|Overall Study||85
2213744|NCT02980224|5427960|P2|STARTED|Overall Study||91
2213745|NCT02980224|5427961|P1|STARTED|Overall Study||89
2213746|NCT02980211|5427971|P1|NOT COMPLETED|Overall Study||0
2213747|NCT02980211|5427971|P1|COMPLETED|Overall Study||17
2213748|NCT02980211|5427971|P1|STARTED|Overall Study||17
2213749|NCT02980107|5427977|P2|NOT COMPLETED|Overall Study||62
2213750|NCT02980107|5427978|P1|NOT COMPLETED|Overall Study||51
2213751|NCT02980107|5427977|P2|COMPLETED|Overall Study||45
2213752|NCT02980107|5427978|P1|COMPLETED|Overall Study||54
2213753|NCT02980107|5427977|P2|STARTED|Overall Study||107
2213754|NCT02980107|5427978|P1|STARTED|Overall Study||105
2213755|NCT02980042|5427992|P2|NOT COMPLETED|Overall Study||0
2213756|NCT02980042|5427993|P1|NOT COMPLETED|Overall Study||7
2213757|NCT02980042|5427992|P2|COMPLETED|Overall Study||100
2213758|NCT02980042|5427993|P1|COMPLETED|Overall Study|All 100 subjects completed their Week 24 infusion. 7 subjects did not complete the 12 month visit.|93
2213759|NCT02980042|5427992|P2|STARTED|Overall Study||100
2213760|NCT02980042|5427993|P1|STARTED|Overall Study||100
2213761|NCT02979639|5428010|P1|NOT COMPLETED|Overall Study||14
2213762|NCT02979639|5428010|P1|COMPLETED|Overall Study||387
2213763|NCT02979639|5428010|P1|STARTED|Overall Study||401
2213764|NCT02979613|5428042|P2|NOT COMPLETED|Open-Label Extension (OLE) Phase||227
2213765|NCT02979613|5428043|P1|NOT COMPLETED|Open-Label Extension (OLE) Phase||223
2213766|NCT02979613|5428042|P2|COMPLETED|Open-Label Extension (OLE) Phase||10
2213767|NCT02979613|5428043|P1|COMPLETED|Open-Label Extension (OLE) Phase||12
2213768|NCT02979613|5428042|P2|STARTED|Open-Label Extension (OLE) Phase||237
2213769|NCT02979613|5428043|P1|STARTED|Open-Label Extension (OLE) Phase||235
2213770|NCT02979613|5428042|P2|NOT COMPLETED|Double-Blind Phase||8
2213771|NCT02979613|5428043|P1|NOT COMPLETED|Double-Blind Phase||10
2213772|NCT02979613|5428042|P2|COMPLETED|Double-Blind Phase||237
2213773|NCT02979613|5428043|P1|COMPLETED|Double-Blind Phase||235
2213774|NCT02979613|5428042|P2|STARTED|Double-Blind Phase||245
2213775|NCT02979613|5428043|P1|STARTED|Double-Blind Phase||245
2213776|NCT02979431|5428079|P4|NOT COMPLETED|Overall Study||1
2213777|NCT02979431|5428080|P3|NOT COMPLETED|Overall Study||2
2213778|NCT02979431|5428081|P2|NOT COMPLETED|Overall Study||2
2213779|NCT02979431|5428082|P1|NOT COMPLETED|Overall Study||4
2213780|NCT02979431|5428079|P4|COMPLETED|Overall Study||44
2213781|NCT02979431|5428080|P3|COMPLETED|Overall Study||43
2213782|NCT02979431|5428081|P2|COMPLETED|Overall Study||44
2213783|NCT02979431|5428082|P1|COMPLETED|Overall Study||40
2213784|NCT02979431|5428079|P4|Included in the Safety Population|Overall Study|Includes a subject that was randomized to placebo but received a dose of ALX-0171 9.0 mg/kg|46
2213785|NCT02979431|5428080|P3|Included in the Safety Population|Overall Study|Includes a subject that was randomized to placebo but received a dose of ALX-0171 6.0 mg/kg|44
2213786|NCT02979431|5428081|P2|Included in the Safety Population|Overall Study||45
2213787|NCT02979431|5428082|P1|Included in the Safety Population|Overall Study||40
2213788|NCT02979431|5428079|P4|Included in the mITT Population|Overall Study||45
2213789|NCT02979431|5428080|P3|Included in the mITT Population|Overall Study||43
2213790|NCT02979431|5428081|P2|Included in the mITT Population|Overall Study||45
2213791|NCT02979431|5428082|P1|Included in the mITT Population|Overall Study||42
2213792|NCT02979431|5428079|P4|STARTED|Overall Study||45
2213793|NCT02979431|5428080|P3|STARTED|Overall Study||45
2213794|NCT02979431|5428081|P2|STARTED|Overall Study||46
2213795|NCT02979431|5428082|P1|STARTED|Overall Study||44
2213796|NCT02979301|5428134|P2|NOT COMPLETED|Overall Study||0
2213797|NCT02979301|5428135|P1|NOT COMPLETED|Overall Study||1
2213798|NCT02979301|5428134|P2|COMPLETED|Overall Study||11
2213799|NCT02979301|5428135|P1|COMPLETED|Overall Study||10
2213800|NCT02979301|5428134|P2|STARTED|Overall Study||11
2213801|NCT02979301|5428135|P1|STARTED|Overall Study||11
2213802|NCT02979262|5428143|P2|NOT COMPLETED|Overall Study||9
2213803|NCT02979262|5428144|P1|NOT COMPLETED|Overall Study||12
2213804|NCT02979262|5428143|P2|COMPLETED|Overall Study||20
2213805|NCT02979262|5428144|P1|COMPLETED|Overall Study||21
2213806|NCT02979262|5428143|P2|Received Allocated Intervention|Overall Study||27
2213807|NCT02979262|5428144|P1|Received Allocated Intervention|Overall Study||30
2213808|NCT02979262|5428143|P2|STARTED|Overall Study||29
2213809|NCT02979262|5428144|P1|STARTED|Overall Study||33
2213810|NCT02979197|5428163|P3|NOT COMPLETED|Overall Study||0
2213811|NCT02979197|5428164|P2|NOT COMPLETED|Overall Study||4
2213812|NCT02979197|5428165|P1|NOT COMPLETED|Overall Study||4
2213813|NCT02979197|5428163|P3|COMPLETED|Overall Study||8
2213814|NCT02979197|5428164|P2|COMPLETED|Overall Study||45
2213815|NCT02979197|5428165|P1|COMPLETED|Overall Study||44
2213816|NCT02979197|5428163|P3|STARTED|Overall Study||8
2213817|NCT02979197|5428164|P2|STARTED|Overall Study||49
2213818|NCT02979197|5428165|P1|STARTED|Overall Study||48
2213819|NCT02979054|5428193|P2|NOT COMPLETED|Overall Study||0
2213820|NCT02979054|5428194|P1|NOT COMPLETED|Overall Study||0
2213821|NCT02979054|5428193|P2|COMPLETED|Overall Study||64
2213822|NCT02979054|5428194|P1|COMPLETED|Overall Study||71
2213823|NCT02979054|5428193|P2|STARTED|Overall Study||64
2213824|NCT02979054|5428194|P1|STARTED|Overall Study||71
2213825|NCT02978833|5428208|P2|NOT COMPLETED|Overall Study||1
2213826|NCT02978833|5428209|P1|NOT COMPLETED|Overall Study||1
2213827|NCT02978833|5428208|P2|COMPLETED|Overall Study||0
2213828|NCT02978833|5428209|P1|COMPLETED|Overall Study||0
2213829|NCT02978833|5428208|P2|STARTED|Overall Study||1
2213830|NCT02978833|5428209|P1|STARTED|Overall Study||1
2213831|NCT02978339|5428225|P1|NOT COMPLETED|Overall Study||0
2213832|NCT02978339|5428225|P1|COMPLETED|Overall Study||15
2213833|NCT02978339|5428225|P1|STARTED|Overall Study||15
2213834|NCT02978157|5428237|P2|NOT COMPLETED|Overall Study||0
2213835|NCT02978157|5428238|P1|NOT COMPLETED|Overall Study||0
2213836|NCT02978157|5428237|P2|COMPLETED|Overall Study||50
2213837|NCT02978157|5428238|P1|COMPLETED|Overall Study||52
2213838|NCT02978157|5428237|P2|STARTED|Overall Study||50
2213839|NCT02978157|5428238|P1|STARTED|Overall Study||52
2213840|NCT02977572|5428246|P2|NOT COMPLETED|Overall Study||2
2213841|NCT02977572|5428247|P1|NOT COMPLETED|Overall Study||2
2213842|NCT02977572|5428246|P2|COMPLETED|Overall Study||54
2213843|NCT02977572|5428247|P1|COMPLETED|Overall Study||56
2213844|NCT02977572|5428246|P2|STARTED|Overall Study||56
2213845|NCT02977572|5428247|P1|STARTED|Overall Study||58
2213846|NCT02977507|5428269|P2|NOT COMPLETED|Overall Study||0
2213847|NCT02977507|5428270|P1|NOT COMPLETED|Overall Study||2
2213848|NCT02977507|5428269|P2|COMPLETED|Overall Study||10
2213849|NCT02977507|5428270|P1|COMPLETED|Overall Study||6
2213850|NCT02977507|5428269|P2|STARTED|Overall Study||10
2213851|NCT02977507|5428270|P1|STARTED|Overall Study||8
2213852|NCT02976519|5428300|P7|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||1
2213853|NCT02976519|5428301|P6|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
2213854|NCT02976519|5428302|P5|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
2213855|NCT02976519|5428303|P4|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
2213856|NCT02976519|5428304|P3|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
2213857|NCT02976519|5428305|P2|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
2213858|NCT02976519|5428306|P1|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
2213859|NCT02976519|5428300|P7|COMPLETED|Treatment Period 2 (Part 2 Only)||9
2213860|NCT02976519|5428301|P6|COMPLETED|Treatment Period 2 (Part 2 Only)||12
2213861|NCT02976519|5428302|P5|COMPLETED|Treatment Period 2 (Part 2 Only)||0
2213862|NCT02976519|5428303|P4|COMPLETED|Treatment Period 2 (Part 2 Only)||0
2213863|NCT02976519|5428304|P3|COMPLETED|Treatment Period 2 (Part 2 Only)||0
2213864|NCT02976519|5428305|P2|COMPLETED|Treatment Period 2 (Part 2 Only)||0
2213865|NCT02976519|5428306|P1|COMPLETED|Treatment Period 2 (Part 2 Only)||0
2213866|NCT02976519|5428300|P7|STARTED|Treatment Period 2 (Part 2 Only)||10
2213867|NCT02976519|5428301|P6|STARTED|Treatment Period 2 (Part 2 Only)||12
2213868|NCT02976519|5428302|P5|STARTED|Treatment Period 2 (Part 2 Only)||0
2213869|NCT02976519|5428303|P4|STARTED|Treatment Period 2 (Part 2 Only)||0
2213870|NCT02976519|5428304|P3|STARTED|Treatment Period 2 (Part 2 Only)||0
2213871|NCT02976519|5428305|P2|STARTED|Treatment Period 2 (Part 2 Only)||0
2213872|NCT02976519|5428306|P1|STARTED|Treatment Period 2 (Part 2 Only)||0
2213873|NCT02976519|5428300|P7|NOT COMPLETED|Wash-out Period (Part 2 Only)||2
2213874|NCT02976519|5428301|P6|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
2213875|NCT02976519|5428302|P5|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
2213876|NCT02976519|5428303|P4|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
2213877|NCT02976519|5428304|P3|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
2213878|NCT02976519|5428305|P2|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
2213879|NCT02976519|5428306|P1|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
2213880|NCT02976519|5428300|P7|COMPLETED|Wash-out Period (Part 2 Only)||10
2213881|NCT02976519|5428301|P6|COMPLETED|Wash-out Period (Part 2 Only)||12
2213882|NCT02976519|5428302|P5|COMPLETED|Wash-out Period (Part 2 Only)||0
2213883|NCT02976519|5428303|P4|COMPLETED|Wash-out Period (Part 2 Only)||0
2213884|NCT02976519|5428304|P3|COMPLETED|Wash-out Period (Part 2 Only)||0
2213885|NCT02976519|5428305|P2|COMPLETED|Wash-out Period (Part 2 Only)||0
2213886|NCT02976519|5428306|P1|COMPLETED|Wash-out Period (Part 2 Only)||0
2213887|NCT02976519|5428300|P7|STARTED|Wash-out Period (Part 2 Only)||12
2213888|NCT02976519|5428301|P6|STARTED|Wash-out Period (Part 2 Only)||12
2213889|NCT02976519|5428302|P5|STARTED|Wash-out Period (Part 2 Only)||0
2213890|NCT02976519|5428303|P4|STARTED|Wash-out Period (Part 2 Only)||0
2213891|NCT02976519|5428304|P3|STARTED|Wash-out Period (Part 2 Only)||0
2213892|NCT02976519|5428305|P2|STARTED|Wash-out Period (Part 2 Only)||0
2213893|NCT02976519|5428306|P1|STARTED|Wash-out Period (Part 2 Only)||0
2213894|NCT02976519|5428300|P7|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
2213895|NCT02976519|5428301|P6|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
2213896|NCT02976519|5428302|P5|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
2213897|NCT02976519|5428303|P4|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||1
2213898|NCT02976519|5428304|P3|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
2213899|NCT02976519|5428305|P2|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||1
2213900|NCT02976519|5428306|P1|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
2213901|NCT02976519|5428300|P7|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||12
2213902|NCT02976519|5428301|P6|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||12
2213903|NCT02976519|5428302|P5|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
2213904|NCT02976519|5428303|P4|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||7
2213905|NCT02976519|5428304|P3|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
2213906|NCT02976519|5428305|P2|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||7
2213907|NCT02976519|5428306|P1|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
2213908|NCT02976519|5428300|P7|STARTED|Treatment Period 1 (Part 1 and Part 2)||12
2213909|NCT02976519|5428301|P6|STARTED|Treatment Period 1 (Part 1 and Part 2)||12
2213910|NCT02976519|5428302|P5|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
2213911|NCT02976519|5428303|P4|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
2213912|NCT02976519|5428304|P3|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
2213913|NCT02976519|5428305|P2|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
2213914|NCT02976519|5428306|P1|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
2213915|NCT02976181|5428330|P1|NOT COMPLETED|Overall Study||1
2213916|NCT02976181|5428330|P1|COMPLETED|Overall Study||112
2213917|NCT02976181|5428330|P1|STARTED|Overall Study||113
2213918|NCT02975804|5428337|P2|NOT COMPLETED|Overall Study||0
2213919|NCT02975804|5428338|P1|NOT COMPLETED|Overall Study||0
2213920|NCT02975804|5428337|P2|COMPLETED|Overall Study||9
2213921|NCT02975804|5428338|P1|COMPLETED|Overall Study||9
2213922|NCT02975804|5428337|P2|STARTED|Overall Study||9
2213923|NCT02975804|5428338|P1|STARTED|Overall Study||9
2213924|NCT02975557|5428379|P3|NOT COMPLETED|Overall Study||1
2213925|NCT02975557|5428380|P2|NOT COMPLETED|Overall Study||3
2213926|NCT02975557|5428381|P1|NOT COMPLETED|Overall Study||1
2213927|NCT02975557|5428379|P3|COMPLETED|Overall Study||5
2213928|NCT02975557|5428380|P2|COMPLETED|Overall Study||2
2213929|NCT02975557|5428381|P1|COMPLETED|Overall Study||3
2213930|NCT02975557|5428379|P3|STARTED|Overall Study||6
2213931|NCT02975557|5428380|P2|STARTED|Overall Study||5
2213932|NCT02975557|5428381|P1|STARTED|Overall Study||4
2213942|NCT02974855|5428412|P4|NOT COMPLETED|Overall Study||1
2213943|NCT02974855|5428413|P3|NOT COMPLETED|Overall Study||0
2213944|NCT02974855|5428414|P2|NOT COMPLETED|Overall Study||1
2213945|NCT02974855|5428415|P1|NOT COMPLETED|Overall Study||0
2213946|NCT02974855|5428412|P4|COMPLETED|Overall Study||6
2213947|NCT02974855|5428413|P3|COMPLETED|Overall Study||6
2213948|NCT02974855|5428414|P2|COMPLETED|Overall Study||5
2213949|NCT02974855|5428415|P1|COMPLETED|Overall Study||7
2213950|NCT02974855|5428412|P4|STARTED|Overall Study||7
2213951|NCT02974855|5428413|P3|STARTED|Overall Study||6
2213952|NCT02974855|5428414|P2|STARTED|Overall Study||6
2213953|NCT02974855|5428415|P1|STARTED|Overall Study||7
2213954|NCT02974543|5428603|P2|NOT COMPLETED|Overall Study||0
2213955|NCT02974543|5428604|P1|NOT COMPLETED|Overall Study||1
2213956|NCT02974543|5428603|P2|COMPLETED|Overall Study||10
2213957|NCT02974543|5428604|P1|COMPLETED|Overall Study||10
2213958|NCT02974543|5428603|P2|Began Crossover Assignment|Overall Study||10
2213959|NCT02974543|5428604|P1|Began Crossover Assignment|Overall Study||10
2213960|NCT02974543|5428603|P2|Began Washout Period|Overall Study||10
2213961|NCT02974543|5428604|P1|Began Washout Period|Overall Study||10
2213962|NCT02974543|5428603|P2|STARTED|Overall Study||10
2213963|NCT02974543|5428604|P1|STARTED|Overall Study||11
2213964|NCT02974140|5428624|P1|NOT COMPLETED|Overall Study||39
2213965|NCT02974140|5428624|P1|COMPLETED|Overall Study||0
2213966|NCT02974140|5428624|P1|Manual (Fellow Eye)|Overall Study||38
2213967|NCT02974140|5428624|P1|CRS (Left or Right Eye)|Overall Study||38
2213968|NCT02974140|5428624|P1|STARTED|Overall Study||39
2213969|NCT02974114|5428640|P3|NOT COMPLETED|Overall Study||2
2213970|NCT02974114|5428641|P2|NOT COMPLETED|Overall Study||1
2213971|NCT02974114|5428642|P1|NOT COMPLETED|Overall Study||0
2213972|NCT02974114|5428640|P3|COMPLETED|Overall Study||6
2213973|NCT02974114|5428641|P2|COMPLETED|Overall Study||6
2213974|NCT02974114|5428642|P1|COMPLETED|Overall Study||6
2213975|NCT02974114|5428640|P3|STARTED|Overall Study||8
2213976|NCT02974114|5428641|P2|STARTED|Overall Study||7
2213977|NCT02974114|5428642|P1|STARTED|Overall Study||6
2213978|NCT02974088|5428685|P2|NOT COMPLETED|Overall Study||3
2213979|NCT02974088|5428686|P1|NOT COMPLETED|Overall Study||0
2213980|NCT02974088|5428685|P2|COMPLETED|Overall Study|Nurse left without notice and took CRFs and data for 2 subjects.|21
2213981|NCT02974088|5428686|P1|COMPLETED|Overall Study||23
2213982|NCT02974088|5428685|P2|STARTED|Overall Study||24
2213983|NCT02974088|5428686|P1|STARTED|Overall Study||23
2213984|NCT02973802|5428692|P1|NOT COMPLETED|Overall Study||2
2213985|NCT02973802|5428692|P1|COMPLETED|Overall Study||10
2213986|NCT02973802|5428692|P1|STARTED|Overall Study||12
2213987|NCT02973100|5428710|P4|NOT COMPLETED|Overall Study||7
2213988|NCT02973100|5428711|P3|NOT COMPLETED|Overall Study||4
2213989|NCT02973100|5428712|P2|NOT COMPLETED|Overall Study||8
2213990|NCT02973100|5428713|P1|NOT COMPLETED|Overall Study||7
2213991|NCT02973100|5428710|P4|COMPLETED|Overall Study||69
2213992|NCT02973100|5428711|P3|COMPLETED|Overall Study||75
2213993|NCT02973100|5428712|P2|COMPLETED|Overall Study||73
2213994|NCT02973100|5428713|P1|COMPLETED|Overall Study||75
2213995|NCT02973100|5428710|P4|Received at Least 1 Dose of Study Drug|Overall Study||76
2213996|NCT02973100|5428711|P3|Received at Least 1 Dose of Study Drug|Overall Study||79
2213997|NCT02973100|5428712|P2|Received at Least 1 Dose of Study Drug|Overall Study||81
2213998|NCT02973100|5428713|P1|Received at Least 1 Dose of Study Drug|Overall Study||81
2213999|NCT02973100|5428710|P4|STARTED|Overall Study||76
2214000|NCT02973100|5428711|P3|STARTED|Overall Study||79
2214001|NCT02973100|5428712|P2|STARTED|Overall Study||81
2214002|NCT02973100|5428713|P1|STARTED|Overall Study||82
2214003|NCT02972658|5428753|P4|NOT COMPLETED|Overall Study||131
2214004|NCT02972658|5428754|P3|NOT COMPLETED|Overall Study||75
2214005|NCT02972658|5428755|P2|NOT COMPLETED|Overall Study||138
2214006|NCT02972658|5428756|P1|NOT COMPLETED|Overall Study||76
2214007|NCT02972658|5428753|P4|COMPLETED|Overall Study||0
2214008|NCT02972658|5428754|P3|COMPLETED|Overall Study||0
2214009|NCT02972658|5428755|P2|COMPLETED|Overall Study|1 participant was incorrectly marked as “Completed” rather than study terminated by Sponsor.|1
2214010|NCT02972658|5428756|P1|COMPLETED|Overall Study||0
2214011|NCT02972658|5428753|P4|Received at Least 1 Dose of Study Drug|Overall Study||131
2214012|NCT02972658|5428754|P3|Received at Least 1 Dose of Study Drug|Overall Study||74
2214013|NCT02972658|5428755|P2|Received at Least 1 Dose of Study Drug|Overall Study||139
2214014|NCT02972658|5428756|P1|Received at Least 1 Dose of Study Drug|Overall Study||76
2214015|NCT02972658|5428753|P4|STARTED|Overall Study||131
2214016|NCT02972658|5428754|P3|STARTED|Overall Study||75
2214017|NCT02972658|5428755|P2|STARTED|Overall Study||139
2214018|NCT02972658|5428756|P1|STARTED|Overall Study||76
2214019|NCT02972632|5428786|P1|NOT COMPLETED|Overall Study||17
2214020|NCT02972632|5428786|P1|COMPLETED|Overall Study||106
2214021|NCT02972632|5428786|P1|Safety Analysis Set|Overall Study||122
2214022|NCT02972632|5428786|P1|STARTED|Overall Study||123
2214023|NCT02972554|5428799|P2|NOT COMPLETED|Overall Study||0
2214024|NCT02972554|5428800|P1|NOT COMPLETED|Overall Study||0
2214025|NCT02972554|5428799|P2|COMPLETED|Overall Study||48
2214026|NCT02972554|5428800|P1|COMPLETED|Overall Study||44
2214027|NCT02972554|5428799|P2|STARTED|Overall Study||48
2214028|NCT02972554|5428800|P1|STARTED|Overall Study||44
2214029|NCT02972515|5428816|P1|NOT COMPLETED|Overall Study||78
2214030|NCT02972515|5428816|P1|COMPLETED|Overall Study||88
2214031|NCT02972515|5428816|P1|STARTED|Overall Study||166
2214032|NCT02972502|5428825|P2|NOT COMPLETED|Overall Study||2
2214033|NCT02972502|5428826|P1|NOT COMPLETED|Overall Study||4
2214034|NCT02972502|5428825|P2|COMPLETED|Overall Study||29
2214035|NCT02972502|5428826|P1|COMPLETED|Overall Study||31
2214036|NCT02972502|5428825|P2|STARTED|Overall Study||31
2214037|NCT02972502|5428826|P1|STARTED|Overall Study||35
2214038|NCT02972359|5428836|P1|NOT COMPLETED|Overall Study||71
2214039|NCT02972359|5428836|P1|COMPLETED|Overall Study||247
2214040|NCT02972359|5428836|P1|STARTED|Overall Study||318
2214041|NCT02971670|5428851|P4|NOT COMPLETED|Overall Study||2
2214042|NCT02971670|5428852|P3|NOT COMPLETED|Overall Study||1
2214043|NCT02971670|5428853|P2|NOT COMPLETED|Overall Study||1
2214044|NCT02971670|5428854|P1|NOT COMPLETED|Overall Study||4
2214045|NCT02971670|5428851|P4|COMPLETED|Overall Study||1
2214046|NCT02971670|5428852|P3|COMPLETED|Overall Study||4
2214047|NCT02971670|5428853|P2|COMPLETED|Overall Study||1
2214048|NCT02971670|5428854|P1|COMPLETED|Overall Study||9
2214049|NCT02971670|5428851|P4|STARTED|Overall Study||3
2214050|NCT02971670|5428852|P3|STARTED|Overall Study||5
2214051|NCT02971670|5428853|P2|STARTED|Overall Study||2
2214052|NCT02971670|5428854|P1|STARTED|Overall Study||13
2214053|NCT02971631|5428872|P2|NOT COMPLETED|Second Intervention - One Day||0
2214054|NCT02971631|5428873|P1|NOT COMPLETED|Second Intervention - One Day||0
2214055|NCT02971631|5428872|P2|COMPLETED|Second Intervention - One Day||2
2214056|NCT02971631|5428873|P1|COMPLETED|Second Intervention - One Day||3
2214057|NCT02971631|5428872|P2|STARTED|Second Intervention - One Day||2
2214058|NCT02971631|5428873|P1|STARTED|Second Intervention - One Day||3
2214059|NCT02971631|5428872|P2|NOT COMPLETED|First Intervention - One Day||0
2214060|NCT02971631|5428873|P1|NOT COMPLETED|First Intervention - One Day||0
2214061|NCT02971631|5428872|P2|COMPLETED|First Intervention - One Day||2
2214062|NCT02971631|5428873|P1|COMPLETED|First Intervention - One Day||3
2214063|NCT02971631|5428872|P2|STARTED|First Intervention - One Day||2
2214064|NCT02971631|5428873|P1|STARTED|First Intervention - One Day||3
2214065|NCT02971605|5428893|P1|NOT COMPLETED|Overall Study||1
2214066|NCT02971605|5428893|P1|COMPLETED|Overall Study||12
2214067|NCT02971605|5428893|P1|STARTED|Overall Study||13
2214068|NCT02971488|5428908|P1|NOT COMPLETED|Overall Study||0
2214069|NCT02971488|5428908|P1|COMPLETED|Overall Study||529
2214070|NCT02971488|5428908|P1|STARTED|Overall Study||529
2214071|NCT02971293|5428918|P1|NOT COMPLETED|Overall Study||11
2214072|NCT02971293|5428918|P1|COMPLETED|Overall Study||31
2214073|NCT02971293|5428918|P1|STARTED|Overall Study||42
2214074|NCT02971202|5429007|P3|NOT COMPLETED|Overall Study||1
2214075|NCT02971202|5429008|P2|NOT COMPLETED|Overall Study||0
2214076|NCT02971202|5429009|P1|NOT COMPLETED|Overall Study||2
2214077|NCT02971202|5429007|P3|COMPLETED|Overall Study||10
2214078|NCT02971202|5429008|P2|COMPLETED|Overall Study||10
2214079|NCT02971202|5429009|P1|COMPLETED|Overall Study||10
2214080|NCT02971202|5429007|P3|Started Study|Overall Study||10
2214081|NCT02971202|5429008|P2|Started Study|Overall Study||10
2214082|NCT02971202|5429009|P1|Started Study|Overall Study||11
2214083|NCT02971202|5429007|P3|STARTED|Overall Study||11
2214084|NCT02971202|5429008|P2|STARTED|Overall Study||10
2214085|NCT02971202|5429009|P1|STARTED|Overall Study||12
2214086|NCT02971007|5429026|P3|NOT COMPLETED|Overall Study||1
2214087|NCT02971007|5429027|P2|NOT COMPLETED|Overall Study||3
2214088|NCT02971007|5429028|P1|NOT COMPLETED|Overall Study||2
2214089|NCT02971007|5429026|P3|COMPLETED|Overall Study||45
2214090|NCT02971007|5429027|P2|COMPLETED|Overall Study||42
2214091|NCT02971007|5429028|P1|COMPLETED|Overall Study||44
2214092|NCT02971007|5429026|P3|STARTED|Overall Study||46
2214093|NCT02971007|5429027|P2|STARTED|Overall Study||45
2214094|NCT02971007|5429028|P1|STARTED|Overall Study||46
2214095|NCT02970812|5429047|P2|NOT COMPLETED|Overall Study||2
2214096|NCT02970812|5429048|P1|NOT COMPLETED|Overall Study||8
2214097|NCT02970812|5429047|P2|COMPLETED|Overall Study||28
2214098|NCT02970812|5429048|P1|COMPLETED|Overall Study||22
2214099|NCT02970812|5429047|P2|STARTED|Overall Study||30
2214100|NCT02970812|5429048|P1|STARTED|Overall Study||30
2214101|NCT02970669|5429056|P2|NOT COMPLETED|Open-label Period||2
2214102|NCT02970669|5429057|P1|NOT COMPLETED|Open-label Period||4
2214103|NCT02970669|5429056|P2|COMPLETED|Open-label Period||62
2214104|NCT02970669|5429057|P1|COMPLETED|Open-label Period||58
2214105|NCT02970669|5429056|P2|STARTED|Open-label Period||64
2214106|NCT02970669|5429057|P1|STARTED|Open-label Period||62
2214107|NCT02970669|5429056|P2|NOT COMPLETED|Double-blind Period||6
2214108|NCT02970669|5429057|P1|NOT COMPLETED|Double-blind Period||8
2214109|NCT02970669|5429056|P2|COMPLETED|Double-blind Period||64
2214110|NCT02970669|5429057|P1|COMPLETED|Double-blind Period||62
2214111|NCT02970669|5429056|P2|STARTED|Double-blind Period||70
2214112|NCT02970669|5429057|P1|STARTED|Double-blind Period||70
2214113|NCT02970552|5429077|P2|NOT COMPLETED|Overall Study||3
2214114|NCT02970552|5429078|P1|NOT COMPLETED|Overall Study||3
2214115|NCT02970552|5429077|P2|COMPLETED|Overall Study||67
2214116|NCT02970552|5429078|P1|COMPLETED|Overall Study||67
2214117|NCT02970552|5429077|P2|STARTED|Overall Study||70
2214118|NCT02970552|5429078|P1|STARTED|Overall Study||70
2214119|NCT02970162|5429108|P2|NOT COMPLETED|Overall Study||0
2214120|NCT02970162|5429109|P1|NOT COMPLETED|Overall Study||0
2214121|NCT02970162|5429108|P2|COMPLETED|Overall Study||13
2214122|NCT02970162|5429109|P1|COMPLETED|Overall Study||13
2214123|NCT02970162|5429108|P2|STARTED|Overall Study||13
2214124|NCT02970162|5429109|P1|STARTED|Overall Study||13
2214125|NCT02970032|5429121|P1|NOT COMPLETED|Real Time Heparin Dose Adjustment||0
2214126|NCT02970032|5429121|P1|COMPLETED|Real Time Heparin Dose Adjustment||20
2214127|NCT02970032|5429121|P1|STARTED|Real Time Heparin Dose Adjustment||20
2214128|NCT02970032|5429121|P1|NOT COMPLETED|Standard Heparin Dose||0
2214129|NCT02970032|5429121|P1|COMPLETED|Standard Heparin Dose||20
2214130|NCT02970032|5429121|P1|STARTED|Standard Heparin Dose||20
2214131|NCT02969876|5429127|P1|NOT COMPLETED|Overall Study||0
2214132|NCT02969876|5429127|P1|COMPLETED|Overall Study||2
2214133|NCT02969876|5429127|P1|STARTED|Overall Study||2
2214134|NCT02969863|5429133|P6|NOT COMPLETED|Overall Study||0
2214135|NCT02969863|5429134|P5|NOT COMPLETED|Overall Study||0
2214136|NCT02969863|5429135|P4|NOT COMPLETED|Overall Study||0
2214137|NCT02969863|5429136|P3|NOT COMPLETED|Overall Study||0
2214138|NCT02969863|5429137|P2|NOT COMPLETED|Overall Study||0
2214139|NCT02969863|5429138|P1|NOT COMPLETED|Overall Study||1
2214140|NCT02969863|5429133|P6|COMPLETED|Overall Study||4
2214141|NCT02969863|5429134|P5|COMPLETED|Overall Study||4
2214142|NCT02969863|5429135|P4|COMPLETED|Overall Study||4
2214143|NCT02969863|5429136|P3|COMPLETED|Overall Study||4
2214144|NCT02969863|5429137|P2|COMPLETED|Overall Study||4
2214145|NCT02969863|5429138|P1|COMPLETED|Overall Study||3
2214146|NCT02969863|5429133|P6|STARTED|Overall Study||4
2214147|NCT02969863|5429134|P5|STARTED|Overall Study||4
2214148|NCT02969863|5429135|P4|STARTED|Overall Study||4
2214149|NCT02969863|5429136|P3|STARTED|Overall Study||4
2214150|NCT02969863|5429137|P2|STARTED|Overall Study||4
2214151|NCT02969863|5429138|P1|STARTED|Overall Study||4
2214152|NCT02969655|5429154|P2|NOT COMPLETED|Overall Study||15
2214153|NCT02969655|5429155|P1|NOT COMPLETED|Overall Study||21
2214154|NCT02969655|5429154|P2|COMPLETED|Overall Study||120
2214155|NCT02969655|5429155|P1|COMPLETED|Overall Study||115
2214156|NCT02969655|5429154|P2|STARTED|Overall Study||135
2214157|NCT02969655|5429155|P1|STARTED|Overall Study||136
2214158|NCT02969590|5429190|P3|NOT COMPLETED|Treatment Period 2||0
2214159|NCT02969590|5429191|P2|NOT COMPLETED|Treatment Period 2||0
2214160|NCT02969590|5429192|P1|NOT COMPLETED|Treatment Period 2||0
2214161|NCT02969590|5429190|P3|COMPLETED|Treatment Period 2||2
2214162|NCT02969590|5429191|P2|COMPLETED|Treatment Period 2||2
2214163|NCT02969590|5429192|P1|COMPLETED|Treatment Period 2||0
2214164|NCT02969590|5429190|P3|STARTED|Treatment Period 2||2
2214165|NCT02969590|5429191|P2|STARTED|Treatment Period 2||2
2214166|NCT02969590|5429192|P1|STARTED|Treatment Period 2||0
2214167|NCT02969590|5429190|P3|NOT COMPLETED|Treatment Period 1||0
2214168|NCT02969590|5429191|P2|NOT COMPLETED|Treatment Period 1||0
2214169|NCT02969590|5429192|P1|NOT COMPLETED|Treatment Period 1||0
2214170|NCT02969590|5429190|P3|COMPLETED|Treatment Period 1||2
2214171|NCT02969590|5429191|P2|COMPLETED|Treatment Period 1||2
2214172|NCT02969590|5429192|P1|COMPLETED|Treatment Period 1||0
2214173|NCT02969590|5429190|P3|STARTED|Treatment Period 1||2
2214174|NCT02969590|5429191|P2|STARTED|Treatment Period 1||2
2214175|NCT02969590|5429192|P1|STARTED|Treatment Period 1||0
2214176|NCT02969590|5429190|P3|NOT COMPLETED|Screening Period||0
2214177|NCT02969590|5429191|P2|NOT COMPLETED|Screening Period||0
2214178|NCT02969590|5429192|P1|NOT COMPLETED|Screening Period||1
2214179|NCT02969590|5429190|P3|COMPLETED|Screening Period||0
2214180|NCT02969590|5429191|P2|COMPLETED|Screening Period||0
2214181|NCT02969590|5429192|P1|COMPLETED|Screening Period||4
2214182|NCT02969590|5429190|P3|STARTED|Screening Period||0
2214183|NCT02969590|5429191|P2|STARTED|Screening Period||0
2214184|NCT02969590|5429192|P1|STARTED|Screening Period||5
2214185|NCT02969421|5429212|P2|NOT COMPLETED|Overall Study||0
2214186|NCT02969421|5429213|P1|NOT COMPLETED|Overall Study||0
2214187|NCT02969421|5429212|P2|COMPLETED|Overall Study||33
2214188|NCT02969421|5429213|P1|COMPLETED|Overall Study||33
2214189|NCT02969421|5429212|P2|STARTED|Overall Study||33
2214190|NCT02969421|5429213|P1|STARTED|Overall Study||33
2214191|NCT02969408|5429223|P1|NOT COMPLETED|Overall Study||16
2214192|NCT02969408|5429223|P1|COMPLETED|Overall Study||381
2214193|NCT02969408|5429223|P1|Used ABS eMDPI at Least Once|Overall Study||370
2214194|NCT02969408|5429223|P1|STARTED|Overall Study||397
2214195|NCT02969356|5429231|P1|NOT COMPLETED|Overall Study||23
2214196|NCT02969356|5429231|P1|COMPLETED|Overall Study||134
2214197|NCT02969356|5429231|P1|Intent-to-Treat (ITT) Population|Overall Study||153
2214198|NCT02969356|5429231|P1|STARTED|Overall Study||157
2214199|NCT02969317|5429249|P1|NOT COMPLETED|Overall Study||0
2214200|NCT02969317|5429249|P1|COMPLETED|Overall Study||12
2214201|NCT02969317|5429249|P1|STARTED|Overall Study||12
2214202|NCT02969044|5429274|P2|NOT COMPLETED|Overall Study||6
2214203|NCT02969044|5429275|P1|NOT COMPLETED|Overall Study||5
2214204|NCT02969044|5429274|P2|COMPLETED|Overall Study||22
2214205|NCT02969044|5429275|P1|COMPLETED|Overall Study||37
2214206|NCT02969044|5429274|P2|STARTED|Overall Study||28
2214207|NCT02969044|5429275|P1|STARTED|Overall Study||42
2214208|NCT02969031|5429317|P2|NOT COMPLETED|Completed and Analyzed||0
2214209|NCT02969031|5429318|P1|NOT COMPLETED|Completed and Analyzed||0
2214210|NCT02969031|5429317|P2|COMPLETED|Completed and Analyzed||12
2214211|NCT02969031|5429318|P1|COMPLETED|Completed and Analyzed||15
2214212|NCT02969031|5429317|P2|STARTED|Completed and Analyzed||12
2214213|NCT02969031|5429318|P1|STARTED|Completed and Analyzed||15
2214214|NCT02969031|5429317|P2|NOT COMPLETED|Collection of Follow-Up Recordings||0
2214215|NCT02969031|5429318|P1|NOT COMPLETED|Collection of Follow-Up Recordings||0
2214216|NCT02969031|5429317|P2|COMPLETED|Collection of Follow-Up Recordings||12
2214217|NCT02969031|5429318|P1|COMPLETED|Collection of Follow-Up Recordings||15
2214218|NCT02969031|5429317|P2|STARTED|Collection of Follow-Up Recordings||12
2214219|NCT02969031|5429318|P1|STARTED|Collection of Follow-Up Recordings||15
2214220|NCT02969031|5429317|P2|NOT COMPLETED|Collection of Follow-Up Surveys||2
2214221|NCT02969031|5429318|P1|NOT COMPLETED|Collection of Follow-Up Surveys||0
2214222|NCT02969031|5429317|P2|COMPLETED|Collection of Follow-Up Surveys||12
2214223|NCT02969031|5429318|P1|COMPLETED|Collection of Follow-Up Surveys||15
2214224|NCT02969031|5429317|P2|STARTED|Collection of Follow-Up Surveys||14
2214225|NCT02969031|5429318|P1|STARTED|Collection of Follow-Up Surveys||15
2214226|NCT02969031|5429317|P2|NOT COMPLETED|Completed Intervention||4
2214227|NCT02969031|5429318|P1|NOT COMPLETED|Completed Intervention||7
2214228|NCT02969031|5429317|P2|COMPLETED|Completed Intervention||14
2214229|NCT02969031|5429318|P1|COMPLETED|Completed Intervention||15
2214230|NCT02969031|5429317|P2|STARTED|Completed Intervention||18
2214231|NCT02969031|5429318|P1|STARTED|Completed Intervention||22
2214232|NCT02969031|5429317|P2|NOT COMPLETED|Collection of Baseline Recordings||5
2214233|NCT02969031|5429318|P1|NOT COMPLETED|Collection of Baseline Recordings||12
2214234|NCT02969031|5429317|P2|COMPLETED|Collection of Baseline Recordings||18
2214235|NCT02969031|5429318|P1|COMPLETED|Collection of Baseline Recordings||22
2214236|NCT02969031|5429317|P2|STARTED|Collection of Baseline Recordings||23
2214237|NCT02969031|5429318|P1|STARTED|Collection of Baseline Recordings||34
2214238|NCT02969031|5429317|P2|NOT COMPLETED|Collection of Baseline Surveys||52
2214239|NCT02969031|5429318|P1|NOT COMPLETED|Collection of Baseline Surveys||39
2214240|NCT02969031|5429317|P2|COMPLETED|Collection of Baseline Surveys||23
2214241|NCT02969031|5429318|P1|COMPLETED|Collection of Baseline Surveys||34
2214242|NCT02969031|5429317|P2|STARTED|Collection of Baseline Surveys||75
2214243|NCT02969031|5429318|P1|STARTED|Collection of Baseline Surveys||73
2214244|NCT02969031|5429317|P2|NOT COMPLETED|Enrolled and Randomized||0
2214245|NCT02969031|5429318|P1|NOT COMPLETED|Enrolled and Randomized||0
2214246|NCT02969031|5429317|P2|COMPLETED|Enrolled and Randomized||75
2214247|NCT02969031|5429318|P1|COMPLETED|Enrolled and Randomized||73
2214248|NCT02969031|5429317|P2|STARTED|Enrolled and Randomized||75
2214249|NCT02969031|5429318|P1|STARTED|Enrolled and Randomized||73
2214250|NCT02969018|5429334|P8|NOT COMPLETED|Overall Study||7
2214251|NCT02969018|5429335|P7|NOT COMPLETED|Overall Study||8
2214252|NCT02969018|5429336|P6|NOT COMPLETED|Overall Study||8
2214253|NCT02969018|5429337|P5|NOT COMPLETED|Overall Study||2
2214254|NCT02969018|5429338|P4|NOT COMPLETED|Overall Study||5
2214255|NCT02969018|5429339|P3|NOT COMPLETED|Overall Study||6
2214256|NCT02969018|5429340|P2|NOT COMPLETED|Overall Study||8
2214257|NCT02969018|5429341|P1|NOT COMPLETED|Overall Study||4
2214258|NCT02969018|5429334|P8|COMPLETED|Overall Study||16
2214259|NCT02969018|5429335|P7|COMPLETED|Overall Study||22
2214260|NCT02969018|5429336|P6|COMPLETED|Overall Study||17
2214261|NCT02969018|5429337|P5|COMPLETED|Overall Study||27
2214262|NCT02969018|5429338|P4|COMPLETED|Overall Study||20
2214263|NCT02969018|5429339|P3|COMPLETED|Overall Study||20
2214264|NCT02969018|5429340|P2|COMPLETED|Overall Study||21
2214265|NCT02969018|5429341|P1|COMPLETED|Overall Study||21
2214266|NCT02969018|5429334|P8|STARTED|Overall Study||23
2214267|NCT02969018|5429335|P7|STARTED|Overall Study||30
2214268|NCT02969018|5429336|P6|STARTED|Overall Study||25
2214269|NCT02969018|5429337|P5|STARTED|Overall Study||29
2214270|NCT02969018|5429338|P4|STARTED|Overall Study||25
2214271|NCT02969018|5429339|P3|STARTED|Overall Study||26
2214272|NCT02969018|5429340|P2|STARTED|Overall Study||29
2214273|NCT02969018|5429341|P1|STARTED|Overall Study||25
2214274|NCT02968979|5429458|P1|NOT COMPLETED|Overall Study||8
2214275|NCT02968979|5429458|P1|COMPLETED|Overall Study|This cross-sectional study had only 1 visit.|531
2214276|NCT02968979|5429458|P1|STARTED|Overall Study||539
2214277|NCT02968914|5429546|P2|NOT COMPLETED|Overall Study||0
2214278|NCT02968914|5429547|P1|NOT COMPLETED|Overall Study||0
2214279|NCT02968914|5429546|P2|COMPLETED|Overall Study||90
2214280|NCT02968914|5429547|P1|COMPLETED|Overall Study||90
2214281|NCT02968914|5429546|P2|STARTED|Overall Study||90
2214282|NCT02968914|5429547|P1|STARTED|Overall Study||90
2214283|NCT02968758|5429571|P2|NOT COMPLETED|Overall Study||0
2214284|NCT02968758|5429572|P1|NOT COMPLETED|Overall Study||0
2214285|NCT02968758|5429571|P2|COMPLETED|Overall Study||1664
2214286|NCT02968758|5429572|P1|COMPLETED|Overall Study||797
2214287|NCT02968758|5429571|P2|STARTED|Overall Study||1664
2214288|NCT02968758|5429572|P1|STARTED|Overall Study||797
2214289|NCT02968576|5429583|P2|NOT COMPLETED|Overall Study||1
2214290|NCT02968576|5429584|P1|NOT COMPLETED|Overall Study||0
2214291|NCT02968576|5429583|P2|COMPLETED|Overall Study||13
2214292|NCT02968576|5429584|P1|COMPLETED|Overall Study||11
2214293|NCT02968576|5429583|P2|STARTED|Overall Study||14
2214294|NCT02968576|5429584|P1|STARTED|Overall Study||11
2214295|NCT02968277|5429592|P3|NOT COMPLETED|Overall Study||0
2214296|NCT02968277|5429593|P2|NOT COMPLETED|Overall Study||0
2214297|NCT02968277|5429594|P1|NOT COMPLETED|Overall Study||0
2214298|NCT02968277|5429592|P3|COMPLETED|Overall Study||13
2214299|NCT02968277|5429593|P2|COMPLETED|Overall Study||7
2214300|NCT02968277|5429594|P1|COMPLETED|Overall Study||10
2214301|NCT02968277|5429592|P3|STARTED|Overall Study||13
2214302|NCT02968277|5429593|P2|STARTED|Overall Study||7
2214303|NCT02968277|5429594|P1|STARTED|Overall Study||10
2214304|NCT02968173|5429620|P1|NOT COMPLETED|Overall Study||1
2214305|NCT02968173|5429620|P1|COMPLETED|Overall Study||49
2214306|NCT02968173|5429620|P1|STARTED|Overall Study||50
2214307|NCT02968134|5429632|P1|NOT COMPLETED|Overall Study||0
2214308|NCT02968134|5429632|P1|COMPLETED|Overall Study||8
2214309|NCT02968134|5429632|P1|STARTED|Overall Study||8
2214310|NCT02967991|5429637|P2|NOT COMPLETED|Overall Study||0
2214311|NCT02967991|5429638|P1|NOT COMPLETED|Overall Study||0
2214312|NCT02967991|5429637|P2|COMPLETED|Overall Study||10
2214313|NCT02967991|5429638|P1|COMPLETED|Overall Study||10
2214314|NCT02967991|5429637|P2|STARTED|Overall Study|First Intervention: 10 minutes Washout: 1 minute Second Intervention: 10 minutes|10
2214315|NCT02967991|5429638|P1|STARTED|Overall Study|First Intervention: 10 minutes Washout: 1 minute Second Intervention: 10 minutes|10
2214316|NCT02967510|5429661|P4|NOT COMPLETED|Overall Study||8
2214317|NCT02967510|5429662|P3|NOT COMPLETED|Overall Study||7
2214318|NCT02967510|5429663|P2|NOT COMPLETED|Overall Study||3
2214319|NCT02967510|5429664|P1|NOT COMPLETED|Overall Study||4
2214320|NCT02967510|5429661|P4|COMPLETED|Overall Study||63
2214321|NCT02967510|5429662|P3|COMPLETED|Overall Study||65
2214322|NCT02967510|5429663|P2|COMPLETED|Overall Study||67
2214323|NCT02967510|5429664|P1|COMPLETED|Overall Study||66
2214324|NCT02967510|5429661|P4|STARTED|Overall Study||71
2214325|NCT02967510|5429662|P3|STARTED|Overall Study||72
2214326|NCT02967510|5429663|P2|STARTED|Overall Study||70
2214327|NCT02967510|5429664|P1|STARTED|Overall Study||70
2214328|NCT02967458|5429790|P1|NOT COMPLETED|Overall Study||0
2214329|NCT02967458|5429790|P1|COMPLETED|Overall Study||55
2214330|NCT02967458|5429790|P1|STARTED|Overall Study||55
2214331|NCT02967393|5429798|P2|NOT COMPLETED|Overall Study||0
2214332|NCT02967393|5429799|P1|NOT COMPLETED|Overall Study||0
2214333|NCT02967393|5429798|P2|COMPLETED|Overall Study||20
2214334|NCT02967393|5429799|P1|COMPLETED|Overall Study||20
2214335|NCT02967393|5429798|P2|STARTED|Overall Study||20
2214336|NCT02967393|5429799|P1|STARTED|Overall Study||20
2214337|NCT02967354|5429829|P5|NOT COMPLETED|Overall Study||0
2214338|NCT02967354|5429830|P4|NOT COMPLETED|Overall Study||0
2214339|NCT02967354|5429831|P3|NOT COMPLETED|Overall Study||0
2214340|NCT02967354|5429832|P2|NOT COMPLETED|Overall Study||0
2214341|NCT02967354|5429833|P1|NOT COMPLETED|Overall Study||0
2214342|NCT02967354|5429829|P5|COMPLETED|Overall Study||8
2214343|NCT02967354|5429830|P4|COMPLETED|Overall Study||7
2214344|NCT02967354|5429831|P3|COMPLETED|Overall Study||9
2214345|NCT02967354|5429832|P2|COMPLETED|Overall Study||7
2214346|NCT02967354|5429833|P1|COMPLETED|Overall Study||8
2214347|NCT02967354|5429829|P5|STARTED|Overall Study||8
2214348|NCT02967354|5429830|P4|STARTED|Overall Study||7
2214349|NCT02967354|5429831|P3|STARTED|Overall Study||9
2214350|NCT02967354|5429832|P2|STARTED|Overall Study||7
2214351|NCT02967354|5429833|P1|STARTED|Overall Study||8
2214352|NCT02966795|5429867|P2|NOT COMPLETED|Overall Study||1
2214353|NCT02966795|5429868|P1|NOT COMPLETED|Overall Study||0
2214354|NCT02966795|5429867|P2|COMPLETED|Overall Study||60
2214355|NCT02966795|5429868|P1|COMPLETED|Overall Study||23
2214356|NCT02966795|5429867|P2|STARTED|Overall Study||61
2214357|NCT02966795|5429868|P1|STARTED|Overall Study||23
2214358|NCT02966509|5429879|P2|NOT COMPLETED|End of Life Utilization and Cost 15month||48
2214359|NCT02966509|5429880|P1|NOT COMPLETED|End of Life Utilization and Cost 15month||45
2214360|NCT02966509|5429879|P2|COMPLETED|End of Life Utilization and Cost 15month||60
2214361|NCT02966509|5429880|P1|COMPLETED|End of Life Utilization and Cost 15month||60
2214362|NCT02966509|5429879|P2|STARTED|End of Life Utilization and Cost 15month||108
2214363|NCT02966509|5429880|P1|STARTED|End of Life Utilization and Cost 15month||105
2214364|NCT02966509|5429879|P2|NOT COMPLETED|End of Life Utilization and Cost 6 Month||75
2214365|NCT02966509|5429880|P1|NOT COMPLETED|End of Life Utilization and Cost 6 Month||69
2214366|NCT02966509|5429879|P2|COMPLETED|End of Life Utilization and Cost 6 Month||33
2214367|NCT02966509|5429880|P1|COMPLETED|End of Life Utilization and Cost 6 Month||36
2214368|NCT02966509|5429879|P2|STARTED|End of Life Utilization and Cost 6 Month||108
2214369|NCT02966509|5429880|P1|STARTED|End of Life Utilization and Cost 6 Month||105
2214370|NCT02966509|5429879|P2|NOT COMPLETED|15-Month Utilization and Cost||0
2214371|NCT02966509|5429880|P1|NOT COMPLETED|15-Month Utilization and Cost||0
2214372|NCT02966509|5429879|P2|COMPLETED|15-Month Utilization and Cost||108
2214373|NCT02966509|5429880|P1|COMPLETED|15-Month Utilization and Cost||105
2214374|NCT02966509|5429879|P2|STARTED|15-Month Utilization and Cost||108
2214375|NCT02966509|5429880|P1|STARTED|15-Month Utilization and Cost||105
2214376|NCT02966509|5429879|P2|NOT COMPLETED|6-Month Utilization and Cost||0
2214377|NCT02966509|5429880|P1|NOT COMPLETED|6-Month Utilization and Cost||0
2214378|NCT02966509|5429879|P2|COMPLETED|6-Month Utilization and Cost||108
2214379|NCT02966509|5429880|P1|COMPLETED|6-Month Utilization and Cost||105
2214380|NCT02966509|5429879|P2|STARTED|6-Month Utilization and Cost||108
2214381|NCT02966509|5429880|P1|STARTED|6-Month Utilization and Cost||105
2214382|NCT02966509|5429879|P2|NOT COMPLETED|6 Month Satisfaction Survey||48
2214383|NCT02966509|5429880|P1|NOT COMPLETED|6 Month Satisfaction Survey||47
2214384|NCT02966509|5429879|P2|COMPLETED|6 Month Satisfaction Survey||60
2214385|NCT02966509|5429880|P1|COMPLETED|6 Month Satisfaction Survey||58
2214386|NCT02966509|5429879|P2|STARTED|6 Month Satisfaction Survey||108
2214387|NCT02966509|5429880|P1|STARTED|6 Month Satisfaction Survey||105
2214388|NCT02966509|5429879|P2|NOT COMPLETED|6 Month Satisfaction Decision Survey||31
2214389|NCT02966509|5429880|P1|NOT COMPLETED|6 Month Satisfaction Decision Survey||25
2214390|NCT02966509|5429879|P2|COMPLETED|6 Month Satisfaction Decision Survey||77
2214391|NCT02966509|5429880|P1|COMPLETED|6 Month Satisfaction Decision Survey||80
2214392|NCT02966509|5429879|P2|STARTED|6 Month Satisfaction Decision Survey||108
2214393|NCT02966509|5429880|P1|STARTED|6 Month Satisfaction Decision Survey||105
2214394|NCT02966509|5429879|P2|NOT COMPLETED|Baseline Satisfaction Survey||7
2214395|NCT02966509|5429880|P1|NOT COMPLETED|Baseline Satisfaction Survey||4
2214396|NCT02966509|5429879|P2|COMPLETED|Baseline Satisfaction Survey||101
2214397|NCT02966509|5429880|P1|COMPLETED|Baseline Satisfaction Survey||101
2214398|NCT02966509|5429879|P2|STARTED|Baseline Satisfaction Survey||108
2214399|NCT02966509|5429880|P1|STARTED|Baseline Satisfaction Survey||105
2214400|NCT02966340|5429904|P2|NOT COMPLETED|Overall Study||3
2214401|NCT02966340|5429905|P1|NOT COMPLETED|Overall Study||3
2214402|NCT02966340|5429904|P2|COMPLETED|Overall Study||30
2214403|NCT02966340|5429905|P1|COMPLETED|Overall Study||34
2214404|NCT02966340|5429904|P2|STARTED|Overall Study||33
2214405|NCT02966340|5429905|P1|STARTED|Overall Study||37
2214406|NCT02966275|5429913|P1|NOT COMPLETED|Overall Study||0
2214407|NCT02966275|5429913|P1|COMPLETED|Overall Study||10
2214408|NCT02966275|5429913|P1|STARTED|Overall Study||10
2214409|NCT02966015|5429950|P2|NOT COMPLETED|Test Period||0
2214410|NCT02966015|5429951|P1|NOT COMPLETED|Test Period||0
2214411|NCT02966015|5429950|P2|COMPLETED|Test Period||55
2214412|NCT02966015|5429951|P1|COMPLETED|Test Period||87
2214413|NCT02966015|5429950|P2|STARTED|Test Period||55
2214414|NCT02966015|5429951|P1|STARTED|Test Period||87
2214415|NCT02966015|5429950|P2|NOT COMPLETED|Inclusion Visit||3
2214416|NCT02966015|5429951|P1|NOT COMPLETED|Inclusion Visit||8
2214417|NCT02966015|5429950|P2|COMPLETED|Inclusion Visit||55
2214418|NCT02966015|5429951|P1|COMPLETED|Inclusion Visit||87
2214419|NCT02966015|5429950|P2|STARTED|Inclusion Visit||58
2214420|NCT02966015|5429951|P1|STARTED|Inclusion Visit||95
2214421|NCT02966002|5429957|P1|NOT COMPLETED|Overall Study||4
2214422|NCT02966002|5429957|P1|COMPLETED|Overall Study||5
2214423|NCT02966002|5429957|P1|STARTED|Overall Study||9
2214424|NCT02965924|5429964|P1|NOT COMPLETED|Overall Study||0
2214425|NCT02965924|5429964|P1|COMPLETED|Overall Study||20
2214426|NCT02965924|5429964|P1|STARTED|Overall Study||20
2214427|NCT02965846|5429972|P3|NOT COMPLETED|Overall Study||33
2214428|NCT02965846|5429973|P2|NOT COMPLETED|Overall Study||5
2214429|NCT02965846|5429974|P1|NOT COMPLETED|Overall Study||5
2214430|NCT02965846|5429972|P3|COMPLETED|Overall Study||0
2214431|NCT02965846|5429973|P2|COMPLETED|Overall Study||0
2214432|NCT02965846|5429974|P1|COMPLETED|Overall Study||0
2214433|NCT02965846|5429972|P3|STARTED|Overall Study||33
2214434|NCT02965846|5429973|P2|STARTED|Overall Study||5
2214435|NCT02965846|5429974|P1|STARTED|Overall Study||5
2214436|NCT02965833|5429982|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
2214437|NCT02965833|5429983|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
2214438|NCT02965833|5429982|P2|COMPLETED|Period 2, Second 30 Days of Wear||52
2214439|NCT02965833|5429983|P1|COMPLETED|Period 2, Second 30 Days of Wear||62
2214440|NCT02965833|5429982|P2|STARTED|Period 2, Second 30 Days of Wear||52
2214441|NCT02965833|5429983|P1|STARTED|Period 2, Second 30 Days of Wear||64
2214442|NCT02965833|5429982|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||2
2214443|NCT02965833|5429983|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||3
2214444|NCT02965833|5429982|P2|COMPLETED|Period 1, First 30 Days of Wear||52
2214445|NCT02965833|5429983|P1|COMPLETED|Period 1, First 30 Days of Wear||64
2214446|NCT02965833|5429982|P2|STARTED|Period 1, First 30 Days of Wear||54
2214447|NCT02965833|5429983|P1|STARTED|Period 1, First 30 Days of Wear||67
2214448|NCT02965820|5429989|P2|NOT COMPLETED|Period 2, Second 30 Days||1
2214449|NCT02965820|5429990|P1|NOT COMPLETED|Period 2, Second 30 Days||1
2214450|NCT02965820|5429989|P2|COMPLETED|Period 2, Second 30 Days||61
2214451|NCT02965820|5429990|P1|COMPLETED|Period 2, Second 30 Days||57
2214452|NCT02965820|5429989|P2|STARTED|Period 2, Second 30 Days||62
2214453|NCT02965820|5429990|P1|STARTED|Period 2, Second 30 Days|One subject discontinued due to an AE after completion of Period 1 but before beginning Period 2.|58
2214454|NCT02965820|5429989|P2|NOT COMPLETED|Period 1, First 30 Days||0
2214455|NCT02965820|5429990|P1|NOT COMPLETED|Period 1, First 30 Days||0
2214456|NCT02965820|5429989|P2|COMPLETED|Period 1, First 30 Days||62
2214457|NCT02965820|5429990|P1|COMPLETED|Period 1, First 30 Days||59
2214458|NCT02965820|5429989|P2|STARTED|Period 1, First 30 Days||62
2214459|NCT02965820|5429990|P1|STARTED|Period 1, First 30 Days||59
2214460|NCT02965729|5429999|P3|NOT COMPLETED|Overall Study||11
2214461|NCT02965729|5430000|P2|NOT COMPLETED|Overall Study||3
2214462|NCT02965729|5430001|P1|NOT COMPLETED|Overall Study||7
2214463|NCT02965729|5429999|P3|COMPLETED|Overall Study||45
2214464|NCT02965729|5430000|P2|COMPLETED|Overall Study||22
2214465|NCT02965729|5430001|P1|COMPLETED|Overall Study||17
2214466|NCT02965729|5429999|P3|STARTED|Overall Study||56
2214467|NCT02965729|5430000|P2|STARTED|Overall Study||25
2214468|NCT02965729|5430001|P1|STARTED|Overall Study||24
2214469|NCT02965599|5430029|P2|NOT COMPLETED|Overall Study||0
2214470|NCT02965599|5430030|P1|NOT COMPLETED|Overall Study||1
2214471|NCT02965599|5430029|P2|COMPLETED|Overall Study||1
2214472|NCT02965599|5430030|P1|COMPLETED|Overall Study||1
2214473|NCT02965599|5430029|P2|STARTED|Overall Study||1
2214474|NCT02965599|5430030|P1|STARTED|Overall Study||2
2214475|NCT02965534|5430092|P2|NOT COMPLETED|Overall Study||0
2214476|NCT02965534|5430093|P1|NOT COMPLETED|Overall Study||0
2214477|NCT02965534|5430092|P2|COMPLETED|Overall Study||55
2214478|NCT02965534|5430093|P1|COMPLETED|Overall Study||45
2214479|NCT02965534|5430092|P2|STARTED|Overall Study|test period: 14 days with each test glasses|55
2214480|NCT02965534|5430093|P1|STARTED|Overall Study|test period: 14 days with each test glasses|45
2214481|NCT02965456|5430109|P2|NOT COMPLETED|Overall Study||43
2214482|NCT02965456|5430110|P1|NOT COMPLETED|Overall Study||71
2214483|NCT02965456|5430109|P2|COMPLETED|Overall Study||364
2214484|NCT02965456|5430110|P1|COMPLETED|Overall Study||342
2214485|NCT02965456|5430109|P2|Safety Population|Overall Study||398
2214486|NCT02965456|5430110|P1|Safety Population|Overall Study||389
2214487|NCT02965456|5430109|P2|Intent-to-treat (ITT) Population|Overall Study||407
2214488|NCT02965456|5430110|P1|Intent-to-treat (ITT) Population|Overall Study||413
2214489|NCT02965456|5430109|P2|STARTED|Overall Study||407
2214490|NCT02965456|5430110|P1|STARTED|Overall Study||413
2214491|NCT02964910|5430126|P2|NOT COMPLETED|Overall Study||44
2214492|NCT02964910|5430127|P1|NOT COMPLETED|Overall Study||43
2214493|NCT02964910|5430126|P2|COMPLETED|Overall Study||196
2214494|NCT02964910|5430127|P1|COMPLETED|Overall Study||192
2214495|NCT02964910|5430126|P2|STARTED|Overall Study||240
2214496|NCT02964910|5430127|P1|STARTED|Overall Study||235
2214497|NCT02964767|5430153|P2|NOT COMPLETED|Overall Study||0
2214498|NCT02964767|5430154|P1|NOT COMPLETED|Overall Study||0
2214499|NCT02964767|5430153|P2|COMPLETED|Overall Study||48
2214500|NCT02964767|5430154|P1|COMPLETED|Overall Study||171
2214501|NCT02964767|5430153|P2|STARTED|Overall Study||48
2214502|NCT02964767|5430154|P1|STARTED|Overall Study||171
2214503|NCT02964338|5430164|P3|NOT COMPLETED|Overall Study||19
2214504|NCT02964338|5430165|P2|NOT COMPLETED|Overall Study||24
2214505|NCT02964338|5430166|P1|NOT COMPLETED|Overall Study||17
2214506|NCT02964338|5430164|P3|COMPLETED|Overall Study||68
2214507|NCT02964338|5430165|P2|COMPLETED|Overall Study||64
2214508|NCT02964338|5430166|P1|COMPLETED|Overall Study||67
2214509|NCT02964338|5430164|P3|Full Analysis Set|Overall Study||87
2214510|NCT02964338|5430165|P2|Full Analysis Set|Overall Study||86
2214511|NCT02964338|5430166|P1|Full Analysis Set|Overall Study||81
2214512|NCT02964338|5430164|P3|Safety Analysis Set|Overall Study||87
2214513|NCT02964338|5430165|P2|Safety Analysis Set|Overall Study||88
2214514|NCT02964338|5430166|P1|Safety Analysis Set|Overall Study||83
2214515|NCT02964338|5430164|P3|STARTED|Overall Study||87
2214516|NCT02964338|5430165|P2|STARTED|Overall Study||88
2214517|NCT02964338|5430166|P1|STARTED|Overall Study||84
2214518|NCT02964312|5430210|P1|NOT COMPLETED|Overall Study||27
2214519|NCT02964312|5430210|P1|COMPLETED|Overall Study||139
2214520|NCT02964312|5430210|P1|12-Month Follow-up|Overall Study||139
2214521|NCT02964312|5430210|P1|6-Month Follow-up|Overall Study||152
2214522|NCT02964312|5430210|P1|3-Month Follow-up|Overall Study||159
2214523|NCT02964312|5430210|P1|1-Month Follow-up|Overall Study||164
2214524|NCT02964312|5430210|P1|STARTED|Overall Study||166
2214525|NCT02964247|5430218|P2|NOT COMPLETED|Overall Study||2
2214526|NCT02964247|5430219|P1|NOT COMPLETED|Overall Study||3
2214527|NCT02964247|5430218|P2|COMPLETED|Overall Study||98
2214528|NCT02964247|5430219|P1|COMPLETED|Overall Study||200
2214529|NCT02964247|5430218|P2|Exposed to Trial Product|Overall Study||100
2214530|NCT02964247|5430219|P1|Exposed to Trial Product|Overall Study||202
2214531|NCT02964247|5430218|P2|STARTED|Overall Study||100
2214532|NCT02964247|5430219|P1|STARTED|Overall Study||203
2214533|NCT02963987|5430275|P2|NOT COMPLETED|Second Intervention Period||0
2214534|NCT02963987|5430276|P1|NOT COMPLETED|Second Intervention Period||0
2214535|NCT02963987|5430275|P2|COMPLETED|Second Intervention Period||19
2214536|NCT02963987|5430276|P1|COMPLETED|Second Intervention Period||31
2214537|NCT02963987|5430275|P2|STARTED|Second Intervention Period||19
2214538|NCT02963987|5430276|P1|STARTED|Second Intervention Period||31
2214539|NCT02963987|5430275|P2|NOT COMPLETED|First Intervention Period||0
2214540|NCT02963987|5430276|P1|NOT COMPLETED|First Intervention Period||0
2214541|NCT02963987|5430275|P2|COMPLETED|First Intervention Period||19
2214542|NCT02963987|5430276|P1|COMPLETED|First Intervention Period||31
2214543|NCT02963987|5430275|P2|STARTED|First Intervention Period||19
2214544|NCT02963987|5430276|P1|STARTED|First Intervention Period||31
2214545|NCT02963935|5430288|P2|NOT COMPLETED|Overall Study||37
2214546|NCT02963935|5430289|P1|NOT COMPLETED|Overall Study||28
2214547|NCT02963935|5430288|P2|COMPLETED|Overall Study||103
2214548|NCT02963935|5430289|P1|COMPLETED|Overall Study||114
2214549|NCT02963935|5430288|P2|STARTED|Overall Study||140
2214550|NCT02963935|5430289|P1|STARTED|Overall Study||142
2214551|NCT02963922|5430397|P2|NOT COMPLETED|Overall Study||30
2214552|NCT02963922|5430398|P1|NOT COMPLETED|Overall Study||32
2214553|NCT02963922|5430397|P2|COMPLETED|Overall Study||168
2214554|NCT02963922|5430398|P1|COMPLETED|Overall Study||166
2214555|NCT02963922|5430397|P2|STARTED|Overall Study||198
2214556|NCT02963922|5430398|P1|STARTED|Overall Study||198
2214557|NCT02963701|5430496|P2|NOT COMPLETED|Period 2 (2 Days)||0
2214558|NCT02963701|5430497|P1|NOT COMPLETED|Period 2 (2 Days)||0
2214559|NCT02963701|5430496|P2|COMPLETED|Period 2 (2 Days)||28
2214560|NCT02963701|5430497|P1|COMPLETED|Period 2 (2 Days)||27
2214561|NCT02963701|5430496|P2|STARTED|Period 2 (2 Days)||28
2214562|NCT02963701|5430497|P1|STARTED|Period 2 (2 Days)||27
2214563|NCT02963701|5430496|P2|NOT COMPLETED|Period 1 (Including Washout) (2 Days)||0
2214564|NCT02963701|5430497|P1|NOT COMPLETED|Period 1 (Including Washout) (2 Days)||1
2214565|NCT02963701|5430496|P2|COMPLETED|Period 1 (Including Washout) (2 Days)||28
2214566|NCT02963701|5430497|P1|COMPLETED|Period 1 (Including Washout) (2 Days)|One subject withdrawn from the study after period 1|27
2214567|NCT02963701|5430496|P2|STARTED|Period 1 (Including Washout) (2 Days)||28
2214568|NCT02963701|5430497|P1|STARTED|Period 1 (Including Washout) (2 Days)||28
2214569|NCT02962960|5430530|P3|NOT COMPLETED|Overall Study||0
2214570|NCT02962960|5430531|P2|NOT COMPLETED|Overall Study||2
2214571|NCT02962960|5430532|P1|NOT COMPLETED|Overall Study||3
2214572|NCT02962960|5430530|P3|COMPLETED|Overall Study||9
2214573|NCT02962960|5430531|P2|COMPLETED|Overall Study||11
2214574|NCT02962960|5430532|P1|COMPLETED|Overall Study||11
2214575|NCT02962960|5430530|P3|STARTED|Overall Study||9
2214576|NCT02962960|5430531|P2|STARTED|Overall Study||13
2214577|NCT02962960|5430532|P1|STARTED|Overall Study||14
2214578|NCT02962934|5430605|P2|NOT COMPLETED|Overall Study||0
2214579|NCT02962934|5430606|P1|NOT COMPLETED|Overall Study||0
2214580|NCT02962934|5430605|P2|COMPLETED|Overall Study||6
2214581|NCT02962934|5430606|P1|COMPLETED|Overall Study||12
2214582|NCT02962934|5430605|P2|STARTED|Overall Study||6
2214583|NCT02962934|5430606|P1|STARTED|Overall Study||12
2214584|NCT02962908|5430616|P4|NOT COMPLETED|Overall Study||3
2214585|NCT02962908|5430617|P3|NOT COMPLETED|Overall Study||0
2214586|NCT02962908|5430618|P2|NOT COMPLETED|Overall Study||8
2214587|NCT02962908|5430619|P1|NOT COMPLETED|Overall Study||0
2214588|NCT02962908|5430616|P4|COMPLETED|Overall Study||24
2214589|NCT02962908|5430617|P3|COMPLETED|Overall Study||32
2214590|NCT02962908|5430618|P2|COMPLETED|Overall Study||50
2214591|NCT02962908|5430619|P1|COMPLETED|Overall Study||58
2214592|NCT02962908|5430616|P4|STARTED|Overall Study||27
2214593|NCT02962908|5430617|P3|STARTED|Overall Study||32
2214594|NCT02962908|5430618|P2|STARTED|Overall Study||58
2214595|NCT02962908|5430619|P1|STARTED|Overall Study||58
2214596|NCT02962882|5430661|P1|NOT COMPLETED|Overall Study||36
2214597|NCT02962882|5430661|P1|COMPLETED|Overall Study||14
2214598|NCT02962882|5430661|P1|STARTED|Overall Study||50
2214599|NCT02962687|5430672|P2|NOT COMPLETED|Overall Study||8
2214600|NCT02962687|5430673|P1|NOT COMPLETED|Overall Study||10
2214601|NCT02962687|5430672|P2|COMPLETED|Overall Study|This number represents 16 dyads (1 Veteran and 1 caregiver in each dyad)|32
2214602|NCT02962687|5430673|P1|COMPLETED|Overall Study|This number represents 15 dyads (1 Veteran and 1 caregiver in each dyad)|30
2214603|NCT02962687|5430672|P2|STARTED|Overall Study|This number represents 20 dyads (1 Veteran and 1 caregiver in each dyad)|40
2214604|NCT02962687|5430673|P1|STARTED|Overall Study|This number represents 20 dyads (1 Veteran and 1 caregiver in each dyad)|40
2214605|NCT02962609|5430699|P2|NOT COMPLETED|Overall Study||0
2214606|NCT02962609|5430700|P1|NOT COMPLETED|Overall Study||0
2214607|NCT02962609|5430699|P2|COMPLETED|Overall Study||42
2214608|NCT02962609|5430700|P1|COMPLETED|Overall Study||38
2214609|NCT02962609|5430699|P2|STARTED|Overall Study||42
2214610|NCT02962609|5430700|P1|STARTED|Overall Study||38
2214611|NCT02962427|5430712|P2|NOT COMPLETED|Overall Study||0
2214612|NCT02962427|5430713|P1|NOT COMPLETED|Overall Study||0
2214613|NCT02962427|5430712|P2|COMPLETED|Overall Study||1
2214614|NCT02962427|5430713|P1|COMPLETED|Overall Study||3
2214615|NCT02962427|5430712|P2|STARTED|Overall Study||1
2214616|NCT02962427|5430713|P1|STARTED|Overall Study||3
2214617|NCT02962284|5430723|P2|NOT COMPLETED|Overall Study||3
2214618|NCT02962284|5430724|P1|NOT COMPLETED|Overall Study||5
2214619|NCT02962284|5430723|P2|COMPLETED|Overall Study||8
2214620|NCT02962284|5430724|P1|COMPLETED|Overall Study||4
2214621|NCT02962284|5430723|P2|STARTED|Overall Study||11
2214622|NCT02962284|5430724|P1|STARTED|Overall Study||9
2214623|NCT02961946|5430743|P3|NOT COMPLETED|Overall Study||0
2214624|NCT02961946|5430744|P2|NOT COMPLETED|Overall Study||0
2214625|NCT02961946|5430745|P1|NOT COMPLETED|Overall Study||0
2214626|NCT02961946|5430743|P3|COMPLETED|Overall Study||66
2214627|NCT02961946|5430744|P2|COMPLETED|Overall Study||66
2214628|NCT02961946|5430745|P1|COMPLETED|Overall Study||66
2214629|NCT02961946|5430743|P3|STARTED|Overall Study||66
2214630|NCT02961946|5430744|P2|STARTED|Overall Study||66
2214631|NCT02961946|5430745|P1|STARTED|Overall Study||66
2214632|NCT02961920|5430755|P2|NOT COMPLETED|Overall Study||1
2214633|NCT02961920|5430756|P1|NOT COMPLETED|Overall Study||1
2214634|NCT02961920|5430755|P2|COMPLETED|Overall Study||24
2214635|NCT02961920|5430756|P1|COMPLETED|Overall Study||24
2214636|NCT02961920|5430755|P2|STARTED|Overall Study||25
2214637|NCT02961920|5430756|P1|STARTED|Overall Study||25
2214638|NCT02961790|5430766|P4|NOT COMPLETED|Overall Study||5
2214639|NCT02961790|5430767|P3|NOT COMPLETED|Overall Study||6
2214640|NCT02961790|5430768|P2|NOT COMPLETED|Overall Study||11
2214641|NCT02961790|5430769|P1|NOT COMPLETED|Overall Study||15
2214642|NCT02961790|5430766|P4|COMPLETED|Overall Study||20
2214643|NCT02961790|5430767|P3|COMPLETED|Overall Study||18
2214644|NCT02961790|5430768|P2|COMPLETED|Overall Study||40
2214645|NCT02961790|5430769|P1|COMPLETED|Overall Study||35
2214646|NCT02961790|5430766|P4|STARTED|Overall Study||25
2214647|NCT02961790|5430767|P3|STARTED|Overall Study||24
2214648|NCT02961790|5430768|P2|STARTED|Overall Study||51
2214649|NCT02961790|5430769|P1|STARTED|Overall Study||50
2214650|NCT02961751|5430790|P1|NOT COMPLETED|Overall Study||15
2214651|NCT02961751|5430790|P1|COMPLETED|Overall Study||196
2214652|NCT02961751|5430790|P1|STARTED|Overall Study||211
2214653|NCT02961244|5430803|P2|NOT COMPLETED|Overall Study||9
2214654|NCT02961244|5430804|P1|NOT COMPLETED|Overall Study||1
2214655|NCT02961244|5430803|P2|COMPLETED|Overall Study||55
2214656|NCT02961244|5430804|P1|COMPLETED|Overall Study||63
2214657|NCT02961244|5430803|P2|Patients Excluded During Randomization|Overall Study||1
2214658|NCT02961244|5430804|P1|Patients Excluded During Randomization|Overall Study||0
2214659|NCT02961244|5430803|P2|STARTED|Overall Study||64
2214660|NCT02961244|5430804|P1|STARTED|Overall Study||64
2214661|NCT02961062|5430814|P2|NOT COMPLETED|Overall Study||0
2214662|NCT02961062|5430815|P1|NOT COMPLETED|Overall Study||0
2214663|NCT02961062|5430814|P2|COMPLETED|Overall Study||20
2214664|NCT02961062|5430815|P1|COMPLETED|Overall Study||20
2214665|NCT02961062|5430814|P2|STARTED|Overall Study||20
2214666|NCT02961062|5430815|P1|STARTED|Overall Study||20
2214667|NCT02960997|5430831|P2|NOT COMPLETED|Follow-up Period, 4 Weeks||0
2214668|NCT02960997|5430832|P1|NOT COMPLETED|Follow-up Period, 4 Weeks||0
2214669|NCT02960997|5430831|P2|COMPLETED|Follow-up Period, 4 Weeks||4
2214670|NCT02960997|5430832|P1|COMPLETED|Follow-up Period, 4 Weeks||4
2214671|NCT02960997|5430831|P2|STARTED|Follow-up Period, 4 Weeks||4
2214672|NCT02960997|5430832|P1|STARTED|Follow-up Period, 4 Weeks||4
2214673|NCT02960997|5430831|P2|NOT COMPLETED|Second Treatment, 12 Weeks||0
2214674|NCT02960997|5430832|P1|NOT COMPLETED|Second Treatment, 12 Weeks||0
2214675|NCT02960997|5430831|P2|COMPLETED|Second Treatment, 12 Weeks||4
2214676|NCT02960997|5430832|P1|COMPLETED|Second Treatment, 12 Weeks||4
2214677|NCT02960997|5430831|P2|STARTED|Second Treatment, 12 Weeks||4
2214678|NCT02960997|5430832|P1|STARTED|Second Treatment, 12 Weeks||4
2214679|NCT02960997|5430831|P2|NOT COMPLETED|Washout Period, 4 Weeks||0
2214680|NCT02960997|5430832|P1|NOT COMPLETED|Washout Period, 4 Weeks||0
2214681|NCT02960997|5430831|P2|COMPLETED|Washout Period, 4 Weeks||4
2214682|NCT02960997|5430832|P1|COMPLETED|Washout Period, 4 Weeks||4
2214683|NCT02960997|5430831|P2|STARTED|Washout Period, 4 Weeks||4
2214684|NCT02960997|5430832|P1|STARTED|Washout Period, 4 Weeks||4
2214685|NCT02960997|5430831|P2|NOT COMPLETED|First Intervention, 12 Weeks||0
2214686|NCT02960997|5430832|P1|NOT COMPLETED|First Intervention, 12 Weeks||0
2214687|NCT02960997|5430831|P2|COMPLETED|First Intervention, 12 Weeks||4
2214688|NCT02960997|5430832|P1|COMPLETED|First Intervention, 12 Weeks||4
2214689|NCT02960997|5430831|P2|STARTED|First Intervention, 12 Weeks||4
2214690|NCT02960997|5430832|P1|STARTED|First Intervention, 12 Weeks||4
2214691|NCT02960854|5430857|P2|NOT COMPLETED|Overall Study||9
2214692|NCT02960854|5430858|P1|NOT COMPLETED|Overall Study||7
2214693|NCT02960854|5430857|P2|COMPLETED|Overall Study||7
2214694|NCT02960854|5430858|P1|COMPLETED|Overall Study||8
2214695|NCT02960854|5430857|P2|STARTED|Overall Study||16
2214696|NCT02960854|5430858|P1|STARTED|Overall Study||15
2214697|NCT02960295|5430888|P1|NOT COMPLETED|Overall Study||0
2214698|NCT02960295|5430888|P1|COMPLETED|Overall Study||10
2214699|NCT02960295|5430888|P1|STARTED|Overall Study||10
2214700|NCT02959996|5430897|P2|NOT COMPLETED|Overall Study||0
2214701|NCT02959996|5430898|P1|NOT COMPLETED|Overall Study||0
2214702|NCT02959996|5430897|P2|COMPLETED|Overall Study||39
2214703|NCT02959996|5430898|P1|COMPLETED|Overall Study||40
2214704|NCT02959996|5430897|P2|STARTED|Overall Study||39
2214705|NCT02959996|5430898|P1|STARTED|Overall Study||40
2214706|NCT02959983|5430922|P2|NOT COMPLETED|Overall Study||25
2214707|NCT02959983|5430923|P1|NOT COMPLETED|Overall Study||26
2214708|NCT02959983|5430922|P2|COMPLETED|Overall Study||149
2214709|NCT02959983|5430923|P1|COMPLETED|Overall Study||146
2214710|NCT02959983|5430922|P2|STARTED|Overall Study||174
2214711|NCT02959983|5430923|P1|STARTED|Overall Study||172
2214712|NCT02959970|5430937|P2|NOT COMPLETED|Overall Study||7
2214713|NCT02959970|5430938|P1|NOT COMPLETED|Overall Study||2
2214714|NCT02959970|5430937|P2|COMPLETED|Overall Study||76
2214715|NCT02959970|5430938|P1|COMPLETED|Overall Study||15
2214716|NCT02959970|5430937|P2|STARTED|Overall Study||83
2214717|NCT02959970|5430938|P1|STARTED|Overall Study||17
2214718|NCT02959892|5430972|P2|NOT COMPLETED|Overall Study||1
2214719|NCT02959892|5430973|P1|NOT COMPLETED|Overall Study||1
2214720|NCT02959892|5430972|P2|COMPLETED|Overall Study||5
2214721|NCT02959892|5430973|P1|COMPLETED|Overall Study||5
2214722|NCT02959892|5430972|P2|STARTED|Overall Study||6
2214723|NCT02959892|5430973|P1|STARTED|Overall Study||6
2214724|NCT02959866|5430981|P1|NOT COMPLETED|Overall Study||1
2214725|NCT02959866|5430981|P1|COMPLETED|Overall Study||58
2214726|NCT02959866|5430981|P1|Telephone Interview at 1 Month Follow-up|Overall Study||59
2214727|NCT02959866|5430981|P1|STARTED|Overall Study||59
2214728|NCT02959853|5430988|P2|NOT COMPLETED|Overall Study||2
2214729|NCT02959853|5430989|P1|NOT COMPLETED|Overall Study||4
2214730|NCT02959853|5430988|P2|COMPLETED|Overall Study||10
2214731|NCT02959853|5430989|P1|COMPLETED|Overall Study||7
2214732|NCT02959853|5430988|P2|STARTED|Overall Study||12
2214733|NCT02959853|5430989|P1|STARTED|Overall Study||11
2214734|NCT02959840|5431008|P3|NOT COMPLETED|Overall Study||0
2214735|NCT02959840|5431009|P2|NOT COMPLETED|Overall Study||0
2214736|NCT02959840|5431010|P1|NOT COMPLETED|Overall Study||0
2214737|NCT02959840|5431008|P3|COMPLETED|Overall Study||60
2214738|NCT02959840|5431009|P2|COMPLETED|Overall Study||60
2214739|NCT02959840|5431010|P1|COMPLETED|Overall Study||60
2214740|NCT02959840|5431008|P3|STARTED|Overall Study||60
2214741|NCT02959840|5431009|P2|STARTED|Overall Study||60
2214742|NCT02959840|5431010|P1|STARTED|Overall Study||60
2214743|NCT02959827|5431051|P1|NOT COMPLETED|Overall Study||0
2214744|NCT02959827|5431051|P1|COMPLETED|Overall Study||2320
2214745|NCT02959827|5431051|P1|STARTED|Overall Study||2320
2214746|NCT02959814|5431070|P1|NOT COMPLETED|Overall Study||57
2214747|NCT02959814|5431070|P1|COMPLETED|Overall Study|17-10-2017|272
2214748|NCT02959814|5431070|P1|STARTED|Overall Study|22-02-2017|329
2214848|NCT02958982|5431204|P3|STARTED|Cohort 3: 400 mg in MAD Study||0
2214770|NCT02959138|5431149|P3|NOT COMPLETED|Overall Study||0
2214771|NCT02959138|5431150|P2|NOT COMPLETED|Overall Study||1
2214772|NCT02959138|5431151|P1|NOT COMPLETED|Overall Study||0
2214773|NCT02959138|5431149|P3|COMPLETED|Overall Study||16
2214774|NCT02959138|5431150|P2|COMPLETED|Overall Study||9
2214775|NCT02959138|5431151|P1|COMPLETED|Overall Study||10
2214776|NCT02959138|5431149|P3|STARTED|Overall Study||16
2214777|NCT02959138|5431150|P2|STARTED|Overall Study||10
2214778|NCT02959138|5431151|P1|STARTED|Overall Study||10
2214779|NCT02958995|5431176|P2|NOT COMPLETED|Overall Study||0
2214780|NCT02958995|5431177|P1|NOT COMPLETED|Overall Study||0
2214781|NCT02958995|5431176|P2|COMPLETED|Overall Study||107495
2214782|NCT02958995|5431177|P1|COMPLETED|Overall Study||2630666
2214783|NCT02958995|5431176|P2|STARTED|Overall Study||107495
2214784|NCT02958995|5431177|P1|STARTED|Overall Study||2630666
2214785|NCT02958982|5431196|P11|NOT COMPLETED|Proof of Concept Study||0
2214786|NCT02958982|5431197|P10|NOT COMPLETED|Proof of Concept Study||0
2214787|NCT02958982|5431198|P9|NOT COMPLETED|Proof of Concept Study||0
2214788|NCT02958982|5431199|P8|NOT COMPLETED|Proof of Concept Study||0
2214789|NCT02958982|5431200|P7|NOT COMPLETED|Proof of Concept Study||0
2214790|NCT02958982|5431201|P6|NOT COMPLETED|Proof of Concept Study||0
2214791|NCT02958982|5431202|P5|NOT COMPLETED|Proof of Concept Study||0
2214792|NCT02958982|5431203|P4|NOT COMPLETED|Proof of Concept Study||0
2214793|NCT02958982|5431204|P3|NOT COMPLETED|Proof of Concept Study||0
2214794|NCT02958982|5431205|P2|NOT COMPLETED|Proof of Concept Study||0
2214795|NCT02958982|5431206|P1|NOT COMPLETED|Proof of Concept Study||0
2214796|NCT02958982|5431196|P11|COMPLETED|Proof of Concept Study||1
2214797|NCT02958982|5431197|P10|COMPLETED|Proof of Concept Study||0
2214798|NCT02958982|5431198|P9|COMPLETED|Proof of Concept Study||0
2214799|NCT02958982|5431199|P8|COMPLETED|Proof of Concept Study||0
2214800|NCT02958982|5431200|P7|COMPLETED|Proof of Concept Study||0
2214801|NCT02958982|5431201|P6|COMPLETED|Proof of Concept Study||0
2214802|NCT02958982|5431202|P5|COMPLETED|Proof of Concept Study||0
2214803|NCT02958982|5431203|P4|COMPLETED|Proof of Concept Study||0
2214804|NCT02958982|5431204|P3|COMPLETED|Proof of Concept Study||0
2214805|NCT02958982|5431205|P2|COMPLETED|Proof of Concept Study||0
2214806|NCT02958982|5431206|P1|COMPLETED|Proof of Concept Study||0
2214807|NCT02958982|5431196|P11|STARTED|Proof of Concept Study||1
2214808|NCT02958982|5431197|P10|STARTED|Proof of Concept Study||0
2214809|NCT02958982|5431198|P9|STARTED|Proof of Concept Study||0
2214810|NCT02958982|5431199|P8|STARTED|Proof of Concept Study||0
2214811|NCT02958982|5431200|P7|STARTED|Proof of Concept Study||0
2214812|NCT02958982|5431201|P6|STARTED|Proof of Concept Study||0
2214813|NCT02958982|5431202|P5|STARTED|Proof of Concept Study||0
2214814|NCT02958982|5431203|P4|STARTED|Proof of Concept Study||0
2214815|NCT02958982|5431204|P3|STARTED|Proof of Concept Study||0
2214816|NCT02958982|5431205|P2|STARTED|Proof of Concept Study||0
2214817|NCT02958982|5431206|P1|STARTED|Proof of Concept Study||0
2214818|NCT02958982|5431196|P11|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
2214819|NCT02958982|5431197|P10|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
2214820|NCT02958982|5431198|P9|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
2214821|NCT02958982|5431199|P8|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
2214822|NCT02958982|5431200|P7|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
2214823|NCT02958982|5431201|P6|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
2214824|NCT02958982|5431202|P5|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
2214825|NCT02958982|5431203|P4|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
2214826|NCT02958982|5431204|P3|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
2214827|NCT02958982|5431205|P2|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
2214828|NCT02958982|5431206|P1|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
2214829|NCT02958982|5431196|P11|COMPLETED|Cohort 3: 400 mg in MAD Study||0
2214830|NCT02958982|5431197|P10|COMPLETED|Cohort 3: 400 mg in MAD Study||6
2214831|NCT02958982|5431198|P9|COMPLETED|Cohort 3: 400 mg in MAD Study||0
2214832|NCT02958982|5431199|P8|COMPLETED|Cohort 3: 400 mg in MAD Study||0
2214833|NCT02958982|5431200|P7|COMPLETED|Cohort 3: 400 mg in MAD Study||2
2214834|NCT02958982|5431201|P6|COMPLETED|Cohort 3: 400 mg in MAD Study||0
2214835|NCT02958982|5431202|P5|COMPLETED|Cohort 3: 400 mg in MAD Study||0
2214836|NCT02958982|5431203|P4|COMPLETED|Cohort 3: 400 mg in MAD Study||0
2214837|NCT02958982|5431204|P3|COMPLETED|Cohort 3: 400 mg in MAD Study||0
2214838|NCT02958982|5431205|P2|COMPLETED|Cohort 3: 400 mg in MAD Study||0
2214839|NCT02958982|5431206|P1|COMPLETED|Cohort 3: 400 mg in MAD Study||0
2214840|NCT02958982|5431196|P11|STARTED|Cohort 3: 400 mg in MAD Study||0
2214841|NCT02958982|5431197|P10|STARTED|Cohort 3: 400 mg in MAD Study||6
2214842|NCT02958982|5431198|P9|STARTED|Cohort 3: 400 mg in MAD Study||0
2214843|NCT02958982|5431199|P8|STARTED|Cohort 3: 400 mg in MAD Study||0
2214844|NCT02958982|5431200|P7|STARTED|Cohort 3: 400 mg in MAD Study||2
2214845|NCT02958982|5431201|P6|STARTED|Cohort 3: 400 mg in MAD Study||0
2214846|NCT02958982|5431202|P5|STARTED|Cohort 3: 400 mg in MAD Study||0
2214847|NCT02958982|5431203|P4|STARTED|Cohort 3: 400 mg in MAD Study||0
2214849|NCT02958982|5431205|P2|STARTED|Cohort 3: 400 mg in MAD Study||0
2214850|NCT02958982|5431206|P1|STARTED|Cohort 3: 400 mg in MAD Study||0
2214851|NCT02958982|5431196|P11|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
2214852|NCT02958982|5431197|P10|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
2214853|NCT02958982|5431198|P9|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
2214854|NCT02958982|5431199|P8|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
2214855|NCT02958982|5431200|P7|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
2214856|NCT02958982|5431201|P6|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
2214857|NCT02958982|5431202|P5|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
2214858|NCT02958982|5431203|P4|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
2214859|NCT02958982|5431204|P3|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
2214860|NCT02958982|5431205|P2|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
2214861|NCT02958982|5431206|P1|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
2214862|NCT02958982|5431196|P11|COMPLETED|Cohort 2: 100 mg in MAD Study||0
2214863|NCT02958982|5431197|P10|COMPLETED|Cohort 2: 100 mg in MAD Study||0
2214864|NCT02958982|5431198|P9|COMPLETED|Cohort 2: 100 mg in MAD Study||6
2214865|NCT02958982|5431199|P8|COMPLETED|Cohort 2: 100 mg in MAD Study||0
2214866|NCT02958982|5431200|P7|COMPLETED|Cohort 2: 100 mg in MAD Study||2
2214867|NCT02958982|5431201|P6|COMPLETED|Cohort 2: 100 mg in MAD Study||0
2214868|NCT02958982|5431202|P5|COMPLETED|Cohort 2: 100 mg in MAD Study||0
2214869|NCT02958982|5431203|P4|COMPLETED|Cohort 2: 100 mg in MAD Study||0
2214870|NCT02958982|5431204|P3|COMPLETED|Cohort 2: 100 mg in MAD Study||0
2214871|NCT02958982|5431205|P2|COMPLETED|Cohort 2: 100 mg in MAD Study||0
2214872|NCT02958982|5431206|P1|COMPLETED|Cohort 2: 100 mg in MAD Study||0
2214873|NCT02958982|5431196|P11|STARTED|Cohort 2: 100 mg in MAD Study||0
2214874|NCT02958982|5431197|P10|STARTED|Cohort 2: 100 mg in MAD Study||0
2214875|NCT02958982|5431198|P9|STARTED|Cohort 2: 100 mg in MAD Study||6
2214876|NCT02958982|5431199|P8|STARTED|Cohort 2: 100 mg in MAD Study||0
2214877|NCT02958982|5431200|P7|STARTED|Cohort 2: 100 mg in MAD Study||2
2214878|NCT02958982|5431201|P6|STARTED|Cohort 2: 100 mg in MAD Study||0
2214879|NCT02958982|5431202|P5|STARTED|Cohort 2: 100 mg in MAD Study||0
2214880|NCT02958982|5431203|P4|STARTED|Cohort 2: 100 mg in MAD Study||0
2214881|NCT02958982|5431204|P3|STARTED|Cohort 2: 100 mg in MAD Study||0
2214882|NCT02958982|5431205|P2|STARTED|Cohort 2: 100 mg in MAD Study||0
2214883|NCT02958982|5431206|P1|STARTED|Cohort 2: 100 mg in MAD Study||0
2214884|NCT02958982|5431196|P11|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
2214885|NCT02958982|5431197|P10|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
2214886|NCT02958982|5431198|P9|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
2214887|NCT02958982|5431199|P8|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
2214888|NCT02958982|5431200|P7|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
2214889|NCT02958982|5431201|P6|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
2214890|NCT02958982|5431202|P5|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
2214891|NCT02958982|5431203|P4|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
2214892|NCT02958982|5431204|P3|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
2214893|NCT02958982|5431205|P2|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
2214894|NCT02958982|5431206|P1|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
2214895|NCT02958982|5431196|P11|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
2214896|NCT02958982|5431197|P10|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
2214897|NCT02958982|5431198|P9|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
2214898|NCT02958982|5431199|P8|COMPLETED|Cohort 1 : 25 mg in MAD Study||6
2214899|NCT02958982|5431200|P7|COMPLETED|Cohort 1 : 25 mg in MAD Study||2
2214900|NCT02958982|5431201|P6|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
2214901|NCT02958982|5431202|P5|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
2214902|NCT02958982|5431203|P4|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
2214903|NCT02958982|5431204|P3|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
2214904|NCT02958982|5431205|P2|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
2214905|NCT02958982|5431206|P1|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
2214906|NCT02958982|5431196|P11|STARTED|Cohort 1 : 25 mg in MAD Study||0
2214907|NCT02958982|5431197|P10|STARTED|Cohort 1 : 25 mg in MAD Study||0
2214908|NCT02958982|5431198|P9|STARTED|Cohort 1 : 25 mg in MAD Study||0
2214909|NCT02958982|5431199|P8|STARTED|Cohort 1 : 25 mg in MAD Study||6
2214910|NCT02958982|5431200|P7|STARTED|Cohort 1 : 25 mg in MAD Study||2
2214911|NCT02958982|5431201|P6|STARTED|Cohort 1 : 25 mg in MAD Study||0
2214912|NCT02958982|5431202|P5|STARTED|Cohort 1 : 25 mg in MAD Study||0
2214913|NCT02958982|5431203|P4|STARTED|Cohort 1 : 25 mg in MAD Study||0
2214914|NCT02958982|5431204|P3|STARTED|Cohort 1 : 25 mg in MAD Study||0
2214915|NCT02958982|5431205|P2|STARTED|Cohort 1 : 25 mg in MAD Study||0
2214916|NCT02958982|5431206|P1|STARTED|Cohort 1 : 25 mg in MAD Study||0
2214917|NCT02958982|5431196|P11|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
2214918|NCT02958982|5431197|P10|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
2214919|NCT02958982|5431198|P9|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
2214920|NCT02958982|5431199|P8|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
2214921|NCT02958982|5431200|P7|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
2214922|NCT02958982|5431201|P6|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
2214923|NCT02958982|5431202|P5|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
2214924|NCT02958982|5431203|P4|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
2214925|NCT02958982|5431204|P3|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
2214926|NCT02958982|5431205|P2|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
2214927|NCT02958982|5431206|P1|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
2214928|NCT02958982|5431196|P11|COMPLETED|Cohort 5: 400 mg in SAD Study||0
2214929|NCT02958982|5431197|P10|COMPLETED|Cohort 5: 400 mg in SAD Study||0
2214930|NCT02958982|5431198|P9|COMPLETED|Cohort 5: 400 mg in SAD Study||0
2214931|NCT02958982|5431199|P8|COMPLETED|Cohort 5: 400 mg in SAD Study||0
2214932|NCT02958982|5431200|P7|COMPLETED|Cohort 5: 400 mg in SAD Study||0
2214933|NCT02958982|5431201|P6|COMPLETED|Cohort 5: 400 mg in SAD Study||6
2214934|NCT02958982|5431202|P5|COMPLETED|Cohort 5: 400 mg in SAD Study||0
2214935|NCT02958982|5431203|P4|COMPLETED|Cohort 5: 400 mg in SAD Study||0
2214936|NCT02958982|5431204|P3|COMPLETED|Cohort 5: 400 mg in SAD Study||0
2214937|NCT02958982|5431205|P2|COMPLETED|Cohort 5: 400 mg in SAD Study||0
2214938|NCT02958982|5431206|P1|COMPLETED|Cohort 5: 400 mg in SAD Study||2
2214939|NCT02958982|5431196|P11|STARTED|Cohort 5: 400 mg in SAD Study||0
2214940|NCT02958982|5431197|P10|STARTED|Cohort 5: 400 mg in SAD Study||0
2214941|NCT02958982|5431198|P9|STARTED|Cohort 5: 400 mg in SAD Study||0
2214942|NCT02958982|5431199|P8|STARTED|Cohort 5: 400 mg in SAD Study||0
2214943|NCT02958982|5431200|P7|STARTED|Cohort 5: 400 mg in SAD Study||0
2214944|NCT02958982|5431201|P6|STARTED|Cohort 5: 400 mg in SAD Study||6
2214945|NCT02958982|5431202|P5|STARTED|Cohort 5: 400 mg in SAD Study||0
2214946|NCT02958982|5431203|P4|STARTED|Cohort 5: 400 mg in SAD Study||0
2214947|NCT02958982|5431204|P3|STARTED|Cohort 5: 400 mg in SAD Study||0
2214948|NCT02958982|5431205|P2|STARTED|Cohort 5: 400 mg in SAD Study||0
2214949|NCT02958982|5431206|P1|STARTED|Cohort 5: 400 mg in SAD Study||2
2214950|NCT02958982|5431196|P11|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
2214951|NCT02958982|5431197|P10|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
2214952|NCT02958982|5431198|P9|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
2214953|NCT02958982|5431199|P8|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
2214954|NCT02958982|5431200|P7|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
2214955|NCT02958982|5431201|P6|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
2214956|NCT02958982|5431202|P5|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
2214957|NCT02958982|5431203|P4|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
2214958|NCT02958982|5431204|P3|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
2214959|NCT02958982|5431205|P2|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
2214960|NCT02958982|5431206|P1|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
2214961|NCT02958982|5431196|P11|COMPLETED|Cohort 4: 200 mg in SAD Study||0
2214962|NCT02958982|5431197|P10|COMPLETED|Cohort 4: 200 mg in SAD Study||0
2214963|NCT02958982|5431198|P9|COMPLETED|Cohort 4: 200 mg in SAD Study||0
2214964|NCT02958982|5431199|P8|COMPLETED|Cohort 4: 200 mg in SAD Study||0
2214965|NCT02958982|5431200|P7|COMPLETED|Cohort 4: 200 mg in SAD Study||0
2214966|NCT02958982|5431201|P6|COMPLETED|Cohort 4: 200 mg in SAD Study||0
2214967|NCT02958982|5431202|P5|COMPLETED|Cohort 4: 200 mg in SAD Study||6
2214968|NCT02958982|5431203|P4|COMPLETED|Cohort 4: 200 mg in SAD Study||0
2214969|NCT02958982|5431204|P3|COMPLETED|Cohort 4: 200 mg in SAD Study||0
2214970|NCT02958982|5431205|P2|COMPLETED|Cohort 4: 200 mg in SAD Study||0
2214971|NCT02958982|5431206|P1|COMPLETED|Cohort 4: 200 mg in SAD Study||2
2214972|NCT02958982|5431196|P11|STARTED|Cohort 4: 200 mg in SAD Study||0
2214973|NCT02958982|5431197|P10|STARTED|Cohort 4: 200 mg in SAD Study||0
2214974|NCT02958982|5431198|P9|STARTED|Cohort 4: 200 mg in SAD Study||0
2214975|NCT02958982|5431199|P8|STARTED|Cohort 4: 200 mg in SAD Study||0
2214976|NCT02958982|5431200|P7|STARTED|Cohort 4: 200 mg in SAD Study||0
2214977|NCT02958982|5431201|P6|STARTED|Cohort 4: 200 mg in SAD Study||0
2214978|NCT02958982|5431202|P5|STARTED|Cohort 4: 200 mg in SAD Study||6
2214979|NCT02958982|5431203|P4|STARTED|Cohort 4: 200 mg in SAD Study||0
2214980|NCT02958982|5431204|P3|STARTED|Cohort 4: 200 mg in SAD Study||0
2214981|NCT02958982|5431205|P2|STARTED|Cohort 4: 200 mg in SAD Study||0
2214982|NCT02958982|5431206|P1|STARTED|Cohort 4: 200 mg in SAD Study||2
2214983|NCT02958982|5431196|P11|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
2214984|NCT02958982|5431197|P10|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
2214985|NCT02958982|5431198|P9|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
2214986|NCT02958982|5431199|P8|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
2214987|NCT02958982|5431200|P7|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
2214988|NCT02958982|5431201|P6|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
2214989|NCT02958982|5431202|P5|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
2214990|NCT02958982|5431203|P4|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
2214991|NCT02958982|5431204|P3|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
2214992|NCT02958982|5431205|P2|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
2214993|NCT02958982|5431206|P1|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
2214994|NCT02958982|5431196|P11|COMPLETED|Cohort 3: 100 mg in SAD Study||0
2214995|NCT02958982|5431197|P10|COMPLETED|Cohort 3: 100 mg in SAD Study||0
2214996|NCT02958982|5431198|P9|COMPLETED|Cohort 3: 100 mg in SAD Study||0
2214997|NCT02958982|5431199|P8|COMPLETED|Cohort 3: 100 mg in SAD Study||0
2214998|NCT02958982|5431200|P7|COMPLETED|Cohort 3: 100 mg in SAD Study||0
2214999|NCT02958982|5431201|P6|COMPLETED|Cohort 3: 100 mg in SAD Study||0
2215000|NCT02958982|5431202|P5|COMPLETED|Cohort 3: 100 mg in SAD Study||0
2215001|NCT02958982|5431203|P4|COMPLETED|Cohort 3: 100 mg in SAD Study||4
2215002|NCT02958982|5431204|P3|COMPLETED|Cohort 3: 100 mg in SAD Study||0
2215003|NCT02958982|5431205|P2|COMPLETED|Cohort 3: 100 mg in SAD Study||0
2215004|NCT02958982|5431206|P1|COMPLETED|Cohort 3: 100 mg in SAD Study||2
2215005|NCT02958982|5431196|P11|STARTED|Cohort 3: 100 mg in SAD Study||0
2215006|NCT02958982|5431197|P10|STARTED|Cohort 3: 100 mg in SAD Study||0
2215007|NCT02958982|5431198|P9|STARTED|Cohort 3: 100 mg in SAD Study||0
2215008|NCT02958982|5431199|P8|STARTED|Cohort 3: 100 mg in SAD Study||0
2215009|NCT02958982|5431200|P7|STARTED|Cohort 3: 100 mg in SAD Study||0
2215010|NCT02958982|5431201|P6|STARTED|Cohort 3: 100 mg in SAD Study||0
2215011|NCT02958982|5431202|P5|STARTED|Cohort 3: 100 mg in SAD Study||0
2215012|NCT02958982|5431203|P4|STARTED|Cohort 3: 100 mg in SAD Study||4
2215013|NCT02958982|5431204|P3|STARTED|Cohort 3: 100 mg in SAD Study||0
2215014|NCT02958982|5431205|P2|STARTED|Cohort 3: 100 mg in SAD Study||0
2215015|NCT02958982|5431206|P1|STARTED|Cohort 3: 100 mg in SAD Study||2
2215016|NCT02958982|5431196|P11|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
2215017|NCT02958982|5431197|P10|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
2215018|NCT02958982|5431198|P9|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
2215019|NCT02958982|5431199|P8|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
2215020|NCT02958982|5431200|P7|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
2215021|NCT02958982|5431201|P6|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
2215022|NCT02958982|5431202|P5|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
2215023|NCT02958982|5431203|P4|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
2215024|NCT02958982|5431204|P3|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
2215025|NCT02958982|5431205|P2|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
2215026|NCT02958982|5431206|P1|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
2215027|NCT02958982|5431196|P11|COMPLETED|Cohort 2: 50 mg in SAD Study||0
2215028|NCT02958982|5431197|P10|COMPLETED|Cohort 2: 50 mg in SAD Study||0
2215029|NCT02958982|5431198|P9|COMPLETED|Cohort 2: 50 mg in SAD Study||0
2215030|NCT02958982|5431199|P8|COMPLETED|Cohort 2: 50 mg in SAD Study||0
2215031|NCT02958982|5431200|P7|COMPLETED|Cohort 2: 50 mg in SAD Study||0
2215032|NCT02958982|5431201|P6|COMPLETED|Cohort 2: 50 mg in SAD Study||0
2215033|NCT02958982|5431202|P5|COMPLETED|Cohort 2: 50 mg in SAD Study||0
2215034|NCT02958982|5431203|P4|COMPLETED|Cohort 2: 50 mg in SAD Study||0
2215035|NCT02958982|5431204|P3|COMPLETED|Cohort 2: 50 mg in SAD Study||4
2215036|NCT02958982|5431205|P2|COMPLETED|Cohort 2: 50 mg in SAD Study||0
2215037|NCT02958982|5431206|P1|COMPLETED|Cohort 2: 50 mg in SAD Study||2
2215038|NCT02958982|5431196|P11|STARTED|Cohort 2: 50 mg in SAD Study||0
2215039|NCT02958982|5431197|P10|STARTED|Cohort 2: 50 mg in SAD Study||0
2215040|NCT02958982|5431198|P9|STARTED|Cohort 2: 50 mg in SAD Study||0
2215041|NCT02958982|5431199|P8|STARTED|Cohort 2: 50 mg in SAD Study||0
2215042|NCT02958982|5431200|P7|STARTED|Cohort 2: 50 mg in SAD Study||0
2215043|NCT02958982|5431201|P6|STARTED|Cohort 2: 50 mg in SAD Study||0
2215044|NCT02958982|5431202|P5|STARTED|Cohort 2: 50 mg in SAD Study||0
2215045|NCT02958982|5431203|P4|STARTED|Cohort 2: 50 mg in SAD Study||0
2215046|NCT02958982|5431204|P3|STARTED|Cohort 2: 50 mg in SAD Study||4
2215047|NCT02958982|5431205|P2|STARTED|Cohort 2: 50 mg in SAD Study||0
2215048|NCT02958982|5431206|P1|STARTED|Cohort 2: 50 mg in SAD Study||2
2215049|NCT02958982|5431196|P11|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
2215050|NCT02958982|5431197|P10|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
2215051|NCT02958982|5431198|P9|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
2215052|NCT02958982|5431199|P8|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
2215053|NCT02958982|5431200|P7|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
2215054|NCT02958982|5431201|P6|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
2215055|NCT02958982|5431202|P5|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
2215056|NCT02958982|5431203|P4|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
2215057|NCT02958982|5431204|P3|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
2215058|NCT02958982|5431205|P2|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
2215059|NCT02958982|5431206|P1|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
2215060|NCT02958982|5431196|P11|COMPLETED|Cohort 1: 25 mg in SAD Study||0
2215061|NCT02958982|5431197|P10|COMPLETED|Cohort 1: 25 mg in SAD Study||0
2215062|NCT02958982|5431198|P9|COMPLETED|Cohort 1: 25 mg in SAD Study||0
2215063|NCT02958982|5431199|P8|COMPLETED|Cohort 1: 25 mg in SAD Study||0
2215064|NCT02958982|5431200|P7|COMPLETED|Cohort 1: 25 mg in SAD Study||0
2215065|NCT02958982|5431201|P6|COMPLETED|Cohort 1: 25 mg in SAD Study||0
2215066|NCT02958982|5431202|P5|COMPLETED|Cohort 1: 25 mg in SAD Study||0
2215067|NCT02958982|5431203|P4|COMPLETED|Cohort 1: 25 mg in SAD Study||0
2215068|NCT02958982|5431204|P3|COMPLETED|Cohort 1: 25 mg in SAD Study||0
2215069|NCT02958982|5431205|P2|COMPLETED|Cohort 1: 25 mg in SAD Study||3
2215070|NCT02958982|5431206|P1|COMPLETED|Cohort 1: 25 mg in SAD Study||1
2215071|NCT02958982|5431196|P11|STARTED|Cohort 1: 25 mg in SAD Study||0
2215072|NCT02958982|5431197|P10|STARTED|Cohort 1: 25 mg in SAD Study||0
2215073|NCT02958982|5431198|P9|STARTED|Cohort 1: 25 mg in SAD Study||0
2215074|NCT02958982|5431199|P8|STARTED|Cohort 1: 25 mg in SAD Study||0
2215075|NCT02958982|5431200|P7|STARTED|Cohort 1: 25 mg in SAD Study||0
2215076|NCT02958982|5431201|P6|STARTED|Cohort 1: 25 mg in SAD Study||0
2215077|NCT02958982|5431202|P5|STARTED|Cohort 1: 25 mg in SAD Study||0
2215078|NCT02958982|5431203|P4|STARTED|Cohort 1: 25 mg in SAD Study||0
2215079|NCT02958982|5431204|P3|STARTED|Cohort 1: 25 mg in SAD Study||0
2215080|NCT02958982|5431205|P2|STARTED|Cohort 1: 25 mg in SAD Study||3
2215081|NCT02958982|5431206|P1|STARTED|Cohort 1: 25 mg in SAD Study||1
2215082|NCT02958969|5431252|P1|NOT COMPLETED|Overall Study||0
2215083|NCT02958969|5431252|P1|COMPLETED|Overall Study||50
2215084|NCT02958969|5431252|P1|STARTED|Overall Study||50
2215085|NCT02958956|5431261|P2|NOT COMPLETED|Overall Study||0
2215086|NCT02958956|5431262|P1|NOT COMPLETED|Overall Study||0
2215087|NCT02958956|5431261|P2|COMPLETED|Overall Study||198317
2215088|NCT02958956|5431262|P1|COMPLETED|Overall Study||38190
2215089|NCT02958956|5431261|P2|STARTED|Overall Study||198317
2215090|NCT02958956|5431262|P1|STARTED|Overall Study||38190
2215091|NCT02958826|5431277|P2|NOT COMPLETED|Overall Study||0
2215092|NCT02958826|5431278|P1|NOT COMPLETED|Overall Study||0
2215093|NCT02958826|5431277|P2|COMPLETED|Overall Study||80
2215094|NCT02958826|5431278|P1|COMPLETED|Overall Study||80
2215095|NCT02958826|5431277|P2|STARTED|Overall Study||80
2215096|NCT02958826|5431278|P1|STARTED|Overall Study||80
2215097|NCT02958787|5431288|P1|NOT COMPLETED|Overall Study||0
2215098|NCT02958787|5431288|P1|COMPLETED|Overall Study||135
2215099|NCT02958787|5431288|P1|STARTED|Overall Study||135
2215100|NCT02958345|5431294|P2|NOT COMPLETED|Overall Study||1
2215101|NCT02958345|5431295|P1|NOT COMPLETED|Overall Study||1
2215102|NCT02958345|5431294|P2|COMPLETED|Overall Study||13
2215103|NCT02958345|5431295|P1|COMPLETED|Overall Study||13
2215104|NCT02958345|5431294|P2|STARTED|Overall Study||14
2215105|NCT02958345|5431295|P1|STARTED|Overall Study||14
2215106|NCT02958267|5431305|P2|NOT COMPLETED|Follow-up Visits||1
2215107|NCT02958267|5431306|P1|NOT COMPLETED|Follow-up Visits||2
2215108|NCT02958267|5431305|P2|COMPLETED|Follow-up Visits||14
2215109|NCT02958267|5431306|P1|COMPLETED|Follow-up Visits||13
2215110|NCT02958267|5431305|P2|12 Month Follow-up|Follow-up Visits||14
2215111|NCT02958267|5431306|P1|12 Month Follow-up|Follow-up Visits||13
2215112|NCT02958267|5431305|P2|6 Month Follow-up|Follow-up Visits||14
2215113|NCT02958267|5431306|P1|6 Month Follow-up|Follow-up Visits||14
2215114|NCT02958267|5431305|P2|3 Month Follow-up|Follow-up Visits||15
2215115|NCT02958267|5431306|P1|3 Month Follow-up|Follow-up Visits||15
2215116|NCT02958267|5431305|P2|STARTED|Follow-up Visits||15
2215117|NCT02958267|5431306|P1|STARTED|Follow-up Visits||15
2215118|NCT02958267|5431305|P2|NOT COMPLETED|Enrollment to Actual Treatment Complete||0
2215119|NCT02958267|5431306|P1|NOT COMPLETED|Enrollment to Actual Treatment Complete||2
2215120|NCT02958267|5431305|P2|COMPLETED|Enrollment to Actual Treatment Complete||15
2215121|NCT02958267|5431306|P1|COMPLETED|Enrollment to Actual Treatment Complete||15
2215122|NCT02958267|5431305|P2|STARTED|Enrollment to Actual Treatment Complete||15
2215123|NCT02958267|5431306|P1|STARTED|Enrollment to Actual Treatment Complete||17
2215124|NCT02958267|5431305|P2|NOT COMPLETED|Enrollment||0
2215125|NCT02958267|5431306|P1|NOT COMPLETED|Enrollment||0
2215126|NCT02958267|5431305|P2|COMPLETED|Enrollment||15
2215127|NCT02958267|5431306|P1|COMPLETED|Enrollment||17
2215128|NCT02958267|5431305|P2|STARTED|Enrollment||15
2215129|NCT02958267|5431306|P1|STARTED|Enrollment||17
2215130|NCT02957747|5431318|P2|NOT COMPLETED|Overall Study||8
2215131|NCT02957747|5431319|P1|NOT COMPLETED|Overall Study||10
2215132|NCT02957747|5431318|P2|COMPLETED|Overall Study||69
2215133|NCT02957747|5431319|P1|COMPLETED|Overall Study||66
2215134|NCT02957747|5431318|P2|STARTED|Overall Study||77
2215135|NCT02957747|5431319|P1|STARTED|Overall Study||76
2215136|NCT02956967|5431345|P1|NOT COMPLETED|Overall Study||48
2215137|NCT02956967|5431345|P1|COMPLETED|Overall Study||123
2215138|NCT02956967|5431345|P1|STARTED|Overall Study||171
2215139|NCT02956837|5431372|P4|NOT COMPLETED|Overall Study||3
2215140|NCT02956837|5431373|P3|NOT COMPLETED|Overall Study||2
2215141|NCT02956837|5431374|P2|NOT COMPLETED|Overall Study||3
2215142|NCT02956837|5431375|P1|NOT COMPLETED|Overall Study||0
2215143|NCT02956837|5431372|P4|COMPLETED|Overall Study||99
2215144|NCT02956837|5431373|P3|COMPLETED|Overall Study||97
2215145|NCT02956837|5431374|P2|COMPLETED|Overall Study||96
2215146|NCT02956837|5431375|P1|COMPLETED|Overall Study||100
2215147|NCT02956837|5431372|P4|STARTED|Overall Study||102
2215148|NCT02956837|5431373|P3|STARTED|Overall Study||99
2215149|NCT02956837|5431374|P2|STARTED|Overall Study||99
2215150|NCT02956837|5431375|P1|STARTED|Overall Study||100
2215151|NCT02956746|5431469|P4|NOT COMPLETED|Overall Study||4
2215152|NCT02956746|5431470|P3|NOT COMPLETED|Overall Study||6
2215153|NCT02956746|5431471|P2|NOT COMPLETED|Overall Study||3
2215154|NCT02956746|5431472|P1|NOT COMPLETED|Overall Study||2
2215155|NCT02956746|5431469|P4|COMPLETED|Overall Study||38
2215156|NCT02956746|5431470|P3|COMPLETED|Overall Study||36
2215157|NCT02956746|5431471|P2|COMPLETED|Overall Study||37
2215158|NCT02956746|5431472|P1|COMPLETED|Overall Study||38
2215159|NCT02956746|5431469|P4|STARTED|Overall Study||42
2215160|NCT02956746|5431470|P3|STARTED|Overall Study||42
2215161|NCT02956746|5431471|P2|STARTED|Overall Study||40
2215162|NCT02956746|5431472|P1|STARTED|Overall Study||40
2215163|NCT02956629|5431510|P6|NOT COMPLETED|Overall Study||1
2215164|NCT02956629|5431511|P5|NOT COMPLETED|Overall Study||0
2215165|NCT02956629|5431512|P4|NOT COMPLETED|Overall Study||1
2215166|NCT02956629|5431513|P3|NOT COMPLETED|Overall Study||4
2215167|NCT02956629|5431514|P2|NOT COMPLETED|Overall Study||6
2215168|NCT02956629|5431515|P1|NOT COMPLETED|Overall Study||5
2215169|NCT02956629|5431510|P6|COMPLETED|Overall Study||21
2215170|NCT02956629|5431511|P5|COMPLETED|Overall Study||18
2215171|NCT02956629|5431512|P4|COMPLETED|Overall Study||55
2215172|NCT02956629|5431513|P3|COMPLETED|Overall Study||57
2215173|NCT02956629|5431514|P2|COMPLETED|Overall Study||41
2215174|NCT02956629|5431515|P1|COMPLETED|Overall Study||73
2215175|NCT02956629|5431510|P6|STARTED|Overall Study||22
2215176|NCT02956629|5431511|P5|STARTED|Overall Study||18
2215177|NCT02956629|5431512|P4|STARTED|Overall Study||56
2215178|NCT02956629|5431513|P3|STARTED|Overall Study||61
2215179|NCT02956629|5431514|P2|STARTED|Overall Study||47
2215180|NCT02956629|5431515|P1|STARTED|Overall Study||78
2215181|NCT02956616|5431579|P2|NOT COMPLETED|Overall Study||0
2215182|NCT02956616|5431580|P1|NOT COMPLETED|Overall Study||0
2215183|NCT02956616|5431579|P2|COMPLETED|Overall Study||60
2215184|NCT02956616|5431580|P1|COMPLETED|Overall Study||58
2215185|NCT02956616|5431579|P2|STARTED|Overall Study||60
2215186|NCT02956616|5431580|P1|STARTED|Overall Study||58
2215187|NCT02956460|5431594|P2|NOT COMPLETED|Lens 2||0
2215188|NCT02956460|5431595|P1|NOT COMPLETED|Lens 2||0
2215189|NCT02956460|5431594|P2|COMPLETED|Lens 2||34
2215190|NCT02956460|5431595|P1|COMPLETED|Lens 2||29
2215191|NCT02956460|5431594|P2|STARTED|Lens 2||34
2215192|NCT02956460|5431595|P1|STARTED|Lens 2||29
2215193|NCT02956460|5431594|P2|NOT COMPLETED|Lens 1||0
2215194|NCT02956460|5431595|P1|NOT COMPLETED|Lens 1||1
2215195|NCT02956460|5431594|P2|COMPLETED|Lens 1||34
2215196|NCT02956460|5431595|P1|COMPLETED|Lens 1||29
2215197|NCT02956460|5431594|P2|STARTED|Lens 1||34
2215198|NCT02956460|5431595|P1|STARTED|Lens 1||30
2215199|NCT02956122|5431621|P1|NOT COMPLETED|Overall Study||0
2215200|NCT02956122|5431621|P1|COMPLETED|Overall Study||1
2215201|NCT02956122|5431621|P1|STARTED|Overall Study||1
2215202|NCT02954952|5431675|P3|NOT COMPLETED|Overall Study||0
2215203|NCT02954952|5431676|P2|NOT COMPLETED|Overall Study||1
2215204|NCT02954952|5431677|P1|NOT COMPLETED|Overall Study||1
2215205|NCT02954952|5431675|P3|COMPLETED|Overall Study||3
2215206|NCT02954952|5431676|P2|COMPLETED|Overall Study||4
2215207|NCT02954952|5431677|P1|COMPLETED|Overall Study||35
2215208|NCT02954952|5431675|P3|STARTED|Overall Study||3
2215209|NCT02954952|5431676|P2|STARTED|Overall Study||5
2215210|NCT02954952|5431677|P1|STARTED|Overall Study||36
2215211|NCT02954848|5431687|P2|NOT COMPLETED|Overall Study||5
2215212|NCT02954848|5431688|P1|NOT COMPLETED|Overall Study||2
2215213|NCT02954848|5431687|P2|COMPLETED|Overall Study||234
2215214|NCT02954848|5431688|P1|COMPLETED|Overall Study||243
2215215|NCT02954848|5431687|P2|Treated|Overall Study||238
2215216|NCT02954848|5431688|P1|Treated|Overall Study||245
2215217|NCT02954848|5431687|P2|STARTED|Overall Study||239
2215218|NCT02954848|5431688|P1|STARTED|Overall Study||245
2215219|NCT02954653|5431748|P9|NOT COMPLETED|Overall Study||0
2215220|NCT02954653|5431749|P8|NOT COMPLETED|Overall Study||0
2215221|NCT02954653|5431750|P7|NOT COMPLETED|Overall Study||0
2215222|NCT02954653|5431751|P6|NOT COMPLETED|Overall Study||0
2215223|NCT02954653|5431752|P5|NOT COMPLETED|Overall Study||0
2215224|NCT02954653|5431753|P4|NOT COMPLETED|Overall Study||0
2215225|NCT02954653|5431754|P3|NOT COMPLETED|Overall Study||0
2215226|NCT02954653|5431755|P2|NOT COMPLETED|Overall Study||3
2215227|NCT02954653|5431756|P1|NOT COMPLETED|Overall Study||4
2215228|NCT02954653|5431748|P9|COMPLETED|Overall Study||0
2215229|NCT02954653|5431749|P8|COMPLETED|Overall Study||0
2215230|NCT02954653|5431750|P7|COMPLETED|Overall Study||0
2215231|NCT02954653|5431751|P6|COMPLETED|Overall Study||0
2215232|NCT02954653|5431752|P5|COMPLETED|Overall Study||0
2215233|NCT02954653|5431753|P4|COMPLETED|Overall Study||0
2215234|NCT02954653|5431754|P3|COMPLETED|Overall Study||0
2215235|NCT02954653|5431755|P2|COMPLETED|Overall Study||1
2215236|NCT02954653|5431756|P1|COMPLETED|Overall Study||0
2215237|NCT02954653|5431748|P9|Received Treatment|Overall Study||0
2215238|NCT02954653|5431749|P8|Received Treatment|Overall Study||0
2215239|NCT02954653|5431750|P7|Received Treatment|Overall Study||0
2215240|NCT02954653|5431751|P6|Received Treatment|Overall Study||0
2215241|NCT02954653|5431752|P5|Received Treatment|Overall Study||0
2215242|NCT02954653|5431753|P4|Received Treatment|Overall Study||0
2215243|NCT02954653|5431754|P3|Received Treatment|Overall Study||0
2215244|NCT02954653|5431755|P2|Received Treatment|Overall Study||4
2215245|NCT02954653|5431756|P1|Received Treatment|Overall Study||3
2215246|NCT02954653|5431748|P9|STARTED|Overall Study|No participants were enrolled in this arm.|0
2215247|NCT02954653|5431749|P8|STARTED|Overall Study|No participants were enrolled in this arm.|0
2215248|NCT02954653|5431750|P7|STARTED|Overall Study|No participants were enrolled in this arm.|0
2215249|NCT02954653|5431751|P6|STARTED|Overall Study|No participants were enrolled in this arm.|0
2215250|NCT02954653|5431752|P5|STARTED|Overall Study|No participants were enrolled in this arm.|0
2215251|NCT02954653|5431753|P4|STARTED|Overall Study|No participants were enrolled in this arm.|0
2215252|NCT02954653|5431754|P3|STARTED|Overall Study|No participants were enrolled in this arm.|0
2215253|NCT02954653|5431755|P2|STARTED|Overall Study||4
2215254|NCT02954653|5431756|P1|STARTED|Overall Study||4
2215255|NCT02954601|5431875|P4|NOT COMPLETED|Third Intervention (Five Days)||0
2215256|NCT02954601|5431876|P3|NOT COMPLETED|Third Intervention (Five Days)||0
2215257|NCT02954601|5431877|P2|NOT COMPLETED|Third Intervention (Five Days)||0
2215258|NCT02954601|5431878|P1|NOT COMPLETED|Third Intervention (Five Days)||0
2215259|NCT02954601|5431875|P4|COMPLETED|Third Intervention (Five Days)||8
2215260|NCT02954601|5431876|P3|COMPLETED|Third Intervention (Five Days)||6
2215261|NCT02954601|5431877|P2|COMPLETED|Third Intervention (Five Days)||8
2215262|NCT02954601|5431878|P1|COMPLETED|Third Intervention (Five Days)||9
2215263|NCT02954601|5431875|P4|STARTED|Third Intervention (Five Days)||8
2215264|NCT02954601|5431876|P3|STARTED|Third Intervention (Five Days)||6
2215265|NCT02954601|5431877|P2|STARTED|Third Intervention (Five Days)||8
2215266|NCT02954601|5431878|P1|STARTED|Third Intervention (Five Days)||9
2215267|NCT02954601|5431875|P4|NOT COMPLETED|Second Intervention (Five Days)||0
2215268|NCT02954601|5431876|P3|NOT COMPLETED|Second Intervention (Five Days)||0
2215269|NCT02954601|5431877|P2|NOT COMPLETED|Second Intervention (Five Days)||0
2215270|NCT02954601|5431878|P1|NOT COMPLETED|Second Intervention (Five Days)||0
2215271|NCT02954601|5431875|P4|COMPLETED|Second Intervention (Five Days)||6
2215272|NCT02954601|5431876|P3|COMPLETED|Second Intervention (Five Days)||8
2215273|NCT02954601|5431877|P2|COMPLETED|Second Intervention (Five Days)||6
2215274|NCT02954601|5431878|P1|COMPLETED|Second Intervention (Five Days)||11
2215275|NCT02954601|5431875|P4|STARTED|Second Intervention (Five Days)||6
2215276|NCT02954601|5431876|P3|STARTED|Second Intervention (Five Days)||8
2215277|NCT02954601|5431877|P2|STARTED|Second Intervention (Five Days)||6
2215278|NCT02954601|5431878|P1|STARTED|Second Intervention (Five Days)||11
2215279|NCT02954601|5431875|P4|NOT COMPLETED|First Intervention (Five Days)||0
2215280|NCT02954601|5431876|P3|NOT COMPLETED|First Intervention (Five Days)||1
2215281|NCT02954601|5431877|P2|NOT COMPLETED|First Intervention (Five Days)||0
2215282|NCT02954601|5431878|P1|NOT COMPLETED|First Intervention (Five Days)||0
2215283|NCT02954601|5431875|P4|COMPLETED|First Intervention (Five Days)||7
2215284|NCT02954601|5431876|P3|COMPLETED|First Intervention (Five Days)||7
2215285|NCT02954601|5431877|P2|COMPLETED|First Intervention (Five Days)||6
2215286|NCT02954601|5431878|P1|COMPLETED|First Intervention (Five Days)||11
2215287|NCT02954601|5431875|P4|STARTED|First Intervention (Five Days)||7
2215288|NCT02954601|5431876|P3|STARTED|First Intervention (Five Days)||8
2215289|NCT02954601|5431877|P2|STARTED|First Intervention (Five Days)||6
2215290|NCT02954601|5431878|P1|STARTED|First Intervention (Five Days)||11
2215291|NCT02954575|5431900|P1|NOT COMPLETED|Overall Study||3
2215292|NCT02954575|5431900|P1|COMPLETED|Overall Study||54
2215293|NCT02954575|5431900|P1|SURG Population|Overall Study||1
2215294|NCT02954575|5431900|P1|PK Population|Overall Study||21
2215295|NCT02954575|5431900|P1|PP Population|Overall Study||52
2215296|NCT02954575|5431900|P1|FAS Population|Overall Study||55
2215297|NCT02954575|5431900|P1|SAF Population|Overall Study||55
2215298|NCT02954575|5431900|P1|Received Treatment|Overall Study||55
2215299|NCT02954575|5431900|P1|STARTED|Overall Study||57
2215300|NCT02954354|5431920|P3|NOT COMPLETED|Overall Study||16
2215301|NCT02954354|5431921|P2|NOT COMPLETED|Overall Study||20
2215302|NCT02954354|5431922|P1|NOT COMPLETED|Overall Study||34
2215303|NCT02954354|5431920|P3|COMPLETED|Overall Study||498
2215304|NCT02954354|5431921|P2|COMPLETED|Overall Study||290
2215305|NCT02954354|5431922|P1|COMPLETED|Overall Study||578
2215306|NCT02954354|5431920|P3|Intention to Treat Infected Population|Overall Study||377
2215307|NCT02954354|5431921|P2|Intention to Treat Infected Population|Overall Study||231
2215308|NCT02954354|5431922|P1|Intention to Treat Infected Population|Overall Study||456
2215309|NCT02954354|5431920|P3|Received Study Drug|Overall Study||513
2215310|NCT02954354|5431921|P2|Received Study Drug|Overall Study||309
2215311|NCT02954354|5431922|P1|Received Study Drug|Overall Study||610
2215312|NCT02954354|5431920|P3|STARTED|Overall Study||514
2215313|NCT02954354|5431921|P2|STARTED|Overall Study||310
2215314|NCT02954354|5431922|P1|STARTED|Overall Study||612
2215315|NCT02954198|5432008|P2|NOT COMPLETED|Overall Study||0
2215316|NCT02954198|5432009|P1|NOT COMPLETED|Overall Study||0
2215317|NCT02954198|5432008|P2|COMPLETED|Overall Study||20
2215318|NCT02954198|5432009|P1|COMPLETED|Overall Study||20
2215319|NCT02954198|5432008|P2|STARTED|Overall Study||20
2215320|NCT02954198|5432009|P1|STARTED|Overall Study||20
2215327|NCT02953886|5432039|P1|NOT COMPLETED|Overall Study||0
2215328|NCT02953886|5432039|P1|COMPLETED|Overall Study||20
2215329|NCT02953886|5432039|P1|STARTED|Overall Study||20
2215330|NCT02953873|5432045|P1|NOT COMPLETED|Overall Study||0
2215331|NCT02953873|5432045|P1|COMPLETED|Overall Study||25
2215332|NCT02953873|5432045|P1|STARTED|Overall Study||25
2215333|NCT02953678|5432053|P1|NOT COMPLETED|Overall Study||60
2215334|NCT02953678|5432053|P1|COMPLETED|Overall Study||11
2215335|NCT02953678|5432053|P1|Participants Continuing in Study|Overall Study||19
2215336|NCT02953678|5432053|P1|Participants Discontinued From Study|Overall Study||41
2215337|NCT02953678|5432053|P1|STARTED|Overall Study||71
2215338|NCT02953314|5432064|P2|NOT COMPLETED|Overall Study||3
2215339|NCT02953314|5432065|P1|NOT COMPLETED|Overall Study||0
2215340|NCT02953314|5432064|P2|COMPLETED|Overall Study||67
2215341|NCT02953314|5432065|P1|COMPLETED|Overall Study||13
2215342|NCT02953314|5432064|P2|STARTED|Overall Study||70
2215343|NCT02953314|5432065|P1|STARTED|Overall Study||13
2215344|NCT02952898|5432091|P3|NOT COMPLETED|Overall Study||15
2215345|NCT02952898|5432092|P2|NOT COMPLETED|Overall Study||19
2215346|NCT02952898|5432093|P1|NOT COMPLETED|Overall Study||22
2215347|NCT02952898|5432091|P3|COMPLETED|Overall Study||209
2215348|NCT02952898|5432092|P2|COMPLETED|Overall Study||202
2215349|NCT02952898|5432093|P1|COMPLETED|Overall Study||198
2215350|NCT02952898|5432091|P3|STARTED|Overall Study||224
2215351|NCT02952898|5432092|P2|STARTED|Overall Study||221
2215352|NCT02952898|5432093|P1|STARTED|Overall Study||220
2215353|NCT02952872|5432117|P16|NOT COMPLETED|Overall Study||0
2215354|NCT02952872|5432118|P15|NOT COMPLETED|Overall Study||0
2215355|NCT02952872|5432119|P14|NOT COMPLETED|Overall Study||0
2215356|NCT02952872|5432120|P13|NOT COMPLETED|Overall Study||0
2215357|NCT02952872|5432121|P12|NOT COMPLETED|Overall Study||0
2215358|NCT02952872|5432122|P11|NOT COMPLETED|Overall Study||0
2215359|NCT02952872|5432123|P10|NOT COMPLETED|Overall Study||0
2215360|NCT02952872|5432124|P9|NOT COMPLETED|Overall Study||0
2215361|NCT02952872|5432125|P8|NOT COMPLETED|Overall Study||0
2215362|NCT02952872|5432126|P7|NOT COMPLETED|Overall Study||0
2215363|NCT02952872|5432127|P6|NOT COMPLETED|Overall Study||0
2215364|NCT02952872|5432128|P5|NOT COMPLETED|Overall Study||0
2215365|NCT02952872|5432129|P4|NOT COMPLETED|Overall Study||0
2215366|NCT02952872|5432130|P3|NOT COMPLETED|Overall Study||0
2215367|NCT02952872|5432131|P2|NOT COMPLETED|Overall Study||0
2215368|NCT02952872|5432132|P1|NOT COMPLETED|Overall Study||0
2215369|NCT02952872|5432117|P16|COMPLETED|Overall Study||23
2215370|NCT02952872|5432118|P15|COMPLETED|Overall Study||22
2215371|NCT02952872|5432119|P14|COMPLETED|Overall Study||22
2215372|NCT02952872|5432120|P13|COMPLETED|Overall Study||22
2215373|NCT02952872|5432121|P12|COMPLETED|Overall Study||22
2215374|NCT02952872|5432122|P11|COMPLETED|Overall Study||23
2215375|NCT02952872|5432123|P10|COMPLETED|Overall Study||22
2215376|NCT02952872|5432124|P9|COMPLETED|Overall Study||22
2215377|NCT02952872|5432125|P8|COMPLETED|Overall Study||21
2215378|NCT02952872|5432126|P7|COMPLETED|Overall Study||22
2215379|NCT02952872|5432127|P6|COMPLETED|Overall Study||21
2215380|NCT02952872|5432128|P5|COMPLETED|Overall Study||22
2215381|NCT02952872|5432129|P4|COMPLETED|Overall Study||22
2215382|NCT02952872|5432130|P3|COMPLETED|Overall Study||22
2215383|NCT02952872|5432131|P2|COMPLETED|Overall Study||22
2215384|NCT02952872|5432132|P1|COMPLETED|Overall Study||22
2215385|NCT02952872|5432117|P16|STARTED|Overall Study||23
2215386|NCT02952872|5432118|P15|STARTED|Overall Study||22
2215387|NCT02952872|5432119|P14|STARTED|Overall Study||22
2215388|NCT02952872|5432120|P13|STARTED|Overall Study||22
2215389|NCT02952872|5432121|P12|STARTED|Overall Study||22
2215390|NCT02952872|5432122|P11|STARTED|Overall Study||23
2215391|NCT02952872|5432123|P10|STARTED|Overall Study||22
2215392|NCT02952872|5432124|P9|STARTED|Overall Study||22
2215393|NCT02952872|5432125|P8|STARTED|Overall Study||21
2215394|NCT02952872|5432126|P7|STARTED|Overall Study||22
2215395|NCT02952872|5432127|P6|STARTED|Overall Study||21
2215396|NCT02952872|5432128|P5|STARTED|Overall Study||22
2215397|NCT02952872|5432129|P4|STARTED|Overall Study||22
2215398|NCT02952872|5432130|P3|STARTED|Overall Study||22
2215399|NCT02952872|5432131|P2|STARTED|Overall Study||22
2215400|NCT02952872|5432132|P1|STARTED|Overall Study||22
2215401|NCT02952820|5432217|P3|NOT COMPLETED|Active Treatment Period (6 Months)||31
2215402|NCT02952820|5432218|P2|NOT COMPLETED|Active Treatment Period (6 Months)||38
2215403|NCT02952820|5432219|P1|NOT COMPLETED|Active Treatment Period (6 Months)||0
2215404|NCT02952820|5432217|P3|COMPLETED|Active Treatment Period (6 Months)||321
2215405|NCT02952820|5432218|P2|COMPLETED|Active Treatment Period (6 Months)||346
2215406|NCT02952820|5432219|P1|COMPLETED|Active Treatment Period (6 Months)||0
2215407|NCT02952820|5432217|P3|STARTED|Active Treatment Period (6 Months)||352
2215408|NCT02952820|5432218|P2|STARTED|Active Treatment Period (6 Months)||384
2215409|NCT02952820|5432219|P1|STARTED|Active Treatment Period (6 Months)|Participants from Placebo were re-randomized to Lemborexant 5 mg and Lemborexant 10 mg.|0
2215410|NCT02952820|5432217|P3|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||88
2215411|NCT02952820|5432218|P2|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||69
2215412|NCT02952820|5432219|P1|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||64
2215413|NCT02952820|5432217|P3|COMPLETED|Placebo-Controlled Treatment (6 Months)||235
2215414|NCT02952820|5432218|P2|COMPLETED|Placebo-Controlled Treatment (6 Months)||254
2215415|NCT02952820|5432219|P1|COMPLETED|Placebo-Controlled Treatment (6 Months)||261
2215416|NCT02952820|5432217|P3|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||314
2215417|NCT02952820|5432218|P2|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||314
2215418|NCT02952820|5432219|P1|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||319
2215419|NCT02952820|5432217|P3|Treated|Placebo-Controlled Treatment (6 Months)||319
2215420|NCT02952820|5432218|P2|Treated|Placebo-Controlled Treatment (6 Months)||319
2215421|NCT02952820|5432219|P1|Treated|Placebo-Controlled Treatment (6 Months)||321
2215422|NCT02952820|5432217|P3|STARTED|Placebo-Controlled Treatment (6 Months)||323
2215423|NCT02952820|5432218|P2|STARTED|Placebo-Controlled Treatment (6 Months)||323
2215424|NCT02952820|5432219|P1|STARTED|Placebo-Controlled Treatment (6 Months)||325
2215425|NCT02952313|5432279|P1|NOT COMPLETED|Overall Study||7
2215426|NCT02952313|5432279|P1|COMPLETED|Overall Study||106
2215427|NCT02952313|5432279|P1|6 Months|Overall Study||106
2215428|NCT02952313|5432279|P1|STARTED|Overall Study||113
2215429|NCT02952261|5432287|P2|NOT COMPLETED|Overall Study||5
2215430|NCT02952261|5432288|P1|NOT COMPLETED|Overall Study||5
2215431|NCT02952261|5432287|P2|COMPLETED|Overall Study||95
2215432|NCT02952261|5432288|P1|COMPLETED|Overall Study||95
2215433|NCT02952261|5432287|P2|STARTED|Overall Study||100
2215434|NCT02952261|5432288|P1|STARTED|Overall Study||100
2215435|NCT02951884|5432303|P3|NOT COMPLETED|Overall Study||0
2215436|NCT02951884|5432304|P2|NOT COMPLETED|Overall Study||0
2215437|NCT02951884|5432305|P1|NOT COMPLETED|Overall Study||0
2215438|NCT02951884|5432303|P3|COMPLETED|Overall Study||1
2215439|NCT02951884|5432304|P2|COMPLETED|Overall Study||1
2215440|NCT02951884|5432305|P1|COMPLETED|Overall Study||0
2215441|NCT02951884|5432303|P3|STARTED|Overall Study||1
2215442|NCT02951884|5432304|P2|STARTED|Overall Study||1
2215443|NCT02951884|5432305|P1|STARTED|Overall Study||0
2215452|NCT02951780|5432350|P9|NOT COMPLETED|Period 3||0
2215453|NCT02951780|5432351|P8|NOT COMPLETED|Period 3||0
2215454|NCT02951780|5432352|P7|NOT COMPLETED|Period 3||0
2215455|NCT02951780|5432353|P6|NOT COMPLETED|Period 3||0
2215456|NCT02951780|5432354|P5|NOT COMPLETED|Period 3||0
2215457|NCT02951780|5432355|P4|NOT COMPLETED|Period 3||0
2215458|NCT02951780|5432356|P3|NOT COMPLETED|Period 3||0
2215459|NCT02951780|5432357|P2|NOT COMPLETED|Period 3||0
2215460|NCT02951780|5432358|P1|NOT COMPLETED|Period 3||0
2215461|NCT02951780|5432350|P9|COMPLETED|Period 3||2
2215462|NCT02951780|5432351|P8|COMPLETED|Period 3||1
2215463|NCT02951780|5432352|P7|COMPLETED|Period 3||2
2215464|NCT02951780|5432353|P6|COMPLETED|Period 3||3
2215465|NCT02951780|5432354|P5|COMPLETED|Period 3||2
2215466|NCT02951780|5432355|P4|COMPLETED|Period 3||2
2215467|NCT02951780|5432356|P3|COMPLETED|Period 3||3
2215468|NCT02951780|5432357|P2|COMPLETED|Period 3||2
2215469|NCT02951780|5432358|P1|COMPLETED|Period 3||3
2215470|NCT02951780|5432350|P9|STARTED|Period 3||2
2215471|NCT02951780|5432351|P8|STARTED|Period 3||1
2215472|NCT02951780|5432352|P7|STARTED|Period 3||2
2215473|NCT02951780|5432353|P6|STARTED|Period 3||3
2215474|NCT02951780|5432354|P5|STARTED|Period 3||2
2215475|NCT02951780|5432355|P4|STARTED|Period 3||2
2215476|NCT02951780|5432356|P3|STARTED|Period 3||3
2215477|NCT02951780|5432357|P2|STARTED|Period 3||2
2215478|NCT02951780|5432358|P1|STARTED|Period 3||3
2215479|NCT02951780|5432350|P9|NOT COMPLETED|Period 2||0
2215480|NCT02951780|5432351|P8|NOT COMPLETED|Period 2||1
2215481|NCT02951780|5432352|P7|NOT COMPLETED|Period 2||0
2215482|NCT02951780|5432353|P6|NOT COMPLETED|Period 2||0
2215483|NCT02951780|5432354|P5|NOT COMPLETED|Period 2||0
2215484|NCT02951780|5432355|P4|NOT COMPLETED|Period 2||0
2215485|NCT02951780|5432356|P3|NOT COMPLETED|Period 2||0
2215486|NCT02951780|5432357|P2|NOT COMPLETED|Period 2||0
2215487|NCT02951780|5432358|P1|NOT COMPLETED|Period 2||0
2215488|NCT02951780|5432350|P9|COMPLETED|Period 2||2
2215489|NCT02951780|5432351|P8|COMPLETED|Period 2||1
2215490|NCT02951780|5432352|P7|COMPLETED|Period 2||2
2215491|NCT02951780|5432353|P6|COMPLETED|Period 2||3
2215492|NCT02951780|5432354|P5|COMPLETED|Period 2||2
2215493|NCT02951780|5432355|P4|COMPLETED|Period 2||2
2215494|NCT02951780|5432356|P3|COMPLETED|Period 2||3
2215495|NCT02951780|5432357|P2|COMPLETED|Period 2||2
2215496|NCT02951780|5432358|P1|COMPLETED|Period 2||3
2215497|NCT02951780|5432350|P9|STARTED|Period 2||2
2215498|NCT02951780|5432351|P8|STARTED|Period 2||2
2215499|NCT02951780|5432352|P7|STARTED|Period 2||2
2215500|NCT02951780|5432353|P6|STARTED|Period 2||3
2215501|NCT02951780|5432354|P5|STARTED|Period 2||2
2215502|NCT02951780|5432355|P4|STARTED|Period 2||2
2215503|NCT02951780|5432356|P3|STARTED|Period 2||3
2215504|NCT02951780|5432357|P2|STARTED|Period 2||2
2215505|NCT02951780|5432358|P1|STARTED|Period 2||3
2215506|NCT02951780|5432350|P9|NOT COMPLETED|Period 1||0
2215507|NCT02951780|5432351|P8|NOT COMPLETED|Period 1||1
2215508|NCT02951780|5432352|P7|NOT COMPLETED|Period 1||0
2215509|NCT02951780|5432353|P6|NOT COMPLETED|Period 1||0
2215510|NCT02951780|5432354|P5|NOT COMPLETED|Period 1||0
2215511|NCT02951780|5432355|P4|NOT COMPLETED|Period 1||1
2215512|NCT02951780|5432356|P3|NOT COMPLETED|Period 1||0
2215513|NCT02951780|5432357|P2|NOT COMPLETED|Period 1||0
2215514|NCT02951780|5432358|P1|NOT COMPLETED|Period 1||0
2215515|NCT02951780|5432350|P9|COMPLETED|Period 1||2
2215516|NCT02951780|5432351|P8|COMPLETED|Period 1||2
2215517|NCT02951780|5432352|P7|COMPLETED|Period 1||2
2215518|NCT02951780|5432353|P6|COMPLETED|Period 1||3
2215519|NCT02951780|5432354|P5|COMPLETED|Period 1||2
2215520|NCT02951780|5432355|P4|COMPLETED|Period 1||2
2215521|NCT02951780|5432356|P3|COMPLETED|Period 1||3
2215522|NCT02951780|5432357|P2|COMPLETED|Period 1||2
2215523|NCT02951780|5432358|P1|COMPLETED|Period 1||3
2215524|NCT02951780|5432350|P9|STARTED|Period 1||2
2215525|NCT02951780|5432351|P8|STARTED|Period 1||3
2215526|NCT02951780|5432352|P7|STARTED|Period 1||2
2215527|NCT02951780|5432353|P6|STARTED|Period 1||3
2215528|NCT02951780|5432354|P5|STARTED|Period 1||2
2215529|NCT02951780|5432355|P4|STARTED|Period 1||3
2215530|NCT02951780|5432356|P3|STARTED|Period 1||3
2215531|NCT02951780|5432357|P2|STARTED|Period 1||2
2215532|NCT02951780|5432358|P1|STARTED|Period 1||3
2215533|NCT02951767|5432423|P1|NOT COMPLETED|Overall Study||119
2215534|NCT02951767|5432423|P1|COMPLETED|Overall Study||0
2215535|NCT02951767|5432423|P1|STARTED|Overall Study||119
2215536|NCT02951702|5432442|P2|NOT COMPLETED|Overall Study||0
2215537|NCT02951702|5432443|P1|NOT COMPLETED|Overall Study||0
2215538|NCT02951702|5432442|P2|COMPLETED|Overall Study||17
2215539|NCT02951702|5432443|P1|COMPLETED|Overall Study||34
2215540|NCT02951702|5432442|P2|STARTED|Overall Study||17
2215541|NCT02951702|5432443|P1|STARTED|Overall Study||34
2215550|NCT02951351|5432486|P2|NOT COMPLETED|Overall Study||0
2215551|NCT02951351|5432487|P1|NOT COMPLETED|Overall Study||0
2215552|NCT02951351|5432486|P2|COMPLETED|Overall Study||17
2215553|NCT02951351|5432487|P1|COMPLETED|Overall Study||19
2215554|NCT02951351|5432486|P2|STARTED|Overall Study||17
2215555|NCT02951351|5432487|P1|STARTED|Overall Study||19
2215556|NCT02951312|5432511|P4|NOT COMPLETED|Study Part 2||0
2215557|NCT02951312|5432512|P3|NOT COMPLETED|Study Part 2||0
2215558|NCT02951312|5432513|P2|NOT COMPLETED|Study Part 2||0
2215559|NCT02951312|5432514|P1|NOT COMPLETED|Study Part 2||0
2215560|NCT02951312|5432511|P4|COMPLETED|Study Part 2||6
2215561|NCT02951312|5432512|P3|COMPLETED|Study Part 2||6
2215562|NCT02951312|5432513|P2|COMPLETED|Study Part 2||0
2215563|NCT02951312|5432514|P1|COMPLETED|Study Part 2||0
2215564|NCT02951312|5432511|P4|STARTED|Study Part 2||6
2215565|NCT02951312|5432512|P3|STARTED|Study Part 2||6
2215566|NCT02951312|5432513|P2|STARTED|Study Part 2||0
2215567|NCT02951312|5432514|P1|STARTED|Study Part 2||0
2215568|NCT02951312|5432511|P4|NOT COMPLETED|Study Part 1||0
2215569|NCT02951312|5432512|P3|NOT COMPLETED|Study Part 1||0
2215570|NCT02951312|5432513|P2|NOT COMPLETED|Study Part 1||0
2215571|NCT02951312|5432514|P1|NOT COMPLETED|Study Part 1||0
2215572|NCT02951312|5432511|P4|COMPLETED|Study Part 1||0
2215573|NCT02951312|5432512|P3|COMPLETED|Study Part 1||0
2215574|NCT02951312|5432513|P2|COMPLETED|Study Part 1||6
2215575|NCT02951312|5432514|P1|COMPLETED|Study Part 1||6
2215576|NCT02951312|5432511|P4|STARTED|Study Part 1||0
2215577|NCT02951312|5432512|P3|STARTED|Study Part 1||0
2215578|NCT02951312|5432513|P2|STARTED|Study Part 1||6
2215579|NCT02951312|5432514|P1|STARTED|Study Part 1||6
2215580|NCT02951273|5432634|P1|NOT COMPLETED|Overall Study||3
2215581|NCT02951273|5432634|P1|COMPLETED|Overall Study||27
2215582|NCT02951273|5432634|P1|STARTED|Overall Study||30
2215583|NCT02951052|5432651|P2|NOT COMPLETED|Overall Study||18
2215584|NCT02951052|5432652|P1|NOT COMPLETED|Overall Study||27
2215585|NCT02951052|5432651|P2|COMPLETED|Overall Study||290
2215586|NCT02951052|5432652|P1|COMPLETED|Overall Study||281
2215587|NCT02951052|5432651|P2|STARTED|Overall Study||308
2215588|NCT02951052|5432652|P1|STARTED|Overall Study||308
2215589|NCT02950896|5432816|P1|NOT COMPLETED|Overall Study||0
2215590|NCT02950896|5432816|P1|COMPLETED|Overall Study||4
2215591|NCT02950896|5432816|P1|STARTED|Overall Study||4
2215592|NCT02950831|5432820|P1|NOT COMPLETED|Overall Study||9
2215593|NCT02950831|5432820|P1|COMPLETED|Overall Study||18
2215594|NCT02950831|5432820|P1|8 Weeks Follow up|Overall Study||19
2215595|NCT02950831|5432820|P1|4 Week Follow up|Overall Study||20
2215596|NCT02950831|5432820|P1|Permanent Implant|Overall Study||20
2215597|NCT02950831|5432820|P1|Complete Trial|Overall Study||26
2215598|NCT02950831|5432820|P1|STARTED|Overall Study||27
2215599|NCT02950753|5432845|P2|NOT COMPLETED|Overall Study||0
2215600|NCT02950753|5432846|P1|NOT COMPLETED|Overall Study||0
2215601|NCT02950753|5432845|P2|COMPLETED|Overall Study||15
2215602|NCT02950753|5432846|P1|COMPLETED|Overall Study||15
2215603|NCT02950753|5432845|P2|STARTED|Overall Study||15
2215604|NCT02950753|5432846|P1|STARTED|Overall Study||15
2215605|NCT02950480|5432858|P2|NOT COMPLETED|Overall Study||0
2215606|NCT02950480|5432859|P1|NOT COMPLETED|Overall Study||1
2215607|NCT02950480|5432858|P2|COMPLETED|Overall Study||2
2215608|NCT02950480|5432859|P1|COMPLETED|Overall Study||1
2215609|NCT02950480|5432858|P2|STARTED|Overall Study||2
2215610|NCT02950480|5432859|P1|STARTED|Overall Study||2
2215611|NCT02950025|5432871|P2|NOT COMPLETED|Overall Study||0
2215612|NCT02950025|5432872|P1|NOT COMPLETED|Overall Study||0
2215613|NCT02950025|5432871|P2|COMPLETED|Overall Study||3
2215614|NCT02950025|5432872|P1|COMPLETED|Overall Study||2
2215615|NCT02950025|5432871|P2|STARTED|Overall Study||3
2215616|NCT02950025|5432872|P1|STARTED|Overall Study||2
2215617|NCT02949921|5432892|P2|NOT COMPLETED|Overall Study||0
2215618|NCT02949921|5432893|P1|NOT COMPLETED|Overall Study||0
2215619|NCT02949921|5432892|P2|COMPLETED|Overall Study||10
2215620|NCT02949921|5432893|P1|COMPLETED|Overall Study||10
2215621|NCT02949921|5432892|P2|STARTED|Overall Study||10
2215622|NCT02949921|5432893|P1|STARTED|Overall Study||10
2215623|NCT02949908|5432917|P1|NOT COMPLETED|Overall Study||2
2215624|NCT02949908|5432917|P1|COMPLETED|Overall Study||0
2215625|NCT02949908|5432917|P1|STARTED|Overall Study||2
2215626|NCT02949674|5432940|P3|NOT COMPLETED|Overall Study||0
2215627|NCT02949674|5432941|P2|NOT COMPLETED|Overall Study||0
2215628|NCT02949674|5432942|P1|NOT COMPLETED|Overall Study||0
2215629|NCT02949674|5432940|P3|COMPLETED|Overall Study||31
2215630|NCT02949674|5432941|P2|COMPLETED|Overall Study||31
2215631|NCT02949674|5432942|P1|COMPLETED|Overall Study||31
2215632|NCT02949674|5432940|P3|STARTED|Overall Study||31
2215633|NCT02949674|5432941|P2|STARTED|Overall Study||31
2215634|NCT02949674|5432942|P1|STARTED|Overall Study||31
2215635|NCT02949271|5432952|P2|NOT COMPLETED|Overall Study||30
2215636|NCT02949271|5432953|P1|NOT COMPLETED|Overall Study||29
2215637|NCT02949271|5432952|P2|COMPLETED|Overall Study||59
2215638|NCT02949271|5432953|P1|COMPLETED|Overall Study||61
2215639|NCT02949271|5432952|P2|STARTED|Overall Study||89
2215640|NCT02949271|5432953|P1|STARTED|Overall Study||90
2215641|NCT02949219|5432979|P1|NOT COMPLETED|Overall Study||1
2215642|NCT02949219|5432979|P1|COMPLETED|Overall Study||40
2215643|NCT02949219|5432979|P1|STARTED|Overall Study||41
2215644|NCT02949141|5432986|P1|NOT COMPLETED|Overall Study||0
2215645|NCT02949141|5432986|P1|COMPLETED|Overall Study||62
2215646|NCT02949141|5432986|P1|STARTED|Overall Study||62
2215647|NCT02949128|5432993|P1|NOT COMPLETED|Extension Period||2
2215648|NCT02949128|5432993|P1|COMPLETED|Extension Period||47
2215649|NCT02949128|5432993|P1|Received At Least 1 Dose of Study Drug|Extension Period||47
2215650|NCT02949128|5432993|P1|STARTED|Extension Period||49
2215651|NCT02949128|5432993|P1|NOT COMPLETED|Initial Evaluation Period||9
2215652|NCT02949128|5432993|P1|COMPLETED|Initial Evaluation Period||49
2215653|NCT02949128|5432993|P1|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||58
2215654|NCT02949128|5432993|P1|STARTED|Initial Evaluation Period||58
2215655|NCT02949011|5433010|P3|NOT COMPLETED|Overall Study||42
2215656|NCT02949011|5433011|P2|NOT COMPLETED|Overall Study||34
2215657|NCT02949011|5433012|P1|NOT COMPLETED|Overall Study||33
2215658|NCT02949011|5433010|P3|COMPLETED|Overall Study||683
2215659|NCT02949011|5433011|P2|COMPLETED|Overall Study||695
2215660|NCT02949011|5433012|P1|COMPLETED|Overall Study||697
2215661|NCT02949011|5433010|P3|Intention to Treat Infected Population|Overall Study||389
2215662|NCT02949011|5433011|P2|Intention to Treat Infected Population|Overall Study||386
2215663|NCT02949011|5433012|P1|Intention to Treat Infected Population|Overall Study||388
2215664|NCT02949011|5433010|P3|Received Study Drug|Overall Study|Includes one participant who received baloxavir marboxil in error|722
2215665|NCT02949011|5433011|P2|Received Study Drug|Overall Study|Includes one participant who received baloxavir marboxil in error|728
2215666|NCT02949011|5433012|P1|Received Study Drug|Overall Study||728
2215667|NCT02949011|5433010|P3|STARTED|Overall Study||725
2215668|NCT02949011|5433011|P2|STARTED|Overall Study||729
2215669|NCT02949011|5433012|P1|STARTED|Overall Study||730
2215670|NCT02948582|5433080|P6|NOT COMPLETED|Wshout Period 6||0
2215671|NCT02948582|5433081|P5|NOT COMPLETED|Wshout Period 6||0
2215672|NCT02948582|5433082|P4|NOT COMPLETED|Wshout Period 6||0
2215673|NCT02948582|5433083|P3|NOT COMPLETED|Wshout Period 6||0
2215674|NCT02948582|5433084|P2|NOT COMPLETED|Wshout Period 6||0
2215675|NCT02948582|5433085|P1|NOT COMPLETED|Wshout Period 6||0
2215676|NCT02948582|5433080|P6|COMPLETED|Wshout Period 6||6
2215677|NCT02948582|5433081|P5|COMPLETED|Wshout Period 6||7
2215678|NCT02948582|5433082|P4|COMPLETED|Wshout Period 6||6
2215679|NCT02948582|5433083|P3|COMPLETED|Wshout Period 6||6
2215680|NCT02948582|5433084|P2|COMPLETED|Wshout Period 6||4
2215681|NCT02948582|5433085|P1|COMPLETED|Wshout Period 6||6
2215682|NCT02948582|5433080|P6|STARTED|Wshout Period 6||6
2215683|NCT02948582|5433081|P5|STARTED|Wshout Period 6||7
2215684|NCT02948582|5433082|P4|STARTED|Wshout Period 6||6
2215685|NCT02948582|5433083|P3|STARTED|Wshout Period 6||6
2215686|NCT02948582|5433084|P2|STARTED|Wshout Period 6||4
2215687|NCT02948582|5433085|P1|STARTED|Wshout Period 6||6
2215688|NCT02948582|5433080|P6|NOT COMPLETED|Treatment Period 6||0
2215689|NCT02948582|5433081|P5|NOT COMPLETED|Treatment Period 6||0
2215690|NCT02948582|5433082|P4|NOT COMPLETED|Treatment Period 6||0
2215691|NCT02948582|5433083|P3|NOT COMPLETED|Treatment Period 6||0
2215692|NCT02948582|5433084|P2|NOT COMPLETED|Treatment Period 6||0
2215693|NCT02948582|5433085|P1|NOT COMPLETED|Treatment Period 6||0
2215694|NCT02948582|5433080|P6|COMPLETED|Treatment Period 6||6
2215695|NCT02948582|5433081|P5|COMPLETED|Treatment Period 6||7
2215696|NCT02948582|5433082|P4|COMPLETED|Treatment Period 6||6
2215697|NCT02948582|5433083|P3|COMPLETED|Treatment Period 6||6
2215698|NCT02948582|5433084|P2|COMPLETED|Treatment Period 6||4
2215699|NCT02948582|5433085|P1|COMPLETED|Treatment Period 6||6
2215700|NCT02948582|5433080|P6|STARTED|Treatment Period 6||6
2215701|NCT02948582|5433081|P5|STARTED|Treatment Period 6||7
2215702|NCT02948582|5433082|P4|STARTED|Treatment Period 6||6
2215703|NCT02948582|5433083|P3|STARTED|Treatment Period 6||6
2215704|NCT02948582|5433084|P2|STARTED|Treatment Period 6||4
2215705|NCT02948582|5433085|P1|STARTED|Treatment Period 6||6
2215706|NCT02948582|5433080|P6|NOT COMPLETED|Washout Period 5||0
2215707|NCT02948582|5433081|P5|NOT COMPLETED|Washout Period 5||0
2215708|NCT02948582|5433082|P4|NOT COMPLETED|Washout Period 5||0
2215709|NCT02948582|5433083|P3|NOT COMPLETED|Washout Period 5||0
2215710|NCT02948582|5433084|P2|NOT COMPLETED|Washout Period 5||0
2215711|NCT02948582|5433085|P1|NOT COMPLETED|Washout Period 5||0
2215712|NCT02948582|5433080|P6|COMPLETED|Washout Period 5||6
2215713|NCT02948582|5433081|P5|COMPLETED|Washout Period 5||7
2215714|NCT02948582|5433082|P4|COMPLETED|Washout Period 5||6
2215715|NCT02948582|5433083|P3|COMPLETED|Washout Period 5||6
2215716|NCT02948582|5433084|P2|COMPLETED|Washout Period 5||4
2215717|NCT02948582|5433085|P1|COMPLETED|Washout Period 5||6
2215718|NCT02948582|5433080|P6|STARTED|Washout Period 5||6
2215719|NCT02948582|5433081|P5|STARTED|Washout Period 5||7
2215720|NCT02948582|5433082|P4|STARTED|Washout Period 5||6
2215721|NCT02948582|5433083|P3|STARTED|Washout Period 5||6
2215722|NCT02948582|5433084|P2|STARTED|Washout Period 5||4
2215723|NCT02948582|5433085|P1|STARTED|Washout Period 5||6
2215724|NCT02948582|5433080|P6|NOT COMPLETED|Treatment Period 5||0
2215725|NCT02948582|5433081|P5|NOT COMPLETED|Treatment Period 5||0
2215726|NCT02948582|5433082|P4|NOT COMPLETED|Treatment Period 5||0
2215727|NCT02948582|5433083|P3|NOT COMPLETED|Treatment Period 5||0
2215728|NCT02948582|5433084|P2|NOT COMPLETED|Treatment Period 5||0
2215729|NCT02948582|5433085|P1|NOT COMPLETED|Treatment Period 5||0
2215730|NCT02948582|5433080|P6|COMPLETED|Treatment Period 5||6
2215731|NCT02948582|5433081|P5|COMPLETED|Treatment Period 5||7
2215732|NCT02948582|5433082|P4|COMPLETED|Treatment Period 5||6
2215733|NCT02948582|5433083|P3|COMPLETED|Treatment Period 5||6
2215734|NCT02948582|5433084|P2|COMPLETED|Treatment Period 5||4
2215735|NCT02948582|5433085|P1|COMPLETED|Treatment Period 5||6
2215736|NCT02948582|5433080|P6|STARTED|Treatment Period 5||6
2215737|NCT02948582|5433081|P5|STARTED|Treatment Period 5||7
2215738|NCT02948582|5433082|P4|STARTED|Treatment Period 5||6
2215739|NCT02948582|5433083|P3|STARTED|Treatment Period 5||6
2215740|NCT02948582|5433084|P2|STARTED|Treatment Period 5||4
2215741|NCT02948582|5433085|P1|STARTED|Treatment Period 5||6
2215742|NCT02948582|5433080|P6|NOT COMPLETED|Washout Period 4||0
2215743|NCT02948582|5433081|P5|NOT COMPLETED|Washout Period 4||0
2215744|NCT02948582|5433082|P4|NOT COMPLETED|Washout Period 4||0
2215745|NCT02948582|5433083|P3|NOT COMPLETED|Washout Period 4||1
2215746|NCT02948582|5433084|P2|NOT COMPLETED|Washout Period 4||0
2215747|NCT02948582|5433085|P1|NOT COMPLETED|Washout Period 4||1
2215748|NCT02948582|5433080|P6|COMPLETED|Washout Period 4||6
2215749|NCT02948582|5433081|P5|COMPLETED|Washout Period 4||7
2215750|NCT02948582|5433082|P4|COMPLETED|Washout Period 4||6
2215751|NCT02948582|5433083|P3|COMPLETED|Washout Period 4||6
2215752|NCT02948582|5433084|P2|COMPLETED|Washout Period 4||4
2215753|NCT02948582|5433085|P1|COMPLETED|Washout Period 4||6
2215754|NCT02948582|5433080|P6|STARTED|Washout Period 4||6
2215755|NCT02948582|5433081|P5|STARTED|Washout Period 4||7
2215756|NCT02948582|5433082|P4|STARTED|Washout Period 4||6
2215757|NCT02948582|5433083|P3|STARTED|Washout Period 4||7
2215758|NCT02948582|5433084|P2|STARTED|Washout Period 4||4
2215759|NCT02948582|5433085|P1|STARTED|Washout Period 4||7
2215760|NCT02948582|5433080|P6|NOT COMPLETED|Treatment Period 4||0
2215761|NCT02948582|5433081|P5|NOT COMPLETED|Treatment Period 4||0
2215762|NCT02948582|5433082|P4|NOT COMPLETED|Treatment Period 4||0
2215763|NCT02948582|5433083|P3|NOT COMPLETED|Treatment Period 4||0
2215764|NCT02948582|5433084|P2|NOT COMPLETED|Treatment Period 4||0
2215765|NCT02948582|5433085|P1|NOT COMPLETED|Treatment Period 4||0
2215766|NCT02948582|5433080|P6|COMPLETED|Treatment Period 4||6
2215767|NCT02948582|5433081|P5|COMPLETED|Treatment Period 4||7
2215768|NCT02948582|5433082|P4|COMPLETED|Treatment Period 4||6
2215769|NCT02948582|5433083|P3|COMPLETED|Treatment Period 4||7
2215770|NCT02948582|5433084|P2|COMPLETED|Treatment Period 4||4
2215771|NCT02948582|5433085|P1|COMPLETED|Treatment Period 4||7
2215772|NCT02948582|5433080|P6|STARTED|Treatment Period 4||6
2215773|NCT02948582|5433081|P5|STARTED|Treatment Period 4||7
2215774|NCT02948582|5433082|P4|STARTED|Treatment Period 4||6
2215775|NCT02948582|5433083|P3|STARTED|Treatment Period 4||7
2215776|NCT02948582|5433084|P2|STARTED|Treatment Period 4||4
2215777|NCT02948582|5433085|P1|STARTED|Treatment Period 4||7
2215778|NCT02948582|5433080|P6|NOT COMPLETED|Washout Period 3||0
2215779|NCT02948582|5433081|P5|NOT COMPLETED|Washout Period 3||0
2215780|NCT02948582|5433082|P4|NOT COMPLETED|Washout Period 3||0
2215781|NCT02948582|5433083|P3|NOT COMPLETED|Washout Period 3||0
2215782|NCT02948582|5433084|P2|NOT COMPLETED|Washout Period 3||0
2215783|NCT02948582|5433085|P1|NOT COMPLETED|Washout Period 3||0
2215784|NCT02948582|5433080|P6|COMPLETED|Washout Period 3||6
2215785|NCT02948582|5433081|P5|COMPLETED|Washout Period 3||7
2215786|NCT02948582|5433082|P4|COMPLETED|Washout Period 3||6
2215787|NCT02948582|5433083|P3|COMPLETED|Washout Period 3||7
2215788|NCT02948582|5433084|P2|COMPLETED|Washout Period 3||4
2215789|NCT02948582|5433085|P1|COMPLETED|Washout Period 3||7
2215790|NCT02948582|5433080|P6|STARTED|Washout Period 3||6
2215791|NCT02948582|5433081|P5|STARTED|Washout Period 3||7
2215792|NCT02948582|5433082|P4|STARTED|Washout Period 3||6
2215793|NCT02948582|5433083|P3|STARTED|Washout Period 3||7
2215794|NCT02948582|5433084|P2|STARTED|Washout Period 3||4
2215795|NCT02948582|5433085|P1|STARTED|Washout Period 3||7
2215796|NCT02948582|5433080|P6|NOT COMPLETED|Treatment Period 3||0
2215797|NCT02948582|5433081|P5|NOT COMPLETED|Treatment Period 3||0
2215798|NCT02948582|5433082|P4|NOT COMPLETED|Treatment Period 3||0
2215799|NCT02948582|5433083|P3|NOT COMPLETED|Treatment Period 3||0
2215800|NCT02948582|5433084|P2|NOT COMPLETED|Treatment Period 3||0
2215801|NCT02948582|5433085|P1|NOT COMPLETED|Treatment Period 3||0
2215802|NCT02948582|5433080|P6|COMPLETED|Treatment Period 3||6
2215803|NCT02948582|5433081|P5|COMPLETED|Treatment Period 3||7
2215804|NCT02948582|5433082|P4|COMPLETED|Treatment Period 3||6
2215805|NCT02948582|5433083|P3|COMPLETED|Treatment Period 3||7
2215806|NCT02948582|5433084|P2|COMPLETED|Treatment Period 3||4
2215807|NCT02948582|5433085|P1|COMPLETED|Treatment Period 3||7
2215808|NCT02948582|5433080|P6|STARTED|Treatment Period 3||6
2215809|NCT02948582|5433081|P5|STARTED|Treatment Period 3||7
2215810|NCT02948582|5433082|P4|STARTED|Treatment Period 3||6
2215811|NCT02948582|5433083|P3|STARTED|Treatment Period 3||7
2215812|NCT02948582|5433084|P2|STARTED|Treatment Period 3||4
2215813|NCT02948582|5433085|P1|STARTED|Treatment Period 3||7
2215814|NCT02948582|5433080|P6|NOT COMPLETED|Washout Period 2||0
2215815|NCT02948582|5433081|P5|NOT COMPLETED|Washout Period 2||0
2215816|NCT02948582|5433082|P4|NOT COMPLETED|Washout Period 2||1
2215817|NCT02948582|5433083|P3|NOT COMPLETED|Washout Period 2||0
2215818|NCT02948582|5433084|P2|NOT COMPLETED|Washout Period 2||1
2215819|NCT02948582|5433085|P1|NOT COMPLETED|Washout Period 2||0
2215820|NCT02948582|5433080|P6|COMPLETED|Washout Period 2||6
2215821|NCT02948582|5433081|P5|COMPLETED|Washout Period 2||7
2215822|NCT02948582|5433082|P4|COMPLETED|Washout Period 2||6
2215823|NCT02948582|5433083|P3|COMPLETED|Washout Period 2||7
2215824|NCT02948582|5433084|P2|COMPLETED|Washout Period 2||4
2215825|NCT02948582|5433085|P1|COMPLETED|Washout Period 2||7
2215826|NCT02948582|5433080|P6|STARTED|Washout Period 2||6
2215827|NCT02948582|5433081|P5|STARTED|Washout Period 2||7
2215828|NCT02948582|5433082|P4|STARTED|Washout Period 2||7
2215829|NCT02948582|5433083|P3|STARTED|Washout Period 2||7
2215830|NCT02948582|5433084|P2|STARTED|Washout Period 2||5
2215831|NCT02948582|5433085|P1|STARTED|Washout Period 2||7
2215832|NCT02948582|5433080|P6|NOT COMPLETED|Treatment Period 2||0
2215833|NCT02948582|5433081|P5|NOT COMPLETED|Treatment Period 2||0
2215834|NCT02948582|5433082|P4|NOT COMPLETED|Treatment Period 2||0
2215835|NCT02948582|5433083|P3|NOT COMPLETED|Treatment Period 2||0
2215836|NCT02948582|5433084|P2|NOT COMPLETED|Treatment Period 2||0
2215837|NCT02948582|5433085|P1|NOT COMPLETED|Treatment Period 2||0
2215838|NCT02948582|5433080|P6|COMPLETED|Treatment Period 2||6
2215839|NCT02948582|5433081|P5|COMPLETED|Treatment Period 2||7
2215840|NCT02948582|5433082|P4|COMPLETED|Treatment Period 2||7
2215841|NCT02948582|5433083|P3|COMPLETED|Treatment Period 2||7
2215842|NCT02948582|5433084|P2|COMPLETED|Treatment Period 2||5
2215843|NCT02948582|5433085|P1|COMPLETED|Treatment Period 2||7
2215844|NCT02948582|5433080|P6|STARTED|Treatment Period 2||6
2215845|NCT02948582|5433081|P5|STARTED|Treatment Period 2||7
2215846|NCT02948582|5433082|P4|STARTED|Treatment Period 2||7
2215847|NCT02948582|5433083|P3|STARTED|Treatment Period 2||7
2215848|NCT02948582|5433084|P2|STARTED|Treatment Period 2||5
2215849|NCT02948582|5433085|P1|STARTED|Treatment Period 2||7
2215850|NCT02948582|5433080|P6|NOT COMPLETED|Washout Period 1||1
2215851|NCT02948582|5433081|P5|NOT COMPLETED|Washout Period 1||0
2215852|NCT02948582|5433082|P4|NOT COMPLETED|Washout Period 1||0
2215853|NCT02948582|5433083|P3|NOT COMPLETED|Washout Period 1||0
2215854|NCT02948582|5433084|P2|NOT COMPLETED|Washout Period 1||2
2215855|NCT02948582|5433085|P1|NOT COMPLETED|Washout Period 1||0
2215856|NCT02948582|5433080|P6|COMPLETED|Washout Period 1||6
2215857|NCT02948582|5433081|P5|COMPLETED|Washout Period 1||7
2215858|NCT02948582|5433082|P4|COMPLETED|Washout Period 1||7
2215859|NCT02948582|5433083|P3|COMPLETED|Washout Period 1||7
2215860|NCT02948582|5433084|P2|COMPLETED|Washout Period 1||5
2215861|NCT02948582|5433085|P1|COMPLETED|Washout Period 1||7
2215862|NCT02948582|5433080|P6|STARTED|Washout Period 1||7
2215863|NCT02948582|5433081|P5|STARTED|Washout Period 1||7
2215864|NCT02948582|5433082|P4|STARTED|Washout Period 1||7
2215865|NCT02948582|5433083|P3|STARTED|Washout Period 1||7
2215866|NCT02948582|5433084|P2|STARTED|Washout Period 1||7
2215867|NCT02948582|5433085|P1|STARTED|Washout Period 1||7
2215868|NCT02948582|5433080|P6|NOT COMPLETED|Treatment Period 1||0
2215869|NCT02948582|5433081|P5|NOT COMPLETED|Treatment Period 1||0
2215870|NCT02948582|5433082|P4|NOT COMPLETED|Treatment Period 1||0
2215871|NCT02948582|5433083|P3|NOT COMPLETED|Treatment Period 1||0
2215872|NCT02948582|5433084|P2|NOT COMPLETED|Treatment Period 1||0
2215873|NCT02948582|5433085|P1|NOT COMPLETED|Treatment Period 1||0
2215874|NCT02948582|5433080|P6|COMPLETED|Treatment Period 1||7
2215875|NCT02948582|5433081|P5|COMPLETED|Treatment Period 1||7
2215876|NCT02948582|5433082|P4|COMPLETED|Treatment Period 1||7
2215877|NCT02948582|5433083|P3|COMPLETED|Treatment Period 1||7
2215878|NCT02948582|5433084|P2|COMPLETED|Treatment Period 1||7
2215879|NCT02948582|5433085|P1|COMPLETED|Treatment Period 1||7
2215880|NCT02948582|5433080|P6|STARTED|Treatment Period 1||7
2215881|NCT02948582|5433081|P5|STARTED|Treatment Period 1||7
2215882|NCT02948582|5433082|P4|STARTED|Treatment Period 1||7
2215883|NCT02948582|5433083|P3|STARTED|Treatment Period 1||7
2215884|NCT02948582|5433084|P2|STARTED|Treatment Period 1||7
2215885|NCT02948582|5433085|P1|STARTED|Treatment Period 1||7
2215886|NCT02948257|5433178|P1|NOT COMPLETED|Overall Study||0
2215887|NCT02948257|5433178|P1|COMPLETED|Overall Study||52
2215888|NCT02948257|5433178|P1|STARTED|Overall Study||52
2215889|NCT02947997|5433188|P1|NOT COMPLETED|Overall Study||0
2215890|NCT02947997|5433188|P1|COMPLETED|Overall Study||4
2215891|NCT02947997|5433188|P1|STARTED|Overall Study||4
2215892|NCT02947984|5433194|P2|NOT COMPLETED|Overall Study||0
2215893|NCT02947984|5433195|P1|NOT COMPLETED|Overall Study||0
2215894|NCT02947984|5433194|P2|COMPLETED|Overall Study||22
2215895|NCT02947984|5433195|P1|COMPLETED|Overall Study||22
2215896|NCT02947984|5433194|P2|STARTED|Overall Study||22
2215897|NCT02947984|5433195|P1|STARTED|Overall Study||22
2215898|NCT02947022|5433207|P1|NOT COMPLETED|Overall Study||1
2215899|NCT02947022|5433207|P1|COMPLETED|Overall Study||0
2215900|NCT02947022|5433207|P1|STARTED|Overall Study||1
2215901|NCT02946580|5433228|P2|NOT COMPLETED|Overall Study||5
2215902|NCT02946580|5433229|P1|NOT COMPLETED|Overall Study||1
2215903|NCT02946580|5433228|P2|COMPLETED|Overall Study||20
2215904|NCT02946580|5433229|P1|COMPLETED|Overall Study||27
2215905|NCT02946580|5433228|P2|STARTED|Overall Study||25
2215906|NCT02946580|5433229|P1|STARTED|Overall Study||28
2215907|NCT02946515|5433247|P2|NOT COMPLETED|Overall Study||1
2215908|NCT02946515|5433248|P1|NOT COMPLETED|Overall Study||2
2215909|NCT02946515|5433247|P2|COMPLETED|Overall Study||21
2215910|NCT02946515|5433248|P1|COMPLETED|Overall Study||20
2215911|NCT02946515|5433247|P2|STARTED|Overall Study||22
2215912|NCT02946515|5433248|P1|STARTED|Overall Study||22
2215913|NCT02946489|5433254|P1|NOT COMPLETED|Overall Study||0
2215914|NCT02946489|5433254|P1|COMPLETED|Overall Study||8
2215915|NCT02946489|5433254|P1|STARTED|Overall Study||8
2215916|NCT02946463|5433261|P2|NOT COMPLETED|Extension Period||119
2215917|NCT02946463|5433262|P1|NOT COMPLETED|Extension Period||124
2215918|NCT02946463|5433261|P2|COMPLETED|Extension Period||0
2215919|NCT02946463|5433262|P1|COMPLETED|Extension Period||0
2215920|NCT02946463|5433261|P2|Received at Least 1 Dose of Ravulizumab|Extension Period||119
2215921|NCT02946463|5433262|P1|Received at Least 1 Dose of Ravulizumab|Extension Period||124
2215922|NCT02946463|5433261|P2|STARTED|Extension Period||119
2215923|NCT02946463|5433262|P1|STARTED|Extension Period||124
2215924|NCT02946463|5433261|P2|NOT COMPLETED|Primary Evaluation Period||2
2215925|NCT02946463|5433262|P1|NOT COMPLETED|Primary Evaluation Period||0
2215926|NCT02946463|5433261|P2|COMPLETED|Primary Evaluation Period||119
2215927|NCT02946463|5433262|P1|COMPLETED|Primary Evaluation Period||125
2215928|NCT02946463|5433261|P2|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||121
2215929|NCT02946463|5433262|P1|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||125
2215930|NCT02946463|5433261|P2|STARTED|Primary Evaluation Period||121
2215931|NCT02946463|5433262|P1|STARTED|Primary Evaluation Period||125
2215932|NCT02946385|5433284|P6|NOT COMPLETED|Overall Study||1
2215933|NCT02946385|5433285|P5|NOT COMPLETED|Overall Study||2
2215934|NCT02946385|5433286|P4|NOT COMPLETED|Overall Study||0
2215935|NCT02946385|5433287|P3|NOT COMPLETED|Overall Study||3
2215936|NCT02946385|5433288|P2|NOT COMPLETED|Overall Study||0
2215937|NCT02946385|5433289|P1|NOT COMPLETED|Overall Study||0
2215938|NCT02946385|5433284|P6|COMPLETED|Overall Study||76
2215939|NCT02946385|5433285|P5|COMPLETED|Overall Study||99
2215940|NCT02946385|5433286|P4|COMPLETED|Overall Study||74
2215941|NCT02946385|5433287|P3|COMPLETED|Overall Study||96
2215942|NCT02946385|5433288|P2|COMPLETED|Overall Study||127
2215943|NCT02946385|5433289|P1|COMPLETED|Overall Study||126
2215944|NCT02946385|5433284|P6|STARTED|Overall Study||77
2215945|NCT02946385|5433285|P5|STARTED|Overall Study||101
2215946|NCT02946385|5433286|P4|STARTED|Overall Study||74
2215947|NCT02946385|5433287|P3|STARTED|Overall Study||99
2215948|NCT02946385|5433288|P2|STARTED|Overall Study||127
2215949|NCT02946385|5433289|P1|STARTED|Overall Study||126
2215950|NCT02946229|5433373|P1|NOT COMPLETED|Overall Study||0
2215951|NCT02946229|5433373|P1|COMPLETED|Overall Study||142
2215952|NCT02946229|5433373|P1|STARTED|Overall Study||142
2215953|NCT02946021|5433379|P2|NOT COMPLETED|Overall Study||0
2215954|NCT02946021|5433380|P1|NOT COMPLETED|Overall Study||0
2215955|NCT02946021|5433379|P2|COMPLETED|Overall Study||5
2215956|NCT02946021|5433380|P1|COMPLETED|Overall Study||6
2215957|NCT02946021|5433379|P2|STARTED|Overall Study||5
2215958|NCT02946021|5433380|P1|STARTED|Overall Study||6
2215959|NCT02945657|5433392|P1|NOT COMPLETED|Overall Study||4
2215960|NCT02945657|5433392|P1|COMPLETED|Overall Study||28
2215961|NCT02945657|5433392|P1|STARTED|Overall Study||32
2215962|NCT02945410|5433415|P6|NOT COMPLETED|Intervention 3 (5 Days)||0
2215963|NCT02945410|5433416|P5|NOT COMPLETED|Intervention 3 (5 Days)||0
2215964|NCT02945410|5433417|P4|NOT COMPLETED|Intervention 3 (5 Days)||0
2215965|NCT02945410|5433418|P3|NOT COMPLETED|Intervention 3 (5 Days)||0
2215966|NCT02945410|5433419|P2|NOT COMPLETED|Intervention 3 (5 Days)||0
2215967|NCT02945410|5433420|P1|NOT COMPLETED|Intervention 3 (5 Days)||0
2215968|NCT02945410|5433415|P6|COMPLETED|Intervention 3 (5 Days)||0
2215969|NCT02945410|5433416|P5|COMPLETED|Intervention 3 (5 Days)||1
2215970|NCT02945410|5433417|P4|COMPLETED|Intervention 3 (5 Days)||3
2215971|NCT02945410|5433418|P3|COMPLETED|Intervention 3 (5 Days)||0
2215972|NCT02945410|5433419|P2|COMPLETED|Intervention 3 (5 Days)||1
2215973|NCT02945410|5433420|P1|COMPLETED|Intervention 3 (5 Days)||2
2215974|NCT02945410|5433415|P6|STARTED|Intervention 3 (5 Days)||0
2215975|NCT02945410|5433416|P5|STARTED|Intervention 3 (5 Days)||1
2215976|NCT02945410|5433417|P4|STARTED|Intervention 3 (5 Days)||3
2215977|NCT02945410|5433418|P3|STARTED|Intervention 3 (5 Days)||0
2215978|NCT02945410|5433419|P2|STARTED|Intervention 3 (5 Days)||1
2215979|NCT02945410|5433420|P1|STARTED|Intervention 3 (5 Days)||2
2215980|NCT02945410|5433415|P6|NOT COMPLETED|Washout 2 (14 Days)||0
2215981|NCT02945410|5433416|P5|NOT COMPLETED|Washout 2 (14 Days)||0
2215982|NCT02945410|5433417|P4|NOT COMPLETED|Washout 2 (14 Days)||0
2215983|NCT02945410|5433418|P3|NOT COMPLETED|Washout 2 (14 Days)||0
2215984|NCT02945410|5433419|P2|NOT COMPLETED|Washout 2 (14 Days)||0
2215985|NCT02945410|5433420|P1|NOT COMPLETED|Washout 2 (14 Days)||0
2215986|NCT02945410|5433415|P6|COMPLETED|Washout 2 (14 Days)||0
2215987|NCT02945410|5433416|P5|COMPLETED|Washout 2 (14 Days)||1
2215988|NCT02945410|5433417|P4|COMPLETED|Washout 2 (14 Days)||3
2215989|NCT02945410|5433418|P3|COMPLETED|Washout 2 (14 Days)||0
2215990|NCT02945410|5433419|P2|COMPLETED|Washout 2 (14 Days)||1
2215991|NCT02945410|5433420|P1|COMPLETED|Washout 2 (14 Days)||2
2215992|NCT02945410|5433415|P6|STARTED|Washout 2 (14 Days)||0
2215993|NCT02945410|5433416|P5|STARTED|Washout 2 (14 Days)||1
2215994|NCT02945410|5433417|P4|STARTED|Washout 2 (14 Days)||3
2215995|NCT02945410|5433418|P3|STARTED|Washout 2 (14 Days)||0
2215996|NCT02945410|5433419|P2|STARTED|Washout 2 (14 Days)||1
2215997|NCT02945410|5433420|P1|STARTED|Washout 2 (14 Days)||2
2215998|NCT02945410|5433415|P6|NOT COMPLETED|Intervention 2 (5 Days)||0
2215999|NCT02945410|5433416|P5|NOT COMPLETED|Intervention 2 (5 Days)||0
2216000|NCT02945410|5433417|P4|NOT COMPLETED|Intervention 2 (5 Days)||0
2216001|NCT02945410|5433418|P3|NOT COMPLETED|Intervention 2 (5 Days)||0
2216002|NCT02945410|5433419|P2|NOT COMPLETED|Intervention 2 (5 Days)||0
2216003|NCT02945410|5433420|P1|NOT COMPLETED|Intervention 2 (5 Days)||0
2216004|NCT02945410|5433415|P6|COMPLETED|Intervention 2 (5 Days)||0
2216005|NCT02945410|5433416|P5|COMPLETED|Intervention 2 (5 Days)||1
2216006|NCT02945410|5433417|P4|COMPLETED|Intervention 2 (5 Days)||3
2216007|NCT02945410|5433418|P3|COMPLETED|Intervention 2 (5 Days)||0
2216008|NCT02945410|5433419|P2|COMPLETED|Intervention 2 (5 Days)||1
2216009|NCT02945410|5433420|P1|COMPLETED|Intervention 2 (5 Days)||2
2216010|NCT02945410|5433415|P6|STARTED|Intervention 2 (5 Days)||0
2216011|NCT02945410|5433416|P5|STARTED|Intervention 2 (5 Days)||1
2216012|NCT02945410|5433417|P4|STARTED|Intervention 2 (5 Days)||3
2216013|NCT02945410|5433418|P3|STARTED|Intervention 2 (5 Days)||0
2216014|NCT02945410|5433419|P2|STARTED|Intervention 2 (5 Days)||1
2216015|NCT02945410|5433420|P1|STARTED|Intervention 2 (5 Days)||2
2216016|NCT02945410|5433415|P6|NOT COMPLETED|Washout 1 (14 Days)||0
2216017|NCT02945410|5433416|P5|NOT COMPLETED|Washout 1 (14 Days)||1
2216018|NCT02945410|5433417|P4|NOT COMPLETED|Washout 1 (14 Days)||0
2216019|NCT02945410|5433418|P3|NOT COMPLETED|Washout 1 (14 Days)||2
2216020|NCT02945410|5433419|P2|NOT COMPLETED|Washout 1 (14 Days)||0
2216021|NCT02945410|5433420|P1|NOT COMPLETED|Washout 1 (14 Days)||0
2216022|NCT02945410|5433415|P6|COMPLETED|Washout 1 (14 Days)||0
2216023|NCT02945410|5433416|P5|COMPLETED|Washout 1 (14 Days)||1
2216024|NCT02945410|5433417|P4|COMPLETED|Washout 1 (14 Days)||3
2216025|NCT02945410|5433418|P3|COMPLETED|Washout 1 (14 Days)||0
2216026|NCT02945410|5433419|P2|COMPLETED|Washout 1 (14 Days)||1
2216027|NCT02945410|5433420|P1|COMPLETED|Washout 1 (14 Days)||2
2216028|NCT02945410|5433415|P6|STARTED|Washout 1 (14 Days)||0
2216029|NCT02945410|5433416|P5|STARTED|Washout 1 (14 Days)||2
2216030|NCT02945410|5433417|P4|STARTED|Washout 1 (14 Days)||3
2216031|NCT02945410|5433418|P3|STARTED|Washout 1 (14 Days)||2
2216032|NCT02945410|5433419|P2|STARTED|Washout 1 (14 Days)||1
2216033|NCT02945410|5433420|P1|STARTED|Washout 1 (14 Days)||2
2216034|NCT02945410|5433415|P6|NOT COMPLETED|Intervention 1 (5 Days)||1
2216035|NCT02945410|5433416|P5|NOT COMPLETED|Intervention 1 (5 Days)||0
2216036|NCT02945410|5433417|P4|NOT COMPLETED|Intervention 1 (5 Days)||0
2216037|NCT02945410|5433418|P3|NOT COMPLETED|Intervention 1 (5 Days)||0
2216038|NCT02945410|5433419|P2|NOT COMPLETED|Intervention 1 (5 Days)||3
2216039|NCT02945410|5433420|P1|NOT COMPLETED|Intervention 1 (5 Days)||1
2216040|NCT02945410|5433415|P6|COMPLETED|Intervention 1 (5 Days)||0
2216041|NCT02945410|5433416|P5|COMPLETED|Intervention 1 (5 Days)||2
2216042|NCT02945410|5433417|P4|COMPLETED|Intervention 1 (5 Days)||3
2216043|NCT02945410|5433418|P3|COMPLETED|Intervention 1 (5 Days)||2
2216044|NCT02945410|5433419|P2|COMPLETED|Intervention 1 (5 Days)||1
2216045|NCT02945410|5433420|P1|COMPLETED|Intervention 1 (5 Days)||2
2216046|NCT02945410|5433415|P6|STARTED|Intervention 1 (5 Days)||1
2216047|NCT02945410|5433416|P5|STARTED|Intervention 1 (5 Days)||2
2216048|NCT02945410|5433417|P4|STARTED|Intervention 1 (5 Days)||3
2216049|NCT02945410|5433418|P3|STARTED|Intervention 1 (5 Days)||2
2216050|NCT02945410|5433419|P2|STARTED|Intervention 1 (5 Days)||4
2216051|NCT02945410|5433420|P1|STARTED|Intervention 1 (5 Days)||3
2216052|NCT02945254|5433451|P2|NOT COMPLETED|Overall Study||0
2216053|NCT02945254|5433452|P1|NOT COMPLETED|Overall Study||2
2216054|NCT02945254|5433451|P2|COMPLETED|Overall Study||10
2216055|NCT02945254|5433452|P1|COMPLETED|Overall Study||8
2216056|NCT02945254|5433451|P2|STARTED|Overall Study||10
2216057|NCT02945254|5433452|P1|STARTED|Overall Study||10
2216058|NCT02944968|5433460|P1|NOT COMPLETED|Overall Study||3
2216059|NCT02944968|5433460|P1|COMPLETED|Overall Study||48
2216060|NCT02944968|5433460|P1|STARTED|Overall Study||51
2216061|NCT02944656|5433467|P2|NOT COMPLETED|Overall Study||10
2216062|NCT02944656|5433468|P1|NOT COMPLETED|Overall Study||10
2216063|NCT02944656|5433467|P2|COMPLETED|Overall Study||47
2216064|NCT02944656|5433468|P1|COMPLETED|Overall Study||47
2216065|NCT02944656|5433467|P2|Completed Day 1 Follow up|Overall Study||47
2216066|NCT02944656|5433468|P1|Completed Day 1 Follow up|Overall Study||47
2216067|NCT02944656|5433467|P2|Completed Procedure Day|Overall Study||57
2216068|NCT02944656|5433468|P1|Completed Procedure Day|Overall Study||54
2216069|NCT02944656|5433467|P2|STARTED|Overall Study||57
2216070|NCT02944656|5433468|P1|STARTED|Overall Study||57
2216071|NCT02944565|5433496|P1|NOT COMPLETED|Overall Study||0
2216072|NCT02944565|5433496|P1|COMPLETED|Overall Study||28
2216073|NCT02944565|5433496|P1|STARTED|Overall Study||28
2216074|NCT02944513|5433504|P2|NOT COMPLETED|Overall Study||1
2216075|NCT02944513|5433505|P1|NOT COMPLETED|Overall Study||4
2216076|NCT02944513|5433504|P2|COMPLETED|Overall Study||32
2216077|NCT02944513|5433505|P1|COMPLETED|Overall Study||31
2216078|NCT02944513|5433504|P2|STARTED|Overall Study||33
2216079|NCT02944513|5433505|P1|STARTED|Overall Study||35
2216080|NCT02944461|5433521|P1|NOT COMPLETED|Overall Study||5
2216081|NCT02944461|5433521|P1|COMPLETED|Overall Study||15
2216082|NCT02944461|5433521|P1|STARTED|Overall Study||20
2216083|NCT02943941|5433528|P1|NOT COMPLETED|Overall Study||0
2216084|NCT02943941|5433528|P1|COMPLETED|Overall Study||16
2216085|NCT02943941|5433528|P1|STARTED|Overall Study||16
2216086|NCT02943577|5433536|P2|NOT COMPLETED|Overall Study||5
2216087|NCT02943577|5433537|P1|NOT COMPLETED|Overall Study||5
2216088|NCT02943577|5433536|P2|COMPLETED|Overall Study||201
2216089|NCT02943577|5433537|P1|COMPLETED|Overall Study||204
2216090|NCT02943577|5433536|P2|STARTED|Overall Study||206
2216091|NCT02943577|5433537|P1|STARTED|Overall Study||209
2216092|NCT02943564|5433552|P3|NOT COMPLETED|Overall Study||9
2216093|NCT02943564|5433553|P2|NOT COMPLETED|Overall Study||13
2216094|NCT02943564|5433554|P1|NOT COMPLETED|Overall Study||10
2216095|NCT02943564|5433552|P3|COMPLETED|Overall Study||201
2216096|NCT02943564|5433553|P2|COMPLETED|Overall Study||198
2216097|NCT02943564|5433554|P1|COMPLETED|Overall Study||207
2216098|NCT02943564|5433552|P3|Non-Responder|Overall Study||133
2216099|NCT02943564|5433553|P2|Non-Responder|Overall Study||134
2216100|NCT02943564|5433554|P1|Non-Responder|Overall Study||134
2216101|NCT02943564|5433552|P3|Responder|Overall Study||77
2216102|NCT02943564|5433553|P2|Responder|Overall Study||77
2216103|NCT02943564|5433554|P1|Responder|Overall Study||83
2216104|NCT02943564|5433552|P3|STARTED|Overall Study||210
2216105|NCT02943564|5433553|P2|STARTED|Overall Study||211
2216106|NCT02943564|5433554|P1|STARTED|Overall Study||217
2216107|NCT02943499|5433567|P2|NOT COMPLETED|Overall Study||5
2216108|NCT02943499|5433568|P1|NOT COMPLETED|Overall Study||7
2216109|NCT02943499|5433567|P2|COMPLETED|Overall Study||34
2216110|NCT02943499|5433568|P1|COMPLETED|Overall Study||34
2216111|NCT02943499|5433567|P2|STARTED|Overall Study||39
2216112|NCT02943499|5433568|P1|STARTED|Overall Study||41
2216113|NCT02943460|5433577|P3|NOT COMPLETED|Open Label Extension (OLE)||9
2216114|NCT02943460|5433578|P2|NOT COMPLETED|Open Label Extension (OLE)||18
2216115|NCT02943460|5433579|P1|NOT COMPLETED|Open Label Extension (OLE)||19
2216116|NCT02943460|5433577|P3|COMPLETED|Open Label Extension (OLE)||0
2216117|NCT02943460|5433578|P2|COMPLETED|Open Label Extension (OLE)||0
2216118|NCT02943460|5433579|P1|COMPLETED|Open Label Extension (OLE)||0
2216119|NCT02943460|5433577|P3|STARTED|Open Label Extension (OLE)|1 participant who discontinued study drug in the Blinded Phase did not enter the OLE Phase.|9
2216120|NCT02943460|5433578|P2|STARTED|Open Label Extension (OLE)|1 participant completed the Blinded Study Phase, but did not continue in the OLE Phase.|18
2216121|NCT02943460|5433579|P1|STARTED|Open Label Extension (OLE)||19
2216122|NCT02943460|5433577|P3|NOT COMPLETED|Blinded Study||0
2216123|NCT02943460|5433578|P2|NOT COMPLETED|Blinded Study||1
2216124|NCT02943460|5433579|P1|NOT COMPLETED|Blinded Study||3
2216125|NCT02943460|5433577|P3|COMPLETED|Blinded Study|1 participant discontinued from study drug in the Blinded Phase, but did not discontinue the study.|10
2216126|NCT02943460|5433578|P2|COMPLETED|Blinded Study||19
2216127|NCT02943460|5433579|P1|COMPLETED|Blinded Study||19
2216128|NCT02943460|5433577|P3|STARTED|Blinded Study||10
2216129|NCT02943460|5433578|P2|STARTED|Blinded Study||20
2216130|NCT02943460|5433579|P1|STARTED|Blinded Study||22
2216131|NCT02943447|5433597|P3|NOT COMPLETED|Overall Study||13
2216132|NCT02943447|5433598|P2|NOT COMPLETED|Overall Study||30
2216133|NCT02943447|5433599|P1|NOT COMPLETED|Overall Study||28
2216134|NCT02943447|5433597|P3|COMPLETED|Overall Study||0
2216135|NCT02943447|5433598|P2|COMPLETED|Overall Study||0
2216136|NCT02943447|5433599|P1|COMPLETED|Overall Study||0
2216137|NCT02943447|5433597|P3|STARTED|Overall Study||13
2216138|NCT02943447|5433598|P2|STARTED|Overall Study||30
2216139|NCT02943447|5433599|P1|STARTED|Overall Study||28
2216140|NCT02943226|5433621|P2|NOT COMPLETED|Overall Study||0
2216141|NCT02943226|5433622|P1|NOT COMPLETED|Overall Study||0
2216142|NCT02943226|5433621|P2|COMPLETED|Overall Study||30
2216143|NCT02943226|5433622|P1|COMPLETED|Overall Study||31
2216144|NCT02943226|5433621|P2|STARTED|Overall Study||30
2216145|NCT02943226|5433622|P1|STARTED|Overall Study||31
2216146|NCT02943213|5433638|P1|NOT COMPLETED|Treatment Period 2||0
2216147|NCT02943213|5433638|P1|COMPLETED|Treatment Period 2||20
2216148|NCT02943213|5433638|P1|STARTED|Treatment Period 2||20
2216149|NCT02943213|5433638|P1|NOT COMPLETED|Treatment Period 1||0
2216150|NCT02943213|5433638|P1|COMPLETED|Treatment Period 1||20
2216151|NCT02943213|5433638|P1|STARTED|Treatment Period 1||20
2216152|NCT02943096|5433668|P2|NOT COMPLETED|Overall Study||1
2216153|NCT02943096|5433669|P1|NOT COMPLETED|Overall Study||0
2216154|NCT02943096|5433668|P2|COMPLETED|Overall Study||2
2216155|NCT02943096|5433669|P1|COMPLETED|Overall Study||3
2216156|NCT02943096|5433668|P2|STARTED|Overall Study||3
2216157|NCT02943096|5433669|P1|STARTED|Overall Study||3
2216158|NCT02942576|5433685|P2|NOT COMPLETED|Overall Study||23
2216159|NCT02942576|5433686|P1|NOT COMPLETED|Overall Study||46
2216160|NCT02942576|5433685|P2|COMPLETED|Overall Study||174
2216161|NCT02942576|5433686|P1|COMPLETED|Overall Study||359
2216162|NCT02942576|5433685|P2|STARTED|Overall Study||197
2216163|NCT02942576|5433686|P1|STARTED|Overall Study||405
2216164|NCT02942017|5433700|P2|NOT COMPLETED|Overall Study||6
2216165|NCT02942017|5433701|P1|NOT COMPLETED|Overall Study||2
2216166|NCT02942017|5433700|P2|COMPLETED|Overall Study||48
2216167|NCT02942017|5433701|P1|COMPLETED|Overall Study||52
2216168|NCT02942017|5433700|P2|Treated|Overall Study||51
2216169|NCT02942017|5433701|P1|Treated|Overall Study||53
2216170|NCT02942017|5433700|P2|STARTED|Overall Study||54
2216171|NCT02942017|5433701|P1|STARTED|Overall Study||54
2216172|NCT02942004|5433732|P3|NOT COMPLETED|Overall Study||9
2216173|NCT02942004|5433733|P2|NOT COMPLETED|Overall Study||12
2216174|NCT02942004|5433734|P1|NOT COMPLETED|Overall Study||4
2216175|NCT02942004|5433732|P3|COMPLETED|Overall Study||36
2216176|NCT02942004|5433733|P2|COMPLETED|Overall Study||35
2216177|NCT02942004|5433734|P1|COMPLETED|Overall Study||42
2216178|NCT02942004|5433732|P3|Participants Who Received Study Drug|Overall Study||41
2216179|NCT02942004|5433733|P2|Participants Who Received Study Drug|Overall Study||38
2216180|NCT02942004|5433734|P1|Participants Who Received Study Drug|Overall Study||43
2216181|NCT02942004|5433732|P3|STARTED|Overall Study||45
2216182|NCT02942004|5433733|P2|STARTED|Overall Study||47
2216183|NCT02942004|5433734|P1|STARTED|Overall Study||46
2216184|NCT02941692|5433777|P2|NOT COMPLETED|Overall Study||0
2216185|NCT02941692|5433778|P1|NOT COMPLETED|Overall Study||0
2216186|NCT02941692|5433777|P2|COMPLETED|Overall Study||34
2216187|NCT02941692|5433778|P1|COMPLETED|Overall Study||32
2216188|NCT02941692|5433777|P2|STARTED|Overall Study||34
2216189|NCT02941692|5433778|P1|STARTED|Overall Study||32
2216190|NCT02941640|5433790|P4|NOT COMPLETED|Overall Study||0
2216191|NCT02941640|5433791|P3|NOT COMPLETED|Overall Study||0
2216192|NCT02941640|5433792|P2|NOT COMPLETED|Overall Study||0
2216193|NCT02941640|5433793|P1|NOT COMPLETED|Overall Study||0
2216194|NCT02941640|5433790|P4|COMPLETED|Overall Study||30
2216195|NCT02941640|5433791|P3|COMPLETED|Overall Study||30
2216196|NCT02941640|5433792|P2|COMPLETED|Overall Study||30
2216197|NCT02941640|5433793|P1|COMPLETED|Overall Study||30
2216198|NCT02941640|5433790|P4|STARTED|Overall Study||30
2216199|NCT02941640|5433791|P3|STARTED|Overall Study||30
2216200|NCT02941640|5433792|P2|STARTED|Overall Study||30
2216201|NCT02941640|5433793|P1|STARTED|Overall Study||30
2216202|NCT02940691|5433823|P1|NOT COMPLETED|Overall Study||6
2216203|NCT02940691|5433823|P1|COMPLETED|Overall Study||26
2216204|NCT02940691|5433823|P1|STARTED|Overall Study||32
2216205|NCT02940626|5433832|P2|NOT COMPLETED|Overall Study||35
2216206|NCT02940626|5433833|P1|NOT COMPLETED|Overall Study||47
2216207|NCT02940626|5433832|P2|COMPLETED|Overall Study||43
2216208|NCT02940626|5433833|P1|COMPLETED|Overall Study||30
2216209|NCT02940626|5433832|P2|Completed Through Study Day 22|Overall Study||49
2216210|NCT02940626|5433833|P1|Completed Through Study Day 22|Overall Study||42
2216211|NCT02940626|5433832|P2|Received Study Treatment|Overall Study||77
2216212|NCT02940626|5433833|P1|Received Study Treatment|Overall Study||77
2216213|NCT02940626|5433832|P2|Randomized Into Treatment Sub-study|Overall Study||1
2216214|NCT02940626|5433833|P1|Randomized Into Treatment Sub-study|Overall Study||0
2216215|NCT02940626|5433832|P2|Randomized Into Primary Prevention Study|Overall Study||77
2216216|NCT02940626|5433833|P1|Randomized Into Primary Prevention Study|Overall Study||77
2216217|NCT02940626|5433832|P2|STARTED|Overall Study||78
2216218|NCT02940626|5433833|P1|STARTED|Overall Study||77
2216219|NCT02940574|5433855|P2|NOT COMPLETED|1-year Follow-up||4
2216220|NCT02940574|5433856|P1|NOT COMPLETED|1-year Follow-up||3
2216221|NCT02940574|5433855|P2|COMPLETED|1-year Follow-up||14
2216222|NCT02940574|5433856|P1|COMPLETED|1-year Follow-up||18
2216223|NCT02940574|5433855|P2|STARTED|1-year Follow-up||18
2216224|NCT02940574|5433856|P1|STARTED|1-year Follow-up||21
2216225|NCT02940574|5433855|P2|NOT COMPLETED|From Study Start to 1-month Follow-up||0
2216226|NCT02940574|5433856|P1|NOT COMPLETED|From Study Start to 1-month Follow-up||1
2216227|NCT02940574|5433855|P2|COMPLETED|From Study Start to 1-month Follow-up|All participants completed, but data from 1 participant was not included in analyses.|18
2216228|NCT02940574|5433856|P1|COMPLETED|From Study Start to 1-month Follow-up|Discontinued intervention (N=1): self-termination unrelated to treatment|21
2216229|NCT02940574|5433855|P2|STARTED|From Study Start to 1-month Follow-up||18
2216230|NCT02940574|5433856|P1|STARTED|From Study Start to 1-month Follow-up||22
2216231|NCT02940522|5433894|P2|NOT COMPLETED|Overall Study||2
2216232|NCT02940522|5433895|P1|NOT COMPLETED|Overall Study||2
2216233|NCT02940522|5433894|P2|COMPLETED|Overall Study||59
2216234|NCT02940522|5433895|P1|COMPLETED|Overall Study||57
2216235|NCT02940522|5433894|P2|STARTED|Overall Study||61
2216236|NCT02940522|5433895|P1|STARTED|Overall Study||59
2216237|NCT02939950|5433913|P2|NOT COMPLETED|Overall Study||81
2216238|NCT02939950|5433914|P1|NOT COMPLETED|Overall Study||66
2216239|NCT02939950|5433913|P2|COMPLETED|Overall Study||329
2216240|NCT02939950|5433914|P1|COMPLETED|Overall Study||340
2216241|NCT02939950|5433913|P2|Eligible at Baseline|Overall Study||402
2216242|NCT02939950|5433914|P1|Eligible at Baseline|Overall Study||403
2216243|NCT02939950|5433913|P2|Dispensed the Assigned Lenses|Overall Study||410
2216244|NCT02939950|5433914|P1|Dispensed the Assigned Lenses|Overall Study||405
2216245|NCT02939950|5433913|P2|STARTED|Overall Study||410
2216246|NCT02939950|5433914|P1|STARTED|Overall Study||406
2216247|NCT02939937|5433924|P2|NOT COMPLETED|Overall Study||3
2216248|NCT02939937|5433925|P1|NOT COMPLETED|Overall Study||6
2216249|NCT02939937|5433924|P2|COMPLETED|Overall Study||47
2216250|NCT02939937|5433925|P1|COMPLETED|Overall Study||15
2216251|NCT02939937|5433924|P2|STARTED|Overall Study|3 patients excluded from study|50
2216252|NCT02939937|5433925|P1|STARTED|Overall Study|5 patients had drug reaction and 1 patient excluded from study,|21
2216253|NCT02939560|5433939|P1|NOT COMPLETED|Overall Study||3
2216254|NCT02939560|5433939|P1|COMPLETED|Overall Study||10
2216255|NCT02939560|5433939|P1|STARTED|Overall Study||13
2216256|NCT02939326|5433956|P8|NOT COMPLETED|Overall Study||0
2216257|NCT02939326|5433957|P7|NOT COMPLETED|Overall Study||0
2216258|NCT02939326|5433958|P6|NOT COMPLETED|Overall Study||0
2216259|NCT02939326|5433959|P5|NOT COMPLETED|Overall Study||0
2216260|NCT02939326|5433960|P4|NOT COMPLETED|Overall Study||0
2216261|NCT02939326|5433961|P3|NOT COMPLETED|Overall Study||0
2216262|NCT02939326|5433962|P2|NOT COMPLETED|Overall Study||0
2216263|NCT02939326|5433963|P1|NOT COMPLETED|Overall Study||0
2216264|NCT02939326|5433956|P8|COMPLETED|Overall Study||5
2216265|NCT02939326|5433957|P7|COMPLETED|Overall Study||5
2216266|NCT02939326|5433958|P6|COMPLETED|Overall Study||5
2216267|NCT02939326|5433959|P5|COMPLETED|Overall Study||5
2216268|NCT02939326|5433960|P4|COMPLETED|Overall Study||5
2216269|NCT02939326|5433961|P3|COMPLETED|Overall Study||5
2216270|NCT02939326|5433962|P2|COMPLETED|Overall Study||5
2216271|NCT02939326|5433963|P1|COMPLETED|Overall Study||7
2216272|NCT02939326|5433956|P8|STARTED|Overall Study||5
2216273|NCT02939326|5433957|P7|STARTED|Overall Study||5
2216274|NCT02939326|5433958|P6|STARTED|Overall Study||5
2216275|NCT02939326|5433959|P5|STARTED|Overall Study||5
2216276|NCT02939326|5433960|P4|STARTED|Overall Study||5
2216277|NCT02939326|5433961|P3|STARTED|Overall Study||5
2216278|NCT02939326|5433962|P2|STARTED|Overall Study||5
2216279|NCT02939326|5433963|P1|STARTED|Overall Study||7
2216280|NCT02939170|5433983|P2|NOT COMPLETED|Overall Study||0
2216281|NCT02939170|5433984|P1|NOT COMPLETED|Overall Study||0
2216282|NCT02939170|5433983|P2|COMPLETED|Overall Study||40
2216283|NCT02939170|5433984|P1|COMPLETED|Overall Study||40
2216284|NCT02939170|5433983|P2|STARTED|Overall Study||40
2216285|NCT02939170|5433984|P1|STARTED|Overall Study||40
2216286|NCT02939079|5433997|P2|NOT COMPLETED|Overall Study||5
2216287|NCT02939079|5433998|P1|NOT COMPLETED|Overall Study||4
2216288|NCT02939079|5433997|P2|COMPLETED|Overall Study||20
2216289|NCT02939079|5433998|P1|COMPLETED|Overall Study||21
2216290|NCT02939079|5433997|P2|STARTED|Overall Study||25
2216291|NCT02939079|5433998|P1|STARTED|Overall Study||25
2216298|NCT02938949|5434058|P2|NOT COMPLETED|Overall Study||0
2216299|NCT02938949|5434059|P1|NOT COMPLETED|Overall Study||0
2216300|NCT02938949|5434058|P2|COMPLETED|Overall Study||10
2216301|NCT02938949|5434059|P1|COMPLETED|Overall Study||10
2216302|NCT02938949|5434058|P2|STARTED|Overall Study||10
2216303|NCT02938949|5434059|P1|STARTED|Overall Study||10
2216304|NCT02938585|5434073|P4|NOT COMPLETED|Overall Study||5
2216305|NCT02938585|5434074|P3|NOT COMPLETED|Overall Study||0
2216306|NCT02938585|5434075|P2|NOT COMPLETED|Overall Study||1
2216307|NCT02938585|5434076|P1|NOT COMPLETED|Overall Study||0
2216308|NCT02938585|5434073|P4|COMPLETED|Overall Study||10
2216309|NCT02938585|5434074|P3|COMPLETED|Overall Study||11
2216310|NCT02938585|5434075|P2|COMPLETED|Overall Study||32
2216311|NCT02938585|5434076|P1|COMPLETED|Overall Study||9
2216312|NCT02938585|5434073|P4|Exposed to On-demand Regimen|Overall Study||8
2216313|NCT02938585|5434074|P3|Exposed to On-demand Regimen|Overall Study||1
2216314|NCT02938585|5434075|P2|Exposed to On-demand Regimen|Overall Study||7
2216315|NCT02938585|5434076|P1|Exposed to On-demand Regimen|Overall Study||1
2216316|NCT02938585|5434073|P4|Exposed to Prophylaxis Regimen|Overall Study||12
2216317|NCT02938585|5434074|P3|Exposed to Prophylaxis Regimen|Overall Study||11
2216318|NCT02938585|5434075|P2|Exposed to Prophylaxis Regimen|Overall Study||31
2216319|NCT02938585|5434076|P1|Exposed to Prophylaxis Regimen|Overall Study||9
2216320|NCT02938585|5434073|P4|STARTED|Overall Study||15
2216321|NCT02938585|5434074|P3|STARTED|Overall Study||11
2216322|NCT02938585|5434075|P2|STARTED|Overall Study||33
2216323|NCT02938585|5434076|P1|STARTED|Overall Study||9
2216324|NCT02938520|5434240|P2|NOT COMPLETED|Overall Study||283
2216325|NCT02938520|5434241|P1|NOT COMPLETED|Overall Study||283
2216326|NCT02938520|5434240|P2|COMPLETED|Overall Study||0
2216327|NCT02938520|5434241|P1|COMPLETED|Overall Study||0
2216328|NCT02938520|5434240|P2|STARTED|Overall Study||283
2216329|NCT02938520|5434241|P1|STARTED|Overall Study||283
2216330|NCT02938052|5434366|P1|NOT COMPLETED|Overall Study||1
2216331|NCT02938052|5434366|P1|COMPLETED|Overall Study||10
2216332|NCT02938052|5434366|P1|STARTED|Overall Study||11
2216333|NCT02937870|5434385|P1|NOT COMPLETED|Overall Study||3
2216334|NCT02937870|5434385|P1|COMPLETED|Overall Study||20
2216335|NCT02937870|5434385|P1|Received no Adhesive|Overall Study||20
2216336|NCT02937870|5434385|P1|Received Positive Control Adhesive|Overall Study||21
2216337|NCT02937870|5434385|P1|Received Test Adhesive 2|Overall Study||22
2216338|NCT02937870|5434385|P1|Received Test Adhesive 1|Overall Study||21
2216339|NCT02937870|5434385|P1|STARTED|Overall Study||23
2216340|NCT02937766|5434403|P2|NOT COMPLETED|Overall Study||0
2216341|NCT02937766|5434404|P1|NOT COMPLETED|Overall Study||7
2216342|NCT02937766|5434403|P2|COMPLETED|Overall Study||30
2216343|NCT02937766|5434404|P1|COMPLETED|Overall Study||23
2216344|NCT02937766|5434403|P2|STARTED|Overall Study||30
2216345|NCT02937766|5434404|P1|STARTED|Overall Study||30
2216346|NCT02937740|5434416|P2|NOT COMPLETED|Uptitrated to TID on Day 90 for 30 Days||2
2216347|NCT02937740|5434417|P1|NOT COMPLETED|Uptitrated to TID on Day 90 for 30 Days||1
2216348|NCT02937740|5434416|P2|COMPLETED|Uptitrated to TID on Day 90 for 30 Days||15
2216349|NCT02937740|5434417|P1|COMPLETED|Uptitrated to TID on Day 90 for 30 Days||12
2216350|NCT02937740|5434416|P2|STARTED|Uptitrated to TID on Day 90 for 30 Days||17
2216351|NCT02937740|5434417|P1|STARTED|Uptitrated to TID on Day 90 for 30 Days||13
2216352|NCT02937740|5434416|P2|NOT COMPLETED|BID for 90 Days, 22 mg/Day||31
2216353|NCT02937740|5434417|P1|NOT COMPLETED|BID for 90 Days, 22 mg/Day||5
2216354|NCT02937740|5434416|P2|COMPLETED|BID for 90 Days, 22 mg/Day||62
2216355|NCT02937740|5434417|P1|COMPLETED|BID for 90 Days, 22 mg/Day||19
2216356|NCT02937740|5434416|P2|STARTED|BID for 90 Days, 22 mg/Day||93
2216357|NCT02937740|5434417|P1|STARTED|BID for 90 Days, 22 mg/Day||24
2216358|NCT02937701|5434433|P5|NOT COMPLETED|Week 22 to Week 50||9
2216359|NCT02937701|5434434|P4|NOT COMPLETED|Week 22 to Week 50||8
2216360|NCT02937701|5434435|P3|NOT COMPLETED|Week 22 to Week 50||32
2216361|NCT02937701|5434436|P2|NOT COMPLETED|Week 22 to Week 50||0
2216362|NCT02937701|5434437|P1|NOT COMPLETED|Week 22 to Week 50||0
2216363|NCT02937701|5434433|P5|COMPLETED|Week 22 to Week 50||110
2216364|NCT02937701|5434434|P4|COMPLETED|Week 22 to Week 50||113
2216365|NCT02937701|5434435|P3|COMPLETED|Week 22 to Week 50||212
2216366|NCT02937701|5434436|P2|COMPLETED|Week 22 to Week 50||0
2216367|NCT02937701|5434437|P1|COMPLETED|Week 22 to Week 50||0
2216368|NCT02937701|5434433|P5|STARTED|Week 22 to Week 50||119
2216369|NCT02937701|5434434|P4|STARTED|Week 22 to Week 50||121
2216370|NCT02937701|5434435|P3|STARTED|Week 22 to Week 50||244
2216371|NCT02937701|5434436|P2|STARTED|Week 22 to Week 50||0
2216372|NCT02937701|5434437|P1|STARTED|Week 22 to Week 50||0
2216373|NCT02937701|5434433|P5|NOT COMPLETED|Day 1 to Week 22||0
2216374|NCT02937701|5434434|P4|NOT COMPLETED|Day 1 to Week 22||0
2216375|NCT02937701|5434435|P3|NOT COMPLETED|Day 1 to Week 22||0
2216376|NCT02937701|5434436|P2|NOT COMPLETED|Day 1 to Week 22||39
2216377|NCT02937701|5434437|P1|NOT COMPLETED|Day 1 to Week 22||35
2216378|NCT02937701|5434433|P5|COMPLETED|Day 1 to Week 22||0
2216379|NCT02937701|5434434|P4|COMPLETED|Day 1 to Week 22||0
2216380|NCT02937701|5434435|P3|COMPLETED|Day 1 to Week 22||0
2216381|NCT02937701|5434436|P2|COMPLETED|Day 1 to Week 22||240
2216382|NCT02937701|5434437|P1|COMPLETED|Day 1 to Week 22||244
2216383|NCT02937701|5434433|P5|Received Treatment|Day 1 to Week 22||0
2216384|NCT02937701|5434434|P4|Received Treatment|Day 1 to Week 22||0
2216385|NCT02937701|5434435|P3|Received Treatment|Day 1 to Week 22||0
2216386|NCT02937701|5434436|P2|Received Treatment|Day 1 to Week 22||278
2216387|NCT02937701|5434437|P1|Received Treatment|Day 1 to Week 22||278
2216388|NCT02937701|5434433|P5|STARTED|Day 1 to Week 22||0
2216389|NCT02937701|5434434|P4|STARTED|Day 1 to Week 22||0
2216390|NCT02937701|5434435|P3|STARTED|Day 1 to Week 22||0
2216391|NCT02937701|5434436|P2|STARTED|Day 1 to Week 22||279
2216392|NCT02937701|5434437|P1|STARTED|Day 1 to Week 22||279
2216393|NCT02937636|5434468|P2|NOT COMPLETED|Overall Study||2
2216394|NCT02937636|5434469|P1|NOT COMPLETED|Overall Study||3
2216395|NCT02937636|5434468|P2|COMPLETED|Overall Study||63
2216396|NCT02937636|5434469|P1|COMPLETED|Overall Study||60
2216397|NCT02937636|5434468|P2|STARTED|Overall Study||65
2216398|NCT02937636|5434469|P1|STARTED|Overall Study||63
2216399|NCT02937623|5434483|P2|NOT COMPLETED|Overall Study||0
2216400|NCT02937623|5434484|P1|NOT COMPLETED|Overall Study||0
2216401|NCT02937623|5434483|P2|COMPLETED|Overall Study||60
2216402|NCT02937623|5434484|P1|COMPLETED|Overall Study||60
2216403|NCT02937623|5434483|P2|STARTED|Overall Study||60
2216404|NCT02937623|5434484|P1|STARTED|Overall Study||60
2216405|NCT02937584|5434496|P2|NOT COMPLETED|Period 2||0
2216406|NCT02937584|5434497|P1|NOT COMPLETED|Period 2||0
2216407|NCT02937584|5434496|P2|COMPLETED|Period 2||9
2216408|NCT02937584|5434497|P1|COMPLETED|Period 2||10
2216409|NCT02937584|5434496|P2|STARTED|Period 2||9
2216410|NCT02937584|5434497|P1|STARTED|Period 2||10
2216411|NCT02937584|5434496|P2|NOT COMPLETED|Washout||1
2216412|NCT02937584|5434497|P1|NOT COMPLETED|Washout||0
2216413|NCT02937584|5434496|P2|COMPLETED|Washout||9
2216414|NCT02937584|5434497|P1|COMPLETED|Washout||10
2216415|NCT02937584|5434496|P2|STARTED|Washout||10
2216416|NCT02937584|5434497|P1|STARTED|Washout||10
2216417|NCT02937584|5434496|P2|NOT COMPLETED|Period 1||2
2216418|NCT02937584|5434497|P1|NOT COMPLETED|Period 1||1
2216419|NCT02937584|5434496|P2|COMPLETED|Period 1||10
2216420|NCT02937584|5434497|P1|COMPLETED|Period 1||10
2216421|NCT02937584|5434496|P2|STARTED|Period 1||12
2216422|NCT02937584|5434497|P1|STARTED|Period 1||11
2216423|NCT02937558|5434515|P2|NOT COMPLETED|Open-label Phase||0
2216424|NCT02937558|5434516|P1|NOT COMPLETED|Open-label Phase||0
2216425|NCT02937558|5434515|P2|COMPLETED|Open-label Phase||0
2216426|NCT02937558|5434516|P1|COMPLETED|Open-label Phase||5
2216427|NCT02937558|5434515|P2|STARTED|Open-label Phase||0
2216428|NCT02937558|5434516|P1|STARTED|Open-label Phase||5
2216429|NCT02937558|5434515|P2|NOT COMPLETED|Double-blind Phase||0
2216430|NCT02937558|5434516|P1|NOT COMPLETED|Double-blind Phase||0
2216431|NCT02937558|5434515|P2|COMPLETED|Double-blind Phase||2
2216432|NCT02937558|5434516|P1|COMPLETED|Double-blind Phase||3
2216433|NCT02937558|5434515|P2|STARTED|Double-blind Phase||2
2216434|NCT02937558|5434516|P1|STARTED|Double-blind Phase||3
2216435|NCT02937506|5434531|P2|NOT COMPLETED|Overall Study||0
2216436|NCT02937506|5434532|P1|NOT COMPLETED|Overall Study||0
2216437|NCT02937506|5434531|P2|COMPLETED|Overall Study||300
2216438|NCT02937506|5434532|P1|COMPLETED|Overall Study||300
2216439|NCT02937506|5434531|P2|STARTED|Overall Study||300
2216440|NCT02937506|5434532|P1|STARTED|Overall Study||300
2216441|NCT02937168|5434538|P3|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
2216442|NCT02937168|5434539|P2|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
2216443|NCT02937168|5434540|P1|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
2216444|NCT02937168|5434538|P3|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
2216445|NCT02937168|5434539|P2|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
2216446|NCT02937168|5434540|P1|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
2216447|NCT02937168|5434538|P3|STARTED|Double-Blind Treatment Period (6 Weeks)||0
2216448|NCT02937168|5434539|P2|STARTED|Double-Blind Treatment Period (6 Weeks)||0
2216449|NCT02937168|5434540|P1|STARTED|Double-Blind Treatment Period (6 Weeks)||0
2216450|NCT02937168|5434538|P3|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
2216451|NCT02937168|5434539|P2|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
2216452|NCT02937168|5434540|P1|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
2216453|NCT02937168|5434538|P3|COMPLETED|PET/CT Screening Period (21 Days)||0
2216454|NCT02937168|5434539|P2|COMPLETED|PET/CT Screening Period (21 Days)||0
2216455|NCT02937168|5434540|P1|COMPLETED|PET/CT Screening Period (21 Days)||5
2216456|NCT02937168|5434538|P3|STARTED|PET/CT Screening Period (21 Days)||0
2216457|NCT02937168|5434539|P2|STARTED|PET/CT Screening Period (21 Days)||0
2216458|NCT02937168|5434540|P1|STARTED|PET/CT Screening Period (21 Days)||5
2216459|NCT02936869|5434560|P2|NOT COMPLETED|Overall Study||5
2216460|NCT02936869|5434561|P1|NOT COMPLETED|Overall Study||2
2216461|NCT02936869|5434560|P2|COMPLETED|Overall Study||98
2216462|NCT02936869|5434561|P1|COMPLETED|Overall Study||102
2216463|NCT02936869|5434560|P2|STARTED|Overall Study||103
2216464|NCT02936869|5434561|P1|STARTED|Overall Study||104
2216465|NCT02936648|5434569|P1|NOT COMPLETED|Overall Study||0
2216466|NCT02936648|5434569|P1|COMPLETED|Overall Study||2209
2216467|NCT02936648|5434569|P1|STARTED|Overall Study||2209
2216468|NCT02936479|5434573|P1|NOT COMPLETED|Overall Study||0
2216469|NCT02936479|5434573|P1|COMPLETED|Overall Study||1
2216470|NCT02936479|5434573|P1|STARTED|Overall Study||1
2216471|NCT02936076|5434579|P2|NOT COMPLETED|Overall Study||4
2216472|NCT02936076|5434580|P1|NOT COMPLETED|Overall Study||6
2216473|NCT02936076|5434579|P2|COMPLETED|Overall Study||20
2216474|NCT02936076|5434580|P1|COMPLETED|Overall Study||19
2216475|NCT02936076|5434579|P2|STARTED|Overall Study||24
2216476|NCT02936076|5434580|P1|STARTED|Overall Study||25
2216477|NCT02935894|5434592|P1|NOT COMPLETED|Overall Study||1
2216478|NCT02935894|5434592|P1|COMPLETED|Overall Study||13
2216479|NCT02935894|5434592|P1|STARTED|Overall Study||14
2216480|NCT02935699|5434605|P2|NOT COMPLETED|Overall Study||0
2216481|NCT02935699|5434606|P1|NOT COMPLETED|Overall Study||0
2216482|NCT02935699|5434605|P2|COMPLETED|Overall Study||135
2216483|NCT02935699|5434606|P1|COMPLETED|Overall Study||127
2216484|NCT02935699|5434605|P2|STARTED|Overall Study||135
2216485|NCT02935699|5434606|P1|STARTED|Overall Study||127
2216486|NCT02935673|5434621|P3|NOT COMPLETED|Overall Study||0
2216487|NCT02935673|5434622|P2|NOT COMPLETED|Overall Study||3
2216488|NCT02935673|5434623|P1|NOT COMPLETED|Overall Study||1
2216489|NCT02935673|5434621|P3|COMPLETED|Overall Study||6
2216490|NCT02935673|5434622|P2|COMPLETED|Overall Study||24
2216491|NCT02935673|5434623|P1|COMPLETED|Overall Study||15
2216492|NCT02935673|5434621|P3|STARTED|Overall Study||6
2216493|NCT02935673|5434622|P2|STARTED|Overall Study||27
2216494|NCT02935673|5434623|P1|STARTED|Overall Study||16
2216495|NCT02935543|5434745|P1|NOT COMPLETED|Overall Study||0
2216496|NCT02935543|5434745|P1|COMPLETED|Overall Study||1
2216497|NCT02935543|5434745|P1|STARTED|Overall Study||1
2216498|NCT02935192|5434757|P2|NOT COMPLETED|Overall Study||4
2216499|NCT02935192|5434758|P1|NOT COMPLETED|Overall Study||8
2216500|NCT02935192|5434757|P2|COMPLETED|Overall Study||156
2216501|NCT02935192|5434758|P1|COMPLETED|Overall Study||312
2216502|NCT02935192|5434757|P2|Received Vaccine/Placebo|Overall Study||156
2216503|NCT02935192|5434758|P1|Received Vaccine/Placebo|Overall Study||312
2216504|NCT02935192|5434757|P2|STARTED|Overall Study|156 subjects were included in the Full Protocol Analysis because 4 withdrew without getting product.|160
2216505|NCT02935192|5434758|P1|STARTED|Overall Study|312 subjects were included in the Full Protocol Analysis because 8 withdrew without getting product.|320
2216506|NCT02935179|5434782|P2|NOT COMPLETED|Overall Study||1
2216507|NCT02935179|5434783|P1|NOT COMPLETED|Overall Study||1
2216508|NCT02935179|5434782|P2|COMPLETED|Overall Study||29
2216509|NCT02935179|5434783|P1|COMPLETED|Overall Study||29
2216510|NCT02935179|5434782|P2|STARTED|Overall Study||30
2216511|NCT02935179|5434783|P1|STARTED|Overall Study||30
2216512|NCT02935088|5434791|P1|NOT COMPLETED|Overall Study||102
2216513|NCT02935088|5434791|P1|COMPLETED|Overall Study||2115
2216514|NCT02935088|5434791|P1|STARTED|Overall Study||2217
2216515|NCT02935062|5434806|P3|NOT COMPLETED|Overall Study||0
2216516|NCT02935062|5434807|P2|NOT COMPLETED|Overall Study||0
2216517|NCT02935062|5434808|P1|NOT COMPLETED|Overall Study||0
2216518|NCT02935062|5434806|P3|COMPLETED|Overall Study||8
2216519|NCT02935062|5434807|P2|COMPLETED|Overall Study||8
2216520|NCT02935062|5434808|P1|COMPLETED|Overall Study||8
2216521|NCT02935062|5434806|P3|STARTED|Overall Study||8
2216522|NCT02935062|5434807|P2|STARTED|Overall Study||8
2216523|NCT02935062|5434808|P1|STARTED|Overall Study||8
2216524|NCT02935036|5434821|P2|NOT COMPLETED|Overall Study||11
2216525|NCT02935036|5434822|P1|NOT COMPLETED|Overall Study||10
2216526|NCT02935036|5434821|P2|COMPLETED|Overall Study||136
2216527|NCT02935036|5434822|P1|COMPLETED|Overall Study||137
2216528|NCT02935036|5434821|P2|STARTED|Overall Study||147
2216529|NCT02935036|5434822|P1|STARTED|Overall Study||147
2216530|NCT02934932|5434832|P1|NOT COMPLETED|Overall Study||3
2216531|NCT02934932|5434832|P1|COMPLETED|Overall Study||6
2216532|NCT02934932|5434832|P1|STARTED|Overall Study||9
2216533|NCT02934698|5434841|P1|NOT COMPLETED|Overall Study||0
2216534|NCT02934698|5434841|P1|COMPLETED|Overall Study||2
2216535|NCT02934698|5434841|P1|STARTED|Overall Study||2
2216536|NCT02934347|5434849|P2|NOT COMPLETED|Overall Study||0
2216537|NCT02934347|5434850|P1|NOT COMPLETED|Overall Study||0
2216538|NCT02934347|5434849|P2|COMPLETED|Overall Study||407
2216539|NCT02934347|5434850|P1|COMPLETED|Overall Study||374
2216540|NCT02934347|5434849|P2|STARTED|Overall Study||407
2216541|NCT02934347|5434850|P1|STARTED|Overall Study||374
2216542|NCT02934191|5434864|P2|NOT COMPLETED|Overall Study||0
2216543|NCT02934191|5434865|P1|NOT COMPLETED|Overall Study||0
2216544|NCT02934191|5434864|P2|COMPLETED|Overall Study||85
2216545|NCT02934191|5434865|P1|COMPLETED|Overall Study||87
2216546|NCT02934191|5434864|P2|STARTED|Overall Study||85
2216547|NCT02934191|5434865|P1|STARTED|Overall Study||87
2216548|NCT02933879|5434876|P3|NOT COMPLETED|Overall Study||17
2216549|NCT02933879|5434877|P2|NOT COMPLETED|Overall Study||14
2216550|NCT02933879|5434878|P1|NOT COMPLETED|Overall Study||16
2216551|NCT02933879|5434876|P3|COMPLETED|Overall Study||41
2216552|NCT02933879|5434877|P2|COMPLETED|Overall Study||48
2216553|NCT02933879|5434878|P1|COMPLETED|Overall Study||48
2216554|NCT02933879|5434876|P3|STARTED|Overall Study||58
2216555|NCT02933879|5434877|P2|STARTED|Overall Study||62
2216556|NCT02933879|5434878|P1|STARTED|Overall Study||64
2216557|NCT02933866|5434914|P2|NOT COMPLETED|Overall Study||9
2216558|NCT02933866|5434915|P1|NOT COMPLETED|Overall Study||12
2216559|NCT02933866|5434914|P2|COMPLETED|Overall Study||176
2216560|NCT02933866|5434915|P1|COMPLETED|Overall Study||174
2216561|NCT02933866|5434914|P2|STARTED|Overall Study||185
2216562|NCT02933866|5434915|P1|STARTED|Overall Study||186
2216563|NCT02933528|5434921|P1|NOT COMPLETED|Overall Study||2
2216564|NCT02933528|5434921|P1|COMPLETED|Overall Study||22
2216565|NCT02933528|5434921|P1|STARTED|Overall Study||24
2216566|NCT02933502|5434925|P1|NOT COMPLETED|Overall Study||0
2216567|NCT02933502|5434925|P1|COMPLETED|Overall Study||3
2216568|NCT02933502|5434925|P1|STARTED|Overall Study||3
2216569|NCT02933476|5434929|P1|NOT COMPLETED|Overall Study||0
2216570|NCT02933476|5434929|P1|COMPLETED|Overall Study||5
2216571|NCT02933476|5434929|P1|STARTED|Overall Study||5
2216572|NCT02933450|5434938|P2|NOT COMPLETED|Overall Study||8
2216573|NCT02933450|5434939|P1|NOT COMPLETED|Overall Study||5
2216574|NCT02933450|5434938|P2|COMPLETED|Overall Study||15
2216575|NCT02933450|5434939|P1|COMPLETED|Overall Study||15
2216576|NCT02933450|5434938|P2|STARTED|Overall Study||23
2216577|NCT02933450|5434939|P1|STARTED|Overall Study||20
2216578|NCT02933060|5434949|P2|NOT COMPLETED|Overall Study||1
2216579|NCT02933060|5434950|P1|NOT COMPLETED|Overall Study||0
2216580|NCT02933060|5434949|P2|COMPLETED|Overall Study||24
2216581|NCT02933060|5434950|P1|COMPLETED|Overall Study||25
2216582|NCT02933060|5434949|P2|STARTED|Overall Study||25
2216583|NCT02933060|5434950|P1|STARTED|Overall Study||25
2216588|NCT02932943|5434991|P2|NOT COMPLETED|Overall Study||7
2216589|NCT02932943|5434992|P1|NOT COMPLETED|Overall Study||5
2216590|NCT02932943|5434991|P2|COMPLETED|Overall Study||224
2216591|NCT02932943|5434992|P1|COMPLETED|Overall Study||222
2216592|NCT02932943|5434991|P2|STARTED|Overall Study||231
2216593|NCT02932943|5434992|P1|STARTED|Overall Study||227
2216594|NCT02932904|5435008|P4|NOT COMPLETED|Overall Study||14
2216595|NCT02932904|5435009|P3|NOT COMPLETED|Overall Study||23
2216596|NCT02932904|5435010|P2|NOT COMPLETED|Overall Study||18
2216597|NCT02932904|5435011|P1|NOT COMPLETED|Overall Study||16
2216598|NCT02932904|5435008|P4|COMPLETED|Overall Study||79
2216599|NCT02932904|5435009|P3|COMPLETED|Overall Study||68
2216600|NCT02932904|5435010|P2|COMPLETED|Overall Study||67
2216601|NCT02932904|5435011|P1|COMPLETED|Overall Study||76
2216602|NCT02932904|5435008|P4|Treated|Overall Study||91
2216603|NCT02932904|5435009|P3|Treated|Overall Study||91
2216604|NCT02932904|5435010|P2|Treated|Overall Study||84
2216605|NCT02932904|5435011|P1|Treated|Overall Study||91
2216606|NCT02932904|5435008|P4|STARTED|Overall Study||93
2216607|NCT02932904|5435009|P3|STARTED|Overall Study||91
2216608|NCT02932904|5435010|P2|STARTED|Overall Study||85
2216609|NCT02932904|5435011|P1|STARTED|Overall Study||92
2216610|NCT02932891|5435046|P1|NOT COMPLETED|Overall Study||4
2216611|NCT02932891|5435046|P1|COMPLETED|Overall Study||24
2216612|NCT02932891|5435046|P1|STARTED|Overall Study||28
2216613|NCT02932878|5435052|P2|NOT COMPLETED|Overall Study||1
2216614|NCT02932878|5435053|P1|NOT COMPLETED|Overall Study||2
2216615|NCT02932878|5435052|P2|COMPLETED|Overall Study||0
2216616|NCT02932878|5435053|P1|COMPLETED|Overall Study||13
2216617|NCT02932878|5435052|P2|STARTED|Overall Study||1
2216618|NCT02932878|5435053|P1|STARTED|Overall Study||15
2216619|NCT02932462|5435061|P2|NOT COMPLETED|Overall Study||13
2216620|NCT02932462|5435062|P1|NOT COMPLETED|Overall Study||7
2216621|NCT02932462|5435061|P2|COMPLETED|Overall Study||176
2216622|NCT02932462|5435062|P1|COMPLETED|Overall Study||177
2216623|NCT02932462|5435061|P2|STARTED|Overall Study||189
2216624|NCT02932462|5435062|P1|STARTED|Overall Study||184
2216625|NCT02932306|5435074|P2|NOT COMPLETED|Overall Study||77
2216626|NCT02932306|5435075|P1|NOT COMPLETED|Overall Study||68
2216627|NCT02932306|5435074|P2|COMPLETED|Overall Study||337
2216628|NCT02932306|5435075|P1|COMPLETED|Overall Study||338
2216629|NCT02932306|5435074|P2|Safety Population|Overall Study||385
2216630|NCT02932306|5435075|P1|Safety Population|Overall Study||378
2216631|NCT02932306|5435074|P2|Intent-to-treat (ITT) Population|Overall Study||414
2216632|NCT02932306|5435075|P1|Intent-to-treat (ITT) Population|Overall Study||406
2216633|NCT02932306|5435074|P2|STARTED|Overall Study||414
2216634|NCT02932306|5435075|P1|STARTED|Overall Study||406
2216635|NCT02932267|5435089|P1|NOT COMPLETED|Overall Study||8
2216636|NCT02932267|5435089|P1|COMPLETED|Overall Study||42
2216637|NCT02932267|5435089|P1|STARTED|Overall Study||50
2216638|NCT02932228|5435095|P2|NOT COMPLETED|Overall Study||28
2216639|NCT02932228|5435096|P1|NOT COMPLETED|Overall Study||10
2216640|NCT02932228|5435095|P2|COMPLETED|Overall Study||405
2216641|NCT02932228|5435096|P1|COMPLETED|Overall Study||140
2216642|NCT02932228|5435095|P2|STARTED|Overall Study||433
2216643|NCT02932228|5435096|P1|STARTED|Overall Study||150
2216644|NCT02931396|5435117|P2|NOT COMPLETED|Overall Study||0
2216645|NCT02931396|5435118|P1|NOT COMPLETED|Overall Study||5
2216646|NCT02931396|5435117|P2|COMPLETED|Overall Study||10
2216647|NCT02931396|5435118|P1|COMPLETED|Overall Study||5
2216648|NCT02931396|5435117|P2|STARTED|Overall Study||10
2216649|NCT02931396|5435118|P1|STARTED|Overall Study||10
2216650|NCT02930980|5435128|P1|NOT COMPLETED|Overall Study||0
2216651|NCT02930980|5435128|P1|COMPLETED|Overall Study||43
2216652|NCT02930980|5435128|P1|STARTED|Overall Study||43
2216653|NCT02930837|5435132|P1|NOT COMPLETED|Overall Study||12
2216654|NCT02930837|5435132|P1|COMPLETED|Overall Study|Completed the trial|108
2216655|NCT02930837|5435132|P1|STARTED|Overall Study|Started are treated patients|120
2216656|NCT02930590|5435142|P6|NOT COMPLETED|Third Intervention (2 Hours)||0
2216657|NCT02930590|5435143|P5|NOT COMPLETED|Third Intervention (2 Hours)||0
2216658|NCT02930590|5435144|P4|NOT COMPLETED|Third Intervention (2 Hours)||0
2216659|NCT02930590|5435145|P3|NOT COMPLETED|Third Intervention (2 Hours)||0
2216660|NCT02930590|5435146|P2|NOT COMPLETED|Third Intervention (2 Hours)||0
2216661|NCT02930590|5435147|P1|NOT COMPLETED|Third Intervention (2 Hours)||0
2216662|NCT02930590|5435142|P6|COMPLETED|Third Intervention (2 Hours)||2
2216663|NCT02930590|5435143|P5|COMPLETED|Third Intervention (2 Hours)||2
2216664|NCT02930590|5435144|P4|COMPLETED|Third Intervention (2 Hours)||2
2216665|NCT02930590|5435145|P3|COMPLETED|Third Intervention (2 Hours)||3
2216666|NCT02930590|5435146|P2|COMPLETED|Third Intervention (2 Hours)||3
2216667|NCT02930590|5435147|P1|COMPLETED|Third Intervention (2 Hours)||3
2216668|NCT02930590|5435142|P6|STARTED|Third Intervention (2 Hours)||2
2216669|NCT02930590|5435143|P5|STARTED|Third Intervention (2 Hours)||2
2216670|NCT02930590|5435144|P4|STARTED|Third Intervention (2 Hours)||2
2216671|NCT02930590|5435145|P3|STARTED|Third Intervention (2 Hours)||3
2216672|NCT02930590|5435146|P2|STARTED|Third Intervention (2 Hours)||3
2216673|NCT02930590|5435147|P1|STARTED|Third Intervention (2 Hours)||3
2216674|NCT02930590|5435142|P6|NOT COMPLETED|Second Intervention (2 Hours)||0
2216675|NCT02930590|5435143|P5|NOT COMPLETED|Second Intervention (2 Hours)||0
2216676|NCT02930590|5435144|P4|NOT COMPLETED|Second Intervention (2 Hours)||0
2216677|NCT02930590|5435145|P3|NOT COMPLETED|Second Intervention (2 Hours)||0
2216678|NCT02930590|5435146|P2|NOT COMPLETED|Second Intervention (2 Hours)||0
2216679|NCT02930590|5435147|P1|NOT COMPLETED|Second Intervention (2 Hours)||0
2216680|NCT02930590|5435142|P6|COMPLETED|Second Intervention (2 Hours)||2
2216681|NCT02930590|5435143|P5|COMPLETED|Second Intervention (2 Hours)||2
2216682|NCT02930590|5435144|P4|COMPLETED|Second Intervention (2 Hours)||2
2216683|NCT02930590|5435145|P3|COMPLETED|Second Intervention (2 Hours)||3
2216684|NCT02930590|5435146|P2|COMPLETED|Second Intervention (2 Hours)||3
2216685|NCT02930590|5435147|P1|COMPLETED|Second Intervention (2 Hours)||3
2216686|NCT02930590|5435142|P6|STARTED|Second Intervention (2 Hours)||2
2216687|NCT02930590|5435143|P5|STARTED|Second Intervention (2 Hours)||2
2216688|NCT02930590|5435144|P4|STARTED|Second Intervention (2 Hours)||2
2216689|NCT02930590|5435145|P3|STARTED|Second Intervention (2 Hours)||3
2216690|NCT02930590|5435146|P2|STARTED|Second Intervention (2 Hours)||3
2216691|NCT02930590|5435147|P1|STARTED|Second Intervention (2 Hours)||3
2216692|NCT02930590|5435142|P6|NOT COMPLETED|First Intervention (2 Hours)||0
2216693|NCT02930590|5435143|P5|NOT COMPLETED|First Intervention (2 Hours)||0
2216694|NCT02930590|5435144|P4|NOT COMPLETED|First Intervention (2 Hours)||0
2216695|NCT02930590|5435145|P3|NOT COMPLETED|First Intervention (2 Hours)||0
2216696|NCT02930590|5435146|P2|NOT COMPLETED|First Intervention (2 Hours)||0
2216697|NCT02930590|5435147|P1|NOT COMPLETED|First Intervention (2 Hours)||0
2216698|NCT02930590|5435142|P6|COMPLETED|First Intervention (2 Hours)||2
2216699|NCT02930590|5435143|P5|COMPLETED|First Intervention (2 Hours)||2
2216700|NCT02930590|5435144|P4|COMPLETED|First Intervention (2 Hours)||2
2216701|NCT02930590|5435145|P3|COMPLETED|First Intervention (2 Hours)||3
2216702|NCT02930590|5435146|P2|COMPLETED|First Intervention (2 Hours)||3
2216703|NCT02930590|5435147|P1|COMPLETED|First Intervention (2 Hours)||3
2216704|NCT02930590|5435142|P6|STARTED|First Intervention (2 Hours)||2
2216705|NCT02930590|5435143|P5|STARTED|First Intervention (2 Hours)||2
2216706|NCT02930590|5435144|P4|STARTED|First Intervention (2 Hours)||2
2216707|NCT02930590|5435145|P3|STARTED|First Intervention (2 Hours)||3
2216708|NCT02930590|5435146|P2|STARTED|First Intervention (2 Hours)||3
2216709|NCT02930590|5435147|P1|STARTED|First Intervention (2 Hours)||3
2216710|NCT02930174|5435424|P2|NOT COMPLETED|Overall Study||0
2216711|NCT02930174|5435425|P1|NOT COMPLETED|Overall Study||0
2216712|NCT02930174|5435424|P2|COMPLETED|Overall Study||8
2216713|NCT02930174|5435425|P1|COMPLETED|Overall Study||12
2216714|NCT02930174|5435424|P2|STARTED|Overall Study||8
2216715|NCT02930174|5435425|P1|STARTED|Overall Study||12
2216716|NCT02930005|5435442|P2|NOT COMPLETED|Overall Study||5
2216717|NCT02930005|5435443|P1|NOT COMPLETED|Overall Study||1
2216718|NCT02930005|5435442|P2|COMPLETED|Overall Study||1
2216719|NCT02930005|5435443|P1|COMPLETED|Overall Study||1
2216720|NCT02930005|5435442|P2|Completed 2 Weeks|Overall Study||2
2216721|NCT02930005|5435443|P1|Completed 2 Weeks|Overall Study||2
2216722|NCT02930005|5435442|P2|STARTED|Overall Study||6
2216723|NCT02930005|5435443|P1|STARTED|Overall Study||2
2216724|NCT02929823|5435454|P3|NOT COMPLETED|Overall Study||4
2216725|NCT02929823|5435455|P2|NOT COMPLETED|Overall Study||6
2216726|NCT02929823|5435456|P1|NOT COMPLETED|Overall Study||3
2216727|NCT02929823|5435454|P3|COMPLETED|Overall Study||38
2216728|NCT02929823|5435455|P2|COMPLETED|Overall Study||40
2216729|NCT02929823|5435456|P1|COMPLETED|Overall Study||39
2216730|NCT02929823|5435454|P3|STARTED|Overall Study||42
2216731|NCT02929823|5435455|P2|STARTED|Overall Study||46
2216732|NCT02929823|5435456|P1|STARTED|Overall Study||42
2216733|NCT02929498|5435467|P3|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
2216734|NCT02929498|5435468|P2|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
2216735|NCT02929498|5435469|P1|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
2216736|NCT02929498|5435467|P3|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
2216737|NCT02929498|5435468|P2|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
2216738|NCT02929498|5435469|P1|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
2216739|NCT02929498|5435467|P3|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
2216740|NCT02929498|5435468|P2|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
2216741|NCT02929498|5435469|P1|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
2216742|NCT02929498|5435467|P3|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
2216743|NCT02929498|5435468|P2|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
2216744|NCT02929498|5435469|P1|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||5
2216745|NCT02929498|5435467|P3|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
2216746|NCT02929498|5435468|P2|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
2216747|NCT02929498|5435469|P1|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
2216748|NCT02929498|5435467|P3|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||0
2216749|NCT02929498|5435468|P2|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||0
2216750|NCT02929498|5435469|P1|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||5
2216751|NCT02929407|5435563|P1|NOT COMPLETED|Overall Study||1
2216752|NCT02929407|5435563|P1|COMPLETED|Overall Study||3
2216753|NCT02929407|5435563|P1|STARTED|Overall Study||4
2216754|NCT02928770|5435578|P1|NOT COMPLETED|Overall Study||2
2216755|NCT02928770|5435578|P1|COMPLETED|Overall Study||30
2216756|NCT02928770|5435578|P1|STARTED|Overall Study||32
2216757|NCT02928536|5435582|P1|NOT COMPLETED|Overall Study||0
2216758|NCT02928536|5435582|P1|COMPLETED|Overall Study||11902
2216759|NCT02928536|5435582|P1|STARTED|Overall Study||11902
2216760|NCT02928380|5435589|P6|NOT COMPLETED|Period 3||0
2216761|NCT02928380|5435590|P5|NOT COMPLETED|Period 3||0
2216762|NCT02928380|5435591|P4|NOT COMPLETED|Period 3||0
2216763|NCT02928380|5435592|P3|NOT COMPLETED|Period 3||0
2216764|NCT02928380|5435593|P2|NOT COMPLETED|Period 3||0
2216765|NCT02928380|5435594|P1|NOT COMPLETED|Period 3||0
2216766|NCT02928380|5435589|P6|COMPLETED|Period 3||14
2216767|NCT02928380|5435590|P5|COMPLETED|Period 3||14
2216768|NCT02928380|5435591|P4|COMPLETED|Period 3||14
2216769|NCT02928380|5435592|P3|COMPLETED|Period 3||14
2216770|NCT02928380|5435593|P2|COMPLETED|Period 3||14
2216771|NCT02928380|5435594|P1|COMPLETED|Period 3||13
2216772|NCT02928380|5435589|P6|STARTED|Period 3||14
2216773|NCT02928380|5435590|P5|STARTED|Period 3||14
2216774|NCT02928380|5435591|P4|STARTED|Period 3||14
2216775|NCT02928380|5435592|P3|STARTED|Period 3||14
2216776|NCT02928380|5435593|P2|STARTED|Period 3||14
2216777|NCT02928380|5435594|P1|STARTED|Period 3||13
2216778|NCT02928380|5435589|P6|NOT COMPLETED|Wash Out Period 2||0
2216779|NCT02928380|5435590|P5|NOT COMPLETED|Wash Out Period 2||0
2216780|NCT02928380|5435591|P4|NOT COMPLETED|Wash Out Period 2||0
2216781|NCT02928380|5435592|P3|NOT COMPLETED|Wash Out Period 2||0
2216782|NCT02928380|5435593|P2|NOT COMPLETED|Wash Out Period 2||0
2216783|NCT02928380|5435594|P1|NOT COMPLETED|Wash Out Period 2||0
2216784|NCT02928380|5435589|P6|COMPLETED|Wash Out Period 2||14
2216785|NCT02928380|5435590|P5|COMPLETED|Wash Out Period 2||14
2216786|NCT02928380|5435591|P4|COMPLETED|Wash Out Period 2||14
2216787|NCT02928380|5435592|P3|COMPLETED|Wash Out Period 2||14
2216788|NCT02928380|5435593|P2|COMPLETED|Wash Out Period 2||14
2216789|NCT02928380|5435594|P1|COMPLETED|Wash Out Period 2||13
2216790|NCT02928380|5435589|P6|STARTED|Wash Out Period 2||14
2216791|NCT02928380|5435590|P5|STARTED|Wash Out Period 2||14
2216792|NCT02928380|5435591|P4|STARTED|Wash Out Period 2||14
2216793|NCT02928380|5435592|P3|STARTED|Wash Out Period 2||14
2216794|NCT02928380|5435593|P2|STARTED|Wash Out Period 2||14
2216795|NCT02928380|5435594|P1|STARTED|Wash Out Period 2||13
2216796|NCT02928380|5435589|P6|NOT COMPLETED|Period 2||0
2216797|NCT02928380|5435590|P5|NOT COMPLETED|Period 2||0
2216798|NCT02928380|5435591|P4|NOT COMPLETED|Period 2||0
2216799|NCT02928380|5435592|P3|NOT COMPLETED|Period 2||0
2216800|NCT02928380|5435593|P2|NOT COMPLETED|Period 2||0
2216801|NCT02928380|5435594|P1|NOT COMPLETED|Period 2||0
2216802|NCT02928380|5435589|P6|COMPLETED|Period 2||14
2216803|NCT02928380|5435590|P5|COMPLETED|Period 2||14
2216804|NCT02928380|5435591|P4|COMPLETED|Period 2||14
2216805|NCT02928380|5435592|P3|COMPLETED|Period 2||14
2216806|NCT02928380|5435593|P2|COMPLETED|Period 2||14
2216807|NCT02928380|5435594|P1|COMPLETED|Period 2||13
2216808|NCT02928380|5435589|P6|STARTED|Period 2||14
2216809|NCT02928380|5435590|P5|STARTED|Period 2||14
2216810|NCT02928380|5435591|P4|STARTED|Period 2||14
2216811|NCT02928380|5435592|P3|STARTED|Period 2||14
2216812|NCT02928380|5435593|P2|STARTED|Period 2||14
2216813|NCT02928380|5435594|P1|STARTED|Period 2||13
2216814|NCT02928380|5435589|P6|NOT COMPLETED|Wash Out Period 1||0
2216815|NCT02928380|5435590|P5|NOT COMPLETED|Wash Out Period 1||0
2216816|NCT02928380|5435591|P4|NOT COMPLETED|Wash Out Period 1||0
2216817|NCT02928380|5435592|P3|NOT COMPLETED|Wash Out Period 1||0
2216818|NCT02928380|5435593|P2|NOT COMPLETED|Wash Out Period 1||0
2216819|NCT02928380|5435594|P1|NOT COMPLETED|Wash Out Period 1||0
2216820|NCT02928380|5435589|P6|COMPLETED|Wash Out Period 1||14
2216821|NCT02928380|5435590|P5|COMPLETED|Wash Out Period 1||14
2216822|NCT02928380|5435591|P4|COMPLETED|Wash Out Period 1||14
2216823|NCT02928380|5435592|P3|COMPLETED|Wash Out Period 1||14
2216824|NCT02928380|5435593|P2|COMPLETED|Wash Out Period 1||14
2216825|NCT02928380|5435594|P1|COMPLETED|Wash Out Period 1||13
2216826|NCT02928380|5435589|P6|STARTED|Wash Out Period 1||14
2216827|NCT02928380|5435590|P5|STARTED|Wash Out Period 1||14
2216828|NCT02928380|5435591|P4|STARTED|Wash Out Period 1||14
2216829|NCT02928380|5435592|P3|STARTED|Wash Out Period 1||14
2216830|NCT02928380|5435593|P2|STARTED|Wash Out Period 1||14
2216831|NCT02928380|5435594|P1|STARTED|Wash Out Period 1||13
2216832|NCT02928380|5435589|P6|NOT COMPLETED|Period 1||0
2216833|NCT02928380|5435590|P5|NOT COMPLETED|Period 1||0
2216834|NCT02928380|5435591|P4|NOT COMPLETED|Period 1||0
2216835|NCT02928380|5435592|P3|NOT COMPLETED|Period 1||0
2216836|NCT02928380|5435593|P2|NOT COMPLETED|Period 1||0
2216837|NCT02928380|5435594|P1|NOT COMPLETED|Period 1||0
2216838|NCT02928380|5435589|P6|COMPLETED|Period 1||14
2216839|NCT02928380|5435590|P5|COMPLETED|Period 1||14
2216840|NCT02928380|5435591|P4|COMPLETED|Period 1||14
2216841|NCT02928380|5435592|P3|COMPLETED|Period 1||14
2216842|NCT02928380|5435593|P2|COMPLETED|Period 1||14
2216843|NCT02928380|5435594|P1|COMPLETED|Period 1||13
2216844|NCT02928380|5435589|P6|STARTED|Period 1||14
2216845|NCT02928380|5435590|P5|STARTED|Period 1||14
2216846|NCT02928380|5435591|P4|STARTED|Period 1||14
2216847|NCT02928380|5435592|P3|STARTED|Period 1||14
2216848|NCT02928380|5435593|P2|STARTED|Period 1||14
2216849|NCT02928380|5435594|P1|STARTED|Period 1||13
2216850|NCT02927795|5435614|P1|NOT COMPLETED|Overall Study||23
2216851|NCT02927795|5435614|P1|COMPLETED|Overall Study||234
2216852|NCT02927795|5435614|P1|Treated|Overall Study||253
2216853|NCT02927795|5435614|P1|STARTED|Overall Study||257
2216854|NCT02927457|5435625|P2|NOT COMPLETED|Overall Study||0
2216855|NCT02927457|5435626|P1|NOT COMPLETED|Overall Study||0
2216856|NCT02927457|5435625|P2|COMPLETED|Overall Study||11
2216857|NCT02927457|5435626|P1|COMPLETED|Overall Study||0
2216858|NCT02927457|5435625|P2|STARTED|Overall Study||11
2216859|NCT02927457|5435626|P1|STARTED|Overall Study||0
2216860|NCT02927431|5435661|P3|NOT COMPLETED|Overall Study||1
2216861|NCT02927431|5435662|P2|NOT COMPLETED|Overall Study||0
2216862|NCT02927431|5435663|P1|NOT COMPLETED|Overall Study||0
2216863|NCT02927431|5435661|P3|COMPLETED|Overall Study||3
2216864|NCT02927431|5435662|P2|COMPLETED|Overall Study||4
2216865|NCT02927431|5435663|P1|COMPLETED|Overall Study||2
2216866|NCT02927431|5435661|P3|STARTED|Overall Study||4
2216867|NCT02927431|5435662|P2|STARTED|Overall Study||4
2216868|NCT02927431|5435663|P1|STARTED|Overall Study||2
2216879|NCT02927327|5435776|P2|NOT COMPLETED|Overall Study||0
2216880|NCT02927327|5435777|P1|NOT COMPLETED|Overall Study||0
2216881|NCT02927327|5435776|P2|COMPLETED|Overall Study||31
2216882|NCT02927327|5435777|P1|COMPLETED|Overall Study||30
2216883|NCT02927327|5435776|P2|STARTED|Overall Study||31
2216884|NCT02927327|5435777|P1|STARTED|Overall Study||30
2216885|NCT02927223|5435789|P1|NOT COMPLETED|Overall Study||0
2216886|NCT02927223|5435789|P1|COMPLETED|Overall Study||6
2216887|NCT02927223|5435789|P1|STARTED|Overall Study||6
2216888|NCT02926573|5435797|P2|NOT COMPLETED|Overall Study||9
2216889|NCT02926573|5435798|P1|NOT COMPLETED|Overall Study||11
2216890|NCT02926573|5435797|P2|COMPLETED|Overall Study||46
2216891|NCT02926573|5435798|P1|COMPLETED|Overall Study||44
2216892|NCT02926573|5435797|P2|STARTED|Overall Study||55
2216893|NCT02926573|5435798|P1|STARTED|Overall Study||55
2216894|NCT02926209|5435816|P2|NOT COMPLETED|Training Cohort - First Patients||0
2216895|NCT02926209|5435817|P1|NOT COMPLETED|Training Cohort - First Patients||0
2216896|NCT02926209|5435816|P2|COMPLETED|Training Cohort - First Patients||0
2216897|NCT02926209|5435817|P1|COMPLETED|Training Cohort - First Patients||20
2216898|NCT02926209|5435816|P2|STARTED|Training Cohort - First Patients||0
2216899|NCT02926209|5435817|P1|STARTED|Training Cohort - First Patients||20
2216900|NCT02926209|5435816|P2|NOT COMPLETED|Study Cohort||0
2216901|NCT02926209|5435817|P1|NOT COMPLETED|Study Cohort||1
2216902|NCT02926209|5435816|P2|COMPLETED|Study Cohort||37
2216903|NCT02926209|5435817|P1|COMPLETED|Study Cohort||41
2216904|NCT02926209|5435816|P2|STARTED|Study Cohort||37
2216905|NCT02926209|5435817|P1|STARTED|Study Cohort|Training cohort patients Aer-O-Scope as first followed by a conventional colonoscopy|42
2216906|NCT02925858|5435830|P2|NOT COMPLETED|Overall Study||0
2216907|NCT02925858|5435831|P1|NOT COMPLETED|Overall Study||0
2216908|NCT02925858|5435830|P2|COMPLETED|Overall Study||38
2216909|NCT02925858|5435831|P1|COMPLETED|Overall Study||42
2216910|NCT02925858|5435830|P2|STARTED|Overall Study||38
2216911|NCT02925858|5435831|P1|STARTED|Overall Study||42
2216912|NCT02925741|5435857|P2|NOT COMPLETED|Overall Study||0
2216913|NCT02925741|5435858|P1|NOT COMPLETED|Overall Study||0
2216914|NCT02925741|5435857|P2|COMPLETED|Overall Study||1706
2216915|NCT02925741|5435858|P1|COMPLETED|Overall Study||1626
2216916|NCT02925741|5435857|P2|STARTED|Overall Study||1706
2216917|NCT02925741|5435858|P1|STARTED|Overall Study||1626
2216918|NCT02925611|5435870|P2|NOT COMPLETED|Overall Study||0
2216919|NCT02925611|5435871|P1|NOT COMPLETED|Overall Study||0
2216920|NCT02925611|5435870|P2|COMPLETED|Overall Study||30
2216921|NCT02925611|5435871|P1|COMPLETED|Overall Study||30
2216922|NCT02925611|5435870|P2|STARTED|Overall Study||30
2216923|NCT02925611|5435871|P1|STARTED|Overall Study||30
2216924|NCT02925403|5435889|P2|NOT COMPLETED|Overall Study||1
2216925|NCT02925403|5435890|P1|NOT COMPLETED|Overall Study||0
2216926|NCT02925403|5435889|P2|COMPLETED|Overall Study||4
2216927|NCT02925403|5435890|P1|COMPLETED|Overall Study||8
2216928|NCT02925403|5435889|P2|STARTED|Overall Study||5
2216929|NCT02925403|5435890|P1|STARTED|Overall Study||8
2216930|NCT02924883|5435904|P2|NOT COMPLETED|Overall Study||133
2216931|NCT02924883|5435905|P1|NOT COMPLETED|Overall Study||69
2216932|NCT02924883|5435904|P2|COMPLETED|Overall Study||0
2216933|NCT02924883|5435905|P1|COMPLETED|Overall Study||0
2216934|NCT02924883|5435904|P2|STARTED|Overall Study||133
2216935|NCT02924883|5435905|P1|STARTED|Overall Study||69
2216954|NCT02924350|5436005|P2|NOT COMPLETED|Overall Study||2
2216955|NCT02924350|5436006|P1|NOT COMPLETED|Overall Study||0
2216956|NCT02924350|5436005|P2|COMPLETED|Overall Study||100
2216957|NCT02924350|5436006|P1|COMPLETED|Overall Study||102
2216958|NCT02924350|5436005|P2|STARTED|Overall Study||102
2216959|NCT02924350|5436006|P1|STARTED|Overall Study||102
2216960|NCT02924051|5436018|P2|NOT COMPLETED|Overall Study||9
2216961|NCT02924051|5436019|P1|NOT COMPLETED|Overall Study||1
2216962|NCT02924051|5436018|P2|COMPLETED|Overall Study||97
2216963|NCT02924051|5436019|P1|COMPLETED|Overall Study||81
2216964|NCT02924051|5436018|P2|STARTED|Overall Study||106
2216965|NCT02924051|5436019|P1|STARTED|Overall Study||82
2216966|NCT02923895|5436031|P2|NOT COMPLETED|Overall Study||0
2216967|NCT02923895|5436032|P1|NOT COMPLETED|Overall Study||0
2216968|NCT02923895|5436031|P2|COMPLETED|Overall Study||95
2216969|NCT02923895|5436032|P1|COMPLETED|Overall Study||97
2216970|NCT02923895|5436031|P2|STARTED|Overall Study||95
2216971|NCT02923895|5436032|P1|STARTED|Overall Study||97
2216972|NCT02923830|5436046|P2|NOT COMPLETED|Overall Study||15
2216973|NCT02923830|5436047|P1|NOT COMPLETED|Overall Study||13
2216974|NCT02923830|5436046|P2|COMPLETED|Overall Study|Study terminated|0
2216975|NCT02923830|5436047|P1|COMPLETED|Overall Study|Study terminated|0
2216976|NCT02923830|5436046|P2|STARTED|Overall Study||15
2216977|NCT02923830|5436047|P1|STARTED|Overall Study||13
2216978|NCT02923271|5436067|P2|NOT COMPLETED|Overall Study||2
2216979|NCT02923271|5436068|P1|NOT COMPLETED|Overall Study||8
2216980|NCT02923271|5436067|P2|COMPLETED|Overall Study||14
2216981|NCT02923271|5436068|P1|COMPLETED|Overall Study||10
2216982|NCT02923271|5436067|P2|STARTED|Overall Study||16
2216983|NCT02923271|5436068|P1|STARTED|Overall Study||18
2216984|NCT02923245|5436078|P2|NOT COMPLETED|Overall Study||1
2216985|NCT02923245|5436079|P1|NOT COMPLETED|Overall Study||2
2216986|NCT02923245|5436078|P2|COMPLETED|Overall Study||59
2216987|NCT02923245|5436079|P1|COMPLETED|Overall Study||58
2216988|NCT02923245|5436078|P2|STARTED|Overall Study||60
2216989|NCT02923245|5436079|P1|STARTED|Overall Study||60
2216990|NCT02922985|5436098|P2|NOT COMPLETED|Overall Study||0
2216991|NCT02922985|5436099|P1|NOT COMPLETED|Overall Study||0
2216992|NCT02922985|5436098|P2|COMPLETED|Overall Study||60
2216993|NCT02922985|5436099|P1|COMPLETED|Overall Study||60
2216994|NCT02922985|5436098|P2|STARTED|Overall Study||60
2216995|NCT02922985|5436099|P1|STARTED|Overall Study||60
2216996|NCT02922868|5436125|P2|NOT COMPLETED|Overall Study||0
2216997|NCT02922868|5436126|P1|NOT COMPLETED|Overall Study||0
2216998|NCT02922868|5436125|P2|COMPLETED|Overall Study||30
2216999|NCT02922868|5436126|P1|COMPLETED|Overall Study||30
2217000|NCT02922868|5436125|P2|STARTED|Overall Study||30
2217001|NCT02922868|5436126|P1|STARTED|Overall Study||30
2217002|NCT02922738|5436146|P2|NOT COMPLETED|Overall Study||0
2217003|NCT02922738|5436147|P1|NOT COMPLETED|Overall Study||0
2217004|NCT02922738|5436146|P2|COMPLETED|Overall Study||290
2217005|NCT02922738|5436147|P1|COMPLETED|Overall Study||175
2217006|NCT02922738|5436146|P2|STARTED|Overall Study|275 patients and 15 providers|290
2217007|NCT02922738|5436147|P1|STARTED|Overall Study|158 patients and 17 providers|175
2217008|NCT02921841|5436157|P2|NOT COMPLETED|Overall Study||13
2217009|NCT02921841|5436158|P1|NOT COMPLETED|Overall Study||16
2217010|NCT02921841|5436157|P2|COMPLETED|Overall Study||44
2217011|NCT02921841|5436158|P1|COMPLETED|Overall Study||52
2217012|NCT02921841|5436157|P2|STARTED|Overall Study||57
2217013|NCT02921841|5436158|P1|STARTED|Overall Study||68
2217017|NCT02921425|5436201|P1|NOT COMPLETED|Overall Study||9
2217018|NCT02921425|5436201|P1|COMPLETED|Overall Study||38
2217019|NCT02921425|5436201|P1|Second Visit|Overall Study|Participants had to wear an accelerometer and make entries into their PHR over the previous 7 days.|47
2217020|NCT02921425|5436201|P1|STARTED|Overall Study||47
2217021|NCT02921412|5436215|P1|NOT COMPLETED|Overall Study||0
2217022|NCT02921412|5436215|P1|COMPLETED|Overall Study||36
2217023|NCT02921412|5436215|P1|STARTED|Overall Study||36
2217024|NCT02921386|5436238|P1|NOT COMPLETED|Sequence E: FDA High Fat Breakfast||0
2217025|NCT02921386|5436238|P1|COMPLETED|Sequence E: FDA High Fat Breakfast||18
2217026|NCT02921386|5436238|P1|STARTED|Sequence E: FDA High Fat Breakfast||18
2217027|NCT02921386|5436238|P1|NOT COMPLETED|Sequence D: 45 g Fat Breakfast||0
2217028|NCT02921386|5436238|P1|COMPLETED|Sequence D: 45 g Fat Breakfast||18
2217029|NCT02921386|5436238|P1|STARTED|Sequence D: 45 g Fat Breakfast||18
2217030|NCT02921386|5436238|P1|NOT COMPLETED|Sequence C: 30 g Fat Breakfast||0
2217031|NCT02921386|5436238|P1|COMPLETED|Sequence C: 30 g Fat Breakfast||18
2217032|NCT02921386|5436238|P1|STARTED|Sequence C: 30 g Fat Breakfast||18
2217033|NCT02921386|5436238|P1|NOT COMPLETED|Sequence B: 15 g Fat Breakfast||0
2217034|NCT02921386|5436238|P1|COMPLETED|Sequence B: 15 g Fat Breakfast||18
2217035|NCT02921386|5436238|P1|STARTED|Sequence B: 15 g Fat Breakfast||18
2217036|NCT02921386|5436238|P1|NOT COMPLETED|Sequence A: Fasting||0
2217037|NCT02921386|5436238|P1|COMPLETED|Sequence A: Fasting||18
2217038|NCT02921386|5436238|P1|STARTED|Sequence A: Fasting||18
2217039|NCT02921295|5436261|P1|NOT COMPLETED|Conventional Prostheses||0
2217040|NCT02921295|5436261|P1|COMPLETED|Conventional Prostheses||1
2217041|NCT02921295|5436261|P1|STARTED|Conventional Prostheses||1
2217042|NCT02921295|5436261|P1|NOT COMPLETED|Sidekicks||0
2217043|NCT02921295|5436261|P1|COMPLETED|Sidekicks||1
2217044|NCT02921295|5436261|P1|STARTED|Sidekicks||1
2217045|NCT02921087|5436273|P2|NOT COMPLETED|Overall Study||1
2217046|NCT02921087|5436274|P1|NOT COMPLETED|Overall Study||0
2217047|NCT02921087|5436273|P2|COMPLETED|Overall Study|One subject dropped out prior to 1 week of lens wear while wearing the control lens (lens 1).|10
2217048|NCT02921087|5436274|P1|COMPLETED|Overall Study||12
2217049|NCT02921087|5436273|P2|STARTED|Overall Study||11
2217050|NCT02921087|5436274|P1|STARTED|Overall Study||12
2217051|NCT02920983|5436294|P6|NOT COMPLETED|Dispense 3||0
2217052|NCT02920983|5436295|P5|NOT COMPLETED|Dispense 3||1
2217053|NCT02920983|5436296|P4|NOT COMPLETED|Dispense 3||0
2217054|NCT02920983|5436297|P3|NOT COMPLETED|Dispense 3||0
2217055|NCT02920983|5436298|P2|NOT COMPLETED|Dispense 3||1
2217056|NCT02920983|5436299|P1|NOT COMPLETED|Dispense 3||1
2217057|NCT02920983|5436294|P6|COMPLETED|Dispense 3||7
2217058|NCT02920983|5436295|P5|COMPLETED|Dispense 3||12
2217059|NCT02920983|5436296|P4|COMPLETED|Dispense 3||6
2217060|NCT02920983|5436297|P3|COMPLETED|Dispense 3||7
2217061|NCT02920983|5436298|P2|COMPLETED|Dispense 3||9
2217062|NCT02920983|5436299|P1|COMPLETED|Dispense 3||7
2217063|NCT02920983|5436294|P6|STARTED|Dispense 3||7
2217064|NCT02920983|5436295|P5|STARTED|Dispense 3||13
2217065|NCT02920983|5436296|P4|STARTED|Dispense 3||6
2217066|NCT02920983|5436297|P3|STARTED|Dispense 3||7
2217067|NCT02920983|5436298|P2|STARTED|Dispense 3||10
2217068|NCT02920983|5436299|P1|STARTED|Dispense 3||8
2217069|NCT02920983|5436294|P6|NOT COMPLETED|Dispense 2||0
2217070|NCT02920983|5436295|P5|NOT COMPLETED|Dispense 2||1
2217071|NCT02920983|5436296|P4|NOT COMPLETED|Dispense 2||0
2217072|NCT02920983|5436297|P3|NOT COMPLETED|Dispense 2||0
2217073|NCT02920983|5436298|P2|NOT COMPLETED|Dispense 2||0
2217074|NCT02920983|5436299|P1|NOT COMPLETED|Dispense 2||1
2217075|NCT02920983|5436294|P6|COMPLETED|Dispense 2||7
2217076|NCT02920983|5436295|P5|COMPLETED|Dispense 2||12
2217077|NCT02920983|5436296|P4|COMPLETED|Dispense 2||6
2217078|NCT02920983|5436297|P3|COMPLETED|Dispense 2||7
2217079|NCT02920983|5436298|P2|COMPLETED|Dispense 2||10
2217080|NCT02920983|5436299|P1|COMPLETED|Dispense 2||7
2217081|NCT02920983|5436294|P6|STARTED|Dispense 2||7
2217082|NCT02920983|5436295|P5|STARTED|Dispense 2||13
2217083|NCT02920983|5436296|P4|STARTED|Dispense 2||6
2217084|NCT02920983|5436297|P3|STARTED|Dispense 2||7
2217085|NCT02920983|5436298|P2|STARTED|Dispense 2||10
2217086|NCT02920983|5436299|P1|STARTED|Dispense 2||8
2217087|NCT02920983|5436294|P6|NOT COMPLETED|Dispense 1||0
2217088|NCT02920983|5436295|P5|NOT COMPLETED|Dispense 1||1
2217089|NCT02920983|5436296|P4|NOT COMPLETED|Dispense 1||0
2217090|NCT02920983|5436297|P3|NOT COMPLETED|Dispense 1||0
2217091|NCT02920983|5436298|P2|NOT COMPLETED|Dispense 1||0
2217092|NCT02920983|5436299|P1|NOT COMPLETED|Dispense 1||0
2217093|NCT02920983|5436294|P6|COMPLETED|Dispense 1||7
2217094|NCT02920983|5436295|P5|COMPLETED|Dispense 1||12
2217095|NCT02920983|5436296|P4|COMPLETED|Dispense 1||6
2217096|NCT02920983|5436297|P3|COMPLETED|Dispense 1||7
2217097|NCT02920983|5436298|P2|COMPLETED|Dispense 1||10
2217098|NCT02920983|5436299|P1|COMPLETED|Dispense 1||8
2217099|NCT02920983|5436294|P6|STARTED|Dispense 1||7
2217100|NCT02920983|5436295|P5|STARTED|Dispense 1||13
2217101|NCT02920983|5436296|P4|STARTED|Dispense 1||6
2217102|NCT02920983|5436297|P3|STARTED|Dispense 1||7
2217103|NCT02920983|5436298|P2|STARTED|Dispense 1||10
2217104|NCT02920983|5436299|P1|STARTED|Dispense 1||8
2217105|NCT02920970|5436328|P2|NOT COMPLETED|Second Intervention||0
2217106|NCT02920970|5436329|P1|NOT COMPLETED|Second Intervention||1
2217107|NCT02920970|5436328|P2|COMPLETED|Second Intervention||30
2217108|NCT02920970|5436329|P1|COMPLETED|Second Intervention||37
2217109|NCT02920970|5436328|P2|STARTED|Second Intervention||30
2217110|NCT02920970|5436329|P1|STARTED|Second Intervention||38
2217111|NCT02920970|5436328|P2|NOT COMPLETED|First Intervention||2
2217112|NCT02920970|5436329|P1|NOT COMPLETED|First Intervention||0
2217113|NCT02920970|5436328|P2|COMPLETED|First Intervention||30
2217114|NCT02920970|5436329|P1|COMPLETED|First Intervention||38
2217115|NCT02920970|5436328|P2|STARTED|First Intervention||32
2217116|NCT02920970|5436329|P1|STARTED|First Intervention||38
2217117|NCT02920957|5436355|P2|NOT COMPLETED|Second Intervention: 1 Month||1
2217118|NCT02920957|5436356|P1|NOT COMPLETED|Second Intervention: 1 Month||0
2217119|NCT02920957|5436355|P2|COMPLETED|Second Intervention: 1 Month||40
2217120|NCT02920957|5436356|P1|COMPLETED|Second Intervention: 1 Month||42
2217121|NCT02920957|5436355|P2|STARTED|Second Intervention: 1 Month||41
2217122|NCT02920957|5436356|P1|STARTED|Second Intervention: 1 Month||42
2217123|NCT02920957|5436355|P2|NOT COMPLETED|First Intervention : 1 Month||0
2217124|NCT02920957|5436356|P1|NOT COMPLETED|First Intervention : 1 Month||4
2217125|NCT02920957|5436355|P2|COMPLETED|First Intervention : 1 Month||41
2217126|NCT02920957|5436356|P1|COMPLETED|First Intervention : 1 Month||42
2217127|NCT02920957|5436355|P2|STARTED|First Intervention : 1 Month||41
2217128|NCT02920957|5436356|P1|STARTED|First Intervention : 1 Month||46
2217129|NCT02920918|5436410|P2|NOT COMPLETED|Overall Study||0
2217130|NCT02920918|5436411|P1|NOT COMPLETED|Overall Study||0
2217131|NCT02920918|5436410|P2|COMPLETED|Overall Study||19
2217132|NCT02920918|5436411|P1|COMPLETED|Overall Study||17
2217133|NCT02920918|5436410|P2|STARTED|Overall Study||19
2217134|NCT02920918|5436411|P1|STARTED|Overall Study||17
2217135|NCT02920749|5436423|P4|NOT COMPLETED|Overall Study||0
2217136|NCT02920749|5436424|P3|NOT COMPLETED|Overall Study||0
2217137|NCT02920749|5436425|P2|NOT COMPLETED|Overall Study||0
2217138|NCT02920749|5436426|P1|NOT COMPLETED|Overall Study||0
2217139|NCT02920749|5436423|P4|COMPLETED|Overall Study||30
2217140|NCT02920749|5436424|P3|COMPLETED|Overall Study||30
2217141|NCT02920749|5436425|P2|COMPLETED|Overall Study||30
2217142|NCT02920749|5436426|P1|COMPLETED|Overall Study||30
2217143|NCT02920749|5436423|P4|STARTED|Overall Study||30
2217144|NCT02920749|5436424|P3|STARTED|Overall Study||30
2217145|NCT02920749|5436425|P2|STARTED|Overall Study||30
2217146|NCT02920749|5436426|P1|STARTED|Overall Study||30
2217147|NCT02920476|5436440|P1|NOT COMPLETED|Overall Study||1
2217148|NCT02920476|5436440|P1|COMPLETED|Overall Study||3
2217149|NCT02920476|5436440|P1|STARTED|Overall Study||4
2217150|NCT02920450|5436445|P4|NOT COMPLETED|Overall Study||0
2217151|NCT02920450|5436446|P3|NOT COMPLETED|Overall Study||0
2217152|NCT02920450|5436447|P2|NOT COMPLETED|Overall Study||0
2217153|NCT02920450|5436448|P1|NOT COMPLETED|Overall Study||2
2217154|NCT02920450|5436445|P4|COMPLETED|Overall Study||0
2217155|NCT02920450|5436446|P3|COMPLETED|Overall Study||0
2217156|NCT02920450|5436447|P2|COMPLETED|Overall Study||0
2217157|NCT02920450|5436448|P1|COMPLETED|Overall Study||1
2217158|NCT02920450|5436445|P4|STARTED|Overall Study||0
2217159|NCT02920450|5436446|P3|STARTED|Overall Study||0
2217160|NCT02920450|5436447|P2|STARTED|Overall Study||0
2217161|NCT02920450|5436448|P1|STARTED|Overall Study||3
2217162|NCT02920242|5436459|P3|NOT COMPLETED|Overall Study||1
2217163|NCT02920242|5436460|P2|NOT COMPLETED|Overall Study||0
2217164|NCT02920242|5436461|P1|NOT COMPLETED|Overall Study||2
2217165|NCT02920242|5436459|P3|COMPLETED|Overall Study||3
2217166|NCT02920242|5436460|P2|COMPLETED|Overall Study||11
2217167|NCT02920242|5436461|P1|COMPLETED|Overall Study||11
2217168|NCT02920242|5436459|P3|Safety Set|Overall Study||4
2217169|NCT02920242|5436460|P2|Safety Set|Overall Study||11
2217170|NCT02920242|5436461|P1|Safety Set|Overall Study||12
2217171|NCT02920242|5436459|P3|STARTED|Overall Study||4
2217172|NCT02920242|5436460|P2|STARTED|Overall Study||11
2217173|NCT02920242|5436461|P1|STARTED|Overall Study||13
2217174|NCT02919995|5436493|P6|NOT COMPLETED|Overall Study||1
2217175|NCT02919995|5436494|P5|NOT COMPLETED|Overall Study||0
2217176|NCT02919995|5436495|P4|NOT COMPLETED|Overall Study||0
2217177|NCT02919995|5436496|P3|NOT COMPLETED|Overall Study||0
2217178|NCT02919995|5436497|P2|NOT COMPLETED|Overall Study||0
2217179|NCT02919995|5436498|P1|NOT COMPLETED|Overall Study||0
2217180|NCT02919995|5436493|P6|COMPLETED|Overall Study||1
2217181|NCT02919995|5436494|P5|COMPLETED|Overall Study||1
2217182|NCT02919995|5436495|P4|COMPLETED|Overall Study||2
2217183|NCT02919995|5436496|P3|COMPLETED|Overall Study||2
2217184|NCT02919995|5436497|P2|COMPLETED|Overall Study||2
2217185|NCT02919995|5436498|P1|COMPLETED|Overall Study||1
2217186|NCT02919995|5436493|P6|STARTED|Overall Study||2
2217187|NCT02919995|5436494|P5|STARTED|Overall Study||1
2217188|NCT02919995|5436495|P4|STARTED|Overall Study||2
2217189|NCT02919995|5436496|P3|STARTED|Overall Study||2
2217190|NCT02919995|5436497|P2|STARTED|Overall Study||2
2217191|NCT02919995|5436498|P1|STARTED|Overall Study||1
2217192|NCT02919813|5436525|P2|NOT COMPLETED|Overall Study||0
2217193|NCT02919813|5436526|P1|NOT COMPLETED|Overall Study||0
2217194|NCT02919813|5436525|P2|COMPLETED|Overall Study||17
2217195|NCT02919813|5436526|P1|COMPLETED|Overall Study||14
2217196|NCT02919813|5436525|P2|STARTED|Overall Study||17
2217197|NCT02919813|5436526|P1|STARTED|Overall Study||14
2217198|NCT02919657|5436544|P2|NOT COMPLETED|Overall Study||0
2217199|NCT02919657|5436545|P1|NOT COMPLETED|Overall Study||0
2217200|NCT02919657|5436544|P2|COMPLETED|Overall Study|completed with the same initial 10 participants|10
2217201|NCT02919657|5436545|P1|COMPLETED|Overall Study|completed with the same initial 10 participants|10
2217202|NCT02919657|5436544|P2|STARTED|Overall Study|10 Participants|10
2217203|NCT02919657|5436545|P1|STARTED|Overall Study|10 Participants|10
2217204|NCT02919618|5436551|P1|NOT COMPLETED|Overall Study||1
2217205|NCT02919618|5436551|P1|COMPLETED|Overall Study||18
2217206|NCT02919618|5436551|P1|Primary Efficacy Endpoint (6 Months)|Overall Study||18
2217207|NCT02919618|5436551|P1|Primary Safety Endpoint (</=90 Days)|Overall Study||19
2217208|NCT02919618|5436551|P1|STARTED|Overall Study||19
2217209|NCT02919423|5436570|P2|NOT COMPLETED|Overall Study||9
2217210|NCT02919423|5436571|P1|NOT COMPLETED|Overall Study||2
2217211|NCT02919423|5436570|P2|COMPLETED|Overall Study||16
2217212|NCT02919423|5436571|P1|COMPLETED|Overall Study||4
2217213|NCT02919423|5436570|P2|STARTED|Overall Study||25
2217214|NCT02919423|5436571|P1|STARTED|Overall Study||6
2217215|NCT02919267|5436581|P4|NOT COMPLETED|Overall Study||4
2217216|NCT02919267|5436582|P3|NOT COMPLETED|Overall Study||3
2217217|NCT02919267|5436583|P2|NOT COMPLETED|Overall Study||3
2217218|NCT02919267|5436584|P1|NOT COMPLETED|Overall Study||0
2217219|NCT02919267|5436581|P4|COMPLETED|Overall Study||10
2217220|NCT02919267|5436582|P3|COMPLETED|Overall Study||10
2217221|NCT02919267|5436583|P2|COMPLETED|Overall Study||9
2217222|NCT02919267|5436584|P1|COMPLETED|Overall Study||10
2217223|NCT02919267|5436581|P4|STARTED|Overall Study||14
2217224|NCT02919267|5436582|P3|STARTED|Overall Study||13
2217225|NCT02919267|5436583|P2|STARTED|Overall Study||12
2217226|NCT02919267|5436584|P1|STARTED|Overall Study||10
2217227|NCT02919007|5436594|P1|NOT COMPLETED|Overall Study||0
2217228|NCT02919007|5436594|P1|COMPLETED|Overall Study||25
2217229|NCT02919007|5436594|P1|STARTED|Overall Study||25
2217230|NCT02918773|5436600|P2|NOT COMPLETED|Overall Study||0
2217231|NCT02918773|5436601|P1|NOT COMPLETED|Overall Study||0
2217232|NCT02918773|5436600|P2|COMPLETED|Overall Study||11
2217233|NCT02918773|5436601|P1|COMPLETED|Overall Study||11
2217234|NCT02918773|5436600|P2|STARTED|Overall Study||11
2217235|NCT02918773|5436601|P1|STARTED|Overall Study||11
2217239|NCT02918656|5436622|P3|NOT COMPLETED|Overall Study||0
2217240|NCT02918656|5436623|P2|NOT COMPLETED|Overall Study||0
2217241|NCT02918656|5436624|P1|NOT COMPLETED|Overall Study||0
2217242|NCT02918656|5436622|P3|COMPLETED|Overall Study||57
2217243|NCT02918656|5436623|P2|COMPLETED|Overall Study||60
2217244|NCT02918656|5436624|P1|COMPLETED|Overall Study||54
2217245|NCT02918656|5436622|P3|STARTED|Overall Study||57
2217246|NCT02918656|5436623|P2|STARTED|Overall Study||60
2217247|NCT02918656|5436624|P1|STARTED|Overall Study||54
2217248|NCT02918630|5436643|P2|NOT COMPLETED|Overall Study||0
2217249|NCT02918630|5436644|P1|NOT COMPLETED|Overall Study||0
2217250|NCT02918630|5436643|P2|COMPLETED|Overall Study||3
2217251|NCT02918630|5436644|P1|COMPLETED|Overall Study||4
2217252|NCT02918630|5436643|P2|STARTED|Overall Study||3
2217253|NCT02918630|5436644|P1|STARTED|Overall Study||4
2217254|NCT02918617|5436667|P9|NOT COMPLETED|Overall Study||0
2217255|NCT02918617|5436668|P8|NOT COMPLETED|Overall Study||1
2217256|NCT02918617|5436669|P7|NOT COMPLETED|Overall Study||0
2217257|NCT02918617|5436670|P6|NOT COMPLETED|Overall Study||0
2217258|NCT02918617|5436671|P5|NOT COMPLETED|Overall Study||0
2217259|NCT02918617|5436672|P4|NOT COMPLETED|Overall Study||0
2217260|NCT02918617|5436673|P3|NOT COMPLETED|Overall Study||3
2217261|NCT02918617|5436674|P2|NOT COMPLETED|Overall Study||0
2217262|NCT02918617|5436675|P1|NOT COMPLETED|Overall Study||1
2217263|NCT02918617|5436667|P9|COMPLETED|Overall Study||26
2217264|NCT02918617|5436668|P8|COMPLETED|Overall Study||25
2217265|NCT02918617|5436669|P7|COMPLETED|Overall Study||22
2217266|NCT02918617|5436670|P6|COMPLETED|Overall Study||20
2217267|NCT02918617|5436671|P5|COMPLETED|Overall Study||24
2217268|NCT02918617|5436672|P4|COMPLETED|Overall Study||22
2217269|NCT02918617|5436673|P3|COMPLETED|Overall Study||19
2217270|NCT02918617|5436674|P2|COMPLETED|Overall Study||20
2217271|NCT02918617|5436675|P1|COMPLETED|Overall Study||20
2217272|NCT02918617|5436667|P9|STARTED|Overall Study||26
2217273|NCT02918617|5436668|P8|STARTED|Overall Study||26
2217274|NCT02918617|5436669|P7|STARTED|Overall Study||22
2217275|NCT02918617|5436670|P6|STARTED|Overall Study||20
2217276|NCT02918617|5436671|P5|STARTED|Overall Study||24
2217277|NCT02918617|5436672|P4|STARTED|Overall Study||22
2217278|NCT02918617|5436673|P3|STARTED|Overall Study||22
2217279|NCT02918617|5436674|P2|STARTED|Overall Study||20
2217280|NCT02918617|5436675|P1|STARTED|Overall Study||21
2217281|NCT02918552|5436724|P2|NOT COMPLETED|Overall Study||2
2217282|NCT02918552|5436725|P1|NOT COMPLETED|Overall Study||1
2217283|NCT02918552|5436724|P2|COMPLETED|Overall Study||6
2217284|NCT02918552|5436725|P1|COMPLETED|Overall Study||6
2217285|NCT02918552|5436724|P2|STARTED|Overall Study||8
2217286|NCT02918552|5436725|P1|STARTED|Overall Study||7
2217287|NCT02918396|5436762|P3|NOT COMPLETED|Overall Study||0
2217288|NCT02918396|5436763|P2|NOT COMPLETED|Overall Study||0
2217289|NCT02918396|5436764|P1|NOT COMPLETED|Overall Study||0
2217290|NCT02918396|5436762|P3|COMPLETED|Overall Study||2
2217291|NCT02918396|5436763|P2|COMPLETED|Overall Study||1
2217292|NCT02918396|5436764|P1|COMPLETED|Overall Study||2
2217293|NCT02918396|5436762|P3|STARTED|Overall Study||2
2217294|NCT02918396|5436763|P2|STARTED|Overall Study||1
2217295|NCT02918396|5436764|P1|STARTED|Overall Study||2
2217296|NCT02918357|5436772|P1|NOT COMPLETED|Overall Study||0
2217297|NCT02918357|5436772|P1|COMPLETED|Overall Study||385
2217298|NCT02918357|5436772|P1|PET/CT Scan|Overall Study||385
2217299|NCT02918357|5436772|P1|Investigational Drug Administration|Overall Study||385
2217300|NCT02918357|5436772|P1|STARTED|Overall Study||385
2217301|NCT02918266|5436808|P11|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
2217302|NCT02918266|5436809|P10|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
2217303|NCT02918266|5436810|P9|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
2217304|NCT02918266|5436811|P8|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
2217305|NCT02918266|5436812|P7|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
2217306|NCT02918266|5436813|P6|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
2217307|NCT02918266|5436814|P5|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
2217611|NCT02918266|5436810|P9|COMPLETED|Part 1||0
2217308|NCT02918266|5436815|P4|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
2217309|NCT02918266|5436816|P3|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
2217310|NCT02918266|5436817|P2|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
2217311|NCT02918266|5436818|P1|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
2217312|NCT02918266|5436808|P11|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
2217313|NCT02918266|5436809|P10|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
2217314|NCT02918266|5436810|P9|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
2217315|NCT02918266|5436811|P8|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
2217316|NCT02918266|5436812|P7|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
2217317|NCT02918266|5436813|P6|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
2217318|NCT02918266|5436814|P5|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
2217319|NCT02918266|5436815|P4|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
2217320|NCT02918266|5436816|P3|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
2217321|NCT02918266|5436817|P2|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
2217322|NCT02918266|5436818|P1|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
2217323|NCT02918266|5436808|P11|STARTED|Part 2: Intervention Period 5 (2 Days)||0
2217324|NCT02918266|5436809|P10|STARTED|Part 2: Intervention Period 5 (2 Days)||0
2217325|NCT02918266|5436810|P9|STARTED|Part 2: Intervention Period 5 (2 Days)||0
2217326|NCT02918266|5436811|P8|STARTED|Part 2: Intervention Period 5 (2 Days)||0
2217327|NCT02918266|5436812|P7|STARTED|Part 2: Intervention Period 5 (2 Days)||0
2217328|NCT02918266|5436813|P6|STARTED|Part 2: Intervention Period 5 (2 Days)||0
2217329|NCT02918266|5436814|P5|STARTED|Part 2: Intervention Period 5 (2 Days)||0
2217330|NCT02918266|5436815|P4|STARTED|Part 2: Intervention Period 5 (2 Days)||0
2217331|NCT02918266|5436816|P3|STARTED|Part 2: Intervention Period 5 (2 Days)||0
2217332|NCT02918266|5436817|P2|STARTED|Part 2: Intervention Period 5 (2 Days)||0
2217333|NCT02918266|5436818|P1|STARTED|Part 2: Intervention Period 5 (2 Days)||0
2217334|NCT02918266|5436808|P11|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
2217335|NCT02918266|5436809|P10|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
2217336|NCT02918266|5436810|P9|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
2217337|NCT02918266|5436811|P8|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
2217338|NCT02918266|5436812|P7|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
2217339|NCT02918266|5436813|P6|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
2217340|NCT02918266|5436814|P5|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
2217341|NCT02918266|5436815|P4|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
2217342|NCT02918266|5436816|P3|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
2217343|NCT02918266|5436817|P2|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
2217344|NCT02918266|5436818|P1|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
2217345|NCT02918266|5436808|P11|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
2217346|NCT02918266|5436809|P10|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
2217347|NCT02918266|5436810|P9|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
2217348|NCT02918266|5436811|P8|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
2217349|NCT02918266|5436812|P7|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
2217350|NCT02918266|5436813|P6|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
2217351|NCT02918266|5436814|P5|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
2217352|NCT02918266|5436815|P4|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
2217353|NCT02918266|5436816|P3|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
2217354|NCT02918266|5436817|P2|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
2217355|NCT02918266|5436818|P1|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
2217356|NCT02918266|5436808|P11|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
2217357|NCT02918266|5436809|P10|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
2217358|NCT02918266|5436810|P9|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
2217359|NCT02918266|5436811|P8|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
2217360|NCT02918266|5436812|P7|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
2217361|NCT02918266|5436813|P6|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
2217362|NCT02918266|5436814|P5|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
2217363|NCT02918266|5436815|P4|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
2217364|NCT02918266|5436816|P3|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
2217365|NCT02918266|5436817|P2|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
2217366|NCT02918266|5436818|P1|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
2217367|NCT02918266|5436808|P11|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
2217368|NCT02918266|5436809|P10|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
2217369|NCT02918266|5436810|P9|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
2217370|NCT02918266|5436811|P8|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
2217371|NCT02918266|5436812|P7|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
2217372|NCT02918266|5436813|P6|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
2217373|NCT02918266|5436814|P5|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
2217374|NCT02918266|5436815|P4|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
2217375|NCT02918266|5436816|P3|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
2217376|NCT02918266|5436817|P2|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
2217377|NCT02918266|5436818|P1|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
2217378|NCT02918266|5436808|P11|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
2217379|NCT02918266|5436809|P10|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
2217380|NCT02918266|5436810|P9|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
2217381|NCT02918266|5436811|P8|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
2217382|NCT02918266|5436812|P7|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
2217383|NCT02918266|5436813|P6|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
2217384|NCT02918266|5436814|P5|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
2217385|NCT02918266|5436815|P4|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
2217386|NCT02918266|5436816|P3|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
2217387|NCT02918266|5436817|P2|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
2217388|NCT02918266|5436818|P1|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
2217389|NCT02918266|5436808|P11|STARTED|Part 2: Intervention Period 4 (2 Days)||0
2217390|NCT02918266|5436809|P10|STARTED|Part 2: Intervention Period 4 (2 Days)||0
2217391|NCT02918266|5436810|P9|STARTED|Part 2: Intervention Period 4 (2 Days)||0
2217392|NCT02918266|5436811|P8|STARTED|Part 2: Intervention Period 4 (2 Days)||0
2217393|NCT02918266|5436812|P7|STARTED|Part 2: Intervention Period 4 (2 Days)||0
2217394|NCT02918266|5436813|P6|STARTED|Part 2: Intervention Period 4 (2 Days)||0
2217395|NCT02918266|5436814|P5|STARTED|Part 2: Intervention Period 4 (2 Days)||0
2217396|NCT02918266|5436815|P4|STARTED|Part 2: Intervention Period 4 (2 Days)||0
2217397|NCT02918266|5436816|P3|STARTED|Part 2: Intervention Period 4 (2 Days)||0
2217398|NCT02918266|5436817|P2|STARTED|Part 2: Intervention Period 4 (2 Days)||0
2217399|NCT02918266|5436818|P1|STARTED|Part 2: Intervention Period 4 (2 Days)||0
2217400|NCT02918266|5436808|P11|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
2217401|NCT02918266|5436809|P10|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
2217402|NCT02918266|5436810|P9|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
2217403|NCT02918266|5436811|P8|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
2217404|NCT02918266|5436812|P7|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
2217405|NCT02918266|5436813|P6|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
2217406|NCT02918266|5436814|P5|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
2217407|NCT02918266|5436815|P4|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
2217408|NCT02918266|5436816|P3|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
2217409|NCT02918266|5436817|P2|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
2217410|NCT02918266|5436818|P1|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
2217411|NCT02918266|5436808|P11|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
2217412|NCT02918266|5436809|P10|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
2217413|NCT02918266|5436810|P9|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
2217414|NCT02918266|5436811|P8|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
2217415|NCT02918266|5436812|P7|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
2217416|NCT02918266|5436813|P6|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
2217417|NCT02918266|5436814|P5|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
2217418|NCT02918266|5436815|P4|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
2217419|NCT02918266|5436816|P3|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
2217420|NCT02918266|5436817|P2|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
2217421|NCT02918266|5436818|P1|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
2217422|NCT02918266|5436808|P11|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
2217423|NCT02918266|5436809|P10|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
2217424|NCT02918266|5436810|P9|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
2217425|NCT02918266|5436811|P8|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
2217426|NCT02918266|5436812|P7|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
2217427|NCT02918266|5436813|P6|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
2217428|NCT02918266|5436814|P5|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
2217429|NCT02918266|5436815|P4|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
2217430|NCT02918266|5436816|P3|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
2217431|NCT02918266|5436817|P2|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
2217432|NCT02918266|5436818|P1|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
2217433|NCT02918266|5436808|P11|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
2217434|NCT02918266|5436809|P10|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
2217435|NCT02918266|5436810|P9|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
2217436|NCT02918266|5436811|P8|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
2217437|NCT02918266|5436812|P7|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
2217438|NCT02918266|5436813|P6|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
2217439|NCT02918266|5436814|P5|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
2217440|NCT02918266|5436815|P4|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
2217441|NCT02918266|5436816|P3|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
2217442|NCT02918266|5436817|P2|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
2217443|NCT02918266|5436818|P1|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
2217444|NCT02918266|5436808|P11|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
2217445|NCT02918266|5436809|P10|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
2217446|NCT02918266|5436810|P9|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
2217447|NCT02918266|5436811|P8|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
2217448|NCT02918266|5436812|P7|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
2217449|NCT02918266|5436813|P6|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
2217450|NCT02918266|5436814|P5|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
2217451|NCT02918266|5436815|P4|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
2217452|NCT02918266|5436816|P3|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
2217453|NCT02918266|5436817|P2|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
2217454|NCT02918266|5436818|P1|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
2217455|NCT02918266|5436808|P11|STARTED|Part 2: Intervention Period 3 (2 Days)||0
2217456|NCT02918266|5436809|P10|STARTED|Part 2: Intervention Period 3 (2 Days)||0
2217457|NCT02918266|5436810|P9|STARTED|Part 2: Intervention Period 3 (2 Days)||0
2217458|NCT02918266|5436811|P8|STARTED|Part 2: Intervention Period 3 (2 Days)||0
2217459|NCT02918266|5436812|P7|STARTED|Part 2: Intervention Period 3 (2 Days)||0
2217460|NCT02918266|5436813|P6|STARTED|Part 2: Intervention Period 3 (2 Days)||0
2217461|NCT02918266|5436814|P5|STARTED|Part 2: Intervention Period 3 (2 Days)||0
2217462|NCT02918266|5436815|P4|STARTED|Part 2: Intervention Period 3 (2 Days)||0
2217463|NCT02918266|5436816|P3|STARTED|Part 2: Intervention Period 3 (2 Days)||0
2217464|NCT02918266|5436817|P2|STARTED|Part 2: Intervention Period 3 (2 Days)||0
2217465|NCT02918266|5436818|P1|STARTED|Part 2: Intervention Period 3 (2 Days)||0
2217466|NCT02918266|5436808|P11|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
2217467|NCT02918266|5436809|P10|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
2217468|NCT02918266|5436810|P9|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
2217469|NCT02918266|5436811|P8|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
2217470|NCT02918266|5436812|P7|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
2217471|NCT02918266|5436813|P6|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
2217472|NCT02918266|5436814|P5|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
2217473|NCT02918266|5436815|P4|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
2217474|NCT02918266|5436816|P3|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
2217475|NCT02918266|5436817|P2|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
2217476|NCT02918266|5436818|P1|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
2217477|NCT02918266|5436808|P11|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
2217478|NCT02918266|5436809|P10|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
2217479|NCT02918266|5436810|P9|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
2217480|NCT02918266|5436811|P8|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
2217481|NCT02918266|5436812|P7|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
2217482|NCT02918266|5436813|P6|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
2217483|NCT02918266|5436814|P5|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
2217484|NCT02918266|5436815|P4|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
2217485|NCT02918266|5436816|P3|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
2217486|NCT02918266|5436817|P2|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
2217487|NCT02918266|5436818|P1|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
2217488|NCT02918266|5436808|P11|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
2217489|NCT02918266|5436809|P10|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
2217490|NCT02918266|5436810|P9|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
2217491|NCT02918266|5436811|P8|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
2217492|NCT02918266|5436812|P7|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
2217493|NCT02918266|5436813|P6|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
2217494|NCT02918266|5436814|P5|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
2217495|NCT02918266|5436815|P4|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
2217496|NCT02918266|5436816|P3|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
2217497|NCT02918266|5436817|P2|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
2217498|NCT02918266|5436818|P1|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
2217499|NCT02918266|5436808|P11|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
2217500|NCT02918266|5436809|P10|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
2217501|NCT02918266|5436810|P9|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
2217502|NCT02918266|5436811|P8|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
2217503|NCT02918266|5436812|P7|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
2217504|NCT02918266|5436813|P6|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
2217505|NCT02918266|5436814|P5|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
2217506|NCT02918266|5436815|P4|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
2217507|NCT02918266|5436816|P3|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
2217508|NCT02918266|5436817|P2|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
2217509|NCT02918266|5436818|P1|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
2217510|NCT02918266|5436808|P11|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
2217511|NCT02918266|5436809|P10|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
2217512|NCT02918266|5436810|P9|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
2217513|NCT02918266|5436811|P8|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
2217514|NCT02918266|5436812|P7|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
2217515|NCT02918266|5436813|P6|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
2217516|NCT02918266|5436814|P5|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
2217517|NCT02918266|5436815|P4|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
2217518|NCT02918266|5436816|P3|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
2217519|NCT02918266|5436817|P2|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
2217520|NCT02918266|5436818|P1|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
2217521|NCT02918266|5436808|P11|STARTED|Part 2: Intervention Period 2 (2 Days)||0
2217522|NCT02918266|5436809|P10|STARTED|Part 2: Intervention Period 2 (2 Days)||0
2217523|NCT02918266|5436810|P9|STARTED|Part 2: Intervention Period 2 (2 Days)||0
2217524|NCT02918266|5436811|P8|STARTED|Part 2: Intervention Period 2 (2 Days)||0
2217525|NCT02918266|5436812|P7|STARTED|Part 2: Intervention Period 2 (2 Days)||0
2217526|NCT02918266|5436813|P6|STARTED|Part 2: Intervention Period 2 (2 Days)||0
2217527|NCT02918266|5436814|P5|STARTED|Part 2: Intervention Period 2 (2 Days)||0
2217528|NCT02918266|5436815|P4|STARTED|Part 2: Intervention Period 2 (2 Days)||0
2217529|NCT02918266|5436816|P3|STARTED|Part 2: Intervention Period 2 (2 Days)||0
2217530|NCT02918266|5436817|P2|STARTED|Part 2: Intervention Period 2 (2 Days)||0
2217531|NCT02918266|5436818|P1|STARTED|Part 2: Intervention Period 2 (2 Days)||0
2217532|NCT02918266|5436808|P11|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
2217533|NCT02918266|5436809|P10|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
2217534|NCT02918266|5436810|P9|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
2217535|NCT02918266|5436811|P8|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
2217536|NCT02918266|5436812|P7|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
2217537|NCT02918266|5436813|P6|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
2217538|NCT02918266|5436814|P5|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
2217539|NCT02918266|5436815|P4|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
2217540|NCT02918266|5436816|P3|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
2217541|NCT02918266|5436817|P2|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
2217542|NCT02918266|5436818|P1|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
2217543|NCT02918266|5436808|P11|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
2217544|NCT02918266|5436809|P10|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
2217545|NCT02918266|5436810|P9|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
2217546|NCT02918266|5436811|P8|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
2217547|NCT02918266|5436812|P7|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
2217548|NCT02918266|5436813|P6|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
2217549|NCT02918266|5436814|P5|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
2217550|NCT02918266|5436815|P4|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
2217551|NCT02918266|5436816|P3|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
2217552|NCT02918266|5436817|P2|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
2217553|NCT02918266|5436818|P1|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
2217554|NCT02918266|5436808|P11|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
2217555|NCT02918266|5436809|P10|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
2217556|NCT02918266|5436810|P9|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
2217557|NCT02918266|5436811|P8|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
2217558|NCT02918266|5436812|P7|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
2217559|NCT02918266|5436813|P6|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
2217560|NCT02918266|5436814|P5|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
2217561|NCT02918266|5436815|P4|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
2217562|NCT02918266|5436816|P3|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
2217563|NCT02918266|5436817|P2|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
2217564|NCT02918266|5436818|P1|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
2217565|NCT02918266|5436808|P11|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
2217566|NCT02918266|5436809|P10|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
2217567|NCT02918266|5436810|P9|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||2
2217568|NCT02918266|5436811|P8|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
2217569|NCT02918266|5436812|P7|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||2
2217570|NCT02918266|5436813|P6|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
2217571|NCT02918266|5436814|P5|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
2217572|NCT02918266|5436815|P4|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
2217573|NCT02918266|5436816|P3|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
2217574|NCT02918266|5436817|P2|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
2217575|NCT02918266|5436818|P1|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
2217576|NCT02918266|5436808|P11|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
2217577|NCT02918266|5436809|P10|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
2217578|NCT02918266|5436810|P9|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
2217579|NCT02918266|5436811|P8|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
2217580|NCT02918266|5436812|P7|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
2217581|NCT02918266|5436813|P6|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
2217582|NCT02918266|5436814|P5|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
2217583|NCT02918266|5436815|P4|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
2217584|NCT02918266|5436816|P3|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
2217585|NCT02918266|5436817|P2|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
2217586|NCT02918266|5436818|P1|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
2217587|NCT02918266|5436808|P11|STARTED|Part 2: Intervention Period 1 (2 Days)||1
2217588|NCT02918266|5436809|P10|STARTED|Part 2: Intervention Period 1 (2 Days)||1
2217589|NCT02918266|5436810|P9|STARTED|Part 2: Intervention Period 1 (2 Days)||2
2217590|NCT02918266|5436811|P8|STARTED|Part 2: Intervention Period 1 (2 Days)||1
2217591|NCT02918266|5436812|P7|STARTED|Part 2: Intervention Period 1 (2 Days)||2
2217592|NCT02918266|5436813|P6|STARTED|Part 2: Intervention Period 1 (2 Days)||1
2217593|NCT02918266|5436814|P5|STARTED|Part 2: Intervention Period 1 (2 Days)||1
2217594|NCT02918266|5436815|P4|STARTED|Part 2: Intervention Period 1 (2 Days)||1
2217595|NCT02918266|5436816|P3|STARTED|Part 2: Intervention Period 1 (2 Days)||1
2217596|NCT02918266|5436817|P2|STARTED|Part 2: Intervention Period 1 (2 Days)||1
2217597|NCT02918266|5436818|P1|STARTED|Part 2: Intervention Period 1 (2 Days)||0
2217598|NCT02918266|5436808|P11|NOT COMPLETED|Part 1||0
2217599|NCT02918266|5436809|P10|NOT COMPLETED|Part 1||0
2217600|NCT02918266|5436810|P9|NOT COMPLETED|Part 1||0
2217601|NCT02918266|5436811|P8|NOT COMPLETED|Part 1||0
2217602|NCT02918266|5436812|P7|NOT COMPLETED|Part 1||0
2217603|NCT02918266|5436813|P6|NOT COMPLETED|Part 1||0
2217604|NCT02918266|5436814|P5|NOT COMPLETED|Part 1||0
2217605|NCT02918266|5436815|P4|NOT COMPLETED|Part 1||0
2217606|NCT02918266|5436816|P3|NOT COMPLETED|Part 1||0
2217607|NCT02918266|5436817|P2|NOT COMPLETED|Part 1||0
2217608|NCT02918266|5436818|P1|NOT COMPLETED|Part 1||0
2217609|NCT02918266|5436808|P11|COMPLETED|Part 1||0
2217610|NCT02918266|5436809|P10|COMPLETED|Part 1||0
2217612|NCT02918266|5436811|P8|COMPLETED|Part 1||0
2217613|NCT02918266|5436812|P7|COMPLETED|Part 1||0
2217614|NCT02918266|5436813|P6|COMPLETED|Part 1||0
2217615|NCT02918266|5436814|P5|COMPLETED|Part 1||0
2217616|NCT02918266|5436815|P4|COMPLETED|Part 1||0
2217617|NCT02918266|5436816|P3|COMPLETED|Part 1||0
2217618|NCT02918266|5436817|P2|COMPLETED|Part 1||0
2217619|NCT02918266|5436818|P1|COMPLETED|Part 1||6
2217620|NCT02918266|5436808|P11|STARTED|Part 1||0
2217621|NCT02918266|5436809|P10|STARTED|Part 1||0
2217622|NCT02918266|5436810|P9|STARTED|Part 1||0
2217623|NCT02918266|5436811|P8|STARTED|Part 1||0
2217624|NCT02918266|5436812|P7|STARTED|Part 1||0
2217625|NCT02918266|5436813|P6|STARTED|Part 1||0
2217626|NCT02918266|5436814|P5|STARTED|Part 1||0
2217627|NCT02918266|5436815|P4|STARTED|Part 1||0
2217628|NCT02918266|5436816|P3|STARTED|Part 1||0
2217629|NCT02918266|5436817|P2|STARTED|Part 1||0
2217630|NCT02918266|5436818|P1|STARTED|Part 1||6
2217631|NCT02918071|5436917|P1|NOT COMPLETED|Overall Study||3
2217632|NCT02918071|5436917|P1|COMPLETED|Overall Study||118
2217633|NCT02918071|5436917|P1|STARTED|Overall Study||121
2217634|NCT02917642|5436929|P2|NOT COMPLETED|Overall Study||0
2217635|NCT02917642|5436930|P1|NOT COMPLETED|Overall Study||0
2217636|NCT02917642|5436929|P2|COMPLETED|Overall Study||25
2217637|NCT02917642|5436930|P1|COMPLETED|Overall Study||25
2217638|NCT02917642|5436929|P2|STARTED|Overall Study||25
2217639|NCT02917642|5436930|P1|STARTED|Overall Study||25
2217640|NCT02917603|5436940|P2|NOT COMPLETED|Overall Study||4
2217641|NCT02917603|5436941|P1|NOT COMPLETED|Overall Study||1
2217642|NCT02917603|5436940|P2|COMPLETED|Overall Study||16
2217643|NCT02917603|5436941|P1|COMPLETED|Overall Study||19
2217644|NCT02917603|5436940|P2|STARTED|Overall Study||20
2217645|NCT02917603|5436941|P1|STARTED|Overall Study||20
2217646|NCT02917265|5436955|P2|NOT COMPLETED|Overall Study||0
2217647|NCT02917265|5436956|P1|NOT COMPLETED|Overall Study||2
2217648|NCT02917265|5436955|P2|COMPLETED|Overall Study||2
2217649|NCT02917265|5436956|P1|COMPLETED|Overall Study||3
2217650|NCT02917265|5436955|P2|STARTED|Overall Study||2
2217651|NCT02917265|5436956|P1|STARTED|Overall Study||5
2217652|NCT02916745|5436970|P1|NOT COMPLETED|Overall Study||0
2217653|NCT02916745|5436970|P1|COMPLETED|Overall Study||5
2217654|NCT02916745|5436970|P1|STARTED|Overall Study||5
2217655|NCT02916498|5437002|P2|NOT COMPLETED|Second Intervention, 21 Days||0
2217656|NCT02916498|5437003|P1|NOT COMPLETED|Second Intervention, 21 Days||0
2217657|NCT02916498|5437002|P2|COMPLETED|Second Intervention, 21 Days||4
2217658|NCT02916498|5437003|P1|COMPLETED|Second Intervention, 21 Days||2
2217659|NCT02916498|5437002|P2|STARTED|Second Intervention, 21 Days||4
2217660|NCT02916498|5437003|P1|STARTED|Second Intervention, 21 Days||2
2217661|NCT02916498|5437002|P2|NOT COMPLETED|First Intervention, 21 Days||0
2217662|NCT02916498|5437003|P1|NOT COMPLETED|First Intervention, 21 Days||0
2217663|NCT02916498|5437002|P2|COMPLETED|First Intervention, 21 Days||4
2217664|NCT02916498|5437003|P1|COMPLETED|First Intervention, 21 Days||2
2217665|NCT02916498|5437002|P2|STARTED|First Intervention, 21 Days||4
2217666|NCT02916498|5437003|P1|STARTED|First Intervention, 21 Days||2
2217667|NCT02916407|5437011|P2|NOT COMPLETED|Overall Study||0
2217668|NCT02916407|5437012|P1|NOT COMPLETED|Overall Study||0
2217669|NCT02916407|5437011|P2|COMPLETED|Overall Study||28
2217670|NCT02916407|5437012|P1|COMPLETED|Overall Study||28
2217671|NCT02916407|5437011|P2|STARTED|Overall Study||28
2217672|NCT02916407|5437012|P1|STARTED|Overall Study||28
2217673|NCT02915978|5437023|P3|NOT COMPLETED|Overall Study||0
2217674|NCT02915978|5437024|P2|NOT COMPLETED|Overall Study||1
2217675|NCT02915978|5437025|P1|NOT COMPLETED|Overall Study||2
2217676|NCT02915978|5437023|P3|COMPLETED|Overall Study||15
2217677|NCT02915978|5437024|P2|COMPLETED|Overall Study||14
2217678|NCT02915978|5437025|P1|COMPLETED|Overall Study||13
2217679|NCT02915978|5437023|P3|STARTED|Overall Study||15
2217680|NCT02915978|5437024|P2|STARTED|Overall Study||15
2217681|NCT02915978|5437025|P1|STARTED|Overall Study||15
2217682|NCT02915874|5437077|P2|NOT COMPLETED|Overall Study||6
2217683|NCT02915874|5437078|P1|NOT COMPLETED|Overall Study||6
2217684|NCT02915874|5437077|P2|COMPLETED|Overall Study||22
2217685|NCT02915874|5437078|P1|COMPLETED|Overall Study||38
2217686|NCT02915874|5437077|P2|Week 6 Follow Up|Overall Study||26
2217687|NCT02915874|5437078|P1|Week 6 Follow Up|Overall Study||41
2217688|NCT02915874|5437077|P2|STARTED|Overall Study||28
2217689|NCT02915874|5437078|P1|STARTED|Overall Study||44
2217690|NCT02915835|5437098|P2|NOT COMPLETED|Overall Study||1
2217691|NCT02915835|5437099|P1|NOT COMPLETED|Overall Study||1
2217692|NCT02915835|5437098|P2|COMPLETED|Overall Study||7
2217693|NCT02915835|5437099|P1|COMPLETED|Overall Study||8
2217694|NCT02915835|5437098|P2|STARTED|Overall Study||8
2217695|NCT02915835|5437099|P1|STARTED|Overall Study||9
2217696|NCT02915705|5437225|P2|NOT COMPLETED|Long Term Extension Period||0
2217697|NCT02915705|5437226|P1|NOT COMPLETED|Long Term Extension Period||0
2217698|NCT02915705|5437225|P2|COMPLETED|Long Term Extension Period||25
2217699|NCT02915705|5437226|P1|COMPLETED|Long Term Extension Period||26
2217700|NCT02915705|5437225|P2|STARTED|Long Term Extension Period|4 participants did not enter the extension period|25
2217701|NCT02915705|5437226|P1|STARTED|Long Term Extension Period|6 participants did not enter the extension period|26
2217702|NCT02915705|5437225|P2|NOT COMPLETED|Treatment Period||0
2217703|NCT02915705|5437226|P1|NOT COMPLETED|Treatment Period||0
2217704|NCT02915705|5437225|P2|COMPLETED|Treatment Period||29
2217705|NCT02915705|5437226|P1|COMPLETED|Treatment Period||32
2217706|NCT02915705|5437225|P2|Completed Week 64|Treatment Period||29
2217707|NCT02915705|5437226|P1|Completed Week 64|Treatment Period||32
2217708|NCT02915705|5437225|P2|Completed Week 40|Treatment Period||29
2217709|NCT02915705|5437226|P1|Completed Week 40|Treatment Period||32
2217710|NCT02915705|5437225|P2|STARTED|Treatment Period||29
2217711|NCT02915705|5437226|P1|STARTED|Treatment Period||32
2217712|NCT02915302|5437299|P2|NOT COMPLETED|Overall Study||78
2217713|NCT02915302|5437300|P1|NOT COMPLETED|Overall Study||65
2217714|NCT02915302|5437299|P2|COMPLETED|Overall Study||917
2217715|NCT02915302|5437300|P1|COMPLETED|Overall Study||890
2217716|NCT02915302|5437299|P2|Vaccinated (Safety Analysis Set)|Overall Study||992
2217717|NCT02915302|5437300|P1|Vaccinated (Safety Analysis Set)|Overall Study||949
2217718|NCT02915302|5437299|P2|STARTED|Overall Study||995
2217719|NCT02915302|5437300|P1|STARTED|Overall Study||955
2217720|NCT02915159|5437312|P2|NOT COMPLETED|Overall Study||8
2217721|NCT02915159|5437313|P1|NOT COMPLETED|Overall Study||11
2217722|NCT02915159|5437312|P2|COMPLETED|Overall Study||87
2217723|NCT02915159|5437313|P1|COMPLETED|Overall Study||81
2217724|NCT02915159|5437312|P2|STARTED|Overall Study||95
2217725|NCT02915159|5437313|P1|STARTED|Overall Study||92
2217726|NCT02915029|5437395|P2|NOT COMPLETED|Overall Study||14
2217727|NCT02915029|5437396|P1|NOT COMPLETED|Overall Study||13
2217728|NCT02915029|5437395|P2|COMPLETED|Overall Study||48
2217729|NCT02915029|5437396|P1|COMPLETED|Overall Study||50
2217730|NCT02915029|5437395|P2|STARTED|Overall Study||62
2217731|NCT02915029|5437396|P1|STARTED|Overall Study||63
2217732|NCT02914275|5437442|P2|NOT COMPLETED|Overall Study||42
2217733|NCT02914275|5437443|P1|NOT COMPLETED|Overall Study||121
2217734|NCT02914275|5437442|P2|COMPLETED|Overall Study||521
2217735|NCT02914275|5437443|P1|COMPLETED|Overall Study||1566
2217736|NCT02914275|5437442|P2|Included in Clinical Database / FAS|Overall Study||563
2217737|NCT02914275|5437443|P1|Included in Clinical Database / FAS|Overall Study||1684
2217738|NCT02914275|5437442|P2|STARTED|Overall Study||563
2217739|NCT02914275|5437443|P1|STARTED|Overall Study||1687
2217740|NCT02914236|5437475|P1|NOT COMPLETED|Overall Study||1
2217741|NCT02914236|5437475|P1|COMPLETED|Overall Study||49
2217742|NCT02914236|5437475|P1|26-week Follow-up Visit|Overall Study||49
2217743|NCT02914236|5437475|P1|12-week Follow-up Visit|Overall Study||50
2217744|NCT02914236|5437475|P1|4-week Follow-up Visit|Overall Study||50
2217745|NCT02914236|5437475|P1|STARTED|Overall Study||50
2217746|NCT02914210|5437485|P2|NOT COMPLETED|Overall Study||9
2217747|NCT02914210|5437486|P1|NOT COMPLETED|Overall Study||10
2217748|NCT02914210|5437485|P2|COMPLETED|Overall Study||144
2217749|NCT02914210|5437486|P1|COMPLETED|Overall Study||143
2217750|NCT02914210|5437485|P2|STARTED|Overall Study||153
2217751|NCT02914210|5437486|P1|STARTED|Overall Study||153
2217752|NCT02914184|5437521|P4|NOT COMPLETED|Overall Study||11
2217753|NCT02914184|5437522|P3|NOT COMPLETED|Overall Study||17
2217754|NCT02914184|5437523|P2|NOT COMPLETED|Overall Study||13
2217755|NCT02914184|5437524|P1|NOT COMPLETED|Overall Study||14
2217756|NCT02914184|5437521|P4|COMPLETED|Overall Study||391
2217757|NCT02914184|5437522|P3|COMPLETED|Overall Study||385
2217758|NCT02914184|5437523|P2|COMPLETED|Overall Study||383
2217759|NCT02914184|5437524|P1|COMPLETED|Overall Study||386
2217760|NCT02914184|5437521|P4|STARTED|Overall Study||402
2217761|NCT02914184|5437522|P3|STARTED|Overall Study||402
2217762|NCT02914184|5437523|P2|STARTED|Overall Study||396
2217763|NCT02914184|5437524|P1|STARTED|Overall Study||400
2217764|NCT02914132|5437563|P1|NOT COMPLETED|Overall Study||0
2217765|NCT02914132|5437563|P1|COMPLETED|Overall Study||15
2217766|NCT02914132|5437563|P1|STARTED|Overall Study||15
2217767|NCT02914119|5437568|P1|NOT COMPLETED|Overall Study||0
2217768|NCT02914119|5437568|P1|COMPLETED|Overall Study||30430
2217769|NCT02914119|5437568|P1|STARTED|Overall Study||30430
2217770|NCT02913326|5437581|P2|NOT COMPLETED|Overall Study||2
2217771|NCT02913326|5437582|P1|NOT COMPLETED|Overall Study||1
2217772|NCT02913326|5437581|P2|COMPLETED|Overall Study||58
2217773|NCT02913326|5437582|P1|COMPLETED|Overall Study||59
2217774|NCT02913326|5437581|P2|STARTED|Overall Study||60
2217775|NCT02913326|5437582|P1|STARTED|Overall Study||60
2217776|NCT02913105|5437605|P3|NOT COMPLETED|Overall Study||7
2217777|NCT02913105|5437606|P2|NOT COMPLETED|Overall Study||5
2217778|NCT02913105|5437607|P1|NOT COMPLETED|Overall Study||15
2217779|NCT02913105|5437605|P3|COMPLETED|Overall Study||33
2217780|NCT02913105|5437606|P2|COMPLETED|Overall Study||39
2217781|NCT02913105|5437607|P1|COMPLETED|Overall Study||22
2217782|NCT02913105|5437605|P3|STARTED|Overall Study||40
2217783|NCT02913105|5437606|P2|STARTED|Overall Study||44
2217784|NCT02913105|5437607|P1|STARTED|Overall Study||37
2217785|NCT02912650|5437660|P4|NOT COMPLETED|Overall Study||5
2217786|NCT02912650|5437661|P3|NOT COMPLETED|Overall Study||2
2217787|NCT02912650|5437662|P2|NOT COMPLETED|Overall Study||0
2217788|NCT02912650|5437663|P1|NOT COMPLETED|Overall Study||1
2217789|NCT02912650|5437660|P4|COMPLETED|Overall Study||160
2217790|NCT02912650|5437661|P3|COMPLETED|Overall Study||173
2217791|NCT02912650|5437662|P2|COMPLETED|Overall Study||172
2217792|NCT02912650|5437663|P1|COMPLETED|Overall Study||55
2217793|NCT02912650|5437660|P4|STARTED|Overall Study||165
2217794|NCT02912650|5437661|P3|STARTED|Overall Study||175
2217795|NCT02912650|5437662|P2|STARTED|Overall Study||172
2217796|NCT02912650|5437663|P1|STARTED|Overall Study||56
2217797|NCT02912468|5437747|P2|NOT COMPLETED|Overall Study||5
2217798|NCT02912468|5437748|P1|NOT COMPLETED|Overall Study||9
2217799|NCT02912468|5437747|P2|COMPLETED|Overall Study||138
2217800|NCT02912468|5437748|P1|COMPLETED|Overall Study||124
2217801|NCT02912468|5437747|P2|Safety Population|Overall Study||143
2217802|NCT02912468|5437748|P1|Safety Population|Overall Study||132
2217803|NCT02912468|5437747|P2|Treated|Overall Study||142
2217804|NCT02912468|5437748|P1|Treated|Overall Study||133
2217805|NCT02912468|5437747|P2|STARTED|Overall Study||143
2217806|NCT02912468|5437748|P1|STARTED|Overall Study||133
2217807|NCT02912364|5437825|P2|NOT COMPLETED|Treatment 2||0
2217808|NCT02912364|5437826|P1|NOT COMPLETED|Treatment 2||1
2217809|NCT02912364|5437825|P2|COMPLETED|Treatment 2||11
2217810|NCT02912364|5437826|P1|COMPLETED|Treatment 2||12
2217811|NCT02912364|5437825|P2|Received Intervention|Treatment 2||11
2217812|NCT02912364|5437826|P1|Received Intervention|Treatment 2||12
2217813|NCT02912364|5437825|P2|STARTED|Treatment 2||11
2217814|NCT02912364|5437826|P1|STARTED|Treatment 2||13
2217815|NCT02912364|5437825|P2|NOT COMPLETED|Washout Period||0
2217816|NCT02912364|5437826|P1|NOT COMPLETED|Washout Period||0
2217817|NCT02912364|5437825|P2|COMPLETED|Washout Period||11
2217818|NCT02912364|5437826|P1|COMPLETED|Washout Period||13
2217819|NCT02912364|5437825|P2|STARTED|Washout Period||11
2217820|NCT02912364|5437826|P1|STARTED|Washout Period||13
2217821|NCT02912364|5437825|P2|NOT COMPLETED|Treatment 1||12
2217822|NCT02912364|5437826|P1|NOT COMPLETED|Treatment 1||10
2217823|NCT02912364|5437825|P2|COMPLETED|Treatment 1||11
2217824|NCT02912364|5437826|P1|COMPLETED|Treatment 1||13
2217825|NCT02912364|5437825|P2|Received Intervention|Treatment 1||18
2217826|NCT02912364|5437826|P1|Received Intervention|Treatment 1||18
2217827|NCT02912364|5437825|P2|STARTED|Treatment 1||23
2217828|NCT02912364|5437826|P1|STARTED|Treatment 1||23
2217835|NCT02911922|5437908|P2|NOT COMPLETED|Overall Study||0
2217836|NCT02911922|5437909|P1|NOT COMPLETED|Overall Study||0
2217837|NCT02911922|5437908|P2|COMPLETED|Overall Study||0
2217838|NCT02911922|5437909|P1|COMPLETED|Overall Study||1
2217839|NCT02911922|5437908|P2|STARTED|Overall Study||0
2217840|NCT02911922|5437909|P1|STARTED|Overall Study||1
2217841|NCT02911857|5437930|P3|NOT COMPLETED|Overall Study||0
2217842|NCT02911857|5437931|P2|NOT COMPLETED|Overall Study||0
2217843|NCT02911857|5437932|P1|NOT COMPLETED|Overall Study||0
2217844|NCT02911857|5437930|P3|COMPLETED|Overall Study||1
2217845|NCT02911857|5437931|P2|COMPLETED|Overall Study||1
2217846|NCT02911857|5437932|P1|COMPLETED|Overall Study||2
2217847|NCT02911857|5437930|P3|STARTED|Overall Study||1
2217848|NCT02911857|5437931|P2|STARTED|Overall Study||1
2217849|NCT02911857|5437932|P1|STARTED|Overall Study||2
2217850|NCT02911844|5437940|P1|NOT COMPLETED|Overall Study||0
2217851|NCT02911844|5437940|P1|COMPLETED|Overall Study||5
2217852|NCT02911844|5437940|P1|STARTED|Overall Study||5
2217853|NCT02911818|5437950|P5|NOT COMPLETED|12 Week Extension Study||1
2217854|NCT02911818|5437951|P4|NOT COMPLETED|12 Week Extension Study||0
2217855|NCT02911818|5437952|P3|NOT COMPLETED|12 Week Extension Study||0
2217856|NCT02911818|5437953|P2|NOT COMPLETED|12 Week Extension Study||0
2217857|NCT02911818|5437954|P1|NOT COMPLETED|12 Week Extension Study||0
2217858|NCT02911818|5437950|P5|COMPLETED|12 Week Extension Study||22
2217859|NCT02911818|5437951|P4|COMPLETED|12 Week Extension Study||22
2217860|NCT02911818|5437952|P3|COMPLETED|12 Week Extension Study||0
2217861|NCT02911818|5437953|P2|COMPLETED|12 Week Extension Study||0
2217862|NCT02911818|5437954|P1|COMPLETED|12 Week Extension Study||0
2217863|NCT02911818|5437950|P5|STARTED|12 Week Extension Study||23
2217864|NCT02911818|5437951|P4|STARTED|12 Week Extension Study||22
2217865|NCT02911818|5437952|P3|STARTED|12 Week Extension Study||0
2217866|NCT02911818|5437953|P2|STARTED|12 Week Extension Study||0
2217867|NCT02911818|5437954|P1|STARTED|12 Week Extension Study||0
2217868|NCT02911818|5437950|P5|NOT COMPLETED|52 Week Study||0
2217869|NCT02911818|5437951|P4|NOT COMPLETED|52 Week Study||0
2217870|NCT02911818|5437952|P3|NOT COMPLETED|52 Week Study||4
2217871|NCT02911818|5437953|P2|NOT COMPLETED|52 Week Study||5
2217872|NCT02911818|5437954|P1|NOT COMPLETED|52 Week Study||4
2217873|NCT02911818|5437950|P5|COMPLETED|52 Week Study||0
2217874|NCT02911818|5437951|P4|COMPLETED|52 Week Study||0
2217875|NCT02911818|5437952|P3|COMPLETED|52 Week Study||46
2217876|NCT02911818|5437953|P2|COMPLETED|52 Week Study||45
2217877|NCT02911818|5437954|P1|COMPLETED|52 Week Study||46
2217878|NCT02911818|5437950|P5|STARTED|52 Week Study||0
2217879|NCT02911818|5437951|P4|STARTED|52 Week Study||0
2217880|NCT02911818|5437952|P3|STARTED|52 Week Study||50
2217881|NCT02911818|5437953|P2|STARTED|52 Week Study||50
2217882|NCT02911818|5437954|P1|STARTED|52 Week Study||50
2217883|NCT02911753|5438049|P3|NOT COMPLETED|Overall Study||0
2217884|NCT02911753|5438050|P2|NOT COMPLETED|Overall Study||3
2217885|NCT02911753|5438051|P1|NOT COMPLETED|Overall Study||3
2217886|NCT02911753|5438049|P3|COMPLETED|Overall Study||10
2217887|NCT02911753|5438050|P2|COMPLETED|Overall Study||16
2217888|NCT02911753|5438051|P1|COMPLETED|Overall Study||18
2217889|NCT02911753|5438049|P3|STARTED|Overall Study||10
2217890|NCT02911753|5438050|P2|STARTED|Overall Study||19
2217891|NCT02911753|5438051|P1|STARTED|Overall Study||21
2217892|NCT02911688|5438079|P2|NOT COMPLETED|Second Intervention||0
2217893|NCT02911688|5438080|P1|NOT COMPLETED|Second Intervention||0
2217894|NCT02911688|5438079|P2|COMPLETED|Second Intervention||7
2217895|NCT02911688|5438080|P1|COMPLETED|Second Intervention||8
2217896|NCT02911688|5438079|P2|STARTED|Second Intervention||7
2217897|NCT02911688|5438080|P1|STARTED|Second Intervention||8
2217898|NCT02911688|5438079|P2|NOT COMPLETED|Washout||2
2217899|NCT02911688|5438080|P1|NOT COMPLETED|Washout||1
2217900|NCT02911688|5438079|P2|COMPLETED|Washout||7
2217901|NCT02911688|5438080|P1|COMPLETED|Washout||8
2217902|NCT02911688|5438079|P2|STARTED|Washout||9
2217903|NCT02911688|5438080|P1|STARTED|Washout||9
2217904|NCT02911688|5438079|P2|NOT COMPLETED|First Intervention||0
2217905|NCT02911688|5438080|P1|NOT COMPLETED|First Intervention||0
2217906|NCT02911688|5438079|P2|COMPLETED|First Intervention||9
2217907|NCT02911688|5438080|P1|COMPLETED|First Intervention||9
2217908|NCT02911688|5438079|P2|Received Intervention|First Intervention||9
2217909|NCT02911688|5438080|P1|Received Intervention|First Intervention||9
2217910|NCT02911688|5438079|P2|STARTED|First Intervention||9
2217911|NCT02911688|5438080|P1|STARTED|First Intervention||9
2217912|NCT02910739|5438104|P4|NOT COMPLETED|Overall Study||0
2217913|NCT02910739|5438105|P3|NOT COMPLETED|Overall Study||0
2217914|NCT02910739|5438106|P2|NOT COMPLETED|Overall Study||0
2217915|NCT02910739|5438107|P1|NOT COMPLETED|Overall Study||1
2217916|NCT02910739|5438104|P4|COMPLETED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
2217917|NCT02910739|5438105|P3|COMPLETED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
2217918|NCT02910739|5438106|P2|COMPLETED|Overall Study||8
2217919|NCT02910739|5438107|P1|COMPLETED|Overall Study||7
2217920|NCT02910739|5438104|P4|STARTED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
2217921|NCT02910739|5438105|P3|STARTED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
2217922|NCT02910739|5438106|P2|STARTED|Overall Study||8
2217923|NCT02910739|5438107|P1|STARTED|Overall Study||8
2217924|NCT02910713|5438133|P1|NOT COMPLETED|Overall Study||42
2217925|NCT02910713|5438133|P1|COMPLETED|Overall Study|Completed=Completed both Intranasal and Extranasal applications.|143
2217926|NCT02910713|5438133|P1|Safety Population: Entered CAE|Overall Study||171
2217927|NCT02910713|5438133|P1|STARTED|Overall Study||185
2217928|NCT02910362|5438142|P2|NOT COMPLETED|Overall Study||0
2217929|NCT02910362|5438143|P1|NOT COMPLETED|Overall Study||0
2217930|NCT02910362|5438142|P2|COMPLETED|Overall Study||7
2217931|NCT02910362|5438143|P1|COMPLETED|Overall Study||8
2217932|NCT02910362|5438142|P2|STARTED|Overall Study||7
2217933|NCT02910362|5438143|P1|STARTED|Overall Study||8
2217934|NCT02910167|5438149|P1|NOT COMPLETED|Overall Study||19
2217935|NCT02910167|5438149|P1|COMPLETED|Overall Study||341
2217936|NCT02910167|5438149|P1|STARTED|Overall Study||360
2217937|NCT02910089|5438159|P2|NOT COMPLETED|Overall Study||16
2217938|NCT02910089|5438160|P1|NOT COMPLETED|Overall Study||22
2217939|NCT02910089|5438159|P2|COMPLETED|Overall Study|16 Patients ineligible (2.3%)|684
2217940|NCT02910089|5438160|P1|COMPLETED|Overall Study|22 patients ineligible (3.1%)|678
2217941|NCT02910089|5438159|P2|STARTED|Overall Study|Patients allocated to control|700
2217942|NCT02910089|5438160|P1|STARTED|Overall Study|Patients allocated to intervention|700
2217943|NCT02909907|5438174|P2|NOT COMPLETED|Overall Study||1
2217944|NCT02909907|5438175|P1|NOT COMPLETED|Overall Study||0
2217945|NCT02909907|5438174|P2|COMPLETED|Overall Study||9
2217946|NCT02909907|5438175|P1|COMPLETED|Overall Study||10
2217947|NCT02909907|5438174|P2|STARTED|Overall Study||10
2217948|NCT02909907|5438175|P1|STARTED|Overall Study||10
2217949|NCT02909764|5438199|P2|NOT COMPLETED|Overall Study||0
2217950|NCT02909764|5438200|P1|NOT COMPLETED|Overall Study||0
2217951|NCT02909764|5438199|P2|COMPLETED|Overall Study||20
2217952|NCT02909764|5438200|P1|COMPLETED|Overall Study||19
2217953|NCT02909764|5438199|P2|STARTED|Overall Study||20
2217954|NCT02909764|5438200|P1|STARTED|Overall Study||19
2217955|NCT02909153|5438221|P5|NOT COMPLETED|Overall Study||0
2217956|NCT02909153|5438222|P4|NOT COMPLETED|Overall Study||0
2217957|NCT02909153|5438223|P3|NOT COMPLETED|Overall Study||0
2217958|NCT02909153|5438224|P2|NOT COMPLETED|Overall Study||1
2217959|NCT02909153|5438225|P1|NOT COMPLETED|Overall Study||0
2217960|NCT02909153|5438221|P5|COMPLETED|Overall Study||6
2217961|NCT02909153|5438222|P4|COMPLETED|Overall Study||6
2217962|NCT02909153|5438223|P3|COMPLETED|Overall Study||6
2217963|NCT02909153|5438224|P2|COMPLETED|Overall Study||5
2217964|NCT02909153|5438225|P1|COMPLETED|Overall Study||6
2217965|NCT02909153|5438221|P5|Triferic in Extraneal PD Solution|Overall Study||6
2217966|NCT02909153|5438222|P4|Triferic in Extraneal PD Solution|Overall Study||6
2217967|NCT02909153|5438223|P3|Triferic in Extraneal PD Solution|Overall Study||0
2217968|NCT02909153|5438224|P2|Triferic in Extraneal PD Solution|Overall Study||0
2217969|NCT02909153|5438225|P1|Triferic in Extraneal PD Solution|Overall Study||0
2217970|NCT02909153|5438221|P5|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
2217971|NCT02909153|5438222|P4|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
2217972|NCT02909153|5438223|P3|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
2217973|NCT02909153|5438224|P2|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||5
2217974|NCT02909153|5438225|P1|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
2217975|NCT02909153|5438221|P5|Triferic in Dianeal PD Solution|Overall Study||0
2217976|NCT02909153|5438222|P4|Triferic in Dianeal PD Solution|Overall Study||0
2217977|NCT02909153|5438223|P3|Triferic in Dianeal PD Solution|Overall Study||6
2217978|NCT02909153|5438224|P2|Triferic in Dianeal PD Solution|Overall Study||6
2217979|NCT02909153|5438225|P1|Triferic in Dianeal PD Solution|Overall Study||6
2217980|NCT02909153|5438221|P5|STARTED|Overall Study||6
2217981|NCT02909153|5438222|P4|STARTED|Overall Study||6
2217982|NCT02909153|5438223|P3|STARTED|Overall Study||6
2217983|NCT02909153|5438224|P2|STARTED|Overall Study||6
2217984|NCT02909153|5438225|P1|STARTED|Overall Study||6
2217985|NCT02909140|5438270|P3|NOT COMPLETED|Overall Study||0
2217986|NCT02909140|5438271|P2|NOT COMPLETED|Overall Study||0
2217987|NCT02909140|5438272|P1|NOT COMPLETED|Overall Study||0
2217988|NCT02909140|5438270|P3|COMPLETED|Overall Study||0
2217989|NCT02909140|5438271|P2|COMPLETED|Overall Study||2
2217990|NCT02909140|5438272|P1|COMPLETED|Overall Study||0
2217991|NCT02909140|5438270|P3|STARTED|Overall Study||0
2217992|NCT02909140|5438271|P2|STARTED|Overall Study||2
2217993|NCT02909140|5438272|P1|STARTED|Overall Study||0
2217994|NCT02909101|5438315|P2|NOT COMPLETED|Overall Study||1
2217995|NCT02909101|5438316|P1|NOT COMPLETED|Overall Study||1
2217996|NCT02909101|5438315|P2|COMPLETED|Overall Study||28
2217997|NCT02909101|5438316|P1|COMPLETED|Overall Study||28
2217998|NCT02909101|5438315|P2|STARTED|Overall Study||29
2217999|NCT02909101|5438316|P1|STARTED|Overall Study||29
2218000|NCT02908880|5438334|P1|NOT COMPLETED|Overall Study||27
2218001|NCT02908880|5438334|P1|COMPLETED|Overall Study|Subjects within the Primary Analysis Cohort that completed all follow-up time points.|236
2218002|NCT02908880|5438334|P1|STARTED|Overall Study|Subjects within the Primary Analysis Cohort that received the MANTA Device|263
2218003|NCT02908620|5438346|P4|NOT COMPLETED|Overall Study||0
2218004|NCT02908620|5438347|P3|NOT COMPLETED|Overall Study||0
2218005|NCT02908620|5438348|P2|NOT COMPLETED|Overall Study||0
2218006|NCT02908620|5438349|P1|NOT COMPLETED|Overall Study||0
2218007|NCT02908620|5438346|P4|COMPLETED|Overall Study||10
2218008|NCT02908620|5438347|P3|COMPLETED|Overall Study||10
2218009|NCT02908620|5438348|P2|COMPLETED|Overall Study||10
2218010|NCT02908620|5438349|P1|COMPLETED|Overall Study||10
2218011|NCT02908620|5438346|P4|STARTED|Overall Study||10
2218012|NCT02908620|5438347|P3|STARTED|Overall Study||10
2218013|NCT02908620|5438348|P2|STARTED|Overall Study||10
2218014|NCT02908620|5438349|P1|STARTED|Overall Study||10
2218015|NCT02908529|5438383|P2|NOT COMPLETED|Overall Study||2
2218016|NCT02908529|5438384|P1|NOT COMPLETED|Overall Study||0
2218017|NCT02908529|5438383|P2|COMPLETED|Overall Study||10
2218018|NCT02908529|5438384|P1|COMPLETED|Overall Study||10
2218019|NCT02908529|5438383|P2|STARTED|Overall Study||12
2218020|NCT02908529|5438384|P1|STARTED|Overall Study||10
2218021|NCT02908516|5438394|P2|NOT COMPLETED|Overall Study||3
2218022|NCT02908516|5438395|P1|NOT COMPLETED|Overall Study||3
2218023|NCT02908516|5438394|P2|COMPLETED|Overall Study||0
2218024|NCT02908516|5438395|P1|COMPLETED|Overall Study||0
2218025|NCT02908516|5438394|P2|STARTED|Overall Study||3
2218026|NCT02908516|5438395|P1|STARTED|Overall Study||3
2218027|NCT02908347|5438411|P2|NOT COMPLETED|Overall Study||1
2218028|NCT02908347|5438412|P1|NOT COMPLETED|Overall Study||1
2218029|NCT02908347|5438411|P2|COMPLETED|Overall Study||22
2218030|NCT02908347|5438412|P1|COMPLETED|Overall Study||22
2218031|NCT02908347|5438411|P2|STARTED|Overall Study||23
2218032|NCT02908347|5438412|P1|STARTED|Overall Study||23
2218033|NCT02908269|5438463|P3|NOT COMPLETED|Overall Study||0
2218034|NCT02908269|5438464|P2|NOT COMPLETED|Overall Study||0
2218035|NCT02908269|5438465|P1|NOT COMPLETED|Overall Study||0
2218036|NCT02908269|5438463|P3|COMPLETED|Overall Study||60
2218037|NCT02908269|5438464|P2|COMPLETED|Overall Study||60
2218038|NCT02908269|5438465|P1|COMPLETED|Overall Study||60
2218039|NCT02908269|5438463|P3|STARTED|Overall Study||60
2218040|NCT02908269|5438464|P2|STARTED|Overall Study||60
2218041|NCT02908269|5438465|P1|STARTED|Overall Study||60
2218042|NCT02908178|5438483|P4|NOT COMPLETED|Overall Study||6819
2218043|NCT02908178|5438484|P3|NOT COMPLETED|Overall Study||0
2218044|NCT02908178|5438485|P2|NOT COMPLETED|Overall Study||8388
2218045|NCT02908178|5438486|P1|NOT COMPLETED|Overall Study||0
2218046|NCT02908178|5438483|P4|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|3965
2218047|NCT02908178|5438484|P3|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|1992
2218048|NCT02908178|5438485|P2|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|4718
2218049|NCT02908178|5438486|P1|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|2409
2218050|NCT02908178|5438483|P4|STARTED|Overall Study|The sample prior to Mahalanobis matching.|10784
2218051|NCT02908178|5438484|P3|STARTED|Overall Study|The sample prior to Mahalanobis matching.|1992
2218052|NCT02908178|5438485|P2|STARTED|Overall Study|The sample prior to Mahalanobis matching.|13106
2218053|NCT02908178|5438486|P1|STARTED|Overall Study|The sample prior to Mahalanobis matching.|2409
2218054|NCT02907892|5438507|P2|NOT COMPLETED|Overall Study||40
2218055|NCT02907892|5438508|P1|NOT COMPLETED|Overall Study||27
2218056|NCT02907892|5438507|P2|COMPLETED|Overall Study||236
2218057|NCT02907892|5438508|P1|COMPLETED|Overall Study||250
2218058|NCT02907892|5438507|P2|STARTED|Overall Study||276
2218059|NCT02907892|5438508|P1|STARTED|Overall Study||277
2218060|NCT02907814|5438516|P2|NOT COMPLETED|Overall Study||0
2218061|NCT02907814|5438517|P1|NOT COMPLETED|Overall Study||6
2218062|NCT02907814|5438516|P2|COMPLETED|Overall Study||0
2218063|NCT02907814|5438517|P1|COMPLETED|Overall Study||0
2218064|NCT02907814|5438516|P2|STARTED|Overall Study||0
2218065|NCT02907814|5438517|P1|STARTED|Overall Study||6
2218066|NCT02907619|5438528|P3|NOT COMPLETED|Overall Study||20
2218067|NCT02907619|5438529|P2|NOT COMPLETED|Overall Study||20
2218068|NCT02907619|5438530|P1|NOT COMPLETED|Overall Study||19
2218069|NCT02907619|5438528|P3|COMPLETED|Overall Study||0
2218070|NCT02907619|5438529|P2|COMPLETED|Overall Study||0
2218071|NCT02907619|5438530|P1|COMPLETED|Overall Study||0
2218072|NCT02907619|5438528|P3|Received Treatment|Overall Study||20
2218073|NCT02907619|5438529|P2|Received Treatment|Overall Study||20
2218074|NCT02907619|5438530|P1|Received Treatment|Overall Study||19
2218075|NCT02907619|5438528|P3|STARTED|Overall Study||20
2218076|NCT02907619|5438529|P2|STARTED|Overall Study||20
2218077|NCT02907619|5438530|P1|STARTED|Overall Study||19
2218078|NCT02907489|5438737|P2|NOT COMPLETED|Overall Study||1
2218079|NCT02907489|5438738|P1|NOT COMPLETED|Overall Study||2
2218080|NCT02907489|5438737|P2|COMPLETED|Overall Study||41
2218081|NCT02907489|5438738|P1|COMPLETED|Overall Study||40
2218082|NCT02907489|5438737|P2|STARTED|Overall Study||42
2218083|NCT02907489|5438738|P1|STARTED|Overall Study||42
2218084|NCT02907463|5438746|P1|NOT COMPLETED|Overall Study||37
2218085|NCT02907463|5438746|P1|COMPLETED|Overall Study||243
2218086|NCT02907463|5438746|P1|Per Protocol Cohort|Overall Study||276
2218087|NCT02907463|5438746|P1|Enrolled Cohort|Overall Study||280
2218088|NCT02907463|5438746|P1|STARTED|Overall Study||280
2218089|NCT02907268|5438818|P2|NOT COMPLETED|Overall Study||0
2218090|NCT02907268|5438819|P1|NOT COMPLETED|Overall Study||0
2218091|NCT02907268|5438818|P2|COMPLETED|Overall Study||5
2218092|NCT02907268|5438819|P1|COMPLETED|Overall Study||5
2218093|NCT02907268|5438818|P2|STARTED|Overall Study||5
2218094|NCT02907268|5438819|P1|STARTED|Overall Study||5
2218095|NCT02907216|5438828|P2|NOT COMPLETED|Overall Study||1
2218096|NCT02907216|5438829|P1|NOT COMPLETED|Overall Study||1
2218097|NCT02907216|5438828|P2|COMPLETED|Overall Study||144
2218098|NCT02907216|5438829|P1|COMPLETED|Overall Study||146
2218099|NCT02907216|5438828|P2|STARTED|Overall Study||145
2218100|NCT02907216|5438829|P1|STARTED|Overall Study||147
2218101|NCT02907073|5438864|P3|NOT COMPLETED|Overall Study||0
2218102|NCT02907073|5438865|P2|NOT COMPLETED|Overall Study||0
2218103|NCT02907073|5438866|P1|NOT COMPLETED|Overall Study||0
2218104|NCT02907073|5438864|P3|COMPLETED|Overall Study||0
2218105|NCT02907073|5438865|P2|COMPLETED|Overall Study||0
2218106|NCT02907073|5438866|P1|COMPLETED|Overall Study||8
2218107|NCT02907073|5438864|P3|STARTED|Overall Study||0
2218108|NCT02907073|5438865|P2|STARTED|Overall Study||0
2218109|NCT02907073|5438866|P1|STARTED|Overall Study||8
2218130|NCT02906917|5439077|P2|NOT COMPLETED|Intensification Period (Week 26-38)||7
2218131|NCT02906917|5439078|P1|NOT COMPLETED|Intensification Period (Week 26-38)||9
2218132|NCT02906917|5439077|P2|COMPLETED|Intensification Period (Week 26-38)||247
2218133|NCT02906917|5439078|P1|COMPLETED|Intensification Period (Week 26-38)||252
2218134|NCT02906917|5439077|P2|STARTED|Intensification Period (Week 26-38)||254
2218135|NCT02906917|5439078|P1|STARTED|Intensification Period (Week 26-38)||261
2218136|NCT02906917|5439077|P2|NOT COMPLETED|Initiation Period (Week 0-26)||11
2218137|NCT02906917|5439078|P1|NOT COMPLETED|Initiation Period (Week 0-26)||6
2218138|NCT02906917|5439077|P2|COMPLETED|Initiation Period (Week 0-26)||254
2218139|NCT02906917|5439078|P1|COMPLETED|Initiation Period (Week 0-26)||261
2218140|NCT02906917|5439077|P2|Exposed|Initiation Period (Week 0-26)||263
2218141|NCT02906917|5439078|P1|Exposed|Initiation Period (Week 0-26)||265
2218142|NCT02906917|5439077|P2|STARTED|Initiation Period (Week 0-26)||265
2218143|NCT02906917|5439078|P1|STARTED|Initiation Period (Week 0-26)||267
2218144|NCT02906813|5439109|P3|NOT COMPLETED|Intervention Period 3 (3 Days)||0
2218145|NCT02906813|5439110|P2|NOT COMPLETED|Intervention Period 3 (3 Days)||0
2218146|NCT02906813|5439111|P1|NOT COMPLETED|Intervention Period 3 (3 Days)||0
2218147|NCT02906813|5439109|P3|COMPLETED|Intervention Period 3 (3 Days)||3
2218148|NCT02906813|5439110|P2|COMPLETED|Intervention Period 3 (3 Days)||3
2218149|NCT02906813|5439111|P1|COMPLETED|Intervention Period 3 (3 Days)||3
2218150|NCT02906813|5439109|P3|STARTED|Intervention Period 3 (3 Days)||3
2218151|NCT02906813|5439110|P2|STARTED|Intervention Period 3 (3 Days)||3
2218152|NCT02906813|5439111|P1|STARTED|Intervention Period 3 (3 Days)||3
2218153|NCT02906813|5439109|P3|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
2218154|NCT02906813|5439110|P2|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
2218155|NCT02906813|5439111|P1|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
2218156|NCT02906813|5439109|P3|COMPLETED|Washout Period 2 (at Least 3 Days)||3
2218157|NCT02906813|5439110|P2|COMPLETED|Washout Period 2 (at Least 3 Days)||3
2218158|NCT02906813|5439111|P1|COMPLETED|Washout Period 2 (at Least 3 Days)||3
2218159|NCT02906813|5439109|P3|STARTED|Washout Period 2 (at Least 3 Days)||3
2218160|NCT02906813|5439110|P2|STARTED|Washout Period 2 (at Least 3 Days)||3
2218161|NCT02906813|5439111|P1|STARTED|Washout Period 2 (at Least 3 Days)||3
2218162|NCT02906813|5439109|P3|NOT COMPLETED|Intervention Period 2 (3 Days)||0
2218163|NCT02906813|5439110|P2|NOT COMPLETED|Intervention Period 2 (3 Days)||0
2218164|NCT02906813|5439111|P1|NOT COMPLETED|Intervention Period 2 (3 Days)||0
2218165|NCT02906813|5439109|P3|COMPLETED|Intervention Period 2 (3 Days)||3
2218166|NCT02906813|5439110|P2|COMPLETED|Intervention Period 2 (3 Days)||3
2218167|NCT02906813|5439111|P1|COMPLETED|Intervention Period 2 (3 Days)||3
2218168|NCT02906813|5439109|P3|STARTED|Intervention Period 2 (3 Days)||3
2218169|NCT02906813|5439110|P2|STARTED|Intervention Period 2 (3 Days)||3
2218170|NCT02906813|5439111|P1|STARTED|Intervention Period 2 (3 Days)||3
2218171|NCT02906813|5439109|P3|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
2218172|NCT02906813|5439110|P2|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
2218173|NCT02906813|5439111|P1|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
2218174|NCT02906813|5439109|P3|COMPLETED|Washout Period 1 (at Least 3 Days)||3
2218175|NCT02906813|5439110|P2|COMPLETED|Washout Period 1 (at Least 3 Days)||3
2218176|NCT02906813|5439111|P1|COMPLETED|Washout Period 1 (at Least 3 Days)||3
2218177|NCT02906813|5439109|P3|STARTED|Washout Period 1 (at Least 3 Days)||3
2218178|NCT02906813|5439110|P2|STARTED|Washout Period 1 (at Least 3 Days)||3
2218179|NCT02906813|5439111|P1|STARTED|Washout Period 1 (at Least 3 Days)||3
2218180|NCT02906813|5439109|P3|NOT COMPLETED|Intervention Period 1 (3 Days)||0
2218181|NCT02906813|5439110|P2|NOT COMPLETED|Intervention Period 1 (3 Days)||0
2218182|NCT02906813|5439111|P1|NOT COMPLETED|Intervention Period 1 (3 Days)||0
2218183|NCT02906813|5439109|P3|COMPLETED|Intervention Period 1 (3 Days)||3
2218184|NCT02906813|5439110|P2|COMPLETED|Intervention Period 1 (3 Days)||3
2218185|NCT02906813|5439111|P1|COMPLETED|Intervention Period 1 (3 Days)||3
2218186|NCT02906813|5439109|P3|STARTED|Intervention Period 1 (3 Days)||3
2218187|NCT02906813|5439110|P2|STARTED|Intervention Period 1 (3 Days)||3
2218188|NCT02906813|5439111|P1|STARTED|Intervention Period 1 (3 Days)||3
2218189|NCT02906709|5439139|P2|NOT COMPLETED|Phase B (Extension, Week 17 to Week 52)||0
2218190|NCT02906709|5439140|P1|NOT COMPLETED|Phase B (Extension, Week 17 to Week 52)||5
2218191|NCT02906709|5439139|P2|COMPLETED|Phase B (Extension, Week 17 to Week 52)||58
2218192|NCT02906709|5439140|P1|COMPLETED|Phase B (Extension, Week 17 to Week 52)||117
2218193|NCT02906709|5439139|P2|STARTED|Phase B (Extension, Week 17 to Week 52)||58
2218194|NCT02906709|5439140|P1|STARTED|Phase B (Extension, Week 17 to Week 52)||122
2218195|NCT02906709|5439139|P2|NOT COMPLETED|Phase A (Week 0 to Week 16)||3
2218196|NCT02906709|5439140|P1|NOT COMPLETED|Phase A (Week 0 to Week 16)||1
2218197|NCT02906709|5439139|P2|COMPLETED|Phase A (Week 0 to Week 16)||58
2218198|NCT02906709|5439140|P1|COMPLETED|Phase A (Week 0 to Week 16)||122
2218199|NCT02906709|5439139|P2|STARTED|Phase A (Week 0 to Week 16)||61
2218200|NCT02906709|5439140|P1|STARTED|Phase A (Week 0 to Week 16)||123
2218201|NCT02906644|5439174|P2|NOT COMPLETED|Weeks 3 to 14||11
2218202|NCT02906644|5439175|P1|NOT COMPLETED|Weeks 3 to 14||16
2218203|NCT02906644|5439174|P2|COMPLETED|Weeks 3 to 14||16
2218204|NCT02906644|5439175|P1|COMPLETED|Weeks 3 to 14||14
2218205|NCT02906644|5439174|P2|Follow-up (6 Months Post Quit Day)|Weeks 3 to 14||16
2218206|NCT02906644|5439175|P1|Follow-up (6 Months Post Quit Day)|Weeks 3 to 14||14
2218207|NCT02906644|5439174|P2|Final Study Visit|Weeks 3 to 14|All participants receiving only 1 week of 14mg & 1 week of 7mg nicotine patches at this visit.|20
2218208|NCT02906644|5439175|P1|Final Study Visit|Weeks 3 to 14|All participants receiving only 1 week of 14mg & 1 week of 7mg nicotine patches at this visit.|17
2218209|NCT02906644|5439174|P2|STARTED|Weeks 3 to 14|All participants receiving active Lorcaserin plus nicotine patches starting at the 2nd study visit.|27
2218210|NCT02906644|5439175|P1|STARTED|Weeks 3 to 14|All participants receiving active Lorcaserin plus nicotine patches starting at the 2nd study visit.|30
2218211|NCT02906644|5439174|P2|NOT COMPLETED|First 2 Weeks||3
2218212|NCT02906644|5439175|P1|NOT COMPLETED|First 2 Weeks||1
2218213|NCT02906644|5439174|P2|COMPLETED|First 2 Weeks||27
2218214|NCT02906644|5439175|P1|COMPLETED|First 2 Weeks||30
2218215|NCT02906644|5439174|P2|STARTED|First 2 Weeks||30
2218216|NCT02906644|5439175|P1|STARTED|First 2 Weeks||31
2218217|NCT02906566|5439193|P2|NOT COMPLETED|Overall Study||0
2218218|NCT02906566|5439194|P1|NOT COMPLETED|Overall Study||3
2218219|NCT02906566|5439193|P2|COMPLETED|Overall Study||10
2218220|NCT02906566|5439194|P1|COMPLETED|Overall Study||21
2218221|NCT02906566|5439193|P2|STARTED|Overall Study||10
2218222|NCT02906566|5439194|P1|STARTED|Overall Study||24
2218223|NCT02906358|5439210|P2|NOT COMPLETED|Overall Study||22
2218224|NCT02906358|5439211|P1|NOT COMPLETED|Overall Study||22
2218225|NCT02906358|5439210|P2|COMPLETED|Overall Study||31
2218226|NCT02906358|5439211|P1|COMPLETED|Overall Study||36
2218227|NCT02906358|5439210|P2|Completed 3 Month Measures|Overall Study||33
2218228|NCT02906358|5439211|P1|Completed 3 Month Measures|Overall Study||36
2218229|NCT02906358|5439210|P2|STARTED|Overall Study||53
2218230|NCT02906358|5439211|P1|STARTED|Overall Study||58
2218231|NCT02905825|5439239|P1|NOT COMPLETED|Overall Study||12
2218232|NCT02905825|5439239|P1|COMPLETED|Overall Study||41
2218233|NCT02905825|5439239|P1|STARTED|Overall Study||53
2218234|NCT02905331|5439247|P3|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||0
2218235|NCT02905331|5439248|P2|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||8
2218236|NCT02905331|5439249|P1|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||0
2218237|NCT02905331|5439247|P3|COMPLETED|Active Treatment and Follow up (wk16-40)||13
2218238|NCT02905331|5439248|P2|COMPLETED|Active Treatment and Follow up (wk16-40)||53
2218239|NCT02905331|5439249|P1|COMPLETED|Active Treatment and Follow up (wk16-40)||0
2218240|NCT02905331|5439247|P3|STARTED|Active Treatment and Follow up (wk16-40)||13
2218241|NCT02905331|5439248|P2|STARTED|Active Treatment and Follow up (wk16-40)||61
2218242|NCT02905331|5439249|P1|STARTED|Active Treatment and Follow up (wk16-40)||0
2218243|NCT02905331|5439247|P3|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||0
2218244|NCT02905331|5439248|P2|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||1
2218245|NCT02905331|5439249|P1|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||3
2218246|NCT02905331|5439247|P3|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||0
2218247|NCT02905331|5439248|P2|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||61
2218248|NCT02905331|5439249|P1|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||13
2218249|NCT02905331|5439247|P3|STARTED|Placebo Controlled Period(Week[wk] 0-16)||0
2218250|NCT02905331|5439248|P2|STARTED|Placebo Controlled Period(Week[wk] 0-16)||62
2218251|NCT02905331|5439249|P1|STARTED|Placebo Controlled Period(Week[wk] 0-16)||16
2218252|NCT02905266|5439277|P2|NOT COMPLETED|Maintenance Phase Part 2||22
2218253|NCT02905266|5439278|P1|NOT COMPLETED|Maintenance Phase Part 2||19
2218254|NCT02905266|5439277|P2|COMPLETED|Maintenance Phase Part 2||0
2218255|NCT02905266|5439278|P1|COMPLETED|Maintenance Phase Part 2||0
2218256|NCT02905266|5439277|P2|STARTED|Maintenance Phase Part 2||22
2218257|NCT02905266|5439278|P1|STARTED|Maintenance Phase Part 2||19
2218258|NCT02905266|5439277|P2|NOT COMPLETED|Treatment Period Part 1||23
2218259|NCT02905266|5439278|P1|NOT COMPLETED|Treatment Period Part 1||29
2218260|NCT02905266|5439277|P2|COMPLETED|Treatment Period Part 1||30
2218261|NCT02905266|5439278|P1|COMPLETED|Treatment Period Part 1||24
2218262|NCT02905266|5439277|P2|STARTED|Treatment Period Part 1||53
2218263|NCT02905266|5439278|P1|STARTED|Treatment Period Part 1||53
2218264|NCT02904915|5439300|P2|NOT COMPLETED|Overall Study||0
2218265|NCT02904915|5439301|P1|NOT COMPLETED|Overall Study||0
2218266|NCT02904915|5439300|P2|COMPLETED|Overall Study||25
2218267|NCT02904915|5439301|P1|COMPLETED|Overall Study||25
2218268|NCT02904915|5439300|P2|STARTED|Overall Study||25
2218269|NCT02904915|5439301|P1|STARTED|Overall Study||25
2218270|NCT02904902|5439311|P1|NOT COMPLETED|Overall Study||1
2218271|NCT02904902|5439311|P1|COMPLETED|Overall Study|completed 24 weeks of treatment and continued on study|14
2218272|NCT02904902|5439311|P1|STARTED|Overall Study||15
2218273|NCT02904356|5439318|P1|NOT COMPLETED|Overall Study||0
2218274|NCT02904356|5439318|P1|COMPLETED|Overall Study||2
2218275|NCT02904356|5439318|P1|STARTED|Overall Study||2
2218276|NCT02904096|5439324|P2|NOT COMPLETED|Overall Study||21
2218277|NCT02904096|5439325|P1|NOT COMPLETED|Overall Study||19
2218278|NCT02904096|5439324|P2|COMPLETED|Overall Study||105
2218279|NCT02904096|5439325|P1|COMPLETED|Overall Study||111
2218280|NCT02904096|5439324|P2|STARTED|Overall Study||126
2218281|NCT02904096|5439325|P1|STARTED|Overall Study||130
2218282|NCT02903836|5439352|P3|NOT COMPLETED|Overall Study||4
2218283|NCT02903836|5439353|P2|NOT COMPLETED|Overall Study||4
2218284|NCT02903836|5439354|P1|NOT COMPLETED|Overall Study||3
2218285|NCT02903836|5439352|P3|COMPLETED|Overall Study||73
2218286|NCT02903836|5439353|P2|COMPLETED|Overall Study||69
2218287|NCT02903836|5439354|P1|COMPLETED|Overall Study||71
2218288|NCT02903836|5439352|P3|STARTED|Overall Study||77
2218289|NCT02903836|5439353|P2|STARTED|Overall Study||73
2218290|NCT02903836|5439354|P1|STARTED|Overall Study||74
2218291|NCT02903394|5439367|P2|NOT COMPLETED|Overall Study||0
2218292|NCT02903394|5439368|P1|NOT COMPLETED|Overall Study||0
2218293|NCT02903394|5439367|P2|COMPLETED|Overall Study||50
2218294|NCT02903394|5439368|P1|COMPLETED|Overall Study||5
2218295|NCT02903394|5439367|P2|STARTED|Overall Study||50
2218296|NCT02903394|5439368|P1|STARTED|Overall Study||5
2218297|NCT02903238|5439378|P1|NOT COMPLETED|Overall Study||4
2218298|NCT02903238|5439378|P1|COMPLETED|Overall Study||17
2218299|NCT02903238|5439378|P1|STARTED|Overall Study||21
2218300|NCT02903030|5439389|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
2218301|NCT02903030|5439390|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
2218302|NCT02903030|5439389|P2|COMPLETED|Second Intervention (8 Weeks)||4
2218303|NCT02903030|5439390|P1|COMPLETED|Second Intervention (8 Weeks)||6
2218304|NCT02903030|5439389|P2|STARTED|Second Intervention (8 Weeks)||4
2218305|NCT02903030|5439390|P1|STARTED|Second Intervention (8 Weeks)||6
2218306|NCT02903030|5439389|P2|NOT COMPLETED|Washout (3 Weeks)||0
2218307|NCT02903030|5439390|P1|NOT COMPLETED|Washout (3 Weeks)||0
2218308|NCT02903030|5439389|P2|COMPLETED|Washout (3 Weeks)||4
2218309|NCT02903030|5439390|P1|COMPLETED|Washout (3 Weeks)||6
2218310|NCT02903030|5439389|P2|STARTED|Washout (3 Weeks)||4
2218311|NCT02903030|5439390|P1|STARTED|Washout (3 Weeks)||6
2218312|NCT02903030|5439389|P2|NOT COMPLETED|First Intervention (8 Weeks)||1
2218313|NCT02903030|5439390|P1|NOT COMPLETED|First Intervention (8 Weeks)||2
2218314|NCT02903030|5439389|P2|COMPLETED|First Intervention (8 Weeks)||4
2218315|NCT02903030|5439390|P1|COMPLETED|First Intervention (8 Weeks)||6
2218316|NCT02903030|5439389|P2|Received Intervention|First Intervention (8 Weeks)||4
2218317|NCT02903030|5439390|P1|Received Intervention|First Intervention (8 Weeks)||6
2218318|NCT02903030|5439389|P2|STARTED|First Intervention (8 Weeks)||5
2218319|NCT02903030|5439390|P1|STARTED|First Intervention (8 Weeks)||8
2218320|NCT02902965|5439408|P1|NOT COMPLETED|Overall Study||10
2218321|NCT02902965|5439408|P1|COMPLETED|Overall Study||64
2218322|NCT02902965|5439408|P1|STARTED|Overall Study||74
2218323|NCT02902913|5439417|P1|NOT COMPLETED|Overall Study||0
2218324|NCT02902913|5439417|P1|COMPLETED|Overall Study||9
2218325|NCT02902913|5439417|P1|Ibuprofen (400mg)|Overall Study||9
2218326|NCT02902913|5439417|P1|Washout (7 Days)|Overall Study||9
2218327|NCT02902913|5439417|P1|Third Intervention (1 Day)|Overall Study||9
2218328|NCT02902913|5439417|P1|Washout (7 Days)|Overall Study||9
2218329|NCT02902913|5439417|P1|Second Intervention (1 Day)|Overall Study||9
2218330|NCT02902913|5439417|P1|Washout (7 Days)|Overall Study||9
2218331|NCT02902913|5439417|P1|First Intervention (1 Day)|Overall Study||9
2218332|NCT02902913|5439417|P1|STARTED|Overall Study||9
2218333|NCT02902809|5439425|P1|NOT COMPLETED|Overall Study||28
2218334|NCT02902809|5439425|P1|COMPLETED|Overall Study||0
2218335|NCT02902809|5439425|P1|Treatment Completed|Overall Study||2
2218336|NCT02902809|5439425|P1|Treatment Received|Overall Study||28
2218337|NCT02902809|5439425|P1|STARTED|Overall Study||28
2218338|NCT02902172|5439435|P2|NOT COMPLETED|Overall Study||0
2218339|NCT02902172|5439436|P1|NOT COMPLETED|Overall Study||0
2218340|NCT02902172|5439435|P2|COMPLETED|Overall Study||20
2218341|NCT02902172|5439436|P1|COMPLETED|Overall Study||16
2218342|NCT02902172|5439435|P2|STARTED|Overall Study||20
2218343|NCT02902172|5439436|P1|STARTED|Overall Study||16
2218344|NCT02902146|5439446|P2|NOT COMPLETED|Overall Study||0
2218345|NCT02902146|5439447|P1|NOT COMPLETED|Overall Study||0
2218346|NCT02902146|5439446|P2|COMPLETED|Overall Study||376
2218347|NCT02902146|5439447|P1|COMPLETED|Overall Study||381
2218348|NCT02902146|5439446|P2|STARTED|Overall Study||376
2218349|NCT02902146|5439447|P1|STARTED|Overall Study||381
2218350|NCT02902081|5439461|P1|NOT COMPLETED|Overall Study||0
2218351|NCT02902081|5439461|P1|COMPLETED|Overall Study||38
2218352|NCT02902081|5439461|P1|STARTED|Overall Study||38
2218353|NCT02901951|5439469|P1|NOT COMPLETED|Overall Study||0
2218354|NCT02901951|5439469|P1|COMPLETED|Overall Study||103
2218355|NCT02901951|5439469|P1|STARTED|Overall Study||103
2218356|NCT02901054|5439480|P1|NOT COMPLETED|Overall Study||4
2218357|NCT02901054|5439480|P1|COMPLETED|Overall Study||15
2218358|NCT02901054|5439480|P1|STARTED|Overall Study|19 consented, 3 withdrew prior to intervention, 1 received study drug but surgery was cancelled.|19
2218359|NCT02900781|5439486|P2|NOT COMPLETED|Overall Study||5
2218360|NCT02900781|5439487|P1|NOT COMPLETED|Overall Study||4
2218361|NCT02900781|5439486|P2|COMPLETED|Overall Study||0
2218362|NCT02900781|5439487|P1|COMPLETED|Overall Study||0
2218363|NCT02900781|5439486|P2|STARTED|Overall Study||5
2218364|NCT02900781|5439487|P1|STARTED|Overall Study||4
2218365|NCT02900378|5439495|P2|NOT COMPLETED|Treatment Phase||0
2218366|NCT02900378|5439496|P1|NOT COMPLETED|Treatment Phase||0
2218367|NCT02900378|5439495|P2|COMPLETED|Treatment Phase||310
2218368|NCT02900378|5439496|P1|COMPLETED|Treatment Phase||309
2218369|NCT02900378|5439495|P2|Full Analysis Set|Treatment Phase||302
2218370|NCT02900378|5439496|P1|Full Analysis Set|Treatment Phase||302
2218371|NCT02900378|5439495|P2|STARTED|Treatment Phase||310
2218372|NCT02900378|5439496|P1|STARTED|Treatment Phase||309
2218373|NCT02900378|5439495|P2|NOT COMPLETED|Randomization (Visit 2)||28
2218374|NCT02900378|5439496|P1|NOT COMPLETED|Randomization (Visit 2)||23
2218375|NCT02900378|5439495|P2|COMPLETED|Randomization (Visit 2)||283
2218376|NCT02900378|5439496|P1|COMPLETED|Randomization (Visit 2)||287
2218377|NCT02900378|5439495|P2|STARTED|Randomization (Visit 2)||311
2218378|NCT02900378|5439496|P1|STARTED|Randomization (Visit 2)||310
2218379|NCT02900092|5439540|P1|NOT COMPLETED|Overall Study||1
2218380|NCT02900092|5439540|P1|COMPLETED|Overall Study||9
2218381|NCT02900092|5439540|P1|STARTED|Overall Study||10
2218382|NCT02899884|5439544|P1|NOT COMPLETED|Overall Study||0
2218383|NCT02899884|5439544|P1|COMPLETED|Overall Study||3765
2218384|NCT02899884|5439544|P1|STARTED|Overall Study||3765
2218385|NCT02899377|5439558|P2|NOT COMPLETED|Overall Study||0
2218386|NCT02899377|5439559|P1|NOT COMPLETED|Overall Study||1
2218387|NCT02899377|5439558|P2|COMPLETED|Overall Study||12
2218388|NCT02899377|5439559|P1|COMPLETED|Overall Study||12
2218389|NCT02899377|5439558|P2|STARTED|Overall Study||12
2218390|NCT02899377|5439559|P1|STARTED|Overall Study||13
2218391|NCT02899338|5439592|P2|NOT COMPLETED|Overall Study||2
2218392|NCT02899338|5439593|P1|NOT COMPLETED|Overall Study||3
2218393|NCT02899338|5439592|P2|COMPLETED|Overall Study||79
2218394|NCT02899338|5439593|P1|COMPLETED|Overall Study||78
2218395|NCT02899338|5439592|P2|STARTED|Overall Study||81
2218396|NCT02899338|5439593|P1|STARTED|Overall Study||81
2218397|NCT02898974|5439607|P2|NOT COMPLETED|Overall Study||0
2218398|NCT02898974|5439608|P1|NOT COMPLETED|Overall Study||0
2218399|NCT02898974|5439607|P2|COMPLETED|Overall Study||9
2218400|NCT02898974|5439608|P1|COMPLETED|Overall Study||13
2218401|NCT02898974|5439607|P2|STARTED|Overall Study||9
2218402|NCT02898974|5439608|P1|STARTED|Overall Study||13
2218403|NCT02898740|5439620|P2|NOT COMPLETED|Overall Study||0
2218404|NCT02898740|5439621|P1|NOT COMPLETED|Overall Study||0
2218405|NCT02898740|5439620|P2|COMPLETED|Overall Study||19
2218406|NCT02898740|5439621|P1|COMPLETED|Overall Study||21
2218407|NCT02898740|5439620|P2|STARTED|Overall Study||19
2218408|NCT02898740|5439621|P1|STARTED|Overall Study||21
2218409|NCT02898662|5439629|P2|NOT COMPLETED|Overall Study||28
2218410|NCT02898662|5439630|P1|NOT COMPLETED|Overall Study||29
2218411|NCT02898662|5439629|P2|COMPLETED|Overall Study||13
2218412|NCT02898662|5439630|P1|COMPLETED|Overall Study||11
2218413|NCT02898662|5439629|P2|Completed Treatment|Overall Study||29
2218414|NCT02898662|5439630|P1|Completed Treatment|Overall Study||25
2218415|NCT02898662|5439629|P2|STARTED|Overall Study||41
2218416|NCT02898662|5439630|P1|STARTED|Overall Study||40
2218417|NCT02898597|5439654|P2|NOT COMPLETED|Overall Study||12
2218418|NCT02898597|5439655|P1|NOT COMPLETED|Overall Study||4
2218419|NCT02898597|5439654|P2|COMPLETED|Overall Study||12
2218420|NCT02898597|5439655|P1|COMPLETED|Overall Study||21
2218421|NCT02898597|5439654|P2|STARTED|Overall Study||24
2218422|NCT02898597|5439655|P1|STARTED|Overall Study||25
2218423|NCT02898454|5439664|P3|NOT COMPLETED|Overall Study||6
2218424|NCT02898454|5439665|P2|NOT COMPLETED|Overall Study||5
2218425|NCT02898454|5439666|P1|NOT COMPLETED|Overall Study||17
2218426|NCT02898454|5439664|P3|COMPLETED|Overall Study||144
2218427|NCT02898454|5439665|P2|COMPLETED|Overall Study||140
2218428|NCT02898454|5439666|P1|COMPLETED|Overall Study||136
2218429|NCT02898454|5439664|P3|Safety Population|Overall Study||149
2218430|NCT02898454|5439665|P2|Safety Population|Overall Study|1 randomized to dupilumab q2w arm received 1dose of placebo: counted in 300 mg q2w then q4w arm.|148
2218431|NCT02898454|5439666|P1|Safety Population|Overall Study|2 participants randomized to placebo received 1 dose of dupilumab:counted in 300 mg q2w then q4w arm|150
2218432|NCT02898454|5439664|P3|Treated|Overall Study||150
2218433|NCT02898454|5439665|P2|Treated|Overall Study||145
2218434|NCT02898454|5439666|P1|Treated|Overall Study||152
2218435|NCT02898454|5439664|P3|Intent-to-Treat (ITT) Population|Overall Study||150
2218436|NCT02898454|5439665|P2|Intent-to-Treat (ITT) Population|Overall Study||145
2218437|NCT02898454|5439666|P1|Intent-to-Treat (ITT) Population|Overall Study||153
2218438|NCT02898454|5439664|P3|STARTED|Overall Study||150
2218439|NCT02898454|5439665|P2|STARTED|Overall Study||145
2218440|NCT02898454|5439666|P1|STARTED|Overall Study||153
2218441|NCT02898116|5439779|P1|NOT COMPLETED|Overall Study||2
2218442|NCT02898116|5439779|P1|COMPLETED|Overall Study||0
2218443|NCT02898116|5439779|P1|STARTED|Overall Study||2
2218444|NCT02897349|5439787|P2|NOT COMPLETED|Overall Study||6
2218445|NCT02897349|5439788|P1|NOT COMPLETED|Overall Study||5
2218446|NCT02897349|5439787|P2|COMPLETED|Overall Study||98
2218447|NCT02897349|5439788|P1|COMPLETED|Overall Study||97
2218448|NCT02897349|5439787|P2|STARTED|Overall Study||104
2218449|NCT02897349|5439788|P1|STARTED|Overall Study||102
2218450|NCT02897141|5439810|P2|NOT COMPLETED|Overall Study||1
2218451|NCT02897141|5439811|P1|NOT COMPLETED|Overall Study||2
2218452|NCT02897141|5439810|P2|COMPLETED|Overall Study||39
2218453|NCT02897141|5439811|P1|COMPLETED|Overall Study||38
2218454|NCT02897141|5439810|P2|STARTED|Overall Study||40
2218455|NCT02897141|5439811|P1|STARTED|Overall Study||40
2218456|NCT02897115|5439830|P2|NOT COMPLETED|Overall Study||8
2218457|NCT02897115|5439831|P1|NOT COMPLETED|Overall Study||11
2218458|NCT02897115|5439830|P2|COMPLETED|Overall Study||0
2218459|NCT02897115|5439831|P1|COMPLETED|Overall Study||3
2218460|NCT02897115|5439830|P2|STARTED|Overall Study||8
2218461|NCT02897115|5439831|P1|STARTED|Overall Study||14
2218462|NCT02896907|5439901|P1|NOT COMPLETED|Overall Study||0
2218463|NCT02896907|5439901|P1|COMPLETED|Overall Study||8
2218464|NCT02896907|5439901|P1|STARTED|Overall Study||8
2218465|NCT02896855|5439908|P2|NOT COMPLETED|Overall Study||122
2218466|NCT02896855|5439909|P1|NOT COMPLETED|Overall Study||121
2218467|NCT02896855|5439908|P2|COMPLETED|Overall Study||0
2218468|NCT02896855|5439909|P1|COMPLETED|Overall Study||0
2218469|NCT02896855|5439908|P2|Received Any Study Treatment|Overall Study||122
2218470|NCT02896855|5439909|P1|Received Any Study Treatment|Overall Study||120
2218471|NCT02896855|5439908|P2|STARTED|Overall Study||122
2218472|NCT02896855|5439909|P1|STARTED|Overall Study||121
2218473|NCT02896595|5439941|P2|NOT COMPLETED|Overall Study||0
2218474|NCT02896595|5439942|P1|NOT COMPLETED|Overall Study||0
2218475|NCT02896595|5439941|P2|COMPLETED|Overall Study||50
2218476|NCT02896595|5439942|P1|COMPLETED|Overall Study||50
2218477|NCT02896595|5439941|P2|STARTED|Overall Study||50
2218478|NCT02896595|5439942|P1|STARTED|Overall Study||50
2218479|NCT02896361|5439990|P3|NOT COMPLETED|Third Intervention (2 Weeks)||0
2218480|NCT02896361|5439991|P2|NOT COMPLETED|Third Intervention (2 Weeks)||1
2218481|NCT02896361|5439992|P1|NOT COMPLETED|Third Intervention (2 Weeks)||1
2218482|NCT02896361|5439990|P3|COMPLETED|Third Intervention (2 Weeks)||8
2218483|NCT02896361|5439991|P2|COMPLETED|Third Intervention (2 Weeks)||9
2218484|NCT02896361|5439992|P1|COMPLETED|Third Intervention (2 Weeks)||8
2218485|NCT02896361|5439990|P3|STARTED|Third Intervention (2 Weeks)||8
2218486|NCT02896361|5439991|P2|STARTED|Third Intervention (2 Weeks)||10
2218487|NCT02896361|5439992|P1|STARTED|Third Intervention (2 Weeks)||9
2218488|NCT02896361|5439990|P3|NOT COMPLETED|Second Intervention (2 Weeks)||0
2218489|NCT02896361|5439991|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
2218490|NCT02896361|5439992|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
2218491|NCT02896361|5439990|P3|COMPLETED|Second Intervention (2 Weeks)||8
2218492|NCT02896361|5439991|P2|COMPLETED|Second Intervention (2 Weeks)||10
2218493|NCT02896361|5439992|P1|COMPLETED|Second Intervention (2 Weeks)||9
2218494|NCT02896361|5439990|P3|STARTED|Second Intervention (2 Weeks)||8
2218495|NCT02896361|5439991|P2|STARTED|Second Intervention (2 Weeks)||10
2218496|NCT02896361|5439992|P1|STARTED|Second Intervention (2 Weeks)||9
2218497|NCT02896361|5439990|P3|NOT COMPLETED|First Intervention (2 Weeks)||0
2218498|NCT02896361|5439991|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
2218499|NCT02896361|5439992|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
2218500|NCT02896361|5439990|P3|COMPLETED|First Intervention (2 Weeks)||8
2218501|NCT02896361|5439991|P2|COMPLETED|First Intervention (2 Weeks)||10
2218502|NCT02896361|5439992|P1|COMPLETED|First Intervention (2 Weeks)||9
2218503|NCT02896361|5439990|P3|STARTED|First Intervention (2 Weeks)||8
2218504|NCT02896361|5439991|P2|STARTED|First Intervention (2 Weeks)||10
2218505|NCT02896361|5439992|P1|STARTED|First Intervention (2 Weeks)||9
2218506|NCT02896296|5440010|P1|NOT COMPLETED|Overall Study||42
2218507|NCT02896296|5440010|P1|COMPLETED|Overall Study||166
2218508|NCT02896296|5440010|P1|STARTED|Overall Study||208
2218509|NCT02895347|5440018|P2|NOT COMPLETED|Overall Study||1
2218510|NCT02895347|5440019|P1|NOT COMPLETED|Overall Study||3
2218511|NCT02895347|5440018|P2|COMPLETED|Overall Study||19
2218512|NCT02895347|5440019|P1|COMPLETED|Overall Study||17
2218513|NCT02895347|5440018|P2|STARTED|Overall Study||20
2218514|NCT02895347|5440019|P1|STARTED|Overall Study||20
2218515|NCT02895295|5440031|P3|NOT COMPLETED|Overall Study||92
2218516|NCT02895295|5440032|P2|NOT COMPLETED|Overall Study||94
2218517|NCT02895295|5440033|P1|NOT COMPLETED|Overall Study||71
2218518|NCT02895295|5440031|P3|COMPLETED|Overall Study||299
2218519|NCT02895295|5440032|P2|COMPLETED|Overall Study||316
2218520|NCT02895295|5440033|P1|COMPLETED|Overall Study||313
2218521|NCT02895295|5440031|P3|STARTED|Overall Study||391
2218522|NCT02895295|5440032|P2|STARTED|Overall Study||410
2218523|NCT02895295|5440033|P1|STARTED|Overall Study||384
2218524|NCT02895035|5440050|P2|NOT COMPLETED|Overall Study||12
2218525|NCT02895035|5440051|P1|NOT COMPLETED|Overall Study||5
2218526|NCT02895035|5440050|P2|COMPLETED|Overall Study||24
2218527|NCT02895035|5440051|P1|COMPLETED|Overall Study||18
2218528|NCT02895035|5440050|P2|STARTED|Overall Study||36
2218529|NCT02895035|5440051|P1|STARTED|Overall Study||23
2218530|NCT02894840|5440067|P4|NOT COMPLETED|Overall Study||0
2218531|NCT02894840|5440068|P3|NOT COMPLETED|Overall Study||3
2218532|NCT02894840|5440069|P2|NOT COMPLETED|Overall Study||0
2218533|NCT02894840|5440070|P1|NOT COMPLETED|Overall Study||1
2218534|NCT02894840|5440067|P4|COMPLETED|Overall Study||100
2218535|NCT02894840|5440068|P3|COMPLETED|Overall Study||197
2218536|NCT02894840|5440069|P2|COMPLETED|Overall Study||20
2218537|NCT02894840|5440070|P1|COMPLETED|Overall Study||19
2218538|NCT02894840|5440067|P4|STARTED|Overall Study||100
2218539|NCT02894840|5440068|P3|STARTED|Overall Study||200
2218540|NCT02894840|5440069|P2|STARTED|Overall Study||20
2218541|NCT02894840|5440070|P1|STARTED|Overall Study||20
2218542|NCT02893878|5440095|P3|NOT COMPLETED|Overall Study||0
2218543|NCT02893878|5440096|P2|NOT COMPLETED|Overall Study||0
2218544|NCT02893878|5440097|P1|NOT COMPLETED|Overall Study||0
2218545|NCT02893878|5440095|P3|COMPLETED|Overall Study||3178
2218546|NCT02893878|5440096|P2|COMPLETED|Overall Study||2295
2218547|NCT02893878|5440097|P1|COMPLETED|Overall Study||13861
2218548|NCT02893878|5440095|P3|STARTED|Overall Study||3178
2218549|NCT02893878|5440096|P2|STARTED|Overall Study||2295
2218550|NCT02893878|5440097|P1|STARTED|Overall Study||13861
2218551|NCT02892734|5440342|P1|NOT COMPLETED|Follow up for 2 Years||3
2218552|NCT02892734|5440342|P1|COMPLETED|Follow up for 2 Years||0
2218553|NCT02892734|5440342|P1|STARTED|Follow up for 2 Years||3
2218554|NCT02892734|5440342|P1|NOT COMPLETED|Treatment on Study||2
2218555|NCT02892734|5440342|P1|COMPLETED|Treatment on Study||1
2218556|NCT02892734|5440342|P1|Went on to Start Cycle 2|Treatment on Study||1
2218557|NCT02892734|5440342|P1|Completed 1st Cycle/Response at 12 Weeks|Treatment on Study||1
2218558|NCT02892734|5440342|P1|STARTED|Treatment on Study||3
2218559|NCT02892513|5440348|P2|NOT COMPLETED|Overall Study||1
2218560|NCT02892513|5440349|P1|NOT COMPLETED|Overall Study||0
2218561|NCT02892513|5440348|P2|COMPLETED|Overall Study|Discontinued intervention early = 6; excluded from analysis = 1|24
2218562|NCT02892513|5440349|P1|COMPLETED|Overall Study|Discontinued intervention early = 5; excluded from analysis = 0|28
2218563|NCT02892513|5440348|P2|STARTED|Overall Study|did not receive allocated intervention = 1 (withdrew per participant request)|25
2218564|NCT02892513|5440349|P1|STARTED|Overall Study||28
2218565|NCT02892409|5440357|P2|NOT COMPLETED|Overall Study||1
2218566|NCT02892409|5440358|P1|NOT COMPLETED|Overall Study||3
2218567|NCT02892409|5440357|P2|COMPLETED|Overall Study||14
2218568|NCT02892409|5440358|P1|COMPLETED|Overall Study||12
2218569|NCT02892409|5440357|P2|STARTED|Overall Study||15
2218570|NCT02892409|5440358|P1|STARTED|Overall Study||15
2218571|NCT02892344|5440380|P2|NOT COMPLETED|Overall Study||21
2218572|NCT02892344|5440381|P1|NOT COMPLETED|Overall Study||4
2218573|NCT02892344|5440380|P2|COMPLETED|Overall Study||383
2218574|NCT02892344|5440381|P1|COMPLETED|Overall Study||394
2218575|NCT02892344|5440380|P2|Full Analysis Set|Overall Study||399
2218576|NCT02892344|5440381|P1|Full Analysis Set|Overall Study||395
2218577|NCT02892344|5440380|P2|STARTED|Overall Study||404
2218578|NCT02892344|5440381|P1|STARTED|Overall Study||398
2218579|NCT02892110|5440417|P2|NOT COMPLETED|Overall Study||12
2218580|NCT02892110|5440418|P1|NOT COMPLETED|Overall Study||13
2218581|NCT02892110|5440417|P2|COMPLETED|Overall Study||25
2218582|NCT02892110|5440418|P1|COMPLETED|Overall Study||22
2218583|NCT02892110|5440417|P2|STARTED|Overall Study||37
2218584|NCT02892110|5440418|P1|STARTED|Overall Study||35
2218585|NCT02892019|5440430|P2|NOT COMPLETED|Overall Study||3
2218586|NCT02892019|5440431|P1|NOT COMPLETED|Overall Study||1
2218587|NCT02892019|5440430|P2|COMPLETED|Overall Study||36
2218588|NCT02892019|5440431|P1|COMPLETED|Overall Study||40
2218589|NCT02892019|5440430|P2|STARTED|Overall Study||39
2218590|NCT02892019|5440431|P1|STARTED|Overall Study||41
2218591|NCT02891863|5440453|P1|NOT COMPLETED|Overall Study||0
2218592|NCT02891863|5440453|P1|COMPLETED|Overall Study||9
2218593|NCT02891863|5440453|P1|STARTED|Overall Study||9
2218594|NCT02891629|5440460|P2|NOT COMPLETED|Overall Study||1
2218595|NCT02891629|5440461|P1|NOT COMPLETED|Overall Study||0
2218596|NCT02891629|5440460|P2|COMPLETED|Overall Study||4
2218597|NCT02891629|5440461|P1|COMPLETED|Overall Study||10
2218598|NCT02891629|5440460|P2|STARTED|Overall Study||5
2218599|NCT02891629|5440461|P1|STARTED|Overall Study||10
2218600|NCT02891174|5440471|P2|NOT COMPLETED|Second Intervention (24 Hours)||7
2218601|NCT02891174|5440472|P1|NOT COMPLETED|Second Intervention (24 Hours)||6
2218602|NCT02891174|5440471|P2|COMPLETED|Second Intervention (24 Hours)||3
2218603|NCT02891174|5440472|P1|COMPLETED|Second Intervention (24 Hours)||11
2218604|NCT02891174|5440471|P2|STARTED|Second Intervention (24 Hours)||10
2218605|NCT02891174|5440472|P1|STARTED|Second Intervention (24 Hours)||17
2218606|NCT02891174|5440471|P2|NOT COMPLETED|First Intervention (24 Hours)||13
2218607|NCT02891174|5440472|P1|NOT COMPLETED|First Intervention (24 Hours)||3
2218608|NCT02891174|5440471|P2|COMPLETED|First Intervention (24 Hours)||10
2218609|NCT02891174|5440472|P1|COMPLETED|First Intervention (24 Hours)||17
2218610|NCT02891174|5440471|P2|Received First Intervention|First Intervention (24 Hours)||18
2218611|NCT02891174|5440472|P1|Received First Intervention|First Intervention (24 Hours)||19
2218612|NCT02891174|5440471|P2|STARTED|First Intervention (24 Hours)||23
2218613|NCT02891174|5440472|P1|STARTED|First Intervention (24 Hours)||20
2218614|NCT02891070|5440486|P2|NOT COMPLETED|Overall Study||8
2218615|NCT02891070|5440487|P1|NOT COMPLETED|Overall Study||10
2218616|NCT02891070|5440486|P2|COMPLETED|Overall Study||106
2218617|NCT02891070|5440487|P1|COMPLETED|Overall Study||100
2218618|NCT02891070|5440486|P2|STARTED|Overall Study||114
2218619|NCT02891070|5440487|P1|STARTED|Overall Study||110
2218620|NCT02890992|5440513|P8|NOT COMPLETED|130 Weeks Open-Label Extension Period||1
2218621|NCT02890992|5440514|P7|NOT COMPLETED|130 Weeks Open-Label Extension Period||1
2218622|NCT02890992|5440515|P6|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
2218623|NCT02890992|5440516|P5|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
2218624|NCT02890992|5440517|P4|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
2218625|NCT02890992|5440518|P3|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
2218626|NCT02890992|5440519|P2|NOT COMPLETED|130 Weeks Open-Label Extension Period||3
2218627|NCT02890992|5440520|P1|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
2218628|NCT02890992|5440513|P8|COMPLETED|130 Weeks Open-Label Extension Period||4
2218629|NCT02890992|5440514|P7|COMPLETED|130 Weeks Open-Label Extension Period||5
2218630|NCT02890992|5440515|P6|COMPLETED|130 Weeks Open-Label Extension Period||5
2218631|NCT02890992|5440516|P5|COMPLETED|130 Weeks Open-Label Extension Period||6
2218632|NCT02890992|5440517|P4|COMPLETED|130 Weeks Open-Label Extension Period||6
2218633|NCT02890992|5440518|P3|COMPLETED|130 Weeks Open-Label Extension Period||4
2218634|NCT02890992|5440519|P2|COMPLETED|130 Weeks Open-Label Extension Period||3
2218635|NCT02890992|5440520|P1|COMPLETED|130 Weeks Open-Label Extension Period||3
2218636|NCT02890992|5440513|P8|Treated|130 Weeks Open-Label Extension Period||4
2218637|NCT02890992|5440514|P7|Treated|130 Weeks Open-Label Extension Period||5
2218638|NCT02890992|5440515|P6|Treated|130 Weeks Open-Label Extension Period||5
2218639|NCT02890992|5440516|P5|Treated|130 Weeks Open-Label Extension Period||6
2218640|NCT02890992|5440517|P4|Treated|130 Weeks Open-Label Extension Period||6
2218641|NCT02890992|5440518|P3|Treated|130 Weeks Open-Label Extension Period||4
2218642|NCT02890992|5440519|P2|Treated|130 Weeks Open-Label Extension Period||6
2218643|NCT02890992|5440520|P1|Treated|130 Weeks Open-Label Extension Period||3
2218644|NCT02890992|5440513|P8|STARTED|130 Weeks Open-Label Extension Period||5
2218645|NCT02890992|5440514|P7|STARTED|130 Weeks Open-Label Extension Period||6
2218646|NCT02890992|5440515|P6|STARTED|130 Weeks Open-Label Extension Period||5
2218647|NCT02890992|5440516|P5|STARTED|130 Weeks Open-Label Extension Period||6
2218648|NCT02890992|5440517|P4|STARTED|130 Weeks Open-Label Extension Period||6
2218649|NCT02890992|5440518|P3|STARTED|130 Weeks Open-Label Extension Period||4
2218650|NCT02890992|5440519|P2|STARTED|130 Weeks Open-Label Extension Period||6
2218651|NCT02890992|5440520|P1|STARTED|130 Weeks Open-Label Extension Period|3 participants from Open-Label Dose Finding Period (OLDFI) entered in OLE period.|3
2218652|NCT02890992|5440513|P8|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
2218653|NCT02890992|5440514|P7|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
2218654|NCT02890992|5440515|P6|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
2218655|NCT02890992|5440516|P5|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
2218656|NCT02890992|5440517|P4|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
2218657|NCT02890992|5440518|P3|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
2218658|NCT02890992|5440519|P2|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
2218659|NCT02890992|5440520|P1|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
2218660|NCT02890992|5440513|P8|COMPLETED|12 Weeks Open-Label Dose Finding Period||5
2218661|NCT02890992|5440514|P7|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
2218662|NCT02890992|5440515|P6|COMPLETED|12 Weeks Open-Label Dose Finding Period||5
2218663|NCT02890992|5440516|P5|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
2218664|NCT02890992|5440517|P4|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
2218665|NCT02890992|5440518|P3|COMPLETED|12 Weeks Open-Label Dose Finding Period||4
2218666|NCT02890992|5440519|P2|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
2218667|NCT02890992|5440520|P1|COMPLETED|12 Weeks Open-Label Dose Finding Period|Out of 4 participants, 3 participants entered into the open-label extension (OLE) period.|4
2218668|NCT02890992|5440513|P8|Treated|12 Weeks Open-Label Dose Finding Period||5
2218669|NCT02890992|5440514|P7|Treated|12 Weeks Open-Label Dose Finding Period||6
2218670|NCT02890992|5440515|P6|Treated|12 Weeks Open-Label Dose Finding Period||5
2218671|NCT02890992|5440516|P5|Treated|12 Weeks Open-Label Dose Finding Period||6
2218672|NCT02890992|5440517|P4|Treated|12 Weeks Open-Label Dose Finding Period||6
2218673|NCT02890992|5440518|P3|Treated|12 Weeks Open-Label Dose Finding Period||4
2218674|NCT02890992|5440519|P2|Treated|12 Weeks Open-Label Dose Finding Period||6
2218675|NCT02890992|5440520|P1|Treated|12 Weeks Open-Label Dose Finding Period||4
2218676|NCT02890992|5440513|P8|STARTED|12 Weeks Open-Label Dose Finding Period||5
2218677|NCT02890992|5440514|P7|STARTED|12 Weeks Open-Label Dose Finding Period||6
2218678|NCT02890992|5440515|P6|STARTED|12 Weeks Open-Label Dose Finding Period||5
2218679|NCT02890992|5440516|P5|STARTED|12 Weeks Open-Label Dose Finding Period||6
2218680|NCT02890992|5440517|P4|STARTED|12 Weeks Open-Label Dose Finding Period||6
2218681|NCT02890992|5440518|P3|STARTED|12 Weeks Open-Label Dose Finding Period||4
2218682|NCT02890992|5440519|P2|STARTED|12 Weeks Open-Label Dose Finding Period||6
2218683|NCT02890992|5440520|P1|STARTED|12 Weeks Open-Label Dose Finding Period||4
2218684|NCT02890381|5440688|P2|NOT COMPLETED|Overall Study||0
2218685|NCT02890381|5440689|P1|NOT COMPLETED|Overall Study||0
2218686|NCT02890381|5440688|P2|COMPLETED|Overall Study||6
2218687|NCT02890381|5440689|P1|COMPLETED|Overall Study||11
2218688|NCT02890381|5440688|P2|STARTED|Overall Study||6
2218689|NCT02890381|5440689|P1|STARTED|Overall Study||11
2218690|NCT02890303|5440715|P1|NOT COMPLETED|Overall Study||0
2218691|NCT02890303|5440715|P1|COMPLETED|Overall Study||100
2218692|NCT02890303|5440715|P1|STARTED|Overall Study||100
2218693|NCT02889289|5440719|P1|NOT COMPLETED|Overall Study||0
2218694|NCT02889289|5440719|P1|COMPLETED|Overall Study||1
2218695|NCT02889289|5440719|P1|STARTED|Overall Study||1
2218696|NCT02888756|5440731|P3|NOT COMPLETED|Analytical Treatment Interruption||5
2218697|NCT02888756|5440732|P2|NOT COMPLETED|Analytical Treatment Interruption||6
2218698|NCT02888756|5440733|P1|NOT COMPLETED|Analytical Treatment Interruption||10
2218699|NCT02888756|5440731|P3|COMPLETED|Analytical Treatment Interruption||3
2218700|NCT02888756|5440732|P2|COMPLETED|Analytical Treatment Interruption||3
2218701|NCT02888756|5440733|P1|COMPLETED|Analytical Treatment Interruption||5
2218702|NCT02888756|5440731|P3|STARTED|Analytical Treatment Interruption||8
2218703|NCT02888756|5440732|P2|STARTED|Analytical Treatment Interruption||9
2218704|NCT02888756|5440733|P1|STARTED|Analytical Treatment Interruption||15
2218705|NCT02888756|5440731|P3|NOT COMPLETED|Vaccination Period||0
2218706|NCT02888756|5440732|P2|NOT COMPLETED|Vaccination Period||0
2218707|NCT02888756|5440733|P1|NOT COMPLETED|Vaccination Period||0
2218708|NCT02888756|5440731|P3|COMPLETED|Vaccination Period||8
2218709|NCT02888756|5440732|P2|COMPLETED|Vaccination Period||9
2218710|NCT02888756|5440733|P1|COMPLETED|Vaccination Period||16
2218711|NCT02888756|5440731|P3|STARTED|Vaccination Period||8
2218712|NCT02888756|5440732|P2|STARTED|Vaccination Period||9
2218713|NCT02888756|5440733|P1|STARTED|Vaccination Period||16
2218714|NCT02888093|5440776|P2|NOT COMPLETED|Overall Study||2
2218715|NCT02888093|5440777|P1|NOT COMPLETED|Overall Study||2
2218716|NCT02888093|5440776|P2|COMPLETED|Overall Study||20
2218717|NCT02888093|5440777|P1|COMPLETED|Overall Study||20
2218718|NCT02888093|5440776|P2|STARTED|Overall Study||22
2218719|NCT02888093|5440777|P1|STARTED|Overall Study||22
2218720|NCT02887989|5440789|P2|NOT COMPLETED|Overall Study||11
2218721|NCT02887989|5440790|P1|NOT COMPLETED|Overall Study||9
2218722|NCT02887989|5440789|P2|COMPLETED|Overall Study||59
2218723|NCT02887989|5440790|P1|COMPLETED|Overall Study||61
2218724|NCT02887989|5440789|P2|STARTED|Overall Study||70
2218725|NCT02887989|5440790|P1|STARTED|Overall Study||70
2218726|NCT02887183|5440800|P1|NOT COMPLETED|Overall Study||141
2218727|NCT02887183|5440800|P1|COMPLETED|Overall Study||654
2218728|NCT02887183|5440800|P1|Full Analysis Set|Overall Study||794
2218729|NCT02887183|5440800|P1|STARTED|Overall Study||795
2218730|NCT02886923|5440813|P2|NOT COMPLETED|Period 2||0
2218731|NCT02886923|5440814|P1|NOT COMPLETED|Period 2||0
2218732|NCT02886923|5440813|P2|COMPLETED|Period 2||11
2218733|NCT02886923|5440814|P1|COMPLETED|Period 2||12
2218734|NCT02886923|5440813|P2|STARTED|Period 2||11
2218735|NCT02886923|5440814|P1|STARTED|Period 2||12
2218736|NCT02886923|5440813|P2|NOT COMPLETED|Period 1||0
2218737|NCT02886923|5440814|P1|NOT COMPLETED|Period 1||0
2218738|NCT02886923|5440813|P2|COMPLETED|Period 1||11
2218739|NCT02886923|5440814|P1|COMPLETED|Period 1||12
2218740|NCT02886923|5440813|P2|STARTED|Period 1||11
2218741|NCT02886923|5440814|P1|STARTED|Period 1||12
2218742|NCT02886715|5440827|P3|NOT COMPLETED|Overall Study||20
2218743|NCT02886715|5440828|P2|NOT COMPLETED|Overall Study||55
2218744|NCT02886715|5440829|P1|NOT COMPLETED|Overall Study||64
2218745|NCT02886715|5440827|P3|COMPLETED|Overall Study||203
2218746|NCT02886715|5440828|P2|COMPLETED|Overall Study||390
2218747|NCT02886715|5440829|P1|COMPLETED|Overall Study||378
2218748|NCT02886715|5440827|P3|Per Protocol (PP) Population|Overall Study||176
2218749|NCT02886715|5440828|P2|Per Protocol (PP) Population|Overall Study||351
2218750|NCT02886715|5440829|P1|Per Protocol (PP) Population|Overall Study||346
2218751|NCT02886715|5440827|P3|Modified ITT (mITT)|Overall Study||217
2218752|NCT02886715|5440828|P2|Modified ITT (mITT)|Overall Study||418
2218753|NCT02886715|5440829|P1|Modified ITT (mITT)|Overall Study||421
2218754|NCT02886715|5440827|P3|STARTED|Overall Study||223
2218755|NCT02886715|5440828|P2|STARTED|Overall Study||445
2218756|NCT02886715|5440829|P1|STARTED|Overall Study||442
2218757|NCT02886702|5440846|P3|NOT COMPLETED|Overall Study||53
2218758|NCT02886702|5440847|P2|NOT COMPLETED|Overall Study||51
2218759|NCT02886702|5440848|P1|NOT COMPLETED|Overall Study||48
2218760|NCT02886702|5440846|P3|COMPLETED|Overall Study||232
2218761|NCT02886702|5440847|P2|COMPLETED|Overall Study||235
2218762|NCT02886702|5440848|P1|COMPLETED|Overall Study||236
2218763|NCT02886702|5440846|P3|Per-Protocol Population (PP)|Overall Study||201
2218764|NCT02886702|5440847|P2|Per-Protocol Population (PP)|Overall Study||209
2218765|NCT02886702|5440848|P1|Per-Protocol Population (PP)|Overall Study||208
2218766|NCT02886702|5440846|P3|Modified Intent-to Treat (mITT)|Overall Study||275
2218767|NCT02886702|5440847|P2|Modified Intent-to Treat (mITT)|Overall Study||266
2218768|NCT02886702|5440848|P1|Modified Intent-to Treat (mITT)|Overall Study||263
2218769|NCT02886702|5440846|P3|STARTED|Overall Study||285
2218770|NCT02886702|5440847|P2|STARTED|Overall Study||286
2218771|NCT02886702|5440848|P1|STARTED|Overall Study||284
2218772|NCT02886624|5440862|P1|NOT COMPLETED|48-week Post Treatment Follow-up||1
2218773|NCT02886624|5440862|P1|COMPLETED|48-week Post Treatment Follow-up||28
2218774|NCT02886624|5440862|P1|STARTED|48-week Post Treatment Follow-up||29
2218775|NCT02886624|5440862|P1|NOT COMPLETED|12-week Post Treatment Follow-up||1
2218776|NCT02886624|5440862|P1|COMPLETED|12-week Post Treatment Follow-up||29
2218777|NCT02886624|5440862|P1|STARTED|12-week Post Treatment Follow-up||30
2218778|NCT02886624|5440862|P1|NOT COMPLETED|8-week Treatment||0
2218779|NCT02886624|5440862|P1|COMPLETED|8-week Treatment||30
2218780|NCT02886624|5440862|P1|STARTED|8-week Treatment||30
2218781|NCT02886338|5440871|P1|NOT COMPLETED|Overall Study||1
2218782|NCT02886338|5440871|P1|COMPLETED|Overall Study||9
2218783|NCT02886338|5440871|P1|STARTED|Overall Study||10
2218784|NCT02886234|5440877|P2|NOT COMPLETED|Overall Study||2
2218785|NCT02886234|5440878|P1|NOT COMPLETED|Overall Study||0
2218786|NCT02886234|5440877|P2|COMPLETED|Overall Study||22
2218787|NCT02886234|5440878|P1|COMPLETED|Overall Study||20
2218788|NCT02886234|5440877|P2|STARTED|Overall Study||24
2218789|NCT02886234|5440878|P1|STARTED|Overall Study||20
2218790|NCT02885636|5440900|P2|NOT COMPLETED|Overall Study||0
2218791|NCT02885636|5440901|P1|NOT COMPLETED|Overall Study||0
2218792|NCT02885636|5440900|P2|COMPLETED|Overall Study||15
2218793|NCT02885636|5440901|P1|COMPLETED|Overall Study||15
2218794|NCT02885636|5440900|P2|STARTED|Overall Study||15
2218795|NCT02885636|5440901|P1|STARTED|Overall Study||15
2218796|NCT02885506|5440943|P10|NOT COMPLETED|Part B||0
2218797|NCT02885506|5440944|P9|NOT COMPLETED|Part B||0
2218798|NCT02885506|5440945|P8|NOT COMPLETED|Part B||0
2218799|NCT02885506|5440946|P7|NOT COMPLETED|Part B||0
2218800|NCT02885506|5440947|P6|NOT COMPLETED|Part B||0
2218801|NCT02885506|5440948|P5|NOT COMPLETED|Part B||0
2218802|NCT02885506|5440949|P4|NOT COMPLETED|Part B||0
2218803|NCT02885506|5440950|P3|NOT COMPLETED|Part B||0
2218804|NCT02885506|5440951|P2|NOT COMPLETED|Part B||0
2218805|NCT02885506|5440952|P1|NOT COMPLETED|Part B||0
2218806|NCT02885506|5440943|P10|COMPLETED|Part B||4
2218807|NCT02885506|5440944|P9|COMPLETED|Part B||4
2218808|NCT02885506|5440945|P8|COMPLETED|Part B||0
2218809|NCT02885506|5440946|P7|COMPLETED|Part B||0
2218810|NCT02885506|5440947|P6|COMPLETED|Part B||0
2218811|NCT02885506|5440948|P5|COMPLETED|Part B||0
2218812|NCT02885506|5440949|P4|COMPLETED|Part B||0
2218813|NCT02885506|5440950|P3|COMPLETED|Part B||0
2218814|NCT02885506|5440951|P2|COMPLETED|Part B||0
2218815|NCT02885506|5440952|P1|COMPLETED|Part B||0
2218816|NCT02885506|5440943|P10|STARTED|Part B||4
2218817|NCT02885506|5440944|P9|STARTED|Part B||4
2218818|NCT02885506|5440945|P8|STARTED|Part B||0
2218819|NCT02885506|5440946|P7|STARTED|Part B||0
2218820|NCT02885506|5440947|P6|STARTED|Part B||0
2218821|NCT02885506|5440948|P5|STARTED|Part B||0
2218822|NCT02885506|5440949|P4|STARTED|Part B||0
2218823|NCT02885506|5440950|P3|STARTED|Part B||0
2218824|NCT02885506|5440951|P2|STARTED|Part B||0
2218825|NCT02885506|5440952|P1|STARTED|Part B||0
2218826|NCT02885506|5440943|P10|NOT COMPLETED|Part A||0
2218827|NCT02885506|5440944|P9|NOT COMPLETED|Part A||0
2218828|NCT02885506|5440945|P8|NOT COMPLETED|Part A||0
2218829|NCT02885506|5440946|P7|NOT COMPLETED|Part A||0
2218830|NCT02885506|5440947|P6|NOT COMPLETED|Part A||0
2218831|NCT02885506|5440948|P5|NOT COMPLETED|Part A||0
2218832|NCT02885506|5440949|P4|NOT COMPLETED|Part A||0
2218833|NCT02885506|5440950|P3|NOT COMPLETED|Part A||0
2218834|NCT02885506|5440951|P2|NOT COMPLETED|Part A||0
2218835|NCT02885506|5440952|P1|NOT COMPLETED|Part A||0
2218836|NCT02885506|5440943|P10|COMPLETED|Part A||0
2218837|NCT02885506|5440944|P9|COMPLETED|Part A||0
2218838|NCT02885506|5440945|P8|COMPLETED|Part A||14
2218839|NCT02885506|5440946|P7|COMPLETED|Part A||6
2218840|NCT02885506|5440947|P6|COMPLETED|Part A||6
2218841|NCT02885506|5440948|P5|COMPLETED|Part A||6
2218842|NCT02885506|5440949|P4|COMPLETED|Part A||6
2218843|NCT02885506|5440950|P3|COMPLETED|Part A||6
2218844|NCT02885506|5440951|P2|COMPLETED|Part A||6
2218845|NCT02885506|5440952|P1|COMPLETED|Part A||6
2218846|NCT02885506|5440943|P10|STARTED|Part A||0
2218847|NCT02885506|5440944|P9|STARTED|Part A||0
2218848|NCT02885506|5440945|P8|STARTED|Part A||14
2218849|NCT02885506|5440946|P7|STARTED|Part A||6
2218850|NCT02885506|5440947|P6|STARTED|Part A||6
2218851|NCT02885506|5440948|P5|STARTED|Part A||6
2218852|NCT02885506|5440949|P4|STARTED|Part A||6
2218853|NCT02885506|5440950|P3|STARTED|Part A||6
2218854|NCT02885506|5440951|P2|STARTED|Part A||6
2218855|NCT02885506|5440952|P1|STARTED|Part A||6
2218856|NCT02885181|5441048|P4|NOT COMPLETED|Overall Study||3
2218857|NCT02885181|5441049|P3|NOT COMPLETED|Overall Study||0
2218858|NCT02885181|5441050|P2|NOT COMPLETED|Overall Study||1
2218859|NCT02885181|5441051|P1|NOT COMPLETED|Overall Study||0
2218860|NCT02885181|5441048|P4|COMPLETED|Overall Study||19
2218861|NCT02885181|5441049|P3|COMPLETED|Overall Study||21
2218862|NCT02885181|5441050|P2|COMPLETED|Overall Study||19
2218863|NCT02885181|5441051|P1|COMPLETED|Overall Study||20
2218864|NCT02885181|5441048|P4|STARTED|Overall Study||22
2218865|NCT02885181|5441049|P3|STARTED|Overall Study||21
2218866|NCT02885181|5441050|P2|STARTED|Overall Study||20
2218867|NCT02885181|5441051|P1|STARTED|Overall Study||20
2218868|NCT02885012|5441079|P2|NOT COMPLETED|Overall Study||0
2218869|NCT02885012|5441080|P1|NOT COMPLETED|Overall Study||0
2218870|NCT02885012|5441079|P2|COMPLETED|Overall Study||2
2218871|NCT02885012|5441080|P1|COMPLETED|Overall Study||1
2218872|NCT02885012|5441079|P2|STARTED|Overall Study||2
2218873|NCT02885012|5441080|P1|STARTED|Overall Study||1
2218874|NCT02884492|5441092|P2|NOT COMPLETED|Overall Study||0
2218875|NCT02884492|5441093|P1|NOT COMPLETED|Overall Study||0
2218876|NCT02884492|5441092|P2|COMPLETED|Overall Study||10
2218877|NCT02884492|5441093|P1|COMPLETED|Overall Study||7
2218878|NCT02884492|5441092|P2|STARTED|Overall Study||10
2218879|NCT02884492|5441093|P1|STARTED|Overall Study||7
2218880|NCT02884427|5441102|P3|NOT COMPLETED|Overall Study||0
2218881|NCT02884427|5441103|P2|NOT COMPLETED|Overall Study||0
2218882|NCT02884427|5441104|P1|NOT COMPLETED|Overall Study||0
2218883|NCT02884427|5441102|P3|COMPLETED|Overall Study||50
2218884|NCT02884427|5441103|P2|COMPLETED|Overall Study||52
2218885|NCT02884427|5441104|P1|COMPLETED|Overall Study||48
2218886|NCT02884427|5441102|P3|STARTED|Overall Study||50
2218887|NCT02884427|5441103|P2|STARTED|Overall Study||52
2218888|NCT02884427|5441104|P1|STARTED|Overall Study||48
2218889|NCT02884089|5441118|P4|NOT COMPLETED|Follow-up Visit||1
2218890|NCT02884089|5441119|P3|NOT COMPLETED|Follow-up Visit||0
2218891|NCT02884089|5441120|P2|NOT COMPLETED|Follow-up Visit||0
2218892|NCT02884089|5441121|P1|NOT COMPLETED|Follow-up Visit||1
2218893|NCT02884089|5441118|P4|COMPLETED|Follow-up Visit||6
2218894|NCT02884089|5441119|P3|COMPLETED|Follow-up Visit||7
2218895|NCT02884089|5441120|P2|COMPLETED|Follow-up Visit||6
2218896|NCT02884089|5441121|P1|COMPLETED|Follow-up Visit||6
2218897|NCT02884089|5441118|P4|STARTED|Follow-up Visit||7
2218898|NCT02884089|5441119|P3|STARTED|Follow-up Visit||7
2218899|NCT02884089|5441120|P2|STARTED|Follow-up Visit||6
2218900|NCT02884089|5441121|P1|STARTED|Follow-up Visit||7
2218901|NCT02884089|5441118|P4|NOT COMPLETED|Period 4||0
2218902|NCT02884089|5441119|P3|NOT COMPLETED|Period 4||0
2218903|NCT02884089|5441120|P2|NOT COMPLETED|Period 4||1
2218904|NCT02884089|5441121|P1|NOT COMPLETED|Period 4||1
2218905|NCT02884089|5441118|P4|COMPLETED|Period 4||7
2218906|NCT02884089|5441119|P3|COMPLETED|Period 4||7
2218907|NCT02884089|5441120|P2|COMPLETED|Period 4||6
2218908|NCT02884089|5441121|P1|COMPLETED|Period 4||7
2218909|NCT02884089|5441118|P4|STARTED|Period 4||7
2218910|NCT02884089|5441119|P3|STARTED|Period 4||7
2218911|NCT02884089|5441120|P2|STARTED|Period 4||7
2218912|NCT02884089|5441121|P1|STARTED|Period 4||8
2218913|NCT02884089|5441118|P4|NOT COMPLETED|Washout Period 3||1
2218914|NCT02884089|5441119|P3|NOT COMPLETED|Washout Period 3||1
2218915|NCT02884089|5441120|P2|NOT COMPLETED|Washout Period 3||0
2218916|NCT02884089|5441121|P1|NOT COMPLETED|Washout Period 3||0
2218917|NCT02884089|5441118|P4|COMPLETED|Washout Period 3||7
2218918|NCT02884089|5441119|P3|COMPLETED|Washout Period 3||7
2218919|NCT02884089|5441120|P2|COMPLETED|Washout Period 3||7
2218920|NCT02884089|5441121|P1|COMPLETED|Washout Period 3||8
2218921|NCT02884089|5441118|P4|STARTED|Washout Period 3||8
2218922|NCT02884089|5441119|P3|STARTED|Washout Period 3||8
2218923|NCT02884089|5441120|P2|STARTED|Washout Period 3||7
2218924|NCT02884089|5441121|P1|STARTED|Washout Period 3||8
2218925|NCT02884089|5441118|P4|NOT COMPLETED|Period 3||0
2218926|NCT02884089|5441119|P3|NOT COMPLETED|Period 3||1
2218927|NCT02884089|5441120|P2|NOT COMPLETED|Period 3||0
2218928|NCT02884089|5441121|P1|NOT COMPLETED|Period 3||0
2218929|NCT02884089|5441118|P4|COMPLETED|Period 3||8
2218930|NCT02884089|5441119|P3|COMPLETED|Period 3||8
2218931|NCT02884089|5441120|P2|COMPLETED|Period 3||7
2218932|NCT02884089|5441121|P1|COMPLETED|Period 3||8
2218933|NCT02884089|5441118|P4|STARTED|Period 3||8
2218934|NCT02884089|5441119|P3|STARTED|Period 3||9
2218935|NCT02884089|5441120|P2|STARTED|Period 3||7
2218936|NCT02884089|5441121|P1|STARTED|Period 3||8
2218937|NCT02884089|5441118|P4|NOT COMPLETED|Washout Period 2||0
2218938|NCT02884089|5441119|P3|NOT COMPLETED|Washout Period 2||0
2218939|NCT02884089|5441120|P2|NOT COMPLETED|Washout Period 2||0
2218940|NCT02884089|5441121|P1|NOT COMPLETED|Washout Period 2||0
2218941|NCT02884089|5441118|P4|COMPLETED|Washout Period 2||8
2218942|NCT02884089|5441119|P3|COMPLETED|Washout Period 2||9
2218943|NCT02884089|5441120|P2|COMPLETED|Washout Period 2||7
2218944|NCT02884089|5441121|P1|COMPLETED|Washout Period 2||8
2218945|NCT02884089|5441118|P4|STARTED|Washout Period 2||8
2218946|NCT02884089|5441119|P3|STARTED|Washout Period 2||9
2218947|NCT02884089|5441120|P2|STARTED|Washout Period 2||7
2218948|NCT02884089|5441121|P1|STARTED|Washout Period 2||8
2218949|NCT02884089|5441118|P4|NOT COMPLETED|Period 2||0
2218950|NCT02884089|5441119|P3|NOT COMPLETED|Period 2||0
2218951|NCT02884089|5441120|P2|NOT COMPLETED|Period 2||0
2218952|NCT02884089|5441121|P1|NOT COMPLETED|Period 2||1
2218953|NCT02884089|5441118|P4|COMPLETED|Period 2||8
2218954|NCT02884089|5441119|P3|COMPLETED|Period 2||9
2218955|NCT02884089|5441120|P2|COMPLETED|Period 2||7
2218956|NCT02884089|5441121|P1|COMPLETED|Period 2||8
2218957|NCT02884089|5441118|P4|STARTED|Period 2||8
2218958|NCT02884089|5441119|P3|STARTED|Period 2||9
2218959|NCT02884089|5441120|P2|STARTED|Period 2||7
2218960|NCT02884089|5441121|P1|STARTED|Period 2||9
2218961|NCT02884089|5441118|P4|NOT COMPLETED|Washout Period 1||1
2218962|NCT02884089|5441119|P3|NOT COMPLETED|Washout Period 1||0
2218963|NCT02884089|5441120|P2|NOT COMPLETED|Washout Period 1||2
2218964|NCT02884089|5441121|P1|NOT COMPLETED|Washout Period 1||0
2218965|NCT02884089|5441118|P4|COMPLETED|Washout Period 1||8
2218966|NCT02884089|5441119|P3|COMPLETED|Washout Period 1||9
2218967|NCT02884089|5441120|P2|COMPLETED|Washout Period 1||7
2218968|NCT02884089|5441121|P1|COMPLETED|Washout Period 1||9
2218969|NCT02884089|5441118|P4|STARTED|Washout Period 1||9
2218970|NCT02884089|5441119|P3|STARTED|Washout Period 1||9
2218971|NCT02884089|5441120|P2|STARTED|Washout Period 1||9
2218972|NCT02884089|5441121|P1|STARTED|Washout Period 1||9
2218973|NCT02884089|5441118|P4|NOT COMPLETED|Period 1||0
2218974|NCT02884089|5441119|P3|NOT COMPLETED|Period 1||0
2218975|NCT02884089|5441120|P2|NOT COMPLETED|Period 1||2
2218976|NCT02884089|5441121|P1|NOT COMPLETED|Period 1||2
2218977|NCT02884089|5441118|P4|COMPLETED|Period 1||9
2218978|NCT02884089|5441119|P3|COMPLETED|Period 1||9
2218979|NCT02884089|5441120|P2|COMPLETED|Period 1||9
2218980|NCT02884089|5441121|P1|COMPLETED|Period 1||9
2218981|NCT02884089|5441118|P4|Received at Least One Dose of Study Drug|Period 1||9
2218982|NCT02884089|5441119|P3|Received at Least One Dose of Study Drug|Period 1||9
2218983|NCT02884089|5441120|P2|Received at Least One Dose of Study Drug|Period 1||11
2218984|NCT02884089|5441121|P1|Received at Least One Dose of Study Drug|Period 1||11
2218985|NCT02884089|5441118|P4|STARTED|Period 1||9
2218986|NCT02884089|5441119|P3|STARTED|Period 1||9
2218987|NCT02884089|5441120|P2|STARTED|Period 1||11
2218988|NCT02884089|5441121|P1|STARTED|Period 1||11
2218989|NCT02883244|5441137|P2|NOT COMPLETED|Overall Study||1
2218990|NCT02883244|5441138|P1|NOT COMPLETED|Overall Study||0
2218991|NCT02883244|5441137|P2|COMPLETED|Overall Study||25
2218992|NCT02883244|5441138|P1|COMPLETED|Overall Study||24
2218993|NCT02883244|5441137|P2|STARTED|Overall Study||26
2218994|NCT02883244|5441138|P1|STARTED|Overall Study||24
2218995|NCT02882854|5441156|P2|NOT COMPLETED|Overall Study||3
2218996|NCT02882854|5441157|P1|NOT COMPLETED|Overall Study||1
2218997|NCT02882854|5441156|P2|COMPLETED|Overall Study||41
2218998|NCT02882854|5441157|P1|COMPLETED|Overall Study||39
2218999|NCT02882854|5441156|P2|STARTED|Overall Study||44
2219000|NCT02882854|5441157|P1|STARTED|Overall Study||40
2219001|NCT02882633|5441181|P2|NOT COMPLETED|Overall Study||0
2219002|NCT02882633|5441182|P1|NOT COMPLETED|Overall Study||2
2219003|NCT02882633|5441181|P2|COMPLETED|Overall Study||25
2219004|NCT02882633|5441182|P1|COMPLETED|Overall Study||23
2219005|NCT02882633|5441181|P2|STARTED|Overall Study||25
2219006|NCT02882633|5441182|P1|STARTED|Overall Study||25
2219007|NCT02882152|5441194|P2|NOT COMPLETED|Overall Study||0
2219008|NCT02882152|5441195|P1|NOT COMPLETED|Overall Study||1
2219009|NCT02882152|5441194|P2|COMPLETED|Overall Study||20
2219010|NCT02882152|5441195|P1|COMPLETED|Overall Study||19
2219011|NCT02882152|5441194|P2|STARTED|Overall Study||20
2219012|NCT02882152|5441195|P1|STARTED|Overall Study||20
2219013|NCT02881840|5441203|P1|NOT COMPLETED|Overall Study||0
2219014|NCT02881840|5441203|P1|COMPLETED|Overall Study||6
2219015|NCT02881840|5441203|P1|STARTED|Overall Study||6
2219016|NCT02881775|5441207|P2|NOT COMPLETED|Second Intervention (1-Hour Session)||0
2219017|NCT02881775|5441208|P1|NOT COMPLETED|Second Intervention (1-Hour Session)||0
2219018|NCT02881775|5441207|P2|COMPLETED|Second Intervention (1-Hour Session)||7
2219019|NCT02881775|5441208|P1|COMPLETED|Second Intervention (1-Hour Session)||9
2219020|NCT02881775|5441207|P2|STARTED|Second Intervention (1-Hour Session)||7
2219021|NCT02881775|5441208|P1|STARTED|Second Intervention (1-Hour Session)||9
2219022|NCT02881775|5441207|P2|NOT COMPLETED|Washout (1 Week)||0
2219023|NCT02881775|5441208|P1|NOT COMPLETED|Washout (1 Week)||0
2219024|NCT02881775|5441207|P2|COMPLETED|Washout (1 Week)||7
2219025|NCT02881775|5441208|P1|COMPLETED|Washout (1 Week)||9
2219026|NCT02881775|5441207|P2|STARTED|Washout (1 Week)||7
2219027|NCT02881775|5441208|P1|STARTED|Washout (1 Week)||9
2219028|NCT02881775|5441207|P2|NOT COMPLETED|First Intervention (1-hr Session)||0
2219029|NCT02881775|5441208|P1|NOT COMPLETED|First Intervention (1-hr Session)||0
2219030|NCT02881775|5441207|P2|COMPLETED|First Intervention (1-hr Session)||7
2219031|NCT02881775|5441208|P1|COMPLETED|First Intervention (1-hr Session)||9
2219032|NCT02881775|5441207|P2|STARTED|First Intervention (1-hr Session)|Two participants dropped out prior to First Intervention (1-hr Session).|7
2219033|NCT02881775|5441208|P1|STARTED|First Intervention (1-hr Session)|Two participants dropped out prior to First Intervention (1-hr Session).|9
2219034|NCT02881775|5441207|P2|NOT COMPLETED|Baseline||0
2219035|NCT02881775|5441208|P1|NOT COMPLETED|Baseline||0
2219036|NCT02881775|5441207|P2|COMPLETED|Baseline||9
2219037|NCT02881775|5441208|P1|COMPLETED|Baseline||11
2219038|NCT02881775|5441207|P2|STARTED|Baseline||9
2219039|NCT02881775|5441208|P1|STARTED|Baseline||11
2219040|NCT02881658|5441230|P2|NOT COMPLETED|Overall Study||5
2219041|NCT02881658|5441231|P1|NOT COMPLETED|Overall Study||2
2219042|NCT02881658|5441230|P2|COMPLETED|Overall Study||96
2219043|NCT02881658|5441231|P1|COMPLETED|Overall Study||98
2219044|NCT02881658|5441230|P2|STARTED|Overall Study||101
2219045|NCT02881658|5441231|P1|STARTED|Overall Study||100
2219046|NCT02881567|5441265|P1|NOT COMPLETED|Overall Study||18
2219047|NCT02881567|5441265|P1|COMPLETED|Overall Study||23
2219048|NCT02881567|5441265|P1|STARTED|Overall Study||41
2219049|NCT02881112|5441277|P1|NOT COMPLETED|Overall Study||28
2219050|NCT02881112|5441277|P1|COMPLETED|Overall Study||152
2219051|NCT02881112|5441277|P1|STARTED|Overall Study||180
2219052|NCT02881008|5441287|P6|NOT COMPLETED|Overall Study||0
2219053|NCT02881008|5441288|P5|NOT COMPLETED|Overall Study||0
2219054|NCT02881008|5441289|P4|NOT COMPLETED|Overall Study||0
2219055|NCT02881008|5441290|P3|NOT COMPLETED|Overall Study||0
2219056|NCT02881008|5441291|P2|NOT COMPLETED|Overall Study||0
2219057|NCT02881008|5441292|P1|NOT COMPLETED|Overall Study||0
2219058|NCT02881008|5441287|P6|COMPLETED|Overall Study||8
2219059|NCT02881008|5441288|P5|COMPLETED|Overall Study||8
2219060|NCT02881008|5441289|P4|COMPLETED|Overall Study||8
2219061|NCT02881008|5441290|P3|COMPLETED|Overall Study||8
2219062|NCT02881008|5441291|P2|COMPLETED|Overall Study||8
2219063|NCT02881008|5441292|P1|COMPLETED|Overall Study||8
2219064|NCT02881008|5441287|P6|STARTED|Overall Study||8
2219065|NCT02881008|5441288|P5|STARTED|Overall Study||8
2219066|NCT02881008|5441289|P4|STARTED|Overall Study||8
2219067|NCT02881008|5441290|P3|STARTED|Overall Study||8
2219068|NCT02881008|5441291|P2|STARTED|Overall Study||8
2219069|NCT02881008|5441292|P1|STARTED|Overall Study||8
2219070|NCT02880852|5441325|P1|NOT COMPLETED|Overall Study||0
2219071|NCT02880852|5441325|P1|COMPLETED|Overall Study||20
2219072|NCT02880852|5441325|P1|STARTED|Overall Study||20
2219073|NCT02880761|5441353|P2|NOT COMPLETED|Overall Study||21
2219074|NCT02880761|5441354|P1|NOT COMPLETED|Overall Study||16
2219075|NCT02880761|5441353|P2|COMPLETED|Overall Study||85
2219076|NCT02880761|5441354|P1|COMPLETED|Overall Study||87
2219077|NCT02880761|5441353|P2|STARTED|Overall Study||106
2219078|NCT02880761|5441354|P1|STARTED|Overall Study||103
2219079|NCT02880514|5441364|P2|NOT COMPLETED|Overall Study||0
2219080|NCT02880514|5441365|P1|NOT COMPLETED|Overall Study||0
2219081|NCT02880514|5441364|P2|COMPLETED|Overall Study||50
2219082|NCT02880514|5441365|P1|COMPLETED|Overall Study||50
2219083|NCT02880514|5441364|P2|STARTED|Overall Study|A total of 50 subjects with one sinus side assigned to the control group|50
2219084|NCT02880514|5441365|P1|STARTED|Overall Study|A total of 50 subjects with one sinus side assigned to the treatment group|50
2219085|NCT02880475|5441374|P2|NOT COMPLETED|Overall Study||0
2219086|NCT02880475|5441375|P1|NOT COMPLETED|Overall Study||0
2219087|NCT02880475|5441374|P2|COMPLETED|Overall Study||17
2219088|NCT02880475|5441375|P1|COMPLETED|Overall Study||13
2219089|NCT02880475|5441374|P2|STARTED|Overall Study||17
2219090|NCT02880475|5441375|P1|STARTED|Overall Study||13
2219091|NCT02880254|5441509|P2|NOT COMPLETED|Overall Study||10
2219092|NCT02880254|5441510|P1|NOT COMPLETED|Overall Study||9
2219093|NCT02880254|5441509|P2|COMPLETED|Overall Study||4
2219094|NCT02880254|5441510|P1|COMPLETED|Overall Study||4
2219095|NCT02880254|5441509|P2|STARTED|Overall Study||14
2219096|NCT02880254|5441510|P1|STARTED|Overall Study||13
2219097|NCT02880228|5441518|P1|NOT COMPLETED|Overall Study||0
2219098|NCT02880228|5441518|P1|COMPLETED|Overall Study||11
2219099|NCT02880228|5441518|P1|STARTED|Overall Study||11
2219100|NCT02880189|5441526|P1|NOT COMPLETED|Overall Study||0
2219101|NCT02880189|5441526|P1|COMPLETED|Overall Study||21
2219102|NCT02880189|5441526|P1|STARTED|Overall Study||21
2219103|NCT02880137|5441531|P1|NOT COMPLETED|Overall Study||0
2219104|NCT02880137|5441531|P1|COMPLETED|Overall Study||36
2219105|NCT02880137|5441531|P1|STARTED|Overall Study||36
2219106|NCT02879747|5441538|P3|NOT COMPLETED|Overall Study||2
2219107|NCT02879747|5441539|P2|NOT COMPLETED|Overall Study||6
2219108|NCT02879747|5441540|P1|NOT COMPLETED|Overall Study||4
2219109|NCT02879747|5441538|P3|COMPLETED|Overall Study||31
2219110|NCT02879747|5441539|P2|COMPLETED|Overall Study||32
2219111|NCT02879747|5441540|P1|COMPLETED|Overall Study||23
2219112|NCT02879747|5441538|P3|STARTED|Overall Study||33
2219113|NCT02879747|5441539|P2|STARTED|Overall Study||38
2219114|NCT02879747|5441540|P1|STARTED|Overall Study||27
2219115|NCT02879032|5441557|P1|NOT COMPLETED|Overall Study||0
2219116|NCT02879032|5441557|P1|COMPLETED|Overall Study||130
2219117|NCT02879032|5441557|P1|STARTED|Overall Study||130
2219118|NCT02878590|5441563|P1|NOT COMPLETED|Overall Study||2
2219119|NCT02878590|5441563|P1|COMPLETED|Overall Study||10
2219120|NCT02878590|5441563|P1|STARTED|Overall Study||12
2219121|NCT02878486|5441569|P2|NOT COMPLETED|Overall Study||0
2219122|NCT02878486|5441570|P1|NOT COMPLETED|Overall Study||0
2219123|NCT02878486|5441569|P2|COMPLETED|Overall Study||3
2219124|NCT02878486|5441570|P1|COMPLETED|Overall Study||3
2219125|NCT02878486|5441569|P2|STARTED|Overall Study||3
2219126|NCT02878486|5441570|P1|STARTED|Overall Study||3
2219127|NCT02878330|5441588|P2|NOT COMPLETED|Overall Study||56
2219128|NCT02878330|5441589|P1|NOT COMPLETED|Overall Study||29
2219129|NCT02878330|5441588|P2|COMPLETED|Overall Study||913
2219130|NCT02878330|5441589|P1|COMPLETED|Overall Study||455
2219131|NCT02878330|5441588|P2|STARTED|Overall Study||969
2219132|NCT02878330|5441589|P1|STARTED|Overall Study||484
2219133|NCT02878213|5441605|P1|NOT COMPLETED|Overall Study||3
2219134|NCT02878213|5441605|P1|COMPLETED|Overall Study||36
2219135|NCT02878213|5441605|P1|STARTED|Overall Study||39
2219136|NCT02877927|5441612|P2|NOT COMPLETED|Overall Study||57
2219137|NCT02877927|5441613|P1|NOT COMPLETED|Overall Study||54
2219138|NCT02877927|5441612|P2|COMPLETED|Overall Study||310
2219139|NCT02877927|5441613|P1|COMPLETED|Overall Study||314
2219140|NCT02877927|5441612|P2|STARTED|Overall Study||367
2219141|NCT02877927|5441613|P1|STARTED|Overall Study||368
2219142|NCT02877732|5441625|P2|NOT COMPLETED|Overall Study||6
2219143|NCT02877732|5441626|P1|NOT COMPLETED|Overall Study||6
2219144|NCT02877732|5441625|P2|COMPLETED|Overall Study||0
2219145|NCT02877732|5441626|P1|COMPLETED|Overall Study||0
2219146|NCT02877732|5441625|P2|STARTED|Overall Study||6
2219147|NCT02877732|5441626|P1|STARTED|Overall Study||6
2219148|NCT02877095|5441644|P2|NOT COMPLETED|Overall Study||0
2219149|NCT02877095|5441645|P1|NOT COMPLETED|Overall Study||0
2219150|NCT02877095|5441644|P2|COMPLETED|Overall Study||20
2219151|NCT02877095|5441645|P1|COMPLETED|Overall Study||20
2219152|NCT02877095|5441644|P2|STARTED|Overall Study||20
2219153|NCT02877095|5441645|P1|STARTED|Overall Study|First patient enrolled 1/9/17.|20
2219154|NCT02877082|5441651|P1|NOT COMPLETED|Overall Study||5
2219155|NCT02877082|5441651|P1|COMPLETED|Overall Study||0
2219156|NCT02877082|5441651|P1|STARTED|Overall Study||5
2219157|NCT02877004|5441662|P3|NOT COMPLETED|Overall Study||1
2219158|NCT02877004|5441663|P2|NOT COMPLETED|Overall Study||0
2219159|NCT02877004|5441664|P1|NOT COMPLETED|Overall Study||0
2219160|NCT02877004|5441662|P3|COMPLETED|Overall Study||19
2219161|NCT02877004|5441663|P2|COMPLETED|Overall Study||20
2219162|NCT02877004|5441664|P1|COMPLETED|Overall Study||20
2219163|NCT02877004|5441662|P3|STARTED|Overall Study||20
2219164|NCT02877004|5441663|P2|STARTED|Overall Study||20
2219165|NCT02877004|5441664|P1|STARTED|Overall Study||20
2219166|NCT02876926|5441678|P3|NOT COMPLETED|Overall Study||20
2219167|NCT02876926|5441679|P2|NOT COMPLETED|Overall Study||19
2219168|NCT02876926|5441680|P1|NOT COMPLETED|Overall Study||18
2219169|NCT02876926|5441678|P3|COMPLETED|Overall Study||2
2219170|NCT02876926|5441679|P2|COMPLETED|Overall Study||3
2219171|NCT02876926|5441680|P1|COMPLETED|Overall Study||3
2219172|NCT02876926|5441678|P3|STARTED|Overall Study||22
2219173|NCT02876926|5441679|P2|STARTED|Overall Study||22
2219174|NCT02876926|5441680|P1|STARTED|Overall Study||21
2219175|NCT02876757|5441696|P2|NOT COMPLETED|Overall Study||0
2219176|NCT02876757|5441697|P1|NOT COMPLETED|Overall Study||0
2219177|NCT02876757|5441696|P2|COMPLETED|Overall Study||93197
2219178|NCT02876757|5441697|P1|COMPLETED|Overall Study||93197
2219179|NCT02876757|5441696|P2|STARTED|Overall Study||93197
2219180|NCT02876757|5441697|P1|STARTED|Overall Study||93197
2219181|NCT02876601|5441711|P4|NOT COMPLETED|Second Intervention (24 Hours)||0
2219182|NCT02876601|5441712|P3|NOT COMPLETED|Second Intervention (24 Hours)||0
2219183|NCT02876601|5441713|P2|NOT COMPLETED|Second Intervention (24 Hours)||0
2219184|NCT02876601|5441714|P1|NOT COMPLETED|Second Intervention (24 Hours)||0
2219185|NCT02876601|5441711|P4|COMPLETED|Second Intervention (24 Hours)||2
2219186|NCT02876601|5441712|P3|COMPLETED|Second Intervention (24 Hours)||1
2219187|NCT02876601|5441713|P2|COMPLETED|Second Intervention (24 Hours)||8
2219188|NCT02876601|5441714|P1|COMPLETED|Second Intervention (24 Hours)||8
2219189|NCT02876601|5441711|P4|STARTED|Second Intervention (24 Hours)||2
2219190|NCT02876601|5441712|P3|STARTED|Second Intervention (24 Hours)||1
2219191|NCT02876601|5441713|P2|STARTED|Second Intervention (24 Hours)||8
2219192|NCT02876601|5441714|P1|STARTED|Second Intervention (24 Hours)||8
2219193|NCT02876601|5441711|P4|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
2219194|NCT02876601|5441712|P3|NOT COMPLETED|Washout (Minimum of 6 Weeks)||1
2219195|NCT02876601|5441713|P2|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
2219196|NCT02876601|5441714|P1|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
2219197|NCT02876601|5441711|P4|COMPLETED|Washout (Minimum of 6 Weeks)||2
2219198|NCT02876601|5441712|P3|COMPLETED|Washout (Minimum of 6 Weeks)||1
2219199|NCT02876601|5441713|P2|COMPLETED|Washout (Minimum of 6 Weeks)||8
2219200|NCT02876601|5441714|P1|COMPLETED|Washout (Minimum of 6 Weeks)||8
2219201|NCT02876601|5441711|P4|STARTED|Washout (Minimum of 6 Weeks)||2
2219202|NCT02876601|5441712|P3|STARTED|Washout (Minimum of 6 Weeks)||2
2219203|NCT02876601|5441713|P2|STARTED|Washout (Minimum of 6 Weeks)||8
2219204|NCT02876601|5441714|P1|STARTED|Washout (Minimum of 6 Weeks)||8
2219205|NCT02876601|5441711|P4|NOT COMPLETED|First Intervention (24 Hours)||0
2219206|NCT02876601|5441712|P3|NOT COMPLETED|First Intervention (24 Hours)||0
2219207|NCT02876601|5441713|P2|NOT COMPLETED|First Intervention (24 Hours)||0
2219208|NCT02876601|5441714|P1|NOT COMPLETED|First Intervention (24 Hours)||0
2219209|NCT02876601|5441711|P4|COMPLETED|First Intervention (24 Hours)||2
2219210|NCT02876601|5441712|P3|COMPLETED|First Intervention (24 Hours)||2
2219211|NCT02876601|5441713|P2|COMPLETED|First Intervention (24 Hours)||8
2219212|NCT02876601|5441714|P1|COMPLETED|First Intervention (24 Hours)||8
2219213|NCT02876601|5441711|P4|STARTED|First Intervention (24 Hours)||2
2219214|NCT02876601|5441712|P3|STARTED|First Intervention (24 Hours)||2
2219215|NCT02876601|5441713|P2|STARTED|First Intervention (24 Hours)||8
2219216|NCT02876601|5441714|P1|STARTED|First Intervention (24 Hours)||8
2219217|NCT02876575|5441764|P1|NOT COMPLETED|Overall Study||0
2219218|NCT02876575|5441764|P1|COMPLETED|Overall Study||48
2219219|NCT02876575|5441764|P1|STARTED|Overall Study||48
2219220|NCT02876159|5441780|P2|NOT COMPLETED|Overall Study||0
2219221|NCT02876159|5441781|P1|NOT COMPLETED|Overall Study||0
2219222|NCT02876159|5441780|P2|COMPLETED|Overall Study||10
2219223|NCT02876159|5441781|P1|COMPLETED|Overall Study||10
2219224|NCT02876159|5441780|P2|STARTED|Overall Study||10
2219225|NCT02876159|5441781|P1|STARTED|Overall Study||10
2219226|NCT02876055|5441800|P3|NOT COMPLETED|Overall Study||0
2219227|NCT02876055|5441801|P2|NOT COMPLETED|Overall Study||0
2219228|NCT02876055|5441802|P1|NOT COMPLETED|Overall Study||0
2219229|NCT02876055|5441800|P3|COMPLETED|Overall Study||42
2219230|NCT02876055|5441801|P2|COMPLETED|Overall Study||41
2219231|NCT02876055|5441802|P1|COMPLETED|Overall Study||42
2219232|NCT02876055|5441800|P3|STARTED|Overall Study||42
2219233|NCT02876055|5441801|P2|STARTED|Overall Study||41
2219234|NCT02876055|5441802|P1|STARTED|Overall Study||42
2219235|NCT02875977|5441812|P2|NOT COMPLETED|Overall Study||29
2219236|NCT02875977|5441813|P1|NOT COMPLETED|Overall Study||42
2219237|NCT02875977|5441812|P2|COMPLETED|Overall Study||71
2219238|NCT02875977|5441813|P1|COMPLETED|Overall Study||58
2219239|NCT02875977|5441812|P2|STARTED|Overall Study||100
2219240|NCT02875977|5441813|P1|STARTED|Overall Study||100
2219241|NCT02875613|5441827|P1|NOT COMPLETED|Overall Study||1
2219242|NCT02875613|5441827|P1|COMPLETED|Overall Study||4
2219243|NCT02875613|5441827|P1|STARTED|Overall Study||5
2219244|NCT02875366|5441833|P2|NOT COMPLETED|Overall Study||3
2219245|NCT02875366|5441834|P1|NOT COMPLETED|Overall Study||0
2219246|NCT02875366|5441833|P2|COMPLETED|Overall Study||31
2219247|NCT02875366|5441834|P1|COMPLETED|Overall Study||36
2219248|NCT02875366|5441833|P2|STARTED|Overall Study||34
2219249|NCT02875366|5441834|P1|STARTED|Overall Study||36
2219250|NCT02875340|5441886|P1|NOT COMPLETED|Overall Study||8
2219251|NCT02875340|5441886|P1|COMPLETED|Overall Study|No patients completed 6 months of continuous treatment|0
2219252|NCT02875340|5441886|P1|STARTED|Overall Study||8
2219253|NCT02875028|5441910|P2|NOT COMPLETED|Second Intervention (24 Hours)||0
2219254|NCT02875028|5441911|P1|NOT COMPLETED|Second Intervention (24 Hours)||0
2219255|NCT02875028|5441910|P2|COMPLETED|Second Intervention (24 Hours)||7
2219256|NCT02875028|5441911|P1|COMPLETED|Second Intervention (24 Hours)||8
2219257|NCT02875028|5441910|P2|STARTED|Second Intervention (24 Hours)||7
2219258|NCT02875028|5441911|P1|STARTED|Second Intervention (24 Hours)||8
2219259|NCT02875028|5441910|P2|NOT COMPLETED|Washout Period||1
2219260|NCT02875028|5441911|P1|NOT COMPLETED|Washout Period||0
2219261|NCT02875028|5441910|P2|COMPLETED|Washout Period||7
2219262|NCT02875028|5441911|P1|COMPLETED|Washout Period||8
2219263|NCT02875028|5441910|P2|STARTED|Washout Period||8
2219264|NCT02875028|5441911|P1|STARTED|Washout Period||8
2219265|NCT02875028|5441910|P2|NOT COMPLETED|First Intervention (24 Hours)||0
2219266|NCT02875028|5441911|P1|NOT COMPLETED|First Intervention (24 Hours)||0
2219267|NCT02875028|5441910|P2|COMPLETED|First Intervention (24 Hours)||8
2219268|NCT02875028|5441911|P1|COMPLETED|First Intervention (24 Hours)||8
2219269|NCT02875028|5441910|P2|STARTED|First Intervention (24 Hours)||8
2219270|NCT02875028|5441911|P1|STARTED|First Intervention (24 Hours)||8
2219271|NCT02874924|5441942|P3|NOT COMPLETED|Overall Study||0
2219272|NCT02874924|5441943|P2|NOT COMPLETED|Overall Study||0
2219273|NCT02874924|5441944|P1|NOT COMPLETED|Overall Study||3
2219274|NCT02874924|5441942|P3|COMPLETED|Overall Study||6
2219275|NCT02874924|5441943|P2|COMPLETED|Overall Study||14
2219276|NCT02874924|5441944|P1|COMPLETED|Overall Study||11
2219277|NCT02874924|5441942|P3|STARTED|Overall Study||6
2219278|NCT02874924|5441943|P2|STARTED|Overall Study||14
2219279|NCT02874924|5441944|P1|STARTED|Overall Study||14
2219280|NCT02874846|5441966|P2|NOT COMPLETED|Overall Study||0
2219281|NCT02874846|5441967|P1|NOT COMPLETED|Overall Study||0
2219282|NCT02874846|5441966|P2|COMPLETED|Overall Study||4
2219283|NCT02874846|5441967|P1|COMPLETED|Overall Study||8
2219284|NCT02874846|5441966|P2|STARTED|Overall Study||4
2219285|NCT02874846|5441967|P1|STARTED|Overall Study||8
2219286|NCT02874742|5441978|P3|NOT COMPLETED|Overall Study||16
2219287|NCT02874742|5441979|P2|NOT COMPLETED|Overall Study||104
2219288|NCT02874742|5441980|P1|NOT COMPLETED|Overall Study||103
2219289|NCT02874742|5441978|P3|COMPLETED|Overall Study||0
2219290|NCT02874742|5441979|P2|COMPLETED|Overall Study||0
2219291|NCT02874742|5441980|P1|COMPLETED|Overall Study||0
2219292|NCT02874742|5441978|P3|Safety|Overall Study||16
2219293|NCT02874742|5441979|P2|Safety|Overall Study||99
2219294|NCT02874742|5441980|P1|Safety|Overall Study||102
2219295|NCT02874742|5441978|P3|STARTED|Overall Study||16
2219296|NCT02874742|5441979|P2|STARTED|Overall Study||104
2219297|NCT02874742|5441980|P1|STARTED|Overall Study||103
2219298|NCT02874066|5442032|P1|NOT COMPLETED|Overall Study||0
2219299|NCT02874066|5442032|P1|COMPLETED|Overall Study||46
2219300|NCT02874066|5442032|P1|STARTED|Overall Study||46
2219301|NCT02873754|5442040|P1|NOT COMPLETED|Overall Study||6
2219302|NCT02873754|5442040|P1|COMPLETED|Overall Study||5
2219303|NCT02873754|5442040|P1|STARTED|Overall Study||11
2219304|NCT02873702|5442057|P4|NOT COMPLETED|Maintenance Period (up to Month 6)||2
2219305|NCT02873702|5442058|P3|NOT COMPLETED|Maintenance Period (up to Month 6)||7
2219306|NCT02873702|5442059|P2|NOT COMPLETED|Maintenance Period (up to Month 6)||0
2219307|NCT02873702|5442060|P1|NOT COMPLETED|Maintenance Period (up to Month 6)||0
2219308|NCT02873702|5442057|P4|COMPLETED|Maintenance Period (up to Month 6)||6
2219309|NCT02873702|5442058|P3|COMPLETED|Maintenance Period (up to Month 6)||1
2219310|NCT02873702|5442059|P2|COMPLETED|Maintenance Period (up to Month 6)||0
2219311|NCT02873702|5442060|P1|COMPLETED|Maintenance Period (up to Month 6)||0
2219312|NCT02873702|5442057|P4|STARTED|Maintenance Period (up to Month 6)||8
2219313|NCT02873702|5442058|P3|STARTED|Maintenance Period (up to Month 6)||8
2219314|NCT02873702|5442059|P2|STARTED|Maintenance Period (up to Month 6)||0
2219315|NCT02873702|5442060|P1|STARTED|Maintenance Period (up to Month 6)||0
2219316|NCT02873702|5442057|P4|NOT COMPLETED|Healing Period (up to Week 8)||0
2219317|NCT02873702|5442058|P3|NOT COMPLETED|Healing Period (up to Week 8)||0
2219318|NCT02873702|5442059|P2|NOT COMPLETED|Healing Period (up to Week 8)||1
2219319|NCT02873702|5442060|P1|NOT COMPLETED|Healing Period (up to Week 8)||1
2219320|NCT02873702|5442057|P4|COMPLETED|Healing Period (up to Week 8)||0
2219321|NCT02873702|5442058|P3|COMPLETED|Healing Period (up to Week 8)||0
2219322|NCT02873702|5442059|P2|COMPLETED|Healing Period (up to Week 8)||16
2219323|NCT02873702|5442060|P1|COMPLETED|Healing Period (up to Week 8)||19
2219324|NCT02873702|5442057|P4|STARTED|Healing Period (up to Week 8)||0
2219325|NCT02873702|5442058|P3|STARTED|Healing Period (up to Week 8)||0
2219326|NCT02873702|5442059|P2|STARTED|Healing Period (up to Week 8)||17
2219327|NCT02873702|5442060|P1|STARTED|Healing Period (up to Week 8)||20
2219328|NCT02873689|5442072|P2|NOT COMPLETED|Overall Study||5
2219329|NCT02873689|5442073|P1|NOT COMPLETED|Overall Study||7
2219330|NCT02873689|5442072|P2|COMPLETED|Overall Study||103
2219331|NCT02873689|5442073|P1|COMPLETED|Overall Study||102
2219332|NCT02873689|5442072|P2|Treated|Overall Study||107
2219333|NCT02873689|5442073|P1|Treated|Overall Study||108
2219334|NCT02873689|5442072|P2|STARTED|Overall Study||108
2219335|NCT02873689|5442073|P1|STARTED|Overall Study||109
2219336|NCT02873481|5442083|P2|NOT COMPLETED|Overall Study||0
2219337|NCT02873481|5442084|P1|NOT COMPLETED|Overall Study||0
2219338|NCT02873481|5442083|P2|COMPLETED|Overall Study||17
2219339|NCT02873481|5442084|P1|COMPLETED|Overall Study||15
2219340|NCT02873481|5442083|P2|STARTED|Overall Study||17
2219341|NCT02873481|5442084|P1|STARTED|Overall Study||15
2219342|NCT02873429|5442101|P2|NOT COMPLETED|16 Weeks||2
2219343|NCT02873429|5442102|P1|NOT COMPLETED|16 Weeks||5
2219344|NCT02873429|5442101|P2|COMPLETED|16 Weeks||96
2219345|NCT02873429|5442102|P1|COMPLETED|16 Weeks||100
2219346|NCT02873429|5442101|P2|STARTED|16 Weeks|1 Conv. participant Missed 6-8 week but was eligible for 16 week|98
2219347|NCT02873429|5442102|P1|STARTED|16 Weeks|10 CAM participants Missed 6-8 week but are eligible for 16 week|105
2219348|NCT02873429|5442101|P2|NOT COMPLETED|6-8 Weeks||1
2219349|NCT02873429|5442102|P1|NOT COMPLETED|6-8 Weeks||10
2219350|NCT02873429|5442101|P2|COMPLETED|6-8 Weeks||97
2219351|NCT02873429|5442102|P1|COMPLETED|6-8 Weeks||95
2219352|NCT02873429|5442101|P2|STARTED|6-8 Weeks|2 Con. participants not eligible to complete follow ups because they did not continue treatment.|98
2219353|NCT02873429|5442102|P1|STARTED|6-8 Weeks|4 CAM participants not eligible to complete follow ups because they did not continue treatment.|105
2219354|NCT02873429|5442101|P2|NOT COMPLETED|Baseline||0
2219355|NCT02873429|5442102|P1|NOT COMPLETED|Baseline||0
2219356|NCT02873429|5442101|P2|COMPLETED|Baseline||100
2219357|NCT02873429|5442102|P1|COMPLETED|Baseline||109
2219358|NCT02873429|5442101|P2|STARTED|Baseline||100
2219359|NCT02873429|5442102|P1|STARTED|Baseline||109
2219360|NCT02873377|5442114|P2|NOT COMPLETED|Period Title 3: 6 Months Follow up||23
2219361|NCT02873377|5442115|P1|NOT COMPLETED|Period Title 3: 6 Months Follow up||15
2219362|NCT02873377|5442114|P2|COMPLETED|Period Title 3: 6 Months Follow up||46
2219363|NCT02873377|5442115|P1|COMPLETED|Period Title 3: 6 Months Follow up||50
2219364|NCT02873377|5442114|P2|STARTED|Period Title 3: 6 Months Follow up||69
2219365|NCT02873377|5442115|P1|STARTED|Period Title 3: 6 Months Follow up||65
2219366|NCT02873377|5442114|P2|NOT COMPLETED|Period Title 2: 3 Months Follow up||22
2219367|NCT02873377|5442115|P1|NOT COMPLETED|Period Title 2: 3 Months Follow up||22
2219368|NCT02873377|5442114|P2|COMPLETED|Period Title 2: 3 Months Follow up||47
2219369|NCT02873377|5442115|P1|COMPLETED|Period Title 2: 3 Months Follow up||43
2219370|NCT02873377|5442114|P2|STARTED|Period Title 2: 3 Months Follow up||69
2219371|NCT02873377|5442115|P1|STARTED|Period Title 2: 3 Months Follow up||65
2219372|NCT02873377|5442114|P2|NOT COMPLETED|Period 1: Enrollment||0
2219373|NCT02873377|5442115|P1|NOT COMPLETED|Period 1: Enrollment||0
2219374|NCT02873377|5442114|P2|COMPLETED|Period 1: Enrollment||69
2219375|NCT02873377|5442115|P1|COMPLETED|Period 1: Enrollment||65
2219376|NCT02873377|5442114|P2|STARTED|Period 1: Enrollment||69
2219377|NCT02873377|5442115|P1|STARTED|Period 1: Enrollment||65
2219378|NCT02873221|5442137|P3|NOT COMPLETED|Safety Follow-up Period||14
2219379|NCT02873221|5442138|P2|NOT COMPLETED|Safety Follow-up Period||17
2219380|NCT02873221|5442139|P1|NOT COMPLETED|Safety Follow-up Period||7
2219381|NCT02873221|5442137|P3|COMPLETED|Safety Follow-up Period||350
2219382|NCT02873221|5442138|P2|COMPLETED|Safety Follow-up Period||339
2219383|NCT02873221|5442139|P1|COMPLETED|Safety Follow-up Period||343
2219384|NCT02873221|5442137|P3|STARTED|Safety Follow-up Period||364
2219385|NCT02873221|5442138|P2|STARTED|Safety Follow-up Period||356
2219386|NCT02873221|5442139|P1|STARTED|Safety Follow-up Period||350
2219387|NCT02873221|5442137|P3|NOT COMPLETED|Treatment Period||105
2219388|NCT02873221|5442138|P2|NOT COMPLETED|Treatment Period||126
2219389|NCT02873221|5442139|P1|NOT COMPLETED|Treatment Period||88
2219390|NCT02873221|5442137|P3|COMPLETED|Treatment Period||315
2219391|NCT02873221|5442138|P2|COMPLETED|Treatment Period||291
2219392|NCT02873221|5442139|P1|COMPLETED|Treatment Period||329
2219393|NCT02873221|5442137|P3|Safety Population: Received Study Drug|Treatment Period||409
2219394|NCT02873221|5442138|P2|Safety Population: Received Study Drug|Treatment Period||404
2219395|NCT02873221|5442139|P1|Safety Population: Received Study Drug|Treatment Period||417
2219396|NCT02873221|5442137|P3|STARTED|Treatment Period||420
2219397|NCT02873221|5442138|P2|STARTED|Treatment Period||417
2219398|NCT02873221|5442139|P1|STARTED|Treatment Period||417
2219399|NCT02873195|5442161|P2|NOT COMPLETED|Overall Study||0
2219400|NCT02873195|5442162|P1|NOT COMPLETED|Overall Study||5
2219401|NCT02873195|5442161|P2|COMPLETED|Overall Study||46
2219402|NCT02873195|5442162|P1|COMPLETED|Overall Study||82
2219403|NCT02873195|5442161|P2|Never Began Treatment (Cancel)|Overall Study||0
2219404|NCT02873195|5442162|P1|Never Began Treatment (Cancel)|Overall Study||1
2219405|NCT02873195|5442161|P2|STARTED|Overall Study||46
2219406|NCT02873195|5442162|P1|STARTED|Overall Study||87
2219407|NCT02873104|5442176|P2|NOT COMPLETED|Overall Study||0
2219408|NCT02873104|5442177|P1|NOT COMPLETED|Overall Study||1
2219409|NCT02873104|5442176|P2|COMPLETED|Overall Study||23
2219410|NCT02873104|5442177|P1|COMPLETED|Overall Study||46
2219411|NCT02873104|5442176|P2|STARTED|Overall Study||23
2219412|NCT02873104|5442177|P1|STARTED|Overall Study||47
2219413|NCT02872909|5442191|P2|NOT COMPLETED|Overall Study||0
2219414|NCT02872909|5442192|P1|NOT COMPLETED|Overall Study||0
2219415|NCT02872909|5442191|P2|COMPLETED|Overall Study||18
2219416|NCT02872909|5442192|P1|COMPLETED|Overall Study||32
2219417|NCT02872909|5442191|P2|STARTED|Overall Study||18
2219418|NCT02872909|5442192|P1|STARTED|Overall Study||32
2219419|NCT02872311|5442209|P5|NOT COMPLETED|Overall Study||0
2219420|NCT02872311|5442210|P4|NOT COMPLETED|Overall Study||0
2219421|NCT02872311|5442211|P3|NOT COMPLETED|Overall Study||1
2219422|NCT02872311|5442212|P2|NOT COMPLETED|Overall Study||2
2219423|NCT02872311|5442213|P1|NOT COMPLETED|Overall Study||4
2219424|NCT02872311|5442209|P5|COMPLETED|Overall Study||20
2219425|NCT02872311|5442210|P4|COMPLETED|Overall Study||20
2219426|NCT02872311|5442211|P3|COMPLETED|Overall Study||19
2219427|NCT02872311|5442212|P2|COMPLETED|Overall Study||58
2219428|NCT02872311|5442213|P1|COMPLETED|Overall Study||55
2219429|NCT02872311|5442209|P5|STARTED|Overall Study||20
2219430|NCT02872311|5442210|P4|STARTED|Overall Study||20
2219431|NCT02872311|5442211|P3|STARTED|Overall Study||20
2219432|NCT02872311|5442212|P2|STARTED|Overall Study||60
2219433|NCT02872311|5442213|P1|STARTED|Overall Study||59
2219434|NCT02872285|5442274|P2|NOT COMPLETED|Overall Study||2
2219435|NCT02872285|5442275|P1|NOT COMPLETED|Overall Study||5
2219436|NCT02872285|5442274|P2|COMPLETED|Overall Study||9
2219437|NCT02872285|5442275|P1|COMPLETED|Overall Study||17
2219438|NCT02872285|5442274|P2|STARTED|Overall Study||11
2219439|NCT02872285|5442275|P1|STARTED|Overall Study||22
2219440|NCT02872103|5442291|P2|NOT COMPLETED|Cycle 2-4||1
2219441|NCT02872103|5442292|P1|NOT COMPLETED|Cycle 2-4||2
2219442|NCT02872103|5442291|P2|COMPLETED|Cycle 2-4||37
2219443|NCT02872103|5442292|P1|COMPLETED|Cycle 2-4||81
2219444|NCT02872103|5442291|P2|STARTED|Cycle 2-4|1 subject withdrawn in Cycle 1|38
2219445|NCT02872103|5442292|P1|STARTED|Cycle 2-4||83
2219446|NCT02872103|5442291|P2|NOT COMPLETED|Cycle 1||1
2219447|NCT02872103|5442292|P1|NOT COMPLETED|Cycle 1||0
2219448|NCT02872103|5442291|P2|COMPLETED|Cycle 1||38
2219449|NCT02872103|5442292|P1|COMPLETED|Cycle 1||83
2219450|NCT02872103|5442291|P2|STARTED|Cycle 1||39
2219451|NCT02872103|5442292|P1|STARTED|Cycle 1||83
2219452|NCT02872012|5442321|P5|NOT COMPLETED|Overall Study||0
2219453|NCT02872012|5442322|P4|NOT COMPLETED|Overall Study||0
2219454|NCT02872012|5442323|P3|NOT COMPLETED|Overall Study||0
2219455|NCT02872012|5442324|P2|NOT COMPLETED|Overall Study||0
2219456|NCT02872012|5442325|P1|NOT COMPLETED|Overall Study||1
2219457|NCT02872012|5442321|P5|COMPLETED|Overall Study||5
2219458|NCT02872012|5442322|P4|COMPLETED|Overall Study||3
2219459|NCT02872012|5442323|P3|COMPLETED|Overall Study||4
2219460|NCT02872012|5442324|P2|COMPLETED|Overall Study||7
2219461|NCT02872012|5442325|P1|COMPLETED|Overall Study||3
2219462|NCT02872012|5442321|P5|STARTED|Overall Study||5
2219463|NCT02872012|5442322|P4|STARTED|Overall Study||3
2219464|NCT02872012|5442323|P3|STARTED|Overall Study||4
2219465|NCT02872012|5442324|P2|STARTED|Overall Study||7
2219466|NCT02872012|5442325|P1|STARTED|Overall Study||4
2219467|NCT02871739|5442343|P4|NOT COMPLETED|Overall Study||2
2219468|NCT02871739|5442344|P3|NOT COMPLETED|Overall Study||0
2219469|NCT02871739|5442345|P2|NOT COMPLETED|Overall Study||2
2219470|NCT02871739|5442346|P1|NOT COMPLETED|Overall Study||3
2219471|NCT02871739|5442343|P4|COMPLETED|Overall Study||5
2219472|NCT02871739|5442344|P3|COMPLETED|Overall Study||4
2219473|NCT02871739|5442345|P2|COMPLETED|Overall Study||4
2219474|NCT02871739|5442346|P1|COMPLETED|Overall Study||3
2219475|NCT02871739|5442343|P4|Complete Final Survey|Overall Study||5
2219476|NCT02871739|5442344|P3|Complete Final Survey|Overall Study||4
2219477|NCT02871739|5442345|P2|Complete Final Survey|Overall Study||4
2219478|NCT02871739|5442346|P1|Complete Final Survey|Overall Study||3
2219479|NCT02871739|5442343|P4|Completed Second SPI|Overall Study||5
2219480|NCT02871739|5442344|P3|Completed Second SPI|Overall Study||4
2219481|NCT02871739|5442345|P2|Completed Second SPI|Overall Study||4
2219482|NCT02871739|5442346|P1|Completed Second SPI|Overall Study||3
2219483|NCT02871739|5442343|P4|Completed First SPI|Overall Study||6
2219484|NCT02871739|5442344|P3|Completed First SPI|Overall Study||4
2219485|NCT02871739|5442345|P2|Completed First SPI|Overall Study||5
2219486|NCT02871739|5442346|P1|Completed First SPI|Overall Study||3
2219487|NCT02871739|5442343|P4|STARTED|Overall Study||7
2219488|NCT02871739|5442344|P3|STARTED|Overall Study||4
2219489|NCT02871739|5442345|P2|STARTED|Overall Study||6
2219490|NCT02871739|5442346|P1|STARTED|Overall Study||6
2219491|NCT02871570|5442358|P2|NOT COMPLETED|Overall Study||0
2219492|NCT02871570|5442359|P1|NOT COMPLETED|Overall Study||0
2219493|NCT02871570|5442358|P2|COMPLETED|Overall Study||8
2219494|NCT02871570|5442359|P1|COMPLETED|Overall Study||8
2219495|NCT02871570|5442358|P2|STARTED|Overall Study||8
2219496|NCT02871570|5442359|P1|STARTED|Overall Study||8
2219497|NCT02871479|5442390|P3|NOT COMPLETED|Overall Study||0
2219498|NCT02871479|5442391|P2|NOT COMPLETED|Overall Study||3
2219499|NCT02871479|5442392|P1|NOT COMPLETED|Overall Study||3
2219500|NCT02871479|5442390|P3|COMPLETED|Overall Study||11
2219501|NCT02871479|5442391|P2|COMPLETED|Overall Study||21
2219502|NCT02871479|5442392|P1|COMPLETED|Overall Study||33
2219503|NCT02871479|5442390|P3|STARTED|Overall Study||11
2219504|NCT02871479|5442391|P2|STARTED|Overall Study||24
2219505|NCT02871479|5442392|P1|STARTED|Overall Study||36
2219506|NCT02871375|5442403|P2|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
2219598|NCT02867202|5442645|P2|COMPLETED|Overall Study||56
2219507|NCT02871375|5442404|P1|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
2219508|NCT02871375|5442403|P2|COMPLETED|Period 2, Second 14 Days of Wear||76
2219509|NCT02871375|5442404|P1|COMPLETED|Period 2, Second 14 Days of Wear||89
2219510|NCT02871375|5442403|P2|STARTED|Period 2, Second 14 Days of Wear||76
2219511|NCT02871375|5442404|P1|STARTED|Period 2, Second 14 Days of Wear||89
2219512|NCT02871375|5442403|P2|NOT COMPLETED|Period 1, First 14 Days of Wear||1
2219513|NCT02871375|5442404|P1|NOT COMPLETED|Period 1, First 14 Days of Wear||0
2219514|NCT02871375|5442403|P2|COMPLETED|Period 1, First 14 Days of Wear||76
2219515|NCT02871375|5442404|P1|COMPLETED|Period 1, First 14 Days of Wear||89
2219516|NCT02871375|5442403|P2|STARTED|Period 1, First 14 Days of Wear||77
2219517|NCT02871375|5442404|P1|STARTED|Period 1, First 14 Days of Wear||89
2219518|NCT02871011|5442415|P2|NOT COMPLETED|Overall Study||0
2219519|NCT02871011|5442416|P1|NOT COMPLETED|Overall Study||0
2219520|NCT02871011|5442415|P2|COMPLETED|Overall Study||13
2219521|NCT02871011|5442416|P1|COMPLETED|Overall Study||7
2219522|NCT02871011|5442415|P2|STARTED|Overall Study||13
2219523|NCT02871011|5442416|P1|STARTED|Overall Study||7
2219524|NCT02870205|5442436|P4|NOT COMPLETED|Overall Study||7
2219525|NCT02870205|5442437|P3|NOT COMPLETED|Overall Study||7
2219526|NCT02870205|5442438|P2|NOT COMPLETED|Overall Study||5
2219527|NCT02870205|5442439|P1|NOT COMPLETED|Overall Study||10
2219528|NCT02870205|5442436|P4|COMPLETED|Overall Study||287
2219529|NCT02870205|5442437|P3|COMPLETED|Overall Study||287
2219530|NCT02870205|5442438|P2|COMPLETED|Overall Study||289
2219531|NCT02870205|5442439|P1|COMPLETED|Overall Study||284
2219532|NCT02870205|5442436|P4|STARTED|Overall Study||294
2219533|NCT02870205|5442437|P3|STARTED|Overall Study||294
2219534|NCT02870205|5442438|P2|STARTED|Overall Study||294
2219535|NCT02870205|5442439|P1|STARTED|Overall Study||294
2219536|NCT02870101|5442449|P1|NOT COMPLETED|Overall Study||169
2219537|NCT02870101|5442449|P1|COMPLETED|Overall Study||2598
2219538|NCT02870101|5442449|P1|STARTED|Overall Study||2767
2219539|NCT02869451|5442464|P1|NOT COMPLETED|Overall Study||0
2219540|NCT02869451|5442464|P1|COMPLETED|Overall Study||5
2219541|NCT02869451|5442464|P1|STARTED|Overall Study||5
2219542|NCT02869438|5442488|P2|NOT COMPLETED|Overall Study||2
2219543|NCT02869438|5442489|P1|NOT COMPLETED|Overall Study||3
2219544|NCT02869438|5442488|P2|COMPLETED|Overall Study||113
2219545|NCT02869438|5442489|P1|COMPLETED|Overall Study||115
2219546|NCT02869438|5442488|P2|STARTED|Overall Study||115
2219547|NCT02869438|5442489|P1|STARTED|Overall Study||118
2219548|NCT02868892|5442537|P1|NOT COMPLETED|Overall Study||6
2219549|NCT02868892|5442537|P1|COMPLETED|Overall Study||0
2219550|NCT02868892|5442537|P1|STARTED|Overall Study||6
2219551|NCT02868554|5442546|P3|NOT COMPLETED|Overall Study||1
2219552|NCT02868554|5442547|P2|NOT COMPLETED|Overall Study||0
2219553|NCT02868554|5442548|P1|NOT COMPLETED|Overall Study||3
2219554|NCT02868554|5442546|P3|COMPLETED|Overall Study||11
2219555|NCT02868554|5442547|P2|COMPLETED|Overall Study||12
2219556|NCT02868554|5442548|P1|COMPLETED|Overall Study||7
2219557|NCT02868554|5442546|P3|STARTED|Overall Study||12
2219558|NCT02868554|5442547|P2|STARTED|Overall Study||12
2219559|NCT02868554|5442548|P1|STARTED|Overall Study||10
2219560|NCT02868242|5442571|P1|NOT COMPLETED|Overall Study||0
2219561|NCT02868242|5442571|P1|COMPLETED|Overall Study||19
2219562|NCT02868242|5442571|P1|STARTED|Overall Study||19
2219563|NCT02868216|5442583|P2|NOT COMPLETED|Overall Study||6
2219564|NCT02868216|5442584|P1|NOT COMPLETED|Overall Study||8
2219565|NCT02868216|5442583|P2|COMPLETED|Overall Study||41
2219566|NCT02868216|5442584|P1|COMPLETED|Overall Study||35
2219567|NCT02868216|5442583|P2|STARTED|Overall Study||47
2219568|NCT02868216|5442584|P1|STARTED|Overall Study||43
2219569|NCT02867995|5442592|P2|NOT COMPLETED|Overall Study||3
2219570|NCT02867995|5442593|P1|NOT COMPLETED|Overall Study||0
2219571|NCT02867995|5442592|P2|COMPLETED|Overall Study|Total patients completed|27
2219572|NCT02867995|5442593|P1|COMPLETED|Overall Study|Total patients completed|9
2219573|NCT02867995|5442592|P2|STARTED|Overall Study|Total patients consented|30
2219574|NCT02867995|5442593|P1|STARTED|Overall Study|Total patients consented|9
2219575|NCT02867709|5442612|P3|NOT COMPLETED|Safety Follow-up Period||14
2219576|NCT02867709|5442613|P2|NOT COMPLETED|Safety Follow-up Period||15
2219577|NCT02867709|5442614|P1|NOT COMPLETED|Safety Follow-up Period||11
2219578|NCT02867709|5442612|P3|COMPLETED|Safety Follow-up Period||473
2219579|NCT02867709|5442613|P2|COMPLETED|Safety Follow-up Period||459
2219580|NCT02867709|5442614|P1|COMPLETED|Safety Follow-up Period||482
2219581|NCT02867709|5442612|P3|STARTED|Safety Follow-up Period||487
2219582|NCT02867709|5442613|P2|STARTED|Safety Follow-up Period||474
2219583|NCT02867709|5442614|P1|STARTED|Safety Follow-up Period||493
2219584|NCT02867709|5442612|P3|NOT COMPLETED|Treatment Period||75
2219585|NCT02867709|5442613|P2|NOT COMPLETED|Treatment Period||87
2219586|NCT02867709|5442614|P1|NOT COMPLETED|Treatment Period||70
2219587|NCT02867709|5442612|P3|COMPLETED|Treatment Period||487
2219588|NCT02867709|5442613|P2|COMPLETED|Treatment Period||474
2219589|NCT02867709|5442614|P1|COMPLETED|Treatment Period||493
2219590|NCT02867709|5442612|P3|Safety Population: Received Study Drug|Treatment Period||488
2219591|NCT02867709|5442613|P2|Safety Population: Received Study Drug|Treatment Period||478
2219592|NCT02867709|5442614|P1|Safety Population: Received Study Drug|Treatment Period||499
2219593|NCT02867709|5442612|P3|STARTED|Treatment Period||562
2219594|NCT02867709|5442613|P2|STARTED|Treatment Period||561
2219595|NCT02867709|5442614|P1|STARTED|Treatment Period||563
2219596|NCT02867202|5442645|P2|NOT COMPLETED|Overall Study||32
2219597|NCT02867202|5442646|P1|NOT COMPLETED|Overall Study||21
2219599|NCT02867202|5442646|P1|COMPLETED|Overall Study||62
2219600|NCT02867202|5442645|P2|STARTED|Overall Study||88
2219601|NCT02867202|5442646|P1|STARTED|Overall Study||83
2219602|NCT02867163|5442652|P1|NOT COMPLETED|Overall Study||0
2219603|NCT02867163|5442652|P1|COMPLETED|Overall Study||25
2219604|NCT02867163|5442652|P1|STARTED|Overall Study||25
2219605|NCT02867150|5442656|P1|NOT COMPLETED|Overall Study||0
2219606|NCT02867150|5442656|P1|COMPLETED|Overall Study||58
2219607|NCT02867150|5442656|P1|STARTED|Overall Study||58
2219608|NCT02866942|5442660|P1|NOT COMPLETED|Overall Study||1
2219609|NCT02866942|5442660|P1|COMPLETED|Overall Study||478
2219610|NCT02866942|5442660|P1|STARTED|Overall Study||479
2219611|NCT02866695|5442665|P1|NOT COMPLETED|Overall Study||2
2219612|NCT02866695|5442665|P1|COMPLETED|Overall Study||18
2219613|NCT02866695|5442665|P1|STARTED|Overall Study||20
2219614|NCT02865720|5442673|P2|NOT COMPLETED|Overall Study||0
2219615|NCT02865720|5442674|P1|NOT COMPLETED|Overall Study||0
2219616|NCT02865720|5442673|P2|COMPLETED|Overall Study||8
2219617|NCT02865720|5442674|P1|COMPLETED|Overall Study||0
2219618|NCT02865720|5442673|P2|STARTED|Overall Study||8
2219619|NCT02865720|5442674|P1|STARTED|Overall Study||0
2219620|NCT02865499|5442697|P1|NOT COMPLETED|12 Weeks||0
2219621|NCT02865499|5442697|P1|COMPLETED|12 Weeks||6
2219622|NCT02865499|5442697|P1|STARTED|12 Weeks||6
2219623|NCT02865499|5442697|P1|NOT COMPLETED|8 Weeks||0
2219624|NCT02865499|5442697|P1|COMPLETED|8 Weeks||6
2219625|NCT02865499|5442697|P1|STARTED|8 Weeks||6
2219626|NCT02865499|5442697|P1|NOT COMPLETED|Baseline||2
2219627|NCT02865499|5442697|P1|COMPLETED|Baseline||6
2219628|NCT02865499|5442697|P1|STARTED|Baseline||8
2219629|NCT02865395|5442704|P3|NOT COMPLETED|Overall Study||7
2219630|NCT02865395|5442705|P2|NOT COMPLETED|Overall Study||10
2219631|NCT02865395|5442706|P1|NOT COMPLETED|Overall Study||6
2219632|NCT02865395|5442704|P3|COMPLETED|Overall Study|Data Not Collected|0
2219633|NCT02865395|5442705|P2|COMPLETED|Overall Study|Data Not Collected|0
2219634|NCT02865395|5442706|P1|COMPLETED|Overall Study|Data Not Collected|0
2219635|NCT02865395|5442704|P3|STARTED|Overall Study||7
2219636|NCT02865395|5442705|P2|STARTED|Overall Study||10
2219637|NCT02865395|5442706|P1|STARTED|Overall Study||6
2219638|NCT02865083|5442719|P2|NOT COMPLETED|Overall Study||1
2219639|NCT02865083|5442720|P1|NOT COMPLETED|Overall Study||3
2219640|NCT02865083|5442719|P2|COMPLETED|Overall Study||0
2219641|NCT02865083|5442720|P1|COMPLETED|Overall Study||0
2219642|NCT02865083|5442719|P2|STARTED|Overall Study||1
2219643|NCT02865083|5442720|P1|STARTED|Overall Study||3
2219644|NCT02864732|5442740|P2|NOT COMPLETED|Overall Study||2
2219645|NCT02864732|5442741|P1|NOT COMPLETED|Overall Study||2
2219646|NCT02864732|5442740|P2|COMPLETED|Overall Study||13
2219647|NCT02864732|5442741|P1|COMPLETED|Overall Study||13
2219648|NCT02864732|5442740|P2|STARTED|Overall Study||15
2219649|NCT02864732|5442741|P1|STARTED|Overall Study||15
2219650|NCT02864706|5442758|P2|NOT COMPLETED|Overall Study||0
2219651|NCT02864706|5442759|P1|NOT COMPLETED|Overall Study||0
2219652|NCT02864706|5442758|P2|COMPLETED|Overall Study||47
2219653|NCT02864706|5442759|P1|COMPLETED|Overall Study||48
2219654|NCT02864706|5442758|P2|Intent to Treat|Overall Study||47
2219655|NCT02864706|5442759|P1|Intent to Treat|Overall Study||46
2219656|NCT02864706|5442758|P2|Safety Set|Overall Study||47
2219657|NCT02864706|5442759|P1|Safety Set|Overall Study||48
2219658|NCT02864706|5442758|P2|STARTED|Overall Study||47
2219659|NCT02864706|5442759|P1|STARTED|Overall Study||48
2219660|NCT02864342|5442781|P2|NOT COMPLETED|Overall Study||19
2219661|NCT02864342|5442782|P1|NOT COMPLETED|Overall Study||15
2219662|NCT02864342|5442781|P2|COMPLETED|Overall Study||49
2219663|NCT02864342|5442782|P1|COMPLETED|Overall Study||55
2219664|NCT02864342|5442781|P2|Full Analysis Set (FAS)|Overall Study||67
2219665|NCT02864342|5442782|P1|Full Analysis Set (FAS)|Overall Study||70
2219666|NCT02864342|5442781|P2|STARTED|Overall Study||68
2219667|NCT02864342|5442782|P1|STARTED|Overall Study||70
2219668|NCT02864316|5442799|P2|NOT COMPLETED|Overall Study||2
2219669|NCT02864316|5442800|P1|NOT COMPLETED|Overall Study||2
2219670|NCT02864316|5442799|P2|COMPLETED|Overall Study||0
2219671|NCT02864316|5442800|P1|COMPLETED|Overall Study||0
2219672|NCT02864316|5442799|P2|STARTED|Overall Study||2
2219673|NCT02864316|5442800|P1|STARTED|Overall Study||2
2219674|NCT02864069|5442819|P3|NOT COMPLETED|Overall Study||8
2219675|NCT02864069|5442820|P2|NOT COMPLETED|Overall Study||8
2219676|NCT02864069|5442821|P1|NOT COMPLETED|Overall Study||6
2219677|NCT02864069|5442819|P3|COMPLETED|Overall Study||13
2219678|NCT02864069|5442820|P2|COMPLETED|Overall Study||5
2219679|NCT02864069|5442821|P1|COMPLETED|Overall Study||12
2219680|NCT02864069|5442819|P3|STARTED|Overall Study||21
2219681|NCT02864069|5442820|P2|STARTED|Overall Study||13
2219682|NCT02864069|5442821|P1|STARTED|Overall Study||18
2219683|NCT02863575|5442838|P3|NOT COMPLETED|Overall Study||1
2219684|NCT02863575|5442839|P2|NOT COMPLETED|Overall Study||2
2219685|NCT02863575|5442840|P1|NOT COMPLETED|Overall Study||1
2219686|NCT02863575|5442838|P3|COMPLETED|Overall Study||51
2219687|NCT02863575|5442839|P2|COMPLETED|Overall Study||159
2219688|NCT02863575|5442840|P1|COMPLETED|Overall Study||160
2219689|NCT02863575|5442838|P3|STARTED|Overall Study||52
2219690|NCT02863575|5442839|P2|STARTED|Overall Study||161
2219691|NCT02863575|5442840|P1|STARTED|Overall Study||161
2219692|NCT02863419|5442892|P3|NOT COMPLETED|Overall Study||8
2219693|NCT02863419|5442893|P2|NOT COMPLETED|Overall Study||10
2219694|NCT02863419|5442894|P1|NOT COMPLETED|Overall Study||8
2219695|NCT02863419|5442892|P3|COMPLETED|Overall Study||134
2219696|NCT02863419|5442893|P2|COMPLETED|Overall Study||274
2219697|NCT02863419|5442894|P1|COMPLETED|Overall Study||277
2219698|NCT02863419|5442892|P3|Safety Analysis Set (SAS)|Overall Study||142
2219699|NCT02863419|5442893|P2|Safety Analysis Set (SAS)|Overall Study||284
2219700|NCT02863419|5442894|P1|Safety Analysis Set (SAS)|Overall Study||285
2219701|NCT02863419|5442892|P3|Full Analysis Set (FAS)|Overall Study||142
2219702|NCT02863419|5442893|P2|Full Analysis Set (FAS)|Overall Study||284
2219703|NCT02863419|5442894|P1|Full Analysis Set (FAS)|Overall Study||285
2219704|NCT02863419|5442892|P3|STARTED|Overall Study||142
2219705|NCT02863419|5442893|P2|STARTED|Overall Study||284
2219706|NCT02863419|5442894|P1|STARTED|Overall Study||285
2219707|NCT02863328|5443011|P2|NOT COMPLETED|Overall Study||23
2219708|NCT02863328|5443012|P1|NOT COMPLETED|Overall Study||11
2219709|NCT02863328|5443011|P2|COMPLETED|Overall Study||387
2219710|NCT02863328|5443012|P1|COMPLETED|Overall Study||400
2219711|NCT02863328|5443011|P2|Safety Analysis Set (SAS)|Overall Study||409
2219712|NCT02863328|5443012|P1|Safety Analysis Set (SAS)|Overall Study||410
2219713|NCT02863328|5443011|P2|Full Analysis Set (FAS)|Overall Study||410
2219714|NCT02863328|5443012|P1|Full Analysis Set (FAS)|Overall Study||411
2219715|NCT02863328|5443011|P2|STARTED|Overall Study||410
2219716|NCT02863328|5443012|P1|STARTED|Overall Study||411
2219717|NCT02863289|5443109|P1|NOT COMPLETED|Overall Study||83
2219718|NCT02863289|5443109|P1|COMPLETED|Overall Study|Study completed on 01/03/2017, 35 study participants have returned the questionnaire.|35
2219719|NCT02863289|5443109|P1|STARTED|Overall Study|Study started on 01/11/2016, with 118 study participants.|118
2219720|NCT02863263|5443116|P2|NOT COMPLETED|Overall Study||1
2219721|NCT02863263|5443117|P1|NOT COMPLETED|Overall Study||1
2219722|NCT02863263|5443116|P2|COMPLETED|Overall Study||1
2219723|NCT02863263|5443117|P1|COMPLETED|Overall Study||2
2219724|NCT02863263|5443116|P2|STARTED|Overall Study||2
2219725|NCT02863263|5443117|P1|STARTED|Overall Study||3
2219726|NCT02863198|5443139|P2|NOT COMPLETED|Overall Study||0
2219727|NCT02863198|5443140|P1|NOT COMPLETED|Overall Study||0
2219728|NCT02863198|5443139|P2|COMPLETED|Overall Study||60
2219729|NCT02863198|5443140|P1|COMPLETED|Overall Study||60
2219730|NCT02863198|5443139|P2|STARTED|Overall Study||60
2219731|NCT02863198|5443140|P1|STARTED|Overall Study||60
2219732|NCT02862730|5443156|P7|NOT COMPLETED|Fourth Intervention (84 Hours)||0
2219733|NCT02862730|5443157|P6|NOT COMPLETED|Fourth Intervention (84 Hours)||0
2219734|NCT02862730|5443158|P5|NOT COMPLETED|Fourth Intervention (84 Hours)||0
2219735|NCT02862730|5443159|P4|NOT COMPLETED|Fourth Intervention (84 Hours)||0
2219736|NCT02862730|5443160|P3|NOT COMPLETED|Fourth Intervention (84 Hours)||0
2219737|NCT02862730|5443161|P2|NOT COMPLETED|Fourth Intervention (84 Hours)||0
2219738|NCT02862730|5443162|P1|NOT COMPLETED|Fourth Intervention (84 Hours)||0
2219739|NCT02862730|5443156|P7|COMPLETED|Fourth Intervention (84 Hours)||1
2219740|NCT02862730|5443157|P6|COMPLETED|Fourth Intervention (84 Hours)||1
2219741|NCT02862730|5443158|P5|COMPLETED|Fourth Intervention (84 Hours)||4
2219742|NCT02862730|5443159|P4|COMPLETED|Fourth Intervention (84 Hours)||4
2219743|NCT02862730|5443160|P3|COMPLETED|Fourth Intervention (84 Hours)||6
2219744|NCT02862730|5443161|P2|COMPLETED|Fourth Intervention (84 Hours)||1
2219745|NCT02862730|5443162|P1|COMPLETED|Fourth Intervention (84 Hours)||3
2219746|NCT02862730|5443156|P7|STARTED|Fourth Intervention (84 Hours)||1
2219747|NCT02862730|5443157|P6|STARTED|Fourth Intervention (84 Hours)||1
2219748|NCT02862730|5443158|P5|STARTED|Fourth Intervention (84 Hours)||4
2219749|NCT02862730|5443159|P4|STARTED|Fourth Intervention (84 Hours)||4
2219750|NCT02862730|5443160|P3|STARTED|Fourth Intervention (84 Hours)||6
2219751|NCT02862730|5443161|P2|STARTED|Fourth Intervention (84 Hours)||1
2219752|NCT02862730|5443162|P1|STARTED|Fourth Intervention (84 Hours)||3
2219753|NCT02862730|5443156|P7|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
2219754|NCT02862730|5443157|P6|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
2219755|NCT02862730|5443158|P5|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
2219756|NCT02862730|5443159|P4|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
2219757|NCT02862730|5443160|P3|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
2219758|NCT02862730|5443161|P2|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
2219759|NCT02862730|5443162|P1|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
2219760|NCT02862730|5443156|P7|COMPLETED|Fourth Rest Period (7-45 Days)||1
2219761|NCT02862730|5443157|P6|COMPLETED|Fourth Rest Period (7-45 Days)||1
2219762|NCT02862730|5443158|P5|COMPLETED|Fourth Rest Period (7-45 Days)||4
2219763|NCT02862730|5443159|P4|COMPLETED|Fourth Rest Period (7-45 Days)||4
2219764|NCT02862730|5443160|P3|COMPLETED|Fourth Rest Period (7-45 Days)||6
2219765|NCT02862730|5443161|P2|COMPLETED|Fourth Rest Period (7-45 Days)||1
2219766|NCT02862730|5443162|P1|COMPLETED|Fourth Rest Period (7-45 Days)||3
2219767|NCT02862730|5443156|P7|STARTED|Fourth Rest Period (7-45 Days)||1
2219768|NCT02862730|5443157|P6|STARTED|Fourth Rest Period (7-45 Days)||1
2219769|NCT02862730|5443158|P5|STARTED|Fourth Rest Period (7-45 Days)||4
2219770|NCT02862730|5443159|P4|STARTED|Fourth Rest Period (7-45 Days)||4
2219771|NCT02862730|5443160|P3|STARTED|Fourth Rest Period (7-45 Days)||6
2219772|NCT02862730|5443161|P2|STARTED|Fourth Rest Period (7-45 Days)||1
2219773|NCT02862730|5443162|P1|STARTED|Fourth Rest Period (7-45 Days)||3
2219774|NCT02862730|5443156|P7|NOT COMPLETED|Third Intervention (84 Hours)||0
2219775|NCT02862730|5443157|P6|NOT COMPLETED|Third Intervention (84 Hours)||0
2219776|NCT02862730|5443158|P5|NOT COMPLETED|Third Intervention (84 Hours)||0
2219777|NCT02862730|5443159|P4|NOT COMPLETED|Third Intervention (84 Hours)||1
2219778|NCT02862730|5443160|P3|NOT COMPLETED|Third Intervention (84 Hours)||0
2219779|NCT02862730|5443161|P2|NOT COMPLETED|Third Intervention (84 Hours)||0
2219780|NCT02862730|5443162|P1|NOT COMPLETED|Third Intervention (84 Hours)||0
2219781|NCT02862730|5443156|P7|COMPLETED|Third Intervention (84 Hours)||1
2219782|NCT02862730|5443157|P6|COMPLETED|Third Intervention (84 Hours)||1
2219783|NCT02862730|5443158|P5|COMPLETED|Third Intervention (84 Hours)||4
2219784|NCT02862730|5443159|P4|COMPLETED|Third Intervention (84 Hours)||4
2219785|NCT02862730|5443160|P3|COMPLETED|Third Intervention (84 Hours)||6
2219786|NCT02862730|5443161|P2|COMPLETED|Third Intervention (84 Hours)||1
2219787|NCT02862730|5443162|P1|COMPLETED|Third Intervention (84 Hours)||3
2219788|NCT02862730|5443156|P7|STARTED|Third Intervention (84 Hours)||1
2219789|NCT02862730|5443157|P6|STARTED|Third Intervention (84 Hours)||1
2219790|NCT02862730|5443158|P5|STARTED|Third Intervention (84 Hours)||4
2219791|NCT02862730|5443159|P4|STARTED|Third Intervention (84 Hours)||5
2219792|NCT02862730|5443160|P3|STARTED|Third Intervention (84 Hours)||6
2219793|NCT02862730|5443161|P2|STARTED|Third Intervention (84 Hours)||1
2219794|NCT02862730|5443162|P1|STARTED|Third Intervention (84 Hours)||3
2219795|NCT02862730|5443156|P7|NOT COMPLETED|Third Rest Period (7-45 Days)||0
2219796|NCT02862730|5443157|P6|NOT COMPLETED|Third Rest Period (7-45 Days)||0
2219797|NCT02862730|5443158|P5|NOT COMPLETED|Third Rest Period (7-45 Days)||1
2219798|NCT02862730|5443159|P4|NOT COMPLETED|Third Rest Period (7-45 Days)||0
2219799|NCT02862730|5443160|P3|NOT COMPLETED|Third Rest Period (7-45 Days)||1
2219800|NCT02862730|5443161|P2|NOT COMPLETED|Third Rest Period (7-45 Days)||0
2219801|NCT02862730|5443162|P1|NOT COMPLETED|Third Rest Period (7-45 Days)||0
2219802|NCT02862730|5443156|P7|COMPLETED|Third Rest Period (7-45 Days)||1
2219803|NCT02862730|5443157|P6|COMPLETED|Third Rest Period (7-45 Days)||1
2219804|NCT02862730|5443158|P5|COMPLETED|Third Rest Period (7-45 Days)||4
2219805|NCT02862730|5443159|P4|COMPLETED|Third Rest Period (7-45 Days)||5
2219806|NCT02862730|5443160|P3|COMPLETED|Third Rest Period (7-45 Days)||6
2219807|NCT02862730|5443161|P2|COMPLETED|Third Rest Period (7-45 Days)||1
2219808|NCT02862730|5443162|P1|COMPLETED|Third Rest Period (7-45 Days)||3
2219809|NCT02862730|5443156|P7|STARTED|Third Rest Period (7-45 Days)||1
2219810|NCT02862730|5443157|P6|STARTED|Third Rest Period (7-45 Days)||1
2219811|NCT02862730|5443158|P5|STARTED|Third Rest Period (7-45 Days)||5
2219812|NCT02862730|5443159|P4|STARTED|Third Rest Period (7-45 Days)||5
2219813|NCT02862730|5443160|P3|STARTED|Third Rest Period (7-45 Days)||7
2219814|NCT02862730|5443161|P2|STARTED|Third Rest Period (7-45 Days)||1
2219815|NCT02862730|5443162|P1|STARTED|Third Rest Period (7-45 Days)||3
2219816|NCT02862730|5443156|P7|NOT COMPLETED|Second Intervention (84 Hours)||0
2219817|NCT02862730|5443157|P6|NOT COMPLETED|Second Intervention (84 Hours)||0
2219818|NCT02862730|5443158|P5|NOT COMPLETED|Second Intervention (84 Hours)||0
2219819|NCT02862730|5443159|P4|NOT COMPLETED|Second Intervention (84 Hours)||0
2219820|NCT02862730|5443160|P3|NOT COMPLETED|Second Intervention (84 Hours)||0
2219821|NCT02862730|5443161|P2|NOT COMPLETED|Second Intervention (84 Hours)||0
2219822|NCT02862730|5443162|P1|NOT COMPLETED|Second Intervention (84 Hours)||1
2219823|NCT02862730|5443156|P7|COMPLETED|Second Intervention (84 Hours)||1
2219824|NCT02862730|5443157|P6|COMPLETED|Second Intervention (84 Hours)||1
2219825|NCT02862730|5443158|P5|COMPLETED|Second Intervention (84 Hours)||5
2219826|NCT02862730|5443159|P4|COMPLETED|Second Intervention (84 Hours)||5
2219827|NCT02862730|5443160|P3|COMPLETED|Second Intervention (84 Hours)||7
2219828|NCT02862730|5443161|P2|COMPLETED|Second Intervention (84 Hours)||1
2219829|NCT02862730|5443162|P1|COMPLETED|Second Intervention (84 Hours)||3
2219830|NCT02862730|5443156|P7|STARTED|Second Intervention (84 Hours)||1
2219831|NCT02862730|5443157|P6|STARTED|Second Intervention (84 Hours)||1
2219832|NCT02862730|5443158|P5|STARTED|Second Intervention (84 Hours)||5
2219833|NCT02862730|5443159|P4|STARTED|Second Intervention (84 Hours)||5
2219834|NCT02862730|5443160|P3|STARTED|Second Intervention (84 Hours)||7
2219835|NCT02862730|5443161|P2|STARTED|Second Intervention (84 Hours)||1
2219836|NCT02862730|5443162|P1|STARTED|Second Intervention (84 Hours)||4
2219837|NCT02862730|5443156|P7|NOT COMPLETED|Second Rest Period (7-45 Days)||0
2219838|NCT02862730|5443157|P6|NOT COMPLETED|Second Rest Period (7-45 Days)||0
2219839|NCT02862730|5443158|P5|NOT COMPLETED|Second Rest Period (7-45 Days)||0
2219840|NCT02862730|5443159|P4|NOT COMPLETED|Second Rest Period (7-45 Days)||0
2219841|NCT02862730|5443160|P3|NOT COMPLETED|Second Rest Period (7-45 Days)||0
2219842|NCT02862730|5443161|P2|NOT COMPLETED|Second Rest Period (7-45 Days)||0
2219843|NCT02862730|5443162|P1|NOT COMPLETED|Second Rest Period (7-45 Days)||0
2219844|NCT02862730|5443156|P7|COMPLETED|Second Rest Period (7-45 Days)||1
2219845|NCT02862730|5443157|P6|COMPLETED|Second Rest Period (7-45 Days)||1
2219846|NCT02862730|5443158|P5|COMPLETED|Second Rest Period (7-45 Days)||5
2219847|NCT02862730|5443159|P4|COMPLETED|Second Rest Period (7-45 Days)||5
2219848|NCT02862730|5443160|P3|COMPLETED|Second Rest Period (7-45 Days)||7
2219849|NCT02862730|5443161|P2|COMPLETED|Second Rest Period (7-45 Days)||1
2219850|NCT02862730|5443162|P1|COMPLETED|Second Rest Period (7-45 Days)||4
2219851|NCT02862730|5443156|P7|STARTED|Second Rest Period (7-45 Days)||1
2219852|NCT02862730|5443157|P6|STARTED|Second Rest Period (7-45 Days)||1
2219853|NCT02862730|5443158|P5|STARTED|Second Rest Period (7-45 Days)||5
2219854|NCT02862730|5443159|P4|STARTED|Second Rest Period (7-45 Days)||5
2219855|NCT02862730|5443160|P3|STARTED|Second Rest Period (7-45 Days)||7
2219856|NCT02862730|5443161|P2|STARTED|Second Rest Period (7-45 Days)||1
2219857|NCT02862730|5443162|P1|STARTED|Second Rest Period (7-45 Days)||4
2219858|NCT02862730|5443156|P7|NOT COMPLETED|First Intervention (84 Hours)||0
2219859|NCT02862730|5443157|P6|NOT COMPLETED|First Intervention (84 Hours)||0
2219860|NCT02862730|5443158|P5|NOT COMPLETED|First Intervention (84 Hours)||0
2219861|NCT02862730|5443159|P4|NOT COMPLETED|First Intervention (84 Hours)||0
2219862|NCT02862730|5443160|P3|NOT COMPLETED|First Intervention (84 Hours)||0
2219863|NCT02862730|5443161|P2|NOT COMPLETED|First Intervention (84 Hours)||0
2219864|NCT02862730|5443162|P1|NOT COMPLETED|First Intervention (84 Hours)||0
2219865|NCT02862730|5443156|P7|COMPLETED|First Intervention (84 Hours)||1
2219866|NCT02862730|5443157|P6|COMPLETED|First Intervention (84 Hours)||1
2219867|NCT02862730|5443158|P5|COMPLETED|First Intervention (84 Hours)||5
2219868|NCT02862730|5443159|P4|COMPLETED|First Intervention (84 Hours)||5
2219869|NCT02862730|5443160|P3|COMPLETED|First Intervention (84 Hours)||7
2219870|NCT02862730|5443161|P2|COMPLETED|First Intervention (84 Hours)||1
2219871|NCT02862730|5443162|P1|COMPLETED|First Intervention (84 Hours)||4
2219872|NCT02862730|5443156|P7|STARTED|First Intervention (84 Hours)||1
2219873|NCT02862730|5443157|P6|STARTED|First Intervention (84 Hours)||1
2219874|NCT02862730|5443158|P5|STARTED|First Intervention (84 Hours)||5
2219875|NCT02862730|5443159|P4|STARTED|First Intervention (84 Hours)||5
2219876|NCT02862730|5443160|P3|STARTED|First Intervention (84 Hours)||7
2219877|NCT02862730|5443161|P2|STARTED|First Intervention (84 Hours)||1
2219878|NCT02862730|5443162|P1|STARTED|First Intervention (84 Hours)||4
2219879|NCT02862730|5443156|P7|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
2219880|NCT02862730|5443157|P6|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
2219881|NCT02862730|5443158|P5|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
2219882|NCT02862730|5443159|P4|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
2219883|NCT02862730|5443160|P3|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
2219884|NCT02862730|5443161|P2|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
2219885|NCT02862730|5443162|P1|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
2219886|NCT02862730|5443156|P7|COMPLETED|First Rest Period (1-12 Weeks)||1
2219887|NCT02862730|5443157|P6|COMPLETED|First Rest Period (1-12 Weeks)||1
2219888|NCT02862730|5443158|P5|COMPLETED|First Rest Period (1-12 Weeks)||5
2219889|NCT02862730|5443159|P4|COMPLETED|First Rest Period (1-12 Weeks)||5
2219890|NCT02862730|5443160|P3|COMPLETED|First Rest Period (1-12 Weeks)||7
2219891|NCT02862730|5443161|P2|COMPLETED|First Rest Period (1-12 Weeks)||1
2219892|NCT02862730|5443162|P1|COMPLETED|First Rest Period (1-12 Weeks)||4
2219893|NCT02862730|5443156|P7|STARTED|First Rest Period (1-12 Weeks)||1
2219894|NCT02862730|5443157|P6|STARTED|First Rest Period (1-12 Weeks)||1
2219895|NCT02862730|5443158|P5|STARTED|First Rest Period (1-12 Weeks)||5
2219896|NCT02862730|5443159|P4|STARTED|First Rest Period (1-12 Weeks)||5
2219897|NCT02862730|5443160|P3|STARTED|First Rest Period (1-12 Weeks)||7
2219898|NCT02862730|5443161|P2|STARTED|First Rest Period (1-12 Weeks)||1
2219899|NCT02862730|5443162|P1|STARTED|First Rest Period (1-12 Weeks)||4
2219900|NCT02862730|5443156|P7|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
2219901|NCT02862730|5443157|P6|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
2219902|NCT02862730|5443158|P5|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
2219903|NCT02862730|5443159|P4|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
2219904|NCT02862730|5443160|P3|NOT COMPLETED|Tslim Training Visit (2 Weeks)||1
2219905|NCT02862730|5443161|P2|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
2219906|NCT02862730|5443162|P1|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
2219907|NCT02862730|5443156|P7|COMPLETED|Tslim Training Visit (2 Weeks)||1
2219908|NCT02862730|5443157|P6|COMPLETED|Tslim Training Visit (2 Weeks)||1
2219909|NCT02862730|5443158|P5|COMPLETED|Tslim Training Visit (2 Weeks)||5
2219910|NCT02862730|5443159|P4|COMPLETED|Tslim Training Visit (2 Weeks)||5
2219911|NCT02862730|5443160|P3|COMPLETED|Tslim Training Visit (2 Weeks)||7
2219912|NCT02862730|5443161|P2|COMPLETED|Tslim Training Visit (2 Weeks)||1
2219913|NCT02862730|5443162|P1|COMPLETED|Tslim Training Visit (2 Weeks)||4
2219914|NCT02862730|5443156|P7|STARTED|Tslim Training Visit (2 Weeks)||1
2219915|NCT02862730|5443157|P6|STARTED|Tslim Training Visit (2 Weeks)||1
2219916|NCT02862730|5443158|P5|STARTED|Tslim Training Visit (2 Weeks)||5
2219917|NCT02862730|5443159|P4|STARTED|Tslim Training Visit (2 Weeks)||5
2219918|NCT02862730|5443160|P3|STARTED|Tslim Training Visit (2 Weeks)||8
2219919|NCT02862730|5443161|P2|STARTED|Tslim Training Visit (2 Weeks)||1
2219920|NCT02862730|5443162|P1|STARTED|Tslim Training Visit (2 Weeks)||4
2219921|NCT02862600|5443217|P1|NOT COMPLETED|Period 2--Perhexiline-high Target Range||7
2219922|NCT02862600|5443217|P1|COMPLETED|Period 2--Perhexiline-high Target Range|Study terminated on April 26, 2017 due to lack of efficacy in first 15 subjects completing Period 2.|15
2219923|NCT02862600|5443217|P1|STARTED|Period 2--Perhexiline-high Target Range|First subject completed Period 1 and moved into Period 2 perhexiline dosing on October 17, 2016|22
2219924|NCT02862600|5443217|P1|NOT COMPLETED|Period 1--Perhexiline-low Target Range||13
2219925|NCT02862600|5443217|P1|COMPLETED|Period 1--Perhexiline-low Target Range|Study terminated on April 26, 2017 due to lack of efficacy.|22
2219926|NCT02862600|5443217|P1|STARTED|Period 1--Perhexiline-low Target Range|First subject underwent baseline functional assessment and perhexiline dosing on August 22, 2016|35
2219927|NCT02862574|5443227|P3|NOT COMPLETED|Open-Label Treatment Period||1
2219928|NCT02862574|5443228|P2|NOT COMPLETED|Open-Label Treatment Period||3
2219929|NCT02862574|5443229|P1|NOT COMPLETED|Open-Label Treatment Period||2
2219930|NCT02862574|5443227|P3|COMPLETED|Open-Label Treatment Period||0
2219931|NCT02862574|5443228|P2|COMPLETED|Open-Label Treatment Period||0
2219932|NCT02862574|5443229|P1|COMPLETED|Open-Label Treatment Period||0
2219933|NCT02862574|5443227|P3|STARTED|Open-Label Treatment Period||1
2219934|NCT02862574|5443228|P2|STARTED|Open-Label Treatment Period||3
2219935|NCT02862574|5443229|P1|STARTED|Open-Label Treatment Period||2
2219936|NCT02862574|5443227|P3|NOT COMPLETED|Double-Blind Treatment Period||4
2219937|NCT02862574|5443228|P2|NOT COMPLETED|Double-Blind Treatment Period||2
2219938|NCT02862574|5443229|P1|NOT COMPLETED|Double-Blind Treatment Period||3
2219939|NCT02862574|5443227|P3|COMPLETED|Double-Blind Treatment Period||1
2219940|NCT02862574|5443228|P2|COMPLETED|Double-Blind Treatment Period||3
2219941|NCT02862574|5443229|P1|COMPLETED|Double-Blind Treatment Period||2
2219942|NCT02862574|5443227|P3|STARTED|Double-Blind Treatment Period||5
2219943|NCT02862574|5443228|P2|STARTED|Double-Blind Treatment Period||5
2219944|NCT02862574|5443229|P1|STARTED|Double-Blind Treatment Period||5
2219945|NCT02862548|5443249|P2|NOT COMPLETED|Open-Label Extension Phase||24
2219946|NCT02862548|5443250|P1|NOT COMPLETED|Open-Label Extension Phase||26
2219947|NCT02862548|5443249|P2|COMPLETED|Open-Label Extension Phase||0
2219948|NCT02862548|5443250|P1|COMPLETED|Open-Label Extension Phase||0
2219949|NCT02862548|5443249|P2|STARTED|Open-Label Extension Phase||24
2219950|NCT02862548|5443250|P1|STARTED|Open-Label Extension Phase||26
2219951|NCT02862548|5443249|P2|NOT COMPLETED|Open-Label Phase||1
2219952|NCT02862548|5443250|P1|NOT COMPLETED|Open-Label Phase||0
2219953|NCT02862548|5443249|P2|COMPLETED|Open-Label Phase||24
2219954|NCT02862548|5443250|P1|COMPLETED|Open-Label Phase||26
2219955|NCT02862548|5443249|P2|STARTED|Open-Label Phase||25
2219956|NCT02862548|5443250|P1|STARTED|Open-Label Phase||26
2219957|NCT02862106|5443280|P2|NOT COMPLETED|Overall Study||6
2219958|NCT02862106|5443281|P1|NOT COMPLETED|Overall Study||38
2219959|NCT02862106|5443280|P2|COMPLETED|Overall Study||20
2219960|NCT02862106|5443281|P1|COMPLETED|Overall Study||145
2219961|NCT02862106|5443280|P2|STARTED|Overall Study||26
2219962|NCT02862106|5443281|P1|STARTED|Overall Study||183
2219963|NCT02861807|5443341|P2|NOT COMPLETED|Overall Study||14
2219964|NCT02861807|5443342|P1|NOT COMPLETED|Overall Study||12
2219965|NCT02861807|5443341|P2|COMPLETED|Overall Study||23
2219966|NCT02861807|5443342|P1|COMPLETED|Overall Study||35
2219967|NCT02861807|5443341|P2|Attended 2-month Follow-up|Overall Study||20
2219968|NCT02861807|5443342|P1|Attended 2-month Follow-up|Overall Study||32
2219969|NCT02861807|5443341|P2|Attended Post-treatment Assessment|Overall Study||18
2219970|NCT02861807|5443342|P1|Attended Post-treatment Assessment|Overall Study||34
2219971|NCT02861807|5443341|P2|STARTED|Overall Study||37
2219972|NCT02861807|5443342|P1|STARTED|Overall Study||47
2219973|NCT02861664|5443358|P2|NOT COMPLETED|Overall Study||1
2219974|NCT02861664|5443359|P1|NOT COMPLETED|Overall Study||0
2219975|NCT02861664|5443358|P2|COMPLETED|Overall Study||67
2219976|NCT02861664|5443359|P1|COMPLETED|Overall Study||67
2219977|NCT02861664|5443358|P2|STARTED|Overall Study||68
2219978|NCT02861664|5443359|P1|STARTED|Overall Study||67
2219979|NCT02861118|5443371|P2|NOT COMPLETED|Overall Study||0
2219980|NCT02861118|5443372|P1|NOT COMPLETED|Overall Study||0
2219981|NCT02861118|5443371|P2|COMPLETED|Overall Study||116
2219982|NCT02861118|5443372|P1|COMPLETED|Overall Study||194
2219983|NCT02861118|5443371|P2|STARTED|Overall Study||116
2219984|NCT02861118|5443372|P1|STARTED|Overall Study||194
2219985|NCT02860845|5443386|P2|NOT COMPLETED|Overall Study||1
2219986|NCT02860845|5443387|P1|NOT COMPLETED|Overall Study||2
2219987|NCT02860845|5443386|P2|COMPLETED|Overall Study||23
2219988|NCT02860845|5443387|P1|COMPLETED|Overall Study||22
2219989|NCT02860845|5443386|P2|Analyzed Patients|Overall Study||23
2219990|NCT02860845|5443387|P1|Analyzed Patients|Overall Study||22
2219991|NCT02860845|5443386|P2|STARTED|Overall Study||24
2219992|NCT02860845|5443387|P1|STARTED|Overall Study||24
2219993|NCT02860507|5443403|P2|NOT COMPLETED|Overall Study||0
2219994|NCT02860507|5443404|P1|NOT COMPLETED|Overall Study||0
2219995|NCT02860507|5443403|P2|COMPLETED|Overall Study||25
2219996|NCT02860507|5443404|P1|COMPLETED|Overall Study||25
2219997|NCT02860507|5443403|P2|STARTED|Overall Study||25
2219998|NCT02860507|5443404|P1|STARTED|Overall Study||25
2219999|NCT02860169|5443414|P1|NOT COMPLETED|Part C||1
2220000|NCT02860169|5443414|P1|COMPLETED|Part C||47
2220001|NCT02860169|5443414|P1|Participants With Cold and Flu|Part C||42
2220002|NCT02860169|5443414|P1|Healthy Participants|Part C||6
2220003|NCT02860169|5443414|P1|STARTED|Part C||48
2220004|NCT02860169|5443414|P1|NOT COMPLETED|Part B||11
2220005|NCT02860169|5443414|P1|COMPLETED|Part B||9
2220006|NCT02860169|5443414|P1|Participants With Cold and Flu|Part B||10
2220007|NCT02860169|5443414|P1|Healthy Participants|Part B||10
2220008|NCT02860169|5443414|P1|STARTED|Part B||20
2220009|NCT02860169|5443414|P1|NOT COMPLETED|Part A||11
2220010|NCT02860169|5443414|P1|COMPLETED|Part A||35
2220011|NCT02860169|5443414|P1|Participants With Cold and Flu|Part A||0
2220012|NCT02860169|5443414|P1|Healthy Participants|Part A||46
2220013|NCT02860169|5443414|P1|STARTED|Part A||46
2220020|NCT02858713|5443445|P2|NOT COMPLETED|Overall Study||5
2220021|NCT02858713|5443446|P1|NOT COMPLETED|Overall Study||7
2220022|NCT02858713|5443445|P2|COMPLETED|Overall Study||61
2220023|NCT02858713|5443446|P1|COMPLETED|Overall Study||61
2220024|NCT02858713|5443445|P2|STARTED|Overall Study||66
2220025|NCT02858713|5443446|P1|STARTED|Overall Study||68
2220026|NCT02858492|5443460|P4|NOT COMPLETED|Overall Study||6
2220027|NCT02858492|5443461|P3|NOT COMPLETED|Overall Study||0
2220028|NCT02858492|5443462|P2|NOT COMPLETED|Overall Study||1
2220029|NCT02858492|5443463|P1|NOT COMPLETED|Overall Study||0
2220030|NCT02858492|5443460|P4|COMPLETED|Overall Study||22
2220031|NCT02858492|5443461|P3|COMPLETED|Overall Study||5
2220032|NCT02858492|5443462|P2|COMPLETED|Overall Study||14
2220033|NCT02858492|5443463|P1|COMPLETED|Overall Study||3
2220034|NCT02858492|5443460|P4|STARTED|Overall Study||28
2220035|NCT02858492|5443461|P3|STARTED|Overall Study||5
2220036|NCT02858492|5443462|P2|STARTED|Overall Study||15
2220037|NCT02858492|5443463|P1|STARTED|Overall Study||3
2220038|NCT02858440|5443639|P1|NOT COMPLETED|Overall Study||12
2220039|NCT02858440|5443639|P1|COMPLETED|Overall Study||223
2220040|NCT02858440|5443639|P1|STARTED|Overall Study||235
2220062|NCT02858362|5444089|P3|NOT COMPLETED|Overall Study||3
2220063|NCT02858362|5444090|P2|NOT COMPLETED|Overall Study||1
2220064|NCT02858362|5444091|P1|NOT COMPLETED|Overall Study||2
2220065|NCT02858362|5444089|P3|COMPLETED|Overall Study||0
2220066|NCT02858362|5444090|P2|COMPLETED|Overall Study||9
2220067|NCT02858362|5444091|P1|COMPLETED|Overall Study||28
2220068|NCT02858362|5444089|P3|Did Not Enter Extension Phase|Overall Study||0
2220069|NCT02858362|5444090|P2|Did Not Enter Extension Phase|Overall Study||2
2220070|NCT02858362|5444091|P1|Did Not Enter Extension Phase|Overall Study||1
2220071|NCT02858362|5444089|P3|STARTED|Overall Study||3
2220072|NCT02858362|5444090|P2|STARTED|Overall Study||10
2220073|NCT02858362|5444091|P1|STARTED|Overall Study||30
2220074|NCT02858349|5444126|P1|NOT COMPLETED|Overall Study||0
2220075|NCT02858349|5444126|P1|COMPLETED|Overall Study||10
2220076|NCT02858349|5444126|P1|STARTED|Overall Study||10
2220077|NCT02858050|5444132|P2|NOT COMPLETED|Overall Study||0
2220078|NCT02858050|5444133|P1|NOT COMPLETED|Overall Study||0
2220079|NCT02858050|5444132|P2|COMPLETED|Overall Study||20
2220080|NCT02858050|5444133|P1|COMPLETED|Overall Study||20
2220081|NCT02858050|5444132|P2|STARTED|Overall Study||20
2220082|NCT02858050|5444133|P1|STARTED|Overall Study||20
2220083|NCT02857816|5444139|P1|NOT COMPLETED|Overall Study||38
2220084|NCT02857816|5444139|P1|COMPLETED|Overall Study||116
2220085|NCT02857816|5444139|P1|Subjects Qualified and Treated With PTNM|Overall Study||120
2220086|NCT02857816|5444139|P1|STARTED|Overall Study||154
2220087|NCT02856880|5444145|P1|NOT COMPLETED|Overall Study||1
2220088|NCT02856880|5444145|P1|COMPLETED|Overall Study||44
2220089|NCT02856880|5444145|P1|Received SLS Negative Control|Overall Study||44
2220090|NCT02856880|5444145|P1|Received Non-SLS Negative Control|Overall Study||44
2220091|NCT02856880|5444145|P1|Received Positive Control|Overall Study||45
2220092|NCT02856880|5444145|P1|Received Test Zinc Non-IPMP|Overall Study||44
2220093|NCT02856880|5444145|P1|Received Test Zinc-IPMP|Overall Study||44
2220094|NCT02856880|5444145|P1|STARTED|Overall Study||45
2220095|NCT02856828|5444171|P2|NOT COMPLETED|Overall Study||0
2220096|NCT02856828|5444172|P1|NOT COMPLETED|Overall Study||0
2220097|NCT02856828|5444171|P2|COMPLETED|Overall Study||3
2220098|NCT02856828|5444172|P1|COMPLETED|Overall Study||2
2220099|NCT02856828|5444171|P2|STARTED|Overall Study||3
2220100|NCT02856828|5444172|P1|STARTED|Overall Study||2
2220101|NCT02856282|5444186|P1|NOT COMPLETED|Overall Study||1
2220102|NCT02856282|5444186|P1|COMPLETED|Overall Study||45
2220103|NCT02856282|5444186|P1|STARTED|Overall Study||46
2220104|NCT02855567|5444198|P2|NOT COMPLETED|Overall Study||0
2220105|NCT02855567|5444199|P1|NOT COMPLETED|Overall Study||0
2220106|NCT02855567|5444198|P2|COMPLETED|Overall Study||56
2220107|NCT02855567|5444199|P1|COMPLETED|Overall Study||54
2220108|NCT02855567|5444198|P2|STARTED|Overall Study||56
2220109|NCT02855567|5444199|P1|STARTED|Overall Study||54
2220110|NCT02855541|5444213|P1|NOT COMPLETED|Overall Study||4
2220111|NCT02855541|5444213|P1|COMPLETED|Overall Study||21
2220112|NCT02855541|5444213|P1|STARTED|Overall Study||25
2220113|NCT02855437|5444224|P2|NOT COMPLETED|Phase 2||1
2220114|NCT02855437|5444225|P1|NOT COMPLETED|Phase 2||1
2220115|NCT02855437|5444224|P2|COMPLETED|Phase 2||18
2220116|NCT02855437|5444225|P1|COMPLETED|Phase 2||20
2220117|NCT02855437|5444224|P2|STARTED|Phase 2||19
2220118|NCT02855437|5444225|P1|STARTED|Phase 2||21
2220119|NCT02855437|5444224|P2|NOT COMPLETED|Crossover Period (Same Day)||0
2220120|NCT02855437|5444225|P1|NOT COMPLETED|Crossover Period (Same Day)||0
2220121|NCT02855437|5444224|P2|COMPLETED|Crossover Period (Same Day)||19
2220122|NCT02855437|5444225|P1|COMPLETED|Crossover Period (Same Day)||21
2220123|NCT02855437|5444224|P2|STARTED|Crossover Period (Same Day)||19
2220124|NCT02855437|5444225|P1|STARTED|Crossover Period (Same Day)||21
2220125|NCT02855437|5444224|P2|NOT COMPLETED|Phase 1||2
2220126|NCT02855437|5444225|P1|NOT COMPLETED|Phase 1||2
2220127|NCT02855437|5444224|P2|COMPLETED|Phase 1||19
2220128|NCT02855437|5444225|P1|COMPLETED|Phase 1||21
2220129|NCT02855437|5444224|P2|STARTED|Phase 1||21
2220130|NCT02855437|5444225|P1|STARTED|Phase 1||23
2220131|NCT02855411|5444233|P1|NOT COMPLETED|Overall Study||35
2220132|NCT02855411|5444233|P1|COMPLETED|Overall Study||0
2220133|NCT02855411|5444233|P1|Assigned to Study Treatment|Overall Study||0
2220134|NCT02855411|5444233|P1|STARTED|Overall Study||35
2220135|NCT02855359|5444255|P4|NOT COMPLETED|Overall Study||0
2220136|NCT02855359|5444256|P3|NOT COMPLETED|Overall Study||0
2220137|NCT02855359|5444257|P2|NOT COMPLETED|Overall Study||13
2220138|NCT02855359|5444258|P1|NOT COMPLETED|Overall Study||11
2220139|NCT02855359|5444255|P4|COMPLETED|Overall Study||0
2220140|NCT02855359|5444256|P3|COMPLETED|Overall Study||0
2220141|NCT02855359|5444257|P2|COMPLETED|Overall Study||0
2220142|NCT02855359|5444258|P1|COMPLETED|Overall Study||0
2220143|NCT02855359|5444255|P4|STARTED|Overall Study||0
2220144|NCT02855359|5444256|P3|STARTED|Overall Study||0
2220145|NCT02855359|5444257|P2|STARTED|Overall Study||13
2220146|NCT02855359|5444258|P1|STARTED|Overall Study||11
2220147|NCT02855086|5444292|P2|NOT COMPLETED|Overall Study||0
2220148|NCT02855086|5444293|P1|NOT COMPLETED|Overall Study||0
2220149|NCT02855086|5444292|P2|COMPLETED|Overall Study||1
2220150|NCT02855086|5444293|P1|COMPLETED|Overall Study||2
2220151|NCT02855086|5444292|P2|STARTED|Overall Study||1
2220152|NCT02855086|5444293|P1|STARTED|Overall Study||2
2220153|NCT02854631|5444303|P2|NOT COMPLETED|Overall Study||15
2220154|NCT02854631|5444304|P1|NOT COMPLETED|Overall Study||26
2220155|NCT02854631|5444303|P2|COMPLETED|Overall Study||37
2220156|NCT02854631|5444304|P1|COMPLETED|Overall Study||26
2220157|NCT02854631|5444303|P2|STARTED|Overall Study||52
2220158|NCT02854631|5444304|P1|STARTED|Overall Study||52
2220159|NCT02854605|5444365|P3|NOT COMPLETED|Overall Study||4
2220160|NCT02854605|5444366|P2|NOT COMPLETED|Overall Study||7
2220161|NCT02854605|5444367|P1|NOT COMPLETED|Overall Study||3
2220162|NCT02854605|5444365|P3|COMPLETED|Overall Study||24
2220163|NCT02854605|5444366|P2|COMPLETED|Overall Study||49
2220164|NCT02854605|5444367|P1|COMPLETED|Overall Study||53
2220165|NCT02854605|5444365|P3|STARTED|Overall Study||28
2220166|NCT02854605|5444366|P2|STARTED|Overall Study||56
2220167|NCT02854605|5444367|P1|STARTED|Overall Study||56
2220168|NCT02854540|5444378|P1|NOT COMPLETED|Overall Study||2
2220169|NCT02854540|5444378|P1|COMPLETED|Overall Study||11
2220170|NCT02854540|5444378|P1|STARTED|Overall Study||13
2220171|NCT02854527|5444397|P10|NOT COMPLETED|Overall Study||0
2220172|NCT02854527|5444398|P9|NOT COMPLETED|Overall Study||0
2220173|NCT02854527|5444399|P8|NOT COMPLETED|Overall Study||0
2220174|NCT02854527|5444400|P7|NOT COMPLETED|Overall Study||0
2220175|NCT02854527|5444401|P6|NOT COMPLETED|Overall Study||0
2220176|NCT02854527|5444402|P5|NOT COMPLETED|Overall Study||1
2220177|NCT02854527|5444403|P4|NOT COMPLETED|Overall Study||1
2220178|NCT02854527|5444404|P3|NOT COMPLETED|Overall Study||0
2220179|NCT02854527|5444405|P2|NOT COMPLETED|Overall Study||0
2220180|NCT02854527|5444406|P1|NOT COMPLETED|Overall Study||0
2220181|NCT02854527|5444397|P10|COMPLETED|Overall Study||3
2220182|NCT02854527|5444398|P9|COMPLETED|Overall Study||3
2220183|NCT02854527|5444399|P8|COMPLETED|Overall Study||3
2220184|NCT02854527|5444400|P7|COMPLETED|Overall Study||3
2220185|NCT02854527|5444401|P6|COMPLETED|Overall Study||3
2220186|NCT02854527|5444402|P5|COMPLETED|Overall Study||2
2220187|NCT02854527|5444403|P4|COMPLETED|Overall Study||2
2220188|NCT02854527|5444404|P3|COMPLETED|Overall Study||3
2220189|NCT02854527|5444405|P2|COMPLETED|Overall Study||3
2220190|NCT02854527|5444406|P1|COMPLETED|Overall Study||3
2220191|NCT02854527|5444397|P10|Received T|Overall Study||3
2220192|NCT02854527|5444398|P9|Received T|Overall Study||3
2220193|NCT02854527|5444399|P8|Received T|Overall Study||3
2220194|NCT02854527|5444400|P7|Received T|Overall Study||3
2220195|NCT02854527|5444401|P6|Received T|Overall Study||3
2220196|NCT02854527|5444402|P5|Received T|Overall Study||2
2220197|NCT02854527|5444403|P4|Received T|Overall Study||2
2220198|NCT02854527|5444404|P3|Received T|Overall Study||3
2220199|NCT02854527|5444405|P2|Received T|Overall Study||3
2220200|NCT02854527|5444406|P1|Received T|Overall Study||3
2220201|NCT02854527|5444397|P10|Received R4|Overall Study||3
2220202|NCT02854527|5444398|P9|Received R4|Overall Study||3
2220203|NCT02854527|5444399|P8|Received R4|Overall Study||3
2220204|NCT02854527|5444400|P7|Received R4|Overall Study||3
2220205|NCT02854527|5444401|P6|Received R4|Overall Study||3
2220206|NCT02854527|5444402|P5|Received R4|Overall Study||3
2220207|NCT02854527|5444403|P4|Received R4|Overall Study||2
2220208|NCT02854527|5444404|P3|Received R4|Overall Study||3
2220209|NCT02854527|5444405|P2|Received R4|Overall Study||3
2220210|NCT02854527|5444406|P1|Received R4|Overall Study||3
2220211|NCT02854527|5444397|P10|Received R3|Overall Study||3
2220212|NCT02854527|5444398|P9|Received R3|Overall Study||3
2220213|NCT02854527|5444399|P8|Received R3|Overall Study||3
2220214|NCT02854527|5444400|P7|Received R3|Overall Study||3
2220215|NCT02854527|5444401|P6|Received R3|Overall Study||3
2220216|NCT02854527|5444402|P5|Received R3|Overall Study||3
2220217|NCT02854527|5444403|P4|Received R3|Overall Study||2
2220218|NCT02854527|5444404|P3|Received R3|Overall Study||3
2220219|NCT02854527|5444405|P2|Received R3|Overall Study||3
2220220|NCT02854527|5444406|P1|Received R3|Overall Study||3
2220221|NCT02854527|5444397|P10|Received R2|Overall Study||3
2220222|NCT02854527|5444398|P9|Received R2|Overall Study||3
2220223|NCT02854527|5444399|P8|Received R2|Overall Study||3
2220224|NCT02854527|5444400|P7|Received R2|Overall Study||3
2220225|NCT02854527|5444401|P6|Received R2|Overall Study||3
2220226|NCT02854527|5444402|P5|Received R2|Overall Study||3
2220227|NCT02854527|5444403|P4|Received R2|Overall Study||3
2220228|NCT02854527|5444404|P3|Received R2|Overall Study||3
2220229|NCT02854527|5444405|P2|Received R2|Overall Study||3
2220230|NCT02854527|5444406|P1|Received R2|Overall Study||3
2220231|NCT02854527|5444397|P10|Received R1|Overall Study||3
2220232|NCT02854527|5444398|P9|Received R1|Overall Study||3
2220233|NCT02854527|5444399|P8|Received R1|Overall Study||3
2220234|NCT02854527|5444400|P7|Received R1|Overall Study||3
2220235|NCT02854527|5444401|P6|Received R1|Overall Study||3
2220236|NCT02854527|5444402|P5|Received R1|Overall Study||2
2220237|NCT02854527|5444403|P4|Received R1|Overall Study||2
2220238|NCT02854527|5444404|P3|Received R1|Overall Study||3
2220239|NCT02854527|5444405|P2|Received R1|Overall Study||3
2220240|NCT02854527|5444406|P1|Received R1|Overall Study||3
2220241|NCT02854527|5444397|P10|STARTED|Overall Study||3
2220242|NCT02854527|5444398|P9|STARTED|Overall Study||3
2220243|NCT02854527|5444399|P8|STARTED|Overall Study||3
2220244|NCT02854527|5444400|P7|STARTED|Overall Study||3
2220245|NCT02854527|5444401|P6|STARTED|Overall Study||3
2220246|NCT02854527|5444402|P5|STARTED|Overall Study||3
2220247|NCT02854527|5444403|P4|STARTED|Overall Study||3
2220248|NCT02854527|5444404|P3|STARTED|Overall Study||3
2220249|NCT02854527|5444405|P2|STARTED|Overall Study||3
2220250|NCT02854527|5444406|P1|STARTED|Overall Study||3
2220251|NCT02854059|5444439|P2|NOT COMPLETED|Overall Study||0
2220252|NCT02854059|5444440|P1|NOT COMPLETED|Overall Study||0
2220253|NCT02854059|5444439|P2|COMPLETED|Overall Study||0
2220254|NCT02854059|5444440|P1|COMPLETED|Overall Study||2
2220255|NCT02854059|5444439|P2|STARTED|Overall Study||0
2220256|NCT02854059|5444440|P1|STARTED|Overall Study||2
2220257|NCT02853929|5444464|P2|NOT COMPLETED|Overall Study||4
2220258|NCT02853929|5444465|P1|NOT COMPLETED|Overall Study||11
2220259|NCT02853929|5444464|P2|COMPLETED|Overall Study||277
2220260|NCT02853929|5444465|P1|COMPLETED|Overall Study||259
2220261|NCT02853929|5444464|P2|Vaccinated|Overall Study||277
2220262|NCT02853929|5444465|P1|Vaccinated|Overall Study||263
2220263|NCT02853929|5444464|P2|STARTED|Overall Study||281
2220264|NCT02853929|5444465|P1|STARTED|Overall Study||270
2220265|NCT02853435|5444506|P6|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
2220266|NCT02853435|5444507|P5|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
2220267|NCT02853435|5444508|P4|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
2220268|NCT02853435|5444509|P3|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
2220269|NCT02853435|5444510|P2|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
2220270|NCT02853435|5444511|P1|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
2220271|NCT02853435|5444506|P6|COMPLETED|Part 3, Period 3 (3 Days)||2
2220272|NCT02853435|5444507|P5|COMPLETED|Part 3, Period 3 (3 Days)||9
2220273|NCT02853435|5444508|P4|COMPLETED|Part 3, Period 3 (3 Days)||0
2220274|NCT02853435|5444509|P3|COMPLETED|Part 3, Period 3 (3 Days)||0
2220275|NCT02853435|5444510|P2|COMPLETED|Part 3, Period 3 (3 Days)||0
2220276|NCT02853435|5444511|P1|COMPLETED|Part 3, Period 3 (3 Days)||0
2220277|NCT02853435|5444506|P6|STARTED|Part 3, Period 3 (3 Days)||2
2220278|NCT02853435|5444507|P5|STARTED|Part 3, Period 3 (3 Days)||9
2220279|NCT02853435|5444508|P4|STARTED|Part 3, Period 3 (3 Days)||0
2220280|NCT02853435|5444509|P3|STARTED|Part 3, Period 3 (3 Days)||0
2220281|NCT02853435|5444510|P2|STARTED|Part 3, Period 3 (3 Days)||0
2220282|NCT02853435|5444511|P1|STARTED|Part 3, Period 3 (3 Days)||0
2220283|NCT02853435|5444506|P6|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
2220284|NCT02853435|5444507|P5|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||1
2220285|NCT02853435|5444508|P4|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
2220286|NCT02853435|5444509|P3|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
2220287|NCT02853435|5444510|P2|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
2220288|NCT02853435|5444511|P1|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
2220289|NCT02853435|5444506|P6|COMPLETED|Part 3, Washout Period 2 (3 Days)||2
2220290|NCT02853435|5444507|P5|COMPLETED|Part 3, Washout Period 2 (3 Days)||9
2220291|NCT02853435|5444508|P4|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
2220292|NCT02853435|5444509|P3|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
2220293|NCT02853435|5444510|P2|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
2220294|NCT02853435|5444511|P1|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
2220295|NCT02853435|5444506|P6|STARTED|Part 3, Washout Period 2 (3 Days)||2
2220296|NCT02853435|5444507|P5|STARTED|Part 3, Washout Period 2 (3 Days)||10
2220297|NCT02853435|5444508|P4|STARTED|Part 3, Washout Period 2 (3 Days)||0
2220298|NCT02853435|5444509|P3|STARTED|Part 3, Washout Period 2 (3 Days)||0
2220299|NCT02853435|5444510|P2|STARTED|Part 3, Washout Period 2 (3 Days)||0
2220300|NCT02853435|5444511|P1|STARTED|Part 3, Washout Period 2 (3 Days)||0
2220301|NCT02853435|5444506|P6|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
2220302|NCT02853435|5444507|P5|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
2220303|NCT02853435|5444508|P4|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
2220304|NCT02853435|5444509|P3|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
2220305|NCT02853435|5444510|P2|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
2220306|NCT02853435|5444511|P1|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
2220307|NCT02853435|5444506|P6|COMPLETED|Part 3, Period 2 (3 Days)||2
2220308|NCT02853435|5444507|P5|COMPLETED|Part 3, Period 2 (3 Days)||10
2220309|NCT02853435|5444508|P4|COMPLETED|Part 3, Period 2 (3 Days)||0
2220310|NCT02853435|5444509|P3|COMPLETED|Part 3, Period 2 (3 Days)||0
2220311|NCT02853435|5444510|P2|COMPLETED|Part 3, Period 2 (3 Days)||0
2220312|NCT02853435|5444511|P1|COMPLETED|Part 3, Period 2 (3 Days)||0
2220313|NCT02853435|5444506|P6|STARTED|Part 3, Period 2 (3 Days)||2
2220314|NCT02853435|5444507|P5|STARTED|Part 3, Period 2 (3 Days)||10
2220315|NCT02853435|5444508|P4|STARTED|Part 3, Period 2 (3 Days)||0
2220316|NCT02853435|5444509|P3|STARTED|Part 3, Period 2 (3 Days)||0
2220317|NCT02853435|5444510|P2|STARTED|Part 3, Period 2 (3 Days)||0
2220318|NCT02853435|5444511|P1|STARTED|Part 3, Period 2 (3 Days)||0
2220319|NCT02853435|5444506|P6|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
2220320|NCT02853435|5444507|P5|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
2220321|NCT02853435|5444508|P4|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
2220322|NCT02853435|5444509|P3|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
2220323|NCT02853435|5444510|P2|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
2220324|NCT02853435|5444511|P1|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
2220325|NCT02853435|5444506|P6|COMPLETED|Part 3, Washout Period 1 (3 Days)||2
2220326|NCT02853435|5444507|P5|COMPLETED|Part 3, Washout Period 1 (3 Days)||10
2220327|NCT02853435|5444508|P4|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
2220328|NCT02853435|5444509|P3|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
2220329|NCT02853435|5444510|P2|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
2220330|NCT02853435|5444511|P1|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
2220331|NCT02853435|5444506|P6|STARTED|Part 3, Washout Period 1 (3 Days)||2
2220332|NCT02853435|5444507|P5|STARTED|Part 3, Washout Period 1 (3 Days)||10
2220333|NCT02853435|5444508|P4|STARTED|Part 3, Washout Period 1 (3 Days)||0
2220334|NCT02853435|5444509|P3|STARTED|Part 3, Washout Period 1 (3 Days)||0
2220335|NCT02853435|5444510|P2|STARTED|Part 3, Washout Period 1 (3 Days)||0
2220336|NCT02853435|5444511|P1|STARTED|Part 3, Washout Period 1 (3 Days)||0
2220337|NCT02853435|5444506|P6|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
2220338|NCT02853435|5444507|P5|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
2220339|NCT02853435|5444508|P4|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
2220340|NCT02853435|5444509|P3|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
2220341|NCT02853435|5444510|P2|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
2220342|NCT02853435|5444511|P1|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
2220343|NCT02853435|5444506|P6|COMPLETED|Part 3, Period 1 (3 Days)||2
2220344|NCT02853435|5444507|P5|COMPLETED|Part 3, Period 1 (3 Days)||10
2220345|NCT02853435|5444508|P4|COMPLETED|Part 3, Period 1 (3 Days)||0
2220346|NCT02853435|5444509|P3|COMPLETED|Part 3, Period 1 (3 Days)||0
2220347|NCT02853435|5444510|P2|COMPLETED|Part 3, Period 1 (3 Days)||0
2220348|NCT02853435|5444511|P1|COMPLETED|Part 3, Period 1 (3 Days)||0
2220349|NCT02853435|5444506|P6|STARTED|Part 3, Period 1 (3 Days)||2
2220350|NCT02853435|5444507|P5|STARTED|Part 3, Period 1 (3 Days)||10
2220351|NCT02853435|5444508|P4|STARTED|Part 3, Period 1 (3 Days)||0
2220352|NCT02853435|5444509|P3|STARTED|Part 3, Period 1 (3 Days)||0
2220353|NCT02853435|5444510|P2|STARTED|Part 3, Period 1 (3 Days)||0
2220354|NCT02853435|5444511|P1|STARTED|Part 3, Period 1 (3 Days)||0
2220355|NCT02853435|5444506|P6|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
2220356|NCT02853435|5444507|P5|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
2220357|NCT02853435|5444508|P4|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
2220358|NCT02853435|5444509|P3|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
2220359|NCT02853435|5444510|P2|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
2220360|NCT02853435|5444511|P1|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
2220361|NCT02853435|5444506|P6|COMPLETED|Part 2, Period 2 (3 Days)||0
2220362|NCT02853435|5444507|P5|COMPLETED|Part 2, Period 2 (3 Days)||0
2220363|NCT02853435|5444508|P4|COMPLETED|Part 2, Period 2 (3 Days)||10
2220364|NCT02853435|5444509|P3|COMPLETED|Part 2, Period 2 (3 Days)||0
2220365|NCT02853435|5444510|P2|COMPLETED|Part 2, Period 2 (3 Days)||0
2220366|NCT02853435|5444511|P1|COMPLETED|Part 2, Period 2 (3 Days)||0
2220367|NCT02853435|5444506|P6|STARTED|Part 2, Period 2 (3 Days)||0
2220368|NCT02853435|5444507|P5|STARTED|Part 2, Period 2 (3 Days)||0
2220369|NCT02853435|5444508|P4|STARTED|Part 2, Period 2 (3 Days)||10
2220370|NCT02853435|5444509|P3|STARTED|Part 2, Period 2 (3 Days)||0
2220371|NCT02853435|5444510|P2|STARTED|Part 2, Period 2 (3 Days)||0
2220372|NCT02853435|5444511|P1|STARTED|Part 2, Period 2 (3 Days)||0
2220373|NCT02853435|5444506|P6|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
2220374|NCT02853435|5444507|P5|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
2220375|NCT02853435|5444508|P4|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
2220376|NCT02853435|5444509|P3|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
2220377|NCT02853435|5444510|P2|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
2220378|NCT02853435|5444511|P1|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
2220379|NCT02853435|5444506|P6|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
2220380|NCT02853435|5444507|P5|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
2220381|NCT02853435|5444508|P4|COMPLETED|Part 2, Washout Period 1 (3 Days)||10
2220382|NCT02853435|5444509|P3|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
2220383|NCT02853435|5444510|P2|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
2220384|NCT02853435|5444511|P1|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
2220385|NCT02853435|5444506|P6|STARTED|Part 2, Washout Period 1 (3 Days)||0
2220386|NCT02853435|5444507|P5|STARTED|Part 2, Washout Period 1 (3 Days)||0
2220387|NCT02853435|5444508|P4|STARTED|Part 2, Washout Period 1 (3 Days)||10
2220388|NCT02853435|5444509|P3|STARTED|Part 2, Washout Period 1 (3 Days)||0
2220389|NCT02853435|5444510|P2|STARTED|Part 2, Washout Period 1 (3 Days)||0
2220390|NCT02853435|5444511|P1|STARTED|Part 2, Washout Period 1 (3 Days)||0
2220391|NCT02853435|5444506|P6|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
2220392|NCT02853435|5444507|P5|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
2220393|NCT02853435|5444508|P4|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
2220394|NCT02853435|5444509|P3|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
2220395|NCT02853435|5444510|P2|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
2220396|NCT02853435|5444511|P1|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
2220397|NCT02853435|5444506|P6|COMPLETED|Part 2, Period 1 (3 Days)||0
2220398|NCT02853435|5444507|P5|COMPLETED|Part 2, Period 1 (3 Days)||0
2220399|NCT02853435|5444508|P4|COMPLETED|Part 2, Period 1 (3 Days)||10
2220400|NCT02853435|5444509|P3|COMPLETED|Part 2, Period 1 (3 Days)||0
2220401|NCT02853435|5444510|P2|COMPLETED|Part 2, Period 1 (3 Days)||0
2220402|NCT02853435|5444511|P1|COMPLETED|Part 2, Period 1 (3 Days)||0
2220403|NCT02853435|5444506|P6|STARTED|Part 2, Period 1 (3 Days)||0
2220404|NCT02853435|5444507|P5|STARTED|Part 2, Period 1 (3 Days)||0
2220405|NCT02853435|5444508|P4|STARTED|Part 2, Period 1 (3 Days)||10
2220406|NCT02853435|5444509|P3|STARTED|Part 2, Period 1 (3 Days)||0
2220407|NCT02853435|5444510|P2|STARTED|Part 2, Period 1 (3 Days)||0
2220408|NCT02853435|5444511|P1|STARTED|Part 2, Period 1 (3 Days)||0
2220409|NCT02853435|5444506|P6|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
2220410|NCT02853435|5444507|P5|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
2220411|NCT02853435|5444508|P4|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
2220412|NCT02853435|5444509|P3|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
2220413|NCT02853435|5444510|P2|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
2220414|NCT02853435|5444511|P1|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
2220415|NCT02853435|5444506|P6|COMPLETED|Part 1a, Period 3 (3 Days)||0
2220416|NCT02853435|5444507|P5|COMPLETED|Part 1a, Period 3 (3 Days)||0
2220417|NCT02853435|5444508|P4|COMPLETED|Part 1a, Period 3 (3 Days)||0
2220418|NCT02853435|5444509|P3|COMPLETED|Part 1a, Period 3 (3 Days)||8
2220419|NCT02853435|5444510|P2|COMPLETED|Part 1a, Period 3 (3 Days)||9
2220420|NCT02853435|5444511|P1|COMPLETED|Part 1a, Period 3 (3 Days)||9
2220421|NCT02853435|5444506|P6|STARTED|Part 1a, Period 3 (3 Days)||0
2220422|NCT02853435|5444507|P5|STARTED|Part 1a, Period 3 (3 Days)||0
2220423|NCT02853435|5444508|P4|STARTED|Part 1a, Period 3 (3 Days)||0
2220424|NCT02853435|5444509|P3|STARTED|Part 1a, Period 3 (3 Days)||8
2220425|NCT02853435|5444510|P2|STARTED|Part 1a, Period 3 (3 Days)||9
2220426|NCT02853435|5444511|P1|STARTED|Part 1a, Period 3 (3 Days)||9
2220427|NCT02853435|5444506|P6|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
2220428|NCT02853435|5444507|P5|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
2220429|NCT02853435|5444508|P4|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
2220430|NCT02853435|5444509|P3|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
2220431|NCT02853435|5444510|P2|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
2220432|NCT02853435|5444511|P1|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
2220433|NCT02853435|5444506|P6|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
2220434|NCT02853435|5444507|P5|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
2220435|NCT02853435|5444508|P4|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
2220436|NCT02853435|5444509|P3|COMPLETED|Part 1a, Washout Period 2 (3 Days)||8
2220437|NCT02853435|5444510|P2|COMPLETED|Part 1a, Washout Period 2 (3 Days)||9
2220438|NCT02853435|5444511|P1|COMPLETED|Part 1a, Washout Period 2 (3 Days)||9
2220439|NCT02853435|5444506|P6|STARTED|Part 1a, Washout Period 2 (3 Days)||0
2220440|NCT02853435|5444507|P5|STARTED|Part 1a, Washout Period 2 (3 Days)||0
2220441|NCT02853435|5444508|P4|STARTED|Part 1a, Washout Period 2 (3 Days)||0
2220442|NCT02853435|5444509|P3|STARTED|Part 1a, Washout Period 2 (3 Days)||8
2220443|NCT02853435|5444510|P2|STARTED|Part 1a, Washout Period 2 (3 Days)||9
2220444|NCT02853435|5444511|P1|STARTED|Part 1a, Washout Period 2 (3 Days)||9
2220445|NCT02853435|5444506|P6|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
2220446|NCT02853435|5444507|P5|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
2220447|NCT02853435|5444508|P4|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
2220448|NCT02853435|5444509|P3|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
2220449|NCT02853435|5444510|P2|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
2220450|NCT02853435|5444511|P1|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
2220451|NCT02853435|5444506|P6|COMPLETED|Part 1a, Period 2 (3 Days)||0
2220452|NCT02853435|5444507|P5|COMPLETED|Part 1a, Period 2 (3 Days)||0
2220453|NCT02853435|5444508|P4|COMPLETED|Part 1a, Period 2 (3 Days)||0
2220454|NCT02853435|5444509|P3|COMPLETED|Part 1a, Period 2 (3 Days)||8
2220455|NCT02853435|5444510|P2|COMPLETED|Part 1a, Period 2 (3 Days)||9
2220456|NCT02853435|5444511|P1|COMPLETED|Part 1a, Period 2 (3 Days)||9
2220457|NCT02853435|5444506|P6|STARTED|Part 1a, Period 2 (3 Days)||0
2220458|NCT02853435|5444507|P5|STARTED|Part 1a, Period 2 (3 Days)||0
2220459|NCT02853435|5444508|P4|STARTED|Part 1a, Period 2 (3 Days)||0
2220460|NCT02853435|5444509|P3|STARTED|Part 1a, Period 2 (3 Days)||8
2220461|NCT02853435|5444510|P2|STARTED|Part 1a, Period 2 (3 Days)||9
2220462|NCT02853435|5444511|P1|STARTED|Part 1a, Period 2 (3 Days)||9
2220463|NCT02853435|5444506|P6|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
2220464|NCT02853435|5444507|P5|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
2220465|NCT02853435|5444508|P4|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
2220466|NCT02853435|5444509|P3|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
2220467|NCT02853435|5444510|P2|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
2220468|NCT02853435|5444511|P1|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
2220469|NCT02853435|5444506|P6|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
2220470|NCT02853435|5444507|P5|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
2220471|NCT02853435|5444508|P4|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
2220472|NCT02853435|5444509|P3|COMPLETED|Part 1a, Washout Period 1 (3 Days)||8
2220473|NCT02853435|5444510|P2|COMPLETED|Part 1a, Washout Period 1 (3 Days)||9
2220474|NCT02853435|5444511|P1|COMPLETED|Part 1a, Washout Period 1 (3 Days)||9
2220475|NCT02853435|5444506|P6|STARTED|Part 1a, Washout Period 1 (3 Days)||0
2220476|NCT02853435|5444507|P5|STARTED|Part 1a, Washout Period 1 (3 Days)||0
2220477|NCT02853435|5444508|P4|STARTED|Part 1a, Washout Period 1 (3 Days)||0
2220478|NCT02853435|5444509|P3|STARTED|Part 1a, Washout Period 1 (3 Days)||8
2220479|NCT02853435|5444510|P2|STARTED|Part 1a, Washout Period 1 (3 Days)||9
2220480|NCT02853435|5444511|P1|STARTED|Part 1a, Washout Period 1 (3 Days)||9
2220481|NCT02853435|5444506|P6|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
2220482|NCT02853435|5444507|P5|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
2220483|NCT02853435|5444508|P4|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
2220484|NCT02853435|5444509|P3|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
2220485|NCT02853435|5444510|P2|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
2220486|NCT02853435|5444511|P1|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
2220487|NCT02853435|5444506|P6|COMPLETED|Part 1a, Period 1 (3 Days)||0
2220488|NCT02853435|5444507|P5|COMPLETED|Part 1a, Period 1 (3 Days)||0
2220489|NCT02853435|5444508|P4|COMPLETED|Part 1a, Period 1 (3 Days)||0
2220490|NCT02853435|5444509|P3|COMPLETED|Part 1a, Period 1 (3 Days)||8
2220491|NCT02853435|5444510|P2|COMPLETED|Part 1a, Period 1 (3 Days)||9
2220492|NCT02853435|5444511|P1|COMPLETED|Part 1a, Period 1 (3 Days)||9
2220493|NCT02853435|5444506|P6|STARTED|Part 1a, Period 1 (3 Days)||0
2220494|NCT02853435|5444507|P5|STARTED|Part 1a, Period 1 (3 Days)||0
2220495|NCT02853435|5444508|P4|STARTED|Part 1a, Period 1 (3 Days)||0
2220496|NCT02853435|5444509|P3|STARTED|Part 1a, Period 1 (3 Days)||8
2220497|NCT02853435|5444510|P2|STARTED|Part 1a, Period 1 (3 Days)||9
2220498|NCT02853435|5444511|P1|STARTED|Part 1a, Period 1 (3 Days)||9
2220499|NCT02853331|5444821|P2|NOT COMPLETED|Overall Study||429
2220500|NCT02853331|5444822|P1|NOT COMPLETED|Overall Study||432
2220501|NCT02853331|5444821|P2|COMPLETED|Overall Study||0
2220502|NCT02853331|5444822|P1|COMPLETED|Overall Study||0
2220503|NCT02853331|5444821|P2|Treated|Overall Study||425
2220504|NCT02853331|5444822|P1|Treated|Overall Study||429
2220505|NCT02853331|5444821|P2|STARTED|Overall Study||429
2220506|NCT02853331|5444822|P1|STARTED|Overall Study||432
2220507|NCT02853123|5444854|P2|NOT COMPLETED|Treatment Period 2||0
2220508|NCT02853123|5444855|P1|NOT COMPLETED|Treatment Period 2||0
2220509|NCT02853123|5444854|P2|COMPLETED|Treatment Period 2||48
2220510|NCT02853123|5444855|P1|COMPLETED|Treatment Period 2||51
2220511|NCT02853123|5444854|P2|STARTED|Treatment Period 2||48
2220512|NCT02853123|5444855|P1|STARTED|Treatment Period 2||51
2220513|NCT02853123|5444854|P2|NOT COMPLETED|Washout Period||3
2220514|NCT02853123|5444855|P1|NOT COMPLETED|Washout Period||1
2220515|NCT02853123|5444854|P2|COMPLETED|Washout Period||48
2220516|NCT02853123|5444855|P1|COMPLETED|Washout Period||51
2220517|NCT02853123|5444854|P2|STARTED|Washout Period||51
2220518|NCT02853123|5444855|P1|STARTED|Washout Period||52
2220519|NCT02853123|5444854|P2|NOT COMPLETED|Treatment Period 1||3
2220520|NCT02853123|5444855|P1|NOT COMPLETED|Treatment Period 1||0
2220521|NCT02853123|5444854|P2|COMPLETED|Treatment Period 1||51
2220522|NCT02853123|5444855|P1|COMPLETED|Treatment Period 1||52
2220523|NCT02853123|5444854|P2|STARTED|Treatment Period 1||54
2220524|NCT02853123|5444855|P1|STARTED|Treatment Period 1||52
2220525|NCT02852434|5444878|P2|NOT COMPLETED|Overall Study||1
2220526|NCT02852434|5444879|P1|NOT COMPLETED|Overall Study||2
2220527|NCT02852434|5444878|P2|COMPLETED|Overall Study||35
2220528|NCT02852434|5444879|P1|COMPLETED|Overall Study||34
2220529|NCT02852434|5444878|P2|STARTED|Overall Study||36
2220530|NCT02852434|5444879|P1|STARTED|Overall Study||36
2220531|NCT02852265|5444895|P2|NOT COMPLETED|6-month Follow-up||0
2220532|NCT02852265|5444896|P1|NOT COMPLETED|6-month Follow-up||0
2220533|NCT02852265|5444895|P2|COMPLETED|6-month Follow-up||9
2220534|NCT02852265|5444896|P1|COMPLETED|6-month Follow-up||9
2220535|NCT02852265|5444895|P2|STARTED|6-month Follow-up||9
2220536|NCT02852265|5444896|P1|STARTED|6-month Follow-up||9
2220537|NCT02852265|5444895|P2|NOT COMPLETED|3-month Follow-up||1
2220538|NCT02852265|5444896|P1|NOT COMPLETED|3-month Follow-up||1
2220539|NCT02852265|5444895|P2|COMPLETED|3-month Follow-up||9
2220540|NCT02852265|5444896|P1|COMPLETED|3-month Follow-up||9
2220541|NCT02852265|5444895|P2|STARTED|3-month Follow-up||10
2220542|NCT02852265|5444896|P1|STARTED|3-month Follow-up||10
2220543|NCT02852265|5444895|P2|NOT COMPLETED|1-month Follow-up||0
2220544|NCT02852265|5444896|P1|NOT COMPLETED|1-month Follow-up||0
2220545|NCT02852265|5444895|P2|COMPLETED|1-month Follow-up||10
2220546|NCT02852265|5444896|P1|COMPLETED|1-month Follow-up||10
2220547|NCT02852265|5444895|P2|STARTED|1-month Follow-up||10
2220548|NCT02852265|5444896|P1|STARTED|1-month Follow-up||10
2220549|NCT02851823|5444912|P1|NOT COMPLETED|Overall Study||0
2220550|NCT02851823|5444912|P1|COMPLETED|Overall Study||25
2220551|NCT02851823|5444912|P1|3 Months|Overall Study||25
2220552|NCT02851823|5444912|P1|1 Month|Overall Study||25
2220553|NCT02851823|5444912|P1|STARTED|Overall Study||25
2220554|NCT02851069|5444920|P1|NOT COMPLETED|Overall Study||6
2220555|NCT02851069|5444920|P1|COMPLETED|Overall Study||59
2220556|NCT02851069|5444920|P1|STARTED|Overall Study||65
2220557|NCT02850978|5444942|P1|NOT COMPLETED|Overall Study||426
2220558|NCT02850978|5444942|P1|COMPLETED|Overall Study||909
2220559|NCT02850978|5444942|P1|Treated|Overall Study||1308
2220560|NCT02850978|5444942|P1|Case Report Form (CRF) Collected|Overall Study||1308
2220561|NCT02850978|5444942|P1|STARTED|Overall Study||1335
2220562|NCT02850965|5444949|P2|NOT COMPLETED|Overall Study||25
2220563|NCT02850965|5444950|P1|NOT COMPLETED|Overall Study||18
2220564|NCT02850965|5444949|P2|COMPLETED|Overall Study||134
2220565|NCT02850965|5444950|P1|COMPLETED|Overall Study||141
2220566|NCT02850965|5444949|P2|Treated|Overall Study||158
2220567|NCT02850965|5444950|P1|Treated|Overall Study||159
2220568|NCT02850965|5444949|P2|STARTED|Overall Study||159
2220569|NCT02850965|5444950|P1|STARTED|Overall Study||159
2220570|NCT02850276|5444966|P1|NOT COMPLETED|Overall Study||61
2220571|NCT02850276|5444966|P1|COMPLETED|Overall Study||15
2220572|NCT02850276|5444966|P1|STARTED|Overall Study||76
2220573|NCT02850159|5444979|P2|NOT COMPLETED|Overall Study||0
2220574|NCT02850159|5444980|P1|NOT COMPLETED|Overall Study||0
2220575|NCT02850159|5444979|P2|COMPLETED|Overall Study||16
2220576|NCT02850159|5444980|P1|COMPLETED|Overall Study||16
2220577|NCT02850159|5444979|P2|STARTED|Overall Study||16
2220578|NCT02850159|5444980|P1|STARTED|Overall Study||16
2220579|NCT02850068|5444986|P1|NOT COMPLETED|Overall Study||20
2220580|NCT02850068|5444986|P1|COMPLETED|Overall Study||0
2220581|NCT02850068|5444986|P1|STARTED|Overall Study||20
2220582|NCT02849990|5444993|P1|NOT COMPLETED|Overall Study||2
2220583|NCT02849990|5444993|P1|COMPLETED|Overall Study||20
2220584|NCT02849990|5444993|P1|STARTED|Overall Study||22
2220585|NCT02849938|5445005|P2|NOT COMPLETED|Overall Study||0
2220586|NCT02849938|5445006|P1|NOT COMPLETED|Overall Study||0
2220587|NCT02849938|5445005|P2|COMPLETED|Overall Study||15
2220588|NCT02849938|5445006|P1|COMPLETED|Overall Study||9
2220589|NCT02849938|5445005|P2|STARTED|Overall Study||15
2220590|NCT02849938|5445006|P1|STARTED|Overall Study||9
2220591|NCT02849704|5445018|P2|NOT COMPLETED|Assessment on PERT - CP Subj - 16 Days||0
2220592|NCT02849704|5445019|P1|NOT COMPLETED|Assessment on PERT - CP Subj - 16 Days||3
2220593|NCT02849704|5445018|P2|COMPLETED|Assessment on PERT - CP Subj - 16 Days||0
2220594|NCT02849704|5445019|P1|COMPLETED|Assessment on PERT - CP Subj - 16 Days||21
2220595|NCT02849704|5445018|P2|STARTED|Assessment on PERT - CP Subj - 16 Days||0
2220596|NCT02849704|5445019|P1|STARTED|Assessment on PERT - CP Subj - 16 Days||24
2220597|NCT02849704|5445018|P2|NOT COMPLETED|Baseline Assessments - All Subj - 7 Days||0
2220598|NCT02849704|5445019|P1|NOT COMPLETED|Baseline Assessments - All Subj - 7 Days||0
2220599|NCT02849704|5445018|P2|COMPLETED|Baseline Assessments - All Subj - 7 Days||24
2220600|NCT02849704|5445019|P1|COMPLETED|Baseline Assessments - All Subj - 7 Days||24
2220601|NCT02849704|5445018|P2|STARTED|Baseline Assessments - All Subj - 7 Days||24
2220602|NCT02849704|5445019|P1|STARTED|Baseline Assessments - All Subj - 7 Days||24
2220603|NCT02849704|5445018|P2|NOT COMPLETED|Washout Period - CP Subj on PERT - 3days||0
2220604|NCT02849704|5445019|P1|NOT COMPLETED|Washout Period - CP Subj on PERT - 3days||0
2220605|NCT02849704|5445018|P2|COMPLETED|Washout Period - CP Subj on PERT - 3days||0
2220606|NCT02849704|5445019|P1|COMPLETED|Washout Period - CP Subj on PERT - 3days||11
2220607|NCT02849704|5445018|P2|STARTED|Washout Period - CP Subj on PERT - 3days||0
2220608|NCT02849704|5445019|P1|STARTED|Washout Period - CP Subj on PERT - 3days||11
2220609|NCT02849678|5445034|P2|NOT COMPLETED|Overall Study||6
2220610|NCT02849678|5445035|P1|NOT COMPLETED|Overall Study||3
2220611|NCT02849678|5445034|P2|COMPLETED|Overall Study||18
2220612|NCT02849678|5445035|P1|COMPLETED|Overall Study||17
2220613|NCT02849678|5445034|P2|STARTED|Overall Study||24
2220614|NCT02849678|5445035|P1|STARTED|Overall Study||20
2220615|NCT02849509|5445056|P3|NOT COMPLETED|Overall Study||85
2220616|NCT02849509|5445057|P2|NOT COMPLETED|Overall Study||166
2220617|NCT02849509|5445058|P1|NOT COMPLETED|Overall Study||90
2220618|NCT02849509|5445056|P3|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|258
2220619|NCT02849509|5445057|P2|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|425
2220620|NCT02849509|5445058|P1|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|289
2220621|NCT02849509|5445056|P3|STARTED|Overall Study||343
2220622|NCT02849509|5445057|P2|STARTED|Overall Study||591
2220623|NCT02849509|5445058|P1|STARTED|Overall Study||379
2220624|NCT02849418|5445087|P6|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
2220625|NCT02849418|5445088|P5|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
2220626|NCT02849418|5445089|P4|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
2220627|NCT02849418|5445090|P3|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
2220628|NCT02849418|5445091|P2|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
2220629|NCT02849418|5445092|P1|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
2220630|NCT02849418|5445087|P6|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||3
2220631|NCT02849418|5445088|P5|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||5
2220632|NCT02849418|5445089|P4|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
2220633|NCT02849418|5445090|P3|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
2220634|NCT02849418|5445091|P2|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
2220635|NCT02849418|5445092|P1|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
2220636|NCT02849418|5445087|P6|STARTED|Open-label(3rd Treatment-Week 12 to 48)||3
2220637|NCT02849418|5445088|P5|STARTED|Open-label(3rd Treatment-Week 12 to 48)||5
2220638|NCT02849418|5445089|P4|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
2220639|NCT02849418|5445090|P3|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
2220640|NCT02849418|5445091|P2|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
2220641|NCT02849418|5445092|P1|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
2220642|NCT02849418|5445087|P6|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
2220643|NCT02849418|5445088|P5|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
2220644|NCT02849418|5445089|P4|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
2220645|NCT02849418|5445090|P3|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
2220646|NCT02849418|5445091|P2|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
2220647|NCT02849418|5445092|P1|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
2220648|NCT02849418|5445087|P6|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
2220649|NCT02849418|5445088|P5|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
2220650|NCT02849418|5445089|P4|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||6
2220651|NCT02849418|5445090|P3|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||10
2220652|NCT02849418|5445091|P2|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
2220653|NCT02849418|5445092|P1|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
2220654|NCT02849418|5445087|P6|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
2220655|NCT02849418|5445088|P5|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
2220656|NCT02849418|5445089|P4|STARTED|Open-label(2nd Treatment-Week 12 to 48)||6
2220657|NCT02849418|5445090|P3|STARTED|Open-label(2nd Treatment-Week 12 to 48)||10
2220658|NCT02849418|5445091|P2|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
2220659|NCT02849418|5445092|P1|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
2220660|NCT02849418|5445087|P6|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
2220661|NCT02849418|5445088|P5|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
2220662|NCT02849418|5445089|P4|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
2220663|NCT02849418|5445090|P3|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
2220664|NCT02849418|5445091|P2|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
2220665|NCT02849418|5445092|P1|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
2220666|NCT02849418|5445087|P6|COMPLETED|Double-blinded (Up to 48 Weeks)||0
2220667|NCT02849418|5445088|P5|COMPLETED|Double-blinded (Up to 48 Weeks)||0
2220668|NCT02849418|5445089|P4|COMPLETED|Double-blinded (Up to 48 Weeks)||0
2220669|NCT02849418|5445090|P3|COMPLETED|Double-blinded (Up to 48 Weeks)||0
2220670|NCT02849418|5445091|P2|COMPLETED|Double-blinded (Up to 48 Weeks)||11
2220671|NCT02849418|5445092|P1|COMPLETED|Double-blinded (Up to 48 Weeks)||10
2220672|NCT02849418|5445087|P6|STARTED|Double-blinded (Up to 48 Weeks)||0
2220673|NCT02849418|5445088|P5|STARTED|Double-blinded (Up to 48 Weeks)||0
2220674|NCT02849418|5445089|P4|STARTED|Double-blinded (Up to 48 Weeks)||0
2220675|NCT02849418|5445090|P3|STARTED|Double-blinded (Up to 48 Weeks)||0
2220676|NCT02849418|5445091|P2|STARTED|Double-blinded (Up to 48 Weeks)||11
2220677|NCT02849418|5445092|P1|STARTED|Double-blinded (Up to 48 Weeks)||10
2220678|NCT02849184|5445242|P2|NOT COMPLETED|Overall Study||0
2220679|NCT02849184|5445243|P1|NOT COMPLETED|Overall Study||0
2220680|NCT02849184|5445242|P2|COMPLETED|Overall Study||42
2220681|NCT02849184|5445243|P1|COMPLETED|Overall Study||40
2220682|NCT02849184|5445242|P2|STARTED|Overall Study||42
2220683|NCT02849184|5445243|P1|STARTED|Overall Study||40
2220696|NCT02848729|5445326|P2|NOT COMPLETED|Overall Study||11
2220697|NCT02848729|5445327|P1|NOT COMPLETED|Overall Study||16
2220698|NCT02848729|5445326|P2|COMPLETED|Overall Study||12
2220699|NCT02848729|5445327|P1|COMPLETED|Overall Study||11
2220700|NCT02848729|5445326|P2|Safety Population|Overall Study||23
2220701|NCT02848729|5445327|P1|Safety Population|Overall Study||27
2220702|NCT02848729|5445326|P2|Per Protocol Population|Overall Study||11
2220703|NCT02848729|5445327|P1|Per Protocol Population|Overall Study||11
2220704|NCT02848729|5445326|P2|STARTED|Overall Study||23
2220705|NCT02848729|5445327|P1|STARTED|Overall Study||27
2220706|NCT02848664|5445344|P1|NOT COMPLETED|Overall Study||4
2220707|NCT02848664|5445344|P1|COMPLETED|Overall Study||7
2220708|NCT02848664|5445344|P1|STARTED|Overall Study||11
2220709|NCT02848326|5445358|P6|NOT COMPLETED|Safety Follow-up Period||5
2220710|NCT02848326|5445359|P5|NOT COMPLETED|Safety Follow-up Period||1
2220711|NCT02848326|5445360|P4|NOT COMPLETED|Safety Follow-up Period||0
2220712|NCT02848326|5445361|P3|NOT COMPLETED|Safety Follow-up Period||3
2220713|NCT02848326|5445362|P2|NOT COMPLETED|Safety Follow-up Period||1
2220714|NCT02848326|5445363|P1|NOT COMPLETED|Safety Follow-up Period||4
2220715|NCT02848326|5445358|P6|COMPLETED|Safety Follow-up Period||77
2220716|NCT02848326|5445359|P5|COMPLETED|Safety Follow-up Period||76
2220717|NCT02848326|5445360|P4|COMPLETED|Safety Follow-up Period||169
2220718|NCT02848326|5445361|P3|COMPLETED|Safety Follow-up Period||153
2220719|NCT02848326|5445362|P2|COMPLETED|Safety Follow-up Period||83
2220720|NCT02848326|5445363|P1|COMPLETED|Safety Follow-up Period||157
2220721|NCT02848326|5445358|P6|STARTED|Safety Follow-up Period||82
2220722|NCT02848326|5445359|P5|STARTED|Safety Follow-up Period||77
2220723|NCT02848326|5445360|P4|STARTED|Safety Follow-up Period||169
2220724|NCT02848326|5445361|P3|STARTED|Safety Follow-up Period||156
2220725|NCT02848326|5445362|P2|STARTED|Safety Follow-up Period||84
2220726|NCT02848326|5445363|P1|STARTED|Safety Follow-up Period||161
2220727|NCT02848326|5445358|P6|NOT COMPLETED|Treatment Period||20
2220728|NCT02848326|5445359|P5|NOT COMPLETED|Treatment Period||19
2220729|NCT02848326|5445360|P4|NOT COMPLETED|Treatment Period||23
2220730|NCT02848326|5445361|P3|NOT COMPLETED|Treatment Period||36
2220731|NCT02848326|5445362|P2|NOT COMPLETED|Treatment Period||14
2220732|NCT02848326|5445363|P1|NOT COMPLETED|Treatment Period||38
2220733|NCT02848326|5445358|P6|COMPLETED|Treatment Period||73
2220734|NCT02848326|5445359|P5|COMPLETED|Treatment Period||70
2220735|NCT02848326|5445360|P4|COMPLETED|Treatment Period||164
2220736|NCT02848326|5445361|P3|COMPLETED|Treatment Period||149
2220737|NCT02848326|5445362|P2|COMPLETED|Treatment Period||80
2220738|NCT02848326|5445363|P1|COMPLETED|Treatment Period||148
2220739|NCT02848326|5445358|P6|Safety Population: Received Study Drug|Treatment Period||91
2220740|NCT02848326|5445359|P5|Safety Population: Received Study Drug|Treatment Period||86
2220741|NCT02848326|5445360|P4|Safety Population: Received Study Drug|Treatment Period||186
2220742|NCT02848326|5445361|P3|Safety Population: Received Study Drug|Treatment Period||183
2220743|NCT02848326|5445362|P2|Safety Population: Received Study Drug|Treatment Period||93
2220744|NCT02848326|5445363|P1|Safety Population: Received Study Drug|Treatment Period||186
2220745|NCT02848326|5445358|P6|STARTED|Treatment Period||93
2220746|NCT02848326|5445359|P5|STARTED|Treatment Period||89
2220747|NCT02848326|5445360|P4|STARTED|Treatment Period||187
2220748|NCT02848326|5445361|P3|STARTED|Treatment Period||185
2220749|NCT02848326|5445362|P2|STARTED|Treatment Period||94
2220750|NCT02848326|5445363|P1|STARTED|Treatment Period||186
2220751|NCT02848222|5445398|P3|NOT COMPLETED|Overall Study||0
2220752|NCT02848222|5445399|P2|NOT COMPLETED|Overall Study||1
2220753|NCT02848222|5445400|P1|NOT COMPLETED|Overall Study||7
2220754|NCT02848222|5445398|P3|COMPLETED|Overall Study||17
2220755|NCT02848222|5445399|P2|COMPLETED|Overall Study||17
2220756|NCT02848222|5445400|P1|COMPLETED|Overall Study||18
2220757|NCT02848222|5445398|P3|STARTED|Overall Study||17
2220758|NCT02848222|5445399|P2|STARTED|Overall Study||18
2220759|NCT02848222|5445400|P1|STARTED|Overall Study||25
2220760|NCT02847858|5445410|P2|NOT COMPLETED|Overall Study||269
2220761|NCT02847858|5445411|P1|NOT COMPLETED|Overall Study||401
2220762|NCT02847858|5445410|P2|COMPLETED|Overall Study||398
2220763|NCT02847858|5445411|P1|COMPLETED|Overall Study||292
2220764|NCT02847858|5445410|P2|STARTED|Overall Study||667
2220765|NCT02847858|5445411|P1|STARTED|Overall Study||693
2220766|NCT02847650|5445437|P2|NOT COMPLETED|Overall Study||6
2220767|NCT02847650|5445438|P1|NOT COMPLETED|Overall Study||4
2220768|NCT02847650|5445437|P2|COMPLETED|Overall Study||22
2220769|NCT02847650|5445438|P1|COMPLETED|Overall Study||25
2220770|NCT02847650|5445437|P2|STARTED|Overall Study||28
2220771|NCT02847650|5445438|P1|STARTED|Overall Study||29
2220772|NCT02847637|5445462|P4|NOT COMPLETED|Overall Study||63
2220773|NCT02847637|5445463|P3|NOT COMPLETED|Overall Study||35
2220774|NCT02847637|5445464|P2|NOT COMPLETED|Overall Study||35
2220775|NCT02847637|5445465|P1|NOT COMPLETED|Overall Study||17
2220776|NCT02847637|5445462|P4|COMPLETED|Overall Study||0
2220777|NCT02847637|5445463|P3|COMPLETED|Overall Study||0
2220778|NCT02847637|5445464|P2|COMPLETED|Overall Study||1
2220779|NCT02847637|5445465|P1|COMPLETED|Overall Study||1
2220780|NCT02847637|5445462|P4|Completed 24 Weeks Emicizumab Treatment|Overall Study||58
2220781|NCT02847637|5445463|P3|Completed 24 Weeks Emicizumab Treatment|Overall Study||34
2220782|NCT02847637|5445464|P2|Completed 24 Weeks Emicizumab Treatment|Overall Study||35
2220783|NCT02847637|5445465|P1|Completed 24 Weeks Emicizumab Treatment|Overall Study|Participants started on 24 weeks No Prophylaxis first before switching to emicizumab.|1
2220784|NCT02847637|5445462|P4|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
2220785|NCT02847637|5445463|P3|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
2220786|NCT02847637|5445464|P2|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
2220787|NCT02847637|5445465|P1|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||16
2220788|NCT02847637|5445462|P4|Completed 24 Weeks on No Prophylaxis|Overall Study||0
2220789|NCT02847637|5445463|P3|Completed 24 Weeks on No Prophylaxis|Overall Study||0
2220790|NCT02847637|5445464|P2|Completed 24 Weeks on No Prophylaxis|Overall Study||0
2220791|NCT02847637|5445465|P1|Completed 24 Weeks on No Prophylaxis|Overall Study|One participant switched to emicizumab prior to completing 24 weeks No Prophylaxis (at 23.5 weeks).|16
2220792|NCT02847637|5445462|P4|STARTED|Overall Study||63
2220793|NCT02847637|5445463|P3|STARTED|Overall Study||35
2220794|NCT02847637|5445464|P2|STARTED|Overall Study||36
2220795|NCT02847637|5445465|P1|STARTED|Overall Study||18
2220796|NCT02847494|5445579|P2|NOT COMPLETED|Overall Study||5
2220797|NCT02847494|5445580|P1|NOT COMPLETED|Overall Study||8
2220798|NCT02847494|5445579|P2|COMPLETED|Overall Study||106
2220799|NCT02847494|5445580|P1|COMPLETED|Overall Study||101
2220800|NCT02847494|5445579|P2|STARTED|Overall Study||111
2220801|NCT02847494|5445580|P1|STARTED|Overall Study||109
2220802|NCT02847260|5445590|P1|NOT COMPLETED|Overall Study||7
2220803|NCT02847260|5445590|P1|COMPLETED|Overall Study||32
2220804|NCT02847260|5445590|P1|STARTED|Overall Study||39
2220805|NCT02847182|5445604|P2|NOT COMPLETED|Overall Study||1
2220806|NCT02847182|5445605|P1|NOT COMPLETED|Overall Study||0
2220807|NCT02847182|5445604|P2|COMPLETED|Overall Study||60
2220808|NCT02847182|5445605|P1|COMPLETED|Overall Study||119
2220809|NCT02847182|5445604|P2|Second Intervention (6 Months)|Overall Study||119
2220810|NCT02847182|5445605|P1|Second Intervention (6 Months)|Overall Study||61
2220811|NCT02847182|5445604|P2|First Intervention (6 Months)|Overall Study||61
2220812|NCT02847182|5445605|P1|First Intervention (6 Months)|Overall Study||119
2220813|NCT02847182|5445604|P2|STARTED|Overall Study||61
2220814|NCT02847182|5445605|P1|STARTED|Overall Study||119
2220815|NCT02847169|5445657|P2|NOT COMPLETED|Second Intervention (1 Week)||0
2220816|NCT02847169|5445658|P1|NOT COMPLETED|Second Intervention (1 Week)||0
2220817|NCT02847169|5445657|P2|COMPLETED|Second Intervention (1 Week)||15
2220818|NCT02847169|5445658|P1|COMPLETED|Second Intervention (1 Week)||15
2220819|NCT02847169|5445657|P2|STARTED|Second Intervention (1 Week)||15
2220820|NCT02847169|5445658|P1|STARTED|Second Intervention (1 Week)||15
2220821|NCT02847169|5445657|P2|NOT COMPLETED|First Intervention (1 Week)||0
2220822|NCT02847169|5445658|P1|NOT COMPLETED|First Intervention (1 Week)||0
2220823|NCT02847169|5445657|P2|COMPLETED|First Intervention (1 Week)||15
2220824|NCT02847169|5445658|P1|COMPLETED|First Intervention (1 Week)||15
2220825|NCT02847169|5445657|P2|STARTED|First Intervention (1 Week)||15
2220826|NCT02847169|5445658|P1|STARTED|First Intervention (1 Week)||15
2220827|NCT02846792|5445692|P1|NOT COMPLETED|Overall Study||0
2220828|NCT02846792|5445692|P1|COMPLETED|Overall Study||5
2220829|NCT02846792|5445692|P1|STARTED|Overall Study||5
2220830|NCT02846779|5445705|P3|NOT COMPLETED|Overall Study||138
2220831|NCT02846779|5445706|P2|NOT COMPLETED|Overall Study||127
2220832|NCT02846779|5445707|P1|NOT COMPLETED|Overall Study||139
2220833|NCT02846779|5445705|P3|COMPLETED|Overall Study||1862
2220834|NCT02846779|5445706|P2|COMPLETED|Overall Study||1873
2220835|NCT02846779|5445707|P1|COMPLETED|Overall Study||1861
2220836|NCT02846779|5445705|P3|STARTED|Overall Study||2000
2220837|NCT02846779|5445706|P2|STARTED|Overall Study||2000
2220838|NCT02846779|5445707|P1|STARTED|Overall Study||2000
2220839|NCT02846740|5445732|P2|NOT COMPLETED|Overall Study||1
2220840|NCT02846740|5445733|P1|NOT COMPLETED|Overall Study||0
2220841|NCT02846740|5445732|P2|COMPLETED|Overall Study||14
2220842|NCT02846740|5445733|P1|COMPLETED|Overall Study||15
2220843|NCT02846740|5445732|P2|STARTED|Overall Study||15
2220844|NCT02846740|5445733|P1|STARTED|Overall Study||15
2220845|NCT02846714|5445743|P1|NOT COMPLETED|Overall Study||6
2220846|NCT02846714|5445743|P1|COMPLETED|Overall Study||36
2220847|NCT02846714|5445743|P1|STARTED|Overall Study||42
2220848|NCT02846558|5445763|P4|NOT COMPLETED|Overall Study||2
2220849|NCT02846558|5445764|P3|NOT COMPLETED|Overall Study||2
2220850|NCT02846558|5445765|P2|NOT COMPLETED|Overall Study||4
2220851|NCT02846558|5445766|P1|NOT COMPLETED|Overall Study||8
2220852|NCT02846558|5445763|P4|COMPLETED|Overall Study||11
2220853|NCT02846558|5445764|P3|COMPLETED|Overall Study||12
2220854|NCT02846558|5445765|P2|COMPLETED|Overall Study||8
2220855|NCT02846558|5445766|P1|COMPLETED|Overall Study||7
2220856|NCT02846558|5445763|P4|3 Month Study Visit|Overall Study||11
2220857|NCT02846558|5445764|P3|3 Month Study Visit|Overall Study||12
2220858|NCT02846558|5445765|P2|3 Month Study Visit|Overall Study||8
2220859|NCT02846558|5445766|P1|3 Month Study Visit|Overall Study||7
2220860|NCT02846558|5445763|P4|Baseline Study Visit|Overall Study||12
2220861|NCT02846558|5445764|P3|Baseline Study Visit|Overall Study||14
2220862|NCT02846558|5445765|P2|Baseline Study Visit|Overall Study||9
2220863|NCT02846558|5445766|P1|Baseline Study Visit|Overall Study||10
2220864|NCT02846558|5445763|P4|STARTED|Overall Study||13
2220865|NCT02846558|5445764|P3|STARTED|Overall Study||14
2220866|NCT02846558|5445765|P2|STARTED|Overall Study||12
2220867|NCT02846558|5445766|P1|STARTED|Overall Study||15
2220868|NCT02845700|5445804|P2|NOT COMPLETED|Month 1 Follow-Up||0
2220869|NCT02845700|5445805|P1|NOT COMPLETED|Month 1 Follow-Up||0
2220870|NCT02845700|5445804|P2|COMPLETED|Month 1 Follow-Up||4
2220871|NCT02845700|5445805|P1|COMPLETED|Month 1 Follow-Up||2
2220872|NCT02845700|5445804|P2|STARTED|Month 1 Follow-Up|2 participants withdrew after completing the Intervention 2 Appointment|4
2220873|NCT02845700|5445805|P1|STARTED|Month 1 Follow-Up|3 participants withdrew after completing the Intervention 2 Appointment|2
2220874|NCT02845700|5445804|P2|NOT COMPLETED|Intervention Session 2||0
2220875|NCT02845700|5445805|P1|NOT COMPLETED|Intervention Session 2||0
2220876|NCT02845700|5445804|P2|COMPLETED|Intervention Session 2||6
2220877|NCT02845700|5445805|P1|COMPLETED|Intervention Session 2||5
2220878|NCT02845700|5445804|P2|STARTED|Intervention Session 2||6
2220879|NCT02845700|5445805|P1|STARTED|Intervention Session 2||5
2220880|NCT02845700|5445804|P2|NOT COMPLETED|Intervention Session 1||0
2220881|NCT02845700|5445805|P1|NOT COMPLETED|Intervention Session 1||0
2220882|NCT02845700|5445804|P2|COMPLETED|Intervention Session 1||6
2220883|NCT02845700|5445805|P1|COMPLETED|Intervention Session 1||5
2220884|NCT02845700|5445804|P2|STARTED|Intervention Session 1|1 participant withdrew after completing the Baseline Appointment|6
2220885|NCT02845700|5445805|P1|STARTED|Intervention Session 1|1 participant withdrew after completing the Baseline Appointment|5
2220886|NCT02845700|5445804|P2|NOT COMPLETED|Baseline Appointment||0
2220887|NCT02845700|5445805|P1|NOT COMPLETED|Baseline Appointment||0
2220888|NCT02845700|5445804|P2|COMPLETED|Baseline Appointment||7
2220889|NCT02845700|5445805|P1|COMPLETED|Baseline Appointment||6
2220890|NCT02845700|5445804|P2|STARTED|Baseline Appointment||7
2220891|NCT02845700|5445805|P1|STARTED|Baseline Appointment||6
2220892|NCT02845674|5445821|P2|NOT COMPLETED|Overall Study||50
2220893|NCT02845674|5445822|P1|NOT COMPLETED|Overall Study||18
2220894|NCT02845674|5445821|P2|COMPLETED|Overall Study||79
2220895|NCT02845674|5445822|P1|COMPLETED|Overall Study||111
2220896|NCT02845674|5445821|P2|STARTED|Overall Study||129
2220897|NCT02845674|5445822|P1|STARTED|Overall Study||129
2220907|NCT02844998|5445847|P3|NOT COMPLETED|Overall Study||4
2220908|NCT02844998|5445848|P2|NOT COMPLETED|Overall Study||4
2220909|NCT02844998|5445849|P1|NOT COMPLETED|Overall Study||7
2220910|NCT02844998|5445847|P3|COMPLETED|Overall Study||35
2220911|NCT02844998|5445848|P2|COMPLETED|Overall Study||35
2220912|NCT02844998|5445849|P1|COMPLETED|Overall Study||35
2220913|NCT02844998|5445847|P3|STARTED|Overall Study||39
2220914|NCT02844998|5445848|P2|STARTED|Overall Study||39
2220915|NCT02844998|5445849|P1|STARTED|Overall Study||42
2220922|NCT02844920|5445881|P1|NOT COMPLETED|Overall Study||2
2220923|NCT02844920|5445881|P1|COMPLETED|Overall Study|Participants with completed the follow-up|35
2220924|NCT02844920|5445881|P1|Completed, Eval. Data, Opposing Fibroids|Overall Study|Participants with completed the follow-up, evaluable hysteroscopy videos, and opposing fibroids|6
2220925|NCT02844920|5445881|P1|Completed With Evaluable Videos|Overall Study|Participants with completed the follow-up and evaluable hysteroscopy videos|34
2220926|NCT02844920|5445881|P1|Completed Without Evaluable Videos|Overall Study|Participants with completed the follow-up but without evaluable hysteroscopy videos|1
2220927|NCT02844920|5445881|P1|STARTED|Overall Study||37
2220928|NCT02844569|5445888|P2|NOT COMPLETED|Overall Study||0
2220929|NCT02844569|5445889|P1|NOT COMPLETED|Overall Study||0
2220930|NCT02844569|5445888|P2|COMPLETED|Overall Study||12
2220931|NCT02844569|5445889|P1|COMPLETED|Overall Study||12
2220932|NCT02844569|5445888|P2|STARTED|Overall Study||12
2220933|NCT02844569|5445889|P1|STARTED|Overall Study||12
2220934|NCT02844543|5445899|P1|NOT COMPLETED|Overall Study||5
2220935|NCT02844543|5445899|P1|COMPLETED|Overall Study||150
2220936|NCT02844543|5445899|P1|STARTED|Overall Study||155
2220937|NCT02843659|5445909|P3|NOT COMPLETED|Overall Study||5
2220938|NCT02843659|5445910|P2|NOT COMPLETED|Overall Study||6
2220939|NCT02843659|5445911|P1|NOT COMPLETED|Overall Study||4
2220940|NCT02843659|5445909|P3|COMPLETED|Overall Study||2
2220941|NCT02843659|5445910|P2|COMPLETED|Overall Study||0
2220942|NCT02843659|5445911|P1|COMPLETED|Overall Study||1
2220943|NCT02843659|5445909|P3|STARTED|Overall Study||7
2220944|NCT02843659|5445910|P2|STARTED|Overall Study||6
2220945|NCT02843659|5445911|P1|STARTED|Overall Study||5
2220946|NCT02843178|5445980|P4|NOT COMPLETED|Overall Study||4
2220947|NCT02843178|5445981|P3|NOT COMPLETED|Overall Study||7
2220948|NCT02843178|5445982|P2|NOT COMPLETED|Overall Study||8
2220949|NCT02843178|5445983|P1|NOT COMPLETED|Overall Study||8
2220950|NCT02843178|5445980|P4|COMPLETED|Overall Study||87
2220951|NCT02843178|5445981|P3|COMPLETED|Overall Study||85
2220952|NCT02843178|5445982|P2|COMPLETED|Overall Study||82
2220953|NCT02843178|5445983|P1|COMPLETED|Overall Study||78
2220954|NCT02843178|5445980|P4|STARTED|Overall Study||91
2220955|NCT02843178|5445981|P3|STARTED|Overall Study||92
2220956|NCT02843178|5445982|P2|STARTED|Overall Study||90
2220957|NCT02843178|5445983|P1|STARTED|Overall Study||86
2220966|NCT02842736|5446032|P1|NOT COMPLETED|Overall Study||12
2220967|NCT02842736|5446032|P1|COMPLETED|Overall Study|Known Month 12 outcome|230
2220968|NCT02842736|5446032|P1|STARTED|Overall Study|Treated|242
2220969|NCT02842242|5446039|P2|NOT COMPLETED|Overall Study||0
2220970|NCT02842242|5446040|P1|NOT COMPLETED|Overall Study||1
2220971|NCT02842242|5446039|P2|COMPLETED|Overall Study||10
2220972|NCT02842242|5446040|P1|COMPLETED|Overall Study||10
2220973|NCT02842242|5446039|P2|STARTED|Overall Study||10
2220974|NCT02842242|5446040|P1|STARTED|Overall Study||11
2220975|NCT02842151|5446062|P1|NOT COMPLETED|Overall Study||2
2220976|NCT02842151|5446062|P1|COMPLETED|Overall Study||148
2220977|NCT02842151|5446062|P1|STARTED|Overall Study||150
2220978|NCT02842073|5446068|P1|NOT COMPLETED|Overall Study||1
2220979|NCT02842073|5446068|P1|COMPLETED|Overall Study||11
2220980|NCT02842073|5446068|P1|STARTED|Overall Study||12
2220981|NCT02842060|5446078|P2|NOT COMPLETED|Overall Study||0
2220982|NCT02842060|5446079|P1|NOT COMPLETED|Overall Study||0
2220983|NCT02842060|5446078|P2|COMPLETED|Overall Study||60
2220984|NCT02842060|5446079|P1|COMPLETED|Overall Study||120
2220985|NCT02842060|5446078|P2|STARTED|Overall Study||60
2220986|NCT02842060|5446079|P1|STARTED|Overall Study||120
2220987|NCT02841787|5446094|P3|NOT COMPLETED|Overall Study||0
2220988|NCT02841787|5446095|P2|NOT COMPLETED|Overall Study||4
2220989|NCT02841787|5446096|P1|NOT COMPLETED|Overall Study||3
2220990|NCT02841787|5446094|P3|COMPLETED|Overall Study||12
2220991|NCT02841787|5446095|P2|COMPLETED|Overall Study||19
2220992|NCT02841787|5446096|P1|COMPLETED|Overall Study||9
2220993|NCT02841787|5446094|P3|STARTED|Overall Study||12
2220994|NCT02841787|5446095|P2|STARTED|Overall Study||23
2220995|NCT02841787|5446096|P1|STARTED|Overall Study||12
2220996|NCT02841241|5446110|P1|NOT COMPLETED|Overall Study||0
2220997|NCT02841241|5446110|P1|COMPLETED|Overall Study||7
2220998|NCT02841241|5446110|P1|STARTED|Overall Study||7
2220999|NCT02840916|5446123|P2|NOT COMPLETED|Overall Study||3
2221000|NCT02840916|5446124|P1|NOT COMPLETED|Overall Study||1
2221001|NCT02840916|5446123|P2|COMPLETED|Overall Study||30
2221002|NCT02840916|5446124|P1|COMPLETED|Overall Study||32
2221003|NCT02840916|5446123|P2|STARTED|Overall Study||33
2221004|NCT02840916|5446124|P1|STARTED|Overall Study||33
2221005|NCT02840721|5446134|P1|NOT COMPLETED|Follow-Up||7
2221006|NCT02840721|5446134|P1|COMPLETED|Follow-Up||42
2221007|NCT02840721|5446134|P1|STARTED|Follow-Up||49
2221008|NCT02840721|5446134|P1|NOT COMPLETED|Treatment Period||1
2221009|NCT02840721|5446134|P1|COMPLETED|Treatment Period||49
2221010|NCT02840721|5446134|P1|STARTED|Treatment Period||50
2221011|NCT02840253|5446153|P1|NOT COMPLETED|Overall Study||4
2221012|NCT02840253|5446153|P1|COMPLETED|Overall Study||19
2221013|NCT02840253|5446153|P1|STARTED|Overall Study||23
2221014|NCT02839902|5446160|P2|NOT COMPLETED|Overall Study||0
2221015|NCT02839902|5446161|P1|NOT COMPLETED|Overall Study||0
2221016|NCT02839902|5446160|P2|COMPLETED|Overall Study||29
2221017|NCT02839902|5446161|P1|COMPLETED|Overall Study||24
2221018|NCT02839902|5446160|P2|STARTED|Overall Study||29
2221019|NCT02839902|5446161|P1|STARTED|Overall Study||24
2221020|NCT02839889|5446199|P2|NOT COMPLETED|Open-Label Period||1
2221021|NCT02839889|5446200|P1|NOT COMPLETED|Open-Label Period||0
2221022|NCT02839889|5446199|P2|COMPLETED|Open-Label Period||4
2221023|NCT02839889|5446200|P1|COMPLETED|Open-Label Period||0
2221024|NCT02839889|5446199|P2|STARTED|Open-Label Period||5
2221025|NCT02839889|5446200|P1|STARTED|Open-Label Period||0
2221026|NCT02839889|5446199|P2|NOT COMPLETED|Randomization Period||0
2221027|NCT02839889|5446200|P1|NOT COMPLETED|Randomization Period||0
2221028|NCT02839889|5446199|P2|COMPLETED|Randomization Period||3
2221029|NCT02839889|5446200|P1|COMPLETED|Randomization Period||2
2221030|NCT02839889|5446199|P2|STARTED|Randomization Period||3
2221031|NCT02839889|5446200|P1|STARTED|Randomization Period||2
2221032|NCT02839876|5446238|P2|NOT COMPLETED|Overall Study||11
2221033|NCT02839876|5446239|P1|NOT COMPLETED|Overall Study||10
2221034|NCT02839876|5446238|P2|COMPLETED|Overall Study||29
2221035|NCT02839876|5446239|P1|COMPLETED|Overall Study||31
2221036|NCT02839876|5446238|P2|STARTED|Overall Study||40
2221037|NCT02839876|5446239|P1|STARTED|Overall Study||41
2221038|NCT02839772|5446303|P2|NOT COMPLETED|Overall Study||0
2221039|NCT02839772|5446304|P1|NOT COMPLETED|Overall Study||1
2221040|NCT02839772|5446303|P2|COMPLETED|Overall Study||96
2221041|NCT02839772|5446304|P1|COMPLETED|Overall Study|1 participant in Clinic B did not return for the 3 months post- intervention data collection.|96
2221042|NCT02839772|5446303|P2|STARTED|Overall Study||96
2221043|NCT02839772|5446304|P1|STARTED|Overall Study|Stratification was used. Clinic A enrolled 94 participants and Clinic B 99 participants|97
2221044|NCT02839746|5446341|P1|NOT COMPLETED|Overall Study||12
2221045|NCT02839746|5446341|P1|COMPLETED|Overall Study||659
2221046|NCT02839746|5446341|P1|STARTED|Overall Study||671
2221047|NCT02839681|5446355|P1|NOT COMPLETED|Overall Study||2
2221048|NCT02839681|5446355|P1|COMPLETED|Overall Study||0
2221049|NCT02839681|5446355|P1|STARTED|Overall Study||2
2221050|NCT02839330|5446368|P4|NOT COMPLETED|Overall Study||51
2221051|NCT02839330|5446369|P3|NOT COMPLETED|Overall Study||48
2221052|NCT02839330|5446370|P2|NOT COMPLETED|Overall Study||58
2221053|NCT02839330|5446371|P1|NOT COMPLETED|Overall Study||58
2221054|NCT02839330|5446368|P4|COMPLETED|Overall Study||747
2221055|NCT02839330|5446369|P3|COMPLETED|Overall Study||747
2221056|NCT02839330|5446370|P2|COMPLETED|Overall Study||741
2221057|NCT02839330|5446371|P1|COMPLETED|Overall Study||746
2221058|NCT02839330|5446368|P4|Exposed|Overall Study||797
2221059|NCT02839330|5446369|P3|Exposed|Overall Study||793
2221060|NCT02839330|5446370|P2|Exposed|Overall Study||797
2221061|NCT02839330|5446371|P1|Exposed|Overall Study||804
2221062|NCT02839330|5446368|P4|STARTED|Overall Study||798
2221063|NCT02839330|5446369|P3|STARTED|Overall Study||795
2221064|NCT02839330|5446370|P2|STARTED|Overall Study||799
2221065|NCT02839330|5446371|P1|STARTED|Overall Study||804
2221066|NCT02838901|5446402|P2|NOT COMPLETED|Overall Study||2
2221067|NCT02838901|5446403|P1|NOT COMPLETED|Overall Study||2
2221068|NCT02838901|5446402|P2|COMPLETED|Overall Study||7
2221069|NCT02838901|5446403|P1|COMPLETED|Overall Study||7
2221070|NCT02838901|5446402|P2|STARTED|Overall Study||9
2221071|NCT02838901|5446403|P1|STARTED|Overall Study||9
2221072|NCT02838420|5446433|P2|NOT COMPLETED|Overall Study||62
2221073|NCT02838420|5446434|P1|NOT COMPLETED|Overall Study||125
2221074|NCT02838420|5446433|P2|COMPLETED|Overall Study||0
2221075|NCT02838420|5446434|P1|COMPLETED|Overall Study||0
2221076|NCT02838420|5446433|P2|STARTED|Overall Study||62
2221077|NCT02838420|5446434|P1|STARTED|Overall Study||125
2221078|NCT02838407|5446448|P1|NOT COMPLETED|Overall Study||0
2221079|NCT02838407|5446448|P1|COMPLETED|Overall Study||197
2221080|NCT02838407|5446448|P1|STARTED|Overall Study||197
2221081|NCT02838134|5446497|P2|NOT COMPLETED|Overall Study||3
2221082|NCT02838134|5446498|P1|NOT COMPLETED|Overall Study||2
2221083|NCT02838134|5446497|P2|COMPLETED|Overall Study||48
2221084|NCT02838134|5446498|P1|COMPLETED|Overall Study||48
2221085|NCT02838134|5446497|P2|STARTED|Overall Study||51
2221086|NCT02838134|5446498|P1|STARTED|Overall Study||50
2221087|NCT02838017|5446530|P2|NOT COMPLETED|Overall Study||11
2221088|NCT02838017|5446531|P1|NOT COMPLETED|Overall Study||14
2221089|NCT02838017|5446530|P2|COMPLETED|Overall Study||241
2221090|NCT02838017|5446531|P1|COMPLETED|Overall Study||238
2221091|NCT02838017|5446530|P2|STARTED|Overall Study||252
2221092|NCT02838017|5446531|P1|STARTED|Overall Study||252
2221093|NCT02837952|5446549|P2|NOT COMPLETED|Overall Study||6
2221094|NCT02837952|5446550|P1|NOT COMPLETED|Overall Study||5
2221095|NCT02837952|5446549|P2|COMPLETED|Overall Study||76
2221096|NCT02837952|5446550|P1|COMPLETED|Overall Study||36
2221097|NCT02837952|5446549|P2|STARTED|Overall Study||82
2221098|NCT02837952|5446550|P1|STARTED|Overall Study||41
2221099|NCT02837913|5446564|P2|NOT COMPLETED|Overall Study||0
2221100|NCT02837913|5446565|P1|NOT COMPLETED|Overall Study||0
2221101|NCT02837913|5446564|P2|COMPLETED|Overall Study||9
2221102|NCT02837913|5446565|P1|COMPLETED|Overall Study||10
2221103|NCT02837913|5446564|P2|STARTED|Overall Study||9
2221104|NCT02837913|5446565|P1|STARTED|Overall Study||10
2221105|NCT02837328|5446587|P2|NOT COMPLETED|Overall Study||0
2221106|NCT02837328|5446588|P1|NOT COMPLETED|Overall Study||0
2221107|NCT02837328|5446587|P2|COMPLETED|Overall Study||30
2221108|NCT02837328|5446588|P1|COMPLETED|Overall Study||29
2221109|NCT02837328|5446587|P2|STARTED|Overall Study||30
2221110|NCT02837328|5446588|P1|STARTED|Overall Study||29
2221111|NCT02837237|5446596|P1|NOT COMPLETED|Overall Study||0
2221112|NCT02837237|5446596|P1|COMPLETED|Overall Study||11
2221113|NCT02837237|5446596|P1|STARTED|Overall Study||11
2221114|NCT02836613|5446602|P2|NOT COMPLETED|Overall Study||3
2221115|NCT02836613|5446603|P1|NOT COMPLETED|Overall Study||1
2221116|NCT02836613|5446602|P2|COMPLETED|Overall Study||77
2221117|NCT02836613|5446603|P1|COMPLETED|Overall Study||79
2221118|NCT02836613|5446602|P2|STARTED|Overall Study||80
2221119|NCT02836613|5446603|P1|STARTED|Overall Study||80
2221132|NCT02836236|5446653|P2|NOT COMPLETED|Overall Study||50
2221133|NCT02836236|5446654|P1|NOT COMPLETED|Overall Study||105
2221134|NCT02836236|5446653|P2|COMPLETED|Overall Study||0
2221135|NCT02836236|5446654|P1|COMPLETED|Overall Study||0
2221136|NCT02836236|5446653|P2|STARTED|Overall Study||50
2221137|NCT02836236|5446654|P1|STARTED|Overall Study||105
2221138|NCT02835820|5446670|P2|NOT COMPLETED|Overall Study||3
2221139|NCT02835820|5446671|P1|NOT COMPLETED|Overall Study||0
2221140|NCT02835820|5446670|P2|COMPLETED|Overall Study||7
2221141|NCT02835820|5446671|P1|COMPLETED|Overall Study||7
2221142|NCT02835820|5446670|P2|Baseline Screen (OGTT)|Overall Study||7
2221143|NCT02835820|5446671|P1|Baseline Screen (OGTT)|Overall Study||7
2221144|NCT02835820|5446670|P2|STARTED|Overall Study||10
2221145|NCT02835820|5446671|P1|STARTED|Overall Study||7
2221146|NCT02835690|5446718|P3|NOT COMPLETED|Overall Study||15
2221147|NCT02835690|5446719|P2|NOT COMPLETED|Overall Study||15
2221148|NCT02835690|5446720|P1|NOT COMPLETED|Overall Study||14
2221149|NCT02835690|5446718|P3|COMPLETED|Overall Study||0
2221150|NCT02835690|5446719|P2|COMPLETED|Overall Study||0
2221151|NCT02835690|5446720|P1|COMPLETED|Overall Study||0
2221152|NCT02835690|5446718|P3|Treated|Overall Study||15
2221153|NCT02835690|5446719|P2|Treated|Overall Study||13
2221154|NCT02835690|5446720|P1|Treated|Overall Study||14
2221155|NCT02835690|5446718|P3|STARTED|Overall Study||15
2221156|NCT02835690|5446719|P2|STARTED|Overall Study||15
2221157|NCT02835690|5446720|P1|STARTED|Overall Study||14
2221158|NCT02835677|5446773|P1|NOT COMPLETED|Overall Study||0
2221159|NCT02835677|5446773|P1|COMPLETED|Overall Study||25
2221160|NCT02835677|5446773|P1|STARTED|Overall Study||25
2221161|NCT02835274|5446783|P2|NOT COMPLETED|Overall Study||0
2221162|NCT02835274|5446784|P1|NOT COMPLETED|Overall Study||0
2221163|NCT02835274|5446783|P2|COMPLETED|Overall Study||6
2221164|NCT02835274|5446784|P1|COMPLETED|Overall Study||6
2221165|NCT02835274|5446783|P2|STARTED|Overall Study||6
2221166|NCT02835274|5446784|P1|STARTED|Overall Study||6
2221167|NCT02835092|5446793|P3|NOT COMPLETED|Overall Study||3
2221168|NCT02835092|5446794|P2|NOT COMPLETED|Overall Study||8
2221169|NCT02835092|5446795|P1|NOT COMPLETED|Overall Study||3
2221170|NCT02835092|5446793|P3|COMPLETED|Overall Study||64
2221171|NCT02835092|5446794|P2|COMPLETED|Overall Study||57
2221172|NCT02835092|5446795|P1|COMPLETED|Overall Study||63
2221173|NCT02835092|5446793|P3|STARTED|Overall Study||67
2221174|NCT02835092|5446794|P2|STARTED|Overall Study||65
2221175|NCT02835092|5446795|P1|STARTED|Overall Study||66
2221176|NCT02834819|5446805|P2|NOT COMPLETED|Overall Study||0
2221177|NCT02834819|5446806|P1|NOT COMPLETED|Overall Study||5
2221178|NCT02834819|5446805|P2|COMPLETED|Overall Study||9
2221179|NCT02834819|5446806|P1|COMPLETED|Overall Study||4
2221180|NCT02834819|5446805|P2|STARTED|Overall Study||9
2221181|NCT02834819|5446806|P1|STARTED|Overall Study||9
2221182|NCT02834624|5446828|P2|NOT COMPLETED|Overall Study||0
2221183|NCT02834624|5446829|P1|NOT COMPLETED|Overall Study||0
2221184|NCT02834624|5446828|P2|COMPLETED|Overall Study||15
2221185|NCT02834624|5446829|P1|COMPLETED|Overall Study||15
2221186|NCT02834624|5446828|P2|STARTED|Overall Study||15
2221187|NCT02834624|5446829|P1|STARTED|Overall Study||15
2221188|NCT02833974|5446841|P2|NOT COMPLETED|Overall Study||3
2221189|NCT02833974|5446842|P1|NOT COMPLETED|Overall Study||1
2221190|NCT02833974|5446841|P2|COMPLETED|Overall Study||19
2221191|NCT02833974|5446842|P1|COMPLETED|Overall Study||13
2221192|NCT02833974|5446841|P2|STARTED|Overall Study||22
2221193|NCT02833974|5446842|P1|STARTED|Overall Study||14
2221194|NCT02833948|5446868|P2|NOT COMPLETED|Overall Study||18
2221195|NCT02833948|5446869|P1|NOT COMPLETED|Overall Study||15
2221196|NCT02833948|5446868|P2|COMPLETED|Overall Study||97
2221197|NCT02833948|5446869|P1|COMPLETED|Overall Study||101
2221198|NCT02833948|5446868|P2|STARTED|Overall Study||115
2221199|NCT02833948|5446869|P1|STARTED|Overall Study||116
2221203|NCT02833857|5446901|P1|NOT COMPLETED|Overall Study||0
2221204|NCT02833857|5446901|P1|COMPLETED|Overall Study||11
2221205|NCT02833857|5446901|P1|STARTED|Overall Study||11
2221206|NCT02833415|5446928|P2|NOT COMPLETED|Overall Study||3
2221207|NCT02833415|5446929|P1|NOT COMPLETED|Overall Study||2
2221208|NCT02833415|5446928|P2|COMPLETED|Overall Study||17
2221209|NCT02833415|5446929|P1|COMPLETED|Overall Study||18
2221210|NCT02833415|5446928|P2|STARTED|Overall Study||20
2221211|NCT02833415|5446929|P1|STARTED|Overall Study||20
2221212|NCT02833350|5446942|P7|NOT COMPLETED|Overall Study||5
2221213|NCT02833350|5446943|P6|NOT COMPLETED|Overall Study||1
2221214|NCT02833350|5446944|P5|NOT COMPLETED|Overall Study||3
2221215|NCT02833350|5446945|P4|NOT COMPLETED|Overall Study||8
2221216|NCT02833350|5446946|P3|NOT COMPLETED|Overall Study||8
2221217|NCT02833350|5446947|P2|NOT COMPLETED|Overall Study||9
2221218|NCT02833350|5446948|P1|NOT COMPLETED|Overall Study||3
2221219|NCT02833350|5446942|P7|COMPLETED|Overall Study||44
2221220|NCT02833350|5446943|P6|COMPLETED|Overall Study||48
2221221|NCT02833350|5446944|P5|COMPLETED|Overall Study||108
2221222|NCT02833350|5446945|P4|COMPLETED|Overall Study||102
2221223|NCT02833350|5446946|P3|COMPLETED|Overall Study||102
2221224|NCT02833350|5446947|P2|COMPLETED|Overall Study||100
2221225|NCT02833350|5446948|P1|COMPLETED|Overall Study||37
2221226|NCT02833350|5446942|P7|Randomized|Overall Study||50
2221227|NCT02833350|5446943|P6|Randomized|Overall Study||48
2221228|NCT02833350|5446944|P5|Randomized|Overall Study||111
2221229|NCT02833350|5446945|P4|Randomized|Overall Study||110
2221230|NCT02833350|5446946|P3|Randomized|Overall Study||110
2221231|NCT02833350|5446947|P2|Randomized|Overall Study||109
2221232|NCT02833350|5446948|P1|Randomized|Overall Study||40
2221233|NCT02833350|5446942|P7|STARTED|Overall Study||49
2221234|NCT02833350|5446943|P6|STARTED|Overall Study||49
2221235|NCT02833350|5446944|P5|STARTED|Overall Study||111
2221236|NCT02833350|5446945|P4|STARTED|Overall Study||110
2221237|NCT02833350|5446946|P3|STARTED|Overall Study||110
2221238|NCT02833350|5446947|P2|STARTED|Overall Study||109
2221239|NCT02833350|5446948|P1|STARTED|Overall Study||40
2221240|NCT02832674|5447149|P1|NOT COMPLETED|Overall Study||5
2221241|NCT02832674|5447149|P1|COMPLETED|Overall Study||67
2221242|NCT02832674|5447149|P1|STARTED|Overall Study||72
2221243|NCT02832375|5447160|P2|NOT COMPLETED|Overall Study||0
2221244|NCT02832375|5447161|P1|NOT COMPLETED|Overall Study||2
2221245|NCT02832375|5447160|P2|COMPLETED|Overall Study||121
2221246|NCT02832375|5447161|P1|COMPLETED|Overall Study||119
2221247|NCT02832375|5447160|P2|STARTED|Overall Study||121
2221248|NCT02832375|5447161|P1|STARTED|Overall Study||121
2221249|NCT02832284|5447171|P1|NOT COMPLETED|Overall Study||0
2221250|NCT02832284|5447171|P1|COMPLETED|Overall Study||23
2221251|NCT02832284|5447171|P1|STARTED|Overall Study||23
2221252|NCT02831855|5447179|P3|NOT COMPLETED|Double Blind Phase (24 Weeks)||19
2221253|NCT02831855|5447180|P2|NOT COMPLETED|Double Blind Phase (24 Weeks)||29
2221254|NCT02831855|5447181|P1|NOT COMPLETED|Double Blind Phase (24 Weeks)||0
2221255|NCT02831855|5447179|P3|COMPLETED|Double Blind Phase (24 Weeks)||247
2221256|NCT02831855|5447180|P2|COMPLETED|Double Blind Phase (24 Weeks)||238
2221257|NCT02831855|5447181|P1|COMPLETED|Double Blind Phase (24 Weeks)||0
2221258|NCT02831855|5447179|P3|Treated|Double Blind Phase (24 Weeks)||266
2221259|NCT02831855|5447180|P2|Treated|Double Blind Phase (24 Weeks)||264
2221260|NCT02831855|5447181|P1|Treated|Double Blind Phase (24 Weeks)||0
2221261|NCT02831855|5447179|P3|STARTED|Double Blind Phase (24 Weeks)|Only eligible participants from open label phase, were randomized into double blind phase. .|266
2221262|NCT02831855|5447180|P2|STARTED|Double Blind Phase (24 Weeks)|Only eligible participants from open label phase, were randomized into double blind phase.|267
2221263|NCT02831855|5447181|P1|STARTED|Double Blind Phase (24 Weeks)||0
2221264|NCT02831855|5447179|P3|NOT COMPLETED|Open Label Phase (24 Weeks)||0
2221265|NCT02831855|5447180|P2|NOT COMPLETED|Open Label Phase (24 Weeks)||0
2221266|NCT02831855|5447181|P1|NOT COMPLETED|Open Label Phase (24 Weeks)||71
2221267|NCT02831855|5447179|P3|COMPLETED|Open Label Phase (24 Weeks)||0
2221268|NCT02831855|5447180|P2|COMPLETED|Open Label Phase (24 Weeks)||0
2221269|NCT02831855|5447181|P1|COMPLETED|Open Label Phase (24 Weeks)||623
2221270|NCT02831855|5447179|P3|STARTED|Open Label Phase (24 Weeks)||0
2221271|NCT02831855|5447180|P2|STARTED|Open Label Phase (24 Weeks)||0
2221272|NCT02831855|5447181|P1|STARTED|Open Label Phase (24 Weeks)||694
2221273|NCT02831764|5447242|P2|NOT COMPLETED|Overall Study||359
2221274|NCT02831764|5447243|P1|NOT COMPLETED|Overall Study||360
2221275|NCT02831764|5447242|P2|COMPLETED|Overall Study||0
2221276|NCT02831764|5447243|P1|COMPLETED|Overall Study||0
2221277|NCT02831764|5447242|P2|STARTED|Overall Study||359
2221278|NCT02831764|5447243|P1|STARTED|Overall Study||360
2221279|NCT02831673|5447307|P2|NOT COMPLETED|Overall Study||358
2221280|NCT02831673|5447308|P1|NOT COMPLETED|Overall Study||356
2221281|NCT02831673|5447307|P2|COMPLETED|Overall Study||0
2221282|NCT02831673|5447308|P1|COMPLETED|Overall Study||0
2221283|NCT02831673|5447307|P2|STARTED|Overall Study||358
2221284|NCT02831673|5447308|P1|STARTED|Overall Study||356
2221285|NCT02831660|5447370|P1|NOT COMPLETED|Overall Study||0
2221286|NCT02831660|5447370|P1|COMPLETED|Overall Study||1
2221287|NCT02831660|5447370|P1|STARTED|Overall Study||1
2221288|NCT02831569|5447374|P1|NOT COMPLETED|Overall Study||0
2221289|NCT02831569|5447374|P1|COMPLETED|Overall Study||80
2221290|NCT02831569|5447374|P1|STARTED|Overall Study||80
2221291|NCT02831387|5447381|P2|NOT COMPLETED|Overall Study||2
2221292|NCT02831387|5447382|P1|NOT COMPLETED|Overall Study||1
2221293|NCT02831387|5447381|P2|COMPLETED|Overall Study||22
2221294|NCT02831387|5447382|P1|COMPLETED|Overall Study||22
2221295|NCT02831387|5447381|P2|STARTED|Overall Study||24
2221296|NCT02831387|5447382|P1|STARTED|Overall Study||23
2221297|NCT02830880|5447400|P1|NOT COMPLETED|Overall Study||3
2221298|NCT02830880|5447400|P1|COMPLETED|Overall Study||4
2221299|NCT02830880|5447400|P1|Completed Visit After Cyle 1|Overall Study||7
2221300|NCT02830880|5447400|P1|STARTED|Overall Study||7
2221301|NCT02830087|5447415|P6|NOT COMPLETED|Overall Study||3
2221302|NCT02830087|5447416|P5|NOT COMPLETED|Overall Study||3
2221303|NCT02830087|5447417|P4|NOT COMPLETED|Overall Study||3
2221304|NCT02830087|5447418|P3|NOT COMPLETED|Overall Study||4
2221305|NCT02830087|5447419|P2|NOT COMPLETED|Overall Study||4
2221306|NCT02830087|5447420|P1|NOT COMPLETED|Overall Study||4
2221307|NCT02830087|5447415|P6|COMPLETED|Overall Study||0
2221308|NCT02830087|5447416|P5|COMPLETED|Overall Study||0
2221309|NCT02830087|5447417|P4|COMPLETED|Overall Study||0
2221310|NCT02830087|5447418|P3|COMPLETED|Overall Study||0
2221311|NCT02830087|5447419|P2|COMPLETED|Overall Study||0
2221312|NCT02830087|5447420|P1|COMPLETED|Overall Study||0
2221313|NCT02830087|5447415|P6|STARTED|Overall Study||3
2221314|NCT02830087|5447416|P5|STARTED|Overall Study||3
2221315|NCT02830087|5447417|P4|STARTED|Overall Study||3
2221316|NCT02830087|5447418|P3|STARTED|Overall Study||4
2221317|NCT02830087|5447419|P2|STARTED|Overall Study||4
2221318|NCT02830087|5447420|P1|STARTED|Overall Study||4
2221319|NCT02829996|5447487|P5|NOT COMPLETED|Overall Study||0
2221320|NCT02829996|5447488|P4|NOT COMPLETED|Overall Study||0
2221321|NCT02829996|5447489|P3|NOT COMPLETED|Overall Study||0
2221322|NCT02829996|5447490|P2|NOT COMPLETED|Overall Study||0
2221323|NCT02829996|5447491|P1|NOT COMPLETED|Overall Study||1
2221324|NCT02829996|5447487|P5|COMPLETED|Overall Study||42
2221325|NCT02829996|5447488|P4|COMPLETED|Overall Study||41
2221326|NCT02829996|5447489|P3|COMPLETED|Overall Study||40
2221327|NCT02829996|5447490|P2|COMPLETED|Overall Study||39
2221328|NCT02829996|5447491|P1|COMPLETED|Overall Study||38
2221329|NCT02829996|5447487|P5|STARTED|Overall Study||42
2221330|NCT02829996|5447488|P4|STARTED|Overall Study||41
2221331|NCT02829996|5447489|P3|STARTED|Overall Study||40
2221332|NCT02829996|5447490|P2|STARTED|Overall Study||39
2221333|NCT02829996|5447491|P1|STARTED|Overall Study||39
2221334|NCT02829983|5447505|P2|NOT COMPLETED|Overall Study||0
2221335|NCT02829983|5447506|P1|NOT COMPLETED|Overall Study||0
2221336|NCT02829983|5447505|P2|COMPLETED|Overall Study||20
2221337|NCT02829983|5447506|P1|COMPLETED|Overall Study||20
2221338|NCT02829983|5447505|P2|STARTED|Overall Study||20
2221339|NCT02829983|5447506|P1|STARTED|Overall Study||20
2221340|NCT02829775|5447514|P1|NOT COMPLETED|Overall Study||5
2221341|NCT02829775|5447514|P1|COMPLETED|Overall Study||4
2221342|NCT02829775|5447514|P1|STARTED|Overall Study||9
2221343|NCT02829463|5447521|P2|NOT COMPLETED|Overall Study||0
2221344|NCT02829463|5447522|P1|NOT COMPLETED|Overall Study||0
2221345|NCT02829463|5447521|P2|COMPLETED|Overall Study||62
2221346|NCT02829463|5447522|P1|COMPLETED|Overall Study||59
2221347|NCT02829463|5447521|P2|STARTED|Overall Study||62
2221348|NCT02829463|5447522|P1|STARTED|Overall Study||59
2221349|NCT02829320|5447528|P1|NOT COMPLETED|Overall Study||0
2221350|NCT02829320|5447528|P1|COMPLETED|Overall Study||28
2221351|NCT02829320|5447528|P1|STARTED|Overall Study||28
2221352|NCT02829307|5447565|P1|NOT COMPLETED|Overall Study||0
2221353|NCT02829307|5447565|P1|COMPLETED|Overall Study||8
2221354|NCT02829307|5447565|P1|STARTED|Overall Study||8
2221355|NCT02829294|5447588|P1|NOT COMPLETED|Overall Study||0
2221356|NCT02829294|5447588|P1|COMPLETED|Overall Study||19
2221357|NCT02829294|5447588|P1|STARTED|Overall Study||19
2221358|NCT02829138|5447596|P2|NOT COMPLETED|Overall Study||0
2221359|NCT02829138|5447597|P1|NOT COMPLETED|Overall Study||1
2221360|NCT02829138|5447596|P2|COMPLETED|Overall Study||28
2221361|NCT02829138|5447597|P1|COMPLETED|Overall Study||28
2221362|NCT02829138|5447596|P2|STARTED|Overall Study||28
2221363|NCT02829138|5447597|P1|STARTED|Overall Study||29
2221364|NCT02829034|5447609|P2|NOT COMPLETED|Overall Study||2
2221365|NCT02829034|5447610|P1|NOT COMPLETED|Overall Study||5
2221366|NCT02829034|5447609|P2|COMPLETED|Overall Study||6
2221367|NCT02829034|5447610|P1|COMPLETED|Overall Study||9
2221368|NCT02829034|5447609|P2|STARTED|Overall Study||8
2221369|NCT02829034|5447610|P1|STARTED|Overall Study||14
2221370|NCT02828644|5447622|P2|NOT COMPLETED|Overall Study||22
2221371|NCT02828644|5447623|P1|NOT COMPLETED|Overall Study||23
2221372|NCT02828644|5447622|P2|COMPLETED|Overall Study||65
2221373|NCT02828644|5447623|P1|COMPLETED|Overall Study||65
2221374|NCT02828644|5447622|P2|STARTED|Overall Study||87
2221375|NCT02828644|5447623|P1|STARTED|Overall Study||88
2221376|NCT02828241|5447632|P2|NOT COMPLETED|Overall Study||2
2221377|NCT02828241|5447633|P1|NOT COMPLETED|Overall Study||8
2221378|NCT02828241|5447632|P2|COMPLETED|Overall Study||21
2221379|NCT02828241|5447633|P1|COMPLETED|Overall Study||30
2221380|NCT02828241|5447632|P2|STARTED|Overall Study||23
2221381|NCT02828241|5447633|P1|STARTED|Overall Study||38
2221382|NCT02828137|5447646|P3|NOT COMPLETED|Overall Study||0
2221383|NCT02828137|5447647|P2|NOT COMPLETED|Overall Study||0
2221384|NCT02828137|5447648|P1|NOT COMPLETED|Overall Study||0
2221385|NCT02828137|5447646|P3|COMPLETED|Overall Study||41
2221386|NCT02828137|5447647|P2|COMPLETED|Overall Study||41
2221387|NCT02828137|5447648|P1|COMPLETED|Overall Study||41
2221388|NCT02828137|5447646|P3|STARTED|Overall Study||41
2221389|NCT02828137|5447647|P2|STARTED|Overall Study||41
2221390|NCT02828137|5447648|P1|STARTED|Overall Study||41
2221391|NCT02828124|5447660|P4|NOT COMPLETED|Overall Study||6
2221392|NCT02828124|5447661|P3|NOT COMPLETED|Overall Study||1
2221393|NCT02828124|5447662|P2|NOT COMPLETED|Overall Study||2
2221394|NCT02828124|5447663|P1|NOT COMPLETED|Overall Study||1
2221395|NCT02828124|5447660|P4|COMPLETED|Overall Study||0
2221396|NCT02828124|5447661|P3|COMPLETED|Overall Study||0
2221397|NCT02828124|5447662|P2|COMPLETED|Overall Study||0
2221398|NCT02828124|5447663|P1|COMPLETED|Overall Study||0
2221399|NCT02828124|5447660|P4|STARTED|Overall Study||6
2221400|NCT02828124|5447661|P3|STARTED|Overall Study||1
2221401|NCT02828124|5447662|P2|STARTED|Overall Study||2
2221402|NCT02828124|5447663|P1|STARTED|Overall Study||1
2221403|NCT02828111|5447778|P5|NOT COMPLETED|Overall Study||1
2221404|NCT02828111|5447779|P4|NOT COMPLETED|Overall Study||1
2221405|NCT02828111|5447780|P3|NOT COMPLETED|Overall Study||2
2221406|NCT02828111|5447781|P2|NOT COMPLETED|Overall Study||0
2221407|NCT02828111|5447782|P1|NOT COMPLETED|Overall Study||0
2221408|NCT02828111|5447778|P5|COMPLETED|Overall Study||11
2221409|NCT02828111|5447779|P4|COMPLETED|Overall Study||5
2221410|NCT02828111|5447780|P3|COMPLETED|Overall Study||4
2221411|NCT02828111|5447781|P2|COMPLETED|Overall Study||6
2221412|NCT02828111|5447782|P1|COMPLETED|Overall Study||6
2221413|NCT02828111|5447778|P5|Received at Least 1 Dose of Study Drug|Overall Study||12
2221414|NCT02828111|5447779|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
2221415|NCT02828111|5447780|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
2221416|NCT02828111|5447781|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
2221417|NCT02828111|5447782|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
2221418|NCT02828111|5447778|P5|STARTED|Overall Study||12
2221419|NCT02828111|5447779|P4|STARTED|Overall Study||6
2221420|NCT02828111|5447780|P3|STARTED|Overall Study||6
2221421|NCT02828111|5447781|P2|STARTED|Overall Study||6
2221422|NCT02828111|5447782|P1|STARTED|Overall Study||6
2221423|NCT02828020|5447843|P3|NOT COMPLETED|Safety Follow-up Period||19
2221424|NCT02828020|5447844|P2|NOT COMPLETED|Safety Follow-up Period||18
2221425|NCT02828020|5447845|P1|NOT COMPLETED|Safety Follow-up Period||20
2221426|NCT02828020|5447843|P3|COMPLETED|Safety Follow-up Period||461
2221427|NCT02828020|5447844|P2|COMPLETED|Safety Follow-up Period||440
2221428|NCT02828020|5447845|P1|COMPLETED|Safety Follow-up Period||460
2221429|NCT02828020|5447843|P3|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|480
2221430|NCT02828020|5447844|P2|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|458
2221431|NCT02828020|5447845|P1|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|480
2221432|NCT02828020|5447843|P3|NOT COMPLETED|Treatment Period||78
2221433|NCT02828020|5447844|P2|NOT COMPLETED|Treatment Period||99
2221434|NCT02828020|5447845|P1|NOT COMPLETED|Treatment Period||80
2221435|NCT02828020|5447843|P3|COMPLETED|Treatment Period||479
2221436|NCT02828020|5447844|P2|COMPLETED|Treatment Period||457
2221437|NCT02828020|5447845|P1|COMPLETED|Treatment Period||479
2221438|NCT02828020|5447843|P3|Safety Population: Received Study Drug|Treatment Period||485
2221439|NCT02828020|5447844|P2|Safety Population: Received Study Drug|Treatment Period||466
2221440|NCT02828020|5447845|P1|Safety Population: Received Study Drug|Treatment Period||485
2221441|NCT02828020|5447843|P3|STARTED|Treatment Period||557
2221442|NCT02828020|5447844|P2|STARTED|Treatment Period||556
2221443|NCT02828020|5447845|P1|STARTED|Treatment Period||559
2221454|NCT02827500|5447956|P2|NOT COMPLETED|Overall Study||7
2221455|NCT02827500|5447957|P1|NOT COMPLETED|Overall Study||19
2221456|NCT02827500|5447956|P2|COMPLETED|Overall Study||45
2221457|NCT02827500|5447957|P1|COMPLETED|Overall Study||33
2221458|NCT02827500|5447956|P2|STARTED|Overall Study||52
2221459|NCT02827500|5447957|P1|STARTED|Overall Study||52
2221460|NCT02826603|5447975|P2|NOT COMPLETED|Overall Study||64
2221461|NCT02826603|5447976|P1|NOT COMPLETED|Overall Study||61
2221462|NCT02826603|5447975|P2|COMPLETED|Overall Study||488
2221463|NCT02826603|5447976|P1|COMPLETED|Overall Study||489
2221464|NCT02826603|5447975|P2|STARTED|Overall Study||552
2221465|NCT02826603|5447976|P1|STARTED|Overall Study||550
2221466|NCT02826551|5448003|P2|NOT COMPLETED|Overall Study||0
2221467|NCT02826551|5448004|P1|NOT COMPLETED|Overall Study||0
2221468|NCT02826551|5448003|P2|COMPLETED|Overall Study||12
2221469|NCT02826551|5448004|P1|COMPLETED|Overall Study||11
2221470|NCT02826551|5448003|P2|STARTED|Overall Study||12
2221471|NCT02826551|5448004|P1|STARTED|Overall Study||11
2221472|NCT02826421|5448016|P4|NOT COMPLETED|Overall Study||2
2221473|NCT02826421|5448017|P3|NOT COMPLETED|Overall Study||2
2221474|NCT02826421|5448018|P2|NOT COMPLETED|Overall Study||3
2221475|NCT02826421|5448019|P1|NOT COMPLETED|Overall Study||3
2221476|NCT02826421|5448016|P4|COMPLETED|Overall Study||28
2221477|NCT02826421|5448017|P3|COMPLETED|Overall Study||26
2221478|NCT02826421|5448018|P2|COMPLETED|Overall Study||26
2221479|NCT02826421|5448019|P1|COMPLETED|Overall Study||19
2221480|NCT02826421|5448016|P4|Treated|Overall Study||28
2221481|NCT02826421|5448017|P3|Treated|Overall Study||26
2221482|NCT02826421|5448018|P2|Treated|Overall Study||26
2221483|NCT02826421|5448019|P1|Treated|Overall Study||19
2221484|NCT02826421|5448016|P4|STARTED|Overall Study||30
2221485|NCT02826421|5448017|P3|STARTED|Overall Study||28
2221486|NCT02826421|5448018|P2|STARTED|Overall Study||29
2221487|NCT02826421|5448019|P1|STARTED|Overall Study||22
2221488|NCT02825550|5448031|P1|NOT COMPLETED|Overall Study||1
2221489|NCT02825550|5448031|P1|COMPLETED|Overall Study||12
2221490|NCT02825550|5448031|P1|STARTED|Overall Study||13
2221491|NCT02825251|5448039|P2|NOT COMPLETED|Overall Study||6
2221492|NCT02825251|5448040|P1|NOT COMPLETED|Overall Study||3
2221493|NCT02825251|5448039|P2|COMPLETED|Overall Study||230
2221494|NCT02825251|5448040|P1|COMPLETED|Overall Study||233
2221495|NCT02825251|5448039|P2|STARTED|Overall Study||236
2221496|NCT02825251|5448040|P1|STARTED|Overall Study||236
2221497|NCT02824913|5448228|P2|NOT COMPLETED|Second Intervention (1 Day)||0
2221498|NCT02824913|5448229|P1|NOT COMPLETED|Second Intervention (1 Day)||0
2221499|NCT02824913|5448228|P2|COMPLETED|Second Intervention (1 Day)||0
2221500|NCT02824913|5448229|P1|COMPLETED|Second Intervention (1 Day)||1
2221501|NCT02824913|5448228|P2|STARTED|Second Intervention (1 Day)||0
2221502|NCT02824913|5448229|P1|STARTED|Second Intervention (1 Day)||1
2221503|NCT02824913|5448228|P2|NOT COMPLETED|Washout (7-14 Days)||0
2221504|NCT02824913|5448229|P1|NOT COMPLETED|Washout (7-14 Days)||0
2221505|NCT02824913|5448228|P2|COMPLETED|Washout (7-14 Days)||0
2221506|NCT02824913|5448229|P1|COMPLETED|Washout (7-14 Days)||1
2221507|NCT02824913|5448228|P2|STARTED|Washout (7-14 Days)||0
2221508|NCT02824913|5448229|P1|STARTED|Washout (7-14 Days)||1
2221509|NCT02824913|5448228|P2|NOT COMPLETED|First Intervention (1 Day)||0
2221510|NCT02824913|5448229|P1|NOT COMPLETED|First Intervention (1 Day)||0
2221511|NCT02824913|5448228|P2|COMPLETED|First Intervention (1 Day)||0
2221512|NCT02824913|5448229|P1|COMPLETED|First Intervention (1 Day)|Only one subject was enrolled in the study and received both study treatments.|1
2221513|NCT02824913|5448228|P2|STARTED|First Intervention (1 Day)||0
2221514|NCT02824913|5448229|P1|STARTED|First Intervention (1 Day)||1
2221515|NCT02824562|5448243|P2|NOT COMPLETED|Overall Study||5
2221516|NCT02824562|5448244|P1|NOT COMPLETED|Overall Study||3
2221517|NCT02824562|5448243|P2|COMPLETED|Overall Study||17
2221518|NCT02824562|5448244|P1|COMPLETED|Overall Study||19
2221519|NCT02824562|5448243|P2|STARTED|Overall Study||22
2221520|NCT02824562|5448244|P1|STARTED|Overall Study||22
2221521|NCT02824432|5448253|P2|NOT COMPLETED|Overall Study||0
2221522|NCT02824432|5448254|P1|NOT COMPLETED|Overall Study||1
2221523|NCT02824432|5448253|P2|COMPLETED|Overall Study||19
2221524|NCT02824432|5448254|P1|COMPLETED|Overall Study||17
2221525|NCT02824432|5448253|P2|STARTED|Overall Study||19
2221526|NCT02824432|5448254|P1|STARTED|Overall Study||18
2221527|NCT02824224|5448330|P2|NOT COMPLETED|Overall Study||1
2221528|NCT02824224|5448331|P1|NOT COMPLETED|Overall Study||2
2221529|NCT02824224|5448330|P2|COMPLETED|Overall Study||17
2221530|NCT02824224|5448331|P1|COMPLETED|Overall Study||17
2221531|NCT02824224|5448330|P2|STARTED|Overall Study||18
2221532|NCT02824224|5448331|P1|STARTED|Overall Study||19
2221533|NCT02824198|5448351|P2|NOT COMPLETED|Overall Study||3
2221534|NCT02824198|5448352|P1|NOT COMPLETED|Overall Study||15
2221535|NCT02824198|5448351|P2|COMPLETED|Overall Study||26
2221536|NCT02824198|5448352|P1|COMPLETED|Overall Study||74
2221537|NCT02824198|5448351|P2|STARTED|Overall Study||29
2221538|NCT02824198|5448352|P1|STARTED|Overall Study||89
2221539|NCT02823964|5448382|P1|NOT COMPLETED|Overall Study||5
2221540|NCT02823964|5448382|P1|COMPLETED|Overall Study||20
2221541|NCT02823964|5448382|P1|STARTED|Overall Study||25
2221542|NCT02823600|5448386|P1|NOT COMPLETED|Overall Study||0
2221543|NCT02823600|5448386|P1|COMPLETED|Overall Study||68
2221544|NCT02823600|5448386|P1|STARTED|Overall Study||68
2221545|NCT02823470|5448396|P2|NOT COMPLETED|Overall Study||15
2221546|NCT02823470|5448397|P1|NOT COMPLETED|Overall Study||9
2221547|NCT02823470|5448396|P2|COMPLETED|Overall Study||0
2221548|NCT02823470|5448397|P1|COMPLETED|Overall Study||0
2221549|NCT02823470|5448396|P2|STARTED|Overall Study||15
2221550|NCT02823470|5448397|P1|STARTED|Overall Study||9
2221551|NCT02823431|5448411|P2|NOT COMPLETED|Overall Study||0
2221552|NCT02823431|5448412|P1|NOT COMPLETED|Overall Study||0
2221553|NCT02823431|5448411|P2|COMPLETED|Overall Study||12
2221554|NCT02823431|5448412|P1|COMPLETED|Overall Study||11
2221555|NCT02823431|5448411|P2|STARTED|Overall Study||12
2221556|NCT02823431|5448412|P1|STARTED|Overall Study||11
2221557|NCT02823080|5448426|P2|NOT COMPLETED|Overall Study||0
2221558|NCT02823080|5448427|P1|NOT COMPLETED|Overall Study||0
2221559|NCT02823080|5448426|P2|COMPLETED|Overall Study||24
2221560|NCT02823080|5448427|P1|COMPLETED|Overall Study||24
2221561|NCT02823080|5448426|P2|STARTED|Overall Study||24
2221562|NCT02823080|5448427|P1|STARTED|Overall Study||24
2221563|NCT02822950|5448445|P1|NOT COMPLETED|Overall Study||0
2221564|NCT02822950|5448445|P1|COMPLETED|Overall Study||10
2221565|NCT02822950|5448445|P1|STARTED|Overall Study||10
2221566|NCT02822885|5448453|P1|NOT COMPLETED|Overall Study||0
2221567|NCT02822885|5448453|P1|COMPLETED|Overall Study||70
2221568|NCT02822885|5448453|P1|STARTED|Overall Study||70
2221569|NCT02822794|5448465|P2|NOT COMPLETED|Overall Study||0
2221570|NCT02822794|5448466|P1|NOT COMPLETED|Overall Study||1
2221571|NCT02822794|5448465|P2|COMPLETED|Overall Study||60
2221572|NCT02822794|5448466|P1|COMPLETED|Overall Study||56
2221573|NCT02822794|5448465|P2|STARTED|Overall Study||60
2221574|NCT02822794|5448466|P1|STARTED|Overall Study||57
2221575|NCT02822287|5448524|P1|NOT COMPLETED|Overall Study||0
2221576|NCT02822287|5448524|P1|COMPLETED|Overall Study||57
2221577|NCT02822287|5448524|P1|STARTED|Overall Study||57
2221590|NCT02821962|5448592|P2|NOT COMPLETED|Overall Study||0
2221591|NCT02821962|5448593|P1|NOT COMPLETED|Overall Study||2
2221592|NCT02821962|5448592|P2|COMPLETED|Overall Study||21
2221593|NCT02821962|5448593|P1|COMPLETED|Overall Study||17
2221594|NCT02821962|5448592|P2|STARTED|Overall Study||21
2221595|NCT02821962|5448593|P1|STARTED|Overall Study||19
2221614|NCT02821819|5448704|P1|NOT COMPLETED|Overall Study||1
2221615|NCT02821819|5448704|P1|COMPLETED|Overall Study||14
2221616|NCT02821819|5448704|P1|STARTED|Overall Study||15
2221617|NCT02821455|5448709|P1|NOT COMPLETED|Overall Study||0
2221618|NCT02821455|5448709|P1|COMPLETED|Overall Study||19
2221619|NCT02821455|5448709|P1|STARTED|Overall Study||19
2221620|NCT02821403|5448716|P2|NOT COMPLETED|"Third Intervention (1 Month)"||0
2221621|NCT02821403|5448717|P1|NOT COMPLETED|"Third Intervention (1 Month)"||0
2221622|NCT02821403|5448716|P2|COMPLETED|"Third Intervention (1 Month)"||40
2221623|NCT02821403|5448717|P1|COMPLETED|"Third Intervention (1 Month)"||40
2221624|NCT02821403|5448716|P2|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||14
2221625|NCT02821403|5448717|P1|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||13
2221626|NCT02821403|5448716|P2|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
2221627|NCT02821403|5448717|P1|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
2221628|NCT02821403|5448716|P2|Used Clear Lens|"Third Intervention (1 Month)"||13
2221629|NCT02821403|5448717|P1|Used Clear Lens|"Third Intervention (1 Month)"||14
2221630|NCT02821403|5448716|P2|STARTED|"Third Intervention (1 Month)"||40
2221631|NCT02821403|5448717|P1|STARTED|"Third Intervention (1 Month)"||40
2221632|NCT02821403|5448716|P2|NOT COMPLETED|"Second Intervention (1 Month)"||0
2221633|NCT02821403|5448717|P1|NOT COMPLETED|"Second Intervention (1 Month)"||0
2221634|NCT02821403|5448716|P2|COMPLETED|"Second Intervention (1 Month)"||40
2221635|NCT02821403|5448717|P1|COMPLETED|"Second Intervention (1 Month)"||40
2221636|NCT02821403|5448716|P2|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
2221637|NCT02821403|5448717|P1|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
2221638|NCT02821403|5448716|P2|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||13
2221639|NCT02821403|5448717|P1|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||14
2221640|NCT02821403|5448716|P2|Used Clear Lens|"Second Intervention (1 Month)"||14
2221641|NCT02821403|5448717|P1|Used Clear Lens|"Second Intervention (1 Month)"||13
2221642|NCT02821403|5448716|P2|STARTED|"Second Intervention (1 Month)"||40
2221643|NCT02821403|5448717|P1|STARTED|"Second Intervention (1 Month)"||40
2221644|NCT02821403|5448716|P2|NOT COMPLETED|"First Intervention (1 Month)"||0
2221645|NCT02821403|5448717|P1|NOT COMPLETED|"First Intervention (1 Month)"||0
2221646|NCT02821403|5448716|P2|COMPLETED|"First Intervention (1 Month)"||40
2221647|NCT02821403|5448717|P1|COMPLETED|"First Intervention (1 Month)"||40
2221648|NCT02821403|5448716|P2|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||13
2221649|NCT02821403|5448717|P1|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||14
2221650|NCT02821403|5448716|P2|Used Yellow Tinted Lens|"First Intervention (1 Month)"||14
2221651|NCT02821403|5448717|P1|Used Yellow Tinted Lens|"First Intervention (1 Month)"||13
2221652|NCT02821403|5448716|P2|Used Clear Lens|"First Intervention (1 Month)"||13
2221653|NCT02821403|5448717|P1|Used Clear Lens|"First Intervention (1 Month)"||13
2221654|NCT02821403|5448716|P2|STARTED|"First Intervention (1 Month)"||40
2221655|NCT02821403|5448717|P1|STARTED|"First Intervention (1 Month)"||40
2221656|NCT02821000|5448735|P1|NOT COMPLETED|Overall Study||103
2221657|NCT02821000|5448735|P1|COMPLETED|Overall Study||0
2221658|NCT02821000|5448735|P1|Treated|Overall Study||103
2221659|NCT02821000|5448735|P1|STARTED|Overall Study||103
2221660|NCT02820870|5448760|P2|NOT COMPLETED|Post Intervention||0
2221661|NCT02820870|5448761|P1|NOT COMPLETED|Post Intervention||0
2221662|NCT02820870|5448760|P2|COMPLETED|Post Intervention||28
2221663|NCT02820870|5448761|P1|COMPLETED|Post Intervention||15
2221664|NCT02820870|5448760|P2|STARTED|Post Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|28
2221665|NCT02820870|5448761|P1|STARTED|Post Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|15
2221666|NCT02820870|5448760|P2|NOT COMPLETED|Intervention||0
2221667|NCT02820870|5448761|P1|NOT COMPLETED|Intervention||0
2221668|NCT02820870|5448760|P2|COMPLETED|Intervention||28
2221669|NCT02820870|5448761|P1|COMPLETED|Intervention||15
2221670|NCT02820870|5448760|P2|STARTED|Intervention||28
2221671|NCT02820870|5448761|P1|STARTED|Intervention||15
2221672|NCT02820870|5448760|P2|NOT COMPLETED|Before Intervention||0
2221673|NCT02820870|5448761|P1|NOT COMPLETED|Before Intervention||0
2221674|NCT02820870|5448760|P2|COMPLETED|Before Intervention||28
2221675|NCT02820870|5448761|P1|COMPLETED|Before Intervention||15
2221676|NCT02820870|5448760|P2|STARTED|Before Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|28
2221677|NCT02820870|5448761|P1|STARTED|Before Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|15
2221678|NCT02820844|5448773|P6|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||1
2221679|NCT02820844|5448774|P5|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||2
2221680|NCT02820844|5448775|P4|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
2221681|NCT02820844|5448776|P3|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
2221682|NCT02820844|5448777|P2|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
2221683|NCT02820844|5448778|P1|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
2221684|NCT02820844|5448773|P6|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||42
2221685|NCT02820844|5448774|P5|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||54
2221686|NCT02820844|5448775|P4|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
2221687|NCT02820844|5448776|P3|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
2221688|NCT02820844|5448777|P2|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
2221689|NCT02820844|5448778|P1|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
2221690|NCT02820844|5448773|P6|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||43
2221691|NCT02820844|5448774|P5|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||56
2221692|NCT02820844|5448775|P4|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
2221693|NCT02820844|5448776|P3|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
2221694|NCT02820844|5448777|P2|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
2221695|NCT02820844|5448778|P1|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
2221696|NCT02820844|5448773|P6|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
2221697|NCT02820844|5448774|P5|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
2221698|NCT02820844|5448775|P4|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||4
2221699|NCT02820844|5448776|P3|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||9
2221700|NCT02820844|5448777|P2|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
2221701|NCT02820844|5448778|P1|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
2221702|NCT02820844|5448773|P6|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
2221703|NCT02820844|5448774|P5|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
2221704|NCT02820844|5448775|P4|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||84
2221705|NCT02820844|5448776|P3|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||99
2221706|NCT02820844|5448777|P2|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
2221707|NCT02820844|5448778|P1|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
2221708|NCT02820844|5448773|P6|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
2221709|NCT02820844|5448774|P5|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
2221710|NCT02820844|5448775|P4|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||88
2221711|NCT02820844|5448776|P3|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||108
2221712|NCT02820844|5448777|P2|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
2221713|NCT02820844|5448778|P1|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
2221714|NCT02820844|5448773|P6|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
2221715|NCT02820844|5448774|P5|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
2221716|NCT02820844|5448775|P4|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
2221717|NCT02820844|5448776|P3|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
2221718|NCT02820844|5448777|P2|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||9
2221719|NCT02820844|5448778|P1|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||5
2221720|NCT02820844|5448773|P6|COMPLETED|Double-blinded (Up to 48 Weeks)||0
2221721|NCT02820844|5448774|P5|COMPLETED|Double-blinded (Up to 48 Weeks)||0
2221722|NCT02820844|5448775|P4|COMPLETED|Double-blinded (Up to 48 Weeks)||0
2221723|NCT02820844|5448776|P3|COMPLETED|Double-blinded (Up to 48 Weeks)||0
2221724|NCT02820844|5448777|P2|COMPLETED|Double-blinded (Up to 48 Weeks)||115
2221725|NCT02820844|5448778|P1|COMPLETED|Double-blinded (Up to 48 Weeks)||119
2221726|NCT02820844|5448773|P6|STARTED|Double-blinded (Up to 48 Weeks)||0
2221727|NCT02820844|5448774|P5|STARTED|Double-blinded (Up to 48 Weeks)||0
2221728|NCT02820844|5448775|P4|STARTED|Double-blinded (Up to 48 Weeks)||0
2221729|NCT02820844|5448776|P3|STARTED|Double-blinded (Up to 48 Weeks)||0
2221730|NCT02820844|5448777|P2|STARTED|Double-blinded (Up to 48 Weeks)||124
2221731|NCT02820844|5448778|P1|STARTED|Double-blinded (Up to 48 Weeks)||124
2221732|NCT02820597|5448992|P1|NOT COMPLETED|Overall Study||12
2221733|NCT02820597|5448992|P1|COMPLETED|Overall Study|12 participants were lost to follow-up.|15
2221734|NCT02820597|5448992|P1|180-day Post Treatment|Overall Study|3 participants missed the 180-day visit, 3 participants were lost to follow-up.|21
2221735|NCT02820597|5448992|P1|90-day Post Treatment|Overall Study|2 participants missed the 90-day visit, 1 participant was lost to follow-up.|24
2221736|NCT02820597|5448992|P1|30-day Post Treatment|Overall Study||27
2221737|NCT02820597|5448992|P1|7-day Post Treatment|Overall Study||27
2221738|NCT02820597|5448992|P1|1-day Post Treatment|Overall Study||27
2221739|NCT02820597|5448992|P1|STARTED|Overall Study||27
2221740|NCT02820038|5449004|P4|NOT COMPLETED|Overall Study||22
2221741|NCT02820038|5449005|P3|NOT COMPLETED|Overall Study||5
2221742|NCT02820038|5449006|P2|NOT COMPLETED|Overall Study||25
2221743|NCT02820038|5449007|P1|NOT COMPLETED|Overall Study||10
2221744|NCT02820038|5449004|P4|COMPLETED|Overall Study||44
2221745|NCT02820038|5449005|P3|COMPLETED|Overall Study||60
2221746|NCT02820038|5449006|P2|COMPLETED|Overall Study||52
2221747|NCT02820038|5449007|P1|COMPLETED|Overall Study||68
2221748|NCT02820038|5449004|P4|STARTED|Overall Study||66
2221749|NCT02820038|5449005|P3|STARTED|Overall Study||65
2221750|NCT02820038|5449006|P2|STARTED|Overall Study||77
2221751|NCT02820038|5449007|P1|STARTED|Overall Study||78
2221752|NCT02819804|5449109|P1|NOT COMPLETED|Follow-up for 1 Year||0
2221753|NCT02819804|5449109|P1|COMPLETED|Follow-up for 1 Year||1
2221754|NCT02819804|5449109|P1|STARTED|Follow-up for 1 Year||1
2221755|NCT02819804|5449109|P1|NOT COMPLETED|Start Cycle 2 and Beyond||0
2221756|NCT02819804|5449109|P1|COMPLETED|Start Cycle 2 and Beyond||0
2221757|NCT02819804|5449109|P1|STARTED|Start Cycle 2 and Beyond||0
2221758|NCT02819804|5449109|P1|NOT COMPLETED|Complete Cycle 1 (28 Days)||1
2221759|NCT02819804|5449109|P1|COMPLETED|Complete Cycle 1 (28 Days)||0
2221760|NCT02819804|5449109|P1|STARTED|Complete Cycle 1 (28 Days)||1
2221785|NCT02818998|5449232|P3|NOT COMPLETED|Overall Study||14
2221786|NCT02818998|5449233|P2|NOT COMPLETED|Overall Study||8
2221787|NCT02818998|5449234|P1|NOT COMPLETED|Overall Study||11
2221788|NCT02818998|5449232|P3|COMPLETED|Overall Study||140
2221789|NCT02818998|5449233|P2|COMPLETED|Overall Study||146
2221790|NCT02818998|5449234|P1|COMPLETED|Overall Study||144
2221791|NCT02818998|5449232|P3|Included in Full Analysis Set (FAS)|Overall Study||153
2221792|NCT02818998|5449233|P2|Included in Full Analysis Set (FAS)|Overall Study||152
2221793|NCT02818998|5449234|P1|Included in Full Analysis Set (FAS)|Overall Study||153
2221794|NCT02818998|5449232|P3|STARTED|Overall Study||154
2221795|NCT02818998|5449233|P2|STARTED|Overall Study||154
2221796|NCT02818998|5449234|P1|STARTED|Overall Study||155
2221797|NCT02818946|5449248|P1|NOT COMPLETED|Overall Study||0
2221798|NCT02818946|5449248|P1|COMPLETED|Overall Study||30
2221799|NCT02818946|5449248|P1|STARTED|Overall Study||30
2221805|NCT02818777|5449259|P1|NOT COMPLETED|Overall Study||3
2221806|NCT02818777|5449259|P1|COMPLETED|Overall Study||10
2221807|NCT02818777|5449259|P1|STARTED|Overall Study|The number of baseline participants was 13.|13
2221808|NCT02818569|5449287|P2|NOT COMPLETED|Overall Study||0
2221809|NCT02818569|5449288|P1|NOT COMPLETED|Overall Study||0
2221810|NCT02818569|5449287|P2|COMPLETED|Overall Study||7
2221811|NCT02818569|5449288|P1|COMPLETED|Overall Study||8
2221812|NCT02818569|5449287|P2|STARTED|Overall Study||7
2221813|NCT02818569|5449288|P1|STARTED|Overall Study||8
2221814|NCT02818244|5449306|P4|NOT COMPLETED|Overall Study||0
2221815|NCT02818244|5449307|P3|NOT COMPLETED|Overall Study||0
2221816|NCT02818244|5449308|P2|NOT COMPLETED|Overall Study||0
2221817|NCT02818244|5449309|P1|NOT COMPLETED|Overall Study||0
2221818|NCT02818244|5449306|P4|COMPLETED|Overall Study||25
2221819|NCT02818244|5449307|P3|COMPLETED|Overall Study||25
2221820|NCT02818244|5449308|P2|COMPLETED|Overall Study||25
2221821|NCT02818244|5449309|P1|COMPLETED|Overall Study||25
2221822|NCT02818244|5449306|P4|STARTED|Overall Study||25
2221823|NCT02818244|5449307|P3|STARTED|Overall Study||25
2221824|NCT02818244|5449308|P2|STARTED|Overall Study||25
2221825|NCT02818244|5449309|P1|STARTED|Overall Study||25
2221826|NCT02818114|5449319|P1|NOT COMPLETED|Overall Study||1
2221827|NCT02818114|5449319|P1|COMPLETED|Overall Study||7
2221828|NCT02818114|5449319|P1|STARTED|Overall Study||8
2221829|NCT02818036|5449326|P2|NOT COMPLETED|Overall Study||0
2221830|NCT02818036|5449327|P1|NOT COMPLETED|Overall Study||2
2221831|NCT02818036|5449326|P2|COMPLETED|Overall Study||40
2221832|NCT02818036|5449327|P1|COMPLETED|Overall Study||40
2221833|NCT02818036|5449326|P2|STARTED|Overall Study||40
2221834|NCT02818036|5449327|P1|STARTED|Overall Study||42
2221835|NCT02817841|5449335|P1|NOT COMPLETED|Overall Study||848
2221836|NCT02817841|5449335|P1|COMPLETED|Overall Study||1016
2221837|NCT02817841|5449335|P1|STARTED|Overall Study||1864
2221838|NCT02817828|5449362|P1|NOT COMPLETED|Overall Study||335
2221839|NCT02817828|5449362|P1|COMPLETED|Overall Study||1218
2221840|NCT02817828|5449362|P1|STARTED|Overall Study||1553
2221841|NCT02817763|5449388|P2|NOT COMPLETED|Overall Study||0
2221842|NCT02817763|5449389|P1|NOT COMPLETED|Overall Study||0
2221843|NCT02817763|5449388|P2|COMPLETED|Overall Study||20
2221844|NCT02817763|5449389|P1|COMPLETED|Overall Study||20
2221845|NCT02817763|5449388|P2|STARTED|Overall Study||20
2221846|NCT02817763|5449389|P1|STARTED|Overall Study||20
2221847|NCT02817594|5449397|P1|NOT COMPLETED|Overall Study||3
2221848|NCT02817594|5449397|P1|COMPLETED|Overall Study||48
2221849|NCT02817594|5449397|P1|Received Treatment|Overall Study||50
2221850|NCT02817594|5449397|P1|STARTED|Overall Study||51
2221851|NCT02817555|5449418|P2|NOT COMPLETED|Overall Study||5
2221852|NCT02817555|5449419|P1|NOT COMPLETED|Overall Study||3
2221853|NCT02817555|5449418|P2|COMPLETED|Overall Study||21
2221854|NCT02817555|5449419|P1|COMPLETED|Overall Study||21
2221855|NCT02817555|5449418|P2|STARTED|Overall Study||26
2221856|NCT02817555|5449419|P1|STARTED|Overall Study||24
2221857|NCT02817516|5449439|P4|NOT COMPLETED|Overall Study||0
2221858|NCT02817516|5449440|P3|NOT COMPLETED|Overall Study||1
2221859|NCT02817516|5449441|P2|NOT COMPLETED|Overall Study||0
2221860|NCT02817516|5449442|P1|NOT COMPLETED|Overall Study||0
2221861|NCT02817516|5449439|P4|COMPLETED|Overall Study||6
2221862|NCT02817516|5449440|P3|COMPLETED|Overall Study||5
2221863|NCT02817516|5449441|P2|COMPLETED|Overall Study||6
2221864|NCT02817516|5449442|P1|COMPLETED|Overall Study||6
2221865|NCT02817516|5449439|P4|STARTED|Overall Study||6
2221866|NCT02817516|5449440|P3|STARTED|Overall Study||6
2221867|NCT02817516|5449441|P2|STARTED|Overall Study||6
2221868|NCT02817516|5449442|P1|STARTED|Overall Study||6
2221869|NCT02816710|5449480|P3|NOT COMPLETED|Overall Study||7
2221870|NCT02816710|5449481|P2|NOT COMPLETED|Overall Study||3
2221871|NCT02816710|5449482|P1|NOT COMPLETED|Overall Study||4
2221872|NCT02816710|5449480|P3|COMPLETED|Overall Study||29
2221873|NCT02816710|5449481|P2|COMPLETED|Overall Study||35
2221874|NCT02816710|5449482|P1|COMPLETED|Overall Study||34
2221875|NCT02816710|5449480|P3|STARTED|Overall Study||36
2221876|NCT02816710|5449481|P2|STARTED|Overall Study||38
2221877|NCT02816710|5449482|P1|STARTED|Overall Study||38
2221878|NCT02816346|5449522|P5|NOT COMPLETED|Overall Study||0
2221879|NCT02816346|5449523|P4|NOT COMPLETED|Overall Study||0
2221880|NCT02816346|5449524|P3|NOT COMPLETED|Overall Study||0
2221881|NCT02816346|5449525|P2|NOT COMPLETED|Overall Study||0
2221882|NCT02816346|5449526|P1|NOT COMPLETED|Overall Study||0
2221883|NCT02816346|5449522|P5|COMPLETED|Overall Study||16
2221884|NCT02816346|5449523|P4|COMPLETED|Overall Study||10
2221885|NCT02816346|5449524|P3|COMPLETED|Overall Study||10
2221886|NCT02816346|5449525|P2|COMPLETED|Overall Study||10
2221887|NCT02816346|5449526|P1|COMPLETED|Overall Study||10
2221888|NCT02816346|5449522|P5|STARTED|Overall Study||16
2221889|NCT02816346|5449523|P4|STARTED|Overall Study||10
2221890|NCT02816346|5449524|P3|STARTED|Overall Study||10
2221891|NCT02816346|5449525|P2|STARTED|Overall Study||10
2221892|NCT02816346|5449526|P1|STARTED|Overall Study||10
2221893|NCT02816138|5449568|P1|NOT COMPLETED|Overall Study||1
2221894|NCT02816138|5449568|P1|COMPLETED|Overall Study||14
2221895|NCT02816138|5449568|P1|STARTED|Overall Study||15
2221896|NCT02815982|5449585|P4|NOT COMPLETED|Overall Study||0
2221897|NCT02815982|5449586|P3|NOT COMPLETED|Overall Study||0
2221898|NCT02815982|5449587|P2|NOT COMPLETED|Overall Study||0
2221899|NCT02815982|5449588|P1|NOT COMPLETED|Overall Study||0
2221900|NCT02815982|5449585|P4|COMPLETED|Overall Study||26
2221901|NCT02815982|5449586|P3|COMPLETED|Overall Study||27
2221902|NCT02815982|5449587|P2|COMPLETED|Overall Study||26
2221903|NCT02815982|5449588|P1|COMPLETED|Overall Study||27
2221904|NCT02815982|5449585|P4|STARTED|Overall Study||26
2221905|NCT02815982|5449586|P3|STARTED|Overall Study||27
2221906|NCT02815982|5449587|P2|STARTED|Overall Study||26
2221907|NCT02815982|5449588|P1|STARTED|Overall Study||27
2221908|NCT02815735|5449614|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
2221909|NCT02815735|5449615|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
2221910|NCT02815735|5449614|P2|COMPLETED|Second Intervention (4 Weeks)||37
2221911|NCT02815735|5449615|P1|COMPLETED|Second Intervention (4 Weeks)||33
2221912|NCT02815735|5449614|P2|STARTED|Second Intervention (4 Weeks)||37
2221913|NCT02815735|5449615|P1|STARTED|Second Intervention (4 Weeks)||34
2221914|NCT02815735|5449614|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
2221915|NCT02815735|5449615|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
2221916|NCT02815735|5449614|P2|COMPLETED|First Intervention (4 Weeks)||37
2221917|NCT02815735|5449615|P1|COMPLETED|First Intervention (4 Weeks)||34
2221918|NCT02815735|5449614|P2|STARTED|First Intervention (4 Weeks)||38
2221919|NCT02815735|5449615|P1|STARTED|First Intervention (4 Weeks)||36
2221920|NCT02815644|5449632|P2|NOT COMPLETED|Treatment Period 2||0
2221921|NCT02815644|5449633|P1|NOT COMPLETED|Treatment Period 2||0
2221922|NCT02815644|5449632|P2|COMPLETED|Treatment Period 2||11
2221923|NCT02815644|5449633|P1|COMPLETED|Treatment Period 2||11
2221924|NCT02815644|5449632|P2|STARTED|Treatment Period 2||11
2221925|NCT02815644|5449633|P1|STARTED|Treatment Period 2||11
2221926|NCT02815644|5449632|P2|NOT COMPLETED|Treatment Period 1 + Washout||0
2221927|NCT02815644|5449633|P1|NOT COMPLETED|Treatment Period 1 + Washout||0
2221928|NCT02815644|5449632|P2|COMPLETED|Treatment Period 1 + Washout||11
2221929|NCT02815644|5449633|P1|COMPLETED|Treatment Period 1 + Washout||11
2221930|NCT02815644|5449632|P2|STARTED|Treatment Period 1 + Washout||11
2221931|NCT02815644|5449633|P1|STARTED|Treatment Period 1 + Washout||11
2221932|NCT02815397|5449651|P1|NOT COMPLETED|Overall Study||2
2221933|NCT02815397|5449651|P1|COMPLETED|Overall Study||0
2221934|NCT02815397|5449651|P1|STARTED|Overall Study||2
2221935|NCT02815293|5449661|P3|NOT COMPLETED|Overall Study||18
2221936|NCT02815293|5449662|P2|NOT COMPLETED|Overall Study||8
2221937|NCT02815293|5449663|P1|NOT COMPLETED|Overall Study||10
2221938|NCT02815293|5449661|P3|COMPLETED|Overall Study||0
2221939|NCT02815293|5449662|P2|COMPLETED|Overall Study||0
2221940|NCT02815293|5449663|P1|COMPLETED|Overall Study||0
2221941|NCT02815293|5449661|P3|STARTED|Overall Study||18
2221942|NCT02815293|5449662|P2|STARTED|Overall Study||8
2221943|NCT02815293|5449663|P1|STARTED|Overall Study||10
2221944|NCT02814656|5449675|P4|NOT COMPLETED|Overall Study||0
2221945|NCT02814656|5449676|P3|NOT COMPLETED|Overall Study||0
2221946|NCT02814656|5449677|P2|NOT COMPLETED|Overall Study||0
2221947|NCT02814656|5449678|P1|NOT COMPLETED|Overall Study||0
2221948|NCT02814656|5449675|P4|COMPLETED|Overall Study||6
2221949|NCT02814656|5449676|P3|COMPLETED|Overall Study||6
2221950|NCT02814656|5449677|P2|COMPLETED|Overall Study||6
2221951|NCT02814656|5449678|P1|COMPLETED|Overall Study||6
2221952|NCT02814656|5449675|P4|STARTED|Overall Study||6
2221953|NCT02814656|5449676|P3|STARTED|Overall Study||6
2221954|NCT02814656|5449677|P2|STARTED|Overall Study||6
2221955|NCT02814656|5449678|P1|STARTED|Overall Study||6
2221956|NCT02814643|5449778|P2|NOT COMPLETED|Overall Study||3
2221957|NCT02814643|5449779|P1|NOT COMPLETED|Overall Study||1
2221958|NCT02814643|5449778|P2|COMPLETED|Overall Study||49
2221959|NCT02814643|5449779|P1|COMPLETED|Overall Study||50
2221960|NCT02814643|5449778|P2|STARTED|Overall Study||52
2221961|NCT02814643|5449779|P1|STARTED|Overall Study||51
2221962|NCT02814565|5449803|P2|NOT COMPLETED|Overall Study||2
2221963|NCT02814565|5449804|P1|NOT COMPLETED|Overall Study||1
2221964|NCT02814565|5449803|P2|COMPLETED|Overall Study||88
2221965|NCT02814565|5449804|P1|COMPLETED|Overall Study||89
2221966|NCT02814565|5449803|P2|STARTED|Overall Study||90
2221967|NCT02814565|5449804|P1|STARTED|Overall Study||90
2221968|NCT02814448|5449833|P5|NOT COMPLETED|Overall Study||2
2221969|NCT02814448|5449834|P4|NOT COMPLETED|Overall Study||0
2221970|NCT02814448|5449835|P3|NOT COMPLETED|Overall Study||1
2221971|NCT02814448|5449836|P2|NOT COMPLETED|Overall Study||0
2221972|NCT02814448|5449837|P1|NOT COMPLETED|Overall Study||0
2221973|NCT02814448|5449833|P5|COMPLETED|Overall Study||26
2221974|NCT02814448|5449834|P4|COMPLETED|Overall Study||25
2221975|NCT02814448|5449835|P3|COMPLETED|Overall Study||25
2221976|NCT02814448|5449836|P2|COMPLETED|Overall Study||24
2221977|NCT02814448|5449837|P1|COMPLETED|Overall Study||27
2221978|NCT02814448|5449833|P5|STARTED|Overall Study||28
2221979|NCT02814448|5449834|P4|STARTED|Overall Study||25
2221980|NCT02814448|5449835|P3|STARTED|Overall Study||26
2221981|NCT02814448|5449836|P2|STARTED|Overall Study||24
2221982|NCT02814448|5449837|P1|STARTED|Overall Study||27
2221983|NCT02814279|5449856|P2|NOT COMPLETED|Overall Study||0
2221984|NCT02814279|5449857|P1|NOT COMPLETED|Overall Study||0
2221985|NCT02814279|5449856|P2|COMPLETED|Overall Study||21
2221986|NCT02814279|5449857|P1|COMPLETED|Overall Study||21
2221987|NCT02814279|5449856|P2|STARTED|Overall Study||21
2221988|NCT02814279|5449857|P1|STARTED|Overall Study||21
2221989|NCT02814227|5449865|P1|NOT COMPLETED|Overall Study||0
2221990|NCT02814227|5449865|P1|COMPLETED|Overall Study||52
2221991|NCT02814227|5449865|P1|STARTED|Overall Study||52
2221992|NCT02813694|5449874|P2|NOT COMPLETED|Overall Study||14
2221993|NCT02813694|5449875|P1|NOT COMPLETED|Overall Study||17
2221994|NCT02813694|5449874|P2|COMPLETED|Overall Study|Completed Study (Late Follow Up Assessment)|354
2221995|NCT02813694|5449875|P1|COMPLETED|Overall Study||353
2221996|NCT02813694|5449874|P2|STARTED|Overall Study|Intent to Treat Analysis Set|368
2221997|NCT02813694|5449875|P1|STARTED|Overall Study|Intent to Treat Analysis Set|370
2221998|NCT02813681|5449888|P3|NOT COMPLETED|Overall Study||0
2221999|NCT02813681|5449889|P2|NOT COMPLETED|Overall Study||6
2222000|NCT02813681|5449890|P1|NOT COMPLETED|Overall Study||5
2222001|NCT02813681|5449888|P3|COMPLETED|Overall Study||19
2222002|NCT02813681|5449889|P2|COMPLETED|Overall Study||28
2222003|NCT02813681|5449890|P1|COMPLETED|Overall Study||22
2222004|NCT02813681|5449888|P3|STARTED|Overall Study||19
2222005|NCT02813681|5449889|P2|STARTED|Overall Study||34
2222006|NCT02813681|5449890|P1|STARTED|Overall Study||27
2222007|NCT02813551|5449913|P2|NOT COMPLETED|Overall Study||2
2222008|NCT02813551|5449914|P1|NOT COMPLETED|Overall Study||1
2222009|NCT02813551|5449913|P2|COMPLETED|Overall Study||57
2222010|NCT02813551|5449914|P1|COMPLETED|Overall Study||58
2222011|NCT02813551|5449913|P2|STARTED|Overall Study||59
2222012|NCT02813551|5449914|P1|STARTED|Overall Study||59
2222013|NCT02813473|5449940|P1|NOT COMPLETED|Overall Study||0
2222014|NCT02813473|5449940|P1|COMPLETED|Overall Study||223
2222015|NCT02813473|5449940|P1|STARTED|Overall Study||223
2222016|NCT02813070|5449947|P3|NOT COMPLETED|Overall Study||11
2222017|NCT02813070|5449948|P2|NOT COMPLETED|Overall Study||3
2222018|NCT02813070|5449949|P1|NOT COMPLETED|Overall Study||3
2222019|NCT02813070|5449947|P3|COMPLETED|Overall Study||25
2222020|NCT02813070|5449948|P2|COMPLETED|Overall Study||20
2222021|NCT02813070|5449949|P1|COMPLETED|Overall Study||25
2222022|NCT02813070|5449947|P3|Treated (Safety Population)|Overall Study||25
2222023|NCT02813070|5449948|P2|Treated (Safety Population)|Overall Study||20
2222024|NCT02813070|5449949|P1|Treated (Safety Population)|Overall Study||25
2222025|NCT02813070|5449947|P3|STARTED|Overall Study||36
2222026|NCT02813070|5449948|P2|STARTED|Overall Study||23
2222027|NCT02813070|5449949|P1|STARTED|Overall Study||28
2222028|NCT02812342|5449958|P1|NOT COMPLETED|Overall Study||0
2222029|NCT02812342|5449958|P1|COMPLETED|Overall Study||10
2222030|NCT02812342|5449958|P1|STARTED|Overall Study||10
2222031|NCT02812238|5449963|P2|NOT COMPLETED|Second Intervention||1
2222032|NCT02812238|5449964|P1|NOT COMPLETED|Second Intervention||0
2222033|NCT02812238|5449963|P2|COMPLETED|Second Intervention||18
2222034|NCT02812238|5449964|P1|COMPLETED|Second Intervention||18
2222035|NCT02812238|5449963|P2|STARTED|Second Intervention||19
2222036|NCT02812238|5449964|P1|STARTED|Second Intervention||18
2222037|NCT02812238|5449963|P2|NOT COMPLETED|First Intervention||0
2222038|NCT02812238|5449964|P1|NOT COMPLETED|First Intervention||1
2222039|NCT02812238|5449963|P2|COMPLETED|First Intervention||19
2222040|NCT02812238|5449964|P1|COMPLETED|First Intervention||18
2222041|NCT02812238|5449963|P2|STARTED|First Intervention||19
2222042|NCT02812238|5449964|P1|STARTED|First Intervention||19
2222043|NCT02811965|5449970|P1|NOT COMPLETED|Overall Study||0
2222044|NCT02811965|5449970|P1|COMPLETED|Overall Study||21
2222045|NCT02811965|5449970|P1|STARTED|Overall Study||21
2222046|NCT02811419|5449995|P2|NOT COMPLETED|Overall Study||13
2222047|NCT02811419|5449996|P1|NOT COMPLETED|Overall Study||12
2222048|NCT02811419|5449995|P2|COMPLETED|Overall Study||358
2222049|NCT02811419|5449996|P1|COMPLETED|Overall Study||357
2222050|NCT02811419|5449995|P2|STARTED|Overall Study||371
2222051|NCT02811419|5449996|P1|STARTED|Overall Study||369
2222052|NCT02811302|5450004|P1|NOT COMPLETED|Overall Study||213
2222053|NCT02811302|5450004|P1|COMPLETED|Overall Study||1282
2222054|NCT02811302|5450004|P1|STARTED|Overall Study||1495
2222055|NCT02811159|5450009|P1|NOT COMPLETED|Treatment Course 2||0
2222056|NCT02811159|5450009|P1|COMPLETED|Treatment Course 2||4
2222057|NCT02811159|5450009|P1|STARTED|Treatment Course 2|Not all participants who completed the Treatment Course 1 entered the Treatment Course 2.|4
2222058|NCT02811159|5450009|P1|NOT COMPLETED|Treatment Course 1||1
2222059|NCT02811159|5450009|P1|COMPLETED|Treatment Course 1||19
2222060|NCT02811159|5450009|P1|STARTED|Treatment Course 1||20
2222061|NCT02810873|5450026|P2|NOT COMPLETED|Overall Study||0
2222062|NCT02810873|5450027|P1|NOT COMPLETED|Overall Study||0
2222063|NCT02810873|5450026|P2|COMPLETED|Overall Study||13
2222064|NCT02810873|5450027|P1|COMPLETED|Overall Study||6
2222065|NCT02810873|5450026|P2|STARTED|Overall Study||13
2222066|NCT02810873|5450027|P1|STARTED|Overall Study||6
2222067|NCT02810509|5450037|P2|NOT COMPLETED|Overall Study||0
2222068|NCT02810509|5450038|P1|NOT COMPLETED|Overall Study||0
2222069|NCT02810509|5450037|P2|COMPLETED|Overall Study||1230
2222070|NCT02810509|5450038|P1|COMPLETED|Overall Study||584
2222071|NCT02810509|5450037|P2|STARTED|Overall Study||1230
2222072|NCT02810509|5450038|P1|STARTED|Overall Study||584
2222073|NCT02810327|5450048|P2|NOT COMPLETED|Overall Study||7
2222074|NCT02810327|5450049|P1|NOT COMPLETED|Overall Study||7
2222075|NCT02810327|5450048|P2|COMPLETED|Overall Study||34
2222076|NCT02810327|5450049|P1|COMPLETED|Overall Study||69
2222077|NCT02810327|5450048|P2|STARTED|Overall Study||41
2222078|NCT02810327|5450049|P1|STARTED|Overall Study||76
2222079|NCT02809911|5450057|P2|NOT COMPLETED|Overall Study||0
2222080|NCT02809911|5450058|P1|NOT COMPLETED|Overall Study||0
2222171|NCT02807402|5450281|P1|COMPLETED|Overall Study||516
2222081|NCT02809911|5450057|P2|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|19
2222082|NCT02809911|5450058|P1|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|22
2222083|NCT02809911|5450057|P2|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|19
2222084|NCT02809911|5450058|P1|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|22
2222085|NCT02809859|5450066|P1|NOT COMPLETED|Overall Study||14
2222086|NCT02809859|5450066|P1|COMPLETED|Overall Study||125
2222087|NCT02809859|5450066|P1|STARTED|Overall Study||139
2222088|NCT02809846|5450076|P2|NOT COMPLETED|Overall Study||7
2222089|NCT02809846|5450077|P1|NOT COMPLETED|Overall Study||9
2222090|NCT02809846|5450076|P2|COMPLETED|Overall Study||9
2222091|NCT02809846|5450077|P1|COMPLETED|Overall Study||8
2222092|NCT02809846|5450076|P2|STARTED|Overall Study||16
2222093|NCT02809846|5450077|P1|STARTED|Overall Study||17
2222094|NCT02809833|5450083|P1|NOT COMPLETED|Overall Study||300
2222095|NCT02809833|5450083|P1|COMPLETED|Overall Study||550
2222096|NCT02809833|5450083|P1|STARTED|Overall Study||850
2222097|NCT02809183|5450162|P6|NOT COMPLETED|Overall Study||0
2222098|NCT02809183|5450163|P5|NOT COMPLETED|Overall Study||0
2222099|NCT02809183|5450164|P4|NOT COMPLETED|Overall Study||0
2222100|NCT02809183|5450165|P3|NOT COMPLETED|Overall Study||0
2222101|NCT02809183|5450166|P2|NOT COMPLETED|Overall Study||0
2222102|NCT02809183|5450167|P1|NOT COMPLETED|Overall Study||0
2222103|NCT02809183|5450162|P6|COMPLETED|Overall Study||28
2222104|NCT02809183|5450163|P5|COMPLETED|Overall Study||6
2222105|NCT02809183|5450164|P4|COMPLETED|Overall Study||26
2222106|NCT02809183|5450165|P3|COMPLETED|Overall Study||25
2222107|NCT02809183|5450166|P2|COMPLETED|Overall Study||25
2222108|NCT02809183|5450167|P1|COMPLETED|Overall Study||25
2222109|NCT02809183|5450162|P6|STARTED|Overall Study||28
2222110|NCT02809183|5450163|P5|STARTED|Overall Study||6
2222111|NCT02809183|5450164|P4|STARTED|Overall Study||26
2222112|NCT02809183|5450165|P3|STARTED|Overall Study||25
2222113|NCT02809183|5450166|P2|STARTED|Overall Study||25
2222114|NCT02809183|5450167|P1|STARTED|Overall Study||25
2222115|NCT02808390|5450204|P3|NOT COMPLETED|Overall Study||3
2222116|NCT02808390|5450205|P2|NOT COMPLETED|Overall Study||6
2222117|NCT02808390|5450206|P1|NOT COMPLETED|Overall Study||2
2222118|NCT02808390|5450204|P3|COMPLETED|Overall Study||4
2222119|NCT02808390|5450205|P2|COMPLETED|Overall Study||2
2222120|NCT02808390|5450206|P1|COMPLETED|Overall Study||2
2222121|NCT02808390|5450204|P3|STARTED|Overall Study||7
2222122|NCT02808390|5450205|P2|STARTED|Overall Study||8
2222123|NCT02808390|5450206|P1|STARTED|Overall Study||4
2222124|NCT02808338|5450214|P1|NOT COMPLETED|Take Home Period||0
2222125|NCT02808338|5450214|P1|COMPLETED|Take Home Period||13
2222126|NCT02808338|5450214|P1|STARTED|Take Home Period||13
2222127|NCT02808338|5450214|P1|NOT COMPLETED|Overnight In-lab Polysomonography||2
2222128|NCT02808338|5450214|P1|COMPLETED|Overnight In-lab Polysomonography||13
2222129|NCT02808338|5450214|P1|ResMed S9 VPAP Adapt|Overnight In-lab Polysomonography||12
2222130|NCT02808338|5450214|P1|Philips BiPAP AutoSV Advanced System One|Overnight In-lab Polysomonography||12
2222131|NCT02808338|5450214|P1|ResMed S7 VPAP Adapt|Overnight In-lab Polysomonography||13
2222132|NCT02808338|5450214|P1|Modified Philips BiPAP ASV|Overnight In-lab Polysomonography||13
2222133|NCT02808338|5450214|P1|STARTED|Overnight In-lab Polysomonography||15
2222134|NCT02808338|5450214|P1|NOT COMPLETED|Screening||10
2222135|NCT02808338|5450214|P1|COMPLETED|Screening||15
2222136|NCT02808338|5450214|P1|STARTED|Screening||25
2222137|NCT02808130|5450231|P6|NOT COMPLETED|Overall Study||0
2222138|NCT02808130|5450232|P5|NOT COMPLETED|Overall Study||0
2222139|NCT02808130|5450233|P4|NOT COMPLETED|Overall Study||0
2222140|NCT02808130|5450234|P3|NOT COMPLETED|Overall Study||0
2222141|NCT02808130|5450235|P2|NOT COMPLETED|Overall Study||0
2222142|NCT02808130|5450236|P1|NOT COMPLETED|Overall Study||0
2222143|NCT02808130|5450231|P6|COMPLETED|Overall Study||15
2222144|NCT02808130|5450232|P5|COMPLETED|Overall Study||15
2222145|NCT02808130|5450233|P4|COMPLETED|Overall Study||15
2222146|NCT02808130|5450234|P3|COMPLETED|Overall Study||15
2222147|NCT02808130|5450235|P2|COMPLETED|Overall Study||15
2222148|NCT02808130|5450236|P1|COMPLETED|Overall Study||15
2222149|NCT02808130|5450231|P6|STARTED|Overall Study||15
2222150|NCT02808130|5450232|P5|STARTED|Overall Study||15
2222151|NCT02808130|5450233|P4|STARTED|Overall Study||15
2222152|NCT02808130|5450234|P3|STARTED|Overall Study||15
2222153|NCT02808130|5450235|P2|STARTED|Overall Study||15
2222154|NCT02808130|5450236|P1|STARTED|Overall Study||15
2222155|NCT02808052|5450265|P3|NOT COMPLETED|Overall Study||0
2222156|NCT02808052|5450266|P2|NOT COMPLETED|Overall Study||0
2222157|NCT02808052|5450267|P1|NOT COMPLETED|Overall Study||0
2222158|NCT02808052|5450265|P3|COMPLETED|Overall Study||2
2222159|NCT02808052|5450266|P2|COMPLETED|Overall Study||3
2222160|NCT02808052|5450267|P1|COMPLETED|Overall Study||4
2222161|NCT02808052|5450265|P3|STARTED|Overall Study||2
2222162|NCT02808052|5450266|P2|STARTED|Overall Study||3
2222163|NCT02808052|5450267|P1|STARTED|Overall Study||4
2222164|NCT02807948|5450275|P2|NOT COMPLETED|Overall Study||0
2222165|NCT02807948|5450276|P1|NOT COMPLETED|Overall Study||1
2222166|NCT02807948|5450275|P2|COMPLETED|Overall Study||57
2222167|NCT02807948|5450276|P1|COMPLETED|Overall Study||131
2222168|NCT02807948|5450275|P2|STARTED|Overall Study||57
2222169|NCT02807948|5450276|P1|STARTED|Overall Study||132
2222170|NCT02807402|5450281|P1|NOT COMPLETED|Overall Study||6
2222172|NCT02807402|5450281|P1|STARTED|Overall Study||522
2222173|NCT02807376|5450319|P2|NOT COMPLETED|Overall Study||1
2222174|NCT02807376|5450320|P1|NOT COMPLETED|Overall Study||3
2222175|NCT02807376|5450319|P2|COMPLETED|Overall Study||130
2222176|NCT02807376|5450320|P1|COMPLETED|Overall Study||136
2222177|NCT02807376|5450319|P2|STARTED|Overall Study||131
2222178|NCT02807376|5450320|P1|STARTED|Overall Study||139
2222179|NCT02806973|5450328|P4|NOT COMPLETED|Period 4||0
2222180|NCT02806973|5450329|P3|NOT COMPLETED|Period 4||0
2222181|NCT02806973|5450330|P2|NOT COMPLETED|Period 4||0
2222182|NCT02806973|5450331|P1|NOT COMPLETED|Period 4||0
2222183|NCT02806973|5450328|P4|COMPLETED|Period 4||3
2222184|NCT02806973|5450329|P3|COMPLETED|Period 4||6
2222185|NCT02806973|5450330|P2|COMPLETED|Period 4||6
2222186|NCT02806973|5450331|P1|COMPLETED|Period 4||8
2222187|NCT02806973|5450328|P4|STARTED|Period 4||3
2222188|NCT02806973|5450329|P3|STARTED|Period 4||6
2222189|NCT02806973|5450330|P2|STARTED|Period 4||6
2222190|NCT02806973|5450331|P1|STARTED|Period 4||8
2222191|NCT02806973|5450328|P4|NOT COMPLETED|Period 3||3
2222192|NCT02806973|5450329|P3|NOT COMPLETED|Period 3||1
2222193|NCT02806973|5450330|P2|NOT COMPLETED|Period 3||0
2222194|NCT02806973|5450331|P1|NOT COMPLETED|Period 3||0
2222195|NCT02806973|5450328|P4|COMPLETED|Period 3||3
2222196|NCT02806973|5450329|P3|COMPLETED|Period 3||6
2222197|NCT02806973|5450330|P2|COMPLETED|Period 3||6
2222198|NCT02806973|5450331|P1|COMPLETED|Period 3||8
2222199|NCT02806973|5450328|P4|STARTED|Period 3||6
2222200|NCT02806973|5450329|P3|STARTED|Period 3||7
2222201|NCT02806973|5450330|P2|STARTED|Period 3||6
2222202|NCT02806973|5450331|P1|STARTED|Period 3||8
2222203|NCT02806973|5450328|P4|NOT COMPLETED|Period 2||0
2222204|NCT02806973|5450329|P3|NOT COMPLETED|Period 2||0
2222205|NCT02806973|5450330|P2|NOT COMPLETED|Period 2||0
2222206|NCT02806973|5450331|P1|NOT COMPLETED|Period 2||0
2222207|NCT02806973|5450328|P4|COMPLETED|Period 2||6
2222208|NCT02806973|5450329|P3|COMPLETED|Period 2||7
2222209|NCT02806973|5450330|P2|COMPLETED|Period 2||6
2222210|NCT02806973|5450331|P1|COMPLETED|Period 2||8
2222211|NCT02806973|5450328|P4|STARTED|Period 2||6
2222212|NCT02806973|5450329|P3|STARTED|Period 2||7
2222213|NCT02806973|5450330|P2|STARTED|Period 2||6
2222214|NCT02806973|5450331|P1|STARTED|Period 2||8
2222215|NCT02806973|5450328|P4|NOT COMPLETED|Period 1||2
2222216|NCT02806973|5450329|P3|NOT COMPLETED|Period 1||1
2222217|NCT02806973|5450330|P2|NOT COMPLETED|Period 1||2
2222218|NCT02806973|5450331|P1|NOT COMPLETED|Period 1||0
2222219|NCT02806973|5450328|P4|COMPLETED|Period 1||6
2222220|NCT02806973|5450329|P3|COMPLETED|Period 1||7
2222221|NCT02806973|5450330|P2|COMPLETED|Period 1||6
2222222|NCT02806973|5450331|P1|COMPLETED|Period 1||8
2222223|NCT02806973|5450328|P4|STARTED|Period 1||8
2222224|NCT02806973|5450329|P3|STARTED|Period 1||8
2222225|NCT02806973|5450330|P2|STARTED|Period 1||8
2222226|NCT02806973|5450331|P1|STARTED|Period 1||8
2222227|NCT02806960|5450365|P4|NOT COMPLETED|Period 4||0
2222228|NCT02806960|5450366|P3|NOT COMPLETED|Period 4||0
2222229|NCT02806960|5450367|P2|NOT COMPLETED|Period 4||0
2222230|NCT02806960|5450368|P1|NOT COMPLETED|Period 4||0
2222231|NCT02806960|5450365|P4|COMPLETED|Period 4||0
2222232|NCT02806960|5450366|P3|COMPLETED|Period 4||0
2222233|NCT02806960|5450367|P2|COMPLETED|Period 4||0
2222234|NCT02806960|5450368|P1|COMPLETED|Period 4||0
2222235|NCT02806960|5450365|P4|STARTED|Period 4||0
2222236|NCT02806960|5450366|P3|STARTED|Period 4||0
2222237|NCT02806960|5450367|P2|STARTED|Period 4||0
2222238|NCT02806960|5450368|P1|STARTED|Period 4||0
2222239|NCT02806960|5450365|P4|NOT COMPLETED|Period 3||0
2222240|NCT02806960|5450366|P3|NOT COMPLETED|Period 3||0
2222241|NCT02806960|5450367|P2|NOT COMPLETED|Period 3||0
2222242|NCT02806960|5450368|P1|NOT COMPLETED|Period 3||0
2222243|NCT02806960|5450365|P4|COMPLETED|Period 3||0
2222244|NCT02806960|5450366|P3|COMPLETED|Period 3||0
2222245|NCT02806960|5450367|P2|COMPLETED|Period 3||0
2222246|NCT02806960|5450368|P1|COMPLETED|Period 3||0
2222247|NCT02806960|5450365|P4|STARTED|Period 3||0
2222248|NCT02806960|5450366|P3|STARTED|Period 3||0
2222249|NCT02806960|5450367|P2|STARTED|Period 3||0
2222250|NCT02806960|5450368|P1|STARTED|Period 3||0
2222251|NCT02806960|5450365|P4|NOT COMPLETED|Period 2||0
2222252|NCT02806960|5450366|P3|NOT COMPLETED|Period 2||0
2222253|NCT02806960|5450367|P2|NOT COMPLETED|Period 2||0
2222254|NCT02806960|5450368|P1|NOT COMPLETED|Period 2||0
2222255|NCT02806960|5450365|P4|COMPLETED|Period 2||0
2222256|NCT02806960|5450366|P3|COMPLETED|Period 2||0
2222257|NCT02806960|5450367|P2|COMPLETED|Period 2||0
2222258|NCT02806960|5450368|P1|COMPLETED|Period 2||0
2222259|NCT02806960|5450365|P4|STARTED|Period 2||0
2222260|NCT02806960|5450366|P3|STARTED|Period 2||0
2222261|NCT02806960|5450367|P2|STARTED|Period 2||0
2222262|NCT02806960|5450368|P1|STARTED|Period 2||0
2222263|NCT02806960|5450365|P4|NOT COMPLETED|Period 1||3
2222264|NCT02806960|5450366|P3|NOT COMPLETED|Period 1||3
2222265|NCT02806960|5450367|P2|NOT COMPLETED|Period 1||3
2222266|NCT02806960|5450368|P1|NOT COMPLETED|Period 1||3
2222267|NCT02806960|5450365|P4|COMPLETED|Period 1||0
2222268|NCT02806960|5450366|P3|COMPLETED|Period 1||0
2222269|NCT02806960|5450367|P2|COMPLETED|Period 1||0
2222270|NCT02806960|5450368|P1|COMPLETED|Period 1||0
2222271|NCT02806960|5450365|P4|STARTED|Period 1||3
2222272|NCT02806960|5450366|P3|STARTED|Period 1||3
2222273|NCT02806960|5450367|P2|STARTED|Period 1||3
2222274|NCT02806960|5450368|P1|STARTED|Period 1||3
2222275|NCT02806947|5450404|P2|NOT COMPLETED|Overall Study||1
2222276|NCT02806947|5450405|P1|NOT COMPLETED|Overall Study||5
2222277|NCT02806947|5450404|P2|COMPLETED|Overall Study||63
2222278|NCT02806947|5450405|P1|COMPLETED|Overall Study||53
2222279|NCT02806947|5450404|P2|STARTED|Overall Study||64
2222280|NCT02806947|5450405|P1|STARTED|Overall Study||58
2222281|NCT02806869|5450435|P2|NOT COMPLETED|Second Intervention (1 Day)||2
2222282|NCT02806869|5450436|P1|NOT COMPLETED|Second Intervention (1 Day)||0
2222283|NCT02806869|5450435|P2|COMPLETED|Second Intervention (1 Day)||5
2222284|NCT02806869|5450436|P1|COMPLETED|Second Intervention (1 Day)||7
2222285|NCT02806869|5450435|P2|STARTED|Second Intervention (1 Day)||7
2222286|NCT02806869|5450436|P1|STARTED|Second Intervention (1 Day)||7
2222287|NCT02806869|5450435|P2|NOT COMPLETED|Washout (7 Days)||0
2222288|NCT02806869|5450436|P1|NOT COMPLETED|Washout (7 Days)||0
2222289|NCT02806869|5450435|P2|COMPLETED|Washout (7 Days)||7
2222290|NCT02806869|5450436|P1|COMPLETED|Washout (7 Days)||7
2222291|NCT02806869|5450435|P2|STARTED|Washout (7 Days)||7
2222292|NCT02806869|5450436|P1|STARTED|Washout (7 Days)||7
2222293|NCT02806869|5450435|P2|NOT COMPLETED|First Intervention (1 Day)||12
2222294|NCT02806869|5450436|P1|NOT COMPLETED|First Intervention (1 Day)||11
2222295|NCT02806869|5450435|P2|COMPLETED|First Intervention (1 Day)||12
2222296|NCT02806869|5450436|P1|COMPLETED|First Intervention (1 Day)||13
2222297|NCT02806869|5450435|P2|STARTED|First Intervention (1 Day)||24
2222298|NCT02806869|5450436|P1|STARTED|First Intervention (1 Day)||24
2222299|NCT02806726|5450446|P1|NOT COMPLETED|Overall Study||1
2222300|NCT02806726|5450446|P1|COMPLETED|Overall Study|Subjects were treated contralaterally|6
2222301|NCT02806726|5450446|P1|STARTED|Overall Study|Subjects were treated contralaterally|7
2222302|NCT02806713|5450455|P2|NOT COMPLETED|Overall Study||2
2222303|NCT02806713|5450456|P1|NOT COMPLETED|Overall Study||2
2222304|NCT02806713|5450455|P2|COMPLETED|Overall Study||44
2222305|NCT02806713|5450456|P1|COMPLETED|Overall Study||44
2222306|NCT02806713|5450455|P2|STARTED|Overall Study||46
2222307|NCT02806713|5450456|P1|STARTED|Overall Study||46
2222308|NCT02806544|5450464|P1|NOT COMPLETED|Overall Study||4
2222309|NCT02806544|5450464|P1|COMPLETED|Overall Study||31
2222310|NCT02806544|5450464|P1|STARTED|Overall Study||35
2222311|NCT02806505|5450475|P2|NOT COMPLETED|Overall Study||11
2222312|NCT02806505|5450476|P1|NOT COMPLETED|Overall Study||10
2222313|NCT02806505|5450475|P2|COMPLETED|Overall Study||32
2222314|NCT02806505|5450476|P1|COMPLETED|Overall Study||28
2222315|NCT02806505|5450475|P2|STARTED|Overall Study||43
2222316|NCT02806505|5450476|P1|STARTED|Overall Study||38
2222317|NCT02806232|5450495|P9|NOT COMPLETED|Overall Study||0
2222318|NCT02806232|5450496|P8|NOT COMPLETED|Overall Study||0
2222319|NCT02806232|5450497|P7|NOT COMPLETED|Overall Study||0
2222320|NCT02806232|5450498|P6|NOT COMPLETED|Overall Study||2
2222321|NCT02806232|5450499|P5|NOT COMPLETED|Overall Study||2
2222322|NCT02806232|5450500|P4|NOT COMPLETED|Overall Study||0
2222323|NCT02806232|5450501|P3|NOT COMPLETED|Overall Study||1
2222324|NCT02806232|5450502|P2|NOT COMPLETED|Overall Study||4
2222325|NCT02806232|5450503|P1|NOT COMPLETED|Overall Study||1
2222326|NCT02806232|5450495|P9|COMPLETED|Overall Study||4
2222327|NCT02806232|5450496|P8|COMPLETED|Overall Study||20
2222328|NCT02806232|5450497|P7|COMPLETED|Overall Study||60
2222329|NCT02806232|5450498|P6|COMPLETED|Overall Study||58
2222330|NCT02806232|5450499|P5|COMPLETED|Overall Study||58
2222331|NCT02806232|5450500|P4|COMPLETED|Overall Study||60
2222332|NCT02806232|5450501|P3|COMPLETED|Overall Study||59
2222333|NCT02806232|5450502|P2|COMPLETED|Overall Study||56
2222334|NCT02806232|5450503|P1|COMPLETED|Overall Study||59
2222335|NCT02806232|5450495|P9|STARTED|Overall Study||4
2222336|NCT02806232|5450496|P8|STARTED|Overall Study||20
2222337|NCT02806232|5450497|P7|STARTED|Overall Study||60
2222338|NCT02806232|5450498|P6|STARTED|Overall Study||60
2222339|NCT02806232|5450499|P5|STARTED|Overall Study||60
2222340|NCT02806232|5450500|P4|STARTED|Overall Study||60
2222341|NCT02806232|5450501|P3|STARTED|Overall Study||60
2222342|NCT02806232|5450502|P2|STARTED|Overall Study||60
2222343|NCT02806232|5450503|P1|STARTED|Overall Study||60
2222344|NCT02806024|5450543|P2|NOT COMPLETED|Overall Study||2
2222345|NCT02806024|5450544|P1|NOT COMPLETED|Overall Study||1
2222346|NCT02806024|5450543|P2|COMPLETED|Overall Study||5
2222347|NCT02806024|5450544|P1|COMPLETED|Overall Study||6
2222348|NCT02806024|5450543|P2|STARTED|Overall Study||7
2222349|NCT02806024|5450544|P1|STARTED|Overall Study||7
2222350|NCT02805907|5450554|P2|NOT COMPLETED|Overall Study||3
2222351|NCT02805907|5450555|P1|NOT COMPLETED|Overall Study||3
2222352|NCT02805907|5450554|P2|COMPLETED|Overall Study||53
2222353|NCT02805907|5450555|P1|COMPLETED|Overall Study||53
2222354|NCT02805907|5450554|P2|STARTED|Overall Study||56
2222355|NCT02805907|5450555|P1|STARTED|Overall Study||56
2222356|NCT02805647|5450569|P2|NOT COMPLETED|Overall Study||0
2222357|NCT02805647|5450570|P1|NOT COMPLETED|Overall Study||0
2222358|NCT02805647|5450569|P2|COMPLETED|Overall Study|after laboratory tests|122
2222359|NCT02805647|5450570|P1|COMPLETED|Overall Study|after laboratory tests|100
2222360|NCT02805647|5450569|P2|STARTED|Overall Study|at the moment of submision|122
2222361|NCT02805647|5450570|P1|STARTED|Overall Study|at the moment of submision|100
2222362|NCT02804750|5450578|P2|NOT COMPLETED|Period 4||5
2222363|NCT02804750|5450579|P1|NOT COMPLETED|Period 4||0
2222364|NCT02804750|5450578|P2|COMPLETED|Period 4||7
2222365|NCT02804750|5450579|P1|COMPLETED|Period 4||0
2222366|NCT02804750|5450578|P2|STARTED|Period 4|One participant completed Period 3 but did not start Period 4 due to a pre-scheduled surgery.|12
2222367|NCT02804750|5450579|P1|STARTED|Period 4|Per-protocol, Group 1 did not participate in Period 4.|0
2222368|NCT02804750|5450578|P2|NOT COMPLETED|Period 3||2
2222369|NCT02804750|5450579|P1|NOT COMPLETED|Period 3||0
2222370|NCT02804750|5450578|P2|COMPLETED|Period 3||13
2222371|NCT02804750|5450579|P1|COMPLETED|Period 3||16
2222372|NCT02804750|5450578|P2|STARTED|Period 3||15
2222373|NCT02804750|5450579|P1|STARTED|Period 3||16
2222374|NCT02804750|5450578|P2|NOT COMPLETED|Period 2||0
2222375|NCT02804750|5450579|P1|NOT COMPLETED|Period 2||1
2222376|NCT02804750|5450578|P2|COMPLETED|Period 2||15
2222377|NCT02804750|5450579|P1|COMPLETED|Period 2||16
2222378|NCT02804750|5450578|P2|STARTED|Period 2||15
2222379|NCT02804750|5450579|P1|STARTED|Period 2||17
2222380|NCT02804750|5450578|P2|NOT COMPLETED|Period 1||3
2222381|NCT02804750|5450579|P1|NOT COMPLETED|Period 1||0
2222382|NCT02804750|5450578|P2|COMPLETED|Period 1||15
2222383|NCT02804750|5450579|P1|COMPLETED|Period 1||17
2222384|NCT02804750|5450578|P2|STARTED|Period 1||18
2222385|NCT02804750|5450579|P1|STARTED|Period 1||17
2222392|NCT02804399|5450606|P2|NOT COMPLETED|Period 2||1
2222393|NCT02804399|5450607|P1|NOT COMPLETED|Period 2||0
2222394|NCT02804399|5450606|P2|COMPLETED|Period 2||11
2222395|NCT02804399|5450607|P1|COMPLETED|Period 2||0
2222396|NCT02804399|5450606|P2|STARTED|Period 2||12
2222397|NCT02804399|5450607|P1|STARTED|Period 2||0
2222398|NCT02804399|5450606|P2|NOT COMPLETED|Washout Period at Least 10 Days||0
2222399|NCT02804399|5450607|P1|NOT COMPLETED|Washout Period at Least 10 Days||0
2222400|NCT02804399|5450606|P2|COMPLETED|Washout Period at Least 10 Days||0
2222401|NCT02804399|5450607|P1|COMPLETED|Washout Period at Least 10 Days||12
2222402|NCT02804399|5450606|P2|STARTED|Washout Period at Least 10 Days||0
2222403|NCT02804399|5450607|P1|STARTED|Washout Period at Least 10 Days||12
2222404|NCT02804399|5450606|P2|NOT COMPLETED|Period 1||0
2222405|NCT02804399|5450607|P1|NOT COMPLETED|Period 1||0
2222406|NCT02804399|5450606|P2|COMPLETED|Period 1||0
2222407|NCT02804399|5450607|P1|COMPLETED|Period 1||12
2222408|NCT02804399|5450606|P2|STARTED|Period 1||0
2222409|NCT02804399|5450607|P1|STARTED|Period 1||12
2222410|NCT02803749|5450658|P2|NOT COMPLETED|Overall Study||0
2222411|NCT02803749|5450659|P1|NOT COMPLETED|Overall Study||5
2222412|NCT02803749|5450658|P2|COMPLETED|Overall Study||4
2222413|NCT02803749|5450659|P1|COMPLETED|Overall Study||12
2222414|NCT02803749|5450658|P2|STARTED|Overall Study||4
2222415|NCT02803749|5450659|P1|STARTED|Overall Study||17
2222416|NCT02803580|5450679|P1|NOT COMPLETED|Overall Study||36
2222417|NCT02803580|5450679|P1|COMPLETED|Overall Study||173
2222418|NCT02803580|5450679|P1|STARTED|Overall Study||209
2222419|NCT02803138|5450718|P1|NOT COMPLETED|Overall Study||70
2222420|NCT02803138|5450718|P1|COMPLETED|Overall Study||166
2222421|NCT02803138|5450718|P1|STARTED|Overall Study||236
2222422|NCT02802878|5450734|P2|NOT COMPLETED|Overall Study||3
2222423|NCT02802878|5450735|P1|NOT COMPLETED|Overall Study||4
2222424|NCT02802878|5450734|P2|COMPLETED|Overall Study||18
2222425|NCT02802878|5450735|P1|COMPLETED|Overall Study||17
2222426|NCT02802878|5450734|P2|STARTED|Overall Study||21
2222427|NCT02802878|5450735|P1|STARTED|Overall Study||21
2222428|NCT02802865|5450751|P2|NOT COMPLETED|Overall Study||2
2222429|NCT02802865|5450752|P1|NOT COMPLETED|Overall Study||1
2222430|NCT02802865|5450751|P2|COMPLETED|Overall Study||33
2222431|NCT02802865|5450752|P1|COMPLETED|Overall Study||34
2222432|NCT02802865|5450751|P2|STARTED|Overall Study||35
2222433|NCT02802865|5450752|P1|STARTED|Overall Study||35
2222434|NCT02802592|5450774|P1|NOT COMPLETED|Overall Study||4
2222435|NCT02802592|5450774|P1|COMPLETED|Overall Study||0
2222436|NCT02802592|5450774|P1|STARTED|Overall Study||4
2222437|NCT02802449|5450787|P2|NOT COMPLETED|Overall Study||17
2222438|NCT02802449|5450788|P1|NOT COMPLETED|Overall Study||9
2222439|NCT02802449|5450787|P2|COMPLETED|Overall Study||202
2222440|NCT02802449|5450788|P1|COMPLETED|Overall Study||102
2222441|NCT02802449|5450787|P2|STARTED|Overall Study||219
2222442|NCT02802449|5450788|P1|STARTED|Overall Study||111
2222443|NCT02802345|5450806|P2|NOT COMPLETED|Overall Study||30
2222444|NCT02802345|5450807|P1|NOT COMPLETED|Overall Study||32
2222445|NCT02802345|5450806|P2|COMPLETED|Overall Study||108
2222446|NCT02802345|5450807|P1|COMPLETED|Overall Study||104
2222447|NCT02802345|5450806|P2|Treated|Overall Study||137
2222448|NCT02802345|5450807|P1|Treated|Overall Study||136
2222449|NCT02802345|5450806|P2|STARTED|Overall Study||138
2222450|NCT02802345|5450807|P1|STARTED|Overall Study||136
2222451|NCT02802319|5450823|P2|NOT COMPLETED|Overall Study||5
2222452|NCT02802319|5450824|P1|NOT COMPLETED|Overall Study||2
2222453|NCT02802319|5450823|P2|COMPLETED|Overall Study||17
2222454|NCT02802319|5450824|P1|COMPLETED|Overall Study||20
2222455|NCT02802319|5450823|P2|STARTED|Overall Study||22
2222456|NCT02802319|5450824|P1|STARTED|Overall Study||22
2222457|NCT02801942|5450834|P2|NOT COMPLETED|Overall Study||0
2222458|NCT02801942|5450835|P1|NOT COMPLETED|Overall Study||0
2222459|NCT02801942|5450834|P2|COMPLETED|Overall Study||10
2222460|NCT02801942|5450835|P1|COMPLETED|Overall Study||12
2222461|NCT02801942|5450834|P2|STARTED|Overall Study||10
2222462|NCT02801942|5450835|P1|STARTED|Overall Study||12
2222463|NCT02801877|5450959|P4|NOT COMPLETED|Overall Study||0
2222464|NCT02801877|5450960|P3|NOT COMPLETED|Overall Study||6
2222465|NCT02801877|5450961|P2|NOT COMPLETED|Overall Study||1
2222466|NCT02801877|5450962|P1|NOT COMPLETED|Overall Study||3
2222467|NCT02801877|5450959|P4|COMPLETED|Overall Study||76
2222468|NCT02801877|5450960|P3|COMPLETED|Overall Study||70
2222469|NCT02801877|5450961|P2|COMPLETED|Overall Study||74
2222470|NCT02801877|5450962|P1|COMPLETED|Overall Study||71
2222471|NCT02801877|5450959|P4|STARTED|Overall Study||76
2222472|NCT02801877|5450960|P3|STARTED|Overall Study||76
2222473|NCT02801877|5450961|P2|STARTED|Overall Study||75
2222474|NCT02801877|5450962|P1|STARTED|Overall Study||74
2222475|NCT02801617|5450982|P2|NOT COMPLETED|Overall Study||6
2222476|NCT02801617|5450983|P1|NOT COMPLETED|Overall Study||2
2222477|NCT02801617|5450982|P2|COMPLETED|Overall Study||50
2222478|NCT02801617|5450983|P1|COMPLETED|Overall Study||49
2222479|NCT02801617|5450982|P2|STARTED|Overall Study||56
2222480|NCT02801617|5450983|P1|STARTED|Overall Study||51
2222481|NCT02801396|5451001|P6|NOT COMPLETED|Period 3||0
2222482|NCT02801396|5451002|P5|NOT COMPLETED|Period 3||0
2222483|NCT02801396|5451003|P4|NOT COMPLETED|Period 3||0
2222484|NCT02801396|5451004|P3|NOT COMPLETED|Period 3||0
2222485|NCT02801396|5451005|P2|NOT COMPLETED|Period 3||0
2222486|NCT02801396|5451006|P1|NOT COMPLETED|Period 3||0
2222487|NCT02801396|5451001|P6|COMPLETED|Period 3||17
2222488|NCT02801396|5451002|P5|COMPLETED|Period 3||16
2222489|NCT02801396|5451003|P4|COMPLETED|Period 3||16
2222490|NCT02801396|5451004|P3|COMPLETED|Period 3||17
2222491|NCT02801396|5451005|P2|COMPLETED|Period 3||17
2222492|NCT02801396|5451006|P1|COMPLETED|Period 3||17
2222493|NCT02801396|5451001|P6|STARTED|Period 3||17
2222494|NCT02801396|5451002|P5|STARTED|Period 3||16
2222495|NCT02801396|5451003|P4|STARTED|Period 3||16
2222496|NCT02801396|5451004|P3|STARTED|Period 3||17
2222497|NCT02801396|5451005|P2|STARTED|Period 3||17
2222498|NCT02801396|5451006|P1|STARTED|Period 3||17
2222499|NCT02801396|5451001|P6|NOT COMPLETED|Period 2||0
2222500|NCT02801396|5451002|P5|NOT COMPLETED|Period 2||0
2222501|NCT02801396|5451003|P4|NOT COMPLETED|Period 2||0
2222502|NCT02801396|5451004|P3|NOT COMPLETED|Period 2||0
2222503|NCT02801396|5451005|P2|NOT COMPLETED|Period 2||0
2222504|NCT02801396|5451006|P1|NOT COMPLETED|Period 2||0
2222505|NCT02801396|5451001|P6|COMPLETED|Period 2||17
2222506|NCT02801396|5451002|P5|COMPLETED|Period 2||16
2222507|NCT02801396|5451003|P4|COMPLETED|Period 2||16
2222508|NCT02801396|5451004|P3|COMPLETED|Period 2||17
2222509|NCT02801396|5451005|P2|COMPLETED|Period 2||17
2222510|NCT02801396|5451006|P1|COMPLETED|Period 2||17
2222511|NCT02801396|5451001|P6|STARTED|Period 2||17
2222512|NCT02801396|5451002|P5|STARTED|Period 2||16
2222513|NCT02801396|5451003|P4|STARTED|Period 2||16
2222514|NCT02801396|5451004|P3|STARTED|Period 2||17
2222515|NCT02801396|5451005|P2|STARTED|Period 2||17
2222516|NCT02801396|5451006|P1|STARTED|Period 2||17
2222517|NCT02801396|5451001|P6|NOT COMPLETED|Period 1||0
2222518|NCT02801396|5451002|P5|NOT COMPLETED|Period 1||1
2222519|NCT02801396|5451003|P4|NOT COMPLETED|Period 1||0
2222520|NCT02801396|5451004|P3|NOT COMPLETED|Period 1||0
2222521|NCT02801396|5451005|P2|NOT COMPLETED|Period 1||0
2222522|NCT02801396|5451006|P1|NOT COMPLETED|Period 1||0
2222523|NCT02801396|5451001|P6|COMPLETED|Period 1||17
2222524|NCT02801396|5451002|P5|COMPLETED|Period 1||16
2222525|NCT02801396|5451003|P4|COMPLETED|Period 1||16
2222526|NCT02801396|5451004|P3|COMPLETED|Period 1||17
2222527|NCT02801396|5451005|P2|COMPLETED|Period 1||17
2222528|NCT02801396|5451006|P1|COMPLETED|Period 1||17
2222529|NCT02801396|5451001|P6|STARTED|Period 1||17
2222530|NCT02801396|5451002|P5|STARTED|Period 1||17
2222531|NCT02801396|5451003|P4|STARTED|Period 1||16
2222532|NCT02801396|5451004|P3|STARTED|Period 1||17
2222533|NCT02801396|5451005|P2|STARTED|Period 1||17
2222534|NCT02801396|5451006|P1|STARTED|Period 1||17
2222535|NCT02801006|5451023|P2|NOT COMPLETED|Lens 2||0
2222536|NCT02801006|5451024|P1|NOT COMPLETED|Lens 2||0
2222537|NCT02801006|5451023|P2|COMPLETED|Lens 2||19
2222538|NCT02801006|5451024|P1|COMPLETED|Lens 2||22
2222539|NCT02801006|5451023|P2|STARTED|Lens 2||19
2222540|NCT02801006|5451024|P1|STARTED|Lens 2||22
2222541|NCT02801006|5451023|P2|NOT COMPLETED|Lens 1||0
2222542|NCT02801006|5451024|P1|NOT COMPLETED|Lens 1||0
2222543|NCT02801006|5451023|P2|COMPLETED|Lens 1||19
2222544|NCT02801006|5451024|P1|COMPLETED|Lens 1||22
2222545|NCT02801006|5451023|P2|STARTED|Lens 1||19
2222546|NCT02801006|5451024|P1|STARTED|Lens 1||22
2222547|NCT02800928|5451040|P2|NOT COMPLETED|Overall Study||2
2222548|NCT02800928|5451041|P1|NOT COMPLETED|Overall Study||2
2222549|NCT02800928|5451040|P2|COMPLETED|Overall Study||6
2222550|NCT02800928|5451041|P1|COMPLETED|Overall Study||7
2222551|NCT02800928|5451040|P2|STARTED|Overall Study||8
2222552|NCT02800928|5451041|P1|STARTED|Overall Study||9
2222556|NCT02800213|5451060|P2|NOT COMPLETED|Second Intervention||0
2222557|NCT02800213|5451061|P1|NOT COMPLETED|Second Intervention||0
2222558|NCT02800213|5451060|P2|COMPLETED|Second Intervention||35
2222559|NCT02800213|5451061|P1|COMPLETED|Second Intervention||35
2222560|NCT02800213|5451060|P2|STARTED|Second Intervention||35
2222561|NCT02800213|5451061|P1|STARTED|Second Intervention||35
2222562|NCT02800213|5451060|P2|NOT COMPLETED|First Intervention||0
2222563|NCT02800213|5451061|P1|NOT COMPLETED|First Intervention||0
2222564|NCT02800213|5451060|P2|COMPLETED|First Intervention||35
2222565|NCT02800213|5451061|P1|COMPLETED|First Intervention||35
2222566|NCT02800213|5451060|P2|STARTED|First Intervention||35
2222567|NCT02800213|5451061|P1|STARTED|First Intervention||35
2222568|NCT02799784|5451067|P2|NOT COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||3
2222569|NCT02799784|5451068|P1|NOT COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||1
2222570|NCT02799784|5451067|P2|COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||115
2222571|NCT02799784|5451068|P1|COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||110
2222572|NCT02799784|5451067|P2|STARTED|Treatment Period 2 (TP2 - 8 Weeks)||118
2222573|NCT02799784|5451068|P1|STARTED|Treatment Period 2 (TP2 - 8 Weeks)||111
2222574|NCT02799784|5451067|P2|NOT COMPLETED|Washout Period (3 Weeks)||0
2222575|NCT02799784|5451068|P1|NOT COMPLETED|Washout Period (3 Weeks)||0
2222576|NCT02799784|5451067|P2|COMPLETED|Washout Period (3 Weeks)||118
2222577|NCT02799784|5451068|P1|COMPLETED|Washout Period (3 Weeks)||111
2222578|NCT02799784|5451067|P2|STARTED|Washout Period (3 Weeks)||118
2222579|NCT02799784|5451068|P1|STARTED|Washout Period (3 Weeks)||111
2222580|NCT02799784|5451067|P2|NOT COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||1
2222581|NCT02799784|5451068|P1|NOT COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||6
2222582|NCT02799784|5451067|P2|COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||118
2222583|NCT02799784|5451068|P1|COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||111
2222584|NCT02799784|5451067|P2|STARTED|Treatment Period 1 (TP1- 8 Weeks)||119
2222585|NCT02799784|5451068|P1|STARTED|Treatment Period 1 (TP1- 8 Weeks)||117
2222586|NCT02799472|5451076|P2|NOT COMPLETED|Overall Study||5
2222587|NCT02799472|5451077|P1|NOT COMPLETED|Overall Study||4
2222588|NCT02799472|5451076|P2|COMPLETED|Overall Study||23
2222589|NCT02799472|5451077|P1|COMPLETED|Overall Study||7
2222590|NCT02799472|5451076|P2|STARTED|Overall Study||28
2222591|NCT02799472|5451077|P1|STARTED|Overall Study||11
2222592|NCT02799082|5451137|P2|NOT COMPLETED|Overall Study||4
2222593|NCT02799082|5451138|P1|NOT COMPLETED|Overall Study||4
2222594|NCT02799082|5451137|P2|COMPLETED|Overall Study||77
2222595|NCT02799082|5451138|P1|COMPLETED|Overall Study||37
2222596|NCT02799082|5451137|P2|STARTED|Overall Study||81
2222597|NCT02799082|5451138|P1|STARTED|Overall Study||41
2222598|NCT02799069|5451175|P3|NOT COMPLETED|Overall Study||7
2222599|NCT02799069|5451176|P2|NOT COMPLETED|Overall Study||7
2222600|NCT02799069|5451177|P1|NOT COMPLETED|Overall Study||8
2222601|NCT02799069|5451175|P3|COMPLETED|Overall Study||240
2222602|NCT02799069|5451176|P2|COMPLETED|Overall Study||241
2222603|NCT02799069|5451177|P1|COMPLETED|Overall Study||68
2222604|NCT02799069|5451175|P3|ITT/Safety|Overall Study|1 subject received medication without Illumination and thus was excluded from ITT/safety population|246
2222605|NCT02799069|5451176|P2|ITT/Safety|Overall Study||248
2222606|NCT02799069|5451177|P1|ITT/Safety|Overall Study||76
2222607|NCT02799069|5451175|P3|STARTED|Overall Study||247
2222608|NCT02799069|5451176|P2|STARTED|Overall Study||248
2222609|NCT02799069|5451177|P1|STARTED|Overall Study||76
2222610|NCT02798978|5451294|P7|NOT COMPLETED|Part 2 (45 Days)||0
2222611|NCT02798978|5451295|P6|NOT COMPLETED|Part 2 (45 Days)||0
2222612|NCT02798978|5451296|P5|NOT COMPLETED|Part 2 (45 Days)||0
2222613|NCT02798978|5451297|P4|NOT COMPLETED|Part 2 (45 Days)||0
2222614|NCT02798978|5451298|P3|NOT COMPLETED|Part 2 (45 Days)||0
2222615|NCT02798978|5451299|P2|NOT COMPLETED|Part 2 (45 Days)||0
2222616|NCT02798978|5451300|P1|NOT COMPLETED|Part 2 (45 Days)||0
2222617|NCT02798978|5451294|P7|COMPLETED|Part 2 (45 Days)||0
2222618|NCT02798978|5451295|P6|COMPLETED|Part 2 (45 Days)||0
2222619|NCT02798978|5451296|P5|COMPLETED|Part 2 (45 Days)||0
2222620|NCT02798978|5451297|P4|COMPLETED|Part 2 (45 Days)||0
2222621|NCT02798978|5451298|P3|COMPLETED|Part 2 (45 Days)||0
2222622|NCT02798978|5451299|P2|COMPLETED|Part 2 (45 Days)||0
2222623|NCT02798978|5451300|P1|COMPLETED|Part 2 (45 Days)||0
2222624|NCT02798978|5451294|P7|STARTED|Part 2 (45 Days)||0
2222625|NCT02798978|5451295|P6|STARTED|Part 2 (45 Days)||0
2222626|NCT02798978|5451296|P5|STARTED|Part 2 (45 Days)||0
2222627|NCT02798978|5451297|P4|STARTED|Part 2 (45 Days)||0
2222628|NCT02798978|5451298|P3|STARTED|Part 2 (45 Days)||0
2222629|NCT02798978|5451299|P2|STARTED|Part 2 (45 Days)||0
2222630|NCT02798978|5451300|P1|STARTED|Part 2 (45 Days)||0
2222631|NCT02798978|5451294|P7|NOT COMPLETED|Part 1 (30 Days)||0
2222632|NCT02798978|5451295|P6|NOT COMPLETED|Part 1 (30 Days)||0
2222633|NCT02798978|5451296|P5|NOT COMPLETED|Part 1 (30 Days)||0
2222634|NCT02798978|5451297|P4|NOT COMPLETED|Part 1 (30 Days)||0
2222635|NCT02798978|5451298|P3|NOT COMPLETED|Part 1 (30 Days)||0
2222636|NCT02798978|5451299|P2|NOT COMPLETED|Part 1 (30 Days)||0
2222637|NCT02798978|5451300|P1|NOT COMPLETED|Part 1 (30 Days)||0
2222638|NCT02798978|5451294|P7|COMPLETED|Part 1 (30 Days)||0
2222639|NCT02798978|5451295|P6|COMPLETED|Part 1 (30 Days)||6
2222640|NCT02798978|5451296|P5|COMPLETED|Part 1 (30 Days)||6
2222641|NCT02798978|5451297|P4|COMPLETED|Part 1 (30 Days)||6
2222642|NCT02798978|5451298|P3|COMPLETED|Part 1 (30 Days)||6
2222643|NCT02798978|5451299|P2|COMPLETED|Part 1 (30 Days)||6
2222644|NCT02798978|5451300|P1|COMPLETED|Part 1 (30 Days)||10
2222645|NCT02798978|5451294|P7|STARTED|Part 1 (30 Days)||0
2222646|NCT02798978|5451295|P6|STARTED|Part 1 (30 Days)||6
2222647|NCT02798978|5451296|P5|STARTED|Part 1 (30 Days)||6
2222648|NCT02798978|5451297|P4|STARTED|Part 1 (30 Days)||6
2222649|NCT02798978|5451298|P3|STARTED|Part 1 (30 Days)||6
2222650|NCT02798978|5451299|P2|STARTED|Part 1 (30 Days)||6
2222651|NCT02798978|5451300|P1|STARTED|Part 1 (30 Days)||10
2222652|NCT02798952|5451503|P1|NOT COMPLETED|Overall Study||0
2222653|NCT02798952|5451503|P1|COMPLETED|Overall Study||302
2222654|NCT02798952|5451503|P1|STARTED|Overall Study||302
2222655|NCT02798380|5451515|P1|NOT COMPLETED|Overall Study||0
2222656|NCT02798380|5451515|P1|COMPLETED|Overall Study||30
2222657|NCT02798380|5451515|P1|STARTED|Overall Study||30
2222658|NCT02798354|5451522|P3|NOT COMPLETED|Third Intervention Period||0
2222659|NCT02798354|5451523|P2|NOT COMPLETED|Third Intervention Period||0
2222660|NCT02798354|5451524|P1|NOT COMPLETED|Third Intervention Period||0
2222661|NCT02798354|5451522|P3|COMPLETED|Third Intervention Period||2715
2222662|NCT02798354|5451523|P2|COMPLETED|Third Intervention Period||1010
2222663|NCT02798354|5451524|P1|COMPLETED|Third Intervention Period||746
2222664|NCT02798354|5451522|P3|Intervention Data Error 3|Third Intervention Period||1248
2222665|NCT02798354|5451523|P2|Intervention Data Error 3|Third Intervention Period||390
2222666|NCT02798354|5451524|P1|Intervention Data Error 3|Third Intervention Period||327
2222667|NCT02798354|5451522|P3|Control Data Error 3|Third Intervention Period||1467
2222668|NCT02798354|5451523|P2|Control Data Error 3|Third Intervention Period||620
2222669|NCT02798354|5451524|P1|Control Data Error 3|Third Intervention Period||419
2222670|NCT02798354|5451522|P3|STARTED|Third Intervention Period||2715
2222671|NCT02798354|5451523|P2|STARTED|Third Intervention Period||1010
2222672|NCT02798354|5451524|P1|STARTED|Third Intervention Period||746
2222673|NCT02798354|5451522|P3|NOT COMPLETED|Second Intervention Period||0
2222674|NCT02798354|5451523|P2|NOT COMPLETED|Second Intervention Period||0
2222675|NCT02798354|5451524|P1|NOT COMPLETED|Second Intervention Period||0
2222676|NCT02798354|5451522|P3|COMPLETED|Second Intervention Period||1368
2222677|NCT02798354|5451523|P2|COMPLETED|Second Intervention Period||1047
2222678|NCT02798354|5451524|P1|COMPLETED|Second Intervention Period||2617
2222679|NCT02798354|5451522|P3|Intervention Data Error 2|Second Intervention Period||700
2222680|NCT02798354|5451523|P2|Intervention Data Error 2|Second Intervention Period||454
2222681|NCT02798354|5451524|P1|Intervention Data Error 2|Second Intervention Period||1239
2222682|NCT02798354|5451522|P3|Control Data Error 2|Second Intervention Period||668
2222683|NCT02798354|5451523|P2|Control Data Error 2|Second Intervention Period||593
2222684|NCT02798354|5451524|P1|Control Data Error 2|Second Intervention Period||1378
2222685|NCT02798354|5451522|P3|STARTED|Second Intervention Period||1368
2222686|NCT02798354|5451523|P2|STARTED|Second Intervention Period||1047
2222687|NCT02798354|5451524|P1|STARTED|Second Intervention Period||2617
2222688|NCT02798354|5451522|P3|NOT COMPLETED|First Intervention Period||0
2222689|NCT02798354|5451523|P2|NOT COMPLETED|First Intervention Period||0
2222690|NCT02798354|5451524|P1|NOT COMPLETED|First Intervention Period||0
2222691|NCT02798354|5451522|P3|COMPLETED|First Intervention Period||990
2222692|NCT02798354|5451523|P2|COMPLETED|First Intervention Period||2176
2222693|NCT02798354|5451524|P1|COMPLETED|First Intervention Period||1184
2222694|NCT02798354|5451522|P3|Intervention Data Error 1|First Intervention Period||645
2222695|NCT02798354|5451523|P2|Intervention Data Error 1|First Intervention Period||1627
2222696|NCT02798354|5451524|P1|Intervention Data Error 1|First Intervention Period||744
2222697|NCT02798354|5451522|P3|Control Data Error 1|First Intervention Period||345
2222698|NCT02798354|5451523|P2|Control Data Error 1|First Intervention Period||549
2222699|NCT02798354|5451524|P1|Control Data Error 1|First Intervention Period||440
2222700|NCT02798354|5451522|P3|STARTED|First Intervention Period||990
2222701|NCT02798354|5451523|P2|STARTED|First Intervention Period||2176
2222702|NCT02798354|5451524|P1|STARTED|First Intervention Period||1184
2222703|NCT02798315|5451546|P1|NOT COMPLETED|Overall Study||1
2222704|NCT02798315|5451546|P1|COMPLETED|Overall Study||39
2222705|NCT02798315|5451546|P1|STARTED|Overall Study||40
2222706|NCT02798289|5451560|P1|NOT COMPLETED|Overall Study||0
2222707|NCT02798289|5451560|P1|COMPLETED|Overall Study||55
2222708|NCT02798289|5451560|P1|STARTED|Overall Study||55
2222709|NCT02797821|5451567|P3|NOT COMPLETED|Overall Study||0
2222710|NCT02797821|5451568|P2|NOT COMPLETED|Overall Study||0
2222711|NCT02797821|5451569|P1|NOT COMPLETED|Overall Study||0
2222712|NCT02797821|5451567|P3|COMPLETED|Overall Study||9
2222713|NCT02797821|5451568|P2|COMPLETED|Overall Study||10
2222714|NCT02797821|5451569|P1|COMPLETED|Overall Study||8
2222715|NCT02797821|5451567|P3|Received at Least 1 Dose of Study Drug|Overall Study||9
2222716|NCT02797821|5451568|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
2222717|NCT02797821|5451569|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
2222718|NCT02797821|5451567|P3|STARTED|Overall Study||9
2222719|NCT02797821|5451568|P2|STARTED|Overall Study||10
2222720|NCT02797821|5451569|P1|STARTED|Overall Study||8
2222721|NCT02797678|5451580|P4|NOT COMPLETED|Sub-Study||0
2222722|NCT02797678|5451581|P3|NOT COMPLETED|Sub-Study||0
2222723|NCT02797678|5451582|P2|NOT COMPLETED|Sub-Study||0
2222724|NCT02797678|5451583|P1|NOT COMPLETED|Sub-Study||0
2222725|NCT02797678|5451580|P4|COMPLETED|Sub-Study||9
2222726|NCT02797678|5451581|P3|COMPLETED|Sub-Study||0
2222727|NCT02797678|5451582|P2|COMPLETED|Sub-Study||0
2222728|NCT02797678|5451583|P1|COMPLETED|Sub-Study||0
2222729|NCT02797678|5451580|P4|STARTED|Sub-Study||9
2222730|NCT02797678|5451581|P3|STARTED|Sub-Study||0
2222731|NCT02797678|5451582|P2|STARTED|Sub-Study||0
2222732|NCT02797678|5451583|P1|STARTED|Sub-Study||0
2222733|NCT02797678|5451580|P4|NOT COMPLETED|Second Intervention (5 Nights)||0
2222734|NCT02797678|5451581|P3|NOT COMPLETED|Second Intervention (5 Nights)||1
2222735|NCT02797678|5451582|P2|NOT COMPLETED|Second Intervention (5 Nights)||0
2222736|NCT02797678|5451583|P1|NOT COMPLETED|Second Intervention (5 Nights)||0
2222737|NCT02797678|5451580|P4|COMPLETED|Second Intervention (5 Nights)||0
2222738|NCT02797678|5451581|P3|COMPLETED|Second Intervention (5 Nights)||16
2222739|NCT02797678|5451582|P2|COMPLETED|Second Intervention (5 Nights)||19
2222740|NCT02797678|5451583|P1|COMPLETED|Second Intervention (5 Nights)||0
2222741|NCT02797678|5451580|P4|STARTED|Second Intervention (5 Nights)||0
2222742|NCT02797678|5451581|P3|STARTED|Second Intervention (5 Nights)||17
2222743|NCT02797678|5451582|P2|STARTED|Second Intervention (5 Nights)||19
2222744|NCT02797678|5451583|P1|STARTED|Second Intervention (5 Nights)||0
2222745|NCT02797678|5451580|P4|NOT COMPLETED|Washout||0
2222746|NCT02797678|5451581|P3|NOT COMPLETED|Washout||0
2222747|NCT02797678|5451582|P2|NOT COMPLETED|Washout||0
2222748|NCT02797678|5451583|P1|NOT COMPLETED|Washout||0
2222749|NCT02797678|5451580|P4|COMPLETED|Washout||0
2222750|NCT02797678|5451581|P3|COMPLETED|Washout||17
2222751|NCT02797678|5451582|P2|COMPLETED|Washout||19
2222752|NCT02797678|5451583|P1|COMPLETED|Washout||0
2222753|NCT02797678|5451580|P4|STARTED|Washout||0
2222754|NCT02797678|5451581|P3|STARTED|Washout||17
2222755|NCT02797678|5451582|P2|STARTED|Washout||19
2222756|NCT02797678|5451583|P1|STARTED|Washout||0
2222757|NCT02797678|5451580|P4|NOT COMPLETED|First Intervention (5 Nights)||0
2222758|NCT02797678|5451581|P3|NOT COMPLETED|First Intervention (5 Nights)||0
2222759|NCT02797678|5451582|P2|NOT COMPLETED|First Intervention (5 Nights)||1
2222760|NCT02797678|5451583|P1|NOT COMPLETED|First Intervention (5 Nights)||0
2222761|NCT02797678|5451580|P4|COMPLETED|First Intervention (5 Nights)||0
2222762|NCT02797678|5451581|P3|COMPLETED|First Intervention (5 Nights)||17
2222763|NCT02797678|5451582|P2|COMPLETED|First Intervention (5 Nights)||19
2222764|NCT02797678|5451583|P1|COMPLETED|First Intervention (5 Nights)||0
2222765|NCT02797678|5451580|P4|STARTED|First Intervention (5 Nights)||0
2222766|NCT02797678|5451581|P3|STARTED|First Intervention (5 Nights)||17
2222767|NCT02797678|5451582|P2|STARTED|First Intervention (5 Nights)||20
2222768|NCT02797678|5451583|P1|STARTED|First Intervention (5 Nights)||0
2222769|NCT02797678|5451580|P4|NOT COMPLETED|Screening Phase||0
2222770|NCT02797678|5451581|P3|NOT COMPLETED|Screening Phase||0
2222771|NCT02797678|5451582|P2|NOT COMPLETED|Screening Phase||0
2222772|NCT02797678|5451583|P1|NOT COMPLETED|Screening Phase||25
2222773|NCT02797678|5451580|P4|COMPLETED|Screening Phase||0
2222774|NCT02797678|5451581|P3|COMPLETED|Screening Phase||0
2222775|NCT02797678|5451582|P2|COMPLETED|Screening Phase||0
2222776|NCT02797678|5451583|P1|COMPLETED|Screening Phase||37
2222777|NCT02797678|5451580|P4|STARTED|Screening Phase||0
2222778|NCT02797678|5451581|P3|STARTED|Screening Phase||0
2222779|NCT02797678|5451582|P2|STARTED|Screening Phase||0
2222780|NCT02797678|5451583|P1|STARTED|Screening Phase||62
2222781|NCT02797522|5451609|P11|NOT COMPLETED|Overall Study||1
2222782|NCT02797522|5451610|P10|NOT COMPLETED|Overall Study||4
2222783|NCT02797522|5451611|P9|NOT COMPLETED|Overall Study||2
2222784|NCT02797522|5451612|P8|NOT COMPLETED|Overall Study||4
2222785|NCT02797522|5451613|P7|NOT COMPLETED|Overall Study||0
2222786|NCT02797522|5451614|P6|NOT COMPLETED|Overall Study||0
2222787|NCT02797522|5451615|P5|NOT COMPLETED|Overall Study||0
2222788|NCT02797522|5451616|P4|NOT COMPLETED|Overall Study||0
2222789|NCT02797522|5451617|P3|NOT COMPLETED|Overall Study||0
2222790|NCT02797522|5451618|P2|NOT COMPLETED|Overall Study||0
2222791|NCT02797522|5451619|P1|NOT COMPLETED|Overall Study||0
2222792|NCT02797522|5451609|P11|COMPLETED|Overall Study||0
2222793|NCT02797522|5451610|P10|COMPLETED|Overall Study||0
2222794|NCT02797522|5451611|P9|COMPLETED|Overall Study||0
2222795|NCT02797522|5451612|P8|COMPLETED|Overall Study||0
2222796|NCT02797522|5451613|P7|COMPLETED|Overall Study||12
2222797|NCT02797522|5451614|P6|COMPLETED|Overall Study||4
2222798|NCT02797522|5451615|P5|COMPLETED|Overall Study||4
2222799|NCT02797522|5451616|P4|COMPLETED|Overall Study||4
2222800|NCT02797522|5451617|P3|COMPLETED|Overall Study||4
2222801|NCT02797522|5451618|P2|COMPLETED|Overall Study||4
2222802|NCT02797522|5451619|P1|COMPLETED|Overall Study||4
2222803|NCT02797522|5451609|P11|STARTED|Overall Study||1
2222804|NCT02797522|5451610|P10|STARTED|Overall Study||4
2222805|NCT02797522|5451611|P9|STARTED|Overall Study||2
2222806|NCT02797522|5451612|P8|STARTED|Overall Study||4
2222807|NCT02797522|5451613|P7|STARTED|Overall Study||12
2222808|NCT02797522|5451614|P6|STARTED|Overall Study||4
2222809|NCT02797522|5451615|P5|STARTED|Overall Study||4
2222810|NCT02797522|5451616|P4|STARTED|Overall Study||4
2222811|NCT02797522|5451617|P3|STARTED|Overall Study||4
2222812|NCT02797522|5451618|P2|STARTED|Overall Study||4
2222813|NCT02797522|5451619|P1|STARTED|Overall Study||4
2222814|NCT02797132|5451725|P1|NOT COMPLETED|Part B (24 Weeks)||3
2222815|NCT02797132|5451725|P1|COMPLETED|Part B (24 Weeks)||57
2222816|NCT02797132|5451725|P1|Part B (>=14 kg Weight)|Part B (24 Weeks)||41
2222817|NCT02797132|5451725|P1|Part B (<14 kg Weight)|Part B (24 Weeks)||19
2222818|NCT02797132|5451725|P1|STARTED|Part B (24 Weeks)|Participants from Part A may have participated in Part B.|60
2222819|NCT02797132|5451725|P1|NOT COMPLETED|Part A (15 Days)||1
2222820|NCT02797132|5451725|P1|COMPLETED|Part A (15 Days)||11
2222821|NCT02797132|5451725|P1|Part A (>=14 kg Weight)|Part A (15 Days)||8
2222822|NCT02797132|5451725|P1|Part A (<14 kg Weight)|Part A (15 Days)||4
2222823|NCT02797132|5451725|P1|STARTED|Part A (15 Days)||12
2222824|NCT02797080|5451777|P1|NOT COMPLETED|Overall Study||2
2222825|NCT02797080|5451777|P1|COMPLETED|Overall Study||36
2222826|NCT02797080|5451777|P1|STARTED|Overall Study||38
2222827|NCT02797054|5451784|P3|NOT COMPLETED|Follow-up||285
2222828|NCT02797054|5451785|P2|NOT COMPLETED|Follow-up||228
2222829|NCT02797054|5451786|P1|NOT COMPLETED|Follow-up||209
2222830|NCT02797054|5451784|P3|COMPLETED|Follow-up||150
2222831|NCT02797054|5451785|P2|COMPLETED|Follow-up||155
2222832|NCT02797054|5451786|P1|COMPLETED|Follow-up||178
2222833|NCT02797054|5451784|P3|STARTED|Follow-up||435
2222834|NCT02797054|5451785|P2|STARTED|Follow-up||383
2222835|NCT02797054|5451786|P1|STARTED|Follow-up||387
2222836|NCT02797054|5451784|P3|NOT COMPLETED|Post-test||348
2222837|NCT02797054|5451785|P2|NOT COMPLETED|Post-test||11
2222838|NCT02797054|5451786|P1|NOT COMPLETED|Post-test||7
2222839|NCT02797054|5451784|P3|COMPLETED|Post-test||87
2222840|NCT02797054|5451785|P2|COMPLETED|Post-test||372
2222841|NCT02797054|5451786|P1|COMPLETED|Post-test||380
2222842|NCT02797054|5451784|P3|STARTED|Post-test||435
2222843|NCT02797054|5451785|P2|STARTED|Post-test||383
2222844|NCT02797054|5451786|P1|STARTED|Post-test||387
2222845|NCT02796963|5451819|P4|NOT COMPLETED|Overall Study||72
2222846|NCT02796963|5451820|P3|NOT COMPLETED|Overall Study||69
2222847|NCT02796963|5451821|P2|NOT COMPLETED|Overall Study||76
2222848|NCT02796963|5451822|P1|NOT COMPLETED|Overall Study||89
2222849|NCT02796963|5451819|P4|COMPLETED|Overall Study||282
2222850|NCT02796963|5451820|P3|COMPLETED|Overall Study||247
2222851|NCT02796963|5451821|P2|COMPLETED|Overall Study||252
2222852|NCT02796963|5451822|P1|COMPLETED|Overall Study||294
2222853|NCT02796963|5451819|P4|HIV Sero Converted|Overall Study||19
2222854|NCT02796963|5451820|P3|HIV Sero Converted|Overall Study||11
2222855|NCT02796963|5451821|P2|HIV Sero Converted|Overall Study||19
2222856|NCT02796963|5451822|P1|HIV Sero Converted|Overall Study||19
2222857|NCT02796963|5451819|P4|Fourth Follow up|Overall Study||263
2222858|NCT02796963|5451820|P3|Fourth Follow up|Overall Study||236
2222859|NCT02796963|5451821|P2|Fourth Follow up|Overall Study||233
2222860|NCT02796963|5451822|P1|Fourth Follow up|Overall Study||275
2222861|NCT02796963|5451819|P4|Third Follow up|Overall Study||286
2222862|NCT02796963|5451820|P3|Third Follow up|Overall Study||245
2222863|NCT02796963|5451821|P2|Third Follow up|Overall Study||237
2222864|NCT02796963|5451822|P1|Third Follow up|Overall Study||276
2222865|NCT02796963|5451819|P4|Second Follow up|Overall Study||293
2222866|NCT02796963|5451820|P3|Second Follow up|Overall Study||255
2222867|NCT02796963|5451821|P2|Second Follow up|Overall Study||260
2222868|NCT02796963|5451822|P1|Second Follow up|Overall Study||280
2222869|NCT02796963|5451819|P4|First Follow up|Overall Study||291
2222870|NCT02796963|5451820|P3|First Follow up|Overall Study||257
2222871|NCT02796963|5451821|P2|First Follow up|Overall Study||279
2222872|NCT02796963|5451822|P1|First Follow up|Overall Study||293
2222873|NCT02796963|5451819|P4|STARTED|Overall Study||354
2222874|NCT02796963|5451820|P3|STARTED|Overall Study||316
2222875|NCT02796963|5451821|P2|STARTED|Overall Study||328
2222876|NCT02796963|5451822|P1|STARTED|Overall Study||383
2222877|NCT02796677|5451888|P4|NOT COMPLETED|Overall Study||74
2222878|NCT02796677|5451889|P3|NOT COMPLETED|Overall Study||53
2222879|NCT02796677|5451890|P2|NOT COMPLETED|Overall Study||73
2222880|NCT02796677|5451891|P1|NOT COMPLETED|Overall Study||38
2222881|NCT02796677|5451888|P4|COMPLETED|Overall Study||405
2222882|NCT02796677|5451889|P3|COMPLETED|Overall Study||267
2222883|NCT02796677|5451890|P2|COMPLETED|Overall Study||405
2222884|NCT02796677|5451891|P1|COMPLETED|Overall Study||279
2222885|NCT02796677|5451888|P4|Completed Treatment and Follow-up|Overall Study||403
2222886|NCT02796677|5451889|P3|Completed Treatment and Follow-up|Overall Study||267
2222887|NCT02796677|5451890|P2|Completed Treatment and Follow-up|Overall Study||405
2222888|NCT02796677|5451891|P1|Completed Treatment and Follow-up|Overall Study||279
2222889|NCT02796677|5451888|P4|STARTED|Overall Study||479
2222890|NCT02796677|5451889|P3|STARTED|Overall Study||320
2222891|NCT02796677|5451890|P2|STARTED|Overall Study||478
2222892|NCT02796677|5451891|P1|STARTED|Overall Study||317
2222893|NCT02796651|5451915|P1|NOT COMPLETED|Overall Study||26
2222894|NCT02796651|5451915|P1|COMPLETED|Overall Study||106
2222895|NCT02796651|5451915|P1|Placebo (Lactose Monohydrate)|Overall Study||38
2222896|NCT02796651|5451915|P1|Perforomist 40 μg|Overall Study||108
2222897|NCT02796651|5451915|P1|Perforomist 20 μg|Overall Study||118
2222898|NCT02796651|5451915|P1|Formoterol Fumarate (FF) 24 μg|Overall Study||105
2222899|NCT02796651|5451915|P1|Formoterol Fumarate (FF) 12 μg|Overall Study||121
2222900|NCT02796651|5451915|P1|Formoterol Fumarate (FF) 6 μg|Overall Study||107
2222901|NCT02796651|5451915|P1|STARTED|Overall Study||132
2222902|NCT02796352|5451944|P1|NOT COMPLETED|Overall Study||0
2222903|NCT02796352|5451944|P1|COMPLETED|Overall Study||1
2222904|NCT02796352|5451944|P1|STARTED|Overall Study||1
2222905|NCT02796274|5451951|P1|NOT COMPLETED|Overall Study||0
2222906|NCT02796274|5451951|P1|COMPLETED|Overall Study||219
2222907|NCT02796274|5451951|P1|STARTED|Overall Study||219
2222908|NCT02796092|5451957|P2|NOT COMPLETED|Overall Study||0
2222909|NCT02796092|5451958|P1|NOT COMPLETED|Overall Study||0
2222910|NCT02796092|5451957|P2|COMPLETED|Overall Study||50
2222911|NCT02796092|5451958|P1|COMPLETED|Overall Study||50
2222912|NCT02796092|5451957|P2|STARTED|Overall Study||50
2222913|NCT02796092|5451958|P1|STARTED|Overall Study||50
2222914|NCT02795832|5451996|P6|NOT COMPLETED|Overall Study||3
2222915|NCT02795832|5451997|P5|NOT COMPLETED|Overall Study||0
2222916|NCT02795832|5451998|P4|NOT COMPLETED|Overall Study||0
2222917|NCT02795832|5451999|P3|NOT COMPLETED|Overall Study||0
2222918|NCT02795832|5452000|P2|NOT COMPLETED|Overall Study||0
2222919|NCT02795832|5452001|P1|NOT COMPLETED|Overall Study||0
2222920|NCT02795832|5451996|P6|COMPLETED|Overall Study||7
2222921|NCT02795832|5451997|P5|COMPLETED|Overall Study||20
2222922|NCT02795832|5451998|P4|COMPLETED|Overall Study||3
2222923|NCT02795832|5451999|P3|COMPLETED|Overall Study||8
2222924|NCT02795832|5452000|P2|COMPLETED|Overall Study||4
2222925|NCT02795832|5452001|P1|COMPLETED|Overall Study||8
2222926|NCT02795832|5451996|P6|STARTED|Overall Study||10
2222927|NCT02795832|5451997|P5|STARTED|Overall Study||20
2222928|NCT02795832|5451998|P4|STARTED|Overall Study||3
2222929|NCT02795832|5451999|P3|STARTED|Overall Study||8
2222930|NCT02795832|5452000|P2|STARTED|Overall Study||4
2222931|NCT02795832|5452001|P1|STARTED|Overall Study||8
2222932|NCT02795819|5452035|P7|NOT COMPLETED|Overall Study||0
2222933|NCT02795819|5452036|P6|NOT COMPLETED|Overall Study||0
2222934|NCT02795819|5452037|P5|NOT COMPLETED|Overall Study||0
2222935|NCT02795819|5452038|P4|NOT COMPLETED|Overall Study||0
2222936|NCT02795819|5452039|P3|NOT COMPLETED|Overall Study||0
2222937|NCT02795819|5452040|P2|NOT COMPLETED|Overall Study||0
2222938|NCT02795819|5452041|P1|NOT COMPLETED|Overall Study||0
2222939|NCT02795819|5452035|P7|COMPLETED|Overall Study||0
2222940|NCT02795819|5452036|P6|COMPLETED|Overall Study||0
2222941|NCT02795819|5452037|P5|COMPLETED|Overall Study||0
2222942|NCT02795819|5452038|P4|COMPLETED|Overall Study||0
2222943|NCT02795819|5452039|P3|COMPLETED|Overall Study||0
2222944|NCT02795819|5452040|P2|COMPLETED|Overall Study||6
2222945|NCT02795819|5452041|P1|COMPLETED|Overall Study||0
2222946|NCT02795819|5452035|P7|STARTED|Overall Study||0
2222947|NCT02795819|5452036|P6|STARTED|Overall Study||0
2222948|NCT02795819|5452037|P5|STARTED|Overall Study||0
2222949|NCT02795819|5452038|P4|STARTED|Overall Study||0
2222950|NCT02795819|5452039|P3|STARTED|Overall Study||0
2222951|NCT02795819|5452040|P2|STARTED|Overall Study||6
2222952|NCT02795819|5452041|P1|STARTED|Overall Study||0
2222953|NCT02795767|5452068|P3|NOT COMPLETED|Overall Study||10
2222954|NCT02795767|5452069|P2|NOT COMPLETED|Overall Study||10
2222955|NCT02795767|5452070|P1|NOT COMPLETED|Overall Study||68
2222956|NCT02795767|5452068|P3|COMPLETED|Overall Study||0
2222957|NCT02795767|5452069|P2|COMPLETED|Overall Study||0
2222958|NCT02795767|5452070|P1|COMPLETED|Overall Study||0
2222959|NCT02795767|5452068|P3|Discontinued From Study Treatment|Overall Study||1
2222960|NCT02795767|5452069|P2|Discontinued From Study Treatment|Overall Study||0
2222961|NCT02795767|5452070|P1|Discontinued From Study Treatment|Overall Study||2
2222962|NCT02795767|5452068|P3|Completed 52 Weeks in Study|Overall Study||0
2222963|NCT02795767|5452069|P2|Completed 52 Weeks in Study|Overall Study||0
2222964|NCT02795767|5452070|P1|Completed 52 Weeks in Study|Overall Study||59
2222965|NCT02795767|5452068|P3|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2
2222966|NCT02795767|5452069|P2|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
2222967|NCT02795767|5452070|P1|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
2222968|NCT02795767|5452068|P3|STARTED|Overall Study||10
2222969|NCT02795767|5452069|P2|STARTED|Overall Study||10
2222970|NCT02795767|5452070|P1|STARTED|Overall Study||68
2222971|NCT02794974|5452191|P2|NOT COMPLETED|Overall Study||1
2222972|NCT02794974|5452192|P1|NOT COMPLETED|Overall Study||0
2222973|NCT02794974|5452191|P2|COMPLETED|Overall Study||14
2222974|NCT02794974|5452192|P1|COMPLETED|Overall Study||14
2222975|NCT02794974|5452191|P2|STARTED|Overall Study||15
2222976|NCT02794974|5452192|P1|STARTED|Overall Study||14
2222977|NCT02794870|5452208|P2|NOT COMPLETED|Overall Study||0
2222978|NCT02794870|5452209|P1|NOT COMPLETED|Overall Study||2
2222979|NCT02794870|5452208|P2|COMPLETED|Overall Study||11
2222980|NCT02794870|5452209|P1|COMPLETED|Overall Study||20
2222981|NCT02794870|5452208|P2|Received Inoculation|Overall Study||11
2222982|NCT02794870|5452209|P1|Received Inoculation|Overall Study||21
2222983|NCT02794870|5452208|P2|STARTED|Overall Study||11
2222984|NCT02794870|5452209|P1|STARTED|Overall Study||22
2222985|NCT02794844|5452235|P1|NOT COMPLETED|Overall Study||5
2222986|NCT02794844|5452235|P1|COMPLETED|Overall Study||23
2222987|NCT02794844|5452235|P1|STARTED|Overall Study||28
2222988|NCT02794480|5452245|P4|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1
2222989|NCT02794480|5452246|P3|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0
2222990|NCT02794480|5452247|P2|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0
2222991|NCT02794480|5452248|P1|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1
2222992|NCT02794480|5452245|P4|COMPLETED|Period 2: Treatment Period 2 (28 Days)||77
2222993|NCT02794480|5452246|P3|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79
2222994|NCT02794480|5452247|P2|COMPLETED|Period 2: Treatment Period 2 (28 Days)||80
2222995|NCT02794480|5452248|P1|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79
2222996|NCT02794480|5452245|P4|STARTED|Period 2: Treatment Period 2 (28 Days)||78
2222997|NCT02794480|5452246|P3|STARTED|Period 2: Treatment Period 2 (28 Days)||79
2222998|NCT02794480|5452247|P2|STARTED|Period 2: Treatment Period 2 (28 Days)||80
2222999|NCT02794480|5452248|P1|STARTED|Period 2: Treatment Period 2 (28 Days)||80
2223000|NCT02794480|5452245|P4|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||3
2223001|NCT02794480|5452246|P3|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2
2223002|NCT02794480|5452247|P2|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2
2223003|NCT02794480|5452248|P1|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||0
2223004|NCT02794480|5452245|P4|COMPLETED|Period 1: Treatment Period 1 (28 Days)||78
2223005|NCT02794480|5452246|P3|COMPLETED|Period 1: Treatment Period 1 (28 Days)||79
2223006|NCT02794480|5452247|P2|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80
2223007|NCT02794480|5452248|P1|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80
2223008|NCT02794480|5452245|P4|STARTED|Period 1: Treatment Period 1 (28 Days)||81
2223009|NCT02794480|5452246|P3|STARTED|Period 1: Treatment Period 1 (28 Days)||81
2223010|NCT02794480|5452247|P2|STARTED|Period 1: Treatment Period 1 (28 Days)||82
2223011|NCT02794480|5452248|P1|STARTED|Period 1: Treatment Period 1 (28 Days)||80
2223012|NCT02794441|5452268|P2|NOT COMPLETED|Overall Study||0
2223013|NCT02794441|5452269|P1|NOT COMPLETED|Overall Study||1
2223014|NCT02794441|5452268|P2|COMPLETED|Overall Study||5
2223015|NCT02794441|5452269|P1|COMPLETED|Overall Study||6
2223016|NCT02794441|5452268|P2|STARTED|Overall Study||5
2223017|NCT02794441|5452269|P1|STARTED|Overall Study||7
2223018|NCT02794207|5452293|P2|NOT COMPLETED|Overall Study||0
2223019|NCT02794207|5452294|P1|NOT COMPLETED|Overall Study||0
2223020|NCT02794207|5452293|P2|COMPLETED|Overall Study||54
2223021|NCT02794207|5452294|P1|COMPLETED|Overall Study||32
2223022|NCT02794207|5452293|P2|STARTED|Overall Study||54
2223023|NCT02794207|5452294|P1|STARTED|Overall Study||32
2223024|NCT02794103|5452299|P1|NOT COMPLETED|Overall Study||3
2223025|NCT02794103|5452299|P1|COMPLETED|Overall Study||15
2223026|NCT02794103|5452299|P1|STARTED|Overall Study||18
2223027|NCT02793947|5452310|P2|NOT COMPLETED|Overall Study||5
2223028|NCT02793947|5452311|P1|NOT COMPLETED|Overall Study||2
2223029|NCT02793947|5452310|P2|COMPLETED|Overall Study||50
2223030|NCT02793947|5452311|P1|COMPLETED|Overall Study||45
2223031|NCT02793947|5452310|P2|STARTED|Overall Study||55
2223032|NCT02793947|5452311|P1|STARTED|Overall Study||47
2223033|NCT02793817|5452323|P2|NOT COMPLETED|Overall Study||5
2223034|NCT02793817|5452324|P1|NOT COMPLETED|Overall Study||3
2223035|NCT02793817|5452323|P2|COMPLETED|Overall Study||254
2223036|NCT02793817|5452324|P1|COMPLETED|Overall Study||258
2223037|NCT02793817|5452323|P2|STARTED|Overall Study||259
2223038|NCT02793817|5452324|P1|STARTED|Overall Study||261
2223039|NCT02793674|5452344|P2|NOT COMPLETED|Overall Study||0
2223040|NCT02793674|5452345|P1|NOT COMPLETED|Overall Study||0
2223041|NCT02793674|5452344|P2|COMPLETED|Overall Study||12
2223042|NCT02793674|5452345|P1|COMPLETED|Overall Study||9
2223043|NCT02793674|5452344|P2|STARTED|Overall Study||12
2223044|NCT02793674|5452345|P1|STARTED|Overall Study||9
2223045|NCT02793232|5452366|P9|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
2223046|NCT02793232|5452367|P8|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
2223047|NCT02793232|5452368|P7|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
2223048|NCT02793232|5452369|P6|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
2223049|NCT02793232|5452370|P5|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
2223050|NCT02793232|5452371|P4|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
2223051|NCT02793232|5452372|P3|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
2223052|NCT02793232|5452373|P2|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
2223053|NCT02793232|5452374|P1|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
2223054|NCT02793232|5452366|P9|COMPLETED|Period 4 (Part A: 5 Days)||0
2223055|NCT02793232|5452367|P8|COMPLETED|Period 4 (Part A: 5 Days)||0
2223056|NCT02793232|5452368|P7|COMPLETED|Period 4 (Part A: 5 Days)||0
2223057|NCT02793232|5452369|P6|COMPLETED|Period 4 (Part A: 5 Days)||0
2223058|NCT02793232|5452370|P5|COMPLETED|Period 4 (Part A: 5 Days)||0
2223059|NCT02793232|5452371|P4|COMPLETED|Period 4 (Part A: 5 Days)||2
2223060|NCT02793232|5452372|P3|COMPLETED|Period 4 (Part A: 5 Days)||2
2223061|NCT02793232|5452373|P2|COMPLETED|Period 4 (Part A: 5 Days)||2
2223062|NCT02793232|5452374|P1|COMPLETED|Period 4 (Part A: 5 Days)||2
2223063|NCT02793232|5452366|P9|STARTED|Period 4 (Part A: 5 Days)||0
2223064|NCT02793232|5452367|P8|STARTED|Period 4 (Part A: 5 Days)||0
2223065|NCT02793232|5452368|P7|STARTED|Period 4 (Part A: 5 Days)||0
2223066|NCT02793232|5452369|P6|STARTED|Period 4 (Part A: 5 Days)||0
2223067|NCT02793232|5452370|P5|STARTED|Period 4 (Part A: 5 Days)||0
2223068|NCT02793232|5452371|P4|STARTED|Period 4 (Part A: 5 Days)||2
2223069|NCT02793232|5452372|P3|STARTED|Period 4 (Part A: 5 Days)||2
2223070|NCT02793232|5452373|P2|STARTED|Period 4 (Part A: 5 Days)||2
2223071|NCT02793232|5452374|P1|STARTED|Period 4 (Part A: 5 Days)||2
2223072|NCT02793232|5452366|P9|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
2223073|NCT02793232|5452367|P8|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
2223074|NCT02793232|5452368|P7|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
2223075|NCT02793232|5452369|P6|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
2223076|NCT02793232|5452370|P5|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
2223077|NCT02793232|5452371|P4|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
2223078|NCT02793232|5452372|P3|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
2223079|NCT02793232|5452373|P2|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
2223080|NCT02793232|5452374|P1|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
2223081|NCT02793232|5452366|P9|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
2223082|NCT02793232|5452367|P8|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
2223083|NCT02793232|5452368|P7|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
2223084|NCT02793232|5452369|P6|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
2223085|NCT02793232|5452370|P5|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
2223086|NCT02793232|5452371|P4|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
2223087|NCT02793232|5452372|P3|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
2223088|NCT02793232|5452373|P2|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
2223089|NCT02793232|5452374|P1|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
2223090|NCT02793232|5452366|P9|STARTED|Washout Period 3(Part A:at Least 10days)||0
2223091|NCT02793232|5452367|P8|STARTED|Washout Period 3(Part A:at Least 10days)||0
2223092|NCT02793232|5452368|P7|STARTED|Washout Period 3(Part A:at Least 10days)||0
2223093|NCT02793232|5452369|P6|STARTED|Washout Period 3(Part A:at Least 10days)||0
2223094|NCT02793232|5452370|P5|STARTED|Washout Period 3(Part A:at Least 10days)||0
2223095|NCT02793232|5452371|P4|STARTED|Washout Period 3(Part A:at Least 10days)||2
2223096|NCT02793232|5452372|P3|STARTED|Washout Period 3(Part A:at Least 10days)||2
2223097|NCT02793232|5452373|P2|STARTED|Washout Period 3(Part A:at Least 10days)||2
2223098|NCT02793232|5452374|P1|STARTED|Washout Period 3(Part A:at Least 10days)||2
2223099|NCT02793232|5452366|P9|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
2223100|NCT02793232|5452367|P8|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
2223101|NCT02793232|5452368|P7|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
2223102|NCT02793232|5452369|P6|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
2223103|NCT02793232|5452370|P5|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
2223104|NCT02793232|5452371|P4|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
2223105|NCT02793232|5452372|P3|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
2223106|NCT02793232|5452373|P2|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
2223107|NCT02793232|5452374|P1|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
2223108|NCT02793232|5452366|P9|COMPLETED|Period 3 (Part A: 5 Days)||0
2223109|NCT02793232|5452367|P8|COMPLETED|Period 3 (Part A: 5 Days)||0
2223110|NCT02793232|5452368|P7|COMPLETED|Period 3 (Part A: 5 Days)||0
2223111|NCT02793232|5452369|P6|COMPLETED|Period 3 (Part A: 5 Days)||0
2223112|NCT02793232|5452370|P5|COMPLETED|Period 3 (Part A: 5 Days)||0
2223113|NCT02793232|5452371|P4|COMPLETED|Period 3 (Part A: 5 Days)||2
2223114|NCT02793232|5452372|P3|COMPLETED|Period 3 (Part A: 5 Days)||2
2223115|NCT02793232|5452373|P2|COMPLETED|Period 3 (Part A: 5 Days)||2
2223116|NCT02793232|5452374|P1|COMPLETED|Period 3 (Part A: 5 Days)||2
2223117|NCT02793232|5452366|P9|STARTED|Period 3 (Part A: 5 Days)||0
2223118|NCT02793232|5452367|P8|STARTED|Period 3 (Part A: 5 Days)||0
2223119|NCT02793232|5452368|P7|STARTED|Period 3 (Part A: 5 Days)||0
2223120|NCT02793232|5452369|P6|STARTED|Period 3 (Part A: 5 Days)||0
2223121|NCT02793232|5452370|P5|STARTED|Period 3 (Part A: 5 Days)||0
2223122|NCT02793232|5452371|P4|STARTED|Period 3 (Part A: 5 Days)||2
2223123|NCT02793232|5452372|P3|STARTED|Period 3 (Part A: 5 Days)||2
2223124|NCT02793232|5452373|P2|STARTED|Period 3 (Part A: 5 Days)||2
2223125|NCT02793232|5452374|P1|STARTED|Period 3 (Part A: 5 Days)||2
2223126|NCT02793232|5452366|P9|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
2223127|NCT02793232|5452367|P8|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
2223128|NCT02793232|5452368|P7|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
2223129|NCT02793232|5452369|P6|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
2223130|NCT02793232|5452370|P5|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
2223131|NCT02793232|5452371|P4|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
2223132|NCT02793232|5452372|P3|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
2223133|NCT02793232|5452373|P2|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
2223134|NCT02793232|5452374|P1|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
2223135|NCT02793232|5452366|P9|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
2223136|NCT02793232|5452367|P8|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
2223137|NCT02793232|5452368|P7|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
2223138|NCT02793232|5452369|P6|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
2223139|NCT02793232|5452370|P5|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
2223140|NCT02793232|5452371|P4|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
2223141|NCT02793232|5452372|P3|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
2223142|NCT02793232|5452373|P2|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
2223143|NCT02793232|5452374|P1|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
2223144|NCT02793232|5452366|P9|STARTED|Washout Period 2(Part A:at Least 10days)||0
2223145|NCT02793232|5452367|P8|STARTED|Washout Period 2(Part A:at Least 10days)||0
2223146|NCT02793232|5452368|P7|STARTED|Washout Period 2(Part A:at Least 10days)||0
2223147|NCT02793232|5452369|P6|STARTED|Washout Period 2(Part A:at Least 10days)||0
2223148|NCT02793232|5452370|P5|STARTED|Washout Period 2(Part A:at Least 10days)||0
2223149|NCT02793232|5452371|P4|STARTED|Washout Period 2(Part A:at Least 10days)||2
2223150|NCT02793232|5452372|P3|STARTED|Washout Period 2(Part A:at Least 10days)||2
2223151|NCT02793232|5452373|P2|STARTED|Washout Period 2(Part A:at Least 10days)||2
2223152|NCT02793232|5452374|P1|STARTED|Washout Period 2(Part A:at Least 10days)||2
2223153|NCT02793232|5452366|P9|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
2223154|NCT02793232|5452367|P8|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
2223155|NCT02793232|5452368|P7|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
2223156|NCT02793232|5452369|P6|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
2223157|NCT02793232|5452370|P5|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
2223158|NCT02793232|5452371|P4|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
2223159|NCT02793232|5452372|P3|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
2223160|NCT02793232|5452373|P2|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
2223161|NCT02793232|5452374|P1|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
2223162|NCT02793232|5452366|P9|COMPLETED|Period 2 (Part A: 5 Days)||0
2223163|NCT02793232|5452367|P8|COMPLETED|Period 2 (Part A: 5 Days)||0
2223164|NCT02793232|5452368|P7|COMPLETED|Period 2 (Part A: 5 Days)||0
2223165|NCT02793232|5452369|P6|COMPLETED|Period 2 (Part A: 5 Days)||0
2223166|NCT02793232|5452370|P5|COMPLETED|Period 2 (Part A: 5 Days)||0
2223167|NCT02793232|5452371|P4|COMPLETED|Period 2 (Part A: 5 Days)||2
2223168|NCT02793232|5452372|P3|COMPLETED|Period 2 (Part A: 5 Days)||2
2223169|NCT02793232|5452373|P2|COMPLETED|Period 2 (Part A: 5 Days)||2
2223170|NCT02793232|5452374|P1|COMPLETED|Period 2 (Part A: 5 Days)||2
2223171|NCT02793232|5452366|P9|STARTED|Period 2 (Part A: 5 Days)||0
2223172|NCT02793232|5452367|P8|STARTED|Period 2 (Part A: 5 Days)||0
2223173|NCT02793232|5452368|P7|STARTED|Period 2 (Part A: 5 Days)||0
2223174|NCT02793232|5452369|P6|STARTED|Period 2 (Part A: 5 Days)||0
2223175|NCT02793232|5452370|P5|STARTED|Period 2 (Part A: 5 Days)||0
2223176|NCT02793232|5452371|P4|STARTED|Period 2 (Part A: 5 Days)||2
2223177|NCT02793232|5452372|P3|STARTED|Period 2 (Part A: 5 Days)||2
2223178|NCT02793232|5452373|P2|STARTED|Period 2 (Part A: 5 Days)||2
2223179|NCT02793232|5452374|P1|STARTED|Period 2 (Part A: 5 Days)||2
2223180|NCT02793232|5452366|P9|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
2223181|NCT02793232|5452367|P8|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
2223182|NCT02793232|5452368|P7|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
2223183|NCT02793232|5452369|P6|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
2223184|NCT02793232|5452370|P5|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
2223185|NCT02793232|5452371|P4|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
2223186|NCT02793232|5452372|P3|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
2223187|NCT02793232|5452373|P2|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
2223188|NCT02793232|5452374|P1|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
2223189|NCT02793232|5452366|P9|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
2223190|NCT02793232|5452367|P8|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
2223191|NCT02793232|5452368|P7|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
2223192|NCT02793232|5452369|P6|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
2223193|NCT02793232|5452370|P5|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
2223194|NCT02793232|5452371|P4|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
2223195|NCT02793232|5452372|P3|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
2223196|NCT02793232|5452373|P2|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
2223197|NCT02793232|5452374|P1|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
2223198|NCT02793232|5452366|P9|STARTED|Washout Period 1(Part A:at Least 10days)||0
2223199|NCT02793232|5452367|P8|STARTED|Washout Period 1(Part A:at Least 10days)||0
2223200|NCT02793232|5452368|P7|STARTED|Washout Period 1(Part A:at Least 10days)||0
2223201|NCT02793232|5452369|P6|STARTED|Washout Period 1(Part A:at Least 10days)||0
2223202|NCT02793232|5452370|P5|STARTED|Washout Period 1(Part A:at Least 10days)||0
2223203|NCT02793232|5452371|P4|STARTED|Washout Period 1(Part A:at Least 10days)||2
2223204|NCT02793232|5452372|P3|STARTED|Washout Period 1(Part A:at Least 10days)||2
2223205|NCT02793232|5452373|P2|STARTED|Washout Period 1(Part A:at Least 10days)||2
2223206|NCT02793232|5452374|P1|STARTED|Washout Period 1(Part A:at Least 10days)||2
2223207|NCT02793232|5452366|P9|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
2223208|NCT02793232|5452367|P8|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
2223209|NCT02793232|5452368|P7|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||1
2223210|NCT02793232|5452369|P6|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
2223211|NCT02793232|5452370|P5|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||1
2223212|NCT02793232|5452371|P4|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
2223213|NCT02793232|5452372|P3|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
2223214|NCT02793232|5452373|P2|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
2223215|NCT02793232|5452374|P1|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
2223216|NCT02793232|5452366|P9|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||8
2223217|NCT02793232|5452367|P8|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
2223218|NCT02793232|5452368|P7|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||8
2223219|NCT02793232|5452369|P6|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||12
2223220|NCT02793232|5452370|P5|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||6
2223221|NCT02793232|5452371|P4|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
2223222|NCT02793232|5452372|P3|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
2223223|NCT02793232|5452373|P2|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
2223224|NCT02793232|5452374|P1|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
2223225|NCT02793232|5452366|P9|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||8
2223226|NCT02793232|5452367|P8|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
2223227|NCT02793232|5452368|P7|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||9
2223228|NCT02793232|5452369|P6|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||12
2223229|NCT02793232|5452370|P5|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||7
2223230|NCT02793232|5452371|P4|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
2223231|NCT02793232|5452372|P3|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
2223232|NCT02793232|5452373|P2|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
2223233|NCT02793232|5452374|P1|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
2223234|NCT02793154|5452559|P3|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
2223235|NCT02793154|5452560|P2|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
2223236|NCT02793154|5452561|P1|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
2223237|NCT02793154|5452559|P3|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
2223238|NCT02793154|5452560|P2|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
2223239|NCT02793154|5452561|P1|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
2223240|NCT02793154|5452559|P3|STARTED|Part B (Parallel Group-up to 84 Days)||0
2223241|NCT02793154|5452560|P2|STARTED|Part B (Parallel Group-up to 84 Days)||0
2223242|NCT02793154|5452561|P1|STARTED|Part B (Parallel Group-up to 84 Days)||0
2223243|NCT02793154|5452559|P3|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
2223244|NCT02793154|5452560|P2|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
2223245|NCT02793154|5452561|P1|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
2223246|NCT02793154|5452559|P3|COMPLETED|Part A (Single Group-up to 12 Days)||0
2223247|NCT02793154|5452560|P2|COMPLETED|Part A (Single Group-up to 12 Days)||0
2223248|NCT02793154|5452561|P1|COMPLETED|Part A (Single Group-up to 12 Days)||4
2223249|NCT02793154|5452559|P3|STARTED|Part A (Single Group-up to 12 Days)||0
2223250|NCT02793154|5452560|P2|STARTED|Part A (Single Group-up to 12 Days)||0
2223251|NCT02793154|5452561|P1|STARTED|Part A (Single Group-up to 12 Days)||4
2223252|NCT02792829|5452635|P8|NOT COMPLETED|Treatment Period 2||2
2223253|NCT02792829|5452636|P7|NOT COMPLETED|Treatment Period 2||1
2223254|NCT02792829|5452637|P6|NOT COMPLETED|Treatment Period 2||0
2223255|NCT02792829|5452638|P5|NOT COMPLETED|Treatment Period 2||1
2223256|NCT02792829|5452639|P4|NOT COMPLETED|Treatment Period 2||0
2223257|NCT02792829|5452640|P3|NOT COMPLETED|Treatment Period 2||0
2223258|NCT02792829|5452641|P2|NOT COMPLETED|Treatment Period 2||1
2223259|NCT02792829|5452642|P1|NOT COMPLETED|Treatment Period 2||0
2223260|NCT02792829|5452635|P8|COMPLETED|Treatment Period 2||8
2223261|NCT02792829|5452636|P7|COMPLETED|Treatment Period 2||9
2223262|NCT02792829|5452637|P6|COMPLETED|Treatment Period 2||5
2223263|NCT02792829|5452638|P5|COMPLETED|Treatment Period 2||4
2223264|NCT02792829|5452639|P4|COMPLETED|Treatment Period 2||5
2223265|NCT02792829|5452640|P3|COMPLETED|Treatment Period 2||5
2223266|NCT02792829|5452641|P2|COMPLETED|Treatment Period 2||9
2223267|NCT02792829|5452642|P1|COMPLETED|Treatment Period 2||10
2223268|NCT02792829|5452635|P8|STARTED|Treatment Period 2||10
2223269|NCT02792829|5452636|P7|STARTED|Treatment Period 2||10
2223270|NCT02792829|5452637|P6|STARTED|Treatment Period 2||5
2223271|NCT02792829|5452638|P5|STARTED|Treatment Period 2||5
2223272|NCT02792829|5452639|P4|STARTED|Treatment Period 2||5
2223273|NCT02792829|5452640|P3|STARTED|Treatment Period 2||5
2223274|NCT02792829|5452641|P2|STARTED|Treatment Period 2||10
2223275|NCT02792829|5452642|P1|STARTED|Treatment Period 2||10
2223276|NCT02792829|5452635|P8|NOT COMPLETED|Wash Out Period||0
2223277|NCT02792829|5452636|P7|NOT COMPLETED|Wash Out Period||0
2223278|NCT02792829|5452637|P6|NOT COMPLETED|Wash Out Period||0
2223279|NCT02792829|5452638|P5|NOT COMPLETED|Wash Out Period||0
2223280|NCT02792829|5452639|P4|NOT COMPLETED|Wash Out Period||0
2223281|NCT02792829|5452640|P3|NOT COMPLETED|Wash Out Period||0
2223282|NCT02792829|5452641|P2|NOT COMPLETED|Wash Out Period||0
2223283|NCT02792829|5452642|P1|NOT COMPLETED|Wash Out Period||0
2223284|NCT02792829|5452635|P8|COMPLETED|Wash Out Period||10
2223285|NCT02792829|5452636|P7|COMPLETED|Wash Out Period||10
2223286|NCT02792829|5452637|P6|COMPLETED|Wash Out Period||5
2223287|NCT02792829|5452638|P5|COMPLETED|Wash Out Period||5
2223288|NCT02792829|5452639|P4|COMPLETED|Wash Out Period||5
2223289|NCT02792829|5452640|P3|COMPLETED|Wash Out Period||5
2223290|NCT02792829|5452641|P2|COMPLETED|Wash Out Period||10
2223291|NCT02792829|5452642|P1|COMPLETED|Wash Out Period||10
2223292|NCT02792829|5452635|P8|STARTED|Wash Out Period||10
2223293|NCT02792829|5452636|P7|STARTED|Wash Out Period||10
2223294|NCT02792829|5452637|P6|STARTED|Wash Out Period||5
2223295|NCT02792829|5452638|P5|STARTED|Wash Out Period||5
2223296|NCT02792829|5452639|P4|STARTED|Wash Out Period||5
2223297|NCT02792829|5452640|P3|STARTED|Wash Out Period||5
2223298|NCT02792829|5452641|P2|STARTED|Wash Out Period||10
2223299|NCT02792829|5452642|P1|STARTED|Wash Out Period||10
2223300|NCT02792829|5452635|P8|NOT COMPLETED|Treatment Period 1||0
2223301|NCT02792829|5452636|P7|NOT COMPLETED|Treatment Period 1||0
2223302|NCT02792829|5452637|P6|NOT COMPLETED|Treatment Period 1||0
2223303|NCT02792829|5452638|P5|NOT COMPLETED|Treatment Period 1||0
2223304|NCT02792829|5452639|P4|NOT COMPLETED|Treatment Period 1||0
2223305|NCT02792829|5452640|P3|NOT COMPLETED|Treatment Period 1||0
2223306|NCT02792829|5452641|P2|NOT COMPLETED|Treatment Period 1||0
2223307|NCT02792829|5452642|P1|NOT COMPLETED|Treatment Period 1||0
2223308|NCT02792829|5452635|P8|COMPLETED|Treatment Period 1||10
2223309|NCT02792829|5452636|P7|COMPLETED|Treatment Period 1||10
2223310|NCT02792829|5452637|P6|COMPLETED|Treatment Period 1||5
2223311|NCT02792829|5452638|P5|COMPLETED|Treatment Period 1||5
2223312|NCT02792829|5452639|P4|COMPLETED|Treatment Period 1||5
2223313|NCT02792829|5452640|P3|COMPLETED|Treatment Period 1||5
2223314|NCT02792829|5452641|P2|COMPLETED|Treatment Period 1||10
2223315|NCT02792829|5452642|P1|COMPLETED|Treatment Period 1||10
2223316|NCT02792829|5452635|P8|STARTED|Treatment Period 1||10
2223317|NCT02792829|5452636|P7|STARTED|Treatment Period 1||10
2223318|NCT02792829|5452637|P6|STARTED|Treatment Period 1||5
2223319|NCT02792829|5452638|P5|STARTED|Treatment Period 1||5
2223320|NCT02792829|5452639|P4|STARTED|Treatment Period 1||5
2223321|NCT02792829|5452640|P3|STARTED|Treatment Period 1||5
2223322|NCT02792829|5452641|P2|STARTED|Treatment Period 1||10
2223323|NCT02792829|5452642|P1|STARTED|Treatment Period 1||10
2223324|NCT02792777|5452750|P2|NOT COMPLETED|Overall Study||0
2223325|NCT02792777|5452751|P1|NOT COMPLETED|Overall Study||7
2223326|NCT02792777|5452750|P2|COMPLETED|Overall Study||52
2223327|NCT02792777|5452751|P1|COMPLETED|Overall Study||89
2223328|NCT02792777|5452750|P2|STARTED|Overall Study||52
2223329|NCT02792777|5452751|P1|STARTED|Overall Study||96
2223330|NCT02792699|5452767|P3|NOT COMPLETED|Overall Study||10
2223331|NCT02792699|5452768|P2|NOT COMPLETED|Overall Study||10
2223332|NCT02792699|5452769|P1|NOT COMPLETED|Overall Study||9
2223333|NCT02792699|5452767|P3|COMPLETED|Overall Study||93
2223334|NCT02792699|5452768|P2|COMPLETED|Overall Study||94
2223335|NCT02792699|5452769|P1|COMPLETED|Overall Study||95
2223336|NCT02792699|5452767|P3|Received Second Infusion of Second Dose|Overall Study||93
2223337|NCT02792699|5452768|P2|Received Second Infusion of Second Dose|Overall Study||99
2223338|NCT02792699|5452769|P1|Received Second Infusion of Second Dose|Overall Study||97
2223339|NCT02792699|5452767|P3|Received First Infusion of Second Dose|Overall Study||95
2223340|NCT02792699|5452768|P2|Received First Infusion of Second Dose|Overall Study||99
2223341|NCT02792699|5452769|P1|Received First Infusion of Second Dose|Overall Study||97
2223342|NCT02792699|5452767|P3|Received Second Infusion of First Dose|Overall Study||99
2223343|NCT02792699|5452768|P2|Received Second Infusion of First Dose|Overall Study||103
2223344|NCT02792699|5452769|P1|Received Second Infusion of First Dose|Overall Study||102
2223345|NCT02792699|5452767|P3|Received First Infusion of First Dose|Overall Study||103
2223346|NCT02792699|5452768|P2|Received First Infusion of First Dose|Overall Study||104
2223347|NCT02792699|5452769|P1|Received First Infusion of First Dose|Overall Study||104
2223348|NCT02792699|5452767|P3|STARTED|Overall Study||103
2223349|NCT02792699|5452768|P2|STARTED|Overall Study||104
2223350|NCT02792699|5452769|P1|STARTED|Overall Study||104
2223351|NCT02792517|5452850|P1|NOT COMPLETED|Overall Study||20
2223352|NCT02792517|5452850|P1|COMPLETED|Overall Study||21
2223353|NCT02792517|5452850|P1|Received Erenumab|Overall Study||24
2223354|NCT02792517|5452850|P1|STARTED|Overall Study||41
2223355|NCT02792062|5452870|P6|NOT COMPLETED|Intervention Period 3 (6 Days)||0
2223356|NCT02792062|5452871|P5|NOT COMPLETED|Intervention Period 3 (6 Days)||0
2223357|NCT02792062|5452872|P4|NOT COMPLETED|Intervention Period 3 (6 Days)||0
2223358|NCT02792062|5452873|P3|NOT COMPLETED|Intervention Period 3 (6 Days)||0
2223359|NCT02792062|5452874|P2|NOT COMPLETED|Intervention Period 3 (6 Days)||0
2223360|NCT02792062|5452875|P1|NOT COMPLETED|Intervention Period 3 (6 Days)||0
2223361|NCT02792062|5452870|P6|COMPLETED|Intervention Period 3 (6 Days)||2
2223362|NCT02792062|5452871|P5|COMPLETED|Intervention Period 3 (6 Days)||2
2223363|NCT02792062|5452872|P4|COMPLETED|Intervention Period 3 (6 Days)||2
2223364|NCT02792062|5452873|P3|COMPLETED|Intervention Period 3 (6 Days)||2
2223365|NCT02792062|5452874|P2|COMPLETED|Intervention Period 3 (6 Days)||2
2223366|NCT02792062|5452875|P1|COMPLETED|Intervention Period 3 (6 Days)||1
2223367|NCT02792062|5452870|P6|STARTED|Intervention Period 3 (6 Days)||2
2223368|NCT02792062|5452871|P5|STARTED|Intervention Period 3 (6 Days)||2
2223369|NCT02792062|5452872|P4|STARTED|Intervention Period 3 (6 Days)||2
2223370|NCT02792062|5452873|P3|STARTED|Intervention Period 3 (6 Days)||2
2223371|NCT02792062|5452874|P2|STARTED|Intervention Period 3 (6 Days)||2
2223372|NCT02792062|5452875|P1|STARTED|Intervention Period 3 (6 Days)||1
2223373|NCT02792062|5452870|P6|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2223374|NCT02792062|5452871|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2223375|NCT02792062|5452872|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2223376|NCT02792062|5452873|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2223377|NCT02792062|5452874|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2223378|NCT02792062|5452875|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||1
2223379|NCT02792062|5452870|P6|COMPLETED|Washout Period (at Least 14 Days)||2
2223380|NCT02792062|5452871|P5|COMPLETED|Washout Period (at Least 14 Days)||2
2223381|NCT02792062|5452872|P4|COMPLETED|Washout Period (at Least 14 Days)||2
2223382|NCT02792062|5452873|P3|COMPLETED|Washout Period (at Least 14 Days)||2
2223383|NCT02792062|5452874|P2|COMPLETED|Washout Period (at Least 14 Days)||2
2223384|NCT02792062|5452875|P1|COMPLETED|Washout Period (at Least 14 Days)||1
2223385|NCT02792062|5452870|P6|STARTED|Washout Period (at Least 14 Days)||2
2223386|NCT02792062|5452871|P5|STARTED|Washout Period (at Least 14 Days)||2
2223387|NCT02792062|5452872|P4|STARTED|Washout Period (at Least 14 Days)||2
2223388|NCT02792062|5452873|P3|STARTED|Washout Period (at Least 14 Days)||2
2223389|NCT02792062|5452874|P2|STARTED|Washout Period (at Least 14 Days)||2
2223390|NCT02792062|5452875|P1|STARTED|Washout Period (at Least 14 Days)||2
2223391|NCT02792062|5452870|P6|NOT COMPLETED|Intervention Period 2 (6 Days)||0
2223392|NCT02792062|5452871|P5|NOT COMPLETED|Intervention Period 2 (6 Days)||0
2223393|NCT02792062|5452872|P4|NOT COMPLETED|Intervention Period 2 (6 Days)||0
2223394|NCT02792062|5452873|P3|NOT COMPLETED|Intervention Period 2 (6 Days)||0
2223395|NCT02792062|5452874|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
2223396|NCT02792062|5452875|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
2223397|NCT02792062|5452870|P6|COMPLETED|Intervention Period 2 (6 Days)||2
2223398|NCT02792062|5452871|P5|COMPLETED|Intervention Period 2 (6 Days)||2
2223399|NCT02792062|5452872|P4|COMPLETED|Intervention Period 2 (6 Days)||2
2223400|NCT02792062|5452873|P3|COMPLETED|Intervention Period 2 (6 Days)||2
2223401|NCT02792062|5452874|P2|COMPLETED|Intervention Period 2 (6 Days)||2
2223402|NCT02792062|5452875|P1|COMPLETED|Intervention Period 2 (6 Days)||2
2223403|NCT02792062|5452870|P6|STARTED|Intervention Period 2 (6 Days)||2
2223404|NCT02792062|5452871|P5|STARTED|Intervention Period 2 (6 Days)||2
2223405|NCT02792062|5452872|P4|STARTED|Intervention Period 2 (6 Days)||2
2223406|NCT02792062|5452873|P3|STARTED|Intervention Period 2 (6 Days)||2
2223407|NCT02792062|5452874|P2|STARTED|Intervention Period 2 (6 Days)||2
2223408|NCT02792062|5452875|P1|STARTED|Intervention Period 2 (6 Days)||2
2223409|NCT02792062|5452870|P6|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2223410|NCT02792062|5452871|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2223411|NCT02792062|5452872|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2223412|NCT02792062|5452873|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2223413|NCT02792062|5452874|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2223414|NCT02792062|5452875|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2223415|NCT02792062|5452870|P6|COMPLETED|Washout Period (at Least 14 Days)||2
2223416|NCT02792062|5452871|P5|COMPLETED|Washout Period (at Least 14 Days)||2
2223417|NCT02792062|5452872|P4|COMPLETED|Washout Period (at Least 14 Days)||2
2223418|NCT02792062|5452873|P3|COMPLETED|Washout Period (at Least 14 Days)||2
2223419|NCT02792062|5452874|P2|COMPLETED|Washout Period (at Least 14 Days)||2
2223420|NCT02792062|5452875|P1|COMPLETED|Washout Period (at Least 14 Days)||2
2223421|NCT02792062|5452870|P6|STARTED|Washout Period (at Least 14 Days)||2
2223422|NCT02792062|5452871|P5|STARTED|Washout Period (at Least 14 Days)||2
2223423|NCT02792062|5452872|P4|STARTED|Washout Period (at Least 14 Days)||2
2223424|NCT02792062|5452873|P3|STARTED|Washout Period (at Least 14 Days)||2
2223425|NCT02792062|5452874|P2|STARTED|Washout Period (at Least 14 Days)||2
2223426|NCT02792062|5452875|P1|STARTED|Washout Period (at Least 14 Days)||2
2223427|NCT02792062|5452870|P6|NOT COMPLETED|Intervention Period 1 (6 Days)||0
2223428|NCT02792062|5452871|P5|NOT COMPLETED|Intervention Period 1 (6 Days)||0
2223429|NCT02792062|5452872|P4|NOT COMPLETED|Intervention Period 1 (6 Days)||0
2223430|NCT02792062|5452873|P3|NOT COMPLETED|Intervention Period 1 (6 Days)||0
2223431|NCT02792062|5452874|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
2223432|NCT02792062|5452875|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
2223433|NCT02792062|5452870|P6|COMPLETED|Intervention Period 1 (6 Days)||2
2223434|NCT02792062|5452871|P5|COMPLETED|Intervention Period 1 (6 Days)||2
2223435|NCT02792062|5452872|P4|COMPLETED|Intervention Period 1 (6 Days)||2
2223436|NCT02792062|5452873|P3|COMPLETED|Intervention Period 1 (6 Days)||2
2223437|NCT02792062|5452874|P2|COMPLETED|Intervention Period 1 (6 Days)||2
2223438|NCT02792062|5452875|P1|COMPLETED|Intervention Period 1 (6 Days)||2
2223439|NCT02792062|5452870|P6|STARTED|Intervention Period 1 (6 Days)||2
2223440|NCT02792062|5452871|P5|STARTED|Intervention Period 1 (6 Days)||2
2223441|NCT02792062|5452872|P4|STARTED|Intervention Period 1 (6 Days)||2
2223442|NCT02792062|5452873|P3|STARTED|Intervention Period 1 (6 Days)||2
2223443|NCT02792062|5452874|P2|STARTED|Intervention Period 1 (6 Days)||2
2223444|NCT02792062|5452875|P1|STARTED|Intervention Period 1 (6 Days)||2
2223445|NCT02792049|5452909|P2|NOT COMPLETED|Overall Study||0
2223446|NCT02792049|5452910|P1|NOT COMPLETED|Overall Study||0
2223447|NCT02792049|5452909|P2|COMPLETED|Overall Study||35
2223448|NCT02792049|5452910|P1|COMPLETED|Overall Study||35
2223449|NCT02792049|5452909|P2|STARTED|Overall Study||35
2223450|NCT02792049|5452910|P1|STARTED|Overall Study||35
2223451|NCT02791763|5452927|P3|NOT COMPLETED|Overall Study||13
2223452|NCT02791763|5452928|P2|NOT COMPLETED|Overall Study||37
2223453|NCT02791763|5452929|P1|NOT COMPLETED|Overall Study||38
2223454|NCT02791763|5452927|P3|COMPLETED|Overall Study||43
2223455|NCT02791763|5452928|P2|COMPLETED|Overall Study||113
2223456|NCT02791763|5452929|P1|COMPLETED|Overall Study||111
2223457|NCT02791763|5452927|P3|STARTED|Overall Study||56
2223458|NCT02791763|5452928|P2|STARTED|Overall Study||150
2223459|NCT02791763|5452929|P1|STARTED|Overall Study||149
2223460|NCT02791659|5453048|P2|NOT COMPLETED|Overall Study||1
2223461|NCT02791659|5453049|P1|NOT COMPLETED|Overall Study||0
2223462|NCT02791659|5453048|P2|COMPLETED|Overall Study||27
2223463|NCT02791659|5453049|P1|COMPLETED|Overall Study||27
2223464|NCT02791659|5453048|P2|STARTED|Overall Study||28
2223465|NCT02791659|5453049|P1|STARTED|Overall Study||27
2223466|NCT02791516|5453057|P2|NOT COMPLETED|Overall Study||1
2223467|NCT02791516|5453058|P1|NOT COMPLETED|Overall Study||1
2223468|NCT02791516|5453057|P2|COMPLETED|Overall Study||33
2223469|NCT02791516|5453058|P1|COMPLETED|Overall Study||32
2223470|NCT02791516|5453057|P2|Completed 6-month Treatment Period|Overall Study||33
2223471|NCT02791516|5453058|P1|Completed 6-month Treatment Period|Overall Study||33
2223472|NCT02791516|5453057|P2|STARTED|Overall Study||34
2223473|NCT02791516|5453058|P1|STARTED|Overall Study||33
2223474|NCT02791490|5453070|P2|NOT COMPLETED|Overall Study||8
2223475|NCT02791490|5453071|P1|NOT COMPLETED|Overall Study||3
2223476|NCT02791490|5453070|P2|COMPLETED|Overall Study||221
2223477|NCT02791490|5453071|P1|COMPLETED|Overall Study||226
2223478|NCT02791490|5453070|P2|STARTED|Overall Study||229
2223479|NCT02791490|5453071|P1|STARTED|Overall Study||229
2223480|NCT02791438|5453091|P2|NOT COMPLETED|Treatment Period||1
2223481|NCT02791438|5453092|P1|NOT COMPLETED|Treatment Period||3
2223482|NCT02791438|5453091|P2|COMPLETED|Treatment Period||4
2223483|NCT02791438|5453092|P1|COMPLETED|Treatment Period||19
2223484|NCT02791438|5453091|P2|STARTED|Treatment Period||5
2223485|NCT02791438|5453092|P1|STARTED|Treatment Period||22
2223486|NCT02791438|5453091|P2|NOT COMPLETED|Run-In Period||0
2223487|NCT02791438|5453092|P1|NOT COMPLETED|Run-In Period||0
2223488|NCT02791438|5453091|P2|COMPLETED|Run-In Period||5
2223489|NCT02791438|5453092|P1|COMPLETED|Run-In Period||22
2223490|NCT02791438|5453091|P2|STARTED|Run-In Period||5
2223491|NCT02791438|5453092|P1|STARTED|Run-In Period||22
2223492|NCT02791269|5453120|P2|NOT COMPLETED|Overall Study||1
2223493|NCT02791269|5453121|P1|NOT COMPLETED|Overall Study||0
2223494|NCT02791269|5453120|P2|COMPLETED|Overall Study||19
2223495|NCT02791269|5453121|P1|COMPLETED|Overall Study||4
2223496|NCT02791269|5453120|P2|STARTED|Overall Study||20
2223497|NCT02791269|5453121|P1|STARTED|Overall Study||4
2223498|NCT02790788|5453137|P2|NOT COMPLETED|Overall Study||0
2223499|NCT02790788|5453138|P1|NOT COMPLETED|Overall Study||0
2223500|NCT02790788|5453137|P2|COMPLETED|Overall Study||54
2223501|NCT02790788|5453138|P1|COMPLETED|Overall Study||46
2223502|NCT02790788|5453137|P2|STARTED|Overall Study||54
2223503|NCT02790788|5453138|P1|STARTED|Overall Study||46
2223504|NCT02790736|5453190|P2|NOT COMPLETED|Overall Study||0
2223505|NCT02790736|5453191|P1|NOT COMPLETED|Overall Study||0
2223506|NCT02790736|5453190|P2|COMPLETED|Overall Study||1
2223507|NCT02790736|5453191|P1|COMPLETED|Overall Study||5
2223508|NCT02790736|5453190|P2|STARTED|Overall Study||1
2223509|NCT02790736|5453191|P1|STARTED|Overall Study||5
2223510|NCT02790606|5453199|P1|NOT COMPLETED|Overall Study||8
2223511|NCT02790606|5453199|P1|COMPLETED|Overall Study||102
2223512|NCT02790606|5453199|P1|STARTED|Overall Study||110
2223513|NCT02790463|5453216|P2|NOT COMPLETED|Overall Study||309
2223514|NCT02790463|5453217|P1|NOT COMPLETED|Overall Study||0
2223515|NCT02790463|5453216|P2|COMPLETED|Overall Study||372
2223516|NCT02790463|5453217|P1|COMPLETED|Overall Study||782
2223517|NCT02790463|5453216|P2|STARTED|Overall Study||681
2223518|NCT02790463|5453217|P1|STARTED|Overall Study||782
2223519|NCT02790281|5453225|P1|NOT COMPLETED|Overall Study||0
2223520|NCT02790281|5453225|P1|COMPLETED|Overall Study||33
2223521|NCT02790281|5453225|P1|STARTED|Overall Study||33
2223522|NCT02790073|5453231|P1|NOT COMPLETED|Overall Study||3
2223523|NCT02790073|5453231|P1|COMPLETED|Overall Study||11
2223524|NCT02790073|5453231|P1|STARTED|Overall Study||14
2223525|NCT02789410|5453239|P2|NOT COMPLETED|Overall Study||0
2223526|NCT02789410|5453240|P1|NOT COMPLETED|Overall Study||0
2223527|NCT02789410|5453239|P2|COMPLETED|Overall Study||68
2223528|NCT02789410|5453240|P1|COMPLETED|Overall Study||66
2223529|NCT02789410|5453239|P2|STARTED|Overall Study||68
2223530|NCT02789410|5453240|P1|STARTED|Overall Study||66
2223537|NCT02788474|5453275|P2|NOT COMPLETED|Open Label Treatment Period||12
2223538|NCT02788474|5453276|P1|NOT COMPLETED|Open Label Treatment Period||32
2223539|NCT02788474|5453275|P2|COMPLETED|Open Label Treatment Period||100
2223540|NCT02788474|5453276|P1|COMPLETED|Open Label Treatment Period||189
2223541|NCT02788474|5453275|P2|STARTED|Open Label Treatment Period||112
2223542|NCT02788474|5453276|P1|STARTED|Open Label Treatment Period||221
2223543|NCT02788474|5453275|P2|NOT COMPLETED|Double Blind Treatment Period||4
2223544|NCT02788474|5453276|P1|NOT COMPLETED|Double Blind Treatment Period||10
2223545|NCT02788474|5453275|P2|COMPLETED|Double Blind Treatment Period||112
2223546|NCT02788474|5453276|P1|COMPLETED|Double Blind Treatment Period||221
2223547|NCT02788474|5453275|P2|Treated|Double Blind Treatment Period||116
2223548|NCT02788474|5453276|P1|Treated|Double Blind Treatment Period||230
2223549|NCT02788474|5453275|P2|STARTED|Double Blind Treatment Period||116
2223550|NCT02788474|5453276|P1|STARTED|Double Blind Treatment Period||231
2223551|NCT02788357|5453291|P2|NOT COMPLETED|Overall Study||0
2223552|NCT02788357|5453292|P1|NOT COMPLETED|Overall Study||3
2223553|NCT02788357|5453291|P2|COMPLETED|Overall Study||6
2223554|NCT02788357|5453292|P1|COMPLETED|Overall Study||3
2223555|NCT02788357|5453291|P2|STARTED|Overall Study||6
2223556|NCT02788357|5453292|P1|STARTED|Overall Study||6
2223557|NCT02788279|5453307|P3|NOT COMPLETED|Overall Study||90
2223558|NCT02788279|5453308|P2|NOT COMPLETED|Overall Study||183
2223559|NCT02788279|5453309|P1|NOT COMPLETED|Overall Study||90
2223560|NCT02788279|5453307|P3|COMPLETED|Overall Study||0
2223561|NCT02788279|5453308|P2|COMPLETED|Overall Study||0
2223562|NCT02788279|5453309|P1|COMPLETED|Overall Study||0
2223563|NCT02788279|5453307|P3|Modified ITT Population|Overall Study||61
2223564|NCT02788279|5453308|P2|Modified ITT Population|Overall Study||125
2223565|NCT02788279|5453309|P1|Modified ITT Population|Overall Study||57
2223566|NCT02788279|5453307|P3|Received Treatment (Safety Population)|Overall Study||90
2223567|NCT02788279|5453308|P2|Received Treatment (Safety Population)|Overall Study||179
2223568|NCT02788279|5453309|P1|Received Treatment (Safety Population)|Overall Study||80
2223569|NCT02788279|5453307|P3|STARTED|Overall Study||90
2223570|NCT02788279|5453308|P2|STARTED|Overall Study||183
2223571|NCT02788279|5453309|P1|STARTED|Overall Study||90
2223572|NCT02788188|5453347|P7|NOT COMPLETED|Overall Study||0
2223573|NCT02788188|5453348|P6|NOT COMPLETED|Overall Study||0
2223574|NCT02788188|5453349|P5|NOT COMPLETED|Overall Study||0
2223575|NCT02788188|5453350|P4|NOT COMPLETED|Overall Study||0
2223576|NCT02788188|5453351|P3|NOT COMPLETED|Overall Study||0
2223577|NCT02788188|5453352|P2|NOT COMPLETED|Overall Study||0
2223578|NCT02788188|5453353|P1|NOT COMPLETED|Overall Study||0
2223579|NCT02788188|5453347|P7|COMPLETED|Overall Study||10
2223580|NCT02788188|5453348|P6|COMPLETED|Overall Study||8
2223581|NCT02788188|5453349|P5|COMPLETED|Overall Study||8
2223582|NCT02788188|5453350|P4|COMPLETED|Overall Study||4
2223583|NCT02788188|5453351|P3|COMPLETED|Overall Study||4
2223584|NCT02788188|5453352|P2|COMPLETED|Overall Study||2
2223585|NCT02788188|5453353|P1|COMPLETED|Overall Study||2
2223586|NCT02788188|5453347|P7|STARTED|Overall Study||10
2223587|NCT02788188|5453348|P6|STARTED|Overall Study||8
2223588|NCT02788188|5453349|P5|STARTED|Overall Study||8
2223589|NCT02788188|5453350|P4|STARTED|Overall Study||4
2223590|NCT02788188|5453351|P3|STARTED|Overall Study||4
2223591|NCT02788188|5453352|P2|STARTED|Overall Study||2
2223592|NCT02788188|5453353|P1|STARTED|Overall Study||2
2223597|NCT02788097|5453376|P2|NOT COMPLETED|Overall Study||0
2223598|NCT02788097|5453377|P1|NOT COMPLETED|Overall Study||0
2223599|NCT02788097|5453376|P2|COMPLETED|Overall Study||69
2223600|NCT02788097|5453377|P1|COMPLETED|Overall Study||61
2223601|NCT02788097|5453376|P2|STARTED|Overall Study||69
2223602|NCT02788097|5453377|P1|STARTED|Overall Study||61
2223643|NCT02787694|5453458|P1|NOT COMPLETED|Overall Study||5
2223644|NCT02787694|5453458|P1|COMPLETED|Overall Study||17
2223645|NCT02787694|5453458|P1|STARTED|Overall Study||22
2223646|NCT02787564|5453464|P2|NOT COMPLETED|Overall Study||2
2223647|NCT02787564|5453465|P1|NOT COMPLETED|Overall Study||7
2223648|NCT02787564|5453464|P2|COMPLETED|Overall Study|n=12 food bank users; n=15 non-food bank users|27
2223649|NCT02787564|5453465|P1|COMPLETED|Overall Study|n=12 food bank users; n=13 non-food bank users|25
2223650|NCT02787564|5453464|P2|STARTED|Overall Study||29
2223651|NCT02787564|5453465|P1|STARTED|Overall Study||32
2223652|NCT02787551|5453483|P2|NOT COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||0
2223653|NCT02787551|5453484|P1|NOT COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||9
2223654|NCT02787551|5453483|P2|COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||0
2223655|NCT02787551|5453484|P1|COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||197
2223656|NCT02787551|5453483|P2|STARTED|Extension Period:26 Weeks(Upto 52 Weeks)||0
2223657|NCT02787551|5453484|P1|STARTED|Extension Period:26 Weeks(Upto 52 Weeks)|Participants who completed core period and met eligibility criteria for extension period.|206
2223658|NCT02787551|5453483|P2|NOT COMPLETED|Core Period: 26 Weeks||11
2223659|NCT02787551|5453484|P1|NOT COMPLETED|Core Period: 26 Weeks||27
2223660|NCT02787551|5453483|P2|COMPLETED|Core Period: 26 Weeks||246
2223661|NCT02787551|5453484|P1|COMPLETED|Core Period: 26 Weeks|Out of 230 participants, 206 participants entered in single arm extension period.|230
2223662|NCT02787551|5453483|P2|Treated|Core Period: 26 Weeks||256
2223663|NCT02787551|5453484|P1|Treated|Core Period: 26 Weeks||255
2223664|NCT02787551|5453483|P2|STARTED|Core Period: 26 Weeks||257
2223665|NCT02787551|5453484|P1|STARTED|Core Period: 26 Weeks||257
2223666|NCT02787304|5453520|P4|NOT COMPLETED|Overall Study||34
2223667|NCT02787304|5453521|P3|NOT COMPLETED|Overall Study||41
2223668|NCT02787304|5453522|P2|NOT COMPLETED|Overall Study||38
2223669|NCT02787304|5453523|P1|NOT COMPLETED|Overall Study||36
2223670|NCT02787304|5453520|P4|COMPLETED|Overall Study||15
2223671|NCT02787304|5453521|P3|COMPLETED|Overall Study||8
2223672|NCT02787304|5453522|P2|COMPLETED|Overall Study||12
2223673|NCT02787304|5453523|P1|COMPLETED|Overall Study||13
2223674|NCT02787304|5453520|P4|STARTED|Overall Study||49
2223675|NCT02787304|5453521|P3|STARTED|Overall Study||49
2223676|NCT02787304|5453522|P2|STARTED|Overall Study|One subject was randomized and received 1 dose of study drug but withdrew from the study.|50
2223677|NCT02787304|5453523|P1|STARTED|Overall Study||49
2223678|NCT02787083|5453571|P2|NOT COMPLETED|Overall Study||2
2223679|NCT02787083|5453572|P1|NOT COMPLETED|Overall Study||3
2223680|NCT02787083|5453571|P2|COMPLETED|Overall Study||3
2223681|NCT02787083|5453572|P1|COMPLETED|Overall Study||1
2223682|NCT02787083|5453571|P2|STARTED|Overall Study||5
2223683|NCT02787083|5453572|P1|STARTED|Overall Study||4
2223684|NCT02786953|5453582|P2|NOT COMPLETED|Overall Study||1
2223685|NCT02786953|5453583|P1|NOT COMPLETED|Overall Study||3
2223686|NCT02786953|5453582|P2|COMPLETED|Overall Study||18
2223687|NCT02786953|5453583|P1|COMPLETED|Overall Study||17
2223688|NCT02786953|5453582|P2|A1C 3 Month|Overall Study||17
2223689|NCT02786953|5453583|P1|A1C 3 Month|Overall Study||15
2223690|NCT02786953|5453582|P2|3 Month Parent Survey Completed|Overall Study||18
2223691|NCT02786953|5453583|P1|3 Month Parent Survey Completed|Overall Study||17
2223692|NCT02786953|5453582|P2|3 Month Teen Survey Completed|Overall Study||18
2223693|NCT02786953|5453583|P1|3 Month Teen Survey Completed|Overall Study||17
2223694|NCT02786953|5453582|P2|Session 3 Completed|Overall Study||0
2223695|NCT02786953|5453583|P1|Session 3 Completed|Overall Study||16
2223696|NCT02786953|5453582|P2|Session 2 Completed|Overall Study||0
2223697|NCT02786953|5453583|P1|Session 2 Completed|Overall Study||16
2223698|NCT02786953|5453582|P2|Session 1 Completed|Overall Study||0
2223699|NCT02786953|5453583|P1|Session 1 Completed|Overall Study||17
2223700|NCT02786953|5453582|P2|A1C Data Baseline|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
2223701|NCT02786953|5453583|P1|A1C Data Baseline|Overall Study||20
2223702|NCT02786953|5453582|P2|Actigraph Data Complete|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|17
2223703|NCT02786953|5453583|P1|Actigraph Data Complete|Overall Study||14
2223704|NCT02786953|5453582|P2|Baseline Parent Survey Completed|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
2223705|NCT02786953|5453583|P1|Baseline Parent Survey Completed|Overall Study||20
2223706|NCT02786953|5453582|P2|Baseline Teen Survey Data Completed|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
2223707|NCT02786953|5453583|P1|Baseline Teen Survey Data Completed|Overall Study||20
2223708|NCT02786953|5453582|P2|STARTED|Overall Study||19
2223709|NCT02786953|5453583|P1|STARTED|Overall Study||20
2223710|NCT02786927|5453605|P1|NOT COMPLETED|Overall Study||5
2223711|NCT02786927|5453605|P1|COMPLETED|Overall Study||207
2223712|NCT02786927|5453605|P1|STARTED|Overall Study||212
2223713|NCT02786810|5453612|P1|NOT COMPLETED|Overall Study||0
2223714|NCT02786810|5453612|P1|COMPLETED|Overall Study||10
2223715|NCT02786810|5453612|P1|STARTED|Overall Study||10
2223716|NCT02786771|5453619|P2|NOT COMPLETED|Overall Study||6
2223717|NCT02786771|5453620|P1|NOT COMPLETED|Overall Study||10
2223718|NCT02786771|5453619|P2|COMPLETED|Overall Study||56
2223719|NCT02786771|5453620|P1|COMPLETED|Overall Study||53
2223720|NCT02786771|5453619|P2|STARTED|Overall Study||62
2223721|NCT02786771|5453620|P1|STARTED|Overall Study||63
2223722|NCT02786355|5453626|P1|NOT COMPLETED|Overall Study||0
2223723|NCT02786355|5453626|P1|COMPLETED|Overall Study||35
2223724|NCT02786355|5453626|P1|STARTED|Overall Study||35
2223725|NCT02786004|5453635|P2|NOT COMPLETED|Overall Study||1
2223726|NCT02786004|5453636|P1|NOT COMPLETED|Overall Study||0
2223727|NCT02786004|5453635|P2|COMPLETED|Overall Study||9
2223728|NCT02786004|5453636|P1|COMPLETED|Overall Study||14
2223729|NCT02786004|5453635|P2|STARTED|Overall Study||10
2223730|NCT02786004|5453636|P1|STARTED|Overall Study||14
2223736|NCT02785900|5453653|P2|NOT COMPLETED|Overall Study||123
2223737|NCT02785900|5453654|P1|NOT COMPLETED|Overall Study||117
2223738|NCT02785900|5453653|P2|COMPLETED|Overall Study||0
2223739|NCT02785900|5453654|P1|COMPLETED|Overall Study||0
2223740|NCT02785900|5453653|P2|STARTED|Overall Study||123
2223741|NCT02785900|5453654|P1|STARTED|Overall Study||117
2223742|NCT02785770|5453678|P4|NOT COMPLETED|Intervention Period 4 (1 Day)||0
2223743|NCT02785770|5453679|P3|NOT COMPLETED|Intervention Period 4 (1 Day)||0
2223744|NCT02785770|5453680|P2|NOT COMPLETED|Intervention Period 4 (1 Day)||0
2223745|NCT02785770|5453681|P1|NOT COMPLETED|Intervention Period 4 (1 Day)||0
2223746|NCT02785770|5453678|P4|COMPLETED|Intervention Period 4 (1 Day)||10
2223747|NCT02785770|5453679|P3|COMPLETED|Intervention Period 4 (1 Day)||10
2223748|NCT02785770|5453680|P2|COMPLETED|Intervention Period 4 (1 Day)||10
2223749|NCT02785770|5453681|P1|COMPLETED|Intervention Period 4 (1 Day)||11
2223750|NCT02785770|5453678|P4|STARTED|Intervention Period 4 (1 Day)||10
2223751|NCT02785770|5453679|P3|STARTED|Intervention Period 4 (1 Day)||10
2223752|NCT02785770|5453680|P2|STARTED|Intervention Period 4 (1 Day)||10
2223753|NCT02785770|5453681|P1|STARTED|Intervention Period 4 (1 Day)||11
2223754|NCT02785770|5453678|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
2223755|NCT02785770|5453679|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
2223756|NCT02785770|5453680|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
2223757|NCT02785770|5453681|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
2223758|NCT02785770|5453678|P4|COMPLETED|Washout Period 3 (7 Days)||10
2223759|NCT02785770|5453679|P3|COMPLETED|Washout Period 3 (7 Days)||10
2223760|NCT02785770|5453680|P2|COMPLETED|Washout Period 3 (7 Days)||10
2223761|NCT02785770|5453681|P1|COMPLETED|Washout Period 3 (7 Days)||11
2223762|NCT02785770|5453678|P4|STARTED|Washout Period 3 (7 Days)||10
2223763|NCT02785770|5453679|P3|STARTED|Washout Period 3 (7 Days)||10
2223764|NCT02785770|5453680|P2|STARTED|Washout Period 3 (7 Days)||10
2223765|NCT02785770|5453681|P1|STARTED|Washout Period 3 (7 Days)||11
2223766|NCT02785770|5453678|P4|NOT COMPLETED|Intervention Period 3 (1 Day)||1
2223767|NCT02785770|5453679|P3|NOT COMPLETED|Intervention Period 3 (1 Day)||0
2223768|NCT02785770|5453680|P2|NOT COMPLETED|Intervention Period 3 (1 Day)||0
2223769|NCT02785770|5453681|P1|NOT COMPLETED|Intervention Period 3 (1 Day)||0
2223770|NCT02785770|5453678|P4|COMPLETED|Intervention Period 3 (1 Day)||10
2223771|NCT02785770|5453679|P3|COMPLETED|Intervention Period 3 (1 Day)||10
2223772|NCT02785770|5453680|P2|COMPLETED|Intervention Period 3 (1 Day)||10
2223773|NCT02785770|5453681|P1|COMPLETED|Intervention Period 3 (1 Day)||11
2223774|NCT02785770|5453678|P4|STARTED|Intervention Period 3 (1 Day)||11
2223775|NCT02785770|5453679|P3|STARTED|Intervention Period 3 (1 Day)||10
2223776|NCT02785770|5453680|P2|STARTED|Intervention Period 3 (1 Day)||10
2223777|NCT02785770|5453681|P1|STARTED|Intervention Period 3 (1 Day)||11
2223778|NCT02785770|5453678|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
2223779|NCT02785770|5453679|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
2223780|NCT02785770|5453680|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
2223781|NCT02785770|5453681|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
2223782|NCT02785770|5453678|P4|COMPLETED|Washout Period 2 (7 Days)||11
2223783|NCT02785770|5453679|P3|COMPLETED|Washout Period 2 (7 Days)||10
2223784|NCT02785770|5453680|P2|COMPLETED|Washout Period 2 (7 Days)||10
2223785|NCT02785770|5453681|P1|COMPLETED|Washout Period 2 (7 Days)||11
2223786|NCT02785770|5453678|P4|STARTED|Washout Period 2 (7 Days)||11
2223787|NCT02785770|5453679|P3|STARTED|Washout Period 2 (7 Days)||10
2223788|NCT02785770|5453680|P2|STARTED|Washout Period 2 (7 Days)||10
2223789|NCT02785770|5453681|P1|STARTED|Washout Period 2 (7 Days)||11
2223790|NCT02785770|5453678|P4|NOT COMPLETED|Intervention Period 2 (1 Day)||0
2223791|NCT02785770|5453679|P3|NOT COMPLETED|Intervention Period 2 (1 Day)||1
2223792|NCT02785770|5453680|P2|NOT COMPLETED|Intervention Period 2 (1 Day)||1
2223793|NCT02785770|5453681|P1|NOT COMPLETED|Intervention Period 2 (1 Day)||0
2223794|NCT02785770|5453678|P4|COMPLETED|Intervention Period 2 (1 Day)||11
2223795|NCT02785770|5453679|P3|COMPLETED|Intervention Period 2 (1 Day)||10
2223796|NCT02785770|5453680|P2|COMPLETED|Intervention Period 2 (1 Day)||10
2223797|NCT02785770|5453681|P1|COMPLETED|Intervention Period 2 (1 Day)||11
2223798|NCT02785770|5453678|P4|STARTED|Intervention Period 2 (1 Day)||11
2223799|NCT02785770|5453679|P3|STARTED|Intervention Period 2 (1 Day)||11
2223800|NCT02785770|5453680|P2|STARTED|Intervention Period 2 (1 Day)||11
2223801|NCT02785770|5453681|P1|STARTED|Intervention Period 2 (1 Day)||11
2223802|NCT02785770|5453678|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
2223803|NCT02785770|5453679|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
2223804|NCT02785770|5453680|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
2223805|NCT02785770|5453681|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
2223806|NCT02785770|5453678|P4|COMPLETED|Washout Period 1 (7 Days)||11
2223807|NCT02785770|5453679|P3|COMPLETED|Washout Period 1 (7 Days)||11
2223808|NCT02785770|5453680|P2|COMPLETED|Washout Period 1 (7 Days)||11
2223809|NCT02785770|5453681|P1|COMPLETED|Washout Period 1 (7 Days)||11
2223810|NCT02785770|5453678|P4|STARTED|Washout Period 1 (7 Days)||11
2223811|NCT02785770|5453679|P3|STARTED|Washout Period 1 (7 Days)||11
2223812|NCT02785770|5453680|P2|STARTED|Washout Period 1 (7 Days)||11
2223813|NCT02785770|5453681|P1|STARTED|Washout Period 1 (7 Days)||11
2223814|NCT02785770|5453678|P4|NOT COMPLETED|Intervention Period 1 (1 Day)||0
2223815|NCT02785770|5453679|P3|NOT COMPLETED|Intervention Period 1 (1 Day)||0
2223816|NCT02785770|5453680|P2|NOT COMPLETED|Intervention Period 1 (1 Day)||0
2223817|NCT02785770|5453681|P1|NOT COMPLETED|Intervention Period 1 (1 Day)||0
2223818|NCT02785770|5453678|P4|COMPLETED|Intervention Period 1 (1 Day)||11
2223819|NCT02785770|5453679|P3|COMPLETED|Intervention Period 1 (1 Day)||11
2223820|NCT02785770|5453680|P2|COMPLETED|Intervention Period 1 (1 Day)||11
2223821|NCT02785770|5453681|P1|COMPLETED|Intervention Period 1 (1 Day)||11
2223822|NCT02785770|5453678|P4|STARTED|Intervention Period 1 (1 Day)||11
2223823|NCT02785770|5453679|P3|STARTED|Intervention Period 1 (1 Day)||11
2223824|NCT02785770|5453680|P2|STARTED|Intervention Period 1 (1 Day)||11
2223825|NCT02785770|5453681|P1|STARTED|Intervention Period 1 (1 Day)||11
2223826|NCT02785588|5453748|P1|NOT COMPLETED|Phase2 Controlled Image &Data Collection||0
2223827|NCT02785588|5453748|P1|COMPLETED|Phase2 Controlled Image &Data Collection||5
2223828|NCT02785588|5453748|P1|STARTED|Phase2 Controlled Image &Data Collection|Phase 2 participants represent newly enrolled participants.|5
2223829|NCT02785588|5453748|P1|NOT COMPLETED|Phase 1: Initial Feasibility Assessment||2
2223830|NCT02785588|5453748|P1|COMPLETED|Phase 1: Initial Feasibility Assessment||47
2223831|NCT02785588|5453748|P1|STARTED|Phase 1: Initial Feasibility Assessment||49
2223832|NCT02785406|5453764|P2|NOT COMPLETED|Overall Study||0
2223833|NCT02785406|5453765|P1|NOT COMPLETED|Overall Study||0
2223834|NCT02785406|5453764|P2|COMPLETED|Overall Study||10
2223835|NCT02785406|5453765|P1|COMPLETED|Overall Study||10
2223836|NCT02785406|5453764|P2|Completed Second Week|Overall Study||10
2223837|NCT02785406|5453765|P1|Completed Second Week|Overall Study||10
2223838|NCT02785406|5453764|P2|Completed First Week|Overall Study||10
2223839|NCT02785406|5453765|P1|Completed First Week|Overall Study||10
2223840|NCT02785406|5453764|P2|STARTED|Overall Study||10
2223841|NCT02785406|5453765|P1|STARTED|Overall Study||10
2223842|NCT02785354|5453840|P3|NOT COMPLETED|Overall Study||0
2223843|NCT02785354|5453841|P2|NOT COMPLETED|Overall Study||0
2223844|NCT02785354|5453842|P1|NOT COMPLETED|Overall Study||0
2223845|NCT02785354|5453840|P3|COMPLETED|Overall Study||44653
2223846|NCT02785354|5453841|P2|COMPLETED|Overall Study||31388
2223847|NCT02785354|5453842|P1|COMPLETED|Overall Study||27060
2223848|NCT02785354|5453840|P3|STARTED|Overall Study||44653
2223849|NCT02785354|5453841|P2|STARTED|Overall Study||31388
2223850|NCT02785354|5453842|P1|STARTED|Overall Study||27060
2223851|NCT02784925|5453871|P1|NOT COMPLETED|Overall Study||0
2223852|NCT02784925|5453871|P1|COMPLETED|Overall Study||30
2223853|NCT02784925|5453871|P1|STARTED|Overall Study||30
2223854|NCT02784834|5453875|P1|NOT COMPLETED|Overall Study||1
2223855|NCT02784834|5453875|P1|COMPLETED|Overall Study||1
2223856|NCT02784834|5453875|P1|STARTED|Overall Study||2
2223857|NCT02784704|5453881|P2|NOT COMPLETED|Overall Study||9
2223858|NCT02784704|5453882|P1|NOT COMPLETED|Overall Study||13
2223859|NCT02784704|5453881|P2|COMPLETED|Overall Study||241
2223860|NCT02784704|5453882|P1|COMPLETED|Overall Study||237
2223861|NCT02784704|5453881|P2|Treated|Overall Study||249
2223862|NCT02784704|5453882|P1|Treated|Overall Study||250
2223863|NCT02784704|5453881|P2|STARTED|Overall Study||250
2223864|NCT02784704|5453882|P1|STARTED|Overall Study||250
2223865|NCT02784613|5453892|P1|NOT COMPLETED|Overall Study||2
2223866|NCT02784613|5453892|P1|COMPLETED|Overall Study||8
2223867|NCT02784613|5453892|P1|STARTED|Overall Study||10
2223868|NCT02784587|5453898|P1|NOT COMPLETED|Overall Study||0
2223869|NCT02784587|5453898|P1|COMPLETED|Overall Study||25
2223870|NCT02784587|5453898|P1|STARTED|Overall Study||25
2223871|NCT02784548|5453902|P1|NOT COMPLETED|Overall Study||0
2223872|NCT02784548|5453902|P1|COMPLETED|Overall Study||15
2223873|NCT02784548|5453902|P1|STARTED|Overall Study||15
2223874|NCT02784275|5453911|P4|NOT COMPLETED|Overall Study||1
2223875|NCT02784275|5453912|P3|NOT COMPLETED|Overall Study||1
2223876|NCT02784275|5453913|P2|NOT COMPLETED|Overall Study||0
2223877|NCT02784275|5453914|P1|NOT COMPLETED|Overall Study||1
2223878|NCT02784275|5453911|P4|COMPLETED|Overall Study||14
2223879|NCT02784275|5453912|P3|COMPLETED|Overall Study||16
2223880|NCT02784275|5453913|P2|COMPLETED|Overall Study||16
2223881|NCT02784275|5453914|P1|COMPLETED|Overall Study||15
2223882|NCT02784275|5453911|P4|STARTED|Overall Study||15
2223883|NCT02784275|5453912|P3|STARTED|Overall Study||17
2223884|NCT02784275|5453913|P2|STARTED|Overall Study||16
2223885|NCT02784275|5453914|P1|STARTED|Overall Study||16
2223886|NCT02784106|5453958|P4|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||2
2223887|NCT02784106|5453959|P3|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||3
2223888|NCT02784106|5453960|P2|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0
2223889|NCT02784106|5453961|P1|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0
2223890|NCT02784106|5453958|P4|COMPLETED|Open-Label Extension Period (26 Weeks)||19
2223891|NCT02784106|5453959|P3|COMPLETED|Open-Label Extension Period (26 Weeks)||15
2223892|NCT02784106|5453960|P2|COMPLETED|Open-Label Extension Period (26 Weeks)||0
2223893|NCT02784106|5453961|P1|COMPLETED|Open-Label Extension Period (26 Weeks)||0
2223894|NCT02784106|5453958|P4|STARTED|Open-Label Extension Period (26 Weeks)||21
2223895|NCT02784106|5453959|P3|STARTED|Open-Label Extension Period (26 Weeks)||18
2223896|NCT02784106|5453960|P2|STARTED|Open-Label Extension Period (26 Weeks)||0
2223897|NCT02784106|5453961|P1|STARTED|Open-Label Extension Period (26 Weeks)||0
2223898|NCT02784106|5453958|P4|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
2223899|NCT02784106|5453959|P3|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
2223900|NCT02784106|5453960|P2|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||6
2223901|NCT02784106|5453961|P1|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||8
2223902|NCT02784106|5453958|P4|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
2223903|NCT02784106|5453959|P3|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
2223904|NCT02784106|5453960|P2|COMPLETED|Double-Blind Treatment Period (12 Weeks)||27
2223905|NCT02784106|5453961|P1|COMPLETED|Double-Blind Treatment Period (12 Weeks)||24
2223906|NCT02784106|5453958|P4|STARTED|Double-Blind Treatment Period (12 Weeks)||0
2223907|NCT02784106|5453959|P3|STARTED|Double-Blind Treatment Period (12 Weeks)||0
2223908|NCT02784106|5453960|P2|STARTED|Double-Blind Treatment Period (12 Weeks)||33
2223909|NCT02784106|5453961|P1|STARTED|Double-Blind Treatment Period (12 Weeks)||32
2223910|NCT02783898|5454024|P2|NOT COMPLETED|Overall Study||1
2223911|NCT02783898|5454025|P1|NOT COMPLETED|Overall Study||1
2223912|NCT02783898|5454024|P2|COMPLETED|Overall Study||116
2223913|NCT02783898|5454025|P1|COMPLETED|Overall Study||124
2223914|NCT02783898|5454024|P2|STARTED|Overall Study||117
2223915|NCT02783898|5454025|P1|STARTED|Overall Study||125
2223916|NCT02783729|5454049|P4|NOT COMPLETED|Overall Study||9
2223917|NCT02783729|5454050|P3|NOT COMPLETED|Overall Study||8
2223918|NCT02783729|5454051|P2|NOT COMPLETED|Overall Study||17
2223919|NCT02783729|5454052|P1|NOT COMPLETED|Overall Study||10
2223920|NCT02783729|5454049|P4|COMPLETED|Overall Study||260
2223921|NCT02783729|5454050|P3|COMPLETED|Overall Study||258
2223922|NCT02783729|5454051|P2|COMPLETED|Overall Study||246
2223923|NCT02783729|5454052|P1|COMPLETED|Overall Study||198
2223924|NCT02783729|5454049|P4|STARTED|Overall Study||269
2223925|NCT02783729|5454050|P3|STARTED|Overall Study||266
2223926|NCT02783729|5454051|P2|STARTED|Overall Study||263
2223927|NCT02783729|5454052|P1|STARTED|Overall Study||208
2223928|NCT02783599|5454118|P1|NOT COMPLETED|Overall Study||40
2223929|NCT02783599|5454118|P1|COMPLETED|Overall Study||11
2223930|NCT02783599|5454118|P1|Received At Least One Dose of Study Drug|Overall Study||51
2223931|NCT02783599|5454118|P1|STARTED|Overall Study||51
2223932|NCT02783573|5454134|P3|NOT COMPLETED|Delayed-Start Period||12
2223933|NCT02783573|5454135|P2|NOT COMPLETED|Delayed-Start Period||17
2223934|NCT02783573|5454136|P1|NOT COMPLETED|Delayed-Start Period||0
2223935|NCT02783573|5454134|P3|COMPLETED|Delayed-Start Period||0
2223936|NCT02783573|5454135|P2|COMPLETED|Delayed-Start Period||0
2223937|NCT02783573|5454136|P1|COMPLETED|Delayed-Start Period||0
2223938|NCT02783573|5454134|P3|Received at Least 1 Dose of Study Drug|Delayed-Start Period||12
2223939|NCT02783573|5454135|P2|Received at Least 1 Dose of Study Drug|Delayed-Start Period||14
2223940|NCT02783573|5454136|P1|Received at Least 1 Dose of Study Drug|Delayed-Start Period||0
2223941|NCT02783573|5454134|P3|STARTED|Delayed-Start Period|Participants completed period 1 may not have entered period 2 due to early termination of the study.|12
2223942|NCT02783573|5454135|P2|STARTED|Delayed-Start Period|Participants completed period 1 may not have entered period 2 due to early termination of the study.|17
2223943|NCT02783573|5454136|P1|STARTED|Delayed-Start Period|Participants from placebo group were randomized to Lanabecestat 20 mg and 50 mg.|0
2223944|NCT02783573|5454134|P3|NOT COMPLETED|Placebo-Controlled Treatment Period||548
2223945|NCT02783573|5454135|P2|NOT COMPLETED|Placebo-Controlled Treatment Period||562
2223946|NCT02783573|5454136|P1|NOT COMPLETED|Placebo-Controlled Treatment Period||536
2223947|NCT02783573|5454134|P3|COMPLETED|Placebo-Controlled Treatment Period||22
2223948|NCT02783573|5454135|P2|COMPLETED|Placebo-Controlled Treatment Period||28
2223949|NCT02783573|5454136|P1|COMPLETED|Placebo-Controlled Treatment Period||26
2223950|NCT02783573|5454134|P3|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||568
2223951|NCT02783573|5454135|P2|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||588
2223952|NCT02783573|5454136|P1|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||558
2223953|NCT02783573|5454134|P3|STARTED|Placebo-Controlled Treatment Period||570
2223954|NCT02783573|5454135|P2|STARTED|Placebo-Controlled Treatment Period||590
2223955|NCT02783573|5454136|P1|STARTED|Placebo-Controlled Treatment Period||562
2223956|NCT02783443|5454192|P2|NOT COMPLETED|Overall Study||0
2223957|NCT02783443|5454193|P1|NOT COMPLETED|Overall Study||0
2223958|NCT02783443|5454192|P2|COMPLETED|Overall Study||30
2223959|NCT02783443|5454193|P1|COMPLETED|Overall Study||30
2223960|NCT02783443|5454192|P2|STARTED|Overall Study||30
2223961|NCT02783443|5454193|P1|STARTED|Overall Study||30
2223962|NCT02783170|5454201|P2|NOT COMPLETED|Overall Study||0
2223963|NCT02783170|5454202|P1|NOT COMPLETED|Overall Study||1
2223964|NCT02783170|5454201|P2|COMPLETED|Overall Study||38
2223965|NCT02783170|5454202|P1|COMPLETED|Overall Study||42
2223966|NCT02783170|5454201|P2|Safety Population|Overall Study|Excluded sub. randomized but not vaccinated. Excluded sub. randomized to seq. but got simultaneous.|38
2223967|NCT02783170|5454202|P1|Safety Population|Overall Study|Added subject randomized to sequential but got simultaneous.|42
2223968|NCT02783170|5454201|P2|STARTED|Overall Study||38
2223969|NCT02783170|5454202|P1|STARTED|Overall Study||43
2223970|NCT02783027|5454245|P2|NOT COMPLETED|Overall Study||17
2223971|NCT02783027|5454246|P1|NOT COMPLETED|Overall Study||23
2223972|NCT02783027|5454245|P2|COMPLETED|Overall Study||27
2223973|NCT02783027|5454246|P1|COMPLETED|Overall Study||16
2223974|NCT02783027|5454245|P2|STARTED|Overall Study||44
2223975|NCT02783027|5454246|P1|STARTED|Overall Study||39
2223976|NCT02782676|5454260|P2|NOT COMPLETED|Overall Study||1
2223977|NCT02782676|5454261|P1|NOT COMPLETED|Overall Study||0
2223978|NCT02782676|5454260|P2|COMPLETED|Overall Study||209
2223979|NCT02782676|5454261|P1|COMPLETED|Overall Study||211
2223980|NCT02782676|5454260|P2|STARTED|Overall Study||210
2223981|NCT02782676|5454261|P1|STARTED|Overall Study||211
2223982|NCT02782325|5454291|P3|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||4
2223983|NCT02782325|5454292|P2|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
2223984|NCT02782325|5454293|P1|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
2223985|NCT02782325|5454291|P3|COMPLETED|Open Label FMT Period (up to 24 Weeks)||1
2223986|NCT02782325|5454292|P2|COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
2223987|NCT02782325|5454293|P1|COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
2223988|NCT02782325|5454291|P3|STARTED|Open Label FMT Period (up to 24 Weeks)|1 participant decided to not participate in the open label period|5
2223989|NCT02782325|5454292|P2|STARTED|Open Label FMT Period (up to 24 Weeks)||0
2223990|NCT02782325|5454293|P1|STARTED|Open Label FMT Period (up to 24 Weeks)||0
2223991|NCT02782325|5454291|P3|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
2223992|NCT02782325|5454292|P2|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||2
2223993|NCT02782325|5454293|P1|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||4
2223994|NCT02782325|5454291|P3|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
2223995|NCT02782325|5454292|P2|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
2223996|NCT02782325|5454293|P1|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
2223997|NCT02782325|5454291|P3|STARTED|Blinded FMT Treatment (up to 24 Weeks)||0
2223998|NCT02782325|5454292|P2|STARTED|Blinded FMT Treatment (up to 24 Weeks)||2
2223999|NCT02782325|5454293|P1|STARTED|Blinded FMT Treatment (up to 24 Weeks)||4
2224000|NCT02782169|5454321|P2|NOT COMPLETED|Overall Study||2
2224001|NCT02782169|5454322|P1|NOT COMPLETED|Overall Study||1
2224002|NCT02782169|5454321|P2|COMPLETED|Overall Study||52
2224003|NCT02782169|5454322|P1|COMPLETED|Overall Study||55
2224004|NCT02782169|5454321|P2|STARTED|Overall Study||54
2224005|NCT02782169|5454322|P1|STARTED|Overall Study||56
2224006|NCT02781818|5454339|P3|NOT COMPLETED|Overall Study||1
2224007|NCT02781818|5454340|P2|NOT COMPLETED|Overall Study||2
2224008|NCT02781818|5454341|P1|NOT COMPLETED|Overall Study||4
2224009|NCT02781818|5454339|P3|COMPLETED|Overall Study||16
2224010|NCT02781818|5454340|P2|COMPLETED|Overall Study||16
2224011|NCT02781818|5454341|P1|COMPLETED|Overall Study||16
2224012|NCT02781818|5454339|P3|STARTED|Overall Study||17
2224013|NCT02781818|5454340|P2|STARTED|Overall Study||18
2224014|NCT02781818|5454341|P1|STARTED|Overall Study||20
2224015|NCT02781649|5454358|P3|NOT COMPLETED|Overall Study||0
2224016|NCT02781649|5454359|P2|NOT COMPLETED|Overall Study||0
2224017|NCT02781649|5454360|P1|NOT COMPLETED|Overall Study||0
2224018|NCT02781649|5454358|P3|COMPLETED|Overall Study||3
2224019|NCT02781649|5454359|P2|COMPLETED|Overall Study||0
2224020|NCT02781649|5454360|P1|COMPLETED|Overall Study||7
2224021|NCT02781649|5454358|P3|STARTED|Overall Study||3
2224022|NCT02781649|5454359|P2|STARTED|Overall Study||0
2224023|NCT02781649|5454360|P1|STARTED|Overall Study|4 in this group had insufficient viral RNA for genotyping. They were treated as 1a|7
2224024|NCT02781571|5454386|P1|NOT COMPLETED|Overall Study||0
2224025|NCT02781571|5454386|P1|COMPLETED|Overall Study||79
2224026|NCT02781571|5454386|P1|STARTED|Overall Study||79
2224027|NCT02781558|5454407|P2|NOT COMPLETED|Overall Study||2
2224028|NCT02781558|5454408|P1|NOT COMPLETED|Overall Study||3
2224029|NCT02781558|5454407|P2|COMPLETED|Overall Study||101
2224030|NCT02781558|5454408|P1|COMPLETED|Overall Study||98
2224031|NCT02781558|5454407|P2|STARTED|Overall Study||103
2224032|NCT02781558|5454408|P1|STARTED|Overall Study||101
2224033|NCT02781454|5454447|P3|NOT COMPLETED|Overall Study||1
2224034|NCT02781454|5454448|P2|NOT COMPLETED|Overall Study||0
2224035|NCT02781454|5454449|P1|NOT COMPLETED|Overall Study||0
2224036|NCT02781454|5454447|P3|COMPLETED|Overall Study||5
2224037|NCT02781454|5454448|P2|COMPLETED|Overall Study||6
2224038|NCT02781454|5454449|P1|COMPLETED|Overall Study||8
2224039|NCT02781454|5454447|P3|STARTED|Overall Study||6
2224040|NCT02781454|5454448|P2|STARTED|Overall Study||6
2224041|NCT02781454|5454449|P1|STARTED|Overall Study||8
2224042|NCT02781324|5454495|P2|NOT COMPLETED|Overall Study||2
2224043|NCT02781324|5454496|P1|NOT COMPLETED|Overall Study||2
2224044|NCT02781324|5454495|P2|COMPLETED|Overall Study||31
2224045|NCT02781324|5454496|P1|COMPLETED|Overall Study||31
2224046|NCT02781324|5454495|P2|STARTED|Overall Study||33
2224047|NCT02781324|5454496|P1|STARTED|Overall Study||33
2224048|NCT02781311|5454525|P3|NOT COMPLETED|Overall Study||4
2224049|NCT02781311|5454526|P2|NOT COMPLETED|Overall Study||26
2224050|NCT02781311|5454527|P1|NOT COMPLETED|Overall Study||26
2224051|NCT02781311|5454525|P3|COMPLETED|Overall Study||8
2224052|NCT02781311|5454526|P2|COMPLETED|Overall Study||57
2224053|NCT02781311|5454527|P1|COMPLETED|Overall Study||48
2224054|NCT02781311|5454525|P3|mITT Population|Overall Study||11
2224055|NCT02781311|5454526|P2|mITT Population|Overall Study||78
2224056|NCT02781311|5454527|P1|mITT Population|Overall Study||70
2224057|NCT02781311|5454525|P3|Safety Population (Treated)|Overall Study||12
2224058|NCT02781311|5454526|P2|Safety Population (Treated)|Overall Study||81
2224059|NCT02781311|5454527|P1|Safety Population (Treated)|Overall Study||73
2224060|NCT02781311|5454525|P3|STARTED|Overall Study||12
2224061|NCT02781311|5454526|P2|STARTED|Overall Study||83
2224062|NCT02781311|5454527|P1|STARTED|Overall Study||74
2224063|NCT02781051|5454536|P1|NOT COMPLETED|Overall Study||2
2224064|NCT02781051|5454536|P1|COMPLETED|Overall Study||14
2224065|NCT02781051|5454536|P1|STARTED|Overall Study||16
2224066|NCT02780869|5454543|P2|NOT COMPLETED|Overall Study||9
2224067|NCT02780869|5454544|P1|NOT COMPLETED|Overall Study||13
2224068|NCT02780869|5454543|P2|COMPLETED|Overall Study||74
2224069|NCT02780869|5454544|P1|COMPLETED|Overall Study||162
2224070|NCT02780869|5454543|P2|STARTED|Overall Study||83
2224071|NCT02780869|5454544|P1|STARTED|Overall Study||175
2224072|NCT02780856|5454554|P1|NOT COMPLETED|Overall Study||1
2224073|NCT02780856|5454554|P1|COMPLETED|Overall Study||109
2224074|NCT02780856|5454554|P1|STARTED|Overall Study||110
2224075|NCT02780765|5454564|P2|NOT COMPLETED|Overall Study||0
2224076|NCT02780765|5454565|P1|NOT COMPLETED|Overall Study||0
2224077|NCT02780765|5454564|P2|COMPLETED|Overall Study||30
2224078|NCT02780765|5454565|P1|COMPLETED|Overall Study||30
2224079|NCT02780765|5454564|P2|STARTED|Overall Study||30
2224080|NCT02780765|5454565|P1|STARTED|Overall Study||30
2224081|NCT02780700|5454573|P1|NOT COMPLETED|Overall Study||1
2224082|NCT02780700|5454573|P1|COMPLETED|Overall Study||0
2224083|NCT02780700|5454573|P1|STARTED|Overall Study||1
2224084|NCT02780661|5454581|P2|NOT COMPLETED|Period 2||0
2224085|NCT02780661|5454582|P1|NOT COMPLETED|Period 2||0
2224086|NCT02780661|5454581|P2|COMPLETED|Period 2||9
2224087|NCT02780661|5454582|P1|COMPLETED|Period 2||10
2224088|NCT02780661|5454581|P2|STARTED|Period 2||9
2224089|NCT02780661|5454582|P1|STARTED|Period 2||10
2224090|NCT02780661|5454581|P2|NOT COMPLETED|Wash Out Period||0
2224091|NCT02780661|5454582|P1|NOT COMPLETED|Wash Out Period||0
2224092|NCT02780661|5454581|P2|COMPLETED|Wash Out Period||9
2224093|NCT02780661|5454582|P1|COMPLETED|Wash Out Period||10
2224094|NCT02780661|5454581|P2|STARTED|Wash Out Period||9
2224095|NCT02780661|5454582|P1|STARTED|Wash Out Period||10
2224096|NCT02780661|5454581|P2|NOT COMPLETED|Period 1||0
2224097|NCT02780661|5454582|P1|NOT COMPLETED|Period 1||0
2224098|NCT02780661|5454581|P2|COMPLETED|Period 1||9
2224099|NCT02780661|5454582|P1|COMPLETED|Period 1||10
2224100|NCT02780661|5454581|P2|STARTED|Period 1||9
2224101|NCT02780661|5454582|P1|STARTED|Period 1||10
2224102|NCT02780622|5454598|P2|NOT COMPLETED|Treatment Period 2||0
2224103|NCT02780622|5454599|P1|NOT COMPLETED|Treatment Period 2||0
2224104|NCT02780622|5454598|P2|COMPLETED|Treatment Period 2||10
2224105|NCT02780622|5454599|P1|COMPLETED|Treatment Period 2||10
2224106|NCT02780622|5454598|P2|STARTED|Treatment Period 2||10
2224107|NCT02780622|5454599|P1|STARTED|Treatment Period 2||10
2224108|NCT02780622|5454598|P2|NOT COMPLETED|Treatment Period 1||0
2224109|NCT02780622|5454599|P1|NOT COMPLETED|Treatment Period 1||0
2224110|NCT02780622|5454598|P2|COMPLETED|Treatment Period 1||10
2224111|NCT02780622|5454599|P1|COMPLETED|Treatment Period 1||10
2224112|NCT02780622|5454598|P2|STARTED|Treatment Period 1||10
2224113|NCT02780622|5454599|P1|STARTED|Treatment Period 1||10
2224114|NCT02780388|5454642|P5|NOT COMPLETED|Overall Study||0
2224115|NCT02780388|5454643|P4|NOT COMPLETED|Overall Study||0
2224116|NCT02780388|5454644|P3|NOT COMPLETED|Overall Study||0
2224117|NCT02780388|5454645|P2|NOT COMPLETED|Overall Study||2
2224118|NCT02780388|5454646|P1|NOT COMPLETED|Overall Study||1
2224119|NCT02780388|5454642|P5|COMPLETED|Overall Study||12
2224120|NCT02780388|5454643|P4|COMPLETED|Overall Study||12
2224121|NCT02780388|5454644|P3|COMPLETED|Overall Study||10
2224122|NCT02780388|5454645|P2|COMPLETED|Overall Study||6
2224123|NCT02780388|5454646|P1|COMPLETED|Overall Study||14
2224124|NCT02780388|5454642|P5|STARTED|Overall Study||12
2224125|NCT02780388|5454643|P4|STARTED|Overall Study||12
2224126|NCT02780388|5454644|P3|STARTED|Overall Study||10
2224127|NCT02780388|5454645|P2|STARTED|Overall Study||8
2224128|NCT02780388|5454646|P1|STARTED|Overall Study||15
2224129|NCT02780349|5454703|P1|NOT COMPLETED|Overall Study||2
2224130|NCT02780349|5454703|P1|COMPLETED|Overall Study||101
2224131|NCT02780349|5454703|P1|STARTED|Overall Study||103
2224132|NCT02780167|5454712|P5|NOT COMPLETED|Overall Study||17
2224133|NCT02780167|5454713|P4|NOT COMPLETED|Overall Study||19
2224134|NCT02780167|5454714|P3|NOT COMPLETED|Overall Study||24
2224135|NCT02780167|5454715|P2|NOT COMPLETED|Overall Study||22
2224136|NCT02780167|5454716|P1|NOT COMPLETED|Overall Study||28
2224137|NCT02780167|5454712|P5|COMPLETED|Overall Study||38
2224138|NCT02780167|5454713|P4|COMPLETED|Overall Study||37
2224139|NCT02780167|5454714|P3|COMPLETED|Overall Study||27
2224140|NCT02780167|5454715|P2|COMPLETED|Overall Study||27
2224141|NCT02780167|5454716|P1|COMPLETED|Overall Study||28
2224142|NCT02780167|5454712|P5|STARTED|Overall Study||55
2224143|NCT02780167|5454713|P4|STARTED|Overall Study||56
2224144|NCT02780167|5454714|P3|STARTED|Overall Study||51
2224145|NCT02780167|5454715|P2|STARTED|Overall Study||49
2224146|NCT02780167|5454716|P1|STARTED|Overall Study||56
2224147|NCT02779543|5454850|P2|NOT COMPLETED|Overall Study||0
2224148|NCT02779543|5454851|P1|NOT COMPLETED|Overall Study||0
2224149|NCT02779543|5454850|P2|COMPLETED|Overall Study||100
2224150|NCT02779543|5454851|P1|COMPLETED|Overall Study||100
2224151|NCT02779543|5454850|P2|STARTED|Overall Study||100
2224152|NCT02779543|5454851|P1|STARTED|Overall Study||100
2224153|NCT02779491|5454867|P4|NOT COMPLETED|Overall Study||2
2224154|NCT02779491|5454868|P3|NOT COMPLETED|Overall Study||1
2224155|NCT02779491|5454869|P2|NOT COMPLETED|Overall Study||1
2224156|NCT02779491|5454870|P1|NOT COMPLETED|Overall Study||0
2224157|NCT02779491|5454867|P4|COMPLETED|Overall Study||15
2224158|NCT02779491|5454868|P3|COMPLETED|Overall Study||17
2224159|NCT02779491|5454869|P2|COMPLETED|Overall Study||26
2224160|NCT02779491|5454870|P1|COMPLETED|Overall Study||32
2224161|NCT02779491|5454867|P4|STARTED|Overall Study||17
2224162|NCT02779491|5454868|P3|STARTED|Overall Study||18
2224163|NCT02779491|5454869|P2|STARTED|Overall Study||27
2224164|NCT02779491|5454870|P1|STARTED|Overall Study||32
2224165|NCT02779166|5454890|P2|NOT COMPLETED|Overall Study||0
2224166|NCT02779166|5454891|P1|NOT COMPLETED|Overall Study||0
2224167|NCT02779166|5454890|P2|COMPLETED|Overall Study||48
2224168|NCT02779166|5454891|P1|COMPLETED|Overall Study||50
2224169|NCT02779166|5454890|P2|STARTED|Overall Study||48
2224170|NCT02779166|5454891|P1|STARTED|Overall Study||50
2224171|NCT02778555|5454904|P3|NOT COMPLETED|Overall Study||107
2224172|NCT02778555|5454905|P2|NOT COMPLETED|Overall Study||32
2224173|NCT02778555|5454906|P1|NOT COMPLETED|Overall Study||55
2224174|NCT02778555|5454904|P3|COMPLETED|Overall Study||211
2224175|NCT02778555|5454905|P2|COMPLETED|Overall Study||177
2224176|NCT02778555|5454906|P1|COMPLETED|Overall Study||131
2224177|NCT02778555|5454904|P3|STARTED|Overall Study||318
2224178|NCT02778555|5454905|P2|STARTED|Overall Study||209
2224179|NCT02778555|5454906|P1|STARTED|Overall Study||186
2224180|NCT02778152|5454914|P1|NOT COMPLETED|Overall Study||0
2224181|NCT02778152|5454914|P1|COMPLETED|Overall Study||13
2224182|NCT02778152|5454914|P1|STARTED|Overall Study||13
2224183|NCT02778113|5454919|P4|NOT COMPLETED|Study Period Four||0
2224184|NCT02778113|5454920|P3|NOT COMPLETED|Study Period Four||0
2224185|NCT02778113|5454921|P2|NOT COMPLETED|Study Period Four||0
2224186|NCT02778113|5454922|P1|NOT COMPLETED|Study Period Four||0
2224187|NCT02778113|5454919|P4|COMPLETED|Study Period Four||4
2224188|NCT02778113|5454920|P3|COMPLETED|Study Period Four||2
2224189|NCT02778113|5454921|P2|COMPLETED|Study Period Four||4
2224190|NCT02778113|5454922|P1|COMPLETED|Study Period Four||3
2224191|NCT02778113|5454919|P4|Received Study Drug|Study Period Four||4
2224192|NCT02778113|5454920|P3|Received Study Drug|Study Period Four||2
2224193|NCT02778113|5454921|P2|Received Study Drug|Study Period Four||4
2224194|NCT02778113|5454922|P1|Received Study Drug|Study Period Four||3
2224195|NCT02778113|5454919|P4|STARTED|Study Period Four||4
2224196|NCT02778113|5454920|P3|STARTED|Study Period Four|One participant completed study period three, but did not enter study period four.|2
2224197|NCT02778113|5454921|P2|STARTED|Study Period Four||4
2224198|NCT02778113|5454922|P1|STARTED|Study Period Four|One participant completed study period three, but did not enter study period four.|3
2224199|NCT02778113|5454919|P4|NOT COMPLETED|Study Period Three||0
2224200|NCT02778113|5454920|P3|NOT COMPLETED|Study Period Three||0
2224201|NCT02778113|5454921|P2|NOT COMPLETED|Study Period Three||0
2224202|NCT02778113|5454922|P1|NOT COMPLETED|Study Period Three||0
2224203|NCT02778113|5454919|P4|COMPLETED|Study Period Three||4
2224204|NCT02778113|5454920|P3|COMPLETED|Study Period Three||3
2224205|NCT02778113|5454921|P2|COMPLETED|Study Period Three||4
2224206|NCT02778113|5454922|P1|COMPLETED|Study Period Three||4
2224207|NCT02778113|5454919|P4|Received Study Drug|Study Period Three||4
2224208|NCT02778113|5454920|P3|Received Study Drug|Study Period Three||3
2224209|NCT02778113|5454921|P2|Received Study Drug|Study Period Three||4
2224210|NCT02778113|5454922|P1|Received Study Drug|Study Period Three||4
2224211|NCT02778113|5454919|P4|STARTED|Study Period Three||4
2224212|NCT02778113|5454920|P3|STARTED|Study Period Three|One participant completed study period two, but did not enter study period three.|3
2224213|NCT02778113|5454921|P2|STARTED|Study Period Three||4
2224214|NCT02778113|5454922|P1|STARTED|Study Period Three||4
2224215|NCT02778113|5454919|P4|NOT COMPLETED|Study Period Two||0
2224216|NCT02778113|5454920|P3|NOT COMPLETED|Study Period Two||0
2224217|NCT02778113|5454921|P2|NOT COMPLETED|Study Period Two||0
2224218|NCT02778113|5454922|P1|NOT COMPLETED|Study Period Two||0
2224219|NCT02778113|5454919|P4|COMPLETED|Study Period Two||4
2224220|NCT02778113|5454920|P3|COMPLETED|Study Period Two||4
2224221|NCT02778113|5454921|P2|COMPLETED|Study Period Two||4
2224222|NCT02778113|5454922|P1|COMPLETED|Study Period Two||4
2224223|NCT02778113|5454919|P4|Received Study Drug|Study Period Two||4
2224224|NCT02778113|5454920|P3|Received Study Drug|Study Period Two||4
2224225|NCT02778113|5454921|P2|Received Study Drug|Study Period Two||4
2224226|NCT02778113|5454922|P1|Received Study Drug|Study Period Two||4
2224227|NCT02778113|5454919|P4|STARTED|Study Period Two||4
2224228|NCT02778113|5454920|P3|STARTED|Study Period Two||4
2224229|NCT02778113|5454921|P2|STARTED|Study Period Two||4
2224230|NCT02778113|5454922|P1|STARTED|Study Period Two||4
2224231|NCT02778113|5454919|P4|NOT COMPLETED|Study Period One||0
2224232|NCT02778113|5454920|P3|NOT COMPLETED|Study Period One||0
2224233|NCT02778113|5454921|P2|NOT COMPLETED|Study Period One||0
2224234|NCT02778113|5454922|P1|NOT COMPLETED|Study Period One||0
2224235|NCT02778113|5454919|P4|COMPLETED|Study Period One||4
2224236|NCT02778113|5454920|P3|COMPLETED|Study Period One||4
2224237|NCT02778113|5454921|P2|COMPLETED|Study Period One||4
2224238|NCT02778113|5454922|P1|COMPLETED|Study Period One||4
2224239|NCT02778113|5454919|P4|Received Study Drug|Study Period One||4
2224240|NCT02778113|5454920|P3|Received Study Drug|Study Period One||4
2224241|NCT02778113|5454921|P2|Received Study Drug|Study Period One||4
2224242|NCT02778113|5454922|P1|Received Study Drug|Study Period One||4
2224243|NCT02778113|5454919|P4|STARTED|Study Period One||4
2224244|NCT02778113|5454920|P3|STARTED|Study Period One||4
2224245|NCT02778113|5454921|P2|STARTED|Study Period One||4
2224246|NCT02778113|5454922|P1|STARTED|Study Period One||4
2224247|NCT02778100|5454962|P2|NOT COMPLETED|Period 2 (No Cold Symptoms)||0
2224248|NCT02778100|5454963|P1|NOT COMPLETED|Period 2 (No Cold Symptoms)||0
2224249|NCT02778100|5454962|P2|COMPLETED|Period 2 (No Cold Symptoms)||0
2224250|NCT02778100|5454963|P1|COMPLETED|Period 2 (No Cold Symptoms)||17
2224251|NCT02778100|5454962|P2|STARTED|Period 2 (No Cold Symptoms)|Cohort 2 only administered NG to participants with a common cold who are taking oxymetazoline.|0
2224252|NCT02778100|5454963|P1|STARTED|Period 2 (No Cold Symptoms)||17
2224253|NCT02778100|5454962|P2|NOT COMPLETED|Period 1 (Common Cold)||0
2224254|NCT02778100|5454963|P1|NOT COMPLETED|Period 1 (Common Cold)||1
2224255|NCT02778100|5454962|P2|COMPLETED|Period 1 (Common Cold)||18
2224256|NCT02778100|5454963|P1|COMPLETED|Period 1 (Common Cold)||17
2224257|NCT02778100|5454962|P2|STARTED|Period 1 (Common Cold)||18
2224258|NCT02778100|5454963|P1|STARTED|Period 1 (Common Cold)||18
2224259|NCT02778074|5454994|P2|NOT COMPLETED|Overall Study||10
2224260|NCT02778074|5454995|P1|NOT COMPLETED|Overall Study||7
2224261|NCT02778074|5454994|P2|COMPLETED|Overall Study||62
2224262|NCT02778074|5454995|P1|COMPLETED|Overall Study||65
2224263|NCT02778074|5454994|P2|STARTED|Overall Study||72
2224264|NCT02778074|5454995|P1|STARTED|Overall Study||72
2224265|NCT02777944|5455003|P2|NOT COMPLETED|Overall Study||0
2224266|NCT02777944|5455004|P1|NOT COMPLETED|Overall Study||0
2224267|NCT02777944|5455003|P2|COMPLETED|Overall Study||156
2224268|NCT02777944|5455004|P1|COMPLETED|Overall Study||157
2224269|NCT02777944|5455003|P2|STARTED|Overall Study||156
2224270|NCT02777944|5455004|P1|STARTED|Overall Study||157
2224271|NCT02777931|5455016|P2|NOT COMPLETED|Overall Study||13
2224272|NCT02777931|5455017|P1|NOT COMPLETED|Overall Study||12
2224273|NCT02777931|5455016|P2|COMPLETED|Overall Study||39
2224274|NCT02777931|5455017|P1|COMPLETED|Overall Study||37
2224275|NCT02777931|5455016|P2|Modified Intent to Treat Population|Overall Study||50
2224276|NCT02777931|5455017|P1|Modified Intent to Treat Population|Overall Study||46
2224277|NCT02777931|5455016|P2|Safety Population|Overall Study||50
2224278|NCT02777931|5455017|P1|Safety Population|Overall Study||47
2224279|NCT02777931|5455016|P2|STARTED|Overall Study||52
2224280|NCT02777931|5455017|P1|STARTED|Overall Study||49
2224281|NCT02777918|5455027|P2|NOT COMPLETED|Overall Study||4
2224282|NCT02777918|5455028|P1|NOT COMPLETED|Overall Study||3
2224283|NCT02777918|5455027|P2|COMPLETED|Overall Study||43
2224284|NCT02777918|5455028|P1|COMPLETED|Overall Study||50
2224285|NCT02777918|5455027|P2|STARTED|Overall Study||47
2224286|NCT02777918|5455028|P1|STARTED|Overall Study||53
2224287|NCT02777827|5455046|P6|NOT COMPLETED|Treatment Period 6||0
2224288|NCT02777827|5455047|P5|NOT COMPLETED|Treatment Period 6||0
2224289|NCT02777827|5455048|P4|NOT COMPLETED|Treatment Period 6||0
2224290|NCT02777827|5455049|P3|NOT COMPLETED|Treatment Period 6||0
2224291|NCT02777827|5455050|P2|NOT COMPLETED|Treatment Period 6||0
2224292|NCT02777827|5455051|P1|NOT COMPLETED|Treatment Period 6||0
2224293|NCT02777827|5455046|P6|COMPLETED|Treatment Period 6||6
2224294|NCT02777827|5455047|P5|COMPLETED|Treatment Period 6||4
2224295|NCT02777827|5455048|P4|COMPLETED|Treatment Period 6||5
2224296|NCT02777827|5455049|P3|COMPLETED|Treatment Period 6||4
2224297|NCT02777827|5455050|P2|COMPLETED|Treatment Period 6||5
2224298|NCT02777827|5455051|P1|COMPLETED|Treatment Period 6||5
2224299|NCT02777827|5455046|P6|STARTED|Treatment Period 6||6
2224300|NCT02777827|5455047|P5|STARTED|Treatment Period 6||4
2224301|NCT02777827|5455048|P4|STARTED|Treatment Period 6||5
2224302|NCT02777827|5455049|P3|STARTED|Treatment Period 6||4
2224303|NCT02777827|5455050|P2|STARTED|Treatment Period 6||5
2224304|NCT02777827|5455051|P1|STARTED|Treatment Period 6||5
2224305|NCT02777827|5455046|P6|NOT COMPLETED|Washout Between Periods 5 and 6||0
2224306|NCT02777827|5455047|P5|NOT COMPLETED|Washout Between Periods 5 and 6||0
2224307|NCT02777827|5455048|P4|NOT COMPLETED|Washout Between Periods 5 and 6||0
2224308|NCT02777827|5455049|P3|NOT COMPLETED|Washout Between Periods 5 and 6||0
2224309|NCT02777827|5455050|P2|NOT COMPLETED|Washout Between Periods 5 and 6||0
2224310|NCT02777827|5455051|P1|NOT COMPLETED|Washout Between Periods 5 and 6||0
2224311|NCT02777827|5455046|P6|COMPLETED|Washout Between Periods 5 and 6||6
2224312|NCT02777827|5455047|P5|COMPLETED|Washout Between Periods 5 and 6||4
2224313|NCT02777827|5455048|P4|COMPLETED|Washout Between Periods 5 and 6||5
2224314|NCT02777827|5455049|P3|COMPLETED|Washout Between Periods 5 and 6||4
2224315|NCT02777827|5455050|P2|COMPLETED|Washout Between Periods 5 and 6||5
2224316|NCT02777827|5455051|P1|COMPLETED|Washout Between Periods 5 and 6||5
2224317|NCT02777827|5455046|P6|STARTED|Washout Between Periods 5 and 6||6
2224318|NCT02777827|5455047|P5|STARTED|Washout Between Periods 5 and 6||4
2224319|NCT02777827|5455048|P4|STARTED|Washout Between Periods 5 and 6||5
2224320|NCT02777827|5455049|P3|STARTED|Washout Between Periods 5 and 6||4
2224321|NCT02777827|5455050|P2|STARTED|Washout Between Periods 5 and 6||5
2224322|NCT02777827|5455051|P1|STARTED|Washout Between Periods 5 and 6||5
2224323|NCT02777827|5455046|P6|NOT COMPLETED|Treatment Period 5||0
2224324|NCT02777827|5455047|P5|NOT COMPLETED|Treatment Period 5||0
2224325|NCT02777827|5455048|P4|NOT COMPLETED|Treatment Period 5||0
2224326|NCT02777827|5455049|P3|NOT COMPLETED|Treatment Period 5||0
2224327|NCT02777827|5455050|P2|NOT COMPLETED|Treatment Period 5||0
2224328|NCT02777827|5455051|P1|NOT COMPLETED|Treatment Period 5||0
2224329|NCT02777827|5455046|P6|COMPLETED|Treatment Period 5||6
2224330|NCT02777827|5455047|P5|COMPLETED|Treatment Period 5||4
2224331|NCT02777827|5455048|P4|COMPLETED|Treatment Period 5||5
2224332|NCT02777827|5455049|P3|COMPLETED|Treatment Period 5||4
2224333|NCT02777827|5455050|P2|COMPLETED|Treatment Period 5||5
2224334|NCT02777827|5455051|P1|COMPLETED|Treatment Period 5||5
2224335|NCT02777827|5455046|P6|STARTED|Treatment Period 5||6
2224336|NCT02777827|5455047|P5|STARTED|Treatment Period 5||4
2224337|NCT02777827|5455048|P4|STARTED|Treatment Period 5||5
2224338|NCT02777827|5455049|P3|STARTED|Treatment Period 5||4
2224339|NCT02777827|5455050|P2|STARTED|Treatment Period 5||5
2224340|NCT02777827|5455051|P1|STARTED|Treatment Period 5||5
2224341|NCT02777827|5455046|P6|NOT COMPLETED|Washout Between Periods 4 and 5||0
2224342|NCT02777827|5455047|P5|NOT COMPLETED|Washout Between Periods 4 and 5||0
2224343|NCT02777827|5455048|P4|NOT COMPLETED|Washout Between Periods 4 and 5||0
2224344|NCT02777827|5455049|P3|NOT COMPLETED|Washout Between Periods 4 and 5||0
2224345|NCT02777827|5455050|P2|NOT COMPLETED|Washout Between Periods 4 and 5||0
2224346|NCT02777827|5455051|P1|NOT COMPLETED|Washout Between Periods 4 and 5||0
2224347|NCT02777827|5455046|P6|COMPLETED|Washout Between Periods 4 and 5||6
2224348|NCT02777827|5455047|P5|COMPLETED|Washout Between Periods 4 and 5||4
2224349|NCT02777827|5455048|P4|COMPLETED|Washout Between Periods 4 and 5||5
2224350|NCT02777827|5455049|P3|COMPLETED|Washout Between Periods 4 and 5||4
2224351|NCT02777827|5455050|P2|COMPLETED|Washout Between Periods 4 and 5||5
2224352|NCT02777827|5455051|P1|COMPLETED|Washout Between Periods 4 and 5||5
2224353|NCT02777827|5455046|P6|STARTED|Washout Between Periods 4 and 5||6
2224354|NCT02777827|5455047|P5|STARTED|Washout Between Periods 4 and 5||4
2224355|NCT02777827|5455048|P4|STARTED|Washout Between Periods 4 and 5||5
2224356|NCT02777827|5455049|P3|STARTED|Washout Between Periods 4 and 5||4
2224357|NCT02777827|5455050|P2|STARTED|Washout Between Periods 4 and 5||5
2224358|NCT02777827|5455051|P1|STARTED|Washout Between Periods 4 and 5||5
2224359|NCT02777827|5455046|P6|NOT COMPLETED|Treatment Period 4||0
2224360|NCT02777827|5455047|P5|NOT COMPLETED|Treatment Period 4||0
2224361|NCT02777827|5455048|P4|NOT COMPLETED|Treatment Period 4||0
2224362|NCT02777827|5455049|P3|NOT COMPLETED|Treatment Period 4||0
2224363|NCT02777827|5455050|P2|NOT COMPLETED|Treatment Period 4||0
2224364|NCT02777827|5455051|P1|NOT COMPLETED|Treatment Period 4||0
2224365|NCT02777827|5455046|P6|COMPLETED|Treatment Period 4||6
2224366|NCT02777827|5455047|P5|COMPLETED|Treatment Period 4||4
2224367|NCT02777827|5455048|P4|COMPLETED|Treatment Period 4||5
2224368|NCT02777827|5455049|P3|COMPLETED|Treatment Period 4||4
2224369|NCT02777827|5455050|P2|COMPLETED|Treatment Period 4||5
2224370|NCT02777827|5455051|P1|COMPLETED|Treatment Period 4||5
2224371|NCT02777827|5455046|P6|STARTED|Treatment Period 4||6
2224372|NCT02777827|5455047|P5|STARTED|Treatment Period 4||4
2224373|NCT02777827|5455048|P4|STARTED|Treatment Period 4||5
2224374|NCT02777827|5455049|P3|STARTED|Treatment Period 4||4
2224375|NCT02777827|5455050|P2|STARTED|Treatment Period 4||5
2224376|NCT02777827|5455051|P1|STARTED|Treatment Period 4||5
2224377|NCT02777827|5455046|P6|NOT COMPLETED|Washout Between Periods 3 and 4||0
2224378|NCT02777827|5455047|P5|NOT COMPLETED|Washout Between Periods 3 and 4||0
2224379|NCT02777827|5455048|P4|NOT COMPLETED|Washout Between Periods 3 and 4||0
2224380|NCT02777827|5455049|P3|NOT COMPLETED|Washout Between Periods 3 and 4||1
2224381|NCT02777827|5455050|P2|NOT COMPLETED|Washout Between Periods 3 and 4||0
2224382|NCT02777827|5455051|P1|NOT COMPLETED|Washout Between Periods 3 and 4||0
2224383|NCT02777827|5455046|P6|COMPLETED|Washout Between Periods 3 and 4||6
2224384|NCT02777827|5455047|P5|COMPLETED|Washout Between Periods 3 and 4||4
2224385|NCT02777827|5455048|P4|COMPLETED|Washout Between Periods 3 and 4||5
2224386|NCT02777827|5455049|P3|COMPLETED|Washout Between Periods 3 and 4||4
2224387|NCT02777827|5455050|P2|COMPLETED|Washout Between Periods 3 and 4||5
2224388|NCT02777827|5455051|P1|COMPLETED|Washout Between Periods 3 and 4||5
2224389|NCT02777827|5455046|P6|STARTED|Washout Between Periods 3 and 4||6
2224390|NCT02777827|5455047|P5|STARTED|Washout Between Periods 3 and 4||4
2224391|NCT02777827|5455048|P4|STARTED|Washout Between Periods 3 and 4||5
2224392|NCT02777827|5455049|P3|STARTED|Washout Between Periods 3 and 4||5
2224393|NCT02777827|5455050|P2|STARTED|Washout Between Periods 3 and 4||5
2224394|NCT02777827|5455051|P1|STARTED|Washout Between Periods 3 and 4||5
2224395|NCT02777827|5455046|P6|NOT COMPLETED|Treatment Period 3||0
2224396|NCT02777827|5455047|P5|NOT COMPLETED|Treatment Period 3||0
2224397|NCT02777827|5455048|P4|NOT COMPLETED|Treatment Period 3||0
2224398|NCT02777827|5455049|P3|NOT COMPLETED|Treatment Period 3||0
2224399|NCT02777827|5455050|P2|NOT COMPLETED|Treatment Period 3||0
2224400|NCT02777827|5455051|P1|NOT COMPLETED|Treatment Period 3||0
2224401|NCT02777827|5455046|P6|COMPLETED|Treatment Period 3||6
2224402|NCT02777827|5455047|P5|COMPLETED|Treatment Period 3||4
2224403|NCT02777827|5455048|P4|COMPLETED|Treatment Period 3||5
2224404|NCT02777827|5455049|P3|COMPLETED|Treatment Period 3||5
2224405|NCT02777827|5455050|P2|COMPLETED|Treatment Period 3||5
2224406|NCT02777827|5455051|P1|COMPLETED|Treatment Period 3||5
2224407|NCT02777827|5455046|P6|STARTED|Treatment Period 3||6
2224408|NCT02777827|5455047|P5|STARTED|Treatment Period 3||4
2224409|NCT02777827|5455048|P4|STARTED|Treatment Period 3||5
2224410|NCT02777827|5455049|P3|STARTED|Treatment Period 3||5
2224411|NCT02777827|5455050|P2|STARTED|Treatment Period 3||5
2224412|NCT02777827|5455051|P1|STARTED|Treatment Period 3||5
2224413|NCT02777827|5455046|P6|NOT COMPLETED|Washout Between Periods 2 and 3||0
2224414|NCT02777827|5455047|P5|NOT COMPLETED|Washout Between Periods 2 and 3||0
2224415|NCT02777827|5455048|P4|NOT COMPLETED|Washout Between Periods 2 and 3||0
2224416|NCT02777827|5455049|P3|NOT COMPLETED|Washout Between Periods 2 and 3||0
2224417|NCT02777827|5455050|P2|NOT COMPLETED|Washout Between Periods 2 and 3||0
2224418|NCT02777827|5455051|P1|NOT COMPLETED|Washout Between Periods 2 and 3||0
2224419|NCT02777827|5455046|P6|COMPLETED|Washout Between Periods 2 and 3||6
2224420|NCT02777827|5455047|P5|COMPLETED|Washout Between Periods 2 and 3||4
2224421|NCT02777827|5455048|P4|COMPLETED|Washout Between Periods 2 and 3||5
2224422|NCT02777827|5455049|P3|COMPLETED|Washout Between Periods 2 and 3||5
2224423|NCT02777827|5455050|P2|COMPLETED|Washout Between Periods 2 and 3||5
2224424|NCT02777827|5455051|P1|COMPLETED|Washout Between Periods 2 and 3||5
2224425|NCT02777827|5455046|P6|STARTED|Washout Between Periods 2 and 3||6
2224426|NCT02777827|5455047|P5|STARTED|Washout Between Periods 2 and 3||4
2224427|NCT02777827|5455048|P4|STARTED|Washout Between Periods 2 and 3||5
2224428|NCT02777827|5455049|P3|STARTED|Washout Between Periods 2 and 3||5
2224429|NCT02777827|5455050|P2|STARTED|Washout Between Periods 2 and 3||5
2224430|NCT02777827|5455051|P1|STARTED|Washout Between Periods 2 and 3||5
2224431|NCT02777827|5455046|P6|NOT COMPLETED|Treatment Period 2||0
2224432|NCT02777827|5455047|P5|NOT COMPLETED|Treatment Period 2||0
2224433|NCT02777827|5455048|P4|NOT COMPLETED|Treatment Period 2||0
2224434|NCT02777827|5455049|P3|NOT COMPLETED|Treatment Period 2||0
2224435|NCT02777827|5455050|P2|NOT COMPLETED|Treatment Period 2||0
2224436|NCT02777827|5455051|P1|NOT COMPLETED|Treatment Period 2||0
2224437|NCT02777827|5455046|P6|COMPLETED|Treatment Period 2||6
2224438|NCT02777827|5455047|P5|COMPLETED|Treatment Period 2||4
2224439|NCT02777827|5455048|P4|COMPLETED|Treatment Period 2||5
2224440|NCT02777827|5455049|P3|COMPLETED|Treatment Period 2||5
2224441|NCT02777827|5455050|P2|COMPLETED|Treatment Period 2||5
2224442|NCT02777827|5455051|P1|COMPLETED|Treatment Period 2||5
2224443|NCT02777827|5455046|P6|STARTED|Treatment Period 2||6
2224444|NCT02777827|5455047|P5|STARTED|Treatment Period 2||4
2224445|NCT02777827|5455048|P4|STARTED|Treatment Period 2||5
2224446|NCT02777827|5455049|P3|STARTED|Treatment Period 2||5
2224447|NCT02777827|5455050|P2|STARTED|Treatment Period 2||5
2224448|NCT02777827|5455051|P1|STARTED|Treatment Period 2||5
2224449|NCT02777827|5455046|P6|NOT COMPLETED|Washout Between Periods 1 and 2||0
2224450|NCT02777827|5455047|P5|NOT COMPLETED|Washout Between Periods 1 and 2||0
2224451|NCT02777827|5455048|P4|NOT COMPLETED|Washout Between Periods 1 and 2||0
2224452|NCT02777827|5455049|P3|NOT COMPLETED|Washout Between Periods 1 and 2||0
2224453|NCT02777827|5455050|P2|NOT COMPLETED|Washout Between Periods 1 and 2||0
2224454|NCT02777827|5455051|P1|NOT COMPLETED|Washout Between Periods 1 and 2||0
2224455|NCT02777827|5455046|P6|COMPLETED|Washout Between Periods 1 and 2||6
2224456|NCT02777827|5455047|P5|COMPLETED|Washout Between Periods 1 and 2||4
2224457|NCT02777827|5455048|P4|COMPLETED|Washout Between Periods 1 and 2||5
2224458|NCT02777827|5455049|P3|COMPLETED|Washout Between Periods 1 and 2||5
2224459|NCT02777827|5455050|P2|COMPLETED|Washout Between Periods 1 and 2||5
2224460|NCT02777827|5455051|P1|COMPLETED|Washout Between Periods 1 and 2||5
2224461|NCT02777827|5455046|P6|STARTED|Washout Between Periods 1 and 2||6
2224462|NCT02777827|5455047|P5|STARTED|Washout Between Periods 1 and 2||4
2224463|NCT02777827|5455048|P4|STARTED|Washout Between Periods 1 and 2||5
2224464|NCT02777827|5455049|P3|STARTED|Washout Between Periods 1 and 2||5
2224465|NCT02777827|5455050|P2|STARTED|Washout Between Periods 1 and 2||5
2224466|NCT02777827|5455051|P1|STARTED|Washout Between Periods 1 and 2||5
2224467|NCT02777827|5455046|P6|NOT COMPLETED|Treatment Period 1||0
2224468|NCT02777827|5455047|P5|NOT COMPLETED|Treatment Period 1||0
2224469|NCT02777827|5455048|P4|NOT COMPLETED|Treatment Period 1||0
2224470|NCT02777827|5455049|P3|NOT COMPLETED|Treatment Period 1||0
2224471|NCT02777827|5455050|P2|NOT COMPLETED|Treatment Period 1||0
2224472|NCT02777827|5455051|P1|NOT COMPLETED|Treatment Period 1||0
2224473|NCT02777827|5455046|P6|COMPLETED|Treatment Period 1||6
2224474|NCT02777827|5455047|P5|COMPLETED|Treatment Period 1||4
2224475|NCT02777827|5455048|P4|COMPLETED|Treatment Period 1||5
2224476|NCT02777827|5455049|P3|COMPLETED|Treatment Period 1||5
2224477|NCT02777827|5455050|P2|COMPLETED|Treatment Period 1||5
2224478|NCT02777827|5455051|P1|COMPLETED|Treatment Period 1||5
2224479|NCT02777827|5455046|P6|STARTED|Treatment Period 1||6
2224480|NCT02777827|5455047|P5|STARTED|Treatment Period 1||4
2224481|NCT02777827|5455048|P4|STARTED|Treatment Period 1||5
2224482|NCT02777827|5455049|P3|STARTED|Treatment Period 1||5
2224483|NCT02777827|5455050|P2|STARTED|Treatment Period 1||5
2224484|NCT02777827|5455051|P1|STARTED|Treatment Period 1||5
2224485|NCT02777749|5455206|P3|NOT COMPLETED|Overall Study||0
2224486|NCT02777749|5455207|P2|NOT COMPLETED|Overall Study||0
2224487|NCT02777749|5455208|P1|NOT COMPLETED|Overall Study||0
2224488|NCT02777749|5455206|P3|COMPLETED|Overall Study||51
2224489|NCT02777749|5455207|P2|COMPLETED|Overall Study||51
2224490|NCT02777749|5455208|P1|COMPLETED|Overall Study||53
2224491|NCT02777749|5455206|P3|STARTED|Overall Study||51
2224492|NCT02777749|5455207|P2|STARTED|Overall Study||51
2224493|NCT02777749|5455208|P1|STARTED|Overall Study||53
2224494|NCT02777268|5455228|P1|NOT COMPLETED|Overall Study||0
2224495|NCT02777268|5455228|P1|COMPLETED|Overall Study||16
2224496|NCT02777268|5455228|P1|STARTED|Overall Study||16
2224497|NCT02777242|5455254|P1|NOT COMPLETED|Overall Study||6
2224498|NCT02777242|5455254|P1|COMPLETED|Overall Study||59
2224499|NCT02777242|5455254|P1|STARTED|Overall Study||65
2224500|NCT02777125|5455260|P2|NOT COMPLETED|Overall Study||47
2224501|NCT02777125|5455261|P1|NOT COMPLETED|Overall Study||43
2224502|NCT02777125|5455260|P2|COMPLETED|Overall Study||445
2224503|NCT02777125|5455261|P1|COMPLETED|Overall Study||445
2224504|NCT02777125|5455260|P2|STARTED|Overall Study||492
2224505|NCT02777125|5455261|P1|STARTED|Overall Study||488
2224506|NCT02777021|5455277|P2|NOT COMPLETED|Overall Study||17
2224507|NCT02777021|5455278|P1|NOT COMPLETED|Overall Study||17
2224508|NCT02777021|5455277|P2|COMPLETED|Overall Study||77
2224509|NCT02777021|5455278|P1|COMPLETED|Overall Study||43
2224510|NCT02777021|5455277|P2|STARTED|Overall Study||94
2224511|NCT02777021|5455278|P1|STARTED|Overall Study||60
2224512|NCT02776774|5455284|P1|NOT COMPLETED|Overall Study||0
2224513|NCT02776774|5455284|P1|COMPLETED|Overall Study|Total after data cleaning|91
2224514|NCT02776774|5455284|P1|STARTED|Overall Study||91
2224515|NCT02776683|5455289|P2|NOT COMPLETED|Post-switch Period||43
2224516|NCT02776683|5455290|P1|NOT COMPLETED|Post-switch Period||0
2224517|NCT02776683|5455289|P2|COMPLETED|Post-switch Period||0
2224518|NCT02776683|5455290|P1|COMPLETED|Post-switch Period||0
2224519|NCT02776683|5455289|P2|STARTED|Post-switch Period|Entered into Switch Set|43
2224520|NCT02776683|5455290|P1|STARTED|Post-switch Period||0
2224521|NCT02776683|5455289|P2|NOT COMPLETED|Pre-switch Period||0
2224522|NCT02776683|5455290|P1|NOT COMPLETED|Pre-switch Period||80
2224523|NCT02776683|5455289|P2|COMPLETED|Pre-switch Period||0
2224524|NCT02776683|5455290|P1|COMPLETED|Pre-switch Period|Entered into Switch Set|43
2224525|NCT02776683|5455289|P2|STARTED|Pre-switch Period||0
2224526|NCT02776683|5455290|P1|STARTED|Pre-switch Period|Assigned to trial medication or enrolled/treated|123
2224527|NCT02776670|5455301|P2|NOT COMPLETED|Overall Study||6
2224528|NCT02776670|5455302|P1|NOT COMPLETED|Overall Study||0
2224529|NCT02776670|5455301|P2|COMPLETED|Overall Study||108
2224530|NCT02776670|5455302|P1|COMPLETED|Overall Study||117
2224531|NCT02776670|5455301|P2|Safety Analysis Set|Overall Study||114
2224532|NCT02776670|5455302|P1|Safety Analysis Set|Overall Study||117
2224533|NCT02776670|5455301|P2|Per Protocol Analysis Set (PPS)|Overall Study||113
2224534|NCT02776670|5455302|P1|Per Protocol Analysis Set (PPS)|Overall Study||115
2224535|NCT02776670|5455301|P2|Full Analysis Set (FAS)|Overall Study||114
2224536|NCT02776670|5455302|P1|Full Analysis Set (FAS)|Overall Study||117
2224537|NCT02776670|5455301|P2|STARTED|Overall Study||114
2224538|NCT02776670|5455302|P1|STARTED|Overall Study||117
2224539|NCT02776644|5455316|P2|NOT COMPLETED|Overall Study||0
2224540|NCT02776644|5455317|P1|NOT COMPLETED|Overall Study||0
2224541|NCT02776644|5455316|P2|COMPLETED|Overall Study||126
2224542|NCT02776644|5455317|P1|COMPLETED|Overall Study||1223
2224543|NCT02776644|5455316|P2|STARTED|Overall Study||126
2224544|NCT02776644|5455317|P1|STARTED|Overall Study||1223
2224545|NCT02776033|5455360|P3|NOT COMPLETED|Overall Study||2
2224546|NCT02776033|5455361|P2|NOT COMPLETED|Overall Study||2
2224547|NCT02776033|5455362|P1|NOT COMPLETED|Overall Study||4
2224548|NCT02776033|5455360|P3|COMPLETED|Overall Study||22
2224549|NCT02776033|5455361|P2|COMPLETED|Overall Study||21
2224550|NCT02776033|5455362|P1|COMPLETED|Overall Study||14
2224551|NCT02776033|5455360|P3|STARTED|Overall Study||24
2224552|NCT02776033|5455361|P2|STARTED|Overall Study||23
2224553|NCT02776033|5455362|P1|STARTED|Overall Study||18
2224554|NCT02775916|5455427|P2|NOT COMPLETED|Overall Study||0
2224555|NCT02775916|5455428|P1|NOT COMPLETED|Overall Study||3
2224556|NCT02775916|5455427|P2|COMPLETED|Overall Study||10
2224557|NCT02775916|5455428|P1|COMPLETED|Overall Study||17
2224558|NCT02775916|5455427|P2|STARTED|Overall Study||10
2224559|NCT02775916|5455428|P1|STARTED|Overall Study||20
2224560|NCT02775864|5455450|P4|NOT COMPLETED|Overall Study||2084
2224561|NCT02775864|5455451|P3|NOT COMPLETED|Overall Study||1860
2224562|NCT02775864|5455452|P2|NOT COMPLETED|Overall Study||4899
2224563|NCT02775864|5455453|P1|NOT COMPLETED|Overall Study||3242
2224564|NCT02775864|5455450|P4|COMPLETED|Overall Study||10765
2224565|NCT02775864|5455451|P3|COMPLETED|Overall Study||10081
2224566|NCT02775864|5455452|P2|COMPLETED|Overall Study||26218
2224567|NCT02775864|5455453|P1|COMPLETED|Overall Study||22772
2224568|NCT02775864|5455450|P4|STARTED|Overall Study||12849
2224569|NCT02775864|5455451|P3|STARTED|Overall Study||11941
2224570|NCT02775864|5455452|P2|STARTED|Overall Study||31117
2224571|NCT02775864|5455453|P1|STARTED|Overall Study||26014
2224572|NCT02775617|5455473|P2|NOT COMPLETED|Overall Study||160
2224573|NCT02775617|5455474|P1|NOT COMPLETED|Overall Study||48
2224574|NCT02775617|5455473|P2|COMPLETED|Overall Study|Participants are seen at via a survey of the community. 76.2% of the resident population|478
2224575|NCT02775617|5455474|P1|COMPLETED|Overall Study|Participants are seen at via a survey of the community. 96.3% of the resident population|605
2224576|NCT02775617|5455473|P2|STARTED|Overall Study|Participants are seen at via a survey of the community. 88.9% of the resident population|638
2224577|NCT02775617|5455474|P1|STARTED|Overall Study|Participants are seen at via a survey of the community. 92.6% of the resident population|653
2224588|NCT02775344|5455505|P2|NOT COMPLETED|Overall Study||2
2224589|NCT02775344|5455506|P1|NOT COMPLETED|Overall Study||3
2224590|NCT02775344|5455505|P2|COMPLETED|Overall Study||38
2224591|NCT02775344|5455506|P1|COMPLETED|Overall Study||37
2224592|NCT02775344|5455505|P2|STARTED|Overall Study||40
2224593|NCT02775344|5455506|P1|STARTED|Overall Study||40
2224594|NCT02775240|5455524|P1|NOT COMPLETED|Overall Study||1
2224595|NCT02775240|5455524|P1|COMPLETED|Overall Study||17
2224596|NCT02775240|5455524|P1|Started Treatment B|Overall Study||17
2224597|NCT02775240|5455524|P1|Started Treatment A|Overall Study||18
2224598|NCT02775240|5455524|P1|STARTED|Overall Study||18
2224599|NCT02774941|5455589|P2|NOT COMPLETED|Overall Study||2
2224600|NCT02774941|5455590|P1|NOT COMPLETED|Overall Study||1
2224601|NCT02774941|5455589|P2|COMPLETED|Overall Study||108
2224602|NCT02774941|5455590|P1|COMPLETED|Overall Study||109
2224603|NCT02774941|5455589|P2|Subjects Excluded|Overall Study||2
2224604|NCT02774941|5455590|P1|Subjects Excluded|Overall Study||1
2224605|NCT02774941|5455589|P2|STARTED|Overall Study||110
2224606|NCT02774941|5455590|P1|STARTED|Overall Study||110
2224607|NCT02774850|5455600|P1|NOT COMPLETED|Overall Study||35
2224608|NCT02774850|5455600|P1|COMPLETED|Overall Study||575
2224609|NCT02774850|5455600|P1|Early Discharge Eligible at Int III|Overall Study|7 of these patients were managed as outpatients. 37 were managed as inpatients.|44
2224610|NCT02774850|5455600|P1|Intensification III|Overall Study||48
2224611|NCT02774850|5455600|P1|Early Discharge Eligible at Int II|Overall Study|56 of these patients were managed as outpatients. 229 were managed as inpatients.|285
2224612|NCT02774850|5455600|P1|Intensification II|Overall Study||342
2224613|NCT02774850|5455600|P1|Early Discharge Eligible at Int I|Overall Study|104 of these patients were managed as outpatients. 270 were managed as inpatients.|374
2224614|NCT02774850|5455600|P1|Intensification I|Overall Study||476
2224615|NCT02774850|5455600|P1|Early Discharge Eligible at Induction II|Overall Study|114 of these patients were managed as outpatients. 379 were managed as inpatients.|493
2224616|NCT02774850|5455600|P1|Induction II|Overall Study||564
2224617|NCT02774850|5455600|P1|Early Discharge Eligible at Induction I|Overall Study|24 of these patients were managed as outpatients. 252 were managed as inpatients.|276
2224618|NCT02774850|5455600|P1|Induction I|Overall Study||585
2224619|NCT02774850|5455600|P1|STARTED|Overall Study||610
2224628|NCT02774616|5455615|P3|NOT COMPLETED|Overall Study||3
2224629|NCT02774616|5455616|P2|NOT COMPLETED|Overall Study||11
2224630|NCT02774616|5455617|P1|NOT COMPLETED|Overall Study||15
2224631|NCT02774616|5455615|P3|COMPLETED|Overall Study||13
2224632|NCT02774616|5455616|P2|COMPLETED|Overall Study||156
2224633|NCT02774616|5455617|P1|COMPLETED|Overall Study||80
2224634|NCT02774616|5455615|P3|Other|Overall Study||1
2224635|NCT02774616|5455616|P2|Other|Overall Study||4
2224636|NCT02774616|5455617|P1|Other|Overall Study||2
2224637|NCT02774616|5455615|P3|Device Explanted|Overall Study||1
2224638|NCT02774616|5455616|P2|Device Explanted|Overall Study||1
2224639|NCT02774616|5455617|P1|Device Explanted|Overall Study||2
2224640|NCT02774616|5455615|P3|Lost to FU|Overall Study||0
2224641|NCT02774616|5455616|P2|Lost to FU|Overall Study||0
2224642|NCT02774616|5455617|P1|Lost to FU|Overall Study||2
2224643|NCT02774616|5455615|P3|Withdrew Consent|Overall Study||0
2224644|NCT02774616|5455616|P2|Withdrew Consent|Overall Study||3
2224645|NCT02774616|5455617|P1|Withdrew Consent|Overall Study||3
2224646|NCT02774616|5455615|P3|Died|Overall Study||1
2224647|NCT02774616|5455616|P2|Died|Overall Study||3
2224648|NCT02774616|5455617|P1|Died|Overall Study||6
2224649|NCT02774616|5455615|P3|STARTED|Overall Study||16
2224650|NCT02774616|5455616|P2|STARTED|Overall Study||167
2224651|NCT02774616|5455617|P1|STARTED|Overall Study||95
2224652|NCT02774343|5455630|P2|NOT COMPLETED|Overall Study||3
2224653|NCT02774343|5455631|P1|NOT COMPLETED|Overall Study||6
2224654|NCT02774343|5455630|P2|COMPLETED|Overall Study||12
2224655|NCT02774343|5455631|P1|COMPLETED|Overall Study||9
2224656|NCT02774343|5455630|P2|Received at Least One Capsule|Overall Study||14
2224657|NCT02774343|5455631|P1|Received at Least One Capsule|Overall Study||12
2224658|NCT02774343|5455630|P2|STARTED|Overall Study||15
2224659|NCT02774343|5455631|P1|STARTED|Overall Study||15
2224660|NCT02774278|5455667|P1|NOT COMPLETED|Overall Study||264
2224661|NCT02774278|5455667|P1|COMPLETED|Overall Study||0
2224662|NCT02774278|5455667|P1|Safety Analysis Population (SAP)|Overall Study|SAP: all participants who received at least 1 dose of trial medication and had a safety follow-up.|261
2224663|NCT02774278|5455667|P1|STARTED|Overall Study||264
2224664|NCT02774265|5455677|P2|NOT COMPLETED|Overall Study||6
2224665|NCT02774265|5455678|P1|NOT COMPLETED|Overall Study||13
2224666|NCT02774265|5455677|P2|COMPLETED|Overall Study||159
2224667|NCT02774265|5455678|P1|COMPLETED|Overall Study||151
2224668|NCT02774265|5455677|P2|STARTED|Overall Study||165
2224669|NCT02774265|5455678|P1|STARTED|Overall Study||164
2224670|NCT02774213|5455688|P1|NOT COMPLETED|Overall Study||19
2224671|NCT02774213|5455688|P1|COMPLETED|Overall Study||55
2224672|NCT02774213|5455688|P1|STARTED|Overall Study||74
2224673|NCT02774148|5455701|P2|NOT COMPLETED|Overall Study||0
2224674|NCT02774148|5455702|P1|NOT COMPLETED|Overall Study||0
2224675|NCT02774148|5455701|P2|COMPLETED|Overall Study||0
2224676|NCT02774148|5455702|P1|COMPLETED|Overall Study||0
2224677|NCT02774148|5455701|P2|STARTED|Overall Study||0
2224678|NCT02774148|5455702|P1|STARTED|Overall Study||0
2224679|NCT02773836|5455722|P6|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
2224680|NCT02773836|5455723|P5|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
2224681|NCT02773836|5455724|P4|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
2224682|NCT02773836|5455725|P3|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
2224683|NCT02773836|5455726|P2|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
2224684|NCT02773836|5455727|P1|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
2224685|NCT02773836|5455722|P6|COMPLETED|Wave 2- Post-TPD Implementation||998
2224686|NCT02773836|5455723|P5|COMPLETED|Wave 2- Post-TPD Implementation||1002
2224687|NCT02773836|5455724|P4|COMPLETED|Wave 2- Post-TPD Implementation||1010
2224688|NCT02773836|5455725|P3|COMPLETED|Wave 2- Post-TPD Implementation||1003
2224689|NCT02773836|5455726|P2|COMPLETED|Wave 2- Post-TPD Implementation||1013
2224690|NCT02773836|5455727|P1|COMPLETED|Wave 2- Post-TPD Implementation||1010
2224691|NCT02773836|5455722|P6|STARTED|Wave 2- Post-TPD Implementation||998
2224692|NCT02773836|5455723|P5|STARTED|Wave 2- Post-TPD Implementation||1002
2224693|NCT02773836|5455724|P4|STARTED|Wave 2- Post-TPD Implementation||1010
2224694|NCT02773836|5455725|P3|STARTED|Wave 2- Post-TPD Implementation||1003
2224695|NCT02773836|5455726|P2|STARTED|Wave 2- Post-TPD Implementation||1013
2224696|NCT02773836|5455727|P1|STARTED|Wave 2- Post-TPD Implementation||1010
2224697|NCT02773836|5455722|P6|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
2224698|NCT02773836|5455723|P5|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
2224699|NCT02773836|5455724|P4|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
2224700|NCT02773836|5455725|P3|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
2224701|NCT02773836|5455726|P2|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
2224702|NCT02773836|5455727|P1|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
2224703|NCT02773836|5455722|P6|COMPLETED|Wave 1- Pre-TPD Implementation||1006
2224704|NCT02773836|5455723|P5|COMPLETED|Wave 1- Pre-TPD Implementation||1000
2224705|NCT02773836|5455724|P4|COMPLETED|Wave 1- Pre-TPD Implementation||1001
2224706|NCT02773836|5455725|P3|COMPLETED|Wave 1- Pre-TPD Implementation||1001
2224707|NCT02773836|5455726|P2|COMPLETED|Wave 1- Pre-TPD Implementation||1003
2224708|NCT02773836|5455727|P1|COMPLETED|Wave 1- Pre-TPD Implementation||1000
2224709|NCT02773836|5455722|P6|STARTED|Wave 1- Pre-TPD Implementation||1006
2224710|NCT02773836|5455723|P5|STARTED|Wave 1- Pre-TPD Implementation||1000
2224711|NCT02773836|5455724|P4|STARTED|Wave 1- Pre-TPD Implementation||1001
2224712|NCT02773836|5455725|P3|STARTED|Wave 1- Pre-TPD Implementation||1001
2224713|NCT02773836|5455726|P2|STARTED|Wave 1- Pre-TPD Implementation||1003
2224714|NCT02773836|5455727|P1|STARTED|Wave 1- Pre-TPD Implementation||1000
2224715|NCT02773758|5455815|P2|NOT COMPLETED|Overall Study||0
2224716|NCT02773758|5455816|P1|NOT COMPLETED|Overall Study||0
2224717|NCT02773758|5455815|P2|COMPLETED|Overall Study||70
2224718|NCT02773758|5455816|P1|COMPLETED|Overall Study||71
2224719|NCT02773758|5455815|P2|STARTED|Overall Study||70
2224720|NCT02773758|5455816|P1|STARTED|Overall Study||71
2224727|NCT02773537|5455842|P3|NOT COMPLETED|Overall Study||4
2224728|NCT02773537|5455843|P2|NOT COMPLETED|Overall Study||1
2224729|NCT02773537|5455844|P1|NOT COMPLETED|Overall Study||0
2224730|NCT02773537|5455842|P3|COMPLETED|Overall Study||21
2224731|NCT02773537|5455843|P2|COMPLETED|Overall Study||24
2224732|NCT02773537|5455844|P1|COMPLETED|Overall Study||25
2224733|NCT02773537|5455842|P3|STARTED|Overall Study||25
2224734|NCT02773537|5455843|P2|STARTED|Overall Study||25
2224735|NCT02773537|5455844|P1|STARTED|Overall Study||25
2224736|NCT02773446|5455879|P6|NOT COMPLETED|Second Admission||0
2224737|NCT02773446|5455880|P5|NOT COMPLETED|Second Admission||0
2224738|NCT02773446|5455881|P4|NOT COMPLETED|Second Admission||0
2224739|NCT02773446|5455882|P3|NOT COMPLETED|Second Admission||0
2224740|NCT02773446|5455883|P2|NOT COMPLETED|Second Admission||0
2224741|NCT02773446|5455884|P1|NOT COMPLETED|Second Admission||0
2224742|NCT02773446|5455879|P6|COMPLETED|Second Admission||19
2224743|NCT02773446|5455880|P5|COMPLETED|Second Admission||11
2224744|NCT02773446|5455881|P4|COMPLETED|Second Admission||0
2224745|NCT02773446|5455882|P3|COMPLETED|Second Admission||0
2224746|NCT02773446|5455883|P2|COMPLETED|Second Admission||0
2224747|NCT02773446|5455884|P1|COMPLETED|Second Admission||0
2224748|NCT02773446|5455879|P6|STARTED|Second Admission||19
2224749|NCT02773446|5455880|P5|STARTED|Second Admission||11
2224750|NCT02773446|5455881|P4|STARTED|Second Admission||0
2224751|NCT02773446|5455882|P3|STARTED|Second Admission||0
2224752|NCT02773446|5455883|P2|STARTED|Second Admission||0
2224753|NCT02773446|5455884|P1|STARTED|Second Admission||0
2224754|NCT02773446|5455879|P6|NOT COMPLETED|First Admission||0
2224755|NCT02773446|5455880|P5|NOT COMPLETED|First Admission||0
2224756|NCT02773446|5455881|P4|NOT COMPLETED|First Admission||1
2224757|NCT02773446|5455882|P3|NOT COMPLETED|First Admission||0
2224758|NCT02773446|5455883|P2|NOT COMPLETED|First Admission||0
2224759|NCT02773446|5455884|P1|NOT COMPLETED|First Admission||1
2224760|NCT02773446|5455879|P6|COMPLETED|First Admission||0
2224761|NCT02773446|5455880|P5|COMPLETED|First Admission||0
2224762|NCT02773446|5455881|P4|COMPLETED|First Admission||6
2224763|NCT02773446|5455882|P3|COMPLETED|First Admission||7
2224764|NCT02773446|5455883|P2|COMPLETED|First Admission||7
2224765|NCT02773446|5455884|P1|COMPLETED|First Admission||6
2224766|NCT02773446|5455879|P6|STARTED|First Admission||0
2224767|NCT02773446|5455880|P5|STARTED|First Admission||0
2224768|NCT02773446|5455881|P4|STARTED|First Admission||7
2224769|NCT02773446|5455882|P3|STARTED|First Admission||7
2224770|NCT02773446|5455883|P2|STARTED|First Admission||7
2224771|NCT02773446|5455884|P1|STARTED|First Admission||7
2224772|NCT02773368|5455925|P2|NOT COMPLETED|Overall Study||4
2224773|NCT02773368|5455926|P1|NOT COMPLETED|Overall Study||10
2224774|NCT02773368|5455925|P2|COMPLETED|Overall Study||206
2224775|NCT02773368|5455926|P1|COMPLETED|Overall Study||200
2224776|NCT02773368|5455925|P2|Exposed|Overall Study||210
2224777|NCT02773368|5455926|P1|Exposed|Overall Study||209
2224778|NCT02773368|5455925|P2|STARTED|Overall Study||210
2224779|NCT02773368|5455926|P1|STARTED|Overall Study||210
2224780|NCT02772757|5455999|P3|NOT COMPLETED|Overall Study||5
2224781|NCT02772757|5456000|P2|NOT COMPLETED|Overall Study||3
2224782|NCT02772757|5456001|P1|NOT COMPLETED|Overall Study||1
2224783|NCT02772757|5455999|P3|COMPLETED|Overall Study||21
2224784|NCT02772757|5456000|P2|COMPLETED|Overall Study||21
2224785|NCT02772757|5456001|P1|COMPLETED|Overall Study||21
2224786|NCT02772757|5455999|P3|STARTED|Overall Study||26
2224787|NCT02772757|5456000|P2|STARTED|Overall Study||24
2224788|NCT02772757|5456001|P1|STARTED|Overall Study||22
2224789|NCT02772666|5456018|P1|NOT COMPLETED|SFT Then O-Glass||0
2224790|NCT02772666|5456018|P1|COMPLETED|SFT Then O-Glass||44
2224791|NCT02772666|5456018|P1|STARTED|SFT Then O-Glass||44
2224792|NCT02772666|5456018|P1|NOT COMPLETED|O-Glas Then SFT||0
2224793|NCT02772666|5456018|P1|COMPLETED|O-Glas Then SFT||44
2224794|NCT02772666|5456018|P1|STARTED|O-Glas Then SFT||44
2224795|NCT02772432|5456025|P2|NOT COMPLETED|Overall Study||1
2224796|NCT02772432|5456026|P1|NOT COMPLETED|Overall Study||12
2224797|NCT02772432|5456025|P2|COMPLETED|Overall Study||21
2224798|NCT02772432|5456026|P1|COMPLETED|Overall Study||19
2224799|NCT02772432|5456025|P2|STARTED|Overall Study||22
2224800|NCT02772432|5456026|P1|STARTED|Overall Study||31
2224801|NCT02771522|5456036|P1|NOT COMPLETED|Overall Study||8
2224802|NCT02771522|5456036|P1|COMPLETED|Overall Study|87 teeth imaged with the Calcivis System fro 22 patients|22
2224803|NCT02771522|5456036|P1|STARTED|Overall Study|119 teeth imaged with the Calcivis System from 30 patients|30
2224804|NCT02771366|5456047|P2|NOT COMPLETED|Period 2 (Crossover)||0
2224805|NCT02771366|5456048|P1|NOT COMPLETED|Period 2 (Crossover)||2
2224806|NCT02771366|5456047|P2|COMPLETED|Period 2 (Crossover)||13
2224807|NCT02771366|5456048|P1|COMPLETED|Period 2 (Crossover)||13
2224808|NCT02771366|5456047|P2|STARTED|Period 2 (Crossover)||13
2224809|NCT02771366|5456048|P1|STARTED|Period 2 (Crossover)||15
2224810|NCT02771366|5456047|P2|NOT COMPLETED|Period 1||2
2224811|NCT02771366|5456048|P1|NOT COMPLETED|Period 1||0
2224812|NCT02771366|5456047|P2|COMPLETED|Period 1||13
2224813|NCT02771366|5456048|P1|COMPLETED|Period 1||15
2224814|NCT02771366|5456047|P2|STARTED|Period 1||15
2224815|NCT02771366|5456048|P1|STARTED|Period 1||15
2224816|NCT02771275|5456055|P1|NOT COMPLETED|Overall Study||13
2224817|NCT02771275|5456055|P1|COMPLETED|Overall Study||0
2224818|NCT02771275|5456055|P1|STARTED|Overall Study||13
2224819|NCT02771145|5456063|P1|NOT COMPLETED|Overall Study||4
2224820|NCT02771145|5456063|P1|COMPLETED|Overall Study||86
2224821|NCT02771145|5456063|P1|STARTED|Overall Study||90
2224822|NCT02771093|5456104|P2|NOT COMPLETED|Overall Study||0
2224823|NCT02771093|5456105|P1|NOT COMPLETED|Overall Study||0
2224824|NCT02771093|5456104|P2|COMPLETED|Overall Study||14
2224825|NCT02771093|5456105|P1|COMPLETED|Overall Study||13
2224826|NCT02771093|5456104|P2|STARTED|Overall Study||14
2224827|NCT02771093|5456105|P1|STARTED|Overall Study||13
2224828|NCT02770625|5456157|P1|NOT COMPLETED|Overall Study||0
2224829|NCT02770625|5456157|P1|COMPLETED|Overall Study||8
2224830|NCT02770625|5456157|P1|STARTED|Overall Study||8
2224831|NCT02770612|5456170|P1|NOT COMPLETED|Overall Study||1
2224832|NCT02770612|5456170|P1|COMPLETED|Overall Study||50
2224833|NCT02770612|5456170|P1|STARTED|Overall Study||51
2224834|NCT02770547|5456176|P2|NOT COMPLETED|Overall Study||1
2224835|NCT02770547|5456177|P1|NOT COMPLETED|Overall Study||1
2224836|NCT02770547|5456176|P2|COMPLETED|Overall Study||15
2224837|NCT02770547|5456177|P1|COMPLETED|Overall Study||15
2224838|NCT02770547|5456176|P2|STARTED|Overall Study||16
2224839|NCT02770547|5456177|P1|STARTED|Overall Study||16
2224840|NCT02770287|5456197|P1|NOT COMPLETED|Overall Study||0
2224841|NCT02770287|5456197|P1|COMPLETED|Overall Study||11
2224842|NCT02770287|5456197|P1|STARTED|Overall Study||11
2224843|NCT02770248|5456203|P2|NOT COMPLETED|Overall Study||2
2224844|NCT02770248|5456204|P1|NOT COMPLETED|Overall Study||0
2224845|NCT02770248|5456203|P2|COMPLETED|Overall Study||61
2224846|NCT02770248|5456204|P1|COMPLETED|Overall Study||62
2224847|NCT02770248|5456203|P2|STARTED|Overall Study||63
2224848|NCT02770248|5456204|P1|STARTED|Overall Study||62
2224849|NCT02770014|5456216|P1|NOT COMPLETED|EGFR Exon 19 Pos, Treated With Erlotinib||5
2224850|NCT02770014|5456216|P1|COMPLETED|EGFR Exon 19 Pos, Treated With Erlotinib|Of the 11 participants that had an activating EGFR mutation, 6 started erlotinib treatment.|6
2224851|NCT02770014|5456216|P1|STARTED|EGFR Exon 19 Pos, Treated With Erlotinib|A total of 11 participants were found to have an activating EGFR mutation (exon 19 del or L858R).|11
2224852|NCT02770014|5456216|P1|NOT COMPLETED|Plasma Genotyping||0
2224853|NCT02770014|5456216|P1|COMPLETED|Plasma Genotyping||43
2224854|NCT02770014|5456216|P1|STARTED|Plasma Genotyping||43
2224855|NCT02769858|5456222|P1|NOT COMPLETED|Overall Study||2
2224856|NCT02769858|5456222|P1|COMPLETED|Overall Study||8
2224857|NCT02769858|5456222|P1|STARTED|Overall Study||10
2224858|NCT02769702|5456228|P1|NOT COMPLETED|Overall Study||0
2224859|NCT02769702|5456228|P1|COMPLETED|Overall Study||2
2224860|NCT02769702|5456228|P1|STARTED|Overall Study||2
2224861|NCT02769442|5456235|P2|NOT COMPLETED|Overall Study||0
2224862|NCT02769442|5456236|P1|NOT COMPLETED|Overall Study||0
2224863|NCT02769442|5456235|P2|COMPLETED|Overall Study||291
2224864|NCT02769442|5456236|P1|COMPLETED|Overall Study||309
2224865|NCT02769442|5456235|P2|STARTED|Overall Study||291
2224866|NCT02769442|5456236|P1|STARTED|Overall Study||309
2224867|NCT02769312|5456246|P2|NOT COMPLETED|Follow-up||1
2224868|NCT02769312|5456247|P1|NOT COMPLETED|Follow-up||1
2224869|NCT02769312|5456246|P2|COMPLETED|Follow-up||23
2224870|NCT02769312|5456247|P1|COMPLETED|Follow-up||22
2224871|NCT02769312|5456246|P2|STARTED|Follow-up||24
2224872|NCT02769312|5456247|P1|STARTED|Follow-up||23
2224873|NCT02769312|5456246|P2|NOT COMPLETED|Unblinded (Optional 2-4 Weeks)||1
2224874|NCT02769312|5456247|P1|NOT COMPLETED|Unblinded (Optional 2-4 Weeks)||1
2224875|NCT02769312|5456246|P2|COMPLETED|Unblinded (Optional 2-4 Weeks)||23
2224876|NCT02769312|5456247|P1|COMPLETED|Unblinded (Optional 2-4 Weeks)||20
2224877|NCT02769312|5456246|P2|STARTED|Unblinded (Optional 2-4 Weeks)||24
2224878|NCT02769312|5456247|P1|STARTED|Unblinded (Optional 2-4 Weeks)|2 participants chose not to continue with the unblinded period.|21
2224879|NCT02769312|5456246|P2|NOT COMPLETED|Double-Blind (0-2 Weeks)||1
2224880|NCT02769312|5456247|P1|NOT COMPLETED|Double-Blind (0-2 Weeks)||2
2224881|NCT02769312|5456246|P2|COMPLETED|Double-Blind (0-2 Weeks)||24
2224882|NCT02769312|5456247|P1|COMPLETED|Double-Blind (0-2 Weeks)||23
2224883|NCT02769312|5456246|P2|STARTED|Double-Blind (0-2 Weeks)||25
2224884|NCT02769312|5456247|P1|STARTED|Double-Blind (0-2 Weeks)||25
2224885|NCT02769247|5456264|P4|NOT COMPLETED|Overall Study||1
2224886|NCT02769247|5456265|P3|NOT COMPLETED|Overall Study||1
2224887|NCT02769247|5456266|P2|NOT COMPLETED|Overall Study||0
2224888|NCT02769247|5456267|P1|NOT COMPLETED|Overall Study||2
2224889|NCT02769247|5456264|P4|COMPLETED|Overall Study|1 patient decided against study participation after enrollment/randomization|39
2224890|NCT02769247|5456265|P3|COMPLETED|Overall Study|1 took non-study med after enrollment/randomization, before IUD insertion (excluded from study)|39
2224891|NCT02769247|5456266|P2|COMPLETED|Overall Study||40
2224892|NCT02769247|5456267|P1|COMPLETED|Overall Study|unable to insert IUD in one patient; 1 pt decided against study participation after enrollment|38
2224893|NCT02769247|5456264|P4|STARTED|Overall Study||40
2224894|NCT02769247|5456265|P3|STARTED|Overall Study||40
2224895|NCT02769247|5456266|P2|STARTED|Overall Study||40
2224896|NCT02769247|5456267|P1|STARTED|Overall Study||40
2224897|NCT02769065|5456335|P30|NOT COMPLETED|Overall Study||0
2224898|NCT02769065|5456336|P29|NOT COMPLETED|Overall Study||0
2224899|NCT02769065|5456337|P28|NOT COMPLETED|Overall Study||0
2224900|NCT02769065|5456338|P27|NOT COMPLETED|Overall Study||0
2224901|NCT02769065|5456339|P26|NOT COMPLETED|Overall Study||0
2224902|NCT02769065|5456340|P25|NOT COMPLETED|Overall Study||0
2224903|NCT02769065|5456341|P24|NOT COMPLETED|Overall Study||0
2224904|NCT02769065|5456342|P23|NOT COMPLETED|Overall Study||0
2224905|NCT02769065|5456343|P22|NOT COMPLETED|Overall Study||0
2224906|NCT02769065|5456344|P21|NOT COMPLETED|Overall Study||0
2224907|NCT02769065|5456345|P20|NOT COMPLETED|Overall Study||0
2224908|NCT02769065|5456346|P19|NOT COMPLETED|Overall Study||0
2224909|NCT02769065|5456347|P18|NOT COMPLETED|Overall Study||0
2224910|NCT02769065|5456348|P17|NOT COMPLETED|Overall Study||0
2224911|NCT02769065|5456349|P16|NOT COMPLETED|Overall Study||0
2224912|NCT02769065|5456350|P15|NOT COMPLETED|Overall Study||0
2224913|NCT02769065|5456351|P14|NOT COMPLETED|Overall Study||0
2224914|NCT02769065|5456352|P13|NOT COMPLETED|Overall Study||0
2224915|NCT02769065|5456353|P12|NOT COMPLETED|Overall Study||0
2224916|NCT02769065|5456354|P11|NOT COMPLETED|Overall Study||1
2224917|NCT02769065|5456355|P10|NOT COMPLETED|Overall Study||0
2224918|NCT02769065|5456356|P9|NOT COMPLETED|Overall Study||0
2224919|NCT02769065|5456357|P8|NOT COMPLETED|Overall Study||0
2224920|NCT02769065|5456358|P7|NOT COMPLETED|Overall Study||1
2224921|NCT02769065|5456359|P6|NOT COMPLETED|Overall Study||0
2224922|NCT02769065|5456360|P5|NOT COMPLETED|Overall Study||0
2224923|NCT02769065|5456361|P4|NOT COMPLETED|Overall Study||0
2224924|NCT02769065|5456362|P3|NOT COMPLETED|Overall Study||0
2224925|NCT02769065|5456363|P2|NOT COMPLETED|Overall Study||0
2224926|NCT02769065|5456364|P1|NOT COMPLETED|Overall Study||1
2224927|NCT02769065|5456335|P30|COMPLETED|Overall Study||6
2224928|NCT02769065|5456336|P29|COMPLETED|Overall Study||6
2224929|NCT02769065|5456337|P28|COMPLETED|Overall Study||5
2224930|NCT02769065|5456338|P27|COMPLETED|Overall Study||9
2224931|NCT02769065|5456339|P26|COMPLETED|Overall Study||9
2224932|NCT02769065|5456340|P25|COMPLETED|Overall Study||6
2224933|NCT02769065|5456341|P24|COMPLETED|Overall Study||6
2224934|NCT02769065|5456342|P23|COMPLETED|Overall Study||4
2224935|NCT02769065|5456343|P22|COMPLETED|Overall Study||4
2224936|NCT02769065|5456344|P21|COMPLETED|Overall Study||4
2224937|NCT02769065|5456345|P20|COMPLETED|Overall Study||0
2224938|NCT02769065|5456346|P19|COMPLETED|Overall Study||5
2224939|NCT02769065|5456347|P18|COMPLETED|Overall Study||5
2224940|NCT02769065|5456348|P17|COMPLETED|Overall Study||5
2224941|NCT02769065|5456349|P16|COMPLETED|Overall Study||3
2224942|NCT02769065|5456350|P15|COMPLETED|Overall Study||6
2224943|NCT02769065|5456351|P14|COMPLETED|Overall Study||6
2224944|NCT02769065|5456352|P13|COMPLETED|Overall Study||6
2224945|NCT02769065|5456353|P12|COMPLETED|Overall Study||6
2224946|NCT02769065|5456354|P11|COMPLETED|Overall Study||5
2224947|NCT02769065|5456355|P10|COMPLETED|Overall Study||6
2224948|NCT02769065|5456356|P9|COMPLETED|Overall Study||6
2224949|NCT02769065|5456357|P8|COMPLETED|Overall Study||6
2224950|NCT02769065|5456358|P7|COMPLETED|Overall Study||6
2224951|NCT02769065|5456359|P6|COMPLETED|Overall Study||6
2224952|NCT02769065|5456360|P5|COMPLETED|Overall Study||6
2224953|NCT02769065|5456361|P4|COMPLETED|Overall Study||6
2224954|NCT02769065|5456362|P3|COMPLETED|Overall Study||6
2224955|NCT02769065|5456363|P2|COMPLETED|Overall Study||6
2224956|NCT02769065|5456364|P1|COMPLETED|Overall Study||16
2224957|NCT02769065|5456335|P30|STARTED|Overall Study||6
2224958|NCT02769065|5456336|P29|STARTED|Overall Study||6
2224959|NCT02769065|5456337|P28|STARTED|Overall Study||5
2224960|NCT02769065|5456338|P27|STARTED|Overall Study||9
2224961|NCT02769065|5456339|P26|STARTED|Overall Study||9
2224962|NCT02769065|5456340|P25|STARTED|Overall Study||6
2224963|NCT02769065|5456341|P24|STARTED|Overall Study||6
2224964|NCT02769065|5456342|P23|STARTED|Overall Study||4
2224965|NCT02769065|5456343|P22|STARTED|Overall Study||4
2224966|NCT02769065|5456344|P21|STARTED|Overall Study||4
2224967|NCT02769065|5456345|P20|STARTED|Overall Study||0
2224968|NCT02769065|5456346|P19|STARTED|Overall Study||5
2224969|NCT02769065|5456347|P18|STARTED|Overall Study||5
2224970|NCT02769065|5456348|P17|STARTED|Overall Study||5
2224971|NCT02769065|5456349|P16|STARTED|Overall Study||3
2224972|NCT02769065|5456350|P15|STARTED|Overall Study||6
2224973|NCT02769065|5456351|P14|STARTED|Overall Study||6
2224974|NCT02769065|5456352|P13|STARTED|Overall Study||6
2224975|NCT02769065|5456353|P12|STARTED|Overall Study||6
2224976|NCT02769065|5456354|P11|STARTED|Overall Study||6
2224977|NCT02769065|5456355|P10|STARTED|Overall Study||6
2224978|NCT02769065|5456356|P9|STARTED|Overall Study||6
2224979|NCT02769065|5456357|P8|STARTED|Overall Study||6
2224980|NCT02769065|5456358|P7|STARTED|Overall Study||7
2224981|NCT02769065|5456359|P6|STARTED|Overall Study||6
2224982|NCT02769065|5456360|P5|STARTED|Overall Study||6
2224983|NCT02769065|5456361|P4|STARTED|Overall Study||6
2224984|NCT02769065|5456362|P3|STARTED|Overall Study||6
2224985|NCT02769065|5456363|P2|STARTED|Overall Study||6
2224986|NCT02769065|5456364|P1|STARTED|Overall Study||17
2224987|NCT02768870|5456774|P1|NOT COMPLETED|Overall Study||26
2224988|NCT02768870|5456774|P1|COMPLETED|Overall Study||0
2224989|NCT02768870|5456774|P1|Implanted With Device|Overall Study||24
2224990|NCT02768870|5456774|P1|STARTED|Overall Study||26
2224991|NCT02768753|5456784|P2|NOT COMPLETED|Overall Study||0
2224992|NCT02768753|5456785|P1|NOT COMPLETED|Overall Study||0
2224993|NCT02768753|5456784|P2|COMPLETED|Overall Study||30
2224994|NCT02768753|5456785|P1|COMPLETED|Overall Study||30
2224995|NCT02768753|5456784|P2|STARTED|Overall Study||30
2224996|NCT02768753|5456785|P1|STARTED|Overall Study||30
2225005|NCT02768194|5456816|P6|NOT COMPLETED|Period 3||0
2225006|NCT02768194|5456817|P5|NOT COMPLETED|Period 3||0
2225007|NCT02768194|5456818|P4|NOT COMPLETED|Period 3||0
2225008|NCT02768194|5456819|P3|NOT COMPLETED|Period 3||0
2225009|NCT02768194|5456820|P2|NOT COMPLETED|Period 3||1
2225010|NCT02768194|5456821|P1|NOT COMPLETED|Period 3||0
2225011|NCT02768194|5456816|P6|COMPLETED|Period 3||4
2225012|NCT02768194|5456817|P5|COMPLETED|Period 3||4
2225013|NCT02768194|5456818|P4|COMPLETED|Period 3||3
2225014|NCT02768194|5456819|P3|COMPLETED|Period 3||4
2225015|NCT02768194|5456820|P2|COMPLETED|Period 3||3
2225016|NCT02768194|5456821|P1|COMPLETED|Period 3||3
2225017|NCT02768194|5456816|P6|STARTED|Period 3||4
2225018|NCT02768194|5456817|P5|STARTED|Period 3||4
2225019|NCT02768194|5456818|P4|STARTED|Period 3||3
2225020|NCT02768194|5456819|P3|STARTED|Period 3||4
2225021|NCT02768194|5456820|P2|STARTED|Period 3||4
2225022|NCT02768194|5456821|P1|STARTED|Period 3||3
2225023|NCT02768194|5456816|P6|NOT COMPLETED|Period 2||0
2225024|NCT02768194|5456817|P5|NOT COMPLETED|Period 2||0
2225025|NCT02768194|5456818|P4|NOT COMPLETED|Period 2||0
2225026|NCT02768194|5456819|P3|NOT COMPLETED|Period 2||0
2225027|NCT02768194|5456820|P2|NOT COMPLETED|Period 2||0
2225028|NCT02768194|5456821|P1|NOT COMPLETED|Period 2||1
2225029|NCT02768194|5456816|P6|COMPLETED|Period 2||4
2225030|NCT02768194|5456817|P5|COMPLETED|Period 2||4
2225031|NCT02768194|5456818|P4|COMPLETED|Period 2||3
2225032|NCT02768194|5456819|P3|COMPLETED|Period 2||4
2225033|NCT02768194|5456820|P2|COMPLETED|Period 2||4
2225034|NCT02768194|5456821|P1|COMPLETED|Period 2||3
2225035|NCT02768194|5456816|P6|STARTED|Period 2||4
2225036|NCT02768194|5456817|P5|STARTED|Period 2||4
2225037|NCT02768194|5456818|P4|STARTED|Period 2||3
2225038|NCT02768194|5456819|P3|STARTED|Period 2||4
2225039|NCT02768194|5456820|P2|STARTED|Period 2||4
2225040|NCT02768194|5456821|P1|STARTED|Period 2||4
2225041|NCT02768194|5456816|P6|NOT COMPLETED|Period 1||0
2225042|NCT02768194|5456817|P5|NOT COMPLETED|Period 1||0
2225043|NCT02768194|5456818|P4|NOT COMPLETED|Period 1||1
2225044|NCT02768194|5456819|P3|NOT COMPLETED|Period 1||0
2225045|NCT02768194|5456820|P2|NOT COMPLETED|Period 1||0
2225046|NCT02768194|5456821|P1|NOT COMPLETED|Period 1||0
2225047|NCT02768194|5456816|P6|COMPLETED|Period 1||4
2225048|NCT02768194|5456817|P5|COMPLETED|Period 1||4
2225049|NCT02768194|5456818|P4|COMPLETED|Period 1||3
2225050|NCT02768194|5456819|P3|COMPLETED|Period 1||4
2225051|NCT02768194|5456820|P2|COMPLETED|Period 1||4
2225052|NCT02768194|5456821|P1|COMPLETED|Period 1||4
2225053|NCT02768194|5456816|P6|STARTED|Period 1||4
2225054|NCT02768194|5456817|P5|STARTED|Period 1||4
2225055|NCT02768194|5456818|P4|STARTED|Period 1||4
2225056|NCT02768194|5456819|P3|STARTED|Period 1||4
2225057|NCT02768194|5456820|P2|STARTED|Period 1||4
2225058|NCT02768194|5456821|P1|STARTED|Period 1||4
2225059|NCT02768129|5456834|P2|NOT COMPLETED|Overall Study||0
2225060|NCT02768129|5456835|P1|NOT COMPLETED|Overall Study||0
2225061|NCT02768129|5456834|P2|COMPLETED|Overall Study||10
2225062|NCT02768129|5456835|P1|COMPLETED|Overall Study||11
2225063|NCT02768129|5456834|P2|STARTED|Overall Study||10
2225064|NCT02768129|5456835|P1|STARTED|Overall Study||11
2225065|NCT02767947|5456845|P2|NOT COMPLETED|Overall Study||0
2225066|NCT02767947|5456846|P1|NOT COMPLETED|Overall Study||0
2225067|NCT02767947|5456845|P2|COMPLETED|Overall Study||15
2225068|NCT02767947|5456846|P1|COMPLETED|Overall Study||60
2225069|NCT02767947|5456845|P2|Pharmacokinetic (PK) Population|Overall Study||3
2225070|NCT02767947|5456846|P1|Pharmacokinetic (PK) Population|Overall Study||12
2225071|NCT02767947|5456845|P2|Safety Population|Overall Study||15
2225072|NCT02767947|5456846|P1|Safety Population|Overall Study||60
2225073|NCT02767947|5456845|P2|STARTED|Overall Study||15
2225074|NCT02767947|5456846|P1|STARTED|Overall Study||60
2225075|NCT02767843|5456854|P1|NOT COMPLETED|Overall Study||0
2225076|NCT02767843|5456854|P1|COMPLETED|Overall Study||4
2225077|NCT02767843|5456854|P1|STARTED|Overall Study||4
2225078|NCT02767765|5456860|P1|NOT COMPLETED|Overall Study||11
2225079|NCT02767765|5456860|P1|COMPLETED|Overall Study||50
2225080|NCT02767765|5456860|P1|STARTED|Overall Study||61
2225081|NCT02767609|5456869|P1|NOT COMPLETED|Overall Study||0
2225082|NCT02767609|5456869|P1|COMPLETED|Overall Study||1
2225083|NCT02767609|5456869|P1|STARTED|Overall Study||1
2225084|NCT02767531|5456873|P2|NOT COMPLETED|Period 4||0
2225085|NCT02767531|5456874|P1|NOT COMPLETED|Period 4||0
2225086|NCT02767531|5456873|P2|COMPLETED|Period 4||1
2225087|NCT02767531|5456874|P1|COMPLETED|Period 4||1
2225088|NCT02767531|5456873|P2|STARTED|Period 4|Orlistat Therapy|1
2225089|NCT02767531|5456874|P1|STARTED|Period 4|Off Orlistat|1
2225090|NCT02767531|5456873|P2|NOT COMPLETED|Period 3||0
2225091|NCT02767531|5456874|P1|NOT COMPLETED|Period 3||0
2225092|NCT02767531|5456873|P2|COMPLETED|Period 3||1
2225093|NCT02767531|5456874|P1|COMPLETED|Period 3||1
2225094|NCT02767531|5456873|P2|STARTED|Period 3|Off Orlistat|1
2225095|NCT02767531|5456874|P1|STARTED|Period 3|Orlistat Therapy|1
2225096|NCT02767531|5456873|P2|NOT COMPLETED|Period 2||0
2225097|NCT02767531|5456874|P1|NOT COMPLETED|Period 2||0
2225098|NCT02767531|5456873|P2|COMPLETED|Period 2||1
2225099|NCT02767531|5456874|P1|COMPLETED|Period 2||1
2225100|NCT02767531|5456873|P2|STARTED|Period 2|Orlistat Therapy|1
2225101|NCT02767531|5456874|P1|STARTED|Period 2|Off Orlistat|1
2225102|NCT02767531|5456873|P2|NOT COMPLETED|Period 1||0
2225103|NCT02767531|5456874|P1|NOT COMPLETED|Period 1||0
2225104|NCT02767531|5456873|P2|COMPLETED|Period 1||1
2225105|NCT02767531|5456874|P1|COMPLETED|Period 1||1
2225106|NCT02767531|5456873|P2|STARTED|Period 1|Off Orlistat|1
2225107|NCT02767531|5456874|P1|STARTED|Period 1|Orlistat therapy|1
2225114|NCT02767388|5456892|P3|NOT COMPLETED|Overall Study||3
2225115|NCT02767388|5456893|P2|NOT COMPLETED|Overall Study||5
2225116|NCT02767388|5456894|P1|NOT COMPLETED|Overall Study||7
2225117|NCT02767388|5456892|P3|COMPLETED|Overall Study||12
2225118|NCT02767388|5456893|P2|COMPLETED|Overall Study||10
2225119|NCT02767388|5456894|P1|COMPLETED|Overall Study||8
2225120|NCT02767388|5456892|P3|STARTED|Overall Study||15
2225121|NCT02767388|5456893|P2|STARTED|Overall Study||15
2225122|NCT02767388|5456894|P1|STARTED|Overall Study||15
2225123|NCT02767271|5456913|P2|NOT COMPLETED|Overall Study||0
2225124|NCT02767271|5456914|P1|NOT COMPLETED|Overall Study||0
2225125|NCT02767271|5456913|P2|COMPLETED|Overall Study||15
2225126|NCT02767271|5456914|P1|COMPLETED|Overall Study||15
2225127|NCT02767271|5456913|P2|Pharmacokinetic Cruris (PKC) Population|Overall Study||15
2225128|NCT02767271|5456914|P1|Pharmacokinetic Cruris (PKC) Population|Overall Study||0
2225129|NCT02767271|5456913|P2|Pharmacokinetic Pedis (PKP) Population|Overall Study||0
2225130|NCT02767271|5456914|P1|Pharmacokinetic Pedis (PKP) Population|Overall Study||15
2225131|NCT02767271|5456913|P2|Safety Population|Overall Study||15
2225132|NCT02767271|5456914|P1|Safety Population|Overall Study||15
2225133|NCT02767271|5456913|P2|STARTED|Overall Study||15
2225134|NCT02767271|5456914|P1|STARTED|Overall Study||15
2225135|NCT02767128|5456924|P1|NOT COMPLETED|Overall Study||0
2225136|NCT02767128|5456924|P1|COMPLETED|Overall Study||14
2225137|NCT02767128|5456924|P1|Shohl's + Triferic Immediately|Overall Study||14
2225138|NCT02767128|5456924|P1|Shohl's + Triferic After 10 Min|Overall Study||14
2225139|NCT02767128|5456924|P1|Triferic|Overall Study||14
2225140|NCT02767128|5456924|P1|Shohl's + Fer-In-Sol|Overall Study||14
2225141|NCT02767128|5456924|P1|Fer-In-Sol|Overall Study||14
2225142|NCT02767128|5456924|P1|Baseline|Overall Study||14
2225143|NCT02767128|5456924|P1|STARTED|Overall Study||14
2225144|NCT02767011|5456952|P2|NOT COMPLETED|Overall Study||0
2225145|NCT02767011|5456953|P1|NOT COMPLETED|Overall Study||0
2225146|NCT02767011|5456952|P2|COMPLETED|Overall Study||14
2225147|NCT02767011|5456953|P1|COMPLETED|Overall Study||16
2225148|NCT02767011|5456952|P2|STARTED|Overall Study||14
2225149|NCT02767011|5456953|P1|STARTED|Overall Study||16
2225150|NCT02766907|5456977|P2|NOT COMPLETED|Overall Study||1
2225151|NCT02766907|5456978|P1|NOT COMPLETED|Overall Study||1
2225152|NCT02766907|5456977|P2|COMPLETED|Overall Study||9
2225153|NCT02766907|5456978|P1|COMPLETED|Overall Study||9
2225154|NCT02766907|5456977|P2|STARTED|Overall Study||10
2225155|NCT02766907|5456978|P1|STARTED|Overall Study||10
2225156|NCT02766673|5456986|P6|NOT COMPLETED|Overall Study||1
2225157|NCT02766673|5456987|P5|NOT COMPLETED|Overall Study||0
2225158|NCT02766673|5456988|P4|NOT COMPLETED|Overall Study||0
2225159|NCT02766673|5456989|P3|NOT COMPLETED|Overall Study||0
2225160|NCT02766673|5456990|P2|NOT COMPLETED|Overall Study||0
2225161|NCT02766673|5456991|P1|NOT COMPLETED|Overall Study||1
2225162|NCT02766673|5456986|P6|COMPLETED|Overall Study||3
2225163|NCT02766673|5456987|P5|COMPLETED|Overall Study||4
2225164|NCT02766673|5456988|P4|COMPLETED|Overall Study||4
2225165|NCT02766673|5456989|P3|COMPLETED|Overall Study||4
2225166|NCT02766673|5456990|P2|COMPLETED|Overall Study||4
2225167|NCT02766673|5456991|P1|COMPLETED|Overall Study||3
2225168|NCT02766673|5456986|P6|STARTED|Overall Study||4
2225169|NCT02766673|5456987|P5|STARTED|Overall Study||4
2225170|NCT02766673|5456988|P4|STARTED|Overall Study||4
2225171|NCT02766673|5456989|P3|STARTED|Overall Study||4
2225172|NCT02766673|5456990|P2|STARTED|Overall Study||4
2225173|NCT02766673|5456991|P1|STARTED|Overall Study||4
2225174|NCT02766608|5457007|P5|NOT COMPLETED|Overall Study||29
2225175|NCT02766608|5457008|P4|NOT COMPLETED|Overall Study||37
2225176|NCT02766608|5457009|P3|NOT COMPLETED|Overall Study||90
2225177|NCT02766608|5457010|P2|NOT COMPLETED|Overall Study||70
2225178|NCT02766608|5457011|P1|NOT COMPLETED|Overall Study||79
2225179|NCT02766608|5457007|P5|COMPLETED|Overall Study||190
2225180|NCT02766608|5457008|P4|COMPLETED|Overall Study||169
2225181|NCT02766608|5457009|P3|COMPLETED|Overall Study||554
2225182|NCT02766608|5457010|P2|COMPLETED|Overall Study||567
2225183|NCT02766608|5457011|P1|COMPLETED|Overall Study||576
2225184|NCT02766608|5457007|P5|STARTED|Overall Study||219
2225185|NCT02766608|5457008|P4|STARTED|Overall Study||206
2225186|NCT02766608|5457009|P3|STARTED|Overall Study||644
2225187|NCT02766608|5457010|P2|STARTED|Overall Study||637
2225188|NCT02766608|5457011|P1|STARTED|Overall Study||655
2225189|NCT02766517|5457088|P3|NOT COMPLETED|Overall Study||0
2225190|NCT02766517|5457089|P2|NOT COMPLETED|Overall Study||0
2225191|NCT02766517|5457090|P1|NOT COMPLETED|Overall Study||0
2225192|NCT02766517|5457088|P3|COMPLETED|Overall Study||9
2225193|NCT02766517|5457089|P2|COMPLETED|Overall Study||9
2225194|NCT02766517|5457090|P1|COMPLETED|Overall Study||19
2225195|NCT02766517|5457088|P3|STARTED|Overall Study||9
2225196|NCT02766517|5457089|P2|STARTED|Overall Study||9
2225197|NCT02766517|5457090|P1|STARTED|Overall Study||19
2225198|NCT02766400|5457103|P2|NOT COMPLETED|Overall Study||2
2225199|NCT02766400|5457104|P1|NOT COMPLETED|Overall Study||2
2225200|NCT02766400|5457103|P2|COMPLETED|Overall Study||20
2225201|NCT02766400|5457104|P1|COMPLETED|Overall Study||19
2225202|NCT02766400|5457103|P2|STARTED|Overall Study||22
2225203|NCT02766400|5457104|P1|STARTED|Overall Study||21
2225204|NCT02766374|5457112|P2|NOT COMPLETED|Overall Study||3
2225205|NCT02766374|5457113|P1|NOT COMPLETED|Overall Study||10
2225206|NCT02766374|5457112|P2|COMPLETED|Overall Study||30
2225207|NCT02766374|5457113|P1|COMPLETED|Overall Study||25
2225208|NCT02766374|5457112|P2|STARTED|Overall Study||33
2225209|NCT02766374|5457113|P1|STARTED|Overall Study||35
2225210|NCT02766283|5457119|P1|NOT COMPLETED|Overall Study||27
2225211|NCT02766283|5457119|P1|COMPLETED|Overall Study||816
2225212|NCT02766283|5457119|P1|STARTED|Overall Study||843
2225213|NCT02766244|5457143|P1|NOT COMPLETED|Overall Study||0
2225214|NCT02766244|5457143|P1|COMPLETED|Overall Study||3
2225215|NCT02766244|5457143|P1|STARTED|Overall Study||3
2225216|NCT02766023|5457154|P2|NOT COMPLETED|Overall Study||17
2225217|NCT02766023|5457155|P1|NOT COMPLETED|Overall Study||30
2225218|NCT02766023|5457154|P2|COMPLETED|Overall Study||59
2225219|NCT02766023|5457155|P1|COMPLETED|Overall Study||122
2225220|NCT02766023|5457154|P2|STARTED|Overall Study||76
2225221|NCT02766023|5457155|P1|STARTED|Overall Study||152
2225222|NCT02765490|5457205|P2|NOT COMPLETED|Overall Study||3
2225223|NCT02765490|5457206|P1|NOT COMPLETED|Overall Study||1
2225224|NCT02765490|5457205|P2|COMPLETED|Overall Study||179
2225225|NCT02765490|5457206|P1|COMPLETED|Overall Study||182
2225226|NCT02765490|5457205|P2|STARTED|Overall Study||182
2225227|NCT02765490|5457206|P1|STARTED|Overall Study||183
2225228|NCT02765269|5457224|P2|NOT COMPLETED|Overall Study||0
2225229|NCT02765269|5457225|P1|NOT COMPLETED|Overall Study||0
2225230|NCT02765269|5457224|P2|COMPLETED|Overall Study||21
2225231|NCT02765269|5457225|P1|COMPLETED|Overall Study||25
2225232|NCT02765269|5457224|P2|STARTED|Overall Study||21
2225233|NCT02765269|5457225|P1|STARTED|Overall Study||25
2225234|NCT02764970|5457239|P2|NOT COMPLETED|Overall Study||0
2225235|NCT02764970|5457240|P1|NOT COMPLETED|Overall Study||0
2225236|NCT02764970|5457239|P2|COMPLETED|Overall Study||47
2225237|NCT02764970|5457240|P1|COMPLETED|Overall Study||65
2225238|NCT02764970|5457239|P2|STARTED|Overall Study||47
2225239|NCT02764970|5457240|P1|STARTED|Overall Study||65
2225240|NCT02764775|5457252|P1|NOT COMPLETED|Overall Study||6
2225241|NCT02764775|5457252|P1|COMPLETED|Overall Study||8
2225242|NCT02764775|5457252|P1|STARTED|Overall Study|All 14 participants were assigned to the Headpod utilization group.|14
2225243|NCT02764697|5457256|P1|NOT COMPLETED|Overall Study||3
2225244|NCT02764697|5457256|P1|COMPLETED|Overall Study||2
2225245|NCT02764697|5457256|P1|STARTED|Overall Study||5
2225246|NCT02764229|5457261|P1|NOT COMPLETED|Overall Study||102
2225247|NCT02764229|5457261|P1|COMPLETED|Overall Study||10
2225248|NCT02764229|5457261|P1|STARTED|Overall Study||112
2225249|NCT02764190|5457267|P2|NOT COMPLETED|Overall Study||13
2225250|NCT02764190|5457268|P1|NOT COMPLETED|Overall Study||17
2225251|NCT02764190|5457267|P2|COMPLETED|Overall Study||122
2225252|NCT02764190|5457268|P1|COMPLETED|Overall Study||150
2225253|NCT02764190|5457267|P2|12 Month Follow-up|Overall Study||122
2225254|NCT02764190|5457268|P1|12 Month Follow-up|Overall Study||150
2225255|NCT02764190|5457267|P2|6 Month Follow-up|Overall Study||128
2225256|NCT02764190|5457268|P1|6 Month Follow-up|Overall Study||155
2225257|NCT02764190|5457267|P2|3 Month Follow-up|Overall Study||128
2225258|NCT02764190|5457268|P1|3 Month Follow-up|Overall Study||156
2225259|NCT02764190|5457267|P2|1 Day Follow-up|Overall Study||131
2225260|NCT02764190|5457268|P1|1 Day Follow-up|Overall Study||161
2225261|NCT02764190|5457267|P2|STARTED|Overall Study||135
2225262|NCT02764190|5457268|P1|STARTED|Overall Study||167
2225263|NCT02764151|5457316|P4|NOT COMPLETED|Overall Study||3
2225264|NCT02764151|5457317|P3|NOT COMPLETED|Overall Study||0
2225265|NCT02764151|5457318|P2|NOT COMPLETED|Overall Study||0
2225266|NCT02764151|5457319|P1|NOT COMPLETED|Overall Study||0
2225267|NCT02764151|5457316|P4|COMPLETED|Overall Study||5
2225268|NCT02764151|5457317|P3|COMPLETED|Overall Study||3
2225269|NCT02764151|5457318|P2|COMPLETED|Overall Study||4
2225270|NCT02764151|5457319|P1|COMPLETED|Overall Study||2
2225271|NCT02764151|5457316|P4|STARTED|Overall Study||8
2225272|NCT02764151|5457317|P3|STARTED|Overall Study||3
2225273|NCT02764151|5457318|P2|STARTED|Overall Study||4
2225274|NCT02764151|5457319|P1|STARTED|Overall Study||2
2225275|NCT02763865|5457443|P2|NOT COMPLETED|Overall Study||0
2225276|NCT02763865|5457444|P1|NOT COMPLETED|Overall Study||0
2225277|NCT02763865|5457443|P2|COMPLETED|Overall Study||5
2225278|NCT02763865|5457444|P1|COMPLETED|Overall Study||5
2225279|NCT02763865|5457443|P2|STARTED|Overall Study||5
2225280|NCT02763865|5457444|P1|STARTED|Overall Study||5
2225281|NCT02763644|5457458|P2|NOT COMPLETED|Overall Study||2
2225282|NCT02763644|5457459|P1|NOT COMPLETED|Overall Study||3
2225283|NCT02763644|5457458|P2|COMPLETED|Overall Study||2
2225284|NCT02763644|5457459|P1|COMPLETED|Overall Study||0
2225285|NCT02763644|5457458|P2|STARTED|Overall Study||4
2225286|NCT02763644|5457459|P1|STARTED|Overall Study||3
2225287|NCT02763579|5457479|P2|NOT COMPLETED|Overall Study||202
2225288|NCT02763579|5457480|P1|NOT COMPLETED|Overall Study||201
2225289|NCT02763579|5457479|P2|COMPLETED|Overall Study||0
2225290|NCT02763579|5457480|P1|COMPLETED|Overall Study||0
2225291|NCT02763579|5457479|P2|STARTED|Overall Study||202
2225292|NCT02763579|5457480|P1|STARTED|Overall Study||201
2225293|NCT02763254|5457488|P1|NOT COMPLETED|Overall Study||1
2225294|NCT02763254|5457488|P1|COMPLETED|Overall Study||0
2225295|NCT02763254|5457488|P1|STARTED|Overall Study||1
2225296|NCT02763189|5457495|P2|NOT COMPLETED|Overall Study||2
2225297|NCT02763189|5457496|P1|NOT COMPLETED|Overall Study||0
2225298|NCT02763189|5457495|P2|COMPLETED|Overall Study||2
2225299|NCT02763189|5457496|P1|COMPLETED|Overall Study||4
2225300|NCT02763189|5457495|P2|STARTED|Overall Study||4
2225301|NCT02763189|5457496|P1|STARTED|Overall Study||4
2225302|NCT02763124|5457504|P1|NOT COMPLETED|Overall Study||0
2225303|NCT02763124|5457504|P1|COMPLETED|Overall Study||18
2225304|NCT02763124|5457504|P1|STARTED|Overall Study||18
2225305|NCT02762877|5457513|P2|NOT COMPLETED|Overall Study||0
2225306|NCT02762877|5457514|P1|NOT COMPLETED|Overall Study||0
2225307|NCT02762877|5457513|P2|COMPLETED|Overall Study||19
2225308|NCT02762877|5457514|P1|COMPLETED|Overall Study||121
2225309|NCT02762877|5457513|P2|STARTED|Overall Study||19
2225310|NCT02762877|5457514|P1|STARTED|Overall Study||121
2225311|NCT02762799|5457525|P4|NOT COMPLETED|Overall Study||0
2225312|NCT02762799|5457526|P3|NOT COMPLETED|Overall Study||1
2225313|NCT02762799|5457527|P2|NOT COMPLETED|Overall Study||0
2225314|NCT02762799|5457528|P1|NOT COMPLETED|Overall Study||0
2225315|NCT02762799|5457525|P4|COMPLETED|Overall Study||12
2225316|NCT02762799|5457526|P3|COMPLETED|Overall Study||11
2225317|NCT02762799|5457527|P2|COMPLETED|Overall Study||18
2225318|NCT02762799|5457528|P1|COMPLETED|Overall Study||18
2225319|NCT02762799|5457525|P4|STARTED|Overall Study||12
2225320|NCT02762799|5457526|P3|STARTED|Overall Study||12
2225321|NCT02762799|5457527|P2|STARTED|Overall Study||18
2225322|NCT02762799|5457528|P1|STARTED|Overall Study||18
2225323|NCT02762578|5457600|P2|NOT COMPLETED|Overall Study||10
2225324|NCT02762578|5457601|P1|NOT COMPLETED|Overall Study||15
2225325|NCT02762578|5457600|P2|COMPLETED|Overall Study||172
2225326|NCT02762578|5457601|P1|COMPLETED|Overall Study||346
2225327|NCT02762578|5457600|P2|Exposed|Overall Study||181
2225328|NCT02762578|5457601|P1|Exposed|Overall Study||360
2225329|NCT02762578|5457600|P2|STARTED|Overall Study||182
2225330|NCT02762578|5457601|P1|STARTED|Overall Study||361
2225331|NCT02762500|5457703|P2|NOT COMPLETED|Overall Study||3
2225332|NCT02762500|5457704|P1|NOT COMPLETED|Overall Study||2
2225333|NCT02762500|5457703|P2|COMPLETED|Overall Study||59
2225334|NCT02762500|5457704|P1|COMPLETED|Overall Study||60
2225335|NCT02762500|5457703|P2|STARTED|Overall Study||62
2225336|NCT02762500|5457704|P1|STARTED|Overall Study||62
2225337|NCT02762370|5457724|P2|NOT COMPLETED|Overall Study||0
2225338|NCT02762370|5457725|P1|NOT COMPLETED|Overall Study||1
2225339|NCT02762370|5457724|P2|COMPLETED|Overall Study||15
2225340|NCT02762370|5457725|P1|COMPLETED|Overall Study||17
2225341|NCT02762370|5457724|P2|STARTED|Overall Study||15
2225342|NCT02762370|5457725|P1|STARTED|Overall Study||18
2225343|NCT02762331|5457745|P2|NOT COMPLETED|Overall Study||0
2225344|NCT02762331|5457746|P1|NOT COMPLETED|Overall Study||0
2225345|NCT02762331|5457745|P2|COMPLETED|Overall Study||2
2225346|NCT02762331|5457746|P1|COMPLETED|Overall Study||4
2225347|NCT02762331|5457745|P2|STARTED|Overall Study||2
2225348|NCT02762331|5457746|P1|STARTED|Overall Study||4
2225349|NCT02762084|5457765|P3|NOT COMPLETED|Overall Study||1
2225350|NCT02762084|5457766|P2|NOT COMPLETED|Overall Study||0
2225351|NCT02762084|5457767|P1|NOT COMPLETED|Overall Study||1
2225352|NCT02762084|5457765|P3|COMPLETED|Overall Study||4
2225353|NCT02762084|5457766|P2|COMPLETED|Overall Study||6
2225354|NCT02762084|5457767|P1|COMPLETED|Overall Study||5
2225355|NCT02762084|5457765|P3|By Tumor Per Protocol Population (PP)|Overall Study||4
2225356|NCT02762084|5457766|P2|By Tumor Per Protocol Population (PP)|Overall Study||6
2225357|NCT02762084|5457767|P1|By Tumor Per Protocol Population (PP)|Overall Study||6
2225358|NCT02762084|5457765|P3|Received at Least 1 Dose of Study Drug|Overall Study||5
2225359|NCT02762084|5457766|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
2225360|NCT02762084|5457767|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
2225361|NCT02762084|5457765|P3|STARTED|Overall Study||5
2225362|NCT02762084|5457766|P2|STARTED|Overall Study||6
2225363|NCT02762084|5457767|P1|STARTED|Overall Study||6
2225364|NCT02761980|5457809|P4|NOT COMPLETED|Overall Study||6
2225365|NCT02761980|5457810|P3|NOT COMPLETED|Overall Study||6
2225366|NCT02761980|5457811|P2|NOT COMPLETED|Overall Study||7
2225367|NCT02761980|5457812|P1|NOT COMPLETED|Overall Study||4
2225368|NCT02761980|5457809|P4|COMPLETED|Overall Study||81
2225369|NCT02761980|5457810|P3|COMPLETED|Overall Study||81
2225370|NCT02761980|5457811|P2|COMPLETED|Overall Study||80
2225371|NCT02761980|5457812|P1|COMPLETED|Overall Study||25
2225372|NCT02761980|5457809|P4|STARTED|Overall Study||87
2225373|NCT02761980|5457810|P3|STARTED|Overall Study||87
2225374|NCT02761980|5457811|P2|STARTED|Overall Study||87
2225375|NCT02761980|5457812|P1|STARTED|Overall Study||29
2225376|NCT02761967|5457844|P2|NOT COMPLETED|Overall Study||6
2225377|NCT02761967|5457845|P1|NOT COMPLETED|Overall Study||5
2225378|NCT02761967|5457844|P2|COMPLETED|Overall Study||64
2225379|NCT02761967|5457845|P1|COMPLETED|Overall Study||65
2225380|NCT02761967|5457844|P2|STARTED|Overall Study||70
2225381|NCT02761967|5457845|P1|STARTED|Overall Study||70
2225382|NCT02761733|5457859|P4|NOT COMPLETED|Overall Study||15
2225383|NCT02761733|5457860|P3|NOT COMPLETED|Overall Study||27
2225384|NCT02761733|5457861|P2|NOT COMPLETED|Overall Study||21
2225385|NCT02761733|5457862|P1|NOT COMPLETED|Overall Study||30
2225386|NCT02761733|5457859|P4|COMPLETED|Overall Study||45
2225387|NCT02761733|5457860|P3|COMPLETED|Overall Study||33
2225388|NCT02761733|5457861|P2|COMPLETED|Overall Study||39
2225389|NCT02761733|5457862|P1|COMPLETED|Overall Study||30
2225390|NCT02761733|5457859|P4|9/30/2015|Overall Study||50
2225391|NCT02761733|5457860|P3|9/30/2015|Overall Study||33
2225392|NCT02761733|5457861|P2|9/30/2015|Overall Study||44
2225393|NCT02761733|5457862|P1|9/30/2015|Overall Study||40
2225394|NCT02761733|5457859|P4|3/31/2015|Overall Study||50
2225395|NCT02761733|5457860|P3|3/31/2015|Overall Study||43
2225396|NCT02761733|5457861|P2|3/31/2015|Overall Study||47
2225397|NCT02761733|5457862|P1|3/31/2015|Overall Study||48
2225398|NCT02761733|5457859|P4|9/30/2014|Overall Study||55
2225399|NCT02761733|5457860|P3|9/30/2014|Overall Study||48
2225400|NCT02761733|5457861|P2|9/30/2014|Overall Study||56
2225401|NCT02761733|5457862|P1|9/30/2014|Overall Study||53
2225402|NCT02761733|5457859|P4|STARTED|Overall Study||60
2225403|NCT02761733|5457860|P3|STARTED|Overall Study||60
2225404|NCT02761733|5457861|P2|STARTED|Overall Study||60
2225405|NCT02761733|5457862|P1|STARTED|Overall Study||60
2225406|NCT02761642|5457892|P1|NOT COMPLETED|Overall Study||70
2225407|NCT02761642|5457892|P1|COMPLETED|Overall Study||130
2225408|NCT02761642|5457892|P1|Treated|Overall Study||197
2225409|NCT02761642|5457892|P1|STARTED|Overall Study||200
2225410|NCT02761629|5457905|P2|NOT COMPLETED|Overall Study||32
2225411|NCT02761629|5457906|P1|NOT COMPLETED|Overall Study||27
2225412|NCT02761629|5457905|P2|COMPLETED|Overall Study||58
2225413|NCT02761629|5457906|P1|COMPLETED|Overall Study||63
2225414|NCT02761629|5457905|P2|Treated|Overall Study||86
2225415|NCT02761629|5457906|P1|Treated|Overall Study||82
2225416|NCT02761629|5457905|P2|STARTED|Overall Study||90
2225417|NCT02761629|5457906|P1|STARTED|Overall Study||90
2225418|NCT02761252|5457929|P3|NOT COMPLETED|Overall Study||14
2225419|NCT02761252|5457930|P2|NOT COMPLETED|Overall Study||8
2225420|NCT02761252|5457931|P1|NOT COMPLETED|Overall Study||10
2225421|NCT02761252|5457929|P3|COMPLETED|Overall Study||123
2225422|NCT02761252|5457930|P2|COMPLETED|Overall Study||132
2225423|NCT02761252|5457931|P1|COMPLETED|Overall Study||133
2225424|NCT02761252|5457929|P3|STARTED|Overall Study||137
2225425|NCT02761252|5457930|P2|STARTED|Overall Study||140
2225426|NCT02761252|5457931|P1|STARTED|Overall Study||143
2225427|NCT02760927|5457953|P1|NOT COMPLETED|Overall Study||1
2225428|NCT02760927|5457953|P1|COMPLETED|Overall Study||3
2225429|NCT02760927|5457953|P1|STARTED|Overall Study||4
2225430|NCT02760810|5457961|P1|NOT COMPLETED|Overall Study||1
2225431|NCT02760810|5457961|P1|COMPLETED|Overall Study||29
2225432|NCT02760810|5457961|P1|STARTED|Overall Study||30
2225433|NCT02760654|5457969|P2|NOT COMPLETED|Overall Study||6
2225434|NCT02760654|5457970|P1|NOT COMPLETED|Overall Study||7
2225435|NCT02760654|5457969|P2|COMPLETED|Overall Study||24
2225436|NCT02760654|5457970|P1|COMPLETED|Overall Study||23
2225437|NCT02760654|5457969|P2|STARTED|Overall Study||30
2225438|NCT02760654|5457970|P1|STARTED|Overall Study||30
2225439|NCT02760602|5457996|P2|NOT COMPLETED|Overall Study||13
2225440|NCT02760602|5457997|P1|NOT COMPLETED|Overall Study||13
2225441|NCT02760602|5457996|P2|COMPLETED|Overall Study||0
2225442|NCT02760602|5457997|P1|COMPLETED|Overall Study||0
2225443|NCT02760602|5457996|P2|STARTED|Overall Study||13
2225444|NCT02760602|5457997|P1|STARTED|Overall Study||13
2225445|NCT02760277|5458039|P4|NOT COMPLETED|6.0 mg/kg/Day||0
2225446|NCT02760277|5458040|P3|NOT COMPLETED|6.0 mg/kg/Day||0
2225447|NCT02760277|5458041|P2|NOT COMPLETED|6.0 mg/kg/Day||0
2225448|NCT02760277|5458042|P1|NOT COMPLETED|6.0 mg/kg/Day||0
2225449|NCT02760277|5458039|P4|COMPLETED|6.0 mg/kg/Day||12
2225450|NCT02760277|5458040|P3|COMPLETED|6.0 mg/kg/Day||0
2225451|NCT02760277|5458041|P2|COMPLETED|6.0 mg/kg/Day||0
2225452|NCT02760277|5458042|P1|COMPLETED|6.0 mg/kg/Day||0
2225453|NCT02760277|5458039|P4|STARTED|6.0 mg/kg/Day||12
2225454|NCT02760277|5458040|P3|STARTED|6.0 mg/kg/Day||0
2225455|NCT02760277|5458041|P2|STARTED|6.0 mg/kg/Day||0
2225456|NCT02760277|5458042|P1|STARTED|6.0 mg/kg/Day||0
2225457|NCT02760277|5458039|P4|NOT COMPLETED|2.0 mg/kg/Day||0
2225458|NCT02760277|5458040|P3|NOT COMPLETED|2.0 mg/kg/Day||0
2225459|NCT02760277|5458041|P2|NOT COMPLETED|2.0 mg/kg/Day||0
2225460|NCT02760277|5458042|P1|NOT COMPLETED|2.0 mg/kg/Day||0
2225461|NCT02760277|5458039|P4|COMPLETED|2.0 mg/kg/Day||0
2225462|NCT02760277|5458040|P3|COMPLETED|2.0 mg/kg/Day||12
2225463|NCT02760277|5458041|P2|COMPLETED|2.0 mg/kg/Day||0
2225464|NCT02760277|5458042|P1|COMPLETED|2.0 mg/kg/Day||0
2225465|NCT02760277|5458039|P4|STARTED|2.0 mg/kg/Day||0
2225466|NCT02760277|5458040|P3|STARTED|2.0 mg/kg/Day||12
2225467|NCT02760277|5458041|P2|STARTED|2.0 mg/kg/Day||0
2225468|NCT02760277|5458042|P1|STARTED|2.0 mg/kg/Day||0
2225469|NCT02760277|5458039|P4|NOT COMPLETED|0.75 mg/kg/Day||0
2225470|NCT02760277|5458040|P3|NOT COMPLETED|0.75 mg/kg/Day||0
2225471|NCT02760277|5458041|P2|NOT COMPLETED|0.75 mg/kg/Day||0
2225472|NCT02760277|5458042|P1|NOT COMPLETED|0.75 mg/kg/Day||0
2225473|NCT02760277|5458039|P4|COMPLETED|0.75 mg/kg/Day||0
2225474|NCT02760277|5458040|P3|COMPLETED|0.75 mg/kg/Day||0
2225475|NCT02760277|5458041|P2|COMPLETED|0.75 mg/kg/Day||12
2225476|NCT02760277|5458042|P1|COMPLETED|0.75 mg/kg/Day||0
2225477|NCT02760277|5458039|P4|STARTED|0.75 mg/kg/Day||0
2225478|NCT02760277|5458040|P3|STARTED|0.75 mg/kg/Day||0
2225479|NCT02760277|5458041|P2|STARTED|0.75 mg/kg/Day||12
2225480|NCT02760277|5458042|P1|STARTED|0.75 mg/kg/Day||0
2225481|NCT02760277|5458039|P4|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
2225482|NCT02760277|5458040|P3|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
2225483|NCT02760277|5458041|P2|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
2225484|NCT02760277|5458042|P1|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
2225485|NCT02760277|5458039|P4|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
2225486|NCT02760277|5458040|P3|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
2225487|NCT02760277|5458041|P2|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
2225488|NCT02760277|5458042|P1|COMPLETED|Vamorolone 0.25 mg/kg/Day||12
2225489|NCT02760277|5458039|P4|STARTED|Vamorolone 0.25 mg/kg/Day||0
2225490|NCT02760277|5458040|P3|STARTED|Vamorolone 0.25 mg/kg/Day||0
2225491|NCT02760277|5458041|P2|STARTED|Vamorolone 0.25 mg/kg/Day||0
2225492|NCT02760277|5458042|P1|STARTED|Vamorolone 0.25 mg/kg/Day||12
2225493|NCT02760264|5458116|P4|NOT COMPLETED|6.0 mg/kg/Day||0
2225494|NCT02760264|5458117|P3|NOT COMPLETED|6.0 mg/kg/Day||0
2225495|NCT02760264|5458118|P2|NOT COMPLETED|6.0 mg/kg/Day||0
2225496|NCT02760264|5458119|P1|NOT COMPLETED|6.0 mg/kg/Day||0
2225497|NCT02760264|5458116|P4|COMPLETED|6.0 mg/kg/Day||12
2225498|NCT02760264|5458117|P3|COMPLETED|6.0 mg/kg/Day||0
2225499|NCT02760264|5458118|P2|COMPLETED|6.0 mg/kg/Day||0
2225500|NCT02760264|5458119|P1|COMPLETED|6.0 mg/kg/Day||0
2225501|NCT02760264|5458116|P4|STARTED|6.0 mg/kg/Day||12
2225502|NCT02760264|5458117|P3|STARTED|6.0 mg/kg/Day||0
2225503|NCT02760264|5458118|P2|STARTED|6.0 mg/kg/Day||0
2225504|NCT02760264|5458119|P1|STARTED|6.0 mg/kg/Day||0
2225505|NCT02760264|5458116|P4|NOT COMPLETED|2.0 mg/kg/Day||0
2225506|NCT02760264|5458117|P3|NOT COMPLETED|2.0 mg/kg/Day||0
2225507|NCT02760264|5458118|P2|NOT COMPLETED|2.0 mg/kg/Day||0
2225508|NCT02760264|5458119|P1|NOT COMPLETED|2.0 mg/kg/Day||0
2225509|NCT02760264|5458116|P4|COMPLETED|2.0 mg/kg/Day||0
2225510|NCT02760264|5458117|P3|COMPLETED|2.0 mg/kg/Day||12
2225511|NCT02760264|5458118|P2|COMPLETED|2.0 mg/kg/Day||0
2225512|NCT02760264|5458119|P1|COMPLETED|2.0 mg/kg/Day||0
2225513|NCT02760264|5458116|P4|STARTED|2.0 mg/kg/Day||0
2225514|NCT02760264|5458117|P3|STARTED|2.0 mg/kg/Day||12
2225515|NCT02760264|5458118|P2|STARTED|2.0 mg/kg/Day||0
2225516|NCT02760264|5458119|P1|STARTED|2.0 mg/kg/Day||0
2225517|NCT02760264|5458116|P4|NOT COMPLETED|0.75 mg/kg/Day||0
2225518|NCT02760264|5458117|P3|NOT COMPLETED|0.75 mg/kg/Day||0
2225519|NCT02760264|5458118|P2|NOT COMPLETED|0.75 mg/kg/Day||0
2225520|NCT02760264|5458119|P1|NOT COMPLETED|0.75 mg/kg/Day||0
2225521|NCT02760264|5458116|P4|COMPLETED|0.75 mg/kg/Day||0
2225522|NCT02760264|5458117|P3|COMPLETED|0.75 mg/kg/Day||0
2225523|NCT02760264|5458118|P2|COMPLETED|0.75 mg/kg/Day||12
2225524|NCT02760264|5458119|P1|COMPLETED|0.75 mg/kg/Day||0
2225525|NCT02760264|5458116|P4|STARTED|0.75 mg/kg/Day||0
2225526|NCT02760264|5458117|P3|STARTED|0.75 mg/kg/Day||0
2225527|NCT02760264|5458118|P2|STARTED|0.75 mg/kg/Day||12
2225528|NCT02760264|5458119|P1|STARTED|0.75 mg/kg/Day||0
2225529|NCT02760264|5458116|P4|NOT COMPLETED|0.25 mg/kg/Day||0
2225530|NCT02760264|5458117|P3|NOT COMPLETED|0.25 mg/kg/Day||0
2225531|NCT02760264|5458118|P2|NOT COMPLETED|0.25 mg/kg/Day||0
2225532|NCT02760264|5458119|P1|NOT COMPLETED|0.25 mg/kg/Day||0
2225533|NCT02760264|5458116|P4|COMPLETED|0.25 mg/kg/Day||0
2225534|NCT02760264|5458117|P3|COMPLETED|0.25 mg/kg/Day||0
2225535|NCT02760264|5458118|P2|COMPLETED|0.25 mg/kg/Day||0
2225536|NCT02760264|5458119|P1|COMPLETED|0.25 mg/kg/Day||12
2225537|NCT02760264|5458116|P4|STARTED|0.25 mg/kg/Day||0
2225538|NCT02760264|5458117|P3|STARTED|0.25 mg/kg/Day||0
2225539|NCT02760264|5458118|P2|STARTED|0.25 mg/kg/Day||0
2225540|NCT02760264|5458119|P1|STARTED|0.25 mg/kg/Day||12
2225541|NCT02760056|5458196|P2|NOT COMPLETED|Overall Study||0
2225542|NCT02760056|5458197|P1|NOT COMPLETED|Overall Study||0
2225543|NCT02760056|5458196|P2|COMPLETED|Overall Study||5
2225544|NCT02760056|5458197|P1|COMPLETED|Overall Study||10
2225545|NCT02760056|5458196|P2|STARTED|Overall Study||5
2225546|NCT02760056|5458197|P1|STARTED|Overall Study||10
2225547|NCT02759939|5458209|P4|NOT COMPLETED|Overall Study||1043
2225548|NCT02759939|5458210|P3|NOT COMPLETED|Overall Study||1154
2225549|NCT02759939|5458211|P2|NOT COMPLETED|Overall Study||972
2225550|NCT02759939|5458212|P1|NOT COMPLETED|Overall Study||1056
2225551|NCT02759939|5458209|P4|COMPLETED|Overall Study||203
2225552|NCT02759939|5458210|P3|COMPLETED|Overall Study||239
2225553|NCT02759939|5458211|P2|COMPLETED|Overall Study||171
2225554|NCT02759939|5458212|P1|COMPLETED|Overall Study||200
2225555|NCT02759939|5458209|P4|Consented to T2 and T3|Overall Study||564
2225556|NCT02759939|5458210|P3|Consented to T2 and T3|Overall Study||702
2225557|NCT02759939|5458211|P2|Consented to T2 and T3|Overall Study||626
2225558|NCT02759939|5458212|P1|Consented to T2 and T3|Overall Study||579
2225559|NCT02759939|5458209|P4|Analyzed at T2 and/or T3|Overall Study||304
2225560|NCT02759939|5458210|P3|Analyzed at T2 and/or T3|Overall Study||373
2225561|NCT02759939|5458211|P2|Analyzed at T2 and/or T3|Overall Study||278
2225562|NCT02759939|5458212|P1|Analyzed at T2 and/or T3|Overall Study||303
2225563|NCT02759939|5458209|P4|Eligible for T2 and T3|Overall Study||853
2225564|NCT02759939|5458210|P3|Eligible for T2 and T3|Overall Study||1022
2225565|NCT02759939|5458211|P2|Eligible for T2 and T3|Overall Study||962
2225566|NCT02759939|5458212|P1|Eligible for T2 and T3|Overall Study||935
2225567|NCT02759939|5458209|P4|Analyzed at T1|Overall Study||1244
2225568|NCT02759939|5458210|P3|Analyzed at T1|Overall Study||1388
2225569|NCT02759939|5458211|P2|Analyzed at T1|Overall Study||1141
2225570|NCT02759939|5458212|P1|Analyzed at T1|Overall Study||1245
2225571|NCT02759939|5458209|P4|STARTED|Overall Study||1246
2225572|NCT02759939|5458210|P3|STARTED|Overall Study||1393
2225573|NCT02759939|5458211|P2|STARTED|Overall Study||1143
2225574|NCT02759939|5458212|P1|STARTED|Overall Study||1256
2225575|NCT02759692|5458222|P2|NOT COMPLETED|Period 3||0
2225576|NCT02759692|5458223|P1|NOT COMPLETED|Period 3||0
2225577|NCT02759692|5458222|P2|COMPLETED|Period 3||139
2225578|NCT02759692|5458223|P1|COMPLETED|Period 3||137
2225579|NCT02759692|5458222|P2|STARTED|Period 3||139
2225580|NCT02759692|5458223|P1|STARTED|Period 3||137
2225581|NCT02759692|5458222|P2|NOT COMPLETED|Period 2||1
2225582|NCT02759692|5458223|P1|NOT COMPLETED|Period 2||1
2225583|NCT02759692|5458222|P2|COMPLETED|Period 2||139
2225584|NCT02759692|5458223|P1|COMPLETED|Period 2||137
2225585|NCT02759692|5458222|P2|STARTED|Period 2||140
2225586|NCT02759692|5458223|P1|STARTED|Period 2||138
2225587|NCT02759692|5458222|P2|NOT COMPLETED|Period 1||2
2225588|NCT02759692|5458223|P1|NOT COMPLETED|Period 1||3
2225589|NCT02759692|5458222|P2|COMPLETED|Period 1||140
2225590|NCT02759692|5458223|P1|COMPLETED|Period 1||138
2225591|NCT02759692|5458222|P2|STARTED|Period 1||142
2225592|NCT02759692|5458223|P1|STARTED|Period 1||141
2225593|NCT02759562|5458241|P2|NOT COMPLETED|Open-Label Treatment Period||2
2225594|NCT02759562|5458242|P1|NOT COMPLETED|Open-Label Treatment Period||2
2225595|NCT02759562|5458241|P2|COMPLETED|Open-Label Treatment Period||0
2225596|NCT02759562|5458242|P1|COMPLETED|Open-Label Treatment Period||0
2225597|NCT02759562|5458241|P2|STARTED|Open-Label Treatment Period||2
2225598|NCT02759562|5458242|P1|STARTED|Open-Label Treatment Period||2
2225599|NCT02759562|5458241|P2|NOT COMPLETED|Double-Blind Treatment Period (8 Weeks)||0
2225600|NCT02759562|5458242|P1|NOT COMPLETED|Double-Blind Treatment Period (8 Weeks)||0
2225601|NCT02759562|5458241|P2|COMPLETED|Double-Blind Treatment Period (8 Weeks)||3
2225602|NCT02759562|5458242|P1|COMPLETED|Double-Blind Treatment Period (8 Weeks)||3
2225603|NCT02759562|5458241|P2|STARTED|Double-Blind Treatment Period (8 Weeks)||3
2225604|NCT02759562|5458242|P1|STARTED|Double-Blind Treatment Period (8 Weeks)||3
2225605|NCT02759471|5458255|P1|NOT COMPLETED|Overall Study||2
2225606|NCT02759471|5458255|P1|COMPLETED|Overall Study||52
2225607|NCT02759471|5458255|P1|STARTED|Overall Study||54
2225608|NCT02759354|5458269|P4|NOT COMPLETED|Overall Study||0
2225609|NCT02759354|5458270|P3|NOT COMPLETED|Overall Study||0
2225610|NCT02759354|5458271|P2|NOT COMPLETED|Overall Study||0
2225611|NCT02759354|5458272|P1|NOT COMPLETED|Overall Study||0
2225612|NCT02759354|5458269|P4|COMPLETED|Overall Study||191
2225613|NCT02759354|5458270|P3|COMPLETED|Overall Study||181
2225614|NCT02759354|5458271|P2|COMPLETED|Overall Study||190
2225615|NCT02759354|5458272|P1|COMPLETED|Overall Study||192
2225616|NCT02759354|5458269|P4|STARTED|Overall Study||191
2225617|NCT02759354|5458270|P3|STARTED|Overall Study||181
2225618|NCT02759354|5458271|P2|STARTED|Overall Study||190
2225619|NCT02759354|5458272|P1|STARTED|Overall Study||192
2225620|NCT02759315|5458311|P5|NOT COMPLETED|Overall Study||1
2225621|NCT02759315|5458312|P4|NOT COMPLETED|Overall Study||1
2225622|NCT02759315|5458313|P3|NOT COMPLETED|Overall Study||10
2225623|NCT02759315|5458314|P2|NOT COMPLETED|Overall Study||1
2225624|NCT02759315|5458315|P1|NOT COMPLETED|Overall Study||4
2225625|NCT02759315|5458311|P5|COMPLETED|Overall Study||2
2225626|NCT02759315|5458312|P4|COMPLETED|Overall Study||19
2225627|NCT02759315|5458313|P3|COMPLETED|Overall Study||29
2225628|NCT02759315|5458314|P2|COMPLETED|Overall Study||28
2225629|NCT02759315|5458315|P1|COMPLETED|Overall Study||65
2225630|NCT02759315|5458311|P5|STARTED|Overall Study||3
2225631|NCT02759315|5458312|P4|STARTED|Overall Study||20
2225632|NCT02759315|5458313|P3|STARTED|Overall Study||39
2225633|NCT02759315|5458314|P2|STARTED|Overall Study||29
2225634|NCT02759315|5458315|P1|STARTED|Overall Study||69
2225635|NCT02758613|5458363|P4|NOT COMPLETED|Follow-up||0
2225636|NCT02758613|5458364|P3|NOT COMPLETED|Follow-up||0
2225637|NCT02758613|5458365|P2|NOT COMPLETED|Follow-up||0
2225638|NCT02758613|5458366|P1|NOT COMPLETED|Follow-up||0
2225639|NCT02758613|5458363|P4|COMPLETED|Follow-up||8
2225640|NCT02758613|5458364|P3|COMPLETED|Follow-up||8
2225641|NCT02758613|5458365|P2|COMPLETED|Follow-up||8
2225642|NCT02758613|5458366|P1|COMPLETED|Follow-up||6
2225643|NCT02758613|5458363|P4|STARTED|Follow-up||8
2225644|NCT02758613|5458364|P3|STARTED|Follow-up||8
2225645|NCT02758613|5458365|P2|STARTED|Follow-up||8
2225646|NCT02758613|5458366|P1|STARTED|Follow-up||6
2225647|NCT02758613|5458363|P4|NOT COMPLETED|Treatment||0
2225648|NCT02758613|5458364|P3|NOT COMPLETED|Treatment||1
2225649|NCT02758613|5458365|P2|NOT COMPLETED|Treatment||0
2225650|NCT02758613|5458366|P1|NOT COMPLETED|Treatment||2
2225651|NCT02758613|5458363|P4|COMPLETED|Treatment||8
2225652|NCT02758613|5458364|P3|COMPLETED|Treatment||8
2225653|NCT02758613|5458365|P2|COMPLETED|Treatment||8
2225654|NCT02758613|5458366|P1|COMPLETED|Treatment||6
2225655|NCT02758613|5458363|P4|Received at Least One Dose of Study Drug|Treatment||8
2225656|NCT02758613|5458364|P3|Received at Least One Dose of Study Drug|Treatment||9
2225657|NCT02758613|5458365|P2|Received at Least One Dose of Study Drug|Treatment||8
2225658|NCT02758613|5458366|P1|Received at Least One Dose of Study Drug|Treatment||8
2225659|NCT02758613|5458363|P4|STARTED|Treatment||8
2225660|NCT02758613|5458364|P3|STARTED|Treatment||9
2225661|NCT02758613|5458365|P2|STARTED|Treatment||8
2225662|NCT02758613|5458366|P1|STARTED|Treatment||8
2225663|NCT02758301|5458384|P2|NOT COMPLETED|Overall Study||8
2225664|NCT02758301|5458385|P1|NOT COMPLETED|Overall Study||34
2225665|NCT02758301|5458384|P2|COMPLETED|Overall Study||0
2225666|NCT02758301|5458385|P1|COMPLETED|Overall Study||70
2225667|NCT02758301|5458384|P2|STARTED|Overall Study||8
2225668|NCT02758301|5458385|P1|STARTED|Overall Study||104
2225669|NCT02758210|5458393|P1|NOT COMPLETED|Overall Study||0
2225670|NCT02758210|5458393|P1|COMPLETED|Overall Study||20
2225671|NCT02758210|5458393|P1|STARTED|Overall Study||20
2225672|NCT02758171|5458404|P2|NOT COMPLETED|Treatment Period 2||0
2225673|NCT02758171|5458405|P1|NOT COMPLETED|Treatment Period 2||0
2225674|NCT02758171|5458404|P2|COMPLETED|Treatment Period 2||28
2225675|NCT02758171|5458405|P1|COMPLETED|Treatment Period 2||26
2225676|NCT02758171|5458404|P2|STARTED|Treatment Period 2||28
2225677|NCT02758171|5458405|P1|STARTED|Treatment Period 2||26
2225678|NCT02758171|5458404|P2|NOT COMPLETED|Wash-out||0
2225679|NCT02758171|5458405|P1|NOT COMPLETED|Wash-out||2
2225680|NCT02758171|5458404|P2|COMPLETED|Wash-out||28
2225681|NCT02758171|5458405|P1|COMPLETED|Wash-out||26
2225682|NCT02758171|5458404|P2|STARTED|Wash-out||28
2225683|NCT02758171|5458405|P1|STARTED|Wash-out||28
2225684|NCT02758171|5458404|P2|NOT COMPLETED|Treatment Period 1||0
2225685|NCT02758171|5458405|P1|NOT COMPLETED|Treatment Period 1||0
2225686|NCT02758171|5458404|P2|COMPLETED|Treatment Period 1||28
2225687|NCT02758171|5458405|P1|COMPLETED|Treatment Period 1||28
2225688|NCT02758171|5458404|P2|STARTED|Treatment Period 1||28
2225689|NCT02758171|5458405|P1|STARTED|Treatment Period 1||28
2225690|NCT02758132|5458423|P2|NOT COMPLETED|Overall Study||1
2225691|NCT02758132|5458424|P1|NOT COMPLETED|Overall Study||0
2225692|NCT02758132|5458423|P2|COMPLETED|Overall Study||0
2225693|NCT02758132|5458424|P1|COMPLETED|Overall Study||0
2225694|NCT02758132|5458423|P2|STARTED|Overall Study||1
2225695|NCT02758132|5458424|P1|STARTED|Overall Study||0
2225696|NCT02758119|5458446|P2|NOT COMPLETED|Overall Study||1
2225697|NCT02758119|5458447|P1|NOT COMPLETED|Overall Study||2
2225698|NCT02758119|5458446|P2|COMPLETED|Overall Study||40
2225699|NCT02758119|5458447|P1|COMPLETED|Overall Study||39
2225700|NCT02758119|5458446|P2|STARTED|Overall Study||41
2225701|NCT02758119|5458447|P1|STARTED|Overall Study||41
2225702|NCT02757963|5458459|P1|NOT COMPLETED|Overall Study||1097
2225703|NCT02757963|5458459|P1|COMPLETED|Overall Study||561
2225704|NCT02757963|5458459|P1|STARTED|Overall Study||1658
2225705|NCT02757950|5458477|P2|NOT COMPLETED|Overall Study||11
2225706|NCT02757950|5458478|P1|NOT COMPLETED|Overall Study||4
2225707|NCT02757950|5458477|P2|COMPLETED|Overall Study||1248
2225708|NCT02757950|5458478|P1|COMPLETED|Overall Study||1199
2225709|NCT02757950|5458477|P2|STARTED|Overall Study||1259
2225710|NCT02757950|5458478|P1|STARTED|Overall Study||1203
2225711|NCT02757768|5458499|P2|NOT COMPLETED|Overall Study||28
2225712|NCT02757768|5458500|P1|NOT COMPLETED|Overall Study||33
2225713|NCT02757768|5458499|P2|COMPLETED|Overall Study||331
2225714|NCT02757768|5458500|P1|COMPLETED|Overall Study||323
2225715|NCT02757768|5458499|P2|Treated|Overall Study||354
2225716|NCT02757768|5458500|P1|Treated|Overall Study||352
2225717|NCT02757768|5458499|P2|STARTED|Overall Study||359
2225718|NCT02757768|5458500|P1|STARTED|Overall Study||356
2225719|NCT02757625|5458548|P4|NOT COMPLETED|Overall Study||0
2225720|NCT02757625|5458549|P3|NOT COMPLETED|Overall Study||2
2225721|NCT02757625|5458550|P2|NOT COMPLETED|Overall Study||0
2225722|NCT02757625|5458551|P1|NOT COMPLETED|Overall Study||0
2225723|NCT02757625|5458548|P4|COMPLETED|Overall Study||12
2225724|NCT02757625|5458549|P3|COMPLETED|Overall Study||17
2225725|NCT02757625|5458550|P2|COMPLETED|Overall Study||18
2225726|NCT02757625|5458551|P1|COMPLETED|Overall Study||14
2225727|NCT02757625|5458548|P4|STARTED|Overall Study||12
2225728|NCT02757625|5458549|P3|STARTED|Overall Study||19
2225729|NCT02757625|5458550|P2|STARTED|Overall Study||18
2225730|NCT02757625|5458551|P1|STARTED|Overall Study||14
2225731|NCT02757547|5458703|P1|NOT COMPLETED|Overall Study||0
2225732|NCT02757547|5458703|P1|COMPLETED|Overall Study||2
2225733|NCT02757547|5458703|P1|STARTED|Overall Study||2
2225734|NCT02757521|5458710|P2|NOT COMPLETED|Overall Study||0
2225735|NCT02757521|5458711|P1|NOT COMPLETED|Overall Study||1
2225736|NCT02757521|5458710|P2|COMPLETED|Overall Study||0
2225737|NCT02757521|5458711|P1|COMPLETED|Overall Study||0
2225738|NCT02757521|5458710|P2|STARTED|Overall Study||0
2225739|NCT02757521|5458711|P1|STARTED|Overall Study||1
2225740|NCT02757430|5458717|P1|NOT COMPLETED|Overall Study||12
2225741|NCT02757430|5458717|P1|COMPLETED|Overall Study|Subjects with pre-discharge visit were considered completed.|503
2225742|NCT02757430|5458717|P1|EP Mapping/Ablation Procedure|Overall Study||503
2225743|NCT02757430|5458717|P1|Baseline Visits|Overall Study||503
2225744|NCT02757430|5458717|P1|STARTED|Overall Study||515
2225745|NCT02757105|5458735|P2|NOT COMPLETED|Overall Study||11
2225746|NCT02757105|5458736|P1|NOT COMPLETED|Overall Study||12
2225747|NCT02757105|5458735|P2|COMPLETED|Overall Study||41
2225748|NCT02757105|5458736|P1|COMPLETED|Overall Study||63
2225749|NCT02757105|5458735|P2|Treated|Overall Study||51
2225750|NCT02757105|5458736|P1|Treated|Overall Study||75
2225751|NCT02757105|5458735|P2|STARTED|Overall Study||52
2225752|NCT02757105|5458736|P1|STARTED|Overall Study||75
2225753|NCT02757053|5458758|P2|NOT COMPLETED|Overall Study||5
2225754|NCT02757053|5458759|P1|NOT COMPLETED|Overall Study||3
2225755|NCT02757053|5458758|P2|COMPLETED|Overall Study||0
2225756|NCT02757053|5458759|P1|COMPLETED|Overall Study||0
2225757|NCT02757053|5458758|P2|STARTED|Overall Study||5
2225758|NCT02757053|5458759|P1|STARTED|Overall Study||3
2225759|NCT02756949|5458773|P2|NOT COMPLETED|Overall Study||8
2225760|NCT02756949|5458774|P1|NOT COMPLETED|Overall Study||0
2225761|NCT02756949|5458773|P2|COMPLETED|Overall Study||164
2225762|NCT02756949|5458774|P1|COMPLETED|Overall Study||181
2225763|NCT02756949|5458773|P2|STARTED|Overall Study||172
2225764|NCT02756949|5458774|P1|STARTED|Overall Study||181
2225765|NCT02756832|5458782|P1|NOT COMPLETED|Overall Study||53
2225766|NCT02756832|5458782|P1|COMPLETED|Overall Study||1356
2225767|NCT02756832|5458782|P1|Included in Efficacy and Safety Analysis|Overall Study||1399
2225768|NCT02756832|5458782|P1|Received Therapy|Overall Study||1393
2225769|NCT02756832|5458782|P1|STARTED|Overall Study||1409
2225770|NCT02756819|5458796|P1|NOT COMPLETED|Overall Study||52
2225771|NCT02756819|5458796|P1|COMPLETED|Overall Study||1893
2225772|NCT02756819|5458796|P1|Safety Analysis Set (SAS)|Overall Study|Participants who received at least one dose of Edarbi® therapy and had any follow-up data.|1934
2225868|NCT02754570|5459094|P1|NOT COMPLETED|Overall Study||0
2225773|NCT02756819|5458796|P1|Per-protocol Set (PPS)|Overall Study|Participants who were enrolled, received Edarbi® therapy and did not have major protocol deviations.|1724
2225774|NCT02756819|5458796|P1|STARTED|Overall Study||1945
2225775|NCT02756689|5458808|P2|NOT COMPLETED|Overall Study||0
2225776|NCT02756689|5458809|P1|NOT COMPLETED|Overall Study||0
2225777|NCT02756689|5458808|P2|COMPLETED|Overall Study||65
2225778|NCT02756689|5458809|P1|COMPLETED|Overall Study||64
2225779|NCT02756689|5458808|P2|STARTED|Overall Study||65
2225780|NCT02756689|5458809|P1|STARTED|Overall Study||64
2225781|NCT02756637|5458897|P2|NOT COMPLETED|Overall Study||54
2225782|NCT02756637|5458898|P1|NOT COMPLETED|Overall Study||87
2225783|NCT02756637|5458897|P2|COMPLETED|Overall Study||263
2225784|NCT02756637|5458898|P1|COMPLETED|Overall Study||230
2225785|NCT02756637|5458897|P2|Completed Curative Treatment|Overall Study||0
2225786|NCT02756637|5458898|P1|Completed Curative Treatment|Overall Study||230
2225787|NCT02756637|5458897|P2|Had NLR Value|Overall Study||263
2225788|NCT02756637|5458898|P1|Had NLR Value|Overall Study||263
2225789|NCT02756637|5458897|P2|Eligible for SWOG 8710|Overall Study||307
2225790|NCT02756637|5458898|P1|Eligible for SWOG 8710|Overall Study||307
2225791|NCT02756637|5458897|P2|STARTED|Overall Study||317
2225792|NCT02756637|5458898|P1|STARTED|Overall Study||317
2225793|NCT02756624|5458906|P2|NOT COMPLETED|Overall Study||7
2225794|NCT02756624|5458907|P1|NOT COMPLETED|Overall Study||16
2225795|NCT02756624|5458906|P2|COMPLETED|Overall Study||166
2225796|NCT02756624|5458907|P1|COMPLETED|Overall Study||327
2225797|NCT02756624|5458906|P2|STARTED|Overall Study||173
2225798|NCT02756624|5458907|P1|STARTED|Overall Study||343
2225799|NCT02756351|5458921|P2|NOT COMPLETED|Overall Study||0
2225800|NCT02756351|5458922|P1|NOT COMPLETED|Overall Study||0
2225801|NCT02756351|5458921|P2|COMPLETED|Overall Study||24
2225802|NCT02756351|5458922|P1|COMPLETED|Overall Study||24
2225803|NCT02756351|5458921|P2|STARTED|Overall Study||24
2225804|NCT02756351|5458922|P1|STARTED|Overall Study||24
2225805|NCT02756338|5458930|P1|NOT COMPLETED|Overall Study||5
2225806|NCT02756338|5458930|P1|COMPLETED|Overall Study||72
2225807|NCT02756338|5458930|P1|STARTED|Overall Study||77
2225808|NCT02756182|5458939|P1|NOT COMPLETED|Overall Study||4
2225809|NCT02756182|5458939|P1|COMPLETED|Overall Study||21
2225810|NCT02756182|5458939|P1|STARTED|Overall Study||25
2225811|NCT02756078|5458954|P2|NOT COMPLETED|Period 2||7
2225812|NCT02756078|5458955|P1|NOT COMPLETED|Period 2||6
2225813|NCT02756078|5458954|P2|COMPLETED|Period 2||57
2225814|NCT02756078|5458955|P1|COMPLETED|Period 2||70
2225815|NCT02756078|5458954|P2|STARTED|Period 2||64
2225816|NCT02756078|5458955|P1|STARTED|Period 2||76
2225817|NCT02756078|5458954|P2|NOT COMPLETED|Period 1||22
2225818|NCT02756078|5458955|P1|NOT COMPLETED|Period 1||9
2225819|NCT02756078|5458954|P2|COMPLETED|Period 1||64
2225820|NCT02756078|5458955|P1|COMPLETED|Period 1||76
2225821|NCT02756078|5458954|P2|STARTED|Period 1||86
2225822|NCT02756078|5458955|P1|STARTED|Period 1||85
2225823|NCT02755935|5458973|P1|NOT COMPLETED|Overall Study||2
2225824|NCT02755935|5458973|P1|COMPLETED|Overall Study||22
2225825|NCT02755935|5458973|P1|STARTED|Overall Study||24
2225826|NCT02755831|5458980|P2|NOT COMPLETED|Overall Study||3
2225827|NCT02755831|5458981|P1|NOT COMPLETED|Overall Study||3
2225828|NCT02755831|5458980|P2|COMPLETED|Overall Study||90
2225829|NCT02755831|5458981|P1|COMPLETED|Overall Study||97
2225830|NCT02755831|5458980|P2|STARTED|Overall Study||93
2225831|NCT02755831|5458981|P1|STARTED|Overall Study||100
2225844|NCT02755805|5459036|P2|NOT COMPLETED|Overall Study||4
2225845|NCT02755805|5459037|P1|NOT COMPLETED|Overall Study||2
2225846|NCT02755805|5459036|P2|COMPLETED|Overall Study||11
2225847|NCT02755805|5459037|P1|COMPLETED|Overall Study||13
2225848|NCT02755805|5459036|P2|STARTED|Overall Study||15
2225849|NCT02755805|5459037|P1|STARTED|Overall Study||15
2225850|NCT02755090|5459051|P2|NOT COMPLETED|Overall Study||0
2225851|NCT02755090|5459052|P1|NOT COMPLETED|Overall Study||1
2225852|NCT02755090|5459051|P2|COMPLETED|Overall Study||20
2225853|NCT02755090|5459052|P1|COMPLETED|Overall Study||18
2225854|NCT02755090|5459051|P2|STARTED|Overall Study||20
2225855|NCT02755090|5459052|P1|STARTED|Overall Study||19
2225856|NCT02754674|5459062|P2|NOT COMPLETED|Overall Study||7
2225857|NCT02754674|5459063|P1|NOT COMPLETED|Overall Study||6
2225858|NCT02754674|5459062|P2|COMPLETED|Overall Study||26
2225859|NCT02754674|5459063|P1|COMPLETED|Overall Study||28
2225860|NCT02754674|5459062|P2|STARTED|Overall Study||33
2225861|NCT02754674|5459063|P1|STARTED|Overall Study||34
2225862|NCT02754661|5459079|P2|NOT COMPLETED|Overall Study||19
2225863|NCT02754661|5459080|P1|NOT COMPLETED|Overall Study||15
2225864|NCT02754661|5459079|P2|COMPLETED|Overall Study||141
2225865|NCT02754661|5459080|P1|COMPLETED|Overall Study||145
2225866|NCT02754661|5459079|P2|STARTED|Overall Study||160
2225867|NCT02754661|5459080|P1|STARTED|Overall Study||160
2225869|NCT02754570|5459094|P1|COMPLETED|Overall Study||27
2225870|NCT02754570|5459094|P1|Visit 3 (PGA + Pilocarpine)|Overall Study||27
2225871|NCT02754570|5459094|P1|Visits 1 and 2 (PGA Only)|Overall Study||27
2225872|NCT02754570|5459094|P1|STARTED|Overall Study||27
2225873|NCT02754492|5459104|P4|NOT COMPLETED|Overall Study||23
2225874|NCT02754492|5459105|P3|NOT COMPLETED|Overall Study||2
2225875|NCT02754492|5459106|P2|NOT COMPLETED|Overall Study||2
2225876|NCT02754492|5459107|P1|NOT COMPLETED|Overall Study||4
2225877|NCT02754492|5459104|P4|COMPLETED|Overall Study||0
2225878|NCT02754492|5459105|P3|COMPLETED|Overall Study||93
2225879|NCT02754492|5459106|P2|COMPLETED|Overall Study||93
2225880|NCT02754492|5459107|P1|COMPLETED|Overall Study||93
2225881|NCT02754492|5459104|P4|STARTED|Overall Study||23
2225882|NCT02754492|5459105|P3|STARTED|Overall Study||95
2225883|NCT02754492|5459106|P2|STARTED|Overall Study||95
2225884|NCT02754492|5459107|P1|STARTED|Overall Study||97
2225885|NCT02754440|5459123|P4|NOT COMPLETED|Overall Study||35
2225886|NCT02754440|5459124|P3|NOT COMPLETED|Overall Study||7
2225887|NCT02754440|5459125|P2|NOT COMPLETED|Overall Study||8
2225888|NCT02754440|5459126|P1|NOT COMPLETED|Overall Study||6
2225889|NCT02754440|5459123|P4|COMPLETED|Overall Study||0
2225890|NCT02754440|5459124|P3|COMPLETED|Overall Study||93
2225891|NCT02754440|5459125|P2|COMPLETED|Overall Study||93
2225892|NCT02754440|5459126|P1|COMPLETED|Overall Study||93
2225893|NCT02754440|5459123|P4|STARTED|Overall Study||35
2225894|NCT02754440|5459124|P3|STARTED|Overall Study||100
2225895|NCT02754440|5459125|P2|STARTED|Overall Study||101
2225896|NCT02754440|5459126|P1|STARTED|Overall Study||99
2225897|NCT02754427|5459140|P2|NOT COMPLETED|Overall Study||1
2225898|NCT02754427|5459141|P1|NOT COMPLETED|Overall Study||0
2225899|NCT02754427|5459140|P2|COMPLETED|Overall Study||19
2225900|NCT02754427|5459141|P1|COMPLETED|Overall Study||21
2225901|NCT02754427|5459140|P2|STARTED|Overall Study||20
2225902|NCT02754427|5459141|P1|STARTED|Overall Study||21
2225903|NCT02754310|5459155|P2|NOT COMPLETED|Overall Study||0
2225904|NCT02754310|5459156|P1|NOT COMPLETED|Overall Study||0
2225905|NCT02754310|5459155|P2|COMPLETED|Overall Study||43
2225906|NCT02754310|5459156|P1|COMPLETED|Overall Study||42
2225907|NCT02754310|5459155|P2|STARTED|Overall Study||43
2225908|NCT02754310|5459156|P1|STARTED|Overall Study||42
2225909|NCT02753946|5459178|P2|NOT COMPLETED|Overall Study||9
2225910|NCT02753946|5459179|P1|NOT COMPLETED|Overall Study||14
2225911|NCT02753946|5459178|P2|COMPLETED|Overall Study||222
2225912|NCT02753946|5459179|P1|COMPLETED|Overall Study||219
2225913|NCT02753946|5459178|P2|STARTED|Overall Study||231
2225914|NCT02753946|5459179|P1|STARTED|Overall Study||233
2225915|NCT02753920|5459191|P2|NOT COMPLETED|Overall Study||0
2225916|NCT02753920|5459192|P1|NOT COMPLETED|Overall Study||0
2225917|NCT02753920|5459191|P2|COMPLETED|Overall Study||86
2225918|NCT02753920|5459192|P1|COMPLETED|Overall Study||87
2225919|NCT02753920|5459191|P2|STARTED|Overall Study||86
2225920|NCT02753920|5459192|P1|STARTED|Overall Study||87
2225921|NCT02753699|5459205|P3|NOT COMPLETED|Overall Study||23
2225922|NCT02753699|5459206|P2|NOT COMPLETED|Overall Study||43
2225923|NCT02753699|5459207|P1|NOT COMPLETED|Overall Study||14
2225924|NCT02753699|5459205|P3|COMPLETED|Overall Study||139
2225925|NCT02753699|5459206|P2|COMPLETED|Overall Study||354
2225926|NCT02753699|5459207|P1|COMPLETED|Overall Study||150
2225927|NCT02753699|5459205|P3|STARTED|Overall Study||162
2225928|NCT02753699|5459206|P2|STARTED|Overall Study||397
2225929|NCT02753699|5459207|P1|STARTED|Overall Study||164
2225930|NCT02753413|5459223|P2|NOT COMPLETED|Overall Study||0
2225931|NCT02753413|5459224|P1|NOT COMPLETED|Overall Study||0
2225932|NCT02753413|5459223|P2|COMPLETED|Overall Study||51
2225933|NCT02753413|5459224|P1|COMPLETED|Overall Study||49
2225934|NCT02753413|5459223|P2|STARTED|Overall Study||51
2225935|NCT02753413|5459224|P1|STARTED|Overall Study||49
2225936|NCT02753075|5459259|P3|NOT COMPLETED|Overall Study||3
2225937|NCT02753075|5459260|P2|NOT COMPLETED|Overall Study||3
2225938|NCT02753075|5459261|P1|NOT COMPLETED|Overall Study||8
2225939|NCT02753075|5459259|P3|COMPLETED|Overall Study||78
2225940|NCT02753075|5459260|P2|COMPLETED|Overall Study||77
2225941|NCT02753075|5459261|P1|COMPLETED|Overall Study||71
2225942|NCT02753075|5459259|P3|STARTED|Overall Study||81
2225943|NCT02753075|5459260|P2|STARTED|Overall Study||80
2225944|NCT02753075|5459261|P1|STARTED|Overall Study||79
2225945|NCT02752958|5459286|P1|NOT COMPLETED|Overall Study||9
2225946|NCT02752958|5459286|P1|COMPLETED|Overall Study||66
2225947|NCT02752958|5459286|P1|STARTED|Overall Study||75
2225948|NCT02752880|5459357|P2|NOT COMPLETED|Overall Study||3
2225949|NCT02752880|5459358|P1|NOT COMPLETED|Overall Study||2
2225950|NCT02752880|5459357|P2|COMPLETED|Overall Study||20
2225951|NCT02752880|5459358|P1|COMPLETED|Overall Study||21
2225952|NCT02752880|5459357|P2|STARTED|Overall Study||23
2225953|NCT02752880|5459358|P1|STARTED|Overall Study||23
2225954|NCT02752802|5459368|P2|NOT COMPLETED|Overall Study||0
2225955|NCT02752802|5459369|P1|NOT COMPLETED|Overall Study||1
2225956|NCT02752802|5459368|P2|COMPLETED|Overall Study||48
2225957|NCT02752802|5459369|P1|COMPLETED|Overall Study||47
2225958|NCT02752802|5459368|P2|STARTED|Overall Study||48
2225959|NCT02752802|5459369|P1|STARTED|Overall Study||48
2225960|NCT02752776|5459381|P3|NOT COMPLETED|Overall Study||48
2225961|NCT02752776|5459382|P2|NOT COMPLETED|Overall Study||76
2225962|NCT02752776|5459383|P1|NOT COMPLETED|Overall Study||52
2225963|NCT02752776|5459381|P3|COMPLETED|Overall Study||276
2225964|NCT02752776|5459382|P2|COMPLETED|Overall Study||597
2225965|NCT02752776|5459383|P1|COMPLETED|Overall Study||611
2225966|NCT02752776|5459381|P3|STARTED|Overall Study||324
2225967|NCT02752776|5459382|P2|STARTED|Overall Study||673
2225968|NCT02752776|5459383|P1|STARTED|Overall Study||663
2225969|NCT02752633|5459429|P1|NOT COMPLETED|Overall Study||1
2225970|NCT02752633|5459429|P1|COMPLETED|Overall Study||8
2225971|NCT02752633|5459429|P1|STARTED|Overall Study||9
2225972|NCT02752490|5459435|P2|NOT COMPLETED|Overall Study||0
2225973|NCT02752490|5459436|P1|NOT COMPLETED|Overall Study||0
2225974|NCT02752490|5459435|P2|COMPLETED|Overall Study||435
2225975|NCT02752490|5459436|P1|COMPLETED|Overall Study||409
2225976|NCT02752490|5459435|P2|STARTED|Overall Study||435
2225977|NCT02752490|5459436|P1|STARTED|Overall Study||409
2225978|NCT02752256|5459458|P2|NOT COMPLETED|Overall Study||0
2225979|NCT02752256|5459459|P1|NOT COMPLETED|Overall Study||0
2225980|NCT02752256|5459458|P2|COMPLETED|Overall Study||41
2225981|NCT02752256|5459459|P1|COMPLETED|Overall Study||35
2225982|NCT02752256|5459458|P2|STARTED|Overall Study||41
2225983|NCT02752256|5459459|P1|STARTED|Overall Study||35
2225984|NCT02752074|5459469|P2|NOT COMPLETED|Overall Study||352
2225985|NCT02752074|5459470|P1|NOT COMPLETED|Overall Study||354
2225986|NCT02752074|5459469|P2|COMPLETED|Overall Study||0
2225987|NCT02752074|5459470|P1|COMPLETED|Overall Study||0
2225988|NCT02752074|5459469|P2|Treated|Overall Study||352
2225989|NCT02752074|5459470|P1|Treated|Overall Study||353
2225990|NCT02752074|5459469|P2|STARTED|Overall Study||352
2225991|NCT02752074|5459470|P1|STARTED|Overall Study||354
2225992|NCT02751983|5459494|P2|NOT COMPLETED|Three-Month Follow-Up Assessments||16
2225993|NCT02751983|5459495|P1|NOT COMPLETED|Three-Month Follow-Up Assessments||12
2225994|NCT02751983|5459494|P2|COMPLETED|Three-Month Follow-Up Assessments||19
2225995|NCT02751983|5459495|P1|COMPLETED|Three-Month Follow-Up Assessments||23
2225996|NCT02751983|5459494|P2|STARTED|Three-Month Follow-Up Assessments||35
2225997|NCT02751983|5459495|P1|STARTED|Three-Month Follow-Up Assessments||35
2225998|NCT02751983|5459494|P2|NOT COMPLETED|One-Month Follow-Up Assessments||12
2225999|NCT02751983|5459495|P1|NOT COMPLETED|One-Month Follow-Up Assessments||14
2226000|NCT02751983|5459494|P2|COMPLETED|One-Month Follow-Up Assessments||23
2226001|NCT02751983|5459495|P1|COMPLETED|One-Month Follow-Up Assessments||21
2226002|NCT02751983|5459494|P2|STARTED|One-Month Follow-Up Assessments||35
2226003|NCT02751983|5459495|P1|STARTED|One-Month Follow-Up Assessments||35
2226004|NCT02751983|5459494|P2|NOT COMPLETED|Post-Treatment Assessment||0
2226005|NCT02751983|5459495|P1|NOT COMPLETED|Post-Treatment Assessment||5
2226006|NCT02751983|5459494|P2|COMPLETED|Post-Treatment Assessment||0
2226007|NCT02751983|5459495|P1|COMPLETED|Post-Treatment Assessment||30
2226008|NCT02751983|5459494|P2|STARTED|Post-Treatment Assessment||0
2226009|NCT02751983|5459495|P1|STARTED|Post-Treatment Assessment||35
2226010|NCT02751983|5459494|P2|NOT COMPLETED|Treatment||0
2226011|NCT02751983|5459495|P1|NOT COMPLETED|Treatment||4
2226012|NCT02751983|5459494|P2|COMPLETED|Treatment||35
2226013|NCT02751983|5459495|P1|COMPLETED|Treatment||31
2226014|NCT02751983|5459494|P2|STARTED|Treatment||35
2226015|NCT02751983|5459495|P1|STARTED|Treatment||35
2226016|NCT02751983|5459494|P2|NOT COMPLETED|Baseline and Randomization||0
2226017|NCT02751983|5459495|P1|NOT COMPLETED|Baseline and Randomization||0
2226018|NCT02751983|5459494|P2|COMPLETED|Baseline and Randomization||35
2226019|NCT02751983|5459495|P1|COMPLETED|Baseline and Randomization||35
2226020|NCT02751983|5459494|P2|STARTED|Baseline and Randomization||35
2226021|NCT02751983|5459495|P1|STARTED|Baseline and Randomization||35
2226022|NCT02751879|5459516|P2|NOT COMPLETED|Overall Study||0
2226023|NCT02751879|5459517|P1|NOT COMPLETED|Overall Study||0
2226024|NCT02751879|5459516|P2|COMPLETED|Overall Study||71
2226025|NCT02751879|5459517|P1|COMPLETED|Overall Study||157
2226026|NCT02751879|5459516|P2|On Treatment at Study Completion|Overall Study||41
2226027|NCT02751879|5459517|P1|On Treatment at Study Completion|Overall Study||81
2226028|NCT02751879|5459516|P2|STARTED|Overall Study||71
2226029|NCT02751879|5459517|P1|STARTED|Overall Study||157
2226030|NCT02751450|5459532|P2|NOT COMPLETED|Overall Study||0
2226031|NCT02751450|5459533|P1|NOT COMPLETED|Overall Study||1
2226032|NCT02751450|5459532|P2|COMPLETED|Overall Study||116
2226033|NCT02751450|5459533|P1|COMPLETED|Overall Study||116
2226034|NCT02751450|5459532|P2|STARTED|Overall Study||116
2226035|NCT02751450|5459533|P1|STARTED|Overall Study||117
2226036|NCT02751424|5459554|P9|NOT COMPLETED|Part 2||0
2226037|NCT02751424|5459555|P8|NOT COMPLETED|Part 2||5
2226038|NCT02751424|5459556|P7|NOT COMPLETED|Part 2||0
2226039|NCT02751424|5459557|P6|NOT COMPLETED|Part 2||0
2226040|NCT02751424|5459558|P5|NOT COMPLETED|Part 2||0
2226041|NCT02751424|5459559|P4|NOT COMPLETED|Part 2||0
2226042|NCT02751424|5459560|P3|NOT COMPLETED|Part 2||0
2226043|NCT02751424|5459561|P2|NOT COMPLETED|Part 2||0
2226044|NCT02751424|5459562|P1|NOT COMPLETED|Part 2||0
2226045|NCT02751424|5459554|P9|COMPLETED|Part 2||3
2226046|NCT02751424|5459555|P8|COMPLETED|Part 2||6
2226047|NCT02751424|5459556|P7|COMPLETED|Part 2||0
2226048|NCT02751424|5459557|P6|COMPLETED|Part 2||0
2226049|NCT02751424|5459558|P5|COMPLETED|Part 2||0
2226050|NCT02751424|5459559|P4|COMPLETED|Part 2||0
2226051|NCT02751424|5459560|P3|COMPLETED|Part 2||0
2226052|NCT02751424|5459561|P2|COMPLETED|Part 2||0
2226053|NCT02751424|5459562|P1|COMPLETED|Part 2||0
2226054|NCT02751424|5459554|P9|STARTED|Part 2||3
2226055|NCT02751424|5459555|P8|STARTED|Part 2||11
2226056|NCT02751424|5459556|P7|STARTED|Part 2||0
2226057|NCT02751424|5459557|P6|STARTED|Part 2||0
2226058|NCT02751424|5459558|P5|STARTED|Part 2||0
2226059|NCT02751424|5459559|P4|STARTED|Part 2||0
2226060|NCT02751424|5459560|P3|STARTED|Part 2||0
2226061|NCT02751424|5459561|P2|STARTED|Part 2||0
2226062|NCT02751424|5459562|P1|STARTED|Part 2||0
2226063|NCT02751424|5459554|P9|NOT COMPLETED|Part 1||0
2226064|NCT02751424|5459555|P8|NOT COMPLETED|Part 1||0
2226065|NCT02751424|5459556|P7|NOT COMPLETED|Part 1||0
2226066|NCT02751424|5459557|P6|NOT COMPLETED|Part 1||0
2226067|NCT02751424|5459558|P5|NOT COMPLETED|Part 1||0
2226068|NCT02751424|5459559|P4|NOT COMPLETED|Part 1||0
2226069|NCT02751424|5459560|P3|NOT COMPLETED|Part 1||0
2226070|NCT02751424|5459561|P2|NOT COMPLETED|Part 1||0
2226071|NCT02751424|5459562|P1|NOT COMPLETED|Part 1||0
2226072|NCT02751424|5459554|P9|COMPLETED|Part 1||0
2226073|NCT02751424|5459555|P8|COMPLETED|Part 1||0
2226074|NCT02751424|5459556|P7|COMPLETED|Part 1||12
2226075|NCT02751424|5459557|P6|COMPLETED|Part 1||6
2226076|NCT02751424|5459558|P5|COMPLETED|Part 1||6
2226077|NCT02751424|5459559|P4|COMPLETED|Part 1||6
2226078|NCT02751424|5459560|P3|COMPLETED|Part 1||6
2226079|NCT02751424|5459561|P2|COMPLETED|Part 1||6
2226080|NCT02751424|5459562|P1|COMPLETED|Part 1||6
2226081|NCT02751424|5459554|P9|STARTED|Part 1||0
2226082|NCT02751424|5459555|P8|STARTED|Part 1||0
2226083|NCT02751424|5459556|P7|STARTED|Part 1||12
2226084|NCT02751424|5459557|P6|STARTED|Part 1||6
2226085|NCT02751424|5459558|P5|STARTED|Part 1||6
2226086|NCT02751424|5459559|P4|STARTED|Part 1||6
2226087|NCT02751424|5459560|P3|STARTED|Part 1||6
2226088|NCT02751424|5459561|P2|STARTED|Part 1||6
2226089|NCT02751424|5459562|P1|STARTED|Part 1||6
2226090|NCT02751385|5459705|P2|NOT COMPLETED|Period 2||0
2226091|NCT02751385|5459706|P1|NOT COMPLETED|Period 2||0
2226092|NCT02751385|5459705|P2|COMPLETED|Period 2||2
2226093|NCT02751385|5459706|P1|COMPLETED|Period 2||0
2226094|NCT02751385|5459705|P2|STARTED|Period 2||2
2226095|NCT02751385|5459706|P1|STARTED|Period 2||0
2226096|NCT02751385|5459705|P2|NOT COMPLETED|Period 1||0
2226097|NCT02751385|5459706|P1|NOT COMPLETED|Period 1||0
2226098|NCT02751385|5459705|P2|COMPLETED|Period 1||0
2226099|NCT02751385|5459706|P1|COMPLETED|Period 1||2
2226100|NCT02751385|5459705|P2|STARTED|Period 1||0
2226101|NCT02751385|5459706|P1|STARTED|Period 1||2
2226102|NCT02751320|5459718|P1|NOT COMPLETED|Overall Study||3
2226103|NCT02751320|5459718|P1|COMPLETED|Overall Study||42
2226104|NCT02751320|5459718|P1|Received Reference Product 3|Overall Study||28
2226105|NCT02751320|5459718|P1|Received Reference Product 2|Overall Study||28
2226106|NCT02751320|5459718|P1|Received Reference Product 1|Overall Study||29
2226107|NCT02751320|5459718|P1|Received Test Prodcut 3|Overall Study||28
2226108|NCT02751320|5459718|P1|Received Test Prodcut 2|Overall Study||28
2226109|NCT02751320|5459718|P1|Received Test Product 1|Overall Study||29
2226110|NCT02751320|5459718|P1|STARTED|Overall Study||45
2226111|NCT02750943|5459756|P2|NOT COMPLETED|Overall Study||9
2226112|NCT02750943|5459757|P1|NOT COMPLETED|Overall Study||6
2226113|NCT02750943|5459756|P2|COMPLETED|Overall Study||119
2226114|NCT02750943|5459757|P1|COMPLETED|Overall Study||119
2226115|NCT02750943|5459756|P2|STARTED|Overall Study||128
2226116|NCT02750943|5459757|P1|STARTED|Overall Study||125
2226117|NCT02750930|5459771|P1|NOT COMPLETED|Overall Study||8
2226118|NCT02750930|5459771|P1|COMPLETED|Overall Study||0
2226119|NCT02750930|5459771|P1|STARTED|Overall Study||8
2226120|NCT02750813|5459783|P2|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
2226121|NCT02750813|5459784|P1|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
2226122|NCT02750813|5459783|P2|COMPLETED|Period 2, Second 14 Days of Wear||120
2226123|NCT02750813|5459784|P1|COMPLETED|Period 2, Second 14 Days of Wear||124
2226124|NCT02750813|5459783|P2|STARTED|Period 2, Second 14 Days of Wear||120
2226125|NCT02750813|5459784|P1|STARTED|Period 2, Second 14 Days of Wear||124
2226126|NCT02750813|5459783|P2|NOT COMPLETED|Period 1, First 14 Days of Wear||1
2226127|NCT02750813|5459784|P1|NOT COMPLETED|Period 1, First 14 Days of Wear||1
2226128|NCT02750813|5459783|P2|COMPLETED|Period 1, First 14 Days of Wear||120
2226129|NCT02750813|5459784|P1|COMPLETED|Period 1, First 14 Days of Wear||124
2226130|NCT02750813|5459783|P2|STARTED|Period 1, First 14 Days of Wear||121
2226131|NCT02750813|5459784|P1|STARTED|Period 1, First 14 Days of Wear||125
2226132|NCT02750800|5459799|P1|NOT COMPLETED|Overall Study||98
2226133|NCT02750800|5459799|P1|COMPLETED|Overall Study||314
2226134|NCT02750800|5459799|P1|STARTED|Overall Study||412
2226135|NCT02750761|5459904|P6|NOT COMPLETED|Overall Study||0
2226136|NCT02750761|5459905|P5|NOT COMPLETED|Overall Study||0
2226137|NCT02750761|5459906|P4|NOT COMPLETED|Overall Study||0
2226138|NCT02750761|5459907|P3|NOT COMPLETED|Overall Study||1
2226139|NCT02750761|5459908|P2|NOT COMPLETED|Overall Study||0
2226140|NCT02750761|5459909|P1|NOT COMPLETED|Overall Study||0
2226141|NCT02750761|5459904|P6|COMPLETED|Overall Study||6
2226142|NCT02750761|5459905|P5|COMPLETED|Overall Study||6
2226143|NCT02750761|5459906|P4|COMPLETED|Overall Study||5
2226144|NCT02750761|5459907|P3|COMPLETED|Overall Study||4
2226145|NCT02750761|5459908|P2|COMPLETED|Overall Study||5
2226146|NCT02750761|5459909|P1|COMPLETED|Overall Study||5
2226147|NCT02750761|5459904|P6|STARTED|Overall Study||6
2226148|NCT02750761|5459905|P5|STARTED|Overall Study||6
2226149|NCT02750761|5459906|P4|STARTED|Overall Study||5
2226150|NCT02750761|5459907|P3|STARTED|Overall Study||5
2226151|NCT02750761|5459908|P2|STARTED|Overall Study||5
2226152|NCT02750761|5459909|P1|STARTED|Overall Study||5
2226153|NCT02750709|5460005|P6|NOT COMPLETED|Treatment Period 3||0
2226154|NCT02750709|5460006|P5|NOT COMPLETED|Treatment Period 3||0
2226155|NCT02750709|5460007|P4|NOT COMPLETED|Treatment Period 3||0
2226156|NCT02750709|5460008|P3|NOT COMPLETED|Treatment Period 3||0
2226157|NCT02750709|5460009|P2|NOT COMPLETED|Treatment Period 3||0
2226158|NCT02750709|5460010|P1|NOT COMPLETED|Treatment Period 3||0
2226159|NCT02750709|5460005|P6|COMPLETED|Treatment Period 3||3
2226160|NCT02750709|5460006|P5|COMPLETED|Treatment Period 3||4
2226161|NCT02750709|5460007|P4|COMPLETED|Treatment Period 3||4
2226162|NCT02750709|5460008|P3|COMPLETED|Treatment Period 3||4
2226163|NCT02750709|5460009|P2|COMPLETED|Treatment Period 3||4
2226164|NCT02750709|5460010|P1|COMPLETED|Treatment Period 3||4
2226165|NCT02750709|5460005|P6|STARTED|Treatment Period 3||3
2226166|NCT02750709|5460006|P5|STARTED|Treatment Period 3||4
2226167|NCT02750709|5460007|P4|STARTED|Treatment Period 3||4
2226168|NCT02750709|5460008|P3|STARTED|Treatment Period 3||4
2226169|NCT02750709|5460009|P2|STARTED|Treatment Period 3||4
2226170|NCT02750709|5460010|P1|STARTED|Treatment Period 3||4
2226171|NCT02750709|5460005|P6|NOT COMPLETED|Treatment Period 2||0
2226172|NCT02750709|5460006|P5|NOT COMPLETED|Treatment Period 2||0
2226173|NCT02750709|5460007|P4|NOT COMPLETED|Treatment Period 2||0
2226174|NCT02750709|5460008|P3|NOT COMPLETED|Treatment Period 2||0
2226175|NCT02750709|5460009|P2|NOT COMPLETED|Treatment Period 2||0
2226176|NCT02750709|5460010|P1|NOT COMPLETED|Treatment Period 2||0
2226177|NCT02750709|5460005|P6|COMPLETED|Treatment Period 2||3
2226178|NCT02750709|5460006|P5|COMPLETED|Treatment Period 2||4
2226179|NCT02750709|5460007|P4|COMPLETED|Treatment Period 2||4
2226180|NCT02750709|5460008|P3|COMPLETED|Treatment Period 2||4
2226181|NCT02750709|5460009|P2|COMPLETED|Treatment Period 2||4
2226182|NCT02750709|5460010|P1|COMPLETED|Treatment Period 2||4
2226183|NCT02750709|5460005|P6|STARTED|Treatment Period 2||3
2226184|NCT02750709|5460006|P5|STARTED|Treatment Period 2||4
2226185|NCT02750709|5460007|P4|STARTED|Treatment Period 2||4
2226186|NCT02750709|5460008|P3|STARTED|Treatment Period 2||4
2226187|NCT02750709|5460009|P2|STARTED|Treatment Period 2||4
2226188|NCT02750709|5460010|P1|STARTED|Treatment Period 2||4
2226189|NCT02750709|5460005|P6|NOT COMPLETED|Treatment Period 1||1
2226190|NCT02750709|5460006|P5|NOT COMPLETED|Treatment Period 1||0
2226191|NCT02750709|5460007|P4|NOT COMPLETED|Treatment Period 1||0
2226192|NCT02750709|5460008|P3|NOT COMPLETED|Treatment Period 1||0
2226193|NCT02750709|5460009|P2|NOT COMPLETED|Treatment Period 1||0
2226194|NCT02750709|5460010|P1|NOT COMPLETED|Treatment Period 1||0
2226195|NCT02750709|5460005|P6|COMPLETED|Treatment Period 1||3
2226196|NCT02750709|5460006|P5|COMPLETED|Treatment Period 1||4
2226197|NCT02750709|5460007|P4|COMPLETED|Treatment Period 1||4
2226198|NCT02750709|5460008|P3|COMPLETED|Treatment Period 1||4
2226199|NCT02750709|5460009|P2|COMPLETED|Treatment Period 1||4
2226200|NCT02750709|5460010|P1|COMPLETED|Treatment Period 1||4
2226201|NCT02750709|5460005|P6|STARTED|Treatment Period 1||4
2226202|NCT02750709|5460006|P5|STARTED|Treatment Period 1||4
2226203|NCT02750709|5460007|P4|STARTED|Treatment Period 1||4
2226204|NCT02750709|5460008|P3|STARTED|Treatment Period 1||4
2226205|NCT02750709|5460009|P2|STARTED|Treatment Period 1||4
2226206|NCT02750709|5460010|P1|STARTED|Treatment Period 1||4
2226207|NCT02750618|5460036|P1|NOT COMPLETED|Overall Study||0
2226208|NCT02750618|5460036|P1|COMPLETED|Overall Study||13
2226209|NCT02750618|5460036|P1|STARTED|Overall Study||13
2226210|NCT02750592|5460052|P1|NOT COMPLETED|Overall Study||5
2226211|NCT02750592|5460052|P1|COMPLETED|Overall Study||25
2226212|NCT02750592|5460052|P1|STARTED|Overall Study||30
2226213|NCT02750501|5460071|P1|NOT COMPLETED|Overall Study||8
2226214|NCT02750501|5460071|P1|COMPLETED|Overall Study||36
2226215|NCT02750501|5460071|P1|Treated|Overall Study||39
2226216|NCT02750501|5460071|P1|Enrolled|Overall Study||44
2226217|NCT02750501|5460071|P1|STARTED|Overall Study||44
2226218|NCT02750410|5460085|P2|NOT COMPLETED|Open-Label Extension Period||6
2226219|NCT02750410|5460086|P1|NOT COMPLETED|Open-Label Extension Period||6
2226220|NCT02750410|5460085|P2|COMPLETED|Open-Label Extension Period||111
2226221|NCT02750410|5460086|P1|COMPLETED|Open-Label Extension Period||31
2226222|NCT02750410|5460085|P2|STARTED|Open-Label Extension Period||117
2226223|NCT02750410|5460086|P1|STARTED|Open-Label Extension Period||37
2226224|NCT02750410|5460085|P2|NOT COMPLETED|Double-Blind Treatment Period||3
2226225|NCT02750410|5460086|P1|NOT COMPLETED|Double-Blind Treatment Period||2
2226226|NCT02750410|5460085|P2|COMPLETED|Double-Blind Treatment Period||117
2226227|NCT02750410|5460086|P1|COMPLETED|Double-Blind Treatment Period||37
2226228|NCT02750410|5460085|P2|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||120
2226229|NCT02750410|5460086|P1|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||39
2226230|NCT02750410|5460085|P2|STARTED|Double-Blind Treatment Period||120
2226231|NCT02750410|5460086|P1|STARTED|Double-Blind Treatment Period||39
2226232|NCT02750345|5460104|P6|NOT COMPLETED|Intervention 3||0
2226233|NCT02750345|5460105|P5|NOT COMPLETED|Intervention 3||0
2226234|NCT02750345|5460106|P4|NOT COMPLETED|Intervention 3||0
2226235|NCT02750345|5460107|P3|NOT COMPLETED|Intervention 3||0
2226236|NCT02750345|5460108|P2|NOT COMPLETED|Intervention 3||0
2226237|NCT02750345|5460109|P1|NOT COMPLETED|Intervention 3||0
2226238|NCT02750345|5460104|P6|COMPLETED|Intervention 3||4
2226239|NCT02750345|5460105|P5|COMPLETED|Intervention 3||3
2226240|NCT02750345|5460106|P4|COMPLETED|Intervention 3||4
2226241|NCT02750345|5460107|P3|COMPLETED|Intervention 3||4
2226242|NCT02750345|5460108|P2|COMPLETED|Intervention 3||4
2226243|NCT02750345|5460109|P1|COMPLETED|Intervention 3||4
2226244|NCT02750345|5460104|P6|STARTED|Intervention 3||4
2226245|NCT02750345|5460105|P5|STARTED|Intervention 3||3
2226246|NCT02750345|5460106|P4|STARTED|Intervention 3||4
2226247|NCT02750345|5460107|P3|STARTED|Intervention 3||4
2226248|NCT02750345|5460108|P2|STARTED|Intervention 3||4
2226249|NCT02750345|5460109|P1|STARTED|Intervention 3||4
2226250|NCT02750345|5460104|P6|NOT COMPLETED|Intervention 2||0
2226251|NCT02750345|5460105|P5|NOT COMPLETED|Intervention 2||0
2226252|NCT02750345|5460106|P4|NOT COMPLETED|Intervention 2||0
2226253|NCT02750345|5460107|P3|NOT COMPLETED|Intervention 2||0
2226254|NCT02750345|5460108|P2|NOT COMPLETED|Intervention 2||0
2226255|NCT02750345|5460109|P1|NOT COMPLETED|Intervention 2||0
2226256|NCT02750345|5460104|P6|COMPLETED|Intervention 2||4
2226257|NCT02750345|5460105|P5|COMPLETED|Intervention 2||3
2226258|NCT02750345|5460106|P4|COMPLETED|Intervention 2||4
2226259|NCT02750345|5460107|P3|COMPLETED|Intervention 2||4
2226260|NCT02750345|5460108|P2|COMPLETED|Intervention 2||4
2226261|NCT02750345|5460109|P1|COMPLETED|Intervention 2||4
2226262|NCT02750345|5460104|P6|STARTED|Intervention 2||4
2226263|NCT02750345|5460105|P5|STARTED|Intervention 2||3
2226264|NCT02750345|5460106|P4|STARTED|Intervention 2||4
2226265|NCT02750345|5460107|P3|STARTED|Intervention 2||4
2226266|NCT02750345|5460108|P2|STARTED|Intervention 2||4
2226267|NCT02750345|5460109|P1|STARTED|Intervention 2||4
2226268|NCT02750345|5460104|P6|NOT COMPLETED|Intervention 1||0
2226269|NCT02750345|5460105|P5|NOT COMPLETED|Intervention 1||1
2226270|NCT02750345|5460106|P4|NOT COMPLETED|Intervention 1||0
2226271|NCT02750345|5460107|P3|NOT COMPLETED|Intervention 1||0
2226272|NCT02750345|5460108|P2|NOT COMPLETED|Intervention 1||0
2226273|NCT02750345|5460109|P1|NOT COMPLETED|Intervention 1||0
2226274|NCT02750345|5460104|P6|COMPLETED|Intervention 1||4
2226275|NCT02750345|5460105|P5|COMPLETED|Intervention 1||3
2226276|NCT02750345|5460106|P4|COMPLETED|Intervention 1||4
2226277|NCT02750345|5460107|P3|COMPLETED|Intervention 1||4
2226278|NCT02750345|5460108|P2|COMPLETED|Intervention 1||4
2226279|NCT02750345|5460109|P1|COMPLETED|Intervention 1||4
2226280|NCT02750345|5460104|P6|STARTED|Intervention 1||4
2226281|NCT02750345|5460105|P5|STARTED|Intervention 1||4
2226282|NCT02750345|5460106|P4|STARTED|Intervention 1||4
2226283|NCT02750345|5460107|P3|STARTED|Intervention 1||4
2226284|NCT02750345|5460108|P2|STARTED|Intervention 1||4
2226285|NCT02750345|5460109|P1|STARTED|Intervention 1||4
2226286|NCT02750332|5460135|P2|NOT COMPLETED|Treatment Period 2||0
2226287|NCT02750332|5460136|P1|NOT COMPLETED|Treatment Period 2||0
2226288|NCT02750332|5460135|P2|COMPLETED|Treatment Period 2||9
2226289|NCT02750332|5460136|P1|COMPLETED|Treatment Period 2||10
2226290|NCT02750332|5460135|P2|STARTED|Treatment Period 2||9
2226291|NCT02750332|5460136|P1|STARTED|Treatment Period 2||10
2226292|NCT02750332|5460135|P2|NOT COMPLETED|Treatment Period 1||1
2226293|NCT02750332|5460136|P1|NOT COMPLETED|Treatment Period 1||0
2226294|NCT02750332|5460135|P2|COMPLETED|Treatment Period 1||9
2226295|NCT02750332|5460136|P1|COMPLETED|Treatment Period 1||10
2226296|NCT02750332|5460135|P2|STARTED|Treatment Period 1||10
2226297|NCT02750332|5460136|P1|STARTED|Treatment Period 1||10
2226298|NCT02750306|5460156|P2|NOT COMPLETED|Overall Study||2
2226299|NCT02750306|5460157|P1|NOT COMPLETED|Overall Study||6
2226300|NCT02750306|5460156|P2|COMPLETED|Overall Study||141
2226301|NCT02750306|5460157|P1|COMPLETED|Overall Study||136
2226302|NCT02750306|5460156|P2|STARTED|Overall Study||143
2226303|NCT02750306|5460157|P1|STARTED|Overall Study||142
2226304|NCT02750267|5460171|P2|NOT COMPLETED|Overall Study||0
2226305|NCT02750267|5460172|P1|NOT COMPLETED|Overall Study||0
2226306|NCT02750267|5460171|P2|COMPLETED|Overall Study||6
2226307|NCT02750267|5460172|P1|COMPLETED|Overall Study||6
2226308|NCT02750267|5460171|P2|STARTED|Overall Study||6
2226309|NCT02750267|5460172|P1|STARTED|Overall Study||6
2226310|NCT02749903|5460210|P1|NOT COMPLETED|Overall Study||0
2226311|NCT02749903|5460210|P1|COMPLETED|Overall Study||46
2226312|NCT02749903|5460210|P1|STARTED|Overall Study||46
2226313|NCT02749370|5460216|P1|NOT COMPLETED|Overall Study||14
2226314|NCT02749370|5460216|P1|COMPLETED|Overall Study||66
2226315|NCT02749370|5460216|P1|STARTED|Overall Study||80
2226316|NCT02748928|5460243|P1|NOT COMPLETED|Overall Study||0
2226317|NCT02748928|5460243|P1|COMPLETED|Overall Study||62
2226318|NCT02748928|5460243|P1|STARTED|Overall Study||62
2226319|NCT02748889|5460254|P2|NOT COMPLETED|Overall Study||0
2226320|NCT02748889|5460255|P1|NOT COMPLETED|Overall Study||0
2226321|NCT02748889|5460254|P2|COMPLETED|Overall Study||1
2226322|NCT02748889|5460255|P1|COMPLETED|Overall Study||0
2226323|NCT02748889|5460254|P2|STARTED|Overall Study||1
2226324|NCT02748889|5460255|P1|STARTED|Overall Study||0
2226325|NCT02748863|5460262|P5|NOT COMPLETED|Treatment Period 2||1
2226326|NCT02748863|5460263|P4|NOT COMPLETED|Treatment Period 2||2
2226327|NCT02748863|5460264|P3|NOT COMPLETED|Treatment Period 2||0
2226328|NCT02748863|5460265|P2|NOT COMPLETED|Treatment Period 2||3
2226329|NCT02748863|5460266|P1|NOT COMPLETED|Treatment Period 2||5
2226330|NCT02748863|5460262|P5|COMPLETED|Treatment Period 2||33
2226331|NCT02748863|5460263|P4|COMPLETED|Treatment Period 2||32
2226332|NCT02748863|5460264|P3|COMPLETED|Treatment Period 2||0
2226333|NCT02748863|5460265|P2|COMPLETED|Treatment Period 2||66
2226334|NCT02748863|5460266|P1|COMPLETED|Treatment Period 2||67
2226335|NCT02748863|5460262|P5|STARTED|Treatment Period 2||34
2226336|NCT02748863|5460263|P4|STARTED|Treatment Period 2||34
2226337|NCT02748863|5460264|P3|STARTED|Treatment Period 2||0
2226338|NCT02748863|5460265|P2|STARTED|Treatment Period 2||69
2226339|NCT02748863|5460266|P1|STARTED|Treatment Period 2||72
2226340|NCT02748863|5460262|P5|NOT COMPLETED|Treatment Period 1||0
2226341|NCT02748863|5460263|P4|NOT COMPLETED|Treatment Period 1||0
2226342|NCT02748863|5460264|P3|NOT COMPLETED|Treatment Period 1||2
2226343|NCT02748863|5460265|P2|NOT COMPLETED|Treatment Period 1||2
2226344|NCT02748863|5460266|P1|NOT COMPLETED|Treatment Period 1||0
2226345|NCT02748863|5460262|P5|COMPLETED|Treatment Period 1||0
2226346|NCT02748863|5460263|P4|COMPLETED|Treatment Period 1||0
2226347|NCT02748863|5460264|P3|COMPLETED|Treatment Period 1||69
2226348|NCT02748863|5460265|P2|COMPLETED|Treatment Period 1||69
2226349|NCT02748863|5460266|P1|COMPLETED|Treatment Period 1||72
2226350|NCT02748863|5460262|P5|STARTED|Treatment Period 1|Not applicable for this period|0
2226351|NCT02748863|5460263|P4|STARTED|Treatment Period 1|Not applicable for this period|0
2226352|NCT02748863|5460264|P3|STARTED|Treatment Period 1||71
2226353|NCT02748863|5460265|P2|STARTED|Treatment Period 1||71
2226354|NCT02748863|5460266|P1|STARTED|Treatment Period 1||72
2226355|NCT02748785|5460292|P4|NOT COMPLETED|Visit 3- Visit 4||2
2226356|NCT02748785|5460293|P3|NOT COMPLETED|Visit 3- Visit 4||2
2226357|NCT02748785|5460294|P2|NOT COMPLETED|Visit 3- Visit 4||1
2226358|NCT02748785|5460295|P1|NOT COMPLETED|Visit 3- Visit 4||1
2226359|NCT02748785|5460292|P4|COMPLETED|Visit 3- Visit 4||50
2226360|NCT02748785|5460293|P3|COMPLETED|Visit 3- Visit 4||47
2226361|NCT02748785|5460294|P2|COMPLETED|Visit 3- Visit 4||43
2226362|NCT02748785|5460295|P1|COMPLETED|Visit 3- Visit 4||53
2226363|NCT02748785|5460292|P4|STARTED|Visit 3- Visit 4||52
2226364|NCT02748785|5460293|P3|STARTED|Visit 3- Visit 4||49
2226365|NCT02748785|5460294|P2|STARTED|Visit 3- Visit 4||44
2226366|NCT02748785|5460295|P1|STARTED|Visit 3- Visit 4||54
2226367|NCT02748785|5460292|P4|NOT COMPLETED|Visit 2-Visit 3||11
2226368|NCT02748785|5460293|P3|NOT COMPLETED|Visit 2-Visit 3||8
2226369|NCT02748785|5460294|P2|NOT COMPLETED|Visit 2-Visit 3||5
2226370|NCT02748785|5460295|P1|NOT COMPLETED|Visit 2-Visit 3||5
2226371|NCT02748785|5460292|P4|COMPLETED|Visit 2-Visit 3||52
2226372|NCT02748785|5460293|P3|COMPLETED|Visit 2-Visit 3||49
2226373|NCT02748785|5460294|P2|COMPLETED|Visit 2-Visit 3||44
2226374|NCT02748785|5460295|P1|COMPLETED|Visit 2-Visit 3||54
2226375|NCT02748785|5460292|P4|STARTED|Visit 2-Visit 3||63
2226376|NCT02748785|5460293|P3|STARTED|Visit 2-Visit 3||57
2226377|NCT02748785|5460294|P2|STARTED|Visit 2-Visit 3||49
2226378|NCT02748785|5460295|P1|STARTED|Visit 2-Visit 3||59
2226379|NCT02748785|5460292|P4|NOT COMPLETED|Visit 1- Visit 2||6
2226380|NCT02748785|5460293|P3|NOT COMPLETED|Visit 1- Visit 2||14
2226381|NCT02748785|5460294|P2|NOT COMPLETED|Visit 1- Visit 2||19
2226382|NCT02748785|5460295|P1|NOT COMPLETED|Visit 1- Visit 2||10
2226383|NCT02748785|5460292|P4|COMPLETED|Visit 1- Visit 2||63
2226384|NCT02748785|5460293|P3|COMPLETED|Visit 1- Visit 2||57
2226385|NCT02748785|5460294|P2|COMPLETED|Visit 1- Visit 2||49
2226386|NCT02748785|5460295|P1|COMPLETED|Visit 1- Visit 2||59
2226387|NCT02748785|5460292|P4|STARTED|Visit 1- Visit 2||69
2226388|NCT02748785|5460293|P3|STARTED|Visit 1- Visit 2||71
2226389|NCT02748785|5460294|P2|STARTED|Visit 1- Visit 2||68
2226390|NCT02748785|5460295|P1|STARTED|Visit 1- Visit 2||69
2226391|NCT02748525|5460341|P1|NOT COMPLETED|Overall Study||11
2226392|NCT02748525|5460341|P1|COMPLETED|Overall Study|Completed 6 months follow up|39
2226393|NCT02748525|5460341|P1|Completed Study Intervention|Overall Study||50
2226394|NCT02748525|5460341|P1|STARTED|Overall Study||50
2226395|NCT02748213|5460350|P2|NOT COMPLETED|Overall Study||112
2226396|NCT02748213|5460351|P1|NOT COMPLETED|Overall Study||113
2226397|NCT02748213|5460350|P2|COMPLETED|Overall Study||0
2226398|NCT02748213|5460351|P1|COMPLETED|Overall Study|"*The reason Refused Treatment also includes those who did not cooperate or withdrew consent."|0
2226399|NCT02748213|5460350|P2|Treated|Overall Study||110
2226400|NCT02748213|5460351|P1|Treated|Overall Study||112
2226401|NCT02748213|5460350|P2|STARTED|Overall Study||112
2226402|NCT02748213|5460351|P1|STARTED|Overall Study||113
2226403|NCT02748057|5460369|P2|NOT COMPLETED|Overall Study||2
2226404|NCT02748057|5460370|P1|NOT COMPLETED|Overall Study||5
2226405|NCT02748057|5460369|P2|COMPLETED|Overall Study||19
2226406|NCT02748057|5460370|P1|COMPLETED|Overall Study||109
2226407|NCT02748057|5460369|P2|STARTED|Overall Study||21
2226408|NCT02748057|5460370|P1|STARTED|Overall Study||114
2226409|NCT02747186|5460380|P2|NOT COMPLETED|Second Intervention||0
2226410|NCT02747186|5460381|P1|NOT COMPLETED|Second Intervention||0
2226411|NCT02747186|5460380|P2|COMPLETED|Second Intervention||12
2226412|NCT02747186|5460381|P1|COMPLETED|Second Intervention||12
2226413|NCT02747186|5460380|P2|STARTED|Second Intervention||12
2226414|NCT02747186|5460381|P1|STARTED|Second Intervention||12
2226415|NCT02747186|5460380|P2|NOT COMPLETED|Washout (1 Week)||0
2226416|NCT02747186|5460381|P1|NOT COMPLETED|Washout (1 Week)||0
2226417|NCT02747186|5460380|P2|COMPLETED|Washout (1 Week)||12
2226418|NCT02747186|5460381|P1|COMPLETED|Washout (1 Week)||12
2226419|NCT02747186|5460380|P2|STARTED|Washout (1 Week)||12
2226420|NCT02747186|5460381|P1|STARTED|Washout (1 Week)||12
2226421|NCT02747186|5460380|P2|NOT COMPLETED|First Intervention||0
2226422|NCT02747186|5460381|P1|NOT COMPLETED|First Intervention||0
2226423|NCT02747186|5460380|P2|COMPLETED|First Intervention||12
2226424|NCT02747186|5460381|P1|COMPLETED|First Intervention||12
2226425|NCT02747186|5460380|P2|STARTED|First Intervention||12
2226426|NCT02747186|5460381|P1|STARTED|First Intervention||12
2226427|NCT02747004|5460392|P3|NOT COMPLETED|Overall Study||47
2226428|NCT02747004|5460393|P2|NOT COMPLETED|Overall Study||49
2226429|NCT02747004|5460394|P1|NOT COMPLETED|Overall Study||57
2226430|NCT02747004|5460392|P3|COMPLETED|Overall Study||30
2226431|NCT02747004|5460393|P2|COMPLETED|Overall Study||30
2226432|NCT02747004|5460394|P1|COMPLETED|Overall Study||21
2226433|NCT02747004|5460392|P3|Received at Least One Dose of Study Drug|Overall Study||77
2226434|NCT02747004|5460393|P2|Received at Least One Dose of Study Drug|Overall Study||79
2226435|NCT02747004|5460394|P1|Received at Least One Dose of Study Drug|Overall Study||78
2226436|NCT02747004|5460392|P3|STARTED|Overall Study||77
2226437|NCT02747004|5460393|P2|STARTED|Overall Study||79
2226438|NCT02747004|5460394|P1|STARTED|Overall Study||78
2226439|NCT02746809|5460422|P1|NOT COMPLETED|Baseline-6 Months||5
2226440|NCT02746809|5460422|P1|COMPLETED|Baseline-6 Months||54
2226441|NCT02746809|5460422|P1|STARTED|Baseline-6 Months||59
2226442|NCT02746809|5460422|P1|NOT COMPLETED|Baseline- 30 Days||1
2226443|NCT02746809|5460422|P1|COMPLETED|Baseline- 30 Days||59
2226444|NCT02746809|5460422|P1|STARTED|Baseline- 30 Days||60
2226445|NCT02746679|5460442|P2|NOT COMPLETED|Overall Study||6
2226446|NCT02746679|5460443|P1|NOT COMPLETED|Overall Study||4
2226447|NCT02746679|5460442|P2|COMPLETED|Overall Study||75
2226448|NCT02746679|5460443|P1|COMPLETED|Overall Study||76
2226449|NCT02746679|5460442|P2|STARTED|Overall Study||81
2226450|NCT02746679|5460443|P1|STARTED|Overall Study||80
2226451|NCT02746627|5460476|P3|NOT COMPLETED|Overall Study||1
2226452|NCT02746627|5460477|P2|NOT COMPLETED|Overall Study||1
2226453|NCT02746627|5460478|P1|NOT COMPLETED|Overall Study||1
2226454|NCT02746627|5460476|P3|COMPLETED|Overall Study||29
2226455|NCT02746627|5460477|P2|COMPLETED|Overall Study||29
2226456|NCT02746627|5460478|P1|COMPLETED|Overall Study||59
2226457|NCT02746627|5460476|P3|STARTED|Overall Study||30
2226458|NCT02746627|5460477|P2|STARTED|Overall Study||30
2226459|NCT02746627|5460478|P1|STARTED|Overall Study||60
2226460|NCT02746575|5460501|P1|NOT COMPLETED|Overall Study||50
2226461|NCT02746575|5460501|P1|COMPLETED|Overall Study||20
2226462|NCT02746575|5460501|P1|STARTED|Overall Study||70
2226463|NCT02746406|5460505|P1|NOT COMPLETED|Overall Study||0
2226464|NCT02746406|5460505|P1|COMPLETED|Overall Study||5
2226465|NCT02746406|5460505|P1|STARTED|Overall Study||5
2226466|NCT02746263|5460511|P2|NOT COMPLETED|Overall Study||0
2226467|NCT02746263|5460512|P1|NOT COMPLETED|Overall Study||0
2226468|NCT02746263|5460511|P2|COMPLETED|Overall Study||1
2226469|NCT02746263|5460512|P1|COMPLETED|Overall Study||0
2226470|NCT02746263|5460511|P2|Per Protocol Analysis Set|Overall Study||0
2226471|NCT02746263|5460512|P1|Per Protocol Analysis Set|Overall Study||0
2226472|NCT02746263|5460511|P2|STARTED|Overall Study||1
2226473|NCT02746263|5460512|P1|STARTED|Overall Study||0
2226474|NCT02746107|5460518|P1|NOT COMPLETED|Overall Study||0
2226475|NCT02746107|5460518|P1|COMPLETED|Overall Study||968
2226476|NCT02746107|5460518|P1|CHA2DS2-VASC Score = 5|Overall Study||192
2226477|NCT02746107|5460518|P1|CHA2DS2-VASC Score = 4|Overall Study||197
2226478|NCT02746107|5460518|P1|CHA2DS2-VASC Score = 3|Overall Study||195
2226479|NCT02746107|5460518|P1|CHA2DS2-VASC Score = 2|Overall Study||189
2226480|NCT02746107|5460518|P1|CHA2DS2-VASC Score = 1|Overall Study||195
2226481|NCT02746107|5460518|P1|Target=Physician|Overall Study||482
2226482|NCT02746107|5460518|P1|Target=Patient|Overall Study||486
2226483|NCT02746107|5460518|P1|5year Risk Estimate|Overall Study||485
2226484|NCT02746107|5460518|P1|1year Risk Estimate|Overall Study||483
2226485|NCT02746107|5460518|P1|1 Diagram DA|Overall Study||486
2226486|NCT02746107|5460518|P1|2 Diagrams DA|Overall Study||482
2226487|NCT02746107|5460518|P1|STARTED|Overall Study||968
2226488|NCT02745626|5460536|P3|NOT COMPLETED|Overall Study||3
2226489|NCT02745626|5460537|P2|NOT COMPLETED|Overall Study||6
2226490|NCT02745626|5460538|P1|NOT COMPLETED|Overall Study||3
2226491|NCT02745626|5460536|P3|COMPLETED|Overall Study||19
2226492|NCT02745626|5460537|P2|COMPLETED|Overall Study||16
2226493|NCT02745626|5460538|P1|COMPLETED|Overall Study||21
2226494|NCT02745626|5460536|P3|STARTED|Overall Study||22
2226495|NCT02745626|5460537|P2|STARTED|Overall Study||22
2226496|NCT02745626|5460538|P1|STARTED|Overall Study||24
2226497|NCT02745535|5460564|P1|NOT COMPLETED|Overall Study||6
2226498|NCT02745535|5460564|P1|COMPLETED|Overall Study|Completed 12 weeks of study medication per protocol|71
2226499|NCT02745535|5460564|P1|Sustained Virologic Repsonse|Overall Study|Sustained Virologic response measured 24 weeks after completing study medication|70
2226500|NCT02745535|5460564|P1|STARTED|Overall Study||77
2226501|NCT02745392|5460576|P4|NOT COMPLETED|Overall Study||0
2226502|NCT02745392|5460577|P3|NOT COMPLETED|Overall Study||0
2226503|NCT02745392|5460578|P2|NOT COMPLETED|Overall Study||1
2226504|NCT02745392|5460579|P1|NOT COMPLETED|Overall Study||0
2226505|NCT02745392|5460576|P4|COMPLETED|Overall Study||92
2226506|NCT02745392|5460577|P3|COMPLETED|Overall Study||92
2226507|NCT02745392|5460578|P2|COMPLETED|Overall Study||89
2226508|NCT02745392|5460579|P1|COMPLETED|Overall Study||91
2226509|NCT02745392|5460576|P4|STARTED|Overall Study||92
2226510|NCT02745392|5460577|P3|STARTED|Overall Study||92
2226511|NCT02745392|5460578|P2|STARTED|Overall Study||90
2226512|NCT02745392|5460579|P1|STARTED|Overall Study||91
2226513|NCT02745353|5460595|P2|NOT COMPLETED|Second Intervention (2 Weeks)||1
2226514|NCT02745353|5460596|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
2226515|NCT02745353|5460595|P2|COMPLETED|Second Intervention (2 Weeks)||0
2226516|NCT02745353|5460596|P1|COMPLETED|Second Intervention (2 Weeks)||1
2226517|NCT02745353|5460595|P2|STARTED|Second Intervention (2 Weeks)||1
2226518|NCT02745353|5460596|P1|STARTED|Second Intervention (2 Weeks)||1
2226519|NCT02745353|5460595|P2|NOT COMPLETED|Washout (3 Days)||0
2226520|NCT02745353|5460596|P1|NOT COMPLETED|Washout (3 Days)||0
2226521|NCT02745353|5460595|P2|COMPLETED|Washout (3 Days)||1
2226522|NCT02745353|5460596|P1|COMPLETED|Washout (3 Days)||1
2226523|NCT02745353|5460595|P2|STARTED|Washout (3 Days)||1
2226524|NCT02745353|5460596|P1|STARTED|Washout (3 Days)||1
2226525|NCT02745353|5460595|P2|NOT COMPLETED|First Intervention (2 Weeks)||2
2226526|NCT02745353|5460596|P1|NOT COMPLETED|First Intervention (2 Weeks)||3
2226527|NCT02745353|5460595|P2|COMPLETED|First Intervention (2 Weeks)||1
2226528|NCT02745353|5460596|P1|COMPLETED|First Intervention (2 Weeks)||1
2226529|NCT02745353|5460595|P2|STARTED|First Intervention (2 Weeks)||3
2226530|NCT02745353|5460596|P1|STARTED|First Intervention (2 Weeks)||4
2226531|NCT02745145|5460605|P3|NOT COMPLETED|Overall Study||9
2226532|NCT02745145|5460606|P2|NOT COMPLETED|Overall Study||5
2226533|NCT02745145|5460607|P1|NOT COMPLETED|Overall Study||10
2226534|NCT02745145|5460605|P3|COMPLETED|Overall Study||0
2226535|NCT02745145|5460606|P2|COMPLETED|Overall Study||0
2226536|NCT02745145|5460607|P1|COMPLETED|Overall Study||0
2226537|NCT02745145|5460605|P3|STARTED|Overall Study||9
2226538|NCT02745145|5460606|P2|STARTED|Overall Study||5
2226539|NCT02745145|5460607|P1|STARTED|Overall Study||10
2226540|NCT02745119|5460646|P4|NOT COMPLETED|Overall Study||277
2226541|NCT02745119|5460647|P3|NOT COMPLETED|Overall Study||146
2226542|NCT02745119|5460648|P2|NOT COMPLETED|Overall Study||274
2226543|NCT02745119|5460649|P1|NOT COMPLETED|Overall Study||145
2226544|NCT02745119|5460646|P4|COMPLETED|Overall Study||0
2226545|NCT02745119|5460647|P3|COMPLETED|Overall Study||0
2226546|NCT02745119|5460648|P2|COMPLETED|Overall Study||0
2226547|NCT02745119|5460649|P1|COMPLETED|Overall Study||0
2226548|NCT02745119|5460646|P4|STARTED|Overall Study||277
2226549|NCT02745119|5460647|P3|STARTED|Overall Study||146
2226550|NCT02745119|5460648|P2|STARTED|Overall Study||274
2226551|NCT02745119|5460649|P1|STARTED|Overall Study||145
2226552|NCT02744846|5460671|P1|NOT COMPLETED|10 Year Outcome Assessment||305820
2226553|NCT02744846|5460671|P1|COMPLETED|10 Year Outcome Assessment||56730
2226554|NCT02744846|5460671|P1|Exclude Ineligible Patients|10 Year Outcome Assessment|Loss to follow-up, patients not yet 9 years, or systems that only had data from 2009 to 2016 or less|305820
2226555|NCT02744846|5460671|P1|STARTED|10 Year Outcome Assessment||362550
2226556|NCT02744846|5460671|P1|NOT COMPLETED|5 Year Outcome Assessment||319189
2226557|NCT02744846|5460671|P1|COMPLETED|5 Year Outcome Assessment|Number of patients that meet eligibility criteria|362550
2226558|NCT02744846|5460671|P1|Excluded Ineligible Patients|5 Year Outcome Assessment|Includes lost to follow-up and patients that had not reached age 4 years by end of study period|319189
2226559|NCT02744846|5460671|P1|STARTED|5 Year Outcome Assessment||681739
2226560|NCT02744755|5460681|P2|NOT COMPLETED|Study Period 2||8
2226561|NCT02744755|5460682|P1|NOT COMPLETED|Study Period 2||14
2226562|NCT02744755|5460681|P2|COMPLETED|Study Period 2||158
2226563|NCT02744755|5460682|P1|COMPLETED|Study Period 2||145
2226564|NCT02744755|5460681|P2|STARTED|Study Period 2||166
2226565|NCT02744755|5460682|P1|STARTED|Study Period 2||159
2226566|NCT02744755|5460681|P2|NOT COMPLETED|Study Period 1||8
2226567|NCT02744755|5460682|P1|NOT COMPLETED|Study Period 1||14
2226568|NCT02744755|5460681|P2|COMPLETED|Study Period 1||168
2226569|NCT02744755|5460682|P1|COMPLETED|Study Period 1||163
2226570|NCT02744755|5460681|P2|STARTED|Study Period 1||176
2226571|NCT02744755|5460682|P1|STARTED|Study Period 1||177
2226572|NCT02744534|5460736|P1|NOT COMPLETED|Overall Study||0
2226573|NCT02744534|5460736|P1|COMPLETED|Overall Study||21
2226574|NCT02744534|5460736|P1|STARTED|Overall Study||21
2226575|NCT02744391|5460742|P1|NOT COMPLETED|Overall Study||14
2226576|NCT02744391|5460742|P1|COMPLETED|Overall Study||33
2226577|NCT02744391|5460742|P1|STARTED|Overall Study||47
2226578|NCT02744066|5460766|P2|NOT COMPLETED|Overall Study||5
2226579|NCT02744066|5460767|P1|NOT COMPLETED|Overall Study||0
2226580|NCT02744066|5460766|P2|COMPLETED|Overall Study||25
2226581|NCT02744066|5460767|P1|COMPLETED|Overall Study||25
2226582|NCT02744066|5460766|P2|STARTED|Overall Study||30
2226583|NCT02744066|5460767|P1|STARTED|Overall Study||25
2226584|NCT02743962|5460777|P2|NOT COMPLETED|Overall Study||0
2226585|NCT02743962|5460778|P1|NOT COMPLETED|Overall Study||1
2226586|NCT02743962|5460777|P2|COMPLETED|Overall Study||5
2226587|NCT02743962|5460778|P1|COMPLETED|Overall Study||4
2226588|NCT02743962|5460777|P2|STARTED|Overall Study||5
2226589|NCT02743962|5460778|P1|STARTED|Overall Study||5
2226599|NCT02743936|5460815|P2|NOT COMPLETED|Overall Study||0
2226600|NCT02743936|5460816|P1|NOT COMPLETED|Overall Study||0
2226601|NCT02743936|5460815|P2|COMPLETED|Overall Study||32
2226602|NCT02743936|5460816|P1|COMPLETED|Overall Study||32
2226603|NCT02743936|5460815|P2|STARTED|Overall Study||32
2226604|NCT02743936|5460816|P1|STARTED|Overall Study||32
2226605|NCT02743780|5460829|P5|NOT COMPLETED|Part 3 (7 Days)||0
2226606|NCT02743780|5460830|P4|NOT COMPLETED|Part 3 (7 Days)||0
2226607|NCT02743780|5460831|P3|NOT COMPLETED|Part 3 (7 Days)||1
2226608|NCT02743780|5460832|P2|NOT COMPLETED|Part 3 (7 Days)||0
2226609|NCT02743780|5460833|P1|NOT COMPLETED|Part 3 (7 Days)||0
2226610|NCT02743780|5460829|P5|COMPLETED|Part 3 (7 Days)||25
2226611|NCT02743780|5460830|P4|COMPLETED|Part 3 (7 Days)||0
2226612|NCT02743780|5460831|P3|COMPLETED|Part 3 (7 Days)||24
2226613|NCT02743780|5460832|P2|COMPLETED|Part 3 (7 Days)||0
2226614|NCT02743780|5460833|P1|COMPLETED|Part 3 (7 Days)||0
2226615|NCT02743780|5460829|P5|STARTED|Part 3 (7 Days)||25
2226616|NCT02743780|5460830|P4|STARTED|Part 3 (7 Days)||0
2226617|NCT02743780|5460831|P3|STARTED|Part 3 (7 Days)||25
2226618|NCT02743780|5460832|P2|STARTED|Part 3 (7 Days)||0
2226619|NCT02743780|5460833|P1|STARTED|Part 3 (7 Days)||0
2226620|NCT02743780|5460829|P5|NOT COMPLETED|Part 2 (8 Days)||0
2226621|NCT02743780|5460830|P4|NOT COMPLETED|Part 2 (8 Days)||0
2226622|NCT02743780|5460831|P3|NOT COMPLETED|Part 2 (8 Days)||0
2226623|NCT02743780|5460832|P2|NOT COMPLETED|Part 2 (8 Days)||0
2226624|NCT02743780|5460833|P1|NOT COMPLETED|Part 2 (8 Days)||0
2226625|NCT02743780|5460829|P5|COMPLETED|Part 2 (8 Days)||4
2226626|NCT02743780|5460830|P4|COMPLETED|Part 2 (8 Days)||0
2226627|NCT02743780|5460831|P3|COMPLETED|Part 2 (8 Days)||6
2226628|NCT02743780|5460832|P2|COMPLETED|Part 2 (8 Days)||6
2226629|NCT02743780|5460833|P1|COMPLETED|Part 2 (8 Days)||0
2226630|NCT02743780|5460829|P5|STARTED|Part 2 (8 Days)||4
2226631|NCT02743780|5460830|P4|STARTED|Part 2 (8 Days)||0
2226632|NCT02743780|5460831|P3|STARTED|Part 2 (8 Days)||6
2226633|NCT02743780|5460832|P2|STARTED|Part 2 (8 Days)||6
2226634|NCT02743780|5460833|P1|STARTED|Part 2 (8 Days)||0
2226635|NCT02743780|5460829|P5|NOT COMPLETED|Part 1 (3 Days)||0
2226636|NCT02743780|5460830|P4|NOT COMPLETED|Part 1 (3 Days)||0
2226637|NCT02743780|5460831|P3|NOT COMPLETED|Part 1 (3 Days)||0
2226638|NCT02743780|5460832|P2|NOT COMPLETED|Part 1 (3 Days)||0
2226639|NCT02743780|5460833|P1|NOT COMPLETED|Part 1 (3 Days)||0
2226640|NCT02743780|5460829|P5|COMPLETED|Part 1 (3 Days)||8
2226641|NCT02743780|5460830|P4|COMPLETED|Part 1 (3 Days)||6
2226642|NCT02743780|5460831|P3|COMPLETED|Part 1 (3 Days)||6
2226643|NCT02743780|5460832|P2|COMPLETED|Part 1 (3 Days)||6
2226644|NCT02743780|5460833|P1|COMPLETED|Part 1 (3 Days)||6
2226645|NCT02743780|5460829|P5|STARTED|Part 1 (3 Days)||8
2226646|NCT02743780|5460830|P4|STARTED|Part 1 (3 Days)||6
2226647|NCT02743780|5460831|P3|STARTED|Part 1 (3 Days)||6
2226648|NCT02743780|5460832|P2|STARTED|Part 1 (3 Days)||6
2226649|NCT02743780|5460833|P1|STARTED|Part 1 (3 Days)||6
2226650|NCT02743702|5460880|P2|NOT COMPLETED|Overall Study||0
2226651|NCT02743702|5460881|P1|NOT COMPLETED|Overall Study||0
2226652|NCT02743702|5460880|P2|COMPLETED|Overall Study||10
2226653|NCT02743702|5460881|P1|COMPLETED|Overall Study||11
2226654|NCT02743702|5460880|P2|STARTED|Overall Study||10
2226655|NCT02743702|5460881|P1|STARTED|Overall Study||11
2226656|NCT02743312|5460889|P2|NOT COMPLETED|Overall Study||0
2226657|NCT02743312|5460890|P1|NOT COMPLETED|Overall Study||0
2226658|NCT02743312|5460889|P2|COMPLETED|Overall Study||2
2226659|NCT02743312|5460890|P1|COMPLETED|Overall Study||3
2226660|NCT02743312|5460889|P2|STARTED|Overall Study||2
2226661|NCT02743312|5460890|P1|STARTED|Overall Study||3
2226662|NCT02743221|5460923|P2|NOT COMPLETED|Overall Study||60
2226663|NCT02743221|5460924|P1|NOT COMPLETED|Overall Study||56
2226664|NCT02743221|5460923|P2|COMPLETED|Overall Study||17
2226665|NCT02743221|5460924|P1|COMPLETED|Overall Study||21
2226666|NCT02743221|5460923|P2|STARTED|Overall Study||77
2226667|NCT02743221|5460924|P1|STARTED|Overall Study||77
2226668|NCT02743117|5460940|P2|NOT COMPLETED|Overall Study||1
2226669|NCT02743117|5460941|P1|NOT COMPLETED|Overall Study||1
2226670|NCT02743117|5460940|P2|COMPLETED|Overall Study||240
2226671|NCT02743117|5460941|P1|COMPLETED|Overall Study||59
2226672|NCT02743117|5460940|P2|Treated|Overall Study||241
2226673|NCT02743117|5460941|P1|Treated|Overall Study||59
2226674|NCT02743117|5460940|P2|STARTED|Overall Study||241
2226675|NCT02743117|5460941|P1|STARTED|Overall Study||60
2226676|NCT02742987|5460957|P2|NOT COMPLETED|Overall Study||0
2226677|NCT02742987|5460958|P1|NOT COMPLETED|Overall Study||0
2226678|NCT02742987|5460957|P2|COMPLETED|Overall Study||21
2226679|NCT02742987|5460958|P1|COMPLETED|Overall Study||21
2226680|NCT02742987|5460957|P2|STARTED|Overall Study||21
2226681|NCT02742987|5460958|P1|STARTED|Overall Study||21
2226682|NCT02742818|5460966|P2|NOT COMPLETED|Overall Study||2
2226683|NCT02742818|5460967|P1|NOT COMPLETED|Overall Study||0
2226684|NCT02742818|5460966|P2|COMPLETED|Overall Study||23
2226685|NCT02742818|5460967|P1|COMPLETED|Overall Study||25
2226686|NCT02742818|5460966|P2|STARTED|Overall Study||25
2226687|NCT02742818|5460967|P1|STARTED|Overall Study||25
2226688|NCT02742766|5461000|P19|NOT COMPLETED|Part 3 (Up to 36 Days)||0
2226689|NCT02742766|5461001|P18|NOT COMPLETED|Part 3 (Up to 36 Days)||0
2226690|NCT02742766|5461002|P17|NOT COMPLETED|Part 3 (Up to 36 Days)||0
2226691|NCT02742766|5461003|P16|NOT COMPLETED|Part 3 (Up to 36 Days)||0
2226692|NCT02742766|5461004|P15|NOT COMPLETED|Part 3 (Up to 36 Days)||0
2226693|NCT02742766|5461005|P14|NOT COMPLETED|Part 3 (Up to 36 Days)||0
2226694|NCT02742766|5461006|P13|NOT COMPLETED|Part 3 (Up to 36 Days)||0
2226695|NCT02742766|5461007|P12|NOT COMPLETED|Part 3 (Up to 36 Days)||0
2226696|NCT02742766|5461008|P11|NOT COMPLETED|Part 3 (Up to 36 Days)||0
2226697|NCT02742766|5461009|P10|NOT COMPLETED|Part 3 (Up to 36 Days)||0
2226698|NCT02742766|5461010|P9|NOT COMPLETED|Part 3 (Up to 36 Days)||0
2226699|NCT02742766|5461011|P8|NOT COMPLETED|Part 3 (Up to 36 Days)||0
2226700|NCT02742766|5461012|P7|NOT COMPLETED|Part 3 (Up to 36 Days)||0
2226701|NCT02742766|5461013|P6|NOT COMPLETED|Part 3 (Up to 36 Days)||0
2226702|NCT02742766|5461014|P5|NOT COMPLETED|Part 3 (Up to 36 Days)||0
2226703|NCT02742766|5461015|P4|NOT COMPLETED|Part 3 (Up to 36 Days)||0
2226704|NCT02742766|5461016|P3|NOT COMPLETED|Part 3 (Up to 36 Days)||0
2226705|NCT02742766|5461017|P2|NOT COMPLETED|Part 3 (Up to 36 Days)||0
2226706|NCT02742766|5461018|P1|NOT COMPLETED|Part 3 (Up to 36 Days)||0
2226707|NCT02742766|5461000|P19|COMPLETED|Part 3 (Up to 36 Days)||0
2226708|NCT02742766|5461001|P18|COMPLETED|Part 3 (Up to 36 Days)||0
2226709|NCT02742766|5461002|P17|COMPLETED|Part 3 (Up to 36 Days)||0
2226710|NCT02742766|5461003|P16|COMPLETED|Part 3 (Up to 36 Days)||0
2226711|NCT02742766|5461004|P15|COMPLETED|Part 3 (Up to 36 Days)||0
2226712|NCT02742766|5461005|P14|COMPLETED|Part 3 (Up to 36 Days)||0
2226713|NCT02742766|5461006|P13|COMPLETED|Part 3 (Up to 36 Days)||0
2226714|NCT02742766|5461007|P12|COMPLETED|Part 3 (Up to 36 Days)||0
2226715|NCT02742766|5461008|P11|COMPLETED|Part 3 (Up to 36 Days)||0
2226716|NCT02742766|5461009|P10|COMPLETED|Part 3 (Up to 36 Days)||0
2226717|NCT02742766|5461010|P9|COMPLETED|Part 3 (Up to 36 Days)||0
2226718|NCT02742766|5461011|P8|COMPLETED|Part 3 (Up to 36 Days)||0
2226719|NCT02742766|5461012|P7|COMPLETED|Part 3 (Up to 36 Days)||0
2226720|NCT02742766|5461013|P6|COMPLETED|Part 3 (Up to 36 Days)||0
2226721|NCT02742766|5461014|P5|COMPLETED|Part 3 (Up to 36 Days)||0
2226722|NCT02742766|5461015|P4|COMPLETED|Part 3 (Up to 36 Days)||0
2226723|NCT02742766|5461016|P3|COMPLETED|Part 3 (Up to 36 Days)||0
2226724|NCT02742766|5461017|P2|COMPLETED|Part 3 (Up to 36 Days)||0
2226725|NCT02742766|5461018|P1|COMPLETED|Part 3 (Up to 36 Days)||0
2226726|NCT02742766|5461000|P19|STARTED|Part 3 (Up to 36 Days)||0
2226727|NCT02742766|5461001|P18|STARTED|Part 3 (Up to 36 Days)||0
2226728|NCT02742766|5461002|P17|STARTED|Part 3 (Up to 36 Days)||0
2226729|NCT02742766|5461003|P16|STARTED|Part 3 (Up to 36 Days)||0
2226730|NCT02742766|5461004|P15|STARTED|Part 3 (Up to 36 Days)||0
2226731|NCT02742766|5461005|P14|STARTED|Part 3 (Up to 36 Days)||0
2226732|NCT02742766|5461006|P13|STARTED|Part 3 (Up to 36 Days)||0
2226733|NCT02742766|5461007|P12|STARTED|Part 3 (Up to 36 Days)||0
2226734|NCT02742766|5461008|P11|STARTED|Part 3 (Up to 36 Days)||0
2226735|NCT02742766|5461009|P10|STARTED|Part 3 (Up to 36 Days)||0
2226736|NCT02742766|5461010|P9|STARTED|Part 3 (Up to 36 Days)||0
2226737|NCT02742766|5461011|P8|STARTED|Part 3 (Up to 36 Days)||0
2226738|NCT02742766|5461012|P7|STARTED|Part 3 (Up to 36 Days)||0
2226739|NCT02742766|5461013|P6|STARTED|Part 3 (Up to 36 Days)||0
2226740|NCT02742766|5461014|P5|STARTED|Part 3 (Up to 36 Days)||0
2226741|NCT02742766|5461015|P4|STARTED|Part 3 (Up to 36 Days)||0
2226742|NCT02742766|5461016|P3|STARTED|Part 3 (Up to 36 Days)||0
2226743|NCT02742766|5461017|P2|STARTED|Part 3 (Up to 36 Days)||0
2226744|NCT02742766|5461018|P1|STARTED|Part 3 (Up to 36 Days)||0
2226745|NCT02742766|5461000|P19|NOT COMPLETED|Part 2 (Up to 22 Days)||0
2226746|NCT02742766|5461001|P18|NOT COMPLETED|Part 2 (Up to 22 Days)||0
2226747|NCT02742766|5461002|P17|NOT COMPLETED|Part 2 (Up to 22 Days)||0
2226748|NCT02742766|5461003|P16|NOT COMPLETED|Part 2 (Up to 22 Days)||1
2226749|NCT02742766|5461004|P15|NOT COMPLETED|Part 2 (Up to 22 Days)||0
2226750|NCT02742766|5461005|P14|NOT COMPLETED|Part 2 (Up to 22 Days)||6
2226751|NCT02742766|5461006|P13|NOT COMPLETED|Part 2 (Up to 22 Days)||2
2226752|NCT02742766|5461007|P12|NOT COMPLETED|Part 2 (Up to 22 Days)||0
2226753|NCT02742766|5461008|P11|NOT COMPLETED|Part 2 (Up to 22 Days)||0
2226754|NCT02742766|5461009|P10|NOT COMPLETED|Part 2 (Up to 22 Days)||0
2226755|NCT02742766|5461010|P9|NOT COMPLETED|Part 2 (Up to 22 Days)||0
2226756|NCT02742766|5461011|P8|NOT COMPLETED|Part 2 (Up to 22 Days)||0
2226757|NCT02742766|5461012|P7|NOT COMPLETED|Part 2 (Up to 22 Days)||0
2226758|NCT02742766|5461013|P6|NOT COMPLETED|Part 2 (Up to 22 Days)||0
2226759|NCT02742766|5461014|P5|NOT COMPLETED|Part 2 (Up to 22 Days)||0
2226760|NCT02742766|5461015|P4|NOT COMPLETED|Part 2 (Up to 22 Days)||0
2226761|NCT02742766|5461016|P3|NOT COMPLETED|Part 2 (Up to 22 Days)||0
2226762|NCT02742766|5461017|P2|NOT COMPLETED|Part 2 (Up to 22 Days)||0
2226763|NCT02742766|5461018|P1|NOT COMPLETED|Part 2 (Up to 22 Days)||0
2226764|NCT02742766|5461000|P19|COMPLETED|Part 2 (Up to 22 Days)||0
2226765|NCT02742766|5461001|P18|COMPLETED|Part 2 (Up to 22 Days)||0
2226766|NCT02742766|5461002|P17|COMPLETED|Part 2 (Up to 22 Days)||0
2226767|NCT02742766|5461003|P16|COMPLETED|Part 2 (Up to 22 Days)|Day 4 study medication interrupted due to an AE and eventually withdrew from study on Day 5.|5
2226768|NCT02742766|5461004|P15|COMPLETED|Part 2 (Up to 22 Days)||6
2226769|NCT02742766|5461005|P14|COMPLETED|Part 2 (Up to 22 Days)||0
2226770|NCT02742766|5461006|P13|COMPLETED|Part 2 (Up to 22 Days)||4
2226771|NCT02742766|5461007|P12|COMPLETED|Part 2 (Up to 22 Days)||0
2226772|NCT02742766|5461008|P11|COMPLETED|Part 2 (Up to 22 Days)||0
2226773|NCT02742766|5461009|P10|COMPLETED|Part 2 (Up to 22 Days)||0
2226774|NCT02742766|5461010|P9|COMPLETED|Part 2 (Up to 22 Days)||0
2226775|NCT02742766|5461011|P8|COMPLETED|Part 2 (Up to 22 Days)||0
2226776|NCT02742766|5461012|P7|COMPLETED|Part 2 (Up to 22 Days)||0
2226777|NCT02742766|5461013|P6|COMPLETED|Part 2 (Up to 22 Days)||0
2226778|NCT02742766|5461014|P5|COMPLETED|Part 2 (Up to 22 Days)||0
2226779|NCT02742766|5461015|P4|COMPLETED|Part 2 (Up to 22 Days)||0
2226780|NCT02742766|5461016|P3|COMPLETED|Part 2 (Up to 22 Days)||0
2226781|NCT02742766|5461017|P2|COMPLETED|Part 2 (Up to 22 Days)||0
2226782|NCT02742766|5461018|P1|COMPLETED|Part 2 (Up to 22 Days)||0
2226783|NCT02742766|5461000|P19|STARTED|Part 2 (Up to 22 Days)||0
2226784|NCT02742766|5461001|P18|STARTED|Part 2 (Up to 22 Days)||0
2226785|NCT02742766|5461002|P17|STARTED|Part 2 (Up to 22 Days)||0
2226786|NCT02742766|5461003|P16|STARTED|Part 2 (Up to 22 Days)||6
2226787|NCT02742766|5461004|P15|STARTED|Part 2 (Up to 22 Days)||6
2226788|NCT02742766|5461005|P14|STARTED|Part 2 (Up to 22 Days)||6
2226789|NCT02742766|5461006|P13|STARTED|Part 2 (Up to 22 Days)||6
2226790|NCT02742766|5461007|P12|STARTED|Part 2 (Up to 22 Days)||0
2226791|NCT02742766|5461008|P11|STARTED|Part 2 (Up to 22 Days)||0
2226792|NCT02742766|5461009|P10|STARTED|Part 2 (Up to 22 Days)||0
2226793|NCT02742766|5461010|P9|STARTED|Part 2 (Up to 22 Days)||0
2226794|NCT02742766|5461011|P8|STARTED|Part 2 (Up to 22 Days)||0
2226795|NCT02742766|5461012|P7|STARTED|Part 2 (Up to 22 Days)||0
2226796|NCT02742766|5461013|P6|STARTED|Part 2 (Up to 22 Days)||0
2226797|NCT02742766|5461014|P5|STARTED|Part 2 (Up to 22 Days)||0
2226798|NCT02742766|5461015|P4|STARTED|Part 2 (Up to 22 Days)||0
2226799|NCT02742766|5461016|P3|STARTED|Part 2 (Up to 22 Days)||0
2226800|NCT02742766|5461017|P2|STARTED|Part 2 (Up to 22 Days)||0
2226801|NCT02742766|5461018|P1|STARTED|Part 2 (Up to 22 Days)||0
2226802|NCT02742766|5461000|P19|NOT COMPLETED|Part 1 (Up to 8 Days)||0
2226803|NCT02742766|5461001|P18|NOT COMPLETED|Part 1 (Up to 8 Days)||0
2226804|NCT02742766|5461002|P17|NOT COMPLETED|Part 1 (Up to 8 Days)||0
2226805|NCT02742766|5461003|P16|NOT COMPLETED|Part 1 (Up to 8 Days)||0
2226806|NCT02742766|5461004|P15|NOT COMPLETED|Part 1 (Up to 8 Days)||0
2226807|NCT02742766|5461005|P14|NOT COMPLETED|Part 1 (Up to 8 Days)||0
2226808|NCT02742766|5461006|P13|NOT COMPLETED|Part 1 (Up to 8 Days)||0
2226809|NCT02742766|5461007|P12|NOT COMPLETED|Part 1 (Up to 8 Days)||0
2226810|NCT02742766|5461008|P11|NOT COMPLETED|Part 1 (Up to 8 Days)||0
2226811|NCT02742766|5461009|P10|NOT COMPLETED|Part 1 (Up to 8 Days)||0
2226812|NCT02742766|5461010|P9|NOT COMPLETED|Part 1 (Up to 8 Days)||0
2226813|NCT02742766|5461011|P8|NOT COMPLETED|Part 1 (Up to 8 Days)||0
2226814|NCT02742766|5461012|P7|NOT COMPLETED|Part 1 (Up to 8 Days)||0
2226815|NCT02742766|5461013|P6|NOT COMPLETED|Part 1 (Up to 8 Days)||0
2226816|NCT02742766|5461014|P5|NOT COMPLETED|Part 1 (Up to 8 Days)||0
2226817|NCT02742766|5461015|P4|NOT COMPLETED|Part 1 (Up to 8 Days)||0
2226818|NCT02742766|5461016|P3|NOT COMPLETED|Part 1 (Up to 8 Days)||0
2226819|NCT02742766|5461017|P2|NOT COMPLETED|Part 1 (Up to 8 Days)||0
2226820|NCT02742766|5461018|P1|NOT COMPLETED|Part 1 (Up to 8 Days)||0
2226821|NCT02742766|5461000|P19|COMPLETED|Part 1 (Up to 8 Days)||0
2226822|NCT02742766|5461001|P18|COMPLETED|Part 1 (Up to 8 Days)||0
2226823|NCT02742766|5461002|P17|COMPLETED|Part 1 (Up to 8 Days)||0
2226824|NCT02742766|5461003|P16|COMPLETED|Part 1 (Up to 8 Days)||0
2226825|NCT02742766|5461004|P15|COMPLETED|Part 1 (Up to 8 Days)||0
2226826|NCT02742766|5461005|P14|COMPLETED|Part 1 (Up to 8 Days)||0
2226827|NCT02742766|5461006|P13|COMPLETED|Part 1 (Up to 8 Days)||0
2226828|NCT02742766|5461007|P12|COMPLETED|Part 1 (Up to 8 Days)||6
2226829|NCT02742766|5461008|P11|COMPLETED|Part 1 (Up to 8 Days)||6
2226830|NCT02742766|5461009|P10|COMPLETED|Part 1 (Up to 8 Days)||0
2226831|NCT02742766|5461010|P9|COMPLETED|Part 1 (Up to 8 Days)||6
2226832|NCT02742766|5461011|P8|COMPLETED|Part 1 (Up to 8 Days)||6
2226833|NCT02742766|5461012|P7|COMPLETED|Part 1 (Up to 8 Days)||6
2226834|NCT02742766|5461013|P6|COMPLETED|Part 1 (Up to 8 Days)||6
2226835|NCT02742766|5461014|P5|COMPLETED|Part 1 (Up to 8 Days)||6
2226836|NCT02742766|5461015|P4|COMPLETED|Part 1 (Up to 8 Days)||6
2226837|NCT02742766|5461016|P3|COMPLETED|Part 1 (Up to 8 Days)||6
2226838|NCT02742766|5461017|P2|COMPLETED|Part 1 (Up to 8 Days)||6
2226839|NCT02742766|5461018|P1|COMPLETED|Part 1 (Up to 8 Days)||20
2226840|NCT02742766|5461000|P19|STARTED|Part 1 (Up to 8 Days)||0
2226841|NCT02742766|5461001|P18|STARTED|Part 1 (Up to 8 Days)||0
2226842|NCT02742766|5461002|P17|STARTED|Part 1 (Up to 8 Days)||0
2226843|NCT02742766|5461003|P16|STARTED|Part 1 (Up to 8 Days)||0
2226844|NCT02742766|5461004|P15|STARTED|Part 1 (Up to 8 Days)||0
2226845|NCT02742766|5461005|P14|STARTED|Part 1 (Up to 8 Days)||0
2226846|NCT02742766|5461006|P13|STARTED|Part 1 (Up to 8 Days)||0
2226847|NCT02742766|5461007|P12|STARTED|Part 1 (Up to 8 Days)||6
2226848|NCT02742766|5461008|P11|STARTED|Part 1 (Up to 8 Days)||6
2226849|NCT02742766|5461009|P10|STARTED|Part 1 (Up to 8 Days)||0
2226850|NCT02742766|5461010|P9|STARTED|Part 1 (Up to 8 Days)||6
2226851|NCT02742766|5461011|P8|STARTED|Part 1 (Up to 8 Days)||6
2226852|NCT02742766|5461012|P7|STARTED|Part 1 (Up to 8 Days)||6
2226853|NCT02742766|5461013|P6|STARTED|Part 1 (Up to 8 Days)||6
2226854|NCT02742766|5461014|P5|STARTED|Part 1 (Up to 8 Days)||6
2226855|NCT02742766|5461015|P4|STARTED|Part 1 (Up to 8 Days)||6
2226856|NCT02742766|5461016|P3|STARTED|Part 1 (Up to 8 Days)||6
2226857|NCT02742766|5461017|P2|STARTED|Part 1 (Up to 8 Days)||6
2226858|NCT02742766|5461018|P1|STARTED|Part 1 (Up to 8 Days)||20
2226859|NCT02742649|5461278|P5|NOT COMPLETED|Open-Label Period||1
2226860|NCT02742649|5461279|P4|NOT COMPLETED|Open-Label Period||0
2226861|NCT02742649|5461280|P3|NOT COMPLETED|Open-Label Period||0
2226862|NCT02742649|5461281|P2|NOT COMPLETED|Open-Label Period||0
2226863|NCT02742649|5461282|P1|NOT COMPLETED|Open-Label Period||0
2226864|NCT02742649|5461278|P5|COMPLETED|Open-Label Period||48
2226865|NCT02742649|5461279|P4|COMPLETED|Open-Label Period||0
2226866|NCT02742649|5461280|P3|COMPLETED|Open-Label Period||0
2226867|NCT02742649|5461281|P2|COMPLETED|Open-Label Period||0
2226868|NCT02742649|5461282|P1|COMPLETED|Open-Label Period||0
2226869|NCT02742649|5461278|P5|STARTED|Open-Label Period||49
2226870|NCT02742649|5461279|P4|STARTED|Open-Label Period||0
2226871|NCT02742649|5461280|P3|STARTED|Open-Label Period||0
2226872|NCT02742649|5461281|P2|STARTED|Open-Label Period||0
2226873|NCT02742649|5461282|P1|STARTED|Open-Label Period||0
2226874|NCT02742649|5461278|P5|NOT COMPLETED|Double-Blind Treatment Period||0
2226875|NCT02742649|5461279|P4|NOT COMPLETED|Double-Blind Treatment Period||0
2226876|NCT02742649|5461280|P3|NOT COMPLETED|Double-Blind Treatment Period||0
2226877|NCT02742649|5461281|P2|NOT COMPLETED|Double-Blind Treatment Period||1
2226878|NCT02742649|5461282|P1|NOT COMPLETED|Double-Blind Treatment Period||0
2226879|NCT02742649|5461278|P5|COMPLETED|Double-Blind Treatment Period||0
2226880|NCT02742649|5461279|P4|COMPLETED|Double-Blind Treatment Period||16
2226881|NCT02742649|5461280|P3|COMPLETED|Double-Blind Treatment Period||17
2226882|NCT02742649|5461281|P2|COMPLETED|Double-Blind Treatment Period||16
2226883|NCT02742649|5461282|P1|COMPLETED|Double-Blind Treatment Period||0
2226884|NCT02742649|5461278|P5|STARTED|Double-Blind Treatment Period||0
2226885|NCT02742649|5461279|P4|STARTED|Double-Blind Treatment Period||16
2226886|NCT02742649|5461280|P3|STARTED|Double-Blind Treatment Period||17
2226887|NCT02742649|5461281|P2|STARTED|Double-Blind Treatment Period||17
2226888|NCT02742649|5461282|P1|STARTED|Double-Blind Treatment Period||0
2226889|NCT02742649|5461278|P5|NOT COMPLETED|Pre-Randomization Washout Period||0
2226890|NCT02742649|5461279|P4|NOT COMPLETED|Pre-Randomization Washout Period||0
2226891|NCT02742649|5461280|P3|NOT COMPLETED|Pre-Randomization Washout Period||0
2226892|NCT02742649|5461281|P2|NOT COMPLETED|Pre-Randomization Washout Period||0
2226893|NCT02742649|5461282|P1|NOT COMPLETED|Pre-Randomization Washout Period||5
2226894|NCT02742649|5461278|P5|COMPLETED|Pre-Randomization Washout Period||0
2226895|NCT02742649|5461279|P4|COMPLETED|Pre-Randomization Washout Period||0
2226896|NCT02742649|5461280|P3|COMPLETED|Pre-Randomization Washout Period||0
2226897|NCT02742649|5461281|P2|COMPLETED|Pre-Randomization Washout Period||0
2226898|NCT02742649|5461282|P1|COMPLETED|Pre-Randomization Washout Period||50
2226899|NCT02742649|5461278|P5|STARTED|Pre-Randomization Washout Period||0
2226900|NCT02742649|5461279|P4|STARTED|Pre-Randomization Washout Period||0
2226901|NCT02742649|5461280|P3|STARTED|Pre-Randomization Washout Period||0
2226902|NCT02742649|5461281|P2|STARTED|Pre-Randomization Washout Period||0
2226903|NCT02742649|5461282|P1|STARTED|Pre-Randomization Washout Period||55
2226904|NCT02742519|5461310|P3|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||10
2226905|NCT02742519|5461311|P2|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||0
2226906|NCT02742519|5461312|P1|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||0
2226907|NCT02742519|5461310|P3|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
2226908|NCT02742519|5461311|P2|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
2226909|NCT02742519|5461312|P1|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
2226910|NCT02742519|5461310|P3|STARTED|Part 2 Open Label Period (32 Weeks)|Of 12 participants who completed DB period, only 10 entered OL period & 2 opted for commercial drug.|10
2226911|NCT02742519|5461311|P2|STARTED|Part 2 Open Label Period (32 Weeks)||0
2226912|NCT02742519|5461312|P1|STARTED|Part 2 Open Label Period (32 Weeks)||0
2226913|NCT02742519|5461310|P3|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||0
2226914|NCT02742519|5461311|P2|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||1
2226915|NCT02742519|5461312|P1|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||1
2226916|NCT02742519|5461310|P3|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||0
2226917|NCT02742519|5461311|P2|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||5
2226918|NCT02742519|5461312|P1|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||7
2226919|NCT02742519|5461310|P3|STARTED|Part 1 Treatment Period 2 (8 Weeks)||0
2226920|NCT02742519|5461311|P2|STARTED|Part 1 Treatment Period 2 (8 Weeks)||6
2226921|NCT02742519|5461312|P1|STARTED|Part 1 Treatment Period 2 (8 Weeks)||8
2226922|NCT02742519|5461310|P3|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
2226923|NCT02742519|5461311|P2|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
2226924|NCT02742519|5461312|P1|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
2226925|NCT02742519|5461310|P3|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
2226926|NCT02742519|5461311|P2|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||6
2226927|NCT02742519|5461312|P1|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||8
2226928|NCT02742519|5461310|P3|STARTED|Part 1 Treatment Period 1 (8 Weeks)||0
2226929|NCT02742519|5461311|P2|STARTED|Part 1 Treatment Period 1 (8 Weeks)||6
2226930|NCT02742519|5461312|P1|STARTED|Part 1 Treatment Period 1 (8 Weeks)||8
2226931|NCT02742441|5461332|P2|NOT COMPLETED|Overall Study||8
2226932|NCT02742441|5461333|P1|NOT COMPLETED|Overall Study||6
2226933|NCT02742441|5461332|P2|COMPLETED|Overall Study||196
2226934|NCT02742441|5461333|P1|COMPLETED|Overall Study||199
2226935|NCT02742441|5461332|P2|STARTED|Overall Study||204
2226936|NCT02742441|5461333|P1|STARTED|Overall Study||205
2226937|NCT02742129|5461351|P2|NOT COMPLETED|Phase 2||2
2226938|NCT02742129|5461352|P1|NOT COMPLETED|Phase 2||1
2226939|NCT02742129|5461351|P2|COMPLETED|Phase 2||48
2226940|NCT02742129|5461352|P1|COMPLETED|Phase 2||50
2226941|NCT02742129|5461351|P2|STARTED|Phase 2||50
2226942|NCT02742129|5461352|P1|STARTED|Phase 2||51
2226943|NCT02742129|5461351|P2|NOT COMPLETED|Phase 1||2
2226944|NCT02742129|5461352|P1|NOT COMPLETED|Phase 1||2
2226945|NCT02742129|5461351|P2|COMPLETED|Phase 1||50
2226946|NCT02742129|5461352|P1|COMPLETED|Phase 1||51
2226947|NCT02742129|5461351|P2|STARTED|Phase 1||52
2226948|NCT02742129|5461352|P1|STARTED|Phase 1||53
2226949|NCT02741713|5461380|P2|NOT COMPLETED|Overall Study||1
2226950|NCT02741713|5461381|P1|NOT COMPLETED|Overall Study||2
2226951|NCT02741713|5461380|P2|COMPLETED|Overall Study||19
2226952|NCT02741713|5461381|P1|COMPLETED|Overall Study||18
2226953|NCT02741713|5461380|P2|STARTED|Overall Study||20
2226954|NCT02741713|5461381|P1|STARTED|Overall Study||20
2226955|NCT02741687|5461396|P2|NOT COMPLETED|Overall Study||0
2226956|NCT02741687|5461397|P1|NOT COMPLETED|Overall Study||0
2226957|NCT02741687|5461396|P2|COMPLETED|Overall Study||44
2226958|NCT02741687|5461397|P1|COMPLETED|Overall Study||36
2226959|NCT02741687|5461396|P2|STARTED|Overall Study||44
2226960|NCT02741687|5461397|P1|STARTED|Overall Study||36
2226961|NCT02741518|5461423|P2|NOT COMPLETED|Overall Study||1
2226962|NCT02741518|5461424|P1|NOT COMPLETED|Overall Study||1
2226963|NCT02741518|5461423|P2|COMPLETED|Overall Study||10
2226964|NCT02741518|5461424|P1|COMPLETED|Overall Study||10
2226965|NCT02741518|5461423|P2|STARTED|Overall Study||11
2226966|NCT02741518|5461424|P1|STARTED|Overall Study||11
2226967|NCT02741310|5461434|P2|NOT COMPLETED|Overall Study||2
2226968|NCT02741310|5461435|P1|NOT COMPLETED|Overall Study||2
2226969|NCT02741310|5461434|P2|COMPLETED|Overall Study||20
2226970|NCT02741310|5461435|P1|COMPLETED|Overall Study||10
2226971|NCT02741310|5461434|P2|STARTED|Overall Study||22
2226972|NCT02741310|5461435|P1|STARTED|Overall Study||12
2226973|NCT02741297|5461455|P1|NOT COMPLETED|Overall Study||14
2226974|NCT02741297|5461455|P1|COMPLETED|Overall Study||59
2226975|NCT02741297|5461455|P1|STARTED|Overall Study||73
2226976|NCT02741284|5461461|P2|NOT COMPLETED|Overall Study||9
2226977|NCT02741284|5461462|P1|NOT COMPLETED|Overall Study||6
2226978|NCT02741284|5461461|P2|COMPLETED|Overall Study||48
2226979|NCT02741284|5461462|P1|COMPLETED|Overall Study||51
2226980|NCT02741284|5461461|P2|STARTED|Overall Study||57
2226981|NCT02741284|5461462|P1|STARTED|Overall Study||57
2226982|NCT02741271|5461480|P2|NOT COMPLETED|Overall Study||2
2226983|NCT02741271|5461481|P1|NOT COMPLETED|Overall Study||2
2226984|NCT02741271|5461480|P2|COMPLETED|Overall Study||88
2226985|NCT02741271|5461481|P1|COMPLETED|Overall Study||89
2226986|NCT02741271|5461480|P2|STARTED|Overall Study||90
2226987|NCT02741271|5461481|P1|STARTED|Overall Study||91
2226988|NCT02741245|5461514|P5|NOT COMPLETED|Overall Study||2
2226989|NCT02741245|5461515|P4|NOT COMPLETED|Overall Study||4
2226990|NCT02741245|5461516|P3|NOT COMPLETED|Overall Study||0
2226991|NCT02741245|5461517|P2|NOT COMPLETED|Overall Study||1
2226992|NCT02741245|5461518|P1|NOT COMPLETED|Overall Study||0
2226993|NCT02741245|5461514|P5|COMPLETED|Overall Study||70
2226994|NCT02741245|5461515|P4|COMPLETED|Overall Study||67
2226995|NCT02741245|5461516|P3|COMPLETED|Overall Study||71
2226996|NCT02741245|5461517|P2|COMPLETED|Overall Study||71
2226997|NCT02741245|5461518|P1|COMPLETED|Overall Study||35
2226998|NCT02741245|5461514|P5|STARTED|Overall Study||72
2226999|NCT02741245|5461515|P4|STARTED|Overall Study||71
2227000|NCT02741245|5461516|P3|STARTED|Overall Study||71
2227001|NCT02741245|5461517|P2|STARTED|Overall Study||72
2227002|NCT02741245|5461518|P1|STARTED|Overall Study||35
2227003|NCT02741076|5461624|P4|NOT COMPLETED|Overall Study||2
2227004|NCT02741076|5461625|P3|NOT COMPLETED|Overall Study||2
2227005|NCT02741076|5461626|P2|NOT COMPLETED|Overall Study||5
2227006|NCT02741076|5461627|P1|NOT COMPLETED|Overall Study||3
2227007|NCT02741076|5461624|P4|COMPLETED|Overall Study||2
2227008|NCT02741076|5461625|P3|COMPLETED|Overall Study||1
2227009|NCT02741076|5461626|P2|COMPLETED|Overall Study||7
2227010|NCT02741076|5461627|P1|COMPLETED|Overall Study||10
2227011|NCT02741076|5461624|P4|STARTED|Overall Study||4
2227012|NCT02741076|5461625|P3|STARTED|Overall Study||3
2227013|NCT02741076|5461626|P2|STARTED|Overall Study||12
2227014|NCT02741076|5461627|P1|STARTED|Overall Study||13
2227015|NCT02740920|5461685|P1|NOT COMPLETED|Overall Study||0
2227016|NCT02740920|5461685|P1|COMPLETED|Overall Study||9
2227017|NCT02740920|5461685|P1|STARTED|Overall Study||9
2227018|NCT02740660|5461692|P2|NOT COMPLETED|Overall Study||0
2227019|NCT02740660|5461693|P1|NOT COMPLETED|Overall Study||0
2227020|NCT02740660|5461692|P2|COMPLETED|Overall Study||6
2227021|NCT02740660|5461693|P1|COMPLETED|Overall Study||6
2227022|NCT02740660|5461692|P2|STARTED|Overall Study||6
2227023|NCT02740660|5461693|P1|STARTED|Overall Study||6
2227024|NCT02740413|5461705|P1|NOT COMPLETED|Overall Study||0
2227025|NCT02740413|5461705|P1|COMPLETED|Overall Study||86
2227026|NCT02740413|5461705|P1|STARTED|Overall Study||86
2227027|NCT02740049|5461743|P1|NOT COMPLETED|Overall Study||1
2227028|NCT02740049|5461743|P1|COMPLETED|Overall Study||8
2227029|NCT02740049|5461743|P1|STARTED|Overall Study||9
2227030|NCT02739997|5461749|P1|NOT COMPLETED|Overall Study||2
2227031|NCT02739997|5461749|P1|COMPLETED|Overall Study||98
2227032|NCT02739997|5461749|P1|STARTED|Overall Study||100
2227033|NCT02739984|5461763|P2|NOT COMPLETED|Overall Study||2
2227034|NCT02739984|5461764|P1|NOT COMPLETED|Overall Study||5
2227035|NCT02739984|5461763|P2|COMPLETED|Overall Study||279
2227036|NCT02739984|5461764|P1|COMPLETED|Overall Study||138
2227037|NCT02739984|5461763|P2|Received Study Drug|Overall Study||280
2227038|NCT02739984|5461764|P1|Received Study Drug|Overall Study||141
2227039|NCT02739984|5461763|P2|STARTED|Overall Study||281
2227040|NCT02739984|5461764|P1|STARTED|Overall Study||143
2227041|NCT02739828|5461812|P1|NOT COMPLETED|Overall Study||5
2227042|NCT02739828|5461812|P1|COMPLETED|Overall Study||19
2227043|NCT02739828|5461812|P1|STARTED|Overall Study||24
2227044|NCT02739698|5461848|P2|NOT COMPLETED|Overall Study||5
2227045|NCT02739698|5461849|P1|NOT COMPLETED|Overall Study||6
2227046|NCT02739698|5461848|P2|COMPLETED|Overall Study||16
2227047|NCT02739698|5461849|P1|COMPLETED|Overall Study||16
2227048|NCT02739698|5461848|P2|STARTED|Overall Study||21
2227049|NCT02739698|5461849|P1|STARTED|Overall Study||22
2227050|NCT02739594|5461857|P2|NOT COMPLETED|Overall Study||28
2227051|NCT02739594|5461858|P1|NOT COMPLETED|Overall Study||25
2227052|NCT02739594|5461857|P2|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|15
2227053|NCT02739594|5461858|P1|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|21
2227054|NCT02739594|5461857|P2|Completed at Week 96|Overall Study||10
2227055|NCT02739594|5461858|P1|Completed at Week 96|Overall Study||10
2227056|NCT02739594|5461857|P2|Completed at Week 44|Overall Study||5
2227057|NCT02739594|5461858|P1|Completed at Week 44|Overall Study||11
2227058|NCT02739594|5461857|P2|STARTED|Overall Study||43
2227059|NCT02739594|5461858|P1|STARTED|Overall Study||46
2227060|NCT02739360|5461888|P1|NOT COMPLETED|Overall Study||3
2227061|NCT02739360|5461888|P1|COMPLETED|Overall Study||0
2227062|NCT02739360|5461888|P1|STARTED|Overall Study||3
2227063|NCT02739321|5461894|P2|NOT COMPLETED|Overall Study||4
2227064|NCT02739321|5461895|P1|NOT COMPLETED|Overall Study||3
2227065|NCT02739321|5461894|P2|COMPLETED|Overall Study||18
2227066|NCT02739321|5461895|P1|COMPLETED|Overall Study||20
2227067|NCT02739321|5461894|P2|STARTED|Overall Study||22
2227068|NCT02739321|5461895|P1|STARTED|Overall Study||23
2227069|NCT02739269|5461941|P2|NOT COMPLETED|Overall Study||4
2227070|NCT02739269|5461942|P1|NOT COMPLETED|Overall Study||7
2227071|NCT02739269|5461941|P2|COMPLETED|Overall Study||96
2227072|NCT02739269|5461942|P1|COMPLETED|Overall Study||93
2227073|NCT02739269|5461941|P2|STARTED|Overall Study||100
2227074|NCT02739269|5461942|P1|STARTED|Overall Study||100
2227075|NCT02739100|5461950|P1|NOT COMPLETED|Overall Study||0
2227076|NCT02739100|5461950|P1|COMPLETED|Overall Study||13
2227077|NCT02739100|5461950|P1|Triferic 6.6. mg IV Post-dialyzer|Overall Study||13
2227078|NCT02739100|5461950|P1|Triferic 6.6 mg IV Predialyzer|Overall Study||13
2227079|NCT02739100|5461950|P1|Triferic 2 Micromolar Via Hemodialysate|Overall Study||13
2227080|NCT02739100|5461950|P1|STARTED|Overall Study||13
2227081|NCT02738879|5461969|P2|NOT COMPLETED|Overall Study||25
2227082|NCT02738879|5461970|P1|NOT COMPLETED|Overall Study||13
2227083|NCT02738879|5461969|P2|COMPLETED|Overall Study||347
2227084|NCT02738879|5461970|P1|COMPLETED|Overall Study||361
2227085|NCT02738879|5461969|P2|Treated|Overall Study||370
2227086|NCT02738879|5461970|P1|Treated|Overall Study||373
2227087|NCT02738879|5461969|P2|STARTED|Overall Study||372
2227088|NCT02738879|5461970|P1|STARTED|Overall Study||374
2227089|NCT02738853|5462004|P1|NOT COMPLETED|30 Days- 6 Months||2
2227090|NCT02738853|5462004|P1|COMPLETED|30 Days- 6 Months||57
2227091|NCT02738853|5462004|P1|STARTED|30 Days- 6 Months||59
2227092|NCT02738853|5462004|P1|NOT COMPLETED|Baseline -30 Days||1
2227093|NCT02738853|5462004|P1|COMPLETED|Baseline -30 Days||59
2227094|NCT02738853|5462004|P1|STARTED|Baseline -30 Days||60
2227095|NCT02738333|5462023|P3|NOT COMPLETED|Overall Study||0
2227096|NCT02738333|5462024|P2|NOT COMPLETED|Overall Study||0
2227097|NCT02738333|5462025|P1|NOT COMPLETED|Overall Study||2
2227098|NCT02738333|5462023|P3|COMPLETED|Overall Study||25
2227099|NCT02738333|5462024|P2|COMPLETED|Overall Study||108
2227100|NCT02738333|5462025|P1|COMPLETED|Overall Study||104
2227101|NCT02738333|5462023|P3|STARTED|Overall Study||25
2227102|NCT02738333|5462024|P2|STARTED|Overall Study||108
2227103|NCT02738333|5462025|P1|STARTED|Overall Study||106
2227104|NCT02738255|5462101|P2|NOT COMPLETED|Overall Study||1
2227105|NCT02738255|5462102|P1|NOT COMPLETED|Overall Study||0
2227106|NCT02738255|5462101|P2|COMPLETED|Overall Study||14
2227107|NCT02738255|5462102|P1|COMPLETED|Overall Study||11
2227108|NCT02738255|5462101|P2|STARTED|Overall Study||15
2227109|NCT02738255|5462102|P1|STARTED|Overall Study||11
2227110|NCT02738203|5462114|P2|NOT COMPLETED|Overall Study||3
2227111|NCT02738203|5462115|P1|NOT COMPLETED|Overall Study||2
2227112|NCT02738203|5462114|P2|COMPLETED|Overall Study||107
2227113|NCT02738203|5462115|P1|COMPLETED|Overall Study||108
2227114|NCT02738203|5462114|P2|STARTED|Overall Study||110
2227115|NCT02738203|5462115|P1|STARTED|Overall Study||110
2227116|NCT02738151|5462131|P2|NOT COMPLETED|Overall Study||31
2227117|NCT02738151|5462132|P1|NOT COMPLETED|Overall Study||23
2227118|NCT02738151|5462131|P2|COMPLETED|Overall Study||432
2227119|NCT02738151|5462132|P1|COMPLETED|Overall Study||443
2227120|NCT02738151|5462131|P2|Treated|Overall Study||462
2227121|NCT02738151|5462132|P1|Treated|Overall Study||462
2227122|NCT02738151|5462131|P2|STARTED|Overall Study||463
2227123|NCT02738151|5462132|P1|STARTED|Overall Study||466
2227124|NCT02738138|5462176|P2|NOT COMPLETED|Overall Study||1
2227125|NCT02738138|5462177|P1|NOT COMPLETED|Overall Study||3
2227126|NCT02738138|5462176|P2|COMPLETED|Overall Study||15
2227127|NCT02738138|5462177|P1|COMPLETED|Overall Study||134
2227128|NCT02738138|5462176|P2|STARTED|Overall Study||16
2227129|NCT02738138|5462177|P1|STARTED|Overall Study||137
2227136|NCT02738008|5462214|P3|NOT COMPLETED|Overall Study||5
2227137|NCT02738008|5462215|P2|NOT COMPLETED|Overall Study||6
2227138|NCT02738008|5462216|P1|NOT COMPLETED|Overall Study||1
2227139|NCT02738008|5462214|P3|COMPLETED|Overall Study||0
2227140|NCT02738008|5462215|P2|COMPLETED|Overall Study||0
2227141|NCT02738008|5462216|P1|COMPLETED|Overall Study||0
2227142|NCT02738008|5462214|P3|STARTED|Overall Study||5
2227143|NCT02738008|5462215|P2|STARTED|Overall Study||6
2227144|NCT02738008|5462216|P1|STARTED|Overall Study||1
2227145|NCT02737917|5462232|P2|NOT COMPLETED|Overall Study||3
2227146|NCT02737917|5462233|P1|NOT COMPLETED|Overall Study||3
2227147|NCT02737917|5462232|P2|COMPLETED|Overall Study||100
2227148|NCT02737917|5462233|P1|COMPLETED|Overall Study||100
2227149|NCT02737917|5462232|P2|STARTED|Overall Study||103
2227150|NCT02737917|5462233|P1|STARTED|Overall Study||103
2227151|NCT02737852|5462241|P1|NOT COMPLETED|Overall Study||2
2227152|NCT02737852|5462241|P1|COMPLETED|Overall Study||30
2227153|NCT02737852|5462241|P1|STARTED|Overall Study||32
2227154|NCT02737722|5462250|P4|NOT COMPLETED|Overall Study||0
2227155|NCT02737722|5462251|P3|NOT COMPLETED|Overall Study||1
2227156|NCT02737722|5462252|P2|NOT COMPLETED|Overall Study||0
2227157|NCT02737722|5462253|P1|NOT COMPLETED|Overall Study||0
2227158|NCT02737722|5462250|P4|COMPLETED|Overall Study||6
2227159|NCT02737722|5462251|P3|COMPLETED|Overall Study||7
2227160|NCT02737722|5462252|P2|COMPLETED|Overall Study||8
2227161|NCT02737722|5462253|P1|COMPLETED|Overall Study||8
2227162|NCT02737722|5462250|P4|STARTED|Overall Study||6
2227163|NCT02737722|5462251|P3|STARTED|Overall Study||8
2227164|NCT02737722|5462252|P2|STARTED|Overall Study||8
2227165|NCT02737722|5462253|P1|STARTED|Overall Study||8
2227166|NCT02737631|5462299|P1|NOT COMPLETED|Overall Study||0
2227167|NCT02737631|5462299|P1|COMPLETED|Overall Study||222
2227168|NCT02737631|5462299|P1|STARTED|Overall Study||222
2227169|NCT02737618|5462304|P1|NOT COMPLETED|Overall Study||9
2227170|NCT02737618|5462304|P1|COMPLETED|Overall Study||34
2227171|NCT02737618|5462304|P1|STARTED|Overall Study||43
2227172|NCT02737592|5462309|P1|NOT COMPLETED|Overall Study||1
2227173|NCT02737592|5462309|P1|COMPLETED|Overall Study||33
2227174|NCT02737592|5462309|P1|STARTED|Overall Study||34
2227175|NCT02737397|5462314|P1|NOT COMPLETED|Overall Study||0
2227176|NCT02737397|5462314|P1|COMPLETED|Overall Study||13
2227177|NCT02737397|5462314|P1|Placebo|Overall Study||13
2227178|NCT02737397|5462314|P1|SJP-223|Overall Study||13
2227179|NCT02737397|5462314|P1|SJP-304|Overall Study||12
2227180|NCT02737397|5462314|P1|JMI-001|Overall Study||13
2227181|NCT02737397|5462314|P1|STARTED|Overall Study||13
2227182|NCT02737163|5462328|P1|NOT COMPLETED|Overall Study||0
2227183|NCT02737163|5462328|P1|COMPLETED|Overall Study||95
2227184|NCT02737163|5462328|P1|STARTED|Overall Study|114 encounter assessments were completed on 95 participants over 15 months|95
2227185|NCT02737072|5462338|P3|NOT COMPLETED|Overall Study||0
2227186|NCT02737072|5462339|P2|NOT COMPLETED|Overall Study||0
2227187|NCT02737072|5462340|P1|NOT COMPLETED|Overall Study||0
2227188|NCT02737072|5462338|P3|COMPLETED|Overall Study||3
2227189|NCT02737072|5462339|P2|COMPLETED|Overall Study||3
2227190|NCT02737072|5462340|P1|COMPLETED|Overall Study||3
2227191|NCT02737072|5462338|P3|Received at Least One Dose of Drug|Overall Study||3
2227192|NCT02737072|5462339|P2|Received at Least One Dose of Drug|Overall Study||3
2227193|NCT02737072|5462340|P1|Received at Least One Dose of Drug|Overall Study||3
2227194|NCT02737072|5462338|P3|STARTED|Overall Study||3
2227195|NCT02737072|5462339|P2|STARTED|Overall Study||3
2227196|NCT02737072|5462340|P1|STARTED|Overall Study||3
2227197|NCT02736955|5462364|P3|NOT COMPLETED|Overall Study||2
2227198|NCT02736955|5462365|P2|NOT COMPLETED|Overall Study||14
2227199|NCT02736955|5462366|P1|NOT COMPLETED|Overall Study||7
2227200|NCT02736955|5462364|P3|COMPLETED|Overall Study||6
2227201|NCT02736955|5462365|P2|COMPLETED|Overall Study||103
2227202|NCT02736955|5462366|P1|COMPLETED|Overall Study||29
2227203|NCT02736955|5462364|P3|STARTED|Overall Study||8
2227204|NCT02736955|5462365|P2|STARTED|Overall Study||117
2227205|NCT02736955|5462366|P1|STARTED|Overall Study||36
2227206|NCT02736890|5462382|P2|NOT COMPLETED|Crossover Next 12 Weeks||2
2227207|NCT02736890|5462383|P1|NOT COMPLETED|Crossover Next 12 Weeks||2
2227208|NCT02736890|5462382|P2|COMPLETED|Crossover Next 12 Weeks||1
2227209|NCT02736890|5462383|P1|COMPLETED|Crossover Next 12 Weeks||3
2227210|NCT02736890|5462382|P2|STARTED|Crossover Next 12 Weeks||3
2227211|NCT02736890|5462383|P1|STARTED|Crossover Next 12 Weeks||5
2227212|NCT02736890|5462382|P2|NOT COMPLETED|First 12 Weeks||0
2227213|NCT02736890|5462383|P1|NOT COMPLETED|First 12 Weeks||0
2227214|NCT02736890|5462382|P2|COMPLETED|First 12 Weeks||3
2227215|NCT02736890|5462383|P1|COMPLETED|First 12 Weeks||5
2227216|NCT02736890|5462382|P2|STARTED|First 12 Weeks||3
2227217|NCT02736890|5462383|P1|STARTED|First 12 Weeks||5
2227224|NCT02736721|5462446|P1|NOT COMPLETED|Overall Study||16
2227225|NCT02736721|5462446|P1|COMPLETED|Overall Study||25
2227226|NCT02736721|5462446|P1|STARTED|Overall Study||41
2227227|NCT02736578|5462457|P2|NOT COMPLETED|Overall Study||0
2227228|NCT02736578|5462458|P1|NOT COMPLETED|Overall Study||1
2227229|NCT02736578|5462457|P2|COMPLETED|Overall Study||2
2227230|NCT02736578|5462458|P1|COMPLETED|Overall Study||5
2227231|NCT02736578|5462457|P2|STARTED|Overall Study||2
2227232|NCT02736578|5462458|P1|STARTED|Overall Study||6
2227233|NCT02736188|5462476|P1|NOT COMPLETED|Overall Study||142
2227234|NCT02736188|5462476|P1|COMPLETED|Overall Study||0
2227235|NCT02736188|5462476|P1|STARTED|Overall Study||142
2227236|NCT02736175|5462502|P2|NOT COMPLETED|Overall Study||1
2227237|NCT02736175|5462503|P1|NOT COMPLETED|Overall Study||2
2227238|NCT02736175|5462502|P2|COMPLETED|Overall Study||221
2227239|NCT02736175|5462503|P1|COMPLETED|Overall Study||214
2227240|NCT02736175|5462502|P2|STARTED|Overall Study||222
2227241|NCT02736175|5462503|P1|STARTED|Overall Study||216
2227242|NCT02735915|5462511|P1|NOT COMPLETED|Overall Study||11
2227243|NCT02735915|5462511|P1|COMPLETED|Overall Study||59
2227244|NCT02735915|5462511|P1|Vaccinated|Overall Study||62
2227245|NCT02735915|5462511|P1|STARTED|Overall Study||70
2227246|NCT02735551|5462533|P3|NOT COMPLETED|Overall Study||0
2227247|NCT02735551|5462534|P2|NOT COMPLETED|Overall Study||0
2227248|NCT02735551|5462535|P1|NOT COMPLETED|Overall Study||0
2227249|NCT02735551|5462533|P3|COMPLETED|Overall Study||0
2227250|NCT02735551|5462534|P2|COMPLETED|Overall Study||0
2227251|NCT02735551|5462535|P1|COMPLETED|Overall Study||3
2227252|NCT02735551|5462533|P3|STARTED|Overall Study||0
2227253|NCT02735551|5462534|P2|STARTED|Overall Study||0
2227254|NCT02735551|5462535|P1|STARTED|Overall Study||3
2227255|NCT02735421|5462543|P1|NOT COMPLETED|Overall Study||13
2227256|NCT02735421|5462543|P1|COMPLETED|Overall Study||54
2227257|NCT02735421|5462543|P1|STARTED|Overall Study||67
2227258|NCT02735382|5462554|P4|NOT COMPLETED|Overall Study||0
2227259|NCT02735382|5462555|P3|NOT COMPLETED|Overall Study||0
2227260|NCT02735382|5462556|P2|NOT COMPLETED|Overall Study||0
2227261|NCT02735382|5462557|P1|NOT COMPLETED|Overall Study||0
2227262|NCT02735382|5462554|P4|COMPLETED|Overall Study||110
2227263|NCT02735382|5462555|P3|COMPLETED|Overall Study||184
2227264|NCT02735382|5462556|P2|COMPLETED|Overall Study||7155
2227265|NCT02735382|5462557|P1|COMPLETED|Overall Study||7481
2227266|NCT02735382|5462554|P4|STARTED|Overall Study||110
2227267|NCT02735382|5462555|P3|STARTED|Overall Study||184
2227268|NCT02735382|5462556|P2|STARTED|Overall Study||7155
2227269|NCT02735382|5462557|P1|STARTED|Overall Study||7481
2227270|NCT02735200|5462573|P2|NOT COMPLETED|Overall Study||5
2227271|NCT02735200|5462574|P1|NOT COMPLETED|Overall Study||8
2227272|NCT02735200|5462573|P2|COMPLETED|Overall Study||345
2227273|NCT02735200|5462574|P1|COMPLETED|Overall Study||192
2227274|NCT02735200|5462573|P2|STARTED|Overall Study||350
2227275|NCT02735200|5462574|P1|STARTED|Overall Study||200
2227276|NCT02735187|5462582|P2|NOT COMPLETED|Overall Study||1
2227277|NCT02735187|5462583|P1|NOT COMPLETED|Overall Study||4
2227278|NCT02735187|5462582|P2|COMPLETED|Overall Study||25
2227279|NCT02735187|5462583|P1|COMPLETED|Overall Study||21
2227280|NCT02735187|5462582|P2|STARTED|Overall Study||26
2227281|NCT02735187|5462583|P1|STARTED|Overall Study||25
2227282|NCT02735096|5462613|P1|NOT COMPLETED|Overall Study||1
2227283|NCT02735096|5462613|P1|COMPLETED|Overall Study||3
2227284|NCT02735096|5462613|P1|STARTED|Overall Study||4
2227285|NCT02735044|5462622|P2|NOT COMPLETED|Overall Study||23
2227286|NCT02735044|5462623|P1|NOT COMPLETED|Overall Study||16
2227287|NCT02735044|5462622|P2|COMPLETED|Overall Study||207
2227288|NCT02735044|5462623|P1|COMPLETED|Overall Study||217
2227289|NCT02735044|5462622|P2|Treated|Overall Study||228
2227290|NCT02735044|5462623|P1|Treated|Overall Study||233
2227291|NCT02735044|5462622|P2|STARTED|Overall Study||230
2227292|NCT02735044|5462623|P1|STARTED|Overall Study||233
2227293|NCT02734953|5462649|P1|NOT COMPLETED|Overall Study||0
2227294|NCT02734953|5462649|P1|COMPLETED|Overall Study||10
2227295|NCT02734953|5462649|P1|STARTED|Overall Study||10
2227296|NCT02734940|5462666|P2|NOT COMPLETED|Overall Study||0
2227297|NCT02734940|5462667|P1|NOT COMPLETED|Overall Study||0
2227298|NCT02734940|5462666|P2|COMPLETED|Overall Study||0
2227299|NCT02734940|5462667|P1|COMPLETED|Overall Study||0
2227300|NCT02734940|5462666|P2|STARTED|Overall Study||0
2227301|NCT02734940|5462667|P1|STARTED|Overall Study||0
2227302|NCT02734810|5462691|P2|NOT COMPLETED|Overall Study||0
2227303|NCT02734810|5462692|P1|NOT COMPLETED|Overall Study||2
2227304|NCT02734810|5462691|P2|COMPLETED|Overall Study||0
2227305|NCT02734810|5462692|P1|COMPLETED|Overall Study||13
2227306|NCT02734810|5462691|P2|STARTED|Overall Study||0
2227307|NCT02734810|5462692|P1|STARTED|Overall Study||15
2227308|NCT02734498|5462701|P3|NOT COMPLETED|Overall Study||0
2227309|NCT02734498|5462702|P2|NOT COMPLETED|Overall Study||0
2227310|NCT02734498|5462703|P1|NOT COMPLETED|Overall Study||0
2227311|NCT02734498|5462701|P3|COMPLETED|Overall Study||0
2227312|NCT02734498|5462702|P2|COMPLETED|Overall Study||0
2227313|NCT02734498|5462703|P1|COMPLETED|Overall Study||2
2227314|NCT02734498|5462701|P3|STARTED|Overall Study||0
2227315|NCT02734498|5462702|P2|STARTED|Overall Study||0
2227316|NCT02734498|5462703|P1|STARTED|Overall Study||2
2227317|NCT02734355|5462722|P2|NOT COMPLETED|Overall Study||0
2227318|NCT02734355|5462723|P1|NOT COMPLETED|Overall Study||0
2227319|NCT02734355|5462722|P2|COMPLETED|Overall Study||30
2227320|NCT02734355|5462723|P1|COMPLETED|Overall Study||34
2227321|NCT02734355|5462722|P2|STARTED|Overall Study||30
2227322|NCT02734355|5462723|P1|STARTED|Overall Study||34
2227323|NCT02734238|5462755|P2|NOT COMPLETED|Overall Study||0
2227324|NCT02734238|5462756|P1|NOT COMPLETED|Overall Study||0
2227325|NCT02734238|5462755|P2|COMPLETED|Overall Study||24
2227326|NCT02734238|5462756|P1|COMPLETED|Overall Study||26
2227327|NCT02734238|5462755|P2|STARTED|Overall Study||24
2227328|NCT02734238|5462756|P1|STARTED|Overall Study||26
2227329|NCT02734212|5462764|P2|NOT COMPLETED|Overall Study||10
2227330|NCT02734212|5462765|P1|NOT COMPLETED|Overall Study||5
2227331|NCT02734212|5462764|P2|COMPLETED|Overall Study||18
2227332|NCT02734212|5462765|P1|COMPLETED|Overall Study||24
2227333|NCT02734212|5462764|P2|STARTED|Overall Study||28
2227334|NCT02734212|5462765|P1|STARTED|Overall Study||29
2227335|NCT02734056|5462777|P2|NOT COMPLETED|Overall Study||1
2227336|NCT02734056|5462778|P1|NOT COMPLETED|Overall Study||0
2227337|NCT02734056|5462777|P2|COMPLETED|Overall Study||49
2227338|NCT02734056|5462778|P1|COMPLETED|Overall Study||50
2227339|NCT02734056|5462777|P2|STARTED|Overall Study||50
2227340|NCT02734056|5462778|P1|STARTED|Overall Study||50
2227341|NCT02733991|5462786|P2|NOT COMPLETED|Overall Study||5
2227342|NCT02733991|5462787|P1|NOT COMPLETED|Overall Study||1
2227343|NCT02733991|5462786|P2|COMPLETED|Overall Study||72
2227344|NCT02733991|5462787|P1|COMPLETED|Overall Study||75
2227345|NCT02733991|5462786|P2|STARTED|Overall Study||77
2227346|NCT02733991|5462787|P1|STARTED|Overall Study||76
2227347|NCT02733653|5462797|P1|NOT COMPLETED|Overall Study||1
2227348|NCT02733653|5462797|P1|COMPLETED|Overall Study||49
2227349|NCT02733653|5462797|P1|STARTED|Overall Study||50
2227350|NCT02733588|5462803|P1|NOT COMPLETED|Overall Study||0
2227351|NCT02733588|5462803|P1|COMPLETED|Overall Study||7
2227352|NCT02733588|5462803|P1|STARTED|Overall Study||7
2227353|NCT02733367|5462810|P1|NOT COMPLETED|Overall Study||6
2227354|NCT02733367|5462810|P1|COMPLETED|Overall Study||12
2227355|NCT02733367|5462810|P1|STARTED|Overall Study||18
2227356|NCT02732951|5462819|P2|NOT COMPLETED|Overall Study||6
2227357|NCT02732951|5462820|P1|NOT COMPLETED|Overall Study||5
2227358|NCT02732951|5462819|P2|COMPLETED|Overall Study||46
2227359|NCT02732951|5462820|P1|COMPLETED|Overall Study||48
2227360|NCT02732951|5462819|P2|STARTED|Overall Study||52
2227361|NCT02732951|5462820|P1|STARTED|Overall Study||53
2227362|NCT02732938|5462830|P3|NOT COMPLETED|Overall Study||0
2227363|NCT02732938|5462831|P2|NOT COMPLETED|Overall Study||18
2227364|NCT02732938|5462832|P1|NOT COMPLETED|Overall Study||4
2227365|NCT02732938|5462830|P3|COMPLETED|Overall Study||0
2227366|NCT02732938|5462831|P2|COMPLETED|Overall Study||0
2227367|NCT02732938|5462832|P1|COMPLETED|Overall Study||0
2227368|NCT02732938|5462830|P3|Received Treatment|Overall Study||0
2227369|NCT02732938|5462831|P2|Received Treatment|Overall Study||17
2227370|NCT02732938|5462832|P1|Received Treatment|Overall Study||4
2227371|NCT02732938|5462830|P3|STARTED|Overall Study||0
2227372|NCT02732938|5462831|P2|STARTED|Overall Study||18
2227373|NCT02732938|5462832|P1|STARTED|Overall Study||4
2227374|NCT02732912|5462878|P2|NOT COMPLETED|Overall Study||18
2227375|NCT02732912|5462879|P1|NOT COMPLETED|Overall Study||10
2227376|NCT02732912|5462878|P2|COMPLETED|Overall Study||91
2227377|NCT02732912|5462879|P1|COMPLETED|Overall Study||87
2227378|NCT02732912|5462878|P2|STARTED|Overall Study||109
2227379|NCT02732912|5462879|P1|STARTED|Overall Study||97
2227380|NCT02732899|5462895|P2|NOT COMPLETED|Overall Study||0
2227381|NCT02732899|5462896|P1|NOT COMPLETED|Overall Study||0
2227382|NCT02732899|5462895|P2|COMPLETED|Overall Study||10
2227383|NCT02732899|5462896|P1|COMPLETED|Overall Study||10
2227384|NCT02732899|5462895|P2|STARTED|Overall Study||10
2227385|NCT02732899|5462896|P1|STARTED|Overall Study||10
2227386|NCT02732639|5462904|P1|NOT COMPLETED|Overall Study||1
2227387|NCT02732639|5462904|P1|COMPLETED|Overall Study||30
2227388|NCT02732639|5462904|P1|STARTED|Overall Study||31
2227389|NCT02732587|5462915|P1|NOT COMPLETED|Overall Study||0
2227390|NCT02732587|5462915|P1|COMPLETED|Overall Study||5
2227391|NCT02732587|5462915|P1|STARTED|Overall Study||5
2227392|NCT02732561|5462921|P2|NOT COMPLETED|Overall Study||1
2227393|NCT02732561|5462922|P1|NOT COMPLETED|Overall Study||2
2227394|NCT02732561|5462921|P2|COMPLETED|Overall Study||4
2227395|NCT02732561|5462922|P1|COMPLETED|Overall Study||3
2227396|NCT02732561|5462921|P2|STARTED|Overall Study||5
2227397|NCT02732561|5462922|P1|STARTED|Overall Study||5
2227398|NCT02732327|5462932|P2|NOT COMPLETED|Overall Study||1
2227399|NCT02732327|5462933|P1|NOT COMPLETED|Overall Study||0
2227400|NCT02732327|5462932|P2|COMPLETED|Overall Study||1
2227401|NCT02732327|5462933|P1|COMPLETED|Overall Study||0
2227402|NCT02732327|5462932|P2|STARTED|Overall Study||2
2227403|NCT02732327|5462933|P1|STARTED|Overall Study||0
2227404|NCT02732210|5462941|P2|NOT COMPLETED|Overall Study||294
2227405|NCT02732210|5462942|P1|NOT COMPLETED|Overall Study||85
2227406|NCT02732210|5462941|P2|COMPLETED|Overall Study||338
2227407|NCT02732210|5462942|P1|COMPLETED|Overall Study||218
2227408|NCT02732210|5462941|P2|STARTED|Overall Study||632
2227409|NCT02732210|5462942|P1|STARTED|Overall Study||303
2227410|NCT02732145|5462962|P4|NOT COMPLETED|Overall Study||0
2227411|NCT02732145|5462963|P3|NOT COMPLETED|Overall Study||0
2227412|NCT02732145|5462964|P2|NOT COMPLETED|Overall Study||0
2227413|NCT02732145|5462965|P1|NOT COMPLETED|Overall Study||0
2227414|NCT02732145|5462962|P4|COMPLETED|Overall Study||82
2227415|NCT02732145|5462963|P3|COMPLETED|Overall Study||82
2227416|NCT02732145|5462964|P2|COMPLETED|Overall Study||82
2227417|NCT02732145|5462965|P1|COMPLETED|Overall Study||82
2227418|NCT02732145|5462962|P4|STARTED|Overall Study||82
2227419|NCT02732145|5462963|P3|STARTED|Overall Study||82
2227420|NCT02732145|5462964|P2|STARTED|Overall Study||82
2227421|NCT02732145|5462965|P1|STARTED|Overall Study||82
2227422|NCT02731833|5463093|P2|NOT COMPLETED|Overall Study||0
2227423|NCT02731833|5463094|P1|NOT COMPLETED|Overall Study||0
2227424|NCT02731833|5463093|P2|COMPLETED|Overall Study||111
2227425|NCT02731833|5463094|P1|COMPLETED|Overall Study||111
2227426|NCT02731833|5463093|P2|STARTED|Overall Study||111
2227427|NCT02731833|5463094|P1|STARTED|Overall Study||111
2227428|NCT02731820|5463108|P2|NOT COMPLETED|Overall Study||2
2227429|NCT02731820|5463109|P1|NOT COMPLETED|Overall Study||3
2227430|NCT02731820|5463108|P2|COMPLETED|Overall Study||18
2227431|NCT02731820|5463109|P1|COMPLETED|Overall Study||17
2227432|NCT02731820|5463108|P2|STARTED|Overall Study||20
2227433|NCT02731820|5463109|P1|STARTED|Overall Study||20
2227434|NCT02731755|5463121|P2|NOT COMPLETED|Second Intervention||0
2227435|NCT02731755|5463122|P1|NOT COMPLETED|Second Intervention||0
2227436|NCT02731755|5463121|P2|COMPLETED|Second Intervention||8
2227437|NCT02731755|5463122|P1|COMPLETED|Second Intervention||8
2227438|NCT02731755|5463121|P2|STARTED|Second Intervention||8
2227439|NCT02731755|5463122|P1|STARTED|Second Intervention||8
2227440|NCT02731755|5463121|P2|NOT COMPLETED|First Intervention||2
2227441|NCT02731755|5463122|P1|NOT COMPLETED|First Intervention||0
2227442|NCT02731755|5463121|P2|COMPLETED|First Intervention||8
2227443|NCT02731755|5463122|P1|COMPLETED|First Intervention||8
2227444|NCT02731755|5463121|P2|STARTED|First Intervention||10
2227445|NCT02731755|5463122|P1|STARTED|First Intervention||8
2227446|NCT02731742|5463146|P4|NOT COMPLETED|Overall Study||2
2227447|NCT02731742|5463147|P3|NOT COMPLETED|Overall Study||6
2227448|NCT02731742|5463148|P2|NOT COMPLETED|Overall Study||3
2227449|NCT02731742|5463149|P1|NOT COMPLETED|Overall Study||3
2227450|NCT02731742|5463146|P4|COMPLETED|Overall Study||0
2227451|NCT02731742|5463147|P3|COMPLETED|Overall Study||0
2227452|NCT02731742|5463148|P2|COMPLETED|Overall Study||0
2227453|NCT02731742|5463149|P1|COMPLETED|Overall Study||0
2227454|NCT02731742|5463146|P4|STARTED|Overall Study||2
2227455|NCT02731742|5463147|P3|STARTED|Overall Study||6
2227456|NCT02731742|5463148|P2|STARTED|Overall Study||3
2227457|NCT02731742|5463149|P1|STARTED|Overall Study||3
2227458|NCT02731690|5463167|P1|NOT COMPLETED|Overall Study||30
2227459|NCT02731690|5463167|P1|COMPLETED|Overall Study||12
2227460|NCT02731690|5463167|P1|STARTED|Overall Study||42
2227461|NCT02731638|5463187|P2|NOT COMPLETED|Overall Study||9
2227462|NCT02731638|5463188|P1|NOT COMPLETED|Overall Study||6
2227463|NCT02731638|5463187|P2|COMPLETED|Overall Study||26
2227464|NCT02731638|5463188|P1|COMPLETED|Overall Study||29
2227465|NCT02731638|5463187|P2|STARTED|Overall Study||35
2227466|NCT02731638|5463188|P1|STARTED|Overall Study||35
2227467|NCT02731469|5463213|P11|NOT COMPLETED|Overall Study||0
2227468|NCT02731469|5463214|P10|NOT COMPLETED|Overall Study||0
2227469|NCT02731469|5463215|P9|NOT COMPLETED|Overall Study||0
2227470|NCT02731469|5463216|P8|NOT COMPLETED|Overall Study||0
2227471|NCT02731469|5463217|P7|NOT COMPLETED|Overall Study||0
2227472|NCT02731469|5463218|P6|NOT COMPLETED|Overall Study||0
2227473|NCT02731469|5463219|P5|NOT COMPLETED|Overall Study||0
2227474|NCT02731469|5463220|P4|NOT COMPLETED|Overall Study||0
2227475|NCT02731469|5463221|P3|NOT COMPLETED|Overall Study||0
2227476|NCT02731469|5463222|P2|NOT COMPLETED|Overall Study||0
2227477|NCT02731469|5463223|P1|NOT COMPLETED|Overall Study||0
2227478|NCT02731469|5463213|P11|COMPLETED|Overall Study||6
2227479|NCT02731469|5463214|P10|COMPLETED|Overall Study||6
2227480|NCT02731469|5463215|P9|COMPLETED|Overall Study||6
2227481|NCT02731469|5463216|P8|COMPLETED|Overall Study||6
2227482|NCT02731469|5463217|P7|COMPLETED|Overall Study||3
2227483|NCT02731469|5463218|P6|COMPLETED|Overall Study||3
2227484|NCT02731469|5463219|P5|COMPLETED|Overall Study||3
2227485|NCT02731469|5463220|P4|COMPLETED|Overall Study||3
2227486|NCT02731469|5463221|P3|COMPLETED|Overall Study||3
2227487|NCT02731469|5463222|P2|COMPLETED|Overall Study||3
2227488|NCT02731469|5463223|P1|COMPLETED|Overall Study||3
2227489|NCT02731469|5463213|P11|STARTED|Overall Study||6
2227490|NCT02731469|5463214|P10|STARTED|Overall Study||6
2227491|NCT02731469|5463215|P9|STARTED|Overall Study||6
2227492|NCT02731469|5463216|P8|STARTED|Overall Study||6
2227493|NCT02731469|5463217|P7|STARTED|Overall Study||3
2227494|NCT02731469|5463218|P6|STARTED|Overall Study||3
2227495|NCT02731469|5463219|P5|STARTED|Overall Study||3
2227496|NCT02731469|5463220|P4|STARTED|Overall Study||3
2227497|NCT02731469|5463221|P3|STARTED|Overall Study||3
2227498|NCT02731469|5463222|P2|STARTED|Overall Study||3
2227499|NCT02731469|5463223|P1|STARTED|Overall Study||3
2227500|NCT02731313|5463412|P1|NOT COMPLETED|Overall Study||0
2227501|NCT02731313|5463412|P1|COMPLETED|Overall Study||367
2227502|NCT02731313|5463412|P1|STARTED|Overall Study||367
2227503|NCT02731300|5463422|P2|NOT COMPLETED|Overall Study||0
2227504|NCT02731300|5463423|P1|NOT COMPLETED|Overall Study||0
2227505|NCT02731300|5463422|P2|COMPLETED|Overall Study||7
2227506|NCT02731300|5463423|P1|COMPLETED|Overall Study||15
2227507|NCT02731300|5463422|P2|STARTED|Overall Study||7
2227508|NCT02731300|5463423|P1|STARTED|Overall Study||15
2227509|NCT02731157|5463431|P1|NOT COMPLETED|Third Standard RCE||0
2227510|NCT02731157|5463431|P1|COMPLETED|Third Standard RCE||3
2227511|NCT02731157|5463431|P1|STARTED|Third Standard RCE||3
2227512|NCT02731157|5463431|P1|NOT COMPLETED|Second Standard RCE||0
2227513|NCT02731157|5463431|P1|COMPLETED|Second Standard RCE||3
2227514|NCT02731157|5463431|P1|STARTED|Second Standard RCE||3
2227515|NCT02731157|5463431|P1|NOT COMPLETED|Third Rejuvenated RCE||0
2227516|NCT02731157|5463431|P1|COMPLETED|Third Rejuvenated RCE||3
2227517|NCT02731157|5463431|P1|STARTED|Third Rejuvenated RCE||3
2227518|NCT02731157|5463431|P1|NOT COMPLETED|Second Rejuvenated RCE||0
2227519|NCT02731157|5463431|P1|COMPLETED|Second Rejuvenated RCE||3
2227520|NCT02731157|5463431|P1|STARTED|Second Rejuvenated RCE||3
2227521|NCT02731157|5463431|P1|NOT COMPLETED|First Rejuvenated RCE||1
2227522|NCT02731157|5463431|P1|COMPLETED|First Rejuvenated RCE||3
2227523|NCT02731157|5463431|P1|STARTED|First Rejuvenated RCE||4
2227524|NCT02731157|5463431|P1|NOT COMPLETED|First Standard RCE||0
2227525|NCT02731157|5463431|P1|COMPLETED|First Standard RCE||4
2227526|NCT02731157|5463431|P1|STARTED|First Standard RCE||4
2227527|NCT02731131|5463449|P2|NOT COMPLETED|Overall Study||2
2227528|NCT02731131|5463450|P1|NOT COMPLETED|Overall Study||0
2227529|NCT02731131|5463449|P2|COMPLETED|Overall Study||4
2227530|NCT02731131|5463450|P1|COMPLETED|Overall Study||6
2227531|NCT02731131|5463449|P2|STARTED|Overall Study||6
2227532|NCT02731131|5463450|P1|STARTED|Overall Study||6
2227533|NCT02730988|5463468|P2|NOT COMPLETED|Overall Study||10
2227534|NCT02730988|5463469|P1|NOT COMPLETED|Overall Study||4
2227535|NCT02730988|5463468|P2|COMPLETED|Overall Study||39
2227536|NCT02730988|5463469|P1|COMPLETED|Overall Study||43
2227537|NCT02730988|5463468|P2|STARTED|Overall Study||49
2227538|NCT02730988|5463469|P1|STARTED|Overall Study||47
2227539|NCT02730871|5463479|P2|NOT COMPLETED|Overall Study||0
2227540|NCT02730871|5463480|P1|NOT COMPLETED|Overall Study||6
2227541|NCT02730871|5463479|P2|COMPLETED|Overall Study||67
2227542|NCT02730871|5463480|P1|COMPLETED|Overall Study||61
2227543|NCT02730871|5463479|P2|Safety Analysis Set|Overall Study||67
2227544|NCT02730871|5463480|P1|Safety Analysis Set|Overall Study||67
2227545|NCT02730871|5463479|P2|Full Analysis Set (FAS)|Overall Study||67
2227546|NCT02730871|5463480|P1|Full Analysis Set (FAS)|Overall Study||67
2227547|NCT02730871|5463479|P2|STARTED|Overall Study||67
2227548|NCT02730871|5463480|P1|STARTED|Overall Study||67
2227549|NCT02730819|5463494|P1|NOT COMPLETED|Overall Study||9
2227550|NCT02730819|5463494|P1|COMPLETED|Overall Study||10
2227551|NCT02730819|5463494|P1|Follow-up Week 20|Overall Study||10
2227552|NCT02730819|5463494|P1|Follow-up Week 16|Overall Study||11
2227553|NCT02730819|5463494|P1|Follow-up Week 12|Overall Study||11
2227554|NCT02730819|5463494|P1|Follow-up Week 8|Overall Study||14
2227555|NCT02730819|5463494|P1|Follow-up Week 4|Overall Study||16
2227556|NCT02730819|5463494|P1|Follow-up Week 2|Overall Study||15
2227557|NCT02730819|5463494|P1|STARTED|Overall Study||19
2227558|NCT02730728|5463503|P3|NOT COMPLETED|Overall Study||1
2227559|NCT02730728|5463504|P2|NOT COMPLETED|Overall Study||2
2227560|NCT02730728|5463505|P1|NOT COMPLETED|Overall Study||0
2227561|NCT02730728|5463503|P3|COMPLETED|Overall Study||52
2227562|NCT02730728|5463504|P2|COMPLETED|Overall Study||51
2227563|NCT02730728|5463505|P1|COMPLETED|Overall Study||53
2227564|NCT02730728|5463503|P3|STARTED|Overall Study||53
2227565|NCT02730728|5463504|P2|STARTED|Overall Study||53
2227566|NCT02730728|5463505|P1|STARTED|Overall Study||53
2227567|NCT02730663|5463522|P1|NOT COMPLETED|Overall Study||1
2227568|NCT02730663|5463522|P1|COMPLETED|Overall Study||35
2227569|NCT02730663|5463522|P1|STARTED|Overall Study||36
2227570|NCT02730598|5463534|P2|NOT COMPLETED|Overall Study||4
2227571|NCT02730598|5463535|P1|NOT COMPLETED|Overall Study||4
2227572|NCT02730598|5463534|P2|COMPLETED|Overall Study||10
2227573|NCT02730598|5463535|P1|COMPLETED|Overall Study||10
2227574|NCT02730598|5463534|P2|STARTED|Overall Study||14
2227575|NCT02730598|5463535|P1|STARTED|Overall Study||14
2227576|NCT02730455|5463558|P3|NOT COMPLETED|Overall Study||11
2227577|NCT02730455|5463559|P2|NOT COMPLETED|Overall Study||14
2227578|NCT02730455|5463560|P1|NOT COMPLETED|Overall Study||13
2227579|NCT02730455|5463558|P3|COMPLETED|Overall Study||81
2227580|NCT02730455|5463559|P2|COMPLETED|Overall Study||77
2227581|NCT02730455|5463560|P1|COMPLETED|Overall Study||81
2227582|NCT02730455|5463558|P3|Who Received Total Volume of Study Drug|Overall Study||89
2227583|NCT02730455|5463559|P2|Who Received Total Volume of Study Drug|Overall Study||88
2227584|NCT02730455|5463560|P1|Who Received Total Volume of Study Drug|Overall Study||90
2227585|NCT02730455|5463558|P3|Participants Dosed|Overall Study||91
2227586|NCT02730455|5463559|P2|Participants Dosed|Overall Study||88
2227587|NCT02730455|5463560|P1|Participants Dosed|Overall Study||91
2227588|NCT02730455|5463558|P3|Safety Population|Overall Study||89
2227589|NCT02730455|5463559|P2|Safety Population|Overall Study||90
2227590|NCT02730455|5463560|P1|Safety Population|Overall Study||91
2227591|NCT02730455|5463558|P3|STARTED|Overall Study||92
2227592|NCT02730455|5463559|P2|STARTED|Overall Study||91
2227593|NCT02730455|5463560|P1|STARTED|Overall Study||94
2227594|NCT02730351|5463592|P2|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
2227595|NCT02730351|5463593|P1|NOT COMPLETED|Treatment Period 2 (2 Weeks)||2
2227596|NCT02730351|5463592|P2|COMPLETED|Treatment Period 2 (2 Weeks)||36
2227597|NCT02730351|5463593|P1|COMPLETED|Treatment Period 2 (2 Weeks)||33
2227598|NCT02730351|5463592|P2|STARTED|Treatment Period 2 (2 Weeks)||36
2227599|NCT02730351|5463593|P1|STARTED|Treatment Period 2 (2 Weeks)||35
2227600|NCT02730351|5463592|P2|NOT COMPLETED|Wash-out Period (2 Weeks)||1
2227601|NCT02730351|5463593|P1|NOT COMPLETED|Wash-out Period (2 Weeks)||1
2227602|NCT02730351|5463592|P2|COMPLETED|Wash-out Period (2 Weeks)||36
2227603|NCT02730351|5463593|P1|COMPLETED|Wash-out Period (2 Weeks)||35
2227604|NCT02730351|5463592|P2|STARTED|Wash-out Period (2 Weeks)||37
2227605|NCT02730351|5463593|P1|STARTED|Wash-out Period (2 Weeks)||36
2227606|NCT02730351|5463592|P2|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
2227607|NCT02730351|5463593|P1|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1
2227608|NCT02730351|5463592|P2|COMPLETED|Treatment Period 1 (2 Weeks)||37
2227609|NCT02730351|5463593|P1|COMPLETED|Treatment Period 1 (2 Weeks)||36
2227610|NCT02730351|5463592|P2|STARTED|Treatment Period 1 (2 Weeks)||37
2227611|NCT02730351|5463593|P1|STARTED|Treatment Period 1 (2 Weeks)||37
2227612|NCT02730260|5463607|P2|NOT COMPLETED|Overall Study||75
2227613|NCT02730260|5463608|P1|NOT COMPLETED|Overall Study||82
2227614|NCT02730260|5463607|P2|COMPLETED|Overall Study||185
2227615|NCT02730260|5463608|P1|COMPLETED|Overall Study||176
2227616|NCT02730260|5463607|P2|STARTED|Overall Study||260
2227617|NCT02730260|5463608|P1|STARTED|Overall Study||258
2227618|NCT02730208|5463616|P2|NOT COMPLETED|Overall Study||1
2227619|NCT02730208|5463617|P1|NOT COMPLETED|Overall Study||0
2227620|NCT02730208|5463616|P2|COMPLETED|Overall Study||20
2227621|NCT02730208|5463617|P1|COMPLETED|Overall Study||20
2227622|NCT02730208|5463616|P2|STARTED|Overall Study||21
2227623|NCT02730208|5463617|P1|STARTED|Overall Study||20
2227624|NCT02730195|5463625|P1|NOT COMPLETED|Overall Study||1
2227625|NCT02730195|5463625|P1|COMPLETED|Overall Study||8
2227626|NCT02730195|5463625|P1|STARTED|Overall Study||9
2227627|NCT02730130|5463631|P1|NOT COMPLETED|Overall Study||0
2227628|NCT02730130|5463631|P1|COMPLETED|Overall Study||17
2227629|NCT02730130|5463631|P1|STARTED|Overall Study||17
2227630|NCT02729909|5463639|P2|NOT COMPLETED|Overall Study||5
2227631|NCT02729909|5463640|P1|NOT COMPLETED|Overall Study||1
2227632|NCT02729909|5463639|P2|COMPLETED|Overall Study||101
2227633|NCT02729909|5463640|P1|COMPLETED|Overall Study||104
2227634|NCT02729909|5463639|P2|STARTED|Overall Study||106
2227635|NCT02729909|5463640|P1|STARTED|Overall Study||105
2227636|NCT02729896|5463659|P3|NOT COMPLETED|Overall Study||16
2227637|NCT02729896|5463660|P2|NOT COMPLETED|Overall Study||2
2227638|NCT02729896|5463661|P1|NOT COMPLETED|Overall Study||0
2227639|NCT02729896|5463659|P3|COMPLETED|Overall Study||7
2227640|NCT02729896|5463660|P2|COMPLETED|Overall Study||8
2227641|NCT02729896|5463661|P1|COMPLETED|Overall Study||3
2227642|NCT02729896|5463659|P3|STARTED|Overall Study||23
2227643|NCT02729896|5463660|P2|STARTED|Overall Study||10
2227644|NCT02729896|5463661|P1|STARTED|Overall Study||3
2227645|NCT02729831|5463682|P4|NOT COMPLETED|6 Month Follow-up||43
2227646|NCT02729831|5463683|P3|NOT COMPLETED|6 Month Follow-up||48
2227647|NCT02729831|5463684|P2|NOT COMPLETED|6 Month Follow-up||54
2227648|NCT02729831|5463685|P1|NOT COMPLETED|6 Month Follow-up||55
2227649|NCT02729831|5463682|P4|COMPLETED|6 Month Follow-up||232
2227650|NCT02729831|5463683|P3|COMPLETED|6 Month Follow-up||227
2227651|NCT02729831|5463684|P2|COMPLETED|6 Month Follow-up||238
2227652|NCT02729831|5463685|P1|COMPLETED|6 Month Follow-up||227
2227653|NCT02729831|5463682|P4|STARTED|6 Month Follow-up||275
2227654|NCT02729831|5463683|P3|STARTED|6 Month Follow-up||275
2227655|NCT02729831|5463684|P2|STARTED|6 Month Follow-up||292
2227656|NCT02729831|5463685|P1|STARTED|6 Month Follow-up||282
2227657|NCT02729831|5463682|P4|NOT COMPLETED|1 Week Post-visit||36
2227658|NCT02729831|5463683|P3|NOT COMPLETED|1 Week Post-visit||38
2227659|NCT02729831|5463684|P2|NOT COMPLETED|1 Week Post-visit||40
2227660|NCT02729831|5463685|P1|NOT COMPLETED|1 Week Post-visit||43
2227661|NCT02729831|5463682|P4|COMPLETED|1 Week Post-visit||239
2227662|NCT02729831|5463683|P3|COMPLETED|1 Week Post-visit||237
2227663|NCT02729831|5463684|P2|COMPLETED|1 Week Post-visit||252
2227664|NCT02729831|5463685|P1|COMPLETED|1 Week Post-visit||239
2227665|NCT02729831|5463682|P4|STARTED|1 Week Post-visit||275
2227666|NCT02729831|5463683|P3|STARTED|1 Week Post-visit||275
2227667|NCT02729831|5463684|P2|STARTED|1 Week Post-visit||292
2227668|NCT02729831|5463685|P1|STARTED|1 Week Post-visit||282
2227669|NCT02729831|5463682|P4|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||17
2227670|NCT02729831|5463683|P3|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||18
2227671|NCT02729831|5463684|P2|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||23
2227672|NCT02729831|5463685|P1|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||38
2227673|NCT02729831|5463682|P4|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||275
2227674|NCT02729831|5463683|P3|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||275
2227675|NCT02729831|5463684|P2|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||292
2227676|NCT02729831|5463685|P1|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||282
2227677|NCT02729831|5463682|P4|STARTED|Baseline (Post Decision Aid, Pre-visit)||292
2227678|NCT02729831|5463683|P3|STARTED|Baseline (Post Decision Aid, Pre-visit)||293
2227679|NCT02729831|5463684|P2|STARTED|Baseline (Post Decision Aid, Pre-visit)||315
2227680|NCT02729831|5463685|P1|STARTED|Baseline (Post Decision Aid, Pre-visit)||320
2227681|NCT02729753|5463713|P2|NOT COMPLETED|Overall Study||1
2227682|NCT02729753|5463714|P1|NOT COMPLETED|Overall Study||0
2227683|NCT02729753|5463713|P2|COMPLETED|Overall Study|Study Complete on 30 Oct 2016|6
2227684|NCT02729753|5463714|P1|COMPLETED|Overall Study|Study Complete on 30 Oct 2016|3
2227685|NCT02729753|5463713|P2|STARTED|Overall Study|First patient enrolled April 2016|7
2227686|NCT02729753|5463714|P1|STARTED|Overall Study|First patient enrolled April 2016|3
2227687|NCT02729545|5463728|P2|NOT COMPLETED|Overall Study||5
2227688|NCT02729545|5463729|P1|NOT COMPLETED|Overall Study||3
2227689|NCT02729545|5463728|P2|COMPLETED|Overall Study||25
2227690|NCT02729545|5463729|P1|COMPLETED|Overall Study||27
2227691|NCT02729545|5463728|P2|STARTED|Overall Study||30
2227692|NCT02729545|5463729|P1|STARTED|Overall Study||30
2227693|NCT02729194|5463751|P1|NOT COMPLETED|Overall Study||3
2227694|NCT02729194|5463751|P1|COMPLETED|Overall Study||13
2227695|NCT02729194|5463751|P1|STARTED|Overall Study||16
2227696|NCT02729051|5463763|P2|NOT COMPLETED|Overall Study||32
2227697|NCT02729051|5463764|P1|NOT COMPLETED|Overall Study||30
2227698|NCT02729051|5463763|P2|COMPLETED|Overall Study||496
2227699|NCT02729051|5463764|P1|COMPLETED|Overall Study||497
2227700|NCT02729051|5463763|P2|STARTED|Overall Study||528
2227701|NCT02729051|5463764|P1|STARTED|Overall Study||527
2227702|NCT02729038|5463784|P4|NOT COMPLETED|Part 2 (Up to 50 Days)||0
2227703|NCT02729038|5463785|P3|NOT COMPLETED|Part 2 (Up to 50 Days)||0
2227704|NCT02729038|5463786|P2|NOT COMPLETED|Part 2 (Up to 50 Days)||0
2227705|NCT02729038|5463787|P1|NOT COMPLETED|Part 2 (Up to 50 Days)||0
2227706|NCT02729038|5463784|P4|COMPLETED|Part 2 (Up to 50 Days)||8
2227707|NCT02729038|5463785|P3|COMPLETED|Part 2 (Up to 50 Days)||0
2227708|NCT02729038|5463786|P2|COMPLETED|Part 2 (Up to 50 Days)||0
2227709|NCT02729038|5463787|P1|COMPLETED|Part 2 (Up to 50 Days)||0
2227710|NCT02729038|5463784|P4|STARTED|Part 2 (Up to 50 Days)||8
2227711|NCT02729038|5463785|P3|STARTED|Part 2 (Up to 50 Days)||0
2227712|NCT02729038|5463786|P2|STARTED|Part 2 (Up to 50 Days)||0
2227713|NCT02729038|5463787|P1|STARTED|Part 2 (Up to 50 Days)||0
2227714|NCT02729038|5463784|P4|NOT COMPLETED|Part 1 (Up to 44 Days)||0
2227715|NCT02729038|5463785|P3|NOT COMPLETED|Part 1 (Up to 44 Days)||0
2227716|NCT02729038|5463786|P2|NOT COMPLETED|Part 1 (Up to 44 Days)||0
2227717|NCT02729038|5463787|P1|NOT COMPLETED|Part 1 (Up to 44 Days)||0
2227718|NCT02729038|5463784|P4|COMPLETED|Part 1 (Up to 44 Days)||0
2227719|NCT02729038|5463785|P3|COMPLETED|Part 1 (Up to 44 Days)||8
2227720|NCT02729038|5463786|P2|COMPLETED|Part 1 (Up to 44 Days)||8
2227721|NCT02729038|5463787|P1|COMPLETED|Part 1 (Up to 44 Days)||8
2227722|NCT02729038|5463784|P4|STARTED|Part 1 (Up to 44 Days)||0
2227723|NCT02729038|5463785|P3|STARTED|Part 1 (Up to 44 Days)||8
2227724|NCT02729038|5463786|P2|STARTED|Part 1 (Up to 44 Days)||8
2227725|NCT02729038|5463787|P1|STARTED|Part 1 (Up to 44 Days)||8
2227726|NCT02729025|5463908|P2|NOT COMPLETED|Overall Study||1
2227727|NCT02729025|5463909|P1|NOT COMPLETED|Overall Study||0
2227728|NCT02729025|5463908|P2|COMPLETED|Overall Study||64
2227729|NCT02729025|5463909|P1|COMPLETED|Overall Study||64
2227730|NCT02729025|5463908|P2|STARTED|Overall Study||65
2227731|NCT02729025|5463909|P1|STARTED|Overall Study||64
2227732|NCT02728895|5463923|P2|NOT COMPLETED|Overall Study||5
2227733|NCT02728895|5463924|P1|NOT COMPLETED|Overall Study||1
2227734|NCT02728895|5463923|P2|COMPLETED|Overall Study||16
2227735|NCT02728895|5463924|P1|COMPLETED|Overall Study||2
2227736|NCT02728895|5463923|P2|STARTED|Overall Study||21
2227737|NCT02728895|5463924|P1|STARTED|Overall Study||3
2227738|NCT02728206|5463944|P1|NOT COMPLETED|Overall Study||1
2227739|NCT02728206|5463944|P1|COMPLETED|Overall Study||8
2227740|NCT02728206|5463944|P1|STARTED|Overall Study||9
2227741|NCT02728089|5463952|P1|NOT COMPLETED|Overall Study||3
2227742|NCT02728089|5463952|P1|COMPLETED|Overall Study||112
2227743|NCT02728089|5463952|P1|Treated|Overall Study||114
2227744|NCT02728089|5463952|P1|STARTED|Overall Study||115
2227745|NCT02727894|5463969|P2|NOT COMPLETED|Overall Study||0
2227746|NCT02727894|5463970|P1|NOT COMPLETED|Overall Study||0
2227747|NCT02727894|5463969|P2|COMPLETED|Overall Study|September 2015|192
2227748|NCT02727894|5463970|P1|COMPLETED|Overall Study|September 2015|73
2227749|NCT02727894|5463969|P2|STARTED|Overall Study|March 2013|192
2227750|NCT02727894|5463970|P1|STARTED|Overall Study|March 2013|73
2227751|NCT02727842|5463986|P1|NOT COMPLETED|Overall Study||0
2227752|NCT02727842|5463986|P1|COMPLETED|Overall Study||30
2227753|NCT02727842|5463986|P1|STARTED|Overall Study||30
2227754|NCT02727816|5463990|P1|NOT COMPLETED|Overall Study||0
2227755|NCT02727816|5463990|P1|COMPLETED|Overall Study||35
2227756|NCT02727816|5463990|P1|STARTED|Overall Study||35
2227757|NCT02727660|5464040|P3|NOT COMPLETED|Overall Study||165
2227758|NCT02727660|5464041|P2|NOT COMPLETED|Overall Study||116
2227759|NCT02727660|5464042|P1|NOT COMPLETED|Overall Study||116
2227760|NCT02727660|5464040|P3|COMPLETED|Overall Study||442
2227761|NCT02727660|5464041|P2|COMPLETED|Overall Study||501
2227762|NCT02727660|5464042|P1|COMPLETED|Overall Study||503
2227763|NCT02727660|5464040|P3|STARTED|Overall Study||607
2227764|NCT02727660|5464041|P2|STARTED|Overall Study||617
2227765|NCT02727660|5464042|P1|STARTED|Overall Study||619
2227766|NCT02727322|5464061|P2|NOT COMPLETED|Overall Study||1
2227767|NCT02727322|5464062|P1|NOT COMPLETED|Overall Study||2
2227768|NCT02727322|5464061|P2|COMPLETED|Overall Study||76
2227769|NCT02727322|5464062|P1|COMPLETED|Overall Study||75
2227770|NCT02727322|5464061|P2|STARTED|Overall Study||77
2227771|NCT02727322|5464062|P1|STARTED|Overall Study||77
2227772|NCT02726971|5464074|P2|NOT COMPLETED|Overall Study||9
2227773|NCT02726971|5464075|P1|NOT COMPLETED|Overall Study||11
2227774|NCT02726971|5464074|P2|COMPLETED|Overall Study||62
2227775|NCT02726971|5464075|P1|COMPLETED|Overall Study||59
2227776|NCT02726971|5464074|P2|STARTED|Overall Study||71
2227777|NCT02726971|5464075|P1|STARTED|Overall Study||70
2227778|NCT02726945|5464088|P3|NOT COMPLETED|Overall Study||1
2227779|NCT02726945|5464089|P2|NOT COMPLETED|Overall Study||1
2227780|NCT02726945|5464090|P1|NOT COMPLETED|Overall Study||0
2227781|NCT02726945|5464088|P3|COMPLETED|Overall Study||12
2227782|NCT02726945|5464089|P2|COMPLETED|Overall Study||12
2227783|NCT02726945|5464090|P1|COMPLETED|Overall Study||13
2227784|NCT02726945|5464088|P3|STARTED|Overall Study||13
2227785|NCT02726945|5464089|P2|STARTED|Overall Study||13
2227786|NCT02726945|5464090|P1|STARTED|Overall Study||13
2227787|NCT02726789|5464101|P1|NOT COMPLETED|Overall Study||0
2227788|NCT02726789|5464101|P1|COMPLETED|Overall Study||5
2227789|NCT02726789|5464101|P1|STARTED|Overall Study||5
2227790|NCT02726620|5464110|P2|NOT COMPLETED|Through End of Study: All Interventions||0
2227791|NCT02726620|5464111|P1|NOT COMPLETED|Through End of Study: All Interventions||0
2227792|NCT02726620|5464110|P2|COMPLETED|Through End of Study: All Interventions||3234
2227793|NCT02726620|5464111|P1|COMPLETED|Through End of Study: All Interventions||0
2227794|NCT02726620|5464110|P2|Correct IOH Notifications|Through End of Study: All Interventions||2072
2227795|NCT02726620|5464111|P1|Correct IOH Notifications|Through End of Study: All Interventions||0
2227796|NCT02726620|5464110|P2|MAP < 65 mmHg: Primary Analysis|Through End of Study: All Interventions||2793
2227797|NCT02726620|5464111|P1|MAP < 65 mmHg: Primary Analysis|Through End of Study: All Interventions||0
2227798|NCT02726620|5464110|P2|STARTED|Through End of Study: All Interventions||3234
2227799|NCT02726620|5464111|P1|STARTED|Through End of Study: All Interventions||0
2227800|NCT02726620|5464110|P2|NOT COMPLETED|Months 2-3: In-room Providers Randomized||0
2227801|NCT02726620|5464111|P1|NOT COMPLETED|Months 2-3: In-room Providers Randomized||0
2227802|NCT02726620|5464110|P2|COMPLETED|Months 2-3: In-room Providers Randomized||1253
2227803|NCT02726620|5464111|P1|COMPLETED|Months 2-3: In-room Providers Randomized||0
2227804|NCT02726620|5464110|P2|Correct IOH Notifications|Months 2-3: In-room Providers Randomized||825
2227805|NCT02726620|5464111|P1|Correct IOH Notifications|Months 2-3: In-room Providers Randomized||0
2227806|NCT02726620|5464110|P2|MAP < 65 mmHg: Primary Analysis|Months 2-3: In-room Providers Randomized||1103
2227807|NCT02726620|5464111|P1|MAP < 65 mmHg: Primary Analysis|Months 2-3: In-room Providers Randomized||0
2227808|NCT02726620|5464110|P2|STARTED|Months 2-3: In-room Providers Randomized||1253
2227809|NCT02726620|5464111|P1|STARTED|Months 2-3: In-room Providers Randomized||0
2227810|NCT02726620|5464110|P2|NOT COMPLETED|Month 1: Attending Randomization||0
2227811|NCT02726620|5464111|P1|NOT COMPLETED|Month 1: Attending Randomization||0
2227812|NCT02726620|5464110|P2|COMPLETED|Month 1: Attending Randomization||485
2227813|NCT02726620|5464111|P1|COMPLETED|Month 1: Attending Randomization||0
2227814|NCT02726620|5464110|P2|Correct IOH Notifications|Month 1: Attending Randomization||313
2227815|NCT02726620|5464111|P1|Correct IOH Notifications|Month 1: Attending Randomization||0
2227816|NCT02726620|5464110|P2|MAP < 65 mmHg: Primary Analysis|Month 1: Attending Randomization||432
2227817|NCT02726620|5464111|P1|MAP < 65 mmHg: Primary Analysis|Month 1: Attending Randomization||0
2227818|NCT02726620|5464110|P2|STARTED|Month 1: Attending Randomization||485
2227819|NCT02726620|5464111|P1|STARTED|Month 1: Attending Randomization||0
2227820|NCT02726620|5464110|P2|NOT COMPLETED|Historic Cohort - Three Years||0
2227821|NCT02726620|5464111|P1|NOT COMPLETED|Historic Cohort - Three Years||0
2227822|NCT02726620|5464110|P2|COMPLETED|Historic Cohort - Three Years||0
2227823|NCT02726620|5464111|P1|COMPLETED|Historic Cohort - Three Years||17463
2227824|NCT02726620|5464110|P2|MAP < 65 mmHg: Primary Analysis|Historic Cohort - Three Years||0
2227825|NCT02726620|5464111|P1|MAP < 65 mmHg: Primary Analysis|Historic Cohort - Three Years||15624
2227826|NCT02726620|5464110|P2|STARTED|Historic Cohort - Three Years||0
2227827|NCT02726620|5464111|P1|STARTED|Historic Cohort - Three Years||17463
2227828|NCT02726399|5464207|P1|NOT COMPLETED|Overall Study||7
2227829|NCT02726399|5464207|P1|COMPLETED|Overall Study||0
2227830|NCT02726399|5464207|P1|STARTED|Overall Study||7
2227831|NCT02726178|5464213|P2|NOT COMPLETED|Overall Study||0
2227832|NCT02726178|5464214|P1|NOT COMPLETED|Overall Study||0
2227833|NCT02726178|5464213|P2|COMPLETED|Overall Study||28
2227834|NCT02726178|5464214|P1|COMPLETED|Overall Study||28
2227835|NCT02726178|5464213|P2|STARTED|Overall Study||28
2227836|NCT02726178|5464214|P1|STARTED|Overall Study||28
2227837|NCT02726113|5464224|P2|NOT COMPLETED|Genomic Analysis||2
2227838|NCT02726113|5464225|P1|NOT COMPLETED|Genomic Analysis||4
2227839|NCT02726113|5464224|P2|COMPLETED|Genomic Analysis||12
2227840|NCT02726113|5464225|P1|COMPLETED|Genomic Analysis||15
2227841|NCT02726113|5464224|P2|STARTED|Genomic Analysis||14
2227842|NCT02726113|5464225|P1|STARTED|Genomic Analysis||19
2227843|NCT02726113|5464224|P2|NOT COMPLETED|Total Enrollment||3
2227844|NCT02726113|5464225|P1|NOT COMPLETED|Total Enrollment||4
2227845|NCT02726113|5464224|P2|COMPLETED|Total Enrollment||19
2227846|NCT02726113|5464225|P1|COMPLETED|Total Enrollment||24
2227847|NCT02726113|5464224|P2|STARTED|Total Enrollment||22
2227848|NCT02726113|5464225|P1|STARTED|Total Enrollment||28
2227849|NCT02726074|5464232|P1|NOT COMPLETED|Overall Study||26
2227850|NCT02726074|5464232|P1|COMPLETED|Overall Study||80
2227851|NCT02726074|5464232|P1|Treated|Overall Study||102
2227852|NCT02726074|5464232|P1|STARTED|Overall Study||106
2227853|NCT02726022|5464244|P1|NOT COMPLETED|Overall Study||36
2227854|NCT02726022|5464244|P1|COMPLETED|Overall Study||78
2227855|NCT02726022|5464244|P1|STARTED|Overall Study||114
2227856|NCT02725866|5464253|P1|NOT COMPLETED|Overall Study||14
2227857|NCT02725866|5464253|P1|COMPLETED|Overall Study||202
2227858|NCT02725866|5464253|P1|STARTED|Overall Study||216
2227859|NCT02725788|5464266|P2|NOT COMPLETED|Overall Study||2
2227860|NCT02725788|5464267|P1|NOT COMPLETED|Overall Study||1
2227861|NCT02725788|5464266|P2|COMPLETED|Overall Study||122
2227862|NCT02725788|5464267|P1|COMPLETED|Overall Study||122
2227863|NCT02725788|5464266|P2|STARTED|Overall Study||124
2227864|NCT02725788|5464267|P1|STARTED|Overall Study||123
2227865|NCT02725710|5464275|P2|NOT COMPLETED|Overall Study||0
2227866|NCT02725710|5464276|P1|NOT COMPLETED|Overall Study||1
2227867|NCT02725710|5464275|P2|COMPLETED|Overall Study||47
2227868|NCT02725710|5464276|P1|COMPLETED|Overall Study||47
2227869|NCT02725710|5464275|P2|STARTED|Overall Study||47
2227870|NCT02725710|5464276|P1|STARTED|Overall Study||48
2227874|NCT02725645|5464308|P1|NOT COMPLETED|Overall Study||0
2227875|NCT02725645|5464308|P1|COMPLETED|Overall Study||14
2227876|NCT02725645|5464308|P1|STARTED|Overall Study||14
2227877|NCT02725515|5464314|P2|NOT COMPLETED|Overall Study||35
2227878|NCT02725515|5464315|P1|NOT COMPLETED|Overall Study||25
2227879|NCT02725515|5464314|P2|COMPLETED|Overall Study||17
2227880|NCT02725515|5464315|P1|COMPLETED|Overall Study||28
2227881|NCT02725515|5464314|P2|STARTED|Overall Study||52
2227882|NCT02725515|5464315|P1|STARTED|Overall Study||53
2227883|NCT02725476|5464327|P2|NOT COMPLETED|Overall Study||1
2227884|NCT02725476|5464328|P1|NOT COMPLETED|Overall Study||3
2227885|NCT02725476|5464327|P2|COMPLETED|Overall Study||4
2227886|NCT02725476|5464328|P1|COMPLETED|Overall Study||12
2227887|NCT02725476|5464327|P2|STARTED|Overall Study||5
2227888|NCT02725476|5464328|P1|STARTED|Overall Study||15
2227889|NCT02725008|5464338|P2|NOT COMPLETED|Overall Study||12
2227890|NCT02725008|5464339|P1|NOT COMPLETED|Overall Study||9
2227891|NCT02725008|5464338|P2|COMPLETED|Overall Study||39
2227892|NCT02725008|5464339|P1|COMPLETED|Overall Study||37
2227893|NCT02725008|5464338|P2|STARTED|Overall Study||51
2227894|NCT02725008|5464339|P1|STARTED|Overall Study||46
2227895|NCT02724787|5464347|P1|NOT COMPLETED|Overall Study||2
2227896|NCT02724787|5464347|P1|COMPLETED|Overall Study|22 completed treatment. 20 participants returned for post-treatment assessment.|22
2227897|NCT02724787|5464347|P1|STARTED|Overall Study||24
2227898|NCT02724644|5464357|P2|NOT COMPLETED|Overall Study||4
2227899|NCT02724644|5464358|P1|NOT COMPLETED|Overall Study||21
2227900|NCT02724644|5464357|P2|COMPLETED|Overall Study||182
2227901|NCT02724644|5464358|P1|COMPLETED|Overall Study||168
2227902|NCT02724644|5464357|P2|STARTED|Overall Study||186
2227903|NCT02724644|5464358|P1|STARTED|Overall Study||189
2227904|NCT02724449|5464386|P1|NOT COMPLETED|Overall Study||0
2227905|NCT02724449|5464386|P1|COMPLETED|Overall Study||16
2227906|NCT02724449|5464386|P1|STARTED|Overall Study||16
2227907|NCT02724111|5464392|P2|NOT COMPLETED|Overall Study||5
2227908|NCT02724111|5464393|P1|NOT COMPLETED|Overall Study||2
2227909|NCT02724111|5464392|P2|COMPLETED|Overall Study||40
2227910|NCT02724111|5464393|P1|COMPLETED|Overall Study||43
2227911|NCT02724111|5464392|P2|STARTED|Overall Study||45
2227912|NCT02724111|5464393|P1|STARTED|Overall Study||45
2227913|NCT02723786|5464413|P1|NOT COMPLETED|Overall Study||1
2227914|NCT02723786|5464413|P1|COMPLETED|Overall Study||6
2227915|NCT02723786|5464413|P1|STARTED|Overall Study||7
2227916|NCT02723630|5464441|P6|NOT COMPLETED|Intervention Period 3||0
2227917|NCT02723630|5464442|P5|NOT COMPLETED|Intervention Period 3||0
2227918|NCT02723630|5464443|P4|NOT COMPLETED|Intervention Period 3||0
2227919|NCT02723630|5464444|P3|NOT COMPLETED|Intervention Period 3||0
2227920|NCT02723630|5464445|P2|NOT COMPLETED|Intervention Period 3||1
2227921|NCT02723630|5464446|P1|NOT COMPLETED|Intervention Period 3||0
2227922|NCT02723630|5464441|P6|COMPLETED|Intervention Period 3||10
2227923|NCT02723630|5464442|P5|COMPLETED|Intervention Period 3||10
2227924|NCT02723630|5464443|P4|COMPLETED|Intervention Period 3||10
2227925|NCT02723630|5464444|P3|COMPLETED|Intervention Period 3||10
2227926|NCT02723630|5464445|P2|COMPLETED|Intervention Period 3||9
2227927|NCT02723630|5464446|P1|COMPLETED|Intervention Period 3||9
2227928|NCT02723630|5464441|P6|STARTED|Intervention Period 3||10
2227929|NCT02723630|5464442|P5|STARTED|Intervention Period 3||10
2227930|NCT02723630|5464443|P4|STARTED|Intervention Period 3||10
2227931|NCT02723630|5464444|P3|STARTED|Intervention Period 3||10
2227932|NCT02723630|5464445|P2|STARTED|Intervention Period 3||10
2227933|NCT02723630|5464446|P1|STARTED|Intervention Period 3||9
2227934|NCT02723630|5464441|P6|NOT COMPLETED|Intervention Period 2||0
2227935|NCT02723630|5464442|P5|NOT COMPLETED|Intervention Period 2||0
2227936|NCT02723630|5464443|P4|NOT COMPLETED|Intervention Period 2||0
2227937|NCT02723630|5464444|P3|NOT COMPLETED|Intervention Period 2||0
2227938|NCT02723630|5464445|P2|NOT COMPLETED|Intervention Period 2||0
2227939|NCT02723630|5464446|P1|NOT COMPLETED|Intervention Period 2||0
2227940|NCT02723630|5464441|P6|COMPLETED|Intervention Period 2||10
2227941|NCT02723630|5464442|P5|COMPLETED|Intervention Period 2||10
2227942|NCT02723630|5464443|P4|COMPLETED|Intervention Period 2||10
2227943|NCT02723630|5464444|P3|COMPLETED|Intervention Period 2||10
2227944|NCT02723630|5464445|P2|COMPLETED|Intervention Period 2||10
2227945|NCT02723630|5464446|P1|COMPLETED|Intervention Period 2||9
2227946|NCT02723630|5464441|P6|STARTED|Intervention Period 2||10
2227947|NCT02723630|5464442|P5|STARTED|Intervention Period 2||10
2227948|NCT02723630|5464443|P4|STARTED|Intervention Period 2||10
2227949|NCT02723630|5464444|P3|STARTED|Intervention Period 2||10
2227950|NCT02723630|5464445|P2|STARTED|Intervention Period 2||10
2227951|NCT02723630|5464446|P1|STARTED|Intervention Period 2||9
2227952|NCT02723630|5464441|P6|NOT COMPLETED|Intervention Period 1||0
2227953|NCT02723630|5464442|P5|NOT COMPLETED|Intervention Period 1||0
2227954|NCT02723630|5464443|P4|NOT COMPLETED|Intervention Period 1||0
2227955|NCT02723630|5464444|P3|NOT COMPLETED|Intervention Period 1||0
2227956|NCT02723630|5464445|P2|NOT COMPLETED|Intervention Period 1||0
2227957|NCT02723630|5464446|P1|NOT COMPLETED|Intervention Period 1||1
2227958|NCT02723630|5464441|P6|COMPLETED|Intervention Period 1||10
2227959|NCT02723630|5464442|P5|COMPLETED|Intervention Period 1||10
2227960|NCT02723630|5464443|P4|COMPLETED|Intervention Period 1||10
2227961|NCT02723630|5464444|P3|COMPLETED|Intervention Period 1||10
2227962|NCT02723630|5464445|P2|COMPLETED|Intervention Period 1||10
2227963|NCT02723630|5464446|P1|COMPLETED|Intervention Period 1||9
2227964|NCT02723630|5464441|P6|STARTED|Intervention Period 1||10
2227965|NCT02723630|5464442|P5|STARTED|Intervention Period 1||10
2227966|NCT02723630|5464443|P4|STARTED|Intervention Period 1||10
2227967|NCT02723630|5464444|P3|STARTED|Intervention Period 1||10
2227968|NCT02723630|5464445|P2|STARTED|Intervention Period 1||10
2227969|NCT02723630|5464446|P1|STARTED|Intervention Period 1||10
2227970|NCT02723201|5464478|P3|NOT COMPLETED|Fourth Intervention Period||0
2227971|NCT02723201|5464479|P2|NOT COMPLETED|Fourth Intervention Period||0
2227972|NCT02723201|5464480|P1|NOT COMPLETED|Fourth Intervention Period||0
2227973|NCT02723201|5464478|P3|COMPLETED|Fourth Intervention Period||0
2227974|NCT02723201|5464479|P2|COMPLETED|Fourth Intervention Period||0
2227975|NCT02723201|5464480|P1|COMPLETED|Fourth Intervention Period||9
2227976|NCT02723201|5464478|P3|STARTED|Fourth Intervention Period||0
2227977|NCT02723201|5464479|P2|STARTED|Fourth Intervention Period||0
2227978|NCT02723201|5464480|P1|STARTED|Fourth Intervention Period||9
2227979|NCT02723201|5464478|P3|NOT COMPLETED|Washout Period 3||0
2227980|NCT02723201|5464479|P2|NOT COMPLETED|Washout Period 3||0
2227981|NCT02723201|5464480|P1|NOT COMPLETED|Washout Period 3||0
2227982|NCT02723201|5464478|P3|COMPLETED|Washout Period 3||0
2227983|NCT02723201|5464479|P2|COMPLETED|Washout Period 3||0
2227984|NCT02723201|5464480|P1|COMPLETED|Washout Period 3||9
2227985|NCT02723201|5464478|P3|STARTED|Washout Period 3||0
2227986|NCT02723201|5464479|P2|STARTED|Washout Period 3||0
2227987|NCT02723201|5464480|P1|STARTED|Washout Period 3||9
2227988|NCT02723201|5464478|P3|NOT COMPLETED|Third Intervention Period||0
2227989|NCT02723201|5464479|P2|NOT COMPLETED|Third Intervention Period||0
2227990|NCT02723201|5464480|P1|NOT COMPLETED|Third Intervention Period||0
2227991|NCT02723201|5464478|P3|COMPLETED|Third Intervention Period||0
2227992|NCT02723201|5464479|P2|COMPLETED|Third Intervention Period||0
2227993|NCT02723201|5464480|P1|COMPLETED|Third Intervention Period||9
2227994|NCT02723201|5464478|P3|STARTED|Third Intervention Period||0
2227995|NCT02723201|5464479|P2|STARTED|Third Intervention Period||0
2227996|NCT02723201|5464480|P1|STARTED|Third Intervention Period||9
2227997|NCT02723201|5464478|P3|NOT COMPLETED|Washout Period 2||0
2227998|NCT02723201|5464479|P2|NOT COMPLETED|Washout Period 2||0
2227999|NCT02723201|5464480|P1|NOT COMPLETED|Washout Period 2||0
2228000|NCT02723201|5464478|P3|COMPLETED|Washout Period 2||0
2228001|NCT02723201|5464479|P2|COMPLETED|Washout Period 2||0
2228002|NCT02723201|5464480|P1|COMPLETED|Washout Period 2||9
2228003|NCT02723201|5464478|P3|STARTED|Washout Period 2||0
2228004|NCT02723201|5464479|P2|STARTED|Washout Period 2||0
2228005|NCT02723201|5464480|P1|STARTED|Washout Period 2||9
2228006|NCT02723201|5464478|P3|NOT COMPLETED|Second Intervention Period||0
2228007|NCT02723201|5464479|P2|NOT COMPLETED|Second Intervention Period||0
2228008|NCT02723201|5464480|P1|NOT COMPLETED|Second Intervention Period||2
2228009|NCT02723201|5464478|P3|COMPLETED|Second Intervention Period||7
2228010|NCT02723201|5464479|P2|COMPLETED|Second Intervention Period||7
2228011|NCT02723201|5464480|P1|COMPLETED|Second Intervention Period||9
2228012|NCT02723201|5464478|P3|STARTED|Second Intervention Period||7
2228013|NCT02723201|5464479|P2|STARTED|Second Intervention Period||7
2228014|NCT02723201|5464480|P1|STARTED|Second Intervention Period||11
2228015|NCT02723201|5464478|P3|NOT COMPLETED|Washout Period 1||0
2228016|NCT02723201|5464479|P2|NOT COMPLETED|Washout Period 1||0
2228017|NCT02723201|5464480|P1|NOT COMPLETED|Washout Period 1||0
2228018|NCT02723201|5464478|P3|COMPLETED|Washout Period 1||7
2228019|NCT02723201|5464479|P2|COMPLETED|Washout Period 1||7
2228020|NCT02723201|5464480|P1|COMPLETED|Washout Period 1||11
2228021|NCT02723201|5464478|P3|STARTED|Washout Period 1||7
2228022|NCT02723201|5464479|P2|STARTED|Washout Period 1||7
2228023|NCT02723201|5464480|P1|STARTED|Washout Period 1||11
2228024|NCT02723201|5464478|P3|NOT COMPLETED|First Intervention Period||0
2228025|NCT02723201|5464479|P2|NOT COMPLETED|First Intervention Period||0
2228026|NCT02723201|5464480|P1|NOT COMPLETED|First Intervention Period||0
2228027|NCT02723201|5464478|P3|COMPLETED|First Intervention Period||7
2228028|NCT02723201|5464479|P2|COMPLETED|First Intervention Period||7
2228029|NCT02723201|5464480|P1|COMPLETED|First Intervention Period||11
2228030|NCT02723201|5464478|P3|STARTED|First Intervention Period||7
2228031|NCT02723201|5464479|P2|STARTED|First Intervention Period||7
2228032|NCT02723201|5464480|P1|STARTED|First Intervention Period||11
2228033|NCT02723188|5464539|P3|NOT COMPLETED|Overall Study||0
2228034|NCT02723188|5464540|P2|NOT COMPLETED|Overall Study||0
2228035|NCT02723188|5464541|P1|NOT COMPLETED|Overall Study||1
2228036|NCT02723188|5464539|P3|COMPLETED|Overall Study||15
2228037|NCT02723188|5464540|P2|COMPLETED|Overall Study||15
2228038|NCT02723188|5464541|P1|COMPLETED|Overall Study||14
2228039|NCT02723188|5464539|P3|STARTED|Overall Study||15
2228040|NCT02723188|5464540|P2|STARTED|Overall Study||15
2228041|NCT02723188|5464541|P1|STARTED|Overall Study||15
2228042|NCT02723175|5464554|P2|NOT COMPLETED|Overall Study||3
2228043|NCT02723175|5464555|P1|NOT COMPLETED|Overall Study||4
2228044|NCT02723175|5464554|P2|COMPLETED|Overall Study||4
2228045|NCT02723175|5464555|P1|COMPLETED|Overall Study||4
2228046|NCT02723175|5464554|P2|STARTED|Overall Study||7
2228047|NCT02723175|5464555|P1|STARTED|Overall Study||8
2228048|NCT02723084|5464597|P2|NOT COMPLETED|Overall Study||1
2228049|NCT02723084|5464598|P1|NOT COMPLETED|Overall Study||4
2228050|NCT02723084|5464597|P2|COMPLETED|Overall Study||45
2228051|NCT02723084|5464598|P1|COMPLETED|Overall Study||86
2228052|NCT02723084|5464597|P2|STARTED|Overall Study||46
2228053|NCT02723084|5464598|P1|STARTED|Overall Study||90
2228054|NCT02722967|5464612|P3|NOT COMPLETED|Overall Study||4
2228055|NCT02722967|5464613|P2|NOT COMPLETED|Overall Study||2
2228056|NCT02722967|5464614|P1|NOT COMPLETED|Overall Study||5
2228057|NCT02722967|5464612|P3|COMPLETED|Overall Study||11
2228058|NCT02722967|5464613|P2|COMPLETED|Overall Study||10
2228059|NCT02722967|5464614|P1|COMPLETED|Overall Study||17
2228060|NCT02722967|5464612|P3|STARTED|Overall Study||15
2228061|NCT02722967|5464613|P2|STARTED|Overall Study||12
2228062|NCT02722967|5464614|P1|STARTED|Overall Study||22
2228063|NCT02722928|5464624|P2|NOT COMPLETED|Overall Study||20
2228064|NCT02722928|5464625|P1|NOT COMPLETED|Overall Study||10
2228065|NCT02722928|5464624|P2|COMPLETED|Overall Study||31
2228066|NCT02722928|5464625|P1|COMPLETED|Overall Study||39
2228067|NCT02722928|5464624|P2|STARTED|Overall Study||51
2228068|NCT02722928|5464625|P1|STARTED|Overall Study||49
2228069|NCT02722837|5464639|P1|NOT COMPLETED|Overall Study||0
2228070|NCT02722837|5464639|P1|COMPLETED|Overall Study||119
2228071|NCT02722837|5464639|P1|STARTED|Overall Study||119
2228072|NCT02722577|5464657|P1|NOT COMPLETED|Overall Study||0
2228073|NCT02722577|5464657|P1|COMPLETED|Overall Study||20
2228074|NCT02722577|5464657|P1|STARTED|Overall Study||20
2228075|NCT02722564|5464661|P1|NOT COMPLETED|Overall Study||0
2228076|NCT02722564|5464661|P1|COMPLETED|Overall Study||55
2228077|NCT02722564|5464661|P1|STARTED|Overall Study||55
2228078|NCT02722330|5464665|P1|NOT COMPLETED|Overall Study||0
2228079|NCT02722330|5464665|P1|COMPLETED|Overall Study||23
2228080|NCT02722330|5464665|P1|STARTED|Overall Study||23
2228081|NCT02722304|5464696|P5|NOT COMPLETED|Overall Study||2
2228082|NCT02722304|5464697|P4|NOT COMPLETED|Overall Study||2
2228083|NCT02722304|5464698|P3|NOT COMPLETED|Overall Study||2
2228084|NCT02722304|5464699|P2|NOT COMPLETED|Overall Study||0
2228085|NCT02722304|5464700|P1|NOT COMPLETED|Overall Study||1
2228086|NCT02722304|5464696|P5|COMPLETED|Overall Study||0
2228087|NCT02722304|5464697|P4|COMPLETED|Overall Study||0
2228088|NCT02722304|5464698|P3|COMPLETED|Overall Study||0
2228089|NCT02722304|5464699|P2|COMPLETED|Overall Study||0
2228090|NCT02722304|5464700|P1|COMPLETED|Overall Study||0
2228091|NCT02722304|5464696|P5|Treated|Overall Study||2
2228092|NCT02722304|5464697|P4|Treated|Overall Study||1
2228093|NCT02722304|5464698|P3|Treated|Overall Study||1
2228094|NCT02722304|5464699|P2|Treated|Overall Study||0
2228095|NCT02722304|5464700|P1|Treated|Overall Study||1
2228096|NCT02722304|5464696|P5|STARTED|Overall Study||2
2228097|NCT02722304|5464697|P4|STARTED|Overall Study||2
2228098|NCT02722304|5464698|P3|STARTED|Overall Study||2
2228099|NCT02722304|5464699|P2|STARTED|Overall Study||0
2228100|NCT02722304|5464700|P1|STARTED|Overall Study||1
2228101|NCT02722278|5464752|P2|NOT COMPLETED|Overall Study||7
2228102|NCT02722278|5464753|P1|NOT COMPLETED|Overall Study||12
2228103|NCT02722278|5464752|P2|COMPLETED|Overall Study||49
2228104|NCT02722278|5464753|P1|COMPLETED|Overall Study||154
2228105|NCT02722278|5464752|P2|STARTED|Overall Study||56
2228106|NCT02722278|5464753|P1|STARTED|Overall Study||166
2228107|NCT02722239|5464763|P2|NOT COMPLETED|Overall Study||0
2228108|NCT02722239|5464764|P1|NOT COMPLETED|Overall Study||0
2228109|NCT02722239|5464763|P2|COMPLETED|Overall Study||20
2228110|NCT02722239|5464764|P1|COMPLETED|Overall Study||20
2228111|NCT02722239|5464763|P2|Second Intervention (1 Day)|Overall Study||20
2228112|NCT02722239|5464764|P1|Second Intervention (1 Day)|Overall Study||20
2228113|NCT02722239|5464763|P2|Washout (7 Days)|Overall Study||20
2228114|NCT02722239|5464764|P1|Washout (7 Days)|Overall Study||20
2228115|NCT02722239|5464763|P2|First Intervention (1 Day)|Overall Study||20
2228116|NCT02722239|5464764|P1|First Intervention (1 Day)|Overall Study||20
2228117|NCT02722239|5464763|P2|STARTED|Overall Study||20
2228118|NCT02722239|5464764|P1|STARTED|Overall Study||20
2228119|NCT02722148|5464777|P1|NOT COMPLETED|Overall Study||5
2228120|NCT02722148|5464777|P1|COMPLETED|Overall Study||19
2228121|NCT02722148|5464777|P1|STARTED|Overall Study||24
2228122|NCT02722044|5464784|P1|NOT COMPLETED|Overall Study||5
2228123|NCT02722044|5464784|P1|COMPLETED|Overall Study||28
2228124|NCT02722044|5464784|P1|STARTED|Overall Study||33
2228125|NCT02721875|5464813|P2|NOT COMPLETED|Overall Study||0
2228126|NCT02721875|5464814|P1|NOT COMPLETED|Overall Study||1
2228127|NCT02721875|5464813|P2|COMPLETED|Overall Study||0
2228128|NCT02721875|5464814|P1|COMPLETED|Overall Study||0
2228129|NCT02721875|5464813|P2|STARTED|Overall Study||0
2228130|NCT02721875|5464814|P1|STARTED|Overall Study||1
2228131|NCT02721641|5464827|P1|NOT COMPLETED|Overall Study||0
2228132|NCT02721641|5464827|P1|COMPLETED|Overall Study|In this continued access study, all participants were considered to have completed per protocol.|69
2228133|NCT02721641|5464827|P1|STARTED|Overall Study||69
2228134|NCT02721277|5464833|P1|NOT COMPLETED|Overall Study||0
2228135|NCT02721277|5464833|P1|COMPLETED|Overall Study||2
2228136|NCT02721277|5464833|P1|STARTED|Overall Study||2
2228137|NCT02721147|5464865|P3|NOT COMPLETED|Overall Study||0
2228138|NCT02721147|5464866|P2|NOT COMPLETED|Overall Study||0
2228139|NCT02721147|5464867|P1|NOT COMPLETED|Overall Study||2
2228140|NCT02721147|5464865|P3|COMPLETED|Overall Study||31
2228141|NCT02721147|5464866|P2|COMPLETED|Overall Study||18
2228142|NCT02721147|5464867|P1|COMPLETED|Overall Study||38
2228143|NCT02721147|5464865|P3|STARTED|Overall Study||31
2228144|NCT02721147|5464866|P2|STARTED|Overall Study||18
2228145|NCT02721147|5464867|P1|STARTED|Overall Study||40
2228146|NCT02720952|5464902|P1|NOT COMPLETED|Overall Study||0
2228147|NCT02720952|5464902|P1|COMPLETED|Overall Study||24
2228148|NCT02720952|5464902|P1|STARTED|Overall Study||24
2228149|NCT02720757|5464911|P1|NOT COMPLETED|Overall Study||18
2228150|NCT02720757|5464911|P1|COMPLETED|Overall Study||114
2228151|NCT02720757|5464911|P1|STARTED|Overall Study||132
2228152|NCT02720523|5464924|P7|NOT COMPLETED|Period 2: Long-term Extension Period||60
2228153|NCT02720523|5464925|P6|NOT COMPLETED|Period 2: Long-term Extension Period||62
2228154|NCT02720523|5464926|P5|NOT COMPLETED|Period 2: Long-term Extension Period||65
2228155|NCT02720523|5464927|P4|NOT COMPLETED|Period 2: Long-term Extension Period||0
2228156|NCT02720523|5464928|P3|NOT COMPLETED|Period 2: Long-term Extension Period||0
2228157|NCT02720523|5464929|P2|NOT COMPLETED|Period 2: Long-term Extension Period||0
2228158|NCT02720523|5464930|P1|NOT COMPLETED|Period 2: Long-term Extension Period||0
2228159|NCT02720523|5464924|P7|COMPLETED|Period 2: Long-term Extension Period||0
2228160|NCT02720523|5464925|P6|COMPLETED|Period 2: Long-term Extension Period||0
2228161|NCT02720523|5464926|P5|COMPLETED|Period 2: Long-term Extension Period||0
2228162|NCT02720523|5464927|P4|COMPLETED|Period 2: Long-term Extension Period||0
2228163|NCT02720523|5464928|P3|COMPLETED|Period 2: Long-term Extension Period||0
2228164|NCT02720523|5464929|P2|COMPLETED|Period 2: Long-term Extension Period||0
2228165|NCT02720523|5464930|P1|COMPLETED|Period 2: Long-term Extension Period||0
2228166|NCT02720523|5464924|P7|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 30 mg|60
2228167|NCT02720523|5464925|P6|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 15 mg|62
2228168|NCT02720523|5464926|P5|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 7.5 mg|65
2228169|NCT02720523|5464927|P4|STARTED|Period 2: Long-term Extension Period||0
2228170|NCT02720523|5464928|P3|STARTED|Period 2: Long-term Extension Period||0
2228171|NCT02720523|5464929|P2|STARTED|Period 2: Long-term Extension Period||0
2228172|NCT02720523|5464930|P1|STARTED|Period 2: Long-term Extension Period||0
2228173|NCT02720523|5464924|P7|NOT COMPLETED|Period 1: Placebo-controlled Period||0
2228174|NCT02720523|5464925|P6|NOT COMPLETED|Period 1: Placebo-controlled Period||0
2228175|NCT02720523|5464926|P5|NOT COMPLETED|Period 1: Placebo-controlled Period||0
2228176|NCT02720523|5464927|P4|NOT COMPLETED|Period 1: Placebo-controlled Period||6
2228177|NCT02720523|5464928|P3|NOT COMPLETED|Period 1: Placebo-controlled Period||2
2228178|NCT02720523|5464929|P2|NOT COMPLETED|Period 1: Placebo-controlled Period||0
2228179|NCT02720523|5464930|P1|NOT COMPLETED|Period 1: Placebo-controlled Period||2
2228180|NCT02720523|5464924|P7|COMPLETED|Period 1: Placebo-controlled Period||0
2228181|NCT02720523|5464925|P6|COMPLETED|Period 1: Placebo-controlled Period||0
2228182|NCT02720523|5464926|P5|COMPLETED|Period 1: Placebo-controlled Period||0
2228183|NCT02720523|5464927|P4|COMPLETED|Period 1: Placebo-controlled Period||44
2228184|NCT02720523|5464928|P3|COMPLETED|Period 1: Placebo-controlled Period||47
2228185|NCT02720523|5464929|P2|COMPLETED|Period 1: Placebo-controlled Period||49
2228186|NCT02720523|5464930|P1|COMPLETED|Period 1: Placebo-controlled Period||47
2228187|NCT02720523|5464924|P7|STARTED|Period 1: Placebo-controlled Period||0
2228188|NCT02720523|5464925|P6|STARTED|Period 1: Placebo-controlled Period||0
2228189|NCT02720523|5464926|P5|STARTED|Period 1: Placebo-controlled Period||0
2228190|NCT02720523|5464927|P4|STARTED|Period 1: Placebo-controlled Period||50
2228191|NCT02720523|5464928|P3|STARTED|Period 1: Placebo-controlled Period||49
2228192|NCT02720523|5464929|P2|STARTED|Period 1: Placebo-controlled Period||49
2228193|NCT02720523|5464930|P1|STARTED|Period 1: Placebo-controlled Period||49
2228194|NCT02720510|5464989|P2|NOT COMPLETED|Overall Study||3
2228195|NCT02720510|5464990|P1|NOT COMPLETED|Overall Study||3
2228196|NCT02720510|5464989|P2|COMPLETED|Overall Study||0
2228197|NCT02720510|5464990|P1|COMPLETED|Overall Study||0
2228198|NCT02720510|5464989|P2|STARTED|Overall Study||3
2228199|NCT02720510|5464990|P1|STARTED|Overall Study||3
2228200|NCT02720484|5465008|P1|NOT COMPLETED|Follow Up for 2 Years||6
2228201|NCT02720484|5465008|P1|COMPLETED|Follow Up for 2 Years||1
2228202|NCT02720484|5465008|P1|STARTED|Follow Up for 2 Years|All patients that receive at least one treatment on study go into follow up.|7
2228203|NCT02720484|5465008|P1|NOT COMPLETED|Treatment on Study||6
2228204|NCT02720484|5465008|P1|COMPLETED|Treatment on Study||4
2228205|NCT02720484|5465008|P1|Treated Cycle 3|Treatment on Study||4
2228206|NCT02720484|5465008|P1|Reached 1st Response/2 Cycles|Treatment on Study||7
2228207|NCT02720484|5465008|P1|STARTED|Treatment on Study||10
2228208|NCT02720224|5465016|P1|NOT COMPLETED|Overall Study||0
2228209|NCT02720224|5465016|P1|COMPLETED|Overall Study||6
2228210|NCT02720224|5465016|P1|STARTED|Overall Study||6
2228211|NCT02720198|5465040|P2|NOT COMPLETED|Overall Study||1
2228212|NCT02720198|5465041|P1|NOT COMPLETED|Overall Study||0
2228213|NCT02720198|5465040|P2|COMPLETED|Overall Study||30
2228214|NCT02720198|5465041|P1|COMPLETED|Overall Study||29
2228215|NCT02720198|5465040|P2|STARTED|Overall Study||31
2228216|NCT02720198|5465041|P1|STARTED|Overall Study||29
2228217|NCT02720107|5465067|P1|NOT COMPLETED|Overall Study||0
2228218|NCT02720107|5465067|P1|COMPLETED|Overall Study||130
2228219|NCT02720107|5465067|P1|STARTED|Overall Study||130
2228220|NCT02720081|5465076|P2|NOT COMPLETED|Overall Study||4
2228221|NCT02720081|5465077|P1|NOT COMPLETED|Overall Study||4
2228222|NCT02720081|5465076|P2|COMPLETED|Overall Study||66
2228223|NCT02720081|5465077|P1|COMPLETED|Overall Study||68
2228224|NCT02720081|5465076|P2|Treated|Overall Study||69
2228225|NCT02720081|5465077|P1|Treated|Overall Study||70
2228226|NCT02720081|5465076|P2|STARTED|Overall Study||70
2228227|NCT02720081|5465077|P1|STARTED|Overall Study||72
2228228|NCT02719938|5465135|P2|NOT COMPLETED|Overall Study||1
2228229|NCT02719938|5465136|P1|NOT COMPLETED|Overall Study||4
2228230|NCT02719938|5465135|P2|COMPLETED|Overall Study||31
2228231|NCT02719938|5465136|P1|COMPLETED|Overall Study||26
2228232|NCT02719938|5465135|P2|STARTED|Overall Study||32
2228233|NCT02719938|5465136|P1|STARTED|Overall Study||30
2228234|NCT02719743|5465159|P5|NOT COMPLETED|Overall Study||2
2228235|NCT02719743|5465160|P4|NOT COMPLETED|Overall Study||1
2228236|NCT02719743|5465161|P3|NOT COMPLETED|Overall Study||0
2228237|NCT02719743|5465162|P2|NOT COMPLETED|Overall Study||3
2228238|NCT02719743|5465163|P1|NOT COMPLETED|Overall Study||1
2228239|NCT02719743|5465159|P5|COMPLETED|Overall Study||33
2228240|NCT02719743|5465160|P4|COMPLETED|Overall Study||36
2228241|NCT02719743|5465161|P3|COMPLETED|Overall Study||38
2228242|NCT02719743|5465162|P2|COMPLETED|Overall Study||34
2228243|NCT02719743|5465163|P1|COMPLETED|Overall Study||37
2228244|NCT02719743|5465159|P5|STARTED|Overall Study||35
2228245|NCT02719743|5465160|P4|STARTED|Overall Study||37
2228246|NCT02719743|5465161|P3|STARTED|Overall Study||38
2228247|NCT02719743|5465162|P2|STARTED|Overall Study||37
2228248|NCT02719743|5465163|P1|STARTED|Overall Study||38
2228249|NCT02719639|5465290|P1|NOT COMPLETED|Overall Study||0
2228250|NCT02719639|5465290|P1|COMPLETED|Overall Study||7443
2228251|NCT02719639|5465290|P1|STARTED|Overall Study||7443
2228252|NCT02719171|5465304|P5|NOT COMPLETED|Overall Study||2
2228253|NCT02719171|5465305|P4|NOT COMPLETED|Overall Study||2
2228254|NCT02719171|5465306|P3|NOT COMPLETED|Overall Study||3
2228255|NCT02719171|5465307|P2|NOT COMPLETED|Overall Study||4
2228256|NCT02719171|5465308|P1|NOT COMPLETED|Overall Study||1
2228257|NCT02719171|5465304|P5|COMPLETED|Overall Study||18
2228258|NCT02719171|5465305|P4|COMPLETED|Overall Study||37
2228259|NCT02719171|5465306|P3|COMPLETED|Overall Study||39
2228260|NCT02719171|5465307|P2|COMPLETED|Overall Study||38
2228261|NCT02719171|5465308|P1|COMPLETED|Overall Study||41
2228262|NCT02719171|5465304|P5|STARTED|Overall Study||20
2228263|NCT02719171|5465305|P4|STARTED|Overall Study||39
2228264|NCT02719171|5465306|P3|STARTED|Overall Study||42
2228265|NCT02719171|5465307|P2|STARTED|Overall Study||42
2228266|NCT02719171|5465308|P1|STARTED|Overall Study||42
2228267|NCT02719028|5465403|P4|NOT COMPLETED|Overall Study||10
2228268|NCT02719028|5465404|P3|NOT COMPLETED|Overall Study||6
2228269|NCT02719028|5465405|P2|NOT COMPLETED|Overall Study||2
2228270|NCT02719028|5465406|P1|NOT COMPLETED|Overall Study||2
2228271|NCT02719028|5465403|P4|COMPLETED|Overall Study||20
2228272|NCT02719028|5465404|P3|COMPLETED|Overall Study||24
2228273|NCT02719028|5465405|P2|COMPLETED|Overall Study||28
2228274|NCT02719028|5465406|P1|COMPLETED|Overall Study||28
2228275|NCT02719028|5465403|P4|STARTED|Overall Study||30
2228276|NCT02719028|5465404|P3|STARTED|Overall Study||30
2228277|NCT02719028|5465405|P2|STARTED|Overall Study||30
2228278|NCT02719028|5465406|P1|STARTED|Overall Study||30
2228279|NCT02718898|5465430|P7|NOT COMPLETED|Post Treatment Follow-up Period||5
2228280|NCT02718898|5465431|P6|NOT COMPLETED|Post Treatment Follow-up Period||11
2228281|NCT02718898|5465432|P5|NOT COMPLETED|Post Treatment Follow-up Period||1
2228282|NCT02718898|5465433|P4|NOT COMPLETED|Post Treatment Follow-up Period||0
2228283|NCT02718898|5465434|P3|NOT COMPLETED|Post Treatment Follow-up Period||0
2228284|NCT02718898|5465435|P2|NOT COMPLETED|Post Treatment Follow-up Period||0
2228285|NCT02718898|5465436|P1|NOT COMPLETED|Post Treatment Follow-up Period||0
2228286|NCT02718898|5465430|P7|COMPLETED|Post Treatment Follow-up Period||44
2228287|NCT02718898|5465431|P6|COMPLETED|Post Treatment Follow-up Period||67
2228288|NCT02718898|5465432|P5|COMPLETED|Post Treatment Follow-up Period||0
2228289|NCT02718898|5465433|P4|COMPLETED|Post Treatment Follow-up Period||0
2228290|NCT02718898|5465434|P3|COMPLETED|Post Treatment Follow-up Period||0
2228291|NCT02718898|5465435|P2|COMPLETED|Post Treatment Follow-up Period||0
2228292|NCT02718898|5465436|P1|COMPLETED|Post Treatment Follow-up Period||0
2228293|NCT02718898|5465430|P7|STARTED|Post Treatment Follow-up Period||49
2228294|NCT02718898|5465431|P6|STARTED|Post Treatment Follow-up Period||78
2228295|NCT02718898|5465432|P5|STARTED|Post Treatment Follow-up Period|One participant who discontinued from placebo blinded treatment had entered post-treatment follow-up|1
2228296|NCT02718898|5465433|P4|STARTED|Post Treatment Follow-up Period||0
2228297|NCT02718898|5465434|P3|STARTED|Post Treatment Follow-up Period||0
2228298|NCT02718898|5465435|P2|STARTED|Post Treatment Follow-up Period||0
2228299|NCT02718898|5465436|P1|STARTED|Post Treatment Follow-up Period||0
2228300|NCT02718898|5465430|P7|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
2228301|NCT02718898|5465431|P6|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
2228302|NCT02718898|5465432|P5|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
2228303|NCT02718898|5465433|P4|NOT COMPLETED|Open Label Treatment Period (OLTP)||10
2228304|NCT02718898|5465434|P3|NOT COMPLETED|Open Label Treatment Period (OLTP)||3
2228305|NCT02718898|5465435|P2|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
2228306|NCT02718898|5465436|P1|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
2228307|NCT02718898|5465430|P7|COMPLETED|Open Label Treatment Period (OLTP)||0
2228308|NCT02718898|5465431|P6|COMPLETED|Open Label Treatment Period (OLTP)||0
2228309|NCT02718898|5465432|P5|COMPLETED|Open Label Treatment Period (OLTP)||0
2228310|NCT02718898|5465433|P4|COMPLETED|Open Label Treatment Period (OLTP)||64
2228311|NCT02718898|5465434|P3|COMPLETED|Open Label Treatment Period (OLTP)||62
2228312|NCT02718898|5465435|P2|COMPLETED|Open Label Treatment Period (OLTP)||0
2228313|NCT02718898|5465436|P1|COMPLETED|Open Label Treatment Period (OLTP)||0
2228314|NCT02718898|5465430|P7|STARTED|Open Label Treatment Period (OLTP)||0
2228315|NCT02718898|5465431|P6|STARTED|Open Label Treatment Period (OLTP)||0
2228316|NCT02718898|5465432|P5|STARTED|Open Label Treatment Period (OLTP)||0
2228317|NCT02718898|5465433|P4|STARTED|Open Label Treatment Period (OLTP)||74
2228318|NCT02718898|5465434|P3|STARTED|Open Label Treatment Period (OLTP)||65
2228319|NCT02718898|5465435|P2|STARTED|Open Label Treatment Period (OLTP)||0
2228320|NCT02718898|5465436|P1|STARTED|Open Label Treatment Period (OLTP)||0
2228321|NCT02718898|5465430|P7|NOT COMPLETED|Blinded Treatment Period||0
2228322|NCT02718898|5465431|P6|NOT COMPLETED|Blinded Treatment Period||0
2228323|NCT02718898|5465432|P5|NOT COMPLETED|Blinded Treatment Period||0
2228324|NCT02718898|5465433|P4|NOT COMPLETED|Blinded Treatment Period||0
2228325|NCT02718898|5465434|P3|NOT COMPLETED|Blinded Treatment Period||0
2228326|NCT02718898|5465435|P2|NOT COMPLETED|Blinded Treatment Period||1
2228327|NCT02718898|5465436|P1|NOT COMPLETED|Blinded Treatment Period||9
2228328|NCT02718898|5465430|P7|COMPLETED|Blinded Treatment Period||0
2228329|NCT02718898|5465431|P6|COMPLETED|Blinded Treatment Period||0
2228330|NCT02718898|5465432|P5|COMPLETED|Blinded Treatment Period||0
2228331|NCT02718898|5465433|P4|COMPLETED|Blinded Treatment Period||0
2228332|NCT02718898|5465434|P3|COMPLETED|Blinded Treatment Period||0
2228333|NCT02718898|5465435|P2|COMPLETED|Blinded Treatment Period||74
2228334|NCT02718898|5465436|P1|COMPLETED|Blinded Treatment Period||65
2228335|NCT02718898|5465430|P7|STARTED|Blinded Treatment Period||0
2228336|NCT02718898|5465431|P6|STARTED|Blinded Treatment Period||0
2228337|NCT02718898|5465432|P5|STARTED|Blinded Treatment Period||0
2228338|NCT02718898|5465433|P4|STARTED|Blinded Treatment Period||0
2228339|NCT02718898|5465434|P3|STARTED|Blinded Treatment Period||0
2228340|NCT02718898|5465435|P2|STARTED|Blinded Treatment Period||75
2228341|NCT02718898|5465436|P1|STARTED|Blinded Treatment Period||74
2228342|NCT02718417|5465472|P3|NOT COMPLETED|Maintenance Phase||286
2228343|NCT02718417|5465473|P2|NOT COMPLETED|Maintenance Phase||287
2228344|NCT02718417|5465474|P1|NOT COMPLETED|Maintenance Phase||267
2228345|NCT02718417|5465472|P3|COMPLETED|Maintenance Phase||1
2228346|NCT02718417|5465473|P2|COMPLETED|Maintenance Phase||0
2228347|NCT02718417|5465474|P1|COMPLETED|Maintenance Phase||0
2228348|NCT02718417|5465472|P3|STARTED|Maintenance Phase|Included participants without evidence of disease progression at the end of Chemotherapy phase.|287
2228349|NCT02718417|5465473|P2|STARTED|Maintenance Phase|Included participants without evidence of disease progression at the end of Chemotherapy phase.|287
2228350|NCT02718417|5465474|P1|STARTED|Maintenance Phase|Included participants without evidence of disease progression at the end of Chemotherapy phase.|267
2228351|NCT02718417|5465472|P3|NOT COMPLETED|Chemotherapy Phase||45
2228352|NCT02718417|5465473|P2|NOT COMPLETED|Chemotherapy Phase||37
2228353|NCT02718417|5465474|P1|NOT COMPLETED|Chemotherapy Phase||52
2228354|NCT02718417|5465472|P3|COMPLETED|Chemotherapy Phase||290
2228355|NCT02718417|5465473|P2|COMPLETED|Chemotherapy Phase||294
2228356|NCT02718417|5465474|P1|COMPLETED|Chemotherapy Phase||280
2228357|NCT02718417|5465472|P3|Safety Population|Chemotherapy Phase||334
2228358|NCT02718417|5465473|P2|Safety Population|Chemotherapy Phase||329
2228359|NCT02718417|5465474|P1|Safety Population|Chemotherapy Phase||328
2228360|NCT02718417|5465472|P3|STARTED|Chemotherapy Phase||335
2228361|NCT02718417|5465473|P2|STARTED|Chemotherapy Phase||331
2228362|NCT02718417|5465474|P1|STARTED|Chemotherapy Phase||332
2228363|NCT02718326|5465536|P3|NOT COMPLETED|Overall Study||10
2228364|NCT02718326|5465537|P2|NOT COMPLETED|Overall Study||13
2228365|NCT02718326|5465538|P1|NOT COMPLETED|Overall Study||24
2228366|NCT02718326|5465536|P3|COMPLETED|Overall Study||124
2228367|NCT02718326|5465537|P2|COMPLETED|Overall Study||122
2228368|NCT02718326|5465538|P1|COMPLETED|Overall Study||109
2228369|NCT02718326|5465536|P3|STARTED|Overall Study||134
2228370|NCT02718326|5465537|P2|STARTED|Overall Study||135
2228371|NCT02718326|5465538|P1|STARTED|Overall Study||133
2228372|NCT02718248|5465569|P1|NOT COMPLETED|Overall Study||0
2228373|NCT02718248|5465569|P1|COMPLETED|Overall Study||7
2228374|NCT02718248|5465569|P1|STARTED|Overall Study||7
2228375|NCT02718157|5465585|P1|NOT COMPLETED|Overall Study||162
2228376|NCT02718157|5465585|P1|COMPLETED|Overall Study||609
2228377|NCT02718157|5465585|P1|STARTED|Overall Study||771
2228378|NCT02718118|5465594|P2|NOT COMPLETED|Overall Study||1
2228379|NCT02718118|5465595|P1|NOT COMPLETED|Overall Study||2
2228380|NCT02718118|5465594|P2|COMPLETED|Overall Study||29
2228381|NCT02718118|5465595|P1|COMPLETED|Overall Study||28
2228382|NCT02718118|5465594|P2|STARTED|Overall Study||30
2228383|NCT02718118|5465595|P1|STARTED|Overall Study||30
2228384|NCT02718040|5465629|P1|NOT COMPLETED|Overall Study||0
2228385|NCT02718040|5465629|P1|COMPLETED|Overall Study||30
2228386|NCT02718040|5465629|P1|STARTED|Overall Study||30
2228387|NCT02717949|5465644|P2|NOT COMPLETED|Overall Study||0
2228388|NCT02717949|5465645|P1|NOT COMPLETED|Overall Study||0
2228389|NCT02717949|5465644|P2|COMPLETED|Overall Study||0
2228390|NCT02717949|5465645|P1|COMPLETED|Overall Study||0
2228391|NCT02717949|5465644|P2|STARTED|Overall Study||0
2228392|NCT02717949|5465645|P1|STARTED|Overall Study||0
2228393|NCT02717754|5465659|P6|NOT COMPLETED|Overall Study||20
2228394|NCT02717754|5465660|P5|NOT COMPLETED|Overall Study||20
2228395|NCT02717754|5465661|P4|NOT COMPLETED|Overall Study||10
2228396|NCT02717754|5465662|P3|NOT COMPLETED|Overall Study||0
2228397|NCT02717754|5465663|P2|NOT COMPLETED|Overall Study||0
2228398|NCT02717754|5465664|P1|NOT COMPLETED|Overall Study||0
2228399|NCT02717754|5465659|P6|COMPLETED|Overall Study||0
2228400|NCT02717754|5465660|P5|COMPLETED|Overall Study||0
2228401|NCT02717754|5465661|P4|COMPLETED|Overall Study||0
2228402|NCT02717754|5465662|P3|COMPLETED|Overall Study||20
2228403|NCT02717754|5465663|P2|COMPLETED|Overall Study||19
2228404|NCT02717754|5465664|P1|COMPLETED|Overall Study||10
2228405|NCT02717754|5465659|P6|STARTED|Overall Study||20
2228406|NCT02717754|5465660|P5|STARTED|Overall Study||20
2228407|NCT02717754|5465661|P4|STARTED|Overall Study||10
2228408|NCT02717754|5465662|P3|STARTED|Overall Study||20
2228409|NCT02717754|5465663|P2|STARTED|Overall Study||19
2228410|NCT02717754|5465664|P1|STARTED|Overall Study||10
2228411|NCT02717494|5465695|P3|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||4
2228412|NCT02717494|5465696|P2|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||0
2228413|NCT02717494|5465697|P1|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||0
2228414|NCT02717494|5465695|P3|COMPLETED|Second Intervention (Step 2 or Step 3)||106
2228415|NCT02717494|5465696|P2|COMPLETED|Second Intervention (Step 2 or Step 3)||0
2228416|NCT02717494|5465697|P1|COMPLETED|Second Intervention (Step 2 or Step 3)||0
2228417|NCT02717494|5465695|P3|Completed Step 3|Second Intervention (Step 2 or Step 3)||4
2228418|NCT02717494|5465696|P2|Completed Step 3|Second Intervention (Step 2 or Step 3)||0
2228419|NCT02717494|5465697|P1|Completed Step 3|Second Intervention (Step 2 or Step 3)||0
2228420|NCT02717494|5465695|P3|Completed Step 2B|Second Intervention (Step 2 or Step 3)||50
2228421|NCT02717494|5465696|P2|Completed Step 2B|Second Intervention (Step 2 or Step 3)||0
2228422|NCT02717494|5465697|P1|Completed Step 2B|Second Intervention (Step 2 or Step 3)||0
2228423|NCT02717494|5465695|P3|Completed Step 2A|Second Intervention (Step 2 or Step 3)||52
2228424|NCT02717494|5465696|P2|Completed Step 2A|Second Intervention (Step 2 or Step 3)||0
2228425|NCT02717494|5465697|P1|Completed Step 2A|Second Intervention (Step 2 or Step 3)||0
2228426|NCT02717494|5465695|P3|STARTED|Second Intervention (Step 2 or Step 3)|One participant who completed Step 1 did not enroll in Step 2.|110
2228427|NCT02717494|5465696|P2|STARTED|Second Intervention (Step 2 or Step 3)|Only Step 1 placebo recipients were enrolled in Step 2.|0
2228428|NCT02717494|5465697|P1|STARTED|Second Intervention (Step 2 or Step 3)|Only Step 1 placebo recipients were enrolled in Step 2.|0
2228429|NCT02717494|5465695|P3|NOT COMPLETED|First Intervention (Step 1)||5
2228430|NCT02717494|5465696|P2|NOT COMPLETED|First Intervention (Step 1)||7
2228431|NCT02717494|5465697|P1|NOT COMPLETED|First Intervention (Step 1)||6
2228432|NCT02717494|5465695|P3|COMPLETED|First Intervention (Step 1)||111
2228433|NCT02717494|5465696|P2|COMPLETED|First Intervention (Step 1)||108
2228434|NCT02717494|5465697|P1|COMPLETED|First Intervention (Step 1)||109
2228435|NCT02717494|5465695|P3|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||4
2228436|NCT02717494|5465696|P2|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||0
2228437|NCT02717494|5465697|P1|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||0
2228438|NCT02717494|5465695|P3|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||53
2228439|NCT02717494|5465696|P2|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||0
2228440|NCT02717494|5465697|P1|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||0
2228441|NCT02717494|5465695|P3|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||53
2228442|NCT02717494|5465696|P2|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||0
2228443|NCT02717494|5465697|P1|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||0
2228444|NCT02717494|5465695|P3|STARTED|First Intervention (Step 1)||116
2228445|NCT02717494|5465696|P2|STARTED|First Intervention (Step 1)||115
2228446|NCT02717494|5465697|P1|STARTED|First Intervention (Step 1)||115
2228447|NCT02717273|5465736|P2|NOT COMPLETED|Overall Study||2
2228448|NCT02717273|5465737|P1|NOT COMPLETED|Overall Study||3
2228449|NCT02717273|5465736|P2|COMPLETED|Overall Study||48
2228450|NCT02717273|5465737|P1|COMPLETED|Overall Study||49
2228451|NCT02717273|5465736|P2|STARTED|Overall Study||50
2228452|NCT02717273|5465737|P1|STARTED|Overall Study||52
2228453|NCT02717195|5465759|P5|NOT COMPLETED|Double-blind Treatment (DBT) Period||30
2228454|NCT02717195|5465760|P4|NOT COMPLETED|Double-blind Treatment (DBT) Period||44
2228455|NCT02717195|5465761|P3|NOT COMPLETED|Double-blind Treatment (DBT) Period||37
2228456|NCT02717195|5465762|P2|NOT COMPLETED|Double-blind Treatment (DBT) Period||0
2228457|NCT02717195|5465763|P1|NOT COMPLETED|Double-blind Treatment (DBT) Period||0
2228458|NCT02717195|5465759|P5|COMPLETED|Double-blind Treatment (DBT) Period||200
2228459|NCT02717195|5465760|P4|COMPLETED|Double-blind Treatment (DBT) Period||188
2228460|NCT02717195|5465761|P3|COMPLETED|Double-blind Treatment (DBT) Period||198
2228461|NCT02717195|5465762|P2|COMPLETED|Double-blind Treatment (DBT) Period||0
2228462|NCT02717195|5465763|P1|COMPLETED|Double-blind Treatment (DBT) Period||0
2228463|NCT02717195|5465759|P5|STARTED|Double-blind Treatment (DBT) Period||230
2228464|NCT02717195|5465760|P4|STARTED|Double-blind Treatment (DBT) Period||232
2228465|NCT02717195|5465761|P3|STARTED|Double-blind Treatment (DBT) Period||235
2228466|NCT02717195|5465762|P2|STARTED|Double-blind Treatment (DBT) Period||0
2228467|NCT02717195|5465763|P1|STARTED|Double-blind Treatment (DBT) Period||0
2228468|NCT02717195|5465759|P5|NOT COMPLETED|Prospective Confirmation (PC) Period||0
2228469|NCT02717195|5465760|P4|NOT COMPLETED|Prospective Confirmation (PC) Period||0
2228470|NCT02717195|5465761|P3|NOT COMPLETED|Prospective Confirmation (PC) Period||0
2228471|NCT02717195|5465762|P2|NOT COMPLETED|Prospective Confirmation (PC) Period||111
2228472|NCT02717195|5465763|P1|NOT COMPLETED|Prospective Confirmation (PC) Period||290
2228473|NCT02717195|5465759|P5|COMPLETED|Prospective Confirmation (PC) Period||0
2228474|NCT02717195|5465760|P4|COMPLETED|Prospective Confirmation (PC) Period||0
2228475|NCT02717195|5465761|P3|COMPLETED|Prospective Confirmation (PC) Period||0
2228476|NCT02717195|5465762|P2|COMPLETED|Prospective Confirmation (PC) Period||276
2228477|NCT02717195|5465763|P1|COMPLETED|Prospective Confirmation (PC) Period||421
2228478|NCT02717195|5465759|P5|STARTED|Prospective Confirmation (PC) Period||0
2228479|NCT02717195|5465760|P4|STARTED|Prospective Confirmation (PC) Period||0
2228480|NCT02717195|5465761|P3|STARTED|Prospective Confirmation (PC) Period||0
2228481|NCT02717195|5465762|P2|STARTED|Prospective Confirmation (PC) Period||387
2228482|NCT02717195|5465763|P1|STARTED|Prospective Confirmation (PC) Period||711
2228483|NCT02716896|5465796|P2|NOT COMPLETED|Overall Study||1
2228484|NCT02716896|5465797|P1|NOT COMPLETED|Overall Study||0
2228485|NCT02716896|5465796|P2|COMPLETED|Overall Study||0
2228486|NCT02716896|5465797|P1|COMPLETED|Overall Study||1
2228487|NCT02716896|5465796|P2|STARTED|Overall Study||1
2228488|NCT02716896|5465797|P1|STARTED|Overall Study||1
2228489|NCT02716818|5465817|P2|NOT COMPLETED|Overall Study||2
2228490|NCT02716818|5465818|P1|NOT COMPLETED|Overall Study||3
2228491|NCT02716818|5465817|P2|COMPLETED|Overall Study||59
2228492|NCT02716818|5465818|P1|COMPLETED|Overall Study||58
2228493|NCT02716818|5465817|P2|STARTED|Overall Study||61
2228494|NCT02716818|5465818|P1|STARTED|Overall Study||61
2228495|NCT02716805|5465848|P4|NOT COMPLETED|Overall Study||0
2228496|NCT02716805|5465849|P3|NOT COMPLETED|Overall Study||0
2228497|NCT02716805|5465850|P2|NOT COMPLETED|Overall Study||0
2228498|NCT02716805|5465851|P1|NOT COMPLETED|Overall Study||2
2228499|NCT02716805|5465848|P4|COMPLETED|Overall Study||0
2228500|NCT02716805|5465849|P3|COMPLETED|Overall Study||0
2228501|NCT02716805|5465850|P2|COMPLETED|Overall Study||0
2228502|NCT02716805|5465851|P1|COMPLETED|Overall Study||4
2228503|NCT02716805|5465848|P4|STARTED|Overall Study||0
2228504|NCT02716805|5465849|P3|STARTED|Overall Study||0
2228505|NCT02716805|5465850|P2|STARTED|Overall Study||0
2228506|NCT02716805|5465851|P1|STARTED|Overall Study||6
2228507|NCT02716779|5465859|P3|NOT COMPLETED|Combination Therapy||1
2228508|NCT02716779|5465860|P2|NOT COMPLETED|Combination Therapy||2
2228509|NCT02716779|5465861|P1|NOT COMPLETED|Combination Therapy||0
2228510|NCT02716779|5465859|P3|COMPLETED|Combination Therapy||25
2228511|NCT02716779|5465860|P2|COMPLETED|Combination Therapy||23
2228512|NCT02716779|5465861|P1|COMPLETED|Combination Therapy||14
2228513|NCT02716779|5465859|P3|STARTED|Combination Therapy||26
2228514|NCT02716779|5465860|P2|STARTED|Combination Therapy||25
2228515|NCT02716779|5465861|P1|STARTED|Combination Therapy||14
2228516|NCT02716779|5465859|P3|NOT COMPLETED|Monotherapy||1
2228517|NCT02716779|5465860|P2|NOT COMPLETED|Monotherapy||1
2228518|NCT02716779|5465861|P1|NOT COMPLETED|Monotherapy||0
2228519|NCT02716779|5465859|P3|COMPLETED|Monotherapy||26
2228520|NCT02716779|5465860|P2|COMPLETED|Monotherapy||25
2228521|NCT02716779|5465861|P1|COMPLETED|Monotherapy||14
2228522|NCT02716779|5465859|P3|STARTED|Monotherapy||27
2228523|NCT02716779|5465860|P2|STARTED|Monotherapy||26
2228524|NCT02716779|5465861|P1|STARTED|Monotherapy||14
2228525|NCT02716714|5465907|P2|NOT COMPLETED|Overall Study||2
2228526|NCT02716714|5465908|P1|NOT COMPLETED|Overall Study||12
2228527|NCT02716714|5465907|P2|COMPLETED|Overall Study||8
2228528|NCT02716714|5465908|P1|COMPLETED|Overall Study||55
2228529|NCT02716714|5465907|P2|STARTED|Overall Study||10
2228530|NCT02716714|5465908|P1|STARTED|Overall Study||67
2228531|NCT02716584|5465936|P2|NOT COMPLETED|Overall Study||5
2228532|NCT02716584|5465937|P1|NOT COMPLETED|Overall Study||8
2228533|NCT02716584|5465936|P2|COMPLETED|Overall Study||13
2228534|NCT02716584|5465937|P1|COMPLETED|Overall Study||27
2228535|NCT02716584|5465936|P2|STARTED|Overall Study||18
2228536|NCT02716584|5465937|P1|STARTED|Overall Study||35
2228537|NCT02716506|5465961|P1|NOT COMPLETED|Overall Study||1164
2228538|NCT02716506|5465961|P1|COMPLETED|Overall Study||2351
2228539|NCT02716506|5465961|P1|2 Years|Overall Study|Patients that completed the questionnaires two years after the operation.|2351
2228540|NCT02716506|5465961|P1|6 Months|Overall Study|Patients that completed the questionnaires six months after the operation.|2528
2228541|NCT02716506|5465961|P1|STARTED|Overall Study||3515
2228542|NCT02716324|5465968|P2|NOT COMPLETED|Overall Study||11
2228543|NCT02716324|5465969|P1|NOT COMPLETED|Overall Study||19
2228544|NCT02716324|5465968|P2|COMPLETED|Overall Study||143
2228545|NCT02716324|5465969|P1|COMPLETED|Overall Study||130
2228546|NCT02716324|5465968|P2|STARTED|Overall Study||154
2228547|NCT02716324|5465969|P1|STARTED|Overall Study||149
2228548|NCT02716298|5465993|P2|NOT COMPLETED|Second Intervention (1 Month)||0
2228549|NCT02716298|5465994|P1|NOT COMPLETED|Second Intervention (1 Month)||0
2228550|NCT02716298|5465993|P2|COMPLETED|Second Intervention (1 Month)||23
2228551|NCT02716298|5465994|P1|COMPLETED|Second Intervention (1 Month)||24
2228552|NCT02716298|5465993|P2|STARTED|Second Intervention (1 Month)||23
2228553|NCT02716298|5465994|P1|STARTED|Second Intervention (1 Month)||24
2228554|NCT02716298|5465993|P2|NOT COMPLETED|First Intervention (1 Month)||1
2228555|NCT02716298|5465994|P1|NOT COMPLETED|First Intervention (1 Month)||1
2228556|NCT02716298|5465993|P2|COMPLETED|First Intervention (1 Month)||23
2228557|NCT02716298|5465994|P1|COMPLETED|First Intervention (1 Month)||24
2228558|NCT02716298|5465993|P2|STARTED|First Intervention (1 Month)||24
2228559|NCT02716298|5465994|P1|STARTED|First Intervention (1 Month)||25
2228560|NCT02716194|5466012|P3|NOT COMPLETED|Period 2 - BAX 826||0
2228561|NCT02716194|5466013|P2|NOT COMPLETED|Period 2 - BAX 826||0
2228562|NCT02716194|5466014|P1|NOT COMPLETED|Period 2 - BAX 826||0
2228563|NCT02716194|5466012|P3|COMPLETED|Period 2 - BAX 826||13
2228564|NCT02716194|5466013|P2|COMPLETED|Period 2 - BAX 826||15
2228565|NCT02716194|5466014|P1|COMPLETED|Period 2 - BAX 826||10
2228566|NCT02716194|5466012|P3|STARTED|Period 2 - BAX 826||13
2228567|NCT02716194|5466013|P2|STARTED|Period 2 - BAX 826||15
2228568|NCT02716194|5466014|P1|STARTED|Period 2 - BAX 826||10
2228569|NCT02716194|5466012|P3|NOT COMPLETED|Period 1 - ADVATE||0
2228570|NCT02716194|5466013|P2|NOT COMPLETED|Period 1 - ADVATE||1
2228571|NCT02716194|5466014|P1|NOT COMPLETED|Period 1 - ADVATE||1
2228572|NCT02716194|5466012|P3|COMPLETED|Period 1 - ADVATE||13
2228573|NCT02716194|5466013|P2|COMPLETED|Period 1 - ADVATE||15
2228574|NCT02716194|5466014|P1|COMPLETED|Period 1 - ADVATE||10
2228575|NCT02716194|5466012|P3|STARTED|Period 1 - ADVATE||13
2228576|NCT02716194|5466013|P2|STARTED|Period 1 - ADVATE||16
2228577|NCT02716194|5466014|P1|STARTED|Period 1 - ADVATE||11
2228578|NCT02715726|5466094|P2|NOT COMPLETED|Overall Study||27
2228579|NCT02715726|5466095|P1|NOT COMPLETED|Overall Study||18
2228580|NCT02715726|5466094|P2|COMPLETED|Overall Study||380
2228581|NCT02715726|5466095|P1|COMPLETED|Overall Study||190
2228582|NCT02715726|5466094|P2|Safety Population|Overall Study||406
2228583|NCT02715726|5466095|P1|Safety Population|Overall Study||206
2228584|NCT02715726|5466094|P2|Treated|Overall Study||405
2228585|NCT02715726|5466095|P1|Treated|Overall Study||207
2228586|NCT02715726|5466094|P2|STARTED|Overall Study|Randomized|407
2228587|NCT02715726|5466095|P1|STARTED|Overall Study|Randomized|208
2228588|NCT02715700|5466143|P1|NOT COMPLETED|Overall Study||0
2228589|NCT02715700|5466143|P1|COMPLETED|Overall Study||14
2228590|NCT02715700|5466143|P1|STARTED|Overall Study||14
2228591|NCT02714868|5466175|P2|NOT COMPLETED|Overall Study||0
2228592|NCT02714868|5466176|P1|NOT COMPLETED|Overall Study||5
2228593|NCT02714868|5466175|P2|COMPLETED|Overall Study||35
2228594|NCT02714868|5466176|P1|COMPLETED|Overall Study||42
2228595|NCT02714868|5466175|P2|STARTED|Overall Study||35
2228596|NCT02714868|5466176|P1|STARTED|Overall Study||47
2228597|NCT02714504|5466194|P2|NOT COMPLETED|Overall Study||0
2228598|NCT02714504|5466195|P1|NOT COMPLETED|Overall Study||0
2228599|NCT02714504|5466194|P2|COMPLETED|Overall Study||178
2228600|NCT02714504|5466195|P1|COMPLETED|Overall Study||61
2228601|NCT02714504|5466194|P2|STARTED|Overall Study||178
2228602|NCT02714504|5466195|P1|STARTED|Overall Study||61
2228603|NCT02714426|5466203|P2|NOT COMPLETED|Overall Study||2
2228604|NCT02714426|5466204|P1|NOT COMPLETED|Overall Study||2
2228605|NCT02714426|5466203|P2|COMPLETED|Overall Study||19
2228606|NCT02714426|5466204|P1|COMPLETED|Overall Study||19
2228607|NCT02714426|5466203|P2|STARTED|Overall Study||21
2228608|NCT02714426|5466204|P1|STARTED|Overall Study||21
2228609|NCT02714283|5466222|P2|NOT COMPLETED|Overall Study||0
2228610|NCT02714283|5466223|P1|NOT COMPLETED|Overall Study||0
2228611|NCT02714283|5466222|P2|COMPLETED|Overall Study||6500
2228612|NCT02714283|5466223|P1|COMPLETED|Overall Study||83589
2228613|NCT02714283|5466222|P2|STARTED|Overall Study||6500
2228614|NCT02714283|5466223|P1|STARTED|Overall Study||83589
2228615|NCT02714218|5466250|P3|NOT COMPLETED|Overall Study||19
2228616|NCT02714218|5466251|P2|NOT COMPLETED|Overall Study||143
2228617|NCT02714218|5466252|P1|NOT COMPLETED|Overall Study||130
2228618|NCT02714218|5466250|P3|COMPLETED|Overall Study||8
2228619|NCT02714218|5466251|P2|COMPLETED|Overall Study||35
2228620|NCT02714218|5466252|P1|COMPLETED|Overall Study||50
2228621|NCT02714218|5466250|P3|STARTED|Overall Study||27
2228622|NCT02714218|5466251|P2|STARTED|Overall Study||178
2228623|NCT02714218|5466252|P1|STARTED|Overall Study||180
2228624|NCT02714062|5466302|P3|NOT COMPLETED|Overall Study||3
2228625|NCT02714062|5466303|P2|NOT COMPLETED|Overall Study||1
2228626|NCT02714062|5466304|P1|NOT COMPLETED|Overall Study||1
2228627|NCT02714062|5466302|P3|COMPLETED|Overall Study||10
2228628|NCT02714062|5466303|P2|COMPLETED|Overall Study||14
2228629|NCT02714062|5466304|P1|COMPLETED|Overall Study||13
2228630|NCT02714062|5466302|P3|STARTED|Overall Study||13
2228631|NCT02714062|5466303|P2|STARTED|Overall Study||15
2228632|NCT02714062|5466304|P1|STARTED|Overall Study||14
2228633|NCT02713828|5466350|P2|NOT COMPLETED|Overall Study||0
2228634|NCT02713828|5466351|P1|NOT COMPLETED|Overall Study||5
2228635|NCT02713828|5466350|P2|COMPLETED|Overall Study||0
2228636|NCT02713828|5466351|P1|COMPLETED|Overall Study||8
2228637|NCT02713828|5466350|P2|STARTED|Overall Study||0
2228638|NCT02713828|5466351|P1|STARTED|Overall Study||13
2228639|NCT02713789|5466363|P3|NOT COMPLETED|Overall Study||1
2228640|NCT02713789|5466364|P2|NOT COMPLETED|Overall Study||1
2228641|NCT02713789|5466365|P1|NOT COMPLETED|Overall Study||0
2228642|NCT02713789|5466363|P3|COMPLETED|Overall Study||7
2228643|NCT02713789|5466364|P2|COMPLETED|Overall Study||9
2228644|NCT02713789|5466365|P1|COMPLETED|Overall Study||8
2228645|NCT02713789|5466363|P3|STARTED|Overall Study||8
2228646|NCT02713789|5466364|P2|STARTED|Overall Study||10
2228647|NCT02713789|5466365|P1|STARTED|Overall Study||8
2228648|NCT02713698|5466403|P3|NOT COMPLETED|Overall Study||0
2228649|NCT02713698|5466404|P2|NOT COMPLETED|Overall Study||0
2228650|NCT02713698|5466405|P1|NOT COMPLETED|Overall Study||0
2228651|NCT02713698|5466403|P3|COMPLETED|Overall Study||20
2228652|NCT02713698|5466404|P2|COMPLETED|Overall Study||20
2228653|NCT02713698|5466405|P1|COMPLETED|Overall Study||20
2228654|NCT02713698|5466403|P3|STARTED|Overall Study||20
2228655|NCT02713698|5466404|P2|STARTED|Overall Study||20
2228656|NCT02713698|5466405|P1|STARTED|Overall Study||20
2228657|NCT02713659|5466415|P2|NOT COMPLETED|24 Month Study Visit||8
2228658|NCT02713659|5466416|P1|NOT COMPLETED|24 Month Study Visit||8
2228659|NCT02713659|5466415|P2|COMPLETED|24 Month Study Visit||44
2228660|NCT02713659|5466416|P1|COMPLETED|24 Month Study Visit||49
2228661|NCT02713659|5466415|P2|STARTED|24 Month Study Visit||52
2228662|NCT02713659|5466416|P1|STARTED|24 Month Study Visit||57
2228663|NCT02713659|5466415|P2|NOT COMPLETED|18 Month Study Visit||3
2228664|NCT02713659|5466416|P1|NOT COMPLETED|18 Month Study Visit||8
2228665|NCT02713659|5466415|P2|COMPLETED|18 Month Study Visit||50
2228666|NCT02713659|5466416|P1|COMPLETED|18 Month Study Visit||50
2228667|NCT02713659|5466415|P2|STARTED|18 Month Study Visit||53
2228668|NCT02713659|5466416|P1|STARTED|18 Month Study Visit||58
2228669|NCT02713659|5466415|P2|NOT COMPLETED|12 Month Study Visit||3
2228670|NCT02713659|5466416|P1|NOT COMPLETED|12 Month Study Visit||3
2228671|NCT02713659|5466415|P2|COMPLETED|12 Month Study Visit||52
2228672|NCT02713659|5466416|P1|COMPLETED|12 Month Study Visit||54
2228673|NCT02713659|5466415|P2|STARTED|12 Month Study Visit||55
2228674|NCT02713659|5466416|P1|STARTED|12 Month Study Visit||57
2228675|NCT02713659|5466415|P2|NOT COMPLETED|6 Month Study Visit||13
2228676|NCT02713659|5466416|P1|NOT COMPLETED|6 Month Study Visit||7
2228677|NCT02713659|5466415|P2|COMPLETED|6 Month Study Visit||47
2228678|NCT02713659|5466416|P1|COMPLETED|6 Month Study Visit||53
2228679|NCT02713659|5466415|P2|STARTED|6 Month Study Visit||60
2228680|NCT02713659|5466416|P1|STARTED|6 Month Study Visit||60
2228681|NCT02713659|5466415|P2|NOT COMPLETED|Baseline||0
2228682|NCT02713659|5466416|P1|NOT COMPLETED|Baseline||0
2228683|NCT02713659|5466415|P2|COMPLETED|Baseline||60
2228684|NCT02713659|5466416|P1|COMPLETED|Baseline||60
2228685|NCT02713659|5466415|P2|STARTED|Baseline||60
2228686|NCT02713659|5466416|P1|STARTED|Baseline||60
2228687|NCT02713594|5466428|P2|NOT COMPLETED|Overall Study||396
2228688|NCT02713594|5466429|P1|NOT COMPLETED|Overall Study||390
2228689|NCT02713594|5466428|P2|COMPLETED|Overall Study||552
2228690|NCT02713594|5466429|P1|COMPLETED|Overall Study||562
2228691|NCT02713594|5466428|P2|STARTED|Overall Study||948
2228692|NCT02713594|5466429|P1|STARTED|Overall Study||952
2228693|NCT02713542|5466441|P2|NOT COMPLETED|Overall Study||6
2228694|NCT02713542|5466442|P1|NOT COMPLETED|Overall Study||18
2228695|NCT02713542|5466441|P2|COMPLETED|Overall Study||24
2228696|NCT02713542|5466442|P1|COMPLETED|Overall Study||42
2228697|NCT02713542|5466441|P2|STARTED|Overall Study||30
2228698|NCT02713542|5466442|P1|STARTED|Overall Study||60
2228699|NCT02713425|5466448|P1|NOT COMPLETED|Overall Study||0
2228700|NCT02713425|5466448|P1|COMPLETED|Overall Study||20
2228701|NCT02713425|5466448|P1|STARTED|Overall Study||20
2228702|NCT02713256|5466453|P1|NOT COMPLETED|Overall Study||0
2228703|NCT02713256|5466453|P1|COMPLETED|Overall Study||15
2228704|NCT02713256|5466453|P1|STARTED|Overall Study||15
2228705|NCT02713243|5466461|P2|NOT COMPLETED|Overall Study||2
2228706|NCT02713243|5466462|P1|NOT COMPLETED|Overall Study||1
2228707|NCT02713243|5466461|P2|COMPLETED|Overall Study||8
2228708|NCT02713243|5466462|P1|COMPLETED|Overall Study||9
2228709|NCT02713243|5466461|P2|PK Analysis Set|Overall Study||9
2228710|NCT02713243|5466462|P1|PK Analysis Set|Overall Study||8
2228711|NCT02713243|5466461|P2|PD Analysis Set|Overall Study||10
2228712|NCT02713243|5466462|P1|PD Analysis Set|Overall Study||9
2228713|NCT02713243|5466461|P2|STARTED|Overall Study||10
2228714|NCT02713243|5466462|P1|STARTED|Overall Study||10
2228715|NCT02713204|5466480|P8|NOT COMPLETED|From Week 12 up to Week 36||4
2228716|NCT02713204|5466481|P7|NOT COMPLETED|From Week 12 up to Week 36||2
2228717|NCT02713204|5466482|P6|NOT COMPLETED|From Week 12 up to Week 36||1
2228718|NCT02713204|5466483|P5|NOT COMPLETED|From Week 12 up to Week 36||2
2228719|NCT02713204|5466484|P4|NOT COMPLETED|From Week 12 up to Week 36||4
2228720|NCT02713204|5466485|P3|NOT COMPLETED|From Week 12 up to Week 36||0
2228721|NCT02713204|5466486|P2|NOT COMPLETED|From Week 12 up to Week 36||0
2228722|NCT02713204|5466487|P1|NOT COMPLETED|From Week 12 up to Week 36||1
2228723|NCT02713204|5466480|P8|COMPLETED|From Week 12 up to Week 36||54
2228724|NCT02713204|5466481|P7|COMPLETED|From Week 12 up to Week 36||60
2228725|NCT02713204|5466482|P6|COMPLETED|From Week 12 up to Week 36||59
2228726|NCT02713204|5466483|P5|COMPLETED|From Week 12 up to Week 36||60
2228727|NCT02713204|5466484|P4|COMPLETED|From Week 12 up to Week 36||53
2228728|NCT02713204|5466485|P3|COMPLETED|From Week 12 up to Week 36||0
2228729|NCT02713204|5466486|P2|COMPLETED|From Week 12 up to Week 36||0
2228730|NCT02713204|5466487|P1|COMPLETED|From Week 12 up to Week 36||57
2228731|NCT02713204|5466480|P8|STARTED|From Week 12 up to Week 36||58
2228732|NCT02713204|5466481|P7|STARTED|From Week 12 up to Week 36||62
2228733|NCT02713204|5466482|P6|STARTED|From Week 12 up to Week 36||60
2228734|NCT02713204|5466483|P5|STARTED|From Week 12 up to Week 36||62
2228735|NCT02713204|5466484|P4|STARTED|From Week 12 up to Week 36||57
2228736|NCT02713204|5466485|P3|STARTED|From Week 12 up to Week 36||0
2228737|NCT02713204|5466486|P2|STARTED|From Week 12 up to Week 36||0
2228738|NCT02713204|5466487|P1|STARTED|From Week 12 up to Week 36||58
2228739|NCT02713204|5466480|P8|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
2228740|NCT02713204|5466481|P7|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
2228741|NCT02713204|5466482|P6|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
2228742|NCT02713204|5466483|P5|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
2228743|NCT02713204|5466484|P4|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
2228744|NCT02713204|5466485|P3|NOT COMPLETED|Baseline (Day 1) up to Week 12||2
2228745|NCT02713204|5466486|P2|NOT COMPLETED|Baseline (Day 1) up to Week 12||1
2228746|NCT02713204|5466487|P1|NOT COMPLETED|Baseline (Day 1) up to Week 12||1
2228747|NCT02713204|5466480|P8|COMPLETED|Baseline (Day 1) up to Week 12||0
2228748|NCT02713204|5466481|P7|COMPLETED|Baseline (Day 1) up to Week 12||0
2228749|NCT02713204|5466482|P6|COMPLETED|Baseline (Day 1) up to Week 12||0
2228750|NCT02713204|5466483|P5|COMPLETED|Baseline (Day 1) up to Week 12||0
2228751|NCT02713204|5466484|P4|COMPLETED|Baseline (Day 1) up to Week 12||0
2228752|NCT02713204|5466485|P3|COMPLETED|Baseline (Day 1) up to Week 12||181
2228753|NCT02713204|5466486|P2|COMPLETED|Baseline (Day 1) up to Week 12||121
2228754|NCT02713204|5466487|P1|COMPLETED|Baseline (Day 1) up to Week 12||59
2228755|NCT02713204|5466480|P8|STARTED|Baseline (Day 1) up to Week 12||0
2228756|NCT02713204|5466481|P7|STARTED|Baseline (Day 1) up to Week 12||0
2228757|NCT02713204|5466482|P6|STARTED|Baseline (Day 1) up to Week 12||0
2228758|NCT02713204|5466483|P5|STARTED|Baseline (Day 1) up to Week 12||0
2228759|NCT02713204|5466484|P4|STARTED|Baseline (Day 1) up to Week 12||0
2228760|NCT02713204|5466485|P3|STARTED|Baseline (Day 1) up to Week 12||183
2228761|NCT02713204|5466486|P2|STARTED|Baseline (Day 1) up to Week 12||122
2228762|NCT02713204|5466487|P1|STARTED|Baseline (Day 1) up to Week 12||60
2228763|NCT02712788|5466546|P2|NOT COMPLETED|Overall Study||0
2228764|NCT02712788|5466547|P1|NOT COMPLETED|Overall Study||2
2228765|NCT02712788|5466546|P2|COMPLETED|Overall Study||2
2228766|NCT02712788|5466547|P1|COMPLETED|Overall Study||0
2228767|NCT02712788|5466546|P2|STARTED|Overall Study||2
2228768|NCT02712788|5466547|P1|STARTED|Overall Study||2
2228769|NCT02712554|5466557|P2|NOT COMPLETED|Part B: Treatment Phase||3
2228770|NCT02712554|5466558|P1|NOT COMPLETED|Part B: Treatment Phase||0
2228771|NCT02712554|5466557|P2|COMPLETED|Part B: Treatment Phase||37
2228772|NCT02712554|5466558|P1|COMPLETED|Part B: Treatment Phase||0
2228773|NCT02712554|5466557|P2|STARTED|Part B: Treatment Phase||40
2228774|NCT02712554|5466558|P1|STARTED|Part B: Treatment Phase||0
2228775|NCT02712554|5466557|P2|NOT COMPLETED|Part B: Qualification Phase||21
2228776|NCT02712554|5466558|P1|NOT COMPLETED|Part B: Qualification Phase||0
2228777|NCT02712554|5466557|P2|COMPLETED|Part B: Qualification Phase||40
2228778|NCT02712554|5466558|P1|COMPLETED|Part B: Qualification Phase||0
2228779|NCT02712554|5466557|P2|STARTED|Part B: Qualification Phase||61
2228780|NCT02712554|5466558|P1|STARTED|Part B: Qualification Phase||0
2228781|NCT02712554|5466557|P2|NOT COMPLETED|Part A: Dose Selection Phase||0
2228782|NCT02712554|5466558|P1|NOT COMPLETED|Part A: Dose Selection Phase||0
2228783|NCT02712554|5466557|P2|COMPLETED|Part A: Dose Selection Phase|Subjects who participated in Dose Selection Phase were not eligible to participate in Part B.|0
2228784|NCT02712554|5466558|P1|COMPLETED|Part A: Dose Selection Phase||12
2228785|NCT02712554|5466557|P2|STARTED|Part A: Dose Selection Phase||0
2228786|NCT02712554|5466558|P1|STARTED|Part A: Dose Selection Phase||12
2228787|NCT02712359|5466680|P4|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
2228788|NCT02712359|5466681|P3|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
2228789|NCT02712359|5466682|P2|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
2228790|NCT02712359|5466683|P1|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
2228791|NCT02712359|5466680|P4|COMPLETED|Epoch 002: Persistence at Year 10||300
2228792|NCT02712359|5466681|P3|COMPLETED|Epoch 002: Persistence at Year 10||299
2228793|NCT02712359|5466682|P2|COMPLETED|Epoch 002: Persistence at Year 10||0
2228794|NCT02712359|5466683|P1|COMPLETED|Epoch 002: Persistence at Year 10||0
2228795|NCT02712359|5466680|P4|STARTED|Epoch 002: Persistence at Year 10||300
2228796|NCT02712359|5466681|P3|STARTED|Epoch 002: Persistence at Year 10||299
2228797|NCT02712359|5466682|P2|STARTED|Epoch 002: Persistence at Year 10||0
2228798|NCT02712359|5466683|P1|STARTED|Epoch 002: Persistence at Year 10||0
2228799|NCT02712359|5466680|P4|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
2228800|NCT02712359|5466681|P3|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
2228801|NCT02712359|5466682|P2|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
2228802|NCT02712359|5466683|P1|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
2228803|NCT02712359|5466680|P4|COMPLETED|Epoch 001: Persistence at Year 8||0
2228804|NCT02712359|5466681|P3|COMPLETED|Epoch 001: Persistence at Year 8||0
2228805|NCT02712359|5466682|P2|COMPLETED|Epoch 001: Persistence at Year 8||300
2228806|NCT02712359|5466683|P1|COMPLETED|Epoch 001: Persistence at Year 8||300
2228807|NCT02712359|5466680|P4|STARTED|Epoch 001: Persistence at Year 8||0
2228808|NCT02712359|5466681|P3|STARTED|Epoch 001: Persistence at Year 8||0
2228809|NCT02712359|5466682|P2|STARTED|Epoch 001: Persistence at Year 8||300
2228810|NCT02712359|5466683|P1|STARTED|Epoch 001: Persistence at Year 8||300
2228811|NCT02712333|5466703|P2|NOT COMPLETED|Second Period||0
2228812|NCT02712333|5466704|P1|NOT COMPLETED|Second Period||0
2228813|NCT02712333|5466703|P2|COMPLETED|Second Period||24
2228814|NCT02712333|5466704|P1|COMPLETED|Second Period||31
2228815|NCT02712333|5466703|P2|STARTED|Second Period||24
2228816|NCT02712333|5466704|P1|STARTED|Second Period||31
2228817|NCT02712333|5466703|P2|NOT COMPLETED|First Period||2
2228818|NCT02712333|5466704|P1|NOT COMPLETED|First Period||3
2228819|NCT02712333|5466703|P2|COMPLETED|First Period||24
2228820|NCT02712333|5466704|P1|COMPLETED|First Period||31
2228821|NCT02712333|5466703|P2|STARTED|First Period||26
2228822|NCT02712333|5466704|P1|STARTED|First Period||34
2228823|NCT02712320|5466722|P1|NOT COMPLETED|Overall Study||5
2228824|NCT02712320|5466722|P1|COMPLETED|Overall Study||25
2228825|NCT02712320|5466722|P1|STARTED|Overall Study||30
2228826|NCT02712099|5466732|P2|NOT COMPLETED|Overall Study||0
2228827|NCT02712099|5466733|P1|NOT COMPLETED|Overall Study||0
2228828|NCT02712099|5466732|P2|COMPLETED|Overall Study||20
2228829|NCT02712099|5466733|P1|COMPLETED|Overall Study||30
2228830|NCT02712099|5466732|P2|STARTED|Overall Study||20
2228831|NCT02712099|5466733|P1|STARTED|Overall Study||30
2228832|NCT02712047|5466749|P2|NOT COMPLETED|Treatment Period 2 (35 Days)||0
2228833|NCT02712047|5466750|P1|NOT COMPLETED|Treatment Period 2 (35 Days)||0
2228834|NCT02712047|5466749|P2|COMPLETED|Treatment Period 2 (35 Days)||13
2228835|NCT02712047|5466750|P1|COMPLETED|Treatment Period 2 (35 Days)||14
2228836|NCT02712047|5466749|P2|STARTED|Treatment Period 2 (35 Days)||13
2228837|NCT02712047|5466750|P1|STARTED|Treatment Period 2 (35 Days)||14
2228838|NCT02712047|5466749|P2|NOT COMPLETED|Washout Period (21 Days)||0
2228839|NCT02712047|5466750|P1|NOT COMPLETED|Washout Period (21 Days)||0
2228840|NCT02712047|5466749|P2|COMPLETED|Washout Period (21 Days)||13
2228841|NCT02712047|5466750|P1|COMPLETED|Washout Period (21 Days)||14
2228842|NCT02712047|5466749|P2|STARTED|Washout Period (21 Days)||13
2228843|NCT02712047|5466750|P1|STARTED|Washout Period (21 Days)||14
2228844|NCT02712047|5466749|P2|NOT COMPLETED|Treatment Period 1 (35 Days)||0
2228845|NCT02712047|5466750|P1|NOT COMPLETED|Treatment Period 1 (35 Days)||0
2228846|NCT02712047|5466749|P2|COMPLETED|Treatment Period 1 (35 Days)||13
2228847|NCT02712047|5466750|P1|COMPLETED|Treatment Period 1 (35 Days)||14
2228848|NCT02712047|5466749|P2|STARTED|Treatment Period 1 (35 Days)||13
2228849|NCT02712047|5466750|P1|STARTED|Treatment Period 1 (35 Days)||14
2228850|NCT02712008|5466765|P8|NOT COMPLETED|From Week 12 up to Week 36||4
2228851|NCT02712008|5466766|P7|NOT COMPLETED|From Week 12 up to Week 36||5
2228852|NCT02712008|5466767|P6|NOT COMPLETED|From Week 12 up to Week 36||0
2228853|NCT02712008|5466768|P5|NOT COMPLETED|From Week 12 up to Week 36||2
2228854|NCT02712008|5466769|P4|NOT COMPLETED|From Week 12 up to Week 36||2
2228855|NCT02712008|5466770|P3|NOT COMPLETED|From Week 12 up to Week 36||0
2228856|NCT02712008|5466771|P2|NOT COMPLETED|From Week 12 up to Week 36||0
2228857|NCT02712008|5466772|P1|NOT COMPLETED|From Week 12 up to Week 36||1
2228858|NCT02712008|5466765|P8|COMPLETED|From Week 12 up to Week 36||45
2228859|NCT02712008|5466766|P7|COMPLETED|From Week 12 up to Week 36||43
2228860|NCT02712008|5466767|P6|COMPLETED|From Week 12 up to Week 36||46
2228861|NCT02712008|5466768|P5|COMPLETED|From Week 12 up to Week 36||50
2228862|NCT02712008|5466769|P4|COMPLETED|From Week 12 up to Week 36||42
2228863|NCT02712008|5466770|P3|COMPLETED|From Week 12 up to Week 36||0
2228864|NCT02712008|5466771|P2|COMPLETED|From Week 12 up to Week 36||0
2228865|NCT02712008|5466772|P1|COMPLETED|From Week 12 up to Week 36||44
2228866|NCT02712008|5466765|P8|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 49 re-randomized from Aflibercept 2mg Q4 to REGN910-3 (6:2mg) Q8|49
2228867|NCT02712008|5466766|P7|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 48 re-randomized from Aflibercept 2mg Q4 to Aflibercept 2mg Q12|48
2228868|NCT02712008|5466767|P6|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 46 re-randomized from Aflibercept 2mg Q4 to Aflibercept 2mg Q8|46
2228869|NCT02712008|5466768|P5|STARTED|From Week 12 up to Week 36|Out of 96 that were re-randomized, 52 re-randomized from REGN910-3(6:2 mg)Q4 to REGN910-3(6:2 mg)Q12|52
2228870|NCT02712008|5466769|P4|STARTED|From Week 12 up to Week 36|Out of 96 that were re-randomized, 44 re-randomized from REGN910-3(6:2 mg)Q4 to REGN910-3(6:2 mg)Q8|44
2228871|NCT02712008|5466770|P3|STARTED|From Week 12 up to Week 36|Out of 148 that completed Week 12,143 re-randomized to Aflibercept 2mg Q8, Q12, REGN910-3 (6:2mg) Q8|0
2228872|NCT02712008|5466771|P2|STARTED|From Week 12 up to Week 36|Out of 97 participants that completed Week 12, 96 re-randomized to REGN910-3 (6:2mg) Q8 and Q12|0
2228873|NCT02712008|5466772|P1|STARTED|From Week 12 up to Week 36|Out of 46 participants that completed Week 12, 45 re-randomized for treatment from Week 12 to 36|45
2228874|NCT02712008|5466765|P8|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
2228875|NCT02712008|5466766|P7|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
2228876|NCT02712008|5466767|P6|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
2228877|NCT02712008|5466768|P5|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
2228878|NCT02712008|5466769|P4|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
2228879|NCT02712008|5466770|P3|NOT COMPLETED|Baseline (Day 1) up to Week 12||4
2228880|NCT02712008|5466771|P2|NOT COMPLETED|Baseline (Day 1) up to Week 12||3
2228881|NCT02712008|5466772|P1|NOT COMPLETED|Baseline (Day 1) up to Week 12||4
2228882|NCT02712008|5466765|P8|COMPLETED|Baseline (Day 1) up to Week 12||0
2228883|NCT02712008|5466766|P7|COMPLETED|Baseline (Day 1) up to Week 12||0
2228884|NCT02712008|5466767|P6|COMPLETED|Baseline (Day 1) up to Week 12||0
2228885|NCT02712008|5466768|P5|COMPLETED|Baseline (Day 1) up to Week 12||0
2228886|NCT02712008|5466769|P4|COMPLETED|Baseline (Day 1) up to Week 12||0
2228887|NCT02712008|5466770|P3|COMPLETED|Baseline (Day 1) up to Week 12||148
2228888|NCT02712008|5466771|P2|COMPLETED|Baseline (Day 1) up to Week 12||97
2228889|NCT02712008|5466772|P1|COMPLETED|Baseline (Day 1) up to Week 12||46
2228890|NCT02712008|5466765|P8|STARTED|Baseline (Day 1) up to Week 12||0
2228891|NCT02712008|5466766|P7|STARTED|Baseline (Day 1) up to Week 12||0
2228892|NCT02712008|5466767|P6|STARTED|Baseline (Day 1) up to Week 12||0
2228893|NCT02712008|5466768|P5|STARTED|Baseline (Day 1) up to Week 12||0
2228894|NCT02712008|5466769|P4|STARTED|Baseline (Day 1) up to Week 12||0
2228895|NCT02712008|5466770|P3|STARTED|Baseline (Day 1) up to Week 12||152
2228896|NCT02712008|5466771|P2|STARTED|Baseline (Day 1) up to Week 12||100
2228897|NCT02712008|5466772|P1|STARTED|Baseline (Day 1) up to Week 12||50
2228898|NCT02711995|5466804|P1|NOT COMPLETED|Second Intervention (30 Days)||0
2228899|NCT02711995|5466804|P1|COMPLETED|Second Intervention (30 Days)||7
2228900|NCT02711995|5466804|P1|STARTED|Second Intervention (30 Days)||7
2228901|NCT02711995|5466804|P1|NOT COMPLETED|Washout (90 Days)||1
2228902|NCT02711995|5466804|P1|COMPLETED|Washout (90 Days)||7
2228903|NCT02711995|5466804|P1|STARTED|Washout (90 Days)||8
2228904|NCT02711995|5466804|P1|NOT COMPLETED|First Intervention (30 Days)||0
2228905|NCT02711995|5466804|P1|COMPLETED|First Intervention (30 Days)||8
2228906|NCT02711995|5466804|P1|STARTED|First Intervention (30 Days)||8
2228907|NCT02711839|5466828|P2|NOT COMPLETED|Overall Study||10
2228908|NCT02711839|5466829|P1|NOT COMPLETED|Overall Study||4
2228909|NCT02711839|5466828|P2|COMPLETED|Overall Study||24
2228910|NCT02711839|5466829|P1|COMPLETED|Overall Study||16
2228911|NCT02711839|5466828|P2|STARTED|Overall Study||34
2228912|NCT02711839|5466829|P1|STARTED|Overall Study||20
2228913|NCT02711800|5466843|P1|NOT COMPLETED|Overall Study||2
2228914|NCT02711800|5466843|P1|COMPLETED|Overall Study||7
2228915|NCT02711800|5466843|P1|STARTED|Overall Study||9
2228916|NCT02711345|5466862|P10|NOT COMPLETED|Overall Study||12
2228917|NCT02711345|5466863|P9|NOT COMPLETED|Overall Study||6
2228918|NCT02711345|5466864|P8|NOT COMPLETED|Overall Study||6
2228919|NCT02711345|5466865|P7|NOT COMPLETED|Overall Study||12
2228920|NCT02711345|5466866|P6|NOT COMPLETED|Overall Study||6
2228921|NCT02711345|5466867|P5|NOT COMPLETED|Overall Study||8
2228922|NCT02711345|5466868|P4|NOT COMPLETED|Overall Study||4
2228923|NCT02711345|5466869|P3|NOT COMPLETED|Overall Study||6
2228924|NCT02711345|5466870|P2|NOT COMPLETED|Overall Study||3
2228925|NCT02711345|5466871|P1|NOT COMPLETED|Overall Study||2
2228926|NCT02711345|5466862|P10|COMPLETED|Overall Study||0
2228927|NCT02711345|5466863|P9|COMPLETED|Overall Study||0
2228928|NCT02711345|5466864|P8|COMPLETED|Overall Study||0
2228929|NCT02711345|5466865|P7|COMPLETED|Overall Study||0
2228930|NCT02711345|5466866|P6|COMPLETED|Overall Study||0
2228931|NCT02711345|5466867|P5|COMPLETED|Overall Study||0
2228932|NCT02711345|5466868|P4|COMPLETED|Overall Study||0
2228933|NCT02711345|5466869|P3|COMPLETED|Overall Study||0
2228934|NCT02711345|5466870|P2|COMPLETED|Overall Study||0
2228935|NCT02711345|5466871|P1|COMPLETED|Overall Study||0
2228936|NCT02711345|5466862|P10|STARTED|Overall Study||12
2228937|NCT02711345|5466863|P9|STARTED|Overall Study||6
2228938|NCT02711345|5466864|P8|STARTED|Overall Study||6
2228939|NCT02711345|5466865|P7|STARTED|Overall Study||12
2228940|NCT02711345|5466866|P6|STARTED|Overall Study||6
2228941|NCT02711345|5466867|P5|STARTED|Overall Study||8
2228942|NCT02711345|5466868|P4|STARTED|Overall Study||4
2228943|NCT02711345|5466869|P3|STARTED|Overall Study||6
2228944|NCT02711345|5466870|P2|STARTED|Overall Study||3
2228945|NCT02711345|5466871|P1|STARTED|Overall Study||2
2228946|NCT02711306|5467057|P2|NOT COMPLETED|Overall Study||2
2228947|NCT02711306|5467058|P1|NOT COMPLETED|Overall Study||2
2228948|NCT02711306|5467057|P2|COMPLETED|Overall Study||16
2228949|NCT02711306|5467058|P1|COMPLETED|Overall Study||16
2228950|NCT02711306|5467057|P2|STARTED|Overall Study||18
2228951|NCT02711306|5467058|P1|STARTED|Overall Study||18
2228952|NCT02710630|5467075|P5|NOT COMPLETED|Period 6||0
2228953|NCT02710630|5467076|P4|NOT COMPLETED|Period 6||0
2228954|NCT02710630|5467077|P3|NOT COMPLETED|Period 6||0
2228955|NCT02710630|5467078|P2|NOT COMPLETED|Period 6||0
2228956|NCT02710630|5467079|P1|NOT COMPLETED|Period 6||0
2228957|NCT02710630|5467075|P5|COMPLETED|Period 6||7
2228958|NCT02710630|5467076|P4|COMPLETED|Period 6||7
2228959|NCT02710630|5467077|P3|COMPLETED|Period 6||7
2228960|NCT02710630|5467078|P2|COMPLETED|Period 6||7
2228961|NCT02710630|5467079|P1|COMPLETED|Period 6||7
2228962|NCT02710630|5467075|P5|STARTED|Period 6||7
2228963|NCT02710630|5467076|P4|STARTED|Period 6||7
2228964|NCT02710630|5467077|P3|STARTED|Period 6||7
2228965|NCT02710630|5467078|P2|STARTED|Period 6||7
2228966|NCT02710630|5467079|P1|STARTED|Period 6||7
2228967|NCT02710630|5467075|P5|NOT COMPLETED|Period 5||0
2228968|NCT02710630|5467076|P4|NOT COMPLETED|Period 5||0
2228969|NCT02710630|5467077|P3|NOT COMPLETED|Period 5||0
2228970|NCT02710630|5467078|P2|NOT COMPLETED|Period 5||0
2228971|NCT02710630|5467079|P1|NOT COMPLETED|Period 5||0
2228972|NCT02710630|5467075|P5|COMPLETED|Period 5||7
2228973|NCT02710630|5467076|P4|COMPLETED|Period 5||7
2228974|NCT02710630|5467077|P3|COMPLETED|Period 5||7
2228975|NCT02710630|5467078|P2|COMPLETED|Period 5||7
2228976|NCT02710630|5467079|P1|COMPLETED|Period 5||7
2228977|NCT02710630|5467075|P5|STARTED|Period 5||7
2228978|NCT02710630|5467076|P4|STARTED|Period 5||7
2228979|NCT02710630|5467077|P3|STARTED|Period 5||7
2228980|NCT02710630|5467078|P2|STARTED|Period 5||7
2228981|NCT02710630|5467079|P1|STARTED|Period 5||7
2228982|NCT02710630|5467075|P5|NOT COMPLETED|Period 4||0
2228983|NCT02710630|5467076|P4|NOT COMPLETED|Period 4||0
2228984|NCT02710630|5467077|P3|NOT COMPLETED|Period 4||0
2228985|NCT02710630|5467078|P2|NOT COMPLETED|Period 4||0
2228986|NCT02710630|5467079|P1|NOT COMPLETED|Period 4||0
2228987|NCT02710630|5467075|P5|COMPLETED|Period 4||7
2228988|NCT02710630|5467076|P4|COMPLETED|Period 4||7
2228989|NCT02710630|5467077|P3|COMPLETED|Period 4||7
2228990|NCT02710630|5467078|P2|COMPLETED|Period 4||7
2228991|NCT02710630|5467079|P1|COMPLETED|Period 4||7
2228992|NCT02710630|5467075|P5|STARTED|Period 4||7
2228993|NCT02710630|5467076|P4|STARTED|Period 4||7
2228994|NCT02710630|5467077|P3|STARTED|Period 4||7
2228995|NCT02710630|5467078|P2|STARTED|Period 4||7
2228996|NCT02710630|5467079|P1|STARTED|Period 4||7
2228997|NCT02710630|5467075|P5|NOT COMPLETED|Period 3||0
2228998|NCT02710630|5467076|P4|NOT COMPLETED|Period 3||0
2228999|NCT02710630|5467077|P3|NOT COMPLETED|Period 3||0
2229000|NCT02710630|5467078|P2|NOT COMPLETED|Period 3||0
2229001|NCT02710630|5467079|P1|NOT COMPLETED|Period 3||0
2229002|NCT02710630|5467075|P5|COMPLETED|Period 3||7
2229003|NCT02710630|5467076|P4|COMPLETED|Period 3||7
2229004|NCT02710630|5467077|P3|COMPLETED|Period 3||7
2229005|NCT02710630|5467078|P2|COMPLETED|Period 3||7
2229006|NCT02710630|5467079|P1|COMPLETED|Period 3||7
2229007|NCT02710630|5467075|P5|STARTED|Period 3||7
2229008|NCT02710630|5467076|P4|STARTED|Period 3||7
2229009|NCT02710630|5467077|P3|STARTED|Period 3||7
2229010|NCT02710630|5467078|P2|STARTED|Period 3||7
2229011|NCT02710630|5467079|P1|STARTED|Period 3||7
2229012|NCT02710630|5467075|P5|NOT COMPLETED|Period 2||0
2229013|NCT02710630|5467076|P4|NOT COMPLETED|Period 2||0
2229014|NCT02710630|5467077|P3|NOT COMPLETED|Period 2||0
2229015|NCT02710630|5467078|P2|NOT COMPLETED|Period 2||0
2229016|NCT02710630|5467079|P1|NOT COMPLETED|Period 2||0
2229017|NCT02710630|5467075|P5|COMPLETED|Period 2||7
2229018|NCT02710630|5467076|P4|COMPLETED|Period 2||7
2229019|NCT02710630|5467077|P3|COMPLETED|Period 2||7
2229020|NCT02710630|5467078|P2|COMPLETED|Period 2||7
2229021|NCT02710630|5467079|P1|COMPLETED|Period 2||7
2229022|NCT02710630|5467075|P5|Not Treated|Period 2||0
2229023|NCT02710630|5467076|P4|Not Treated|Period 2||0
2229024|NCT02710630|5467077|P3|Not Treated|Period 2||0
2229025|NCT02710630|5467078|P2|Not Treated|Period 2||0
2229026|NCT02710630|5467079|P1|Not Treated|Period 2||1
2229027|NCT02710630|5467075|P5|STARTED|Period 2||7
2229028|NCT02710630|5467076|P4|STARTED|Period 2||7
2229029|NCT02710630|5467077|P3|STARTED|Period 2||7
2229030|NCT02710630|5467078|P2|STARTED|Period 2||7
2229031|NCT02710630|5467079|P1|STARTED|Period 2||7
2229032|NCT02710630|5467075|P5|NOT COMPLETED|Period 1||0
2229033|NCT02710630|5467076|P4|NOT COMPLETED|Period 1||0
2229034|NCT02710630|5467077|P3|NOT COMPLETED|Period 1||0
2229035|NCT02710630|5467078|P2|NOT COMPLETED|Period 1||0
2229036|NCT02710630|5467079|P1|NOT COMPLETED|Period 1||0
2229037|NCT02710630|5467075|P5|COMPLETED|Period 1||7
2229038|NCT02710630|5467076|P4|COMPLETED|Period 1||7
2229039|NCT02710630|5467077|P3|COMPLETED|Period 1||7
2229040|NCT02710630|5467078|P2|COMPLETED|Period 1||7
2229041|NCT02710630|5467079|P1|COMPLETED|Period 1||7
2229042|NCT02710630|5467075|P5|STARTED|Period 1||7
2229043|NCT02710630|5467076|P4|STARTED|Period 1||7
2229044|NCT02710630|5467077|P3|STARTED|Period 1||7
2229045|NCT02710630|5467078|P2|STARTED|Period 1||7
2229046|NCT02710630|5467079|P1|STARTED|Period 1||7
2229047|NCT02710591|5467127|P4|NOT COMPLETED|Overall Study||0
2229048|NCT02710591|5467128|P3|NOT COMPLETED|Overall Study||0
2229049|NCT02710591|5467129|P2|NOT COMPLETED|Overall Study||0
2229050|NCT02710591|5467130|P1|NOT COMPLETED|Overall Study||0
2229051|NCT02710591|5467127|P4|COMPLETED|Overall Study||5
2229052|NCT02710591|5467128|P3|COMPLETED|Overall Study||5
2229053|NCT02710591|5467129|P2|COMPLETED|Overall Study||5
2229054|NCT02710591|5467130|P1|COMPLETED|Overall Study||5
2229055|NCT02710591|5467127|P4|STARTED|Overall Study||5
2229056|NCT02710591|5467128|P3|STARTED|Overall Study||5
2229057|NCT02710591|5467129|P2|STARTED|Overall Study||5
2229058|NCT02710591|5467130|P1|STARTED|Overall Study||5
2229059|NCT02710422|5467146|P2|NOT COMPLETED|Overall Study||9
2229060|NCT02710422|5467147|P1|NOT COMPLETED|Overall Study||9
2229061|NCT02710422|5467146|P2|COMPLETED|Overall Study||3
2229062|NCT02710422|5467147|P1|COMPLETED|Overall Study||3
2229063|NCT02710422|5467146|P2|12 Month Visit|Overall Study||3
2229064|NCT02710422|5467147|P1|12 Month Visit|Overall Study||3
2229065|NCT02710422|5467146|P2|9 Month Visit|Overall Study||5
2229066|NCT02710422|5467147|P1|9 Month Visit|Overall Study||5
2229067|NCT02710422|5467146|P2|6 Month Visit|Overall Study||8
2229068|NCT02710422|5467147|P1|6 Month Visit|Overall Study||7
2229069|NCT02710422|5467146|P2|3 Month Visit|Overall Study||11
2229070|NCT02710422|5467147|P1|3 Month Visit|Overall Study||9
2229071|NCT02710422|5467146|P2|STARTED|Overall Study||12
2229072|NCT02710422|5467147|P1|STARTED|Overall Study||12
2229073|NCT02710292|5467163|P2|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
2229074|NCT02710292|5467164|P1|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
2229075|NCT02710292|5467163|P2|COMPLETED|Period 2, Second 10 Days of Wear||49
2229076|NCT02710292|5467164|P1|COMPLETED|Period 2, Second 10 Days of Wear||46
2229077|NCT02710292|5467163|P2|STARTED|Period 2, Second 10 Days of Wear||49
2229078|NCT02710292|5467164|P1|STARTED|Period 2, Second 10 Days of Wear||46
2229079|NCT02710292|5467163|P2|NOT COMPLETED|Period 1, First 10 Days of Wear||3
2229080|NCT02710292|5467164|P1|NOT COMPLETED|Period 1, First 10 Days of Wear||1
2229081|NCT02710292|5467163|P2|COMPLETED|Period 1, First 10 Days of Wear||49
2229082|NCT02710292|5467164|P1|COMPLETED|Period 1, First 10 Days of Wear||46
2229083|NCT02710292|5467163|P2|STARTED|Period 1, First 10 Days of Wear||52
2229084|NCT02710292|5467164|P1|STARTED|Period 1, First 10 Days of Wear||47
2229085|NCT02710136|5467173|P2|NOT COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
2229086|NCT02710136|5467174|P1|NOT COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
2229087|NCT02710136|5467173|P2|COMPLETED|Phase 2 [Refer to Arm/Group Description]||25
2229088|NCT02710136|5467174|P1|COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
2229089|NCT02710136|5467173|P2|STARTED|Phase 2 [Refer to Arm/Group Description]||25
2229090|NCT02710136|5467174|P1|STARTED|Phase 2 [Refer to Arm/Group Description]||0
2229091|NCT02710136|5467173|P2|NOT COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
2229092|NCT02710136|5467174|P1|NOT COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
2229093|NCT02710136|5467173|P2|COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
2229094|NCT02710136|5467174|P1|COMPLETED|Phase 1b[Refer to Arm/Group Description]||4
2229095|NCT02710136|5467173|P2|STARTED|Phase 1b[Refer to Arm/Group Description]||0
2229096|NCT02710136|5467174|P1|STARTED|Phase 1b[Refer to Arm/Group Description]||4
2229097|NCT02710136|5467173|P2|NOT COMPLETED|Phase 1a[Refer to Arm/Group Description]||0
2229098|NCT02710136|5467174|P1|NOT COMPLETED|Phase 1a[Refer to Arm/Group Description]||1
2229099|NCT02710136|5467173|P2|COMPLETED|Phase 1a[Refer to Arm/Group Description]||0
2229100|NCT02710136|5467174|P1|COMPLETED|Phase 1a[Refer to Arm/Group Description]||9
2229101|NCT02710136|5467173|P2|STARTED|Phase 1a[Refer to Arm/Group Description]||0
2229102|NCT02710136|5467174|P1|STARTED|Phase 1a[Refer to Arm/Group Description]||10
2229103|NCT02710136|5467173|P2|NOT COMPLETED|Study Enrollment||0
2229104|NCT02710136|5467174|P1|NOT COMPLETED|Study Enrollment||0
2229105|NCT02710136|5467173|P2|COMPLETED|Study Enrollment||25
2229106|NCT02710136|5467174|P1|COMPLETED|Study Enrollment||10
2229107|NCT02710136|5467173|P2|STARTED|Study Enrollment||25
2229108|NCT02710136|5467174|P1|STARTED|Study Enrollment||10
2229109|NCT02710045|5467200|P3|NOT COMPLETED|Overall Study||13
2229110|NCT02710045|5467201|P2|NOT COMPLETED|Overall Study||17
2229111|NCT02710045|5467202|P1|NOT COMPLETED|Overall Study||11
2229112|NCT02710045|5467200|P3|COMPLETED|Overall Study||68
2229113|NCT02710045|5467201|P2|COMPLETED|Overall Study||98
2229114|NCT02710045|5467202|P1|COMPLETED|Overall Study||95
2229115|NCT02710045|5467200|P3|STARTED|Overall Study||81
2229116|NCT02710045|5467201|P2|STARTED|Overall Study||115
2229117|NCT02710045|5467202|P1|STARTED|Overall Study||106
2229118|NCT02709785|5467231|P3|NOT COMPLETED|Overall Study||1
2229119|NCT02709785|5467232|P2|NOT COMPLETED|Overall Study||2
2229120|NCT02709785|5467233|P1|NOT COMPLETED|Overall Study||1
2229121|NCT02709785|5467231|P3|COMPLETED|Overall Study||27
2229122|NCT02709785|5467232|P2|COMPLETED|Overall Study||26
2229123|NCT02709785|5467233|P1|COMPLETED|Overall Study||23
2229124|NCT02709785|5467231|P3|6 Weeks|Overall Study||27
2229125|NCT02709785|5467232|P2|6 Weeks|Overall Study||26
2229126|NCT02709785|5467233|P1|6 Weeks|Overall Study||23
2229127|NCT02709785|5467231|P3|3 Weeks|Overall Study||27
2229128|NCT02709785|5467232|P2|3 Weeks|Overall Study||27
2229129|NCT02709785|5467233|P1|3 Weeks|Overall Study||23
2229130|NCT02709785|5467231|P3|STARTED|Overall Study||28
2229131|NCT02709785|5467232|P2|STARTED|Overall Study||28
2229132|NCT02709785|5467233|P1|STARTED|Overall Study||24
2229133|NCT02709577|5467255|P4|NOT COMPLETED|Overall Study||0
2229134|NCT02709577|5467256|P3|NOT COMPLETED|Overall Study||2
2229135|NCT02709577|5467257|P2|NOT COMPLETED|Overall Study||5
2229136|NCT02709577|5467258|P1|NOT COMPLETED|Overall Study||2
2229137|NCT02709577|5467255|P4|COMPLETED|Overall Study||5
2229138|NCT02709577|5467256|P3|COMPLETED|Overall Study||4
2229139|NCT02709577|5467257|P2|COMPLETED|Overall Study||8
2229140|NCT02709577|5467258|P1|COMPLETED|Overall Study||10
2229141|NCT02709577|5467255|P4|STARTED|Overall Study||5
2229142|NCT02709577|5467256|P3|STARTED|Overall Study||6
2229143|NCT02709577|5467257|P2|STARTED|Overall Study||13
2229144|NCT02709577|5467258|P1|STARTED|Overall Study||12
2229154|NCT02709486|5467286|P3|NOT COMPLETED|Overall Study||45
2229155|NCT02709486|5467287|P2|NOT COMPLETED|Overall Study||34
2229156|NCT02709486|5467288|P1|NOT COMPLETED|Overall Study||44
2229157|NCT02709486|5467286|P3|COMPLETED|Overall Study||239
2229158|NCT02709486|5467287|P2|COMPLETED|Overall Study||249
2229159|NCT02709486|5467288|P1|COMPLETED|Overall Study||238
2229160|NCT02709486|5467286|P3|STARTED|Overall Study||284
2229161|NCT02709486|5467287|P2|STARTED|Overall Study||283
2229162|NCT02709486|5467288|P1|STARTED|Overall Study||282
2229163|NCT02709369|5467479|P1|NOT COMPLETED|Overall Study||27
2229164|NCT02709369|5467479|P1|COMPLETED|Overall Study||273
2229165|NCT02709369|5467479|P1|STARTED|Overall Study||300
2229166|NCT02709330|5467513|P2|NOT COMPLETED|Overall Study||0
2229167|NCT02709330|5467514|P1|NOT COMPLETED|Overall Study||13
2229168|NCT02709330|5467513|P2|COMPLETED|Overall Study||10
2229169|NCT02709330|5467514|P1|COMPLETED|Overall Study||37
2229170|NCT02709330|5467513|P2|STARTED|Overall Study||10
2229171|NCT02709330|5467514|P1|STARTED|Overall Study||50
2229172|NCT02709096|5467528|P2|NOT COMPLETED|Overall Study||1
2229173|NCT02709096|5467529|P1|NOT COMPLETED|Overall Study||1
2229174|NCT02709096|5467528|P2|COMPLETED|Overall Study||10
2229175|NCT02709096|5467529|P1|COMPLETED|Overall Study||21
2229176|NCT02709096|5467528|P2|STARTED|Overall Study||11
2229177|NCT02709096|5467529|P1|STARTED|Overall Study||22
2229178|NCT02709083|5467535|P1|NOT COMPLETED|Overall Study||7
2229179|NCT02709083|5467535|P1|COMPLETED|Overall Study||0
2229180|NCT02709083|5467535|P1|STARTED|Overall Study||7
2229181|NCT02709005|5467548|P2|NOT COMPLETED|Overall Study||1
2229182|NCT02709005|5467549|P1|NOT COMPLETED|Overall Study||4
2229183|NCT02709005|5467548|P2|COMPLETED|Overall Study||35
2229184|NCT02709005|5467549|P1|COMPLETED|Overall Study||69
2229185|NCT02709005|5467548|P2|STARTED|Overall Study||36
2229186|NCT02709005|5467549|P1|STARTED|Overall Study||73
2229187|NCT02708862|5467577|P1|NOT COMPLETED|Overall Study||0
2229188|NCT02708862|5467577|P1|COMPLETED|Overall Study||26
2229189|NCT02708862|5467577|P1|STARTED|Overall Study||26
2229190|NCT02708745|5467588|P4|NOT COMPLETED|Overall Study||82
2229191|NCT02708745|5467589|P3|NOT COMPLETED|Overall Study||83
2229192|NCT02708745|5467590|P2|NOT COMPLETED|Overall Study||4
2229193|NCT02708745|5467591|P1|NOT COMPLETED|Overall Study||0
2229194|NCT02708745|5467588|P4|COMPLETED|Overall Study||116
2229195|NCT02708745|5467589|P3|COMPLETED|Overall Study||121
2229196|NCT02708745|5467590|P2|COMPLETED|Overall Study||65
2229197|NCT02708745|5467591|P1|COMPLETED|Overall Study||91
2229198|NCT02708745|5467588|P4|STARTED|Overall Study||198
2229199|NCT02708745|5467589|P3|STARTED|Overall Study||204
2229200|NCT02708745|5467590|P2|STARTED|Overall Study||69
2229201|NCT02708745|5467591|P1|STARTED|Overall Study||91
2229202|NCT02708524|5467607|P4|NOT COMPLETED|Overall Study||0
2229203|NCT02708524|5467608|P3|NOT COMPLETED|Overall Study||3
2229204|NCT02708524|5467609|P2|NOT COMPLETED|Overall Study||6
2229205|NCT02708524|5467610|P1|NOT COMPLETED|Overall Study||4
2229206|NCT02708524|5467607|P4|COMPLETED|Overall Study||136
2229207|NCT02708524|5467608|P3|COMPLETED|Overall Study||134
2229208|NCT02708524|5467609|P2|COMPLETED|Overall Study||130
2229209|NCT02708524|5467610|P1|COMPLETED|Overall Study||135
2229210|NCT02708524|5467607|P4|STARTED|Overall Study||136
2229211|NCT02708524|5467608|P3|STARTED|Overall Study||137
2229212|NCT02708524|5467609|P2|STARTED|Overall Study||136
2229213|NCT02708524|5467610|P1|STARTED|Overall Study||139
2229214|NCT02708485|5467658|P2|NOT COMPLETED|Overall Study||2
2229215|NCT02708485|5467659|P1|NOT COMPLETED|Overall Study||3
2229216|NCT02708485|5467658|P2|COMPLETED|Overall Study||10
2229217|NCT02708485|5467659|P1|COMPLETED|Overall Study||0
2229218|NCT02708485|5467658|P2|STARTED|Overall Study||12
2229219|NCT02708485|5467659|P1|STARTED|Overall Study||3
2229220|NCT02708433|5467667|P2|NOT COMPLETED|Second Intervention (Visit 2)||0
2229221|NCT02708433|5467668|P1|NOT COMPLETED|Second Intervention (Visit 2)||0
2229222|NCT02708433|5467667|P2|COMPLETED|Second Intervention (Visit 2)||11
2229223|NCT02708433|5467668|P1|COMPLETED|Second Intervention (Visit 2)||12
2229224|NCT02708433|5467667|P2|STARTED|Second Intervention (Visit 2)||11
2229225|NCT02708433|5467668|P1|STARTED|Second Intervention (Visit 2)||12
2229226|NCT02708433|5467667|P2|NOT COMPLETED|Washout (at Least 1 Week)||0
2229227|NCT02708433|5467668|P1|NOT COMPLETED|Washout (at Least 1 Week)||0
2229228|NCT02708433|5467667|P2|COMPLETED|Washout (at Least 1 Week)||11
2229229|NCT02708433|5467668|P1|COMPLETED|Washout (at Least 1 Week)||12
2229230|NCT02708433|5467667|P2|STARTED|Washout (at Least 1 Week)||11
2229231|NCT02708433|5467668|P1|STARTED|Washout (at Least 1 Week)||12
2229232|NCT02708433|5467667|P2|NOT COMPLETED|First Intervention (Visit 1)||0
2229233|NCT02708433|5467668|P1|NOT COMPLETED|First Intervention (Visit 1)||0
2229234|NCT02708433|5467667|P2|COMPLETED|First Intervention (Visit 1)||11
2229235|NCT02708433|5467668|P1|COMPLETED|First Intervention (Visit 1)||12
2229236|NCT02708433|5467667|P2|STARTED|First Intervention (Visit 1)||11
2229237|NCT02708433|5467668|P1|STARTED|First Intervention (Visit 1)||12
2229238|NCT02708355|5467679|P3|NOT COMPLETED|Overall Study||0
2229239|NCT02708355|5467680|P2|NOT COMPLETED|Overall Study||0
2229240|NCT02708355|5467681|P1|NOT COMPLETED|Overall Study||1
2229241|NCT02708355|5467679|P3|COMPLETED|Overall Study||12
2229242|NCT02708355|5467680|P2|COMPLETED|Overall Study||22
2229243|NCT02708355|5467681|P1|COMPLETED|Overall Study||20
2229244|NCT02708355|5467679|P3|STARTED|Overall Study||12
2229245|NCT02708355|5467680|P2|STARTED|Overall Study||22
2229246|NCT02708355|5467681|P1|STARTED|Overall Study||21
2229247|NCT02708290|5467694|P2|NOT COMPLETED|Overall Study||0
2229248|NCT02708290|5467695|P1|NOT COMPLETED|Overall Study||0
2229249|NCT02708290|5467694|P2|COMPLETED|Overall Study||5226
2229250|NCT02708290|5467695|P1|COMPLETED|Overall Study||3540
2229251|NCT02708290|5467694|P2|STARTED|Overall Study||5226
2229252|NCT02708290|5467695|P1|STARTED|Overall Study||3540
2229253|NCT02708277|5467705|P2|NOT COMPLETED|Overall Study||4
2229254|NCT02708277|5467706|P1|NOT COMPLETED|Overall Study||7
2229255|NCT02708277|5467705|P2|COMPLETED|Overall Study||39
2229256|NCT02708277|5467706|P1|COMPLETED|Overall Study||43
2229257|NCT02708277|5467705|P2|STARTED|Overall Study||43
2229258|NCT02708277|5467706|P1|STARTED|Overall Study||50
2229259|NCT02708238|5467721|P3|NOT COMPLETED|Overall Study||3
2229260|NCT02708238|5467722|P2|NOT COMPLETED|Overall Study||1
2229261|NCT02708238|5467723|P1|NOT COMPLETED|Overall Study||0
2229262|NCT02708238|5467721|P3|COMPLETED|Overall Study||57
2229263|NCT02708238|5467722|P2|COMPLETED|Overall Study||59
2229264|NCT02708238|5467723|P1|COMPLETED|Overall Study||60
2229265|NCT02708238|5467721|P3|STARTED|Overall Study||60
2229266|NCT02708238|5467722|P2|STARTED|Overall Study||60
2229267|NCT02708238|5467723|P1|STARTED|Overall Study||60
2229268|NCT02708212|5467736|P2|NOT COMPLETED|Overall Study||0
2229269|NCT02708212|5467737|P1|NOT COMPLETED|Overall Study||0
2229270|NCT02708212|5467736|P2|COMPLETED|Overall Study||60
2229271|NCT02708212|5467737|P1|COMPLETED|Overall Study||60
2229272|NCT02708212|5467736|P2|STARTED|Overall Study||60
2229273|NCT02708212|5467737|P1|STARTED|Overall Study||60
2229274|NCT02708121|5467749|P2|NOT COMPLETED|Overall Study||5
2229275|NCT02708121|5467750|P1|NOT COMPLETED|Overall Study||1
2229276|NCT02708121|5467749|P2|COMPLETED|Overall Study||26
2229277|NCT02708121|5467750|P1|COMPLETED|Overall Study||34
2229278|NCT02708121|5467749|P2|6 Month Weight Data Via EHR|Overall Study||13
2229279|NCT02708121|5467750|P1|6 Month Weight Data Via EHR|Overall Study||14
2229280|NCT02708121|5467749|P2|6 Month In-Person Follow Up Data|Overall Study||19
2229281|NCT02708121|5467750|P1|6 Month In-Person Follow Up Data|Overall Study||22
2229282|NCT02708121|5467749|P2|Treatment Program Use Data Available|Overall Study||24
2229283|NCT02708121|5467750|P1|Treatment Program Use Data Available|Overall Study||34
2229284|NCT02708121|5467749|P2|Provided Acceptability Data|Overall Study|This condition did not participate in acceptability survey|0
2229285|NCT02708121|5467750|P1|Provided Acceptability Data|Overall Study||20
2229286|NCT02708121|5467749|P2|STARTED|Overall Study||31
2229287|NCT02708121|5467750|P1|STARTED|Overall Study||35
2229288|NCT02708095|5467762|P3|NOT COMPLETED|Overall Study||18
2229289|NCT02708095|5467763|P2|NOT COMPLETED|Overall Study||19
2229290|NCT02708095|5467764|P1|NOT COMPLETED|Overall Study||22
2229291|NCT02708095|5467762|P3|COMPLETED|Overall Study||86
2229292|NCT02708095|5467763|P2|COMPLETED|Overall Study||86
2229293|NCT02708095|5467764|P1|COMPLETED|Overall Study||83
2229294|NCT02708095|5467762|P3|Received at Least 1 Dose of Study Drug|Overall Study||104
2229295|NCT02708095|5467763|P2|Received at Least 1 Dose of Study Drug|Overall Study||105
2229296|NCT02708095|5467764|P1|Received at Least 1 Dose of Study Drug|Overall Study||105
2229297|NCT02708095|5467762|P3|STARTED|Overall Study||104
2229298|NCT02708095|5467763|P2|STARTED|Overall Study||105
2229299|NCT02708095|5467764|P1|STARTED|Overall Study||105
2229300|NCT02707991|5467787|P2|NOT COMPLETED|Overall Study||1
2229301|NCT02707991|5467788|P1|NOT COMPLETED|Overall Study||1
2229302|NCT02707991|5467787|P2|COMPLETED|Overall Study||34
2229303|NCT02707991|5467788|P1|COMPLETED|Overall Study||32
2229304|NCT02707991|5467787|P2|Month 6 Data Collection|Overall Study||34
2229305|NCT02707991|5467788|P1|Month 6 Data Collection|Overall Study||32
2229306|NCT02707991|5467787|P2|Day 60 Data Collectio|Overall Study||34
2229307|NCT02707991|5467788|P1|Day 60 Data Collectio|Overall Study||32
2229308|NCT02707991|5467787|P2|STARTED|Overall Study||35
2229309|NCT02707991|5467788|P1|STARTED|Overall Study||33
2229310|NCT02707952|5467800|P4|NOT COMPLETED|Overall Study||0
2229311|NCT02707952|5467801|P3|NOT COMPLETED|Overall Study||2
2229312|NCT02707952|5467802|P2|NOT COMPLETED|Overall Study||1
2229313|NCT02707952|5467803|P1|NOT COMPLETED|Overall Study||2
2229314|NCT02707952|5467800|P4|COMPLETED|Overall Study||10
2229315|NCT02707952|5467801|P3|COMPLETED|Overall Study||101
2229316|NCT02707952|5467802|P2|COMPLETED|Overall Study||52
2229317|NCT02707952|5467803|P1|COMPLETED|Overall Study||127
2229318|NCT02707952|5467800|P4|Participants Who Received Study Drug|Overall Study||10
2229319|NCT02707952|5467801|P3|Participants Who Received Study Drug|Overall Study||103
2229320|NCT02707952|5467802|P2|Participants Who Received Study Drug|Overall Study||52
2229321|NCT02707952|5467803|P1|Participants Who Received Study Drug|Overall Study||129
2229322|NCT02707952|5467800|P4|STARTED|Overall Study||10
2229323|NCT02707952|5467801|P3|STARTED|Overall Study||103
2229324|NCT02707952|5467802|P2|STARTED|Overall Study||53
2229325|NCT02707952|5467803|P1|STARTED|Overall Study||129
2229326|NCT02707640|5467824|P2|NOT COMPLETED|Overall Study||7
2229327|NCT02707640|5467825|P1|NOT COMPLETED|Overall Study||9
2229328|NCT02707640|5467824|P2|COMPLETED|Overall Study||55
2229329|NCT02707640|5467825|P1|COMPLETED|Overall Study||52
2229330|NCT02707640|5467824|P2|STARTED|Overall Study||62
2229331|NCT02707640|5467825|P1|STARTED|Overall Study||61
2229332|NCT02707601|5467845|P2|NOT COMPLETED|Overall Study||4
2229333|NCT02707601|5467846|P1|NOT COMPLETED|Overall Study||4
2229334|NCT02707601|5467845|P2|COMPLETED|Overall Study||70
2229335|NCT02707601|5467846|P1|COMPLETED|Overall Study||72
2229336|NCT02707601|5467845|P2|STARTED|Overall Study||74
2229337|NCT02707601|5467846|P1|STARTED|Overall Study||76
2229338|NCT02707172|5467860|P1|NOT COMPLETED|2nd Set of Experiment||0
2229339|NCT02707172|5467860|P1|COMPLETED|2nd Set of Experiment||28
2229340|NCT02707172|5467860|P1|STARTED|2nd Set of Experiment||28
2229341|NCT02707172|5467860|P1|NOT COMPLETED|Wash Out||0
2229342|NCT02707172|5467860|P1|COMPLETED|Wash Out||28
2229343|NCT02707172|5467860|P1|STARTED|Wash Out||28
2229344|NCT02707172|5467860|P1|NOT COMPLETED|1st Set of Experiment||0
2229345|NCT02707172|5467860|P1|COMPLETED|1st Set of Experiment||28
2229346|NCT02707172|5467860|P1|STARTED|1st Set of Experiment||28
2229347|NCT02707146|5467867|P2|NOT COMPLETED|Overall Study||3
2229348|NCT02707146|5467868|P1|NOT COMPLETED|Overall Study||0
2229349|NCT02707146|5467867|P2|COMPLETED|Overall Study||388
2229350|NCT02707146|5467868|P1|COMPLETED|Overall Study||359
2229351|NCT02707146|5467867|P2|STARTED|Overall Study||391
2229352|NCT02707146|5467868|P1|STARTED|Overall Study||359
2229362|NCT02706938|5467915|P2|NOT COMPLETED|Second Period, 6 Weeks||10
2229363|NCT02706938|5467916|P1|NOT COMPLETED|Second Period, 6 Weeks||0
2229364|NCT02706938|5467915|P2|COMPLETED|Second Period, 6 Weeks|Only data from 19 patients were finally analyzed because of missing data.|21
2229365|NCT02706938|5467916|P1|COMPLETED|Second Period, 6 Weeks|Only data from 20 patients were finally analyzed because of missing data.|21
2229366|NCT02706938|5467915|P2|STARTED|Second Period, 6 Weeks||31
2229367|NCT02706938|5467916|P1|STARTED|Second Period, 6 Weeks||21
2229368|NCT02706938|5467915|P2|NOT COMPLETED|First Period, 6 Weeks||2
2229369|NCT02706938|5467916|P1|NOT COMPLETED|First Period, 6 Weeks||11
2229370|NCT02706938|5467915|P2|COMPLETED|First Period, 6 Weeks||31
2229371|NCT02706938|5467916|P1|COMPLETED|First Period, 6 Weeks||21
2229372|NCT02706938|5467915|P2|STARTED|First Period, 6 Weeks||33
2229373|NCT02706938|5467916|P1|STARTED|First Period, 6 Weeks||32
2229374|NCT02706925|5467934|P9|NOT COMPLETED|Overall Study||0
2229375|NCT02706925|5467935|P8|NOT COMPLETED|Overall Study||0
2229376|NCT02706925|5467936|P7|NOT COMPLETED|Overall Study||0
2229377|NCT02706925|5467937|P6|NOT COMPLETED|Overall Study||0
2229378|NCT02706925|5467938|P5|NOT COMPLETED|Overall Study||0
2229379|NCT02706925|5467939|P4|NOT COMPLETED|Overall Study||0
2229380|NCT02706925|5467940|P3|NOT COMPLETED|Overall Study||0
2229381|NCT02706925|5467941|P2|NOT COMPLETED|Overall Study||0
2229382|NCT02706925|5467942|P1|NOT COMPLETED|Overall Study||0
2229383|NCT02706925|5467934|P9|COMPLETED|Overall Study||6
2229384|NCT02706925|5467935|P8|COMPLETED|Overall Study||6
2229385|NCT02706925|5467936|P7|COMPLETED|Overall Study||6
2229386|NCT02706925|5467937|P6|COMPLETED|Overall Study||5
2229387|NCT02706925|5467938|P5|COMPLETED|Overall Study||6
2229388|NCT02706925|5467939|P4|COMPLETED|Overall Study||6
2229389|NCT02706925|5467940|P3|COMPLETED|Overall Study||6
2229390|NCT02706925|5467941|P2|COMPLETED|Overall Study||6
2229391|NCT02706925|5467942|P1|COMPLETED|Overall Study||16
2229392|NCT02706925|5467934|P9|STARTED|Overall Study||6
2229393|NCT02706925|5467935|P8|STARTED|Overall Study||6
2229394|NCT02706925|5467936|P7|STARTED|Overall Study||6
2229395|NCT02706925|5467937|P6|STARTED|Overall Study||5
2229396|NCT02706925|5467938|P5|STARTED|Overall Study||6
2229397|NCT02706925|5467939|P4|STARTED|Overall Study||6
2229398|NCT02706925|5467940|P3|STARTED|Overall Study||6
2229399|NCT02706925|5467941|P2|STARTED|Overall Study||6
2229400|NCT02706925|5467942|P1|STARTED|Overall Study||16
2229401|NCT02706899|5467980|P2|NOT COMPLETED|Overall Study||6
2229402|NCT02706899|5467981|P1|NOT COMPLETED|Overall Study||13
2229403|NCT02706899|5467980|P2|COMPLETED|Overall Study||0
2229404|NCT02706899|5467981|P1|COMPLETED|Overall Study||0
2229405|NCT02706899|5467980|P2|STARTED|Overall Study||6
2229406|NCT02706899|5467981|P1|STARTED|Overall Study||13
2229407|NCT02706886|5468012|P9|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
2229408|NCT02706886|5468013|P8|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
2229409|NCT02706886|5468014|P7|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
2229410|NCT02706886|5468015|P6|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
2229411|NCT02706886|5468016|P5|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
2229412|NCT02706886|5468017|P4|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
2229413|NCT02706886|5468018|P3|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
2229414|NCT02706886|5468019|P2|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
2229415|NCT02706886|5468020|P1|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
2229416|NCT02706886|5468012|P9|COMPLETED|Part B: MAD Study Day 85-End of Study||4
2229417|NCT02706886|5468013|P8|COMPLETED|Part B: MAD Study Day 85-End of Study||8
2229418|NCT02706886|5468014|P7|COMPLETED|Part B: MAD Study Day 85-End of Study||8
2229419|NCT02706886|5468015|P6|COMPLETED|Part B: MAD Study Day 85-End of Study||0
2229420|NCT02706886|5468016|P5|COMPLETED|Part B: MAD Study Day 85-End of Study||0
2229421|NCT02706886|5468017|P4|COMPLETED|Part B: MAD Study Day 85-End of Study||0
2229422|NCT02706886|5468018|P3|COMPLETED|Part B: MAD Study Day 85-End of Study||0
2229423|NCT02706886|5468019|P2|COMPLETED|Part B: MAD Study Day 85-End of Study||0
2229424|NCT02706886|5468020|P1|COMPLETED|Part B: MAD Study Day 85-End of Study||0
2229425|NCT02706886|5468012|P9|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|4
2229426|NCT02706886|5468013|P8|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|8
2229427|NCT02706886|5468014|P7|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|8
2229428|NCT02706886|5468015|P6|STARTED|Part B: MAD Study Day 85-End of Study||0
2229429|NCT02706886|5468016|P5|STARTED|Part B: MAD Study Day 85-End of Study||0
2229430|NCT02706886|5468017|P4|STARTED|Part B: MAD Study Day 85-End of Study||0
2229431|NCT02706886|5468018|P3|STARTED|Part B: MAD Study Day 85-End of Study||0
2229432|NCT02706886|5468019|P2|STARTED|Part B: MAD Study Day 85-End of Study||0
2229433|NCT02706886|5468020|P1|STARTED|Part B: MAD Study Day 85-End of Study||0
2229434|NCT02706886|5468012|P9|NOT COMPLETED|Part B: MAD Study Days 1-85||0
2229435|NCT02706886|5468013|P8|NOT COMPLETED|Part B: MAD Study Days 1-85||0
2229436|NCT02706886|5468014|P7|NOT COMPLETED|Part B: MAD Study Days 1-85||0
2229437|NCT02706886|5468015|P6|NOT COMPLETED|Part B: MAD Study Days 1-85||0
2229438|NCT02706886|5468016|P5|NOT COMPLETED|Part B: MAD Study Days 1-85||0
2229439|NCT02706886|5468017|P4|NOT COMPLETED|Part B: MAD Study Days 1-85||0
2229440|NCT02706886|5468018|P3|NOT COMPLETED|Part B: MAD Study Days 1-85||0
2229441|NCT02706886|5468019|P2|NOT COMPLETED|Part B: MAD Study Days 1-85||0
2229442|NCT02706886|5468020|P1|NOT COMPLETED|Part B: MAD Study Days 1-85||0
2229443|NCT02706886|5468012|P9|COMPLETED|Part B: MAD Study Days 1-85||3
2229444|NCT02706886|5468013|P8|COMPLETED|Part B: MAD Study Days 1-85||7
2229445|NCT02706886|5468014|P7|COMPLETED|Part B: MAD Study Days 1-85||7
2229446|NCT02706886|5468015|P6|COMPLETED|Part B: MAD Study Days 1-85||3
2229447|NCT02706886|5468016|P5|COMPLETED|Part B: MAD Study Days 1-85||0
2229448|NCT02706886|5468017|P4|COMPLETED|Part B: MAD Study Days 1-85||0
2229449|NCT02706886|5468018|P3|COMPLETED|Part B: MAD Study Days 1-85||0
2229450|NCT02706886|5468019|P2|COMPLETED|Part B: MAD Study Days 1-85||0
2229451|NCT02706886|5468020|P1|COMPLETED|Part B: MAD Study Days 1-85||0
2229452|NCT02706886|5468012|P9|STARTED|Part B: MAD Study Days 1-85||3
2229453|NCT02706886|5468013|P8|STARTED|Part B: MAD Study Days 1-85||7
2229454|NCT02706886|5468014|P7|STARTED|Part B: MAD Study Days 1-85||7
2229455|NCT02706886|5468015|P6|STARTED|Part B: MAD Study Days 1-85||3
2229456|NCT02706886|5468016|P5|STARTED|Part B: MAD Study Days 1-85||0
2229457|NCT02706886|5468017|P4|STARTED|Part B: MAD Study Days 1-85||0
2229458|NCT02706886|5468018|P3|STARTED|Part B: MAD Study Days 1-85||0
2229459|NCT02706886|5468019|P2|STARTED|Part B: MAD Study Days 1-85||0
2229460|NCT02706886|5468020|P1|STARTED|Part B: MAD Study Days 1-85||0
2229461|NCT02706886|5468012|P9|NOT COMPLETED|Part A: SAD Period||0
2229462|NCT02706886|5468013|P8|NOT COMPLETED|Part A: SAD Period||0
2229463|NCT02706886|5468014|P7|NOT COMPLETED|Part A: SAD Period||0
2229464|NCT02706886|5468015|P6|NOT COMPLETED|Part A: SAD Period||0
2229465|NCT02706886|5468016|P5|NOT COMPLETED|Part A: SAD Period||0
2229466|NCT02706886|5468017|P4|NOT COMPLETED|Part A: SAD Period||2
2229467|NCT02706886|5468018|P3|NOT COMPLETED|Part A: SAD Period||0
2229468|NCT02706886|5468019|P2|NOT COMPLETED|Part A: SAD Period||0
2229469|NCT02706886|5468020|P1|NOT COMPLETED|Part A: SAD Period||0
2229470|NCT02706886|5468012|P9|COMPLETED|Part A: SAD Period||0
2229471|NCT02706886|5468013|P8|COMPLETED|Part A: SAD Period||0
2229472|NCT02706886|5468014|P7|COMPLETED|Part A: SAD Period||0
2229473|NCT02706886|5468015|P6|COMPLETED|Part A: SAD Period||0
2229474|NCT02706886|5468016|P5|COMPLETED|Part A: SAD Period||6
2229475|NCT02706886|5468017|P4|COMPLETED|Part A: SAD Period||4
2229476|NCT02706886|5468018|P3|COMPLETED|Part A: SAD Period||6
2229477|NCT02706886|5468019|P2|COMPLETED|Part A: SAD Period||6
2229478|NCT02706886|5468020|P1|COMPLETED|Part A: SAD Period||8
2229479|NCT02706886|5468012|P9|STARTED|Part A: SAD Period||0
2229480|NCT02706886|5468013|P8|STARTED|Part A: SAD Period||0
2229481|NCT02706886|5468014|P7|STARTED|Part A: SAD Period||0
2229482|NCT02706886|5468015|P6|STARTED|Part A: SAD Period||0
2229483|NCT02706886|5468016|P5|STARTED|Part A: SAD Period||6
2229484|NCT02706886|5468017|P4|STARTED|Part A: SAD Period||6
2229485|NCT02706886|5468018|P3|STARTED|Part A: SAD Period||6
2229486|NCT02706886|5468019|P2|STARTED|Part A: SAD Period||6
2229487|NCT02706886|5468020|P1|STARTED|Part A: SAD Period||8
2229544|NCT02706834|5468285|P11|NOT COMPLETED|Overall Study||1
2229545|NCT02706834|5468286|P10|NOT COMPLETED|Overall Study||1
2229546|NCT02706834|5468287|P9|NOT COMPLETED|Overall Study||0
2229547|NCT02706834|5468288|P8|NOT COMPLETED|Overall Study||0
2229548|NCT02706834|5468289|P7|NOT COMPLETED|Overall Study||0
2229549|NCT02706834|5468290|P6|NOT COMPLETED|Overall Study||0
2229550|NCT02706834|5468291|P5|NOT COMPLETED|Overall Study||1
2229551|NCT02706834|5468292|P4|NOT COMPLETED|Overall Study||0
2229552|NCT02706834|5468293|P3|NOT COMPLETED|Overall Study||1
2229553|NCT02706834|5468294|P2|NOT COMPLETED|Overall Study||1
2229554|NCT02706834|5468295|P1|NOT COMPLETED|Overall Study||2
2229555|NCT02706834|5468285|P11|COMPLETED|Overall Study||3
2229556|NCT02706834|5468286|P10|COMPLETED|Overall Study||3
2229557|NCT02706834|5468287|P9|COMPLETED|Overall Study||4
2229558|NCT02706834|5468288|P8|COMPLETED|Overall Study||3
2229559|NCT02706834|5468289|P7|COMPLETED|Overall Study||3
2229560|NCT02706834|5468290|P6|COMPLETED|Overall Study||3
2229561|NCT02706834|5468291|P5|COMPLETED|Overall Study||2
2229562|NCT02706834|5468292|P4|COMPLETED|Overall Study||3
2229563|NCT02706834|5468293|P3|COMPLETED|Overall Study||2
2229564|NCT02706834|5468294|P2|COMPLETED|Overall Study||2
2229565|NCT02706834|5468295|P1|COMPLETED|Overall Study|Completed = completed study drug|1
2229566|NCT02706834|5468285|P11|STARTED|Overall Study||4
2229567|NCT02706834|5468286|P10|STARTED|Overall Study||4
2229568|NCT02706834|5468287|P9|STARTED|Overall Study||4
2229569|NCT02706834|5468288|P8|STARTED|Overall Study||3
2229570|NCT02706834|5468289|P7|STARTED|Overall Study||3
2229571|NCT02706834|5468290|P6|STARTED|Overall Study||3
2229572|NCT02706834|5468291|P5|STARTED|Overall Study||3
2229573|NCT02706834|5468292|P4|STARTED|Overall Study||3
2229574|NCT02706834|5468293|P3|STARTED|Overall Study||3
2229575|NCT02706834|5468294|P2|STARTED|Overall Study||3
2229576|NCT02706834|5468295|P1|STARTED|Overall Study||3
2229577|NCT02706717|5468439|P2|NOT COMPLETED|Overall Study||11
2229578|NCT02706717|5468440|P1|NOT COMPLETED|Overall Study||1
2229579|NCT02706717|5468439|P2|COMPLETED|Overall Study||35
2229580|NCT02706717|5468440|P1|COMPLETED|Overall Study||46
2229581|NCT02706717|5468439|P2|STARTED|Overall Study|3 placebo participants never initiated study treatment.|46
2229582|NCT02706717|5468440|P1|STARTED|Overall Study||47
2229583|NCT02706691|5468504|P1|NOT COMPLETED|Overall Study||1
2229584|NCT02706691|5468504|P1|COMPLETED|Overall Study||0
2229585|NCT02706691|5468504|P1|STARTED|Overall Study||1
2229586|NCT02706327|5468514|P3|NOT COMPLETED|Overall Study||2
2229587|NCT02706327|5468515|P2|NOT COMPLETED|Overall Study||1
2229588|NCT02706327|5468516|P1|NOT COMPLETED|Overall Study||1
2229589|NCT02706327|5468514|P3|COMPLETED|Overall Study||21
2229590|NCT02706327|5468515|P2|COMPLETED|Overall Study||21
2229591|NCT02706327|5468516|P1|COMPLETED|Overall Study||21
2229592|NCT02706327|5468514|P3|STARTED|Overall Study||23
2229593|NCT02706327|5468515|P2|STARTED|Overall Study||22
2229594|NCT02706327|5468516|P1|STARTED|Overall Study||22
2229595|NCT02705807|5468536|P1|NOT COMPLETED|Overall Study||0
2229596|NCT02705807|5468536|P1|COMPLETED|Overall Study||10
2229597|NCT02705807|5468536|P1|STARTED|Overall Study||10
2229598|NCT02705716|5468568|P2|NOT COMPLETED|Overall Study||2
2229599|NCT02705716|5468569|P1|NOT COMPLETED|Overall Study||4
2229600|NCT02705716|5468568|P2|COMPLETED|Overall Study||68
2229601|NCT02705716|5468569|P1|COMPLETED|Overall Study||68
2229602|NCT02705716|5468568|P2|STARTED|Overall Study||70
2229603|NCT02705716|5468569|P1|STARTED|Overall Study||72
2229604|NCT02705625|5468582|P3|NOT COMPLETED|Overall Study||11
2229605|NCT02705625|5468583|P2|NOT COMPLETED|Overall Study||10
2229606|NCT02705625|5468584|P1|NOT COMPLETED|Overall Study||8
2229607|NCT02705625|5468582|P3|COMPLETED|Overall Study||69
2229608|NCT02705625|5468583|P2|COMPLETED|Overall Study||72
2229609|NCT02705625|5468584|P1|COMPLETED|Overall Study||74
2229610|NCT02705625|5468582|P3|STARTED|Overall Study||80
2229611|NCT02705625|5468583|P2|STARTED|Overall Study||82
2229612|NCT02705625|5468584|P1|STARTED|Overall Study||82
2229613|NCT02705586|5468613|P1|NOT COMPLETED|Overall Study||8
2229614|NCT02705586|5468613|P1|COMPLETED|Overall Study||5
2229615|NCT02705586|5468613|P1|STARTED|Overall Study||13
2229616|NCT02705365|5468619|P2|NOT COMPLETED|Overall Study||0
2229617|NCT02705365|5468620|P1|NOT COMPLETED|Overall Study||0
2229618|NCT02705365|5468619|P2|COMPLETED|Overall Study||800
2229619|NCT02705365|5468620|P1|COMPLETED|Overall Study||400
2229620|NCT02705365|5468619|P2|STARTED|Overall Study||800
2229621|NCT02705365|5468620|P1|STARTED|Overall Study||400
2229628|NCT02704702|5468649|P6|NOT COMPLETED|Overall Study||2
2229629|NCT02704702|5468650|P5|NOT COMPLETED|Overall Study||2
2229630|NCT02704702|5468651|P4|NOT COMPLETED|Overall Study||1
2229631|NCT02704702|5468652|P3|NOT COMPLETED|Overall Study||0
2229632|NCT02704702|5468653|P2|NOT COMPLETED|Overall Study||0
2229633|NCT02704702|5468654|P1|NOT COMPLETED|Overall Study||1
2229634|NCT02704702|5468649|P6|COMPLETED|Overall Study||4
2229635|NCT02704702|5468650|P5|COMPLETED|Overall Study||4
2229636|NCT02704702|5468651|P4|COMPLETED|Overall Study||5
2229637|NCT02704702|5468652|P3|COMPLETED|Overall Study||6
2229638|NCT02704702|5468653|P2|COMPLETED|Overall Study||6
2229639|NCT02704702|5468654|P1|COMPLETED|Overall Study||5
2229640|NCT02704702|5468649|P6|STARTED|Overall Study||6
2229641|NCT02704702|5468650|P5|STARTED|Overall Study||6
2229642|NCT02704702|5468651|P4|STARTED|Overall Study||6
2229643|NCT02704702|5468652|P3|STARTED|Overall Study||6
2229644|NCT02704702|5468653|P2|STARTED|Overall Study||6
2229645|NCT02704702|5468654|P1|STARTED|Overall Study||6
2229646|NCT02704689|5468686|P1|NOT COMPLETED|Overall Study||3
2229647|NCT02704689|5468686|P1|COMPLETED|Overall Study||6
2229648|NCT02704689|5468686|P1|STARTED|Overall Study||9
2229649|NCT02704104|5468703|P1|NOT COMPLETED|Overall Study||0
2229650|NCT02704104|5468703|P1|COMPLETED|Overall Study||46
2229651|NCT02704104|5468703|P1|STARTED|Overall Study||46
2229652|NCT02703948|5468717|P1|NOT COMPLETED|Overall Study||3
2229653|NCT02703948|5468717|P1|COMPLETED|Overall Study||57
2229654|NCT02703948|5468717|P1|STARTED|Overall Study||60
2229655|NCT02703909|5468725|P4|NOT COMPLETED|Overall Study||0
2229656|NCT02703909|5468726|P3|NOT COMPLETED|Overall Study||0
2229657|NCT02703909|5468727|P2|NOT COMPLETED|Overall Study||0
2229658|NCT02703909|5468728|P1|NOT COMPLETED|Overall Study||0
2229659|NCT02703909|5468725|P4|COMPLETED|Overall Study||35
2229660|NCT02703909|5468726|P3|COMPLETED|Overall Study||36
2229661|NCT02703909|5468727|P2|COMPLETED|Overall Study||37
2229662|NCT02703909|5468728|P1|COMPLETED|Overall Study||36
2229663|NCT02703909|5468725|P4|STARTED|Overall Study||35
2229664|NCT02703909|5468726|P3|STARTED|Overall Study||36
2229665|NCT02703909|5468727|P2|STARTED|Overall Study||37
2229666|NCT02703909|5468728|P1|STARTED|Overall Study||36
2229667|NCT02703636|5468744|P1|NOT COMPLETED|Overall Study||16
2229668|NCT02703636|5468744|P1|COMPLETED|Overall Study||102
2229669|NCT02703636|5468744|P1|STARTED|Overall Study||118
2229670|NCT02703532|5468759|P4|NOT COMPLETED|Overall Study||1
2229671|NCT02703532|5468760|P3|NOT COMPLETED|Overall Study||2
2229672|NCT02703532|5468761|P2|NOT COMPLETED|Overall Study||1
2229673|NCT02703532|5468762|P1|NOT COMPLETED|Overall Study||2
2229674|NCT02703532|5468759|P4|COMPLETED|Overall Study||10
2229675|NCT02703532|5468760|P3|COMPLETED|Overall Study||19
2229676|NCT02703532|5468761|P2|COMPLETED|Overall Study||10
2229677|NCT02703532|5468762|P1|COMPLETED|Overall Study||19
2229678|NCT02703532|5468759|P4|STARTED|Overall Study||11
2229679|NCT02703532|5468760|P3|STARTED|Overall Study||21
2229680|NCT02703532|5468761|P2|STARTED|Overall Study||11
2229681|NCT02703532|5468762|P1|STARTED|Overall Study||21
2229682|NCT02703467|5468800|P3|NOT COMPLETED|Overall Study||0
2229683|NCT02703467|5468801|P2|NOT COMPLETED|Overall Study||0
2229684|NCT02703467|5468802|P1|NOT COMPLETED|Overall Study||0
2229685|NCT02703467|5468800|P3|COMPLETED|Overall Study||45
2229686|NCT02703467|5468801|P2|COMPLETED|Overall Study||5
2229687|NCT02703467|5468802|P1|COMPLETED|Overall Study||20
2229688|NCT02703467|5468800|P3|STARTED|Overall Study||45
2229689|NCT02703467|5468801|P2|STARTED|Overall Study||5
2229690|NCT02703467|5468802|P1|STARTED|Overall Study||20
2229691|NCT02703454|5468824|P2|NOT COMPLETED|Overall Study||16
2229692|NCT02703454|5468825|P1|NOT COMPLETED|Overall Study||11
2229693|NCT02703454|5468824|P2|COMPLETED|Overall Study||11
2229694|NCT02703454|5468825|P1|COMPLETED|Overall Study||13
2229695|NCT02703454|5468824|P2|Treated|Overall Study||24
2229696|NCT02703454|5468825|P1|Treated|Overall Study||23
2229697|NCT02703454|5468824|P2|STARTED|Overall Study||27
2229698|NCT02703454|5468825|P1|STARTED|Overall Study||24
2229699|NCT02703259|5468835|P2|NOT COMPLETED|2 Weeks Postoperative Assessment||10
2229700|NCT02703259|5468836|P1|NOT COMPLETED|2 Weeks Postoperative Assessment||10
2229701|NCT02703259|5468835|P2|COMPLETED|2 Weeks Postoperative Assessment||51
2229702|NCT02703259|5468836|P1|COMPLETED|2 Weeks Postoperative Assessment||58
2229703|NCT02703259|5468835|P2|STARTED|2 Weeks Postoperative Assessment||61
2229704|NCT02703259|5468836|P1|STARTED|2 Weeks Postoperative Assessment||68
2229705|NCT02703259|5468835|P2|NOT COMPLETED|24 Hours Postoperative Assessment||6
2229706|NCT02703259|5468836|P1|NOT COMPLETED|24 Hours Postoperative Assessment||2
2229707|NCT02703259|5468835|P2|COMPLETED|24 Hours Postoperative Assessment||61
2229708|NCT02703259|5468836|P1|COMPLETED|24 Hours Postoperative Assessment||68
2229709|NCT02703259|5468835|P2|STARTED|24 Hours Postoperative Assessment||67
2229710|NCT02703259|5468836|P1|STARTED|24 Hours Postoperative Assessment||70
2229711|NCT02702999|5468854|P2|NOT COMPLETED|Overall Study||0
2229712|NCT02702999|5468855|P1|NOT COMPLETED|Overall Study||0
2229713|NCT02702999|5468854|P2|COMPLETED|Overall Study||104
2229714|NCT02702999|5468855|P1|COMPLETED|Overall Study||102
2229715|NCT02702999|5468854|P2|STARTED|Overall Study||104
2229716|NCT02702999|5468855|P1|STARTED|Overall Study||102
2229717|NCT02702921|5468873|P2|NOT COMPLETED|Overall Study||8
2229718|NCT02702921|5468874|P1|NOT COMPLETED|Overall Study||14
2229719|NCT02702921|5468873|P2|COMPLETED|Overall Study||95
2229720|NCT02702921|5468874|P1|COMPLETED|Overall Study||84
2229721|NCT02702921|5468873|P2|STARTED|Overall Study||103
2229722|NCT02702921|5468874|P1|STARTED|Overall Study||98
2229731|NCT02702193|5468907|P2|NOT COMPLETED|12 Month Follow up||18
2229732|NCT02702193|5468908|P1|NOT COMPLETED|12 Month Follow up||17
2229733|NCT02702193|5468907|P2|COMPLETED|12 Month Follow up||69
2229734|NCT02702193|5468908|P1|COMPLETED|12 Month Follow up||69
2229735|NCT02702193|5468907|P2|STARTED|12 Month Follow up||87
2229736|NCT02702193|5468908|P1|STARTED|12 Month Follow up||86
2229737|NCT02702193|5468907|P2|NOT COMPLETED|8 Month Follow up||18
2229738|NCT02702193|5468908|P1|NOT COMPLETED|8 Month Follow up||15
2229739|NCT02702193|5468907|P2|COMPLETED|8 Month Follow up||69
2229740|NCT02702193|5468908|P1|COMPLETED|8 Month Follow up||71
2229741|NCT02702193|5468907|P2|STARTED|8 Month Follow up||87
2229742|NCT02702193|5468908|P1|STARTED|8 Month Follow up||86
2229743|NCT02702193|5468907|P2|NOT COMPLETED|4 Month Follow up||18
2229744|NCT02702193|5468908|P1|NOT COMPLETED|4 Month Follow up||18
2229745|NCT02702193|5468907|P2|COMPLETED|4 Month Follow up||69
2229746|NCT02702193|5468908|P1|COMPLETED|4 Month Follow up||68
2229747|NCT02702193|5468907|P2|STARTED|4 Month Follow up||87
2229748|NCT02702193|5468908|P1|STARTED|4 Month Follow up||86
2229749|NCT02702193|5468907|P2|NOT COMPLETED|Baseline Assessment/Randomization||0
2229750|NCT02702193|5468908|P1|NOT COMPLETED|Baseline Assessment/Randomization||1
2229751|NCT02702193|5468907|P2|COMPLETED|Baseline Assessment/Randomization||87
2229752|NCT02702193|5468908|P1|COMPLETED|Baseline Assessment/Randomization||85
2229753|NCT02702193|5468907|P2|STARTED|Baseline Assessment/Randomization||87
2229754|NCT02702193|5468908|P1|STARTED|Baseline Assessment/Randomization||86
2229755|NCT02702011|5468936|P4|NOT COMPLETED|Overall Study||0
2229756|NCT02702011|5468937|P3|NOT COMPLETED|Overall Study||0
2229757|NCT02702011|5468938|P2|NOT COMPLETED|Overall Study||1
2229758|NCT02702011|5468939|P1|NOT COMPLETED|Overall Study||0
2229759|NCT02702011|5468936|P4|COMPLETED|Overall Study||12
2229760|NCT02702011|5468937|P3|COMPLETED|Overall Study||12
2229761|NCT02702011|5468938|P2|COMPLETED|Overall Study||12
2229762|NCT02702011|5468939|P1|COMPLETED|Overall Study||11
2229763|NCT02702011|5468936|P4|STARTED|Overall Study|Started are the treated patients.|12
2229764|NCT02702011|5468937|P3|STARTED|Overall Study|Started are the treated patients.|12
2229765|NCT02702011|5468938|P2|STARTED|Overall Study|Started are the treated patients.|13
2229766|NCT02702011|5468939|P1|STARTED|Overall Study|Started are the treated patients.|11
2229767|NCT02701985|5468951|P2|NOT COMPLETED|Overall Study||6
2229768|NCT02701985|5468952|P1|NOT COMPLETED|Overall Study||3
2229769|NCT02701985|5468951|P2|COMPLETED|Overall Study||32
2229770|NCT02701985|5468952|P1|COMPLETED|Overall Study||34
2229771|NCT02701985|5468951|P2|STARTED|Overall Study||38
2229772|NCT02701985|5468952|P1|STARTED|Overall Study||37
2229773|NCT02701764|5468995|P2|NOT COMPLETED|Overall Study||1
2229774|NCT02701764|5468996|P1|NOT COMPLETED|Overall Study||0
2229775|NCT02701764|5468995|P2|COMPLETED|Overall Study||21
2229776|NCT02701764|5468996|P1|COMPLETED|Overall Study||21
2229777|NCT02701764|5468995|P2|STARTED|Overall Study||22
2229778|NCT02701764|5468996|P1|STARTED|Overall Study||21
2229779|NCT02701647|5469019|P3|NOT COMPLETED|Overall Study||1
2229780|NCT02701647|5469020|P2|NOT COMPLETED|Overall Study||0
2229781|NCT02701647|5469021|P1|NOT COMPLETED|Overall Study||0
2229782|NCT02701647|5469019|P3|COMPLETED|Overall Study|One participant from sham-TT withdraw due a back injury unrelated to study.|16
2229783|NCT02701647|5469020|P2|COMPLETED|Overall Study||17
2229784|NCT02701647|5469021|P1|COMPLETED|Overall Study||17
2229785|NCT02701647|5469019|P3|STARTED|Overall Study||17
2229786|NCT02701647|5469020|P2|STARTED|Overall Study||17
2229787|NCT02701647|5469021|P1|STARTED|Overall Study||17
2229788|NCT02701634|5469055|P2|NOT COMPLETED|Overall Study||31
2229789|NCT02701634|5469056|P1|NOT COMPLETED|Overall Study||32
2229790|NCT02701634|5469055|P2|COMPLETED|Overall Study||2
2229791|NCT02701634|5469056|P1|COMPLETED|Overall Study||1
2229792|NCT02701634|5469055|P2|STARTED|Overall Study||33
2229793|NCT02701634|5469056|P1|STARTED|Overall Study||33
2229794|NCT02701582|5469086|P2|NOT COMPLETED|Overall Study||0
2229795|NCT02701582|5469087|P1|NOT COMPLETED|Overall Study||2
2229796|NCT02701582|5469086|P2|COMPLETED|Overall Study||33
2229797|NCT02701582|5469087|P1|COMPLETED|Overall Study||33
2229798|NCT02701582|5469086|P2|STARTED|Overall Study||33
2229799|NCT02701582|5469087|P1|STARTED|Overall Study||35
2229800|NCT02701556|5469111|P2|NOT COMPLETED|Overall Study||20
2229801|NCT02701556|5469112|P1|NOT COMPLETED|Overall Study||23
2229802|NCT02701556|5469111|P2|COMPLETED|Overall Study||178
2229803|NCT02701556|5469112|P1|COMPLETED|Overall Study||175
2229804|NCT02701556|5469111|P2|STARTED|Overall Study||198
2229805|NCT02701556|5469112|P1|STARTED|Overall Study||198
2229806|NCT02701387|5469118|P1|NOT COMPLETED|Overall Study||0
2229807|NCT02701387|5469118|P1|COMPLETED|Overall Study||7
2229808|NCT02701387|5469118|P1|STARTED|Overall Study||7
2229809|NCT02701361|5469126|P3|NOT COMPLETED|Overall Study||2
2229810|NCT02701361|5469127|P2|NOT COMPLETED|Overall Study||3
2229811|NCT02701361|5469128|P1|NOT COMPLETED|Overall Study||9
2229812|NCT02701361|5469126|P3|COMPLETED|Overall Study||16
2229813|NCT02701361|5469127|P2|COMPLETED|Overall Study||28
2229814|NCT02701361|5469128|P1|COMPLETED|Overall Study||22
2229815|NCT02701361|5469126|P3|STARTED|Overall Study||18
2229816|NCT02701361|5469127|P2|STARTED|Overall Study||31
2229817|NCT02701361|5469128|P1|STARTED|Overall Study||31
2229818|NCT02701296|5469169|P2|NOT COMPLETED|Overall Study||2
2229819|NCT02701296|5469170|P1|NOT COMPLETED|Overall Study||0
2229820|NCT02701296|5469169|P2|COMPLETED|Overall Study|Data was incomplete for two participants their data was not included in the overall data analysis.|36
2229821|NCT02701296|5469170|P1|COMPLETED|Overall Study||42
2229822|NCT02701296|5469169|P2|STARTED|Overall Study||38
2229823|NCT02701296|5469170|P1|STARTED|Overall Study||42
2229824|NCT02701270|5469186|P4|NOT COMPLETED|Fourth Intervention at Visit 4||0
2229825|NCT02701270|5469187|P3|NOT COMPLETED|Fourth Intervention at Visit 4||0
2229826|NCT02701270|5469188|P2|NOT COMPLETED|Fourth Intervention at Visit 4||0
2229827|NCT02701270|5469189|P1|NOT COMPLETED|Fourth Intervention at Visit 4||0
2229828|NCT02701270|5469186|P4|COMPLETED|Fourth Intervention at Visit 4||3
2229829|NCT02701270|5469187|P3|COMPLETED|Fourth Intervention at Visit 4||3
2229830|NCT02701270|5469188|P2|COMPLETED|Fourth Intervention at Visit 4||3
2229831|NCT02701270|5469189|P1|COMPLETED|Fourth Intervention at Visit 4||2
2229832|NCT02701270|5469186|P4|STARTED|Fourth Intervention at Visit 4||3
2229833|NCT02701270|5469187|P3|STARTED|Fourth Intervention at Visit 4||3
2229834|NCT02701270|5469188|P2|STARTED|Fourth Intervention at Visit 4||3
2229835|NCT02701270|5469189|P1|STARTED|Fourth Intervention at Visit 4||2
2229836|NCT02701270|5469186|P4|NOT COMPLETED|Third Intervention at Visit 3||0
2229837|NCT02701270|5469187|P3|NOT COMPLETED|Third Intervention at Visit 3||0
2229838|NCT02701270|5469188|P2|NOT COMPLETED|Third Intervention at Visit 3||0
2229839|NCT02701270|5469189|P1|NOT COMPLETED|Third Intervention at Visit 3||0
2229840|NCT02701270|5469186|P4|COMPLETED|Third Intervention at Visit 3||3
2229841|NCT02701270|5469187|P3|COMPLETED|Third Intervention at Visit 3||3
2229842|NCT02701270|5469188|P2|COMPLETED|Third Intervention at Visit 3||3
2229843|NCT02701270|5469189|P1|COMPLETED|Third Intervention at Visit 3||2
2229844|NCT02701270|5469186|P4|STARTED|Third Intervention at Visit 3||3
2229845|NCT02701270|5469187|P3|STARTED|Third Intervention at Visit 3||3
2229846|NCT02701270|5469188|P2|STARTED|Third Intervention at Visit 3||3
2229847|NCT02701270|5469189|P1|STARTED|Third Intervention at Visit 3||2
2229848|NCT02701270|5469186|P4|NOT COMPLETED|Second Intervention at Visit 2||0
2229849|NCT02701270|5469187|P3|NOT COMPLETED|Second Intervention at Visit 2||0
2229850|NCT02701270|5469188|P2|NOT COMPLETED|Second Intervention at Visit 2||0
2229851|NCT02701270|5469189|P1|NOT COMPLETED|Second Intervention at Visit 2||0
2229852|NCT02701270|5469186|P4|COMPLETED|Second Intervention at Visit 2||3
2229853|NCT02701270|5469187|P3|COMPLETED|Second Intervention at Visit 2||3
2229854|NCT02701270|5469188|P2|COMPLETED|Second Intervention at Visit 2||3
2229855|NCT02701270|5469189|P1|COMPLETED|Second Intervention at Visit 2||2
2229856|NCT02701270|5469186|P4|STARTED|Second Intervention at Visit 2||3
2229857|NCT02701270|5469187|P3|STARTED|Second Intervention at Visit 2||3
2229858|NCT02701270|5469188|P2|STARTED|Second Intervention at Visit 2||3
2229859|NCT02701270|5469189|P1|STARTED|Second Intervention at Visit 2||2
2229860|NCT02701270|5469186|P4|NOT COMPLETED|First Intervention at Visit 1||0
2229861|NCT02701270|5469187|P3|NOT COMPLETED|First Intervention at Visit 1||0
2229862|NCT02701270|5469188|P2|NOT COMPLETED|First Intervention at Visit 1||0
2229863|NCT02701270|5469189|P1|NOT COMPLETED|First Intervention at Visit 1||0
2229864|NCT02701270|5469186|P4|COMPLETED|First Intervention at Visit 1||3
2229865|NCT02701270|5469187|P3|COMPLETED|First Intervention at Visit 1||3
2229866|NCT02701270|5469188|P2|COMPLETED|First Intervention at Visit 1||3
2229867|NCT02701270|5469189|P1|COMPLETED|First Intervention at Visit 1||2
2229868|NCT02701270|5469186|P4|STARTED|First Intervention at Visit 1||3
2229869|NCT02701270|5469187|P3|STARTED|First Intervention at Visit 1||3
2229870|NCT02701270|5469188|P2|STARTED|First Intervention at Visit 1||3
2229871|NCT02701270|5469189|P1|STARTED|First Intervention at Visit 1||2
2229872|NCT02701257|5469208|P5|NOT COMPLETED|Overall Study||3
2229873|NCT02701257|5469209|P4|NOT COMPLETED|Overall Study||1
2229874|NCT02701257|5469210|P3|NOT COMPLETED|Overall Study||0
2229875|NCT02701257|5469211|P2|NOT COMPLETED|Overall Study||3
2229876|NCT02701257|5469212|P1|NOT COMPLETED|Overall Study||0
2229877|NCT02701257|5469208|P5|COMPLETED|Overall Study||1
2229878|NCT02701257|5469209|P4|COMPLETED|Overall Study||3
2229879|NCT02701257|5469210|P3|COMPLETED|Overall Study||0
2229880|NCT02701257|5469211|P2|COMPLETED|Overall Study||3
2229881|NCT02701257|5469212|P1|COMPLETED|Overall Study||6
2229882|NCT02701257|5469208|P5|STARTED|Overall Study||4
2229883|NCT02701257|5469209|P4|STARTED|Overall Study||4
2229884|NCT02701257|5469210|P3|STARTED|Overall Study||0
2229885|NCT02701257|5469211|P2|STARTED|Overall Study||6
2229886|NCT02701257|5469212|P1|STARTED|Overall Study||6
2229887|NCT02701049|5469402|P3|NOT COMPLETED|Overall Study||0
2229888|NCT02701049|5469403|P2|NOT COMPLETED|Overall Study||0
2229889|NCT02701049|5469404|P1|NOT COMPLETED|Overall Study||0
2229890|NCT02701049|5469402|P3|COMPLETED|Overall Study|Total patients included in analysis|198
2229891|NCT02701049|5469403|P2|COMPLETED|Overall Study|Total patients included in analysis|342
2229892|NCT02701049|5469404|P1|COMPLETED|Overall Study|Total patients included in analysis|209
2229893|NCT02701049|5469402|P3|STARTED|Overall Study|Patients who completed a follow-up survey|198
2229894|NCT02701049|5469403|P2|STARTED|Overall Study|Patients who completed a follow-up survey|342
2229895|NCT02701049|5469404|P1|STARTED|Overall Study|Patients who completed a follow-up survey|209
2229896|NCT02700997|5469416|P1|NOT COMPLETED|Overall Study||2
2229897|NCT02700997|5469416|P1|COMPLETED|Overall Study||15
2229898|NCT02700997|5469416|P1|STARTED|Overall Study||17
2229899|NCT02700984|5469422|P2|NOT COMPLETED|Overall Study||14
2229900|NCT02700984|5469423|P1|NOT COMPLETED|Overall Study||15
2229901|NCT02700984|5469422|P2|COMPLETED|Overall Study||53
2229902|NCT02700984|5469423|P1|COMPLETED|Overall Study||200
2229903|NCT02700984|5469422|P2|STARTED|Overall Study||67
2229904|NCT02700984|5469423|P1|STARTED|Overall Study||215
2229905|NCT02700815|5469476|P4|NOT COMPLETED|Overall Study||7
2229906|NCT02700815|5469477|P3|NOT COMPLETED|Overall Study||4
2229907|NCT02700815|5469478|P2|NOT COMPLETED|Overall Study||7
2229908|NCT02700815|5469479|P1|NOT COMPLETED|Overall Study||1
2229909|NCT02700815|5469476|P4|COMPLETED|Overall Study||218
2229910|NCT02700815|5469477|P3|COMPLETED|Overall Study||219
2229911|NCT02700815|5469478|P2|COMPLETED|Overall Study||216
2229912|NCT02700815|5469479|P1|COMPLETED|Overall Study||74
2229913|NCT02700815|5469476|P4|STARTED|Overall Study||225
2229914|NCT02700815|5469477|P3|STARTED|Overall Study||223
2229915|NCT02700815|5469478|P2|STARTED|Overall Study||223
2229916|NCT02700815|5469479|P1|STARTED|Overall Study||75
2229917|NCT02699983|5469519|P2|NOT COMPLETED|Overall Study||0
2229918|NCT02699983|5469520|P1|NOT COMPLETED|Overall Study||1
2229919|NCT02699983|5469519|P2|COMPLETED|Overall Study||17
2229920|NCT02699983|5469520|P1|COMPLETED|Overall Study||17
2229921|NCT02699983|5469519|P2|STARTED|Overall Study||17
2229922|NCT02699983|5469520|P1|STARTED|Overall Study||18
2229923|NCT02699970|5469580|P1|NOT COMPLETED|Overall Study||0
2229924|NCT02699970|5469580|P1|COMPLETED|Overall Study||399
2229925|NCT02699970|5469580|P1|Inter-system|Overall Study||399
2229926|NCT02699970|5469580|P1|Intra-system|Overall Study||399
2229927|NCT02699970|5469580|P1|STARTED|Overall Study||399
2229928|NCT02699892|5469585|P1|NOT COMPLETED|Overall Study||36
2229929|NCT02699892|5469585|P1|COMPLETED|Overall Study||94
2229930|NCT02699892|5469585|P1|STARTED|Overall Study||130
2229931|NCT02699684|5469590|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
2229932|NCT02699684|5469591|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
2229933|NCT02699684|5469590|P2|COMPLETED|Period 2, Second 30 Days of Wear||38
2229934|NCT02699684|5469591|P1|COMPLETED|Period 2, Second 30 Days of Wear||36
2229935|NCT02699684|5469590|P2|STARTED|Period 2, Second 30 Days of Wear||38
2229936|NCT02699684|5469591|P1|STARTED|Period 2, Second 30 Days of Wear||37
2229937|NCT02699684|5469590|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||0
2229938|NCT02699684|5469591|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
2229939|NCT02699684|5469590|P2|COMPLETED|Period 1, First 30 Days of Wear||38
2229940|NCT02699684|5469591|P1|COMPLETED|Period 1, First 30 Days of Wear||37
2229941|NCT02699684|5469590|P2|STARTED|Period 1, First 30 Days of Wear||38
2229942|NCT02699684|5469591|P1|STARTED|Period 1, First 30 Days of Wear||37
2229943|NCT02699632|5469601|P1|NOT COMPLETED|Overall Study||2
2229944|NCT02699632|5469601|P1|COMPLETED|Overall Study||358
2229945|NCT02699632|5469601|P1|STARTED|Overall Study||360
2229946|NCT02699593|5469608|P2|NOT COMPLETED|Period 2||2
2229947|NCT02699593|5469609|P1|NOT COMPLETED|Period 2||2
2229948|NCT02699593|5469608|P2|COMPLETED|Period 2||60
2229949|NCT02699593|5469609|P1|COMPLETED|Period 2||65
2229950|NCT02699593|5469608|P2|STARTED|Period 2||62
2229951|NCT02699593|5469609|P1|STARTED|Period 2||67
2229952|NCT02699593|5469608|P2|NOT COMPLETED|Period 1||7
2229953|NCT02699593|5469609|P1|NOT COMPLETED|Period 1||5
2229954|NCT02699593|5469608|P2|COMPLETED|Period 1||62
2229955|NCT02699593|5469609|P1|COMPLETED|Period 1||67
2229956|NCT02699593|5469608|P2|STARTED|Period 1||69
2229957|NCT02699593|5469609|P1|STARTED|Period 1||72
2229958|NCT02699099|5469620|P3|NOT COMPLETED|Overall Study||3
2229959|NCT02699099|5469621|P2|NOT COMPLETED|Overall Study||2
2229960|NCT02699099|5469622|P1|NOT COMPLETED|Overall Study||7
2229961|NCT02699099|5469620|P3|COMPLETED|Overall Study||229
2229962|NCT02699099|5469621|P2|COMPLETED|Overall Study||234
2229963|NCT02699099|5469622|P1|COMPLETED|Overall Study||224
2229964|NCT02699099|5469620|P3|STARTED|Overall Study||232
2229965|NCT02699099|5469621|P2|STARTED|Overall Study||236
2229966|NCT02699099|5469622|P1|STARTED|Overall Study||231
2229967|NCT02698800|5469696|P2|NOT COMPLETED|Overall Study||0
2229968|NCT02698800|5469697|P1|NOT COMPLETED|Overall Study||1
2229969|NCT02698800|5469696|P2|COMPLETED|Overall Study||8
2229970|NCT02698800|5469697|P1|COMPLETED|Overall Study||6
2229971|NCT02698800|5469696|P2|STARTED|Overall Study||8
2229972|NCT02698800|5469697|P1|STARTED|Overall Study||7
2229973|NCT02698735|5469705|P1|NOT COMPLETED|Overall Study||0
2229974|NCT02698735|5469705|P1|COMPLETED|Overall Study|There are only 18 out of 20 samples because one patient declined intradermal injection intervention.|5
2229975|NCT02698735|5469705|P1|STARTED|Overall Study||5
2229976|NCT02698566|5469719|P2|NOT COMPLETED|Overall Study||0
2229977|NCT02698566|5469720|P1|NOT COMPLETED|Overall Study||0
2229978|NCT02698566|5469719|P2|COMPLETED|Overall Study||3
2229979|NCT02698566|5469720|P1|COMPLETED|Overall Study||35
2229980|NCT02698566|5469719|P2|STARTED|Overall Study||3
2229981|NCT02698566|5469720|P1|STARTED|Overall Study||35
2229982|NCT02698436|5469728|P2|NOT COMPLETED|Overall Study||7
2229983|NCT02698436|5469729|P1|NOT COMPLETED|Overall Study||7
2229984|NCT02698436|5469728|P2|COMPLETED|Overall Study||51
2229985|NCT02698436|5469729|P1|COMPLETED|Overall Study||52
2229986|NCT02698436|5469728|P2|STARTED|Overall Study||58
2229987|NCT02698436|5469729|P1|STARTED|Overall Study||59
2229988|NCT02698423|5469769|P2|NOT COMPLETED|Overall Study||24
2229989|NCT02698423|5469770|P1|NOT COMPLETED|Overall Study||19
2229990|NCT02698423|5469769|P2|COMPLETED|Overall Study||307
2229991|NCT02698423|5469770|P1|COMPLETED|Overall Study||317
2229992|NCT02698423|5469769|P2|STARTED|Overall Study||331
2229993|NCT02698423|5469770|P1|STARTED|Overall Study||336
2229994|NCT02698371|5469778|P1|NOT COMPLETED|ADU-SE (G6) Arm/Group Flow||2
2229995|NCT02698371|5469778|P1|COMPLETED|ADU-SE (G6) Arm/Group Flow||33
2229996|NCT02698371|5469778|P1|STARTED|ADU-SE (G6) Arm/Group Flow|Each participant received one NCCLs restoration with ADU-SE (G6 Arm/group)|35
2229997|NCT02698371|5469778|P1|NOT COMPLETED|ADU-ER (G5) Arm/Group Flow||3
2229998|NCT02698371|5469778|P1|COMPLETED|ADU-ER (G5) Arm/Group Flow||32
2229999|NCT02698371|5469778|P1|STARTED|ADU-ER (G5) Arm/Group Flow|Each participant received one NCCLs restoration with ADU-ER (G5 Arm/group)|35
2230000|NCT02698371|5469778|P1|NOT COMPLETED|FBU-SE (G4) Arm/Group Flow||3
2230001|NCT02698371|5469778|P1|COMPLETED|FBU-SE (G4) Arm/Group Flow||32
2230002|NCT02698371|5469778|P1|STARTED|FBU-SE (G4) Arm/Group Flow|Each participant received one NCCLs restoration with FBU-SE (G4 Arm/group)|35
2230003|NCT02698371|5469778|P1|NOT COMPLETED|FBU-ER (G3) Arm/Group Flow||3
2230004|NCT02698371|5469778|P1|COMPLETED|FBU-ER (G3) Arm/Group Flow||32
2230005|NCT02698371|5469778|P1|STARTED|FBU-ER (G3) Arm/Group Flow|Each participant received one NCCLs restoration with FBU-ER (G3 Arm/group)|35
2230006|NCT02698371|5469778|P1|NOT COMPLETED|FBDC-SE-EE (G2; Control ) Arm/Group Flow||3
2230007|NCT02698371|5469778|P1|COMPLETED|FBDC-SE-EE (G2; Control ) Arm/Group Flow||32
2230008|NCT02698371|5469778|P1|STARTED|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Each participant received one NCCLs restoration with FBDC-SE-EE (G2 control Arm/group)|35
2230009|NCT02698371|5469778|P1|NOT COMPLETED|FBDC-SE (G1; Control) Arm/Group Flow||3
2230010|NCT02698371|5469778|P1|COMPLETED|FBDC-SE (G1; Control) Arm/Group Flow||32
2230011|NCT02698371|5469778|P1|STARTED|FBDC-SE (G1; Control) Arm/Group Flow|Each participant received one NCCLs restoration with FBDC-SE (G1control Arm/Group).|35
2230012|NCT02698371|5469778|P1|NOT COMPLETED|All Participants Flow||3
2230013|NCT02698371|5469778|P1|COMPLETED|All Participants Flow||35
2230014|NCT02698371|5469778|P1|STARTED|All Participants Flow||38
2230015|NCT02698241|5469900|P1|NOT COMPLETED|Overall Study||34
2230016|NCT02698241|5469900|P1|COMPLETED|Overall Study|Number of subjects completed the study (no early exit or death)|45
2230109|NCT02697214|5470210|P6|STARTED|Overall Study||50
2230017|NCT02698241|5469900|P1|Baseline & Programming|Overall Study|Number of subjects that passed screening and completed baseline and programming visit|66
2230018|NCT02698241|5469900|P1|STARTED|Overall Study|Number of subjects enrolled the study|79
2230019|NCT02698189|5469907|P2|NOT COMPLETED|Overall Study||6
2230020|NCT02698189|5469908|P1|NOT COMPLETED|Overall Study||3
2230021|NCT02698189|5469907|P2|COMPLETED|Overall Study||0
2230022|NCT02698189|5469908|P1|COMPLETED|Overall Study||0
2230023|NCT02698189|5469907|P2|STARTED|Overall Study||6
2230024|NCT02698189|5469908|P1|STARTED|Overall Study||3
2230025|NCT02698176|5469938|P4|NOT COMPLETED|Overall Study||0
2230026|NCT02698176|5469939|P3|NOT COMPLETED|Overall Study||1
2230027|NCT02698176|5469940|P2|NOT COMPLETED|Overall Study||3
2230028|NCT02698176|5469941|P1|NOT COMPLETED|Overall Study||9
2230029|NCT02698176|5469938|P4|COMPLETED|Overall Study||0
2230030|NCT02698176|5469939|P3|COMPLETED|Overall Study||0
2230031|NCT02698176|5469940|P2|COMPLETED|Overall Study||0
2230032|NCT02698176|5469941|P1|COMPLETED|Overall Study||0
2230033|NCT02698176|5469938|P4|STARTED|Overall Study|No participants were enrolled in Part B.|0
2230034|NCT02698176|5469939|P3|STARTED|Overall Study||1
2230035|NCT02698176|5469940|P2|STARTED|Overall Study||3
2230036|NCT02698176|5469941|P1|STARTED|Overall Study||9
2230037|NCT02698033|5469976|P1|NOT COMPLETED|Overall Study||1
2230038|NCT02698033|5469976|P1|COMPLETED|Overall Study||6
2230039|NCT02698033|5469976|P1|STARTED|Overall Study||7
2230040|NCT02697890|5469982|P2|NOT COMPLETED|Overall Study||0
2230041|NCT02697890|5469983|P1|NOT COMPLETED|Overall Study||0
2230042|NCT02697890|5469982|P2|COMPLETED|Overall Study||14
2230043|NCT02697890|5469983|P1|COMPLETED|Overall Study||14
2230044|NCT02697890|5469982|P2|STARTED|Overall Study||14
2230045|NCT02697890|5469983|P1|STARTED|Overall Study||14
2230046|NCT02697773|5469998|P3|NOT COMPLETED|Overall Study||40
2230047|NCT02697773|5469999|P2|NOT COMPLETED|Overall Study||38
2230048|NCT02697773|5470000|P1|NOT COMPLETED|Overall Study||38
2230049|NCT02697773|5469998|P3|COMPLETED|Overall Study||193
2230050|NCT02697773|5469999|P2|COMPLETED|Overall Study||194
2230051|NCT02697773|5470000|P1|COMPLETED|Overall Study||195
2230052|NCT02697773|5469998|P3|Treated|Overall Study||233
2230053|NCT02697773|5469999|P2|Treated|Overall Study||231
2230054|NCT02697773|5470000|P1|Treated|Overall Study||232
2230055|NCT02697773|5469998|P3|STARTED|Overall Study||233
2230056|NCT02697773|5469999|P2|STARTED|Overall Study||232
2230057|NCT02697773|5470000|P1|STARTED|Overall Study||233
2230058|NCT02697435|5470181|P2|NOT COMPLETED|Overall Study||4
2230059|NCT02697435|5470182|P1|NOT COMPLETED|Overall Study||1
2230060|NCT02697435|5470181|P2|COMPLETED|Overall Study||26
2230061|NCT02697435|5470182|P1|COMPLETED|Overall Study||24
2230062|NCT02697435|5470181|P2|STARTED|Overall Study||30
2230063|NCT02697435|5470182|P1|STARTED|Overall Study||25
2230064|NCT02697292|5470192|P2|NOT COMPLETED|Overall Study||0
2230065|NCT02697292|5470193|P1|NOT COMPLETED|Overall Study||0
2230066|NCT02697292|5470192|P2|COMPLETED|Overall Study||8
2230067|NCT02697292|5470193|P1|COMPLETED|Overall Study||9
2230068|NCT02697292|5470192|P2|STARTED|Overall Study||8
2230069|NCT02697292|5470193|P1|STARTED|Overall Study||9
2230070|NCT02697240|5470201|P1|NOT COMPLETED|Overall Study||0
2230071|NCT02697240|5470201|P1|COMPLETED|Overall Study||4
2230072|NCT02697240|5470201|P1|STARTED|Overall Study||4
2230073|NCT02697214|5470210|P6|NOT COMPLETED|Overall Study||0
2230074|NCT02697214|5470211|P5|NOT COMPLETED|Overall Study||0
2230075|NCT02697214|5470212|P4|NOT COMPLETED|Overall Study||0
2230076|NCT02697214|5470213|P3|NOT COMPLETED|Overall Study||0
2230077|NCT02697214|5470214|P2|NOT COMPLETED|Overall Study||0
2230078|NCT02697214|5470215|P1|NOT COMPLETED|Overall Study||0
2230079|NCT02697214|5470210|P6|COMPLETED|Overall Study||50
2230080|NCT02697214|5470211|P5|COMPLETED|Overall Study||50
2230081|NCT02697214|5470212|P4|COMPLETED|Overall Study||24
2230082|NCT02697214|5470213|P3|COMPLETED|Overall Study||25
2230083|NCT02697214|5470214|P2|COMPLETED|Overall Study||25
2230084|NCT02697214|5470215|P1|COMPLETED|Overall Study||26
2230085|NCT02697214|5470210|P6|Heart Rate at 6mph|Overall Study||50
2230086|NCT02697214|5470211|P5|Heart Rate at 6mph|Overall Study||50
2230087|NCT02697214|5470212|P4|Heart Rate at 6mph|Overall Study||24
2230088|NCT02697214|5470213|P3|Heart Rate at 6mph|Overall Study||25
2230089|NCT02697214|5470214|P2|Heart Rate at 6mph|Overall Study||25
2230090|NCT02697214|5470215|P1|Heart Rate at 6mph|Overall Study||26
2230091|NCT02697214|5470210|P6|Heart Rate at 4mph|Overall Study||50
2230092|NCT02697214|5470211|P5|Heart Rate at 4mph|Overall Study||50
2230093|NCT02697214|5470212|P4|Heart Rate at 4mph|Overall Study||24
2230094|NCT02697214|5470213|P3|Heart Rate at 4mph|Overall Study||25
2230095|NCT02697214|5470214|P2|Heart Rate at 4mph|Overall Study||25
2230096|NCT02697214|5470215|P1|Heart Rate at 4mph|Overall Study||26
2230097|NCT02697214|5470210|P6|Heart Rate at 3mph|Overall Study||50
2230098|NCT02697214|5470211|P5|Heart Rate at 3mph|Overall Study||50
2230099|NCT02697214|5470212|P4|Heart Rate at 3mph|Overall Study||24
2230100|NCT02697214|5470213|P3|Heart Rate at 3mph|Overall Study||25
2230101|NCT02697214|5470214|P2|Heart Rate at 3mph|Overall Study||25
2230102|NCT02697214|5470215|P1|Heart Rate at 3mph|Overall Study||26
2230103|NCT02697214|5470210|P6|Heart Rate at 2mph|Overall Study||50
2230104|NCT02697214|5470211|P5|Heart Rate at 2mph|Overall Study||50
2230105|NCT02697214|5470212|P4|Heart Rate at 2mph|Overall Study||24
2230106|NCT02697214|5470213|P3|Heart Rate at 2mph|Overall Study||25
2230107|NCT02697214|5470214|P2|Heart Rate at 2mph|Overall Study||25
2230108|NCT02697214|5470215|P1|Heart Rate at 2mph|Overall Study||26
2230110|NCT02697214|5470211|P5|STARTED|Overall Study||50
2230111|NCT02697214|5470212|P4|STARTED|Overall Study||24
2230112|NCT02697214|5470213|P3|STARTED|Overall Study||25
2230113|NCT02697214|5470214|P2|STARTED|Overall Study||25
2230114|NCT02697214|5470215|P1|STARTED|Overall Study||26
2230115|NCT02697188|5470225|P1|NOT COMPLETED|TE Period 5 - 800 mg BID||0
2230116|NCT02697188|5470225|P1|COMPLETED|TE Period 5 - 800 mg BID||12
2230117|NCT02697188|5470225|P1|STARTED|TE Period 5 - 800 mg BID||12
2230118|NCT02697188|5470225|P1|NOT COMPLETED|TU Period 4 - 400 BID||0
2230119|NCT02697188|5470225|P1|COMPLETED|TU Period 4 - 400 BID||12
2230120|NCT02697188|5470225|P1|STARTED|TU Period 4 - 400 BID||12
2230121|NCT02697188|5470225|P1|NOT COMPLETED|TU Period 3 - 200 mg BID||0
2230122|NCT02697188|5470225|P1|COMPLETED|TU Period 3 - 200 mg BID||12
2230123|NCT02697188|5470225|P1|STARTED|TU Period 3 - 200 mg BID||12
2230124|NCT02697188|5470225|P1|NOT COMPLETED|TU Period 2 – 200 mg QD||0
2230125|NCT02697188|5470225|P1|COMPLETED|TU Period 2 – 200 mg QD||12
2230126|NCT02697188|5470225|P1|STARTED|TU Period 2 – 200 mg QD||12
2230127|NCT02697188|5470225|P1|NOT COMPLETED|TE Period 1 - 400 mg QD||0
2230128|NCT02697188|5470225|P1|COMPLETED|TE Period 1 - 400 mg QD||12
2230129|NCT02697188|5470225|P1|STARTED|TE Period 1 - 400 mg QD||12
2230130|NCT02696850|5470236|P2|NOT COMPLETED|Overall Study||8
2230131|NCT02696850|5470237|P1|NOT COMPLETED|Overall Study||11
2230132|NCT02696850|5470236|P2|COMPLETED|Overall Study||32
2230133|NCT02696850|5470237|P1|COMPLETED|Overall Study||29
2230134|NCT02696850|5470236|P2|STARTED|Overall Study||40
2230135|NCT02696850|5470237|P1|STARTED|Overall Study||40
2230136|NCT02696798|5470250|P3|NOT COMPLETED|Post-treatment Follow-up Period||19
2230137|NCT02696798|5470251|P2|NOT COMPLETED|Post-treatment Follow-up Period||26
2230138|NCT02696798|5470252|P1|NOT COMPLETED|Post-treatment Follow-up Period||5
2230139|NCT02696798|5470250|P3|COMPLETED|Post-treatment Follow-up Period||3
2230140|NCT02696798|5470251|P2|COMPLETED|Post-treatment Follow-up Period||8
2230141|NCT02696798|5470252|P1|COMPLETED|Post-treatment Follow-up Period||0
2230142|NCT02696798|5470250|P3|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|22
2230143|NCT02696798|5470251|P2|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|34
2230144|NCT02696798|5470252|P1|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|5
2230145|NCT02696798|5470250|P3|NOT COMPLETED|Extended Treatment Period||10
2230146|NCT02696798|5470251|P2|NOT COMPLETED|Extended Treatment Period||9
2230147|NCT02696798|5470252|P1|NOT COMPLETED|Extended Treatment Period||12
2230148|NCT02696798|5470250|P3|COMPLETED|Extended Treatment Period||80
2230149|NCT02696798|5470251|P2|COMPLETED|Extended Treatment Period||89
2230150|NCT02696798|5470252|P1|COMPLETED|Extended Treatment Period||81
2230151|NCT02696798|5470250|P3|STARTED|Extended Treatment Period||90
2230152|NCT02696798|5470251|P2|STARTED|Extended Treatment Period|1 participant completed blinded treatment period and entered post-treatment followup period directly|98
2230153|NCT02696798|5470252|P1|STARTED|Extended Treatment Period||93
2230154|NCT02696798|5470250|P3|NOT COMPLETED|Blinded Treatment Dosing Period||8
2230155|NCT02696798|5470251|P2|NOT COMPLETED|Blinded Treatment Dosing Period||15
2230156|NCT02696798|5470252|P1|NOT COMPLETED|Blinded Treatment Dosing Period||11
2230157|NCT02696798|5470250|P3|COMPLETED|Blinded Treatment Dosing Period||90
2230158|NCT02696798|5470251|P2|COMPLETED|Blinded Treatment Dosing Period||99
2230159|NCT02696798|5470252|P1|COMPLETED|Blinded Treatment Dosing Period||93
2230160|NCT02696798|5470250|P3|STARTED|Blinded Treatment Dosing Period||98
2230161|NCT02696798|5470251|P2|STARTED|Blinded Treatment Dosing Period||114
2230162|NCT02696798|5470252|P1|STARTED|Blinded Treatment Dosing Period||104
2230163|NCT02696785|5470349|P4|NOT COMPLETED|Follow-up Period||8
2230164|NCT02696785|5470350|P3|NOT COMPLETED|Follow-up Period||13
2230165|NCT02696785|5470351|P2|NOT COMPLETED|Follow-up Period||0
2230166|NCT02696785|5470352|P1|NOT COMPLETED|Follow-up Period||1
2230167|NCT02696785|5470349|P4|COMPLETED|Follow-up Period||8
2230168|NCT02696785|5470350|P3|COMPLETED|Follow-up Period||11
2230169|NCT02696785|5470351|P2|COMPLETED|Follow-up Period||0
2230170|NCT02696785|5470352|P1|COMPLETED|Follow-up Period||0
2230171|NCT02696785|5470349|P4|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|16
2230172|NCT02696785|5470350|P3|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|24
2230173|NCT02696785|5470351|P2|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|0
2230174|NCT02696785|5470352|P1|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|1
2230175|NCT02696785|5470349|P4|NOT COMPLETED|Extended Treatment Period||6
2230176|NCT02696785|5470350|P3|NOT COMPLETED|Extended Treatment Period||5
2230177|NCT02696785|5470351|P2|NOT COMPLETED|Extended Treatment Period||6
2230178|NCT02696785|5470352|P1|NOT COMPLETED|Extended Treatment Period||3
2230179|NCT02696785|5470349|P4|COMPLETED|Extended Treatment Period||72
2230180|NCT02696785|5470350|P3|COMPLETED|Extended Treatment Period||74
2230181|NCT02696785|5470351|P2|COMPLETED|Extended Treatment Period||80
2230182|NCT02696785|5470352|P1|COMPLETED|Extended Treatment Period||83
2230183|NCT02696785|5470349|P4|STARTED|Extended Treatment Period||78
2230184|NCT02696785|5470350|P3|STARTED|Extended Treatment Period||79
2230185|NCT02696785|5470351|P2|STARTED|Extended Treatment Period||86
2230186|NCT02696785|5470352|P1|STARTED|Extended Treatment Period||86
2230187|NCT02696785|5470349|P4|NOT COMPLETED|Washout Period||0
2230188|NCT02696785|5470350|P3|NOT COMPLETED|Washout Period||0
2230189|NCT02696785|5470351|P2|NOT COMPLETED|Washout Period||2
2230190|NCT02696785|5470352|P1|NOT COMPLETED|Washout Period||0
2230191|NCT02696785|5470349|P4|COMPLETED|Washout Period||0
2230192|NCT02696785|5470350|P3|COMPLETED|Washout Period||0
2230193|NCT02696785|5470351|P2|COMPLETED|Washout Period||86
2230194|NCT02696785|5470352|P1|COMPLETED|Washout Period||0
2230195|NCT02696785|5470349|P4|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
2230196|NCT02696785|5470350|P3|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
2230197|NCT02696785|5470351|P2|STARTED|Washout Period||88
2230198|NCT02696785|5470352|P1|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
2230199|NCT02696785|5470349|P4|NOT COMPLETED|Blinded Treatment Period||3
2230200|NCT02696785|5470350|P3|NOT COMPLETED|Blinded Treatment Period||4
2230201|NCT02696785|5470351|P2|NOT COMPLETED|Blinded Treatment Period||2
2230202|NCT02696785|5470352|P1|NOT COMPLETED|Blinded Treatment Period||1
2230203|NCT02696785|5470349|P4|COMPLETED|Blinded Treatment Period||78
2230204|NCT02696785|5470350|P3|COMPLETED|Blinded Treatment Period||79
2230205|NCT02696785|5470351|P2|COMPLETED|Blinded Treatment Period||88
2230206|NCT02696785|5470352|P1|COMPLETED|Blinded Treatment Period||86
2230207|NCT02696785|5470349|P4|Received at Least One Dose of Study Drug|Blinded Treatment Period||81
2230208|NCT02696785|5470350|P3|Received at Least One Dose of Study Drug|Blinded Treatment Period||83
2230209|NCT02696785|5470351|P2|Received at Least One Dose of Study Drug|Blinded Treatment Period||90
2230210|NCT02696785|5470352|P1|Received at Least One Dose of Study Drug|Blinded Treatment Period||86
2230211|NCT02696785|5470349|P4|STARTED|Blinded Treatment Period||81
2230212|NCT02696785|5470350|P3|STARTED|Blinded Treatment Period||83
2230213|NCT02696785|5470351|P2|STARTED|Blinded Treatment Period||90
2230214|NCT02696785|5470352|P1|STARTED|Blinded Treatment Period||87
2230215|NCT02696434|5470472|P2|NOT COMPLETED|Overall Study||18
2230216|NCT02696434|5470473|P1|NOT COMPLETED|Overall Study||22
2230217|NCT02696434|5470472|P2|COMPLETED|Overall Study||33
2230218|NCT02696434|5470473|P1|COMPLETED|Overall Study||28
2230219|NCT02696434|5470472|P2|STARTED|Overall Study||51
2230220|NCT02696434|5470473|P1|STARTED|Overall Study||50
2230221|NCT02696317|5470491|P2|NOT COMPLETED|Period 2, 10 Days of Wear||0
2230222|NCT02696317|5470492|P1|NOT COMPLETED|Period 2, 10 Days of Wear||1
2230223|NCT02696317|5470491|P2|COMPLETED|Period 2, 10 Days of Wear||36
2230224|NCT02696317|5470492|P1|COMPLETED|Period 2, 10 Days of Wear||39
2230225|NCT02696317|5470491|P2|STARTED|Period 2, 10 Days of Wear||36
2230226|NCT02696317|5470492|P1|STARTED|Period 2, 10 Days of Wear||40
2230227|NCT02696317|5470491|P2|NOT COMPLETED|Period 1, 10 Days of Wear||0
2230228|NCT02696317|5470492|P1|NOT COMPLETED|Period 1, 10 Days of Wear||0
2230229|NCT02696317|5470491|P2|COMPLETED|Period 1, 10 Days of Wear||36
2230230|NCT02696317|5470492|P1|COMPLETED|Period 1, 10 Days of Wear||40
2230231|NCT02696317|5470491|P2|STARTED|Period 1, 10 Days of Wear||36
2230232|NCT02696317|5470492|P1|STARTED|Period 1, 10 Days of Wear||40
2230233|NCT02696317|5470491|P2|NOT COMPLETED|Habitual, 10 Days of Wear||4
2230234|NCT02696317|5470492|P1|NOT COMPLETED|Habitual, 10 Days of Wear||2
2230235|NCT02696317|5470491|P2|COMPLETED|Habitual, 10 Days of Wear||36
2230236|NCT02696317|5470492|P1|COMPLETED|Habitual, 10 Days of Wear||40
2230237|NCT02696317|5470491|P2|STARTED|Habitual, 10 Days of Wear||40
2230238|NCT02696317|5470492|P1|STARTED|Habitual, 10 Days of Wear||42
2230239|NCT02696291|5470508|P2|NOT COMPLETED|Overall Study||0
2230240|NCT02696291|5470509|P1|NOT COMPLETED|Overall Study||0
2230241|NCT02696291|5470508|P2|COMPLETED|Overall Study||2
2230242|NCT02696291|5470509|P1|COMPLETED|Overall Study||5
2230243|NCT02696291|5470508|P2|STARTED|Overall Study||2
2230244|NCT02696291|5470509|P1|STARTED|Overall Study||5
2230245|NCT02696226|5470536|P4|NOT COMPLETED|Overall Study||0
2230246|NCT02696226|5470537|P3|NOT COMPLETED|Overall Study||2
2230247|NCT02696226|5470538|P2|NOT COMPLETED|Overall Study||0
2230248|NCT02696226|5470539|P1|NOT COMPLETED|Overall Study||1
2230249|NCT02696226|5470536|P4|COMPLETED|Overall Study||0
2230250|NCT02696226|5470537|P3|COMPLETED|Overall Study||0
2230251|NCT02696226|5470538|P2|COMPLETED|Overall Study||0
2230252|NCT02696226|5470539|P1|COMPLETED|Overall Study||0
2230253|NCT02696226|5470536|P4|STARTED|Overall Study||0
2230254|NCT02696226|5470537|P3|STARTED|Overall Study||2
2230255|NCT02696226|5470538|P2|STARTED|Overall Study||0
2230256|NCT02696226|5470539|P1|STARTED|Overall Study||1
2230257|NCT02696083|5470549|P1|NOT COMPLETED|Overall Study||6
2230258|NCT02696083|5470549|P1|COMPLETED|Overall Study||13
2230259|NCT02696083|5470549|P1|STARTED|Overall Study||19
2230260|NCT02696070|5470560|P2|NOT COMPLETED|Overall Study||2
2230261|NCT02696070|5470561|P1|NOT COMPLETED|Overall Study||1
2230262|NCT02696070|5470560|P2|COMPLETED|Overall Study||12
2230263|NCT02696070|5470561|P1|COMPLETED|Overall Study||7
2230264|NCT02696070|5470560|P2|STARTED|Overall Study||14
2230265|NCT02696070|5470561|P1|STARTED|Overall Study||8
2230266|NCT02695719|5470569|P2|NOT COMPLETED|Overall Study||10
2230267|NCT02695719|5470570|P1|NOT COMPLETED|Overall Study||3
2230268|NCT02695719|5470569|P2|COMPLETED|Overall Study||72
2230269|NCT02695719|5470570|P1|COMPLETED|Overall Study||71
2230270|NCT02695719|5470569|P2|STARTED|Overall Study||82
2230271|NCT02695719|5470570|P1|STARTED|Overall Study||74
2230272|NCT02695628|5470588|P1|NOT COMPLETED|Overall Study||1
2230273|NCT02695628|5470588|P1|COMPLETED|Overall Study||4
2230274|NCT02695628|5470588|P1|STARTED|Overall Study||5
2230275|NCT02695524|5470596|P2|NOT COMPLETED|Overall Study||3
2230276|NCT02695524|5470597|P1|NOT COMPLETED|Overall Study||3
2230277|NCT02695524|5470596|P2|COMPLETED|Overall Study||27
2230278|NCT02695524|5470597|P1|COMPLETED|Overall Study||27
2230279|NCT02695524|5470596|P2|STARTED|Overall Study||30
2230280|NCT02695524|5470597|P1|STARTED|Overall Study||30
2230281|NCT02695446|5470617|P1|NOT COMPLETED|Overall Study||0
2230282|NCT02695446|5470617|P1|COMPLETED|Overall Study||12
2230283|NCT02695446|5470617|P1|STARTED|Overall Study||12
2230284|NCT02695420|5470626|P4|NOT COMPLETED|Overall Study||0
2230285|NCT02695420|5470627|P3|NOT COMPLETED|Overall Study||0
2230286|NCT02695420|5470628|P2|NOT COMPLETED|Overall Study||1
2230287|NCT02695420|5470629|P1|NOT COMPLETED|Overall Study||0
2230288|NCT02695420|5470626|P4|COMPLETED|Overall Study||20
2230289|NCT02695420|5470627|P3|COMPLETED|Overall Study||19
2230290|NCT02695420|5470628|P2|COMPLETED|Overall Study||20
2230291|NCT02695420|5470629|P1|COMPLETED|Overall Study||21
2230292|NCT02695420|5470626|P4|STARTED|Overall Study||20
2230293|NCT02695420|5470627|P3|STARTED|Overall Study||19
2230294|NCT02695420|5470628|P2|STARTED|Overall Study||21
2230295|NCT02695420|5470629|P1|STARTED|Overall Study||21
2230296|NCT02695329|5470651|P2|NOT COMPLETED|Overall Study||5
2230297|NCT02695329|5470652|P1|NOT COMPLETED|Overall Study||5
2230298|NCT02695329|5470651|P2|COMPLETED|Overall Study||45
2230299|NCT02695329|5470652|P1|COMPLETED|Overall Study||45
2230300|NCT02695329|5470651|P2|STARTED|Overall Study||50
2230301|NCT02695329|5470652|P1|STARTED|Overall Study||50
2230302|NCT02695290|5470664|P1|NOT COMPLETED|Overall Study||0
2230303|NCT02695290|5470664|P1|COMPLETED|Overall Study||1
2230304|NCT02695290|5470664|P1|STARTED|Overall Study||1
2230305|NCT02694978|5470672|P2|NOT COMPLETED|Overall Study||60
2230306|NCT02694978|5470673|P1|NOT COMPLETED|Overall Study||71
2230307|NCT02694978|5470672|P2|COMPLETED|Overall Study||948
2230308|NCT02694978|5470673|P1|COMPLETED|Overall Study||935
2230309|NCT02694978|5470672|P2|Received at Least 1 Dose of Study Drug|Overall Study||1000
2230310|NCT02694978|5470673|P1|Received at Least 1 Dose of Study Drug|Overall Study||997
2230311|NCT02694978|5470672|P2|STARTED|Overall Study||1008
2230312|NCT02694978|5470673|P1|STARTED|Overall Study||1006
2230313|NCT02694835|5470687|P2|NOT COMPLETED|Overall Study||0
2230314|NCT02694835|5470688|P1|NOT COMPLETED|Overall Study||0
2230315|NCT02694835|5470687|P2|COMPLETED|Overall Study||39
2230316|NCT02694835|5470688|P1|COMPLETED|Overall Study||41
2230317|NCT02694835|5470687|P2|STARTED|Overall Study||39
2230318|NCT02694835|5470688|P1|STARTED|Overall Study||41
2230319|NCT02694744|5470696|P2|NOT COMPLETED|Overall Study||5
2230320|NCT02694744|5470697|P1|NOT COMPLETED|Overall Study||6
2230321|NCT02694744|5470696|P2|COMPLETED|Overall Study||52
2230322|NCT02694744|5470697|P1|COMPLETED|Overall Study||51
2230323|NCT02694744|5470696|P2|ITT|Overall Study||55
2230324|NCT02694744|5470697|P1|ITT|Overall Study||57
2230325|NCT02694744|5470696|P2|Safety Population|Overall Study||56
2230326|NCT02694744|5470697|P1|Safety Population|Overall Study||57
2230327|NCT02694744|5470696|P2|STARTED|Overall Study||57
2230328|NCT02694744|5470697|P1|STARTED|Overall Study||57
2230329|NCT02694718|5470705|P1|NOT COMPLETED|Overall Study||2
2230330|NCT02694718|5470705|P1|COMPLETED|Overall Study||58
2230331|NCT02694718|5470705|P1|STARTED|Overall Study||60
2230332|NCT02694601|5470715|P1|NOT COMPLETED|Overall Study||0
2230333|NCT02694601|5470715|P1|COMPLETED|Overall Study||10
2230334|NCT02694601|5470715|P1|STARTED|Overall Study||10
2230335|NCT02694562|5470723|P1|NOT COMPLETED|Overall Study||18
2230336|NCT02694562|5470723|P1|COMPLETED|Overall Study||2
2230337|NCT02694562|5470723|P1|STARTED|Overall Study||20
2230338|NCT02694549|5470732|P1|NOT COMPLETED|Overall Study||2
2230339|NCT02694549|5470732|P1|COMPLETED|Overall Study||10
2230340|NCT02694549|5470732|P1|STARTED|Overall Study||12
2230341|NCT02694536|5470738|P1|NOT COMPLETED|Overall Study||80
2230342|NCT02694536|5470738|P1|COMPLETED|Overall Study||0
2230343|NCT02694536|5470738|P1|STARTED|Overall Study||80
2230344|NCT02694523|5470749|P7|NOT COMPLETED|Part B||2
2230345|NCT02694523|5470750|P6|NOT COMPLETED|Part B||5
2230346|NCT02694523|5470751|P5|NOT COMPLETED|Part B||4
2230347|NCT02694523|5470752|P4|NOT COMPLETED|Part B||4
2230348|NCT02694523|5470753|P3|NOT COMPLETED|Part B||20
2230349|NCT02694523|5470754|P2|NOT COMPLETED|Part B||0
2230350|NCT02694523|5470755|P1|NOT COMPLETED|Part B||0
2230351|NCT02694523|5470749|P7|COMPLETED|Part B||51
2230352|NCT02694523|5470750|P6|COMPLETED|Part B||51
2230353|NCT02694523|5470751|P5|COMPLETED|Part B||34
2230354|NCT02694523|5470752|P4|COMPLETED|Part B||140
2230355|NCT02694523|5470753|P3|COMPLETED|Part B||274
2230356|NCT02694523|5470754|P2|COMPLETED|Part B||0
2230357|NCT02694523|5470755|P1|COMPLETED|Part B||0
2230358|NCT02694523|5470749|P7|STARTED|Part B|Adalimumab inadequate responders in Part A, rerandomized to risankizumab in Part B|53
2230359|NCT02694523|5470750|P6|STARTED|Part B|Adalimumab inadequate responders in Part A, rerandomized to adalimumab in Part B|56
2230360|NCT02694523|5470751|P5|STARTED|Part B|Adalimumab nonresponders in Part A switched to risankizumab in Part B|38
2230361|NCT02694523|5470752|P4|STARTED|Part B|Adalimumab responders in Part A continued to received adalimumab in Part B|144
2230362|NCT02694523|5470753|P3|STARTED|Part B|Participants who received risankizumab in Part A continued to received risankizumab in Part B|294
2230363|NCT02694523|5470754|P2|STARTED|Part B||0
2230364|NCT02694523|5470755|P1|STARTED|Part B||0
2230365|NCT02694523|5470749|P7|NOT COMPLETED|Part A||0
2230366|NCT02694523|5470750|P6|NOT COMPLETED|Part A||0
2230367|NCT02694523|5470751|P5|NOT COMPLETED|Part A||0
2230368|NCT02694523|5470752|P4|NOT COMPLETED|Part A||0
2230369|NCT02694523|5470753|P3|NOT COMPLETED|Part A||0
2230370|NCT02694523|5470754|P2|NOT COMPLETED|Part A||7
2230371|NCT02694523|5470755|P1|NOT COMPLETED|Part A||13
2230372|NCT02694523|5470749|P7|COMPLETED|Part A||0
2230373|NCT02694523|5470750|P6|COMPLETED|Part A||0
2230374|NCT02694523|5470751|P5|COMPLETED|Part A||0
2230375|NCT02694523|5470752|P4|COMPLETED|Part A||0
2230376|NCT02694523|5470753|P3|COMPLETED|Part A||0
2230377|NCT02694523|5470754|P2|COMPLETED|Part A||294
2230378|NCT02694523|5470755|P1|COMPLETED|Part A||291
2230379|NCT02694523|5470749|P7|STARTED|Part A||0
2230380|NCT02694523|5470750|P6|STARTED|Part A||0
2230381|NCT02694523|5470751|P5|STARTED|Part A||0
2230382|NCT02694523|5470752|P4|STARTED|Part A||0
2230383|NCT02694523|5470753|P3|STARTED|Part A||0
2230384|NCT02694523|5470754|P2|STARTED|Part A||301
2230385|NCT02694523|5470755|P1|STARTED|Part A||304
2230386|NCT02694328|5470781|P2|NOT COMPLETED|Overall Study||98
2230387|NCT02694328|5470782|P1|NOT COMPLETED|Overall Study||100
2230388|NCT02694328|5470781|P2|COMPLETED|Overall Study||176
2230389|NCT02694328|5470782|P1|COMPLETED|Overall Study||176
2230390|NCT02694328|5470781|P2|STARTED|Overall Study||274
2230391|NCT02694328|5470782|P1|STARTED|Overall Study||276
2230392|NCT02694315|5470794|P1|NOT COMPLETED|Overall Study||0
2230393|NCT02694315|5470794|P1|COMPLETED|Overall Study||200
2230394|NCT02694315|5470794|P1|STARTED|Overall Study||200
2230395|NCT02694198|5470799|P1|NOT COMPLETED|Overall Study||0
2230396|NCT02694198|5470799|P1|COMPLETED|Overall Study||135
2230397|NCT02694198|5470799|P1|STARTED|Overall Study||135
2230398|NCT02693704|5470808|P4|NOT COMPLETED|Overall Study||0
2230399|NCT02693704|5470809|P3|NOT COMPLETED|Overall Study||0
2230400|NCT02693704|5470810|P2|NOT COMPLETED|Overall Study||0
2230401|NCT02693704|5470811|P1|NOT COMPLETED|Overall Study||0
2230402|NCT02693704|5470808|P4|COMPLETED|Overall Study||10
2230403|NCT02693704|5470809|P3|COMPLETED|Overall Study||10
2230404|NCT02693704|5470810|P2|COMPLETED|Overall Study||10
2230405|NCT02693704|5470811|P1|COMPLETED|Overall Study||10
2230406|NCT02693704|5470808|P4|STARTED|Overall Study||10
2230407|NCT02693704|5470809|P3|STARTED|Overall Study||10
2230408|NCT02693704|5470810|P2|STARTED|Overall Study||10
2230409|NCT02693704|5470811|P1|STARTED|Overall Study||10
2230410|NCT02693171|5470829|P1|NOT COMPLETED|Overall Study||9
2230411|NCT02693171|5470829|P1|COMPLETED|Overall Study||3
2230412|NCT02693171|5470829|P1|STARTED|Overall Study|At study termination, 13 subjects had enrolled, 12 subjects received at least 1 dose of study drug.|12
2230413|NCT02693132|5470839|P3|NOT COMPLETED|Overall Study||1
2230414|NCT02693132|5470840|P2|NOT COMPLETED|Overall Study||1
2230415|NCT02693132|5470841|P1|NOT COMPLETED|Overall Study||1
2230416|NCT02693132|5470839|P3|COMPLETED|Overall Study||17
2230417|NCT02693132|5470840|P2|COMPLETED|Overall Study||16
2230418|NCT02693132|5470841|P1|COMPLETED|Overall Study||16
2230419|NCT02693132|5470839|P3|STARTED|Overall Study||18
2230420|NCT02693132|5470840|P2|STARTED|Overall Study||17
2230421|NCT02693132|5470841|P1|STARTED|Overall Study||17
2230422|NCT02693002|5470863|P2|NOT COMPLETED|Overall Study||0
2230423|NCT02693002|5470864|P1|NOT COMPLETED|Overall Study||1
2230424|NCT02693002|5470863|P2|COMPLETED|Overall Study||2
2230425|NCT02693002|5470864|P1|COMPLETED|Overall Study||1
2230426|NCT02693002|5470863|P2|STARTED|Overall Study||2
2230427|NCT02693002|5470864|P1|STARTED|Overall Study||2
2230428|NCT02692859|5470878|P2|NOT COMPLETED|Overall Study||95
2230429|NCT02692859|5470879|P1|NOT COMPLETED|Overall Study||84
2230430|NCT02692859|5470878|P2|COMPLETED|Overall Study||901
2230431|NCT02692859|5470879|P1|COMPLETED|Overall Study||912
2230432|NCT02692859|5470878|P2|STARTED|Overall Study||996
2230433|NCT02692859|5470879|P1|STARTED|Overall Study||996
2230434|NCT02692703|5470885|P1|NOT COMPLETED|Overall Study||2
2230435|NCT02692703|5470885|P1|COMPLETED|Overall Study||98
2230436|NCT02692703|5470885|P1|STARTED|Overall Study||100
2230437|NCT02692560|5470893|P2|NOT COMPLETED|Overall Study||6
2230438|NCT02692560|5470894|P1|NOT COMPLETED|Overall Study||0
2230439|NCT02692560|5470893|P2|COMPLETED|Overall Study||25
2230440|NCT02692560|5470894|P1|COMPLETED|Overall Study||29
2230441|NCT02692560|5470893|P2|STARTED|Overall Study||31
2230442|NCT02692560|5470894|P1|STARTED|Overall Study||29
2230443|NCT02692495|5470916|P2|NOT COMPLETED|Overall Study||0
2230444|NCT02692495|5470917|P1|NOT COMPLETED|Overall Study||0
2230445|NCT02692495|5470916|P2|COMPLETED|Overall Study||4
2230446|NCT02692495|5470917|P1|COMPLETED|Overall Study||12
2230447|NCT02692495|5470916|P2|STARTED|Overall Study||4
2230448|NCT02692495|5470917|P1|STARTED|Overall Study||12
2230449|NCT02692482|5470934|P2|NOT COMPLETED|Overall Study||4
2230450|NCT02692482|5470935|P1|NOT COMPLETED|Overall Study||3
2230451|NCT02692482|5470934|P2|COMPLETED|Overall Study||178
2230452|NCT02692482|5470935|P1|COMPLETED|Overall Study||174
2230453|NCT02692482|5470934|P2|STARTED|Overall Study||182
2230454|NCT02692482|5470935|P1|STARTED|Overall Study||177
2230455|NCT02692417|5470949|P2|NOT COMPLETED|Overall Study||1
2230456|NCT02692417|5470950|P1|NOT COMPLETED|Overall Study||6
2230457|NCT02692417|5470949|P2|COMPLETED|Overall Study||6
2230458|NCT02692417|5470950|P1|COMPLETED|Overall Study||3
2230459|NCT02692417|5470949|P2|STARTED|Overall Study||7
2230460|NCT02692417|5470950|P1|STARTED|Overall Study||9
2230461|NCT02692235|5470962|P2|NOT COMPLETED|Overall Study||3
2230462|NCT02692235|5470963|P1|NOT COMPLETED|Overall Study||3
2230463|NCT02692235|5470962|P2|COMPLETED|Overall Study||11
2230464|NCT02692235|5470963|P1|COMPLETED|Overall Study||11
2230465|NCT02692235|5470962|P2|STARTED|Overall Study||14
2230466|NCT02692235|5470963|P1|STARTED|Overall Study||14
2230467|NCT02691936|5470973|P2|NOT COMPLETED|Overall Study||5
2230468|NCT02691936|5470974|P1|NOT COMPLETED|Overall Study||2
2230469|NCT02691936|5470973|P2|COMPLETED|Overall Study||29
2230470|NCT02691936|5470974|P1|COMPLETED|Overall Study||33
2230471|NCT02691936|5470973|P2|STARTED|Overall Study||34
2230472|NCT02691936|5470974|P1|STARTED|Overall Study||35
2230473|NCT02691741|5470996|P2|NOT COMPLETED|Overall Study||7
2230474|NCT02691741|5470997|P1|NOT COMPLETED|Overall Study||1
2230475|NCT02691741|5470996|P2|COMPLETED|Overall Study||87
2230476|NCT02691741|5470997|P1|COMPLETED|Overall Study||93
2230477|NCT02691741|5470996|P2|Safety Analysis Set|Overall Study||89
2230478|NCT02691741|5470997|P1|Safety Analysis Set|Overall Study||93
2230479|NCT02691741|5470996|P2|Best-Case Analysis Set|Overall Study||85
2230480|NCT02691741|5470997|P1|Best-Case Analysis Set|Overall Study||86
2230481|NCT02691741|5470996|P2|All-Implanted Analysis Set|Overall Study||89
2230482|NCT02691741|5470997|P1|All-Implanted Analysis Set|Overall Study||93
2230483|NCT02691741|5470996|P2|STARTED|Overall Study||94
2230484|NCT02691741|5470997|P1|STARTED|Overall Study||94
2230485|NCT02691702|5471037|P11|NOT COMPLETED|Overall Study||2
2230486|NCT02691702|5471038|P10|NOT COMPLETED|Overall Study||2
2230487|NCT02691702|5471039|P9|NOT COMPLETED|Overall Study||2
2230488|NCT02691702|5471040|P8|NOT COMPLETED|Overall Study||0
2230489|NCT02691702|5471041|P7|NOT COMPLETED|Overall Study||3
2230490|NCT02691702|5471042|P6|NOT COMPLETED|Overall Study||3
2230491|NCT02691702|5471043|P5|NOT COMPLETED|Overall Study||0
2230492|NCT02691702|5471044|P4|NOT COMPLETED|Overall Study||0
2230493|NCT02691702|5471045|P3|NOT COMPLETED|Overall Study||1
2230494|NCT02691702|5471046|P2|NOT COMPLETED|Overall Study||1
2230495|NCT02691702|5471047|P1|NOT COMPLETED|Overall Study||2
2230496|NCT02691702|5471037|P11|COMPLETED|Overall Study||6
2230497|NCT02691702|5471038|P10|COMPLETED|Overall Study||6
2230498|NCT02691702|5471039|P9|COMPLETED|Overall Study||6
2230499|NCT02691702|5471040|P8|COMPLETED|Overall Study||12
2230500|NCT02691702|5471041|P7|COMPLETED|Overall Study||5
2230501|NCT02691702|5471042|P6|COMPLETED|Overall Study||5
2230502|NCT02691702|5471043|P5|COMPLETED|Overall Study||8
2230503|NCT02691702|5471044|P4|COMPLETED|Overall Study||8
2230504|NCT02691702|5471045|P3|COMPLETED|Overall Study||7
2230505|NCT02691702|5471046|P2|COMPLETED|Overall Study||10
2230506|NCT02691702|5471047|P1|COMPLETED|Overall Study||8
2230507|NCT02691702|5471037|P11|STARTED|Overall Study||8
2230508|NCT02691702|5471038|P10|STARTED|Overall Study||8
2230509|NCT02691702|5471039|P9|STARTED|Overall Study||8
2230510|NCT02691702|5471040|P8|STARTED|Overall Study||12
2230511|NCT02691702|5471041|P7|STARTED|Overall Study||8
2230512|NCT02691702|5471042|P6|STARTED|Overall Study||8
2230513|NCT02691702|5471043|P5|STARTED|Overall Study||8
2230514|NCT02691702|5471044|P4|STARTED|Overall Study||8
2230515|NCT02691702|5471045|P3|STARTED|Overall Study||8
2230516|NCT02691702|5471046|P2|STARTED|Overall Study||11
2230517|NCT02691702|5471047|P1|STARTED|Overall Study||10
2230518|NCT02691572|5471333|P2|NOT COMPLETED|Overall Study||1
2230519|NCT02691572|5471334|P1|NOT COMPLETED|Overall Study||1
2230520|NCT02691572|5471333|P2|COMPLETED|Overall Study||39
2230521|NCT02691572|5471334|P1|COMPLETED|Overall Study||39
2230522|NCT02691572|5471333|P2|STARTED|Overall Study||40
2230523|NCT02691572|5471334|P1|STARTED|Overall Study||40
2230524|NCT02691507|5471342|P2|NOT COMPLETED|Overall Study||1
2230525|NCT02691507|5471343|P1|NOT COMPLETED|Overall Study||0
2230526|NCT02691507|5471342|P2|COMPLETED|Overall Study||12
2230527|NCT02691507|5471343|P1|COMPLETED|Overall Study||40
2230528|NCT02691507|5471342|P2|STARTED|Overall Study||13
2230529|NCT02691507|5471343|P1|STARTED|Overall Study||40
2230530|NCT02691468|5471475|P2|NOT COMPLETED|Overall Study||2
2230531|NCT02691468|5471476|P1|NOT COMPLETED|Overall Study||6
2230532|NCT02691468|5471475|P2|COMPLETED|Overall Study||52
2230533|NCT02691468|5471476|P1|COMPLETED|Overall Study||48
2230534|NCT02691468|5471475|P2|STARTED|Overall Study||54
2230535|NCT02691468|5471476|P1|STARTED|Overall Study||54
2230536|NCT02691416|5471486|P2|NOT COMPLETED|Overall Study||0
2230537|NCT02691416|5471487|P1|NOT COMPLETED|Overall Study||0
2230538|NCT02691416|5471486|P2|COMPLETED|Overall Study||30
2230539|NCT02691416|5471487|P1|COMPLETED|Overall Study||30
2230540|NCT02691416|5471486|P2|STARTED|Overall Study||30
2230541|NCT02691416|5471487|P1|STARTED|Overall Study||30
2230542|NCT02691260|5471511|P4|NOT COMPLETED|Overall Study||3
2230543|NCT02691260|5471512|P3|NOT COMPLETED|Overall Study||2
2230544|NCT02691260|5471513|P2|NOT COMPLETED|Overall Study||2
2230545|NCT02691260|5471514|P1|NOT COMPLETED|Overall Study||2
2230546|NCT02691260|5471511|P4|COMPLETED|Overall Study||23
2230547|NCT02691260|5471512|P3|COMPLETED|Overall Study||25
2230548|NCT02691260|5471513|P2|COMPLETED|Overall Study||24
2230549|NCT02691260|5471514|P1|COMPLETED|Overall Study||24
2230550|NCT02691260|5471511|P4|STARTED|Overall Study||26
2230551|NCT02691260|5471512|P3|STARTED|Overall Study||27
2230552|NCT02691260|5471513|P2|STARTED|Overall Study||26
2230553|NCT02691260|5471514|P1|STARTED|Overall Study||26
2230554|NCT02691143|5471526|P2|NOT COMPLETED|Overall Study||0
2230555|NCT02691143|5471527|P1|NOT COMPLETED|Overall Study||0
2230556|NCT02691143|5471526|P2|COMPLETED|Overall Study||23
2230557|NCT02691143|5471527|P1|COMPLETED|Overall Study||27
2230558|NCT02691143|5471526|P2|STARTED|Overall Study||23
2230559|NCT02691143|5471527|P1|STARTED|Overall Study||27
2230560|NCT02691013|5471537|P2|NOT COMPLETED|Overall Study||0
2230561|NCT02691013|5471538|P1|NOT COMPLETED|Overall Study||3
2230562|NCT02691013|5471537|P2|COMPLETED|Overall Study||59
2230563|NCT02691013|5471538|P1|COMPLETED|Overall Study||58
2230564|NCT02691013|5471537|P2|STARTED|Overall Study||59
2230565|NCT02691013|5471538|P1|STARTED|Overall Study||61
2230566|NCT02690974|5471552|P1|NOT COMPLETED|Overall Study||40
2230567|NCT02690974|5471552|P1|COMPLETED|Overall Study||262
2230568|NCT02690974|5471552|P1|STARTED|Overall Study||302
2230569|NCT02690948|5471565|P2|NOT COMPLETED|Overall Study||0
2230570|NCT02690948|5471566|P1|NOT COMPLETED|Overall Study||0
2230571|NCT02690948|5471565|P2|COMPLETED|Overall Study||7
2230572|NCT02690948|5471566|P1|COMPLETED|Overall Study||9
2230573|NCT02690948|5471565|P2|STARTED|Overall Study||7
2230574|NCT02690948|5471566|P1|STARTED|Overall Study||9
2230575|NCT02690935|5471584|P2|NOT COMPLETED|Overall Study||0
2230576|NCT02690935|5471585|P1|NOT COMPLETED|Overall Study||0
2230577|NCT02690935|5471584|P2|COMPLETED|Overall Study|Count of participants|51
2230578|NCT02690935|5471585|P1|COMPLETED|Overall Study|Count of participants|51
2230579|NCT02690935|5471584|P2|STARTED|Overall Study|Count of participants|51
2230580|NCT02690935|5471585|P1|STARTED|Overall Study|Count of participants|51
2230581|NCT02690727|5471593|P2|NOT COMPLETED|Overall Study||2
2230582|NCT02690727|5471594|P1|NOT COMPLETED|Overall Study||2
2230583|NCT02690727|5471593|P2|COMPLETED|Overall Study||7
2230584|NCT02690727|5471594|P1|COMPLETED|Overall Study||7
2230585|NCT02690727|5471593|P2|STARTED|Overall Study||9
2230586|NCT02690727|5471594|P1|STARTED|Overall Study||9
2230587|NCT02690701|5471606|P2|NOT COMPLETED|Treatment Period 2||5
2230588|NCT02690701|5471607|P1|NOT COMPLETED|Treatment Period 2||3
2230589|NCT02690701|5471606|P2|COMPLETED|Treatment Period 2||37
2230590|NCT02690701|5471607|P1|COMPLETED|Treatment Period 2|Completed Treatment Period 2|41
2230591|NCT02690701|5471606|P2|STARTED|Treatment Period 2||42
2230592|NCT02690701|5471607|P1|STARTED|Treatment Period 2|Completed Treatment Period 1 and continued to Treatment Period 2|44
2230593|NCT02690701|5471606|P2|NOT COMPLETED|Treatment Period 1||3
2230594|NCT02690701|5471607|P1|NOT COMPLETED|Treatment Period 1||2
2230595|NCT02690701|5471606|P2|COMPLETED|Treatment Period 1||42
2230596|NCT02690701|5471607|P1|COMPLETED|Treatment Period 1||44
2230597|NCT02690701|5471606|P2|STARTED|Treatment Period 1||45
2230598|NCT02690701|5471607|P1|STARTED|Treatment Period 1||46
2230599|NCT02690194|5471675|P3|NOT COMPLETED|Overall Study||0
2230600|NCT02690194|5471676|P2|NOT COMPLETED|Overall Study||4
2230601|NCT02690194|5471677|P1|NOT COMPLETED|Overall Study||1
2230602|NCT02690194|5471675|P3|COMPLETED|Overall Study||19
2230603|NCT02690194|5471676|P2|COMPLETED|Overall Study||14
2230604|NCT02690194|5471677|P1|COMPLETED|Overall Study||16
2230605|NCT02690194|5471675|P3|STARTED|Overall Study||19
2230606|NCT02690194|5471676|P2|STARTED|Overall Study||18
2230607|NCT02690194|5471677|P1|STARTED|Overall Study||17
2230608|NCT02690181|5471726|P6|NOT COMPLETED|Overall Study||0
2230609|NCT02690181|5471727|P5|NOT COMPLETED|Overall Study||0
2230610|NCT02690181|5471728|P4|NOT COMPLETED|Overall Study||0
2230611|NCT02690181|5471729|P3|NOT COMPLETED|Overall Study||0
2230612|NCT02690181|5471730|P2|NOT COMPLETED|Overall Study||0
2230613|NCT02690181|5471731|P1|NOT COMPLETED|Overall Study||0
2230614|NCT02690181|5471726|P6|COMPLETED|Overall Study||21
2230615|NCT02690181|5471727|P5|COMPLETED|Overall Study||6
2230616|NCT02690181|5471728|P4|COMPLETED|Overall Study||10
2230617|NCT02690181|5471729|P3|COMPLETED|Overall Study||15
2230618|NCT02690181|5471730|P2|COMPLETED|Overall Study||14
2230619|NCT02690181|5471731|P1|COMPLETED|Overall Study||14
2230620|NCT02690181|5471726|P6|STARTED|Overall Study||21
2230621|NCT02690181|5471727|P5|STARTED|Overall Study||6
2230622|NCT02690181|5471728|P4|STARTED|Overall Study||10
2230623|NCT02690181|5471729|P3|STARTED|Overall Study||15
2230624|NCT02690181|5471730|P2|STARTED|Overall Study||14
2230625|NCT02690181|5471731|P1|STARTED|Overall Study||14
2230626|NCT02689973|5471857|P4|NOT COMPLETED|Overall Study||53
2230627|NCT02689973|5471858|P3|NOT COMPLETED|Overall Study||72
2230628|NCT02689973|5471859|P2|NOT COMPLETED|Overall Study||49
2230629|NCT02689973|5471860|P1|NOT COMPLETED|Overall Study||54
2230630|NCT02689973|5471857|P4|COMPLETED|Overall Study||232
2230631|NCT02689973|5471858|P3|COMPLETED|Overall Study||279
2230632|NCT02689973|5471859|P2|COMPLETED|Overall Study||221
2230633|NCT02689973|5471860|P1|COMPLETED|Overall Study||257
2230634|NCT02689973|5471857|P4|STARTED|Overall Study||285
2230635|NCT02689973|5471858|P3|STARTED|Overall Study||351
2230636|NCT02689973|5471859|P2|STARTED|Overall Study||270
2230637|NCT02689973|5471860|P1|STARTED|Overall Study||311
2230638|NCT02689804|5471884|P2|NOT COMPLETED|Overall Study||0
2230639|NCT02689804|5471885|P1|NOT COMPLETED|Overall Study||2
2230640|NCT02689804|5471884|P2|COMPLETED|Overall Study||16
2230641|NCT02689804|5471885|P1|COMPLETED|Overall Study||16
2230642|NCT02689804|5471884|P2|STARTED|Overall Study||16
2230643|NCT02689804|5471885|P1|STARTED|Overall Study||18
2230644|NCT02689492|5471911|P1|NOT COMPLETED|Overall Study||86
2230645|NCT02689492|5471911|P1|COMPLETED|Overall Study||315
2230646|NCT02689492|5471911|P1|STARTED|Overall Study||401
2230647|NCT02689219|5471927|P2|NOT COMPLETED|Overall Study||7
2230648|NCT02689219|5471928|P1|NOT COMPLETED|Overall Study||11
2230649|NCT02689219|5471927|P2|COMPLETED|Overall Study||0
2230650|NCT02689219|5471928|P1|COMPLETED|Overall Study||0
2230651|NCT02689219|5471927|P2|STARTED|Overall Study||7
2230652|NCT02689219|5471928|P1|STARTED|Overall Study||11
2230668|NCT02689154|5472153|P1|NOT COMPLETED|Overall Study||0
2230669|NCT02689154|5472153|P1|COMPLETED|Overall Study||18
2230670|NCT02689154|5472153|P1|STARTED|Overall Study||18
2230671|NCT02688933|5472162|P2|NOT COMPLETED|Overall Study||37
2230672|NCT02688933|5472163|P1|NOT COMPLETED|Overall Study||29
2230673|NCT02688933|5472162|P2|COMPLETED|Overall Study||281
2230674|NCT02688933|5472163|P1|COMPLETED|Overall Study||291
2230675|NCT02688933|5472162|P2|STARTED|Overall Study||318
2230676|NCT02688933|5472163|P1|STARTED|Overall Study||320
2230683|NCT02688829|5472212|P1|NOT COMPLETED|Overall Study||2
2230684|NCT02688829|5472212|P1|COMPLETED|Overall Study||19
2230685|NCT02688829|5472212|P1|STARTED|Overall Study||21
2230686|NCT02688764|5472224|P2|NOT COMPLETED|Overall Study||17
2230687|NCT02688764|5472225|P1|NOT COMPLETED|Overall Study||40
2230688|NCT02688764|5472224|P2|COMPLETED|Overall Study||2
2230689|NCT02688764|5472225|P1|COMPLETED|Overall Study||26
2230690|NCT02688764|5472224|P2|Treated in Stage 2|Overall Study||8
2230691|NCT02688764|5472225|P1|Treated in Stage 2|Overall Study||43
2230692|NCT02688764|5472224|P2|Treated in Stage 1|Overall Study||19
2230693|NCT02688764|5472225|P1|Treated in Stage 1|Overall Study||66
2230694|NCT02688764|5472224|P2|STARTED|Overall Study||19
2230695|NCT02688764|5472225|P1|STARTED|Overall Study||66
2230696|NCT02688556|5472275|P2|NOT COMPLETED|Overall Study||12
2230697|NCT02688556|5472276|P1|NOT COMPLETED|Overall Study||25
2230698|NCT02688556|5472275|P2|COMPLETED|Overall Study||361
2230699|NCT02688556|5472276|P1|COMPLETED|Overall Study||347
2230700|NCT02688556|5472275|P2|STARTED|Overall Study||373
2230701|NCT02688556|5472276|P1|STARTED|Overall Study||372
2230702|NCT02688387|5472292|P22|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230703|NCT02688387|5472293|P21|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230704|NCT02688387|5472294|P20|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230705|NCT02688387|5472295|P19|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230706|NCT02688387|5472296|P18|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230707|NCT02688387|5472297|P17|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230708|NCT02688387|5472298|P16|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230709|NCT02688387|5472299|P15|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230710|NCT02688387|5472300|P14|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230711|NCT02688387|5472301|P13|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230712|NCT02688387|5472302|P12|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230713|NCT02688387|5472303|P11|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230714|NCT02688387|5472304|P10|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230715|NCT02688387|5472305|P9|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230716|NCT02688387|5472306|P8|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230717|NCT02688387|5472307|P7|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230718|NCT02688387|5472308|P6|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230719|NCT02688387|5472309|P5|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230720|NCT02688387|5472310|P4|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230721|NCT02688387|5472311|P3|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230722|NCT02688387|5472312|P2|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230723|NCT02688387|5472313|P1|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230724|NCT02688387|5472292|P22|COMPLETED|Part 3B, Period 4 (up to 6 Days)||8
2230725|NCT02688387|5472293|P21|COMPLETED|Part 3B, Period 4 (up to 6 Days)||6
2230726|NCT02688387|5472294|P20|COMPLETED|Part 3B, Period 4 (up to 6 Days)||7
2230727|NCT02688387|5472295|P19|COMPLETED|Part 3B, Period 4 (up to 6 Days)||7
2230728|NCT02688387|5472296|P18|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230729|NCT02688387|5472297|P17|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230730|NCT02688387|5472298|P16|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230731|NCT02688387|5472299|P15|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230732|NCT02688387|5472300|P14|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230733|NCT02688387|5472301|P13|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230734|NCT02688387|5472302|P12|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230735|NCT02688387|5472303|P11|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230736|NCT02688387|5472304|P10|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230737|NCT02688387|5472305|P9|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230738|NCT02688387|5472306|P8|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230739|NCT02688387|5472307|P7|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230740|NCT02688387|5472308|P6|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230741|NCT02688387|5472309|P5|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230742|NCT02688387|5472310|P4|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230743|NCT02688387|5472311|P3|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230744|NCT02688387|5472312|P2|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230745|NCT02688387|5472313|P1|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
2230746|NCT02688387|5472292|P22|STARTED|Part 3B, Period 4 (up to 6 Days)||8
2230747|NCT02688387|5472293|P21|STARTED|Part 3B, Period 4 (up to 6 Days)||6
2230748|NCT02688387|5472294|P20|STARTED|Part 3B, Period 4 (up to 6 Days)||7
2230749|NCT02688387|5472295|P19|STARTED|Part 3B, Period 4 (up to 6 Days)||7
2230750|NCT02688387|5472296|P18|STARTED|Part 3B, Period 4 (up to 6 Days)||0
2230751|NCT02688387|5472297|P17|STARTED|Part 3B, Period 4 (up to 6 Days)||0
2230752|NCT02688387|5472298|P16|STARTED|Part 3B, Period 4 (up to 6 Days)||0
2230753|NCT02688387|5472299|P15|STARTED|Part 3B, Period 4 (up to 6 Days)||0
2230754|NCT02688387|5472300|P14|STARTED|Part 3B, Period 4 (up to 6 Days)||0
2230755|NCT02688387|5472301|P13|STARTED|Part 3B, Period 4 (up to 6 Days)||0
2230756|NCT02688387|5472302|P12|STARTED|Part 3B, Period 4 (up to 6 Days)||0
2230757|NCT02688387|5472303|P11|STARTED|Part 3B, Period 4 (up to 6 Days)||0
2230758|NCT02688387|5472304|P10|STARTED|Part 3B, Period 4 (up to 6 Days)||0
2230759|NCT02688387|5472305|P9|STARTED|Part 3B, Period 4 (up to 6 Days)||0
2230760|NCT02688387|5472306|P8|STARTED|Part 3B, Period 4 (up to 6 Days)||0
2230761|NCT02688387|5472307|P7|STARTED|Part 3B, Period 4 (up to 6 Days)||0
2230762|NCT02688387|5472308|P6|STARTED|Part 3B, Period 4 (up to 6 Days)||0
2230763|NCT02688387|5472309|P5|STARTED|Part 3B, Period 4 (up to 6 Days)||0
2230764|NCT02688387|5472310|P4|STARTED|Part 3B, Period 4 (up to 6 Days)||0
2230765|NCT02688387|5472311|P3|STARTED|Part 3B, Period 4 (up to 6 Days)||0
2230766|NCT02688387|5472312|P2|STARTED|Part 3B, Period 4 (up to 6 Days)||0
2230767|NCT02688387|5472313|P1|STARTED|Part 3B, Period 4 (up to 6 Days)||0
2230768|NCT02688387|5472292|P22|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230769|NCT02688387|5472293|P21|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
2230770|NCT02688387|5472294|P20|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
2230771|NCT02688387|5472295|P19|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
2230772|NCT02688387|5472296|P18|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230773|NCT02688387|5472297|P17|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230774|NCT02688387|5472298|P16|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230775|NCT02688387|5472299|P15|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230776|NCT02688387|5472300|P14|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230777|NCT02688387|5472301|P13|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230778|NCT02688387|5472302|P12|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230779|NCT02688387|5472303|P11|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230780|NCT02688387|5472304|P10|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230781|NCT02688387|5472305|P9|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230782|NCT02688387|5472306|P8|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230783|NCT02688387|5472307|P7|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230784|NCT02688387|5472308|P6|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230785|NCT02688387|5472309|P5|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230786|NCT02688387|5472310|P4|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230787|NCT02688387|5472311|P3|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230788|NCT02688387|5472312|P2|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230789|NCT02688387|5472313|P1|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230790|NCT02688387|5472292|P22|COMPLETED|Part 3B, Washout Period 3 (10 Days)||8
2230791|NCT02688387|5472293|P21|COMPLETED|Part 3B, Washout Period 3 (10 Days)||6
2230792|NCT02688387|5472294|P20|COMPLETED|Part 3B, Washout Period 3 (10 Days)||7
2230793|NCT02688387|5472295|P19|COMPLETED|Part 3B, Washout Period 3 (10 Days)||7
2230794|NCT02688387|5472296|P18|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230795|NCT02688387|5472297|P17|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230796|NCT02688387|5472298|P16|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230797|NCT02688387|5472299|P15|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230798|NCT02688387|5472300|P14|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230799|NCT02688387|5472301|P13|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230800|NCT02688387|5472302|P12|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230801|NCT02688387|5472303|P11|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230802|NCT02688387|5472304|P10|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230803|NCT02688387|5472305|P9|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230804|NCT02688387|5472306|P8|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230805|NCT02688387|5472307|P7|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230806|NCT02688387|5472308|P6|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230807|NCT02688387|5472309|P5|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230808|NCT02688387|5472310|P4|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230809|NCT02688387|5472311|P3|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230810|NCT02688387|5472312|P2|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230811|NCT02688387|5472313|P1|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
2230812|NCT02688387|5472292|P22|STARTED|Part 3B, Washout Period 3 (10 Days)||8
2230813|NCT02688387|5472293|P21|STARTED|Part 3B, Washout Period 3 (10 Days)||7
2230814|NCT02688387|5472294|P20|STARTED|Part 3B, Washout Period 3 (10 Days)||8
2230815|NCT02688387|5472295|P19|STARTED|Part 3B, Washout Period 3 (10 Days)||8
2230816|NCT02688387|5472296|P18|STARTED|Part 3B, Washout Period 3 (10 Days)||0
2230817|NCT02688387|5472297|P17|STARTED|Part 3B, Washout Period 3 (10 Days)||0
2230818|NCT02688387|5472298|P16|STARTED|Part 3B, Washout Period 3 (10 Days)||0
2230819|NCT02688387|5472299|P15|STARTED|Part 3B, Washout Period 3 (10 Days)||0
2230820|NCT02688387|5472300|P14|STARTED|Part 3B, Washout Period 3 (10 Days)||0
2230821|NCT02688387|5472301|P13|STARTED|Part 3B, Washout Period 3 (10 Days)||0
2230822|NCT02688387|5472302|P12|STARTED|Part 3B, Washout Period 3 (10 Days)||0
2230823|NCT02688387|5472303|P11|STARTED|Part 3B, Washout Period 3 (10 Days)||0
2230824|NCT02688387|5472304|P10|STARTED|Part 3B, Washout Period 3 (10 Days)||0
2230825|NCT02688387|5472305|P9|STARTED|Part 3B, Washout Period 3 (10 Days)||0
2230826|NCT02688387|5472306|P8|STARTED|Part 3B, Washout Period 3 (10 Days)||0
2230827|NCT02688387|5472307|P7|STARTED|Part 3B, Washout Period 3 (10 Days)||0
2230828|NCT02688387|5472308|P6|STARTED|Part 3B, Washout Period 3 (10 Days)||0
2230829|NCT02688387|5472309|P5|STARTED|Part 3B, Washout Period 3 (10 Days)||0
2230830|NCT02688387|5472310|P4|STARTED|Part 3B, Washout Period 3 (10 Days)||0
2230831|NCT02688387|5472311|P3|STARTED|Part 3B, Washout Period 3 (10 Days)||0
2230832|NCT02688387|5472312|P2|STARTED|Part 3B, Washout Period 3 (10 Days)||0
2230833|NCT02688387|5472313|P1|STARTED|Part 3B, Washout Period 3 (10 Days)||0
2230834|NCT02688387|5472292|P22|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230835|NCT02688387|5472293|P21|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||1
2230836|NCT02688387|5472294|P20|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230837|NCT02688387|5472295|P19|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230838|NCT02688387|5472296|P18|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230839|NCT02688387|5472297|P17|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230840|NCT02688387|5472298|P16|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230841|NCT02688387|5472299|P15|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230842|NCT02688387|5472300|P14|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230843|NCT02688387|5472301|P13|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230844|NCT02688387|5472302|P12|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230845|NCT02688387|5472303|P11|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230846|NCT02688387|5472304|P10|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230847|NCT02688387|5472305|P9|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230848|NCT02688387|5472306|P8|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230849|NCT02688387|5472307|P7|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230850|NCT02688387|5472308|P6|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230851|NCT02688387|5472309|P5|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230852|NCT02688387|5472310|P4|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230853|NCT02688387|5472311|P3|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230854|NCT02688387|5472312|P2|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230855|NCT02688387|5472313|P1|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230856|NCT02688387|5472292|P22|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
2230857|NCT02688387|5472293|P21|COMPLETED|Part 3B, Period 3 (up to 6 Days)||7
2230858|NCT02688387|5472294|P20|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
2230859|NCT02688387|5472295|P19|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
2230860|NCT02688387|5472296|P18|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230861|NCT02688387|5472297|P17|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230862|NCT02688387|5472298|P16|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230863|NCT02688387|5472299|P15|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230864|NCT02688387|5472300|P14|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230865|NCT02688387|5472301|P13|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230866|NCT02688387|5472302|P12|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230867|NCT02688387|5472303|P11|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230868|NCT02688387|5472304|P10|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230869|NCT02688387|5472305|P9|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230870|NCT02688387|5472306|P8|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230871|NCT02688387|5472307|P7|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230872|NCT02688387|5472308|P6|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230873|NCT02688387|5472309|P5|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230874|NCT02688387|5472310|P4|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230875|NCT02688387|5472311|P3|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230876|NCT02688387|5472312|P2|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230877|NCT02688387|5472313|P1|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
2230878|NCT02688387|5472292|P22|STARTED|Part 3B, Period 3 (up to 6 Days)||8
2230879|NCT02688387|5472293|P21|STARTED|Part 3B, Period 3 (up to 6 Days)||8
2230880|NCT02688387|5472294|P20|STARTED|Part 3B, Period 3 (up to 6 Days)||8
2230881|NCT02688387|5472295|P19|STARTED|Part 3B, Period 3 (up to 6 Days)||8
2230882|NCT02688387|5472296|P18|STARTED|Part 3B, Period 3 (up to 6 Days)||0
2230883|NCT02688387|5472297|P17|STARTED|Part 3B, Period 3 (up to 6 Days)||0
2230884|NCT02688387|5472298|P16|STARTED|Part 3B, Period 3 (up to 6 Days)||0
2230885|NCT02688387|5472299|P15|STARTED|Part 3B, Period 3 (up to 6 Days)||0
2230886|NCT02688387|5472300|P14|STARTED|Part 3B, Period 3 (up to 6 Days)||0
2230887|NCT02688387|5472301|P13|STARTED|Part 3B, Period 3 (up to 6 Days)||0
2230888|NCT02688387|5472302|P12|STARTED|Part 3B, Period 3 (up to 6 Days)||0
2230889|NCT02688387|5472303|P11|STARTED|Part 3B, Period 3 (up to 6 Days)||0
2230890|NCT02688387|5472304|P10|STARTED|Part 3B, Period 3 (up to 6 Days)||0
2230891|NCT02688387|5472305|P9|STARTED|Part 3B, Period 3 (up to 6 Days)||0
2230892|NCT02688387|5472306|P8|STARTED|Part 3B, Period 3 (up to 6 Days)||0
2230893|NCT02688387|5472307|P7|STARTED|Part 3B, Period 3 (up to 6 Days)||0
2230894|NCT02688387|5472308|P6|STARTED|Part 3B, Period 3 (up to 6 Days)||0
2230895|NCT02688387|5472309|P5|STARTED|Part 3B, Period 3 (up to 6 Days)||0
2230896|NCT02688387|5472310|P4|STARTED|Part 3B, Period 3 (up to 6 Days)||0
2230897|NCT02688387|5472311|P3|STARTED|Part 3B, Period 3 (up to 6 Days)||0
2230898|NCT02688387|5472312|P2|STARTED|Part 3B, Period 3 (up to 6 Days)||0
2230899|NCT02688387|5472313|P1|STARTED|Part 3B, Period 3 (up to 6 Days)||0
2230900|NCT02688387|5472292|P22|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230901|NCT02688387|5472293|P21|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230902|NCT02688387|5472294|P20|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230903|NCT02688387|5472295|P19|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230904|NCT02688387|5472296|P18|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230905|NCT02688387|5472297|P17|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230906|NCT02688387|5472298|P16|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230907|NCT02688387|5472299|P15|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230908|NCT02688387|5472300|P14|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230909|NCT02688387|5472301|P13|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230910|NCT02688387|5472302|P12|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230911|NCT02688387|5472303|P11|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230912|NCT02688387|5472304|P10|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230913|NCT02688387|5472305|P9|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230914|NCT02688387|5472306|P8|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230915|NCT02688387|5472307|P7|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230916|NCT02688387|5472308|P6|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230917|NCT02688387|5472309|P5|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230918|NCT02688387|5472310|P4|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230919|NCT02688387|5472311|P3|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230920|NCT02688387|5472312|P2|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230921|NCT02688387|5472313|P1|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230922|NCT02688387|5472292|P22|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
2230923|NCT02688387|5472293|P21|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
2230924|NCT02688387|5472294|P20|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
2230925|NCT02688387|5472295|P19|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
2230926|NCT02688387|5472296|P18|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230927|NCT02688387|5472297|P17|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230928|NCT02688387|5472298|P16|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230929|NCT02688387|5472299|P15|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230930|NCT02688387|5472300|P14|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230931|NCT02688387|5472301|P13|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230932|NCT02688387|5472302|P12|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230933|NCT02688387|5472303|P11|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230934|NCT02688387|5472304|P10|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230935|NCT02688387|5472305|P9|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230936|NCT02688387|5472306|P8|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230937|NCT02688387|5472307|P7|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230938|NCT02688387|5472308|P6|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230939|NCT02688387|5472309|P5|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230940|NCT02688387|5472310|P4|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230941|NCT02688387|5472311|P3|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230942|NCT02688387|5472312|P2|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230943|NCT02688387|5472313|P1|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
2230944|NCT02688387|5472292|P22|STARTED|Part 3B, Washout Period 2 (10 Days)||8
2230945|NCT02688387|5472293|P21|STARTED|Part 3B, Washout Period 2 (10 Days)||8
2230946|NCT02688387|5472294|P20|STARTED|Part 3B, Washout Period 2 (10 Days)||8
2230947|NCT02688387|5472295|P19|STARTED|Part 3B, Washout Period 2 (10 Days)||8
2230948|NCT02688387|5472296|P18|STARTED|Part 3B, Washout Period 2 (10 Days)||0
2230949|NCT02688387|5472297|P17|STARTED|Part 3B, Washout Period 2 (10 Days)||0
2230950|NCT02688387|5472298|P16|STARTED|Part 3B, Washout Period 2 (10 Days)||0
2230951|NCT02688387|5472299|P15|STARTED|Part 3B, Washout Period 2 (10 Days)||0
2230952|NCT02688387|5472300|P14|STARTED|Part 3B, Washout Period 2 (10 Days)||0
2230953|NCT02688387|5472301|P13|STARTED|Part 3B, Washout Period 2 (10 Days)||0
2230954|NCT02688387|5472302|P12|STARTED|Part 3B, Washout Period 2 (10 Days)||0
2230955|NCT02688387|5472303|P11|STARTED|Part 3B, Washout Period 2 (10 Days)||0
2230956|NCT02688387|5472304|P10|STARTED|Part 3B, Washout Period 2 (10 Days)||0
2230957|NCT02688387|5472305|P9|STARTED|Part 3B, Washout Period 2 (10 Days)||0
2230958|NCT02688387|5472306|P8|STARTED|Part 3B, Washout Period 2 (10 Days)||0
2230959|NCT02688387|5472307|P7|STARTED|Part 3B, Washout Period 2 (10 Days)||0
2230960|NCT02688387|5472308|P6|STARTED|Part 3B, Washout Period 2 (10 Days)||0
2230961|NCT02688387|5472309|P5|STARTED|Part 3B, Washout Period 2 (10 Days)||0
2230962|NCT02688387|5472310|P4|STARTED|Part 3B, Washout Period 2 (10 Days)||0
2230963|NCT02688387|5472311|P3|STARTED|Part 3B, Washout Period 2 (10 Days)||0
2230964|NCT02688387|5472312|P2|STARTED|Part 3B, Washout Period 2 (10 Days)||0
2230965|NCT02688387|5472313|P1|STARTED|Part 3B, Washout Period 2 (10 Days)||0
2230966|NCT02688387|5472292|P22|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2230967|NCT02688387|5472293|P21|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2230968|NCT02688387|5472294|P20|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2230969|NCT02688387|5472295|P19|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2230970|NCT02688387|5472296|P18|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2230971|NCT02688387|5472297|P17|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2230972|NCT02688387|5472298|P16|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2230973|NCT02688387|5472299|P15|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2230974|NCT02688387|5472300|P14|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2230975|NCT02688387|5472301|P13|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2230976|NCT02688387|5472302|P12|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2230977|NCT02688387|5472303|P11|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2230978|NCT02688387|5472304|P10|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2230979|NCT02688387|5472305|P9|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2230980|NCT02688387|5472306|P8|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2230981|NCT02688387|5472307|P7|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2230982|NCT02688387|5472308|P6|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2230983|NCT02688387|5472309|P5|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2230984|NCT02688387|5472310|P4|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2230985|NCT02688387|5472311|P3|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2230986|NCT02688387|5472312|P2|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2230987|NCT02688387|5472313|P1|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2230988|NCT02688387|5472292|P22|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
2230989|NCT02688387|5472293|P21|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
2230990|NCT02688387|5472294|P20|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
2230991|NCT02688387|5472295|P19|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
2230992|NCT02688387|5472296|P18|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2230993|NCT02688387|5472297|P17|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2230994|NCT02688387|5472298|P16|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2230995|NCT02688387|5472299|P15|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2230996|NCT02688387|5472300|P14|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2230997|NCT02688387|5472301|P13|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2230998|NCT02688387|5472302|P12|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2230999|NCT02688387|5472303|P11|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2231000|NCT02688387|5472304|P10|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2231001|NCT02688387|5472305|P9|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2231002|NCT02688387|5472306|P8|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2231003|NCT02688387|5472307|P7|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2231004|NCT02688387|5472308|P6|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2231005|NCT02688387|5472309|P5|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2231006|NCT02688387|5472310|P4|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2231007|NCT02688387|5472311|P3|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2231008|NCT02688387|5472312|P2|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2231009|NCT02688387|5472313|P1|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
2231010|NCT02688387|5472292|P22|STARTED|Part 3B, Period 2 (up to 6 Days)||8
2231011|NCT02688387|5472293|P21|STARTED|Part 3B, Period 2 (up to 6 Days)||8
2231012|NCT02688387|5472294|P20|STARTED|Part 3B, Period 2 (up to 6 Days)||8
2231013|NCT02688387|5472295|P19|STARTED|Part 3B, Period 2 (up to 6 Days)||8
2231014|NCT02688387|5472296|P18|STARTED|Part 3B, Period 2 (up to 6 Days)||0
2231015|NCT02688387|5472297|P17|STARTED|Part 3B, Period 2 (up to 6 Days)||0
2231016|NCT02688387|5472298|P16|STARTED|Part 3B, Period 2 (up to 6 Days)||0
2231017|NCT02688387|5472299|P15|STARTED|Part 3B, Period 2 (up to 6 Days)||0
2231018|NCT02688387|5472300|P14|STARTED|Part 3B, Period 2 (up to 6 Days)||0
2231019|NCT02688387|5472301|P13|STARTED|Part 3B, Period 2 (up to 6 Days)||0
2231020|NCT02688387|5472302|P12|STARTED|Part 3B, Period 2 (up to 6 Days)||0
2231021|NCT02688387|5472303|P11|STARTED|Part 3B, Period 2 (up to 6 Days)||0
2231022|NCT02688387|5472304|P10|STARTED|Part 3B, Period 2 (up to 6 Days)||0
2231023|NCT02688387|5472305|P9|STARTED|Part 3B, Period 2 (up to 6 Days)||0
2231024|NCT02688387|5472306|P8|STARTED|Part 3B, Period 2 (up to 6 Days)||0
2231025|NCT02688387|5472307|P7|STARTED|Part 3B, Period 2 (up to 6 Days)||0
2231026|NCT02688387|5472308|P6|STARTED|Part 3B, Period 2 (up to 6 Days)||0
2231027|NCT02688387|5472309|P5|STARTED|Part 3B, Period 2 (up to 6 Days)||0
2231028|NCT02688387|5472310|P4|STARTED|Part 3B, Period 2 (up to 6 Days)||0
2231029|NCT02688387|5472311|P3|STARTED|Part 3B, Period 2 (up to 6 Days)||0
2231030|NCT02688387|5472312|P2|STARTED|Part 3B, Period 2 (up to 6 Days)||0
2231031|NCT02688387|5472313|P1|STARTED|Part 3B, Period 2 (up to 6 Days)||0
2231032|NCT02688387|5472292|P22|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231033|NCT02688387|5472293|P21|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231034|NCT02688387|5472294|P20|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231035|NCT02688387|5472295|P19|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231036|NCT02688387|5472296|P18|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231037|NCT02688387|5472297|P17|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231038|NCT02688387|5472298|P16|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231039|NCT02688387|5472299|P15|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231040|NCT02688387|5472300|P14|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231041|NCT02688387|5472301|P13|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231042|NCT02688387|5472302|P12|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231043|NCT02688387|5472303|P11|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231044|NCT02688387|5472304|P10|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231045|NCT02688387|5472305|P9|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231046|NCT02688387|5472306|P8|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231047|NCT02688387|5472307|P7|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231048|NCT02688387|5472308|P6|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231049|NCT02688387|5472309|P5|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231050|NCT02688387|5472310|P4|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231051|NCT02688387|5472311|P3|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231052|NCT02688387|5472312|P2|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231053|NCT02688387|5472313|P1|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231054|NCT02688387|5472292|P22|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
2231055|NCT02688387|5472293|P21|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
2231056|NCT02688387|5472294|P20|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
2231057|NCT02688387|5472295|P19|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
2231058|NCT02688387|5472296|P18|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231059|NCT02688387|5472297|P17|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231060|NCT02688387|5472298|P16|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231061|NCT02688387|5472299|P15|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231062|NCT02688387|5472300|P14|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231063|NCT02688387|5472301|P13|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231064|NCT02688387|5472302|P12|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231065|NCT02688387|5472303|P11|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231066|NCT02688387|5472304|P10|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231067|NCT02688387|5472305|P9|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231068|NCT02688387|5472306|P8|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231069|NCT02688387|5472307|P7|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231070|NCT02688387|5472308|P6|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231071|NCT02688387|5472309|P5|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231072|NCT02688387|5472310|P4|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231073|NCT02688387|5472311|P3|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231074|NCT02688387|5472312|P2|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231075|NCT02688387|5472313|P1|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
2231076|NCT02688387|5472292|P22|STARTED|Part 3B, Washout Period 1 (10 Days)||8
2231077|NCT02688387|5472293|P21|STARTED|Part 3B, Washout Period 1 (10 Days)||8
2231078|NCT02688387|5472294|P20|STARTED|Part 3B, Washout Period 1 (10 Days)||8
2231079|NCT02688387|5472295|P19|STARTED|Part 3B, Washout Period 1 (10 Days)||8
2231080|NCT02688387|5472296|P18|STARTED|Part 3B, Washout Period 1 (10 Days)||0
2231081|NCT02688387|5472297|P17|STARTED|Part 3B, Washout Period 1 (10 Days)||0
2231082|NCT02688387|5472298|P16|STARTED|Part 3B, Washout Period 1 (10 Days)||0
2231083|NCT02688387|5472299|P15|STARTED|Part 3B, Washout Period 1 (10 Days)||0
2231084|NCT02688387|5472300|P14|STARTED|Part 3B, Washout Period 1 (10 Days)||0
2231085|NCT02688387|5472301|P13|STARTED|Part 3B, Washout Period 1 (10 Days)||0
2231086|NCT02688387|5472302|P12|STARTED|Part 3B, Washout Period 1 (10 Days)||0
2231087|NCT02688387|5472303|P11|STARTED|Part 3B, Washout Period 1 (10 Days)||0
2231088|NCT02688387|5472304|P10|STARTED|Part 3B, Washout Period 1 (10 Days)||0
2231089|NCT02688387|5472305|P9|STARTED|Part 3B, Washout Period 1 (10 Days)||0
2231090|NCT02688387|5472306|P8|STARTED|Part 3B, Washout Period 1 (10 Days)||0
2231091|NCT02688387|5472307|P7|STARTED|Part 3B, Washout Period 1 (10 Days)||0
2231092|NCT02688387|5472308|P6|STARTED|Part 3B, Washout Period 1 (10 Days)||0
2231093|NCT02688387|5472309|P5|STARTED|Part 3B, Washout Period 1 (10 Days)||0
2231094|NCT02688387|5472310|P4|STARTED|Part 3B, Washout Period 1 (10 Days)||0
2231095|NCT02688387|5472311|P3|STARTED|Part 3B, Washout Period 1 (10 Days)||0
2231096|NCT02688387|5472312|P2|STARTED|Part 3B, Washout Period 1 (10 Days)||0
2231097|NCT02688387|5472313|P1|STARTED|Part 3B, Washout Period 1 (10 Days)||0
2231098|NCT02688387|5472292|P22|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231099|NCT02688387|5472293|P21|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231100|NCT02688387|5472294|P20|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231101|NCT02688387|5472295|P19|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231102|NCT02688387|5472296|P18|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231103|NCT02688387|5472297|P17|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231104|NCT02688387|5472298|P16|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231105|NCT02688387|5472299|P15|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231106|NCT02688387|5472300|P14|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231107|NCT02688387|5472301|P13|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231108|NCT02688387|5472302|P12|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231109|NCT02688387|5472303|P11|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231110|NCT02688387|5472304|P10|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231111|NCT02688387|5472305|P9|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231112|NCT02688387|5472306|P8|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231113|NCT02688387|5472307|P7|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231114|NCT02688387|5472308|P6|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231115|NCT02688387|5472309|P5|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231116|NCT02688387|5472310|P4|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231117|NCT02688387|5472311|P3|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231118|NCT02688387|5472312|P2|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231119|NCT02688387|5472313|P1|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231120|NCT02688387|5472292|P22|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
2231121|NCT02688387|5472293|P21|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
2231122|NCT02688387|5472294|P20|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
2231123|NCT02688387|5472295|P19|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
2231124|NCT02688387|5472296|P18|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231125|NCT02688387|5472297|P17|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231126|NCT02688387|5472298|P16|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231127|NCT02688387|5472299|P15|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231128|NCT02688387|5472300|P14|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231129|NCT02688387|5472301|P13|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231130|NCT02688387|5472302|P12|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231131|NCT02688387|5472303|P11|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231132|NCT02688387|5472304|P10|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231133|NCT02688387|5472305|P9|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231134|NCT02688387|5472306|P8|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231135|NCT02688387|5472307|P7|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231136|NCT02688387|5472308|P6|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231137|NCT02688387|5472309|P5|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231138|NCT02688387|5472310|P4|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231139|NCT02688387|5472311|P3|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231140|NCT02688387|5472312|P2|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231141|NCT02688387|5472313|P1|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
2231142|NCT02688387|5472292|P22|STARTED|Part 3B, Period 1 (up to 6 Days)||8
2231143|NCT02688387|5472293|P21|STARTED|Part 3B, Period 1 (up to 6 Days)||8
2231144|NCT02688387|5472294|P20|STARTED|Part 3B, Period 1 (up to 6 Days)||8
2231145|NCT02688387|5472295|P19|STARTED|Part 3B, Period 1 (up to 6 Days)||8
2231146|NCT02688387|5472296|P18|STARTED|Part 3B, Period 1 (up to 6 Days)||0
2231147|NCT02688387|5472297|P17|STARTED|Part 3B, Period 1 (up to 6 Days)||0
2231148|NCT02688387|5472298|P16|STARTED|Part 3B, Period 1 (up to 6 Days)||0
2231149|NCT02688387|5472299|P15|STARTED|Part 3B, Period 1 (up to 6 Days)||0
2231150|NCT02688387|5472300|P14|STARTED|Part 3B, Period 1 (up to 6 Days)||0
2231151|NCT02688387|5472301|P13|STARTED|Part 3B, Period 1 (up to 6 Days)||0
2231152|NCT02688387|5472302|P12|STARTED|Part 3B, Period 1 (up to 6 Days)||0
2231153|NCT02688387|5472303|P11|STARTED|Part 3B, Period 1 (up to 6 Days)||0
2231154|NCT02688387|5472304|P10|STARTED|Part 3B, Period 1 (up to 6 Days)||0
2231155|NCT02688387|5472305|P9|STARTED|Part 3B, Period 1 (up to 6 Days)||0
2231156|NCT02688387|5472306|P8|STARTED|Part 3B, Period 1 (up to 6 Days)||0
2231157|NCT02688387|5472307|P7|STARTED|Part 3B, Period 1 (up to 6 Days)||0
2231158|NCT02688387|5472308|P6|STARTED|Part 3B, Period 1 (up to 6 Days)||0
2231159|NCT02688387|5472309|P5|STARTED|Part 3B, Period 1 (up to 6 Days)||0
2231160|NCT02688387|5472310|P4|STARTED|Part 3B, Period 1 (up to 6 Days)||0
2231161|NCT02688387|5472311|P3|STARTED|Part 3B, Period 1 (up to 6 Days)||0
2231162|NCT02688387|5472312|P2|STARTED|Part 3B, Period 1 (up to 6 Days)||0
2231163|NCT02688387|5472313|P1|STARTED|Part 3B, Period 1 (up to 6 Days)||0
2231164|NCT02688387|5472292|P22|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231165|NCT02688387|5472293|P21|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231166|NCT02688387|5472294|P20|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231167|NCT02688387|5472295|P19|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231168|NCT02688387|5472296|P18|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231169|NCT02688387|5472297|P17|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231170|NCT02688387|5472298|P16|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231171|NCT02688387|5472299|P15|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231172|NCT02688387|5472300|P14|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231173|NCT02688387|5472301|P13|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231174|NCT02688387|5472302|P12|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231175|NCT02688387|5472303|P11|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231176|NCT02688387|5472304|P10|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231177|NCT02688387|5472305|P9|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231178|NCT02688387|5472306|P8|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231179|NCT02688387|5472307|P7|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231180|NCT02688387|5472308|P6|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231181|NCT02688387|5472309|P5|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231182|NCT02688387|5472310|P4|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231183|NCT02688387|5472311|P3|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231184|NCT02688387|5472312|P2|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231185|NCT02688387|5472313|P1|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231186|NCT02688387|5472292|P22|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231187|NCT02688387|5472293|P21|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231188|NCT02688387|5472294|P20|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231189|NCT02688387|5472295|P19|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231190|NCT02688387|5472296|P18|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
2231191|NCT02688387|5472297|P17|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
2231192|NCT02688387|5472298|P16|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
2231193|NCT02688387|5472299|P15|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
2231194|NCT02688387|5472300|P14|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231195|NCT02688387|5472301|P13|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231196|NCT02688387|5472302|P12|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231197|NCT02688387|5472303|P11|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231198|NCT02688387|5472304|P10|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231199|NCT02688387|5472305|P9|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231200|NCT02688387|5472306|P8|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231201|NCT02688387|5472307|P7|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231202|NCT02688387|5472308|P6|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231203|NCT02688387|5472309|P5|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231204|NCT02688387|5472310|P4|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231205|NCT02688387|5472311|P3|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231206|NCT02688387|5472312|P2|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231207|NCT02688387|5472313|P1|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
2231208|NCT02688387|5472292|P22|STARTED|Part 3A, Period 4 (up to 6 Days)||0
2231209|NCT02688387|5472293|P21|STARTED|Part 3A, Period 4 (up to 6 Days)||0
2231210|NCT02688387|5472294|P20|STARTED|Part 3A, Period 4 (up to 6 Days)||0
2231211|NCT02688387|5472295|P19|STARTED|Part 3A, Period 4 (up to 6 Days)||0
2231212|NCT02688387|5472296|P18|STARTED|Part 3A, Period 4 (up to 6 Days)||8
2231213|NCT02688387|5472297|P17|STARTED|Part 3A, Period 4 (up to 6 Days)||8
2231214|NCT02688387|5472298|P16|STARTED|Part 3A, Period 4 (up to 6 Days)||8
2231215|NCT02688387|5472299|P15|STARTED|Part 3A, Period 4 (up to 6 Days)||8
2231216|NCT02688387|5472300|P14|STARTED|Part 3A, Period 4 (up to 6 Days)||0
2231217|NCT02688387|5472301|P13|STARTED|Part 3A, Period 4 (up to 6 Days)||0
2231218|NCT02688387|5472302|P12|STARTED|Part 3A, Period 4 (up to 6 Days)||0
2231219|NCT02688387|5472303|P11|STARTED|Part 3A, Period 4 (up to 6 Days)||0
2231220|NCT02688387|5472304|P10|STARTED|Part 3A, Period 4 (up to 6 Days)||0
2231221|NCT02688387|5472305|P9|STARTED|Part 3A, Period 4 (up to 6 Days)||0
2231222|NCT02688387|5472306|P8|STARTED|Part 3A, Period 4 (up to 6 Days)||0
2231223|NCT02688387|5472307|P7|STARTED|Part 3A, Period 4 (up to 6 Days)||0
2231224|NCT02688387|5472308|P6|STARTED|Part 3A, Period 4 (up to 6 Days)||0
2231225|NCT02688387|5472309|P5|STARTED|Part 3A, Period 4 (up to 6 Days)||0
2231226|NCT02688387|5472310|P4|STARTED|Part 3A, Period 4 (up to 6 Days)||0
2231227|NCT02688387|5472311|P3|STARTED|Part 3A, Period 4 (up to 6 Days)||0
2231228|NCT02688387|5472312|P2|STARTED|Part 3A, Period 4 (up to 6 Days)||0
2231229|NCT02688387|5472313|P1|STARTED|Part 3A, Period 4 (up to 6 Days)||0
2231230|NCT02688387|5472292|P22|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231231|NCT02688387|5472293|P21|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231232|NCT02688387|5472294|P20|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231233|NCT02688387|5472295|P19|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231234|NCT02688387|5472296|P18|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231235|NCT02688387|5472297|P17|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231236|NCT02688387|5472298|P16|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231237|NCT02688387|5472299|P15|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231238|NCT02688387|5472300|P14|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231239|NCT02688387|5472301|P13|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231240|NCT02688387|5472302|P12|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231241|NCT02688387|5472303|P11|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231242|NCT02688387|5472304|P10|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231243|NCT02688387|5472305|P9|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231244|NCT02688387|5472306|P8|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231245|NCT02688387|5472307|P7|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231246|NCT02688387|5472308|P6|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231247|NCT02688387|5472309|P5|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231248|NCT02688387|5472310|P4|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231249|NCT02688387|5472311|P3|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231250|NCT02688387|5472312|P2|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231251|NCT02688387|5472313|P1|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231252|NCT02688387|5472292|P22|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231253|NCT02688387|5472293|P21|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231254|NCT02688387|5472294|P20|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231255|NCT02688387|5472295|P19|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231256|NCT02688387|5472296|P18|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
2231257|NCT02688387|5472297|P17|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
2231258|NCT02688387|5472298|P16|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
2231259|NCT02688387|5472299|P15|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
2231260|NCT02688387|5472300|P14|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231261|NCT02688387|5472301|P13|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231262|NCT02688387|5472302|P12|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231263|NCT02688387|5472303|P11|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231264|NCT02688387|5472304|P10|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231265|NCT02688387|5472305|P9|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231266|NCT02688387|5472306|P8|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231267|NCT02688387|5472307|P7|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231268|NCT02688387|5472308|P6|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231269|NCT02688387|5472309|P5|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231270|NCT02688387|5472310|P4|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231271|NCT02688387|5472311|P3|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231272|NCT02688387|5472312|P2|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231273|NCT02688387|5472313|P1|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
2231274|NCT02688387|5472292|P22|STARTED|Part 3A, Washout Period 3 (10 Days)||0
2231275|NCT02688387|5472293|P21|STARTED|Part 3A, Washout Period 3 (10 Days)||0
2231276|NCT02688387|5472294|P20|STARTED|Part 3A, Washout Period 3 (10 Days)||0
2231277|NCT02688387|5472295|P19|STARTED|Part 3A, Washout Period 3 (10 Days)||0
2231278|NCT02688387|5472296|P18|STARTED|Part 3A, Washout Period 3 (10 Days)||8
2231279|NCT02688387|5472297|P17|STARTED|Part 3A, Washout Period 3 (10 Days)||8
2231280|NCT02688387|5472298|P16|STARTED|Part 3A, Washout Period 3 (10 Days)||8
2231281|NCT02688387|5472299|P15|STARTED|Part 3A, Washout Period 3 (10 Days)||8
2231282|NCT02688387|5472300|P14|STARTED|Part 3A, Washout Period 3 (10 Days)||0
2231283|NCT02688387|5472301|P13|STARTED|Part 3A, Washout Period 3 (10 Days)||0
2231284|NCT02688387|5472302|P12|STARTED|Part 3A, Washout Period 3 (10 Days)||0
2231285|NCT02688387|5472303|P11|STARTED|Part 3A, Washout Period 3 (10 Days)||0
2231286|NCT02688387|5472304|P10|STARTED|Part 3A, Washout Period 3 (10 Days)||0
2231287|NCT02688387|5472305|P9|STARTED|Part 3A, Washout Period 3 (10 Days)||0
2231288|NCT02688387|5472306|P8|STARTED|Part 3A, Washout Period 3 (10 Days)||0
2231289|NCT02688387|5472307|P7|STARTED|Part 3A, Washout Period 3 (10 Days)||0
2231290|NCT02688387|5472308|P6|STARTED|Part 3A, Washout Period 3 (10 Days)||0
2231291|NCT02688387|5472309|P5|STARTED|Part 3A, Washout Period 3 (10 Days)||0
2231292|NCT02688387|5472310|P4|STARTED|Part 3A, Washout Period 3 (10 Days)||0
2231293|NCT02688387|5472311|P3|STARTED|Part 3A, Washout Period 3 (10 Days)||0
2231294|NCT02688387|5472312|P2|STARTED|Part 3A, Washout Period 3 (10 Days)||0
2231295|NCT02688387|5472313|P1|STARTED|Part 3A, Washout Period 3 (10 Days)||0
2231296|NCT02688387|5472292|P22|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231297|NCT02688387|5472293|P21|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231298|NCT02688387|5472294|P20|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231299|NCT02688387|5472295|P19|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231300|NCT02688387|5472296|P18|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231301|NCT02688387|5472297|P17|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231302|NCT02688387|5472298|P16|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231303|NCT02688387|5472299|P15|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231304|NCT02688387|5472300|P14|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231305|NCT02688387|5472301|P13|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231306|NCT02688387|5472302|P12|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231307|NCT02688387|5472303|P11|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231308|NCT02688387|5472304|P10|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231309|NCT02688387|5472305|P9|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231310|NCT02688387|5472306|P8|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231311|NCT02688387|5472307|P7|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231312|NCT02688387|5472308|P6|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231313|NCT02688387|5472309|P5|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231314|NCT02688387|5472310|P4|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231315|NCT02688387|5472311|P3|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231316|NCT02688387|5472312|P2|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231317|NCT02688387|5472313|P1|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231318|NCT02688387|5472292|P22|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231319|NCT02688387|5472293|P21|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231320|NCT02688387|5472294|P20|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231321|NCT02688387|5472295|P19|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231322|NCT02688387|5472296|P18|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
2231323|NCT02688387|5472297|P17|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
2231324|NCT02688387|5472298|P16|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
2231325|NCT02688387|5472299|P15|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
2231326|NCT02688387|5472300|P14|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231327|NCT02688387|5472301|P13|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231328|NCT02688387|5472302|P12|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231329|NCT02688387|5472303|P11|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231330|NCT02688387|5472304|P10|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231331|NCT02688387|5472305|P9|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231332|NCT02688387|5472306|P8|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231333|NCT02688387|5472307|P7|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231334|NCT02688387|5472308|P6|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231335|NCT02688387|5472309|P5|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231336|NCT02688387|5472310|P4|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231337|NCT02688387|5472311|P3|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231338|NCT02688387|5472312|P2|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231339|NCT02688387|5472313|P1|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
2231340|NCT02688387|5472292|P22|STARTED|Part 3A, Period 3 (up to 6 Days)||0
2231341|NCT02688387|5472293|P21|STARTED|Part 3A, Period 3 (up to 6 Days)||0
2231342|NCT02688387|5472294|P20|STARTED|Part 3A, Period 3 (up to 6 Days)||0
2231343|NCT02688387|5472295|P19|STARTED|Part 3A, Period 3 (up to 6 Days)||0
2231344|NCT02688387|5472296|P18|STARTED|Part 3A, Period 3 (up to 6 Days)||8
2231345|NCT02688387|5472297|P17|STARTED|Part 3A, Period 3 (up to 6 Days)||8
2231346|NCT02688387|5472298|P16|STARTED|Part 3A, Period 3 (up to 6 Days)||8
2231347|NCT02688387|5472299|P15|STARTED|Part 3A, Period 3 (up to 6 Days)||8
2231348|NCT02688387|5472300|P14|STARTED|Part 3A, Period 3 (up to 6 Days)||0
2231349|NCT02688387|5472301|P13|STARTED|Part 3A, Period 3 (up to 6 Days)||0
2231350|NCT02688387|5472302|P12|STARTED|Part 3A, Period 3 (up to 6 Days)||0
2231351|NCT02688387|5472303|P11|STARTED|Part 3A, Period 3 (up to 6 Days)||0
2231352|NCT02688387|5472304|P10|STARTED|Part 3A, Period 3 (up to 6 Days)||0
2231353|NCT02688387|5472305|P9|STARTED|Part 3A, Period 3 (up to 6 Days)||0
2231354|NCT02688387|5472306|P8|STARTED|Part 3A, Period 3 (up to 6 Days)||0
2231355|NCT02688387|5472307|P7|STARTED|Part 3A, Period 3 (up to 6 Days)||0
2231356|NCT02688387|5472308|P6|STARTED|Part 3A, Period 3 (up to 6 Days)||0
2231357|NCT02688387|5472309|P5|STARTED|Part 3A, Period 3 (up to 6 Days)||0
2231358|NCT02688387|5472310|P4|STARTED|Part 3A, Period 3 (up to 6 Days)||0
2231359|NCT02688387|5472311|P3|STARTED|Part 3A, Period 3 (up to 6 Days)||0
2231360|NCT02688387|5472312|P2|STARTED|Part 3A, Period 3 (up to 6 Days)||0
2231361|NCT02688387|5472313|P1|STARTED|Part 3A, Period 3 (up to 6 Days)||0
2231362|NCT02688387|5472292|P22|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231363|NCT02688387|5472293|P21|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231364|NCT02688387|5472294|P20|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231365|NCT02688387|5472295|P19|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231366|NCT02688387|5472296|P18|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231367|NCT02688387|5472297|P17|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231368|NCT02688387|5472298|P16|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231369|NCT02688387|5472299|P15|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231370|NCT02688387|5472300|P14|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231371|NCT02688387|5472301|P13|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231372|NCT02688387|5472302|P12|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231373|NCT02688387|5472303|P11|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231374|NCT02688387|5472304|P10|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231375|NCT02688387|5472305|P9|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231376|NCT02688387|5472306|P8|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231377|NCT02688387|5472307|P7|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231378|NCT02688387|5472308|P6|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231379|NCT02688387|5472309|P5|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231380|NCT02688387|5472310|P4|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231381|NCT02688387|5472311|P3|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231382|NCT02688387|5472312|P2|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231383|NCT02688387|5472313|P1|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231384|NCT02688387|5472292|P22|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231385|NCT02688387|5472293|P21|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231386|NCT02688387|5472294|P20|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231387|NCT02688387|5472295|P19|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231388|NCT02688387|5472296|P18|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
2231389|NCT02688387|5472297|P17|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
2231390|NCT02688387|5472298|P16|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
2231391|NCT02688387|5472299|P15|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
2231392|NCT02688387|5472300|P14|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231393|NCT02688387|5472301|P13|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231394|NCT02688387|5472302|P12|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231395|NCT02688387|5472303|P11|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231396|NCT02688387|5472304|P10|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231397|NCT02688387|5472305|P9|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231398|NCT02688387|5472306|P8|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231399|NCT02688387|5472307|P7|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231400|NCT02688387|5472308|P6|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231401|NCT02688387|5472309|P5|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231402|NCT02688387|5472310|P4|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231403|NCT02688387|5472311|P3|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231404|NCT02688387|5472312|P2|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231405|NCT02688387|5472313|P1|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
2231406|NCT02688387|5472292|P22|STARTED|Part 3A, Washout Period 2 (10 Days)||0
2231407|NCT02688387|5472293|P21|STARTED|Part 3A, Washout Period 2 (10 Days)||0
2231408|NCT02688387|5472294|P20|STARTED|Part 3A, Washout Period 2 (10 Days)||0
2231409|NCT02688387|5472295|P19|STARTED|Part 3A, Washout Period 2 (10 Days)||0
2231410|NCT02688387|5472296|P18|STARTED|Part 3A, Washout Period 2 (10 Days)||8
2231411|NCT02688387|5472297|P17|STARTED|Part 3A, Washout Period 2 (10 Days)||8
2231412|NCT02688387|5472298|P16|STARTED|Part 3A, Washout Period 2 (10 Days)||8
2231413|NCT02688387|5472299|P15|STARTED|Part 3A, Washout Period 2 (10 Days)||8
2231414|NCT02688387|5472300|P14|STARTED|Part 3A, Washout Period 2 (10 Days)||0
2231415|NCT02688387|5472301|P13|STARTED|Part 3A, Washout Period 2 (10 Days)||0
2231416|NCT02688387|5472302|P12|STARTED|Part 3A, Washout Period 2 (10 Days)||0
2231417|NCT02688387|5472303|P11|STARTED|Part 3A, Washout Period 2 (10 Days)||0
2231418|NCT02688387|5472304|P10|STARTED|Part 3A, Washout Period 2 (10 Days)||0
2231419|NCT02688387|5472305|P9|STARTED|Part 3A, Washout Period 2 (10 Days)||0
2231420|NCT02688387|5472306|P8|STARTED|Part 3A, Washout Period 2 (10 Days)||0
2231421|NCT02688387|5472307|P7|STARTED|Part 3A, Washout Period 2 (10 Days)||0
2231422|NCT02688387|5472308|P6|STARTED|Part 3A, Washout Period 2 (10 Days)||0
2231423|NCT02688387|5472309|P5|STARTED|Part 3A, Washout Period 2 (10 Days)||0
2231424|NCT02688387|5472310|P4|STARTED|Part 3A, Washout Period 2 (10 Days)||0
2231425|NCT02688387|5472311|P3|STARTED|Part 3A, Washout Period 2 (10 Days)||0
2231426|NCT02688387|5472312|P2|STARTED|Part 3A, Washout Period 2 (10 Days)||0
2231427|NCT02688387|5472313|P1|STARTED|Part 3A, Washout Period 2 (10 Days)||0
2231428|NCT02688387|5472292|P22|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231429|NCT02688387|5472293|P21|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231430|NCT02688387|5472294|P20|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231431|NCT02688387|5472295|P19|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231432|NCT02688387|5472296|P18|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231433|NCT02688387|5472297|P17|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231434|NCT02688387|5472298|P16|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231435|NCT02688387|5472299|P15|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231436|NCT02688387|5472300|P14|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231437|NCT02688387|5472301|P13|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231438|NCT02688387|5472302|P12|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231439|NCT02688387|5472303|P11|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231440|NCT02688387|5472304|P10|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231441|NCT02688387|5472305|P9|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231442|NCT02688387|5472306|P8|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231443|NCT02688387|5472307|P7|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231444|NCT02688387|5472308|P6|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231445|NCT02688387|5472309|P5|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231446|NCT02688387|5472310|P4|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231447|NCT02688387|5472311|P3|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231448|NCT02688387|5472312|P2|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231449|NCT02688387|5472313|P1|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231450|NCT02688387|5472292|P22|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231451|NCT02688387|5472293|P21|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231452|NCT02688387|5472294|P20|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231453|NCT02688387|5472295|P19|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231454|NCT02688387|5472296|P18|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
2231455|NCT02688387|5472297|P17|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
2231456|NCT02688387|5472298|P16|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
2231457|NCT02688387|5472299|P15|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
2231458|NCT02688387|5472300|P14|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231459|NCT02688387|5472301|P13|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231460|NCT02688387|5472302|P12|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231461|NCT02688387|5472303|P11|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231462|NCT02688387|5472304|P10|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231463|NCT02688387|5472305|P9|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231464|NCT02688387|5472306|P8|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231465|NCT02688387|5472307|P7|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231466|NCT02688387|5472308|P6|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231467|NCT02688387|5472309|P5|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231468|NCT02688387|5472310|P4|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231469|NCT02688387|5472311|P3|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231470|NCT02688387|5472312|P2|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231471|NCT02688387|5472313|P1|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
2231472|NCT02688387|5472292|P22|STARTED|Part 3A, Period 2 (up to 6 Days)||0
2231473|NCT02688387|5472293|P21|STARTED|Part 3A, Period 2 (up to 6 Days)||0
2231474|NCT02688387|5472294|P20|STARTED|Part 3A, Period 2 (up to 6 Days)||0
2231475|NCT02688387|5472295|P19|STARTED|Part 3A, Period 2 (up to 6 Days)||0
2231476|NCT02688387|5472296|P18|STARTED|Part 3A, Period 2 (up to 6 Days)||8
2231477|NCT02688387|5472297|P17|STARTED|Part 3A, Period 2 (up to 6 Days)||8
2231478|NCT02688387|5472298|P16|STARTED|Part 3A, Period 2 (up to 6 Days)||8
2231479|NCT02688387|5472299|P15|STARTED|Part 3A, Period 2 (up to 6 Days)||8
2231480|NCT02688387|5472300|P14|STARTED|Part 3A, Period 2 (up to 6 Days)||0
2231481|NCT02688387|5472301|P13|STARTED|Part 3A, Period 2 (up to 6 Days)||0
2231482|NCT02688387|5472302|P12|STARTED|Part 3A, Period 2 (up to 6 Days)||0
2231483|NCT02688387|5472303|P11|STARTED|Part 3A, Period 2 (up to 6 Days)||0
2231484|NCT02688387|5472304|P10|STARTED|Part 3A, Period 2 (up to 6 Days)||0
2231485|NCT02688387|5472305|P9|STARTED|Part 3A, Period 2 (up to 6 Days)||0
2231486|NCT02688387|5472306|P8|STARTED|Part 3A, Period 2 (up to 6 Days)||0
2231487|NCT02688387|5472307|P7|STARTED|Part 3A, Period 2 (up to 6 Days)||0
2231488|NCT02688387|5472308|P6|STARTED|Part 3A, Period 2 (up to 6 Days)||0
2231489|NCT02688387|5472309|P5|STARTED|Part 3A, Period 2 (up to 6 Days)||0
2231490|NCT02688387|5472310|P4|STARTED|Part 3A, Period 2 (up to 6 Days)||0
2231491|NCT02688387|5472311|P3|STARTED|Part 3A, Period 2 (up to 6 Days)||0
2231492|NCT02688387|5472312|P2|STARTED|Part 3A, Period 2 (up to 6 Days)||0
2231493|NCT02688387|5472313|P1|STARTED|Part 3A, Period 2 (up to 6 Days)||0
2231494|NCT02688387|5472292|P22|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231495|NCT02688387|5472293|P21|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231496|NCT02688387|5472294|P20|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231497|NCT02688387|5472295|P19|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231498|NCT02688387|5472296|P18|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231499|NCT02688387|5472297|P17|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231500|NCT02688387|5472298|P16|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231501|NCT02688387|5472299|P15|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231502|NCT02688387|5472300|P14|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231503|NCT02688387|5472301|P13|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231504|NCT02688387|5472302|P12|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231505|NCT02688387|5472303|P11|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231506|NCT02688387|5472304|P10|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231507|NCT02688387|5472305|P9|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231508|NCT02688387|5472306|P8|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231509|NCT02688387|5472307|P7|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231510|NCT02688387|5472308|P6|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231511|NCT02688387|5472309|P5|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231512|NCT02688387|5472310|P4|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231513|NCT02688387|5472311|P3|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231514|NCT02688387|5472312|P2|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231515|NCT02688387|5472313|P1|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231516|NCT02688387|5472292|P22|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231517|NCT02688387|5472293|P21|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231518|NCT02688387|5472294|P20|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231519|NCT02688387|5472295|P19|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231520|NCT02688387|5472296|P18|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
2231521|NCT02688387|5472297|P17|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
2231522|NCT02688387|5472298|P16|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
2231523|NCT02688387|5472299|P15|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
2231524|NCT02688387|5472300|P14|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231525|NCT02688387|5472301|P13|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231526|NCT02688387|5472302|P12|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231527|NCT02688387|5472303|P11|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231528|NCT02688387|5472304|P10|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231529|NCT02688387|5472305|P9|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231530|NCT02688387|5472306|P8|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231531|NCT02688387|5472307|P7|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231532|NCT02688387|5472308|P6|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231533|NCT02688387|5472309|P5|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231534|NCT02688387|5472310|P4|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231535|NCT02688387|5472311|P3|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231536|NCT02688387|5472312|P2|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231537|NCT02688387|5472313|P1|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
2231538|NCT02688387|5472292|P22|STARTED|Part 3A, Washout Period 1 (10 Days)||0
2231539|NCT02688387|5472293|P21|STARTED|Part 3A, Washout Period 1 (10 Days)||0
2231540|NCT02688387|5472294|P20|STARTED|Part 3A, Washout Period 1 (10 Days)||0
2231541|NCT02688387|5472295|P19|STARTED|Part 3A, Washout Period 1 (10 Days)||0
2231542|NCT02688387|5472296|P18|STARTED|Part 3A, Washout Period 1 (10 Days)||8
2231543|NCT02688387|5472297|P17|STARTED|Part 3A, Washout Period 1 (10 Days)||8
2231544|NCT02688387|5472298|P16|STARTED|Part 3A, Washout Period 1 (10 Days)||8
2231545|NCT02688387|5472299|P15|STARTED|Part 3A, Washout Period 1 (10 Days)||8
2231546|NCT02688387|5472300|P14|STARTED|Part 3A, Washout Period 1 (10 Days)||0
2231547|NCT02688387|5472301|P13|STARTED|Part 3A, Washout Period 1 (10 Days)||0
2231548|NCT02688387|5472302|P12|STARTED|Part 3A, Washout Period 1 (10 Days)||0
2231549|NCT02688387|5472303|P11|STARTED|Part 3A, Washout Period 1 (10 Days)||0
2231550|NCT02688387|5472304|P10|STARTED|Part 3A, Washout Period 1 (10 Days)||0
2231551|NCT02688387|5472305|P9|STARTED|Part 3A, Washout Period 1 (10 Days)||0
2231552|NCT02688387|5472306|P8|STARTED|Part 3A, Washout Period 1 (10 Days)||0
2231553|NCT02688387|5472307|P7|STARTED|Part 3A, Washout Period 1 (10 Days)||0
2231554|NCT02688387|5472308|P6|STARTED|Part 3A, Washout Period 1 (10 Days)||0
2231555|NCT02688387|5472309|P5|STARTED|Part 3A, Washout Period 1 (10 Days)||0
2231556|NCT02688387|5472310|P4|STARTED|Part 3A, Washout Period 1 (10 Days)||0
2231557|NCT02688387|5472311|P3|STARTED|Part 3A, Washout Period 1 (10 Days)||0
2231558|NCT02688387|5472312|P2|STARTED|Part 3A, Washout Period 1 (10 Days)||0
2231559|NCT02688387|5472313|P1|STARTED|Part 3A, Washout Period 1 (10 Days)||0
2231560|NCT02688387|5472292|P22|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231561|NCT02688387|5472293|P21|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231562|NCT02688387|5472294|P20|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231563|NCT02688387|5472295|P19|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231564|NCT02688387|5472296|P18|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231565|NCT02688387|5472297|P17|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231566|NCT02688387|5472298|P16|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231567|NCT02688387|5472299|P15|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||1
2231568|NCT02688387|5472300|P14|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231569|NCT02688387|5472301|P13|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231570|NCT02688387|5472302|P12|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231571|NCT02688387|5472303|P11|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231572|NCT02688387|5472304|P10|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231573|NCT02688387|5472305|P9|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231574|NCT02688387|5472306|P8|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231575|NCT02688387|5472307|P7|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231576|NCT02688387|5472308|P6|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231577|NCT02688387|5472309|P5|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231578|NCT02688387|5472310|P4|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231579|NCT02688387|5472311|P3|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231580|NCT02688387|5472312|P2|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231581|NCT02688387|5472313|P1|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231582|NCT02688387|5472292|P22|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231583|NCT02688387|5472293|P21|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231584|NCT02688387|5472294|P20|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231585|NCT02688387|5472295|P19|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231586|NCT02688387|5472296|P18|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
2231587|NCT02688387|5472297|P17|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
2231588|NCT02688387|5472298|P16|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
2231589|NCT02688387|5472299|P15|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
2231590|NCT02688387|5472300|P14|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231591|NCT02688387|5472301|P13|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231592|NCT02688387|5472302|P12|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231593|NCT02688387|5472303|P11|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231594|NCT02688387|5472304|P10|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231595|NCT02688387|5472305|P9|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231596|NCT02688387|5472306|P8|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231597|NCT02688387|5472307|P7|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231598|NCT02688387|5472308|P6|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231599|NCT02688387|5472309|P5|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231600|NCT02688387|5472310|P4|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231601|NCT02688387|5472311|P3|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231602|NCT02688387|5472312|P2|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231603|NCT02688387|5472313|P1|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
2231604|NCT02688387|5472292|P22|STARTED|Part 3A, Period 1 (up to 6 Days)||0
2231605|NCT02688387|5472293|P21|STARTED|Part 3A, Period 1 (up to 6 Days)||0
2231606|NCT02688387|5472294|P20|STARTED|Part 3A, Period 1 (up to 6 Days)||0
2231607|NCT02688387|5472295|P19|STARTED|Part 3A, Period 1 (up to 6 Days)||0
2231608|NCT02688387|5472296|P18|STARTED|Part 3A, Period 1 (up to 6 Days)||8
2231609|NCT02688387|5472297|P17|STARTED|Part 3A, Period 1 (up to 6 Days)||8
2231610|NCT02688387|5472298|P16|STARTED|Part 3A, Period 1 (up to 6 Days)||8
2231611|NCT02688387|5472299|P15|STARTED|Part 3A, Period 1 (up to 6 Days)||9
2231612|NCT02688387|5472300|P14|STARTED|Part 3A, Period 1 (up to 6 Days)||0
2231613|NCT02688387|5472301|P13|STARTED|Part 3A, Period 1 (up to 6 Days)||0
2231614|NCT02688387|5472302|P12|STARTED|Part 3A, Period 1 (up to 6 Days)||0
2231615|NCT02688387|5472303|P11|STARTED|Part 3A, Period 1 (up to 6 Days)||0
2231616|NCT02688387|5472304|P10|STARTED|Part 3A, Period 1 (up to 6 Days)||0
2231617|NCT02688387|5472305|P9|STARTED|Part 3A, Period 1 (up to 6 Days)||0
2231618|NCT02688387|5472306|P8|STARTED|Part 3A, Period 1 (up to 6 Days)||0
2231619|NCT02688387|5472307|P7|STARTED|Part 3A, Period 1 (up to 6 Days)||0
2231620|NCT02688387|5472308|P6|STARTED|Part 3A, Period 1 (up to 6 Days)||0
2231621|NCT02688387|5472309|P5|STARTED|Part 3A, Period 1 (up to 6 Days)||0
2231622|NCT02688387|5472310|P4|STARTED|Part 3A, Period 1 (up to 6 Days)||0
2231623|NCT02688387|5472311|P3|STARTED|Part 3A, Period 1 (up to 6 Days)||0
2231624|NCT02688387|5472312|P2|STARTED|Part 3A, Period 1 (up to 6 Days)||0
2231625|NCT02688387|5472313|P1|STARTED|Part 3A, Period 1 (up to 6 Days)||0
2231626|NCT02688387|5472292|P22|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231627|NCT02688387|5472293|P21|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231628|NCT02688387|5472294|P20|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231629|NCT02688387|5472295|P19|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231630|NCT02688387|5472296|P18|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231631|NCT02688387|5472297|P17|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231632|NCT02688387|5472298|P16|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231633|NCT02688387|5472299|P15|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231634|NCT02688387|5472300|P14|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231635|NCT02688387|5472301|P13|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231636|NCT02688387|5472302|P12|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231637|NCT02688387|5472303|P11|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231638|NCT02688387|5472304|P10|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231639|NCT02688387|5472305|P9|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231640|NCT02688387|5472306|P8|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231641|NCT02688387|5472307|P7|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231642|NCT02688387|5472308|P6|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231643|NCT02688387|5472309|P5|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231644|NCT02688387|5472310|P4|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231645|NCT02688387|5472311|P3|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231646|NCT02688387|5472312|P2|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231647|NCT02688387|5472313|P1|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231648|NCT02688387|5472292|P22|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231649|NCT02688387|5472293|P21|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231650|NCT02688387|5472294|P20|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231651|NCT02688387|5472295|P19|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231652|NCT02688387|5472296|P18|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231653|NCT02688387|5472297|P17|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231654|NCT02688387|5472298|P16|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231655|NCT02688387|5472299|P15|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231656|NCT02688387|5472300|P14|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
2231657|NCT02688387|5472301|P13|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
2231658|NCT02688387|5472302|P12|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
2231659|NCT02688387|5472303|P11|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
2231660|NCT02688387|5472304|P10|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231661|NCT02688387|5472305|P9|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231662|NCT02688387|5472306|P8|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231663|NCT02688387|5472307|P7|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231664|NCT02688387|5472308|P6|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231665|NCT02688387|5472309|P5|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231666|NCT02688387|5472310|P4|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231667|NCT02688387|5472311|P3|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231668|NCT02688387|5472312|P2|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231669|NCT02688387|5472313|P1|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
2231670|NCT02688387|5472292|P22|STARTED|Part 2, Period 4 (up to 6 Days)||0
2231671|NCT02688387|5472293|P21|STARTED|Part 2, Period 4 (up to 6 Days)||0
2231672|NCT02688387|5472294|P20|STARTED|Part 2, Period 4 (up to 6 Days)||0
2231673|NCT02688387|5472295|P19|STARTED|Part 2, Period 4 (up to 6 Days)||0
2231674|NCT02688387|5472296|P18|STARTED|Part 2, Period 4 (up to 6 Days)||0
2231675|NCT02688387|5472297|P17|STARTED|Part 2, Period 4 (up to 6 Days)||0
2231676|NCT02688387|5472298|P16|STARTED|Part 2, Period 4 (up to 6 Days)||0
2231677|NCT02688387|5472299|P15|STARTED|Part 2, Period 4 (up to 6 Days)||0
2231678|NCT02688387|5472300|P14|STARTED|Part 2, Period 4 (up to 6 Days)||5
2231679|NCT02688387|5472301|P13|STARTED|Part 2, Period 4 (up to 6 Days)||5
2231680|NCT02688387|5472302|P12|STARTED|Part 2, Period 4 (up to 6 Days)||5
2231681|NCT02688387|5472303|P11|STARTED|Part 2, Period 4 (up to 6 Days)||5
2231682|NCT02688387|5472304|P10|STARTED|Part 2, Period 4 (up to 6 Days)||0
2231683|NCT02688387|5472305|P9|STARTED|Part 2, Period 4 (up to 6 Days)||0
2231684|NCT02688387|5472306|P8|STARTED|Part 2, Period 4 (up to 6 Days)||0
2231685|NCT02688387|5472307|P7|STARTED|Part 2, Period 4 (up to 6 Days)||0
2231686|NCT02688387|5472308|P6|STARTED|Part 2, Period 4 (up to 6 Days)||0
2231687|NCT02688387|5472309|P5|STARTED|Part 2, Period 4 (up to 6 Days)||0
2231688|NCT02688387|5472310|P4|STARTED|Part 2, Period 4 (up to 6 Days)||0
2231689|NCT02688387|5472311|P3|STARTED|Part 2, Period 4 (up to 6 Days)||0
2231690|NCT02688387|5472312|P2|STARTED|Part 2, Period 4 (up to 6 Days)||0
2231691|NCT02688387|5472313|P1|STARTED|Part 2, Period 4 (up to 6 Days)||0
2231692|NCT02688387|5472292|P22|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231693|NCT02688387|5472293|P21|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231694|NCT02688387|5472294|P20|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231695|NCT02688387|5472295|P19|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231696|NCT02688387|5472296|P18|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231697|NCT02688387|5472297|P17|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231698|NCT02688387|5472298|P16|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231699|NCT02688387|5472299|P15|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231700|NCT02688387|5472300|P14|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231701|NCT02688387|5472301|P13|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231702|NCT02688387|5472302|P12|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231703|NCT02688387|5472303|P11|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231704|NCT02688387|5472304|P10|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231705|NCT02688387|5472305|P9|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231706|NCT02688387|5472306|P8|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231707|NCT02688387|5472307|P7|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231708|NCT02688387|5472308|P6|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231709|NCT02688387|5472309|P5|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231710|NCT02688387|5472310|P4|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231711|NCT02688387|5472311|P3|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231712|NCT02688387|5472312|P2|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231713|NCT02688387|5472313|P1|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231714|NCT02688387|5472292|P22|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231715|NCT02688387|5472293|P21|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231716|NCT02688387|5472294|P20|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231717|NCT02688387|5472295|P19|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231718|NCT02688387|5472296|P18|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231719|NCT02688387|5472297|P17|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231720|NCT02688387|5472298|P16|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231721|NCT02688387|5472299|P15|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231722|NCT02688387|5472300|P14|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
2231723|NCT02688387|5472301|P13|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
2231724|NCT02688387|5472302|P12|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
2231725|NCT02688387|5472303|P11|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
2231726|NCT02688387|5472304|P10|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231727|NCT02688387|5472305|P9|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231728|NCT02688387|5472306|P8|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231729|NCT02688387|5472307|P7|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231730|NCT02688387|5472308|P6|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231731|NCT02688387|5472309|P5|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231732|NCT02688387|5472310|P4|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231733|NCT02688387|5472311|P3|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231734|NCT02688387|5472312|P2|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231735|NCT02688387|5472313|P1|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
2231736|NCT02688387|5472292|P22|STARTED|Part 2, Washout Period 3 (10 Days)||0
2231737|NCT02688387|5472293|P21|STARTED|Part 2, Washout Period 3 (10 Days)||0
2231738|NCT02688387|5472294|P20|STARTED|Part 2, Washout Period 3 (10 Days)||0
2231739|NCT02688387|5472295|P19|STARTED|Part 2, Washout Period 3 (10 Days)||0
2231740|NCT02688387|5472296|P18|STARTED|Part 2, Washout Period 3 (10 Days)||0
2231741|NCT02688387|5472297|P17|STARTED|Part 2, Washout Period 3 (10 Days)||0
2231742|NCT02688387|5472298|P16|STARTED|Part 2, Washout Period 3 (10 Days)||0
2231743|NCT02688387|5472299|P15|STARTED|Part 2, Washout Period 3 (10 Days)||0
2231744|NCT02688387|5472300|P14|STARTED|Part 2, Washout Period 3 (10 Days)||5
2231745|NCT02688387|5472301|P13|STARTED|Part 2, Washout Period 3 (10 Days)||5
2231746|NCT02688387|5472302|P12|STARTED|Part 2, Washout Period 3 (10 Days)||5
2231747|NCT02688387|5472303|P11|STARTED|Part 2, Washout Period 3 (10 Days)||5
2231748|NCT02688387|5472304|P10|STARTED|Part 2, Washout Period 3 (10 Days)||0
2231749|NCT02688387|5472305|P9|STARTED|Part 2, Washout Period 3 (10 Days)||0
2231750|NCT02688387|5472306|P8|STARTED|Part 2, Washout Period 3 (10 Days)||0
2231751|NCT02688387|5472307|P7|STARTED|Part 2, Washout Period 3 (10 Days)||0
2231752|NCT02688387|5472308|P6|STARTED|Part 2, Washout Period 3 (10 Days)||0
2231753|NCT02688387|5472309|P5|STARTED|Part 2, Washout Period 3 (10 Days)||0
2231754|NCT02688387|5472310|P4|STARTED|Part 2, Washout Period 3 (10 Days)||0
2231755|NCT02688387|5472311|P3|STARTED|Part 2, Washout Period 3 (10 Days)||0
2231756|NCT02688387|5472312|P2|STARTED|Part 2, Washout Period 3 (10 Days)||0
2231757|NCT02688387|5472313|P1|STARTED|Part 2, Washout Period 3 (10 Days)||0
2231758|NCT02688387|5472292|P22|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231759|NCT02688387|5472293|P21|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231760|NCT02688387|5472294|P20|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231761|NCT02688387|5472295|P19|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231762|NCT02688387|5472296|P18|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231763|NCT02688387|5472297|P17|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231764|NCT02688387|5472298|P16|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231765|NCT02688387|5472299|P15|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231766|NCT02688387|5472300|P14|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231767|NCT02688387|5472301|P13|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231768|NCT02688387|5472302|P12|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231769|NCT02688387|5472303|P11|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231770|NCT02688387|5472304|P10|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231771|NCT02688387|5472305|P9|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231772|NCT02688387|5472306|P8|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231773|NCT02688387|5472307|P7|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231774|NCT02688387|5472308|P6|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231775|NCT02688387|5472309|P5|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231776|NCT02688387|5472310|P4|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231777|NCT02688387|5472311|P3|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231778|NCT02688387|5472312|P2|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231779|NCT02688387|5472313|P1|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231780|NCT02688387|5472292|P22|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231781|NCT02688387|5472293|P21|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231782|NCT02688387|5472294|P20|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231783|NCT02688387|5472295|P19|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231784|NCT02688387|5472296|P18|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231785|NCT02688387|5472297|P17|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231786|NCT02688387|5472298|P16|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231787|NCT02688387|5472299|P15|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231788|NCT02688387|5472300|P14|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
2231789|NCT02688387|5472301|P13|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
2231790|NCT02688387|5472302|P12|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
2231791|NCT02688387|5472303|P11|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
2231792|NCT02688387|5472304|P10|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231793|NCT02688387|5472305|P9|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231794|NCT02688387|5472306|P8|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231795|NCT02688387|5472307|P7|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231796|NCT02688387|5472308|P6|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231797|NCT02688387|5472309|P5|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231798|NCT02688387|5472310|P4|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231799|NCT02688387|5472311|P3|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231800|NCT02688387|5472312|P2|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231801|NCT02688387|5472313|P1|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
2231802|NCT02688387|5472292|P22|STARTED|Part 2, Period 3 (up to 6 Days)||0
2231803|NCT02688387|5472293|P21|STARTED|Part 2, Period 3 (up to 6 Days)||0
2231804|NCT02688387|5472294|P20|STARTED|Part 2, Period 3 (up to 6 Days)||0
2231805|NCT02688387|5472295|P19|STARTED|Part 2, Period 3 (up to 6 Days)||0
2231806|NCT02688387|5472296|P18|STARTED|Part 2, Period 3 (up to 6 Days)||0
2231807|NCT02688387|5472297|P17|STARTED|Part 2, Period 3 (up to 6 Days)||0
2231808|NCT02688387|5472298|P16|STARTED|Part 2, Period 3 (up to 6 Days)||0
2231809|NCT02688387|5472299|P15|STARTED|Part 2, Period 3 (up to 6 Days)||0
2231810|NCT02688387|5472300|P14|STARTED|Part 2, Period 3 (up to 6 Days)||5
2231811|NCT02688387|5472301|P13|STARTED|Part 2, Period 3 (up to 6 Days)||5
2231812|NCT02688387|5472302|P12|STARTED|Part 2, Period 3 (up to 6 Days)||5
2231813|NCT02688387|5472303|P11|STARTED|Part 2, Period 3 (up to 6 Days)||5
2231814|NCT02688387|5472304|P10|STARTED|Part 2, Period 3 (up to 6 Days)||0
2231815|NCT02688387|5472305|P9|STARTED|Part 2, Period 3 (up to 6 Days)||0
2231816|NCT02688387|5472306|P8|STARTED|Part 2, Period 3 (up to 6 Days)||0
2231817|NCT02688387|5472307|P7|STARTED|Part 2, Period 3 (up to 6 Days)||0
2231818|NCT02688387|5472308|P6|STARTED|Part 2, Period 3 (up to 6 Days)||0
2231819|NCT02688387|5472309|P5|STARTED|Part 2, Period 3 (up to 6 Days)||0
2231820|NCT02688387|5472310|P4|STARTED|Part 2, Period 3 (up to 6 Days)||0
2231821|NCT02688387|5472311|P3|STARTED|Part 2, Period 3 (up to 6 Days)||0
2231822|NCT02688387|5472312|P2|STARTED|Part 2, Period 3 (up to 6 Days)||0
2231823|NCT02688387|5472313|P1|STARTED|Part 2, Period 3 (up to 6 Days)||0
2231824|NCT02688387|5472292|P22|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231825|NCT02688387|5472293|P21|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231826|NCT02688387|5472294|P20|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231827|NCT02688387|5472295|P19|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231828|NCT02688387|5472296|P18|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231829|NCT02688387|5472297|P17|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231830|NCT02688387|5472298|P16|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231831|NCT02688387|5472299|P15|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231832|NCT02688387|5472300|P14|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231833|NCT02688387|5472301|P13|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231834|NCT02688387|5472302|P12|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231835|NCT02688387|5472303|P11|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231836|NCT02688387|5472304|P10|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231837|NCT02688387|5472305|P9|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231838|NCT02688387|5472306|P8|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231839|NCT02688387|5472307|P7|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231840|NCT02688387|5472308|P6|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231841|NCT02688387|5472309|P5|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231842|NCT02688387|5472310|P4|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231843|NCT02688387|5472311|P3|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231844|NCT02688387|5472312|P2|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231845|NCT02688387|5472313|P1|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231846|NCT02688387|5472292|P22|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231847|NCT02688387|5472293|P21|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231848|NCT02688387|5472294|P20|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231849|NCT02688387|5472295|P19|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231850|NCT02688387|5472296|P18|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231851|NCT02688387|5472297|P17|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231852|NCT02688387|5472298|P16|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231853|NCT02688387|5472299|P15|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231854|NCT02688387|5472300|P14|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
2231855|NCT02688387|5472301|P13|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
2231856|NCT02688387|5472302|P12|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
2231857|NCT02688387|5472303|P11|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
2231858|NCT02688387|5472304|P10|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231859|NCT02688387|5472305|P9|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231860|NCT02688387|5472306|P8|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231861|NCT02688387|5472307|P7|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231862|NCT02688387|5472308|P6|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231863|NCT02688387|5472309|P5|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231864|NCT02688387|5472310|P4|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231865|NCT02688387|5472311|P3|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231866|NCT02688387|5472312|P2|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231867|NCT02688387|5472313|P1|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
2231868|NCT02688387|5472292|P22|STARTED|Part 2, Washout Period 2 (10 Days)||0
2231869|NCT02688387|5472293|P21|STARTED|Part 2, Washout Period 2 (10 Days)||0
2231870|NCT02688387|5472294|P20|STARTED|Part 2, Washout Period 2 (10 Days)||0
2231871|NCT02688387|5472295|P19|STARTED|Part 2, Washout Period 2 (10 Days)||0
2231872|NCT02688387|5472296|P18|STARTED|Part 2, Washout Period 2 (10 Days)||0
2231873|NCT02688387|5472297|P17|STARTED|Part 2, Washout Period 2 (10 Days)||0
2231874|NCT02688387|5472298|P16|STARTED|Part 2, Washout Period 2 (10 Days)||0
2231875|NCT02688387|5472299|P15|STARTED|Part 2, Washout Period 2 (10 Days)||0
2231876|NCT02688387|5472300|P14|STARTED|Part 2, Washout Period 2 (10 Days)||5
2231877|NCT02688387|5472301|P13|STARTED|Part 2, Washout Period 2 (10 Days)||5
2231878|NCT02688387|5472302|P12|STARTED|Part 2, Washout Period 2 (10 Days)||5
2231879|NCT02688387|5472303|P11|STARTED|Part 2, Washout Period 2 (10 Days)||5
2231880|NCT02688387|5472304|P10|STARTED|Part 2, Washout Period 2 (10 Days)||0
2231881|NCT02688387|5472305|P9|STARTED|Part 2, Washout Period 2 (10 Days)||0
2231882|NCT02688387|5472306|P8|STARTED|Part 2, Washout Period 2 (10 Days)||0
2231883|NCT02688387|5472307|P7|STARTED|Part 2, Washout Period 2 (10 Days)||0
2231884|NCT02688387|5472308|P6|STARTED|Part 2, Washout Period 2 (10 Days)||0
2231885|NCT02688387|5472309|P5|STARTED|Part 2, Washout Period 2 (10 Days)||0
2231886|NCT02688387|5472310|P4|STARTED|Part 2, Washout Period 2 (10 Days)||0
2231887|NCT02688387|5472311|P3|STARTED|Part 2, Washout Period 2 (10 Days)||0
2231888|NCT02688387|5472312|P2|STARTED|Part 2, Washout Period 2 (10 Days)||0
2231889|NCT02688387|5472313|P1|STARTED|Part 2, Washout Period 2 (10 Days)||0
2231890|NCT02688387|5472292|P22|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231891|NCT02688387|5472293|P21|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231892|NCT02688387|5472294|P20|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231893|NCT02688387|5472295|P19|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231894|NCT02688387|5472296|P18|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231895|NCT02688387|5472297|P17|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231896|NCT02688387|5472298|P16|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231897|NCT02688387|5472299|P15|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231898|NCT02688387|5472300|P14|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231899|NCT02688387|5472301|P13|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231900|NCT02688387|5472302|P12|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231901|NCT02688387|5472303|P11|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231902|NCT02688387|5472304|P10|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231903|NCT02688387|5472305|P9|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231904|NCT02688387|5472306|P8|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231905|NCT02688387|5472307|P7|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231906|NCT02688387|5472308|P6|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231907|NCT02688387|5472309|P5|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231908|NCT02688387|5472310|P4|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231909|NCT02688387|5472311|P3|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231910|NCT02688387|5472312|P2|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231911|NCT02688387|5472313|P1|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231912|NCT02688387|5472292|P22|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231913|NCT02688387|5472293|P21|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231914|NCT02688387|5472294|P20|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231915|NCT02688387|5472295|P19|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231916|NCT02688387|5472296|P18|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231917|NCT02688387|5472297|P17|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231918|NCT02688387|5472298|P16|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231919|NCT02688387|5472299|P15|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231920|NCT02688387|5472300|P14|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
2231921|NCT02688387|5472301|P13|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
2231922|NCT02688387|5472302|P12|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
2231923|NCT02688387|5472303|P11|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
2231924|NCT02688387|5472304|P10|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231925|NCT02688387|5472305|P9|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231926|NCT02688387|5472306|P8|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231927|NCT02688387|5472307|P7|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231928|NCT02688387|5472308|P6|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231929|NCT02688387|5472309|P5|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231930|NCT02688387|5472310|P4|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231931|NCT02688387|5472311|P3|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231932|NCT02688387|5472312|P2|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231933|NCT02688387|5472313|P1|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
2231934|NCT02688387|5472292|P22|STARTED|Part 2, Period 2 (up to 6 Days)||0
2231935|NCT02688387|5472293|P21|STARTED|Part 2, Period 2 (up to 6 Days)||0
2231936|NCT02688387|5472294|P20|STARTED|Part 2, Period 2 (up to 6 Days)||0
2231937|NCT02688387|5472295|P19|STARTED|Part 2, Period 2 (up to 6 Days)||0
2231938|NCT02688387|5472296|P18|STARTED|Part 2, Period 2 (up to 6 Days)||0
2231939|NCT02688387|5472297|P17|STARTED|Part 2, Period 2 (up to 6 Days)||0
2231940|NCT02688387|5472298|P16|STARTED|Part 2, Period 2 (up to 6 Days)||0
2231941|NCT02688387|5472299|P15|STARTED|Part 2, Period 2 (up to 6 Days)||0
2231942|NCT02688387|5472300|P14|STARTED|Part 2, Period 2 (up to 6 Days)||5
2231943|NCT02688387|5472301|P13|STARTED|Part 2, Period 2 (up to 6 Days)||5
2231944|NCT02688387|5472302|P12|STARTED|Part 2, Period 2 (up to 6 Days)||5
2231945|NCT02688387|5472303|P11|STARTED|Part 2, Period 2 (up to 6 Days)||5
2231946|NCT02688387|5472304|P10|STARTED|Part 2, Period 2 (up to 6 Days)||0
2231947|NCT02688387|5472305|P9|STARTED|Part 2, Period 2 (up to 6 Days)||0
2231948|NCT02688387|5472306|P8|STARTED|Part 2, Period 2 (up to 6 Days)||0
2231949|NCT02688387|5472307|P7|STARTED|Part 2, Period 2 (up to 6 Days)||0
2231950|NCT02688387|5472308|P6|STARTED|Part 2, Period 2 (up to 6 Days)||0
2231951|NCT02688387|5472309|P5|STARTED|Part 2, Period 2 (up to 6 Days)||0
2231952|NCT02688387|5472310|P4|STARTED|Part 2, Period 2 (up to 6 Days)||0
2231953|NCT02688387|5472311|P3|STARTED|Part 2, Period 2 (up to 6 Days)||0
2231954|NCT02688387|5472312|P2|STARTED|Part 2, Period 2 (up to 6 Days)||0
2231955|NCT02688387|5472313|P1|STARTED|Part 2, Period 2 (up to 6 Days)||0
2231956|NCT02688387|5472292|P22|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231957|NCT02688387|5472293|P21|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231958|NCT02688387|5472294|P20|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231959|NCT02688387|5472295|P19|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231960|NCT02688387|5472296|P18|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231961|NCT02688387|5472297|P17|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231962|NCT02688387|5472298|P16|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231963|NCT02688387|5472299|P15|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231964|NCT02688387|5472300|P14|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231965|NCT02688387|5472301|P13|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231966|NCT02688387|5472302|P12|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231967|NCT02688387|5472303|P11|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231968|NCT02688387|5472304|P10|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231969|NCT02688387|5472305|P9|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231970|NCT02688387|5472306|P8|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231971|NCT02688387|5472307|P7|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231972|NCT02688387|5472308|P6|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231973|NCT02688387|5472309|P5|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231974|NCT02688387|5472310|P4|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231975|NCT02688387|5472311|P3|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231976|NCT02688387|5472312|P2|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231977|NCT02688387|5472313|P1|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231978|NCT02688387|5472292|P22|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231979|NCT02688387|5472293|P21|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231980|NCT02688387|5472294|P20|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231981|NCT02688387|5472295|P19|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231982|NCT02688387|5472296|P18|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231983|NCT02688387|5472297|P17|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231984|NCT02688387|5472298|P16|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231985|NCT02688387|5472299|P15|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231986|NCT02688387|5472300|P14|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
2231987|NCT02688387|5472301|P13|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
2231988|NCT02688387|5472302|P12|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
2231989|NCT02688387|5472303|P11|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
2231990|NCT02688387|5472304|P10|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231991|NCT02688387|5472305|P9|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231992|NCT02688387|5472306|P8|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231993|NCT02688387|5472307|P7|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231994|NCT02688387|5472308|P6|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231995|NCT02688387|5472309|P5|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231996|NCT02688387|5472310|P4|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231997|NCT02688387|5472311|P3|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231998|NCT02688387|5472312|P2|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2231999|NCT02688387|5472313|P1|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
2232000|NCT02688387|5472292|P22|STARTED|Part 2, Washout Period 1 (10 Days)||0
2232001|NCT02688387|5472293|P21|STARTED|Part 2, Washout Period 1 (10 Days)||0
2232002|NCT02688387|5472294|P20|STARTED|Part 2, Washout Period 1 (10 Days)||0
2232003|NCT02688387|5472295|P19|STARTED|Part 2, Washout Period 1 (10 Days)||0
2232004|NCT02688387|5472296|P18|STARTED|Part 2, Washout Period 1 (10 Days)||0
2232005|NCT02688387|5472297|P17|STARTED|Part 2, Washout Period 1 (10 Days)||0
2232006|NCT02688387|5472298|P16|STARTED|Part 2, Washout Period 1 (10 Days)||0
2232007|NCT02688387|5472299|P15|STARTED|Part 2, Washout Period 1 (10 Days)||0
2232008|NCT02688387|5472300|P14|STARTED|Part 2, Washout Period 1 (10 Days)||5
2232009|NCT02688387|5472301|P13|STARTED|Part 2, Washout Period 1 (10 Days)||5
2232010|NCT02688387|5472302|P12|STARTED|Part 2, Washout Period 1 (10 Days)||5
2232011|NCT02688387|5472303|P11|STARTED|Part 2, Washout Period 1 (10 Days)||5
2232012|NCT02688387|5472304|P10|STARTED|Part 2, Washout Period 1 (10 Days)||0
2232013|NCT02688387|5472305|P9|STARTED|Part 2, Washout Period 1 (10 Days)||0
2232014|NCT02688387|5472306|P8|STARTED|Part 2, Washout Period 1 (10 Days)||0
2232015|NCT02688387|5472307|P7|STARTED|Part 2, Washout Period 1 (10 Days)||0
2232016|NCT02688387|5472308|P6|STARTED|Part 2, Washout Period 1 (10 Days)||0
2232017|NCT02688387|5472309|P5|STARTED|Part 2, Washout Period 1 (10 Days)||0
2232018|NCT02688387|5472310|P4|STARTED|Part 2, Washout Period 1 (10 Days)||0
2232019|NCT02688387|5472311|P3|STARTED|Part 2, Washout Period 1 (10 Days)||0
2232020|NCT02688387|5472312|P2|STARTED|Part 2, Washout Period 1 (10 Days)||0
2232021|NCT02688387|5472313|P1|STARTED|Part 2, Washout Period 1 (10 Days)||0
2232022|NCT02688387|5472292|P22|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232023|NCT02688387|5472293|P21|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232024|NCT02688387|5472294|P20|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232025|NCT02688387|5472295|P19|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232026|NCT02688387|5472296|P18|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232027|NCT02688387|5472297|P17|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232028|NCT02688387|5472298|P16|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232029|NCT02688387|5472299|P15|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232030|NCT02688387|5472300|P14|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232031|NCT02688387|5472301|P13|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232032|NCT02688387|5472302|P12|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232033|NCT02688387|5472303|P11|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||1
2232034|NCT02688387|5472304|P10|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232035|NCT02688387|5472305|P9|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232036|NCT02688387|5472306|P8|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232037|NCT02688387|5472307|P7|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232038|NCT02688387|5472308|P6|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232039|NCT02688387|5472309|P5|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232040|NCT02688387|5472310|P4|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232041|NCT02688387|5472311|P3|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232042|NCT02688387|5472312|P2|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232043|NCT02688387|5472313|P1|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232044|NCT02688387|5472292|P22|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232045|NCT02688387|5472293|P21|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232046|NCT02688387|5472294|P20|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232047|NCT02688387|5472295|P19|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232048|NCT02688387|5472296|P18|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232049|NCT02688387|5472297|P17|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232050|NCT02688387|5472298|P16|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232051|NCT02688387|5472299|P15|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232052|NCT02688387|5472300|P14|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
2232053|NCT02688387|5472301|P13|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
2232054|NCT02688387|5472302|P12|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
2232055|NCT02688387|5472303|P11|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
2232056|NCT02688387|5472304|P10|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232057|NCT02688387|5472305|P9|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232058|NCT02688387|5472306|P8|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232059|NCT02688387|5472307|P7|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232060|NCT02688387|5472308|P6|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232061|NCT02688387|5472309|P5|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232062|NCT02688387|5472310|P4|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232063|NCT02688387|5472311|P3|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232064|NCT02688387|5472312|P2|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232065|NCT02688387|5472313|P1|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
2232066|NCT02688387|5472292|P22|STARTED|Part 2, Period 1 (up to 6 Days)||0
2232067|NCT02688387|5472293|P21|STARTED|Part 2, Period 1 (up to 6 Days)||0
2232068|NCT02688387|5472294|P20|STARTED|Part 2, Period 1 (up to 6 Days)||0
2232069|NCT02688387|5472295|P19|STARTED|Part 2, Period 1 (up to 6 Days)||0
2232070|NCT02688387|5472296|P18|STARTED|Part 2, Period 1 (up to 6 Days)||0
2232071|NCT02688387|5472297|P17|STARTED|Part 2, Period 1 (up to 6 Days)||0
2232072|NCT02688387|5472298|P16|STARTED|Part 2, Period 1 (up to 6 Days)||0
2232073|NCT02688387|5472299|P15|STARTED|Part 2, Period 1 (up to 6 Days)||0
2232074|NCT02688387|5472300|P14|STARTED|Part 2, Period 1 (up to 6 Days)||5
2232075|NCT02688387|5472301|P13|STARTED|Part 2, Period 1 (up to 6 Days)||5
2232076|NCT02688387|5472302|P12|STARTED|Part 2, Period 1 (up to 6 Days)||5
2232077|NCT02688387|5472303|P11|STARTED|Part 2, Period 1 (up to 6 Days)||6
2232078|NCT02688387|5472304|P10|STARTED|Part 2, Period 1 (up to 6 Days)||0
2232079|NCT02688387|5472305|P9|STARTED|Part 2, Period 1 (up to 6 Days)||0
2232080|NCT02688387|5472306|P8|STARTED|Part 2, Period 1 (up to 6 Days)||0
2232081|NCT02688387|5472307|P7|STARTED|Part 2, Period 1 (up to 6 Days)||0
2232082|NCT02688387|5472308|P6|STARTED|Part 2, Period 1 (up to 6 Days)||0
2232083|NCT02688387|5472309|P5|STARTED|Part 2, Period 1 (up to 6 Days)||0
2232084|NCT02688387|5472310|P4|STARTED|Part 2, Period 1 (up to 6 Days)||0
2232085|NCT02688387|5472311|P3|STARTED|Part 2, Period 1 (up to 6 Days)||0
2232086|NCT02688387|5472312|P2|STARTED|Part 2, Period 1 (up to 6 Days)||0
2232087|NCT02688387|5472313|P1|STARTED|Part 2, Period 1 (up to 6 Days)||0
2232088|NCT02688387|5472292|P22|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
2232089|NCT02688387|5472293|P21|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
2232090|NCT02688387|5472294|P20|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
2232091|NCT02688387|5472295|P19|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
2232092|NCT02688387|5472296|P18|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
2232093|NCT02688387|5472297|P17|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
2232094|NCT02688387|5472298|P16|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
2232095|NCT02688387|5472299|P15|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
2232096|NCT02688387|5472300|P14|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
2232097|NCT02688387|5472301|P13|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
2232098|NCT02688387|5472302|P12|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
2232099|NCT02688387|5472303|P11|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
2232100|NCT02688387|5472304|P10|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
2232101|NCT02688387|5472305|P9|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
2232102|NCT02688387|5472306|P8|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
2232103|NCT02688387|5472307|P7|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
2232104|NCT02688387|5472308|P6|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
2232105|NCT02688387|5472309|P5|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
2232106|NCT02688387|5472310|P4|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
2232107|NCT02688387|5472311|P3|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
2232108|NCT02688387|5472312|P2|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
2232109|NCT02688387|5472313|P1|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
2232110|NCT02688387|5472292|P22|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
2232111|NCT02688387|5472293|P21|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
2232112|NCT02688387|5472294|P20|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
2232113|NCT02688387|5472295|P19|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
2232114|NCT02688387|5472296|P18|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
2232115|NCT02688387|5472297|P17|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
2232116|NCT02688387|5472298|P16|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
2232117|NCT02688387|5472299|P15|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
2232118|NCT02688387|5472300|P14|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
2232119|NCT02688387|5472301|P13|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
2232120|NCT02688387|5472302|P12|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
2232121|NCT02688387|5472303|P11|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
2232122|NCT02688387|5472304|P10|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
2232123|NCT02688387|5472305|P9|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
2232124|NCT02688387|5472306|P8|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
2232125|NCT02688387|5472307|P7|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
2232126|NCT02688387|5472308|P6|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
2232127|NCT02688387|5472309|P5|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
2232128|NCT02688387|5472310|P4|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
2232129|NCT02688387|5472311|P3|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
2232130|NCT02688387|5472312|P2|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
2232131|NCT02688387|5472313|P1|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
2232132|NCT02688387|5472292|P22|STARTED|Part 1, Period 5 (up to 6 Days)||0
2232133|NCT02688387|5472293|P21|STARTED|Part 1, Period 5 (up to 6 Days)||0
2232134|NCT02688387|5472294|P20|STARTED|Part 1, Period 5 (up to 6 Days)||0
2232135|NCT02688387|5472295|P19|STARTED|Part 1, Period 5 (up to 6 Days)||0
2232136|NCT02688387|5472296|P18|STARTED|Part 1, Period 5 (up to 6 Days)||0
2232137|NCT02688387|5472297|P17|STARTED|Part 1, Period 5 (up to 6 Days)||0
2232138|NCT02688387|5472298|P16|STARTED|Part 1, Period 5 (up to 6 Days)||0
2232139|NCT02688387|5472299|P15|STARTED|Part 1, Period 5 (up to 6 Days)||0
2232140|NCT02688387|5472300|P14|STARTED|Part 1, Period 5 (up to 6 Days)||0
2232141|NCT02688387|5472301|P13|STARTED|Part 1, Period 5 (up to 6 Days)||0
2232142|NCT02688387|5472302|P12|STARTED|Part 1, Period 5 (up to 6 Days)||0
2232143|NCT02688387|5472303|P11|STARTED|Part 1, Period 5 (up to 6 Days)||0
2232144|NCT02688387|5472304|P10|STARTED|Part 1, Period 5 (up to 6 Days)||2
2232145|NCT02688387|5472305|P9|STARTED|Part 1, Period 5 (up to 6 Days)||2
2232146|NCT02688387|5472306|P8|STARTED|Part 1, Period 5 (up to 6 Days)||2
2232147|NCT02688387|5472307|P7|STARTED|Part 1, Period 5 (up to 6 Days)||2
2232148|NCT02688387|5472308|P6|STARTED|Part 1, Period 5 (up to 6 Days)||2
2232149|NCT02688387|5472309|P5|STARTED|Part 1, Period 5 (up to 6 Days)||2
2232150|NCT02688387|5472310|P4|STARTED|Part 1, Period 5 (up to 6 Days)||2
2232151|NCT02688387|5472311|P3|STARTED|Part 1, Period 5 (up to 6 Days)||2
2232152|NCT02688387|5472312|P2|STARTED|Part 1, Period 5 (up to 6 Days)||2
2232153|NCT02688387|5472313|P1|STARTED|Part 1, Period 5 (up to 6 Days)||2
2232154|NCT02688387|5472292|P22|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
2232155|NCT02688387|5472293|P21|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
2232156|NCT02688387|5472294|P20|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
2232157|NCT02688387|5472295|P19|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
2232158|NCT02688387|5472296|P18|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
2232159|NCT02688387|5472297|P17|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
2232160|NCT02688387|5472298|P16|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
2232161|NCT02688387|5472299|P15|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
2232162|NCT02688387|5472300|P14|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
2232163|NCT02688387|5472301|P13|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
2232164|NCT02688387|5472302|P12|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
2232165|NCT02688387|5472303|P11|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
2232166|NCT02688387|5472304|P10|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
2232167|NCT02688387|5472305|P9|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
2232168|NCT02688387|5472306|P8|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
2232169|NCT02688387|5472307|P7|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
2232170|NCT02688387|5472308|P6|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
2232171|NCT02688387|5472309|P5|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
2232172|NCT02688387|5472310|P4|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
2232173|NCT02688387|5472311|P3|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
2232174|NCT02688387|5472312|P2|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
2232175|NCT02688387|5472313|P1|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
2232176|NCT02688387|5472292|P22|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
2232177|NCT02688387|5472293|P21|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
2232178|NCT02688387|5472294|P20|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
2232179|NCT02688387|5472295|P19|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
2232180|NCT02688387|5472296|P18|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
2232181|NCT02688387|5472297|P17|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
2232182|NCT02688387|5472298|P16|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
2232183|NCT02688387|5472299|P15|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
2232184|NCT02688387|5472300|P14|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
2232185|NCT02688387|5472301|P13|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
2232186|NCT02688387|5472302|P12|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
2232187|NCT02688387|5472303|P11|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
2232188|NCT02688387|5472304|P10|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
2232189|NCT02688387|5472305|P9|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
2232190|NCT02688387|5472306|P8|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
2232191|NCT02688387|5472307|P7|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
2232192|NCT02688387|5472308|P6|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
2232193|NCT02688387|5472309|P5|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
2232194|NCT02688387|5472310|P4|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
2232195|NCT02688387|5472311|P3|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
2232196|NCT02688387|5472312|P2|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
2232197|NCT02688387|5472313|P1|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
2232198|NCT02688387|5472292|P22|STARTED|Part 1, Washout Period 4 (7 Days)||0
2232199|NCT02688387|5472293|P21|STARTED|Part 1, Washout Period 4 (7 Days)||0
2232200|NCT02688387|5472294|P20|STARTED|Part 1, Washout Period 4 (7 Days)||0
2232201|NCT02688387|5472295|P19|STARTED|Part 1, Washout Period 4 (7 Days)||0
2232202|NCT02688387|5472296|P18|STARTED|Part 1, Washout Period 4 (7 Days)||0
2232203|NCT02688387|5472297|P17|STARTED|Part 1, Washout Period 4 (7 Days)||0
2232204|NCT02688387|5472298|P16|STARTED|Part 1, Washout Period 4 (7 Days)||0
2232205|NCT02688387|5472299|P15|STARTED|Part 1, Washout Period 4 (7 Days)||0
2232206|NCT02688387|5472300|P14|STARTED|Part 1, Washout Period 4 (7 Days)||0
2232207|NCT02688387|5472301|P13|STARTED|Part 1, Washout Period 4 (7 Days)||0
2232208|NCT02688387|5472302|P12|STARTED|Part 1, Washout Period 4 (7 Days)||0
2232209|NCT02688387|5472303|P11|STARTED|Part 1, Washout Period 4 (7 Days)||0
2232210|NCT02688387|5472304|P10|STARTED|Part 1, Washout Period 4 (7 Days)||2
2232211|NCT02688387|5472305|P9|STARTED|Part 1, Washout Period 4 (7 Days)||2
2232212|NCT02688387|5472306|P8|STARTED|Part 1, Washout Period 4 (7 Days)||2
2232213|NCT02688387|5472307|P7|STARTED|Part 1, Washout Period 4 (7 Days)||2
2232214|NCT02688387|5472308|P6|STARTED|Part 1, Washout Period 4 (7 Days)||2
2232215|NCT02688387|5472309|P5|STARTED|Part 1, Washout Period 4 (7 Days)||2
2232216|NCT02688387|5472310|P4|STARTED|Part 1, Washout Period 4 (7 Days)||2
2232217|NCT02688387|5472311|P3|STARTED|Part 1, Washout Period 4 (7 Days)||2
2232218|NCT02688387|5472312|P2|STARTED|Part 1, Washout Period 4 (7 Days)||2
2232219|NCT02688387|5472313|P1|STARTED|Part 1, Washout Period 4 (7 Days)||2
2232220|NCT02688387|5472292|P22|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
2232221|NCT02688387|5472293|P21|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
2232222|NCT02688387|5472294|P20|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
2232223|NCT02688387|5472295|P19|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
2232224|NCT02688387|5472296|P18|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
2232225|NCT02688387|5472297|P17|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
2232226|NCT02688387|5472298|P16|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
2232227|NCT02688387|5472299|P15|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
2232228|NCT02688387|5472300|P14|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
2232229|NCT02688387|5472301|P13|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
2232230|NCT02688387|5472302|P12|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
2232231|NCT02688387|5472303|P11|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
2232232|NCT02688387|5472304|P10|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
2232233|NCT02688387|5472305|P9|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
2232234|NCT02688387|5472306|P8|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
2232235|NCT02688387|5472307|P7|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
2232236|NCT02688387|5472308|P6|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
2232237|NCT02688387|5472309|P5|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
2232238|NCT02688387|5472310|P4|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
2232239|NCT02688387|5472311|P3|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
2232240|NCT02688387|5472312|P2|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
2232241|NCT02688387|5472313|P1|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
2232242|NCT02688387|5472292|P22|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
2232243|NCT02688387|5472293|P21|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
2232244|NCT02688387|5472294|P20|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
2232245|NCT02688387|5472295|P19|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
2232246|NCT02688387|5472296|P18|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
2232247|NCT02688387|5472297|P17|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
2232248|NCT02688387|5472298|P16|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
2232249|NCT02688387|5472299|P15|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
2232250|NCT02688387|5472300|P14|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
2232251|NCT02688387|5472301|P13|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
2232252|NCT02688387|5472302|P12|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
2232253|NCT02688387|5472303|P11|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
2232254|NCT02688387|5472304|P10|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
2232255|NCT02688387|5472305|P9|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
2232256|NCT02688387|5472306|P8|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
2232257|NCT02688387|5472307|P7|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
2232258|NCT02688387|5472308|P6|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
2232259|NCT02688387|5472309|P5|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
2232260|NCT02688387|5472310|P4|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
2232261|NCT02688387|5472311|P3|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
2232262|NCT02688387|5472312|P2|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
2232263|NCT02688387|5472313|P1|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
2232264|NCT02688387|5472292|P22|STARTED|Part 1, Period 4 (up to 6 Days)||0
2232265|NCT02688387|5472293|P21|STARTED|Part 1, Period 4 (up to 6 Days)||0
2232266|NCT02688387|5472294|P20|STARTED|Part 1, Period 4 (up to 6 Days)||0
2232267|NCT02688387|5472295|P19|STARTED|Part 1, Period 4 (up to 6 Days)||0
2232268|NCT02688387|5472296|P18|STARTED|Part 1, Period 4 (up to 6 Days)||0
2232269|NCT02688387|5472297|P17|STARTED|Part 1, Period 4 (up to 6 Days)||0
2232270|NCT02688387|5472298|P16|STARTED|Part 1, Period 4 (up to 6 Days)||0
2232271|NCT02688387|5472299|P15|STARTED|Part 1, Period 4 (up to 6 Days)||0
2232272|NCT02688387|5472300|P14|STARTED|Part 1, Period 4 (up to 6 Days)||0
2232273|NCT02688387|5472301|P13|STARTED|Part 1, Period 4 (up to 6 Days)||0
2232274|NCT02688387|5472302|P12|STARTED|Part 1, Period 4 (up to 6 Days)||0
2232275|NCT02688387|5472303|P11|STARTED|Part 1, Period 4 (up to 6 Days)||0
2232276|NCT02688387|5472304|P10|STARTED|Part 1, Period 4 (up to 6 Days)||2
2232277|NCT02688387|5472305|P9|STARTED|Part 1, Period 4 (up to 6 Days)||2
2232278|NCT02688387|5472306|P8|STARTED|Part 1, Period 4 (up to 6 Days)||2
2232279|NCT02688387|5472307|P7|STARTED|Part 1, Period 4 (up to 6 Days)||2
2232280|NCT02688387|5472308|P6|STARTED|Part 1, Period 4 (up to 6 Days)||2
2232281|NCT02688387|5472309|P5|STARTED|Part 1, Period 4 (up to 6 Days)||2
2232282|NCT02688387|5472310|P4|STARTED|Part 1, Period 4 (up to 6 Days)||2
2232283|NCT02688387|5472311|P3|STARTED|Part 1, Period 4 (up to 6 Days)||2
2232284|NCT02688387|5472312|P2|STARTED|Part 1, Period 4 (up to 6 Days)||2
2232285|NCT02688387|5472313|P1|STARTED|Part 1, Period 4 (up to 6 Days)||2
2232286|NCT02688387|5472292|P22|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
2232287|NCT02688387|5472293|P21|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
2232288|NCT02688387|5472294|P20|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
2232289|NCT02688387|5472295|P19|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
2232290|NCT02688387|5472296|P18|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
2232291|NCT02688387|5472297|P17|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
2232292|NCT02688387|5472298|P16|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
2232293|NCT02688387|5472299|P15|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
2232294|NCT02688387|5472300|P14|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
2232295|NCT02688387|5472301|P13|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
2232296|NCT02688387|5472302|P12|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
2232297|NCT02688387|5472303|P11|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
2232298|NCT02688387|5472304|P10|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
2232299|NCT02688387|5472305|P9|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
2232300|NCT02688387|5472306|P8|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
2232301|NCT02688387|5472307|P7|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
2232302|NCT02688387|5472308|P6|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
2232303|NCT02688387|5472309|P5|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
2232304|NCT02688387|5472310|P4|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
2232305|NCT02688387|5472311|P3|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
2232306|NCT02688387|5472312|P2|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
2232307|NCT02688387|5472313|P1|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||1
2232308|NCT02688387|5472292|P22|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
2232309|NCT02688387|5472293|P21|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
2232310|NCT02688387|5472294|P20|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
2232311|NCT02688387|5472295|P19|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
2232312|NCT02688387|5472296|P18|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
2232313|NCT02688387|5472297|P17|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
2232314|NCT02688387|5472298|P16|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
2232315|NCT02688387|5472299|P15|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
2232316|NCT02688387|5472300|P14|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
2232317|NCT02688387|5472301|P13|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
2232318|NCT02688387|5472302|P12|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
2232319|NCT02688387|5472303|P11|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
2232320|NCT02688387|5472304|P10|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
2232321|NCT02688387|5472305|P9|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
2232322|NCT02688387|5472306|P8|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
2232323|NCT02688387|5472307|P7|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
2232324|NCT02688387|5472308|P6|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
2232325|NCT02688387|5472309|P5|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
2232326|NCT02688387|5472310|P4|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
2232327|NCT02688387|5472311|P3|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
2232328|NCT02688387|5472312|P2|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
2232329|NCT02688387|5472313|P1|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
2232330|NCT02688387|5472292|P22|STARTED|Part 1, Washout Period 3 (7 Days)||0
2232331|NCT02688387|5472293|P21|STARTED|Part 1, Washout Period 3 (7 Days)||0
2232332|NCT02688387|5472294|P20|STARTED|Part 1, Washout Period 3 (7 Days)||0
2232333|NCT02688387|5472295|P19|STARTED|Part 1, Washout Period 3 (7 Days)||0
2232334|NCT02688387|5472296|P18|STARTED|Part 1, Washout Period 3 (7 Days)||0
2232335|NCT02688387|5472297|P17|STARTED|Part 1, Washout Period 3 (7 Days)||0
2232336|NCT02688387|5472298|P16|STARTED|Part 1, Washout Period 3 (7 Days)||0
2232337|NCT02688387|5472299|P15|STARTED|Part 1, Washout Period 3 (7 Days)||0
2232338|NCT02688387|5472300|P14|STARTED|Part 1, Washout Period 3 (7 Days)||0
2232339|NCT02688387|5472301|P13|STARTED|Part 1, Washout Period 3 (7 Days)||0
2232340|NCT02688387|5472302|P12|STARTED|Part 1, Washout Period 3 (7 Days)||0
2232341|NCT02688387|5472303|P11|STARTED|Part 1, Washout Period 3 (7 Days)||0
2232342|NCT02688387|5472304|P10|STARTED|Part 1, Washout Period 3 (7 Days)||2
2232343|NCT02688387|5472305|P9|STARTED|Part 1, Washout Period 3 (7 Days)||2
2232344|NCT02688387|5472306|P8|STARTED|Part 1, Washout Period 3 (7 Days)||2
2232345|NCT02688387|5472307|P7|STARTED|Part 1, Washout Period 3 (7 Days)||2
2232346|NCT02688387|5472308|P6|STARTED|Part 1, Washout Period 3 (7 Days)||2
2232347|NCT02688387|5472309|P5|STARTED|Part 1, Washout Period 3 (7 Days)||2
2232348|NCT02688387|5472310|P4|STARTED|Part 1, Washout Period 3 (7 Days)||2
2232349|NCT02688387|5472311|P3|STARTED|Part 1, Washout Period 3 (7 Days)||2
2232350|NCT02688387|5472312|P2|STARTED|Part 1, Washout Period 3 (7 Days)||2
2232351|NCT02688387|5472313|P1|STARTED|Part 1, Washout Period 3 (7 Days)||3
2232352|NCT02688387|5472292|P22|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
2232353|NCT02688387|5472293|P21|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
2232354|NCT02688387|5472294|P20|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
2232355|NCT02688387|5472295|P19|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
2232356|NCT02688387|5472296|P18|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
2232357|NCT02688387|5472297|P17|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
2232358|NCT02688387|5472298|P16|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
2232359|NCT02688387|5472299|P15|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
2232360|NCT02688387|5472300|P14|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
2232361|NCT02688387|5472301|P13|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
2232362|NCT02688387|5472302|P12|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
2232363|NCT02688387|5472303|P11|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
2232364|NCT02688387|5472304|P10|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
2232365|NCT02688387|5472305|P9|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
2232366|NCT02688387|5472306|P8|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
2232367|NCT02688387|5472307|P7|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
2232368|NCT02688387|5472308|P6|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
2232369|NCT02688387|5472309|P5|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
2232370|NCT02688387|5472310|P4|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
2232371|NCT02688387|5472311|P3|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
2232372|NCT02688387|5472312|P2|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
2232373|NCT02688387|5472313|P1|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
2232374|NCT02688387|5472292|P22|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
2232375|NCT02688387|5472293|P21|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
2232376|NCT02688387|5472294|P20|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
2232377|NCT02688387|5472295|P19|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
2232378|NCT02688387|5472296|P18|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
2232379|NCT02688387|5472297|P17|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
2232380|NCT02688387|5472298|P16|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
2232381|NCT02688387|5472299|P15|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
2232382|NCT02688387|5472300|P14|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
2232383|NCT02688387|5472301|P13|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
2232384|NCT02688387|5472302|P12|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
2232385|NCT02688387|5472303|P11|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
2232386|NCT02688387|5472304|P10|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
2232387|NCT02688387|5472305|P9|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
2232388|NCT02688387|5472306|P8|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
2232389|NCT02688387|5472307|P7|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
2232390|NCT02688387|5472308|P6|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
2232391|NCT02688387|5472309|P5|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
2232392|NCT02688387|5472310|P4|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
2232393|NCT02688387|5472311|P3|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
2232394|NCT02688387|5472312|P2|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
2232395|NCT02688387|5472313|P1|COMPLETED|Part 1, Period 3 (up to 6 Days)||3
2232396|NCT02688387|5472292|P22|STARTED|Part 1, Period 3 (up to 6 Days)||0
2232397|NCT02688387|5472293|P21|STARTED|Part 1, Period 3 (up to 6 Days)||0
2232398|NCT02688387|5472294|P20|STARTED|Part 1, Period 3 (up to 6 Days)||0
2232399|NCT02688387|5472295|P19|STARTED|Part 1, Period 3 (up to 6 Days)||0
2232400|NCT02688387|5472296|P18|STARTED|Part 1, Period 3 (up to 6 Days)||0
2232401|NCT02688387|5472297|P17|STARTED|Part 1, Period 3 (up to 6 Days)||0
2232402|NCT02688387|5472298|P16|STARTED|Part 1, Period 3 (up to 6 Days)||0
2232403|NCT02688387|5472299|P15|STARTED|Part 1, Period 3 (up to 6 Days)||0
2232404|NCT02688387|5472300|P14|STARTED|Part 1, Period 3 (up to 6 Days)||0
2232405|NCT02688387|5472301|P13|STARTED|Part 1, Period 3 (up to 6 Days)||0
2232406|NCT02688387|5472302|P12|STARTED|Part 1, Period 3 (up to 6 Days)||0
2232407|NCT02688387|5472303|P11|STARTED|Part 1, Period 3 (up to 6 Days)||0
2232408|NCT02688387|5472304|P10|STARTED|Part 1, Period 3 (up to 6 Days)||2
2232409|NCT02688387|5472305|P9|STARTED|Part 1, Period 3 (up to 6 Days)||2
2232410|NCT02688387|5472306|P8|STARTED|Part 1, Period 3 (up to 6 Days)||2
2232411|NCT02688387|5472307|P7|STARTED|Part 1, Period 3 (up to 6 Days)||2
2232412|NCT02688387|5472308|P6|STARTED|Part 1, Period 3 (up to 6 Days)||2
2232413|NCT02688387|5472309|P5|STARTED|Part 1, Period 3 (up to 6 Days)||2
2232414|NCT02688387|5472310|P4|STARTED|Part 1, Period 3 (up to 6 Days)||2
2232415|NCT02688387|5472311|P3|STARTED|Part 1, Period 3 (up to 6 Days)||2
2232416|NCT02688387|5472312|P2|STARTED|Part 1, Period 3 (up to 6 Days)||2
2232417|NCT02688387|5472313|P1|STARTED|Part 1, Period 3 (up to 6 Days)||3
2232418|NCT02688387|5472292|P22|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2232419|NCT02688387|5472293|P21|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2232420|NCT02688387|5472294|P20|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2232421|NCT02688387|5472295|P19|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2232422|NCT02688387|5472296|P18|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2232423|NCT02688387|5472297|P17|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2232424|NCT02688387|5472298|P16|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2232425|NCT02688387|5472299|P15|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2232426|NCT02688387|5472300|P14|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2232427|NCT02688387|5472301|P13|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2232428|NCT02688387|5472302|P12|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2232429|NCT02688387|5472303|P11|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2232430|NCT02688387|5472304|P10|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2232431|NCT02688387|5472305|P9|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2232432|NCT02688387|5472306|P8|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2232433|NCT02688387|5472307|P7|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2232434|NCT02688387|5472308|P6|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2232435|NCT02688387|5472309|P5|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2232436|NCT02688387|5472310|P4|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2232437|NCT02688387|5472311|P3|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2232438|NCT02688387|5472312|P2|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2232439|NCT02688387|5472313|P1|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2232440|NCT02688387|5472292|P22|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2232441|NCT02688387|5472293|P21|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2232442|NCT02688387|5472294|P20|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2232443|NCT02688387|5472295|P19|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2232444|NCT02688387|5472296|P18|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2232445|NCT02688387|5472297|P17|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2232446|NCT02688387|5472298|P16|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2232447|NCT02688387|5472299|P15|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2232448|NCT02688387|5472300|P14|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2232449|NCT02688387|5472301|P13|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2232450|NCT02688387|5472302|P12|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2232451|NCT02688387|5472303|P11|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
2232452|NCT02688387|5472304|P10|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
2232453|NCT02688387|5472305|P9|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
2232454|NCT02688387|5472306|P8|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
2232455|NCT02688387|5472307|P7|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
2232456|NCT02688387|5472308|P6|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
2232457|NCT02688387|5472309|P5|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
2232458|NCT02688387|5472310|P4|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
2232459|NCT02688387|5472311|P3|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
2232460|NCT02688387|5472312|P2|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
2232461|NCT02688387|5472313|P1|COMPLETED|Part 1, Washout Period 2 (7 Days)||3
2232462|NCT02688387|5472292|P22|STARTED|Part 1, Washout Period 2 (7 Days)||0
2232463|NCT02688387|5472293|P21|STARTED|Part 1, Washout Period 2 (7 Days)||0
2232464|NCT02688387|5472294|P20|STARTED|Part 1, Washout Period 2 (7 Days)||0
2232465|NCT02688387|5472295|P19|STARTED|Part 1, Washout Period 2 (7 Days)||0
2232466|NCT02688387|5472296|P18|STARTED|Part 1, Washout Period 2 (7 Days)||0
2232467|NCT02688387|5472297|P17|STARTED|Part 1, Washout Period 2 (7 Days)||0
2232468|NCT02688387|5472298|P16|STARTED|Part 1, Washout Period 2 (7 Days)||0
2232469|NCT02688387|5472299|P15|STARTED|Part 1, Washout Period 2 (7 Days)||0
2232470|NCT02688387|5472300|P14|STARTED|Part 1, Washout Period 2 (7 Days)||0
2232471|NCT02688387|5472301|P13|STARTED|Part 1, Washout Period 2 (7 Days)||0
2232472|NCT02688387|5472302|P12|STARTED|Part 1, Washout Period 2 (7 Days)||0
2232473|NCT02688387|5472303|P11|STARTED|Part 1, Washout Period 2 (7 Days)||0
2232474|NCT02688387|5472304|P10|STARTED|Part 1, Washout Period 2 (7 Days)||2
2232475|NCT02688387|5472305|P9|STARTED|Part 1, Washout Period 2 (7 Days)||2
2232476|NCT02688387|5472306|P8|STARTED|Part 1, Washout Period 2 (7 Days)||2
2232477|NCT02688387|5472307|P7|STARTED|Part 1, Washout Period 2 (7 Days)||2
2232478|NCT02688387|5472308|P6|STARTED|Part 1, Washout Period 2 (7 Days)||2
2232479|NCT02688387|5472309|P5|STARTED|Part 1, Washout Period 2 (7 Days)||2
2232480|NCT02688387|5472310|P4|STARTED|Part 1, Washout Period 2 (7 Days)||2
2232481|NCT02688387|5472311|P3|STARTED|Part 1, Washout Period 2 (7 Days)||2
2232482|NCT02688387|5472312|P2|STARTED|Part 1, Washout Period 2 (7 Days)||2
2232483|NCT02688387|5472313|P1|STARTED|Part 1, Washout Period 2 (7 Days)||3
2232484|NCT02688387|5472292|P22|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
2232485|NCT02688387|5472293|P21|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
2232486|NCT02688387|5472294|P20|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
2232487|NCT02688387|5472295|P19|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
2232488|NCT02688387|5472296|P18|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
2232489|NCT02688387|5472297|P17|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
2232490|NCT02688387|5472298|P16|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
2232491|NCT02688387|5472299|P15|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
2232492|NCT02688387|5472300|P14|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
2232493|NCT02688387|5472301|P13|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
2232494|NCT02688387|5472302|P12|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
2232495|NCT02688387|5472303|P11|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
2232496|NCT02688387|5472304|P10|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
2232497|NCT02688387|5472305|P9|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
2232498|NCT02688387|5472306|P8|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
2232499|NCT02688387|5472307|P7|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
2232500|NCT02688387|5472308|P6|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
2232501|NCT02688387|5472309|P5|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||1
2232502|NCT02688387|5472310|P4|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
2232503|NCT02688387|5472311|P3|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||1
2232504|NCT02688387|5472312|P2|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
2232505|NCT02688387|5472313|P1|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
2232506|NCT02688387|5472292|P22|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
2232507|NCT02688387|5472293|P21|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
2232508|NCT02688387|5472294|P20|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
2232509|NCT02688387|5472295|P19|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
2232510|NCT02688387|5472296|P18|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
2232511|NCT02688387|5472297|P17|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
2232512|NCT02688387|5472298|P16|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
2232513|NCT02688387|5472299|P15|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
2232514|NCT02688387|5472300|P14|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
2232515|NCT02688387|5472301|P13|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
2232516|NCT02688387|5472302|P12|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
2232517|NCT02688387|5472303|P11|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
2232518|NCT02688387|5472304|P10|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
2232519|NCT02688387|5472305|P9|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
2232520|NCT02688387|5472306|P8|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
2232521|NCT02688387|5472307|P7|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
2232522|NCT02688387|5472308|P6|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
2232523|NCT02688387|5472309|P5|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
2232524|NCT02688387|5472310|P4|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
2232525|NCT02688387|5472311|P3|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
2232526|NCT02688387|5472312|P2|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
2232527|NCT02688387|5472313|P1|COMPLETED|Part 1, Period 2 (up to 6 Days)||3
2232528|NCT02688387|5472292|P22|STARTED|Part 1, Period 2 (up to 6 Days)||0
2232529|NCT02688387|5472293|P21|STARTED|Part 1, Period 2 (up to 6 Days)||0
2232530|NCT02688387|5472294|P20|STARTED|Part 1, Period 2 (up to 6 Days)||0
2232531|NCT02688387|5472295|P19|STARTED|Part 1, Period 2 (up to 6 Days)||0
2232532|NCT02688387|5472296|P18|STARTED|Part 1, Period 2 (up to 6 Days)||0
2232533|NCT02688387|5472297|P17|STARTED|Part 1, Period 2 (up to 6 Days)||0
2232534|NCT02688387|5472298|P16|STARTED|Part 1, Period 2 (up to 6 Days)||0
2232535|NCT02688387|5472299|P15|STARTED|Part 1, Period 2 (up to 6 Days)||0
2232536|NCT02688387|5472300|P14|STARTED|Part 1, Period 2 (up to 6 Days)||0
2232537|NCT02688387|5472301|P13|STARTED|Part 1, Period 2 (up to 6 Days)||0
2232538|NCT02688387|5472302|P12|STARTED|Part 1, Period 2 (up to 6 Days)||0
2232539|NCT02688387|5472303|P11|STARTED|Part 1, Period 2 (up to 6 Days)||0
2232540|NCT02688387|5472304|P10|STARTED|Part 1, Period 2 (up to 6 Days)||2
2232541|NCT02688387|5472305|P9|STARTED|Part 1, Period 2 (up to 6 Days)||2
2232542|NCT02688387|5472306|P8|STARTED|Part 1, Period 2 (up to 6 Days)||2
2232543|NCT02688387|5472307|P7|STARTED|Part 1, Period 2 (up to 6 Days)||2
2232544|NCT02688387|5472308|P6|STARTED|Part 1, Period 2 (up to 6 Days)||2
2232545|NCT02688387|5472309|P5|STARTED|Part 1, Period 2 (up to 6 Days)||3
2232546|NCT02688387|5472310|P4|STARTED|Part 1, Period 2 (up to 6 Days)||2
2232547|NCT02688387|5472311|P3|STARTED|Part 1, Period 2 (up to 6 Days)||3
2232548|NCT02688387|5472312|P2|STARTED|Part 1, Period 2 (up to 6 Days)||2
2232549|NCT02688387|5472313|P1|STARTED|Part 1, Period 2 (up to 6 Days)||3
2232550|NCT02688387|5472292|P22|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2232551|NCT02688387|5472293|P21|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2232552|NCT02688387|5472294|P20|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2232553|NCT02688387|5472295|P19|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2232554|NCT02688387|5472296|P18|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2232555|NCT02688387|5472297|P17|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2232556|NCT02688387|5472298|P16|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2232557|NCT02688387|5472299|P15|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2232558|NCT02688387|5472300|P14|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2232559|NCT02688387|5472301|P13|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2232560|NCT02688387|5472302|P12|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2232561|NCT02688387|5472303|P11|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2232562|NCT02688387|5472304|P10|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2232563|NCT02688387|5472305|P9|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2232564|NCT02688387|5472306|P8|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2232565|NCT02688387|5472307|P7|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2232566|NCT02688387|5472308|P6|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2232567|NCT02688387|5472309|P5|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2232568|NCT02688387|5472310|P4|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2232569|NCT02688387|5472311|P3|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2232570|NCT02688387|5472312|P2|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||1
2232571|NCT02688387|5472313|P1|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2232572|NCT02688387|5472292|P22|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2232573|NCT02688387|5472293|P21|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2232574|NCT02688387|5472294|P20|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2232575|NCT02688387|5472295|P19|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2232576|NCT02688387|5472296|P18|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2232577|NCT02688387|5472297|P17|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2232578|NCT02688387|5472298|P16|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2232579|NCT02688387|5472299|P15|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2232580|NCT02688387|5472300|P14|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2232581|NCT02688387|5472301|P13|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2232582|NCT02688387|5472302|P12|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2232583|NCT02688387|5472303|P11|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
2232584|NCT02688387|5472304|P10|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
2232585|NCT02688387|5472305|P9|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
2232586|NCT02688387|5472306|P8|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
2232587|NCT02688387|5472307|P7|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
2232588|NCT02688387|5472308|P6|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
2232589|NCT02688387|5472309|P5|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
2232590|NCT02688387|5472310|P4|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
2232591|NCT02688387|5472311|P3|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
2232592|NCT02688387|5472312|P2|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
2232593|NCT02688387|5472313|P1|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
2232594|NCT02688387|5472292|P22|STARTED|Part 1, Washout Period 1 (7 Days)||0
2232595|NCT02688387|5472293|P21|STARTED|Part 1, Washout Period 1 (7 Days)||0
2232596|NCT02688387|5472294|P20|STARTED|Part 1, Washout Period 1 (7 Days)||0
2232597|NCT02688387|5472295|P19|STARTED|Part 1, Washout Period 1 (7 Days)||0
2232598|NCT02688387|5472296|P18|STARTED|Part 1, Washout Period 1 (7 Days)||0
2232599|NCT02688387|5472297|P17|STARTED|Part 1, Washout Period 1 (7 Days)||0
2232600|NCT02688387|5472298|P16|STARTED|Part 1, Washout Period 1 (7 Days)||0
2232601|NCT02688387|5472299|P15|STARTED|Part 1, Washout Period 1 (7 Days)||0
2232602|NCT02688387|5472300|P14|STARTED|Part 1, Washout Period 1 (7 Days)||0
2232603|NCT02688387|5472301|P13|STARTED|Part 1, Washout Period 1 (7 Days)||0
2232604|NCT02688387|5472302|P12|STARTED|Part 1, Washout Period 1 (7 Days)||0
2232605|NCT02688387|5472303|P11|STARTED|Part 1, Washout Period 1 (7 Days)||0
2232606|NCT02688387|5472304|P10|STARTED|Part 1, Washout Period 1 (7 Days)||2
2232607|NCT02688387|5472305|P9|STARTED|Part 1, Washout Period 1 (7 Days)||2
2232608|NCT02688387|5472306|P8|STARTED|Part 1, Washout Period 1 (7 Days)||2
2232609|NCT02688387|5472307|P7|STARTED|Part 1, Washout Period 1 (7 Days)||2
2232610|NCT02688387|5472308|P6|STARTED|Part 1, Washout Period 1 (7 Days)||2
2232611|NCT02688387|5472309|P5|STARTED|Part 1, Washout Period 1 (7 Days)||3
2232612|NCT02688387|5472310|P4|STARTED|Part 1, Washout Period 1 (7 Days)||2
2232613|NCT02688387|5472311|P3|STARTED|Part 1, Washout Period 1 (7 Days)||3
2232614|NCT02688387|5472312|P2|STARTED|Part 1, Washout Period 1 (7 Days)||3
2232615|NCT02688387|5472313|P1|STARTED|Part 1, Washout Period 1 (7 Days)||3
2232616|NCT02688387|5472292|P22|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
2232617|NCT02688387|5472293|P21|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
2232618|NCT02688387|5472294|P20|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
2232619|NCT02688387|5472295|P19|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
2232620|NCT02688387|5472296|P18|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
2232621|NCT02688387|5472297|P17|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
2232622|NCT02688387|5472298|P16|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
2232623|NCT02688387|5472299|P15|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
2232624|NCT02688387|5472300|P14|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
2232625|NCT02688387|5472301|P13|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
2232626|NCT02688387|5472302|P12|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
2232627|NCT02688387|5472303|P11|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
2232628|NCT02688387|5472304|P10|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
2232629|NCT02688387|5472305|P9|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
2232630|NCT02688387|5472306|P8|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
2232631|NCT02688387|5472307|P7|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
2232632|NCT02688387|5472308|P6|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
2232633|NCT02688387|5472309|P5|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
2232634|NCT02688387|5472310|P4|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||1
2232635|NCT02688387|5472311|P3|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||1
2232636|NCT02688387|5472312|P2|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
2232637|NCT02688387|5472313|P1|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
2232638|NCT02688387|5472292|P22|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
2232639|NCT02688387|5472293|P21|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
2232640|NCT02688387|5472294|P20|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
2232641|NCT02688387|5472295|P19|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
2232642|NCT02688387|5472296|P18|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
2232643|NCT02688387|5472297|P17|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
2232644|NCT02688387|5472298|P16|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
2232645|NCT02688387|5472299|P15|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
2232646|NCT02688387|5472300|P14|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
2232647|NCT02688387|5472301|P13|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
2232648|NCT02688387|5472302|P12|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
2232649|NCT02688387|5472303|P11|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
2232650|NCT02688387|5472304|P10|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
2232651|NCT02688387|5472305|P9|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
2232652|NCT02688387|5472306|P8|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
2232653|NCT02688387|5472307|P7|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
2232654|NCT02688387|5472308|P6|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
2232655|NCT02688387|5472309|P5|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
2232656|NCT02688387|5472310|P4|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
2232657|NCT02688387|5472311|P3|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
2232658|NCT02688387|5472312|P2|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
2232659|NCT02688387|5472313|P1|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
2232660|NCT02688387|5472292|P22|STARTED|Part 1, Period 1 (up to 6 Days)||0
2232661|NCT02688387|5472293|P21|STARTED|Part 1, Period 1 (up to 6 Days)||0
2232662|NCT02688387|5472294|P20|STARTED|Part 1, Period 1 (up to 6 Days)||0
2232663|NCT02688387|5472295|P19|STARTED|Part 1, Period 1 (up to 6 Days)||0
2232664|NCT02688387|5472296|P18|STARTED|Part 1, Period 1 (up to 6 Days)||0
2232665|NCT02688387|5472297|P17|STARTED|Part 1, Period 1 (up to 6 Days)||0
2232666|NCT02688387|5472298|P16|STARTED|Part 1, Period 1 (up to 6 Days)||0
2232667|NCT02688387|5472299|P15|STARTED|Part 1, Period 1 (up to 6 Days)||0
2232668|NCT02688387|5472300|P14|STARTED|Part 1, Period 1 (up to 6 Days)||0
2232669|NCT02688387|5472301|P13|STARTED|Part 1, Period 1 (up to 6 Days)||0
2232670|NCT02688387|5472302|P12|STARTED|Part 1, Period 1 (up to 6 Days)||0
2232671|NCT02688387|5472303|P11|STARTED|Part 1, Period 1 (up to 6 Days)||0
2232672|NCT02688387|5472304|P10|STARTED|Part 1, Period 1 (up to 6 Days)||2
2232673|NCT02688387|5472305|P9|STARTED|Part 1, Period 1 (up to 6 Days)||2
2232674|NCT02688387|5472306|P8|STARTED|Part 1, Period 1 (up to 6 Days)||2
2232675|NCT02688387|5472307|P7|STARTED|Part 1, Period 1 (up to 6 Days)||2
2232676|NCT02688387|5472308|P6|STARTED|Part 1, Period 1 (up to 6 Days)||2
2232677|NCT02688387|5472309|P5|STARTED|Part 1, Period 1 (up to 6 Days)||3
2232678|NCT02688387|5472310|P4|STARTED|Part 1, Period 1 (up to 6 Days)||3
2232679|NCT02688387|5472311|P3|STARTED|Part 1, Period 1 (up to 6 Days)||4
2232680|NCT02688387|5472312|P2|STARTED|Part 1, Period 1 (up to 6 Days)||3
2232681|NCT02688387|5472313|P1|STARTED|Part 1, Period 1 (up to 6 Days)||3
2232682|NCT02688218|5472572|P2|NOT COMPLETED|Second Exercise Intervention (2 Hours)||0
2232683|NCT02688218|5472573|P1|NOT COMPLETED|Second Exercise Intervention (2 Hours)||0
2232684|NCT02688218|5472572|P2|COMPLETED|Second Exercise Intervention (2 Hours)||6
2232685|NCT02688218|5472573|P1|COMPLETED|Second Exercise Intervention (2 Hours)||24
2232686|NCT02688218|5472572|P2|STARTED|Second Exercise Intervention (2 Hours)||6
2232687|NCT02688218|5472573|P1|STARTED|Second Exercise Intervention (2 Hours)||24
2232688|NCT02688218|5472572|P2|NOT COMPLETED|Washout (30 Minutes)||0
2232689|NCT02688218|5472573|P1|NOT COMPLETED|Washout (30 Minutes)||0
2232690|NCT02688218|5472572|P2|COMPLETED|Washout (30 Minutes)||6
2232691|NCT02688218|5472573|P1|COMPLETED|Washout (30 Minutes)||24
2232692|NCT02688218|5472572|P2|STARTED|Washout (30 Minutes)||6
2232693|NCT02688218|5472573|P1|STARTED|Washout (30 Minutes)||24
2232694|NCT02688218|5472572|P2|NOT COMPLETED|First Exercise Intervention (2 Hours)||0
2232695|NCT02688218|5472573|P1|NOT COMPLETED|First Exercise Intervention (2 Hours)||0
2232696|NCT02688218|5472572|P2|COMPLETED|First Exercise Intervention (2 Hours)||6
2232697|NCT02688218|5472573|P1|COMPLETED|First Exercise Intervention (2 Hours)||24
2232698|NCT02688218|5472572|P2|STARTED|First Exercise Intervention (2 Hours)||6
2232699|NCT02688218|5472573|P1|STARTED|First Exercise Intervention (2 Hours)||24
2232700|NCT02688153|5472581|P2|NOT COMPLETED|Overall Study||7
2232701|NCT02688153|5472582|P1|NOT COMPLETED|Overall Study||15
2232702|NCT02688153|5472581|P2|COMPLETED|Overall Study||51
2232703|NCT02688153|5472582|P1|COMPLETED|Overall Study||47
2232704|NCT02688153|5472581|P2|Final Randomized Arm/Group|Overall Study||61
2232705|NCT02688153|5472582|P1|Final Randomized Arm/Group|Overall Study||59
2232706|NCT02688153|5472581|P2|STARTED|Overall Study||58
2232707|NCT02688153|5472582|P1|STARTED|Overall Study||62
2232708|NCT02687919|5472642|P2|NOT COMPLETED|Overall Study||6
2232709|NCT02687919|5472643|P1|NOT COMPLETED|Overall Study||8
2232710|NCT02687919|5472642|P2|COMPLETED|Overall Study||9
2232711|NCT02687919|5472643|P1|COMPLETED|Overall Study||8
2232712|NCT02687919|5472642|P2|STARTED|Overall Study||15
2232713|NCT02687919|5472643|P1|STARTED|Overall Study||16
2232714|NCT02687542|5472676|P5|NOT COMPLETED|Overall Study||20
2232715|NCT02687542|5472677|P4|NOT COMPLETED|Overall Study||10
2232716|NCT02687542|5472678|P3|NOT COMPLETED|Overall Study||14
2232717|NCT02687542|5472679|P2|NOT COMPLETED|Overall Study||12
2232718|NCT02687542|5472680|P1|NOT COMPLETED|Overall Study||8
2232719|NCT02687542|5472676|P5|COMPLETED|Overall Study||24
2232720|NCT02687542|5472677|P4|COMPLETED|Overall Study||3
2232721|NCT02687542|5472678|P3|COMPLETED|Overall Study||1
2232722|NCT02687542|5472679|P2|COMPLETED|Overall Study||1
2232723|NCT02687542|5472680|P1|COMPLETED|Overall Study||15
2232724|NCT02687542|5472676|P5|STARTED|Overall Study||44
2232725|NCT02687542|5472677|P4|STARTED|Overall Study||13
2232726|NCT02687542|5472678|P3|STARTED|Overall Study||15
2232727|NCT02687542|5472679|P2|STARTED|Overall Study||13
2232728|NCT02687542|5472680|P1|STARTED|Overall Study||23
2232729|NCT02687529|5472754|P2|NOT COMPLETED|Overall Study||0
2232730|NCT02687529|5472755|P1|NOT COMPLETED|Overall Study||0
2232731|NCT02687529|5472754|P2|COMPLETED|Overall Study||32
2232732|NCT02687529|5472755|P1|COMPLETED|Overall Study||34
2232733|NCT02687529|5472754|P2|STARTED|Overall Study||32
2232734|NCT02687529|5472755|P1|STARTED|Overall Study||34
2232735|NCT02687412|5472763|P2|NOT COMPLETED|Overall Study||0
2232736|NCT02687412|5472764|P1|NOT COMPLETED|Overall Study||0
2232737|NCT02687412|5472763|P2|COMPLETED|Overall Study||57
2232738|NCT02687412|5472764|P1|COMPLETED|Overall Study||50
2232739|NCT02687412|5472763|P2|STARTED|Overall Study||57
2232740|NCT02687412|5472764|P1|STARTED|Overall Study||50
2232741|NCT02687217|5472792|P2|NOT COMPLETED|Overall Study||0
2232742|NCT02687217|5472793|P1|NOT COMPLETED|Overall Study||0
2232743|NCT02687217|5472792|P2|COMPLETED|Overall Study||30
2232744|NCT02687217|5472793|P1|COMPLETED|Overall Study||30
2232745|NCT02687217|5472792|P2|STARTED|Overall Study||30
2232746|NCT02687217|5472793|P1|STARTED|Overall Study||30
2232747|NCT02687191|5472809|P6|NOT COMPLETED|Overall Study||1
2232748|NCT02687191|5472810|P5|NOT COMPLETED|Overall Study||1
2232749|NCT02687191|5472811|P4|NOT COMPLETED|Overall Study||1
2232750|NCT02687191|5472812|P3|NOT COMPLETED|Overall Study||1
2232751|NCT02687191|5472813|P2|NOT COMPLETED|Overall Study||1
2232752|NCT02687191|5472814|P1|NOT COMPLETED|Overall Study||0
2232753|NCT02687191|5472809|P6|COMPLETED|Overall Study||2
2232754|NCT02687191|5472810|P5|COMPLETED|Overall Study||2
2232755|NCT02687191|5472811|P4|COMPLETED|Overall Study||5
2232756|NCT02687191|5472812|P3|COMPLETED|Overall Study||2
2232757|NCT02687191|5472813|P2|COMPLETED|Overall Study||2
2232758|NCT02687191|5472814|P1|COMPLETED|Overall Study||3
2232759|NCT02687191|5472809|P6|STARTED|Overall Study||3
2232760|NCT02687191|5472810|P5|STARTED|Overall Study||3
2232761|NCT02687191|5472811|P4|STARTED|Overall Study||6
2232762|NCT02687191|5472812|P3|STARTED|Overall Study||3
2232763|NCT02687191|5472813|P2|STARTED|Overall Study||3
2232764|NCT02687191|5472814|P1|STARTED|Overall Study||3
2232765|NCT02687126|5472948|P1|NOT COMPLETED|Data Analysis||0
2232766|NCT02687126|5472948|P1|COMPLETED|Data Analysis||106
2232767|NCT02687126|5472948|P1|STARTED|Data Analysis||106
2232768|NCT02687126|5472948|P1|NOT COMPLETED|Data Collection||0
2232769|NCT02687126|5472948|P1|COMPLETED|Data Collection||106
2232770|NCT02687126|5472948|P1|STARTED|Data Collection||106
2232771|NCT02686437|5472957|P2|NOT COMPLETED|Overall Study||8
2232772|NCT02686437|5472958|P1|NOT COMPLETED|Overall Study||3
2232773|NCT02686437|5472957|P2|COMPLETED|Overall Study||12
2232774|NCT02686437|5472958|P1|COMPLETED|Overall Study||13
2232775|NCT02686437|5472957|P2|STARTED|Overall Study||20
2232776|NCT02686437|5472958|P1|STARTED|Overall Study||16
2232777|NCT02686164|5472966|P1|NOT COMPLETED|Overall Study||3
2232778|NCT02686164|5472966|P1|COMPLETED|Overall Study||27
2232779|NCT02686164|5472966|P1|STARTED|Overall Study||30
2232780|NCT02686034|5472978|P2|NOT COMPLETED|Open Label Period 3||1
2232781|NCT02686034|5472979|P1|NOT COMPLETED|Open Label Period 3||0
2232782|NCT02686034|5472978|P2|COMPLETED|Open Label Period 3||121
2232783|NCT02686034|5472979|P1|COMPLETED|Open Label Period 3||117
2232784|NCT02686034|5472978|P2|STARTED|Open Label Period 3||122
2232785|NCT02686034|5472979|P1|STARTED|Open Label Period 3||117
2232786|NCT02686034|5472978|P2|NOT COMPLETED|Randomized Controlled Period 2||4
2232787|NCT02686034|5472979|P1|NOT COMPLETED|Randomized Controlled Period 2||5
2232788|NCT02686034|5472978|P2|COMPLETED|Randomized Controlled Period 2||122
2232789|NCT02686034|5472979|P1|COMPLETED|Randomized Controlled Period 2||117
2232790|NCT02686034|5472978|P2|STARTED|Randomized Controlled Period 2||126
2232791|NCT02686034|5472979|P1|STARTED|Randomized Controlled Period 2||122
2232792|NCT02686034|5472978|P2|NOT COMPLETED|Run-In Period 1||17
2232793|NCT02686034|5472979|P1|NOT COMPLETED|Run-In Period 1||20
2232794|NCT02686034|5472978|P2|COMPLETED|Run-In Period 1||126
2232795|NCT02686034|5472979|P1|COMPLETED|Run-In Period 1||122
2232796|NCT02686034|5472978|P2|STARTED|Run-In Period 1||143
2232797|NCT02686034|5472979|P1|STARTED|Run-In Period 1||142
2232798|NCT02685826|5473018|P3|NOT COMPLETED|Overall Study||21
2232799|NCT02685826|5473019|P2|NOT COMPLETED|Overall Study||10
2232800|NCT02685826|5473020|P1|NOT COMPLETED|Overall Study||25
2232801|NCT02685826|5473018|P3|COMPLETED|Overall Study||0
2232802|NCT02685826|5473019|P2|COMPLETED|Overall Study||0
2232803|NCT02685826|5473020|P1|COMPLETED|Overall Study||0
2232804|NCT02685826|5473018|P3|STARTED|Overall Study||21
2232805|NCT02685826|5473019|P2|STARTED|Overall Study||10
2232806|NCT02685826|5473020|P1|STARTED|Overall Study||25
2232807|NCT02685488|5473105|P2|NOT COMPLETED|Overall Study||1
2232808|NCT02685488|5473106|P1|NOT COMPLETED|Overall Study||0
2232809|NCT02685488|5473105|P2|COMPLETED|Overall Study||13
2232810|NCT02685488|5473106|P1|COMPLETED|Overall Study||12
2232811|NCT02685488|5473105|P2|STARTED|Overall Study||14
2232812|NCT02685488|5473106|P1|STARTED|Overall Study||12
2232813|NCT02685436|5473120|P1|NOT COMPLETED|Overall Study||14
2232814|NCT02685436|5473120|P1|COMPLETED|Overall Study|GERD positive patients by either combined MII-pH or esophageal biopsy|38
2232815|NCT02685436|5473120|P1|STARTED|Overall Study|the overall studied group|52
2232816|NCT02685293|5473124|P2|NOT COMPLETED|Treatment Period 2||0
2232817|NCT02685293|5473125|P1|NOT COMPLETED|Treatment Period 2||0
2232818|NCT02685293|5473124|P2|COMPLETED|Treatment Period 2||3
2232819|NCT02685293|5473125|P1|COMPLETED|Treatment Period 2||1
2232820|NCT02685293|5473124|P2|STARTED|Treatment Period 2||3
2232821|NCT02685293|5473125|P1|STARTED|Treatment Period 2||1
2232822|NCT02685293|5473124|P2|NOT COMPLETED|Washout Period||0
2232823|NCT02685293|5473125|P1|NOT COMPLETED|Washout Period||0
2232824|NCT02685293|5473124|P2|COMPLETED|Washout Period||3
2232825|NCT02685293|5473125|P1|COMPLETED|Washout Period||1
2232826|NCT02685293|5473124|P2|STARTED|Washout Period||3
2232827|NCT02685293|5473125|P1|STARTED|Washout Period||1
2232828|NCT02685293|5473124|P2|NOT COMPLETED|Treatment Period 1||0
2232829|NCT02685293|5473125|P1|NOT COMPLETED|Treatment Period 1||0
2232830|NCT02685293|5473124|P2|COMPLETED|Treatment Period 1||3
2232831|NCT02685293|5473125|P1|COMPLETED|Treatment Period 1||1
2232832|NCT02685293|5473124|P2|STARTED|Treatment Period 1||3
2232833|NCT02685293|5473125|P1|STARTED|Treatment Period 1||1
2232834|NCT02685202|5473159|P1|NOT COMPLETED|Overall Study||9
2232835|NCT02685202|5473159|P1|COMPLETED|Overall Study||0
2232836|NCT02685202|5473159|P1|STARTED|Overall Study||9
2232837|NCT02685072|5473167|P2|NOT COMPLETED|3-Month Follow-Up||0
2232838|NCT02685072|5473168|P1|NOT COMPLETED|3-Month Follow-Up||0
2232839|NCT02685072|5473167|P2|COMPLETED|3-Month Follow-Up||22
2232840|NCT02685072|5473168|P1|COMPLETED|3-Month Follow-Up||19
2232841|NCT02685072|5473167|P2|STARTED|3-Month Follow-Up||22
2232842|NCT02685072|5473168|P1|STARTED|3-Month Follow-Up||19
2232843|NCT02685072|5473167|P2|NOT COMPLETED|1-Month Follow-Up||0
2232844|NCT02685072|5473168|P1|NOT COMPLETED|1-Month Follow-Up||1
2232845|NCT02685072|5473167|P2|COMPLETED|1-Month Follow-Up||22
2232846|NCT02685072|5473168|P1|COMPLETED|1-Month Follow-Up||19
2232847|NCT02685072|5473167|P2|STARTED|1-Month Follow-Up||22
2232848|NCT02685072|5473168|P1|STARTED|1-Month Follow-Up||20
2232849|NCT02685072|5473167|P2|NOT COMPLETED|Treatment Period||9
2232850|NCT02685072|5473168|P1|NOT COMPLETED|Treatment Period||13
2232851|NCT02685072|5473167|P2|COMPLETED|Treatment Period||22
2232852|NCT02685072|5473168|P1|COMPLETED|Treatment Period||20
2232853|NCT02685072|5473167|P2|Completed Week 8 Visit|Treatment Period|Week 8 data were collected at the 1-month follow-up for 1 participant|22
2232854|NCT02685072|5473168|P1|Completed Week 8 Visit|Treatment Period||20
2232855|NCT02685072|5473167|P2|Completed Week 7 Visit|Treatment Period||18
2232856|NCT02685072|5473168|P1|Completed Week 7 Visit|Treatment Period||17
2232857|NCT02685072|5473167|P2|Completed Week 6 Visit|Treatment Period||19
2232858|NCT02685072|5473168|P1|Completed Week 6 Visit|Treatment Period||18
2232859|NCT02685072|5473167|P2|Completed Week 5 Visit|Treatment Period||22
2232860|NCT02685072|5473168|P1|Completed Week 5 Visit|Treatment Period||19
2232861|NCT02685072|5473167|P2|Completed Week 4 Visit|Treatment Period||23
2232862|NCT02685072|5473168|P1|Completed Week 4 Visit|Treatment Period||19
2232863|NCT02685072|5473167|P2|Completed Week 3 Visit|Treatment Period||23
2232864|NCT02685072|5473168|P1|Completed Week 3 Visit|Treatment Period||20
2232865|NCT02685072|5473167|P2|Completed Week 2 Visit|Treatment Period||26
2232866|NCT02685072|5473168|P1|Completed Week 2 Visit|Treatment Period||23
2232867|NCT02685072|5473167|P2|STARTED|Treatment Period||31
2232868|NCT02685072|5473168|P1|STARTED|Treatment Period||33
2232869|NCT02685033|5473212|P2|NOT COMPLETED|Overall Study||2
2232870|NCT02685033|5473213|P1|NOT COMPLETED|Overall Study||3
2232871|NCT02685033|5473212|P2|COMPLETED|Overall Study||8
2232872|NCT02685033|5473213|P1|COMPLETED|Overall Study||67
2232873|NCT02685033|5473212|P2|STARTED|Overall Study||10
2232874|NCT02685033|5473213|P1|STARTED|Overall Study||70
2232875|NCT02684981|5473242|P3|NOT COMPLETED|Overall Study||127
2232876|NCT02684981|5473243|P2|NOT COMPLETED|Overall Study||210
2232877|NCT02684981|5473244|P1|NOT COMPLETED|Overall Study||240
2232878|NCT02684981|5473242|P3|COMPLETED|Overall Study||2059
2232879|NCT02684981|5473243|P2|COMPLETED|Overall Study||2969
2232880|NCT02684981|5473244|P1|COMPLETED|Overall Study||3860
2232881|NCT02684981|5473242|P3|STARTED|Overall Study||2186
2232882|NCT02684981|5473243|P2|STARTED|Overall Study||3179
2232883|NCT02684981|5473244|P1|STARTED|Overall Study||4100
2232884|NCT02684942|5473280|P6|NOT COMPLETED|Overall Study||0
2232885|NCT02684942|5473281|P5|NOT COMPLETED|Overall Study||0
2232886|NCT02684942|5473282|P4|NOT COMPLETED|Overall Study||0
2232887|NCT02684942|5473283|P3|NOT COMPLETED|Overall Study||0
2232888|NCT02684942|5473284|P2|NOT COMPLETED|Overall Study||0
2232889|NCT02684942|5473285|P1|NOT COMPLETED|Overall Study||0
2232890|NCT02684942|5473280|P6|COMPLETED|Overall Study||6
2232891|NCT02684942|5473281|P5|COMPLETED|Overall Study||6
2232892|NCT02684942|5473282|P4|COMPLETED|Overall Study||7
2232893|NCT02684942|5473283|P3|COMPLETED|Overall Study||7
2232894|NCT02684942|5473284|P2|COMPLETED|Overall Study||7
2232895|NCT02684942|5473285|P1|COMPLETED|Overall Study||7
2232896|NCT02684942|5473280|P6|STARTED|Overall Study||6
2232897|NCT02684942|5473281|P5|STARTED|Overall Study||6
2232898|NCT02684942|5473282|P4|STARTED|Overall Study||7
2232899|NCT02684942|5473283|P3|STARTED|Overall Study||7
2232900|NCT02684942|5473284|P2|STARTED|Overall Study||7
2232901|NCT02684942|5473285|P1|STARTED|Overall Study||7
2232902|NCT02684630|5473301|P2|NOT COMPLETED|Overall Study||3
2232903|NCT02684630|5473302|P1|NOT COMPLETED|Overall Study||5
2232904|NCT02684630|5473301|P2|COMPLETED|Overall Study||60
2232905|NCT02684630|5473302|P1|COMPLETED|Overall Study||60
2232906|NCT02684630|5473301|P2|STARTED|Overall Study||63
2232907|NCT02684630|5473302|P1|STARTED|Overall Study||65
2232908|NCT02684604|5473312|P2|NOT COMPLETED|Overall Study||0
2232909|NCT02684604|5473313|P1|NOT COMPLETED|Overall Study||0
2232910|NCT02684604|5473312|P2|COMPLETED|Overall Study||44
2232911|NCT02684604|5473313|P1|COMPLETED|Overall Study||44
2232912|NCT02684604|5473312|P2|STARTED|Overall Study||44
2232913|NCT02684604|5473313|P1|STARTED|Overall Study||44
2232914|NCT02684591|5473321|P2|NOT COMPLETED|Overall Study||3
2232915|NCT02684591|5473322|P1|NOT COMPLETED|Overall Study||1
2232916|NCT02684591|5473321|P2|COMPLETED|Overall Study||22
2232917|NCT02684591|5473322|P1|COMPLETED|Overall Study||24
2232918|NCT02684591|5473321|P2|STARTED|Overall Study||25
2232919|NCT02684591|5473322|P1|STARTED|Overall Study||25
2232920|NCT02684435|5473330|P1|NOT COMPLETED|Overall Study||0
2232921|NCT02684435|5473330|P1|COMPLETED|Overall Study||63
2232922|NCT02684435|5473330|P1|STARTED|Overall Study||63
2232923|NCT02684396|5473344|P6|NOT COMPLETED|Overall Study||0
2232924|NCT02684396|5473345|P5|NOT COMPLETED|Overall Study||0
2232925|NCT02684396|5473346|P4|NOT COMPLETED|Overall Study||0
2232926|NCT02684396|5473347|P3|NOT COMPLETED|Overall Study||0
2232927|NCT02684396|5473348|P2|NOT COMPLETED|Overall Study||0
2232928|NCT02684396|5473349|P1|NOT COMPLETED|Overall Study||0
2232929|NCT02684396|5473344|P6|COMPLETED|Overall Study||10
2232930|NCT02684396|5473345|P5|COMPLETED|Overall Study||5
2232931|NCT02684396|5473346|P4|COMPLETED|Overall Study||6
2232932|NCT02684396|5473347|P3|COMPLETED|Overall Study||6
2232933|NCT02684396|5473348|P2|COMPLETED|Overall Study||6
2232934|NCT02684396|5473349|P1|COMPLETED|Overall Study||6
2232935|NCT02684396|5473344|P6|STARTED|Overall Study||10
2232936|NCT02684396|5473345|P5|STARTED|Overall Study||5
2232937|NCT02684396|5473346|P4|STARTED|Overall Study||6
2232938|NCT02684396|5473347|P3|STARTED|Overall Study||6
2232939|NCT02684396|5473348|P2|STARTED|Overall Study||6
2232940|NCT02684396|5473349|P1|STARTED|Overall Study||6
2232941|NCT02684370|5473404|P6|NOT COMPLETED|Part B||8
2232942|NCT02684370|5473405|P5|NOT COMPLETED|Part B||5
2232943|NCT02684370|5473406|P4|NOT COMPLETED|Part B||2
2232944|NCT02684370|5473407|P3|NOT COMPLETED|Part B||0
2232945|NCT02684370|5473408|P2|NOT COMPLETED|Part B||0
2232946|NCT02684370|5473409|P1|NOT COMPLETED|Part B||0
2232947|NCT02684370|5473404|P6|COMPLETED|Part B||289
2232948|NCT02684370|5473405|P5|COMPLETED|Part B||94
2232949|NCT02684370|5473406|P4|COMPLETED|Part B||95
2232950|NCT02684370|5473407|P3|COMPLETED|Part B||0
2232951|NCT02684370|5473408|P2|COMPLETED|Part B||0
2232952|NCT02684370|5473409|P1|COMPLETED|Part B||0
2232953|NCT02684370|5473404|P6|STARTED|Part B|2 participants who received risankizumab in Part A did not receive a dose of study drug in Part B|297
2232954|NCT02684370|5473405|P5|STARTED|Part B|Participants who received ustekinumab in Part A received ustekinumab in Part B|99
2232955|NCT02684370|5473406|P4|STARTED|Part B|1 participant who received placebo in Part A did not receive a dose of study drug in Part B|97
2232956|NCT02684370|5473407|P3|STARTED|Part B||0
2232957|NCT02684370|5473408|P2|STARTED|Part B||0
2232958|NCT02684370|5473409|P1|STARTED|Part B||0
2232959|NCT02684370|5473404|P6|NOT COMPLETED|Part A||0
2232960|NCT02684370|5473405|P5|NOT COMPLETED|Part A||0
2232961|NCT02684370|5473406|P4|NOT COMPLETED|Part A||0
2232962|NCT02684370|5473407|P3|NOT COMPLETED|Part A||5
2232963|NCT02684370|5473408|P2|NOT COMPLETED|Part A||1
2232964|NCT02684370|5473409|P1|NOT COMPLETED|Part A||4
2232965|NCT02684370|5473404|P6|COMPLETED|Part A||0
2232966|NCT02684370|5473405|P5|COMPLETED|Part A||0
2232967|NCT02684370|5473406|P4|COMPLETED|Part A||0
2232968|NCT02684370|5473407|P3|COMPLETED|Part A||299
2232969|NCT02684370|5473408|P2|COMPLETED|Part A||99
2232970|NCT02684370|5473409|P1|COMPLETED|Part A||98
2232971|NCT02684370|5473404|P6|STARTED|Part A||0
2232972|NCT02684370|5473405|P5|STARTED|Part A||0
2232973|NCT02684370|5473406|P4|STARTED|Part A||0
2232974|NCT02684370|5473407|P3|STARTED|Part A||304
2232975|NCT02684370|5473408|P2|STARTED|Part A||100
2232976|NCT02684370|5473409|P1|STARTED|Part A||102
2232977|NCT02684357|5473454|P6|NOT COMPLETED|Part B||13
2232978|NCT02684357|5473455|P5|NOT COMPLETED|Part B||4
2232979|NCT02684357|5473456|P4|NOT COMPLETED|Part B||3
2232980|NCT02684357|5473457|P3|NOT COMPLETED|Part B||0
2232981|NCT02684357|5473458|P2|NOT COMPLETED|Part B||0
2232982|NCT02684357|5473459|P1|NOT COMPLETED|Part B||0
2232983|NCT02684357|5473454|P6|COMPLETED|Part B||278
2232984|NCT02684357|5473455|P5|COMPLETED|Part B||90
2232985|NCT02684357|5473456|P4|COMPLETED|Part B||91
2232986|NCT02684357|5473457|P3|COMPLETED|Part B||0
2232987|NCT02684357|5473458|P2|COMPLETED|Part B||0
2232988|NCT02684357|5473459|P1|COMPLETED|Part B||0
2232989|NCT02684357|5473454|P6|STARTED|Part B|1 participant who received risankizumab in Part A did not receive a dose of study drug in Part B|291
2232990|NCT02684357|5473455|P5|STARTED|Part B|2 participants who received ustekinumab in Part A did not receive a dose of study drug in Part B.|94
2232991|NCT02684357|5473456|P4|STARTED|Part B|Participants who received placebo in Part A received risankizumab in Part B|94
2232992|NCT02684357|5473457|P3|STARTED|Part B||0
2232993|NCT02684357|5473458|P2|STARTED|Part B||0
2232994|NCT02684357|5473459|P1|STARTED|Part B||0
2232995|NCT02684357|5473454|P6|NOT COMPLETED|Part A||0
2232996|NCT02684357|5473455|P5|NOT COMPLETED|Part A||0
2232997|NCT02684357|5473456|P4|NOT COMPLETED|Part A||0
2232998|NCT02684357|5473457|P3|NOT COMPLETED|Part A||2
2232999|NCT02684357|5473458|P2|NOT COMPLETED|Part A||3
2233000|NCT02684357|5473459|P1|NOT COMPLETED|Part A||4
2233001|NCT02684357|5473454|P6|COMPLETED|Part A||0
2233002|NCT02684357|5473455|P5|COMPLETED|Part A||0
2233003|NCT02684357|5473456|P4|COMPLETED|Part A||0
2233004|NCT02684357|5473457|P3|COMPLETED|Part A||292
2233005|NCT02684357|5473458|P2|COMPLETED|Part A||96
2233006|NCT02684357|5473459|P1|COMPLETED|Part A||94
2233007|NCT02684357|5473454|P6|STARTED|Part A||0
2233008|NCT02684357|5473455|P5|STARTED|Part A||0
2233009|NCT02684357|5473456|P4|STARTED|Part A||0
2233010|NCT02684357|5473457|P3|STARTED|Part A||294
2233011|NCT02684357|5473458|P2|STARTED|Part A||99
2233012|NCT02684357|5473459|P1|STARTED|Part A||98
2233013|NCT02684344|5473509|P2|NOT COMPLETED|Overall Study||1
2233014|NCT02684344|5473510|P1|NOT COMPLETED|Overall Study||0
2233015|NCT02684344|5473509|P2|COMPLETED|Overall Study||3
2233016|NCT02684344|5473510|P1|COMPLETED|Overall Study||1
2233017|NCT02684344|5473509|P2|STARTED|Overall Study||4
2233018|NCT02684344|5473510|P1|STARTED|Overall Study||1
2233019|NCT02684188|5473518|P2|NOT COMPLETED|Overall Study||3
2233020|NCT02684188|5473519|P1|NOT COMPLETED|Overall Study||2
2233021|NCT02684188|5473518|P2|COMPLETED|Overall Study||47
2233022|NCT02684188|5473519|P1|COMPLETED|Overall Study||75
2233023|NCT02684188|5473518|P2|STARTED|Overall Study||50
2233024|NCT02684188|5473519|P1|STARTED|Overall Study||77
2233025|NCT02684097|5473545|P2|NOT COMPLETED|Overall Study||6
2233026|NCT02684097|5473546|P1|NOT COMPLETED|Overall Study||13
2233027|NCT02684097|5473545|P2|COMPLETED|Overall Study||1
2233028|NCT02684097|5473546|P1|COMPLETED|Overall Study||2
2233029|NCT02684097|5473545|P2|STARTED|Overall Study||7
2233030|NCT02684097|5473546|P1|STARTED|Overall Study||15
2233031|NCT02683954|5473564|P2|NOT COMPLETED|Overall Study||0
2233032|NCT02683954|5473565|P1|NOT COMPLETED|Overall Study||0
2233033|NCT02683954|5473564|P2|COMPLETED|Overall Study||30
2233034|NCT02683954|5473565|P1|COMPLETED|Overall Study||30
2233035|NCT02683954|5473564|P2|STARTED|Overall Study||30
2233036|NCT02683954|5473565|P1|STARTED|Overall Study||30
2233037|NCT02683785|5473573|P2|NOT COMPLETED|Overall Study||4
2233038|NCT02683785|5473574|P1|NOT COMPLETED|Overall Study||1
2233039|NCT02683785|5473573|P2|COMPLETED|Overall Study||18
2233040|NCT02683785|5473574|P1|COMPLETED|Overall Study||21
2233041|NCT02683785|5473573|P2|STARTED|Overall Study||22
2233042|NCT02683785|5473574|P1|STARTED|Overall Study||22
2233043|NCT02683772|5473614|P2|NOT COMPLETED|Overall Study||0
2233044|NCT02683772|5473615|P1|NOT COMPLETED|Overall Study||0
2233045|NCT02683772|5473614|P2|COMPLETED|Overall Study||23
2233046|NCT02683772|5473615|P1|COMPLETED|Overall Study||15
2233047|NCT02683772|5473614|P2|STARTED|Overall Study||23
2233048|NCT02683772|5473615|P1|STARTED|Overall Study||15
2233049|NCT02683746|5473631|P2|NOT COMPLETED|Overall Study||14
2233050|NCT02683746|5473632|P1|NOT COMPLETED|Overall Study||16
2233051|NCT02683746|5473631|P2|COMPLETED|Overall Study||140
2233052|NCT02683746|5473632|P1|COMPLETED|Overall Study||138
2233053|NCT02683746|5473631|P2|STARTED|Overall Study||154
2233054|NCT02683746|5473632|P1|STARTED|Overall Study||154
2233055|NCT02683707|5473662|P2|NOT COMPLETED|Overall Study||0
2233056|NCT02683707|5473663|P1|NOT COMPLETED|Overall Study||0
2233057|NCT02683707|5473662|P2|COMPLETED|Overall Study||107
2233058|NCT02683707|5473663|P1|COMPLETED|Overall Study||105
2233059|NCT02683707|5473662|P2|STARTED|Overall Study||107
2233060|NCT02683707|5473663|P1|STARTED|Overall Study||105
2233061|NCT02683668|5473675|P3|NOT COMPLETED|Period 3||0
2233062|NCT02683668|5473676|P2|NOT COMPLETED|Period 3||0
2233063|NCT02683668|5473677|P1|NOT COMPLETED|Period 3||0
2233064|NCT02683668|5473675|P3|COMPLETED|Period 3||43
2233065|NCT02683668|5473676|P2|COMPLETED|Period 3||0
2233066|NCT02683668|5473677|P1|COMPLETED|Period 3||0
2233067|NCT02683668|5473675|P3|STARTED|Period 3||43
2233068|NCT02683668|5473676|P2|STARTED|Period 3||0
2233069|NCT02683668|5473677|P1|STARTED|Period 3||0
2233070|NCT02683668|5473675|P3|NOT COMPLETED|Period 2||0
2233071|NCT02683668|5473676|P2|NOT COMPLETED|Period 2||1
2233072|NCT02683668|5473677|P1|NOT COMPLETED|Period 2||0
2233073|NCT02683668|5473675|P3|COMPLETED|Period 2||0
2233074|NCT02683668|5473676|P2|COMPLETED|Period 2||43
2233075|NCT02683668|5473677|P1|COMPLETED|Period 2||0
2233076|NCT02683668|5473675|P3|STARTED|Period 2||0
2233077|NCT02683668|5473676|P2|STARTED|Period 2||44
2233078|NCT02683668|5473677|P1|STARTED|Period 2||0
2233079|NCT02683668|5473675|P3|NOT COMPLETED|Period 1||0
2233080|NCT02683668|5473676|P2|NOT COMPLETED|Period 1||0
2233081|NCT02683668|5473677|P1|NOT COMPLETED|Period 1||0
2233082|NCT02683668|5473675|P3|COMPLETED|Period 1||0
2233083|NCT02683668|5473676|P2|COMPLETED|Period 1||0
2233084|NCT02683668|5473677|P1|COMPLETED|Period 1||44
2233085|NCT02683668|5473675|P3|STARTED|Period 1||0
2233086|NCT02683668|5473676|P2|STARTED|Period 1||0
2233087|NCT02683668|5473677|P1|STARTED|Period 1||44
2233088|NCT02683577|5473695|P3|NOT COMPLETED|Overall Study||0
2233089|NCT02683577|5473696|P2|NOT COMPLETED|Overall Study||0
2233090|NCT02683577|5473697|P1|NOT COMPLETED|Overall Study||0
2233091|NCT02683577|5473695|P3|COMPLETED|Overall Study||8
2233092|NCT02683577|5473696|P2|COMPLETED|Overall Study||8
2233093|NCT02683577|5473697|P1|COMPLETED|Overall Study||8
2233094|NCT02683577|5473695|P3|STARTED|Overall Study||8
2233095|NCT02683577|5473696|P2|STARTED|Overall Study||8
2233096|NCT02683577|5473697|P1|STARTED|Overall Study||8
2233097|NCT02683421|5473747|P4|NOT COMPLETED|Overall Study||0
2233098|NCT02683421|5473748|P3|NOT COMPLETED|Overall Study||0
2233099|NCT02683421|5473749|P2|NOT COMPLETED|Overall Study||0
2233100|NCT02683421|5473750|P1|NOT COMPLETED|Overall Study||0
2233101|NCT02683421|5473747|P4|COMPLETED|Overall Study||5
2233102|NCT02683421|5473748|P3|COMPLETED|Overall Study||4
2233103|NCT02683421|5473749|P2|COMPLETED|Overall Study||4
2233104|NCT02683421|5473750|P1|COMPLETED|Overall Study||5
2233105|NCT02683421|5473747|P4|STARTED|Overall Study||5
2233106|NCT02683421|5473748|P3|STARTED|Overall Study||4
2233107|NCT02683421|5473749|P2|STARTED|Overall Study||4
2233108|NCT02683421|5473750|P1|STARTED|Overall Study||5
2233109|NCT02683174|5473768|P1|NOT COMPLETED|Overall Study||0
2233110|NCT02683174|5473768|P1|COMPLETED|Overall Study||86
2233111|NCT02683174|5473768|P1|STARTED|Overall Study||86
2233112|NCT02683161|5473778|P1|NOT COMPLETED|Overall Study||0
2233113|NCT02683161|5473778|P1|COMPLETED|Overall Study||5
2233114|NCT02683161|5473778|P1|STARTED|Overall Study||5
2233115|NCT02683109|5473784|P2|NOT COMPLETED|Overall Study||0
2233116|NCT02683109|5473785|P1|NOT COMPLETED|Overall Study||1
2233117|NCT02683109|5473784|P2|COMPLETED|Overall Study||111
2233118|NCT02683109|5473785|P1|COMPLETED|Overall Study||109
2233119|NCT02683109|5473784|P2|STARTED|Overall Study||111
2233120|NCT02683109|5473785|P1|STARTED|Overall Study||110
2233121|NCT02683083|5473796|P1|NOT COMPLETED|Overall Study||0
2233122|NCT02683083|5473796|P1|COMPLETED|Overall Study||9
2233123|NCT02683083|5473796|P1|STARTED|Overall Study||9
2233124|NCT02682823|5473806|P5|NOT COMPLETED|Overall Study||1
2233125|NCT02682823|5473807|P4|NOT COMPLETED|Overall Study||1
2233126|NCT02682823|5473808|P3|NOT COMPLETED|Overall Study||1
2233127|NCT02682823|5473809|P2|NOT COMPLETED|Overall Study||1
2233128|NCT02682823|5473810|P1|NOT COMPLETED|Overall Study||0
2233129|NCT02682823|5473806|P5|COMPLETED|Overall Study||18
2233130|NCT02682823|5473807|P4|COMPLETED|Overall Study||16
2233131|NCT02682823|5473808|P3|COMPLETED|Overall Study||18
2233132|NCT02682823|5473809|P2|COMPLETED|Overall Study||18
2233133|NCT02682823|5473810|P1|COMPLETED|Overall Study||17
2233134|NCT02682823|5473806|P5|Safety Population|Overall Study|All participants who received at least one dose of study drug.|19
2233135|NCT02682823|5473807|P4|Safety Population|Overall Study|All participants who received at least one dose of study drug.|17
2233136|NCT02682823|5473808|P3|Safety Population|Overall Study|All participants who received at least one dose of study drug.|18
2233137|NCT02682823|5473809|P2|Safety Population|Overall Study|All HCPs who administered at least one dose of study drug.|19
2233138|NCT02682823|5473810|P1|Safety Population|Overall Study|All CGs who administered at least one dose of study drug.|17
2233139|NCT02682823|5473806|P5|STARTED|Overall Study||19
2233140|NCT02682823|5473807|P4|STARTED|Overall Study||17
2233141|NCT02682823|5473808|P3|STARTED|Overall Study||19
2233142|NCT02682823|5473809|P2|STARTED|Overall Study||19
2233143|NCT02682823|5473810|P1|STARTED|Overall Study||17
2233144|NCT02682602|5473846|P2|NOT COMPLETED|Post-operative Fluoroscopy for Implanted||0
2233145|NCT02682602|5473847|P1|NOT COMPLETED|Post-operative Fluoroscopy for Implanted||3
2233146|NCT02682602|5473846|P2|COMPLETED|Post-operative Fluoroscopy for Implanted|Nonimplanted subjects were not analyzed again for the second period, because this would be redundant|0
2233147|NCT02682602|5473847|P1|COMPLETED|Post-operative Fluoroscopy for Implanted||7
2233148|NCT02682602|5473846|P2|STARTED|Post-operative Fluoroscopy for Implanted||0
2233149|NCT02682602|5473847|P1|STARTED|Post-operative Fluoroscopy for Implanted||10
2233150|NCT02682602|5473846|P2|NOT COMPLETED|Pre-operative Diseased & Normal Hips||0
2233151|NCT02682602|5473847|P1|NOT COMPLETED|Pre-operative Diseased & Normal Hips||1
2233152|NCT02682602|5473846|P2|COMPLETED|Pre-operative Diseased & Normal Hips||10
2233153|NCT02682602|5473847|P1|COMPLETED|Pre-operative Diseased & Normal Hips||10
2233154|NCT02682602|5473846|P2|STARTED|Pre-operative Diseased & Normal Hips||10
2233155|NCT02682602|5473847|P1|STARTED|Pre-operative Diseased & Normal Hips||11
2233156|NCT02682498|5473866|P2|NOT COMPLETED|Overall Study||0
2233157|NCT02682498|5473867|P1|NOT COMPLETED|Overall Study||0
2233158|NCT02682498|5473866|P2|COMPLETED|Overall Study||20
2233159|NCT02682498|5473867|P1|COMPLETED|Overall Study||18
2233160|NCT02682498|5473866|P2|STARTED|Overall Study||20
2233161|NCT02682498|5473867|P1|STARTED|Overall Study||18
2233162|NCT02682381|5473884|P3|NOT COMPLETED|Overall Study||0
2233163|NCT02682381|5473885|P2|NOT COMPLETED|Overall Study||0
2233164|NCT02682381|5473886|P1|NOT COMPLETED|Overall Study||0
2233165|NCT02682381|5473884|P3|COMPLETED|Overall Study||9
2233166|NCT02682381|5473885|P2|COMPLETED|Overall Study||26
2233167|NCT02682381|5473886|P1|COMPLETED|Overall Study||24
2233168|NCT02682381|5473884|P3|STARTED|Overall Study||9
2233169|NCT02682381|5473885|P2|STARTED|Overall Study||26
2233170|NCT02682381|5473886|P1|STARTED|Overall Study||24
2233174|NCT02682056|5473955|P1|NOT COMPLETED|Overall Study||0
2233175|NCT02682056|5473955|P1|COMPLETED|Overall Study||15
2233176|NCT02682056|5473955|P1|STARTED|Overall Study||15
2233177|NCT02681757|5473971|P2|NOT COMPLETED|Overall Study||0
2233178|NCT02681757|5473972|P1|NOT COMPLETED|Overall Study||0
2233179|NCT02681757|5473971|P2|COMPLETED|Overall Study||49
2233180|NCT02681757|5473972|P1|COMPLETED|Overall Study||47
2233181|NCT02681757|5473971|P2|STARTED|Overall Study||49
2233182|NCT02681757|5473972|P1|STARTED|Overall Study||47
2233183|NCT02681510|5473982|P1|NOT COMPLETED|Overall Study||10
2233184|NCT02681510|5473982|P1|COMPLETED|Overall Study||26
2233185|NCT02681510|5473982|P1|STARTED|Overall Study||36
2233186|NCT02681458|5473991|P2|NOT COMPLETED|Overall Study||656
2233187|NCT02681458|5473992|P1|NOT COMPLETED|Overall Study||645
2233188|NCT02681458|5473991|P2|COMPLETED|Overall Study||62
2233189|NCT02681458|5473992|P1|COMPLETED|Overall Study||73
2233190|NCT02681458|5473991|P2|STARTED|Overall Study||718
2233191|NCT02681458|5473992|P1|STARTED|Overall Study||718
2233192|NCT02681172|5473998|P1|NOT COMPLETED|Overall Study||13
2233193|NCT02681172|5473998|P1|COMPLETED|Overall Study||205
2233194|NCT02681172|5473998|P1|Per Protocol Set|Overall Study||205
2233195|NCT02681172|5473998|P1|Full Analysis Set|Overall Study||205
2233196|NCT02681172|5473998|P1|Safety Analysis Set|Overall Study||205
2233197|NCT02681172|5473998|P1|STARTED|Overall Study||218
2233198|NCT02681094|5474012|P3|NOT COMPLETED|2 - Enrolled Participants Set||54
2233199|NCT02681094|5474013|P2|NOT COMPLETED|2 - Enrolled Participants Set||41
2233200|NCT02681094|5474014|P1|NOT COMPLETED|2 - Enrolled Participants Set||40
2233201|NCT02681094|5474012|P3|COMPLETED|2 - Enrolled Participants Set||248
2233202|NCT02681094|5474013|P2|COMPLETED|2 - Enrolled Participants Set||261
2233203|NCT02681094|5474014|P1|COMPLETED|2 - Enrolled Participants Set||261
2233204|NCT02681094|5474012|P3|Participants Completed Treatment Period|2 - Enrolled Participants Set|A participant was randomized but did not receive treatment due to screen failure.|289
2233205|NCT02681094|5474013|P2|Participants Completed Treatment Period|2 - Enrolled Participants Set|A participant was randomized but did not receive treatment due to screen failure.|284
2233206|NCT02681094|5474014|P1|Participants Completed Treatment Period|2 - Enrolled Participants Set||281
2233207|NCT02681094|5474012|P3|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|302
2233208|NCT02681094|5474013|P2|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|302
2233209|NCT02681094|5474014|P1|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|301
2233210|NCT02681094|5474012|P3|NOT COMPLETED|1 -Modified Enrolled Participants Set||53
2233211|NCT02681094|5474013|P2|NOT COMPLETED|1 -Modified Enrolled Participants Set||39
2233212|NCT02681094|5474014|P1|NOT COMPLETED|1 -Modified Enrolled Participants Set||37
2233213|NCT02681094|5474012|P3|COMPLETED|1 -Modified Enrolled Participants Set||243
2233214|NCT02681094|5474013|P2|COMPLETED|1 -Modified Enrolled Participants Set||255
2233215|NCT02681094|5474014|P1|COMPLETED|1 -Modified Enrolled Participants Set||256
2233216|NCT02681094|5474012|P3|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||283
2233217|NCT02681094|5474013|P2|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||276
2233218|NCT02681094|5474014|P1|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||273
2233219|NCT02681094|5474012|P3|STARTED|1 -Modified Enrolled Participants Set|A participant was randomized but did not receive treatment|296
2233220|NCT02681094|5474013|P2|STARTED|1 -Modified Enrolled Participants Set|A participant was randomized but did not receive treatment|294
2233221|NCT02681094|5474014|P1|STARTED|1 -Modified Enrolled Participants Set||293
2233222|NCT02680847|5474033|P3|NOT COMPLETED|Overall Study||3
2233223|NCT02680847|5474034|P2|NOT COMPLETED|Overall Study||3
2233224|NCT02680847|5474035|P1|NOT COMPLETED|Overall Study||5
2233225|NCT02680847|5474033|P3|COMPLETED|Overall Study||4
2233226|NCT02680847|5474034|P2|COMPLETED|Overall Study||6
2233227|NCT02680847|5474035|P1|COMPLETED|Overall Study||11
2233228|NCT02680847|5474033|P3|STARTED|Overall Study||7
2233229|NCT02680847|5474034|P2|STARTED|Overall Study||9
2233230|NCT02680847|5474035|P1|STARTED|Overall Study||16
2233245|NCT02680665|5474118|P1|NOT COMPLETED|Overall Study||5
2233246|NCT02680665|5474118|P1|COMPLETED|Overall Study||115
2233247|NCT02680665|5474118|P1|STARTED|Overall Study||120
2233248|NCT02680639|5474124|P3|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
2233249|NCT02680639|5474125|P2|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
2233250|NCT02680639|5474126|P1|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
2233251|NCT02680639|5474124|P3|COMPLETED|High Frequency Oscillation (HFO) Therapy||1
2233252|NCT02680639|5474125|P2|COMPLETED|High Frequency Oscillation (HFO) Therapy||2
2233253|NCT02680639|5474126|P1|COMPLETED|High Frequency Oscillation (HFO) Therapy||0
2233254|NCT02680639|5474124|P3|STARTED|High Frequency Oscillation (HFO) Therapy||1
2233255|NCT02680639|5474125|P2|STARTED|High Frequency Oscillation (HFO) Therapy||2
2233256|NCT02680639|5474126|P1|STARTED|High Frequency Oscillation (HFO) Therapy||0
2233257|NCT02680639|5474124|P3|NOT COMPLETED|Screening Period||0
2233258|NCT02680639|5474125|P2|NOT COMPLETED|Screening Period||0
2233259|NCT02680639|5474126|P1|NOT COMPLETED|Screening Period||7
2233260|NCT02680639|5474124|P3|COMPLETED|Screening Period||0
2233261|NCT02680639|5474125|P2|COMPLETED|Screening Period||0
2233262|NCT02680639|5474126|P1|COMPLETED|Screening Period||3
2233263|NCT02680639|5474124|P3|STARTED|Screening Period||0
2233264|NCT02680639|5474125|P2|STARTED|Screening Period||0
2233265|NCT02680639|5474126|P1|STARTED|Screening Period||10
2233266|NCT02680301|5474149|P2|NOT COMPLETED|Overall Study||1
2233267|NCT02680301|5474150|P1|NOT COMPLETED|Overall Study||0
2233268|NCT02680301|5474149|P2|COMPLETED|Overall Study||17
2233269|NCT02680301|5474150|P1|COMPLETED|Overall Study||22
2233270|NCT02680301|5474149|P2|STARTED|Overall Study||18
2233271|NCT02680301|5474150|P1|STARTED|Overall Study||22
2233272|NCT02680158|5474158|P6|NOT COMPLETED|Overall Study||0
2233273|NCT02680158|5474159|P5|NOT COMPLETED|Overall Study||0
2233274|NCT02680158|5474160|P4|NOT COMPLETED|Overall Study||0
2233275|NCT02680158|5474161|P3|NOT COMPLETED|Overall Study||0
2233276|NCT02680158|5474162|P2|NOT COMPLETED|Overall Study||0
2233277|NCT02680158|5474163|P1|NOT COMPLETED|Overall Study||0
2233278|NCT02680158|5474158|P6|COMPLETED|Overall Study||8
2233279|NCT02680158|5474159|P5|COMPLETED|Overall Study||8
2233280|NCT02680158|5474160|P4|COMPLETED|Overall Study||8
2233281|NCT02680158|5474161|P3|COMPLETED|Overall Study||8
2233282|NCT02680158|5474162|P2|COMPLETED|Overall Study||8
2233283|NCT02680158|5474163|P1|COMPLETED|Overall Study||8
2233284|NCT02680158|5474158|P6|STARTED|Overall Study||8
2233285|NCT02680158|5474159|P5|STARTED|Overall Study||8
2233286|NCT02680158|5474160|P4|STARTED|Overall Study||8
2233287|NCT02680158|5474161|P3|STARTED|Overall Study||8
2233288|NCT02680158|5474162|P2|STARTED|Overall Study||8
2233289|NCT02680158|5474163|P1|STARTED|Overall Study||8
2233290|NCT02680054|5474174|P1|NOT COMPLETED|Overall Study||11
2233291|NCT02680054|5474174|P1|COMPLETED|Overall Study||27
2233292|NCT02680054|5474174|P1|STARTED|Overall Study||38
2233293|NCT02680041|5474192|P1|NOT COMPLETED|Overall Study||10
2233294|NCT02680041|5474192|P1|COMPLETED|Overall Study||211
2233295|NCT02680041|5474192|P1|Received 18F-fluciclovine|Overall Study||213
2233296|NCT02680041|5474192|P1|STARTED|Overall Study||221
2233297|NCT02679976|5474201|P1|NOT COMPLETED|Overall Study||0
2233298|NCT02679976|5474201|P1|COMPLETED|Overall Study||30
2233299|NCT02679976|5474201|P1|Myopes|Overall Study||14
2233300|NCT02679976|5474201|P1|Hyperopes|Overall Study||16
2233301|NCT02679976|5474201|P1|STARTED|Overall Study||30
2233302|NCT02679911|5474210|P1|NOT COMPLETED|Overall Study||0
2233303|NCT02679911|5474210|P1|COMPLETED|Overall Study||20
2233304|NCT02679911|5474210|P1|STARTED|Overall Study|Intra-individual study|20
2233305|NCT02679729|5474226|P9|NOT COMPLETED|Overall Study||0
2233306|NCT02679729|5474227|P8|NOT COMPLETED|Overall Study||0
2233307|NCT02679729|5474228|P7|NOT COMPLETED|Overall Study||1
2233308|NCT02679729|5474229|P6|NOT COMPLETED|Overall Study||0
2233309|NCT02679729|5474230|P5|NOT COMPLETED|Overall Study||1
2233310|NCT02679729|5474231|P4|NOT COMPLETED|Overall Study||0
2233311|NCT02679729|5474232|P3|NOT COMPLETED|Overall Study||0
2233312|NCT02679729|5474233|P2|NOT COMPLETED|Overall Study||2
2233313|NCT02679729|5474234|P1|NOT COMPLETED|Overall Study||0
2233314|NCT02679729|5474226|P9|COMPLETED|Overall Study||6
2233315|NCT02679729|5474227|P8|COMPLETED|Overall Study||14
2233316|NCT02679729|5474228|P7|COMPLETED|Overall Study||5
2233317|NCT02679729|5474229|P6|COMPLETED|Overall Study||6
2233318|NCT02679729|5474230|P5|COMPLETED|Overall Study||5
2233319|NCT02679729|5474231|P4|COMPLETED|Overall Study||6
2233320|NCT02679729|5474232|P3|COMPLETED|Overall Study||6
2233321|NCT02679729|5474233|P2|COMPLETED|Overall Study||5
2233322|NCT02679729|5474234|P1|COMPLETED|Overall Study||6
2233323|NCT02679729|5474226|P9|STARTED|Overall Study||6
2233324|NCT02679729|5474227|P8|STARTED|Overall Study||14
2233325|NCT02679729|5474228|P7|STARTED|Overall Study||6
2233326|NCT02679729|5474229|P6|STARTED|Overall Study||6
2233327|NCT02679729|5474230|P5|STARTED|Overall Study||6
2233328|NCT02679729|5474231|P4|STARTED|Overall Study||6
2233329|NCT02679729|5474232|P3|STARTED|Overall Study||6
2233330|NCT02679729|5474233|P2|STARTED|Overall Study||7
2233331|NCT02679729|5474234|P1|STARTED|Overall Study||6
2233332|NCT02679690|5474338|P1|NOT COMPLETED|Overall Study||1
2233333|NCT02679690|5474338|P1|COMPLETED|Overall Study||9
2233334|NCT02679690|5474338|P1|STARTED|Overall Study||10
2233335|NCT02679469|5474344|P1|NOT COMPLETED|Overall Study||0
2233336|NCT02679469|5474344|P1|COMPLETED|Overall Study||7
2233337|NCT02679469|5474344|P1|STARTED|Overall Study||7
2233338|NCT02679274|5474352|P2|NOT COMPLETED|Overall Study||0
2233339|NCT02679274|5474353|P1|NOT COMPLETED|Overall Study||1
2233340|NCT02679274|5474352|P2|COMPLETED|Overall Study||1
2233341|NCT02679274|5474353|P1|COMPLETED|Overall Study||1
2233342|NCT02679274|5474352|P2|STARTED|Overall Study||1
2233343|NCT02679274|5474353|P1|STARTED|Overall Study||2
2233344|NCT02678923|5474385|P2|NOT COMPLETED|Overall Study||5
2233345|NCT02678923|5474386|P1|NOT COMPLETED|Overall Study||6
2233346|NCT02678923|5474385|P2|COMPLETED|Overall Study||62
2233347|NCT02678923|5474386|P1|COMPLETED|Overall Study||53
2233348|NCT02678923|5474385|P2|mITT Population|Overall Study||61
2233349|NCT02678923|5474386|P1|mITT Population|Overall Study||52
2233350|NCT02678923|5474385|P2|Received at Least 1 Dose of Study Drug|Overall Study||64
2233351|NCT02678923|5474386|P1|Received at Least 1 Dose of Study Drug|Overall Study||58
2233352|NCT02678923|5474385|P2|STARTED|Overall Study||67
2233353|NCT02678923|5474386|P1|STARTED|Overall Study||59
2233354|NCT02678676|5474402|P2|NOT COMPLETED|Overall Study||872
2233355|NCT02678676|5474403|P1|NOT COMPLETED|Overall Study||888
2233356|NCT02678676|5474402|P2|COMPLETED|Overall Study||907
2233357|NCT02678676|5474403|P1|COMPLETED|Overall Study||932
2233358|NCT02678676|5474402|P2|STARTED|Overall Study||1779
2233359|NCT02678676|5474403|P1|STARTED|Overall Study||1820
2233360|NCT02678442|5474413|P2|NOT COMPLETED|Second Intervention||2
2233361|NCT02678442|5474414|P1|NOT COMPLETED|Second Intervention||2
2233362|NCT02678442|5474413|P2|COMPLETED|Second Intervention||23
2233363|NCT02678442|5474414|P1|COMPLETED|Second Intervention||23
2233364|NCT02678442|5474413|P2|STARTED|Second Intervention||25
2233365|NCT02678442|5474414|P1|STARTED|Second Intervention||25
2233366|NCT02678442|5474413|P2|NOT COMPLETED|First Intervention||0
2233367|NCT02678442|5474414|P1|NOT COMPLETED|First Intervention||0
2233368|NCT02678442|5474413|P2|COMPLETED|First Intervention||25
2233369|NCT02678442|5474414|P1|COMPLETED|First Intervention||25
2233370|NCT02678442|5474413|P2|STARTED|First Intervention||25
2233371|NCT02678442|5474414|P1|STARTED|First Intervention||25
2233372|NCT02678416|5474434|P1|NOT COMPLETED|Part 2||3
2233373|NCT02678416|5474434|P1|COMPLETED|Part 2||64
2233374|NCT02678416|5474434|P1|Per Protocol Population|Part 2||64
2233375|NCT02678416|5474434|P1|Pharmacokinetic Population|Part 2||65
2233376|NCT02678416|5474434|P1|Modified Intent to Treat Population|Part 2||66
2233377|NCT02678416|5474434|P1|Treated (Safety Population)|Part 2||66
2233378|NCT02678416|5474434|P1|STARTED|Part 2|Part 2 enrolled all new participants|67
2233379|NCT02678416|5474434|P1|NOT COMPLETED|Part 1||1
2233380|NCT02678416|5474434|P1|COMPLETED|Part 1||11
2233381|NCT02678416|5474434|P1|Per Protocol Population|Part 1||8
2233382|NCT02678416|5474434|P1|Modified Intent to Treat (mITT)|Part 1||12
2233383|NCT02678416|5474434|P1|Safety Population|Part 1||12
2233384|NCT02678416|5474434|P1|STARTED|Part 1||12
2233385|NCT02678286|5474454|P2|NOT COMPLETED|Study Overall (28 Day Follow-Up)||4
2233386|NCT02678286|5474455|P1|NOT COMPLETED|Study Overall (28 Day Follow-Up)||6
2233387|NCT02678286|5474454|P2|COMPLETED|Study Overall (28 Day Follow-Up)||105
2233388|NCT02678286|5474455|P1|COMPLETED|Study Overall (28 Day Follow-Up)||104
2233389|NCT02678286|5474454|P2|STARTED|Study Overall (28 Day Follow-Up)||109
2233390|NCT02678286|5474455|P1|STARTED|Study Overall (28 Day Follow-Up)||110
2233391|NCT02678286|5474454|P2|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2
2233392|NCT02678286|5474455|P1|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2
2233393|NCT02678286|5474454|P2|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||107
2233394|NCT02678286|5474455|P1|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||108
2233395|NCT02678286|5474454|P2|STARTED|Treatment Phase (48 Hours Post-Dose 1)||109
2233396|NCT02678286|5474455|P1|STARTED|Treatment Phase (48 Hours Post-Dose 1)||110
2233397|NCT02678039|5474487|P2|NOT COMPLETED|Overall Study||0
2233398|NCT02678039|5474488|P1|NOT COMPLETED|Overall Study||0
2233399|NCT02678039|5474487|P2|COMPLETED|Overall Study||47
2233400|NCT02678039|5474488|P1|COMPLETED|Overall Study||53
2233401|NCT02678039|5474487|P2|STARTED|Overall Study||47
2233402|NCT02678039|5474488|P1|STARTED|Overall Study||53
2233403|NCT02678000|5474507|P5|NOT COMPLETED|PART 2||0
2233404|NCT02678000|5474508|P4|NOT COMPLETED|PART 2||1
2233405|NCT02678000|5474509|P3|NOT COMPLETED|PART 2||3
2233406|NCT02678000|5474510|P2|NOT COMPLETED|PART 2||0
2233407|NCT02678000|5474511|P1|NOT COMPLETED|PART 2||0
2233408|NCT02678000|5474507|P5|COMPLETED|PART 2||18
2233409|NCT02678000|5474508|P4|COMPLETED|PART 2||26
2233410|NCT02678000|5474509|P3|COMPLETED|PART 2||25
2233411|NCT02678000|5474510|P2|COMPLETED|PART 2||0
2233412|NCT02678000|5474511|P1|COMPLETED|PART 2||0
2233413|NCT02678000|5474507|P5|STARTED|PART 2||18
2233414|NCT02678000|5474508|P4|STARTED|PART 2||27
2233415|NCT02678000|5474509|P3|STARTED|PART 2||28
2233416|NCT02678000|5474510|P2|STARTED|PART 2||0
2233417|NCT02678000|5474511|P1|STARTED|PART 2||0
2233418|NCT02678000|5474507|P5|NOT COMPLETED|PART 1||0
2233419|NCT02678000|5474508|P4|NOT COMPLETED|PART 1||0
2233420|NCT02678000|5474509|P3|NOT COMPLETED|PART 1||0
2233421|NCT02678000|5474510|P2|NOT COMPLETED|PART 1||0
2233422|NCT02678000|5474511|P1|NOT COMPLETED|PART 1||0
2233423|NCT02678000|5474507|P5|COMPLETED|PART 1||0
2233424|NCT02678000|5474508|P4|COMPLETED|PART 1||0
2233425|NCT02678000|5474509|P3|COMPLETED|PART 1||0
2233426|NCT02678000|5474510|P2|COMPLETED|PART 1||4
2233427|NCT02678000|5474511|P1|COMPLETED|PART 1||7
2233428|NCT02678000|5474507|P5|STARTED|PART 1||0
2233429|NCT02678000|5474508|P4|STARTED|PART 1||0
2233430|NCT02678000|5474509|P3|STARTED|PART 1||0
2233431|NCT02678000|5474510|P2|STARTED|PART 1||4
2233432|NCT02678000|5474511|P1|STARTED|PART 1||7
2233441|NCT02677844|5474578|P7|NOT COMPLETED|Period 7||0
2233442|NCT02677844|5474579|P6|NOT COMPLETED|Period 7||0
2233443|NCT02677844|5474580|P5|NOT COMPLETED|Period 7||0
2233444|NCT02677844|5474581|P4|NOT COMPLETED|Period 7||0
2233445|NCT02677844|5474582|P3|NOT COMPLETED|Period 7||0
2233446|NCT02677844|5474583|P2|NOT COMPLETED|Period 7||0
2233447|NCT02677844|5474584|P1|NOT COMPLETED|Period 7||0
2233448|NCT02677844|5474578|P7|COMPLETED|Period 7||4
2233449|NCT02677844|5474579|P6|COMPLETED|Period 7||4
2233450|NCT02677844|5474580|P5|COMPLETED|Period 7||7
2233451|NCT02677844|5474581|P4|COMPLETED|Period 7||0
2233452|NCT02677844|5474582|P3|COMPLETED|Period 7||0
2233453|NCT02677844|5474583|P2|COMPLETED|Period 7||0
2233454|NCT02677844|5474584|P1|COMPLETED|Period 7||0
2233455|NCT02677844|5474578|P7|STARTED|Period 7||4
2233456|NCT02677844|5474579|P6|STARTED|Period 7||4
2233457|NCT02677844|5474580|P5|STARTED|Period 7||7
2233458|NCT02677844|5474581|P4|STARTED|Period 7||0
2233459|NCT02677844|5474582|P3|STARTED|Period 7||0
2233460|NCT02677844|5474583|P2|STARTED|Period 7||0
2233461|NCT02677844|5474584|P1|STARTED|Period 7||0
2233462|NCT02677844|5474578|P7|NOT COMPLETED|Period 6||0
2233463|NCT02677844|5474579|P6|NOT COMPLETED|Period 6||0
2233464|NCT02677844|5474580|P5|NOT COMPLETED|Period 6||0
2233465|NCT02677844|5474581|P4|NOT COMPLETED|Period 6||0
2233466|NCT02677844|5474582|P3|NOT COMPLETED|Period 6||0
2233467|NCT02677844|5474583|P2|NOT COMPLETED|Period 6||0
2233468|NCT02677844|5474584|P1|NOT COMPLETED|Period 6||0
2233469|NCT02677844|5474578|P7|COMPLETED|Period 6||4
2233470|NCT02677844|5474579|P6|COMPLETED|Period 6||4
2233471|NCT02677844|5474580|P5|COMPLETED|Period 6||7
2233472|NCT02677844|5474581|P4|COMPLETED|Period 6||0
2233473|NCT02677844|5474582|P3|COMPLETED|Period 6||0
2233474|NCT02677844|5474583|P2|COMPLETED|Period 6||0
2233475|NCT02677844|5474584|P1|COMPLETED|Period 6||0
2233476|NCT02677844|5474578|P7|STARTED|Period 6||4
2233477|NCT02677844|5474579|P6|STARTED|Period 6||4
2233478|NCT02677844|5474580|P5|STARTED|Period 6||7
2233479|NCT02677844|5474581|P4|STARTED|Period 6||0
2233480|NCT02677844|5474582|P3|STARTED|Period 6||0
2233481|NCT02677844|5474583|P2|STARTED|Period 6||0
2233482|NCT02677844|5474584|P1|STARTED|Period 6||0
2233483|NCT02677844|5474578|P7|NOT COMPLETED|Period 5||0
2233484|NCT02677844|5474579|P6|NOT COMPLETED|Period 5||0
2233485|NCT02677844|5474580|P5|NOT COMPLETED|Period 5||0
2233486|NCT02677844|5474581|P4|NOT COMPLETED|Period 5||0
2233487|NCT02677844|5474582|P3|NOT COMPLETED|Period 5||0
2233488|NCT02677844|5474583|P2|NOT COMPLETED|Period 5||0
2233489|NCT02677844|5474584|P1|NOT COMPLETED|Period 5||0
2233490|NCT02677844|5474578|P7|COMPLETED|Period 5||4
2233491|NCT02677844|5474579|P6|COMPLETED|Period 5||4
2233492|NCT02677844|5474580|P5|COMPLETED|Period 5||7
2233493|NCT02677844|5474581|P4|COMPLETED|Period 5||0
2233494|NCT02677844|5474582|P3|COMPLETED|Period 5||0
2233495|NCT02677844|5474583|P2|COMPLETED|Period 5||0
2233496|NCT02677844|5474584|P1|COMPLETED|Period 5||0
2233497|NCT02677844|5474578|P7|STARTED|Period 5||4
2233498|NCT02677844|5474579|P6|STARTED|Period 5||4
2233499|NCT02677844|5474580|P5|STARTED|Period 5||7
2233500|NCT02677844|5474581|P4|STARTED|Period 5||0
2233501|NCT02677844|5474582|P3|STARTED|Period 5||0
2233502|NCT02677844|5474583|P2|STARTED|Period 5||0
2233503|NCT02677844|5474584|P1|STARTED|Period 5||0
2233504|NCT02677844|5474578|P7|NOT COMPLETED|Period 4 (DDI)||0
2233505|NCT02677844|5474579|P6|NOT COMPLETED|Period 4 (DDI)||0
2233506|NCT02677844|5474580|P5|NOT COMPLETED|Period 4 (DDI)||0
2233507|NCT02677844|5474581|P4|NOT COMPLETED|Period 4 (DDI)||0
2233508|NCT02677844|5474582|P3|NOT COMPLETED|Period 4 (DDI)||0
2233509|NCT02677844|5474583|P2|NOT COMPLETED|Period 4 (DDI)||0
2233510|NCT02677844|5474584|P1|NOT COMPLETED|Period 4 (DDI)||0
2233511|NCT02677844|5474578|P7|COMPLETED|Period 4 (DDI)||4
2233512|NCT02677844|5474579|P6|COMPLETED|Period 4 (DDI)||4
2233513|NCT02677844|5474580|P5|COMPLETED|Period 4 (DDI)||7
2233514|NCT02677844|5474581|P4|COMPLETED|Period 4 (DDI)||0
2233515|NCT02677844|5474582|P3|COMPLETED|Period 4 (DDI)||0
2233516|NCT02677844|5474583|P2|COMPLETED|Period 4 (DDI)||0
2233517|NCT02677844|5474584|P1|COMPLETED|Period 4 (DDI)||0
2233518|NCT02677844|5474578|P7|STARTED|Period 4 (DDI)||4
2233519|NCT02677844|5474579|P6|STARTED|Period 4 (DDI)||4
2233520|NCT02677844|5474580|P5|STARTED|Period 4 (DDI)||7
2233521|NCT02677844|5474581|P4|STARTED|Period 4 (DDI)||0
2233522|NCT02677844|5474582|P3|STARTED|Period 4 (DDI)||0
2233523|NCT02677844|5474583|P2|STARTED|Period 4 (DDI)||0
2233524|NCT02677844|5474584|P1|STARTED|Period 4 (DDI)||0
2233525|NCT02677844|5474578|P7|NOT COMPLETED|Period 4||0
2233526|NCT02677844|5474579|P6|NOT COMPLETED|Period 4||0
2233527|NCT02677844|5474580|P5|NOT COMPLETED|Period 4||0
2233528|NCT02677844|5474581|P4|NOT COMPLETED|Period 4||0
2233529|NCT02677844|5474582|P3|NOT COMPLETED|Period 4||0
2233530|NCT02677844|5474583|P2|NOT COMPLETED|Period 4||0
2233531|NCT02677844|5474584|P1|NOT COMPLETED|Period 4||0
2233532|NCT02677844|5474578|P7|COMPLETED|Period 4||0
2233533|NCT02677844|5474579|P6|COMPLETED|Period 4||0
2233534|NCT02677844|5474580|P5|COMPLETED|Period 4||0
2233535|NCT02677844|5474581|P4|COMPLETED|Period 4||4
2233536|NCT02677844|5474582|P3|COMPLETED|Period 4||5
2233537|NCT02677844|5474583|P2|COMPLETED|Period 4||5
2233538|NCT02677844|5474584|P1|COMPLETED|Period 4||5
2233539|NCT02677844|5474578|P7|STARTED|Period 4||0
2233540|NCT02677844|5474579|P6|STARTED|Period 4||0
2233541|NCT02677844|5474580|P5|STARTED|Period 4||0
2233542|NCT02677844|5474581|P4|STARTED|Period 4||4
2233543|NCT02677844|5474582|P3|STARTED|Period 4||5
2233544|NCT02677844|5474583|P2|STARTED|Period 4||5
2233545|NCT02677844|5474584|P1|STARTED|Period 4||5
2233546|NCT02677844|5474578|P7|NOT COMPLETED|Period 3||0
2233547|NCT02677844|5474579|P6|NOT COMPLETED|Period 3||0
2233548|NCT02677844|5474580|P5|NOT COMPLETED|Period 3||0
2233549|NCT02677844|5474581|P4|NOT COMPLETED|Period 3||1
2233550|NCT02677844|5474582|P3|NOT COMPLETED|Period 3||0
2233551|NCT02677844|5474583|P2|NOT COMPLETED|Period 3||0
2233552|NCT02677844|5474584|P1|NOT COMPLETED|Period 3||0
2233553|NCT02677844|5474578|P7|COMPLETED|Period 3||0
2233554|NCT02677844|5474579|P6|COMPLETED|Period 3||0
2233555|NCT02677844|5474580|P5|COMPLETED|Period 3||0
2233556|NCT02677844|5474581|P4|COMPLETED|Period 3||4
2233557|NCT02677844|5474582|P3|COMPLETED|Period 3||5
2233558|NCT02677844|5474583|P2|COMPLETED|Period 3||5
2233559|NCT02677844|5474584|P1|COMPLETED|Period 3||5
2233560|NCT02677844|5474578|P7|STARTED|Period 3||0
2233561|NCT02677844|5474579|P6|STARTED|Period 3||0
2233562|NCT02677844|5474580|P5|STARTED|Period 3||0
2233563|NCT02677844|5474581|P4|STARTED|Period 3||5
2233564|NCT02677844|5474582|P3|STARTED|Period 3||5
2233565|NCT02677844|5474583|P2|STARTED|Period 3||5
2233566|NCT02677844|5474584|P1|STARTED|Period 3||5
2233567|NCT02677844|5474578|P7|NOT COMPLETED|Period 2||0
2233568|NCT02677844|5474579|P6|NOT COMPLETED|Period 2||0
2233569|NCT02677844|5474580|P5|NOT COMPLETED|Period 2||0
2233570|NCT02677844|5474581|P4|NOT COMPLETED|Period 2||0
2233571|NCT02677844|5474582|P3|NOT COMPLETED|Period 2||0
2233572|NCT02677844|5474583|P2|NOT COMPLETED|Period 2||0
2233573|NCT02677844|5474584|P1|NOT COMPLETED|Period 2||0
2233574|NCT02677844|5474578|P7|COMPLETED|Period 2||0
2233575|NCT02677844|5474579|P6|COMPLETED|Period 2||0
2233576|NCT02677844|5474580|P5|COMPLETED|Period 2||0
2233577|NCT02677844|5474581|P4|COMPLETED|Period 2||5
2233578|NCT02677844|5474582|P3|COMPLETED|Period 2||5
2233579|NCT02677844|5474583|P2|COMPLETED|Period 2||5
2233580|NCT02677844|5474584|P1|COMPLETED|Period 2||5
2233581|NCT02677844|5474578|P7|STARTED|Period 2||0
2233582|NCT02677844|5474579|P6|STARTED|Period 2||0
2233583|NCT02677844|5474580|P5|STARTED|Period 2||0
2233584|NCT02677844|5474581|P4|STARTED|Period 2||5
2233585|NCT02677844|5474582|P3|STARTED|Period 2||5
2233586|NCT02677844|5474583|P2|STARTED|Period 2||5
2233587|NCT02677844|5474584|P1|STARTED|Period 2||5
2233588|NCT02677844|5474578|P7|NOT COMPLETED|Period 1||0
2233589|NCT02677844|5474579|P6|NOT COMPLETED|Period 1||0
2233590|NCT02677844|5474580|P5|NOT COMPLETED|Period 1||0
2233591|NCT02677844|5474581|P4|NOT COMPLETED|Period 1||0
2233592|NCT02677844|5474582|P3|NOT COMPLETED|Period 1||0
2233593|NCT02677844|5474583|P2|NOT COMPLETED|Period 1||0
2233594|NCT02677844|5474584|P1|NOT COMPLETED|Period 1||0
2233595|NCT02677844|5474578|P7|COMPLETED|Period 1||0
2233596|NCT02677844|5474579|P6|COMPLETED|Period 1||0
2233597|NCT02677844|5474580|P5|COMPLETED|Period 1||0
2233598|NCT02677844|5474581|P4|COMPLETED|Period 1||5
2233599|NCT02677844|5474582|P3|COMPLETED|Period 1||5
2233600|NCT02677844|5474583|P2|COMPLETED|Period 1||5
2233601|NCT02677844|5474584|P1|COMPLETED|Period 1||5
2233602|NCT02677844|5474578|P7|STARTED|Period 1||0
2233603|NCT02677844|5474579|P6|STARTED|Period 1||0
2233604|NCT02677844|5474580|P5|STARTED|Period 1||0
2233605|NCT02677844|5474581|P4|STARTED|Period 1||5
2233606|NCT02677844|5474582|P3|STARTED|Period 1||5
2233607|NCT02677844|5474583|P2|STARTED|Period 1||5
2233608|NCT02677844|5474584|P1|STARTED|Period 1||5
2233609|NCT02677779|5474614|P2|NOT COMPLETED|Overall Study||0
2233610|NCT02677779|5474615|P1|NOT COMPLETED|Overall Study||0
2233611|NCT02677779|5474614|P2|COMPLETED|Overall Study||10
2233612|NCT02677779|5474615|P1|COMPLETED|Overall Study||10
2233613|NCT02677779|5474614|P2|STARTED|Overall Study||10
2233614|NCT02677779|5474615|P1|STARTED|Overall Study||10
2233615|NCT02677766|5474631|P2|NOT COMPLETED|Overall Study||3
2233616|NCT02677766|5474632|P1|NOT COMPLETED|Overall Study||5
2233617|NCT02677766|5474631|P2|COMPLETED|Overall Study||17
2233618|NCT02677766|5474632|P1|COMPLETED|Overall Study||15
2233619|NCT02677766|5474631|P2|STARTED|Overall Study||20
2233620|NCT02677766|5474632|P1|STARTED|Overall Study||20
2233621|NCT02677740|5474640|P2|NOT COMPLETED|Overall Study||0
2233622|NCT02677740|5474641|P1|NOT COMPLETED|Overall Study||0
2233623|NCT02677740|5474640|P2|COMPLETED|Overall Study||1
2233624|NCT02677740|5474641|P1|COMPLETED|Overall Study||7
2233625|NCT02677740|5474640|P2|STARTED|Overall Study||1
2233626|NCT02677740|5474641|P1|STARTED|Overall Study||7
2233627|NCT02677623|5474657|P4|NOT COMPLETED|Overall Study||0
2233628|NCT02677623|5474658|P3|NOT COMPLETED|Overall Study||0
2233629|NCT02677623|5474659|P2|NOT COMPLETED|Overall Study||0
2233630|NCT02677623|5474660|P1|NOT COMPLETED|Overall Study||0
2233631|NCT02677623|5474657|P4|COMPLETED|Overall Study||33
2233632|NCT02677623|5474658|P3|COMPLETED|Overall Study||32
2233633|NCT02677623|5474659|P2|COMPLETED|Overall Study||32
2233634|NCT02677623|5474660|P1|COMPLETED|Overall Study||33
2233635|NCT02677623|5474657|P4|STARTED|Overall Study||33
2233636|NCT02677623|5474658|P3|STARTED|Overall Study||32
2233637|NCT02677623|5474659|P2|STARTED|Overall Study||32
2233638|NCT02677623|5474660|P1|STARTED|Overall Study||33
2233639|NCT02677493|5474673|P3|NOT COMPLETED|Overall Study||3
2233640|NCT02677493|5474674|P2|NOT COMPLETED|Overall Study||2
2233641|NCT02677493|5474675|P1|NOT COMPLETED|Overall Study||11
2233642|NCT02677493|5474673|P3|COMPLETED|Overall Study||296
2233643|NCT02677493|5474674|P2|COMPLETED|Overall Study||296
2233644|NCT02677493|5474675|P1|COMPLETED|Overall Study||1186
2233645|NCT02677493|5474673|P3|STARTED|Overall Study||299
2233646|NCT02677493|5474674|P2|STARTED|Overall Study||298
2233647|NCT02677493|5474675|P1|STARTED|Overall Study||1197
2233648|NCT02677220|5474686|P1|NOT COMPLETED|Overall Study||1
2233649|NCT02677220|5474686|P1|COMPLETED|Overall Study||0
2233650|NCT02677220|5474686|P1|STARTED|Overall Study||1
2233651|NCT02676895|5474695|P3|NOT COMPLETED|Overall Study||3
2233652|NCT02676895|5474696|P2|NOT COMPLETED|Overall Study||3
2233653|NCT02676895|5474697|P1|NOT COMPLETED|Overall Study||2
2233654|NCT02676895|5474695|P3|COMPLETED|Overall Study||21
2233655|NCT02676895|5474696|P2|COMPLETED|Overall Study||23
2233656|NCT02676895|5474697|P1|COMPLETED|Overall Study||20
2233657|NCT02676895|5474695|P3|STARTED|Overall Study||24
2233658|NCT02676895|5474696|P2|STARTED|Overall Study||26
2233659|NCT02676895|5474697|P1|STARTED|Overall Study||22
2233660|NCT02676882|5474740|P2|NOT COMPLETED|Overall Study||2
2233661|NCT02676882|5474741|P1|NOT COMPLETED|Overall Study||3
2233662|NCT02676882|5474740|P2|COMPLETED|Overall Study||5
2233663|NCT02676882|5474741|P1|COMPLETED|Overall Study||10
2233664|NCT02676882|5474740|P2|Evaluable|Overall Study||6
2233665|NCT02676882|5474741|P1|Evaluable|Overall Study||11
2233666|NCT02676882|5474740|P2|STARTED|Overall Study||7
2233667|NCT02676882|5474741|P1|STARTED|Overall Study||13
2233668|NCT02676843|5474747|P1|NOT COMPLETED|Overall Study||0
2233669|NCT02676843|5474747|P1|COMPLETED|Overall Study||7
2233670|NCT02676843|5474747|P1|STARTED|Overall Study||7
2233671|NCT02676466|5474760|P8|NOT COMPLETED|Overall Study||1
2233672|NCT02676466|5474761|P7|NOT COMPLETED|Overall Study||1
2233673|NCT02676466|5474762|P6|NOT COMPLETED|Overall Study||1
2233674|NCT02676466|5474763|P5|NOT COMPLETED|Overall Study||3
2233675|NCT02676466|5474764|P4|NOT COMPLETED|Overall Study||0
2233676|NCT02676466|5474765|P3|NOT COMPLETED|Overall Study||2
2233677|NCT02676466|5474766|P2|NOT COMPLETED|Overall Study||5
2233678|NCT02676466|5474767|P1|NOT COMPLETED|Overall Study||4
2233679|NCT02676466|5474760|P8|COMPLETED|Overall Study||13
2233680|NCT02676466|5474761|P7|COMPLETED|Overall Study||12
2233681|NCT02676466|5474762|P6|COMPLETED|Overall Study||12
2233682|NCT02676466|5474763|P5|COMPLETED|Overall Study||23
2233683|NCT02676466|5474764|P4|COMPLETED|Overall Study||17
2233684|NCT02676466|5474765|P3|COMPLETED|Overall Study||24
2233685|NCT02676466|5474766|P2|COMPLETED|Overall Study||66
2233686|NCT02676466|5474767|P1|COMPLETED|Overall Study||105
2233687|NCT02676466|5474760|P8|STARTED|Overall Study||14
2233688|NCT02676466|5474761|P7|STARTED|Overall Study||13
2233689|NCT02676466|5474762|P6|STARTED|Overall Study||13
2233690|NCT02676466|5474763|P5|STARTED|Overall Study||26
2233691|NCT02676466|5474764|P4|STARTED|Overall Study||17
2233692|NCT02676466|5474765|P3|STARTED|Overall Study||26
2233693|NCT02676466|5474766|P2|STARTED|Overall Study||71
2233694|NCT02676466|5474767|P1|STARTED|Overall Study||109
2233695|NCT02676375|5474836|P3|NOT COMPLETED|Overall Study||3
2233696|NCT02676375|5474837|P2|NOT COMPLETED|Overall Study||4
2233697|NCT02676375|5474838|P1|NOT COMPLETED|Overall Study||1
2233698|NCT02676375|5474836|P3|COMPLETED|Overall Study||11
2233699|NCT02676375|5474837|P2|COMPLETED|Overall Study||10
2233700|NCT02676375|5474838|P1|COMPLETED|Overall Study||13
2233701|NCT02676375|5474836|P3|STARTED|Overall Study||14
2233702|NCT02676375|5474837|P2|STARTED|Overall Study||14
2233703|NCT02676375|5474838|P1|STARTED|Overall Study||14
2233704|NCT02675907|5474848|P2|NOT COMPLETED|Study Overall||4
2233705|NCT02675907|5474849|P1|NOT COMPLETED|Study Overall||3
2233706|NCT02675907|5474848|P2|COMPLETED|Study Overall||97
2233707|NCT02675907|5474849|P1|COMPLETED|Study Overall||97
2233708|NCT02675907|5474848|P2|STARTED|Study Overall||101
2233709|NCT02675907|5474849|P1|STARTED|Study Overall||100
2233710|NCT02675907|5474848|P2|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
2233711|NCT02675907|5474849|P1|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
2233712|NCT02675907|5474848|P2|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||96
2233713|NCT02675907|5474849|P1|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||95
2233714|NCT02675907|5474848|P2|STARTED|Treatment Phase (48 Hours Post-Dose 1)||101
2233715|NCT02675907|5474849|P1|STARTED|Treatment Phase (48 Hours Post-Dose 1)||100
2233716|NCT02675764|5474881|P2|NOT COMPLETED|Overall Study||0
2233717|NCT02675764|5474882|P1|NOT COMPLETED|Overall Study||0
2233718|NCT02675764|5474881|P2|COMPLETED|Overall Study||6
2233719|NCT02675764|5474882|P1|COMPLETED|Overall Study||6
2233720|NCT02675764|5474881|P2|STARTED|Overall Study||6
2233721|NCT02675764|5474882|P1|STARTED|Overall Study||6
2233722|NCT02675751|5474894|P1|NOT COMPLETED|Overall Study||16
2233723|NCT02675751|5474894|P1|COMPLETED|Overall Study||151
2233724|NCT02675751|5474894|P1|STARTED|Overall Study||167
2233725|NCT02675634|5474898|P6|NOT COMPLETED|Test Period 3||0
2233726|NCT02675634|5474899|P5|NOT COMPLETED|Test Period 3||0
2233727|NCT02675634|5474900|P4|NOT COMPLETED|Test Period 3||0
2233728|NCT02675634|5474901|P3|NOT COMPLETED|Test Period 3||0
2233729|NCT02675634|5474902|P2|NOT COMPLETED|Test Period 3||0
2233730|NCT02675634|5474903|P1|NOT COMPLETED|Test Period 3||0
2233731|NCT02675634|5474898|P6|COMPLETED|Test Period 3||8
2233732|NCT02675634|5474899|P5|COMPLETED|Test Period 3||10
2233733|NCT02675634|5474900|P4|COMPLETED|Test Period 3||8
2233734|NCT02675634|5474901|P3|COMPLETED|Test Period 3||8
2233735|NCT02675634|5474902|P2|COMPLETED|Test Period 3||7
2233736|NCT02675634|5474903|P1|COMPLETED|Test Period 3||9
2233737|NCT02675634|5474898|P6|STARTED|Test Period 3||8
2233738|NCT02675634|5474899|P5|STARTED|Test Period 3||10
2233739|NCT02675634|5474900|P4|STARTED|Test Period 3||8
2233740|NCT02675634|5474901|P3|STARTED|Test Period 3||8
2233741|NCT02675634|5474902|P2|STARTED|Test Period 3||7
2233742|NCT02675634|5474903|P1|STARTED|Test Period 3||9
2233743|NCT02675634|5474898|P6|NOT COMPLETED|Test Period 2||1
2233744|NCT02675634|5474899|P5|NOT COMPLETED|Test Period 2||0
2233745|NCT02675634|5474900|P4|NOT COMPLETED|Test Period 2||0
2233746|NCT02675634|5474901|P3|NOT COMPLETED|Test Period 2||0
2233747|NCT02675634|5474902|P2|NOT COMPLETED|Test Period 2||0
2233748|NCT02675634|5474903|P1|NOT COMPLETED|Test Period 2||1
2233749|NCT02675634|5474898|P6|COMPLETED|Test Period 2||8
2233750|NCT02675634|5474899|P5|COMPLETED|Test Period 2||10
2233751|NCT02675634|5474900|P4|COMPLETED|Test Period 2||8
2233752|NCT02675634|5474901|P3|COMPLETED|Test Period 2||8
2233753|NCT02675634|5474902|P2|COMPLETED|Test Period 2||7
2233754|NCT02675634|5474903|P1|COMPLETED|Test Period 2||9
2233755|NCT02675634|5474898|P6|STARTED|Test Period 2||9
2233756|NCT02675634|5474899|P5|STARTED|Test Period 2||10
2233757|NCT02675634|5474900|P4|STARTED|Test Period 2||8
2233758|NCT02675634|5474901|P3|STARTED|Test Period 2||8
2233759|NCT02675634|5474902|P2|STARTED|Test Period 2||7
2233760|NCT02675634|5474903|P1|STARTED|Test Period 2||10
2233761|NCT02675634|5474898|P6|NOT COMPLETED|Test Period 1||0
2233762|NCT02675634|5474899|P5|NOT COMPLETED|Test Period 1||0
2233763|NCT02675634|5474900|P4|NOT COMPLETED|Test Period 1||1
2233764|NCT02675634|5474901|P3|NOT COMPLETED|Test Period 1||1
2233765|NCT02675634|5474902|P2|NOT COMPLETED|Test Period 1||1
2233766|NCT02675634|5474903|P1|NOT COMPLETED|Test Period 1||0
2233767|NCT02675634|5474898|P6|COMPLETED|Test Period 1||9
2233768|NCT02675634|5474899|P5|COMPLETED|Test Period 1||10
2233769|NCT02675634|5474900|P4|COMPLETED|Test Period 1||8
2233770|NCT02675634|5474901|P3|COMPLETED|Test Period 1||8
2233771|NCT02675634|5474902|P2|COMPLETED|Test Period 1||7
2233772|NCT02675634|5474903|P1|COMPLETED|Test Period 1||10
2233773|NCT02675634|5474898|P6|STARTED|Test Period 1||9
2233774|NCT02675634|5474899|P5|STARTED|Test Period 1||10
2233775|NCT02675634|5474900|P4|STARTED|Test Period 1||9
2233776|NCT02675634|5474901|P3|STARTED|Test Period 1||9
2233777|NCT02675634|5474902|P2|STARTED|Test Period 1||8
2233778|NCT02675634|5474903|P1|STARTED|Test Period 1||10
2233779|NCT02675543|5474913|P2|NOT COMPLETED|Overall Study||0
2233780|NCT02675543|5474914|P1|NOT COMPLETED|Overall Study||0
2233781|NCT02675543|5474913|P2|COMPLETED|Overall Study||20
2233782|NCT02675543|5474914|P1|COMPLETED|Overall Study||15
2233783|NCT02675543|5474913|P2|STARTED|Overall Study||20
2233784|NCT02675543|5474914|P1|STARTED|Overall Study||15
2233785|NCT02675517|5474920|P1|NOT COMPLETED|Overall Study||159
2233786|NCT02675517|5474920|P1|COMPLETED|Overall Study||1578
2233787|NCT02675517|5474920|P1|STARTED|Overall Study||1737
2233800|NCT02674854|5474978|P3|NOT COMPLETED|Overall Study||14
2233801|NCT02674854|5474979|P2|NOT COMPLETED|Overall Study||27
2233802|NCT02674854|5474980|P1|NOT COMPLETED|Overall Study||24
2233803|NCT02674854|5474978|P3|COMPLETED|Overall Study||236
2233804|NCT02674854|5474979|P2|COMPLETED|Overall Study||228
2233805|NCT02674854|5474980|P1|COMPLETED|Overall Study||221
2233806|NCT02674854|5474978|P3|STARTED|Overall Study||250
2233807|NCT02674854|5474979|P2|STARTED|Overall Study||255
2233808|NCT02674854|5474980|P1|STARTED|Overall Study||245
2233809|NCT02674659|5474990|P2|NOT COMPLETED|Overall Study||4
2233810|NCT02674659|5474991|P1|NOT COMPLETED|Overall Study||4
2233811|NCT02674659|5474990|P2|COMPLETED|Overall Study||40
2233812|NCT02674659|5474991|P1|COMPLETED|Overall Study||39
2233813|NCT02674659|5474990|P2|STARTED|Overall Study||44
2233814|NCT02674659|5474991|P1|STARTED|Overall Study||43
2233815|NCT02674568|5475013|P1|NOT COMPLETED|Overall Study||339
2233816|NCT02674568|5475013|P1|COMPLETED|Overall Study||0
2233817|NCT02674568|5475013|P1|DLL3 Positive|Overall Study||287
2233818|NCT02674568|5475013|P1|Delta-like Protein 3 (DLL3) High|Overall Study||238
2233819|NCT02674568|5475013|P1|STARTED|Overall Study|Enrolled and dosed.|339
2233820|NCT02674477|5475038|P2|NOT COMPLETED|Overall Study||2
2233821|NCT02674477|5475039|P1|NOT COMPLETED|Overall Study||8
2233822|NCT02674477|5475038|P2|COMPLETED|Overall Study||45
2233823|NCT02674477|5475039|P1|COMPLETED|Overall Study||40
2233824|NCT02674477|5475038|P2|STARTED|Overall Study||47
2233825|NCT02674477|5475039|P1|STARTED|Overall Study||48
2233826|NCT02674412|5475049|P2|NOT COMPLETED|Overall Study||0
2233827|NCT02674412|5475050|P1|NOT COMPLETED|Overall Study||0
2233828|NCT02674412|5475049|P2|COMPLETED|Overall Study||5
2233829|NCT02674412|5475050|P1|COMPLETED|Overall Study||5
2233830|NCT02674412|5475049|P2|STARTED|Overall Study||5
2233831|NCT02674412|5475050|P1|STARTED|Overall Study||5
2233832|NCT02674334|5475062|P2|NOT COMPLETED|Overall Study||3
2233833|NCT02674334|5475063|P1|NOT COMPLETED|Overall Study||7
2233834|NCT02674334|5475062|P2|COMPLETED|Overall Study||40
2233835|NCT02674334|5475063|P1|COMPLETED|Overall Study||40
2233836|NCT02674334|5475062|P2|STARTED|Overall Study||43
2233837|NCT02674334|5475063|P1|STARTED|Overall Study||47
2233838|NCT02674204|5475073|P2|NOT COMPLETED|Overall Study||0
2233839|NCT02674204|5475074|P1|NOT COMPLETED|Overall Study||1
2233840|NCT02674204|5475073|P2|COMPLETED|Overall Study||1
2233841|NCT02674204|5475074|P1|COMPLETED|Overall Study||0
2233842|NCT02674204|5475073|P2|STARTED|Overall Study||1
2233843|NCT02674204|5475074|P1|STARTED|Overall Study||1
2233844|NCT02673944|5475108|P1|NOT COMPLETED|Overall Study||0
2233845|NCT02673944|5475108|P1|COMPLETED|Overall Study||10
2233846|NCT02673944|5475108|P1|STARTED|Overall Study||10
2233847|NCT02673918|5475115|P2|NOT COMPLETED|Overall Study||4
2233848|NCT02673918|5475116|P1|NOT COMPLETED|Overall Study||6
2233849|NCT02673918|5475115|P2|COMPLETED|Overall Study||20
2233850|NCT02673918|5475116|P1|COMPLETED|Overall Study||29
2233851|NCT02673918|5475115|P2|STARTED|Overall Study||24
2233852|NCT02673918|5475116|P1|STARTED|Overall Study||35
2233853|NCT02673619|5475146|P4|NOT COMPLETED|Overall Study||0
2233854|NCT02673619|5475147|P3|NOT COMPLETED|Overall Study||3
2233855|NCT02673619|5475148|P2|NOT COMPLETED|Overall Study||1
2233856|NCT02673619|5475149|P1|NOT COMPLETED|Overall Study||2
2233857|NCT02673619|5475146|P4|COMPLETED|Overall Study||7
2233858|NCT02673619|5475147|P3|COMPLETED|Overall Study||23
2233859|NCT02673619|5475148|P2|COMPLETED|Overall Study||4
2233860|NCT02673619|5475149|P1|COMPLETED|Overall Study||18
2233861|NCT02673619|5475146|P4|STARTED|Overall Study||7
2233862|NCT02673619|5475147|P3|STARTED|Overall Study||26
2233863|NCT02673619|5475148|P2|STARTED|Overall Study||5
2233864|NCT02673619|5475149|P1|STARTED|Overall Study||20
2233865|NCT02673541|5475241|P2|NOT COMPLETED|Overall Study||0
2233866|NCT02673541|5475242|P1|NOT COMPLETED|Overall Study||0
2233867|NCT02673541|5475241|P2|COMPLETED|Overall Study||2
2233868|NCT02673541|5475242|P1|COMPLETED|Overall Study||3
2233869|NCT02673541|5475241|P2|STARTED|Overall Study||2
2233870|NCT02673541|5475242|P1|STARTED|Overall Study||3
2233871|NCT02673489|5475260|P2|NOT COMPLETED|Follow Up Period||2
2233872|NCT02673489|5475261|P1|NOT COMPLETED|Follow Up Period||0
2233873|NCT02673489|5475260|P2|COMPLETED|Follow Up Period||21
2233874|NCT02673489|5475261|P1|COMPLETED|Follow Up Period||50
2233875|NCT02673489|5475260|P2|STARTED|Follow Up Period||23
2233876|NCT02673489|5475261|P1|STARTED|Follow Up Period||50
2233877|NCT02673489|5475260|P2|NOT COMPLETED|Treatment Period||3
2233878|NCT02673489|5475261|P1|NOT COMPLETED|Treatment Period||5
2233879|NCT02673489|5475260|P2|COMPLETED|Treatment Period||21
2233880|NCT02673489|5475261|P1|COMPLETED|Treatment Period||49
2233881|NCT02673489|5475260|P2|STARTED|Treatment Period||24
2233882|NCT02673489|5475261|P1|STARTED|Treatment Period||54
2233883|NCT02673372|5475276|P2|NOT COMPLETED|Overall Study||0
2233884|NCT02673372|5475277|P1|NOT COMPLETED|Overall Study||0
2233885|NCT02673372|5475276|P2|COMPLETED|Overall Study||30
2233886|NCT02673372|5475277|P1|COMPLETED|Overall Study||30
2233887|NCT02673372|5475276|P2|STARTED|Overall Study||30
2233888|NCT02673372|5475277|P1|STARTED|Overall Study||30
2233889|NCT02673333|5475283|P1|NOT COMPLETED|Overall Study||0
2233890|NCT02673333|5475283|P1|COMPLETED|Overall Study||39
2233891|NCT02673333|5475283|P1|STARTED|Overall Study||39
2233892|NCT02673203|5475289|P2|NOT COMPLETED|Overall Study||0
2233893|NCT02673203|5475290|P1|NOT COMPLETED|Overall Study||0
2233894|NCT02673203|5475289|P2|COMPLETED|Overall Study||15
2233895|NCT02673203|5475290|P1|COMPLETED|Overall Study||16
2233896|NCT02673203|5475289|P2|STARTED|Overall Study||15
2233897|NCT02673203|5475290|P1|STARTED|Overall Study||16
2233898|NCT02673138|5475312|P1|NOT COMPLETED|Overall Study||0
2233899|NCT02673138|5475312|P1|COMPLETED|Overall Study||10
2233900|NCT02673138|5475312|P1|STARTED|Overall Study||10
2233901|NCT02672852|5475326|P7|NOT COMPLETED|Part B||12
2233902|NCT02672852|5475327|P6|NOT COMPLETED|Part B||11
2233903|NCT02672852|5475328|P5|NOT COMPLETED|Part B||16
2233904|NCT02672852|5475329|P4|NOT COMPLETED|Part B||0
2233905|NCT02672852|5475330|P3|NOT COMPLETED|Part B||0
2233906|NCT02672852|5475331|P2|NOT COMPLETED|Part B||0
2233907|NCT02672852|5475332|P1|NOT COMPLETED|Part B||0
2233908|NCT02672852|5475326|P7|COMPLETED|Part B||51
2233909|NCT02672852|5475327|P6|COMPLETED|Part B||100
2233910|NCT02672852|5475328|P5|COMPLETED|Part B||209
2233911|NCT02672852|5475329|P4|COMPLETED|Part B||0
2233912|NCT02672852|5475330|P3|COMPLETED|Part B||0
2233913|NCT02672852|5475331|P2|COMPLETED|Part B||0
2233914|NCT02672852|5475332|P1|COMPLETED|Part B||0
2233915|NCT02672852|5475326|P7|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|63
2233916|NCT02672852|5475327|P6|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|111
2233917|NCT02672852|5475328|P5|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|225
2233918|NCT02672852|5475329|P4|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|0
2233919|NCT02672852|5475330|P3|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|0
2233920|NCT02672852|5475331|P2|STARTED|Part B||0
2233921|NCT02672852|5475332|P1|STARTED|Part B||0
2233922|NCT02672852|5475326|P7|NOT COMPLETED|Part A2||0
2233923|NCT02672852|5475327|P6|NOT COMPLETED|Part A2||0
2233924|NCT02672852|5475328|P5|NOT COMPLETED|Part A2||0
2233925|NCT02672852|5475329|P4|NOT COMPLETED|Part A2||4
2233926|NCT02672852|5475330|P3|NOT COMPLETED|Part A2||10
2233927|NCT02672852|5475331|P2|NOT COMPLETED|Part A2||0
2233928|NCT02672852|5475332|P1|NOT COMPLETED|Part A2||0
2233929|NCT02672852|5475326|P7|COMPLETED|Part A2||0
2233930|NCT02672852|5475327|P6|COMPLETED|Part A2||0
2233931|NCT02672852|5475328|P5|COMPLETED|Part A2||0
2233932|NCT02672852|5475329|P4|COMPLETED|Part A2||399
2233933|NCT02672852|5475330|P3|COMPLETED|Part A2||83
2233934|NCT02672852|5475331|P2|COMPLETED|Part A2||0
2233935|NCT02672852|5475332|P1|COMPLETED|Part A2||0
2233936|NCT02672852|5475326|P7|STARTED|Part A2||0
2233937|NCT02672852|5475327|P6|STARTED|Part A2||0
2233938|NCT02672852|5475328|P5|STARTED|Part A2||0
2233939|NCT02672852|5475329|P4|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|403
2233940|NCT02672852|5475330|P3|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|93
2233941|NCT02672852|5475331|P2|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|0
2233942|NCT02672852|5475332|P1|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|0
2233943|NCT02672852|5475326|P7|NOT COMPLETED|Part A1||0
2233944|NCT02672852|5475327|P6|NOT COMPLETED|Part A1||0
2233945|NCT02672852|5475328|P5|NOT COMPLETED|Part A1||0
2233946|NCT02672852|5475329|P4|NOT COMPLETED|Part A1||0
2233947|NCT02672852|5475330|P3|NOT COMPLETED|Part A1||0
2233948|NCT02672852|5475331|P2|NOT COMPLETED|Part A1||4
2233949|NCT02672852|5475332|P1|NOT COMPLETED|Part A1||3
2233950|NCT02672852|5475326|P7|COMPLETED|Part A1||0
2233951|NCT02672852|5475327|P6|COMPLETED|Part A1||0
2233952|NCT02672852|5475328|P5|COMPLETED|Part A1||0
2233953|NCT02672852|5475329|P4|COMPLETED|Part A1||0
2233954|NCT02672852|5475330|P3|COMPLETED|Part A1||0
2233955|NCT02672852|5475331|P2|COMPLETED|Part A1||403
2233956|NCT02672852|5475332|P1|COMPLETED|Part A1||97
2233957|NCT02672852|5475326|P7|STARTED|Part A1||0
2233958|NCT02672852|5475327|P6|STARTED|Part A1||0
2233959|NCT02672852|5475328|P5|STARTED|Part A1||0
2233960|NCT02672852|5475329|P4|STARTED|Part A1||0
2233961|NCT02672852|5475330|P3|STARTED|Part A1||0
2233962|NCT02672852|5475331|P2|STARTED|Part A1||407
2233963|NCT02672852|5475332|P1|STARTED|Part A1||100
2233964|NCT02672553|5475363|P2|NOT COMPLETED|Overall Study||8
2233965|NCT02672553|5475364|P1|NOT COMPLETED|Overall Study||12
2233966|NCT02672553|5475363|P2|COMPLETED|Overall Study||41
2233967|NCT02672553|5475364|P1|COMPLETED|Overall Study||39
2233968|NCT02672553|5475363|P2|As Intended (AI) Randomized Arm/Group|Overall Study||48
2233969|NCT02672553|5475364|P1|As Intended (AI) Randomized Arm/Group|Overall Study||46
2233970|NCT02672553|5475363|P2|As Treated (AT) Randomized Arm/Group|Overall Study||51
2233971|NCT02672553|5475364|P1|As Treated (AT) Randomized Arm/Group|Overall Study||46
2233972|NCT02672553|5475363|P2|Intent To Treated (ITT) Randomized Arm|Overall Study|One (1) subject randomized to Control arm/group withdrew prior to study procedure|48
2233973|NCT02672553|5475364|P1|Intent To Treated (ITT) Randomized Arm|Overall Study|Two (2) subjects randomized to Edwards INTUITY were intraoperative screen failures|49
2233974|NCT02672553|5475363|P2|STARTED|Overall Study||49
2233975|NCT02672553|5475364|P1|STARTED|Overall Study||51
2233976|NCT02672514|5475426|P2|NOT COMPLETED|Overall Study||0
2233977|NCT02672514|5475427|P1|NOT COMPLETED|Overall Study||0
2233978|NCT02672514|5475426|P2|COMPLETED|Overall Study||51
2233979|NCT02672514|5475427|P1|COMPLETED|Overall Study||53
2233980|NCT02672514|5475426|P2|STARTED|Overall Study||51
2233981|NCT02672514|5475427|P1|STARTED|Overall Study||53
2233982|NCT02672423|5475436|P10|NOT COMPLETED|Period 3||0
2233983|NCT02672423|5475437|P9|NOT COMPLETED|Period 3||0
2233984|NCT02672423|5475438|P8|NOT COMPLETED|Period 3||1
2233985|NCT02672423|5475439|P7|NOT COMPLETED|Period 3||0
2233986|NCT02672423|5475440|P6|NOT COMPLETED|Period 3||1
2233987|NCT02672423|5475441|P5|NOT COMPLETED|Period 3||0
2233988|NCT02672423|5475442|P4|NOT COMPLETED|Period 3||0
2233989|NCT02672423|5475443|P3|NOT COMPLETED|Period 3||0
2233990|NCT02672423|5475444|P2|NOT COMPLETED|Period 3||0
2233991|NCT02672423|5475445|P1|NOT COMPLETED|Period 3||0
2233992|NCT02672423|5475436|P10|COMPLETED|Period 3||0
2233993|NCT02672423|5475437|P9|COMPLETED|Period 3||0
2233994|NCT02672423|5475438|P8|COMPLETED|Period 3||14
2233995|NCT02672423|5475439|P7|COMPLETED|Period 3||15
2233996|NCT02672423|5475440|P6|COMPLETED|Period 3||14
2233997|NCT02672423|5475441|P5|COMPLETED|Period 3||14
2233998|NCT02672423|5475442|P4|COMPLETED|Period 3||15
2233999|NCT02672423|5475443|P3|COMPLETED|Period 3||13
2234000|NCT02672423|5475444|P2|COMPLETED|Period 3||0
2234001|NCT02672423|5475445|P1|COMPLETED|Period 3||0
2234002|NCT02672423|5475436|P10|STARTED|Period 3|Part C was a 2-period study design.|0
2234003|NCT02672423|5475437|P9|STARTED|Period 3|Part C was a 2-period study design.|0
2234004|NCT02672423|5475438|P8|STARTED|Period 3||15
2234005|NCT02672423|5475439|P7|STARTED|Period 3||15
2234006|NCT02672423|5475440|P6|STARTED|Period 3||15
2234007|NCT02672423|5475441|P5|STARTED|Period 3||14
2234008|NCT02672423|5475442|P4|STARTED|Period 3||15
2234009|NCT02672423|5475443|P3|STARTED|Period 3||13
2234010|NCT02672423|5475444|P2|STARTED|Period 3|Part A was a 2-period study design.|0
2234011|NCT02672423|5475445|P1|STARTED|Period 3|Part A was a 2-period study design.|0
2234012|NCT02672423|5475436|P10|NOT COMPLETED|Washout 2||0
2234013|NCT02672423|5475437|P9|NOT COMPLETED|Washout 2||0
2234014|NCT02672423|5475438|P8|NOT COMPLETED|Washout 2||0
2234015|NCT02672423|5475439|P7|NOT COMPLETED|Washout 2||0
2234016|NCT02672423|5475440|P6|NOT COMPLETED|Washout 2||0
2234017|NCT02672423|5475441|P5|NOT COMPLETED|Washout 2||0
2234018|NCT02672423|5475442|P4|NOT COMPLETED|Washout 2||0
2234019|NCT02672423|5475443|P3|NOT COMPLETED|Washout 2||0
2234020|NCT02672423|5475444|P2|NOT COMPLETED|Washout 2||0
2234021|NCT02672423|5475445|P1|NOT COMPLETED|Washout 2||0
2234022|NCT02672423|5475436|P10|COMPLETED|Washout 2||12
2234023|NCT02672423|5475437|P9|COMPLETED|Washout 2||12
2234024|NCT02672423|5475438|P8|COMPLETED|Washout 2||15
2234025|NCT02672423|5475439|P7|COMPLETED|Washout 2||15
2234026|NCT02672423|5475440|P6|COMPLETED|Washout 2||15
2234027|NCT02672423|5475441|P5|COMPLETED|Washout 2||14
2234028|NCT02672423|5475442|P4|COMPLETED|Washout 2||15
2234029|NCT02672423|5475443|P3|COMPLETED|Washout 2||13
2234030|NCT02672423|5475444|P2|COMPLETED|Washout 2||7
2234031|NCT02672423|5475445|P1|COMPLETED|Washout 2||7
2234032|NCT02672423|5475436|P10|STARTED|Washout 2||12
2234033|NCT02672423|5475437|P9|STARTED|Washout 2||12
2234034|NCT02672423|5475438|P8|STARTED|Washout 2||15
2234035|NCT02672423|5475439|P7|STARTED|Washout 2||15
2234036|NCT02672423|5475440|P6|STARTED|Washout 2||15
2234037|NCT02672423|5475441|P5|STARTED|Washout 2||14
2234038|NCT02672423|5475442|P4|STARTED|Washout 2||15
2234039|NCT02672423|5475443|P3|STARTED|Washout 2||13
2234040|NCT02672423|5475444|P2|STARTED|Washout 2||7
2234041|NCT02672423|5475445|P1|STARTED|Washout 2||7
2234042|NCT02672423|5475436|P10|NOT COMPLETED|Period 2||0
2234043|NCT02672423|5475437|P9|NOT COMPLETED|Period 2||0
2234044|NCT02672423|5475438|P8|NOT COMPLETED|Period 2||0
2234045|NCT02672423|5475439|P7|NOT COMPLETED|Period 2||0
2234046|NCT02672423|5475440|P6|NOT COMPLETED|Period 2||0
2234047|NCT02672423|5475441|P5|NOT COMPLETED|Period 2||0
2234048|NCT02672423|5475442|P4|NOT COMPLETED|Period 2||0
2234049|NCT02672423|5475443|P3|NOT COMPLETED|Period 2||1
2234050|NCT02672423|5475444|P2|NOT COMPLETED|Period 2||0
2234051|NCT02672423|5475445|P1|NOT COMPLETED|Period 2||0
2234052|NCT02672423|5475436|P10|COMPLETED|Period 2||12
2234053|NCT02672423|5475437|P9|COMPLETED|Period 2||12
2234054|NCT02672423|5475438|P8|COMPLETED|Period 2||15
2234055|NCT02672423|5475439|P7|COMPLETED|Period 2||15
2234056|NCT02672423|5475440|P6|COMPLETED|Period 2||15
2234057|NCT02672423|5475441|P5|COMPLETED|Period 2||14
2234058|NCT02672423|5475442|P4|COMPLETED|Period 2||15
2234059|NCT02672423|5475443|P3|COMPLETED|Period 2||13
2234060|NCT02672423|5475444|P2|COMPLETED|Period 2||7
2234061|NCT02672423|5475445|P1|COMPLETED|Period 2||7
2234062|NCT02672423|5475436|P10|STARTED|Period 2||12
2234063|NCT02672423|5475437|P9|STARTED|Period 2||12
2234064|NCT02672423|5475438|P8|STARTED|Period 2||15
2234065|NCT02672423|5475439|P7|STARTED|Period 2||15
2234066|NCT02672423|5475440|P6|STARTED|Period 2||15
2234067|NCT02672423|5475441|P5|STARTED|Period 2||14
2234068|NCT02672423|5475442|P4|STARTED|Period 2||15
2234069|NCT02672423|5475443|P3|STARTED|Period 2||14
2234070|NCT02672423|5475444|P2|STARTED|Period 2||7
2234071|NCT02672423|5475445|P1|STARTED|Period 2||7
2234072|NCT02672423|5475436|P10|NOT COMPLETED|Washout 1||0
2234073|NCT02672423|5475437|P9|NOT COMPLETED|Washout 1||0
2234074|NCT02672423|5475438|P8|NOT COMPLETED|Washout 1||0
2234075|NCT02672423|5475439|P7|NOT COMPLETED|Washout 1||0
2234076|NCT02672423|5475440|P6|NOT COMPLETED|Washout 1||0
2234077|NCT02672423|5475441|P5|NOT COMPLETED|Washout 1||0
2234078|NCT02672423|5475442|P4|NOT COMPLETED|Washout 1||0
2234079|NCT02672423|5475443|P3|NOT COMPLETED|Washout 1||0
2234080|NCT02672423|5475444|P2|NOT COMPLETED|Washout 1||0
2234081|NCT02672423|5475445|P1|NOT COMPLETED|Washout 1||0
2234082|NCT02672423|5475436|P10|COMPLETED|Washout 1||12
2234083|NCT02672423|5475437|P9|COMPLETED|Washout 1||12
2234084|NCT02672423|5475438|P8|COMPLETED|Washout 1||15
2234085|NCT02672423|5475439|P7|COMPLETED|Washout 1||15
2234086|NCT02672423|5475440|P6|COMPLETED|Washout 1||15
2234087|NCT02672423|5475441|P5|COMPLETED|Washout 1||14
2234088|NCT02672423|5475442|P4|COMPLETED|Washout 1||15
2234089|NCT02672423|5475443|P3|COMPLETED|Washout 1||14
2234090|NCT02672423|5475444|P2|COMPLETED|Washout 1||7
2234091|NCT02672423|5475445|P1|COMPLETED|Washout 1||7
2234092|NCT02672423|5475436|P10|STARTED|Washout 1||12
2234093|NCT02672423|5475437|P9|STARTED|Washout 1||12
2234094|NCT02672423|5475438|P8|STARTED|Washout 1||15
2234095|NCT02672423|5475439|P7|STARTED|Washout 1||15
2234096|NCT02672423|5475440|P6|STARTED|Washout 1||15
2234097|NCT02672423|5475441|P5|STARTED|Washout 1||14
2234098|NCT02672423|5475442|P4|STARTED|Washout 1||15
2234099|NCT02672423|5475443|P3|STARTED|Washout 1||14
2234100|NCT02672423|5475444|P2|STARTED|Washout 1||7
2234101|NCT02672423|5475445|P1|STARTED|Washout 1||7
2234102|NCT02672423|5475436|P10|NOT COMPLETED|Period 1||0
2234103|NCT02672423|5475437|P9|NOT COMPLETED|Period 1||0
2234104|NCT02672423|5475438|P8|NOT COMPLETED|Period 1||0
2234105|NCT02672423|5475439|P7|NOT COMPLETED|Period 1||0
2234106|NCT02672423|5475440|P6|NOT COMPLETED|Period 1||0
2234107|NCT02672423|5475441|P5|NOT COMPLETED|Period 1||1
2234108|NCT02672423|5475442|P4|NOT COMPLETED|Period 1||0
2234109|NCT02672423|5475443|P3|NOT COMPLETED|Period 1||0
2234110|NCT02672423|5475444|P2|NOT COMPLETED|Period 1||0
2234111|NCT02672423|5475445|P1|NOT COMPLETED|Period 1||0
2234112|NCT02672423|5475436|P10|COMPLETED|Period 1||12
2234113|NCT02672423|5475437|P9|COMPLETED|Period 1||12
2234114|NCT02672423|5475438|P8|COMPLETED|Period 1||15
2234115|NCT02672423|5475439|P7|COMPLETED|Period 1||15
2234116|NCT02672423|5475440|P6|COMPLETED|Period 1||15
2234117|NCT02672423|5475441|P5|COMPLETED|Period 1||14
2234118|NCT02672423|5475442|P4|COMPLETED|Period 1||15
2234119|NCT02672423|5475443|P3|COMPLETED|Period 1||14
2234120|NCT02672423|5475444|P2|COMPLETED|Period 1||7
2234121|NCT02672423|5475445|P1|COMPLETED|Period 1||7
2234122|NCT02672423|5475436|P10|Received at Least One Dose of Study Drug|Period 1||12
2234123|NCT02672423|5475437|P9|Received at Least One Dose of Study Drug|Period 1||12
2234124|NCT02672423|5475438|P8|Received at Least One Dose of Study Drug|Period 1||15
2234125|NCT02672423|5475439|P7|Received at Least One Dose of Study Drug|Period 1||15
2234126|NCT02672423|5475440|P6|Received at Least One Dose of Study Drug|Period 1||15
2234127|NCT02672423|5475441|P5|Received at Least One Dose of Study Drug|Period 1||15
2234128|NCT02672423|5475442|P4|Received at Least One Dose of Study Drug|Period 1||15
2234129|NCT02672423|5475443|P3|Received at Least One Dose of Study Drug|Period 1||14
2234130|NCT02672423|5475444|P2|Received at Least One Dose of Study Drug|Period 1||7
2234131|NCT02672423|5475445|P1|Received at Least One Dose of Study Drug|Period 1||7
2234132|NCT02672423|5475436|P10|STARTED|Period 1||12
2234133|NCT02672423|5475437|P9|STARTED|Period 1||12
2234134|NCT02672423|5475438|P8|STARTED|Period 1||15
2234135|NCT02672423|5475439|P7|STARTED|Period 1||15
2234136|NCT02672423|5475440|P6|STARTED|Period 1||15
2234137|NCT02672423|5475441|P5|STARTED|Period 1||15
2234138|NCT02672423|5475442|P4|STARTED|Period 1||15
2234139|NCT02672423|5475443|P3|STARTED|Period 1||14
2234140|NCT02672423|5475444|P2|STARTED|Period 1||7
2234141|NCT02672423|5475445|P1|STARTED|Period 1||7
2234142|NCT02672176|5475470|P2|NOT COMPLETED|Overall Study||26
2234143|NCT02672176|5475471|P1|NOT COMPLETED|Overall Study||6
2234144|NCT02672176|5475470|P2|COMPLETED|Overall Study||132
2234145|NCT02672176|5475471|P1|COMPLETED|Overall Study||155
2234146|NCT02672176|5475470|P2|STARTED|Overall Study||158
2234147|NCT02672176|5475471|P1|STARTED|Overall Study||161
2234148|NCT02672111|5475507|P2|NOT COMPLETED|Overall Study||12
2234149|NCT02672111|5475508|P1|NOT COMPLETED|Overall Study||58
2234150|NCT02672111|5475507|P2|COMPLETED|Overall Study||25
2234151|NCT02672111|5475508|P1|COMPLETED|Overall Study||132
2234152|NCT02672111|5475507|P2|Completed Treatment|Overall Study||29
2234153|NCT02672111|5475508|P1|Completed Treatment|Overall Study||138
2234154|NCT02672111|5475507|P2|STARTED|Overall Study||37
2234155|NCT02672111|5475508|P1|STARTED|Overall Study||190
2234159|NCT02671760|5475540|P3|NOT COMPLETED|Overall Study||0
2234160|NCT02671760|5475541|P2|NOT COMPLETED|Overall Study||1
2234161|NCT02671760|5475542|P1|NOT COMPLETED|Overall Study||0
2234162|NCT02671760|5475540|P3|COMPLETED|Overall Study||13
2234163|NCT02671760|5475541|P2|COMPLETED|Overall Study|1 Subject could not be contacted for f/u phone call. Data included in safety and efficacy analyses.|12
2234164|NCT02671760|5475542|P1|COMPLETED|Overall Study||13
2234165|NCT02671760|5475540|P3|STARTED|Overall Study||13
2234166|NCT02671760|5475541|P2|STARTED|Overall Study||13
2234167|NCT02671760|5475542|P1|STARTED|Overall Study||13
2234168|NCT02671500|5475568|P1|NOT COMPLETED|Overall Study||14
2234169|NCT02671500|5475568|P1|COMPLETED|Overall Study||361
2234170|NCT02671500|5475568|P1|STARTED|Overall Study||375
2234171|NCT02671461|5475583|P3|NOT COMPLETED|Follow-up||1
2234172|NCT02671461|5475584|P2|NOT COMPLETED|Follow-up||1
2234173|NCT02671461|5475585|P1|NOT COMPLETED|Follow-up||1
2234174|NCT02671461|5475583|P3|COMPLETED|Follow-up||6
2234175|NCT02671461|5475584|P2|COMPLETED|Follow-up||4
2234176|NCT02671461|5475585|P1|COMPLETED|Follow-up||1
2234177|NCT02671461|5475583|P3|STARTED|Follow-up||7
2234178|NCT02671461|5475584|P2|STARTED|Follow-up||5
2234179|NCT02671461|5475585|P1|STARTED|Follow-up||2
2234180|NCT02671461|5475583|P3|NOT COMPLETED|Treatment||5
2234181|NCT02671461|5475584|P2|NOT COMPLETED|Treatment||3
2234182|NCT02671461|5475585|P1|NOT COMPLETED|Treatment||2
2234183|NCT02671461|5475583|P3|COMPLETED|Treatment||2
2234184|NCT02671461|5475584|P2|COMPLETED|Treatment||2
2234185|NCT02671461|5475585|P1|COMPLETED|Treatment||1
2234186|NCT02671461|5475583|P3|STARTED|Treatment||7
2234187|NCT02671461|5475584|P2|STARTED|Treatment||5
2234188|NCT02671461|5475585|P1|STARTED|Treatment||3
2234189|NCT02671266|5475610|P2|NOT COMPLETED|Overall Study||1
2234190|NCT02671266|5475611|P1|NOT COMPLETED|Overall Study||1
2234191|NCT02671266|5475610|P2|COMPLETED|Overall Study||20
2234192|NCT02671266|5475611|P1|COMPLETED|Overall Study||19
2234193|NCT02671266|5475610|P2|Healthy Participants|Overall Study||8
2234194|NCT02671266|5475611|P1|Healthy Participants|Overall Study||8
2234195|NCT02671266|5475610|P2|OCD Participants|Overall Study||3
2234196|NCT02671266|5475611|P1|OCD Participants|Overall Study||2
2234197|NCT02671266|5475610|P2|BDD Participants|Overall Study||9
2234198|NCT02671266|5475611|P1|BDD Participants|Overall Study||9
2234199|NCT02671266|5475610|P2|STARTED|Overall Study||21
2234200|NCT02671266|5475611|P1|STARTED|Overall Study||20
2234201|NCT02671136|5475625|P2|NOT COMPLETED|Overall Study||0
2234202|NCT02671136|5475626|P1|NOT COMPLETED|Overall Study||0
2234203|NCT02671136|5475625|P2|COMPLETED|Overall Study||0
2234204|NCT02671136|5475626|P1|COMPLETED|Overall Study||3
2234205|NCT02671136|5475625|P2|STARTED|Overall Study||0
2234206|NCT02671136|5475626|P1|STARTED|Overall Study||3
2234207|NCT02670928|5475634|P2|NOT COMPLETED|Overall Study||1
2234208|NCT02670928|5475635|P1|NOT COMPLETED|Overall Study||10
2234209|NCT02670928|5475634|P2|COMPLETED|Overall Study||29
2234210|NCT02670928|5475635|P1|COMPLETED|Overall Study||90
2234211|NCT02670928|5475634|P2|STARTED|Overall Study||30
2234212|NCT02670928|5475635|P1|STARTED|Overall Study||100
2234213|NCT02670915|5475662|P3|NOT COMPLETED|Overall Study||5
2234214|NCT02670915|5475663|P2|NOT COMPLETED|Overall Study||8
2234215|NCT02670915|5475664|P1|NOT COMPLETED|Overall Study||4
2234216|NCT02670915|5475662|P3|COMPLETED|Overall Study||253
2234217|NCT02670915|5475663|P2|COMPLETED|Overall Study||251
2234218|NCT02670915|5475664|P1|COMPLETED|Overall Study||256
2234219|NCT02670915|5475662|P3|STARTED|Overall Study||258
2234220|NCT02670915|5475663|P2|STARTED|Overall Study||259
2234221|NCT02670915|5475664|P1|STARTED|Overall Study||260
2234222|NCT02670811|5475911|P2|NOT COMPLETED|Overall Study||0
2234223|NCT02670811|5475912|P1|NOT COMPLETED|Overall Study||1
2234224|NCT02670811|5475911|P2|COMPLETED|Overall Study||18
2234225|NCT02670811|5475912|P1|COMPLETED|Overall Study||17
2234226|NCT02670811|5475911|P2|STARTED|Overall Study||18
2234227|NCT02670811|5475912|P1|STARTED|Overall Study||18
2234228|NCT02670629|5475930|P2|NOT COMPLETED|Overall Study||0
2234229|NCT02670629|5475931|P1|NOT COMPLETED|Overall Study||0
2234230|NCT02670629|5475930|P2|COMPLETED|Overall Study||29
2234231|NCT02670629|5475931|P1|COMPLETED|Overall Study||29
2234232|NCT02670629|5475930|P2|STARTED|Overall Study||29
2234233|NCT02670629|5475931|P1|STARTED|Overall Study||29
2234234|NCT02670551|5475948|P3|NOT COMPLETED|Overall Study||31
2234235|NCT02670551|5475949|P2|NOT COMPLETED|Overall Study||26
2234236|NCT02670551|5475950|P1|NOT COMPLETED|Overall Study||28
2234237|NCT02670551|5475948|P3|COMPLETED|Overall Study||134
2234238|NCT02670551|5475949|P2|COMPLETED|Overall Study||134
2234239|NCT02670551|5475950|P1|COMPLETED|Overall Study||135
2234240|NCT02670551|5475948|P3|Received Treatment (Safety Population)|Overall Study||165
2234241|NCT02670551|5475949|P2|Received Treatment (Safety Population)|Overall Study||157
2234242|NCT02670551|5475950|P1|Received Treatment (Safety Population)|Overall Study||158
2234243|NCT02670551|5475948|P3|STARTED|Overall Study||165
2234244|NCT02670551|5475949|P2|STARTED|Overall Study||160
2234245|NCT02670551|5475950|P1|STARTED|Overall Study||163
2234246|NCT02670538|5475964|P3|NOT COMPLETED|Overall Study||30
2234247|NCT02670538|5475965|P2|NOT COMPLETED|Overall Study||32
2234248|NCT02670538|5475966|P1|NOT COMPLETED|Overall Study||32
2234249|NCT02670538|5475964|P3|COMPLETED|Overall Study||128
2234250|NCT02670538|5475965|P2|COMPLETED|Overall Study||136
2234251|NCT02670538|5475966|P1|COMPLETED|Overall Study||135
2234252|NCT02670538|5475964|P3|Intent-to-Treat Population|Overall Study||153
2234253|NCT02670538|5475965|P2|Intent-to-Treat Population|Overall Study||162
2234254|NCT02670538|5475966|P1|Intent-to-Treat Population|Overall Study||163
2234255|NCT02670538|5475964|P3|Safety Population : Received Study Drug|Overall Study||158
2234256|NCT02670538|5475965|P2|Safety Population : Received Study Drug|Overall Study||167
2234257|NCT02670538|5475966|P1|Safety Population : Received Study Drug|Overall Study||165
2234258|NCT02670538|5475964|P3|STARTED|Overall Study||158
2234259|NCT02670538|5475965|P2|STARTED|Overall Study||168
2234260|NCT02670538|5475966|P1|STARTED|Overall Study||167
2234261|NCT02670473|5475977|P1|NOT COMPLETED|Overall Study||1
2234262|NCT02670473|5475977|P1|COMPLETED|Overall Study||34
2234263|NCT02670473|5475977|P1|STARTED|Overall Study||35
2234264|NCT02670343|5476030|P1|NOT COMPLETED|Overall Study||0
2234265|NCT02670343|5476030|P1|COMPLETED|Overall Study||8
2234266|NCT02670343|5476030|P1|STARTED|Overall Study||8
2234267|NCT02670330|5476036|P2|NOT COMPLETED|Overall Study||77
2234268|NCT02670330|5476037|P1|NOT COMPLETED|Overall Study||75
2234269|NCT02670330|5476036|P2|COMPLETED|Overall Study||0
2234270|NCT02670330|5476037|P1|COMPLETED|Overall Study||0
2234271|NCT02670330|5476036|P2|Received At Least 1 Dose Of Study Drug|Overall Study||77
2234272|NCT02670330|5476037|P1|Received At Least 1 Dose Of Study Drug|Overall Study||75
2234273|NCT02670330|5476036|P2|STARTED|Overall Study||77
2234274|NCT02670330|5476037|P1|STARTED|Overall Study||75
2234275|NCT02669940|5476049|P2|NOT COMPLETED|Overall Study||3
2234276|NCT02669940|5476050|P1|NOT COMPLETED|Overall Study||1
2234277|NCT02669940|5476049|P2|COMPLETED|Overall Study||92
2234278|NCT02669940|5476050|P1|COMPLETED|Overall Study||62
2234279|NCT02669940|5476049|P2|STARTED|Overall Study||95
2234280|NCT02669940|5476050|P1|STARTED|Overall Study||63
2234281|NCT02669914|5476106|P3|NOT COMPLETED|Overall Study||0
2234282|NCT02669914|5476107|P2|NOT COMPLETED|Overall Study||0
2234283|NCT02669914|5476108|P1|NOT COMPLETED|Overall Study||0
2234284|NCT02669914|5476106|P3|COMPLETED|Overall Study||0
2234285|NCT02669914|5476107|P2|COMPLETED|Overall Study||0
2234286|NCT02669914|5476108|P1|COMPLETED|Overall Study||4
2234287|NCT02669914|5476106|P3|STARTED|Overall Study||0
2234288|NCT02669914|5476107|P2|STARTED|Overall Study||0
2234289|NCT02669914|5476108|P1|STARTED|Overall Study||4
2234290|NCT02669862|5476152|P3|NOT COMPLETED|Overall Study||5
2234291|NCT02669862|5476153|P2|NOT COMPLETED|Overall Study||5
2234292|NCT02669862|5476154|P1|NOT COMPLETED|Overall Study||2
2234293|NCT02669862|5476152|P3|COMPLETED|Overall Study||26
2234294|NCT02669862|5476153|P2|COMPLETED|Overall Study||29
2234295|NCT02669862|5476154|P1|COMPLETED|Overall Study||31
2234296|NCT02669862|5476152|P3|STARTED|Overall Study||31
2234297|NCT02669862|5476153|P2|STARTED|Overall Study||34
2234298|NCT02669862|5476154|P1|STARTED|Overall Study||33
2234299|NCT02669849|5476170|P3|NOT COMPLETED|Overall Study||24
2234300|NCT02669849|5476171|P2|NOT COMPLETED|Overall Study||2
2234301|NCT02669849|5476172|P1|NOT COMPLETED|Overall Study||18
2234302|NCT02669849|5476170|P3|COMPLETED|Overall Study||8
2234303|NCT02669849|5476171|P2|COMPLETED|Overall Study||4
2234304|NCT02669849|5476172|P1|COMPLETED|Overall Study||11
2234305|NCT02669849|5476170|P3|STARTED|Overall Study||32
2234306|NCT02669849|5476171|P2|STARTED|Overall Study||6
2234307|NCT02669849|5476172|P1|STARTED|Overall Study||29
2234308|NCT02669784|5476194|P2|NOT COMPLETED|Overall Study||0
2234309|NCT02669784|5476195|P1|NOT COMPLETED|Overall Study||0
2234310|NCT02669784|5476194|P2|COMPLETED|Overall Study||16
2234311|NCT02669784|5476195|P1|COMPLETED|Overall Study||18
2234312|NCT02669784|5476194|P2|STARTED|Overall Study||16
2234313|NCT02669784|5476195|P1|STARTED|Overall Study||18
2234314|NCT02669758|5476215|P1|NOT COMPLETED|Overall Study||94
2234315|NCT02669758|5476215|P1|COMPLETED|Overall Study||183
2234316|NCT02669758|5476215|P1|STARTED|Overall Study||277
2234317|NCT02669667|5476226|P7|NOT COMPLETED|Overall Study||0
2234318|NCT02669667|5476227|P6|NOT COMPLETED|Overall Study||1
2234319|NCT02669667|5476228|P5|NOT COMPLETED|Overall Study||0
2234320|NCT02669667|5476229|P4|NOT COMPLETED|Overall Study||0
2234321|NCT02669667|5476230|P3|NOT COMPLETED|Overall Study||0
2234322|NCT02669667|5476231|P2|NOT COMPLETED|Overall Study||0
2234323|NCT02669667|5476232|P1|NOT COMPLETED|Overall Study||0
2234324|NCT02669667|5476226|P7|COMPLETED|Overall Study||6
2234325|NCT02669667|5476227|P6|COMPLETED|Overall Study||5
2234326|NCT02669667|5476228|P5|COMPLETED|Overall Study||6
2234327|NCT02669667|5476229|P4|COMPLETED|Overall Study||6
2234328|NCT02669667|5476230|P3|COMPLETED|Overall Study||4
2234329|NCT02669667|5476231|P2|COMPLETED|Overall Study||4
2234330|NCT02669667|5476232|P1|COMPLETED|Overall Study||12
2234331|NCT02669667|5476226|P7|STARTED|Overall Study||6
2234332|NCT02669667|5476227|P6|STARTED|Overall Study||6
2234333|NCT02669667|5476228|P5|STARTED|Overall Study||6
2234334|NCT02669667|5476229|P4|STARTED|Overall Study||6
2234335|NCT02669667|5476230|P3|STARTED|Overall Study||4
2234336|NCT02669667|5476231|P2|STARTED|Overall Study||4
2234337|NCT02669667|5476232|P1|STARTED|Overall Study||12
2234338|NCT02669615|5476326|P1|NOT COMPLETED|Overall Study||0
2234339|NCT02669615|5476326|P1|COMPLETED|Overall Study||24
2234340|NCT02669615|5476326|P1|STARTED|Overall Study||24
2234341|NCT02669433|5476335|P3|NOT COMPLETED|Overall Study||15
2234342|NCT02669433|5476336|P2|NOT COMPLETED|Overall Study||14
2234343|NCT02669433|5476337|P1|NOT COMPLETED|Overall Study||15
2234344|NCT02669433|5476335|P3|COMPLETED|Overall Study||74
2234345|NCT02669433|5476336|P2|COMPLETED|Overall Study||75
2234346|NCT02669433|5476337|P1|COMPLETED|Overall Study||76
2234347|NCT02669433|5476335|P3|UPDRS Primary Population|Overall Study||84
2234348|NCT02669433|5476336|P2|UPDRS Primary Population|Overall Study||87
2234349|NCT02669433|5476337|P1|UPDRS Primary Population|Overall Study||87
2234350|NCT02669433|5476335|P3|Completers Population|Overall Study||69
2234351|NCT02669433|5476336|P2|Completers Population|Overall Study||72
2234352|NCT02669433|5476337|P1|Completers Population|Overall Study||73
2234353|NCT02669433|5476335|P3|Per-Protocol Population|Overall Study||82
2234354|NCT02669433|5476336|P2|Per-Protocol Population|Overall Study||79
2234355|NCT02669433|5476337|P1|Per-Protocol Population|Overall Study||78
2234356|NCT02669433|5476335|P3|Intent to Treat (ITT) Population|Overall Study||87
2234357|NCT02669433|5476336|P2|Intent to Treat (ITT) Population|Overall Study||89
2234358|NCT02669433|5476337|P1|Intent to Treat (ITT) Population|Overall Study||89
2234359|NCT02669433|5476335|P3|Safety Population|Overall Study||88
2234360|NCT02669433|5476336|P2|Safety Population|Overall Study||89
2234361|NCT02669433|5476337|P1|Safety Population|Overall Study||91
2234362|NCT02669433|5476335|P3|STARTED|Overall Study||89
2234363|NCT02669433|5476336|P2|STARTED|Overall Study||89
2234364|NCT02669433|5476337|P1|STARTED|Overall Study||91
2234365|NCT02669407|5476351|P1|NOT COMPLETED|Overall Study||3
2234366|NCT02669407|5476351|P1|COMPLETED|Overall Study||11
2234367|NCT02669407|5476351|P1|STARTED|Overall Study||14
2234368|NCT02669264|5476375|P7|NOT COMPLETED|Overall Study||5
2234369|NCT02669264|5476376|P6|NOT COMPLETED|Overall Study||6
2234370|NCT02669264|5476377|P5|NOT COMPLETED|Overall Study||5
2234371|NCT02669264|5476378|P4|NOT COMPLETED|Overall Study||3
2234372|NCT02669264|5476379|P3|NOT COMPLETED|Overall Study||3
2234373|NCT02669264|5476380|P2|NOT COMPLETED|Overall Study||6
2234374|NCT02669264|5476381|P1|NOT COMPLETED|Overall Study||5
2234375|NCT02669264|5476375|P7|COMPLETED|Overall Study||0
2234376|NCT02669264|5476376|P6|COMPLETED|Overall Study||0
2234377|NCT02669264|5476377|P5|COMPLETED|Overall Study||0
2234378|NCT02669264|5476378|P4|COMPLETED|Overall Study||1
2234379|NCT02669264|5476379|P3|COMPLETED|Overall Study||0
2234380|NCT02669264|5476380|P2|COMPLETED|Overall Study||1
2234381|NCT02669264|5476381|P1|COMPLETED|Overall Study||0
2234382|NCT02669264|5476375|P7|STARTED|Overall Study||5
2234383|NCT02669264|5476376|P6|STARTED|Overall Study||6
2234384|NCT02669264|5476377|P5|STARTED|Overall Study||5
2234385|NCT02669264|5476378|P4|STARTED|Overall Study||4
2234386|NCT02669264|5476379|P3|STARTED|Overall Study||3
2234387|NCT02669264|5476380|P2|STARTED|Overall Study||7
2234388|NCT02669264|5476381|P1|STARTED|Overall Study||5
2234389|NCT02669095|5476527|P2|NOT COMPLETED|Overall Study||3
2234390|NCT02669095|5476528|P1|NOT COMPLETED|Overall Study||1
2234391|NCT02669095|5476527|P2|COMPLETED|Overall Study||72
2234392|NCT02669095|5476528|P1|COMPLETED|Overall Study||74
2234393|NCT02669095|5476527|P2|STARTED|Overall Study||75
2234394|NCT02669095|5476528|P1|STARTED|Overall Study||75
2234395|NCT02669082|5476536|P1|NOT COMPLETED|Overall Study||1
2234396|NCT02669082|5476536|P1|COMPLETED|Overall Study||25
2234397|NCT02669082|5476536|P1|STARTED|Overall Study||26
2234398|NCT02669043|5476548|P1|NOT COMPLETED|Overall Study||4
2234399|NCT02669043|5476548|P1|COMPLETED|Overall Study||4
2234400|NCT02669043|5476548|P1|STARTED|Overall Study||8
2234401|NCT02668952|5476554|P2|NOT COMPLETED|Overall Study||0
2234402|NCT02668952|5476555|P1|NOT COMPLETED|Overall Study||0
2234403|NCT02668952|5476554|P2|COMPLETED|Overall Study||14
2234404|NCT02668952|5476555|P1|COMPLETED|Overall Study||16
2234405|NCT02668952|5476554|P2|STARTED|Overall Study||14
2234406|NCT02668952|5476555|P1|STARTED|Overall Study||16
2234407|NCT02668822|5476575|P2|NOT COMPLETED|Overall Study||9
2234408|NCT02668822|5476576|P1|NOT COMPLETED|Overall Study||9
2234409|NCT02668822|5476575|P2|COMPLETED|Overall Study||0
2234410|NCT02668822|5476576|P1|COMPLETED|Overall Study||0
2234411|NCT02668822|5476575|P2|STARTED|Overall Study||9
2234412|NCT02668822|5476576|P1|STARTED|Overall Study||9
2234413|NCT02668783|5476598|P2|NOT COMPLETED|Overall Study||12
2234414|NCT02668783|5476599|P1|NOT COMPLETED|Overall Study||13
2234415|NCT02668783|5476598|P2|COMPLETED|Overall Study||0
2234416|NCT02668783|5476599|P1|COMPLETED|Overall Study||0
2234417|NCT02668783|5476598|P2|Treated|Overall Study||11
2234418|NCT02668783|5476599|P1|Treated|Overall Study||13
2234419|NCT02668783|5476598|P2|STARTED|Overall Study||12
2234420|NCT02668783|5476599|P1|STARTED|Overall Study||13
2234421|NCT02668640|5476619|P1|NOT COMPLETED|Overall Study||14
2234422|NCT02668640|5476619|P1|COMPLETED|Overall Study||41
2234423|NCT02668640|5476619|P1|STARTED|Overall Study||55
2234424|NCT02668432|5476632|P2|NOT COMPLETED|Overall Study||0
2234425|NCT02668432|5476633|P1|NOT COMPLETED|Overall Study||0
2234426|NCT02668432|5476632|P2|COMPLETED|Overall Study||4
2234427|NCT02668432|5476633|P1|COMPLETED|Overall Study||5
2234428|NCT02668432|5476632|P2|STARTED|Overall Study||4
2234429|NCT02668432|5476633|P1|STARTED|Overall Study||5
2234430|NCT02668302|5476671|P2|NOT COMPLETED|Overall Study||0
2234431|NCT02668302|5476672|P1|NOT COMPLETED|Overall Study||1
2234432|NCT02668302|5476671|P2|COMPLETED|Overall Study||20
2234433|NCT02668302|5476672|P1|COMPLETED|Overall Study||19
2234434|NCT02668302|5476671|P2|STARTED|Overall Study||20
2234435|NCT02668302|5476672|P1|STARTED|Overall Study||20
2234436|NCT02668198|5476678|P1|NOT COMPLETED|Overall Study||0
2234437|NCT02668198|5476678|P1|COMPLETED|Overall Study||230
2234438|NCT02668198|5476678|P1|STARTED|Overall Study||230
2234439|NCT02667912|5476692|P2|NOT COMPLETED|Overall Study||3
2234440|NCT02667912|5476693|P1|NOT COMPLETED|Overall Study||5
2234441|NCT02667912|5476692|P2|COMPLETED|Overall Study||24
2234442|NCT02667912|5476693|P1|COMPLETED|Overall Study||23
2234443|NCT02667912|5476692|P2|Six Months|Overall Study||24
2234444|NCT02667912|5476693|P1|Six Months|Overall Study||27
2234445|NCT02667912|5476692|P2|STARTED|Overall Study||27
2234446|NCT02667912|5476693|P1|STARTED|Overall Study||28
2234447|NCT02667821|5476745|P1|NOT COMPLETED|Overall Study||0
2234448|NCT02667821|5476745|P1|COMPLETED|Overall Study||20
2234449|NCT02667821|5476745|P1|STARTED|Overall Study||20
2234450|NCT02667704|5476751|P1|NOT COMPLETED|Treatment Period 2||0
2234451|NCT02667704|5476751|P1|COMPLETED|Treatment Period 2||13
2234452|NCT02667704|5476751|P1|STARTED|Treatment Period 2||13
2234453|NCT02667704|5476751|P1|NOT COMPLETED|Treatment Period 1||0
2234454|NCT02667704|5476751|P1|COMPLETED|Treatment Period 1||13
2234455|NCT02667704|5476751|P1|STARTED|Treatment Period 1||13
2234456|NCT02667639|5476764|P2|NOT COMPLETED|Overall Study||0
2234457|NCT02667639|5476765|P1|NOT COMPLETED|Overall Study||0
2234458|NCT02667639|5476764|P2|COMPLETED|Overall Study||10
2234459|NCT02667639|5476765|P1|COMPLETED|Overall Study||25
2234460|NCT02667639|5476764|P2|STARTED|Overall Study||10
2234461|NCT02667639|5476765|P1|STARTED|Overall Study||25
2234462|NCT02667288|5476791|P1|NOT COMPLETED|Overall Study||13
2234463|NCT02667288|5476791|P1|COMPLETED|Overall Study||134
2234464|NCT02667288|5476791|P1|STARTED|Overall Study||147
2234465|NCT02667275|5476798|P2|NOT COMPLETED|Overall Study||15
2234466|NCT02667275|5476799|P1|NOT COMPLETED|Overall Study||11
2234467|NCT02667275|5476798|P2|COMPLETED|Overall Study||228
2234468|NCT02667275|5476799|P1|COMPLETED|Overall Study||233
2234469|NCT02667275|5476798|P2|STARTED|Overall Study||243
2234470|NCT02667275|5476799|P1|STARTED|Overall Study||244
2234471|NCT02667236|5476809|P2|NOT COMPLETED|Overall Study||1
2234472|NCT02667236|5476810|P1|NOT COMPLETED|Overall Study||3
2234473|NCT02667236|5476809|P2|COMPLETED|Overall Study||226
2234474|NCT02667236|5476810|P1|COMPLETED|Overall Study||220
2234475|NCT02667236|5476809|P2|STARTED|Overall Study||227
2234476|NCT02667236|5476810|P1|STARTED|Overall Study||223
2234477|NCT02666950|5476818|P1|NOT COMPLETED|Overall Study||0
2234478|NCT02666950|5476818|P1|COMPLETED|Overall Study||3
2234479|NCT02666950|5476818|P1|STARTED|Overall Study||3
2234480|NCT02666560|5476828|P2|NOT COMPLETED|Condition 2 (1 Day)||0
2234481|NCT02666560|5476829|P1|NOT COMPLETED|Condition 2 (1 Day)||0
2234482|NCT02666560|5476828|P2|COMPLETED|Condition 2 (1 Day)||11
2234483|NCT02666560|5476829|P1|COMPLETED|Condition 2 (1 Day)||8
2234484|NCT02666560|5476828|P2|STARTED|Condition 2 (1 Day)||11
2234485|NCT02666560|5476829|P1|STARTED|Condition 2 (1 Day)||8
2234486|NCT02666560|5476828|P2|NOT COMPLETED|Condition 1 (1 Day)||0
2234487|NCT02666560|5476829|P1|NOT COMPLETED|Condition 1 (1 Day)||0
2234488|NCT02666560|5476828|P2|COMPLETED|Condition 1 (1 Day)||11
2234489|NCT02666560|5476829|P1|COMPLETED|Condition 1 (1 Day)||8
2234490|NCT02666560|5476828|P2|STARTED|Condition 1 (1 Day)||11
2234491|NCT02666560|5476829|P1|STARTED|Condition 1 (1 Day)||8
2234492|NCT02666352|5476848|P3|NOT COMPLETED|Overall Study||0
2234493|NCT02666352|5476849|P2|NOT COMPLETED|Overall Study||0
2234494|NCT02666352|5476850|P1|NOT COMPLETED|Overall Study||0
2234495|NCT02666352|5476848|P3|COMPLETED|Overall Study||8
2234496|NCT02666352|5476849|P2|COMPLETED|Overall Study||8
2234497|NCT02666352|5476850|P1|COMPLETED|Overall Study||8
2234498|NCT02666352|5476848|P3|STARTED|Overall Study||8
2234499|NCT02666352|5476849|P2|STARTED|Overall Study||8
2234500|NCT02666352|5476850|P1|STARTED|Overall Study||8
2234501|NCT02666222|5476954|P1|NOT COMPLETED|Overall Study||2
2234502|NCT02666222|5476954|P1|COMPLETED|Overall Study||49
2234503|NCT02666222|5476954|P1|STARTED|Overall Study||51
2234504|NCT02665689|5476964|P2|NOT COMPLETED|Overall Study||2
2234505|NCT02665689|5476965|P1|NOT COMPLETED|Overall Study||2
2234506|NCT02665689|5476964|P2|COMPLETED|Overall Study||0
2234507|NCT02665689|5476965|P1|COMPLETED|Overall Study||0
2234508|NCT02665689|5476964|P2|STARTED|Overall Study||2
2234509|NCT02665689|5476965|P1|STARTED|Overall Study||2
2234510|NCT02665468|5476987|P2|NOT COMPLETED|Overall Study||0
2234511|NCT02665468|5476988|P1|NOT COMPLETED|Overall Study||0
2234512|NCT02665468|5476987|P2|COMPLETED|Overall Study||601
2234513|NCT02665468|5476988|P1|COMPLETED|Overall Study||595
2234514|NCT02665468|5476987|P2|STARTED|Overall Study||601
2234515|NCT02665468|5476988|P1|STARTED|Overall Study||595
2234516|NCT02665455|5477000|P1|NOT COMPLETED|Overall Study||9
2234517|NCT02665455|5477000|P1|COMPLETED|Overall Study||74
2234518|NCT02665455|5477000|P1|STARTED|Overall Study||83
2234519|NCT02665286|5477007|P3|NOT COMPLETED|Overall Study||1
2234520|NCT02665286|5477008|P2|NOT COMPLETED|Overall Study||2
2234521|NCT02665286|5477009|P1|NOT COMPLETED|Overall Study||3
2234522|NCT02665286|5477007|P3|COMPLETED|Overall Study||80
2234523|NCT02665286|5477008|P2|COMPLETED|Overall Study||78
2234524|NCT02665286|5477009|P1|COMPLETED|Overall Study||76
2234525|NCT02665286|5477007|P3|STARTED|Overall Study||81
2234526|NCT02665286|5477008|P2|STARTED|Overall Study||80
2234527|NCT02665286|5477009|P1|STARTED|Overall Study||79
2234528|NCT02665260|5477030|P4|NOT COMPLETED|Overall Study||1
2234529|NCT02665260|5477031|P3|NOT COMPLETED|Overall Study||4
2234530|NCT02665260|5477032|P2|NOT COMPLETED|Overall Study||1
2234531|NCT02665260|5477033|P1|NOT COMPLETED|Overall Study||2
2234532|NCT02665260|5477030|P4|COMPLETED|Overall Study||21
2234533|NCT02665260|5477031|P3|COMPLETED|Overall Study||21
2234534|NCT02665260|5477032|P2|COMPLETED|Overall Study||22
2234535|NCT02665260|5477033|P1|COMPLETED|Overall Study||22
2234536|NCT02665260|5477030|P4|STARTED|Overall Study||22
2234537|NCT02665260|5477031|P3|STARTED|Overall Study||25
2234538|NCT02665260|5477032|P2|STARTED|Overall Study||23
2234539|NCT02665260|5477033|P1|STARTED|Overall Study||24
2234540|NCT02665221|5477049|P2|NOT COMPLETED|Overall Study||15
2234541|NCT02665221|5477050|P1|NOT COMPLETED|Overall Study||15
2234542|NCT02665221|5477049|P2|COMPLETED|Overall Study||0
2234543|NCT02665221|5477050|P1|COMPLETED|Overall Study||0
2234544|NCT02665221|5477049|P2|STARTED|Overall Study||15
2234545|NCT02665221|5477050|P1|STARTED|Overall Study||15
2234546|NCT02664987|5477062|P1|NOT COMPLETED|Overall Study||0
2234547|NCT02664987|5477062|P1|COMPLETED|Overall Study||462
2234548|NCT02664987|5477062|P1|STARTED|Overall Study||462
2234549|NCT02664961|5477071|P1|NOT COMPLETED|Overall Study||0
2234550|NCT02664961|5477071|P1|COMPLETED|Overall Study||3
2234551|NCT02664961|5477071|P1|STARTED|Overall Study||3
2234552|NCT02664610|5477082|P2|NOT COMPLETED|Overall Study||7
2234553|NCT02664610|5477083|P1|NOT COMPLETED|Overall Study||14
2234554|NCT02664610|5477082|P2|COMPLETED|Overall Study||41
2234555|NCT02664610|5477083|P1|COMPLETED|Overall Study||32
2234556|NCT02664610|5477082|P2|STARTED|Overall Study||48
2234557|NCT02664610|5477083|P1|STARTED|Overall Study||46
2234558|NCT02664532|5477093|P2|NOT COMPLETED|Overall Study||0
2234559|NCT02664532|5477094|P1|NOT COMPLETED|Overall Study||0
2234560|NCT02664532|5477093|P2|COMPLETED|Overall Study||75
2234561|NCT02664532|5477094|P1|COMPLETED|Overall Study||75
2234562|NCT02664532|5477093|P2|STARTED|Overall Study||75
2234563|NCT02664532|5477094|P1|STARTED|Overall Study||75
2234564|NCT02664415|5477108|P2|NOT COMPLETED|Overall Study||0
2234565|NCT02664415|5477109|P1|NOT COMPLETED|Overall Study||1
2234566|NCT02664415|5477108|P2|COMPLETED|Overall Study||5
2234567|NCT02664415|5477109|P1|COMPLETED|Overall Study||13
2234568|NCT02664415|5477108|P2|STARTED|Overall Study||5
2234569|NCT02664415|5477109|P1|STARTED|Overall Study||14
2234570|NCT02664311|5477139|P2|NOT COMPLETED|Overall Study||0
2234571|NCT02664311|5477140|P1|NOT COMPLETED|Overall Study||0
2234572|NCT02664311|5477139|P2|COMPLETED|Overall Study||3
2234573|NCT02664311|5477140|P1|COMPLETED|Overall Study||6
2234574|NCT02664311|5477139|P2|STARTED|Overall Study||3
2234575|NCT02664311|5477140|P1|STARTED|Overall Study||6
2234576|NCT02664272|5477150|P1|NOT COMPLETED|Overall Study||2
2234577|NCT02664272|5477150|P1|COMPLETED|Overall Study||38
2234578|NCT02664272|5477150|P1|STARTED|Overall Study||40
2234579|NCT02664220|5477158|P2|NOT COMPLETED|Overall Study||0
2234580|NCT02664220|5477159|P1|NOT COMPLETED|Overall Study||0
2234581|NCT02664220|5477158|P2|COMPLETED|Overall Study||50
2234582|NCT02664220|5477159|P1|COMPLETED|Overall Study||50
2234583|NCT02664220|5477158|P2|STARTED|Overall Study||50
2234584|NCT02664220|5477159|P1|STARTED|Overall Study||50
2234585|NCT02663817|5477171|P1|NOT COMPLETED|Overall Study||2
2234586|NCT02663817|5477171|P1|COMPLETED|Overall Study||50
2234587|NCT02663817|5477171|P1|STARTED|Overall Study||52
2234588|NCT02663752|5477177|P1|NOT COMPLETED|Overall Study||0
2234589|NCT02663752|5477177|P1|COMPLETED|Overall Study||1
2234590|NCT02663752|5477177|P1|STARTED|Overall Study||1
2234591|NCT02663687|5477191|P5|NOT COMPLETED|Overall Study||0
2234592|NCT02663687|5477192|P4|NOT COMPLETED|Overall Study||0
2234593|NCT02663687|5477193|P3|NOT COMPLETED|Overall Study||1
2234594|NCT02663687|5477194|P2|NOT COMPLETED|Overall Study||0
2234595|NCT02663687|5477195|P1|NOT COMPLETED|Overall Study||2
2234596|NCT02663687|5477191|P5|COMPLETED|Overall Study||9
2234597|NCT02663687|5477192|P4|COMPLETED|Overall Study||9
2234598|NCT02663687|5477193|P3|COMPLETED|Overall Study||8
2234599|NCT02663687|5477194|P2|COMPLETED|Overall Study||9
2234600|NCT02663687|5477195|P1|COMPLETED|Overall Study||10
2234601|NCT02663687|5477191|P5|Treatment Period 2 (SC)|Overall Study||9
2234602|NCT02663687|5477192|P4|Treatment Period 2 (SC)|Overall Study||9
2234603|NCT02663687|5477193|P3|Treatment Period 2 (SC)|Overall Study||8
2234604|NCT02663687|5477194|P2|Treatment Period 2 (SC)|Overall Study||9
2234605|NCT02663687|5477195|P1|Treatment Period 2 (SC)|Overall Study||10
2234606|NCT02663687|5477191|P5|Treatment Period 1 (IV)|Overall Study||9
2234607|NCT02663687|5477192|P4|Treatment Period 1 (IV)|Overall Study||9
2234608|NCT02663687|5477193|P3|Treatment Period 1 (IV)|Overall Study||9
2234609|NCT02663687|5477194|P2|Treatment Period 1 (IV)|Overall Study||9
2234610|NCT02663687|5477195|P1|Treatment Period 1 (IV)|Overall Study||12
2234611|NCT02663687|5477191|P5|STARTED|Overall Study||9
2234612|NCT02663687|5477192|P4|STARTED|Overall Study||9
2234613|NCT02663687|5477193|P3|STARTED|Overall Study||9
2234614|NCT02663687|5477194|P2|STARTED|Overall Study||9
2234615|NCT02663687|5477195|P1|STARTED|Overall Study||12
2234616|NCT02663674|5477249|P2|NOT COMPLETED|Overall Study||10
2234617|NCT02663674|5477250|P1|NOT COMPLETED|Overall Study||7
2234618|NCT02663674|5477249|P2|COMPLETED|Overall Study||29
2234619|NCT02663674|5477250|P1|COMPLETED|Overall Study||26
2234620|NCT02663674|5477249|P2|STARTED|Overall Study||39
2234621|NCT02663674|5477250|P1|STARTED|Overall Study||33
2234622|NCT02663453|5477514|P2|NOT COMPLETED|Overall Study||4
2234623|NCT02663453|5477515|P1|NOT COMPLETED|Overall Study||5
2234624|NCT02663453|5477514|P2|COMPLETED|Overall Study||18
2234625|NCT02663453|5477515|P1|COMPLETED|Overall Study||17
2234626|NCT02663453|5477514|P2|STARTED|Overall Study||22
2234627|NCT02663453|5477515|P1|STARTED|Overall Study||22
2234628|NCT02663232|5477537|P1|NOT COMPLETED|Overall Study||0
2234629|NCT02663232|5477537|P1|COMPLETED|Overall Study||264
2234630|NCT02663232|5477537|P1|STARTED|Overall Study||264
2234631|NCT02663128|5477560|P6|NOT COMPLETED|Period 3||0
2234632|NCT02663128|5477561|P5|NOT COMPLETED|Period 3||0
2234633|NCT02663128|5477562|P4|NOT COMPLETED|Period 3||0
2234634|NCT02663128|5477563|P3|NOT COMPLETED|Period 3||0
2234635|NCT02663128|5477564|P2|NOT COMPLETED|Period 3||0
2234636|NCT02663128|5477565|P1|NOT COMPLETED|Period 3||0
2234637|NCT02663128|5477560|P6|COMPLETED|Period 3||3
2234638|NCT02663128|5477561|P5|COMPLETED|Period 3||2
2234639|NCT02663128|5477562|P4|COMPLETED|Period 3||3
2234640|NCT02663128|5477563|P3|COMPLETED|Period 3||3
2234641|NCT02663128|5477564|P2|COMPLETED|Period 3||3
2234642|NCT02663128|5477565|P1|COMPLETED|Period 3||3
2234643|NCT02663128|5477560|P6|STARTED|Period 3||3
2234644|NCT02663128|5477561|P5|STARTED|Period 3||2
2234645|NCT02663128|5477562|P4|STARTED|Period 3||3
2234646|NCT02663128|5477563|P3|STARTED|Period 3||3
2234647|NCT02663128|5477564|P2|STARTED|Period 3||3
2234648|NCT02663128|5477565|P1|STARTED|Period 3||3
2234649|NCT02663128|5477560|P6|NOT COMPLETED|Period 2||0
2234650|NCT02663128|5477561|P5|NOT COMPLETED|Period 2||1
2234651|NCT02663128|5477562|P4|NOT COMPLETED|Period 2||0
2234652|NCT02663128|5477563|P3|NOT COMPLETED|Period 2||0
2234653|NCT02663128|5477564|P2|NOT COMPLETED|Period 2||0
2234654|NCT02663128|5477565|P1|NOT COMPLETED|Period 2||0
2234655|NCT02663128|5477560|P6|COMPLETED|Period 2||3
2234656|NCT02663128|5477561|P5|COMPLETED|Period 2||2
2234657|NCT02663128|5477562|P4|COMPLETED|Period 2||3
2234658|NCT02663128|5477563|P3|COMPLETED|Period 2||3
2234659|NCT02663128|5477564|P2|COMPLETED|Period 2||3
2234660|NCT02663128|5477565|P1|COMPLETED|Period 2||3
2234661|NCT02663128|5477560|P6|STARTED|Period 2||3
2234662|NCT02663128|5477561|P5|STARTED|Period 2||3
2234663|NCT02663128|5477562|P4|STARTED|Period 2||3
2234664|NCT02663128|5477563|P3|STARTED|Period 2||3
2234665|NCT02663128|5477564|P2|STARTED|Period 2||3
2234666|NCT02663128|5477565|P1|STARTED|Period 2||3
2234667|NCT02663128|5477560|P6|NOT COMPLETED|Period 1||0
2234668|NCT02663128|5477561|P5|NOT COMPLETED|Period 1||0
2234669|NCT02663128|5477562|P4|NOT COMPLETED|Period 1||0
2234670|NCT02663128|5477563|P3|NOT COMPLETED|Period 1||0
2234671|NCT02663128|5477564|P2|NOT COMPLETED|Period 1||0
2234672|NCT02663128|5477565|P1|NOT COMPLETED|Period 1||0
2234673|NCT02663128|5477560|P6|COMPLETED|Period 1||3
2234674|NCT02663128|5477561|P5|COMPLETED|Period 1||3
2234675|NCT02663128|5477562|P4|COMPLETED|Period 1||3
2234676|NCT02663128|5477563|P3|COMPLETED|Period 1||3
2234677|NCT02663128|5477564|P2|COMPLETED|Period 1||3
2234678|NCT02663128|5477565|P1|COMPLETED|Period 1||3
2234773|NCT02661061|5477964|P2|NOT COMPLETED|Overall Study||2
2234679|NCT02663128|5477560|P6|Received at Least One Dose of Study Drug|Period 1||3
2234680|NCT02663128|5477561|P5|Received at Least One Dose of Study Drug|Period 1||3
2234681|NCT02663128|5477562|P4|Received at Least One Dose of Study Drug|Period 1||3
2234682|NCT02663128|5477563|P3|Received at Least One Dose of Study Drug|Period 1||3
2234683|NCT02663128|5477564|P2|Received at Least One Dose of Study Drug|Period 1||3
2234684|NCT02663128|5477565|P1|Received at Least One Dose of Study Drug|Period 1||3
2234685|NCT02663128|5477560|P6|STARTED|Period 1||3
2234686|NCT02663128|5477561|P5|STARTED|Period 1||3
2234687|NCT02663128|5477562|P4|STARTED|Period 1||3
2234688|NCT02663128|5477563|P3|STARTED|Period 1||3
2234689|NCT02663128|5477564|P2|STARTED|Period 1||3
2234690|NCT02663128|5477565|P1|STARTED|Period 1||3
2234691|NCT02662764|5477579|P1|NOT COMPLETED|Overall Study||30
2234692|NCT02662764|5477579|P1|COMPLETED|Overall Study|First 24-hours of study treatment|290
2234693|NCT02662764|5477579|P1|STARTED|Overall Study||320
2234694|NCT02662608|5477639|P1|NOT COMPLETED|Overall Study||0
2234695|NCT02662608|5477639|P1|COMPLETED|Overall Study||1
2234696|NCT02662608|5477639|P1|STARTED|Overall Study||1
2234697|NCT02662569|5477647|P4|NOT COMPLETED|Overall Study||4
2234698|NCT02662569|5477648|P3|NOT COMPLETED|Overall Study||6
2234699|NCT02662569|5477649|P2|NOT COMPLETED|Overall Study||1
2234700|NCT02662569|5477650|P1|NOT COMPLETED|Overall Study||7
2234701|NCT02662569|5477647|P4|COMPLETED|Overall Study||328
2234702|NCT02662569|5477648|P3|COMPLETED|Overall Study||321
2234703|NCT02662569|5477649|P2|COMPLETED|Overall Study||160
2234704|NCT02662569|5477650|P1|COMPLETED|Overall Study||159
2234705|NCT02662569|5477647|P4|Received Study Drug|Overall Study||332
2234706|NCT02662569|5477648|P3|Received Study Drug|Overall Study||325
2234707|NCT02662569|5477649|P2|Received Study Drug|Overall Study||160
2234708|NCT02662569|5477650|P1|Received Study Drug|Overall Study||164
2234709|NCT02662569|5477647|P4|STARTED|Overall Study||332
2234710|NCT02662569|5477648|P3|STARTED|Overall Study||327
2234711|NCT02662569|5477649|P2|STARTED|Overall Study||161
2234712|NCT02662569|5477650|P1|STARTED|Overall Study||166
2234713|NCT02662556|5477748|P1|NOT COMPLETED|Overall Study||8
2234714|NCT02662556|5477748|P1|COMPLETED|Overall Study||132
2234715|NCT02662556|5477748|P1|STARTED|Overall Study||140
2234716|NCT02662387|5477757|P2|NOT COMPLETED|Overall Study||0
2234717|NCT02662387|5477758|P1|NOT COMPLETED|Overall Study||0
2234718|NCT02662387|5477757|P2|COMPLETED|Overall Study||28
2234719|NCT02662387|5477758|P1|COMPLETED|Overall Study||27
2234720|NCT02662387|5477757|P2|STARTED|Overall Study||28
2234721|NCT02662387|5477758|P1|STARTED|Overall Study||27
2234722|NCT02662244|5477766|P1|NOT COMPLETED|Overall Study||2
2234723|NCT02662244|5477766|P1|COMPLETED|Overall Study||31
2234724|NCT02662244|5477766|P1|STARTED|Overall Study||33
2234725|NCT02662036|5477776|P2|NOT COMPLETED|Overall Study||13
2234726|NCT02662036|5477777|P1|NOT COMPLETED|Overall Study||13
2234727|NCT02662036|5477776|P2|COMPLETED|Overall Study||22
2234728|NCT02662036|5477777|P1|COMPLETED|Overall Study||22
2234729|NCT02662036|5477776|P2|STARTED|Overall Study||35
2234730|NCT02662036|5477777|P1|STARTED|Overall Study||35
2234731|NCT02661828|5477805|P2|NOT COMPLETED|Overall Study||0
2234732|NCT02661828|5477806|P1|NOT COMPLETED|Overall Study||0
2234733|NCT02661828|5477805|P2|COMPLETED|Overall Study||0
2234734|NCT02661828|5477806|P1|COMPLETED|Overall Study||1
2234735|NCT02661828|5477805|P2|STARTED|Overall Study||0
2234736|NCT02661828|5477806|P1|STARTED|Overall Study||1
2234737|NCT02661815|5477817|P4|NOT COMPLETED|Overall Study||0
2234738|NCT02661815|5477818|P3|NOT COMPLETED|Overall Study||0
2234739|NCT02661815|5477819|P2|NOT COMPLETED|Overall Study||0
2234740|NCT02661815|5477820|P1|NOT COMPLETED|Overall Study||1
2234741|NCT02661815|5477817|P4|COMPLETED|Overall Study||0
2234742|NCT02661815|5477818|P3|COMPLETED|Overall Study||0
2234743|NCT02661815|5477819|P2|COMPLETED|Overall Study||0
2234744|NCT02661815|5477820|P1|COMPLETED|Overall Study||5
2234745|NCT02661815|5477817|P4|STARTED|Overall Study||0
2234746|NCT02661815|5477818|P3|STARTED|Overall Study||0
2234747|NCT02661815|5477819|P2|STARTED|Overall Study||0
2234748|NCT02661815|5477820|P1|STARTED|Overall Study||6
2234749|NCT02661737|5477834|P1|NOT COMPLETED|Overall Study||34
2234750|NCT02661737|5477834|P1|COMPLETED|Overall Study||469
2234751|NCT02661737|5477834|P1|STARTED|Overall Study||503
2234752|NCT02661594|5477842|P4|NOT COMPLETED|Overall Study||0
2234753|NCT02661594|5477843|P3|NOT COMPLETED|Overall Study||1
2234754|NCT02661594|5477844|P2|NOT COMPLETED|Overall Study||0
2234755|NCT02661594|5477845|P1|NOT COMPLETED|Overall Study||1
2234756|NCT02661594|5477842|P4|COMPLETED|Overall Study||9
2234757|NCT02661594|5477843|P3|COMPLETED|Overall Study||9
2234758|NCT02661594|5477844|P2|COMPLETED|Overall Study||11
2234759|NCT02661594|5477845|P1|COMPLETED|Overall Study||9
2234760|NCT02661594|5477842|P4|STARTED|Overall Study||9
2234761|NCT02661594|5477843|P3|STARTED|Overall Study||10
2234762|NCT02661594|5477844|P2|STARTED|Overall Study||11
2234763|NCT02661594|5477845|P1|STARTED|Overall Study||10
2234764|NCT02661256|5477855|P1|NOT COMPLETED|Overall Study||0
2234765|NCT02661256|5477855|P1|COMPLETED|Overall Study||7
2234766|NCT02661256|5477855|P1|STARTED|Overall Study|Each participant went through arms in same order: on nCPAP then off nCPAP. 1 participant at a time.|7
2234767|NCT02661126|5477873|P2|NOT COMPLETED|Overall Study||0
2234768|NCT02661126|5477874|P1|NOT COMPLETED|Overall Study||0
2234769|NCT02661126|5477873|P2|COMPLETED|Overall Study||8
2234770|NCT02661126|5477874|P1|COMPLETED|Overall Study||8
2234771|NCT02661126|5477873|P2|STARTED|Overall Study||8
2234772|NCT02661126|5477874|P1|STARTED|Overall Study||8
2234774|NCT02661061|5477965|P1|NOT COMPLETED|Overall Study||2
2234775|NCT02661061|5477964|P2|COMPLETED|Overall Study||2
2234776|NCT02661061|5477965|P1|COMPLETED|Overall Study||3
2234777|NCT02661061|5477964|P2|STARTED|Overall Study||4
2234778|NCT02661061|5477965|P1|STARTED|Overall Study||5
2234779|NCT02660983|5477975|P2|NOT COMPLETED|Open Label Extension Phase (24 Weeks)||9
2234780|NCT02660983|5477976|P1|NOT COMPLETED|Open Label Extension Phase (24 Weeks)||3
2234781|NCT02660983|5477975|P2|COMPLETED|Open Label Extension Phase (24 Weeks)||66
2234782|NCT02660983|5477976|P1|COMPLETED|Open Label Extension Phase (24 Weeks)||83
2234783|NCT02660983|5477975|P2|Safety Set|Open Label Extension Phase (24 Weeks)||75
2234784|NCT02660983|5477976|P1|Safety Set|Open Label Extension Phase (24 Weeks)||86
2234785|NCT02660983|5477975|P2|STARTED|Open Label Extension Phase (24 Weeks)|Eligible participants who consented to continue from DB phase to OLE phase.|75
2234786|NCT02660983|5477976|P1|STARTED|Open Label Extension Phase (24 Weeks)|Eligible participants who consented to continue from DB phase to OLE phase.|86
2234787|NCT02660983|5477975|P2|NOT COMPLETED|Double-blind (DB) Phase (24 Weeks)||26
2234788|NCT02660983|5477976|P1|NOT COMPLETED|Double-blind (DB) Phase (24 Weeks)||24
2234789|NCT02660983|5477975|P2|COMPLETED|Double-blind (DB) Phase (24 Weeks)||122
2234790|NCT02660983|5477976|P1|COMPLETED|Double-blind (DB) Phase (24 Weeks)||130
2234791|NCT02660983|5477975|P2|Treated/Safety Set|Double-blind (DB) Phase (24 Weeks)||147
2234792|NCT02660983|5477976|P1|Treated/Safety Set|Double-blind (DB) Phase (24 Weeks)||153
2234793|NCT02660983|5477975|P2|STARTED|Double-blind (DB) Phase (24 Weeks)||148
2234794|NCT02660983|5477976|P1|STARTED|Double-blind (DB) Phase (24 Weeks)||154
2234795|NCT02660918|5477991|P2|NOT COMPLETED|Overall Study||1
2234796|NCT02660918|5477992|P1|NOT COMPLETED|Overall Study||1
2234797|NCT02660918|5477991|P2|COMPLETED|Overall Study|Age ineligible|41
2234798|NCT02660918|5477992|P1|COMPLETED|Overall Study|Age ineligible|41
2234799|NCT02660918|5477991|P2|STARTED|Overall Study||42
2234800|NCT02660918|5477992|P1|STARTED|Overall Study||42
2234801|NCT02660853|5478014|P1|NOT COMPLETED|Overall Study||0
2234802|NCT02660853|5478014|P1|COMPLETED|Overall Study||25
2234803|NCT02660853|5478014|P1|STARTED|Overall Study||25
2234804|NCT02660827|5478025|P1|NOT COMPLETED|Overall Study||0
2234805|NCT02660827|5478025|P1|COMPLETED|Overall Study||105
2234806|NCT02660827|5478025|P1|STARTED|Overall Study||105
2234807|NCT02660801|5478035|P2|NOT COMPLETED|Overall Study||0
2234808|NCT02660801|5478036|P1|NOT COMPLETED|Overall Study||0
2234809|NCT02660801|5478035|P2|COMPLETED|Overall Study||15
2234810|NCT02660801|5478036|P1|COMPLETED|Overall Study||11
2234811|NCT02660801|5478035|P2|STARTED|Overall Study||15
2234812|NCT02660801|5478036|P1|STARTED|Overall Study||11
2234813|NCT02660580|5478052|P5|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||11
2234814|NCT02660580|5478053|P4|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||11
2234815|NCT02660580|5478054|P3|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||18
2234816|NCT02660580|5478055|P2|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||0
2234817|NCT02660580|5478056|P1|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||0
2234818|NCT02660580|5478052|P5|COMPLETED|Extended Treatment Period(Week 16 to 52)||90
2234819|NCT02660580|5478053|P4|COMPLETED|Extended Treatment Period(Week 16 to 52)||90
2234820|NCT02660580|5478054|P3|COMPLETED|Extended Treatment Period(Week 16 to 52)||195
2234821|NCT02660580|5478055|P2|COMPLETED|Extended Treatment Period(Week 16 to 52)||0
2234822|NCT02660580|5478056|P1|COMPLETED|Extended Treatment Period(Week 16 to 52)||0
2234823|NCT02660580|5478052|P5|STARTED|Extended Treatment Period(Week 16 to 52)||101
2234824|NCT02660580|5478053|P4|STARTED|Extended Treatment Period(Week 16 to 52)||101
2234825|NCT02660580|5478054|P3|STARTED|Extended Treatment Period(Week 16 to 52)||213
2234826|NCT02660580|5478055|P2|STARTED|Extended Treatment Period(Week 16 to 52)||0
2234827|NCT02660580|5478056|P1|STARTED|Extended Treatment Period(Week 16 to 52)||0
2234828|NCT02660580|5478052|P5|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
2234829|NCT02660580|5478053|P4|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
2234830|NCT02660580|5478054|P3|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
2234831|NCT02660580|5478055|P2|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||19
2234832|NCT02660580|5478056|P1|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||9
2234833|NCT02660580|5478052|P5|COMPLETED|Core Treatment Period (Week 1 to 16)||0
2234834|NCT02660580|5478053|P4|COMPLETED|Core Treatment Period (Week 1 to 16)||0
2234835|NCT02660580|5478054|P3|COMPLETED|Core Treatment Period (Week 1 to 16)||0
2234836|NCT02660580|5478055|P2|COMPLETED|Core Treatment Period (Week 1 to 16)||202
2234837|NCT02660580|5478056|P1|COMPLETED|Core Treatment Period (Week 1 to 16)||213
2234838|NCT02660580|5478052|P5|Treated|Core Treatment Period (Week 1 to 16)||0
2234839|NCT02660580|5478053|P4|Treated|Core Treatment Period (Week 1 to 16)||0
2234840|NCT02660580|5478054|P3|Treated|Core Treatment Period (Week 1 to 16)||0
2234841|NCT02660580|5478055|P2|Treated|Core Treatment Period (Week 1 to 16)||220
2234842|NCT02660580|5478056|P1|Treated|Core Treatment Period (Week 1 to 16)||221
2234843|NCT02660580|5478052|P5|STARTED|Core Treatment Period (Week 1 to 16)||0
2234844|NCT02660580|5478053|P4|STARTED|Core Treatment Period (Week 1 to 16)||0
2234845|NCT02660580|5478054|P3|STARTED|Core Treatment Period (Week 1 to 16)||0
2234846|NCT02660580|5478055|P2|STARTED|Core Treatment Period (Week 1 to 16)||221
2234847|NCT02660580|5478056|P1|STARTED|Core Treatment Period (Week 1 to 16)||222
2234848|NCT02660242|5478165|P1|NOT COMPLETED|Glucagon Injection||1
2234849|NCT02660242|5478165|P1|COMPLETED|Glucagon Injection||15
2234850|NCT02660242|5478165|P1|STARTED|Glucagon Injection|16 participants were randomized but only 15 completed all 4 periods.|16
2234851|NCT02660242|5478165|P1|NOT COMPLETED|Glucose Tabs||1
2234852|NCT02660242|5478165|P1|COMPLETED|Glucose Tabs||15
2234853|NCT02660242|5478165|P1|STARTED|Glucose Tabs|16 participants were randomized but only 15 completed all 4 periods.|16
2234854|NCT02660242|5478165|P1|NOT COMPLETED|Basal Insulin Reduction||0
2234855|NCT02660242|5478165|P1|COMPLETED|Basal Insulin Reduction||16
2234856|NCT02660242|5478165|P1|STARTED|Basal Insulin Reduction||16
2234857|NCT02660242|5478165|P1|NOT COMPLETED|Control||0
2234858|NCT02660242|5478165|P1|COMPLETED|Control||16
2234859|NCT02660242|5478165|P1|STARTED|Control||16
2234860|NCT02660229|5478221|P2|NOT COMPLETED|Overall Study||1
2234861|NCT02660229|5478222|P1|NOT COMPLETED|Overall Study||2
2234862|NCT02660229|5478221|P2|COMPLETED|Overall Study||31
2234863|NCT02660229|5478222|P1|COMPLETED|Overall Study||32
2234864|NCT02660229|5478221|P2|Per Protocol Set|Overall Study|Withdrawal of ICF N=1, IC/EC deviation N=1, Prohibited medication N=1|29
2234865|NCT02660229|5478222|P1|Per Protocol Set|Overall Study|Adverse events N=1, Prohibited medication N=4|28
2234866|NCT02660229|5478221|P2|FAS Set|Overall Study||32
2234867|NCT02660229|5478222|P1|FAS Set|Overall Study|Oxycodone group: 1 patient was missed any efficacy assessment.|33
2234868|NCT02660229|5478221|P2|Safety Analysis Set|Overall Study||32
2234869|NCT02660229|5478222|P1|Safety Analysis Set|Overall Study||34
2234870|NCT02660229|5478221|P2|STARTED|Overall Study|Randomization|32
2234871|NCT02660229|5478222|P1|STARTED|Overall Study|Randomization|34
2234872|NCT02660112|5478234|P1|NOT COMPLETED|Overall Study||0
2234873|NCT02660112|5478234|P1|COMPLETED|Overall Study||10
2234874|NCT02660112|5478234|P1|STARTED|Overall Study||10
2234875|NCT02659787|5478239|P2|NOT COMPLETED|Second Intervention (1 Day)||0
2234876|NCT02659787|5478240|P1|NOT COMPLETED|Second Intervention (1 Day)||0
2234877|NCT02659787|5478239|P2|COMPLETED|Second Intervention (1 Day)||19
2234878|NCT02659787|5478240|P1|COMPLETED|Second Intervention (1 Day)||19
2234879|NCT02659787|5478239|P2|STARTED|Second Intervention (1 Day)||19
2234880|NCT02659787|5478240|P1|STARTED|Second Intervention (1 Day)||19
2234881|NCT02659787|5478239|P2|NOT COMPLETED|Washout (3 Days)||0
2234882|NCT02659787|5478240|P1|NOT COMPLETED|Washout (3 Days)||0
2234883|NCT02659787|5478239|P2|COMPLETED|Washout (3 Days)||19
2234884|NCT02659787|5478240|P1|COMPLETED|Washout (3 Days)||19
2234885|NCT02659787|5478239|P2|STARTED|Washout (3 Days)||19
2234886|NCT02659787|5478240|P1|STARTED|Washout (3 Days)||19
2234887|NCT02659787|5478239|P2|NOT COMPLETED|First Intervention (1 Day)||0
2234888|NCT02659787|5478240|P1|NOT COMPLETED|First Intervention (1 Day)||0
2234889|NCT02659787|5478239|P2|COMPLETED|First Intervention (1 Day)||19
2234890|NCT02659787|5478240|P1|COMPLETED|First Intervention (1 Day)||19
2234891|NCT02659787|5478239|P2|STARTED|First Intervention (1 Day)||19
2234892|NCT02659787|5478240|P1|STARTED|First Intervention (1 Day)||19
2234893|NCT02659709|5478246|P1|NOT COMPLETED|Overall Study||0
2234894|NCT02659709|5478246|P1|COMPLETED|Overall Study||50
2234895|NCT02659709|5478246|P1|STARTED|Overall Study||50
2234896|NCT02659540|5478255|P2|NOT COMPLETED|Overall Study||8
2234897|NCT02659540|5478256|P1|NOT COMPLETED|Overall Study||6
2234898|NCT02659540|5478255|P2|COMPLETED|Overall Study||2
2234899|NCT02659540|5478256|P1|COMPLETED|Overall Study||4
2234900|NCT02659540|5478255|P2|STARTED|Overall Study||10
2234901|NCT02659540|5478256|P1|STARTED|Overall Study||10
2234902|NCT02659501|5478272|P2|NOT COMPLETED|Overall Study||0
2234903|NCT02659501|5478273|P1|NOT COMPLETED|Overall Study||0
2234904|NCT02659501|5478272|P2|COMPLETED|Overall Study||12
2234905|NCT02659501|5478273|P1|COMPLETED|Overall Study||12
2234906|NCT02659501|5478272|P2|STARTED|Overall Study||12
2234907|NCT02659501|5478273|P1|STARTED|Overall Study||12
2234908|NCT02658877|5478289|P2|NOT COMPLETED|Overall Study||0
2234909|NCT02658877|5478290|P1|NOT COMPLETED|Overall Study||0
2234910|NCT02658877|5478289|P2|COMPLETED|Overall Study||0
2234911|NCT02658877|5478290|P1|COMPLETED|Overall Study||3
2234912|NCT02658877|5478289|P2|STARTED|Overall Study||0
2234913|NCT02658877|5478290|P1|STARTED|Overall Study||3
2234914|NCT02658461|5478319|P3|NOT COMPLETED|Overall Study||0
2234915|NCT02658461|5478320|P2|NOT COMPLETED|Overall Study||0
2234916|NCT02658461|5478321|P1|NOT COMPLETED|Overall Study||0
2234917|NCT02658461|5478319|P3|COMPLETED|Overall Study||12
2234918|NCT02658461|5478320|P2|COMPLETED|Overall Study||12
2234919|NCT02658461|5478321|P1|COMPLETED|Overall Study||12
2234920|NCT02658461|5478319|P3|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
2234921|NCT02658461|5478320|P2|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
2234922|NCT02658461|5478321|P1|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
2234929|NCT02658240|5478362|P2|NOT COMPLETED|Overall Study||0
2234930|NCT02658240|5478363|P1|NOT COMPLETED|Overall Study||0
2234931|NCT02658240|5478362|P2|COMPLETED|Overall Study||30
2234932|NCT02658240|5478363|P1|COMPLETED|Overall Study||30
2234933|NCT02658240|5478362|P2|STARTED|Overall Study||30
2234934|NCT02658240|5478363|P1|STARTED|Overall Study||30
2234935|NCT02658149|5478377|P2|NOT COMPLETED|Overall Study||0
2234936|NCT02658149|5478378|P1|NOT COMPLETED|Overall Study||1
2234937|NCT02658149|5478377|P2|COMPLETED|Overall Study||50
2234938|NCT02658149|5478378|P1|COMPLETED|Overall Study||49
2234939|NCT02658149|5478377|P2|STARTED|Overall Study||50
2234940|NCT02658149|5478378|P1|STARTED|Overall Study||50
2234941|NCT02658084|5478394|P2|NOT COMPLETED|Overall Study||0
2234942|NCT02658084|5478395|P1|NOT COMPLETED|Overall Study||2
2234943|NCT02658084|5478394|P2|COMPLETED|Overall Study||0
2234944|NCT02658084|5478395|P1|COMPLETED|Overall Study||0
2234945|NCT02658084|5478394|P2|STARTED|Overall Study||0
2234946|NCT02658084|5478395|P1|STARTED|Overall Study||2
2234947|NCT02657928|5478406|P2|NOT COMPLETED|Overall Study||0
2234948|NCT02657928|5478407|P1|NOT COMPLETED|Overall Study||0
2234949|NCT02657928|5478406|P2|COMPLETED|Overall Study||20
2234950|NCT02657928|5478407|P1|COMPLETED|Overall Study||20
2234951|NCT02657928|5478406|P2|STARTED|Overall Study||20
2234952|NCT02657928|5478407|P1|STARTED|Overall Study||20
2234953|NCT02657915|5478423|P2|NOT COMPLETED|Overall Study||0
2234954|NCT02657915|5478424|P1|NOT COMPLETED|Overall Study||0
2234955|NCT02657915|5478423|P2|COMPLETED|Overall Study||28
2234956|NCT02657915|5478424|P1|COMPLETED|Overall Study||24
2234957|NCT02657915|5478423|P2|Per-protocol Population|Overall Study||24
2234958|NCT02657915|5478424|P1|Per-protocol Population|Overall Study||23
2234959|NCT02657915|5478423|P2|Intent-to Treat (ITT) Population|Overall Study||28
2234960|NCT02657915|5478424|P1|Intent-to Treat (ITT) Population|Overall Study||24
2234961|NCT02657915|5478423|P2|STARTED|Overall Study||28
2234962|NCT02657915|5478424|P1|STARTED|Overall Study||24
2234963|NCT02657889|5478448|P4|NOT COMPLETED|Overall Study||55
2234964|NCT02657889|5478449|P3|NOT COMPLETED|Overall Study||53
2234965|NCT02657889|5478450|P2|NOT COMPLETED|Overall Study||7
2234966|NCT02657889|5478451|P1|NOT COMPLETED|Overall Study||7
2234967|NCT02657889|5478448|P4|COMPLETED|Overall Study||0
2234968|NCT02657889|5478449|P3|COMPLETED|Overall Study||0
2234969|NCT02657889|5478450|P2|COMPLETED|Overall Study||0
2234970|NCT02657889|5478451|P1|COMPLETED|Overall Study||0
2234971|NCT02657889|5478448|P4|STARTED|Overall Study||55
2234972|NCT02657889|5478449|P3|STARTED|Overall Study||53
2234973|NCT02657889|5478450|P2|STARTED|Overall Study||7
2234974|NCT02657889|5478451|P1|STARTED|Overall Study||7
2234975|NCT02657629|5478471|P2|NOT COMPLETED|Overall Study||0
2234976|NCT02657629|5478472|P1|NOT COMPLETED|Overall Study||2
2234977|NCT02657629|5478471|P2|COMPLETED|Overall Study||14
2234978|NCT02657629|5478472|P1|COMPLETED|Overall Study||12
2234979|NCT02657629|5478471|P2|STARTED|Overall Study||14
2234980|NCT02657629|5478472|P1|STARTED|Overall Study||14
2234981|NCT02657564|5478478|P1|NOT COMPLETED|Overall Study||74
2234982|NCT02657564|5478478|P1|COMPLETED|Overall Study||1163
2234983|NCT02657564|5478478|P1|STARTED|Overall Study||1237
2234984|NCT02657538|5478483|P1|NOT COMPLETED|Overall Study||4
2234985|NCT02657538|5478483|P1|COMPLETED|Overall Study||31
2234986|NCT02657538|5478483|P1|Received Visual Caries Detection + Bite|Overall Study||35
2234987|NCT02657538|5478483|P1|Received Near Infrared Transillumination|Overall Study||35
2234988|NCT02657538|5478483|P1|STARTED|Overall Study||35
2234989|NCT02657408|5478492|P2|NOT COMPLETED|Overall Study||7
2234990|NCT02657408|5478493|P1|NOT COMPLETED|Overall Study||3
2234991|NCT02657408|5478492|P2|COMPLETED|Overall Study||22
2234992|NCT02657408|5478493|P1|COMPLETED|Overall Study||25
2234993|NCT02657408|5478492|P2|STARTED|Overall Study||29
2234994|NCT02657408|5478493|P1|STARTED|Overall Study||28
2234995|NCT02657369|5478517|P1|NOT COMPLETED|Overall Study||34
2234996|NCT02657369|5478517|P1|COMPLETED|Overall Study||0
2234997|NCT02657369|5478517|P1|STARTED|Overall Study||34
2234998|NCT02657252|5478527|P2|NOT COMPLETED|Overall Study||7
2234999|NCT02657252|5478528|P1|NOT COMPLETED|Overall Study||10
2235000|NCT02657252|5478527|P2|COMPLETED|Overall Study||51
2235001|NCT02657252|5478528|P1|COMPLETED|Overall Study||47
2235002|NCT02657252|5478527|P2|STARTED|Overall Study||58
2235003|NCT02657252|5478528|P1|STARTED|Overall Study||57
2235004|NCT02657226|5478538|P1|NOT COMPLETED|Overall Study||0
2235005|NCT02657226|5478538|P1|COMPLETED|Overall Study||15724
2235006|NCT02657226|5478538|P1|STARTED|Overall Study||15724
2235007|NCT02657031|5478548|P2|NOT COMPLETED|Overall Study||2
2235008|NCT02657031|5478549|P1|NOT COMPLETED|Overall Study||1
2235009|NCT02657031|5478548|P2|COMPLETED|Overall Study||23
2235010|NCT02657031|5478549|P1|COMPLETED|Overall Study||28
2235011|NCT02657031|5478548|P2|STARTED|Overall Study||25
2235012|NCT02657031|5478549|P1|STARTED|Overall Study||29
2235013|NCT02656836|5478563|P1|NOT COMPLETED|Overall Study||3
2235014|NCT02656836|5478563|P1|COMPLETED|Overall Study||6
2235015|NCT02656836|5478563|P1|STARTED|Overall Study||9
2235016|NCT02656745|5478567|P1|NOT COMPLETED|Overall Study||0
2235017|NCT02656745|5478567|P1|COMPLETED|Overall Study||416
2235018|NCT02656745|5478567|P1|STARTED|Overall Study||416
2235019|NCT02656693|5478577|P3|NOT COMPLETED|Overall Study||3
2235020|NCT02656693|5478578|P2|NOT COMPLETED|Overall Study||2
2235021|NCT02656693|5478579|P1|NOT COMPLETED|Overall Study||1
2235022|NCT02656693|5478577|P3|COMPLETED|Overall Study||295
2235023|NCT02656693|5478578|P2|COMPLETED|Overall Study||214
2235024|NCT02656693|5478579|P1|COMPLETED|Overall Study||325
2235025|NCT02656693|5478577|P3|STARTED|Overall Study||298
2235026|NCT02656693|5478578|P2|STARTED|Overall Study||216
2235027|NCT02656693|5478579|P1|STARTED|Overall Study||326
2235028|NCT02656485|5478624|P4|NOT COMPLETED|Overall Study||2
2235029|NCT02656485|5478625|P3|NOT COMPLETED|Overall Study||2
2235030|NCT02656485|5478626|P2|NOT COMPLETED|Overall Study||3
2235031|NCT02656485|5478627|P1|NOT COMPLETED|Overall Study||2
2235032|NCT02656485|5478624|P4|COMPLETED|Overall Study||7
2235033|NCT02656485|5478625|P3|COMPLETED|Overall Study||7
2235034|NCT02656485|5478626|P2|COMPLETED|Overall Study||6
2235035|NCT02656485|5478627|P1|COMPLETED|Overall Study||7
2235036|NCT02656485|5478624|P4|STARTED|Overall Study||9
2235037|NCT02656485|5478625|P3|STARTED|Overall Study||9
2235038|NCT02656485|5478626|P2|STARTED|Overall Study||9
2235039|NCT02656485|5478627|P1|STARTED|Overall Study||9
2235040|NCT02656420|5478643|P4|NOT COMPLETED|Overall Study||0
2235041|NCT02656420|5478644|P3|NOT COMPLETED|Overall Study||0
2235042|NCT02656420|5478645|P2|NOT COMPLETED|Overall Study||1
2235043|NCT02656420|5478646|P1|NOT COMPLETED|Overall Study||0
2235044|NCT02656420|5478643|P4|COMPLETED|Overall Study||55
2235045|NCT02656420|5478644|P3|COMPLETED|Overall Study||35
2235046|NCT02656420|5478645|P2|COMPLETED|Overall Study||24
2235047|NCT02656420|5478646|P1|COMPLETED|Overall Study||55
2235048|NCT02656420|5478643|P4|STARTED|Overall Study||55
2235049|NCT02656420|5478644|P3|STARTED|Overall Study||35
2235050|NCT02656420|5478645|P2|STARTED|Overall Study||25
2235051|NCT02656420|5478646|P1|STARTED|Overall Study||55
2235052|NCT02656329|5478662|P2|NOT COMPLETED|Overall Study||157
2235053|NCT02656329|5478663|P1|NOT COMPLETED|Overall Study||164
2235054|NCT02656329|5478662|P2|COMPLETED|Overall Study||0
2235055|NCT02656329|5478663|P1|COMPLETED|Overall Study||0
2235056|NCT02656329|5478662|P2|STARTED|Overall Study||157
2235057|NCT02656329|5478663|P1|STARTED|Overall Study||164
2235058|NCT02656173|5478688|P2|NOT COMPLETED|Overall Study||11
2235059|NCT02656173|5478689|P1|NOT COMPLETED|Overall Study||13
2235060|NCT02656173|5478688|P2|COMPLETED|Overall Study||272
2235061|NCT02656173|5478689|P1|COMPLETED|Overall Study||272
2235062|NCT02656173|5478688|P2|Received Treatment|Overall Study||282
2235063|NCT02656173|5478689|P1|Received Treatment|Overall Study||284
2235064|NCT02656173|5478688|P2|STARTED|Overall Study||283
2235065|NCT02656173|5478689|P1|STARTED|Overall Study||285
2235066|NCT02656160|5478725|P2|NOT COMPLETED|Second Study Night||0
2235067|NCT02656160|5478726|P1|NOT COMPLETED|Second Study Night||0
2235068|NCT02656160|5478725|P2|COMPLETED|Second Study Night||6
2235069|NCT02656160|5478726|P1|COMPLETED|Second Study Night||4
2235070|NCT02656160|5478725|P2|STARTED|Second Study Night||6
2235071|NCT02656160|5478726|P1|STARTED|Second Study Night|3 subjects did not return for the second study night|4
2235072|NCT02656160|5478725|P2|NOT COMPLETED|First Study Night||0
2235073|NCT02656160|5478726|P1|NOT COMPLETED|First Study Night||0
2235074|NCT02656160|5478725|P2|COMPLETED|First Study Night||6
2235075|NCT02656160|5478726|P1|COMPLETED|First Study Night||7
2235076|NCT02656160|5478725|P2|STARTED|First Study Night||6
2235077|NCT02656160|5478726|P1|STARTED|First Study Night||7
2235078|NCT02656069|5478736|P2|NOT COMPLETED|Second Intervention||1
2235079|NCT02656069|5478737|P1|NOT COMPLETED|Second Intervention||1
2235080|NCT02656069|5478736|P2|COMPLETED|Second Intervention||35
2235081|NCT02656069|5478737|P1|COMPLETED|Second Intervention||43
2235082|NCT02656069|5478736|P2|STARTED|Second Intervention||36
2235083|NCT02656069|5478737|P1|STARTED|Second Intervention||44
2235084|NCT02656069|5478736|P2|NOT COMPLETED|First Intervention||0
2235085|NCT02656069|5478737|P1|NOT COMPLETED|First Intervention||0
2235086|NCT02656069|5478736|P2|COMPLETED|First Intervention||36
2235087|NCT02656069|5478737|P1|COMPLETED|First Intervention||44
2235088|NCT02656069|5478736|P2|STARTED|First Intervention||36
2235089|NCT02656069|5478737|P1|STARTED|First Intervention||44
2235090|NCT02655887|5478761|P1|NOT COMPLETED|Overall Study||14
2235091|NCT02655887|5478761|P1|COMPLETED|Overall Study|Completed 12-month follow-up.|156
2235092|NCT02655887|5478761|P1|STARTED|Overall Study|Intent to Treat (ITT) population.|170
2235093|NCT02655679|5478780|P5|NOT COMPLETED|Overall Study||1
2235094|NCT02655679|5478781|P4|NOT COMPLETED|Overall Study||4
2235095|NCT02655679|5478782|P3|NOT COMPLETED|Overall Study||1
2235096|NCT02655679|5478783|P2|NOT COMPLETED|Overall Study||3
2235097|NCT02655679|5478784|P1|NOT COMPLETED|Overall Study||3
2235098|NCT02655679|5478780|P5|COMPLETED|Overall Study||19
2235099|NCT02655679|5478781|P4|COMPLETED|Overall Study||20
2235100|NCT02655679|5478782|P3|COMPLETED|Overall Study||19
2235101|NCT02655679|5478783|P2|COMPLETED|Overall Study||16
2235102|NCT02655679|5478784|P1|COMPLETED|Overall Study||18
2235103|NCT02655679|5478780|P5|Received Study Drug (Safety Population)|Overall Study||20
2235104|NCT02655679|5478781|P4|Received Study Drug (Safety Population)|Overall Study||24
2235105|NCT02655679|5478782|P3|Received Study Drug (Safety Population)|Overall Study||20
2235106|NCT02655679|5478783|P2|Received Study Drug (Safety Population)|Overall Study||19
2235107|NCT02655679|5478784|P1|Received Study Drug (Safety Population)|Overall Study||20
2235108|NCT02655679|5478780|P5|STARTED|Overall Study||20
2235109|NCT02655679|5478781|P4|STARTED|Overall Study||24
2235110|NCT02655679|5478782|P3|STARTED|Overall Study||20
2235111|NCT02655679|5478783|P2|STARTED|Overall Study||19
2235112|NCT02655679|5478784|P1|STARTED|Overall Study||21
2235113|NCT02655666|5478856|P1|NOT COMPLETED|Overall Study||12
2235114|NCT02655666|5478856|P1|COMPLETED|Overall Study||4
2235115|NCT02655666|5478856|P1|STARTED|Overall Study||16
2235116|NCT02655510|5478873|P3|NOT COMPLETED|Overall Study||0
2235117|NCT02655510|5478874|P2|NOT COMPLETED|Overall Study||0
2235118|NCT02655510|5478875|P1|NOT COMPLETED|Overall Study||0
2235119|NCT02655510|5478873|P3|COMPLETED|Overall Study||6
2235120|NCT02655510|5478874|P2|COMPLETED|Overall Study||6
2235121|NCT02655510|5478875|P1|COMPLETED|Overall Study||6
2235122|NCT02655510|5478873|P3|STARTED|Overall Study||6
2235123|NCT02655510|5478874|P2|STARTED|Overall Study||6
2235124|NCT02655510|5478875|P1|STARTED|Overall Study||6
2235125|NCT02655419|5478885|P2|NOT COMPLETED|Overall Study||7
2235126|NCT02655419|5478886|P1|NOT COMPLETED|Overall Study||5
2235127|NCT02655419|5478885|P2|COMPLETED|Overall Study||16
2235128|NCT02655419|5478886|P1|COMPLETED|Overall Study||12
2235129|NCT02655419|5478885|P2|Treated|Overall Study||18
2235130|NCT02655419|5478886|P1|Treated|Overall Study||16
2235131|NCT02655419|5478885|P2|STARTED|Overall Study||23
2235132|NCT02655419|5478886|P1|STARTED|Overall Study||17
2235133|NCT02655237|5479006|P2|NOT COMPLETED|Overall Study||11
2235134|NCT02655237|5479007|P1|NOT COMPLETED|Overall Study||17
2235135|NCT02655237|5479006|P2|COMPLETED|Overall Study||131
2235136|NCT02655237|5479007|P1|COMPLETED|Overall Study||122
2235137|NCT02655237|5479006|P2|STARTED|Overall Study||142
2235138|NCT02655237|5479007|P1|STARTED|Overall Study||139
2235139|NCT02655224|5479047|P2|NOT COMPLETED|Overall Study||1
2235140|NCT02655224|5479048|P1|NOT COMPLETED|Overall Study||1
2235141|NCT02655224|5479047|P2|COMPLETED|Overall Study||31
2235142|NCT02655224|5479048|P1|COMPLETED|Overall Study||32
2235143|NCT02655224|5479047|P2|STARTED|Overall Study||32
2235144|NCT02655224|5479048|P1|STARTED|Overall Study||33
2235145|NCT02654782|5479080|P2|NOT COMPLETED|Overall Study||0
2235146|NCT02654782|5479081|P1|NOT COMPLETED|Overall Study||0
2235147|NCT02654782|5479080|P2|COMPLETED|Overall Study||5
2235148|NCT02654782|5479081|P1|COMPLETED|Overall Study||5
2235149|NCT02654782|5479080|P2|STARTED|Overall Study||5
2235150|NCT02654782|5479081|P1|STARTED|Overall Study||5
2235151|NCT02654717|5479091|P2|NOT COMPLETED|Overall Study||5
2235152|NCT02654717|5479092|P1|NOT COMPLETED|Overall Study||6
2235153|NCT02654717|5479091|P2|COMPLETED|Overall Study||50
2235154|NCT02654717|5479092|P1|COMPLETED|Overall Study||50
2235155|NCT02654717|5479091|P2|STARTED|Overall Study||55
2235156|NCT02654717|5479092|P1|STARTED|Overall Study||56
2235157|NCT02654652|5479100|P2|NOT COMPLETED|Overall Study||3
2235158|NCT02654652|5479101|P1|NOT COMPLETED|Overall Study||1
2235159|NCT02654652|5479100|P2|COMPLETED|Overall Study||18
2235160|NCT02654652|5479101|P1|COMPLETED|Overall Study||18
2235161|NCT02654652|5479100|P2|STARTED|Overall Study||21
2235162|NCT02654652|5479101|P1|STARTED|Overall Study||19
2235163|NCT02654639|5479109|P1|NOT COMPLETED|Overall Study||0
2235164|NCT02654639|5479109|P1|COMPLETED|Overall Study||4
2235165|NCT02654639|5479109|P1|STARTED|Overall Study||4
2235166|NCT02654483|5479115|P2|NOT COMPLETED|Open-label||0
2235167|NCT02654483|5479116|P1|NOT COMPLETED|Open-label||0
2235168|NCT02654483|5479115|P2|COMPLETED|Open-label||3
2235169|NCT02654483|5479116|P1|COMPLETED|Open-label||5
2235170|NCT02654483|5479115|P2|STARTED|Open-label|4 participants did not continue to open-label arm|3
2235171|NCT02654483|5479116|P1|STARTED|Open-label|2 participants did not proceed to open-label arm|5
2235172|NCT02654483|5479115|P2|NOT COMPLETED|Double-blind||0
2235173|NCT02654483|5479116|P1|NOT COMPLETED|Double-blind||0
2235174|NCT02654483|5479115|P2|COMPLETED|Double-blind||7
2235175|NCT02654483|5479116|P1|COMPLETED|Double-blind||7
2235176|NCT02654483|5479115|P2|STARTED|Double-blind||7
2235177|NCT02654483|5479116|P1|STARTED|Double-blind||7
2235178|NCT02654314|5479130|P2|NOT COMPLETED|Overall Study||0
2235179|NCT02654314|5479131|P1|NOT COMPLETED|Overall Study||0
2235180|NCT02654314|5479130|P2|COMPLETED|Overall Study||141
2235181|NCT02654314|5479131|P1|COMPLETED|Overall Study||136
2235182|NCT02654314|5479130|P2|STARTED|Overall Study||141
2235183|NCT02654314|5479131|P1|STARTED|Overall Study||136
2235184|NCT02654145|5479143|P1|NOT COMPLETED|Overall Study||7
2235185|NCT02654145|5479143|P1|COMPLETED|Overall Study||138
2235186|NCT02654145|5479143|P1|STARTED|Overall Study||145
2235187|NCT02654132|5479152|P2|NOT COMPLETED|Overall Study||46
2235188|NCT02654132|5479153|P1|NOT COMPLETED|Overall Study||36
2235189|NCT02654132|5479152|P2|COMPLETED|Overall Study||11
2235190|NCT02654132|5479153|P1|COMPLETED|Overall Study||24
2235191|NCT02654132|5479152|P2|STARTED|Overall Study||57
2235192|NCT02654132|5479153|P1|STARTED|Overall Study||60
2235193|NCT02653872|5479161|P1|NOT COMPLETED|Overall Study||0
2235194|NCT02653872|5479161|P1|COMPLETED|Overall Study||15
2235195|NCT02653872|5479161|P1|Treatment Period 3:|Overall Study|Participants received: itraconazole 200 mg + AZD7986.|15
2235196|NCT02653872|5479161|P1|Treatment Period 2:|Overall Study|Participants received Verapamil (240 mg; extended release formulation) + AZD7986 (25 mg).|15
2235197|NCT02653872|5479161|P1|Treatment Period 1:|Overall Study|Participants received single AZD7986 (25 mg).|15
2235198|NCT02653872|5479161|P1|STARTED|Overall Study||15
2235199|NCT02653625|5479196|P1|NOT COMPLETED|Overall Study||4
2235200|NCT02653625|5479196|P1|COMPLETED|Overall Study||20
2235201|NCT02653625|5479196|P1|STARTED|Overall Study||24
2235202|NCT02653560|5479205|P4|NOT COMPLETED|Placebo Phase||0
2235203|NCT02653560|5479206|P3|NOT COMPLETED|Placebo Phase||0
2235204|NCT02653560|5479207|P2|NOT COMPLETED|Placebo Phase||0
2235205|NCT02653560|5479208|P1|NOT COMPLETED|Placebo Phase||0
2235206|NCT02653560|5479205|P4|COMPLETED|Placebo Phase||30
2235207|NCT02653560|5479206|P3|COMPLETED|Placebo Phase||0
2235208|NCT02653560|5479207|P2|COMPLETED|Placebo Phase||0
2235209|NCT02653560|5479208|P1|COMPLETED|Placebo Phase||0
2235210|NCT02653560|5479205|P4|STARTED|Placebo Phase||30
2235211|NCT02653560|5479206|P3|STARTED|Placebo Phase||0
2235212|NCT02653560|5479207|P2|STARTED|Placebo Phase||0
2235213|NCT02653560|5479208|P1|STARTED|Placebo Phase||0
2235214|NCT02653560|5479205|P4|NOT COMPLETED|KCl Phase||0
2235215|NCT02653560|5479206|P3|NOT COMPLETED|KCl Phase||0
2235216|NCT02653560|5479207|P2|NOT COMPLETED|KCl Phase||0
2235217|NCT02653560|5479208|P1|NOT COMPLETED|KCl Phase||0
2235218|NCT02653560|5479205|P4|COMPLETED|KCl Phase||0
2235219|NCT02653560|5479206|P3|COMPLETED|KCl Phase||30
2235220|NCT02653560|5479207|P2|COMPLETED|KCl Phase||0
2235221|NCT02653560|5479208|P1|COMPLETED|KCl Phase||0
2235222|NCT02653560|5479205|P4|STARTED|KCl Phase||0
2235223|NCT02653560|5479206|P3|STARTED|KCl Phase||30
2235224|NCT02653560|5479207|P2|STARTED|KCl Phase||0
2235225|NCT02653560|5479208|P1|STARTED|KCl Phase||0
2235226|NCT02653560|5479205|P4|NOT COMPLETED|K Citrate Phase||0
2235227|NCT02653560|5479206|P3|NOT COMPLETED|K Citrate Phase||0
2235228|NCT02653560|5479207|P2|NOT COMPLETED|K Citrate Phase||0
2235229|NCT02653560|5479208|P1|NOT COMPLETED|K Citrate Phase||0
2235230|NCT02653560|5479205|P4|COMPLETED|K Citrate Phase||0
2235231|NCT02653560|5479206|P3|COMPLETED|K Citrate Phase||0
2235232|NCT02653560|5479207|P2|COMPLETED|K Citrate Phase||30
2235233|NCT02653560|5479208|P1|COMPLETED|K Citrate Phase||0
2235234|NCT02653560|5479205|P4|STARTED|K Citrate Phase||0
2235235|NCT02653560|5479206|P3|STARTED|K Citrate Phase||0
2235236|NCT02653560|5479207|P2|STARTED|K Citrate Phase||30
2235237|NCT02653560|5479208|P1|STARTED|K Citrate Phase||0
2235238|NCT02653560|5479205|P4|NOT COMPLETED|KMgCit Phase||0
2235239|NCT02653560|5479206|P3|NOT COMPLETED|KMgCit Phase||0
2235240|NCT02653560|5479207|P2|NOT COMPLETED|KMgCit Phase||0
2235241|NCT02653560|5479208|P1|NOT COMPLETED|KMgCit Phase||0
2235242|NCT02653560|5479205|P4|COMPLETED|KMgCit Phase||0
2235243|NCT02653560|5479206|P3|COMPLETED|KMgCit Phase||0
2235244|NCT02653560|5479207|P2|COMPLETED|KMgCit Phase||0
2235245|NCT02653560|5479208|P1|COMPLETED|KMgCit Phase||30
2235246|NCT02653560|5479205|P4|STARTED|KMgCit Phase||0
2235247|NCT02653560|5479206|P3|STARTED|KMgCit Phase||0
2235248|NCT02653560|5479207|P2|STARTED|KMgCit Phase||0
2235249|NCT02653560|5479208|P1|STARTED|KMgCit Phase||30
2235250|NCT02653495|5479220|P2|NOT COMPLETED|Overall Study||0
2235251|NCT02653495|5479221|P1|NOT COMPLETED|Overall Study||12
2235252|NCT02653495|5479220|P2|COMPLETED|Overall Study||2
2235253|NCT02653495|5479221|P1|COMPLETED|Overall Study||3
2235254|NCT02653495|5479220|P2|STARTED|Overall Study||2
2235255|NCT02653495|5479221|P1|STARTED|Overall Study||15
2235256|NCT02653456|5479235|P1|NOT COMPLETED|Overall Study||5
2235257|NCT02653456|5479235|P1|COMPLETED|Overall Study||59
2235258|NCT02653456|5479235|P1|STARTED|Overall Study||64
2235259|NCT02653417|5479246|P4|NOT COMPLETED|Overall Study||5
2235260|NCT02653417|5479247|P3|NOT COMPLETED|Overall Study||3
2235261|NCT02653417|5479248|P2|NOT COMPLETED|Overall Study||2
2235262|NCT02653417|5479249|P1|NOT COMPLETED|Overall Study||1
2235263|NCT02653417|5479246|P4|COMPLETED|Overall Study||33
2235264|NCT02653417|5479247|P3|COMPLETED|Overall Study||26
2235265|NCT02653417|5479248|P2|COMPLETED|Overall Study||32
2235266|NCT02653417|5479249|P1|COMPLETED|Overall Study||37
2235267|NCT02653417|5479246|P4|STARTED|Overall Study||38
2235268|NCT02653417|5479247|P3|STARTED|Overall Study||29
2235269|NCT02653417|5479248|P2|STARTED|Overall Study||34
2235270|NCT02653417|5479249|P1|STARTED|Overall Study||38
2235271|NCT02653326|5479273|P2|NOT COMPLETED|Overall Study||7
2235272|NCT02653326|5479274|P1|NOT COMPLETED|Overall Study||10
2235273|NCT02653326|5479273|P2|COMPLETED|Overall Study||27
2235274|NCT02653326|5479274|P1|COMPLETED|Overall Study||22
2235275|NCT02653326|5479273|P2|STARTED|Overall Study||34
2235276|NCT02653326|5479274|P1|STARTED|Overall Study||32
2235277|NCT02653183|5479288|P2|NOT COMPLETED|Overall Study||4
2235278|NCT02653183|5479289|P1|NOT COMPLETED|Overall Study||4
2235279|NCT02653183|5479288|P2|COMPLETED|Overall Study||46
2235280|NCT02653183|5479289|P1|COMPLETED|Overall Study||49
2235281|NCT02653183|5479288|P2|STARTED|Overall Study||50
2235282|NCT02653183|5479289|P1|STARTED|Overall Study||53
2235283|NCT02653170|5479312|P3|NOT COMPLETED|Overall Study||18
2235284|NCT02653170|5479313|P2|NOT COMPLETED|Overall Study||16
2235285|NCT02653170|5479314|P1|NOT COMPLETED|Overall Study||17
2235286|NCT02653170|5479312|P3|COMPLETED|Overall Study||72
2235287|NCT02653170|5479313|P2|COMPLETED|Overall Study||72
2235288|NCT02653170|5479314|P1|COMPLETED|Overall Study||70
2235289|NCT02653170|5479312|P3|STARTED|Overall Study||90
2235290|NCT02653170|5479313|P2|STARTED|Overall Study||88
2235291|NCT02653170|5479314|P1|STARTED|Overall Study||87
2235292|NCT02652949|5479334|P1|NOT COMPLETED|Overall Study||1
2235293|NCT02652949|5479334|P1|COMPLETED|Overall Study||86
2235294|NCT02652949|5479334|P1|30 Day Follow-Up (FU)|Overall Study||87
2235295|NCT02652949|5479334|P1|STARTED|Overall Study||87
2235296|NCT02652780|5479339|P1|NOT COMPLETED|Overall Study||0
2235297|NCT02652780|5479339|P1|COMPLETED|Overall Study||37
2235298|NCT02652780|5479339|P1|STARTED|Overall Study||37
2235299|NCT02652767|5479365|P1|NOT COMPLETED|Overall Study||4
2235300|NCT02652767|5479365|P1|COMPLETED|Overall Study||35
2235301|NCT02652767|5479365|P1|Completed Week 48|Overall Study||38
2235302|NCT02652767|5479365|P1|STARTED|Overall Study||39
2235303|NCT02652624|5479393|P2|NOT COMPLETED|Extension Phase||4
2235304|NCT02652624|5479394|P1|NOT COMPLETED|Extension Phase||4
2235305|NCT02652624|5479393|P2|COMPLETED|Extension Phase||224
2235306|NCT02652624|5479394|P1|COMPLETED|Extension Phase||227
2235307|NCT02652624|5479393|P2|STARTED|Extension Phase|3 participants completed the Randomized Phase, but did not enter the Extension Phase.|228
2235308|NCT02652624|5479394|P1|STARTED|Extension Phase||231
2235309|NCT02652624|5479393|P2|NOT COMPLETED|Randomized Phase||5
2235310|NCT02652624|5479394|P1|NOT COMPLETED|Randomized Phase||3
2235311|NCT02652624|5479393|P2|COMPLETED|Randomized Phase||231
2235312|NCT02652624|5479394|P1|COMPLETED|Randomized Phase||231
2235313|NCT02652624|5479393|P2|STARTED|Randomized Phase||236
2235314|NCT02652624|5479394|P1|STARTED|Randomized Phase||234
2235315|NCT02652481|5479406|P1|NOT COMPLETED|Phase 2||18
2235316|NCT02652481|5479406|P1|COMPLETED|Phase 2||243
2235317|NCT02652481|5479406|P1|STARTED|Phase 2||261
2235318|NCT02652481|5479406|P1|NOT COMPLETED|Phase 1||98
2235319|NCT02652481|5479406|P1|COMPLETED|Phase 1||141
2235320|NCT02652481|5479406|P1|STARTED|Phase 1||239
2235321|NCT02652468|5479414|P1|NOT COMPLETED|Overall Study||0
2235322|NCT02652468|5479414|P1|COMPLETED|Overall Study||11
2235323|NCT02652468|5479414|P1|STARTED|Overall Study||11
2235324|NCT02652416|5479422|P4|NOT COMPLETED|Overall Study||0
2235325|NCT02652416|5479423|P3|NOT COMPLETED|Overall Study||0
2235326|NCT02652416|5479424|P2|NOT COMPLETED|Overall Study||0
2235327|NCT02652416|5479425|P1|NOT COMPLETED|Overall Study||0
2235328|NCT02652416|5479422|P4|COMPLETED|Overall Study||18
2235329|NCT02652416|5479423|P3|COMPLETED|Overall Study||18
2235330|NCT02652416|5479424|P2|COMPLETED|Overall Study||18
2235331|NCT02652416|5479425|P1|COMPLETED|Overall Study||18
2235332|NCT02652416|5479422|P4|Subjects Who Participated in MD Part|Overall Study||18
2235333|NCT02652416|5479423|P3|Subjects Who Participated in MD Part|Overall Study||0
2235334|NCT02652416|5479424|P2|Subjects Who Participated in MD Part|Overall Study||0
2235335|NCT02652416|5479425|P1|Subjects Who Participated in MD Part|Overall Study||6
2235336|NCT02652416|5479422|P4|STARTED|Overall Study||18
2235337|NCT02652416|5479423|P3|STARTED|Overall Study||18
2235338|NCT02652416|5479424|P2|STARTED|Overall Study||18
2235339|NCT02652416|5479425|P1|STARTED|Overall Study||18
2235340|NCT02652390|5479456|P3|NOT COMPLETED|Overall Study||0
2235341|NCT02652390|5479457|P2|NOT COMPLETED|Overall Study||0
2235342|NCT02652390|5479458|P1|NOT COMPLETED|Overall Study||0
2235343|NCT02652390|5479456|P3|COMPLETED|Overall Study||37
2235344|NCT02652390|5479457|P2|COMPLETED|Overall Study||37
2235345|NCT02652390|5479458|P1|COMPLETED|Overall Study||37
2235346|NCT02652390|5479456|P3|STARTED|Overall Study||37
2235347|NCT02652390|5479457|P2|STARTED|Overall Study||37
2235348|NCT02652390|5479458|P1|STARTED|Overall Study||37
2235349|NCT02652260|5479482|P2|NOT COMPLETED|Overall Study||2
2235350|NCT02652260|5479483|P1|NOT COMPLETED|Overall Study||0
2235351|NCT02652260|5479482|P2|COMPLETED|Overall Study||41
2235352|NCT02652260|5479483|P1|COMPLETED|Overall Study||43
2235353|NCT02652260|5479482|P2|STARTED|Overall Study||43
2235354|NCT02652260|5479483|P1|STARTED|Overall Study||43
2235355|NCT02652221|5479519|P1|NOT COMPLETED|Overall Study||0
2235356|NCT02652221|5479519|P1|COMPLETED|Overall Study||55
2235357|NCT02652221|5479519|P1|STARTED|Overall Study||55
2235358|NCT02652208|5479528|P2|NOT COMPLETED|Overall Study||2
2235359|NCT02652208|5479529|P1|NOT COMPLETED|Overall Study||4
2235360|NCT02652208|5479528|P2|COMPLETED|Overall Study||15
2235361|NCT02652208|5479529|P1|COMPLETED|Overall Study||13
2235362|NCT02652208|5479528|P2|STARTED|Overall Study||17
2235363|NCT02652208|5479529|P1|STARTED|Overall Study||17
2235364|NCT02652156|5479542|P3|NOT COMPLETED|Overall Study||0
2235365|NCT02652156|5479543|P2|NOT COMPLETED|Overall Study||0
2235366|NCT02652156|5479544|P1|NOT COMPLETED|Overall Study||1
2235367|NCT02652156|5479542|P3|COMPLETED|Overall Study||4
2235368|NCT02652156|5479543|P2|COMPLETED|Overall Study||6
2235369|NCT02652156|5479544|P1|COMPLETED|Overall Study||3
2235370|NCT02652156|5479542|P3|STARTED|Overall Study||4
2235371|NCT02652156|5479543|P2|STARTED|Overall Study||6
2235372|NCT02652156|5479544|P1|STARTED|Overall Study||4
2235373|NCT02651922|5479570|P1|NOT COMPLETED|Overall Study||2
2235374|NCT02651922|5479570|P1|COMPLETED|Overall Study||154
2235375|NCT02651922|5479570|P1|STARTED|Overall Study||156
2235376|NCT02651688|5479590|P3|NOT COMPLETED|Overall Study||3
2235377|NCT02651688|5479591|P2|NOT COMPLETED|Overall Study||5
2235378|NCT02651688|5479592|P1|NOT COMPLETED|Overall Study||2
2235379|NCT02651688|5479590|P3|COMPLETED|Overall Study||12
2235380|NCT02651688|5479591|P2|COMPLETED|Overall Study||12
2235381|NCT02651688|5479592|P1|COMPLETED|Overall Study||16
2235382|NCT02651688|5479590|P3|STARTED|Overall Study||15
2235383|NCT02651688|5479591|P2|STARTED|Overall Study||17
2235384|NCT02651688|5479592|P1|STARTED|Overall Study||18
2235385|NCT02651584|5479659|P2|NOT COMPLETED|Overall Study||92
2235386|NCT02651584|5479660|P1|NOT COMPLETED|Overall Study||89
2235387|NCT02651584|5479659|P2|COMPLETED|Overall Study||121
2235388|NCT02651584|5479660|P1|COMPLETED|Overall Study||126
2235389|NCT02651584|5479659|P2|STARTED|Overall Study||213
2235390|NCT02651584|5479660|P1|STARTED|Overall Study||215
2235391|NCT02651467|5479675|P3|NOT COMPLETED|Overall Study||4
2235392|NCT02651467|5479676|P2|NOT COMPLETED|Overall Study||0
2235393|NCT02651467|5479677|P1|NOT COMPLETED|Overall Study||1
2235394|NCT02651467|5479675|P3|COMPLETED|Overall Study||69
2235395|NCT02651467|5479676|P2|COMPLETED|Overall Study||74
2235396|NCT02651467|5479677|P1|COMPLETED|Overall Study||73
2235397|NCT02651467|5479675|P3|STARTED|Overall Study||73
2235398|NCT02651467|5479676|P2|STARTED|Overall Study||74
2235399|NCT02651467|5479677|P1|STARTED|Overall Study||74
2235400|NCT02651415|5479696|P1|NOT COMPLETED|Overall Study||2
2235401|NCT02651415|5479696|P1|COMPLETED|Overall Study|10 patients were evaluable.|10
2235402|NCT02651415|5479696|P1|STARTED|Overall Study|12 patients were enrolled.|12
2235403|NCT02651194|5479705|P1|NOT COMPLETED|Overall Study||5
2235404|NCT02651194|5479705|P1|COMPLETED|Overall Study||99
2235405|NCT02651194|5479705|P1|STARTED|Overall Study||104
2235406|NCT02651155|5479713|P2|NOT COMPLETED|Overall Study||2
2235407|NCT02651155|5479714|P1|NOT COMPLETED|Overall Study||6
2235408|NCT02651155|5479713|P2|COMPLETED|Overall Study||103
2235409|NCT02651155|5479714|P1|COMPLETED|Overall Study||93
2235410|NCT02651155|5479713|P2|STARTED|Overall Study||105
2235411|NCT02651155|5479714|P1|STARTED|Overall Study||99
2235412|NCT02651103|5479730|P1|NOT COMPLETED|Overall Study||0
2235413|NCT02651103|5479730|P1|COMPLETED|Overall Study||30
2235414|NCT02651103|5479730|P1|STARTED|Overall Study||30
2235415|NCT02650921|5479734|P1|NOT COMPLETED|Overall Study||8
2235416|NCT02650921|5479734|P1|COMPLETED|Overall Study||84
2235417|NCT02650921|5479734|P1|STARTED|Overall Study||92
2235418|NCT02650895|5479788|P6|NOT COMPLETED|Overall Study||0
2235419|NCT02650895|5479789|P5|NOT COMPLETED|Overall Study||0
2235420|NCT02650895|5479790|P4|NOT COMPLETED|Overall Study||0
2235421|NCT02650895|5479791|P3|NOT COMPLETED|Overall Study||0
2235422|NCT02650895|5479792|P2|NOT COMPLETED|Overall Study||1
2235423|NCT02650895|5479793|P1|NOT COMPLETED|Overall Study||0
2235424|NCT02650895|5479788|P6|COMPLETED|Overall Study||6
2235425|NCT02650895|5479789|P5|COMPLETED|Overall Study||6
2235426|NCT02650895|5479790|P4|COMPLETED|Overall Study||6
2235427|NCT02650895|5479791|P3|COMPLETED|Overall Study||6
2235428|NCT02650895|5479792|P2|COMPLETED|Overall Study||5
2235429|NCT02650895|5479793|P1|COMPLETED|Overall Study||10
2235430|NCT02650895|5479788|P6|STARTED|Overall Study||6
2235431|NCT02650895|5479789|P5|STARTED|Overall Study||6
2235432|NCT02650895|5479790|P4|STARTED|Overall Study||6
2235433|NCT02650895|5479791|P3|STARTED|Overall Study||6
2235434|NCT02650895|5479792|P2|STARTED|Overall Study||6
2235435|NCT02650895|5479793|P1|STARTED|Overall Study||10
2235436|NCT02650466|5479827|P1|NOT COMPLETED|Overall Study||7
2235437|NCT02650466|5479827|P1|COMPLETED|Overall Study||17
2235438|NCT02650466|5479827|P1|STARTED|Overall Study||24
2235439|NCT02650440|5479835|P2|NOT COMPLETED|Overall Study||2
2235440|NCT02650440|5479836|P1|NOT COMPLETED|Overall Study||0
2235441|NCT02650440|5479835|P2|COMPLETED|Overall Study||8
2235442|NCT02650440|5479836|P1|COMPLETED|Overall Study||10
2235443|NCT02650440|5479835|P2|STARTED|Overall Study||10
2235444|NCT02650440|5479836|P1|STARTED|Overall Study||10
2235445|NCT02650219|5479854|P2|NOT COMPLETED|Overall Study||0
2235446|NCT02650219|5479855|P1|NOT COMPLETED|Overall Study||0
2235447|NCT02650219|5479854|P2|COMPLETED|Overall Study||20
2235448|NCT02650219|5479855|P1|COMPLETED|Overall Study||40
2235449|NCT02650219|5479854|P2|STARTED|Overall Study||20
2235450|NCT02650219|5479855|P1|STARTED|Overall Study||40
2235451|NCT02650193|5479868|P3|NOT COMPLETED|Overall Study||0
2235452|NCT02650193|5479869|P2|NOT COMPLETED|Overall Study||0
2235453|NCT02650193|5479870|P1|NOT COMPLETED|Overall Study||0
2235454|NCT02650193|5479868|P3|COMPLETED|Overall Study||13
2235455|NCT02650193|5479869|P2|COMPLETED|Overall Study||6
2235456|NCT02650193|5479870|P1|COMPLETED|Overall Study||6
2235457|NCT02650193|5479868|P3|STARTED|Overall Study||13
2235458|NCT02650193|5479869|P2|STARTED|Overall Study||6
2235459|NCT02650193|5479870|P1|STARTED|Overall Study||6
2235460|NCT02650128|5479957|P1|NOT COMPLETED|Overall Study||2
2235461|NCT02650128|5479957|P1|COMPLETED|Overall Study||58
2235462|NCT02650128|5479957|P1|30 Day Primary and Safety Endpoint|Overall Study||60
2235463|NCT02650128|5479957|P1|STARTED|Overall Study||60
2235464|NCT02649946|5479966|P2|NOT COMPLETED|Overall Study||15
2235465|NCT02649946|5479967|P1|NOT COMPLETED|Overall Study||12
2235466|NCT02649946|5479966|P2|COMPLETED|Overall Study||123
2235467|NCT02649946|5479967|P1|COMPLETED|Overall Study||130
2235468|NCT02649946|5479966|P2|STARTED|Overall Study||138
2235469|NCT02649946|5479967|P1|STARTED|Overall Study||142
2235470|NCT02649842|5479994|P1|NOT COMPLETED|Overall Study||0
2235471|NCT02649842|5479994|P1|COMPLETED|Overall Study||101
2235472|NCT02649842|5479994|P1|STARTED|Overall Study||101
2235473|NCT02649634|5480002|P2|NOT COMPLETED|Overall Study||6
2235474|NCT02649634|5480003|P1|NOT COMPLETED|Overall Study||3
2235475|NCT02649634|5480002|P2|COMPLETED|Overall Study||60
2235476|NCT02649634|5480003|P1|COMPLETED|Overall Study||66
2235477|NCT02649634|5480002|P2|STARTED|Overall Study||66
2235478|NCT02649634|5480003|P1|STARTED|Overall Study||69
2235479|NCT02649608|5480059|P7|NOT COMPLETED|Overall Study||0
2235480|NCT02649608|5480060|P6|NOT COMPLETED|Overall Study||0
2235481|NCT02649608|5480061|P5|NOT COMPLETED|Overall Study||0
2235482|NCT02649608|5480062|P4|NOT COMPLETED|Overall Study||0
2235483|NCT02649608|5480063|P3|NOT COMPLETED|Overall Study||0
2235484|NCT02649608|5480064|P2|NOT COMPLETED|Overall Study||0
2235485|NCT02649608|5480065|P1|NOT COMPLETED|Overall Study||0
2235486|NCT02649608|5480059|P7|COMPLETED|Overall Study||1
2235487|NCT02649608|5480060|P6|COMPLETED|Overall Study||2
2235488|NCT02649608|5480061|P5|COMPLETED|Overall Study||3
2235489|NCT02649608|5480062|P4|COMPLETED|Overall Study||3
2235490|NCT02649608|5480063|P3|COMPLETED|Overall Study||3
2235491|NCT02649608|5480064|P2|COMPLETED|Overall Study||1
2235492|NCT02649608|5480065|P1|COMPLETED|Overall Study||2
2235493|NCT02649608|5480059|P7|STARTED|Overall Study||1
2235494|NCT02649608|5480060|P6|STARTED|Overall Study||2
2235495|NCT02649608|5480061|P5|STARTED|Overall Study||3
2235496|NCT02649608|5480062|P4|STARTED|Overall Study||3
2235497|NCT02649608|5480063|P3|STARTED|Overall Study||3
2235498|NCT02649608|5480064|P2|STARTED|Overall Study||1
2235499|NCT02649608|5480065|P1|STARTED|Overall Study||2
2235500|NCT02649192|5480113|P6|NOT COMPLETED|Overall Study||0
2235501|NCT02649192|5480114|P5|NOT COMPLETED|Overall Study||1
2235502|NCT02649192|5480115|P4|NOT COMPLETED|Overall Study||2
2235503|NCT02649192|5480116|P3|NOT COMPLETED|Overall Study||1
2235504|NCT02649192|5480117|P2|NOT COMPLETED|Overall Study||0
2235505|NCT02649192|5480118|P1|NOT COMPLETED|Overall Study||0
2235506|NCT02649192|5480113|P6|COMPLETED|Overall Study||14
2235507|NCT02649192|5480114|P5|COMPLETED|Overall Study||11
2235508|NCT02649192|5480115|P4|COMPLETED|Overall Study||20
2235509|NCT02649192|5480116|P3|COMPLETED|Overall Study||21
2235510|NCT02649192|5480117|P2|COMPLETED|Overall Study||4
2235511|NCT02649192|5480118|P1|COMPLETED|Overall Study||5
2235512|NCT02649192|5480113|P6|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||6
2235513|NCT02649192|5480114|P5|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||5
2235514|NCT02649192|5480115|P4|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||10
2235515|NCT02649192|5480116|P3|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||11
2235516|NCT02649192|5480117|P2|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||2
2235517|NCT02649192|5480118|P1|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||3
2235518|NCT02649192|5480113|P6|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||8
2235519|NCT02649192|5480114|P5|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||7
2235520|NCT02649192|5480115|P4|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||12
2235521|NCT02649192|5480116|P3|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||11
2235522|NCT02649192|5480117|P2|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||2
2235523|NCT02649192|5480118|P1|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||2
2235524|NCT02649192|5480113|P6|STARTED|Overall Study||14
2235525|NCT02649192|5480114|P5|STARTED|Overall Study||12
2235526|NCT02649192|5480115|P4|STARTED|Overall Study||22
2235527|NCT02649192|5480116|P3|STARTED|Overall Study||22
2235528|NCT02649192|5480117|P2|STARTED|Overall Study||4
2235529|NCT02649192|5480118|P1|STARTED|Overall Study||5
2235530|NCT02648646|5480174|P1|NOT COMPLETED|Overall Study||2
2235531|NCT02648646|5480174|P1|COMPLETED|Overall Study||8
2235532|NCT02648646|5480174|P1|STARTED|Overall Study||10
2235533|NCT02648438|5480225|P3|NOT COMPLETED|Overall Study||0
2235534|NCT02648438|5480226|P2|NOT COMPLETED|Overall Study||3
2235535|NCT02648438|5480227|P1|NOT COMPLETED|Overall Study||3
2235536|NCT02648438|5480225|P3|COMPLETED|Overall Study||6
2235537|NCT02648438|5480226|P2|COMPLETED|Overall Study||9
2235538|NCT02648438|5480227|P1|COMPLETED|Overall Study||9
2235539|NCT02648438|5480225|P3|STARTED|Overall Study||6
2235540|NCT02648438|5480226|P2|STARTED|Overall Study||12
2235541|NCT02648438|5480227|P1|STARTED|Overall Study||12
2235542|NCT02648230|5480267|P1|NOT COMPLETED|Overall Study||0
2235543|NCT02648230|5480267|P1|COMPLETED|Overall Study||74
2235544|NCT02648230|5480267|P1|STARTED|Overall Study||74
2235545|NCT02648217|5480273|P2|NOT COMPLETED|Overall Study||5
2235546|NCT02648217|5480274|P1|NOT COMPLETED|Overall Study||10
2235547|NCT02648217|5480273|P2|COMPLETED|Overall Study||127
2235548|NCT02648217|5480274|P1|COMPLETED|Overall Study||121
2235549|NCT02648217|5480273|P2|Exposed|Overall Study||132
2235550|NCT02648217|5480274|P1|Exposed|Overall Study||130
2235551|NCT02648217|5480273|P2|STARTED|Overall Study||132
2235552|NCT02648217|5480274|P1|STARTED|Overall Study||131
2235553|NCT02648204|5480296|P4|NOT COMPLETED|Overall Study||16
2235554|NCT02648204|5480297|P3|NOT COMPLETED|Overall Study||13
2235555|NCT02648204|5480298|P2|NOT COMPLETED|Overall Study||21
2235556|NCT02648204|5480299|P1|NOT COMPLETED|Overall Study||22
2235557|NCT02648204|5480296|P4|COMPLETED|Overall Study||284
2235558|NCT02648204|5480297|P3|COMPLETED|Overall Study||287
2235559|NCT02648204|5480298|P2|COMPLETED|Overall Study||279
2235560|NCT02648204|5480299|P1|COMPLETED|Overall Study||279
2235561|NCT02648204|5480296|P4|Exposed|Overall Study||299
2235562|NCT02648204|5480297|P3|Exposed|Overall Study||299
2235563|NCT02648204|5480298|P2|Exposed|Overall Study||300
2235564|NCT02648204|5480299|P1|Exposed|Overall Study||301
2235565|NCT02648204|5480296|P4|STARTED|Overall Study||300
2235566|NCT02648204|5480297|P3|STARTED|Overall Study||300
2235567|NCT02648204|5480298|P2|STARTED|Overall Study||300
2235568|NCT02648204|5480299|P1|STARTED|Overall Study||301
2235569|NCT02648178|5480417|P1|NOT COMPLETED|Overall Study||9
2235570|NCT02648178|5480417|P1|COMPLETED|Overall Study||10
2235571|NCT02648178|5480417|P1|STARTED|Overall Study||19
2235572|NCT02648022|5480424|P2|NOT COMPLETED|Overall Study||0
2235573|NCT02648022|5480425|P1|NOT COMPLETED|Overall Study||0
2235574|NCT02648022|5480424|P2|COMPLETED|Overall Study||39
2235575|NCT02648022|5480425|P1|COMPLETED|Overall Study||40
2235576|NCT02648022|5480424|P2|STARTED|Overall Study||39
2235577|NCT02648022|5480425|P1|STARTED|Overall Study||40
2235578|NCT02647944|5480437|P2|NOT COMPLETED|Overall Study||3
2235579|NCT02647944|5480438|P1|NOT COMPLETED|Overall Study||2
2235580|NCT02647944|5480437|P2|COMPLETED|Overall Study||18
2235581|NCT02647944|5480438|P1|COMPLETED|Overall Study||17
2235582|NCT02647944|5480437|P2|STARTED|Overall Study||21
2235583|NCT02647944|5480438|P1|STARTED|Overall Study||19
2235584|NCT02647905|5480462|P1|NOT COMPLETED|Overall Study||3
2235585|NCT02647905|5480462|P1|COMPLETED|Overall Study||87
2235586|NCT02647905|5480462|P1|STARTED|Overall Study||90
2235587|NCT02647788|5480469|P2|NOT COMPLETED|Overall Study||13
2235588|NCT02647788|5480470|P1|NOT COMPLETED|Overall Study||16
2235589|NCT02647788|5480469|P2|COMPLETED|Overall Study||57
2235590|NCT02647788|5480470|P1|COMPLETED|Overall Study||54
2235591|NCT02647788|5480469|P2|STARTED|Overall Study||70
2235592|NCT02647788|5480470|P1|STARTED|Overall Study||70
2235593|NCT02647658|5480482|P2|NOT COMPLETED|Overall Study||24
2235594|NCT02647658|5480483|P1|NOT COMPLETED|Overall Study||15
2235595|NCT02647658|5480482|P2|COMPLETED|Overall Study||1069
2235596|NCT02647658|5480483|P1|COMPLETED|Overall Study||1192
2235597|NCT02647658|5480482|P2|6 Month Assessment|Overall Study||635
2235598|NCT02647658|5480483|P1|6 Month Assessment|Overall Study||658
2235599|NCT02647658|5480482|P2|STARTED|Overall Study||1093
2235600|NCT02647658|5480483|P1|STARTED|Overall Study||1207
2235601|NCT02647645|5480511|P2|NOT COMPLETED|Overall Study||1
2235602|NCT02647645|5480512|P1|NOT COMPLETED|Overall Study||2
2235603|NCT02647645|5480511|P2|COMPLETED|Overall Study||9
2235604|NCT02647645|5480512|P1|COMPLETED|Overall Study||9
2235605|NCT02647645|5480511|P2|STARTED|Overall Study||10
2235606|NCT02647645|5480512|P1|STARTED|Overall Study||11
2235610|NCT02647320|5480534|P5|NOT COMPLETED|Overall Study||17
2235611|NCT02647320|5480535|P4|NOT COMPLETED|Overall Study||10
2235612|NCT02647320|5480536|P3|NOT COMPLETED|Overall Study||15
2235613|NCT02647320|5480537|P2|NOT COMPLETED|Overall Study||11
2235614|NCT02647320|5480538|P1|NOT COMPLETED|Overall Study||12
2235615|NCT02647320|5480534|P5|COMPLETED|Overall Study||52
2235616|NCT02647320|5480535|P4|COMPLETED|Overall Study||58
2235617|NCT02647320|5480536|P3|COMPLETED|Overall Study||54
2235618|NCT02647320|5480537|P2|COMPLETED|Overall Study||35
2235619|NCT02647320|5480538|P1|COMPLETED|Overall Study||34
2235620|NCT02647320|5480534|P5|Modified Intent-to-Treat Set (mITT)|Overall Study||62
2235621|NCT02647320|5480535|P4|Modified Intent-to-Treat Set (mITT)|Overall Study||62
2235622|NCT02647320|5480536|P3|Modified Intent-to-Treat Set (mITT)|Overall Study||61
2235623|NCT02647320|5480537|P2|Modified Intent-to-Treat Set (mITT)|Overall Study||38
2235624|NCT02647320|5480538|P1|Modified Intent-to-Treat Set (mITT)|Overall Study||40
2235625|NCT02647320|5480534|P5|Safety Set|Overall Study||69
2235626|NCT02647320|5480535|P4|Safety Set|Overall Study||68
2235627|NCT02647320|5480536|P3|Safety Set|Overall Study||68
2235628|NCT02647320|5480537|P2|Safety Set|Overall Study||44
2235629|NCT02647320|5480538|P1|Safety Set|Overall Study||43
2235630|NCT02647320|5480534|P5|Inadvertently Randomized|Overall Study||0
2235631|NCT02647320|5480535|P4|Inadvertently Randomized|Overall Study||1
2235632|NCT02647320|5480536|P3|Inadvertently Randomized|Overall Study||0
2235633|NCT02647320|5480537|P2|Inadvertently Randomized|Overall Study||0
2235634|NCT02647320|5480538|P1|Inadvertently Randomized|Overall Study||0
2235635|NCT02647320|5480534|P5|STARTED|Overall Study||69
2235636|NCT02647320|5480535|P4|STARTED|Overall Study||68
2235637|NCT02647320|5480536|P3|STARTED|Overall Study||69
2235638|NCT02647320|5480537|P2|STARTED|Overall Study||46
2235639|NCT02647320|5480538|P1|STARTED|Overall Study||46
2235640|NCT02647281|5480629|P9|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||1
2235641|NCT02647281|5480630|P8|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
2235642|NCT02647281|5480631|P7|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
2235643|NCT02647281|5480632|P6|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
2235644|NCT02647281|5480633|P5|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
2235645|NCT02647281|5480634|P4|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
2235646|NCT02647281|5480635|P3|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
2235647|NCT02647281|5480636|P2|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
2235648|NCT02647281|5480637|P1|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
2235649|NCT02647281|5480629|P9|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||5
2235650|NCT02647281|5480630|P8|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
2235651|NCT02647281|5480631|P7|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
2235652|NCT02647281|5480632|P6|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
2235653|NCT02647281|5480633|P5|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
2235654|NCT02647281|5480634|P4|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
2235655|NCT02647281|5480635|P3|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
2235656|NCT02647281|5480636|P2|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
2235657|NCT02647281|5480637|P1|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
2235658|NCT02647281|5480629|P9|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
2235659|NCT02647281|5480630|P8|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
2235660|NCT02647281|5480631|P7|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
2235661|NCT02647281|5480632|P6|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
2235662|NCT02647281|5480633|P5|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
2235663|NCT02647281|5480634|P4|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
2235664|NCT02647281|5480635|P3|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
2235665|NCT02647281|5480636|P2|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
2235666|NCT02647281|5480637|P1|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
2235667|NCT02647281|5480629|P9|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
2235668|NCT02647281|5480630|P8|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
2235669|NCT02647281|5480631|P7|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
2235670|NCT02647281|5480632|P6|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
2235671|NCT02647281|5480633|P5|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
2235672|NCT02647281|5480634|P4|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
2235673|NCT02647281|5480635|P3|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
2235674|NCT02647281|5480636|P2|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
2235675|NCT02647281|5480637|P1|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
2235676|NCT02647281|5480629|P9|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
2235677|NCT02647281|5480630|P8|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
2235678|NCT02647281|5480631|P7|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
2235679|NCT02647281|5480632|P6|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
2235680|NCT02647281|5480633|P5|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
2235681|NCT02647281|5480634|P4|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
2235682|NCT02647281|5480635|P3|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
2235683|NCT02647281|5480636|P2|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
2235684|NCT02647281|5480637|P1|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||8
2235685|NCT02647281|5480629|P9|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
2235686|NCT02647281|5480630|P8|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
2235687|NCT02647281|5480631|P7|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
2235688|NCT02647281|5480632|P6|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
2235689|NCT02647281|5480633|P5|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
2235690|NCT02647281|5480634|P4|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
2235691|NCT02647281|5480635|P3|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
2235692|NCT02647281|5480636|P2|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
2235693|NCT02647281|5480637|P1|STARTED|Single-Ascending Dose(Part 1-62 Days)||8
2235694|NCT02646826|5480819|P4|NOT COMPLETED|Overall Study||1
2235695|NCT02646826|5480820|P3|NOT COMPLETED|Overall Study||1
2235696|NCT02646826|5480821|P2|NOT COMPLETED|Overall Study||0
2235697|NCT02646826|5480822|P1|NOT COMPLETED|Overall Study||2
2235698|NCT02646826|5480819|P4|COMPLETED|Overall Study||21
2235699|NCT02646826|5480820|P3|COMPLETED|Overall Study||20
2235700|NCT02646826|5480821|P2|COMPLETED|Overall Study||22
2235701|NCT02646826|5480822|P1|COMPLETED|Overall Study||19
2235702|NCT02646826|5480819|P4|STARTED|Overall Study||22
2235703|NCT02646826|5480820|P3|STARTED|Overall Study||21
2235704|NCT02646826|5480821|P2|STARTED|Overall Study||22
2235705|NCT02646826|5480822|P1|STARTED|Overall Study||21
2235706|NCT02646761|5480846|P2|NOT COMPLETED|Overall Study||10
2235707|NCT02646761|5480847|P1|NOT COMPLETED|Overall Study||8
2235708|NCT02646761|5480846|P2|COMPLETED|Overall Study||10
2235709|NCT02646761|5480847|P1|COMPLETED|Overall Study||10
2235710|NCT02646761|5480846|P2|5-week Assessment|Overall Study||10
2235711|NCT02646761|5480847|P1|5-week Assessment|Overall Study||12
2235712|NCT02646761|5480846|P2|Baseline Assessment|Overall Study||12
2235713|NCT02646761|5480847|P1|Baseline Assessment|Overall Study||13
2235714|NCT02646761|5480846|P2|Subject Withdrew Before Baseline|Overall Study||8
2235715|NCT02646761|5480847|P1|Subject Withdrew Before Baseline|Overall Study||5
2235716|NCT02646761|5480846|P2|STARTED|Overall Study||20
2235717|NCT02646761|5480847|P1|STARTED|Overall Study||18
2235718|NCT02646566|5480865|P3|NOT COMPLETED|Overall Study||5
2235719|NCT02646566|5480866|P2|NOT COMPLETED|Overall Study||4
2235720|NCT02646566|5480867|P1|NOT COMPLETED|Overall Study||6
2235721|NCT02646566|5480865|P3|COMPLETED|Overall Study||230
2235722|NCT02646566|5480866|P2|COMPLETED|Overall Study||226
2235723|NCT02646566|5480867|P1|COMPLETED|Overall Study||231
2235724|NCT02646566|5480865|P3|STARTED|Overall Study||235
2235725|NCT02646566|5480866|P2|STARTED|Overall Study||230
2235726|NCT02646566|5480867|P1|STARTED|Overall Study||237
2235727|NCT02646449|5480907|P2|NOT COMPLETED|Overall Study||0
2235728|NCT02646449|5480908|P1|NOT COMPLETED|Overall Study||0
2235729|NCT02646449|5480907|P2|COMPLETED|Overall Study||3
2235730|NCT02646449|5480908|P1|COMPLETED|Overall Study||4
2235731|NCT02646449|5480907|P2|STARTED|Overall Study||3
2235732|NCT02646449|5480908|P1|STARTED|Overall Study||4
2235733|NCT02646124|5480918|P2|NOT COMPLETED|Overall Study||2
2235734|NCT02646124|5480919|P1|NOT COMPLETED|Overall Study||0
2235735|NCT02646124|5480918|P2|COMPLETED|Overall Study||55
2235736|NCT02646124|5480919|P1|COMPLETED|Overall Study||57
2235737|NCT02646124|5480918|P2|STARTED|Overall Study||57
2235738|NCT02646124|5480919|P1|STARTED|Overall Study||57
2235739|NCT02645760|5480935|P2|NOT COMPLETED|Overall Study||0
2235740|NCT02645760|5480936|P1|NOT COMPLETED|Overall Study||0
2235741|NCT02645760|5480935|P2|COMPLETED|Overall Study||19
2235742|NCT02645760|5480936|P1|COMPLETED|Overall Study||19
2235743|NCT02645760|5480935|P2|STARTED|Overall Study||19
2235744|NCT02645760|5480936|P1|STARTED|Overall Study||19
2235745|NCT02645617|5480948|P1|NOT COMPLETED|Overall Study||0
2235746|NCT02645617|5480948|P1|COMPLETED|Overall Study||12
2235747|NCT02645617|5480948|P1|STARTED|Overall Study||12
2235754|NCT02645253|5480965|P4|NOT COMPLETED|Overall Study||0
2235755|NCT02645253|5480966|P3|NOT COMPLETED|Overall Study||0
2235756|NCT02645253|5480967|P2|NOT COMPLETED|Overall Study||0
2235757|NCT02645253|5480968|P1|NOT COMPLETED|Overall Study||0
2235758|NCT02645253|5480965|P4|COMPLETED|Overall Study||6
2235759|NCT02645253|5480966|P3|COMPLETED|Overall Study||7
2235760|NCT02645253|5480967|P2|COMPLETED|Overall Study||7
2235761|NCT02645253|5480968|P1|COMPLETED|Overall Study||7
2235762|NCT02645253|5480965|P4|STARTED|Overall Study||6
2235763|NCT02645253|5480966|P3|STARTED|Overall Study||7
2235764|NCT02645253|5480967|P2|STARTED|Overall Study||7
2235765|NCT02645253|5480968|P1|STARTED|Overall Study||7
2235766|NCT02645123|5481090|P3|NOT COMPLETED|Overall Study||0
2235767|NCT02645123|5481091|P2|NOT COMPLETED|Overall Study||0
2235768|NCT02645123|5481092|P1|NOT COMPLETED|Overall Study||0
2235769|NCT02645123|5481090|P3|COMPLETED|Overall Study||25
2235770|NCT02645123|5481091|P2|COMPLETED|Overall Study||25
2235771|NCT02645123|5481092|P1|COMPLETED|Overall Study||25
2235772|NCT02645123|5481090|P3|STARTED|Overall Study||25
2235773|NCT02645123|5481091|P2|STARTED|Overall Study||25
2235774|NCT02645123|5481092|P1|STARTED|Overall Study||25
2235775|NCT02645019|5481114|P5|NOT COMPLETED|Overall Study||0
2235776|NCT02645019|5481115|P4|NOT COMPLETED|Overall Study||0
2235777|NCT02645019|5481116|P3|NOT COMPLETED|Overall Study||0
2235778|NCT02645019|5481117|P2|NOT COMPLETED|Overall Study||0
2235779|NCT02645019|5481118|P1|NOT COMPLETED|Overall Study||0
2235780|NCT02645019|5481114|P5|COMPLETED|Overall Study||24
2235781|NCT02645019|5481115|P4|COMPLETED|Overall Study||33
2235782|NCT02645019|5481116|P3|COMPLETED|Overall Study||15
2235783|NCT02645019|5481117|P2|COMPLETED|Overall Study||15
2235784|NCT02645019|5481118|P1|COMPLETED|Overall Study||13
2235785|NCT02645019|5481114|P5|STARTED|Overall Study||24
2235786|NCT02645019|5481115|P4|STARTED|Overall Study||33
2235787|NCT02645019|5481116|P3|STARTED|Overall Study||15
2235788|NCT02645019|5481117|P2|STARTED|Overall Study||15
2235789|NCT02645019|5481118|P1|STARTED|Overall Study||13
2235790|NCT02644356|5481140|P1|NOT COMPLETED|Overall Study||2
2235791|NCT02644356|5481140|P1|COMPLETED|Overall Study|49 of the 51 consented subjects completed pre-post knowledge testing (96%)|49
2235792|NCT02644356|5481140|P1|STARTED|Overall Study||51
2235793|NCT02644278|5481154|P4|NOT COMPLETED|Overall Study||0
2235794|NCT02644278|5481155|P3|NOT COMPLETED|Overall Study||0
2235795|NCT02644278|5481156|P2|NOT COMPLETED|Overall Study||0
2235796|NCT02644278|5481157|P1|NOT COMPLETED|Overall Study||0
2235797|NCT02644278|5481154|P4|COMPLETED|Overall Study||3
2235798|NCT02644278|5481155|P3|COMPLETED|Overall Study||6
2235799|NCT02644278|5481156|P2|COMPLETED|Overall Study||3
2235800|NCT02644278|5481157|P1|COMPLETED|Overall Study||3
2235801|NCT02644278|5481154|P4|STARTED|Overall Study||3
2235802|NCT02644278|5481155|P3|STARTED|Overall Study||6
2235803|NCT02644278|5481156|P2|STARTED|Overall Study||3
2235804|NCT02644278|5481157|P1|STARTED|Overall Study||3
2235805|NCT02644122|5481223|P1|NOT COMPLETED|Overall Study||1
2235806|NCT02644122|5481223|P1|COMPLETED|Overall Study||0
2235807|NCT02644122|5481223|P1|STARTED|Overall Study||1
2235808|NCT02644109|5481233|P2|NOT COMPLETED|Overall Study||4
2235809|NCT02644109|5481234|P1|NOT COMPLETED|Overall Study||0
2235810|NCT02644109|5481233|P2|COMPLETED|Overall Study||24
2235811|NCT02644109|5481234|P1|COMPLETED|Overall Study||24
2235812|NCT02644109|5481233|P2|STARTED|Overall Study||28
2235813|NCT02644109|5481234|P1|STARTED|Overall Study||24
2235814|NCT02644096|5481242|P2|NOT COMPLETED|Overall Study||25
2235815|NCT02644096|5481243|P1|NOT COMPLETED|Overall Study||28
2235816|NCT02644096|5481242|P2|COMPLETED|Overall Study||57
2235817|NCT02644096|5481243|P1|COMPLETED|Overall Study||65
2235818|NCT02644096|5481242|P2|9 Month SF-36 Questionnaire|Overall Study||57
2235819|NCT02644096|5481243|P1|9 Month SF-36 Questionnaire|Overall Study||65
2235820|NCT02644096|5481242|P2|12 Week SF-36 Questionnaire|Overall Study||59
2235821|NCT02644096|5481243|P1|12 Week SF-36 Questionnaire|Overall Study||68
2235822|NCT02644096|5481242|P2|10 Week Interview|Overall Study||59
2235823|NCT02644096|5481243|P1|10 Week Interview|Overall Study|Not done in control group|0
2235824|NCT02644096|5481242|P2|2 Week Interview|Overall Study||68
2235825|NCT02644096|5481243|P1|2 Week Interview|Overall Study|Not done in control group|0
2235826|NCT02644096|5481242|P2|STARTED|Overall Study||82
2235827|NCT02644096|5481243|P1|STARTED|Overall Study||93
2235828|NCT02643979|5481251|P2|NOT COMPLETED|Overall Study||0
2235829|NCT02643979|5481252|P1|NOT COMPLETED|Overall Study||0
2235830|NCT02643979|5481251|P2|COMPLETED|Overall Study||11
2235831|NCT02643979|5481252|P1|COMPLETED|Overall Study||11
2235832|NCT02643979|5481251|P2|STARTED|Overall Study||11
2235833|NCT02643979|5481252|P1|STARTED|Overall Study||11
2235834|NCT02643862|5481272|P2|NOT COMPLETED|Overall Study||0
2235835|NCT02643862|5481273|P1|NOT COMPLETED|Overall Study||0
2235836|NCT02643862|5481272|P2|COMPLETED|Overall Study||12
2235837|NCT02643862|5481273|P1|COMPLETED|Overall Study||36
2235838|NCT02643862|5481272|P2|STARTED|Overall Study||12
2235839|NCT02643862|5481273|P1|STARTED|Overall Study||36
2235840|NCT02643693|5481281|P6|NOT COMPLETED|Overall Study||1
2235841|NCT02643693|5481282|P5|NOT COMPLETED|Overall Study||0
2235842|NCT02643693|5481283|P4|NOT COMPLETED|Overall Study||0
2235843|NCT02643693|5481284|P3|NOT COMPLETED|Overall Study||1
2235844|NCT02643693|5481285|P2|NOT COMPLETED|Overall Study||2
2235845|NCT02643693|5481286|P1|NOT COMPLETED|Overall Study||2
2235846|NCT02643693|5481281|P6|COMPLETED|Overall Study||3
2235847|NCT02643693|5481282|P5|COMPLETED|Overall Study||4
2235848|NCT02643693|5481283|P4|COMPLETED|Overall Study||4
2235849|NCT02643693|5481284|P3|COMPLETED|Overall Study||3
2235850|NCT02643693|5481285|P2|COMPLETED|Overall Study||2
2235851|NCT02643693|5481286|P1|COMPLETED|Overall Study||2
2235852|NCT02643693|5481281|P6|STARTED|Overall Study||4
2235853|NCT02643693|5481282|P5|STARTED|Overall Study||4
2235854|NCT02643693|5481283|P4|STARTED|Overall Study||4
2235855|NCT02643693|5481284|P3|STARTED|Overall Study||4
2235856|NCT02643693|5481285|P2|STARTED|Overall Study||4
2235857|NCT02643693|5481286|P1|STARTED|Overall Study||4
2235858|NCT02643628|5481299|P2|NOT COMPLETED|Overall Study||6
2235859|NCT02643628|5481300|P1|NOT COMPLETED|Overall Study||1
2235860|NCT02643628|5481299|P2|COMPLETED|Overall Study||17
2235861|NCT02643628|5481300|P1|COMPLETED|Overall Study||20
2235862|NCT02643628|5481299|P2|STARTED|Overall Study||23
2235863|NCT02643628|5481300|P1|STARTED|Overall Study||21
2235864|NCT02643615|5481316|P2|NOT COMPLETED|Overall Study||0
2235865|NCT02643615|5481317|P1|NOT COMPLETED|Overall Study||0
2235866|NCT02643615|5481316|P2|COMPLETED|Overall Study||11
2235867|NCT02643615|5481317|P1|COMPLETED|Overall Study||9
2235868|NCT02643615|5481316|P2|STARTED|Overall Study||11
2235869|NCT02643615|5481317|P1|STARTED|Overall Study||9
2235870|NCT02643472|5481331|P2|NOT COMPLETED|Overall Study||34
2235871|NCT02643472|5481332|P1|NOT COMPLETED|Overall Study||27
2235872|NCT02643472|5481331|P2|COMPLETED|Overall Study|One participant completed CESD-10 but not other measures at 12 months; n=115 for other measures.|116
2235873|NCT02643472|5481332|P1|COMPLETED|Overall Study||123
2235874|NCT02643472|5481331|P2|STARTED|Overall Study||150
2235875|NCT02643472|5481332|P1|STARTED|Overall Study||150
2235876|NCT02643394|5481358|P2|NOT COMPLETED|Overall Study||5
2235877|NCT02643394|5481359|P1|NOT COMPLETED|Overall Study||4
2235878|NCT02643394|5481358|P2|COMPLETED|Overall Study||50
2235879|NCT02643394|5481359|P1|COMPLETED|Overall Study||51
2235880|NCT02643394|5481358|P2|STARTED|Overall Study||55
2235881|NCT02643394|5481359|P1|STARTED|Overall Study||55
2235882|NCT02643355|5481369|P2|NOT COMPLETED|Overall Study||5
2235883|NCT02643355|5481370|P1|NOT COMPLETED|Overall Study||1
2235884|NCT02643355|5481369|P2|COMPLETED|Overall Study||30
2235885|NCT02643355|5481370|P1|COMPLETED|Overall Study||33
2235886|NCT02643355|5481369|P2|STARTED|Overall Study||35
2235887|NCT02643355|5481370|P1|STARTED|Overall Study||34
2235888|NCT02643251|5481384|P2|NOT COMPLETED|Overall Study||2
2235889|NCT02643251|5481385|P1|NOT COMPLETED|Overall Study||11
2235890|NCT02643251|5481384|P2|COMPLETED|Overall Study||67
2235891|NCT02643251|5481385|P1|COMPLETED|Overall Study||58
2235892|NCT02643251|5481384|P2|STARTED|Overall Study||69
2235893|NCT02643251|5481385|P1|STARTED|Overall Study||69
2235894|NCT02643225|5481395|P2|NOT COMPLETED|Overall Study||0
2235895|NCT02643225|5481396|P1|NOT COMPLETED|Overall Study||0
2235896|NCT02643225|5481395|P2|COMPLETED|Overall Study||40
2235897|NCT02643225|5481396|P1|COMPLETED|Overall Study||40
2235898|NCT02643225|5481395|P2|STARTED|Overall Study||40
2235899|NCT02643225|5481396|P1|STARTED|Overall Study||40
2235900|NCT02643199|5481408|P1|NOT COMPLETED|Overall Study||0
2235901|NCT02643199|5481408|P1|COMPLETED|Overall Study||90
2235902|NCT02643199|5481408|P1|STARTED|Overall Study||90
2235903|NCT02643095|5481413|P1|NOT COMPLETED|Overall Study||1
2235904|NCT02643095|5481413|P1|COMPLETED|Overall Study||21
2235905|NCT02643095|5481413|P1|STARTED|Overall Study||22
2235906|NCT02643082|5481417|P2|NOT COMPLETED|Period 2||0
2235907|NCT02643082|5481418|P1|NOT COMPLETED|Period 2||0
2235908|NCT02643082|5481417|P2|COMPLETED|Period 2||10
2235909|NCT02643082|5481418|P1|COMPLETED|Period 2||9
2235910|NCT02643082|5481417|P2|STARTED|Period 2||10
2235911|NCT02643082|5481418|P1|STARTED|Period 2||9
2235912|NCT02643082|5481417|P2|NOT COMPLETED|Washout||0
2235913|NCT02643082|5481418|P1|NOT COMPLETED|Washout||0
2235914|NCT02643082|5481417|P2|COMPLETED|Washout||10
2235915|NCT02643082|5481418|P1|COMPLETED|Washout||9
2235916|NCT02643082|5481417|P2|STARTED|Washout||10
2235917|NCT02643082|5481418|P1|STARTED|Washout||9
2235918|NCT02643082|5481417|P2|NOT COMPLETED|Period 1||0
2235919|NCT02643082|5481418|P1|NOT COMPLETED|Period 1||1
2235920|NCT02643082|5481417|P2|COMPLETED|Period 1||10
2235921|NCT02643082|5481418|P1|COMPLETED|Period 1||9
2235922|NCT02643082|5481417|P2|STARTED|Period 1||10
2235923|NCT02643082|5481418|P1|STARTED|Period 1||10
2235924|NCT02643004|5481435|P2|NOT COMPLETED|Second Intervention (One Week)||0
2235925|NCT02643004|5481436|P1|NOT COMPLETED|Second Intervention (One Week)||0
2235926|NCT02643004|5481435|P2|COMPLETED|Second Intervention (One Week)||35
2235927|NCT02643004|5481436|P1|COMPLETED|Second Intervention (One Week)||35
2235928|NCT02643004|5481435|P2|STARTED|Second Intervention (One Week)||35
2235929|NCT02643004|5481436|P1|STARTED|Second Intervention (One Week)||35
2235930|NCT02643004|5481435|P2|NOT COMPLETED|First Intervention (One Week)||0
2235931|NCT02643004|5481436|P1|NOT COMPLETED|First Intervention (One Week)||0
2235932|NCT02643004|5481435|P2|COMPLETED|First Intervention (One Week)||35
2235933|NCT02643004|5481436|P1|COMPLETED|First Intervention (One Week)||35
2235934|NCT02643004|5481435|P2|STARTED|First Intervention (One Week)||35
2235935|NCT02643004|5481436|P1|STARTED|First Intervention (One Week)||35
2235936|NCT02642965|5481476|P1|NOT COMPLETED|Overall Study||13
2235937|NCT02642965|5481476|P1|COMPLETED|Overall Study||25
2235938|NCT02642965|5481476|P1|STARTED|Overall Study||38
2235939|NCT02642952|5481492|P2|NOT COMPLETED|Overall Study||5
2235940|NCT02642952|5481493|P1|NOT COMPLETED|Overall Study||2
2235941|NCT02642952|5481492|P2|COMPLETED|Overall Study||25
2235942|NCT02642952|5481493|P1|COMPLETED|Overall Study||19
2235943|NCT02642952|5481492|P2|STARTED|Overall Study||30
2235944|NCT02642952|5481493|P1|STARTED|Overall Study||21
2235945|NCT02642835|5481507|P1|NOT COMPLETED|Overall Study||0
2235946|NCT02642835|5481507|P1|COMPLETED|Overall Study||48
2235947|NCT02642835|5481507|P1|STARTED|Overall Study||48
2235948|NCT02642679|5481520|P1|NOT COMPLETED|Overall Study||3
2235949|NCT02642679|5481520|P1|COMPLETED|Overall Study||16
2235950|NCT02642679|5481520|P1|STARTED|Overall Study||19
2235951|NCT02642653|5481528|P2|NOT COMPLETED|Overall Study||0
2235952|NCT02642653|5481529|P1|NOT COMPLETED|Overall Study||2
2235953|NCT02642653|5481528|P2|COMPLETED|Overall Study||16
2235954|NCT02642653|5481529|P1|COMPLETED|Overall Study||12
2235955|NCT02642653|5481528|P2|STARTED|Overall Study||16
2235956|NCT02642653|5481529|P1|STARTED|Overall Study||14
2235957|NCT02642614|5481565|P4|NOT COMPLETED|Overall Study||2
2235958|NCT02642614|5481566|P3|NOT COMPLETED|Overall Study||2
2235959|NCT02642614|5481567|P2|NOT COMPLETED|Overall Study||2
2235960|NCT02642614|5481568|P1|NOT COMPLETED|Overall Study||3
2235961|NCT02642614|5481565|P4|COMPLETED|Overall Study||28
2235962|NCT02642614|5481566|P3|COMPLETED|Overall Study||28
2235963|NCT02642614|5481567|P2|COMPLETED|Overall Study||28
2235964|NCT02642614|5481568|P1|COMPLETED|Overall Study||27
2235965|NCT02642614|5481565|P4|STARTED|Overall Study||30
2235966|NCT02642614|5481566|P3|STARTED|Overall Study||30
2235967|NCT02642614|5481567|P2|STARTED|Overall Study||30
2235968|NCT02642614|5481568|P1|STARTED|Overall Study||30
2235969|NCT02642575|5481600|P1|NOT COMPLETED|Overall Study||0
2235970|NCT02642575|5481600|P1|COMPLETED|Overall Study||67
2235971|NCT02642575|5481600|P1|STARTED|Overall Study||67
2235972|NCT02642536|5481608|P2|NOT COMPLETED|Overall Study||5
2235973|NCT02642536|5481609|P1|NOT COMPLETED|Overall Study||2
2235974|NCT02642536|5481608|P2|COMPLETED|Overall Study||18
2235975|NCT02642536|5481609|P1|COMPLETED|Overall Study||19
2235976|NCT02642536|5481608|P2|STARTED|Overall Study||23
2235977|NCT02642536|5481609|P1|STARTED|Overall Study||21
2235978|NCT02642432|5481635|P1|NOT COMPLETED|Overall Study||8
2235979|NCT02642432|5481635|P1|COMPLETED|Overall Study||138
2235980|NCT02642432|5481635|P1|STARTED|Overall Study||146
2235981|NCT02642237|5481643|P2|NOT COMPLETED|Overall Study||0
2235982|NCT02642237|5481644|P1|NOT COMPLETED|Overall Study||0
2235983|NCT02642237|5481643|P2|COMPLETED|Overall Study||15
2235984|NCT02642237|5481644|P1|COMPLETED|Overall Study||15
2235985|NCT02642237|5481643|P2|STARTED|Overall Study||15
2235986|NCT02642237|5481644|P1|STARTED|Overall Study||15
2235987|NCT02642159|5481652|P2|NOT COMPLETED|Overall Study||8
2235988|NCT02642159|5481653|P1|NOT COMPLETED|Overall Study||31
2235989|NCT02642159|5481652|P2|COMPLETED|Overall Study||129
2235990|NCT02642159|5481653|P1|COMPLETED|Overall Study||245
2235991|NCT02642159|5481652|P2|ITT: Intent to Prescribe Fenofibrate|Overall Study||24
2235992|NCT02642159|5481653|P1|ITT: Intent to Prescribe Fenofibrate|Overall Study|Fenofibrate was only ‘intended to prescribe’ in the Alirocumab arm but not actually administered.|47
2235993|NCT02642159|5481652|P2|ITT Population|Overall Study||136
2235994|NCT02642159|5481653|P1|ITT Population|Overall Study||273
2235995|NCT02642159|5481652|P2|Treated (Safety Population)|Overall Study||137
2235996|NCT02642159|5481653|P1|Treated (Safety Population)|Overall Study||275
2235997|NCT02642159|5481652|P2|STARTED|Overall Study|Randomized|137
2235998|NCT02642159|5481653|P1|STARTED|Overall Study|Randomized|276
2235999|NCT02641912|5481705|P2|NOT COMPLETED|Overall Study||0
2236000|NCT02641912|5481706|P1|NOT COMPLETED|Overall Study||0
2236001|NCT02641912|5481705|P2|COMPLETED|Overall Study||47
2236002|NCT02641912|5481706|P1|COMPLETED|Overall Study||53
2236003|NCT02641912|5481705|P2|STARTED|Overall Study||47
2236004|NCT02641912|5481706|P1|STARTED|Overall Study||53
2236005|NCT02641730|5481777|P5|NOT COMPLETED|Observational Period (Week 60 - Week 84)||1
2236006|NCT02641730|5481778|P4|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
2236007|NCT02641730|5481779|P3|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
2236008|NCT02641730|5481780|P2|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
2236009|NCT02641730|5481781|P1|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
2236010|NCT02641730|5481777|P5|COMPLETED|Observational Period (Week 60 - Week 84)||43
2236011|NCT02641730|5481778|P4|COMPLETED|Observational Period (Week 60 - Week 84)||45
2236012|NCT02641730|5481779|P3|COMPLETED|Observational Period (Week 60 - Week 84)||24
2236013|NCT02641730|5481780|P2|COMPLETED|Observational Period (Week 60 - Week 84)||21
2236014|NCT02641730|5481781|P1|COMPLETED|Observational Period (Week 60 - Week 84)||0
2236015|NCT02641730|5481777|P5|STARTED|Observational Period (Week 60 - Week 84)||44
2236016|NCT02641730|5481778|P4|STARTED|Observational Period (Week 60 - Week 84)||45
2236017|NCT02641730|5481779|P3|STARTED|Observational Period (Week 60 - Week 84)||24
2236018|NCT02641730|5481780|P2|STARTED|Observational Period (Week 60 - Week 84)||21
2236019|NCT02641730|5481781|P1|STARTED|Observational Period (Week 60 - Week 84)||0
2236020|NCT02641730|5481777|P5|NOT COMPLETED|After Controlled Period (Week 16 – 52)||6
2236021|NCT02641730|5481778|P4|NOT COMPLETED|After Controlled Period (Week 16 – 52)||8
2236022|NCT02641730|5481779|P3|NOT COMPLETED|After Controlled Period (Week 16 – 52)||2
2236023|NCT02641730|5481780|P2|NOT COMPLETED|After Controlled Period (Week 16 – 52)||4
2236024|NCT02641730|5481781|P1|NOT COMPLETED|After Controlled Period (Week 16 – 52)||0
2236025|NCT02641730|5481777|P5|COMPLETED|After Controlled Period (Week 16 – 52)||44
2236026|NCT02641730|5481778|P4|COMPLETED|After Controlled Period (Week 16 – 52)||45
2236027|NCT02641730|5481779|P3|COMPLETED|After Controlled Period (Week 16 – 52)||24
2236028|NCT02641730|5481780|P2|COMPLETED|After Controlled Period (Week 16 – 52)||21
2236029|NCT02641730|5481781|P1|COMPLETED|After Controlled Period (Week 16 – 52)||0
2236030|NCT02641730|5481777|P5|STARTED|After Controlled Period (Week 16 – 52)||50
2236031|NCT02641730|5481778|P4|STARTED|After Controlled Period (Week 16 – 52)||53
2236032|NCT02641730|5481779|P3|STARTED|After Controlled Period (Week 16 – 52)||26
2236033|NCT02641730|5481780|P2|STARTED|After Controlled Period (Week 16 – 52)||25
2236034|NCT02641730|5481781|P1|STARTED|After Controlled Period (Week 16 – 52)||0
2236035|NCT02641730|5481777|P5|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||2
2236036|NCT02641730|5481778|P4|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||1
2236037|NCT02641730|5481779|P3|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
2236038|NCT02641730|5481780|P2|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
2236039|NCT02641730|5481781|P1|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||2
2236040|NCT02641730|5481777|P5|COMPLETED|Placebo Controlled Period (Week 0 - 16)||50
2236041|NCT02641730|5481778|P4|COMPLETED|Placebo Controlled Period (Week 0 - 16)||53
2236042|NCT02641730|5481779|P3|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
2236043|NCT02641730|5481780|P2|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
2236044|NCT02641730|5481781|P1|COMPLETED|Placebo Controlled Period (Week 0 - 16)||51
2236045|NCT02641730|5481777|P5|STARTED|Placebo Controlled Period (Week 0 - 16)||52
2236046|NCT02641730|5481778|P4|STARTED|Placebo Controlled Period (Week 0 - 16)||54
2236047|NCT02641730|5481779|P3|STARTED|Placebo Controlled Period (Week 0 - 16)||0
2236048|NCT02641730|5481780|P2|STARTED|Placebo Controlled Period (Week 0 - 16)||0
2236049|NCT02641730|5481781|P1|STARTED|Placebo Controlled Period (Week 0 - 16)||53
2236050|NCT02641587|5481885|P2|NOT COMPLETED|Ambulatory Period||0
2236051|NCT02641587|5481886|P1|NOT COMPLETED|Ambulatory Period||1
2236052|NCT02641587|5481885|P2|COMPLETED|Ambulatory Period||39
2236053|NCT02641587|5481886|P1|COMPLETED|Ambulatory Period||76
2236054|NCT02641587|5481885|P2|STARTED|Ambulatory Period||39
2236055|NCT02641587|5481886|P1|STARTED|Ambulatory Period||77
2236056|NCT02641587|5481885|P2|NOT COMPLETED|Confinement Period||1
2236057|NCT02641587|5481886|P1|NOT COMPLETED|Confinement Period||3
2236058|NCT02641587|5481885|P2|COMPLETED|Confinement Period||39
2236059|NCT02641587|5481886|P1|COMPLETED|Confinement Period||77
2236060|NCT02641587|5481885|P2|STARTED|Confinement Period||40
2236061|NCT02641587|5481886|P1|STARTED|Confinement Period||80
2236062|NCT02641561|5481911|P4|NOT COMPLETED|Overall Study||0
2236063|NCT02641561|5481912|P3|NOT COMPLETED|Overall Study||0
2236064|NCT02641561|5481913|P2|NOT COMPLETED|Overall Study||0
2236065|NCT02641561|5481914|P1|NOT COMPLETED|Overall Study||0
2236066|NCT02641561|5481911|P4|COMPLETED|Overall Study||48
2236067|NCT02641561|5481912|P3|COMPLETED|Overall Study||48
2236068|NCT02641561|5481913|P2|COMPLETED|Overall Study||48
2236069|NCT02641561|5481914|P1|COMPLETED|Overall Study||48
2236070|NCT02641561|5481911|P4|STARTED|Overall Study||48
2236071|NCT02641561|5481912|P3|STARTED|Overall Study||48
2236072|NCT02641561|5481913|P2|STARTED|Overall Study||48
2236073|NCT02641561|5481914|P1|STARTED|Overall Study||48
2236074|NCT02641522|5482000|P1|NOT COMPLETED|Overall Study||0
2236075|NCT02641522|5482000|P1|COMPLETED|Overall Study||10
2236076|NCT02641522|5482000|P1|STARTED|Overall Study||10
2236077|NCT02641392|5482007|P3|NOT COMPLETED|Overall Study||293
2236078|NCT02641392|5482008|P2|NOT COMPLETED|Overall Study||13
2236079|NCT02641392|5482009|P1|NOT COMPLETED|Overall Study||4
2236080|NCT02641392|5482007|P3|COMPLETED|Overall Study||0
2236081|NCT02641392|5482008|P2|COMPLETED|Overall Study||0
2236082|NCT02641392|5482009|P1|COMPLETED|Overall Study||0
2236083|NCT02641392|5482007|P3|STARTED|Overall Study||293
2236084|NCT02641392|5482008|P2|STARTED|Overall Study||13
2236085|NCT02641392|5482009|P1|STARTED|Overall Study||4
2236086|NCT02641379|5482028|P11|NOT COMPLETED|Overall Study||8
2236087|NCT02641379|5482029|P10|NOT COMPLETED|Overall Study||9
2236088|NCT02641379|5482030|P9|NOT COMPLETED|Overall Study||6
2236089|NCT02641379|5482031|P8|NOT COMPLETED|Overall Study||19
2236090|NCT02641379|5482032|P7|NOT COMPLETED|Overall Study||13
2236091|NCT02641379|5482033|P6|NOT COMPLETED|Overall Study||16
2236092|NCT02641379|5482034|P5|NOT COMPLETED|Overall Study||17
2236093|NCT02641379|5482035|P4|NOT COMPLETED|Overall Study||17
2236094|NCT02641379|5482036|P3|NOT COMPLETED|Overall Study||71
2236095|NCT02641379|5482037|P2|NOT COMPLETED|Overall Study||51
2236096|NCT02641379|5482038|P1|NOT COMPLETED|Overall Study||35
2236097|NCT02641379|5482028|P11|COMPLETED|Overall Study||0
2236098|NCT02641379|5482029|P10|COMPLETED|Overall Study||36
2236099|NCT02641379|5482030|P9|COMPLETED|Overall Study||36
2236100|NCT02641379|5482031|P8|COMPLETED|Overall Study||1
2236101|NCT02641379|5482032|P7|COMPLETED|Overall Study||12
2236102|NCT02641379|5482033|P6|COMPLETED|Overall Study||20
2236103|NCT02641379|5482034|P5|COMPLETED|Overall Study||0
2236104|NCT02641379|5482035|P4|COMPLETED|Overall Study||139
2236105|NCT02641379|5482036|P3|COMPLETED|Overall Study||7
2236106|NCT02641379|5482037|P2|COMPLETED|Overall Study||101
2236107|NCT02641379|5482038|P1|COMPLETED|Overall Study||107
2236108|NCT02641379|5482028|P11|STARTED|Overall Study||8
2236109|NCT02641379|5482029|P10|STARTED|Overall Study||45
2236110|NCT02641379|5482030|P9|STARTED|Overall Study||42
2236111|NCT02641379|5482031|P8|STARTED|Overall Study||20
2236112|NCT02641379|5482032|P7|STARTED|Overall Study||25
2236113|NCT02641379|5482033|P6|STARTED|Overall Study||36
2236114|NCT02641379|5482034|P5|STARTED|Overall Study||17
2236115|NCT02641379|5482035|P4|STARTED|Overall Study||156
2236116|NCT02641379|5482036|P3|STARTED|Overall Study||78
2236117|NCT02641379|5482037|P2|STARTED|Overall Study||152
2236118|NCT02641379|5482038|P1|STARTED|Overall Study||142
2236119|NCT02641249|5482103|P1|NOT COMPLETED|Overall Study||4
2236120|NCT02641249|5482103|P1|COMPLETED|Overall Study||15
2236121|NCT02641249|5482103|P1|STARTED|Overall Study||19
2236122|NCT02641067|5482114|P2|NOT COMPLETED|Overall Study||0
2236123|NCT02641067|5482115|P1|NOT COMPLETED|Overall Study||0
2236124|NCT02641067|5482114|P2|COMPLETED|Overall Study||8
2236125|NCT02641067|5482115|P1|COMPLETED|Overall Study||8
2236126|NCT02641067|5482114|P2|STARTED|Overall Study||8
2236127|NCT02641067|5482115|P1|STARTED|Overall Study||8
2236128|NCT02640755|5482137|P2|NOT COMPLETED|Multiple Dose Period (Day 8 - EoS)||1
2236129|NCT02640755|5482138|P1|NOT COMPLETED|Multiple Dose Period (Day 8 - EoS)||2
2236130|NCT02640755|5482137|P2|COMPLETED|Multiple Dose Period (Day 8 - EoS)||0
2236131|NCT02640755|5482138|P1|COMPLETED|Multiple Dose Period (Day 8 - EoS)||1
2236132|NCT02640755|5482137|P2|STARTED|Multiple Dose Period (Day 8 - EoS)||1
2236133|NCT02640755|5482138|P1|STARTED|Multiple Dose Period (Day 8 - EoS)||3
2236134|NCT02640755|5482137|P2|NOT COMPLETED|Single Dose Period (Day 1 - 8)||0
2236135|NCT02640755|5482138|P1|NOT COMPLETED|Single Dose Period (Day 1 - 8)||0
2236136|NCT02640755|5482137|P2|COMPLETED|Single Dose Period (Day 1 - 8)||1
2236137|NCT02640755|5482138|P1|COMPLETED|Single Dose Period (Day 1 - 8)||3
2236138|NCT02640755|5482137|P2|STARTED|Single Dose Period (Day 1 - 8)||1
2236139|NCT02640755|5482138|P1|STARTED|Single Dose Period (Day 1 - 8)||3
2236140|NCT02640612|5482176|P3|NOT COMPLETED|Overall Study||6
2236141|NCT02640612|5482177|P2|NOT COMPLETED|Overall Study||14
2236142|NCT02640612|5482178|P1|NOT COMPLETED|Overall Study||22
2236143|NCT02640612|5482176|P3|COMPLETED|Overall Study||96
2236144|NCT02640612|5482177|P2|COMPLETED|Overall Study||89
2236145|NCT02640612|5482178|P1|COMPLETED|Overall Study||203
2236146|NCT02640612|5482176|P3|STARTED|Overall Study||102
2236147|NCT02640612|5482177|P2|STARTED|Overall Study||103
2236148|NCT02640612|5482178|P1|STARTED|Overall Study||225
2236149|NCT02640573|5482198|P1|NOT COMPLETED|Overall Study||1
2236150|NCT02640573|5482198|P1|COMPLETED|Overall Study||0
2236151|NCT02640573|5482198|P1|STARTED|Overall Study||1
2236152|NCT02640547|5482202|P1|NOT COMPLETED|Overall Study||11
2236153|NCT02640547|5482202|P1|COMPLETED|Overall Study||383
2236154|NCT02640547|5482202|P1|STARTED|Overall Study||394
2236155|NCT02640482|5482279|P2|NOT COMPLETED|Overall Study||0
2236156|NCT02640482|5482280|P1|NOT COMPLETED|Overall Study||3
2236157|NCT02640482|5482279|P2|COMPLETED|Overall Study||100
2236158|NCT02640482|5482280|P1|COMPLETED|Overall Study||199
2236159|NCT02640482|5482279|P2|STARTED|Overall Study||100
2236160|NCT02640482|5482280|P1|STARTED|Overall Study||202
2236161|NCT02640404|5482292|P2|NOT COMPLETED|Overall Study||0
2236162|NCT02640404|5482293|P1|NOT COMPLETED|Overall Study||2
2236163|NCT02640404|5482292|P2|COMPLETED|Overall Study||112
2236164|NCT02640404|5482293|P1|COMPLETED|Overall Study||110
2236165|NCT02640404|5482292|P2|STARTED|Overall Study||112
2236166|NCT02640404|5482293|P1|STARTED|Overall Study||112
2236167|NCT02640157|5482304|P3|NOT COMPLETED|Overall Study||10
2236168|NCT02640157|5482305|P2|NOT COMPLETED|Overall Study||5
2236169|NCT02640157|5482306|P1|NOT COMPLETED|Overall Study||13
2236170|NCT02640157|5482304|P3|COMPLETED|Overall Study||147
2236171|NCT02640157|5482305|P2|COMPLETED|Overall Study||111
2236172|NCT02640157|5482306|P1|COMPLETED|Overall Study||220
2236173|NCT02640157|5482304|P3|Discontinued Study Drug|Overall Study||3
2236174|NCT02640157|5482305|P2|Discontinued Study Drug|Overall Study||3
2236175|NCT02640157|5482306|P1|Discontinued Study Drug|Overall Study||8
2236176|NCT02640157|5482304|P3|Completed Study Drug|Overall Study||154
2236177|NCT02640157|5482305|P2|Completed Study Drug|Overall Study||112
2236178|NCT02640157|5482306|P1|Completed Study Drug|Overall Study||225
2236179|NCT02640157|5482304|P3|Received Study Drug|Overall Study||157
2236180|NCT02640157|5482305|P2|Received Study Drug|Overall Study|One participant in Arm B was randomized in error and never dispensed study drug.|115
2236181|NCT02640157|5482306|P1|Received Study Drug|Overall Study||233
2236182|NCT02640157|5482304|P3|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|157
2236183|NCT02640157|5482305|P2|STARTED|Overall Study||116
2236184|NCT02640157|5482306|P1|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|233
2236185|NCT02640053|5482325|P2|NOT COMPLETED|Overall Study||4
2236186|NCT02640053|5482326|P1|NOT COMPLETED|Overall Study||4
2236187|NCT02640053|5482325|P2|COMPLETED|Overall Study||17
2236188|NCT02640053|5482326|P1|COMPLETED|Overall Study||17
2236189|NCT02640053|5482325|P2|STARTED|Overall Study||21
2236190|NCT02640053|5482326|P1|STARTED|Overall Study||21
2236191|NCT02639910|5482348|P2|NOT COMPLETED|Overall Study||8
2236192|NCT02639910|5482349|P1|NOT COMPLETED|Overall Study||4
2236193|NCT02639910|5482348|P2|COMPLETED|Overall Study||5
2236194|NCT02639910|5482349|P1|COMPLETED|Overall Study||7
2236195|NCT02639910|5482348|P2|STARTED|Overall Study||13
2236196|NCT02639910|5482349|P1|STARTED|Overall Study||11
2236197|NCT02639637|5482366|P4|NOT COMPLETED|Overall Study||0
2236198|NCT02639637|5482367|P3|NOT COMPLETED|Overall Study||0
2236199|NCT02639637|5482368|P2|NOT COMPLETED|Overall Study||0
2236200|NCT02639637|5482369|P1|NOT COMPLETED|Overall Study||0
2236201|NCT02639637|5482366|P4|COMPLETED|Overall Study||3
2236202|NCT02639637|5482367|P3|COMPLETED|Overall Study||2
2236203|NCT02639637|5482368|P2|COMPLETED|Overall Study||6
2236204|NCT02639637|5482369|P1|COMPLETED|Overall Study||7
2236205|NCT02639637|5482366|P4|STARTED|Overall Study||3
2236206|NCT02639637|5482367|P3|STARTED|Overall Study||2
2236207|NCT02639637|5482368|P2|STARTED|Overall Study||6
2236208|NCT02639637|5482369|P1|STARTED|Overall Study||7
2236209|NCT02639559|5482433|P2|NOT COMPLETED|Overall Study||3
2236210|NCT02639559|5482434|P1|NOT COMPLETED|Overall Study||1
2236211|NCT02639559|5482433|P2|COMPLETED|Overall Study||22
2236212|NCT02639559|5482434|P1|COMPLETED|Overall Study||24
2236213|NCT02639559|5482433|P2|STARTED|Overall Study||25
2236214|NCT02639559|5482434|P1|STARTED|Overall Study||25
2236215|NCT02639494|5482450|P1|NOT COMPLETED|Overall Study||0
2236216|NCT02639494|5482450|P1|COMPLETED|Overall Study||20
2236217|NCT02639494|5482450|P1|STARTED|Overall Study||20
2236218|NCT02639429|5482467|P2|NOT COMPLETED|Overall Study||0
2236219|NCT02639429|5482468|P1|NOT COMPLETED|Overall Study||0
2236220|NCT02639429|5482467|P2|COMPLETED|Overall Study||123
2236221|NCT02639429|5482468|P1|COMPLETED|Overall Study||113
2236222|NCT02639429|5482467|P2|STARTED|Overall Study||123
2236223|NCT02639429|5482468|P1|STARTED|Overall Study||113
2236224|NCT02639351|5482507|P5|NOT COMPLETED|Overall Study||0
2236225|NCT02639351|5482508|P4|NOT COMPLETED|Overall Study||0
2236226|NCT02639351|5482509|P3|NOT COMPLETED|Overall Study||0
2236227|NCT02639351|5482510|P2|NOT COMPLETED|Overall Study||0
2236228|NCT02639351|5482511|P1|NOT COMPLETED|Overall Study||0
2236229|NCT02639351|5482507|P5|COMPLETED|Overall Study||16
2236230|NCT02639351|5482508|P4|COMPLETED|Overall Study||16
2236231|NCT02639351|5482509|P3|COMPLETED|Overall Study||16
2236232|NCT02639351|5482510|P2|COMPLETED|Overall Study||16
2236233|NCT02639351|5482511|P1|COMPLETED|Overall Study||16
2236234|NCT02639351|5482507|P5|STARTED|Overall Study||16
2236235|NCT02639351|5482508|P4|STARTED|Overall Study||16
2236236|NCT02639351|5482509|P3|STARTED|Overall Study||16
2236237|NCT02639351|5482510|P2|STARTED|Overall Study||16
2236238|NCT02639351|5482511|P1|STARTED|Overall Study||16
2236239|NCT02639338|5482860|P2|NOT COMPLETED|Overall Study||5
2236240|NCT02639338|5482861|P1|NOT COMPLETED|Overall Study||4
2236241|NCT02639338|5482860|P2|COMPLETED|Overall Study||105
2236242|NCT02639338|5482861|P1|COMPLETED|Overall Study||106
2236243|NCT02639338|5482860|P2|STARTED|Overall Study||110
2236244|NCT02639338|5482861|P1|STARTED|Overall Study||110
2236245|NCT02639247|5482879|P2|NOT COMPLETED|Overall Study||2
2236246|NCT02639247|5482880|P1|NOT COMPLETED|Overall Study||5
2236247|NCT02639247|5482879|P2|COMPLETED|Overall Study||149
2236248|NCT02639247|5482880|P1|COMPLETED|Overall Study||177
2236249|NCT02639247|5482879|P2|STARTED|Overall Study||151
2236250|NCT02639247|5482880|P1|STARTED|Overall Study||182
2236251|NCT02639052|5482896|P1|NOT COMPLETED|Overall Study||1
2236252|NCT02639052|5482896|P1|COMPLETED|Overall Study||34
2236253|NCT02639052|5482896|P1|Visit 4 (3-month Follow-up)|Overall Study||34
2236254|NCT02639052|5482896|P1|Visit 3 (1-month Follow-up)|Overall Study||35
2236255|NCT02639052|5482896|P1|Visit 2 (1-week Follow-up)|Overall Study||35
2236256|NCT02639052|5482896|P1|Visit 1 (Baseline)|Overall Study||35
2236257|NCT02639052|5482896|P1|STARTED|Overall Study||35
2236258|NCT02638974|5482912|P2|NOT COMPLETED|Overall Study||3
2236259|NCT02638974|5482913|P1|NOT COMPLETED|Overall Study||3
2236260|NCT02638974|5482912|P2|COMPLETED|Overall Study||22
2236261|NCT02638974|5482913|P1|COMPLETED|Overall Study||23
2236262|NCT02638974|5482912|P2|STARTED|Overall Study||25
2236263|NCT02638974|5482913|P1|STARTED|Overall Study||26
2236264|NCT02638948|5482933|P4|NOT COMPLETED|Overall Study||8
2236265|NCT02638948|5482934|P3|NOT COMPLETED|Overall Study||7
2236266|NCT02638948|5482935|P2|NOT COMPLETED|Overall Study||11
2236267|NCT02638948|5482936|P1|NOT COMPLETED|Overall Study||9
2236268|NCT02638948|5482933|P4|COMPLETED|Overall Study||18
2236269|NCT02638948|5482934|P3|COMPLETED|Overall Study||66
2236270|NCT02638948|5482935|P2|COMPLETED|Overall Study||62
2236271|NCT02638948|5482936|P1|COMPLETED|Overall Study||66
2236272|NCT02638948|5482933|P4|STARTED|Overall Study||26
2236273|NCT02638948|5482934|P3|STARTED|Overall Study||73
2236274|NCT02638948|5482935|P2|STARTED|Overall Study||73
2236275|NCT02638948|5482936|P1|STARTED|Overall Study||75
2236276|NCT02638597|5483023|P2|NOT COMPLETED|Overall Study||5
2236277|NCT02638597|5483024|P1|NOT COMPLETED|Overall Study||4
2236278|NCT02638597|5483023|P2|COMPLETED|Overall Study||3
2236279|NCT02638597|5483024|P1|COMPLETED|Overall Study||4
2236280|NCT02638597|5483023|P2|STARTED|Overall Study||8
2236281|NCT02638597|5483024|P1|STARTED|Overall Study||8
2236282|NCT02638493|5483035|P3|NOT COMPLETED|Overall Study||0
2236283|NCT02638493|5483036|P2|NOT COMPLETED|Overall Study||0
2236284|NCT02638493|5483037|P1|NOT COMPLETED|Overall Study||2
2236285|NCT02638493|5483035|P3|COMPLETED|Overall Study||8
2236286|NCT02638493|5483036|P2|COMPLETED|Overall Study||8
2236287|NCT02638493|5483037|P1|COMPLETED|Overall Study||8
2236288|NCT02638493|5483035|P3|STARTED|Overall Study||8
2236289|NCT02638493|5483036|P2|STARTED|Overall Study||8
2236290|NCT02638493|5483037|P1|STARTED|Overall Study|Two men were not able to provide semen samples, and thus were replaced|10
2236291|NCT02638337|5483068|P2|NOT COMPLETED|Overall Study||36
2236292|NCT02638337|5483069|P1|NOT COMPLETED|Overall Study||33
2236293|NCT02638337|5483068|P2|COMPLETED|Overall Study||279
2236294|NCT02638337|5483069|P1|COMPLETED|Overall Study||283
2236295|NCT02638337|5483068|P2|Received Treatment|Overall Study||315
2236296|NCT02638337|5483069|P1|Received Treatment|Overall Study||313
2236297|NCT02638337|5483068|P2|STARTED|Overall Study||315
2236298|NCT02638337|5483069|P1|STARTED|Overall Study||316
2236299|NCT02638259|5483153|P2|NOT COMPLETED|Treatment Period 2||11
2236300|NCT02638259|5483154|P1|NOT COMPLETED|Treatment Period 2||6
2236301|NCT02638259|5483153|P2|COMPLETED|Treatment Period 2||155
2236302|NCT02638259|5483154|P1|COMPLETED|Treatment Period 2||169
2236303|NCT02638259|5483153|P2|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (4 not eligible, 1 consent withdrawal, 1 adverse event).|166
2236304|NCT02638259|5483154|P1|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (3 not eligible, 2 consent withdrawal, 1 IP delay)|175
2236305|NCT02638259|5483153|P2|NOT COMPLETED|Treatment Period 1||18
2236306|NCT02638259|5483154|P1|NOT COMPLETED|Treatment Period 1||5
2236307|NCT02638259|5483153|P2|COMPLETED|Treatment Period 1||172
2236308|NCT02638259|5483154|P1|COMPLETED|Treatment Period 1||181
2236309|NCT02638259|5483153|P2|STARTED|Treatment Period 1||190
2236310|NCT02638259|5483154|P1|STARTED|Treatment Period 1||186
2236311|NCT02638168|5483228|P2|NOT COMPLETED|Overall Study||0
2236312|NCT02638168|5483229|P1|NOT COMPLETED|Overall Study||0
2236313|NCT02638168|5483228|P2|COMPLETED|Overall Study||0
2236314|NCT02638168|5483229|P1|COMPLETED|Overall Study||3
2236315|NCT02638168|5483228|P2|STARTED|Overall Study||0
2236316|NCT02638168|5483229|P1|STARTED|Overall Study||3
2236317|NCT02638129|5483246|P2|NOT COMPLETED|Overall Study||30
2236318|NCT02638129|5483247|P1|NOT COMPLETED|Overall Study||28
2236319|NCT02638129|5483246|P2|COMPLETED|Overall Study||0
2236320|NCT02638129|5483247|P1|COMPLETED|Overall Study||0
2236321|NCT02638129|5483246|P2|STARTED|Overall Study||30
2236322|NCT02638129|5483247|P1|STARTED|Overall Study||28
2236343|NCT02638051|5483342|P2|NOT COMPLETED|Overall Study||0
2236344|NCT02638051|5483343|P1|NOT COMPLETED|Overall Study||0
2236345|NCT02638051|5483342|P2|COMPLETED|Overall Study||130
2236346|NCT02638051|5483343|P1|COMPLETED|Overall Study||130
2236347|NCT02638051|5483342|P2|STARTED|Overall Study||130
2236348|NCT02638051|5483343|P1|STARTED|Overall Study||130
2236349|NCT02637999|5483356|P3|NOT COMPLETED|Overall Study||2
2236350|NCT02637999|5483357|P2|NOT COMPLETED|Overall Study||2
2236351|NCT02637999|5483358|P1|NOT COMPLETED|Overall Study||1
2236352|NCT02637999|5483356|P3|COMPLETED|Overall Study||6
2236353|NCT02637999|5483357|P2|COMPLETED|Overall Study||6
2236354|NCT02637999|5483358|P1|COMPLETED|Overall Study||7
2236355|NCT02637999|5483356|P3|STARTED|Overall Study||8
2236356|NCT02637999|5483357|P2|STARTED|Overall Study||8
2236357|NCT02637999|5483358|P1|STARTED|Overall Study||8
2236358|NCT02637804|5483392|P4|NOT COMPLETED|Second Intervention (1 Week)||0
2236359|NCT02637804|5483393|P3|NOT COMPLETED|Second Intervention (1 Week)||0
2236360|NCT02637804|5483394|P2|NOT COMPLETED|Second Intervention (1 Week)||0
2236361|NCT02637804|5483395|P1|NOT COMPLETED|Second Intervention (1 Week)||0
2236362|NCT02637804|5483392|P4|COMPLETED|Second Intervention (1 Week)||26
2236363|NCT02637804|5483393|P3|COMPLETED|Second Intervention (1 Week)||25
2236364|NCT02637804|5483394|P2|COMPLETED|Second Intervention (1 Week)||28
2236365|NCT02637804|5483395|P1|COMPLETED|Second Intervention (1 Week)||27
2236366|NCT02637804|5483392|P4|STARTED|Second Intervention (1 Week)||26
2236367|NCT02637804|5483393|P3|STARTED|Second Intervention (1 Week)||25
2236368|NCT02637804|5483394|P2|STARTED|Second Intervention (1 Week)||28
2236369|NCT02637804|5483395|P1|STARTED|Second Intervention (1 Week)||27
2236370|NCT02637804|5483392|P4|NOT COMPLETED|First Intervention (1 Week)||0
2236371|NCT02637804|5483393|P3|NOT COMPLETED|First Intervention (1 Week)||0
2236372|NCT02637804|5483394|P2|NOT COMPLETED|First Intervention (1 Week)||0
2236373|NCT02637804|5483395|P1|NOT COMPLETED|First Intervention (1 Week)||0
2236374|NCT02637804|5483392|P4|COMPLETED|First Intervention (1 Week)||26
2236375|NCT02637804|5483393|P3|COMPLETED|First Intervention (1 Week)||25
2236376|NCT02637804|5483394|P2|COMPLETED|First Intervention (1 Week)||28
2236377|NCT02637804|5483395|P1|COMPLETED|First Intervention (1 Week)||27
2236378|NCT02637804|5483392|P4|STARTED|First Intervention (1 Week)||26
2236379|NCT02637804|5483393|P3|STARTED|First Intervention (1 Week)||25
2236380|NCT02637804|5483394|P2|STARTED|First Intervention (1 Week)||28
2236381|NCT02637804|5483395|P1|STARTED|First Intervention (1 Week)||27
2236382|NCT02637557|5483503|P4|NOT COMPLETED|Overall Study||7
2236383|NCT02637557|5483504|P3|NOT COMPLETED|Overall Study||9
2236384|NCT02637557|5483505|P2|NOT COMPLETED|Overall Study||5
2236385|NCT02637557|5483506|P1|NOT COMPLETED|Overall Study||8
2236386|NCT02637557|5483503|P4|COMPLETED|Overall Study||62
2236387|NCT02637557|5483504|P3|COMPLETED|Overall Study||62
2236388|NCT02637557|5483505|P2|COMPLETED|Overall Study||66
2236389|NCT02637557|5483506|P1|COMPLETED|Overall Study||63
2236390|NCT02637557|5483503|P4|STARTED|Overall Study||69
2236391|NCT02637557|5483504|P3|STARTED|Overall Study||71
2236392|NCT02637557|5483505|P2|STARTED|Overall Study||71
2236393|NCT02637557|5483506|P1|STARTED|Overall Study||71
2236394|NCT02637323|5483598|P2|NOT COMPLETED|Overall Study||1
2236395|NCT02637323|5483599|P1|NOT COMPLETED|Overall Study||2
2236396|NCT02637323|5483598|P2|COMPLETED|Overall Study||17
2236397|NCT02637323|5483599|P1|COMPLETED|Overall Study||61
2236398|NCT02637323|5483598|P2|STARTED|Overall Study||18
2236399|NCT02637323|5483599|P1|STARTED|Overall Study||63
2236400|NCT02637141|5483610|P3|NOT COMPLETED|Overall Study||1
2236401|NCT02637141|5483611|P2|NOT COMPLETED|Overall Study||2
2236402|NCT02637141|5483612|P1|NOT COMPLETED|Overall Study||2
2236403|NCT02637141|5483610|P3|COMPLETED|Overall Study||19
2236404|NCT02637141|5483611|P2|COMPLETED|Overall Study||20
2236405|NCT02637141|5483612|P1|COMPLETED|Overall Study||20
2236406|NCT02637141|5483610|P3|Received Study Drug|Overall Study||19
2236407|NCT02637141|5483611|P2|Received Study Drug|Overall Study||21
2236408|NCT02637141|5483612|P1|Received Study Drug|Overall Study||22
2236409|NCT02637141|5483610|P3|STARTED|Overall Study||20
2236410|NCT02637141|5483611|P2|STARTED|Overall Study||22
2236411|NCT02637141|5483612|P1|STARTED|Overall Study||22
2236412|NCT02637063|5483647|P3|NOT COMPLETED|Overall Study||6
2236413|NCT02637063|5483648|P2|NOT COMPLETED|Overall Study||4
2236414|NCT02637063|5483649|P1|NOT COMPLETED|Overall Study||5
2236415|NCT02637063|5483647|P3|COMPLETED|Overall Study||62
2236416|NCT02637063|5483648|P2|COMPLETED|Overall Study||64
2236417|NCT02637063|5483649|P1|COMPLETED|Overall Study||62
2236418|NCT02637063|5483647|P3|STARTED|Overall Study||68
2236419|NCT02637063|5483648|P2|STARTED|Overall Study||68
2236420|NCT02637063|5483649|P1|STARTED|Overall Study||67
2236421|NCT02637037|5483677|P2|NOT COMPLETED|Overall Study||1
2236422|NCT02637037|5483678|P1|NOT COMPLETED|Overall Study||4
2236423|NCT02637037|5483677|P2|COMPLETED|Overall Study||39
2236424|NCT02637037|5483678|P1|COMPLETED|Overall Study||36
2236425|NCT02637037|5483677|P2|STARTED|Overall Study||40
2236426|NCT02637037|5483678|P1|STARTED|Overall Study||40
2236427|NCT02636907|5483744|P1|NOT COMPLETED|Extension Phase||10
2236428|NCT02636907|5483744|P1|COMPLETED|Extension Phase||62
2236429|NCT02636907|5483744|P1|STARTED|Extension Phase||72
2236430|NCT02636907|5483744|P1|NOT COMPLETED|Autoinjector Assessment Period||4
2236431|NCT02636907|5483744|P1|COMPLETED|Autoinjector Assessment Period|Completed autoinjector assessment period (Day 50).|73
2236432|NCT02636907|5483744|P1|STARTED|Autoinjector Assessment Period|Assigned to treatment.|77
2236433|NCT02636712|5483753|P1|NOT COMPLETED|Overall Study||0
2236434|NCT02636712|5483753|P1|COMPLETED|Overall Study||10
2236435|NCT02636712|5483753|P1|STARTED|Overall Study||10
2236436|NCT02636608|5483761|P1|NOT COMPLETED|Overall Study||11
2236437|NCT02636608|5483761|P1|COMPLETED|Overall Study||233
2236438|NCT02636608|5483761|P1|Received Treatment|Overall Study||243
2236439|NCT02636608|5483761|P1|STARTED|Overall Study||244
2236440|NCT02636595|5483789|P1|NOT COMPLETED|Overall Study||2
2236441|NCT02636595|5483789|P1|COMPLETED|Overall Study||119
2236442|NCT02636595|5483789|P1|STARTED|Overall Study||121
2236443|NCT02636283|5483797|P2|NOT COMPLETED|Overall Study||3
2236444|NCT02636283|5483798|P1|NOT COMPLETED|Overall Study||2
2236445|NCT02636283|5483797|P2|COMPLETED|Overall Study||0
2236446|NCT02636283|5483798|P1|COMPLETED|Overall Study||1
2236447|NCT02636283|5483797|P2|STARTED|Overall Study||3
2236448|NCT02636283|5483798|P1|STARTED|Overall Study||3
2236449|NCT02636049|5483812|P1|NOT COMPLETED|Overall Study||0
2236450|NCT02636049|5483812|P1|COMPLETED|Overall Study||12
2236451|NCT02636049|5483812|P1|Triferic 35 Micrograms/kg IV Push|Overall Study||12
2236452|NCT02636049|5483812|P1|Triferic 6 mg IV Over 3 Hours|Overall Study||12
2236453|NCT02636049|5483812|P1|STARTED|Overall Study||12
2236454|NCT02635984|5483826|P2|NOT COMPLETED|Overall Study||4
2236455|NCT02635984|5483827|P1|NOT COMPLETED|Overall Study||3
2236456|NCT02635984|5483826|P2|COMPLETED|Overall Study||51
2236457|NCT02635984|5483827|P1|COMPLETED|Overall Study||50
2236458|NCT02635984|5483826|P2|STARTED|Overall Study||55
2236459|NCT02635984|5483827|P1|STARTED|Overall Study||53
2236460|NCT02635880|5483847|P1|NOT COMPLETED|Overall Study||0
2236461|NCT02635880|5483847|P1|COMPLETED|Overall Study||32
2236462|NCT02635880|5483847|P1|STARTED|Overall Study||32
2236463|NCT02635828|5483852|P1|NOT COMPLETED|Overall Study||14
2236464|NCT02635828|5483852|P1|COMPLETED|Overall Study||40
2236465|NCT02635828|5483852|P1|STARTED|Overall Study||54
2236466|NCT02635646|5483859|P2|NOT COMPLETED|Overall Study||26
2236467|NCT02635646|5483860|P1|NOT COMPLETED|Overall Study||25
2236468|NCT02635646|5483859|P2|COMPLETED|Overall Study||39
2236469|NCT02635646|5483860|P1|COMPLETED|Overall Study||32
2236470|NCT02635646|5483859|P2|STARTED|Overall Study||65
2236471|NCT02635646|5483860|P1|STARTED|Overall Study||57
2236472|NCT02635542|5483876|P2|NOT COMPLETED|Overall Study||0
2236473|NCT02635542|5483877|P1|NOT COMPLETED|Overall Study||0
2236474|NCT02635542|5483876|P2|COMPLETED|Overall Study||50
2236475|NCT02635542|5483877|P1|COMPLETED|Overall Study||50
2236476|NCT02635542|5483876|P2|STARTED|Overall Study||50
2236477|NCT02635542|5483877|P1|STARTED|Overall Study||50
2236478|NCT02635425|5483887|P2|NOT COMPLETED|Overall Study||0
2236479|NCT02635425|5483888|P1|NOT COMPLETED|Overall Study||0
2236480|NCT02635425|5483887|P2|COMPLETED|Overall Study||15
2236481|NCT02635425|5483888|P1|COMPLETED|Overall Study||15
2236482|NCT02635425|5483887|P2|STARTED|Overall Study||15
2236483|NCT02635425|5483888|P1|STARTED|Overall Study||15
2236484|NCT02635347|5483896|P2|NOT COMPLETED|Overall Study||7
2236485|NCT02635347|5483897|P1|NOT COMPLETED|Overall Study||20
2236486|NCT02635347|5483896|P2|COMPLETED|Overall Study||63
2236487|NCT02635347|5483897|P1|COMPLETED|Overall Study||31
2236488|NCT02635347|5483896|P2|Analyses|Overall Study||63
2236489|NCT02635347|5483897|P1|Analyses|Overall Study||30
2236490|NCT02635347|5483896|P2|Follow up|Overall Study||63
2236491|NCT02635347|5483897|P1|Follow up|Overall Study||31
2236492|NCT02635347|5483896|P2|Protocol Completion|Overall Study||63
2236493|NCT02635347|5483897|P1|Protocol Completion|Overall Study||22
2236494|NCT02635347|5483896|P2|Enrollment|Overall Study||63
2236495|NCT02635347|5483897|P1|Enrollment|Overall Study||31
2236496|NCT02635347|5483896|P2|Screening|Overall Study||70
2236497|NCT02635347|5483897|P1|Screening|Overall Study||51
2236498|NCT02635347|5483896|P2|STARTED|Overall Study||70
2236499|NCT02635347|5483897|P1|STARTED|Overall Study||51
2236500|NCT02635204|5483928|P2|NOT COMPLETED|Overall Study||1
2236501|NCT02635204|5483929|P1|NOT COMPLETED|Overall Study||2
2236502|NCT02635204|5483928|P2|COMPLETED|Overall Study||88
2236503|NCT02635204|5483929|P1|COMPLETED|Overall Study||176
2236504|NCT02635204|5483928|P2|STARTED|Overall Study||89
2236505|NCT02635204|5483929|P1|STARTED|Overall Study||178
2236506|NCT02634983|5483939|P2|NOT COMPLETED|Period 2 (Second Treatment, 8-10 Days)||0
2236507|NCT02634983|5483940|P1|NOT COMPLETED|Period 2 (Second Treatment, 8-10 Days)||2
2236508|NCT02634983|5483939|P2|COMPLETED|Period 2 (Second Treatment, 8-10 Days)||15
2236509|NCT02634983|5483940|P1|COMPLETED|Period 2 (Second Treatment, 8-10 Days)||14
2236510|NCT02634983|5483939|P2|STARTED|Period 2 (Second Treatment, 8-10 Days)||15
2236511|NCT02634983|5483940|P1|STARTED|Period 2 (Second Treatment, 8-10 Days)||16
2236512|NCT02634983|5483939|P2|NOT COMPLETED|Washout (Approximately 7-14 Days)||0
2236513|NCT02634983|5483940|P1|NOT COMPLETED|Washout (Approximately 7-14 Days)||0
2236514|NCT02634983|5483939|P2|COMPLETED|Washout (Approximately 7-14 Days)||15
2236515|NCT02634983|5483940|P1|COMPLETED|Washout (Approximately 7-14 Days)||16
2236516|NCT02634983|5483939|P2|STARTED|Washout (Approximately 7-14 Days)||15
2236517|NCT02634983|5483940|P1|STARTED|Washout (Approximately 7-14 Days)||16
2236518|NCT02634983|5483939|P2|NOT COMPLETED|Period One (First Treatment, 8-10 Days)||0
2236519|NCT02634983|5483940|P1|NOT COMPLETED|Period One (First Treatment, 8-10 Days)||0
2236520|NCT02634983|5483939|P2|COMPLETED|Period One (First Treatment, 8-10 Days)||15
2236521|NCT02634983|5483940|P1|COMPLETED|Period One (First Treatment, 8-10 Days)||16
2236522|NCT02634983|5483939|P2|STARTED|Period One (First Treatment, 8-10 Days)||15
2236523|NCT02634983|5483940|P1|STARTED|Period One (First Treatment, 8-10 Days)||16
2236524|NCT02634827|5483960|P1|NOT COMPLETED|Overall Study||0
2236525|NCT02634827|5483960|P1|COMPLETED|Overall Study||1
2236526|NCT02634827|5483960|P1|STARTED|Overall Study||1
2236527|NCT02634814|5483974|P3|NOT COMPLETED|Overall Study||0
2236528|NCT02634814|5483975|P2|NOT COMPLETED|Overall Study||6
2236529|NCT02634814|5483976|P1|NOT COMPLETED|Overall Study||2
2236530|NCT02634814|5483974|P3|COMPLETED|Overall Study||29
2236531|NCT02634814|5483975|P2|COMPLETED|Overall Study||23
2236532|NCT02634814|5483976|P1|COMPLETED|Overall Study||30
2236533|NCT02634814|5483974|P3|STARTED|Overall Study||29
2236534|NCT02634814|5483975|P2|STARTED|Overall Study||29
2236535|NCT02634814|5483976|P1|STARTED|Overall Study||32
2236536|NCT02634801|5483999|P3|NOT COMPLETED|Follow-up Period||8
2236537|NCT02634801|5484000|P2|NOT COMPLETED|Follow-up Period||8
2236538|NCT02634801|5484001|P1|NOT COMPLETED|Follow-up Period||5
2236539|NCT02634801|5483999|P3|COMPLETED|Follow-up Period||38
2236540|NCT02634801|5484000|P2|COMPLETED|Follow-up Period||18
2236541|NCT02634801|5484001|P1|COMPLETED|Follow-up Period||36
2236542|NCT02634801|5483999|P3|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|46
2236543|NCT02634801|5484000|P2|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|26
2236544|NCT02634801|5484001|P1|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|41
2236545|NCT02634801|5483999|P3|NOT COMPLETED|Extension Period (Weeks 24 to 36)||2
2236546|NCT02634801|5484000|P2|NOT COMPLETED|Extension Period (Weeks 24 to 36)||1
2236547|NCT02634801|5484001|P1|NOT COMPLETED|Extension Period (Weeks 24 to 36)||3
2236548|NCT02634801|5483999|P3|COMPLETED|Extension Period (Weeks 24 to 36)||29
2236549|NCT02634801|5484000|P2|COMPLETED|Extension Period (Weeks 24 to 36)||18
2236550|NCT02634801|5484001|P1|COMPLETED|Extension Period (Weeks 24 to 36)||45
2236551|NCT02634801|5483999|P3|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|31
2236552|NCT02634801|5484000|P2|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|19
2236553|NCT02634801|5484001|P1|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|48
2236554|NCT02634801|5483999|P3|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||5
2236555|NCT02634801|5484000|P2|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||31
2236556|NCT02634801|5484001|P1|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||4
2236557|NCT02634801|5483999|P3|COMPLETED|Treatment Period (Weeks 0 to 24)||49
2236558|NCT02634801|5484000|P2|COMPLETED|Treatment Period (Weeks 0 to 24)||23
2236559|NCT02634801|5484001|P1|COMPLETED|Treatment Period (Weeks 0 to 24)||50
2236560|NCT02634801|5483999|P3|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||52
2236561|NCT02634801|5484000|P2|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||52
2236562|NCT02634801|5484001|P1|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||54
2236563|NCT02634801|5483999|P3|STARTED|Treatment Period (Weeks 0 to 24)||54
2236564|NCT02634801|5484000|P2|STARTED|Treatment Period (Weeks 0 to 24)||54
2236565|NCT02634801|5484001|P1|STARTED|Treatment Period (Weeks 0 to 24)||54
2236566|NCT02634788|5484101|P4|NOT COMPLETED|Overall Study||5
2236567|NCT02634788|5484102|P3|NOT COMPLETED|Overall Study||5
2236568|NCT02634788|5484103|P2|NOT COMPLETED|Overall Study||10
2236569|NCT02634788|5484104|P1|NOT COMPLETED|Overall Study||4
2236570|NCT02634788|5484101|P4|COMPLETED|Overall Study||77
2236571|NCT02634788|5484102|P3|COMPLETED|Overall Study||75
2236572|NCT02634788|5484103|P2|COMPLETED|Overall Study||71
2236573|NCT02634788|5484104|P1|COMPLETED|Overall Study||75
2236574|NCT02634788|5484101|P4|STARTED|Overall Study||82
2236575|NCT02634788|5484102|P3|STARTED|Overall Study||80
2236576|NCT02634788|5484103|P2|STARTED|Overall Study||81
2236577|NCT02634788|5484104|P1|STARTED|Overall Study||79
2236578|NCT02634606|5484170|P1|NOT COMPLETED|Overall Study||13
2236579|NCT02634606|5484170|P1|COMPLETED|Overall Study||0
2236580|NCT02634606|5484170|P1|STARTED|Overall Study||13
2236581|NCT02634580|5484182|P4|NOT COMPLETED|Overall Study||1
2236582|NCT02634580|5484183|P3|NOT COMPLETED|Overall Study||1
2236583|NCT02634580|5484184|P2|NOT COMPLETED|Overall Study||0
2236584|NCT02634580|5484185|P1|NOT COMPLETED|Overall Study||1
2236585|NCT02634580|5484182|P4|COMPLETED|Overall Study||20
2236586|NCT02634580|5484183|P3|COMPLETED|Overall Study||18
2236587|NCT02634580|5484184|P2|COMPLETED|Overall Study||11
2236588|NCT02634580|5484185|P1|COMPLETED|Overall Study||9
2236589|NCT02634580|5484182|P4|STARTED|Overall Study||21
2236590|NCT02634580|5484183|P3|STARTED|Overall Study||19
2236591|NCT02634580|5484184|P2|STARTED|Overall Study||11
2236592|NCT02634580|5484185|P1|STARTED|Overall Study||10
2236593|NCT02634346|5484242|P3|NOT COMPLETED|Overall Study||23
2236594|NCT02634346|5484243|P2|NOT COMPLETED|Overall Study||14
2236595|NCT02634346|5484244|P1|NOT COMPLETED|Overall Study||12
2236596|NCT02634346|5484242|P3|COMPLETED|Overall Study||111
2236597|NCT02634346|5484243|P2|COMPLETED|Overall Study||119
2236598|NCT02634346|5484244|P1|COMPLETED|Overall Study||122
2236599|NCT02634346|5484242|P3|STARTED|Overall Study||134
2236600|NCT02634346|5484243|P2|STARTED|Overall Study||133
2236601|NCT02634346|5484244|P1|STARTED|Overall Study||134
2236602|NCT02634320|5484258|P1|NOT COMPLETED|Overall Study||16
2236603|NCT02634320|5484258|P1|COMPLETED|Overall Study||35
2236604|NCT02634320|5484258|P1|STARTED|Overall Study||51
2236605|NCT02634073|5484267|P4|NOT COMPLETED|Overall Study||0
2236606|NCT02634073|5484268|P3|NOT COMPLETED|Overall Study||0
2236607|NCT02634073|5484269|P2|NOT COMPLETED|Overall Study||0
2236608|NCT02634073|5484270|P1|NOT COMPLETED|Overall Study||0
2236609|NCT02634073|5484267|P4|COMPLETED|Overall Study||4
2236610|NCT02634073|5484268|P3|COMPLETED|Overall Study||4
2236611|NCT02634073|5484269|P2|COMPLETED|Overall Study||4
2236612|NCT02634073|5484270|P1|COMPLETED|Overall Study||4
2236613|NCT02634073|5484267|P4|STARTED|Overall Study||4
2236614|NCT02634073|5484268|P3|STARTED|Overall Study||4
2236615|NCT02634073|5484269|P2|STARTED|Overall Study||4
2236616|NCT02634073|5484270|P1|STARTED|Overall Study||4
2236617|NCT02633956|5484360|P4|NOT COMPLETED|Overall Study||0
2236618|NCT02633956|5484361|P3|NOT COMPLETED|Overall Study||2
2236619|NCT02633956|5484362|P2|NOT COMPLETED|Overall Study||2
2236620|NCT02633956|5484363|P1|NOT COMPLETED|Overall Study||1
2236621|NCT02633956|5484360|P4|COMPLETED|Overall Study||21
2236622|NCT02633956|5484361|P3|COMPLETED|Overall Study||20
2236623|NCT02633956|5484362|P2|COMPLETED|Overall Study||19
2236624|NCT02633956|5484363|P1|COMPLETED|Overall Study||19
2236625|NCT02633956|5484360|P4|STARTED|Overall Study||21
2236626|NCT02633956|5484361|P3|STARTED|Overall Study||22
2236627|NCT02633956|5484362|P2|STARTED|Overall Study||21
2236628|NCT02633956|5484363|P1|STARTED|Overall Study||20
2236629|NCT02633800|5484383|P2|NOT COMPLETED|Overall Study||43
2236630|NCT02633800|5484384|P1|NOT COMPLETED|Overall Study||44
2236631|NCT02633800|5484383|P2|COMPLETED|Overall Study||0
2236632|NCT02633800|5484384|P1|COMPLETED|Overall Study||0
2236633|NCT02633800|5484383|P2|STARTED|Overall Study||43
2236634|NCT02633800|5484384|P1|STARTED|Overall Study||44
2236635|NCT02633787|5484394|P1|NOT COMPLETED|Overall Study||1
2236636|NCT02633787|5484394|P1|COMPLETED|Overall Study||109
2236637|NCT02633787|5484394|P1|STARTED|Overall Study||110
2236638|NCT02633501|5484406|P6|NOT COMPLETED|Overall Study||15
2236639|NCT02633501|5484407|P5|NOT COMPLETED|Overall Study||11
2236640|NCT02633501|5484408|P4|NOT COMPLETED|Overall Study||4
2236641|NCT02633501|5484409|P3|NOT COMPLETED|Overall Study||7
2236642|NCT02633501|5484410|P2|NOT COMPLETED|Overall Study||3
2236643|NCT02633501|5484411|P1|NOT COMPLETED|Overall Study||2
2236644|NCT02633501|5484406|P6|COMPLETED|Overall Study||48
2236645|NCT02633501|5484407|P5|COMPLETED|Overall Study||53
2236646|NCT02633501|5484408|P4|COMPLETED|Overall Study||59
2236647|NCT02633501|5484409|P3|COMPLETED|Overall Study||55
2236648|NCT02633501|5484410|P2|COMPLETED|Overall Study||11
2236649|NCT02633501|5484411|P1|COMPLETED|Overall Study||12
2236650|NCT02633501|5484406|P6|STARTED|Overall Study||63
2236651|NCT02633501|5484407|P5|STARTED|Overall Study||64
2236652|NCT02633501|5484408|P4|STARTED|Overall Study||63
2236653|NCT02633501|5484409|P3|STARTED|Overall Study||62
2236654|NCT02633501|5484410|P2|STARTED|Overall Study||14
2236655|NCT02633501|5484411|P1|STARTED|Overall Study||14
2236656|NCT02633371|5484430|P1|NOT COMPLETED|Overall Study||3
2236657|NCT02633371|5484430|P1|COMPLETED|Overall Study||7
2236658|NCT02633371|5484430|P1|STARTED|Overall Study||10
2236659|NCT02633358|5484436|P2|NOT COMPLETED|Overall Study||0
2236660|NCT02633358|5484437|P1|NOT COMPLETED|Overall Study||0
2236661|NCT02633358|5484436|P2|COMPLETED|Overall Study||54
2236662|NCT02633358|5484437|P1|COMPLETED|Overall Study||87
2236663|NCT02633358|5484436|P2|STARTED|Overall Study||54
2236664|NCT02633358|5484437|P1|STARTED|Overall Study||87
2236665|NCT02633241|5484451|P1|NOT COMPLETED|Overall Study||3
2236666|NCT02633241|5484451|P1|COMPLETED|Overall Study||27
2236667|NCT02633241|5484451|P1|STARTED|Overall Study||30
2236668|NCT02633215|5484464|P2|NOT COMPLETED|Overall Study||3
2236669|NCT02633215|5484465|P1|NOT COMPLETED|Overall Study||2
2236670|NCT02633215|5484464|P2|COMPLETED|Overall Study||15
2236671|NCT02633215|5484465|P1|COMPLETED|Overall Study||16
2236672|NCT02633215|5484464|P2|STARTED|Overall Study||18
2236673|NCT02633215|5484465|P1|STARTED|Overall Study||18
2236674|NCT02633020|5484477|P2|NOT COMPLETED|Overall Study||0
2236675|NCT02633020|5484478|P1|NOT COMPLETED|Overall Study||1
2236676|NCT02633020|5484477|P2|COMPLETED|Overall Study||9
2236677|NCT02633020|5484478|P1|COMPLETED|Overall Study||18
2236678|NCT02633020|5484477|P2|STARTED|Overall Study||9
2236679|NCT02633020|5484478|P1|STARTED|Overall Study||19
2236680|NCT02632838|5484502|P2|NOT COMPLETED|Overall Study||2
2236681|NCT02632838|5484503|P1|NOT COMPLETED|Overall Study||3
2236682|NCT02632838|5484502|P2|COMPLETED|Overall Study||13
2236683|NCT02632838|5484503|P1|COMPLETED|Overall Study||12
2236684|NCT02632838|5484502|P2|STARTED|Overall Study||15
2236685|NCT02632838|5484503|P1|STARTED|Overall Study||15
2236686|NCT02632812|5484519|P2|NOT COMPLETED|Overall Study||0
2236687|NCT02632812|5484520|P1|NOT COMPLETED|Overall Study||0
2236688|NCT02632812|5484519|P2|COMPLETED|Overall Study||12
2236689|NCT02632812|5484520|P1|COMPLETED|Overall Study||12
2236690|NCT02632812|5484519|P2|STARTED|Overall Study||12
2236691|NCT02632812|5484520|P1|STARTED|Overall Study||12
2236692|NCT02632786|5484540|P2|NOT COMPLETED|Overall Study||7
2236693|NCT02632786|5484541|P1|NOT COMPLETED|Overall Study||11
2236694|NCT02632786|5484540|P2|COMPLETED|Overall Study||56
2236695|NCT02632786|5484541|P1|COMPLETED|Overall Study||55
2236696|NCT02632786|5484540|P2|Randomized and Dosed|Overall Study||63
2236697|NCT02632786|5484541|P1|Randomized and Dosed|Overall Study||66
2236698|NCT02632786|5484540|P2|Informed Consent Obtained|Overall Study||63
2236699|NCT02632786|5484541|P1|Informed Consent Obtained|Overall Study||66
2236700|NCT02632786|5484540|P2|STARTED|Overall Study||63
2236701|NCT02632786|5484541|P1|STARTED|Overall Study||66
2236702|NCT02632526|5484565|P6|NOT COMPLETED|Overall Study||0
2236703|NCT02632526|5484566|P5|NOT COMPLETED|Overall Study||0
2236704|NCT02632526|5484567|P4|NOT COMPLETED|Overall Study||0
2236705|NCT02632526|5484568|P3|NOT COMPLETED|Overall Study||0
2236706|NCT02632526|5484569|P2|NOT COMPLETED|Overall Study||0
2236707|NCT02632526|5484570|P1|NOT COMPLETED|Overall Study||0
2236708|NCT02632526|5484565|P6|COMPLETED|Overall Study||8
2236709|NCT02632526|5484566|P5|COMPLETED|Overall Study||4
2236710|NCT02632526|5484567|P4|COMPLETED|Overall Study||12
2236711|NCT02632526|5484568|P3|COMPLETED|Overall Study||24
2236712|NCT02632526|5484569|P2|COMPLETED|Overall Study||12
2236713|NCT02632526|5484570|P1|COMPLETED|Overall Study||36
2236714|NCT02632526|5484565|P6|STARTED|Overall Study||8
2236715|NCT02632526|5484566|P5|STARTED|Overall Study||4
2236716|NCT02632526|5484567|P4|STARTED|Overall Study||12
2236717|NCT02632526|5484568|P3|STARTED|Overall Study||24
2236718|NCT02632526|5484569|P2|STARTED|Overall Study||12
2236719|NCT02632526|5484570|P1|STARTED|Overall Study||36
2236720|NCT02632110|5484751|P10|NOT COMPLETED|Overall Study||1
2236721|NCT02632110|5484752|P9|NOT COMPLETED|Overall Study||1
2236722|NCT02632110|5484753|P8|NOT COMPLETED|Overall Study||3
2236723|NCT02632110|5484754|P7|NOT COMPLETED|Overall Study||3
2236724|NCT02632110|5484755|P6|NOT COMPLETED|Overall Study||1
2236725|NCT02632110|5484756|P5|NOT COMPLETED|Overall Study||1
2236726|NCT02632110|5484757|P4|NOT COMPLETED|Overall Study||0
2236727|NCT02632110|5484758|P3|NOT COMPLETED|Overall Study||0
2236728|NCT02632110|5484759|P2|NOT COMPLETED|Overall Study||1
2236729|NCT02632110|5484760|P1|NOT COMPLETED|Overall Study||1
2236730|NCT02632110|5484751|P10|COMPLETED|Overall Study||29
2236731|NCT02632110|5484752|P9|COMPLETED|Overall Study||29
2236732|NCT02632110|5484753|P8|COMPLETED|Overall Study||23
2236733|NCT02632110|5484754|P7|COMPLETED|Overall Study||23
2236734|NCT02632110|5484755|P6|COMPLETED|Overall Study||28
2236735|NCT02632110|5484756|P5|COMPLETED|Overall Study||28
2236736|NCT02632110|5484757|P4|COMPLETED|Overall Study||27
2236737|NCT02632110|5484758|P3|COMPLETED|Overall Study||27
2236738|NCT02632110|5484759|P2|COMPLETED|Overall Study||24
2236739|NCT02632110|5484760|P1|COMPLETED|Overall Study||24
2236740|NCT02632110|5484751|P10|STARTED|Overall Study||30
2236741|NCT02632110|5484752|P9|STARTED|Overall Study||30
2236742|NCT02632110|5484753|P8|STARTED|Overall Study||26
2236743|NCT02632110|5484754|P7|STARTED|Overall Study||26
2236744|NCT02632110|5484755|P6|STARTED|Overall Study||29
2236745|NCT02632110|5484756|P5|STARTED|Overall Study||29
2236746|NCT02632110|5484757|P4|STARTED|Overall Study||27
2236747|NCT02632110|5484758|P3|STARTED|Overall Study||27
2236748|NCT02632110|5484759|P2|STARTED|Overall Study||25
2236749|NCT02632110|5484760|P1|STARTED|Overall Study||25
2236750|NCT02631772|5485229|P2|NOT COMPLETED|Overall Study||0
2236751|NCT02631772|5485230|P1|NOT COMPLETED|Overall Study||0
2236752|NCT02631772|5485229|P2|COMPLETED|Overall Study||16
2236753|NCT02631772|5485230|P1|COMPLETED|Overall Study||16
2236754|NCT02631772|5485229|P2|STARTED|Overall Study||16
2236755|NCT02631772|5485230|P1|STARTED|Overall Study||16
2236756|NCT02631746|5485240|P1|NOT COMPLETED|Overall Study||3
2236757|NCT02631746|5485240|P1|COMPLETED|Overall Study||0
2236758|NCT02631746|5485240|P1|STARTED|Overall Study||3
2236759|NCT02631577|5485253|P2|NOT COMPLETED|Overall Study||4
2236760|NCT02631577|5485254|P1|NOT COMPLETED|Overall Study||1
2236761|NCT02631577|5485253|P2|COMPLETED|Overall Study||30
2236762|NCT02631577|5485254|P1|COMPLETED|Overall Study||3
2236763|NCT02631577|5485253|P2|STARTED|Overall Study||34
2236764|NCT02631577|5485254|P1|STARTED|Overall Study||4
2236765|NCT02631551|5485272|P4|NOT COMPLETED|Overall Study||11
2236766|NCT02631551|5485273|P3|NOT COMPLETED|Overall Study||11
2236767|NCT02631551|5485274|P2|NOT COMPLETED|Overall Study||19
2236768|NCT02631551|5485275|P1|NOT COMPLETED|Overall Study||13
2236769|NCT02631551|5485272|P4|COMPLETED|Overall Study||276
2236770|NCT02631551|5485273|P3|COMPLETED|Overall Study||283
2236771|NCT02631551|5485274|P2|COMPLETED|Overall Study||278
2236772|NCT02631551|5485275|P1|COMPLETED|Overall Study||289
2236773|NCT02631551|5485272|P4|STARTED|Overall Study||287
2236774|NCT02631551|5485273|P3|STARTED|Overall Study||294
2236775|NCT02631551|5485274|P2|STARTED|Overall Study||297
2236776|NCT02631551|5485275|P1|STARTED|Overall Study||302
2236777|NCT02631057|5485287|P2|NOT COMPLETED|Overall Study||0
2236778|NCT02631057|5485288|P1|NOT COMPLETED|Overall Study||0
2236779|NCT02631057|5485287|P2|COMPLETED|Overall Study||3414
2236780|NCT02631057|5485288|P1|COMPLETED|Overall Study||899
2236781|NCT02631057|5485287|P2|STARTED|Overall Study||3414
2236782|NCT02631057|5485288|P1|STARTED|Overall Study||899
2236783|NCT02630992|5485294|P1|NOT COMPLETED|Overall Study||13
2236784|NCT02630992|5485294|P1|COMPLETED|Overall Study||99
2236785|NCT02630992|5485294|P1|STARTED|Overall Study||112
2236786|NCT02630966|5485313|P2|NOT COMPLETED|Overall Study||8
2236787|NCT02630966|5485314|P1|NOT COMPLETED|Overall Study||2
2236788|NCT02630966|5485313|P2|COMPLETED|Overall Study||10
2236789|NCT02630966|5485314|P1|COMPLETED|Overall Study||14
2236790|NCT02630966|5485313|P2|STARTED|Overall Study||18
2236791|NCT02630966|5485314|P1|STARTED|Overall Study||16
2236792|NCT02630719|5485332|P2|NOT COMPLETED|Overall Study||0
2236793|NCT02630719|5485333|P1|NOT COMPLETED|Overall Study||0
2236794|NCT02630719|5485332|P2|COMPLETED|Overall Study||6
2236795|NCT02630719|5485333|P1|COMPLETED|Overall Study||4
2236796|NCT02630719|5485332|P2|STARTED|Overall Study||6
2236797|NCT02630719|5485333|P1|STARTED|Overall Study||4
2236798|NCT02630706|5485342|P3|NOT COMPLETED|Overall Study||10
2236799|NCT02630706|5485343|P2|NOT COMPLETED|Overall Study||9
2236800|NCT02630706|5485344|P1|NOT COMPLETED|Overall Study||7
2236801|NCT02630706|5485342|P3|COMPLETED|Overall Study||157
2236802|NCT02630706|5485343|P2|COMPLETED|Overall Study||160
2236803|NCT02630706|5485344|P1|COMPLETED|Overall Study||163
2236804|NCT02630706|5485342|P3|Treated|Overall Study||167
2236805|NCT02630706|5485343|P2|Treated|Overall Study||169
2236806|NCT02630706|5485344|P1|Treated|Overall Study||170
2236807|NCT02630706|5485342|P3|STARTED|Overall Study||167
2236808|NCT02630706|5485343|P2|STARTED|Overall Study||169
2236809|NCT02630706|5485344|P1|STARTED|Overall Study||170
2236810|NCT02630693|5485453|P2|NOT COMPLETED|Overall Study||1
2236811|NCT02630693|5485454|P1|NOT COMPLETED|Overall Study||0
2236812|NCT02630693|5485453|P2|COMPLETED|Overall Study||89
2236813|NCT02630693|5485454|P1|COMPLETED|Overall Study||90
2236814|NCT02630693|5485453|P2|STARTED|Overall Study||90
2236815|NCT02630693|5485454|P1|STARTED|Overall Study||90
2236816|NCT02630563|5485466|P1|NOT COMPLETED|Overall Study||1
2236817|NCT02630563|5485466|P1|COMPLETED|Overall Study||8
2236818|NCT02630563|5485466|P1|STARTED|Overall Study||9
2236819|NCT02630472|5485477|P2|NOT COMPLETED|Overall Study||0
2236820|NCT02630472|5485478|P1|NOT COMPLETED|Overall Study||10
2236821|NCT02630472|5485477|P2|COMPLETED|Overall Study||0
2236822|NCT02630472|5485478|P1|COMPLETED|Overall Study||0
2236823|NCT02630472|5485477|P2|STARTED|Overall Study||0
2236824|NCT02630472|5485478|P1|STARTED|Overall Study||10
2236825|NCT02630459|5485496|P4|NOT COMPLETED|Overall Study||3
2236826|NCT02630459|5485497|P3|NOT COMPLETED|Overall Study||5
2236827|NCT02630459|5485498|P2|NOT COMPLETED|Overall Study||2
2236828|NCT02630459|5485499|P1|NOT COMPLETED|Overall Study||3
2236829|NCT02630459|5485496|P4|COMPLETED|Overall Study||134
2236830|NCT02630459|5485497|P3|COMPLETED|Overall Study||130
2236831|NCT02630459|5485498|P2|COMPLETED|Overall Study||65
2236832|NCT02630459|5485499|P1|COMPLETED|Overall Study||133
2236833|NCT02630459|5485496|P4|Received Investigational Product|Overall Study||137
2236834|NCT02630459|5485497|P3|Received Investigational Product|Overall Study||135
2236835|NCT02630459|5485498|P2|Received Investigational Product|Overall Study||66
2236836|NCT02630459|5485499|P1|Received Investigational Product|Overall Study||136
2236837|NCT02630459|5485496|P4|STARTED|Overall Study||137
2236838|NCT02630459|5485497|P3|STARTED|Overall Study||135
2236839|NCT02630459|5485498|P2|STARTED|Overall Study||67
2236840|NCT02630459|5485499|P1|STARTED|Overall Study||136
2236841|NCT02630251|5485521|P4|NOT COMPLETED|Overall Study||0
2236842|NCT02630251|5485522|P3|NOT COMPLETED|Overall Study||1
2236843|NCT02630251|5485523|P2|NOT COMPLETED|Overall Study||0
2236844|NCT02630251|5485524|P1|NOT COMPLETED|Overall Study||0
2236845|NCT02630251|5485521|P4|COMPLETED|Overall Study||1
2236846|NCT02630251|5485522|P3|COMPLETED|Overall Study||0
2236847|NCT02630251|5485523|P2|COMPLETED|Overall Study||1
2236848|NCT02630251|5485524|P1|COMPLETED|Overall Study||2
2236849|NCT02630251|5485521|P4|STARTED|Overall Study||1
2236850|NCT02630251|5485522|P3|STARTED|Overall Study||1
2236851|NCT02630251|5485523|P2|STARTED|Overall Study||1
2236852|NCT02630251|5485524|P1|STARTED|Overall Study||2
2236853|NCT02630186|5485638|P1|NOT COMPLETED|Overall Study||1
2236854|NCT02630186|5485638|P1|COMPLETED|Overall Study||2
2236855|NCT02630186|5485638|P1|STARTED|Overall Study||3
2236856|NCT02629965|5485654|P2|NOT COMPLETED|Period 2||0
2236857|NCT02629965|5485655|P1|NOT COMPLETED|Period 2||1
2236858|NCT02629965|5485654|P2|COMPLETED|Period 2||90
2236859|NCT02629965|5485655|P1|COMPLETED|Period 2||87
2236860|NCT02629965|5485654|P2|STARTED|Period 2||90
2236861|NCT02629965|5485655|P1|STARTED|Period 2||88
2236862|NCT02629965|5485654|P2|NOT COMPLETED|Period 1||2
2236863|NCT02629965|5485655|P1|NOT COMPLETED|Period 1||4
2236864|NCT02629965|5485654|P2|COMPLETED|Period 1||90
2236865|NCT02629965|5485655|P1|COMPLETED|Period 1||88
2236866|NCT02629965|5485654|P2|STARTED|Period 1||92
2236867|NCT02629965|5485655|P1|STARTED|Period 1||92
2236868|NCT02629861|5485694|P3|NOT COMPLETED|Overall Study||28
2236869|NCT02629861|5485695|P2|NOT COMPLETED|Overall Study||27
2236870|NCT02629861|5485696|P1|NOT COMPLETED|Overall Study||29
2236871|NCT02629861|5485694|P3|COMPLETED|Overall Study||262
2236872|NCT02629861|5485695|P2|COMPLETED|Overall Study||264
2236873|NCT02629861|5485696|P1|COMPLETED|Overall Study||265
2236874|NCT02629861|5485694|P3|Full Analysis Set|Overall Study||287
2236875|NCT02629861|5485695|P2|Full Analysis Set|Overall Study||288
2236876|NCT02629861|5485696|P1|Full Analysis Set|Overall Study||290
2236877|NCT02629861|5485694|P3|Safety Population|Overall Study||289
2236878|NCT02629861|5485695|P2|Safety Population|Overall Study||291
2236879|NCT02629861|5485696|P1|Safety Population|Overall Study||294
2236880|NCT02629861|5485694|P3|Intent to Treat (ITT)|Overall Study||290
2236881|NCT02629861|5485695|P2|Intent to Treat (ITT)|Overall Study||291
2236882|NCT02629861|5485696|P1|Intent to Treat (ITT)|Overall Study||294
2236883|NCT02629861|5485694|P3|STARTED|Overall Study||290
2236884|NCT02629861|5485695|P2|STARTED|Overall Study||291
2236885|NCT02629861|5485696|P1|STARTED|Overall Study||294
2236886|NCT02629822|5485743|P1|NOT COMPLETED|Extension Study||6
2236887|NCT02629822|5485743|P1|COMPLETED|Extension Study||0
2236888|NCT02629822|5485743|P1|STARTED|Extension Study|Enrollment in Extension Study was voluntary.|6
2236889|NCT02629822|5485743|P1|NOT COMPLETED|Base Study||3
2236890|NCT02629822|5485743|P1|COMPLETED|Base Study||7
2236891|NCT02629822|5485743|P1|STARTED|Base Study||10
2236892|NCT02629354|5485759|P2|NOT COMPLETED|Follow-up||0
2236893|NCT02629354|5485760|P1|NOT COMPLETED|Follow-up||0
2236894|NCT02629354|5485759|P2|COMPLETED|Follow-up||18
2236895|NCT02629354|5485760|P1|COMPLETED|Follow-up||18
2236896|NCT02629354|5485759|P2|STARTED|Follow-up||18
2236897|NCT02629354|5485760|P1|STARTED|Follow-up||18
2236898|NCT02629354|5485759|P2|NOT COMPLETED|Period 2||0
2236899|NCT02629354|5485760|P1|NOT COMPLETED|Period 2||0
2236900|NCT02629354|5485759|P2|COMPLETED|Period 2||18
2236901|NCT02629354|5485760|P1|COMPLETED|Period 2||18
2236902|NCT02629354|5485759|P2|STARTED|Period 2||18
2236903|NCT02629354|5485760|P1|STARTED|Period 2||18
2236904|NCT02629354|5485759|P2|NOT COMPLETED|Washout Period||0
2236905|NCT02629354|5485760|P1|NOT COMPLETED|Washout Period||0
2236906|NCT02629354|5485759|P2|COMPLETED|Washout Period||18
2236907|NCT02629354|5485760|P1|COMPLETED|Washout Period||18
2236908|NCT02629354|5485759|P2|STARTED|Washout Period||18
2236909|NCT02629354|5485760|P1|STARTED|Washout Period||18
2236910|NCT02629354|5485759|P2|NOT COMPLETED|Period 1||0
2236911|NCT02629354|5485760|P1|NOT COMPLETED|Period 1||0
2236912|NCT02629354|5485759|P2|COMPLETED|Period 1||18
2236913|NCT02629354|5485760|P1|COMPLETED|Period 1||18
2236914|NCT02629354|5485759|P2|STARTED|Period 1||18
2236915|NCT02629354|5485760|P1|STARTED|Period 1||18
2236916|NCT02629159|5485785|P3|NOT COMPLETED|Overall Study||51
2236917|NCT02629159|5485786|P2|NOT COMPLETED|Overall Study||39
2236918|NCT02629159|5485787|P1|NOT COMPLETED|Overall Study||56
2236919|NCT02629159|5485785|P3|COMPLETED|Overall Study||600
2236920|NCT02629159|5485786|P2|COMPLETED|Overall Study||288
2236921|NCT02629159|5485787|P1|COMPLETED|Overall Study||595
2236922|NCT02629159|5485785|P3|Rescued at Week 22|Overall Study||18
2236923|NCT02629159|5485786|P2|Rescued at Week 22|Overall Study||7
2236924|NCT02629159|5485787|P1|Rescued at Week 22|Overall Study||26
2236925|NCT02629159|5485785|P3|Rescued at Week 18|Overall Study||29
2236926|NCT02629159|5485786|P2|Rescued at Week 18|Overall Study||14
2236927|NCT02629159|5485787|P1|Rescued at Week 18|Overall Study|One participant rescued at week 18 did not receive any dose of upadacitinib|48
2236928|NCT02629159|5485785|P3|Rescued at Week 14|Overall Study||78
2236929|NCT02629159|5485786|P2|Rescued at Week 14|Overall Study||56
2236930|NCT02629159|5485787|P1|Rescued at Week 14|Overall Study||231
2236931|NCT02629159|5485785|P3|Completed Week 14 on Study Drug|Overall Study||620
2236932|NCT02629159|5485786|P2|Completed Week 14 on Study Drug|Overall Study||300
2236933|NCT02629159|5485787|P1|Completed Week 14 on Study Drug|Overall Study||620
2236934|NCT02629159|5485785|P3|Received Assigned Study Drug|Overall Study|One participant received a placebo injection but no oral study drug before discontinuing the study|650
2236935|NCT02629159|5485786|P2|Received Assigned Study Drug|Overall Study||327
2236936|NCT02629159|5485787|P1|Received Assigned Study Drug|Overall Study||651
2236937|NCT02629159|5485785|P3|STARTED|Overall Study||651
2236938|NCT02629159|5485786|P2|STARTED|Overall Study||327
2236939|NCT02629159|5485787|P1|STARTED|Overall Study||651
2236940|NCT02629094|5485837|P1|NOT COMPLETED|Overall Study||0
2236941|NCT02629094|5485837|P1|COMPLETED|Overall Study||5
2236942|NCT02629094|5485837|P1|STARTED|Overall Study||5
2236949|NCT02628938|5485866|P3|NOT COMPLETED|Overall Study||4
2236950|NCT02628938|5485867|P2|NOT COMPLETED|Overall Study||2
2236951|NCT02628938|5485868|P1|NOT COMPLETED|Overall Study||5
2236952|NCT02628938|5485866|P3|COMPLETED|Overall Study||11
2236953|NCT02628938|5485867|P2|COMPLETED|Overall Study||13
2236954|NCT02628938|5485868|P1|COMPLETED|Overall Study||10
2236955|NCT02628938|5485866|P3|STARTED|Overall Study||15
2236956|NCT02628938|5485867|P2|STARTED|Overall Study||15
2236957|NCT02628938|5485868|P1|STARTED|Overall Study||15
2236958|NCT02628769|5485882|P2|NOT COMPLETED|Second Intervention||1
2236959|NCT02628769|5485883|P1|NOT COMPLETED|Second Intervention||2
2236960|NCT02628769|5485882|P2|COMPLETED|Second Intervention||1
2236961|NCT02628769|5485883|P1|COMPLETED|Second Intervention||0
2236962|NCT02628769|5485882|P2|STARTED|Second Intervention||2
2236963|NCT02628769|5485883|P1|STARTED|Second Intervention||2
2236964|NCT02628769|5485882|P2|NOT COMPLETED|Wash Out (28 Days)||0
2236965|NCT02628769|5485883|P1|NOT COMPLETED|Wash Out (28 Days)||0
2236966|NCT02628769|5485882|P2|COMPLETED|Wash Out (28 Days)||2
2236967|NCT02628769|5485883|P1|COMPLETED|Wash Out (28 Days)||2
2236968|NCT02628769|5485882|P2|STARTED|Wash Out (28 Days)||2
2236969|NCT02628769|5485883|P1|STARTED|Wash Out (28 Days)||2
2236970|NCT02628769|5485882|P2|NOT COMPLETED|First Intervention||1
2236971|NCT02628769|5485883|P1|NOT COMPLETED|First Intervention||1
2236972|NCT02628769|5485882|P2|COMPLETED|First Intervention||2
2236973|NCT02628769|5485883|P1|COMPLETED|First Intervention||2
2236974|NCT02628769|5485882|P2|STARTED|First Intervention||3
2236975|NCT02628769|5485883|P1|STARTED|First Intervention||3
2236976|NCT02628743|5485921|P1|NOT COMPLETED|Overall Study||131
2236977|NCT02628743|5485921|P1|COMPLETED|Overall Study||0
2236978|NCT02628743|5485921|P1|STARTED|Overall Study||131
2236979|NCT02628600|5485947|P2|NOT COMPLETED|Overall Study||32
2236980|NCT02628600|5485948|P1|NOT COMPLETED|Overall Study||24
2236981|NCT02628600|5485947|P2|COMPLETED|Overall Study||58
2236982|NCT02628600|5485948|P1|COMPLETED|Overall Study||49
2236983|NCT02628600|5485947|P2|Participant Discontinued the Study|Overall Study||32
2236984|NCT02628600|5485948|P1|Participant Discontinued the Study|Overall Study||24
2236985|NCT02628600|5485947|P2|STARTED|Overall Study||90
2236986|NCT02628600|5485948|P1|STARTED|Overall Study||73
2236987|NCT02628418|5485962|P2|NOT COMPLETED|Overall Study||2
2236988|NCT02628418|5485963|P1|NOT COMPLETED|Overall Study||1
2236989|NCT02628418|5485962|P2|COMPLETED|Overall Study||13
2236990|NCT02628418|5485963|P1|COMPLETED|Overall Study||14
2236991|NCT02628418|5485962|P2|STARTED|Overall Study||15
2236992|NCT02628418|5485963|P1|STARTED|Overall Study||15
2236993|NCT02628236|5485984|P1|NOT COMPLETED|Overall Study||0
2236994|NCT02628236|5485984|P1|COMPLETED|Overall Study||14
2236995|NCT02628236|5485984|P1|STARTED|Overall Study||14
2236996|NCT02628106|5486021|P1|NOT COMPLETED|Overall Study||0
2236997|NCT02628106|5486021|P1|COMPLETED|Overall Study||21
2236998|NCT02628106|5486021|P1|STARTED|Overall Study||21
2236999|NCT02628093|5486027|P2|NOT COMPLETED|Overall Study||0
2237000|NCT02628093|5486028|P1|NOT COMPLETED|Overall Study||0
2237001|NCT02628093|5486027|P2|COMPLETED|Overall Study||29
2237002|NCT02628093|5486028|P1|COMPLETED|Overall Study||31
2237003|NCT02628093|5486027|P2|STARTED|Overall Study||29
2237004|NCT02628093|5486028|P1|STARTED|Overall Study||31
2237005|NCT02628028|5486054|P8|NOT COMPLETED|Long-term Extension (LTE) Period||61
2237006|NCT02628028|5486055|P7|NOT COMPLETED|Long-term Extension (LTE) Period||58
2237007|NCT02628028|5486056|P6|NOT COMPLETED|Long-term Extension (LTE) Period||60
2237008|NCT02628028|5486057|P5|NOT COMPLETED|Long-term Extension (LTE) Period||0
2237009|NCT02628028|5486058|P4|NOT COMPLETED|Long-term Extension (LTE) Period||0
2237010|NCT02628028|5486059|P3|NOT COMPLETED|Long-term Extension (LTE) Period||0
2237011|NCT02628028|5486060|P2|NOT COMPLETED|Long-term Extension (LTE) Period||0
2237012|NCT02628028|5486061|P1|NOT COMPLETED|Long-term Extension (LTE) Period||0
2237013|NCT02628028|5486054|P8|COMPLETED|Long-term Extension (LTE) Period||0
2237014|NCT02628028|5486055|P7|COMPLETED|Long-term Extension (LTE) Period||0
2237015|NCT02628028|5486056|P6|COMPLETED|Long-term Extension (LTE) Period||1
2237016|NCT02628028|5486057|P5|COMPLETED|Long-term Extension (LTE) Period||0
2237017|NCT02628028|5486058|P4|COMPLETED|Long-term Extension (LTE) Period||0
2237018|NCT02628028|5486059|P3|COMPLETED|Long-term Extension (LTE) Period||0
2237019|NCT02628028|5486060|P2|COMPLETED|Long-term Extension (LTE) Period||0
2237020|NCT02628028|5486061|P1|COMPLETED|Long-term Extension (LTE) Period||0
2237021|NCT02628028|5486054|P8|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
2237022|NCT02628028|5486055|P7|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
2237023|NCT02628028|5486056|P6|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
2237024|NCT02628028|5486057|P5|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
2237025|NCT02628028|5486058|P4|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
2237026|NCT02628028|5486059|P3|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
2237027|NCT02628028|5486060|P2|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
2237028|NCT02628028|5486061|P1|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
2237029|NCT02628028|5486054|P8|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|61
2237030|NCT02628028|5486055|P7|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|58
2237031|NCT02628028|5486056|P6|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|61
2237032|NCT02628028|5486057|P5|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;42 participants completed part B placebo period,re-randomized to LTE period.|0
2237033|NCT02628028|5486058|P4|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
2237034|NCT02628028|5486059|P3|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
2237035|NCT02628028|5486060|P2|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
2237036|NCT02628028|5486061|P1|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
2237037|NCT02628028|5486054|P8|NOT COMPLETED|Dosing Period||15
2237038|NCT02628028|5486055|P7|NOT COMPLETED|Dosing Period||16
2237039|NCT02628028|5486056|P6|NOT COMPLETED|Dosing Period||14
2237040|NCT02628028|5486057|P5|NOT COMPLETED|Dosing Period||16
2237041|NCT02628028|5486058|P4|NOT COMPLETED|Dosing Period||0
2237042|NCT02628028|5486059|P3|NOT COMPLETED|Dosing Period||1
2237043|NCT02628028|5486060|P2|NOT COMPLETED|Dosing Period||0
2237044|NCT02628028|5486061|P1|NOT COMPLETED|Dosing Period||0
2237045|NCT02628028|5486054|P8|COMPLETED|Dosing Period||48
2237046|NCT02628028|5486055|P7|COMPLETED|Dosing Period||46
2237047|NCT02628028|5486056|P6|COMPLETED|Dosing Period||49
2237048|NCT02628028|5486057|P5|COMPLETED|Dosing Period||46
2237049|NCT02628028|5486058|P4|COMPLETED|Dosing Period||8
2237050|NCT02628028|5486059|P3|COMPLETED|Dosing Period||9
2237051|NCT02628028|5486060|P2|COMPLETED|Dosing Period||9
2237052|NCT02628028|5486061|P1|COMPLETED|Dosing Period||9
2237053|NCT02628028|5486054|P8|Received at Least 1dose of Study Drug|Dosing Period||63
2237054|NCT02628028|5486055|P7|Received at Least 1dose of Study Drug|Dosing Period||62
2237055|NCT02628028|5486056|P6|Received at Least 1dose of Study Drug|Dosing Period||63
2237056|NCT02628028|5486057|P5|Received at Least 1dose of Study Drug|Dosing Period||62
2237057|NCT02628028|5486058|P4|Received at Least 1dose of Study Drug|Dosing Period||8
2237058|NCT02628028|5486059|P3|Received at Least 1dose of Study Drug|Dosing Period||10
2237059|NCT02628028|5486060|P2|Received at Least 1dose of Study Drug|Dosing Period||9
2237060|NCT02628028|5486061|P1|Received at Least 1dose of Study Drug|Dosing Period||9
2237061|NCT02628028|5486054|P8|STARTED|Dosing Period||63
2237062|NCT02628028|5486055|P7|STARTED|Dosing Period||62
2237063|NCT02628028|5486056|P6|STARTED|Dosing Period||63
2237064|NCT02628028|5486057|P5|STARTED|Dosing Period||62
2237065|NCT02628028|5486058|P4|STARTED|Dosing Period||8
2237066|NCT02628028|5486059|P3|STARTED|Dosing Period||10
2237067|NCT02628028|5486060|P2|STARTED|Dosing Period||9
2237068|NCT02628028|5486061|P1|STARTED|Dosing Period||9
2237075|NCT02627924|5486116|P1|NOT COMPLETED|Overall Study||12
2237076|NCT02627924|5486116|P1|COMPLETED|Overall Study||79
2237077|NCT02627924|5486116|P1|STARTED|Overall Study||91
2237078|NCT02627794|5486133|P1|NOT COMPLETED|Overall Study||0
2237079|NCT02627794|5486133|P1|COMPLETED|Overall Study||3
2237080|NCT02627794|5486133|P1|STARTED|Overall Study||3
2237081|NCT02627144|5486146|P1|NOT COMPLETED|Overall Study||365
2237082|NCT02627144|5486146|P1|COMPLETED|Overall Study||0
2237083|NCT02627144|5486146|P1|Treated|Overall Study||359
2237084|NCT02627144|5486146|P1|STARTED|Overall Study||365
2237085|NCT02627118|5486154|P1|NOT COMPLETED|Overall Study||0
2237086|NCT02627118|5486154|P1|COMPLETED|Overall Study||10
2237087|NCT02627118|5486154|P1|STARTED|Overall Study||10
2237088|NCT02627001|5486161|P2|NOT COMPLETED|Overall Study||0
2237089|NCT02627001|5486162|P1|NOT COMPLETED|Overall Study||0
2237090|NCT02627001|5486161|P2|COMPLETED|Overall Study||14
2237091|NCT02627001|5486162|P1|COMPLETED|Overall Study||13
2237092|NCT02627001|5486161|P2|STARTED|Overall Study||14
2237093|NCT02627001|5486162|P1|STARTED|Overall Study||13
2237094|NCT02626910|5486172|P4|NOT COMPLETED|Overall Study||0
2237095|NCT02626910|5486173|P3|NOT COMPLETED|Overall Study||0
2237096|NCT02626910|5486174|P2|NOT COMPLETED|Overall Study||0
2237097|NCT02626910|5486175|P1|NOT COMPLETED|Overall Study||0
2237098|NCT02626910|5486172|P4|COMPLETED|Overall Study||10
2237099|NCT02626910|5486173|P3|COMPLETED|Overall Study||6
2237100|NCT02626910|5486174|P2|COMPLETED|Overall Study||10
2237101|NCT02626910|5486175|P1|COMPLETED|Overall Study||23
2237102|NCT02626910|5486172|P4|STARTED|Overall Study||10
2237103|NCT02626910|5486173|P3|STARTED|Overall Study||6
2237104|NCT02626910|5486174|P2|STARTED|Overall Study||10
2237105|NCT02626910|5486175|P1|STARTED|Overall Study||23
2237106|NCT02626819|5486187|P2|NOT COMPLETED|Overall Study||3
2237107|NCT02626819|5486188|P1|NOT COMPLETED|Overall Study||4
2237108|NCT02626819|5486187|P2|COMPLETED|Overall Study||20
2237109|NCT02626819|5486188|P1|COMPLETED|Overall Study||18
2237110|NCT02626819|5486187|P2|STARTED|Overall Study||23
2237111|NCT02626819|5486188|P1|STARTED|Overall Study||22
2237112|NCT02626780|5486208|P1|NOT COMPLETED|Overall Study||3
2237113|NCT02626780|5486208|P1|COMPLETED|Overall Study||4
2237114|NCT02626780|5486208|P1|Withdrew From Study|Overall Study||3
2237115|NCT02626780|5486208|P1|STARTED|Overall Study||7
2237116|NCT02626611|5486216|P3|NOT COMPLETED|Overall Study||3
2237117|NCT02626611|5486217|P2|NOT COMPLETED|Overall Study||1
2237118|NCT02626611|5486218|P1|NOT COMPLETED|Overall Study||4
2237119|NCT02626611|5486216|P3|COMPLETED|Overall Study||16
2237120|NCT02626611|5486217|P2|COMPLETED|Overall Study||20
2237121|NCT02626611|5486218|P1|COMPLETED|Overall Study||16
2237122|NCT02626611|5486216|P3|STARTED|Overall Study||19
2237123|NCT02626611|5486217|P2|STARTED|Overall Study||21
2237124|NCT02626611|5486218|P1|STARTED|Overall Study||20
2237125|NCT02626520|5486241|P2|NOT COMPLETED|Overall Study||10
2237126|NCT02626520|5486242|P1|NOT COMPLETED|Overall Study||1
2237127|NCT02626520|5486241|P2|COMPLETED|Overall Study||0
2237128|NCT02626520|5486242|P1|COMPLETED|Overall Study||0
2237129|NCT02626520|5486241|P2|STARTED|Overall Study||10
2237130|NCT02626520|5486242|P1|STARTED|Overall Study||1
2237131|NCT02626182|5486254|P2|NOT COMPLETED|Overall Study||0
2237132|NCT02626182|5486255|P1|NOT COMPLETED|Overall Study||2
2237133|NCT02626182|5486254|P2|COMPLETED|Overall Study||3
2237134|NCT02626182|5486255|P1|COMPLETED|Overall Study||9
2237135|NCT02626182|5486254|P2|STARTED|Overall Study||3
2237136|NCT02626182|5486255|P1|STARTED|Overall Study||11
2237137|NCT02626000|5486265|P1|NOT COMPLETED|Overall Study||36
2237138|NCT02626000|5486265|P1|COMPLETED|Overall Study||0
2237139|NCT02626000|5486265|P1|STARTED|Overall Study||36
2237140|NCT02625974|5486279|P2|NOT COMPLETED|Overall Study||6
2237141|NCT02625974|5486280|P1|NOT COMPLETED|Overall Study||16
2237142|NCT02625974|5486279|P2|COMPLETED|Overall Study||105
2237143|NCT02625974|5486280|P1|COMPLETED|Overall Study||203
2237144|NCT02625974|5486279|P2|Received Treatment|Overall Study||111
2237145|NCT02625974|5486280|P1|Received Treatment|Overall Study||219
2237146|NCT02625974|5486279|P2|STARTED|Overall Study||111
2237147|NCT02625974|5486280|P1|STARTED|Overall Study||219
2237148|NCT02625922|5486388|P2|NOT COMPLETED|Overall Study||2
2237149|NCT02625922|5486389|P1|NOT COMPLETED|Overall Study||2
2237150|NCT02625922|5486388|P2|COMPLETED|Overall Study||10
2237151|NCT02625922|5486389|P1|COMPLETED|Overall Study||12
2237152|NCT02625922|5486388|P2|Completed Treatment Period 2|Overall Study||8
2237153|NCT02625922|5486389|P1|Completed Treatment Period 2|Overall Study||11
2237154|NCT02625922|5486388|P2|Completed Treatment Period 1|Overall Study||10
2237155|NCT02625922|5486389|P1|Completed Treatment Period 1|Overall Study||12
2237156|NCT02625922|5486388|P2|STARTED|Overall Study||12
2237157|NCT02625922|5486389|P1|STARTED|Overall Study||14
2237158|NCT02625844|5486402|P1|NOT COMPLETED|Overall Study||0
2237159|NCT02625844|5486402|P1|COMPLETED|Overall Study||110
2237160|NCT02625844|5486402|P1|STARTED|Overall Study||110
2237161|NCT02625623|5486408|P2|NOT COMPLETED|Overall Study||35
2237162|NCT02625623|5486409|P1|NOT COMPLETED|Overall Study||49
2237163|NCT02625623|5486408|P2|COMPLETED|Overall Study||150
2237164|NCT02625623|5486409|P1|COMPLETED|Overall Study||137
2237165|NCT02625623|5486408|P2|Treated|Overall Study||184
2237166|NCT02625623|5486409|P1|Treated|Overall Study||177
2237167|NCT02625623|5486408|P2|STARTED|Overall Study||185
2237168|NCT02625623|5486409|P1|STARTED|Overall Study||186
2237169|NCT02625571|5486429|P1|NOT COMPLETED|Overall Study||3
2237170|NCT02625571|5486429|P1|COMPLETED|Overall Study||10
2237171|NCT02625571|5486429|P1|STARTED|Overall Study||13
2237172|NCT02625545|5486434|P1|NOT COMPLETED|Overall Study||0
2237173|NCT02625545|5486434|P1|COMPLETED|Overall Study||45
2237174|NCT02625545|5486434|P1|12 Month|Overall Study||45
2237175|NCT02625545|5486434|P1|6 Month|Overall Study||45
2237176|NCT02625545|5486434|P1|3 Month|Overall Study||45
2237177|NCT02625545|5486434|P1|STARTED|Overall Study||45
2237178|NCT02625402|5486450|P2|NOT COMPLETED|Overall Study||12
2237179|NCT02625402|5486451|P1|NOT COMPLETED|Overall Study||9
2237180|NCT02625402|5486450|P2|COMPLETED|Overall Study||25
2237181|NCT02625402|5486451|P1|COMPLETED|Overall Study||33
2237182|NCT02625402|5486450|P2|STARTED|Overall Study||37
2237183|NCT02625402|5486451|P1|STARTED|Overall Study||42
2237184|NCT02625324|5486461|P1|NOT COMPLETED|Overall Study||1
2237185|NCT02625324|5486461|P1|COMPLETED|Overall Study|Patients are in further follow up until study end at 60 months|86
2237186|NCT02625324|5486461|P1|30 Days Follow Up|Overall Study||87
2237187|NCT02625324|5486461|P1|STARTED|Overall Study||87
2237188|NCT02625298|5486468|P2|NOT COMPLETED|Overall Study||0
2237189|NCT02625298|5486469|P1|NOT COMPLETED|Overall Study||1
2237190|NCT02625298|5486468|P2|COMPLETED|Overall Study||13
2237191|NCT02625298|5486469|P1|COMPLETED|Overall Study||10
2237192|NCT02625298|5486468|P2|STARTED|Overall Study||13
2237193|NCT02625298|5486469|P1|STARTED|Overall Study||11
2237194|NCT02625259|5486482|P5|NOT COMPLETED|Second Intervention (Day 15)||0
2237195|NCT02625259|5486483|P4|NOT COMPLETED|Second Intervention (Day 15)||0
2237196|NCT02625259|5486484|P3|NOT COMPLETED|Second Intervention (Day 15)||0
2237197|NCT02625259|5486485|P2|NOT COMPLETED|Second Intervention (Day 15)||0
2237198|NCT02625259|5486486|P1|NOT COMPLETED|Second Intervention (Day 15)||0
2237199|NCT02625259|5486482|P5|COMPLETED|Second Intervention (Day 15)||0
2237200|NCT02625259|5486483|P4|COMPLETED|Second Intervention (Day 15)||9
2237201|NCT02625259|5486484|P3|COMPLETED|Second Intervention (Day 15)||7
2237202|NCT02625259|5486485|P2|COMPLETED|Second Intervention (Day 15)||8
2237203|NCT02625259|5486486|P1|COMPLETED|Second Intervention (Day 15)||9
2237204|NCT02625259|5486482|P5|STARTED|Second Intervention (Day 15)||0
2237205|NCT02625259|5486483|P4|STARTED|Second Intervention (Day 15)||9
2237206|NCT02625259|5486484|P3|STARTED|Second Intervention (Day 15)||7
2237207|NCT02625259|5486485|P2|STARTED|Second Intervention (Day 15)||8
2237208|NCT02625259|5486486|P1|STARTED|Second Intervention (Day 15)||9
2237209|NCT02625259|5486482|P5|NOT COMPLETED|Washout (Day 2 to Day 14)||0
2237210|NCT02625259|5486483|P4|NOT COMPLETED|Washout (Day 2 to Day 14)||0
2237211|NCT02625259|5486484|P3|NOT COMPLETED|Washout (Day 2 to Day 14)||0
2237212|NCT02625259|5486485|P2|NOT COMPLETED|Washout (Day 2 to Day 14)||0
2237213|NCT02625259|5486486|P1|NOT COMPLETED|Washout (Day 2 to Day 14)||0
2237214|NCT02625259|5486482|P5|COMPLETED|Washout (Day 2 to Day 14)||0
2237215|NCT02625259|5486483|P4|COMPLETED|Washout (Day 2 to Day 14)||9
2237216|NCT02625259|5486484|P3|COMPLETED|Washout (Day 2 to Day 14)||7
2237217|NCT02625259|5486485|P2|COMPLETED|Washout (Day 2 to Day 14)||8
2237218|NCT02625259|5486486|P1|COMPLETED|Washout (Day 2 to Day 14)||9
2237219|NCT02625259|5486482|P5|STARTED|Washout (Day 2 to Day 14)||0
2237220|NCT02625259|5486483|P4|STARTED|Washout (Day 2 to Day 14)||9
2237221|NCT02625259|5486484|P3|STARTED|Washout (Day 2 to Day 14)||7
2237222|NCT02625259|5486485|P2|STARTED|Washout (Day 2 to Day 14)||8
2237223|NCT02625259|5486486|P1|STARTED|Washout (Day 2 to Day 14)||9
2237224|NCT02625259|5486482|P5|NOT COMPLETED|First Intervention (Day 1)||0
2237225|NCT02625259|5486483|P4|NOT COMPLETED|First Intervention (Day 1)||1
2237226|NCT02625259|5486484|P3|NOT COMPLETED|First Intervention (Day 1)||1
2237227|NCT02625259|5486485|P2|NOT COMPLETED|First Intervention (Day 1)||1
2237228|NCT02625259|5486486|P1|NOT COMPLETED|First Intervention (Day 1)||2
2237229|NCT02625259|5486482|P5|COMPLETED|First Intervention (Day 1)||16
2237230|NCT02625259|5486483|P4|COMPLETED|First Intervention (Day 1)||9
2237231|NCT02625259|5486484|P3|COMPLETED|First Intervention (Day 1)||7
2237232|NCT02625259|5486485|P2|COMPLETED|First Intervention (Day 1)||8
2237233|NCT02625259|5486486|P1|COMPLETED|First Intervention (Day 1)||9
2237234|NCT02625259|5486482|P5|STARTED|First Intervention (Day 1)||16
2237235|NCT02625259|5486483|P4|STARTED|First Intervention (Day 1)||10
2237236|NCT02625259|5486484|P3|STARTED|First Intervention (Day 1)||8
2237237|NCT02625259|5486485|P2|STARTED|First Intervention (Day 1)||9
2237238|NCT02625259|5486486|P1|STARTED|First Intervention (Day 1)||11
2237239|NCT02625233|5486523|P2|NOT COMPLETED|Overall Study||0
2237240|NCT02625233|5486524|P1|NOT COMPLETED|Overall Study||2
2237241|NCT02625233|5486523|P2|COMPLETED|Overall Study||56
2237242|NCT02625233|5486524|P1|COMPLETED|Overall Study||47
2237243|NCT02625233|5486523|P2|STARTED|Overall Study||56
2237244|NCT02625233|5486524|P1|STARTED|Overall Study||49
2237245|NCT02625220|5486532|P1|NOT COMPLETED|Overall Study||7
2237246|NCT02625220|5486532|P1|COMPLETED|Overall Study||163
2237247|NCT02625220|5486532|P1|STARTED|Overall Study||170
2237248|NCT02625207|5486543|P4|NOT COMPLETED|Part 2 (11 Days)||0
2237249|NCT02625207|5486544|P3|NOT COMPLETED|Part 2 (11 Days)||0
2237250|NCT02625207|5486545|P2|NOT COMPLETED|Part 2 (11 Days)||0
2237251|NCT02625207|5486546|P1|NOT COMPLETED|Part 2 (11 Days)||0
2237252|NCT02625207|5486543|P4|COMPLETED|Part 2 (11 Days)||0
2237253|NCT02625207|5486544|P3|COMPLETED|Part 2 (11 Days)||12
2237254|NCT02625207|5486545|P2|COMPLETED|Part 2 (11 Days)||0
2237255|NCT02625207|5486546|P1|COMPLETED|Part 2 (11 Days)||11
2237256|NCT02625207|5486543|P4|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
2237257|NCT02625207|5486544|P3|STARTED|Part 2 (11 Days)||12
2237258|NCT02625207|5486545|P2|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
2237259|NCT02625207|5486546|P1|STARTED|Part 2 (11 Days)||11
2237260|NCT02625207|5486543|P4|NOT COMPLETED|Part 1 (6 Days)||0
2237261|NCT02625207|5486544|P3|NOT COMPLETED|Part 1 (6 Days)||0
2237262|NCT02625207|5486545|P2|NOT COMPLETED|Part 1 (6 Days)||0
2237263|NCT02625207|5486546|P1|NOT COMPLETED|Part 1 (6 Days)||0
2237264|NCT02625207|5486543|P4|COMPLETED|Part 1 (6 Days)||12
2237265|NCT02625207|5486544|P3|COMPLETED|Part 1 (6 Days)||12
2237266|NCT02625207|5486545|P2|COMPLETED|Part 1 (6 Days)||12
2237267|NCT02625207|5486546|P1|COMPLETED|Part 1 (6 Days)||11
2237268|NCT02625207|5486543|P4|STARTED|Part 1 (6 Days)||12
2237269|NCT02625207|5486544|P3|STARTED|Part 1 (6 Days)||12
2237270|NCT02625207|5486545|P2|STARTED|Part 1 (6 Days)||12
2237271|NCT02625207|5486546|P1|STARTED|Part 1 (6 Days)||11
2237272|NCT02625181|5486635|P3|NOT COMPLETED|Overall Study||0
2237273|NCT02625181|5486636|P2|NOT COMPLETED|Overall Study||0
2237274|NCT02625181|5486637|P1|NOT COMPLETED|Overall Study||0
2237275|NCT02625181|5486635|P3|COMPLETED|Overall Study||12707
2237276|NCT02625181|5486636|P2|COMPLETED|Overall Study||12809
2237277|NCT02625181|5486637|P1|COMPLETED|Overall Study||1518
2237278|NCT02625181|5486635|P3|STARTED|Overall Study||12707
2237279|NCT02625181|5486636|P2|STARTED|Overall Study||12809
2237280|NCT02625181|5486637|P1|STARTED|Overall Study||1518
2237281|NCT02624791|5486652|P6|NOT COMPLETED|Overall Study||0
2237282|NCT02624791|5486653|P5|NOT COMPLETED|Overall Study||0
2237283|NCT02624791|5486654|P4|NOT COMPLETED|Overall Study||0
2237284|NCT02624791|5486655|P3|NOT COMPLETED|Overall Study||0
2237285|NCT02624791|5486656|P2|NOT COMPLETED|Overall Study||0
2237286|NCT02624791|5486657|P1|NOT COMPLETED|Overall Study||2
2237287|NCT02624791|5486652|P6|COMPLETED|Overall Study||2
2237288|NCT02624791|5486653|P5|COMPLETED|Overall Study||2
2237289|NCT02624791|5486654|P4|COMPLETED|Overall Study||2
2237290|NCT02624791|5486655|P3|COMPLETED|Overall Study||2
2237291|NCT02624791|5486656|P2|COMPLETED|Overall Study||1
2237292|NCT02624791|5486657|P1|COMPLETED|Overall Study||0
2237293|NCT02624791|5486652|P6|STARTED|Overall Study||2
2237294|NCT02624791|5486653|P5|STARTED|Overall Study||2
2237295|NCT02624791|5486654|P4|STARTED|Overall Study||2
2237296|NCT02624791|5486655|P3|STARTED|Overall Study||2
2237297|NCT02624791|5486656|P2|STARTED|Overall Study||1
2237298|NCT02624791|5486657|P1|STARTED|Overall Study||2
2237299|NCT02624713|5486664|P2|NOT COMPLETED|Overall Study||0
2237300|NCT02624713|5486665|P1|NOT COMPLETED|Overall Study||14
2237301|NCT02624713|5486664|P2|COMPLETED|Overall Study||81
2237302|NCT02624713|5486665|P1|COMPLETED|Overall Study||64
2237303|NCT02624713|5486664|P2|STARTED|Overall Study||81
2237304|NCT02624713|5486665|P1|STARTED|Overall Study||78
2237305|NCT02624687|5486674|P2|NOT COMPLETED|Overall Study||2
2237306|NCT02624687|5486675|P1|NOT COMPLETED|Overall Study||1
2237307|NCT02624687|5486674|P2|COMPLETED|Overall Study||12
2237308|NCT02624687|5486675|P1|COMPLETED|Overall Study||12
2237309|NCT02624687|5486674|P2|STARTED|Overall Study||14
2237310|NCT02624687|5486675|P1|STARTED|Overall Study||13
2237311|NCT02624492|5486706|P3|NOT COMPLETED|Overall Study||5
2237312|NCT02624492|5486707|P2|NOT COMPLETED|Overall Study||4
2237313|NCT02624492|5486708|P1|NOT COMPLETED|Overall Study||2
2237314|NCT02624492|5486706|P3|COMPLETED|Overall Study||3
2237315|NCT02624492|5486707|P2|COMPLETED|Overall Study||4
2237316|NCT02624492|5486708|P1|COMPLETED|Overall Study||3
2237317|NCT02624492|5486706|P3|STARTED|Overall Study||8
2237318|NCT02624492|5486707|P2|STARTED|Overall Study||8
2237319|NCT02624492|5486708|P1|STARTED|Overall Study||5
2237320|NCT02624375|5486734|P1|NOT COMPLETED|Overall Study||0
2237321|NCT02624375|5486734|P1|COMPLETED|Overall Study||10
2237322|NCT02624375|5486734|P1|STARTED|Overall Study||10
2237323|NCT02624284|5486743|P3|NOT COMPLETED|Overall Study||11
2237324|NCT02624284|5486744|P2|NOT COMPLETED|Overall Study||18
2237325|NCT02624284|5486745|P1|NOT COMPLETED|Overall Study||14
2237326|NCT02624284|5486743|P3|COMPLETED|Overall Study||36
2237327|NCT02624284|5486744|P2|COMPLETED|Overall Study||35
2237328|NCT02624284|5486745|P1|COMPLETED|Overall Study||35
2237329|NCT02624284|5486743|P3|STARTED|Overall Study||47
2237330|NCT02624284|5486744|P2|STARTED|Overall Study||53
2237331|NCT02624284|5486745|P1|STARTED|Overall Study||49
2237332|NCT02624050|5486764|P2|NOT COMPLETED|Overall Study||0
2237333|NCT02624050|5486765|P1|NOT COMPLETED|Overall Study||6
2237334|NCT02624050|5486764|P2|COMPLETED|Overall Study||25
2237335|NCT02624050|5486765|P1|COMPLETED|Overall Study||20
2237336|NCT02624050|5486764|P2|STARTED|Overall Study||25
2237337|NCT02624050|5486765|P1|STARTED|Overall Study||26
2237338|NCT02623959|5486793|P2|NOT COMPLETED|Overall Study||1
2237339|NCT02623959|5486794|P1|NOT COMPLETED|Overall Study||0
2237340|NCT02623959|5486793|P2|COMPLETED|Overall Study|due to progression|0
2237341|NCT02623959|5486794|P1|COMPLETED|Overall Study||0
2237342|NCT02623959|5486793|P2|STARTED|Overall Study||1
2237343|NCT02623959|5486794|P1|STARTED|Overall Study||0
2237344|NCT02623855|5486804|P2|NOT COMPLETED|Overall Study||16
2237345|NCT02623855|5486805|P1|NOT COMPLETED|Overall Study||10
2237346|NCT02623855|5486804|P2|COMPLETED|Overall Study||84
2237347|NCT02623855|5486805|P1|COMPLETED|Overall Study||46
2237348|NCT02623855|5486804|P2|STARTED|Overall Study||100
2237349|NCT02623855|5486805|P1|STARTED|Overall Study||56
2237350|NCT02623803|5486827|P2|NOT COMPLETED|Overall Study||0
2237351|NCT02623803|5486828|P1|NOT COMPLETED|Overall Study||0
2237352|NCT02623803|5486827|P2|COMPLETED|Overall Study||23
2237353|NCT02623803|5486828|P1|COMPLETED|Overall Study||25
2237354|NCT02623803|5486827|P2|STARTED|Overall Study||23
2237355|NCT02623803|5486828|P1|STARTED|Overall Study||25
2237356|NCT02623725|5486874|P2|NOT COMPLETED|Overall Study||6
2237357|NCT02623725|5486875|P1|NOT COMPLETED|Overall Study||16
2237358|NCT02623725|5486874|P2|COMPLETED|Overall Study||58
2237359|NCT02623725|5486875|P1|COMPLETED|Overall Study||171
2237360|NCT02623725|5486874|P2|STARTED|Overall Study||64
2237361|NCT02623725|5486875|P1|STARTED|Overall Study||187
2237362|NCT02623361|5486909|P2|NOT COMPLETED|Overall Study||2
2237363|NCT02623361|5486910|P1|NOT COMPLETED|Overall Study||0
2237364|NCT02623361|5486909|P2|COMPLETED|Overall Study||38
2237365|NCT02623361|5486910|P1|COMPLETED|Overall Study||40
2237366|NCT02623361|5486909|P2|STARTED|Overall Study||40
2237367|NCT02623361|5486910|P1|STARTED|Overall Study||40
2237368|NCT02623348|5486922|P2|NOT COMPLETED|Overall Study||2
2237369|NCT02623348|5486923|P1|NOT COMPLETED|Overall Study||3
2237370|NCT02623348|5486922|P2|COMPLETED|Overall Study||28
2237371|NCT02623348|5486923|P1|COMPLETED|Overall Study||27
2237372|NCT02623348|5486922|P2|3-month Assessment|Overall Study||26
2237373|NCT02623348|5486923|P1|3-month Assessment|Overall Study||27
2237374|NCT02623348|5486922|P2|STARTED|Overall Study||30
2237375|NCT02623348|5486923|P1|STARTED|Overall Study||30
2237376|NCT02623335|5486949|P2|NOT COMPLETED|Overall Study||36
2237377|NCT02623335|5486950|P1|NOT COMPLETED|Overall Study||27
2237378|NCT02623335|5486949|P2|COMPLETED|Overall Study||187
2237379|NCT02623335|5486950|P1|COMPLETED|Overall Study||196
2237380|NCT02623335|5486949|P2|T3 Survey (12-14 Weeks)|Overall Study||187
2237381|NCT02623335|5486950|P1|T3 Survey (12-14 Weeks)|Overall Study||196
2237382|NCT02623335|5486949|P2|T2 Survey (6-8 Weeks)|Overall Study||192
2237383|NCT02623335|5486950|P1|T2 Survey (6-8 Weeks)|Overall Study||199
2237384|NCT02623335|5486949|P2|T1 Survey (24-48 Hours)|Overall Study||214
2237385|NCT02623335|5486950|P1|T1 Survey (24-48 Hours)|Overall Study||216
2237386|NCT02623335|5486949|P2|T0 Audio Recording (Day of Consultation)|Overall Study||222
2237387|NCT02623335|5486950|P1|T0 Audio Recording (Day of Consultation)|Overall Study||223
2237388|NCT02623335|5486949|P2|STARTED|Overall Study||223
2237389|NCT02623335|5486950|P1|STARTED|Overall Study||223
2237390|NCT02623322|5486977|P3|NOT COMPLETED|Overall Study||0
2237391|NCT02623322|5486978|P2|NOT COMPLETED|Overall Study||1
2237392|NCT02623322|5486979|P1|NOT COMPLETED|Overall Study||2
2237393|NCT02623322|5486977|P3|COMPLETED|Overall Study||40
2237394|NCT02623322|5486978|P2|COMPLETED|Overall Study||40
2237395|NCT02623322|5486979|P1|COMPLETED|Overall Study||41
2237396|NCT02623322|5486977|P3|STARTED|Overall Study||40
2237397|NCT02623322|5486978|P2|STARTED|Overall Study||41
2237398|NCT02623322|5486979|P1|STARTED|Overall Study||43
2237399|NCT02623218|5487017|P5|NOT COMPLETED|Overall Study||0
2237400|NCT02623218|5487018|P4|NOT COMPLETED|Overall Study||0
2237401|NCT02623218|5487019|P3|NOT COMPLETED|Overall Study||0
2237402|NCT02623218|5487020|P2|NOT COMPLETED|Overall Study||1
2237403|NCT02623218|5487021|P1|NOT COMPLETED|Overall Study||0
2237404|NCT02623218|5487017|P5|COMPLETED|Overall Study||4
2237405|NCT02623218|5487018|P4|COMPLETED|Overall Study||4
2237406|NCT02623218|5487019|P3|COMPLETED|Overall Study||4
2237407|NCT02623218|5487020|P2|COMPLETED|Overall Study||3
2237408|NCT02623218|5487021|P1|COMPLETED|Overall Study||5
2237409|NCT02623218|5487017|P5|STARTED|Overall Study||4
2237410|NCT02623218|5487018|P4|STARTED|Overall Study||4
2237411|NCT02623218|5487019|P3|STARTED|Overall Study||4
2237412|NCT02623218|5487020|P2|STARTED|Overall Study||4
2237413|NCT02623218|5487021|P1|STARTED|Overall Study||5
2237414|NCT02622828|5487043|P1|NOT COMPLETED|Overall Study||3
2237415|NCT02622828|5487043|P1|COMPLETED|Overall Study||1
2237416|NCT02622828|5487043|P1|STARTED|Overall Study||4
2237417|NCT02622568|5487050|P2|NOT COMPLETED|Overall Study||5
2237418|NCT02622568|5487051|P1|NOT COMPLETED|Overall Study||5
2237419|NCT02622568|5487050|P2|COMPLETED|Overall Study||9
2237420|NCT02622568|5487051|P1|COMPLETED|Overall Study||9
2237421|NCT02622568|5487050|P2|STARTED|Overall Study||14
2237422|NCT02622568|5487051|P1|STARTED|Overall Study||14
2237423|NCT02622321|5487061|P4|NOT COMPLETED|Overall Study||7
2237424|NCT02622321|5487062|P3|NOT COMPLETED|Overall Study||49
2237425|NCT02622321|5487063|P2|NOT COMPLETED|Overall Study||18
2237426|NCT02622321|5487064|P1|NOT COMPLETED|Overall Study||35
2237427|NCT02622321|5487061|P4|COMPLETED|Overall Study||0
2237428|NCT02622321|5487062|P3|COMPLETED|Overall Study||0
2237429|NCT02622321|5487063|P2|COMPLETED|Overall Study||0
2237430|NCT02622321|5487064|P1|COMPLETED|Overall Study||0
2237431|NCT02622321|5487061|P4|Treated|Overall Study||7
2237432|NCT02622321|5487062|P3|Treated|Overall Study||49
2237433|NCT02622321|5487063|P2|Treated|Overall Study||18
2237434|NCT02622321|5487064|P1|Treated|Overall Study||34
2237435|NCT02622321|5487061|P4|STARTED|Overall Study||7
2237436|NCT02622321|5487062|P3|STARTED|Overall Study||49
2237437|NCT02622321|5487063|P2|STARTED|Overall Study||18
2237438|NCT02622321|5487064|P1|STARTED|Overall Study||35
2237439|NCT02622191|5487109|P2|NOT COMPLETED|Overall Study||0
2237440|NCT02622191|5487110|P1|NOT COMPLETED|Overall Study||0
2237441|NCT02622191|5487109|P2|COMPLETED|Overall Study||14
2237442|NCT02622191|5487110|P1|COMPLETED|Overall Study||19
2237443|NCT02622191|5487109|P2|STARTED|Overall Study||14
2237444|NCT02622191|5487110|P1|STARTED|Overall Study||19
2237445|NCT02622178|5487120|P3|NOT COMPLETED|Overall Study||0
2237446|NCT02622178|5487121|P2|NOT COMPLETED|Overall Study||0
2237447|NCT02622178|5487122|P1|NOT COMPLETED|Overall Study||0
2237448|NCT02622178|5487120|P3|COMPLETED|Overall Study||49
2237449|NCT02622178|5487121|P2|COMPLETED|Overall Study||45
2237450|NCT02622178|5487122|P1|COMPLETED|Overall Study||42
2237451|NCT02622178|5487120|P3|STARTED|Overall Study||49
2237452|NCT02622178|5487121|P2|STARTED|Overall Study||45
2237453|NCT02622178|5487122|P1|STARTED|Overall Study||42
2237454|NCT02622113|5487135|P2|NOT COMPLETED|Overall Study||10
2237455|NCT02622113|5487136|P1|NOT COMPLETED|Overall Study||5
2237456|NCT02622113|5487135|P2|COMPLETED|Overall Study||66
2237457|NCT02622113|5487136|P1|COMPLETED|Overall Study||62
2237458|NCT02622113|5487135|P2|STARTED|Overall Study||76
2237459|NCT02622113|5487136|P1|STARTED|Overall Study||67
2237460|NCT02622074|5487154|P6|NOT COMPLETED|Overall Study||10
2237461|NCT02622074|5487155|P5|NOT COMPLETED|Overall Study||10
2237462|NCT02622074|5487156|P4|NOT COMPLETED|Overall Study||10
2237463|NCT02622074|5487157|P3|NOT COMPLETED|Overall Study||10
2237464|NCT02622074|5487158|P2|NOT COMPLETED|Overall Study||10
2237465|NCT02622074|5487159|P1|NOT COMPLETED|Overall Study||10
2237466|NCT02622074|5487154|P6|COMPLETED|Overall Study||0
2237467|NCT02622074|5487155|P5|COMPLETED|Overall Study||0
2237468|NCT02622074|5487156|P4|COMPLETED|Overall Study||0
2237469|NCT02622074|5487157|P3|COMPLETED|Overall Study||0
2237470|NCT02622074|5487158|P2|COMPLETED|Overall Study||0
2237471|NCT02622074|5487159|P1|COMPLETED|Overall Study||0
2237472|NCT02622074|5487154|P6|STARTED|Overall Study||10
2237473|NCT02622074|5487155|P5|STARTED|Overall Study||10
2237474|NCT02622074|5487156|P4|STARTED|Overall Study||10
2237475|NCT02622074|5487157|P3|STARTED|Overall Study||10
2237476|NCT02622074|5487158|P2|STARTED|Overall Study||10
2237477|NCT02622074|5487159|P1|STARTED|Overall Study||10
2237478|NCT02621983|5487235|P2|NOT COMPLETED|Overall Study||11
2237479|NCT02621983|5487236|P1|NOT COMPLETED|Overall Study||12
2237480|NCT02621983|5487235|P2|COMPLETED|Overall Study||6
2237481|NCT02621983|5487236|P1|COMPLETED|Overall Study||9
2237482|NCT02621983|5487235|P2|STARTED|Overall Study||17
2237483|NCT02621983|5487236|P1|STARTED|Overall Study||21
2237484|NCT02621931|5487251|P3|NOT COMPLETED|Overall Study||36
2237485|NCT02621931|5487252|P2|NOT COMPLETED|Overall Study||27
2237486|NCT02621931|5487253|P1|NOT COMPLETED|Overall Study||33
2237487|NCT02621931|5487251|P3|COMPLETED|Overall Study||343
2237488|NCT02621931|5487252|P2|COMPLETED|Overall Study||349
2237489|NCT02621931|5487253|P1|COMPLETED|Overall Study||342
2237490|NCT02621931|5487251|P3|Full Analysis Set|Overall Study||375
2237491|NCT02621931|5487252|P2|Full Analysis Set|Overall Study||375
2237492|NCT02621931|5487253|P1|Full Analysis Set|Overall Study||371
2237493|NCT02621931|5487251|P3|Safety and ITT Populations|Overall Study||379
2237494|NCT02621931|5487252|P2|Safety and ITT Populations|Overall Study||376
2237495|NCT02621931|5487253|P1|Safety and ITT Populations|Overall Study||375
2237496|NCT02621931|5487251|P3|STARTED|Overall Study||379
2237497|NCT02621931|5487252|P2|STARTED|Overall Study||376
2237498|NCT02621931|5487253|P1|STARTED|Overall Study||375
2237499|NCT02621619|5487304|P2|NOT COMPLETED|Overall Study||0
2237500|NCT02621619|5487305|P1|NOT COMPLETED|Overall Study||0
2237501|NCT02621619|5487304|P2|COMPLETED|Overall Study||79
2237502|NCT02621619|5487305|P1|COMPLETED|Overall Study||80
2237503|NCT02621619|5487304|P2|STARTED|Overall Study||79
2237504|NCT02621619|5487305|P1|STARTED|Overall Study||80
2237505|NCT02621606|5487316|P3|NOT COMPLETED|Overall Study||0
2237506|NCT02621606|5487317|P2|NOT COMPLETED|Overall Study||1
2237507|NCT02621606|5487318|P1|NOT COMPLETED|Overall Study||0
2237508|NCT02621606|5487316|P3|COMPLETED|Overall Study||10
2237509|NCT02621606|5487317|P2|COMPLETED|Overall Study||6
2237510|NCT02621606|5487318|P1|COMPLETED|Overall Study||3
2237511|NCT02621606|5487316|P3|Treated|Overall Study||10
2237512|NCT02621606|5487317|P2|Treated|Overall Study||7
2237513|NCT02621606|5487318|P1|Treated|Overall Study||3
2237514|NCT02621606|5487316|P3|STARTED|Overall Study||10
2237515|NCT02621606|5487317|P2|STARTED|Overall Study||7
2237516|NCT02621606|5487318|P1|STARTED|Overall Study||3
2237517|NCT02621073|5487346|P2|NOT COMPLETED|Overall Study||3
2237518|NCT02621073|5487347|P1|NOT COMPLETED|Overall Study||3
2237519|NCT02621073|5487346|P2|COMPLETED|Overall Study||0
2237520|NCT02621073|5487347|P1|COMPLETED|Overall Study||1
2237521|NCT02621073|5487346|P2|STARTED|Overall Study||3
2237522|NCT02621073|5487347|P1|STARTED|Overall Study||4
2237523|NCT02621060|5487357|P2|NOT COMPLETED|Overall Study||1
2237524|NCT02621060|5487358|P1|NOT COMPLETED|Overall Study||3
2237525|NCT02621060|5487357|P2|COMPLETED|Overall Study||14
2237526|NCT02621060|5487358|P1|COMPLETED|Overall Study||12
2237527|NCT02621060|5487357|P2|STARTED|Overall Study||15
2237528|NCT02621060|5487358|P1|STARTED|Overall Study||15
2237529|NCT02621047|5487409|P3|NOT COMPLETED|Overall Study||1
2237530|NCT02621047|5487410|P2|NOT COMPLETED|Overall Study||0
2237531|NCT02621047|5487411|P1|NOT COMPLETED|Overall Study||0
2237532|NCT02621047|5487409|P3|COMPLETED|Overall Study||11
2237533|NCT02621047|5487410|P2|COMPLETED|Overall Study||8
2237534|NCT02621047|5487411|P1|COMPLETED|Overall Study||8
2237535|NCT02621047|5487409|P3|STARTED|Overall Study||12
2237536|NCT02621047|5487410|P2|STARTED|Overall Study||8
2237537|NCT02621047|5487411|P1|STARTED|Overall Study||8
2237538|NCT02621034|5487527|P3|NOT COMPLETED|Overall Study||5
2237539|NCT02621034|5487528|P2|NOT COMPLETED|Overall Study||2
2237540|NCT02621034|5487529|P1|NOT COMPLETED|Overall Study||3
2237541|NCT02621034|5487527|P3|COMPLETED|Overall Study||50
2237542|NCT02621034|5487528|P2|COMPLETED|Overall Study||50
2237543|NCT02621034|5487529|P1|COMPLETED|Overall Study||50
2237544|NCT02621034|5487527|P3|STARTED|Overall Study||55
2237545|NCT02621034|5487528|P2|STARTED|Overall Study||52
2237546|NCT02621034|5487529|P1|STARTED|Overall Study||53
2237547|NCT02620878|5487542|P2|NOT COMPLETED|Overall Study||0
2237548|NCT02620878|5487543|P1|NOT COMPLETED|Overall Study||0
2237549|NCT02620878|5487542|P2|COMPLETED|Overall Study||16
2237550|NCT02620878|5487543|P1|COMPLETED|Overall Study||16
2237551|NCT02620878|5487542|P2|STARTED|Overall Study||16
2237552|NCT02620878|5487543|P1|STARTED|Overall Study||16
2237553|NCT02620787|5487554|P2|NOT COMPLETED|Overall Study||0
2237554|NCT02620787|5487555|P1|NOT COMPLETED|Overall Study||2
2237555|NCT02620787|5487554|P2|COMPLETED|Overall Study||6
2237556|NCT02620787|5487555|P1|COMPLETED|Overall Study||10
2237557|NCT02620787|5487554|P2|STARTED|Overall Study||6
2237558|NCT02620787|5487555|P1|STARTED|Overall Study||12
2237559|NCT02620774|5487567|P2|NOT COMPLETED|Overall Study||0
2237560|NCT02620774|5487568|P1|NOT COMPLETED|Overall Study||0
2237561|NCT02620774|5487567|P2|COMPLETED|Overall Study||6
2237562|NCT02620774|5487568|P1|COMPLETED|Overall Study||10
2237563|NCT02620774|5487567|P2|STARTED|Overall Study||6
2237564|NCT02620774|5487568|P1|STARTED|Overall Study||10
2237565|NCT02620683|5487586|P2|NOT COMPLETED|Second Intervention (Visit 2)||0
2237566|NCT02620683|5487587|P1|NOT COMPLETED|Second Intervention (Visit 2)||0
2237567|NCT02620683|5487586|P2|COMPLETED|Second Intervention (Visit 2)||11
2237568|NCT02620683|5487587|P1|COMPLETED|Second Intervention (Visit 2)||12
2237569|NCT02620683|5487586|P2|STARTED|Second Intervention (Visit 2)||11
2237570|NCT02620683|5487587|P1|STARTED|Second Intervention (Visit 2)||12
2237571|NCT02620683|5487586|P2|NOT COMPLETED|Washout (2 Weeks)||0
2237572|NCT02620683|5487587|P1|NOT COMPLETED|Washout (2 Weeks)||0
2237573|NCT02620683|5487586|P2|COMPLETED|Washout (2 Weeks)||11
2237574|NCT02620683|5487587|P1|COMPLETED|Washout (2 Weeks)||12
2237575|NCT02620683|5487586|P2|STARTED|Washout (2 Weeks)||11
2237576|NCT02620683|5487587|P1|STARTED|Washout (2 Weeks)||12
2237577|NCT02620683|5487586|P2|NOT COMPLETED|First Intervention (Visit 1)||0
2237578|NCT02620683|5487587|P1|NOT COMPLETED|First Intervention (Visit 1)||0
2237579|NCT02620683|5487586|P2|COMPLETED|First Intervention (Visit 1)||11
2237580|NCT02620683|5487587|P1|COMPLETED|First Intervention (Visit 1)||12
2237581|NCT02620683|5487586|P2|STARTED|First Intervention (Visit 1)||11
2237582|NCT02620683|5487587|P1|STARTED|First Intervention (Visit 1)||12
2237583|NCT02620384|5487597|P2|NOT COMPLETED|Overall Study||7
2237584|NCT02620384|5487598|P1|NOT COMPLETED|Overall Study||4
2237585|NCT02620384|5487597|P2|COMPLETED|Overall Study|Per protocol design patients must receive both doses of investigational product to be in analysis.|66
2237586|NCT02620384|5487598|P1|COMPLETED|Overall Study|Per protocol design patients must receive both doses of investigational product to be in analysis.|66
2237587|NCT02620384|5487597|P2|STARTED|Overall Study||73
2237588|NCT02620384|5487598|P1|STARTED|Overall Study||70
2237589|NCT02620020|5487630|P4|NOT COMPLETED|Overall Study||26
2237590|NCT02620020|5487631|P3|NOT COMPLETED|Overall Study||25
2237591|NCT02620020|5487632|P2|NOT COMPLETED|Overall Study||35
2237592|NCT02620020|5487633|P1|NOT COMPLETED|Overall Study||44
2237593|NCT02620020|5487630|P4|COMPLETED|Overall Study||115
2237594|NCT02620020|5487631|P3|COMPLETED|Overall Study||115
2237595|NCT02620020|5487632|P2|COMPLETED|Overall Study||106
2237596|NCT02620020|5487633|P1|COMPLETED|Overall Study||97
2237597|NCT02620020|5487630|P4|Modified Intent to Treat Set (mITT)|Overall Study||140
2237598|NCT02620020|5487631|P3|Modified Intent to Treat Set (mITT)|Overall Study||139
2237599|NCT02620020|5487632|P2|Modified Intent to Treat Set (mITT)|Overall Study||139
2237600|NCT02620020|5487633|P1|Modified Intent to Treat Set (mITT)|Overall Study||140
2237601|NCT02620020|5487630|P4|STARTED|Overall Study||141
2237602|NCT02620020|5487631|P3|STARTED|Overall Study||140
2237603|NCT02620020|5487632|P2|STARTED|Overall Study||141
2237604|NCT02620020|5487633|P1|STARTED|Overall Study||141
2237605|NCT02619812|5487659|P4|NOT COMPLETED|Overall Study||2
2237606|NCT02619812|5487660|P3|NOT COMPLETED|Overall Study||1
2237607|NCT02619812|5487661|P2|NOT COMPLETED|Overall Study||0
2237608|NCT02619812|5487662|P1|NOT COMPLETED|Overall Study||0
2237609|NCT02619812|5487659|P4|COMPLETED|Overall Study||0
2237610|NCT02619812|5487660|P3|COMPLETED|Overall Study||0
2237611|NCT02619812|5487661|P2|COMPLETED|Overall Study||0
2237612|NCT02619812|5487662|P1|COMPLETED|Overall Study||0
2237613|NCT02619812|5487659|P4|STARTED|Overall Study||2
2237614|NCT02619812|5487660|P3|STARTED|Overall Study||1
2237615|NCT02619812|5487661|P2|STARTED|Overall Study||0
2237616|NCT02619812|5487662|P1|STARTED|Overall Study||0
2237617|NCT02619799|5487678|P2|NOT COMPLETED|Overall Study||0
2237618|NCT02619799|5487679|P1|NOT COMPLETED|Overall Study||0
2237619|NCT02619799|5487678|P2|COMPLETED|Overall Study||25
2237620|NCT02619799|5487679|P1|COMPLETED|Overall Study||25
2237621|NCT02619799|5487678|P2|STARTED|Overall Study||25
2237622|NCT02619799|5487679|P1|STARTED|Overall Study||25
2237623|NCT02619617|5487695|P2|NOT COMPLETED|Period 2 SOM230 - 2nd Attack||4
2237624|NCT02619617|5487696|P1|NOT COMPLETED|Period 2 SOM230 - 2nd Attack||0
2237625|NCT02619617|5487695|P2|COMPLETED|Period 2 SOM230 - 2nd Attack||24
2237626|NCT02619617|5487696|P1|COMPLETED|Period 2 SOM230 - 2nd Attack||0
2237627|NCT02619617|5487695|P2|Participants in Safety Set for Period 2|Period 2 SOM230 - 2nd Attack||28
2237628|NCT02619617|5487696|P1|Participants in Safety Set for Period 2|Period 2 SOM230 - 2nd Attack||0
2237629|NCT02619617|5487695|P2|STARTED|Period 2 SOM230 - 2nd Attack||28
2237630|NCT02619617|5487696|P1|STARTED|Period 2 SOM230 - 2nd Attack||0
2237631|NCT02619617|5487695|P2|NOT COMPLETED|Period 1 Placebo - 1st AttacK||0
2237632|NCT02619617|5487696|P1|NOT COMPLETED|Period 1 Placebo - 1st AttacK||0
2237633|NCT02619617|5487695|P2|COMPLETED|Period 1 Placebo - 1st AttacK||0
2237634|NCT02619617|5487696|P1|COMPLETED|Period 1 Placebo - 1st AttacK||28
2237635|NCT02619617|5487695|P2|Participants in Safety Set for Period 1|Period 1 Placebo - 1st AttacK||0
2237636|NCT02619617|5487696|P1|Participants in Safety Set for Period 1|Period 1 Placebo - 1st AttacK||28
2237637|NCT02619617|5487695|P2|Participants Included in PD Analysis|Period 1 Placebo - 1st AttacK||0
2237638|NCT02619617|5487696|P1|Participants Included in PD Analysis|Period 1 Placebo - 1st AttacK||20
2237639|NCT02619617|5487695|P2|STARTED|Period 1 Placebo - 1st AttacK||0
2237640|NCT02619617|5487696|P1|STARTED|Period 1 Placebo - 1st AttacK||28
2237641|NCT02619591|5487708|P2|NOT COMPLETED|Overall Study||121
2237642|NCT02619591|5487709|P1|NOT COMPLETED|Overall Study||139
2237643|NCT02619591|5487708|P2|COMPLETED|Overall Study||0
2237644|NCT02619591|5487709|P1|COMPLETED|Overall Study||0
2237645|NCT02619591|5487708|P2|STARTED|Overall Study||121
2237646|NCT02619591|5487709|P1|STARTED|Overall Study||139
2237647|NCT02619409|5487720|P5|NOT COMPLETED|Overall Study||0
2237648|NCT02619409|5487721|P4|NOT COMPLETED|Overall Study||0
2237649|NCT02619409|5487722|P3|NOT COMPLETED|Overall Study||0
2237650|NCT02619409|5487723|P2|NOT COMPLETED|Overall Study||0
2237651|NCT02619409|5487724|P1|NOT COMPLETED|Overall Study||0
2237652|NCT02619409|5487720|P5|COMPLETED|Overall Study||6
2237653|NCT02619409|5487721|P4|COMPLETED|Overall Study||6
2237654|NCT02619409|5487722|P3|COMPLETED|Overall Study||6
2237655|NCT02619409|5487723|P2|COMPLETED|Overall Study||6
2237656|NCT02619409|5487724|P1|COMPLETED|Overall Study||6
2237657|NCT02619409|5487720|P5|STARTED|Overall Study||6
2237658|NCT02619409|5487721|P4|STARTED|Overall Study||6
2237659|NCT02619409|5487722|P3|STARTED|Overall Study||6
2237660|NCT02619409|5487723|P2|STARTED|Overall Study||6
2237661|NCT02619409|5487724|P1|STARTED|Overall Study||6
2237662|NCT02619175|5487743|P2|NOT COMPLETED|Overall Study||0
2237663|NCT02619175|5487744|P1|NOT COMPLETED|Overall Study||2
2237664|NCT02619175|5487743|P2|COMPLETED|Overall Study||16
2237665|NCT02619175|5487744|P1|COMPLETED|Overall Study||16
2237666|NCT02619175|5487743|P2|STARTED|Overall Study||16
2237667|NCT02619175|5487744|P1|STARTED|Overall Study||18
2237668|NCT02618928|5487758|P1|NOT COMPLETED|Overall Study||58
2237669|NCT02618928|5487758|P1|COMPLETED|Overall Study||677
2237670|NCT02618928|5487758|P1|Received Treatment|Overall Study||728
2237671|NCT02618928|5487758|P1|STARTED|Overall Study||735
2237672|NCT02618915|5487791|P2|NOT COMPLETED|Overall Study||0
2237673|NCT02618915|5487792|P1|NOT COMPLETED|Overall Study||0
2237674|NCT02618915|5487791|P2|COMPLETED|Overall Study||3
2237675|NCT02618915|5487792|P1|COMPLETED|Overall Study||3
2237676|NCT02618915|5487791|P2|STARTED|Overall Study||3
2237677|NCT02618915|5487792|P1|STARTED|Overall Study||3
2237678|NCT02618772|5487818|P2|NOT COMPLETED|Overall Study||0
2237679|NCT02618772|5487819|P1|NOT COMPLETED|Overall Study||1
2237680|NCT02618772|5487818|P2|COMPLETED|Overall Study||40
2237681|NCT02618772|5487819|P1|COMPLETED|Overall Study||38
2237682|NCT02618772|5487818|P2|Withdrawal by Subject|Overall Study||0
2237683|NCT02618772|5487819|P1|Withdrawal by Subject|Overall Study|The participant's family withdrew from the study after administration of the trial intervention.|1
2237684|NCT02618772|5487818|P2|STARTED|Overall Study||40
2237685|NCT02618772|5487819|P1|STARTED|Overall Study||39
2237686|NCT02618759|5487853|P2|NOT COMPLETED|Overall Study||5
2237687|NCT02618759|5487854|P1|NOT COMPLETED|Overall Study||2
2237688|NCT02618759|5487853|P2|COMPLETED|Overall Study||54
2237689|NCT02618759|5487854|P1|COMPLETED|Overall Study||58
2237690|NCT02618759|5487853|P2|STARTED|Overall Study||59
2237691|NCT02618759|5487854|P1|STARTED|Overall Study||60
2237692|NCT02618642|5487874|P4|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
2237693|NCT02618642|5487875|P3|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
2237694|NCT02618642|5487876|P2|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
2237695|NCT02618642|5487877|P1|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
2237696|NCT02618642|5487874|P4|COMPLETED|After 10 PILER Irradiation Treatments||15
2237697|NCT02618642|5487875|P3|COMPLETED|After 10 PILER Irradiation Treatments||15
2237698|NCT02618642|5487876|P2|COMPLETED|After 10 PILER Irradiation Treatments||15
2237699|NCT02618642|5487877|P1|COMPLETED|After 10 PILER Irradiation Treatments||15
2237700|NCT02618642|5487874|P4|STARTED|After 10 PILER Irradiation Treatments||15
2237701|NCT02618642|5487875|P3|STARTED|After 10 PILER Irradiation Treatments||15
2237702|NCT02618642|5487876|P2|STARTED|After 10 PILER Irradiation Treatments||15
2237703|NCT02618642|5487877|P1|STARTED|After 10 PILER Irradiation Treatments||15
2237704|NCT02618642|5487874|P4|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
2237705|NCT02618642|5487875|P3|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
2237706|NCT02618642|5487876|P2|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
2237707|NCT02618642|5487877|P1|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
2237708|NCT02618642|5487874|P4|COMPLETED|Before 10 PILER Irradiation Treatments||15
2237709|NCT02618642|5487875|P3|COMPLETED|Before 10 PILER Irradiation Treatments||15
2237710|NCT02618642|5487876|P2|COMPLETED|Before 10 PILER Irradiation Treatments||15
2237711|NCT02618642|5487877|P1|COMPLETED|Before 10 PILER Irradiation Treatments||15
2237712|NCT02618642|5487874|P4|STARTED|Before 10 PILER Irradiation Treatments||15
2237713|NCT02618642|5487875|P3|STARTED|Before 10 PILER Irradiation Treatments||15
2237714|NCT02618642|5487876|P2|STARTED|Before 10 PILER Irradiation Treatments||15
2237715|NCT02618642|5487877|P1|STARTED|Before 10 PILER Irradiation Treatments||15
2237716|NCT02618512|5487903|P1|NOT COMPLETED|Overall Study||0
2237717|NCT02618512|5487903|P1|COMPLETED|Overall Study||3
2237718|NCT02618512|5487903|P1|STARTED|Overall Study||3
2237719|NCT02618187|5487911|P4|NOT COMPLETED|Overall Study||5
2237720|NCT02618187|5487912|P3|NOT COMPLETED|Overall Study||4
2237721|NCT02618187|5487913|P2|NOT COMPLETED|Overall Study||2
2237722|NCT02618187|5487914|P1|NOT COMPLETED|Overall Study||2
2237723|NCT02618187|5487911|P4|COMPLETED|Overall Study||12
2237724|NCT02618187|5487912|P3|COMPLETED|Overall Study||11
2237725|NCT02618187|5487913|P2|COMPLETED|Overall Study||9
2237726|NCT02618187|5487914|P1|COMPLETED|Overall Study||13
2237727|NCT02618187|5487911|P4|Completed|Overall Study||13
2237728|NCT02618187|5487912|P3|Completed|Overall Study||13
2237729|NCT02618187|5487913|P2|Completed|Overall Study||10
2237730|NCT02618187|5487914|P1|Completed|Overall Study||13
2237731|NCT02618187|5487911|P4|STARTED|Overall Study||17
2237732|NCT02618187|5487912|P3|STARTED|Overall Study||15
2237733|NCT02618187|5487913|P2|STARTED|Overall Study||11
2237734|NCT02618187|5487914|P1|STARTED|Overall Study||15
2237735|NCT02618031|5487942|P2|NOT COMPLETED|Overall Study||0
2237736|NCT02618031|5487943|P1|NOT COMPLETED|Overall Study||1
2237737|NCT02618031|5487942|P2|COMPLETED|Overall Study||11
2237738|NCT02618031|5487943|P1|COMPLETED|Overall Study||45
2237739|NCT02618031|5487942|P2|STARTED|Overall Study||11
2237740|NCT02618031|5487943|P1|STARTED|Overall Study||46
2237741|NCT02617901|5487955|P1|NOT COMPLETED|Overall Study||0
2237742|NCT02617901|5487955|P1|COMPLETED|Overall Study||20
2237743|NCT02617901|5487955|P1|STARTED|Overall Study||20
2237744|NCT02617888|5487962|P3|NOT COMPLETED|Overall Study||0
2237745|NCT02617888|5487963|P2|NOT COMPLETED|Overall Study||7
2237746|NCT02617888|5487964|P1|NOT COMPLETED|Overall Study||1
2237747|NCT02617888|5487962|P3|COMPLETED|Overall Study||127
2237748|NCT02617888|5487963|P2|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break samples.|44
2237749|NCT02617888|5487964|P1|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break sample.|49
2237750|NCT02617888|5487962|P3|STARTED|Overall Study||127
2237751|NCT02617888|5487963|P2|STARTED|Overall Study||51
2237752|NCT02617888|5487964|P1|STARTED|Overall Study||50
2237753|NCT02617784|5487973|P2|NOT COMPLETED|Overall Study||0
2237754|NCT02617784|5487974|P1|NOT COMPLETED|Overall Study||0
2237755|NCT02617784|5487973|P2|COMPLETED|Overall Study||12
2237756|NCT02617784|5487974|P1|COMPLETED|Overall Study||12
2237757|NCT02617784|5487973|P2|Second Dose Assessment Period|Overall Study||12
2237758|NCT02617784|5487974|P1|Second Dose Assessment Period|Overall Study||11
2237759|NCT02617784|5487973|P2|First Dose Assessment Period|Overall Study||12
2237760|NCT02617784|5487974|P1|First Dose Assessment Period|Overall Study||12
2237761|NCT02617784|5487973|P2|STARTED|Overall Study||12
2237762|NCT02617784|5487974|P1|STARTED|Overall Study|None were prematurely withdrawn; 1 switched to CAPD mid-study and was excluded from second analysis.|12
2237763|NCT02617667|5488025|P4|NOT COMPLETED|Overall Study||1
2237764|NCT02617667|5488026|P3|NOT COMPLETED|Overall Study||4
2237765|NCT02617667|5488027|P2|NOT COMPLETED|Overall Study||1
2237766|NCT02617667|5488028|P1|NOT COMPLETED|Overall Study||1
2237767|NCT02617667|5488025|P4|COMPLETED|Overall Study||52
2237768|NCT02617667|5488026|P3|COMPLETED|Overall Study||48
2237769|NCT02617667|5488027|P2|COMPLETED|Overall Study||50
2237770|NCT02617667|5488028|P1|COMPLETED|Overall Study||50
2237771|NCT02617667|5488025|P4|STARTED|Overall Study||53
2237772|NCT02617667|5488026|P3|STARTED|Overall Study||52
2237773|NCT02617667|5488027|P2|STARTED|Overall Study||51
2237774|NCT02617667|5488028|P1|STARTED|Overall Study||51
2237775|NCT02616900|5488040|P1|NOT COMPLETED|Overall Study||23
2237776|NCT02616900|5488040|P1|COMPLETED|Overall Study|Six participants not included in study results because of incomplete data.|51
2237777|NCT02616900|5488040|P1|Completed 3mo Trial|Overall Study||57
2237778|NCT02616900|5488040|P1|STARTED|Overall Study||74
2237779|NCT02616783|5488048|P2|NOT COMPLETED|Overall Study||2
2237780|NCT02616783|5488049|P1|NOT COMPLETED|Overall Study||6
2237781|NCT02616783|5488048|P2|COMPLETED|Overall Study||54
2237782|NCT02616783|5488049|P1|COMPLETED|Overall Study||105
2237783|NCT02616783|5488048|P2|STARTED|Overall Study||56
2237784|NCT02616783|5488049|P1|STARTED|Overall Study||111
2237785|NCT02616601|5488072|P3|NOT COMPLETED|Overall Study||7
2237786|NCT02616601|5488073|P2|NOT COMPLETED|Overall Study||4
2237787|NCT02616601|5488074|P1|NOT COMPLETED|Overall Study||9
2237788|NCT02616601|5488072|P3|COMPLETED|Overall Study||135
2237789|NCT02616601|5488073|P2|COMPLETED|Overall Study||136
2237790|NCT02616601|5488074|P1|COMPLETED|Overall Study||131
2237791|NCT02616601|5488072|P3|PP Population|Overall Study||123
2237792|NCT02616601|5488073|P2|PP Population|Overall Study||121
2237793|NCT02616601|5488074|P1|PP Population|Overall Study||112
2237794|NCT02616601|5488072|P3|mITT Population|Overall Study||138
2237795|NCT02616601|5488073|P2|mITT Population|Overall Study||136
2237796|NCT02616601|5488074|P1|mITT Population|Overall Study||137
2237797|NCT02616601|5488072|P3|Safety Population|Overall Study||142
2237798|NCT02616601|5488073|P2|Safety Population|Overall Study||140
2237799|NCT02616601|5488074|P1|Safety Population|Overall Study||140
2237800|NCT02616601|5488072|P3|STARTED|Overall Study||142
2237801|NCT02616601|5488073|P2|STARTED|Overall Study||140
2237802|NCT02616601|5488074|P1|STARTED|Overall Study||140
2237803|NCT02616523|5488085|P3|NOT COMPLETED|Overall Study||0
2237804|NCT02616523|5488086|P2|NOT COMPLETED|Overall Study||0
2237805|NCT02616523|5488087|P1|NOT COMPLETED|Overall Study||1
2237806|NCT02616523|5488085|P3|COMPLETED|Overall Study|April 2015|20
2237807|NCT02616523|5488086|P2|COMPLETED|Overall Study|April 2015|20
2237808|NCT02616523|5488087|P1|COMPLETED|Overall Study|April 2015|19
2237809|NCT02616523|5488085|P3|STARTED|Overall Study|June 2014|20
2237810|NCT02616523|5488086|P2|STARTED|Overall Study|June 2014|20
2237811|NCT02616523|5488087|P1|STARTED|Overall Study|June 2014|20
2237812|NCT02616380|5488101|P1|NOT COMPLETED|Overall Study||3
2237813|NCT02616380|5488101|P1|COMPLETED|Overall Study||97
2237814|NCT02616380|5488101|P1|STARTED|Overall Study||100
2237815|NCT02616250|5488116|P2|NOT COMPLETED|Overall Study||9
2237816|NCT02616250|5488117|P1|NOT COMPLETED|Overall Study||10
2237817|NCT02616250|5488116|P2|COMPLETED|Overall Study||86
2237818|NCT02616250|5488117|P1|COMPLETED|Overall Study||85
2237819|NCT02616250|5488116|P2|STARTED|Overall Study||95
2237820|NCT02616250|5488117|P1|STARTED|Overall Study||95
2237821|NCT02616146|5488125|P2|NOT COMPLETED|Overall Study||504
2237822|NCT02616146|5488126|P1|NOT COMPLETED|Overall Study||1512
2237823|NCT02616146|5488125|P2|COMPLETED|Overall Study|Due to termination of study, LNG-EE reporting group received only up to 9 cycles of treatment.|0
2237824|NCT02616146|5488126|P1|COMPLETED|Overall Study|Due to termination of study, ENG-E2 reporting group received only up to 10 cycles of treatment.|0
2237825|NCT02616146|5488125|P2|STARTED|Overall Study||504
2237826|NCT02616146|5488126|P1|STARTED|Overall Study||1512
2237827|NCT02616029|5488142|P2|NOT COMPLETED|Overall Study||9
2237828|NCT02616029|5488143|P1|NOT COMPLETED|Overall Study||4
2237829|NCT02616029|5488142|P2|COMPLETED|Overall Study||19
2237830|NCT02616029|5488143|P1|COMPLETED|Overall Study||34
2237831|NCT02616029|5488142|P2|STARTED|Overall Study||28
2237832|NCT02616029|5488143|P1|STARTED|Overall Study||38
2237833|NCT02615990|5488166|P2|NOT COMPLETED|Overall Study||1
2237834|NCT02615990|5488167|P1|NOT COMPLETED|Overall Study||1
2237835|NCT02615990|5488166|P2|COMPLETED|Overall Study||0
2237836|NCT02615990|5488167|P1|COMPLETED|Overall Study||0
2237837|NCT02615990|5488166|P2|STARTED|Overall Study||1
2237838|NCT02615990|5488167|P1|STARTED|Overall Study||1
2237839|NCT02615743|5488213|P2|NOT COMPLETED|Overall Study||3
2237840|NCT02615743|5488214|P1|NOT COMPLETED|Overall Study||6
2237841|NCT02615743|5488213|P2|COMPLETED|Overall Study||17
2237842|NCT02615743|5488214|P1|COMPLETED|Overall Study||15
2237843|NCT02615743|5488213|P2|STARTED|Overall Study||20
2237844|NCT02615743|5488214|P1|STARTED|Overall Study||21
2237845|NCT02615717|5488228|P2|NOT COMPLETED|Overall Study||0
2237846|NCT02615717|5488229|P1|NOT COMPLETED|Overall Study||0
2237847|NCT02615717|5488228|P2|COMPLETED|Overall Study||3
2237848|NCT02615717|5488229|P1|COMPLETED|Overall Study||3
2237849|NCT02615717|5488228|P2|STARTED|Overall Study||3
2237850|NCT02615717|5488229|P1|STARTED|Overall Study||3
2237851|NCT02615535|5488243|P2|NOT COMPLETED|Overall Study||1
2237852|NCT02615535|5488244|P1|NOT COMPLETED|Overall Study||4
2237853|NCT02615535|5488243|P2|COMPLETED|Overall Study||10
2237854|NCT02615535|5488244|P1|COMPLETED|Overall Study||10
2237855|NCT02615535|5488243|P2|STARTED|Overall Study||11
2237856|NCT02615535|5488244|P1|STARTED|Overall Study||14
2237857|NCT02615470|5488266|P2|NOT COMPLETED|Overall Study||32
2237858|NCT02615470|5488267|P1|NOT COMPLETED|Overall Study||21
2237859|NCT02615470|5488266|P2|COMPLETED|Overall Study||30
2237860|NCT02615470|5488267|P1|COMPLETED|Overall Study||37
2237861|NCT02615470|5488266|P2|Completed the Baseline Surveys|Overall Study||47
2237862|NCT02615470|5488267|P1|Completed the Baseline Surveys|Overall Study||46
2237863|NCT02615470|5488266|P2|STARTED|Overall Study||62
2237864|NCT02615470|5488267|P1|STARTED|Overall Study||58
2237865|NCT02615145|5488280|P4|NOT COMPLETED|Overall Study||1
2237866|NCT02615145|5488281|P3|NOT COMPLETED|Overall Study||8
2237867|NCT02615145|5488282|P2|NOT COMPLETED|Overall Study||15
2237868|NCT02615145|5488283|P1|NOT COMPLETED|Overall Study||27
2237869|NCT02615145|5488280|P4|COMPLETED|Overall Study||0
2237870|NCT02615145|5488281|P3|COMPLETED|Overall Study||40
2237871|NCT02615145|5488282|P2|COMPLETED|Overall Study||263
2237872|NCT02615145|5488283|P1|COMPLETED|Overall Study||118
2237873|NCT02615145|5488280|P4|3DAA + RBV|Overall Study||0
2237874|NCT02615145|5488281|P3|3DAA + RBV|Overall Study||2
2237875|NCT02615145|5488282|P2|3DAA + RBV|Overall Study||17
2237876|NCT02615145|5488283|P1|3DAA + RBV|Overall Study||140
2237877|NCT02615145|5488280|P4|3DAA|Overall Study||0
2237878|NCT02615145|5488281|P3|3DAA|Overall Study||0
2237879|NCT02615145|5488282|P2|3DAA|Overall Study||261
2237880|NCT02615145|5488283|P1|3DAA|Overall Study||5
2237881|NCT02615145|5488280|P4|2 DAA + Ribavirin (RBV)|Overall Study||0
2237882|NCT02615145|5488281|P3|2 DAA + Ribavirin (RBV)|Overall Study||45
2237883|NCT02615145|5488282|P2|2 DAA + Ribavirin (RBV)|Overall Study||0
2237884|NCT02615145|5488283|P1|2 DAA + Ribavirin (RBV)|Overall Study||0
2237885|NCT02615145|5488280|P4|STARTED|Overall Study||1
2237886|NCT02615145|5488281|P3|STARTED|Overall Study||48
2237887|NCT02615145|5488282|P2|STARTED|Overall Study||278
2237888|NCT02615145|5488283|P1|STARTED|Overall Study||145
2237889|NCT02614924|5488359|P2|NOT COMPLETED|Overall Study||0
2237890|NCT02614924|5488360|P1|NOT COMPLETED|Overall Study||0
2237891|NCT02614924|5488359|P2|COMPLETED|Overall Study||20
2237892|NCT02614924|5488360|P1|COMPLETED|Overall Study||20
2237893|NCT02614924|5488359|P2|STARTED|Overall Study||20
2237894|NCT02614924|5488360|P1|STARTED|Overall Study||20
2237895|NCT02614898|5488370|P2|NOT COMPLETED|Overall Study||51
2237896|NCT02614898|5488371|P1|NOT COMPLETED|Overall Study||15
2237897|NCT02614898|5488370|P2|COMPLETED|Overall Study||1
2237898|NCT02614898|5488371|P1|COMPLETED|Overall Study||0
2237899|NCT02614898|5488370|P2|Safety Population|Overall Study||52
2237900|NCT02614898|5488371|P1|Safety Population|Overall Study||15
2237901|NCT02614898|5488370|P2|STARTED|Overall Study||52
2237902|NCT02614898|5488371|P1|STARTED|Overall Study||15
2237903|NCT02614729|5488383|P2|NOT COMPLETED|Overall Study||0
2237904|NCT02614729|5488384|P1|NOT COMPLETED|Overall Study||1
2237905|NCT02614729|5488383|P2|COMPLETED|Overall Study||17
2237906|NCT02614729|5488384|P1|COMPLETED|Overall Study||17
2237907|NCT02614729|5488383|P2|STARTED|Overall Study||17
2237908|NCT02614729|5488384|P1|STARTED|Overall Study||18
2237909|NCT02614703|5488404|P2|NOT COMPLETED|Overall Study||1
2237910|NCT02614703|5488405|P1|NOT COMPLETED|Overall Study||7
2237911|NCT02614703|5488404|P2|COMPLETED|Overall Study||28
2237912|NCT02614703|5488405|P1|COMPLETED|Overall Study||24
2237913|NCT02614703|5488404|P2|STARTED|Overall Study||29
2237914|NCT02614703|5488405|P1|STARTED|Overall Study||31
2237915|NCT02614690|5488414|P3|NOT COMPLETED|Overall Study||0
2237916|NCT02614690|5488415|P2|NOT COMPLETED|Overall Study||0
2237917|NCT02614690|5488416|P1|NOT COMPLETED|Overall Study||0
2237918|NCT02614690|5488414|P3|COMPLETED|Overall Study||20
2237919|NCT02614690|5488415|P2|COMPLETED|Overall Study||20
2237920|NCT02614690|5488416|P1|COMPLETED|Overall Study||20
2237921|NCT02614690|5488414|P3|STARTED|Overall Study||20
2237922|NCT02614690|5488415|P2|STARTED|Overall Study||20
2237923|NCT02614690|5488416|P1|STARTED|Overall Study||20
2237924|NCT02614586|5488442|P1|NOT COMPLETED|Overall Study||0
2237925|NCT02614586|5488442|P1|COMPLETED|Overall Study||11
2237926|NCT02614586|5488442|P1|STARTED|Overall Study||11
2237927|NCT02614560|5488449|P2|NOT COMPLETED|Overall Study||2
2237928|NCT02614560|5488450|P1|NOT COMPLETED|Overall Study||6
2237929|NCT02614560|5488449|P2|COMPLETED|Overall Study||6
2237930|NCT02614560|5488450|P1|COMPLETED|Overall Study||0
2237931|NCT02614560|5488449|P2|STARTED|Overall Study||8
2237932|NCT02614560|5488450|P1|STARTED|Overall Study||6
2237933|NCT02614469|5488467|P2|NOT COMPLETED|Period 2||0
2237934|NCT02614469|5488468|P1|NOT COMPLETED|Period 2||0
2237935|NCT02614469|5488467|P2|COMPLETED|Period 2||9
2237936|NCT02614469|5488468|P1|COMPLETED|Period 2||9
2237937|NCT02614469|5488467|P2|STARTED|Period 2||9
2237938|NCT02614469|5488468|P1|STARTED|Period 2||9
2237939|NCT02614469|5488467|P2|NOT COMPLETED|Period 1||0
2237940|NCT02614469|5488468|P1|NOT COMPLETED|Period 1||0
2237941|NCT02614469|5488467|P2|COMPLETED|Period 1||9
2237942|NCT02614469|5488468|P1|COMPLETED|Period 1||9
2237943|NCT02614469|5488467|P2|STARTED|Period 1||9
2237944|NCT02614469|5488468|P1|STARTED|Period 1||9
2237945|NCT02614287|5488498|P2|NOT COMPLETED|Post Treatment Follow-up Phase||5
2237946|NCT02614287|5488499|P1|NOT COMPLETED|Post Treatment Follow-up Phase||9
2237947|NCT02614287|5488498|P2|COMPLETED|Post Treatment Follow-up Phase||119
2237948|NCT02614287|5488499|P1|COMPLETED|Post Treatment Follow-up Phase||103
2237949|NCT02614287|5488498|P2|STARTED|Post Treatment Follow-up Phase|Follow-up period was optional, few participants who completed OL period didn't enter follow-up.|124
2237950|NCT02614287|5488499|P1|STARTED|Post Treatment Follow-up Phase|Follow-up period was optional, few participants who completed OL period didn't enter follow-up.|112
2237951|NCT02614287|5488498|P2|NOT COMPLETED|Open Label (OL) Treatment Phase||22
2237952|NCT02614287|5488499|P1|NOT COMPLETED|Open Label (OL) Treatment Phase||38
2237953|NCT02614287|5488498|P2|COMPLETED|Open Label (OL) Treatment Phase||113
2237954|NCT02614287|5488499|P1|COMPLETED|Open Label (OL) Treatment Phase||97
2237955|NCT02614287|5488498|P2|Received at Least One Dose of Study Drug|Open Label (OL) Treatment Phase||135
2237956|NCT02614287|5488499|P1|Received at Least One Dose of Study Drug|Open Label (OL) Treatment Phase||135
2237957|NCT02614287|5488498|P2|STARTED|Open Label (OL) Treatment Phase||135
2237958|NCT02614287|5488499|P1|STARTED|Open Label (OL) Treatment Phase||135
2237959|NCT02614274|5488533|P1|NOT COMPLETED|Overall Study||4
2237960|NCT02614274|5488533|P1|COMPLETED|Overall Study||5
2237961|NCT02614274|5488533|P1|STARTED|Overall Study||9
2237962|NCT02614261|5488545|P3|NOT COMPLETED|Overall Study||11
2237963|NCT02614261|5488546|P2|NOT COMPLETED|Overall Study||15
2237964|NCT02614261|5488547|P1|NOT COMPLETED|Overall Study||49
2237965|NCT02614261|5488545|P3|COMPLETED|Overall Study||266
2237966|NCT02614261|5488546|P2|COMPLETED|Overall Study||263
2237967|NCT02614261|5488547|P1|COMPLETED|Overall Study||509
2237968|NCT02614261|5488545|P3|Received at Least One Dose of Study Drug|Overall Study||277
2237969|NCT02614261|5488546|P2|Received at Least One Dose of Study Drug|Overall Study||278
2237970|NCT02614261|5488547|P1|Received at Least One Dose of Study Drug|Overall Study||558
2237971|NCT02614261|5488545|P3|STARTED|Overall Study||277
2237972|NCT02614261|5488546|P2|STARTED|Overall Study||278
2237973|NCT02614261|5488547|P1|STARTED|Overall Study||558
2237974|NCT02614222|5488586|P2|NOT COMPLETED|Overall Study||0
2237975|NCT02614222|5488587|P1|NOT COMPLETED|Overall Study||0
2237976|NCT02614222|5488586|P2|COMPLETED|Overall Study||14
2237977|NCT02614222|5488587|P1|COMPLETED|Overall Study||13
2237978|NCT02614222|5488586|P2|STARTED|Overall Study||14
2237979|NCT02614222|5488587|P1|STARTED|Overall Study||13
2237980|NCT02614196|5488613|P6|NOT COMPLETED|Post Treatment Follow-up Phase||0
2237981|NCT02614196|5488614|P5|NOT COMPLETED|Post Treatment Follow-up Phase||2
2237982|NCT02614196|5488615|P4|NOT COMPLETED|Post Treatment Follow-up Phase||1
2237983|NCT02614196|5488616|P3|NOT COMPLETED|Post Treatment Follow-up Phase||8
2237984|NCT02614196|5488617|P2|NOT COMPLETED|Post Treatment Follow-up Phase||5
2237985|NCT02614196|5488618|P1|NOT COMPLETED|Post Treatment Follow-up Phase||20
2237986|NCT02614196|5488613|P6|COMPLETED|Post Treatment Follow-up Phase||19
2237987|NCT02614196|5488614|P5|COMPLETED|Post Treatment Follow-up Phase||13
2237988|NCT02614196|5488615|P4|COMPLETED|Post Treatment Follow-up Phase||24
2237989|NCT02614196|5488616|P3|COMPLETED|Post Treatment Follow-up Phase||199
2237990|NCT02614196|5488617|P2|COMPLETED|Post Treatment Follow-up Phase||208
2237991|NCT02614196|5488618|P1|COMPLETED|Post Treatment Follow-up Phase||390
2237992|NCT02614196|5488613|P6|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|19
2237993|NCT02614196|5488614|P5|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|15
2237994|NCT02614196|5488615|P4|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|25
2237995|NCT02614196|5488616|P3|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|207
2237996|NCT02614196|5488617|P2|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|213
2237997|NCT02614196|5488618|P1|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|410
2237998|NCT02614196|5488613|P6|NOT COMPLETED|Double Blind Treatment Phase||0
2237999|NCT02614196|5488614|P5|NOT COMPLETED|Double Blind Treatment Phase||1
2238000|NCT02614196|5488615|P4|NOT COMPLETED|Double Blind Treatment Phase||4
2238001|NCT02614196|5488616|P3|NOT COMPLETED|Double Blind Treatment Phase||31
2238002|NCT02614196|5488617|P2|NOT COMPLETED|Double Blind Treatment Phase||30
2238003|NCT02614196|5488618|P1|NOT COMPLETED|Double Blind Treatment Phase||76
2238004|NCT02614196|5488613|P6|COMPLETED|Double Blind Treatment Phase||19
2238005|NCT02614196|5488614|P5|COMPLETED|Double Blind Treatment Phase||14
2238006|NCT02614196|5488615|P4|COMPLETED|Double Blind Treatment Phase||26
2238007|NCT02614196|5488616|P3|COMPLETED|Double Blind Treatment Phase||195
2238008|NCT02614196|5488617|P2|COMPLETED|Double Blind Treatment Phase||203
2238009|NCT02614196|5488618|P1|COMPLETED|Double Blind Treatment Phase||387
2238010|NCT02614196|5488613|P6|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||19
2238011|NCT02614196|5488614|P5|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||14
2238012|NCT02614196|5488615|P4|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||30
2238013|NCT02614196|5488616|P3|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||223
2238014|NCT02614196|5488617|P2|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||231
2238015|NCT02614196|5488618|P1|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||461
2238016|NCT02614196|5488613|P6|STARTED|Double Blind Treatment Phase||19
2238017|NCT02614196|5488614|P5|STARTED|Double Blind Treatment Phase||15
2238018|NCT02614196|5488615|P4|STARTED|Double Blind Treatment Phase||30
2238019|NCT02614196|5488616|P3|STARTED|Double Blind Treatment Phase||226
2238020|NCT02614196|5488617|P2|STARTED|Double Blind Treatment Phase||233
2238021|NCT02614196|5488618|P1|STARTED|Double Blind Treatment Phase||463
2238022|NCT02614183|5488664|P3|NOT COMPLETED|Post Treatment Follow-up Phase||12
2238023|NCT02614183|5488665|P2|NOT COMPLETED|Post Treatment Follow-up Phase||6
2238024|NCT02614183|5488666|P1|NOT COMPLETED|Post Treatment Follow-up Phase||18
2238025|NCT02614183|5488664|P3|COMPLETED|Post Treatment Follow-up Phase||171
2238026|NCT02614183|5488665|P2|COMPLETED|Post Treatment Follow-up Phase||179
2238027|NCT02614183|5488666|P1|COMPLETED|Post Treatment Follow-up Phase||354
2238028|NCT02614183|5488664|P3|Safety Population|Post Treatment Follow-up Phase|Two participants who received only 240mg loading dose prior to discontinuation moved to this group.|185
2238029|NCT02614183|5488665|P2|Safety Population|Post Treatment Follow-up Phase||183
2238030|NCT02614183|5488666|P1|Safety Population|Post Treatment Follow-up Phase||372
2238031|NCT02614183|5488664|P3|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|183
2238115|NCT02613403|5488887|P4|Treated|Overall Study||13
2238032|NCT02614183|5488665|P2|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|185
2238033|NCT02614183|5488666|P1|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|372
2238034|NCT02614183|5488664|P3|NOT COMPLETED|Double Blind Treatment Phase||39
2238035|NCT02614183|5488665|P2|NOT COMPLETED|Double Blind Treatment Phase||37
2238036|NCT02614183|5488666|P1|NOT COMPLETED|Double Blind Treatment Phase||83
2238037|NCT02614183|5488664|P3|COMPLETED|Double Blind Treatment Phase||175
2238038|NCT02614183|5488665|P2|COMPLETED|Double Blind Treatment Phase||177
2238039|NCT02614183|5488666|P1|COMPLETED|Double Blind Treatment Phase||351
2238040|NCT02614183|5488664|P3|Safety Population|Double Blind Treatment Phase|Eight pts discontinued after loading dose of 240mg galcanezumab in 120mg group moved to this group.|220
2238041|NCT02614183|5488665|P2|Safety Population|Double Blind Treatment Phase|One pt randomized to placebo received galcanezumab 120mg due to dosing error moved to this group.|206
2238042|NCT02614183|5488666|P1|Safety Population|Double Blind Treatment Phase||432
2238043|NCT02614183|5488664|P3|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||212
2238044|NCT02614183|5488665|P2|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||213
2238045|NCT02614183|5488666|P1|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||433
2238046|NCT02614183|5488664|P3|STARTED|Double Blind Treatment Phase||214
2238047|NCT02614183|5488665|P2|STARTED|Double Blind Treatment Phase||214
2238048|NCT02614183|5488666|P1|STARTED|Double Blind Treatment Phase||434
2238049|NCT02614131|5488710|P7|NOT COMPLETED|Overall Study||1
2238050|NCT02614131|5488711|P6|NOT COMPLETED|Overall Study||0
2238051|NCT02614131|5488712|P5|NOT COMPLETED|Overall Study||0
2238052|NCT02614131|5488713|P4|NOT COMPLETED|Overall Study||0
2238053|NCT02614131|5488714|P3|NOT COMPLETED|Overall Study||0
2238054|NCT02614131|5488715|P2|NOT COMPLETED|Overall Study||0
2238055|NCT02614131|5488716|P1|NOT COMPLETED|Overall Study||1
2238056|NCT02614131|5488710|P7|COMPLETED|Overall Study||4
2238057|NCT02614131|5488711|P6|COMPLETED|Overall Study||2
2238058|NCT02614131|5488712|P5|COMPLETED|Overall Study||8
2238059|NCT02614131|5488713|P4|COMPLETED|Overall Study||8
2238060|NCT02614131|5488714|P3|COMPLETED|Overall Study||8
2238061|NCT02614131|5488715|P2|COMPLETED|Overall Study||8
2238062|NCT02614131|5488716|P1|COMPLETED|Overall Study||10
2238063|NCT02614131|5488710|P7|Received at Least One Dose of Drug|Overall Study||5
2238064|NCT02614131|5488711|P6|Received at Least One Dose of Drug|Overall Study||2
2238065|NCT02614131|5488712|P5|Received at Least One Dose of Drug|Overall Study||8
2238066|NCT02614131|5488713|P4|Received at Least One Dose of Drug|Overall Study||8
2238067|NCT02614131|5488714|P3|Received at Least One Dose of Drug|Overall Study||8
2238068|NCT02614131|5488715|P2|Received at Least One Dose of Drug|Overall Study||8
2238069|NCT02614131|5488716|P1|Received at Least One Dose of Drug|Overall Study||11
2238070|NCT02614131|5488710|P7|STARTED|Overall Study||5
2238071|NCT02614131|5488711|P6|STARTED|Overall Study||2
2238072|NCT02614131|5488712|P5|STARTED|Overall Study||8
2238073|NCT02614131|5488713|P4|STARTED|Overall Study||8
2238074|NCT02614131|5488714|P3|STARTED|Overall Study||8
2238075|NCT02614131|5488715|P2|STARTED|Overall Study||8
2238076|NCT02614131|5488716|P1|STARTED|Overall Study||11
2238077|NCT02614079|5488747|P1|NOT COMPLETED|Overall Study||1
2238078|NCT02614079|5488747|P1|COMPLETED|Overall Study|1 participant withdrew from the study prior to completion of DSSEP testing|5
2238079|NCT02614079|5488747|P1|STARTED|Overall Study||6
2238080|NCT02613910|5488751|P1|NOT COMPLETED|Overall Study||1
2238081|NCT02613910|5488751|P1|COMPLETED|Overall Study||0
2238082|NCT02613910|5488751|P1|STARTED|Overall Study||1
2238083|NCT02613897|5488803|P3|NOT COMPLETED|Overall Study||0
2238084|NCT02613897|5488804|P2|NOT COMPLETED|Overall Study||0
2238085|NCT02613897|5488805|P1|NOT COMPLETED|Overall Study||0
2238086|NCT02613897|5488803|P3|COMPLETED|Overall Study||12
2238087|NCT02613897|5488804|P2|COMPLETED|Overall Study||22
2238088|NCT02613897|5488805|P1|COMPLETED|Overall Study||22
2238089|NCT02613897|5488803|P3|STARTED|Overall Study||12
2238090|NCT02613897|5488804|P2|STARTED|Overall Study||22
2238091|NCT02613897|5488805|P1|STARTED|Overall Study||22
2238092|NCT02613871|5488837|P1|NOT COMPLETED|Overall Study||3
2238093|NCT02613871|5488837|P1|COMPLETED|Overall Study||108
2238094|NCT02613871|5488837|P1|STARTED|Overall Study||111
2238095|NCT02613507|5488858|P2|NOT COMPLETED|Overall Study||164
2238096|NCT02613507|5488859|P1|NOT COMPLETED|Overall Study||288
2238097|NCT02613507|5488858|P2|COMPLETED|Overall Study||2
2238098|NCT02613507|5488859|P1|COMPLETED|Overall Study||50
2238099|NCT02613507|5488858|P2|STARTED|Overall Study||166
2238100|NCT02613507|5488859|P1|STARTED|Overall Study||338
2238101|NCT02613481|5488875|P1|NOT COMPLETED|Overall Study||9
2238102|NCT02613481|5488875|P1|COMPLETED|Overall Study||41
2238103|NCT02613481|5488875|P1|STARTED|Overall Study||50
2238104|NCT02613403|5488886|P5|NOT COMPLETED|Overall Study||0
2238105|NCT02613403|5488887|P4|NOT COMPLETED|Overall Study||0
2238106|NCT02613403|5488888|P3|NOT COMPLETED|Overall Study||0
2238107|NCT02613403|5488889|P2|NOT COMPLETED|Overall Study||1
2238108|NCT02613403|5488890|P1|NOT COMPLETED|Overall Study||2
2238109|NCT02613403|5488886|P5|COMPLETED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
2238110|NCT02613403|5488887|P4|COMPLETED|Overall Study||13
2238111|NCT02613403|5488888|P3|COMPLETED|Overall Study||9
2238112|NCT02613403|5488889|P2|COMPLETED|Overall Study||35
2238113|NCT02613403|5488890|P1|COMPLETED|Overall Study||34
2238114|NCT02613403|5488886|P5|Treated|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
2238116|NCT02613403|5488888|P3|Treated|Overall Study||9
2238117|NCT02613403|5488889|P2|Treated|Overall Study||36
2238118|NCT02613403|5488890|P1|Treated|Overall Study||35
2238119|NCT02613403|5488886|P5|STARTED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
2238120|NCT02613403|5488887|P4|STARTED|Overall Study||13
2238121|NCT02613403|5488888|P3|STARTED|Overall Study||9
2238122|NCT02613403|5488889|P2|STARTED|Overall Study||36
2238123|NCT02613403|5488890|P1|STARTED|Overall Study||36
2238124|NCT02613338|5488932|P1|NOT COMPLETED|Overall Study||0
2238125|NCT02613338|5488932|P1|COMPLETED|Overall Study||30
2238126|NCT02613338|5488932|P1|STARTED|Overall Study||30
2238127|NCT02613221|5488942|P1|NOT COMPLETED|Overall Study||55
2238128|NCT02613221|5488942|P1|COMPLETED|Overall Study||1
2238129|NCT02613221|5488942|P1|Safety Population: Received Study Drug|Overall Study||55
2238130|NCT02613221|5488942|P1|STARTED|Overall Study||56
2238134|NCT02613182|5488968|P1|NOT COMPLETED|Overall Study||34
2238135|NCT02613182|5488968|P1|COMPLETED|Overall Study||0
2238136|NCT02613182|5488968|P1|Number of Patients Dosed|Overall Study||34
2238137|NCT02613182|5488968|P1|STARTED|Overall Study||34
2238138|NCT02612909|5488977|P5|NOT COMPLETED|Phase 3||0
2238139|NCT02612909|5488978|P4|NOT COMPLETED|Phase 3||1
2238140|NCT02612909|5488979|P3|NOT COMPLETED|Phase 3||0
2238141|NCT02612909|5488980|P2|NOT COMPLETED|Phase 3||0
2238142|NCT02612909|5488981|P1|NOT COMPLETED|Phase 3||0
2238143|NCT02612909|5488977|P5|COMPLETED|Phase 3||525
2238144|NCT02612909|5488978|P4|COMPLETED|Phase 3||104
2238145|NCT02612909|5488979|P3|COMPLETED|Phase 3||0
2238146|NCT02612909|5488980|P2|COMPLETED|Phase 3||0
2238147|NCT02612909|5488981|P1|COMPLETED|Phase 3||0
2238148|NCT02612909|5488977|P5|Completed Day 43 Clinic Visit|Phase 3||524
2238149|NCT02612909|5488978|P4|Completed Day 43 Clinic Visit|Phase 3||104
2238150|NCT02612909|5488979|P3|Completed Day 43 Clinic Visit|Phase 3||0
2238151|NCT02612909|5488980|P2|Completed Day 43 Clinic Visit|Phase 3||0
2238152|NCT02612909|5488981|P1|Completed Day 43 Clinic Visit|Phase 3||0
2238153|NCT02612909|5488977|P5|Completed Day 29 Clinic Visit|Phase 3||525
2238154|NCT02612909|5488978|P4|Completed Day 29 Clinic Visit|Phase 3||104
2238155|NCT02612909|5488979|P3|Completed Day 29 Clinic Visit|Phase 3||0
2238156|NCT02612909|5488980|P2|Completed Day 29 Clinic Visit|Phase 3||0
2238157|NCT02612909|5488981|P1|Completed Day 29 Clinic Visit|Phase 3||0
2238158|NCT02612909|5488977|P5|Received Injection 2|Phase 3||520
2238159|NCT02612909|5488978|P4|Received Injection 2|Phase 3||103
2238160|NCT02612909|5488979|P3|Received Injection 2|Phase 3||0
2238161|NCT02612909|5488980|P2|Received Injection 2|Phase 3||0
2238162|NCT02612909|5488981|P1|Received Injection 2|Phase 3||0
2238163|NCT02612909|5488977|P5|Received Injection 1|Phase 3||525
2238164|NCT02612909|5488978|P4|Received Injection 1|Phase 3||105
2238165|NCT02612909|5488979|P3|Received Injection 1|Phase 3||0
2238166|NCT02612909|5488980|P2|Received Injection 1|Phase 3||0
2238167|NCT02612909|5488981|P1|Received Injection 1|Phase 3||0
2238168|NCT02612909|5488977|P5|STARTED|Phase 3||525
2238169|NCT02612909|5488978|P4|STARTED|Phase 3||105
2238170|NCT02612909|5488979|P3|STARTED|Phase 3||0
2238171|NCT02612909|5488980|P2|STARTED|Phase 3||0
2238172|NCT02612909|5488981|P1|STARTED|Phase 3||0
2238173|NCT02612909|5488977|P5|NOT COMPLETED|Phase 2||0
2238174|NCT02612909|5488978|P4|NOT COMPLETED|Phase 2||0
2238175|NCT02612909|5488979|P3|NOT COMPLETED|Phase 2||1
2238176|NCT02612909|5488980|P2|NOT COMPLETED|Phase 2||5
2238177|NCT02612909|5488981|P1|NOT COMPLETED|Phase 2||2
2238178|NCT02612909|5488977|P5|COMPLETED|Phase 2||0
2238179|NCT02612909|5488978|P4|COMPLETED|Phase 2||0
2238180|NCT02612909|5488979|P3|COMPLETED|Phase 2||99
2238181|NCT02612909|5488980|P2|COMPLETED|Phase 2||95
2238182|NCT02612909|5488981|P1|COMPLETED|Phase 2||98
2238183|NCT02612909|5488977|P5|Completed Day 43 Clinic Visit|Phase 2||0
2238184|NCT02612909|5488978|P4|Completed Day 43 Clinic Visit|Phase 2||0
2238185|NCT02612909|5488979|P3|Completed Day 43 Clinic Visit|Phase 2||99
2238186|NCT02612909|5488980|P2|Completed Day 43 Clinic Visit|Phase 2||94
2238187|NCT02612909|5488981|P1|Completed Day 43 Clinic Visit|Phase 2||97
2238188|NCT02612909|5488977|P5|Completed Day 29 Clinic Visit|Phase 2||0
2238189|NCT02612909|5488978|P4|Completed Day 29 Clinic Visit|Phase 2||0
2238190|NCT02612909|5488979|P3|Completed Day 29 Clinic Visit|Phase 2||99
2238191|NCT02612909|5488980|P2|Completed Day 29 Clinic Visit|Phase 2||95
2238192|NCT02612909|5488981|P1|Completed Day 29 Clinic Visit|Phase 2||98
2238193|NCT02612909|5488977|P5|Received Injection 2|Phase 2||0
2238194|NCT02612909|5488978|P4|Received Injection 2|Phase 2||0
2238195|NCT02612909|5488979|P3|Received Injection 2|Phase 2||99
2238196|NCT02612909|5488980|P2|Received Injection 2|Phase 2||95
2238197|NCT02612909|5488981|P1|Received Injection 2|Phase 2||98
2238198|NCT02612909|5488977|P5|Received Injection 1|Phase 2||0
2238199|NCT02612909|5488978|P4|Received Injection 1|Phase 2||0
2238200|NCT02612909|5488979|P3|Received Injection 1|Phase 2||100
2238201|NCT02612909|5488980|P2|Received Injection 1|Phase 2||100
2238202|NCT02612909|5488981|P1|Received Injection 1|Phase 2||100
2238203|NCT02612909|5488977|P5|STARTED|Phase 2||0
2238204|NCT02612909|5488978|P4|STARTED|Phase 2||0
2238205|NCT02612909|5488979|P3|STARTED|Phase 2||100
2238206|NCT02612909|5488980|P2|STARTED|Phase 2||100
2238207|NCT02612909|5488981|P1|STARTED|Phase 2||100
2238208|NCT02612857|5489049|P3|NOT COMPLETED|Overall Study||4
2238209|NCT02612857|5489050|P2|NOT COMPLETED|Overall Study||4
2238210|NCT02612857|5489051|P1|NOT COMPLETED|Overall Study||3
2238211|NCT02612857|5489049|P3|COMPLETED|Overall Study||6
2238212|NCT02612857|5489050|P2|COMPLETED|Overall Study||5
2238213|NCT02612857|5489051|P1|COMPLETED|Overall Study||8
2238214|NCT02612857|5489049|P3|STARTED|Overall Study||10
2238215|NCT02612857|5489050|P2|STARTED|Overall Study||9
2238216|NCT02612857|5489051|P1|STARTED|Overall Study||11
2238217|NCT02612727|5489064|P2|NOT COMPLETED|Overall Study||4
2238218|NCT02612727|5489065|P1|NOT COMPLETED|Overall Study||5
2238219|NCT02612727|5489064|P2|COMPLETED|Overall Study||83
2238220|NCT02612727|5489065|P1|COMPLETED|Overall Study||82
2238221|NCT02612727|5489064|P2|STARTED|Overall Study||87
2238222|NCT02612727|5489065|P1|STARTED|Overall Study||87
2238223|NCT02612623|5489077|P4|NOT COMPLETED|Overall Study||0
2238224|NCT02612623|5489078|P3|NOT COMPLETED|Overall Study||1
2238225|NCT02612623|5489079|P2|NOT COMPLETED|Overall Study||1
2238226|NCT02612623|5489080|P1|NOT COMPLETED|Overall Study||1
2238227|NCT02612623|5489077|P4|COMPLETED|Overall Study||4
2238228|NCT02612623|5489078|P3|COMPLETED|Overall Study||5
2238229|NCT02612623|5489079|P2|COMPLETED|Overall Study||5
2238230|NCT02612623|5489080|P1|COMPLETED|Overall Study||7
2238231|NCT02612623|5489077|P4|Treated|Overall Study||4
2238232|NCT02612623|5489078|P3|Treated|Overall Study||6
2238233|NCT02612623|5489079|P2|Treated|Overall Study||5
2238234|NCT02612623|5489080|P1|Treated|Overall Study||8
2238235|NCT02612623|5489077|P4|STARTED|Overall Study||4
2238236|NCT02612623|5489078|P3|STARTED|Overall Study||6
2238237|NCT02612623|5489079|P2|STARTED|Overall Study||6
2238238|NCT02612623|5489080|P1|STARTED|Overall Study||8
2238239|NCT02612610|5489094|P4|NOT COMPLETED|Overall Study||13
2238240|NCT02612610|5489095|P3|NOT COMPLETED|Overall Study||5
2238241|NCT02612610|5489096|P2|NOT COMPLETED|Overall Study||8
2238242|NCT02612610|5489097|P1|NOT COMPLETED|Overall Study||5
2238243|NCT02612610|5489094|P4|COMPLETED|Overall Study||50
2238244|NCT02612610|5489095|P3|COMPLETED|Overall Study||58
2238245|NCT02612610|5489096|P2|COMPLETED|Overall Study||56
2238246|NCT02612610|5489097|P1|COMPLETED|Overall Study||58
2238247|NCT02612610|5489094|P4|Treated|Overall Study||63
2238248|NCT02612610|5489095|P3|Treated|Overall Study||63
2238249|NCT02612610|5489096|P2|Treated|Overall Study||63
2238250|NCT02612610|5489097|P1|Treated|Overall Study||63
2238251|NCT02612610|5489094|P4|STARTED|Overall Study||63
2238252|NCT02612610|5489095|P3|STARTED|Overall Study||63
2238253|NCT02612610|5489096|P2|STARTED|Overall Study||64
2238254|NCT02612610|5489097|P1|STARTED|Overall Study||63
2238255|NCT02612428|5489341|P2|NOT COMPLETED|VTL-308E||7
2238256|NCT02612428|5489342|P1|NOT COMPLETED|VTL-308E||11
2238257|NCT02612428|5489341|P2|COMPLETED|VTL-308E||49
2238258|NCT02612428|5489342|P1|COMPLETED|VTL-308E||53
2238259|NCT02612428|5489341|P2|STARTED|VTL-308E||56
2238260|NCT02612428|5489342|P1|STARTED|VTL-308E||64
2238261|NCT02612428|5489341|P2|NOT COMPLETED|VTL-308||17
2238262|NCT02612428|5489342|P1|NOT COMPLETED|VTL-308||14
2238263|NCT02612428|5489341|P2|COMPLETED|VTL-308||56
2238264|NCT02612428|5489342|P1|COMPLETED|VTL-308||64
2238265|NCT02612428|5489341|P2|STARTED|VTL-308||73
2238266|NCT02612428|5489342|P1|STARTED|VTL-308||78
2238267|NCT02612285|5489352|P1|NOT COMPLETED|Overall Study||1
2238268|NCT02612285|5489352|P1|COMPLETED|Overall Study|Subject did not complete Cycle 1; no data points recorded|0
2238269|NCT02612285|5489352|P1|STARTED|Overall Study||1
2238270|NCT02612077|5489356|P1|NOT COMPLETED|Overall Study||466
2238271|NCT02612077|5489356|P1|COMPLETED|Overall Study||299
2238272|NCT02612077|5489356|P1|Efficacy Analysis Set|Overall Study||737
2238273|NCT02612077|5489356|P1|Safety Analysis Set|Overall Study||760
2238274|NCT02612077|5489356|P1|Did Not Receive Study Product|Overall Study||5
2238275|NCT02612077|5489356|P1|STARTED|Overall Study||765
2238276|NCT02612064|5489368|P2|NOT COMPLETED|Overall Study||3
2238277|NCT02612064|5489369|P1|NOT COMPLETED|Overall Study||1
2238278|NCT02612064|5489368|P2|COMPLETED|Overall Study||112
2238279|NCT02612064|5489369|P1|COMPLETED|Overall Study||114
2238280|NCT02612064|5489368|P2|STARTED|Overall Study||115
2238281|NCT02612064|5489369|P1|STARTED|Overall Study||115
2238282|NCT02611830|5489383|P4|NOT COMPLETED|Maintenance Phase||15
2238283|NCT02611830|5489384|P3|NOT COMPLETED|Maintenance Phase||31
2238284|NCT02611830|5489385|P2|NOT COMPLETED|Maintenance Phase||36
2238285|NCT02611830|5489386|P1|NOT COMPLETED|Maintenance Phase||0
2238286|NCT02611830|5489383|P4|COMPLETED|Maintenance Phase||39
2238287|NCT02611830|5489384|P3|COMPLETED|Maintenance Phase||75
2238288|NCT02611830|5489385|P2|COMPLETED|Maintenance Phase||20
2238289|NCT02611830|5489386|P1|COMPLETED|Maintenance Phase||0
2238290|NCT02611830|5489383|P4|STARTED|Maintenance Phase||54
2238291|NCT02611830|5489384|P3|STARTED|Maintenance Phase||106
2238292|NCT02611830|5489385|P2|STARTED|Maintenance Phase||56
2238293|NCT02611830|5489386|P1|STARTED|Maintenance Phase||0
2238294|NCT02611830|5489383|P4|NOT COMPLETED|OL Induction Phase||0
2238295|NCT02611830|5489384|P3|NOT COMPLETED|OL Induction Phase||0
2238296|NCT02611830|5489385|P2|NOT COMPLETED|OL Induction Phase||0
2238297|NCT02611830|5489386|P1|NOT COMPLETED|OL Induction Phase||30
2238298|NCT02611830|5489383|P4|COMPLETED|OL Induction Phase||0
2238299|NCT02611830|5489384|P3|COMPLETED|OL Induction Phase||0
2238300|NCT02611830|5489385|P2|COMPLETED|OL Induction Phase||0
2238301|NCT02611830|5489386|P1|COMPLETED|OL Induction Phase||353
2238302|NCT02611830|5489383|P4|STARTED|OL Induction Phase||0
2238303|NCT02611830|5489384|P3|STARTED|OL Induction Phase||0
2238304|NCT02611830|5489385|P2|STARTED|OL Induction Phase||0
2238305|NCT02611830|5489386|P1|STARTED|OL Induction Phase||383
2238306|NCT02611765|5489409|P2|NOT COMPLETED|Overall Study||6
2238307|NCT02611765|5489410|P1|NOT COMPLETED|Overall Study||2
2238308|NCT02611765|5489409|P2|COMPLETED|Overall Study||29
2238309|NCT02611765|5489410|P1|COMPLETED|Overall Study||27
2238310|NCT02611765|5489409|P2|STARTED|Overall Study||35
2238311|NCT02611765|5489410|P1|STARTED|Overall Study||29
2238312|NCT02611752|5489418|P2|NOT COMPLETED|Overall Study||1
2238313|NCT02611752|5489419|P1|NOT COMPLETED|Overall Study||0
2238314|NCT02611752|5489418|P2|COMPLETED|Overall Study||24
2238315|NCT02611752|5489419|P1|COMPLETED|Overall Study||22
2238316|NCT02611752|5489418|P2|Day11-13 Hydromorphone Challenge Injs|Overall Study||24
2238317|NCT02611752|5489419|P1|Day11-13 Hydromorphone Challenge Injs|Overall Study||22
2238318|NCT02611752|5489418|P2|Day 8-10 Hydromorphone Challenge Injs|Overall Study||24
2238319|NCT02611752|5489419|P1|Day 8-10 Hydromorphone Challenge Injs|Overall Study||22
2238320|NCT02611752|5489418|P2|Day 4-6 Hydromorphone Challenge Injs|Overall Study||24
2238321|NCT02611752|5489419|P1|Day 4-6 Hydromorphone Challenge Injs|Overall Study||22
2238322|NCT02611752|5489418|P2|Day 1-3 Hydromorphone Challenge Injs|Overall Study||25
2238323|NCT02611752|5489419|P1|Day 1-3 Hydromorphone Challenge Injs|Overall Study||22
2238324|NCT02611752|5489418|P2|STARTED|Overall Study||25
2238325|NCT02611752|5489419|P1|STARTED|Overall Study||22
2238326|NCT02611479|5489451|P1|NOT COMPLETED|Data Cleaning||2
2238327|NCT02611479|5489451|P1|COMPLETED|Data Cleaning||149
2238328|NCT02611479|5489451|P1|STARTED|Data Cleaning||151
2238329|NCT02611479|5489451|P1|NOT COMPLETED|Post-Surgery Follow-up at 1-Year||18
2238330|NCT02611479|5489451|P1|COMPLETED|Post-Surgery Follow-up at 1-Year||151
2238331|NCT02611479|5489451|P1|STARTED|Post-Surgery Follow-up at 1-Year||169
2238332|NCT02611479|5489451|P1|NOT COMPLETED|Post-Surgery Follow-up at 30-90 Days||2
2238333|NCT02611479|5489451|P1|COMPLETED|Post-Surgery Follow-up at 30-90 Days||169
2238334|NCT02611479|5489451|P1|STARTED|Post-Surgery Follow-up at 30-90 Days||171
2238335|NCT02611479|5489451|P1|NOT COMPLETED|Baseline Enrollment||13
2238336|NCT02611479|5489451|P1|COMPLETED|Baseline Enrollment||171
2238337|NCT02611479|5489451|P1|STARTED|Baseline Enrollment||184
2238338|NCT02611154|5489455|P1|NOT COMPLETED|Overall Study||0
2238339|NCT02611154|5489455|P1|COMPLETED|Overall Study||5
2238340|NCT02611154|5489455|P1|STARTED|Overall Study||5
2238341|NCT02610972|5489476|P2|NOT COMPLETED|Overall Study||0
2238342|NCT02610972|5489477|P1|NOT COMPLETED|Overall Study||0
2238343|NCT02610972|5489476|P2|COMPLETED|Overall Study||50
2238344|NCT02610972|5489477|P1|COMPLETED|Overall Study||100
2238345|NCT02610972|5489476|P2|STARTED|Overall Study||50
2238346|NCT02610972|5489477|P1|STARTED|Overall Study||100
2238347|NCT02610868|5489483|P1|NOT COMPLETED|MYOBLOC: Treatment Session 4||2
2238348|NCT02610868|5489483|P1|COMPLETED|MYOBLOC: Treatment Session 4||22
2238349|NCT02610868|5489483|P1|STARTED|MYOBLOC: Treatment Session 4||24
2238350|NCT02610868|5489483|P1|NOT COMPLETED|MYOBLOC: Treatment Session 3||7
2238351|NCT02610868|5489483|P1|COMPLETED|MYOBLOC: Treatment Session 3||43
2238352|NCT02610868|5489483|P1|STARTED|MYOBLOC: Treatment Session 3||50
2238353|NCT02610868|5489483|P1|NOT COMPLETED|MYOBLOC: Treatment Session 2||12
2238354|NCT02610868|5489483|P1|COMPLETED|MYOBLOC: Treatment Session 2||165
2238355|NCT02610868|5489483|P1|STARTED|MYOBLOC: Treatment Session 2||177
2238356|NCT02610868|5489483|P1|NOT COMPLETED|MYOBLOC: Treatment Session 1||7
2238357|NCT02610868|5489483|P1|COMPLETED|MYOBLOC: Treatment Session 1||180
2238358|NCT02610868|5489483|P1|STARTED|MYOBLOC: Treatment Session 1||187
2238359|NCT02610842|5489583|P1|NOT COMPLETED|Overall Study||5
2238360|NCT02610842|5489583|P1|COMPLETED|Overall Study||22
2238361|NCT02610842|5489583|P1|STARTED|Overall Study||27
2238362|NCT02610816|5489592|P4|NOT COMPLETED|Phase 2||6
2238363|NCT02610816|5489593|P3|NOT COMPLETED|Phase 2||11
2238364|NCT02610816|5489594|P2|NOT COMPLETED|Phase 2||0
2238365|NCT02610816|5489595|P1|NOT COMPLETED|Phase 2||0
2238366|NCT02610816|5489592|P4|COMPLETED|Phase 2||4
2238367|NCT02610816|5489593|P3|COMPLETED|Phase 2||8
2238368|NCT02610816|5489594|P2|COMPLETED|Phase 2||0
2238369|NCT02610816|5489595|P1|COMPLETED|Phase 2||0
2238370|NCT02610816|5489592|P4|STARTED|Phase 2||10
2238371|NCT02610816|5489593|P3|STARTED|Phase 2||19
2238372|NCT02610816|5489594|P2|STARTED|Phase 2||0
2238373|NCT02610816|5489595|P1|STARTED|Phase 2||0
2238374|NCT02610816|5489592|P4|NOT COMPLETED|Phase 1||0
2238375|NCT02610816|5489593|P3|NOT COMPLETED|Phase 1||0
2238376|NCT02610816|5489594|P2|NOT COMPLETED|Phase 1||8
2238377|NCT02610816|5489595|P1|NOT COMPLETED|Phase 1||4
2238378|NCT02610816|5489592|P4|COMPLETED|Phase 1||0
2238379|NCT02610816|5489593|P3|COMPLETED|Phase 1||0
2238380|NCT02610816|5489594|P2|COMPLETED|Phase 1||17
2238381|NCT02610816|5489595|P1|COMPLETED|Phase 1||34
2238382|NCT02610816|5489592|P4|STARTED|Phase 1||0
2238383|NCT02610816|5489593|P3|STARTED|Phase 1||0
2238384|NCT02610816|5489594|P2|STARTED|Phase 1||25
2238385|NCT02610816|5489595|P1|STARTED|Phase 1||38
2238386|NCT02610725|5489616|P1|NOT COMPLETED|Overall Study||206
2238387|NCT02610725|5489616|P1|COMPLETED|Overall Study||75
2238388|NCT02610725|5489616|P1|STARTED|Overall Study||281
2238389|NCT02610634|5489624|P2|NOT COMPLETED|Overall Study||0
2238390|NCT02610634|5489625|P1|NOT COMPLETED|Overall Study||0
2238391|NCT02610634|5489624|P2|COMPLETED|Overall Study||40
2238392|NCT02610634|5489625|P1|COMPLETED|Overall Study||60
2238393|NCT02610634|5489624|P2|STARTED|Overall Study||40
2238394|NCT02610634|5489625|P1|STARTED|Overall Study||60
2238395|NCT02610231|5489631|P1|NOT COMPLETED|Overall Study||60
2238396|NCT02610231|5489631|P1|COMPLETED|Overall Study||179
2238397|NCT02610231|5489631|P1|STARTED|Overall Study||239
2238398|NCT02610192|5489638|P1|NOT COMPLETED|Overall Study||9
2238399|NCT02610192|5489638|P1|COMPLETED|Overall Study||41
2238400|NCT02610192|5489638|P1|STARTED|Overall Study|52 subjects had signed consent form, but 50 subjects have been treated. 2 subjects became SF.|50
2238401|NCT02609841|5489653|P1|NOT COMPLETED|Overall Study||28
2238402|NCT02609841|5489653|P1|COMPLETED|Overall Study||212
2238403|NCT02609841|5489653|P1|STARTED|Overall Study||240
2238404|NCT02609672|5489661|P2|NOT COMPLETED|Overall Study||1
2238405|NCT02609672|5489662|P1|NOT COMPLETED|Overall Study||3
2238406|NCT02609672|5489661|P2|COMPLETED|Overall Study||11
2238407|NCT02609672|5489662|P1|COMPLETED|Overall Study||9
2238408|NCT02609672|5489661|P2|STARTED|Overall Study||12
2238409|NCT02609672|5489662|P1|STARTED|Overall Study||12
2238410|NCT02609659|5489696|P1|NOT COMPLETED|Overall Study||8
2238411|NCT02609659|5489696|P1|COMPLETED|Overall Study||97
2238412|NCT02609659|5489696|P1|STARTED|Overall Study||105
2238413|NCT02609633|5489706|P2|NOT COMPLETED|Overall Study||2
2238414|NCT02609633|5489707|P1|NOT COMPLETED|Overall Study||5
2238415|NCT02609633|5489706|P2|COMPLETED|Overall Study||54
2238416|NCT02609633|5489707|P1|COMPLETED|Overall Study||37
2238417|NCT02609633|5489706|P2|Full Analysis Set (FAS)|Overall Study||46
2238418|NCT02609633|5489707|P1|Full Analysis Set (FAS)|Overall Study||32
2238419|NCT02609633|5489706|P2|STARTED|Overall Study||56
2238420|NCT02609633|5489707|P1|STARTED|Overall Study||42
2238421|NCT02609607|5489734|P2|NOT COMPLETED|Overall Study||1
2238422|NCT02609607|5489735|P1|NOT COMPLETED|Overall Study||0
2238423|NCT02609607|5489734|P2|COMPLETED|Overall Study||4
2238424|NCT02609607|5489735|P1|COMPLETED|Overall Study||6
2238425|NCT02609607|5489734|P2|STARTED|Overall Study||5
2238426|NCT02609607|5489735|P1|STARTED|Overall Study||6
2238427|NCT02609399|5489759|P2|NOT COMPLETED|Influenza Season 2016-2017||5
2238428|NCT02609399|5489760|P1|NOT COMPLETED|Influenza Season 2016-2017||9
2238429|NCT02609399|5489759|P2|COMPLETED|Influenza Season 2016-2017||59
2238430|NCT02609399|5489760|P1|COMPLETED|Influenza Season 2016-2017||49
2238431|NCT02609399|5489759|P2|STARTED|Influenza Season 2016-2017||64
2238432|NCT02609399|5489760|P1|STARTED|Influenza Season 2016-2017||58
2238433|NCT02609399|5489759|P2|NOT COMPLETED|Influenza Season 2015-2016||2
2238434|NCT02609399|5489760|P1|NOT COMPLETED|Influenza Season 2015-2016||3
2238435|NCT02609399|5489759|P2|COMPLETED|Influenza Season 2015-2016||29
2238436|NCT02609399|5489760|P1|COMPLETED|Influenza Season 2015-2016||24
2238437|NCT02609399|5489759|P2|STARTED|Influenza Season 2015-2016||31
2238438|NCT02609399|5489760|P1|STARTED|Influenza Season 2015-2016||27
2238439|NCT02609308|5489774|P2|NOT COMPLETED|Overall Study||0
2238440|NCT02609308|5489775|P1|NOT COMPLETED|Overall Study||0
2238441|NCT02609308|5489774|P2|COMPLETED|Overall Study||11
2238442|NCT02609308|5489775|P1|COMPLETED|Overall Study||10
2238443|NCT02609308|5489774|P2|STARTED|Overall Study||11
2238444|NCT02609308|5489775|P1|STARTED|Overall Study||10
2238445|NCT02609204|5489785|P1|NOT COMPLETED|Overall Study||0
2238446|NCT02609204|5489785|P1|COMPLETED|Overall Study||51
2238447|NCT02609204|5489785|P1|STARTED|Overall Study||51
2238448|NCT02609178|5489790|P6|NOT COMPLETED|Third Crown||0
2238449|NCT02609178|5489791|P5|NOT COMPLETED|Third Crown||0
2238450|NCT02609178|5489792|P4|NOT COMPLETED|Third Crown||0
2238451|NCT02609178|5489793|P3|NOT COMPLETED|Third Crown||0
2238452|NCT02609178|5489794|P2|NOT COMPLETED|Third Crown||0
2238453|NCT02609178|5489795|P1|NOT COMPLETED|Third Crown||0
2238454|NCT02609178|5489790|P6|COMPLETED|Third Crown||2
2238455|NCT02609178|5489791|P5|COMPLETED|Third Crown||0
2238456|NCT02609178|5489792|P4|COMPLETED|Third Crown||2
2238457|NCT02609178|5489793|P3|COMPLETED|Third Crown||5
2238458|NCT02609178|5489794|P2|COMPLETED|Third Crown||1
2238459|NCT02609178|5489795|P1|COMPLETED|Third Crown||0
2238460|NCT02609178|5489790|P6|STARTED|Third Crown||2
2238461|NCT02609178|5489791|P5|STARTED|Third Crown||0
2238462|NCT02609178|5489792|P4|STARTED|Third Crown||2
2238463|NCT02609178|5489793|P3|STARTED|Third Crown||5
2238464|NCT02609178|5489794|P2|STARTED|Third Crown||1
2238465|NCT02609178|5489795|P1|STARTED|Third Crown||0
2238466|NCT02609178|5489790|P6|NOT COMPLETED|5-minute Washout Time||0
2238467|NCT02609178|5489791|P5|NOT COMPLETED|5-minute Washout Time||0
2238468|NCT02609178|5489792|P4|NOT COMPLETED|5-minute Washout Time||0
2238469|NCT02609178|5489793|P3|NOT COMPLETED|5-minute Washout Time||0
2238470|NCT02609178|5489794|P2|NOT COMPLETED|5-minute Washout Time||0
2238471|NCT02609178|5489795|P1|NOT COMPLETED|5-minute Washout Time||0
2238472|NCT02609178|5489790|P6|COMPLETED|5-minute Washout Time||2
2238473|NCT02609178|5489791|P5|COMPLETED|5-minute Washout Time||0
2238474|NCT02609178|5489792|P4|COMPLETED|5-minute Washout Time||2
2238475|NCT02609178|5489793|P3|COMPLETED|5-minute Washout Time||5
2238476|NCT02609178|5489794|P2|COMPLETED|5-minute Washout Time||1
2238477|NCT02609178|5489795|P1|COMPLETED|5-minute Washout Time||0
2238478|NCT02609178|5489790|P6|STARTED|5-minute Washout Time||2
2238479|NCT02609178|5489791|P5|STARTED|5-minute Washout Time||0
2238480|NCT02609178|5489792|P4|STARTED|5-minute Washout Time||2
2238481|NCT02609178|5489793|P3|STARTED|5-minute Washout Time||5
2238482|NCT02609178|5489794|P2|STARTED|5-minute Washout Time||1
2238483|NCT02609178|5489795|P1|STARTED|5-minute Washout Time||0
2238484|NCT02609178|5489790|P6|NOT COMPLETED|Second Crown||0
2238485|NCT02609178|5489791|P5|NOT COMPLETED|Second Crown||0
2238486|NCT02609178|5489792|P4|NOT COMPLETED|Second Crown||0
2238487|NCT02609178|5489793|P3|NOT COMPLETED|Second Crown||0
2238488|NCT02609178|5489794|P2|NOT COMPLETED|Second Crown||0
2238489|NCT02609178|5489795|P1|NOT COMPLETED|Second Crown||0
2238490|NCT02609178|5489790|P6|COMPLETED|Second Crown||2
2238491|NCT02609178|5489791|P5|COMPLETED|Second Crown||0
2238492|NCT02609178|5489792|P4|COMPLETED|Second Crown||2
2238493|NCT02609178|5489793|P3|COMPLETED|Second Crown||5
2238494|NCT02609178|5489794|P2|COMPLETED|Second Crown||1
2238495|NCT02609178|5489795|P1|COMPLETED|Second Crown||0
2238496|NCT02609178|5489790|P6|STARTED|Second Crown||2
2238497|NCT02609178|5489791|P5|STARTED|Second Crown||0
2238498|NCT02609178|5489792|P4|STARTED|Second Crown||2
2238499|NCT02609178|5489793|P3|STARTED|Second Crown||5
2238500|NCT02609178|5489794|P2|STARTED|Second Crown||1
2238501|NCT02609178|5489795|P1|STARTED|Second Crown||0
2238502|NCT02609178|5489790|P6|NOT COMPLETED|5-minute Washout Time||0
2238503|NCT02609178|5489791|P5|NOT COMPLETED|5-minute Washout Time||0
2238504|NCT02609178|5489792|P4|NOT COMPLETED|5-minute Washout Time||0
2238505|NCT02609178|5489793|P3|NOT COMPLETED|5-minute Washout Time||0
2238506|NCT02609178|5489794|P2|NOT COMPLETED|5-minute Washout Time||0
2238507|NCT02609178|5489795|P1|NOT COMPLETED|5-minute Washout Time||0
2238508|NCT02609178|5489790|P6|COMPLETED|5-minute Washout Time||2
2238509|NCT02609178|5489791|P5|COMPLETED|5-minute Washout Time||0
2238510|NCT02609178|5489792|P4|COMPLETED|5-minute Washout Time||2
2238511|NCT02609178|5489793|P3|COMPLETED|5-minute Washout Time||5
2238512|NCT02609178|5489794|P2|COMPLETED|5-minute Washout Time||1
2238513|NCT02609178|5489795|P1|COMPLETED|5-minute Washout Time||0
2238514|NCT02609178|5489790|P6|STARTED|5-minute Washout Time||2
2238515|NCT02609178|5489791|P5|STARTED|5-minute Washout Time||0
2238516|NCT02609178|5489792|P4|STARTED|5-minute Washout Time||2
2238517|NCT02609178|5489793|P3|STARTED|5-minute Washout Time||5
2238518|NCT02609178|5489794|P2|STARTED|5-minute Washout Time||1
2238519|NCT02609178|5489795|P1|STARTED|5-minute Washout Time||0
2238520|NCT02609178|5489790|P6|NOT COMPLETED|First Crown||0
2238521|NCT02609178|5489791|P5|NOT COMPLETED|First Crown||0
2238522|NCT02609178|5489792|P4|NOT COMPLETED|First Crown||1
2238523|NCT02609178|5489793|P3|NOT COMPLETED|First Crown||1
2238524|NCT02609178|5489794|P2|NOT COMPLETED|First Crown||0
2238525|NCT02609178|5489795|P1|NOT COMPLETED|First Crown||0
2238526|NCT02609178|5489790|P6|COMPLETED|First Crown||2
2238527|NCT02609178|5489791|P5|COMPLETED|First Crown||0
2238528|NCT02609178|5489792|P4|COMPLETED|First Crown||2
2238529|NCT02609178|5489793|P3|COMPLETED|First Crown||5
2238530|NCT02609178|5489794|P2|COMPLETED|First Crown||1
2238531|NCT02609178|5489795|P1|COMPLETED|First Crown||0
2238532|NCT02609178|5489790|P6|STARTED|First Crown||2
2238533|NCT02609178|5489791|P5|STARTED|First Crown||0
2238534|NCT02609178|5489792|P4|STARTED|First Crown||3
2238535|NCT02609178|5489793|P3|STARTED|First Crown||6
2238536|NCT02609178|5489794|P2|STARTED|First Crown||1
2238537|NCT02609178|5489795|P1|STARTED|First Crown||0
2238538|NCT02609113|5489812|P2|NOT COMPLETED|Overall Study||2
2238539|NCT02609113|5489813|P1|NOT COMPLETED|Overall Study||2
2238540|NCT02609113|5489812|P2|COMPLETED|Overall Study||9
2238541|NCT02609113|5489813|P1|COMPLETED|Overall Study||9
2238542|NCT02609113|5489812|P2|STARTED|Overall Study||11
2238543|NCT02609113|5489813|P1|STARTED|Overall Study||11
2238544|NCT02609100|5489827|P2|NOT COMPLETED|Overall Study||0
2238545|NCT02609100|5489828|P1|NOT COMPLETED|Overall Study||0
2238546|NCT02609100|5489827|P2|COMPLETED|Overall Study||2
2238547|NCT02609100|5489828|P1|COMPLETED|Overall Study||2
2238548|NCT02609100|5489827|P2|STARTED|Overall Study||2
2238549|NCT02609100|5489828|P1|STARTED|Overall Study||2
2238550|NCT02608892|5489846|P2|NOT COMPLETED|Overall Study||0
2238551|NCT02608892|5489847|P1|NOT COMPLETED|Overall Study||1
2238552|NCT02608892|5489846|P2|COMPLETED|Overall Study||49
2238553|NCT02608892|5489847|P1|COMPLETED|Overall Study||50
2238554|NCT02608892|5489846|P2|STARTED|Overall Study||49
2238555|NCT02608892|5489847|P1|STARTED|Overall Study||51
2238556|NCT02608489|5489858|P2|NOT COMPLETED|Overall Study||10
2238557|NCT02608489|5489859|P1|NOT COMPLETED|Overall Study||13
2238558|NCT02608489|5489858|P2|COMPLETED|Overall Study||33
2238559|NCT02608489|5489859|P1|COMPLETED|Overall Study||30
2238560|NCT02608489|5489858|P2|STARTED|Overall Study||43
2238561|NCT02608489|5489859|P1|STARTED|Overall Study||43
2238562|NCT02608177|5489881|P2|NOT COMPLETED|Overall Study||0
2238563|NCT02608177|5489882|P1|NOT COMPLETED|Overall Study||0
2238564|NCT02608177|5489881|P2|COMPLETED|Overall Study||1
2238565|NCT02608177|5489882|P1|COMPLETED|Overall Study||2
2238566|NCT02608177|5489881|P2|STARTED|Overall Study||1
2238567|NCT02608177|5489882|P1|STARTED|Overall Study||2
2238568|NCT02607956|5489904|P2|NOT COMPLETED|Overall Study||330
2238569|NCT02607956|5489905|P1|NOT COMPLETED|Overall Study||327
2238570|NCT02607956|5489904|P2|COMPLETED|Overall Study||0
2238571|NCT02607956|5489905|P1|COMPLETED|Overall Study||0
2238572|NCT02607956|5489904|P2|STARTED|Overall Study||330
2238573|NCT02607956|5489905|P1|STARTED|Overall Study||327
2238574|NCT02607930|5489927|P2|NOT COMPLETED|Overall Study||315
2238575|NCT02607930|5489928|P1|NOT COMPLETED|Overall Study||316
2238576|NCT02607930|5489927|P2|COMPLETED|Overall Study||0
2238577|NCT02607930|5489928|P1|COMPLETED|Overall Study||0
2238578|NCT02607930|5489927|P2|STARTED|Overall Study||315
2238579|NCT02607930|5489928|P1|STARTED|Overall Study||316
2238580|NCT02607800|5489962|P2|NOT COMPLETED|Overall Study||11
2238581|NCT02607800|5489963|P1|NOT COMPLETED|Overall Study||10
2238582|NCT02607800|5489962|P2|COMPLETED|Overall Study||430
2238583|NCT02607800|5489963|P1|COMPLETED|Overall Study||492
2238584|NCT02607800|5489962|P2|STARTED|Overall Study||441
2238585|NCT02607800|5489963|P1|STARTED|Overall Study||502
2238586|NCT02607735|5489981|P3|NOT COMPLETED|Deferred Treatment Substudy||5
2238587|NCT02607735|5489982|P2|NOT COMPLETED|Deferred Treatment Substudy||0
2238588|NCT02607735|5489983|P1|NOT COMPLETED|Deferred Treatment Substudy||0
2238589|NCT02607735|5489981|P3|COMPLETED|Deferred Treatment Substudy||142
2238590|NCT02607735|5489982|P2|COMPLETED|Deferred Treatment Substudy||0
2238591|NCT02607735|5489983|P1|COMPLETED|Deferred Treatment Substudy||0
2238592|NCT02607735|5489981|P3|STARTED|Deferred Treatment Substudy||147
2238593|NCT02607735|5489982|P2|STARTED|Deferred Treatment Substudy||0
2238594|NCT02607735|5489983|P1|STARTED|Deferred Treatment Substudy||0
2238595|NCT02607735|5489981|P3|NOT COMPLETED|Primary Study||0
2238596|NCT02607735|5489982|P2|NOT COMPLETED|Primary Study||0
2238597|NCT02607735|5489983|P1|NOT COMPLETED|Primary Study||7
2238598|NCT02607735|5489981|P3|COMPLETED|Primary Study||0
2238599|NCT02607735|5489982|P2|COMPLETED|Primary Study||152
2238600|NCT02607735|5489983|P1|COMPLETED|Primary Study||257
2238601|NCT02607735|5489981|P3|STARTED|Primary Study||0
2238602|NCT02607735|5489982|P2|STARTED|Primary Study||152
2238603|NCT02607735|5489983|P1|STARTED|Primary Study||264
2238604|NCT02607618|5490005|P2|NOT COMPLETED|Overall Study||2
2238605|NCT02607618|5490006|P1|NOT COMPLETED|Overall Study||11
2238606|NCT02607618|5490005|P2|COMPLETED|Overall Study||305
2238607|NCT02607618|5490006|P1|COMPLETED|Overall Study||295
2238608|NCT02607618|5490005|P2|STARTED|Overall Study||307
2238609|NCT02607618|5490006|P1|STARTED|Overall Study||306
2238619|NCT02607254|5490142|P3|NOT COMPLETED|Overall Study||0
2238620|NCT02607254|5490143|P2|NOT COMPLETED|Overall Study||0
2238621|NCT02607254|5490144|P1|NOT COMPLETED|Overall Study||0
2238622|NCT02607254|5490142|P3|COMPLETED|Overall Study||5
2238623|NCT02607254|5490143|P2|COMPLETED|Overall Study||3
2238624|NCT02607254|5490144|P1|COMPLETED|Overall Study||3
2238625|NCT02607254|5490142|P3|STARTED|Overall Study||5
2238626|NCT02607254|5490143|P2|STARTED|Overall Study||3
2238627|NCT02607254|5490144|P1|STARTED|Overall Study||3
2238628|NCT02606903|5490163|P2|NOT COMPLETED|Overall Study||0
2238629|NCT02606903|5490164|P1|NOT COMPLETED|Overall Study||0
2238630|NCT02606903|5490163|P2|COMPLETED|Overall Study||36
2238631|NCT02606903|5490164|P1|COMPLETED|Overall Study||35
2238632|NCT02606903|5490163|P2|STARTED|Overall Study||36
2238633|NCT02606903|5490164|P1|STARTED|Overall Study||35
2238634|NCT02606877|5490178|P2|NOT COMPLETED|Overall Study||1
2238635|NCT02606877|5490179|P1|NOT COMPLETED|Overall Study||4
2238636|NCT02606877|5490178|P2|COMPLETED|Overall Study||16
2238637|NCT02606877|5490179|P1|COMPLETED|Overall Study||16
2238638|NCT02606877|5490178|P2|STARTED|Overall Study||17
2238639|NCT02606877|5490179|P1|STARTED|Overall Study||20
2238640|NCT02606838|5490193|P1|NOT COMPLETED|Overall Study||0
2238641|NCT02606838|5490193|P1|COMPLETED|Overall Study||119
2238642|NCT02606838|5490193|P1|STARTED|Overall Study||119
2238643|NCT02606734|5490201|P1|NOT COMPLETED|Overall Study||0
2238644|NCT02606734|5490201|P1|COMPLETED|Overall Study||44
2238645|NCT02606734|5490201|P1|STARTED|Overall Study||44
2238646|NCT02606643|5490207|P2|NOT COMPLETED|Overall Study||3
2238647|NCT02606643|5490208|P1|NOT COMPLETED|Overall Study||1
2238648|NCT02606643|5490207|P2|COMPLETED|Overall Study||73
2238649|NCT02606643|5490208|P1|COMPLETED|Overall Study||67
2238650|NCT02606643|5490207|P2|STARTED|Overall Study||76
2238651|NCT02606643|5490208|P1|STARTED|Overall Study||68
2238652|NCT02606604|5490220|P2|NOT COMPLETED|Overall Study||0
2238653|NCT02606604|5490221|P1|NOT COMPLETED|Overall Study||1
2238654|NCT02606604|5490220|P2|COMPLETED|Overall Study||7
2238655|NCT02606604|5490221|P1|COMPLETED|Overall Study||7
2238656|NCT02606604|5490220|P2|STARTED|Overall Study||7
2238657|NCT02606604|5490221|P1|STARTED|Overall Study||8
2238658|NCT02606500|5490247|P2|NOT COMPLETED|Overall Study||0
2238659|NCT02606500|5490248|P1|NOT COMPLETED|Overall Study||0
2238660|NCT02606500|5490247|P2|COMPLETED|Overall Study||35
2238661|NCT02606500|5490248|P1|COMPLETED|Overall Study||35
2238662|NCT02606500|5490247|P2|STARTED|Overall Study||35
2238663|NCT02606500|5490248|P1|STARTED|Overall Study||35
2238664|NCT02606279|5490266|P2|NOT COMPLETED|Overall Study||1
2238665|NCT02606279|5490267|P1|NOT COMPLETED|Overall Study||0
2238666|NCT02606279|5490266|P2|COMPLETED|Overall Study||0
2238667|NCT02606279|5490267|P1|COMPLETED|Overall Study||0
2238668|NCT02606279|5490266|P2|STARTED|Overall Study||1
2238669|NCT02606279|5490267|P1|STARTED|Overall Study||0
2238670|NCT02606253|5490282|P3|NOT COMPLETED|Overall Study||0
2238671|NCT02606253|5490283|P2|NOT COMPLETED|Overall Study||2
2238672|NCT02606253|5490284|P1|NOT COMPLETED|Overall Study||5
2238673|NCT02606253|5490282|P3|COMPLETED|Overall Study||20
2238674|NCT02606253|5490283|P2|COMPLETED|Overall Study||18
2238675|NCT02606253|5490284|P1|COMPLETED|Overall Study||15
2238676|NCT02606253|5490282|P3|STARTED|Overall Study||20
2238677|NCT02606253|5490283|P2|STARTED|Overall Study||20
2238678|NCT02606253|5490284|P1|STARTED|Overall Study||20
2238679|NCT02605993|5490347|P4|NOT COMPLETED|Extension Period||7
2238680|NCT02605993|5490348|P3|NOT COMPLETED|Extension Period||7
2238681|NCT02605993|5490349|P2|NOT COMPLETED|Extension Period||6
2238682|NCT02605993|5490350|P1|NOT COMPLETED|Extension Period||6
2238683|NCT02605993|5490347|P4|COMPLETED|Extension Period||0
2238684|NCT02605993|5490348|P3|COMPLETED|Extension Period||0
2238685|NCT02605993|5490349|P2|COMPLETED|Extension Period||0
2238686|NCT02605993|5490350|P1|COMPLETED|Extension Period||0
2238687|NCT02605993|5490347|P4|STARTED|Extension Period||7
2238688|NCT02605993|5490348|P3|STARTED|Extension Period||7
2238689|NCT02605993|5490349|P2|STARTED|Extension Period||6
2238690|NCT02605993|5490350|P1|STARTED|Extension Period||6
2238691|NCT02605993|5490347|P4|NOT COMPLETED|Treatment Period||0
2238692|NCT02605993|5490348|P3|NOT COMPLETED|Treatment Period||0
2238693|NCT02605993|5490349|P2|NOT COMPLETED|Treatment Period||0
2238694|NCT02605993|5490350|P1|NOT COMPLETED|Treatment Period||0
2238695|NCT02605993|5490347|P4|COMPLETED|Treatment Period||7
2238696|NCT02605993|5490348|P3|COMPLETED|Treatment Period||7
2238697|NCT02605993|5490349|P2|COMPLETED|Treatment Period||6
2238698|NCT02605993|5490350|P1|COMPLETED|Treatment Period||6
2238699|NCT02605993|5490347|P4|Received at Least 1 Dose of Study Drug|Treatment Period||7
2238700|NCT02605993|5490348|P3|Received at Least 1 Dose of Study Drug|Treatment Period||7
2238701|NCT02605993|5490349|P2|Received at Least 1 Dose of Study Drug|Treatment Period||6
2238702|NCT02605993|5490350|P1|Received at Least 1 Dose of Study Drug|Treatment Period||6
2238703|NCT02605993|5490347|P4|STARTED|Treatment Period||7
2238704|NCT02605993|5490348|P3|STARTED|Treatment Period||7
2238705|NCT02605993|5490349|P2|STARTED|Treatment Period||6
2238706|NCT02605993|5490350|P1|STARTED|Treatment Period||6
2238707|NCT02605954|5490386|P2|NOT COMPLETED|Overall Study||4
2238708|NCT02605954|5490387|P1|NOT COMPLETED|Overall Study||12
2238709|NCT02605954|5490386|P2|COMPLETED|Overall Study||88
2238710|NCT02605954|5490387|P1|COMPLETED|Overall Study||171
2238711|NCT02605954|5490386|P2|STARTED|Overall Study||92
2238712|NCT02605954|5490387|P1|STARTED|Overall Study||183
2238713|NCT02605928|5490404|P1|NOT COMPLETED|Overall Study||33
2238714|NCT02605928|5490404|P1|COMPLETED|Overall Study||46
2238715|NCT02605928|5490404|P1|Pivotal Phase, Statistical Phase|Overall Study||51
2238716|NCT02605928|5490404|P1|STARTED|Overall Study||79
2238717|NCT02605876|5490411|P3|NOT COMPLETED|Overall Study||0
2238718|NCT02605876|5490412|P2|NOT COMPLETED|Overall Study||0
2238719|NCT02605876|5490413|P1|NOT COMPLETED|Overall Study||0
2238720|NCT02605876|5490411|P3|COMPLETED|Overall Study||25
2238721|NCT02605876|5490412|P2|COMPLETED|Overall Study||25
2238722|NCT02605876|5490413|P1|COMPLETED|Overall Study||25
2238723|NCT02605876|5490411|P3|STARTED|Overall Study||25
2238724|NCT02605876|5490412|P2|STARTED|Overall Study||25
2238725|NCT02605876|5490413|P1|STARTED|Overall Study||25
2238726|NCT02605863|5490438|P2|NOT COMPLETED|Overall Study||0
2238727|NCT02605863|5490439|P1|NOT COMPLETED|Overall Study||0
2238728|NCT02605863|5490438|P2|COMPLETED|Overall Study||0
2238729|NCT02605863|5490439|P1|COMPLETED|Overall Study||1
2238730|NCT02605863|5490438|P2|STARTED|Overall Study||0
2238731|NCT02605863|5490439|P1|STARTED|Overall Study||1
2238732|NCT02605824|5490447|P2|NOT COMPLETED|Overall Study||0
2238733|NCT02605824|5490448|P1|NOT COMPLETED|Overall Study||1
2238734|NCT02605824|5490447|P2|COMPLETED|Overall Study||0
2238735|NCT02605824|5490448|P1|COMPLETED|Overall Study||0
2238736|NCT02605824|5490447|P2|STARTED|Overall Study||0
2238737|NCT02605824|5490448|P1|STARTED|Overall Study||1
2238738|NCT02605642|5490458|P2|NOT COMPLETED|Overall Study||21
2238739|NCT02605642|5490459|P1|NOT COMPLETED|Overall Study||96
2238740|NCT02605642|5490458|P2|COMPLETED|Overall Study||86
2238741|NCT02605642|5490459|P1|COMPLETED|Overall Study||131
2238742|NCT02605642|5490458|P2|Safety Set|Overall Study||107
2238743|NCT02605642|5490459|P1|Safety Set|Overall Study||221
2238744|NCT02605642|5490458|P2|STARTED|Overall Study||107
2238745|NCT02605642|5490459|P1|STARTED|Overall Study||227
2238746|NCT02605395|5490501|P2|NOT COMPLETED|Period 2, Day 8||0
2238747|NCT02605395|5490502|P1|NOT COMPLETED|Period 2, Day 8||0
2238748|NCT02605395|5490501|P2|COMPLETED|Period 2, Day 8||35
2238749|NCT02605395|5490502|P1|COMPLETED|Period 2, Day 8||35
2238750|NCT02605395|5490501|P2|STARTED|Period 2, Day 8||35
2238751|NCT02605395|5490502|P1|STARTED|Period 2, Day 8||35
2238752|NCT02605395|5490501|P2|NOT COMPLETED|Washout Period, Day 2 to Day 7||0
2238753|NCT02605395|5490502|P1|NOT COMPLETED|Washout Period, Day 2 to Day 7||0
2238754|NCT02605395|5490501|P2|COMPLETED|Washout Period, Day 2 to Day 7||35
2238755|NCT02605395|5490502|P1|COMPLETED|Washout Period, Day 2 to Day 7||35
2238756|NCT02605395|5490501|P2|STARTED|Washout Period, Day 2 to Day 7||35
2238757|NCT02605395|5490502|P1|STARTED|Washout Period, Day 2 to Day 7||35
2238758|NCT02605395|5490501|P2|NOT COMPLETED|Period 1, Day 1||0
2238759|NCT02605395|5490502|P1|NOT COMPLETED|Period 1, Day 1||0
2238760|NCT02605395|5490501|P2|COMPLETED|Period 1, Day 1||35
2238761|NCT02605395|5490502|P1|COMPLETED|Period 1, Day 1||35
2238762|NCT02605395|5490501|P2|STARTED|Period 1, Day 1||35
2238763|NCT02605395|5490502|P1|STARTED|Period 1, Day 1||35
2238764|NCT02605304|5490520|P2|NOT COMPLETED|Overall Study||0
2238765|NCT02605304|5490521|P1|NOT COMPLETED|Overall Study||0
2238766|NCT02605304|5490520|P2|COMPLETED|Overall Study||3
2238767|NCT02605304|5490521|P1|COMPLETED|Overall Study||4
2238768|NCT02605304|5490520|P2|STARTED|Overall Study||3
2238769|NCT02605304|5490521|P1|STARTED|Overall Study||4
2238770|NCT02605187|5490545|P4|NOT COMPLETED|Overall Study||1
2238771|NCT02605187|5490546|P3|NOT COMPLETED|Overall Study||11
2238772|NCT02605187|5490547|P2|NOT COMPLETED|Overall Study||2
2238773|NCT02605187|5490548|P1|NOT COMPLETED|Overall Study||8
2238774|NCT02605187|5490545|P4|COMPLETED|Overall Study||15
2238775|NCT02605187|5490546|P3|COMPLETED|Overall Study||72
2238776|NCT02605187|5490547|P2|COMPLETED|Overall Study||19
2238777|NCT02605187|5490548|P1|COMPLETED|Overall Study||32
2238778|NCT02605187|5490545|P4|STARTED|Overall Study||16
2238779|NCT02605187|5490546|P3|STARTED|Overall Study||83
2238780|NCT02605187|5490547|P2|STARTED|Overall Study||21
2238781|NCT02605187|5490548|P1|STARTED|Overall Study||40
2238782|NCT02605174|5490606|P7|NOT COMPLETED|Overall Study||89
2238783|NCT02605174|5490607|P6|NOT COMPLETED|Overall Study||32
2238784|NCT02605174|5490608|P5|NOT COMPLETED|Overall Study||53
2238785|NCT02605174|5490609|P4|NOT COMPLETED|Overall Study||36
2238786|NCT02605174|5490610|P3|NOT COMPLETED|Overall Study||76
2238787|NCT02605174|5490611|P2|NOT COMPLETED|Overall Study||23
2238788|NCT02605174|5490612|P1|NOT COMPLETED|Overall Study||64
2238789|NCT02605174|5490606|P7|COMPLETED|Overall Study||662
2238790|NCT02605174|5490607|P6|COMPLETED|Overall Study||217
2238791|NCT02605174|5490608|P5|COMPLETED|Overall Study||448
2238792|NCT02605174|5490609|P4|COMPLETED|Overall Study||216
2238793|NCT02605174|5490610|P3|COMPLETED|Overall Study||426
2238794|NCT02605174|5490611|P2|COMPLETED|Overall Study||226
2238795|NCT02605174|5490612|P1|COMPLETED|Overall Study||437
2238796|NCT02605174|5490606|P7|Received Optional 2nd Dose|Overall Study||361
2238797|NCT02605174|5490607|P6|Received Optional 2nd Dose|Overall Study||74
2238798|NCT02605174|5490608|P5|Received Optional 2nd Dose|Overall Study||144
2238799|NCT02605174|5490609|P4|Received Optional 2nd Dose|Overall Study||83
2238800|NCT02605174|5490610|P3|Received Optional 2nd Dose|Overall Study||177
2238801|NCT02605174|5490611|P2|Received Optional 2nd Dose|Overall Study||96
2238802|NCT02605174|5490612|P1|Received Optional 2nd Dose|Overall Study||206
2238803|NCT02605174|5490606|P7|Received at Least 1 Dose of Study Drug|Overall Study||645
2238804|NCT02605174|5490607|P6|Received at Least 1 Dose of Study Drug|Overall Study||215
2238805|NCT02605174|5490608|P5|Received at Least 1 Dose of Study Drug|Overall Study||434
2238806|NCT02605174|5490609|P4|Received at Least 1 Dose of Study Drug|Overall Study||212
2238807|NCT02605174|5490610|P3|Received at Least 1 Dose of Study Drug|Overall Study||423
2238808|NCT02605174|5490611|P2|Received at Least 1 Dose of Study Drug|Overall Study||225
2238809|NCT02605174|5490612|P1|Received at Least 1 Dose of Study Drug|Overall Study||429
2238810|NCT02605174|5490606|P7|STARTED|Overall Study||751
2238811|NCT02605174|5490607|P6|STARTED|Overall Study||249
2238812|NCT02605174|5490608|P5|STARTED|Overall Study||501
2238813|NCT02605174|5490609|P4|STARTED|Overall Study||252
2238814|NCT02605174|5490610|P3|STARTED|Overall Study||502
2238815|NCT02605174|5490611|P2|STARTED|Overall Study||249
2238816|NCT02605174|5490612|P1|STARTED|Overall Study||501
2238817|NCT02605122|5490674|P2|NOT COMPLETED|Overall Study||2
2238818|NCT02605122|5490675|P1|NOT COMPLETED|Overall Study||5
2238819|NCT02605122|5490674|P2|COMPLETED|Overall Study||22
2238820|NCT02605122|5490675|P1|COMPLETED|Overall Study||68
2238821|NCT02605122|5490674|P2|Received Study Drug|Overall Study||24
2238822|NCT02605122|5490675|P1|Received Study Drug|Overall Study||70
2238823|NCT02605122|5490674|P2|STARTED|Overall Study||24
2238824|NCT02605122|5490675|P1|STARTED|Overall Study||73
2238825|NCT02604810|5490687|P1|NOT COMPLETED|IGSC 20%, 24 Weeks||7
2238826|NCT02604810|5490687|P1|COMPLETED|IGSC 20%, 24 Weeks||42
2238827|NCT02604810|5490687|P1|STARTED|IGSC 20%, 24 Weeks||49
2238828|NCT02604810|5490687|P1|NOT COMPLETED|IGIV-C 10%, 4-5 Weeks||3
2238829|NCT02604810|5490687|P1|COMPLETED|IGIV-C 10%, 4-5 Weeks||49
2238830|NCT02604810|5490687|P1|STARTED|IGIV-C 10%, 4-5 Weeks||52
2238831|NCT02604589|5490698|P3|NOT COMPLETED|Overall Study||1
2238832|NCT02604589|5490699|P2|NOT COMPLETED|Overall Study||0
2238833|NCT02604589|5490700|P1|NOT COMPLETED|Overall Study||0
2238834|NCT02604589|5490698|P3|COMPLETED|Overall Study||1
2238835|NCT02604589|5490699|P2|COMPLETED|Overall Study||5
2238836|NCT02604589|5490700|P1|COMPLETED|Overall Study||3
2238837|NCT02604589|5490698|P3|STARTED|Overall Study||2
2238838|NCT02604589|5490699|P2|STARTED|Overall Study||5
2238839|NCT02604589|5490700|P1|STARTED|Overall Study||3
2238840|NCT02604550|5490728|P2|NOT COMPLETED|Overall Study||26
2238841|NCT02604550|5490729|P1|NOT COMPLETED|Overall Study||25
2238842|NCT02604550|5490728|P2|COMPLETED|Overall Study||33
2238843|NCT02604550|5490729|P1|COMPLETED|Overall Study||31
2238844|NCT02604550|5490728|P2|STARTED|Overall Study||59
2238845|NCT02604550|5490729|P1|STARTED|Overall Study||56
2238846|NCT02604433|5490755|P2|NOT COMPLETED|Post Treatment Follow-up Period||24
2238847|NCT02604433|5490756|P1|NOT COMPLETED|Post Treatment Follow-up Period||42
2238848|NCT02604433|5490755|P2|COMPLETED|Post Treatment Follow-up Period||0
2238849|NCT02604433|5490756|P1|COMPLETED|Post Treatment Follow-up Period||0
2238850|NCT02604433|5490755|P2|STARTED|Post Treatment Follow-up Period||24
2238851|NCT02604433|5490756|P1|STARTED|Post Treatment Follow-up Period||42
2238852|NCT02604433|5490755|P2|NOT COMPLETED|Open-Label Treatment Period||0
2238853|NCT02604433|5490756|P1|NOT COMPLETED|Open-Label Treatment Period||0
2238854|NCT02604433|5490755|P2|COMPLETED|Open-Label Treatment Period||0
2238855|NCT02604433|5490756|P1|COMPLETED|Open-Label Treatment Period||0
2238856|NCT02604433|5490755|P2|STARTED|Open-Label Treatment Period||0
2238857|NCT02604433|5490756|P1|STARTED|Open-Label Treatment Period||0
2238858|NCT02604433|5490755|P2|NOT COMPLETED|Double-blind Treatment Period||106
2238859|NCT02604433|5490756|P1|NOT COMPLETED|Double-blind Treatment Period||218
2238860|NCT02604433|5490755|P2|COMPLETED|Double-blind Treatment Period|Completed study per original protocol|6
2238861|NCT02604433|5490756|P1|COMPLETED|Double-blind Treatment Period|Completed study per original protocol|6
2238862|NCT02604433|5490755|P2|Completed 48 Weeks of Treatment|Double-blind Treatment Period||96
2238863|NCT02604433|5490756|P1|Completed 48 Weeks of Treatment|Double-blind Treatment Period||200
2238864|NCT02604433|5490755|P2|Completed 24 Weeks of Treatment|Double-blind Treatment Period||102
2238865|NCT02604433|5490756|P1|Completed 24 Weeks of Treatment|Double-blind Treatment Period||210
2238866|NCT02604433|5490755|P2|Health-Related Quality of Life Populatio|Double-blind Treatment Period||103
2238867|NCT02604433|5490756|P1|Health-Related Quality of Life Populatio|Double-blind Treatment Period||211
2238868|NCT02604433|5490755|P2|Pharmacokinetic Population|Double-blind Treatment Period|Participants did not take luspatercept.|0
2238869|NCT02604433|5490756|P1|Pharmacokinetic Population|Double-blind Treatment Period||221
2238870|NCT02604433|5490755|P2|Safety Population|Double-blind Treatment Period||109
2238871|NCT02604433|5490756|P1|Safety Population|Double-blind Treatment Period||223
2238872|NCT02604433|5490755|P2|Intent to Treat Population|Double-blind Treatment Period||112
2238873|NCT02604433|5490756|P1|Intent to Treat Population|Double-blind Treatment Period||224
2238874|NCT02604433|5490755|P2|STARTED|Double-blind Treatment Period||112
2238875|NCT02604433|5490756|P1|STARTED|Double-blind Treatment Period||224
2238876|NCT02604407|5490825|P3|NOT COMPLETED|Overall Study||16
2238877|NCT02604407|5490826|P2|NOT COMPLETED|Overall Study||12
2238878|NCT02604407|5490827|P1|NOT COMPLETED|Overall Study||11
2238879|NCT02604407|5490825|P3|COMPLETED|Overall Study||76
2238880|NCT02604407|5490826|P2|COMPLETED|Overall Study||80
2238881|NCT02604407|5490827|P1|COMPLETED|Overall Study||80
2238882|NCT02604407|5490825|P3|TREATED|Overall Study||90
2238883|NCT02604407|5490826|P2|TREATED|Overall Study||92
2238884|NCT02604407|5490827|P1|TREATED|Overall Study||89
2238885|NCT02604407|5490825|P3|STARTED|Overall Study||92
2238886|NCT02604407|5490826|P2|STARTED|Overall Study||92
2238887|NCT02604407|5490827|P1|STARTED|Overall Study||91
2238888|NCT02604342|5490840|P2|NOT COMPLETED|Overall Study||23
2238889|NCT02604342|5490841|P1|NOT COMPLETED|Overall Study||43
2238890|NCT02604342|5490840|P2|COMPLETED|Overall Study||17
2238891|NCT02604342|5490841|P1|COMPLETED|Overall Study||36
2238892|NCT02604342|5490840|P2|STARTED|Overall Study||40
2238893|NCT02604342|5490841|P1|STARTED|Overall Study||79
2238894|NCT02604264|5490893|P2|NOT COMPLETED|Intervention||242
2238895|NCT02604264|5490894|P1|NOT COMPLETED|Intervention||200
2238896|NCT02604264|5490893|P2|COMPLETED|Intervention||1225
2238897|NCT02604264|5490894|P1|COMPLETED|Intervention||1245
2238898|NCT02604264|5490893|P2|STARTED|Intervention||1467
2238899|NCT02604264|5490894|P1|STARTED|Intervention||1445
2238900|NCT02604264|5490893|P2|NOT COMPLETED|Run-In||0
2238901|NCT02604264|5490894|P1|NOT COMPLETED|Run-In||0
2238902|NCT02604264|5490893|P2|COMPLETED|Run-In||611
2238903|NCT02604264|5490894|P1|COMPLETED|Run-In||618
2238904|NCT02604264|5490893|P2|STARTED|Run-In|The 1-mo run-in period data was used to determine pre-study demographics and PBC rate.|611
2238905|NCT02604264|5490894|P1|STARTED|Run-In||618
2238906|NCT02604212|5490904|P4|NOT COMPLETED|Overall Study||3
2238907|NCT02604212|5490905|P3|NOT COMPLETED|Overall Study||4
2238908|NCT02604212|5490906|P2|NOT COMPLETED|Overall Study||1
2238909|NCT02604212|5490907|P1|NOT COMPLETED|Overall Study||2
2238910|NCT02604212|5490904|P4|COMPLETED|Overall Study||8
2238911|NCT02604212|5490905|P3|COMPLETED|Overall Study||6
2238912|NCT02604212|5490906|P2|COMPLETED|Overall Study||4
2238913|NCT02604212|5490907|P1|COMPLETED|Overall Study||4
2238914|NCT02604212|5490904|P4|STARTED|Overall Study||11
2238915|NCT02604212|5490905|P3|STARTED|Overall Study||10
2238916|NCT02604212|5490906|P2|STARTED|Overall Study||5
2238917|NCT02604212|5490907|P1|STARTED|Overall Study||6
2238918|NCT02604199|5490975|P4|NOT COMPLETED|Overall Study||3
2238919|NCT02604199|5490976|P3|NOT COMPLETED|Overall Study||0
2238920|NCT02604199|5490977|P2|NOT COMPLETED|Overall Study||3
2238921|NCT02604199|5490978|P1|NOT COMPLETED|Overall Study||0
2238922|NCT02604199|5490975|P4|COMPLETED|Overall Study||18
2238923|NCT02604199|5490976|P3|COMPLETED|Overall Study||17
2238924|NCT02604199|5490977|P2|COMPLETED|Overall Study||8
2238925|NCT02604199|5490978|P1|COMPLETED|Overall Study||9
2238926|NCT02604199|5490975|P4|STARTED|Overall Study||21
2238927|NCT02604199|5490976|P3|STARTED|Overall Study||17
2238928|NCT02604199|5490977|P2|STARTED|Overall Study||11
2238929|NCT02604199|5490978|P1|STARTED|Overall Study||9
2238930|NCT02604173|5491029|P3|NOT COMPLETED|Overall Study||0
2238931|NCT02604173|5491030|P2|NOT COMPLETED|Overall Study||0
2238932|NCT02604173|5491031|P1|NOT COMPLETED|Overall Study||0
2238933|NCT02604173|5491029|P3|COMPLETED|Overall Study||35
2238934|NCT02604173|5491030|P2|COMPLETED|Overall Study||35
2238935|NCT02604173|5491031|P1|COMPLETED|Overall Study||33
2238936|NCT02604173|5491029|P3|STARTED|Overall Study||35
2238937|NCT02604173|5491030|P2|STARTED|Overall Study||35
2238938|NCT02604173|5491031|P1|STARTED|Overall Study||33
2238939|NCT02604160|5491047|P2|NOT COMPLETED|Overall Study||2
2238940|NCT02604160|5491048|P1|NOT COMPLETED|Overall Study||0
2238941|NCT02604160|5491047|P2|COMPLETED|Overall Study||3
2238942|NCT02604160|5491048|P1|COMPLETED|Overall Study||2
2238943|NCT02604160|5491047|P2|Received at Least One Dose of Study Drug|Overall Study||5
2238944|NCT02604160|5491048|P1|Received at Least One Dose of Study Drug|Overall Study||2
2238945|NCT02604160|5491047|P2|STARTED|Overall Study||5
2238946|NCT02604160|5491048|P1|STARTED|Overall Study||2
2238947|NCT02604017|5491062|P2|NOT COMPLETED|Overall Study||8
2238948|NCT02604017|5491063|P1|NOT COMPLETED|Overall Study||6
2238949|NCT02604017|5491062|P2|COMPLETED|Overall Study||343
2238950|NCT02604017|5491063|P1|COMPLETED|Overall Study||346
2238951|NCT02604017|5491062|P2|STARTED|Overall Study||351
2238952|NCT02604017|5491063|P1|STARTED|Overall Study||352
2238953|NCT02603952|5491092|P4|NOT COMPLETED|Overall Study||1
2238954|NCT02603952|5491093|P3|NOT COMPLETED|Overall Study||0
2238955|NCT02603952|5491094|P2|NOT COMPLETED|Overall Study||0
2238956|NCT02603952|5491095|P1|NOT COMPLETED|Overall Study||1
2238957|NCT02603952|5491092|P4|COMPLETED|Overall Study||31
2238958|NCT02603952|5491093|P3|COMPLETED|Overall Study||31
2238959|NCT02603952|5491094|P2|COMPLETED|Overall Study||31
2238960|NCT02603952|5491095|P1|COMPLETED|Overall Study||31
2238961|NCT02603952|5491092|P4|Treated|Overall Study||31
2238962|NCT02603952|5491093|P3|Treated|Overall Study||31
2238963|NCT02603952|5491094|P2|Treated|Overall Study||31
2238964|NCT02603952|5491095|P1|Treated|Overall Study||32
2238965|NCT02603952|5491092|P4|STARTED|Overall Study||32
2238966|NCT02603952|5491093|P3|STARTED|Overall Study||31
2238967|NCT02603952|5491094|P2|STARTED|Overall Study||31
2238968|NCT02603952|5491095|P1|STARTED|Overall Study||32
2238969|NCT02603926|5491136|P1|NOT COMPLETED|Overall Study||0
2238970|NCT02603926|5491136|P1|COMPLETED|Overall Study||6
2238971|NCT02603926|5491136|P1|STARTED|Overall Study||6
2238972|NCT02603666|5491143|P1|NOT COMPLETED|Overall Study||0
2238973|NCT02603666|5491143|P1|COMPLETED|Overall Study||130
2238974|NCT02603666|5491143|P1|STARTED|Overall Study||130
2238975|NCT02603393|5491149|P2|NOT COMPLETED|Overall Study||54
2238976|NCT02603393|5491150|P1|NOT COMPLETED|Overall Study||71
2238977|NCT02603393|5491149|P2|COMPLETED|Overall Study||472
2238978|NCT02603393|5491150|P1|COMPLETED|Overall Study||456
2238979|NCT02603393|5491149|P2|STARTED|Overall Study||526
2238980|NCT02603393|5491150|P1|STARTED|Overall Study||527
2238981|NCT02603211|5491176|P1|NOT COMPLETED|Overall Study||0
2238982|NCT02603211|5491176|P1|COMPLETED|Overall Study||20
2238983|NCT02603211|5491176|P1|STARTED|Overall Study||20
2238984|NCT02603172|5491189|P8|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
2238985|NCT02603172|5491190|P7|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
2238986|NCT02603172|5491191|P6|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
2238987|NCT02603172|5491192|P5|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
2238988|NCT02603172|5491193|P4|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
2238989|NCT02603172|5491194|P3|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
2238990|NCT02603172|5491195|P2|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
2238991|NCT02603172|5491196|P1|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
2238992|NCT02603172|5491189|P8|COMPLETED|Part C (Approximately 13 Weeks)||0
2238993|NCT02603172|5491190|P7|COMPLETED|Part C (Approximately 13 Weeks)||0
2238994|NCT02603172|5491191|P6|COMPLETED|Part C (Approximately 13 Weeks)||0
2238995|NCT02603172|5491192|P5|COMPLETED|Part C (Approximately 13 Weeks)||0
2238996|NCT02603172|5491193|P4|COMPLETED|Part C (Approximately 13 Weeks)||0
2238997|NCT02603172|5491194|P3|COMPLETED|Part C (Approximately 13 Weeks)||0
2238998|NCT02603172|5491195|P2|COMPLETED|Part C (Approximately 13 Weeks)||0
2238999|NCT02603172|5491196|P1|COMPLETED|Part C (Approximately 13 Weeks)||0
2239000|NCT02603172|5491189|P8|STARTED|Part C (Approximately 13 Weeks)||0
2239001|NCT02603172|5491190|P7|STARTED|Part C (Approximately 13 Weeks)||0
2239002|NCT02603172|5491191|P6|STARTED|Part C (Approximately 13 Weeks)||0
2239003|NCT02603172|5491192|P5|STARTED|Part C (Approximately 13 Weeks)||0
2239004|NCT02603172|5491193|P4|STARTED|Part C (Approximately 13 Weeks)||0
2239005|NCT02603172|5491194|P3|STARTED|Part C (Approximately 13 Weeks)||0
2239006|NCT02603172|5491195|P2|STARTED|Part C (Approximately 13 Weeks)||0
2239007|NCT02603172|5491196|P1|STARTED|Part C (Approximately 13 Weeks)||0
2239008|NCT02603172|5491189|P8|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
2239009|NCT02603172|5491190|P7|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
2239010|NCT02603172|5491191|P6|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
2239011|NCT02603172|5491192|P5|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
2239012|NCT02603172|5491193|P4|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
2239013|NCT02603172|5491194|P3|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
2239014|NCT02603172|5491195|P2|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
2239015|NCT02603172|5491196|P1|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
2239016|NCT02603172|5491189|P8|COMPLETED|Part B (Approximately 7 Weeks)||0
2239017|NCT02603172|5491190|P7|COMPLETED|Part B (Approximately 7 Weeks)||0
2239018|NCT02603172|5491191|P6|COMPLETED|Part B (Approximately 7 Weeks)||0
2239019|NCT02603172|5491192|P5|COMPLETED|Part B (Approximately 7 Weeks)||6
2239020|NCT02603172|5491193|P4|COMPLETED|Part B (Approximately 7 Weeks)||1
2239021|NCT02603172|5491194|P3|COMPLETED|Part B (Approximately 7 Weeks)||0
2239022|NCT02603172|5491195|P2|COMPLETED|Part B (Approximately 7 Weeks)||1
2239023|NCT02603172|5491196|P1|COMPLETED|Part B (Approximately 7 Weeks)||0
2239024|NCT02603172|5491189|P8|STARTED|Part B (Approximately 7 Weeks)||0
2239025|NCT02603172|5491190|P7|STARTED|Part B (Approximately 7 Weeks)||0
2239026|NCT02603172|5491191|P6|STARTED|Part B (Approximately 7 Weeks)||0
2239027|NCT02603172|5491192|P5|STARTED|Part B (Approximately 7 Weeks)||6
2239028|NCT02603172|5491193|P4|STARTED|Part B (Approximately 7 Weeks)||1
2239029|NCT02603172|5491194|P3|STARTED|Part B (Approximately 7 Weeks)||0
2239030|NCT02603172|5491195|P2|STARTED|Part B (Approximately 7 Weeks)||1
2239031|NCT02603172|5491196|P1|STARTED|Part B (Approximately 7 Weeks)||0
2239032|NCT02603172|5491189|P8|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
2239033|NCT02603172|5491190|P7|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
2239034|NCT02603172|5491191|P6|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
2239035|NCT02603172|5491192|P5|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
2239036|NCT02603172|5491193|P4|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
2239037|NCT02603172|5491194|P3|NOT COMPLETED|Part A (Approximately 16 Weeks)||1
2239038|NCT02603172|5491195|P2|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
2239039|NCT02603172|5491196|P1|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
2239040|NCT02603172|5491189|P8|COMPLETED|Part A (Approximately 16 Weeks)||0
2239041|NCT02603172|5491190|P7|COMPLETED|Part A (Approximately 16 Weeks)||0
2239042|NCT02603172|5491191|P6|COMPLETED|Part A (Approximately 16 Weeks)||0
2239043|NCT02603172|5491192|P5|COMPLETED|Part A (Approximately 16 Weeks)||0
2239044|NCT02603172|5491193|P4|COMPLETED|Part A (Approximately 16 Weeks)||1
2239045|NCT02603172|5491194|P3|COMPLETED|Part A (Approximately 16 Weeks)||7
2239046|NCT02603172|5491195|P2|COMPLETED|Part A (Approximately 16 Weeks)||1
2239047|NCT02603172|5491196|P1|COMPLETED|Part A (Approximately 16 Weeks)||7
2239048|NCT02603172|5491189|P8|STARTED|Part A (Approximately 16 Weeks)||0
2239049|NCT02603172|5491190|P7|STARTED|Part A (Approximately 16 Weeks)||0
2239050|NCT02603172|5491191|P6|STARTED|Part A (Approximately 16 Weeks)||0
2239051|NCT02603172|5491192|P5|STARTED|Part A (Approximately 16 Weeks)||0
2239052|NCT02603172|5491193|P4|STARTED|Part A (Approximately 16 Weeks)||1
2239053|NCT02603172|5491194|P3|STARTED|Part A (Approximately 16 Weeks)||8
2239054|NCT02603172|5491195|P2|STARTED|Part A (Approximately 16 Weeks)||1
2239055|NCT02603172|5491196|P1|STARTED|Part A (Approximately 16 Weeks)||7
2239056|NCT02603120|5491324|P2|NOT COMPLETED|Overall Study||283
2239057|NCT02603120|5491325|P1|NOT COMPLETED|Overall Study||284
2239058|NCT02603120|5491324|P2|COMPLETED|Overall Study||0
2239059|NCT02603120|5491325|P1|COMPLETED|Overall Study||0
2239060|NCT02603120|5491324|P2|STARTED|Overall Study||283
2239061|NCT02603120|5491325|P1|STARTED|Overall Study||284
2239062|NCT02603107|5491345|P2|NOT COMPLETED|Optional Extension Phase||213
2239063|NCT02603107|5491346|P1|NOT COMPLETED|Optional Extension Phase||241
2239064|NCT02603107|5491345|P2|COMPLETED|Optional Extension Phase||0
2239065|NCT02603107|5491346|P1|COMPLETED|Optional Extension Phase||0
2239066|NCT02603107|5491345|P2|STARTED|Optional Extension Phase|27 participants who completed the Randomized Phase did not continue in the Optional Extension Phase.|213
2239067|NCT02603107|5491346|P1|STARTED|Optional Extension Phase|4 participants who completed the Randomized Phase did not continue in the Optional Extension Phase.|241
2239068|NCT02603107|5491345|P2|NOT COMPLETED|Randomized Phase||48
2239069|NCT02603107|5491346|P1|NOT COMPLETED|Randomized Phase||45
2239070|NCT02603107|5491345|P2|COMPLETED|Randomized Phase||240
2239071|NCT02603107|5491346|P1|COMPLETED|Randomized Phase||245
2239072|NCT02603107|5491345|P2|STARTED|Randomized Phase||288
2239073|NCT02603107|5491346|P1|STARTED|Randomized Phase||290
2239074|NCT02602496|5491359|P3|NOT COMPLETED|Overall Study||0
2239075|NCT02602496|5491360|P2|NOT COMPLETED|Overall Study||2
2239076|NCT02602496|5491361|P1|NOT COMPLETED|Overall Study||1
2239077|NCT02602496|5491359|P3|COMPLETED|Overall Study||17
2239078|NCT02602496|5491360|P2|COMPLETED|Overall Study||18
2239079|NCT02602496|5491361|P1|COMPLETED|Overall Study||14
2239080|NCT02602496|5491359|P3|STARTED|Overall Study||17
2239081|NCT02602496|5491360|P2|STARTED|Overall Study||20
2239082|NCT02602496|5491361|P1|STARTED|Overall Study||15
2239083|NCT02602223|5491390|P1|NOT COMPLETED|Overall Study||0
2239084|NCT02602223|5491390|P1|COMPLETED|Overall Study||9
2239085|NCT02602223|5491390|P1|STARTED|Overall Study||9
2239086|NCT02602080|5491409|P3|NOT COMPLETED|Overall Study||3
2239087|NCT02602080|5491410|P2|NOT COMPLETED|Overall Study||1
2239088|NCT02602080|5491411|P1|NOT COMPLETED|Overall Study||6
2239089|NCT02602080|5491409|P3|COMPLETED|Overall Study||15
2239090|NCT02602080|5491410|P2|COMPLETED|Overall Study||15
2239091|NCT02602080|5491411|P1|COMPLETED|Overall Study||15
2239092|NCT02602080|5491409|P3|STARTED|Overall Study||18
2239093|NCT02602080|5491410|P2|STARTED|Overall Study||16
2239094|NCT02602080|5491411|P1|STARTED|Overall Study||21
2239095|NCT02601976|5491446|P1|NOT COMPLETED|Overall Study||0
2239096|NCT02601976|5491446|P1|COMPLETED|Overall Study||64
2239097|NCT02601976|5491446|P1|STARTED|Overall Study||64
2239098|NCT02601820|5491454|P1|NOT COMPLETED|1-Yr Post-Treatment (T5)||88
2239099|NCT02601820|5491454|P1|COMPLETED|1-Yr Post-Treatment (T5)|Of 1528, 88 were excluded for a missing T5 record. 1440 provided data at T5. Some outcomes missing.|1440
2239100|NCT02601820|5491454|P1|STARTED|1-Yr Post-Treatment (T5)|Of 1601, 73 were excluded at T5 due to death, withdrawal, other reason. 1528 remained in the study.|1528
2239101|NCT02601820|5491454|P1|NOT COMPLETED|12 Weeks Post-Treatment (T4)||3
2239102|NCT02601820|5491454|P1|COMPLETED|12 Weeks Post-Treatment (T4)|Of 1564, 3 were excluded for a missing T4 record. 1561 provided data at T4. Some outcomes missing.|1561
2239103|NCT02601820|5491454|P1|STARTED|12 Weeks Post-Treatment (T4)|Of 1601, 37 were excluded at T4 due to death, withdrawal, other reason. 1564 remained in the study.|1564
2239104|NCT02601820|5491454|P1|NOT COMPLETED|Late On-Treatment (T3)||49
2239105|NCT02601820|5491454|P1|COMPLETED|Late On-Treatment (T3)|Of 1573, 49 were excluded for a missing T3 record. 1524 provided data at T3. Some outcomes missing.|1524
2239106|NCT02601820|5491454|P1|STARTED|Late On-Treatment (T3)|Of 1601, 28 were excluded at T3 due to death, withdrawal, other reason. 1573 remained in the study.|1573
2239107|NCT02601820|5491454|P1|NOT COMPLETED|Early On-Treatment (T2)||51
2239108|NCT02601820|5491454|P1|COMPLETED|Early On-Treatment (T2)|Of 1584, 51 were excluded for a missing T2 record. 1533 provided data at T2. Some outcomes missing.|1533
2239109|NCT02601820|5491454|P1|STARTED|Early On-Treatment (T2)|Of 1601, 17 were excluded at T2 due to death, withdrawal, other reason. 1584 remained in the study.|1584
2239110|NCT02601820|5491454|P1|NOT COMPLETED|Pre-Treatment (T1)||0
2239111|NCT02601820|5491454|P1|COMPLETED|Pre-Treatment (T1)||1601
2239112|NCT02601820|5491454|P1|STARTED|Pre-Treatment (T1)|1601 patients were enrolled and completed Baseline PROs (T1).|1601
2239113|NCT02601625|5491483|P4|NOT COMPLETED|Overall Study||1
2239114|NCT02601625|5491484|P3|NOT COMPLETED|Overall Study||1
2239115|NCT02601625|5491485|P2|NOT COMPLETED|Overall Study||0
2239116|NCT02601625|5491486|P1|NOT COMPLETED|Overall Study||0
2239117|NCT02601625|5491483|P4|COMPLETED|Overall Study||11
2239118|NCT02601625|5491484|P3|COMPLETED|Overall Study||5
2239119|NCT02601625|5491485|P2|COMPLETED|Overall Study||6
2239120|NCT02601625|5491486|P1|COMPLETED|Overall Study||6
2239121|NCT02601625|5491483|P4|STARTED|Overall Study||12
2239122|NCT02601625|5491484|P3|STARTED|Overall Study||6
2239123|NCT02601625|5491485|P2|STARTED|Overall Study||6
2239124|NCT02601625|5491486|P1|STARTED|Overall Study||6
2239125|NCT02601573|5491539|P5|NOT COMPLETED|Overall Study||2
2239126|NCT02601573|5491540|P4|NOT COMPLETED|Overall Study||1
2239127|NCT02601573|5491541|P3|NOT COMPLETED|Overall Study||1
2239128|NCT02601573|5491542|P2|NOT COMPLETED|Overall Study||4
2239129|NCT02601573|5491543|P1|NOT COMPLETED|Overall Study||0
2239130|NCT02601573|5491539|P5|COMPLETED|Overall Study||16
2239131|NCT02601573|5491540|P4|COMPLETED|Overall Study||17
2239132|NCT02601573|5491541|P3|COMPLETED|Overall Study||16
2239133|NCT02601573|5491542|P2|COMPLETED|Overall Study||20
2239134|NCT02601573|5491543|P1|COMPLETED|Overall Study||23
2239135|NCT02601573|5491539|P5|STARTED|Overall Study|Number randomized and treated.|18
2239136|NCT02601573|5491540|P4|STARTED|Overall Study|Number randomized and treated.|18
2239137|NCT02601573|5491541|P3|STARTED|Overall Study|Number randomized and treated.|17
2239138|NCT02601573|5491542|P2|STARTED|Overall Study|Number randomized and treated.|24
2239139|NCT02601573|5491543|P1|STARTED|Overall Study|Number randomized and treated.|23
2239140|NCT02601560|5491578|P8|NOT COMPLETED|Overall Study||0
2239141|NCT02601560|5491579|P7|NOT COMPLETED|Overall Study||1
2239142|NCT02601560|5491580|P6|NOT COMPLETED|Overall Study||0
2239143|NCT02601560|5491581|P5|NOT COMPLETED|Overall Study||0
2239144|NCT02601560|5491582|P4|NOT COMPLETED|Overall Study||0
2239145|NCT02601560|5491583|P3|NOT COMPLETED|Overall Study||0
2239146|NCT02601560|5491584|P2|NOT COMPLETED|Overall Study||0
2239147|NCT02601560|5491585|P1|NOT COMPLETED|Overall Study||0
2239148|NCT02601560|5491578|P8|COMPLETED|Overall Study||6
2239149|NCT02601560|5491579|P7|COMPLETED|Overall Study||5
2239150|NCT02601560|5491580|P6|COMPLETED|Overall Study||4
2239151|NCT02601560|5491581|P5|COMPLETED|Overall Study||6
2239152|NCT02601560|5491582|P4|COMPLETED|Overall Study||6
2239153|NCT02601560|5491583|P3|COMPLETED|Overall Study||6
2239154|NCT02601560|5491584|P2|COMPLETED|Overall Study||6
2239155|NCT02601560|5491585|P1|COMPLETED|Overall Study||8
2239156|NCT02601560|5491578|P8|STARTED|Overall Study||6
2239157|NCT02601560|5491579|P7|STARTED|Overall Study||6
2239158|NCT02601560|5491580|P6|STARTED|Overall Study||4
2239159|NCT02601560|5491581|P5|STARTED|Overall Study||6
2239160|NCT02601560|5491582|P4|STARTED|Overall Study||6
2239161|NCT02601560|5491583|P3|STARTED|Overall Study||6
2239162|NCT02601560|5491584|P2|STARTED|Overall Study||6
2239163|NCT02601560|5491585|P1|STARTED|Overall Study||8
2239164|NCT02601469|5491769|P2|NOT COMPLETED|Overall Study||0
2239165|NCT02601469|5491770|P1|NOT COMPLETED|Overall Study||1
2239166|NCT02601469|5491769|P2|COMPLETED|Overall Study||1
2239167|NCT02601469|5491770|P1|COMPLETED|Overall Study||24
2239168|NCT02601469|5491769|P2|STARTED|Overall Study||1
2239169|NCT02601469|5491770|P1|STARTED|Overall Study||25
2239170|NCT02601300|5491776|P1|NOT COMPLETED|Extension Phase||17
2239171|NCT02601300|5491776|P1|COMPLETED|Extension Phase||18
2239172|NCT02601300|5491776|P1|Treated With IP|Extension Phase||34
2239173|NCT02601300|5491776|P1|STARTED|Extension Phase|3 completed induction phase; did not enter extension due to withdrawal and lack of efficacy|35
2239174|NCT02601300|5491776|P1|NOT COMPLETED|Induction Phase||3
2239175|NCT02601300|5491776|P1|COMPLETED|Induction Phase||38
2239176|NCT02601300|5491776|P1|STARTED|Induction Phase||41
2239177|NCT02600871|5491791|P2|NOT COMPLETED|Overall Study||10
2239178|NCT02600871|5491792|P1|NOT COMPLETED|Overall Study||13
2239179|NCT02600871|5491791|P2|COMPLETED|Overall Study|45 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39
2239180|NCT02600871|5491792|P1|COMPLETED|Overall Study|51 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39
2239181|NCT02600871|5491791|P2|STARTED|Overall Study||49
2239182|NCT02600871|5491792|P1|STARTED|Overall Study||52
2239183|NCT02600845|5491802|P1|NOT COMPLETED|Overall Study||18
2239184|NCT02600845|5491802|P1|COMPLETED|Overall Study||104
2239185|NCT02600845|5491802|P1|STARTED|Overall Study||122
2239186|NCT02600819|5491817|P2|NOT COMPLETED|Open-Label Extension (OLE) (B/F/TAF)||7
2239187|NCT02600819|5491818|P1|NOT COMPLETED|Open-Label Extension (OLE) (B/F/TAF)||0
2239188|NCT02600819|5491817|P2|COMPLETED|Open-Label Extension (OLE) (B/F/TAF)||0
2239189|NCT02600819|5491818|P1|COMPLETED|Open-Label Extension (OLE) (B/F/TAF)||0
2239190|NCT02600819|5491817|P2|STARTED|Open-Label Extension (OLE) (B/F/TAF)|Only US participants were eligible to roll over into the Extension Phase per the study protocol.|7
2239191|NCT02600819|5491818|P1|STARTED|Open-Label Extension (OLE) (B/F/TAF)|Only US participants were eligible to roll over into the Extension Phase per the study protocol.|0
2239192|NCT02600819|5491817|P2|NOT COMPLETED|Main Study (E/C/F/TAF)||0
2239193|NCT02600819|5491818|P1|NOT COMPLETED|Main Study (E/C/F/TAF)||19
2239194|NCT02600819|5491817|P2|COMPLETED|Main Study (E/C/F/TAF)||0
2239195|NCT02600819|5491818|P1|COMPLETED|Main Study (E/C/F/TAF)||36
2239196|NCT02600819|5491817|P2|STARTED|Main Study (E/C/F/TAF)||0
2239197|NCT02600819|5491818|P1|STARTED|Main Study (E/C/F/TAF)||55
2239198|NCT02600767|5491830|P1|NOT COMPLETED|Overall Study||5
2239199|NCT02600767|5491830|P1|COMPLETED|Overall Study||74
2239200|NCT02600767|5491830|P1|STARTED|Overall Study||79
2239201|NCT02600715|5491836|P2|NOT COMPLETED|Overall Study||0
2239202|NCT02600715|5491837|P1|NOT COMPLETED|Overall Study||0
2239203|NCT02600715|5491836|P2|COMPLETED|Overall Study||13
2239204|NCT02600715|5491837|P1|COMPLETED|Overall Study||13
2239205|NCT02600715|5491836|P2|Completed 2-week Follow-up Appointment|Overall Study||12
2239206|NCT02600715|5491837|P1|Completed 2-week Follow-up Appointment|Overall Study||13
2239207|NCT02600715|5491836|P2|Received Treatment and Suppository|Overall Study||13
2239208|NCT02600715|5491837|P1|Received Treatment and Suppository|Overall Study||13
2239209|NCT02600715|5491836|P2|Allocated to Randomization|Overall Study||13
2239210|NCT02600715|5491837|P1|Allocated to Randomization|Overall Study||13
2239211|NCT02600715|5491836|P2|STARTED|Overall Study||13
2239212|NCT02600715|5491837|P1|STARTED|Overall Study||13
2239213|NCT02600637|5491868|P2|NOT COMPLETED|Overall Study||5
2239214|NCT02600637|5491869|P1|NOT COMPLETED|Overall Study||5
2239215|NCT02600637|5491868|P2|COMPLETED|Overall Study||13
2239216|NCT02600637|5491869|P1|COMPLETED|Overall Study||14
2239217|NCT02600637|5491868|P2|STARTED|Overall Study||18
2239218|NCT02600637|5491869|P1|STARTED|Overall Study||19
2239219|NCT02600611|5491881|P2|NOT COMPLETED|Overall Study||0
2239220|NCT02600611|5491882|P1|NOT COMPLETED|Overall Study||2
2239221|NCT02600611|5491881|P2|COMPLETED|Overall Study||300
2239222|NCT02600611|5491882|P1|COMPLETED|Overall Study||298
2239223|NCT02600611|5491881|P2|STARTED|Overall Study||300
2239224|NCT02600611|5491882|P1|STARTED|Overall Study||300
2239225|NCT02600403|5491893|P3|NOT COMPLETED|Overall Study||0
2239226|NCT02600403|5491894|P2|NOT COMPLETED|Overall Study||0
2239227|NCT02600403|5491895|P1|NOT COMPLETED|Overall Study||0
2239228|NCT02600403|5491893|P3|COMPLETED|Overall Study||11
2239229|NCT02600403|5491894|P2|COMPLETED|Overall Study||6
2239230|NCT02600403|5491895|P1|COMPLETED|Overall Study||44
2239231|NCT02600403|5491893|P3|STARTED|Overall Study||11
2239232|NCT02600403|5491894|P2|STARTED|Overall Study||6
2239233|NCT02600403|5491895|P1|STARTED|Overall Study||44
2239234|NCT02600351|5491922|P4|NOT COMPLETED|Overall Study||5
2239235|NCT02600351|5491923|P3|NOT COMPLETED|Overall Study||6
2239236|NCT02600351|5491924|P2|NOT COMPLETED|Overall Study||0
2239237|NCT02600351|5491925|P1|NOT COMPLETED|Overall Study||5
2239238|NCT02600351|5491922|P4|COMPLETED|Overall Study||22
2239239|NCT02600351|5491923|P3|COMPLETED|Overall Study||20
2239240|NCT02600351|5491924|P2|COMPLETED|Overall Study||17
2239241|NCT02600351|5491925|P1|COMPLETED|Overall Study||12
2239242|NCT02600351|5491922|P4|STARTED|Overall Study||27
2239243|NCT02600351|5491923|P3|STARTED|Overall Study||26
2239244|NCT02600351|5491924|P2|STARTED|Overall Study||17
2239245|NCT02600351|5491925|P1|STARTED|Overall Study||17
2239246|NCT02600325|5491955|P1|NOT COMPLETED|Overall Study||0
2239247|NCT02600325|5491955|P1|COMPLETED|Overall Study||80
2239248|NCT02600325|5491955|P1|STARTED|Overall Study||80
2239249|NCT02599766|5491960|P1|NOT COMPLETED|Overall Study||3
2239250|NCT02599766|5491960|P1|COMPLETED|Overall Study||19
2239251|NCT02599766|5491960|P1|STARTED|Overall Study||22
2239252|NCT02599649|5491996|P4|NOT COMPLETED|Overall Study||0
2239253|NCT02599649|5491997|P3|NOT COMPLETED|Overall Study||0
2239254|NCT02599649|5491998|P2|NOT COMPLETED|Overall Study||0
2239255|NCT02599649|5491999|P1|NOT COMPLETED|Overall Study||0
2239256|NCT02599649|5491996|P4|COMPLETED|Overall Study||0
2239257|NCT02599649|5491997|P3|COMPLETED|Overall Study||8
2239258|NCT02599649|5491998|P2|COMPLETED|Overall Study||0
2239259|NCT02599649|5491999|P1|COMPLETED|Overall Study||2
2239260|NCT02599649|5491996|P4|STARTED|Overall Study||0
2239261|NCT02599649|5491997|P3|STARTED|Overall Study||8
2239262|NCT02599649|5491998|P2|STARTED|Overall Study||0
2239263|NCT02599649|5491999|P1|STARTED|Overall Study||2
2239264|NCT02599441|5492009|P1|NOT COMPLETED|Overall Study||0
2239265|NCT02599441|5492009|P1|COMPLETED|Overall Study||9
2239266|NCT02599441|5492009|P1|STARTED|Overall Study||9
2239267|NCT02599194|5492015|P1|NOT COMPLETED|Overall Study||0
2239268|NCT02599194|5492015|P1|COMPLETED|Overall Study||7
2239269|NCT02599194|5492015|P1|STARTED|Overall Study||7
2239270|NCT02599129|5492024|P2|NOT COMPLETED|Overall Study||3
2239271|NCT02599129|5492025|P1|NOT COMPLETED|Overall Study||5
2239272|NCT02599129|5492024|P2|COMPLETED|Overall Study||1
2239273|NCT02599129|5492025|P1|COMPLETED|Overall Study||2
2239274|NCT02599129|5492024|P2|STARTED|Overall Study||4
2239275|NCT02599129|5492025|P1|STARTED|Overall Study||7
2239276|NCT02598934|5492041|P2|NOT COMPLETED|Overall Study||22
2239277|NCT02598934|5492042|P1|NOT COMPLETED|Overall Study||19
2239278|NCT02598934|5492041|P2|COMPLETED|Overall Study||132
2239279|NCT02598934|5492042|P1|COMPLETED|Overall Study||135
2239280|NCT02598934|5492041|P2|STARTED|Overall Study||154
2239281|NCT02598934|5492042|P1|STARTED|Overall Study||154
2239282|NCT02598622|5492054|P2|NOT COMPLETED|Overall Study||0
2239283|NCT02598622|5492055|P1|NOT COMPLETED|Overall Study||6
2239284|NCT02598622|5492054|P2|COMPLETED|Overall Study||0
2239285|NCT02598622|5492055|P1|COMPLETED|Overall Study||2
2239286|NCT02598622|5492054|P2|STARTED|Overall Study|Study terminated prior to randomization phase. No enrollment in this arm.|0
2239287|NCT02598622|5492055|P1|STARTED|Overall Study||8
2239288|NCT02598583|5492063|P2|NOT COMPLETED|Overall Study||0
2239289|NCT02598583|5492064|P1|NOT COMPLETED|Overall Study||0
2239290|NCT02598583|5492063|P2|COMPLETED|Overall Study||7
2239291|NCT02598583|5492064|P1|COMPLETED|Overall Study||6
2239292|NCT02598583|5492063|P2|STARTED|Overall Study||7
2239293|NCT02598583|5492064|P1|STARTED|Overall Study||6
2239294|NCT02598297|5492084|P2|NOT COMPLETED|Overall Study||24
2239295|NCT02598297|5492085|P1|NOT COMPLETED|Overall Study||25
2239296|NCT02598297|5492084|P2|COMPLETED|Overall Study||0
2239297|NCT02598297|5492085|P1|COMPLETED|Overall Study||0
2239298|NCT02598297|5492084|P2|Subjects Followed for Survival|Overall Study||0
2239299|NCT02598297|5492085|P1|Subjects Followed for Survival|Overall Study||1
2239300|NCT02598297|5492084|P2|Not Treted Wit Study Drug|Overall Study||0
2239301|NCT02598297|5492085|P1|Not Treted Wit Study Drug|Overall Study||1
2239302|NCT02598297|5492084|P2|STARTED|Overall Study||24
2239303|NCT02598297|5492085|P1|STARTED|Overall Study|One subject in the ruxolitinib arm was not treated with the study drug|25
2239304|NCT02598193|5492111|P1|NOT COMPLETED|Overall Study||16
2239305|NCT02598193|5492111|P1|COMPLETED|Overall Study||73
2239306|NCT02598193|5492111|P1|STARTED|Overall Study||89
2239307|NCT02598128|5492119|P4|NOT COMPLETED|Period C: Days 12 to 20||0
2239308|NCT02598128|5492120|P3|NOT COMPLETED|Period C: Days 12 to 20||0
2239309|NCT02598128|5492121|P2|NOT COMPLETED|Period C: Days 12 to 20||0
2239310|NCT02598128|5492122|P1|NOT COMPLETED|Period C: Days 12 to 20||0
2239311|NCT02598128|5492119|P4|COMPLETED|Period C: Days 12 to 20||33
2239312|NCT02598128|5492120|P3|COMPLETED|Period C: Days 12 to 20||0
2239313|NCT02598128|5492121|P2|COMPLETED|Period C: Days 12 to 20||0
2239314|NCT02598128|5492122|P1|COMPLETED|Period C: Days 12 to 20||0
2239315|NCT02598128|5492119|P4|STARTED|Period C: Days 12 to 20||33
2239316|NCT02598128|5492120|P3|STARTED|Period C: Days 12 to 20||0
2239317|NCT02598128|5492121|P2|STARTED|Period C: Days 12 to 20||0
2239318|NCT02598128|5492122|P1|STARTED|Period C: Days 12 to 20||0
2239319|NCT02598128|5492119|P4|NOT COMPLETED|Period B: Days 1 to 11||0
2239320|NCT02598128|5492120|P3|NOT COMPLETED|Period B: Days 1 to 11||0
2239321|NCT02598128|5492121|P2|NOT COMPLETED|Period B: Days 1 to 11||0
2239322|NCT02598128|5492122|P1|NOT COMPLETED|Period B: Days 1 to 11||0
2239323|NCT02598128|5492119|P4|COMPLETED|Period B: Days 1 to 11||0
2239324|NCT02598128|5492120|P3|COMPLETED|Period B: Days 1 to 11||16
2239325|NCT02598128|5492121|P2|COMPLETED|Period B: Days 1 to 11||17
2239326|NCT02598128|5492122|P1|COMPLETED|Period B: Days 1 to 11||0
2239327|NCT02598128|5492119|P4|STARTED|Period B: Days 1 to 11||0
2239328|NCT02598128|5492120|P3|STARTED|Period B: Days 1 to 11||16
2239329|NCT02598128|5492121|P2|STARTED|Period B: Days 1 to 11||17
2239330|NCT02598128|5492122|P1|STARTED|Period B: Days 1 to 11||0
2239331|NCT02598128|5492119|P4|NOT COMPLETED|Period A: Days -7 to -1||0
2239332|NCT02598128|5492120|P3|NOT COMPLETED|Period A: Days -7 to -1||0
2239333|NCT02598128|5492121|P2|NOT COMPLETED|Period A: Days -7 to -1||0
2239334|NCT02598128|5492122|P1|NOT COMPLETED|Period A: Days -7 to -1||1
2239335|NCT02598128|5492119|P4|COMPLETED|Period A: Days -7 to -1||0
2239336|NCT02598128|5492120|P3|COMPLETED|Period A: Days -7 to -1||0
2239337|NCT02598128|5492121|P2|COMPLETED|Period A: Days -7 to -1||0
2239338|NCT02598128|5492122|P1|COMPLETED|Period A: Days -7 to -1||33
2239339|NCT02598128|5492119|P4|STARTED|Period A: Days -7 to -1||0
2239340|NCT02598128|5492120|P3|STARTED|Period A: Days -7 to -1||0
2239341|NCT02598128|5492121|P2|STARTED|Period A: Days -7 to -1||0
2239342|NCT02598128|5492122|P1|STARTED|Period A: Days -7 to -1||34
2239343|NCT02598089|5492136|P2|NOT COMPLETED|Overall Study||0
2239344|NCT02598089|5492137|P1|NOT COMPLETED|Overall Study||0
2239345|NCT02598089|5492136|P2|COMPLETED|Overall Study||30
2239346|NCT02598089|5492137|P1|COMPLETED|Overall Study||30
2239347|NCT02598089|5492136|P2|STARTED|Overall Study||30
2239348|NCT02598089|5492137|P1|STARTED|Overall Study||30
2239349|NCT02598076|5492165|P2|NOT COMPLETED|Overall Study||3
2239350|NCT02598076|5492166|P1|NOT COMPLETED|Overall Study||2
2239351|NCT02598076|5492165|P2|COMPLETED|Overall Study||26
2239352|NCT02598076|5492166|P1|COMPLETED|Overall Study||29
2239353|NCT02598076|5492165|P2|STARTED|Overall Study||29
2239354|NCT02598076|5492166|P1|STARTED|Overall Study||31
2239355|NCT02597946|5492180|P1|NOT COMPLETED|Overall Study||18
2239356|NCT02597946|5492180|P1|COMPLETED|Overall Study||0
2239357|NCT02597946|5492180|P1|STARTED|Overall Study||18
2239358|NCT02597933|5492191|P2|NOT COMPLETED|Overall Study||51
2239359|NCT02597933|5492192|P1|NOT COMPLETED|Overall Study||38
2239360|NCT02597933|5492191|P2|COMPLETED|Overall Study||239
2239361|NCT02597933|5492192|P1|COMPLETED|Overall Study||252
2239362|NCT02597933|5492191|P2|Treated Patients|Overall Study||288
2239363|NCT02597933|5492192|P1|Treated Patients|Overall Study||288
2239364|NCT02597933|5492191|P2|STARTED|Overall Study|Started are randomised|290
2239365|NCT02597933|5492192|P1|STARTED|Overall Study|Started are randomised|290
2239366|NCT02597920|5492223|P3|NOT COMPLETED|Overall Study||6
2239367|NCT02597920|5492224|P2|NOT COMPLETED|Overall Study||84
2239368|NCT02597920|5492225|P1|NOT COMPLETED|Overall Study||41
2239369|NCT02597920|5492223|P3|COMPLETED|Overall Study||72
2239370|NCT02597920|5492224|P2|COMPLETED|Overall Study||1075
2239371|NCT02597920|5492225|P1|COMPLETED|Overall Study||544
2239372|NCT02597920|5492223|P3|STARTED|Overall Study||78
2239373|NCT02597920|5492224|P2|STARTED|Overall Study||1159
2239374|NCT02597920|5492225|P1|STARTED|Overall Study|Information about study termination is not available for 1 subject.|585
2239375|NCT02597907|5492250|P2|NOT COMPLETED|Overall Study||0
2239376|NCT02597907|5492251|P1|NOT COMPLETED|Overall Study||0
2239377|NCT02597907|5492250|P2|COMPLETED|Overall Study||44
2239378|NCT02597907|5492251|P1|COMPLETED|Overall Study||44
2239379|NCT02597907|5492250|P2|STARTED|Overall Study||44
2239380|NCT02597907|5492251|P1|STARTED|Overall Study||44
2239381|NCT02597855|5492259|P2|NOT COMPLETED|Overall Study||1
2239382|NCT02597855|5492260|P1|NOT COMPLETED|Overall Study||2
2239383|NCT02597855|5492259|P2|COMPLETED|Overall Study||13
2239384|NCT02597855|5492260|P1|COMPLETED|Overall Study||16
2239385|NCT02597855|5492259|P2|STARTED|Overall Study||14
2239386|NCT02597855|5492260|P1|STARTED|Overall Study||18
2239387|NCT02597582|5492270|P2|NOT COMPLETED|Overall Study||0
2239388|NCT02597582|5492271|P1|NOT COMPLETED|Overall Study||0
2239389|NCT02597582|5492270|P2|COMPLETED|Overall Study||20
2239390|NCT02597582|5492271|P1|COMPLETED|Overall Study||21
2239391|NCT02597582|5492270|P2|STARTED|Overall Study||20
2239392|NCT02597582|5492271|P1|STARTED|Overall Study||21
2239393|NCT02597543|5492289|P2|NOT COMPLETED|Overall Study||0
2239394|NCT02597543|5492290|P1|NOT COMPLETED|Overall Study||0
2239395|NCT02597543|5492289|P2|COMPLETED|Overall Study||8
2239396|NCT02597543|5492290|P1|COMPLETED|Overall Study||6
2239397|NCT02597543|5492289|P2|STARTED|Overall Study||8
2239398|NCT02597543|5492290|P1|STARTED|Overall Study||6
2239399|NCT02597127|5492314|P8|NOT COMPLETED|Overall Study||2
2239400|NCT02597127|5492315|P7|NOT COMPLETED|Overall Study||4
2239401|NCT02597127|5492316|P6|NOT COMPLETED|Overall Study||4
2239402|NCT02597127|5492317|P5|NOT COMPLETED|Overall Study||5
2239403|NCT02597127|5492318|P4|NOT COMPLETED|Overall Study||5
2239404|NCT02597127|5492319|P3|NOT COMPLETED|Overall Study||8
2239405|NCT02597127|5492320|P2|NOT COMPLETED|Overall Study||3
2239406|NCT02597127|5492321|P1|NOT COMPLETED|Overall Study||1
2239407|NCT02597127|5492314|P8|COMPLETED|Overall Study||60
2239408|NCT02597127|5492315|P7|COMPLETED|Overall Study||57
2239409|NCT02597127|5492316|P6|COMPLETED|Overall Study||59
2239410|NCT02597127|5492317|P5|COMPLETED|Overall Study||57
2239411|NCT02597127|5492318|P4|COMPLETED|Overall Study||60
2239412|NCT02597127|5492319|P3|COMPLETED|Overall Study||58
2239413|NCT02597127|5492320|P2|COMPLETED|Overall Study||59
2239414|NCT02597127|5492321|P1|COMPLETED|Overall Study||59
2239415|NCT02597127|5492314|P8|Treated|Overall Study||62
2239416|NCT02597127|5492315|P7|Treated|Overall Study||61
2239417|NCT02597127|5492316|P6|Treated|Overall Study||62
2239418|NCT02597127|5492317|P5|Treated|Overall Study||61
2239419|NCT02597127|5492318|P4|Treated|Overall Study||65
2239420|NCT02597127|5492319|P3|Treated|Overall Study||65
2239421|NCT02597127|5492320|P2|Treated|Overall Study||61
2239422|NCT02597127|5492321|P1|Treated|Overall Study||60
2239423|NCT02597127|5492314|P8|STARTED|Overall Study||62
2239424|NCT02597127|5492315|P7|STARTED|Overall Study||61
2239425|NCT02597127|5492316|P6|STARTED|Overall Study||63
2239426|NCT02597127|5492317|P5|STARTED|Overall Study||62
2239427|NCT02597127|5492318|P4|STARTED|Overall Study||65
2239428|NCT02597127|5492319|P3|STARTED|Overall Study||66
2239429|NCT02597127|5492320|P2|STARTED|Overall Study||62
2239430|NCT02597127|5492321|P1|STARTED|Overall Study||60
2239431|NCT02597049|5492411|P3|NOT COMPLETED|Overall Study||3
2239432|NCT02597049|5492412|P2|NOT COMPLETED|Overall Study||5
2239433|NCT02597049|5492413|P1|NOT COMPLETED|Overall Study||7
2239434|NCT02597049|5492411|P3|COMPLETED|Overall Study||137
2239435|NCT02597049|5492412|P2|COMPLETED|Overall Study||137
2239436|NCT02597049|5492413|P1|COMPLETED|Overall Study||135
2239437|NCT02597049|5492411|P3|Received at Least One Dose of Study Drug|Overall Study||140
2239438|NCT02597049|5492412|P2|Received at Least One Dose of Study Drug|Overall Study||141
2239439|NCT02597049|5492413|P1|Received at Least One Dose of Study Drug|Overall Study||142
2239440|NCT02597049|5492411|P3|STARTED|Overall Study||140
2239441|NCT02597049|5492412|P2|STARTED|Overall Study||142
2239442|NCT02597049|5492413|P1|STARTED|Overall Study||142
2239443|NCT02596971|5492454|P3|NOT COMPLETED|Overall Study||42
2239444|NCT02596971|5492455|P2|NOT COMPLETED|Overall Study||7
2239445|NCT02596971|5492456|P1|NOT COMPLETED|Overall Study||42
2239446|NCT02596971|5492454|P3|COMPLETED|Overall Study||0
2239447|NCT02596971|5492455|P2|COMPLETED|Overall Study||0
2239448|NCT02596971|5492456|P1|COMPLETED|Overall Study||0
2239449|NCT02596971|5492454|P3|STARTED|Overall Study||42
2239450|NCT02596971|5492455|P2|STARTED|Overall Study||7
2239451|NCT02596971|5492456|P1|STARTED|Overall Study||42
2239452|NCT02596958|5492485|P1|NOT COMPLETED|Overall Study||996
2239453|NCT02596958|5492485|P1|COMPLETED|Overall Study||0
2239454|NCT02596958|5492485|P1|STARTED|Overall Study||996
2239455|NCT02596945|5492497|P1|NOT COMPLETED|Overall Study||56
2239456|NCT02596945|5492497|P1|COMPLETED|Overall Study||167
2239457|NCT02596945|5492497|P1|Treated|Overall Study||220
2239458|NCT02596945|5492497|P1|STARTED|Overall Study||223
2239459|NCT02596893|5492507|P4|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
2239460|NCT02596893|5492508|P3|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
2239461|NCT02596893|5492509|P2|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
2239462|NCT02596893|5492510|P1|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
2239463|NCT02596893|5492507|P4|COMPLETED|Follow-Up Period Weeks 0 to 52||47
2239464|NCT02596893|5492508|P3|COMPLETED|Follow-Up Period Weeks 0 to 52||56
2239465|NCT02596893|5492509|P2|COMPLETED|Follow-Up Period Weeks 0 to 52||51
2239466|NCT02596893|5492510|P1|COMPLETED|Follow-Up Period Weeks 0 to 52||57
2239467|NCT02596893|5492507|P4|STARTED|Follow-Up Period Weeks 0 to 52||47
2239468|NCT02596893|5492508|P3|STARTED|Follow-Up Period Weeks 0 to 52||56
2239469|NCT02596893|5492509|P2|STARTED|Follow-Up Period Weeks 0 to 52||51
2239470|NCT02596893|5492510|P1|STARTED|Follow-Up Period Weeks 0 to 52||57
2239471|NCT02596893|5492507|P4|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||166
2239472|NCT02596893|5492508|P3|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||162
2239473|NCT02596893|5492509|P2|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||168
2239474|NCT02596893|5492510|P1|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||164
2239475|NCT02596893|5492507|P4|COMPLETED|Overall Double-Blind Period Weeks 0-52||9
2239476|NCT02596893|5492508|P3|COMPLETED|Overall Double-Blind Period Weeks 0-52||14
2239477|NCT02596893|5492509|P2|COMPLETED|Overall Double-Blind Period Weeks 0-52||8
2239478|NCT02596893|5492510|P1|COMPLETED|Overall Double-Blind Period Weeks 0-52||10
2239479|NCT02596893|5492507|P4|STARTED|Overall Double-Blind Period Weeks 0-52||175
2239480|NCT02596893|5492508|P3|STARTED|Overall Double-Blind Period Weeks 0-52||176
2239481|NCT02596893|5492509|P2|STARTED|Overall Double-Blind Period Weeks 0-52||176
2239482|NCT02596893|5492510|P1|STARTED|Overall Double-Blind Period Weeks 0-52||174
2239483|NCT02596867|5492564|P1|NOT COMPLETED|Overall Study||0
2239484|NCT02596867|5492564|P1|COMPLETED|Overall Study||2
2239485|NCT02596867|5492564|P1|2 Patients Prospectively Recruited|Overall Study||2
2239486|NCT02596867|5492564|P1|STARTED|Overall Study||2
2239487|NCT02596854|5492569|P1|NOT COMPLETED|Overall Study||8
2239488|NCT02596854|5492569|P1|COMPLETED|Overall Study||109
2239489|NCT02596854|5492569|P1|STARTED|Overall Study||117
2239490|NCT02596750|5492575|P2|NOT COMPLETED|30 Minutes||0
2239491|NCT02596750|5492576|P1|NOT COMPLETED|30 Minutes||0
2239492|NCT02596750|5492575|P2|COMPLETED|30 Minutes||21
2239493|NCT02596750|5492576|P1|COMPLETED|30 Minutes||21
2239494|NCT02596750|5492575|P2|STARTED|30 Minutes||21
2239495|NCT02596750|5492576|P1|STARTED|30 Minutes||21
2239496|NCT02596750|5492575|P2|NOT COMPLETED|10 Minutes||0
2239497|NCT02596750|5492576|P1|NOT COMPLETED|10 Minutes||0
2239498|NCT02596750|5492575|P2|COMPLETED|10 Minutes||21
2239499|NCT02596750|5492576|P1|COMPLETED|10 Minutes||21
2239500|NCT02596750|5492575|P2|STARTED|10 Minutes||21
2239501|NCT02596750|5492576|P1|STARTED|10 Minutes||21
2239502|NCT02596750|5492575|P2|NOT COMPLETED|5 Minutes||0
2239503|NCT02596750|5492576|P1|NOT COMPLETED|5 Minutes||0
2239504|NCT02596750|5492575|P2|COMPLETED|5 Minutes||21
2239505|NCT02596750|5492576|P1|COMPLETED|5 Minutes||21
2239506|NCT02596750|5492575|P2|STARTED|5 Minutes||21
2239507|NCT02596750|5492576|P1|STARTED|5 Minutes||21
2239508|NCT02596750|5492575|P2|NOT COMPLETED|2 Minutes||0
2239509|NCT02596750|5492576|P1|NOT COMPLETED|2 Minutes||0
2239510|NCT02596750|5492575|P2|COMPLETED|2 Minutes||21
2239511|NCT02596750|5492576|P1|COMPLETED|2 Minutes||21
2239512|NCT02596750|5492575|P2|STARTED|2 Minutes||21
2239513|NCT02596750|5492576|P1|STARTED|2 Minutes||21
2239514|NCT02596750|5492575|P2|NOT COMPLETED|Baseline||0
2239515|NCT02596750|5492576|P1|NOT COMPLETED|Baseline||0
2239516|NCT02596750|5492575|P2|COMPLETED|Baseline||21
2239517|NCT02596750|5492576|P1|COMPLETED|Baseline||21
2239518|NCT02596750|5492575|P2|STARTED|Baseline||21
2239519|NCT02596750|5492576|P1|STARTED|Baseline||21
2239520|NCT02596620|5492590|P2|NOT COMPLETED|Overall Study||1
2239521|NCT02596620|5492591|P1|NOT COMPLETED|Overall Study||1
2239522|NCT02596620|5492590|P2|COMPLETED|Overall Study|Completed on 30th September 2015|81
2239523|NCT02596620|5492591|P1|COMPLETED|Overall Study|Completed on 30th September 2015|81
2239524|NCT02596620|5492590|P2|STARTED|Overall Study|Started from 1st October 2013|82
2239525|NCT02596620|5492591|P1|STARTED|Overall Study|Started from 1st October 2013|82
2239526|NCT02596451|5492600|P3|NOT COMPLETED|Overall Study||14
2239527|NCT02596451|5492601|P2|NOT COMPLETED|Overall Study||18
2239528|NCT02596451|5492602|P1|NOT COMPLETED|Overall Study||4
2239529|NCT02596451|5492600|P3|COMPLETED|Overall Study||373
2239530|NCT02596451|5492601|P2|COMPLETED|Overall Study||374
2239531|NCT02596451|5492602|P1|COMPLETED|Overall Study||381
2239532|NCT02596451|5492600|P3|STARTED|Overall Study||387
2239533|NCT02596451|5492601|P2|STARTED|Overall Study||392
2239534|NCT02596451|5492602|P1|STARTED|Overall Study||385
2239535|NCT02596321|5492611|P2|NOT COMPLETED|Overall Study||0
2239536|NCT02596321|5492612|P1|NOT COMPLETED|Overall Study||3
2239537|NCT02596321|5492611|P2|COMPLETED|Overall Study||56
2239538|NCT02596321|5492612|P1|COMPLETED|Overall Study||53
2239539|NCT02596321|5492611|P2|STARTED|Overall Study||56
2239540|NCT02596321|5492612|P1|STARTED|Overall Study||56
2239541|NCT02596035|5492627|P3|NOT COMPLETED|Overall Study||1
2239542|NCT02596035|5492628|P2|NOT COMPLETED|Overall Study||44
2239543|NCT02596035|5492629|P1|NOT COMPLETED|Overall Study||86
2239544|NCT02596035|5492627|P3|COMPLETED|Overall Study||0
2239545|NCT02596035|5492628|P2|COMPLETED|Overall Study||0
2239546|NCT02596035|5492629|P1|COMPLETED|Overall Study||11
2239547|NCT02596035|5492627|P3|STARTED|Overall Study||1
2239548|NCT02596035|5492628|P2|STARTED|Overall Study||44
2239549|NCT02596035|5492629|P1|STARTED|Overall Study||97
2239550|NCT02596022|5492658|P2|NOT COMPLETED|Overall Study||0
2239551|NCT02596022|5492659|P1|NOT COMPLETED|Overall Study||0
2239552|NCT02596022|5492658|P2|COMPLETED|Overall Study||8
2239553|NCT02596022|5492659|P1|COMPLETED|Overall Study||10
2239554|NCT02596022|5492658|P2|STARTED|Overall Study||8
2239555|NCT02596022|5492659|P1|STARTED|Overall Study||10
2239556|NCT02596009|5492665|P6|NOT COMPLETED|Overall Study||0
2239557|NCT02596009|5492666|P5|NOT COMPLETED|Overall Study||0
2239558|NCT02596009|5492667|P4|NOT COMPLETED|Overall Study||0
2239559|NCT02596009|5492668|P3|NOT COMPLETED|Overall Study||0
2239560|NCT02596009|5492669|P2|NOT COMPLETED|Overall Study||1
2239561|NCT02596009|5492670|P1|NOT COMPLETED|Overall Study||0
2239562|NCT02596009|5492665|P6|COMPLETED|Overall Study||17
2239563|NCT02596009|5492666|P5|COMPLETED|Overall Study||18
2239564|NCT02596009|5492667|P4|COMPLETED|Overall Study||16
2239565|NCT02596009|5492668|P3|COMPLETED|Overall Study||16
2239566|NCT02596009|5492669|P2|COMPLETED|Overall Study||15
2239567|NCT02596009|5492670|P1|COMPLETED|Overall Study||14
2239568|NCT02596009|5492665|P6|STARTED|Overall Study||17
2239569|NCT02596009|5492666|P5|STARTED|Overall Study||18
2239570|NCT02596009|5492667|P4|STARTED|Overall Study||16
2239571|NCT02596009|5492668|P3|STARTED|Overall Study||16
2239572|NCT02596009|5492669|P2|STARTED|Overall Study||16
2239573|NCT02596009|5492670|P1|STARTED|Overall Study||14
2239574|NCT02595983|5492679|P1|NOT COMPLETED|Overall Study||4
2239575|NCT02595983|5492679|P1|COMPLETED|Overall Study||8
2239576|NCT02595983|5492679|P1|STARTED|Overall Study||12
2239577|NCT02595970|5492687|P1|NOT COMPLETED|Overall Study||20
2239578|NCT02595970|5492687|P1|COMPLETED|Overall Study|Out of 100 patients who completed treatment period 2, 20 patients completed the extension period.|100
2239579|NCT02595970|5492687|P1|STARTED|Overall Study||120
2239580|NCT02595723|5492704|P3|NOT COMPLETED|Third Intervention (4 Days)||0
2239581|NCT02595723|5492705|P2|NOT COMPLETED|Third Intervention (4 Days)||0
2239582|NCT02595723|5492706|P1|NOT COMPLETED|Third Intervention (4 Days)||0
2239583|NCT02595723|5492704|P3|COMPLETED|Third Intervention (4 Days)||7
2239584|NCT02595723|5492705|P2|COMPLETED|Third Intervention (4 Days)||5
2239585|NCT02595723|5492706|P1|COMPLETED|Third Intervention (4 Days)||6
2239586|NCT02595723|5492704|P3|STARTED|Third Intervention (4 Days)||7
2239587|NCT02595723|5492705|P2|STARTED|Third Intervention (4 Days)||5
2239588|NCT02595723|5492706|P1|STARTED|Third Intervention (4 Days)||6
2239589|NCT02595723|5492704|P3|NOT COMPLETED|Second Washout (21 Days)||0
2239590|NCT02595723|5492705|P2|NOT COMPLETED|Second Washout (21 Days)||1
2239591|NCT02595723|5492706|P1|NOT COMPLETED|Second Washout (21 Days)||0
2239592|NCT02595723|5492704|P3|COMPLETED|Second Washout (21 Days)||7
2239593|NCT02595723|5492705|P2|COMPLETED|Second Washout (21 Days)||5
2239594|NCT02595723|5492706|P1|COMPLETED|Second Washout (21 Days)||6
2239595|NCT02595723|5492704|P3|STARTED|Second Washout (21 Days)||7
2239596|NCT02595723|5492705|P2|STARTED|Second Washout (21 Days)||6
2239597|NCT02595723|5492706|P1|STARTED|Second Washout (21 Days)||6
2239598|NCT02595723|5492704|P3|NOT COMPLETED|Second Intervention (4 Days)||0
2239599|NCT02595723|5492705|P2|NOT COMPLETED|Second Intervention (4 Days)||0
2239600|NCT02595723|5492706|P1|NOT COMPLETED|Second Intervention (4 Days)||0
2239601|NCT02595723|5492704|P3|COMPLETED|Second Intervention (4 Days)||7
2239602|NCT02595723|5492705|P2|COMPLETED|Second Intervention (4 Days)||6
2239603|NCT02595723|5492706|P1|COMPLETED|Second Intervention (4 Days)||6
2239604|NCT02595723|5492704|P3|STARTED|Second Intervention (4 Days)||7
2239605|NCT02595723|5492705|P2|STARTED|Second Intervention (4 Days)||6
2239606|NCT02595723|5492706|P1|STARTED|Second Intervention (4 Days)||6
2239607|NCT02595723|5492704|P3|NOT COMPLETED|First Washout (21 Days)||0
2239608|NCT02595723|5492705|P2|NOT COMPLETED|First Washout (21 Days)||0
2239609|NCT02595723|5492706|P1|NOT COMPLETED|First Washout (21 Days)||2
2239610|NCT02595723|5492704|P3|COMPLETED|First Washout (21 Days)||7
2239611|NCT02595723|5492705|P2|COMPLETED|First Washout (21 Days)||6
2239612|NCT02595723|5492706|P1|COMPLETED|First Washout (21 Days)||6
2239613|NCT02595723|5492704|P3|STARTED|First Washout (21 Days)||7
2239614|NCT02595723|5492705|P2|STARTED|First Washout (21 Days)||6
2239615|NCT02595723|5492706|P1|STARTED|First Washout (21 Days)||8
2239616|NCT02595723|5492704|P3|NOT COMPLETED|First Intervention (4 Days)||0
2239617|NCT02595723|5492705|P2|NOT COMPLETED|First Intervention (4 Days)||0
2239618|NCT02595723|5492706|P1|NOT COMPLETED|First Intervention (4 Days)||0
2239619|NCT02595723|5492704|P3|COMPLETED|First Intervention (4 Days)||7
2239620|NCT02595723|5492705|P2|COMPLETED|First Intervention (4 Days)||6
2239621|NCT02595723|5492706|P1|COMPLETED|First Intervention (4 Days)||8
2239622|NCT02595723|5492704|P3|STARTED|First Intervention (4 Days)||7
2239623|NCT02595723|5492705|P2|STARTED|First Intervention (4 Days)||6
2239624|NCT02595723|5492706|P1|STARTED|First Intervention (4 Days)||8
2239625|NCT02595567|5492714|P1|NOT COMPLETED|Overall Study||0
2239626|NCT02595567|5492714|P1|COMPLETED|Overall Study||25
2239627|NCT02595567|5492714|P1|STARTED|Overall Study||25
2239628|NCT02595502|5492718|P2|NOT COMPLETED|Period 3||2
2239629|NCT02595502|5492719|P1|NOT COMPLETED|Period 3||1
2239630|NCT02595502|5492718|P2|COMPLETED|Period 3||136
2239631|NCT02595502|5492719|P1|COMPLETED|Period 3||140
2239632|NCT02595502|5492718|P2|STARTED|Period 3||138
2239633|NCT02595502|5492719|P1|STARTED|Period 3||141
2239634|NCT02595502|5492718|P2|NOT COMPLETED|Period 2||2
2239635|NCT02595502|5492719|P1|NOT COMPLETED|Period 2||1
2239636|NCT02595502|5492718|P2|COMPLETED|Period 2||138
2239637|NCT02595502|5492719|P1|COMPLETED|Period 2||141
2239638|NCT02595502|5492718|P2|STARTED|Period 2||140
2239639|NCT02595502|5492719|P1|STARTED|Period 2||142
2239640|NCT02595502|5492718|P2|NOT COMPLETED|Period 1||2
2239641|NCT02595502|5492719|P1|NOT COMPLETED|Period 1||1
2239642|NCT02595502|5492718|P2|COMPLETED|Period 1||140
2239643|NCT02595502|5492719|P1|COMPLETED|Period 1||142
2239644|NCT02595502|5492718|P2|STARTED|Period 1||142
2239645|NCT02595502|5492719|P1|STARTED|Period 1||143
2239646|NCT02595450|5492725|P1|NOT COMPLETED|Overall Study||81
2239647|NCT02595450|5492725|P1|COMPLETED|Overall Study||218
2239648|NCT02595450|5492725|P1|Treated|Overall Study||291
2239649|NCT02595450|5492725|P1|STARTED|Overall Study||299
2239650|NCT02595437|5492731|P1|NOT COMPLETED|Triferic Via Hemodialysate||0
2239651|NCT02595437|5492731|P1|COMPLETED|Triferic Via Hemodialysate||21
2239652|NCT02595437|5492731|P1|STARTED|Triferic Via Hemodialysate||21
2239653|NCT02595437|5492731|P1|NOT COMPLETED|Triferic Via IV||1
2239654|NCT02595437|5492731|P1|COMPLETED|Triferic Via IV||21
2239655|NCT02595437|5492731|P1|STARTED|Triferic Via IV||22
2239656|NCT02595073|5492751|P2|NOT COMPLETED|Overall Study||1
2239657|NCT02595073|5492752|P1|NOT COMPLETED|Overall Study||2
2239658|NCT02595073|5492751|P2|COMPLETED|Overall Study||62
2239659|NCT02595073|5492752|P1|COMPLETED|Overall Study||59
2239660|NCT02595073|5492751|P2|STARTED|Overall Study||63
2239661|NCT02595073|5492752|P1|STARTED|Overall Study||61
2239662|NCT02595008|5492762|P2|NOT COMPLETED|Overall Study||0
2239663|NCT02595008|5492763|P1|NOT COMPLETED|Overall Study||1
2239664|NCT02595008|5492762|P2|COMPLETED|Overall Study||4
2239665|NCT02595008|5492763|P1|COMPLETED|Overall Study||19
2239666|NCT02595008|5492762|P2|STARTED|Overall Study||4
2239667|NCT02595008|5492763|P1|STARTED|Overall Study||20
2239668|NCT02594826|5492771|P2|NOT COMPLETED|Overall Study||60
2239669|NCT02594826|5492772|P1|NOT COMPLETED|Overall Study||57
2239670|NCT02594826|5492771|P2|COMPLETED|Overall Study||298
2239671|NCT02594826|5492772|P1|COMPLETED|Overall Study||290
2239672|NCT02594826|5492771|P2|STARTED|Overall Study||358
2239673|NCT02594826|5492772|P1|STARTED|Overall Study||347
2239674|NCT02594644|5492782|P2|NOT COMPLETED|Overall Study||1
2239675|NCT02594644|5492783|P1|NOT COMPLETED|Overall Study||0
2239676|NCT02594644|5492782|P2|COMPLETED|Overall Study||15
2239677|NCT02594644|5492783|P1|COMPLETED|Overall Study||16
2239678|NCT02594644|5492782|P2|STARTED|Overall Study||16
2239679|NCT02594644|5492783|P1|STARTED|Overall Study||16
2239680|NCT02594163|5492801|P2|NOT COMPLETED|Follow-up Period||12
2239681|NCT02594163|5492802|P1|NOT COMPLETED|Follow-up Period||11
2239682|NCT02594163|5492801|P2|COMPLETED|Follow-up Period||1
2239683|NCT02594163|5492802|P1|COMPLETED|Follow-up Period||1
2239684|NCT02594163|5492801|P2|STARTED|Follow-up Period|All participants were to be followed after treatment|13
2239685|NCT02594163|5492802|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|12
2239686|NCT02594163|5492801|P2|NOT COMPLETED|Treatment Period||12
2239687|NCT02594163|5492802|P1|NOT COMPLETED|Treatment Period||7
2239688|NCT02594163|5492801|P2|COMPLETED|Treatment Period||1
2239689|NCT02594163|5492802|P1|COMPLETED|Treatment Period||5
2239690|NCT02594163|5492801|P2|STARTED|Treatment Period||13
2239691|NCT02594163|5492802|P1|STARTED|Treatment Period||12
2239692|NCT02594098|5492820|P2|NOT COMPLETED|Overall Study||13
2239693|NCT02594098|5492821|P1|NOT COMPLETED|Overall Study||26
2239694|NCT02594098|5492820|P2|COMPLETED|Overall Study||1
2239695|NCT02594098|5492821|P1|COMPLETED|Overall Study||1
2239696|NCT02594098|5492820|P2|STARTED|Overall Study||14
2239697|NCT02594098|5492821|P1|STARTED|Overall Study||27
2239698|NCT02593903|5492883|P2|NOT COMPLETED|Overall Study||1
2239699|NCT02593903|5492884|P1|NOT COMPLETED|Overall Study||0
2239700|NCT02593903|5492883|P2|COMPLETED|Overall Study||31
2239701|NCT02593903|5492884|P1|COMPLETED|Overall Study||35
2239702|NCT02593903|5492883|P2|STARTED|Overall Study||32
2239703|NCT02593903|5492884|P1|STARTED|Overall Study||35
2239704|NCT02593864|5492890|P1|NOT COMPLETED|Overall Study||6
2239705|NCT02593864|5492890|P1|COMPLETED|Overall Study||19
2239706|NCT02593864|5492890|P1|STARTED|Overall Study||25
2239707|NCT02593773|5492895|P1|NOT COMPLETED|Overall Study||35
2239708|NCT02593773|5492895|P1|COMPLETED|Overall Study||51
2239709|NCT02593773|5492895|P1|STARTED|Overall Study||86
2239710|NCT02593630|5492905|P1|NOT COMPLETED|Overall Study||1
2239711|NCT02593630|5492905|P1|COMPLETED|Overall Study||53
2239712|NCT02593630|5492905|P1|STARTED|Overall Study||54
2239713|NCT02593396|5492913|P2|NOT COMPLETED|Overall Study||14
2239714|NCT02593396|5492914|P1|NOT COMPLETED|Overall Study||15
2239715|NCT02593396|5492913|P2|COMPLETED|Overall Study||26
2239716|NCT02593396|5492914|P1|COMPLETED|Overall Study||25
2239717|NCT02593396|5492913|P2|At Least Done One Efficacy Assessment|Overall Study||36
2239718|NCT02593396|5492914|P1|At Least Done One Efficacy Assessment|Overall Study||36
2239719|NCT02593396|5492913|P2|STARTED|Overall Study||40
2239720|NCT02593396|5492914|P1|STARTED|Overall Study||40
2239721|NCT02593305|5492927|P3|NOT COMPLETED|Post 2||0
2239722|NCT02593305|5492928|P2|NOT COMPLETED|Post 2||0
2239723|NCT02593305|5492929|P1|NOT COMPLETED|Post 2||0
2239724|NCT02593305|5492927|P3|COMPLETED|Post 2||0
2239725|NCT02593305|5492928|P2|COMPLETED|Post 2||6
2239726|NCT02593305|5492929|P1|COMPLETED|Post 2||7
2239727|NCT02593305|5492927|P3|STARTED|Post 2||0
2239728|NCT02593305|5492928|P2|STARTED|Post 2||6
2239729|NCT02593305|5492929|P1|STARTED|Post 2||7
2239730|NCT02593305|5492927|P3|NOT COMPLETED|Baseline 2||0
2239731|NCT02593305|5492928|P2|NOT COMPLETED|Baseline 2||0
2239732|NCT02593305|5492929|P1|NOT COMPLETED|Baseline 2||0
2239733|NCT02593305|5492927|P3|COMPLETED|Baseline 2||0
2239734|NCT02593305|5492928|P2|COMPLETED|Baseline 2||6
2239735|NCT02593305|5492929|P1|COMPLETED|Baseline 2||7
2239736|NCT02593305|5492927|P3|STARTED|Baseline 2||0
2239737|NCT02593305|5492928|P2|STARTED|Baseline 2||6
2239738|NCT02593305|5492929|P1|STARTED|Baseline 2||7
2239739|NCT02593305|5492927|P3|NOT COMPLETED|Post 1||10
2239740|NCT02593305|5492928|P2|NOT COMPLETED|Post 1||0
2239741|NCT02593305|5492929|P1|NOT COMPLETED|Post 1||0
2239742|NCT02593305|5492927|P3|COMPLETED|Post 1||0
2239743|NCT02593305|5492928|P2|COMPLETED|Post 1||6
2239744|NCT02593305|5492929|P1|COMPLETED|Post 1||7
2239745|NCT02593305|5492927|P3|STARTED|Post 1||10
2239746|NCT02593305|5492928|P2|STARTED|Post 1||6
2239747|NCT02593305|5492929|P1|STARTED|Post 1||7
2239748|NCT02593305|5492927|P3|NOT COMPLETED|Baseline 1||0
2239749|NCT02593305|5492928|P2|NOT COMPLETED|Baseline 1||0
2239750|NCT02593305|5492929|P1|NOT COMPLETED|Baseline 1||0
2239751|NCT02593305|5492927|P3|COMPLETED|Baseline 1||10
2239752|NCT02593305|5492928|P2|COMPLETED|Baseline 1||6
2239753|NCT02593305|5492929|P1|COMPLETED|Baseline 1||7
2239754|NCT02593305|5492927|P3|STARTED|Baseline 1||10
2239755|NCT02593305|5492928|P2|STARTED|Baseline 1||6
2239756|NCT02593305|5492929|P1|STARTED|Baseline 1||7
2239757|NCT02593149|5492944|P2|NOT COMPLETED|Intervention||115
2239758|NCT02593149|5492945|P1|NOT COMPLETED|Intervention||116
2239759|NCT02593149|5492944|P2|COMPLETED|Intervention||845
2239760|NCT02593149|5492945|P1|COMPLETED|Intervention||826
2239761|NCT02593149|5492944|P2|STARTED|Intervention||960
2239762|NCT02593149|5492945|P1|STARTED|Intervention||942
2239763|NCT02593149|5492944|P2|NOT COMPLETED|Run-In||38
2239764|NCT02593149|5492945|P1|NOT COMPLETED|Run-In||36
2239765|NCT02593149|5492944|P2|COMPLETED|Run-In||323
2239766|NCT02593149|5492945|P1|COMPLETED|Run-In||304
2239767|NCT02593149|5492944|P2|STARTED|Run-In||361
2239768|NCT02593149|5492945|P1|STARTED|Run-In||340
2239769|NCT02592876|5492953|P2|NOT COMPLETED|Overall Study||40
2239770|NCT02592876|5492954|P1|NOT COMPLETED|Overall Study||41
2239771|NCT02592876|5492953|P2|COMPLETED|Overall Study||0
2239772|NCT02592876|5492954|P1|COMPLETED|Overall Study||0
2239773|NCT02592876|5492953|P2|Completed Treatment|Overall Study||32
2239774|NCT02592876|5492954|P1|Completed Treatment|Overall Study||34
2239775|NCT02592876|5492953|P2|Received Study Drug|Overall Study||40
2239776|NCT02592876|5492954|P1|Received Study Drug|Overall Study||40
2239777|NCT02592876|5492953|P2|STARTED|Overall Study||40
2239778|NCT02592876|5492954|P1|STARTED|Overall Study||41
2239779|NCT02592655|5492980|P1|NOT COMPLETED|Fourth Tourniquet Right Thigh.||0
2239780|NCT02592655|5492980|P1|COMPLETED|Fourth Tourniquet Right Thigh.||4
2239781|NCT02592655|5492980|P1|Tourniquet Tape 5 cm Width|Fourth Tourniquet Right Thigh.||0
2239782|NCT02592655|5492980|P1|Tourniquet Tape 10 cm Width|Fourth Tourniquet Right Thigh.||3
2239783|NCT02592655|5492980|P1|Windlass Tourniquet|Fourth Tourniquet Right Thigh.||0
2239784|NCT02592655|5492980|P1|ATS (Pneumatic)|Fourth Tourniquet Right Thigh.||1
2239785|NCT02592655|5492980|P1|STARTED|Fourth Tourniquet Right Thigh.|Only the first 4 participants received all four interventions.|4
2239786|NCT02592655|5492980|P1|NOT COMPLETED|Third Tourniquet, Left Thigh.||0
2239787|NCT02592655|5492980|P1|COMPLETED|Third Tourniquet, Left Thigh.||19
2239788|NCT02592655|5492980|P1|Tourniquet Tape 5 cm Width|Third Tourniquet, Left Thigh.||1
2239789|NCT02592655|5492980|P1|Tourniquet Tape 10 cm Width|Third Tourniquet, Left Thigh.||6
2239790|NCT02592655|5492980|P1|Windlass Tourniquet|Third Tourniquet, Left Thigh.||4
2239791|NCT02592655|5492980|P1|ATS (Pneumatic)|Third Tourniquet, Left Thigh.||8
2239792|NCT02592655|5492980|P1|STARTED|Third Tourniquet, Left Thigh.||19
2239793|NCT02592655|5492980|P1|NOT COMPLETED|Second Tourniquet Right Thigh.||0
2239794|NCT02592655|5492980|P1|COMPLETED|Second Tourniquet Right Thigh.||19
2239795|NCT02592655|5492980|P1|Tourniquet Tape 5 cm Width|Second Tourniquet Right Thigh.||1
2239796|NCT02592655|5492980|P1|Tourniquet Tape 10 cm Width|Second Tourniquet Right Thigh.||5
2239797|NCT02592655|5492980|P1|Windlass Tourniquet|Second Tourniquet Right Thigh.||8
2239798|NCT02592655|5492980|P1|ATS (Pneumatic)|Second Tourniquet Right Thigh.||5
2239799|NCT02592655|5492980|P1|STARTED|Second Tourniquet Right Thigh.||19
2239800|NCT02592655|5492980|P1|NOT COMPLETED|First Tourniquet, Left Thigh.||0
2239801|NCT02592655|5492980|P1|COMPLETED|First Tourniquet, Left Thigh.||19
2239802|NCT02592655|5492980|P1|Tourniquet Tape 5 cm Width|First Tourniquet, Left Thigh.||2
2239803|NCT02592655|5492980|P1|Tourniquet Tape 10 cm Width|First Tourniquet, Left Thigh.||5
2239804|NCT02592655|5492980|P1|Windlass Tourniquet|First Tourniquet, Left Thigh.||7
2239805|NCT02592655|5492980|P1|ATS (Pneumatic)|First Tourniquet, Left Thigh.||5
2239806|NCT02592655|5492980|P1|STARTED|First Tourniquet, Left Thigh.||19
2239807|NCT02592629|5492998|P3|NOT COMPLETED|Overall Study||0
2239808|NCT02592629|5492999|P2|NOT COMPLETED|Overall Study||0
2239809|NCT02592629|5493000|P1|NOT COMPLETED|Overall Study||0
2239810|NCT02592629|5492998|P3|COMPLETED|Overall Study||5
2239811|NCT02592629|5492999|P2|COMPLETED|Overall Study||9
2239812|NCT02592629|5493000|P1|COMPLETED|Overall Study||5
2239813|NCT02592629|5492998|P3|STARTED|Overall Study||5
2239814|NCT02592629|5492999|P2|STARTED|Overall Study||9
2239815|NCT02592629|5493000|P1|STARTED|Overall Study||5
2239816|NCT02592486|5493010|P2|NOT COMPLETED|Overall Study||5
2239817|NCT02592486|5493011|P1|NOT COMPLETED|Overall Study||0
2239818|NCT02592486|5493010|P2|COMPLETED|Overall Study||76
2239819|NCT02592486|5493011|P1|COMPLETED|Overall Study||81
2239820|NCT02592486|5493010|P2|STARTED|Overall Study||81
2239821|NCT02592486|5493011|P1|STARTED|Overall Study||81
2239822|NCT02592447|5493025|P2|NOT COMPLETED|Overall Study||1
2239823|NCT02592447|5493026|P1|NOT COMPLETED|Overall Study||2
2239824|NCT02592447|5493025|P2|COMPLETED|Overall Study||14
2239825|NCT02592447|5493026|P1|COMPLETED|Overall Study||27
2239826|NCT02592447|5493025|P2|STARTED|Overall Study||15
2239827|NCT02592447|5493026|P1|STARTED|Overall Study||29
2239852|NCT02592421|5493154|P2|NOT COMPLETED|Study 3: Pancreatic Clamp Conditions||0
2239853|NCT02592421|5493155|P1|NOT COMPLETED|Study 3: Pancreatic Clamp Conditions||0
2239854|NCT02592421|5493154|P2|COMPLETED|Study 3: Pancreatic Clamp Conditions||10
2239855|NCT02592421|5493155|P1|COMPLETED|Study 3: Pancreatic Clamp Conditions||20
2239856|NCT02592421|5493154|P2|STARTED|Study 3: Pancreatic Clamp Conditions||10
2239857|NCT02592421|5493155|P1|STARTED|Study 3: Pancreatic Clamp Conditions||20
2239858|NCT02592421|5493154|P2|NOT COMPLETED|Study 2: Glucose Clamp Conditions||0
2239859|NCT02592421|5493155|P1|NOT COMPLETED|Study 2: Glucose Clamp Conditions||0
2239860|NCT02592421|5493154|P2|COMPLETED|Study 2: Glucose Clamp Conditions||10
2239861|NCT02592421|5493155|P1|COMPLETED|Study 2: Glucose Clamp Conditions||20
2239862|NCT02592421|5493154|P2|STARTED|Study 2: Glucose Clamp Conditions||10
2239863|NCT02592421|5493155|P1|STARTED|Study 2: Glucose Clamp Conditions||20
2239864|NCT02592421|5493154|P2|NOT COMPLETED|Study 1||0
2239865|NCT02592421|5493155|P1|NOT COMPLETED|Study 1||0
2239866|NCT02592421|5493154|P2|COMPLETED|Study 1||10
2239867|NCT02592421|5493155|P1|COMPLETED|Study 1||20
2239868|NCT02592421|5493154|P2|STARTED|Study 1||10
2239869|NCT02592421|5493155|P1|STARTED|Study 1||20
2239870|NCT02591537|5493169|P2|NOT COMPLETED|Overall Study||0
2239871|NCT02591537|5493170|P1|NOT COMPLETED|Overall Study||0
2239872|NCT02591537|5493169|P2|COMPLETED|Overall Study||8
2239873|NCT02591537|5493170|P1|COMPLETED|Overall Study||8
2239874|NCT02591537|5493169|P2|STARTED|Overall Study||8
2239875|NCT02591537|5493170|P1|STARTED|Overall Study||8
2239876|NCT02591511|5493192|P2|NOT COMPLETED|Overall Study||0
2239877|NCT02591511|5493193|P1|NOT COMPLETED|Overall Study||0
2239878|NCT02591511|5493192|P2|COMPLETED|Overall Study||33
2239879|NCT02591511|5493193|P1|COMPLETED|Overall Study||30
2239880|NCT02591511|5493192|P2|STARTED|Overall Study||33
2239881|NCT02591511|5493193|P1|STARTED|Overall Study||30
2239882|NCT02591290|5493199|P1|NOT COMPLETED|Overall Study||2
2239883|NCT02591290|5493199|P1|COMPLETED|Overall Study||58
2239884|NCT02591290|5493199|P1|Vaccinated Dose 2|Overall Study||58
2239885|NCT02591290|5493199|P1|Vaccinated Dose 1|Overall Study||60
2239886|NCT02591290|5493199|P1|STARTED|Overall Study||60
2239887|NCT02591238|5493209|P4|NOT COMPLETED|Overall Study||3
2239888|NCT02591238|5493210|P3|NOT COMPLETED|Overall Study||0
2239889|NCT02591238|5493211|P2|NOT COMPLETED|Overall Study||1
2239890|NCT02591238|5493212|P1|NOT COMPLETED|Overall Study||1
2239891|NCT02591238|5493209|P4|COMPLETED|Overall Study||15
2239892|NCT02591238|5493210|P3|COMPLETED|Overall Study||17
2239893|NCT02591238|5493211|P2|COMPLETED|Overall Study||16
2239894|NCT02591238|5493212|P1|COMPLETED|Overall Study||15
2239895|NCT02591238|5493209|P4|STARTED|Overall Study||18
2239896|NCT02591238|5493210|P3|STARTED|Overall Study||17
2239897|NCT02591238|5493211|P2|STARTED|Overall Study||17
2239898|NCT02591238|5493212|P1|STARTED|Overall Study||16
2239899|NCT02591056|5493242|P1|NOT COMPLETED|Overall Study||0
2239900|NCT02591056|5493242|P1|COMPLETED|Overall Study||27
2239901|NCT02591056|5493242|P1|STARTED|Overall Study||27
2239902|NCT02590939|5493248|P2|NOT COMPLETED|Overall Study||2
2239903|NCT02590939|5493249|P1|NOT COMPLETED|Overall Study||5
2239904|NCT02590939|5493248|P2|COMPLETED|Overall Study||52
2239905|NCT02590939|5493249|P1|COMPLETED|Overall Study||47
2239906|NCT02590939|5493248|P2|STARTED|Overall Study||54
2239907|NCT02590939|5493249|P1|STARTED|Overall Study||52
2239908|NCT02590588|5493269|P1|NOT COMPLETED|Overall Study||1
2239909|NCT02590588|5493269|P1|COMPLETED|Overall Study||0
2239910|NCT02590588|5493269|P1|STARTED|Overall Study||1
2239911|NCT02590562|5493277|P1|NOT COMPLETED|Overall Study||6
2239912|NCT02590562|5493277|P1|COMPLETED|Overall Study||802
2239913|NCT02590562|5493277|P1|STARTED|Overall Study||808
2239914|NCT02590432|5493336|P9|NOT COMPLETED|Dose-reduced Open Label Treatment Period||18
2239915|NCT02590432|5493337|P8|NOT COMPLETED|Dose-reduced Open Label Treatment Period||18
2239916|NCT02590432|5493338|P7|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
2239917|NCT02590432|5493339|P6|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
2239918|NCT02590432|5493340|P5|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
2239919|NCT02590432|5493341|P4|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
2239920|NCT02590432|5493342|P3|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
2239921|NCT02590432|5493343|P2|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
2239922|NCT02590432|5493344|P1|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
2239923|NCT02590432|5493336|P9|COMPLETED|Dose-reduced Open Label Treatment Period||8
2239924|NCT02590432|5493337|P8|COMPLETED|Dose-reduced Open Label Treatment Period||13
2239925|NCT02590432|5493338|P7|COMPLETED|Dose-reduced Open Label Treatment Period||0
2239926|NCT02590432|5493339|P6|COMPLETED|Dose-reduced Open Label Treatment Period||0
2239927|NCT02590432|5493340|P5|COMPLETED|Dose-reduced Open Label Treatment Period||0
2239928|NCT02590432|5493341|P4|COMPLETED|Dose-reduced Open Label Treatment Period||0
2239929|NCT02590432|5493342|P3|COMPLETED|Dose-reduced Open Label Treatment Period||0
2239930|NCT02590432|5493343|P2|COMPLETED|Dose-reduced Open Label Treatment Period||0
2239931|NCT02590432|5493344|P1|COMPLETED|Dose-reduced Open Label Treatment Period||0
2239932|NCT02590432|5493336|P9|STARTED|Dose-reduced Open Label Treatment Period||26
2239933|NCT02590432|5493337|P8|STARTED|Dose-reduced Open Label Treatment Period||31
2239934|NCT02590432|5493338|P7|STARTED|Dose-reduced Open Label Treatment Period||0
2239935|NCT02590432|5493339|P6|STARTED|Dose-reduced Open Label Treatment Period||0
2239936|NCT02590432|5493340|P5|STARTED|Dose-reduced Open Label Treatment Period||0
2239937|NCT02590432|5493341|P4|STARTED|Dose-reduced Open Label Treatment Period||0
2239938|NCT02590432|5493342|P3|STARTED|Dose-reduced Open Label Treatment Period||0
2239939|NCT02590432|5493343|P2|STARTED|Dose-reduced Open Label Treatment Period||0
2239940|NCT02590432|5493344|P1|STARTED|Dose-reduced Open Label Treatment Period||0
2239941|NCT02590432|5493336|P9|NOT COMPLETED|Double-blind Treatment Period||0
2239942|NCT02590432|5493337|P8|NOT COMPLETED|Double-blind Treatment Period||0
2239943|NCT02590432|5493338|P7|NOT COMPLETED|Double-blind Treatment Period||21
2239944|NCT02590432|5493339|P6|NOT COMPLETED|Double-blind Treatment Period||26
2239945|NCT02590432|5493340|P5|NOT COMPLETED|Double-blind Treatment Period||9
2239946|NCT02590432|5493341|P4|NOT COMPLETED|Double-blind Treatment Period||15
2239947|NCT02590432|5493342|P3|NOT COMPLETED|Double-blind Treatment Period||17
2239948|NCT02590432|5493343|P2|NOT COMPLETED|Double-blind Treatment Period||0
2239949|NCT02590432|5493344|P1|NOT COMPLETED|Double-blind Treatment Period||0
2239950|NCT02590432|5493336|P9|COMPLETED|Double-blind Treatment Period||0
2239951|NCT02590432|5493337|P8|COMPLETED|Double-blind Treatment Period||0
2239952|NCT02590432|5493338|P7|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|9
2239953|NCT02590432|5493339|P6|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|6
2239954|NCT02590432|5493340|P5|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|7
2239955|NCT02590432|5493341|P4|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|3
2239956|NCT02590432|5493342|P3|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|1
2239957|NCT02590432|5493343|P2|COMPLETED|Double-blind Treatment Period||0
2239958|NCT02590432|5493344|P1|COMPLETED|Double-blind Treatment Period||0
2239959|NCT02590432|5493336|P9|STARTED|Double-blind Treatment Period||0
2239960|NCT02590432|5493337|P8|STARTED|Double-blind Treatment Period||0
2239961|NCT02590432|5493338|P7|STARTED|Double-blind Treatment Period||30
2239962|NCT02590432|5493339|P6|STARTED|Double-blind Treatment Period||32
2239963|NCT02590432|5493340|P5|STARTED|Double-blind Treatment Period||16
2239964|NCT02590432|5493341|P4|STARTED|Double-blind Treatment Period||18
2239965|NCT02590432|5493342|P3|STARTED|Double-blind Treatment Period||18
2239966|NCT02590432|5493343|P2|STARTED|Double-blind Treatment Period||0
2239967|NCT02590432|5493344|P1|STARTED|Double-blind Treatment Period||0
2239968|NCT02590432|5493336|P9|NOT COMPLETED|Open-label Treatment Period||0
2239969|NCT02590432|5493337|P8|NOT COMPLETED|Open-label Treatment Period||0
2239970|NCT02590432|5493338|P7|NOT COMPLETED|Open-label Treatment Period||0
2239971|NCT02590432|5493339|P6|NOT COMPLETED|Open-label Treatment Period||0
2239972|NCT02590432|5493340|P5|NOT COMPLETED|Open-label Treatment Period||0
2239973|NCT02590432|5493341|P4|NOT COMPLETED|Open-label Treatment Period||0
2239974|NCT02590432|5493342|P3|NOT COMPLETED|Open-label Treatment Period||0
2239975|NCT02590432|5493343|P2|NOT COMPLETED|Open-label Treatment Period||152
2239976|NCT02590432|5493344|P1|NOT COMPLETED|Open-label Treatment Period||232
2239977|NCT02590432|5493336|P9|COMPLETED|Open-label Treatment Period||0
2239978|NCT02590432|5493337|P8|COMPLETED|Open-label Treatment Period||0
2239979|NCT02590432|5493338|P7|COMPLETED|Open-label Treatment Period||0
2239980|NCT02590432|5493339|P6|COMPLETED|Open-label Treatment Period||0
2239981|NCT02590432|5493340|P5|COMPLETED|Open-label Treatment Period||0
2239982|NCT02590432|5493341|P4|COMPLETED|Open-label Treatment Period||0
2239983|NCT02590432|5493342|P3|COMPLETED|Open-label Treatment Period||0
2239984|NCT02590432|5493343|P2|COMPLETED|Open-label Treatment Period|Participants were not randomized to Double-blind Treatment Period.|166
2239985|NCT02590432|5493344|P1|COMPLETED|Open-label Treatment Period|Participants were not randomized to Double-blind Treatment Period.|276
2239986|NCT02590432|5493336|P9|STARTED|Open-label Treatment Period||0
2239987|NCT02590432|5493337|P8|STARTED|Open-label Treatment Period||0
2239988|NCT02590432|5493338|P7|STARTED|Open-label Treatment Period||0
2239989|NCT02590432|5493339|P6|STARTED|Open-label Treatment Period||0
2239990|NCT02590432|5493340|P5|STARTED|Open-label Treatment Period||0
2239991|NCT02590432|5493341|P4|STARTED|Open-label Treatment Period||0
2239992|NCT02590432|5493342|P3|STARTED|Open-label Treatment Period||0
2239993|NCT02590432|5493343|P2|STARTED|Open-label Treatment Period||318
2239994|NCT02590432|5493344|P1|STARTED|Open-label Treatment Period||508
2239995|NCT02590354|5493378|P1|NOT COMPLETED|Phase 2 - Treatment Interruption||2
2239996|NCT02590354|5493378|P1|COMPLETED|Phase 2 - Treatment Interruption||14
2239997|NCT02590354|5493378|P1|STARTED|Phase 2 - Treatment Interruption||16
2239998|NCT02590354|5493378|P1|NOT COMPLETED|Phase 1||98
2239999|NCT02590354|5493378|P1|COMPLETED|Phase 1||16
2240000|NCT02590354|5493378|P1|STARTED|Phase 1||114
2240001|NCT02590068|5493388|P2|NOT COMPLETED|Overall Study||0
2240002|NCT02590068|5493389|P1|NOT COMPLETED|Overall Study||0
2240003|NCT02590068|5493388|P2|COMPLETED|Overall Study||14
2240004|NCT02590068|5493389|P1|COMPLETED|Overall Study||0
2240005|NCT02590068|5493388|P2|STARTED|Overall Study||14
2240006|NCT02590068|5493389|P1|STARTED|Overall Study||0
2240007|NCT02590003|5493405|P2|NOT COMPLETED|Overall Study||2
2240008|NCT02590003|5493406|P1|NOT COMPLETED|Overall Study||1
2240009|NCT02590003|5493405|P2|COMPLETED|Overall Study||0
2240010|NCT02590003|5493406|P1|COMPLETED|Overall Study||0
2240011|NCT02590003|5493405|P2|STARTED|Overall Study||2
2240012|NCT02590003|5493406|P1|STARTED|Overall Study||1
2240013|NCT02589808|5493426|P1|NOT COMPLETED|Overall Study||0
2240014|NCT02589808|5493426|P1|COMPLETED|Overall Study||76
2240015|NCT02589808|5493426|P1|STARTED|Overall Study||76
2240016|NCT02589639|5493433|P3|NOT COMPLETED|Overall Study||4
2240017|NCT02589639|5493434|P2|NOT COMPLETED|Overall Study||10
2240018|NCT02589639|5493435|P1|NOT COMPLETED|Overall Study||10
2240019|NCT02589639|5493433|P3|COMPLETED|Overall Study||86
2240020|NCT02589639|5493434|P2|COMPLETED|Overall Study||79
2240021|NCT02589639|5493435|P1|COMPLETED|Overall Study||80
2240022|NCT02589639|5493433|P3|Treated|Overall Study||90
2240023|NCT02589639|5493434|P2|Treated|Overall Study||86
2240024|NCT02589639|5493435|P1|Treated|Overall Study||90
2240025|NCT02589639|5493433|P3|STARTED|Overall Study||90
2240026|NCT02589639|5493434|P2|STARTED|Overall Study||89
2240027|NCT02589639|5493435|P1|STARTED|Overall Study||90
2240028|NCT02589626|5493448|P2|NOT COMPLETED|Overall Study||2
2240029|NCT02589626|5493449|P1|NOT COMPLETED|Overall Study||3
2240030|NCT02589626|5493448|P2|COMPLETED|Overall Study||31
2240031|NCT02589626|5493449|P1|COMPLETED|Overall Study||29
2240032|NCT02589626|5493448|P2|STARTED|Overall Study|Entered are treated patients|33
2240033|NCT02589626|5493449|P1|STARTED|Overall Study|Entered are treated patients|32
2240034|NCT02589405|5493457|P1|NOT COMPLETED|Overall Study||4
2240035|NCT02589405|5493457|P1|COMPLETED|Overall Study||46
2240036|NCT02589405|5493457|P1|STARTED|Overall Study||50
2240037|NCT02589171|5493463|P2|NOT COMPLETED|Overall Study||5
2240038|NCT02589171|5493464|P1|NOT COMPLETED|Overall Study||7
2240039|NCT02589171|5493463|P2|COMPLETED|Overall Study||30
2240040|NCT02589171|5493464|P1|COMPLETED|Overall Study||28
2240041|NCT02589171|5493463|P2|Week 6 Follow up|Overall Study||30
2240042|NCT02589171|5493464|P1|Week 6 Follow up|Overall Study||28
2240043|NCT02589171|5493463|P2|Week 1 Follow up|Overall Study||34
2240044|NCT02589171|5493464|P1|Week 1 Follow up|Overall Study||35
2240045|NCT02589171|5493463|P2|Day 1 Follow up|Overall Study||35
2240046|NCT02589171|5493464|P1|Day 1 Follow up|Overall Study||35
2240047|NCT02589171|5493463|P2|STARTED|Overall Study||35
2240048|NCT02589171|5493464|P1|STARTED|Overall Study||35
2240049|NCT02589145|5493507|P3|NOT COMPLETED|Overall Study||0
2240050|NCT02589145|5493508|P2|NOT COMPLETED|Overall Study||0
2240051|NCT02589145|5493509|P1|NOT COMPLETED|Overall Study||0
2240052|NCT02589145|5493507|P3|COMPLETED|Overall Study||2
2240053|NCT02589145|5493508|P2|COMPLETED|Overall Study||2
2240054|NCT02589145|5493509|P1|COMPLETED|Overall Study||4
2240055|NCT02589145|5493507|P3|STARTED|Overall Study||2
2240056|NCT02589145|5493508|P2|STARTED|Overall Study||2
2240057|NCT02589145|5493509|P1|STARTED|Overall Study||4
2240058|NCT02588976|5493535|P1|NOT COMPLETED|Overall Study||0
2240059|NCT02588976|5493535|P1|COMPLETED|Overall Study||30
2240060|NCT02588976|5493535|P1|STARTED|Overall Study||30
2240061|NCT02588872|5493542|P2|NOT COMPLETED|Overall Study||0
2240062|NCT02588872|5493543|P1|NOT COMPLETED|Overall Study||0
2240063|NCT02588872|5493542|P2|COMPLETED|Overall Study||52
2240064|NCT02588872|5493543|P1|COMPLETED|Overall Study||59
2240065|NCT02588872|5493542|P2|STARTED|Overall Study||52
2240066|NCT02588872|5493543|P1|STARTED|Overall Study||59
2240067|NCT02588599|5493557|P1|NOT COMPLETED|Overall Study||0
2240068|NCT02588599|5493557|P1|COMPLETED|Overall Study||54
2240069|NCT02588599|5493557|P1|STARTED|Overall Study||54
2240070|NCT02588573|5493564|P2|NOT COMPLETED|Overall Study||0
2240071|NCT02588573|5493565|P1|NOT COMPLETED|Overall Study||0
2240072|NCT02588573|5493564|P2|COMPLETED|Overall Study||45
2240073|NCT02588573|5493565|P1|COMPLETED|Overall Study||45
2240074|NCT02588573|5493564|P2|Randomized Eye Somofilcon A|Overall Study||45
2240075|NCT02588573|5493565|P1|Randomized Eye Somofilcon A|Overall Study||45
2240076|NCT02588573|5493564|P2|Randomized Eye Etafilcon A|Overall Study||45
2240077|NCT02588573|5493565|P1|Randomized Eye Etafilcon A|Overall Study||45
2240078|NCT02588573|5493564|P2|STARTED|Overall Study||45
2240079|NCT02588573|5493565|P1|STARTED|Overall Study||45
2240080|NCT02588339|5493595|P1|NOT COMPLETED|Overall Study||3
2240081|NCT02588339|5493595|P1|COMPLETED|Overall Study||39
2240082|NCT02588339|5493595|P1|STARTED|Overall Study||42
2240083|NCT02588261|5493607|P2|NOT COMPLETED|Overall Study||263
2240084|NCT02588261|5493608|P1|NOT COMPLETED|Overall Study||267
2240085|NCT02588261|5493607|P2|COMPLETED|Overall Study||0
2240086|NCT02588261|5493608|P1|COMPLETED|Overall Study||0
2240087|NCT02588261|5493607|P2|Treated|Overall Study||262
2240088|NCT02588261|5493608|P1|Treated|Overall Study||265
2240089|NCT02588261|5493607|P2|STARTED|Overall Study||263
2240090|NCT02588261|5493608|P1|STARTED|Overall Study||267
2240091|NCT02587819|5493634|P1|NOT COMPLETED|Overall Study||2
2240092|NCT02587819|5493634|P1|COMPLETED|Overall Study||19
2240093|NCT02587819|5493634|P1|Exposed|Overall Study||21
2240094|NCT02587819|5493634|P1|STARTED|Overall Study||21
2240095|NCT02587650|5493641|P4|NOT COMPLETED|Overall Study||0
2240096|NCT02587650|5493642|P3|NOT COMPLETED|Overall Study||0
2240097|NCT02587650|5493643|P2|NOT COMPLETED|Overall Study||0
2240098|NCT02587650|5493644|P1|NOT COMPLETED|Overall Study||0
2240099|NCT02587650|5493641|P4|COMPLETED|Overall Study||0
2240100|NCT02587650|5493642|P3|COMPLETED|Overall Study||1
2240101|NCT02587650|5493643|P2|COMPLETED|Overall Study||0
2240102|NCT02587650|5493644|P1|COMPLETED|Overall Study||0
2240103|NCT02587650|5493641|P4|STARTED|Overall Study||0
2240104|NCT02587650|5493642|P3|STARTED|Overall Study||1
2240105|NCT02587650|5493643|P2|STARTED|Overall Study||0
2240106|NCT02587650|5493644|P1|STARTED|Overall Study||0
2240107|NCT02587234|5493654|P2|NOT COMPLETED|Overall Study||3
2240108|NCT02587234|5493655|P1|NOT COMPLETED|Overall Study||1
2240109|NCT02587234|5493654|P2|COMPLETED|Overall Study||7
2240110|NCT02587234|5493655|P1|COMPLETED|Overall Study||10
2240111|NCT02587234|5493654|P2|STARTED|Overall Study||10
2240112|NCT02587234|5493655|P1|STARTED|Overall Study||11
2240113|NCT02587143|5493667|P2|NOT COMPLETED|Overall Study||0
2240114|NCT02587143|5493668|P1|NOT COMPLETED|Overall Study||1
2240115|NCT02587143|5493667|P2|COMPLETED|Overall Study||60
2240116|NCT02587143|5493668|P1|COMPLETED|Overall Study||65
2240117|NCT02587143|5493667|P2|STARTED|Overall Study||60
2240118|NCT02587143|5493668|P1|STARTED|Overall Study||66
2240119|NCT02587117|5493676|P2|NOT COMPLETED|Overall Study||0
2240120|NCT02587117|5493677|P1|NOT COMPLETED|Overall Study||0
2240121|NCT02587117|5493676|P2|COMPLETED|Overall Study||15
2240122|NCT02587117|5493677|P1|COMPLETED|Overall Study||13
2240123|NCT02587117|5493676|P2|STARTED|Overall Study||15
2240124|NCT02587117|5493677|P1|STARTED|Overall Study||13
2240125|NCT02587065|5493685|P1|NOT COMPLETED|Overall Study||27
2240126|NCT02587065|5493685|P1|COMPLETED|Overall Study||166
2240127|NCT02587065|5493685|P1|STARTED|Overall Study||193
2240128|NCT02586974|5493701|P2|NOT COMPLETED|Overall Study||0
2240129|NCT02586974|5493702|P1|NOT COMPLETED|Overall Study||0
2240130|NCT02586974|5493701|P2|COMPLETED|Overall Study||32
2240131|NCT02586974|5493702|P1|COMPLETED|Overall Study||32
2240132|NCT02586974|5493701|P2|STARTED|Overall Study||32
2240133|NCT02586974|5493702|P1|STARTED|Overall Study||32
2240134|NCT02586805|5493718|P4|NOT COMPLETED|Overall Study||2
2240135|NCT02586805|5493719|P3|NOT COMPLETED|Overall Study||3
2240136|NCT02586805|5493720|P2|NOT COMPLETED|Overall Study||1
2240137|NCT02586805|5493721|P1|NOT COMPLETED|Overall Study||6
2240138|NCT02586805|5493718|P4|COMPLETED|Overall Study||25
2240139|NCT02586805|5493719|P3|COMPLETED|Overall Study||26
2240140|NCT02586805|5493720|P2|COMPLETED|Overall Study||27
2240141|NCT02586805|5493721|P1|COMPLETED|Overall Study||35
2240142|NCT02586805|5493718|P4|STARTED|Overall Study||27
2240143|NCT02586805|5493719|P3|STARTED|Overall Study||29
2240144|NCT02586805|5493720|P2|STARTED|Overall Study||28
2240145|NCT02586805|5493721|P1|STARTED|Overall Study||41
2240146|NCT02586675|5493743|P1|NOT COMPLETED|Overall Study||0
2240147|NCT02586675|5493743|P1|COMPLETED|Overall Study||7
2240148|NCT02586675|5493743|P1|STARTED|Overall Study||7
2240149|NCT02586506|5493749|P1|NOT COMPLETED|Overall Study||9
2240150|NCT02586506|5493749|P1|COMPLETED|Overall Study||250
2240151|NCT02586506|5493749|P1|STARTED|Overall Study||259
2240152|NCT02586493|5493755|P1|NOT COMPLETED|Overall Study||12
2240153|NCT02586493|5493755|P1|COMPLETED|Overall Study||266
2240154|NCT02586493|5493755|P1|STARTED|Overall Study||278
2240155|NCT02586415|5493763|P2|NOT COMPLETED|Overall Study||25
2240156|NCT02586415|5493764|P1|NOT COMPLETED|Overall Study||14
2240157|NCT02586415|5493763|P2|COMPLETED|Overall Study||65
2240158|NCT02586415|5493764|P1|COMPLETED|Overall Study||78
2240159|NCT02586415|5493763|P2|Day 90 Assessment|Overall Study||65
2240160|NCT02586415|5493764|P1|Day 90 Assessment|Overall Study||78
2240161|NCT02586415|5493763|P2|Day 30 Assessment|Overall Study||70
2240162|NCT02586415|5493764|P1|Day 30 Assessment|Overall Study||81
2240163|NCT02586415|5493763|P2|24 Hour Assessment|Overall Study||90
2240164|NCT02586415|5493764|P1|24 Hour Assessment|Overall Study||91
2240165|NCT02586415|5493763|P2|STARTED|Overall Study||90
2240166|NCT02586415|5493764|P1|STARTED|Overall Study||92
2240167|NCT02586025|5493776|P2|NOT COMPLETED|Treatment-Free Follow-Up||35
2240168|NCT02586025|5493777|P1|NOT COMPLETED|Treatment-Free Follow-Up||56
2240169|NCT02586025|5493776|P2|COMPLETED|Treatment-Free Follow-Up||3
2240170|NCT02586025|5493777|P1|COMPLETED|Treatment-Free Follow-Up||3
2240171|NCT02586025|5493776|P2|STARTED|Treatment-Free Follow-Up||38
2240172|NCT02586025|5493777|P1|STARTED|Treatment-Free Follow-Up||59
2240173|NCT02586025|5493776|P2|NOT COMPLETED|Adjuvant Treatment||69
2240174|NCT02586025|5493777|P1|NOT COMPLETED|Adjuvant Treatment||139
2240175|NCT02586025|5493776|P2|COMPLETED|Adjuvant Treatment||34
2240176|NCT02586025|5493777|P1|COMPLETED|Adjuvant Treatment||69
2240177|NCT02586025|5493776|P2|Started Adjuvant HER2 Treatment|Adjuvant Treatment||99
2240178|NCT02586025|5493777|P1|Started Adjuvant HER2 Treatment|Adjuvant Treatment||204
2240179|NCT02586025|5493776|P2|Started Adjuvant FEC Treatment|Adjuvant Treatment||103
2240180|NCT02586025|5493777|P1|Started Adjuvant FEC Treatment|Adjuvant Treatment||208
2240181|NCT02586025|5493776|P2|STARTED|Adjuvant Treatment||103
2240182|NCT02586025|5493777|P1|STARTED|Adjuvant Treatment||208
2240183|NCT02586025|5493776|P2|NOT COMPLETED|Neoadjuvant Treatment||7
2240184|NCT02586025|5493777|P1|NOT COMPLETED|Neoadjuvant Treatment||11
2240185|NCT02586025|5493776|P2|COMPLETED|Neoadjuvant Treatment||103
2240186|NCT02586025|5493777|P1|COMPLETED|Neoadjuvant Treatment||208
2240187|NCT02586025|5493776|P2|Underwent Surgery|Neoadjuvant Treatment||105
2240188|NCT02586025|5493777|P1|Underwent Surgery|Neoadjuvant Treatment||210
2240189|NCT02586025|5493776|P2|Completed Neoadjuvant Treatment|Neoadjuvant Treatment||108
2240190|NCT02586025|5493777|P1|Completed Neoadjuvant Treatment|Neoadjuvant Treatment||214
2240191|NCT02586025|5493776|P2|Received at Least One Dose of Study Drug|Neoadjuvant Treatment||110
2240192|NCT02586025|5493777|P1|Received at Least One Dose of Study Drug|Neoadjuvant Treatment||218
2240193|NCT02586025|5493776|P2|STARTED|Neoadjuvant Treatment||110
2240194|NCT02586025|5493777|P1|STARTED|Neoadjuvant Treatment||219
2240195|NCT02585999|5493813|P1|NOT COMPLETED|Overall Study||2
2240196|NCT02585999|5493813|P1|COMPLETED|Overall Study|28 participants enrolled; 2 withdrew prior to starting, leaving 26 to complete study activity.|26
2240197|NCT02585999|5493813|P1|STARTED|Overall Study||28
2240198|NCT02585960|5493821|P3|NOT COMPLETED|Prophylactic Treatment Period||0
2240199|NCT02585960|5493822|P2|NOT COMPLETED|Prophylactic Treatment Period||5
2240200|NCT02585960|5493823|P1|NOT COMPLETED|Prophylactic Treatment Period||0
2240201|NCT02585960|5493821|P3|COMPLETED|Prophylactic Treatment Period||0
2240202|NCT02585960|5493822|P2|COMPLETED|Prophylactic Treatment Period||43
2240203|NCT02585960|5493823|P1|COMPLETED|Prophylactic Treatment Period||52
2240204|NCT02585960|5493821|P3|STARTED|Prophylactic Treatment Period||0
2240205|NCT02585960|5493822|P2|STARTED|Prophylactic Treatment Period||48
2240206|NCT02585960|5493823|P1|STARTED|Prophylactic Treatment Period||52
2240207|NCT02585960|5493821|P3|NOT COMPLETED|PK/Safety Assessment Period||6
2240208|NCT02585960|5493822|P2|NOT COMPLETED|PK/Safety Assessment Period||10
2240209|NCT02585960|5493823|P1|NOT COMPLETED|PK/Safety Assessment Period||5
2240210|NCT02585960|5493821|P3|COMPLETED|PK/Safety Assessment Period||0
2240211|NCT02585960|5493822|P2|COMPLETED|PK/Safety Assessment Period||48
2240212|NCT02585960|5493823|P1|COMPLETED|PK/Safety Assessment Period||52
2240213|NCT02585960|5493821|P3|Completed 2nd 6 Month Period|PK/Safety Assessment Period||0
2240214|NCT02585960|5493822|P2|Completed 2nd 6 Month Period|PK/Safety Assessment Period||48
2240215|NCT02585960|5493823|P1|Completed 2nd 6 Month Period|PK/Safety Assessment Period||52
2240216|NCT02585960|5493821|P3|Completed 1st 6 Month Period|PK/Safety Assessment Period||0
2240217|NCT02585960|5493822|P2|Completed 1st 6 Month Period|PK/Safety Assessment Period||53
2240218|NCT02585960|5493823|P1|Completed 1st 6 Month Period|PK/Safety Assessment Period||57
2240219|NCT02585960|5493821|P3|STARTED|PK/Safety Assessment Period||6
2240220|NCT02585960|5493822|P2|STARTED|PK/Safety Assessment Period||58
2240221|NCT02585960|5493823|P1|STARTED|PK/Safety Assessment Period||57
2240222|NCT02585934|5493893|P2|NOT COMPLETED|Overall Study||73
2240223|NCT02585934|5493894|P1|NOT COMPLETED|Overall Study||69
2240224|NCT02585934|5493893|P2|COMPLETED|Overall Study||581
2240225|NCT02585934|5493894|P1|COMPLETED|Overall Study||592
2240226|NCT02585934|5493893|P2|Per Protocol (PP)|Overall Study||582
2240227|NCT02585934|5493894|P1|Per Protocol (PP)|Overall Study||603
2240228|NCT02585934|5493893|P2|Intent to Treat (ITT)|Overall Study||633
2240229|NCT02585934|5493894|P1|Intent to Treat (ITT)|Overall Study||643
2240230|NCT02585934|5493893|P2|Safety Population|Overall Study||651
2240231|NCT02585934|5493894|P1|Safety Population|Overall Study||656
2240232|NCT02585934|5493893|P2|STARTED|Overall Study||654
2240233|NCT02585934|5493894|P1|STARTED|Overall Study||661
2240234|NCT02585895|5493917|P2|NOT COMPLETED|Post-primary Period||0
2240235|NCT02585895|5493918|P1|NOT COMPLETED|Post-primary Period||0
2240236|NCT02585895|5493917|P2|COMPLETED|Post-primary Period||19
2240237|NCT02585895|5493918|P1|COMPLETED|Post-primary Period||20
2240238|NCT02585895|5493917|P2|STARTED|Post-primary Period||19
2240239|NCT02585895|5493918|P1|STARTED|Post-primary Period||20
2240240|NCT02585895|5493917|P2|NOT COMPLETED|Primary Period||0
2240241|NCT02585895|5493918|P1|NOT COMPLETED|Primary Period||0
2240242|NCT02585895|5493917|P2|COMPLETED|Primary Period||19
2240243|NCT02585895|5493918|P1|COMPLETED|Primary Period||20
2240244|NCT02585895|5493917|P2|STARTED|Primary Period||19
2240245|NCT02585895|5493918|P1|STARTED|Primary Period||20
2240246|NCT02585843|5493935|P2|NOT COMPLETED|Overall Study||0
2240247|NCT02585843|5493936|P1|NOT COMPLETED|Overall Study||1
2240248|NCT02585843|5493935|P2|COMPLETED|Overall Study||10
2240249|NCT02585843|5493936|P1|COMPLETED|Overall Study||9
2240250|NCT02585843|5493935|P2|STARTED|Overall Study||10
2240251|NCT02585843|5493936|P1|STARTED|Overall Study||10
2240255|NCT02585778|5493959|P2|NOT COMPLETED|Overall Study||15
2240256|NCT02585778|5493960|P1|NOT COMPLETED|Overall Study||33
2240257|NCT02585778|5493959|P2|COMPLETED|Overall Study||157
2240258|NCT02585778|5493960|P1|COMPLETED|Overall Study||312
2240259|NCT02585778|5493959|P2|T2DM Participants|Overall Study||147
2240260|NCT02585778|5493960|P1|T2DM Participants|Overall Study||294
2240261|NCT02585778|5493959|P2|T1DM Participants|Overall Study||25
2240262|NCT02585778|5493960|P1|T1DM Participants|Overall Study||51
2240263|NCT02585778|5493959|P2|mITT Population|Overall Study||164
2240264|NCT02585778|5493960|P1|mITT Population|Overall Study||333
2240265|NCT02585778|5493959|P2|ITT Population|Overall Study||167
2240266|NCT02585778|5493960|P1|ITT Population|Overall Study||336
2240267|NCT02585778|5493959|P2|Treated (Safety Population)|Overall Study||170
2240268|NCT02585778|5493960|P1|Treated (Safety Population)|Overall Study||344
2240269|NCT02585778|5493959|P2|STARTED|Overall Study|Randomized|172
2240270|NCT02585778|5493960|P1|STARTED|Overall Study|Randomized|345
2240271|NCT02585713|5494076|P2|NOT COMPLETED|Overall Study||8
2240272|NCT02585713|5494077|P1|NOT COMPLETED|Overall Study||5
2240273|NCT02585713|5494076|P2|COMPLETED|Overall Study||142
2240274|NCT02585713|5494077|P1|COMPLETED|Overall Study||145
2240275|NCT02585713|5494076|P2|STARTED|Overall Study||150
2240276|NCT02585713|5494077|P1|STARTED|Overall Study||150
2240277|NCT02585700|5494089|P2|NOT COMPLETED|Overall Study||0
2240278|NCT02585700|5494090|P1|NOT COMPLETED|Overall Study||0
2240279|NCT02585700|5494089|P2|COMPLETED|Overall Study||30
2240280|NCT02585700|5494090|P1|COMPLETED|Overall Study||30
2240281|NCT02585700|5494089|P2|STARTED|Overall Study||30
2240282|NCT02585700|5494090|P1|STARTED|Overall Study||30
2240283|NCT02585245|5494116|P1|NOT COMPLETED|Overall Study||13
2240284|NCT02585245|5494116|P1|COMPLETED|Overall Study||594
2240285|NCT02585245|5494116|P1|STARTED|Overall Study||607
2240286|NCT02584998|5494124|P3|NOT COMPLETED|Overall Study||0
2240287|NCT02584998|5494125|P2|NOT COMPLETED|Overall Study||0
2240288|NCT02584998|5494126|P1|NOT COMPLETED|Overall Study||0
2240289|NCT02584998|5494124|P3|COMPLETED|Overall Study||261
2240290|NCT02584998|5494125|P2|COMPLETED|Overall Study||261
2240291|NCT02584998|5494126|P1|COMPLETED|Overall Study||260
2240292|NCT02584998|5494124|P3|STARTED|Overall Study||261
2240293|NCT02584998|5494125|P2|STARTED|Overall Study||261
2240294|NCT02584998|5494126|P1|STARTED|Overall Study||260
2240295|NCT02584959|5494140|P3|NOT COMPLETED|Period 2||2
2240296|NCT02584959|5494141|P2|NOT COMPLETED|Period 2||1
2240297|NCT02584959|5494142|P1|NOT COMPLETED|Period 2||6
2240298|NCT02584959|5494140|P3|COMPLETED|Period 2||13
2240299|NCT02584959|5494141|P2|COMPLETED|Period 2||24
2240300|NCT02584959|5494142|P1|COMPLETED|Period 2||22
2240301|NCT02584959|5494140|P3|STARTED|Period 2||15
2240302|NCT02584959|5494141|P2|STARTED|Period 2||25
2240303|NCT02584959|5494142|P1|STARTED|Period 2||28
2240304|NCT02584959|5494140|P3|NOT COMPLETED|Period 1||0
2240305|NCT02584959|5494141|P2|NOT COMPLETED|Period 1||4
2240306|NCT02584959|5494142|P1|NOT COMPLETED|Period 1||3
2240307|NCT02584959|5494140|P3|COMPLETED|Period 1||15
2240308|NCT02584959|5494141|P2|COMPLETED|Period 1||25
2240309|NCT02584959|5494142|P1|COMPLETED|Period 1||28
2240310|NCT02584959|5494140|P3|STARTED|Period 1||15
2240311|NCT02584959|5494141|P2|STARTED|Period 1||29
2240312|NCT02584959|5494142|P1|STARTED|Period 1||31
2240313|NCT02584855|5494197|P6|NOT COMPLETED|Post Treatment Follow-up Period||0
2240314|NCT02584855|5494198|P5|NOT COMPLETED|Post Treatment Follow-up Period||8
2240315|NCT02584855|5494199|P4|NOT COMPLETED|Post Treatment Follow-up Period||0
2240316|NCT02584855|5494200|P3|NOT COMPLETED|Post Treatment Follow-up Period||0
2240317|NCT02584855|5494201|P2|NOT COMPLETED|Post Treatment Follow-up Period||0
2240318|NCT02584855|5494202|P1|NOT COMPLETED|Post Treatment Follow-up Period||0
2240319|NCT02584855|5494197|P6|COMPLETED|Post Treatment Follow-up Period||12
2240320|NCT02584855|5494198|P5|COMPLETED|Post Treatment Follow-up Period||347
2240321|NCT02584855|5494199|P4|COMPLETED|Post Treatment Follow-up Period||0
2240322|NCT02584855|5494200|P3|COMPLETED|Post Treatment Follow-up Period||0
2240323|NCT02584855|5494201|P2|COMPLETED|Post Treatment Follow-up Period||0
2240324|NCT02584855|5494202|P1|COMPLETED|Post Treatment Follow-up Period||0
2240325|NCT02584855|5494197|P6|STARTED|Post Treatment Follow-up Period||12
2240326|NCT02584855|5494198|P5|STARTED|Post Treatment Follow-up Period||355
2240327|NCT02584855|5494199|P4|STARTED|Post Treatment Follow-up Period||0
2240328|NCT02584855|5494200|P3|STARTED|Post Treatment Follow-up Period||0
2240329|NCT02584855|5494201|P2|STARTED|Post Treatment Follow-up Period||0
2240330|NCT02584855|5494202|P1|STARTED|Post Treatment Follow-up Period||0
2240331|NCT02584855|5494197|P6|NOT COMPLETED|Double-Blind Withdrawal Period||0
2240332|NCT02584855|5494198|P5|NOT COMPLETED|Double-Blind Withdrawal Period||0
2240333|NCT02584855|5494199|P4|NOT COMPLETED|Double-Blind Withdrawal Period||1
2240334|NCT02584855|5494200|P3|NOT COMPLETED|Double-Blind Withdrawal Period||2
2240335|NCT02584855|5494201|P2|NOT COMPLETED|Double-Blind Withdrawal Period||15
2240336|NCT02584855|5494202|P1|NOT COMPLETED|Double-Blind Withdrawal Period||0
2240337|NCT02584855|5494197|P6|COMPLETED|Double-Blind Withdrawal Period||0
2240338|NCT02584855|5494198|P5|COMPLETED|Double-Blind Withdrawal Period||0
2240339|NCT02584855|5494199|P4|COMPLETED|Double-Blind Withdrawal Period||78
2240340|NCT02584855|5494200|P3|COMPLETED|Double-Blind Withdrawal Period||77
2240341|NCT02584855|5494201|P2|COMPLETED|Double-Blind Withdrawal Period||118
2240342|NCT02584855|5494202|P1|COMPLETED|Double-Blind Withdrawal Period||0
2240343|NCT02584855|5494197|P6|Relapsed|Double-Blind Withdrawal Period||0
2240344|NCT02584855|5494198|P5|Relapsed|Double-Blind Withdrawal Period||0
2240345|NCT02584855|5494199|P4|Relapsed|Double-Blind Withdrawal Period||30
2240346|NCT02584855|5494200|P3|Relapsed|Double-Blind Withdrawal Period||67
2240347|NCT02584855|5494201|P2|Relapsed|Double-Blind Withdrawal Period||0
2240348|NCT02584855|5494202|P1|Relapsed|Double-Blind Withdrawal Period||0
2240349|NCT02584855|5494197|P6|STARTED|Double-Blind Withdrawal Period||0
2240350|NCT02584855|5494198|P5|STARTED|Double-Blind Withdrawal Period||0
2240351|NCT02584855|5494199|P4|STARTED|Double-Blind Withdrawal Period|Participants completed open label and met criteria for double-blind withdrawal period.|79
2240352|NCT02584855|5494200|P3|STARTED|Double-Blind Withdrawal Period|Participants completed open label and met criteria for double-blind withdrawal period.|79
2240353|NCT02584855|5494201|P2|STARTED|Double-Blind Withdrawal Period|Participants completed open label but did not meet criteria for double-blind withdrawal period.|133
2240354|NCT02584855|5494202|P1|STARTED|Double-Blind Withdrawal Period||0
2240355|NCT02584855|5494197|P6|NOT COMPLETED|Open-Label Treatment Period||0
2240356|NCT02584855|5494198|P5|NOT COMPLETED|Open-Label Treatment Period||0
2240357|NCT02584855|5494199|P4|NOT COMPLETED|Open-Label Treatment Period||0
2240358|NCT02584855|5494200|P3|NOT COMPLETED|Open-Label Treatment Period||0
2240359|NCT02584855|5494201|P2|NOT COMPLETED|Open-Label Treatment Period||0
2240360|NCT02584855|5494202|P1|NOT COMPLETED|Open-Label Treatment Period||103
2240361|NCT02584855|5494197|P6|COMPLETED|Open-Label Treatment Period||0
2240362|NCT02584855|5494198|P5|COMPLETED|Open-Label Treatment Period||0
2240363|NCT02584855|5494199|P4|COMPLETED|Open-Label Treatment Period||0
2240364|NCT02584855|5494200|P3|COMPLETED|Open-Label Treatment Period||0
2240365|NCT02584855|5494201|P2|COMPLETED|Open-Label Treatment Period||0
2240366|NCT02584855|5494202|P1|COMPLETED|Open-Label Treatment Period||291
2240367|NCT02584855|5494197|P6|Non-randomized|Open-Label Treatment Period||0
2240368|NCT02584855|5494198|P5|Non-randomized|Open-Label Treatment Period||0
2240369|NCT02584855|5494199|P4|Non-randomized|Open-Label Treatment Period||0
2240370|NCT02584855|5494200|P3|Non-randomized|Open-Label Treatment Period||0
2240371|NCT02584855|5494201|P2|Non-randomized|Open-Label Treatment Period||0
2240372|NCT02584855|5494202|P1|Non-randomized|Open-Label Treatment Period||133
2240373|NCT02584855|5494197|P6|Met Randomization Criteria|Open-Label Treatment Period||0
2240374|NCT02584855|5494198|P5|Met Randomization Criteria|Open-Label Treatment Period||0
2240375|NCT02584855|5494199|P4|Met Randomization Criteria|Open-Label Treatment Period||0
2240376|NCT02584855|5494200|P3|Met Randomization Criteria|Open-Label Treatment Period||0
2240377|NCT02584855|5494201|P2|Met Randomization Criteria|Open-Label Treatment Period||0
2240378|NCT02584855|5494202|P1|Met Randomization Criteria|Open-Label Treatment Period||158
2240379|NCT02584855|5494197|P6|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
2240380|NCT02584855|5494198|P5|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
2240381|NCT02584855|5494199|P4|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
2240382|NCT02584855|5494200|P3|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
2240383|NCT02584855|5494201|P2|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
2240384|NCT02584855|5494202|P1|Received at Least One Dose of Study Drug|Open-Label Treatment Period||394
2240385|NCT02584855|5494197|P6|STARTED|Open-Label Treatment Period||0
2240386|NCT02584855|5494198|P5|STARTED|Open-Label Treatment Period||0
2240387|NCT02584855|5494199|P4|STARTED|Open-Label Treatment Period|Participants were randomized to this arm during double-blind withdrawal period.|0
2240388|NCT02584855|5494200|P3|STARTED|Open-Label Treatment Period|Participants were randomized to this arm during double-blind withdrawal period.|0
2240389|NCT02584855|5494201|P2|STARTED|Open-Label Treatment Period|Participants completed Open-Label Treatment Period.|0
2240390|NCT02584855|5494202|P1|STARTED|Open-Label Treatment Period||394
2240391|NCT02584790|5494236|P1|NOT COMPLETED|Overall Study||15
2240392|NCT02584790|5494236|P1|COMPLETED|Overall Study||40
2240393|NCT02584790|5494236|P1|STARTED|Overall Study||55
2240394|NCT02584686|5494244|P2|NOT COMPLETED|Overall Study||0
2240395|NCT02584686|5494245|P1|NOT COMPLETED|Overall Study||0
2240396|NCT02584686|5494244|P2|COMPLETED|Overall Study||12
2240397|NCT02584686|5494245|P1|COMPLETED|Overall Study||12
2240398|NCT02584686|5494244|P2|STARTED|Overall Study||12
2240399|NCT02584686|5494245|P1|STARTED|Overall Study||12
2240400|NCT02584673|5494273|P2|NOT COMPLETED|Overall Study||0
2240401|NCT02584673|5494274|P1|NOT COMPLETED|Overall Study||0
2240402|NCT02584673|5494273|P2|COMPLETED|Overall Study||15
2240403|NCT02584673|5494274|P1|COMPLETED|Overall Study||15
2240404|NCT02584673|5494273|P2|STARTED|Overall Study||15
2240405|NCT02584673|5494274|P1|STARTED|Overall Study||15
2240406|NCT02584660|5494288|P2|NOT COMPLETED|Overall Study||8
2240407|NCT02584660|5494289|P1|NOT COMPLETED|Overall Study||7
2240408|NCT02584660|5494288|P2|COMPLETED|Overall Study||55
2240409|NCT02584660|5494289|P1|COMPLETED|Overall Study||44
2240410|NCT02584660|5494288|P2|Treated|Overall Study||63
2240411|NCT02584660|5494289|P1|Treated|Overall Study||49
2240412|NCT02584660|5494288|P2|STARTED|Overall Study||63
2240413|NCT02584660|5494289|P1|STARTED|Overall Study||51
2240414|NCT02584504|5494308|P3|NOT COMPLETED|Open-label Treatment||8
2240415|NCT02584504|5494309|P2|NOT COMPLETED|Open-label Treatment||4
2240416|NCT02584504|5494310|P1|NOT COMPLETED|Open-label Treatment||2
2240417|NCT02584504|5494308|P3|COMPLETED|Open-label Treatment||47
2240418|NCT02584504|5494309|P2|COMPLETED|Open-label Treatment||47
2240419|NCT02584504|5494310|P1|COMPLETED|Open-label Treatment||52
2240420|NCT02584504|5494308|P3|Treated|Open-label Treatment||54
2240421|NCT02584504|5494309|P2|Treated|Open-label Treatment||50
2240422|NCT02584504|5494310|P1|Treated|Open-label Treatment||54
2240423|NCT02584504|5494308|P3|STARTED|Open-label Treatment||55
2240424|NCT02584504|5494309|P2|STARTED|Open-label Treatment||51
2240425|NCT02584504|5494310|P1|STARTED|Open-label Treatment||54
2240426|NCT02584504|5494308|P3|NOT COMPLETED|Double-blind Treatment||1
2240427|NCT02584504|5494309|P2|NOT COMPLETED|Double-blind Treatment||2
2240428|NCT02584504|5494310|P1|NOT COMPLETED|Double-blind Treatment||0
2240429|NCT02584504|5494308|P3|COMPLETED|Double-blind Treatment||55
2240430|NCT02584504|5494309|P2|COMPLETED|Double-blind Treatment||51
2240431|NCT02584504|5494310|P1|COMPLETED|Double-blind Treatment||54
2240432|NCT02584504|5494308|P3|Safety Population|Double-blind Treatment||56
2240433|NCT02584504|5494309|P2|Safety Population|Double-blind Treatment||53
2240434|NCT02584504|5494310|P1|Safety Population|Double-blind Treatment||54
2240435|NCT02584504|5494308|P3|mITT Population|Double-blind Treatment||56
2240436|NCT02584504|5494309|P2|mITT Population|Double-blind Treatment||53
2240437|NCT02584504|5494310|P1|mITT Population|Double-blind Treatment||54
2240438|NCT02584504|5494308|P3|ITT Population|Double-blind Treatment||56
2240439|NCT02584504|5494309|P2|ITT Population|Double-blind Treatment||53
2240440|NCT02584504|5494310|P1|ITT Population|Double-blind Treatment||54
2240441|NCT02584504|5494308|P3|STARTED|Double-blind Treatment|Randomized|56
2240442|NCT02584504|5494309|P2|STARTED|Double-blind Treatment|Randomized|53
2240443|NCT02584504|5494310|P1|STARTED|Double-blind Treatment|Randomized|54
2240444|NCT02584452|5494366|P2|NOT COMPLETED|Overall Study||2
2240445|NCT02584452|5494367|P1|NOT COMPLETED|Overall Study||2
2240446|NCT02584452|5494366|P2|COMPLETED|Overall Study||21
2240447|NCT02584452|5494367|P1|COMPLETED|Overall Study||32
2240448|NCT02584452|5494366|P2|STARTED|Overall Study||23
2240449|NCT02584452|5494367|P1|STARTED|Overall Study||34
2240450|NCT02583477|5494397|P2|NOT COMPLETED|Overall Study||20
2240451|NCT02583477|5494398|P1|NOT COMPLETED|Overall Study||3
2240452|NCT02583477|5494397|P2|COMPLETED|Overall Study||0
2240453|NCT02583477|5494398|P1|COMPLETED|Overall Study||0
2240454|NCT02583477|5494397|P2|Completed Treatment|Overall Study||0
2240455|NCT02583477|5494398|P1|Completed Treatment|Overall Study||0
2240456|NCT02583477|5494397|P2|Received Treatment|Overall Study||20
2240457|NCT02583477|5494398|P1|Received Treatment|Overall Study||3
2240458|NCT02583477|5494397|P2|STARTED|Overall Study||20
2240459|NCT02583477|5494398|P1|STARTED|Overall Study||3
2240460|NCT02583425|5494418|P1|NOT COMPLETED|Treatment Period||1
2240461|NCT02583425|5494418|P1|COMPLETED|Treatment Period||9
2240462|NCT02583425|5494418|P1|STARTED|Treatment Period||10
2240463|NCT02583425|5494418|P1|NOT COMPLETED|Baseline||5
2240464|NCT02583425|5494418|P1|COMPLETED|Baseline||10
2240465|NCT02583425|5494418|P1|STARTED|Baseline||15
2240466|NCT02583425|5494418|P1|NOT COMPLETED|Screening||12
2240467|NCT02583425|5494418|P1|COMPLETED|Screening||15
2240468|NCT02583425|5494418|P1|STARTED|Screening||27
2240469|NCT02583269|5494428|P5|NOT COMPLETED|Overall Study||0
2240470|NCT02583269|5494429|P4|NOT COMPLETED|Overall Study||0
2240471|NCT02583269|5494430|P3|NOT COMPLETED|Overall Study||0
2240472|NCT02583269|5494431|P2|NOT COMPLETED|Overall Study||0
2240473|NCT02583269|5494432|P1|NOT COMPLETED|Overall Study||1
2240474|NCT02583269|5494428|P5|COMPLETED|Overall Study||6
2240475|NCT02583269|5494429|P4|COMPLETED|Overall Study||5
2240476|NCT02583269|5494430|P3|COMPLETED|Overall Study||3
2240477|NCT02583269|5494431|P2|COMPLETED|Overall Study||7
2240478|NCT02583269|5494432|P1|COMPLETED|Overall Study||2
2240479|NCT02583269|5494428|P5|STARTED|Overall Study||6
2240480|NCT02583269|5494429|P4|STARTED|Overall Study||5
2240481|NCT02583269|5494430|P3|STARTED|Overall Study||3
2240482|NCT02583269|5494431|P2|STARTED|Overall Study||7
2240483|NCT02583269|5494432|P1|STARTED|Overall Study||3
2240484|NCT02583256|5494461|P4|NOT COMPLETED|Overall Study||3
2240485|NCT02583256|5494462|P3|NOT COMPLETED|Overall Study||2
2240486|NCT02583256|5494463|P2|NOT COMPLETED|Overall Study||2
2240487|NCT02583256|5494464|P1|NOT COMPLETED|Overall Study||3
2240488|NCT02583256|5494461|P4|COMPLETED|Overall Study||390
2240489|NCT02583256|5494462|P3|COMPLETED|Overall Study||400
2240490|NCT02583256|5494463|P2|COMPLETED|Overall Study||401
2240491|NCT02583256|5494464|P1|COMPLETED|Overall Study||400
2240492|NCT02583256|5494461|P4|Exposed|Overall Study||393
2240493|NCT02583256|5494462|P3|Exposed|Overall Study||402
2240494|NCT02583256|5494463|P2|Exposed|Overall Study||403
2240495|NCT02583256|5494464|P1|Exposed|Overall Study||403
2240496|NCT02583256|5494461|P4|STARTED|Overall Study||393
2240497|NCT02583256|5494462|P3|STARTED|Overall Study||402
2240498|NCT02583256|5494463|P2|STARTED|Overall Study||403
2240499|NCT02583256|5494464|P1|STARTED|Overall Study||403
2240500|NCT02583230|5494552|P1|NOT COMPLETED|Overall Study||0
2240501|NCT02583230|5494552|P1|COMPLETED|Overall Study||11
2240502|NCT02583230|5494552|P1|STARTED|Overall Study||11
2240503|NCT02583048|5494561|P3|NOT COMPLETED|Overall Study||1
2240504|NCT02583048|5494562|P2|NOT COMPLETED|Overall Study||1
2240505|NCT02583048|5494563|P1|NOT COMPLETED|Overall Study||0
2240506|NCT02583048|5494561|P3|COMPLETED|Overall Study||27
2240507|NCT02583048|5494562|P2|COMPLETED|Overall Study||27
2240508|NCT02583048|5494563|P1|COMPLETED|Overall Study||28
2240509|NCT02583048|5494561|P3|STARTED|Overall Study||28
2240510|NCT02583048|5494562|P2|STARTED|Overall Study||28
2240511|NCT02583048|5494563|P1|STARTED|Overall Study||28
2240512|NCT02582983|5494598|P1|NOT COMPLETED|Overall Study||6
2240513|NCT02582983|5494598|P1|COMPLETED|Overall Study||17
2240514|NCT02582983|5494598|P1|STARTED|Overall Study||23
2240515|NCT02582970|5494603|P1|NOT COMPLETED|Overall Study||0
2240516|NCT02582970|5494603|P1|COMPLETED|Overall Study||40
2240517|NCT02582970|5494603|P1|STARTED|Overall Study||40
2240518|NCT02582840|5494616|P3|NOT COMPLETED|Overall Study||0
2240519|NCT02582840|5494617|P2|NOT COMPLETED|Overall Study||0
2240520|NCT02582840|5494618|P1|NOT COMPLETED|Overall Study||0
2240521|NCT02582840|5494616|P3|COMPLETED|Overall Study||14
2240522|NCT02582840|5494617|P2|COMPLETED|Overall Study||14
2240523|NCT02582840|5494618|P1|COMPLETED|Overall Study||14
2240524|NCT02582840|5494616|P3|STARTED|Overall Study||14
2240525|NCT02582840|5494617|P2|STARTED|Overall Study||14
2240526|NCT02582840|5494618|P1|STARTED|Overall Study||14
2240527|NCT02582814|5494661|P2|NOT COMPLETED|Overall Study||7
2240528|NCT02582814|5494662|P1|NOT COMPLETED|Overall Study||9
2240529|NCT02582814|5494661|P2|COMPLETED|Overall Study||68
2240530|NCT02582814|5494662|P1|COMPLETED|Overall Study||67
2240531|NCT02582814|5494661|P2|STARTED|Overall Study||75
2240532|NCT02582814|5494662|P1|STARTED|Overall Study||76
2240533|NCT02582749|5494702|P2|NOT COMPLETED|Overall Study||11
2240534|NCT02582749|5494703|P1|NOT COMPLETED|Overall Study||5
2240535|NCT02582749|5494702|P2|COMPLETED|Overall Study||0
2240536|NCT02582749|5494703|P1|COMPLETED|Overall Study||0
2240537|NCT02582749|5494702|P2|STARTED|Overall Study||11
2240538|NCT02582749|5494703|P1|STARTED|Overall Study||5
2240539|NCT02582684|5494733|P1|NOT COMPLETED|Overall Study||17
2240540|NCT02582684|5494733|P1|COMPLETED|Overall Study||105
2240541|NCT02582684|5494733|P1|STARTED|Overall Study||122
2240542|NCT02582671|5494752|P1|NOT COMPLETED|Overall Study||2
2240543|NCT02582671|5494752|P1|COMPLETED|Overall Study||99
2240544|NCT02582671|5494752|P1|STARTED|Overall Study||101
2240545|NCT02582658|5494764|P1|NOT COMPLETED|Overall Study||25
2240546|NCT02582658|5494764|P1|COMPLETED|Overall Study||146
2240547|NCT02582658|5494764|P1|STARTED|Overall Study||171
2240548|NCT02582632|5494782|P1|NOT COMPLETED|Overall Study||1
2240549|NCT02582632|5494782|P1|COMPLETED|Overall Study||165
2240550|NCT02582632|5494782|P1|STARTED|Overall Study||166
2240551|NCT02582515|5494797|P2|NOT COMPLETED|Overall Study||1
2240552|NCT02582515|5494798|P1|NOT COMPLETED|Overall Study||0
2240553|NCT02582515|5494797|P2|COMPLETED|Overall Study||10
2240554|NCT02582515|5494798|P1|COMPLETED|Overall Study||9
2240555|NCT02582515|5494797|P2|Received Study Intervention|Overall Study||10
2240556|NCT02582515|5494798|P1|Received Study Intervention|Overall Study||9
2240557|NCT02582515|5494797|P2|STARTED|Overall Study||11
2240558|NCT02582515|5494798|P1|STARTED|Overall Study||9
2240559|NCT02582255|5494806|P2|NOT COMPLETED|Overall Study||3
2240560|NCT02582255|5494807|P1|NOT COMPLETED|Overall Study||0
2240561|NCT02582255|5494806|P2|COMPLETED|Overall Study||47
2240562|NCT02582255|5494807|P1|COMPLETED|Overall Study||50
2240563|NCT02582255|5494806|P2|STARTED|Overall Study||50
2240564|NCT02582255|5494807|P1|STARTED|Overall Study||50
2240565|NCT02582242|5494820|P2|NOT COMPLETED|Overall Study||17
2240566|NCT02582242|5494821|P1|NOT COMPLETED|Overall Study||20
2240567|NCT02582242|5494820|P2|COMPLETED|Overall Study||200
2240568|NCT02582242|5494821|P1|COMPLETED|Overall Study||200
2240569|NCT02582242|5494820|P2|STARTED|Overall Study||217
2240570|NCT02582242|5494821|P1|STARTED|Overall Study||220
2240571|NCT02582151|5494863|P2|NOT COMPLETED|Overall Study||0
2240572|NCT02582151|5494864|P1|NOT COMPLETED|Overall Study||2
2240573|NCT02582151|5494863|P2|COMPLETED|Overall Study||16
2240574|NCT02582151|5494864|P1|COMPLETED|Overall Study||12
2240575|NCT02582151|5494863|P2|STARTED|Overall Study||16
2240576|NCT02582151|5494864|P1|STARTED|Overall Study||14
2240577|NCT02581995|5494880|P1|NOT COMPLETED|Overall Study||31
2240578|NCT02581995|5494880|P1|COMPLETED|Overall Study||529
2240579|NCT02581995|5494880|P1|Treated|Overall Study||560
2240580|NCT02581995|5494880|P1|STARTED|Overall Study||560
2240581|NCT02581930|5494894|P1|NOT COMPLETED|Overall Study||2
2240582|NCT02581930|5494894|P1|COMPLETED|Overall Study||16
2240583|NCT02581930|5494894|P1|STARTED|Overall Study||18
2240584|NCT02581488|5494902|P2|NOT COMPLETED|Overall Study||11
2240585|NCT02581488|5494903|P1|NOT COMPLETED|Overall Study||9
2240586|NCT02581488|5494902|P2|COMPLETED|Overall Study||40
2240587|NCT02581488|5494903|P1|COMPLETED|Overall Study||42
2240588|NCT02581488|5494902|P2|STARTED|Overall Study||51
2240589|NCT02581488|5494903|P1|STARTED|Overall Study||51
2240590|NCT02581475|5494919|P2|NOT COMPLETED|Overall Study||15
2240591|NCT02581475|5494920|P1|NOT COMPLETED|Overall Study||11
2240592|NCT02581475|5494919|P2|COMPLETED|Overall Study||178
2240593|NCT02581475|5494920|P1|COMPLETED|Overall Study||182
2240594|NCT02581475|5494919|P2|STARTED|Overall Study||193
2240595|NCT02581475|5494920|P1|STARTED|Overall Study||193
2240596|NCT02581410|5494934|P2|NOT COMPLETED|End of Study Phase||11
2240597|NCT02581410|5494935|P1|NOT COMPLETED|End of Study Phase||5
2240598|NCT02581410|5494934|P2|COMPLETED|End of Study Phase||204
2240599|NCT02581410|5494935|P1|COMPLETED|End of Study Phase||210
2240600|NCT02581410|5494934|P2|STARTED|End of Study Phase||215
2240601|NCT02581410|5494935|P1|STARTED|End of Study Phase||215
2240602|NCT02581410|5494934|P2|NOT COMPLETED|Vaccination Phase||3
2240603|NCT02581410|5494935|P1|NOT COMPLETED|Vaccination Phase||2
2240604|NCT02581410|5494934|P2|COMPLETED|Vaccination Phase||212
2240605|NCT02581410|5494935|P1|COMPLETED|Vaccination Phase||213
2240606|NCT02581410|5494934|P2|STARTED|Vaccination Phase||215
2240607|NCT02581410|5494935|P1|STARTED|Vaccination Phase||215
2240608|NCT02581345|5494965|P4|NOT COMPLETED|Part 2: Week 17 to Week 47||12
2240609|NCT02581345|5494966|P3|NOT COMPLETED|Part 2: Week 17 to Week 47||15
2240610|NCT02581345|5494967|P2|NOT COMPLETED|Part 2: Week 17 to Week 47||0
2240611|NCT02581345|5494968|P1|NOT COMPLETED|Part 2: Week 17 to Week 47||29
2240612|NCT02581345|5494965|P4|COMPLETED|Part 2: Week 17 to Week 47||119
2240613|NCT02581345|5494966|P3|COMPLETED|Part 2: Week 17 to Week 47||117
2240614|NCT02581345|5494967|P2|COMPLETED|Part 2: Week 17 to Week 47||0
2240615|NCT02581345|5494968|P1|COMPLETED|Part 2: Week 17 to Week 47||242
2240616|NCT02581345|5494965|P4|STARTED|Part 2: Week 17 to Week 47||131
2240617|NCT02581345|5494966|P3|STARTED|Part 2: Week 17 to Week 47||132
2240618|NCT02581345|5494967|P2|STARTED|Part 2: Week 17 to Week 47||0
2240619|NCT02581345|5494968|P1|STARTED|Part 2: Week 17 to Week 47||271
2240620|NCT02581345|5494965|P4|NOT COMPLETED|Part 1: up to Week 16||0
2240621|NCT02581345|5494966|P3|NOT COMPLETED|Part 1: up to Week 16||0
2240622|NCT02581345|5494967|P2|NOT COMPLETED|Part 1: up to Week 16||23
2240623|NCT02581345|5494968|P1|NOT COMPLETED|Part 1: up to Week 16||15
2240624|NCT02581345|5494965|P4|COMPLETED|Part 1: up to Week 16||0
2240625|NCT02581345|5494966|P3|COMPLETED|Part 1: up to Week 16||0
2240626|NCT02581345|5494967|P2|COMPLETED|Part 1: up to Week 16||263
2240627|NCT02581345|5494968|P1|COMPLETED|Part 1: up to Week 16||271
2240628|NCT02581345|5494965|P4|STARTED|Part 1: up to Week 16||0
2240629|NCT02581345|5494966|P3|STARTED|Part 1: up to Week 16||0
2240630|NCT02581345|5494967|P2|STARTED|Part 1: up to Week 16||286
2240631|NCT02581345|5494968|P1|STARTED|Part 1: up to Week 16||286
2240632|NCT02581202|5495070|P1|NOT COMPLETED|Overall Study||14
2240633|NCT02581202|5495070|P1|COMPLETED|Overall Study||202
2240634|NCT02581202|5495070|P1|STARTED|Overall Study||216
2240635|NCT02581189|5495109|P1|NOT COMPLETED|Overall Study||53
2240636|NCT02581189|5495109|P1|COMPLETED|Overall Study||481
2240637|NCT02581189|5495109|P1|STARTED|Overall Study||534
2240638|NCT02581163|5495123|P1|NOT COMPLETED|Overall Study||29
2240639|NCT02581163|5495123|P1|COMPLETED|Overall Study||282
2240640|NCT02581163|5495123|P1|STARTED|Overall Study||311
2240641|NCT02581137|5495137|P1|NOT COMPLETED|Overall Study||4
2240642|NCT02581137|5495137|P1|COMPLETED|Overall Study||22
2240643|NCT02581137|5495137|P1|STARTED|Overall Study||26
2240644|NCT02581111|5495144|P2|NOT COMPLETED|Overall Study||7
2240645|NCT02581111|5495145|P1|NOT COMPLETED|Overall Study||2
2240646|NCT02581111|5495144|P2|COMPLETED|Overall Study||94
2240647|NCT02581111|5495145|P1|COMPLETED|Overall Study||96
2240648|NCT02581111|5495144|P2|STARTED|Overall Study||101
2240649|NCT02581111|5495145|P1|STARTED|Overall Study||98
2240650|NCT02580799|5495155|P1|NOT COMPLETED|Overall Study||0
2240651|NCT02580799|5495155|P1|COMPLETED|Overall Study||30
2240652|NCT02580799|5495155|P1|STARTED|Overall Study||30
2240653|NCT02580591|5495181|P4|NOT COMPLETED|Overall Study||12
2240654|NCT02580591|5495182|P3|NOT COMPLETED|Overall Study||13
2240655|NCT02580591|5495183|P2|NOT COMPLETED|Overall Study||10
2240656|NCT02580591|5495184|P1|NOT COMPLETED|Overall Study||18
2240657|NCT02580591|5495181|P4|COMPLETED|Overall Study||233
2240658|NCT02580591|5495182|P3|COMPLETED|Overall Study||235
2240659|NCT02580591|5495183|P2|COMPLETED|Overall Study||232
2240660|NCT02580591|5495184|P1|COMPLETED|Overall Study||224
2240661|NCT02580591|5495181|P4|Treated|Overall Study||245
2240662|NCT02580591|5495182|P3|Treated|Overall Study||248
2240663|NCT02580591|5495183|P2|Treated|Overall Study||241
2240664|NCT02580591|5495184|P1|Treated|Overall Study||241
2240665|NCT02580591|5495181|P4|STARTED|Overall Study||245
2240666|NCT02580591|5495182|P3|STARTED|Overall Study||248
2240667|NCT02580591|5495183|P2|STARTED|Overall Study||242
2240668|NCT02580591|5495184|P1|STARTED|Overall Study||242
2240669|NCT02580357|5495217|P3|NOT COMPLETED|Overall Study||0
2240670|NCT02580357|5495218|P2|NOT COMPLETED|Overall Study||0
2240671|NCT02580357|5495219|P1|NOT COMPLETED|Overall Study||3
2240672|NCT02580357|5495217|P3|COMPLETED|Overall Study||18
2240673|NCT02580357|5495218|P2|COMPLETED|Overall Study||18
2240674|NCT02580357|5495219|P1|COMPLETED|Overall Study||15
2240675|NCT02580357|5495217|P3|STARTED|Overall Study||18
2240676|NCT02580357|5495218|P2|STARTED|Overall Study||18
2240677|NCT02580357|5495219|P1|STARTED|Overall Study||18
2240678|NCT02580318|5495230|P1|NOT COMPLETED|Overall Study||0
2240679|NCT02580318|5495230|P1|COMPLETED|Overall Study||54
2240680|NCT02580318|5495230|P1|Drinking Water (5 Minutes)|Overall Study||54
2240681|NCT02580318|5495230|P1|Drinking Water (Immediate)|Overall Study||51
2240682|NCT02580318|5495230|P1|Hyperventilation (10 Minutes)|Overall Study||54
2240683|NCT02580318|5495230|P1|Hyperventilation (5 Minutes)|Overall Study||54
2240684|NCT02580318|5495230|P1|Hyperventilation (Immediate)|Overall Study||54
2240685|NCT02580318|5495230|P1|Poor Effort|Overall Study||53
2240686|NCT02580318|5495230|P1|STARTED|Overall Study||54
2240687|NCT02580240|5495236|P2|NOT COMPLETED|Overall Study||0
2240688|NCT02580240|5495237|P1|NOT COMPLETED|Overall Study||2
2240689|NCT02580240|5495236|P2|COMPLETED|Overall Study||58
2240690|NCT02580240|5495237|P1|COMPLETED|Overall Study||60
2240691|NCT02580240|5495236|P2|STARTED|Overall Study||58
2240692|NCT02580240|5495237|P1|STARTED|Overall Study||62
2240693|NCT02580188|5495247|P2|NOT COMPLETED|Overall Study||3
2240694|NCT02580188|5495248|P1|NOT COMPLETED|Overall Study||3
2240695|NCT02580188|5495247|P2|COMPLETED|Overall Study||32
2240696|NCT02580188|5495248|P1|COMPLETED|Overall Study||32
2240697|NCT02580188|5495247|P2|STARTED|Overall Study||35
2240698|NCT02580188|5495248|P1|STARTED|Overall Study||35
2240699|NCT02580058|5495261|P3|NOT COMPLETED|Overall Study||86
2240700|NCT02580058|5495262|P2|NOT COMPLETED|Overall Study||86
2240701|NCT02580058|5495263|P1|NOT COMPLETED|Overall Study||79
2240702|NCT02580058|5495261|P3|COMPLETED|Overall Study||104
2240703|NCT02580058|5495262|P2|COMPLETED|Overall Study||102
2240704|NCT02580058|5495263|P1|COMPLETED|Overall Study||109
2240705|NCT02580058|5495261|P3|Treated|Overall Study||177
2240706|NCT02580058|5495262|P2|Treated|Overall Study||182
2240707|NCT02580058|5495263|P1|Treated|Overall Study||187
2240708|NCT02580058|5495261|P3|STARTED|Overall Study||190
2240709|NCT02580058|5495262|P2|STARTED|Overall Study||188
2240710|NCT02580058|5495263|P1|STARTED|Overall Study||188
2240711|NCT02579915|5495330|P2|NOT COMPLETED|Overall Study||5
2240712|NCT02579915|5495331|P1|NOT COMPLETED|Overall Study||10
2240713|NCT02579915|5495330|P2|COMPLETED|Overall Study||16
2240714|NCT02579915|5495331|P1|COMPLETED|Overall Study||9
2240715|NCT02579915|5495330|P2|STARTED|Overall Study||21
2240716|NCT02579915|5495331|P1|STARTED|Overall Study||19
2240717|NCT02579876|5495339|P2|NOT COMPLETED|Overall Study||0
2240718|NCT02579876|5495340|P1|NOT COMPLETED|Overall Study||1
2240719|NCT02579876|5495339|P2|COMPLETED|Overall Study||5
2240720|NCT02579876|5495340|P1|COMPLETED|Overall Study||14
2240721|NCT02579876|5495339|P2|STARTED|Overall Study||5
2240722|NCT02579876|5495340|P1|STARTED|Overall Study||15
2240723|NCT02579863|5495362|P2|NOT COMPLETED|Overall Study||154
2240724|NCT02579863|5495363|P1|NOT COMPLETED|Overall Study||156
2240725|NCT02579863|5495362|P2|COMPLETED|Overall Study||0
2240726|NCT02579863|5495363|P1|COMPLETED|Overall Study||0
2240727|NCT02579863|5495362|P2|Treated|Overall Study||148
2240728|NCT02579863|5495363|P1|Treated|Overall Study||154
2240729|NCT02579863|5495362|P2|STARTED|Overall Study||154
2240730|NCT02579863|5495363|P1|STARTED|Overall Study||156
2240731|NCT02579772|5495383|P2|NOT COMPLETED|Overall Study||2
2240732|NCT02579772|5495384|P1|NOT COMPLETED|Overall Study||2
2240733|NCT02579772|5495383|P2|COMPLETED|Overall Study||3
2240734|NCT02579772|5495384|P1|COMPLETED|Overall Study||6
2240735|NCT02579772|5495383|P2|STARTED|Overall Study||5
2240736|NCT02579772|5495384|P1|STARTED|Overall Study||8
2240737|NCT02579603|5495404|P2|NOT COMPLETED|Overall Study||2
2240738|NCT02579603|5495405|P1|NOT COMPLETED|Overall Study||4
2240739|NCT02579603|5495404|P2|COMPLETED|Overall Study||51
2240740|NCT02579603|5495405|P1|COMPLETED|Overall Study||48
2240741|NCT02579603|5495404|P2|Number of Patients Treated|Overall Study||53
2240742|NCT02579603|5495405|P1|Number of Patients Treated|Overall Study||51
2240743|NCT02579603|5495404|P2|STARTED|Overall Study|Started are the randomised patients|53
2240744|NCT02579603|5495405|P1|STARTED|Overall Study|Started are the randomised patients|52
2240745|NCT02579421|5495418|P4|NOT COMPLETED|Overall Study||3
2240746|NCT02579421|5495419|P3|NOT COMPLETED|Overall Study||1
2240747|NCT02579421|5495420|P2|NOT COMPLETED|Overall Study||5
2240748|NCT02579421|5495421|P1|NOT COMPLETED|Overall Study||6
2240749|NCT02579421|5495418|P4|COMPLETED|Overall Study||3
2240750|NCT02579421|5495419|P3|COMPLETED|Overall Study||5
2240751|NCT02579421|5495420|P2|COMPLETED|Overall Study||18
2240752|NCT02579421|5495421|P1|COMPLETED|Overall Study||17
2240753|NCT02579421|5495418|P4|STARTED|Overall Study||6
2240754|NCT02579421|5495419|P3|STARTED|Overall Study||6
2240755|NCT02579421|5495420|P2|STARTED|Overall Study||23
2240756|NCT02579421|5495421|P1|STARTED|Overall Study||23
2240757|NCT02579135|5495433|P2|NOT COMPLETED|Overall Study||9
2240758|NCT02579135|5495434|P1|NOT COMPLETED|Overall Study||2
2240759|NCT02579135|5495433|P2|COMPLETED|Overall Study||106
2240760|NCT02579135|5495434|P1|COMPLETED|Overall Study||105
2240761|NCT02579135|5495433|P2|STARTED|Overall Study||115
2240762|NCT02579135|5495434|P1|STARTED|Overall Study||107
2240763|NCT02579057|5495445|P2|NOT COMPLETED|Overall Study||0
2240764|NCT02579057|5495446|P1|NOT COMPLETED|Overall Study||0
2240765|NCT02579057|5495445|P2|COMPLETED|Overall Study||21
2240766|NCT02579057|5495446|P1|COMPLETED|Overall Study||19
2240767|NCT02579057|5495445|P2|STARTED|Overall Study||21
2240768|NCT02579057|5495446|P1|STARTED|Overall Study||19
2240769|NCT02578992|5495460|P2|NOT COMPLETED|Overall Study||3
2240770|NCT02578992|5495461|P1|NOT COMPLETED|Overall Study||3
2240771|NCT02578992|5495460|P2|COMPLETED|Overall Study|October 2015|62
2240772|NCT02578992|5495461|P1|COMPLETED|Overall Study|October 2015|62
2240773|NCT02578992|5495460|P2|STARTED|Overall Study|November 2014|65
2240774|NCT02578992|5495461|P1|STARTED|Overall Study|November 2014|65
2240775|NCT02578940|5495473|P1|NOT COMPLETED|Overall Study||6
2240776|NCT02578940|5495473|P1|COMPLETED|Overall Study||103
2240777|NCT02578940|5495473|P1|Received 18F-fluciclovine|Overall Study||104
2240778|NCT02578940|5495473|P1|STARTED|Overall Study||109
2240779|NCT02578862|5495482|P2|NOT COMPLETED|Overall Study||2
2240780|NCT02578862|5495483|P1|NOT COMPLETED|Overall Study||0
2240781|NCT02578862|5495482|P2|COMPLETED|Overall Study||33
2240782|NCT02578862|5495483|P1|COMPLETED|Overall Study||37
2240783|NCT02578862|5495482|P2|STARTED|Overall Study||35
2240784|NCT02578862|5495483|P1|STARTED|Overall Study||37
2240785|NCT02578745|5495501|P2|NOT COMPLETED|Overall Study||0
2240786|NCT02578745|5495502|P1|NOT COMPLETED|Overall Study||0
2240787|NCT02578745|5495501|P2|COMPLETED|Overall Study||60
2240788|NCT02578745|5495502|P1|COMPLETED|Overall Study||60
2240789|NCT02578745|5495501|P2|STARTED|Overall Study||60
2240790|NCT02578745|5495502|P1|STARTED|Overall Study||60
2240791|NCT02578706|5495521|P3|NOT COMPLETED|Overall Study||0
2240792|NCT02578706|5495522|P2|NOT COMPLETED|Overall Study||5
2240793|NCT02578706|5495523|P1|NOT COMPLETED|Overall Study||1
2240794|NCT02578706|5495521|P3|COMPLETED|Overall Study||8
2240795|NCT02578706|5495522|P2|COMPLETED|Overall Study||5
2240796|NCT02578706|5495523|P1|COMPLETED|Overall Study||8
2240797|NCT02578706|5495521|P3|STARTED|Overall Study||8
2240798|NCT02578706|5495522|P2|STARTED|Overall Study||10
2240799|NCT02578706|5495523|P1|STARTED|Overall Study||9
2240800|NCT02578680|5495602|P2|NOT COMPLETED|Overall Study||206
2240801|NCT02578680|5495603|P1|NOT COMPLETED|Overall Study||410
2240802|NCT02578680|5495602|P2|COMPLETED|Overall Study||0
2240803|NCT02578680|5495603|P1|COMPLETED|Overall Study||0
2240804|NCT02578680|5495602|P2|Switched to Pembrolizumab|Overall Study||67
2240805|NCT02578680|5495603|P1|Switched to Pembrolizumab|Overall Study||0
2240806|NCT02578680|5495602|P2|Treated|Overall Study||202
2240807|NCT02578680|5495603|P1|Treated|Overall Study||405
2240808|NCT02578680|5495602|P2|STARTED|Overall Study||206
2240809|NCT02578680|5495603|P1|STARTED|Overall Study||410
2240810|NCT02578316|5495619|P1|NOT COMPLETED|Extension Phase||6
2240811|NCT02578316|5495619|P1|COMPLETED|Extension Phase||0
2240812|NCT02578316|5495619|P1|STARTED|Extension Phase||6
2240813|NCT02578316|5495619|P1|NOT COMPLETED|Study Phase||0
2240814|NCT02578316|5495619|P1|COMPLETED|Study Phase||6
2240815|NCT02578316|5495619|P1|STARTED|Study Phase||6
2240816|NCT02578238|5495643|P1|NOT COMPLETED|Overall Study||0
2240817|NCT02578238|5495643|P1|COMPLETED|Overall Study||143
2240818|NCT02578238|5495643|P1|STARTED|Overall Study||143
2240819|NCT02578199|5495647|P1|NOT COMPLETED|Overall Study||4
2240820|NCT02578199|5495647|P1|COMPLETED|Overall Study||27
2240821|NCT02578199|5495647|P1|STARTED|Overall Study||31
2240822|NCT02578186|5495652|P2|NOT COMPLETED|Period 2 (Second of Crossover)||0
2240823|NCT02578186|5495653|P1|NOT COMPLETED|Period 2 (Second of Crossover)||0
2240824|NCT02578186|5495652|P2|COMPLETED|Period 2 (Second of Crossover)||13
2240825|NCT02578186|5495653|P1|COMPLETED|Period 2 (Second of Crossover)||12
2240826|NCT02578186|5495652|P2|STARTED|Period 2 (Second of Crossover)||13
2240827|NCT02578186|5495653|P1|STARTED|Period 2 (Second of Crossover)||12
2240828|NCT02578186|5495652|P2|NOT COMPLETED|Period 1 (First of Crossover)||5
2240829|NCT02578186|5495653|P1|NOT COMPLETED|Period 1 (First of Crossover)||5
2240830|NCT02578186|5495652|P2|COMPLETED|Period 1 (First of Crossover)||13
2240831|NCT02578186|5495653|P1|COMPLETED|Period 1 (First of Crossover)||12
2240832|NCT02578186|5495652|P2|STARTED|Period 1 (First of Crossover)||18
2240833|NCT02578186|5495653|P1|STARTED|Period 1 (First of Crossover)||17
2240834|NCT02577991|5495662|P3|NOT COMPLETED|Overall Study||0
2240835|NCT02577991|5495663|P2|NOT COMPLETED|Overall Study||2
2240836|NCT02577991|5495664|P1|NOT COMPLETED|Overall Study||3
2240837|NCT02577991|5495662|P3|COMPLETED|Overall Study||29
2240838|NCT02577991|5495663|P2|COMPLETED|Overall Study||25
2240839|NCT02577991|5495664|P1|COMPLETED|Overall Study||21
2240840|NCT02577991|5495662|P3|STARTED|Overall Study||29
2240841|NCT02577991|5495663|P2|STARTED|Overall Study||27
2240842|NCT02577991|5495664|P1|STARTED|Overall Study||24
2240843|NCT02577978|5495686|P2|NOT COMPLETED|Overall Study||4
2240844|NCT02577978|5495687|P1|NOT COMPLETED|Overall Study||7
2240845|NCT02577978|5495686|P2|COMPLETED|Overall Study||25
2240846|NCT02577978|5495687|P1|COMPLETED|Overall Study||25
2240847|NCT02577978|5495686|P2|STARTED|Overall Study||29
2240848|NCT02577978|5495687|P1|STARTED|Overall Study||32
2240849|NCT02577900|5495720|P3|NOT COMPLETED|Overall Study||0
2240850|NCT02577900|5495721|P2|NOT COMPLETED|Overall Study||0
2240851|NCT02577900|5495722|P1|NOT COMPLETED|Overall Study||0
2240852|NCT02577900|5495720|P3|COMPLETED|Overall Study||10
2240853|NCT02577900|5495721|P2|COMPLETED|Overall Study||10
2240854|NCT02577900|5495722|P1|COMPLETED|Overall Study||11
2240855|NCT02577900|5495720|P3|STARTED|Overall Study||10
2240856|NCT02577900|5495721|P2|STARTED|Overall Study||10
2240857|NCT02577900|5495722|P1|STARTED|Overall Study||11
2240858|NCT02577887|5495742|P1|NOT COMPLETED|Overall Study||298
2240859|NCT02577887|5495742|P1|COMPLETED|Overall Study||1803
2240860|NCT02577887|5495742|P1|6 Month Follow-up|Overall Study||1938
2240861|NCT02577887|5495742|P1|STARTED|Overall Study||2101
2240862|NCT02577822|5495751|P2|NOT COMPLETED|Overall Study||13
2240863|NCT02577822|5495752|P1|NOT COMPLETED|Overall Study||6
2240864|NCT02577822|5495751|P2|COMPLETED|Overall Study||20
2240865|NCT02577822|5495752|P1|COMPLETED|Overall Study||21
2240866|NCT02577822|5495751|P2|STARTED|Overall Study||33
2240867|NCT02577822|5495752|P1|STARTED|Overall Study||27
2240868|NCT02577718|5495768|P1|NOT COMPLETED|Overall Study||8
2240869|NCT02577718|5495768|P1|COMPLETED|Overall Study||52
2240870|NCT02577718|5495768|P1|STARTED|Overall Study||60
2240871|NCT02577601|5495774|P1|NOT COMPLETED|UPA+COC (1 Month)||0
2240872|NCT02577601|5495774|P1|COMPLETED|UPA+COC (1 Month)||33
2240873|NCT02577601|5495774|P1|STARTED|UPA+COC (1 Month)||33
2240874|NCT02577601|5495774|P1|NOT COMPLETED|Washout (1 Month)||0
2240875|NCT02577601|5495774|P1|COMPLETED|Washout (1 Month)||33
2240876|NCT02577601|5495774|P1|STARTED|Washout (1 Month)||33
2240877|NCT02577601|5495774|P1|NOT COMPLETED|UPA Only (1 Month)||0
2240878|NCT02577601|5495774|P1|COMPLETED|UPA Only (1 Month)||36
2240879|NCT02577601|5495774|P1|STARTED|UPA Only (1 Month)||36
2240880|NCT02577510|5495781|P2|NOT COMPLETED|Overall Study||0
2240881|NCT02577510|5495782|P1|NOT COMPLETED|Overall Study||0
2240882|NCT02577510|5495781|P2|COMPLETED|Overall Study||21
2240883|NCT02577510|5495782|P1|COMPLETED|Overall Study||21
2240884|NCT02577510|5495781|P2|STARTED|Overall Study||21
2240885|NCT02577510|5495782|P1|STARTED|Overall Study||21
2240886|NCT02577445|5495796|P2|NOT COMPLETED|Overall Study||17
2240887|NCT02577445|5495797|P1|NOT COMPLETED|Overall Study||14
2240888|NCT02577445|5495796|P2|COMPLETED|Overall Study|study terminated prematurely|0
2240889|NCT02577445|5495797|P1|COMPLETED|Overall Study|study terminated prematurely|0
2240890|NCT02577445|5495796|P2|STARTED|Overall Study||17
2240891|NCT02577445|5495797|P1|STARTED|Overall Study||14
2240892|NCT02577315|5495810|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
2240893|NCT02577315|5495811|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
2240894|NCT02577315|5495810|P2|COMPLETED|Treatment Period 2 (4 Days)||12
2240895|NCT02577315|5495811|P1|COMPLETED|Treatment Period 2 (4 Days)||12
2240896|NCT02577315|5495810|P2|STARTED|Treatment Period 2 (4 Days)||12
2240897|NCT02577315|5495811|P1|STARTED|Treatment Period 2 (4 Days)||12
2240898|NCT02577315|5495810|P2|NOT COMPLETED|Washout Period (5 Days)||0
2240899|NCT02577315|5495811|P1|NOT COMPLETED|Washout Period (5 Days)||0
2240900|NCT02577315|5495810|P2|COMPLETED|Washout Period (5 Days)||12
2240901|NCT02577315|5495811|P1|COMPLETED|Washout Period (5 Days)||12
2240902|NCT02577315|5495810|P2|STARTED|Washout Period (5 Days)||12
2240903|NCT02577315|5495811|P1|STARTED|Washout Period (5 Days)||12
2240904|NCT02577315|5495810|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||1
2240905|NCT02577315|5495811|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
2240906|NCT02577315|5495810|P2|COMPLETED|Treatment Period 1 (4 Days)||12
2240907|NCT02577315|5495811|P1|COMPLETED|Treatment Period 1 (4 Days)||12
2240908|NCT02577315|5495810|P2|STARTED|Treatment Period 1 (4 Days)||13
2240909|NCT02577315|5495811|P1|STARTED|Treatment Period 1 (4 Days)||12
2240910|NCT02577146|5495827|P1|NOT COMPLETED|Overall Study||28
2240911|NCT02577146|5495827|P1|COMPLETED|Overall Study||46
2240912|NCT02577146|5495827|P1|STARTED|Overall Study||74
2240913|NCT02577107|5495834|P2|NOT COMPLETED|Overall Study||1
2240914|NCT02577107|5495835|P1|NOT COMPLETED|Overall Study||0
2240915|NCT02577107|5495834|P2|COMPLETED|Overall Study||5
2240916|NCT02577107|5495835|P1|COMPLETED|Overall Study||6
2240917|NCT02577107|5495834|P2|STARTED|Overall Study||6
2240918|NCT02577107|5495835|P1|STARTED|Overall Study||6
2240919|NCT02577029|5495855|P8|NOT COMPLETED|Overall Study||12
2240920|NCT02577029|5495856|P7|NOT COMPLETED|Overall Study||12
2240921|NCT02577029|5495857|P6|NOT COMPLETED|Overall Study||13
2240922|NCT02577029|5495858|P5|NOT COMPLETED|Overall Study||11
2240923|NCT02577029|5495859|P4|NOT COMPLETED|Overall Study||12
2240924|NCT02577029|5495860|P3|NOT COMPLETED|Overall Study||7
2240925|NCT02577029|5495861|P2|NOT COMPLETED|Overall Study||2
2240926|NCT02577029|5495862|P1|NOT COMPLETED|Overall Study||10
2240927|NCT02577029|5495855|P8|COMPLETED|Overall Study||0
2240928|NCT02577029|5495856|P7|COMPLETED|Overall Study||0
2240929|NCT02577029|5495857|P6|COMPLETED|Overall Study||0
2240930|NCT02577029|5495858|P5|COMPLETED|Overall Study||0
2240931|NCT02577029|5495859|P4|COMPLETED|Overall Study||0
2240932|NCT02577029|5495860|P3|COMPLETED|Overall Study||0
2240933|NCT02577029|5495861|P2|COMPLETED|Overall Study||0
2240934|NCT02577029|5495862|P1|COMPLETED|Overall Study||0
2240935|NCT02577029|5495855|P8|STARTED|Overall Study||12
2240936|NCT02577029|5495856|P7|STARTED|Overall Study||12
2240937|NCT02577029|5495857|P6|STARTED|Overall Study||13
2240938|NCT02577029|5495858|P5|STARTED|Overall Study||11
2240939|NCT02577029|5495859|P4|STARTED|Overall Study||12
2240940|NCT02577029|5495860|P3|STARTED|Overall Study||7
2240941|NCT02577029|5495861|P2|STARTED|Overall Study||2
2240942|NCT02577029|5495862|P1|STARTED|Overall Study||10
2240943|NCT02577016|5495970|P2|NOT COMPLETED|Overall Study||2
2240944|NCT02577016|5495971|P1|NOT COMPLETED|Overall Study||2
2240945|NCT02577016|5495970|P2|COMPLETED|Overall Study||69
2240946|NCT02577016|5495971|P1|COMPLETED|Overall Study||68
2240947|NCT02577016|5495970|P2|STARTED|Overall Study||71
2240948|NCT02577016|5495971|P1|STARTED|Overall Study||70
2240949|NCT02577003|5495989|P2|NOT COMPLETED|Overall Study||5
2240950|NCT02577003|5495990|P1|NOT COMPLETED|Overall Study||2
2240951|NCT02577003|5495989|P2|COMPLETED|Overall Study||65
2240952|NCT02577003|5495990|P1|COMPLETED|Overall Study||71
2240953|NCT02577003|5495989|P2|STARTED|Overall Study||70
2240954|NCT02577003|5495990|P1|STARTED|Overall Study||73
2240955|NCT02576977|5496010|P2|NOT COMPLETED|Overall Study||125
2240956|NCT02576977|5496011|P1|NOT COMPLETED|Overall Study||126
2240957|NCT02576977|5496010|P2|COMPLETED|Overall Study||0
2240958|NCT02576977|5496011|P1|COMPLETED|Overall Study||0
2240959|NCT02576977|5496010|P2|Treated|Overall Study||123
2240960|NCT02576977|5496011|P1|Treated|Overall Study||122
2240961|NCT02576977|5496010|P2|STARTED|Overall Study||125
2240962|NCT02576977|5496011|P1|STARTED|Overall Study||126
2240963|NCT02576951|5496033|P4|NOT COMPLETED|Overall Study||5
2240964|NCT02576951|5496034|P3|NOT COMPLETED|Overall Study||2
2240965|NCT02576951|5496035|P2|NOT COMPLETED|Overall Study||0
2240966|NCT02576951|5496036|P1|NOT COMPLETED|Overall Study||1
2240967|NCT02576951|5496033|P4|COMPLETED|Overall Study||75
2240968|NCT02576951|5496034|P3|COMPLETED|Overall Study||78
2240969|NCT02576951|5496035|P2|COMPLETED|Overall Study||3
2240970|NCT02576951|5496036|P1|COMPLETED|Overall Study||14
2240971|NCT02576951|5496033|P4|Received at Least One Dose of Study Drug|Overall Study||80
2240972|NCT02576951|5496034|P3|Received at Least One Dose of Study Drug|Overall Study||80
2240973|NCT02576951|5496035|P2|Received at Least One Dose of Study Drug|Overall Study||3
2240974|NCT02576951|5496036|P1|Received at Least One Dose of Study Drug|Overall Study||15
2240975|NCT02576951|5496033|P4|STARTED|Overall Study||80
2240976|NCT02576951|5496034|P3|STARTED|Overall Study||80
2240977|NCT02576951|5496035|P2|STARTED|Overall Study||3
2240978|NCT02576951|5496036|P1|STARTED|Overall Study||15
2240979|NCT02576938|5496060|P3|NOT COMPLETED|Overall Study||12
2240980|NCT02576938|5496061|P2|NOT COMPLETED|Overall Study||12
2240981|NCT02576938|5496062|P1|NOT COMPLETED|Overall Study||20
2240982|NCT02576938|5496060|P3|COMPLETED|Overall Study||26
2240983|NCT02576938|5496061|P2|COMPLETED|Overall Study||25
2240984|NCT02576938|5496062|P1|COMPLETED|Overall Study||29
2240985|NCT02576938|5496060|P3|Received at Least One Dose of Study Drug|Overall Study||38
2240986|NCT02576938|5496061|P2|Received at Least One Dose of Study Drug|Overall Study||37
2240987|NCT02576938|5496062|P1|Received at Least One Dose of Study Drug|Overall Study||49
2240988|NCT02576938|5496060|P3|STARTED|Overall Study||38
2240989|NCT02576938|5496061|P2|STARTED|Overall Study||37
2240990|NCT02576938|5496062|P1|STARTED|Overall Study||49
2241003|NCT02576652|5496127|P1|NOT COMPLETED|Overall Study||2
2241004|NCT02576652|5496127|P1|COMPLETED|Overall Study||4
2241005|NCT02576652|5496127|P1|STARTED|Overall Study||6
2241006|NCT02576639|5496139|P5|NOT COMPLETED|Overall Study||4
2241007|NCT02576639|5496140|P4|NOT COMPLETED|Overall Study||1
2241008|NCT02576639|5496141|P3|NOT COMPLETED|Overall Study||2
2241009|NCT02576639|5496142|P2|NOT COMPLETED|Overall Study||2
2241010|NCT02576639|5496143|P1|NOT COMPLETED|Overall Study||2
2241011|NCT02576639|5496139|P5|COMPLETED|Overall Study||20
2241012|NCT02576639|5496140|P4|COMPLETED|Overall Study||25
2241013|NCT02576639|5496141|P3|COMPLETED|Overall Study||23
2241014|NCT02576639|5496142|P2|COMPLETED|Overall Study||23
2241015|NCT02576639|5496143|P1|COMPLETED|Overall Study||22
2241016|NCT02576639|5496139|P5|Safety Analysis Set|Overall Study||24
2241017|NCT02576639|5496140|P4|Safety Analysis Set|Overall Study||26
2241018|NCT02576639|5496141|P3|Safety Analysis Set|Overall Study||25
2241019|NCT02576639|5496142|P2|Safety Analysis Set|Overall Study||25
2241020|NCT02576639|5496143|P1|Safety Analysis Set|Overall Study||24
2241021|NCT02576639|5496139|P5|Pharmacokinetic Analysis Set|Overall Study||24
2241022|NCT02576639|5496140|P4|Pharmacokinetic Analysis Set|Overall Study||26
2241023|NCT02576639|5496141|P3|Pharmacokinetic Analysis Set|Overall Study||25
2241024|NCT02576639|5496142|P2|Pharmacokinetic Analysis Set|Overall Study||25
2241025|NCT02576639|5496143|P1|Pharmacokinetic Analysis Set|Overall Study||0
2241026|NCT02576639|5496139|P5|Pharmacodynamic Analysis Set|Overall Study||25
2241027|NCT02576639|5496140|P4|Pharmacodynamic Analysis Set|Overall Study||25
2241028|NCT02576639|5496141|P3|Pharmacodynamic Analysis Set|Overall Study||25
2241029|NCT02576639|5496142|P2|Pharmacodynamic Analysis Set|Overall Study||24
2241030|NCT02576639|5496143|P1|Pharmacodynamic Analysis Set|Overall Study||24
2241031|NCT02576639|5496139|P5|STARTED|Overall Study||24
2241032|NCT02576639|5496140|P4|STARTED|Overall Study||26
2241033|NCT02576639|5496141|P3|STARTED|Overall Study||25
2241034|NCT02576639|5496142|P2|STARTED|Overall Study||25
2241035|NCT02576639|5496143|P1|STARTED|Overall Study||24
2241036|NCT02576587|5496202|P2|NOT COMPLETED|Follow up Period (Case Only)||155
2241037|NCT02576587|5496203|P1|NOT COMPLETED|Follow up Period (Case Only)||117
2241038|NCT02576587|5496202|P2|COMPLETED|Follow up Period (Case Only)||0
2241039|NCT02576587|5496203|P1|COMPLETED|Follow up Period (Case Only)||44
2241040|NCT02576587|5496202|P2|Selected for Follow up|Follow up Period (Case Only)||0
2241041|NCT02576587|5496203|P1|Selected for Follow up|Follow up Period (Case Only)||61
2241042|NCT02576587|5496202|P2|STARTED|Follow up Period (Case Only)|Controls not eligible for follow-up|155
2241043|NCT02576587|5496203|P1|STARTED|Follow up Period (Case Only)|Completed baseline.|161
2241044|NCT02576587|5496202|P2|NOT COMPLETED|Baseline||1
2241045|NCT02576587|5496203|P1|NOT COMPLETED|Baseline||0
2241046|NCT02576587|5496202|P2|COMPLETED|Baseline|Baseline visit completed|155
2241047|NCT02576587|5496203|P1|COMPLETED|Baseline|Baseline visit completed|161
2241048|NCT02576587|5496202|P2|STARTED|Baseline|Total controls baseline visit|156
2241049|NCT02576587|5496203|P1|STARTED|Baseline|Total cases baseline visit|161
2241050|NCT02576535|5496221|P1|NOT COMPLETED|Overall Study||2
2241051|NCT02576535|5496221|P1|COMPLETED|Overall Study||16
2241052|NCT02576535|5496221|P1|STARTED|Overall Study||18
2241053|NCT02576249|5496232|P2|NOT COMPLETED|Overall Study||0
2241054|NCT02576249|5496233|P1|NOT COMPLETED|Overall Study||0
2241055|NCT02576249|5496232|P2|COMPLETED|Overall Study||14
2241056|NCT02576249|5496233|P1|COMPLETED|Overall Study||15
2241057|NCT02576249|5496232|P2|STARTED|Overall Study||14
2241058|NCT02576249|5496233|P1|STARTED|Overall Study||15
2241059|NCT02576145|5496245|P2|NOT COMPLETED|Overall Study||1
2241060|NCT02576145|5496246|P1|NOT COMPLETED|Overall Study||3
2241061|NCT02576145|5496245|P2|COMPLETED|Overall Study||4
2241062|NCT02576145|5496246|P1|COMPLETED|Overall Study||3
2241063|NCT02576145|5496245|P2|STARTED|Overall Study||5
2241064|NCT02576145|5496246|P1|STARTED|Overall Study||6
2241065|NCT02576054|5496282|P1|NOT COMPLETED|Overall Study||1
2241066|NCT02576054|5496282|P1|COMPLETED|Overall Study||100
2241067|NCT02576054|5496282|P1|Vaccination 3|Overall Study||100
2241068|NCT02576054|5496282|P1|Vaccination 2|Overall Study||100
2241069|NCT02576054|5496282|P1|Vaccination 1|Overall Study||100
2241070|NCT02576054|5496282|P1|STARTED|Overall Study||101
2241071|NCT02576041|5496297|P1|NOT COMPLETED|Bilastine (Active Treatement)||0
2241072|NCT02576041|5496297|P1|COMPLETED|Bilastine (Active Treatement)||18
2241073|NCT02576041|5496297|P1|STARTED|Bilastine (Active Treatement)||18
2241074|NCT02576041|5496297|P1|NOT COMPLETED|Placebo (run-in)||0
2241075|NCT02576041|5496297|P1|COMPLETED|Placebo (run-in)||18
2241076|NCT02576041|5496297|P1|STARTED|Placebo (run-in)||18
2241077|NCT02575950|5496303|P4|NOT COMPLETED|Overall Study||5
2241078|NCT02575950|5496304|P3|NOT COMPLETED|Overall Study||0
2241079|NCT02575950|5496305|P2|NOT COMPLETED|Overall Study||1
2241080|NCT02575950|5496306|P1|NOT COMPLETED|Overall Study||0
2241081|NCT02575950|5496303|P4|COMPLETED|Overall Study||20
2241082|NCT02575950|5496304|P3|COMPLETED|Overall Study||6
2241083|NCT02575950|5496305|P2|COMPLETED|Overall Study||5
2241084|NCT02575950|5496306|P1|COMPLETED|Overall Study||3
2241085|NCT02575950|5496303|P4|STARTED|Overall Study||25
2241086|NCT02575950|5496304|P3|STARTED|Overall Study||6
2241087|NCT02575950|5496305|P2|STARTED|Overall Study||6
2241088|NCT02575950|5496306|P1|STARTED|Overall Study||3
2241089|NCT02575911|5496335|P1|NOT COMPLETED|Overall Study||1
2241090|NCT02575911|5496335|P1|COMPLETED|Overall Study||29
2241091|NCT02575911|5496335|P1|STARTED|Overall Study||30
2241092|NCT02575833|5496355|P2|NOT COMPLETED|Overall Study||1
2241093|NCT02575833|5496356|P1|NOT COMPLETED|Overall Study||1
2241094|NCT02575833|5496355|P2|COMPLETED|Overall Study||44
2241095|NCT02575833|5496356|P1|COMPLETED|Overall Study||43
2241096|NCT02575833|5496355|P2|Received Study Drug|Overall Study||44
2241097|NCT02575833|5496356|P1|Received Study Drug|Overall Study||44
2241098|NCT02575833|5496355|P2|STARTED|Overall Study||45
2241099|NCT02575833|5496356|P1|STARTED|Overall Study||44
2241100|NCT02575807|5496371|P5|NOT COMPLETED|Overall Study||4
2241101|NCT02575807|5496372|P4|NOT COMPLETED|Overall Study||2
2241102|NCT02575807|5496373|P3|NOT COMPLETED|Overall Study||16
2241103|NCT02575807|5496374|P2|NOT COMPLETED|Overall Study||4
2241104|NCT02575807|5496375|P1|NOT COMPLETED|Overall Study||9
2241105|NCT02575807|5496371|P5|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
2241106|NCT02575807|5496372|P4|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
2241107|NCT02575807|5496373|P3|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
2241108|NCT02575807|5496374|P2|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
2241109|NCT02575807|5496375|P1|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
2241110|NCT02575807|5496371|P5|Treated|Overall Study||3
2241111|NCT02575807|5496372|P4|Treated|Overall Study||1
2241112|NCT02575807|5496373|P3|Treated|Overall Study||16
2241113|NCT02575807|5496374|P2|Treated|Overall Study||4
2241114|NCT02575807|5496375|P1|Treated|Overall Study||8
2241115|NCT02575807|5496371|P5|STARTED|Overall Study||4
2241116|NCT02575807|5496372|P4|STARTED|Overall Study||2
2241117|NCT02575807|5496373|P3|STARTED|Overall Study||16
2241118|NCT02575807|5496374|P2|STARTED|Overall Study||4
2241119|NCT02575807|5496375|P1|STARTED|Overall Study||9
2241120|NCT02575365|5496415|P1|NOT COMPLETED|Overall Study||4
2241121|NCT02575365|5496415|P1|COMPLETED|Overall Study||0
2241122|NCT02575365|5496415|P1|STARTED|Overall Study||4
2241123|NCT02575300|5496425|P1|NOT COMPLETED|Overall Study||0
2241124|NCT02575300|5496425|P1|COMPLETED|Overall Study||20
2241125|NCT02575300|5496425|P1|STARTED|Overall Study||20
2241126|NCT02575079|5496435|P2|NOT COMPLETED|Overall Study||0
2241127|NCT02575079|5496436|P1|NOT COMPLETED|Overall Study||6
2241128|NCT02575079|5496435|P2|COMPLETED|Overall Study||71
2241129|NCT02575079|5496436|P1|COMPLETED|Overall Study||42
2241130|NCT02575079|5496435|P2|STARTED|Overall Study||71
2241131|NCT02575079|5496436|P1|STARTED|Overall Study||48
2241132|NCT02574858|5496450|P1|NOT COMPLETED|Overall Study||0
2241133|NCT02574858|5496450|P1|COMPLETED|Overall Study||25
2241134|NCT02574858|5496450|P1|STARTED|Overall Study||25
2241135|NCT02574845|5496461|P6|NOT COMPLETED|Overall Study||1
2241136|NCT02574845|5496462|P5|NOT COMPLETED|Overall Study||1
2241137|NCT02574845|5496463|P4|NOT COMPLETED|Overall Study||0
2241138|NCT02574845|5496464|P3|NOT COMPLETED|Overall Study||0
2241139|NCT02574845|5496465|P2|NOT COMPLETED|Overall Study||1
2241140|NCT02574845|5496466|P1|NOT COMPLETED|Overall Study||0
2241141|NCT02574845|5496461|P6|COMPLETED|Overall Study||2
2241142|NCT02574845|5496462|P5|COMPLETED|Overall Study||2
2241143|NCT02574845|5496463|P4|COMPLETED|Overall Study||3
2241144|NCT02574845|5496464|P3|COMPLETED|Overall Study||3
2241145|NCT02574845|5496465|P2|COMPLETED|Overall Study||2
2241146|NCT02574845|5496466|P1|COMPLETED|Overall Study||3
2241147|NCT02574845|5496461|P6|Received R|Overall Study||3
2241148|NCT02574845|5496462|P5|Received R|Overall Study||2
2241149|NCT02574845|5496463|P4|Received R|Overall Study||3
2241150|NCT02574845|5496464|P3|Received R|Overall Study||3
2241151|NCT02574845|5496465|P2|Received R|Overall Study||2
2241152|NCT02574845|5496466|P1|Received R|Overall Study||3
2241153|NCT02574845|5496461|P6|Received T5|Overall Study||2
2241154|NCT02574845|5496462|P5|Received T5|Overall Study||3
2241155|NCT02574845|5496463|P4|Received T5|Overall Study||3
2241156|NCT02574845|5496464|P3|Received T5|Overall Study||3
2241157|NCT02574845|5496465|P2|Received T5|Overall Study||2
2241158|NCT02574845|5496466|P1|Received T5|Overall Study||3
2241159|NCT02574845|5496461|P6|Received T4|Overall Study||2
2241160|NCT02574845|5496462|P5|Received T4|Overall Study||2
2241161|NCT02574845|5496463|P4|Received T4|Overall Study||3
2241162|NCT02574845|5496464|P3|Received T4|Overall Study||3
2241163|NCT02574845|5496465|P2|Received T4|Overall Study||2
2241164|NCT02574845|5496466|P1|Received T4|Overall Study||3
2241165|NCT02574845|5496461|P6|Received T3|Overall Study||3
2241166|NCT02574845|5496462|P5|Received T3|Overall Study||2
2241167|NCT02574845|5496463|P4|Received T3|Overall Study||3
2241168|NCT02574845|5496464|P3|Received T3|Overall Study||3
2241169|NCT02574845|5496465|P2|Received T3|Overall Study||2
2241170|NCT02574845|5496466|P1|Received T3|Overall Study|one subject missed treatment period 2|2
2241171|NCT02574845|5496461|P6|Received T2|Overall Study||3
2241172|NCT02574845|5496462|P5|Received T2|Overall Study||2
2241173|NCT02574845|5496463|P4|Received T2|Overall Study||3
2241174|NCT02574845|5496464|P3|Received T2|Overall Study||3
2241175|NCT02574845|5496465|P2|Received T2|Overall Study||3
2241176|NCT02574845|5496466|P1|Received T2|Overall Study||3
2241177|NCT02574845|5496461|P6|Received T1|Overall Study|one subject missed treatment period 2|2
2241178|NCT02574845|5496462|P5|Received T1|Overall Study||2
2241179|NCT02574845|5496463|P4|Received T1|Overall Study||3
2241180|NCT02574845|5496464|P3|Received T1|Overall Study||3
2241181|NCT02574845|5496465|P2|Received T1|Overall Study||2
2241182|NCT02574845|5496466|P1|Received T1|Overall Study||3
2241183|NCT02574845|5496461|P6|STARTED|Overall Study||3
2241184|NCT02574845|5496462|P5|STARTED|Overall Study||3
2241185|NCT02574845|5496463|P4|STARTED|Overall Study||3
2241186|NCT02574845|5496464|P3|STARTED|Overall Study||3
2241187|NCT02574845|5496465|P2|STARTED|Overall Study||3
2241188|NCT02574845|5496466|P1|STARTED|Overall Study||3
2241189|NCT02574832|5496492|P1|NOT COMPLETED|Overall Study||0
2241190|NCT02574832|5496492|P1|COMPLETED|Overall Study||2
2241191|NCT02574832|5496492|P1|STARTED|Overall Study||2
2241192|NCT02574481|5496500|P4|NOT COMPLETED|Overall Study||0
2241193|NCT02574481|5496501|P3|NOT COMPLETED|Overall Study||3
2241194|NCT02574481|5496502|P2|NOT COMPLETED|Overall Study||14
2241195|NCT02574481|5496503|P1|NOT COMPLETED|Overall Study||27
2241196|NCT02574481|5496500|P4|COMPLETED|Overall Study||13
2241197|NCT02574481|5496501|P3|COMPLETED|Overall Study||47
2241198|NCT02574481|5496502|P2|COMPLETED|Overall Study||142
2241199|NCT02574481|5496503|P1|COMPLETED|Overall Study||282
2241200|NCT02574481|5496500|P4|STARTED|Overall Study||13
2241201|NCT02574481|5496501|P3|STARTED|Overall Study||50
2241202|NCT02574481|5496502|P2|STARTED|Overall Study||156
2241203|NCT02574481|5496503|P1|STARTED|Overall Study||309
2241204|NCT02574260|5496541|P1|NOT COMPLETED|Overall Study||1
2241205|NCT02574260|5496541|P1|COMPLETED|Overall Study||2
2241206|NCT02574260|5496541|P1|STARTED|Overall Study||3
2241207|NCT02574247|5496550|P3|NOT COMPLETED|Overall Study||5
2241208|NCT02574247|5496551|P2|NOT COMPLETED|Overall Study||3
2241209|NCT02574247|5496552|P1|NOT COMPLETED|Overall Study||5
2241210|NCT02574247|5496550|P3|COMPLETED|Overall Study||5
2241211|NCT02574247|5496551|P2|COMPLETED|Overall Study||5
2241212|NCT02574247|5496552|P1|COMPLETED|Overall Study||5
2241213|NCT02574247|5496550|P3|STARTED|Overall Study||10
2241214|NCT02574247|5496551|P2|STARTED|Overall Study||8
2241215|NCT02574247|5496552|P1|STARTED|Overall Study||10
2241216|NCT02573948|5496564|P1|NOT COMPLETED|Longitudinal Cohort||56
2241217|NCT02573948|5496564|P1|COMPLETED|Longitudinal Cohort||194
2241218|NCT02573948|5496564|P1|STARTED|Longitudinal Cohort|Not on ART a/o MMT. MSM and FSW were prioritized for enrolling,|250
2241219|NCT02573948|5496564|P1|NOT COMPLETED|RDS||0
2241220|NCT02573948|5496564|P1|COMPLETED|RDS||603
2241221|NCT02573948|5496564|P1|STARTED|RDS||603
2241222|NCT02573870|5496574|P2|NOT COMPLETED|Overall Study||7
2241223|NCT02573870|5496575|P1|NOT COMPLETED|Overall Study||0
2241224|NCT02573870|5496574|P2|COMPLETED|Overall Study||35
2241225|NCT02573870|5496575|P1|COMPLETED|Overall Study||20
2241226|NCT02573870|5496574|P2|STARTED|Overall Study||42
2241227|NCT02573870|5496575|P1|STARTED|Overall Study||20
2241228|NCT02573467|5496585|P4|NOT COMPLETED|Post-treatment Follow up Epoch||3
2241229|NCT02573467|5496586|P3|NOT COMPLETED|Post-treatment Follow up Epoch||10
2241230|NCT02573467|5496587|P2|NOT COMPLETED|Post-treatment Follow up Epoch||5
2241231|NCT02573467|5496588|P1|NOT COMPLETED|Post-treatment Follow up Epoch||6
2241232|NCT02573467|5496585|P4|COMPLETED|Post-treatment Follow up Epoch||44
2241233|NCT02573467|5496586|P3|COMPLETED|Post-treatment Follow up Epoch||34
2241234|NCT02573467|5496587|P2|COMPLETED|Post-treatment Follow up Epoch||41
2241235|NCT02573467|5496588|P1|COMPLETED|Post-treatment Follow up Epoch||35
2241236|NCT02573467|5496585|P4|STARTED|Post-treatment Follow up Epoch||47
2241237|NCT02573467|5496586|P3|STARTED|Post-treatment Follow up Epoch||44
2241238|NCT02573467|5496587|P2|STARTED|Post-treatment Follow up Epoch||46
2241239|NCT02573467|5496588|P1|STARTED|Post-treatment Follow up Epoch||41
2241240|NCT02573467|5496585|P4|NOT COMPLETED|Double-blind Treatment Epoch||55
2241241|NCT02573467|5496586|P3|NOT COMPLETED|Double-blind Treatment Epoch||51
2241242|NCT02573467|5496587|P2|NOT COMPLETED|Double-blind Treatment Epoch||52
2241243|NCT02573467|5496588|P1|NOT COMPLETED|Double-blind Treatment Epoch||53
2241244|NCT02573467|5496585|P4|COMPLETED|Double-blind Treatment Epoch||0
2241245|NCT02573467|5496586|P3|COMPLETED|Double-blind Treatment Epoch||0
2241246|NCT02573467|5496587|P2|COMPLETED|Double-blind Treatment Epoch||0
2241247|NCT02573467|5496588|P1|COMPLETED|Double-blind Treatment Epoch||0
2241248|NCT02573467|5496585|P4|Full Analysis Set|Double-blind Treatment Epoch||55
2241249|NCT02573467|5496586|P3|Full Analysis Set|Double-blind Treatment Epoch||51
2241250|NCT02573467|5496587|P2|Full Analysis Set|Double-blind Treatment Epoch||52
2241251|NCT02573467|5496588|P1|Full Analysis Set|Double-blind Treatment Epoch||53
2241252|NCT02573467|5496585|P4|STARTED|Double-blind Treatment Epoch||55
2241253|NCT02573467|5496586|P3|STARTED|Double-blind Treatment Epoch||51
2241254|NCT02573467|5496587|P2|STARTED|Double-blind Treatment Epoch||52
2241255|NCT02573467|5496588|P1|STARTED|Double-blind Treatment Epoch||53
2241256|NCT02573402|5496629|P2|NOT COMPLETED|Overall Study||0
2241257|NCT02573402|5496630|P1|NOT COMPLETED|Overall Study||0
2241258|NCT02573402|5496629|P2|COMPLETED|Overall Study||7
2241259|NCT02573402|5496630|P1|COMPLETED|Overall Study||12
2241260|NCT02573402|5496629|P2|STARTED|Overall Study||7
2241261|NCT02573402|5496630|P1|STARTED|Overall Study||12
2241262|NCT02573233|5496652|P2|NOT COMPLETED|Overall Study||0
2241263|NCT02573233|5496653|P1|NOT COMPLETED|Overall Study||0
2241264|NCT02573233|5496652|P2|COMPLETED|Overall Study||20
2241265|NCT02573233|5496653|P1|COMPLETED|Overall Study||22
2241266|NCT02573233|5496652|P2|STARTED|Overall Study||20
2241267|NCT02573233|5496653|P1|STARTED|Overall Study||22
2241268|NCT02573181|5496680|P2|NOT COMPLETED|Overall Study||0
2241269|NCT02573181|5496681|P1|NOT COMPLETED|Overall Study||0
2241270|NCT02573181|5496680|P2|COMPLETED|Overall Study||126
2241271|NCT02573181|5496681|P1|COMPLETED|Overall Study||127
2241272|NCT02573181|5496680|P2|Vaccinated|Overall Study||126
2241273|NCT02573181|5496681|P1|Vaccinated|Overall Study||127
2241274|NCT02573181|5496680|P2|STARTED|Overall Study||126
2241275|NCT02573181|5496681|P1|STARTED|Overall Study||127
2241276|NCT02573155|5496705|P2|NOT COMPLETED|Period 5||0
2241277|NCT02573155|5496706|P1|NOT COMPLETED|Period 5||0
2241278|NCT02573155|5496705|P2|COMPLETED|Period 5||28
2241279|NCT02573155|5496706|P1|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
2241280|NCT02573155|5496705|P2|STARTED|Period 5||28
2241281|NCT02573155|5496706|P1|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
2241282|NCT02573155|5496705|P2|NOT COMPLETED|Washout Between Treatment Period 4 and 5||1
2241283|NCT02573155|5496706|P1|NOT COMPLETED|Washout Between Treatment Period 4 and 5||0
2241284|NCT02573155|5496705|P2|COMPLETED|Washout Between Treatment Period 4 and 5||28
2241285|NCT02573155|5496706|P1|COMPLETED|Washout Between Treatment Period 4 and 5|Part 1 comprised 3 treatment periods only|0
2241286|NCT02573155|5496705|P2|STARTED|Washout Between Treatment Period 4 and 5||29
2241287|NCT02573155|5496706|P1|STARTED|Washout Between Treatment Period 4 and 5|Part 1 comprised 3 treatment periods only|0
2241288|NCT02573155|5496705|P2|NOT COMPLETED|Period 4||0
2241289|NCT02573155|5496706|P1|NOT COMPLETED|Period 4||0
2241290|NCT02573155|5496705|P2|COMPLETED|Period 4||29
2241291|NCT02573155|5496706|P1|COMPLETED|Period 4|Part 1 comprised 3 treatment periods only|0
2241292|NCT02573155|5496705|P2|STARTED|Period 4||29
2241293|NCT02573155|5496706|P1|STARTED|Period 4|Part 1 comprised 3 treatment periods only|0
2241294|NCT02573155|5496705|P2|NOT COMPLETED|Washout Between Treatment Period 3 and 4||2
2241295|NCT02573155|5496706|P1|NOT COMPLETED|Washout Between Treatment Period 3 and 4||0
2241296|NCT02573155|5496705|P2|COMPLETED|Washout Between Treatment Period 3 and 4||29
2241297|NCT02573155|5496706|P1|COMPLETED|Washout Between Treatment Period 3 and 4|Part 1 comprised 3 treatment periods only|0
2241298|NCT02573155|5496705|P2|STARTED|Washout Between Treatment Period 3 and 4||31
2241299|NCT02573155|5496706|P1|STARTED|Washout Between Treatment Period 3 and 4|Part 1 comprised 3 treatment periods only|0
2241300|NCT02573155|5496705|P2|NOT COMPLETED|Period 3||0
2241301|NCT02573155|5496706|P1|NOT COMPLETED|Period 3||0
2241302|NCT02573155|5496705|P2|COMPLETED|Period 3||31
2241303|NCT02573155|5496706|P1|COMPLETED|Period 3||15
2241304|NCT02573155|5496705|P2|STARTED|Period 3||31
2241305|NCT02573155|5496706|P1|STARTED|Period 3||15
2241306|NCT02573155|5496705|P2|NOT COMPLETED|Washout Between Treatment Period 2 and 3||2
2241307|NCT02573155|5496706|P1|NOT COMPLETED|Washout Between Treatment Period 2 and 3||1
2241308|NCT02573155|5496705|P2|COMPLETED|Washout Between Treatment Period 2 and 3||31
2241309|NCT02573155|5496706|P1|COMPLETED|Washout Between Treatment Period 2 and 3||15
2241310|NCT02573155|5496705|P2|STARTED|Washout Between Treatment Period 2 and 3||33
2241311|NCT02573155|5496706|P1|STARTED|Washout Between Treatment Period 2 and 3||16
2241312|NCT02573155|5496705|P2|NOT COMPLETED|Period 2||0
2241313|NCT02573155|5496706|P1|NOT COMPLETED|Period 2||0
2241314|NCT02573155|5496705|P2|COMPLETED|Period 2||33
2241315|NCT02573155|5496706|P1|COMPLETED|Period 2||16
2241316|NCT02573155|5496705|P2|STARTED|Period 2||33
2241317|NCT02573155|5496706|P1|STARTED|Period 2||16
2241318|NCT02573155|5496705|P2|NOT COMPLETED|Washout Between Treatment Period 1 and 2||5
2241319|NCT02573155|5496706|P1|NOT COMPLETED|Washout Between Treatment Period 1 and 2||0
2241320|NCT02573155|5496705|P2|COMPLETED|Washout Between Treatment Period 1 and 2||33
2241321|NCT02573155|5496706|P1|COMPLETED|Washout Between Treatment Period 1 and 2||16
2241322|NCT02573155|5496705|P2|STARTED|Washout Between Treatment Period 1 and 2||38
2241323|NCT02573155|5496706|P1|STARTED|Washout Between Treatment Period 1 and 2||16
2241324|NCT02573155|5496705|P2|NOT COMPLETED|Treatment Period 1||0
2241325|NCT02573155|5496706|P1|NOT COMPLETED|Treatment Period 1||0
2241326|NCT02573155|5496705|P2|COMPLETED|Treatment Period 1||38
2241327|NCT02573155|5496706|P1|COMPLETED|Treatment Period 1||16
2241328|NCT02573155|5496705|P2|STARTED|Treatment Period 1||38
2241329|NCT02573155|5496706|P1|STARTED|Treatment Period 1||16
2241330|NCT02573012|5496854|P2|NOT COMPLETED|Overall Study||15
2241331|NCT02573012|5496855|P1|NOT COMPLETED|Overall Study||15
2241332|NCT02573012|5496854|P2|COMPLETED|Overall Study||113
2241333|NCT02573012|5496855|P1|COMPLETED|Overall Study||116
2241334|NCT02573012|5496854|P2|STARTED|Overall Study||128
2241335|NCT02573012|5496855|P1|STARTED|Overall Study||131
2241336|NCT02572817|5496907|P2|NOT COMPLETED|Overall Study||6
2241337|NCT02572817|5496908|P1|NOT COMPLETED|Overall Study||9
2241338|NCT02572817|5496907|P2|COMPLETED|Overall Study||41
2241339|NCT02572817|5496908|P1|COMPLETED|Overall Study||82
2241340|NCT02572817|5496907|P2|STARTED|Overall Study||47
2241341|NCT02572817|5496908|P1|STARTED|Overall Study||91
2241342|NCT02572752|5496975|P3|NOT COMPLETED|Period 3 Including Washout||0
2241343|NCT02572752|5496976|P2|NOT COMPLETED|Period 3 Including Washout||0
2241344|NCT02572752|5496977|P1|NOT COMPLETED|Period 3 Including Washout||0
2241345|NCT02572752|5496975|P3|COMPLETED|Period 3 Including Washout||24
2241346|NCT02572752|5496976|P2|COMPLETED|Period 3 Including Washout||23
2241347|NCT02572752|5496977|P1|COMPLETED|Period 3 Including Washout||23
2241348|NCT02572752|5496975|P3|STARTED|Period 3 Including Washout||24
2241349|NCT02572752|5496976|P2|STARTED|Period 3 Including Washout||23
2241350|NCT02572752|5496977|P1|STARTED|Period 3 Including Washout||23
2241351|NCT02572752|5496975|P3|NOT COMPLETED|Period 2 Including Washout||0
2241352|NCT02572752|5496976|P2|NOT COMPLETED|Period 2 Including Washout||0
2241353|NCT02572752|5496977|P1|NOT COMPLETED|Period 2 Including Washout||0
2241354|NCT02572752|5496975|P3|COMPLETED|Period 2 Including Washout||24
2241355|NCT02572752|5496976|P2|COMPLETED|Period 2 Including Washout||23
2241356|NCT02572752|5496977|P1|COMPLETED|Period 2 Including Washout||23
2241357|NCT02572752|5496975|P3|STARTED|Period 2 Including Washout||24
2241358|NCT02572752|5496976|P2|STARTED|Period 2 Including Washout||23
2241359|NCT02572752|5496977|P1|STARTED|Period 2 Including Washout||23
2241360|NCT02572752|5496975|P3|NOT COMPLETED|Period 1 Including Washout||0
2241361|NCT02572752|5496976|P2|NOT COMPLETED|Period 1 Including Washout||0
2241362|NCT02572752|5496977|P1|NOT COMPLETED|Period 1 Including Washout||0
2241363|NCT02572752|5496975|P3|COMPLETED|Period 1 Including Washout||24
2241364|NCT02572752|5496976|P2|COMPLETED|Period 1 Including Washout||23
2241365|NCT02572752|5496977|P1|COMPLETED|Period 1 Including Washout||23
2241366|NCT02572752|5496975|P3|STARTED|Period 1 Including Washout||24
2241367|NCT02572752|5496976|P2|STARTED|Period 1 Including Washout||23
2241368|NCT02572752|5496977|P1|STARTED|Period 1 Including Washout||23
2241369|NCT02572609|5496992|P2|NOT COMPLETED|Period 2: Treatment Period 2||0
2241370|NCT02572609|5496993|P1|NOT COMPLETED|Period 2: Treatment Period 2||0
2241371|NCT02572609|5496992|P2|COMPLETED|Period 2: Treatment Period 2||18
2241372|NCT02572609|5496993|P1|COMPLETED|Period 2: Treatment Period 2||18
2241373|NCT02572609|5496992|P2|STARTED|Period 2: Treatment Period 2||18
2241374|NCT02572609|5496993|P1|STARTED|Period 2: Treatment Period 2||18
2241375|NCT02572609|5496992|P2|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
2241376|NCT02572609|5496993|P1|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
2241377|NCT02572609|5496992|P2|COMPLETED|Period 1: Treatment Period 1 + Washout||18
2241378|NCT02572609|5496993|P1|COMPLETED|Period 1: Treatment Period 1 + Washout||18
2241379|NCT02572609|5496992|P2|STARTED|Period 1: Treatment Period 1 + Washout||18
2241380|NCT02572609|5496993|P1|STARTED|Period 1: Treatment Period 1 + Washout||18
2241381|NCT02572427|5497003|P2|NOT COMPLETED|Overall Study||9
2241382|NCT02572427|5497004|P1|NOT COMPLETED|Overall Study||6
2241383|NCT02572427|5497003|P2|COMPLETED|Overall Study||36
2241384|NCT02572427|5497004|P1|COMPLETED|Overall Study||31
2241385|NCT02572427|5497003|P2|STARTED|Overall Study||45
2241386|NCT02572427|5497004|P1|STARTED|Overall Study||37
2241387|NCT02572401|5497016|P4|NOT COMPLETED|Overall Study||10
2241388|NCT02572401|5497017|P3|NOT COMPLETED|Overall Study||9
2241389|NCT02572401|5497018|P2|NOT COMPLETED|Overall Study||8
2241390|NCT02572401|5497019|P1|NOT COMPLETED|Overall Study||5
2241391|NCT02572401|5497016|P4|COMPLETED|Overall Study||88
2241392|NCT02572401|5497017|P3|COMPLETED|Overall Study||89
2241393|NCT02572401|5497018|P2|COMPLETED|Overall Study||90
2241394|NCT02572401|5497019|P1|COMPLETED|Overall Study||92
2241395|NCT02572401|5497016|P4|STARTED|Overall Study||98
2241396|NCT02572401|5497017|P3|STARTED|Overall Study||98
2241397|NCT02572401|5497018|P2|STARTED|Overall Study||98
2241398|NCT02572401|5497019|P1|STARTED|Overall Study||97
2241399|NCT02572388|5497049|P4|NOT COMPLETED|Overall Study||2
2241400|NCT02572388|5497050|P3|NOT COMPLETED|Overall Study||2
2241401|NCT02572388|5497051|P2|NOT COMPLETED|Overall Study||1
2241402|NCT02572388|5497052|P1|NOT COMPLETED|Overall Study||1
2241403|NCT02572388|5497049|P4|COMPLETED|Overall Study||4
2241404|NCT02572388|5497050|P3|COMPLETED|Overall Study||8
2241405|NCT02572388|5497051|P2|COMPLETED|Overall Study||3
2241406|NCT02572388|5497052|P1|COMPLETED|Overall Study||10
2241407|NCT02572388|5497049|P4|STARTED|Overall Study||6
2241408|NCT02572388|5497050|P3|STARTED|Overall Study||10
2241409|NCT02572388|5497051|P2|STARTED|Overall Study||4
2241410|NCT02572388|5497052|P1|STARTED|Overall Study||11
2241411|NCT02572167|5497077|P3|NOT COMPLETED|Overall Study||31
2241412|NCT02572167|5497078|P2|NOT COMPLETED|Overall Study||56
2241413|NCT02572167|5497079|P1|NOT COMPLETED|Overall Study||6
2241414|NCT02572167|5497077|P3|COMPLETED|Overall Study||0
2241415|NCT02572167|5497078|P2|COMPLETED|Overall Study||0
2241416|NCT02572167|5497079|P1|COMPLETED|Overall Study||0
2241417|NCT02572167|5497077|P3|STARTED|Overall Study||31
2241418|NCT02572167|5497078|P2|STARTED|Overall Study||56
2241419|NCT02572167|5497079|P1|STARTED|Overall Study||6
2241420|NCT02572076|5497093|P1|NOT COMPLETED|Overall Study||1
2241421|NCT02572076|5497093|P1|COMPLETED|Overall Study||9
2241422|NCT02572076|5497093|P1|STARTED|Overall Study||10
2241423|NCT02571972|5497097|P1|NOT COMPLETED|Overall Study||4
2241424|NCT02571972|5497097|P1|COMPLETED|Overall Study||10
2241425|NCT02571972|5497097|P1|STARTED|Overall Study|2 patients signed consent but withdrew from the study prior to using dorzolamide-timolol drops.|14
2241426|NCT02571634|5497104|P1|NOT COMPLETED|Overall Study||0
2241427|NCT02571634|5497104|P1|COMPLETED|Overall Study|The final subject was enrolled on this date.|23
2241428|NCT02571634|5497104|P1|STARTED|Overall Study|First subject wasn't enrolled until July related to receipt of medications from sponsor.|23
2241429|NCT02571452|5497114|P2|NOT COMPLETED|Overall Study 6-Month Follow-up||0
2241430|NCT02571452|5497115|P1|NOT COMPLETED|Overall Study 6-Month Follow-up||5
2241431|NCT02571452|5497114|P2|COMPLETED|Overall Study 6-Month Follow-up||0
2241432|NCT02571452|5497115|P1|COMPLETED|Overall Study 6-Month Follow-up||42
2241433|NCT02571452|5497114|P2|STARTED|Overall Study 6-Month Follow-up|Participants in the PMRT arm were not invited to complete 6-Month Follow-up.|0
2241434|NCT02571452|5497115|P1|STARTED|Overall Study 6-Month Follow-up||47
2241435|NCT02571452|5497114|P2|NOT COMPLETED|Overall Study Treatment||1
2241436|NCT02571452|5497115|P1|NOT COMPLETED|Overall Study Treatment||0
2241437|NCT02571452|5497114|P2|COMPLETED|Overall Study Treatment||45
2241438|NCT02571452|5497115|P1|COMPLETED|Overall Study Treatment||47
2241439|NCT02571452|5497114|P2|STARTED|Overall Study Treatment||46
2241440|NCT02571452|5497115|P1|STARTED|Overall Study Treatment||47
2241441|NCT02571439|5497129|P2|NOT COMPLETED|Overall Study||0
2241442|NCT02571439|5497130|P1|NOT COMPLETED|Overall Study||0
2241443|NCT02571439|5497129|P2|COMPLETED|Overall Study||21
2241444|NCT02571439|5497130|P1|COMPLETED|Overall Study||20
2241445|NCT02571439|5497129|P2|STARTED|Overall Study||21
2241446|NCT02571439|5497130|P1|STARTED|Overall Study||20
2241447|NCT02571244|5497156|P2|NOT COMPLETED|Overall Study||1
2241448|NCT02571244|5497157|P1|NOT COMPLETED|Overall Study||3
2241449|NCT02571244|5497156|P2|COMPLETED|Overall Study||21
2241450|NCT02571244|5497157|P1|COMPLETED|Overall Study||41
2241451|NCT02571244|5497156|P2|STARTED|Overall Study||22
2241452|NCT02571244|5497157|P1|STARTED|Overall Study||44
2241453|NCT02571218|5497173|P2|NOT COMPLETED|Overall Study||0
2241454|NCT02571218|5497174|P1|NOT COMPLETED|Overall Study||0
2241455|NCT02571218|5497173|P2|COMPLETED|Overall Study||41
2241456|NCT02571218|5497174|P1|COMPLETED|Overall Study||40
2241457|NCT02571218|5497173|P2|STARTED|Overall Study||41
2241458|NCT02571218|5497174|P1|STARTED|Overall Study||40
2241459|NCT02571153|5497185|P3|NOT COMPLETED|Overall Study||2
2241460|NCT02571153|5497186|P2|NOT COMPLETED|Overall Study||8
2241461|NCT02571153|5497187|P1|NOT COMPLETED|Overall Study||6
2241462|NCT02571153|5497185|P3|COMPLETED|Overall Study||43
2241463|NCT02571153|5497186|P2|COMPLETED|Overall Study||37
2241464|NCT02571153|5497187|P1|COMPLETED|Overall Study||39
2241465|NCT02571153|5497185|P3|STARTED|Overall Study||45
2241466|NCT02571153|5497186|P2|STARTED|Overall Study||45
2241467|NCT02571153|5497187|P1|STARTED|Overall Study||45
2241468|NCT02571075|5497215|P2|NOT COMPLETED|Overall Study||24
2241469|NCT02571075|5497216|P1|NOT COMPLETED|Overall Study||20
2241470|NCT02571075|5497215|P2|COMPLETED|Overall Study||26
2241471|NCT02571075|5497216|P1|COMPLETED|Overall Study||25
2241472|NCT02571075|5497215|P2|STARTED|Overall Study||50
2241473|NCT02571075|5497216|P1|STARTED|Overall Study||45
2241474|NCT02571049|5497230|P2|NOT COMPLETED|Randomization||2
2241475|NCT02571049|5497231|P1|NOT COMPLETED|Randomization||0
2241476|NCT02571049|5497230|P2|COMPLETED|Randomization||10
2241477|NCT02571049|5497231|P1|COMPLETED|Randomization||8
2241478|NCT02571049|5497230|P2|STARTED|Randomization||12
2241479|NCT02571049|5497231|P1|STARTED|Randomization||8
2241480|NCT02571049|5497230|P2|NOT COMPLETED|Screening||2
2241481|NCT02571049|5497231|P1|NOT COMPLETED|Screening||2
2241482|NCT02571049|5497230|P2|COMPLETED|Screening||12
2241483|NCT02571049|5497231|P1|COMPLETED|Screening||8
2241484|NCT02571049|5497230|P2|STARTED|Screening||14
2241485|NCT02571049|5497231|P1|STARTED|Screening||10
2241486|NCT02570750|5497239|P2|NOT COMPLETED|Overall Study||5
2241487|NCT02570750|5497240|P1|NOT COMPLETED|Overall Study||14
2241488|NCT02570750|5497239|P2|COMPLETED|Overall Study||68
2241489|NCT02570750|5497240|P1|COMPLETED|Overall Study||96
2241490|NCT02570750|5497239|P2|STARTED|Overall Study||73
2241491|NCT02570750|5497240|P1|STARTED|Overall Study||110
2241492|NCT02570711|5497258|P2|NOT COMPLETED|Overall Study||2
2241493|NCT02570711|5497259|P1|NOT COMPLETED|Overall Study||1
2241494|NCT02570711|5497258|P2|COMPLETED|Overall Study||0
2241495|NCT02570711|5497259|P1|COMPLETED|Overall Study||0
2241496|NCT02570711|5497258|P2|STARTED|Overall Study||2
2241497|NCT02570711|5497259|P1|STARTED|Overall Study||1
2241498|NCT02570425|5497267|P2|NOT COMPLETED|Visit 3||0
2241499|NCT02570425|5497268|P1|NOT COMPLETED|Visit 3||0
2241500|NCT02570425|5497267|P2|COMPLETED|Visit 3||231
2241501|NCT02570425|5497268|P1|COMPLETED|Visit 3||229
2241502|NCT02570425|5497267|P2|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|231
2241503|NCT02570425|5497268|P1|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|229
2241504|NCT02570425|5497267|P2|NOT COMPLETED|Visit 2||0
2241505|NCT02570425|5497268|P1|NOT COMPLETED|Visit 2||0
2241506|NCT02570425|5497267|P2|COMPLETED|Visit 2||247
2241507|NCT02570425|5497268|P1|COMPLETED|Visit 2||251
2241508|NCT02570425|5497267|P2|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|247
2241509|NCT02570425|5497268|P1|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|251
2241510|NCT02570425|5497267|P2|NOT COMPLETED|Visit 1||0
2241511|NCT02570425|5497268|P1|NOT COMPLETED|Visit 1||0
2241512|NCT02570425|5497267|P2|COMPLETED|Visit 1||242
2241513|NCT02570425|5497268|P1|COMPLETED|Visit 1||274
2241514|NCT02570425|5497267|P2|STARTED|Visit 1||242
2241515|NCT02570425|5497268|P1|STARTED|Visit 1||274
2241516|NCT02570295|5497317|P2|NOT COMPLETED|Overall Study||58
2241517|NCT02570295|5497318|P1|NOT COMPLETED|Overall Study||11
2241518|NCT02570295|5497317|P2|COMPLETED|Overall Study||289
2241519|NCT02570295|5497318|P1|COMPLETED|Overall Study||364
2241520|NCT02570295|5497317|P2|STARTED|Overall Study||347
2241521|NCT02570295|5497318|P1|STARTED|Overall Study||375
2241522|NCT02570165|5497347|P7|NOT COMPLETED|Overall Study||0
2241523|NCT02570165|5497348|P6|NOT COMPLETED|Overall Study||2
2241524|NCT02570165|5497349|P5|NOT COMPLETED|Overall Study||6
2241525|NCT02570165|5497350|P4|NOT COMPLETED|Overall Study||5
2241526|NCT02570165|5497351|P3|NOT COMPLETED|Overall Study||5
2241527|NCT02570165|5497352|P2|NOT COMPLETED|Overall Study||3
2241528|NCT02570165|5497353|P1|NOT COMPLETED|Overall Study||2
2241529|NCT02570165|5497347|P7|COMPLETED|Overall Study||47
2241530|NCT02570165|5497348|P6|COMPLETED|Overall Study||44
2241531|NCT02570165|5497349|P5|COMPLETED|Overall Study||41
2241532|NCT02570165|5497350|P4|COMPLETED|Overall Study||40
2241533|NCT02570165|5497351|P3|COMPLETED|Overall Study||41
2241534|NCT02570165|5497352|P2|COMPLETED|Overall Study||43
2241535|NCT02570165|5497353|P1|COMPLETED|Overall Study||44
2241536|NCT02570165|5497347|P7|STARTED|Overall Study||47
2241537|NCT02570165|5497348|P6|STARTED|Overall Study||46
2241538|NCT02570165|5497349|P5|STARTED|Overall Study||47
2241539|NCT02570165|5497350|P4|STARTED|Overall Study||45
2241540|NCT02570165|5497351|P3|STARTED|Overall Study||46
2241541|NCT02570165|5497352|P2|STARTED|Overall Study||46
2241542|NCT02570165|5497353|P1|STARTED|Overall Study||46
2241543|NCT02570139|5497378|P2|NOT COMPLETED|Overall Study||0
2241544|NCT02570139|5497379|P1|NOT COMPLETED|Overall Study||0
2241545|NCT02570139|5497378|P2|COMPLETED|Overall Study||21
2241546|NCT02570139|5497379|P1|COMPLETED|Overall Study||24
2241547|NCT02570139|5497378|P2|STARTED|Overall Study|21 subjects treated with SensiCare Protective Barrier|21
2241548|NCT02570139|5497379|P1|STARTED|Overall Study|24 subjects were treated w/ Cavilon Advanced Skin Protectant. Study terminated due to low enrollment|24
2241549|NCT02570126|5497393|P2|NOT COMPLETED|Overall Study||9
2241550|NCT02570126|5497394|P1|NOT COMPLETED|Overall Study||6
2241551|NCT02570126|5497393|P2|COMPLETED|Overall Study||607
2241552|NCT02570126|5497394|P1|COMPLETED|Overall Study||609
2241553|NCT02570126|5497393|P2|STARTED|Overall Study||616
2241554|NCT02570126|5497394|P1|STARTED|Overall Study||615
2241555|NCT02570074|5497420|P2|NOT COMPLETED|Period 2 (Second Dosing Regimen)||0
2241556|NCT02570074|5497421|P1|NOT COMPLETED|Period 2 (Second Dosing Regimen)||1
2241557|NCT02570074|5497420|P2|COMPLETED|Period 2 (Second Dosing Regimen)||10
2241558|NCT02570074|5497421|P1|COMPLETED|Period 2 (Second Dosing Regimen)||8
2241559|NCT02570074|5497420|P2|STARTED|Period 2 (Second Dosing Regimen)||10
2241560|NCT02570074|5497421|P1|STARTED|Period 2 (Second Dosing Regimen)||9
2241561|NCT02570074|5497420|P2|NOT COMPLETED|Period 1 (First Dosing Regimen)||0
2241562|NCT02570074|5497421|P1|NOT COMPLETED|Period 1 (First Dosing Regimen)||0
2241563|NCT02570074|5497420|P2|COMPLETED|Period 1 (First Dosing Regimen)||10
2241564|NCT02570074|5497421|P1|COMPLETED|Period 1 (First Dosing Regimen)||9
2241565|NCT02570074|5497420|P2|STARTED|Period 1 (First Dosing Regimen)||10
2241566|NCT02570074|5497421|P1|STARTED|Period 1 (First Dosing Regimen)||9
2241567|NCT02570022|5497481|P2|NOT COMPLETED|Overall Study||0
2241568|NCT02570022|5497482|P1|NOT COMPLETED|Overall Study||0
2241569|NCT02570022|5497481|P2|COMPLETED|Overall Study||31
2241570|NCT02570022|5497482|P1|COMPLETED|Overall Study||26
2241571|NCT02570022|5497481|P2|STARTED|Overall Study||31
2241572|NCT02570022|5497482|P1|STARTED|Overall Study||26
2241573|NCT02569996|5497490|P1|NOT COMPLETED|Overall Study||55
2241574|NCT02569996|5497490|P1|COMPLETED|Overall Study||69
2241575|NCT02569996|5497490|P1|STARTED|Overall Study||124
2241576|NCT02569957|5497502|P2|NOT COMPLETED|Overall Study||1
2241577|NCT02569957|5497503|P1|NOT COMPLETED|Overall Study||0
2241578|NCT02569957|5497502|P2|COMPLETED|Overall Study||0
2241579|NCT02569957|5497503|P1|COMPLETED|Overall Study||0
2241580|NCT02569957|5497502|P2|STARTED|Overall Study||1
2241581|NCT02569957|5497503|P1|STARTED|Overall Study||0
2241582|NCT02569853|5497535|P2|NOT COMPLETED|Overall Study||14
2241583|NCT02569853|5497536|P1|NOT COMPLETED|Overall Study||20
2241584|NCT02569853|5497535|P2|COMPLETED|Overall Study||123
2241585|NCT02569853|5497536|P1|COMPLETED|Overall Study||111
2241586|NCT02569853|5497535|P2|STARTED|Overall Study||137
2241587|NCT02569853|5497536|P1|STARTED|Overall Study||131
2241588|NCT02569710|5497554|P10|NOT COMPLETED|Overall Study||0
2241589|NCT02569710|5497555|P9|NOT COMPLETED|Overall Study||1
2241590|NCT02569710|5497556|P8|NOT COMPLETED|Overall Study||0
2241591|NCT02569710|5497557|P7|NOT COMPLETED|Overall Study||2
2241592|NCT02569710|5497558|P6|NOT COMPLETED|Overall Study||1
2241593|NCT02569710|5497559|P5|NOT COMPLETED|Overall Study||1
2241594|NCT02569710|5497560|P4|NOT COMPLETED|Overall Study||0
2241595|NCT02569710|5497561|P3|NOT COMPLETED|Overall Study||0
2241596|NCT02569710|5497562|P2|NOT COMPLETED|Overall Study||0
2241597|NCT02569710|5497563|P1|NOT COMPLETED|Overall Study||1
2241598|NCT02569710|5497554|P10|COMPLETED|Overall Study||4
2241599|NCT02569710|5497555|P9|COMPLETED|Overall Study||14
2241600|NCT02569710|5497556|P8|COMPLETED|Overall Study||30
2241601|NCT02569710|5497557|P7|COMPLETED|Overall Study||12
2241602|NCT02569710|5497558|P6|COMPLETED|Overall Study||4
2241603|NCT02569710|5497559|P5|COMPLETED|Overall Study||7
2241604|NCT02569710|5497560|P4|COMPLETED|Overall Study||20
2241605|NCT02569710|5497561|P3|COMPLETED|Overall Study||20
2241606|NCT02569710|5497562|P2|COMPLETED|Overall Study||25
2241607|NCT02569710|5497563|P1|COMPLETED|Overall Study||19
2241608|NCT02569710|5497554|P10|STARTED|Overall Study||4
2241609|NCT02569710|5497555|P9|STARTED|Overall Study||15
2241610|NCT02569710|5497556|P8|STARTED|Overall Study||30
2241611|NCT02569710|5497557|P7|STARTED|Overall Study||14
2241612|NCT02569710|5497558|P6|STARTED|Overall Study||5
2241613|NCT02569710|5497559|P5|STARTED|Overall Study||8
2241614|NCT02569710|5497560|P4|STARTED|Overall Study||20
2241615|NCT02569710|5497561|P3|STARTED|Overall Study||20
2241616|NCT02569710|5497562|P2|STARTED|Overall Study||25
2241617|NCT02569710|5497563|P1|STARTED|Overall Study||20
2241618|NCT02569658|5497873|P2|NOT COMPLETED|Overall Study||1
2241619|NCT02569658|5497874|P1|NOT COMPLETED|Overall Study||1
2241620|NCT02569658|5497873|P2|COMPLETED|Overall Study||56
2241621|NCT02569658|5497874|P1|COMPLETED|Overall Study||52
2241622|NCT02569658|5497873|P2|STARTED|Overall Study||57
2241623|NCT02569658|5497874|P1|STARTED|Overall Study||53
2241624|NCT02569541|5497890|P1|NOT COMPLETED|Overall Study||21
2241625|NCT02569541|5497890|P1|COMPLETED|Overall Study||9
2241626|NCT02569541|5497890|P1|STARTED|Overall Study||30
2241627|NCT02569437|5497903|P2|NOT COMPLETED|Overall Study||14
2241628|NCT02569437|5497904|P1|NOT COMPLETED|Overall Study||12
2241629|NCT02569437|5497903|P2|COMPLETED|Overall Study||11
2241630|NCT02569437|5497904|P1|COMPLETED|Overall Study||12
2241631|NCT02569437|5497903|P2|STARTED|Overall Study||25
2241632|NCT02569437|5497904|P1|STARTED|Overall Study||24
2241633|NCT02569398|5497921|P3|NOT COMPLETED|Overall Study||183
2241634|NCT02569398|5497922|P2|NOT COMPLETED|Overall Study||189
2241635|NCT02569398|5497923|P1|NOT COMPLETED|Overall Study||185
2241636|NCT02569398|5497921|P3|COMPLETED|Overall Study||0
2241637|NCT02569398|5497922|P2|COMPLETED|Overall Study||0
2241638|NCT02569398|5497923|P1|COMPLETED|Overall Study||0
2241639|NCT02569398|5497921|P3|STARTED|Overall Study||183
2241640|NCT02569398|5497922|P2|STARTED|Overall Study||189
2241641|NCT02569398|5497923|P1|STARTED|Overall Study||185
2241642|NCT02569112|5497946|P2|NOT COMPLETED|Overall Study||0
2241643|NCT02569112|5497947|P1|NOT COMPLETED|Overall Study||0
2241644|NCT02569112|5497946|P2|COMPLETED|Overall Study|Each subject received multipolar RF with varipulse technology to only one side of their body.|10
2241645|NCT02569112|5497947|P1|COMPLETED|Overall Study||10
2241646|NCT02569112|5497946|P2|STARTED|Overall Study||10
2241647|NCT02569112|5497947|P1|STARTED|Overall Study||10
2241648|NCT02569086|5497952|P1|NOT COMPLETED|Overall Study||0
2241649|NCT02569086|5497952|P1|COMPLETED|Overall Study||22
2241650|NCT02569086|5497952|P1|STARTED|Overall Study||22
2241651|NCT02568852|5497959|P2|NOT COMPLETED|Overall Study||0
2241652|NCT02568852|5497960|P1|NOT COMPLETED|Overall Study||0
2241653|NCT02568852|5497959|P2|COMPLETED|Overall Study||25
2241654|NCT02568852|5497960|P1|COMPLETED|Overall Study||25
2241655|NCT02568852|5497959|P2|STARTED|Overall Study||25
2241656|NCT02568852|5497960|P1|STARTED|Overall Study||25
2241657|NCT02568683|5497998|P2|NOT COMPLETED|Overall Study||4
2241658|NCT02568683|5497999|P1|NOT COMPLETED|Overall Study||6
2241659|NCT02568683|5497998|P2|COMPLETED|Overall Study||0
2241660|NCT02568683|5497999|P1|COMPLETED|Overall Study||0
2241661|NCT02568683|5497998|P2|STARTED|Overall Study||4
2241662|NCT02568683|5497999|P1|STARTED|Overall Study||6
2241663|NCT02568397|5498011|P2|NOT COMPLETED|Period 2||2
2241664|NCT02568397|5498012|P1|NOT COMPLETED|Period 2||0
2241665|NCT02568397|5498011|P2|COMPLETED|Period 2||58
2241666|NCT02568397|5498012|P1|COMPLETED|Period 2||0
2241667|NCT02568397|5498011|P2|STARTED|Period 2|Daily doses of 50 mg LY3314814 were administered daily on Days 3 to 21 of Period 2.|60
2241668|NCT02568397|5498012|P1|STARTED|Period 2|A single oral dose of 150 mg dabigatran etexilate was administered on Day 1 of Period 1.|0
2241669|NCT02568397|5498011|P2|NOT COMPLETED|Period 1||0
2241670|NCT02568397|5498012|P1|NOT COMPLETED|Period 1||0
2241671|NCT02568397|5498011|P2|COMPLETED|Period 1||0
2241672|NCT02568397|5498012|P1|COMPLETED|Period 1||60
2241673|NCT02568397|5498011|P2|Received at Least 1 Dose of Study Drug|Period 1||0
2241674|NCT02568397|5498012|P1|Received at Least 1 Dose of Study Drug|Period 1||60
2241675|NCT02568397|5498011|P2|STARTED|Period 1||0
2241676|NCT02568397|5498012|P1|STARTED|Period 1||60
2241677|NCT02568384|5498036|P1|NOT COMPLETED|Overall Study||2
2241678|NCT02568384|5498036|P1|COMPLETED|Overall Study||43
2241679|NCT02568384|5498036|P1|STARTED|Overall Study||45
2241680|NCT02568345|5498046|P1|NOT COMPLETED|Overall Study||0
2241681|NCT02568345|5498046|P1|COMPLETED|Overall Study||31
2241682|NCT02568345|5498046|P1|Treated at 2.6 mg/kg|Overall Study|Patients: 8th-10th|3
2241683|NCT02568345|5498046|P1|Treated at 2.4 mg/kg|Overall Study|Patients: 1st-5th; 7th; 11th-15th; 21st-25th; 27th-31st|25
2241684|NCT02568345|5498046|P1|Treated at 2.2 mg/kg|Overall Study|patients: 6th, 20th, 26th|3
2241685|NCT02568345|5498046|P1|STARTED|Overall Study||31
2241686|NCT02568254|5498050|P6|NOT COMPLETED|Period 3||0
2241687|NCT02568254|5498051|P5|NOT COMPLETED|Period 3||1
2241688|NCT02568254|5498052|P4|NOT COMPLETED|Period 3||0
2241689|NCT02568254|5498053|P3|NOT COMPLETED|Period 3||0
2241690|NCT02568254|5498054|P2|NOT COMPLETED|Period 3||0
2241691|NCT02568254|5498055|P1|NOT COMPLETED|Period 3||0
2241692|NCT02568254|5498050|P6|COMPLETED|Period 3||12
2241693|NCT02568254|5498051|P5|COMPLETED|Period 3||11
2241694|NCT02568254|5498052|P4|COMPLETED|Period 3||12
2241695|NCT02568254|5498053|P3|COMPLETED|Period 3||12
2241696|NCT02568254|5498054|P2|COMPLETED|Period 3||12
2241697|NCT02568254|5498055|P1|COMPLETED|Period 3||13
2241698|NCT02568254|5498050|P6|STARTED|Period 3||12
2241699|NCT02568254|5498051|P5|STARTED|Period 3||12
2241700|NCT02568254|5498052|P4|STARTED|Period 3||12
2241701|NCT02568254|5498053|P3|STARTED|Period 3||12
2241702|NCT02568254|5498054|P2|STARTED|Period 3||12
2241703|NCT02568254|5498055|P1|STARTED|Period 3||13
2241704|NCT02568254|5498050|P6|NOT COMPLETED|Period 2||0
2241705|NCT02568254|5498051|P5|NOT COMPLETED|Period 2||0
2241706|NCT02568254|5498052|P4|NOT COMPLETED|Period 2||0
2241707|NCT02568254|5498053|P3|NOT COMPLETED|Period 2||1
2241708|NCT02568254|5498054|P2|NOT COMPLETED|Period 2||0
2241709|NCT02568254|5498055|P1|NOT COMPLETED|Period 2||0
2241710|NCT02568254|5498050|P6|COMPLETED|Period 2||12
2241711|NCT02568254|5498051|P5|COMPLETED|Period 2||12
2241712|NCT02568254|5498052|P4|COMPLETED|Period 2||12
2241713|NCT02568254|5498053|P3|COMPLETED|Period 2||12
2241714|NCT02568254|5498054|P2|COMPLETED|Period 2||12
2241715|NCT02568254|5498055|P1|COMPLETED|Period 2||13
2241716|NCT02568254|5498050|P6|STARTED|Period 2||12
2241717|NCT02568254|5498051|P5|STARTED|Period 2||12
2241718|NCT02568254|5498052|P4|STARTED|Period 2||12
2241719|NCT02568254|5498053|P3|STARTED|Period 2||13
2241720|NCT02568254|5498054|P2|STARTED|Period 2||12
2241721|NCT02568254|5498055|P1|STARTED|Period 2||13
2241722|NCT02568254|5498050|P6|NOT COMPLETED|Period 1||0
2241723|NCT02568254|5498051|P5|NOT COMPLETED|Period 1||0
2241724|NCT02568254|5498052|P4|NOT COMPLETED|Period 1||0
2241725|NCT02568254|5498053|P3|NOT COMPLETED|Period 1||0
2241726|NCT02568254|5498054|P2|NOT COMPLETED|Period 1||0
2241727|NCT02568254|5498055|P1|NOT COMPLETED|Period 1||0
2241728|NCT02568254|5498050|P6|COMPLETED|Period 1||12
2241729|NCT02568254|5498051|P5|COMPLETED|Period 1||12
2241730|NCT02568254|5498052|P4|COMPLETED|Period 1||12
2241731|NCT02568254|5498053|P3|COMPLETED|Period 1||13
2241732|NCT02568254|5498054|P2|COMPLETED|Period 1||12
2241733|NCT02568254|5498055|P1|COMPLETED|Period 1||13
2241734|NCT02568254|5498050|P6|STARTED|Period 1||12
2241735|NCT02568254|5498051|P5|STARTED|Period 1||12
2241736|NCT02568254|5498052|P4|STARTED|Period 1||12
2241737|NCT02568254|5498053|P3|STARTED|Period 1||13
2241738|NCT02568254|5498054|P2|STARTED|Period 1||12
2241739|NCT02568254|5498055|P1|STARTED|Period 1||13
2241740|NCT02568046|5498065|P2|NOT COMPLETED|Overall Study||3
2241741|NCT02568046|5498066|P1|NOT COMPLETED|Overall Study||5
2241742|NCT02568046|5498065|P2|COMPLETED|Overall Study||2
2241743|NCT02568046|5498066|P1|COMPLETED|Overall Study||0
2241744|NCT02568046|5498065|P2|STARTED|Overall Study||5
2241745|NCT02568046|5498066|P1|STARTED|Overall Study||5
2241746|NCT02568007|5498075|P3|NOT COMPLETED|Overall Study||0
2241747|NCT02568007|5498076|P2|NOT COMPLETED|Overall Study||0
2241748|NCT02568007|5498077|P1|NOT COMPLETED|Overall Study||0
2241749|NCT02568007|5498075|P3|COMPLETED|Overall Study||0
2241750|NCT02568007|5498076|P2|COMPLETED|Overall Study||2
2241751|NCT02568007|5498077|P1|COMPLETED|Overall Study||2
2241752|NCT02568007|5498075|P3|STARTED|Overall Study||0
2241753|NCT02568007|5498076|P2|STARTED|Overall Study||2
2241754|NCT02568007|5498077|P1|STARTED|Overall Study||2
2241755|NCT02567968|5498106|P2|NOT COMPLETED|Second Intervention||0
2241756|NCT02567968|5498107|P1|NOT COMPLETED|Second Intervention||0
2241757|NCT02567968|5498106|P2|COMPLETED|Second Intervention||4
2241758|NCT02567968|5498107|P1|COMPLETED|Second Intervention||4
2241759|NCT02567968|5498106|P2|STARTED|Second Intervention||4
2241760|NCT02567968|5498107|P1|STARTED|Second Intervention||4
2241761|NCT02567968|5498106|P2|NOT COMPLETED|Washout (2 Weeks)||0
2241762|NCT02567968|5498107|P1|NOT COMPLETED|Washout (2 Weeks)||0
2241763|NCT02567968|5498106|P2|COMPLETED|Washout (2 Weeks)||4
2241764|NCT02567968|5498107|P1|COMPLETED|Washout (2 Weeks)||4
2241765|NCT02567968|5498106|P2|STARTED|Washout (2 Weeks)||4
2241766|NCT02567968|5498107|P1|STARTED|Washout (2 Weeks)||4
2241767|NCT02567968|5498106|P2|NOT COMPLETED|First Intervention||0
2241768|NCT02567968|5498107|P1|NOT COMPLETED|First Intervention||0
2241769|NCT02567968|5498106|P2|COMPLETED|First Intervention||4
2241770|NCT02567968|5498107|P1|COMPLETED|First Intervention||4
2241771|NCT02567968|5498106|P2|STARTED|First Intervention||4
2241772|NCT02567968|5498107|P1|STARTED|First Intervention||4
2241773|NCT02567708|5498129|P2|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||3
2241774|NCT02567708|5498130|P1|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
2241775|NCT02567708|5498129|P2|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||20
2241776|NCT02567708|5498130|P1|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||22
2241777|NCT02567708|5498129|P2|STARTED|Treatment Period 2 (Up to 4 Weeks)||23
2241778|NCT02567708|5498130|P1|STARTED|Treatment Period 2 (Up to 4 Weeks)||22
2241779|NCT02567708|5498129|P2|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
2241780|NCT02567708|5498130|P1|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
2241781|NCT02567708|5498129|P2|COMPLETED|Washout Period (Up to 4 Weeks)||23
2241782|NCT02567708|5498130|P1|COMPLETED|Washout Period (Up to 4 Weeks)||22
2241783|NCT02567708|5498129|P2|STARTED|Washout Period (Up to 4 Weeks)||23
2241784|NCT02567708|5498130|P1|STARTED|Washout Period (Up to 4 Weeks)||22
2241785|NCT02567708|5498129|P2|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||3
2241786|NCT02567708|5498130|P1|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||2
2241787|NCT02567708|5498129|P2|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||23
2241788|NCT02567708|5498130|P1|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||22
2241789|NCT02567708|5498129|P2|STARTED|Treatment Period 1 (Up to 4 Weeks)||26
2241790|NCT02567708|5498130|P1|STARTED|Treatment Period 1 (Up to 4 Weeks)||24
2241791|NCT02567656|5498175|P6|NOT COMPLETED|Overall Study||0
2241792|NCT02567656|5498176|P5|NOT COMPLETED|Overall Study||0
2241793|NCT02567656|5498177|P4|NOT COMPLETED|Overall Study||0
2241794|NCT02567656|5498178|P3|NOT COMPLETED|Overall Study||2
2241795|NCT02567656|5498179|P2|NOT COMPLETED|Overall Study||1
2241796|NCT02567656|5498180|P1|NOT COMPLETED|Overall Study||1
2241797|NCT02567656|5498175|P6|COMPLETED|Overall Study||20
2241798|NCT02567656|5498176|P5|COMPLETED|Overall Study||19
2241799|NCT02567656|5498177|P4|COMPLETED|Overall Study||6
2241800|NCT02567656|5498178|P3|COMPLETED|Overall Study||3
2241801|NCT02567656|5498179|P2|COMPLETED|Overall Study||3
2241802|NCT02567656|5498180|P1|COMPLETED|Overall Study||3
2241803|NCT02567656|5498175|P6|STARTED|Overall Study||20
2241804|NCT02567656|5498176|P5|STARTED|Overall Study||19
2241805|NCT02567656|5498177|P4|STARTED|Overall Study||6
2241806|NCT02567656|5498178|P3|STARTED|Overall Study||5
2241807|NCT02567656|5498179|P2|STARTED|Overall Study||4
2241808|NCT02567656|5498180|P1|STARTED|Overall Study||4
2241809|NCT02567552|5498212|P2|NOT COMPLETED|Overall Study||1
2241810|NCT02567552|5498213|P1|NOT COMPLETED|Overall Study||0
2241811|NCT02567552|5498212|P2|COMPLETED|Overall Study|dropout by pain in the puncture site|11
2241812|NCT02567552|5498213|P1|COMPLETED|Overall Study||12
2241813|NCT02567552|5498212|P2|STARTED|Overall Study||12
2241814|NCT02567552|5498213|P1|STARTED|Overall Study||12
2241815|NCT02567188|5498243|P1|NOT COMPLETED|Overall Study||35
2241816|NCT02567188|5498243|P1|COMPLETED|Overall Study||109
2241817|NCT02567188|5498243|P1|STARTED|Overall Study||144
2241818|NCT02566785|5498274|P2|NOT COMPLETED|Overall Study||3
2241819|NCT02566785|5498275|P1|NOT COMPLETED|Overall Study||1
2241820|NCT02566785|5498274|P2|COMPLETED|Overall Study||15
2241821|NCT02566785|5498275|P1|COMPLETED|Overall Study||14
2241822|NCT02566785|5498274|P2|STARTED|Overall Study||18
2241823|NCT02566785|5498275|P1|STARTED|Overall Study||15
2241824|NCT02566759|5498302|P17|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241825|NCT02566759|5498303|P16|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241826|NCT02566759|5498304|P15|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241827|NCT02566759|5498305|P14|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241828|NCT02566759|5498306|P13|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241829|NCT02566759|5498307|P12|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241830|NCT02566759|5498308|P11|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241831|NCT02566759|5498309|P10|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241832|NCT02566759|5498310|P9|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241833|NCT02566759|5498311|P8|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241834|NCT02566759|5498312|P7|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241835|NCT02566759|5498313|P6|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241836|NCT02566759|5498314|P5|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241837|NCT02566759|5498315|P4|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241838|NCT02566759|5498316|P3|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241839|NCT02566759|5498317|P2|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241840|NCT02566759|5498318|P1|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241841|NCT02566759|5498302|P17|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7
2241842|NCT02566759|5498303|P16|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
2241843|NCT02566759|5498304|P15|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
2241844|NCT02566759|5498305|P14|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241845|NCT02566759|5498306|P13|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241846|NCT02566759|5498307|P12|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241847|NCT02566759|5498308|P11|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241848|NCT02566759|5498309|P10|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241849|NCT02566759|5498310|P9|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241850|NCT02566759|5498311|P8|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241851|NCT02566759|5498312|P7|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241852|NCT02566759|5498313|P6|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241853|NCT02566759|5498314|P5|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241854|NCT02566759|5498315|P4|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241855|NCT02566759|5498316|P3|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241856|NCT02566759|5498317|P2|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241857|NCT02566759|5498318|P1|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241858|NCT02566759|5498302|P17|STARTED|Crossover Treatment (Part 4: 1 Day)||7
2241859|NCT02566759|5498303|P16|STARTED|Crossover Treatment (Part 4: 1 Day)||8
2241860|NCT02566759|5498304|P15|STARTED|Crossover Treatment (Part 4: 1 Day)||8
2241861|NCT02566759|5498305|P14|STARTED|Crossover Treatment (Part 4: 1 Day)||0
2241862|NCT02566759|5498306|P13|STARTED|Crossover Treatment (Part 4: 1 Day)||0
2241863|NCT02566759|5498307|P12|STARTED|Crossover Treatment (Part 4: 1 Day)||0
2241864|NCT02566759|5498308|P11|STARTED|Crossover Treatment (Part 4: 1 Day)||0
2241865|NCT02566759|5498309|P10|STARTED|Crossover Treatment (Part 4: 1 Day)||0
2241866|NCT02566759|5498310|P9|STARTED|Crossover Treatment (Part 4: 1 Day)||0
2241867|NCT02566759|5498311|P8|STARTED|Crossover Treatment (Part 4: 1 Day)||0
2241868|NCT02566759|5498312|P7|STARTED|Crossover Treatment (Part 4: 1 Day)||0
2241869|NCT02566759|5498313|P6|STARTED|Crossover Treatment (Part 4: 1 Day)||0
2241870|NCT02566759|5498314|P5|STARTED|Crossover Treatment (Part 4: 1 Day)||0
2241871|NCT02566759|5498315|P4|STARTED|Crossover Treatment (Part 4: 1 Day)||0
2241872|NCT02566759|5498316|P3|STARTED|Crossover Treatment (Part 4: 1 Day)||0
2241873|NCT02566759|5498317|P2|STARTED|Crossover Treatment (Part 4: 1 Day)||0
2241874|NCT02566759|5498318|P1|STARTED|Crossover Treatment (Part 4: 1 Day)||0
2241875|NCT02566759|5498302|P17|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241876|NCT02566759|5498303|P16|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241877|NCT02566759|5498304|P15|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241878|NCT02566759|5498305|P14|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241879|NCT02566759|5498306|P13|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241880|NCT02566759|5498307|P12|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241881|NCT02566759|5498308|P11|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241882|NCT02566759|5498309|P10|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241883|NCT02566759|5498310|P9|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241884|NCT02566759|5498311|P8|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241885|NCT02566759|5498312|P7|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241886|NCT02566759|5498313|P6|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241887|NCT02566759|5498314|P5|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241888|NCT02566759|5498315|P4|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241889|NCT02566759|5498316|P3|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241890|NCT02566759|5498317|P2|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241891|NCT02566759|5498318|P1|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241892|NCT02566759|5498302|P17|COMPLETED|Washout Crossover Period (Part 4:5 Days)||7
2241893|NCT02566759|5498303|P16|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
2241894|NCT02566759|5498304|P15|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
2241895|NCT02566759|5498305|P14|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241896|NCT02566759|5498306|P13|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241897|NCT02566759|5498307|P12|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241898|NCT02566759|5498308|P11|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241899|NCT02566759|5498309|P10|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241900|NCT02566759|5498310|P9|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241901|NCT02566759|5498311|P8|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241902|NCT02566759|5498312|P7|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241903|NCT02566759|5498313|P6|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241904|NCT02566759|5498314|P5|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241905|NCT02566759|5498315|P4|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241906|NCT02566759|5498316|P3|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241907|NCT02566759|5498317|P2|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241908|NCT02566759|5498318|P1|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241909|NCT02566759|5498302|P17|STARTED|Washout Crossover Period (Part 4:5 Days)||7
2241910|NCT02566759|5498303|P16|STARTED|Washout Crossover Period (Part 4:5 Days)||8
2241911|NCT02566759|5498304|P15|STARTED|Washout Crossover Period (Part 4:5 Days)||8
2241912|NCT02566759|5498305|P14|STARTED|Washout Crossover Period (Part 4:5 Days)||0
2241913|NCT02566759|5498306|P13|STARTED|Washout Crossover Period (Part 4:5 Days)||0
2241914|NCT02566759|5498307|P12|STARTED|Washout Crossover Period (Part 4:5 Days)||0
2241915|NCT02566759|5498308|P11|STARTED|Washout Crossover Period (Part 4:5 Days)||0
2241916|NCT02566759|5498309|P10|STARTED|Washout Crossover Period (Part 4:5 Days)||0
2241917|NCT02566759|5498310|P9|STARTED|Washout Crossover Period (Part 4:5 Days)||0
2241918|NCT02566759|5498311|P8|STARTED|Washout Crossover Period (Part 4:5 Days)||0
2241919|NCT02566759|5498312|P7|STARTED|Washout Crossover Period (Part 4:5 Days)||0
2241920|NCT02566759|5498313|P6|STARTED|Washout Crossover Period (Part 4:5 Days)||0
2241921|NCT02566759|5498314|P5|STARTED|Washout Crossover Period (Part 4:5 Days)||0
2241922|NCT02566759|5498315|P4|STARTED|Washout Crossover Period (Part 4:5 Days)||0
2241923|NCT02566759|5498316|P3|STARTED|Washout Crossover Period (Part 4:5 Days)||0
2241924|NCT02566759|5498317|P2|STARTED|Washout Crossover Period (Part 4:5 Days)||0
2241925|NCT02566759|5498318|P1|STARTED|Washout Crossover Period (Part 4:5 Days)||0
2241926|NCT02566759|5498302|P17|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||1
2241927|NCT02566759|5498303|P16|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241928|NCT02566759|5498304|P15|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241929|NCT02566759|5498305|P14|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241930|NCT02566759|5498306|P13|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241931|NCT02566759|5498307|P12|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241932|NCT02566759|5498308|P11|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241933|NCT02566759|5498309|P10|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241934|NCT02566759|5498310|P9|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241935|NCT02566759|5498311|P8|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241936|NCT02566759|5498312|P7|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241937|NCT02566759|5498313|P6|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241938|NCT02566759|5498314|P5|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241939|NCT02566759|5498315|P4|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241940|NCT02566759|5498316|P3|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241941|NCT02566759|5498317|P2|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241942|NCT02566759|5498318|P1|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241943|NCT02566759|5498302|P17|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7
2241944|NCT02566759|5498303|P16|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
2241945|NCT02566759|5498304|P15|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
2241946|NCT02566759|5498305|P14|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241947|NCT02566759|5498306|P13|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241948|NCT02566759|5498307|P12|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241949|NCT02566759|5498308|P11|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241950|NCT02566759|5498309|P10|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241951|NCT02566759|5498310|P9|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241952|NCT02566759|5498311|P8|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241953|NCT02566759|5498312|P7|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241954|NCT02566759|5498313|P6|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241955|NCT02566759|5498314|P5|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241956|NCT02566759|5498315|P4|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241957|NCT02566759|5498316|P3|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241958|NCT02566759|5498317|P2|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241959|NCT02566759|5498318|P1|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
2241960|NCT02566759|5498302|P17|STARTED|Crossover Treatment (Part 4: 1 Day)||8
2241961|NCT02566759|5498303|P16|STARTED|Crossover Treatment (Part 4: 1 Day)||8
2241962|NCT02566759|5498304|P15|STARTED|Crossover Treatment (Part 4: 1 Day)||8
2241963|NCT02566759|5498305|P14|STARTED|Crossover Treatment (Part 4: 1 Day)||0
2241964|NCT02566759|5498306|P13|STARTED|Crossover Treatment (Part 4: 1 Day)||0
2241965|NCT02566759|5498307|P12|STARTED|Crossover Treatment (Part 4: 1 Day)||0
2241966|NCT02566759|5498308|P11|STARTED|Crossover Treatment (Part 4: 1 Day)||0
2241967|NCT02566759|5498309|P10|STARTED|Crossover Treatment (Part 4: 1 Day)||0
2241968|NCT02566759|5498310|P9|STARTED|Crossover Treatment (Part 4: 1 Day)||0
2241969|NCT02566759|5498311|P8|STARTED|Crossover Treatment (Part 4: 1 Day)||0
2241970|NCT02566759|5498312|P7|STARTED|Crossover Treatment (Part 4: 1 Day)||0
2241971|NCT02566759|5498313|P6|STARTED|Crossover Treatment (Part 4: 1 Day)||0
2241972|NCT02566759|5498314|P5|STARTED|Crossover Treatment (Part 4: 1 Day)||0
2241973|NCT02566759|5498315|P4|STARTED|Crossover Treatment (Part 4: 1 Day)||0
2241974|NCT02566759|5498316|P3|STARTED|Crossover Treatment (Part 4: 1 Day)||0
2241975|NCT02566759|5498317|P2|STARTED|Crossover Treatment (Part 4: 1 Day)||0
2241976|NCT02566759|5498318|P1|STARTED|Crossover Treatment (Part 4: 1 Day)||0
2241977|NCT02566759|5498302|P17|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241978|NCT02566759|5498303|P16|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241979|NCT02566759|5498304|P15|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241980|NCT02566759|5498305|P14|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241981|NCT02566759|5498306|P13|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241982|NCT02566759|5498307|P12|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241983|NCT02566759|5498308|P11|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241984|NCT02566759|5498309|P10|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241985|NCT02566759|5498310|P9|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241986|NCT02566759|5498311|P8|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241987|NCT02566759|5498312|P7|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241988|NCT02566759|5498313|P6|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241989|NCT02566759|5498314|P5|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241990|NCT02566759|5498315|P4|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241991|NCT02566759|5498316|P3|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241992|NCT02566759|5498317|P2|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241993|NCT02566759|5498318|P1|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241994|NCT02566759|5498302|P17|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
2241995|NCT02566759|5498303|P16|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
2241996|NCT02566759|5498304|P15|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
2241997|NCT02566759|5498305|P14|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241998|NCT02566759|5498306|P13|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2241999|NCT02566759|5498307|P12|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2242000|NCT02566759|5498308|P11|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2242001|NCT02566759|5498309|P10|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2242002|NCT02566759|5498310|P9|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2242003|NCT02566759|5498311|P8|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2242004|NCT02566759|5498312|P7|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2242005|NCT02566759|5498313|P6|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2242006|NCT02566759|5498314|P5|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2242007|NCT02566759|5498315|P4|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2242008|NCT02566759|5498316|P3|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2242009|NCT02566759|5498317|P2|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2242010|NCT02566759|5498318|P1|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
2242011|NCT02566759|5498302|P17|STARTED|Washout Crossover Period (Part 4:5 Days)||8
2242012|NCT02566759|5498303|P16|STARTED|Washout Crossover Period (Part 4:5 Days)||8
2242013|NCT02566759|5498304|P15|STARTED|Washout Crossover Period (Part 4:5 Days)||8
2242014|NCT02566759|5498305|P14|STARTED|Washout Crossover Period (Part 4:5 Days)||0
2242015|NCT02566759|5498306|P13|STARTED|Washout Crossover Period (Part 4:5 Days)||0
2242016|NCT02566759|5498307|P12|STARTED|Washout Crossover Period (Part 4:5 Days)||0
2242017|NCT02566759|5498308|P11|STARTED|Washout Crossover Period (Part 4:5 Days)||0
2242018|NCT02566759|5498309|P10|STARTED|Washout Crossover Period (Part 4:5 Days)||0
2242019|NCT02566759|5498310|P9|STARTED|Washout Crossover Period (Part 4:5 Days)||0
2242020|NCT02566759|5498311|P8|STARTED|Washout Crossover Period (Part 4:5 Days)||0
2242021|NCT02566759|5498312|P7|STARTED|Washout Crossover Period (Part 4:5 Days)||0
2242022|NCT02566759|5498313|P6|STARTED|Washout Crossover Period (Part 4:5 Days)||0
2242023|NCT02566759|5498314|P5|STARTED|Washout Crossover Period (Part 4:5 Days)||0
2242024|NCT02566759|5498315|P4|STARTED|Washout Crossover Period (Part 4:5 Days)||0
2242025|NCT02566759|5498316|P3|STARTED|Washout Crossover Period (Part 4:5 Days)||0
2242026|NCT02566759|5498317|P2|STARTED|Washout Crossover Period (Part 4:5 Days)||0
2242027|NCT02566759|5498318|P1|STARTED|Washout Crossover Period (Part 4:5 Days)||0
2242028|NCT02566759|5498302|P17|NOT COMPLETED|All Parts||0
2242029|NCT02566759|5498303|P16|NOT COMPLETED|All Parts||0
2242030|NCT02566759|5498304|P15|NOT COMPLETED|All Parts||0
2242031|NCT02566759|5498305|P14|NOT COMPLETED|All Parts||5
2242032|NCT02566759|5498306|P13|NOT COMPLETED|All Parts||1
2242033|NCT02566759|5498307|P12|NOT COMPLETED|All Parts||0
2242034|NCT02566759|5498308|P11|NOT COMPLETED|All Parts||0
2242035|NCT02566759|5498309|P10|NOT COMPLETED|All Parts||0
2242036|NCT02566759|5498310|P9|NOT COMPLETED|All Parts||0
2242037|NCT02566759|5498311|P8|NOT COMPLETED|All Parts||0
2242038|NCT02566759|5498312|P7|NOT COMPLETED|All Parts||0
2242039|NCT02566759|5498313|P6|NOT COMPLETED|All Parts||0
2242040|NCT02566759|5498314|P5|NOT COMPLETED|All Parts||0
2242041|NCT02566759|5498315|P4|NOT COMPLETED|All Parts||0
2242042|NCT02566759|5498316|P3|NOT COMPLETED|All Parts||0
2242043|NCT02566759|5498317|P2|NOT COMPLETED|All Parts||1
2242044|NCT02566759|5498318|P1|NOT COMPLETED|All Parts||0
2242045|NCT02566759|5498302|P17|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
2242046|NCT02566759|5498303|P16|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
2242047|NCT02566759|5498304|P15|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
2242048|NCT02566759|5498305|P14|COMPLETED|All Parts||0
2242049|NCT02566759|5498306|P13|COMPLETED|All Parts||0
2242050|NCT02566759|5498307|P12|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
2242051|NCT02566759|5498308|P11|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
2242052|NCT02566759|5498309|P10|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
2242053|NCT02566759|5498310|P9|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
2242054|NCT02566759|5498311|P8|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|8
2242055|NCT02566759|5498312|P7|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
2242056|NCT02566759|5498313|P6|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
2242057|NCT02566759|5498314|P5|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
2242058|NCT02566759|5498315|P4|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
2242059|NCT02566759|5498316|P3|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
2242060|NCT02566759|5498317|P2|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|5
2242061|NCT02566759|5498318|P1|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|12
2242062|NCT02566759|5498302|P17|STARTED|All Parts||8
2242063|NCT02566759|5498303|P16|STARTED|All Parts||8
2242064|NCT02566759|5498304|P15|STARTED|All Parts||8
2242065|NCT02566759|5498305|P14|STARTED|All Parts||5
2242066|NCT02566759|5498306|P13|STARTED|All Parts||1
2242067|NCT02566759|5498307|P12|STARTED|All Parts||6
2242068|NCT02566759|5498308|P11|STARTED|All Parts||6
2242069|NCT02566759|5498309|P10|STARTED|All Parts||6
2242070|NCT02566759|5498310|P9|STARTED|All Parts||6
2242071|NCT02566759|5498311|P8|STARTED|All Parts||8
2242072|NCT02566759|5498312|P7|STARTED|All Parts||6
2242073|NCT02566759|5498313|P6|STARTED|All Parts||6
2242074|NCT02566759|5498314|P5|STARTED|All Parts||6
2242075|NCT02566759|5498315|P4|STARTED|All Parts||6
2242076|NCT02566759|5498316|P3|STARTED|All Parts||6
2242077|NCT02566759|5498317|P2|STARTED|All Parts||6
2242078|NCT02566759|5498318|P1|STARTED|All Parts||12
2242079|NCT02566590|5498471|P2|NOT COMPLETED|Overall Study||0
2242080|NCT02566590|5498472|P1|NOT COMPLETED|Overall Study||0
2242081|NCT02566590|5498471|P2|COMPLETED|Overall Study||10
2242082|NCT02566590|5498472|P1|COMPLETED|Overall Study||10
2242083|NCT02566590|5498471|P2|STARTED|Overall Study||10
2242084|NCT02566590|5498472|P1|STARTED|Overall Study||10
2242085|NCT02566577|5498480|P2|NOT COMPLETED|Overall Study||2
2242086|NCT02566577|5498481|P1|NOT COMPLETED|Overall Study||3
2242087|NCT02566577|5498480|P2|COMPLETED|Overall Study||4
2242088|NCT02566577|5498481|P1|COMPLETED|Overall Study||6
2242089|NCT02566577|5498480|P2|STARTED|Overall Study||6
2242090|NCT02566577|5498481|P1|STARTED|Overall Study||9
2242091|NCT02566369|5498509|P2|NOT COMPLETED|Overall Study||61
2242092|NCT02566369|5498510|P1|NOT COMPLETED|Overall Study||72
2242093|NCT02566369|5498509|P2|COMPLETED|Overall Study||535
2242094|NCT02566369|5498510|P1|COMPLETED|Overall Study||540
2242095|NCT02566369|5498509|P2|STARTED|Overall Study||596
2242096|NCT02566369|5498510|P1|STARTED|Overall Study||612
2242097|NCT02566317|5498518|P2|NOT COMPLETED|Overall Study||62
2242098|NCT02566317|5498519|P1|NOT COMPLETED|Overall Study||29
2242099|NCT02566317|5498518|P2|COMPLETED|Overall Study||292
2242100|NCT02566317|5498519|P1|COMPLETED|Overall Study||247
2242101|NCT02566317|5498518|P2|STARTED|Overall Study||354
2242102|NCT02566317|5498519|P1|STARTED|Overall Study||276
2242103|NCT02566265|5498531|P2|NOT COMPLETED|Overall Study||6
2242104|NCT02566265|5498532|P1|NOT COMPLETED|Overall Study||9
2242105|NCT02566265|5498531|P2|COMPLETED|Overall Study||35
2242106|NCT02566265|5498532|P1|COMPLETED|Overall Study||72
2242107|NCT02566265|5498531|P2|End of Study Visit (Optional)|Overall Study||18
2242108|NCT02566265|5498532|P1|End of Study Visit (Optional)|Overall Study||38
2242109|NCT02566265|5498531|P2|30 Days Following 2nd Vaccine|Overall Study||35
2242110|NCT02566265|5498532|P1|30 Days Following 2nd Vaccine|Overall Study||72
2242111|NCT02566265|5498531|P2|Day of Second Vaccine|Overall Study||41
2242112|NCT02566265|5498532|P1|Day of Second Vaccine|Overall Study||74
2242113|NCT02566265|5498531|P2|Day 7 (+/- 2 Days) (Optional)|Overall Study||12
2242114|NCT02566265|5498532|P1|Day 7 (+/- 2 Days) (Optional)|Overall Study||19
2242115|NCT02566265|5498531|P2|STARTED|Overall Study||41
2242116|NCT02566265|5498532|P1|STARTED|Overall Study||81
2242117|NCT02566135|5498540|P2|NOT COMPLETED|Overall Study||0
2242118|NCT02566135|5498541|P1|NOT COMPLETED|Overall Study||0
2242119|NCT02566135|5498540|P2|COMPLETED|Overall Study||29
2242120|NCT02566135|5498541|P1|COMPLETED|Overall Study||29
2242121|NCT02566135|5498540|P2|STARTED|Overall Study||29
2242122|NCT02566135|5498541|P1|STARTED|Overall Study||29
2242123|NCT02566109|5498561|P1|NOT COMPLETED|Overall Study||1
2242124|NCT02566109|5498561|P1|COMPLETED|Overall Study||5
2242125|NCT02566109|5498561|P1|STARTED|Overall Study||6
2242126|NCT02566083|5498573|P2|NOT COMPLETED|Overall Study||10
2242127|NCT02566083|5498574|P1|NOT COMPLETED|Overall Study||16
2242128|NCT02566083|5498573|P2|COMPLETED|Overall Study||141
2242129|NCT02566083|5498574|P1|COMPLETED|Overall Study||198
2242130|NCT02566083|5498573|P2|STARTED|Overall Study||151
2242131|NCT02566083|5498574|P1|STARTED|Overall Study||214
2242132|NCT02566044|5498583|P3|NOT COMPLETED|Overall Study||0
2242133|NCT02566044|5498584|P2|NOT COMPLETED|Overall Study||0
2242134|NCT02566044|5498585|P1|NOT COMPLETED|Overall Study||0
2242135|NCT02566044|5498583|P3|COMPLETED|Overall Study||4
2242136|NCT02566044|5498584|P2|COMPLETED|Overall Study||6
2242137|NCT02566044|5498585|P1|COMPLETED|Overall Study||6
2242138|NCT02566044|5498583|P3|STARTED|Overall Study||4
2242139|NCT02566044|5498584|P2|STARTED|Overall Study||6
2242140|NCT02566044|5498585|P1|STARTED|Overall Study||6
2242141|NCT02566031|5498625|P2|NOT COMPLETED|Overall Study||12
2242142|NCT02566031|5498626|P1|NOT COMPLETED|Overall Study||20
2242143|NCT02566031|5498625|P2|COMPLETED|Overall Study||178
2242144|NCT02566031|5498626|P1|COMPLETED|Overall Study||169
2242145|NCT02566031|5498625|P2|STARTED|Overall Study||190
2242146|NCT02566031|5498626|P1|STARTED|Overall Study||189
2242147|NCT02566005|5498643|P2|NOT COMPLETED|Overall Study||6
2242148|NCT02566005|5498644|P1|NOT COMPLETED|Overall Study||8
2242149|NCT02566005|5498643|P2|COMPLETED|Overall Study||94
2242150|NCT02566005|5498644|P1|COMPLETED|Overall Study||92
2242151|NCT02566005|5498643|P2|STARTED|Overall Study||100
2242152|NCT02566005|5498644|P1|STARTED|Overall Study||100
2242153|NCT02565810|5498672|P1|NOT COMPLETED|Overall Study||1
2242154|NCT02565810|5498672|P1|COMPLETED|Overall Study||48
2242155|NCT02565810|5498672|P1|STARTED|Overall Study||49
2242156|NCT02565784|5498681|P1|NOT COMPLETED|Second Treatment||2
2242157|NCT02565784|5498681|P1|COMPLETED|Second Treatment||96
2242158|NCT02565784|5498681|P1|12 Months Follow-up|Second Treatment||96
2242159|NCT02565784|5498681|P1|6 Months Follow-up|Second Treatment||97
2242160|NCT02565784|5498681|P1|STARTED|Second Treatment||98
2242161|NCT02565784|5498681|P1|NOT COMPLETED|First Treatment||2
2242162|NCT02565784|5498681|P1|COMPLETED|First Treatment||98
2242163|NCT02565784|5498681|P1|12 Months Follow-up|First Treatment||98
2242164|NCT02565784|5498681|P1|6 Months Follow-up|First Treatment||99
2242165|NCT02565784|5498681|P1|STARTED|First Treatment||100
2242166|NCT02565706|5498693|P4|NOT COMPLETED|Overall Study||85
2242167|NCT02565706|5498694|P3|NOT COMPLETED|Overall Study||89
2242168|NCT02565706|5498695|P2|NOT COMPLETED|Overall Study||82
2242169|NCT02565706|5498696|P1|NOT COMPLETED|Overall Study||77
2242170|NCT02565706|5498693|P4|COMPLETED|Overall Study||116
2242171|NCT02565706|5498694|P3|COMPLETED|Overall Study||104
2242172|NCT02565706|5498695|P2|COMPLETED|Overall Study||90
2242173|NCT02565706|5498696|P1|COMPLETED|Overall Study||101
2242174|NCT02565706|5498693|P4|STARTED|Overall Study||201
2242175|NCT02565706|5498694|P3|STARTED|Overall Study||193
2242176|NCT02565706|5498695|P2|STARTED|Overall Study||172
2242177|NCT02565706|5498696|P1|STARTED|Overall Study||178
2242178|NCT02565628|5498768|P2|NOT COMPLETED|Overall Study||0
2242179|NCT02565628|5498769|P1|NOT COMPLETED|Overall Study||0
2242180|NCT02565628|5498768|P2|COMPLETED|Overall Study||9
2242181|NCT02565628|5498769|P1|COMPLETED|Overall Study||10
2242182|NCT02565628|5498768|P2|Received Treatment|Overall Study||9
2242183|NCT02565628|5498769|P1|Received Treatment|Overall Study||10
2242184|NCT02565628|5498768|P2|STARTED|Overall Study||9
2242185|NCT02565628|5498769|P1|STARTED|Overall Study||10
2242186|NCT02565615|5498802|P5|NOT COMPLETED|Overall Study||1601
2242187|NCT02565615|5498803|P4|NOT COMPLETED|Overall Study||3
2242188|NCT02565615|5498804|P3|NOT COMPLETED|Overall Study||0
2242189|NCT02565615|5498805|P2|NOT COMPLETED|Overall Study||36
2242190|NCT02565615|5498806|P1|NOT COMPLETED|Overall Study||3
2242191|NCT02565615|5498802|P5|COMPLETED|Overall Study||21
2242192|NCT02565615|5498803|P4|COMPLETED|Overall Study||98
2242193|NCT02565615|5498804|P3|COMPLETED|Overall Study||21
2242194|NCT02565615|5498805|P2|COMPLETED|Overall Study||3044
2242195|NCT02565615|5498806|P1|COMPLETED|Overall Study||288
2242196|NCT02565615|5498802|P5|Treated|Overall Study||1055
2242197|NCT02565615|5498803|P4|Treated|Overall Study||101
2242198|NCT02565615|5498804|P3|Treated|Overall Study||21
2242199|NCT02565615|5498805|P2|Treated|Overall Study||3080
2242200|NCT02565615|5498806|P1|Treated|Overall Study||291
2242201|NCT02565615|5498802|P5|STARTED|Overall Study||1622
2242202|NCT02565615|5498803|P4|STARTED|Overall Study||101
2242203|NCT02565615|5498804|P3|STARTED|Overall Study||21
2242204|NCT02565615|5498805|P2|STARTED|Overall Study||3080
2242205|NCT02565615|5498806|P1|STARTED|Overall Study||291
2242206|NCT02565576|5498920|P2|NOT COMPLETED|Overall Study||5
2242207|NCT02565576|5498921|P1|NOT COMPLETED|Overall Study||5
2242208|NCT02565576|5498920|P2|COMPLETED|Overall Study||17
2242209|NCT02565576|5498921|P1|COMPLETED|Overall Study||17
2242210|NCT02565576|5498920|P2|STARTED|Overall Study||22
2242211|NCT02565576|5498921|P1|STARTED|Overall Study||22
2242212|NCT02565485|5498948|P2|NOT COMPLETED|Overall Study||0
2242213|NCT02565485|5498949|P1|NOT COMPLETED|Overall Study||0
2242214|NCT02565485|5498948|P2|COMPLETED|Overall Study||137
2242215|NCT02565485|5498949|P1|COMPLETED|Overall Study||139
2242216|NCT02565485|5498948|P2|STARTED|Overall Study||137
2242217|NCT02565485|5498949|P1|STARTED|Overall Study||139
2242218|NCT02565381|5498964|P3|NOT COMPLETED|Overall Study||1
2242219|NCT02565381|5498965|P2|NOT COMPLETED|Overall Study||0
2242220|NCT02565381|5498966|P1|NOT COMPLETED|Overall Study||1
2242221|NCT02565381|5498964|P3|COMPLETED|Overall Study||24
2242222|NCT02565381|5498965|P2|COMPLETED|Overall Study||25
2242223|NCT02565381|5498966|P1|COMPLETED|Overall Study||24
2242224|NCT02565381|5498964|P3|STARTED|Overall Study||25
2242225|NCT02565381|5498965|P2|STARTED|Overall Study||25
2242226|NCT02565381|5498966|P1|STARTED|Overall Study||25
2242227|NCT02565147|5499006|P2|NOT COMPLETED|Overall Study||3
2242228|NCT02565147|5499007|P1|NOT COMPLETED|Overall Study||6
2242229|NCT02565147|5499006|P2|COMPLETED|Overall Study||37
2242230|NCT02565147|5499007|P1|COMPLETED|Overall Study||32
2242231|NCT02565147|5499006|P2|Per-Protocol Population|Overall Study||36
2242232|NCT02565147|5499007|P1|Per-Protocol Population|Overall Study||28
2242233|NCT02565147|5499006|P2|Received Study Drug|Overall Study||40
2242234|NCT02565147|5499007|P1|Received Study Drug|Overall Study||38
2242235|NCT02565147|5499006|P2|STARTED|Overall Study||40
2242236|NCT02565147|5499007|P1|STARTED|Overall Study||38
2242237|NCT02565108|5499031|P2|NOT COMPLETED|Overall Study||0
2242238|NCT02565108|5499032|P1|NOT COMPLETED|Overall Study||2
2242239|NCT02565108|5499031|P2|COMPLETED|Overall Study||4
2242240|NCT02565108|5499032|P1|COMPLETED|Overall Study||14
2242241|NCT02565108|5499031|P2|Pharmacokinetic (PK) Set|Overall Study||3
2242242|NCT02565108|5499032|P1|Pharmacokinetic (PK) Set|Overall Study||10
2242243|NCT02565108|5499031|P2|Safety Set|Overall Study||4
2242244|NCT02565108|5499032|P1|Safety Set|Overall Study||16
2242245|NCT02565108|5499031|P2|STARTED|Overall Study||4
2242246|NCT02565108|5499032|P1|STARTED|Overall Study||16
2242247|NCT02564952|5499048|P1|NOT COMPLETED|Overall Study||11
2242248|NCT02564952|5499048|P1|COMPLETED|Overall Study||7
2242249|NCT02564952|5499048|P1|Completed OLE Titration Period|Overall Study||16
2242250|NCT02564952|5499048|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
2242251|NCT02564952|5499048|P1|STARTED|Overall Study||18
2242252|NCT02564926|5499054|P2|NOT COMPLETED|Overall Study||7
2242253|NCT02564926|5499055|P1|NOT COMPLETED|Overall Study||8
2242254|NCT02564926|5499054|P2|COMPLETED|Overall Study||54
2242255|NCT02564926|5499055|P1|COMPLETED|Overall Study||52
2242256|NCT02564926|5499054|P2|STARTED|Overall Study||61
2242257|NCT02564926|5499055|P1|STARTED|Overall Study||60
2242258|NCT02564718|5499093|P2|NOT COMPLETED|Overall Study||1
2242259|NCT02564718|5499094|P1|NOT COMPLETED|Overall Study||0
2242260|NCT02564718|5499093|P2|COMPLETED|Overall Study||4
2242261|NCT02564718|5499094|P1|COMPLETED|Overall Study||5
2242262|NCT02564718|5499093|P2|STARTED|Overall Study||5
2242263|NCT02564718|5499094|P1|STARTED|Overall Study||5
2242264|NCT02564497|5499124|P2|NOT COMPLETED|Overall Study||0
2242265|NCT02564497|5499125|P1|NOT COMPLETED|Overall Study||0
2242266|NCT02564497|5499124|P2|COMPLETED|Overall Study||72
2242267|NCT02564497|5499125|P1|COMPLETED|Overall Study||74
2242268|NCT02564497|5499124|P2|STARTED|Overall Study||72
2242269|NCT02564497|5499125|P1|STARTED|Overall Study||74
2242273|NCT02564263|5499151|P2|NOT COMPLETED|Overall Study||314
2242274|NCT02564263|5499152|P1|NOT COMPLETED|Overall Study||314
2242275|NCT02564263|5499151|P2|COMPLETED|Overall Study||0
2242276|NCT02564263|5499152|P1|COMPLETED|Overall Study||0
2242277|NCT02564263|5499151|P2|Treated|Overall Study||296
2242278|NCT02564263|5499152|P1|Treated|Overall Study||314
2242279|NCT02564263|5499151|P2|STARTED|Overall Study||314
2242280|NCT02564263|5499152|P1|STARTED|Overall Study||314
2242281|NCT02564211|5499174|P1|NOT COMPLETED|Overall Study||4
2242282|NCT02564211|5499174|P1|COMPLETED|Overall Study||73
2242283|NCT02564211|5499174|P1|STARTED|Overall Study||77
2242284|NCT02564055|5499186|P6|NOT COMPLETED|Overall Study||12
2242285|NCT02564055|5499187|P5|NOT COMPLETED|Overall Study||15
2242286|NCT02564055|5499188|P4|NOT COMPLETED|Overall Study||6
2242287|NCT02564055|5499189|P3|NOT COMPLETED|Overall Study||12
2242288|NCT02564055|5499190|P2|NOT COMPLETED|Overall Study||5
2242289|NCT02564055|5499191|P1|NOT COMPLETED|Overall Study||6
2242290|NCT02564055|5499186|P6|COMPLETED|Overall Study||28
2242291|NCT02564055|5499187|P5|COMPLETED|Overall Study||27
2242292|NCT02564055|5499188|P4|COMPLETED|Overall Study||35
2242293|NCT02564055|5499189|P3|COMPLETED|Overall Study||31
2242294|NCT02564055|5499190|P2|COMPLETED|Overall Study||36
2242295|NCT02564055|5499191|P1|COMPLETED|Overall Study||34
2242296|NCT02564055|5499186|P6|STARTED|Overall Study||40
2242297|NCT02564055|5499187|P5|STARTED|Overall Study||42
2242298|NCT02564055|5499188|P4|STARTED|Overall Study||41
2242299|NCT02564055|5499189|P3|STARTED|Overall Study||43
2242300|NCT02564055|5499190|P2|STARTED|Overall Study||41
2242301|NCT02564055|5499191|P1|STARTED|Overall Study||40
2242302|NCT02564042|5499445|P6|NOT COMPLETED|Overall Study||14
2242303|NCT02564042|5499446|P5|NOT COMPLETED|Overall Study||11
2242304|NCT02564042|5499447|P4|NOT COMPLETED|Overall Study||3
2242305|NCT02564042|5499448|P3|NOT COMPLETED|Overall Study||6
2242306|NCT02564042|5499449|P2|NOT COMPLETED|Overall Study||8
2242307|NCT02564042|5499450|P1|NOT COMPLETED|Overall Study||11
2242308|NCT02564042|5499445|P6|COMPLETED|Overall Study||24
2242309|NCT02564042|5499446|P5|COMPLETED|Overall Study||26
2242310|NCT02564042|5499447|P4|COMPLETED|Overall Study||35
2242311|NCT02564042|5499448|P3|COMPLETED|Overall Study||32
2242312|NCT02564042|5499449|P2|COMPLETED|Overall Study||30
2242313|NCT02564042|5499450|P1|COMPLETED|Overall Study||27
2242314|NCT02564042|5499445|P6|STARTED|Overall Study||38
2242315|NCT02564042|5499446|P5|STARTED|Overall Study||37
2242316|NCT02564042|5499447|P4|STARTED|Overall Study||38
2242317|NCT02564042|5499448|P3|STARTED|Overall Study||38
2242318|NCT02564042|5499449|P2|STARTED|Overall Study||38
2242319|NCT02564042|5499450|P1|STARTED|Overall Study||38
2242320|NCT02564029|5499662|P1|NOT COMPLETED|Overall Study||0
2242321|NCT02564029|5499662|P1|COMPLETED|Overall Study||7
2242322|NCT02564029|5499662|P1|STARTED|Overall Study||7
2242323|NCT02564016|5499705|P2|NOT COMPLETED|Overall Study||10
2242324|NCT02564016|5499706|P1|NOT COMPLETED|Overall Study||18
2242325|NCT02564016|5499705|P2|COMPLETED|Overall Study||4
2242326|NCT02564016|5499706|P1|COMPLETED|Overall Study||4
2242327|NCT02564016|5499705|P2|STARTED|Overall Study||14
2242328|NCT02564016|5499706|P1|STARTED|Overall Study||22
2242329|NCT02563990|5499718|P2|NOT COMPLETED|Overall Study||0
2242330|NCT02563990|5499719|P1|NOT COMPLETED|Overall Study||0
2242331|NCT02563990|5499718|P2|COMPLETED|Overall Study||14
2242332|NCT02563990|5499719|P1|COMPLETED|Overall Study||12
2242333|NCT02563990|5499718|P2|STARTED|Overall Study||14
2242334|NCT02563990|5499719|P1|STARTED|Overall Study||12
2242335|NCT02563899|5499745|P4|NOT COMPLETED|Overall Study||0
2242336|NCT02563899|5499746|P3|NOT COMPLETED|Overall Study||1
2242337|NCT02563899|5499747|P2|NOT COMPLETED|Overall Study||0
2242338|NCT02563899|5499748|P1|NOT COMPLETED|Overall Study||1
2242339|NCT02563899|5499745|P4|COMPLETED|Overall Study||6
2242340|NCT02563899|5499746|P3|COMPLETED|Overall Study||9
2242341|NCT02563899|5499747|P2|COMPLETED|Overall Study||5
2242342|NCT02563899|5499748|P1|COMPLETED|Overall Study||17
2242343|NCT02563899|5499745|P4|STARTED|Overall Study||6
2242344|NCT02563899|5499746|P3|STARTED|Overall Study||10
2242345|NCT02563899|5499747|P2|STARTED|Overall Study||5
2242346|NCT02563899|5499748|P1|STARTED|Overall Study||18
2242347|NCT02563860|5499789|P1|NOT COMPLETED|Overall Study||1
2242348|NCT02563860|5499789|P1|COMPLETED|Overall Study||19
2242349|NCT02563860|5499789|P1|STARTED|Overall Study||20
2242350|NCT02563834|5499796|P2|NOT COMPLETED|Insulin Infusion (*Day 2)||0
2242351|NCT02563834|5499797|P1|NOT COMPLETED|Insulin Infusion (*Day 2)||0
2242352|NCT02563834|5499796|P2|COMPLETED|Insulin Infusion (*Day 2)||8
2242353|NCT02563834|5499797|P1|COMPLETED|Insulin Infusion (*Day 2)||10
2242354|NCT02563834|5499796|P2|STARTED|Insulin Infusion (*Day 2)||8
2242355|NCT02563834|5499797|P1|STARTED|Insulin Infusion (*Day 2)||10
2242356|NCT02563834|5499796|P2|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
2242357|NCT02563834|5499797|P1|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
2242358|NCT02563834|5499796|P2|COMPLETED|Control (Saline) Infusion (*Day 1)||8
2242359|NCT02563834|5499797|P1|COMPLETED|Control (Saline) Infusion (*Day 1)||10
2242360|NCT02563834|5499796|P2|STARTED|Control (Saline) Infusion (*Day 1)||8
2242361|NCT02563834|5499797|P1|STARTED|Control (Saline) Infusion (*Day 1)||10
2242362|NCT02563808|5499815|P2|NOT COMPLETED|Overall Study||0
2242363|NCT02563808|5499816|P1|NOT COMPLETED|Overall Study||0
2242364|NCT02563808|5499815|P2|COMPLETED|Overall Study||88
2242365|NCT02563808|5499816|P1|COMPLETED|Overall Study||96
2242366|NCT02563808|5499815|P2|STARTED|Overall Study|A total of 5 participants enrolled were not included in final data due to data collection error|88
2242367|NCT02563808|5499816|P1|STARTED|Overall Study||96
2242368|NCT02563548|5499824|P6|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||17
2242369|NCT02563548|5499825|P5|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||25
2242370|NCT02563548|5499826|P4|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
2242371|NCT02563548|5499827|P3|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
2242372|NCT02563548|5499828|P2|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
2242373|NCT02563548|5499829|P1|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
2242374|NCT02563548|5499824|P6|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
2242375|NCT02563548|5499825|P5|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
2242376|NCT02563548|5499826|P4|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
2242377|NCT02563548|5499827|P3|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
2242378|NCT02563548|5499828|P2|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
2242379|NCT02563548|5499829|P1|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
2242380|NCT02563548|5499824|P6|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||17
2242381|NCT02563548|5499825|P5|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||24
2242382|NCT02563548|5499826|P4|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
2242383|NCT02563548|5499827|P3|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
2242384|NCT02563548|5499828|P2|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
2242385|NCT02563548|5499829|P1|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
2242386|NCT02563548|5499824|P6|STARTED|Dose Expansion (Up to 60 Weeks)||17
2242387|NCT02563548|5499825|P5|STARTED|Dose Expansion (Up to 60 Weeks)||25
2242388|NCT02563548|5499826|P4|STARTED|Dose Expansion (Up to 60 Weeks)||0
2242389|NCT02563548|5499827|P3|STARTED|Dose Expansion (Up to 60 Weeks)||0
2242390|NCT02563548|5499828|P2|STARTED|Dose Expansion (Up to 60 Weeks)||0
2242391|NCT02563548|5499829|P1|STARTED|Dose Expansion (Up to 60 Weeks)||0
2242392|NCT02563548|5499824|P6|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||0
2242393|NCT02563548|5499825|P5|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||0
2242394|NCT02563548|5499826|P4|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||2
2242395|NCT02563548|5499827|P3|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||7
2242396|NCT02563548|5499828|P2|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||2
2242397|NCT02563548|5499829|P1|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||3
2242398|NCT02563548|5499824|P6|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
2242399|NCT02563548|5499825|P5|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
2242400|NCT02563548|5499826|P4|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
2242401|NCT02563548|5499827|P3|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
2242402|NCT02563548|5499828|P2|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
2242403|NCT02563548|5499829|P1|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
2242404|NCT02563548|5499824|P6|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||0
2242405|NCT02563548|5499825|P5|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||0
2242406|NCT02563548|5499826|P4|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||2
2242407|NCT02563548|5499827|P3|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||7
2242408|NCT02563548|5499828|P2|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||2
2242409|NCT02563548|5499829|P1|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||3
2242410|NCT02563548|5499824|P6|STARTED|Dose Escalation (Up to 46 Weeks)||0
2242411|NCT02563548|5499825|P5|STARTED|Dose Escalation (Up to 46 Weeks)||0
2242412|NCT02563548|5499826|P4|STARTED|Dose Escalation (Up to 46 Weeks)||2
2242413|NCT02563548|5499827|P3|STARTED|Dose Escalation (Up to 46 Weeks)||7
2242414|NCT02563548|5499828|P2|STARTED|Dose Escalation (Up to 46 Weeks)||2
2242415|NCT02563548|5499829|P1|STARTED|Dose Escalation (Up to 46 Weeks)||3
2242416|NCT02563106|5499893|P2|NOT COMPLETED|Overall Study||29
2242417|NCT02563106|5499894|P1|NOT COMPLETED|Overall Study||34
2242418|NCT02563106|5499893|P2|COMPLETED|Overall Study||178
2242419|NCT02563106|5499894|P1|COMPLETED|Overall Study||172
2242420|NCT02563106|5499893|P2|STARTED|Overall Study||207
2242421|NCT02563106|5499894|P1|STARTED|Overall Study||206
2242422|NCT02563093|5499904|P4|NOT COMPLETED|Overall Study||0
2242423|NCT02563093|5499905|P3|NOT COMPLETED|Overall Study||0
2242424|NCT02563093|5499906|P2|NOT COMPLETED|Overall Study||0
2242425|NCT02563093|5499907|P1|NOT COMPLETED|Overall Study||0
2242426|NCT02563093|5499904|P4|COMPLETED|Overall Study||51
2242427|NCT02563093|5499905|P3|COMPLETED|Overall Study||53
2242428|NCT02563093|5499906|P2|COMPLETED|Overall Study||52
2242429|NCT02563093|5499907|P1|COMPLETED|Overall Study||52
2242430|NCT02563093|5499904|P4|STARTED|Overall Study||51
2242431|NCT02563093|5499905|P3|STARTED|Overall Study||53
2242432|NCT02563093|5499906|P2|STARTED|Overall Study||52
2242433|NCT02563093|5499907|P1|STARTED|Overall Study||52
2242434|NCT02563028|5499933|P1|NOT COMPLETED|Overall Study||2
2242435|NCT02563028|5499933|P1|COMPLETED|Overall Study||18
2242436|NCT02563028|5499933|P1|STARTED|Overall Study||20
2242437|NCT02562989|5499943|P3|NOT COMPLETED|Overall Study||0
2242438|NCT02562989|5499944|P2|NOT COMPLETED|Overall Study||0
2242439|NCT02562989|5499945|P1|NOT COMPLETED|Overall Study||0
2242440|NCT02562989|5499943|P3|COMPLETED|Overall Study||6
2242441|NCT02562989|5499944|P2|COMPLETED|Overall Study||4
2242442|NCT02562989|5499945|P1|COMPLETED|Overall Study||3
2242443|NCT02562989|5499943|P3|STARTED|Overall Study||6
2242444|NCT02562989|5499944|P2|STARTED|Overall Study||4
2242445|NCT02562989|5499945|P1|STARTED|Overall Study||3
2242446|NCT02562924|5499971|P3|NOT COMPLETED|Overall Study||4
2242447|NCT02562924|5499972|P2|NOT COMPLETED|Overall Study||11
2242448|NCT02562924|5499973|P1|NOT COMPLETED|Overall Study||1
2242449|NCT02562924|5499971|P3|COMPLETED|Overall Study||8
2242450|NCT02562924|5499972|P2|COMPLETED|Overall Study||1
2242451|NCT02562924|5499973|P1|COMPLETED|Overall Study||12
2242452|NCT02562924|5499971|P3|STARTED|Overall Study||12
2242453|NCT02562924|5499972|P2|STARTED|Overall Study||12
2242454|NCT02562924|5499973|P1|STARTED|Overall Study||13
2242455|NCT02562521|5499992|P2|NOT COMPLETED|Overall Study||0
2242456|NCT02562521|5499993|P1|NOT COMPLETED|Overall Study||0
2242457|NCT02562521|5499992|P2|COMPLETED|Overall Study||7
2242458|NCT02562521|5499993|P1|COMPLETED|Overall Study||18
2242459|NCT02562521|5499992|P2|STARTED|Overall Study||7
2242460|NCT02562521|5499993|P1|STARTED|Overall Study||18
2242471|NCT02561897|5500034|P2|NOT COMPLETED|Overall Study||0
2242472|NCT02561897|5500035|P1|NOT COMPLETED|Overall Study||0
2242473|NCT02561897|5500034|P2|COMPLETED|Overall Study||3
2242474|NCT02561897|5500035|P1|COMPLETED|Overall Study||2
2242475|NCT02561897|5500034|P2|STARTED|Overall Study||3
2242476|NCT02561897|5500035|P1|STARTED|Overall Study||2
2242477|NCT02561832|5500045|P2|NOT COMPLETED|Overall Study||4
2242478|NCT02561832|5500046|P1|NOT COMPLETED|Overall Study||7
2242479|NCT02561832|5500045|P2|COMPLETED|Overall Study||3
2242480|NCT02561832|5500046|P1|COMPLETED|Overall Study||1
2242481|NCT02561832|5500045|P2|INFORMED CONSENT OBTAINED|Overall Study||7
2242482|NCT02561832|5500046|P1|INFORMED CONSENT OBTAINED|Overall Study||8
2242483|NCT02561832|5500045|P2|STARTED|Overall Study||7
2242484|NCT02561832|5500046|P1|STARTED|Overall Study||8
2242485|NCT02561806|5500054|P2|NOT COMPLETED|Post-Treatment Follow-up||1
2242486|NCT02561806|5500055|P1|NOT COMPLETED|Post-Treatment Follow-up||2
2242487|NCT02561806|5500054|P2|COMPLETED|Post-Treatment Follow-up||59
2242488|NCT02561806|5500055|P1|COMPLETED|Post-Treatment Follow-up||155
2242489|NCT02561806|5500054|P2|STARTED|Post-Treatment Follow-up|Participants who discontinued previous periods had option to enter post treatment follow-up period.|60
2242490|NCT02561806|5500055|P1|STARTED|Post-Treatment Follow-up|Participants who discontinued previous periods had option to enter post treatment follow-up period.|157
2242491|NCT02561806|5500054|P2|NOT COMPLETED|Maintenance Period||8
2242492|NCT02561806|5500055|P1|NOT COMPLETED|Maintenance Period||13
2242493|NCT02561806|5500054|P2|COMPLETED|Maintenance Period||123
2242494|NCT02561806|5500055|P1|COMPLETED|Maintenance Period||151
2242495|NCT02561806|5500054|P2|STARTED|Maintenance Period||131
2242496|NCT02561806|5500055|P1|STARTED|Maintenance Period||164
2242497|NCT02561806|5500054|P2|NOT COMPLETED|Induction Period||5
2242498|NCT02561806|5500055|P1|NOT COMPLETED|Induction Period||2
2242499|NCT02561806|5500054|P2|COMPLETED|Induction Period||131
2242500|NCT02561806|5500055|P1|COMPLETED|Induction Period||164
2242501|NCT02561806|5500054|P2|Received At Least One Dose of Study Drug|Induction Period||135
2242502|NCT02561806|5500055|P1|Received At Least One Dose of Study Drug|Induction Period||166
2242503|NCT02561806|5500054|P2|STARTED|Induction Period||136
2242504|NCT02561806|5500055|P1|STARTED|Induction Period||166
2242505|NCT02561702|5500111|P2|NOT COMPLETED|Second Intervention||0
2242506|NCT02561702|5500112|P1|NOT COMPLETED|Second Intervention||0
2242507|NCT02561702|5500111|P2|COMPLETED|Second Intervention||2
2242508|NCT02561702|5500112|P1|COMPLETED|Second Intervention||2
2242509|NCT02561702|5500111|P2|STARTED|Second Intervention||2
2242510|NCT02561702|5500112|P1|STARTED|Second Intervention||2
2242511|NCT02561702|5500111|P2|NOT COMPLETED|Washout||0
2242512|NCT02561702|5500112|P1|NOT COMPLETED|Washout||0
2242513|NCT02561702|5500111|P2|COMPLETED|Washout||2
2242514|NCT02561702|5500112|P1|COMPLETED|Washout||2
2242515|NCT02561702|5500111|P2|STARTED|Washout||2
2242516|NCT02561702|5500112|P1|STARTED|Washout||2
2242517|NCT02561702|5500111|P2|NOT COMPLETED|First Intervention||0
2242518|NCT02561702|5500112|P1|NOT COMPLETED|First Intervention||0
2242519|NCT02561702|5500111|P2|COMPLETED|First Intervention||2
2242520|NCT02561702|5500112|P1|COMPLETED|First Intervention||2
2242521|NCT02561702|5500111|P2|STARTED|First Intervention||2
2242522|NCT02561702|5500112|P1|STARTED|First Intervention||2
2242523|NCT02561585|5500122|P2|NOT COMPLETED|Overall Study||5
2242524|NCT02561585|5500123|P1|NOT COMPLETED|Overall Study||3
2242525|NCT02561585|5500122|P2|COMPLETED|Overall Study||6
2242526|NCT02561585|5500123|P1|COMPLETED|Overall Study||17
2242527|NCT02561585|5500122|P2|STARTED|Overall Study||11
2242528|NCT02561585|5500123|P1|STARTED|Overall Study||20
2242529|NCT02561572|5500159|P2|NOT COMPLETED|Overall Study||2
2242530|NCT02561572|5500160|P1|NOT COMPLETED|Overall Study||2
2242531|NCT02561572|5500159|P2|COMPLETED|Overall Study||62
2242532|NCT02561572|5500160|P1|COMPLETED|Overall Study||62
2242533|NCT02561572|5500159|P2|STARTED|Overall Study||64
2242534|NCT02561572|5500160|P1|STARTED|Overall Study||64
2242535|NCT02561195|5500182|P6|NOT COMPLETED|Overall Study||10
2242536|NCT02561195|5500183|P5|NOT COMPLETED|Overall Study||28
2242537|NCT02561195|5500184|P4|NOT COMPLETED|Overall Study||26
2242538|NCT02561195|5500185|P3|NOT COMPLETED|Overall Study||6
2242539|NCT02561195|5500186|P2|NOT COMPLETED|Overall Study||22
2242540|NCT02561195|5500187|P1|NOT COMPLETED|Overall Study||23
2242541|NCT02561195|5500182|P6|COMPLETED|Overall Study||51
2242542|NCT02561195|5500183|P5|COMPLETED|Overall Study||155
2242543|NCT02561195|5500184|P4|COMPLETED|Overall Study||157
2242544|NCT02561195|5500185|P3|COMPLETED|Overall Study||55
2242545|NCT02561195|5500186|P2|COMPLETED|Overall Study||162
2242546|NCT02561195|5500187|P1|COMPLETED|Overall Study||160
2242547|NCT02561195|5500182|P6|Treated|Overall Study||61
2242548|NCT02561195|5500183|P5|Treated|Overall Study||183
2242549|NCT02561195|5500184|P4|Treated|Overall Study||183
2242550|NCT02561195|5500185|P3|Treated|Overall Study||61
2242551|NCT02561195|5500186|P2|Treated|Overall Study||184
2242552|NCT02561195|5500187|P1|Treated|Overall Study||182
2242553|NCT02561195|5500182|P6|STARTED|Overall Study||61
2242554|NCT02561195|5500183|P5|STARTED|Overall Study||183
2242555|NCT02561195|5500184|P4|STARTED|Overall Study||183
2242556|NCT02561195|5500185|P3|STARTED|Overall Study||61
2242557|NCT02561195|5500186|P2|STARTED|Overall Study||184
2242558|NCT02561195|5500187|P1|STARTED|Overall Study||183
2242559|NCT02561156|5500348|P13|NOT COMPLETED|Part 2||0
2242560|NCT02561156|5500349|P12|NOT COMPLETED|Part 2||1
2242561|NCT02561156|5500350|P11|NOT COMPLETED|Part 2||0
2242562|NCT02561156|5500351|P10|NOT COMPLETED|Part 2||0
2242563|NCT02561156|5500352|P9|NOT COMPLETED|Part 2||0
2242564|NCT02561156|5500353|P8|NOT COMPLETED|Part 2||0
2242565|NCT02561156|5500354|P7|NOT COMPLETED|Part 2||0
2242566|NCT02561156|5500355|P6|NOT COMPLETED|Part 2||0
2242567|NCT02561156|5500356|P5|NOT COMPLETED|Part 2||0
2242568|NCT02561156|5500357|P4|NOT COMPLETED|Part 2||0
2242569|NCT02561156|5500358|P3|NOT COMPLETED|Part 2||0
2242570|NCT02561156|5500359|P2|NOT COMPLETED|Part 2||0
2242571|NCT02561156|5500360|P1|NOT COMPLETED|Part 2||0
2242572|NCT02561156|5500348|P13|COMPLETED|Part 2||6
2242573|NCT02561156|5500349|P12|COMPLETED|Part 2||5
2242574|NCT02561156|5500350|P11|COMPLETED|Part 2||6
2242575|NCT02561156|5500351|P10|COMPLETED|Part 2||6
2242576|NCT02561156|5500352|P9|COMPLETED|Part 2||6
2242577|NCT02561156|5500353|P8|COMPLETED|Part 2||10
2242578|NCT02561156|5500354|P7|COMPLETED|Part 2||0
2242579|NCT02561156|5500355|P6|COMPLETED|Part 2||0
2242580|NCT02561156|5500356|P5|COMPLETED|Part 2||0
2242581|NCT02561156|5500357|P4|COMPLETED|Part 2||0
2242582|NCT02561156|5500358|P3|COMPLETED|Part 2||0
2242583|NCT02561156|5500359|P2|COMPLETED|Part 2||0
2242584|NCT02561156|5500360|P1|COMPLETED|Part 2||0
2242585|NCT02561156|5500348|P13|STARTED|Part 2||6
2242586|NCT02561156|5500349|P12|STARTED|Part 2||6
2242587|NCT02561156|5500350|P11|STARTED|Part 2||6
2242588|NCT02561156|5500351|P10|STARTED|Part 2||6
2242589|NCT02561156|5500352|P9|STARTED|Part 2||6
2242590|NCT02561156|5500353|P8|STARTED|Part 2||10
2242591|NCT02561156|5500354|P7|STARTED|Part 2||0
2242592|NCT02561156|5500355|P6|STARTED|Part 2||0
2242593|NCT02561156|5500356|P5|STARTED|Part 2||0
2242594|NCT02561156|5500357|P4|STARTED|Part 2||0
2242595|NCT02561156|5500358|P3|STARTED|Part 2||0
2242596|NCT02561156|5500359|P2|STARTED|Part 2||0
2242597|NCT02561156|5500360|P1|STARTED|Part 2||0
2242598|NCT02561156|5500348|P13|NOT COMPLETED|Part 1||0
2242599|NCT02561156|5500349|P12|NOT COMPLETED|Part 1||0
2242600|NCT02561156|5500350|P11|NOT COMPLETED|Part 1||0
2242601|NCT02561156|5500351|P10|NOT COMPLETED|Part 1||0
2242602|NCT02561156|5500352|P9|NOT COMPLETED|Part 1||0
2242603|NCT02561156|5500353|P8|NOT COMPLETED|Part 1||0
2242604|NCT02561156|5500354|P7|NOT COMPLETED|Part 1||0
2242605|NCT02561156|5500355|P6|NOT COMPLETED|Part 1||0
2242606|NCT02561156|5500356|P5|NOT COMPLETED|Part 1||0
2242607|NCT02561156|5500357|P4|NOT COMPLETED|Part 1||0
2242608|NCT02561156|5500358|P3|NOT COMPLETED|Part 1||0
2242609|NCT02561156|5500359|P2|NOT COMPLETED|Part 1||0
2242610|NCT02561156|5500360|P1|NOT COMPLETED|Part 1||0
2242611|NCT02561156|5500348|P13|COMPLETED|Part 1||0
2242612|NCT02561156|5500349|P12|COMPLETED|Part 1||0
2242613|NCT02561156|5500350|P11|COMPLETED|Part 1||0
2242614|NCT02561156|5500351|P10|COMPLETED|Part 1||0
2242615|NCT02561156|5500352|P9|COMPLETED|Part 1||0
2242616|NCT02561156|5500353|P8|COMPLETED|Part 1||0
2242617|NCT02561156|5500354|P7|COMPLETED|Part 1||6
2242618|NCT02561156|5500355|P6|COMPLETED|Part 1||6
2242619|NCT02561156|5500356|P5|COMPLETED|Part 1||6
2242620|NCT02561156|5500357|P4|COMPLETED|Part 1||6
2242621|NCT02561156|5500358|P3|COMPLETED|Part 1||6
2242622|NCT02561156|5500359|P2|COMPLETED|Part 1||6
2242623|NCT02561156|5500360|P1|COMPLETED|Part 1||12
2242624|NCT02561156|5500348|P13|STARTED|Part 1||0
2242625|NCT02561156|5500349|P12|STARTED|Part 1||0
2242626|NCT02561156|5500350|P11|STARTED|Part 1||0
2242627|NCT02561156|5500351|P10|STARTED|Part 1||0
2242628|NCT02561156|5500352|P9|STARTED|Part 1||0
2242629|NCT02561156|5500353|P8|STARTED|Part 1||0
2242630|NCT02561156|5500354|P7|STARTED|Part 1||6
2242631|NCT02561156|5500355|P6|STARTED|Part 1||6
2242632|NCT02561156|5500356|P5|STARTED|Part 1||6
2242633|NCT02561156|5500357|P4|STARTED|Part 1||6
2242634|NCT02561156|5500358|P3|STARTED|Part 1||6
2242635|NCT02561156|5500359|P2|STARTED|Part 1||6
2242636|NCT02561156|5500360|P1|STARTED|Part 1||12
2242637|NCT02560922|5500532|P2|NOT COMPLETED|Overall Study||12
2242638|NCT02560922|5500533|P1|NOT COMPLETED|Overall Study||26
2242639|NCT02560922|5500532|P2|COMPLETED|Overall Study||112
2242640|NCT02560922|5500533|P1|COMPLETED|Overall Study||98
2242641|NCT02560922|5500532|P2|STARTED|Overall Study||124
2242642|NCT02560922|5500533|P1|STARTED|Overall Study||124
2242643|NCT02560753|5500561|P4|NOT COMPLETED|Overall Study||0
2242644|NCT02560753|5500562|P3|NOT COMPLETED|Overall Study||1
2242645|NCT02560753|5500563|P2|NOT COMPLETED|Overall Study||0
2242646|NCT02560753|5500564|P1|NOT COMPLETED|Overall Study||1
2242647|NCT02560753|5500561|P4|COMPLETED|Overall Study||8
2242648|NCT02560753|5500562|P3|COMPLETED|Overall Study||9
2242649|NCT02560753|5500563|P2|COMPLETED|Overall Study||9
2242650|NCT02560753|5500564|P1|COMPLETED|Overall Study||8
2242651|NCT02560753|5500561|P4|STARTED|Overall Study||8
2242652|NCT02560753|5500562|P3|STARTED|Overall Study||10
2242653|NCT02560753|5500563|P2|STARTED|Overall Study||9
2242654|NCT02560753|5500564|P1|STARTED|Overall Study||9
2242655|NCT02560701|5500592|P2|NOT COMPLETED|Overall Study||51466
2242656|NCT02560701|5500593|P1|NOT COMPLETED|Overall Study||4543
2242657|NCT02560701|5500592|P2|COMPLETED|Overall Study||37776
2242658|NCT02560701|5500593|P1|COMPLETED|Overall Study||3517
2242659|NCT02560701|5500592|P2|Matched Cohort|Overall Study||37776
2242660|NCT02560701|5500593|P1|Matched Cohort|Overall Study||3517
2242661|NCT02560701|5500592|P2|Bipolar Diagnosis Time Constraints|Overall Study||39427
2242662|NCT02560701|5500593|P1|Bipolar Diagnosis Time Constraints|Overall Study||3533
2242663|NCT02560701|5500592|P2|Restrict to Patients Between 12 and 64|Overall Study||82367
2242664|NCT02560701|5500593|P1|Restrict to Patients Between 12 and 64|Overall Study||7598
2242665|NCT02560701|5500592|P2|Carve Out|Overall Study||88729
2242666|NCT02560701|5500593|P1|Carve Out|Overall Study||8060
2242667|NCT02560701|5500592|P2|STARTED|Overall Study||89242
2242668|NCT02560701|5500593|P1|STARTED|Overall Study||8060
2242669|NCT02560584|5500609|P1|NOT COMPLETED|Overall Study||0
2242670|NCT02560584|5500609|P1|COMPLETED|Overall Study||304
2242671|NCT02560584|5500609|P1|STARTED|Overall Study||304
2242672|NCT02560493|5500618|P2|NOT COMPLETED|Overall Study||0
2242673|NCT02560493|5500619|P1|NOT COMPLETED|Overall Study||1
2242674|NCT02560493|5500618|P2|COMPLETED|Overall Study||23
2242675|NCT02560493|5500619|P1|COMPLETED|Overall Study||22
2242676|NCT02560493|5500618|P2|STARTED|Overall Study||23
2242677|NCT02560493|5500619|P1|STARTED|Overall Study||23
2242678|NCT02560389|5500642|P3|NOT COMPLETED|Overall Study||2
2242679|NCT02560389|5500643|P2|NOT COMPLETED|Overall Study||3
2242680|NCT02560389|5500644|P1|NOT COMPLETED|Overall Study||1
2242681|NCT02560389|5500642|P3|COMPLETED|Overall Study||27
2242682|NCT02560389|5500643|P2|COMPLETED|Overall Study||25
2242683|NCT02560389|5500644|P1|COMPLETED|Overall Study||33
2242684|NCT02560389|5500642|P3|STARTED|Overall Study||29
2242685|NCT02560389|5500643|P2|STARTED|Overall Study||28
2242686|NCT02560389|5500644|P1|STARTED|Overall Study||34
2242687|NCT02560324|5500660|P2|NOT COMPLETED|Period 2 (2 Weeks)||2
2242688|NCT02560324|5500661|P1|NOT COMPLETED|Period 2 (2 Weeks)||1
2242689|NCT02560324|5500660|P2|COMPLETED|Period 2 (2 Weeks)||21
2242690|NCT02560324|5500661|P1|COMPLETED|Period 2 (2 Weeks)||22
2242691|NCT02560324|5500660|P2|STARTED|Period 2 (2 Weeks)||23
2242692|NCT02560324|5500661|P1|STARTED|Period 2 (2 Weeks)||23
2242693|NCT02560324|5500660|P2|NOT COMPLETED|Washout (2 Weeks)||2
2242694|NCT02560324|5500661|P1|NOT COMPLETED|Washout (2 Weeks)||0
2242695|NCT02560324|5500660|P2|COMPLETED|Washout (2 Weeks)||23
2242696|NCT02560324|5500661|P1|COMPLETED|Washout (2 Weeks)||23
2242697|NCT02560324|5500660|P2|STARTED|Washout (2 Weeks)||25
2242698|NCT02560324|5500661|P1|STARTED|Washout (2 Weeks)||23
2242699|NCT02560324|5500660|P2|NOT COMPLETED|Period 1 (2 Weeks)||9
2242700|NCT02560324|5500661|P1|NOT COMPLETED|Period 1 (2 Weeks)||12
2242701|NCT02560324|5500660|P2|COMPLETED|Period 1 (2 Weeks)||25
2242702|NCT02560324|5500661|P1|COMPLETED|Period 1 (2 Weeks)||23
2242703|NCT02560324|5500660|P2|STARTED|Period 1 (2 Weeks)||34
2242704|NCT02560324|5500661|P1|STARTED|Period 1 (2 Weeks)||35
2242705|NCT02560051|5500678|P3|NOT COMPLETED|Overall Study||1
2242706|NCT02560051|5500679|P2|NOT COMPLETED|Overall Study||4
2242707|NCT02560051|5500680|P1|NOT COMPLETED|Overall Study||3
2242708|NCT02560051|5500678|P3|COMPLETED|Overall Study||4
2242709|NCT02560051|5500679|P2|COMPLETED|Overall Study||4
2242710|NCT02560051|5500680|P1|COMPLETED|Overall Study||3
2242711|NCT02560051|5500678|P3|STARTED|Overall Study||5
2242712|NCT02560051|5500679|P2|STARTED|Overall Study||8
2242713|NCT02560051|5500680|P1|STARTED|Overall Study||6
2242714|NCT02560038|5500736|P1|NOT COMPLETED|Overall Study||2
2242715|NCT02560038|5500736|P1|COMPLETED|Overall Study||1
2242716|NCT02560038|5500736|P1|STARTED|Overall Study||3
2242717|NCT02560025|5500742|P1|NOT COMPLETED|Overall Study||3
2242718|NCT02560025|5500742|P1|COMPLETED|Overall Study||39
2242719|NCT02560025|5500742|P1|STARTED|Overall Study||42
2242720|NCT02560012|5500748|P1|NOT COMPLETED|Overall Study||2
2242721|NCT02560012|5500748|P1|COMPLETED|Overall Study||1
2242722|NCT02560012|5500748|P1|STARTED|Overall Study||3
2242726|NCT02559622|5500765|P4|NOT COMPLETED|Overall Study||3
2242727|NCT02559622|5500766|P3|NOT COMPLETED|Overall Study||2
2242728|NCT02559622|5500767|P2|NOT COMPLETED|Overall Study||5
2242729|NCT02559622|5500768|P1|NOT COMPLETED|Overall Study||1
2242730|NCT02559622|5500765|P4|COMPLETED|Overall Study||20
2242731|NCT02559622|5500766|P3|COMPLETED|Overall Study||24
2242732|NCT02559622|5500767|P2|COMPLETED|Overall Study||49
2242733|NCT02559622|5500768|P1|COMPLETED|Overall Study||47
2242734|NCT02559622|5500765|P4|STARTED|Overall Study||23
2242735|NCT02559622|5500766|P3|STARTED|Overall Study||26
2242736|NCT02559622|5500767|P2|STARTED|Overall Study||54
2242737|NCT02559622|5500768|P1|STARTED|Overall Study||48
2242738|NCT02559570|5500852|P5|NOT COMPLETED|Overall Study||2
2242739|NCT02559570|5500853|P4|NOT COMPLETED|Overall Study||3
2242740|NCT02559570|5500854|P3|NOT COMPLETED|Overall Study||2
2242741|NCT02559570|5500855|P2|NOT COMPLETED|Overall Study||2
2242742|NCT02559570|5500856|P1|NOT COMPLETED|Overall Study||2
2242743|NCT02559570|5500852|P5|COMPLETED|Overall Study||14
2242744|NCT02559570|5500853|P4|COMPLETED|Overall Study||36
2242745|NCT02559570|5500854|P3|COMPLETED|Overall Study||39
2242746|NCT02559570|5500855|P2|COMPLETED|Overall Study||34
2242747|NCT02559570|5500856|P1|COMPLETED|Overall Study||39
2242748|NCT02559570|5500852|P5|STARTED|Overall Study||16
2242749|NCT02559570|5500853|P4|STARTED|Overall Study||39
2242750|NCT02559570|5500854|P3|STARTED|Overall Study||41
2242751|NCT02559570|5500855|P2|STARTED|Overall Study||36
2242752|NCT02559570|5500856|P1|STARTED|Overall Study||41
2242753|NCT02559414|5500894|P3|NOT COMPLETED|Overall Study||2
2242754|NCT02559414|5500895|P2|NOT COMPLETED|Overall Study||2
2242755|NCT02559414|5500896|P1|NOT COMPLETED|Overall Study||1
2242756|NCT02559414|5500894|P3|COMPLETED|Overall Study||20
2242757|NCT02559414|5500895|P2|COMPLETED|Overall Study||20
2242758|NCT02559414|5500896|P1|COMPLETED|Overall Study||10
2242759|NCT02559414|5500894|P3|STARTED|Overall Study||22
2242760|NCT02559414|5500895|P2|STARTED|Overall Study||22
2242761|NCT02559414|5500896|P1|STARTED|Overall Study||11
2242762|NCT02559310|5500936|P2|NOT COMPLETED|Overall Study||19
2242763|NCT02559310|5500937|P1|NOT COMPLETED|Overall Study||27
2242764|NCT02559310|5500936|P2|COMPLETED|Overall Study||256
2242765|NCT02559310|5500937|P1|COMPLETED|Overall Study||249
2242766|NCT02559310|5500936|P2|STARTED|Overall Study||275
2242767|NCT02559310|5500937|P1|STARTED|Overall Study||276
2242768|NCT02558894|5500949|P2|NOT COMPLETED|Overall Study||33
2242769|NCT02558894|5500950|P1|NOT COMPLETED|Overall Study||32
2242770|NCT02558894|5500949|P2|COMPLETED|Overall Study||0
2242771|NCT02558894|5500950|P1|COMPLETED|Overall Study||0
2242772|NCT02558894|5500949|P2|Patients Who Received IP|Overall Study||32
2242773|NCT02558894|5500950|P1|Patients Who Received IP|Overall Study||32
2242774|NCT02558894|5500949|P2|STARTED|Overall Study||33
2242775|NCT02558894|5500950|P1|STARTED|Overall Study||32
2242776|NCT02558829|5500978|P8|NOT COMPLETED|Overall Study||3
2242777|NCT02558829|5500979|P7|NOT COMPLETED|Overall Study||1
2242778|NCT02558829|5500980|P6|NOT COMPLETED|Overall Study||2
2242779|NCT02558829|5500981|P5|NOT COMPLETED|Overall Study||2
2242780|NCT02558829|5500982|P4|NOT COMPLETED|Overall Study||2
2242781|NCT02558829|5500983|P3|NOT COMPLETED|Overall Study||3
2242782|NCT02558829|5500984|P2|NOT COMPLETED|Overall Study||3
2242783|NCT02558829|5500985|P1|NOT COMPLETED|Overall Study||1
2242784|NCT02558829|5500978|P8|COMPLETED|Overall Study||8
2242785|NCT02558829|5500979|P7|COMPLETED|Overall Study||17
2242786|NCT02558829|5500980|P6|COMPLETED|Overall Study||24
2242787|NCT02558829|5500981|P5|COMPLETED|Overall Study||16
2242788|NCT02558829|5500982|P4|COMPLETED|Overall Study||16
2242789|NCT02558829|5500983|P3|COMPLETED|Overall Study||21
2242790|NCT02558829|5500984|P2|COMPLETED|Overall Study||18
2242791|NCT02558829|5500985|P1|COMPLETED|Overall Study||20
2242792|NCT02558829|5500978|P8|STARTED|Overall Study||11
2242793|NCT02558829|5500979|P7|STARTED|Overall Study||18
2242794|NCT02558829|5500980|P6|STARTED|Overall Study||26
2242795|NCT02558829|5500981|P5|STARTED|Overall Study||18
2242796|NCT02558829|5500982|P4|STARTED|Overall Study||18
2242797|NCT02558829|5500983|P3|STARTED|Overall Study||24
2242798|NCT02558829|5500984|P2|STARTED|Overall Study||21
2242799|NCT02558829|5500985|P1|STARTED|Overall Study||21
2242800|NCT02558790|5501011|P1|NOT COMPLETED|Overall Study||7
2242801|NCT02558790|5501011|P1|COMPLETED|Overall Study||13
2242802|NCT02558790|5501011|P1|Treated|Overall Study||15
2242803|NCT02558790|5501011|P1|STARTED|Overall Study|20 subjects signed consent to participate in the study. 15 subjects began taking L-TAMS.|20
2242804|NCT02558400|5501018|P3|NOT COMPLETED|Overall Study||33
2242805|NCT02558400|5501019|P2|NOT COMPLETED|Overall Study||96
2242806|NCT02558400|5501020|P1|NOT COMPLETED|Overall Study||79
2242807|NCT02558400|5501018|P3|COMPLETED|Overall Study||203
2242808|NCT02558400|5501019|P2|COMPLETED|Overall Study||148
2242809|NCT02558400|5501020|P1|COMPLETED|Overall Study||159
2242810|NCT02558400|5501018|P3|STARTED|Overall Study||236
2242811|NCT02558400|5501019|P2|STARTED|Overall Study||244
2242812|NCT02558400|5501020|P1|STARTED|Overall Study||238
2242813|NCT02558374|5501033|P2|NOT COMPLETED|Overall Study||43
2242814|NCT02558374|5501034|P1|NOT COMPLETED|Overall Study||108
2242815|NCT02558374|5501033|P2|COMPLETED|Overall Study||314
2242816|NCT02558374|5501034|P1|COMPLETED|Overall Study||243
2242817|NCT02558374|5501033|P2|STARTED|Overall Study||357
2242818|NCT02558374|5501034|P1|STARTED|Overall Study||351
2242819|NCT02557698|5501044|P2|NOT COMPLETED|Overall Study||0
2242820|NCT02557698|5501045|P1|NOT COMPLETED|Overall Study||0
2242821|NCT02557698|5501044|P2|COMPLETED|Overall Study||30
2242822|NCT02557698|5501045|P1|COMPLETED|Overall Study||30
2242823|NCT02557698|5501044|P2|STARTED|Overall Study||30
2242824|NCT02557698|5501045|P1|STARTED|Overall Study||30
2242825|NCT02557646|5501109|P1|NOT COMPLETED|Overall Study||276
2242826|NCT02557646|5501109|P1|COMPLETED|Overall Study||417
2242827|NCT02557646|5501109|P1|STARTED|Overall Study||693
2242828|NCT02557555|5501127|P1|NOT COMPLETED|Overall Study||0
2242829|NCT02557555|5501127|P1|COMPLETED|Overall Study||100
2242830|NCT02557555|5501127|P1|STARTED|Overall Study||100
2242831|NCT02557516|5501136|P4|NOT COMPLETED|Overall Study||9
2242832|NCT02557516|5501137|P3|NOT COMPLETED|Overall Study||4
2242833|NCT02557516|5501138|P2|NOT COMPLETED|Overall Study||5
2242834|NCT02557516|5501139|P1|NOT COMPLETED|Overall Study||1
2242835|NCT02557516|5501136|P4|COMPLETED|Overall Study||0
2242836|NCT02557516|5501137|P3|COMPLETED|Overall Study||0
2242837|NCT02557516|5501138|P2|COMPLETED|Overall Study||1
2242838|NCT02557516|5501139|P1|COMPLETED|Overall Study||2
2242839|NCT02557516|5501136|P4|STARTED|Overall Study||9
2242840|NCT02557516|5501137|P3|STARTED|Overall Study||4
2242841|NCT02557516|5501138|P2|STARTED|Overall Study||6
2242842|NCT02557516|5501139|P1|STARTED|Overall Study||3
2242843|NCT02557399|5501160|P2|NOT COMPLETED|Overall Study||8
2242844|NCT02557399|5501161|P1|NOT COMPLETED|Overall Study||7
2242845|NCT02557399|5501160|P2|COMPLETED|Overall Study||169
2242846|NCT02557399|5501161|P1|COMPLETED|Overall Study||165
2242847|NCT02557399|5501160|P2|STARTED|Overall Study||177
2242848|NCT02557399|5501161|P1|STARTED|Overall Study||172
2242849|NCT02557035|5501195|P2|NOT COMPLETED|Overall Study||9
2242850|NCT02557035|5501196|P1|NOT COMPLETED|Overall Study||7
2242851|NCT02557035|5501195|P2|COMPLETED|Overall Study||206
2242852|NCT02557035|5501196|P1|COMPLETED|Overall Study||218
2242853|NCT02557035|5501195|P2|STARTED|Overall Study||215
2242854|NCT02557035|5501196|P1|STARTED|Overall Study||225
2242855|NCT02556918|5501220|P2|NOT COMPLETED|Overall Study||10
2242856|NCT02556918|5501221|P1|NOT COMPLETED|Overall Study||9
2242857|NCT02556918|5501220|P2|COMPLETED|Overall Study||91
2242858|NCT02556918|5501221|P1|COMPLETED|Overall Study||91
2242859|NCT02556918|5501220|P2|STARTED|Overall Study||101
2242860|NCT02556918|5501221|P1|STARTED|Overall Study||100
2242861|NCT02556801|5501281|P4|NOT COMPLETED|Overall Study||5
2242862|NCT02556801|5501282|P3|NOT COMPLETED|Overall Study||4
2242863|NCT02556801|5501283|P2|NOT COMPLETED|Overall Study||7
2242864|NCT02556801|5501284|P1|NOT COMPLETED|Overall Study||2
2242865|NCT02556801|5501281|P4|COMPLETED|Overall Study||37
2242866|NCT02556801|5501282|P3|COMPLETED|Overall Study||38
2242867|NCT02556801|5501283|P2|COMPLETED|Overall Study||35
2242868|NCT02556801|5501284|P1|COMPLETED|Overall Study||40
2242869|NCT02556801|5501281|P4|STARTED|Overall Study||42
2242870|NCT02556801|5501282|P3|STARTED|Overall Study||42
2242871|NCT02556801|5501283|P2|STARTED|Overall Study||42
2242872|NCT02556801|5501284|P1|STARTED|Overall Study||42
2242873|NCT02556788|5501336|P2|NOT COMPLETED|Overall Study||37
2242874|NCT02556788|5501337|P1|NOT COMPLETED|Overall Study||44
2242875|NCT02556788|5501336|P2|COMPLETED|Overall Study||573
2242876|NCT02556788|5501337|P1|COMPLETED|Overall Study||558
2242877|NCT02556788|5501336|P2|STARTED|Overall Study||610
2242878|NCT02556788|5501337|P1|STARTED|Overall Study||602
2242879|NCT02556632|5501346|P3|NOT COMPLETED|Overall Study||9
2242880|NCT02556632|5501347|P2|NOT COMPLETED|Overall Study||6
2242881|NCT02556632|5501348|P1|NOT COMPLETED|Overall Study||5
2242882|NCT02556632|5501346|P3|COMPLETED|Overall Study||53
2242883|NCT02556632|5501347|P2|COMPLETED|Overall Study||59
2242884|NCT02556632|5501348|P1|COMPLETED|Overall Study||59
2242885|NCT02556632|5501346|P3|STARTED|Overall Study||62
2242886|NCT02556632|5501347|P2|STARTED|Overall Study||65
2242887|NCT02556632|5501348|P1|STARTED|Overall Study||64
2242888|NCT02556333|5501362|P1|NOT COMPLETED|Overall Study||0
2242889|NCT02556333|5501362|P1|COMPLETED|Overall Study||1
2242890|NCT02556333|5501362|P1|STARTED|Overall Study||1
2242891|NCT02556307|5501366|P1|NOT COMPLETED|Overall Study||53
2242892|NCT02556307|5501366|P1|COMPLETED|Overall Study||217
2242893|NCT02556307|5501366|P1|Treated|Overall Study||268
2242894|NCT02556307|5501366|P1|STARTED|Overall Study||270
2242895|NCT02556255|5501376|P1|NOT COMPLETED|Overall Study||4
2242896|NCT02556255|5501376|P1|COMPLETED|Overall Study||46
2242897|NCT02556255|5501376|P1|STARTED|Overall Study||50
2242898|NCT02556203|5501391|P2|NOT COMPLETED|Overall Study||26
2242899|NCT02556203|5501392|P1|NOT COMPLETED|Overall Study||27
2242900|NCT02556203|5501391|P2|COMPLETED|Overall Study||792
2242901|NCT02556203|5501392|P1|COMPLETED|Overall Study||799
2242902|NCT02556203|5501391|P2|Received Treatment|Overall Study||807
2242903|NCT02556203|5501392|P1|Received Treatment|Overall Study||801
2242904|NCT02556203|5501391|P2|STARTED|Overall Study||818
2242905|NCT02556203|5501392|P1|STARTED|Overall Study||826
2242906|NCT02556177|5501414|P2|NOT COMPLETED|Overall Study||61
2242907|NCT02556177|5501415|P1|NOT COMPLETED|Overall Study||283
2242908|NCT02556177|5501414|P2|COMPLETED|Overall Study||91
2242909|NCT02556177|5501415|P1|COMPLETED|Overall Study||42
2242910|NCT02556177|5501414|P2|STARTED|Overall Study||152
2242911|NCT02556177|5501415|P1|STARTED|Overall Study||325
2242912|NCT02556138|5501423|P1|NOT COMPLETED|Overall Study||1
2242913|NCT02556138|5501423|P1|COMPLETED|Overall Study|One patient withdrew from the study due to intolerance of the balloon after 1 month.|7
2242914|NCT02556138|5501423|P1|STARTED|Overall Study||8
2242915|NCT02555878|5501431|P2|NOT COMPLETED|Overall Study||150
2242916|NCT02555878|5501432|P1|NOT COMPLETED|Overall Study||166
2242917|NCT02555878|5501431|P2|COMPLETED|Overall Study||270
2242918|NCT02555878|5501432|P1|COMPLETED|Overall Study||255
2242919|NCT02555878|5501431|P2|Treated|Overall Study||405
2242920|NCT02555878|5501432|P1|Treated|Overall Study||404
2242921|NCT02555878|5501431|P2|STARTED|Overall Study||420
2242922|NCT02555878|5501432|P1|STARTED|Overall Study||421
2242923|NCT02555722|5501464|P2|NOT COMPLETED|Month 3||0
2242924|NCT02555722|5501465|P1|NOT COMPLETED|Month 3||0
2242925|NCT02555722|5501464|P2|COMPLETED|Month 3||29
2242926|NCT02555722|5501465|P1|COMPLETED|Month 3||54
2242927|NCT02555722|5501464|P2|STARTED|Month 3||29
2242928|NCT02555722|5501465|P1|STARTED|Month 3||54
2242929|NCT02555722|5501464|P2|NOT COMPLETED|Month 2||0
2242930|NCT02555722|5501465|P1|NOT COMPLETED|Month 2||4
2242931|NCT02555722|5501464|P2|COMPLETED|Month 2||29
2242932|NCT02555722|5501465|P1|COMPLETED|Month 2||54
2242933|NCT02555722|5501464|P2|STARTED|Month 2||29
2242934|NCT02555722|5501465|P1|STARTED|Month 2||58
2242935|NCT02555722|5501464|P2|NOT COMPLETED|Month 1||0
2242936|NCT02555722|5501465|P1|NOT COMPLETED|Month 1||1
2242937|NCT02555722|5501464|P2|COMPLETED|Month 1||29
2242938|NCT02555722|5501465|P1|COMPLETED|Month 1||58
2242939|NCT02555722|5501464|P2|STARTED|Month 1||29
2242940|NCT02555722|5501465|P1|STARTED|Month 1||59
2242941|NCT02555722|5501464|P2|NOT COMPLETED|Week 2||1
2242942|NCT02555722|5501465|P1|NOT COMPLETED|Week 2||1
2242943|NCT02555722|5501464|P2|COMPLETED|Week 2||29
2242944|NCT02555722|5501465|P1|COMPLETED|Week 2||59
2242945|NCT02555722|5501464|P2|STARTED|Week 2||30
2242946|NCT02555722|5501465|P1|STARTED|Week 2||60
2242947|NCT02555722|5501464|P2|NOT COMPLETED|Week 1||0
2242948|NCT02555722|5501465|P1|NOT COMPLETED|Week 1||0
2242949|NCT02555722|5501464|P2|COMPLETED|Week 1||30
2242950|NCT02555722|5501465|P1|COMPLETED|Week 1||60
2242951|NCT02555722|5501464|P2|STARTED|Week 1||30
2242952|NCT02555722|5501465|P1|STARTED|Week 1||60
2242953|NCT02555722|5501464|P2|NOT COMPLETED|Lens Dispensed||0
2242954|NCT02555722|5501465|P1|NOT COMPLETED|Lens Dispensed||0
2242955|NCT02555722|5501464|P2|COMPLETED|Lens Dispensed||30
2242956|NCT02555722|5501465|P1|COMPLETED|Lens Dispensed||60
2242957|NCT02555722|5501464|P2|STARTED|Lens Dispensed||30
2242958|NCT02555722|5501465|P1|STARTED|Lens Dispensed||60
2242959|NCT02555631|5501647|P1|NOT COMPLETED|Overall Study||4
2242960|NCT02555631|5501647|P1|COMPLETED|Overall Study||25
2242961|NCT02555631|5501647|P1|STARTED|Overall Study||29
2242962|NCT02555618|5501656|P2|NOT COMPLETED|Overall Study||0
2242963|NCT02555618|5501657|P1|NOT COMPLETED|Overall Study||1
2242964|NCT02555618|5501656|P2|COMPLETED|Overall Study||200
2242965|NCT02555618|5501657|P1|COMPLETED|Overall Study||199
2242966|NCT02555618|5501656|P2|STARTED|Overall Study||200
2242967|NCT02555618|5501657|P1|STARTED|Overall Study||200
2242968|NCT02555371|5501699|P5|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||3
2242969|NCT02555371|5501700|P4|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||4
2242970|NCT02555371|5501701|P3|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
2242971|NCT02555371|5501702|P2|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
2242972|NCT02555371|5501703|P1|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
2242973|NCT02555371|5501699|P5|COMPLETED|PartD(OL: 52W Post-randomization PartC)||42
2242974|NCT02555371|5501700|P4|COMPLETED|PartD(OL: 52W Post-randomization PartC)||80
2242975|NCT02555371|5501701|P3|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
2242976|NCT02555371|5501702|P2|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
2242977|NCT02555371|5501703|P1|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
2242978|NCT02555371|5501699|P5|STARTED|PartD(OL: 52W Post-randomization PartC)||45
2242979|NCT02555371|5501700|P4|STARTED|PartD(OL: 52W Post-randomization PartC)||84
2242980|NCT02555371|5501701|P3|STARTED|PartD(OL: 52W Post-randomization PartC)||0
2242981|NCT02555371|5501702|P2|STARTED|PartD(OL: 52W Post-randomization PartC)||0
2242982|NCT02555371|5501703|P1|STARTED|PartD(OL: 52W Post-randomization PartC)||0
2242983|NCT02555371|5501699|P5|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
2242984|NCT02555371|5501700|P4|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
2242985|NCT02555371|5501701|P3|NOT COMPLETED|Part C (DB Period: Up to 52W)||48
2242986|NCT02555371|5501702|P2|NOT COMPLETED|Part C (DB Period: Up to 52W)||89
2242987|NCT02555371|5501703|P1|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
2242988|NCT02555371|5501699|P5|COMPLETED|Part C (DB Period: Up to 52W)||0
2242989|NCT02555371|5501700|P4|COMPLETED|Part C (DB Period: Up to 52W)||0
2242990|NCT02555371|5501701|P3|COMPLETED|Part C (DB Period: Up to 52W)||96
2242991|NCT02555371|5501702|P2|COMPLETED|Part C (DB Period: Up to 52W)||62
2242992|NCT02555371|5501703|P1|COMPLETED|Part C (DB Period: Up to 52W)||0
2242993|NCT02555371|5501699|P5|STARTED|Part C (DB Period: Up to 52W)||0
2242994|NCT02555371|5501700|P4|STARTED|Part C (DB Period: Up to 52W)||0
2242995|NCT02555371|5501701|P3|STARTED|Part C (DB Period: Up to 52W)||144
2242996|NCT02555371|5501702|P2|STARTED|Part C (DB Period: Up to 52W)||151
2242997|NCT02555371|5501703|P1|STARTED|Part C (DB Period: Up to 52W)||0
2242998|NCT02555371|5501699|P5|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
2242999|NCT02555371|5501700|P4|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
2243000|NCT02555371|5501701|P3|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
2243001|NCT02555371|5501702|P2|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
2243002|NCT02555371|5501703|P1|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||11
2243003|NCT02555371|5501699|P5|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
2243004|NCT02555371|5501700|P4|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
2243005|NCT02555371|5501701|P3|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
2243006|NCT02555371|5501702|P2|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
2243007|NCT02555371|5501703|P1|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||295
2243008|NCT02555371|5501699|P5|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
2243009|NCT02555371|5501700|P4|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
2243010|NCT02555371|5501701|P3|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
2243011|NCT02555371|5501702|P2|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
2243012|NCT02555371|5501703|P1|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||306
2243013|NCT02555306|5501722|P4|NOT COMPLETED|Overall Study||0
2243014|NCT02555306|5501723|P3|NOT COMPLETED|Overall Study||0
2243015|NCT02555306|5501724|P2|NOT COMPLETED|Overall Study||0
2243016|NCT02555306|5501725|P1|NOT COMPLETED|Overall Study||0
2243017|NCT02555306|5501722|P4|COMPLETED|Overall Study||3
2243018|NCT02555306|5501723|P3|COMPLETED|Overall Study||3
2243019|NCT02555306|5501724|P2|COMPLETED|Overall Study||3
2243020|NCT02555306|5501725|P1|COMPLETED|Overall Study||3
2243021|NCT02555306|5501722|P4|STARTED|Overall Study||3
2243022|NCT02555306|5501723|P3|STARTED|Overall Study||3
2243023|NCT02555306|5501724|P2|STARTED|Overall Study||3
2243024|NCT02555306|5501725|P1|STARTED|Overall Study||3
2243025|NCT02555228|5501741|P2|NOT COMPLETED|Overall Study||0
2243026|NCT02555228|5501742|P1|NOT COMPLETED|Overall Study||0
2243027|NCT02555228|5501741|P2|COMPLETED|Overall Study|29th October 2015|27
2243028|NCT02555228|5501742|P1|COMPLETED|Overall Study|19th November 2015|27
2243029|NCT02555228|5501741|P2|STARTED|Overall Study|14th August 2015|27
2243030|NCT02555228|5501742|P1|STARTED|Overall Study|20th August 2015|27
2243031|NCT02555215|5501754|P1|NOT COMPLETED|Overall Study||3
2243032|NCT02555215|5501754|P1|COMPLETED|Overall Study||17
2243033|NCT02555215|5501754|P1|STARTED|Overall Study||20
2243034|NCT02554981|5501765|P1|NOT COMPLETED|Overall Study||5
2243035|NCT02554981|5501765|P1|COMPLETED|Overall Study||46
2243036|NCT02554981|5501765|P1|STARTED|Overall Study||51
2243037|NCT02554929|5501791|P2|NOT COMPLETED|Overall Study||12
2243038|NCT02554929|5501792|P1|NOT COMPLETED|Overall Study||6
2243039|NCT02554929|5501791|P2|COMPLETED|Overall Study||32
2243040|NCT02554929|5501792|P1|COMPLETED|Overall Study||40
2243041|NCT02554929|5501791|P2|Per Protocol 6 Month Follow-up|Overall Study||32
2243042|NCT02554929|5501792|P1|Per Protocol 6 Month Follow-up|Overall Study||40
2243043|NCT02554929|5501791|P2|Per Protocol Post-Intervention|Overall Study||36
2243044|NCT02554929|5501792|P1|Per Protocol Post-Intervention|Overall Study||42
2243045|NCT02554929|5501791|P2|Per Protocol Received Intervention|Overall Study||36
2243046|NCT02554929|5501792|P1|Per Protocol Received Intervention|Overall Study||44
2243047|NCT02554929|5501791|P2|STARTED|Overall Study||44
2243048|NCT02554929|5501792|P1|STARTED|Overall Study||46
2243049|NCT02554890|5501810|P2|NOT COMPLETED|Open-label||52
2243050|NCT02554890|5501811|P1|NOT COMPLETED|Open-label||0
2243051|NCT02554890|5501810|P2|COMPLETED|Open-label||835
2243052|NCT02554890|5501811|P1|COMPLETED|Open-label||0
2243053|NCT02554890|5501810|P2|STARTED|Open-label||887
2243054|NCT02554890|5501811|P1|STARTED|Open-label||0
2243055|NCT02554890|5501810|P2|NOT COMPLETED|Double-blind||91
2243056|NCT02554890|5501811|P1|NOT COMPLETED|Double-blind||96
2243057|NCT02554890|5501810|P2|COMPLETED|Double-blind||352
2243058|NCT02554890|5501811|P1|COMPLETED|Double-blind||348
2243059|NCT02554890|5501810|P2|Treated Patients|Double-blind||439
2243060|NCT02554890|5501811|P1|Treated Patients|Double-blind||436
2243061|NCT02554890|5501810|P2|STARTED|Double-blind||443
2243062|NCT02554890|5501811|P1|STARTED|Double-blind||444
2243063|NCT02554877|5501839|P4|NOT COMPLETED|Overall Study||7
2243064|NCT02554877|5501840|P3|NOT COMPLETED|Overall Study||6
2243065|NCT02554877|5501841|P2|NOT COMPLETED|Overall Study||7
2243066|NCT02554877|5501842|P1|NOT COMPLETED|Overall Study||12
2243067|NCT02554877|5501839|P4|COMPLETED|Overall Study||45
2243068|NCT02554877|5501840|P3|COMPLETED|Overall Study||46
2243069|NCT02554877|5501841|P2|COMPLETED|Overall Study||44
2243070|NCT02554877|5501842|P1|COMPLETED|Overall Study||39
2243071|NCT02554877|5501839|P4|STARTED|Overall Study||52
2243072|NCT02554877|5501840|P3|STARTED|Overall Study||52
2243073|NCT02554877|5501841|P2|STARTED|Overall Study||51
2243074|NCT02554877|5501842|P1|STARTED|Overall Study||51
2243075|NCT02554799|5501906|P2|NOT COMPLETED|Overall Study||0
2243076|NCT02554799|5501907|P1|NOT COMPLETED|Overall Study||0
2243077|NCT02554799|5501906|P2|COMPLETED|Overall Study||9
2243078|NCT02554799|5501907|P1|COMPLETED|Overall Study||9
2243079|NCT02554799|5501906|P2|STARTED|Overall Study||9
2243080|NCT02554799|5501907|P1|STARTED|Overall Study||9
2243081|NCT02554682|5501935|P10|NOT COMPLETED|Overall Study||2
2243082|NCT02554682|5501936|P9|NOT COMPLETED|Overall Study||2
2243083|NCT02554682|5501937|P8|NOT COMPLETED|Overall Study||6
2243084|NCT02554682|5501938|P7|NOT COMPLETED|Overall Study||6
2243085|NCT02554682|5501939|P6|NOT COMPLETED|Overall Study||1
2243086|NCT02554682|5501940|P5|NOT COMPLETED|Overall Study||2
2243087|NCT02554682|5501941|P4|NOT COMPLETED|Overall Study||3
2243088|NCT02554682|5501942|P3|NOT COMPLETED|Overall Study||4
2243089|NCT02554682|5501943|P2|NOT COMPLETED|Overall Study||12
2243090|NCT02554682|5501944|P1|NOT COMPLETED|Overall Study||15
2243091|NCT02554682|5501935|P10|COMPLETED|Overall Study||24
2243092|NCT02554682|5501936|P9|COMPLETED|Overall Study||24
2243093|NCT02554682|5501937|P8|COMPLETED|Overall Study||22
2243094|NCT02554682|5501938|P7|COMPLETED|Overall Study||22
2243095|NCT02554682|5501939|P6|COMPLETED|Overall Study||39
2243096|NCT02554682|5501940|P5|COMPLETED|Overall Study||38
2243097|NCT02554682|5501941|P4|COMPLETED|Overall Study||37
2243098|NCT02554682|5501942|P3|COMPLETED|Overall Study||36
2243099|NCT02554682|5501943|P2|COMPLETED|Overall Study||28
2243100|NCT02554682|5501944|P1|COMPLETED|Overall Study||25
2243101|NCT02554682|5501935|P10|STARTED|Overall Study||26
2243102|NCT02554682|5501936|P9|STARTED|Overall Study||26
2243103|NCT02554682|5501937|P8|STARTED|Overall Study||28
2243104|NCT02554682|5501938|P7|STARTED|Overall Study||28
2243105|NCT02554682|5501939|P6|STARTED|Overall Study||40
2243106|NCT02554682|5501940|P5|STARTED|Overall Study||40
2243107|NCT02554682|5501941|P4|STARTED|Overall Study||40
2243108|NCT02554682|5501942|P3|STARTED|Overall Study||40
2243109|NCT02554682|5501943|P2|STARTED|Overall Study||40
2243110|NCT02554682|5501944|P1|STARTED|Overall Study||40
2243111|NCT02554656|5501993|P1|NOT COMPLETED|Overall Study||3
2243112|NCT02554656|5501993|P1|COMPLETED|Overall Study||86
2243113|NCT02554656|5501993|P1|STARTED|Overall Study||89
2243114|NCT02554435|5502003|P2|NOT COMPLETED|Overall Study||1
2243115|NCT02554435|5502004|P1|NOT COMPLETED|Overall Study||6
2243116|NCT02554435|5502003|P2|COMPLETED|Overall Study||19
2243117|NCT02554435|5502004|P1|COMPLETED|Overall Study||14
2243118|NCT02554435|5502003|P2|STARTED|Overall Study||20
2243119|NCT02554435|5502004|P1|STARTED|Overall Study||20
2243120|NCT02554279|5502038|P2|NOT COMPLETED|Overall Study||18
2243121|NCT02554279|5502039|P1|NOT COMPLETED|Overall Study||32
2243122|NCT02554279|5502038|P2|COMPLETED|Overall Study||291
2243123|NCT02554279|5502039|P1|COMPLETED|Overall Study||279
2243124|NCT02554279|5502038|P2|Completed Fresh Blastocyst Transfer|Overall Study||191
2243125|NCT02554279|5502039|P1|Completed Fresh Blastocyst Transfer|Overall Study||201
2243126|NCT02554279|5502038|P2|Completed Oocyte Retrieval|Overall Study||306
2243127|NCT02554279|5502039|P1|Completed Oocyte Retrieval|Overall Study||292
2243128|NCT02554279|5502038|P2|Received Trigger|Overall Study||307
2243129|NCT02554279|5502039|P1|Received Trigger|Overall Study||293
2243130|NCT02554279|5502038|P2|Completed Day 6 of Stimulation|Overall Study||309
2243131|NCT02554279|5502039|P1|Completed Day 6 of Stimulation|Overall Study||308
2243132|NCT02554279|5502038|P2|Treated|Overall Study||309
2243133|NCT02554279|5502039|P1|Treated|Overall Study||310
2243134|NCT02554279|5502038|P2|STARTED|Overall Study||309
2243135|NCT02554279|5502039|P1|STARTED|Overall Study||311
2243136|NCT02554019|5502074|P3|NOT COMPLETED|Overall Study||2
2243137|NCT02554019|5502075|P2|NOT COMPLETED|Overall Study||0
2243138|NCT02554019|5502076|P1|NOT COMPLETED|Overall Study||2
2243139|NCT02554019|5502074|P3|COMPLETED|Overall Study||10
2243140|NCT02554019|5502075|P2|COMPLETED|Overall Study||12
2243141|NCT02554019|5502076|P1|COMPLETED|Overall Study||10
2243142|NCT02554019|5502074|P3|STARTED|Overall Study||12
2243143|NCT02554019|5502075|P2|STARTED|Overall Study||12
2243144|NCT02554019|5502076|P1|STARTED|Overall Study||12
2243145|NCT02553928|5502098|P2|NOT COMPLETED|Overall Study||3
2243146|NCT02553928|5502099|P1|NOT COMPLETED|Overall Study||2
2243147|NCT02553928|5502098|P2|COMPLETED|Overall Study||29
2243148|NCT02553928|5502099|P1|COMPLETED|Overall Study||28
2243149|NCT02553928|5502098|P2|STARTED|Overall Study||32
2243150|NCT02553928|5502099|P1|STARTED|Overall Study||30
2243151|NCT02553915|5502111|P4|NOT COMPLETED|Overall Study||3
2243152|NCT02553915|5502112|P3|NOT COMPLETED|Overall Study||3
2243153|NCT02553915|5502113|P2|NOT COMPLETED|Overall Study||1
2243154|NCT02553915|5502114|P1|NOT COMPLETED|Overall Study||4
2243155|NCT02553915|5502111|P4|COMPLETED|Overall Study||13
2243156|NCT02553915|5502112|P3|COMPLETED|Overall Study||12
2243157|NCT02553915|5502113|P2|COMPLETED|Overall Study||14
2243158|NCT02553915|5502114|P1|COMPLETED|Overall Study||11
2243159|NCT02553915|5502111|P4|STARTED|Overall Study||16
2243160|NCT02553915|5502112|P3|STARTED|Overall Study||15
2243161|NCT02553915|5502113|P2|STARTED|Overall Study||15
2243162|NCT02553915|5502114|P1|STARTED|Overall Study||15
2243163|NCT02553798|5502144|P1|NOT COMPLETED|Overall Study||338
2243164|NCT02553798|5502144|P1|COMPLETED|Overall Study||226
2243165|NCT02553798|5502144|P1|STARTED|Overall Study||564
2243166|NCT02553772|5502153|P2|NOT COMPLETED|Overall Study||6
2243167|NCT02553772|5502154|P1|NOT COMPLETED|Overall Study||6
2243168|NCT02553772|5502153|P2|COMPLETED|Overall Study||116
2243169|NCT02553772|5502154|P1|COMPLETED|Overall Study||114
2243170|NCT02553772|5502153|P2|STARTED|Overall Study||122
2243171|NCT02553772|5502154|P1|STARTED|Overall Study||120
2243172|NCT02553746|5502170|P2|NOT COMPLETED|Overall Study||2
2243173|NCT02553746|5502171|P1|NOT COMPLETED|Overall Study||3
2243174|NCT02553746|5502170|P2|COMPLETED|Overall Study||64
2243175|NCT02553746|5502171|P1|COMPLETED|Overall Study||77
2243176|NCT02553746|5502170|P2|STARTED|Overall Study||66
2243177|NCT02553746|5502171|P1|STARTED|Overall Study||80
2243178|NCT02553629|5502199|P2|NOT COMPLETED|Overall Study||6
2243179|NCT02553629|5502200|P1|NOT COMPLETED|Overall Study||3
2243180|NCT02553629|5502199|P2|COMPLETED|Overall Study||50
2243181|NCT02553629|5502200|P1|COMPLETED|Overall Study||50
2243182|NCT02553629|5502199|P2|STARTED|Overall Study||56
2243183|NCT02553629|5502200|P1|STARTED|Overall Study||53
2243184|NCT02553538|5502216|P2|NOT COMPLETED|Overall Study||56
2243185|NCT02553538|5502217|P1|NOT COMPLETED|Overall Study||187
2243186|NCT02553538|5502216|P2|COMPLETED|Overall Study||764
2243187|NCT02553538|5502217|P1|COMPLETED|Overall Study||605
2243188|NCT02553538|5502216|P2|STARTED|Overall Study||820
2243189|NCT02553538|5502217|P1|STARTED|Overall Study||792
2243190|NCT02553512|5502229|P1|NOT COMPLETED|Overall Study||23
2243191|NCT02553512|5502229|P1|COMPLETED|Overall Study||144
2243192|NCT02553512|5502229|P1|STARTED|Overall Study||167
2243193|NCT02553499|5502251|P14|NOT COMPLETED|Overall Study||2
2243194|NCT02553499|5502252|P13|NOT COMPLETED|Overall Study||3
2243195|NCT02553499|5502253|P12|NOT COMPLETED|Overall Study||3
2243196|NCT02553499|5502254|P11|NOT COMPLETED|Overall Study||3
2243197|NCT02553499|5502255|P10|NOT COMPLETED|Overall Study||3
2243198|NCT02553499|5502256|P9|NOT COMPLETED|Overall Study||3
2243199|NCT02553499|5502257|P8|NOT COMPLETED|Overall Study||3
2243200|NCT02553499|5502258|P7|NOT COMPLETED|Overall Study||3
2243201|NCT02553499|5502259|P6|NOT COMPLETED|Overall Study||3
2243202|NCT02553499|5502260|P5|NOT COMPLETED|Overall Study||3
2243203|NCT02553499|5502261|P4|NOT COMPLETED|Overall Study||2
2243204|NCT02553499|5502262|P3|NOT COMPLETED|Overall Study||2
2243205|NCT02553499|5502263|P2|NOT COMPLETED|Overall Study||2
2243206|NCT02553499|5502264|P1|NOT COMPLETED|Overall Study||2
2243207|NCT02553499|5502251|P14|COMPLETED|Overall Study||0
2243208|NCT02553499|5502252|P13|COMPLETED|Overall Study||0
2243209|NCT02553499|5502253|P12|COMPLETED|Overall Study||0
2243210|NCT02553499|5502254|P11|COMPLETED|Overall Study||0
2243211|NCT02553499|5502255|P10|COMPLETED|Overall Study||0
2243212|NCT02553499|5502256|P9|COMPLETED|Overall Study||0
2243213|NCT02553499|5502257|P8|COMPLETED|Overall Study||0
2243214|NCT02553499|5502258|P7|COMPLETED|Overall Study||0
2243215|NCT02553499|5502259|P6|COMPLETED|Overall Study||0
2243216|NCT02553499|5502260|P5|COMPLETED|Overall Study||0
2243217|NCT02553499|5502261|P4|COMPLETED|Overall Study||0
2243218|NCT02553499|5502262|P3|COMPLETED|Overall Study||0
2243219|NCT02553499|5502263|P2|COMPLETED|Overall Study||0
2243220|NCT02553499|5502264|P1|COMPLETED|Overall Study||0
2243221|NCT02553499|5502251|P14|STARTED|Overall Study||2
2243222|NCT02553499|5502252|P13|STARTED|Overall Study||3
2243223|NCT02553499|5502253|P12|STARTED|Overall Study||3
2243224|NCT02553499|5502254|P11|STARTED|Overall Study||3
2243225|NCT02553499|5502255|P10|STARTED|Overall Study||3
2243226|NCT02553499|5502256|P9|STARTED|Overall Study||3
2243227|NCT02553499|5502257|P8|STARTED|Overall Study||3
2243228|NCT02553499|5502258|P7|STARTED|Overall Study||3
2243229|NCT02553499|5502259|P6|STARTED|Overall Study||3
2243230|NCT02553499|5502260|P5|STARTED|Overall Study||3
2243231|NCT02553499|5502261|P4|STARTED|Overall Study||2
2243232|NCT02553499|5502262|P3|STARTED|Overall Study||2
2243233|NCT02553499|5502263|P2|STARTED|Overall Study||2
2243234|NCT02553499|5502264|P1|STARTED|Overall Study||2
2243235|NCT02553421|5502366|P2|NOT COMPLETED|Overall Study||1
2243236|NCT02553421|5502367|P1|NOT COMPLETED|Overall Study||29
2243237|NCT02553421|5502366|P2|COMPLETED|Overall Study||57
2243238|NCT02553421|5502367|P1|COMPLETED|Overall Study||156
2243239|NCT02553421|5502366|P2|STARTED|Overall Study||58
2243240|NCT02553421|5502367|P1|STARTED|Overall Study||185
2243241|NCT02553317|5502377|P2|NOT COMPLETED|Open-label (OL) Treatment Period||4
2243242|NCT02553317|5502378|P1|NOT COMPLETED|Open-label (OL) Treatment Period||0
2243243|NCT02553317|5502377|P2|COMPLETED|Open-label (OL) Treatment Period||22
2243244|NCT02553317|5502378|P1|COMPLETED|Open-label (OL) Treatment Period||2
2243245|NCT02553317|5502377|P2|STARTED|Open-label (OL) Treatment Period|26 patients on placebo had a recurrence of TTP during the DB period and started OL treatment.|26
2243334|NCT02552121|5502544|P1|NOT COMPLETED|Part 2: Cohort Expansion||0
2243246|NCT02553317|5502378|P1|STARTED|Open-label (OL) Treatment Period|2 patients on caplacizumab had a recurrence of TTP during the DB period and started OL treatment.|2
2243247|NCT02553317|5502377|P2|NOT COMPLETED|Double-blind (DB) Treatment Period||8
2243248|NCT02553317|5502378|P1|NOT COMPLETED|Double-blind (DB) Treatment Period||3
2243249|NCT02553317|5502377|P2|COMPLETED|Double-blind (DB) Treatment Period||65
2243250|NCT02553317|5502378|P1|COMPLETED|Double-blind (DB) Treatment Period||68
2243251|NCT02553317|5502377|P2|STARTED|Double-blind (DB) Treatment Period||73
2243252|NCT02553317|5502378|P1|STARTED|Double-blind (DB) Treatment Period|One patient withdrew consent prior to first dosing and did not start the DB treatment period.|71
2243253|NCT02553317|5502377|P2|NOT COMPLETED|Overall Treatment Period + Follow-up||23
2243254|NCT02553317|5502378|P1|NOT COMPLETED|Overall Treatment Period + Follow-up||14
2243255|NCT02553317|5502377|P2|COMPLETED|Overall Treatment Period + Follow-up||50
2243256|NCT02553317|5502378|P1|COMPLETED|Overall Treatment Period + Follow-up||58
2243257|NCT02553317|5502377|P2|Received Study Drug|Overall Treatment Period + Follow-up||73
2243258|NCT02553317|5502378|P1|Received Study Drug|Overall Treatment Period + Follow-up||71
2243259|NCT02553317|5502377|P2|STARTED|Overall Treatment Period + Follow-up||73
2243260|NCT02553317|5502378|P1|STARTED|Overall Treatment Period + Follow-up||72
2243261|NCT02553135|5502401|P1|NOT COMPLETED|Overall Study||0
2243262|NCT02553135|5502401|P1|COMPLETED|Overall Study||6
2243263|NCT02553135|5502401|P1|STARTED|Overall Study||6
2243264|NCT02552810|5502410|P2|NOT COMPLETED|Overall Study||0
2243265|NCT02552810|5502411|P1|NOT COMPLETED|Overall Study||0
2243266|NCT02552810|5502410|P2|COMPLETED|Overall Study||15
2243267|NCT02552810|5502411|P1|COMPLETED|Overall Study||15
2243268|NCT02552810|5502410|P2|STARTED|Overall Study||15
2243269|NCT02552810|5502411|P1|STARTED|Overall Study||15
2243270|NCT02552368|5502427|P1|NOT COMPLETED|Overall Study||13
2243271|NCT02552368|5502427|P1|COMPLETED|Overall Study||10
2243272|NCT02552368|5502427|P1|STARTED|Overall Study||23
2243273|NCT02552355|5502436|P4|NOT COMPLETED|Overall Study||1
2243274|NCT02552355|5502437|P3|NOT COMPLETED|Overall Study||2
2243275|NCT02552355|5502438|P2|NOT COMPLETED|Overall Study||2
2243276|NCT02552355|5502439|P1|NOT COMPLETED|Overall Study||0
2243277|NCT02552355|5502436|P4|COMPLETED|Overall Study||14
2243278|NCT02552355|5502437|P3|COMPLETED|Overall Study||12
2243279|NCT02552355|5502438|P2|COMPLETED|Overall Study||11
2243280|NCT02552355|5502439|P1|COMPLETED|Overall Study||14
2243281|NCT02552355|5502436|P4|STARTED|Overall Study||15
2243282|NCT02552355|5502437|P3|STARTED|Overall Study||14
2243283|NCT02552355|5502438|P2|STARTED|Overall Study||13
2243284|NCT02552355|5502439|P1|STARTED|Overall Study||14
2243285|NCT02552303|5502485|P4|NOT COMPLETED|Follow-Up||0
2243286|NCT02552303|5502486|P3|NOT COMPLETED|Follow-Up||1
2243287|NCT02552303|5502487|P2|NOT COMPLETED|Follow-Up||2
2243288|NCT02552303|5502488|P1|NOT COMPLETED|Follow-Up||0
2243289|NCT02552303|5502485|P4|COMPLETED|Follow-Up||10
2243290|NCT02552303|5502486|P3|COMPLETED|Follow-Up||6
2243291|NCT02552303|5502487|P2|COMPLETED|Follow-Up||6
2243292|NCT02552303|5502488|P1|COMPLETED|Follow-Up||7
2243293|NCT02552303|5502485|P4|STARTED|Follow-Up||10
2243294|NCT02552303|5502486|P3|STARTED|Follow-Up||7
2243295|NCT02552303|5502487|P2|STARTED|Follow-Up||8
2243296|NCT02552303|5502488|P1|STARTED|Follow-Up||7
2243297|NCT02552303|5502485|P4|NOT COMPLETED|Allocation||1
2243298|NCT02552303|5502486|P3|NOT COMPLETED|Allocation||1
2243299|NCT02552303|5502487|P2|NOT COMPLETED|Allocation||2
2243300|NCT02552303|5502488|P1|NOT COMPLETED|Allocation||3
2243301|NCT02552303|5502485|P4|COMPLETED|Allocation||10
2243302|NCT02552303|5502486|P3|COMPLETED|Allocation||7
2243303|NCT02552303|5502487|P2|COMPLETED|Allocation||8
2243304|NCT02552303|5502488|P1|COMPLETED|Allocation||7
2243305|NCT02552303|5502485|P4|STARTED|Allocation||11
2243306|NCT02552303|5502486|P3|STARTED|Allocation||8
2243307|NCT02552303|5502487|P2|STARTED|Allocation||10
2243308|NCT02552303|5502488|P1|STARTED|Allocation||10
2243309|NCT02552147|5502502|P2|NOT COMPLETED|Second Intervention (7 Days)||0
2243310|NCT02552147|5502503|P1|NOT COMPLETED|Second Intervention (7 Days)||2
2243311|NCT02552147|5502502|P2|COMPLETED|Second Intervention (7 Days)||4
2243312|NCT02552147|5502503|P1|COMPLETED|Second Intervention (7 Days)||1
2243313|NCT02552147|5502502|P2|STARTED|Second Intervention (7 Days)||4
2243314|NCT02552147|5502503|P1|STARTED|Second Intervention (7 Days)||3
2243315|NCT02552147|5502502|P2|NOT COMPLETED|Washout (7 Days)||0
2243316|NCT02552147|5502503|P1|NOT COMPLETED|Washout (7 Days)||0
2243317|NCT02552147|5502502|P2|COMPLETED|Washout (7 Days)||4
2243318|NCT02552147|5502503|P1|COMPLETED|Washout (7 Days)||3
2243319|NCT02552147|5502502|P2|STARTED|Washout (7 Days)||4
2243320|NCT02552147|5502503|P1|STARTED|Washout (7 Days)||3
2243321|NCT02552147|5502502|P2|NOT COMPLETED|First Intervention (7 Days)||0
2243322|NCT02552147|5502503|P1|NOT COMPLETED|First Intervention (7 Days)||1
2243323|NCT02552147|5502502|P2|COMPLETED|First Intervention (7 Days)||4
2243324|NCT02552147|5502503|P1|COMPLETED|First Intervention (7 Days)||3
2243325|NCT02552147|5502502|P2|STARTED|First Intervention (7 Days)||4
2243326|NCT02552147|5502503|P1|STARTED|First Intervention (7 Days)||4
2243327|NCT02552121|5502537|P8|NOT COMPLETED|Part 2: Cohort Expansion||3
2243328|NCT02552121|5502538|P7|NOT COMPLETED|Part 2: Cohort Expansion||1
2243329|NCT02552121|5502539|P6|NOT COMPLETED|Part 2: Cohort Expansion||4
2243330|NCT02552121|5502540|P5|NOT COMPLETED|Part 2: Cohort Expansion||1
2243331|NCT02552121|5502541|P4|NOT COMPLETED|Part 2: Cohort Expansion||3
2243332|NCT02552121|5502542|P3|NOT COMPLETED|Part 2: Cohort Expansion||11
2243333|NCT02552121|5502543|P2|NOT COMPLETED|Part 2: Cohort Expansion||0
2243335|NCT02552121|5502537|P8|COMPLETED|Part 2: Cohort Expansion||0
2243336|NCT02552121|5502538|P7|COMPLETED|Part 2: Cohort Expansion||0
2243337|NCT02552121|5502539|P6|COMPLETED|Part 2: Cohort Expansion||1
2243338|NCT02552121|5502540|P5|COMPLETED|Part 2: Cohort Expansion||0
2243339|NCT02552121|5502541|P4|COMPLETED|Part 2: Cohort Expansion||0
2243340|NCT02552121|5502542|P3|COMPLETED|Part 2: Cohort Expansion||0
2243341|NCT02552121|5502543|P2|COMPLETED|Part 2: Cohort Expansion||0
2243342|NCT02552121|5502544|P1|COMPLETED|Part 2: Cohort Expansion||0
2243343|NCT02552121|5502537|P8|STARTED|Part 2: Cohort Expansion||3
2243344|NCT02552121|5502538|P7|STARTED|Part 2: Cohort Expansion||1
2243345|NCT02552121|5502539|P6|STARTED|Part 2: Cohort Expansion||5
2243346|NCT02552121|5502540|P5|STARTED|Part 2: Cohort Expansion||1
2243347|NCT02552121|5502541|P4|STARTED|Part 2: Cohort Expansion||3
2243348|NCT02552121|5502542|P3|STARTED|Part 2: Cohort Expansion||11
2243349|NCT02552121|5502543|P2|STARTED|Part 2: Cohort Expansion||0
2243350|NCT02552121|5502544|P1|STARTED|Part 2: Cohort Expansion||0
2243351|NCT02552121|5502537|P8|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
2243352|NCT02552121|5502538|P7|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
2243353|NCT02552121|5502539|P6|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
2243354|NCT02552121|5502540|P5|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
2243355|NCT02552121|5502541|P4|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
2243356|NCT02552121|5502542|P3|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
2243357|NCT02552121|5502543|P2|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||6
2243358|NCT02552121|5502544|P1|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
2243359|NCT02552121|5502537|P8|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
2243360|NCT02552121|5502538|P7|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
2243361|NCT02552121|5502539|P6|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
2243362|NCT02552121|5502540|P5|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
2243363|NCT02552121|5502541|P4|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
2243364|NCT02552121|5502542|P3|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
2243365|NCT02552121|5502543|P2|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
2243366|NCT02552121|5502544|P1|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
2243367|NCT02552121|5502537|P8|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
2243368|NCT02552121|5502538|P7|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
2243369|NCT02552121|5502539|P6|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
2243370|NCT02552121|5502540|P5|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
2243371|NCT02552121|5502541|P4|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
2243372|NCT02552121|5502542|P3|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
2243373|NCT02552121|5502543|P2|STARTED|Part 1: Dose Level 2 (Week 17-48)||6
2243374|NCT02552121|5502544|P1|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
2243375|NCT02552121|5502537|P8|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
2243376|NCT02552121|5502538|P7|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
2243377|NCT02552121|5502539|P6|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
2243378|NCT02552121|5502540|P5|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
2243379|NCT02552121|5502541|P4|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
2243380|NCT02552121|5502542|P3|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
2243381|NCT02552121|5502543|P2|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
2243382|NCT02552121|5502544|P1|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||3
2243383|NCT02552121|5502537|P8|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
2243384|NCT02552121|5502538|P7|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
2243385|NCT02552121|5502539|P6|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
2243386|NCT02552121|5502540|P5|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
2243387|NCT02552121|5502541|P4|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
2243388|NCT02552121|5502542|P3|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
2243389|NCT02552121|5502543|P2|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
2243390|NCT02552121|5502544|P1|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
2243391|NCT02552121|5502537|P8|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
2243392|NCT02552121|5502538|P7|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
2243393|NCT02552121|5502539|P6|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
2243394|NCT02552121|5502540|P5|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
2243395|NCT02552121|5502541|P4|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
2243396|NCT02552121|5502542|P3|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
2243397|NCT02552121|5502543|P2|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
2243398|NCT02552121|5502544|P1|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||3
2243399|NCT02551887|5502790|P3|NOT COMPLETED|Overall Study||0
2243400|NCT02551887|5502791|P2|NOT COMPLETED|Overall Study||0
2243401|NCT02551887|5502792|P1|NOT COMPLETED|Overall Study||0
2243402|NCT02551887|5502790|P3|COMPLETED|Overall Study||222
2243403|NCT02551887|5502791|P2|COMPLETED|Overall Study||124
2243404|NCT02551887|5502792|P1|COMPLETED|Overall Study||301
2243405|NCT02551887|5502790|P3|STARTED|Overall Study||222
2243406|NCT02551887|5502791|P2|STARTED|Overall Study||124
2243407|NCT02551887|5502792|P1|STARTED|Overall Study||301
2243408|NCT02551874|5502805|P2|NOT COMPLETED|Overall Study||39
2243409|NCT02551874|5502806|P1|NOT COMPLETED|Overall Study||28
2243410|NCT02551874|5502805|P2|COMPLETED|Overall Study||287
2243411|NCT02551874|5502806|P1|COMPLETED|Overall Study||296
2243412|NCT02551874|5502805|P2|Received Treatment in Long-term Study|Overall Study||284
2243413|NCT02551874|5502806|P1|Received Treatment in Long-term Study|Overall Study||295
2243414|NCT02551874|5502805|P2|Entered Long-term Study|Overall Study||294
2243415|NCT02551874|5502806|P1|Entered Long-term Study|Overall Study||306
2243416|NCT02551874|5502805|P2|Received Treatment in Short-term Study|Overall Study||319
2243417|NCT02551874|5502806|P1|Received Treatment in Short-term Study|Overall Study||324
2243418|NCT02551874|5502805|P2|STARTED|Overall Study||326
2243419|NCT02551874|5502806|P1|STARTED|Overall Study||324
2243420|NCT02551822|5502824|P2|NOT COMPLETED|Overall Study||2
2243421|NCT02551822|5502825|P1|NOT COMPLETED|Overall Study||2
2243422|NCT02551822|5502824|P2|COMPLETED|Overall Study||10
2243423|NCT02551822|5502825|P1|COMPLETED|Overall Study||9
2243424|NCT02551822|5502824|P2|STARTED|Overall Study||12
2243425|NCT02551822|5502825|P1|STARTED|Overall Study||11
2243426|NCT02551809|5502838|P3|NOT COMPLETED|Overall Study||1
2243427|NCT02551809|5502839|P2|NOT COMPLETED|Overall Study||1
2243428|NCT02551809|5502840|P1|NOT COMPLETED|Overall Study||0
2243429|NCT02551809|5502838|P3|COMPLETED|Overall Study||13
2243430|NCT02551809|5502839|P2|COMPLETED|Overall Study||14
2243431|NCT02551809|5502840|P1|COMPLETED|Overall Study||14
2243432|NCT02551809|5502838|P3|STARTED|Overall Study||14
2243433|NCT02551809|5502839|P2|STARTED|Overall Study||15
2243434|NCT02551809|5502840|P1|STARTED|Overall Study||14
2243435|NCT02551770|5502848|P2|NOT COMPLETED|Overall Study||3
2243436|NCT02551770|5502849|P1|NOT COMPLETED|Overall Study||3
2243437|NCT02551770|5502848|P2|COMPLETED|Overall Study||48
2243438|NCT02551770|5502849|P1|COMPLETED|Overall Study||48
2243439|NCT02551770|5502848|P2|STARTED|Overall Study||51
2243440|NCT02551770|5502849|P1|STARTED|Overall Study||51
2243441|NCT02551744|5502868|P2|NOT COMPLETED|Overall Study||0
2243442|NCT02551744|5502869|P1|NOT COMPLETED|Overall Study||0
2243443|NCT02551744|5502868|P2|COMPLETED|Overall Study||51
2243444|NCT02551744|5502869|P1|COMPLETED|Overall Study||50
2243445|NCT02551744|5502868|P2|STARTED|Overall Study||51
2243446|NCT02551744|5502869|P1|STARTED|Overall Study||50
2243447|NCT02551731|5502875|P1|NOT COMPLETED|Overall Study||2
2243448|NCT02551731|5502875|P1|COMPLETED|Overall Study||7
2243449|NCT02551731|5502875|P1|STARTED|Overall Study||9
2243450|NCT02551692|5502895|P3|NOT COMPLETED|Overall Study||5
2243451|NCT02551692|5502896|P2|NOT COMPLETED|Overall Study||1
2243452|NCT02551692|5502897|P1|NOT COMPLETED|Overall Study||1
2243453|NCT02551692|5502895|P3|COMPLETED|Overall Study||25
2243454|NCT02551692|5502896|P2|COMPLETED|Overall Study||26
2243455|NCT02551692|5502897|P1|COMPLETED|Overall Study||30
2243456|NCT02551692|5502895|P3|STARTED|Overall Study||30
2243457|NCT02551692|5502896|P2|STARTED|Overall Study||27
2243458|NCT02551692|5502897|P1|STARTED|Overall Study||31
2243459|NCT02551653|5502913|P2|NOT COMPLETED|Overall Study||0
2243460|NCT02551653|5502914|P1|NOT COMPLETED|Overall Study||0
2243461|NCT02551653|5502913|P2|COMPLETED|Overall Study||5
2243462|NCT02551653|5502914|P1|COMPLETED|Overall Study||5
2243463|NCT02551653|5502913|P2|STARTED|Overall Study||5
2243464|NCT02551653|5502914|P1|STARTED|Overall Study||5
2243465|NCT02551432|5502922|P1|NOT COMPLETED|Overall Study||0
2243466|NCT02551432|5502922|P1|COMPLETED|Overall Study||26
2243467|NCT02551432|5502922|P1|STARTED|Overall Study||26
2243468|NCT02551224|5502928|P2|NOT COMPLETED|Second Intervention (5 Min After First )||0
2243469|NCT02551224|5502929|P1|NOT COMPLETED|Second Intervention (5 Min After First )||0
2243470|NCT02551224|5502928|P2|COMPLETED|Second Intervention (5 Min After First )||50
2243471|NCT02551224|5502929|P1|COMPLETED|Second Intervention (5 Min After First )||50
2243472|NCT02551224|5502928|P2|STARTED|Second Intervention (5 Min After First )||50
2243473|NCT02551224|5502929|P1|STARTED|Second Intervention (5 Min After First )||50
2243474|NCT02551224|5502928|P2|NOT COMPLETED|First Intervention||0
2243475|NCT02551224|5502929|P1|NOT COMPLETED|First Intervention||0
2243476|NCT02551224|5502928|P2|COMPLETED|First Intervention||50
2243477|NCT02551224|5502929|P1|COMPLETED|First Intervention||50
2243478|NCT02551224|5502928|P2|STARTED|First Intervention||50
2243479|NCT02551224|5502929|P1|STARTED|First Intervention||50
2243480|NCT02551055|5502944|P8|NOT COMPLETED|Overall Study||0
2243481|NCT02551055|5502945|P7|NOT COMPLETED|Overall Study||3
2243482|NCT02551055|5502946|P6|NOT COMPLETED|Overall Study||1
2243483|NCT02551055|5502947|P5|NOT COMPLETED|Overall Study||7
2243484|NCT02551055|5502948|P4|NOT COMPLETED|Overall Study||5
2243485|NCT02551055|5502949|P3|NOT COMPLETED|Overall Study||2
2243486|NCT02551055|5502950|P2|NOT COMPLETED|Overall Study||6
2243487|NCT02551055|5502951|P1|NOT COMPLETED|Overall Study||4
2243488|NCT02551055|5502944|P8|COMPLETED|Overall Study||0
2243489|NCT02551055|5502945|P7|COMPLETED|Overall Study||1
2243490|NCT02551055|5502946|P6|COMPLETED|Overall Study||1
2243491|NCT02551055|5502947|P5|COMPLETED|Overall Study||0
2243492|NCT02551055|5502948|P4|COMPLETED|Overall Study||1
2243493|NCT02551055|5502949|P3|COMPLETED|Overall Study||1
2243494|NCT02551055|5502950|P2|COMPLETED|Overall Study||0
2243495|NCT02551055|5502951|P1|COMPLETED|Overall Study||0
2243496|NCT02551055|5502944|P8|STARTED|Overall Study||0
2243497|NCT02551055|5502945|P7|STARTED|Overall Study||4
2243498|NCT02551055|5502946|P6|STARTED|Overall Study||2
2243499|NCT02551055|5502947|P5|STARTED|Overall Study||7
2243500|NCT02551055|5502948|P4|STARTED|Overall Study||6
2243501|NCT02551055|5502949|P3|STARTED|Overall Study||3
2243502|NCT02551055|5502950|P2|STARTED|Overall Study||6
2243503|NCT02551055|5502951|P1|STARTED|Overall Study||4
2243504|NCT02550873|5503026|P3|NOT COMPLETED|Open Label Extension||111
2243505|NCT02550873|5503027|P2|NOT COMPLETED|Open Label Extension||0
2243506|NCT02550873|5503028|P1|NOT COMPLETED|Open Label Extension||0
2243507|NCT02550873|5503026|P3|COMPLETED|Open Label Extension|Open Label extension is ongoing|0
2243508|NCT02550873|5503027|P2|COMPLETED|Open Label Extension||0
2243509|NCT02550873|5503028|P1|COMPLETED|Open Label Extension||0
2243510|NCT02550873|5503026|P3|STARTED|Open Label Extension||111
2243511|NCT02550873|5503027|P2|STARTED|Open Label Extension||0
2243512|NCT02550873|5503028|P1|STARTED|Open Label Extension||0
2243513|NCT02550873|5503026|P3|NOT COMPLETED|Randomized Double Blind||0
2243514|NCT02550873|5503027|P2|NOT COMPLETED|Randomized Double Blind||2
2243515|NCT02550873|5503028|P1|NOT COMPLETED|Randomized Double Blind||4
2243516|NCT02550873|5503026|P3|COMPLETED|Randomized Double Blind||0
2243517|NCT02550873|5503027|P2|COMPLETED|Randomized Double Blind||37
2243518|NCT02550873|5503028|P1|COMPLETED|Randomized Double Blind||74
2243519|NCT02550873|5503026|P3|Continue to Open Label Extension|Randomized Double Blind||0
2243520|NCT02550873|5503027|P2|Continue to Open Label Extension|Randomized Double Blind||37
2243521|NCT02550873|5503028|P1|Continue to Open Label Extension|Randomized Double Blind||74
2243522|NCT02550873|5503026|P3|Received Treatment|Randomized Double Blind||0
2243523|NCT02550873|5503027|P2|Received Treatment|Randomized Double Blind||39
2243524|NCT02550873|5503028|P1|Received Treatment|Randomized Double Blind||77
2243525|NCT02550873|5503026|P3|STARTED|Randomized Double Blind||0
2243526|NCT02550873|5503027|P2|STARTED|Randomized Double Blind||39
2243527|NCT02550873|5503028|P1|STARTED|Randomized Double Blind||78
2243528|NCT02550288|5503111|P5|NOT COMPLETED|Overall Study||3
2243529|NCT02550288|5503112|P4|NOT COMPLETED|Overall Study||3
2243530|NCT02550288|5503113|P3|NOT COMPLETED|Overall Study||1
2243531|NCT02550288|5503114|P2|NOT COMPLETED|Overall Study||3
2243532|NCT02550288|5503115|P1|NOT COMPLETED|Overall Study||2
2243533|NCT02550288|5503111|P5|COMPLETED|Overall Study||66
2243534|NCT02550288|5503112|P4|COMPLETED|Overall Study||65
2243535|NCT02550288|5503113|P3|COMPLETED|Overall Study||68
2243536|NCT02550288|5503114|P2|COMPLETED|Overall Study||65
2243537|NCT02550288|5503115|P1|COMPLETED|Overall Study||33
2243538|NCT02550288|5503111|P5|STARTED|Overall Study||69
2243539|NCT02550288|5503112|P4|STARTED|Overall Study||68
2243540|NCT02550288|5503113|P3|STARTED|Overall Study||69
2243541|NCT02550288|5503114|P2|STARTED|Overall Study||68
2243542|NCT02550288|5503115|P1|STARTED|Overall Study||35
2243543|NCT02550210|5503212|P1|NOT COMPLETED|Overall Study||4
2243544|NCT02550210|5503212|P1|COMPLETED|Overall Study||19
2243545|NCT02550210|5503212|P1|STARTED|Overall Study||23
2243546|NCT02550197|5503221|P2|NOT COMPLETED|Overall Study||0
2243547|NCT02550197|5503222|P1|NOT COMPLETED|Overall Study||0
2243548|NCT02550197|5503221|P2|COMPLETED|Overall Study||100
2243549|NCT02550197|5503222|P1|COMPLETED|Overall Study||200
2243550|NCT02550197|5503221|P2|STARTED|Overall Study||100
2243551|NCT02550197|5503222|P1|STARTED|Overall Study||200
2243552|NCT02550132|5503240|P1|NOT COMPLETED|Overall Study||0
2243553|NCT02550132|5503240|P1|COMPLETED|Overall Study||25
2243554|NCT02550132|5503240|P1|STARTED|Overall Study||25
2243558|NCT02549755|5503295|P1|NOT COMPLETED|Overall Study||1
2243559|NCT02549755|5503295|P1|COMPLETED|Overall Study||0
2243560|NCT02549755|5503295|P1|STARTED|Overall Study||1
2243561|NCT02549716|5503301|P2|NOT COMPLETED|Overall Study||0
2243562|NCT02549716|5503302|P1|NOT COMPLETED|Overall Study||0
2243563|NCT02549716|5503301|P2|COMPLETED|Overall Study||2
2243564|NCT02549716|5503302|P1|COMPLETED|Overall Study||1
2243565|NCT02549716|5503301|P2|STARTED|Overall Study||2
2243566|NCT02549716|5503302|P1|STARTED|Overall Study||1
2243567|NCT02549573|5503316|P2|NOT COMPLETED|Overall Study||3
2243568|NCT02549573|5503317|P1|NOT COMPLETED|Overall Study||0
2243569|NCT02549573|5503316|P2|COMPLETED|Overall Study||4
2243570|NCT02549573|5503317|P1|COMPLETED|Overall Study||6
2243571|NCT02549573|5503316|P2|STARTED|Overall Study||7
2243572|NCT02549573|5503317|P1|STARTED|Overall Study||6
2243573|NCT02549365|5503361|P2|NOT COMPLETED|Overall Study||0
2243574|NCT02549365|5503362|P1|NOT COMPLETED|Overall Study||0
2243575|NCT02549365|5503361|P2|COMPLETED|Overall Study||112
2243576|NCT02549365|5503362|P1|COMPLETED|Overall Study||164
2243577|NCT02549365|5503361|P2|STARTED|Overall Study||112
2243578|NCT02549365|5503362|P1|STARTED|Overall Study||164
2243579|NCT02549352|5503371|P2|NOT COMPLETED|12-month Follow-up||12
2243580|NCT02549352|5503372|P1|NOT COMPLETED|12-month Follow-up||8
2243581|NCT02549352|5503371|P2|COMPLETED|12-month Follow-up||81
2243582|NCT02549352|5503372|P1|COMPLETED|12-month Follow-up||199
2243583|NCT02549352|5503371|P2|STARTED|12-month Follow-up||93
2243584|NCT02549352|5503372|P1|STARTED|12-month Follow-up||207
2243585|NCT02549352|5503371|P2|NOT COMPLETED|3-day Treatment and 8-week Follow-up||6
2243586|NCT02549352|5503372|P1|NOT COMPLETED|3-day Treatment and 8-week Follow-up||2
2243587|NCT02549352|5503371|P2|COMPLETED|3-day Treatment and 8-week Follow-up||96
2243588|NCT02549352|5503372|P1|COMPLETED|3-day Treatment and 8-week Follow-up||207
2243589|NCT02549352|5503371|P2|Treated|3-day Treatment and 8-week Follow-up|1 participant was included in 0.037% in the safety analysis set as they received both IMPs in error|101
2243590|NCT02549352|5503372|P1|Treated|3-day Treatment and 8-week Follow-up||209
2243591|NCT02549352|5503371|P2|STARTED|3-day Treatment and 8-week Follow-up||102
2243592|NCT02549352|5503372|P1|STARTED|3-day Treatment and 8-week Follow-up||209
2243593|NCT02549339|5503388|P2|NOT COMPLETED|12-month Follow-up||11
2243594|NCT02549339|5503389|P1|NOT COMPLETED|12-month Follow-up||9
2243595|NCT02549339|5503388|P2|COMPLETED|12-month Follow-up||87
2243596|NCT02549339|5503389|P1|COMPLETED|12-month Follow-up||192
2243597|NCT02549339|5503388|P2|STARTED|12-month Follow-up||98
2243598|NCT02549339|5503389|P1|STARTED|12-month Follow-up||201
2243599|NCT02549339|5503388|P2|NOT COMPLETED|3-day Treatment and 8-week Follow-up||5
2243600|NCT02549339|5503389|P1|NOT COMPLETED|3-day Treatment and 8-week Follow-up||4
2243601|NCT02549339|5503388|P2|COMPLETED|3-day Treatment and 8-week Follow-up||99
2243602|NCT02549339|5503389|P1|COMPLETED|3-day Treatment and 8-week Follow-up||201
2243603|NCT02549339|5503388|P2|Treated|3-day Treatment and 8-week Follow-up||104
2243604|NCT02549339|5503389|P1|Treated|3-day Treatment and 8-week Follow-up||202
2243605|NCT02549339|5503388|P2|STARTED|3-day Treatment and 8-week Follow-up||104
2243606|NCT02549339|5503389|P1|STARTED|3-day Treatment and 8-week Follow-up||205
2243607|NCT02549287|5503405|P2|NOT COMPLETED|Overall Study||32
2243608|NCT02549287|5503406|P1|NOT COMPLETED|Overall Study||80
2243609|NCT02549287|5503405|P2|COMPLETED|Overall Study||64
2243610|NCT02549287|5503406|P1|COMPLETED|Overall Study||113
2243611|NCT02549287|5503405|P2|STARTED|Overall Study||96
2243612|NCT02549287|5503406|P1|STARTED|Overall Study||193
2243613|NCT02549196|5503440|P4|NOT COMPLETED|Overall Study||1
2243614|NCT02549196|5503441|P3|NOT COMPLETED|Overall Study||1
2243615|NCT02549196|5503442|P2|NOT COMPLETED|Overall Study||0
2243616|NCT02549196|5503443|P1|NOT COMPLETED|Overall Study||1
2243617|NCT02549196|5503440|P4|COMPLETED|Overall Study||12
2243618|NCT02549196|5503441|P3|COMPLETED|Overall Study||5
2243619|NCT02549196|5503442|P2|COMPLETED|Overall Study||1
2243620|NCT02549196|5503443|P1|COMPLETED|Overall Study||7
2243621|NCT02549196|5503440|P4|STARTED|Overall Study||13
2243622|NCT02549196|5503441|P3|STARTED|Overall Study||6
2243623|NCT02549196|5503442|P2|STARTED|Overall Study||1
2243624|NCT02549196|5503443|P1|STARTED|Overall Study||8
2243625|NCT02549040|5503457|P1|NOT COMPLETED|Period 5||0
2243626|NCT02549040|5503457|P1|COMPLETED|Period 5||16
2243627|NCT02549040|5503457|P1|STARTED|Period 5||16
2243628|NCT02549040|5503457|P1|NOT COMPLETED|Period 4||0
2243629|NCT02549040|5503457|P1|COMPLETED|Period 4||16
2243630|NCT02549040|5503457|P1|STARTED|Period 4||16
2243631|NCT02549040|5503457|P1|NOT COMPLETED|Period 3||0
2243632|NCT02549040|5503457|P1|COMPLETED|Period 3||16
2243633|NCT02549040|5503457|P1|STARTED|Period 3||16
2243634|NCT02549040|5503457|P1|NOT COMPLETED|Period 2||0
2243635|NCT02549040|5503457|P1|COMPLETED|Period 2||16
2243636|NCT02549040|5503457|P1|STARTED|Period 2||16
2243637|NCT02549040|5503457|P1|NOT COMPLETED|Period 1||0
2243638|NCT02549040|5503457|P1|COMPLETED|Period 1||16
2243639|NCT02549040|5503457|P1|STARTED|Period 1||16
2243640|NCT02549027|5503499|P6|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
2243641|NCT02549027|5503500|P5|NOT COMPLETED|Period 5 - MK-6096 or Placebo||2
2243642|NCT02549027|5503501|P4|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
2243643|NCT02549027|5503502|P3|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
2243644|NCT02549027|5503503|P2|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
2243645|NCT02549027|5503504|P1|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
2243646|NCT02549027|5503499|P6|COMPLETED|Period 5 - MK-6096 or Placebo||1
2243647|NCT02549027|5503500|P5|COMPLETED|Period 5 - MK-6096 or Placebo|The 2 participants who did not complete Period 5 did not receive study drug in Period 5|14
2243648|NCT02549027|5503501|P4|COMPLETED|Period 5 - MK-6096 or Placebo||0
2243649|NCT02549027|5503502|P3|COMPLETED|Period 5 - MK-6096 or Placebo||0
2243650|NCT02549027|5503503|P2|COMPLETED|Period 5 - MK-6096 or Placebo||0
2243651|NCT02549027|5503504|P1|COMPLETED|Period 5 - MK-6096 or Placebo||0
2243652|NCT02549027|5503499|P6|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|1
2243653|NCT02549027|5503500|P5|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|16
2243654|NCT02549027|5503501|P4|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
2243655|NCT02549027|5503502|P3|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
2243656|NCT02549027|5503503|P2|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
2243657|NCT02549027|5503504|P1|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg/Placebo (Period 5) arms|0
2243658|NCT02549027|5503499|P6|NOT COMPLETED|Washout After Period 4||0
2243659|NCT02549027|5503500|P5|NOT COMPLETED|Washout After Period 4||0
2243660|NCT02549027|5503501|P4|NOT COMPLETED|Washout After Period 4||1
2243661|NCT02549027|5503502|P3|NOT COMPLETED|Washout After Period 4||1
2243662|NCT02549027|5503503|P2|NOT COMPLETED|Washout After Period 4||1
2243663|NCT02549027|5503504|P1|NOT COMPLETED|Washout After Period 4||0
2243664|NCT02549027|5503499|P6|COMPLETED|Washout After Period 4||0
2243665|NCT02549027|5503500|P5|COMPLETED|Washout After Period 4||0
2243666|NCT02549027|5503501|P4|COMPLETED|Washout After Period 4||4
2243667|NCT02549027|5503502|P3|COMPLETED|Washout After Period 4||4
2243668|NCT02549027|5503503|P2|COMPLETED|Washout After Period 4||4
2243669|NCT02549027|5503504|P1|COMPLETED|Washout After Period 4||5
2243670|NCT02549027|5503499|P6|STARTED|Washout After Period 4||0
2243671|NCT02549027|5503500|P5|STARTED|Washout After Period 4||0
2243672|NCT02549027|5503501|P4|STARTED|Washout After Period 4||5
2243673|NCT02549027|5503502|P3|STARTED|Washout After Period 4||5
2243674|NCT02549027|5503503|P2|STARTED|Washout After Period 4||5
2243675|NCT02549027|5503504|P1|STARTED|Washout After Period 4||5
2243676|NCT02549027|5503499|P6|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
2243677|NCT02549027|5503500|P5|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
2243678|NCT02549027|5503501|P4|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
2243679|NCT02549027|5503502|P3|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
2243680|NCT02549027|5503503|P2|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
2243681|NCT02549027|5503504|P1|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
2243682|NCT02549027|5503499|P6|COMPLETED|Period 4 - MK-1064 or Placebo||0
2243683|NCT02549027|5503500|P5|COMPLETED|Period 4 - MK-1064 or Placebo||0
2243684|NCT02549027|5503501|P4|COMPLETED|Period 4 - MK-1064 or Placebo||5
2243685|NCT02549027|5503502|P3|COMPLETED|Period 4 - MK-1064 or Placebo||5
2243686|NCT02549027|5503503|P2|COMPLETED|Period 4 - MK-1064 or Placebo||5
2243687|NCT02549027|5503504|P1|COMPLETED|Period 4 - MK-1064 or Placebo||5
2243688|NCT02549027|5503499|P6|STARTED|Period 4 - MK-1064 or Placebo||0
2243689|NCT02549027|5503500|P5|STARTED|Period 4 - MK-1064 or Placebo||0
2243690|NCT02549027|5503501|P4|STARTED|Period 4 - MK-1064 or Placebo||5
2243691|NCT02549027|5503502|P3|STARTED|Period 4 - MK-1064 or Placebo||5
2243692|NCT02549027|5503503|P2|STARTED|Period 4 - MK-1064 or Placebo||5
2243693|NCT02549027|5503504|P1|STARTED|Period 4 - MK-1064 or Placebo||5
2243694|NCT02549027|5503499|P6|NOT COMPLETED|Washout After Period 3||0
2243695|NCT02549027|5503500|P5|NOT COMPLETED|Washout After Period 3||0
2243696|NCT02549027|5503501|P4|NOT COMPLETED|Washout After Period 3||0
2243697|NCT02549027|5503502|P3|NOT COMPLETED|Washout After Period 3||0
2243698|NCT02549027|5503503|P2|NOT COMPLETED|Washout After Period 3||0
2243699|NCT02549027|5503504|P1|NOT COMPLETED|Washout After Period 3||0
2243700|NCT02549027|5503499|P6|COMPLETED|Washout After Period 3||0
2243701|NCT02549027|5503500|P5|COMPLETED|Washout After Period 3||0
2243702|NCT02549027|5503501|P4|COMPLETED|Washout After Period 3||5
2243703|NCT02549027|5503502|P3|COMPLETED|Washout After Period 3||5
2243704|NCT02549027|5503503|P2|COMPLETED|Washout After Period 3||5
2243705|NCT02549027|5503504|P1|COMPLETED|Washout After Period 3||5
2243706|NCT02549027|5503499|P6|STARTED|Washout After Period 3||0
2243707|NCT02549027|5503500|P5|STARTED|Washout After Period 3||0
2243708|NCT02549027|5503501|P4|STARTED|Washout After Period 3||5
2243709|NCT02549027|5503502|P3|STARTED|Washout After Period 3||5
2243710|NCT02549027|5503503|P2|STARTED|Washout After Period 3||5
2243711|NCT02549027|5503504|P1|STARTED|Washout After Period 3||5
2243712|NCT02549027|5503499|P6|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
2243713|NCT02549027|5503500|P5|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
2243714|NCT02549027|5503501|P4|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
2243715|NCT02549027|5503502|P3|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
2243716|NCT02549027|5503503|P2|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
2243717|NCT02549027|5503504|P1|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
2243718|NCT02549027|5503499|P6|COMPLETED|Period 3 - MK-1064 or Placebo||0
2243719|NCT02549027|5503500|P5|COMPLETED|Period 3 - MK-1064 or Placebo||0
2243720|NCT02549027|5503501|P4|COMPLETED|Period 3 - MK-1064 or Placebo||5
2243721|NCT02549027|5503502|P3|COMPLETED|Period 3 - MK-1064 or Placebo||5
2243722|NCT02549027|5503503|P2|COMPLETED|Period 3 - MK-1064 or Placebo||5
2243723|NCT02549027|5503504|P1|COMPLETED|Period 3 - MK-1064 or Placebo||5
2243724|NCT02549027|5503499|P6|STARTED|Period 3 - MK-1064 or Placebo||0
2243725|NCT02549027|5503500|P5|STARTED|Period 3 - MK-1064 or Placebo||0
2243726|NCT02549027|5503501|P4|STARTED|Period 3 - MK-1064 or Placebo||5
2243727|NCT02549027|5503502|P3|STARTED|Period 3 - MK-1064 or Placebo||5
2243728|NCT02549027|5503503|P2|STARTED|Period 3 - MK-1064 or Placebo||5
2243729|NCT02549027|5503504|P1|STARTED|Period 3 - MK-1064 or Placebo||5
2243730|NCT02549027|5503499|P6|NOT COMPLETED|Washout After Period 2||0
2243731|NCT02549027|5503500|P5|NOT COMPLETED|Washout After Period 2||0
2243732|NCT02549027|5503501|P4|NOT COMPLETED|Washout After Period 2||0
2243733|NCT02549027|5503502|P3|NOT COMPLETED|Washout After Period 2||0
2243734|NCT02549027|5503503|P2|NOT COMPLETED|Washout After Period 2||0
2243735|NCT02549027|5503504|P1|NOT COMPLETED|Washout After Period 2||0
2243736|NCT02549027|5503499|P6|COMPLETED|Washout After Period 2||0
2243737|NCT02549027|5503500|P5|COMPLETED|Washout After Period 2||0
2243738|NCT02549027|5503501|P4|COMPLETED|Washout After Period 2||5
2243739|NCT02549027|5503502|P3|COMPLETED|Washout After Period 2||5
2243740|NCT02549027|5503503|P2|COMPLETED|Washout After Period 2||5
2243741|NCT02549027|5503504|P1|COMPLETED|Washout After Period 2||5
2243742|NCT02549027|5503499|P6|STARTED|Washout After Period 2||0
2243743|NCT02549027|5503500|P5|STARTED|Washout After Period 2||0
2243744|NCT02549027|5503501|P4|STARTED|Washout After Period 2||5
2243745|NCT02549027|5503502|P3|STARTED|Washout After Period 2||5
2243746|NCT02549027|5503503|P2|STARTED|Washout After Period 2||5
2243747|NCT02549027|5503504|P1|STARTED|Washout After Period 2||5
2243748|NCT02549027|5503499|P6|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
2243749|NCT02549027|5503500|P5|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
2243750|NCT02549027|5503501|P4|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
2243751|NCT02549027|5503502|P3|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
2243752|NCT02549027|5503503|P2|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
2243753|NCT02549027|5503504|P1|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
2243754|NCT02549027|5503499|P6|COMPLETED|Period 2 - MK-1064 or Placebo||0
2243755|NCT02549027|5503500|P5|COMPLETED|Period 2 - MK-1064 or Placebo||0
2243756|NCT02549027|5503501|P4|COMPLETED|Period 2 - MK-1064 or Placebo||5
2243757|NCT02549027|5503502|P3|COMPLETED|Period 2 - MK-1064 or Placebo||5
2243758|NCT02549027|5503503|P2|COMPLETED|Period 2 - MK-1064 or Placebo||5
2243759|NCT02549027|5503504|P1|COMPLETED|Period 2 - MK-1064 or Placebo||5
2243760|NCT02549027|5503499|P6|STARTED|Period 2 - MK-1064 or Placebo||0
2243761|NCT02549027|5503500|P5|STARTED|Period 2 - MK-1064 or Placebo||0
2243762|NCT02549027|5503501|P4|STARTED|Period 2 - MK-1064 or Placebo||5
2243763|NCT02549027|5503502|P3|STARTED|Period 2 - MK-1064 or Placebo||5
2243764|NCT02549027|5503503|P2|STARTED|Period 2 - MK-1064 or Placebo||5
2243765|NCT02549027|5503504|P1|STARTED|Period 2 - MK-1064 or Placebo||5
2243766|NCT02549027|5503499|P6|NOT COMPLETED|Washout After Period 1||0
2243767|NCT02549027|5503500|P5|NOT COMPLETED|Washout After Period 1||0
2243768|NCT02549027|5503501|P4|NOT COMPLETED|Washout After Period 1||0
2243769|NCT02549027|5503502|P3|NOT COMPLETED|Washout After Period 1||0
2243770|NCT02549027|5503503|P2|NOT COMPLETED|Washout After Period 1||0
2243771|NCT02549027|5503504|P1|NOT COMPLETED|Washout After Period 1||0
2243772|NCT02549027|5503499|P6|COMPLETED|Washout After Period 1||0
2243773|NCT02549027|5503500|P5|COMPLETED|Washout After Period 1||0
2243774|NCT02549027|5503501|P4|COMPLETED|Washout After Period 1||5
2243775|NCT02549027|5503502|P3|COMPLETED|Washout After Period 1||5
2243776|NCT02549027|5503503|P2|COMPLETED|Washout After Period 1||5
2243777|NCT02549027|5503504|P1|COMPLETED|Washout After Period 1||5
2243778|NCT02549027|5503499|P6|STARTED|Washout After Period 1||0
2243779|NCT02549027|5503500|P5|STARTED|Washout After Period 1||0
2243780|NCT02549027|5503501|P4|STARTED|Washout After Period 1||5
2243781|NCT02549027|5503502|P3|STARTED|Washout After Period 1||5
2243782|NCT02549027|5503503|P2|STARTED|Washout After Period 1||5
2243783|NCT02549027|5503504|P1|STARTED|Washout After Period 1||5
2243784|NCT02549027|5503499|P6|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
2243785|NCT02549027|5503500|P5|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
2243786|NCT02549027|5503501|P4|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
2243787|NCT02549027|5503502|P3|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
2243788|NCT02549027|5503503|P2|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
2243789|NCT02549027|5503504|P1|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
2243790|NCT02549027|5503499|P6|COMPLETED|Period 1 - MK-1064 or Placebo||0
2243791|NCT02549027|5503500|P5|COMPLETED|Period 1 - MK-1064 or Placebo||0
2243792|NCT02549027|5503501|P4|COMPLETED|Period 1 - MK-1064 or Placebo||5
2243793|NCT02549027|5503502|P3|COMPLETED|Period 1 - MK-1064 or Placebo||5
2243794|NCT02549027|5503503|P2|COMPLETED|Period 1 - MK-1064 or Placebo||5
2243795|NCT02549027|5503504|P1|COMPLETED|Period 1 - MK-1064 or Placebo||5
2243796|NCT02549027|5503499|P6|STARTED|Period 1 - MK-1064 or Placebo||0
2243797|NCT02549027|5503500|P5|STARTED|Period 1 - MK-1064 or Placebo||0
2243798|NCT02549027|5503501|P4|STARTED|Period 1 - MK-1064 or Placebo||5
2243799|NCT02549027|5503502|P3|STARTED|Period 1 - MK-1064 or Placebo||5
2243800|NCT02549027|5503503|P2|STARTED|Period 1 - MK-1064 or Placebo||5
2243801|NCT02549027|5503504|P1|STARTED|Period 1 - MK-1064 or Placebo||5
2243802|NCT02549014|5503541|P2|NOT COMPLETED|Overall Study||0
2243803|NCT02549014|5503542|P1|NOT COMPLETED|Overall Study||0
2243804|NCT02549014|5503541|P2|COMPLETED|Overall Study||8
2243805|NCT02549014|5503542|P1|COMPLETED|Overall Study||8
2243806|NCT02549014|5503541|P2|STARTED|Overall Study||8
2243807|NCT02549014|5503542|P1|STARTED|Overall Study||8
2243808|NCT02548962|5503634|P2|NOT COMPLETED|Overall Study||0
2243809|NCT02548962|5503635|P1|NOT COMPLETED|Overall Study||1
2243810|NCT02548962|5503634|P2|COMPLETED|Overall Study||3
2243811|NCT02548962|5503635|P1|COMPLETED|Overall Study||7
2243812|NCT02548962|5503634|P2|STARTED|Overall Study||3
2243813|NCT02548962|5503635|P1|STARTED|Overall Study||8
2243814|NCT02548845|5503645|P1|NOT COMPLETED|Overall Study||0
2243815|NCT02548845|5503645|P1|COMPLETED|Overall Study||70
2243816|NCT02548845|5503645|P1|STARTED|Overall Study||70
2243817|NCT02548728|5503659|P2|NOT COMPLETED|Overall Study||0
2243818|NCT02548728|5503660|P1|NOT COMPLETED|Overall Study||0
2243819|NCT02548728|5503659|P2|COMPLETED|Overall Study||6
2243820|NCT02548728|5503660|P1|COMPLETED|Overall Study||6
2243821|NCT02548728|5503659|P2|STARTED|Overall Study||6
2243822|NCT02548728|5503660|P1|STARTED|Overall Study||6
2243823|NCT02548650|5503674|P2|NOT COMPLETED|Double Therapy||2
2243824|NCT02548650|5503675|P1|NOT COMPLETED|Double Therapy||1
2243825|NCT02548650|5503674|P2|COMPLETED|Double Therapy||30
2243826|NCT02548650|5503675|P1|COMPLETED|Double Therapy||28
2243827|NCT02548650|5503674|P2|STARTED|Double Therapy||32
2243828|NCT02548650|5503675|P1|STARTED|Double Therapy||29
2243829|NCT02548650|5503674|P2|NOT COMPLETED|Triple Therapy||4
2243830|NCT02548650|5503675|P1|NOT COMPLETED|Triple Therapy||1
2243831|NCT02548650|5503674|P2|COMPLETED|Triple Therapy||32
2243832|NCT02548650|5503675|P1|COMPLETED|Triple Therapy||29
2243833|NCT02548650|5503674|P2|STARTED|Triple Therapy||36
2243834|NCT02548650|5503675|P1|STARTED|Triple Therapy||30
2243835|NCT02548585|5503690|P7|NOT COMPLETED|Overall Study||1
2243836|NCT02548585|5503691|P6|NOT COMPLETED|Overall Study||2
2243837|NCT02548585|5503692|P5|NOT COMPLETED|Overall Study||3
2243838|NCT02548585|5503693|P4|NOT COMPLETED|Overall Study||2
2243839|NCT02548585|5503694|P3|NOT COMPLETED|Overall Study||0
2243840|NCT02548585|5503695|P2|NOT COMPLETED|Overall Study||0
2243841|NCT02548585|5503696|P1|NOT COMPLETED|Overall Study||2
2243842|NCT02548585|5503690|P7|COMPLETED|Overall Study||11
2243843|NCT02548585|5503691|P6|COMPLETED|Overall Study||10
2243844|NCT02548585|5503692|P5|COMPLETED|Overall Study||22
2243845|NCT02548585|5503693|P4|COMPLETED|Overall Study||5
2243846|NCT02548585|5503694|P3|COMPLETED|Overall Study||6
2243847|NCT02548585|5503695|P2|COMPLETED|Overall Study||6
2243848|NCT02548585|5503696|P1|COMPLETED|Overall Study||43
2243849|NCT02548585|5503690|P7|Treated|Overall Study||12
2243850|NCT02548585|5503691|P6|Treated|Overall Study||11
2243851|NCT02548585|5503692|P5|Treated|Overall Study||25
2243852|NCT02548585|5503693|P4|Treated|Overall Study||7
2243853|NCT02548585|5503694|P3|Treated|Overall Study||6
2243854|NCT02548585|5503695|P2|Treated|Overall Study||6
2243855|NCT02548585|5503696|P1|Treated|Overall Study||45
2243856|NCT02548585|5503690|P7|STARTED|Overall Study||12
2243857|NCT02548585|5503691|P6|STARTED|Overall Study||12
2243858|NCT02548585|5503692|P5|STARTED|Overall Study||25
2243859|NCT02548585|5503693|P4|STARTED|Overall Study||7
2243860|NCT02548585|5503694|P3|STARTED|Overall Study||6
2243861|NCT02548585|5503695|P2|STARTED|Overall Study||6
2243862|NCT02548585|5503696|P1|STARTED|Overall Study||45
2243863|NCT02548455|5503914|P1|NOT COMPLETED|Overall Study||240
2243864|NCT02548455|5503914|P1|COMPLETED|Overall Study|Completed 6-Month Follow-up|259
2243865|NCT02548455|5503914|P1|Completed 12-Month Follow-up|Overall Study|Study completed prior to all subjects reaching the 6- and 12-month visits.|61
2243866|NCT02548455|5503914|P1|Completed 6-Month Follow-up|Overall Study||259
2243867|NCT02548455|5503914|P1|Completed Pre-Discharge|Overall Study||484
2243868|NCT02548455|5503914|P1|STARTED|Overall Study|A total of 499 subjects were enrolled at 31 investigational sites.|499
2243869|NCT02548312|5503926|P8|NOT COMPLETED|Overall Study||42
2243870|NCT02548312|5503927|P7|NOT COMPLETED|Overall Study||40
2243871|NCT02548312|5503928|P6|NOT COMPLETED|Overall Study||40
2243872|NCT02548312|5503929|P5|NOT COMPLETED|Overall Study||34
2243873|NCT02548312|5503930|P4|NOT COMPLETED|Overall Study||46
2243874|NCT02548312|5503931|P3|NOT COMPLETED|Overall Study||38
2243875|NCT02548312|5503932|P2|NOT COMPLETED|Overall Study||43
2243876|NCT02548312|5503933|P1|NOT COMPLETED|Overall Study||33
2243877|NCT02548312|5503926|P8|COMPLETED|Overall Study||91
2243878|NCT02548312|5503927|P7|COMPLETED|Overall Study||93
2243879|NCT02548312|5503928|P6|COMPLETED|Overall Study||93
2243880|NCT02548312|5503929|P5|COMPLETED|Overall Study||99
2243881|NCT02548312|5503930|P4|COMPLETED|Overall Study||87
2243882|NCT02548312|5503931|P3|COMPLETED|Overall Study||96
2243883|NCT02548312|5503932|P2|COMPLETED|Overall Study||90
2243884|NCT02548312|5503933|P1|COMPLETED|Overall Study||100
2243885|NCT02548312|5503926|P8|STARTED|Overall Study||133
2243886|NCT02548312|5503927|P7|STARTED|Overall Study||133
2243887|NCT02548312|5503928|P6|STARTED|Overall Study||133
2243888|NCT02548312|5503929|P5|STARTED|Overall Study||133
2243889|NCT02548312|5503930|P4|STARTED|Overall Study||133
2243890|NCT02548312|5503931|P3|STARTED|Overall Study||134
2243891|NCT02548312|5503932|P2|STARTED|Overall Study||133
2243892|NCT02548312|5503933|P1|STARTED|Overall Study||133
2243893|NCT02548156|5503975|P6|NOT COMPLETED|Period 3||0
2243894|NCT02548156|5503976|P5|NOT COMPLETED|Period 3||0
2243895|NCT02548156|5503977|P4|NOT COMPLETED|Period 3||0
2243896|NCT02548156|5503978|P3|NOT COMPLETED|Period 3||0
2243897|NCT02548156|5503979|P2|NOT COMPLETED|Period 3||0
2243898|NCT02548156|5503980|P1|NOT COMPLETED|Period 3||0
2243899|NCT02548156|5503975|P6|COMPLETED|Period 3||5
2243900|NCT02548156|5503976|P5|COMPLETED|Period 3||4
2243901|NCT02548156|5503977|P4|COMPLETED|Period 3||5
2243902|NCT02548156|5503978|P3|COMPLETED|Period 3||4
2243903|NCT02548156|5503979|P2|COMPLETED|Period 3||5
2243904|NCT02548156|5503980|P1|COMPLETED|Period 3||5
2243905|NCT02548156|5503975|P6|STARTED|Period 3||5
2243906|NCT02548156|5503976|P5|STARTED|Period 3||4
2243907|NCT02548156|5503977|P4|STARTED|Period 3||5
2243908|NCT02548156|5503978|P3|STARTED|Period 3||4
2243909|NCT02548156|5503979|P2|STARTED|Period 3||5
2243910|NCT02548156|5503980|P1|STARTED|Period 3||5
2243911|NCT02548156|5503975|P6|NOT COMPLETED|Washout Period 2||0
2243912|NCT02548156|5503976|P5|NOT COMPLETED|Washout Period 2||0
2243913|NCT02548156|5503977|P4|NOT COMPLETED|Washout Period 2||0
2243914|NCT02548156|5503978|P3|NOT COMPLETED|Washout Period 2||0
2243915|NCT02548156|5503979|P2|NOT COMPLETED|Washout Period 2||0
2243916|NCT02548156|5503980|P1|NOT COMPLETED|Washout Period 2||0
2243917|NCT02548156|5503975|P6|COMPLETED|Washout Period 2||5
2243918|NCT02548156|5503976|P5|COMPLETED|Washout Period 2||4
2243919|NCT02548156|5503977|P4|COMPLETED|Washout Period 2||5
2243920|NCT02548156|5503978|P3|COMPLETED|Washout Period 2||4
2243921|NCT02548156|5503979|P2|COMPLETED|Washout Period 2||5
2243922|NCT02548156|5503980|P1|COMPLETED|Washout Period 2||5
2243923|NCT02548156|5503975|P6|STARTED|Washout Period 2||5
2243924|NCT02548156|5503976|P5|STARTED|Washout Period 2||4
2243925|NCT02548156|5503977|P4|STARTED|Washout Period 2||5
2243926|NCT02548156|5503978|P3|STARTED|Washout Period 2||4
2243927|NCT02548156|5503979|P2|STARTED|Washout Period 2||5
2243928|NCT02548156|5503980|P1|STARTED|Washout Period 2||5
2243929|NCT02548156|5503975|P6|NOT COMPLETED|Period 2||0
2243930|NCT02548156|5503976|P5|NOT COMPLETED|Period 2||0
2243931|NCT02548156|5503977|P4|NOT COMPLETED|Period 2||0
2243932|NCT02548156|5503978|P3|NOT COMPLETED|Period 2||0
2243933|NCT02548156|5503979|P2|NOT COMPLETED|Period 2||0
2243934|NCT02548156|5503980|P1|NOT COMPLETED|Period 2||0
2243935|NCT02548156|5503975|P6|COMPLETED|Period 2||5
2243936|NCT02548156|5503976|P5|COMPLETED|Period 2||4
2243937|NCT02548156|5503977|P4|COMPLETED|Period 2||5
2243938|NCT02548156|5503978|P3|COMPLETED|Period 2||4
2243939|NCT02548156|5503979|P2|COMPLETED|Period 2||5
2243940|NCT02548156|5503980|P1|COMPLETED|Period 2||5
2243941|NCT02548156|5503975|P6|STARTED|Period 2||5
2243942|NCT02548156|5503976|P5|STARTED|Period 2||4
2243943|NCT02548156|5503977|P4|STARTED|Period 2||5
2243944|NCT02548156|5503978|P3|STARTED|Period 2||4
2243945|NCT02548156|5503979|P2|STARTED|Period 2||5
2243946|NCT02548156|5503980|P1|STARTED|Period 2||5
2243947|NCT02548156|5503975|P6|NOT COMPLETED|Washout Period 1||0
2243948|NCT02548156|5503976|P5|NOT COMPLETED|Washout Period 1||1
2243949|NCT02548156|5503977|P4|NOT COMPLETED|Washout Period 1||0
2243950|NCT02548156|5503978|P3|NOT COMPLETED|Washout Period 1||0
2243951|NCT02548156|5503979|P2|NOT COMPLETED|Washout Period 1||0
2243952|NCT02548156|5503980|P1|NOT COMPLETED|Washout Period 1||0
2243953|NCT02548156|5503975|P6|COMPLETED|Washout Period 1||5
2243954|NCT02548156|5503976|P5|COMPLETED|Washout Period 1||4
2243955|NCT02548156|5503977|P4|COMPLETED|Washout Period 1||5
2243956|NCT02548156|5503978|P3|COMPLETED|Washout Period 1||4
2243957|NCT02548156|5503979|P2|COMPLETED|Washout Period 1||5
2243958|NCT02548156|5503980|P1|COMPLETED|Washout Period 1||5
2243959|NCT02548156|5503975|P6|STARTED|Washout Period 1||5
2243960|NCT02548156|5503976|P5|STARTED|Washout Period 1||5
2243961|NCT02548156|5503977|P4|STARTED|Washout Period 1||5
2243962|NCT02548156|5503978|P3|STARTED|Washout Period 1||4
2243963|NCT02548156|5503979|P2|STARTED|Washout Period 1||5
2243964|NCT02548156|5503980|P1|STARTED|Washout Period 1||5
2243965|NCT02548156|5503975|P6|NOT COMPLETED|Period 1||0
2243966|NCT02548156|5503976|P5|NOT COMPLETED|Period 1||0
2243967|NCT02548156|5503977|P4|NOT COMPLETED|Period 1||0
2243968|NCT02548156|5503978|P3|NOT COMPLETED|Period 1||0
2243969|NCT02548156|5503979|P2|NOT COMPLETED|Period 1||0
2243970|NCT02548156|5503980|P1|NOT COMPLETED|Period 1||0
2243971|NCT02548156|5503975|P6|COMPLETED|Period 1||5
2243972|NCT02548156|5503976|P5|COMPLETED|Period 1||5
2243973|NCT02548156|5503977|P4|COMPLETED|Period 1||5
2243974|NCT02548156|5503978|P3|COMPLETED|Period 1||4
2243975|NCT02548156|5503979|P2|COMPLETED|Period 1||5
2243976|NCT02548156|5503980|P1|COMPLETED|Period 1||5
2243977|NCT02548156|5503975|P6|STARTED|Period 1||5
2243978|NCT02548156|5503976|P5|STARTED|Period 1||5
2243979|NCT02548156|5503977|P4|STARTED|Period 1||5
2243980|NCT02548156|5503978|P3|STARTED|Period 1||4
2243981|NCT02548156|5503979|P2|STARTED|Period 1||5
2243982|NCT02548156|5503980|P1|STARTED|Period 1||5
2243983|NCT02548143|5503999|P2|NOT COMPLETED|Overall Study||1
2243984|NCT02548143|5504000|P1|NOT COMPLETED|Overall Study||1
2243985|NCT02548143|5503999|P2|COMPLETED|Overall Study||5
2243986|NCT02548143|5504000|P1|COMPLETED|Overall Study||5
2243987|NCT02548143|5503999|P2|STARTED|Overall Study||6
2243988|NCT02548143|5504000|P1|STARTED|Overall Study||6
2243989|NCT02548078|5504012|P2|NOT COMPLETED|Overall Study||6
2243990|NCT02548078|5504013|P1|NOT COMPLETED|Overall Study||5
2243991|NCT02548078|5504012|P2|COMPLETED|Overall Study||294
2243992|NCT02548078|5504013|P1|COMPLETED|Overall Study||295
2243993|NCT02548078|5504012|P2|STARTED|Overall Study||300
2243994|NCT02548078|5504013|P1|STARTED|Overall Study||300
2243995|NCT02547987|5504201|P1|NOT COMPLETED|Overall Study||3
2243996|NCT02547987|5504201|P1|COMPLETED|Overall Study||22
2243997|NCT02547987|5504201|P1|STARTED|Overall Study||25
2243998|NCT02547974|5504209|P4|NOT COMPLETED|Overall Study||0
2243999|NCT02547974|5504210|P3|NOT COMPLETED|Overall Study||0
2244000|NCT02547974|5504211|P2|NOT COMPLETED|Overall Study||0
2244001|NCT02547974|5504212|P1|NOT COMPLETED|Overall Study||1
2244002|NCT02547974|5504209|P4|COMPLETED|Overall Study||44
2244003|NCT02547974|5504210|P3|COMPLETED|Overall Study||30
2244004|NCT02547974|5504211|P2|COMPLETED|Overall Study||31
2244005|NCT02547974|5504212|P1|COMPLETED|Overall Study||14
2244006|NCT02547974|5504209|P4|STARTED|Overall Study||44
2244007|NCT02547974|5504210|P3|STARTED|Overall Study||30
2244008|NCT02547974|5504211|P2|STARTED|Overall Study||31
2244009|NCT02547974|5504212|P1|STARTED|Overall Study||15
2244010|NCT02547935|5504299|P3|NOT COMPLETED|Overall Study||5
2244011|NCT02547935|5504300|P2|NOT COMPLETED|Overall Study||8
2244012|NCT02547935|5504301|P1|NOT COMPLETED|Overall Study||5
2244013|NCT02547935|5504299|P3|COMPLETED|Overall Study||143
2244014|NCT02547935|5504300|P2|COMPLETED|Overall Study||137
2244015|NCT02547935|5504301|P1|COMPLETED|Overall Study||150
2244016|NCT02547935|5504299|P3|Safety Analysis Set|Overall Study||148
2244017|NCT02547935|5504300|P2|Safety Analysis Set|Overall Study||145
2244018|NCT02547935|5504301|P1|Safety Analysis Set|Overall Study||152
2244019|NCT02547935|5504299|P3|Full Analysis Set|Overall Study||148
2244020|NCT02547935|5504300|P2|Full Analysis Set|Overall Study||144
2244021|NCT02547935|5504301|P1|Full Analysis Set|Overall Study||152
2244022|NCT02547935|5504299|P3|Received Treatment|Overall Study||148
2244023|NCT02547935|5504300|P2|Received Treatment|Overall Study||145
2244024|NCT02547935|5504301|P1|Received Treatment|Overall Study||152
2244025|NCT02547935|5504299|P3|STARTED|Overall Study||148
2244026|NCT02547935|5504300|P2|STARTED|Overall Study||145
2244027|NCT02547935|5504301|P1|STARTED|Overall Study||155
2244028|NCT02547779|5504330|P2|NOT COMPLETED|Overall Study||0
2244029|NCT02547779|5504331|P1|NOT COMPLETED|Overall Study||0
2244030|NCT02547779|5504330|P2|COMPLETED|Overall Study||5207
2244031|NCT02547779|5504331|P1|COMPLETED|Overall Study||5214
2244032|NCT02547779|5504330|P2|STARTED|Overall Study||5207
2244033|NCT02547779|5504331|P1|STARTED|Overall Study||5214
2244037|NCT02547714|5504346|P1|NOT COMPLETED|Overall Study||0
2244038|NCT02547714|5504346|P1|COMPLETED|Overall Study||34
2244039|NCT02547714|5504346|P1|STARTED|Overall Study||34
2244040|NCT02547649|5504359|P3|NOT COMPLETED|Overall Study||4
2244041|NCT02547649|5504360|P2|NOT COMPLETED|Overall Study||5
2244042|NCT02547649|5504361|P1|NOT COMPLETED|Overall Study||3
2244043|NCT02547649|5504359|P3|COMPLETED|Overall Study||224
2244044|NCT02547649|5504360|P2|COMPLETED|Overall Study||226
2244045|NCT02547649|5504361|P1|COMPLETED|Overall Study||228
2244046|NCT02547649|5504359|P3|Vaccinated|Overall Study||227
2244047|NCT02547649|5504360|P2|Vaccinated|Overall Study||231
2244048|NCT02547649|5504361|P1|Vaccinated|Overall Study||231
2244049|NCT02547649|5504359|P3|STARTED|Overall Study||228
2244050|NCT02547649|5504360|P2|STARTED|Overall Study||231
2244051|NCT02547649|5504361|P1|STARTED|Overall Study||231
2244052|NCT02547623|5504395|P2|NOT COMPLETED|Overall Study||3
2244053|NCT02547623|5504396|P1|NOT COMPLETED|Overall Study||4
2244054|NCT02547623|5504395|P2|COMPLETED|Overall Study||52
2244055|NCT02547623|5504396|P1|COMPLETED|Overall Study||122
2244056|NCT02547623|5504395|P2|STARTED|Overall Study||55
2244057|NCT02547623|5504396|P1|STARTED|Overall Study||126
2244058|NCT02547454|5504426|P1|NOT COMPLETED|Overall Study||172
2244059|NCT02547454|5504426|P1|COMPLETED|Overall Study||221
2244060|NCT02547454|5504426|P1|STARTED|Overall Study||393
2244061|NCT02547363|5504456|P2|NOT COMPLETED|12-month Follow-up||5
2244062|NCT02547363|5504457|P1|NOT COMPLETED|12-month Follow-up||10
2244063|NCT02547363|5504456|P2|COMPLETED|12-month Follow-up||81
2244064|NCT02547363|5504457|P1|COMPLETED|12-month Follow-up||194
2244065|NCT02547363|5504456|P2|STARTED|12-month Follow-up||86
2244066|NCT02547363|5504457|P1|STARTED|12-month Follow-up||204
2244067|NCT02547363|5504456|P2|NOT COMPLETED|3-day Treatment and 8-week Follow-up||11
2244068|NCT02547363|5504457|P1|NOT COMPLETED|3-day Treatment and 8-week Follow-up||4
2244069|NCT02547363|5504456|P2|COMPLETED|3-day Treatment and 8-week Follow-up||94
2244070|NCT02547363|5504457|P1|COMPLETED|3-day Treatment and 8-week Follow-up||207
2244071|NCT02547363|5504456|P2|Treated|3-day Treatment and 8-week Follow-up||104
2244072|NCT02547363|5504457|P1|Treated|3-day Treatment and 8-week Follow-up||209
2244073|NCT02547363|5504456|P2|STARTED|3-day Treatment and 8-week Follow-up||105
2244074|NCT02547363|5504457|P1|STARTED|3-day Treatment and 8-week Follow-up||211
2244075|NCT02547233|5504473|P2|NOT COMPLETED|12-month Follow-up||17
2244076|NCT02547233|5504474|P1|NOT COMPLETED|12-month Follow-up||14
2244077|NCT02547233|5504473|P2|COMPLETED|12-month Follow-up||67
2244078|NCT02547233|5504474|P1|COMPLETED|12-month Follow-up||185
2244079|NCT02547233|5504473|P2|STARTED|12-month Follow-up||84
2244080|NCT02547233|5504474|P1|STARTED|12-month Follow-up||199
2244081|NCT02547233|5504473|P2|NOT COMPLETED|3-day Treatment and 8-week Follow-up||10
2244082|NCT02547233|5504474|P1|NOT COMPLETED|3-day Treatment and 8-week Follow-up||2
2244083|NCT02547233|5504473|P2|COMPLETED|3-day Treatment and 8-week Follow-up||92
2244084|NCT02547233|5504474|P1|COMPLETED|3-day Treatment and 8-week Follow-up||203
2244085|NCT02547233|5504473|P2|Treated|3-day Treatment and 8-week Follow-up||100
2244086|NCT02547233|5504474|P1|Treated|3-day Treatment and 8-week Follow-up||205
2244087|NCT02547233|5504473|P2|STARTED|3-day Treatment and 8-week Follow-up||102
2244088|NCT02547233|5504474|P1|STARTED|3-day Treatment and 8-week Follow-up||205
2244089|NCT02547129|5504490|P2|NOT COMPLETED|Overall Study||0
2244090|NCT02547129|5504491|P1|NOT COMPLETED|Overall Study||1
2244091|NCT02547129|5504490|P2|COMPLETED|Overall Study||2
2244092|NCT02547129|5504491|P1|COMPLETED|Overall Study||1
2244093|NCT02547129|5504490|P2|STARTED|Overall Study||2
2244094|NCT02547129|5504491|P1|STARTED|Overall Study||2
2244095|NCT02547064|5504505|P2|NOT COMPLETED|Overall Study||2
2244096|NCT02547064|5504506|P1|NOT COMPLETED|Overall Study||3
2244097|NCT02547064|5504505|P2|COMPLETED|Overall Study||79
2244098|NCT02547064|5504506|P1|COMPLETED|Overall Study||78
2244099|NCT02547064|5504505|P2|STARTED|Overall Study||81
2244100|NCT02547064|5504506|P1|STARTED|Overall Study||81
2244101|NCT02547038|5504534|P2|NOT COMPLETED|Overall Study||2
2244102|NCT02547038|5504535|P1|NOT COMPLETED|Overall Study||3
2244103|NCT02547038|5504534|P2|COMPLETED|Overall Study||174
2244104|NCT02547038|5504535|P1|COMPLETED|Overall Study||173
2244105|NCT02547038|5504534|P2|STARTED|Overall Study||176
2244106|NCT02547038|5504535|P1|STARTED|Overall Study||176
2244107|NCT02547012|5504543|P2|NOT COMPLETED|Overall Study||0
2244108|NCT02547012|5504544|P1|NOT COMPLETED|Overall Study||0
2244109|NCT02547012|5504543|P2|COMPLETED|Overall Study||27
2244110|NCT02547012|5504544|P1|COMPLETED|Overall Study||24
2244111|NCT02547012|5504543|P2|STARTED|Overall Study||27
2244112|NCT02547012|5504544|P1|STARTED|Overall Study||24
2244113|NCT02546986|5504552|P2|NOT COMPLETED|Survival Follow-Up Phase||35
2244114|NCT02546986|5504553|P1|NOT COMPLETED|Survival Follow-Up Phase||36
2244115|NCT02546986|5504552|P2|COMPLETED|Survival Follow-Up Phase||0
2244116|NCT02546986|5504553|P1|COMPLETED|Survival Follow-Up Phase||0
2244117|NCT02546986|5504552|P2|STARTED|Survival Follow-Up Phase||35
2244118|NCT02546986|5504553|P1|STARTED|Survival Follow-Up Phase||36
2244119|NCT02546986|5504552|P2|NOT COMPLETED|Treatment Period||49
2244120|NCT02546986|5504553|P1|NOT COMPLETED|Treatment Period||51
2244121|NCT02546986|5504552|P2|COMPLETED|Treatment Period||0
2244122|NCT02546986|5504553|P1|COMPLETED|Treatment Period||0
2244123|NCT02546986|5504552|P2|STARTED|Treatment Period||49
2244124|NCT02546986|5504553|P1|STARTED|Treatment Period||51
2244125|NCT02546765|5504580|P4|NOT COMPLETED|Overall Study||0
2244126|NCT02546765|5504581|P3|NOT COMPLETED|Overall Study||0
2244127|NCT02546765|5504582|P2|NOT COMPLETED|Overall Study||1
2244128|NCT02546765|5504583|P1|NOT COMPLETED|Overall Study||0
2244129|NCT02546765|5504580|P4|COMPLETED|Overall Study||30
2244130|NCT02546765|5504581|P3|COMPLETED|Overall Study||30
2244131|NCT02546765|5504582|P2|COMPLETED|Overall Study|29 Received study drug; 1 withdrew before surgery and after randomization|29
2244132|NCT02546765|5504583|P1|COMPLETED|Overall Study||31
2244133|NCT02546765|5504580|P4|STARTED|Overall Study||30
2244134|NCT02546765|5504581|P3|STARTED|Overall Study||30
2244135|NCT02546765|5504582|P2|STARTED|Overall Study||30
2244136|NCT02546765|5504583|P1|STARTED|Overall Study||31
2244137|NCT02546609|5504624|P3|NOT COMPLETED|Overall Study||7
2244138|NCT02546609|5504625|P2|NOT COMPLETED|Overall Study||11
2244139|NCT02546609|5504626|P1|NOT COMPLETED|Overall Study||2
2244140|NCT02546609|5504624|P3|COMPLETED|Overall Study||25
2244141|NCT02546609|5504625|P2|COMPLETED|Overall Study||24
2244142|NCT02546609|5504626|P1|COMPLETED|Overall Study||22
2244143|NCT02546609|5504624|P3|STARTED|Overall Study||32
2244144|NCT02546609|5504625|P2|STARTED|Overall Study||35
2244145|NCT02546609|5504626|P1|STARTED|Overall Study||24
2244146|NCT02546544|5504667|P1|NOT COMPLETED|Overall Study||16
2244147|NCT02546544|5504667|P1|COMPLETED|Overall Study||0
2244148|NCT02546544|5504667|P1|Received Allocated Intervention|Overall Study||16
2244149|NCT02546544|5504667|P1|STARTED|Overall Study||16
2244150|NCT02546375|5504676|P1|NOT COMPLETED|Overall Study||0
2244151|NCT02546375|5504676|P1|COMPLETED|Overall Study||87
2244152|NCT02546375|5504676|P1|STARTED|Overall Study||87
2244153|NCT02546362|5504698|P1|NOT COMPLETED|12-week Treatment Period||9
2244154|NCT02546362|5504698|P1|COMPLETED|12-week Treatment Period||38
2244155|NCT02546362|5504698|P1|STARTED|12-week Treatment Period||47
2244156|NCT02546362|5504698|P1|NOT COMPLETED|4-week Treatment Period||3
2244157|NCT02546362|5504698|P1|COMPLETED|4-week Treatment Period||47
2244158|NCT02546362|5504698|P1|STARTED|4-week Treatment Period||50
2244159|NCT02546323|5504719|P2|NOT COMPLETED|Overall Study||66
2244160|NCT02546323|5504720|P1|NOT COMPLETED|Overall Study||60
2244161|NCT02546323|5504719|P2|COMPLETED|Overall Study||205
2244162|NCT02546323|5504720|P1|COMPLETED|Overall Study||212
2244163|NCT02546323|5504719|P2|Received Treatment|Overall Study||268
2244164|NCT02546323|5504720|P1|Received Treatment|Overall Study||272
2244165|NCT02546323|5504719|P2|STARTED|Overall Study||271
2244166|NCT02546323|5504720|P1|STARTED|Overall Study||272
2244167|NCT02546193|5504740|P4|NOT COMPLETED|Overall Study||0
2244168|NCT02546193|5504741|P3|NOT COMPLETED|Overall Study||2
2244169|NCT02546193|5504742|P2|NOT COMPLETED|Overall Study||6
2244170|NCT02546193|5504743|P1|NOT COMPLETED|Overall Study||6
2244171|NCT02546193|5504740|P4|COMPLETED|Overall Study||0
2244172|NCT02546193|5504741|P3|COMPLETED|Overall Study||0
2244173|NCT02546193|5504742|P2|COMPLETED|Overall Study||4
2244174|NCT02546193|5504743|P1|COMPLETED|Overall Study||4
2244175|NCT02546193|5504740|P4|STARTED|Overall Study||0
2244176|NCT02546193|5504741|P3|STARTED|Overall Study|Enrolled independently (Prospective study). Not counted in Outpatient Foley Catheter Arm.|2
2244177|NCT02546193|5504742|P2|STARTED|Overall Study||10
2244178|NCT02546193|5504743|P1|STARTED|Overall Study||10
2244179|NCT02545868|5504780|P3|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||34
2244180|NCT02545868|5504781|P2|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||35
2244181|NCT02545868|5504782|P1|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||33
2244182|NCT02545868|5504780|P3|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
2244183|NCT02545868|5504781|P2|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
2244184|NCT02545868|5504782|P1|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
2244185|NCT02545868|5504780|P3|STARTED|Optional Ocrelizumab Ext (OOE) Period||34
2244186|NCT02545868|5504781|P2|STARTED|Optional Ocrelizumab Ext (OOE) Period||35
2244187|NCT02545868|5504782|P1|STARTED|Optional Ocrelizumab Ext (OOE) Period||33
2244188|NCT02545868|5504780|P3|NOT COMPLETED|Immunization Study Period (ISP)||0
2244189|NCT02545868|5504781|P2|NOT COMPLETED|Immunization Study Period (ISP)||0
2244190|NCT02545868|5504782|P1|NOT COMPLETED|Immunization Study Period (ISP)||0
2244191|NCT02545868|5504780|P3|COMPLETED|Immunization Study Period (ISP)||34
2244192|NCT02545868|5504781|P2|COMPLETED|Immunization Study Period (ISP)||35
2244193|NCT02545868|5504782|P1|COMPLETED|Immunization Study Period (ISP)||33
2244194|NCT02545868|5504780|P3|STARTED|Immunization Study Period (ISP)||34
2244195|NCT02545868|5504781|P2|STARTED|Immunization Study Period (ISP)||35
2244196|NCT02545868|5504782|P1|STARTED|Immunization Study Period (ISP)||33
2244197|NCT02545608|5504855|P2|NOT COMPLETED|Overall Study||7
2244198|NCT02545608|5504856|P1|NOT COMPLETED|Overall Study||0
2244199|NCT02545608|5504855|P2|COMPLETED|Overall Study||93
2244200|NCT02545608|5504856|P1|COMPLETED|Overall Study||9
2244201|NCT02545608|5504855|P2|STARTED|Overall Study|Split hand study design. Total no. of subjects in Randomised group and No-treatment control is 100.|100
2244202|NCT02545608|5504856|P1|STARTED|Overall Study||9
2244203|NCT02545543|5504865|P2|NOT COMPLETED|Overall Study||34
2244204|NCT02545543|5504866|P1|NOT COMPLETED|Overall Study||81
2244205|NCT02545543|5504865|P2|COMPLETED|Overall Study||535
2244206|NCT02545543|5504866|P1|COMPLETED|Overall Study||1628
2244207|NCT02545543|5504865|P2|STARTED|Overall Study||569
2244208|NCT02545543|5504866|P1|STARTED|Overall Study||1709
2244209|NCT02545322|5504890|P1|NOT COMPLETED|Overall Study||3
2244210|NCT02545322|5504890|P1|COMPLETED|Overall Study||15
2244211|NCT02545322|5504890|P1|STARTED|Overall Study||18
2244212|NCT02545270|5504898|P3|NOT COMPLETED|Overall Study||2
2244213|NCT02545270|5504899|P2|NOT COMPLETED|Overall Study||1
2244214|NCT02545270|5504900|P1|NOT COMPLETED|Overall Study||0
2244215|NCT02545270|5504898|P3|COMPLETED|Overall Study||3
2244216|NCT02545270|5504899|P2|COMPLETED|Overall Study||4
2244217|NCT02545270|5504900|P1|COMPLETED|Overall Study||6
2244218|NCT02545270|5504898|P3|STARTED|Overall Study||5
2244219|NCT02545270|5504899|P2|STARTED|Overall Study||5
2244220|NCT02545270|5504900|P1|STARTED|Overall Study||6
2244221|NCT02545101|5504910|P1|NOT COMPLETED|Overall Study||0
2244222|NCT02545101|5504910|P1|COMPLETED|Overall Study||100
2244223|NCT02545101|5504910|P1|STARTED|Overall Study||100
2244224|NCT02544984|5504929|P2|NOT COMPLETED|Overall Study||2
2244225|NCT02544984|5504930|P1|NOT COMPLETED|Overall Study||2
2244226|NCT02544984|5504929|P2|COMPLETED|Overall Study||28
2244227|NCT02544984|5504930|P1|COMPLETED|Overall Study||28
2244228|NCT02544984|5504929|P2|STARTED|Overall Study||30
2244229|NCT02544984|5504930|P1|STARTED|Overall Study||30
2244230|NCT02544633|5504944|P4|NOT COMPLETED|Survival Follow-up Period||12
2244231|NCT02544633|5504945|P3|NOT COMPLETED|Survival Follow-up Period||7
2244232|NCT02544633|5504946|P2|NOT COMPLETED|Survival Follow-up Period||19
2244233|NCT02544633|5504947|P1|NOT COMPLETED|Survival Follow-up Period||28
2244234|NCT02544633|5504944|P4|COMPLETED|Survival Follow-up Period||0
2244235|NCT02544633|5504945|P3|COMPLETED|Survival Follow-up Period||0
2244236|NCT02544633|5504946|P2|COMPLETED|Survival Follow-up Period||0
2244237|NCT02544633|5504947|P1|COMPLETED|Survival Follow-up Period||0
2244238|NCT02544633|5504944|P4|STARTED|Survival Follow-up Period||12
2244239|NCT02544633|5504945|P3|STARTED|Survival Follow-up Period||7
2244240|NCT02544633|5504946|P2|STARTED|Survival Follow-up Period||19
2244241|NCT02544633|5504947|P1|STARTED|Survival Follow-up Period||28
2244242|NCT02544633|5504944|P4|NOT COMPLETED|Treatment Period||12
2244243|NCT02544633|5504945|P3|NOT COMPLETED|Treatment Period||8
2244244|NCT02544633|5504946|P2|NOT COMPLETED|Treatment Period||20
2244245|NCT02544633|5504947|P1|NOT COMPLETED|Treatment Period||28
2244246|NCT02544633|5504944|P4|COMPLETED|Treatment Period||0
2244247|NCT02544633|5504945|P3|COMPLETED|Treatment Period||0
2244248|NCT02544633|5504946|P2|COMPLETED|Treatment Period||0
2244249|NCT02544633|5504947|P1|COMPLETED|Treatment Period||0
2244250|NCT02544633|5504944|P4|STARTED|Treatment Period||12
2244251|NCT02544633|5504945|P3|STARTED|Treatment Period||8
2244252|NCT02544633|5504946|P2|STARTED|Treatment Period||20
2244253|NCT02544633|5504947|P1|STARTED|Treatment Period||28
2244254|NCT02544607|5504978|P1|NOT COMPLETED|Overall Study||0
2244255|NCT02544607|5504978|P1|COMPLETED|Overall Study||16
2244256|NCT02544607|5504978|P1|STARTED|Overall Study||16
2244257|NCT02544451|5504989|P3|NOT COMPLETED|Overall Study||1
2244258|NCT02544451|5504990|P2|NOT COMPLETED|Overall Study||12
2244259|NCT02544451|5504991|P1|NOT COMPLETED|Overall Study||14
2244260|NCT02544451|5504989|P3|COMPLETED|Overall Study||5
2244261|NCT02544451|5504990|P2|COMPLETED|Overall Study||84
2244262|NCT02544451|5504991|P1|COMPLETED|Overall Study||129
2244263|NCT02544451|5504989|P3|STARTED|Overall Study||6
2244264|NCT02544451|5504990|P2|STARTED|Overall Study||96
2244265|NCT02544451|5504991|P1|STARTED|Overall Study||143
2244266|NCT02544152|5505036|P2|NOT COMPLETED|Overall Study||7
2244267|NCT02544152|5505037|P1|NOT COMPLETED|Overall Study||1
2244268|NCT02544152|5505036|P2|COMPLETED|Overall Study||30
2244269|NCT02544152|5505037|P1|COMPLETED|Overall Study||33
2244270|NCT02544152|5505036|P2|Safety Analysis Set (SAS)|Overall Study||37
2244271|NCT02544152|5505037|P1|Safety Analysis Set (SAS)|Overall Study||34
2244272|NCT02544152|5505036|P2|Modified Intent to Treat (mITT)|Overall Study||37
2244273|NCT02544152|5505037|P1|Modified Intent to Treat (mITT)|Overall Study||34
2244274|NCT02544152|5505036|P2|STARTED|Overall Study||37
2244275|NCT02544152|5505037|P1|STARTED|Overall Study||34
2244276|NCT02544074|5505080|P21|NOT COMPLETED|Overall Study||0
2244277|NCT02544074|5505081|P20|NOT COMPLETED|Overall Study||0
2244278|NCT02544074|5505082|P19|NOT COMPLETED|Overall Study||0
2244279|NCT02544074|5505083|P18|NOT COMPLETED|Overall Study||0
2244280|NCT02544074|5505084|P17|NOT COMPLETED|Overall Study||0
2244281|NCT02544074|5505085|P16|NOT COMPLETED|Overall Study||0
2244282|NCT02544074|5505086|P15|NOT COMPLETED|Overall Study||0
2244283|NCT02544074|5505087|P14|NOT COMPLETED|Overall Study||0
2244284|NCT02544074|5505088|P13|NOT COMPLETED|Overall Study||0
2244285|NCT02544074|5505089|P12|NOT COMPLETED|Overall Study||0
2244286|NCT02544074|5505090|P11|NOT COMPLETED|Overall Study||0
2244287|NCT02544074|5505091|P10|NOT COMPLETED|Overall Study||1
2244288|NCT02544074|5505092|P9|NOT COMPLETED|Overall Study||0
2244289|NCT02544074|5505093|P8|NOT COMPLETED|Overall Study||0
2244290|NCT02544074|5505094|P7|NOT COMPLETED|Overall Study||0
2244291|NCT02544074|5505095|P6|NOT COMPLETED|Overall Study||1
2244292|NCT02544074|5505096|P5|NOT COMPLETED|Overall Study||0
2244293|NCT02544074|5505097|P4|NOT COMPLETED|Overall Study||0
2244294|NCT02544074|5505098|P3|NOT COMPLETED|Overall Study||0
2244295|NCT02544074|5505099|P2|NOT COMPLETED|Overall Study||1
2244296|NCT02544074|5505100|P1|NOT COMPLETED|Overall Study||0
2244297|NCT02544074|5505080|P21|COMPLETED|Overall Study||3
2244298|NCT02544074|5505081|P20|COMPLETED|Overall Study||3
2244299|NCT02544074|5505082|P19|COMPLETED|Overall Study||4
2244300|NCT02544074|5505083|P18|COMPLETED|Overall Study||3
2244301|NCT02544074|5505084|P17|COMPLETED|Overall Study||6
2244302|NCT02544074|5505085|P16|COMPLETED|Overall Study||8
2244303|NCT02544074|5505086|P15|COMPLETED|Overall Study||5
2244304|NCT02544074|5505087|P14|COMPLETED|Overall Study||5
2244305|NCT02544074|5505088|P13|COMPLETED|Overall Study||4
2244306|NCT02544074|5505089|P12|COMPLETED|Overall Study||3
2244307|NCT02544074|5505090|P11|COMPLETED|Overall Study||2
2244308|NCT02544074|5505091|P10|COMPLETED|Overall Study||1
2244309|NCT02544074|5505092|P9|COMPLETED|Overall Study||6
2244310|NCT02544074|5505093|P8|COMPLETED|Overall Study||4
2244311|NCT02544074|5505094|P7|COMPLETED|Overall Study||2
2244312|NCT02544074|5505095|P6|COMPLETED|Overall Study||0
2244313|NCT02544074|5505096|P5|COMPLETED|Overall Study||4
2244314|NCT02544074|5505097|P4|COMPLETED|Overall Study||1
2244315|NCT02544074|5505098|P3|COMPLETED|Overall Study||1
2244316|NCT02544074|5505099|P2|COMPLETED|Overall Study||0
2244317|NCT02544074|5505100|P1|COMPLETED|Overall Study||1
2244318|NCT02544074|5505080|P21|STARTED|Overall Study||3
2244319|NCT02544074|5505081|P20|STARTED|Overall Study||3
2244320|NCT02544074|5505082|P19|STARTED|Overall Study||4
2244321|NCT02544074|5505083|P18|STARTED|Overall Study||3
2244322|NCT02544074|5505084|P17|STARTED|Overall Study||6
2244323|NCT02544074|5505085|P16|STARTED|Overall Study||8
2244324|NCT02544074|5505086|P15|STARTED|Overall Study||5
2244325|NCT02544074|5505087|P14|STARTED|Overall Study||5
2244326|NCT02544074|5505088|P13|STARTED|Overall Study||4
2244327|NCT02544074|5505089|P12|STARTED|Overall Study||3
2244328|NCT02544074|5505090|P11|STARTED|Overall Study||2
2244329|NCT02544074|5505091|P10|STARTED|Overall Study||2
2244330|NCT02544074|5505092|P9|STARTED|Overall Study||6
2244331|NCT02544074|5505093|P8|STARTED|Overall Study||4
2244332|NCT02544074|5505094|P7|STARTED|Overall Study||2
2244333|NCT02544074|5505095|P6|STARTED|Overall Study||1
2244334|NCT02544074|5505096|P5|STARTED|Overall Study||4
2244335|NCT02544074|5505097|P4|STARTED|Overall Study||1
2244336|NCT02544074|5505098|P3|STARTED|Overall Study||1
2244337|NCT02544074|5505099|P2|STARTED|Overall Study||1
2244338|NCT02544074|5505100|P1|STARTED|Overall Study||1
2244339|NCT02543918|5505136|P2|NOT COMPLETED|Overall Study||4
2244340|NCT02543918|5505137|P1|NOT COMPLETED|Overall Study||3
2244341|NCT02543918|5505136|P2|COMPLETED|Overall Study||39
2244342|NCT02543918|5505137|P1|COMPLETED|Overall Study||38
2244343|NCT02543918|5505136|P2|Received at Least 1 Dose of Study Drug|Overall Study||42
2244344|NCT02543918|5505137|P1|Received at Least 1 Dose of Study Drug|Overall Study||41
2244345|NCT02543918|5505136|P2|STARTED|Overall Study||43
2244346|NCT02543918|5505137|P1|STARTED|Overall Study||41
2244347|NCT02543892|5505151|P8|NOT COMPLETED|Had Immunology Data||0
2244348|NCT02543892|5505152|P7|NOT COMPLETED|Had Immunology Data||1
2244349|NCT02543892|5505153|P6|NOT COMPLETED|Had Immunology Data||0
2244350|NCT02543892|5505154|P5|NOT COMPLETED|Had Immunology Data||0
2244351|NCT02543892|5505155|P4|NOT COMPLETED|Had Immunology Data||0
2244352|NCT02543892|5505156|P3|NOT COMPLETED|Had Immunology Data||0
2244353|NCT02543892|5505157|P2|NOT COMPLETED|Had Immunology Data||0
2244354|NCT02543892|5505158|P1|NOT COMPLETED|Had Immunology Data||0
2244355|NCT02543892|5505151|P8|COMPLETED|Had Immunology Data||49
2244356|NCT02543892|5505152|P7|COMPLETED|Had Immunology Data|Subject received both vaccinations and attended last visit, but withdrew consent afterwards.|49
2244357|NCT02543892|5505153|P6|COMPLETED|Had Immunology Data||49
2244358|NCT02543892|5505154|P5|COMPLETED|Had Immunology Data||50
2244359|NCT02543892|5505155|P4|COMPLETED|Had Immunology Data||12
2244360|NCT02543892|5505156|P3|COMPLETED|Had Immunology Data||12
2244361|NCT02543892|5505157|P2|COMPLETED|Had Immunology Data||11
2244362|NCT02543892|5505158|P1|COMPLETED|Had Immunology Data||11
2244363|NCT02543892|5505151|P8|STARTED|Had Immunology Data||49
2244364|NCT02543892|5505152|P7|STARTED|Had Immunology Data||50
2244365|NCT02543892|5505153|P6|STARTED|Had Immunology Data||49
2244366|NCT02543892|5505154|P5|STARTED|Had Immunology Data||50
2244367|NCT02543892|5505155|P4|STARTED|Had Immunology Data||12
2244368|NCT02543892|5505156|P3|STARTED|Had Immunology Data||12
2244369|NCT02543892|5505157|P2|STARTED|Had Immunology Data||11
2244370|NCT02543892|5505158|P1|STARTED|Had Immunology Data||11
2244371|NCT02543892|5505151|P8|NOT COMPLETED|Received Vaccination 2||1
2244372|NCT02543892|5505152|P7|NOT COMPLETED|Received Vaccination 2||0
2244373|NCT02543892|5505153|P6|NOT COMPLETED|Received Vaccination 2||1
2244374|NCT02543892|5505154|P5|NOT COMPLETED|Received Vaccination 2||0
2244375|NCT02543892|5505155|P4|NOT COMPLETED|Received Vaccination 2||0
2244376|NCT02543892|5505156|P3|NOT COMPLETED|Received Vaccination 2||0
2244377|NCT02543892|5505157|P2|NOT COMPLETED|Received Vaccination 2||1
2244378|NCT02543892|5505158|P1|NOT COMPLETED|Received Vaccination 2||1
2244379|NCT02543892|5505151|P8|COMPLETED|Received Vaccination 2||49
2244380|NCT02543892|5505152|P7|COMPLETED|Received Vaccination 2||50
2244381|NCT02543892|5505153|P6|COMPLETED|Received Vaccination 2||49
2244382|NCT02543892|5505154|P5|COMPLETED|Received Vaccination 2||50
2244383|NCT02543892|5505155|P4|COMPLETED|Received Vaccination 2||12
2244384|NCT02543892|5505156|P3|COMPLETED|Received Vaccination 2||12
2244385|NCT02543892|5505157|P2|COMPLETED|Received Vaccination 2||11
2244386|NCT02543892|5505158|P1|COMPLETED|Received Vaccination 2||11
2244387|NCT02543892|5505151|P8|STARTED|Received Vaccination 2||50
2244388|NCT02543892|5505152|P7|STARTED|Received Vaccination 2||50
2244389|NCT02543892|5505153|P6|STARTED|Received Vaccination 2||50
2244390|NCT02543892|5505154|P5|STARTED|Received Vaccination 2||50
2244391|NCT02543892|5505155|P4|STARTED|Received Vaccination 2||12
2244392|NCT02543892|5505156|P3|STARTED|Received Vaccination 2||12
2244393|NCT02543892|5505157|P2|STARTED|Received Vaccination 2||12
2244394|NCT02543892|5505158|P1|STARTED|Received Vaccination 2||12
2244395|NCT02543892|5505151|P8|NOT COMPLETED|Received Vaccination 1||0
2244396|NCT02543892|5505152|P7|NOT COMPLETED|Received Vaccination 1||0
2244397|NCT02543892|5505153|P6|NOT COMPLETED|Received Vaccination 1||0
2244398|NCT02543892|5505154|P5|NOT COMPLETED|Received Vaccination 1||0
2244399|NCT02543892|5505155|P4|NOT COMPLETED|Received Vaccination 1||0
2244400|NCT02543892|5505156|P3|NOT COMPLETED|Received Vaccination 1||0
2244401|NCT02543892|5505157|P2|NOT COMPLETED|Received Vaccination 1||0
2244402|NCT02543892|5505158|P1|NOT COMPLETED|Received Vaccination 1||0
2244403|NCT02543892|5505151|P8|COMPLETED|Received Vaccination 1||50
2244404|NCT02543892|5505152|P7|COMPLETED|Received Vaccination 1||50
2244405|NCT02543892|5505153|P6|COMPLETED|Received Vaccination 1||50
2244406|NCT02543892|5505154|P5|COMPLETED|Received Vaccination 1||50
2244407|NCT02543892|5505155|P4|COMPLETED|Received Vaccination 1||12
2244408|NCT02543892|5505156|P3|COMPLETED|Received Vaccination 1||12
2244409|NCT02543892|5505157|P2|COMPLETED|Received Vaccination 1||12
2244410|NCT02543892|5505158|P1|COMPLETED|Received Vaccination 1||12
2244411|NCT02543892|5505151|P8|STARTED|Received Vaccination 1||50
2244412|NCT02543892|5505152|P7|STARTED|Received Vaccination 1||50
2244413|NCT02543892|5505153|P6|STARTED|Received Vaccination 1||50
2244414|NCT02543892|5505154|P5|STARTED|Received Vaccination 1||50
2244415|NCT02543892|5505155|P4|STARTED|Received Vaccination 1||12
2244416|NCT02543892|5505156|P3|STARTED|Received Vaccination 1||12
2244417|NCT02543892|5505157|P2|STARTED|Received Vaccination 1||12
2244418|NCT02543892|5505158|P1|STARTED|Received Vaccination 1||12
2244419|NCT02543801|5505208|P4|NOT COMPLETED|Overall Study||0
2244420|NCT02543801|5505209|P3|NOT COMPLETED|Overall Study||0
2244421|NCT02543801|5505210|P2|NOT COMPLETED|Overall Study||2
2244422|NCT02543801|5505211|P1|NOT COMPLETED|Overall Study||1
2244423|NCT02543801|5505208|P4|COMPLETED|Overall Study||59
2244424|NCT02543801|5505209|P3|COMPLETED|Overall Study||59
2244425|NCT02543801|5505210|P2|COMPLETED|Overall Study||58
2244426|NCT02543801|5505211|P1|COMPLETED|Overall Study||60
2244427|NCT02543801|5505208|P4|STARTED|Overall Study||59
2244428|NCT02543801|5505209|P3|STARTED|Overall Study||59
2244429|NCT02543801|5505210|P2|STARTED|Overall Study||60
2244430|NCT02543801|5505211|P1|STARTED|Overall Study||61
2244431|NCT02543554|5505231|P2|NOT COMPLETED|Overall Study||0
2244432|NCT02543554|5505232|P1|NOT COMPLETED|Overall Study||0
2244433|NCT02543554|5505231|P2|COMPLETED|Overall Study||513
2244434|NCT02543554|5505232|P1|COMPLETED|Overall Study||1192
2244435|NCT02543554|5505231|P2|STARTED|Overall Study||513
2244436|NCT02543554|5505232|P1|STARTED|Overall Study||1192
2244437|NCT02543528|5505240|P5|NOT COMPLETED|Extended Wear Period||0
2244438|NCT02543528|5505241|P4|NOT COMPLETED|Extended Wear Period||12
2244439|NCT02543528|5505242|P3|NOT COMPLETED|Extended Wear Period||23
2244440|NCT02543528|5505243|P2|NOT COMPLETED|Extended Wear Period||21
2244441|NCT02543528|5505244|P1|NOT COMPLETED|Extended Wear Period||28
2244442|NCT02543528|5505240|P5|COMPLETED|Extended Wear Period||0
2244443|NCT02543528|5505241|P4|COMPLETED|Extended Wear Period||23
2244444|NCT02543528|5505242|P3|COMPLETED|Extended Wear Period||13
2244445|NCT02543528|5505243|P2|COMPLETED|Extended Wear Period||14
2244446|NCT02543528|5505244|P1|COMPLETED|Extended Wear Period||8
2244447|NCT02543528|5505240|P5|STARTED|Extended Wear Period||0
2244448|NCT02543528|5505241|P4|STARTED|Extended Wear Period||35
2244449|NCT02543528|5505242|P3|STARTED|Extended Wear Period||36
2244450|NCT02543528|5505243|P2|STARTED|Extended Wear Period||35
2244451|NCT02543528|5505244|P1|STARTED|Extended Wear Period||36
2244452|NCT02543528|5505240|P5|NOT COMPLETED|Adaptation Period||26
2244453|NCT02543528|5505241|P4|NOT COMPLETED|Adaptation Period||0
2244454|NCT02543528|5505242|P3|NOT COMPLETED|Adaptation Period||0
2244455|NCT02543528|5505243|P2|NOT COMPLETED|Adaptation Period||0
2244456|NCT02543528|5505244|P1|NOT COMPLETED|Adaptation Period||0
2244457|NCT02543528|5505240|P5|COMPLETED|Adaptation Period||142
2244458|NCT02543528|5505241|P4|COMPLETED|Adaptation Period||0
2244459|NCT02543528|5505242|P3|COMPLETED|Adaptation Period||0
2244460|NCT02543528|5505243|P2|COMPLETED|Adaptation Period||0
2244461|NCT02543528|5505244|P1|COMPLETED|Adaptation Period||0
2244462|NCT02543528|5505240|P5|STARTED|Adaptation Period||168
2244463|NCT02543528|5505241|P4|STARTED|Adaptation Period||0
2244464|NCT02543528|5505242|P3|STARTED|Adaptation Period||0
2244465|NCT02543528|5505243|P2|STARTED|Adaptation Period||0
2244466|NCT02543528|5505244|P1|STARTED|Adaptation Period||0
2244467|NCT02543437|5505263|P1|NOT COMPLETED|Overall Study||0
2244468|NCT02543437|5505263|P1|COMPLETED|Overall Study||117
2244469|NCT02543437|5505263|P1|STARTED|Overall Study||117
2244470|NCT02543398|5505270|P2|NOT COMPLETED|Overall Study||0
2244471|NCT02543398|5505271|P1|NOT COMPLETED|Overall Study||0
2244472|NCT02543398|5505270|P2|COMPLETED|Overall Study||20
2244473|NCT02543398|5505271|P1|COMPLETED|Overall Study||20
2244474|NCT02543398|5505270|P2|STARTED|Overall Study||20
2244475|NCT02543398|5505271|P1|STARTED|Overall Study||20
2244476|NCT02543346|5505277|P4|NOT COMPLETED|Second Treatment Visit||0
2244477|NCT02543346|5505278|P3|NOT COMPLETED|Second Treatment Visit||0
2244478|NCT02543346|5505279|P2|NOT COMPLETED|Second Treatment Visit||0
2244479|NCT02543346|5505280|P1|NOT COMPLETED|Second Treatment Visit||0
2244480|NCT02543346|5505277|P4|COMPLETED|Second Treatment Visit||21
2244481|NCT02543346|5505278|P3|COMPLETED|Second Treatment Visit||22
2244482|NCT02543346|5505279|P2|COMPLETED|Second Treatment Visit||23
2244483|NCT02543346|5505280|P1|COMPLETED|Second Treatment Visit||25
2244484|NCT02543346|5505277|P4|STARTED|Second Treatment Visit||21
2244485|NCT02543346|5505278|P3|STARTED|Second Treatment Visit||22
2244486|NCT02543346|5505279|P2|STARTED|Second Treatment Visit||23
2244487|NCT02543346|5505280|P1|STARTED|Second Treatment Visit||25
2244488|NCT02543346|5505277|P4|NOT COMPLETED|Second Priming Visit||2
2244489|NCT02543346|5505278|P3|NOT COMPLETED|Second Priming Visit||2
2244490|NCT02543346|5505279|P2|NOT COMPLETED|Second Priming Visit||2
2244491|NCT02543346|5505280|P1|NOT COMPLETED|Second Priming Visit||1
2244492|NCT02543346|5505277|P4|COMPLETED|Second Priming Visit||21
2244493|NCT02543346|5505278|P3|COMPLETED|Second Priming Visit||22
2244494|NCT02543346|5505279|P2|COMPLETED|Second Priming Visit||23
2244495|NCT02543346|5505280|P1|COMPLETED|Second Priming Visit||25
2244496|NCT02543346|5505277|P4|STARTED|Second Priming Visit||23
2244497|NCT02543346|5505278|P3|STARTED|Second Priming Visit||24
2244498|NCT02543346|5505279|P2|STARTED|Second Priming Visit||25
2244499|NCT02543346|5505280|P1|STARTED|Second Priming Visit||26
2244500|NCT02543346|5505277|P4|NOT COMPLETED|Washout (at Least 14 Days)||0
2244501|NCT02543346|5505278|P3|NOT COMPLETED|Washout (at Least 14 Days)||0
2244502|NCT02543346|5505279|P2|NOT COMPLETED|Washout (at Least 14 Days)||0
2244503|NCT02543346|5505280|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
2244504|NCT02543346|5505277|P4|COMPLETED|Washout (at Least 14 Days)||23
2244505|NCT02543346|5505278|P3|COMPLETED|Washout (at Least 14 Days)||24
2244506|NCT02543346|5505279|P2|COMPLETED|Washout (at Least 14 Days)||25
2244507|NCT02543346|5505280|P1|COMPLETED|Washout (at Least 14 Days)||26
2244508|NCT02543346|5505277|P4|STARTED|Washout (at Least 14 Days)||23
2244509|NCT02543346|5505278|P3|STARTED|Washout (at Least 14 Days)||24
2244510|NCT02543346|5505279|P2|STARTED|Washout (at Least 14 Days)||25
2244511|NCT02543346|5505280|P1|STARTED|Washout (at Least 14 Days)||26
2244512|NCT02543346|5505277|P4|NOT COMPLETED|First Treatment Visit||0
2244513|NCT02543346|5505278|P3|NOT COMPLETED|First Treatment Visit||0
2244514|NCT02543346|5505279|P2|NOT COMPLETED|First Treatment Visit||0
2244515|NCT02543346|5505280|P1|NOT COMPLETED|First Treatment Visit||0
2244516|NCT02543346|5505277|P4|COMPLETED|First Treatment Visit||23
2244517|NCT02543346|5505278|P3|COMPLETED|First Treatment Visit||24
2244518|NCT02543346|5505279|P2|COMPLETED|First Treatment Visit||25
2244519|NCT02543346|5505280|P1|COMPLETED|First Treatment Visit||26
2244520|NCT02543346|5505277|P4|STARTED|First Treatment Visit||23
2244521|NCT02543346|5505278|P3|STARTED|First Treatment Visit||24
2244522|NCT02543346|5505279|P2|STARTED|First Treatment Visit||25
2244523|NCT02543346|5505280|P1|STARTED|First Treatment Visit||26
2244524|NCT02543346|5505277|P4|NOT COMPLETED|First Priming Visit||0
2244525|NCT02543346|5505278|P3|NOT COMPLETED|First Priming Visit||0
2244526|NCT02543346|5505279|P2|NOT COMPLETED|First Priming Visit||0
2244527|NCT02543346|5505280|P1|NOT COMPLETED|First Priming Visit||0
2244528|NCT02543346|5505277|P4|COMPLETED|First Priming Visit||23
2244529|NCT02543346|5505278|P3|COMPLETED|First Priming Visit||24
2244530|NCT02543346|5505279|P2|COMPLETED|First Priming Visit||25
2244531|NCT02543346|5505280|P1|COMPLETED|First Priming Visit||26
2244532|NCT02543346|5505277|P4|STARTED|First Priming Visit||23
2244533|NCT02543346|5505278|P3|STARTED|First Priming Visit||24
2244534|NCT02543346|5505279|P2|STARTED|First Priming Visit||25
2244535|NCT02543346|5505280|P1|STARTED|First Priming Visit||26
2244536|NCT02543294|5505306|P1|NOT COMPLETED|Overall Study||12
2244537|NCT02543294|5505306|P1|COMPLETED|Overall Study||8
2244538|NCT02543294|5505306|P1|STARTED|Overall Study||20
2244539|NCT02542943|5505314|P3|NOT COMPLETED|Overall Study||0
2244540|NCT02542943|5505315|P2|NOT COMPLETED|Overall Study||1
2244541|NCT02542943|5505316|P1|NOT COMPLETED|Overall Study||1
2244542|NCT02542943|5505314|P3|COMPLETED|Overall Study||81
2244543|NCT02542943|5505315|P2|COMPLETED|Overall Study||79
2244544|NCT02542943|5505316|P1|COMPLETED|Overall Study||78
2244545|NCT02542943|5505314|P3|STARTED|Overall Study||81
2244546|NCT02542943|5505315|P2|STARTED|Overall Study||80
2244547|NCT02542943|5505316|P1|STARTED|Overall Study||79
2244548|NCT02542865|5505343|P2|NOT COMPLETED|Overall Study||0
2244549|NCT02542865|5505344|P1|NOT COMPLETED|Overall Study||17
2244550|NCT02542865|5505343|P2|COMPLETED|Overall Study||462
2244551|NCT02542865|5505344|P1|COMPLETED|Overall Study||445
2244552|NCT02542865|5505343|P2|Treated|Overall Study||462
2244553|NCT02542865|5505344|P1|Treated|Overall Study||460
2244554|NCT02542865|5505343|P2|STARTED|Overall Study||462
2244555|NCT02542865|5505344|P1|STARTED|Overall Study||462
2244556|NCT02542761|5505388|P2|NOT COMPLETED|Second Intervention||0
2244557|NCT02542761|5505389|P1|NOT COMPLETED|Second Intervention||0
2244558|NCT02542761|5505388|P2|COMPLETED|Second Intervention||5
2244559|NCT02542761|5505389|P1|COMPLETED|Second Intervention||5
2244560|NCT02542761|5505388|P2|STARTED|Second Intervention||5
2244561|NCT02542761|5505389|P1|STARTED|Second Intervention||5
2244562|NCT02542761|5505388|P2|NOT COMPLETED|Acclimation Period 2||0
2244563|NCT02542761|5505389|P1|NOT COMPLETED|Acclimation Period 2||0
2244564|NCT02542761|5505388|P2|COMPLETED|Acclimation Period 2||5
2244565|NCT02542761|5505389|P1|COMPLETED|Acclimation Period 2||5
2244566|NCT02542761|5505388|P2|STARTED|Acclimation Period 2||5
2244567|NCT02542761|5505389|P1|STARTED|Acclimation Period 2||5
2244568|NCT02542761|5505388|P2|NOT COMPLETED|First Intervention||0
2244569|NCT02542761|5505389|P1|NOT COMPLETED|First Intervention||0
2244570|NCT02542761|5505388|P2|COMPLETED|First Intervention||5
2244571|NCT02542761|5505389|P1|COMPLETED|First Intervention||5
2244572|NCT02542761|5505388|P2|STARTED|First Intervention||5
2244573|NCT02542761|5505389|P1|STARTED|First Intervention||5
2244574|NCT02542761|5505388|P2|NOT COMPLETED|Acclimation Period 1||0
2244575|NCT02542761|5505389|P1|NOT COMPLETED|Acclimation Period 1||0
2244576|NCT02542761|5505388|P2|COMPLETED|Acclimation Period 1||5
2244577|NCT02542761|5505389|P1|COMPLETED|Acclimation Period 1||5
2244578|NCT02542761|5505388|P2|STARTED|Acclimation Period 1||5
2244579|NCT02542761|5505389|P1|STARTED|Acclimation Period 1||5
2244580|NCT02542631|5505407|P2|NOT COMPLETED|Overall Study||31
2244581|NCT02542631|5505408|P1|NOT COMPLETED|Overall Study||31
2244582|NCT02542631|5505407|P2|COMPLETED|Overall Study||108
2244583|NCT02542631|5505408|P1|COMPLETED|Overall Study||108
2244584|NCT02542631|5505407|P2|STARTED|Overall Study||139
2244585|NCT02542631|5505408|P1|STARTED|Overall Study||139
2244586|NCT02542605|5505430|P3|NOT COMPLETED|Part B: Randomization Phase||1
2244587|NCT02542605|5505431|P2|NOT COMPLETED|Part B: Randomization Phase||0
2244588|NCT02542605|5505432|P1|NOT COMPLETED|Part B: Randomization Phase||0
2244589|NCT02542605|5505430|P3|COMPLETED|Part B: Randomization Phase||7
2244590|NCT02542605|5505431|P2|COMPLETED|Part B: Randomization Phase||9
2244591|NCT02542605|5505432|P1|COMPLETED|Part B: Randomization Phase||0
2244592|NCT02542605|5505430|P3|Received Placebo/Erenumab|Part B: Randomization Phase||7
2244593|NCT02542605|5505431|P2|Received Placebo/Erenumab|Part B: Randomization Phase||9
2244594|NCT02542605|5505432|P1|Received Placebo/Erenumab|Part B: Randomization Phase||0
2244595|NCT02542605|5505430|P3|PACAP-38 naïve Participants|Part B: Randomization Phase||8
2244596|NCT02542605|5505431|P2|PACAP-38 naïve Participants|Part B: Randomization Phase||7
2244597|NCT02542605|5505432|P1|PACAP-38 naïve Participants|Part B: Randomization Phase||0
2244598|NCT02542605|5505430|P3|Not PACAP-38 naïve Participants|Part B: Randomization Phase||0
2244599|NCT02542605|5505431|P2|Not PACAP-38 naïve Participants|Part B: Randomization Phase||2
2244600|NCT02542605|5505432|P1|Not PACAP-38 naïve Participants|Part B: Randomization Phase||0
2244601|NCT02542605|5505430|P3|STARTED|Part B: Randomization Phase||8
2244602|NCT02542605|5505431|P2|STARTED|Part B: Randomization Phase||9
2244603|NCT02542605|5505432|P1|STARTED|Part B: Randomization Phase||0
2244604|NCT02542605|5505430|P3|NOT COMPLETED|Part B: Challenge Phase||0
2244605|NCT02542605|5505431|P2|NOT COMPLETED|Part B: Challenge Phase||0
2244606|NCT02542605|5505432|P1|NOT COMPLETED|Part B: Challenge Phase||1
2244607|NCT02542605|5505430|P3|COMPLETED|Part B: Challenge Phase||0
2244608|NCT02542605|5505431|P2|COMPLETED|Part B: Challenge Phase||0
2244609|NCT02542605|5505432|P1|COMPLETED|Part B: Challenge Phase||22
2244610|NCT02542605|5505430|P3|Proceeded to Randomization Phase|Part B: Challenge Phase||0
2244611|NCT02542605|5505431|P2|Proceeded to Randomization Phase|Part B: Challenge Phase||0
2244612|NCT02542605|5505432|P1|Proceeded to Randomization Phase|Part B: Challenge Phase||15
2244613|NCT02542605|5505430|P3|Received PACAP-38|Part B: Challenge Phase||0
2244614|NCT02542605|5505431|P2|Received PACAP-38|Part B: Challenge Phase||0
2244615|NCT02542605|5505432|P1|Received PACAP-38|Part B: Challenge Phase||23
2244616|NCT02542605|5505430|P3|STARTED|Part B: Challenge Phase||0
2244617|NCT02542605|5505431|P2|STARTED|Part B: Challenge Phase||0
2244618|NCT02542605|5505432|P1|STARTED|Part B: Challenge Phase||23
2244619|NCT02542605|5505430|P3|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
2244620|NCT02542605|5505431|P2|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
2244621|NCT02542605|5505432|P1|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
2244622|NCT02542605|5505430|P3|COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
2244623|NCT02542605|5505431|P2|COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
2244624|NCT02542605|5505432|P1|COMPLETED|Part A: PACAP-38 Dose Selection Phase||12
2244625|NCT02542605|5505430|P3|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||0
2244626|NCT02542605|5505431|P2|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||0
2244627|NCT02542605|5505432|P1|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||2
2244628|NCT02542605|5505430|P3|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||0
2244629|NCT02542605|5505431|P2|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||0
2244630|NCT02542605|5505432|P1|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||12
2244631|NCT02542605|5505430|P3|STARTED|Part A: PACAP-38 Dose Selection Phase||0
2244632|NCT02542605|5505431|P2|STARTED|Part A: PACAP-38 Dose Selection Phase||0
2244633|NCT02542605|5505432|P1|STARTED|Part A: PACAP-38 Dose Selection Phase||12
2244634|NCT02542462|5505483|P4|NOT COMPLETED|Overall Study||1
2244635|NCT02542462|5505484|P3|NOT COMPLETED|Overall Study||0
2244636|NCT02542462|5505485|P2|NOT COMPLETED|Overall Study||0
2244637|NCT02542462|5505486|P1|NOT COMPLETED|Overall Study||0
2244638|NCT02542462|5505483|P4|COMPLETED|Overall Study||25
2244639|NCT02542462|5505484|P3|COMPLETED|Overall Study||25
2244640|NCT02542462|5505485|P2|COMPLETED|Overall Study||25
2244641|NCT02542462|5505486|P1|COMPLETED|Overall Study||25
2244642|NCT02542462|5505483|P4|STARTED|Overall Study||26
2244643|NCT02542462|5505484|P3|STARTED|Overall Study||25
2244644|NCT02542462|5505485|P2|STARTED|Overall Study||25
2244645|NCT02542462|5505486|P1|STARTED|Overall Study||25
2244646|NCT02542410|5505500|P2|NOT COMPLETED|Overall Study||1
2244647|NCT02542410|5505501|P1|NOT COMPLETED|Overall Study||2
2244648|NCT02542410|5505500|P2|COMPLETED|Overall Study||4
2244649|NCT02542410|5505501|P1|COMPLETED|Overall Study||3
2244650|NCT02542410|5505500|P2|STARTED|Overall Study||5
2244651|NCT02542410|5505501|P1|STARTED|Overall Study||5
2244652|NCT02542280|5505511|P2|NOT COMPLETED|Overall Study||8
2244653|NCT02542280|5505512|P1|NOT COMPLETED|Overall Study||12
2244654|NCT02542280|5505511|P2|COMPLETED|Overall Study||167
2244655|NCT02542280|5505512|P1|COMPLETED|Overall Study||162
2244656|NCT02542280|5505511|P2|STARTED|Overall Study||175
2244657|NCT02542280|5505512|P1|STARTED|Overall Study||174
2244658|NCT02542072|5505522|P2|NOT COMPLETED|Second Intervention (1 Month)||0
2244659|NCT02542072|5505523|P1|NOT COMPLETED|Second Intervention (1 Month)||2
2244660|NCT02542072|5505522|P2|COMPLETED|Second Intervention (1 Month)||43
2244661|NCT02542072|5505523|P1|COMPLETED|Second Intervention (1 Month)||37
2244662|NCT02542072|5505522|P2|STARTED|Second Intervention (1 Month)||43
2244663|NCT02542072|5505523|P1|STARTED|Second Intervention (1 Month)||39
2244664|NCT02542072|5505522|P2|NOT COMPLETED|First Intervention (1 Month)||3
2244665|NCT02542072|5505523|P1|NOT COMPLETED|First Intervention (1 Month)||5
2244666|NCT02542072|5505522|P2|COMPLETED|First Intervention (1 Month)||43
2244667|NCT02542072|5505523|P1|COMPLETED|First Intervention (1 Month)||39
2244668|NCT02542072|5505522|P2|STARTED|First Intervention (1 Month)||46
2244669|NCT02542072|5505523|P1|STARTED|First Intervention (1 Month)||44
2244670|NCT02542046|5505626|P3|NOT COMPLETED|Overall Study||0
2244671|NCT02542046|5505627|P2|NOT COMPLETED|Overall Study||0
2244672|NCT02542046|5505628|P1|NOT COMPLETED|Overall Study||0
2244673|NCT02542046|5505626|P3|COMPLETED|Overall Study||300
2244674|NCT02542046|5505627|P2|COMPLETED|Overall Study||300
2244675|NCT02542046|5505628|P1|COMPLETED|Overall Study||300
2244676|NCT02542046|5505626|P3|STARTED|Overall Study||300
2244677|NCT02542046|5505627|P2|STARTED|Overall Study||300
2244678|NCT02542046|5505628|P1|STARTED|Overall Study||300
2244679|NCT02541942|5505642|P1|NOT COMPLETED|Overall Study||0
2244680|NCT02541942|5505642|P1|COMPLETED|Overall Study||19
2244681|NCT02541942|5505642|P1|STARTED|Overall Study||19
2244682|NCT02541864|5505649|P2|NOT COMPLETED|Overall Study||0
2244683|NCT02541864|5505650|P1|NOT COMPLETED|Overall Study||0
2244684|NCT02541864|5505649|P2|COMPLETED|Overall Study||166
2244685|NCT02541864|5505650|P1|COMPLETED|Overall Study||164
2244686|NCT02541864|5505649|P2|STARTED|Overall Study||166
2244687|NCT02541864|5505650|P1|STARTED|Overall Study||164
2244688|NCT02541669|5505661|P5|NOT COMPLETED|Double-Blinded Treatment Period||1
2244689|NCT02541669|5505662|P4|NOT COMPLETED|Double-Blinded Treatment Period||0
2244690|NCT02541669|5505663|P3|NOT COMPLETED|Double-Blinded Treatment Period||1
2244691|NCT02541669|5505664|P2|NOT COMPLETED|Double-Blinded Treatment Period||0
2244692|NCT02541669|5505665|P1|NOT COMPLETED|Double-Blinded Treatment Period||0
2244693|NCT02541669|5505661|P5|COMPLETED|Double-Blinded Treatment Period||15
2244694|NCT02541669|5505662|P4|COMPLETED|Double-Blinded Treatment Period||16
2244695|NCT02541669|5505663|P3|COMPLETED|Double-Blinded Treatment Period||15
2244696|NCT02541669|5505664|P2|COMPLETED|Double-Blinded Treatment Period||0
2244697|NCT02541669|5505665|P1|COMPLETED|Double-Blinded Treatment Period||0
2244698|NCT02541669|5505661|P5|STARTED|Double-Blinded Treatment Period||16
2244699|NCT02541669|5505662|P4|STARTED|Double-Blinded Treatment Period||16
2244700|NCT02541669|5505663|P3|STARTED|Double-Blinded Treatment Period||16
2244701|NCT02541669|5505664|P2|STARTED|Double-Blinded Treatment Period||0
2244702|NCT02541669|5505665|P1|STARTED|Double-Blinded Treatment Period||0
2244703|NCT02541669|5505661|P5|NOT COMPLETED|Open Label Treatment Period||0
2244704|NCT02541669|5505662|P4|NOT COMPLETED|Open Label Treatment Period||0
2244705|NCT02541669|5505663|P3|NOT COMPLETED|Open Label Treatment Period||0
2244706|NCT02541669|5505664|P2|NOT COMPLETED|Open Label Treatment Period||0
2244707|NCT02541669|5505665|P1|NOT COMPLETED|Open Label Treatment Period||0
2244708|NCT02541669|5505661|P5|COMPLETED|Open Label Treatment Period||0
2244709|NCT02541669|5505662|P4|COMPLETED|Open Label Treatment Period||0
2244710|NCT02541669|5505663|P3|COMPLETED|Open Label Treatment Period||0
2244711|NCT02541669|5505664|P2|COMPLETED|Open Label Treatment Period||8
2244712|NCT02541669|5505665|P1|COMPLETED|Open Label Treatment Period||8
2244713|NCT02541669|5505661|P5|STARTED|Open Label Treatment Period||0
2244714|NCT02541669|5505662|P4|STARTED|Open Label Treatment Period||0
2244715|NCT02541669|5505663|P3|STARTED|Open Label Treatment Period||0
2244716|NCT02541669|5505664|P2|STARTED|Open Label Treatment Period||8
2244717|NCT02541669|5505665|P1|STARTED|Open Label Treatment Period||8
2244754|NCT02541422|5505828|P2|NOT COMPLETED|Second Intervention||0
2244755|NCT02541422|5505829|P1|NOT COMPLETED|Second Intervention||0
2244756|NCT02541422|5505828|P2|COMPLETED|Second Intervention||26
2244757|NCT02541422|5505829|P1|COMPLETED|Second Intervention||23
2244758|NCT02541422|5505828|P2|STARTED|Second Intervention||26
2244759|NCT02541422|5505829|P1|STARTED|Second Intervention||23
2244760|NCT02541422|5505828|P2|NOT COMPLETED|First Intervention||0
2244761|NCT02541422|5505829|P1|NOT COMPLETED|First Intervention||0
2244762|NCT02541422|5505828|P2|COMPLETED|First Intervention||26
2244763|NCT02541422|5505829|P1|COMPLETED|First Intervention||23
2244764|NCT02541422|5505828|P2|STARTED|First Intervention||26
2244765|NCT02541422|5505829|P1|STARTED|First Intervention||23
2244766|NCT02540850|5505838|P3|NOT COMPLETED|Overall Study||34
2244767|NCT02540850|5505839|P2|NOT COMPLETED|Overall Study||66
2244768|NCT02540850|5505840|P1|NOT COMPLETED|Overall Study||69
2244769|NCT02540850|5505838|P3|COMPLETED|Overall Study||410
2244770|NCT02540850|5505839|P2|COMPLETED|Overall Study||330
2244771|NCT02540850|5505840|P1|COMPLETED|Overall Study||291
2244772|NCT02540850|5505838|P3|STARTED|Overall Study||444
2244773|NCT02540850|5505839|P2|STARTED|Overall Study||396
2244774|NCT02540850|5505840|P1|STARTED|Overall Study||360
2244775|NCT02540772|5505868|P2|NOT COMPLETED|Overall Study||0
2244776|NCT02540772|5505869|P1|NOT COMPLETED|Overall Study||0
2244777|NCT02540772|5505868|P2|COMPLETED|Overall Study||10
2244778|NCT02540772|5505869|P1|COMPLETED|Overall Study||10
2244779|NCT02540772|5505868|P2|STARTED|Overall Study||10
2244780|NCT02540772|5505869|P1|STARTED|Overall Study||10
2244781|NCT02540668|5505881|P2|NOT COMPLETED|Period 2 - LY3314814 and Warfarin||1
2244782|NCT02540668|5505882|P1|NOT COMPLETED|Period 2 - LY3314814 and Warfarin||0
2244783|NCT02540668|5505881|P2|COMPLETED|Period 2 - LY3314814 and Warfarin||14
2244784|NCT02540668|5505882|P1|COMPLETED|Period 2 - LY3314814 and Warfarin||0
2244785|NCT02540668|5505881|P2|STARTED|Period 2 - LY3314814 and Warfarin|Warfarin was co-administered with LY3314814 only in Period 2.|15
2244786|NCT02540668|5505882|P1|STARTED|Period 2 - LY3314814 and Warfarin|Warfarin was administered alone only in Period 1.|0
2244787|NCT02540668|5505881|P2|NOT COMPLETED|Period 1 - Warfarin Single Dose||0
2244788|NCT02540668|5505882|P1|NOT COMPLETED|Period 1 - Warfarin Single Dose||0
2244789|NCT02540668|5505881|P2|COMPLETED|Period 1 - Warfarin Single Dose||0
2244790|NCT02540668|5505882|P1|COMPLETED|Period 1 - Warfarin Single Dose||15
2244791|NCT02540668|5505881|P2|Received at Least One Dose of Study Drug|Period 1 - Warfarin Single Dose||0
2244792|NCT02540668|5505882|P1|Received at Least One Dose of Study Drug|Period 1 - Warfarin Single Dose||15
2244793|NCT02540668|5505881|P2|STARTED|Period 1 - Warfarin Single Dose||0
2244794|NCT02540668|5505882|P1|STARTED|Period 1 - Warfarin Single Dose||15
2244795|NCT02540538|5505902|P3|NOT COMPLETED|Overall Study||0
2244796|NCT02540538|5505903|P2|NOT COMPLETED|Overall Study||1
2244797|NCT02540538|5505904|P1|NOT COMPLETED|Overall Study||0
2244798|NCT02540538|5505902|P3|COMPLETED|Overall Study||10
2244799|NCT02540538|5505903|P2|COMPLETED|Overall Study||11
2244800|NCT02540538|5505904|P1|COMPLETED|Overall Study||12
2244801|NCT02540538|5505902|P3|STARTED|Overall Study||10
2244802|NCT02540538|5505903|P2|STARTED|Overall Study||12
2244803|NCT02540538|5505904|P1|STARTED|Overall Study||12
2244804|NCT02540447|5505920|P2|NOT COMPLETED|Overall Study||0
2244805|NCT02540447|5505921|P1|NOT COMPLETED|Overall Study||0
2244806|NCT02540447|5505920|P2|COMPLETED|Overall Study||40
2244807|NCT02540447|5505921|P1|COMPLETED|Overall Study||40
2244808|NCT02540447|5505920|P2|STARTED|Overall Study||40
2244809|NCT02540447|5505921|P1|STARTED|Overall Study||40
2244810|NCT02540434|5505937|P2|NOT COMPLETED|Overall Study||0
2244811|NCT02540434|5505938|P1|NOT COMPLETED|Overall Study||0
2244812|NCT02540434|5505937|P2|COMPLETED|Overall Study||1
2244813|NCT02540434|5505938|P1|COMPLETED|Overall Study||1
2244814|NCT02540434|5505937|P2|STARTED|Overall Study||1
2244815|NCT02540434|5505938|P1|STARTED|Overall Study||1
2244816|NCT02540356|5505972|P2|NOT COMPLETED|Overall Study||0
2244817|NCT02540356|5505973|P1|NOT COMPLETED|Overall Study||1
2244818|NCT02540356|5505972|P2|COMPLETED|Overall Study||0
2244819|NCT02540356|5505973|P1|COMPLETED|Overall Study||0
2244820|NCT02540356|5505972|P2|STARTED|Overall Study||0
2244821|NCT02540356|5505973|P1|STARTED|Overall Study||1
2244834|NCT02540265|5506046|P3|NOT COMPLETED|Overall Study||1
2244835|NCT02540265|5506047|P2|NOT COMPLETED|Overall Study||0
2244836|NCT02540265|5506048|P1|NOT COMPLETED|Overall Study||0
2244837|NCT02540265|5506046|P3|COMPLETED|Overall Study||18
2244838|NCT02540265|5506047|P2|COMPLETED|Overall Study||20
2244839|NCT02540265|5506048|P1|COMPLETED|Overall Study||20
2244840|NCT02540265|5506046|P3|Treatment Completion|Overall Study||18
2244841|NCT02540265|5506047|P2|Treatment Completion|Overall Study||19
2244842|NCT02540265|5506048|P1|Treatment Completion|Overall Study||20
2244843|NCT02540265|5506046|P3|STARTED|Overall Study||19
2244844|NCT02540265|5506047|P2|STARTED|Overall Study||20
2244845|NCT02540265|5506048|P1|STARTED|Overall Study||20
2244846|NCT02540213|5506068|P1|NOT COMPLETED|Overall Study||39
2244847|NCT02540213|5506068|P1|COMPLETED|Overall Study||201
2244848|NCT02540213|5506068|P1|STARTED|Overall Study||240
2244849|NCT02540083|5506089|P1|NOT COMPLETED|Overall Study||16
2244850|NCT02540083|5506089|P1|COMPLETED|Overall Study||78
2244851|NCT02540083|5506089|P1|STARTED|Overall Study||94
2244852|NCT02539992|5506102|P3|NOT COMPLETED|Overall Study||4
2244853|NCT02539992|5506103|P2|NOT COMPLETED|Overall Study||4
2244854|NCT02539992|5506104|P1|NOT COMPLETED|Overall Study||0
2244855|NCT02539992|5506102|P3|COMPLETED|Overall Study||14
2244856|NCT02539992|5506103|P2|COMPLETED|Overall Study||7
2244857|NCT02539992|5506104|P1|COMPLETED|Overall Study||15
2244858|NCT02539992|5506102|P3|STARTED|Overall Study||18
2244859|NCT02539992|5506103|P2|STARTED|Overall Study||11
2244860|NCT02539992|5506104|P1|STARTED|Overall Study||15
2244861|NCT02539797|5506130|P3|NOT COMPLETED|Overall Study||0
2244862|NCT02539797|5506131|P2|NOT COMPLETED|Overall Study||1
2244863|NCT02539797|5506132|P1|NOT COMPLETED|Overall Study||0
2244864|NCT02539797|5506130|P3|COMPLETED|Overall Study||13
2244865|NCT02539797|5506131|P2|COMPLETED|Overall Study||12
2244866|NCT02539797|5506132|P1|COMPLETED|Overall Study||12
2244867|NCT02539797|5506130|P3|STARTED|Overall Study||13
2244868|NCT02539797|5506131|P2|STARTED|Overall Study||13
2244869|NCT02539797|5506132|P1|STARTED|Overall Study||12
2244870|NCT02539654|5506143|P1|NOT COMPLETED|Overall Study||0
2244871|NCT02539654|5506143|P1|COMPLETED|Overall Study||14
2244872|NCT02539654|5506143|P1|STARTED|Overall Study||14
2244873|NCT02539563|5506155|P2|NOT COMPLETED|Overall Study||14
2244874|NCT02539563|5506156|P1|NOT COMPLETED|Overall Study||6
2244875|NCT02539563|5506155|P2|COMPLETED|Overall Study||42
2244876|NCT02539563|5506156|P1|COMPLETED|Overall Study||39
2244877|NCT02539563|5506155|P2|STARTED|Overall Study||56
2244878|NCT02539563|5506156|P1|STARTED|Overall Study||45
2244879|NCT02539511|5506172|P2|NOT COMPLETED|Overall Study||0
2244880|NCT02539511|5506173|P1|NOT COMPLETED|Overall Study||6
2244881|NCT02539511|5506172|P2|COMPLETED|Overall Study||17
2244882|NCT02539511|5506173|P1|COMPLETED|Overall Study||17
2244883|NCT02539511|5506172|P2|STARTED|Overall Study||17
2244884|NCT02539511|5506173|P1|STARTED|Overall Study||23
2244885|NCT02539368|5506184|P5|NOT COMPLETED|Overall Study||14
2244886|NCT02539368|5506185|P4|NOT COMPLETED|Overall Study||7
2244887|NCT02539368|5506186|P3|NOT COMPLETED|Overall Study||67
2244888|NCT02539368|5506187|P2|NOT COMPLETED|Overall Study||101
2244889|NCT02539368|5506188|P1|NOT COMPLETED|Overall Study||405
2244890|NCT02539368|5506184|P5|COMPLETED|Overall Study||88
2244891|NCT02539368|5506185|P4|COMPLETED|Overall Study||60
2244892|NCT02539368|5506186|P3|COMPLETED|Overall Study||291
2244893|NCT02539368|5506187|P2|COMPLETED|Overall Study||393
2244894|NCT02539368|5506188|P1|COMPLETED|Overall Study||1117
2244895|NCT02539368|5506184|P5|STARTED|Overall Study||102
2244896|NCT02539368|5506185|P4|STARTED|Overall Study||67
2244897|NCT02539368|5506186|P3|STARTED|Overall Study||358
2244898|NCT02539368|5506187|P2|STARTED|Overall Study||494
2244899|NCT02539368|5506188|P1|STARTED|Overall Study||1522
2244900|NCT02539342|5506310|P2|NOT COMPLETED|Overall Study||0
2244901|NCT02539342|5506311|P1|NOT COMPLETED|Overall Study||0
2244902|NCT02539342|5506310|P2|COMPLETED|Overall Study||0
2244903|NCT02539342|5506311|P1|COMPLETED|Overall Study||1
2244904|NCT02539342|5506310|P2|STARTED|Overall Study||0
2244905|NCT02539342|5506311|P1|STARTED|Overall Study||1
2244926|NCT02539134|5506349|P6|NOT COMPLETED|Overall Study||0
2244927|NCT02539134|5506350|P5|NOT COMPLETED|Overall Study||0
2244928|NCT02539134|5506351|P4|NOT COMPLETED|Overall Study||0
2244929|NCT02539134|5506352|P3|NOT COMPLETED|Overall Study||0
2244930|NCT02539134|5506353|P2|NOT COMPLETED|Overall Study||0
2244931|NCT02539134|5506354|P1|NOT COMPLETED|Overall Study||1
2244932|NCT02539134|5506349|P6|COMPLETED|Overall Study||6
2244933|NCT02539134|5506350|P5|COMPLETED|Overall Study||6
2244934|NCT02539134|5506351|P4|COMPLETED|Overall Study||6
2244935|NCT02539134|5506352|P3|COMPLETED|Overall Study||6
2244936|NCT02539134|5506353|P2|COMPLETED|Overall Study||6
2244937|NCT02539134|5506354|P1|COMPLETED|Overall Study||9
2244938|NCT02539134|5506349|P6|STARTED|Overall Study||6
2244939|NCT02539134|5506350|P5|STARTED|Overall Study||6
2244940|NCT02539134|5506351|P4|STARTED|Overall Study||6
2244941|NCT02539134|5506352|P3|STARTED|Overall Study||6
2244942|NCT02539134|5506353|P2|STARTED|Overall Study||6
2244943|NCT02539134|5506354|P1|STARTED|Overall Study||10
2244944|NCT02539108|5506408|P2|NOT COMPLETED|Overall Study||0
2244945|NCT02539108|5506409|P1|NOT COMPLETED|Overall Study||0
2244946|NCT02539108|5506408|P2|COMPLETED|Overall Study||30
2244947|NCT02539108|5506409|P1|COMPLETED|Overall Study||30
2244948|NCT02539108|5506408|P2|STARTED|Overall Study||30
2244949|NCT02539108|5506409|P1|STARTED|Overall Study||30
2244950|NCT02538965|5506423|P1|NOT COMPLETED|Follow-Up Period||17
2244951|NCT02538965|5506423|P1|COMPLETED|Follow-Up Period||0
2244952|NCT02538965|5506423|P1|STARTED|Follow-Up Period||17
2244953|NCT02538965|5506423|P1|NOT COMPLETED|Treatment Period||17
2244954|NCT02538965|5506423|P1|COMPLETED|Treatment Period||0
2244955|NCT02538965|5506423|P1|STARTED|Treatment Period||17
2244956|NCT02538783|5506444|P2|NOT COMPLETED|Overall Study||1
2244957|NCT02538783|5506445|P1|NOT COMPLETED|Overall Study||0
2244958|NCT02538783|5506444|P2|COMPLETED|Overall Study||128
2244959|NCT02538783|5506445|P1|COMPLETED|Overall Study||130
2244960|NCT02538783|5506444|P2|STARTED|Overall Study||129
2244961|NCT02538783|5506445|P1|STARTED|Overall Study||130
2244962|NCT02538679|5506456|P3|NOT COMPLETED|Overall Study||8
2244963|NCT02538679|5506457|P2|NOT COMPLETED|Overall Study||9
2244964|NCT02538679|5506458|P1|NOT COMPLETED|Overall Study||3
2244965|NCT02538679|5506456|P3|COMPLETED|Overall Study||41
2244966|NCT02538679|5506457|P2|COMPLETED|Overall Study||45
2244967|NCT02538679|5506458|P1|COMPLETED|Overall Study||21
2244968|NCT02538679|5506456|P3|STARTED|Overall Study||49
2244969|NCT02538679|5506457|P2|STARTED|Overall Study||54
2244970|NCT02538679|5506458|P1|STARTED|Overall Study||24
2244980|NCT02538523|5506492|P2|NOT COMPLETED|Overall Study||0
2244981|NCT02538523|5506493|P1|NOT COMPLETED|Overall Study||0
2244982|NCT02538523|5506492|P2|COMPLETED|Overall Study||29
2244983|NCT02538523|5506493|P1|COMPLETED|Overall Study||29
2244984|NCT02538523|5506492|P2|STARTED|Overall Study||29
2244985|NCT02538523|5506493|P1|STARTED|Overall Study||29
2244986|NCT02538471|5506501|P1|NOT COMPLETED|Overall Study||2
2244987|NCT02538471|5506501|P1|COMPLETED|Overall Study||1
2244988|NCT02538471|5506501|P1|STARTED|Overall Study||3
2244989|NCT02538419|5506511|P2|NOT COMPLETED|Overall Study||0
2244990|NCT02538419|5506512|P1|NOT COMPLETED|Overall Study||0
2244991|NCT02538419|5506511|P2|COMPLETED|Overall Study||20
2244992|NCT02538419|5506512|P1|COMPLETED|Overall Study||20
2244993|NCT02538419|5506511|P2|STARTED|Overall Study||20
2244994|NCT02538419|5506512|P1|STARTED|Overall Study||20
2244995|NCT02538107|5506528|P1|NOT COMPLETED|Overall Study||110
2244996|NCT02538107|5506528|P1|COMPLETED|Overall Study||180
2244997|NCT02538107|5506528|P1|STARTED|Overall Study||290
2244998|NCT02538042|5506550|P2|NOT COMPLETED|Overall Study||11
2244999|NCT02538042|5506551|P1|NOT COMPLETED|Overall Study||11
2245000|NCT02538042|5506550|P2|COMPLETED|Overall Study||6
2245001|NCT02538042|5506551|P1|COMPLETED|Overall Study||6
2245002|NCT02538042|5506550|P2|Completed All Post-Quit Visits|Overall Study||12
2245003|NCT02538042|5506551|P1|Completed All Post-Quit Visits|Overall Study||12
2245004|NCT02538042|5506550|P2|Attended Post-Quit Visit|Overall Study||14
2245005|NCT02538042|5506551|P1|Attended Post-Quit Visit|Overall Study||15
2245006|NCT02538042|5506550|P2|Completed All MCE Sessions|Overall Study||15
2245007|NCT02538042|5506551|P1|Completed All MCE Sessions|Overall Study||15
2245008|NCT02538042|5506550|P2|STARTED|Overall Study||17
2245009|NCT02538042|5506551|P1|STARTED|Overall Study||17
2245010|NCT02538029|5506570|P3|NOT COMPLETED|Overall Study||1
2245011|NCT02538029|5506571|P2|NOT COMPLETED|Overall Study||0
2245012|NCT02538029|5506572|P1|NOT COMPLETED|Overall Study||1
2245013|NCT02538029|5506570|P3|COMPLETED|Overall Study||10
2245014|NCT02538029|5506571|P2|COMPLETED|Overall Study||10
2245015|NCT02538029|5506572|P1|COMPLETED|Overall Study||23
2245016|NCT02538029|5506570|P3|STARTED|Overall Study||11
2245017|NCT02538029|5506571|P2|STARTED|Overall Study||10
2245018|NCT02538029|5506572|P1|STARTED|Overall Study||24
2245019|NCT02537951|5506594|P1|NOT COMPLETED|Overall Study||0
2245020|NCT02537951|5506594|P1|COMPLETED|Overall Study||10
2245021|NCT02537951|5506594|P1|STARTED|Overall Study||10
2245022|NCT02537730|5506602|P2|NOT COMPLETED|Second Intervention (7 Days)||0
2245023|NCT02537730|5506603|P1|NOT COMPLETED|Second Intervention (7 Days)||0
2245024|NCT02537730|5506602|P2|COMPLETED|Second Intervention (7 Days)||16
2245025|NCT02537730|5506603|P1|COMPLETED|Second Intervention (7 Days)||17
2245026|NCT02537730|5506602|P2|STARTED|Second Intervention (7 Days)||16
2245027|NCT02537730|5506603|P1|STARTED|Second Intervention (7 Days)||17
2245028|NCT02537730|5506602|P2|NOT COMPLETED|First Intervention (7 Days)||0
2245029|NCT02537730|5506603|P1|NOT COMPLETED|First Intervention (7 Days)||0
2245030|NCT02537730|5506602|P2|COMPLETED|First Intervention (7 Days)||16
2245031|NCT02537730|5506603|P1|COMPLETED|First Intervention (7 Days)||17
2245032|NCT02537730|5506602|P2|STARTED|First Intervention (7 Days)||16
2245033|NCT02537730|5506603|P1|STARTED|First Intervention (7 Days)||17
2245034|NCT02537574|5506618|P3|NOT COMPLETED|Overall Study||108
2245035|NCT02537574|5506619|P2|NOT COMPLETED|Overall Study||103
2245036|NCT02537574|5506620|P1|NOT COMPLETED|Overall Study||99
2245037|NCT02537574|5506618|P3|COMPLETED|Overall Study||18
2245038|NCT02537574|5506619|P2|COMPLETED|Overall Study||23
2245039|NCT02537574|5506620|P1|COMPLETED|Overall Study||27
2245040|NCT02537574|5506618|P3|STARTED|Overall Study||126
2245041|NCT02537574|5506619|P2|STARTED|Overall Study||126
2245042|NCT02537574|5506620|P1|STARTED|Overall Study||126
2245043|NCT02537522|5506646|P4|NOT COMPLETED|Phase II - Period 2 Bilateral||0
2245044|NCT02537522|5506647|P3|NOT COMPLETED|Phase II - Period 2 Bilateral||0
2245045|NCT02537522|5506648|P2|NOT COMPLETED|Phase II - Period 2 Bilateral||0
2245046|NCT02537522|5506649|P1|NOT COMPLETED|Phase II - Period 2 Bilateral||0
2245047|NCT02537522|5506646|P4|COMPLETED|Phase II - Period 2 Bilateral||22
2245048|NCT02537522|5506647|P3|COMPLETED|Phase II - Period 2 Bilateral||23
2245049|NCT02537522|5506648|P2|COMPLETED|Phase II - Period 2 Bilateral||0
2245050|NCT02537522|5506649|P1|COMPLETED|Phase II - Period 2 Bilateral||0
2245051|NCT02537522|5506646|P4|STARTED|Phase II - Period 2 Bilateral||22
2245052|NCT02537522|5506647|P3|STARTED|Phase II - Period 2 Bilateral||23
2245053|NCT02537522|5506648|P2|STARTED|Phase II - Period 2 Bilateral||0
2245054|NCT02537522|5506649|P1|STARTED|Phase II - Period 2 Bilateral||0
2245055|NCT02537522|5506646|P4|NOT COMPLETED|Phase II - Period 1 Bilateral||1
2245056|NCT02537522|5506647|P3|NOT COMPLETED|Phase II - Period 1 Bilateral||0
2245057|NCT02537522|5506648|P2|NOT COMPLETED|Phase II - Period 1 Bilateral||0
2245058|NCT02537522|5506649|P1|NOT COMPLETED|Phase II - Period 1 Bilateral||0
2245059|NCT02537522|5506646|P4|COMPLETED|Phase II - Period 1 Bilateral||22
2245060|NCT02537522|5506647|P3|COMPLETED|Phase II - Period 1 Bilateral||23
2245061|NCT02537522|5506648|P2|COMPLETED|Phase II - Period 1 Bilateral||0
2245062|NCT02537522|5506649|P1|COMPLETED|Phase II - Period 1 Bilateral||0
2245063|NCT02537522|5506646|P4|STARTED|Phase II - Period 1 Bilateral||23
2245064|NCT02537522|5506647|P3|STARTED|Phase II - Period 1 Bilateral||23
2245065|NCT02537522|5506648|P2|STARTED|Phase II - Period 1 Bilateral||0
2245066|NCT02537522|5506649|P1|STARTED|Phase II - Period 1 Bilateral||0
2245067|NCT02537522|5506646|P4|NOT COMPLETED|Phase I - Contralateral||0
2245068|NCT02537522|5506647|P3|NOT COMPLETED|Phase I - Contralateral||0
2245069|NCT02537522|5506648|P2|NOT COMPLETED|Phase I - Contralateral||10
2245070|NCT02537522|5506649|P1|NOT COMPLETED|Phase I - Contralateral||15
2245071|NCT02537522|5506646|P4|COMPLETED|Phase I - Contralateral||0
2245072|NCT02537522|5506647|P3|COMPLETED|Phase I - Contralateral||0
2245073|NCT02537522|5506648|P2|COMPLETED|Phase I - Contralateral||27
2245074|NCT02537522|5506649|P1|COMPLETED|Phase I - Contralateral||19
2245075|NCT02537522|5506646|P4|STARTED|Phase I - Contralateral||0
2245076|NCT02537522|5506647|P3|STARTED|Phase I - Contralateral||0
2245077|NCT02537522|5506648|P2|STARTED|Phase I - Contralateral||37
2245078|NCT02537522|5506649|P1|STARTED|Phase I - Contralateral||34
2245079|NCT02537444|5506659|P2|NOT COMPLETED|Overall Study||39
2245080|NCT02537444|5506660|P1|NOT COMPLETED|Overall Study||39
2245081|NCT02537444|5506659|P2|COMPLETED|Overall Study||0
2245082|NCT02537444|5506660|P1|COMPLETED|Overall Study||0
2245083|NCT02537444|5506659|P2|Discontinued Study|Overall Study||39
2245084|NCT02537444|5506660|P1|Discontinued Study|Overall Study||39
2245085|NCT02537444|5506659|P2|Received Study Medication|Overall Study||39
2245086|NCT02537444|5506660|P1|Received Study Medication|Overall Study||38
2245087|NCT02537444|5506659|P2|Enrolled|Overall Study||39
2245088|NCT02537444|5506660|P1|Enrolled|Overall Study||39
2245089|NCT02537444|5506659|P2|STARTED|Overall Study||39
2245090|NCT02537444|5506660|P1|STARTED|Overall Study||39
2245091|NCT02537431|5506666|P1|NOT COMPLETED|Treatment Extension Period II||0
2245092|NCT02537431|5506666|P1|COMPLETED|Treatment Extension Period II||8
2245093|NCT02537431|5506666|P1|STARTED|Treatment Extension Period II|5 participants completing Treatment Extension Period I did not enter Treatment Extension Period II|8
2245094|NCT02537431|5506666|P1|NOT COMPLETED|Treatment Extension Period I||0
2245095|NCT02537431|5506666|P1|COMPLETED|Treatment Extension Period I||13
2245096|NCT02537431|5506666|P1|STARTED|Treatment Extension Period I||13
2245097|NCT02537431|5506666|P1|NOT COMPLETED|Open-Label Period (Week 0 to Week 48)||1
2245098|NCT02537431|5506666|P1|COMPLETED|Open-Label Period (Week 0 to Week 48)|Completed Open-Label Period (Week 0 - Week 48)|13
2245099|NCT02537431|5506666|P1|STARTED|Open-Label Period (Week 0 to Week 48)|Screened and received at least 1 dose of study drug.|14
2245100|NCT02537015|5506695|P1|NOT COMPLETED|Overall Study||6
2245101|NCT02537015|5506695|P1|COMPLETED|Overall Study||75
2245102|NCT02537015|5506695|P1|STARTED|Overall Study||81
2245103|NCT02536976|5506701|P2|NOT COMPLETED|Overall Study||1
2245104|NCT02536976|5506702|P1|NOT COMPLETED|Overall Study||0
2245105|NCT02536976|5506701|P2|COMPLETED|Overall Study||1
2245106|NCT02536976|5506702|P1|COMPLETED|Overall Study||3
2245107|NCT02536976|5506701|P2|Washout|Overall Study||1
2245108|NCT02536976|5506702|P1|Washout|Overall Study||3
2245109|NCT02536976|5506701|P2|Dose Escalation and Maintenance|Overall Study|10 weeks double blind placebo matching mirabegron|1
2245110|NCT02536976|5506702|P1|Dose Escalation and Maintenance|Overall Study|10 weeks double blind mirabegron|3
2245111|NCT02536976|5506701|P2|Randomization|Overall Study|2 weeks double blind placebo matching mirabegron|1
2245112|NCT02536976|5506702|P1|Randomization|Overall Study|2 weeks double blind mirabegron|3
2245113|NCT02536976|5506701|P2|STARTED|Overall Study|2 weeks single blind placebo run-in. 1 participant terminated due to unrelated failing health|2
2245114|NCT02536976|5506702|P1|STARTED|Overall Study|2 weeks single blind placebo run-in|3
2245115|NCT02536781|5506714|P2|NOT COMPLETED|Overall Study||0
2245116|NCT02536781|5506715|P1|NOT COMPLETED|Overall Study||2
2245117|NCT02536781|5506714|P2|COMPLETED|Overall Study||34
2245118|NCT02536781|5506715|P1|COMPLETED|Overall Study||34
2245119|NCT02536781|5506714|P2|STARTED|Overall Study||34
2245120|NCT02536781|5506715|P1|STARTED|Overall Study||36
2245121|NCT02536664|5506725|P2|NOT COMPLETED|Overall Study||80
2245122|NCT02536664|5506726|P1|NOT COMPLETED|Overall Study||107
2245123|NCT02536664|5506725|P2|COMPLETED|Overall Study||97
2245124|NCT02536664|5506726|P1|COMPLETED|Overall Study||205
2245125|NCT02536664|5506725|P2|STARTED|Overall Study||177
2245126|NCT02536664|5506726|P1|STARTED|Overall Study||312
2245127|NCT02536313|5506746|P2|NOT COMPLETED|Overall Study||1
2245128|NCT02536313|5506747|P1|NOT COMPLETED|Overall Study||0
2245129|NCT02536313|5506746|P2|COMPLETED|Overall Study||24
2245130|NCT02536313|5506747|P1|COMPLETED|Overall Study||24
2245131|NCT02536313|5506746|P2|STARTED|Overall Study||25
2245132|NCT02536313|5506747|P1|STARTED|Overall Study||24
2245133|NCT02536105|5506763|P1|NOT COMPLETED|Methylphenidate HCl ER Suspension||2
2245134|NCT02536105|5506763|P1|COMPLETED|Methylphenidate HCl ER Suspension||72
2245135|NCT02536105|5506763|P1|Completion of MPH HCl ER Susp Phase|Methylphenidate HCl ER Suspension||74
2245136|NCT02536105|5506763|P1|STARTED|Methylphenidate HCl ER Suspension||74
2245137|NCT02536105|5506763|P1|NOT COMPLETED|Methylphenidate HCl ER Tablet 2||1
2245138|NCT02536105|5506763|P1|COMPLETED|Methylphenidate HCl ER Tablet 2||72
2245139|NCT02536105|5506763|P1|Completion of MPH HCl ER Tablet 2 Phase|Methylphenidate HCl ER Tablet 2||73
2245140|NCT02536105|5506763|P1|STARTED|Methylphenidate HCl ER Tablet 2||73
2245141|NCT02536105|5506763|P1|NOT COMPLETED|Methylphenidate HCl ER Tablet 1||0
2245142|NCT02536105|5506763|P1|COMPLETED|Methylphenidate HCl ER Tablet 1||72
2245143|NCT02536105|5506763|P1|Completion of MPH HCl ER Tab 1 Day|Methylphenidate HCl ER Tablet 1||72
2245144|NCT02536105|5506763|P1|STARTED|Methylphenidate HCl ER Tablet 1||72
2245145|NCT02536105|5506763|P1|NOT COMPLETED|Placebo||2
2245146|NCT02536105|5506763|P1|COMPLETED|Placebo||72
2245147|NCT02536105|5506763|P1|Completion of Placebo Day|Placebo||74
2245148|NCT02536105|5506763|P1|STARTED|Placebo||74
2245149|NCT02536105|5506763|P1|NOT COMPLETED|Concerta Open Label||8
2245150|NCT02536105|5506763|P1|COMPLETED|Concerta Open Label||72
2245151|NCT02536105|5506763|P1|Completion of Phase|Concerta Open Label||76
2245152|NCT02536105|5506763|P1|STARTED|Concerta Open Label||80
2245153|NCT02536040|5506787|P2|NOT COMPLETED|Overall Study||1
2245154|NCT02536040|5506788|P1|NOT COMPLETED|Overall Study||1
2245155|NCT02536040|5506787|P2|COMPLETED|Overall Study||35
2245156|NCT02536040|5506788|P1|COMPLETED|Overall Study||29
2245157|NCT02536040|5506787|P2|STARTED|Overall Study||36
2245158|NCT02536040|5506788|P1|STARTED|Overall Study||30
2245159|NCT02535806|5506794|P1|NOT COMPLETED|Overall Study||0
2245160|NCT02535806|5506794|P1|COMPLETED|Overall Study||2
2245161|NCT02535806|5506794|P1|STARTED|Overall Study||2
2245162|NCT02535741|5506801|P1|NOT COMPLETED|Overall Study||32
2245163|NCT02535741|5506801|P1|COMPLETED|Overall Study|Completed cases at 2 years follow-up|136
2245164|NCT02535741|5506801|P1|STARTED|Overall Study||168
2245165|NCT02535715|5506809|P3|NOT COMPLETED|Overall Study||1
2245166|NCT02535715|5506810|P2|NOT COMPLETED|Overall Study||0
2245167|NCT02535715|5506811|P1|NOT COMPLETED|Overall Study||0
2245168|NCT02535715|5506809|P3|COMPLETED|Overall Study||2
2245169|NCT02535715|5506810|P2|COMPLETED|Overall Study||4
2245170|NCT02535715|5506811|P1|COMPLETED|Overall Study||4
2245171|NCT02535715|5506809|P3|STARTED|Overall Study||3
2245172|NCT02535715|5506810|P2|STARTED|Overall Study||4
2245173|NCT02535715|5506811|P1|STARTED|Overall Study||4
2245174|NCT02535416|5506840|P9|NOT COMPLETED|Overall Study||0
2245175|NCT02535416|5506841|P8|NOT COMPLETED|Overall Study||0
2245176|NCT02535416|5506842|P7|NOT COMPLETED|Overall Study||0
2245177|NCT02535416|5506843|P6|NOT COMPLETED|Overall Study||0
2245178|NCT02535416|5506844|P5|NOT COMPLETED|Overall Study||0
2245179|NCT02535416|5506845|P4|NOT COMPLETED|Overall Study||0
2245180|NCT02535416|5506846|P3|NOT COMPLETED|Overall Study||0
2245181|NCT02535416|5506847|P2|NOT COMPLETED|Overall Study||0
2245182|NCT02535416|5506848|P1|NOT COMPLETED|Overall Study||1
2245183|NCT02535416|5506840|P9|COMPLETED|Overall Study||6
2245184|NCT02535416|5506841|P8|COMPLETED|Overall Study||6
2245185|NCT02535416|5506842|P7|COMPLETED|Overall Study||6
2245186|NCT02535416|5506843|P6|COMPLETED|Overall Study||4
2245187|NCT02535416|5506844|P5|COMPLETED|Overall Study||4
2245188|NCT02535416|5506845|P4|COMPLETED|Overall Study||4
2245189|NCT02535416|5506846|P3|COMPLETED|Overall Study||4
2245190|NCT02535416|5506847|P2|COMPLETED|Overall Study||2
2245191|NCT02535416|5506848|P1|COMPLETED|Overall Study||3
2245192|NCT02535416|5506840|P9|STARTED|Overall Study||6
2245193|NCT02535416|5506841|P8|STARTED|Overall Study||6
2245194|NCT02535416|5506842|P7|STARTED|Overall Study||6
2245195|NCT02535416|5506843|P6|STARTED|Overall Study||4
2245196|NCT02535416|5506844|P5|STARTED|Overall Study||4
2245197|NCT02535416|5506845|P4|STARTED|Overall Study||4
2245198|NCT02535416|5506846|P3|STARTED|Overall Study||4
2245199|NCT02535416|5506847|P2|STARTED|Overall Study||2
2245200|NCT02535416|5506848|P1|STARTED|Overall Study||4
2245201|NCT02535364|5506900|P1|NOT COMPLETED|12-Month Follow-up Period||35
2245202|NCT02535364|5506900|P1|COMPLETED|12-Month Follow-up Period||3
2245203|NCT02535364|5506900|P1|STARTED|12-Month Follow-up Period||38
2245204|NCT02535364|5506900|P1|NOT COMPLETED|Study Treatment||2
2245205|NCT02535364|5506900|P1|COMPLETED|Study Treatment||38
2245206|NCT02535364|5506900|P1|STARTED|Study Treatment||40
2245207|NCT02535364|5506900|P1|NOT COMPLETED|Part B Screening||17
2245208|NCT02535364|5506900|P1|COMPLETED|Part B Screening||40
2245209|NCT02535364|5506900|P1|STARTED|Part B Screening||57
2245210|NCT02535364|5506900|P1|NOT COMPLETED|Part A Screening Through Leukapheresis||25
2245211|NCT02535364|5506900|P1|COMPLETED|Part A Screening Through Leukapheresis||57
2245212|NCT02535364|5506900|P1|STARTED|Part A Screening Through Leukapheresis||82
2245213|NCT02535065|5506925|P1|NOT COMPLETED|Overall Study||62
2245214|NCT02535065|5506925|P1|COMPLETED|Overall Study||0
2245215|NCT02535065|5506925|P1|12-Month Follow-up|Overall Study||61
2245216|NCT02535065|5506925|P1|1-Month Follow-up|Overall Study||62
2245217|NCT02535065|5506925|P1|STARTED|Overall Study||62
2245218|NCT02535026|5506930|P1|NOT COMPLETED|Overall Study||0
2245219|NCT02535026|5506930|P1|COMPLETED|Overall Study||580
2245220|NCT02535026|5506930|P1|STARTED|Overall Study||580
2245221|NCT02534935|5506985|P3|NOT COMPLETED|Overall Study||5
2245222|NCT02534935|5506986|P2|NOT COMPLETED|Overall Study||10
2245223|NCT02534935|5506987|P1|NOT COMPLETED|Overall Study||0
2245224|NCT02534935|5506985|P3|COMPLETED|Overall Study||127
2245225|NCT02534935|5506986|P2|COMPLETED|Overall Study||210
2245226|NCT02534935|5506987|P1|COMPLETED|Overall Study||44
2245227|NCT02534935|5506985|P3|STARTED|Overall Study||132
2245228|NCT02534935|5506986|P2|STARTED|Overall Study||220
2245229|NCT02534935|5506987|P1|STARTED|Overall Study||44
2245230|NCT02534896|5507148|P3|NOT COMPLETED|Overall Study||1
2245231|NCT02534896|5507149|P2|NOT COMPLETED|Overall Study||1
2245232|NCT02534896|5507150|P1|NOT COMPLETED|Overall Study||4
2245233|NCT02534896|5507148|P3|COMPLETED|Overall Study||48
2245234|NCT02534896|5507149|P2|COMPLETED|Overall Study||51
2245235|NCT02534896|5507150|P1|COMPLETED|Overall Study||45
2245236|NCT02534896|5507148|P3|STARTED|Overall Study||49
2245237|NCT02534896|5507149|P2|STARTED|Overall Study||52
2245238|NCT02534896|5507150|P1|STARTED|Overall Study||49
2245239|NCT02534883|5507169|P2|NOT COMPLETED|Overall Study||3
2245240|NCT02534883|5507170|P1|NOT COMPLETED|Overall Study||8
2245241|NCT02534883|5507169|P2|COMPLETED|Overall Study||0
2245242|NCT02534883|5507170|P1|COMPLETED|Overall Study||0
2245243|NCT02534883|5507169|P2|STARTED|Overall Study||3
2245244|NCT02534883|5507170|P1|STARTED|Overall Study||8
2245245|NCT02534493|5507186|P1|NOT COMPLETED|Overall Study||2
2245246|NCT02534493|5507186|P1|COMPLETED|Overall Study||11
2245247|NCT02534493|5507186|P1|STARTED|Overall Study||13
2245248|NCT02534350|5507197|P2|NOT COMPLETED|Overall Study||0
2245249|NCT02534350|5507198|P1|NOT COMPLETED|Overall Study||4
2245250|NCT02534350|5507197|P2|COMPLETED|Overall Study||20
2245251|NCT02534350|5507198|P1|COMPLETED|Overall Study||37
2245252|NCT02534350|5507197|P2|STARTED|Overall Study||20
2245253|NCT02534350|5507198|P1|STARTED|Overall Study||41
2245254|NCT02534324|5507212|P2|NOT COMPLETED|Overall Study||8
2245255|NCT02534324|5507213|P1|NOT COMPLETED|Overall Study||25
2245256|NCT02534324|5507212|P2|COMPLETED|Overall Study||40
2245257|NCT02534324|5507213|P1|COMPLETED|Overall Study||73
2245258|NCT02534324|5507212|P2|STARTED|Overall Study||48
2245259|NCT02534324|5507213|P1|STARTED|Overall Study||98
2245260|NCT02534129|5507223|P2|NOT COMPLETED|Overall Study||0
2245261|NCT02534129|5507224|P1|NOT COMPLETED|Overall Study||0
2245262|NCT02534129|5507223|P2|COMPLETED|Overall Study||13
2245263|NCT02534129|5507224|P1|COMPLETED|Overall Study||13
2245264|NCT02534129|5507223|P2|STARTED|Overall Study||13
2245265|NCT02534129|5507224|P1|STARTED|Overall Study||13
2245266|NCT02533999|5507232|P2|NOT COMPLETED|Overall Study||7
2245267|NCT02533999|5507233|P1|NOT COMPLETED|Overall Study||6
2245268|NCT02533999|5507232|P2|COMPLETED|Overall Study||30
2245269|NCT02533999|5507233|P1|COMPLETED|Overall Study||32
2245270|NCT02533999|5507232|P2|STARTED|Overall Study||37
2245271|NCT02533999|5507233|P1|STARTED|Overall Study||38
2245272|NCT02533921|5507253|P2|NOT COMPLETED|Overall Study||11
2245273|NCT02533921|5507254|P1|NOT COMPLETED|Overall Study||16
2245274|NCT02533921|5507253|P2|COMPLETED|Overall Study||95
2245275|NCT02533921|5507254|P1|COMPLETED|Overall Study||88
2245276|NCT02533921|5507253|P2|STARTED|Overall Study||106
2245277|NCT02533921|5507254|P1|STARTED|Overall Study||104
2245278|NCT02533726|5507272|P2|NOT COMPLETED|Treatment||0
2245279|NCT02533726|5507273|P1|NOT COMPLETED|Treatment||0
2245280|NCT02533726|5507272|P2|COMPLETED|Treatment||603
2245281|NCT02533726|5507273|P1|COMPLETED|Treatment||709
2245282|NCT02533726|5507272|P2|Per Protocol Population|Treatment||555
2245283|NCT02533726|5507273|P1|Per Protocol Population|Treatment||671
2245284|NCT02533726|5507272|P2|STARTED|Treatment|4 participants allocated to Optimal Turning actually received Standard Care|603
2245285|NCT02533726|5507273|P1|STARTED|Treatment|54 participants allocated to Standard Care actually received Optimal Turning|709
2245286|NCT02533726|5507272|P2|NOT COMPLETED|Initial Allocation||0
2245287|NCT02533726|5507273|P1|NOT COMPLETED|Initial Allocation||0
2245288|NCT02533726|5507272|P2|COMPLETED|Initial Allocation||653
2245289|NCT02533726|5507273|P1|COMPLETED|Initial Allocation||659
2245290|NCT02533726|5507272|P2|STARTED|Initial Allocation||653
2245291|NCT02533726|5507273|P1|STARTED|Initial Allocation||659
2245292|NCT02533570|5507284|P3|NOT COMPLETED|Overall Study||1
2245293|NCT02533570|5507285|P2|NOT COMPLETED|Overall Study||1
2245294|NCT02533570|5507286|P1|NOT COMPLETED|Overall Study||0
2245295|NCT02533570|5507284|P3|COMPLETED|Overall Study||7
2245296|NCT02533570|5507285|P2|COMPLETED|Overall Study||7
2245297|NCT02533570|5507286|P1|COMPLETED|Overall Study||4
2245298|NCT02533570|5507284|P3|STARTED|Overall Study||8
2245299|NCT02533570|5507285|P2|STARTED|Overall Study||8
2245300|NCT02533570|5507286|P1|STARTED|Overall Study||4
2245301|NCT02533531|5507297|P1|NOT COMPLETED|Overall Study||1
2245302|NCT02533531|5507297|P1|COMPLETED|Overall Study||0
2245303|NCT02533531|5507297|P1|STARTED|Overall Study||1
2245304|NCT02533505|5507302|P2|NOT COMPLETED|Overall Study||1
2245305|NCT02533505|5507303|P1|NOT COMPLETED|Overall Study||3
2245306|NCT02533505|5507302|P2|COMPLETED|Overall Study||24
2245307|NCT02533505|5507303|P1|COMPLETED|Overall Study||23
2245308|NCT02533505|5507302|P2|STARTED|Overall Study||25
2245309|NCT02533505|5507303|P1|STARTED|Overall Study||26
2245310|NCT02533466|5507335|P2|NOT COMPLETED|Overall Study||0
2245311|NCT02533466|5507336|P1|NOT COMPLETED|Overall Study||0
2245312|NCT02533466|5507335|P2|COMPLETED|Overall Study||14
2245313|NCT02533466|5507336|P1|COMPLETED|Overall Study||16
2245314|NCT02533466|5507335|P2|STARTED|Overall Study||14
2245315|NCT02533466|5507336|P1|STARTED|Overall Study||16
2245316|NCT02533453|5507360|P1|NOT COMPLETED|Overall Study||9
2245317|NCT02533453|5507360|P1|COMPLETED|Overall Study||101
2245318|NCT02533453|5507360|P1|STARTED|Overall Study||110
2245319|NCT02533401|5507369|P1|NOT COMPLETED|Overall Study||11
2245320|NCT02533401|5507369|P1|COMPLETED|Overall Study||23
2245321|NCT02533401|5507369|P1|STARTED|Overall Study||34
2245322|NCT02533375|5507377|P1|NOT COMPLETED|Overall Study||5
2245323|NCT02533375|5507377|P1|COMPLETED|Overall Study||5
2245324|NCT02533375|5507377|P1|STARTED|Overall Study||10
2245325|NCT02533258|5507409|P1|NOT COMPLETED|Overall Study||8
2245326|NCT02533258|5507409|P1|COMPLETED|Overall Study||5
2245327|NCT02533258|5507409|P1|STARTED|Overall Study||13
2245328|NCT02533167|5507421|P1|NOT COMPLETED|Overall Study||15
2245329|NCT02533167|5507421|P1|COMPLETED|Overall Study||55
2245330|NCT02533167|5507421|P1|STARTED|Overall Study||70
2245331|NCT02533063|5507432|P2|NOT COMPLETED|Intervention 2 (8 Weeks)||0
2245332|NCT02533063|5507433|P1|NOT COMPLETED|Intervention 2 (8 Weeks)||0
2245333|NCT02533063|5507432|P2|COMPLETED|Intervention 2 (8 Weeks)||11
2245334|NCT02533063|5507433|P1|COMPLETED|Intervention 2 (8 Weeks)||14
2245335|NCT02533063|5507432|P2|STARTED|Intervention 2 (8 Weeks)||11
2245336|NCT02533063|5507433|P1|STARTED|Intervention 2 (8 Weeks)||14
2245337|NCT02533063|5507432|P2|NOT COMPLETED|Washout (4 Weeks)||0
2245338|NCT02533063|5507433|P1|NOT COMPLETED|Washout (4 Weeks)||0
2245339|NCT02533063|5507432|P2|COMPLETED|Washout (4 Weeks)||11
2245340|NCT02533063|5507433|P1|COMPLETED|Washout (4 Weeks)||14
2245341|NCT02533063|5507432|P2|STARTED|Washout (4 Weeks)||11
2245342|NCT02533063|5507433|P1|STARTED|Washout (4 Weeks)||14
2245343|NCT02533063|5507432|P2|NOT COMPLETED|Intervention 1 (8 Weeks)||5
2245344|NCT02533063|5507433|P1|NOT COMPLETED|Intervention 1 (8 Weeks)||2
2245345|NCT02533063|5507432|P2|COMPLETED|Intervention 1 (8 Weeks)||11
2245346|NCT02533063|5507433|P1|COMPLETED|Intervention 1 (8 Weeks)||14
2245347|NCT02533063|5507432|P2|STARTED|Intervention 1 (8 Weeks)||16
2245348|NCT02533063|5507433|P1|STARTED|Intervention 1 (8 Weeks)||16
2245349|NCT02532998|5507455|P1|NOT COMPLETED|Overall Study||0
2245350|NCT02532998|5507455|P1|COMPLETED|Overall Study||23
2245351|NCT02532998|5507455|P1|STARTED|Overall Study||23
2245352|NCT02532933|5507539|P2|NOT COMPLETED|Overall Study||6
2245353|NCT02532933|5507540|P1|NOT COMPLETED|Overall Study||6
2245354|NCT02532933|5507539|P2|COMPLETED|Overall Study||16
2245355|NCT02532933|5507540|P1|COMPLETED|Overall Study||16
2245356|NCT02532933|5507539|P2|STARTED|Overall Study||22
2245357|NCT02532933|5507540|P1|STARTED|Overall Study||22
2245358|NCT02532855|5507548|P2|NOT COMPLETED|Overall Study||11
2245359|NCT02532855|5507549|P1|NOT COMPLETED|Overall Study||8
2245360|NCT02532855|5507548|P2|COMPLETED|Overall Study||296
2245361|NCT02532855|5507549|P1|COMPLETED|Overall Study||299
2245362|NCT02532855|5507548|P2|Treated|Overall Study|One participant had a protocol violation, was randomized but did not take study medication.|306
2245363|NCT02532855|5507549|P1|Treated|Overall Study||307
2245364|NCT02532855|5507548|P2|STARTED|Overall Study||307
2245365|NCT02532855|5507549|P1|STARTED|Overall Study||307
2245366|NCT02532764|5507583|P10|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
2245367|NCT02532764|5507584|P9|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
2245368|NCT02532764|5507585|P8|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
2245369|NCT02532764|5507586|P7|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
2245370|NCT02532764|5507587|P6|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
2245371|NCT02532764|5507588|P5|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
2245372|NCT02532764|5507589|P4|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
2245373|NCT02532764|5507590|P3|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
2245374|NCT02532764|5507591|P2|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
2245375|NCT02532764|5507592|P1|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
2245376|NCT02532764|5507583|P10|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||8
2245377|NCT02532764|5507584|P9|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||5
2245378|NCT02532764|5507585|P8|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
2245379|NCT02532764|5507586|P7|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
2245380|NCT02532764|5507587|P6|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
2245381|NCT02532764|5507588|P5|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
2245382|NCT02532764|5507589|P4|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
2245383|NCT02532764|5507590|P3|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
2245384|NCT02532764|5507591|P2|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
2245385|NCT02532764|5507592|P1|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
2245386|NCT02532764|5507583|P10|STARTED|Multiple Ascending Dose (MAD) Cohorst||9
2245387|NCT02532764|5507584|P9|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
2245388|NCT02532764|5507585|P8|STARTED|Multiple Ascending Dose (MAD) Cohorst||7
2245389|NCT02532764|5507586|P7|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
2245390|NCT02532764|5507587|P6|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
2245477|NCT02531802|5507894|P19|NOT COMPLETED|Received Vaccination 2||3
2245391|NCT02532764|5507588|P5|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
2245392|NCT02532764|5507589|P4|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
2245393|NCT02532764|5507590|P3|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
2245394|NCT02532764|5507591|P2|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
2245395|NCT02532764|5507592|P1|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
2245396|NCT02532764|5507583|P10|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
2245397|NCT02532764|5507584|P9|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
2245398|NCT02532764|5507585|P8|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
2245399|NCT02532764|5507586|P7|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
2245400|NCT02532764|5507587|P6|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
2245401|NCT02532764|5507588|P5|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
2245402|NCT02532764|5507589|P4|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
2245403|NCT02532764|5507590|P3|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
2245404|NCT02532764|5507591|P2|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
2245405|NCT02532764|5507592|P1|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
2245406|NCT02532764|5507583|P10|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
2245407|NCT02532764|5507584|P9|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
2245408|NCT02532764|5507585|P8|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
2245409|NCT02532764|5507586|P7|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
2245410|NCT02532764|5507587|P6|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
2245411|NCT02532764|5507588|P5|COMPLETED|Single Ascending Dose (SAD) Cohorts||9
2245412|NCT02532764|5507589|P4|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
2245413|NCT02532764|5507590|P3|COMPLETED|Single Ascending Dose (SAD) Cohorts||9
2245414|NCT02532764|5507591|P2|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
2245415|NCT02532764|5507592|P1|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
2245416|NCT02532764|5507583|P10|STARTED|Single Ascending Dose (SAD) Cohorts||0
2245417|NCT02532764|5507584|P9|STARTED|Single Ascending Dose (SAD) Cohorts||0
2245418|NCT02532764|5507585|P8|STARTED|Single Ascending Dose (SAD) Cohorts||0
2245419|NCT02532764|5507586|P7|STARTED|Single Ascending Dose (SAD) Cohorts||0
2245420|NCT02532764|5507587|P6|STARTED|Single Ascending Dose (SAD) Cohorts||0
2245421|NCT02532764|5507588|P5|STARTED|Single Ascending Dose (SAD) Cohorts||9
2245422|NCT02532764|5507589|P4|STARTED|Single Ascending Dose (SAD) Cohorts||6
2245423|NCT02532764|5507590|P3|STARTED|Single Ascending Dose (SAD) Cohorts||9
2245424|NCT02532764|5507591|P2|STARTED|Single Ascending Dose (SAD) Cohorts||6
2245425|NCT02532764|5507592|P1|STARTED|Single Ascending Dose (SAD) Cohorts||6
2245426|NCT02532647|5507743|P3|NOT COMPLETED|Overall Study||1
2245427|NCT02532647|5507744|P2|NOT COMPLETED|Overall Study||0
2245428|NCT02532647|5507745|P1|NOT COMPLETED|Overall Study||1
2245429|NCT02532647|5507743|P3|COMPLETED|Overall Study||30
2245430|NCT02532647|5507744|P2|COMPLETED|Overall Study||16
2245431|NCT02532647|5507745|P1|COMPLETED|Overall Study||31
2245432|NCT02532647|5507743|P3|Safety Population|Overall Study||30
2245433|NCT02532647|5507744|P2|Safety Population|Overall Study||16
2245434|NCT02532647|5507745|P1|Safety Population|Overall Study||31
2245435|NCT02532647|5507743|P3|STARTED|Overall Study||31
2245436|NCT02532647|5507744|P2|STARTED|Overall Study||16
2245437|NCT02532647|5507745|P1|STARTED|Overall Study||32
2245438|NCT02532543|5507763|P4|NOT COMPLETED|Overall Study||0
2245439|NCT02532543|5507764|P3|NOT COMPLETED|Overall Study||1
2245440|NCT02532543|5507765|P2|NOT COMPLETED|Overall Study||0
2245441|NCT02532543|5507766|P1|NOT COMPLETED|Overall Study||0
2245442|NCT02532543|5507763|P4|COMPLETED|Overall Study||4
2245443|NCT02532543|5507764|P3|COMPLETED|Overall Study||4
2245444|NCT02532543|5507765|P2|COMPLETED|Overall Study||4
2245445|NCT02532543|5507766|P1|COMPLETED|Overall Study||3
2245446|NCT02532543|5507763|P4|STARTED|Overall Study||4
2245447|NCT02532543|5507764|P3|STARTED|Overall Study||5
2245448|NCT02532543|5507765|P2|STARTED|Overall Study||4
2245449|NCT02532543|5507766|P1|STARTED|Overall Study||3
2245450|NCT02532465|5507802|P2|NOT COMPLETED|Overall Study||1
2245451|NCT02532465|5507803|P1|NOT COMPLETED|Overall Study||1
2245452|NCT02532465|5507802|P2|COMPLETED|Overall Study||24
2245453|NCT02532465|5507803|P1|COMPLETED|Overall Study||24
2245454|NCT02532465|5507802|P2|STARTED|Overall Study||25
2245455|NCT02532465|5507803|P1|STARTED|Overall Study||25
2245463|NCT02532179|5507837|P1|NOT COMPLETED|Overall Study||3
2245464|NCT02532179|5507837|P1|COMPLETED|Overall Study||9
2245465|NCT02532179|5507837|P1|STARTED|Overall Study||12
2245466|NCT02532010|5507848|P2|NOT COMPLETED|Overall Study||4
2245467|NCT02532010|5507849|P1|NOT COMPLETED|Overall Study||9
2245468|NCT02532010|5507848|P2|COMPLETED|Overall Study||0
2245469|NCT02532010|5507849|P1|COMPLETED|Overall Study||0
2245470|NCT02532010|5507848|P2|STARTED|Overall Study||4
2245471|NCT02532010|5507849|P1|STARTED|Overall Study||9
2245472|NCT02531867|5507867|P1|NOT COMPLETED|Overall Study||0
2245473|NCT02531867|5507867|P1|COMPLETED|Overall Study||13
2245474|NCT02531867|5507867|P1|STARTED|Overall Study||13
2245475|NCT02531802|5507892|P21|NOT COMPLETED|Received Vaccination 2||1
2245476|NCT02531802|5507893|P20|NOT COMPLETED|Received Vaccination 2||1
2245478|NCT02531802|5507895|P18|NOT COMPLETED|Received Vaccination 2||4
2245479|NCT02531802|5507896|P17|NOT COMPLETED|Received Vaccination 2||0
2245480|NCT02531802|5507897|P16|NOT COMPLETED|Received Vaccination 2||0
2245481|NCT02531802|5507898|P15|NOT COMPLETED|Received Vaccination 2||1
2245482|NCT02531802|5507899|P14|NOT COMPLETED|Received Vaccination 2||2
2245483|NCT02531802|5507900|P13|NOT COMPLETED|Received Vaccination 2||2
2245484|NCT02531802|5507901|P12|NOT COMPLETED|Received Vaccination 2||0
2245485|NCT02531802|5507902|P11|NOT COMPLETED|Received Vaccination 2||2
2245486|NCT02531802|5507903|P10|NOT COMPLETED|Received Vaccination 2||3
2245487|NCT02531802|5507904|P9|NOT COMPLETED|Received Vaccination 2||0
2245488|NCT02531802|5507905|P8|NOT COMPLETED|Received Vaccination 2||0
2245489|NCT02531802|5507906|P7|NOT COMPLETED|Received Vaccination 2||0
2245490|NCT02531802|5507907|P6|NOT COMPLETED|Received Vaccination 2||3
2245491|NCT02531802|5507908|P5|NOT COMPLETED|Received Vaccination 2||0
2245492|NCT02531802|5507909|P4|NOT COMPLETED|Received Vaccination 2||0
2245493|NCT02531802|5507910|P3|NOT COMPLETED|Received Vaccination 2||1
2245494|NCT02531802|5507911|P2|NOT COMPLETED|Received Vaccination 2||0
2245495|NCT02531802|5507912|P1|NOT COMPLETED|Received Vaccination 2||0
2245496|NCT02531802|5507892|P21|COMPLETED|Received Vaccination 2||49
2245497|NCT02531802|5507893|P20|COMPLETED|Received Vaccination 2||29
2245498|NCT02531802|5507894|P19|COMPLETED|Received Vaccination 2||27
2245499|NCT02531802|5507895|P18|COMPLETED|Received Vaccination 2||26
2245500|NCT02531802|5507896|P17|COMPLETED|Received Vaccination 2||30
2245501|NCT02531802|5507897|P16|COMPLETED|Received Vaccination 2||30
2245502|NCT02531802|5507898|P15|COMPLETED|Received Vaccination 2||39
2245503|NCT02531802|5507899|P14|COMPLETED|Received Vaccination 2||13
2245504|NCT02531802|5507900|P13|COMPLETED|Received Vaccination 2||13
2245505|NCT02531802|5507901|P12|COMPLETED|Received Vaccination 2||15
2245506|NCT02531802|5507902|P11|COMPLETED|Received Vaccination 2||13
2245507|NCT02531802|5507903|P10|COMPLETED|Received Vaccination 2||49
2245508|NCT02531802|5507904|P9|COMPLETED|Received Vaccination 2||15
2245509|NCT02531802|5507905|P8|COMPLETED|Received Vaccination 2||15
2245510|NCT02531802|5507906|P7|COMPLETED|Received Vaccination 2||15
2245511|NCT02531802|5507907|P6|COMPLETED|Received Vaccination 2||0
2245512|NCT02531802|5507908|P5|COMPLETED|Received Vaccination 2||15
2245513|NCT02531802|5507909|P4|COMPLETED|Received Vaccination 2||15
2245514|NCT02531802|5507910|P3|COMPLETED|Received Vaccination 2||14
2245515|NCT02531802|5507911|P2|COMPLETED|Received Vaccination 2||15
2245516|NCT02531802|5507912|P1|COMPLETED|Received Vaccination 2||15
2245517|NCT02531802|5507892|P21|STARTED|Received Vaccination 2||50
2245518|NCT02531802|5507893|P20|STARTED|Received Vaccination 2||30
2245519|NCT02531802|5507894|P19|STARTED|Received Vaccination 2||30
2245520|NCT02531802|5507895|P18|STARTED|Received Vaccination 2||30
2245521|NCT02531802|5507896|P17|STARTED|Received Vaccination 2||30
2245522|NCT02531802|5507897|P16|STARTED|Received Vaccination 2||30
2245523|NCT02531802|5507898|P15|STARTED|Received Vaccination 2||40
2245524|NCT02531802|5507899|P14|STARTED|Received Vaccination 2||15
2245525|NCT02531802|5507900|P13|STARTED|Received Vaccination 2||15
2245526|NCT02531802|5507901|P12|STARTED|Received Vaccination 2||15
2245527|NCT02531802|5507902|P11|STARTED|Received Vaccination 2||15
2245528|NCT02531802|5507903|P10|STARTED|Received Vaccination 2||52
2245529|NCT02531802|5507904|P9|STARTED|Received Vaccination 2||15
2245530|NCT02531802|5507905|P8|STARTED|Received Vaccination 2||15
2245531|NCT02531802|5507906|P7|STARTED|Received Vaccination 2||15
2245532|NCT02531802|5507907|P6|STARTED|Received Vaccination 2||3
2245533|NCT02531802|5507908|P5|STARTED|Received Vaccination 2||15
2245534|NCT02531802|5507909|P4|STARTED|Received Vaccination 2||15
2245535|NCT02531802|5507910|P3|STARTED|Received Vaccination 2||15
2245536|NCT02531802|5507911|P2|STARTED|Received Vaccination 2||15
2245537|NCT02531802|5507912|P1|STARTED|Received Vaccination 2||15
2245538|NCT02531802|5507892|P21|NOT COMPLETED|Received Vaccination 1||0
2245539|NCT02531802|5507893|P20|NOT COMPLETED|Received Vaccination 1||0
2245540|NCT02531802|5507894|P19|NOT COMPLETED|Received Vaccination 1||0
2245541|NCT02531802|5507895|P18|NOT COMPLETED|Received Vaccination 1||0
2245542|NCT02531802|5507896|P17|NOT COMPLETED|Received Vaccination 1||0
2245543|NCT02531802|5507897|P16|NOT COMPLETED|Received Vaccination 1||0
2245544|NCT02531802|5507898|P15|NOT COMPLETED|Received Vaccination 1||0
2245545|NCT02531802|5507899|P14|NOT COMPLETED|Received Vaccination 1||0
2245546|NCT02531802|5507900|P13|NOT COMPLETED|Received Vaccination 1||0
2245547|NCT02531802|5507901|P12|NOT COMPLETED|Received Vaccination 1||0
2245548|NCT02531802|5507902|P11|NOT COMPLETED|Received Vaccination 1||0
2245549|NCT02531802|5507903|P10|NOT COMPLETED|Received Vaccination 1||0
2245550|NCT02531802|5507904|P9|NOT COMPLETED|Received Vaccination 1||0
2245551|NCT02531802|5507905|P8|NOT COMPLETED|Received Vaccination 1||0
2245552|NCT02531802|5507906|P7|NOT COMPLETED|Received Vaccination 1||0
2245553|NCT02531802|5507907|P6|NOT COMPLETED|Received Vaccination 1||0
2245554|NCT02531802|5507908|P5|NOT COMPLETED|Received Vaccination 1||0
2245555|NCT02531802|5507909|P4|NOT COMPLETED|Received Vaccination 1||0
2245556|NCT02531802|5507910|P3|NOT COMPLETED|Received Vaccination 1||0
2245557|NCT02531802|5507911|P2|NOT COMPLETED|Received Vaccination 1||0
2245558|NCT02531802|5507912|P1|NOT COMPLETED|Received Vaccination 1||0
2245559|NCT02531802|5507892|P21|COMPLETED|Received Vaccination 1||50
2245560|NCT02531802|5507893|P20|COMPLETED|Received Vaccination 1||30
2245561|NCT02531802|5507894|P19|COMPLETED|Received Vaccination 1||30
2245562|NCT02531802|5507895|P18|COMPLETED|Received Vaccination 1||30
2245563|NCT02531802|5507896|P17|COMPLETED|Received Vaccination 1||30
2245564|NCT02531802|5507897|P16|COMPLETED|Received Vaccination 1||30
2245565|NCT02531802|5507898|P15|COMPLETED|Received Vaccination 1||40
2245566|NCT02531802|5507899|P14|COMPLETED|Received Vaccination 1||15
2245567|NCT02531802|5507900|P13|COMPLETED|Received Vaccination 1||15
2245568|NCT02531802|5507901|P12|COMPLETED|Received Vaccination 1||15
2245569|NCT02531802|5507902|P11|COMPLETED|Received Vaccination 1||15
2245570|NCT02531802|5507903|P10|COMPLETED|Received Vaccination 1||52
2245571|NCT02531802|5507904|P9|COMPLETED|Received Vaccination 1||15
2245572|NCT02531802|5507905|P8|COMPLETED|Received Vaccination 1||15
2245573|NCT02531802|5507906|P7|COMPLETED|Received Vaccination 1||15
2245574|NCT02531802|5507907|P6|COMPLETED|Received Vaccination 1||3
2245575|NCT02531802|5507908|P5|COMPLETED|Received Vaccination 1||15
2245576|NCT02531802|5507909|P4|COMPLETED|Received Vaccination 1||15
2245577|NCT02531802|5507910|P3|COMPLETED|Received Vaccination 1||15
2245578|NCT02531802|5507911|P2|COMPLETED|Received Vaccination 1||15
2245579|NCT02531802|5507912|P1|COMPLETED|Received Vaccination 1||15
2245580|NCT02531802|5507892|P21|STARTED|Received Vaccination 1||50
2245581|NCT02531802|5507893|P20|STARTED|Received Vaccination 1||30
2245582|NCT02531802|5507894|P19|STARTED|Received Vaccination 1||30
2245583|NCT02531802|5507895|P18|STARTED|Received Vaccination 1||30
2245584|NCT02531802|5507896|P17|STARTED|Received Vaccination 1||30
2245585|NCT02531802|5507897|P16|STARTED|Received Vaccination 1||30
2245586|NCT02531802|5507898|P15|STARTED|Received Vaccination 1||40
2245587|NCT02531802|5507899|P14|STARTED|Received Vaccination 1||15
2245588|NCT02531802|5507900|P13|STARTED|Received Vaccination 1||15
2245589|NCT02531802|5507901|P12|STARTED|Received Vaccination 1||15
2245590|NCT02531802|5507902|P11|STARTED|Received Vaccination 1||15
2245591|NCT02531802|5507903|P10|STARTED|Received Vaccination 1||52
2245592|NCT02531802|5507904|P9|STARTED|Received Vaccination 1||15
2245593|NCT02531802|5507905|P8|STARTED|Received Vaccination 1||15
2245594|NCT02531802|5507906|P7|STARTED|Received Vaccination 1||15
2245595|NCT02531802|5507907|P6|STARTED|Received Vaccination 1||3
2245596|NCT02531802|5507908|P5|STARTED|Received Vaccination 1||15
2245597|NCT02531802|5507909|P4|STARTED|Received Vaccination 1||15
2245598|NCT02531802|5507910|P3|STARTED|Received Vaccination 1||15
2245599|NCT02531802|5507911|P2|STARTED|Received Vaccination 1||15
2245600|NCT02531802|5507912|P1|STARTED|Received Vaccination 1||15
2245601|NCT02531698|5508344|P2|NOT COMPLETED|Overall Study||2
2245602|NCT02531698|5508345|P1|NOT COMPLETED|Overall Study||11
2245603|NCT02531698|5508344|P2|COMPLETED|Overall Study||104
2245604|NCT02531698|5508345|P1|COMPLETED|Overall Study||283
2245605|NCT02531698|5508344|P2|STARTED|Overall Study||106
2245606|NCT02531698|5508345|P1|STARTED|Overall Study||294
2245607|NCT02531646|5508592|P3|NOT COMPLETED|Overall Study||0
2245608|NCT02531646|5508593|P2|NOT COMPLETED|Overall Study||1
2245609|NCT02531646|5508594|P1|NOT COMPLETED|Overall Study||5
2245610|NCT02531646|5508592|P3|COMPLETED|Overall Study||11
2245611|NCT02531646|5508593|P2|COMPLETED|Overall Study||17
2245612|NCT02531646|5508594|P1|COMPLETED|Overall Study||32
2245613|NCT02531646|5508592|P3|STARTED|Overall Study||11
2245614|NCT02531646|5508593|P2|STARTED|Overall Study||18
2245615|NCT02531646|5508594|P1|STARTED|Overall Study||37
2245616|NCT02531633|5508613|P10|NOT COMPLETED|Part B (104 Weeks)||4
2245617|NCT02531633|5508614|P9|NOT COMPLETED|Part B (104 Weeks)||5
2245618|NCT02531633|5508615|P8|NOT COMPLETED|Part B (104 Weeks)||4
2245619|NCT02531633|5508616|P7|NOT COMPLETED|Part B (104 Weeks)||5
2245620|NCT02531633|5508617|P6|NOT COMPLETED|Part B (104 Weeks)||8
2245621|NCT02531633|5508618|P5|NOT COMPLETED|Part B (104 Weeks)||0
2245622|NCT02531633|5508619|P4|NOT COMPLETED|Part B (104 Weeks)||0
2245623|NCT02531633|5508620|P3|NOT COMPLETED|Part B (104 Weeks)||0
2245624|NCT02531633|5508621|P2|NOT COMPLETED|Part B (104 Weeks)||0
2245625|NCT02531633|5508622|P1|NOT COMPLETED|Part B (104 Weeks)||0
2245626|NCT02531633|5508613|P10|COMPLETED|Part B (104 Weeks)||0
2245627|NCT02531633|5508614|P9|COMPLETED|Part B (104 Weeks)||0
2245628|NCT02531633|5508615|P8|COMPLETED|Part B (104 Weeks)||0
2245629|NCT02531633|5508616|P7|COMPLETED|Part B (104 Weeks)||0
2245630|NCT02531633|5508617|P6|COMPLETED|Part B (104 Weeks)||0
2245631|NCT02531633|5508618|P5|COMPLETED|Part B (104 Weeks)||0
2245632|NCT02531633|5508619|P4|COMPLETED|Part B (104 Weeks)||0
2245633|NCT02531633|5508620|P3|COMPLETED|Part B (104 Weeks)||0
2245634|NCT02531633|5508621|P2|COMPLETED|Part B (104 Weeks)||0
2245635|NCT02531633|5508622|P1|COMPLETED|Part B (104 Weeks)||0
2245636|NCT02531633|5508613|P10|STARTED|Part B (104 Weeks)||4
2245637|NCT02531633|5508614|P9|STARTED|Part B (104 Weeks)||5
2245638|NCT02531633|5508615|P8|STARTED|Part B (104 Weeks)||4
2245639|NCT02531633|5508616|P7|STARTED|Part B (104 Weeks)||5
2245640|NCT02531633|5508617|P6|STARTED|Part B (104 Weeks)||8
2245641|NCT02531633|5508618|P5|STARTED|Part B (104 Weeks)||0
2245642|NCT02531633|5508619|P4|STARTED|Part B (104 Weeks)||0
2245643|NCT02531633|5508620|P3|STARTED|Part B (104 Weeks)||0
2245644|NCT02531633|5508621|P2|STARTED|Part B (104 Weeks)||0
2245645|NCT02531633|5508622|P1|STARTED|Part B (104 Weeks)||0
2245646|NCT02531633|5508613|P10|NOT COMPLETED|Part A (52 Weeks)||0
2245647|NCT02531633|5508614|P9|NOT COMPLETED|Part A (52 Weeks)||0
2245648|NCT02531633|5508615|P8|NOT COMPLETED|Part A (52 Weeks)||0
2245649|NCT02531633|5508616|P7|NOT COMPLETED|Part A (52 Weeks)||0
2245650|NCT02531633|5508617|P6|NOT COMPLETED|Part A (52 Weeks)||0
2245651|NCT02531633|5508618|P5|NOT COMPLETED|Part A (52 Weeks)||23
2245652|NCT02531633|5508619|P4|NOT COMPLETED|Part A (52 Weeks)||22
2245653|NCT02531633|5508620|P3|NOT COMPLETED|Part A (52 Weeks)||22
2245654|NCT02531633|5508621|P2|NOT COMPLETED|Part A (52 Weeks)||34
2245655|NCT02531633|5508622|P1|NOT COMPLETED|Part A (52 Weeks)||34
2245656|NCT02531633|5508613|P10|COMPLETED|Part A (52 Weeks)||0
2245657|NCT02531633|5508614|P9|COMPLETED|Part A (52 Weeks)||0
2245658|NCT02531633|5508615|P8|COMPLETED|Part A (52 Weeks)||0
2245659|NCT02531633|5508616|P7|COMPLETED|Part A (52 Weeks)||0
2245660|NCT02531633|5508617|P6|COMPLETED|Part A (52 Weeks)||0
2245661|NCT02531633|5508618|P5|COMPLETED|Part A (52 Weeks)||4
2245662|NCT02531633|5508619|P4|COMPLETED|Part A (52 Weeks)||5
2245663|NCT02531633|5508620|P3|COMPLETED|Part A (52 Weeks)||4
2245664|NCT02531633|5508621|P2|COMPLETED|Part A (52 Weeks)||5
2245665|NCT02531633|5508622|P1|COMPLETED|Part A (52 Weeks)||8
2245666|NCT02531633|5508613|P10|Completed Part A and Didn’t Enter Part B|Part A (52 Weeks)||0
2245667|NCT02531633|5508614|P9|Completed Part A and Didn’t Enter Part B|Part A (52 Weeks)||0
2245668|NCT02531633|5508615|P8|Completed Part A and Didn’t Enter Part B|Part A (52 Weeks)||0
2245669|NCT02531633|5508616|P7|Completed Part A and Didn’t Enter Part B|Part A (52 Weeks)||0
2245670|NCT02531633|5508617|P6|Completed Part A and Didn’t Enter Part B|Part A (52 Weeks)||0
2245671|NCT02531633|5508618|P5|Completed Part A and Didn’t Enter Part B|Part A (52 Weeks)||0
2245672|NCT02531633|5508619|P4|Completed Part A and Didn’t Enter Part B|Part A (52 Weeks)||0
2245673|NCT02531633|5508620|P3|Completed Part A and Didn’t Enter Part B|Part A (52 Weeks)||1
2245674|NCT02531633|5508621|P2|Completed Part A and Didn’t Enter Part B|Part A (52 Weeks)||0
2245675|NCT02531633|5508622|P1|Completed Part A and Didn’t Enter Part B|Part A (52 Weeks)||1
2245676|NCT02531633|5508613|P10|STARTED|Part A (52 Weeks)||0
2245677|NCT02531633|5508614|P9|STARTED|Part A (52 Weeks)||0
2245678|NCT02531633|5508615|P8|STARTED|Part A (52 Weeks)||0
2245679|NCT02531633|5508616|P7|STARTED|Part A (52 Weeks)||0
2245680|NCT02531633|5508617|P6|STARTED|Part A (52 Weeks)||0
2245681|NCT02531633|5508618|P5|STARTED|Part A (52 Weeks)||27
2245682|NCT02531633|5508619|P4|STARTED|Part A (52 Weeks)||27
2245683|NCT02531633|5508620|P3|STARTED|Part A (52 Weeks)||26
2245684|NCT02531633|5508621|P2|STARTED|Part A (52 Weeks)||39
2245685|NCT02531633|5508622|P1|STARTED|Part A (52 Weeks)||42
2245686|NCT02531438|5509101|P2|NOT COMPLETED|Overall Study||26
2245687|NCT02531438|5509102|P1|NOT COMPLETED|Overall Study||30
2245688|NCT02531438|5509101|P2|COMPLETED|Overall Study||362
2245689|NCT02531438|5509102|P1|COMPLETED|Overall Study||356
2245690|NCT02531438|5509101|P2|STARTED|Overall Study||388
2245691|NCT02531438|5509102|P1|STARTED|Overall Study||386
2245692|NCT02531373|5509121|P9|NOT COMPLETED|Overall Study||9
2245693|NCT02531373|5509122|P8|NOT COMPLETED|Overall Study||9
2245694|NCT02531373|5509123|P7|NOT COMPLETED|Overall Study||11
2245695|NCT02531373|5509124|P6|NOT COMPLETED|Overall Study||9
2245696|NCT02531373|5509125|P5|NOT COMPLETED|Overall Study||8
2245697|NCT02531373|5509126|P4|NOT COMPLETED|Overall Study||0
2245698|NCT02531373|5509127|P3|NOT COMPLETED|Overall Study||0
2245699|NCT02531373|5509128|P2|NOT COMPLETED|Overall Study||0
2245700|NCT02531373|5509129|P1|NOT COMPLETED|Overall Study||0
2245701|NCT02531373|5509121|P9|COMPLETED|Overall Study||43
2245702|NCT02531373|5509122|P8|COMPLETED|Overall Study||43
2245703|NCT02531373|5509123|P7|COMPLETED|Overall Study||41
2245704|NCT02531373|5509124|P6|COMPLETED|Overall Study||42
2245705|NCT02531373|5509125|P5|COMPLETED|Overall Study||43
2245706|NCT02531373|5509126|P4|COMPLETED|Overall Study||20
2245707|NCT02531373|5509127|P3|COMPLETED|Overall Study||20
2245708|NCT02531373|5509128|P2|COMPLETED|Overall Study||20
2245709|NCT02531373|5509129|P1|COMPLETED|Overall Study||20
2245710|NCT02531373|5509121|P9|Vaccination 4|Overall Study||43
2245711|NCT02531373|5509122|P8|Vaccination 4|Overall Study||43
2245712|NCT02531373|5509123|P7|Vaccination 4|Overall Study||43
2245713|NCT02531373|5509124|P6|Vaccination 4|Overall Study||43
2245714|NCT02531373|5509125|P5|Vaccination 4|Overall Study||44
2245715|NCT02531373|5509126|P4|Vaccination 4|Overall Study||0
2245716|NCT02531373|5509127|P3|Vaccination 4|Overall Study||0
2245717|NCT02531373|5509128|P2|Vaccination 4|Overall Study||0
2245718|NCT02531373|5509129|P1|Vaccination 4|Overall Study||0
2245719|NCT02531373|5509121|P9|Vaccination 3|Overall Study||49
2245720|NCT02531373|5509122|P8|Vaccination 3|Overall Study||51
2245721|NCT02531373|5509123|P7|Vaccination 3|Overall Study||49
2245722|NCT02531373|5509124|P6|Vaccination 3|Overall Study||47
2245723|NCT02531373|5509125|P5|Vaccination 3|Overall Study||48
2245724|NCT02531373|5509126|P4|Vaccination 3|Overall Study||0
2245725|NCT02531373|5509127|P3|Vaccination 3|Overall Study||0
2245726|NCT02531373|5509128|P2|Vaccination 3|Overall Study||0
2245727|NCT02531373|5509129|P1|Vaccination 3|Overall Study||0
2245728|NCT02531373|5509121|P9|Vaccination 2|Overall Study||51
2245729|NCT02531373|5509122|P8|Vaccination 2|Overall Study||51
2245730|NCT02531373|5509123|P7|Vaccination 2|Overall Study||50
2245731|NCT02531373|5509124|P6|Vaccination 2|Overall Study||48
2245732|NCT02531373|5509125|P5|Vaccination 2|Overall Study||49
2245733|NCT02531373|5509126|P4|Vaccination 2|Overall Study||0
2245734|NCT02531373|5509127|P3|Vaccination 2|Overall Study||0
2245735|NCT02531373|5509128|P2|Vaccination 2|Overall Study||0
2245736|NCT02531373|5509129|P1|Vaccination 2|Overall Study||0
2245737|NCT02531373|5509121|P9|Vaccination 1|Overall Study||52
2245738|NCT02531373|5509122|P8|Vaccination 1|Overall Study||52
2245739|NCT02531373|5509123|P7|Vaccination 1|Overall Study||52
2245740|NCT02531373|5509124|P6|Vaccination 1|Overall Study||50
2245741|NCT02531373|5509125|P5|Vaccination 1|Overall Study||50
2245742|NCT02531373|5509126|P4|Vaccination 1|Overall Study||20
2245743|NCT02531373|5509127|P3|Vaccination 1|Overall Study||20
2245744|NCT02531373|5509128|P2|Vaccination 1|Overall Study||20
2245745|NCT02531373|5509129|P1|Vaccination 1|Overall Study||20
2245746|NCT02531373|5509121|P9|STARTED|Overall Study||52
2245747|NCT02531373|5509122|P8|STARTED|Overall Study||52
2245748|NCT02531373|5509123|P7|STARTED|Overall Study||52
2245749|NCT02531373|5509124|P6|STARTED|Overall Study||51
2245750|NCT02531373|5509125|P5|STARTED|Overall Study||51
2245751|NCT02531373|5509126|P4|STARTED|Overall Study||20
2245752|NCT02531373|5509127|P3|STARTED|Overall Study||20
2245753|NCT02531373|5509128|P2|STARTED|Overall Study||20
2245754|NCT02531373|5509129|P1|STARTED|Overall Study||20
2245755|NCT02531321|5509188|P2|NOT COMPLETED|Overall Study||0
2245756|NCT02531321|5509189|P1|NOT COMPLETED|Overall Study||2
2245757|NCT02531321|5509188|P2|COMPLETED|Overall Study||10
2245758|NCT02531321|5509189|P1|COMPLETED|Overall Study||5
2245759|NCT02531321|5509188|P2|STARTED|Overall Study||10
2245760|NCT02531321|5509189|P1|STARTED|Overall Study||7
2245761|NCT02531308|5509197|P1|NOT COMPLETED|Overall Study||3
2245762|NCT02531308|5509197|P1|COMPLETED|Overall Study||2
2245763|NCT02531308|5509197|P1|STARTED|Overall Study||5
2245764|NCT02531035|5509203|P2|NOT COMPLETED|Overall Study||95
2245765|NCT02531035|5509204|P1|NOT COMPLETED|Overall Study||81
2245766|NCT02531035|5509203|P2|COMPLETED|Overall Study||605
2245767|NCT02531035|5509204|P1|COMPLETED|Overall Study||624
2245768|NCT02531035|5509203|P2|Treated|Overall Study||699
2245769|NCT02531035|5509204|P1|Treated|Overall Study||703
2245770|NCT02531035|5509203|P2|STARTED|Overall Study||700
2245771|NCT02531035|5509204|P1|STARTED|Overall Study||705
2245772|NCT02531022|5509220|P2|NOT COMPLETED|Overall Study||2
2245773|NCT02531022|5509221|P1|NOT COMPLETED|Overall Study||0
2245774|NCT02531022|5509220|P2|COMPLETED|Overall Study||48
2245775|NCT02531022|5509221|P1|COMPLETED|Overall Study||55
2245776|NCT02531022|5509220|P2|STARTED|Overall Study||50
2245777|NCT02531022|5509221|P1|STARTED|Overall Study||55
2245778|NCT02530671|5509231|P2|NOT COMPLETED|Overall Study||0
2245779|NCT02530671|5509232|P1|NOT COMPLETED|Overall Study||3
2245780|NCT02530671|5509231|P2|COMPLETED|Overall Study||55
2245781|NCT02530671|5509232|P1|COMPLETED|Overall Study||52
2245782|NCT02530671|5509231|P2|STARTED|Overall Study||55
2245783|NCT02530671|5509232|P1|STARTED|Overall Study||55
2245784|NCT02530515|5509251|P3|NOT COMPLETED|Overall Study||0
2245785|NCT02530515|5509252|P2|NOT COMPLETED|Overall Study||0
2245786|NCT02530515|5509253|P1|NOT COMPLETED|Overall Study||0
2245787|NCT02530515|5509251|P3|COMPLETED|Overall Study||8
2245788|NCT02530515|5509252|P2|COMPLETED|Overall Study||0
2245789|NCT02530515|5509253|P1|COMPLETED|Overall Study||0
2245790|NCT02530515|5509251|P3|STARTED|Overall Study||8
2245791|NCT02530515|5509252|P2|STARTED|Overall Study||0
2245792|NCT02530515|5509253|P1|STARTED|Overall Study||0
2245793|NCT02530450|5509272|P2|NOT COMPLETED|Overall Study||5
2245794|NCT02530450|5509273|P1|NOT COMPLETED|Overall Study||6
2245795|NCT02530450|5509272|P2|COMPLETED|Overall Study||9
2245796|NCT02530450|5509273|P1|COMPLETED|Overall Study||10
2245797|NCT02530450|5509272|P2|STARTED|Overall Study||14
2245798|NCT02530450|5509273|P1|STARTED|Overall Study||16
2245799|NCT02530385|5509281|P2|NOT COMPLETED|Overall Study||1
2245800|NCT02530385|5509282|P1|NOT COMPLETED|Overall Study||0
2245801|NCT02530385|5509281|P2|COMPLETED|Overall Study||11
2245802|NCT02530385|5509282|P1|COMPLETED|Overall Study||12
2245803|NCT02530385|5509281|P2|STARTED|Overall Study||12
2245804|NCT02530385|5509282|P1|STARTED|Overall Study||12
2245805|NCT02530294|5509298|P2|NOT COMPLETED|Overall Study||6
2245806|NCT02530294|5509299|P1|NOT COMPLETED|Overall Study||16
2245807|NCT02530294|5509298|P2|COMPLETED|Overall Study||113
2245808|NCT02530294|5509299|P1|COMPLETED|Overall Study||218
2245809|NCT02530294|5509298|P2|STARTED|Overall Study||119
2245810|NCT02530294|5509299|P1|STARTED|Overall Study||234
2245811|NCT02530281|5509315|P2|NOT COMPLETED|Overall Study||3
2245812|NCT02530281|5509316|P1|NOT COMPLETED|Overall Study||21
2245813|NCT02530281|5509315|P2|COMPLETED|Overall Study||112
2245814|NCT02530281|5509316|P1|COMPLETED|Overall Study||208
2245815|NCT02530281|5509315|P2|STARTED|Overall Study||115
2245816|NCT02530281|5509316|P1|STARTED|Overall Study||229
2245817|NCT02530151|5509334|P2|NOT COMPLETED|Overall Study||16
2245818|NCT02530151|5509335|P1|NOT COMPLETED|Overall Study||21
2245819|NCT02530151|5509334|P2|COMPLETED|Overall Study||17
2245820|NCT02530151|5509335|P1|COMPLETED|Overall Study||16
2245821|NCT02530151|5509334|P2|STARTED|Overall Study||33
2245822|NCT02530151|5509335|P1|STARTED|Overall Study||37
2245823|NCT02530125|5509345|P1|NOT COMPLETED|Followed for Survival for 2 Years||3
2245824|NCT02530125|5509345|P1|COMPLETED|Followed for Survival for 2 Years||0
2245825|NCT02530125|5509345|P1|STARTED|Followed for Survival for 2 Years||3
2245826|NCT02530125|5509345|P1|NOT COMPLETED|Completed Treatment||1
2245827|NCT02530125|5509345|P1|COMPLETED|Completed Treatment||3
2245828|NCT02530125|5509345|P1|STARTED|Completed Treatment||4
2245829|NCT02529995|5509359|P2|NOT COMPLETED|Part B||12
2245830|NCT02529995|5509360|P1|NOT COMPLETED|Part B||6
2245831|NCT02529995|5509359|P2|COMPLETED|Part B||4
2245832|NCT02529995|5509360|P1|COMPLETED|Part B||9
2245833|NCT02529995|5509359|P2|STARTED|Part B||16
2245834|NCT02529995|5509360|P1|STARTED|Part B||15
2245835|NCT02529995|5509359|P2|NOT COMPLETED|Part A||16
2245836|NCT02529995|5509360|P1|NOT COMPLETED|Part A||15
2245837|NCT02529995|5509359|P2|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0
2245838|NCT02529995|5509360|P1|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0
2245839|NCT02529995|5509359|P2|STARTED|Part A||16
2245840|NCT02529995|5509360|P1|STARTED|Part A||15
2245841|NCT02529488|5509394|P1|NOT COMPLETED|Overall Study||4
2245842|NCT02529488|5509394|P1|COMPLETED|Overall Study||145
2245843|NCT02529488|5509394|P1|STARTED|Overall Study||149
2245844|NCT02529137|5509402|P1|NOT COMPLETED|Overall Study||8
2245845|NCT02529137|5509402|P1|COMPLETED|Overall Study||1992
2245846|NCT02529137|5509402|P1|STARTED|Overall Study||2000
2245847|NCT02528786|5509407|P1|NOT COMPLETED|Overall Study||0
2245848|NCT02528786|5509407|P1|COMPLETED|Overall Study||8
2245849|NCT02528786|5509407|P1|STARTED|Overall Study||8
2245850|NCT02528721|5509413|P2|NOT COMPLETED|Overall Study||3
2245851|NCT02528721|5509414|P1|NOT COMPLETED|Overall Study||7
2245852|NCT02528721|5509413|P2|COMPLETED|Overall Study||76
2245853|NCT02528721|5509414|P1|COMPLETED|Overall Study||196
2245854|NCT02528721|5509413|P2|STARTED|Overall Study||79
2245855|NCT02528721|5509414|P1|STARTED|Overall Study||203
2245856|NCT02528643|5509426|P2|NOT COMPLETED|Overall Study||85
2245857|NCT02528643|5509427|P1|NOT COMPLETED|Overall Study||39
2245858|NCT02528643|5509426|P2|COMPLETED|Overall Study||25
2245859|NCT02528643|5509427|P1|COMPLETED|Overall Study||16
2245860|NCT02528643|5509426|P2|Treated|Overall Study||107
2245861|NCT02528643|5509427|P1|Treated|Overall Study||55
2245862|NCT02528643|5509426|P2|STARTED|Overall Study||110
2245863|NCT02528643|5509427|P1|STARTED|Overall Study||55
2245864|NCT02528500|5509440|P1|NOT COMPLETED|Overall Study||0
2245865|NCT02528500|5509440|P1|COMPLETED|Overall Study||10
2245866|NCT02528500|5509440|P1|STARTED|Overall Study||10
2245867|NCT02528331|5509444|P1|NOT COMPLETED|Overall Study||2
2245868|NCT02528331|5509444|P1|COMPLETED|Overall Study||0
2245869|NCT02528331|5509444|P1|STARTED|Overall Study||2
2245870|NCT02528318|5509456|P5|NOT COMPLETED|Overall Study||0
2245871|NCT02528318|5509457|P4|NOT COMPLETED|Overall Study||0
2245872|NCT02528318|5509458|P3|NOT COMPLETED|Overall Study||0
2245873|NCT02528318|5509459|P2|NOT COMPLETED|Overall Study||0
2245874|NCT02528318|5509460|P1|NOT COMPLETED|Overall Study||0
2245875|NCT02528318|5509456|P5|COMPLETED|Overall Study||24
2245876|NCT02528318|5509457|P4|COMPLETED|Overall Study||0
2245877|NCT02528318|5509458|P3|COMPLETED|Overall Study||8
2245878|NCT02528318|5509459|P2|COMPLETED|Overall Study||8
2245879|NCT02528318|5509460|P1|COMPLETED|Overall Study||8
2245880|NCT02528318|5509456|P5|STARTED|Overall Study||24
2245881|NCT02528318|5509457|P4|STARTED|Overall Study|Study was terminated prior to initiation of this intervention|0
2245882|NCT02528318|5509458|P3|STARTED|Overall Study||8
2245883|NCT02528318|5509459|P2|STARTED|Overall Study||8
2245884|NCT02528318|5509460|P1|STARTED|Overall Study||8
2245885|NCT02528305|5509512|P1|NOT COMPLETED|Overall Study||3
2245886|NCT02528305|5509512|P1|COMPLETED|Overall Study||9
2245887|NCT02528305|5509512|P1|End of Intervention Period Assessment|Overall Study||9
2245888|NCT02528305|5509512|P1|End of Control Period Assessment|Overall Study||11
2245889|NCT02528305|5509512|P1|STARTED|Overall Study||12
2245915|NCT02528214|5509856|P2|NOT COMPLETED|Overall Study||3
2245916|NCT02528214|5509857|P1|NOT COMPLETED|Overall Study||0
2245917|NCT02528214|5509856|P2|COMPLETED|Overall Study||100
2245918|NCT02528214|5509857|P1|COMPLETED|Overall Study||107
2245919|NCT02528214|5509856|P2|Treated|Overall Study||103
2245920|NCT02528214|5509857|P1|Treated|Overall Study||107
2245921|NCT02528214|5509856|P2|STARTED|Overall Study||103
2245922|NCT02528214|5509857|P1|STARTED|Overall Study||107
2245923|NCT02528188|5509892|P3|NOT COMPLETED|Overall Study||251
2245924|NCT02528188|5509893|P2|NOT COMPLETED|Overall Study||276
2245925|NCT02528188|5509894|P1|NOT COMPLETED|Overall Study||267
2245926|NCT02528188|5509892|P3|COMPLETED|Overall Study||757
2245927|NCT02528188|5509893|P2|COMPLETED|Overall Study||729
2245928|NCT02528188|5509894|P1|COMPLETED|Overall Study||741
2245929|NCT02528188|5509892|P3|Treated|Overall Study||996
2245930|NCT02528188|5509893|P2|Treated|Overall Study||998
2245931|NCT02528188|5509894|P1|Treated|Overall Study||1002
2245932|NCT02528188|5509892|P3|STARTED|Overall Study||1008
2245933|NCT02528188|5509893|P2|STARTED|Overall Study||1005
2245934|NCT02528188|5509894|P1|STARTED|Overall Study||1008
2245935|NCT02528097|5510146|P2|NOT COMPLETED|Overall Study||0
2245936|NCT02528097|5510147|P1|NOT COMPLETED|Overall Study||0
2245937|NCT02528097|5510146|P2|COMPLETED|Overall Study||1
2245938|NCT02528097|5510147|P1|COMPLETED|Overall Study||1
2245939|NCT02528097|5510146|P2|STARTED|Overall Study||1
2245940|NCT02528097|5510147|P1|STARTED|Overall Study||1
2245941|NCT02527694|5510157|P2|NOT COMPLETED|Overall Study||8
2245942|NCT02527694|5510158|P1|NOT COMPLETED|Overall Study||10
2245943|NCT02527694|5510157|P2|COMPLETED|Overall Study||21
2245944|NCT02527694|5510158|P1|COMPLETED|Overall Study||10
2245945|NCT02527694|5510157|P2|STARTED|Overall Study||29
2245946|NCT02527694|5510158|P1|STARTED|Overall Study||20
2245962|NCT02527161|5510229|P1|NOT COMPLETED|Overall Study||62
2245963|NCT02527161|5510229|P1|COMPLETED|Overall Study|Completed/Not completed counts are for knees at the 6 mo primary outcome interval.|96
2245964|NCT02527161|5510229|P1|STARTED|Overall Study|All results are reported by knee throughout record. Participant=knee.|158
2245965|NCT02527148|5510248|P2|NOT COMPLETED|Overall Study||0
2245966|NCT02527148|5510249|P1|NOT COMPLETED|Overall Study||1
2245967|NCT02527148|5510248|P2|COMPLETED|Overall Study||50
2245968|NCT02527148|5510249|P1|COMPLETED|Overall Study||49
2245969|NCT02527148|5510248|P2|STARTED|Overall Study||50
2245970|NCT02527148|5510249|P1|STARTED|Overall Study||50
2245971|NCT02526693|5510269|P2|NOT COMPLETED|Overall Study||1
2245972|NCT02526693|5510270|P1|NOT COMPLETED|Overall Study||3
2245973|NCT02526693|5510269|P2|COMPLETED|Overall Study||50
2245974|NCT02526693|5510270|P1|COMPLETED|Overall Study||50
2245975|NCT02526693|5510269|P2|STARTED|Overall Study||51
2245976|NCT02526693|5510270|P1|STARTED|Overall Study||53
2245977|NCT02526680|5510280|P1|NOT COMPLETED|Overall Study||0
2245978|NCT02526680|5510280|P1|COMPLETED|Overall Study||27
2245979|NCT02526680|5510280|P1|STARTED|Overall Study||27
2245980|NCT02526654|5510289|P2|NOT COMPLETED|Overall Study||0
2245981|NCT02526654|5510290|P1|NOT COMPLETED|Overall Study||0
2245982|NCT02526654|5510289|P2|COMPLETED|Overall Study||36
2245983|NCT02526654|5510290|P1|COMPLETED|Overall Study||79
2245984|NCT02526654|5510289|P2|STARTED|Overall Study||36
2245985|NCT02526654|5510290|P1|STARTED|Overall Study||79
2245986|NCT02526550|5510299|P1|NOT COMPLETED|Overall Study||1
2245987|NCT02526550|5510299|P1|COMPLETED|Overall Study||49
2245988|NCT02526550|5510299|P1|STARTED|Overall Study||50
2245989|NCT02526524|5510311|P6|NOT COMPLETED|Overall Study||21
2245990|NCT02526524|5510312|P5|NOT COMPLETED|Overall Study||24
2245991|NCT02526524|5510313|P4|NOT COMPLETED|Overall Study||7
2245992|NCT02526524|5510314|P3|NOT COMPLETED|Overall Study||26
2245993|NCT02526524|5510315|P2|NOT COMPLETED|Overall Study||9
2245994|NCT02526524|5510316|P1|NOT COMPLETED|Overall Study||12
2245995|NCT02526524|5510311|P6|COMPLETED|Overall Study||73
2245996|NCT02526524|5510312|P5|COMPLETED|Overall Study||72
2245997|NCT02526524|5510313|P4|COMPLETED|Overall Study||89
2245998|NCT02526524|5510314|P3|COMPLETED|Overall Study||70
2245999|NCT02526524|5510315|P2|COMPLETED|Overall Study||86
2246000|NCT02526524|5510316|P1|COMPLETED|Overall Study||82
2246001|NCT02526524|5510311|P6|STARTED|Overall Study||94
2246002|NCT02526524|5510312|P5|STARTED|Overall Study||96
2246003|NCT02526524|5510313|P4|STARTED|Overall Study||96
2246004|NCT02526524|5510314|P3|STARTED|Overall Study||96
2246005|NCT02526524|5510315|P2|STARTED|Overall Study||95
2246006|NCT02526524|5510316|P1|STARTED|Overall Study||94
2246007|NCT02526290|5510330|P1|NOT COMPLETED|Overall Study||8
2246008|NCT02526290|5510330|P1|COMPLETED|Overall Study||89
2246009|NCT02526290|5510330|P1|STARTED|Overall Study||97
2246022|NCT02525874|5510362|P1|NOT COMPLETED|Overall Study||60
2246023|NCT02525874|5510362|P1|COMPLETED|Overall Study||158
2246024|NCT02525874|5510362|P1|STARTED|Overall Study||218
2246025|NCT02525718|5510377|P2|NOT COMPLETED|Overall Study||1
2246026|NCT02525718|5510378|P1|NOT COMPLETED|Overall Study||1
2246027|NCT02525718|5510377|P2|COMPLETED|Overall Study||23
2246028|NCT02525718|5510378|P1|COMPLETED|Overall Study||22
2246029|NCT02525718|5510377|P2|STARTED|Overall Study||24
2246030|NCT02525718|5510378|P1|STARTED|Overall Study||23
2246031|NCT02525627|5510392|P2|NOT COMPLETED|Overall Study||13
2246032|NCT02525627|5510393|P1|NOT COMPLETED|Overall Study||14
2246033|NCT02525627|5510392|P2|COMPLETED|Overall Study||5
2246034|NCT02525627|5510393|P1|COMPLETED|Overall Study||2
2246035|NCT02525627|5510392|P2|STARTED|Overall Study||18
2246036|NCT02525627|5510393|P1|STARTED|Overall Study||16
2246037|NCT02525575|5510403|P1|NOT COMPLETED|Overall Study||15
2246038|NCT02525575|5510403|P1|COMPLETED|Overall Study||22
2246039|NCT02525575|5510403|P1|STARTED|Overall Study||37
2246040|NCT02525536|5510413|P3|NOT COMPLETED|Overall Study||0
2246041|NCT02525536|5510414|P2|NOT COMPLETED|Overall Study||0
2246042|NCT02525536|5510415|P1|NOT COMPLETED|Overall Study||0
2246043|NCT02525536|5510413|P3|COMPLETED|Overall Study||6
2246044|NCT02525536|5510414|P2|COMPLETED|Overall Study||6
2246045|NCT02525536|5510415|P1|COMPLETED|Overall Study||6
2246046|NCT02525536|5510413|P3|STARTED|Overall Study||6
2246047|NCT02525536|5510414|P2|STARTED|Overall Study||6
2246048|NCT02525536|5510415|P1|STARTED|Overall Study||6
2246055|NCT02525094|5510499|P2|NOT COMPLETED|Overall Study||8
2246056|NCT02525094|5510500|P1|NOT COMPLETED|Overall Study||8
2246057|NCT02525094|5510499|P2|COMPLETED|Overall Study||48
2246058|NCT02525094|5510500|P1|COMPLETED|Overall Study||49
2246059|NCT02525094|5510499|P2|Treated|Overall Study||55
2246060|NCT02525094|5510500|P1|Treated|Overall Study||56
2246061|NCT02525094|5510499|P2|STARTED|Overall Study||56
2246062|NCT02525094|5510500|P1|STARTED|Overall Study||57
2246063|NCT02525055|5510533|P6|NOT COMPLETED|Overall Study||0
2246064|NCT02525055|5510534|P5|NOT COMPLETED|Overall Study||0
2246065|NCT02525055|5510535|P4|NOT COMPLETED|Overall Study||0
2246066|NCT02525055|5510536|P3|NOT COMPLETED|Overall Study||0
2246067|NCT02525055|5510537|P2|NOT COMPLETED|Overall Study||0
2246068|NCT02525055|5510538|P1|NOT COMPLETED|Overall Study||0
2246069|NCT02525055|5510533|P6|COMPLETED|Overall Study||16
2246070|NCT02525055|5510534|P5|COMPLETED|Overall Study||6
2246071|NCT02525055|5510535|P4|COMPLETED|Overall Study||6
2246072|NCT02525055|5510536|P3|COMPLETED|Overall Study||6
2246073|NCT02525055|5510537|P2|COMPLETED|Overall Study||6
2246074|NCT02525055|5510538|P1|COMPLETED|Overall Study||6
2246075|NCT02525055|5510533|P6|STARTED|Overall Study||16
2246076|NCT02525055|5510534|P5|STARTED|Overall Study||6
2246077|NCT02525055|5510535|P4|STARTED|Overall Study||6
2246078|NCT02525055|5510536|P3|STARTED|Overall Study||6
2246079|NCT02525055|5510537|P2|STARTED|Overall Study||6
2246080|NCT02525055|5510538|P1|STARTED|Overall Study||6
2246081|NCT02524977|5510554|P2|NOT COMPLETED|Overall Study||45
2246082|NCT02524977|5510555|P1|NOT COMPLETED|Overall Study||46
2246083|NCT02524977|5510554|P2|COMPLETED|Overall Study||801
2246084|NCT02524977|5510555|P1|COMPLETED|Overall Study||692
2246085|NCT02524977|5510554|P2|STARTED|Overall Study||846
2246086|NCT02524977|5510555|P1|STARTED|Overall Study||738
2246087|NCT02524665|5510563|P1|NOT COMPLETED|Overall Study||1
2246088|NCT02524665|5510563|P1|COMPLETED|Overall Study||19
2246089|NCT02524665|5510563|P1|STARTED|Overall Study||20
2246090|NCT02524561|5510581|P3|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
2246091|NCT02524561|5510582|P2|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
2246092|NCT02524561|5510583|P1|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
2246093|NCT02524561|5510581|P3|COMPLETED|Final: Year 3 or 4 Post-randomization||187
2246094|NCT02524561|5510582|P2|COMPLETED|Final: Year 3 or 4 Post-randomization||162
2246095|NCT02524561|5510583|P1|COMPLETED|Final: Year 3 or 4 Post-randomization||168
2246096|NCT02524561|5510581|P3|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||151
2246097|NCT02524561|5510582|P2|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||139
2246098|NCT02524561|5510583|P1|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||143
2246099|NCT02524561|5510581|P3|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|187
2246100|NCT02524561|5510582|P2|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|162
2246101|NCT02524561|5510583|P1|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|168
2246102|NCT02524561|5510581|P3|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
2246103|NCT02524561|5510582|P2|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
2246104|NCT02524561|5510583|P1|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
2246105|NCT02524561|5510581|P3|COMPLETED|Year 1: Post Randomization Mammograms||187
2246106|NCT02524561|5510582|P2|COMPLETED|Year 1: Post Randomization Mammograms||162
2246107|NCT02524561|5510583|P1|COMPLETED|Year 1: Post Randomization Mammograms||168
2246108|NCT02524561|5510581|P3|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|148
2246109|NCT02524561|5510582|P2|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|123
2246110|NCT02524561|5510583|P1|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post-randomization mammogram|136
2246111|NCT02524561|5510581|P3|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|187
2246112|NCT02524561|5510582|P2|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|162
2246113|NCT02524561|5510583|P1|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|168
2246114|NCT02524561|5510581|P3|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
2246115|NCT02524561|5510582|P2|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
2246116|NCT02524561|5510583|P1|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
2246117|NCT02524561|5510581|P3|COMPLETED|Baseline: Pre-randomization Mammogram||187
2246118|NCT02524561|5510582|P2|COMPLETED|Baseline: Pre-randomization Mammogram||162
2246119|NCT02524561|5510583|P1|COMPLETED|Baseline: Pre-randomization Mammogram||168
2246120|NCT02524561|5510581|P3|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||151
2246121|NCT02524561|5510582|P2|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||133
2246122|NCT02524561|5510583|P1|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||137
2246123|NCT02524561|5510581|P3|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS.|187
2246124|NCT02524561|5510582|P2|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|162
2246125|NCT02524561|5510583|P1|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|168
2246126|NCT02524418|5510600|P1|NOT COMPLETED|Overall Study||13
2246127|NCT02524418|5510600|P1|COMPLETED|Overall Study||75
2246128|NCT02524418|5510600|P1|STARTED|Overall Study||88
2246129|NCT02524288|5510614|P1|NOT COMPLETED|Overall Study||1941
2246130|NCT02524288|5510614|P1|COMPLETED|Overall Study||0
2246131|NCT02524288|5510614|P1|Treated|Overall Study||1936
2246132|NCT02524288|5510614|P1|STARTED|Overall Study||1941
2246133|NCT02524158|5510624|P2|NOT COMPLETED|6-month Assessment||21
2246134|NCT02524158|5510625|P1|NOT COMPLETED|6-month Assessment||22
2246135|NCT02524158|5510624|P2|COMPLETED|6-month Assessment||55
2246136|NCT02524158|5510625|P1|COMPLETED|6-month Assessment||54
2246137|NCT02524158|5510624|P2|STARTED|6-month Assessment||76
2246138|NCT02524158|5510625|P1|STARTED|6-month Assessment||76
2246139|NCT02524158|5510624|P2|NOT COMPLETED|12-weeks Assessment||13
2246140|NCT02524158|5510625|P1|NOT COMPLETED|12-weeks Assessment||19
2246141|NCT02524158|5510624|P2|COMPLETED|12-weeks Assessment||63
2246142|NCT02524158|5510625|P1|COMPLETED|12-weeks Assessment||57
2246143|NCT02524158|5510624|P2|STARTED|12-weeks Assessment||76
2246144|NCT02524158|5510625|P1|STARTED|12-weeks Assessment||76
2246145|NCT02524145|5510667|P3|NOT COMPLETED|Overall Study||3
2246146|NCT02524145|5510668|P2|NOT COMPLETED|Overall Study||2
2246147|NCT02524145|5510669|P1|NOT COMPLETED|Overall Study||2
2246148|NCT02524145|5510667|P3|COMPLETED|Overall Study||7
2246149|NCT02524145|5510668|P2|COMPLETED|Overall Study||13
2246150|NCT02524145|5510669|P1|COMPLETED|Overall Study||13
2246151|NCT02524145|5510667|P3|STARTED|Overall Study||10
2246152|NCT02524145|5510668|P2|STARTED|Overall Study||15
2246153|NCT02524145|5510669|P1|STARTED|Overall Study||15
2246154|NCT02524106|5510681|P2|NOT COMPLETED|Overall Study||0
2246155|NCT02524106|5510682|P1|NOT COMPLETED|Overall Study||0
2246156|NCT02524106|5510681|P2|COMPLETED|Overall Study||5
2246157|NCT02524106|5510682|P1|COMPLETED|Overall Study||6
2246158|NCT02524106|5510681|P2|STARTED|Overall Study||5
2246159|NCT02524106|5510682|P1|STARTED|Overall Study||6
2246160|NCT02524054|5510692|P3|NOT COMPLETED|Overall Study||0
2246161|NCT02524054|5510693|P2|NOT COMPLETED|Overall Study||0
2246162|NCT02524054|5510694|P1|NOT COMPLETED|Overall Study||0
2246163|NCT02524054|5510692|P3|COMPLETED|Overall Study||8
2246164|NCT02524054|5510693|P2|COMPLETED|Overall Study||9
2246165|NCT02524054|5510694|P1|COMPLETED|Overall Study||7
2246166|NCT02524054|5510692|P3|STARTED|Overall Study||8
2246167|NCT02524054|5510693|P2|STARTED|Overall Study||9
2246168|NCT02524054|5510694|P1|STARTED|Overall Study||7
2246169|NCT02523924|5510705|P1|NOT COMPLETED|Overall Study||0
2246170|NCT02523924|5510705|P1|COMPLETED|Overall Study||31
2246171|NCT02523924|5510705|P1|STARTED|Overall Study||31
2246172|NCT02523690|5510715|P2|NOT COMPLETED|Overall Study||0
2246173|NCT02523690|5510716|P1|NOT COMPLETED|Overall Study||0
2246174|NCT02523690|5510715|P2|COMPLETED|Overall Study||2
2246175|NCT02523690|5510716|P1|COMPLETED|Overall Study||3
2246176|NCT02523690|5510715|P2|STARTED|Overall Study||2
2246177|NCT02523690|5510716|P1|STARTED|Overall Study||3
2246178|NCT02523586|5510732|P1|NOT COMPLETED|Overall Study||4
2246179|NCT02523586|5510732|P1|COMPLETED|Overall Study||10
2246180|NCT02523586|5510732|P1|STARTED|Overall Study||14
2246181|NCT02523235|5510745|P2|NOT COMPLETED|Overall Study||0
2246182|NCT02523235|5510746|P1|NOT COMPLETED|Overall Study||0
2246183|NCT02523235|5510745|P2|COMPLETED|Overall Study||58
2246184|NCT02523235|5510746|P1|COMPLETED|Overall Study||56
2246185|NCT02523235|5510745|P2|STARTED|Overall Study||58
2246186|NCT02523235|5510746|P1|STARTED|Overall Study||56
2246187|NCT02522884|5510766|P1|NOT COMPLETED|Overall Study||18
2246188|NCT02522884|5510766|P1|COMPLETED|Overall Study|Completed 12-month follow-up.|195
2246189|NCT02522884|5510766|P1|STARTED|Overall Study|Intent to Treat (ITT) population.|213
2246190|NCT02522728|5510773|P2|NOT COMPLETED|Overall Study||11
2246191|NCT02522728|5510774|P1|NOT COMPLETED|Overall Study||12
2246192|NCT02522728|5510773|P2|COMPLETED|Overall Study||19
2246193|NCT02522728|5510774|P1|COMPLETED|Overall Study||16
2246194|NCT02522728|5510773|P2|STARTED|Overall Study||30
2246195|NCT02522728|5510774|P1|STARTED|Overall Study||28
2246196|NCT02522624|5510790|P2|NOT COMPLETED|Overall Study||0
2246197|NCT02522624|5510791|P1|NOT COMPLETED|Overall Study||1
2246198|NCT02522624|5510790|P2|COMPLETED|Overall Study||163
2246199|NCT02522624|5510791|P1|COMPLETED|Overall Study|Discontinued intervention due to technical failure (n=1)|164
2246200|NCT02522624|5510790|P2|STARTED|Overall Study||163
2246201|NCT02522624|5510791|P1|STARTED|Overall Study||165
2246202|NCT02522442|5510809|P2|NOT COMPLETED|Overall Study||0
2246203|NCT02522442|5510810|P1|NOT COMPLETED|Overall Study||0
2246204|NCT02522442|5510809|P2|COMPLETED|Overall Study||22
2246205|NCT02522442|5510810|P1|COMPLETED|Overall Study||26
2246206|NCT02522442|5510809|P2|STARTED|Overall Study||22
2246207|NCT02522442|5510810|P1|STARTED|Overall Study||26
2246208|NCT02522403|5510826|P2|NOT COMPLETED|Overall Study||6
2246209|NCT02522403|5510827|P1|NOT COMPLETED|Overall Study||4
2246210|NCT02522403|5510826|P2|COMPLETED|Overall Study||13
2246211|NCT02522403|5510827|P1|COMPLETED|Overall Study||13
2246212|NCT02522403|5510826|P2|STARTED|Overall Study||19
2246213|NCT02522403|5510827|P1|STARTED|Overall Study||17
2246214|NCT02522377|5510839|P2|NOT COMPLETED|Overall Study||0
2246215|NCT02522377|5510840|P1|NOT COMPLETED|Overall Study||4
2246216|NCT02522377|5510839|P2|COMPLETED|Overall Study||5
2246217|NCT02522377|5510840|P1|COMPLETED|Overall Study||3
2246218|NCT02522377|5510839|P2|STARTED|Overall Study||5
2246219|NCT02522377|5510840|P1|STARTED|Overall Study||7
2246220|NCT02522325|5510856|P2|NOT COMPLETED|Overall Study||1
2246221|NCT02522325|5510857|P1|NOT COMPLETED|Overall Study||0
2246222|NCT02522325|5510856|P2|COMPLETED|Overall Study||14
2246223|NCT02522325|5510857|P1|COMPLETED|Overall Study||15
2246224|NCT02522325|5510856|P2|STARTED|Overall Study||15
2246225|NCT02522325|5510857|P1|STARTED|Overall Study||15
2246226|NCT02522299|5510865|P2|NOT COMPLETED|Overall Study||1
2246227|NCT02522299|5510866|P1|NOT COMPLETED|Overall Study||4
2246228|NCT02522299|5510865|P2|COMPLETED|Overall Study||21
2246229|NCT02522299|5510866|P1|COMPLETED|Overall Study||18
2246230|NCT02522299|5510865|P2|STARTED|Overall Study||22
2246231|NCT02522299|5510866|P1|STARTED|Overall Study||22
2246232|NCT02522286|5510949|P4|NOT COMPLETED|Overall Study||3
2246233|NCT02522286|5510950|P3|NOT COMPLETED|Overall Study||0
2246234|NCT02522286|5510951|P2|NOT COMPLETED|Overall Study||0
2246235|NCT02522286|5510952|P1|NOT COMPLETED|Overall Study||3
2246236|NCT02522286|5510949|P4|COMPLETED|Overall Study||75
2246237|NCT02522286|5510950|P3|COMPLETED|Overall Study||75
2246238|NCT02522286|5510951|P2|COMPLETED|Overall Study||75
2246239|NCT02522286|5510952|P1|COMPLETED|Overall Study||75
2246240|NCT02522286|5510949|P4|STARTED|Overall Study||78
2246241|NCT02522286|5510950|P3|STARTED|Overall Study||75
2246242|NCT02522286|5510951|P2|STARTED|Overall Study||75
2246243|NCT02522286|5510952|P1|STARTED|Overall Study||78
2246244|NCT02521948|5510978|P1|NOT COMPLETED|Overall Study||13
2246245|NCT02521948|5510978|P1|COMPLETED|Overall Study||37
2246246|NCT02521948|5510978|P1|STARTED|Overall Study||50
2246247|NCT02521376|5510991|P4|NOT COMPLETED|Overall Study||0
2246248|NCT02521376|5510992|P3|NOT COMPLETED|Overall Study||0
2246249|NCT02521376|5510993|P2|NOT COMPLETED|Overall Study||0
2246250|NCT02521376|5510994|P1|NOT COMPLETED|Overall Study||1
2246251|NCT02521376|5510991|P4|COMPLETED|Overall Study||20
2246252|NCT02521376|5510992|P3|COMPLETED|Overall Study||10
2246253|NCT02521376|5510993|P2|COMPLETED|Overall Study||18
2246254|NCT02521376|5510994|P1|COMPLETED|Overall Study||7
2246255|NCT02521376|5510991|P4|STARTED|Overall Study||20
2246256|NCT02521376|5510992|P3|STARTED|Overall Study||10
2246257|NCT02521376|5510993|P2|STARTED|Overall Study||18
2246258|NCT02521376|5510994|P1|STARTED|Overall Study||8
2246259|NCT02521259|5511026|P2|NOT COMPLETED|Overall Study||5
2246260|NCT02521259|5511027|P1|NOT COMPLETED|Overall Study||1
2246261|NCT02521259|5511026|P2|COMPLETED|Overall Study||28
2246262|NCT02521259|5511027|P1|COMPLETED|Overall Study||34
2246263|NCT02521259|5511026|P2|STARTED|Overall Study||33
2246264|NCT02521259|5511027|P1|STARTED|Overall Study||35
2246265|NCT02520726|5511035|P2|NOT COMPLETED|Overall Study||2
2246266|NCT02520726|5511036|P1|NOT COMPLETED|Overall Study||3
2246267|NCT02520726|5511035|P2|COMPLETED|Overall Study||0
2246268|NCT02520726|5511036|P1|COMPLETED|Overall Study||0
2246269|NCT02520726|5511035|P2|STARTED|Overall Study||2
2246270|NCT02520726|5511036|P1|STARTED|Overall Study||3
2246271|NCT02520531|5511046|P2|NOT COMPLETED|Overall Study||6
2246272|NCT02520531|5511047|P1|NOT COMPLETED|Overall Study||6
2246273|NCT02520531|5511046|P2|COMPLETED|Overall Study||36
2246274|NCT02520531|5511047|P1|COMPLETED|Overall Study||36
2246275|NCT02520531|5511046|P2|STARTED|Overall Study||42
2246276|NCT02520531|5511047|P1|STARTED|Overall Study||42
2246277|NCT02520518|5511065|P4|NOT COMPLETED|Overall Study||1
2246278|NCT02520518|5511066|P3|NOT COMPLETED|Overall Study||2
2246279|NCT02520518|5511067|P2|NOT COMPLETED|Overall Study||0
2246280|NCT02520518|5511068|P1|NOT COMPLETED|Overall Study||0
2246281|NCT02520518|5511065|P4|COMPLETED|Overall Study||1
2246282|NCT02520518|5511066|P3|COMPLETED|Overall Study||1
2246283|NCT02520518|5511067|P2|COMPLETED|Overall Study||1
2246284|NCT02520518|5511068|P1|COMPLETED|Overall Study||3
2246285|NCT02520518|5511065|P4|STARTED|Overall Study||2
2246286|NCT02520518|5511066|P3|STARTED|Overall Study||3
2246287|NCT02520518|5511067|P2|STARTED|Overall Study||1
2246288|NCT02520518|5511068|P1|STARTED|Overall Study||3
2246289|NCT02520414|5511126|P1|NOT COMPLETED|Overall Study||0
2246290|NCT02520414|5511126|P1|COMPLETED|Overall Study||10
2246291|NCT02520414|5511126|P1|STARTED|Overall Study||10
2246292|NCT02520388|5511132|P2|NOT COMPLETED|Overall Study||16
2246293|NCT02520388|5511133|P1|NOT COMPLETED|Overall Study||9
2246294|NCT02520388|5511132|P2|COMPLETED|Overall Study||65
2246295|NCT02520388|5511133|P1|COMPLETED|Overall Study||73
2246296|NCT02520388|5511132|P2|Treated|Overall Study||80
2246297|NCT02520388|5511133|P1|Treated|Overall Study||81
2246298|NCT02520388|5511132|P2|STARTED|Overall Study||81
2246299|NCT02520388|5511133|P1|STARTED|Overall Study||82
2246300|NCT02520310|5511141|P1|NOT COMPLETED|At 1 Year Clinical Follow-up||1
2246301|NCT02520310|5511141|P1|COMPLETED|At 1 Year Clinical Follow-up||28
2246302|NCT02520310|5511141|P1|STARTED|At 1 Year Clinical Follow-up||29
2246303|NCT02520310|5511141|P1|NOT COMPLETED|At 6 Months Clinical Follow-up||1
2246304|NCT02520310|5511141|P1|COMPLETED|At 6 Months Clinical Follow-up||29
2246305|NCT02520310|5511141|P1|STARTED|At 6 Months Clinical Follow-up||30
2246306|NCT02520310|5511141|P1|NOT COMPLETED|At 30 Days Clinical Follow-up||0
2246307|NCT02520310|5511141|P1|COMPLETED|At 30 Days Clinical Follow-up||30
2246308|NCT02520310|5511141|P1|STARTED|At 30 Days Clinical Follow-up||30
2246309|NCT02520284|5511276|P3|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||34
2246310|NCT02520284|5511277|P2|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||35
2246311|NCT02520284|5511278|P1|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||32
2246312|NCT02520284|5511276|P3|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
2246313|NCT02520284|5511277|P2|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
2246314|NCT02520284|5511278|P1|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
2246315|NCT02520284|5511276|P3|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|34
2246316|NCT02520284|5511277|P2|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|35
2246317|NCT02520284|5511278|P1|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|32
2246318|NCT02520284|5511276|P3|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||18
2246319|NCT02520284|5511277|P2|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||16
2246320|NCT02520284|5511278|P1|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||20
2246321|NCT02520284|5511276|P3|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
2246322|NCT02520284|5511277|P2|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
2246323|NCT02520284|5511278|P1|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
2246324|NCT02520284|5511276|P3|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|18
2246325|NCT02520284|5511277|P2|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|16
2246326|NCT02520284|5511278|P1|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|20
2246327|NCT02520284|5511276|P3|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||2
2246328|NCT02520284|5511277|P2|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||4
2246329|NCT02520284|5511278|P1|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||2
2246330|NCT02520284|5511276|P3|COMPLETED|Blinded Induction Phase: Up to Week 8|1 Participant completed Blinded Induction Phase but did not continue further in study.|53
2246331|NCT02520284|5511277|P2|COMPLETED|Blinded Induction Phase: Up to Week 8|1 Participant completed Blinded Induction Phase but did not continue further in study.|52
2246332|NCT02520284|5511278|P1|COMPLETED|Blinded Induction Phase: Up to Week 8||52
2246333|NCT02520284|5511276|P3|STARTED|Blinded Induction Phase: Up to Week 8||55
2246334|NCT02520284|5511277|P2|STARTED|Blinded Induction Phase: Up to Week 8||56
2246335|NCT02520284|5511278|P1|STARTED|Blinded Induction Phase: Up to Week 8||54
2246336|NCT02520089|5511312|P2|NOT COMPLETED|Overall Study||4
2246337|NCT02520089|5511313|P1|NOT COMPLETED|Overall Study||3
2246338|NCT02520089|5511312|P2|COMPLETED|Overall Study||7
2246339|NCT02520089|5511313|P1|COMPLETED|Overall Study||9
2246340|NCT02520089|5511312|P2|STARTED|Overall Study||11
2246341|NCT02520089|5511313|P1|STARTED|Overall Study||12
2246342|NCT02519855|5511323|P2|NOT COMPLETED|Overall Study||4
2246343|NCT02519855|5511324|P1|NOT COMPLETED|Overall Study||3
2246344|NCT02519855|5511323|P2|COMPLETED|Overall Study||437
2246345|NCT02519855|5511324|P1|COMPLETED|Overall Study||438
2246346|NCT02519855|5511323|P2|Vaccinated at Week 4|Overall Study||424
2246347|NCT02519855|5511324|P1|Vaccinated at Week 4|Overall Study||432
2246348|NCT02519855|5511323|P2|Vaccinated on Day 1|Overall Study||441
2246349|NCT02519855|5511324|P1|Vaccinated on Day 1|Overall Study||440
2246350|NCT02519855|5511323|P2|STARTED|Overall Study|Participants are included as treated|441
2246351|NCT02519855|5511324|P1|STARTED|Overall Study|Participants are included as treated|441
2246352|NCT02519842|5511342|P3|NOT COMPLETED|Optional Extension: Cycles 2-6||29
2246353|NCT02519842|5511343|P2|NOT COMPLETED|Optional Extension: Cycles 2-6||0
2246354|NCT02519842|5511344|P1|NOT COMPLETED|Optional Extension: Cycles 2-6||0
2246355|NCT02519842|5511342|P3|COMPLETED|Optional Extension: Cycles 2-6||26
2246356|NCT02519842|5511343|P2|COMPLETED|Optional Extension: Cycles 2-6||0
2246357|NCT02519842|5511344|P1|COMPLETED|Optional Extension: Cycles 2-6||0
2246358|NCT02519842|5511342|P3|Treated|Optional Extension: Cycles 2-6||55
2246359|NCT02519842|5511343|P2|Treated|Optional Extension: Cycles 2-6||0
2246360|NCT02519842|5511344|P1|Treated|Optional Extension: Cycles 2-6||0
2246361|NCT02519842|5511342|P3|STARTED|Optional Extension: Cycles 2-6|Enrollment in Cycles 2-6 was optional.|55
2246362|NCT02519842|5511343|P2|STARTED|Optional Extension: Cycles 2-6|28 participants from this arm in Cycle 1 entered optional Cycles 2-6|0
2246363|NCT02519842|5511344|P1|STARTED|Optional Extension: Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6|0
2246364|NCT02519842|5511342|P3|NOT COMPLETED|Base Study: Cycle 1||0
2246365|NCT02519842|5511343|P2|NOT COMPLETED|Base Study: Cycle 1||3
2246366|NCT02519842|5511344|P1|NOT COMPLETED|Base Study: Cycle 1||2
2246367|NCT02519842|5511342|P3|COMPLETED|Base Study: Cycle 1||0
2246368|NCT02519842|5511343|P2|COMPLETED|Base Study: Cycle 1||34
2246369|NCT02519842|5511344|P1|COMPLETED|Base Study: Cycle 1||36
2246370|NCT02519842|5511342|P3|Treated|Base Study: Cycle 1||0
2246371|NCT02519842|5511343|P2|Treated|Base Study: Cycle 1||34
2246372|NCT02519842|5511344|P1|Treated|Base Study: Cycle 1||37
2246373|NCT02519842|5511342|P3|STARTED|Base Study: Cycle 1||0
2246374|NCT02519842|5511343|P2|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|37
2246375|NCT02519842|5511344|P1|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|38
2246376|NCT02519712|5511363|P1|NOT COMPLETED|Overall Study||4
2246377|NCT02519712|5511363|P1|COMPLETED|Overall Study||0
2246378|NCT02519712|5511363|P1|STARTED|Overall Study||4
2246379|NCT02519595|5511370|P3|NOT COMPLETED|Overall Study||16
2246380|NCT02519595|5511371|P2|NOT COMPLETED|Overall Study||22
2246381|NCT02519595|5511372|P1|NOT COMPLETED|Overall Study||8
2246382|NCT02519595|5511370|P3|COMPLETED|Overall Study||40
2246383|NCT02519595|5511371|P2|COMPLETED|Overall Study||35
2246384|NCT02519595|5511372|P1|COMPLETED|Overall Study||50
2246385|NCT02519595|5511370|P3|STARTED|Overall Study||56
2246386|NCT02519595|5511371|P2|STARTED|Overall Study||57
2246387|NCT02519595|5511372|P1|STARTED|Overall Study||58
2246388|NCT02519504|5511397|P2|NOT COMPLETED|Overall Study||103
2246389|NCT02519504|5511398|P1|NOT COMPLETED|Overall Study||113
2246390|NCT02519504|5511397|P2|COMPLETED|Overall Study||144
2246391|NCT02519504|5511398|P1|COMPLETED|Overall Study||206
2246392|NCT02519504|5511397|P2|Attended Direct Testing|Overall Study||149
2246393|NCT02519504|5511398|P1|Attended Direct Testing|Overall Study||212
2246394|NCT02519504|5511397|P2|STARTED|Overall Study||247
2246395|NCT02519504|5511398|P1|STARTED|Overall Study||319
2246396|NCT02519387|5511458|P1|NOT COMPLETED|Overall Study||22
2246397|NCT02519387|5511458|P1|COMPLETED|Overall Study||56
2246398|NCT02519387|5511458|P1|STARTED|Overall Study||78
2246399|NCT02519244|5511466|P1|NOT COMPLETED|Overall Study||0
2246400|NCT02519244|5511466|P1|COMPLETED|Overall Study||10
2246401|NCT02519244|5511466|P1|STARTED|Overall Study||10
2246402|NCT02519036|5511501|P6|NOT COMPLETED|Overall Study||0
2246403|NCT02519036|5511502|P5|NOT COMPLETED|Overall Study||0
2246404|NCT02519036|5511503|P4|NOT COMPLETED|Overall Study||0
2246405|NCT02519036|5511504|P3|NOT COMPLETED|Overall Study||0
2246406|NCT02519036|5511505|P2|NOT COMPLETED|Overall Study||0
2246407|NCT02519036|5511506|P1|NOT COMPLETED|Overall Study||0
2246408|NCT02519036|5511501|P6|COMPLETED|Overall Study||10
2246409|NCT02519036|5511502|P5|COMPLETED|Overall Study||9
2246410|NCT02519036|5511503|P4|COMPLETED|Overall Study||6
2246411|NCT02519036|5511504|P3|COMPLETED|Overall Study||6
2246412|NCT02519036|5511505|P2|COMPLETED|Overall Study||3
2246413|NCT02519036|5511506|P1|COMPLETED|Overall Study||12
2246414|NCT02519036|5511501|P6|STARTED|Overall Study||10
2246415|NCT02519036|5511502|P5|STARTED|Overall Study||9
2246416|NCT02519036|5511503|P4|STARTED|Overall Study||6
2246417|NCT02519036|5511504|P3|STARTED|Overall Study||6
2246418|NCT02519036|5511505|P2|STARTED|Overall Study||3
2246419|NCT02519036|5511506|P1|STARTED|Overall Study||12
2246420|NCT02519023|5511561|P2|NOT COMPLETED|Overall Study||7
2246421|NCT02519023|5511562|P1|NOT COMPLETED|Overall Study||18
2246422|NCT02519023|5511561|P2|COMPLETED|Overall Study||31
2246423|NCT02519023|5511562|P1|COMPLETED|Overall Study||31
2246424|NCT02519023|5511561|P2|STARTED|Overall Study||38
2246425|NCT02519023|5511562|P1|STARTED|Overall Study||49
2246426|NCT02518997|5511594|P1|NOT COMPLETED|Overall Study||0
2246427|NCT02518997|5511594|P1|COMPLETED|Overall Study||18
2246428|NCT02518997|5511594|P1|STARTED|Overall Study||18
2246429|NCT02518971|5511603|P2|NOT COMPLETED|Overall Study||20
2246430|NCT02518971|5511604|P1|NOT COMPLETED|Overall Study||23
2246431|NCT02518971|5511603|P2|COMPLETED|Overall Study||67
2246432|NCT02518971|5511604|P1|COMPLETED|Overall Study||64
2246433|NCT02518971|5511603|P2|STARTED|Overall Study||87
2246434|NCT02518971|5511604|P1|STARTED|Overall Study||87
2246435|NCT02518919|5511624|P3|NOT COMPLETED|Overall Study||2
2246436|NCT02518919|5511625|P2|NOT COMPLETED|Overall Study||1
2246437|NCT02518919|5511626|P1|NOT COMPLETED|Overall Study||1
2246438|NCT02518919|5511624|P3|COMPLETED|Overall Study||19
2246439|NCT02518919|5511625|P2|COMPLETED|Overall Study||20
2246440|NCT02518919|5511626|P1|COMPLETED|Overall Study||20
2246441|NCT02518919|5511624|P3|STARTED|Overall Study||21
2246442|NCT02518919|5511625|P2|STARTED|Overall Study||21
2246443|NCT02518919|5511626|P1|STARTED|Overall Study||21
2246444|NCT02518750|5511646|P1|NOT COMPLETED|Overall Study||2
2246445|NCT02518750|5511646|P1|COMPLETED|Overall Study||1
2246446|NCT02518750|5511646|P1|STARTED|Overall Study||3
2246447|NCT02518685|5511656|P2|NOT COMPLETED|Overall Study||10
2246448|NCT02518685|5511657|P1|NOT COMPLETED|Overall Study||49
2246449|NCT02518685|5511656|P2|COMPLETED|Overall Study||79
2246450|NCT02518685|5511657|P1|COMPLETED|Overall Study|Randomized Completers (139) plus Open-Label Completers (25)|164
2246451|NCT02518685|5511656|P2|Per Protocol Analysis|Overall Study||89
2246452|NCT02518685|5511657|P1|Per Protocol Analysis|Overall Study|Three TPS-treated subjects were inadvertently unblinded, excluding them from efficacy analyses.|168
2246453|NCT02518685|5511656|P2|Enrolled|Overall Study||89
2246454|NCT02518685|5511657|P1|Enrolled|Overall Study|Includes 171 Successful device deployments, 10 unsuccessful delivery attempts and 32 Open-Label|213
2246455|NCT02518685|5511656|P2|Randomized Cohort|Overall Study||89
2246456|NCT02518685|5511657|P1|Randomized Cohort|Overall Study||181
2246457|NCT02518685|5511656|P2|Safety Cohort|Overall Study||89
2246458|NCT02518685|5511657|P1|Safety Cohort|Overall Study|Randomized to and successfully received TPS (171) + Open-Label TPS-treated Subjects (32)|203
2246459|NCT02518685|5511656|P2|STARTED|Overall Study||89
2246460|NCT02518685|5511657|P1|STARTED|Overall Study||213
2246461|NCT02518620|5511666|P2|NOT COMPLETED|Overall Study||26
2246462|NCT02518620|5511667|P1|NOT COMPLETED|Overall Study||52
2246463|NCT02518620|5511666|P2|COMPLETED|Overall Study||123
2246464|NCT02518620|5511667|P1|COMPLETED|Overall Study||205
2246465|NCT02518620|5511666|P2|STARTED|Overall Study||149
2246466|NCT02518620|5511667|P1|STARTED|Overall Study||257
2246467|NCT02518464|5511690|P1|NOT COMPLETED|Overall Study||2
2246468|NCT02518464|5511690|P1|COMPLETED|Overall Study||38
2246469|NCT02518464|5511690|P1|STARTED|Overall Study||40
2246470|NCT02518139|5511697|P3|NOT COMPLETED|Overall Study||94
2246471|NCT02518139|5511698|P2|NOT COMPLETED|Overall Study||144
2246472|NCT02518139|5511699|P1|NOT COMPLETED|Overall Study||145
2246473|NCT02518139|5511697|P3|COMPLETED|Overall Study||262
2246474|NCT02518139|5511698|P2|COMPLETED|Overall Study||191
2246475|NCT02518139|5511699|P1|COMPLETED|Overall Study||219
2246476|NCT02518139|5511697|P3|STARTED|Overall Study||356
2246477|NCT02518139|5511698|P2|STARTED|Overall Study||335
2246478|NCT02518139|5511699|P1|STARTED|Overall Study||364
2246479|NCT02518113|5511711|P4|NOT COMPLETED|Overall Study||0
2246480|NCT02518113|5511712|P3|NOT COMPLETED|Overall Study||4
2246481|NCT02518113|5511713|P2|NOT COMPLETED|Overall Study||5
2246482|NCT02518113|5511714|P1|NOT COMPLETED|Overall Study||3
2246483|NCT02518113|5511711|P4|COMPLETED|Overall Study||3
2246484|NCT02518113|5511712|P3|COMPLETED|Overall Study||11
2246485|NCT02518113|5511713|P2|COMPLETED|Overall Study||7
2246486|NCT02518113|5511714|P1|COMPLETED|Overall Study||3
2246487|NCT02518113|5511711|P4|STARTED|Overall Study||3
2246488|NCT02518113|5511712|P3|STARTED|Overall Study||15
2246489|NCT02518113|5511713|P2|STARTED|Overall Study||12
2246490|NCT02518113|5511714|P1|STARTED|Overall Study||6
2246491|NCT02518048|5511755|P1|NOT COMPLETED|Overall Study||1
2246492|NCT02518048|5511755|P1|COMPLETED|Overall Study||34
2246493|NCT02518048|5511755|P1|STARTED|Overall Study||35
2246494|NCT02517996|5511768|P2|NOT COMPLETED|Overall Study||0
2246495|NCT02517996|5511769|P1|NOT COMPLETED|Overall Study||0
2246496|NCT02517996|5511768|P2|COMPLETED|Overall Study||9
2246497|NCT02517996|5511769|P1|COMPLETED|Overall Study||8
2246498|NCT02517996|5511768|P2|STARTED|Overall Study||9
2246499|NCT02517996|5511769|P1|STARTED|Overall Study||8
2246500|NCT02517866|5511781|P3|NOT COMPLETED|Overall Study||0
2246501|NCT02517866|5511782|P2|NOT COMPLETED|Overall Study||6
2246502|NCT02517866|5511783|P1|NOT COMPLETED|Overall Study||20
2246503|NCT02517866|5511781|P3|COMPLETED|Overall Study||1
2246504|NCT02517866|5511782|P2|COMPLETED|Overall Study||84
2246505|NCT02517866|5511783|P1|COMPLETED|Overall Study||269
2246506|NCT02517866|5511781|P3|STARTED|Overall Study||1
2246507|NCT02517866|5511782|P2|STARTED|Overall Study||90
2246508|NCT02517866|5511783|P1|STARTED|Overall Study||289
2246509|NCT02517658|5511828|P3|NOT COMPLETED|Overall Study||0
2246510|NCT02517658|5511829|P2|NOT COMPLETED|Overall Study||0
2246511|NCT02517658|5511830|P1|NOT COMPLETED|Overall Study||0
2246512|NCT02517658|5511828|P3|COMPLETED|Overall Study||33
2246513|NCT02517658|5511829|P2|COMPLETED|Overall Study||33
2246514|NCT02517658|5511830|P1|COMPLETED|Overall Study||33
2246515|NCT02517658|5511828|P3|STARTED|Overall Study||33
2246516|NCT02517658|5511829|P2|STARTED|Overall Study||33
2246517|NCT02517658|5511830|P1|STARTED|Overall Study||33
2246518|NCT02517580|5511838|P1|NOT COMPLETED|Overall Study||4
2246519|NCT02517580|5511838|P1|COMPLETED|Overall Study||56
2246520|NCT02517580|5511838|P1|STARTED|Overall Study||60
2246521|NCT02517567|5511842|P4|NOT COMPLETED|Fourth Exposure (8 Hours)||0
2246522|NCT02517567|5511843|P3|NOT COMPLETED|Fourth Exposure (8 Hours)||0
2246523|NCT02517567|5511844|P2|NOT COMPLETED|Fourth Exposure (8 Hours)||0
2246524|NCT02517567|5511845|P1|NOT COMPLETED|Fourth Exposure (8 Hours)||0
2246525|NCT02517567|5511842|P4|COMPLETED|Fourth Exposure (8 Hours)||8
2246526|NCT02517567|5511843|P3|COMPLETED|Fourth Exposure (8 Hours)||6
2246527|NCT02517567|5511844|P2|COMPLETED|Fourth Exposure (8 Hours)||8
2246528|NCT02517567|5511845|P1|COMPLETED|Fourth Exposure (8 Hours)||6
2246529|NCT02517567|5511842|P4|STARTED|Fourth Exposure (8 Hours)||8
2246530|NCT02517567|5511843|P3|STARTED|Fourth Exposure (8 Hours)|One subject discontinued between Period 3 and Period 4 (withdrawal by subject)|6
2246531|NCT02517567|5511844|P2|STARTED|Fourth Exposure (8 Hours)||8
2246532|NCT02517567|5511845|P1|STARTED|Fourth Exposure (8 Hours)||6
2246533|NCT02517567|5511842|P4|NOT COMPLETED|Third Exposure (8 Hours)||0
2246534|NCT02517567|5511843|P3|NOT COMPLETED|Third Exposure (8 Hours)||0
2246535|NCT02517567|5511844|P2|NOT COMPLETED|Third Exposure (8 Hours)||0
2246536|NCT02517567|5511845|P1|NOT COMPLETED|Third Exposure (8 Hours)||0
2246537|NCT02517567|5511842|P4|COMPLETED|Third Exposure (8 Hours)||8
2246538|NCT02517567|5511843|P3|COMPLETED|Third Exposure (8 Hours)||7
2246539|NCT02517567|5511844|P2|COMPLETED|Third Exposure (8 Hours)||8
2246540|NCT02517567|5511845|P1|COMPLETED|Third Exposure (8 Hours)||6
2246541|NCT02517567|5511842|P4|STARTED|Third Exposure (8 Hours)||8
2246542|NCT02517567|5511843|P3|STARTED|Third Exposure (8 Hours)||7
2246543|NCT02517567|5511844|P2|STARTED|Third Exposure (8 Hours)||8
2246544|NCT02517567|5511845|P1|STARTED|Third Exposure (8 Hours)||6
2246545|NCT02517567|5511842|P4|NOT COMPLETED|Second Exposure (8 Hours)||0
2246546|NCT02517567|5511843|P3|NOT COMPLETED|Second Exposure (8 Hours)||0
2246547|NCT02517567|5511844|P2|NOT COMPLETED|Second Exposure (8 Hours)||0
2246548|NCT02517567|5511845|P1|NOT COMPLETED|Second Exposure (8 Hours)||0
2246549|NCT02517567|5511842|P4|COMPLETED|Second Exposure (8 Hours)||8
2246550|NCT02517567|5511843|P3|COMPLETED|Second Exposure (8 Hours)||7
2246551|NCT02517567|5511844|P2|COMPLETED|Second Exposure (8 Hours)||8
2246552|NCT02517567|5511845|P1|COMPLETED|Second Exposure (8 Hours)||6
2246553|NCT02517567|5511842|P4|STARTED|Second Exposure (8 Hours)||8
2246554|NCT02517567|5511843|P3|STARTED|Second Exposure (8 Hours)||7
2246555|NCT02517567|5511844|P2|STARTED|Second Exposure (8 Hours)||8
2246556|NCT02517567|5511845|P1|STARTED|Second Exposure (8 Hours)||6
2246557|NCT02517567|5511842|P4|NOT COMPLETED|First Exposure (8 Hours)||0
2246558|NCT02517567|5511843|P3|NOT COMPLETED|First Exposure (8 Hours)||0
2246559|NCT02517567|5511844|P2|NOT COMPLETED|First Exposure (8 Hours)||0
2246560|NCT02517567|5511845|P1|NOT COMPLETED|First Exposure (8 Hours)||0
2246561|NCT02517567|5511842|P4|COMPLETED|First Exposure (8 Hours)||8
2246562|NCT02517567|5511843|P3|COMPLETED|First Exposure (8 Hours)||7
2246563|NCT02517567|5511844|P2|COMPLETED|First Exposure (8 Hours)||8
2246564|NCT02517567|5511845|P1|COMPLETED|First Exposure (8 Hours)||6
2246565|NCT02517567|5511842|P4|STARTED|First Exposure (8 Hours)||8
2246566|NCT02517567|5511843|P3|STARTED|First Exposure (8 Hours)||7
2246567|NCT02517567|5511844|P2|STARTED|First Exposure (8 Hours)||8
2246568|NCT02517567|5511845|P1|STARTED|First Exposure (8 Hours)||6
2246569|NCT02517541|5511854|P1|NOT COMPLETED|Test Period (SenSura Mio Convex Soft)||12
2246570|NCT02517541|5511854|P1|COMPLETED|Test Period (SenSura Mio Convex Soft)||61
2246571|NCT02517541|5511854|P1|STARTED|Test Period (SenSura Mio Convex Soft)||73
2246572|NCT02517541|5511854|P1|NOT COMPLETED|Baseline Period (Own Product)||1
2246573|NCT02517541|5511854|P1|COMPLETED|Baseline Period (Own Product)||73
2246574|NCT02517541|5511854|P1|STARTED|Baseline Period (Own Product)||74
2246575|NCT02517528|5511860|P1|NOT COMPLETED|Overall Study||1
2246576|NCT02517528|5511860|P1|COMPLETED|Overall Study||103
2246577|NCT02517528|5511860|P1|STARTED|Overall Study||104
2246578|NCT02517515|5511870|P2|NOT COMPLETED|Overall Study||2
2246579|NCT02517515|5511871|P1|NOT COMPLETED|Overall Study||2
2246580|NCT02517515|5511870|P2|COMPLETED|Overall Study||323
2246581|NCT02517515|5511871|P1|COMPLETED|Overall Study||323
2246582|NCT02517515|5511870|P2|STARTED|Overall Study||325
2246583|NCT02517515|5511871|P1|STARTED|Overall Study||325
2246584|NCT02517463|5511888|P2|NOT COMPLETED|Overall Study||2
2246585|NCT02517463|5511889|P1|NOT COMPLETED|Overall Study||5
2246586|NCT02517463|5511888|P2|COMPLETED|Overall Study||329
2246587|NCT02517463|5511889|P1|COMPLETED|Overall Study||364
2246588|NCT02517463|5511888|P2|STARTED|Overall Study||331
2246589|NCT02517463|5511889|P1|STARTED|Overall Study||369
2246590|NCT02517268|5511901|P2|NOT COMPLETED|Overall Study||0
2246591|NCT02517268|5511902|P1|NOT COMPLETED|Overall Study||1
2246592|NCT02517268|5511901|P2|COMPLETED|Overall Study||37
2246593|NCT02517268|5511902|P1|COMPLETED|Overall Study||39
2246594|NCT02517268|5511901|P2|STARTED|Overall Study||37
2246595|NCT02517268|5511902|P1|STARTED|Overall Study||40
2246596|NCT02517047|5511916|P1|NOT COMPLETED|Overall Study||2
2246597|NCT02517047|5511916|P1|COMPLETED|Overall Study||24
2246598|NCT02517047|5511916|P1|STARTED|Overall Study||26
2246599|NCT02517021|5511925|P2|NOT COMPLETED|Overall Study||85
2246600|NCT02517021|5511926|P1|NOT COMPLETED|Overall Study||83
2246601|NCT02517021|5511925|P2|COMPLETED|Overall Study||117
2246602|NCT02517021|5511926|P1|COMPLETED|Overall Study||120
2246603|NCT02517021|5511925|P2|STARTED|Overall Study||202
2246604|NCT02517021|5511926|P1|STARTED|Overall Study||203
2246605|NCT02516982|5511954|P4|NOT COMPLETED|Overall Study||50
2246606|NCT02516982|5511955|P3|NOT COMPLETED|Overall Study||48
2246607|NCT02516982|5511956|P2|NOT COMPLETED|Overall Study||35
2246608|NCT02516982|5511957|P1|NOT COMPLETED|Overall Study||32
2246609|NCT02516982|5511954|P4|COMPLETED|Overall Study||125
2246610|NCT02516982|5511955|P3|COMPLETED|Overall Study||126
2246611|NCT02516982|5511956|P2|COMPLETED|Overall Study||257
2246612|NCT02516982|5511957|P1|COMPLETED|Overall Study||273
2246613|NCT02516982|5511954|P4|STARTED|Overall Study||175
2246614|NCT02516982|5511955|P3|STARTED|Overall Study||174
2246615|NCT02516982|5511956|P2|STARTED|Overall Study||292
2246616|NCT02516982|5511957|P1|STARTED|Overall Study||305
2246617|NCT02516605|5511984|P5|NOT COMPLETED|Overall Study||1
2246618|NCT02516605|5511985|P4|NOT COMPLETED|Overall Study||1
2246619|NCT02516605|5511986|P3|NOT COMPLETED|Overall Study||0
2246620|NCT02516605|5511987|P2|NOT COMPLETED|Overall Study||0
2246621|NCT02516605|5511988|P1|NOT COMPLETED|Overall Study||0
2246622|NCT02516605|5511984|P5|COMPLETED|Overall Study||20
2246623|NCT02516605|5511985|P4|COMPLETED|Overall Study||7
2246624|NCT02516605|5511986|P3|COMPLETED|Overall Study||12
2246625|NCT02516605|5511987|P2|COMPLETED|Overall Study||9
2246626|NCT02516605|5511988|P1|COMPLETED|Overall Study||11
2246627|NCT02516605|5511984|P5|STARTED|Overall Study||21
2246628|NCT02516605|5511985|P4|STARTED|Overall Study||8
2246629|NCT02516605|5511986|P3|STARTED|Overall Study||12
2246630|NCT02516605|5511987|P2|STARTED|Overall Study||9
2246631|NCT02516605|5511988|P1|STARTED|Overall Study||11
2246632|NCT02516592|5512059|P2|NOT COMPLETED|Overall Study||13
2246633|NCT02516592|5512060|P1|NOT COMPLETED|Overall Study||16
2246634|NCT02516592|5512059|P2|COMPLETED|Overall Study||238
2246635|NCT02516592|5512060|P1|COMPLETED|Overall Study||235
2246636|NCT02516592|5512059|P2|Full Analysis Set|Overall Study||250
2246637|NCT02516592|5512060|P1|Full Analysis Set|Overall Study||248
2246638|NCT02516592|5512059|P2|STARTED|Overall Study||251
2246639|NCT02516592|5512060|P1|STARTED|Overall Study||251
2246640|NCT02516410|5512076|P2|NOT COMPLETED|Overall Study||2
2246641|NCT02516410|5512077|P1|NOT COMPLETED|Overall Study||0
2246642|NCT02516410|5512076|P2|COMPLETED|Overall Study||81
2246643|NCT02516410|5512077|P1|COMPLETED|Overall Study||85
2246644|NCT02516410|5512076|P2|STARTED|Overall Study||83
2246645|NCT02516410|5512077|P1|STARTED|Overall Study||85
2246646|NCT02516306|5512106|P2|NOT COMPLETED|Period 2: Day 8 - 91||2
2246647|NCT02516306|5512107|P1|NOT COMPLETED|Period 2: Day 8 - 91||1
2246648|NCT02516306|5512106|P2|COMPLETED|Period 2: Day 8 - 91||23
2246649|NCT02516306|5512107|P1|COMPLETED|Period 2: Day 8 - 91||49
2246650|NCT02516306|5512106|P2|STARTED|Period 2: Day 8 - 91||25
2246651|NCT02516306|5512107|P1|STARTED|Period 2: Day 8 - 91||50
2246652|NCT02516306|5512106|P2|NOT COMPLETED|Period 1: Day 1 - 7||0
2246653|NCT02516306|5512107|P1|NOT COMPLETED|Period 1: Day 1 - 7||0
2246654|NCT02516306|5512106|P2|COMPLETED|Period 1: Day 1 - 7||25
2246655|NCT02516306|5512107|P1|COMPLETED|Period 1: Day 1 - 7||50
2246656|NCT02516306|5512106|P2|STARTED|Period 1: Day 1 - 7||25
2246657|NCT02516306|5512107|P1|STARTED|Period 1: Day 1 - 7||50
2246658|NCT02516202|5512116|P3|NOT COMPLETED|Overall Study||3
2246659|NCT02516202|5512117|P2|NOT COMPLETED|Overall Study||1
2246660|NCT02516202|5512118|P1|NOT COMPLETED|Overall Study||2
2246661|NCT02516202|5512116|P3|COMPLETED|Overall Study||97
2246662|NCT02516202|5512117|P2|COMPLETED|Overall Study||99
2246663|NCT02516202|5512118|P1|COMPLETED|Overall Study||100
2246664|NCT02516202|5512116|P3|STARTED|Overall Study||100
2246665|NCT02516202|5512117|P2|STARTED|Overall Study||100
2246666|NCT02516202|5512118|P1|STARTED|Overall Study||102
2246667|NCT02516163|5512144|P1|NOT COMPLETED|Overall Study||28
2246668|NCT02516163|5512144|P1|COMPLETED|Overall Study||24
2246669|NCT02516163|5512144|P1|STARTED|Overall Study||52
2246670|NCT02516150|5512148|P1|NOT COMPLETED|Overall Study||0
2246671|NCT02516150|5512148|P1|COMPLETED|Overall Study||15
2246672|NCT02516150|5512148|P1|STARTED|Overall Study||15
2246673|NCT02516098|5512158|P2|NOT COMPLETED|Washout After Period 2||0
2246674|NCT02516098|5512159|P1|NOT COMPLETED|Washout After Period 2||0
2246675|NCT02516098|5512158|P2|COMPLETED|Washout After Period 2||26
2246676|NCT02516098|5512159|P1|COMPLETED|Washout After Period 2||27
2246677|NCT02516098|5512158|P2|STARTED|Washout After Period 2||26
2246678|NCT02516098|5512159|P1|STARTED|Washout After Period 2||27
2246679|NCT02516098|5512158|P2|NOT COMPLETED|Period 2||1
2246680|NCT02516098|5512159|P1|NOT COMPLETED|Period 2||0
2246681|NCT02516098|5512158|P2|COMPLETED|Period 2||26
2246682|NCT02516098|5512159|P1|COMPLETED|Period 2||27
2246683|NCT02516098|5512158|P2|STARTED|Period 2||27
2246684|NCT02516098|5512159|P1|STARTED|Period 2||27
2246685|NCT02516098|5512158|P2|NOT COMPLETED|Washout After Period 1||1
2246686|NCT02516098|5512159|P1|NOT COMPLETED|Washout After Period 1||0
2246687|NCT02516098|5512158|P2|COMPLETED|Washout After Period 1||27
2246688|NCT02516098|5512159|P1|COMPLETED|Washout After Period 1||27
2246689|NCT02516098|5512158|P2|STARTED|Washout After Period 1||28
2246690|NCT02516098|5512159|P1|STARTED|Washout After Period 1||27
2246691|NCT02516098|5512158|P2|NOT COMPLETED|Period 1||0
2246692|NCT02516098|5512159|P1|NOT COMPLETED|Period 1||1
2246693|NCT02516098|5512158|P2|COMPLETED|Period 1||28
2246694|NCT02516098|5512159|P1|COMPLETED|Period 1||27
2246695|NCT02516098|5512158|P2|STARTED|Period 1||28
2246696|NCT02516098|5512159|P1|STARTED|Period 1||28
2246697|NCT02515994|5512173|P2|NOT COMPLETED|Overall Study||7
2246698|NCT02515994|5512174|P1|NOT COMPLETED|Overall Study||10
2246699|NCT02515994|5512173|P2|COMPLETED|Overall Study||105
2246700|NCT02515994|5512174|P1|COMPLETED|Overall Study||99
2246701|NCT02515994|5512173|P2|STARTED|Overall Study||112
2246702|NCT02515994|5512174|P1|STARTED|Overall Study||109
2246703|NCT02515942|5512189|P3|NOT COMPLETED|Overall Study||4
2246704|NCT02515942|5512190|P2|NOT COMPLETED|Overall Study||3
2246705|NCT02515942|5512191|P1|NOT COMPLETED|Overall Study||7
2246706|NCT02515942|5512189|P3|COMPLETED|Overall Study||35
2246707|NCT02515942|5512190|P2|COMPLETED|Overall Study||36
2246708|NCT02515942|5512191|P1|COMPLETED|Overall Study||29
2246709|NCT02515942|5512189|P3|Completed Day 337|Overall Study||35
2246710|NCT02515942|5512190|P2|Completed Day 337|Overall Study||36
2246711|NCT02515942|5512191|P1|Completed Day 337|Overall Study||30
2246712|NCT02515942|5512189|P3|Completed Day 253|Overall Study||36
2246713|NCT02515942|5512190|P2|Completed Day 253|Overall Study||37
2246714|NCT02515942|5512191|P1|Completed Day 253|Overall Study|One subject missed Day 253 visit|29
2246715|NCT02515942|5512189|P3|Completed Day 169|Overall Study||37
2246716|NCT02515942|5512190|P2|Completed Day 169|Overall Study||37
2246717|NCT02515942|5512191|P1|Completed Day 169|Overall Study||32
2246718|NCT02515942|5512189|P3|Completed Day 85|Overall Study||37
2246719|NCT02515942|5512190|P2|Completed Day 85|Overall Study||38
2246720|NCT02515942|5512191|P1|Completed Day 85|Overall Study||35
2246721|NCT02515942|5512189|P3|Pharmacokinetics (PK) Analysis Set|Overall Study||0
2246722|NCT02515942|5512190|P2|Pharmacokinetics (PK) Analysis Set|Overall Study||39
2246723|NCT02515942|5512191|P1|Pharmacokinetics (PK) Analysis Set|Overall Study||36
2246724|NCT02515942|5512189|P3|Per Protocol Analysis Set (PPS)|Overall Study||34
2246725|NCT02515942|5512190|P2|Per Protocol Analysis Set (PPS)|Overall Study||35
2246726|NCT02515942|5512191|P1|Per Protocol Analysis Set (PPS)|Overall Study||30
2246727|NCT02515942|5512189|P3|Full Analysis Set (FAS)|Overall Study||38
2246728|NCT02515942|5512190|P2|Full Analysis Set (FAS)|Overall Study||37
2246729|NCT02515942|5512191|P1|Full Analysis Set (FAS)|Overall Study||35
2246730|NCT02515942|5512189|P3|Safety Analysis Set|Overall Study||39
2246731|NCT02515942|5512190|P2|Safety Analysis Set|Overall Study||39
2246732|NCT02515942|5512191|P1|Safety Analysis Set|Overall Study||36
2246733|NCT02515942|5512189|P3|STARTED|Overall Study||39
2246734|NCT02515942|5512190|P2|STARTED|Overall Study||39
2246735|NCT02515942|5512191|P1|STARTED|Overall Study||36
2246736|NCT02515851|5512240|P2|NOT COMPLETED|Overall Study||0
2246737|NCT02515851|5512241|P1|NOT COMPLETED|Overall Study||0
2246738|NCT02515851|5512240|P2|COMPLETED|Overall Study||15
2246739|NCT02515851|5512241|P1|COMPLETED|Overall Study||15
2246740|NCT02515851|5512240|P2|STARTED|Overall Study||15
2246741|NCT02515851|5512241|P1|STARTED|Overall Study||15
2246766|NCT02515656|5512325|P2|NOT COMPLETED|Overall Study||71
2246767|NCT02515656|5512326|P1|NOT COMPLETED|Overall Study||56
2246768|NCT02515656|5512325|P2|COMPLETED|Overall Study||261
2246769|NCT02515656|5512326|P1|COMPLETED|Overall Study||270
2246770|NCT02515656|5512325|P2|Safety Population|Overall Study||328
2246771|NCT02515656|5512326|P1|Safety Population|Overall Study||325
2246772|NCT02515656|5512325|P2|Per Protocol Set (PPS)|Overall Study||275
2246773|NCT02515656|5512326|P1|Per Protocol Set (PPS)|Overall Study||277
2246774|NCT02515656|5512325|P2|Full Analysis Set (FAS)|Overall Study||309
2246775|NCT02515656|5512326|P1|Full Analysis Set (FAS)|Overall Study||302
2246776|NCT02515656|5512325|P2|STARTED|Overall Study||332
2246777|NCT02515656|5512326|P1|STARTED|Overall Study||326
2246778|NCT02515331|5512345|P3|NOT COMPLETED|Overall Study||4
2246779|NCT02515331|5512346|P2|NOT COMPLETED|Overall Study||0
2246780|NCT02515331|5512347|P1|NOT COMPLETED|Overall Study||2
2246781|NCT02515331|5512345|P3|COMPLETED|Overall Study||28
2246782|NCT02515331|5512346|P2|COMPLETED|Overall Study||15
2246783|NCT02515331|5512347|P1|COMPLETED|Overall Study||15
2246784|NCT02515331|5512345|P3|Pharmacokinetic (PK) Analysis Set|Overall Study||0
2246785|NCT02515331|5512346|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||15
2246786|NCT02515331|5512347|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||17
2246787|NCT02515331|5512345|P3|Primary Pharmacodynamic Analysis Set|Overall Study||29
2246788|NCT02515331|5512346|P2|Primary Pharmacodynamic Analysis Set|Overall Study||14
2246789|NCT02515331|5512347|P1|Primary Pharmacodynamic Analysis Set|Overall Study||15
2246790|NCT02515331|5512345|P3|STARTED|Overall Study||32
2246791|NCT02515331|5512346|P2|STARTED|Overall Study||15
2246792|NCT02515331|5512347|P1|STARTED|Overall Study||17
2246793|NCT02515279|5512368|P1|NOT COMPLETED|Overall Study||104
2246794|NCT02515279|5512368|P1|COMPLETED|Overall Study||359
2246795|NCT02515279|5512368|P1|STARTED|Overall Study||463
2246796|NCT02515253|5512376|P2|NOT COMPLETED|Overall Study||8
2246797|NCT02515253|5512377|P1|NOT COMPLETED|Overall Study||7
2246798|NCT02515253|5512376|P2|COMPLETED|Overall Study||8
2246799|NCT02515253|5512377|P1|COMPLETED|Overall Study||10
2246800|NCT02515253|5512376|P2|STARTED|Overall Study||16
2246801|NCT02515253|5512377|P1|STARTED|Overall Study||17
2246802|NCT02515097|5512387|P2|NOT COMPLETED|Overall Study||6
2246803|NCT02515097|5512388|P1|NOT COMPLETED|Overall Study||7
2246804|NCT02515097|5512387|P2|COMPLETED|Overall Study||65
2246805|NCT02515097|5512388|P1|COMPLETED|Overall Study||135
2246806|NCT02515097|5512387|P2|Safety Population|Overall Study||70
2246807|NCT02515097|5512388|P1|Safety Population|Overall Study||142
2246808|NCT02515097|5512387|P2|Intent-to-Treat (ITT) Population|Overall Study||71
2246809|NCT02515097|5512388|P1|Intent-to-Treat (ITT) Population|Overall Study||142
2246810|NCT02515097|5512387|P2|STARTED|Overall Study||71
2246811|NCT02515097|5512388|P1|STARTED|Overall Study||142
2246812|NCT02515058|5512398|P2|NOT COMPLETED|Overall Study||2
2246813|NCT02515058|5512399|P1|NOT COMPLETED|Overall Study||3
2246814|NCT02515058|5512398|P2|COMPLETED|Overall Study||20
2246815|NCT02515058|5512399|P1|COMPLETED|Overall Study||18
2246816|NCT02515058|5512398|P2|STARTED|Overall Study||22
2246817|NCT02515058|5512399|P1|STARTED|Overall Study||21
2246818|NCT02515045|5512409|P3|NOT COMPLETED|Overall Study||4
2246819|NCT02515045|5512410|P2|NOT COMPLETED|Overall Study||4
2246820|NCT02515045|5512411|P1|NOT COMPLETED|Overall Study||0
2246821|NCT02515045|5512409|P3|COMPLETED|Overall Study||55
2246822|NCT02515045|5512410|P2|COMPLETED|Overall Study||26
2246823|NCT02515045|5512411|P1|COMPLETED|Overall Study||29
2246824|NCT02515045|5512409|P3|STARTED|Overall Study||59
2246825|NCT02515045|5512410|P2|STARTED|Overall Study||30
2246826|NCT02515045|5512411|P1|STARTED|Overall Study||29
2246827|NCT02514889|5512427|P2|NOT COMPLETED|Follow-up Assessment Participation||12
2246828|NCT02514889|5512428|P1|NOT COMPLETED|Follow-up Assessment Participation||10
2246829|NCT02514889|5512427|P2|COMPLETED|Follow-up Assessment Participation||86
2246830|NCT02514889|5512428|P1|COMPLETED|Follow-up Assessment Participation||92
2246831|NCT02514889|5512427|P2|STARTED|Follow-up Assessment Participation||98
2246832|NCT02514889|5512428|P1|STARTED|Follow-up Assessment Participation||102
2246833|NCT02514889|5512427|P2|NOT COMPLETED|Intervention Participation||8
2246834|NCT02514889|5512428|P1|NOT COMPLETED|Intervention Participation||9
2246835|NCT02514889|5512427|P2|COMPLETED|Intervention Participation||98
2246836|NCT02514889|5512428|P1|COMPLETED|Intervention Participation||102
2246837|NCT02514889|5512427|P2|STARTED|Intervention Participation||106
2246838|NCT02514889|5512428|P1|STARTED|Intervention Participation||111
2246839|NCT02514889|5512427|P2|NOT COMPLETED|Randomization/Allocation to Condition||24
2246840|NCT02514889|5512428|P1|NOT COMPLETED|Randomization/Allocation to Condition||20
2246841|NCT02514889|5512427|P2|COMPLETED|Randomization/Allocation to Condition||106
2246842|NCT02514889|5512428|P1|COMPLETED|Randomization/Allocation to Condition||111
2246843|NCT02514889|5512427|P2|STARTED|Randomization/Allocation to Condition||130
2246844|NCT02514889|5512428|P1|STARTED|Randomization/Allocation to Condition||131
2246845|NCT02514772|5512448|P2|NOT COMPLETED|Overall Study||2
2246846|NCT02514772|5512449|P1|NOT COMPLETED|Overall Study||3
2246847|NCT02514772|5512448|P2|COMPLETED|Overall Study||52
2246848|NCT02514772|5512449|P1|COMPLETED|Overall Study||50
2246849|NCT02514772|5512448|P2|STARTED|Overall Study||54
2246850|NCT02514772|5512449|P1|STARTED|Overall Study||53
2246851|NCT02514577|5512463|P2|NOT COMPLETED|Overall Study||13
2246852|NCT02514577|5512464|P1|NOT COMPLETED|Overall Study||14
2246853|NCT02514577|5512463|P2|COMPLETED|Overall Study||61
2246854|NCT02514577|5512464|P1|COMPLETED|Overall Study||129
2246855|NCT02514577|5512463|P2|Safety Population|Overall Study||72
2246856|NCT02514577|5512464|P1|Safety Population|Overall Study||142
2246857|NCT02514577|5512463|P2|Intent-to-Treat (ITT) Population|Overall Study||74
2246858|NCT02514577|5512464|P1|Intent-to-Treat (ITT) Population|Overall Study||143
2246859|NCT02514577|5512463|P2|STARTED|Overall Study||74
2246860|NCT02514577|5512464|P1|STARTED|Overall Study||143
2246861|NCT02514551|5512474|P2|NOT COMPLETED|Overall Study||3
2246862|NCT02514551|5512475|P1|NOT COMPLETED|Overall Study||0
2246863|NCT02514551|5512474|P2|COMPLETED|Overall Study||119
2246864|NCT02514551|5512475|P1|COMPLETED|Overall Study||123
2246865|NCT02514551|5512474|P2|Received at Least One Dose of Study Drug|Overall Study||120
2246866|NCT02514551|5512475|P1|Received at Least One Dose of Study Drug|Overall Study||123
2246867|NCT02514551|5512474|P2|STARTED|Overall Study||122
2246868|NCT02514551|5512475|P1|STARTED|Overall Study||123
2246869|NCT02514473|5512492|P2|NOT COMPLETED|Overall Study||5
2246870|NCT02514473|5512493|P1|NOT COMPLETED|Overall Study||3
2246871|NCT02514473|5512492|P2|COMPLETED|Overall Study||98
2246872|NCT02514473|5512493|P1|COMPLETED|Overall Study||98
2246873|NCT02514473|5512492|P2|STARTED|Overall Study||103
2246874|NCT02514473|5512493|P1|STARTED|Overall Study||101
2246875|NCT02514122|5512536|P2|NOT COMPLETED|Overall Study||0
2246876|NCT02514122|5512537|P1|NOT COMPLETED|Overall Study||2
2246877|NCT02514122|5512536|P2|COMPLETED|Overall Study||29
2246878|NCT02514122|5512537|P1|COMPLETED|Overall Study|one participant dropped out for religious reasons; one for needle phobia|30
2246879|NCT02514122|5512536|P2|STARTED|Overall Study||29
2246880|NCT02514122|5512537|P1|STARTED|Overall Study||32
2246881|NCT02514044|5512545|P1|NOT COMPLETED|Placebo+tDCS+Speech Therapy (1 Day)||0
2246882|NCT02514044|5512545|P1|COMPLETED|Placebo+tDCS+Speech Therapy (1 Day)||10
2246883|NCT02514044|5512545|P1|STARTED|Placebo+tDCS+Speech Therapy (1 Day)||10
2246884|NCT02514044|5512545|P1|NOT COMPLETED|Washout (1 Week)||0
2246885|NCT02514044|5512545|P1|COMPLETED|Washout (1 Week)||10
2246886|NCT02514044|5512545|P1|STARTED|Washout (1 Week)||10
2246887|NCT02514044|5512545|P1|NOT COMPLETED|Dexedrine+tDCS+Speech Therapy (1 Day)||0
2246888|NCT02514044|5512545|P1|COMPLETED|Dexedrine+tDCS+Speech Therapy (1 Day)||10
2246889|NCT02514044|5512545|P1|STARTED|Dexedrine+tDCS+Speech Therapy (1 Day)||10
2246890|NCT02513940|5512559|P6|NOT COMPLETED|Overall Study||0
2246891|NCT02513940|5512560|P5|NOT COMPLETED|Overall Study||0
2246892|NCT02513940|5512561|P4|NOT COMPLETED|Overall Study||0
2246893|NCT02513940|5512562|P3|NOT COMPLETED|Overall Study||0
2246894|NCT02513940|5512563|P2|NOT COMPLETED|Overall Study||0
2246895|NCT02513940|5512564|P1|NOT COMPLETED|Overall Study||0
2246896|NCT02513940|5512559|P6|COMPLETED|Overall Study||3
2246897|NCT02513940|5512560|P5|COMPLETED|Overall Study||2
2246898|NCT02513940|5512561|P4|COMPLETED|Overall Study||2
2246899|NCT02513940|5512562|P3|COMPLETED|Overall Study||2
2246900|NCT02513940|5512563|P2|COMPLETED|Overall Study||3
2246901|NCT02513940|5512564|P1|COMPLETED|Overall Study||2
2246902|NCT02513940|5512559|P6|STARTED|Overall Study||3
2246903|NCT02513940|5512560|P5|STARTED|Overall Study||2
2246904|NCT02513940|5512561|P4|STARTED|Overall Study||2
2246905|NCT02513940|5512562|P3|STARTED|Overall Study||2
2246906|NCT02513940|5512563|P2|STARTED|Overall Study||3
2246907|NCT02513940|5512564|P1|STARTED|Overall Study|This was a crossover study, with a total n=14. All 14 subjects completed each phase of the study|2
2246908|NCT02513823|5512584|P1|NOT COMPLETED|Overall Study||5
2246909|NCT02513823|5512584|P1|COMPLETED|Overall Study||22
2246910|NCT02513823|5512584|P1|STARTED|Overall Study||27
2246911|NCT02513771|5512591|P2|NOT COMPLETED|Overall Study||1
2246912|NCT02513771|5512592|P1|NOT COMPLETED|Overall Study||2
2246913|NCT02513771|5512591|P2|COMPLETED|Overall Study||44
2246914|NCT02513771|5512592|P1|COMPLETED|Overall Study||43
2246915|NCT02513771|5512591|P2|STARTED|Overall Study||45
2246916|NCT02513771|5512592|P1|STARTED|Overall Study||45
2246917|NCT02513745|5512630|P2|NOT COMPLETED|Overall Study||3
2246918|NCT02513745|5512631|P1|NOT COMPLETED|Overall Study||3
2246919|NCT02513745|5512630|P2|COMPLETED|Overall Study||39
2246920|NCT02513745|5512631|P1|COMPLETED|Overall Study||39
2246921|NCT02513745|5512630|P2|STARTED|Overall Study||42
2246922|NCT02513745|5512631|P1|STARTED|Overall Study||42
2246923|NCT02513732|5512641|P1|NOT COMPLETED|Overall Study||0
2246924|NCT02513732|5512641|P1|COMPLETED|Overall Study||100
2246925|NCT02513732|5512641|P1|STARTED|Overall Study||100
2246926|NCT02513719|5512753|P1|NOT COMPLETED|At 5 Years Clinical Follow-up||234
2246927|NCT02513719|5512753|P1|COMPLETED|At 5 Years Clinical Follow-up||39
2246928|NCT02513719|5512753|P1|STARTED|At 5 Years Clinical Follow-up||273
2246929|NCT02513719|5512753|P1|NOT COMPLETED|At 4 Years Clinical Follow-up||16
2246930|NCT02513719|5512753|P1|COMPLETED|At 4 Years Clinical Follow-up||273
2246931|NCT02513719|5512753|P1|STARTED|At 4 Years Clinical Follow-up||289
2246932|NCT02513719|5512753|P1|NOT COMPLETED|At 3 Years Clinical Follow-up||11
2246933|NCT02513719|5512753|P1|COMPLETED|At 3 Years Clinical Follow-up||289
2246934|NCT02513719|5512753|P1|STARTED|At 3 Years Clinical Follow-up||300
2246935|NCT02513719|5512753|P1|NOT COMPLETED|At 2 Years Clinical Follow-up||5
2246936|NCT02513719|5512753|P1|COMPLETED|At 2 Years Clinical Follow-up||300
2246937|NCT02513719|5512753|P1|STARTED|At 2 Years Clinical Follow-up||305
2246938|NCT02513719|5512753|P1|NOT COMPLETED|At 1 Year Clinical Follow-up||7
2246939|NCT02513719|5512753|P1|COMPLETED|At 1 Year Clinical Follow-up||305
2246940|NCT02513719|5512753|P1|STARTED|At 1 Year Clinical Follow-up||312
2246941|NCT02513719|5512753|P1|NOT COMPLETED|At 8 Months Clinical Follow-up||0
2246942|NCT02513719|5512753|P1|COMPLETED|At 8 Months Clinical Follow-up||312
2246943|NCT02513719|5512753|P1|STARTED|At 8 Months Clinical Follow-up||312
2246944|NCT02513641|5512838|P1|NOT COMPLETED|Overall Study||0
2246945|NCT02513641|5512838|P1|COMPLETED|Overall Study||8
2246946|NCT02513641|5512838|P1|STARTED|Overall Study||8
2246947|NCT02513550|5512852|P6|NOT COMPLETED|Post-Treatment Follow-up Period||0
2246948|NCT02513550|5512853|P5|NOT COMPLETED|Post-Treatment Follow-up Period||0
2246949|NCT02513550|5512854|P4|NOT COMPLETED|Post-Treatment Follow-up Period||0
2246950|NCT02513550|5512855|P3|NOT COMPLETED|Post-Treatment Follow-up Period||63
2246951|NCT02513550|5512856|P2|NOT COMPLETED|Post-Treatment Follow-up Period||39
2246952|NCT02513550|5512857|P1|NOT COMPLETED|Post-Treatment Follow-up Period||31
2246953|NCT02513550|5512852|P6|COMPLETED|Post-Treatment Follow-up Period||15
2246954|NCT02513550|5512853|P5|COMPLETED|Post-Treatment Follow-up Period||4
2246955|NCT02513550|5512854|P4|COMPLETED|Post-Treatment Follow-up Period||9
2246956|NCT02513550|5512855|P3|COMPLETED|Post-Treatment Follow-up Period||496
2246957|NCT02513550|5512856|P2|COMPLETED|Post-Treatment Follow-up Period||244
2246958|NCT02513550|5512857|P1|COMPLETED|Post-Treatment Follow-up Period||254
2246959|NCT02513550|5512852|P6|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|15
2246960|NCT02513550|5512853|P5|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|4
2246961|NCT02513550|5512854|P4|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|9
2246962|NCT02513550|5512855|P3|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|559
2246963|NCT02513550|5512856|P2|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|283
2246964|NCT02513550|5512857|P1|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|285
2246965|NCT02513550|5512852|P6|NOT COMPLETED|Double Blind Treatment Period||1
2246966|NCT02513550|5512853|P5|NOT COMPLETED|Double Blind Treatment Period||1
2246967|NCT02513550|5512854|P4|NOT COMPLETED|Double Blind Treatment Period||0
2246968|NCT02513550|5512855|P3|NOT COMPLETED|Double Blind Treatment Period||74
2246969|NCT02513550|5512856|P2|NOT COMPLETED|Double Blind Treatment Period||38
2246970|NCT02513550|5512857|P1|NOT COMPLETED|Double Blind Treatment Period||36
2246971|NCT02513550|5512852|P6|COMPLETED|Double Blind Treatment Period||15
2246972|NCT02513550|5512853|P5|COMPLETED|Double Blind Treatment Period||4
2246973|NCT02513550|5512854|P4|COMPLETED|Double Blind Treatment Period||9
2246974|NCT02513550|5512855|P3|COMPLETED|Double Blind Treatment Period||537
2246975|NCT02513550|5512856|P2|COMPLETED|Double Blind Treatment Period||268
2246976|NCT02513550|5512857|P1|COMPLETED|Double Blind Treatment Period||274
2246977|NCT02513550|5512852|P6|Received at Least One Dose of Study Drug|Double Blind Treatment Period||16
2246978|NCT02513550|5512853|P5|Received at Least One Dose of Study Drug|Double Blind Treatment Period||5
2246979|NCT02513550|5512854|P4|Received at Least One Dose of Study Drug|Double Blind Treatment Period||9
2246980|NCT02513550|5512855|P3|Received at Least One Dose of Study Drug|Double Blind Treatment Period||609
2246981|NCT02513550|5512856|P2|Received at Least One Dose of Study Drug|Double Blind Treatment Period||306
2246982|NCT02513550|5512857|P1|Received at Least One Dose of Study Drug|Double Blind Treatment Period||310
2246983|NCT02513550|5512852|P6|STARTED|Double Blind Treatment Period||16
2246984|NCT02513550|5512853|P5|STARTED|Double Blind Treatment Period||5
2246985|NCT02513550|5512854|P4|STARTED|Double Blind Treatment Period||9
2246986|NCT02513550|5512855|P3|STARTED|Double Blind Treatment Period||611
2246987|NCT02513550|5512856|P2|STARTED|Double Blind Treatment Period||306
2246988|NCT02513550|5512857|P1|STARTED|Double Blind Treatment Period||310
2246989|NCT02513498|5512929|P1|NOT COMPLETED|Overall Study||24
2246990|NCT02513498|5512929|P1|COMPLETED|Overall Study||26
2246991|NCT02513498|5512929|P1|STARTED|Overall Study||50
2246992|NCT02513446|5512951|P2|NOT COMPLETED|Period 2||0
2246993|NCT02513446|5512952|P1|NOT COMPLETED|Period 2||0
2246994|NCT02513446|5512951|P2|COMPLETED|Period 2||8
2246995|NCT02513446|5512952|P1|COMPLETED|Period 2||8
2246996|NCT02513446|5512951|P2|STARTED|Period 2||8
2246997|NCT02513446|5512952|P1|STARTED|Period 2||8
2246998|NCT02513446|5512951|P2|NOT COMPLETED|Washout Period of 10 Days||0
2246999|NCT02513446|5512952|P1|NOT COMPLETED|Washout Period of 10 Days||0
2247000|NCT02513446|5512951|P2|COMPLETED|Washout Period of 10 Days||8
2247001|NCT02513446|5512952|P1|COMPLETED|Washout Period of 10 Days||8
2247002|NCT02513446|5512951|P2|STARTED|Washout Period of 10 Days||8
2247003|NCT02513446|5512952|P1|STARTED|Washout Period of 10 Days||8
2247004|NCT02513446|5512951|P2|NOT COMPLETED|Period 1||0
2247005|NCT02513446|5512952|P1|NOT COMPLETED|Period 1||0
2247006|NCT02513446|5512951|P2|COMPLETED|Period 1||8
2247007|NCT02513446|5512952|P1|COMPLETED|Period 1||8
2247008|NCT02513446|5512951|P2|STARTED|Period 1||8
2247009|NCT02513446|5512952|P1|STARTED|Period 1||8
2247010|NCT02513160|5512967|P4|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||2
2247011|NCT02513160|5512968|P3|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||1
2247012|NCT02513160|5512969|P2|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||4
2247013|NCT02513160|5512970|P1|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||6
2247014|NCT02513160|5512967|P4|COMPLETED|Treatment Period (Day 0 to Week 6)||103
2247015|NCT02513160|5512968|P3|COMPLETED|Treatment Period (Day 0 to Week 6)||104
2247016|NCT02513160|5512969|P2|COMPLETED|Treatment Period (Day 0 to Week 6)||104
2247017|NCT02513160|5512970|P1|COMPLETED|Treatment Period (Day 0 to Week 6)||101
2247018|NCT02513160|5512967|P4|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
2247019|NCT02513160|5512968|P3|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
2247020|NCT02513160|5512969|P2|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|108
2247021|NCT02513160|5512970|P1|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|107
2247022|NCT02513160|5512967|P4|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
2247023|NCT02513160|5512968|P3|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
2247024|NCT02513160|5512969|P2|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
2247025|NCT02513160|5512970|P1|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||288
2247026|NCT02513160|5512967|P4|COMPLETED|Run-In Period (Days -14 to Day -1)||0
2247027|NCT02513160|5512968|P3|COMPLETED|Run-In Period (Days -14 to Day -1)||0
2247028|NCT02513160|5512969|P2|COMPLETED|Run-In Period (Days -14 to Day -1)||0
2247029|NCT02513160|5512970|P1|COMPLETED|Run-In Period (Days -14 to Day -1)||425
2247030|NCT02513160|5512967|P4|STARTED|Run-In Period (Days -14 to Day -1)||0
2247031|NCT02513160|5512968|P3|STARTED|Run-In Period (Days -14 to Day -1)||0
2247032|NCT02513160|5512969|P2|STARTED|Run-In Period (Days -14 to Day -1)||0
2247033|NCT02513160|5512970|P1|STARTED|Run-In Period (Days -14 to Day -1)|Enrolled|713
2247034|NCT02513121|5513007|P2|NOT COMPLETED|Overall Study||0
2247035|NCT02513121|5513008|P1|NOT COMPLETED|Overall Study||0
2247036|NCT02513121|5513007|P2|COMPLETED|Overall Study||20
2247037|NCT02513121|5513008|P1|COMPLETED|Overall Study||20
2247038|NCT02513121|5513007|P2|STARTED|Overall Study||20
2247039|NCT02513121|5513008|P1|STARTED|Overall Study||20
2247040|NCT02513095|5513028|P2|NOT COMPLETED|Overall Study||16
2247041|NCT02513095|5513029|P1|NOT COMPLETED|Overall Study||14
2247042|NCT02513095|5513028|P2|COMPLETED|Overall Study||1
2247043|NCT02513095|5513029|P1|COMPLETED|Overall Study||3
2247044|NCT02513095|5513028|P2|STARTED|Overall Study||17
2247045|NCT02513095|5513029|P1|STARTED|Overall Study||17
2247046|NCT02512900|5513037|P2|NOT COMPLETED|Overall Study||0
2247047|NCT02512900|5513038|P1|NOT COMPLETED|Overall Study||0
2247048|NCT02512900|5513037|P2|COMPLETED|Overall Study||10
2247049|NCT02512900|5513038|P1|COMPLETED|Overall Study||11
2247050|NCT02512900|5513037|P2|STARTED|Overall Study||10
2247051|NCT02512900|5513038|P1|STARTED|Overall Study||11
2247052|NCT02512874|5513069|P1|NOT COMPLETED|Overall Study||2
2247053|NCT02512874|5513069|P1|COMPLETED|Overall Study||63
2247054|NCT02512874|5513069|P1|STARTED|Overall Study||65
2247055|NCT02512861|5513075|P2|NOT COMPLETED|Overall Study||9
2247056|NCT02512861|5513076|P1|NOT COMPLETED|Overall Study||6
2247057|NCT02512861|5513075|P2|COMPLETED|Overall Study||40
2247058|NCT02512861|5513076|P1|COMPLETED|Overall Study||38
2247059|NCT02512861|5513075|P2|STARTED|Overall Study||49
2247060|NCT02512861|5513076|P1|STARTED|Overall Study||44
2247061|NCT02512809|5513097|P1|NOT COMPLETED|Overall Study||0
2247062|NCT02512809|5513097|P1|COMPLETED|Overall Study||25
2247063|NCT02512809|5513097|P1|STARTED|Overall Study||25
2247064|NCT02512783|5513103|P2|NOT COMPLETED|Overall Study||0
2247065|NCT02512783|5513104|P1|NOT COMPLETED|Overall Study||0
2247066|NCT02512783|5513103|P2|COMPLETED|Overall Study||75
2247067|NCT02512783|5513104|P1|COMPLETED|Overall Study||96
2247068|NCT02512783|5513103|P2|STARTED|Overall Study||75
2247069|NCT02512783|5513104|P1|STARTED|Overall Study||96
2247070|NCT02512679|5513112|P2|NOT COMPLETED|Overall Study||0
2247071|NCT02512679|5513113|P1|NOT COMPLETED|Overall Study||0
2247072|NCT02512679|5513112|P2|COMPLETED|Overall Study||0
2247073|NCT02512679|5513113|P1|COMPLETED|Overall Study||20
2247074|NCT02512679|5513112|P2|STARTED|Overall Study||0
2247075|NCT02512679|5513113|P1|STARTED|Overall Study||20
2247076|NCT02512575|5513131|P10|NOT COMPLETED|Overall Study||0
2247077|NCT02512575|5513132|P9|NOT COMPLETED|Overall Study||0
2247078|NCT02512575|5513133|P8|NOT COMPLETED|Overall Study||0
2247079|NCT02512575|5513134|P7|NOT COMPLETED|Overall Study||0
2247080|NCT02512575|5513135|P6|NOT COMPLETED|Overall Study||0
2247081|NCT02512575|5513136|P5|NOT COMPLETED|Overall Study||0
2247082|NCT02512575|5513137|P4|NOT COMPLETED|Overall Study||0
2247083|NCT02512575|5513138|P3|NOT COMPLETED|Overall Study||0
2247084|NCT02512575|5513139|P2|NOT COMPLETED|Overall Study||0
2247085|NCT02512575|5513140|P1|NOT COMPLETED|Overall Study||0
2247086|NCT02512575|5513131|P10|COMPLETED|Overall Study||18
2247087|NCT02512575|5513132|P9|COMPLETED|Overall Study||6
2247088|NCT02512575|5513133|P8|COMPLETED|Overall Study||6
2247089|NCT02512575|5513134|P7|COMPLETED|Overall Study||6
2247090|NCT02512575|5513135|P6|COMPLETED|Overall Study||6
2247091|NCT02512575|5513136|P5|COMPLETED|Overall Study||6
2247092|NCT02512575|5513137|P4|COMPLETED|Overall Study||6
2247093|NCT02512575|5513138|P3|COMPLETED|Overall Study||6
2247094|NCT02512575|5513139|P2|COMPLETED|Overall Study||6
2247095|NCT02512575|5513140|P1|COMPLETED|Overall Study||6
2247096|NCT02512575|5513131|P10|STARTED|Overall Study||18
2247097|NCT02512575|5513132|P9|STARTED|Overall Study||6
2247098|NCT02512575|5513133|P8|STARTED|Overall Study||6
2247099|NCT02512575|5513134|P7|STARTED|Overall Study||6
2247100|NCT02512575|5513135|P6|STARTED|Overall Study||6
2247101|NCT02512575|5513136|P5|STARTED|Overall Study||6
2247102|NCT02512575|5513137|P4|STARTED|Overall Study||6
2247103|NCT02512575|5513138|P3|STARTED|Overall Study||6
2247104|NCT02512575|5513139|P2|STARTED|Overall Study||6
2247105|NCT02512575|5513140|P1|STARTED|Overall Study||6
2247106|NCT02512510|5513235|P3|NOT COMPLETED|Overall Study||52
2247107|NCT02512510|5513236|P2|NOT COMPLETED|Overall Study||35
2247108|NCT02512510|5513237|P1|NOT COMPLETED|Overall Study||42
2247109|NCT02512510|5513235|P3|COMPLETED|Overall Study||157
2247110|NCT02512510|5513236|P2|COMPLETED|Overall Study||162
2247111|NCT02512510|5513237|P1|COMPLETED|Overall Study||163
2247112|NCT02512510|5513235|P3|STARTED|Overall Study||209
2247113|NCT02512510|5513236|P2|STARTED|Overall Study||197
2247114|NCT02512510|5513237|P1|STARTED|Overall Study||205
2247115|NCT02512419|5513262|P2|NOT COMPLETED|Overall Study||0
2247116|NCT02512419|5513263|P1|NOT COMPLETED|Overall Study||2
2247117|NCT02512419|5513262|P2|COMPLETED|Overall Study||24
2247118|NCT02512419|5513263|P1|COMPLETED|Overall Study|2 participants became ineligible after enrolling therefore were not included in analysis.|22
2247119|NCT02512419|5513262|P2|STARTED|Overall Study||24
2247120|NCT02512419|5513263|P1|STARTED|Overall Study||24
2247121|NCT02512393|5513273|P2|NOT COMPLETED|Overall Study||0
2247122|NCT02512393|5513274|P1|NOT COMPLETED|Overall Study||1
2247123|NCT02512393|5513273|P2|COMPLETED|Overall Study||20
2247124|NCT02512393|5513274|P1|COMPLETED|Overall Study||20
2247125|NCT02512393|5513273|P2|STARTED|Overall Study||20
2247126|NCT02512393|5513274|P1|STARTED|Overall Study||21
2247127|NCT02512302|5513354|P10|NOT COMPLETED|Period 5||0
2247128|NCT02512302|5513355|P9|NOT COMPLETED|Period 5||0
2247129|NCT02512302|5513356|P8|NOT COMPLETED|Period 5||0
2247130|NCT02512302|5513357|P7|NOT COMPLETED|Period 5||0
2247131|NCT02512302|5513358|P6|NOT COMPLETED|Period 5||0
2247132|NCT02512302|5513359|P5|NOT COMPLETED|Period 5||0
2247133|NCT02512302|5513360|P4|NOT COMPLETED|Period 5||0
2247134|NCT02512302|5513361|P3|NOT COMPLETED|Period 5||0
2247135|NCT02512302|5513362|P2|NOT COMPLETED|Period 5||0
2247136|NCT02512302|5513363|P1|NOT COMPLETED|Period 5||0
2247137|NCT02512302|5513354|P10|COMPLETED|Period 5||2
2247138|NCT02512302|5513355|P9|COMPLETED|Period 5||3
2247139|NCT02512302|5513356|P8|COMPLETED|Period 5||3
2247140|NCT02512302|5513357|P7|COMPLETED|Period 5||1
2247141|NCT02512302|5513358|P6|COMPLETED|Period 5||3
2247142|NCT02512302|5513359|P5|COMPLETED|Period 5||3
2247143|NCT02512302|5513360|P4|COMPLETED|Period 5||3
2247144|NCT02512302|5513361|P3|COMPLETED|Period 5||3
2247145|NCT02512302|5513362|P2|COMPLETED|Period 5||2
2247146|NCT02512302|5513363|P1|COMPLETED|Period 5||3
2247147|NCT02512302|5513354|P10|STARTED|Period 5||2
2247148|NCT02512302|5513355|P9|STARTED|Period 5||3
2247149|NCT02512302|5513356|P8|STARTED|Period 5||3
2247150|NCT02512302|5513357|P7|STARTED|Period 5||1
2247151|NCT02512302|5513358|P6|STARTED|Period 5||3
2247152|NCT02512302|5513359|P5|STARTED|Period 5||3
2247153|NCT02512302|5513360|P4|STARTED|Period 5||3
2247154|NCT02512302|5513361|P3|STARTED|Period 5||3
2247155|NCT02512302|5513362|P2|STARTED|Period 5||2
2247156|NCT02512302|5513363|P1|STARTED|Period 5||3
2247157|NCT02512302|5513354|P10|NOT COMPLETED|Period 4||0
2247158|NCT02512302|5513355|P9|NOT COMPLETED|Period 4||0
2247159|NCT02512302|5513356|P8|NOT COMPLETED|Period 4||0
2247160|NCT02512302|5513357|P7|NOT COMPLETED|Period 4||1
2247161|NCT02512302|5513358|P6|NOT COMPLETED|Period 4||0
2247162|NCT02512302|5513359|P5|NOT COMPLETED|Period 4||0
2247163|NCT02512302|5513360|P4|NOT COMPLETED|Period 4||0
2247164|NCT02512302|5513361|P3|NOT COMPLETED|Period 4||0
2247165|NCT02512302|5513362|P2|NOT COMPLETED|Period 4||0
2247166|NCT02512302|5513363|P1|NOT COMPLETED|Period 4||0
2247167|NCT02512302|5513354|P10|COMPLETED|Period 4||2
2247168|NCT02512302|5513355|P9|COMPLETED|Period 4||3
2247169|NCT02512302|5513356|P8|COMPLETED|Period 4||3
2247170|NCT02512302|5513357|P7|COMPLETED|Period 4||1
2247171|NCT02512302|5513358|P6|COMPLETED|Period 4||3
2247172|NCT02512302|5513359|P5|COMPLETED|Period 4||3
2247173|NCT02512302|5513360|P4|COMPLETED|Period 4||3
2247174|NCT02512302|5513361|P3|COMPLETED|Period 4||3
2247175|NCT02512302|5513362|P2|COMPLETED|Period 4||2
2247176|NCT02512302|5513363|P1|COMPLETED|Period 4||3
2247177|NCT02512302|5513354|P10|STARTED|Period 4||2
2247178|NCT02512302|5513355|P9|STARTED|Period 4||3
2247179|NCT02512302|5513356|P8|STARTED|Period 4||3
2247180|NCT02512302|5513357|P7|STARTED|Period 4||2
2247181|NCT02512302|5513358|P6|STARTED|Period 4||3
2247182|NCT02512302|5513359|P5|STARTED|Period 4||3
2247183|NCT02512302|5513360|P4|STARTED|Period 4||3
2247184|NCT02512302|5513361|P3|STARTED|Period 4||3
2247185|NCT02512302|5513362|P2|STARTED|Period 4||2
2247186|NCT02512302|5513363|P1|STARTED|Period 4||3
2247187|NCT02512302|5513354|P10|NOT COMPLETED|Period 3||0
2247188|NCT02512302|5513355|P9|NOT COMPLETED|Period 3||0
2247189|NCT02512302|5513356|P8|NOT COMPLETED|Period 3||0
2247190|NCT02512302|5513357|P7|NOT COMPLETED|Period 3||0
2247191|NCT02512302|5513358|P6|NOT COMPLETED|Period 3||0
2247192|NCT02512302|5513359|P5|NOT COMPLETED|Period 3||0
2247193|NCT02512302|5513360|P4|NOT COMPLETED|Period 3||0
2247194|NCT02512302|5513361|P3|NOT COMPLETED|Period 3||1
2247195|NCT02512302|5513362|P2|NOT COMPLETED|Period 3||0
2247196|NCT02512302|5513363|P1|NOT COMPLETED|Period 3||0
2247197|NCT02512302|5513354|P10|COMPLETED|Period 3||2
2247198|NCT02512302|5513355|P9|COMPLETED|Period 3||3
2247199|NCT02512302|5513356|P8|COMPLETED|Period 3||3
2247200|NCT02512302|5513357|P7|COMPLETED|Period 3||2
2247201|NCT02512302|5513358|P6|COMPLETED|Period 3||3
2247202|NCT02512302|5513359|P5|COMPLETED|Period 3||3
2247203|NCT02512302|5513360|P4|COMPLETED|Period 3||3
2247204|NCT02512302|5513361|P3|COMPLETED|Period 3||3
2247205|NCT02512302|5513362|P2|COMPLETED|Period 3||2
2247206|NCT02512302|5513363|P1|COMPLETED|Period 3||3
2247207|NCT02512302|5513354|P10|STARTED|Period 3||2
2247208|NCT02512302|5513355|P9|STARTED|Period 3||3
2247209|NCT02512302|5513356|P8|STARTED|Period 3||3
2247210|NCT02512302|5513357|P7|STARTED|Period 3||2
2247211|NCT02512302|5513358|P6|STARTED|Period 3||3
2247212|NCT02512302|5513359|P5|STARTED|Period 3||3
2247213|NCT02512302|5513360|P4|STARTED|Period 3||3
2247214|NCT02512302|5513361|P3|STARTED|Period 3||4
2247215|NCT02512302|5513362|P2|STARTED|Period 3||2
2247216|NCT02512302|5513363|P1|STARTED|Period 3||3
2247217|NCT02512302|5513354|P10|NOT COMPLETED|Period 2||1
2247218|NCT02512302|5513355|P9|NOT COMPLETED|Period 2||0
2247219|NCT02512302|5513356|P8|NOT COMPLETED|Period 2||0
2247220|NCT02512302|5513357|P7|NOT COMPLETED|Period 2||0
2247221|NCT02512302|5513358|P6|NOT COMPLETED|Period 2||0
2247222|NCT02512302|5513359|P5|NOT COMPLETED|Period 2||0
2247223|NCT02512302|5513360|P4|NOT COMPLETED|Period 2||0
2247224|NCT02512302|5513361|P3|NOT COMPLETED|Period 2||0
2247225|NCT02512302|5513362|P2|NOT COMPLETED|Period 2||0
2247226|NCT02512302|5513363|P1|NOT COMPLETED|Period 2||0
2247227|NCT02512302|5513354|P10|COMPLETED|Period 2||2
2247228|NCT02512302|5513355|P9|COMPLETED|Period 2||3
2247229|NCT02512302|5513356|P8|COMPLETED|Period 2||3
2247230|NCT02512302|5513357|P7|COMPLETED|Period 2||2
2247231|NCT02512302|5513358|P6|COMPLETED|Period 2||3
2247232|NCT02512302|5513359|P5|COMPLETED|Period 2||3
2247233|NCT02512302|5513360|P4|COMPLETED|Period 2||3
2247234|NCT02512302|5513361|P3|COMPLETED|Period 2||4
2247235|NCT02512302|5513362|P2|COMPLETED|Period 2||2
2247236|NCT02512302|5513363|P1|COMPLETED|Period 2||3
2247237|NCT02512302|5513354|P10|STARTED|Period 2||3
2247238|NCT02512302|5513355|P9|STARTED|Period 2||3
2247239|NCT02512302|5513356|P8|STARTED|Period 2||3
2247240|NCT02512302|5513357|P7|STARTED|Period 2||2
2247241|NCT02512302|5513358|P6|STARTED|Period 2||3
2247242|NCT02512302|5513359|P5|STARTED|Period 2||3
2247243|NCT02512302|5513360|P4|STARTED|Period 2||3
2247244|NCT02512302|5513361|P3|STARTED|Period 2||4
2247245|NCT02512302|5513362|P2|STARTED|Period 2||2
2247246|NCT02512302|5513363|P1|STARTED|Period 2||3
2247247|NCT02512302|5513354|P10|NOT COMPLETED|Period 1||0
2247248|NCT02512302|5513355|P9|NOT COMPLETED|Period 1||0
2247249|NCT02512302|5513356|P8|NOT COMPLETED|Period 1||0
2247250|NCT02512302|5513357|P7|NOT COMPLETED|Period 1||0
2247251|NCT02512302|5513358|P6|NOT COMPLETED|Period 1||0
2247252|NCT02512302|5513359|P5|NOT COMPLETED|Period 1||0
2247253|NCT02512302|5513360|P4|NOT COMPLETED|Period 1||0
2247254|NCT02512302|5513361|P3|NOT COMPLETED|Period 1||0
2247255|NCT02512302|5513362|P2|NOT COMPLETED|Period 1||1
2247256|NCT02512302|5513363|P1|NOT COMPLETED|Period 1||0
2247257|NCT02512302|5513354|P10|COMPLETED|Period 1||3
2247258|NCT02512302|5513355|P9|COMPLETED|Period 1||3
2247259|NCT02512302|5513356|P8|COMPLETED|Period 1||3
2247260|NCT02512302|5513357|P7|COMPLETED|Period 1||2
2247261|NCT02512302|5513358|P6|COMPLETED|Period 1||3
2247262|NCT02512302|5513359|P5|COMPLETED|Period 1||3
2247263|NCT02512302|5513360|P4|COMPLETED|Period 1||3
2247264|NCT02512302|5513361|P3|COMPLETED|Period 1||4
2247265|NCT02512302|5513362|P2|COMPLETED|Period 1||2
2247266|NCT02512302|5513363|P1|COMPLETED|Period 1||3
2247267|NCT02512302|5513354|P10|STARTED|Period 1||3
2247268|NCT02512302|5513355|P9|STARTED|Period 1||3
2247269|NCT02512302|5513356|P8|STARTED|Period 1||3
2247270|NCT02512302|5513357|P7|STARTED|Period 1||2
2247271|NCT02512302|5513358|P6|STARTED|Period 1||3
2247272|NCT02512302|5513359|P5|STARTED|Period 1||3
2247273|NCT02512302|5513360|P4|STARTED|Period 1||3
2247274|NCT02512302|5513361|P3|STARTED|Period 1||4
2247275|NCT02512302|5513362|P2|STARTED|Period 1||3
2247276|NCT02512302|5513363|P1|STARTED|Period 1||3
2247277|NCT02512276|5513437|P2|NOT COMPLETED|Overall Study||11
2247278|NCT02512276|5513438|P1|NOT COMPLETED|Overall Study||8
2247279|NCT02512276|5513437|P2|COMPLETED|Overall Study||2029
2247280|NCT02512276|5513438|P1|COMPLETED|Overall Study||2030
2247281|NCT02512276|5513437|P2|STARTED|Overall Study||2040
2247282|NCT02512276|5513438|P1|STARTED|Overall Study||2038
2247283|NCT02512224|5513456|P2|NOT COMPLETED|Overall Study||0
2247284|NCT02512224|5513457|P1|NOT COMPLETED|Overall Study||0
2247285|NCT02512224|5513456|P2|COMPLETED|Overall Study||2912
2247286|NCT02512224|5513457|P1|COMPLETED|Overall Study||2912
2247287|NCT02512224|5513456|P2|STARTED|Overall Study||2912
2247288|NCT02512224|5513457|P1|STARTED|Overall Study||2912
2247289|NCT02512094|5513473|P1|NOT COMPLETED|Overall Study||0
2247290|NCT02512094|5513473|P1|COMPLETED|Overall Study||53
2247291|NCT02512094|5513473|P1|STARTED|Overall Study||53
2247292|NCT02512068|5513479|P2|NOT COMPLETED|Overall Study||13
2247293|NCT02512068|5513480|P1|NOT COMPLETED|Overall Study||12
2247294|NCT02512068|5513479|P2|COMPLETED|Overall Study||39
2247295|NCT02512068|5513480|P1|COMPLETED|Overall Study||43
2247296|NCT02512068|5513479|P2|STARTED|Overall Study||52
2247297|NCT02512068|5513480|P1|STARTED|Overall Study||55
2247298|NCT02511782|5513507|P3|NOT COMPLETED|Overall Study||0
2247299|NCT02511782|5513508|P2|NOT COMPLETED|Overall Study||0
2247300|NCT02511782|5513509|P1|NOT COMPLETED|Overall Study||1
2247301|NCT02511782|5513507|P3|COMPLETED|Overall Study||10
2247302|NCT02511782|5513508|P2|COMPLETED|Overall Study||2
2247303|NCT02511782|5513509|P1|COMPLETED|Overall Study||50
2247304|NCT02511782|5513507|P3|STARTED|Overall Study||10
2247305|NCT02511782|5513508|P2|STARTED|Overall Study||2
2247306|NCT02511782|5513509|P1|STARTED|Overall Study||51
2247307|NCT02511717|5513521|P2|NOT COMPLETED|Overall Study||0
2247308|NCT02511717|5513522|P1|NOT COMPLETED|Overall Study||2
2247309|NCT02511717|5513521|P2|COMPLETED|Overall Study||10
2247310|NCT02511717|5513522|P1|COMPLETED|Overall Study||8
2247311|NCT02511717|5513521|P2|STARTED|Overall Study||10
2247312|NCT02511717|5513522|P1|STARTED|Overall Study||10
2247313|NCT02511678|5513528|P1|NOT COMPLETED|Overall Study||36
2247314|NCT02511678|5513528|P1|COMPLETED|Overall Study||37
2247315|NCT02511678|5513528|P1|Safety Population|Overall Study|Participants for whom received the complete study cryoablation procedure.|65
2247316|NCT02511678|5513528|P1|Participants Discontinued Pre-Treatment|Overall Study||7
2247317|NCT02511678|5513528|P1|Intent-to-Treat (ITT) Population|Overall Study|Participants for whom cryoablation via Galil Medical cryoablation system was attempted or performed.|66
2247318|NCT02511678|5513528|P1|STARTED|Overall Study||73
2247319|NCT02511587|5513543|P2|NOT COMPLETED|Overall Study||0
2247320|NCT02511587|5513544|P1|NOT COMPLETED|Overall Study||0
2247321|NCT02511587|5513543|P2|COMPLETED|Overall Study||58
2247322|NCT02511587|5513544|P1|COMPLETED|Overall Study||58
2247323|NCT02511587|5513543|P2|STARTED|Overall Study||58
2247324|NCT02511587|5513544|P1|STARTED|Overall Study||58
2247325|NCT02511535|5513557|P3|NOT COMPLETED|Overall Study||0
2247326|NCT02511535|5513558|P2|NOT COMPLETED|Overall Study||0
2247327|NCT02511535|5513559|P1|NOT COMPLETED|Overall Study||0
2247328|NCT02511535|5513557|P3|COMPLETED|Overall Study||49
2247329|NCT02511535|5513558|P2|COMPLETED|Overall Study||21
2247330|NCT02511535|5513559|P1|COMPLETED|Overall Study||49
2247331|NCT02511535|5513557|P3|STARTED|Overall Study||49
2247332|NCT02511535|5513558|P2|STARTED|Overall Study||21
2247333|NCT02511535|5513559|P1|STARTED|Overall Study||49
2247334|NCT02511431|5513582|P6|NOT COMPLETED|Post-treatment Follow-up||0
2247335|NCT02511431|5513583|P5|NOT COMPLETED|Post-treatment Follow-up||0
2247336|NCT02511431|5513584|P4|NOT COMPLETED|Post-treatment Follow-up||0
2247337|NCT02511431|5513585|P3|NOT COMPLETED|Post-treatment Follow-up||0
2247338|NCT02511431|5513586|P2|NOT COMPLETED|Post-treatment Follow-up||0
2247339|NCT02511431|5513587|P1|NOT COMPLETED|Post-treatment Follow-up||0
2247340|NCT02511431|5513582|P6|COMPLETED|Post-treatment Follow-up||2
2247341|NCT02511431|5513583|P5|COMPLETED|Post-treatment Follow-up||3
2247342|NCT02511431|5513584|P4|COMPLETED|Post-treatment Follow-up||3
2247343|NCT02511431|5513585|P3|COMPLETED|Post-treatment Follow-up||3
2247344|NCT02511431|5513586|P2|COMPLETED|Post-treatment Follow-up||4
2247345|NCT02511431|5513587|P1|COMPLETED|Post-treatment Follow-up||4
2247346|NCT02511431|5513582|P6|STARTED|Post-treatment Follow-up||2
2247347|NCT02511431|5513583|P5|STARTED|Post-treatment Follow-up||3
2247348|NCT02511431|5513584|P4|STARTED|Post-treatment Follow-up||3
2247349|NCT02511431|5513585|P3|STARTED|Post-treatment Follow-up||3
2247350|NCT02511431|5513586|P2|STARTED|Post-treatment Follow-up||4
2247351|NCT02511431|5513587|P1|STARTED|Post-treatment Follow-up||4
2247352|NCT02511431|5513582|P6|NOT COMPLETED|Treatment||1
2247353|NCT02511431|5513583|P5|NOT COMPLETED|Treatment||0
2247354|NCT02511431|5513584|P4|NOT COMPLETED|Treatment||0
2247355|NCT02511431|5513585|P3|NOT COMPLETED|Treatment||1
2247356|NCT02511431|5513586|P2|NOT COMPLETED|Treatment||0
2247357|NCT02511431|5513587|P1|NOT COMPLETED|Treatment||0
2247358|NCT02511431|5513582|P6|COMPLETED|Treatment||2
2247359|NCT02511431|5513583|P5|COMPLETED|Treatment||3
2247360|NCT02511431|5513584|P4|COMPLETED|Treatment||3
2247361|NCT02511431|5513585|P3|COMPLETED|Treatment||3
2247362|NCT02511431|5513586|P2|COMPLETED|Treatment||4
2247363|NCT02511431|5513587|P1|COMPLETED|Treatment||4
2247364|NCT02511431|5513582|P6|STARTED|Treatment||3
2247365|NCT02511431|5513583|P5|STARTED|Treatment||3
2247366|NCT02511431|5513584|P4|STARTED|Treatment||3
2247367|NCT02511431|5513585|P3|STARTED|Treatment||4
2247368|NCT02511431|5513586|P2|STARTED|Treatment||4
2247369|NCT02511431|5513587|P1|STARTED|Treatment||4
2247370|NCT02511379|5513608|P1|NOT COMPLETED|Overall Study||0
2247371|NCT02511379|5513608|P1|COMPLETED|Overall Study||14
2247372|NCT02511379|5513608|P1|STARTED|Overall Study||14
2247373|NCT02511184|5513614|P2|NOT COMPLETED|Overall Study||7
2247374|NCT02511184|5513615|P1|NOT COMPLETED|Overall Study||2
2247375|NCT02511184|5513614|P2|COMPLETED|Overall Study||0
2247376|NCT02511184|5513615|P1|COMPLETED|Overall Study||0
2247377|NCT02511184|5513614|P2|STARTED|Overall Study||7
2247378|NCT02511184|5513615|P1|STARTED|Overall Study||2
2247379|NCT02510820|5513665|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
2247380|NCT02510820|5513666|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
2247381|NCT02510820|5513665|P2|COMPLETED|Second Intervention (4 Weeks)||26
2247382|NCT02510820|5513666|P1|COMPLETED|Second Intervention (4 Weeks)||20
2247383|NCT02510820|5513665|P2|STARTED|Second Intervention (4 Weeks)||26
2247384|NCT02510820|5513666|P1|STARTED|Second Intervention (4 Weeks)||21
2247385|NCT02510820|5513665|P2|NOT COMPLETED|Washout (1 Week)||0
2247386|NCT02510820|5513666|P1|NOT COMPLETED|Washout (1 Week)||0
2247387|NCT02510820|5513665|P2|COMPLETED|Washout (1 Week)||26
2247388|NCT02510820|5513666|P1|COMPLETED|Washout (1 Week)||21
2247389|NCT02510820|5513665|P2|STARTED|Washout (1 Week)||26
2247390|NCT02510820|5513666|P1|STARTED|Washout (1 Week)||21
2247391|NCT02510820|5513665|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
2247392|NCT02510820|5513666|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
2247393|NCT02510820|5513665|P2|COMPLETED|First Intervention (4 Weeks)||26
2247394|NCT02510820|5513666|P1|COMPLETED|First Intervention (4 Weeks)||21
2247395|NCT02510820|5513665|P2|STARTED|First Intervention (4 Weeks)||27
2247396|NCT02510820|5513666|P1|STARTED|First Intervention (4 Weeks)||21
2247406|NCT02510144|5513740|P2|NOT COMPLETED|Overall Study||0
2247407|NCT02510144|5513741|P1|NOT COMPLETED|Overall Study||0
2247408|NCT02510144|5513740|P2|COMPLETED|Overall Study||41
2247409|NCT02510144|5513741|P1|COMPLETED|Overall Study||39
2247410|NCT02510144|5513740|P2|STARTED|Overall Study||41
2247411|NCT02510144|5513741|P1|STARTED|Overall Study||39
2247412|NCT02510014|5513751|P2|NOT COMPLETED|Treatment Period||57
2247413|NCT02510014|5513752|P1|NOT COMPLETED|Treatment Period||206
2247414|NCT02510014|5513751|P2|COMPLETED|Treatment Period||200
2247415|NCT02510014|5513752|P1|COMPLETED|Treatment Period||206
2247416|NCT02510014|5513751|P2|STARTED|Treatment Period||257
2247417|NCT02510014|5513752|P1|STARTED|Treatment Period||412
2247418|NCT02510014|5513751|P2|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||10
2247419|NCT02510014|5513752|P1|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||96
2247420|NCT02510014|5513751|P2|COMPLETED|Run-In Period (Days -14 to Day -1)||257
2247421|NCT02510014|5513752|P1|COMPLETED|Run-In Period (Days -14 to Day -1)||412
2247422|NCT02510014|5513751|P2|STARTED|Run-In Period (Days -14 to Day -1)||267
2247423|NCT02510014|5513752|P1|STARTED|Run-In Period (Days -14 to Day -1)||508
2247424|NCT02509936|5513774|P2|NOT COMPLETED|Overall Study||16
2247425|NCT02509936|5513775|P1|NOT COMPLETED|Overall Study||12
2247426|NCT02509936|5513774|P2|COMPLETED|Overall Study||145
2247427|NCT02509936|5513775|P1|COMPLETED|Overall Study||151
2247428|NCT02509936|5513774|P2|STARTED|Overall Study||161
2247429|NCT02509936|5513775|P1|STARTED|Overall Study||163
2247430|NCT02509767|5513801|P2|NOT COMPLETED|Overall Study||41
2247431|NCT02509767|5513802|P1|NOT COMPLETED|Overall Study||44
2247432|NCT02509767|5513801|P2|COMPLETED|Overall Study||159
2247433|NCT02509767|5513802|P1|COMPLETED|Overall Study||157
2247434|NCT02509767|5513801|P2|STARTED|Overall Study||200
2247435|NCT02509767|5513802|P1|STARTED|Overall Study||201
2247436|NCT02509585|5513813|P1|NOT COMPLETED|Overall Study||0
2247437|NCT02509585|5513813|P1|COMPLETED|Overall Study||18
2247438|NCT02509585|5513813|P1|STARTED|Overall Study||18
2247439|NCT02509481|5513828|P2|NOT COMPLETED|Overall Study||0
2247440|NCT02509481|5513829|P1|NOT COMPLETED|Overall Study||0
2247441|NCT02509481|5513828|P2|COMPLETED|Overall Study||1447
2247442|NCT02509481|5513829|P1|COMPLETED|Overall Study||1265
2247443|NCT02509481|5513828|P2|STARTED|Overall Study||1447
2247444|NCT02509481|5513829|P1|STARTED|Overall Study||1265
2247445|NCT02509117|5513855|P10|NOT COMPLETED|Period 4 -Part A: 4 Days||0
2247446|NCT02509117|5513856|P9|NOT COMPLETED|Period 4 -Part A: 4 Days||0
2247447|NCT02509117|5513857|P8|NOT COMPLETED|Period 4 -Part A: 4 Days||0
2247448|NCT02509117|5513858|P7|NOT COMPLETED|Period 4 -Part A: 4 Days||0
2247449|NCT02509117|5513859|P6|NOT COMPLETED|Period 4 -Part A: 4 Days||0
2247450|NCT02509117|5513860|P5|NOT COMPLETED|Period 4 -Part A: 4 Days||0
2247451|NCT02509117|5513861|P4|NOT COMPLETED|Period 4 -Part A: 4 Days||0
2247452|NCT02509117|5513862|P3|NOT COMPLETED|Period 4 -Part A: 4 Days||0
2247453|NCT02509117|5513863|P2|NOT COMPLETED|Period 4 -Part A: 4 Days||0
2247454|NCT02509117|5513864|P1|NOT COMPLETED|Period 4 -Part A: 4 Days||0
2247455|NCT02509117|5513855|P10|COMPLETED|Period 4 -Part A: 4 Days||0
2247456|NCT02509117|5513856|P9|COMPLETED|Period 4 -Part A: 4 Days||0
2247457|NCT02509117|5513857|P8|COMPLETED|Period 4 -Part A: 4 Days||0
2247458|NCT02509117|5513858|P7|COMPLETED|Period 4 -Part A: 4 Days||0
2247459|NCT02509117|5513859|P6|COMPLETED|Period 4 -Part A: 4 Days||0
2247460|NCT02509117|5513860|P5|COMPLETED|Period 4 -Part A: 4 Days||0
2247461|NCT02509117|5513861|P4|COMPLETED|Period 4 -Part A: 4 Days||2
2247462|NCT02509117|5513862|P3|COMPLETED|Period 4 -Part A: 4 Days||2
2247463|NCT02509117|5513863|P2|COMPLETED|Period 4 -Part A: 4 Days||2
2247464|NCT02509117|5513864|P1|COMPLETED|Period 4 -Part A: 4 Days||2
2247465|NCT02509117|5513855|P10|STARTED|Period 4 -Part A: 4 Days||0
2247466|NCT02509117|5513856|P9|STARTED|Period 4 -Part A: 4 Days||0
2247467|NCT02509117|5513857|P8|STARTED|Period 4 -Part A: 4 Days||0
2247468|NCT02509117|5513858|P7|STARTED|Period 4 -Part A: 4 Days||0
2247469|NCT02509117|5513859|P6|STARTED|Period 4 -Part A: 4 Days||0
2247470|NCT02509117|5513860|P5|STARTED|Period 4 -Part A: 4 Days||0
2247471|NCT02509117|5513861|P4|STARTED|Period 4 -Part A: 4 Days||2
2247472|NCT02509117|5513862|P3|STARTED|Period 4 -Part A: 4 Days||2
2247473|NCT02509117|5513863|P2|STARTED|Period 4 -Part A: 4 Days||2
2247474|NCT02509117|5513864|P1|STARTED|Period 4 -Part A: 4 Days||2
2247475|NCT02509117|5513855|P10|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
2247476|NCT02509117|5513856|P9|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
2247477|NCT02509117|5513857|P8|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
2247478|NCT02509117|5513858|P7|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
2247479|NCT02509117|5513859|P6|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
2247480|NCT02509117|5513860|P5|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
2247481|NCT02509117|5513861|P4|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
2247482|NCT02509117|5513862|P3|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
2247483|NCT02509117|5513863|P2|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
2247484|NCT02509117|5513864|P1|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
2247485|NCT02509117|5513855|P10|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
2247486|NCT02509117|5513856|P9|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
2247487|NCT02509117|5513857|P8|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
2247488|NCT02509117|5513858|P7|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
2247489|NCT02509117|5513859|P6|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
2247490|NCT02509117|5513860|P5|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
2247491|NCT02509117|5513861|P4|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
2247492|NCT02509117|5513862|P3|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
2247493|NCT02509117|5513863|P2|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
2247494|NCT02509117|5513864|P1|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
2247495|NCT02509117|5513855|P10|STARTED|Washout Period 3 (Part A: 7 Days)||0
2247496|NCT02509117|5513856|P9|STARTED|Washout Period 3 (Part A: 7 Days)||0
2247497|NCT02509117|5513857|P8|STARTED|Washout Period 3 (Part A: 7 Days)||0
2247498|NCT02509117|5513858|P7|STARTED|Washout Period 3 (Part A: 7 Days)||0
2247499|NCT02509117|5513859|P6|STARTED|Washout Period 3 (Part A: 7 Days)||0
2247500|NCT02509117|5513860|P5|STARTED|Washout Period 3 (Part A: 7 Days)||0
2247501|NCT02509117|5513861|P4|STARTED|Washout Period 3 (Part A: 7 Days)||2
2247502|NCT02509117|5513862|P3|STARTED|Washout Period 3 (Part A: 7 Days)||2
2247503|NCT02509117|5513863|P2|STARTED|Washout Period 3 (Part A: 7 Days)||2
2247504|NCT02509117|5513864|P1|STARTED|Washout Period 3 (Part A: 7 Days)||2
2247505|NCT02509117|5513855|P10|NOT COMPLETED|Period 3 -Part A: 4 Days||0
2247506|NCT02509117|5513856|P9|NOT COMPLETED|Period 3 -Part A: 4 Days||0
2247507|NCT02509117|5513857|P8|NOT COMPLETED|Period 3 -Part A: 4 Days||0
2247508|NCT02509117|5513858|P7|NOT COMPLETED|Period 3 -Part A: 4 Days||0
2247509|NCT02509117|5513859|P6|NOT COMPLETED|Period 3 -Part A: 4 Days||0
2247510|NCT02509117|5513860|P5|NOT COMPLETED|Period 3 -Part A: 4 Days||0
2247511|NCT02509117|5513861|P4|NOT COMPLETED|Period 3 -Part A: 4 Days||0
2247512|NCT02509117|5513862|P3|NOT COMPLETED|Period 3 -Part A: 4 Days||0
2247513|NCT02509117|5513863|P2|NOT COMPLETED|Period 3 -Part A: 4 Days||0
2247514|NCT02509117|5513864|P1|NOT COMPLETED|Period 3 -Part A: 4 Days||0
2247515|NCT02509117|5513855|P10|COMPLETED|Period 3 -Part A: 4 Days||0
2247516|NCT02509117|5513856|P9|COMPLETED|Period 3 -Part A: 4 Days||0
2247517|NCT02509117|5513857|P8|COMPLETED|Period 3 -Part A: 4 Days||0
2247518|NCT02509117|5513858|P7|COMPLETED|Period 3 -Part A: 4 Days||0
2247519|NCT02509117|5513859|P6|COMPLETED|Period 3 -Part A: 4 Days||0
2247520|NCT02509117|5513860|P5|COMPLETED|Period 3 -Part A: 4 Days||0
2247521|NCT02509117|5513861|P4|COMPLETED|Period 3 -Part A: 4 Days||2
2247522|NCT02509117|5513862|P3|COMPLETED|Period 3 -Part A: 4 Days||2
2247523|NCT02509117|5513863|P2|COMPLETED|Period 3 -Part A: 4 Days||2
2247524|NCT02509117|5513864|P1|COMPLETED|Period 3 -Part A: 4 Days||2
2247525|NCT02509117|5513855|P10|STARTED|Period 3 -Part A: 4 Days||0
2247526|NCT02509117|5513856|P9|STARTED|Period 3 -Part A: 4 Days||0
2247527|NCT02509117|5513857|P8|STARTED|Period 3 -Part A: 4 Days||0
2247528|NCT02509117|5513858|P7|STARTED|Period 3 -Part A: 4 Days||0
2247529|NCT02509117|5513859|P6|STARTED|Period 3 -Part A: 4 Days||0
2247530|NCT02509117|5513860|P5|STARTED|Period 3 -Part A: 4 Days||0
2247531|NCT02509117|5513861|P4|STARTED|Period 3 -Part A: 4 Days||2
2247532|NCT02509117|5513862|P3|STARTED|Period 3 -Part A: 4 Days||2
2247533|NCT02509117|5513863|P2|STARTED|Period 3 -Part A: 4 Days||2
2247534|NCT02509117|5513864|P1|STARTED|Period 3 -Part A: 4 Days||2
2247535|NCT02509117|5513855|P10|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
2247536|NCT02509117|5513856|P9|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
2247537|NCT02509117|5513857|P8|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
2247538|NCT02509117|5513858|P7|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
2247539|NCT02509117|5513859|P6|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
2247540|NCT02509117|5513860|P5|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
2247541|NCT02509117|5513861|P4|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
2247542|NCT02509117|5513862|P3|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
2247543|NCT02509117|5513863|P2|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
2247544|NCT02509117|5513864|P1|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
2247545|NCT02509117|5513855|P10|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
2247546|NCT02509117|5513856|P9|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
2247547|NCT02509117|5513857|P8|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
2247548|NCT02509117|5513858|P7|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
2247549|NCT02509117|5513859|P6|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
2247550|NCT02509117|5513860|P5|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
2247551|NCT02509117|5513861|P4|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
2247552|NCT02509117|5513862|P3|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
2247553|NCT02509117|5513863|P2|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
2247554|NCT02509117|5513864|P1|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
2247555|NCT02509117|5513855|P10|STARTED|Washout Period 2 (Part A: 7 Days)||0
2247556|NCT02509117|5513856|P9|STARTED|Washout Period 2 (Part A: 7 Days)||0
2247557|NCT02509117|5513857|P8|STARTED|Washout Period 2 (Part A: 7 Days)||0
2247558|NCT02509117|5513858|P7|STARTED|Washout Period 2 (Part A: 7 Days)||0
2247559|NCT02509117|5513859|P6|STARTED|Washout Period 2 (Part A: 7 Days)||0
2247560|NCT02509117|5513860|P5|STARTED|Washout Period 2 (Part A: 7 Days)||0
2247561|NCT02509117|5513861|P4|STARTED|Washout Period 2 (Part A: 7 Days)||2
2247562|NCT02509117|5513862|P3|STARTED|Washout Period 2 (Part A: 7 Days)||2
2247563|NCT02509117|5513863|P2|STARTED|Washout Period 2 (Part A: 7 Days)||2
2247564|NCT02509117|5513864|P1|STARTED|Washout Period 2 (Part A: 7 Days)||2
2247565|NCT02509117|5513855|P10|NOT COMPLETED|Period 2 -Part A: 4 Days||0
2247566|NCT02509117|5513856|P9|NOT COMPLETED|Period 2 -Part A: 4 Days||0
2247567|NCT02509117|5513857|P8|NOT COMPLETED|Period 2 -Part A: 4 Days||0
2247568|NCT02509117|5513858|P7|NOT COMPLETED|Period 2 -Part A: 4 Days||0
2247569|NCT02509117|5513859|P6|NOT COMPLETED|Period 2 -Part A: 4 Days||0
2247570|NCT02509117|5513860|P5|NOT COMPLETED|Period 2 -Part A: 4 Days||0
2247571|NCT02509117|5513861|P4|NOT COMPLETED|Period 2 -Part A: 4 Days||0
2247572|NCT02509117|5513862|P3|NOT COMPLETED|Period 2 -Part A: 4 Days||0
2247573|NCT02509117|5513863|P2|NOT COMPLETED|Period 2 -Part A: 4 Days||0
2247574|NCT02509117|5513864|P1|NOT COMPLETED|Period 2 -Part A: 4 Days||0
2247575|NCT02509117|5513855|P10|COMPLETED|Period 2 -Part A: 4 Days||0
2247576|NCT02509117|5513856|P9|COMPLETED|Period 2 -Part A: 4 Days||0
2247577|NCT02509117|5513857|P8|COMPLETED|Period 2 -Part A: 4 Days||0
2247578|NCT02509117|5513858|P7|COMPLETED|Period 2 -Part A: 4 Days||0
2247579|NCT02509117|5513859|P6|COMPLETED|Period 2 -Part A: 4 Days||0
2247580|NCT02509117|5513860|P5|COMPLETED|Period 2 -Part A: 4 Days||0
2247581|NCT02509117|5513861|P4|COMPLETED|Period 2 -Part A: 4 Days||2
2247582|NCT02509117|5513862|P3|COMPLETED|Period 2 -Part A: 4 Days||2
2247583|NCT02509117|5513863|P2|COMPLETED|Period 2 -Part A: 4 Days||2
2247584|NCT02509117|5513864|P1|COMPLETED|Period 2 -Part A: 4 Days||2
2247585|NCT02509117|5513855|P10|Treated|Period 2 -Part A: 4 Days||0
2247586|NCT02509117|5513856|P9|Treated|Period 2 -Part A: 4 Days||0
2247587|NCT02509117|5513857|P8|Treated|Period 2 -Part A: 4 Days||0
2247588|NCT02509117|5513858|P7|Treated|Period 2 -Part A: 4 Days||0
2247589|NCT02509117|5513859|P6|Treated|Period 2 -Part A: 4 Days||0
2247590|NCT02509117|5513860|P5|Treated|Period 2 -Part A: 4 Days||0
2247591|NCT02509117|5513861|P4|Treated|Period 2 -Part A: 4 Days||2
2247592|NCT02509117|5513862|P3|Treated|Period 2 -Part A: 4 Days||2
2247593|NCT02509117|5513863|P2|Treated|Period 2 -Part A: 4 Days||2
2247594|NCT02509117|5513864|P1|Treated|Period 2 -Part A: 4 Days||2
2247595|NCT02509117|5513855|P10|STARTED|Period 2 -Part A: 4 Days||0
2247596|NCT02509117|5513856|P9|STARTED|Period 2 -Part A: 4 Days||0
2247597|NCT02509117|5513857|P8|STARTED|Period 2 -Part A: 4 Days||0
2247598|NCT02509117|5513858|P7|STARTED|Period 2 -Part A: 4 Days||0
2247599|NCT02509117|5513859|P6|STARTED|Period 2 -Part A: 4 Days||0
2247600|NCT02509117|5513860|P5|STARTED|Period 2 -Part A: 4 Days||0
2247601|NCT02509117|5513861|P4|STARTED|Period 2 -Part A: 4 Days||2
2247602|NCT02509117|5513862|P3|STARTED|Period 2 -Part A: 4 Days||2
2247603|NCT02509117|5513863|P2|STARTED|Period 2 -Part A: 4 Days|1 participant was added in intervention period 2|2
2247604|NCT02509117|5513864|P1|STARTED|Period 2 -Part A: 4 Days||2
2247605|NCT02509117|5513855|P10|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
2247606|NCT02509117|5513856|P9|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
2247607|NCT02509117|5513857|P8|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
2247608|NCT02509117|5513858|P7|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
2247609|NCT02509117|5513859|P6|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
2247610|NCT02509117|5513860|P5|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
2247611|NCT02509117|5513861|P4|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
2247612|NCT02509117|5513862|P3|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
2247613|NCT02509117|5513863|P2|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
2247614|NCT02509117|5513864|P1|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
2247615|NCT02509117|5513855|P10|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
2247616|NCT02509117|5513856|P9|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
2247617|NCT02509117|5513857|P8|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
2247618|NCT02509117|5513858|P7|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
2247619|NCT02509117|5513859|P6|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
2247620|NCT02509117|5513860|P5|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
2247621|NCT02509117|5513861|P4|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
2247622|NCT02509117|5513862|P3|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
2247623|NCT02509117|5513863|P2|COMPLETED|Washout Period 1 (Part A: 7 Days)||1
2247624|NCT02509117|5513864|P1|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
2247625|NCT02509117|5513855|P10|STARTED|Washout Period 1 (Part A: 7 Days)||0
2247626|NCT02509117|5513856|P9|STARTED|Washout Period 1 (Part A: 7 Days)||0
2247627|NCT02509117|5513857|P8|STARTED|Washout Period 1 (Part A: 7 Days)||0
2247628|NCT02509117|5513858|P7|STARTED|Washout Period 1 (Part A: 7 Days)||0
2247629|NCT02509117|5513859|P6|STARTED|Washout Period 1 (Part A: 7 Days)||0
2247630|NCT02509117|5513860|P5|STARTED|Washout Period 1 (Part A: 7 Days)||0
2247631|NCT02509117|5513861|P4|STARTED|Washout Period 1 (Part A: 7 Days)||2
2247632|NCT02509117|5513862|P3|STARTED|Washout Period 1 (Part A: 7 Days)||2
2247633|NCT02509117|5513863|P2|STARTED|Washout Period 1 (Part A: 7 Days)||1
2247634|NCT02509117|5513864|P1|STARTED|Washout Period 1 (Part A: 7 Days)||2
2247635|NCT02509117|5513855|P10|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
2247636|NCT02509117|5513856|P9|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
2247637|NCT02509117|5513857|P8|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
2247638|NCT02509117|5513858|P7|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
2247639|NCT02509117|5513859|P6|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
2247640|NCT02509117|5513860|P5|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
2247641|NCT02509117|5513861|P4|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
2247642|NCT02509117|5513862|P3|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
2247643|NCT02509117|5513863|P2|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||1
2247644|NCT02509117|5513864|P1|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
2247645|NCT02509117|5513855|P10|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
2247646|NCT02509117|5513856|P9|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||4
2247647|NCT02509117|5513857|P8|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
2247648|NCT02509117|5513858|P7|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
2247649|NCT02509117|5513859|P6|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
2247650|NCT02509117|5513860|P5|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
2247651|NCT02509117|5513861|P4|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
2247652|NCT02509117|5513862|P3|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
2247653|NCT02509117|5513863|P2|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||1
2247654|NCT02509117|5513864|P1|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
2247655|NCT02509117|5513855|P10|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||10
2247656|NCT02509117|5513856|P9|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||4
2247657|NCT02509117|5513857|P8|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
2247658|NCT02509117|5513858|P7|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
2247659|NCT02509117|5513859|P6|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
2247660|NCT02509117|5513860|P5|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
2247661|NCT02509117|5513861|P4|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
2247662|NCT02509117|5513862|P3|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
2247663|NCT02509117|5513863|P2|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||1
2247664|NCT02509117|5513864|P1|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
2247665|NCT02509117|5513855|P10|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||10
2247666|NCT02509117|5513856|P9|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||4
2247667|NCT02509117|5513857|P8|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
2247668|NCT02509117|5513858|P7|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
2247669|NCT02509117|5513859|P6|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
2247670|NCT02509117|5513860|P5|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
2247671|NCT02509117|5513861|P4|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
2247672|NCT02509117|5513862|P3|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
2247673|NCT02509117|5513863|P2|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
2247674|NCT02509117|5513864|P1|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
2247675|NCT02509078|5514075|P2|NOT COMPLETED|Overall Study||1
2247676|NCT02509078|5514076|P1|NOT COMPLETED|Overall Study||1
2247677|NCT02509078|5514075|P2|COMPLETED|Overall Study||505
2247678|NCT02509078|5514076|P1|COMPLETED|Overall Study||501
2247679|NCT02509078|5514075|P2|STARTED|Overall Study||506
2247680|NCT02509078|5514076|P1|STARTED|Overall Study||502
2247681|NCT02509065|5514112|P23|NOT COMPLETED|Overall Study||0
2247682|NCT02509065|5514113|P22|NOT COMPLETED|Overall Study||0
2247683|NCT02509065|5514114|P21|NOT COMPLETED|Overall Study||0
2247684|NCT02509065|5514115|P20|NOT COMPLETED|Overall Study||0
2247685|NCT02509065|5514116|P19|NOT COMPLETED|Overall Study||0
2247686|NCT02509065|5514117|P18|NOT COMPLETED|Overall Study||0
2247687|NCT02509065|5514118|P17|NOT COMPLETED|Overall Study||0
2247688|NCT02509065|5514119|P16|NOT COMPLETED|Overall Study||0
2247689|NCT02509065|5514120|P15|NOT COMPLETED|Overall Study||0
2247690|NCT02509065|5514121|P14|NOT COMPLETED|Overall Study||0
2247691|NCT02509065|5514122|P13|NOT COMPLETED|Overall Study||0
2247692|NCT02509065|5514123|P12|NOT COMPLETED|Overall Study||0
2247693|NCT02509065|5514124|P11|NOT COMPLETED|Overall Study||0
2247694|NCT02509065|5514125|P10|NOT COMPLETED|Overall Study||0
2247695|NCT02509065|5514126|P9|NOT COMPLETED|Overall Study||0
2247696|NCT02509065|5514127|P8|NOT COMPLETED|Overall Study||0
2247697|NCT02509065|5514128|P7|NOT COMPLETED|Overall Study||0
2247698|NCT02509065|5514129|P6|NOT COMPLETED|Overall Study||0
2247699|NCT02509065|5514130|P5|NOT COMPLETED|Overall Study||0
2247700|NCT02509065|5514131|P4|NOT COMPLETED|Overall Study||0
2247701|NCT02509065|5514132|P3|NOT COMPLETED|Overall Study||0
2247702|NCT02509065|5514133|P2|NOT COMPLETED|Overall Study||0
2247703|NCT02509065|5514134|P1|NOT COMPLETED|Overall Study||0
2247704|NCT02509065|5514112|P23|COMPLETED|Overall Study||1
2247705|NCT02509065|5514113|P22|COMPLETED|Overall Study||1
2247706|NCT02509065|5514114|P21|COMPLETED|Overall Study||1
2247707|NCT02509065|5514115|P20|COMPLETED|Overall Study||1
2247708|NCT02509065|5514116|P19|COMPLETED|Overall Study||1
2247709|NCT02509065|5514117|P18|COMPLETED|Overall Study||1
2247710|NCT02509065|5514118|P17|COMPLETED|Overall Study||1
2247711|NCT02509065|5514119|P16|COMPLETED|Overall Study||1
2247712|NCT02509065|5514120|P15|COMPLETED|Overall Study||1
2247713|NCT02509065|5514121|P14|COMPLETED|Overall Study||1
2247714|NCT02509065|5514122|P13|COMPLETED|Overall Study||1
2247715|NCT02509065|5514123|P12|COMPLETED|Overall Study||1
2247716|NCT02509065|5514124|P11|COMPLETED|Overall Study||1
2247717|NCT02509065|5514125|P10|COMPLETED|Overall Study||1
2247718|NCT02509065|5514126|P9|COMPLETED|Overall Study||1
2247719|NCT02509065|5514127|P8|COMPLETED|Overall Study||1
2247720|NCT02509065|5514128|P7|COMPLETED|Overall Study||1
2247721|NCT02509065|5514129|P6|COMPLETED|Overall Study||1
2247722|NCT02509065|5514130|P5|COMPLETED|Overall Study||1
2247723|NCT02509065|5514131|P4|COMPLETED|Overall Study||1
2247724|NCT02509065|5514132|P3|COMPLETED|Overall Study||2
2247725|NCT02509065|5514133|P2|COMPLETED|Overall Study||1
2247726|NCT02509065|5514134|P1|COMPLETED|Overall Study||1
2247727|NCT02509065|5514112|P23|STARTED|Overall Study||1
2247728|NCT02509065|5514113|P22|STARTED|Overall Study||1
2247729|NCT02509065|5514114|P21|STARTED|Overall Study||1
2247730|NCT02509065|5514115|P20|STARTED|Overall Study||1
2247731|NCT02509065|5514116|P19|STARTED|Overall Study||1
2247732|NCT02509065|5514117|P18|STARTED|Overall Study||1
2247733|NCT02509065|5514118|P17|STARTED|Overall Study||1
2247734|NCT02509065|5514119|P16|STARTED|Overall Study||1
2247735|NCT02509065|5514120|P15|STARTED|Overall Study||1
2247736|NCT02509065|5514121|P14|STARTED|Overall Study||1
2247737|NCT02509065|5514122|P13|STARTED|Overall Study||1
2247738|NCT02509065|5514123|P12|STARTED|Overall Study||1
2247739|NCT02509065|5514124|P11|STARTED|Overall Study||1
2247740|NCT02509065|5514125|P10|STARTED|Overall Study||1
2247741|NCT02509065|5514126|P9|STARTED|Overall Study||1
2247742|NCT02509065|5514127|P8|STARTED|Overall Study||1
2247743|NCT02509065|5514128|P7|STARTED|Overall Study||1
2247744|NCT02509065|5514129|P6|STARTED|Overall Study||1
2247745|NCT02509065|5514130|P5|STARTED|Overall Study||1
2247746|NCT02509065|5514131|P4|STARTED|Overall Study||1
2247747|NCT02509065|5514132|P3|STARTED|Overall Study||2
2247748|NCT02509065|5514133|P2|STARTED|Overall Study||1
2247749|NCT02509065|5514134|P1|STARTED|Overall Study||1
2247750|NCT02508935|5514219|P1|NOT COMPLETED|Overall Study||23
2247751|NCT02508935|5514219|P1|COMPLETED|Overall Study||0
2247752|NCT02508935|5514219|P1|STARTED|Overall Study||23
2247753|NCT02508701|5514235|P4|NOT COMPLETED|Overall Study||3
2247754|NCT02508701|5514236|P3|NOT COMPLETED|Overall Study||5
2247755|NCT02508701|5514237|P2|NOT COMPLETED|Overall Study||5
2247756|NCT02508701|5514238|P1|NOT COMPLETED|Overall Study||9
2247757|NCT02508701|5514235|P4|COMPLETED|Overall Study||1
2247758|NCT02508701|5514236|P3|COMPLETED|Overall Study||0
2247759|NCT02508701|5514237|P2|COMPLETED|Overall Study||1
2247760|NCT02508701|5514238|P1|COMPLETED|Overall Study||0
2247761|NCT02508701|5514235|P4|STARTED|Overall Study||4
2247762|NCT02508701|5514236|P3|STARTED|Overall Study||5
2247763|NCT02508701|5514237|P2|STARTED|Overall Study||6
2247764|NCT02508701|5514238|P1|STARTED|Overall Study||9
2247765|NCT02508259|5514262|P2|NOT COMPLETED|Overall Study||0
2247766|NCT02508259|5514263|P1|NOT COMPLETED|Overall Study||0
2247767|NCT02508259|5514262|P2|COMPLETED|Overall Study||5
2247768|NCT02508259|5514263|P1|COMPLETED|Overall Study||5
2247769|NCT02508259|5514262|P2|STARTED|Overall Study||5
2247770|NCT02508259|5514263|P1|STARTED|Overall Study||5
2247771|NCT02508207|5514281|P2|NOT COMPLETED|Overall Study||0
2247772|NCT02508207|5514282|P1|NOT COMPLETED|Overall Study||0
2247773|NCT02508207|5514281|P2|COMPLETED|Overall Study||27
2247774|NCT02508207|5514282|P1|COMPLETED|Overall Study||7
2247775|NCT02508207|5514281|P2|STARTED|Overall Study||27
2247776|NCT02508207|5514282|P1|STARTED|Overall Study||7
2247777|NCT02508194|5514298|P2|NOT COMPLETED|Overall Study||44
2247778|NCT02508194|5514299|P1|NOT COMPLETED|Overall Study||52
2247779|NCT02508194|5514298|P2|COMPLETED|Overall Study||907
2247780|NCT02508194|5514299|P1|COMPLETED|Overall Study||897
2247781|NCT02508194|5514298|P2|STARTED|Overall Study||951
2247782|NCT02508194|5514299|P1|STARTED|Overall Study||949
2247783|NCT02508116|5514339|P2|NOT COMPLETED|Overall Study||7
2247784|NCT02508116|5514340|P1|NOT COMPLETED|Overall Study||8
2247785|NCT02508116|5514339|P2|COMPLETED|Overall Study||250
2247786|NCT02508116|5514340|P1|COMPLETED|Overall Study||244
2247787|NCT02508116|5514339|P2|Received Intervention as Randomized|Overall Study||255
2247788|NCT02508116|5514340|P1|Received Intervention as Randomized|Overall Study||249
2247789|NCT02508116|5514339|P2|STARTED|Overall Study||257
2247790|NCT02508116|5514340|P1|STARTED|Overall Study||252
2247791|NCT02508103|5514354|P2|NOT COMPLETED|Overall Study||0
2247792|NCT02508103|5514355|P1|NOT COMPLETED|Overall Study||0
2247793|NCT02508103|5514354|P2|COMPLETED|Overall Study||5
2247794|NCT02508103|5514355|P1|COMPLETED|Overall Study||5
2247795|NCT02508103|5514354|P2|STARTED|Overall Study||5
2247796|NCT02508103|5514355|P1|STARTED|Overall Study||5
2247797|NCT02508077|5514363|P1|NOT COMPLETED|Overall Study||0
2247798|NCT02508077|5514363|P1|COMPLETED|Overall Study||1
2247799|NCT02508077|5514363|P1|STARTED|Overall Study||1
2247800|NCT02507973|5514367|P1|NOT COMPLETED|Overall Study||1
2247801|NCT02507973|5514367|P1|COMPLETED|Overall Study||7
2247802|NCT02507973|5514367|P1|STARTED|Overall Study||8
2247803|NCT02507752|5514373|P1|NOT COMPLETED|Overall Study||17
2247804|NCT02507752|5514373|P1|COMPLETED|Overall Study||55
2247805|NCT02507752|5514373|P1|STARTED|Overall Study||72
2247806|NCT02507388|5514393|P2|NOT COMPLETED|Overall Study||0
2247807|NCT02507388|5514394|P1|NOT COMPLETED|Overall Study||0
2247808|NCT02507388|5514393|P2|COMPLETED|Overall Study||25
2247809|NCT02507388|5514394|P1|COMPLETED|Overall Study||25
2247810|NCT02507388|5514393|P2|STARTED|Overall Study||25
2247811|NCT02507388|5514394|P1|STARTED|Overall Study||25
2247812|NCT02507375|5514417|P2|NOT COMPLETED|Overall Study||8
2247813|NCT02507375|5514418|P1|NOT COMPLETED|Overall Study||4
2247814|NCT02507375|5514417|P2|COMPLETED|Overall Study||1
2247815|NCT02507375|5514418|P1|COMPLETED|Overall Study||2
2247816|NCT02507375|5514417|P2|Extension Period|Overall Study||1
2247817|NCT02507375|5514418|P1|Extension Period|Overall Study||2
2247818|NCT02507375|5514417|P2|Cycle 6|Overall Study||1
2247819|NCT02507375|5514418|P1|Cycle 6|Overall Study||3
2247820|NCT02507375|5514417|P2|Cycle 5|Overall Study||1
2247821|NCT02507375|5514418|P1|Cycle 5|Overall Study||3
2247822|NCT02507375|5514417|P2|Cycle 4|Overall Study||2
2247823|NCT02507375|5514418|P1|Cycle 4|Overall Study||4
2247824|NCT02507375|5514417|P2|Cycle 3|Overall Study||5
2247825|NCT02507375|5514418|P1|Cycle 3|Overall Study||4
2247826|NCT02507375|5514417|P2|Cycle 2|Overall Study||5
2247827|NCT02507375|5514418|P1|Cycle 2|Overall Study||5
2247828|NCT02507375|5514417|P2|Received Pertuzumab|Overall Study||6
2247829|NCT02507375|5514418|P1|Received Pertuzumab|Overall Study||6
2247830|NCT02507375|5514417|P2|Cycle 1|Overall Study||9
2247831|NCT02507375|5514418|P1|Cycle 1|Overall Study||6
2247832|NCT02507375|5514417|P2|STARTED|Overall Study|Two patients in cohort 2 did not begin treatment in Cycle 1 so were not included in the analysis set|9
2247833|NCT02507375|5514418|P1|STARTED|Overall Study||6
2247834|NCT02507349|5514437|P2|NOT COMPLETED|Overall Study||161
2247835|NCT02507349|5514438|P1|NOT COMPLETED|Overall Study||187
2247836|NCT02507349|5514437|P2|COMPLETED|Overall Study||1050
2247837|NCT02507349|5514438|P1|COMPLETED|Overall Study||1045
2247838|NCT02507349|5514437|P2|STARTED|Overall Study||1211
2247839|NCT02507349|5514438|P1|STARTED|Overall Study||1232
2247840|NCT02507219|5514462|P6|NOT COMPLETED|Overall Study||0
2247841|NCT02507219|5514463|P5|NOT COMPLETED|Overall Study||1
2247842|NCT02507219|5514464|P4|NOT COMPLETED|Overall Study||0
2247843|NCT02507219|5514465|P3|NOT COMPLETED|Overall Study||0
2247844|NCT02507219|5514466|P2|NOT COMPLETED|Overall Study||0
2247845|NCT02507219|5514467|P1|NOT COMPLETED|Overall Study||1
2247846|NCT02507219|5514462|P6|COMPLETED|Overall Study||3
2247847|NCT02507219|5514463|P5|COMPLETED|Overall Study||3
2247848|NCT02507219|5514464|P4|COMPLETED|Overall Study||3
2247849|NCT02507219|5514465|P3|COMPLETED|Overall Study||3
2247850|NCT02507219|5514466|P2|COMPLETED|Overall Study||4
2247851|NCT02507219|5514467|P1|COMPLETED|Overall Study||4
2247852|NCT02507219|5514462|P6|STARTED|Overall Study||3
2247853|NCT02507219|5514463|P5|STARTED|Overall Study||4
2247854|NCT02507219|5514464|P4|STARTED|Overall Study||3
2247855|NCT02507219|5514465|P3|STARTED|Overall Study||3
2247856|NCT02507219|5514466|P2|STARTED|Overall Study||4
2247857|NCT02507219|5514467|P1|STARTED|Overall Study||5
2247858|NCT02506985|5514477|P2|NOT COMPLETED|Overall Study||0
2247859|NCT02506985|5514478|P1|NOT COMPLETED|Overall Study||0
2247860|NCT02506985|5514477|P2|COMPLETED|Overall Study||6
2247861|NCT02506985|5514478|P1|COMPLETED|Overall Study||4
2247862|NCT02506985|5514477|P2|STARTED|Overall Study||6
2247863|NCT02506985|5514478|P1|STARTED|Overall Study||4
2247864|NCT02506881|5514496|P4|NOT COMPLETED|Second Intervention (Day 1)||0
2247865|NCT02506881|5514497|P3|NOT COMPLETED|Second Intervention (Day 1)||0
2247866|NCT02506881|5514498|P2|NOT COMPLETED|Second Intervention (Day 1)||0
2247867|NCT02506881|5514499|P1|NOT COMPLETED|Second Intervention (Day 1)||0
2247868|NCT02506881|5514496|P4|COMPLETED|Second Intervention (Day 1)||12
2247869|NCT02506881|5514497|P3|COMPLETED|Second Intervention (Day 1)||12
2247870|NCT02506881|5514498|P2|COMPLETED|Second Intervention (Day 1)||12
2247871|NCT02506881|5514499|P1|COMPLETED|Second Intervention (Day 1)||12
2247872|NCT02506881|5514496|P4|STARTED|Second Intervention (Day 1)||12
2247873|NCT02506881|5514497|P3|STARTED|Second Intervention (Day 1)||12
2247874|NCT02506881|5514498|P2|STARTED|Second Intervention (Day 1)||12
2247875|NCT02506881|5514499|P1|STARTED|Second Intervention (Day 1)||12
2247876|NCT02506881|5514496|P4|NOT COMPLETED|Washout (at Least 25 Days)||0
2247877|NCT02506881|5514497|P3|NOT COMPLETED|Washout (at Least 25 Days)||0
2247878|NCT02506881|5514498|P2|NOT COMPLETED|Washout (at Least 25 Days)||0
2247879|NCT02506881|5514499|P1|NOT COMPLETED|Washout (at Least 25 Days)||0
2247880|NCT02506881|5514496|P4|COMPLETED|Washout (at Least 25 Days)||12
2247881|NCT02506881|5514497|P3|COMPLETED|Washout (at Least 25 Days)||12
2247882|NCT02506881|5514498|P2|COMPLETED|Washout (at Least 25 Days)||12
2247883|NCT02506881|5514499|P1|COMPLETED|Washout (at Least 25 Days)||12
2247884|NCT02506881|5514496|P4|STARTED|Washout (at Least 25 Days)||12
2247885|NCT02506881|5514497|P3|STARTED|Washout (at Least 25 Days)||12
2247886|NCT02506881|5514498|P2|STARTED|Washout (at Least 25 Days)||12
2247887|NCT02506881|5514499|P1|STARTED|Washout (at Least 25 Days)||12
2247888|NCT02506881|5514496|P4|NOT COMPLETED|First Intervention (Day 1)||12
2247889|NCT02506881|5514497|P3|NOT COMPLETED|First Intervention (Day 1)||13
2247890|NCT02506881|5514498|P2|NOT COMPLETED|First Intervention (Day 1)||0
2247891|NCT02506881|5514499|P1|NOT COMPLETED|First Intervention (Day 1)||1
2247892|NCT02506881|5514496|P4|COMPLETED|First Intervention (Day 1)||12
2247893|NCT02506881|5514497|P3|COMPLETED|First Intervention (Day 1)||12
2247894|NCT02506881|5514498|P2|COMPLETED|First Intervention (Day 1)||12
2247895|NCT02506881|5514499|P1|COMPLETED|First Intervention (Day 1)||12
2247896|NCT02506881|5514496|P4|STARTED|First Intervention (Day 1)||24
2247897|NCT02506881|5514497|P3|STARTED|First Intervention (Day 1)||25
2247898|NCT02506881|5514498|P2|STARTED|First Intervention (Day 1)||12
2247899|NCT02506881|5514499|P1|STARTED|First Intervention (Day 1)||13
2247900|NCT02506868|5514535|P2|NOT COMPLETED|Additional Period of Study (Until 52W)||5
2247901|NCT02506868|5514536|P1|NOT COMPLETED|Additional Period of Study (Until 52W)||3
2247902|NCT02506868|5514535|P2|COMPLETED|Additional Period of Study (Until 52W)||85
2247903|NCT02506868|5514536|P1|COMPLETED|Additional Period of Study (Until 52W)||83
2247904|NCT02506868|5514535|P2|STARTED|Additional Period of Study (Until 52W)||90
2247905|NCT02506868|5514536|P1|STARTED|Additional Period of Study (Until 52W)||86
2247906|NCT02506868|5514535|P2|NOT COMPLETED|Main Period of Study (24 Weeks)||8
2247907|NCT02506868|5514536|P1|NOT COMPLETED|Main Period of Study (24 Weeks)||12
2247908|NCT02506868|5514535|P2|COMPLETED|Main Period of Study (24 Weeks)||90
2247909|NCT02506868|5514536|P1|COMPLETED|Main Period of Study (24 Weeks)||86
2247910|NCT02506868|5514535|P2|Per Protocol Population|Main Period of Study (24 Weeks)||90
2247911|NCT02506868|5514536|P1|Per Protocol Population|Main Period of Study (24 Weeks)||86
2247912|NCT02506868|5514535|P2|mITT Population|Main Period of Study (24 Weeks)|One patient from Aranesp group was excluded prior to the first administration|97
2247913|NCT02506868|5514536|P1|mITT Population|Main Period of Study (24 Weeks)||98
2247914|NCT02506868|5514535|P2|STARTED|Main Period of Study (24 Weeks)||98
2247915|NCT02506868|5514536|P1|STARTED|Main Period of Study (24 Weeks)||98
2247916|NCT02506816|5514572|P1|NOT COMPLETED|Overall Study||3
2247917|NCT02506816|5514572|P1|COMPLETED|Overall Study||33
2247918|NCT02506816|5514572|P1|Samples Availability|Overall Study|31 of 36 patients had valid samples for analysis of biomarkers (primary and secondary analysis)|31
2247919|NCT02506816|5514572|P1|STARTED|Overall Study||36
2247920|NCT02506673|5514581|P2|NOT COMPLETED|Overall Study||0
2247921|NCT02506673|5514582|P1|NOT COMPLETED|Overall Study||0
2247922|NCT02506673|5514581|P2|COMPLETED|Overall Study||13
2247923|NCT02506673|5514582|P1|COMPLETED|Overall Study||13
2247924|NCT02506673|5514581|P2|STARTED|Overall Study||13
2247925|NCT02506673|5514582|P1|STARTED|Overall Study||13
2247926|NCT02506660|5514614|P2|NOT COMPLETED|Overall Study||1
2247927|NCT02506660|5514615|P1|NOT COMPLETED|Overall Study||2
2247928|NCT02506660|5514614|P2|COMPLETED|Overall Study||63
2247929|NCT02506660|5514615|P1|COMPLETED|Overall Study||62
2247930|NCT02506660|5514614|P2|STARTED|Overall Study||64
2247931|NCT02506660|5514615|P1|STARTED|Overall Study||64
2247932|NCT02506634|5514641|P1|NOT COMPLETED|Overall Study||17
2247933|NCT02506634|5514641|P1|COMPLETED|Overall Study||357
2247934|NCT02506634|5514641|P1|Participants Who Finished GERDQ|Overall Study||342
2247935|NCT02506634|5514641|P1|Participants Who Received PPI Treatment|Overall Study||357
2247936|NCT02506634|5514641|P1|Participants Who Were Diagnosed as GERD|Overall Study||154
2247937|NCT02506634|5514641|P1|STARTED|Overall Study||374
2247944|NCT02506257|5514698|P4|NOT COMPLETED|Overall Study||0
2247945|NCT02506257|5514699|P3|NOT COMPLETED|Overall Study||4
2247946|NCT02506257|5514700|P2|NOT COMPLETED|Overall Study||2
2247947|NCT02506257|5514701|P1|NOT COMPLETED|Overall Study||0
2247948|NCT02506257|5514698|P4|COMPLETED|Overall Study||9
2247949|NCT02506257|5514699|P3|COMPLETED|Overall Study||23
2247950|NCT02506257|5514700|P2|COMPLETED|Overall Study||26
2247951|NCT02506257|5514701|P1|COMPLETED|Overall Study||26
2247952|NCT02506257|5514698|P4|STARTED|Overall Study||9
2247953|NCT02506257|5514699|P3|STARTED|Overall Study||27
2247954|NCT02506257|5514700|P2|STARTED|Overall Study||28
2247955|NCT02506257|5514701|P1|STARTED|Overall Study||26
2247956|NCT02506101|5514733|P2|NOT COMPLETED|Overall Study||0
2247957|NCT02506101|5514734|P1|NOT COMPLETED|Overall Study||2
2247958|NCT02506101|5514733|P2|COMPLETED|Overall Study||0
2247959|NCT02506101|5514734|P1|COMPLETED|Overall Study||0
2247960|NCT02506101|5514733|P2|STARTED|Overall Study||0
2247961|NCT02506101|5514734|P1|STARTED|Overall Study||2
2247962|NCT02506036|5514750|P2|NOT COMPLETED|Second Intervention (4-6 Weeks)||0
2247963|NCT02506036|5514751|P1|NOT COMPLETED|Second Intervention (4-6 Weeks)||0
2247964|NCT02506036|5514750|P2|COMPLETED|Second Intervention (4-6 Weeks)||1
2247965|NCT02506036|5514751|P1|COMPLETED|Second Intervention (4-6 Weeks)||2
2247966|NCT02506036|5514750|P2|STARTED|Second Intervention (4-6 Weeks)||1
2247967|NCT02506036|5514751|P1|STARTED|Second Intervention (4-6 Weeks)||2
2247968|NCT02506036|5514750|P2|NOT COMPLETED|Washout (1-2 Weeks)||0
2247969|NCT02506036|5514751|P1|NOT COMPLETED|Washout (1-2 Weeks)||0
2247970|NCT02506036|5514750|P2|COMPLETED|Washout (1-2 Weeks)||1
2247971|NCT02506036|5514751|P1|COMPLETED|Washout (1-2 Weeks)||2
2247972|NCT02506036|5514750|P2|STARTED|Washout (1-2 Weeks)||1
2247973|NCT02506036|5514751|P1|STARTED|Washout (1-2 Weeks)||2
2247974|NCT02506036|5514750|P2|NOT COMPLETED|First Intervention (4-6 Weeks)||2
2247975|NCT02506036|5514751|P1|NOT COMPLETED|First Intervention (4-6 Weeks)||1
2247976|NCT02506036|5514750|P2|COMPLETED|First Intervention (4-6 Weeks)||1
2247977|NCT02506036|5514751|P1|COMPLETED|First Intervention (4-6 Weeks)||2
2247978|NCT02506036|5514750|P2|STARTED|First Intervention (4-6 Weeks)||3
2247979|NCT02506036|5514751|P1|STARTED|First Intervention (4-6 Weeks)||3
2247980|NCT02505945|5514759|P2|NOT COMPLETED|Overall Study||4
2247981|NCT02505945|5514760|P1|NOT COMPLETED|Overall Study||22
2247982|NCT02505945|5514759|P2|COMPLETED|Overall Study||46
2247983|NCT02505945|5514760|P1|COMPLETED|Overall Study||80
2247984|NCT02505945|5514759|P2|STARTED|Overall Study||50
2247985|NCT02505945|5514760|P1|STARTED|Overall Study||102
2247986|NCT02505867|5514770|P2|NOT COMPLETED|Overall Study||6
2247987|NCT02505867|5514771|P1|NOT COMPLETED|Overall Study||6
2247988|NCT02505867|5514770|P2|COMPLETED|Overall Study||0
2247989|NCT02505867|5514771|P1|COMPLETED|Overall Study||0
2247990|NCT02505867|5514770|P2|STARTED|Overall Study||6
2247991|NCT02505867|5514771|P1|STARTED|Overall Study||6
2247992|NCT02505334|5514779|P2|NOT COMPLETED|Extension Treatment Period||0
2247993|NCT02505334|5514780|P1|NOT COMPLETED|Extension Treatment Period||18
2247994|NCT02505334|5514779|P2|COMPLETED|Extension Treatment Period||0
2247995|NCT02505334|5514780|P1|COMPLETED|Extension Treatment Period||194
2247996|NCT02505334|5514779|P2|STARTED|Extension Treatment Period|This treatment arm is not considered for this period as the subjects were treated for 26 weeks|0
2247997|NCT02505334|5514780|P1|STARTED|Extension Treatment Period|6 subjects withdrew from the trial after the main period and prior to entering the extension period|212
2247998|NCT02505334|5514779|P2|NOT COMPLETED|Main Treatment Period||39
2247999|NCT02505334|5514780|P1|NOT COMPLETED|Main Treatment Period||15
2248000|NCT02505334|5514779|P2|COMPLETED|Main Treatment Period||194
2248001|NCT02505334|5514780|P1|COMPLETED|Main Treatment Period||218
2248002|NCT02505334|5514779|P2|STARTED|Main Treatment Period||233
2248003|NCT02505334|5514780|P1|STARTED|Main Treatment Period||233
2248004|NCT02504931|5514907|P2|NOT COMPLETED|Overall Study||10
2248005|NCT02504931|5514908|P1|NOT COMPLETED|Overall Study||12
2248006|NCT02504931|5514907|P2|COMPLETED|Overall Study||13
2248007|NCT02504931|5514908|P1|COMPLETED|Overall Study||14
2248008|NCT02504931|5514907|P2|STARTED|Overall Study||23
2248009|NCT02504931|5514908|P1|STARTED|Overall Study||26
2248010|NCT02504892|5514916|P1|NOT COMPLETED|Overall Study||2
2248011|NCT02504892|5514916|P1|COMPLETED|Overall Study||1
2248012|NCT02504892|5514916|P1|STARTED|Overall Study||3
2248013|NCT02504827|5514923|P1|NOT COMPLETED|Overall Study||1
2248014|NCT02504827|5514923|P1|COMPLETED|Overall Study||11
2248015|NCT02504827|5514923|P1|STARTED|Overall Study||12
2248016|NCT02504775|5514928|P2|NOT COMPLETED|Period 2||0
2248017|NCT02504775|5514929|P1|NOT COMPLETED|Period 2||0
2248018|NCT02504775|5514928|P2|COMPLETED|Period 2||14
2248019|NCT02504775|5514929|P1|COMPLETED|Period 2||14
2248020|NCT02504775|5514928|P2|STARTED|Period 2||14
2248021|NCT02504775|5514929|P1|STARTED|Period 2||14
2248022|NCT02504775|5514928|P2|NOT COMPLETED|Washout||0
2248023|NCT02504775|5514929|P1|NOT COMPLETED|Washout||0
2248024|NCT02504775|5514928|P2|COMPLETED|Washout||14
2248025|NCT02504775|5514929|P1|COMPLETED|Washout||14
2248026|NCT02504775|5514928|P2|STARTED|Washout||14
2248027|NCT02504775|5514929|P1|STARTED|Washout||14
2248028|NCT02504775|5514928|P2|NOT COMPLETED|Period 1||0
2248029|NCT02504775|5514929|P1|NOT COMPLETED|Period 1||0
2248030|NCT02504775|5514928|P2|COMPLETED|Period 1||14
2248031|NCT02504775|5514929|P1|COMPLETED|Period 1||14
2248032|NCT02504775|5514928|P2|STARTED|Period 1||14
2248033|NCT02504775|5514929|P1|STARTED|Period 1||14
2248034|NCT02504723|5514943|P2|NOT COMPLETED|Overall Study||0
2248035|NCT02504723|5514944|P1|NOT COMPLETED|Overall Study||0
2248036|NCT02504723|5514943|P2|COMPLETED|Overall Study||61
2248037|NCT02504723|5514944|P1|COMPLETED|Overall Study||60
2248038|NCT02504723|5514943|P2|STARTED|Overall Study||61
2248039|NCT02504723|5514944|P1|STARTED|Overall Study||60
2248040|NCT02504671|5514962|P6|NOT COMPLETED|Overall Study||14
2248041|NCT02504671|5514963|P5|NOT COMPLETED|Overall Study||12
2248042|NCT02504671|5514964|P4|NOT COMPLETED|Overall Study||10
2248043|NCT02504671|5514965|P3|NOT COMPLETED|Overall Study||10
2248044|NCT02504671|5514966|P2|NOT COMPLETED|Overall Study||14
2248045|NCT02504671|5514967|P1|NOT COMPLETED|Overall Study||12
2248046|NCT02504671|5514962|P6|COMPLETED|Overall Study||23
2248047|NCT02504671|5514963|P5|COMPLETED|Overall Study||25
2248048|NCT02504671|5514964|P4|COMPLETED|Overall Study||27
2248049|NCT02504671|5514965|P3|COMPLETED|Overall Study||27
2248050|NCT02504671|5514966|P2|COMPLETED|Overall Study||23
2248051|NCT02504671|5514967|P1|COMPLETED|Overall Study||25
2248052|NCT02504671|5514962|P6|STARTED|Overall Study||37
2248053|NCT02504671|5514963|P5|STARTED|Overall Study||37
2248054|NCT02504671|5514964|P4|STARTED|Overall Study||37
2248055|NCT02504671|5514965|P3|STARTED|Overall Study||37
2248056|NCT02504671|5514966|P2|STARTED|Overall Study||37
2248057|NCT02504671|5514967|P1|STARTED|Overall Study||37
2248058|NCT02504645|5515109|P2|NOT COMPLETED|Overall Study||25
2248059|NCT02504645|5515110|P1|NOT COMPLETED|Overall Study||24
2248060|NCT02504645|5515109|P2|COMPLETED|Overall Study||76
2248061|NCT02504645|5515110|P1|COMPLETED|Overall Study||77
2248062|NCT02504645|5515109|P2|STARTED|Overall Study||101
2248063|NCT02504645|5515110|P1|STARTED|Overall Study||101
2248064|NCT02504619|5515118|P1|NOT COMPLETED|Overall Study||0
2248065|NCT02504619|5515118|P1|COMPLETED|Overall Study||1
2248066|NCT02504619|5515118|P1|STARTED|Overall Study||1
2248067|NCT02504554|5515126|P2|NOT COMPLETED|Overall Study||0
2248068|NCT02504554|5515127|P1|NOT COMPLETED|Overall Study||0
2248069|NCT02504554|5515126|P2|COMPLETED|Overall Study||6
2248070|NCT02504554|5515127|P1|COMPLETED|Overall Study||12
2248071|NCT02504554|5515126|P2|STARTED|Overall Study||6
2248072|NCT02504554|5515127|P1|STARTED|Overall Study|1 participant was switched from the oral group to the rectal group due to nausea/vomiting.|12
2248073|NCT02504541|5515139|P1|NOT COMPLETED|Overall Study||20
2248074|NCT02504541|5515139|P1|COMPLETED|Overall Study||113
2248075|NCT02504541|5515139|P1|STARTED|Overall Study||133
2248076|NCT02504502|5515145|P2|NOT COMPLETED|Crossover to Enhanced Report||0
2248077|NCT02504502|5515146|P1|NOT COMPLETED|Crossover to Enhanced Report||5
2248078|NCT02504502|5515145|P2|COMPLETED|Crossover to Enhanced Report|the enhanced report arm was completed in first period and does not carry forward to period 2|0
2248079|NCT02504502|5515146|P1|COMPLETED|Crossover to Enhanced Report||15
2248080|NCT02504502|5515145|P2|STARTED|Crossover to Enhanced Report|The enhanced report arm was completed in first period and does not carry forward to period 2.|0
2248081|NCT02504502|5515146|P1|STARTED|Crossover to Enhanced Report||20
2248082|NCT02504502|5515145|P2|NOT COMPLETED|Routine Care vs. Enhanced Report||7
2248083|NCT02504502|5515146|P1|NOT COMPLETED|Routine Care vs. Enhanced Report||4
2248084|NCT02504502|5515145|P2|COMPLETED|Routine Care vs. Enhanced Report||21
2248085|NCT02504502|5515146|P1|COMPLETED|Routine Care vs. Enhanced Report||20
2248086|NCT02504502|5515145|P2|STARTED|Routine Care vs. Enhanced Report||28
2248087|NCT02504502|5515146|P1|STARTED|Routine Care vs. Enhanced Report||24
2248088|NCT02504424|5515152|P1|NOT COMPLETED|Overall Study||2
2248089|NCT02504424|5515152|P1|COMPLETED|Overall Study||48
2248090|NCT02504424|5515152|P1|STARTED|Overall Study||50
2248091|NCT02504320|5515161|P4|NOT COMPLETED|Treatment Period 4||0
2248092|NCT02504320|5515162|P3|NOT COMPLETED|Treatment Period 4||0
2248093|NCT02504320|5515163|P2|NOT COMPLETED|Treatment Period 4||0
2248094|NCT02504320|5515164|P1|NOT COMPLETED|Treatment Period 4||0
2248095|NCT02504320|5515161|P4|COMPLETED|Treatment Period 4||19
2248096|NCT02504320|5515162|P3|COMPLETED|Treatment Period 4||18
2248097|NCT02504320|5515163|P2|COMPLETED|Treatment Period 4||18
2248098|NCT02504320|5515164|P1|COMPLETED|Treatment Period 4||19
2248099|NCT02504320|5515161|P4|STARTED|Treatment Period 4||19
2248100|NCT02504320|5515162|P3|STARTED|Treatment Period 4||18
2248101|NCT02504320|5515163|P2|STARTED|Treatment Period 4||18
2248102|NCT02504320|5515164|P1|STARTED|Treatment Period 4||19
2248103|NCT02504320|5515161|P4|NOT COMPLETED|Treatment Period 3||1
2248104|NCT02504320|5515162|P3|NOT COMPLETED|Treatment Period 3||1
2248105|NCT02504320|5515163|P2|NOT COMPLETED|Treatment Period 3||0
2248106|NCT02504320|5515164|P1|NOT COMPLETED|Treatment Period 3||0
2248107|NCT02504320|5515161|P4|COMPLETED|Treatment Period 3||19
2248108|NCT02504320|5515162|P3|COMPLETED|Treatment Period 3||18
2248109|NCT02504320|5515163|P2|COMPLETED|Treatment Period 3||18
2248110|NCT02504320|5515164|P1|COMPLETED|Treatment Period 3||19
2248111|NCT02504320|5515161|P4|STARTED|Treatment Period 3||20
2248112|NCT02504320|5515162|P3|STARTED|Treatment Period 3||19
2248113|NCT02504320|5515163|P2|STARTED|Treatment Period 3||18
2248114|NCT02504320|5515164|P1|STARTED|Treatment Period 3||19
2248115|NCT02504320|5515161|P4|NOT COMPLETED|Treatment Period 2||0
2248116|NCT02504320|5515162|P3|NOT COMPLETED|Treatment Period 2||0
2248117|NCT02504320|5515163|P2|NOT COMPLETED|Treatment Period 2||1
2248118|NCT02504320|5515164|P1|NOT COMPLETED|Treatment Period 2||0
2248119|NCT02504320|5515161|P4|COMPLETED|Treatment Period 2||20
2248120|NCT02504320|5515162|P3|COMPLETED|Treatment Period 2||19
2248121|NCT02504320|5515163|P2|COMPLETED|Treatment Period 2||18
2248122|NCT02504320|5515164|P1|COMPLETED|Treatment Period 2||19
2248123|NCT02504320|5515161|P4|STARTED|Treatment Period 2||20
2248124|NCT02504320|5515162|P3|STARTED|Treatment Period 2||19
2248125|NCT02504320|5515163|P2|STARTED|Treatment Period 2||19
2248126|NCT02504320|5515164|P1|STARTED|Treatment Period 2||19
2248127|NCT02504320|5515161|P4|NOT COMPLETED|Treatment Period 1||0
2248128|NCT02504320|5515162|P3|NOT COMPLETED|Treatment Period 1||1
2248129|NCT02504320|5515163|P2|NOT COMPLETED|Treatment Period 1||0
2248130|NCT02504320|5515164|P1|NOT COMPLETED|Treatment Period 1||0
2248131|NCT02504320|5515161|P4|COMPLETED|Treatment Period 1||20
2248132|NCT02504320|5515162|P3|COMPLETED|Treatment Period 1||19
2248133|NCT02504320|5515163|P2|COMPLETED|Treatment Period 1||19
2248134|NCT02504320|5515164|P1|COMPLETED|Treatment Period 1||19
2248135|NCT02504320|5515161|P4|STARTED|Treatment Period 1||20
2248136|NCT02504320|5515162|P3|STARTED|Treatment Period 1||20
2248137|NCT02504320|5515163|P2|STARTED|Treatment Period 1||19
2248138|NCT02504320|5515164|P1|STARTED|Treatment Period 1||19
2248139|NCT02504294|5515184|P2|NOT COMPLETED|Overall Study||48
2248140|NCT02504294|5515185|P1|NOT COMPLETED|Overall Study||56
2248141|NCT02504294|5515184|P2|COMPLETED|Overall Study||158
2248142|NCT02504294|5515185|P1|COMPLETED|Overall Study||156
2248143|NCT02504294|5515184|P2|STARTED|Overall Study||206
2248144|NCT02504294|5515185|P1|STARTED|Overall Study||212
2248145|NCT02504268|5515195|P2|NOT COMPLETED|Overall Study||68
2248146|NCT02504268|5515196|P1|NOT COMPLETED|Overall Study||63
2248147|NCT02504268|5515195|P2|COMPLETED|Overall Study||233
2248148|NCT02504268|5515196|P1|COMPLETED|Overall Study||388
2248149|NCT02504268|5515195|P2|STARTED|Overall Study||301
2248150|NCT02504268|5515196|P1|STARTED|Overall Study||451
2248151|NCT02504099|5515210|P1|NOT COMPLETED|Overall Study||0
2248152|NCT02504099|5515210|P1|COMPLETED|Overall Study||3
2248153|NCT02504099|5515210|P1|STARTED|Overall Study||3
2248154|NCT02504073|5515218|P1|NOT COMPLETED|Overall Study||0
2248155|NCT02504073|5515218|P1|COMPLETED|Overall Study||54
2248156|NCT02504073|5515218|P1|STARTED|Overall Study||54
2248157|NCT02503982|5515224|P1|NOT COMPLETED|Overall Study||0
2248158|NCT02503982|5515224|P1|COMPLETED|Overall Study||13
2248159|NCT02503982|5515224|P1|STARTED|Overall Study||13
2248160|NCT02503865|5515231|P3|NOT COMPLETED|Overall Study||2
2248161|NCT02503865|5515232|P2|NOT COMPLETED|Overall Study||47
2248162|NCT02503865|5515233|P1|NOT COMPLETED|Overall Study||5
2248163|NCT02503865|5515231|P3|COMPLETED|Overall Study||64
2248164|NCT02503865|5515232|P2|COMPLETED|Overall Study||222
2248165|NCT02503865|5515233|P1|COMPLETED|Overall Study||65
2248166|NCT02503865|5515231|P3|STARTED|Overall Study||66
2248167|NCT02503865|5515232|P2|STARTED|Overall Study||269
2248168|NCT02503865|5515233|P1|STARTED|Overall Study||70
2248169|NCT02503852|5515257|P4|NOT COMPLETED|Overall Study||1
2248170|NCT02503852|5515258|P3|NOT COMPLETED|Overall Study||3
2248171|NCT02503852|5515259|P2|NOT COMPLETED|Overall Study||3
2248172|NCT02503852|5515260|P1|NOT COMPLETED|Overall Study||4
2248173|NCT02503852|5515257|P4|COMPLETED|Overall Study||8
2248174|NCT02503852|5515258|P3|COMPLETED|Overall Study||21
2248175|NCT02503852|5515259|P2|COMPLETED|Overall Study||19
2248176|NCT02503852|5515260|P1|COMPLETED|Overall Study||12
2248177|NCT02503852|5515257|P4|STARTED|Overall Study||9
2248178|NCT02503852|5515258|P3|STARTED|Overall Study||24
2248179|NCT02503852|5515259|P2|STARTED|Overall Study||22
2248180|NCT02503852|5515260|P1|STARTED|Overall Study||16
2248181|NCT02503787|5515278|P1|NOT COMPLETED|Implant to 3 Month Endpoint||3
2248182|NCT02503787|5515278|P1|COMPLETED|Implant to 3 Month Endpoint||29
2248183|NCT02503787|5515278|P1|STARTED|Implant to 3 Month Endpoint||32
2248184|NCT02503787|5515278|P1|NOT COMPLETED|Successful Trial (≥50% Pain Relief)||5
2248185|NCT02503787|5515278|P1|COMPLETED|Successful Trial (≥50% Pain Relief)||32
2248186|NCT02503787|5515278|P1|STARTED|Successful Trial (≥50% Pain Relief)||37
2248187|NCT02503787|5515278|P1|NOT COMPLETED|Device Trial (HD Programming Trial)||7
2248188|NCT02503787|5515278|P1|COMPLETED|Device Trial (HD Programming Trial)||37
2248189|NCT02503787|5515278|P1|STARTED|Device Trial (HD Programming Trial)||44
2248190|NCT02503787|5515278|P1|NOT COMPLETED|Enrollment||20
2248191|NCT02503787|5515278|P1|COMPLETED|Enrollment||44
2248192|NCT02503787|5515278|P1|STARTED|Enrollment||64
2248193|NCT02503735|5515285|P1|NOT COMPLETED|Overall Study||0
2248194|NCT02503735|5515285|P1|COMPLETED|Overall Study||10
2248195|NCT02503735|5515285|P1|SVR 12 (12week Post Treatment RNA Neg)|Overall Study||8
2248196|NCT02503735|5515285|P1|STARTED|Overall Study||10
2248197|NCT02503540|5515295|P1|NOT COMPLETED|Overall Study||3
2248198|NCT02503540|5515295|P1|COMPLETED|Overall Study||28
2248199|NCT02503540|5515295|P1|STARTED|Overall Study||31
2248200|NCT02503410|5515316|P2|NOT COMPLETED|Overall Study||0
2248201|NCT02503410|5515317|P1|NOT COMPLETED|Overall Study||0
2248202|NCT02503410|5515316|P2|COMPLETED|Overall Study||3
2248203|NCT02503410|5515317|P1|COMPLETED|Overall Study||4
2248204|NCT02503410|5515316|P2|STARTED|Overall Study||3
2248205|NCT02503410|5515317|P1|STARTED|Overall Study||4
2248206|NCT02503254|5515339|P2|NOT COMPLETED|Overall Study||0
2248207|NCT02503254|5515340|P1|NOT COMPLETED|Overall Study||0
2248208|NCT02503254|5515339|P2|COMPLETED|Overall Study||39
2248209|NCT02503254|5515340|P1|COMPLETED|Overall Study||41
2248210|NCT02503254|5515339|P2|STARTED|Overall Study||39
2248211|NCT02503254|5515340|P1|STARTED|Overall Study||41
2248212|NCT02503215|5515353|P1|NOT COMPLETED|Overall Study||3
2248213|NCT02503215|5515353|P1|COMPLETED|Overall Study||14
2248214|NCT02503215|5515353|P1|STARTED|Overall Study||17
2248215|NCT02503202|5515364|P5|NOT COMPLETED|Extension: Month 6 to 24||1
2248216|NCT02503202|5515365|P4|NOT COMPLETED|Extension: Month 6 to 24||18
2248217|NCT02503202|5515366|P3|NOT COMPLETED|Extension: Month 6 to 24||9
2248218|NCT02503202|5515367|P2|NOT COMPLETED|Extension: Month 6 to 24||16
2248219|NCT02503202|5515368|P1|NOT COMPLETED|Extension: Month 6 to 24||11
2248220|NCT02503202|5515364|P5|COMPLETED|Extension: Month 6 to 24||67
2248221|NCT02503202|5515365|P4|COMPLETED|Extension: Month 6 to 24||119
2248222|NCT02503202|5515366|P3|COMPLETED|Extension: Month 6 to 24||103
2248223|NCT02503202|5515367|P2|COMPLETED|Extension: Month 6 to 24||114
2248224|NCT02503202|5515368|P1|COMPLETED|Extension: Month 6 to 24||108
2248225|NCT02503202|5515364|P5|STARTED|Extension: Month 6 to 24||68
2248226|NCT02503202|5515365|P4|STARTED|Extension: Month 6 to 24||137
2248227|NCT02503202|5515366|P3|STARTED|Extension: Month 6 to 24||112
2248228|NCT02503202|5515367|P2|STARTED|Extension: Month 6 to 24||130
2248229|NCT02503202|5515368|P1|STARTED|Extension: Month 6 to 24||119
2248230|NCT02503202|5515364|P5|NOT COMPLETED|Base Study: Up to Month 6||3
2248231|NCT02503202|5515365|P4|NOT COMPLETED|Base Study: Up to Month 6||11
2248232|NCT02503202|5515366|P3|NOT COMPLETED|Base Study: Up to Month 6||15
2248233|NCT02503202|5515367|P2|NOT COMPLETED|Base Study: Up to Month 6||12
2248234|NCT02503202|5515368|P1|NOT COMPLETED|Base Study: Up to Month 6||18
2248235|NCT02503202|5515364|P5|COMPLETED|Base Study: Up to Month 6||130
2248236|NCT02503202|5515365|P4|COMPLETED|Base Study: Up to Month 6||255
2248237|NCT02503202|5515366|P3|COMPLETED|Base Study: Up to Month 6||252
2248238|NCT02503202|5515367|P2|COMPLETED|Base Study: Up to Month 6||253
2248239|NCT02503202|5515368|P1|COMPLETED|Base Study: Up to Month 6||248
2248240|NCT02503202|5515364|P5|Vaccinated|Base Study: Up to Month 6||133
2248241|NCT02503202|5515365|P4|Vaccinated|Base Study: Up to Month 6||264
2248242|NCT02503202|5515366|P3|Vaccinated|Base Study: Up to Month 6||266
2248243|NCT02503202|5515367|P2|Vaccinated|Base Study: Up to Month 6||265
2248244|NCT02503202|5515368|P1|Vaccinated|Base Study: Up to Month 6||266
2248245|NCT02503202|5515364|P5|STARTED|Base Study: Up to Month 6||133
2248246|NCT02503202|5515365|P4|STARTED|Base Study: Up to Month 6||266
2248247|NCT02503202|5515366|P3|STARTED|Base Study: Up to Month 6||267
2248248|NCT02503202|5515367|P2|STARTED|Base Study: Up to Month 6||265
2248249|NCT02503202|5515368|P1|STARTED|Base Study: Up to Month 6||266
2248250|NCT02503085|5515410|P4|NOT COMPLETED|Period 4||0
2248251|NCT02503085|5515411|P3|NOT COMPLETED|Period 4||0
2248252|NCT02503085|5515412|P2|NOT COMPLETED|Period 4||0
2248253|NCT02503085|5515413|P1|NOT COMPLETED|Period 4||0
2248254|NCT02503085|5515410|P4|COMPLETED|Period 4||7
2248255|NCT02503085|5515411|P3|COMPLETED|Period 4||6
2248256|NCT02503085|5515412|P2|COMPLETED|Period 4||7
2248257|NCT02503085|5515413|P1|COMPLETED|Period 4||6
2248258|NCT02503085|5515410|P4|STARTED|Period 4||7
2248259|NCT02503085|5515411|P3|STARTED|Period 4||6
2248260|NCT02503085|5515412|P2|STARTED|Period 4||7
2248261|NCT02503085|5515413|P1|STARTED|Period 4||6
2248262|NCT02503085|5515410|P4|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
2248263|NCT02503085|5515411|P3|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
2248264|NCT02503085|5515412|P2|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
2248265|NCT02503085|5515413|P1|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
2248266|NCT02503085|5515410|P4|COMPLETED|Period 3: Washout (3 to 7 Days)||7
2248267|NCT02503085|5515411|P3|COMPLETED|Period 3: Washout (3 to 7 Days)||6
2248268|NCT02503085|5515412|P2|COMPLETED|Period 3: Washout (3 to 7 Days)||7
2248269|NCT02503085|5515413|P1|COMPLETED|Period 3: Washout (3 to 7 Days)||6
2248270|NCT02503085|5515410|P4|STARTED|Period 3: Washout (3 to 7 Days)||7
2248271|NCT02503085|5515411|P3|STARTED|Period 3: Washout (3 to 7 Days)||6
2248272|NCT02503085|5515412|P2|STARTED|Period 3: Washout (3 to 7 Days)||7
2248273|NCT02503085|5515413|P1|STARTED|Period 3: Washout (3 to 7 Days)||6
2248274|NCT02503085|5515410|P4|NOT COMPLETED|Period 3||0
2248275|NCT02503085|5515411|P3|NOT COMPLETED|Period 3||0
2248276|NCT02503085|5515412|P2|NOT COMPLETED|Period 3||0
2248277|NCT02503085|5515413|P1|NOT COMPLETED|Period 3||0
2248278|NCT02503085|5515410|P4|COMPLETED|Period 3||7
2248279|NCT02503085|5515411|P3|COMPLETED|Period 3||6
2248280|NCT02503085|5515412|P2|COMPLETED|Period 3||7
2248281|NCT02503085|5515413|P1|COMPLETED|Period 3||6
2248282|NCT02503085|5515410|P4|STARTED|Period 3||7
2248283|NCT02503085|5515411|P3|STARTED|Period 3||6
2248284|NCT02503085|5515412|P2|STARTED|Period 3||7
2248285|NCT02503085|5515413|P1|STARTED|Period 3||6
2248286|NCT02503085|5515410|P4|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
2248287|NCT02503085|5515411|P3|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1
2248288|NCT02503085|5515412|P2|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
2248289|NCT02503085|5515413|P1|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1
2248290|NCT02503085|5515410|P4|COMPLETED|Period 2: Washout (3 to 7 Days)||7
2248291|NCT02503085|5515411|P3|COMPLETED|Period 2: Washout (3 to 7 Days)||6
2248292|NCT02503085|5515412|P2|COMPLETED|Period 2: Washout (3 to 7 Days)||7
2248293|NCT02503085|5515413|P1|COMPLETED|Period 2: Washout (3 to 7 Days)||6
2248294|NCT02503085|5515410|P4|STARTED|Period 2: Washout (3 to 7 Days)||7
2248295|NCT02503085|5515411|P3|STARTED|Period 2: Washout (3 to 7 Days)||7
2248296|NCT02503085|5515412|P2|STARTED|Period 2: Washout (3 to 7 Days)||7
2248297|NCT02503085|5515413|P1|STARTED|Period 2: Washout (3 to 7 Days)||7
2248298|NCT02503085|5515410|P4|NOT COMPLETED|Period 2||0
2248299|NCT02503085|5515411|P3|NOT COMPLETED|Period 2||0
2248300|NCT02503085|5515412|P2|NOT COMPLETED|Period 2||0
2248301|NCT02503085|5515413|P1|NOT COMPLETED|Period 2||0
2248302|NCT02503085|5515410|P4|COMPLETED|Period 2||7
2248303|NCT02503085|5515411|P3|COMPLETED|Period 2||7
2248304|NCT02503085|5515412|P2|COMPLETED|Period 2||7
2248305|NCT02503085|5515413|P1|COMPLETED|Period 2||7
2248306|NCT02503085|5515410|P4|STARTED|Period 2||7
2248307|NCT02503085|5515411|P3|STARTED|Period 2||7
2248308|NCT02503085|5515412|P2|STARTED|Period 2||7
2248309|NCT02503085|5515413|P1|STARTED|Period 2||7
2248310|NCT02503085|5515410|P4|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
2248311|NCT02503085|5515411|P3|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
2248312|NCT02503085|5515412|P2|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
2248313|NCT02503085|5515413|P1|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
2248314|NCT02503085|5515410|P4|COMPLETED|Period 1: Washout (3 to 7 Days)||7
2248315|NCT02503085|5515411|P3|COMPLETED|Period 1: Washout (3 to 7 Days)||7
2248316|NCT02503085|5515412|P2|COMPLETED|Period 1: Washout (3 to 7 Days)||7
2248317|NCT02503085|5515413|P1|COMPLETED|Period 1: Washout (3 to 7 Days)||7
2248318|NCT02503085|5515410|P4|STARTED|Period 1: Washout (3 to 7 Days)||7
2248319|NCT02503085|5515411|P3|STARTED|Period 1: Washout (3 to 7 Days)||7
2248320|NCT02503085|5515412|P2|STARTED|Period 1: Washout (3 to 7 Days)||7
2248321|NCT02503085|5515413|P1|STARTED|Period 1: Washout (3 to 7 Days)||7
2248322|NCT02503085|5515410|P4|NOT COMPLETED|Period 1||0
2248323|NCT02503085|5515411|P3|NOT COMPLETED|Period 1||0
2248324|NCT02503085|5515412|P2|NOT COMPLETED|Period 1||0
2248325|NCT02503085|5515413|P1|NOT COMPLETED|Period 1||0
2248326|NCT02503085|5515410|P4|COMPLETED|Period 1||7
2248327|NCT02503085|5515411|P3|COMPLETED|Period 1||7
2248328|NCT02503085|5515412|P2|COMPLETED|Period 1||7
2248329|NCT02503085|5515413|P1|COMPLETED|Period 1||7
2248330|NCT02503085|5515410|P4|STARTED|Period 1||7
2248331|NCT02503085|5515411|P3|STARTED|Period 1||7
2248332|NCT02503085|5515412|P2|STARTED|Period 1||7
2248333|NCT02503085|5515413|P1|STARTED|Period 1||7
2248334|NCT02502864|5515452|P1|NOT COMPLETED|Overall Study||1
2248335|NCT02502864|5515452|P1|COMPLETED|Overall Study||8
2248336|NCT02502864|5515452|P1|STARTED|Overall Study||9
2248337|NCT02502734|5515461|P2|NOT COMPLETED|Double-blind Treatment Period 2||0
2248338|NCT02502734|5515462|P1|NOT COMPLETED|Double-blind Treatment Period 2||0
2248339|NCT02502734|5515461|P2|COMPLETED|Double-blind Treatment Period 2||30
2248340|NCT02502734|5515462|P1|COMPLETED|Double-blind Treatment Period 2||28
2248341|NCT02502734|5515461|P2|STARTED|Double-blind Treatment Period 2||30
2248342|NCT02502734|5515462|P1|STARTED|Double-blind Treatment Period 2||28
2248343|NCT02502734|5515461|P2|NOT COMPLETED|Washout Period||0
2248344|NCT02502734|5515462|P1|NOT COMPLETED|Washout Period||1
2248345|NCT02502734|5515461|P2|COMPLETED|Washout Period||30
2248346|NCT02502734|5515462|P1|COMPLETED|Washout Period||28
2248347|NCT02502734|5515461|P2|STARTED|Washout Period||30
2248348|NCT02502734|5515462|P1|STARTED|Washout Period||29
2248349|NCT02502734|5515461|P2|NOT COMPLETED|Double-blind Treatment Period 1||0
2248350|NCT02502734|5515462|P1|NOT COMPLETED|Double-blind Treatment Period 1||1
2248351|NCT02502734|5515461|P2|COMPLETED|Double-blind Treatment Period 1||30
2248352|NCT02502734|5515462|P1|COMPLETED|Double-blind Treatment Period 1||29
2248353|NCT02502734|5515461|P2|STARTED|Double-blind Treatment Period 1||30
2248354|NCT02502734|5515462|P1|STARTED|Double-blind Treatment Period 1||30
2248355|NCT02502526|5515473|P3|NOT COMPLETED|Overall Study||6
2248356|NCT02502526|5515474|P2|NOT COMPLETED|Overall Study||4
2248357|NCT02502526|5515475|P1|NOT COMPLETED|Overall Study||6
2248358|NCT02502526|5515473|P3|COMPLETED|Overall Study||55
2248359|NCT02502526|5515474|P2|COMPLETED|Overall Study||55
2248360|NCT02502526|5515475|P1|COMPLETED|Overall Study||56
2248361|NCT02502526|5515473|P3|Intent-to-Treat (ITT)|Overall Study||59
2248362|NCT02502526|5515474|P2|Intent-to-Treat (ITT)|Overall Study||57
2248363|NCT02502526|5515475|P1|Intent-to-Treat (ITT)|Overall Study||57
2248364|NCT02502526|5515473|P3|STARTED|Overall Study||61
2248365|NCT02502526|5515474|P2|STARTED|Overall Study||59
2248366|NCT02502526|5515475|P1|STARTED|Overall Study||62
2248367|NCT02502487|5515491|P3|NOT COMPLETED|Overall Study||0
2248368|NCT02502487|5515492|P2|NOT COMPLETED|Overall Study||0
2248369|NCT02502487|5515493|P1|NOT COMPLETED|Overall Study||0
2248370|NCT02502487|5515491|P3|COMPLETED|Overall Study||86
2248371|NCT02502487|5515492|P2|COMPLETED|Overall Study||86
2248372|NCT02502487|5515493|P1|COMPLETED|Overall Study||86
2248373|NCT02502487|5515491|P3|STARTED|Overall Study||86
2248374|NCT02502487|5515492|P2|STARTED|Overall Study||86
2248375|NCT02502487|5515493|P1|STARTED|Overall Study||86
2248376|NCT02502461|5515563|P2|NOT COMPLETED|Overall Study||0
2248377|NCT02502461|5515564|P1|NOT COMPLETED|Overall Study||0
2248378|NCT02502461|5515563|P2|COMPLETED|Overall Study||44
2248379|NCT02502461|5515564|P1|COMPLETED|Overall Study||46
2248380|NCT02502461|5515563|P2|STARTED|Overall Study||44
2248381|NCT02502461|5515564|P1|STARTED|Overall Study||46
2248382|NCT02502149|5515572|P5|NOT COMPLETED|Treatment Period||0
2248383|NCT02502149|5515573|P4|NOT COMPLETED|Treatment Period||0
2248384|NCT02502149|5515574|P3|NOT COMPLETED|Treatment Period||0
2248385|NCT02502149|5515575|P2|NOT COMPLETED|Treatment Period||0
2248386|NCT02502149|5515576|P1|NOT COMPLETED|Treatment Period||0
2248387|NCT02502149|5515572|P5|COMPLETED|Treatment Period||12
2248388|NCT02502149|5515573|P4|COMPLETED|Treatment Period||11
2248389|NCT02502149|5515574|P3|COMPLETED|Treatment Period||0
2248390|NCT02502149|5515575|P2|COMPLETED|Treatment Period||0
2248391|NCT02502149|5515576|P1|COMPLETED|Treatment Period||0
2248392|NCT02502149|5515572|P5|STARTED|Treatment Period||12
2248393|NCT02502149|5515573|P4|STARTED|Treatment Period||11
2248394|NCT02502149|5515574|P3|STARTED|Treatment Period||0
2248395|NCT02502149|5515575|P2|STARTED|Treatment Period||0
2248396|NCT02502149|5515576|P1|STARTED|Treatment Period||0
2248397|NCT02502149|5515572|P5|NOT COMPLETED|PK2 Assessment Period||0
2248398|NCT02502149|5515573|P4|NOT COMPLETED|PK2 Assessment Period||0
2248399|NCT02502149|5515574|P3|NOT COMPLETED|PK2 Assessment Period||0
2248400|NCT02502149|5515575|P2|NOT COMPLETED|PK2 Assessment Period||0
2248401|NCT02502149|5515576|P1|NOT COMPLETED|PK2 Assessment Period||0
2248402|NCT02502149|5515572|P5|COMPLETED|PK2 Assessment Period||0
2248403|NCT02502149|5515573|P4|COMPLETED|PK2 Assessment Period||0
2248404|NCT02502149|5515574|P3|COMPLETED|PK2 Assessment Period||12
2248405|NCT02502149|5515575|P2|COMPLETED|PK2 Assessment Period||11
2248406|NCT02502149|5515576|P1|COMPLETED|PK2 Assessment Period||0
2248407|NCT02502149|5515572|P5|STARTED|PK2 Assessment Period||0
2248408|NCT02502149|5515573|P4|STARTED|PK2 Assessment Period||0
2248409|NCT02502149|5515574|P3|STARTED|PK2 Assessment Period||12
2248410|NCT02502149|5515575|P2|STARTED|PK2 Assessment Period||11
2248411|NCT02502149|5515576|P1|STARTED|PK2 Assessment Period||0
2248412|NCT02502149|5515572|P5|NOT COMPLETED|Intermediate||0
2248413|NCT02502149|5515573|P4|NOT COMPLETED|Intermediate||0
2248414|NCT02502149|5515574|P3|NOT COMPLETED|Intermediate||0
2248415|NCT02502149|5515575|P2|NOT COMPLETED|Intermediate||0
2248416|NCT02502149|5515576|P1|NOT COMPLETED|Intermediate||1
2248417|NCT02502149|5515572|P5|COMPLETED|Intermediate||0
2248418|NCT02502149|5515573|P4|COMPLETED|Intermediate||0
2248419|NCT02502149|5515574|P3|COMPLETED|Intermediate||0
2248420|NCT02502149|5515575|P2|COMPLETED|Intermediate||0
2248421|NCT02502149|5515576|P1|COMPLETED|Intermediate||23
2248422|NCT02502149|5515572|P5|STARTED|Intermediate||0
2248423|NCT02502149|5515573|P4|STARTED|Intermediate||0
2248424|NCT02502149|5515574|P3|STARTED|Intermediate||0
2248425|NCT02502149|5515575|P2|STARTED|Intermediate||0
2248426|NCT02502149|5515576|P1|STARTED|Intermediate||24
2248427|NCT02502149|5515572|P5|NOT COMPLETED|PK1 Assessment Period||0
2248428|NCT02502149|5515573|P4|NOT COMPLETED|PK1 Assessment Period||0
2248429|NCT02502149|5515574|P3|NOT COMPLETED|PK1 Assessment Period||0
2248430|NCT02502149|5515575|P2|NOT COMPLETED|PK1 Assessment Period||0
2248431|NCT02502149|5515576|P1|NOT COMPLETED|PK1 Assessment Period||0
2248432|NCT02502149|5515572|P5|COMPLETED|PK1 Assessment Period||0
2248433|NCT02502149|5515573|P4|COMPLETED|PK1 Assessment Period||0
2248434|NCT02502149|5515574|P3|COMPLETED|PK1 Assessment Period||0
2248435|NCT02502149|5515575|P2|COMPLETED|PK1 Assessment Period||0
2248436|NCT02502149|5515576|P1|COMPLETED|PK1 Assessment Period||24
2248437|NCT02502149|5515572|P5|STARTED|PK1 Assessment Period||0
2248438|NCT02502149|5515573|P4|STARTED|PK1 Assessment Period||0
2248439|NCT02502149|5515574|P3|STARTED|PK1 Assessment Period||0
2248440|NCT02502149|5515575|P2|STARTED|PK1 Assessment Period||0
2248441|NCT02502149|5515576|P1|STARTED|PK1 Assessment Period||24
2248442|NCT02502071|5515695|P1|NOT COMPLETED|Overall Study||0
2248443|NCT02502071|5515695|P1|COMPLETED|Overall Study||45
2248444|NCT02502071|5515695|P1|STARTED|Overall Study||45
2248445|NCT02502019|5515700|P1|NOT COMPLETED|Overall Study||0
2248446|NCT02502019|5515700|P1|COMPLETED|Overall Study||27
2248447|NCT02502019|5515700|P1|STARTED|Overall Study||27
2248448|NCT02501759|5515708|P1|NOT COMPLETED|Overall Study||1
2248449|NCT02501759|5515708|P1|COMPLETED|Overall Study||1
2248450|NCT02501759|5515708|P1|STARTED|Overall Study||2
2248451|NCT02501629|5515716|P2|NOT COMPLETED|Overall Study||7
2248452|NCT02501629|5515717|P1|NOT COMPLETED|Overall Study||5
2248453|NCT02501629|5515716|P2|COMPLETED|Overall Study||81
2248454|NCT02501629|5515717|P1|COMPLETED|Overall Study||84
2248455|NCT02501629|5515716|P2|STARTED|Overall Study||88
2248456|NCT02501629|5515717|P1|STARTED|Overall Study||89
2248457|NCT02501590|5515741|P2|NOT COMPLETED|Overall Study||0
2248458|NCT02501590|5515742|P1|NOT COMPLETED|Overall Study||0
2248459|NCT02501590|5515741|P2|COMPLETED|Overall Study||35
2248460|NCT02501590|5515742|P1|COMPLETED|Overall Study||13
2248461|NCT02501590|5515741|P2|STARTED|Overall Study||35
2248462|NCT02501590|5515742|P1|STARTED|Overall Study||13
2248463|NCT02501161|5515750|P2|NOT COMPLETED|Overall Study||25
2248464|NCT02501161|5515751|P1|NOT COMPLETED|Overall Study||22
2248465|NCT02501161|5515750|P2|COMPLETED|Overall Study||481
2248466|NCT02501161|5515751|P1|COMPLETED|Overall Study||484
2248467|NCT02501161|5515750|P2|Exposed|Overall Study||504
2248468|NCT02501161|5515751|P1|Exposed|Overall Study||506
2248469|NCT02501161|5515750|P2|STARTED|Overall Study||506
2248470|NCT02501161|5515751|P1|STARTED|Overall Study||506
2248471|NCT02501135|5515863|P1|NOT COMPLETED|Overall Study||0
2248472|NCT02501135|5515863|P1|COMPLETED|Overall Study||281
2248473|NCT02501135|5515863|P1|STARTED|Overall Study||281
2248474|NCT02500979|5515875|P2|NOT COMPLETED|Period 2||0
2248475|NCT02500979|5515876|P1|NOT COMPLETED|Period 2||1
2248476|NCT02500979|5515875|P2|COMPLETED|Period 2||16
2248477|NCT02500979|5515876|P1|COMPLETED|Period 2||11
2248478|NCT02500979|5515875|P2|STARTED|Period 2||16
2248479|NCT02500979|5515876|P1|STARTED|Period 2||12
2248480|NCT02500979|5515875|P2|NOT COMPLETED|Period 1||1
2248481|NCT02500979|5515876|P1|NOT COMPLETED|Period 1||4
2248482|NCT02500979|5515875|P2|COMPLETED|Period 1||16
2248483|NCT02500979|5515876|P1|COMPLETED|Period 1||12
2248484|NCT02500979|5515875|P2|STARTED|Period 1||17
2248485|NCT02500979|5515876|P1|STARTED|Period 1||16
2248486|NCT02500901|5515910|P1|NOT COMPLETED|Overall Study||2
2248487|NCT02500901|5515910|P1|COMPLETED|Overall Study||0
2248488|NCT02500901|5515910|P1|STARTED|Overall Study||2
2248489|NCT02500836|5515919|P3|NOT COMPLETED|Overall Study||1
2248490|NCT02500836|5515920|P2|NOT COMPLETED|Overall Study||5
2248491|NCT02500836|5515921|P1|NOT COMPLETED|Overall Study||3
2248492|NCT02500836|5515919|P3|COMPLETED|Overall Study||127
2248493|NCT02500836|5515920|P2|COMPLETED|Overall Study||254
2248494|NCT02500836|5515921|P1|COMPLETED|Overall Study||256
2248495|NCT02500836|5515919|P3|STARTED|Overall Study||128
2248496|NCT02500836|5515920|P2|STARTED|Overall Study||259
2248497|NCT02500836|5515921|P1|STARTED|Overall Study||259
2248498|NCT02500758|5515932|P2|NOT COMPLETED|Second Intervention (2 Minutes)||2
2248499|NCT02500758|5515933|P1|NOT COMPLETED|Second Intervention (2 Minutes)||3
2248500|NCT02500758|5515932|P2|COMPLETED|Second Intervention (2 Minutes)||10
2248501|NCT02500758|5515933|P1|COMPLETED|Second Intervention (2 Minutes)||10
2248502|NCT02500758|5515932|P2|STARTED|Second Intervention (2 Minutes)||12
2248503|NCT02500758|5515933|P1|STARTED|Second Intervention (2 Minutes)||13
2248504|NCT02500758|5515932|P2|NOT COMPLETED|Washout (1 Week)||2
2248505|NCT02500758|5515933|P1|NOT COMPLETED|Washout (1 Week)||2
2248506|NCT02500758|5515932|P2|COMPLETED|Washout (1 Week)||12
2248507|NCT02500758|5515933|P1|COMPLETED|Washout (1 Week)||13
2248508|NCT02500758|5515932|P2|STARTED|Washout (1 Week)||14
2248509|NCT02500758|5515933|P1|STARTED|Washout (1 Week)||15
2248510|NCT02500758|5515932|P2|NOT COMPLETED|First Intervention (2 Minutes)||1
2248511|NCT02500758|5515933|P1|NOT COMPLETED|First Intervention (2 Minutes)||0
2248512|NCT02500758|5515932|P2|COMPLETED|First Intervention (2 Minutes)||14
2248513|NCT02500758|5515933|P1|COMPLETED|First Intervention (2 Minutes)||15
2248514|NCT02500758|5515932|P2|STARTED|First Intervention (2 Minutes)||15
2248515|NCT02500758|5515933|P1|STARTED|First Intervention (2 Minutes)||15
2248516|NCT02500706|5515944|P3|NOT COMPLETED|Overall Study||7
2248517|NCT02500706|5515945|P2|NOT COMPLETED|Overall Study||7
2248518|NCT02500706|5515946|P1|NOT COMPLETED|Overall Study||4
2248519|NCT02500706|5515944|P3|COMPLETED|Overall Study||335
2248520|NCT02500706|5515945|P2|COMPLETED|Overall Study||334
2248521|NCT02500706|5515946|P1|COMPLETED|Overall Study||338
2248522|NCT02500706|5515944|P3|Exposed|Overall Study||342
2248523|NCT02500706|5515945|P2|Exposed|Overall Study||341
2248524|NCT02500706|5515946|P1|Exposed|Overall Study||342
2248525|NCT02500706|5515944|P3|STARTED|Overall Study||342
2248526|NCT02500706|5515945|P2|STARTED|Overall Study||341
2248527|NCT02500706|5515946|P1|STARTED|Overall Study||342
2248528|NCT02500641|5516100|P2|NOT COMPLETED|Overall Study||12
2248529|NCT02500641|5516101|P1|NOT COMPLETED|Overall Study||10
2248530|NCT02500641|5516100|P2|COMPLETED|Overall Study||86
2248531|NCT02500641|5516101|P1|COMPLETED|Overall Study||88
2248532|NCT02500641|5516100|P2|STARTED|Overall Study||98
2248533|NCT02500641|5516101|P1|STARTED|Overall Study||98
2248534|NCT02500628|5516109|P2|NOT COMPLETED|Overall Study||0
2248535|NCT02500628|5516110|P1|NOT COMPLETED|Overall Study||0
2248536|NCT02500628|5516109|P2|COMPLETED|Overall Study||23
2248537|NCT02500628|5516110|P1|COMPLETED|Overall Study||38
2248538|NCT02500628|5516109|P2|STARTED|Overall Study||23
2248539|NCT02500628|5516110|P1|STARTED|Overall Study||38
2248540|NCT02500537|5516122|P2|NOT COMPLETED|Overall Study||1
2248541|NCT02500537|5516123|P1|NOT COMPLETED|Overall Study||3
2248542|NCT02500537|5516122|P2|COMPLETED|Overall Study||39
2248543|NCT02500537|5516123|P1|COMPLETED|Overall Study||57
2248544|NCT02500537|5516122|P2|STARTED|Overall Study||40
2248545|NCT02500537|5516123|P1|STARTED|Overall Study||60
2248546|NCT02500368|5516141|P2|NOT COMPLETED|Second Intervention (1 Week)||0
2248547|NCT02500368|5516142|P1|NOT COMPLETED|Second Intervention (1 Week)||0
2248548|NCT02500368|5516141|P2|COMPLETED|Second Intervention (1 Week)||20
2248549|NCT02500368|5516142|P1|COMPLETED|Second Intervention (1 Week)||20
2248550|NCT02500368|5516141|P2|STARTED|Second Intervention (1 Week)||20
2248551|NCT02500368|5516142|P1|STARTED|Second Intervention (1 Week)||20
2248552|NCT02500368|5516141|P2|NOT COMPLETED|First Intervention (1 Week)||0
2248553|NCT02500368|5516142|P1|NOT COMPLETED|First Intervention (1 Week)||0
2248554|NCT02500368|5516141|P2|COMPLETED|First Intervention (1 Week)||20
2248555|NCT02500368|5516142|P1|COMPLETED|First Intervention (1 Week)||20
2248556|NCT02500368|5516141|P2|STARTED|First Intervention (1 Week)||20
2248557|NCT02500368|5516142|P1|STARTED|First Intervention (1 Week)||20
2248558|NCT02500056|5516192|P2|NOT COMPLETED|Overall Study||8
2248559|NCT02500056|5516193|P1|NOT COMPLETED|Overall Study||7
2248560|NCT02500056|5516192|P2|COMPLETED|Overall Study||65
2248561|NCT02500056|5516193|P1|COMPLETED|Overall Study||63
2248562|NCT02500056|5516192|P2|STARTED|Overall Study||73
2248563|NCT02500056|5516193|P1|STARTED|Overall Study||70
2248564|NCT02499952|5516203|P1|NOT COMPLETED|Overall Study||10
2248565|NCT02499952|5516203|P1|COMPLETED|Overall Study||2
2248566|NCT02499952|5516203|P1|STARTED|Overall Study||12
2248567|NCT02499900|5516212|P2|NOT COMPLETED|Extension Study Period||20
2248568|NCT02499900|5516213|P1|NOT COMPLETED|Extension Study Period||12
2248569|NCT02499900|5516212|P2|COMPLETED|Extension Study Period||377
2248570|NCT02499900|5516213|P1|COMPLETED|Extension Study Period||380
2248571|NCT02499900|5516212|P2|Safety Analysis Set|Extension Study Period|One participant was not treated in the Extension Study Period|396
2248572|NCT02499900|5516213|P1|Safety Analysis Set|Extension Study Period||392
2248573|NCT02499900|5516212|P2|STARTED|Extension Study Period||397
2248574|NCT02499900|5516213|P1|STARTED|Extension Study Period||392
2248575|NCT02499900|5516212|P2|NOT COMPLETED|Completed Core, Continued Into Extension||2
2248576|NCT02499900|5516213|P1|NOT COMPLETED|Completed Core, Continued Into Extension||3
2248577|NCT02499900|5516212|P2|COMPLETED|Completed Core, Continued Into Extension||397
2248578|NCT02499900|5516213|P1|COMPLETED|Completed Core, Continued Into Extension||392
2248579|NCT02499900|5516212|P2|STARTED|Completed Core, Continued Into Extension||399
2248580|NCT02499900|5516213|P1|STARTED|Completed Core, Continued Into Extension||395
2248581|NCT02499900|5516212|P2|NOT COMPLETED|Core Study Period||32
2248582|NCT02499900|5516213|P1|NOT COMPLETED|Core Study Period||35
2248583|NCT02499900|5516212|P2|COMPLETED|Core Study Period||399
2248584|NCT02499900|5516213|P1|COMPLETED|Core Study Period||395
2248585|NCT02499900|5516212|P2|Safety Analysis Set|Core Study Period||430
2248586|NCT02499900|5516213|P1|Safety Analysis Set|Core Study Period||427
2248587|NCT02499900|5516212|P2|STARTED|Core Study Period||431
2248588|NCT02499900|5516213|P1|STARTED|Core Study Period||430
2248589|NCT02499887|5516235|P2|NOT COMPLETED|Overall Study||0
2248590|NCT02499887|5516236|P1|NOT COMPLETED|Overall Study||0
2248591|NCT02499887|5516235|P2|COMPLETED|Overall Study||3
2248592|NCT02499887|5516236|P1|COMPLETED|Overall Study||3
2248593|NCT02499887|5516235|P2|STARTED|Overall Study||3
2248594|NCT02499887|5516236|P1|STARTED|Overall Study||3
2248595|NCT02499783|5516244|P3|NOT COMPLETED|Open Label Period: Weeks 8 to 26||29
2248596|NCT02499783|5516245|P2|NOT COMPLETED|Open Label Period: Weeks 8 to 26||0
2248597|NCT02499783|5516246|P1|NOT COMPLETED|Open Label Period: Weeks 8 to 26||0
2248598|NCT02499783|5516244|P3|COMPLETED|Open Label Period: Weeks 8 to 26||159
2248599|NCT02499783|5516245|P2|COMPLETED|Open Label Period: Weeks 8 to 26||0
2248600|NCT02499783|5516246|P1|COMPLETED|Open Label Period: Weeks 8 to 26||0
2248601|NCT02499783|5516244|P3|STARTED|Open Label Period: Weeks 8 to 26||188
2248602|NCT02499783|5516245|P2|STARTED|Open Label Period: Weeks 8 to 26||0
2248603|NCT02499783|5516246|P1|STARTED|Open Label Period: Weeks 8 to 26||0
2248604|NCT02499783|5516244|P3|NOT COMPLETED|DB Period: Weeks 0-8||0
2248605|NCT02499783|5516245|P2|NOT COMPLETED|DB Period: Weeks 0-8||7
2248606|NCT02499783|5516246|P1|NOT COMPLETED|DB Period: Weeks 0-8||10
2248607|NCT02499783|5516244|P3|COMPLETED|DB Period: Weeks 0-8||0
2248608|NCT02499783|5516245|P2|COMPLETED|DB Period: Weeks 0-8||96
2248609|NCT02499783|5516246|P1|COMPLETED|DB Period: Weeks 0-8||92
2248610|NCT02499783|5516244|P3|STARTED|DB Period: Weeks 0-8||0
2248611|NCT02499783|5516245|P2|STARTED|DB Period: Weeks 0-8||103
2248612|NCT02499783|5516246|P1|STARTED|DB Period: Weeks 0-8||102
2248613|NCT02499783|5516244|P3|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||0
2248614|NCT02499783|5516245|P2|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||5
2248615|NCT02499783|5516246|P1|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||4
2248616|NCT02499783|5516244|P3|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||0
2248617|NCT02499783|5516245|P2|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||98
2248618|NCT02499783|5516246|P1|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||98
2248619|NCT02499783|5516244|P3|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||0
2248620|NCT02499783|5516245|P2|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||103
2248621|NCT02499783|5516246|P1|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||102
2248622|NCT02499692|5516293|P1|NOT COMPLETED|Overall Study||0
2248623|NCT02499692|5516293|P1|COMPLETED|Overall Study||103
2248624|NCT02499692|5516293|P1|STARTED|Overall Study||103
2248625|NCT02499575|5516304|P2|NOT COMPLETED|Overall Study||1
2248626|NCT02499575|5516305|P1|NOT COMPLETED|Overall Study||0
2248627|NCT02499575|5516304|P2|COMPLETED|Overall Study||0
2248628|NCT02499575|5516305|P1|COMPLETED|Overall Study||1
2248629|NCT02499575|5516304|P2|STARTED|Overall Study||1
2248630|NCT02499575|5516305|P1|STARTED|Overall Study||1
2248631|NCT02499406|5516315|P1|NOT COMPLETED|Overall Study||4
2248632|NCT02499406|5516315|P1|COMPLETED|Overall Study||13
2248633|NCT02499406|5516315|P1|STARTED|Overall Study||17
2248634|NCT02499380|5516331|P1|NOT COMPLETED|Overall Study||3
2248635|NCT02499380|5516331|P1|COMPLETED|Overall Study||17
2248636|NCT02499380|5516331|P1|STARTED|Overall Study||20
2248637|NCT02499263|5516336|P1|NOT COMPLETED|Overall Study||62
2248638|NCT02499263|5516336|P1|COMPLETED|Overall Study||84
2248639|NCT02499263|5516336|P1|STARTED|Overall Study||146
2248640|NCT02499172|5516373|P4|NOT COMPLETED|Overall Study||436
2248641|NCT02499172|5516374|P3|NOT COMPLETED|Overall Study||523
2248642|NCT02499172|5516375|P2|NOT COMPLETED|Overall Study||64
2248643|NCT02499172|5516376|P1|NOT COMPLETED|Overall Study||65
2248644|NCT02499172|5516373|P4|COMPLETED|Overall Study||0
2248645|NCT02499172|5516374|P3|COMPLETED|Overall Study||0
2248646|NCT02499172|5516375|P2|COMPLETED|Overall Study||835
2248647|NCT02499172|5516376|P1|COMPLETED|Overall Study||835
2248648|NCT02499172|5516373|P4|STARTED|Overall Study||436
2248649|NCT02499172|5516374|P3|STARTED|Overall Study||523
2248650|NCT02499172|5516375|P2|STARTED|Overall Study||899
2248651|NCT02499172|5516376|P1|STARTED|Overall Study||900
2248652|NCT02499159|5516388|P2|NOT COMPLETED|30-Day Follow-Up Phone Call||2
2248653|NCT02499159|5516389|P1|NOT COMPLETED|30-Day Follow-Up Phone Call||7
2248654|NCT02499159|5516388|P2|COMPLETED|30-Day Follow-Up Phone Call||47
2248655|NCT02499159|5516389|P1|COMPLETED|30-Day Follow-Up Phone Call||42
2248656|NCT02499159|5516388|P2|STARTED|30-Day Follow-Up Phone Call||49
2248657|NCT02499159|5516389|P1|STARTED|30-Day Follow-Up Phone Call||49
2248658|NCT02499159|5516388|P2|NOT COMPLETED|Randomization||1
2248659|NCT02499159|5516389|P1|NOT COMPLETED|Randomization||1
2248660|NCT02499159|5516388|P2|COMPLETED|Randomization||49
2248661|NCT02499159|5516389|P1|COMPLETED|Randomization||49
2248662|NCT02499159|5516388|P2|STARTED|Randomization||50
2248663|NCT02499159|5516389|P1|STARTED|Randomization||50
2248664|NCT02499146|5516413|P1|NOT COMPLETED|Overall Study||26
2248665|NCT02499146|5516413|P1|COMPLETED|Overall Study||0
2248666|NCT02499146|5516413|P1|STARTED|Overall Study||26
2248667|NCT02499120|5516453|P2|NOT COMPLETED|Overall Study||60
2248668|NCT02499120|5516454|P1|NOT COMPLETED|Overall Study||65
2248669|NCT02499120|5516453|P2|COMPLETED|Overall Study||0
2248670|NCT02499120|5516454|P1|COMPLETED|Overall Study||0
2248671|NCT02499120|5516453|P2|Received Treatment|Overall Study||60
2248672|NCT02499120|5516454|P1|Received Treatment|Overall Study||64
2248673|NCT02499120|5516453|P2|STARTED|Overall Study||60
2248674|NCT02499120|5516454|P1|STARTED|Overall Study||65
2248675|NCT02499029|5516485|P2|NOT COMPLETED|Overall Study||3
2248676|NCT02499029|5516486|P1|NOT COMPLETED|Overall Study||5
2248677|NCT02499029|5516485|P2|COMPLETED|Overall Study||14
2248678|NCT02499029|5516486|P1|COMPLETED|Overall Study||13
2248679|NCT02499029|5516485|P2|STARTED|Overall Study||17
2248680|NCT02499029|5516486|P1|STARTED|Overall Study||18
2248681|NCT02498834|5516500|P2|NOT COMPLETED|Overall Study||10
2248682|NCT02498834|5516501|P1|NOT COMPLETED|Overall Study||10
2248683|NCT02498834|5516500|P2|COMPLETED|Overall Study||164
2248684|NCT02498834|5516501|P1|COMPLETED|Overall Study||175
2248685|NCT02498834|5516500|P2|STARTED|Overall Study||174
2248686|NCT02498834|5516501|P1|STARTED|Overall Study||185
2248687|NCT02498821|5516513|P2|NOT COMPLETED|Overall Study||5
2248688|NCT02498821|5516514|P1|NOT COMPLETED|Overall Study||3
2248689|NCT02498821|5516513|P2|COMPLETED|Overall Study||60
2248690|NCT02498821|5516514|P1|COMPLETED|Overall Study||60
2248691|NCT02498821|5516513|P2|STARTED|Overall Study||65
2248692|NCT02498821|5516514|P1|STARTED|Overall Study||63
2248693|NCT02498769|5516543|P2|NOT COMPLETED|Overall Study||0
2248694|NCT02498769|5516544|P1|NOT COMPLETED|Overall Study||0
2248695|NCT02498769|5516543|P2|COMPLETED|Overall Study||67
2248696|NCT02498769|5516544|P1|COMPLETED|Overall Study||63
2248697|NCT02498769|5516543|P2|STARTED|Overall Study||67
2248698|NCT02498769|5516544|P1|STARTED|Overall Study||63
2248699|NCT02498678|5516558|P2|NOT COMPLETED|Overall Study||2
2248700|NCT02498678|5516559|P1|NOT COMPLETED|Overall Study||0
2248701|NCT02498678|5516558|P2|COMPLETED|Overall Study||23
2248702|NCT02498678|5516559|P1|COMPLETED|Overall Study||25
2248703|NCT02498678|5516558|P2|STARTED|Overall Study||25
2248704|NCT02498678|5516559|P1|STARTED|Overall Study||25
2248705|NCT02498652|5516575|P2|NOT COMPLETED|Overall Study||1
2248706|NCT02498652|5516576|P1|NOT COMPLETED|Overall Study||0
2248707|NCT02498652|5516575|P2|COMPLETED|Overall Study|One subject was withdrawn due to noncompliance/protocol violation|20
2248708|NCT02498652|5516576|P1|COMPLETED|Overall Study||20
2248709|NCT02498652|5516575|P2|STARTED|Overall Study||21
2248710|NCT02498652|5516576|P1|STARTED|Overall Study||20
2248711|NCT02498522|5516677|P2|NOT COMPLETED|Overall Study||2
2248712|NCT02498522|5516678|P1|NOT COMPLETED|Overall Study||2
2248713|NCT02498522|5516677|P2|COMPLETED|Overall Study||83
2248714|NCT02498522|5516678|P1|COMPLETED|Overall Study||83
2248715|NCT02498522|5516677|P2|STARTED|Overall Study||85
2248716|NCT02498522|5516678|P1|STARTED|Overall Study||85
2248717|NCT02498483|5516686|P2|NOT COMPLETED|Overall Study||0
2248718|NCT02498483|5516687|P1|NOT COMPLETED|Overall Study||0
2248719|NCT02498483|5516686|P2|COMPLETED|Overall Study||5
2248720|NCT02498483|5516687|P1|COMPLETED|Overall Study||6
2248721|NCT02498483|5516686|P2|STARTED|Overall Study||5
2248722|NCT02498483|5516687|P1|STARTED|Overall Study||6
2248723|NCT02498418|5516704|P3|NOT COMPLETED|Overall Study||6
2248724|NCT02498418|5516705|P2|NOT COMPLETED|Overall Study||2
2248725|NCT02498418|5516706|P1|NOT COMPLETED|Overall Study||2
2248726|NCT02498418|5516704|P3|COMPLETED|Overall Study||238
2248727|NCT02498418|5516705|P2|COMPLETED|Overall Study||246
2248728|NCT02498418|5516706|P1|COMPLETED|Overall Study||245
2248729|NCT02498418|5516704|P3|Per-protocol Analysis Set|Overall Study||176
2248730|NCT02498418|5516705|P2|Per-protocol Analysis Set|Overall Study||181
2248731|NCT02498418|5516706|P1|Per-protocol Analysis Set|Overall Study||182
2248732|NCT02498418|5516704|P3|Modified Intent-to-treat Population|Overall Study||180
2248733|NCT02498418|5516705|P2|Modified Intent-to-treat Population|Overall Study||186
2248734|NCT02498418|5516706|P1|Modified Intent-to-treat Population|Overall Study||183
2248735|NCT02498418|5516704|P3|Safety Population|Overall Study||244
2248736|NCT02498418|5516705|P2|Safety Population|Overall Study||247
2248737|NCT02498418|5516706|P1|Safety Population|Overall Study||246
2248738|NCT02498418|5516704|P3|STARTED|Overall Study||244
2248739|NCT02498418|5516705|P2|STARTED|Overall Study||248
2248740|NCT02498418|5516706|P1|STARTED|Overall Study||247
2248741|NCT02498236|5516730|P8|NOT COMPLETED|Overall Study||1
2248742|NCT02498236|5516731|P7|NOT COMPLETED|Overall Study||1
2248743|NCT02498236|5516732|P6|NOT COMPLETED|Overall Study||0
2248744|NCT02498236|5516733|P5|NOT COMPLETED|Overall Study||1
2248745|NCT02498236|5516734|P4|NOT COMPLETED|Overall Study||0
2248746|NCT02498236|5516735|P3|NOT COMPLETED|Overall Study||0
2248747|NCT02498236|5516736|P2|NOT COMPLETED|Overall Study||0
2248748|NCT02498236|5516737|P1|NOT COMPLETED|Overall Study||1
2248749|NCT02498236|5516730|P8|COMPLETED|Overall Study||6
2248750|NCT02498236|5516731|P7|COMPLETED|Overall Study||6
2248751|NCT02498236|5516732|P6|COMPLETED|Overall Study||6
2248752|NCT02498236|5516733|P5|COMPLETED|Overall Study||6
2248753|NCT02498236|5516734|P4|COMPLETED|Overall Study||6
2248754|NCT02498236|5516735|P3|COMPLETED|Overall Study||6
2248755|NCT02498236|5516736|P2|COMPLETED|Overall Study||6
2248756|NCT02498236|5516737|P1|COMPLETED|Overall Study||5
2248757|NCT02498236|5516730|P8|Randomized|Overall Study||7
2248758|NCT02498236|5516731|P7|Randomized|Overall Study||7
2248759|NCT02498236|5516732|P6|Randomized|Overall Study||6
2248760|NCT02498236|5516733|P5|Randomized|Overall Study||7
2248761|NCT02498236|5516734|P4|Randomized|Overall Study||6
2248762|NCT02498236|5516735|P3|Randomized|Overall Study||6
2248763|NCT02498236|5516736|P2|Randomized|Overall Study||6
2248764|NCT02498236|5516737|P1|Randomized|Overall Study||6
2248765|NCT02498236|5516730|P8|STARTED|Overall Study||7
2248766|NCT02498236|5516731|P7|STARTED|Overall Study||7
2248767|NCT02498236|5516732|P6|STARTED|Overall Study||6
2248768|NCT02498236|5516733|P5|STARTED|Overall Study||7
2248769|NCT02498236|5516734|P4|STARTED|Overall Study||6
2248770|NCT02498236|5516735|P3|STARTED|Overall Study||6
2248771|NCT02498236|5516736|P2|STARTED|Overall Study||6
2248772|NCT02498236|5516737|P1|STARTED|Overall Study||6
2248773|NCT02497976|5516768|P2|NOT COMPLETED|Overall Study||1
2248774|NCT02497976|5516769|P1|NOT COMPLETED|Overall Study||2
2248775|NCT02497976|5516768|P2|COMPLETED|Overall Study||13
2248776|NCT02497976|5516769|P1|COMPLETED|Overall Study||26
2248777|NCT02497976|5516768|P2|STARTED|Overall Study||14
2248778|NCT02497976|5516769|P1|STARTED|Overall Study||28
2248779|NCT02497937|5516785|P2|NOT COMPLETED|Period 2 (Up to 7 Days)||0
2248780|NCT02497937|5516786|P1|NOT COMPLETED|Period 2 (Up to 7 Days)||0
2248781|NCT02497937|5516785|P2|COMPLETED|Period 2 (Up to 7 Days)||5
2248782|NCT02497937|5516786|P1|COMPLETED|Period 2 (Up to 7 Days)||6
2248783|NCT02497937|5516785|P2|STARTED|Period 2 (Up to 7 Days)||5
2248784|NCT02497937|5516786|P1|STARTED|Period 2 (Up to 7 Days)||6
2248785|NCT02497937|5516785|P2|NOT COMPLETED|Washout Period (Up to 14 Days)||0
2248786|NCT02497937|5516786|P1|NOT COMPLETED|Washout Period (Up to 14 Days)||0
2248787|NCT02497937|5516785|P2|COMPLETED|Washout Period (Up to 14 Days)||5
2248788|NCT02497937|5516786|P1|COMPLETED|Washout Period (Up to 14 Days)||6
2248789|NCT02497937|5516785|P2|STARTED|Washout Period (Up to 14 Days)||5
2248790|NCT02497937|5516786|P1|STARTED|Washout Period (Up to 14 Days)||6
2248791|NCT02497937|5516785|P2|NOT COMPLETED|Period 1 (Up to 7 Days)||0
2248792|NCT02497937|5516786|P1|NOT COMPLETED|Period 1 (Up to 7 Days)||0
2248793|NCT02497937|5516785|P2|COMPLETED|Period 1 (Up to 7 Days)||5
2248794|NCT02497937|5516786|P1|COMPLETED|Period 1 (Up to 7 Days)||6
2248795|NCT02497937|5516785|P2|STARTED|Period 1 (Up to 7 Days)||5
2248796|NCT02497937|5516786|P1|STARTED|Period 1 (Up to 7 Days)||6
2248797|NCT02497781|5516864|P2|NOT COMPLETED|Overall Study||3
2248798|NCT02497781|5516865|P1|NOT COMPLETED|Overall Study||4
2248799|NCT02497781|5516864|P2|COMPLETED|Overall Study||26
2248800|NCT02497781|5516865|P1|COMPLETED|Overall Study||64
2248801|NCT02497781|5516864|P2|Treated|Overall Study||28
2248802|NCT02497781|5516865|P1|Treated|Overall Study||67
2248803|NCT02497781|5516864|P2|STARTED|Overall Study||29
2248804|NCT02497781|5516865|P1|STARTED|Overall Study||68
2248805|NCT02497755|5516928|P2|NOT COMPLETED|Overall Study||0
2248806|NCT02497755|5516929|P1|NOT COMPLETED|Overall Study||1
2248807|NCT02497755|5516928|P2|COMPLETED|Overall Study||1
2248808|NCT02497755|5516929|P1|COMPLETED|Overall Study||17
2248809|NCT02497755|5516928|P2|STARTED|Overall Study||1
2248810|NCT02497755|5516929|P1|STARTED|Overall Study||18
2248811|NCT02497469|5516944|P2|NOT COMPLETED|Overall Study||115
2248812|NCT02497469|5516945|P1|NOT COMPLETED|Overall Study||169
2248813|NCT02497469|5516944|P2|COMPLETED|Overall Study||270
2248814|NCT02497469|5516945|P1|COMPLETED|Overall Study||217
2248815|NCT02497469|5516944|P2|Safety Analysis Set|Overall Study||383
2248816|NCT02497469|5516945|P1|Safety Analysis Set|Overall Study||386
2248817|NCT02497469|5516944|P2|STARTED|Overall Study||385
2248818|NCT02497469|5516945|P1|STARTED|Overall Study||386
2248819|NCT02497391|5516955|P6|NOT COMPLETED|Period 3 (14 Days)||0
2248820|NCT02497391|5516956|P5|NOT COMPLETED|Period 3 (14 Days)||1
2248821|NCT02497391|5516957|P4|NOT COMPLETED|Period 3 (14 Days)||0
2248822|NCT02497391|5516958|P3|NOT COMPLETED|Period 3 (14 Days)||1
2248823|NCT02497391|5516959|P2|NOT COMPLETED|Period 3 (14 Days)||1
2248824|NCT02497391|5516960|P1|NOT COMPLETED|Period 3 (14 Days)||0
2248825|NCT02497391|5516955|P6|COMPLETED|Period 3 (14 Days)||13
2248826|NCT02497391|5516956|P5|COMPLETED|Period 3 (14 Days)||13
2248827|NCT02497391|5516957|P4|COMPLETED|Period 3 (14 Days)||13
2248828|NCT02497391|5516958|P3|COMPLETED|Period 3 (14 Days)||12
2248829|NCT02497391|5516959|P2|COMPLETED|Period 3 (14 Days)||13
2248830|NCT02497391|5516960|P1|COMPLETED|Period 3 (14 Days)||12
2248831|NCT02497391|5516955|P6|STARTED|Period 3 (14 Days)||13
2248832|NCT02497391|5516956|P5|STARTED|Period 3 (14 Days)||14
2248833|NCT02497391|5516957|P4|STARTED|Period 3 (14 Days)||13
2248834|NCT02497391|5516958|P3|STARTED|Period 3 (14 Days)||13
2248835|NCT02497391|5516959|P2|STARTED|Period 3 (14 Days)||14
2248836|NCT02497391|5516960|P1|STARTED|Period 3 (14 Days)||12
2248837|NCT02497391|5516955|P6|NOT COMPLETED|Period 2 (14 Days)||3
2248838|NCT02497391|5516956|P5|NOT COMPLETED|Period 2 (14 Days)||2
2248839|NCT02497391|5516957|P4|NOT COMPLETED|Period 2 (14 Days)||3
2248840|NCT02497391|5516958|P3|NOT COMPLETED|Period 2 (14 Days)||3
2248841|NCT02497391|5516959|P2|NOT COMPLETED|Period 2 (14 Days)||1
2248842|NCT02497391|5516960|P1|NOT COMPLETED|Period 2 (14 Days)||4
2248843|NCT02497391|5516955|P6|COMPLETED|Period 2 (14 Days)||13
2248844|NCT02497391|5516956|P5|COMPLETED|Period 2 (14 Days)||14
2248845|NCT02497391|5516957|P4|COMPLETED|Period 2 (14 Days)||13
2248846|NCT02497391|5516958|P3|COMPLETED|Period 2 (14 Days)||13
2248847|NCT02497391|5516959|P2|COMPLETED|Period 2 (14 Days)||14
2248848|NCT02497391|5516960|P1|COMPLETED|Period 2 (14 Days)||12
2248849|NCT02497391|5516955|P6|STARTED|Period 2 (14 Days)||16
2248850|NCT02497391|5516956|P5|STARTED|Period 2 (14 Days)||16
2248851|NCT02497391|5516957|P4|STARTED|Period 2 (14 Days)||16
2248852|NCT02497391|5516958|P3|STARTED|Period 2 (14 Days)||16
2248853|NCT02497391|5516959|P2|STARTED|Period 2 (14 Days)||15
2248854|NCT02497391|5516960|P1|STARTED|Period 2 (14 Days)||16
2248855|NCT02497391|5516955|P6|NOT COMPLETED|Period 1 (14 Days)||0
2248856|NCT02497391|5516956|P5|NOT COMPLETED|Period 1 (14 Days)||0
2248857|NCT02497391|5516957|P4|NOT COMPLETED|Period 1 (14 Days)||0
2248858|NCT02497391|5516958|P3|NOT COMPLETED|Period 1 (14 Days)||0
2248859|NCT02497391|5516959|P2|NOT COMPLETED|Period 1 (14 Days)||0
2248860|NCT02497391|5516960|P1|NOT COMPLETED|Period 1 (14 Days)||0
2248861|NCT02497391|5516955|P6|COMPLETED|Period 1 (14 Days)||16
2248862|NCT02497391|5516956|P5|COMPLETED|Period 1 (14 Days)||16
2248863|NCT02497391|5516957|P4|COMPLETED|Period 1 (14 Days)||16
2248864|NCT02497391|5516958|P3|COMPLETED|Period 1 (14 Days)||16
2248865|NCT02497391|5516959|P2|COMPLETED|Period 1 (14 Days)||15
2248866|NCT02497391|5516960|P1|COMPLETED|Period 1 (14 Days)||16
2248867|NCT02497391|5516955|P6|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
2248868|NCT02497391|5516956|P5|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
2248869|NCT02497391|5516957|P4|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
2248870|NCT02497391|5516958|P3|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
2248871|NCT02497391|5516959|P2|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||15
2248872|NCT02497391|5516960|P1|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
2248873|NCT02497391|5516955|P6|STARTED|Period 1 (14 Days)||16
2248874|NCT02497391|5516956|P5|STARTED|Period 1 (14 Days)||16
2248875|NCT02497391|5516957|P4|STARTED|Period 1 (14 Days)||16
2248876|NCT02497391|5516958|P3|STARTED|Period 1 (14 Days)||16
2248877|NCT02497391|5516959|P2|STARTED|Period 1 (14 Days)||15
2248878|NCT02497391|5516960|P1|STARTED|Period 1 (14 Days)||16
2248879|NCT02497287|5516971|P1|NOT COMPLETED|Follow-up Phase (4 Week)||31
2248880|NCT02497287|5516971|P1|COMPLETED|Follow-up Phase (4 Week)||326
2248881|NCT02497287|5516971|P1|STARTED|Follow-up Phase (4 Week)|Included non-responders (IND phase) or discontinued treatment phase or completed OP/MA phase.|357
2248882|NCT02497287|5516971|P1|NOT COMPLETED|Optimization/Maintenance (48 Weeks)||453
2248883|NCT02497287|5516971|P1|COMPLETED|Optimization/Maintenance (48 Weeks)||150
2248884|NCT02497287|5516971|P1|STARTED|Optimization/Maintenance (48 Weeks)|Included who completed IND phase (580) + responders from TRD3005 (23).|603
2248885|NCT02497287|5516971|P1|NOT COMPLETED|Induction Phase (4 Weeks)||199
2248886|NCT02497287|5516971|P1|COMPLETED|Induction Phase (4 Weeks)||580
2248887|NCT02497287|5516971|P1|STARTED|Induction Phase (4 Weeks)|Included DE participants (691) and non-responders from TRD3005 (88).|779
2248888|NCT02497235|5517015|P5|NOT COMPLETED|Overall Study||0
2248889|NCT02497235|5517016|P4|NOT COMPLETED|Overall Study||0
2248890|NCT02497235|5517017|P3|NOT COMPLETED|Overall Study||0
2248891|NCT02497235|5517018|P2|NOT COMPLETED|Overall Study||0
2248892|NCT02497235|5517019|P1|NOT COMPLETED|Overall Study||0
2248893|NCT02497235|5517015|P5|COMPLETED|Overall Study||3
2248894|NCT02497235|5517016|P4|COMPLETED|Overall Study||2
2248895|NCT02497235|5517017|P3|COMPLETED|Overall Study||2
2248896|NCT02497235|5517018|P2|COMPLETED|Overall Study||2
2248897|NCT02497235|5517019|P1|COMPLETED|Overall Study||2
2248898|NCT02497235|5517015|P5|STARTED|Overall Study||3
2248899|NCT02497235|5517016|P4|STARTED|Overall Study||2
2248900|NCT02497235|5517017|P3|STARTED|Overall Study||2
2248901|NCT02497235|5517018|P2|STARTED|Overall Study||2
2248902|NCT02497235|5517019|P1|STARTED|Overall Study||2
2248903|NCT02497040|5517052|P3|NOT COMPLETED|Overall Study||0
2248904|NCT02497040|5517053|P2|NOT COMPLETED|Overall Study||0
2248905|NCT02497040|5517054|P1|NOT COMPLETED|Overall Study||0
2248906|NCT02497040|5517052|P3|COMPLETED|Overall Study||30
2248907|NCT02497040|5517053|P2|COMPLETED|Overall Study||30
2248908|NCT02497040|5517054|P1|COMPLETED|Overall Study||30
2248909|NCT02497040|5517052|P3|STARTED|Overall Study||30
2248910|NCT02497040|5517053|P2|STARTED|Overall Study||30
2248911|NCT02497040|5517054|P1|STARTED|Overall Study||30
2248912|NCT02496702|5517064|P2|NOT COMPLETED|Overall Study||8
2248913|NCT02496702|5517065|P1|NOT COMPLETED|Overall Study||8
2248914|NCT02496702|5517064|P2|COMPLETED|Overall Study||22
2248915|NCT02496702|5517065|P1|COMPLETED|Overall Study||22
2248916|NCT02496702|5517064|P2|Did Not Receive Allocated Intervention|Overall Study||0
2248917|NCT02496702|5517065|P1|Did Not Receive Allocated Intervention|Overall Study||9
2248918|NCT02496702|5517064|P2|Received Allocated Intervention|Overall Study||0
2248919|NCT02496702|5517065|P1|Received Allocated Intervention|Overall Study||21
2248920|NCT02496702|5517064|P2|STARTED|Overall Study||30
2248921|NCT02496702|5517065|P1|STARTED|Overall Study||30
2248922|NCT02496533|5517087|P2|NOT COMPLETED|Overall Study||6
2248923|NCT02496533|5517088|P1|NOT COMPLETED|Overall Study||3
2248924|NCT02496533|5517087|P2|COMPLETED|Overall Study||106
2248925|NCT02496533|5517088|P1|COMPLETED|Overall Study||102
2248926|NCT02496533|5517087|P2|STARTED|Overall Study||112
2248927|NCT02496533|5517088|P1|STARTED|Overall Study||105
2248928|NCT02496221|5517100|P2|NOT COMPLETED|Treatment Period 2 - 4 Days||1
2248929|NCT02496221|5517101|P1|NOT COMPLETED|Treatment Period 2 - 4 Days||2
2248930|NCT02496221|5517100|P2|COMPLETED|Treatment Period 2 - 4 Days||9
2248931|NCT02496221|5517101|P1|COMPLETED|Treatment Period 2 - 4 Days||8
2248932|NCT02496221|5517100|P2|STARTED|Treatment Period 2 - 4 Days||10
2248933|NCT02496221|5517101|P1|STARTED|Treatment Period 2 - 4 Days||10
2248934|NCT02496221|5517100|P2|NOT COMPLETED|Treatment Period 1 - 4 Days||0
2248935|NCT02496221|5517101|P1|NOT COMPLETED|Treatment Period 1 - 4 Days||0
2248936|NCT02496221|5517100|P2|COMPLETED|Treatment Period 1 - 4 Days||10
2248937|NCT02496221|5517101|P1|COMPLETED|Treatment Period 1 - 4 Days||10
2248938|NCT02496221|5517100|P2|STARTED|Treatment Period 1 - 4 Days||10
2248939|NCT02496221|5517101|P1|STARTED|Treatment Period 1 - 4 Days||10
2248940|NCT02496039|5517135|P1|NOT COMPLETED|Overall Study||4
2248941|NCT02496039|5517135|P1|COMPLETED|Overall Study||1
2248942|NCT02496039|5517135|P1|STARTED|Overall Study||5
2248943|NCT02496000|5517150|P3|NOT COMPLETED|Overall Study||2
2248944|NCT02496000|5517151|P2|NOT COMPLETED|Overall Study||5
2248945|NCT02496000|5517152|P1|NOT COMPLETED|Overall Study||2
2248946|NCT02496000|5517150|P3|COMPLETED|Overall Study||61
2248947|NCT02496000|5517151|P2|COMPLETED|Overall Study||56
2248948|NCT02496000|5517152|P1|COMPLETED|Overall Study||62
2248949|NCT02496000|5517150|P3|STARTED|Overall Study||63
2248950|NCT02496000|5517151|P2|STARTED|Overall Study||61
2248951|NCT02496000|5517152|P1|STARTED|Overall Study||64
2248952|NCT02495948|5517173|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
2248953|NCT02495948|5517174|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
2248954|NCT02495948|5517173|P2|COMPLETED|Period 2, Second 30 Days of Wear||82
2248955|NCT02495948|5517174|P1|COMPLETED|Period 2, Second 30 Days of Wear||82
2248956|NCT02495948|5517173|P2|STARTED|Period 2, Second 30 Days of Wear||83
2248957|NCT02495948|5517174|P1|STARTED|Period 2, Second 30 Days of Wear||83
2248958|NCT02495948|5517173|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||1
2248959|NCT02495948|5517174|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
2248960|NCT02495948|5517173|P2|COMPLETED|Period 1, First 30 Days of Wear||83
2248961|NCT02495948|5517174|P1|COMPLETED|Period 1, First 30 Days of Wear||83
2248962|NCT02495948|5517173|P2|STARTED|Period 1, First 30 Days of Wear||84
2248963|NCT02495948|5517174|P1|STARTED|Period 1, First 30 Days of Wear||83
2248964|NCT02495844|5517183|P2|NOT COMPLETED|Overall Study||4
2248965|NCT02495844|5517184|P1|NOT COMPLETED|Overall Study||1
2248966|NCT02495844|5517183|P2|COMPLETED|Overall Study||24
2248967|NCT02495844|5517184|P1|COMPLETED|Overall Study||26
2248968|NCT02495844|5517183|P2|STARTED|Overall Study||28
2248969|NCT02495844|5517184|P1|STARTED|Overall Study||27
2248970|NCT02495831|5517214|P2|NOT COMPLETED|Second Intervention||0
2248971|NCT02495831|5517215|P1|NOT COMPLETED|Second Intervention||0
2248972|NCT02495831|5517214|P2|COMPLETED|Second Intervention||10
2248973|NCT02495831|5517215|P1|COMPLETED|Second Intervention||12
2248974|NCT02495831|5517214|P2|STARTED|Second Intervention||10
2248975|NCT02495831|5517215|P1|STARTED|Second Intervention|One participant withdrew at the end of period 1|12
2248976|NCT02495831|5517214|P2|NOT COMPLETED|First Intervention||0
2248977|NCT02495831|5517215|P1|NOT COMPLETED|First Intervention||0
2248978|NCT02495831|5517214|P2|COMPLETED|First Intervention||10
2248979|NCT02495831|5517215|P1|COMPLETED|First Intervention||13
2248980|NCT02495831|5517214|P2|STARTED|First Intervention||10
2248981|NCT02495831|5517215|P1|STARTED|First Intervention||13
2248982|NCT02495779|5517229|P1|NOT COMPLETED|Overall Study||6
2248983|NCT02495779|5517229|P1|COMPLETED|Overall Study||48
2248984|NCT02495779|5517229|P1|STARTED|Overall Study||54
2248985|NCT02495623|5517236|P3|NOT COMPLETED|Overall Study||8
2248986|NCT02495623|5517237|P2|NOT COMPLETED|Overall Study||9
2248987|NCT02495623|5517238|P1|NOT COMPLETED|Overall Study||5
2248988|NCT02495623|5517236|P3|COMPLETED|Overall Study||20
2248989|NCT02495623|5517237|P2|COMPLETED|Overall Study||17
2248990|NCT02495623|5517238|P1|COMPLETED|Overall Study||20
2248991|NCT02495623|5517236|P3|Dosed|Overall Study||22
2248992|NCT02495623|5517237|P2|Dosed|Overall Study||19
2248993|NCT02495623|5517238|P1|Dosed|Overall Study||22
2248994|NCT02495623|5517236|P3|STARTED|Overall Study||28
2248995|NCT02495623|5517237|P2|STARTED|Overall Study||26
2248996|NCT02495623|5517238|P1|STARTED|Overall Study||25
2248997|NCT02495467|5517248|P2|NOT COMPLETED|Second Intervention (4 Weeks)||3
2248998|NCT02495467|5517249|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
2248999|NCT02495467|5517248|P2|COMPLETED|Second Intervention (4 Weeks)||113
2249000|NCT02495467|5517249|P1|COMPLETED|Second Intervention (4 Weeks)||112
2249001|NCT02495467|5517248|P2|STARTED|Second Intervention (4 Weeks)||116
2249002|NCT02495467|5517249|P1|STARTED|Second Intervention (4 Weeks)||112
2249003|NCT02495467|5517248|P2|NOT COMPLETED|Washout (1 Week)||2
2249004|NCT02495467|5517249|P1|NOT COMPLETED|Washout (1 Week)||2
2249005|NCT02495467|5517248|P2|COMPLETED|Washout (1 Week)||116
2249006|NCT02495467|5517249|P1|COMPLETED|Washout (1 Week)||112
2249007|NCT02495467|5517248|P2|STARTED|Washout (1 Week)||118
2249008|NCT02495467|5517249|P1|STARTED|Washout (1 Week)||114
2249009|NCT02495467|5517248|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
2249010|NCT02495467|5517249|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
2249011|NCT02495467|5517248|P2|COMPLETED|First Intervention (4 Weeks)|One subject completed visits in treatment Period 1 but never used treatment|118
2249012|NCT02495467|5517249|P1|COMPLETED|First Intervention (4 Weeks)||114
2249013|NCT02495467|5517248|P2|STARTED|First Intervention (4 Weeks)||118
2249014|NCT02495467|5517249|P1|STARTED|First Intervention (4 Weeks)||114
2249015|NCT02495259|5517280|P3|NOT COMPLETED|Overall Study||0
2249016|NCT02495259|5517281|P2|NOT COMPLETED|Overall Study||1
2249017|NCT02495259|5517282|P1|NOT COMPLETED|Overall Study||0
2249018|NCT02495259|5517280|P3|COMPLETED|Overall Study||8
2249019|NCT02495259|5517281|P2|COMPLETED|Overall Study||3
2249020|NCT02495259|5517282|P1|COMPLETED|Overall Study||7
2249021|NCT02495259|5517280|P3|STARTED|Overall Study||8
2249022|NCT02495259|5517281|P2|STARTED|Overall Study||4
2249023|NCT02495259|5517282|P1|STARTED|Overall Study||7
2249024|NCT02495233|5517307|P2|NOT COMPLETED|Overall Study||1
2249025|NCT02495233|5517308|P1|NOT COMPLETED|Overall Study||0
2249026|NCT02495233|5517307|P2|COMPLETED|Overall Study||6
2249027|NCT02495233|5517308|P1|COMPLETED|Overall Study||3
2249028|NCT02495233|5517307|P2|STARTED|Overall Study||7
2249029|NCT02495233|5517308|P1|STARTED|Overall Study||3
2249030|NCT02495168|5517337|P3|NOT COMPLETED|Overall Study||17
2249031|NCT02495168|5517338|P2|NOT COMPLETED|Overall Study||54
2249032|NCT02495168|5517339|P1|NOT COMPLETED|Overall Study||38
2249033|NCT02495168|5517337|P3|COMPLETED|Overall Study||110
2249034|NCT02495168|5517338|P2|COMPLETED|Overall Study||462
2249035|NCT02495168|5517339|P1|COMPLETED|Overall Study||466
2249036|NCT02495168|5517337|P3|Day 42 (D42PPS) Population|Overall Study||88
2249037|NCT02495168|5517338|P2|Day 42 (D42PPS) Population|Overall Study||383
2249038|NCT02495168|5517339|P1|Day 42 (D42PPS) Population|Overall Study||382
2249039|NCT02495168|5517337|P3|Day1 Per-protocol Set (D1PPS) Population|Overall Study||99
2249040|NCT02495168|5517338|P2|Day1 Per-protocol Set (D1PPS) Population|Overall Study||437
2249041|NCT02495168|5517339|P1|Day1 Per-protocol Set (D1PPS) Population|Overall Study||437
2249042|NCT02495168|5517337|P3|Modified Intent-to-Treat Population|Overall Study||111
2249043|NCT02495168|5517338|P2|Modified Intent-to-Treat Population|Overall Study||478
2249044|NCT02495168|5517339|P1|Modified Intent-to-Treat Population|Overall Study||468
2249045|NCT02495168|5517337|P3|Safety Population|Overall Study||126
2249046|NCT02495168|5517338|P2|Safety Population|Overall Study||514
2249047|NCT02495168|5517339|P1|Safety Population|Overall Study||501
2249048|NCT02495168|5517337|P3|STARTED|Overall Study||127
2249049|NCT02495168|5517338|P2|STARTED|Overall Study||516
2249050|NCT02495168|5517339|P1|STARTED|Overall Study||504
2249051|NCT02495038|5517359|P3|NOT COMPLETED|Overall Study||0
2249052|NCT02495038|5517360|P2|NOT COMPLETED|Overall Study||0
2249053|NCT02495038|5517361|P1|NOT COMPLETED|Overall Study||0
2249054|NCT02495038|5517359|P3|COMPLETED|Overall Study||27
2249055|NCT02495038|5517360|P2|COMPLETED|Overall Study||27
2249056|NCT02495038|5517361|P1|COMPLETED|Overall Study||27
2249057|NCT02495038|5517359|P3|STARTED|Overall Study||27
2249058|NCT02495038|5517360|P2|STARTED|Overall Study||27
2249059|NCT02495038|5517361|P1|STARTED|Overall Study||27
2249060|NCT02495025|5517398|P2|NOT COMPLETED|Overall Study||14
2249061|NCT02495025|5517399|P1|NOT COMPLETED|Overall Study||26
2249062|NCT02495025|5517398|P2|COMPLETED|Overall Study||61
2249063|NCT02495025|5517399|P1|COMPLETED|Overall Study||51
2249064|NCT02495025|5517398|P2|STARTED|Overall Study||75
2249065|NCT02495025|5517399|P1|STARTED|Overall Study||77
2249066|NCT02494817|5517413|P2|NOT COMPLETED|Overall Study||49
2249067|NCT02494817|5517414|P1|NOT COMPLETED|Overall Study||55
2249068|NCT02494817|5517413|P2|COMPLETED|Overall Study|41 couples and 5 partnered men completed all 3 assessments (baseline, 3- and 6-month)|87
2249069|NCT02494817|5517414|P1|COMPLETED|Overall Study|49 couples and 9 partnered men completed all 3 assessments (baseline, 3- and 6-month)|107
2249070|NCT02494817|5517413|P2|6 Month Assessment|Overall Study|represents 45 couples and 8 partnered men|98
2249071|NCT02494817|5517414|P1|6 Month Assessment|Overall Study|represents 52 couples and 11 partnered men|115
2249072|NCT02494817|5517413|P2|3 Month Assessment|Overall Study|represents 44 couples and 4 partnered men|92
2249073|NCT02494817|5517414|P1|3 Month Assessment|Overall Study|represents 59 couples and 7 partnered men|125
2249074|NCT02494817|5517413|P2|STARTED|Overall Study|representing 68 couples|136
2249075|NCT02494817|5517414|P1|STARTED|Overall Study|representing 81 couples|162
2249076|NCT02494713|5517434|P1|NOT COMPLETED|Overall Study||0
2249077|NCT02494713|5517434|P1|COMPLETED|Overall Study||4
2249078|NCT02494713|5517434|P1|STARTED|Overall Study||4
2249079|NCT02494596|5517451|P3|NOT COMPLETED|Overall Study||1
2249080|NCT02494596|5517452|P2|NOT COMPLETED|Overall Study||5
2249081|NCT02494596|5517453|P1|NOT COMPLETED|Overall Study||3
2249082|NCT02494596|5517451|P3|COMPLETED|Overall Study||6
2249083|NCT02494596|5517452|P2|COMPLETED|Overall Study||2
2249084|NCT02494596|5517453|P1|COMPLETED|Overall Study||2
2249085|NCT02494596|5517451|P3|STARTED|Overall Study||7
2249086|NCT02494596|5517452|P2|STARTED|Overall Study||7
2249087|NCT02494596|5517453|P1|STARTED|Overall Study||5
2249088|NCT02494518|5517481|P3|NOT COMPLETED|Overall Study||3
2249089|NCT02494518|5517482|P2|NOT COMPLETED|Overall Study||2
2249090|NCT02494518|5517483|P1|NOT COMPLETED|Overall Study||1
2249091|NCT02494518|5517481|P3|COMPLETED|Overall Study||8
2249092|NCT02494518|5517482|P2|COMPLETED|Overall Study||10
2249093|NCT02494518|5517483|P1|COMPLETED|Overall Study||10
2249094|NCT02494518|5517481|P3|STARTED|Overall Study||11
2249095|NCT02494518|5517482|P2|STARTED|Overall Study||12
2249096|NCT02494518|5517483|P1|STARTED|Overall Study||11
2249097|NCT02494440|5517515|P1|NOT COMPLETED|Overall Study||0
2249098|NCT02494440|5517515|P1|COMPLETED|Overall Study||90
2249099|NCT02494440|5517515|P1|STARTED|Overall Study||90
2249100|NCT02494401|5517523|P2|NOT COMPLETED|Overall Study||27
2249101|NCT02494401|5517524|P1|NOT COMPLETED|Overall Study||25
2249102|NCT02494401|5517523|P2|COMPLETED|Overall Study||106
2249103|NCT02494401|5517524|P1|COMPLETED|Overall Study||109
2249104|NCT02494401|5517523|P2|6 Month Follow up|Overall Study||106
2249105|NCT02494401|5517524|P1|6 Month Follow up|Overall Study||109
2249106|NCT02494401|5517523|P2|Week 16|Overall Study||124
2249107|NCT02494401|5517524|P1|Week 16|Overall Study||123
2249108|NCT02494401|5517523|P2|STARTED|Overall Study||133
2249109|NCT02494401|5517524|P1|STARTED|Overall Study||134
2249110|NCT02494323|5517562|P1|NOT COMPLETED|Overall Study||0
2249111|NCT02494323|5517562|P1|COMPLETED|Overall Study||70
2249112|NCT02494323|5517562|P1|STARTED|Overall Study||70
2249113|NCT02494206|5517567|P1|NOT COMPLETED|Overall Study||2
2249114|NCT02494206|5517567|P1|COMPLETED|Overall Study||7
2249115|NCT02494206|5517567|P1|STARTED|Overall Study||9
2249116|NCT02494180|5517573|P2|NOT COMPLETED|Overall Study||0
2249117|NCT02494180|5517574|P1|NOT COMPLETED|Overall Study||0
2249118|NCT02494180|5517573|P2|COMPLETED|Overall Study||85
2249119|NCT02494180|5517574|P1|COMPLETED|Overall Study||85
2249120|NCT02494180|5517573|P2|STARTED|Overall Study||85
2249121|NCT02494180|5517574|P1|STARTED|Overall Study||85
2249122|NCT02494102|5517596|P2|NOT COMPLETED|Overall Study||0
2249123|NCT02494102|5517597|P1|NOT COMPLETED|Overall Study||0
2249124|NCT02494102|5517596|P2|COMPLETED|Overall Study||47
2249125|NCT02494102|5517597|P1|COMPLETED|Overall Study||42
2249126|NCT02494102|5517596|P2|STARTED|Overall Study||47
2249127|NCT02494102|5517597|P1|STARTED|Overall Study||42
2249128|NCT02494076|5517607|P2|NOT COMPLETED|Overall Study||0
2249129|NCT02494076|5517608|P1|NOT COMPLETED|Overall Study||0
2249130|NCT02494076|5517607|P2|COMPLETED|Overall Study||26
2249131|NCT02494076|5517608|P1|COMPLETED|Overall Study||26
2249132|NCT02494076|5517607|P2|STARTED|Overall Study||26
2249133|NCT02494076|5517608|P1|STARTED|Overall Study||26
2249134|NCT02493946|5517621|P3|NOT COMPLETED|Open Label Period||86
2249135|NCT02493946|5517622|P2|NOT COMPLETED|Open Label Period||0
2249136|NCT02493946|5517623|P1|NOT COMPLETED|Open Label Period||0
2249137|NCT02493946|5517621|P3|COMPLETED|Open Label Period||509
2249138|NCT02493946|5517622|P2|COMPLETED|Open Label Period||0
2249139|NCT02493946|5517623|P1|COMPLETED|Open Label Period||0
2249140|NCT02493946|5517621|P3|STARTED|Open Label Period|The previous period relates to DB period only, this period relates to OL treatment only.|595
2249141|NCT02493946|5517622|P2|STARTED|Open Label Period|Only the BTX-A-HAC Solution 50 U - LT Analyses arm is applicable for this period.|0
2249142|NCT02493946|5517623|P1|STARTED|Open Label Period|Only the BTX-A-HAC Solution 50 U - LT Analyses arm is applicable for this period.|0
2249143|NCT02493946|5517621|P3|NOT COMPLETED|DB Period||0
2249144|NCT02493946|5517622|P2|NOT COMPLETED|DB Period||5
2249145|NCT02493946|5517623|P1|NOT COMPLETED|DB Period||8
2249146|NCT02493946|5517621|P3|COMPLETED|DB Period||0
2249147|NCT02493946|5517622|P2|COMPLETED|DB Period||59
2249148|NCT02493946|5517623|P1|COMPLETED|DB Period||118
2249149|NCT02493946|5517621|P3|STARTED|DB Period||0
2249150|NCT02493946|5517622|P2|STARTED|DB Period||64
2249151|NCT02493946|5517623|P1|STARTED|DB Period||126
2249152|NCT02493868|5517656|P2|NOT COMPLETED|Follow-up Phase||2
2249153|NCT02493868|5517657|P1|NOT COMPLETED|Follow-up Phase||11
2249154|NCT02493868|5517656|P2|COMPLETED|Follow-up Phase||62
2249155|NCT02493868|5517657|P1|COMPLETED|Follow-up Phase||470
2249156|NCT02493868|5517656|P2|STARTED|Follow-up Phase||64
2249157|NCT02493868|5517657|P1|STARTED|Follow-up Phase||481
2249158|NCT02493868|5517656|P2|NOT COMPLETED|Maintenance Phase: DE+TE Participants||22
2249159|NCT02493868|5517657|P1|NOT COMPLETED|Maintenance Phase: DE+TE Participants||13
2249160|NCT02493868|5517656|P2|COMPLETED|Maintenance Phase: DE+TE Participants||177
2249161|NCT02493868|5517657|P1|COMPLETED|Maintenance Phase: DE+TE Participants||139
2249162|NCT02493868|5517656|P2|Stable Responders|Maintenance Phase: DE+TE Participants||59
2249163|NCT02493868|5517657|P1|Stable Responders|Maintenance Phase: DE+TE Participants||62
2249164|NCT02493868|5517656|P2|Stable Remitters|Maintenance Phase: DE+TE Participants||86
2249165|NCT02493868|5517657|P1|Stable Remitters|Maintenance Phase: DE+TE Participants||90
2249166|NCT02493868|5517656|P2|STARTED|Maintenance Phase: DE+TE Participants|145 participants randomized from intranasal esketamine arm after OP phase+54 continued from OP phase|199
2249167|NCT02493868|5517657|P1|STARTED|Maintenance Phase: DE+TE Participants|152 participants randomized from intranasal esketamine arm after OP phase: DE (90) + TE (62)|152
2249168|NCT02493868|5517656|P2|NOT COMPLETED|Optimization Phase: DE+TE Participants||32
2249169|NCT02493868|5517657|P1|NOT COMPLETED|Optimization Phase: DE+TE Participants||158
2249170|NCT02493868|5517656|P2|COMPLETED|Optimization Phase: DE+TE Participants|Participants who completed and met predefined remission/response criteria continued to MA phase.|54
2249171|NCT02493868|5517657|P1|COMPLETED|Optimization Phase: DE+TE Participants|Participants who completed and met predefined remission/response criteria randomized to MA phase|297
2249172|NCT02493868|5517656|P2|STARTED|Optimization Phase: DE+TE Participants|Placebo treated transferred-entry participant.|86
2249173|NCT02493868|5517657|P1|STARTED|Optimization Phase: DE+TE Participants|Total participants: direct-entry (273) + esketamine-treated transferred-entry participants (182).|455
2249174|NCT02493868|5517656|P2|NOT COMPLETED|Induction Phase: DE Participants||0
2249175|NCT02493868|5517657|P1|NOT COMPLETED|Induction Phase: DE Participants||164
2249176|NCT02493868|5517656|P2|COMPLETED|Induction Phase: DE Participants||0
2249177|NCT02493868|5517657|P1|COMPLETED|Induction Phase: DE Participants|Participants who completed and met predefined response criteria continued to OP phase.|273
2249178|NCT02493868|5517656|P2|STARTED|Induction Phase: DE Participants||0
2249179|NCT02493868|5517657|P1|STARTED|Induction Phase: DE Participants||437
2249180|NCT02493855|5517706|P3|NOT COMPLETED|Overall Study||0
2249181|NCT02493855|5517707|P2|NOT COMPLETED|Overall Study||1
2249182|NCT02493855|5517708|P1|NOT COMPLETED|Overall Study||2
2249183|NCT02493855|5517706|P3|COMPLETED|Overall Study||6
2249184|NCT02493855|5517707|P2|COMPLETED|Overall Study||18
2249185|NCT02493855|5517708|P1|COMPLETED|Overall Study||19
2249186|NCT02493855|5517706|P3|STARTED|Overall Study||6
2249187|NCT02493855|5517707|P2|STARTED|Overall Study||19
2249188|NCT02493855|5517708|P1|STARTED|Overall Study||21
2249189|NCT02493777|5517718|P2|NOT COMPLETED|Overall Study||1
2249190|NCT02493777|5517719|P1|NOT COMPLETED|Overall Study||0
2249191|NCT02493777|5517718|P2|COMPLETED|Overall Study||53
2249192|NCT02493777|5517719|P1|COMPLETED|Overall Study||65
2249193|NCT02493777|5517718|P2|STARTED|Overall Study||54
2249194|NCT02493777|5517719|P1|STARTED|Overall Study||65
2249195|NCT02493751|5517729|P2|NOT COMPLETED|Overall Study||29
2249196|NCT02493751|5517730|P1|NOT COMPLETED|Overall Study||13
2249197|NCT02493751|5517729|P2|COMPLETED|Overall Study|Participants who died were considered as completed.|10
2249198|NCT02493751|5517730|P1|COMPLETED|Overall Study|Participants who died were considered as completed.|3
2249199|NCT02493751|5517729|P2|STARTED|Overall Study||39
2249200|NCT02493751|5517730|P1|STARTED|Overall Study||16
2249201|NCT02493621|5517737|P2|NOT COMPLETED|Overall Study||0
2249202|NCT02493621|5517738|P1|NOT COMPLETED|Overall Study||0
2249203|NCT02493621|5517737|P2|COMPLETED|Overall Study||58
2249204|NCT02493621|5517738|P1|COMPLETED|Overall Study||58
2249205|NCT02493621|5517737|P2|STARTED|Overall Study||58
2249206|NCT02493621|5517738|P1|STARTED|Overall Study||58
2249207|NCT02493517|5517748|P2|NOT COMPLETED|Overall Study||7
2249208|NCT02493517|5517749|P1|NOT COMPLETED|Overall Study||2
2249209|NCT02493517|5517748|P2|COMPLETED|Overall Study||57
2249210|NCT02493517|5517749|P1|COMPLETED|Overall Study||62
2249211|NCT02493517|5517748|P2|STARTED|Overall Study||64
2249212|NCT02493517|5517749|P1|STARTED|Overall Study||64
2249213|NCT02493452|5517774|P3|NOT COMPLETED|Overall Study||54
2249214|NCT02493452|5517775|P2|NOT COMPLETED|Overall Study||49
2249215|NCT02493452|5517776|P1|NOT COMPLETED|Overall Study||50
2249216|NCT02493452|5517774|P3|COMPLETED|Overall Study||325
2249217|NCT02493452|5517775|P2|COMPLETED|Overall Study||328
2249218|NCT02493452|5517776|P1|COMPLETED|Overall Study||329
2249219|NCT02493452|5517774|P3|STARTED|Overall Study||379
2249220|NCT02493452|5517775|P2|STARTED|Overall Study||377
2249221|NCT02493452|5517776|P1|STARTED|Overall Study||379
2249222|NCT02493361|5517808|P1|NOT COMPLETED|Overall Study||14
2249223|NCT02493361|5517808|P1|COMPLETED|Overall Study||10
2249224|NCT02493361|5517808|P1|STARTED|Overall Study||24
2249225|NCT02493127|5517814|P2|NOT COMPLETED|Overall Study||1
2249226|NCT02493127|5517815|P1|NOT COMPLETED|Overall Study||1
2249227|NCT02493127|5517814|P2|COMPLETED|Overall Study||60
2249228|NCT02493127|5517815|P1|COMPLETED|Overall Study||60
2249229|NCT02493127|5517814|P2|STARTED|Overall Study||61
2249230|NCT02493127|5517815|P1|STARTED|Overall Study||61
2249231|NCT02493088|5517827|P1|NOT COMPLETED|Overall Study||0
2249232|NCT02493088|5517827|P1|COMPLETED|Overall Study||11
2249233|NCT02493088|5517827|P1|STARTED|Overall Study||11
2249234|NCT02493062|5517833|P1|NOT COMPLETED|Overall Study||12
2249235|NCT02493062|5517833|P1|COMPLETED|Overall Study||23
2249236|NCT02493062|5517833|P1|STARTED|Overall Study||35
2249237|NCT02493036|5517844|P3|NOT COMPLETED|Overall Study||2
2249238|NCT02493036|5517845|P2|NOT COMPLETED|Overall Study||2
2249239|NCT02493036|5517846|P1|NOT COMPLETED|Overall Study||1
2249240|NCT02493036|5517844|P3|COMPLETED|Overall Study||15
2249241|NCT02493036|5517845|P2|COMPLETED|Overall Study||18
2249242|NCT02493036|5517846|P1|COMPLETED|Overall Study||16
2249243|NCT02493036|5517844|P3|STARTED|Overall Study||17
2249244|NCT02493036|5517845|P2|STARTED|Overall Study||20
2249245|NCT02493036|5517846|P1|STARTED|Overall Study||17
2249246|NCT02492984|5517856|P2|NOT COMPLETED|Overall Study||0
2249247|NCT02492984|5517857|P1|NOT COMPLETED|Overall Study||3
2249248|NCT02492984|5517856|P2|COMPLETED|Overall Study||14
2249249|NCT02492984|5517857|P1|COMPLETED|Overall Study||70
2249250|NCT02492984|5517856|P2|STARTED|Overall Study||14
2249251|NCT02492984|5517857|P1|STARTED|Overall Study||73
2249252|NCT02492958|5517881|P4|NOT COMPLETED|Overall Study||0
2249253|NCT02492958|5517882|P3|NOT COMPLETED|Overall Study||2
2249254|NCT02492958|5517883|P2|NOT COMPLETED|Overall Study||0
2249255|NCT02492958|5517884|P1|NOT COMPLETED|Overall Study||1
2249256|NCT02492958|5517881|P4|COMPLETED|Overall Study||34
2249257|NCT02492958|5517882|P3|COMPLETED|Overall Study||32
2249258|NCT02492958|5517883|P2|COMPLETED|Overall Study||34
2249259|NCT02492958|5517884|P1|COMPLETED|Overall Study||33
2249260|NCT02492958|5517881|P4|STARTED|Overall Study||34
2249261|NCT02492958|5517882|P3|STARTED|Overall Study||34
2249262|NCT02492958|5517883|P2|STARTED|Overall Study||34
2249263|NCT02492958|5517884|P1|STARTED|Overall Study||34
2249264|NCT02492880|5517970|P1|NOT COMPLETED|Overall Study||2
2249265|NCT02492880|5517970|P1|COMPLETED|Overall Study||13
2249266|NCT02492880|5517970|P1|STARTED|Overall Study||15
2249267|NCT02492841|5517977|P3|NOT COMPLETED|Overall Study||35
2249268|NCT02492841|5517978|P2|NOT COMPLETED|Overall Study||31
2249269|NCT02492841|5517979|P1|NOT COMPLETED|Overall Study||34
2249270|NCT02492841|5517977|P3|COMPLETED|Overall Study||25
2249271|NCT02492841|5517978|P2|COMPLETED|Overall Study||22
2249272|NCT02492841|5517979|P1|COMPLETED|Overall Study||22
2249273|NCT02492841|5517977|P3|STARTED|Overall Study||60
2249274|NCT02492841|5517978|P2|STARTED|Overall Study||53
2249275|NCT02492841|5517979|P1|STARTED|Overall Study||56
2249276|NCT02492802|5517990|P1|NOT COMPLETED|Overall Study||0
2249277|NCT02492802|5517990|P1|COMPLETED|Overall Study||64
2249278|NCT02492802|5517990|P1|STARTED|Overall Study||64
2249279|NCT02492763|5517998|P4|NOT COMPLETED|Overall Study||13
2249280|NCT02492763|5517999|P3|NOT COMPLETED|Overall Study||10
2249281|NCT02492763|5518000|P2|NOT COMPLETED|Overall Study||15
2249282|NCT02492763|5518001|P1|NOT COMPLETED|Overall Study||16
2249283|NCT02492763|5517998|P4|COMPLETED|Overall Study||30
2249284|NCT02492763|5517999|P3|COMPLETED|Overall Study||33
2249285|NCT02492763|5518000|P2|COMPLETED|Overall Study||29
2249286|NCT02492763|5518001|P1|COMPLETED|Overall Study||30
2249287|NCT02492763|5517998|P4|Treated|Overall Study||42
2249288|NCT02492763|5517999|P3|Treated|Overall Study||43
2249289|NCT02492763|5518000|P2|Treated|Overall Study||44
2249290|NCT02492763|5518001|P1|Treated|Overall Study||46
2249291|NCT02492763|5517998|P4|STARTED|Overall Study||43
2249292|NCT02492763|5517999|P3|STARTED|Overall Study||43
2249293|NCT02492763|5518000|P2|STARTED|Overall Study||44
2249294|NCT02492763|5518001|P1|STARTED|Overall Study||46
2249295|NCT02492451|5518058|P3|NOT COMPLETED|Overall Study||0
2249296|NCT02492451|5518059|P2|NOT COMPLETED|Overall Study||0
2249297|NCT02492451|5518060|P1|NOT COMPLETED|Overall Study||0
2249298|NCT02492451|5518058|P3|COMPLETED|Overall Study||39
2249299|NCT02492451|5518059|P2|COMPLETED|Overall Study||39
2249300|NCT02492451|5518060|P1|COMPLETED|Overall Study||40
2249301|NCT02492451|5518058|P3|STARTED|Overall Study||39
2249302|NCT02492451|5518059|P2|STARTED|Overall Study||39
2249303|NCT02492451|5518060|P1|STARTED|Overall Study||40
2249304|NCT02492165|5518072|P4|NOT COMPLETED|Overall Study||0
2249305|NCT02492165|5518073|P3|NOT COMPLETED|Overall Study||0
2249306|NCT02492165|5518074|P2|NOT COMPLETED|Overall Study||1
2249307|NCT02492165|5518075|P1|NOT COMPLETED|Overall Study||0
2249308|NCT02492165|5518072|P4|COMPLETED|Overall Study||30
2249309|NCT02492165|5518073|P3|COMPLETED|Overall Study||60
2249310|NCT02492165|5518074|P2|COMPLETED|Overall Study||59
2249311|NCT02492165|5518075|P1|COMPLETED|Overall Study||100
2249312|NCT02492165|5518072|P4|STARTED|Overall Study||30
2249313|NCT02492165|5518073|P3|STARTED|Overall Study||60
2249314|NCT02492165|5518074|P2|STARTED|Overall Study||60
2249315|NCT02492165|5518075|P1|STARTED|Overall Study||100
2249316|NCT02492100|5518097|P1|NOT COMPLETED|Overall Study||1
2249317|NCT02492100|5518097|P1|COMPLETED|Overall Study||46
2249318|NCT02492100|5518097|P1|STARTED|Overall Study||47
2249319|NCT02491944|5518104|P1|NOT COMPLETED|Overall Study||0
2249320|NCT02491944|5518104|P1|COMPLETED|Overall Study||10
2249321|NCT02491944|5518104|P1|STARTED|Overall Study||10
2249322|NCT02491892|5518126|P2|NOT COMPLETED|Overall Study||38
2249323|NCT02491892|5518127|P1|NOT COMPLETED|Overall Study||41
2249324|NCT02491892|5518126|P2|COMPLETED|Overall Study||0
2249325|NCT02491892|5518127|P1|COMPLETED|Overall Study||0
2249326|NCT02491892|5518126|P2|Treated|Overall Study|One participant was randomized but died before receiving study medication.|37
2249327|NCT02491892|5518127|P1|Treated|Overall Study||41
2249328|NCT02491892|5518126|P2|STARTED|Overall Study||38
2249329|NCT02491892|5518127|P1|STARTED|Overall Study||41
2249330|NCT02491684|5518173|P2|NOT COMPLETED|Treatment Phase||3
2249331|NCT02491684|5518174|P1|NOT COMPLETED|Treatment Phase||3
2249332|NCT02491684|5518173|P2|COMPLETED|Treatment Phase||57
2249333|NCT02491684|5518174|P1|COMPLETED|Treatment Phase||58
2249334|NCT02491684|5518173|P2|STARTED|Treatment Phase||60
2249335|NCT02491684|5518174|P1|STARTED|Treatment Phase||61
2249336|NCT02491684|5518173|P2|NOT COMPLETED|Pre-treatment Phase||0
2249337|NCT02491684|5518174|P1|NOT COMPLETED|Pre-treatment Phase||0
2249338|NCT02491684|5518173|P2|COMPLETED|Pre-treatment Phase||60
2249339|NCT02491684|5518174|P1|COMPLETED|Pre-treatment Phase||61
2249340|NCT02491684|5518173|P2|STARTED|Pre-treatment Phase||60
2249341|NCT02491684|5518174|P1|STARTED|Pre-treatment Phase||61
2249342|NCT02491463|5518212|P4|NOT COMPLETED|Overall Study||1
2249343|NCT02491463|5518213|P3|NOT COMPLETED|Overall Study||4
2249344|NCT02491463|5518214|P2|NOT COMPLETED|Overall Study||10
2249345|NCT02491463|5518215|P1|NOT COMPLETED|Overall Study||2
2249346|NCT02491463|5518212|P4|COMPLETED|Overall Study||14
2249347|NCT02491463|5518213|P3|COMPLETED|Overall Study||15
2249348|NCT02491463|5518214|P2|COMPLETED|Overall Study||21
2249349|NCT02491463|5518215|P1|COMPLETED|Overall Study||5
2249350|NCT02491463|5518212|P4|STARTED|Overall Study||15
2249351|NCT02491463|5518213|P3|STARTED|Overall Study||19
2249352|NCT02491463|5518214|P2|STARTED|Overall Study||31
2249353|NCT02491463|5518215|P1|STARTED|Overall Study||7
2249354|NCT02491437|5518303|P2|NOT COMPLETED|Overall Study||357
2249355|NCT02491437|5518304|P1|NOT COMPLETED|Overall Study||352
2249356|NCT02491437|5518303|P2|COMPLETED|Overall Study||157
2249357|NCT02491437|5518304|P1|COMPLETED|Overall Study||168
2249358|NCT02491437|5518303|P2|Full Analysis Sample|Overall Study||489
2249359|NCT02491437|5518304|P1|Full Analysis Sample|Overall Study||494
2249360|NCT02491437|5518303|P2|Safety Sample|Overall Study||512
2249361|NCT02491437|5518304|P1|Safety Sample|Overall Study||518
2249362|NCT02491437|5518303|P2|STARTED|Overall Study||514
2249363|NCT02491437|5518304|P1|STARTED|Overall Study||520
2249364|NCT02491411|5518318|P1|NOT COMPLETED|Overall Study||4
2249365|NCT02491411|5518318|P1|COMPLETED|Overall Study||0
2249366|NCT02491411|5518318|P1|STARTED|Overall Study||4
2249367|NCT02491359|5518328|P1|NOT COMPLETED|Overall Study||16
2249368|NCT02491359|5518328|P1|COMPLETED|Overall Study||4
2249369|NCT02491359|5518328|P1|STARTED|Overall Study||20
2249370|NCT02491073|5518349|P2|NOT COMPLETED|Overall Study||0
2249371|NCT02491073|5518350|P1|NOT COMPLETED|Overall Study||1
2249372|NCT02491073|5518349|P2|COMPLETED|Overall Study||34
2249373|NCT02491073|5518350|P1|COMPLETED|Overall Study||36
2249374|NCT02491073|5518349|P2|STARTED|Overall Study||34
2249375|NCT02491073|5518350|P1|STARTED|Overall Study||37
2249376|NCT02490670|5518378|P2|NOT COMPLETED|Period 2 (19 Days)||0
2249377|NCT02490670|5518379|P1|NOT COMPLETED|Period 2 (19 Days)||0
2249378|NCT02490670|5518378|P2|COMPLETED|Period 2 (19 Days)||14
2249379|NCT02490670|5518379|P1|COMPLETED|Period 2 (19 Days)||14
2249380|NCT02490670|5518378|P2|STARTED|Period 2 (19 Days)||14
2249381|NCT02490670|5518379|P1|STARTED|Period 2 (19 Days)||14
2249382|NCT02490670|5518378|P2|NOT COMPLETED|Washout Period (7 Days)||0
2249383|NCT02490670|5518379|P1|NOT COMPLETED|Washout Period (7 Days)||0
2249384|NCT02490670|5518378|P2|COMPLETED|Washout Period (7 Days)||14
2249385|NCT02490670|5518379|P1|COMPLETED|Washout Period (7 Days)||14
2249386|NCT02490670|5518378|P2|STARTED|Washout Period (7 Days)||14
2249387|NCT02490670|5518379|P1|STARTED|Washout Period (7 Days)||14
2249388|NCT02490670|5518378|P2|NOT COMPLETED|Period 1 (19 Days)||0
2249389|NCT02490670|5518379|P1|NOT COMPLETED|Period 1 (19 Days)||0
2249390|NCT02490670|5518378|P2|COMPLETED|Period 1 (19 Days)||14
2249391|NCT02490670|5518379|P1|COMPLETED|Period 1 (19 Days)||14
2249392|NCT02490670|5518378|P2|STARTED|Period 1 (19 Days)||14
2249393|NCT02490670|5518379|P1|STARTED|Period 1 (19 Days)||14
2249400|NCT02490475|5518402|P4|NOT COMPLETED|Period 2: Extension Phase||1
2249401|NCT02490475|5518403|P3|NOT COMPLETED|Period 2: Extension Phase||3
2249402|NCT02490475|5518404|P2|NOT COMPLETED|Period 2: Extension Phase||0
2249403|NCT02490475|5518405|P1|NOT COMPLETED|Period 2: Extension Phase||1
2249404|NCT02490475|5518402|P4|COMPLETED|Period 2: Extension Phase||0
2249405|NCT02490475|5518403|P3|COMPLETED|Period 2: Extension Phase||0
2249406|NCT02490475|5518404|P2|COMPLETED|Period 2: Extension Phase||0
2249407|NCT02490475|5518405|P1|COMPLETED|Period 2: Extension Phase||0
2249408|NCT02490475|5518402|P4|STARTED|Period 2: Extension Phase||1
2249409|NCT02490475|5518403|P3|STARTED|Period 2: Extension Phase||3
2249410|NCT02490475|5518404|P2|STARTED|Period 2: Extension Phase||0
2249411|NCT02490475|5518405|P1|STARTED|Period 2: Extension Phase||1
2249412|NCT02490475|5518402|P4|NOT COMPLETED|Period 1: First 6 Cycles||5
2249413|NCT02490475|5518403|P3|NOT COMPLETED|Period 1: First 6 Cycles||6
2249414|NCT02490475|5518404|P2|NOT COMPLETED|Period 1: First 6 Cycles||2
2249415|NCT02490475|5518405|P1|NOT COMPLETED|Period 1: First 6 Cycles||6
2249416|NCT02490475|5518402|P4|COMPLETED|Period 1: First 6 Cycles||0
2249417|NCT02490475|5518403|P3|COMPLETED|Period 1: First 6 Cycles||0
2249418|NCT02490475|5518404|P2|COMPLETED|Period 1: First 6 Cycles||0
2249419|NCT02490475|5518405|P1|COMPLETED|Period 1: First 6 Cycles||0
2249420|NCT02490475|5518402|P4|STARTED|Period 1: First 6 Cycles||5
2249421|NCT02490475|5518403|P3|STARTED|Period 1: First 6 Cycles||6
2249422|NCT02490475|5518404|P2|STARTED|Period 1: First 6 Cycles||2
2249423|NCT02490475|5518405|P1|STARTED|Period 1: First 6 Cycles||6
2249424|NCT02490371|5518483|P2|NOT COMPLETED|Overall Study||1
2249425|NCT02490371|5518484|P1|NOT COMPLETED|Overall Study||1
2249426|NCT02490371|5518483|P2|COMPLETED|Overall Study||11
2249427|NCT02490371|5518484|P1|COMPLETED|Overall Study||11
2249428|NCT02490371|5518483|P2|STARTED|Overall Study||12
2249429|NCT02490371|5518484|P1|STARTED|Overall Study||12
2249430|NCT02490293|5518502|P2|NOT COMPLETED|Overall Study||3
2249431|NCT02490293|5518503|P1|NOT COMPLETED|Overall Study||2
2249432|NCT02490293|5518502|P2|COMPLETED|Overall Study||99
2249433|NCT02490293|5518503|P1|COMPLETED|Overall Study||94
2249434|NCT02490293|5518502|P2|STARTED|Overall Study||102
2249435|NCT02490293|5518503|P1|STARTED|Overall Study||96
2249436|NCT02489981|5518511|P1|NOT COMPLETED|Overall Study||127
2249437|NCT02489981|5518511|P1|COMPLETED|Overall Study||213
2249438|NCT02489981|5518511|P1|STARTED|Overall Study||340
2249439|NCT02489968|5518518|P6|NOT COMPLETED|Double-blind Treatment Period||8
2249440|NCT02489968|5518519|P5|NOT COMPLETED|Double-blind Treatment Period||6
2249441|NCT02489968|5518520|P4|NOT COMPLETED|Double-blind Treatment Period||8
2249442|NCT02489968|5518521|P3|NOT COMPLETED|Double-blind Treatment Period||2
2249443|NCT02489968|5518522|P2|NOT COMPLETED|Double-blind Treatment Period||0
2249444|NCT02489968|5518523|P1|NOT COMPLETED|Double-blind Treatment Period||0
2249445|NCT02489968|5518518|P6|COMPLETED|Double-blind Treatment Period||108
2249446|NCT02489968|5518519|P5|COMPLETED|Double-blind Treatment Period||110
2249447|NCT02489968|5518520|P4|COMPLETED|Double-blind Treatment Period||100
2249448|NCT02489968|5518521|P3|COMPLETED|Double-blind Treatment Period||105
2249449|NCT02489968|5518522|P2|COMPLETED|Double-blind Treatment Period||0
2249450|NCT02489968|5518523|P1|COMPLETED|Double-blind Treatment Period||0
2249451|NCT02489968|5518518|P6|STARTED|Double-blind Treatment Period||116
2249452|NCT02489968|5518519|P5|STARTED|Double-blind Treatment Period||116
2249453|NCT02489968|5518520|P4|STARTED|Double-blind Treatment Period||108
2249454|NCT02489968|5518521|P3|STARTED|Double-blind Treatment Period||107
2249455|NCT02489968|5518522|P2|STARTED|Double-blind Treatment Period||0
2249456|NCT02489968|5518523|P1|STARTED|Double-blind Treatment Period||0
2249457|NCT02489968|5518518|P6|NOT COMPLETED|Open-label Treatment Period||0
2249458|NCT02489968|5518519|P5|NOT COMPLETED|Open-label Treatment Period||0
2249459|NCT02489968|5518520|P4|NOT COMPLETED|Open-label Treatment Period||0
2249460|NCT02489968|5518521|P3|NOT COMPLETED|Open-label Treatment Period||0
2249461|NCT02489968|5518522|P2|NOT COMPLETED|Open-label Treatment Period||208
2249462|NCT02489968|5518523|P1|NOT COMPLETED|Open-label Treatment Period||224
2249463|NCT02489968|5518518|P6|COMPLETED|Open-label Treatment Period||0
2249464|NCT02489968|5518519|P5|COMPLETED|Open-label Treatment Period||0
2249465|NCT02489968|5518520|P4|COMPLETED|Open-label Treatment Period||0
2249466|NCT02489968|5518521|P3|COMPLETED|Open-label Treatment Period||0
2249467|NCT02489968|5518522|P2|COMPLETED|Open-label Treatment Period||232
2249468|NCT02489968|5518523|P1|COMPLETED|Open-label Treatment Period||215
2249469|NCT02489968|5518518|P6|STARTED|Open-label Treatment Period||0
2249470|NCT02489968|5518519|P5|STARTED|Open-label Treatment Period||0
2249471|NCT02489968|5518520|P4|STARTED|Open-label Treatment Period||0
2249472|NCT02489968|5518521|P3|STARTED|Open-label Treatment Period||0
2249473|NCT02489968|5518522|P2|STARTED|Open-label Treatment Period|1 subject did not receive treatment and hence excluded. Started represents treated numbers.|440
2249474|NCT02489968|5518523|P1|STARTED|Open-label Treatment Period||439
2249475|NCT02489799|5518537|P2|NOT COMPLETED|Overall Study||9
2249476|NCT02489799|5518538|P1|NOT COMPLETED|Overall Study||9
2249477|NCT02489799|5518537|P2|COMPLETED|Overall Study||38
2249478|NCT02489799|5518538|P1|COMPLETED|Overall Study||36
2249479|NCT02489799|5518537|P2|Postsurgical One Week Visit (V3)|Overall Study||39
2249480|NCT02489799|5518538|P1|Postsurgical One Week Visit (V3)|Overall Study||40
2249481|NCT02489799|5518537|P2|Presurgical Consent Visit (V2)|Overall Study||39
2249482|NCT02489799|5518538|P1|Presurgical Consent Visit (V2)|Overall Study||40
2249483|NCT02489799|5518537|P2|STARTED|Overall Study||47
2249484|NCT02489799|5518538|P1|STARTED|Overall Study||45
2249485|NCT02489773|5518564|P2|NOT COMPLETED|Overall Study||2
2249486|NCT02489773|5518565|P1|NOT COMPLETED|Overall Study||7
2249487|NCT02489773|5518564|P2|COMPLETED|Overall Study||50
2249488|NCT02489773|5518565|P1|COMPLETED|Overall Study||91
2249489|NCT02489773|5518564|P2|STARTED|Overall Study||52
2249490|NCT02489773|5518565|P1|STARTED|Overall Study||98
2249491|NCT02489500|5518575|P2|NOT COMPLETED|Overall Study||1
2249492|NCT02489500|5518576|P1|NOT COMPLETED|Overall Study||1
2249493|NCT02489500|5518575|P2|COMPLETED|Overall Study||0
2249494|NCT02489500|5518576|P1|COMPLETED|Overall Study||1
2249495|NCT02489500|5518575|P2|STARTED|Overall Study||1
2249496|NCT02489500|5518576|P1|STARTED|Overall Study||2
2249497|NCT02489357|5518588|P1|NOT COMPLETED|Overall Study||0
2249498|NCT02489357|5518588|P1|COMPLETED|Overall Study||12
2249499|NCT02489357|5518588|P1|STARTED|Overall Study||12
2249500|NCT02489344|5518594|P1|NOT COMPLETED|LTS14116 (Extension Study): 31 Months||3
2249501|NCT02489344|5518594|P1|COMPLETED|LTS14116 (Extension Study): 31 Months||5
2249502|NCT02489344|5518594|P1|STARTED|LTS14116 (Extension Study): 31 Months||8
2249503|NCT02489344|5518594|P1|NOT COMPLETED|ACT13739 (Initial Study): 26 Weeks||2
2249504|NCT02489344|5518594|P1|COMPLETED|ACT13739 (Initial Study): 26 Weeks||9
2249505|NCT02489344|5518594|P1|STARTED|ACT13739 (Initial Study): 26 Weeks||11
2249506|NCT02489279|5518636|P2|NOT COMPLETED|Overall Study||10
2249507|NCT02489279|5518637|P1|NOT COMPLETED|Overall Study||12
2249508|NCT02489279|5518636|P2|COMPLETED|Overall Study||31
2249509|NCT02489279|5518637|P1|COMPLETED|Overall Study||32
2249510|NCT02489279|5518636|P2|STARTED|Overall Study||41
2249511|NCT02489279|5518637|P1|STARTED|Overall Study||44
2249512|NCT02489227|5518652|P3|NOT COMPLETED|Overall Study||19
2249513|NCT02489227|5518653|P2|NOT COMPLETED|Overall Study||34
2249514|NCT02489227|5518654|P1|NOT COMPLETED|Overall Study||54
2249515|NCT02489227|5518652|P3|COMPLETED|Overall Study||117
2249516|NCT02489227|5518653|P2|COMPLETED|Overall Study||101
2249517|NCT02489227|5518654|P1|COMPLETED|Overall Study||220
2249518|NCT02489227|5518652|P3|STARTED|Overall Study||136
2249519|NCT02489227|5518653|P2|STARTED|Overall Study||135
2249520|NCT02489227|5518654|P1|STARTED|Overall Study||274
2249521|NCT02489110|5518666|P2|NOT COMPLETED|Overall Study||25
2249522|NCT02489110|5518667|P1|NOT COMPLETED|Overall Study||27
2249523|NCT02489110|5518666|P2|COMPLETED|Overall Study||50
2249524|NCT02489110|5518667|P1|COMPLETED|Overall Study||48
2249525|NCT02489110|5518666|P2|STARTED|Overall Study||75
2249526|NCT02489110|5518667|P1|STARTED|Overall Study||75
2249527|NCT02488980|5518678|P3|NOT COMPLETED|Overall Study||2
2249528|NCT02488980|5518679|P2|NOT COMPLETED|Overall Study||2
2249529|NCT02488980|5518680|P1|NOT COMPLETED|Overall Study||2
2249530|NCT02488980|5518678|P3|COMPLETED|Overall Study||99
2249531|NCT02488980|5518679|P2|COMPLETED|Overall Study||99
2249532|NCT02488980|5518680|P1|COMPLETED|Overall Study||102
2249533|NCT02488980|5518678|P3|STARTED|Overall Study||101
2249534|NCT02488980|5518679|P2|STARTED|Overall Study||101
2249535|NCT02488980|5518680|P1|STARTED|Overall Study||104
2249536|NCT02488915|5518697|P1|NOT COMPLETED|Overall Study||26
2249537|NCT02488915|5518697|P1|COMPLETED|Overall Study||202
2249538|NCT02488915|5518697|P1|STARTED|Overall Study||228
2249539|NCT02488824|5518715|P2|NOT COMPLETED|Overall Study||1
2249540|NCT02488824|5518716|P1|NOT COMPLETED|Overall Study||1
2249541|NCT02488824|5518715|P2|COMPLETED|Overall Study||19
2249542|NCT02488824|5518716|P1|COMPLETED|Overall Study||20
2249543|NCT02488824|5518715|P2|STARTED|Overall Study||20
2249544|NCT02488824|5518716|P1|STARTED|Overall Study||21
2249545|NCT02488681|5518730|P1|NOT COMPLETED|Overall Study||7
2249546|NCT02488681|5518730|P1|COMPLETED|Overall Study|Patients successfully implanted with Micra|269
2249547|NCT02488681|5518730|P1|STARTED|Overall Study|Patients with Micra implant attempt|276
2249548|NCT02488330|5518734|P1|NOT COMPLETED|Overall Study||12
2249549|NCT02488330|5518734|P1|COMPLETED|Overall Study||0
2249550|NCT02488330|5518734|P1|STARTED|Overall Study||12
2249551|NCT02488317|5518740|P2|NOT COMPLETED|Overall Study||47
2249552|NCT02488317|5518741|P1|NOT COMPLETED|Overall Study||54
2249553|NCT02488317|5518740|P2|COMPLETED|Overall Study||70
2249554|NCT02488317|5518741|P1|COMPLETED|Overall Study||63
2249555|NCT02488317|5518740|P2|STARTED|Overall Study||117
2249556|NCT02488317|5518741|P1|STARTED|Overall Study||117
2249557|NCT02488239|5518755|P1|NOT COMPLETED|Overall Study||10
2249558|NCT02488239|5518755|P1|COMPLETED|Overall Study||54
2249559|NCT02488239|5518755|P1|STARTED|Overall Study||64
2249560|NCT02488070|5518760|P1|NOT COMPLETED|Overall Study||0
2249561|NCT02488070|5518760|P1|COMPLETED|Overall Study||10
2249562|NCT02488070|5518760|P1|STARTED|Overall Study||10
2249563|NCT02488018|5518768|P1|NOT COMPLETED|Overall Study||0
2249564|NCT02488018|5518768|P1|COMPLETED|Overall Study||10
2249565|NCT02488018|5518768|P1|STARTED|Overall Study||10
2249566|NCT02488005|5518772|P1|NOT COMPLETED|Overall Study||2
2249567|NCT02488005|5518772|P1|COMPLETED|Overall Study||13
2249568|NCT02488005|5518772|P1|STARTED|Overall Study||15
2249569|NCT02487979|5518782|P1|NOT COMPLETED|Overall Study||21
2249570|NCT02487979|5518782|P1|COMPLETED|Overall Study||1
2249571|NCT02487979|5518782|P1|STARTED|Overall Study||22
2249572|NCT02487810|5518794|P2|NOT COMPLETED|Overall Study||0
2249573|NCT02487810|5518795|P1|NOT COMPLETED|Overall Study||1
2249574|NCT02487810|5518794|P2|COMPLETED|Overall Study||102
2249575|NCT02487810|5518795|P1|COMPLETED|Overall Study||97
2249576|NCT02487810|5518794|P2|STARTED|Overall Study||102
2249577|NCT02487810|5518795|P1|STARTED|Overall Study||98
2249578|NCT02487771|5518827|P2|NOT COMPLETED|Overall Study||14
2249579|NCT02487771|5518828|P1|NOT COMPLETED|Overall Study||10
2249580|NCT02487771|5518827|P2|COMPLETED|Overall Study||85
2249581|NCT02487771|5518828|P1|COMPLETED|Overall Study||81
2249582|NCT02487771|5518827|P2|STARTED|Overall Study||99
2249583|NCT02487771|5518828|P1|STARTED|Overall Study||91
2249584|NCT02487498|5518978|P2|NOT COMPLETED|Period: Period 2||5
2249585|NCT02487498|5518979|P1|NOT COMPLETED|Period: Period 2||6
2249586|NCT02487498|5518978|P2|COMPLETED|Period: Period 2||154
2249587|NCT02487498|5518979|P1|COMPLETED|Period: Period 2||164
2249588|NCT02487498|5518978|P2|STARTED|Period: Period 2||159
2249589|NCT02487498|5518979|P1|STARTED|Period: Period 2||170
2249590|NCT02487498|5518978|P2|NOT COMPLETED|Period: Washout||7
2249591|NCT02487498|5518979|P1|NOT COMPLETED|Period: Washout||2
2249592|NCT02487498|5518978|P2|COMPLETED|Period: Washout||159
2249593|NCT02487498|5518979|P1|COMPLETED|Period: Washout||170
2249594|NCT02487498|5518978|P2|STARTED|Period: Washout||166
2249595|NCT02487498|5518979|P1|STARTED|Period: Washout||172
2249596|NCT02487498|5518978|P2|NOT COMPLETED|Period: Period 1||11
2249597|NCT02487498|5518979|P1|NOT COMPLETED|Period: Period 1||6
2249598|NCT02487498|5518978|P2|COMPLETED|Period: Period 1||166
2249599|NCT02487498|5518979|P1|COMPLETED|Period: Period 1||172
2249600|NCT02487498|5518978|P2|STARTED|Period: Period 1||177
2249601|NCT02487498|5518979|P1|STARTED|Period: Period 1||178
2249602|NCT02487472|5519002|P1|NOT COMPLETED|Overall Study||11
2249603|NCT02487472|5519002|P1|COMPLETED|Overall Study||90
2249604|NCT02487472|5519002|P1|STARTED|Overall Study||101
2249605|NCT02487446|5519018|P2|NOT COMPLETED|Period 2||5
2249606|NCT02487446|5519019|P1|NOT COMPLETED|Period 2||8
2249607|NCT02487446|5519018|P2|COMPLETED|Period 2||158
2249608|NCT02487446|5519019|P1|COMPLETED|Period 2||154
2249609|NCT02487446|5519018|P2|STARTED|Period 2||163
2249610|NCT02487446|5519019|P1|STARTED|Period 2||162
2249611|NCT02487446|5519018|P2|NOT COMPLETED|Washout||8
2249612|NCT02487446|5519019|P1|NOT COMPLETED|Washout||3
2249613|NCT02487446|5519018|P2|COMPLETED|Washout||163
2249614|NCT02487446|5519019|P1|COMPLETED|Washout||162
2249615|NCT02487446|5519018|P2|STARTED|Washout||171
2249616|NCT02487446|5519019|P1|STARTED|Washout||165
2249617|NCT02487446|5519018|P2|NOT COMPLETED|Period 1||8
2249618|NCT02487446|5519019|P1|NOT COMPLETED|Period 1||13
2249619|NCT02487446|5519018|P2|COMPLETED|Period 1||171
2249620|NCT02487446|5519019|P1|COMPLETED|Period 1||165
2249621|NCT02487446|5519018|P2|STARTED|Period 1||179
2249622|NCT02487446|5519019|P1|STARTED|Period 1||178
2249623|NCT02487303|5519045|P3|NOT COMPLETED|Overall Study||1
2249624|NCT02487303|5519046|P2|NOT COMPLETED|Overall Study||4
2249625|NCT02487303|5519047|P1|NOT COMPLETED|Overall Study||2
2249626|NCT02487303|5519045|P3|COMPLETED|Overall Study||47
2249627|NCT02487303|5519046|P2|COMPLETED|Overall Study||47
2249628|NCT02487303|5519047|P1|COMPLETED|Overall Study||47
2249629|NCT02487303|5519045|P3|STARTED|Overall Study||48
2249630|NCT02487303|5519046|P2|STARTED|Overall Study||51
2249631|NCT02487303|5519047|P1|STARTED|Overall Study||49
2249632|NCT02487277|5519066|P2|NOT COMPLETED|Overall Study||0
2249633|NCT02487277|5519067|P1|NOT COMPLETED|Overall Study||0
2249634|NCT02487277|5519066|P2|COMPLETED|Overall Study||0
2249635|NCT02487277|5519067|P1|COMPLETED|Overall Study||3
2249636|NCT02487277|5519066|P2|STARTED|Overall Study||0
2249637|NCT02487277|5519067|P1|STARTED|Overall Study||3
2249638|NCT02487225|5519084|P2|NOT COMPLETED|Overall Study||30
2249639|NCT02487225|5519085|P1|NOT COMPLETED|Overall Study||27
2249640|NCT02487225|5519084|P2|COMPLETED|Overall Study||8
2249641|NCT02487225|5519085|P1|COMPLETED|Overall Study||18
2249642|NCT02487225|5519084|P2|STARTED|Overall Study||38
2249643|NCT02487225|5519085|P1|STARTED|Overall Study||45
2249644|NCT02487199|5519099|P2|NOT COMPLETED|Overall Study||1
2249645|NCT02487199|5519100|P1|NOT COMPLETED|Overall Study||0
2249646|NCT02487199|5519099|P2|COMPLETED|Overall Study||4
2249647|NCT02487199|5519100|P1|COMPLETED|Overall Study||13
2249648|NCT02487199|5519099|P2|STARTED|Overall Study||5
2249649|NCT02487199|5519100|P1|STARTED|Overall Study||13
2249650|NCT02487030|5519119|P7|NOT COMPLETED|Overall Study||0
2249651|NCT02487030|5519120|P6|NOT COMPLETED|Overall Study||1
2249652|NCT02487030|5519121|P5|NOT COMPLETED|Overall Study||2
2249653|NCT02487030|5519122|P4|NOT COMPLETED|Overall Study||2
2249654|NCT02487030|5519123|P3|NOT COMPLETED|Overall Study||2
2249655|NCT02487030|5519124|P2|NOT COMPLETED|Overall Study||4
2249656|NCT02487030|5519125|P1|NOT COMPLETED|Overall Study||2
2249657|NCT02487030|5519119|P7|COMPLETED|Overall Study||11
2249658|NCT02487030|5519120|P6|COMPLETED|Overall Study||37
2249659|NCT02487030|5519121|P5|COMPLETED|Overall Study||34
2249660|NCT02487030|5519122|P4|COMPLETED|Overall Study||40
2249661|NCT02487030|5519123|P3|COMPLETED|Overall Study||41
2249662|NCT02487030|5519124|P2|COMPLETED|Overall Study||38
2249663|NCT02487030|5519125|P1|COMPLETED|Overall Study||41
2249664|NCT02487030|5519119|P7|STARTED|Overall Study||11
2249665|NCT02487030|5519120|P6|STARTED|Overall Study||38
2249666|NCT02487030|5519121|P5|STARTED|Overall Study||36
2249667|NCT02487030|5519122|P4|STARTED|Overall Study||42
2249668|NCT02487030|5519123|P3|STARTED|Overall Study||43
2249669|NCT02487030|5519124|P2|STARTED|Overall Study||42
2249670|NCT02487030|5519125|P1|STARTED|Overall Study||43
2249671|NCT02486952|5519156|P1|NOT COMPLETED|Overall Study||50
2249672|NCT02486952|5519156|P1|COMPLETED|Overall Study||104
2249673|NCT02486952|5519156|P1|Started Induction Therapy|Overall Study||151
2249674|NCT02486952|5519156|P1|STARTED|Overall Study||154
2249675|NCT02486939|5519163|P2|NOT COMPLETED|Overall Study||2
2249676|NCT02486939|5519164|P1|NOT COMPLETED|Overall Study||1
2249677|NCT02486939|5519163|P2|COMPLETED|Overall Study||132
2249678|NCT02486939|5519164|P1|COMPLETED|Overall Study||224
2249679|NCT02486939|5519163|P2|STARTED|Overall Study||134
2249680|NCT02486939|5519164|P1|STARTED|Overall Study||225
2249681|NCT02486796|5519174|P2|NOT COMPLETED|Overall Study||1
2249682|NCT02486796|5519175|P1|NOT COMPLETED|Overall Study||2
2249683|NCT02486796|5519174|P2|COMPLETED|Overall Study||1
2249684|NCT02486796|5519175|P1|COMPLETED|Overall Study||1
2249685|NCT02486796|5519174|P2|STARTED|Overall Study||2
2249686|NCT02486796|5519175|P1|STARTED|Overall Study||3
2249687|NCT02486757|5519187|P1|NOT COMPLETED|Overall Study||1
2249688|NCT02486757|5519187|P1|COMPLETED|Overall Study||5
2249689|NCT02486757|5519187|P1|STARTED|Overall Study||6
2249690|NCT02486692|5519193|P2|NOT COMPLETED|Overall Study||7
2249691|NCT02486692|5519194|P1|NOT COMPLETED|Overall Study||4
2249692|NCT02486692|5519193|P2|COMPLETED|Overall Study||23
2249693|NCT02486692|5519194|P1|COMPLETED|Overall Study||26
2249694|NCT02486692|5519193|P2|STARTED|Overall Study||30
2249695|NCT02486692|5519194|P1|STARTED|Overall Study||30
2249696|NCT02486653|5519206|P2|NOT COMPLETED|Overall Study||4
2249697|NCT02486653|5519207|P1|NOT COMPLETED|Overall Study||6
2249698|NCT02486653|5519206|P2|COMPLETED|Overall Study||71
2249699|NCT02486653|5519207|P1|COMPLETED|Overall Study||70
2249700|NCT02486653|5519206|P2|STARTED|Overall Study||75
2249701|NCT02486653|5519207|P1|STARTED|Overall Study||76
2249702|NCT02486627|5519231|P2|NOT COMPLETED|Overall Study||9
2249703|NCT02486627|5519232|P1|NOT COMPLETED|Overall Study||7
2249704|NCT02486627|5519231|P2|COMPLETED|Overall Study||294
2249705|NCT02486627|5519232|P1|COMPLETED|Overall Study||299
2249706|NCT02486627|5519231|P2|STARTED|Overall Study||303
2249707|NCT02486627|5519232|P1|STARTED|Overall Study||306
2249708|NCT02486302|5519249|P1|NOT COMPLETED|Overall Study||676
2249709|NCT02486302|5519249|P1|COMPLETED|Overall Study||858
2249710|NCT02486302|5519249|P1|Treated|Overall Study||1523
2249711|NCT02486302|5519249|P1|STARTED|Overall Study||1534
2249712|NCT02486211|5519306|P2|NOT COMPLETED|Overall Study||0
2249713|NCT02486211|5519307|P1|NOT COMPLETED|Overall Study||1
2249714|NCT02486211|5519306|P2|COMPLETED|Overall Study||7
2249715|NCT02486211|5519307|P1|COMPLETED|Overall Study||6
2249716|NCT02486211|5519306|P2|STARTED|Overall Study||7
2249717|NCT02486211|5519307|P1|STARTED|Overall Study||7
2249718|NCT02486016|5519321|P1|NOT COMPLETED|Overall Study||0
2249719|NCT02486016|5519321|P1|COMPLETED|Overall Study||10
2249720|NCT02486016|5519321|P1|STARTED|Overall Study|Same 10 volunteers completed Apotex, Duragesic and Mylan arms of the study; crossover study.|10
2249721|NCT02485925|5519329|P1|NOT COMPLETED|Overall Study||15
2249722|NCT02485925|5519329|P1|COMPLETED|Overall Study||185
2249723|NCT02485925|5519329|P1|Per-Protocol Population|Overall Study||166
2249724|NCT02485925|5519329|P1|Intent to Treat (ITT) Population|Overall Study||193
2249725|NCT02485925|5519329|P1|Safety Population|Overall Study||200
2249726|NCT02485925|5519329|P1|STARTED|Overall Study||200
2249727|NCT02485912|5519339|P2|NOT COMPLETED|Overall Study||0
2249728|NCT02485912|5519340|P1|NOT COMPLETED|Overall Study||0
2249729|NCT02485912|5519339|P2|COMPLETED|Overall Study||20
2249730|NCT02485912|5519340|P1|COMPLETED|Overall Study||20
2249731|NCT02485912|5519339|P2|STARTED|Overall Study||20
2249732|NCT02485912|5519340|P1|STARTED|Overall Study||20
2249733|NCT02485834|5519348|P2|NOT COMPLETED|Overall Study||0
2249734|NCT02485834|5519349|P1|NOT COMPLETED|Overall Study||0
2249735|NCT02485834|5519348|P2|COMPLETED|Overall Study||2
2249736|NCT02485834|5519349|P1|COMPLETED|Overall Study||3
2249737|NCT02485834|5519348|P2|STARTED|Overall Study||2
2249738|NCT02485834|5519349|P1|STARTED|Overall Study||3
2249739|NCT02485717|5519361|P3|NOT COMPLETED|Overall Study||1
2249740|NCT02485717|5519362|P2|NOT COMPLETED|Overall Study||2
2249741|NCT02485717|5519363|P1|NOT COMPLETED|Overall Study||6
2249742|NCT02485717|5519361|P3|COMPLETED|Overall Study||27
2249743|NCT02485717|5519362|P2|COMPLETED|Overall Study||158
2249744|NCT02485717|5519363|P1|COMPLETED|Overall Study||170
2249745|NCT02485717|5519361|P3|STARTED|Overall Study||28
2249746|NCT02485717|5519362|P2|STARTED|Overall Study||160
2249747|NCT02485717|5519363|P1|STARTED|Overall Study||176
2249748|NCT02485704|5519378|P2|NOT COMPLETED|Overall Study||8
2249749|NCT02485704|5519379|P1|NOT COMPLETED|Overall Study||5
2249750|NCT02485704|5519378|P2|COMPLETED|Overall Study||118
2249751|NCT02485704|5519379|P1|COMPLETED|Overall Study||149
2249752|NCT02485704|5519378|P2|STARTED|Overall Study||126
2249753|NCT02485704|5519379|P1|STARTED|Overall Study||154
2249754|NCT02485561|5519388|P3|NOT COMPLETED|Overall Study||23
2249755|NCT02485561|5519389|P2|NOT COMPLETED|Overall Study||39
2249756|NCT02485561|5519390|P1|NOT COMPLETED|Overall Study||28
2249757|NCT02485561|5519388|P3|COMPLETED|Overall Study||136
2249758|NCT02485561|5519389|P2|COMPLETED|Overall Study||118
2249759|NCT02485561|5519390|P1|COMPLETED|Overall Study||133
2249760|NCT02485561|5519388|P3|Completed 1 mo Survey|Overall Study||144
2249761|NCT02485561|5519389|P2|Completed 1 mo Survey|Overall Study||138
2249762|NCT02485561|5519390|P1|Completed 1 mo Survey|Overall Study||145
2249763|NCT02485561|5519388|P3|STARTED|Overall Study||159
2249764|NCT02485561|5519389|P2|STARTED|Overall Study||157
2249765|NCT02485561|5519390|P1|STARTED|Overall Study||161
2249766|NCT02485483|5519427|P2|NOT COMPLETED|Overall Study||0
2249767|NCT02485483|5519428|P1|NOT COMPLETED|Overall Study||54
2249768|NCT02485483|5519427|P2|COMPLETED|Overall Study||1015
2249769|NCT02485483|5519428|P1|COMPLETED|Overall Study||223
2249770|NCT02485483|5519427|P2|STARTED|Overall Study||1015
2249771|NCT02485483|5519428|P1|STARTED|Overall Study||277
2249772|NCT02485353|5519443|P1|NOT COMPLETED|Overall Study||2
2249773|NCT02485353|5519443|P1|COMPLETED|Overall Study||0
2249774|NCT02485353|5519443|P1|STARTED|Overall Study||2
2249775|NCT02485301|5519450|P2|NOT COMPLETED|Overall Study||49
2249776|NCT02485301|5519451|P1|NOT COMPLETED|Overall Study||38
2249777|NCT02485301|5519450|P2|COMPLETED|Overall Study||1455
2249778|NCT02485301|5519451|P1|COMPLETED|Overall Study||1471
2249779|NCT02485301|5519450|P2|STARTED|Overall Study||1504
2249780|NCT02485301|5519451|P1|STARTED|Overall Study||1509
2249781|NCT02485158|5519501|P1|NOT COMPLETED|Overall Study||4
2249782|NCT02485158|5519501|P1|COMPLETED|Overall Study||24
2249783|NCT02485158|5519501|P1|STARTED|Overall Study||28
2249784|NCT02484911|5519590|P2|NOT COMPLETED|Overall Study||2
2249785|NCT02484911|5519591|P1|NOT COMPLETED|Overall Study||4
2249786|NCT02484911|5519590|P2|COMPLETED|Overall Study||58
2249787|NCT02484911|5519591|P1|COMPLETED|Overall Study||56
2249788|NCT02484911|5519590|P2|STARTED|Overall Study||60
2249789|NCT02484911|5519591|P1|STARTED|Overall Study||60
2249790|NCT02484898|5519619|P1|NOT COMPLETED|Overall Study||18
2249791|NCT02484898|5519619|P1|COMPLETED|Overall Study||182
2249792|NCT02484898|5519619|P1|STARTED|Overall Study||200
2249793|NCT02484859|5519625|P2|NOT COMPLETED|Overall Study||0
2249794|NCT02484859|5519626|P1|NOT COMPLETED|Overall Study||0
2249795|NCT02484859|5519625|P2|COMPLETED|Overall Study||44
2249796|NCT02484859|5519626|P1|COMPLETED|Overall Study||44
2249797|NCT02484859|5519625|P2|STARTED|Overall Study||44
2249798|NCT02484859|5519626|P1|STARTED|Overall Study||44
2249799|NCT02484807|5519646|P6|NOT COMPLETED|Overall Study||0
2249800|NCT02484807|5519647|P5|NOT COMPLETED|Overall Study||0
2249801|NCT02484807|5519648|P4|NOT COMPLETED|Overall Study||0
2249802|NCT02484807|5519649|P3|NOT COMPLETED|Overall Study||0
2249803|NCT02484807|5519650|P2|NOT COMPLETED|Overall Study||0
2249804|NCT02484807|5519651|P1|NOT COMPLETED|Overall Study||0
2249805|NCT02484807|5519646|P6|COMPLETED|Overall Study||6
2249806|NCT02484807|5519647|P5|COMPLETED|Overall Study||33
2249807|NCT02484807|5519648|P4|COMPLETED|Overall Study||21
2249808|NCT02484807|5519649|P3|COMPLETED|Overall Study||19
2249809|NCT02484807|5519650|P2|COMPLETED|Overall Study||7
2249810|NCT02484807|5519651|P1|COMPLETED|Overall Study||39
2249811|NCT02484807|5519646|P6|STARTED|Overall Study||6
2249812|NCT02484807|5519647|P5|STARTED|Overall Study||33
2249813|NCT02484807|5519648|P4|STARTED|Overall Study||21
2249814|NCT02484807|5519649|P3|STARTED|Overall Study||19
2249815|NCT02484807|5519650|P2|STARTED|Overall Study||7
2249816|NCT02484807|5519651|P1|STARTED|Overall Study||39
2249817|NCT02484729|5519681|P10|NOT COMPLETED|Overall Study||1
2249818|NCT02484729|5519682|P9|NOT COMPLETED|Overall Study||0
2249819|NCT02484729|5519683|P8|NOT COMPLETED|Overall Study||0
2249820|NCT02484729|5519684|P7|NOT COMPLETED|Overall Study||0
2249821|NCT02484729|5519685|P6|NOT COMPLETED|Overall Study||0
2249822|NCT02484729|5519686|P5|NOT COMPLETED|Overall Study||0
2249823|NCT02484729|5519687|P4|NOT COMPLETED|Overall Study||0
2249824|NCT02484729|5519688|P3|NOT COMPLETED|Overall Study||0
2249825|NCT02484729|5519689|P2|NOT COMPLETED|Overall Study||0
2249826|NCT02484729|5519690|P1|NOT COMPLETED|Overall Study||0
2249827|NCT02484729|5519681|P10|COMPLETED|Overall Study||7
2249828|NCT02484729|5519682|P9|COMPLETED|Overall Study||6
2249829|NCT02484729|5519683|P8|COMPLETED|Overall Study||6
2249830|NCT02484729|5519684|P7|COMPLETED|Overall Study||5
2249831|NCT02484729|5519685|P6|COMPLETED|Overall Study||6
2249832|NCT02484729|5519686|P5|COMPLETED|Overall Study||5
2249833|NCT02484729|5519687|P4|COMPLETED|Overall Study||6
2249834|NCT02484729|5519688|P3|COMPLETED|Overall Study||6
2249835|NCT02484729|5519689|P2|COMPLETED|Overall Study||6
2249836|NCT02484729|5519690|P1|COMPLETED|Overall Study||16
2249837|NCT02484729|5519681|P10|STARTED|Overall Study||8
2249838|NCT02484729|5519682|P9|STARTED|Overall Study||6
2249839|NCT02484729|5519683|P8|STARTED|Overall Study||6
2249840|NCT02484729|5519684|P7|STARTED|Overall Study||5
2249841|NCT02484729|5519685|P6|STARTED|Overall Study||6
2249842|NCT02484729|5519686|P5|STARTED|Overall Study||5
2249843|NCT02484729|5519687|P4|STARTED|Overall Study||6
2249844|NCT02484729|5519688|P3|STARTED|Overall Study||6
2249845|NCT02484729|5519689|P2|STARTED|Overall Study||6
2249846|NCT02484729|5519690|P1|STARTED|Overall Study||16
2249847|NCT02484651|5519888|P2|NOT COMPLETED|Overall Study||4
2249848|NCT02484651|5519889|P1|NOT COMPLETED|Overall Study||3
2249849|NCT02484651|5519888|P2|COMPLETED|Overall Study||31
2249850|NCT02484651|5519889|P1|COMPLETED|Overall Study||32
2249851|NCT02484651|5519888|P2|Data Analysis|Overall Study||31
2249852|NCT02484651|5519889|P1|Data Analysis|Overall Study||32
2249853|NCT02484651|5519888|P2|End of Clinical Study|Overall Study||35
2249854|NCT02484651|5519889|P1|End of Clinical Study|Overall Study||35
2249855|NCT02484651|5519888|P2|STARTED|Overall Study|35 patients were randomized|35
2249856|NCT02484651|5519889|P1|STARTED|Overall Study|35 patients were randomized|35
2249857|NCT02484222|5519901|P1|NOT COMPLETED|Overall Study||3
2249858|NCT02484222|5519901|P1|COMPLETED|Overall Study||77
2249859|NCT02484222|5519901|P1|STARTED|Overall Study||80
2249860|NCT02483975|5519910|P2|NOT COMPLETED|Overall Study||2
2249861|NCT02483975|5519911|P1|NOT COMPLETED|Overall Study||2
2249862|NCT02483975|5519910|P2|COMPLETED|Overall Study|Subject reported as not completed due to AE was discontinued due to exacerbation, was not an AE/SAE|53
2249863|NCT02483975|5519911|P1|COMPLETED|Overall Study||54
2249864|NCT02483975|5519910|P2|STARTED|Overall Study||55
2249865|NCT02483975|5519911|P1|STARTED|Overall Study||56
2249866|NCT02483611|5519928|P3|NOT COMPLETED|Overall Study||1
2249867|NCT02483611|5519929|P2|NOT COMPLETED|Overall Study||0
2249868|NCT02483611|5519930|P1|NOT COMPLETED|Overall Study||0
2249869|NCT02483611|5519928|P3|COMPLETED|Overall Study|One patient required decurarization|15
2249870|NCT02483611|5519929|P2|COMPLETED|Overall Study||16
2249871|NCT02483611|5519930|P1|COMPLETED|Overall Study||16
2249872|NCT02483611|5519928|P3|STARTED|Overall Study||16
2249873|NCT02483611|5519929|P2|STARTED|Overall Study||16
2249874|NCT02483611|5519930|P1|STARTED|Overall Study||16
2249875|NCT02483585|5520027|P2|NOT COMPLETED|Open-label Treatment Phase||25
2249876|NCT02483585|5520028|P1|NOT COMPLETED|Open-label Treatment Phase||27
2249877|NCT02483585|5520027|P2|COMPLETED|Open-label Treatment Phase||243
2249878|NCT02483585|5520028|P1|COMPLETED|Open-label Treatment Phase||243
2249879|NCT02483585|5520027|P2|STARTED|Open-label Treatment Phase|Three participants who completed the double-blind phase did not enter the open-label treatment phase|268
2249880|NCT02483585|5520028|P1|STARTED|Open-label Treatment Phase|Five participants who completed the double-blind phase did not enter the open-label treatment phase|270
2249881|NCT02483585|5520027|P2|NOT COMPLETED|Double-blind Treatment Phase||15
2249882|NCT02483585|5520028|P1|NOT COMPLETED|Double-blind Treatment Phase||16
2249883|NCT02483585|5520027|P2|COMPLETED|Double-blind Treatment Phase||271
2249884|NCT02483585|5520028|P1|COMPLETED|Double-blind Treatment Phase||275
2249885|NCT02483585|5520027|P2|Received Treatment|Double-blind Treatment Phase||283
2249886|NCT02483585|5520028|P1|Received Treatment|Double-blind Treatment Phase||289
2249887|NCT02483585|5520027|P2|STARTED|Double-blind Treatment Phase||286
2249888|NCT02483585|5520028|P1|STARTED|Double-blind Treatment Phase||291
2249889|NCT02483572|5520050|P2|NOT COMPLETED|Overall Study||1
2249890|NCT02483572|5520051|P1|NOT COMPLETED|Overall Study||2
2249891|NCT02483572|5520050|P2|COMPLETED|Overall Study||1
2249892|NCT02483572|5520051|P1|COMPLETED|Overall Study||0
2249893|NCT02483572|5520050|P2|STARTED|Overall Study||2
2249894|NCT02483572|5520051|P1|STARTED|Overall Study||2
2249895|NCT02483533|5520065|P2|NOT COMPLETED|Overall Study||50
2249896|NCT02483533|5520066|P1|NOT COMPLETED|Overall Study||50
2249897|NCT02483533|5520065|P2|COMPLETED|Overall Study||0
2249898|NCT02483533|5520066|P1|COMPLETED|Overall Study||0
2249899|NCT02483533|5520065|P2|STARTED|Overall Study||50
2249900|NCT02483533|5520066|P1|STARTED|Overall Study||50
2249901|NCT02483416|5520076|P2|NOT COMPLETED|Overall Study||1
2249902|NCT02483416|5520077|P1|NOT COMPLETED|Overall Study||3
2249903|NCT02483416|5520076|P2|COMPLETED|Overall Study||6
2249904|NCT02483416|5520077|P1|COMPLETED|Overall Study||18
2249905|NCT02483416|5520076|P2|STARTED|Overall Study||7
2249906|NCT02483416|5520077|P1|STARTED|Overall Study||21
2249907|NCT02482935|5520132|P2|NOT COMPLETED|Period 2||0
2249908|NCT02482935|5520133|P1|NOT COMPLETED|Period 2||0
2249909|NCT02482935|5520132|P2|COMPLETED|Period 2||15
2249910|NCT02482935|5520133|P1|COMPLETED|Period 2||14
2249911|NCT02482935|5520132|P2|Follow-up|Period 2||15
2249912|NCT02482935|5520133|P1|Follow-up|Period 2||14
2249913|NCT02482935|5520132|P2|Received Abemaciclib|Period 2||15
2249914|NCT02482935|5520133|P1|Received Abemaciclib|Period 2||14
2249915|NCT02482935|5520132|P2|STARTED|Period 2||15
2249916|NCT02482935|5520133|P1|STARTED|Period 2||14
2249917|NCT02482935|5520132|P2|NOT COMPLETED|Period 1||0
2249918|NCT02482935|5520133|P1|NOT COMPLETED|Period 1||1
2249919|NCT02482935|5520132|P2|COMPLETED|Period 1||15
2249920|NCT02482935|5520133|P1|COMPLETED|Period 1||14
2249921|NCT02482935|5520132|P2|Washout|Period 1||15
2249922|NCT02482935|5520133|P1|Washout|Period 1||15
2249923|NCT02482935|5520132|P2|Received Abemaciclib|Period 1||15
2249924|NCT02482935|5520133|P1|Received Abemaciclib|Period 1||15
2249925|NCT02482935|5520132|P2|STARTED|Period 1||15
2249926|NCT02482935|5520133|P1|STARTED|Period 1||15
2249927|NCT02482870|5520143|P2|NOT COMPLETED|Period 2 - Rest of the Study||0
2249928|NCT02482870|5520144|P1|NOT COMPLETED|Period 2 - Rest of the Study||0
2249929|NCT02482870|5520143|P2|COMPLETED|Period 2 - Rest of the Study||202
2249930|NCT02482870|5520144|P1|COMPLETED|Period 2 - Rest of the Study||186
2249931|NCT02482870|5520143|P2|STARTED|Period 2 - Rest of the Study||202
2249932|NCT02482870|5520144|P1|STARTED|Period 2 - Rest of the Study||186
2249933|NCT02482870|5520143|P2|NOT COMPLETED|Period 1 - First 60 Patients||0
2249934|NCT02482870|5520144|P1|NOT COMPLETED|Period 1 - First 60 Patients||0
2249935|NCT02482870|5520143|P2|COMPLETED|Period 1 - First 60 Patients||30
2249936|NCT02482870|5520144|P1|COMPLETED|Period 1 - First 60 Patients||30
2249937|NCT02482870|5520143|P2|STARTED|Period 1 - First 60 Patients||30
2249938|NCT02482870|5520144|P1|STARTED|Period 1 - First 60 Patients||30
2249939|NCT02482805|5520161|P3|NOT COMPLETED|Overall Study||0
2249940|NCT02482805|5520162|P2|NOT COMPLETED|Overall Study||4
2249941|NCT02482805|5520163|P1|NOT COMPLETED|Overall Study||4
2249942|NCT02482805|5520161|P3|COMPLETED|Overall Study||20
2249943|NCT02482805|5520162|P2|COMPLETED|Overall Study||23
2249944|NCT02482805|5520163|P1|COMPLETED|Overall Study||22
2249945|NCT02482805|5520161|P3|STARTED|Overall Study||20
2249946|NCT02482805|5520162|P2|STARTED|Overall Study||27
2249947|NCT02482805|5520163|P1|STARTED|Overall Study||26
2249948|NCT02482675|5520177|P23|NOT COMPLETED|Overall Study||0
2249949|NCT02482675|5520178|P22|NOT COMPLETED|Overall Study||0
2249950|NCT02482675|5520179|P21|NOT COMPLETED|Overall Study||0
2249951|NCT02482675|5520180|P20|NOT COMPLETED|Overall Study||0
2249952|NCT02482675|5520181|P19|NOT COMPLETED|Overall Study||0
2249953|NCT02482675|5520182|P18|NOT COMPLETED|Overall Study||0
2249954|NCT02482675|5520183|P17|NOT COMPLETED|Overall Study||0
2249955|NCT02482675|5520184|P16|NOT COMPLETED|Overall Study||0
2249956|NCT02482675|5520185|P15|NOT COMPLETED|Overall Study||0
2249957|NCT02482675|5520186|P14|NOT COMPLETED|Overall Study||0
2249958|NCT02482675|5520187|P13|NOT COMPLETED|Overall Study||0
2249959|NCT02482675|5520188|P12|NOT COMPLETED|Overall Study||0
2249960|NCT02482675|5520189|P11|NOT COMPLETED|Overall Study||0
2249961|NCT02482675|5520190|P10|NOT COMPLETED|Overall Study||0
2249962|NCT02482675|5520191|P9|NOT COMPLETED|Overall Study||0
2249963|NCT02482675|5520192|P8|NOT COMPLETED|Overall Study||0
2249964|NCT02482675|5520193|P7|NOT COMPLETED|Overall Study||0
2249965|NCT02482675|5520194|P6|NOT COMPLETED|Overall Study||0
2249966|NCT02482675|5520195|P5|NOT COMPLETED|Overall Study||0
2249967|NCT02482675|5520196|P4|NOT COMPLETED|Overall Study||0
2249968|NCT02482675|5520197|P3|NOT COMPLETED|Overall Study||0
2249969|NCT02482675|5520198|P2|NOT COMPLETED|Overall Study||0
2249970|NCT02482675|5520199|P1|NOT COMPLETED|Overall Study||0
2249971|NCT02482675|5520177|P23|COMPLETED|Overall Study||1
2249972|NCT02482675|5520178|P22|COMPLETED|Overall Study||1
2249973|NCT02482675|5520179|P21|COMPLETED|Overall Study||1
2249974|NCT02482675|5520180|P20|COMPLETED|Overall Study||1
2249975|NCT02482675|5520181|P19|COMPLETED|Overall Study||1
2249976|NCT02482675|5520182|P18|COMPLETED|Overall Study||1
2249977|NCT02482675|5520183|P17|COMPLETED|Overall Study||1
2249978|NCT02482675|5520184|P16|COMPLETED|Overall Study||1
2249979|NCT02482675|5520185|P15|COMPLETED|Overall Study||1
2249980|NCT02482675|5520186|P14|COMPLETED|Overall Study||1
2249981|NCT02482675|5520187|P13|COMPLETED|Overall Study||1
2249982|NCT02482675|5520188|P12|COMPLETED|Overall Study||1
2249983|NCT02482675|5520189|P11|COMPLETED|Overall Study||1
2249984|NCT02482675|5520190|P10|COMPLETED|Overall Study||1
2249985|NCT02482675|5520191|P9|COMPLETED|Overall Study||1
2249986|NCT02482675|5520192|P8|COMPLETED|Overall Study||1
2249987|NCT02482675|5520193|P7|COMPLETED|Overall Study||1
2249988|NCT02482675|5520194|P6|COMPLETED|Overall Study||1
2249989|NCT02482675|5520195|P5|COMPLETED|Overall Study||1
2249990|NCT02482675|5520196|P4|COMPLETED|Overall Study||1
2249991|NCT02482675|5520197|P3|COMPLETED|Overall Study||1
2249992|NCT02482675|5520198|P2|COMPLETED|Overall Study||1
2249993|NCT02482675|5520199|P1|COMPLETED|Overall Study||1
2249994|NCT02482675|5520177|P23|STARTED|Overall Study||1
2249995|NCT02482675|5520178|P22|STARTED|Overall Study||1
2249996|NCT02482675|5520179|P21|STARTED|Overall Study||1
2249997|NCT02482675|5520180|P20|STARTED|Overall Study||1
2249998|NCT02482675|5520181|P19|STARTED|Overall Study||1
2249999|NCT02482675|5520182|P18|STARTED|Overall Study||1
2250000|NCT02482675|5520183|P17|STARTED|Overall Study||1
2250001|NCT02482675|5520184|P16|STARTED|Overall Study||1
2250002|NCT02482675|5520185|P15|STARTED|Overall Study||1
2250003|NCT02482675|5520186|P14|STARTED|Overall Study||1
2250004|NCT02482675|5520187|P13|STARTED|Overall Study||1
2250005|NCT02482675|5520188|P12|STARTED|Overall Study||1
2250006|NCT02482675|5520189|P11|STARTED|Overall Study||1
2250007|NCT02482675|5520190|P10|STARTED|Overall Study||1
2250008|NCT02482675|5520191|P9|STARTED|Overall Study||1
2250009|NCT02482675|5520192|P8|STARTED|Overall Study||1
2250010|NCT02482675|5520193|P7|STARTED|Overall Study||1
2250011|NCT02482675|5520194|P6|STARTED|Overall Study||1
2250012|NCT02482675|5520195|P5|STARTED|Overall Study||1
2250013|NCT02482675|5520196|P4|STARTED|Overall Study||1
2250014|NCT02482675|5520197|P3|STARTED|Overall Study||1
2250015|NCT02482675|5520198|P2|STARTED|Overall Study||1
2250016|NCT02482675|5520199|P1|STARTED|Overall Study||1
2250017|NCT02482610|5520257|P6|NOT COMPLETED|Overall Study||0
2250018|NCT02482610|5520258|P5|NOT COMPLETED|Overall Study||0
2250019|NCT02482610|5520259|P4|NOT COMPLETED|Overall Study||0
2250020|NCT02482610|5520260|P3|NOT COMPLETED|Overall Study||0
2250021|NCT02482610|5520261|P2|NOT COMPLETED|Overall Study||0
2250022|NCT02482610|5520262|P1|NOT COMPLETED|Overall Study||0
2250023|NCT02482610|5520257|P6|COMPLETED|Overall Study||5
2250024|NCT02482610|5520258|P5|COMPLETED|Overall Study||3
2250025|NCT02482610|5520259|P4|COMPLETED|Overall Study||3
2250026|NCT02482610|5520260|P3|COMPLETED|Overall Study||2
2250027|NCT02482610|5520261|P2|COMPLETED|Overall Study||5
2250028|NCT02482610|5520262|P1|COMPLETED|Overall Study||4
2250029|NCT02482610|5520257|P6|STARTED|Overall Study||5
2250030|NCT02482610|5520258|P5|STARTED|Overall Study||3
2250031|NCT02482610|5520259|P4|STARTED|Overall Study||3
2250032|NCT02482610|5520260|P3|STARTED|Overall Study||2
2250033|NCT02482610|5520261|P2|STARTED|Overall Study||5
2250034|NCT02482610|5520262|P1|STARTED|Overall Study||4
2250035|NCT02482571|5520282|P1|NOT COMPLETED|Overall Study||8
2250036|NCT02482571|5520282|P1|COMPLETED|Overall Study||17
2250037|NCT02482571|5520282|P1|STARTED|Overall Study||25
2250038|NCT02482428|5520294|P5|NOT COMPLETED|Overall Study||7
2250039|NCT02482428|5520295|P4|NOT COMPLETED|Overall Study||2
2250040|NCT02482428|5520296|P3|NOT COMPLETED|Overall Study||1
2250041|NCT02482428|5520297|P2|NOT COMPLETED|Overall Study||12
2250042|NCT02482428|5520298|P1|NOT COMPLETED|Overall Study||9
2250043|NCT02482428|5520294|P5|COMPLETED|Overall Study||15
2250044|NCT02482428|5520295|P4|COMPLETED|Overall Study||8
2250045|NCT02482428|5520296|P3|COMPLETED|Overall Study||9
2250046|NCT02482428|5520297|P2|COMPLETED|Overall Study||10
2250047|NCT02482428|5520298|P1|COMPLETED|Overall Study||15
2250048|NCT02482428|5520294|P5|STARTED|Overall Study||22
2250049|NCT02482428|5520295|P4|STARTED|Overall Study||10
2250050|NCT02482428|5520296|P3|STARTED|Overall Study||10
2250051|NCT02482428|5520297|P2|STARTED|Overall Study||22
2250052|NCT02482428|5520298|P1|STARTED|Overall Study||24
2250053|NCT02482298|5520321|P3|NOT COMPLETED|Overall Study||3
2250054|NCT02482298|5520322|P2|NOT COMPLETED|Overall Study||3
2250055|NCT02482298|5520323|P1|NOT COMPLETED|Overall Study||2
2250056|NCT02482298|5520321|P3|COMPLETED|Overall Study||27
2250057|NCT02482298|5520322|P2|COMPLETED|Overall Study||24
2250058|NCT02482298|5520323|P1|COMPLETED|Overall Study||28
2250059|NCT02482298|5520321|P3|STARTED|Overall Study||30
2250060|NCT02482298|5520322|P2|STARTED|Overall Study||27
2250061|NCT02482298|5520323|P1|STARTED|Overall Study||30
2250062|NCT02482233|5520345|P2|NOT COMPLETED|Overall Study||1
2250063|NCT02482233|5520346|P1|NOT COMPLETED|Overall Study||1
2250064|NCT02482233|5520345|P2|COMPLETED|Overall Study||19
2250065|NCT02482233|5520346|P1|COMPLETED|Overall Study||9
2250066|NCT02482233|5520345|P2|STARTED|Overall Study||20
2250067|NCT02482233|5520346|P1|STARTED|Overall Study||10
2250068|NCT02482129|5520382|P2|NOT COMPLETED|Overall Study||2
2250069|NCT02482129|5520383|P1|NOT COMPLETED|Overall Study||6
2250070|NCT02482129|5520382|P2|COMPLETED|Overall Study||9
2250071|NCT02482129|5520383|P1|COMPLETED|Overall Study||26
2250072|NCT02482129|5520382|P2|Treated, as Randomized|Overall Study||9
2250073|NCT02482129|5520383|P1|Treated, as Randomized|Overall Study||30
2250074|NCT02482129|5520382|P2|STARTED|Overall Study||11
2250075|NCT02482129|5520383|P1|STARTED|Overall Study||32
2250076|NCT02481934|5520410|P1|NOT COMPLETED|Overall Study||2
2250077|NCT02481934|5520410|P1|COMPLETED|Overall Study||3
2250078|NCT02481934|5520410|P1|STARTED|Overall Study||5
2250079|NCT02481830|5520417|P2|NOT COMPLETED|Overall Study||20
2250080|NCT02481830|5520418|P1|NOT COMPLETED|Overall Study||2
2250081|NCT02481830|5520417|P2|COMPLETED|Overall Study||265
2250082|NCT02481830|5520418|P1|COMPLETED|Overall Study||282
2250083|NCT02481830|5520417|P2|STARTED|Overall Study||285
2250084|NCT02481830|5520418|P1|STARTED|Overall Study||284
2250085|NCT02481596|5520431|P3|NOT COMPLETED|Overall Study||8
2250086|NCT02481596|5520432|P2|NOT COMPLETED|Overall Study||1
2250087|NCT02481596|5520433|P1|NOT COMPLETED|Overall Study||3
2250088|NCT02481596|5520431|P3|COMPLETED|Overall Study||245
2250089|NCT02481596|5520432|P2|COMPLETED|Overall Study||126
2250090|NCT02481596|5520433|P1|COMPLETED|Overall Study||123
2250091|NCT02481596|5520431|P3|STARTED|Overall Study||253
2250092|NCT02481596|5520432|P2|STARTED|Overall Study||127
2250093|NCT02481596|5520433|P1|STARTED|Overall Study||126
2250094|NCT02481557|5520458|P2|NOT COMPLETED|Overall Study||0
2250095|NCT02481557|5520459|P1|NOT COMPLETED|Overall Study||0
2250096|NCT02481557|5520458|P2|COMPLETED|Overall Study||19
2250097|NCT02481557|5520459|P1|COMPLETED|Overall Study||17
2250098|NCT02481557|5520458|P2|STARTED|Overall Study||19
2250099|NCT02481557|5520459|P1|STARTED|Overall Study||17
2250100|NCT02481375|5520471|P4|NOT COMPLETED|Overall Study||14
2250101|NCT02481375|5520472|P3|NOT COMPLETED|Overall Study||10
2250102|NCT02481375|5520473|P2|NOT COMPLETED|Overall Study||11
2250103|NCT02481375|5520474|P1|NOT COMPLETED|Overall Study||14
2250104|NCT02481375|5520471|P4|COMPLETED|Overall Study||186
2250105|NCT02481375|5520472|P3|COMPLETED|Overall Study||191
2250106|NCT02481375|5520473|P2|COMPLETED|Overall Study||191
2250107|NCT02481375|5520474|P1|COMPLETED|Overall Study||192
2250108|NCT02481375|5520471|P4|STARTED|Overall Study||200
2250109|NCT02481375|5520472|P3|STARTED|Overall Study||201
2250110|NCT02481375|5520473|P2|STARTED|Overall Study||202
2250111|NCT02481375|5520474|P1|STARTED|Overall Study||206
2250112|NCT02481258|5520486|P2|NOT COMPLETED|Overall Study||0
2250113|NCT02481258|5520487|P1|NOT COMPLETED|Overall Study||0
2250114|NCT02481258|5520486|P2|COMPLETED|Overall Study||11
2250115|NCT02481258|5520487|P1|COMPLETED|Overall Study||12
2250116|NCT02481258|5520486|P2|STARTED|Overall Study||11
2250117|NCT02481258|5520487|P1|STARTED|Overall Study||12
2250118|NCT02481219|5520495|P2|NOT COMPLETED|Overall Study||1
2250119|NCT02481219|5520496|P1|NOT COMPLETED|Overall Study||2
2250120|NCT02481219|5520495|P2|COMPLETED|Overall Study||61
2250121|NCT02481219|5520496|P1|COMPLETED|Overall Study||58
2250122|NCT02481219|5520495|P2|STARTED|Overall Study||62
2250123|NCT02481219|5520496|P1|STARTED|Overall Study||60
2250124|NCT02481141|5520514|P2|NOT COMPLETED|Overall Study||5
2250125|NCT02481141|5520515|P1|NOT COMPLETED|Overall Study||9
2250126|NCT02481141|5520514|P2|COMPLETED|Overall Study||13
2250127|NCT02481141|5520515|P1|COMPLETED|Overall Study||26
2250128|NCT02481141|5520514|P2|STARTED|Overall Study||18
2250129|NCT02481141|5520515|P1|STARTED|Overall Study||35
2250130|NCT02481050|5520567|P1|NOT COMPLETED|Overall Study||58
2250131|NCT02481050|5520567|P1|COMPLETED|Overall Study||0
2250132|NCT02481050|5520567|P1|STARTED|Overall Study||58
2250133|NCT02480998|5520578|P2|NOT COMPLETED|Overall Study||0
2250134|NCT02480998|5520579|P1|NOT COMPLETED|Overall Study||0
2250135|NCT02480998|5520578|P2|COMPLETED|Overall Study||28
2250136|NCT02480998|5520579|P1|COMPLETED|Overall Study||56
2250137|NCT02480998|5520578|P2|STARTED|Overall Study||28
2250138|NCT02480998|5520579|P1|STARTED|Overall Study||56
2250139|NCT02480920|5520587|P1|NOT COMPLETED|Overall Study||0
2250140|NCT02480920|5520587|P1|COMPLETED|Overall Study||2738
2250141|NCT02480920|5520587|P1|STARTED|Overall Study||2738
2250142|NCT02480764|5520594|P3|NOT COMPLETED|Overall Study||21
2250143|NCT02480764|5520595|P2|NOT COMPLETED|Overall Study||20
2250144|NCT02480764|5520596|P1|NOT COMPLETED|Overall Study||10
2250145|NCT02480764|5520594|P3|COMPLETED|Overall Study||183
2250146|NCT02480764|5520595|P2|COMPLETED|Overall Study||189
2250147|NCT02480764|5520596|P1|COMPLETED|Overall Study||189
2250148|NCT02480764|5520594|P3|STARTED|Overall Study||204
2250149|NCT02480764|5520595|P2|STARTED|Overall Study||209
2250150|NCT02480764|5520596|P1|STARTED|Overall Study||199
2250151|NCT02480712|5520622|P1|NOT COMPLETED|Overall Study||11
2250152|NCT02480712|5520622|P1|COMPLETED|Overall Study||96
2250153|NCT02480712|5520622|P1|STARTED|Overall Study||107
2250154|NCT02480621|5520641|P2|NOT COMPLETED|Follow Up||2
2250155|NCT02480621|5520642|P1|NOT COMPLETED|Follow Up||4
2250156|NCT02480621|5520641|P2|COMPLETED|Follow Up||37
2250157|NCT02480621|5520642|P1|COMPLETED|Follow Up||39
2250158|NCT02480621|5520641|P2|STARTED|Follow Up||39
2250159|NCT02480621|5520642|P1|STARTED|Follow Up||43
2250160|NCT02480621|5520641|P2|NOT COMPLETED|Randomization||1
2250161|NCT02480621|5520642|P1|NOT COMPLETED|Randomization||1
2250162|NCT02480621|5520641|P2|COMPLETED|Randomization||39
2250163|NCT02480621|5520642|P1|COMPLETED|Randomization||43
2250164|NCT02480621|5520641|P2|STARTED|Randomization||40
2250165|NCT02480621|5520642|P1|STARTED|Randomization||44
2250166|NCT02480582|5520648|P6|NOT COMPLETED|Overall Study||0
2250167|NCT02480582|5520649|P5|NOT COMPLETED|Overall Study||0
2250168|NCT02480582|5520650|P4|NOT COMPLETED|Overall Study||0
2250169|NCT02480582|5520651|P3|NOT COMPLETED|Overall Study||0
2250170|NCT02480582|5520652|P2|NOT COMPLETED|Overall Study||0
2250171|NCT02480582|5520653|P1|NOT COMPLETED|Overall Study||0
2250172|NCT02480582|5520648|P6|COMPLETED|Overall Study||7
2250173|NCT02480582|5520649|P5|COMPLETED|Overall Study||7
2250174|NCT02480582|5520650|P4|COMPLETED|Overall Study||7
2250175|NCT02480582|5520651|P3|COMPLETED|Overall Study||7
2250176|NCT02480582|5520652|P2|COMPLETED|Overall Study||7
2250177|NCT02480582|5520653|P1|COMPLETED|Overall Study||7
2250178|NCT02480582|5520648|P6|STARTED|Overall Study||7
2250179|NCT02480582|5520649|P5|STARTED|Overall Study||7
2250180|NCT02480582|5520650|P4|STARTED|Overall Study||7
2250181|NCT02480582|5520651|P3|STARTED|Overall Study||7
2250182|NCT02480582|5520652|P2|STARTED|Overall Study||7
2250183|NCT02480582|5520653|P1|STARTED|Overall Study||7
2250184|NCT02480439|5520676|P3|NOT COMPLETED|Treatment Period 3||0
2250185|NCT02480439|5520677|P2|NOT COMPLETED|Treatment Period 3||0
2250186|NCT02480439|5520678|P1|NOT COMPLETED|Treatment Period 3||0
2250187|NCT02480439|5520676|P3|COMPLETED|Treatment Period 3||7
2250188|NCT02480439|5520677|P2|COMPLETED|Treatment Period 3||7
2250189|NCT02480439|5520678|P1|COMPLETED|Treatment Period 3||8
2250190|NCT02480439|5520676|P3|STARTED|Treatment Period 3|1 Participant was withdrawn due to an Adverse Event after completing Period 2.|7
2250191|NCT02480439|5520677|P2|STARTED|Treatment Period 3||7
2250192|NCT02480439|5520678|P1|STARTED|Treatment Period 3||8
2250193|NCT02480439|5520676|P3|NOT COMPLETED|Treatment Period 2||0
2250194|NCT02480439|5520677|P2|NOT COMPLETED|Treatment Period 2||0
2250195|NCT02480439|5520678|P1|NOT COMPLETED|Treatment Period 2||0
2250196|NCT02480439|5520676|P3|COMPLETED|Treatment Period 2||8
2250197|NCT02480439|5520677|P2|COMPLETED|Treatment Period 2||7
2250198|NCT02480439|5520678|P1|COMPLETED|Treatment Period 2||8
2250199|NCT02480439|5520676|P3|STARTED|Treatment Period 2||8
2250200|NCT02480439|5520677|P2|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|7
2250201|NCT02480439|5520678|P1|STARTED|Treatment Period 2||8
2250202|NCT02480439|5520676|P3|NOT COMPLETED|Treatment Period 1||0
2250203|NCT02480439|5520677|P2|NOT COMPLETED|Treatment Period 1||0
2250204|NCT02480439|5520678|P1|NOT COMPLETED|Treatment Period 1||0
2250205|NCT02480439|5520676|P3|COMPLETED|Treatment Period 1||8
2250206|NCT02480439|5520677|P2|COMPLETED|Treatment Period 1||8
2250207|NCT02480439|5520678|P1|COMPLETED|Treatment Period 1||8
2250208|NCT02480439|5520676|P3|STARTED|Treatment Period 1||8
2250209|NCT02480439|5520677|P2|STARTED|Treatment Period 1||8
2250210|NCT02480439|5520678|P1|STARTED|Treatment Period 1||8
2250211|NCT02480166|5520704|P3|NOT COMPLETED|Overall Study||0
2250212|NCT02480166|5520705|P2|NOT COMPLETED|Overall Study||0
2250213|NCT02480166|5520706|P1|NOT COMPLETED|Overall Study||0
2250214|NCT02480166|5520704|P3|COMPLETED|Overall Study||4
2250215|NCT02480166|5520705|P2|COMPLETED|Overall Study||36
2250216|NCT02480166|5520706|P1|COMPLETED|Overall Study||20
2250217|NCT02480166|5520704|P3|STARTED|Overall Study||4
2250218|NCT02480166|5520705|P2|STARTED|Overall Study||36
2250219|NCT02480166|5520706|P1|STARTED|Overall Study||20
2250220|NCT02480153|5520719|P3|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||4
2250221|NCT02480153|5520720|P2|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||3
2250222|NCT02480153|5520721|P1|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||7
2250223|NCT02480153|5520719|P3|COMPLETED|Period 3: Week 52 Dosing to Week 78||123
2250224|NCT02480153|5520720|P2|COMPLETED|Period 3: Week 52 Dosing to Week 78||118
2250225|NCT02480153|5520721|P1|COMPLETED|Period 3: Week 52 Dosing to Week 78||252
2250226|NCT02480153|5520719|P3|Received Treatment|Period 3: Week 52 Dosing to Week 78||127
2250227|NCT02480153|5520720|P2|Received Treatment|Period 3: Week 52 Dosing to Week 78||120
2250228|NCT02480153|5520721|P1|Received Treatment|Period 3: Week 52 Dosing to Week 78||258
2250229|NCT02480153|5520719|P3|STARTED|Period 3: Week 52 Dosing to Week 78||127
2250230|NCT02480153|5520720|P2|STARTED|Period 3: Week 52 Dosing to Week 78||121
2250231|NCT02480153|5520721|P1|STARTED|Period 3: Week 52 Dosing to Week 78||259
2250232|NCT02480153|5520719|P3|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||7
2250233|NCT02480153|5520720|P2|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||13
2250234|NCT02480153|5520721|P1|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||20
2250235|NCT02480153|5520719|P3|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||127
2250236|NCT02480153|5520720|P2|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||122
2250237|NCT02480153|5520721|P1|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||263
2250238|NCT02480153|5520719|P3|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||133
2250239|NCT02480153|5520720|P2|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||135
2250240|NCT02480153|5520721|P1|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||283
2250241|NCT02480153|5520719|P3|STARTED|Period 2: Week 26 to Week 52 Pre-dose||134
2250242|NCT02480153|5520720|P2|STARTED|Period 2: Week 26 to Week 52 Pre-dose||135
2250243|NCT02480153|5520721|P1|STARTED|Period 2: Week 26 to Week 52 Pre-dose||283
2250244|NCT02480153|5520719|P3|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||0
2250245|NCT02480153|5520720|P2|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||16
2250246|NCT02480153|5520721|P1|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||4
2250247|NCT02480153|5520719|P3|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||0
2250248|NCT02480153|5520720|P2|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||284
2250249|NCT02480153|5520721|P1|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||293
2250250|NCT02480153|5520719|P3|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||0
2250251|NCT02480153|5520720|P2|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||299
2250252|NCT02480153|5520721|P1|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||297
2250253|NCT02480153|5520719|P3|STARTED|Period 1: First Dose to Week 26 Pre-dose||0
2250254|NCT02480153|5520720|P2|STARTED|Period 1: First Dose to Week 26 Pre-dose||300
2250255|NCT02480153|5520721|P1|STARTED|Period 1: First Dose to Week 26 Pre-dose||297
2250256|NCT02480010|5520898|P2|NOT COMPLETED|Overall Study||33
2250257|NCT02480010|5520899|P1|NOT COMPLETED|Overall Study||35
2250258|NCT02480010|5520898|P2|COMPLETED|Overall Study||0
2250259|NCT02480010|5520899|P1|COMPLETED|Overall Study||0
2250260|NCT02480010|5520898|P2|STARTED|Overall Study||33
2250261|NCT02480010|5520899|P1|STARTED|Overall Study||35
2250262|NCT02479880|5520945|P2|NOT COMPLETED|Overall Study||13
2250263|NCT02479880|5520946|P1|NOT COMPLETED|Overall Study||13
2250264|NCT02479880|5520945|P2|COMPLETED|Overall Study||2
2250265|NCT02479880|5520946|P1|COMPLETED|Overall Study||2
2250266|NCT02479880|5520945|P2|STARTED|Overall Study||15
2250267|NCT02479880|5520946|P1|STARTED|Overall Study||15
2250268|NCT02479763|5520954|P2|NOT COMPLETED|Overall Study||3
2250269|NCT02479763|5520955|P1|NOT COMPLETED|Overall Study||3
2250270|NCT02479763|5520954|P2|COMPLETED|Overall Study||50
2250271|NCT02479763|5520955|P1|COMPLETED|Overall Study||50
2250272|NCT02479763|5520954|P2|STARTED|Overall Study||53
2250273|NCT02479763|5520955|P1|STARTED|Overall Study||53
2250274|NCT02479412|5520970|P9|NOT COMPLETED|Overall Study||1
2250275|NCT02479412|5520971|P8|NOT COMPLETED|Overall Study||1
2250276|NCT02479412|5520972|P7|NOT COMPLETED|Overall Study||0
2250277|NCT02479412|5520973|P6|NOT COMPLETED|Overall Study||0
2250278|NCT02479412|5520974|P5|NOT COMPLETED|Overall Study||1
2250279|NCT02479412|5520975|P4|NOT COMPLETED|Overall Study||1
2250280|NCT02479412|5520976|P3|NOT COMPLETED|Overall Study||2
2250281|NCT02479412|5520977|P2|NOT COMPLETED|Overall Study||0
2250282|NCT02479412|5520978|P1|NOT COMPLETED|Overall Study||0
2250283|NCT02479412|5520970|P9|COMPLETED|Overall Study||6
2250284|NCT02479412|5520971|P8|COMPLETED|Overall Study||4
2250285|NCT02479412|5520972|P7|COMPLETED|Overall Study||6
2250286|NCT02479412|5520973|P6|COMPLETED|Overall Study||5
2250287|NCT02479412|5520974|P5|COMPLETED|Overall Study||5
2250288|NCT02479412|5520975|P4|COMPLETED|Overall Study||6
2250289|NCT02479412|5520976|P3|COMPLETED|Overall Study||4
2250290|NCT02479412|5520977|P2|COMPLETED|Overall Study||6
2250291|NCT02479412|5520978|P1|COMPLETED|Overall Study||6
2250292|NCT02479412|5520970|P9|STARTED|Overall Study||7
2250293|NCT02479412|5520971|P8|STARTED|Overall Study||5
2250294|NCT02479412|5520972|P7|STARTED|Overall Study||6
2250295|NCT02479412|5520973|P6|STARTED|Overall Study||5
2250296|NCT02479412|5520974|P5|STARTED|Overall Study||6
2250297|NCT02479412|5520975|P4|STARTED|Overall Study||7
2250298|NCT02479412|5520976|P3|STARTED|Overall Study||6
2250299|NCT02479412|5520977|P2|STARTED|Overall Study||6
2250300|NCT02479412|5520978|P1|STARTED|Overall Study||6
2250301|NCT02479139|5521055|P6|NOT COMPLETED|Overall Study||6
2250302|NCT02479139|5521056|P5|NOT COMPLETED|Overall Study||5
2250303|NCT02479139|5521057|P4|NOT COMPLETED|Overall Study||7
2250304|NCT02479139|5521058|P3|NOT COMPLETED|Overall Study||7
2250305|NCT02479139|5521059|P2|NOT COMPLETED|Overall Study||10
2250306|NCT02479139|5521060|P1|NOT COMPLETED|Overall Study||8
2250307|NCT02479139|5521055|P6|COMPLETED|Overall Study||19
2250308|NCT02479139|5521056|P5|COMPLETED|Overall Study||17
2250309|NCT02479139|5521057|P4|COMPLETED|Overall Study||14
2250310|NCT02479139|5521058|P3|COMPLETED|Overall Study||21
2250311|NCT02479139|5521059|P2|COMPLETED|Overall Study||12
2250312|NCT02479139|5521060|P1|COMPLETED|Overall Study||19
2250313|NCT02479139|5521055|P6|STARTED|Overall Study||25
2250314|NCT02479139|5521056|P5|STARTED|Overall Study||22
2250315|NCT02479139|5521057|P4|STARTED|Overall Study||21
2250316|NCT02479139|5521058|P3|STARTED|Overall Study||28
2250317|NCT02479139|5521059|P2|STARTED|Overall Study||22
2250318|NCT02479139|5521060|P1|STARTED|Overall Study||27
2250319|NCT02478671|5521086|P1|NOT COMPLETED|Overall Study||0
2250320|NCT02478671|5521086|P1|COMPLETED|Overall Study||4
2250321|NCT02478671|5521086|P1|STARTED|Overall Study||4
2250322|NCT02478632|5521093|P2|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||4
2250323|NCT02478632|5521094|P1|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||7
2250324|NCT02478632|5521093|P2|COMPLETED|Late Switch Phase (Week 52 to Week 148)||40
2250325|NCT02478632|5521094|P1|COMPLETED|Late Switch Phase (Week 52 to Week 148)||42
2250326|NCT02478632|5521093|P2|STARTED|Late Switch Phase (Week 52 to Week 148)||44
2250327|NCT02478632|5521094|P1|STARTED|Late Switch Phase (Week 52 to Week 148)||49
2250328|NCT02478632|5521093|P2|NOT COMPLETED|Early Switch Phase (Up to Week 52)||5
2250329|NCT02478632|5521094|P1|NOT COMPLETED|Early Switch Phase (Up to Week 52)||4
2250330|NCT02478632|5521093|P2|COMPLETED|Early Switch Phase (Up to Week 52)||44
2250331|NCT02478632|5521094|P1|COMPLETED|Early Switch Phase (Up to Week 52)||49
2250332|NCT02478632|5521093|P2|STARTED|Early Switch Phase (Up to Week 52)||49
2250333|NCT02478632|5521094|P1|STARTED|Early Switch Phase (Up to Week 52)||53
2250334|NCT02478580|5521120|P2|NOT COMPLETED|Overall Study||0
2250335|NCT02478580|5521121|P1|NOT COMPLETED|Overall Study||0
2250336|NCT02478580|5521120|P2|COMPLETED|Overall Study||33
2250337|NCT02478580|5521121|P1|COMPLETED|Overall Study||34
2250338|NCT02478580|5521120|P2|STARTED|Overall Study||33
2250339|NCT02478580|5521121|P1|STARTED|Overall Study||34
2250340|NCT02478398|5521131|P2|NOT COMPLETED|Overall Study||21
2250341|NCT02478398|5521132|P1|NOT COMPLETED|Overall Study||52
2250342|NCT02478398|5521131|P2|COMPLETED|Overall Study||491
2250343|NCT02478398|5521132|P1|COMPLETED|Overall Study||461
2250344|NCT02478398|5521131|P2|Treated|Overall Study||510
2250345|NCT02478398|5521132|P1|Treated|Overall Study||512
2250346|NCT02478398|5521131|P2|STARTED|Overall Study||512
2250347|NCT02478398|5521132|P1|STARTED|Overall Study||513
2250348|NCT02478372|5521152|P2|NOT COMPLETED|Overall Study||14
2250349|NCT02478372|5521153|P1|NOT COMPLETED|Overall Study||13
2250350|NCT02478372|5521152|P2|COMPLETED|Overall Study||107
2250351|NCT02478372|5521153|P1|COMPLETED|Overall Study||108
2250352|NCT02478372|5521152|P2|Reviewed at One Year|Overall Study|Routine folow up at one year - four patients did not attend, two patients died|107
2250353|NCT02478372|5521153|P1|Reviewed at One Year|Overall Study|Routine follow up at one year|108
2250354|NCT02478372|5521152|P2|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks|113
2250355|NCT02478372|5521153|P1|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks - one patient refused to attend|108
2250356|NCT02478372|5521152|P2|Recieved Allocation Intervention|Overall Study||113
2250357|NCT02478372|5521153|P1|Recieved Allocation Intervention|Overall Study||109
2250358|NCT02478372|5521152|P2|STARTED|Overall Study||121
2250359|NCT02478372|5521153|P1|STARTED|Overall Study||121
2250368|NCT02478164|5521250|P1|NOT COMPLETED|Overall Study||15
2250369|NCT02478164|5521250|P1|COMPLETED|Overall Study||0
2250370|NCT02478164|5521250|P1|STARTED|Overall Study|17 participants enrolled. 15 of 17 received ponatinib as 2 participants withdrew prior to ponatinib.|15
2250371|NCT02477709|5521257|P1|NOT COMPLETED|Overall Study||0
2250372|NCT02477709|5521257|P1|COMPLETED|Overall Study||6
2250373|NCT02477709|5521257|P1|STARTED|Overall Study||6
2250374|NCT02477618|5521263|P2|NOT COMPLETED|Overall Study||14
2250375|NCT02477618|5521264|P1|NOT COMPLETED|Overall Study||15
2250376|NCT02477618|5521263|P2|COMPLETED|Overall Study||53
2250377|NCT02477618|5521264|P1|COMPLETED|Overall Study||50
2250378|NCT02477618|5521263|P2|Intent-to-Treat Analysis Set|Overall Study||66
2250379|NCT02477618|5521264|P1|Intent-to-Treat Analysis Set|Overall Study||66
2250380|NCT02477618|5521263|P2|STARTED|Overall Study||67
2250381|NCT02477618|5521264|P1|STARTED|Overall Study||65
2250382|NCT02477605|5521288|P2|NOT COMPLETED|Overall Study||4
2250383|NCT02477605|5521289|P1|NOT COMPLETED|Overall Study||1
2250384|NCT02477605|5521288|P2|COMPLETED|Overall Study||64
2250385|NCT02477605|5521289|P1|COMPLETED|Overall Study||67
2250386|NCT02477605|5521288|P2|Randomized and Treated|Overall Study||68
2250387|NCT02477605|5521289|P1|Randomized and Treated|Overall Study||67
2250388|NCT02477605|5521288|P2|STARTED|Overall Study||68
2250389|NCT02477605|5521289|P1|STARTED|Overall Study||68
2250390|NCT02477553|5521305|P2|NOT COMPLETED|Overall Study||20
2250391|NCT02477553|5521306|P1|NOT COMPLETED|Overall Study||20
2250392|NCT02477553|5521305|P2|COMPLETED|Overall Study||344
2250393|NCT02477553|5521306|P1|COMPLETED|Overall Study||344
2250394|NCT02477553|5521305|P2|STARTED|Overall Study||364
2250395|NCT02477553|5521306|P1|STARTED|Overall Study||364
2250396|NCT02477527|5521326|P1|NOT COMPLETED|Overall Study||6
2250397|NCT02477527|5521326|P1|COMPLETED|Overall Study||21
2250398|NCT02477527|5521326|P1|STARTED|Overall Study||27
2250399|NCT02477332|5521340|P6|NOT COMPLETED|Overall Study||5
2250400|NCT02477332|5521341|P5|NOT COMPLETED|Overall Study||4
2250401|NCT02477332|5521342|P4|NOT COMPLETED|Overall Study||13
2250402|NCT02477332|5521343|P3|NOT COMPLETED|Overall Study||12
2250403|NCT02477332|5521344|P2|NOT COMPLETED|Overall Study||7
2250404|NCT02477332|5521345|P1|NOT COMPLETED|Overall Study||3
2250405|NCT02477332|5521340|P6|COMPLETED|Overall Study||37
2250406|NCT02477332|5521341|P5|COMPLETED|Overall Study||39
2250407|NCT02477332|5521342|P4|COMPLETED|Overall Study||72
2250408|NCT02477332|5521343|P3|COMPLETED|Overall Study||73
2250409|NCT02477332|5521344|P2|COMPLETED|Overall Study||77
2250410|NCT02477332|5521345|P1|COMPLETED|Overall Study||40
2250411|NCT02477332|5521340|P6|STARTED|Overall Study||42
2250412|NCT02477332|5521341|P5|STARTED|Overall Study||43
2250413|NCT02477332|5521342|P4|STARTED|Overall Study||85
2250414|NCT02477332|5521343|P3|STARTED|Overall Study||85
2250415|NCT02477332|5521344|P2|STARTED|Overall Study||84
2250416|NCT02477332|5521345|P1|STARTED|Overall Study||43
2250417|NCT02477215|5521423|P3|NOT COMPLETED|Fixed Dose Phase||0
2250418|NCT02477215|5521424|P2|NOT COMPLETED|Fixed Dose Phase||7
2250419|NCT02477215|5521425|P1|NOT COMPLETED|Fixed Dose Phase||0
2250420|NCT02477215|5521423|P3|COMPLETED|Fixed Dose Phase||0
2250421|NCT02477215|5521424|P2|COMPLETED|Fixed Dose Phase||13
2250422|NCT02477215|5521425|P1|COMPLETED|Fixed Dose Phase||0
2250423|NCT02477215|5521423|P3|STARTED|Fixed Dose Phase|No subjects were started in this group as it was not the optimal dose.|0
2250424|NCT02477215|5521424|P2|STARTED|Fixed Dose Phase|Subjects in Period 1 did not continue into Period 2. This is a new subject population.|20
2250425|NCT02477215|5521425|P1|STARTED|Fixed Dose Phase|No subjects were started in this group as it was not the optimal dose.|0
2250426|NCT02477215|5521423|P3|NOT COMPLETED|Dose Escalation Phase||0
2250427|NCT02477215|5521424|P2|NOT COMPLETED|Dose Escalation Phase||2
2250428|NCT02477215|5521425|P1|NOT COMPLETED|Dose Escalation Phase||1
2250429|NCT02477215|5521423|P3|COMPLETED|Dose Escalation Phase||6
2250430|NCT02477215|5521424|P2|COMPLETED|Dose Escalation Phase||6
2250431|NCT02477215|5521425|P1|COMPLETED|Dose Escalation Phase||3
2250432|NCT02477215|5521423|P3|STARTED|Dose Escalation Phase||6
2250433|NCT02477215|5521424|P2|STARTED|Dose Escalation Phase||8
2250434|NCT02477215|5521425|P1|STARTED|Dose Escalation Phase||4
2250435|NCT02477020|5521441|P2|NOT COMPLETED|Overall Study||28
2250436|NCT02477020|5521442|P1|NOT COMPLETED|Overall Study||30
2250437|NCT02477020|5521441|P2|COMPLETED|Overall Study|Completed = participants who completed study treatment.|55
2250438|NCT02477020|5521442|P1|COMPLETED|Overall Study|Completed = participants who completed study treatment.|51
2250439|NCT02477020|5521441|P2|STARTED|Overall Study||83
2250440|NCT02477020|5521442|P1|STARTED|Overall Study||81
2250441|NCT02476994|5521472|P2|NOT COMPLETED|Overall Study||0
2250442|NCT02476994|5521473|P1|NOT COMPLETED|Overall Study||1
2250443|NCT02476994|5521472|P2|COMPLETED|Overall Study||0
2250444|NCT02476994|5521473|P1|COMPLETED|Overall Study||0
2250445|NCT02476994|5521472|P2|STARTED|Overall Study||0
2250446|NCT02476994|5521473|P1|STARTED|Overall Study||1
2250447|NCT02476890|5521503|P4|NOT COMPLETED|Overall Study||0
2250448|NCT02476890|5521504|P3|NOT COMPLETED|Overall Study||0
2250449|NCT02476890|5521505|P2|NOT COMPLETED|Overall Study||0
2250450|NCT02476890|5521506|P1|NOT COMPLETED|Overall Study||0
2250451|NCT02476890|5521503|P4|COMPLETED|Overall Study||12
2250452|NCT02476890|5521504|P3|COMPLETED|Overall Study||12
2250453|NCT02476890|5521505|P2|COMPLETED|Overall Study||6
2250454|NCT02476890|5521506|P1|COMPLETED|Overall Study||6
2250455|NCT02476890|5521503|P4|Washout|Overall Study||12
2250456|NCT02476890|5521504|P3|Washout|Overall Study||12
2250457|NCT02476890|5521505|P2|Washout|Overall Study||6
2250458|NCT02476890|5521506|P1|Washout|Overall Study||6
2250459|NCT02476890|5521503|P4|STARTED|Overall Study|Crossover study|12
2250460|NCT02476890|5521504|P3|STARTED|Overall Study|Crossover study|12
2250461|NCT02476890|5521505|P2|STARTED|Overall Study|Crossover study|6
2250462|NCT02476890|5521506|P1|STARTED|Overall Study|Crossover study|6
2250463|NCT02476617|5521542|P1|NOT COMPLETED|Overall Study||2
2250464|NCT02476617|5521542|P1|COMPLETED|Overall Study||23
2250465|NCT02476617|5521542|P1|STARTED|Overall Study||25
2250466|NCT02476578|5521548|P2|NOT COMPLETED|Overall Study||56
2250467|NCT02476578|5521549|P1|NOT COMPLETED|Overall Study||41
2250468|NCT02476578|5521548|P2|COMPLETED|Overall Study||4218
2250469|NCT02476578|5521549|P1|COMPLETED|Overall Study||4269
2250470|NCT02476578|5521548|P2|Left Before End of Trial|Overall Study||13
2250471|NCT02476578|5521549|P1|Left Before End of Trial|Overall Study||6
2250472|NCT02476578|5521548|P2|Died Before Email Was Sent|Overall Study||43
2250473|NCT02476578|5521549|P1|Died Before Email Was Sent|Overall Study||35
2250474|NCT02476578|5521548|P2|STARTED|Overall Study||4274
2250475|NCT02476578|5521549|P1|STARTED|Overall Study||4310
2250476|NCT02476565|5521563|P2|NOT COMPLETED|Overall Study||0
2250477|NCT02476565|5521564|P1|NOT COMPLETED|Overall Study||0
2250478|NCT02476565|5521563|P2|COMPLETED|Overall Study||19
2250479|NCT02476565|5521564|P1|COMPLETED|Overall Study||20
2250480|NCT02476565|5521563|P2|STARTED|Overall Study||19
2250481|NCT02476565|5521564|P1|STARTED|Overall Study||20
2250482|NCT02476448|5521588|P4|NOT COMPLETED|Overall Study||0
2250483|NCT02476448|5521589|P3|NOT COMPLETED|Overall Study||0
2250484|NCT02476448|5521590|P2|NOT COMPLETED|Overall Study||0
2250485|NCT02476448|5521591|P1|NOT COMPLETED|Overall Study||0
2250486|NCT02476448|5521588|P4|COMPLETED|Overall Study||44
2250487|NCT02476448|5521589|P3|COMPLETED|Overall Study||44
2250488|NCT02476448|5521590|P2|COMPLETED|Overall Study||44
2250489|NCT02476448|5521591|P1|COMPLETED|Overall Study||44
2250490|NCT02476448|5521588|P4|STARTED|Overall Study||44
2250491|NCT02476448|5521589|P3|STARTED|Overall Study||44
2250492|NCT02476448|5521590|P2|STARTED|Overall Study||44
2250493|NCT02476448|5521591|P1|STARTED|Overall Study|one given phenazopyridine pre-op and was analyzed in her randomization group per intention to treat|44
2250494|NCT02476422|5521611|P2|NOT COMPLETED|Overall Study||1
2250495|NCT02476422|5521612|P1|NOT COMPLETED|Overall Study||0
2250496|NCT02476422|5521611|P2|COMPLETED|Overall Study||161
2250497|NCT02476422|5521612|P1|COMPLETED|Overall Study||166
2250498|NCT02476422|5521611|P2|STARTED|Overall Study||162
2250499|NCT02476422|5521612|P1|STARTED|Overall Study|"started = Randomized Set/Full analysis set/Safety set"|166
2250500|NCT02476175|5521642|P1|NOT COMPLETED|Overall Study||2
2250501|NCT02476175|5521642|P1|COMPLETED|Overall Study||33
2250502|NCT02476175|5521642|P1|STARTED|Overall Study||35
2250503|NCT02476032|5521653|P3|NOT COMPLETED|Overall Study||1
2250504|NCT02476032|5521654|P2|NOT COMPLETED|Overall Study||1
2250505|NCT02476032|5521655|P1|NOT COMPLETED|Overall Study||0
2250506|NCT02476032|5521653|P3|COMPLETED|Overall Study||19
2250507|NCT02476032|5521654|P2|COMPLETED|Overall Study||19
2250508|NCT02476032|5521655|P1|COMPLETED|Overall Study||20
2250509|NCT02476032|5521653|P3|STARTED|Overall Study||20
2250510|NCT02476032|5521654|P2|STARTED|Overall Study||20
2250511|NCT02476032|5521655|P1|STARTED|Overall Study||20
2250512|NCT02475980|5521666|P1|NOT COMPLETED|Overall Study||5
2250513|NCT02475980|5521666|P1|COMPLETED|Overall Study||8
2250514|NCT02475980|5521666|P1|STARTED|Overall Study||13
2250515|NCT02475837|5521677|P2|NOT COMPLETED|Overall Study||0
2250516|NCT02475837|5521678|P1|NOT COMPLETED|Overall Study||0
2250517|NCT02475837|5521677|P2|COMPLETED|Overall Study||7
2250518|NCT02475837|5521678|P1|COMPLETED|Overall Study||6
2250519|NCT02475837|5521677|P2|STARTED|Overall Study||7
2250520|NCT02475837|5521678|P1|STARTED|Overall Study||6
2250521|NCT02475733|5521692|P2|NOT COMPLETED|Overall Study||0
2250522|NCT02475733|5521693|P1|NOT COMPLETED|Overall Study||2
2250523|NCT02475733|5521692|P2|COMPLETED|Overall Study||22
2250524|NCT02475733|5521693|P1|COMPLETED|Overall Study||59
2250525|NCT02475733|5521692|P2|STARTED|Overall Study||22
2250526|NCT02475733|5521693|P1|STARTED|Overall Study||61
2250527|NCT02475655|5521750|P2|NOT COMPLETED|Overall Study||1
2250528|NCT02475655|5521751|P1|NOT COMPLETED|Overall Study||0
2250529|NCT02475655|5521750|P2|COMPLETED|Overall Study||19
2250530|NCT02475655|5521751|P1|COMPLETED|Overall Study||40
2250531|NCT02475655|5521750|P2|STARTED|Overall Study||20
2250532|NCT02475655|5521751|P1|STARTED|Overall Study||40
2250533|NCT02475564|5521812|P2|NOT COMPLETED|Overall Study||1
2250534|NCT02475564|5521813|P1|NOT COMPLETED|Overall Study||4
2250535|NCT02475564|5521812|P2|COMPLETED|Overall Study||21
2250536|NCT02475564|5521813|P1|COMPLETED|Overall Study||18
2250537|NCT02475564|5521812|P2|STARTED|Overall Study||22
2250538|NCT02475564|5521813|P1|STARTED|Overall Study||22
2250539|NCT02475395|5521825|P2|NOT COMPLETED|Overall Study||3
2250540|NCT02475395|5521826|P1|NOT COMPLETED|Overall Study||30
2250541|NCT02475395|5521825|P2|COMPLETED|Overall Study||11
2250542|NCT02475395|5521826|P1|COMPLETED|Overall Study||228
2250543|NCT02475395|5521825|P2|STARTED|Overall Study||14
2250544|NCT02475395|5521826|P1|STARTED|Overall Study||258
2250545|NCT02475278|5521836|P1|NOT COMPLETED|Overall Study||2
2250546|NCT02475278|5521836|P1|COMPLETED|Overall Study||48
2250547|NCT02475278|5521836|P1|STARTED|Overall Study||50
2250548|NCT02475265|5521847|P1|NOT COMPLETED|Overall Study||3
2250549|NCT02475265|5521847|P1|COMPLETED|Overall Study||8
2250550|NCT02475265|5521847|P1|STARTED|Overall Study||11
2250551|NCT02475070|5521853|P2|NOT COMPLETED|Overall Study||0
2250552|NCT02475070|5521854|P1|NOT COMPLETED|Overall Study||0
2250553|NCT02475070|5521853|P2|COMPLETED|Overall Study||11
2250554|NCT02475070|5521854|P1|COMPLETED|Overall Study||17
2250555|NCT02475070|5521853|P2|STARTED|Overall Study||11
2250556|NCT02475070|5521854|P1|STARTED|Overall Study||17
2250557|NCT02475031|5521864|P2|NOT COMPLETED|Overall Study||0
2250558|NCT02475031|5521865|P1|NOT COMPLETED|Overall Study||0
2250559|NCT02475031|5521864|P2|COMPLETED|Overall Study||35
2250560|NCT02475031|5521865|P1|COMPLETED|Overall Study||35
2250561|NCT02475031|5521864|P2|STARTED|Overall Study||35
2250562|NCT02475031|5521865|P1|STARTED|Overall Study||35
2250563|NCT02474901|5521881|P2|NOT COMPLETED|Overall Study||0
2250564|NCT02474901|5521882|P1|NOT COMPLETED|Overall Study||1
2250565|NCT02474901|5521881|P2|COMPLETED|Overall Study||56
2250566|NCT02474901|5521882|P1|COMPLETED|Overall Study||44
2250567|NCT02474901|5521881|P2|STARTED|Overall Study||56
2250568|NCT02474901|5521882|P1|STARTED|Overall Study||45
2250569|NCT02474589|5521898|P2|NOT COMPLETED|Overall Study||5
2250570|NCT02474589|5521899|P1|NOT COMPLETED|Overall Study||25
2250571|NCT02474589|5521898|P2|COMPLETED|Overall Study||85
2250572|NCT02474589|5521899|P1|COMPLETED|Overall Study||334
2250573|NCT02474589|5521898|P2|STARTED|Overall Study||90
2250574|NCT02474589|5521899|P1|STARTED|Overall Study||359
2250575|NCT02474498|5521908|P3|NOT COMPLETED|Overall Study||0
2250576|NCT02474498|5521909|P2|NOT COMPLETED|Overall Study||0
2250577|NCT02474498|5521910|P1|NOT COMPLETED|Overall Study||0
2250578|NCT02474498|5521908|P3|COMPLETED|Overall Study||14
2250579|NCT02474498|5521909|P2|COMPLETED|Overall Study||14
2250580|NCT02474498|5521910|P1|COMPLETED|Overall Study||13
2250581|NCT02474498|5521908|P3|STARTED|Overall Study||14
2250582|NCT02474498|5521909|P2|STARTED|Overall Study||14
2250583|NCT02474498|5521910|P1|STARTED|Overall Study||13
2250584|NCT02474407|5521927|P2|NOT COMPLETED|Second Intervention (14 Days)||0
2250585|NCT02474407|5521928|P1|NOT COMPLETED|Second Intervention (14 Days)||0
2250586|NCT02474407|5521927|P2|COMPLETED|Second Intervention (14 Days)||39
2250587|NCT02474407|5521928|P1|COMPLETED|Second Intervention (14 Days)||39
2250588|NCT02474407|5521927|P2|STARTED|Second Intervention (14 Days)||39
2250589|NCT02474407|5521928|P1|STARTED|Second Intervention (14 Days)||39
2250590|NCT02474407|5521927|P2|NOT COMPLETED|Washout (14 Days)||0
2250591|NCT02474407|5521928|P1|NOT COMPLETED|Washout (14 Days)||0
2250592|NCT02474407|5521927|P2|COMPLETED|Washout (14 Days)||39
2250593|NCT02474407|5521928|P1|COMPLETED|Washout (14 Days)||39
2250594|NCT02474407|5521927|P2|STARTED|Washout (14 Days)||39
2250595|NCT02474407|5521928|P1|STARTED|Washout (14 Days)||39
2250596|NCT02474407|5521927|P2|NOT COMPLETED|First Intervention (14 Days)||0
2250597|NCT02474407|5521928|P1|NOT COMPLETED|First Intervention (14 Days)||0
2250598|NCT02474407|5521927|P2|COMPLETED|First Intervention (14 Days)||39
2250599|NCT02474407|5521928|P1|COMPLETED|First Intervention (14 Days)||39
2250600|NCT02474407|5521927|P2|STARTED|First Intervention (14 Days)||39
2250601|NCT02474407|5521928|P1|STARTED|First Intervention (14 Days)||39
2250602|NCT02474082|5521958|P2|NOT COMPLETED|Overall Study||54
2250603|NCT02474082|5521959|P1|NOT COMPLETED|Overall Study||6
2250604|NCT02474082|5521958|P2|COMPLETED|Overall Study||43
2250605|NCT02474082|5521959|P1|COMPLETED|Overall Study||99
2250606|NCT02474082|5521958|P2|Full Analysis Set (FAS)|Overall Study||95
2250607|NCT02474082|5521959|P1|Full Analysis Set (FAS)|Overall Study||105
2250608|NCT02474082|5521958|P2|STARTED|Overall Study||97
2250609|NCT02474082|5521959|P1|STARTED|Overall Study||105
2250610|NCT02474069|5521993|P3|NOT COMPLETED|Comparative Dosing Phase (CDP)||6
2250611|NCT02474069|5521994|P2|NOT COMPLETED|Comparative Dosing Phase (CDP)||9
2250612|NCT02474069|5521995|P1|NOT COMPLETED|Comparative Dosing Phase (CDP)||0
2250613|NCT02474069|5521993|P3|COMPLETED|Comparative Dosing Phase (CDP)||157
2250614|NCT02474069|5521994|P2|COMPLETED|Comparative Dosing Phase (CDP)||153
2250615|NCT02474069|5521995|P1|COMPLETED|Comparative Dosing Phase (CDP)||0
2250616|NCT02474069|5521993|P3|STARTED|Comparative Dosing Phase (CDP)||163
2250617|NCT02474069|5521994|P2|STARTED|Comparative Dosing Phase (CDP)||162
2250618|NCT02474069|5521995|P1|STARTED|Comparative Dosing Phase (CDP)||0
2250619|NCT02474069|5521993|P3|NOT COMPLETED|Selection Phase (SP)||0
2250620|NCT02474069|5521994|P2|NOT COMPLETED|Selection Phase (SP)||0
2250621|NCT02474069|5521995|P1|NOT COMPLETED|Selection Phase (SP)||23
2250622|NCT02474069|5521993|P3|COMPLETED|Selection Phase (SP)||0
2250623|NCT02474069|5521994|P2|COMPLETED|Selection Phase (SP)||0
2250624|NCT02474069|5521995|P1|COMPLETED|Selection Phase (SP)||749
2250625|NCT02474069|5521993|P3|STARTED|Selection Phase (SP)||0
2250626|NCT02474069|5521994|P2|STARTED|Selection Phase (SP)||0
2250627|NCT02474069|5521995|P1|STARTED|Selection Phase (SP)||772
2250628|NCT02473991|5522020|P1|NOT COMPLETED|Overall Study||0
2250629|NCT02473991|5522020|P1|COMPLETED|Overall Study||395
2250630|NCT02473991|5522020|P1|STARTED|Overall Study||395
2250631|NCT02473952|5522028|P2|NOT COMPLETED|Overall Study||8
2250632|NCT02473952|5522029|P1|NOT COMPLETED|Overall Study||2
2250633|NCT02473952|5522028|P2|COMPLETED|Overall Study||24
2250634|NCT02473952|5522029|P1|COMPLETED|Overall Study||28
2250635|NCT02473952|5522028|P2|STARTED|Overall Study||32
2250636|NCT02473952|5522029|P1|STARTED|Overall Study||30
2250637|NCT02473783|5522037|P2|NOT COMPLETED|Overall Study||0
2250638|NCT02473783|5522038|P1|NOT COMPLETED|Overall Study||0
2250639|NCT02473783|5522037|P2|COMPLETED|Overall Study||17
2250640|NCT02473783|5522038|P1|COMPLETED|Overall Study||20
2250641|NCT02473783|5522037|P2|STARTED|Overall Study||17
2250642|NCT02473783|5522038|P1|STARTED|Overall Study||20
2250643|NCT02473718|5522048|P2|NOT COMPLETED|Overall Study||0
2250644|NCT02473718|5522049|P1|NOT COMPLETED|Overall Study||0
2250645|NCT02473718|5522048|P2|COMPLETED|Overall Study||41
2250646|NCT02473718|5522049|P1|COMPLETED|Overall Study||41
2250647|NCT02473718|5522048|P2|STARTED|Overall Study||41
2250648|NCT02473718|5522049|P1|STARTED|Overall Study||41
2250649|NCT02473640|5522069|P1|NOT COMPLETED|Treatment Period 2||0
2250650|NCT02473640|5522069|P1|COMPLETED|Treatment Period 2||14
2250651|NCT02473640|5522069|P1|STARTED|Treatment Period 2||14
2250652|NCT02473640|5522069|P1|NOT COMPLETED|Run-in Phase||0
2250653|NCT02473640|5522069|P1|COMPLETED|Run-in Phase||14
2250654|NCT02473640|5522069|P1|STARTED|Run-in Phase||14
2250655|NCT02473640|5522069|P1|NOT COMPLETED|Treatment Period 1||1
2250656|NCT02473640|5522069|P1|COMPLETED|Treatment Period 1||14
2250657|NCT02473640|5522069|P1|STARTED|Treatment Period 1||15
2250658|NCT02473523|5522078|P1|NOT COMPLETED|Overall Study||2
2250659|NCT02473523|5522078|P1|COMPLETED|Overall Study||0
2250660|NCT02473523|5522078|P1|STARTED|Overall Study||2
2250661|NCT02473510|5522099|P2|NOT COMPLETED|Overall Study||2
2250662|NCT02473510|5522100|P1|NOT COMPLETED|Overall Study||1
2250663|NCT02473510|5522099|P2|COMPLETED|Overall Study||238
2250664|NCT02473510|5522100|P1|COMPLETED|Overall Study||59
2250665|NCT02473510|5522099|P2|STARTED|Overall Study||240
2250666|NCT02473510|5522100|P1|STARTED|Overall Study||60
2250667|NCT02473471|5522114|P1|NOT COMPLETED|Overall Study||3
2250668|NCT02473471|5522114|P1|COMPLETED|Overall Study||32
2250669|NCT02473471|5522114|P1|Randomized Not Treated|Overall Study||2
2250670|NCT02473471|5522114|P1|Received Allocated Intervention|Overall Study||33
2250671|NCT02473471|5522114|P1|STARTED|Overall Study||35
2250672|NCT02473445|5522145|P1|NOT COMPLETED|Overall Study||22
2250673|NCT02473445|5522145|P1|COMPLETED|Overall Study||0
2250674|NCT02473445|5522145|P1|STARTED|Overall Study||22
2250675|NCT02473367|5522151|P1|NOT COMPLETED|Period 4||1
2250676|NCT02473367|5522151|P1|COMPLETED|Period 4||18
2250677|NCT02473367|5522151|P1|STARTED|Period 4||19
2250678|NCT02473367|5522151|P1|NOT COMPLETED|Wait 3||0
2250679|NCT02473367|5522151|P1|COMPLETED|Wait 3||19
2250680|NCT02473367|5522151|P1|STARTED|Wait 3||19
2250681|NCT02473367|5522151|P1|NOT COMPLETED|Period 3||0
2250682|NCT02473367|5522151|P1|COMPLETED|Period 3||19
2250683|NCT02473367|5522151|P1|STARTED|Period 3||19
2250684|NCT02473367|5522151|P1|NOT COMPLETED|Wait 2||0
2250685|NCT02473367|5522151|P1|COMPLETED|Wait 2||19
2250686|NCT02473367|5522151|P1|STARTED|Wait 2||19
2250687|NCT02473367|5522151|P1|NOT COMPLETED|Period 2||0
2250688|NCT02473367|5522151|P1|COMPLETED|Period 2||19
2250689|NCT02473367|5522151|P1|STARTED|Period 2||19
2250690|NCT02473367|5522151|P1|NOT COMPLETED|Wait 1||1
2250691|NCT02473367|5522151|P1|COMPLETED|Wait 1||19
2250692|NCT02473367|5522151|P1|STARTED|Wait 1||20
2250693|NCT02473367|5522151|P1|NOT COMPLETED|Period 1||0
2250694|NCT02473367|5522151|P1|COMPLETED|Period 1||20
2250695|NCT02473367|5522151|P1|STARTED|Period 1||20
2250696|NCT02473289|5522171|P2|NOT COMPLETED|Overall Study||13
2250697|NCT02473289|5522172|P1|NOT COMPLETED|Overall Study||11
2250698|NCT02473289|5522171|P2|COMPLETED|Overall Study||81
2250699|NCT02473289|5522172|P1|COMPLETED|Overall Study||88
2250700|NCT02473289|5522171|P2|STARTED|Overall Study||94
2250701|NCT02473289|5522172|P1|STARTED|Overall Study||99
2250702|NCT02472977|5522197|P3|NOT COMPLETED|Overall Study||8
2250703|NCT02472977|5522198|P2|NOT COMPLETED|Overall Study||27
2250704|NCT02472977|5522199|P1|NOT COMPLETED|Overall Study||6
2250705|NCT02472977|5522197|P3|COMPLETED|Overall Study||0
2250706|NCT02472977|5522198|P2|COMPLETED|Overall Study||0
2250707|NCT02472977|5522199|P1|COMPLETED|Overall Study||0
2250708|NCT02472977|5522197|P3|STARTED|Overall Study||8
2250709|NCT02472977|5522198|P2|STARTED|Overall Study||27
2250710|NCT02472977|5522199|P1|STARTED|Overall Study||6
2250711|NCT02472964|5522224|P2|NOT COMPLETED|Part 2 (Week 24-week 48)||63
2250712|NCT02472964|5522225|P1|NOT COMPLETED|Part 2 (Week 24-week 48)||65
2250713|NCT02472964|5522224|P2|COMPLETED|Part 2 (Week 24-week 48)||116
2250714|NCT02472964|5522225|P1|COMPLETED|Part 2 (Week 24-week 48)||98
2250715|NCT02472964|5522224|P2|STARTED|Part 2 (Week 24-week 48)||179
2250716|NCT02472964|5522225|P1|STARTED|Part 2 (Week 24-week 48)||163
2250717|NCT02472964|5522224|P2|NOT COMPLETED|Part 1 (up to Week 24)||62
2250718|NCT02472964|5522225|P1|NOT COMPLETED|Part 1 (up to Week 24)||75
2250719|NCT02472964|5522224|P2|COMPLETED|Part 1 (up to Week 24)||185
2250720|NCT02472964|5522225|P1|COMPLETED|Part 1 (up to Week 24)||171
2250721|NCT02472964|5522224|P2|STARTED|Part 1 (up to Week 24)||247
2250722|NCT02472964|5522225|P1|STARTED|Part 1 (up to Week 24)||246
2250723|NCT02472886|5522234|P3|NOT COMPLETED|Overall Study||1
2250724|NCT02472886|5522235|P2|NOT COMPLETED|Overall Study||2
2250725|NCT02472886|5522236|P1|NOT COMPLETED|Overall Study||0
2250726|NCT02472886|5522234|P3|COMPLETED|Overall Study||26
2250727|NCT02472886|5522235|P2|COMPLETED|Overall Study||57
2250728|NCT02472886|5522236|P1|COMPLETED|Overall Study||67
2250729|NCT02472886|5522234|P3|STARTED|Overall Study||27
2250730|NCT02472886|5522235|P2|STARTED|Overall Study||59
2250731|NCT02472886|5522236|P1|STARTED|Overall Study||67
2250732|NCT02472847|5522264|P2|NOT COMPLETED|Overall Study||5
2250733|NCT02472847|5522265|P1|NOT COMPLETED|Overall Study||1
2250734|NCT02472847|5522264|P2|COMPLETED|Overall Study||21
2250735|NCT02472847|5522265|P1|COMPLETED|Overall Study||23
2250736|NCT02472847|5522264|P2|STARTED|Overall Study||26
2250737|NCT02472847|5522265|P1|STARTED|Overall Study||24
2250738|NCT02472756|5522271|P1|NOT COMPLETED|Maintenance (Approximately 2 Years)||10
2250739|NCT02472756|5522271|P1|COMPLETED|Maintenance (Approximately 2 Years)||10
2250740|NCT02472756|5522271|P1|STARTED|Maintenance (Approximately 2 Years)|Out of 39 participants who completed induction period, 19 did not continue in maintenance period.|20
2250741|NCT02472756|5522271|P1|NOT COMPLETED|Induction (Approximately 6 Months)||2
2250742|NCT02472756|5522271|P1|COMPLETED|Induction (Approximately 6 Months)||39
2250743|NCT02472756|5522271|P1|Treated|Induction (Approximately 6 Months)||40
2250744|NCT02472756|5522271|P1|STARTED|Induction (Approximately 6 Months)||41
2250745|NCT02472730|5522279|P2|NOT COMPLETED|Overall Study||7
2250746|NCT02472730|5522280|P1|NOT COMPLETED|Overall Study||9
2250747|NCT02472730|5522279|P2|COMPLETED|Overall Study||102
2250748|NCT02472730|5522280|P1|COMPLETED|Overall Study||101
2250749|NCT02472730|5522279|P2|STARTED|Overall Study||109
2250750|NCT02472730|5522280|P1|STARTED|Overall Study||110
2250751|NCT02472652|5522292|P1|NOT COMPLETED|Overall Study||1
2250752|NCT02472652|5522292|P1|COMPLETED|Overall Study||1
2250753|NCT02472652|5522292|P1|STARTED|Overall Study||2
2250754|NCT02472639|5522299|P2|NOT COMPLETED|Overall Study||3
2250755|NCT02472639|5522300|P1|NOT COMPLETED|Overall Study||4
2250756|NCT02472639|5522299|P2|COMPLETED|Overall Study||0
2250757|NCT02472639|5522300|P1|COMPLETED|Overall Study||0
2250758|NCT02472639|5522299|P2|STARTED|Overall Study||3
2250759|NCT02472639|5522300|P1|STARTED|Overall Study||4
2250760|NCT02472522|5522316|P2|NOT COMPLETED|Overall Study||0
2250761|NCT02472522|5522317|P1|NOT COMPLETED|Overall Study||0
2250762|NCT02472522|5522316|P2|COMPLETED|Overall Study||50
2250763|NCT02472522|5522317|P1|COMPLETED|Overall Study||50
2250764|NCT02472522|5522316|P2|STARTED|Overall Study||50
2250765|NCT02472522|5522317|P1|STARTED|Overall Study||50
2250766|NCT02472405|5522347|P1|NOT COMPLETED|Overall Study||10
2250767|NCT02472405|5522347|P1|COMPLETED|Overall Study||8
2250768|NCT02472405|5522347|P1|STARTED|Overall Study||18
2250769|NCT02472366|5522355|P2|NOT COMPLETED|Overall Study||0
2250770|NCT02472366|5522356|P1|NOT COMPLETED|Overall Study||1
2250771|NCT02472366|5522355|P2|COMPLETED|Overall Study||10
2250772|NCT02472366|5522356|P1|COMPLETED|Overall Study||5
2250773|NCT02472366|5522355|P2|STARTED|Overall Study||10
2250774|NCT02472366|5522356|P1|STARTED|Overall Study|6 subjects receiving ILUVIEN, 7 eyes receiving ILUVIEN|6
2250775|NCT02472353|5522372|P2|NOT COMPLETED|Overall Study||6
2250776|NCT02472353|5522373|P1|NOT COMPLETED|Overall Study||4
2250777|NCT02472353|5522372|P2|COMPLETED|Overall Study||10
2250778|NCT02472353|5522373|P1|COMPLETED|Overall Study||10
2250779|NCT02472353|5522372|P2|STARTED|Overall Study||16
2250780|NCT02472353|5522373|P1|STARTED|Overall Study||14
2250781|NCT02472314|5522381|P2|NOT COMPLETED|Overall Study||0
2250782|NCT02472314|5522382|P1|NOT COMPLETED|Overall Study||0
2250783|NCT02472314|5522381|P2|COMPLETED|Overall Study||36
2250784|NCT02472314|5522382|P1|COMPLETED|Overall Study||34
2250785|NCT02472314|5522381|P2|STARTED|Overall Study||36
2250786|NCT02472314|5522382|P1|STARTED|Overall Study||34
2250787|NCT02472262|5522397|P3|NOT COMPLETED|Overall Study||25
2250788|NCT02472262|5522398|P2|NOT COMPLETED|Overall Study||21
2250789|NCT02472262|5522399|P1|NOT COMPLETED|Overall Study||18
2250790|NCT02472262|5522397|P3|COMPLETED|Overall Study||93
2250791|NCT02472262|5522398|P2|COMPLETED|Overall Study||99
2250792|NCT02472262|5522399|P1|COMPLETED|Overall Study||99
2250793|NCT02472262|5522397|P3|STARTED|Overall Study||118
2250794|NCT02472262|5522398|P2|STARTED|Overall Study||120
2250795|NCT02472262|5522399|P1|STARTED|Overall Study||117
2250796|NCT02472145|5522410|P3|NOT COMPLETED|Overall Study||157
2250797|NCT02472145|5522411|P2|NOT COMPLETED|Overall Study||159
2250798|NCT02472145|5522412|P1|NOT COMPLETED|Overall Study||10
2250799|NCT02472145|5522410|P3|COMPLETED|Overall Study||0
2250800|NCT02472145|5522411|P2|COMPLETED|Overall Study||0
2250801|NCT02472145|5522412|P1|COMPLETED|Overall Study||0
2250802|NCT02472145|5522410|P3|Safety|Overall Study|1 participant who was not treated and 9 participants who received only decitabine were excluded.|147
2250895|NCT02470403|5522626|P5|NOT COMPLETED|Overall Study||0
2250803|NCT02472145|5522411|P2|Safety|Overall Study|9 participants who received decitabine,not JNJ-56022473 included,3 untreated participant excluded.|165
2250804|NCT02472145|5522412|P1|Safety|Overall Study||10
2250805|NCT02472145|5522410|P3|Treated|Overall Study||156
2250806|NCT02472145|5522411|P2|Treated|Overall Study||156
2250807|NCT02472145|5522412|P1|Treated|Overall Study||10
2250808|NCT02472145|5522410|P3|STARTED|Overall Study||157
2250809|NCT02472145|5522411|P2|STARTED|Overall Study||159
2250810|NCT02472145|5522412|P1|STARTED|Overall Study||10
2250811|NCT02471755|5522433|P2|NOT COMPLETED|Overall Study||1
2250812|NCT02471755|5522434|P1|NOT COMPLETED|Overall Study||1
2250813|NCT02471755|5522433|P2|COMPLETED|Overall Study||44
2250814|NCT02471755|5522434|P1|COMPLETED|Overall Study||44
2250815|NCT02471755|5522433|P2|STARTED|Overall Study||45
2250816|NCT02471755|5522434|P1|STARTED|Overall Study||45
2250817|NCT02471651|5522452|P2|NOT COMPLETED|Overall Study||5
2250818|NCT02471651|5522453|P1|NOT COMPLETED|Overall Study||5
2250819|NCT02471651|5522452|P2|COMPLETED|Overall Study||15
2250820|NCT02471651|5522453|P1|COMPLETED|Overall Study||15
2250821|NCT02471651|5522452|P2|STARTED|Overall Study||20
2250822|NCT02471651|5522453|P1|STARTED|Overall Study||20
2250823|NCT02471612|5522463|P1|NOT COMPLETED|Overall Study||2
2250824|NCT02471612|5522463|P1|COMPLETED|Overall Study||157
2250825|NCT02471612|5522463|P1|STARTED|Overall Study||159
2250826|NCT02471521|5522482|P2|NOT COMPLETED|Overall Study||8
2250827|NCT02471521|5522483|P1|NOT COMPLETED|Overall Study||0
2250828|NCT02471521|5522482|P2|COMPLETED|Overall Study||52
2250829|NCT02471521|5522483|P1|COMPLETED|Overall Study||60
2250830|NCT02471521|5522482|P2|STARTED|Overall Study||60
2250831|NCT02471521|5522483|P1|STARTED|Overall Study||60
2250832|NCT02471404|5522494|P3|NOT COMPLETED|Overall Study||25
2250833|NCT02471404|5522495|P2|NOT COMPLETED|Overall Study||14
2250834|NCT02471404|5522496|P1|NOT COMPLETED|Overall Study||33
2250835|NCT02471404|5522494|P3|COMPLETED|Overall Study||288
2250836|NCT02471404|5522495|P2|COMPLETED|Overall Study||298
2250837|NCT02471404|5522496|P1|COMPLETED|Overall Study||281
2250838|NCT02471404|5522494|P3|STARTED|Overall Study||313
2250839|NCT02471404|5522495|P2|STARTED|Overall Study||312
2250840|NCT02471404|5522496|P1|STARTED|Overall Study||314
2250841|NCT02471326|5522519|P1|NOT COMPLETED|Overall Study||1
2250842|NCT02471326|5522519|P1|COMPLETED|Overall Study||9
2250843|NCT02471326|5522519|P1|STARTED|Overall Study||10
2250844|NCT02471313|5522524|P1|NOT COMPLETED|Overall Study||0
2250845|NCT02471313|5522524|P1|COMPLETED|Overall Study||3
2250846|NCT02471313|5522524|P1|STARTED|Overall Study||3
2250847|NCT02471183|5522528|P1|NOT COMPLETED|Extended Treatment Period||1
2250848|NCT02471183|5522528|P1|COMPLETED|Extended Treatment Period||31
2250849|NCT02471183|5522528|P1|STARTED|Extended Treatment Period||32
2250850|NCT02471183|5522528|P1|NOT COMPLETED|Main Treatment Period||2
2250851|NCT02471183|5522528|P1|COMPLETED|Main Treatment Period||32
2250852|NCT02471183|5522528|P1|STARTED|Main Treatment Period||34
2250853|NCT02470949|5522543|P2|NOT COMPLETED|Second Intervention||0
2250854|NCT02470949|5522544|P1|NOT COMPLETED|Second Intervention||0
2250855|NCT02470949|5522543|P2|COMPLETED|Second Intervention||2
2250856|NCT02470949|5522544|P1|COMPLETED|Second Intervention||4
2250857|NCT02470949|5522543|P2|STARTED|Second Intervention||2
2250858|NCT02470949|5522544|P1|STARTED|Second Intervention||4
2250859|NCT02470949|5522543|P2|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
2250860|NCT02470949|5522544|P1|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
2250861|NCT02470949|5522543|P2|COMPLETED|Washout Period for a Minimum of 4 Weeks||5
2250862|NCT02470949|5522544|P1|COMPLETED|Washout Period for a Minimum of 4 Weeks||4
2250863|NCT02470949|5522543|P2|STARTED|Washout Period for a Minimum of 4 Weeks||5
2250864|NCT02470949|5522544|P1|STARTED|Washout Period for a Minimum of 4 Weeks||4
2250865|NCT02470949|5522543|P2|NOT COMPLETED|First Intervention||0
2250866|NCT02470949|5522544|P1|NOT COMPLETED|First Intervention||0
2250867|NCT02470949|5522543|P2|COMPLETED|First Intervention||5
2250868|NCT02470949|5522544|P1|COMPLETED|First Intervention||4
2250869|NCT02470949|5522543|P2|STARTED|First Intervention||5
2250870|NCT02470949|5522544|P1|STARTED|First Intervention||4
2250871|NCT02470910|5522554|P1|NOT COMPLETED|Overall Study||0
2250872|NCT02470910|5522554|P1|COMPLETED|Overall Study||15
2250873|NCT02470910|5522554|P1|STARTED|Overall Study||15
2250874|NCT02470754|5522561|P2|NOT COMPLETED|Overall Study||0
2250875|NCT02470754|5522562|P1|NOT COMPLETED|Overall Study||2
2250876|NCT02470754|5522561|P2|COMPLETED|Overall Study||19
2250877|NCT02470754|5522562|P1|COMPLETED|Overall Study||17
2250878|NCT02470754|5522561|P2|STARTED|Overall Study||19
2250879|NCT02470754|5522562|P1|STARTED|Overall Study||19
2250880|NCT02470741|5522590|P2|NOT COMPLETED|Overall Study||2
2250881|NCT02470741|5522591|P1|NOT COMPLETED|Overall Study||3
2250882|NCT02470741|5522590|P2|COMPLETED|Overall Study||4
2250883|NCT02470741|5522591|P1|COMPLETED|Overall Study||3
2250884|NCT02470741|5522590|P2|STARTED|Overall Study||6
2250885|NCT02470741|5522591|P1|STARTED|Overall Study||6
2250886|NCT02470494|5522597|P1|NOT COMPLETED|Overall Study||5
2250887|NCT02470494|5522597|P1|COMPLETED|Overall Study||41
2250888|NCT02470494|5522597|P1|STARTED|Overall Study||46
2250889|NCT02470429|5522607|P2|NOT COMPLETED|Overall Study||0
2250890|NCT02470429|5522608|P1|NOT COMPLETED|Overall Study||2
2250891|NCT02470429|5522607|P2|COMPLETED|Overall Study||49
2250892|NCT02470429|5522608|P1|COMPLETED|Overall Study||48
2250893|NCT02470429|5522607|P2|STARTED|Overall Study||49
2250894|NCT02470429|5522608|P1|STARTED|Overall Study||50
2250896|NCT02470403|5522627|P4|NOT COMPLETED|Overall Study||4
2250897|NCT02470403|5522628|P3|NOT COMPLETED|Overall Study||0
2250898|NCT02470403|5522629|P2|NOT COMPLETED|Overall Study||1
2250899|NCT02470403|5522630|P1|NOT COMPLETED|Overall Study||2
2250900|NCT02470403|5522626|P5|COMPLETED|Overall Study||10
2250901|NCT02470403|5522627|P4|COMPLETED|Overall Study||39
2250902|NCT02470403|5522628|P3|COMPLETED|Overall Study||40
2250903|NCT02470403|5522629|P2|COMPLETED|Overall Study||43
2250904|NCT02470403|5522630|P1|COMPLETED|Overall Study||42
2250905|NCT02470403|5522626|P5|Normoglycemic|Overall Study||5
2250906|NCT02470403|5522627|P4|Normoglycemic|Overall Study||23
2250907|NCT02470403|5522628|P3|Normoglycemic|Overall Study||20
2250908|NCT02470403|5522629|P2|Normoglycemic|Overall Study||20
2250909|NCT02470403|5522630|P1|Normoglycemic|Overall Study||20
2250910|NCT02470403|5522626|P5|Dysglycemic|Overall Study||5
2250911|NCT02470403|5522627|P4|Dysglycemic|Overall Study||20
2250912|NCT02470403|5522628|P3|Dysglycemic|Overall Study||20
2250913|NCT02470403|5522629|P2|Dysglycemic|Overall Study||24
2250914|NCT02470403|5522630|P1|Dysglycemic|Overall Study||24
2250915|NCT02470403|5522626|P5|STARTED|Overall Study||10
2250916|NCT02470403|5522627|P4|STARTED|Overall Study||43
2250917|NCT02470403|5522628|P3|STARTED|Overall Study||40
2250918|NCT02470403|5522629|P2|STARTED|Overall Study||44
2250919|NCT02470403|5522630|P1|STARTED|Overall Study||44
2250920|NCT02470390|5522670|P2|NOT COMPLETED|Overall Study||1
2250921|NCT02470390|5522671|P1|NOT COMPLETED|Overall Study||0
2250922|NCT02470390|5522670|P2|COMPLETED|Overall Study||6
2250923|NCT02470390|5522671|P1|COMPLETED|Overall Study||6
2250924|NCT02470390|5522670|P2|STARTED|Overall Study||7
2250925|NCT02470390|5522671|P1|STARTED|Overall Study||6
2250926|NCT02470312|5522699|P2|NOT COMPLETED|Overall Study||12
2250927|NCT02470312|5522700|P1|NOT COMPLETED|Overall Study||5
2250928|NCT02470312|5522699|P2|COMPLETED|Overall Study||419
2250929|NCT02470312|5522700|P1|COMPLETED|Overall Study||142
2250930|NCT02470312|5522699|P2|STARTED|Overall Study||431
2250931|NCT02470312|5522700|P1|STARTED|Overall Study||147
2250932|NCT02469961|5522710|P2|NOT COMPLETED|Overall Study||1
2250933|NCT02469961|5522711|P1|NOT COMPLETED|Overall Study||4
2250934|NCT02469961|5522710|P2|COMPLETED|Overall Study||24
2250935|NCT02469961|5522711|P1|COMPLETED|Overall Study||21
2250936|NCT02469961|5522710|P2|STARTED|Overall Study||25
2250937|NCT02469961|5522711|P1|STARTED|Overall Study||25
2250938|NCT02469896|5522725|P2|NOT COMPLETED|Overall Study||0
2250939|NCT02469896|5522726|P1|NOT COMPLETED|Overall Study||2
2250940|NCT02469896|5522725|P2|COMPLETED|Overall Study||14
2250941|NCT02469896|5522726|P1|COMPLETED|Overall Study||6
2250942|NCT02469896|5522725|P2|STARTED|Overall Study||14
2250943|NCT02469896|5522726|P1|STARTED|Overall Study||8
2250944|NCT02469870|5522752|P2|NOT COMPLETED|Overall Study||7
2250945|NCT02469870|5522753|P1|NOT COMPLETED|Overall Study||4
2250946|NCT02469870|5522752|P2|COMPLETED|Overall Study||72
2250947|NCT02469870|5522753|P1|COMPLETED|Overall Study||73
2250948|NCT02469870|5522752|P2|STARTED|Overall Study||79
2250949|NCT02469870|5522753|P1|STARTED|Overall Study||77
2250950|NCT02469714|5522771|P2|NOT COMPLETED|Overall Study||5
2250951|NCT02469714|5522772|P1|NOT COMPLETED|Overall Study||8
2250952|NCT02469714|5522771|P2|COMPLETED|Overall Study||50
2250953|NCT02469714|5522772|P1|COMPLETED|Overall Study||47
2250954|NCT02469714|5522771|P2|8 Month Follow-Up|Overall Study||50
2250955|NCT02469714|5522772|P1|8 Month Follow-Up|Overall Study||49
2250956|NCT02469714|5522771|P2|4 Month Follow-Up|Overall Study||51
2250957|NCT02469714|5522772|P1|4 Month Follow-Up|Overall Study||50
2250958|NCT02469714|5522771|P2|STARTED|Overall Study||55
2250959|NCT02469714|5522772|P1|STARTED|Overall Study||55
2250963|NCT02469623|5522796|P1|NOT COMPLETED|Overall Study||13
2250964|NCT02469623|5522796|P1|COMPLETED|Overall Study||72
2250965|NCT02469623|5522796|P1|STARTED|Overall Study||85
2250966|NCT02469610|5522803|P2|NOT COMPLETED|Overall Study||1
2250967|NCT02469610|5522804|P1|NOT COMPLETED|Overall Study||4
2250968|NCT02469610|5522803|P2|COMPLETED|Overall Study||30
2250969|NCT02469610|5522804|P1|COMPLETED|Overall Study||30
2250970|NCT02469610|5522803|P2|STARTED|Overall Study||31
2250971|NCT02469610|5522804|P1|STARTED|Overall Study||34
2250972|NCT02469597|5522814|P2|NOT COMPLETED|Overall Study||0
2250973|NCT02469597|5522815|P1|NOT COMPLETED|Overall Study||0
2250974|NCT02469597|5522814|P2|COMPLETED|Overall Study||24
2250975|NCT02469597|5522815|P1|COMPLETED|Overall Study||22
2250976|NCT02469597|5522814|P2|STARTED|Overall Study||24
2250977|NCT02469597|5522815|P1|STARTED|Overall Study||22
2250978|NCT02469415|5522831|P1|NOT COMPLETED|Overall Study||3
2250979|NCT02469415|5522831|P1|COMPLETED|Overall Study||0
2250980|NCT02469415|5522831|P1|STARTED|Overall Study||3
2250981|NCT02469298|5522839|P4|NOT COMPLETED|Overall Study||2
2250982|NCT02469298|5522840|P3|NOT COMPLETED|Overall Study||2
2250983|NCT02469298|5522841|P2|NOT COMPLETED|Overall Study||1
2250984|NCT02469298|5522842|P1|NOT COMPLETED|Overall Study||1
2250985|NCT02469298|5522839|P4|COMPLETED|Overall Study||5
2250986|NCT02469298|5522840|P3|COMPLETED|Overall Study||14
2250987|NCT02469298|5522841|P2|COMPLETED|Overall Study||6
2250988|NCT02469298|5522842|P1|COMPLETED|Overall Study||14
2250989|NCT02469298|5522839|P4|STARTED|Overall Study||7
2250990|NCT02469298|5522840|P3|STARTED|Overall Study||16
2250991|NCT02469298|5522841|P2|STARTED|Overall Study||7
2250992|NCT02469298|5522842|P1|STARTED|Overall Study||15
2250993|NCT02469246|5522982|P2|NOT COMPLETED|Open-Label Extension (OLE)||0
2250994|NCT02469246|5522983|P1|NOT COMPLETED|Open-Label Extension (OLE)||0
2250995|NCT02469246|5522982|P2|COMPLETED|Open-Label Extension (OLE)||5
2250996|NCT02469246|5522983|P1|COMPLETED|Open-Label Extension (OLE)||6
2250997|NCT02469246|5522982|P2|STARTED|Open-Label Extension (OLE)|Only participants in countries where F/TAF was not commercially available were eligible for the OLE.|5
2250998|NCT02469246|5522983|P1|STARTED|Open-Label Extension (OLE)|Only participants in countries where F/TAF was not commercially available were eligible for the OLE.|6
2250999|NCT02469246|5522982|P2|NOT COMPLETED|Double-Blind Phase||56
2251000|NCT02469246|5522983|P1|NOT COMPLETED|Double-Blind Phase||67
2251001|NCT02469246|5522982|P2|COMPLETED|Double-Blind Phase||226
2251002|NCT02469246|5522983|P1|COMPLETED|Double-Blind Phase||218
2251003|NCT02469246|5522982|P2|STARTED|Double-Blind Phase||282
2251004|NCT02469246|5522983|P1|STARTED|Double-Blind Phase||285
2251005|NCT02469168|5523015|P2|NOT COMPLETED|Overall Study||0
2251006|NCT02469168|5523016|P1|NOT COMPLETED|Overall Study||1
2251007|NCT02469168|5523015|P2|COMPLETED|Overall Study||0
2251008|NCT02469168|5523016|P1|COMPLETED|Overall Study||0
2251009|NCT02469168|5523015|P2|STARTED|Overall Study||0
2251010|NCT02469168|5523016|P1|STARTED|Overall Study||1
2251011|NCT02469116|5523024|P1|NOT COMPLETED|Overall Study||0
2251012|NCT02469116|5523024|P1|COMPLETED|Overall Study||18
2251013|NCT02469116|5523024|P1|STARTED|Overall Study||18
2251014|NCT02469064|5523036|P2|NOT COMPLETED|Overall Study||3
2251015|NCT02469064|5523037|P1|NOT COMPLETED|Overall Study||1
2251016|NCT02469064|5523036|P2|COMPLETED|Overall Study||59
2251017|NCT02469064|5523037|P1|COMPLETED|Overall Study||63
2251018|NCT02469064|5523036|P2|STARTED|Overall Study||62
2251019|NCT02469064|5523037|P1|STARTED|Overall Study||64
2251020|NCT02468934|5523045|P1|NOT COMPLETED|Overall Study||7
2251021|NCT02468934|5523045|P1|COMPLETED|Overall Study||20
2251022|NCT02468934|5523045|P1|Underwent Total Knee Arthroplasty|Overall Study||20
2251023|NCT02468934|5523045|P1|Enrolled/Received Leads|Overall Study||24
2251024|NCT02468934|5523045|P1|STARTED|Overall Study||27
2251025|NCT02468830|5523064|P1|NOT COMPLETED|Overall Study||3
2251026|NCT02468830|5523064|P1|COMPLETED|Overall Study||55
2251027|NCT02468830|5523064|P1|STARTED|Overall Study||58
2251028|NCT02468700|5523074|P2|NOT COMPLETED|Overall Study||2
2251029|NCT02468700|5523075|P1|NOT COMPLETED|Overall Study||2
2251030|NCT02468700|5523074|P2|COMPLETED|Overall Study||19
2251031|NCT02468700|5523075|P1|COMPLETED|Overall Study||20
2251032|NCT02468700|5523074|P2|STARTED|Overall Study||21
2251033|NCT02468700|5523075|P1|STARTED|Overall Study||22
2251034|NCT02468674|5523096|P9|NOT COMPLETED|Overall Study||3
2251035|NCT02468674|5523097|P8|NOT COMPLETED|Overall Study||4
2251036|NCT02468674|5523098|P7|NOT COMPLETED|Overall Study||1
2251037|NCT02468674|5523099|P6|NOT COMPLETED|Overall Study||1
2251038|NCT02468674|5523100|P5|NOT COMPLETED|Overall Study||1
2251039|NCT02468674|5523101|P4|NOT COMPLETED|Overall Study||1
2251040|NCT02468674|5523102|P3|NOT COMPLETED|Overall Study||0
2251041|NCT02468674|5523103|P2|NOT COMPLETED|Overall Study||0
2251042|NCT02468674|5523104|P1|NOT COMPLETED|Overall Study||1
2251043|NCT02468674|5523096|P9|COMPLETED|Overall Study||40
2251044|NCT02468674|5523097|P8|COMPLETED|Overall Study||65
2251045|NCT02468674|5523098|P7|COMPLETED|Overall Study||14
2251046|NCT02468674|5523099|P6|COMPLETED|Overall Study||6
2251047|NCT02468674|5523100|P5|COMPLETED|Overall Study||6
2251048|NCT02468674|5523101|P4|COMPLETED|Overall Study||3
2251049|NCT02468674|5523102|P3|COMPLETED|Overall Study||5
2251050|NCT02468674|5523103|P2|COMPLETED|Overall Study||5
2251051|NCT02468674|5523104|P1|COMPLETED|Overall Study||4
2251052|NCT02468674|5523096|P9|STARTED|Overall Study||43
2251053|NCT02468674|5523097|P8|STARTED|Overall Study||69
2251054|NCT02468674|5523098|P7|STARTED|Overall Study||15
2251055|NCT02468674|5523099|P6|STARTED|Overall Study||7
2251056|NCT02468674|5523100|P5|STARTED|Overall Study||7
2251057|NCT02468674|5523101|P4|STARTED|Overall Study||4
2251058|NCT02468674|5523102|P3|STARTED|Overall Study||5
2251059|NCT02468674|5523103|P2|STARTED|Overall Study||5
2251060|NCT02468674|5523104|P1|STARTED|Overall Study||5
2251061|NCT02468583|5523162|P2|NOT COMPLETED|Overall Study||0
2251062|NCT02468583|5523163|P1|NOT COMPLETED|Overall Study||0
2251063|NCT02468583|5523162|P2|COMPLETED|Overall Study||3
2251064|NCT02468583|5523163|P1|COMPLETED|Overall Study||3
2251065|NCT02468583|5523162|P2|STARTED|Overall Study||3
2251066|NCT02468583|5523163|P1|STARTED|Overall Study||3
2251067|NCT02468414|5523201|P2|NOT COMPLETED|Overall Study||0
2251068|NCT02468414|5523202|P1|NOT COMPLETED|Overall Study||3
2251069|NCT02468414|5523201|P2|COMPLETED|Overall Study||0
2251070|NCT02468414|5523202|P1|COMPLETED|Overall Study||0
2251071|NCT02468414|5523201|P2|Safety Follow-up|Overall Study||0
2251072|NCT02468414|5523202|P1|Safety Follow-up|Overall Study||0
2251073|NCT02468414|5523201|P2|Implantation|Overall Study||0
2251074|NCT02468414|5523202|P1|Implantation|Overall Study||1
2251075|NCT02468414|5523201|P2|Harvesting|Overall Study||0
2251076|NCT02468414|5523202|P1|Harvesting|Overall Study||1
2251077|NCT02468414|5523201|P2|Successfully Screened|Overall Study||0
2251078|NCT02468414|5523202|P1|Successfully Screened|Overall Study||2
2251079|NCT02468414|5523201|P2|STARTED|Overall Study||0
2251080|NCT02468414|5523202|P1|STARTED|Overall Study||3
2251081|NCT02468154|5523210|P2|NOT COMPLETED|Overall Study||0
2251082|NCT02468154|5523211|P1|NOT COMPLETED|Overall Study||0
2251083|NCT02468154|5523210|P2|COMPLETED|Overall Study||28
2251084|NCT02468154|5523211|P1|COMPLETED|Overall Study||29
2251085|NCT02468154|5523210|P2|STARTED|Overall Study||28
2251086|NCT02468154|5523211|P1|STARTED|Overall Study||29
2251087|NCT02467777|5523225|P2|NOT COMPLETED|Overall Study||0
2251088|NCT02467777|5523226|P1|NOT COMPLETED|Overall Study||0
2251089|NCT02467777|5523225|P2|COMPLETED|Overall Study||27
2251090|NCT02467777|5523226|P1|COMPLETED|Overall Study||23
2251091|NCT02467777|5523225|P2|STARTED|Overall Study||27
2251092|NCT02467777|5523226|P1|STARTED|Overall Study||23
2251093|NCT02467621|5523234|P2|NOT COMPLETED|Overall Study||6
2251094|NCT02467621|5523235|P1|NOT COMPLETED|Overall Study||1
2251095|NCT02467621|5523234|P2|COMPLETED|Overall Study||1647
2251096|NCT02467621|5523235|P1|COMPLETED|Overall Study||1644
2251097|NCT02467621|5523234|P2|STARTED|Overall Study||1653
2251098|NCT02467621|5523235|P1|STARTED|Overall Study||1645
2251099|NCT02467504|5523255|P2|NOT COMPLETED|Overall Study||1
2251100|NCT02467504|5523256|P1|NOT COMPLETED|Overall Study||6
2251101|NCT02467504|5523255|P2|COMPLETED|Overall Study||23
2251102|NCT02467504|5523256|P1|COMPLETED|Overall Study||17
2251103|NCT02467504|5523255|P2|STARTED|Overall Study||24
2251104|NCT02467504|5523256|P1|STARTED|Overall Study||23
2251105|NCT02467491|5523300|P1|NOT COMPLETED|Overall Study||0
2251106|NCT02467491|5523300|P1|COMPLETED|Overall Study||12
2251107|NCT02467491|5523300|P1|STARTED|Overall Study||12
2251108|NCT02467387|5523309|P2|NOT COMPLETED|Second Intervention||0
2251109|NCT02467387|5523310|P1|NOT COMPLETED|Second Intervention||3
2251110|NCT02467387|5523309|P2|COMPLETED|Second Intervention||12
2251111|NCT02467387|5523310|P1|COMPLETED|Second Intervention||7
2251112|NCT02467387|5523309|P2|STARTED|Second Intervention||12
2251113|NCT02467387|5523310|P1|STARTED|Second Intervention||10
2251114|NCT02467387|5523309|P2|NOT COMPLETED|First Intervention||0
2251115|NCT02467387|5523310|P1|NOT COMPLETED|First Intervention||1
2251116|NCT02467387|5523309|P2|COMPLETED|First Intervention||12
2251117|NCT02467387|5523310|P1|COMPLETED|First Intervention||10
2251118|NCT02467387|5523309|P2|Received Treatment as Randomized|First Intervention||12
2251119|NCT02467387|5523310|P1|Received Treatment as Randomized|First Intervention||10
2251120|NCT02467387|5523309|P2|STARTED|First Intervention||12
2251121|NCT02467387|5523310|P1|STARTED|First Intervention||11
2251122|NCT02467179|5523320|P2|NOT COMPLETED|Overall Study||0
2251123|NCT02467179|5523321|P1|NOT COMPLETED|Overall Study||0
2251124|NCT02467179|5523320|P2|COMPLETED|Overall Study||25
2251125|NCT02467179|5523321|P1|COMPLETED|Overall Study||25
2251126|NCT02467179|5523320|P2|STARTED|Overall Study||25
2251127|NCT02467179|5523321|P1|STARTED|Overall Study||25
2251128|NCT02467075|5523331|P2|NOT COMPLETED|30 Day Follow-up||0
2251129|NCT02467075|5523332|P1|NOT COMPLETED|30 Day Follow-up||0
2251130|NCT02467075|5523331|P2|COMPLETED|30 Day Follow-up||1
2251131|NCT02467075|5523332|P1|COMPLETED|30 Day Follow-up||0
2251132|NCT02467075|5523331|P2|STARTED|30 Day Follow-up||1
2251133|NCT02467075|5523332|P1|STARTED|30 Day Follow-up||0
2251134|NCT02467075|5523331|P2|NOT COMPLETED|72 Hour Follow-up||0
2251135|NCT02467075|5523332|P1|NOT COMPLETED|72 Hour Follow-up||0
2251136|NCT02467075|5523331|P2|COMPLETED|72 Hour Follow-up||1
2251137|NCT02467075|5523332|P1|COMPLETED|72 Hour Follow-up||0
2251138|NCT02467075|5523331|P2|STARTED|72 Hour Follow-up||1
2251139|NCT02467075|5523332|P1|STARTED|72 Hour Follow-up||0
2251140|NCT02467075|5523331|P2|NOT COMPLETED|48 Hour Follow-up||0
2251141|NCT02467075|5523332|P1|NOT COMPLETED|48 Hour Follow-up||0
2251142|NCT02467075|5523331|P2|COMPLETED|48 Hour Follow-up||1
2251143|NCT02467075|5523332|P1|COMPLETED|48 Hour Follow-up||0
2251144|NCT02467075|5523331|P2|STARTED|48 Hour Follow-up||1
2251145|NCT02467075|5523332|P1|STARTED|48 Hour Follow-up||0
2251146|NCT02467075|5523331|P2|NOT COMPLETED|Initial CT Scan||0
2251147|NCT02467075|5523332|P1|NOT COMPLETED|Initial CT Scan||0
2251148|NCT02467075|5523331|P2|COMPLETED|Initial CT Scan||1
2251149|NCT02467075|5523332|P1|COMPLETED|Initial CT Scan||0
2251150|NCT02467075|5523331|P2|STARTED|Initial CT Scan||1
2251151|NCT02467075|5523332|P1|STARTED|Initial CT Scan||0
2251152|NCT02466958|5523350|P2|NOT COMPLETED|Overall Study||3
2251153|NCT02466958|5523351|P1|NOT COMPLETED|Overall Study||10
2251154|NCT02466958|5523350|P2|COMPLETED|Overall Study||9
2251155|NCT02466958|5523351|P1|COMPLETED|Overall Study||7
2251156|NCT02466958|5523350|P2|STARTED|Overall Study||12
2251157|NCT02466958|5523351|P1|STARTED|Overall Study||17
2251158|NCT02466659|5523363|P2|NOT COMPLETED|Overall Study||2
2251159|NCT02466659|5523364|P1|NOT COMPLETED|Overall Study||5
2251160|NCT02466659|5523363|P2|COMPLETED|Overall Study||1
2251161|NCT02466659|5523364|P1|COMPLETED|Overall Study||0
2251162|NCT02466659|5523363|P2|STARTED|Overall Study||3
2251163|NCT02466659|5523364|P1|STARTED|Overall Study||5
2251164|NCT02466555|5523372|P1|NOT COMPLETED|Overall Study||2
2251165|NCT02466555|5523372|P1|COMPLETED|Overall Study||28
2251166|NCT02466555|5523372|P1|STARTED|Overall Study||30
2251167|NCT02466516|5523384|P5|NOT COMPLETED|Overall Study||0
2251168|NCT02466516|5523385|P4|NOT COMPLETED|Overall Study||0
2251169|NCT02466516|5523386|P3|NOT COMPLETED|Overall Study||1
2251170|NCT02466516|5523387|P2|NOT COMPLETED|Overall Study||1
2251171|NCT02466516|5523388|P1|NOT COMPLETED|Overall Study||4
2251172|NCT02466516|5523384|P5|COMPLETED|Overall Study||10
2251173|NCT02466516|5523385|P4|COMPLETED|Overall Study||10
2251174|NCT02466516|5523386|P3|COMPLETED|Overall Study||9
2251175|NCT02466516|5523387|P2|COMPLETED|Overall Study||21
2251176|NCT02466516|5523388|P1|COMPLETED|Overall Study||16
2251177|NCT02466516|5523384|P5|STARTED|Overall Study||10
2251178|NCT02466516|5523385|P4|STARTED|Overall Study||10
2251179|NCT02466516|5523386|P3|STARTED|Overall Study||10
2251180|NCT02466516|5523387|P2|STARTED|Overall Study||22
2251181|NCT02466516|5523388|P1|STARTED|Overall Study||20
2251182|NCT02466425|5523407|P2|NOT COMPLETED|Overall Study||16
2251183|NCT02466425|5523408|P1|NOT COMPLETED|Overall Study||14
2251184|NCT02466425|5523407|P2|COMPLETED|Overall Study||116
2251185|NCT02466425|5523408|P1|COMPLETED|Overall Study||118
2251186|NCT02466425|5523407|P2|Treated|Overall Study||132
2251187|NCT02466425|5523408|P1|Treated|Overall Study||131
2251188|NCT02466425|5523407|P2|STARTED|Overall Study||132
2251189|NCT02466425|5523408|P1|STARTED|Overall Study||132
2251190|NCT02466412|5523418|P2|NOT COMPLETED|Second Intervention (Day 3)||0
2251191|NCT02466412|5523419|P1|NOT COMPLETED|Second Intervention (Day 3)||0
2251192|NCT02466412|5523418|P2|COMPLETED|Second Intervention (Day 3)||24
2251193|NCT02466412|5523419|P1|COMPLETED|Second Intervention (Day 3)||24
2251194|NCT02466412|5523418|P2|STARTED|Second Intervention (Day 3)||24
2251195|NCT02466412|5523419|P1|STARTED|Second Intervention (Day 3)||24
2251196|NCT02466412|5523418|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
2251197|NCT02466412|5523419|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
2251198|NCT02466412|5523418|P2|COMPLETED|Washout Period of 1 Day (Day 2)||24
2251199|NCT02466412|5523419|P1|COMPLETED|Washout Period of 1 Day (Day 2)||24
2251200|NCT02466412|5523418|P2|STARTED|Washout Period of 1 Day (Day 2)||24
2251201|NCT02466412|5523419|P1|STARTED|Washout Period of 1 Day (Day 2)||24
2251202|NCT02466412|5523418|P2|NOT COMPLETED|First Intervention (Day 1)||0
2251203|NCT02466412|5523419|P1|NOT COMPLETED|First Intervention (Day 1)||0
2251204|NCT02466412|5523418|P2|COMPLETED|First Intervention (Day 1)||24
2251205|NCT02466412|5523419|P1|COMPLETED|First Intervention (Day 1)||24
2251206|NCT02466412|5523418|P2|STARTED|First Intervention (Day 1)||24
2251207|NCT02466412|5523419|P1|STARTED|First Intervention (Day 1)||24
2251208|NCT02466412|5523418|P2|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
2251209|NCT02466412|5523419|P1|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
2251210|NCT02466412|5523418|P2|COMPLETED|Washout Period of 1 Day (Day -1)||24
2251211|NCT02466412|5523419|P1|COMPLETED|Washout Period of 1 Day (Day -1)||24
2251212|NCT02466412|5523418|P2|STARTED|Washout Period of 1 Day (Day -1)||24
2251213|NCT02466412|5523419|P1|STARTED|Washout Period of 1 Day (Day -1)||24
2251214|NCT02466230|5523428|P1|NOT COMPLETED|Overall Study||0
2251215|NCT02466230|5523428|P1|COMPLETED|Overall Study||28
2251216|NCT02466230|5523428|P1|STARTED|Overall Study||28
2251217|NCT02466087|5523433|P2|NOT COMPLETED|Second Intervention: Weeks 7-12||0
2251218|NCT02466087|5523434|P1|NOT COMPLETED|Second Intervention: Weeks 7-12||0
2251219|NCT02466087|5523433|P2|COMPLETED|Second Intervention: Weeks 7-12||57
2251220|NCT02466087|5523434|P1|COMPLETED|Second Intervention: Weeks 7-12||55
2251221|NCT02466087|5523433|P2|STARTED|Second Intervention: Weeks 7-12||57
2251222|NCT02466087|5523434|P1|STARTED|Second Intervention: Weeks 7-12||55
2251223|NCT02466087|5523433|P2|NOT COMPLETED|First Intervention: Weeks 1-6||7
2251224|NCT02466087|5523434|P1|NOT COMPLETED|First Intervention: Weeks 1-6||7
2251225|NCT02466087|5523433|P2|COMPLETED|First Intervention: Weeks 1-6||57
2251226|NCT02466087|5523434|P1|COMPLETED|First Intervention: Weeks 1-6||55
2251227|NCT02466087|5523433|P2|STARTED|First Intervention: Weeks 1-6||64
2251228|NCT02466087|5523434|P1|STARTED|First Intervention: Weeks 1-6||62
2251229|NCT02465931|5523446|P2|NOT COMPLETED|Overall Study||11
2251230|NCT02465931|5523447|P1|NOT COMPLETED|Overall Study||11
2251231|NCT02465931|5523446|P2|COMPLETED|Overall Study||45
2251232|NCT02465931|5523447|P1|COMPLETED|Overall Study||44
2251233|NCT02465931|5523446|P2|STARTED|Overall Study||56
2251234|NCT02465931|5523447|P1|STARTED|Overall Study||55
2251235|NCT02465866|5523453|P4|NOT COMPLETED|Period 4: Washout (14 Days)||0
2251236|NCT02465866|5523454|P3|NOT COMPLETED|Period 4: Washout (14 Days)||0
2251237|NCT02465866|5523455|P2|NOT COMPLETED|Period 4: Washout (14 Days)||0
2251238|NCT02465866|5523456|P1|NOT COMPLETED|Period 4: Washout (14 Days)||0
2251239|NCT02465866|5523453|P4|COMPLETED|Period 4: Washout (14 Days)||5
2251240|NCT02465866|5523454|P3|COMPLETED|Period 4: Washout (14 Days)||5
2251241|NCT02465866|5523455|P2|COMPLETED|Period 4: Washout (14 Days)||4
2251242|NCT02465866|5523456|P1|COMPLETED|Period 4: Washout (14 Days)||5
2251243|NCT02465866|5523453|P4|STARTED|Period 4: Washout (14 Days)||5
2251244|NCT02465866|5523454|P3|STARTED|Period 4: Washout (14 Days)||5
2251245|NCT02465866|5523455|P2|STARTED|Period 4: Washout (14 Days)||4
2251246|NCT02465866|5523456|P1|STARTED|Period 4: Washout (14 Days)||5
2251247|NCT02465866|5523453|P4|NOT COMPLETED|Period 4||0
2251248|NCT02465866|5523454|P3|NOT COMPLETED|Period 4||0
2251249|NCT02465866|5523455|P2|NOT COMPLETED|Period 4||0
2251250|NCT02465866|5523456|P1|NOT COMPLETED|Period 4||0
2251251|NCT02465866|5523453|P4|COMPLETED|Period 4||5
2251252|NCT02465866|5523454|P3|COMPLETED|Period 4||5
2251253|NCT02465866|5523455|P2|COMPLETED|Period 4||4
2251254|NCT02465866|5523456|P1|COMPLETED|Period 4||5
2251255|NCT02465866|5523453|P4|STARTED|Period 4||5
2251256|NCT02465866|5523454|P3|STARTED|Period 4||5
2251257|NCT02465866|5523455|P2|STARTED|Period 4||4
2251258|NCT02465866|5523456|P1|STARTED|Period 4||5
2251259|NCT02465866|5523453|P4|NOT COMPLETED|Period 3: Washout (14 Days)||0
2251260|NCT02465866|5523454|P3|NOT COMPLETED|Period 3: Washout (14 Days)||0
2251261|NCT02465866|5523455|P2|NOT COMPLETED|Period 3: Washout (14 Days)||0
2251262|NCT02465866|5523456|P1|NOT COMPLETED|Period 3: Washout (14 Days)||0
2251263|NCT02465866|5523453|P4|COMPLETED|Period 3: Washout (14 Days)||5
2251264|NCT02465866|5523454|P3|COMPLETED|Period 3: Washout (14 Days)||5
2251265|NCT02465866|5523455|P2|COMPLETED|Period 3: Washout (14 Days)||4
2251266|NCT02465866|5523456|P1|COMPLETED|Period 3: Washout (14 Days)||5
2251267|NCT02465866|5523453|P4|STARTED|Period 3: Washout (14 Days)||5
2251268|NCT02465866|5523454|P3|STARTED|Period 3: Washout (14 Days)||5
2251269|NCT02465866|5523455|P2|STARTED|Period 3: Washout (14 Days)||4
2251270|NCT02465866|5523456|P1|STARTED|Period 3: Washout (14 Days)||5
2251271|NCT02465866|5523453|P4|NOT COMPLETED|Period 3||0
2251272|NCT02465866|5523454|P3|NOT COMPLETED|Period 3||0
2251273|NCT02465866|5523455|P2|NOT COMPLETED|Period 3||1
2251274|NCT02465866|5523456|P1|NOT COMPLETED|Period 3||0
2251275|NCT02465866|5523453|P4|COMPLETED|Period 3||5
2251276|NCT02465866|5523454|P3|COMPLETED|Period 3||5
2251277|NCT02465866|5523455|P2|COMPLETED|Period 3||4
2251278|NCT02465866|5523456|P1|COMPLETED|Period 3||5
2251279|NCT02465866|5523453|P4|STARTED|Period 3||5
2251280|NCT02465866|5523454|P3|STARTED|Period 3||5
2251281|NCT02465866|5523455|P2|STARTED|Period 3||5
2251282|NCT02465866|5523456|P1|STARTED|Period 3||5
2251283|NCT02465866|5523453|P4|NOT COMPLETED|Period 2: Washout (14 Days)||0
2251284|NCT02465866|5523454|P3|NOT COMPLETED|Period 2: Washout (14 Days)||0
2251285|NCT02465866|5523455|P2|NOT COMPLETED|Period 2: Washout (14 Days)||0
2251286|NCT02465866|5523456|P1|NOT COMPLETED|Period 2: Washout (14 Days)||0
2251287|NCT02465866|5523453|P4|COMPLETED|Period 2: Washout (14 Days)||5
2251288|NCT02465866|5523454|P3|COMPLETED|Period 2: Washout (14 Days)||5
2251289|NCT02465866|5523455|P2|COMPLETED|Period 2: Washout (14 Days)||5
2251290|NCT02465866|5523456|P1|COMPLETED|Period 2: Washout (14 Days)||5
2251291|NCT02465866|5523453|P4|STARTED|Period 2: Washout (14 Days)||5
2251292|NCT02465866|5523454|P3|STARTED|Period 2: Washout (14 Days)||5
2251293|NCT02465866|5523455|P2|STARTED|Period 2: Washout (14 Days)||5
2251294|NCT02465866|5523456|P1|STARTED|Period 2: Washout (14 Days)||5
2251295|NCT02465866|5523453|P4|NOT COMPLETED|Period 2||0
2251296|NCT02465866|5523454|P3|NOT COMPLETED|Period 2||0
2251297|NCT02465866|5523455|P2|NOT COMPLETED|Period 2||0
2251298|NCT02465866|5523456|P1|NOT COMPLETED|Period 2||0
2251299|NCT02465866|5523453|P4|COMPLETED|Period 2||5
2251300|NCT02465866|5523454|P3|COMPLETED|Period 2||5
2251301|NCT02465866|5523455|P2|COMPLETED|Period 2||5
2251302|NCT02465866|5523456|P1|COMPLETED|Period 2||5
2251303|NCT02465866|5523453|P4|STARTED|Period 2||5
2251304|NCT02465866|5523454|P3|STARTED|Period 2||5
2251305|NCT02465866|5523455|P2|STARTED|Period 2||5
2251306|NCT02465866|5523456|P1|STARTED|Period 2||5
2251307|NCT02465866|5523453|P4|NOT COMPLETED|Period 1: Washout (14 Days)||0
2251308|NCT02465866|5523454|P3|NOT COMPLETED|Period 1: Washout (14 Days)||0
2251309|NCT02465866|5523455|P2|NOT COMPLETED|Period 1: Washout (14 Days)||0
2251310|NCT02465866|5523456|P1|NOT COMPLETED|Period 1: Washout (14 Days)||0
2251311|NCT02465866|5523453|P4|COMPLETED|Period 1: Washout (14 Days)||5
2251312|NCT02465866|5523454|P3|COMPLETED|Period 1: Washout (14 Days)||5
2251313|NCT02465866|5523455|P2|COMPLETED|Period 1: Washout (14 Days)||5
2251314|NCT02465866|5523456|P1|COMPLETED|Period 1: Washout (14 Days)||5
2251315|NCT02465866|5523453|P4|STARTED|Period 1: Washout (14 Days)||5
2251316|NCT02465866|5523454|P3|STARTED|Period 1: Washout (14 Days)||5
2251317|NCT02465866|5523455|P2|STARTED|Period 1: Washout (14 Days)||5
2251318|NCT02465866|5523456|P1|STARTED|Period 1: Washout (14 Days)||5
2251319|NCT02465866|5523453|P4|NOT COMPLETED|Period 1||0
2251320|NCT02465866|5523454|P3|NOT COMPLETED|Period 1||0
2251321|NCT02465866|5523455|P2|NOT COMPLETED|Period 1||0
2251322|NCT02465866|5523456|P1|NOT COMPLETED|Period 1||0
2251323|NCT02465866|5523453|P4|COMPLETED|Period 1||5
2251324|NCT02465866|5523454|P3|COMPLETED|Period 1||5
2251325|NCT02465866|5523455|P2|COMPLETED|Period 1||5
2251326|NCT02465866|5523456|P1|COMPLETED|Period 1||5
2251327|NCT02465866|5523453|P4|STARTED|Period 1||5
2251328|NCT02465866|5523454|P3|STARTED|Period 1||5
2251329|NCT02465866|5523455|P2|STARTED|Period 1||5
2251330|NCT02465866|5523456|P1|STARTED|Period 1||5
2251331|NCT02465632|5523529|P3|NOT COMPLETED|Overall Study||17
2251332|NCT02465632|5523530|P2|NOT COMPLETED|Overall Study||23
2251333|NCT02465632|5523531|P1|NOT COMPLETED|Overall Study||31
2251334|NCT02465632|5523529|P3|COMPLETED|Overall Study||203
2251335|NCT02465632|5523530|P2|COMPLETED|Overall Study||417
2251336|NCT02465632|5523531|P1|COMPLETED|Overall Study||409
2251337|NCT02465632|5523529|P3|STARTED|Overall Study||220
2251338|NCT02465632|5523530|P2|STARTED|Overall Study||440
2251339|NCT02465632|5523531|P1|STARTED|Overall Study||440
2251340|NCT02465528|5523546|P4|NOT COMPLETED|Overall Study||5
2251341|NCT02465528|5523547|P3|NOT COMPLETED|Overall Study||12
2251342|NCT02465528|5523548|P2|NOT COMPLETED|Overall Study||4
2251343|NCT02465528|5523549|P1|NOT COMPLETED|Overall Study||1
2251344|NCT02465528|5523546|P4|COMPLETED|Overall Study||0
2251345|NCT02465528|5523547|P3|COMPLETED|Overall Study||0
2251346|NCT02465528|5523548|P2|COMPLETED|Overall Study||0
2251347|NCT02465528|5523549|P1|COMPLETED|Overall Study||0
2251348|NCT02465528|5523546|P4|STARTED|Overall Study||5
2251349|NCT02465528|5523547|P3|STARTED|Overall Study||12
2251350|NCT02465528|5523548|P2|STARTED|Overall Study||4
2251351|NCT02465528|5523549|P1|STARTED|Overall Study||1
2251352|NCT02465515|5523582|P2|NOT COMPLETED|Overall Study||111
2251353|NCT02465515|5523583|P1|NOT COMPLETED|Overall Study||154
2251354|NCT02465515|5523582|P2|COMPLETED|Overall Study||4620
2251355|NCT02465515|5523583|P1|COMPLETED|Overall Study||4578
2251356|NCT02465515|5523582|P2|STARTED|Overall Study||4731
2251357|NCT02465515|5523583|P1|STARTED|Overall Study||4732
2251358|NCT02465489|5523629|P1|NOT COMPLETED|Overall Study||5
2251359|NCT02465489|5523629|P1|COMPLETED|Overall Study||15
2251360|NCT02465489|5523629|P1|STARTED|Overall Study||20
2251361|NCT02465463|5523658|P2|NOT COMPLETED|Overall Study||1
2251362|NCT02465463|5523659|P1|NOT COMPLETED|Overall Study||4
2251363|NCT02465463|5523658|P2|COMPLETED|Overall Study||4
2251364|NCT02465463|5523659|P1|COMPLETED|Overall Study||4
2251365|NCT02465463|5523658|P2|STARTED|Overall Study||5
2251366|NCT02465463|5523659|P1|STARTED|Overall Study||8
2251367|NCT02465450|5523678|P6|NOT COMPLETED|Treatment Period 2||0
2251368|NCT02465450|5523679|P5|NOT COMPLETED|Treatment Period 2||4
2251369|NCT02465450|5523680|P4|NOT COMPLETED|Treatment Period 2||3
2251370|NCT02465450|5523681|P3|NOT COMPLETED|Treatment Period 2||0
2251371|NCT02465450|5523682|P2|NOT COMPLETED|Treatment Period 2||0
2251372|NCT02465450|5523683|P1|NOT COMPLETED|Treatment Period 2||0
2251373|NCT02465450|5523678|P6|COMPLETED|Treatment Period 2||23
2251374|NCT02465450|5523679|P5|COMPLETED|Treatment Period 2||24
2251375|NCT02465450|5523680|P4|COMPLETED|Treatment Period 2||27
2251376|NCT02465450|5523681|P3|COMPLETED|Treatment Period 2||0
2251377|NCT02465450|5523682|P2|COMPLETED|Treatment Period 2||0
2251378|NCT02465450|5523683|P1|COMPLETED|Treatment Period 2||0
2251379|NCT02465450|5523678|P6|STARTED|Treatment Period 2||23
2251380|NCT02465450|5523679|P5|STARTED|Treatment Period 2||28
2251381|NCT02465450|5523680|P4|STARTED|Treatment Period 2||30
2251382|NCT02465450|5523681|P3|STARTED|Treatment Period 2||0
2251383|NCT02465450|5523682|P2|STARTED|Treatment Period 2||0
2251384|NCT02465450|5523683|P1|STARTED|Treatment Period 2||0
2251385|NCT02465450|5523678|P6|NOT COMPLETED|Treatment Period 1||0
2251386|NCT02465450|5523679|P5|NOT COMPLETED|Treatment Period 1||0
2251387|NCT02465450|5523680|P4|NOT COMPLETED|Treatment Period 1||0
2251388|NCT02465450|5523681|P3|NOT COMPLETED|Treatment Period 1||1
2251389|NCT02465450|5523682|P2|NOT COMPLETED|Treatment Period 1||1
2251390|NCT02465450|5523683|P1|NOT COMPLETED|Treatment Period 1||2
2251391|NCT02465450|5523678|P6|COMPLETED|Treatment Period 1||0
2251392|NCT02465450|5523679|P5|COMPLETED|Treatment Period 1||0
2251393|NCT02465450|5523680|P4|COMPLETED|Treatment Period 1||0
2251394|NCT02465450|5523681|P3|COMPLETED|Treatment Period 1||34
2251395|NCT02465450|5523682|P2|COMPLETED|Treatment Period 1||23
2251396|NCT02465450|5523683|P1|COMPLETED|Treatment Period 1||24
2251397|NCT02465450|5523678|P6|STARTED|Treatment Period 1||0
2251398|NCT02465450|5523679|P5|STARTED|Treatment Period 1||0
2251399|NCT02465450|5523680|P4|STARTED|Treatment Period 1||0
2251400|NCT02465450|5523681|P3|STARTED|Treatment Period 1||35
2251401|NCT02465450|5523682|P2|STARTED|Treatment Period 1||24
2251402|NCT02465450|5523683|P1|STARTED|Treatment Period 1||26
2251403|NCT02465437|5523707|P4|NOT COMPLETED|Overall Study||1
2251404|NCT02465437|5523708|P3|NOT COMPLETED|Overall Study||1
2251405|NCT02465437|5523709|P2|NOT COMPLETED|Overall Study||1
2251406|NCT02465437|5523710|P1|NOT COMPLETED|Overall Study||1
2251407|NCT02465437|5523707|P4|COMPLETED|Overall Study||14
2251408|NCT02465437|5523708|P3|COMPLETED|Overall Study||8
2251409|NCT02465437|5523709|P2|COMPLETED|Overall Study||8
2251410|NCT02465437|5523710|P1|COMPLETED|Overall Study||8
2251411|NCT02465437|5523707|P4|STARTED|Overall Study||15
2251412|NCT02465437|5523708|P3|STARTED|Overall Study||9
2251413|NCT02465437|5523709|P2|STARTED|Overall Study||9
2251414|NCT02465437|5523710|P1|STARTED|Overall Study||9
2251415|NCT02465372|5523730|P2|NOT COMPLETED|Overall Study||97
2251416|NCT02465372|5523731|P1|NOT COMPLETED|Overall Study||122
2251417|NCT02465372|5523730|P2|COMPLETED|Overall Study||153
2251418|NCT02465372|5523731|P1|COMPLETED|Overall Study||227
2251419|NCT02465372|5523730|P2|STARTED|Overall Study||250
2251420|NCT02465372|5523731|P1|STARTED|Overall Study||349
2251421|NCT02465216|5523746|P5|NOT COMPLETED|Overall Study||3
2251422|NCT02465216|5523747|P4|NOT COMPLETED|Overall Study||2
2251423|NCT02465216|5523748|P3|NOT COMPLETED|Overall Study||1
2251424|NCT02465216|5523749|P2|NOT COMPLETED|Overall Study||0
2251425|NCT02465216|5523750|P1|NOT COMPLETED|Overall Study||3
2251426|NCT02465216|5523746|P5|COMPLETED|Overall Study||9
2251427|NCT02465216|5523747|P4|COMPLETED|Overall Study||12
2251428|NCT02465216|5523748|P3|COMPLETED|Overall Study||13
2251429|NCT02465216|5523749|P2|COMPLETED|Overall Study||5
2251430|NCT02465216|5523750|P1|COMPLETED|Overall Study||12
2251431|NCT02465216|5523746|P5|STARTED|Overall Study||12
2251432|NCT02465216|5523747|P4|STARTED|Overall Study||14
2251433|NCT02465216|5523748|P3|STARTED|Overall Study||14
2251434|NCT02465216|5523749|P2|STARTED|Overall Study||5
2251435|NCT02465216|5523750|P1|STARTED|Overall Study||15
2251436|NCT02465203|5523770|P3|NOT COMPLETED|Overall Study||13
2251437|NCT02465203|5523771|P2|NOT COMPLETED|Overall Study||36
2251438|NCT02465203|5523772|P1|NOT COMPLETED|Overall Study||56
2251439|NCT02465203|5523770|P3|COMPLETED|Overall Study||0
2251440|NCT02465203|5523771|P2|COMPLETED|Overall Study||0
2251441|NCT02465203|5523772|P1|COMPLETED|Overall Study||0
2251442|NCT02465203|5523770|P3|STARTED|Overall Study||13
2251443|NCT02465203|5523771|P2|STARTED|Overall Study||36
2251444|NCT02465203|5523772|P1|STARTED|Overall Study||56
2251445|NCT02465099|5523785|P2|NOT COMPLETED|Overall Study||0
2251446|NCT02465099|5523786|P1|NOT COMPLETED|Overall Study||0
2251447|NCT02465099|5523785|P2|COMPLETED|Overall Study||19
2251448|NCT02465099|5523786|P1|COMPLETED|Overall Study||45
2251449|NCT02465099|5523785|P2|STARTED|Overall Study||19
2251450|NCT02465099|5523786|P1|STARTED|Overall Study||45
2251451|NCT02465073|5523795|P3|NOT COMPLETED|Overall Study||1
2251452|NCT02465073|5523796|P2|NOT COMPLETED|Overall Study||1
2251453|NCT02465073|5523797|P1|NOT COMPLETED|Overall Study||2
2251454|NCT02465073|5523795|P3|COMPLETED|Overall Study||15
2251455|NCT02465073|5523796|P2|COMPLETED|Overall Study||15
2251456|NCT02465073|5523797|P1|COMPLETED|Overall Study||15
2251457|NCT02465073|5523795|P3|STARTED|Overall Study||16
2251458|NCT02465073|5523796|P2|STARTED|Overall Study||16
2251459|NCT02465073|5523797|P1|STARTED|Overall Study||17
2251460|NCT02464917|5523807|P2|NOT COMPLETED|Overall Study||0
2251461|NCT02464917|5523808|P1|NOT COMPLETED|Overall Study||0
2251462|NCT02464917|5523807|P2|COMPLETED|Overall Study||35
2251463|NCT02464917|5523808|P1|COMPLETED|Overall Study||35
2251464|NCT02464917|5523807|P2|STARTED|Overall Study||35
2251465|NCT02464917|5523808|P1|STARTED|Overall Study||35
2251472|NCT02464176|5523844|P3|NOT COMPLETED|Overall Study||0
2251473|NCT02464176|5523845|P2|NOT COMPLETED|Overall Study||0
2251474|NCT02464176|5523846|P1|NOT COMPLETED|Overall Study||0
2251475|NCT02464176|5523844|P3|COMPLETED|Overall Study||15
2251476|NCT02464176|5523845|P2|COMPLETED|Overall Study||50
2251477|NCT02464176|5523846|P1|COMPLETED|Overall Study||50
2251478|NCT02464176|5523844|P3|STARTED|Overall Study||15
2251479|NCT02464176|5523845|P2|STARTED|Overall Study||50
2251480|NCT02464176|5523846|P1|STARTED|Overall Study||50
2251481|NCT02464163|5523867|P4|NOT COMPLETED|Overall Study||5
2251482|NCT02464163|5523868|P3|NOT COMPLETED|Overall Study||5
2251483|NCT02464163|5523869|P2|NOT COMPLETED|Overall Study||8
2251484|NCT02464163|5523870|P1|NOT COMPLETED|Overall Study||3
2251485|NCT02464163|5523867|P4|COMPLETED|Overall Study||96
2251486|NCT02464163|5523868|P3|COMPLETED|Overall Study||97
2251487|NCT02464163|5523869|P2|COMPLETED|Overall Study||94
2251488|NCT02464163|5523870|P1|COMPLETED|Overall Study||99
2251489|NCT02464163|5523867|P4|STARTED|Overall Study||101
2251490|NCT02464163|5523868|P3|STARTED|Overall Study||102
2251491|NCT02464163|5523869|P2|STARTED|Overall Study||102
2251492|NCT02464163|5523870|P1|STARTED|Overall Study||102
2251493|NCT02464033|5523892|P1|NOT COMPLETED|Overall Study||0
2251494|NCT02464033|5523892|P1|COMPLETED|Overall Study||20
2251495|NCT02464033|5523892|P1|STARTED|Overall Study||20
2251496|NCT02463981|5523923|P2|NOT COMPLETED|Overall Study||2
2251497|NCT02463981|5523924|P1|NOT COMPLETED|Overall Study||3
2251498|NCT02463981|5523923|P2|COMPLETED|Overall Study||14
2251499|NCT02463981|5523924|P1|COMPLETED|Overall Study||18
2251500|NCT02463981|5523923|P2|STARTED|Overall Study||16
2251501|NCT02463981|5523924|P1|STARTED|Overall Study||21
2251502|NCT02463409|5523932|P1|NOT COMPLETED|Overall Study||2
2251503|NCT02463409|5523932|P1|COMPLETED|Overall Study||4
2251504|NCT02463409|5523932|P1|STARTED|Overall Study||6
2251505|NCT02463331|5523940|P2|NOT COMPLETED|Overall Study||6
2251506|NCT02463331|5523941|P1|NOT COMPLETED|Overall Study||16
2251507|NCT02463331|5523940|P2|COMPLETED|Overall Study||25
2251508|NCT02463331|5523941|P1|COMPLETED|Overall Study||10
2251509|NCT02463331|5523940|P2|STARTED|Overall Study||31
2251510|NCT02463331|5523941|P1|STARTED|Overall Study||26
2251511|NCT02463227|5523949|P1|NOT COMPLETED|Overall Study||0
2251512|NCT02463227|5523949|P1|COMPLETED|Overall Study||14
2251513|NCT02463227|5523949|P1|STARTED|Overall Study||14
2251514|NCT02463097|5523957|P1|NOT COMPLETED|Overall Study||1
2251515|NCT02463097|5523957|P1|COMPLETED|Overall Study||123
2251516|NCT02463097|5523957|P1|STARTED|Overall Study||124
2251517|NCT02463071|5523966|P3|NOT COMPLETED|Overall Study||6
2251518|NCT02463071|5523967|P2|NOT COMPLETED|Overall Study||16
2251519|NCT02463071|5523968|P1|NOT COMPLETED|Overall Study||12
2251520|NCT02463071|5523966|P3|COMPLETED|Overall Study||71
2251521|NCT02463071|5523967|P2|COMPLETED|Overall Study||138
2251522|NCT02463071|5523968|P1|COMPLETED|Overall Study||140
2251523|NCT02463071|5523966|P3|STARTED|Overall Study||77
2251524|NCT02463071|5523967|P2|STARTED|Overall Study||154
2251525|NCT02463071|5523968|P1|STARTED|Overall Study||152
2251526|NCT02462759|5523996|P3|NOT COMPLETED|Part 2: Open-Label Phase||0
2251527|NCT02462759|5523997|P2|NOT COMPLETED|Part 2: Open-Label Phase||0
2251528|NCT02462759|5523998|P1|NOT COMPLETED|Part 2: Open-Label Phase||0
2251529|NCT02462759|5523996|P3|COMPLETED|Part 2: Open-Label Phase||20
2251530|NCT02462759|5523997|P2|COMPLETED|Part 2: Open-Label Phase||0
2251531|NCT02462759|5523998|P1|COMPLETED|Part 2: Open-Label Phase||0
2251532|NCT02462759|5523996|P3|STARTED|Part 2: Open-Label Phase||20
2251533|NCT02462759|5523997|P2|STARTED|Part 2: Open-Label Phase||0
2251534|NCT02462759|5523998|P1|STARTED|Part 2: Open-Label Phase||0
2251535|NCT02462759|5523996|P3|NOT COMPLETED|Part 1: Double Blind||0
2251536|NCT02462759|5523997|P2|NOT COMPLETED|Part 1: Double Blind||0
2251537|NCT02462759|5523998|P1|NOT COMPLETED|Part 1: Double Blind||1
2251538|NCT02462759|5523996|P3|COMPLETED|Part 1: Double Blind||0
2251539|NCT02462759|5523997|P2|COMPLETED|Part 1: Double Blind||14
2251540|NCT02462759|5523998|P1|COMPLETED|Part 1: Double Blind||6
2251541|NCT02462759|5523996|P3|STARTED|Part 1: Double Blind||0
2251542|NCT02462759|5523997|P2|STARTED|Part 1: Double Blind||14
2251543|NCT02462759|5523998|P1|STARTED|Part 1: Double Blind||7
2251544|NCT02462720|5524046|P2|NOT COMPLETED|Part 2||1
2251545|NCT02462720|5524047|P1|NOT COMPLETED|Part 2||1
2251546|NCT02462720|5524046|P2|COMPLETED|Part 2||16
2251547|NCT02462720|5524047|P1|COMPLETED|Part 2||17
2251548|NCT02462720|5524046|P2|STARTED|Part 2||17
2251549|NCT02462720|5524047|P1|STARTED|Part 2||18
2251550|NCT02462720|5524046|P2|NOT COMPLETED|Part 1||0
2251551|NCT02462720|5524047|P1|NOT COMPLETED|Part 1||0
2251552|NCT02462720|5524046|P2|COMPLETED|Part 1||17
2251553|NCT02462720|5524047|P1|COMPLETED|Part 1||18
2251554|NCT02462720|5524046|P2|STARTED|Part 1||17
2251555|NCT02462720|5524047|P1|STARTED|Part 1||18
2251556|NCT02462473|5524057|P1|NOT COMPLETED|Overall Study||4
2251557|NCT02462473|5524057|P1|COMPLETED|Overall Study||5
2251558|NCT02462473|5524057|P1|STARTED|Overall Study||9
2251559|NCT02462291|5524070|P2|NOT COMPLETED|Overall Study||6
2251560|NCT02462291|5524071|P1|NOT COMPLETED|Overall Study||5
2251561|NCT02462291|5524070|P2|COMPLETED|Overall Study||75
2251562|NCT02462291|5524071|P1|COMPLETED|Overall Study||77
2251563|NCT02462291|5524070|P2|STARTED|Overall Study||81
2251564|NCT02462291|5524071|P1|STARTED|Overall Study||82
2251565|NCT02462148|5524112|P3|NOT COMPLETED|Overall Study||0
2251566|NCT02462148|5524113|P2|NOT COMPLETED|Overall Study||0
2251567|NCT02462148|5524114|P1|NOT COMPLETED|Overall Study||1
2251568|NCT02462148|5524112|P3|COMPLETED|Overall Study||12
2251569|NCT02462148|5524113|P2|COMPLETED|Overall Study||36
2251570|NCT02462148|5524114|P1|COMPLETED|Overall Study||36
2251571|NCT02462148|5524112|P3|STARTED|Overall Study||12
2251572|NCT02462148|5524113|P2|STARTED|Overall Study||36
2251573|NCT02462148|5524114|P1|STARTED|Overall Study||37
2251574|NCT02462083|5524137|P1|NOT COMPLETED|Overall Study||419
2251575|NCT02462083|5524137|P1|COMPLETED|Overall Study||136
2251576|NCT02462083|5524137|P1|Safety Population|Overall Study||550
2251577|NCT02462083|5524137|P1|STARTED|Overall Study||555
2251578|NCT02462057|5524146|P5|NOT COMPLETED|Overall Study||50
2251579|NCT02462057|5524147|P4|NOT COMPLETED|Overall Study||51
2251580|NCT02462057|5524148|P3|NOT COMPLETED|Overall Study||46
2251581|NCT02462057|5524149|P2|NOT COMPLETED|Overall Study||40
2251582|NCT02462057|5524150|P1|NOT COMPLETED|Overall Study||54
2251583|NCT02462057|5524146|P5|COMPLETED|Overall Study||708
2251584|NCT02462057|5524147|P4|COMPLETED|Overall Study||701
2251585|NCT02462057|5524148|P3|COMPLETED|Overall Study||766
2251586|NCT02462057|5524149|P2|COMPLETED|Overall Study||753
2251587|NCT02462057|5524150|P1|COMPLETED|Overall Study||737
2251588|NCT02462057|5524146|P5|STARTED|Overall Study||758
2251589|NCT02462057|5524147|P4|STARTED|Overall Study||752
2251590|NCT02462057|5524148|P3|STARTED|Overall Study||812
2251591|NCT02462057|5524149|P2|STARTED|Overall Study||793
2251592|NCT02462057|5524150|P1|STARTED|Overall Study||791
2251593|NCT02461992|5524162|P1|NOT COMPLETED|Overall Study||0
2251594|NCT02461992|5524162|P1|COMPLETED|Overall Study||13
2251595|NCT02461992|5524162|P1|STARTED|Overall Study||13
2251596|NCT02461966|5524182|P3|NOT COMPLETED|Overall Study||0
2251597|NCT02461966|5524183|P2|NOT COMPLETED|Overall Study||0
2251598|NCT02461966|5524184|P1|NOT COMPLETED|Overall Study||0
2251599|NCT02461966|5524182|P3|COMPLETED|Overall Study||60
2251600|NCT02461966|5524183|P2|COMPLETED|Overall Study||80
2251601|NCT02461966|5524184|P1|COMPLETED|Overall Study||160
2251602|NCT02461966|5524182|P3|STARTED|Overall Study||60
2251603|NCT02461966|5524183|P2|STARTED|Overall Study||80
2251604|NCT02461966|5524184|P1|STARTED|Overall Study||160
2251605|NCT02461758|5524196|P4|NOT COMPLETED|Overall Study||0
2251606|NCT02461758|5524197|P3|NOT COMPLETED|Overall Study||1
2251607|NCT02461758|5524198|P2|NOT COMPLETED|Overall Study||1
2251608|NCT02461758|5524199|P1|NOT COMPLETED|Overall Study||0
2251609|NCT02461758|5524196|P4|COMPLETED|Overall Study||15
2251610|NCT02461758|5524197|P3|COMPLETED|Overall Study||25
2251611|NCT02461758|5524198|P2|COMPLETED|Overall Study||19
2251612|NCT02461758|5524199|P1|COMPLETED|Overall Study||20
2251613|NCT02461758|5524196|P4|STARTED|Overall Study||15
2251614|NCT02461758|5524197|P3|STARTED|Overall Study||26
2251615|NCT02461758|5524198|P2|STARTED|Overall Study||20
2251616|NCT02461758|5524199|P1|STARTED|Overall Study||20
2251617|NCT02461693|5524225|P2|NOT COMPLETED|Overall Study||0
2251618|NCT02461693|5524226|P1|NOT COMPLETED|Overall Study||0
2251619|NCT02461693|5524225|P2|COMPLETED|Overall Study||102
2251620|NCT02461693|5524226|P1|COMPLETED|Overall Study||103
2251621|NCT02461693|5524225|P2|STARTED|Overall Study||102
2251622|NCT02461693|5524226|P1|STARTED|Overall Study||103
2251623|NCT02461628|5524240|P2|NOT COMPLETED|Overall Study||7
2251624|NCT02461628|5524241|P1|NOT COMPLETED|Overall Study||4
2251625|NCT02461628|5524240|P2|COMPLETED|Overall Study||3625
2251626|NCT02461628|5524241|P1|COMPLETED|Overall Study||3729
2251627|NCT02461628|5524240|P2|18 Month Survey|Overall Study||905
2251628|NCT02461628|5524241|P1|18 Month Survey|Overall Study||995
2251629|NCT02461628|5524240|P2|12 Month Survey|Overall Study||914
2251630|NCT02461628|5524241|P1|12 Month Survey|Overall Study||882
2251631|NCT02461628|5524240|P2|6 Month Survey|Overall Study||832
2251632|NCT02461628|5524241|P1|6 Month Survey|Overall Study||814
2251633|NCT02461628|5524240|P2|Baseline Survey|Overall Study||974
2251634|NCT02461628|5524241|P1|Baseline Survey|Overall Study||1038
2251635|NCT02461628|5524240|P2|STARTED|Overall Study||3632
2251636|NCT02461628|5524241|P1|STARTED|Overall Study||3733
2251637|NCT02461589|5524265|P10|NOT COMPLETED|Overall Study||5
2251638|NCT02461589|5524266|P9|NOT COMPLETED|Overall Study||6
2251639|NCT02461589|5524267|P8|NOT COMPLETED|Overall Study||5
2251640|NCT02461589|5524268|P7|NOT COMPLETED|Overall Study||6
2251641|NCT02461589|5524269|P6|NOT COMPLETED|Overall Study||3
2251642|NCT02461589|5524270|P5|NOT COMPLETED|Overall Study||2
2251643|NCT02461589|5524271|P4|NOT COMPLETED|Overall Study||5
2251644|NCT02461589|5524272|P3|NOT COMPLETED|Overall Study||5
2251645|NCT02461589|5524273|P2|NOT COMPLETED|Overall Study||2
2251646|NCT02461589|5524274|P1|NOT COMPLETED|Overall Study||6
2251647|NCT02461589|5524265|P10|COMPLETED|Overall Study||60
2251648|NCT02461589|5524266|P9|COMPLETED|Overall Study||123
2251649|NCT02461589|5524267|P8|COMPLETED|Overall Study||60
2251650|NCT02461589|5524268|P7|COMPLETED|Overall Study||58
2251651|NCT02461589|5524269|P6|COMPLETED|Overall Study||61
2251652|NCT02461589|5524270|P5|COMPLETED|Overall Study||62
2251653|NCT02461589|5524271|P4|COMPLETED|Overall Study||58
2251654|NCT02461589|5524272|P3|COMPLETED|Overall Study||60
2251655|NCT02461589|5524273|P2|COMPLETED|Overall Study||61
2251656|NCT02461589|5524274|P1|COMPLETED|Overall Study||58
2251657|NCT02461589|5524265|P10|Exposed|Overall Study||64
2251658|NCT02461589|5524266|P9|Exposed|Overall Study||129
2251659|NCT02461589|5524267|P8|Exposed|Overall Study||65
2251660|NCT02461589|5524268|P7|Exposed|Overall Study||64
2251661|NCT02461589|5524269|P6|Exposed|Overall Study||64
2251662|NCT02461589|5524270|P5|Exposed|Overall Study||64
2251663|NCT02461589|5524271|P4|Exposed|Overall Study||63
2251664|NCT02461589|5524272|P3|Exposed|Overall Study||65
2251665|NCT02461589|5524273|P2|Exposed|Overall Study||63
2251666|NCT02461589|5524274|P1|Exposed|Overall Study||64
2251667|NCT02461589|5524265|P10|STARTED|Overall Study||65
2251668|NCT02461589|5524266|P9|STARTED|Overall Study||129
2251669|NCT02461589|5524267|P8|STARTED|Overall Study||65
2251670|NCT02461589|5524268|P7|STARTED|Overall Study||64
2251671|NCT02461589|5524269|P6|STARTED|Overall Study||64
2251672|NCT02461589|5524270|P5|STARTED|Overall Study||64
2251673|NCT02461589|5524271|P4|STARTED|Overall Study||63
2251674|NCT02461589|5524272|P3|STARTED|Overall Study||65
2251675|NCT02461589|5524273|P2|STARTED|Overall Study||63
2251676|NCT02461589|5524274|P1|STARTED|Overall Study||64
2251677|NCT02461563|5524330|P4|NOT COMPLETED|Overall Study||0
2251678|NCT02461563|5524331|P3|NOT COMPLETED|Overall Study||0
2251679|NCT02461563|5524332|P2|NOT COMPLETED|Overall Study||0
2251680|NCT02461563|5524333|P1|NOT COMPLETED|Overall Study||0
2251681|NCT02461563|5524330|P4|COMPLETED|Overall Study||3
2251682|NCT02461563|5524331|P3|COMPLETED|Overall Study||3
2251683|NCT02461563|5524332|P2|COMPLETED|Overall Study||3
2251684|NCT02461563|5524333|P1|COMPLETED|Overall Study||3
2251685|NCT02461563|5524330|P4|STARTED|Overall Study||3
2251686|NCT02461563|5524331|P3|STARTED|Overall Study||3
2251687|NCT02461563|5524332|P2|STARTED|Overall Study||3
2251688|NCT02461563|5524333|P1|STARTED|Overall Study||3
2251689|NCT02461550|5524367|P1|NOT COMPLETED|Overall Study||0
2251690|NCT02461550|5524367|P1|COMPLETED|Overall Study||2
2251691|NCT02461550|5524367|P1|STARTED|Overall Study||2
2251692|NCT02461433|5524373|P2|NOT COMPLETED|Overall Study||0
2251693|NCT02461433|5524374|P1|NOT COMPLETED|Overall Study||0
2251694|NCT02461433|5524373|P2|COMPLETED|Overall Study||1
2251695|NCT02461433|5524374|P1|COMPLETED|Overall Study||1
2251696|NCT02461433|5524373|P2|STARTED|Overall Study||1
2251697|NCT02461433|5524374|P1|STARTED|Overall Study||1
2251698|NCT02461355|5524400|P1|NOT COMPLETED|Overall Study||0
2251699|NCT02461355|5524400|P1|COMPLETED|Overall Study||2
2251700|NCT02461355|5524400|P1|STARTED|Overall Study||2
2251701|NCT02461290|5524407|P1|NOT COMPLETED|Overall Study||10
2251702|NCT02461290|5524407|P1|COMPLETED|Overall Study||89
2251703|NCT02461290|5524407|P1|STARTED|Overall Study||99
2251704|NCT02461160|5524427|P13|NOT COMPLETED|Overall Study||0
2251705|NCT02461160|5524428|P12|NOT COMPLETED|Overall Study||0
2251706|NCT02461160|5524429|P11|NOT COMPLETED|Overall Study||0
2251707|NCT02461160|5524430|P10|NOT COMPLETED|Overall Study||0
2251708|NCT02461160|5524431|P9|NOT COMPLETED|Overall Study||0
2251709|NCT02461160|5524432|P8|NOT COMPLETED|Overall Study||1
2251710|NCT02461160|5524433|P7|NOT COMPLETED|Overall Study||0
2251711|NCT02461160|5524434|P6|NOT COMPLETED|Overall Study||0
2251712|NCT02461160|5524435|P5|NOT COMPLETED|Overall Study||0
2251713|NCT02461160|5524436|P4|NOT COMPLETED|Overall Study||0
2251714|NCT02461160|5524437|P3|NOT COMPLETED|Overall Study||0
2251715|NCT02461160|5524438|P2|NOT COMPLETED|Overall Study||0
2251716|NCT02461160|5524439|P1|NOT COMPLETED|Overall Study||0
2251717|NCT02461160|5524427|P13|COMPLETED|Overall Study||8
2251718|NCT02461160|5524428|P12|COMPLETED|Overall Study||4
2251719|NCT02461160|5524429|P11|COMPLETED|Overall Study||4
2251720|NCT02461160|5524430|P10|COMPLETED|Overall Study||4
2251721|NCT02461160|5524431|P9|COMPLETED|Overall Study||12
2251722|NCT02461160|5524432|P8|COMPLETED|Overall Study||5
2251723|NCT02461160|5524433|P7|COMPLETED|Overall Study||6
2251724|NCT02461160|5524434|P6|COMPLETED|Overall Study||6
2251725|NCT02461160|5524435|P5|COMPLETED|Overall Study||6
2251726|NCT02461160|5524436|P4|COMPLETED|Overall Study||12
2251727|NCT02461160|5524437|P3|COMPLETED|Overall Study||6
2251728|NCT02461160|5524438|P2|COMPLETED|Overall Study||6
2251729|NCT02461160|5524439|P1|COMPLETED|Overall Study||8
2251730|NCT02461160|5524427|P13|STARTED|Overall Study||8
2251731|NCT02461160|5524428|P12|STARTED|Overall Study||4
2251732|NCT02461160|5524429|P11|STARTED|Overall Study||4
2251733|NCT02461160|5524430|P10|STARTED|Overall Study||4
2251734|NCT02461160|5524431|P9|STARTED|Overall Study||12
2251735|NCT02461160|5524432|P8|STARTED|Overall Study||6
2251736|NCT02461160|5524433|P7|STARTED|Overall Study||6
2251737|NCT02461160|5524434|P6|STARTED|Overall Study||6
2251738|NCT02461160|5524435|P5|STARTED|Overall Study||6
2251739|NCT02461160|5524436|P4|STARTED|Overall Study||12
2251740|NCT02461160|5524437|P3|STARTED|Overall Study||6
2251741|NCT02461160|5524438|P2|STARTED|Overall Study||6
2251742|NCT02461160|5524439|P1|STARTED|Overall Study||8
2251743|NCT02461134|5524650|P1|NOT COMPLETED|Overall Study||1
2251744|NCT02461134|5524650|P1|COMPLETED|Overall Study||0
2251745|NCT02461134|5524650|P1|STARTED|Overall Study||1
2251746|NCT02460991|5524658|P2|NOT COMPLETED|Overall Study||2
2251747|NCT02460991|5524659|P1|NOT COMPLETED|Overall Study||0
2251748|NCT02460991|5524658|P2|COMPLETED|Overall Study||0
2251749|NCT02460991|5524659|P1|COMPLETED|Overall Study||0
2251750|NCT02460991|5524658|P2|STARTED|Overall Study||2
2251751|NCT02460991|5524659|P1|STARTED|Overall Study||0
2251752|NCT02460978|5524676|P3|NOT COMPLETED|Overall Study||33
2251753|NCT02460978|5524677|P2|NOT COMPLETED|Overall Study||25
2251754|NCT02460978|5524678|P1|NOT COMPLETED|Overall Study||27
2251755|NCT02460978|5524676|P3|COMPLETED|Overall Study||239
2251756|NCT02460978|5524677|P2|COMPLETED|Overall Study||245
2251757|NCT02460978|5524678|P1|COMPLETED|Overall Study||244
2251758|NCT02460978|5524676|P3|STARTED|Overall Study||272
2251759|NCT02460978|5524677|P2|STARTED|Overall Study||270
2251760|NCT02460978|5524678|P1|STARTED|Overall Study||271
2251761|NCT02460822|5524704|P1|NOT COMPLETED|Overall Study||1
2251762|NCT02460822|5524704|P1|COMPLETED|Overall Study||15
2251763|NCT02460822|5524704|P1|STARTED|Overall Study||16
2251764|NCT02460562|5524715|P2|NOT COMPLETED|Overall Study||16
2251765|NCT02460562|5524716|P1|NOT COMPLETED|Overall Study||15
2251766|NCT02460562|5524715|P2|COMPLETED|Overall Study||60
2251767|NCT02460562|5524716|P1|COMPLETED|Overall Study||59
2251768|NCT02460562|5524715|P2|STARTED|Overall Study||76
2251769|NCT02460562|5524716|P1|STARTED|Overall Study||74
2251770|NCT02460458|5524724|P1|NOT COMPLETED|Prospective Phase||0
2251771|NCT02460458|5524724|P1|COMPLETED|Prospective Phase|Information not yet available.|0
2251772|NCT02460458|5524724|P1|STARTED|Prospective Phase|Information not yet available.|0
2251773|NCT02460458|5524724|P1|NOT COMPLETED|Confirmatory Phase||266
2251774|NCT02460458|5524724|P1|COMPLETED|Confirmatory Phase|Information not yet available.|0
2251775|NCT02460458|5524724|P1|STARTED|Confirmatory Phase||266
2251776|NCT02460458|5524724|P1|NOT COMPLETED|Retrospective Phase||0
2251777|NCT02460458|5524724|P1|COMPLETED|Retrospective Phase||266
2251778|NCT02460458|5524724|P1|STARTED|Retrospective Phase||266
2251779|NCT02460380|5524732|P2|NOT COMPLETED|Overall Study||5
2251780|NCT02460380|5524733|P1|NOT COMPLETED|Overall Study||10
2251781|NCT02460380|5524732|P2|COMPLETED|Overall Study||18
2251782|NCT02460380|5524733|P1|COMPLETED|Overall Study||35
2251783|NCT02460380|5524732|P2|STARTED|Overall Study||23
2251784|NCT02460380|5524733|P1|STARTED|Overall Study||45
2251785|NCT02460172|5524753|P1|NOT COMPLETED|Overall Study||0
2251786|NCT02460172|5524753|P1|COMPLETED|Overall Study||25
2251787|NCT02460172|5524753|P1|STARTED|Overall Study||25
2251788|NCT02460159|5524769|P2|NOT COMPLETED|Overall Study||1
2251789|NCT02460159|5524770|P1|NOT COMPLETED|Overall Study||6
2251790|NCT02460159|5524769|P2|COMPLETED|Overall Study||17
2251791|NCT02460159|5524770|P1|COMPLETED|Overall Study||111
2251792|NCT02460159|5524769|P2|STARTED|Overall Study||18
2251793|NCT02460159|5524770|P1|STARTED|Overall Study||117
2251794|NCT02459951|5524798|P1|NOT COMPLETED|Overall Study||1
2251795|NCT02459951|5524798|P1|COMPLETED|Overall Study||9
2251796|NCT02459951|5524798|P1|STARTED|Overall Study||10
2251797|NCT02459899|5524809|P4|NOT COMPLETED|Overall Study||2
2251798|NCT02459899|5524810|P3|NOT COMPLETED|Overall Study||0
2251799|NCT02459899|5524811|P2|NOT COMPLETED|Overall Study||6
2251800|NCT02459899|5524812|P1|NOT COMPLETED|Overall Study||3
2251801|NCT02459899|5524809|P4|COMPLETED|Overall Study||33
2251802|NCT02459899|5524810|P3|COMPLETED|Overall Study||35
2251803|NCT02459899|5524811|P2|COMPLETED|Overall Study||29
2251804|NCT02459899|5524812|P1|COMPLETED|Overall Study||33
2251805|NCT02459899|5524809|P4|STARTED|Overall Study||35
2251806|NCT02459899|5524810|P3|STARTED|Overall Study||35
2251807|NCT02459899|5524811|P2|STARTED|Overall Study||35
2251808|NCT02459899|5524812|P1|STARTED|Overall Study||36
2251809|NCT02459665|5524846|P4|NOT COMPLETED|Overall Study||2
2251810|NCT02459665|5524847|P3|NOT COMPLETED|Overall Study||1
2251811|NCT02459665|5524848|P2|NOT COMPLETED|Overall Study||1
2251812|NCT02459665|5524849|P1|NOT COMPLETED|Overall Study||0
2251813|NCT02459665|5524846|P4|COMPLETED|Overall Study||15
2251814|NCT02459665|5524847|P3|COMPLETED|Overall Study||16
2251815|NCT02459665|5524848|P2|COMPLETED|Overall Study||16
2251816|NCT02459665|5524849|P1|COMPLETED|Overall Study||17
2251817|NCT02459665|5524846|P4|Month 6 Visit|Overall Study||15
2251818|NCT02459665|5524847|P3|Month 6 Visit|Overall Study||16
2251819|NCT02459665|5524848|P2|Month 6 Visit|Overall Study||16
2251820|NCT02459665|5524849|P1|Month 6 Visit|Overall Study||17
2251821|NCT02459665|5524846|P4|Month 2 Visit|Overall Study||16
2251822|NCT02459665|5524847|P3|Month 2 Visit|Overall Study||17
2251823|NCT02459665|5524848|P2|Month 2 Visit|Overall Study||16
2251824|NCT02459665|5524849|P1|Month 2 Visit|Overall Study||17
2251825|NCT02459665|5524846|P4|Month 1 Visit|Overall Study||16
2251826|NCT02459665|5524847|P3|Month 1 Visit|Overall Study||17
2251827|NCT02459665|5524848|P2|Month 1 Visit|Overall Study||17
2251828|NCT02459665|5524849|P1|Month 1 Visit|Overall Study||17
2251829|NCT02459665|5524846|P4|Day 7 Visit|Overall Study||16
2251830|NCT02459665|5524847|P3|Day 7 Visit|Overall Study||17
2251831|NCT02459665|5524848|P2|Day 7 Visit|Overall Study||17
2251832|NCT02459665|5524849|P1|Day 7 Visit|Overall Study||17
2251833|NCT02459665|5524846|P4|STARTED|Overall Study||17
2251834|NCT02459665|5524847|P3|STARTED|Overall Study||17
2251835|NCT02459665|5524848|P2|STARTED|Overall Study||17
2251836|NCT02459665|5524849|P1|STARTED|Overall Study||17
2251837|NCT02459418|5524880|P2|NOT COMPLETED|Overall Study||6
2251838|NCT02459418|5524881|P1|NOT COMPLETED|Overall Study||8
2251839|NCT02459418|5524880|P2|COMPLETED|Overall Study||15
2251840|NCT02459418|5524881|P1|COMPLETED|Overall Study||13
2251841|NCT02459418|5524880|P2|Received Second Treatment|Overall Study||15
2251842|NCT02459418|5524881|P1|Received Second Treatment|Overall Study||13
2251843|NCT02459418|5524880|P2|Received First Treatment|Overall Study||21
2251844|NCT02459418|5524881|P1|Received First Treatment|Overall Study||21
2251845|NCT02459418|5524880|P2|STARTED|Overall Study||21
2251846|NCT02459418|5524881|P1|STARTED|Overall Study||21
2251847|NCT02459197|5524903|P2|NOT COMPLETED|Overall Study||1
2251848|NCT02459197|5524904|P1|NOT COMPLETED|Overall Study||0
2251849|NCT02459197|5524903|P2|COMPLETED|Overall Study||55
2251850|NCT02459197|5524904|P1|COMPLETED|Overall Study||58
2251851|NCT02459197|5524903|P2|STARTED|Overall Study||56
2251852|NCT02459197|5524904|P1|STARTED|Overall Study||58
2251853|NCT02459093|5524920|P2|NOT COMPLETED|Overall Study||18
2251854|NCT02459093|5524921|P1|NOT COMPLETED|Overall Study||12
2251855|NCT02459093|5524920|P2|COMPLETED|Overall Study||257
2251856|NCT02459093|5524921|P1|COMPLETED|Overall Study||263
2251857|NCT02459093|5524920|P2|STARTED|Overall Study||275
2251858|NCT02459093|5524921|P1|STARTED|Overall Study||275
2251859|NCT02459080|5524932|P3|NOT COMPLETED|Overall Study||58
2251860|NCT02459080|5524933|P2|NOT COMPLETED|Overall Study||40
2251861|NCT02459080|5524934|P1|NOT COMPLETED|Overall Study||44
2251862|NCT02459080|5524932|P3|COMPLETED|Overall Study||151
2251863|NCT02459080|5524933|P2|COMPLETED|Overall Study||158
2251864|NCT02459080|5524934|P1|COMPLETED|Overall Study||168
2251865|NCT02459080|5524932|P3|STARTED|Overall Study||209
2251866|NCT02459080|5524933|P2|STARTED|Overall Study||198
2251867|NCT02459080|5524934|P1|STARTED|Overall Study||212
2251868|NCT02458768|5524959|P2|NOT COMPLETED|Overall Study||5
2251869|NCT02458768|5524960|P1|NOT COMPLETED|Overall Study||7
2251870|NCT02458768|5524959|P2|COMPLETED|Overall Study||50
2251871|NCT02458768|5524960|P1|COMPLETED|Overall Study||50
2251872|NCT02458768|5524959|P2|STARTED|Overall Study||55
2251873|NCT02458768|5524960|P1|STARTED|Overall Study||57
2251874|NCT02458365|5524968|P2|NOT COMPLETED|Overall Study||294
2251875|NCT02458365|5524969|P1|NOT COMPLETED|Overall Study||277
2251876|NCT02458365|5524968|P2|COMPLETED|Overall Study||1607
2251877|NCT02458365|5524969|P1|COMPLETED|Overall Study||1723
2251878|NCT02458365|5524968|P2|STARTED|Overall Study||1901
2251879|NCT02458365|5524969|P1|STARTED|Overall Study||2000
2251880|NCT02458352|5524989|P1|NOT COMPLETED|Overall Study||0
2251881|NCT02458352|5524989|P1|COMPLETED|Overall Study||105
2251882|NCT02458352|5524989|P1|STARTED|Overall Study||105
2251883|NCT02458287|5525001|P4|NOT COMPLETED|Overall Study||3
2251884|NCT02458287|5525002|P3|NOT COMPLETED|Overall Study||3
2251885|NCT02458287|5525003|P2|NOT COMPLETED|Overall Study||4
2251886|NCT02458287|5525004|P1|NOT COMPLETED|Overall Study||0
2251887|NCT02458287|5525001|P4|COMPLETED|Overall Study||97
2251888|NCT02458287|5525002|P3|COMPLETED|Overall Study||46
2251889|NCT02458287|5525003|P2|COMPLETED|Overall Study||96
2251890|NCT02458287|5525004|P1|COMPLETED|Overall Study||50
2251891|NCT02458287|5525001|P4|STARTED|Overall Study||100
2251892|NCT02458287|5525002|P3|STARTED|Overall Study||49
2251893|NCT02458287|5525003|P2|STARTED|Overall Study||100
2251894|NCT02458287|5525004|P1|STARTED|Overall Study||50
2251895|NCT02457897|5525049|P1|NOT COMPLETED|Part 2 Long-term (6 Month) Study||0
2251896|NCT02457897|5525049|P1|COMPLETED|Part 2 Long-term (6 Month) Study||5
2251897|NCT02457897|5525049|P1|STARTED|Part 2 Long-term (6 Month) Study|Two patients were not eligible for Part 2 study because their HbA1c was less than 7.|5
2251898|NCT02457897|5525049|P1|NOT COMPLETED|Part 1 Short-term (2 Weeks) Study||0
2251899|NCT02457897|5525049|P1|COMPLETED|Part 1 Short-term (2 Weeks) Study||7
2251900|NCT02457897|5525049|P1|STARTED|Part 1 Short-term (2 Weeks) Study||7
2251901|NCT02457819|5525056|P1|NOT COMPLETED|Overall Study||99
2251902|NCT02457819|5525056|P1|COMPLETED|Overall Study||138
2251903|NCT02457819|5525056|P1|Safety Population|Overall Study||236
2251904|NCT02457819|5525056|P1|STARTED|Overall Study||237
2251905|NCT02457793|5525068|P6|NOT COMPLETED|Overall Study||6
2251906|NCT02457793|5525069|P5|NOT COMPLETED|Overall Study||4
2251907|NCT02457793|5525070|P4|NOT COMPLETED|Overall Study||5
2251908|NCT02457793|5525071|P3|NOT COMPLETED|Overall Study||3
2251909|NCT02457793|5525072|P2|NOT COMPLETED|Overall Study||4
2251910|NCT02457793|5525073|P1|NOT COMPLETED|Overall Study||1
2251911|NCT02457793|5525068|P6|COMPLETED|Overall Study||0
2251912|NCT02457793|5525069|P5|COMPLETED|Overall Study||0
2251913|NCT02457793|5525070|P4|COMPLETED|Overall Study||0
2251914|NCT02457793|5525071|P3|COMPLETED|Overall Study||0
2251915|NCT02457793|5525072|P2|COMPLETED|Overall Study||1
2251916|NCT02457793|5525073|P1|COMPLETED|Overall Study||0
2251917|NCT02457793|5525068|P6|STARTED|Overall Study||6
2251918|NCT02457793|5525069|P5|STARTED|Overall Study||4
2251919|NCT02457793|5525070|P4|STARTED|Overall Study||5
2251920|NCT02457793|5525071|P3|STARTED|Overall Study||3
2251921|NCT02457793|5525072|P2|STARTED|Overall Study||5
2251922|NCT02457793|5525073|P1|STARTED|Overall Study||1
2251923|NCT02457728|5525213|P1|NOT COMPLETED|Overall Study||0
2251924|NCT02457728|5525213|P1|COMPLETED|Overall Study||34
2251925|NCT02457728|5525213|P1|STARTED|Overall Study||34
2251926|NCT02457637|5525217|P1|NOT COMPLETED|Clinic or Telephone Follow-up||71
2251927|NCT02457637|5525217|P1|COMPLETED|Clinic or Telephone Follow-up||2529
2251928|NCT02457637|5525217|P1|One-year Death|Clinic or Telephone Follow-up||475
2252098|NCT02455076|5525456|P2|NOT COMPLETED|Outpatient||0
2251929|NCT02457637|5525217|P1|One-year Liver Transplantation|Clinic or Telephone Follow-up||182
2251930|NCT02457637|5525217|P1|STARTED|Clinic or Telephone Follow-up||2600
2251931|NCT02457637|5525217|P1|NOT COMPLETED|28-Days Hospitalization and Observation||0
2251932|NCT02457637|5525217|P1|COMPLETED|28-Days Hospitalization and Observation|Death and receiving Liver transplantation are two end points of our observation.|2600
2251933|NCT02457637|5525217|P1|Death|28-Days Hospitalization and Observation||74
2251934|NCT02457637|5525217|P1|Liver Transplantation|28-Days Hospitalization and Observation||124
2251935|NCT02457637|5525217|P1|STARTED|28-Days Hospitalization and Observation||2600
2251936|NCT02457637|5525217|P1|NOT COMPLETED|Recruitment||0
2251937|NCT02457637|5525217|P1|COMPLETED|Recruitment|2361 patients were excluded according to our exclusion criteria,2600 patients remained.|2600
2251938|NCT02457637|5525217|P1|STARTED|Recruitment|2600 is the number of inpatients who met our eligibility.|2600
2251939|NCT02457611|5525224|P1|NOT COMPLETED|Overall Study||3
2251940|NCT02457611|5525224|P1|COMPLETED|Overall Study||23
2251941|NCT02457611|5525224|P1|STARTED|Overall Study||26
2251942|NCT02457546|5525238|P2|NOT COMPLETED|Overall Study||4
2251943|NCT02457546|5525239|P1|NOT COMPLETED|Overall Study||9
2251944|NCT02457546|5525238|P2|COMPLETED|Overall Study||116
2251945|NCT02457546|5525239|P1|COMPLETED|Overall Study||105
2251946|NCT02457546|5525238|P2|STARTED|Overall Study||120
2251947|NCT02457546|5525239|P1|STARTED|Overall Study||114
2251948|NCT02457260|5525250|P3|NOT COMPLETED|Overall Study||1
2251949|NCT02457260|5525251|P2|NOT COMPLETED|Overall Study||3
2251950|NCT02457260|5525252|P1|NOT COMPLETED|Overall Study||2
2251951|NCT02457260|5525250|P3|COMPLETED|Overall Study||1
2251952|NCT02457260|5525251|P2|COMPLETED|Overall Study||4
2251953|NCT02457260|5525252|P1|COMPLETED|Overall Study||10
2251954|NCT02457260|5525250|P3|STARTED|Overall Study||2
2251955|NCT02457260|5525251|P2|STARTED|Overall Study||7
2251956|NCT02457260|5525252|P1|STARTED|Overall Study||12
2251957|NCT02457247|5525294|P4|NOT COMPLETED|Period 2||0
2251958|NCT02457247|5525295|P3|NOT COMPLETED|Period 2||0
2251959|NCT02457247|5525296|P2|NOT COMPLETED|Period 2||3
2251960|NCT02457247|5525297|P1|NOT COMPLETED|Period 2||2
2251961|NCT02457247|5525294|P4|COMPLETED|Period 2||70
2251962|NCT02457247|5525295|P3|COMPLETED|Period 2||68
2251963|NCT02457247|5525296|P2|COMPLETED|Period 2||65
2251964|NCT02457247|5525297|P1|COMPLETED|Period 2||64
2251965|NCT02457247|5525294|P4|STARTED|Period 2||70
2251966|NCT02457247|5525295|P3|STARTED|Period 2||68
2251967|NCT02457247|5525296|P2|STARTED|Period 2||68
2251968|NCT02457247|5525297|P1|STARTED|Period 2||66
2251969|NCT02457247|5525294|P4|NOT COMPLETED|Period 1||0
2251970|NCT02457247|5525295|P3|NOT COMPLETED|Period 1||0
2251971|NCT02457247|5525296|P2|NOT COMPLETED|Period 1||2
2251972|NCT02457247|5525297|P1|NOT COMPLETED|Period 1||2
2251973|NCT02457247|5525294|P4|COMPLETED|Period 1||70
2251974|NCT02457247|5525295|P3|COMPLETED|Period 1||68
2251975|NCT02457247|5525296|P2|COMPLETED|Period 1||68
2251976|NCT02457247|5525297|P1|COMPLETED|Period 1||66
2251977|NCT02457247|5525294|P4|STARTED|Period 1||70
2251978|NCT02457247|5525295|P3|STARTED|Period 1||68
2251979|NCT02457247|5525296|P2|STARTED|Period 1||70
2251980|NCT02457247|5525297|P1|STARTED|Period 1||68
2251981|NCT02457195|5525317|P1|NOT COMPLETED|Overall Study||9
2251982|NCT02457195|5525317|P1|COMPLETED|Overall Study||41
2251983|NCT02457195|5525317|P1|STARTED|Overall Study||50
2251984|NCT02457182|5525323|P2|NOT COMPLETED|Overall Study||0
2251985|NCT02457182|5525324|P1|NOT COMPLETED|Overall Study||1
2251986|NCT02457182|5525323|P2|COMPLETED|Overall Study||11
2251987|NCT02457182|5525324|P1|COMPLETED|Overall Study||8
2251988|NCT02457182|5525323|P2|STARTED|Overall Study||11
2251989|NCT02457182|5525324|P1|STARTED|Overall Study||9
2251990|NCT02457065|5525342|P2|NOT COMPLETED|Overall Study||11
2251991|NCT02457065|5525343|P1|NOT COMPLETED|Overall Study||9
2251992|NCT02457065|5525342|P2|COMPLETED|Overall Study||16
2251993|NCT02457065|5525343|P1|COMPLETED|Overall Study||18
2251994|NCT02457065|5525342|P2|STARTED|Overall Study||27
2251995|NCT02457065|5525343|P1|STARTED|Overall Study||27
2251996|NCT02456896|5525353|P2|NOT COMPLETED|Overall Study||4
2251997|NCT02456896|5525354|P1|NOT COMPLETED|Overall Study||6
2251998|NCT02456896|5525353|P2|COMPLETED|Overall Study||21
2251999|NCT02456896|5525354|P1|COMPLETED|Overall Study||19
2252000|NCT02456896|5525353|P2|STARTED|Overall Study||25
2252001|NCT02456896|5525354|P1|STARTED|Overall Study||25
2252002|NCT02456740|5525365|P9|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||18
2252003|NCT02456740|5525366|P8|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12
2252004|NCT02456740|5525367|P7|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||9
2252005|NCT02456740|5525368|P6|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||13
2252006|NCT02456740|5525369|P5|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||17
2252007|NCT02456740|5525370|P4|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||14
2252008|NCT02456740|5525371|P3|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
2252009|NCT02456740|5525372|P2|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
2252010|NCT02456740|5525373|P1|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
2252011|NCT02456740|5525365|P9|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||126
2252012|NCT02456740|5525366|P8|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||128
2252013|NCT02456740|5525367|P7|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||131
2252014|NCT02456740|5525368|P6|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||130
2252015|NCT02456740|5525369|P5|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||123
2252016|NCT02456740|5525370|P4|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||124
2252017|NCT02456740|5525371|P3|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
2252018|NCT02456740|5525372|P2|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
2252019|NCT02456740|5525373|P1|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
2252020|NCT02456740|5525365|P9|STARTED|Active Treatment Phase (Weeks 24 - 52)||144
2252021|NCT02456740|5525366|P8|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
2252022|NCT02456740|5525367|P7|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
2252023|NCT02456740|5525368|P6|STARTED|Active Treatment Phase (Weeks 24 - 52)||143
2252024|NCT02456740|5525369|P5|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
2252025|NCT02456740|5525370|P4|STARTED|Active Treatment Phase (Weeks 24 - 52)||138
2252026|NCT02456740|5525371|P3|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
2252027|NCT02456740|5525372|P2|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
2252028|NCT02456740|5525373|P1|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
2252029|NCT02456740|5525365|P9|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
2252030|NCT02456740|5525366|P8|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
2252031|NCT02456740|5525367|P7|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
2252032|NCT02456740|5525368|P6|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
2252033|NCT02456740|5525369|P5|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
2252034|NCT02456740|5525370|P4|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
2252035|NCT02456740|5525371|P3|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||27
2252036|NCT02456740|5525372|P2|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||33
2252037|NCT02456740|5525373|P1|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||37
2252038|NCT02456740|5525365|P9|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
2252039|NCT02456740|5525366|P8|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
2252040|NCT02456740|5525367|P7|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
2252041|NCT02456740|5525368|P6|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
2252042|NCT02456740|5525369|P5|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
2252043|NCT02456740|5525370|P4|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
2252044|NCT02456740|5525371|P3|COMPLETED|Double-blind Treatment Phase (24 Weeks)||292
2252045|NCT02456740|5525372|P2|COMPLETED|Double-blind Treatment Phase (24 Weeks)||284
2252046|NCT02456740|5525373|P1|COMPLETED|Double-blind Treatment Phase (24 Weeks)||282
2252047|NCT02456740|5525365|P9|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
2252048|NCT02456740|5525366|P8|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
2252049|NCT02456740|5525367|P7|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
2252050|NCT02456740|5525368|P6|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
2252051|NCT02456740|5525369|P5|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
2252052|NCT02456740|5525370|P4|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
2252053|NCT02456740|5525371|P3|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||319
2252054|NCT02456740|5525372|P2|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||314
2252055|NCT02456740|5525373|P1|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||319
2252056|NCT02456740|5525365|P9|STARTED|Double-blind Treatment Phase (24 Weeks)||0
2252057|NCT02456740|5525366|P8|STARTED|Double-blind Treatment Phase (24 Weeks)||0
2252058|NCT02456740|5525367|P7|STARTED|Double-blind Treatment Phase (24 Weeks)||0
2252059|NCT02456740|5525368|P6|STARTED|Double-blind Treatment Phase (24 Weeks)||0
2252060|NCT02456740|5525369|P5|STARTED|Double-blind Treatment Phase (24 Weeks)||0
2252061|NCT02456740|5525370|P4|STARTED|Double-blind Treatment Phase (24 Weeks)||0
2252062|NCT02456740|5525371|P3|STARTED|Double-blind Treatment Phase (24 Weeks)||319
2252063|NCT02456740|5525372|P2|STARTED|Double-blind Treatment Phase (24 Weeks)||317
2252064|NCT02456740|5525373|P1|STARTED|Double-blind Treatment Phase (24 Weeks)||319
2252065|NCT02455518|5525399|P4|NOT COMPLETED|Overall Study||3
2252066|NCT02455518|5525400|P3|NOT COMPLETED|Overall Study||1
2252067|NCT02455518|5525401|P2|NOT COMPLETED|Overall Study||1
2252068|NCT02455518|5525402|P1|NOT COMPLETED|Overall Study||0
2252069|NCT02455518|5525399|P4|COMPLETED|Overall Study||101
2252070|NCT02455518|5525400|P3|COMPLETED|Overall Study||103
2252071|NCT02455518|5525401|P2|COMPLETED|Overall Study||103
2252072|NCT02455518|5525402|P1|COMPLETED|Overall Study||104
2252073|NCT02455518|5525399|P4|STARTED|Overall Study||104
2252074|NCT02455518|5525400|P3|STARTED|Overall Study||104
2252075|NCT02455518|5525401|P2|STARTED|Overall Study||104
2252076|NCT02455518|5525402|P1|STARTED|Overall Study||104
2252077|NCT02455453|5525416|P1|NOT COMPLETED|Overall Study||0
2252078|NCT02455453|5525416|P1|COMPLETED|Overall Study||47
2252079|NCT02455453|5525416|P1|STARTED|Overall Study||47
2252080|NCT02455388|5525424|P3|NOT COMPLETED|Overall Study||11
2252081|NCT02455388|5525425|P2|NOT COMPLETED|Overall Study||0
2252082|NCT02455388|5525426|P1|NOT COMPLETED|Overall Study||1
2252083|NCT02455388|5525424|P3|COMPLETED|Overall Study||326
2252084|NCT02455388|5525425|P2|COMPLETED|Overall Study||15
2252085|NCT02455388|5525426|P1|COMPLETED|Overall Study||17
2252086|NCT02455388|5525424|P3|STARTED|Overall Study||337
2252087|NCT02455388|5525425|P2|STARTED|Overall Study||15
2252088|NCT02455388|5525426|P1|STARTED|Overall Study||18
2252089|NCT02455336|5525437|P2|NOT COMPLETED|Overall Study||2
2252090|NCT02455336|5525438|P1|NOT COMPLETED|Overall Study||5
2252091|NCT02455336|5525437|P2|COMPLETED|Overall Study||6
2252092|NCT02455336|5525438|P1|COMPLETED|Overall Study||10
2252093|NCT02455336|5525437|P2|STARTED|Overall Study||8
2252094|NCT02455336|5525438|P1|STARTED|Overall Study||15
2252095|NCT02455076|5525453|P5|NOT COMPLETED|Outpatient||12
2252096|NCT02455076|5525454|P4|NOT COMPLETED|Outpatient||6
2252097|NCT02455076|5525455|P3|NOT COMPLETED|Outpatient||0
2252099|NCT02455076|5525457|P1|NOT COMPLETED|Outpatient||0
2252100|NCT02455076|5525453|P5|COMPLETED|Outpatient||43
2252101|NCT02455076|5525454|P4|COMPLETED|Outpatient||42
2252102|NCT02455076|5525455|P3|COMPLETED|Outpatient||0
2252103|NCT02455076|5525456|P2|COMPLETED|Outpatient||0
2252104|NCT02455076|5525457|P1|COMPLETED|Outpatient||0
2252105|NCT02455076|5525453|P5|STARTED|Outpatient||55
2252106|NCT02455076|5525454|P4|STARTED|Outpatient||48
2252107|NCT02455076|5525455|P3|STARTED|Outpatient||0
2252108|NCT02455076|5525456|P2|STARTED|Outpatient||0
2252109|NCT02455076|5525457|P1|STARTED|Outpatient||0
2252110|NCT02455076|5525453|P5|NOT COMPLETED|Inpatient||0
2252111|NCT02455076|5525454|P4|NOT COMPLETED|Inpatient||0
2252112|NCT02455076|5525455|P3|NOT COMPLETED|Inpatient||0
2252113|NCT02455076|5525456|P2|NOT COMPLETED|Inpatient||1
2252114|NCT02455076|5525457|P1|NOT COMPLETED|Inpatient||4
2252115|NCT02455076|5525453|P5|COMPLETED|Inpatient||0
2252116|NCT02455076|5525454|P4|COMPLETED|Inpatient||0
2252117|NCT02455076|5525455|P3|COMPLETED|Inpatient||52
2252118|NCT02455076|5525456|P2|COMPLETED|Inpatient||50
2252119|NCT02455076|5525457|P1|COMPLETED|Inpatient||43
2252120|NCT02455076|5525453|P5|STARTED|Inpatient||0
2252121|NCT02455076|5525454|P4|STARTED|Inpatient||0
2252122|NCT02455076|5525455|P3|STARTED|Inpatient||52
2252123|NCT02455076|5525456|P2|STARTED|Inpatient||51
2252124|NCT02455076|5525457|P1|STARTED|Inpatient||47
2252125|NCT02455050|5525543|P4|NOT COMPLETED|Treatment Period 2||1
2252126|NCT02455050|5525544|P3|NOT COMPLETED|Treatment Period 2||2
2252127|NCT02455050|5525545|P2|NOT COMPLETED|Treatment Period 2||0
2252128|NCT02455050|5525546|P1|NOT COMPLETED|Treatment Period 2||1
2252129|NCT02455050|5525543|P4|COMPLETED|Treatment Period 2||17
2252130|NCT02455050|5525544|P3|COMPLETED|Treatment Period 2||17
2252131|NCT02455050|5525545|P2|COMPLETED|Treatment Period 2||18
2252132|NCT02455050|5525546|P1|COMPLETED|Treatment Period 2||18
2252133|NCT02455050|5525543|P4|STARTED|Treatment Period 2||18
2252134|NCT02455050|5525544|P3|STARTED|Treatment Period 2||19
2252135|NCT02455050|5525545|P2|STARTED|Treatment Period 2||18
2252136|NCT02455050|5525546|P1|STARTED|Treatment Period 2||19
2252137|NCT02455050|5525543|P4|NOT COMPLETED|Treatment Period 1||2
2252138|NCT02455050|5525544|P3|NOT COMPLETED|Treatment Period 1||1
2252139|NCT02455050|5525545|P2|NOT COMPLETED|Treatment Period 1||1
2252140|NCT02455050|5525546|P1|NOT COMPLETED|Treatment Period 1||1
2252141|NCT02455050|5525543|P4|COMPLETED|Treatment Period 1||18
2252142|NCT02455050|5525544|P3|COMPLETED|Treatment Period 1||19
2252143|NCT02455050|5525545|P2|COMPLETED|Treatment Period 1||18
2252144|NCT02455050|5525546|P1|COMPLETED|Treatment Period 1||19
2252145|NCT02455050|5525543|P4|STARTED|Treatment Period 1||20
2252146|NCT02455050|5525544|P3|STARTED|Treatment Period 1||20
2252147|NCT02455050|5525545|P2|STARTED|Treatment Period 1||19
2252148|NCT02455050|5525546|P1|STARTED|Treatment Period 1||20
2252149|NCT02454959|5525610|P1|NOT COMPLETED|Overall Study||9
2252150|NCT02454959|5525610|P1|COMPLETED|Overall Study||70
2252151|NCT02454959|5525610|P1|GFF MDI (PT003) Without Aerochamber|Overall Study||77
2252152|NCT02454959|5525610|P1|GFF MDI (PT003) With Aerochamber|Overall Study||73
2252153|NCT02454959|5525610|P1|STARTED|Overall Study||79
2252154|NCT02454933|5525630|P2|NOT COMPLETED|Overall Study||8
2252155|NCT02454933|5525631|P1|NOT COMPLETED|Overall Study||8
2252156|NCT02454933|5525630|P2|COMPLETED|Overall Study||4
2252157|NCT02454933|5525631|P1|COMPLETED|Overall Study||9
2252158|NCT02454933|5525630|P2|Treatment Group Randomised to|Overall Study||14
2252159|NCT02454933|5525631|P1|Treatment Group Randomised to|Overall Study||15
2252160|NCT02454933|5525630|P2|STARTED|Overall Study|2 subjects switched to osimertinib monotherapy Cycle 1 Day 1|12
2252161|NCT02454933|5525631|P1|STARTED|Overall Study||17
2252162|NCT02454608|5525639|P3|NOT COMPLETED|Open Label Period||19
2252163|NCT02454608|5525640|P2|NOT COMPLETED|Open Label Period||0
2252164|NCT02454608|5525641|P1|NOT COMPLETED|Open Label Period||0
2252165|NCT02454608|5525639|P3|COMPLETED|Open Label Period||10
2252166|NCT02454608|5525640|P2|COMPLETED|Open Label Period|This arm is not part of this period of the study|0
2252167|NCT02454608|5525641|P1|COMPLETED|Open Label Period|This arm is not part of this period of the study|0
2252168|NCT02454608|5525639|P3|STARTED|Open Label Period||29
2252169|NCT02454608|5525640|P2|STARTED|Open Label Period|This arm is not part of this period of the study|0
2252170|NCT02454608|5525641|P1|STARTED|Open Label Period|This arm is not part of this period of the study|0
2252171|NCT02454608|5525639|P3|NOT COMPLETED|Double-Blind Period||0
2252172|NCT02454608|5525640|P2|NOT COMPLETED|Double-Blind Period||2
2252173|NCT02454608|5525641|P1|NOT COMPLETED|Double-Blind Period||0
2252174|NCT02454608|5525639|P3|COMPLETED|Double-Blind Period|This arm is not part of this period of the study|0
2252175|NCT02454608|5525640|P2|COMPLETED|Double-Blind Period||12
2252176|NCT02454608|5525641|P1|COMPLETED|Double-Blind Period||15
2252177|NCT02454608|5525639|P3|STARTED|Double-Blind Period|This arm is not part of this period of the study|0
2252178|NCT02454608|5525640|P2|STARTED|Double-Blind Period||14
2252179|NCT02454608|5525641|P1|STARTED|Double-Blind Period||15
2252180|NCT02454530|5525664|P2|NOT COMPLETED|Overall Study||127
2252181|NCT02454530|5525665|P1|NOT COMPLETED|Overall Study||70
2252182|NCT02454530|5525664|P2|COMPLETED|Overall Study||481
2252183|NCT02454530|5525665|P1|COMPLETED|Overall Study||482
2252184|NCT02454530|5525664|P2|STARTED|Overall Study||608
2252185|NCT02454530|5525665|P1|STARTED|Overall Study||552
2252186|NCT02454478|5525702|P1|NOT COMPLETED|Overall Study||1
2252187|NCT02454478|5525702|P1|COMPLETED|Overall Study||6
2252188|NCT02454478|5525702|P1|STARTED|Overall Study||7
2252189|NCT02454296|5525718|P2|NOT COMPLETED|Overall Study||0
2252190|NCT02454296|5525719|P1|NOT COMPLETED|Overall Study||0
2252191|NCT02454296|5525718|P2|COMPLETED|Overall Study||21
2252192|NCT02454296|5525719|P1|COMPLETED|Overall Study||20
2252193|NCT02454296|5525718|P2|STARTED|Overall Study||21
2252194|NCT02454296|5525719|P1|STARTED|Overall Study||20
2252195|NCT02454283|5525731|P2|NOT COMPLETED|Overall Study||0
2252196|NCT02454283|5525732|P1|NOT COMPLETED|Overall Study||0
2252197|NCT02454283|5525731|P2|COMPLETED|Overall Study||15
2252198|NCT02454283|5525732|P1|COMPLETED|Overall Study||26
2252199|NCT02454283|5525731|P2|STARTED|Overall Study||15
2252200|NCT02454283|5525732|P1|STARTED|Overall Study||26
2252201|NCT02454179|5525742|P2|NOT COMPLETED|Overall Study||39
2252202|NCT02454179|5525743|P1|NOT COMPLETED|Overall Study||39
2252203|NCT02454179|5525742|P2|COMPLETED|Overall Study||0
2252204|NCT02454179|5525743|P1|COMPLETED|Overall Study||0
2252205|NCT02454179|5525742|P2|Discontinue Study|Overall Study||39
2252206|NCT02454179|5525743|P1|Discontinue Study|Overall Study||39
2252207|NCT02454179|5525742|P2|Received Study Medication|Overall Study||37
2252208|NCT02454179|5525743|P1|Received Study Medication|Overall Study||39
2252209|NCT02454179|5525742|P2|Enrolled|Overall Study||39
2252210|NCT02454179|5525743|P1|Enrolled|Overall Study||39
2252211|NCT02454179|5525742|P2|STARTED|Overall Study||39
2252212|NCT02454179|5525743|P1|STARTED|Overall Study||39
2252213|NCT02454127|5525753|P4|NOT COMPLETED|Overall Study||20
2252214|NCT02454127|5525754|P3|NOT COMPLETED|Overall Study||14
2252215|NCT02454127|5525755|P2|NOT COMPLETED|Overall Study||14
2252216|NCT02454127|5525756|P1|NOT COMPLETED|Overall Study||19
2252217|NCT02454127|5525753|P4|COMPLETED|Overall Study||20
2252218|NCT02454127|5525754|P3|COMPLETED|Overall Study||26
2252219|NCT02454127|5525755|P2|COMPLETED|Overall Study||26
2252220|NCT02454127|5525756|P1|COMPLETED|Overall Study||21
2252221|NCT02454127|5525753|P4|STARTED|Overall Study||40
2252222|NCT02454127|5525754|P3|STARTED|Overall Study||40
2252223|NCT02454127|5525755|P2|STARTED|Overall Study||40
2252224|NCT02454127|5525756|P1|STARTED|Overall Study||40
2252225|NCT02454101|5525796|P2|NOT COMPLETED|Overall Study||7
2252226|NCT02454101|5525797|P1|NOT COMPLETED|Overall Study||5
2252227|NCT02454101|5525796|P2|COMPLETED|Overall Study||143
2252228|NCT02454101|5525797|P1|COMPLETED|Overall Study||145
2252229|NCT02454101|5525796|P2|STARTED|Overall Study||150
2252230|NCT02454101|5525797|P1|STARTED|Overall Study||150
2252231|NCT02453841|5525819|P1|NOT COMPLETED|Overall Study||3
2252232|NCT02453841|5525819|P1|COMPLETED|Overall Study||27
2252233|NCT02453841|5525819|P1|STARTED|Overall Study||30
2252234|NCT02453750|5525826|P1|NOT COMPLETED|Overall Study||0
2252235|NCT02453750|5525826|P1|COMPLETED|Overall Study||21
2252236|NCT02453750|5525826|P1|STARTED|Overall Study||21
2252237|NCT02453685|5525835|P2|NOT COMPLETED|Overall Study||12
2252238|NCT02453685|5525836|P1|NOT COMPLETED|Overall Study||19
2252239|NCT02453685|5525835|P2|COMPLETED|Overall Study||155
2252240|NCT02453685|5525836|P1|COMPLETED|Overall Study||149
2252241|NCT02453685|5525835|P2|Exposed|Overall Study||166
2252242|NCT02453685|5525836|P1|Exposed|Overall Study||166
2252243|NCT02453685|5525835|P2|STARTED|Overall Study||167
2252244|NCT02453685|5525836|P1|STARTED|Overall Study||168
2252245|NCT02453672|5525851|P3|NOT COMPLETED|Overall Study||1
2252246|NCT02453672|5525852|P2|NOT COMPLETED|Overall Study||2
2252247|NCT02453672|5525853|P1|NOT COMPLETED|Overall Study||3
2252248|NCT02453672|5525851|P3|COMPLETED|Overall Study||38
2252249|NCT02453672|5525852|P2|COMPLETED|Overall Study||38
2252250|NCT02453672|5525853|P1|COMPLETED|Overall Study||37
2252251|NCT02453672|5525851|P3|STARTED|Overall Study||39
2252252|NCT02453672|5525852|P2|STARTED|Overall Study||40
2252253|NCT02453672|5525853|P1|STARTED|Overall Study||40
2252254|NCT02453581|5525870|P3|NOT COMPLETED|Overall Study||0
2252255|NCT02453581|5525871|P2|NOT COMPLETED|Overall Study||0
2252256|NCT02453581|5525872|P1|NOT COMPLETED|Overall Study||0
2252257|NCT02453581|5525870|P3|COMPLETED|Overall Study||8
2252258|NCT02453581|5525871|P2|COMPLETED|Overall Study||8
2252259|NCT02453581|5525872|P1|COMPLETED|Overall Study||8
2252260|NCT02453581|5525870|P3|STARTED|Overall Study||8
2252261|NCT02453581|5525871|P2|STARTED|Overall Study||8
2252262|NCT02453581|5525872|P1|STARTED|Overall Study||8
2252263|NCT02453555|5525894|P6|NOT COMPLETED|Extension Period||1
2252264|NCT02453555|5525895|P5|NOT COMPLETED|Extension Period||1
2252265|NCT02453555|5525896|P4|NOT COMPLETED|Extension Period||2
2252266|NCT02453555|5525897|P3|NOT COMPLETED|Extension Period||3
2252267|NCT02453555|5525898|P2|NOT COMPLETED|Extension Period||0
2252268|NCT02453555|5525899|P1|NOT COMPLETED|Extension Period||0
2252269|NCT02453555|5525894|P6|COMPLETED|Extension Period||5
2252270|NCT02453555|5525895|P5|COMPLETED|Extension Period||79
2252271|NCT02453555|5525896|P4|COMPLETED|Extension Period||49
2252272|NCT02453555|5525897|P3|COMPLETED|Extension Period||123
2252273|NCT02453555|5525898|P2|COMPLETED|Extension Period||0
2252274|NCT02453555|5525899|P1|COMPLETED|Extension Period||0
2252275|NCT02453555|5525894|P6|STARTED|Extension Period||6
2252276|NCT02453555|5525895|P5|STARTED|Extension Period||80
2252277|NCT02453555|5525896|P4|STARTED|Extension Period||51
2252278|NCT02453555|5525897|P3|STARTED|Extension Period||126
2252279|NCT02453555|5525898|P2|STARTED|Extension Period|This reporting group is not applicable in this period.|0
2252280|NCT02453555|5525899|P1|STARTED|Extension Period|This reporting group is not applicable in this period.|0
2252281|NCT02453555|5525894|P6|NOT COMPLETED|24-week Double-blind Treatment Period||0
2252282|NCT02453555|5525895|P5|NOT COMPLETED|24-week Double-blind Treatment Period||0
2252371|NCT02453048|5526215|P2|STARTED|Overall Study||12
2252283|NCT02453555|5525896|P4|NOT COMPLETED|24-week Double-blind Treatment Period||0
2252284|NCT02453555|5525897|P3|NOT COMPLETED|24-week Double-blind Treatment Period||0
2252285|NCT02453555|5525898|P2|NOT COMPLETED|24-week Double-blind Treatment Period||7
2252286|NCT02453555|5525899|P1|NOT COMPLETED|24-week Double-blind Treatment Period||5
2252287|NCT02453555|5525894|P6|COMPLETED|24-week Double-blind Treatment Period||0
2252288|NCT02453555|5525895|P5|COMPLETED|24-week Double-blind Treatment Period||0
2252289|NCT02453555|5525896|P4|COMPLETED|24-week Double-blind Treatment Period||0
2252290|NCT02453555|5525897|P3|COMPLETED|24-week Double-blind Treatment Period||0
2252291|NCT02453555|5525898|P2|COMPLETED|24-week Double-blind Treatment Period||86
2252292|NCT02453555|5525899|P1|COMPLETED|24-week Double-blind Treatment Period||177
2252293|NCT02453555|5525894|P6|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
2252294|NCT02453555|5525895|P5|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
2252295|NCT02453555|5525896|P4|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
2252296|NCT02453555|5525897|P3|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
2252297|NCT02453555|5525898|P2|STARTED|24-week Double-blind Treatment Period|Started are treated subjects.|93
2252298|NCT02453555|5525899|P1|STARTED|24-week Double-blind Treatment Period|Started are treated subjects.|182
2252299|NCT02453386|5525915|P3|NOT COMPLETED|Overall Study||41
2252300|NCT02453386|5525916|P2|NOT COMPLETED|Overall Study||49
2252301|NCT02453386|5525917|P1|NOT COMPLETED|Overall Study||49
2252302|NCT02453386|5525915|P3|COMPLETED|Overall Study||108
2252303|NCT02453386|5525916|P2|COMPLETED|Overall Study||100
2252304|NCT02453386|5525917|P1|COMPLETED|Overall Study||102
2252305|NCT02453386|5525915|P3|STARTED|Overall Study||149
2252306|NCT02453386|5525916|P2|STARTED|Overall Study||149
2252307|NCT02453386|5525917|P1|STARTED|Overall Study||151
2252308|NCT02453360|5525943|P3|NOT COMPLETED|Overall Study||0
2252309|NCT02453360|5525944|P2|NOT COMPLETED|Overall Study||0
2252310|NCT02453360|5525945|P1|NOT COMPLETED|Overall Study||0
2252311|NCT02453360|5525943|P3|COMPLETED|Overall Study||20
2252312|NCT02453360|5525944|P2|COMPLETED|Overall Study||20
2252313|NCT02453360|5525945|P1|COMPLETED|Overall Study||20
2252314|NCT02453360|5525943|P3|STARTED|Overall Study||20
2252315|NCT02453360|5525944|P2|STARTED|Overall Study||20
2252316|NCT02453360|5525945|P1|STARTED|Overall Study||20
2252317|NCT02453347|5525965|P1|NOT COMPLETED|Overall Study||0
2252318|NCT02453347|5525965|P1|COMPLETED|Overall Study||6
2252319|NCT02453347|5525965|P1|STARTED|Overall Study||6
2252320|NCT02453321|5525981|P3|NOT COMPLETED|Overall Study||2
2252321|NCT02453321|5525982|P2|NOT COMPLETED|Overall Study||2
2252322|NCT02453321|5525983|P1|NOT COMPLETED|Overall Study||1
2252323|NCT02453321|5525981|P3|COMPLETED|Overall Study||19
2252324|NCT02453321|5525982|P2|COMPLETED|Overall Study||19
2252325|NCT02453321|5525983|P1|COMPLETED|Overall Study||19
2252326|NCT02453321|5525981|P3|STARTED|Overall Study||21
2252327|NCT02453321|5525982|P2|STARTED|Overall Study||21
2252328|NCT02453321|5525983|P1|STARTED|Overall Study||20
2252329|NCT02453282|5526003|P3|NOT COMPLETED|Overall Study||372
2252330|NCT02453282|5526004|P2|NOT COMPLETED|Overall Study||372
2252331|NCT02453282|5526005|P1|NOT COMPLETED|Overall Study||374
2252332|NCT02453282|5526003|P3|COMPLETED|Overall Study||0
2252333|NCT02453282|5526004|P2|COMPLETED|Overall Study||0
2252334|NCT02453282|5526005|P1|COMPLETED|Overall Study||0
2252335|NCT02453282|5526003|P3|Received Treatment|Overall Study||352
2252336|NCT02453282|5526004|P2|Received Treatment|Overall Study||371
2252337|NCT02453282|5526005|P1|Received Treatment|Overall Study||369
2252338|NCT02453282|5526003|P3|STARTED|Overall Study||372
2252339|NCT02453282|5526004|P2|STARTED|Overall Study||372
2252340|NCT02453282|5526005|P1|STARTED|Overall Study||374
2252341|NCT02453256|5526086|P2|NOT COMPLETED|Open Label Period||7
2252342|NCT02453256|5526087|P1|NOT COMPLETED|Open Label Period||7
2252343|NCT02453256|5526086|P2|COMPLETED|Open Label Period||85
2252344|NCT02453256|5526087|P1|COMPLETED|Open Label Period||82
2252345|NCT02453256|5526086|P2|STARTED|Open Label Period||92
2252346|NCT02453256|5526087|P1|STARTED|Open Label Period||89
2252347|NCT02453256|5526086|P2|NOT COMPLETED|Double Blind Period||9
2252348|NCT02453256|5526087|P1|NOT COMPLETED|Double Blind Period||13
2252349|NCT02453256|5526086|P2|COMPLETED|Double Blind Period||95
2252350|NCT02453256|5526087|P1|COMPLETED|Double Blind Period||93
2252351|NCT02453256|5526086|P2|STARTED|Double Blind Period||104
2252352|NCT02453256|5526087|P1|STARTED|Double Blind Period||106
2252353|NCT02453048|5526212|P5|NOT COMPLETED|Overall Study||6
2252354|NCT02453048|5526213|P4|NOT COMPLETED|Overall Study||0
2252355|NCT02453048|5526214|P3|NOT COMPLETED|Overall Study||2
2252356|NCT02453048|5526215|P2|NOT COMPLETED|Overall Study||1
2252357|NCT02453048|5526216|P1|NOT COMPLETED|Overall Study||0
2252358|NCT02453048|5526212|P5|COMPLETED|Overall Study||0
2252359|NCT02453048|5526213|P4|COMPLETED|Overall Study||12
2252360|NCT02453048|5526214|P3|COMPLETED|Overall Study||10
2252361|NCT02453048|5526215|P2|COMPLETED|Overall Study||11
2252362|NCT02453048|5526216|P1|COMPLETED|Overall Study||12
2252363|NCT02453048|5526212|P5|6-month Follow-up|Overall Study||6
2252364|NCT02453048|5526213|P4|6-month Follow-up|Overall Study||12
2252365|NCT02453048|5526214|P3|6-month Follow-up|Overall Study||12
2252366|NCT02453048|5526215|P2|6-month Follow-up|Overall Study||12
2252367|NCT02453048|5526216|P1|6-month Follow-up|Overall Study||12
2252368|NCT02453048|5526212|P5|STARTED|Overall Study||6
2252369|NCT02453048|5526213|P4|STARTED|Overall Study||12
2252370|NCT02453048|5526214|P3|STARTED|Overall Study||12
2252372|NCT02453048|5526216|P1|STARTED|Overall Study||12
2252373|NCT02452944|5526240|P2|NOT COMPLETED|Overall Study||0
2252374|NCT02452944|5526241|P1|NOT COMPLETED|Overall Study||0
2252375|NCT02452944|5526240|P2|COMPLETED|Overall Study||31
2252376|NCT02452944|5526241|P1|COMPLETED|Overall Study||31
2252377|NCT02452944|5526240|P2|STARTED|Overall Study||31
2252378|NCT02452944|5526241|P1|STARTED|Overall Study||31
2252379|NCT02452892|5526253|P4|NOT COMPLETED|Follow-up||1
2252380|NCT02452892|5526254|P3|NOT COMPLETED|Follow-up||0
2252381|NCT02452892|5526255|P2|NOT COMPLETED|Follow-up||0
2252382|NCT02452892|5526256|P1|NOT COMPLETED|Follow-up||1
2252383|NCT02452892|5526253|P4|COMPLETED|Follow-up||38
2252384|NCT02452892|5526254|P3|COMPLETED|Follow-up||7
2252385|NCT02452892|5526255|P2|COMPLETED|Follow-up||7
2252386|NCT02452892|5526256|P1|COMPLETED|Follow-up||62
2252387|NCT02452892|5526253|P4|STARTED|Follow-up||39
2252388|NCT02452892|5526254|P3|STARTED|Follow-up||7
2252389|NCT02452892|5526255|P2|STARTED|Follow-up||7
2252390|NCT02452892|5526256|P1|STARTED|Follow-up||63
2252391|NCT02452892|5526253|P4|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2
2252392|NCT02452892|5526254|P3|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0
2252393|NCT02452892|5526255|P2|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0
2252394|NCT02452892|5526256|P1|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2
2252395|NCT02452892|5526253|P4|COMPLETED|Week 2 Stratification & Re-Randomization||39
2252396|NCT02452892|5526254|P3|COMPLETED|Week 2 Stratification & Re-Randomization||7
2252397|NCT02452892|5526255|P2|COMPLETED|Week 2 Stratification & Re-Randomization||7
2252398|NCT02452892|5526256|P1|COMPLETED|Week 2 Stratification & Re-Randomization||63
2252399|NCT02452892|5526253|P4|Responders|Week 2 Stratification & Re-Randomization||0
2252400|NCT02452892|5526254|P3|Responders|Week 2 Stratification & Re-Randomization||7
2252401|NCT02452892|5526255|P2|Responders|Week 2 Stratification & Re-Randomization||7
2252402|NCT02452892|5526256|P1|Responders|Week 2 Stratification & Re-Randomization||27
2252403|NCT02452892|5526253|P4|Non-reponders|Week 2 Stratification & Re-Randomization||41
2252404|NCT02452892|5526254|P3|Non-reponders|Week 2 Stratification & Re-Randomization||0
2252405|NCT02452892|5526255|P2|Non-reponders|Week 2 Stratification & Re-Randomization||0
2252406|NCT02452892|5526256|P1|Non-reponders|Week 2 Stratification & Re-Randomization||38
2252407|NCT02452892|5526253|P4|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (13), LFMS 20min (14), and LFMS 60 min (14).|41
2252408|NCT02452892|5526254|P3|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0),LFMS 20min (0), LFMS 60min (7)|7
2252409|NCT02452892|5526255|P2|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0), LFMS 20min (7), and LFMS 60min(0).|7
2252410|NCT02452892|5526256|P1|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that started LFMS sham (27), LFMS 20min (19), and LFMS 60min (19)|65
2252411|NCT02452892|5526253|P4|NOT COMPLETED|Week 1 Initial Randommization||0
2252412|NCT02452892|5526254|P3|NOT COMPLETED|Week 1 Initial Randommization||1
2252413|NCT02452892|5526255|P2|NOT COMPLETED|Week 1 Initial Randommization||0
2252414|NCT02452892|5526256|P1|NOT COMPLETED|Week 1 Initial Randommization||1
2252415|NCT02452892|5526253|P4|COMPLETED|Week 1 Initial Randommization||0
2252416|NCT02452892|5526254|P3|COMPLETED|Week 1 Initial Randommization||40
2252417|NCT02452892|5526255|P2|COMPLETED|Week 1 Initial Randommization||40
2252418|NCT02452892|5526256|P1|COMPLETED|Week 1 Initial Randommization||40
2252419|NCT02452892|5526253|P4|STARTED|Week 1 Initial Randommization||0
2252420|NCT02452892|5526254|P3|STARTED|Week 1 Initial Randommization||41
2252421|NCT02452892|5526255|P2|STARTED|Week 1 Initial Randommization||40
2252422|NCT02452892|5526256|P1|STARTED|Week 1 Initial Randommization||41
2252423|NCT02452554|5526291|P6|NOT COMPLETED|Overall Study||9
2252424|NCT02452554|5526292|P5|NOT COMPLETED|Overall Study||5
2252425|NCT02452554|5526293|P4|NOT COMPLETED|Overall Study||1
2252426|NCT02452554|5526294|P3|NOT COMPLETED|Overall Study||11
2252427|NCT02452554|5526295|P2|NOT COMPLETED|Overall Study||17
2252428|NCT02452554|5526296|P1|NOT COMPLETED|Overall Study||17
2252429|NCT02452554|5526291|P6|COMPLETED|Overall Study||1
2252430|NCT02452554|5526292|P5|COMPLETED|Overall Study||0
2252431|NCT02452554|5526293|P4|COMPLETED|Overall Study||0
2252432|NCT02452554|5526294|P3|COMPLETED|Overall Study||1
2252433|NCT02452554|5526295|P2|COMPLETED|Overall Study||0
2252434|NCT02452554|5526296|P1|COMPLETED|Overall Study||0
2252435|NCT02452554|5526291|P6|STARTED|Overall Study||10
2252436|NCT02452554|5526292|P5|STARTED|Overall Study||5
2252437|NCT02452554|5526293|P4|STARTED|Overall Study||1
2252438|NCT02452554|5526294|P3|STARTED|Overall Study||12
2252439|NCT02452554|5526295|P2|STARTED|Overall Study||17
2252440|NCT02452554|5526296|P1|STARTED|Overall Study||17
2252441|NCT02452528|5526313|P2|NOT COMPLETED|Overall Study||1
2252442|NCT02452528|5526314|P1|NOT COMPLETED|Overall Study||1
2252443|NCT02452528|5526313|P2|COMPLETED|Overall Study||1
2252444|NCT02452528|5526314|P1|COMPLETED|Overall Study||1
2252445|NCT02452528|5526313|P2|STARTED|Overall Study||2
2252446|NCT02452528|5526314|P1|STARTED|Overall Study||2
2252447|NCT02452424|5526357|P11|NOT COMPLETED|Overall Study||2
2252448|NCT02452424|5526358|P10|NOT COMPLETED|Overall Study||2
2252449|NCT02452424|5526359|P9|NOT COMPLETED|Overall Study||6
2252450|NCT02452424|5526360|P8|NOT COMPLETED|Overall Study||4
2252451|NCT02452424|5526361|P7|NOT COMPLETED|Overall Study||10
2252452|NCT02452424|5526362|P6|NOT COMPLETED|Overall Study||1
2252453|NCT02452424|5526363|P5|NOT COMPLETED|Overall Study||2
2252454|NCT02452424|5526364|P4|NOT COMPLETED|Overall Study||8
2252455|NCT02452424|5526365|P3|NOT COMPLETED|Overall Study||7
2252456|NCT02452424|5526366|P2|NOT COMPLETED|Overall Study||3
2252457|NCT02452424|5526367|P1|NOT COMPLETED|Overall Study||2
2252458|NCT02452424|5526357|P11|COMPLETED|Overall Study||4
2252459|NCT02452424|5526358|P10|COMPLETED|Overall Study||1
2252460|NCT02452424|5526359|P9|COMPLETED|Overall Study||9
2252461|NCT02452424|5526360|P8|COMPLETED|Overall Study||4
2252462|NCT02452424|5526361|P7|COMPLETED|Overall Study||3
2252463|NCT02452424|5526362|P6|COMPLETED|Overall Study||5
2252464|NCT02452424|5526363|P5|COMPLETED|Overall Study||2
2252465|NCT02452424|5526364|P4|COMPLETED|Overall Study||1
2252466|NCT02452424|5526365|P3|COMPLETED|Overall Study||0
2252467|NCT02452424|5526366|P2|COMPLETED|Overall Study||0
2252468|NCT02452424|5526367|P1|COMPLETED|Overall Study||2
2252469|NCT02452424|5526357|P11|STARTED|Overall Study||6
2252470|NCT02452424|5526358|P10|STARTED|Overall Study||3
2252471|NCT02452424|5526359|P9|STARTED|Overall Study||15
2252472|NCT02452424|5526360|P8|STARTED|Overall Study||8
2252473|NCT02452424|5526361|P7|STARTED|Overall Study||13
2252474|NCT02452424|5526362|P6|STARTED|Overall Study||6
2252475|NCT02452424|5526363|P5|STARTED|Overall Study||4
2252476|NCT02452424|5526364|P4|STARTED|Overall Study||9
2252477|NCT02452424|5526365|P3|STARTED|Overall Study||7
2252478|NCT02452424|5526366|P2|STARTED|Overall Study||3
2252479|NCT02452424|5526367|P1|STARTED|Overall Study||4
2252480|NCT02452346|5526402|P1|NOT COMPLETED|Overall Study||9
2252481|NCT02452346|5526402|P1|COMPLETED|Overall Study||3
2252482|NCT02452346|5526402|P1|STARTED|Overall Study||12
2252483|NCT02452320|5526410|P2|NOT COMPLETED|Overall Study||1
2252484|NCT02452320|5526411|P1|NOT COMPLETED|Overall Study||0
2252485|NCT02452320|5526410|P2|COMPLETED|Overall Study||63
2252486|NCT02452320|5526411|P1|COMPLETED|Overall Study||64
2252487|NCT02452320|5526410|P2|STARTED|Overall Study||64
2252488|NCT02452320|5526411|P1|STARTED|Overall Study||64
2252489|NCT02452190|5526423|P2|NOT COMPLETED|Overall Study||24
2252490|NCT02452190|5526424|P1|NOT COMPLETED|Overall Study||35
2252491|NCT02452190|5526423|P2|COMPLETED|Overall Study||212
2252492|NCT02452190|5526424|P1|COMPLETED|Overall Study||197
2252493|NCT02452190|5526423|P2|Safety Population|Overall Study||237
2252494|NCT02452190|5526424|P1|Safety Population|Overall Study||231
2252495|NCT02452190|5526423|P2|Intent to Treat (ITT) Population|Overall Study||234
2252496|NCT02452190|5526424|P1|Intent to Treat (ITT) Population|Overall Study||230
2252497|NCT02452190|5526423|P2|STARTED|Overall Study||236
2252498|NCT02452190|5526424|P1|STARTED|Overall Study||232
2252499|NCT02452047|5526451|P3|NOT COMPLETED|Overall Study||2
2252500|NCT02452047|5526452|P2|NOT COMPLETED|Overall Study||5
2252501|NCT02452047|5526453|P1|NOT COMPLETED|Overall Study||4
2252502|NCT02452047|5526451|P3|COMPLETED|Overall Study||1
2252503|NCT02452047|5526452|P2|COMPLETED|Overall Study||11
2252504|NCT02452047|5526453|P1|COMPLETED|Overall Study||27
2252505|NCT02452047|5526451|P3|STARTED|Overall Study||3
2252506|NCT02452047|5526452|P2|STARTED|Overall Study||16
2252507|NCT02452047|5526453|P1|STARTED|Overall Study||31
2252508|NCT02452034|5526518|P6|NOT COMPLETED|Overall Study||3
2252509|NCT02452034|5526519|P5|NOT COMPLETED|Overall Study||1
2252510|NCT02452034|5526520|P4|NOT COMPLETED|Overall Study||1
2252511|NCT02452034|5526521|P3|NOT COMPLETED|Overall Study||1
2252512|NCT02452034|5526522|P2|NOT COMPLETED|Overall Study||1
2252513|NCT02452034|5526523|P1|NOT COMPLETED|Overall Study||2
2252514|NCT02452034|5526518|P6|COMPLETED|Overall Study||26
2252515|NCT02452034|5526519|P5|COMPLETED|Overall Study||19
2252516|NCT02452034|5526520|P4|COMPLETED|Overall Study||16
2252517|NCT02452034|5526521|P3|COMPLETED|Overall Study||14
2252518|NCT02452034|5526522|P2|COMPLETED|Overall Study||20
2252519|NCT02452034|5526523|P1|COMPLETED|Overall Study||14
2252520|NCT02452034|5526518|P6|Treated|Overall Study||29
2252521|NCT02452034|5526519|P5|Treated|Overall Study||20
2252522|NCT02452034|5526520|P4|Treated|Overall Study||16
2252523|NCT02452034|5526521|P3|Treated|Overall Study||15
2252524|NCT02452034|5526522|P2|Treated|Overall Study||21
2252525|NCT02452034|5526523|P1|Treated|Overall Study||14
2252526|NCT02452034|5526518|P6|STARTED|Overall Study||29
2252527|NCT02452034|5526519|P5|STARTED|Overall Study||20
2252528|NCT02452034|5526520|P4|STARTED|Overall Study||17
2252529|NCT02452034|5526521|P3|STARTED|Overall Study||15
2252530|NCT02452034|5526522|P2|STARTED|Overall Study||21
2252531|NCT02452034|5526523|P1|STARTED|Overall Study||16
2252532|NCT02451995|5526587|P2|NOT COMPLETED|Overall Study||0
2252533|NCT02451995|5526588|P1|NOT COMPLETED|Overall Study||0
2252534|NCT02451995|5526587|P2|COMPLETED|Overall Study||41
2252535|NCT02451995|5526588|P1|COMPLETED|Overall Study||42
2252536|NCT02451995|5526587|P2|STARTED|Overall Study||41
2252537|NCT02451995|5526588|P1|STARTED|Overall Study||42
2252538|NCT02451943|5526596|P2|NOT COMPLETED|Overall Study||24
2252539|NCT02451943|5526597|P1|NOT COMPLETED|Overall Study||20
2252540|NCT02451943|5526596|P2|COMPLETED|Overall Study||227
2252541|NCT02451943|5526597|P1|COMPLETED|Overall Study||238
2252542|NCT02451943|5526596|P2|Leiomyosarcoma (LMS) Population|Overall Study||115
2252543|NCT02451943|5526597|P1|Leiomyosarcoma (LMS) Population|Overall Study||119
2252544|NCT02451943|5526596|P2|Received at Least One Dose of Study Drug|Overall Study||249
2252545|NCT02451943|5526597|P1|Received at Least One Dose of Study Drug|Overall Study||257
2252546|NCT02451943|5526596|P2|STARTED|Overall Study||251
2252547|NCT02451943|5526597|P1|STARTED|Overall Study||258
2252548|NCT02451917|5526625|P2|NOT COMPLETED|Second Intervention (24 Weeks)||0
2252549|NCT02451917|5526626|P1|NOT COMPLETED|Second Intervention (24 Weeks)||0
2252550|NCT02451917|5526625|P2|COMPLETED|Second Intervention (24 Weeks)||15
2252551|NCT02451917|5526626|P1|COMPLETED|Second Intervention (24 Weeks)||14
2252552|NCT02451917|5526625|P2|STARTED|Second Intervention (24 Weeks)||15
2252553|NCT02451917|5526626|P1|STARTED|Second Intervention (24 Weeks)||14
2252554|NCT02451917|5526625|P2|NOT COMPLETED|First Intervention (24 Weeks)||3
2252555|NCT02451917|5526626|P1|NOT COMPLETED|First Intervention (24 Weeks)||2
2252556|NCT02451917|5526625|P2|COMPLETED|First Intervention (24 Weeks)||15
2252557|NCT02451917|5526626|P1|COMPLETED|First Intervention (24 Weeks)||14
2252558|NCT02451917|5526625|P2|STARTED|First Intervention (24 Weeks)||18
2252559|NCT02451917|5526626|P1|STARTED|First Intervention (24 Weeks)||16
2252560|NCT02451839|5526644|P3|NOT COMPLETED|Overall Study||7
2252561|NCT02451839|5526645|P2|NOT COMPLETED|Overall Study||19
2252562|NCT02451839|5526646|P1|NOT COMPLETED|Overall Study||28
2252563|NCT02451839|5526644|P3|COMPLETED|Overall Study||30
2252564|NCT02451839|5526645|P2|COMPLETED|Overall Study||40
2252565|NCT02451839|5526646|P1|COMPLETED|Overall Study||44
2252566|NCT02451839|5526644|P3|Baseline WHODAS Data Recorded|Overall Study||37
2252567|NCT02451839|5526645|P2|Baseline WHODAS Data Recorded|Overall Study||57
2252568|NCT02451839|5526646|P1|Baseline WHODAS Data Recorded|Overall Study||70
2252569|NCT02451839|5526644|P3|STARTED|Overall Study||37
2252570|NCT02451839|5526645|P2|STARTED|Overall Study||59
2252571|NCT02451839|5526646|P1|STARTED|Overall Study||72
2252572|NCT02451670|5526668|P2|NOT COMPLETED|Overall Study||696
2252573|NCT02451670|5526669|P1|NOT COMPLETED|Overall Study||714
2252574|NCT02451670|5526668|P2|COMPLETED|Overall Study||4387
2252575|NCT02451670|5526669|P1|COMPLETED|Overall Study||4550
2252576|NCT02451670|5526668|P2|STARTED|Overall Study||5083
2252577|NCT02451670|5526669|P1|STARTED|Overall Study||5264
2252578|NCT02451488|5526677|P2|NOT COMPLETED|Overall Study||0
2252579|NCT02451488|5526678|P1|NOT COMPLETED|Overall Study||0
2252580|NCT02451488|5526677|P2|COMPLETED|Overall Study||4
2252581|NCT02451488|5526678|P1|COMPLETED|Overall Study||4
2252582|NCT02451488|5526677|P2|STARTED|Overall Study||4
2252583|NCT02451488|5526678|P1|STARTED|Overall Study||4
2252584|NCT02451358|5526688|P4|NOT COMPLETED|Overall Study||0
2252585|NCT02451358|5526689|P3|NOT COMPLETED|Overall Study||1
2252586|NCT02451358|5526690|P2|NOT COMPLETED|Overall Study||2
2252587|NCT02451358|5526691|P1|NOT COMPLETED|Overall Study||1
2252588|NCT02451358|5526688|P4|COMPLETED|Overall Study||100
2252589|NCT02451358|5526689|P3|COMPLETED|Overall Study||99
2252590|NCT02451358|5526690|P2|COMPLETED|Overall Study||98
2252591|NCT02451358|5526691|P1|COMPLETED|Overall Study||99
2252592|NCT02451358|5526688|P4|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0
2252593|NCT02451358|5526689|P3|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0
2252594|NCT02451358|5526690|P2|Vaccinated at Day 28|Overall Study||98
2252595|NCT02451358|5526691|P1|Vaccinated at Day 28|Overall Study||99
2252596|NCT02451358|5526688|P4|Vaccinated at Day 0|Overall Study||100
2252597|NCT02451358|5526689|P3|Vaccinated at Day 0|Overall Study||100
2252598|NCT02451358|5526690|P2|Vaccinated at Day 0|Overall Study||100
2252599|NCT02451358|5526691|P1|Vaccinated at Day 0|Overall Study||100
2252600|NCT02451358|5526688|P4|STARTED|Overall Study||100
2252601|NCT02451358|5526689|P3|STARTED|Overall Study||100
2252602|NCT02451358|5526690|P2|STARTED|Overall Study||100
2252603|NCT02451358|5526691|P1|STARTED|Overall Study||100
2252604|NCT02451202|5526715|P2|NOT COMPLETED|Overall Study||3
2252605|NCT02451202|5526716|P1|NOT COMPLETED|Overall Study||2
2252606|NCT02451202|5526715|P2|COMPLETED|Overall Study||48
2252607|NCT02451202|5526716|P1|COMPLETED|Overall Study||49
2252608|NCT02451202|5526715|P2|STARTED|Overall Study||51
2252609|NCT02451202|5526716|P1|STARTED|Overall Study||51
2252610|NCT02451150|5526726|P2|NOT COMPLETED|Overall Study||0
2252611|NCT02451150|5526727|P1|NOT COMPLETED|Overall Study||0
2252612|NCT02451150|5526726|P2|COMPLETED|Overall Study||3
2252613|NCT02451150|5526727|P1|COMPLETED|Overall Study||3
2252614|NCT02451150|5526726|P2|STARTED|Overall Study||3
2252615|NCT02451150|5526727|P1|STARTED|Overall Study||3
2252616|NCT02451137|5526779|P2|NOT COMPLETED|Overall Study||298
2252617|NCT02451137|5526780|P1|NOT COMPLETED|Overall Study||246
2252618|NCT02451137|5526779|P2|COMPLETED|Overall Study||1355
2252619|NCT02451137|5526780|P1|COMPLETED|Overall Study||1405
2252620|NCT02451137|5526779|P2|Safety Population|Overall Study|9 participants received Toujeo instead of Standard of Care.|1621
2252621|NCT02451137|5526780|P1|Safety Population|Overall Study|4 participants received Standard of Care instead of Toujeo.|1637
2252622|NCT02451137|5526779|P2|Treated|Overall Study||1626
2252623|NCT02451137|5526780|P1|Treated|Overall Study||1632
2252624|NCT02451137|5526779|P2|STARTED|Overall Study||1653
2252625|NCT02451137|5526780|P1|STARTED|Overall Study||1651
2252626|NCT02451124|5526810|P1|NOT COMPLETED|Overall Study||1
2252627|NCT02451124|5526810|P1|COMPLETED|Overall Study||155
2252628|NCT02451124|5526810|P1|STARTED|Overall Study||156
2252629|NCT02451007|5526821|P1|NOT COMPLETED|Overall Study||7
2252630|NCT02451007|5526821|P1|COMPLETED|Overall Study||32
2252631|NCT02451007|5526821|P1|STARTED|Overall Study||39
2252632|NCT02450799|5526831|P3|NOT COMPLETED|Overall Study||0
2252633|NCT02450799|5526832|P2|NOT COMPLETED|Overall Study||0
2252634|NCT02450799|5526833|P1|NOT COMPLETED|Overall Study||0
2252635|NCT02450799|5526831|P3|COMPLETED|Overall Study||30
2252636|NCT02450799|5526832|P2|COMPLETED|Overall Study||37
2252637|NCT02450799|5526833|P1|COMPLETED|Overall Study||31
2252638|NCT02450799|5526831|P3|STARTED|Overall Study||30
2252639|NCT02450799|5526832|P2|STARTED|Overall Study||37
2252640|NCT02450799|5526833|P1|STARTED|Overall Study||31
2252641|NCT02450747|5526844|P1|NOT COMPLETED|Overall Study||0
2252642|NCT02450747|5526844|P1|COMPLETED|Overall Study||39
2252643|NCT02450747|5526844|P1|STARTED|Overall Study||39
2252644|NCT02450591|5526853|P1|NOT COMPLETED|Overall Study||0
2252645|NCT02450591|5526853|P1|COMPLETED|Overall Study||4
2252646|NCT02450591|5526853|P1|STARTED|Overall Study||4
2252647|NCT02450552|5526860|P3|NOT COMPLETED|Overall Study||5
2252648|NCT02450552|5526861|P2|NOT COMPLETED|Overall Study||0
2252649|NCT02450552|5526862|P1|NOT COMPLETED|Overall Study||5
2252650|NCT02450552|5526860|P3|COMPLETED|Overall Study||18
2252651|NCT02450552|5526861|P2|COMPLETED|Overall Study||23
2252652|NCT02450552|5526862|P1|COMPLETED|Overall Study||14
2252653|NCT02450552|5526860|P3|STARTED|Overall Study||23
2252654|NCT02450552|5526861|P2|STARTED|Overall Study||23
2252655|NCT02450552|5526862|P1|STARTED|Overall Study||19
2252656|NCT02450539|5526905|P2|NOT COMPLETED|Overall Study||33
2252657|NCT02450539|5526906|P1|NOT COMPLETED|Overall Study||50
2252658|NCT02450539|5526905|P2|COMPLETED|Overall Study||20
2252659|NCT02450539|5526906|P1|COMPLETED|Overall Study||56
2252660|NCT02450539|5526905|P2|Death|Overall Study||20
2252661|NCT02450539|5526906|P1|Death|Overall Study||56
2252662|NCT02450539|5526905|P2|Received at Least One Dose of Study Drug|Overall Study||52
2252663|NCT02450539|5526906|P1|Received at Least One Dose of Study Drug|Overall Study||106
2252664|NCT02450539|5526905|P2|STARTED|Overall Study||53
2252665|NCT02450539|5526906|P1|STARTED|Overall Study||106
2252666|NCT02450526|5526930|P5|NOT COMPLETED|OL Period (Cycles 2-5)||41
2252667|NCT02450526|5526931|P4|NOT COMPLETED|OL Period (Cycles 2-5)||0
2252668|NCT02450526|5526932|P3|NOT COMPLETED|OL Period (Cycles 2-5)||0
2252669|NCT02450526|5526933|P2|NOT COMPLETED|OL Period (Cycles 2-5)||0
2252670|NCT02450526|5526934|P1|NOT COMPLETED|OL Period (Cycles 2-5)||0
2252671|NCT02450526|5526930|P5|COMPLETED|OL Period (Cycles 2-5)||424
2252672|NCT02450526|5526931|P4|COMPLETED|OL Period (Cycles 2-5)||0
2252673|NCT02450526|5526932|P3|COMPLETED|OL Period (Cycles 2-5)||0
2252674|NCT02450526|5526933|P2|COMPLETED|OL Period (Cycles 2-5)||0
2252675|NCT02450526|5526934|P1|COMPLETED|OL Period (Cycles 2-5)||0
2252676|NCT02450526|5526930|P5|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
2252677|NCT02450526|5526931|P4|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
2252678|NCT02450526|5526932|P3|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
2252679|NCT02450526|5526933|P2|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
2252680|NCT02450526|5526934|P1|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
2252681|NCT02450526|5526930|P5|Discontinued During Cycle 4|OL Period (Cycles 2-5)||2
2252682|NCT02450526|5526931|P4|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
2252683|NCT02450526|5526932|P3|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
2252684|NCT02450526|5526933|P2|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
2252685|NCT02450526|5526934|P1|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
2252686|NCT02450526|5526930|P5|Discontinued During Cycle 3|OL Period (Cycles 2-5)||11
2252687|NCT02450526|5526931|P4|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
2252688|NCT02450526|5526932|P3|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
2252689|NCT02450526|5526933|P2|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
2252690|NCT02450526|5526934|P1|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
2252691|NCT02450526|5526930|P5|Discontinued During Cycle 2|OL Period (Cycles 2-5)||28
2252692|NCT02450526|5526931|P4|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
2252693|NCT02450526|5526932|P3|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
2252694|NCT02450526|5526933|P2|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
2252695|NCT02450526|5526934|P1|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
2252696|NCT02450526|5526930|P5|Safety Population|OL Period (Cycles 2-5)||465
2252697|NCT02450526|5526931|P4|Safety Population|OL Period (Cycles 2-5)||0
2252698|NCT02450526|5526932|P3|Safety Population|OL Period (Cycles 2-5)||0
2252699|NCT02450526|5526933|P2|Safety Population|OL Period (Cycles 2-5)||0
2252700|NCT02450526|5526934|P1|Safety Population|OL Period (Cycles 2-5)||0
2252701|NCT02450526|5526930|P5|STARTED|OL Period (Cycles 2-5)|Nine subjects completed the DB Period but were not eligible for retreatment in the OL Period.|465
2252702|NCT02450526|5526931|P4|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
2252703|NCT02450526|5526932|P3|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
2252704|NCT02450526|5526933|P2|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
2252705|NCT02450526|5526934|P1|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
2252706|NCT02450526|5526930|P5|NOT COMPLETED|DB Period (Cycle 1)||0
2252707|NCT02450526|5526931|P4|NOT COMPLETED|DB Period (Cycle 1)||2
2252708|NCT02450526|5526932|P3|NOT COMPLETED|DB Period (Cycle 1)||10
2252709|NCT02450526|5526933|P2|NOT COMPLETED|DB Period (Cycle 1)||3
2252710|NCT02450526|5526934|P1|NOT COMPLETED|DB Period (Cycle 1)||31
2252711|NCT02450526|5526930|P5|COMPLETED|DB Period (Cycle 1)|This arm was not included in DB Period (Cycle 1).|0
2252712|NCT02450526|5526931|P4|COMPLETED|DB Period (Cycle 1)||20
2252713|NCT02450526|5526932|P3|COMPLETED|DB Period (Cycle 1)||97
2252714|NCT02450526|5526933|P2|COMPLETED|DB Period (Cycle 1)||63
2252715|NCT02450526|5526934|P1|COMPLETED|DB Period (Cycle 1)||294
2252716|NCT02450526|5526930|P5|Safety Population|DB Period (Cycle 1)||0
2252717|NCT02450526|5526931|P4|Safety Population|DB Period (Cycle 1)||21
2252718|NCT02450526|5526932|P3|Safety Population|DB Period (Cycle 1)||107
2252719|NCT02450526|5526933|P2|Safety Population|DB Period (Cycle 1)||66
2252720|NCT02450526|5526934|P1|Safety Population|DB Period (Cycle 1)||326
2252721|NCT02450526|5526930|P5|STARTED|DB Period (Cycle 1)|This arm was not included in DB Period (Cycle 1).|0
2252722|NCT02450526|5526931|P4|STARTED|DB Period (Cycle 1)||22
2252723|NCT02450526|5526932|P3|STARTED|DB Period (Cycle 1)||107
2252724|NCT02450526|5526933|P2|STARTED|DB Period (Cycle 1)||66
2252725|NCT02450526|5526934|P1|STARTED|DB Period (Cycle 1)||325
2252726|NCT02450383|5527021|P2|NOT COMPLETED|Overall Study||0
2252727|NCT02450383|5527022|P1|NOT COMPLETED|Overall Study||0
2252728|NCT02450383|5527021|P2|COMPLETED|Overall Study||10
2252729|NCT02450383|5527022|P1|COMPLETED|Overall Study||10
2252730|NCT02450383|5527021|P2|STARTED|Overall Study||10
2252731|NCT02450383|5527022|P1|STARTED|Overall Study||10
2252732|NCT02449915|5527036|P2|NOT COMPLETED|Overall Study||4
2252733|NCT02449915|5527037|P1|NOT COMPLETED|Overall Study||2
2252734|NCT02449915|5527036|P2|COMPLETED|Overall Study||31
2252735|NCT02449915|5527037|P1|COMPLETED|Overall Study||33
2252736|NCT02449915|5527036|P2|STARTED|Overall Study||35
2252737|NCT02449915|5527037|P1|STARTED|Overall Study||35
2252738|NCT02449902|5527045|P2|NOT COMPLETED|Overall Study||2
2252739|NCT02449902|5527046|P1|NOT COMPLETED|Overall Study||0
2252740|NCT02449902|5527045|P2|COMPLETED|Overall Study||24
2252741|NCT02449902|5527046|P1|COMPLETED|Overall Study||24
2252742|NCT02449902|5527045|P2|STARTED|Overall Study||26
2252743|NCT02449902|5527046|P1|STARTED|Overall Study||24
2252744|NCT02449889|5527073|P3|NOT COMPLETED|Overall Study||1
2252745|NCT02449889|5527074|P2|NOT COMPLETED|Overall Study||6
2252746|NCT02449889|5527075|P1|NOT COMPLETED|Overall Study||1
2252747|NCT02449889|5527073|P3|COMPLETED|Overall Study||59
2252748|NCT02449889|5527074|P2|COMPLETED|Overall Study||52
2252749|NCT02449889|5527075|P1|COMPLETED|Overall Study||57
2252750|NCT02449889|5527073|P3|STARTED|Overall Study||60
2252751|NCT02449889|5527074|P2|STARTED|Overall Study||58
2252752|NCT02449889|5527075|P1|STARTED|Overall Study||58
2252753|NCT02449798|5527101|P1|NOT COMPLETED|Overall Study||0
2252754|NCT02449798|5527101|P1|COMPLETED|Overall Study||120
2252755|NCT02449798|5527101|P1|STARTED|Overall Study||120
2252756|NCT02449473|5527115|P2|NOT COMPLETED|Overall Study||0
2252757|NCT02449473|5527116|P1|NOT COMPLETED|Overall Study||0
2252758|NCT02449473|5527115|P2|COMPLETED|Overall Study||40
2252759|NCT02449473|5527116|P1|COMPLETED|Overall Study||39
2252760|NCT02449473|5527115|P2|STARTED|Overall Study||40
2252761|NCT02449473|5527116|P1|STARTED|Overall Study||39
2252762|NCT02449356|5527132|P2|NOT COMPLETED|Overall Study||0
2252763|NCT02449356|5527133|P1|NOT COMPLETED|Overall Study||0
2252764|NCT02449356|5527132|P2|COMPLETED|Overall Study||30
2252765|NCT02449356|5527133|P1|COMPLETED|Overall Study||30
2252766|NCT02449356|5527132|P2|STARTED|Overall Study||30
2252767|NCT02449356|5527133|P1|STARTED|Overall Study||30
2252768|NCT02449291|5527152|P3|NOT COMPLETED|Overall Study||1
2252769|NCT02449291|5527153|P2|NOT COMPLETED|Overall Study||2
2252770|NCT02449291|5527154|P1|NOT COMPLETED|Overall Study||5
2252771|NCT02449291|5527152|P3|COMPLETED|Overall Study||180
2252772|NCT02449291|5527153|P2|COMPLETED|Overall Study||186
2252773|NCT02449291|5527154|P1|COMPLETED|Overall Study||186
2252774|NCT02449291|5527152|P3|STARTED|Overall Study||181
2252775|NCT02449291|5527153|P2|STARTED|Overall Study||188
2252776|NCT02449291|5527154|P1|STARTED|Overall Study||191
2252777|NCT02449174|5527191|P2|NOT COMPLETED|Overall Study||0
2252778|NCT02449174|5527192|P1|NOT COMPLETED|Overall Study||0
2252779|NCT02449174|5527191|P2|COMPLETED|Overall Study||32
2252780|NCT02449174|5527192|P1|COMPLETED|Overall Study||36
2252781|NCT02449174|5527191|P2|STARTED|Overall Study||32
2252782|NCT02449174|5527192|P1|STARTED|Overall Study||36
2252783|NCT02449044|5527200|P1|NOT COMPLETED|Overall Study||64
2252784|NCT02449044|5527200|P1|COMPLETED|Overall Study|Participants who completed Weeks 58, 106 and 216 visit.|47
2252785|NCT02449044|5527200|P1|STARTED|Overall Study||111
2252786|NCT02449018|5527221|P2|NOT COMPLETED|Overall Study||2
2252787|NCT02449018|5527222|P1|NOT COMPLETED|Overall Study||12
2252788|NCT02449018|5527221|P2|COMPLETED|Overall Study||26
2252789|NCT02449018|5527222|P1|COMPLETED|Overall Study||52
2252790|NCT02449018|5527221|P2|STARTED|Overall Study||28
2252791|NCT02449018|5527222|P1|STARTED|Overall Study||64
2252792|NCT02448914|5527249|P2|NOT COMPLETED|Second Intervention (1 Day)||0
2252793|NCT02448914|5527250|P1|NOT COMPLETED|Second Intervention (1 Day)||0
2252794|NCT02448914|5527249|P2|COMPLETED|Second Intervention (1 Day)||5
2252795|NCT02448914|5527250|P1|COMPLETED|Second Intervention (1 Day)||6
2252796|NCT02448914|5527249|P2|STARTED|Second Intervention (1 Day)||5
2252797|NCT02448914|5527250|P1|STARTED|Second Intervention (1 Day)||6
2252798|NCT02448914|5527249|P2|NOT COMPLETED|First Intervention (1 Day)||0
2252799|NCT02448914|5527250|P1|NOT COMPLETED|First Intervention (1 Day)||0
2252800|NCT02448914|5527249|P2|COMPLETED|First Intervention (1 Day)||5
2252801|NCT02448914|5527250|P1|COMPLETED|First Intervention (1 Day)||6
2252802|NCT02448914|5527249|P2|STARTED|First Intervention (1 Day)||5
2252803|NCT02448914|5527250|P1|STARTED|First Intervention (1 Day)||6
2252804|NCT02448875|5527269|P3|NOT COMPLETED|Overall Study||1
2252805|NCT02448875|5527270|P2|NOT COMPLETED|Overall Study||1
2252806|NCT02448875|5527271|P1|NOT COMPLETED|Overall Study||7
2252807|NCT02448875|5527269|P3|COMPLETED|Overall Study||60
2252808|NCT02448875|5527270|P2|COMPLETED|Overall Study||20
2252809|NCT02448875|5527271|P1|COMPLETED|Overall Study||53
2252810|NCT02448875|5527269|P3|Safety Analysis Set|Overall Study||61
2252811|NCT02448875|5527270|P2|Safety Analysis Set|Overall Study||21
2252812|NCT02448875|5527271|P1|Safety Analysis Set|Overall Study||60
2252813|NCT02448875|5527269|P3|Full Analysis Set|Overall Study||61
2252814|NCT02448875|5527270|P2|Full Analysis Set|Overall Study||21
2252815|NCT02448875|5527271|P1|Full Analysis Set|Overall Study||60
2252816|NCT02448875|5527269|P3|Completed Dose Selection Phase|Overall Study||20
2252817|NCT02448875|5527270|P2|Completed Dose Selection Phase|Overall Study||21
2252818|NCT02448875|5527271|P1|Completed Dose Selection Phase|Overall Study||20
2252819|NCT02448875|5527269|P3|STARTED|Overall Study||61
2252820|NCT02448875|5527270|P2|STARTED|Overall Study||21
2252821|NCT02448875|5527271|P1|STARTED|Overall Study||60
2252822|NCT02448862|5527296|P2|NOT COMPLETED|Overall Study||0
2252823|NCT02448862|5527297|P1|NOT COMPLETED|Overall Study||0
2252824|NCT02448862|5527296|P2|COMPLETED|Overall Study||6050
2252825|NCT02448862|5527297|P1|COMPLETED|Overall Study||4525
2252826|NCT02448862|5527296|P2|STARTED|Overall Study||6050
2252827|NCT02448862|5527297|P1|STARTED|Overall Study||4525
2252828|NCT02448810|5527319|P8|NOT COMPLETED|Overall Study||8
2252829|NCT02448810|5527320|P7|NOT COMPLETED|Overall Study||18
2252830|NCT02448810|5527321|P6|NOT COMPLETED|Overall Study||16
2252831|NCT02448810|5527322|P5|NOT COMPLETED|Overall Study||31
2252832|NCT02448810|5527323|P4|NOT COMPLETED|Overall Study||3
2252833|NCT02448810|5527324|P3|NOT COMPLETED|Overall Study||3
2252834|NCT02448810|5527325|P2|NOT COMPLETED|Overall Study||3
2252835|NCT02448810|5527326|P1|NOT COMPLETED|Overall Study||3
2252836|NCT02448810|5527319|P8|COMPLETED|Overall Study||0
2252837|NCT02448810|5527320|P7|COMPLETED|Overall Study||0
2252838|NCT02448810|5527321|P6|COMPLETED|Overall Study||0
2252839|NCT02448810|5527322|P5|COMPLETED|Overall Study||0
2252840|NCT02448810|5527323|P4|COMPLETED|Overall Study||0
2252841|NCT02448810|5527324|P3|COMPLETED|Overall Study||0
2252842|NCT02448810|5527325|P2|COMPLETED|Overall Study||0
2252843|NCT02448810|5527326|P1|COMPLETED|Overall Study||0
2252844|NCT02448810|5527319|P8|Treated|Overall Study||7
2252845|NCT02448810|5527320|P7|Treated|Overall Study||18
2252846|NCT02448810|5527321|P6|Treated|Overall Study||13
2252847|NCT02448810|5527322|P5|Treated|Overall Study||29
2252848|NCT02448810|5527323|P4|Treated|Overall Study||3
2252849|NCT02448810|5527324|P3|Treated|Overall Study||3
2252850|NCT02448810|5527325|P2|Treated|Overall Study||3
2252851|NCT02448810|5527326|P1|Treated|Overall Study||3
2252852|NCT02448810|5527319|P8|STARTED|Overall Study||8
2252853|NCT02448810|5527320|P7|STARTED|Overall Study||18
2252854|NCT02448810|5527321|P6|STARTED|Overall Study||16
2252855|NCT02448810|5527322|P5|STARTED|Overall Study||31
2252856|NCT02448810|5527323|P4|STARTED|Overall Study||3
2252857|NCT02448810|5527324|P3|STARTED|Overall Study||3
2252858|NCT02448810|5527325|P2|STARTED|Overall Study||3
2252859|NCT02448810|5527326|P1|STARTED|Overall Study||3
2252860|NCT02448719|5527403|P11|NOT COMPLETED|Overall Study||0
2252861|NCT02448719|5527404|P10|NOT COMPLETED|Overall Study||0
2252862|NCT02448719|5527405|P9|NOT COMPLETED|Overall Study||0
2252863|NCT02448719|5527406|P8|NOT COMPLETED|Overall Study||0
2252864|NCT02448719|5527407|P7|NOT COMPLETED|Overall Study||0
2252865|NCT02448719|5527408|P6|NOT COMPLETED|Overall Study||0
2252866|NCT02448719|5527409|P5|NOT COMPLETED|Overall Study||1
2252867|NCT02448719|5527410|P4|NOT COMPLETED|Overall Study||0
2252868|NCT02448719|5527411|P3|NOT COMPLETED|Overall Study||0
2252869|NCT02448719|5527412|P2|NOT COMPLETED|Overall Study||0
2252870|NCT02448719|5527413|P1|NOT COMPLETED|Overall Study||0
2252871|NCT02448719|5527403|P11|COMPLETED|Overall Study||6
2252872|NCT02448719|5527404|P10|COMPLETED|Overall Study||6
2252873|NCT02448719|5527405|P9|COMPLETED|Overall Study||6
2252874|NCT02448719|5527406|P8|COMPLETED|Overall Study||6
2252875|NCT02448719|5527407|P7|COMPLETED|Overall Study||6
2252876|NCT02448719|5527408|P6|COMPLETED|Overall Study||6
2252877|NCT02448719|5527409|P5|COMPLETED|Overall Study||5
2252878|NCT02448719|5527410|P4|COMPLETED|Overall Study||6
2252879|NCT02448719|5527411|P3|COMPLETED|Overall Study||6
2252880|NCT02448719|5527412|P2|COMPLETED|Overall Study||6
2252881|NCT02448719|5527413|P1|COMPLETED|Overall Study||12
2252882|NCT02448719|5527403|P11|STARTED|Overall Study||6
2252883|NCT02448719|5527404|P10|STARTED|Overall Study||6
2252884|NCT02448719|5527405|P9|STARTED|Overall Study||6
2252885|NCT02448719|5527406|P8|STARTED|Overall Study||6
2252886|NCT02448719|5527407|P7|STARTED|Overall Study||6
2252887|NCT02448719|5527408|P6|STARTED|Overall Study||6
2252888|NCT02448719|5527409|P5|STARTED|Overall Study||6
2252889|NCT02448719|5527410|P4|STARTED|Overall Study||6
2252890|NCT02448719|5527411|P3|STARTED|Overall Study||6
2252891|NCT02448719|5527412|P2|STARTED|Overall Study||6
2252892|NCT02448719|5527413|P1|STARTED|Overall Study||12
2252893|NCT02448706|5527637|P2|NOT COMPLETED|Overall Study||4
2252894|NCT02448706|5527638|P1|NOT COMPLETED|Overall Study||5
2252895|NCT02448706|5527637|P2|COMPLETED|Overall Study||20
2252896|NCT02448706|5527638|P1|COMPLETED|Overall Study||20
2252897|NCT02448706|5527637|P2|Completed Baseline Testing|Overall Study||23
2252898|NCT02448706|5527638|P1|Completed Baseline Testing|Overall Study||24
2252899|NCT02448706|5527637|P2|Withdrew for Personal Reasons|Overall Study||1
2252900|NCT02448706|5527638|P1|Withdrew for Personal Reasons|Overall Study||1
2252901|NCT02448706|5527637|P2|STARTED|Overall Study||24
2252902|NCT02448706|5527638|P1|STARTED|Overall Study||25
2252903|NCT02448563|5527654|P2|NOT COMPLETED|Overall Study||11
2252904|NCT02448563|5527655|P1|NOT COMPLETED|Overall Study||16
2252905|NCT02448563|5527654|P2|COMPLETED|Overall Study||19
2252906|NCT02448563|5527655|P1|COMPLETED|Overall Study||16
2252907|NCT02448563|5527654|P2|STARTED|Overall Study|Randomized after completing Visit 2|30
2252908|NCT02448563|5527655|P1|STARTED|Overall Study|Randomized after completing Visit 2|32
2252909|NCT02448537|5527677|P3|NOT COMPLETED|Overall Study||1
2252910|NCT02448537|5527678|P2|NOT COMPLETED|Overall Study||1
2252911|NCT02448537|5527679|P1|NOT COMPLETED|Overall Study||1
2252912|NCT02448537|5527677|P3|COMPLETED|Overall Study||11
2252913|NCT02448537|5527678|P2|COMPLETED|Overall Study||9
2252914|NCT02448537|5527679|P1|COMPLETED|Overall Study||19
2252915|NCT02448537|5527677|P3|STARTED|Overall Study||12
2252916|NCT02448537|5527678|P2|STARTED|Overall Study||10
2252917|NCT02448537|5527679|P1|STARTED|Overall Study||20
2252918|NCT02448368|5527695|P13|NOT COMPLETED|Overall Study||0
2252919|NCT02448368|5527696|P12|NOT COMPLETED|Overall Study||0
2252920|NCT02448368|5527697|P11|NOT COMPLETED|Overall Study||0
2252921|NCT02448368|5527698|P10|NOT COMPLETED|Overall Study||0
2252922|NCT02448368|5527699|P9|NOT COMPLETED|Overall Study||0
2252923|NCT02448368|5527700|P8|NOT COMPLETED|Overall Study||0
2252924|NCT02448368|5527701|P7|NOT COMPLETED|Overall Study||0
2252925|NCT02448368|5527702|P6|NOT COMPLETED|Overall Study||0
2252926|NCT02448368|5527703|P5|NOT COMPLETED|Overall Study||0
2252927|NCT02448368|5527704|P4|NOT COMPLETED|Overall Study||0
2252928|NCT02448368|5527705|P3|NOT COMPLETED|Overall Study||0
2252929|NCT02448368|5527706|P2|NOT COMPLETED|Overall Study||0
2252930|NCT02448368|5527707|P1|NOT COMPLETED|Overall Study||0
2252931|NCT02448368|5527695|P13|COMPLETED|Overall Study||5
2252932|NCT02448368|5527696|P12|COMPLETED|Overall Study||5
2252933|NCT02448368|5527697|P11|COMPLETED|Overall Study||5
2252934|NCT02448368|5527698|P10|COMPLETED|Overall Study||2
2252935|NCT02448368|5527699|P9|COMPLETED|Overall Study||2
2252936|NCT02448368|5527700|P8|COMPLETED|Overall Study||2
2252937|NCT02448368|5527701|P7|COMPLETED|Overall Study||2
2252938|NCT02448368|5527702|P6|COMPLETED|Overall Study||2
2252939|NCT02448368|5527703|P5|COMPLETED|Overall Study||2
2252940|NCT02448368|5527704|P4|COMPLETED|Overall Study||2
2252941|NCT02448368|5527705|P3|COMPLETED|Overall Study||2
2252942|NCT02448368|5527706|P2|COMPLETED|Overall Study||2
2252943|NCT02448368|5527707|P1|COMPLETED|Overall Study||2
2252944|NCT02448368|5527695|P13|STARTED|Overall Study||5
2252945|NCT02448368|5527696|P12|STARTED|Overall Study||5
2252946|NCT02448368|5527697|P11|STARTED|Overall Study||5
2252947|NCT02448368|5527698|P10|STARTED|Overall Study||2
2252948|NCT02448368|5527699|P9|STARTED|Overall Study||2
2252949|NCT02448368|5527700|P8|STARTED|Overall Study||2
2252950|NCT02448368|5527701|P7|STARTED|Overall Study||2
2252951|NCT02448368|5527702|P6|STARTED|Overall Study||2
2252952|NCT02448368|5527703|P5|STARTED|Overall Study||2
2252953|NCT02448368|5527704|P4|STARTED|Overall Study||2
2252954|NCT02448368|5527705|P3|STARTED|Overall Study||2
2252955|NCT02448368|5527706|P2|STARTED|Overall Study||2
2252956|NCT02448368|5527707|P1|STARTED|Overall Study||2
2252957|NCT02448303|5527784|P2|NOT COMPLETED|Overall Study||36
2252958|NCT02448303|5527785|P1|NOT COMPLETED|Overall Study||38
2252959|NCT02448303|5527784|P2|COMPLETED|Overall Study||0
2252960|NCT02448303|5527785|P1|COMPLETED|Overall Study||0
2252961|NCT02448303|5527784|P2|Discontinued Study|Overall Study||36
2252962|NCT02448303|5527785|P1|Discontinued Study|Overall Study||38
2252963|NCT02448303|5527784|P2|Received Study Medication|Overall Study||35
2252964|NCT02448303|5527785|P1|Received Study Medication|Overall Study||33
2252965|NCT02448303|5527784|P2|Enrolled|Overall Study||36
2252966|NCT02448303|5527785|P1|Enrolled|Overall Study||38
2252967|NCT02448303|5527784|P2|STARTED|Overall Study||36
2252968|NCT02448303|5527785|P1|STARTED|Overall Study||38
2252969|NCT02448043|5527793|P2|NOT COMPLETED|Overall Study||4
2252970|NCT02448043|5527794|P1|NOT COMPLETED|Overall Study||3
2252971|NCT02448043|5527793|P2|COMPLETED|Overall Study||18
2252972|NCT02448043|5527794|P1|COMPLETED|Overall Study||20
2252973|NCT02448043|5527793|P2|STARTED|Overall Study||22
2252974|NCT02448043|5527794|P1|STARTED|Overall Study||23
2252975|NCT02447952|5527812|P1|NOT COMPLETED|Overall Study||7
2252976|NCT02447952|5527812|P1|COMPLETED|Overall Study||18
2252977|NCT02447952|5527812|P1|STARTED|Overall Study||25
2252978|NCT02447926|5527864|P1|NOT COMPLETED|Overall Study||0
2252979|NCT02447926|5527864|P1|COMPLETED|Overall Study||1
2252980|NCT02447926|5527864|P1|STARTED|Overall Study||1
2252981|NCT02447887|5527869|P1|NOT COMPLETED|Overall Study||3
2252982|NCT02447887|5527869|P1|COMPLETED|Overall Study||0
2252983|NCT02447887|5527869|P1|STARTED|Overall Study||3
2252984|NCT02447848|5527882|P1|NOT COMPLETED|Overall Study||11
2252985|NCT02447848|5527882|P1|COMPLETED|Overall Study||65
2252986|NCT02447848|5527882|P1|STARTED|Overall Study||76
2252987|NCT02447458|5527894|P6|NOT COMPLETED|Overall Study||0
2252988|NCT02447458|5527895|P5|NOT COMPLETED|Overall Study||0
2252989|NCT02447458|5527896|P4|NOT COMPLETED|Overall Study||0
2252990|NCT02447458|5527897|P3|NOT COMPLETED|Overall Study||1
2252991|NCT02447458|5527898|P2|NOT COMPLETED|Overall Study||0
2252992|NCT02447458|5527899|P1|NOT COMPLETED|Overall Study||0
2252993|NCT02447458|5527894|P6|COMPLETED|Overall Study||10
2252994|NCT02447458|5527895|P5|COMPLETED|Overall Study||6
2252995|NCT02447458|5527896|P4|COMPLETED|Overall Study||6
2252996|NCT02447458|5527897|P3|COMPLETED|Overall Study||5
2252997|NCT02447458|5527898|P2|COMPLETED|Overall Study||6
2252998|NCT02447458|5527899|P1|COMPLETED|Overall Study||5
2252999|NCT02447458|5527894|P6|STARTED|Overall Study||10
2253000|NCT02447458|5527895|P5|STARTED|Overall Study||6
2253001|NCT02447458|5527896|P4|STARTED|Overall Study||6
2253002|NCT02447458|5527897|P3|STARTED|Overall Study||6
2253003|NCT02447458|5527898|P2|STARTED|Overall Study||6
2253004|NCT02447458|5527899|P1|STARTED|Overall Study||5
2253005|NCT02447432|5527997|P2|NOT COMPLETED|Epoch 002||0
2253006|NCT02447432|5527998|P1|NOT COMPLETED|Epoch 002||0
2253007|NCT02447432|5527997|P2|COMPLETED|Epoch 002||145
2253008|NCT02447432|5527998|P1|COMPLETED|Epoch 002||152
2253009|NCT02447432|5527997|P2|STARTED|Epoch 002||145
2253010|NCT02447432|5527998|P1|STARTED|Epoch 002||152
2253011|NCT02447432|5527997|P2|NOT COMPLETED|Epoch 001||13
2253012|NCT02447432|5527998|P1|NOT COMPLETED|Epoch 001||5
2253013|NCT02447432|5527997|P2|COMPLETED|Epoch 001||147
2253014|NCT02447432|5527998|P1|COMPLETED|Epoch 001||155
2253015|NCT02447432|5527997|P2|STARTED|Epoch 001||160
2253016|NCT02447432|5527998|P1|STARTED|Epoch 001||160
2253017|NCT02447328|5528030|P1|NOT COMPLETED|Overall Study||1
2253018|NCT02447328|5528030|P1|COMPLETED|Overall Study||82
2253019|NCT02447328|5528030|P1|STARTED|Overall Study|Enrolment 85 Screening Failure 2 starting study drug 83|83
2253020|NCT02447250|5528034|P1|NOT COMPLETED|Third Dose (360 mcg Albuterol)||5
2253021|NCT02447250|5528034|P1|COMPLETED|Third Dose (360 mcg Albuterol)||8
2253022|NCT02447250|5528034|P1|STARTED|Third Dose (360 mcg Albuterol)||13
2253023|NCT02447250|5528034|P1|NOT COMPLETED|Second Dose (270 mcg Albuterol)||1
2253024|NCT02447250|5528034|P1|COMPLETED|Second Dose (270 mcg Albuterol)||13
2253025|NCT02447250|5528034|P1|STARTED|Second Dose (270 mcg Albuterol)||14
2253026|NCT02447250|5528034|P1|NOT COMPLETED|First Dose (180 mcg Albuterol)||0
2253027|NCT02447250|5528034|P1|COMPLETED|First Dose (180 mcg Albuterol)||14
2253028|NCT02447250|5528034|P1|STARTED|First Dose (180 mcg Albuterol)||14
2253029|NCT02447133|5528045|P1|NOT COMPLETED|Overall Study||0
2253030|NCT02447133|5528045|P1|COMPLETED|Overall Study||12
2253031|NCT02447133|5528045|P1|STARTED|Overall Study||12
2253032|NCT02447081|5528051|P1|NOT COMPLETED|Overall Study||224
2253033|NCT02447081|5528051|P1|COMPLETED|Overall Study||864
2253034|NCT02447081|5528051|P1|STARTED|Overall Study||1088
2253035|NCT02447029|5528067|P2|NOT COMPLETED|Overall Study||2
2253036|NCT02447029|5528068|P1|NOT COMPLETED|Overall Study||3
2253037|NCT02447029|5528067|P2|COMPLETED|Overall Study||68
2253038|NCT02447029|5528068|P1|COMPLETED|Overall Study||69
2253039|NCT02447029|5528067|P2|Treated|Overall Study||68
2253040|NCT02447029|5528068|P1|Treated|Overall Study||69
2253041|NCT02447029|5528067|P2|STARTED|Overall Study||70
2253042|NCT02447029|5528068|P1|STARTED|Overall Study||72
2253043|NCT02446990|5528088|P2|NOT COMPLETED|Overall Study||658
2253044|NCT02446990|5528089|P1|NOT COMPLETED|Overall Study||720
2253045|NCT02446990|5528088|P2|COMPLETED|Overall Study||8894
2253046|NCT02446990|5528089|P1|COMPLETED|Overall Study||8830
2253047|NCT02446990|5528088|P2|STARTED|Overall Study||9552
2253048|NCT02446990|5528089|P1|STARTED|Overall Study||9550
2253049|NCT02446912|5528124|P3|NOT COMPLETED|Overall Study||35
2253050|NCT02446912|5528125|P2|NOT COMPLETED|Overall Study||35
2253051|NCT02446912|5528126|P1|NOT COMPLETED|Overall Study||18
2253052|NCT02446912|5528124|P3|COMPLETED|Overall Study||149
2253053|NCT02446912|5528125|P2|COMPLETED|Overall Study||145
2253054|NCT02446912|5528126|P1|COMPLETED|Overall Study||75
2253055|NCT02446912|5528124|P3|Participants Who Completed Week 52|Overall Study||157
2253056|NCT02446912|5528125|P2|Participants Who Completed Week 52|Overall Study||153
2253057|NCT02446912|5528126|P1|Participants Who Completed Week 52|Overall Study||80
2253058|NCT02446912|5528124|P3|STARTED|Overall Study||184
2253059|NCT02446912|5528125|P2|STARTED|Overall Study||180
2253060|NCT02446912|5528126|P1|STARTED|Overall Study||93
2253061|NCT02446769|5528197|P3|NOT COMPLETED|Study Period||0
2253062|NCT02446769|5528198|P2|NOT COMPLETED|Study Period||2
2253063|NCT02446769|5528199|P1|NOT COMPLETED|Study Period||0
2253064|NCT02446769|5528197|P3|COMPLETED|Study Period||3
2253065|NCT02446769|5528198|P2|COMPLETED|Study Period||2
2253066|NCT02446769|5528199|P1|COMPLETED|Study Period||0
2253067|NCT02446769|5528197|P3|STARTED|Study Period||3
2253068|NCT02446769|5528198|P2|STARTED|Study Period||4
2253069|NCT02446769|5528199|P1|STARTED|Study Period||0
2253070|NCT02446769|5528197|P3|NOT COMPLETED|Screening Period||0
2253071|NCT02446769|5528198|P2|NOT COMPLETED|Screening Period||0
2253072|NCT02446769|5528199|P1|NOT COMPLETED|Screening Period||11
2253073|NCT02446769|5528197|P3|COMPLETED|Screening Period||0
2253074|NCT02446769|5528198|P2|COMPLETED|Screening Period||0
2253075|NCT02446769|5528199|P1|COMPLETED|Screening Period||7
2253076|NCT02446769|5528197|P3|STARTED|Screening Period||0
2253077|NCT02446769|5528198|P2|STARTED|Screening Period||0
2253078|NCT02446769|5528199|P1|STARTED|Screening Period||18
2253079|NCT02446743|5528220|P2|NOT COMPLETED|Overall Study||5
2253080|NCT02446743|5528221|P1|NOT COMPLETED|Overall Study||5
2253081|NCT02446743|5528220|P2|COMPLETED|Overall Study||250
2253082|NCT02446743|5528221|P1|COMPLETED|Overall Study||271
2253083|NCT02446743|5528220|P2|STARTED|Overall Study||255
2253084|NCT02446743|5528221|P1|STARTED|Overall Study||276
2253085|NCT02446717|5528376|P5|NOT COMPLETED|Overall Study||1
2253086|NCT02446717|5528377|P4|NOT COMPLETED|Overall Study||1
2253087|NCT02446717|5528378|P3|NOT COMPLETED|Overall Study||2
2253088|NCT02446717|5528379|P2|NOT COMPLETED|Overall Study||1
2253089|NCT02446717|5528380|P1|NOT COMPLETED|Overall Study||0
2253090|NCT02446717|5528376|P5|COMPLETED|Overall Study||46
2253091|NCT02446717|5528377|P4|COMPLETED|Overall Study||43
2253092|NCT02446717|5528378|P3|COMPLETED|Overall Study||20
2253093|NCT02446717|5528379|P2|COMPLETED|Overall Study||21
2253094|NCT02446717|5528380|P1|COMPLETED|Overall Study||6
2253095|NCT02446717|5528376|P5|STARTED|Overall Study||47
2253096|NCT02446717|5528377|P4|STARTED|Overall Study||44
2253097|NCT02446717|5528378|P3|STARTED|Overall Study||22
2253098|NCT02446717|5528379|P2|STARTED|Overall Study||22
2253099|NCT02446717|5528380|P1|STARTED|Overall Study||6
2253100|NCT02446691|5528407|P1|NOT COMPLETED|Overall Study||11
2253101|NCT02446691|5528407|P1|COMPLETED|Overall Study||117
2253102|NCT02446691|5528407|P1|STARTED|Overall Study||128
2253103|NCT02446613|5528427|P2|NOT COMPLETED|Overall Study||0
2253104|NCT02446613|5528428|P1|NOT COMPLETED|Overall Study||0
2253105|NCT02446613|5528427|P2|COMPLETED|Overall Study||10
2253106|NCT02446613|5528428|P1|COMPLETED|Overall Study||6
2253107|NCT02446613|5528427|P2|STARTED|Overall Study||10
2253108|NCT02446613|5528428|P1|STARTED|Overall Study||6
2253109|NCT02446496|5528450|P1|NOT COMPLETED|Overall Study||0
2253110|NCT02446496|5528450|P1|COMPLETED|Overall Study||24
2253111|NCT02446496|5528450|P1|STARTED|Overall Study||24
2253112|NCT02446483|5528462|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
2253113|NCT02446483|5528463|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
2253114|NCT02446483|5528462|P2|COMPLETED|Period 3: Intervention Period 2||30
2253115|NCT02446483|5528463|P1|COMPLETED|Period 3: Intervention Period 2||30
2253116|NCT02446483|5528462|P2|STARTED|Period 3: Intervention Period 2||30
2253117|NCT02446483|5528463|P1|STARTED|Period 3: Intervention Period 2||30
2253118|NCT02446483|5528462|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
2253119|NCT02446483|5528463|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
2253120|NCT02446483|5528462|P2|COMPLETED|Period 2: Washout Period (7 Days)||30
2253121|NCT02446483|5528463|P1|COMPLETED|Period 2: Washout Period (7 Days)||30
2253122|NCT02446483|5528462|P2|STARTED|Period 2: Washout Period (7 Days)||30
2253123|NCT02446483|5528463|P1|STARTED|Period 2: Washout Period (7 Days)||30
2253124|NCT02446483|5528462|P2|NOT COMPLETED|Period 1: Intervention Period 1||0
2253125|NCT02446483|5528463|P1|NOT COMPLETED|Period 1: Intervention Period 1||0
2253126|NCT02446483|5528462|P2|COMPLETED|Period 1: Intervention Period 1||30
2253127|NCT02446483|5528463|P1|COMPLETED|Period 1: Intervention Period 1||30
2253128|NCT02446483|5528462|P2|STARTED|Period 1: Intervention Period 1||30
2253129|NCT02446483|5528463|P1|STARTED|Period 1: Intervention Period 1||30
2253130|NCT02446418|5528477|P2|NOT COMPLETED|Overall Study||16
2253131|NCT02446418|5528478|P1|NOT COMPLETED|Overall Study||18
2253132|NCT02446418|5528477|P2|COMPLETED|Overall Study||194
2253133|NCT02446418|5528478|P1|COMPLETED|Overall Study||192
2253134|NCT02446418|5528477|P2|STARTED|Overall Study||210
2253135|NCT02446418|5528478|P1|STARTED|Overall Study||210
2253136|NCT02446314|5528492|P4|NOT COMPLETED|Thirteen to Twenty Four Weeks||1
2253137|NCT02446314|5528493|P3|NOT COMPLETED|Thirteen to Twenty Four Weeks||2
2253138|NCT02446314|5528494|P2|NOT COMPLETED|Thirteen to Twenty Four Weeks||1
2253139|NCT02446314|5528495|P1|NOT COMPLETED|Thirteen to Twenty Four Weeks||0
2253140|NCT02446314|5528492|P4|COMPLETED|Thirteen to Twenty Four Weeks||28
2253141|NCT02446314|5528493|P3|COMPLETED|Thirteen to Twenty Four Weeks||29
2253142|NCT02446314|5528494|P2|COMPLETED|Thirteen to Twenty Four Weeks||28
2253143|NCT02446314|5528495|P1|COMPLETED|Thirteen to Twenty Four Weeks||27
2253144|NCT02446314|5528492|P4|STARTED|Thirteen to Twenty Four Weeks||29
2253145|NCT02446314|5528493|P3|STARTED|Thirteen to Twenty Four Weeks||31
2253146|NCT02446314|5528494|P2|STARTED|Thirteen to Twenty Four Weeks||29
2253147|NCT02446314|5528495|P1|STARTED|Thirteen to Twenty Four Weeks||27
2253148|NCT02446314|5528492|P4|NOT COMPLETED|Zero to Twelve Weeks.||2
2253149|NCT02446314|5528493|P3|NOT COMPLETED|Zero to Twelve Weeks.||0
2253150|NCT02446314|5528494|P2|NOT COMPLETED|Zero to Twelve Weeks.||1
2253151|NCT02446314|5528495|P1|NOT COMPLETED|Zero to Twelve Weeks.||3
2253152|NCT02446314|5528492|P4|COMPLETED|Zero to Twelve Weeks.||29
2253153|NCT02446314|5528493|P3|COMPLETED|Zero to Twelve Weeks.||31
2253154|NCT02446314|5528494|P2|COMPLETED|Zero to Twelve Weeks.||29
2253155|NCT02446314|5528495|P1|COMPLETED|Zero to Twelve Weeks.||27
2253156|NCT02446314|5528492|P4|STARTED|Zero to Twelve Weeks.||31
2253157|NCT02446314|5528493|P3|STARTED|Zero to Twelve Weeks.||31
2253158|NCT02446314|5528494|P2|STARTED|Zero to Twelve Weeks.||30
2253159|NCT02446314|5528495|P1|STARTED|Zero to Twelve Weeks.||30
2253160|NCT02446223|5528541|P1|NOT COMPLETED|Overall Study||1
2253161|NCT02446223|5528541|P1|COMPLETED|Overall Study||20
2253162|NCT02446223|5528541|P1|STARTED|Overall Study||21
2253163|NCT02446171|5528549|P4|NOT COMPLETED|Overall Study||0
2253164|NCT02446171|5528550|P3|NOT COMPLETED|Overall Study||2
2253165|NCT02446171|5528551|P2|NOT COMPLETED|Overall Study||0
2253166|NCT02446171|5528552|P1|NOT COMPLETED|Overall Study||0
2253167|NCT02446171|5528549|P4|COMPLETED|Overall Study||11
2253168|NCT02446171|5528550|P3|COMPLETED|Overall Study||9
2253169|NCT02446171|5528551|P2|COMPLETED|Overall Study||11
2253170|NCT02446171|5528552|P1|COMPLETED|Overall Study||11
2253171|NCT02446171|5528549|P4|STARTED|Overall Study||11
2253172|NCT02446171|5528550|P3|STARTED|Overall Study||11
2253173|NCT02446171|5528551|P2|STARTED|Overall Study||11
2253174|NCT02446171|5528552|P1|STARTED|Overall Study||11
2253175|NCT02446015|5528623|P2|NOT COMPLETED|Overall Study||1
2253176|NCT02446015|5528624|P1|NOT COMPLETED|Overall Study||1
2253177|NCT02446015|5528623|P2|COMPLETED|Overall Study||62
2253178|NCT02446015|5528624|P1|COMPLETED|Overall Study||33
2253179|NCT02446015|5528623|P2|STARTED|Overall Study||63
2253180|NCT02446015|5528624|P1|STARTED|Overall Study||34
2253181|NCT02445911|5528639|P4|NOT COMPLETED|Overall Study||0
2253182|NCT02445911|5528640|P3|NOT COMPLETED|Overall Study||0
2253183|NCT02445911|5528641|P2|NOT COMPLETED|Overall Study||0
2253184|NCT02445911|5528642|P1|NOT COMPLETED|Overall Study||0
2253185|NCT02445911|5528639|P4|COMPLETED|Overall Study||20
2253186|NCT02445911|5528640|P3|COMPLETED|Overall Study||21
2253187|NCT02445911|5528641|P2|COMPLETED|Overall Study||20
2253188|NCT02445911|5528642|P1|COMPLETED|Overall Study||20
2253189|NCT02445911|5528639|P4|STARTED|Overall Study||20
2253190|NCT02445911|5528640|P3|STARTED|Overall Study||21
2253191|NCT02445911|5528641|P2|STARTED|Overall Study||20
2253192|NCT02445911|5528642|P1|STARTED|Overall Study||20
2253193|NCT02445859|5528714|P2|NOT COMPLETED|Overall Study||3
2253194|NCT02445859|5528715|P1|NOT COMPLETED|Overall Study||2
2253195|NCT02445859|5528714|P2|COMPLETED|Overall Study||42
2253196|NCT02445859|5528715|P1|COMPLETED|Overall Study||43
2253197|NCT02445859|5528714|P2|STARTED|Overall Study||45
2253198|NCT02445859|5528715|P1|STARTED|Overall Study||45
2253199|NCT02445807|5528723|P2|NOT COMPLETED|Overall Study||0
2253200|NCT02445807|5528724|P1|NOT COMPLETED|Overall Study||0
2253201|NCT02445807|5528723|P2|COMPLETED|Overall Study||89
2253202|NCT02445807|5528724|P1|COMPLETED|Overall Study||176
2253203|NCT02445807|5528723|P2|STARTED|Overall Study||89
2253204|NCT02445807|5528724|P1|STARTED|Overall Study||176
2253205|NCT02445755|5528734|P1|NOT COMPLETED|Overall Study||13
2253206|NCT02445755|5528734|P1|COMPLETED|Overall Study||100
2253207|NCT02445755|5528734|P1|STARTED|Overall Study|Neonates will be tested with 3 transcutaneous (TcB) devices +/-30 minutes of routine bilirubin labs|113
2253208|NCT02445625|5528741|P1|NOT COMPLETED|Overall Study||0
2253209|NCT02445625|5528741|P1|COMPLETED|Overall Study||15
2253210|NCT02445625|5528741|P1|STARTED|Overall Study||15
2253211|NCT02445586|5528748|P1|NOT COMPLETED|Overall Study||39
2253212|NCT02445586|5528748|P1|COMPLETED|Overall Study||13
2253213|NCT02445586|5528748|P1|Received at Least One Dose of Study Drug|Overall Study||52
2253214|NCT02445586|5528748|P1|STARTED|Overall Study||52
2253215|NCT02445573|5528788|P2|NOT COMPLETED|Overall Study||2
2253216|NCT02445573|5528789|P1|NOT COMPLETED|Overall Study||1
2253217|NCT02445573|5528788|P2|COMPLETED|Overall Study||38
2253218|NCT02445573|5528789|P1|COMPLETED|Overall Study||39
2253219|NCT02445573|5528788|P2|STARTED|Overall Study||40
2253220|NCT02445573|5528789|P1|STARTED|Overall Study||40
2253221|NCT02445326|5528805|P2|NOT COMPLETED|Overall Study||1
2253222|NCT02445326|5528806|P1|NOT COMPLETED|Overall Study||2
2253223|NCT02445326|5528805|P2|COMPLETED|Overall Study||37
2253224|NCT02445326|5528806|P1|COMPLETED|Overall Study||33
2253225|NCT02445326|5528805|P2|STARTED|Overall Study||38
2253226|NCT02445326|5528806|P1|STARTED|Overall Study||35
2253227|NCT02445287|5528824|P2|NOT COMPLETED|Overall Study||0
2253228|NCT02445287|5528825|P1|NOT COMPLETED|Overall Study||0
2253229|NCT02445287|5528824|P2|COMPLETED|Overall Study||13
2253230|NCT02445287|5528825|P1|COMPLETED|Overall Study||35
2253231|NCT02445287|5528824|P2|STARTED|Overall Study||13
2253232|NCT02445287|5528825|P1|STARTED|Overall Study||35
2253233|NCT02445196|5528840|P2|NOT COMPLETED|Overall Study||6
2253234|NCT02445196|5528841|P1|NOT COMPLETED|Overall Study||11
2253235|NCT02445196|5528840|P2|COMPLETED|Overall Study||52
2253236|NCT02445196|5528841|P1|COMPLETED|Overall Study||51
2253237|NCT02445196|5528840|P2|STARTED|Overall Study||58
2253238|NCT02445196|5528841|P1|STARTED|Overall Study||62
2253239|NCT02445027|5528854|P1|NOT COMPLETED|Overall Study||15
2253240|NCT02445027|5528854|P1|COMPLETED|Overall Study||45
2253241|NCT02445027|5528854|P1|STARTED|Overall Study||60
2253242|NCT02445014|5528858|P1|NOT COMPLETED|Overall Study||0
2253243|NCT02445014|5528858|P1|COMPLETED|Overall Study||3
2253244|NCT02445014|5528858|P1|STARTED|Overall Study||3
2253245|NCT02444988|5528864|P2|NOT COMPLETED|Overall Study||0
2253246|NCT02444988|5528865|P1|NOT COMPLETED|Overall Study||0
2253247|NCT02444988|5528864|P2|COMPLETED|Overall Study||2735
2253248|NCT02444988|5528865|P1|COMPLETED|Overall Study||2646
2253249|NCT02444988|5528864|P2|STARTED|Overall Study||2735
2253250|NCT02444988|5528865|P1|STARTED|Overall Study||2646
2253251|NCT02444936|5528875|P2|NOT COMPLETED|Overall Study||0
2253252|NCT02444936|5528876|P1|NOT COMPLETED|Overall Study||0
2253253|NCT02444936|5528875|P2|COMPLETED|Overall Study||12
2253254|NCT02444936|5528876|P1|COMPLETED|Overall Study||10
2253255|NCT02444936|5528875|P2|STARTED|Overall Study||12
2253256|NCT02444936|5528876|P1|STARTED|Overall Study||10
2253257|NCT02444793|5528886|P4|NOT COMPLETED|Overall Study||3
2253258|NCT02444793|5528887|P3|NOT COMPLETED|Overall Study||4
2253259|NCT02444793|5528888|P2|NOT COMPLETED|Overall Study||6
2253260|NCT02444793|5528889|P1|NOT COMPLETED|Overall Study||11
2253261|NCT02444793|5528886|P4|COMPLETED|Overall Study||0
2253262|NCT02444793|5528887|P3|COMPLETED|Overall Study||0
2253263|NCT02444793|5528888|P2|COMPLETED|Overall Study||0
2253264|NCT02444793|5528889|P1|COMPLETED|Overall Study||0
2253265|NCT02444793|5528886|P4|STARTED|Overall Study||3
2253266|NCT02444793|5528887|P3|STARTED|Overall Study||4
2253267|NCT02444793|5528888|P2|STARTED|Overall Study||6
2253268|NCT02444793|5528889|P1|STARTED|Overall Study||11
2253269|NCT02444715|5529016|P2|NOT COMPLETED|Overall Study||16
2253270|NCT02444715|5529017|P1|NOT COMPLETED|Overall Study||10
2253271|NCT02444715|5529016|P2|COMPLETED|Overall Study||32
2253272|NCT02444715|5529017|P1|COMPLETED|Overall Study||36
2253273|NCT02444715|5529016|P2|STARTED|Overall Study||48
2253274|NCT02444715|5529017|P1|STARTED|Overall Study||46
2253275|NCT02444533|5529048|P2|NOT COMPLETED|Overall Study||4
2253276|NCT02444533|5529049|P1|NOT COMPLETED|Overall Study||2
2253277|NCT02444533|5529048|P2|COMPLETED|Overall Study||18
2253278|NCT02444533|5529049|P1|COMPLETED|Overall Study||15
2253279|NCT02444533|5529048|P2|STARTED|Overall Study||22
2253280|NCT02444533|5529049|P1|STARTED|Overall Study||17
2253281|NCT02444234|5529063|P2|NOT COMPLETED|Second Intervention (3 Days)||0
2253282|NCT02444234|5529064|P1|NOT COMPLETED|Second Intervention (3 Days)||0
2253283|NCT02444234|5529063|P2|COMPLETED|Second Intervention (3 Days)||5
2253284|NCT02444234|5529064|P1|COMPLETED|Second Intervention (3 Days)||6
2253285|NCT02444234|5529063|P2|STARTED|Second Intervention (3 Days)||5
2253286|NCT02444234|5529064|P1|STARTED|Second Intervention (3 Days)||6
2253287|NCT02444234|5529063|P2|NOT COMPLETED|Washout (2 Day Minimum)||0
2253288|NCT02444234|5529064|P1|NOT COMPLETED|Washout (2 Day Minimum)||0
2253289|NCT02444234|5529063|P2|COMPLETED|Washout (2 Day Minimum)||5
2253290|NCT02444234|5529064|P1|COMPLETED|Washout (2 Day Minimum)||6
2253291|NCT02444234|5529063|P2|STARTED|Washout (2 Day Minimum)||5
2253292|NCT02444234|5529064|P1|STARTED|Washout (2 Day Minimum)||6
2253293|NCT02444234|5529063|P2|NOT COMPLETED|First Intervention (3 Days)||0
2253294|NCT02444234|5529064|P1|NOT COMPLETED|First Intervention (3 Days)||0
2253295|NCT02444234|5529063|P2|COMPLETED|First Intervention (3 Days)||5
2253296|NCT02444234|5529064|P1|COMPLETED|First Intervention (3 Days)||6
2253297|NCT02444234|5529063|P2|STARTED|First Intervention (3 Days)||5
2253298|NCT02444234|5529064|P1|STARTED|First Intervention (3 Days)||6
2253299|NCT02444182|5529082|P2|NOT COMPLETED|Overall Study||5
2253300|NCT02444182|5529083|P1|NOT COMPLETED|Overall Study||2
2253301|NCT02444182|5529082|P2|COMPLETED|Overall Study||49
2253302|NCT02444182|5529083|P1|COMPLETED|Overall Study||52
2253303|NCT02444182|5529082|P2|STARTED|Overall Study||54
2253304|NCT02444182|5529083|P1|STARTED|Overall Study||54
2253305|NCT02444143|5529093|P2|NOT COMPLETED|Overall Study||1
2253306|NCT02444143|5529094|P1|NOT COMPLETED|Overall Study||0
2253307|NCT02444143|5529093|P2|COMPLETED|Overall Study|1 patient withdrawal|9
2253308|NCT02444143|5529094|P1|COMPLETED|Overall Study||10
2253309|NCT02444143|5529093|P2|STARTED|Overall Study||10
2253310|NCT02444143|5529094|P1|STARTED|Overall Study||10
2253311|NCT02443883|5529106|P4|NOT COMPLETED|Overall Study||7
2253312|NCT02443883|5529107|P3|NOT COMPLETED|Overall Study||4
2253313|NCT02443883|5529108|P2|NOT COMPLETED|Overall Study||5
2253314|NCT02443883|5529109|P1|NOT COMPLETED|Overall Study||6
2253315|NCT02443883|5529106|P4|COMPLETED|Overall Study||34
2253316|NCT02443883|5529107|P3|COMPLETED|Overall Study||37
2253317|NCT02443883|5529108|P2|COMPLETED|Overall Study||37
2253318|NCT02443883|5529109|P1|COMPLETED|Overall Study||34
2253319|NCT02443883|5529106|P4|Received at Least One Dose of Study Drug|Overall Study||40
2253320|NCT02443883|5529107|P3|Received at Least One Dose of Study Drug|Overall Study||41
2253321|NCT02443883|5529108|P2|Received at Least One Dose of Study Drug|Overall Study||42
2253322|NCT02443883|5529109|P1|Received at Least One Dose of Study Drug|Overall Study||38
2253323|NCT02443883|5529106|P4|STARTED|Overall Study||41
2253324|NCT02443883|5529107|P3|STARTED|Overall Study||41
2253325|NCT02443883|5529108|P2|STARTED|Overall Study||42
2253326|NCT02443883|5529109|P1|STARTED|Overall Study||40
2253327|NCT02443805|5529129|P2|NOT COMPLETED|Overall Study||127
2253328|NCT02443805|5529130|P1|NOT COMPLETED|Overall Study||213
2253329|NCT02443805|5529129|P2|COMPLETED|Overall Study||678
2253330|NCT02443805|5529130|P1|COMPLETED|Overall Study||589
2253331|NCT02443805|5529129|P2|STARTED|Overall Study||805
2253332|NCT02443805|5529130|P1|STARTED|Overall Study||802
2253333|NCT02443792|5529142|P2|NOT COMPLETED|Overall Study||2
2253334|NCT02443792|5529143|P1|NOT COMPLETED|Overall Study||7
2253335|NCT02443792|5529142|P2|COMPLETED|Overall Study||23
2253336|NCT02443792|5529143|P1|COMPLETED|Overall Study||43
2253337|NCT02443792|5529142|P2|STARTED|Overall Study||25
2253338|NCT02443792|5529143|P1|STARTED|Overall Study||50
2253339|NCT02443740|5529161|P11|NOT COMPLETED|Intervention Period 4 (3 Days)||0
2253340|NCT02443740|5529162|P10|NOT COMPLETED|Intervention Period 4 (3 Days)||0
2253341|NCT02443740|5529163|P9|NOT COMPLETED|Intervention Period 4 (3 Days)||0
2253342|NCT02443740|5529164|P8|NOT COMPLETED|Intervention Period 4 (3 Days)||0
2253343|NCT02443740|5529165|P7|NOT COMPLETED|Intervention Period 4 (3 Days)||0
2253344|NCT02443740|5529166|P6|NOT COMPLETED|Intervention Period 4 (3 Days)||0
2253345|NCT02443740|5529167|P5|NOT COMPLETED|Intervention Period 4 (3 Days)||0
2253346|NCT02443740|5529168|P4|NOT COMPLETED|Intervention Period 4 (3 Days)||0
2253347|NCT02443740|5529169|P3|NOT COMPLETED|Intervention Period 4 (3 Days)||0
2253348|NCT02443740|5529170|P2|NOT COMPLETED|Intervention Period 4 (3 Days)||0
2253349|NCT02443740|5529171|P1|NOT COMPLETED|Intervention Period 4 (3 Days)||0
2253350|NCT02443740|5529161|P11|COMPLETED|Intervention Period 4 (3 Days)||0
2253351|NCT02443740|5529162|P10|COMPLETED|Intervention Period 4 (3 Days)||0
2253352|NCT02443740|5529163|P9|COMPLETED|Intervention Period 4 (3 Days)||0
2253353|NCT02443740|5529164|P8|COMPLETED|Intervention Period 4 (3 Days)||2
2253354|NCT02443740|5529165|P7|COMPLETED|Intervention Period 4 (3 Days)||2
2253355|NCT02443740|5529166|P6|COMPLETED|Intervention Period 4 (3 Days)||2
2253356|NCT02443740|5529167|P5|COMPLETED|Intervention Period 4 (3 Days)||2
2253357|NCT02443740|5529168|P4|COMPLETED|Intervention Period 4 (3 Days)||3
2253358|NCT02443740|5529169|P3|COMPLETED|Intervention Period 4 (3 Days)||2
2253359|NCT02443740|5529170|P2|COMPLETED|Intervention Period 4 (3 Days)||2
2253360|NCT02443740|5529171|P1|COMPLETED|Intervention Period 4 (3 Days)||1
2253361|NCT02443740|5529161|P11|STARTED|Intervention Period 4 (3 Days)||0
2253362|NCT02443740|5529162|P10|STARTED|Intervention Period 4 (3 Days)||0
2253363|NCT02443740|5529163|P9|STARTED|Intervention Period 4 (3 Days)||0
2253364|NCT02443740|5529164|P8|STARTED|Intervention Period 4 (3 Days)||2
2253365|NCT02443740|5529165|P7|STARTED|Intervention Period 4 (3 Days)||2
2253366|NCT02443740|5529166|P6|STARTED|Intervention Period 4 (3 Days)||2
2253367|NCT02443740|5529167|P5|STARTED|Intervention Period 4 (3 Days)||2
2253368|NCT02443740|5529168|P4|STARTED|Intervention Period 4 (3 Days)||3
2253369|NCT02443740|5529169|P3|STARTED|Intervention Period 4 (3 Days)||2
2253370|NCT02443740|5529170|P2|STARTED|Intervention Period 4 (3 Days)||2
2253371|NCT02443740|5529171|P1|STARTED|Intervention Period 4 (3 Days)||1
2253372|NCT02443740|5529161|P11|NOT COMPLETED|Washout Period 3 (7 Days)||0
2253373|NCT02443740|5529162|P10|NOT COMPLETED|Washout Period 3 (7 Days)||0
2253374|NCT02443740|5529163|P9|NOT COMPLETED|Washout Period 3 (7 Days)||0
2253375|NCT02443740|5529164|P8|NOT COMPLETED|Washout Period 3 (7 Days)||0
2253376|NCT02443740|5529165|P7|NOT COMPLETED|Washout Period 3 (7 Days)||0
2253377|NCT02443740|5529166|P6|NOT COMPLETED|Washout Period 3 (7 Days)||0
2253378|NCT02443740|5529167|P5|NOT COMPLETED|Washout Period 3 (7 Days)||0
2253379|NCT02443740|5529168|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
2253380|NCT02443740|5529169|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
2253381|NCT02443740|5529170|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
2253382|NCT02443740|5529171|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
2253383|NCT02443740|5529161|P11|COMPLETED|Washout Period 3 (7 Days)||0
2253384|NCT02443740|5529162|P10|COMPLETED|Washout Period 3 (7 Days)||0
2253385|NCT02443740|5529163|P9|COMPLETED|Washout Period 3 (7 Days)||0
2253386|NCT02443740|5529164|P8|COMPLETED|Washout Period 3 (7 Days)||2
2253387|NCT02443740|5529165|P7|COMPLETED|Washout Period 3 (7 Days)||2
2253388|NCT02443740|5529166|P6|COMPLETED|Washout Period 3 (7 Days)||2
2253389|NCT02443740|5529167|P5|COMPLETED|Washout Period 3 (7 Days)||2
2253390|NCT02443740|5529168|P4|COMPLETED|Washout Period 3 (7 Days)||3
2253391|NCT02443740|5529169|P3|COMPLETED|Washout Period 3 (7 Days)||2
2253392|NCT02443740|5529170|P2|COMPLETED|Washout Period 3 (7 Days)||2
2253393|NCT02443740|5529171|P1|COMPLETED|Washout Period 3 (7 Days)||1
2253394|NCT02443740|5529161|P11|STARTED|Washout Period 3 (7 Days)||0
2253395|NCT02443740|5529162|P10|STARTED|Washout Period 3 (7 Days)||0
2253396|NCT02443740|5529163|P9|STARTED|Washout Period 3 (7 Days)||0
2253397|NCT02443740|5529164|P8|STARTED|Washout Period 3 (7 Days)||2
2253398|NCT02443740|5529165|P7|STARTED|Washout Period 3 (7 Days)||2
2253399|NCT02443740|5529166|P6|STARTED|Washout Period 3 (7 Days)||2
2253400|NCT02443740|5529167|P5|STARTED|Washout Period 3 (7 Days)||2
2253401|NCT02443740|5529168|P4|STARTED|Washout Period 3 (7 Days)||3
2253402|NCT02443740|5529169|P3|STARTED|Washout Period 3 (7 Days)||2
2253403|NCT02443740|5529170|P2|STARTED|Washout Period 3 (7 Days)||2
2253404|NCT02443740|5529171|P1|STARTED|Washout Period 3 (7 Days)||1
2253405|NCT02443740|5529161|P11|NOT COMPLETED|Intervention Period 3 (3 Days)||0
2253406|NCT02443740|5529162|P10|NOT COMPLETED|Intervention Period 3 (3 Days)||0
2253407|NCT02443740|5529163|P9|NOT COMPLETED|Intervention Period 3 (3 Days)||0
2253408|NCT02443740|5529164|P8|NOT COMPLETED|Intervention Period 3 (3 Days)||0
2253409|NCT02443740|5529165|P7|NOT COMPLETED|Intervention Period 3 (3 Days)||0
2253410|NCT02443740|5529166|P6|NOT COMPLETED|Intervention Period 3 (3 Days)||0
2253411|NCT02443740|5529167|P5|NOT COMPLETED|Intervention Period 3 (3 Days)||0
2253412|NCT02443740|5529168|P4|NOT COMPLETED|Intervention Period 3 (3 Days)||0
2253413|NCT02443740|5529169|P3|NOT COMPLETED|Intervention Period 3 (3 Days)||0
2253414|NCT02443740|5529170|P2|NOT COMPLETED|Intervention Period 3 (3 Days)||0
2253415|NCT02443740|5529171|P1|NOT COMPLETED|Intervention Period 3 (3 Days)||0
2253416|NCT02443740|5529161|P11|COMPLETED|Intervention Period 3 (3 Days)||0
2253417|NCT02443740|5529162|P10|COMPLETED|Intervention Period 3 (3 Days)||0
2253418|NCT02443740|5529163|P9|COMPLETED|Intervention Period 3 (3 Days)||0
2253419|NCT02443740|5529164|P8|COMPLETED|Intervention Period 3 (3 Days)||2
2253420|NCT02443740|5529165|P7|COMPLETED|Intervention Period 3 (3 Days)||2
2253421|NCT02443740|5529166|P6|COMPLETED|Intervention Period 3 (3 Days)||2
2253422|NCT02443740|5529167|P5|COMPLETED|Intervention Period 3 (3 Days)||2
2253423|NCT02443740|5529168|P4|COMPLETED|Intervention Period 3 (3 Days)||3
2253424|NCT02443740|5529169|P3|COMPLETED|Intervention Period 3 (3 Days)||2
2253425|NCT02443740|5529170|P2|COMPLETED|Intervention Period 3 (3 Days)||2
2253426|NCT02443740|5529171|P1|COMPLETED|Intervention Period 3 (3 Days)||1
2253427|NCT02443740|5529161|P11|STARTED|Intervention Period 3 (3 Days)||0
2253428|NCT02443740|5529162|P10|STARTED|Intervention Period 3 (3 Days)||0
2253429|NCT02443740|5529163|P9|STARTED|Intervention Period 3 (3 Days)||0
2253430|NCT02443740|5529164|P8|STARTED|Intervention Period 3 (3 Days)||2
2253431|NCT02443740|5529165|P7|STARTED|Intervention Period 3 (3 Days)||2
2253432|NCT02443740|5529166|P6|STARTED|Intervention Period 3 (3 Days)||2
2253433|NCT02443740|5529167|P5|STARTED|Intervention Period 3 (3 Days)||2
2253434|NCT02443740|5529168|P4|STARTED|Intervention Period 3 (3 Days)||3
2253435|NCT02443740|5529169|P3|STARTED|Intervention Period 3 (3 Days)||2
2253436|NCT02443740|5529170|P2|STARTED|Intervention Period 3 (3 Days)||2
2253437|NCT02443740|5529171|P1|STARTED|Intervention Period 3 (3 Days)||1
2253438|NCT02443740|5529161|P11|NOT COMPLETED|Washout Period 2 (7 Days)||0
2253439|NCT02443740|5529162|P10|NOT COMPLETED|Washout Period 2 (7 Days)||0
2253440|NCT02443740|5529163|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
2253441|NCT02443740|5529164|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
2253442|NCT02443740|5529165|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
2253443|NCT02443740|5529166|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
2253444|NCT02443740|5529167|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
2253445|NCT02443740|5529168|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
2253446|NCT02443740|5529169|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
2253447|NCT02443740|5529170|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
2253448|NCT02443740|5529171|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
2253449|NCT02443740|5529161|P11|COMPLETED|Washout Period 2 (7 Days)||0
2253450|NCT02443740|5529162|P10|COMPLETED|Washout Period 2 (7 Days)||0
2253451|NCT02443740|5529163|P9|COMPLETED|Washout Period 2 (7 Days)||0
2253452|NCT02443740|5529164|P8|COMPLETED|Washout Period 2 (7 Days)||2
2253453|NCT02443740|5529165|P7|COMPLETED|Washout Period 2 (7 Days)||2
2253454|NCT02443740|5529166|P6|COMPLETED|Washout Period 2 (7 Days)||2
2253455|NCT02443740|5529167|P5|COMPLETED|Washout Period 2 (7 Days)||2
2253456|NCT02443740|5529168|P4|COMPLETED|Washout Period 2 (7 Days)||3
2253457|NCT02443740|5529169|P3|COMPLETED|Washout Period 2 (7 Days)||2
2253458|NCT02443740|5529170|P2|COMPLETED|Washout Period 2 (7 Days)||2
2253459|NCT02443740|5529171|P1|COMPLETED|Washout Period 2 (7 Days)||1
2253460|NCT02443740|5529161|P11|STARTED|Washout Period 2 (7 Days)||0
2253461|NCT02443740|5529162|P10|STARTED|Washout Period 2 (7 Days)||0
2253462|NCT02443740|5529163|P9|STARTED|Washout Period 2 (7 Days)||0
2253463|NCT02443740|5529164|P8|STARTED|Washout Period 2 (7 Days)||2
2253464|NCT02443740|5529165|P7|STARTED|Washout Period 2 (7 Days)||2
2253465|NCT02443740|5529166|P6|STARTED|Washout Period 2 (7 Days)||2
2253466|NCT02443740|5529167|P5|STARTED|Washout Period 2 (7 Days)||2
2253467|NCT02443740|5529168|P4|STARTED|Washout Period 2 (7 Days)||3
2253468|NCT02443740|5529169|P3|STARTED|Washout Period 2 (7 Days)||2
2253469|NCT02443740|5529170|P2|STARTED|Washout Period 2 (7 Days)||2
2253470|NCT02443740|5529171|P1|STARTED|Washout Period 2 (7 Days)||1
2253471|NCT02443740|5529161|P11|NOT COMPLETED|Intervention Period 2 (3 Days)||0
2253472|NCT02443740|5529162|P10|NOT COMPLETED|Intervention Period 2 (3 Days)||0
2253473|NCT02443740|5529163|P9|NOT COMPLETED|Intervention Period 2 (3 Days)||0
2253474|NCT02443740|5529164|P8|NOT COMPLETED|Intervention Period 2 (3 Days)||0
2253475|NCT02443740|5529165|P7|NOT COMPLETED|Intervention Period 2 (3 Days)||0
2253476|NCT02443740|5529166|P6|NOT COMPLETED|Intervention Period 2 (3 Days)||0
2253477|NCT02443740|5529167|P5|NOT COMPLETED|Intervention Period 2 (3 Days)||0
2253478|NCT02443740|5529168|P4|NOT COMPLETED|Intervention Period 2 (3 Days)||0
2253479|NCT02443740|5529169|P3|NOT COMPLETED|Intervention Period 2 (3 Days)||0
2253480|NCT02443740|5529170|P2|NOT COMPLETED|Intervention Period 2 (3 Days)||0
2253481|NCT02443740|5529171|P1|NOT COMPLETED|Intervention Period 2 (3 Days)||0
2253482|NCT02443740|5529161|P11|COMPLETED|Intervention Period 2 (3 Days)||3
2253483|NCT02443740|5529162|P10|COMPLETED|Intervention Period 2 (3 Days)||3
2253484|NCT02443740|5529163|P9|COMPLETED|Intervention Period 2 (3 Days)||0
2253485|NCT02443740|5529164|P8|COMPLETED|Intervention Period 2 (3 Days)||2
2253486|NCT02443740|5529165|P7|COMPLETED|Intervention Period 2 (3 Days)||2
2253487|NCT02443740|5529166|P6|COMPLETED|Intervention Period 2 (3 Days)||2
2253488|NCT02443740|5529167|P5|COMPLETED|Intervention Period 2 (3 Days)||2
2253489|NCT02443740|5529168|P4|COMPLETED|Intervention Period 2 (3 Days)||3
2253490|NCT02443740|5529169|P3|COMPLETED|Intervention Period 2 (3 Days)||2
2253491|NCT02443740|5529170|P2|COMPLETED|Intervention Period 2 (3 Days)||2
2253492|NCT02443740|5529171|P1|COMPLETED|Intervention Period 2 (3 Days)||1
2253493|NCT02443740|5529161|P11|STARTED|Intervention Period 2 (3 Days)||3
2253494|NCT02443740|5529162|P10|STARTED|Intervention Period 2 (3 Days)||3
2253495|NCT02443740|5529163|P9|STARTED|Intervention Period 2 (3 Days)||0
2253496|NCT02443740|5529164|P8|STARTED|Intervention Period 2 (3 Days)||2
2253497|NCT02443740|5529165|P7|STARTED|Intervention Period 2 (3 Days)||2
2253498|NCT02443740|5529166|P6|STARTED|Intervention Period 2 (3 Days)||2
2253499|NCT02443740|5529167|P5|STARTED|Intervention Period 2 (3 Days)||2
2253500|NCT02443740|5529168|P4|STARTED|Intervention Period 2 (3 Days)||3
2253501|NCT02443740|5529169|P3|STARTED|Intervention Period 2 (3 Days)||2
2253502|NCT02443740|5529170|P2|STARTED|Intervention Period 2 (3 Days)||2
2253503|NCT02443740|5529171|P1|STARTED|Intervention Period 2 (3 Days)||1
2253504|NCT02443740|5529161|P11|NOT COMPLETED|Washout Period 1 (7 Days)||0
2253505|NCT02443740|5529162|P10|NOT COMPLETED|Washout Period 1 (7 Days)||0
2253506|NCT02443740|5529163|P9|NOT COMPLETED|Washout Period 1 (7 Days)||0
2253507|NCT02443740|5529164|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
2253508|NCT02443740|5529165|P7|NOT COMPLETED|Washout Period 1 (7 Days)||0
2253509|NCT02443740|5529166|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
2253510|NCT02443740|5529167|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
2253511|NCT02443740|5529168|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
2253512|NCT02443740|5529169|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
2253513|NCT02443740|5529170|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
2253514|NCT02443740|5529171|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
2253515|NCT02443740|5529161|P11|COMPLETED|Washout Period 1 (7 Days)||3
2253516|NCT02443740|5529162|P10|COMPLETED|Washout Period 1 (7 Days)||3
2253517|NCT02443740|5529163|P9|COMPLETED|Washout Period 1 (7 Days)||0
2253518|NCT02443740|5529164|P8|COMPLETED|Washout Period 1 (7 Days)||2
2253519|NCT02443740|5529165|P7|COMPLETED|Washout Period 1 (7 Days)||2
2253520|NCT02443740|5529166|P6|COMPLETED|Washout Period 1 (7 Days)||2
2253521|NCT02443740|5529167|P5|COMPLETED|Washout Period 1 (7 Days)||2
2253522|NCT02443740|5529168|P4|COMPLETED|Washout Period 1 (7 Days)||3
2253523|NCT02443740|5529169|P3|COMPLETED|Washout Period 1 (7 Days)||2
2253524|NCT02443740|5529170|P2|COMPLETED|Washout Period 1 (7 Days)||2
2253525|NCT02443740|5529171|P1|COMPLETED|Washout Period 1 (7 Days)||1
2253526|NCT02443740|5529161|P11|STARTED|Washout Period 1 (7 Days)||3
2253527|NCT02443740|5529162|P10|STARTED|Washout Period 1 (7 Days)||3
2253528|NCT02443740|5529163|P9|STARTED|Washout Period 1 (7 Days)||0
2253529|NCT02443740|5529164|P8|STARTED|Washout Period 1 (7 Days)||2
2253530|NCT02443740|5529165|P7|STARTED|Washout Period 1 (7 Days)||2
2253531|NCT02443740|5529166|P6|STARTED|Washout Period 1 (7 Days)||2
2253532|NCT02443740|5529167|P5|STARTED|Washout Period 1 (7 Days)||2
2253533|NCT02443740|5529168|P4|STARTED|Washout Period 1 (7 Days)||3
2253534|NCT02443740|5529169|P3|STARTED|Washout Period 1 (7 Days)||2
2253535|NCT02443740|5529170|P2|STARTED|Washout Period 1 (7 Days)||2
2253536|NCT02443740|5529171|P1|STARTED|Washout Period 1 (7 Days)||1
2253537|NCT02443740|5529161|P11|NOT COMPLETED|Intervention Period 1 (3 Days)||0
2253538|NCT02443740|5529162|P10|NOT COMPLETED|Intervention Period 1 (3 Days)||0
2253539|NCT02443740|5529163|P9|NOT COMPLETED|Intervention Period 1 (3 Days)||0
2253540|NCT02443740|5529164|P8|NOT COMPLETED|Intervention Period 1 (3 Days)||0
2253541|NCT02443740|5529165|P7|NOT COMPLETED|Intervention Period 1 (3 Days)||1
2253542|NCT02443740|5529166|P6|NOT COMPLETED|Intervention Period 1 (3 Days)||2
2253543|NCT02443740|5529167|P5|NOT COMPLETED|Intervention Period 1 (3 Days)||0
2253544|NCT02443740|5529168|P4|NOT COMPLETED|Intervention Period 1 (3 Days)||0
2253545|NCT02443740|5529169|P3|NOT COMPLETED|Intervention Period 1 (3 Days)||0
2253546|NCT02443740|5529170|P2|NOT COMPLETED|Intervention Period 1 (3 Days)||0
2253547|NCT02443740|5529171|P1|NOT COMPLETED|Intervention Period 1 (3 Days)||1
2253548|NCT02443740|5529161|P11|COMPLETED|Intervention Period 1 (3 Days)||3
2253549|NCT02443740|5529162|P10|COMPLETED|Intervention Period 1 (3 Days)||3
2253550|NCT02443740|5529163|P9|COMPLETED|Intervention Period 1 (3 Days)||6
2253551|NCT02443740|5529164|P8|COMPLETED|Intervention Period 1 (3 Days)||2
2253552|NCT02443740|5529165|P7|COMPLETED|Intervention Period 1 (3 Days)||2
2253553|NCT02443740|5529166|P6|COMPLETED|Intervention Period 1 (3 Days)||2
2253554|NCT02443740|5529167|P5|COMPLETED|Intervention Period 1 (3 Days)||2
2253555|NCT02443740|5529168|P4|COMPLETED|Intervention Period 1 (3 Days)||3
2253556|NCT02443740|5529169|P3|COMPLETED|Intervention Period 1 (3 Days)||2
2253557|NCT02443740|5529170|P2|COMPLETED|Intervention Period 1 (3 Days)||2
2253558|NCT02443740|5529171|P1|COMPLETED|Intervention Period 1 (3 Days)||1
2253559|NCT02443740|5529161|P11|STARTED|Intervention Period 1 (3 Days)||3
2253560|NCT02443740|5529162|P10|STARTED|Intervention Period 1 (3 Days)||3
2253561|NCT02443740|5529163|P9|STARTED|Intervention Period 1 (3 Days)||6
2253562|NCT02443740|5529164|P8|STARTED|Intervention Period 1 (3 Days)||2
2253563|NCT02443740|5529165|P7|STARTED|Intervention Period 1 (3 Days)||3
2253564|NCT02443740|5529166|P6|STARTED|Intervention Period 1 (3 Days)||4
2253565|NCT02443740|5529167|P5|STARTED|Intervention Period 1 (3 Days)||2
2253566|NCT02443740|5529168|P4|STARTED|Intervention Period 1 (3 Days)||3
2253567|NCT02443740|5529169|P3|STARTED|Intervention Period 1 (3 Days)||2
2253568|NCT02443740|5529170|P2|STARTED|Intervention Period 1 (3 Days)||2
2253569|NCT02443740|5529171|P1|STARTED|Intervention Period 1 (3 Days)||2
2253570|NCT02443688|5529353|P3|NOT COMPLETED|Overall Study||12
2253571|NCT02443688|5529354|P2|NOT COMPLETED|Overall Study||9
2253572|NCT02443688|5529355|P1|NOT COMPLETED|Overall Study||12
2253573|NCT02443688|5529353|P3|COMPLETED|Overall Study||55
2253574|NCT02443688|5529354|P2|COMPLETED|Overall Study||58
2253575|NCT02443688|5529355|P1|COMPLETED|Overall Study||54
2253576|NCT02443688|5529353|P3|STARTED|Overall Study||67
2253577|NCT02443688|5529354|P2|STARTED|Overall Study||67
2253578|NCT02443688|5529355|P1|STARTED|Overall Study||66
2253579|NCT02443571|5529420|P3|NOT COMPLETED|Overall Study||0
2253580|NCT02443571|5529421|P2|NOT COMPLETED|Overall Study||0
2253581|NCT02443571|5529422|P1|NOT COMPLETED|Overall Study||0
2253582|NCT02443571|5529420|P3|COMPLETED|Overall Study||23
2253583|NCT02443571|5529421|P2|COMPLETED|Overall Study||95
2253584|NCT02443571|5529422|P1|COMPLETED|Overall Study||596
2253585|NCT02443571|5529420|P3|STARTED|Overall Study||23
2253586|NCT02443571|5529421|P2|STARTED|Overall Study||95
2253587|NCT02443571|5529422|P1|STARTED|Overall Study||596
2253588|NCT02443402|5529434|P2|NOT COMPLETED|Overall Study||3
2253589|NCT02443402|5529435|P1|NOT COMPLETED|Overall Study||4
2253590|NCT02443402|5529434|P2|COMPLETED|Overall Study||28
2253591|NCT02443402|5529435|P1|COMPLETED|Overall Study||32
2253592|NCT02443402|5529434|P2|STARTED|Overall Study||31
2253593|NCT02443402|5529435|P1|STARTED|Overall Study||36
2253594|NCT02443298|5529497|P2|NOT COMPLETED|Overall Study||5
2253595|NCT02443298|5529498|P1|NOT COMPLETED|Overall Study||4
2253596|NCT02443298|5529497|P2|COMPLETED|Overall Study||104
2253597|NCT02443298|5529498|P1|COMPLETED|Overall Study||101
2253598|NCT02443298|5529497|P2|STARTED|Overall Study||109
2253599|NCT02443298|5529498|P1|STARTED|Overall Study||105
2253600|NCT02443103|5529518|P1|NOT COMPLETED|Overall Study||3
2253601|NCT02443103|5529518|P1|COMPLETED|Overall Study||1
2253602|NCT02443103|5529518|P1|STARTED|Overall Study||4
2253603|NCT02442856|5529523|P1|NOT COMPLETED|Overall Study||0
2253604|NCT02442856|5529523|P1|COMPLETED|Overall Study||21
2253605|NCT02442856|5529523|P1|STARTED|Overall Study||21
2253606|NCT02442830|5529531|P2|NOT COMPLETED|Overall Study||1
2253607|NCT02442830|5529532|P1|NOT COMPLETED|Overall Study||0
2253608|NCT02442830|5529531|P2|COMPLETED|Overall Study||44
2253609|NCT02442830|5529532|P1|COMPLETED|Overall Study||42
2253610|NCT02442830|5529531|P2|STARTED|Overall Study||45
2253611|NCT02442830|5529532|P1|STARTED|Overall Study||42
2253612|NCT02442804|5529542|P2|NOT COMPLETED|Overall Study||1
2253613|NCT02442804|5529543|P1|NOT COMPLETED|Overall Study||1
2253614|NCT02442804|5529542|P2|COMPLETED|Overall Study||7
2253615|NCT02442804|5529543|P1|COMPLETED|Overall Study||7
2253616|NCT02442804|5529542|P2|STARTED|Overall Study||8
2253617|NCT02442804|5529543|P1|STARTED|Overall Study||8
2253618|NCT02442700|5529573|P2|NOT COMPLETED|Later 12 Weeks||0
2253619|NCT02442700|5529574|P1|NOT COMPLETED|Later 12 Weeks||0
2253620|NCT02442700|5529573|P2|COMPLETED|Later 12 Weeks||12
2253621|NCT02442700|5529574|P1|COMPLETED|Later 12 Weeks||12
2253622|NCT02442700|5529573|P2|STARTED|Later 12 Weeks||12
2253623|NCT02442700|5529574|P1|STARTED|Later 12 Weeks||12
2253624|NCT02442700|5529573|P2|NOT COMPLETED|First 12 Weeks||0
2253625|NCT02442700|5529574|P1|NOT COMPLETED|First 12 Weeks||0
2253626|NCT02442700|5529573|P2|COMPLETED|First 12 Weeks||12
2253627|NCT02442700|5529574|P1|COMPLETED|First 12 Weeks||12
2253628|NCT02442700|5529573|P2|STARTED|First 12 Weeks||12
2253629|NCT02442700|5529574|P1|STARTED|First 12 Weeks||12
2253630|NCT02442687|5529585|P3|NOT COMPLETED|Overall Study||3
2253631|NCT02442687|5529586|P2|NOT COMPLETED|Overall Study||11
2253632|NCT02442687|5529587|P1|NOT COMPLETED|Overall Study||8
2253633|NCT02442687|5529585|P3|COMPLETED|Overall Study||19
2253634|NCT02442687|5529586|P2|COMPLETED|Overall Study||11
2253635|NCT02442687|5529587|P1|COMPLETED|Overall Study||13
2253636|NCT02442687|5529585|P3|STARTED|Overall Study||22
2253637|NCT02442687|5529586|P2|STARTED|Overall Study||22
2253638|NCT02442687|5529587|P1|STARTED|Overall Study||21
2253639|NCT02442349|5529648|P1|NOT COMPLETED|Overall Study||171
2253640|NCT02442349|5529648|P1|COMPLETED|Overall Study||0
2253641|NCT02442349|5529648|P1|STARTED|Overall Study||171
2253642|NCT02442310|5529653|P1|NOT COMPLETED|Overall Study||3
2253643|NCT02442310|5529653|P1|COMPLETED|Overall Study||17
2253644|NCT02442310|5529653|P1|STARTED|Overall Study||20
2253645|NCT02442284|5529675|P1|NOT COMPLETED|Overall Study||7
2253646|NCT02442284|5529675|P1|COMPLETED|Overall Study||92
2253647|NCT02442284|5529675|P1|STARTED|Overall Study||99
2253648|NCT02442271|5529682|P1|NOT COMPLETED|Overall Study||4
2253649|NCT02442271|5529682|P1|COMPLETED|Overall Study||218
2253650|NCT02442271|5529682|P1|STARTED|Overall Study||222
2253651|NCT02442206|5529708|P2|NOT COMPLETED|Period 2||0
2253652|NCT02442206|5529709|P1|NOT COMPLETED|Period 2||1
2253653|NCT02442206|5529708|P2|COMPLETED|Period 2||29
2253654|NCT02442206|5529709|P1|COMPLETED|Period 2||28
2253655|NCT02442206|5529708|P2|STARTED|Period 2||29
2253656|NCT02442206|5529709|P1|STARTED|Period 2||29
2253657|NCT02442206|5529708|P2|NOT COMPLETED|Period 1||3
2253658|NCT02442206|5529709|P1|NOT COMPLETED|Period 1||1
2253659|NCT02442206|5529708|P2|COMPLETED|Period 1||29
2253660|NCT02442206|5529709|P1|COMPLETED|Period 1||29
2253661|NCT02442206|5529708|P2|STARTED|Period 1||32
2253662|NCT02442206|5529709|P1|STARTED|Period 1||30
2253663|NCT02441946|5529741|P3|NOT COMPLETED|Extension Period (8 Weeks)||0
2253664|NCT02441946|5529742|P2|NOT COMPLETED|Extension Period (8 Weeks)||0
2253665|NCT02441946|5529743|P1|NOT COMPLETED|Extension Period (8 Weeks)||2
2253666|NCT02441946|5529741|P3|COMPLETED|Extension Period (8 Weeks)||0
2253667|NCT02441946|5529742|P2|COMPLETED|Extension Period (8 Weeks)||0
2253668|NCT02441946|5529743|P1|COMPLETED|Extension Period (8 Weeks)||40
2253669|NCT02441946|5529741|P3|STARTED|Extension Period (8 Weeks)||0
2253670|NCT02441946|5529742|P2|STARTED|Extension Period (8 Weeks)||0
2253671|NCT02441946|5529743|P1|STARTED|Extension Period (8 Weeks)|All participants who did not discontinue continued to the extension period.|42
2253672|NCT02441946|5529741|P3|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
2253673|NCT02441946|5529742|P2|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
2253674|NCT02441946|5529743|P1|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||27
2253675|NCT02441946|5529741|P3|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
2253676|NCT02441946|5529742|P2|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
2253677|NCT02441946|5529743|P1|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||190
2253678|NCT02441946|5529741|P3|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||0
2253679|NCT02441946|5529742|P2|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||0
2253680|NCT02441946|5529743|P1|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||5
2253681|NCT02441946|5529741|P3|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0
2253682|NCT02441946|5529742|P2|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0
2253683|NCT02441946|5529743|P1|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||217
2253684|NCT02441946|5529741|P3|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0
2253685|NCT02441946|5529742|P2|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0
2253686|NCT02441946|5529743|P1|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned to abemaciclib + anastrozole post cycle 1.|217
2253687|NCT02441946|5529741|P3|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
2253688|NCT02441946|5529742|P2|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
2253689|NCT02441946|5529743|P1|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||2
2253690|NCT02441946|5529741|P3|COMPLETED|Cycle 1 Period 1 (2 Weeks)||74
2253691|NCT02441946|5529742|P2|COMPLETED|Cycle 1 Period 1 (2 Weeks)||71
2253692|NCT02441946|5529743|P1|COMPLETED|Cycle 1 Period 1 (2 Weeks)||72
2253693|NCT02441946|5529741|P3|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74
2253694|NCT02441946|5529742|P2|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)|1 participant did not receive drug due to an error in randomization.|75
2253695|NCT02441946|5529743|P1|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74
2253696|NCT02441946|5529741|P3|STARTED|Cycle 1 Period 1 (2 Weeks)||74
2253697|NCT02441946|5529742|P2|STARTED|Cycle 1 Period 1 (2 Weeks)||76
2253698|NCT02441946|5529743|P1|STARTED|Cycle 1 Period 1 (2 Weeks)||74
2253699|NCT02441517|5529764|P1|NOT COMPLETED|Overall Study||4
2253700|NCT02441517|5529764|P1|COMPLETED|Overall Study||0
2253701|NCT02441517|5529764|P1|Received Treatment|Overall Study||4
2253702|NCT02441517|5529764|P1|STARTED|Overall Study||4
2253703|NCT02441309|5529777|P3|NOT COMPLETED|Overall Study||3
2253704|NCT02441309|5529778|P2|NOT COMPLETED|Overall Study||2
2253705|NCT02441309|5529779|P1|NOT COMPLETED|Overall Study||3
2253706|NCT02441309|5529777|P3|COMPLETED|Overall Study||0
2253707|NCT02441309|5529778|P2|COMPLETED|Overall Study||0
2253708|NCT02441309|5529779|P1|COMPLETED|Overall Study||0
2253709|NCT02441309|5529777|P3|Received Allocated Intervention|Overall Study||3
2253710|NCT02441309|5529778|P2|Received Allocated Intervention|Overall Study||2
2253711|NCT02441309|5529779|P1|Received Allocated Intervention|Overall Study||1
2253712|NCT02441309|5529777|P3|STARTED|Overall Study||3
2253713|NCT02441309|5529778|P2|STARTED|Overall Study||2
2253714|NCT02441309|5529779|P1|STARTED|Overall Study||3
2253715|NCT02441218|5529810|P2|NOT COMPLETED|Overall Study||612
2253716|NCT02441218|5529811|P1|NOT COMPLETED|Overall Study||578
2253717|NCT02441218|5529810|P2|COMPLETED|Overall Study||2652
2253718|NCT02441218|5529811|P1|COMPLETED|Overall Study||2663
2253719|NCT02441218|5529810|P2|STARTED|Overall Study||3264
2253720|NCT02441218|5529811|P1|STARTED|Overall Study||3241
2253721|NCT02441179|5529837|P2|NOT COMPLETED|Overall Study||1
2253722|NCT02441179|5529838|P1|NOT COMPLETED|Overall Study||1
2253723|NCT02441179|5529837|P2|COMPLETED|Overall Study||16
2253724|NCT02441179|5529838|P1|COMPLETED|Overall Study||17
2253725|NCT02441179|5529837|P2|STARTED|Overall Study||17
2253726|NCT02441179|5529838|P1|STARTED|Overall Study||18
2253727|NCT02441114|5529856|P1|NOT COMPLETED|Period3||0
2253728|NCT02441114|5529856|P1|COMPLETED|Period3||6
2253729|NCT02441114|5529856|P1|STARTED|Period3||6
2253730|NCT02441114|5529856|P1|NOT COMPLETED|Washout2||4
2253731|NCT02441114|5529856|P1|COMPLETED|Washout2||6
2253732|NCT02441114|5529856|P1|STARTED|Washout2||10
2253733|NCT02441114|5529856|P1|NOT COMPLETED|Period2||0
2253734|NCT02441114|5529856|P1|COMPLETED|Period2||10
2253735|NCT02441114|5529856|P1|STARTED|Period2||10
2253736|NCT02441114|5529856|P1|NOT COMPLETED|Washout1||0
2253737|NCT02441114|5529856|P1|COMPLETED|Washout1||10
2253738|NCT02441114|5529856|P1|STARTED|Washout1||10
2253739|NCT02441114|5529856|P1|NOT COMPLETED|Period1||0
2253740|NCT02441114|5529856|P1|COMPLETED|Period1||10
2253741|NCT02441114|5529856|P1|STARTED|Period1||10
2253742|NCT02441036|5529867|P5|NOT COMPLETED|Overall Study||0
2253743|NCT02441036|5529868|P4|NOT COMPLETED|Overall Study||1
2253744|NCT02441036|5529869|P3|NOT COMPLETED|Overall Study||0
2253745|NCT02441036|5529870|P2|NOT COMPLETED|Overall Study||1
2253746|NCT02441036|5529871|P1|NOT COMPLETED|Overall Study||0
2253747|NCT02441036|5529867|P5|COMPLETED|Overall Study||1
2253748|NCT02441036|5529868|P4|COMPLETED|Overall Study||3
2253749|NCT02441036|5529869|P3|COMPLETED|Overall Study||3
2253750|NCT02441036|5529870|P2|COMPLETED|Overall Study||4
2253751|NCT02441036|5529871|P1|COMPLETED|Overall Study||3
2253752|NCT02441036|5529867|P5|Tissue Resected|Overall Study||1
2253753|NCT02441036|5529868|P4|Tissue Resected|Overall Study||3
2253754|NCT02441036|5529869|P3|Tissue Resected|Overall Study||3
2253755|NCT02441036|5529870|P2|Tissue Resected|Overall Study||4
2253756|NCT02441036|5529871|P1|Tissue Resected|Overall Study||3
2253757|NCT02441036|5529867|P5|Treated|Overall Study||1
2253758|NCT02441036|5529868|P4|Treated|Overall Study||4
2253759|NCT02441036|5529869|P3|Treated|Overall Study||3
2253760|NCT02441036|5529870|P2|Treated|Overall Study||5
2253761|NCT02441036|5529871|P1|Treated|Overall Study||3
2253762|NCT02441036|5529867|P5|STARTED|Overall Study||1
2253763|NCT02441036|5529868|P4|STARTED|Overall Study||4
2253764|NCT02441036|5529869|P3|STARTED|Overall Study||3
2253765|NCT02441036|5529870|P2|STARTED|Overall Study||5
2253766|NCT02441036|5529871|P1|STARTED|Overall Study||3
2253767|NCT02440789|5529898|P1|NOT COMPLETED|Overall Study||4
2253768|NCT02440789|5529898|P1|COMPLETED|Overall Study||28
2253769|NCT02440789|5529898|P1|Completed 20 Weeks of Sirolimus|Overall Study||16
2253770|NCT02440789|5529898|P1|Initiated Sirolimus|Overall Study||30
2253771|NCT02440789|5529898|P1|STARTED|Overall Study||32
2253772|NCT02440659|5529949|P2|NOT COMPLETED|Overall Study||335
2253773|NCT02440659|5529950|P1|NOT COMPLETED|Overall Study||651
2253774|NCT02440659|5529949|P2|COMPLETED|Overall Study||614
2253775|NCT02440659|5529950|P1|COMPLETED|Overall Study||1346
2253776|NCT02440659|5529949|P2|STARTED|Overall Study||949
2253777|NCT02440659|5529950|P1|STARTED|Overall Study||1997
2253778|NCT02440633|5529956|P1|NOT COMPLETED|Overall Study||0
2253779|NCT02440633|5529956|P1|COMPLETED|Overall Study||8
2253780|NCT02440633|5529956|P1|STARTED|Overall Study||8
2253781|NCT02440594|5529973|P8|NOT COMPLETED|Overall Study||56
2253782|NCT02440594|5529974|P7|NOT COMPLETED|Overall Study||37
2253783|NCT02440594|5529975|P6|NOT COMPLETED|Overall Study||7
2253784|NCT02440594|5529976|P5|NOT COMPLETED|Overall Study||9
2253785|NCT02440594|5529977|P4|NOT COMPLETED|Overall Study||89
2253786|NCT02440594|5529978|P3|NOT COMPLETED|Overall Study||117
2253787|NCT02440594|5529979|P2|NOT COMPLETED|Overall Study||108
2253788|NCT02440594|5529980|P1|NOT COMPLETED|Overall Study||132
2253789|NCT02440594|5529973|P8|COMPLETED|Overall Study||234
2253790|NCT02440594|5529974|P7|COMPLETED|Overall Study||113
2253791|NCT02440594|5529975|P6|COMPLETED|Overall Study||47
2253792|NCT02440594|5529976|P5|COMPLETED|Overall Study||46
2253793|NCT02440594|5529977|P4|COMPLETED|Overall Study||340
2253794|NCT02440594|5529978|P3|COMPLETED|Overall Study||319
2253795|NCT02440594|5529979|P2|COMPLETED|Overall Study||401
2253796|NCT02440594|5529980|P1|COMPLETED|Overall Study||377
2253797|NCT02440594|5529973|P8|STARTED|Overall Study||290
2253798|NCT02440594|5529974|P7|STARTED|Overall Study||150
2253799|NCT02440594|5529975|P6|STARTED|Overall Study||54
2253800|NCT02440594|5529976|P5|STARTED|Overall Study||55
2253801|NCT02440594|5529977|P4|STARTED|Overall Study||429
2253802|NCT02440594|5529978|P3|STARTED|Overall Study||436
2253803|NCT02440594|5529979|P2|STARTED|Overall Study||509
2253804|NCT02440594|5529980|P1|STARTED|Overall Study||509
2253805|NCT02440451|5530012|P1|NOT COMPLETED|Overall Study||0
2253806|NCT02440451|5530012|P1|COMPLETED|Overall Study||15
2253807|NCT02440451|5530012|P1|STARTED|Overall Study||15
2253808|NCT02440334|5530018|P1|NOT COMPLETED|Overall Study||0
2253809|NCT02440334|5530018|P1|COMPLETED|Overall Study||53
2253810|NCT02440334|5530018|P1|STARTED|Overall Study||53
2253811|NCT02440308|5530022|P1|NOT COMPLETED|Overall Study||0
2253812|NCT02440308|5530022|P1|COMPLETED|Overall Study||10
2253813|NCT02440308|5530022|P1|STARTED|Overall Study||10
2253814|NCT02440204|5530030|P3|NOT COMPLETED|Overall Study||0
2253815|NCT02440204|5530031|P2|NOT COMPLETED|Overall Study||0
2253816|NCT02440204|5530032|P1|NOT COMPLETED|Overall Study||0
2253817|NCT02440204|5530030|P3|COMPLETED|Overall Study||22
2253818|NCT02440204|5530031|P2|COMPLETED|Overall Study||24
2253819|NCT02440204|5530032|P1|COMPLETED|Overall Study||22
2253820|NCT02440204|5530030|P3|STARTED|Overall Study||22
2253821|NCT02440204|5530031|P2|STARTED|Overall Study||24
2253822|NCT02440204|5530032|P1|STARTED|Overall Study||22
2253823|NCT02439879|5530045|P2|NOT COMPLETED|Overall Study||0
2253824|NCT02439879|5530046|P1|NOT COMPLETED|Overall Study||0
2253825|NCT02439879|5530045|P2|COMPLETED|Overall Study||17
2253826|NCT02439879|5530046|P1|COMPLETED|Overall Study||16
2253827|NCT02439879|5530045|P2|STARTED|Overall Study||17
2253828|NCT02439879|5530046|P1|STARTED|Overall Study||16
2253829|NCT02439814|5530054|P2|NOT COMPLETED|Overall Study||0
2253830|NCT02439814|5530055|P1|NOT COMPLETED|Overall Study||0
2253831|NCT02439814|5530054|P2|COMPLETED|Overall Study||10
2253832|NCT02439814|5530055|P1|COMPLETED|Overall Study||11
2253833|NCT02439814|5530054|P2|STARTED|Overall Study||10
2253834|NCT02439814|5530055|P1|STARTED|Overall Study||11
2253835|NCT02439710|5530061|P1|NOT COMPLETED|Overall Study||0
2253836|NCT02439710|5530061|P1|COMPLETED|Overall Study||656
2253837|NCT02439710|5530061|P1|STARTED|Overall Study||656
2253838|NCT02439320|5530070|P3|NOT COMPLETED|Overall Study||99
2253839|NCT02439320|5530071|P2|NOT COMPLETED|Overall Study||114
2253840|NCT02439320|5530072|P1|NOT COMPLETED|Overall Study||96
2253841|NCT02439320|5530070|P3|COMPLETED|Overall Study||643
2253842|NCT02439320|5530071|P2|COMPLETED|Overall Study||631
2253843|NCT02439320|5530072|P1|COMPLETED|Overall Study||648
2253844|NCT02439320|5530070|P3|2nd Dose (After 2 Hour Assessment)|Overall Study||401
2253845|NCT02439320|5530071|P2|2nd Dose (After 2 Hour Assessment)|Overall Study||238
2253846|NCT02439320|5530072|P1|2nd Dose (After 2 Hour Assessment)|Overall Study||289
2253847|NCT02439320|5530070|P3|1st Dose (by 4 Hours Migraine Onset)|Overall Study||617
2253848|NCT02439320|5530071|P2|1st Dose (by 4 Hours Migraine Onset)|Overall Study||609
2253849|NCT02439320|5530072|P1|1st Dose (by 4 Hours Migraine Onset)|Overall Study||630
2253850|NCT02439320|5530070|P3|Confirmed Eligibility|Overall Study||705
2253851|NCT02439320|5530071|P2|Confirmed Eligibility|Overall Study||695
2253852|NCT02439320|5530072|P1|Confirmed Eligibility|Overall Study||710
2253853|NCT02439320|5530070|P3|STARTED|Overall Study||742
2253854|NCT02439320|5530071|P2|STARTED|Overall Study||745
2253855|NCT02439320|5530072|P1|STARTED|Overall Study||744
2253856|NCT02439281|5530117|P2|NOT COMPLETED|Overall Study||0
2253857|NCT02439281|5530118|P1|NOT COMPLETED|Overall Study||0
2253858|NCT02439281|5530117|P2|COMPLETED|Overall Study||26
2253859|NCT02439281|5530118|P1|COMPLETED|Overall Study||24
2253860|NCT02439281|5530117|P2|STARTED|Overall Study||26
2253861|NCT02439281|5530118|P1|STARTED|Overall Study||24
2253862|NCT02439164|5530138|P2|NOT COMPLETED|Overall Study||0
2253863|NCT02439164|5530139|P1|NOT COMPLETED|Overall Study||0
2253864|NCT02439164|5530138|P2|COMPLETED|Overall Study||18
2253865|NCT02439164|5530139|P1|COMPLETED|Overall Study||18
2253866|NCT02439164|5530138|P2|STARTED|Overall Study||18
2253867|NCT02439164|5530139|P1|STARTED|Overall Study||18
2253868|NCT02439138|5530152|P1|NOT COMPLETED|Overall Study||3
2253869|NCT02439138|5530152|P1|COMPLETED|Overall Study||2
2253870|NCT02439138|5530152|P1|STARTED|Overall Study||5
2253871|NCT02438826|5530165|P2|NOT COMPLETED|Overall Study||4
2253872|NCT02438826|5530166|P1|NOT COMPLETED|Overall Study||6
2253873|NCT02438826|5530165|P2|COMPLETED|Overall Study||113
2253874|NCT02438826|5530166|P1|COMPLETED|Overall Study||117
2253875|NCT02438826|5530165|P2|Received at Least 1 Dose of Study Drug|Overall Study||117
2253876|NCT02438826|5530166|P1|Received at Least 1 Dose of Study Drug|Overall Study||120
2253877|NCT02438826|5530165|P2|STARTED|Overall Study||117
2253878|NCT02438826|5530166|P1|STARTED|Overall Study||123
2253879|NCT02438813|5530194|P1|NOT COMPLETED|Overall Study||525
2253880|NCT02438813|5530194|P1|COMPLETED|Overall Study||504
2253881|NCT02438813|5530194|P1|Did Not ReceiveTreatment for SMF|Overall Study||353
2253882|NCT02438813|5530194|P1|Received Treatment for SMF|Overall Study||676
2253883|NCT02438813|5530194|P1|STARTED|Overall Study||1029
2253884|NCT02438787|5530246|P3|NOT COMPLETED|Overall Study||83
2253885|NCT02438787|5530247|P2|NOT COMPLETED|Overall Study||83
2253886|NCT02438787|5530248|P1|NOT COMPLETED|Overall Study||81
2253887|NCT02438787|5530246|P3|COMPLETED|Overall Study||22
2253888|NCT02438787|5530247|P2|COMPLETED|Overall Study||23
2253889|NCT02438787|5530248|P1|COMPLETED|Overall Study||23
2253890|NCT02438787|5530246|P3|Cross Over at Week 24|Overall Study||0
2253891|NCT02438787|5530247|P2|Cross Over at Week 24|Overall Study||0
2253892|NCT02438787|5530248|P1|Cross Over at Week 24|Overall Study|Out of 43: crossed over to Ustekinumab 45 mg (n=21) and Ustekinumab 90 mg (n=22)|43
2253893|NCT02438787|5530246|P3|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|20
2253986|NCT02437318|5530758|P1|Untreated (Protocol Deviation)|Overall Study||0
2253894|NCT02438787|5530247|P2|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
2253895|NCT02438787|5530248|P1|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
2253896|NCT02438787|5530246|P3|STARTED|Overall Study||105
2253897|NCT02438787|5530247|P2|STARTED|Overall Study||106
2253898|NCT02438787|5530248|P1|STARTED|Overall Study||104
2253899|NCT02438540|5530293|P2|NOT COMPLETED|Overall Study||0
2253900|NCT02438540|5530294|P1|NOT COMPLETED|Overall Study||0
2253901|NCT02438540|5530293|P2|COMPLETED|Overall Study||20
2253902|NCT02438540|5530294|P1|COMPLETED|Overall Study||19
2253903|NCT02438540|5530293|P2|STARTED|Overall Study||20
2253904|NCT02438540|5530294|P1|STARTED|Overall Study||19
2253905|NCT02438423|5530338|P4|NOT COMPLETED|Overall Study||0
2253906|NCT02438423|5530339|P3|NOT COMPLETED|Overall Study||0
2253907|NCT02438423|5530340|P2|NOT COMPLETED|Overall Study||0
2253908|NCT02438423|5530341|P1|NOT COMPLETED|Overall Study||0
2253909|NCT02438423|5530338|P4|COMPLETED|Overall Study||25
2253910|NCT02438423|5530339|P3|COMPLETED|Overall Study||25
2253911|NCT02438423|5530340|P2|COMPLETED|Overall Study||25
2253912|NCT02438423|5530341|P1|COMPLETED|Overall Study||25
2253913|NCT02438423|5530338|P4|STARTED|Overall Study||25
2253914|NCT02438423|5530339|P3|STARTED|Overall Study||25
2253915|NCT02438423|5530340|P2|STARTED|Overall Study||25
2253916|NCT02438423|5530341|P1|STARTED|Overall Study||25
2253917|NCT02438280|5530367|P2|NOT COMPLETED|Overall Study||0
2253918|NCT02438280|5530368|P1|NOT COMPLETED|Overall Study||1
2253919|NCT02438280|5530367|P2|COMPLETED|Overall Study||13
2253920|NCT02438280|5530368|P1|COMPLETED|Overall Study||13
2253921|NCT02438280|5530367|P2|STARTED|Overall Study||13
2253922|NCT02438280|5530368|P1|STARTED|Overall Study||14
2253923|NCT02438137|5530378|P2|NOT COMPLETED|Overall Study||6
2253924|NCT02438137|5530379|P1|NOT COMPLETED|Overall Study||8
2253925|NCT02438137|5530378|P2|COMPLETED|Overall Study||15
2253926|NCT02438137|5530379|P1|COMPLETED|Overall Study||36
2253927|NCT02438137|5530378|P2|STARTED|Overall Study||21
2253928|NCT02438137|5530379|P1|STARTED|Overall Study||44
2253929|NCT02437903|5530387|P1|NOT COMPLETED|Overall Study||5
2253930|NCT02437903|5530387|P1|COMPLETED|Overall Study||25
2253931|NCT02437903|5530387|P1|STARTED|Overall Study||30
2253932|NCT02437890|5530400|P5|NOT COMPLETED|Overall Study||16
2253933|NCT02437890|5530401|P4|NOT COMPLETED|Overall Study||22
2253934|NCT02437890|5530402|P3|NOT COMPLETED|Overall Study||15
2253935|NCT02437890|5530403|P2|NOT COMPLETED|Overall Study||16
2253936|NCT02437890|5530404|P1|NOT COMPLETED|Overall Study||8
2253937|NCT02437890|5530400|P5|COMPLETED|Overall Study||46
2253938|NCT02437890|5530401|P4|COMPLETED|Overall Study||40
2253939|NCT02437890|5530402|P3|COMPLETED|Overall Study||47
2253940|NCT02437890|5530403|P2|COMPLETED|Overall Study||48
2253941|NCT02437890|5530404|P1|COMPLETED|Overall Study||54
2253942|NCT02437890|5530400|P5|STARTED|Overall Study||62
2253943|NCT02437890|5530401|P4|STARTED|Overall Study||62
2253944|NCT02437890|5530402|P3|STARTED|Overall Study||62
2253945|NCT02437890|5530403|P2|STARTED|Overall Study||64
2253946|NCT02437890|5530404|P1|STARTED|Overall Study||62
2253947|NCT02437864|5530617|P2|NOT COMPLETED|Overall Study||0
2253948|NCT02437864|5530618|P1|NOT COMPLETED|Overall Study||4
2253949|NCT02437864|5530617|P2|COMPLETED|Overall Study||160
2253950|NCT02437864|5530618|P1|COMPLETED|Overall Study||196
2253951|NCT02437864|5530617|P2|STARTED|Overall Study||160
2253952|NCT02437864|5530618|P1|STARTED|Overall Study||200
2253953|NCT02437669|5530632|P1|NOT COMPLETED|Overall Study||0
2253954|NCT02437669|5530632|P1|COMPLETED|Overall Study||35
2253955|NCT02437669|5530632|P1|STARTED|Overall Study||35
2253956|NCT02437513|5530639|P1|NOT COMPLETED|Overall Study||2
2253957|NCT02437513|5530639|P1|COMPLETED|Overall Study||0
2253958|NCT02437513|5530639|P1|STARTED|Overall Study||2
2253959|NCT02437487|5530649|P2|NOT COMPLETED|Overall Study||14
2253960|NCT02437487|5530650|P1|NOT COMPLETED|Overall Study||27
2253961|NCT02437487|5530649|P2|COMPLETED|Overall Study||16
2253962|NCT02437487|5530650|P1|COMPLETED|Overall Study||32
2253963|NCT02437487|5530649|P2|Intention-to-Treat Population|Overall Study||30
2253964|NCT02437487|5530650|P1|Intention-to-Treat Population|Overall Study||59
2253965|NCT02437487|5530649|P2|Actual Treatment Received|Overall Study||29
2253966|NCT02437487|5530650|P1|Actual Treatment Received|Overall Study||60
2253967|NCT02437487|5530649|P2|STARTED|Overall Study||30
2253968|NCT02437487|5530650|P1|STARTED|Overall Study||59
2253969|NCT02437409|5530664|P1|NOT COMPLETED|Overall Study||15
2253970|NCT02437409|5530664|P1|COMPLETED|Overall Study|In total 100 patients fulfilled the in-and exclusion criteria,15 patients were excluded/discontinued|100
2253971|NCT02437409|5530664|P1|STARTED|Overall Study|Eventually 100 evaluable patients, attrition rate of 15%|115
2253972|NCT02437383|5530675|P2|NOT COMPLETED|Overall Study||13
2253973|NCT02437383|5530676|P1|NOT COMPLETED|Overall Study||13
2253974|NCT02437383|5530675|P2|COMPLETED|Overall Study||87
2253975|NCT02437383|5530676|P1|COMPLETED|Overall Study||87
2253976|NCT02437383|5530675|P2|STARTED|Overall Study||100
2253977|NCT02437383|5530676|P1|STARTED|Overall Study||100
2253978|NCT02437344|5530750|P1|NOT COMPLETED|Overall Study||1
2253979|NCT02437344|5530750|P1|COMPLETED|Overall Study||15
2253980|NCT02437344|5530750|P1|STARTED|Overall Study||16
2253981|NCT02437318|5530757|P2|NOT COMPLETED|Overall Study||242
2253982|NCT02437318|5530758|P1|NOT COMPLETED|Overall Study||229
2253983|NCT02437318|5530757|P2|COMPLETED|Overall Study||46
2253984|NCT02437318|5530758|P1|COMPLETED|Overall Study||55
2253985|NCT02437318|5530757|P2|Untreated (Protocol Deviation)|Overall Study||1
2253987|NCT02437318|5530757|P2|End of Treatment (Didn't Complete)|Overall Study||241
2253988|NCT02437318|5530758|P1|End of Treatment (Didn't Complete)|Overall Study||229
2253989|NCT02437318|5530757|P2|STARTED|Overall Study||288
2253990|NCT02437318|5530758|P1|STARTED|Overall Study||284
2253991|NCT02437305|5530766|P2|NOT COMPLETED|Overall Study||12
2253992|NCT02437305|5530767|P1|NOT COMPLETED|Overall Study||18
2253993|NCT02437305|5530766|P2|COMPLETED|Overall Study||38
2253994|NCT02437305|5530767|P1|COMPLETED|Overall Study||32
2253995|NCT02437305|5530766|P2|STARTED|Overall Study||50
2253996|NCT02437305|5530767|P1|STARTED|Overall Study||50
2253997|NCT02437253|5530777|P2|NOT COMPLETED|Overall Study||0
2253998|NCT02437253|5530778|P1|NOT COMPLETED|Overall Study||0
2253999|NCT02437253|5530777|P2|COMPLETED|Overall Study||1
2254000|NCT02437253|5530778|P1|COMPLETED|Overall Study||1
2254001|NCT02437253|5530777|P2|STARTED|Overall Study||1
2254002|NCT02437253|5530778|P1|STARTED|Overall Study||1
2254003|NCT02437188|5530794|P2|NOT COMPLETED|Overall Study||9
2254004|NCT02437188|5530795|P1|NOT COMPLETED|Overall Study||4
2254005|NCT02437188|5530794|P2|COMPLETED|Overall Study||35
2254006|NCT02437188|5530795|P1|COMPLETED|Overall Study||40
2254007|NCT02437188|5530794|P2|STARTED|Overall Study||44
2254008|NCT02437188|5530795|P1|STARTED|Overall Study||44
2254009|NCT02437162|5530812|P3|NOT COMPLETED|Overall Study||109
2254010|NCT02437162|5530813|P2|NOT COMPLETED|Overall Study||108
2254011|NCT02437162|5530814|P1|NOT COMPLETED|Overall Study||107
2254012|NCT02437162|5530812|P3|COMPLETED|Overall Study||6
2254013|NCT02437162|5530813|P2|COMPLETED|Overall Study||8
2254014|NCT02437162|5530814|P1|COMPLETED|Overall Study||9
2254015|NCT02437162|5530812|P3|Cross Over at Week 24|Overall Study||0
2254016|NCT02437162|5530813|P2|Cross Over at Week 24|Overall Study||0
2254017|NCT02437162|5530814|P1|Cross Over at Week 24|Overall Study|Out of 87: crossed over to Ustekinumab 45 mg (n=44) and Ustekinumab 90 mg (n=43)|87
2254018|NCT02437162|5530812|P3|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|14
2254019|NCT02437162|5530813|P2|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
2254020|NCT02437162|5530814|P1|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|26
2254021|NCT02437162|5530812|P3|Treated|Overall Study||114
2254022|NCT02437162|5530813|P2|Treated|Overall Study||116
2254023|NCT02437162|5530814|P1|Treated|Overall Study||116
2254024|NCT02437162|5530812|P3|STARTED|Overall Study||115
2254025|NCT02437162|5530813|P2|STARTED|Overall Study||116
2254026|NCT02437162|5530814|P1|STARTED|Overall Study||116
2254027|NCT02436915|5530934|P2|NOT COMPLETED|Overall Study||1
2254028|NCT02436915|5530935|P1|NOT COMPLETED|Overall Study||0
2254029|NCT02436915|5530934|P2|COMPLETED|Overall Study||9
2254030|NCT02436915|5530935|P1|COMPLETED|Overall Study||9
2254031|NCT02436915|5530934|P2|STARTED|Overall Study||10
2254032|NCT02436915|5530935|P1|STARTED|Overall Study||9
2254033|NCT02436889|5530957|P2|NOT COMPLETED|Overall Study||1
2254034|NCT02436889|5530958|P1|NOT COMPLETED|Overall Study||1
2254035|NCT02436889|5530957|P2|COMPLETED|Overall Study||10
2254036|NCT02436889|5530958|P1|COMPLETED|Overall Study||11
2254037|NCT02436889|5530957|P2|STARTED|Overall Study||11
2254038|NCT02436889|5530958|P1|STARTED|Overall Study||12
2254039|NCT02436811|5530977|P3|NOT COMPLETED|Overall Study||7
2254040|NCT02436811|5530978|P2|NOT COMPLETED|Overall Study||9
2254041|NCT02436811|5530979|P1|NOT COMPLETED|Overall Study||2
2254042|NCT02436811|5530977|P3|COMPLETED|Overall Study||53
2254043|NCT02436811|5530978|P2|COMPLETED|Overall Study||51
2254044|NCT02436811|5530979|P1|COMPLETED|Overall Study||58
2254045|NCT02436811|5530977|P3|STARTED|Overall Study||60
2254046|NCT02436811|5530978|P2|STARTED|Overall Study||60
2254047|NCT02436811|5530979|P1|STARTED|Overall Study||60
2254048|NCT02436681|5530987|P1|NOT COMPLETED|Overall Study||14
2254049|NCT02436681|5530987|P1|COMPLETED|Overall Study||27
2254050|NCT02436681|5530987|P1|STARTED|Overall Study||41
2254051|NCT02436577|5531004|P6|NOT COMPLETED|Overall Study||0
2254052|NCT02436577|5531005|P5|NOT COMPLETED|Overall Study||0
2254053|NCT02436577|5531006|P4|NOT COMPLETED|Overall Study||0
2254054|NCT02436577|5531007|P3|NOT COMPLETED|Overall Study||0
2254055|NCT02436577|5531008|P2|NOT COMPLETED|Overall Study||1
2254056|NCT02436577|5531009|P1|NOT COMPLETED|Overall Study||0
2254057|NCT02436577|5531004|P6|COMPLETED|Overall Study||7
2254058|NCT02436577|5531005|P5|COMPLETED|Overall Study||7
2254059|NCT02436577|5531006|P4|COMPLETED|Overall Study||7
2254060|NCT02436577|5531007|P3|COMPLETED|Overall Study||7
2254061|NCT02436577|5531008|P2|COMPLETED|Overall Study||6
2254062|NCT02436577|5531009|P1|COMPLETED|Overall Study||7
2254063|NCT02436577|5531004|P6|STARTED|Overall Study||7
2254064|NCT02436577|5531005|P5|STARTED|Overall Study||7
2254065|NCT02436577|5531006|P4|STARTED|Overall Study||7
2254066|NCT02436577|5531007|P3|STARTED|Overall Study||7
2254067|NCT02436577|5531008|P2|STARTED|Overall Study||7
2254068|NCT02436577|5531009|P1|STARTED|Overall Study||7
2254069|NCT02436330|5531064|P2|NOT COMPLETED|Cohort 6||1
2254070|NCT02436330|5531065|P1|NOT COMPLETED|Cohort 6||3
2254071|NCT02436330|5531064|P2|COMPLETED|Cohort 6||4
2254072|NCT02436330|5531065|P1|COMPLETED|Cohort 6||1
2254073|NCT02436330|5531064|P2|STARTED|Cohort 6||5
2254074|NCT02436330|5531065|P1|STARTED|Cohort 6||4
2254075|NCT02436330|5531064|P2|NOT COMPLETED|Cohort 5||4
2254076|NCT02436330|5531065|P1|NOT COMPLETED|Cohort 5||6
2254077|NCT02436330|5531064|P2|COMPLETED|Cohort 5||1
2254078|NCT02436330|5531065|P1|COMPLETED|Cohort 5||4
2254079|NCT02436330|5531064|P2|STARTED|Cohort 5||5
2254080|NCT02436330|5531065|P1|STARTED|Cohort 5||10
2254081|NCT02436330|5531064|P2|NOT COMPLETED|Cohort 4||0
2254082|NCT02436330|5531065|P1|NOT COMPLETED|Cohort 4||2
2254083|NCT02436330|5531064|P2|COMPLETED|Cohort 4||0
2254084|NCT02436330|5531065|P1|COMPLETED|Cohort 4||4
2254085|NCT02436330|5531064|P2|STARTED|Cohort 4|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
2254086|NCT02436330|5531065|P1|STARTED|Cohort 4||6
2254087|NCT02436330|5531064|P2|NOT COMPLETED|Cohort 3||0
2254088|NCT02436330|5531065|P1|NOT COMPLETED|Cohort 3||5
2254089|NCT02436330|5531064|P2|COMPLETED|Cohort 3||0
2254090|NCT02436330|5531065|P1|COMPLETED|Cohort 3||7
2254091|NCT02436330|5531064|P2|STARTED|Cohort 3|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
2254092|NCT02436330|5531065|P1|STARTED|Cohort 3||12
2254093|NCT02436330|5531064|P2|NOT COMPLETED|Cohort 2||3
2254094|NCT02436330|5531065|P1|NOT COMPLETED|Cohort 2||4
2254095|NCT02436330|5531064|P2|COMPLETED|Cohort 2||7
2254096|NCT02436330|5531065|P1|COMPLETED|Cohort 2||10
2254097|NCT02436330|5531064|P2|STARTED|Cohort 2||10
2254098|NCT02436330|5531065|P1|STARTED|Cohort 2||14
2254099|NCT02436330|5531064|P2|NOT COMPLETED|Cohort 1||3
2254100|NCT02436330|5531065|P1|NOT COMPLETED|Cohort 1||5
2254101|NCT02436330|5531064|P2|COMPLETED|Cohort 1||1
2254102|NCT02436330|5531065|P1|COMPLETED|Cohort 1||9
2254103|NCT02436330|5531064|P2|STARTED|Cohort 1||4
2254104|NCT02436330|5531065|P1|STARTED|Cohort 1||14
2254105|NCT02436304|5531110|P3|NOT COMPLETED|Overall Study||1
2254106|NCT02436304|5531111|P2|NOT COMPLETED|Overall Study||2
2254107|NCT02436304|5531112|P1|NOT COMPLETED|Overall Study||0
2254108|NCT02436304|5531110|P3|COMPLETED|Overall Study||100
2254109|NCT02436304|5531111|P2|COMPLETED|Overall Study||100
2254110|NCT02436304|5531112|P1|COMPLETED|Overall Study||153
2254111|NCT02436304|5531110|P3|STARTED|Overall Study||101
2254112|NCT02436304|5531111|P2|STARTED|Overall Study||102
2254113|NCT02436304|5531112|P1|STARTED|Overall Study||153
2254114|NCT02436239|5531131|P4|NOT COMPLETED|Down-Taper Period||2
2254115|NCT02436239|5531132|P3|NOT COMPLETED|Down-Taper Period||1
2254116|NCT02436239|5531133|P2|NOT COMPLETED|Down-Taper Period||4
2254117|NCT02436239|5531134|P1|NOT COMPLETED|Down-Taper Period||4
2254118|NCT02436239|5531131|P4|COMPLETED|Down-Taper Period||4
2254119|NCT02436239|5531132|P3|COMPLETED|Down-Taper Period||43
2254120|NCT02436239|5531133|P2|COMPLETED|Down-Taper Period||99
2254121|NCT02436239|5531134|P1|COMPLETED|Down-Taper Period||86
2254122|NCT02436239|5531131|P4|STARTED|Down-Taper Period|One participant who completed the open-label treatment period did not enter the down-taper period.|6
2254123|NCT02436239|5531132|P3|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|44
2254124|NCT02436239|5531133|P2|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|103
2254125|NCT02436239|5531134|P1|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|90
2254126|NCT02436239|5531131|P4|NOT COMPLETED|Open-Lable Treatment Period||5
2254127|NCT02436239|5531132|P3|NOT COMPLETED|Open-Lable Treatment Period||27
2254128|NCT02436239|5531133|P2|NOT COMPLETED|Open-Lable Treatment Period||34
2254129|NCT02436239|5531134|P1|NOT COMPLETED|Open-Lable Treatment Period||33
2254130|NCT02436239|5531131|P4|COMPLETED|Open-Lable Treatment Period||7
2254131|NCT02436239|5531132|P3|COMPLETED|Open-Lable Treatment Period||38
2254132|NCT02436239|5531133|P2|COMPLETED|Open-Lable Treatment Period||97
2254133|NCT02436239|5531134|P1|COMPLETED|Open-Lable Treatment Period||89
2254134|NCT02436239|5531131|P4|STARTED|Open-Lable Treatment Period||12
2254135|NCT02436239|5531132|P3|STARTED|Open-Lable Treatment Period||65
2254136|NCT02436239|5531133|P2|STARTED|Open-Lable Treatment Period||131
2254137|NCT02436239|5531134|P1|STARTED|Open-Lable Treatment Period||122
2254138|NCT02436200|5531156|P1|NOT COMPLETED|Overall Study||1
2254139|NCT02436200|5531156|P1|COMPLETED|Overall Study||20
2254140|NCT02436200|5531156|P1|STARTED|Overall Study||21
2254141|NCT02436031|5531161|P2|NOT COMPLETED|Second Study Night||0
2254142|NCT02436031|5531162|P1|NOT COMPLETED|Second Study Night||0
2254143|NCT02436031|5531161|P2|COMPLETED|Second Study Night||8
2254144|NCT02436031|5531162|P1|COMPLETED|Second Study Night||7
2254145|NCT02436031|5531161|P2|STARTED|Second Study Night||8
2254146|NCT02436031|5531162|P1|STARTED|Second Study Night|1 participant did not tolerate the study setup so did not participate in the second study night|7
2254147|NCT02436031|5531161|P2|NOT COMPLETED|First Study Night||0
2254148|NCT02436031|5531162|P1|NOT COMPLETED|First Study Night||0
2254149|NCT02436031|5531161|P2|COMPLETED|First Study Night||8
2254150|NCT02436031|5531162|P1|COMPLETED|First Study Night||8
2254151|NCT02436031|5531161|P2|STARTED|First Study Night||8
2254152|NCT02436031|5531162|P1|STARTED|First Study Night||8
2254153|NCT02435966|5531175|P3|NOT COMPLETED|Overall Study||0
2254154|NCT02435966|5531176|P2|NOT COMPLETED|Overall Study||1
2254155|NCT02435966|5531177|P1|NOT COMPLETED|Overall Study||0
2254156|NCT02435966|5531175|P3|COMPLETED|Overall Study||30
2254157|NCT02435966|5531176|P2|COMPLETED|Overall Study||53
2254158|NCT02435966|5531177|P1|COMPLETED|Overall Study||47
2254159|NCT02435966|5531175|P3|Follow-up|Overall Study||30
2254160|NCT02435966|5531176|P2|Follow-up|Overall Study||53
2254161|NCT02435966|5531177|P1|Follow-up|Overall Study||47
2254162|NCT02435966|5531175|P3|Second Intervention|Overall Study||30
2254163|NCT02435966|5531176|P2|Second Intervention|Overall Study||53
2254164|NCT02435966|5531177|P1|Second Intervention|Overall Study||47
2254165|NCT02435966|5531175|P3|First Intervention|Overall Study||30
2254166|NCT02435966|5531176|P2|First Intervention|Overall Study||54
2254167|NCT02435966|5531177|P1|First Intervention|Overall Study||47
2254168|NCT02435966|5531175|P3|STARTED|Overall Study||30
2254169|NCT02435966|5531176|P2|STARTED|Overall Study||54
2254170|NCT02435966|5531177|P1|STARTED|Overall Study||47
2254171|NCT02435914|5531189|P4|NOT COMPLETED|Overall Study||0
2254172|NCT02435914|5531190|P3|NOT COMPLETED|Overall Study||1
2254173|NCT02435914|5531191|P2|NOT COMPLETED|Overall Study||1
2254174|NCT02435914|5531192|P1|NOT COMPLETED|Overall Study||1
2254175|NCT02435914|5531189|P4|COMPLETED|Overall Study||59
2254176|NCT02435914|5531190|P3|COMPLETED|Overall Study||59
2254177|NCT02435914|5531191|P2|COMPLETED|Overall Study||58
2254178|NCT02435914|5531192|P1|COMPLETED|Overall Study||57
2254179|NCT02435914|5531189|P4|STARTED|Overall Study||59
2254180|NCT02435914|5531190|P3|STARTED|Overall Study||60
2254181|NCT02435914|5531191|P2|STARTED|Overall Study||59
2254182|NCT02435914|5531192|P1|STARTED|Overall Study||58
2254183|NCT02435836|5531214|P1|NOT COMPLETED|Overall Study||631
2254184|NCT02435836|5531214|P1|COMPLETED|Overall Study||0
2254185|NCT02435836|5531214|P1|STARTED|Overall Study||631
2254186|NCT02435706|5531232|P2|NOT COMPLETED|Overall Study||1
2254187|NCT02435706|5531233|P1|NOT COMPLETED|Overall Study||2
2254188|NCT02435706|5531232|P2|COMPLETED|Overall Study||20
2254189|NCT02435706|5531233|P1|COMPLETED|Overall Study||16
2254190|NCT02435706|5531232|P2|STARTED|Overall Study||21
2254191|NCT02435706|5531233|P1|STARTED|Overall Study||18
2254192|NCT02435524|5531247|P2|NOT COMPLETED|Endline Survey||0
2254193|NCT02435524|5531248|P1|NOT COMPLETED|Endline Survey||0
2254194|NCT02435524|5531247|P2|COMPLETED|Endline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1161
2254195|NCT02435524|5531248|P1|COMPLETED|Endline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1092
2254196|NCT02435524|5531247|P2|STARTED|Endline Survey||1161
2254197|NCT02435524|5531248|P1|STARTED|Endline Survey||1092
2254198|NCT02435524|5531247|P2|NOT COMPLETED|Baseline Survey||0
2254199|NCT02435524|5531248|P1|NOT COMPLETED|Baseline Survey||0
2254200|NCT02435524|5531247|P2|COMPLETED|Baseline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1177
2254201|NCT02435524|5531248|P1|COMPLETED|Baseline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1111
2254202|NCT02435524|5531247|P2|STARTED|Baseline Survey||1177
2254203|NCT02435524|5531248|P1|STARTED|Baseline Survey||1111
2254204|NCT02435511|5531256|P2|NOT COMPLETED|Overall Study||35
2254205|NCT02435511|5531257|P1|NOT COMPLETED|Overall Study||44
2254206|NCT02435511|5531256|P2|COMPLETED|Overall Study|Defined as completing the 3 month follow-up; not necessarily all time points|174
2254207|NCT02435511|5531257|P1|COMPLETED|Overall Study|Defined as completing the 3 month follow-up, not necessarily all time points|158
2254208|NCT02435511|5531256|P2|STARTED|Overall Study|Defined as enrolled and completed baseline|209
2254209|NCT02435511|5531257|P1|STARTED|Overall Study|Defined as enrolled and completed baseline|202
2254210|NCT02435433|5531273|P5|NOT COMPLETED|Overall Study||0
2254211|NCT02435433|5531274|P4|NOT COMPLETED|Overall Study||0
2254212|NCT02435433|5531275|P3|NOT COMPLETED|Overall Study||0
2254213|NCT02435433|5531276|P2|NOT COMPLETED|Overall Study||5
2254214|NCT02435433|5531277|P1|NOT COMPLETED|Overall Study||15
2254215|NCT02435433|5531273|P5|COMPLETED|Overall Study||0
2254216|NCT02435433|5531274|P4|COMPLETED|Overall Study||0
2254217|NCT02435433|5531275|P3|COMPLETED|Overall Study||0
2254218|NCT02435433|5531276|P2|COMPLETED|Overall Study||90
2254219|NCT02435433|5531277|P1|COMPLETED|Overall Study||182
2254220|NCT02435433|5531273|P5|Participants Who Received Study Drug|Overall Study||0
2254221|NCT02435433|5531274|P4|Participants Who Received Study Drug|Overall Study||0
2254222|NCT02435433|5531275|P3|Participants Who Received Study Drug|Overall Study||0
2254223|NCT02435433|5531276|P2|Participants Who Received Study Drug|Overall Study||95
2254224|NCT02435433|5531277|P1|Participants Who Received Study Drug|Overall Study||197
2254225|NCT02435433|5531273|P5|STARTED|Overall Study||0
2254226|NCT02435433|5531274|P4|STARTED|Overall Study||0
2254227|NCT02435433|5531275|P3|STARTED|Overall Study||0
2254228|NCT02435433|5531276|P2|STARTED|Overall Study||95
2254229|NCT02435433|5531277|P1|STARTED|Overall Study||197
2254230|NCT02435277|5531303|P4|NOT COMPLETED|Overall Study||0
2254231|NCT02435277|5531304|P3|NOT COMPLETED|Overall Study||0
2254232|NCT02435277|5531305|P2|NOT COMPLETED|Overall Study||1
2254233|NCT02435277|5531306|P1|NOT COMPLETED|Overall Study||2
2254234|NCT02435277|5531303|P4|COMPLETED|Overall Study||11
2254235|NCT02435277|5531304|P3|COMPLETED|Overall Study||11
2254236|NCT02435277|5531305|P2|COMPLETED|Overall Study||15
2254237|NCT02435277|5531306|P1|COMPLETED|Overall Study||10
2254238|NCT02435277|5531303|P4|STARTED|Overall Study||11
2254239|NCT02435277|5531304|P3|STARTED|Overall Study||11
2254240|NCT02435277|5531305|P2|STARTED|Overall Study||16
2254241|NCT02435277|5531306|P1|STARTED|Overall Study||12
2254242|NCT02435147|5531320|P1|NOT COMPLETED|Overall Study||11
2254243|NCT02435147|5531320|P1|COMPLETED|Overall Study||75
2254244|NCT02435147|5531320|P1|STARTED|Overall Study||86
2254245|NCT02435069|5531325|P5|NOT COMPLETED|Effectiveness - Second Intervention||1
2254246|NCT02435069|5531326|P4|NOT COMPLETED|Effectiveness - Second Intervention||0
2254247|NCT02435069|5531327|P3|NOT COMPLETED|Effectiveness - Second Intervention||0
2254248|NCT02435069|5531328|P2|NOT COMPLETED|Effectiveness - Second Intervention||0
2254249|NCT02435069|5531329|P1|NOT COMPLETED|Effectiveness - Second Intervention||0
2254250|NCT02435069|5531325|P5|COMPLETED|Effectiveness - Second Intervention||0
2254251|NCT02435069|5531326|P4|COMPLETED|Effectiveness - Second Intervention||1
2254252|NCT02435069|5531327|P3|COMPLETED|Effectiveness - Second Intervention||0
2254253|NCT02435069|5531328|P2|COMPLETED|Effectiveness - Second Intervention||0
2254254|NCT02435069|5531329|P1|COMPLETED|Effectiveness - Second Intervention||0
2254255|NCT02435069|5531325|P5|STARTED|Effectiveness - Second Intervention||1
2254256|NCT02435069|5531326|P4|STARTED|Effectiveness - Second Intervention||1
2254257|NCT02435069|5531327|P3|STARTED|Effectiveness - Second Intervention||0
2254258|NCT02435069|5531328|P2|STARTED|Effectiveness - Second Intervention||0
2254259|NCT02435069|5531329|P1|STARTED|Effectiveness - Second Intervention||0
2254260|NCT02435069|5531325|P5|NOT COMPLETED|Dose Response - First Intervention||0
2254261|NCT02435069|5531326|P4|NOT COMPLETED|Dose Response - First Intervention||0
2254262|NCT02435069|5531327|P3|NOT COMPLETED|Dose Response - First Intervention||1
2254263|NCT02435069|5531328|P2|NOT COMPLETED|Dose Response - First Intervention||1
2254264|NCT02435069|5531329|P1|NOT COMPLETED|Dose Response - First Intervention||0
2254265|NCT02435069|5531325|P5|COMPLETED|Dose Response - First Intervention||0
2254266|NCT02435069|5531326|P4|COMPLETED|Dose Response - First Intervention||0
2254267|NCT02435069|5531327|P3|COMPLETED|Dose Response - First Intervention||1
2254268|NCT02435069|5531328|P2|COMPLETED|Dose Response - First Intervention||2
2254269|NCT02435069|5531329|P1|COMPLETED|Dose Response - First Intervention||0
2254270|NCT02435069|5531325|P5|STARTED|Dose Response - First Intervention||0
2254271|NCT02435069|5531326|P4|STARTED|Dose Response - First Intervention||0
2254272|NCT02435069|5531327|P3|STARTED|Dose Response - First Intervention||2
2254273|NCT02435069|5531328|P2|STARTED|Dose Response - First Intervention||3
2254274|NCT02435069|5531329|P1|STARTED|Dose Response - First Intervention||0
2254275|NCT02435069|5531325|P5|NOT COMPLETED|Preoperative Baseline Phase||0
2254276|NCT02435069|5531326|P4|NOT COMPLETED|Preoperative Baseline Phase||0
2254277|NCT02435069|5531327|P3|NOT COMPLETED|Preoperative Baseline Phase||0
2254278|NCT02435069|5531328|P2|NOT COMPLETED|Preoperative Baseline Phase||0
2254279|NCT02435069|5531329|P1|NOT COMPLETED|Preoperative Baseline Phase||0
2254280|NCT02435069|5531325|P5|COMPLETED|Preoperative Baseline Phase||0
2254281|NCT02435069|5531326|P4|COMPLETED|Preoperative Baseline Phase||0
2254282|NCT02435069|5531327|P3|COMPLETED|Preoperative Baseline Phase||0
2254283|NCT02435069|5531328|P2|COMPLETED|Preoperative Baseline Phase||0
2254284|NCT02435069|5531329|P1|COMPLETED|Preoperative Baseline Phase||5
2254285|NCT02435069|5531325|P5|STARTED|Preoperative Baseline Phase||0
2254286|NCT02435069|5531326|P4|STARTED|Preoperative Baseline Phase||0
2254287|NCT02435069|5531327|P3|STARTED|Preoperative Baseline Phase||0
2254288|NCT02435069|5531328|P2|STARTED|Preoperative Baseline Phase||0
2254289|NCT02435069|5531329|P1|STARTED|Preoperative Baseline Phase||5
2254290|NCT02434939|5531351|P2|NOT COMPLETED|Overall Study||49
2254291|NCT02434939|5531352|P1|NOT COMPLETED|Overall Study||37
2254292|NCT02434939|5531351|P2|COMPLETED|Overall Study||71
2254293|NCT02434939|5531352|P1|COMPLETED|Overall Study||83
2254294|NCT02434939|5531351|P2|STARTED|Overall Study||120
2254295|NCT02434939|5531352|P1|STARTED|Overall Study||120
2254296|NCT02434523|5531366|P2|NOT COMPLETED|Overall Study||6
2254297|NCT02434523|5531367|P1|NOT COMPLETED|Overall Study||5
2254298|NCT02434523|5531366|P2|COMPLETED|Overall Study||9
2254299|NCT02434523|5531367|P1|COMPLETED|Overall Study||10
2254300|NCT02434523|5531366|P2|STARTED|Overall Study||15
2254301|NCT02434523|5531367|P1|STARTED|Overall Study||15
2254302|NCT02434497|5531379|P1|NOT COMPLETED|Overall Study||5
2254303|NCT02434497|5531379|P1|COMPLETED|Overall Study||4
2254304|NCT02434497|5531379|P1|STARTED|Overall Study||9
2254305|NCT02434471|5531479|P1|NOT COMPLETED|Overall Study||9
2254306|NCT02434471|5531479|P1|COMPLETED|Overall Study||25
2254307|NCT02434471|5531479|P1|STARTED|Overall Study||34
2254308|NCT02434328|5531488|P2|NOT COMPLETED|Overall Study||42
2254309|NCT02434328|5531489|P1|NOT COMPLETED|Overall Study||30
2254310|NCT02434328|5531488|P2|COMPLETED|Overall Study||329
2254311|NCT02434328|5531489|P1|COMPLETED|Overall Study||342
2254312|NCT02434328|5531488|P2|Randomized and Treated|Overall Study||369
2254313|NCT02434328|5531489|P1|Randomized and Treated|Overall Study||370
2254314|NCT02434328|5531488|P2|STARTED|Overall Study||371
2254315|NCT02434328|5531489|P1|STARTED|Overall Study||372
2254316|NCT02434146|5531552|P1|NOT COMPLETED|Overall Study||0
2254317|NCT02434146|5531552|P1|COMPLETED|Overall Study||3
2254318|NCT02434146|5531552|P1|STARTED|Overall Study||3
2254319|NCT02433834|5531564|P1|NOT COMPLETED|Overall Study||37
2254320|NCT02433834|5531564|P1|COMPLETED|Overall Study|Subject PT001101-040014 did not complete Period 4 but completed the study. CSR states 210 completed.|211
2254321|NCT02433834|5531564|P1|SAL 50 µg|Overall Study||167
2254322|NCT02433834|5531564|P1|Placebo MDI|Overall Study||174
2254323|NCT02433834|5531564|P1|GP MDI 1.9 µg|Overall Study||107
2254324|NCT02433834|5531564|P1|GP MDI 3.6 µg|Overall Study||118
2254325|NCT02433834|5531564|P1|GP MDI 7.2 µg|Overall Study||228
2254326|NCT02433834|5531564|P1|GP MDI 14.4 µg|Overall Study||230
2254327|NCT02433834|5531564|P1|GP MDI 28.8 µg|Overall Study||112
2254328|NCT02433834|5531564|P1|STARTED|Overall Study||248
2254329|NCT02433678|5531624|P2|NOT COMPLETED|Overall Study||2
2254330|NCT02433678|5531625|P1|NOT COMPLETED|Overall Study||1
2254331|NCT02433678|5531624|P2|COMPLETED|Overall Study||24
2254332|NCT02433678|5531625|P1|COMPLETED|Overall Study||25
2254333|NCT02433678|5531624|P2|STARTED|Overall Study||26
2254334|NCT02433678|5531625|P1|STARTED|Overall Study||26
2254335|NCT02433496|5531660|P3|NOT COMPLETED|Overall Study||0
2254336|NCT02433496|5531661|P2|NOT COMPLETED|Overall Study||0
2254337|NCT02433496|5531662|P1|NOT COMPLETED|Overall Study||0
2254430|NCT02432040|5532753|P1|NOT COMPLETED|Overall Study||8
2254338|NCT02433496|5531660|P3|COMPLETED|Overall Study|This includes patients (9813) and providers (20).|9833
2254339|NCT02433496|5531661|P2|COMPLETED|Overall Study|This includes patients (13296) and providers (13).|13309
2254340|NCT02433496|5531662|P1|COMPLETED|Overall Study|This includes patients (29956) and providers (34).|29990
2254341|NCT02433496|5531660|P3|STARTED|Overall Study|This includes patients (9813) and providers (20).|9833
2254342|NCT02433496|5531661|P2|STARTED|Overall Study|This includes patients (13296) and providers (13).|13309
2254343|NCT02433496|5531662|P1|STARTED|Overall Study|This includes patients (29956) and providers (34).|29990
2254344|NCT02433483|5531692|P1|NOT COMPLETED|Overall Study||2
2254345|NCT02433483|5531692|P1|COMPLETED|Overall Study||0
2254346|NCT02433483|5531692|P1|STARTED|Overall Study||2
2254347|NCT02433366|5531706|P2|NOT COMPLETED|Overall Study||0
2254348|NCT02433366|5531707|P1|NOT COMPLETED|Overall Study||0
2254349|NCT02433366|5531706|P2|COMPLETED|Overall Study||802
2254350|NCT02433366|5531707|P1|COMPLETED|Overall Study||411
2254351|NCT02433366|5531706|P2|STARTED|Overall Study||802
2254352|NCT02433366|5531707|P1|STARTED|Overall Study||411
2254353|NCT02433340|5531719|P4|NOT COMPLETED|Overall Study||2
2254354|NCT02433340|5531720|P3|NOT COMPLETED|Overall Study||2
2254355|NCT02433340|5531721|P2|NOT COMPLETED|Overall Study||2
2254356|NCT02433340|5531722|P1|NOT COMPLETED|Overall Study||2
2254357|NCT02433340|5531719|P4|COMPLETED|Overall Study||38
2254358|NCT02433340|5531720|P3|COMPLETED|Overall Study||37
2254359|NCT02433340|5531721|P2|COMPLETED|Overall Study||35
2254360|NCT02433340|5531722|P1|COMPLETED|Overall Study||40
2254361|NCT02433340|5531719|P4|STARTED|Overall Study||40
2254362|NCT02433340|5531720|P3|STARTED|Overall Study||39
2254363|NCT02433340|5531721|P2|STARTED|Overall Study||37
2254364|NCT02433340|5531722|P1|STARTED|Overall Study||42
2254365|NCT02433288|5532616|P2|NOT COMPLETED|Overall Study||126
2254366|NCT02433288|5532617|P1|NOT COMPLETED|Overall Study||123
2254367|NCT02433288|5532616|P2|COMPLETED|Overall Study||316
2254368|NCT02433288|5532617|P1|COMPLETED|Overall Study||320
2254369|NCT02433288|5532616|P2|STARTED|Overall Study||442
2254370|NCT02433288|5532617|P1|STARTED|Overall Study||443
2254371|NCT02432729|5532631|P1|NOT COMPLETED|Month 12 Visit||196
2254372|NCT02432729|5532631|P1|COMPLETED|Month 12 Visit||436
2254373|NCT02432729|5532631|P1|STARTED|Month 12 Visit||632
2254374|NCT02432729|5532631|P1|NOT COMPLETED|Month 6 Visit||86
2254375|NCT02432729|5532631|P1|COMPLETED|Month 6 Visit||632
2254376|NCT02432729|5532631|P1|STARTED|Month 6 Visit||718
2254377|NCT02432729|5532631|P1|NOT COMPLETED|Month 3 Visit||2
2254378|NCT02432729|5532631|P1|COMPLETED|Month 3 Visit||718
2254379|NCT02432729|5532631|P1|STARTED|Month 3 Visit||720
2254380|NCT02432716|5532659|P2|NOT COMPLETED|Overall Study||0
2254381|NCT02432716|5532660|P1|NOT COMPLETED|Overall Study||0
2254382|NCT02432716|5532659|P2|COMPLETED|Overall Study||6
2254383|NCT02432716|5532660|P1|COMPLETED|Overall Study||6
2254384|NCT02432716|5532659|P2|STARTED|Overall Study||6
2254385|NCT02432716|5532660|P1|STARTED|Overall Study||6
2254386|NCT02432456|5532676|P2|NOT COMPLETED|Overall Study||0
2254387|NCT02432456|5532677|P1|NOT COMPLETED|Overall Study||0
2254388|NCT02432456|5532676|P2|COMPLETED|Overall Study||75
2254389|NCT02432456|5532677|P1|COMPLETED|Overall Study||75
2254390|NCT02432456|5532676|P2|STARTED|Overall Study||75
2254391|NCT02432456|5532677|P1|STARTED|Overall Study||75
2254392|NCT02432300|5532699|P1|NOT COMPLETED|Overall Study||4
2254393|NCT02432300|5532699|P1|COMPLETED|Overall Study||13
2254394|NCT02432300|5532699|P1|STARTED|Overall Study||17
2254395|NCT02432287|5532708|P2|NOT COMPLETED|Second Intervention||0
2254396|NCT02432287|5532709|P1|NOT COMPLETED|Second Intervention||0
2254397|NCT02432287|5532708|P2|COMPLETED|Second Intervention||7
2254398|NCT02432287|5532709|P1|COMPLETED|Second Intervention||7
2254399|NCT02432287|5532708|P2|STARTED|Second Intervention||7
2254400|NCT02432287|5532709|P1|STARTED|Second Intervention||7
2254401|NCT02432287|5532708|P2|NOT COMPLETED|Washout Period||0
2254402|NCT02432287|5532709|P1|NOT COMPLETED|Washout Period||0
2254403|NCT02432287|5532708|P2|COMPLETED|Washout Period||7
2254404|NCT02432287|5532709|P1|COMPLETED|Washout Period||7
2254405|NCT02432287|5532708|P2|STARTED|Washout Period||7
2254406|NCT02432287|5532709|P1|STARTED|Washout Period||7
2254407|NCT02432287|5532708|P2|NOT COMPLETED|First Intervention||1
2254408|NCT02432287|5532709|P1|NOT COMPLETED|First Intervention||0
2254409|NCT02432287|5532708|P2|COMPLETED|First Intervention||7
2254410|NCT02432287|5532709|P1|COMPLETED|First Intervention||8
2254411|NCT02432287|5532708|P2|STARTED|First Intervention||8
2254412|NCT02432287|5532709|P1|STARTED|First Intervention||8
2254413|NCT02432196|5532717|P1|NOT COMPLETED|Overall Study||26
2254414|NCT02432196|5532717|P1|COMPLETED|Overall Study||0
2254415|NCT02432196|5532717|P1|Implanted With Device|Overall Study||25
2254416|NCT02432196|5532717|P1|STARTED|Overall Study||26
2254417|NCT02432144|5532725|P1|NOT COMPLETED|Overall Study||1
2254418|NCT02432144|5532725|P1|COMPLETED|Overall Study||11
2254419|NCT02432144|5532725|P1|STARTED|Overall Study||12
2254420|NCT02432105|5532733|P3|NOT COMPLETED|Overall Study||3
2254421|NCT02432105|5532734|P2|NOT COMPLETED|Overall Study||2
2254422|NCT02432105|5532735|P1|NOT COMPLETED|Overall Study||2
2254423|NCT02432105|5532733|P3|COMPLETED|Overall Study||108
2254424|NCT02432105|5532734|P2|COMPLETED|Overall Study||108
2254425|NCT02432105|5532735|P1|COMPLETED|Overall Study||162
2254426|NCT02432105|5532733|P3|STARTED|Overall Study||111
2254427|NCT02432105|5532734|P2|STARTED|Overall Study||110
2254428|NCT02432105|5532735|P1|STARTED|Overall Study||164
2254429|NCT02432040|5532752|P2|NOT COMPLETED|Overall Study||6
2254431|NCT02432040|5532752|P2|COMPLETED|Overall Study||8
2254432|NCT02432040|5532753|P1|COMPLETED|Overall Study||6
2254433|NCT02432040|5532752|P2|STARTED|Overall Study||14
2254434|NCT02432040|5532753|P1|STARTED|Overall Study||14
2254435|NCT02431793|5532776|P3|NOT COMPLETED|Overall Study||117
2254436|NCT02431793|5532777|P2|NOT COMPLETED|Overall Study||134
2254437|NCT02431793|5532778|P1|NOT COMPLETED|Overall Study||119
2254438|NCT02431793|5532776|P3|COMPLETED|Overall Study||90
2254439|NCT02431793|5532777|P2|COMPLETED|Overall Study||109
2254440|NCT02431793|5532778|P1|COMPLETED|Overall Study||83
2254441|NCT02431793|5532776|P3|Completed T3 (30 Days Post Enrollment)|Overall Study||93
2254442|NCT02431793|5532777|P2|Completed T3 (30 Days Post Enrollment)|Overall Study||113
2254443|NCT02431793|5532778|P1|Completed T3 (30 Days Post Enrollment)|Overall Study||85
2254444|NCT02431793|5532776|P3|Completed T2 (7-14 Days Post Enrollment)|Overall Study||107
2254445|NCT02431793|5532777|P2|Completed T2 (7-14 Days Post Enrollment)|Overall Study||141
2254446|NCT02431793|5532778|P1|Completed T2 (7-14 Days Post Enrollment)|Overall Study||95
2254447|NCT02431793|5532776|P3|Completed T1 (3-5 Days Post Enrollment)|Overall Study||143
2254448|NCT02431793|5532777|P2|Completed T1 (3-5 Days Post Enrollment)|Overall Study||180
2254449|NCT02431793|5532778|P1|Completed T1 (3-5 Days Post Enrollment)|Overall Study||136
2254450|NCT02431793|5532776|P3|STARTED|Overall Study||207
2254451|NCT02431793|5532777|P2|STARTED|Overall Study||243
2254452|NCT02431793|5532778|P1|STARTED|Overall Study||202
2254453|NCT02431754|5532800|P2|NOT COMPLETED|Period 2 (8 Weeks)||4
2254454|NCT02431754|5532801|P1|NOT COMPLETED|Period 2 (8 Weeks)||1
2254455|NCT02431754|5532800|P2|COMPLETED|Period 2 (8 Weeks)||78
2254456|NCT02431754|5532801|P1|COMPLETED|Period 2 (8 Weeks)||74
2254457|NCT02431754|5532800|P2|STARTED|Period 2 (8 Weeks)||82
2254458|NCT02431754|5532801|P1|STARTED|Period 2 (8 Weeks)||75
2254459|NCT02431754|5532800|P2|NOT COMPLETED|Wash-out Period (4 Weeks)||0
2254460|NCT02431754|5532801|P1|NOT COMPLETED|Wash-out Period (4 Weeks)||4
2254461|NCT02431754|5532800|P2|COMPLETED|Wash-out Period (4 Weeks)||82
2254462|NCT02431754|5532801|P1|COMPLETED|Wash-out Period (4 Weeks)||75
2254463|NCT02431754|5532800|P2|STARTED|Wash-out Period (4 Weeks)||82
2254464|NCT02431754|5532801|P1|STARTED|Wash-out Period (4 Weeks)||79
2254465|NCT02431754|5532800|P2|NOT COMPLETED|Period 1 (8 Weeks)||4
2254466|NCT02431754|5532801|P1|NOT COMPLETED|Period 1 (8 Weeks)||6
2254467|NCT02431754|5532800|P2|COMPLETED|Period 1 (8 Weeks)||82
2254468|NCT02431754|5532801|P1|COMPLETED|Period 1 (8 Weeks)||79
2254469|NCT02431754|5532800|P2|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||86
2254470|NCT02431754|5532801|P1|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||85
2254471|NCT02431754|5532800|P2|STARTED|Period 1 (8 Weeks)||86
2254472|NCT02431754|5532801|P1|STARTED|Period 1 (8 Weeks)||85
2254473|NCT02431741|5532819|P1|NOT COMPLETED|Overall Study||0
2254474|NCT02431741|5532819|P1|COMPLETED|Overall Study||14
2254475|NCT02431741|5532819|P1|STARTED|Overall Study||14
2254476|NCT02431598|5532823|P6|NOT COMPLETED|Overall Study||0
2254477|NCT02431598|5532824|P5|NOT COMPLETED|Overall Study||0
2254478|NCT02431598|5532825|P4|NOT COMPLETED|Overall Study||0
2254479|NCT02431598|5532826|P3|NOT COMPLETED|Overall Study||0
2254480|NCT02431598|5532827|P2|NOT COMPLETED|Overall Study||0
2254481|NCT02431598|5532828|P1|NOT COMPLETED|Overall Study||0
2254482|NCT02431598|5532823|P6|COMPLETED|Overall Study||6
2254483|NCT02431598|5532824|P5|COMPLETED|Overall Study||7
2254484|NCT02431598|5532825|P4|COMPLETED|Overall Study||7
2254485|NCT02431598|5532826|P3|COMPLETED|Overall Study||9
2254486|NCT02431598|5532827|P2|COMPLETED|Overall Study||9
2254487|NCT02431598|5532828|P1|COMPLETED|Overall Study||6
2254488|NCT02431598|5532823|P6|STARTED|Overall Study||6
2254489|NCT02431598|5532824|P5|STARTED|Overall Study||7
2254490|NCT02431598|5532825|P4|STARTED|Overall Study||7
2254491|NCT02431598|5532826|P3|STARTED|Overall Study||9
2254492|NCT02431598|5532827|P2|STARTED|Overall Study||9
2254493|NCT02431598|5532828|P1|STARTED|Overall Study||6
2254494|NCT02431559|5532856|P4|NOT COMPLETED|Overall Study||31
2254495|NCT02431559|5532857|P3|NOT COMPLETED|Overall Study||4
2254496|NCT02431559|5532858|P2|NOT COMPLETED|Overall Study||3
2254497|NCT02431559|5532859|P1|NOT COMPLETED|Overall Study||2
2254498|NCT02431559|5532856|P4|COMPLETED|Overall Study||9
2254499|NCT02431559|5532857|P3|COMPLETED|Overall Study||2
2254500|NCT02431559|5532858|P2|COMPLETED|Overall Study||1
2254501|NCT02431559|5532859|P1|COMPLETED|Overall Study||1
2254502|NCT02431559|5532856|P4|STARTED|Overall Study||40
2254503|NCT02431559|5532857|P3|STARTED|Overall Study||6
2254504|NCT02431559|5532858|P2|STARTED|Overall Study||4
2254505|NCT02431559|5532859|P1|STARTED|Overall Study||3
2254506|NCT02431533|5532883|P2|NOT COMPLETED|Overall Study||3
2254507|NCT02431533|5532884|P1|NOT COMPLETED|Overall Study||2
2254508|NCT02431533|5532883|P2|COMPLETED|Overall Study||22
2254509|NCT02431533|5532884|P1|COMPLETED|Overall Study||23
2254510|NCT02431533|5532883|P2|STARTED|Overall Study||25
2254511|NCT02431533|5532884|P1|STARTED|Overall Study||25
2254521|NCT02431468|5532950|P3|NOT COMPLETED|Overall Study||9
2254522|NCT02431468|5532951|P2|NOT COMPLETED|Overall Study||18
2254523|NCT02431468|5532952|P1|NOT COMPLETED|Overall Study||8
2254524|NCT02431468|5532950|P3|COMPLETED|Overall Study||39
2254525|NCT02431468|5532951|P2|COMPLETED|Overall Study||29
2254526|NCT02431468|5532952|P1|COMPLETED|Overall Study||38
2254527|NCT02431468|5532950|P3|STARTED|Overall Study||48
2254528|NCT02431468|5532951|P2|STARTED|Overall Study||47
2254529|NCT02431468|5532952|P1|STARTED|Overall Study||46
2254530|NCT02431455|5532974|P2|NOT COMPLETED|Overall Study||0
2254531|NCT02431455|5532975|P1|NOT COMPLETED|Overall Study||0
2254532|NCT02431455|5532974|P2|COMPLETED|Overall Study||112
2254533|NCT02431455|5532975|P1|COMPLETED|Overall Study||112
2254534|NCT02431455|5532974|P2|STARTED|Overall Study||112
2254535|NCT02431455|5532975|P1|STARTED|Overall Study||112
2254536|NCT02431299|5532989|P2|NOT COMPLETED|Overall Study||1
2254537|NCT02431299|5532990|P1|NOT COMPLETED|Overall Study||53
2254538|NCT02431299|5532989|P2|COMPLETED|Overall Study||62
2254539|NCT02431299|5532990|P1|COMPLETED|Overall Study||183
2254540|NCT02431299|5532989|P2|STARTED|Overall Study||63
2254541|NCT02431299|5532990|P1|STARTED|Overall Study||236
2254542|NCT02431273|5533003|P1|NOT COMPLETED|TDF-FTC-MVC (Triple IVR)||0
2254543|NCT02431273|5533003|P1|COMPLETED|TDF-FTC-MVC (Triple IVR)||6
2254544|NCT02431273|5533003|P1|STARTED|TDF-FTC-MVC (Triple IVR)||6
2254545|NCT02431273|5533003|P1|NOT COMPLETED|TDF-FTC (Dual IVR)||0
2254546|NCT02431273|5533003|P1|COMPLETED|TDF-FTC (Dual IVR)||6
2254547|NCT02431273|5533003|P1|STARTED|TDF-FTC (Dual IVR)||6
2254548|NCT02431273|5533003|P1|NOT COMPLETED|TDF (Single IVR)||0
2254549|NCT02431273|5533003|P1|COMPLETED|TDF (Single IVR)||6
2254550|NCT02431273|5533003|P1|STARTED|TDF (Single IVR)||6
2254551|NCT02431260|5533043|P14|NOT COMPLETED|Overall Study||1
2254552|NCT02431260|5533044|P13|NOT COMPLETED|Overall Study||10
2254553|NCT02431260|5533045|P12|NOT COMPLETED|Overall Study||4
2254554|NCT02431260|5533046|P11|NOT COMPLETED|Overall Study||4
2254555|NCT02431260|5533047|P10|NOT COMPLETED|Overall Study||8
2254556|NCT02431260|5533048|P9|NOT COMPLETED|Overall Study||8
2254557|NCT02431260|5533049|P8|NOT COMPLETED|Overall Study||3
2254558|NCT02431260|5533050|P7|NOT COMPLETED|Overall Study||4
2254559|NCT02431260|5533051|P6|NOT COMPLETED|Overall Study||4
2254560|NCT02431260|5533052|P5|NOT COMPLETED|Overall Study||3
2254561|NCT02431260|5533053|P4|NOT COMPLETED|Overall Study||5
2254562|NCT02431260|5533054|P3|NOT COMPLETED|Overall Study||6
2254563|NCT02431260|5533055|P2|NOT COMPLETED|Overall Study||5
2254564|NCT02431260|5533056|P1|NOT COMPLETED|Overall Study||4
2254565|NCT02431260|5533043|P14|COMPLETED|Overall Study||0
2254566|NCT02431260|5533044|P13|COMPLETED|Overall Study||0
2254567|NCT02431260|5533045|P12|COMPLETED|Overall Study||0
2254568|NCT02431260|5533046|P11|COMPLETED|Overall Study||0
2254569|NCT02431260|5533047|P10|COMPLETED|Overall Study||0
2254570|NCT02431260|5533048|P9|COMPLETED|Overall Study||0
2254571|NCT02431260|5533049|P8|COMPLETED|Overall Study||0
2254572|NCT02431260|5533050|P7|COMPLETED|Overall Study||0
2254573|NCT02431260|5533051|P6|COMPLETED|Overall Study||0
2254574|NCT02431260|5533052|P5|COMPLETED|Overall Study||0
2254575|NCT02431260|5533053|P4|COMPLETED|Overall Study||0
2254576|NCT02431260|5533054|P3|COMPLETED|Overall Study||0
2254577|NCT02431260|5533055|P2|COMPLETED|Overall Study||0
2254578|NCT02431260|5533056|P1|COMPLETED|Overall Study||0
2254579|NCT02431260|5533043|P14|STARTED|Overall Study||1
2254580|NCT02431260|5533044|P13|STARTED|Overall Study||10
2254581|NCT02431260|5533045|P12|STARTED|Overall Study||4
2254582|NCT02431260|5533046|P11|STARTED|Overall Study||4
2254583|NCT02431260|5533047|P10|STARTED|Overall Study||8
2254584|NCT02431260|5533048|P9|STARTED|Overall Study||8
2254585|NCT02431260|5533049|P8|STARTED|Overall Study||3
2254586|NCT02431260|5533050|P7|STARTED|Overall Study||4
2254587|NCT02431260|5533051|P6|STARTED|Overall Study||4
2254588|NCT02431260|5533052|P5|STARTED|Overall Study||3
2254589|NCT02431260|5533053|P4|STARTED|Overall Study||5
2254590|NCT02431260|5533054|P3|STARTED|Overall Study||6
2254591|NCT02431260|5533055|P2|STARTED|Overall Study||5
2254592|NCT02431260|5533056|P1|STARTED|Overall Study||4
2254593|NCT02431247|5533149|P2|NOT COMPLETED|Overall Study||363
2254594|NCT02431247|5533150|P1|NOT COMPLETED|Overall Study||362
2254595|NCT02431247|5533149|P2|COMPLETED|Overall Study||0
2254596|NCT02431247|5533150|P1|COMPLETED|Overall Study||0
2254597|NCT02431247|5533149|P2|STARTED|Overall Study||363
2254598|NCT02431247|5533150|P1|STARTED|Overall Study||362
2254599|NCT02431052|5533209|P5|NOT COMPLETED|Overall Study||15
2254600|NCT02431052|5533210|P4|NOT COMPLETED|Overall Study||16
2254601|NCT02431052|5533211|P3|NOT COMPLETED|Overall Study||12
2254602|NCT02431052|5533212|P2|NOT COMPLETED|Overall Study||4
2254603|NCT02431052|5533213|P1|NOT COMPLETED|Overall Study||11
2254604|NCT02431052|5533209|P5|COMPLETED|Overall Study||86
2254605|NCT02431052|5533210|P4|COMPLETED|Overall Study||94
2254606|NCT02431052|5533211|P3|COMPLETED|Overall Study||94
2254607|NCT02431052|5533212|P2|COMPLETED|Overall Study||46
2254608|NCT02431052|5533213|P1|COMPLETED|Overall Study||42
2254609|NCT02431052|5533209|P5|STARTED|Overall Study||101
2254610|NCT02431052|5533210|P4|STARTED|Overall Study||110
2254611|NCT02431052|5533211|P3|STARTED|Overall Study||106
2254612|NCT02431052|5533212|P2|STARTED|Overall Study||50
2254613|NCT02431052|5533213|P1|STARTED|Overall Study||53
2254614|NCT02430870|5533243|P8|NOT COMPLETED|Part 2||1
2254615|NCT02430870|5533244|P7|NOT COMPLETED|Part 2||1
2254616|NCT02430870|5533245|P6|NOT COMPLETED|Part 2||0
2254617|NCT02430870|5533246|P5|NOT COMPLETED|Part 2||0
2254618|NCT02430870|5533247|P4|NOT COMPLETED|Part 2||0
2254619|NCT02430870|5533248|P3|NOT COMPLETED|Part 2||0
2254620|NCT02430870|5533249|P2|NOT COMPLETED|Part 2||0
2254621|NCT02430870|5533250|P1|NOT COMPLETED|Part 2||0
2254622|NCT02430870|5533243|P8|COMPLETED|Part 2||7
2254623|NCT02430870|5533244|P7|COMPLETED|Part 2||5
2254624|NCT02430870|5533245|P6|COMPLETED|Part 2||6
2254625|NCT02430870|5533246|P5|COMPLETED|Part 2||6
2254626|NCT02430870|5533247|P4|COMPLETED|Part 2||6
2254627|NCT02430870|5533248|P3|COMPLETED|Part 2||0
2254628|NCT02430870|5533249|P2|COMPLETED|Part 2||0
2254629|NCT02430870|5533250|P1|COMPLETED|Part 2||0
2254630|NCT02430870|5533243|P8|STARTED|Part 2||8
2254631|NCT02430870|5533244|P7|STARTED|Part 2||6
2254632|NCT02430870|5533245|P6|STARTED|Part 2||6
2254633|NCT02430870|5533246|P5|STARTED|Part 2||6
2254634|NCT02430870|5533247|P4|STARTED|Part 2||6
2254635|NCT02430870|5533248|P3|STARTED|Part 2||0
2254636|NCT02430870|5533249|P2|STARTED|Part 2||0
2254637|NCT02430870|5533250|P1|STARTED|Part 2||0
2254638|NCT02430870|5533243|P8|NOT COMPLETED|Part 1||0
2254639|NCT02430870|5533244|P7|NOT COMPLETED|Part 1||0
2254640|NCT02430870|5533245|P6|NOT COMPLETED|Part 1||0
2254641|NCT02430870|5533246|P5|NOT COMPLETED|Part 1||0
2254642|NCT02430870|5533247|P4|NOT COMPLETED|Part 1||0
2254643|NCT02430870|5533248|P3|NOT COMPLETED|Part 1||0
2254644|NCT02430870|5533249|P2|NOT COMPLETED|Part 1||0
2254645|NCT02430870|5533250|P1|NOT COMPLETED|Part 1||0
2254646|NCT02430870|5533243|P8|COMPLETED|Part 1||0
2254647|NCT02430870|5533244|P7|COMPLETED|Part 1||0
2254648|NCT02430870|5533245|P6|COMPLETED|Part 1||0
2254649|NCT02430870|5533246|P5|COMPLETED|Part 1||0
2254650|NCT02430870|5533247|P4|COMPLETED|Part 1||0
2254651|NCT02430870|5533248|P3|COMPLETED|Part 1||4
2254652|NCT02430870|5533249|P2|COMPLETED|Part 1||6
2254653|NCT02430870|5533250|P1|COMPLETED|Part 1||6
2254654|NCT02430870|5533243|P8|STARTED|Part 1||0
2254655|NCT02430870|5533244|P7|STARTED|Part 1||0
2254656|NCT02430870|5533245|P6|STARTED|Part 1||0
2254657|NCT02430870|5533246|P5|STARTED|Part 1||0
2254658|NCT02430870|5533247|P4|STARTED|Part 1||0
2254659|NCT02430870|5533248|P3|STARTED|Part 1||4
2254660|NCT02430870|5533249|P2|STARTED|Part 1||6
2254661|NCT02430870|5533250|P1|STARTED|Part 1||6
2254662|NCT02430818|5533324|P2|NOT COMPLETED|Overall Study||0
2254663|NCT02430818|5533325|P1|NOT COMPLETED|Overall Study||0
2254664|NCT02430818|5533324|P2|COMPLETED|Overall Study||6
2254665|NCT02430818|5533325|P1|COMPLETED|Overall Study||7
2254666|NCT02430818|5533324|P2|STARTED|Overall Study||6
2254667|NCT02430818|5533325|P1|STARTED|Overall Study||7
2254668|NCT02430532|5533337|P2|NOT COMPLETED|Overall Study||28
2254669|NCT02430532|5533338|P1|NOT COMPLETED|Overall Study||30
2254670|NCT02430532|5533337|P2|COMPLETED|Overall Study||0
2254671|NCT02430532|5533338|P1|COMPLETED|Overall Study||0
2254672|NCT02430532|5533337|P2|STARTED|Overall Study||28
2254673|NCT02430532|5533338|P1|STARTED|Overall Study||30
2254674|NCT02430389|5533354|P2|NOT COMPLETED|Overall Study||0
2254675|NCT02430389|5533355|P1|NOT COMPLETED|Overall Study||0
2254676|NCT02430389|5533354|P2|COMPLETED|Overall Study||10
2254677|NCT02430389|5533355|P1|COMPLETED|Overall Study||10
2254678|NCT02430389|5533354|P2|STARTED|Overall Study||10
2254679|NCT02430389|5533355|P1|STARTED|Overall Study||10
2254680|NCT02430337|5533365|P2|NOT COMPLETED|Overall Study||0
2254681|NCT02430337|5533366|P1|NOT COMPLETED|Overall Study||0
2254682|NCT02430337|5533365|P2|COMPLETED|Overall Study||20
2254683|NCT02430337|5533366|P1|COMPLETED|Overall Study||11
2254684|NCT02430337|5533365|P2|STARTED|Overall Study||20
2254685|NCT02430337|5533366|P1|STARTED|Overall Study||11
2254686|NCT02430311|5533379|P2|NOT COMPLETED|Part B||8
2254687|NCT02430311|5533380|P1|NOT COMPLETED|Part B||10
2254688|NCT02430311|5533379|P2|COMPLETED|Part B||7
2254689|NCT02430311|5533380|P1|COMPLETED|Part B||9
2254690|NCT02430311|5533379|P2|Received Paclitaxel|Part B||14
2254691|NCT02430311|5533380|P1|Received Paclitaxel|Part B|Cohort 1 patients are planned to receive olaparib monotherapy|0
2254692|NCT02430311|5533379|P2|Received Olaparib|Part B||15
2254693|NCT02430311|5533380|P1|Received Olaparib|Part B||19
2254694|NCT02430311|5533379|P2|STARTED|Part B||15
2254695|NCT02430311|5533380|P1|STARTED|Part B||19
2254696|NCT02430311|5533379|P2|NOT COMPLETED|Part A||1
2254697|NCT02430311|5533380|P1|NOT COMPLETED|Part A||1
2254698|NCT02430311|5533379|P2|COMPLETED|Part A||15
2254699|NCT02430311|5533380|P1|COMPLETED|Part A||19
2254700|NCT02430311|5533379|P2|Received Paclitaxel|Part A||16
2254701|NCT02430311|5533380|P1|Received Paclitaxel|Part A|Cohort 1 patients are planned to receive olaparib monotherapy|0
2254702|NCT02430311|5533379|P2|Received Olaparib|Part A||16
2254703|NCT02430311|5533380|P1|Received Olaparib|Part A||20
2254704|NCT02430311|5533379|P2|STARTED|Part A||16
2254705|NCT02430311|5533380|P1|STARTED|Part A||20
2254706|NCT02430090|5533416|P3|NOT COMPLETED|Overall Study||0
2254707|NCT02430090|5533417|P2|NOT COMPLETED|Overall Study||0
2254708|NCT02430090|5533418|P1|NOT COMPLETED|Overall Study||0
2254709|NCT02430090|5533416|P3|COMPLETED|Overall Study||15
2254710|NCT02430090|5533417|P2|COMPLETED|Overall Study||15
2254711|NCT02430090|5533418|P1|COMPLETED|Overall Study||15
2254712|NCT02430090|5533416|P3|STARTED|Overall Study||15
2254713|NCT02430090|5533417|P2|STARTED|Overall Study||15
2254714|NCT02430090|5533418|P1|STARTED|Overall Study||15
2254715|NCT02429869|5533426|P1|NOT COMPLETED|Overall Study||0
2254716|NCT02429869|5533426|P1|COMPLETED|Overall Study||10
2254717|NCT02429869|5533426|P1|STARTED|Overall Study||10
2254718|NCT02429856|5533434|P2|NOT COMPLETED|Overall Study||19
2254719|NCT02429856|5533435|P1|NOT COMPLETED|Overall Study||19
2254720|NCT02429856|5533434|P2|COMPLETED|Overall Study||32
2254721|NCT02429856|5533435|P1|COMPLETED|Overall Study||30
2254722|NCT02429856|5533434|P2|STARTED|Overall Study||51
2254723|NCT02429856|5533435|P1|STARTED|Overall Study||49
2254724|NCT02429791|5533453|P2|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||28
2254725|NCT02429791|5533454|P1|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||25
2254726|NCT02429791|5533453|P2|COMPLETED|Late Switch Phase (Week 52 to Week 148)||210
2254727|NCT02429791|5533454|P1|COMPLETED|Late Switch Phase (Week 52 to Week 148)||214
2254728|NCT02429791|5533453|P2|STARTED|Late Switch Phase (Week 52 to Week 148)||238
2254729|NCT02429791|5533454|P1|STARTED|Late Switch Phase (Week 52 to Week 148)||239
2254730|NCT02429791|5533453|P2|NOT COMPLETED|Early Switch Phase (Up to Week 52)||18
2254731|NCT02429791|5533454|P1|NOT COMPLETED|Early Switch Phase (Up to Week 52)||13
2254732|NCT02429791|5533453|P2|COMPLETED|Early Switch Phase (Up to Week 52)||238
2254733|NCT02429791|5533454|P1|COMPLETED|Early Switch Phase (Up to Week 52)||239
2254734|NCT02429791|5533453|P2|STARTED|Early Switch Phase (Up to Week 52)||256
2254735|NCT02429791|5533454|P1|STARTED|Early Switch Phase (Up to Week 52)||252
2254736|NCT02429778|5533542|P2|NOT COMPLETED|Overall Study||0
2254737|NCT02429778|5533543|P1|NOT COMPLETED|Overall Study||7
2254738|NCT02429778|5533542|P2|COMPLETED|Overall Study||20
2254739|NCT02429778|5533543|P1|COMPLETED|Overall Study||13
2254740|NCT02429778|5533542|P2|STARTED|Overall Study||20
2254741|NCT02429778|5533543|P1|STARTED|Overall Study||20
2254742|NCT02429310|5533557|P2|NOT COMPLETED|Overall Study||3
2254743|NCT02429310|5533558|P1|NOT COMPLETED|Overall Study||2
2254744|NCT02429310|5533557|P2|COMPLETED|Overall Study||17
2254745|NCT02429310|5533558|P1|COMPLETED|Overall Study||20
2254746|NCT02429310|5533557|P2|STARTED|Overall Study||20
2254747|NCT02429310|5533558|P1|STARTED|Overall Study||22
2254748|NCT02429258|5533568|P2|NOT COMPLETED|Overall Study||1
2254749|NCT02429258|5533569|P1|NOT COMPLETED|Overall Study||2
2254750|NCT02429258|5533568|P2|COMPLETED|Overall Study||49
2254751|NCT02429258|5533569|P1|COMPLETED|Overall Study||48
2254752|NCT02429258|5533568|P2|STARTED|Overall Study||50
2254753|NCT02429258|5533569|P1|STARTED|Overall Study||50
2254754|NCT02429115|5533601|P6|NOT COMPLETED|Overall Study||1
2254755|NCT02429115|5533602|P5|NOT COMPLETED|Overall Study||7
2254756|NCT02429115|5533603|P4|NOT COMPLETED|Overall Study||8
2254757|NCT02429115|5533604|P3|NOT COMPLETED|Overall Study||16
2254758|NCT02429115|5533605|P2|NOT COMPLETED|Overall Study||10
2254759|NCT02429115|5533606|P1|NOT COMPLETED|Overall Study||12
2254760|NCT02429115|5533601|P6|COMPLETED|Overall Study||27
2254761|NCT02429115|5533602|P5|COMPLETED|Overall Study||22
2254762|NCT02429115|5533603|P4|COMPLETED|Overall Study||21
2254763|NCT02429115|5533604|P3|COMPLETED|Overall Study||35
2254764|NCT02429115|5533605|P2|COMPLETED|Overall Study||42
2254765|NCT02429115|5533606|P1|COMPLETED|Overall Study||40
2254766|NCT02429115|5533601|P6|STARTED|Overall Study||28
2254767|NCT02429115|5533602|P5|STARTED|Overall Study||29
2254768|NCT02429115|5533603|P4|STARTED|Overall Study||29
2254769|NCT02429115|5533604|P3|STARTED|Overall Study||51
2254770|NCT02429115|5533605|P2|STARTED|Overall Study||52
2254771|NCT02429115|5533606|P1|STARTED|Overall Study||52
2254772|NCT02428699|5533623|P2|NOT COMPLETED|Period 2||0
2254773|NCT02428699|5533624|P1|NOT COMPLETED|Period 2||0
2254774|NCT02428699|5533623|P2|COMPLETED|Period 2||23
2254775|NCT02428699|5533624|P1|COMPLETED|Period 2||24
2254776|NCT02428699|5533623|P2|STARTED|Period 2||23
2254777|NCT02428699|5533624|P1|STARTED|Period 2||24
2254778|NCT02428699|5533623|P2|NOT COMPLETED|Washout Period 1||2
2254779|NCT02428699|5533624|P1|NOT COMPLETED|Washout Period 1||1
2254780|NCT02428699|5533623|P2|COMPLETED|Washout Period 1||23
2254781|NCT02428699|5533624|P1|COMPLETED|Washout Period 1||24
2254782|NCT02428699|5533623|P2|STARTED|Washout Period 1||25
2254783|NCT02428699|5533624|P1|STARTED|Washout Period 1||25
2254784|NCT02428699|5533623|P2|NOT COMPLETED|Period 1||0
2254785|NCT02428699|5533624|P1|NOT COMPLETED|Period 1||0
2254786|NCT02428699|5533623|P2|COMPLETED|Period 1||25
2254787|NCT02428699|5533624|P1|COMPLETED|Period 1||25
2254788|NCT02428699|5533623|P2|STARTED|Period 1||25
2254789|NCT02428699|5533624|P1|STARTED|Period 1||25
2254790|NCT02428608|5533652|P1|NOT COMPLETED|Overall Study||83
2254791|NCT02428608|5533652|P1|COMPLETED|Overall Study||487
2254792|NCT02428608|5533652|P1|STARTED|Overall Study||570
2254793|NCT02428595|5533657|P1|NOT COMPLETED|Treatment||19
2254794|NCT02428595|5533657|P1|COMPLETED|Treatment||54
2254795|NCT02428595|5533657|P1|STARTED|Treatment||73
2254796|NCT02428595|5533657|P1|NOT COMPLETED|Fitting||64
2254797|NCT02428595|5533657|P1|COMPLETED|Fitting||73
2254798|NCT02428595|5533657|P1|STARTED|Fitting||137
2254799|NCT02428478|5533673|P2|NOT COMPLETED|Second Study Night||0
2254800|NCT02428478|5533674|P1|NOT COMPLETED|Second Study Night||0
2254801|NCT02428478|5533673|P2|COMPLETED|Second Study Night||6
2254802|NCT02428478|5533674|P1|COMPLETED|Second Study Night||8
2254803|NCT02428478|5533673|P2|STARTED|Second Study Night|2 participants did not return for the second study night|6
2254804|NCT02428478|5533674|P1|STARTED|Second Study Night|1 participant did not return for the second study night|8
2254805|NCT02428478|5533673|P2|NOT COMPLETED|First Study Night||0
2254806|NCT02428478|5533674|P1|NOT COMPLETED|First Study Night||0
2254807|NCT02428478|5533673|P2|COMPLETED|First Study Night||8
2254808|NCT02428478|5533674|P1|COMPLETED|First Study Night||9
2254809|NCT02428478|5533673|P2|STARTED|First Study Night||8
2254810|NCT02428478|5533674|P1|STARTED|First Study Night||9
2254811|NCT02428413|5533684|P2|NOT COMPLETED|Overall Study||9
2254812|NCT02428413|5533685|P1|NOT COMPLETED|Overall Study||8
2254813|NCT02428413|5533684|P2|COMPLETED|Overall Study||52
2254814|NCT02428413|5533685|P1|COMPLETED|Overall Study||56
2254815|NCT02428413|5533684|P2|STARTED|Overall Study||61
2254816|NCT02428413|5533685|P1|STARTED|Overall Study||64
2254817|NCT02428309|5533697|P1|NOT COMPLETED|Overall Study||0
2254818|NCT02428309|5533697|P1|COMPLETED|Overall Study|The enrolled participant completed treatment and was followed through week 152, per protocol.|1
2254819|NCT02428309|5533697|P1|STARTED|Overall Study||1
2254820|NCT02428296|5533720|P1|NOT COMPLETED|Overall Study||9
2254821|NCT02428296|5533720|P1|COMPLETED|Overall Study|Number of participants who completed the full course of treatment.|30
2254822|NCT02428296|5533720|P1|Treated|Overall Study||39
2254823|NCT02428296|5533720|P1|STARTED|Overall Study||39
2254824|NCT02428231|5533732|P2|NOT COMPLETED|Overall Study||17
2254825|NCT02428231|5533733|P1|NOT COMPLETED|Overall Study||13
2254826|NCT02428231|5533732|P2|COMPLETED|Overall Study||15
2254827|NCT02428231|5533733|P1|COMPLETED|Overall Study||17
2254828|NCT02428231|5533732|P2|STARTED|Overall Study||32
2254829|NCT02428231|5533733|P1|STARTED|Overall Study||30
2254830|NCT02427984|5533750|P3|NOT COMPLETED|Overall Study||18
2254831|NCT02427984|5533751|P2|NOT COMPLETED|Overall Study||5
2254832|NCT02427984|5533752|P1|NOT COMPLETED|Overall Study||13
2254833|NCT02427984|5533750|P3|COMPLETED|Overall Study||32
2254834|NCT02427984|5533751|P2|COMPLETED|Overall Study||40
2254835|NCT02427984|5533752|P1|COMPLETED|Overall Study||40
2254836|NCT02427984|5533750|P3|STARTED|Overall Study||50
2254837|NCT02427984|5533751|P2|STARTED|Overall Study||45
2254838|NCT02427984|5533752|P1|STARTED|Overall Study||53
2254839|NCT02427958|5533766|P1|NOT COMPLETED|Overall Study||24
2254840|NCT02427958|5533766|P1|COMPLETED|Overall Study||283
2254841|NCT02427958|5533766|P1|STARTED|Overall Study||307
2254842|NCT02427750|5533773|P2|NOT COMPLETED|Overall Study||0
2254843|NCT02427750|5533774|P1|NOT COMPLETED|Overall Study||0
2254844|NCT02427750|5533773|P2|COMPLETED|Overall Study||63
2254845|NCT02427750|5533774|P1|COMPLETED|Overall Study||63
2254846|NCT02427750|5533773|P2|STARTED|Overall Study||63
2254847|NCT02427750|5533774|P1|STARTED|Overall Study||63
2254848|NCT02427737|5533799|P2|NOT COMPLETED|Duke Pre- and Post-Training Groups||395
2254849|NCT02427737|5533800|P1|NOT COMPLETED|Duke Pre- and Post-Training Groups||779
2254850|NCT02427737|5533799|P2|COMPLETED|Duke Pre- and Post-Training Groups||4051
2254851|NCT02427737|5533800|P1|COMPLETED|Duke Pre- and Post-Training Groups||8879
2254852|NCT02427737|5533799|P2|STARTED|Duke Pre- and Post-Training Groups|Note Control=Baseline|4446
2254853|NCT02427737|5533800|P1|STARTED|Duke Pre- and Post-Training Groups|Note this is a pre-training to post-training comparison.|9658
2254854|NCT02427737|5533799|P2|NOT COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||215
2254855|NCT02427737|5533800|P1|NOT COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||220
2254856|NCT02427737|5533799|P2|COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||2716
2254857|NCT02427737|5533800|P1|COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||3928
2254858|NCT02427737|5533799|P2|STARTED|OSU Q3FY16 (Third Post Training Quarter)||2931
2254859|NCT02427737|5533800|P1|STARTED|OSU Q3FY16 (Third Post Training Quarter)||4148
2254860|NCT02427737|5533799|P2|NOT COMPLETED|OSU Q2FY16(Second Post Training Quarter)||213
2254861|NCT02427737|5533800|P1|NOT COMPLETED|OSU Q2FY16(Second Post Training Quarter)||214
2254862|NCT02427737|5533799|P2|COMPLETED|OSU Q2FY16(Second Post Training Quarter)||2857
2254863|NCT02427737|5533800|P1|COMPLETED|OSU Q2FY16(Second Post Training Quarter)||3907
2254864|NCT02427737|5533799|P2|STARTED|OSU Q2FY16(Second Post Training Quarter)||3070
2254865|NCT02427737|5533800|P1|STARTED|OSU Q2FY16(Second Post Training Quarter)||4121
2254866|NCT02427737|5533799|P2|NOT COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||214
2254867|NCT02427737|5533800|P1|NOT COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||215
2254868|NCT02427737|5533799|P2|COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||3032
2254869|NCT02427737|5533800|P1|COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||3815
2254870|NCT02427737|5533799|P2|STARTED|OSU Q1FY16 (First Post-Training Quarter)||3246
2254871|NCT02427737|5533800|P1|STARTED|OSU Q1FY16 (First Post-Training Quarter)||4030
2254872|NCT02427737|5533799|P2|NOT COMPLETED|OSU Baseline Q4FY15||216
2254873|NCT02427737|5533800|P1|NOT COMPLETED|OSU Baseline Q4FY15||218
2254874|NCT02427737|5533799|P2|COMPLETED|OSU Baseline Q4FY15||3230
2254875|NCT02427737|5533800|P1|COMPLETED|OSU Baseline Q4FY15||3940
2254876|NCT02427737|5533799|P2|STARTED|OSU Baseline Q4FY15||3446
2254877|NCT02427737|5533800|P1|STARTED|OSU Baseline Q4FY15||4158
2254878|NCT02427672|5533848|P2|NOT COMPLETED|Overall Study||2
2254879|NCT02427672|5533849|P1|NOT COMPLETED|Overall Study||1
2254880|NCT02427672|5533848|P2|COMPLETED|Overall Study||42
2254881|NCT02427672|5533849|P1|COMPLETED|Overall Study||39
2254882|NCT02427672|5533848|P2|STARTED|Overall Study||44
2254883|NCT02427672|5533849|P1|STARTED|Overall Study||40
2254884|NCT02427646|5533859|P2|NOT COMPLETED|Overall Study||14
2254885|NCT02427646|5533860|P1|NOT COMPLETED|Overall Study||8
2254886|NCT02427646|5533859|P2|COMPLETED|Overall Study||14
2254887|NCT02427646|5533860|P1|COMPLETED|Overall Study||16
2254888|NCT02427646|5533859|P2|STARTED|Overall Study||28
2254889|NCT02427646|5533860|P1|STARTED|Overall Study||24
2254890|NCT02427607|5533868|P1|NOT COMPLETED|Overall Study||1
2254891|NCT02427607|5533868|P1|COMPLETED|Overall Study||6
2254892|NCT02427607|5533868|P1|STARTED|Overall Study||7
2254893|NCT02427477|5533874|P2|NOT COMPLETED|Period 3||0
2254894|NCT02427477|5533875|P1|NOT COMPLETED|Period 3||0
2254895|NCT02427477|5533874|P2|COMPLETED|Period 3||60
2254896|NCT02427477|5533875|P1|COMPLETED|Period 3||59
2254897|NCT02427477|5533874|P2|STARTED|Period 3||60
2254898|NCT02427477|5533875|P1|STARTED|Period 3||59
2254899|NCT02427477|5533874|P2|NOT COMPLETED|Period 2||0
2254900|NCT02427477|5533875|P1|NOT COMPLETED|Period 2||0
2254901|NCT02427477|5533874|P2|COMPLETED|Period 2||60
2254902|NCT02427477|5533875|P1|COMPLETED|Period 2||59
2254903|NCT02427477|5533874|P2|STARTED|Period 2||60
2254904|NCT02427477|5533875|P1|STARTED|Period 2||59
2254905|NCT02427477|5533874|P2|NOT COMPLETED|Period 1||0
2254906|NCT02427477|5533875|P1|NOT COMPLETED|Period 1||1
2254907|NCT02427477|5533874|P2|COMPLETED|Period 1||60
2254908|NCT02427477|5533875|P1|COMPLETED|Period 1||59
2254909|NCT02427477|5533874|P2|STARTED|Period 1||60
2254910|NCT02427477|5533875|P1|STARTED|Period 1||60
2254911|NCT02427399|5533888|P5|NOT COMPLETED|Overall Study||15
2254912|NCT02427399|5533889|P4|NOT COMPLETED|Overall Study||18
2254913|NCT02427399|5533890|P3|NOT COMPLETED|Overall Study||12
2254914|NCT02427399|5533891|P2|NOT COMPLETED|Overall Study||16
2254915|NCT02427399|5533892|P1|NOT COMPLETED|Overall Study||14
2254916|NCT02427399|5533888|P5|COMPLETED|Overall Study||205
2254917|NCT02427399|5533889|P4|COMPLETED|Overall Study||202
2254918|NCT02427399|5533890|P3|COMPLETED|Overall Study||208
2254919|NCT02427399|5533891|P2|COMPLETED|Overall Study||204
2254920|NCT02427399|5533892|P1|COMPLETED|Overall Study||206
2254921|NCT02427399|5533888|P5|STARTED|Overall Study||220
2254922|NCT02427399|5533889|P4|STARTED|Overall Study||220
2254923|NCT02427399|5533890|P3|STARTED|Overall Study||220
2254924|NCT02427399|5533891|P2|STARTED|Overall Study||220
2254925|NCT02427399|5533892|P1|STARTED|Overall Study||220
2254926|NCT02427100|5533916|P2|NOT COMPLETED|Overall Study||2
2254927|NCT02427100|5533917|P1|NOT COMPLETED|Overall Study||0
2254928|NCT02427100|5533916|P2|COMPLETED|Overall Study||15
2254929|NCT02427100|5533917|P1|COMPLETED|Overall Study||15
2254930|NCT02427100|5533916|P2|STARTED|Overall Study||17
2254931|NCT02427100|5533917|P1|STARTED|Overall Study||15
2254932|NCT02426918|5533928|P3|NOT COMPLETED|Overall Study||14
2254933|NCT02426918|5533929|P2|NOT COMPLETED|Overall Study||19
2254934|NCT02426918|5533930|P1|NOT COMPLETED|Overall Study||17
2254935|NCT02426918|5533928|P3|COMPLETED|Overall Study||97
2254936|NCT02426918|5533929|P2|COMPLETED|Overall Study||90
2254937|NCT02426918|5533930|P1|COMPLETED|Overall Study||93
2254938|NCT02426918|5533928|P3|Safety Population|Overall Study||107
2254939|NCT02426918|5533929|P2|Safety Population|Overall Study||107
2254940|NCT02426918|5533930|P1|Safety Population|Overall Study||110
2254941|NCT02426918|5533928|P3|STARTED|Overall Study||111
2254942|NCT02426918|5533929|P2|STARTED|Overall Study||109
2254943|NCT02426918|5533930|P1|STARTED|Overall Study||110
2254944|NCT02426749|5533952|P2|NOT COMPLETED|Overall Study||1
2254945|NCT02426749|5533953|P1|NOT COMPLETED|Overall Study||3
2254946|NCT02426749|5533952|P2|COMPLETED|Overall Study||9
2254947|NCT02426749|5533953|P1|COMPLETED|Overall Study||9
2254948|NCT02426749|5533952|P2|STARTED|Overall Study||10
2254949|NCT02426749|5533953|P1|STARTED|Overall Study||12
2254950|NCT02426580|5533967|P2|NOT COMPLETED|Overall Study||16
2254951|NCT02426580|5533968|P1|NOT COMPLETED|Overall Study||11
2254952|NCT02426580|5533967|P2|COMPLETED|Overall Study|the last patient in this group enrolled in April 2017|54
2254953|NCT02426580|5533968|P1|COMPLETED|Overall Study|the last patient enrolled in this group in April 2017|59
2254954|NCT02426580|5533967|P2|STARTED|Overall Study|January 2014|70
2254955|NCT02426580|5533968|P1|STARTED|Overall Study|April 2015|70
2254956|NCT02426541|5533976|P2|NOT COMPLETED|Overall Study||0
2254957|NCT02426541|5533977|P1|NOT COMPLETED|Overall Study||1
2254958|NCT02426541|5533976|P2|COMPLETED|Overall Study||16
2254959|NCT02426541|5533977|P1|COMPLETED|Overall Study||15
2254960|NCT02426541|5533976|P2|STARTED|Overall Study||16
2254961|NCT02426541|5533977|P1|STARTED|Overall Study||16
2254962|NCT02426138|5533989|P2|NOT COMPLETED|Intent to Treat Population Milestone||0
2254963|NCT02426138|5533990|P1|NOT COMPLETED|Intent to Treat Population Milestone||0
2254964|NCT02426138|5533989|P2|COMPLETED|Intent to Treat Population Milestone||22
2254965|NCT02426138|5533990|P1|COMPLETED|Intent to Treat Population Milestone||20
2254966|NCT02426138|5533989|P2|STARTED|Intent to Treat Population Milestone||22
2254967|NCT02426138|5533990|P1|STARTED|Intent to Treat Population Milestone||20
2254968|NCT02426138|5533989|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
2254969|NCT02426138|5533990|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
2254970|NCT02426138|5533989|P2|COMPLETED|Second Intervention (12 Weeks)||22
2254971|NCT02426138|5533990|P1|COMPLETED|Second Intervention (12 Weeks)||20
2254972|NCT02426138|5533989|P2|STARTED|Second Intervention (12 Weeks)||22
2254973|NCT02426138|5533990|P1|STARTED|Second Intervention (12 Weeks)||20
2254974|NCT02426138|5533989|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
2254975|NCT02426138|5533990|P1|NOT COMPLETED|First Intervention (12 Weeks)||1
2254976|NCT02426138|5533989|P2|COMPLETED|First Intervention (12 Weeks)||22
2254977|NCT02426138|5533990|P1|COMPLETED|First Intervention (12 Weeks)||20
2254978|NCT02426138|5533989|P2|STARTED|First Intervention (12 Weeks)||23
2254979|NCT02426138|5533990|P1|STARTED|First Intervention (12 Weeks)||21
2254980|NCT02426125|5534030|P2|NOT COMPLETED|Overall Study||26
2254981|NCT02426125|5534031|P1|NOT COMPLETED|Overall Study||29
2254982|NCT02426125|5534030|P2|COMPLETED|Overall Study||241
2254983|NCT02426125|5534031|P1|COMPLETED|Overall Study||234
2254984|NCT02426125|5534030|P2|First Randomized Participants|Overall Study||221
2254985|NCT02426125|5534031|P1|First Randomized Participants|Overall Study||216
2254986|NCT02426125|5534030|P2|Received at Least One Dose of Study Drug|Overall Study||265
2254987|NCT02426125|5534031|P1|Received at Least One Dose of Study Drug|Overall Study||258
2254988|NCT02426125|5534030|P2|STARTED|Overall Study||267
2254989|NCT02426125|5534031|P1|STARTED|Overall Study||263
2254990|NCT02425956|5534055|P1|NOT COMPLETED|Overall Study||0
2254991|NCT02425956|5534055|P1|COMPLETED|Overall Study||21
2254992|NCT02425956|5534055|P1|STARTED|Overall Study||21
2254993|NCT02425826|5534062|P3|NOT COMPLETED|Post-Treatment Observational Follow-Up||0
2254994|NCT02425826|5534063|P2|NOT COMPLETED|Post-Treatment Observational Follow-Up||0
2254995|NCT02425826|5534064|P1|NOT COMPLETED|Post-Treatment Observational Follow-Up||1
2254996|NCT02425826|5534062|P3|COMPLETED|Post-Treatment Observational Follow-Up||49
2254997|NCT02425826|5534063|P2|COMPLETED|Post-Treatment Observational Follow-Up||0
2254998|NCT02425826|5534064|P1|COMPLETED|Post-Treatment Observational Follow-Up||80
2254999|NCT02425826|5534062|P3|STARTED|Post-Treatment Observational Follow-Up||49
2255000|NCT02425826|5534063|P2|STARTED|Post-Treatment Observational Follow-Up||0
2255001|NCT02425826|5534064|P1|STARTED|Post-Treatment Observational Follow-Up||81
2255002|NCT02425826|5534062|P3|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||14
2255003|NCT02425826|5534063|P2|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0
2255004|NCT02425826|5534064|P1|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||35
2255005|NCT02425826|5534062|P3|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||50
2255006|NCT02425826|5534063|P2|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0
2255007|NCT02425826|5534064|P1|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||86
2255008|NCT02425826|5534062|P3|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||64
2255009|NCT02425826|5534063|P2|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||0
2255010|NCT02425826|5534064|P1|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||121
2255011|NCT02425826|5534062|P3|STARTED|Apremilast Extension Phase (Weeks 16-52)||64
2255012|NCT02425826|5534063|P2|STARTED|Apremilast Extension Phase (Weeks 16-52)||0
2255013|NCT02425826|5534064|P1|STARTED|Apremilast Extension Phase (Weeks 16-52)||121
2255014|NCT02425826|5534062|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0
2255015|NCT02425826|5534063|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||9
2255016|NCT02425826|5534064|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||27
2255017|NCT02425826|5534062|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0
2255018|NCT02425826|5534063|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|64
2255019|NCT02425826|5534064|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|121
2255020|NCT02425826|5534062|P3|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)||0
2255021|NCT02425826|5534063|P2|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|73
2255022|NCT02425826|5534064|P1|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|147
2255023|NCT02425826|5534062|P3|STARTED|Placebo-controlled Phase (Week 0 - 16)||0
2255024|NCT02425826|5534063|P2|STARTED|Placebo-controlled Phase (Week 0 - 16)||73
2255025|NCT02425826|5534064|P1|STARTED|Placebo-controlled Phase (Week 0 - 16)||148
2255026|NCT02425449|5534102|P5|NOT COMPLETED|Overall Study||0
2255027|NCT02425449|5534103|P4|NOT COMPLETED|Overall Study||0
2255028|NCT02425449|5534104|P3|NOT COMPLETED|Overall Study||0
2255029|NCT02425449|5534105|P2|NOT COMPLETED|Overall Study||0
2255030|NCT02425449|5534106|P1|NOT COMPLETED|Overall Study||0
2255031|NCT02425449|5534102|P5|COMPLETED|Overall Study||5
2255032|NCT02425449|5534103|P4|COMPLETED|Overall Study||5
2255033|NCT02425449|5534104|P3|COMPLETED|Overall Study||5
2255034|NCT02425449|5534105|P2|COMPLETED|Overall Study||4
2255035|NCT02425449|5534106|P1|COMPLETED|Overall Study||0
2255036|NCT02425449|5534102|P5|STARTED|Overall Study||5
2255037|NCT02425449|5534103|P4|STARTED|Overall Study||5
2255038|NCT02425449|5534104|P3|STARTED|Overall Study||5
2255039|NCT02425449|5534105|P2|STARTED|Overall Study||4
2255040|NCT02425449|5534106|P1|STARTED|Overall Study||0
2255041|NCT02425111|5534118|P1|NOT COMPLETED|Part B: Treatment Extension Period||10
2255042|NCT02425111|5534118|P1|COMPLETED|Part B: Treatment Extension Period||46
2255043|NCT02425111|5534118|P1|STARTED|Part B: Treatment Extension Period||56
2255044|NCT02425111|5534118|P1|NOT COMPLETED|Part A: Treatment Period||23
2255045|NCT02425111|5534118|P1|COMPLETED|Part A: Treatment Period||78
2255046|NCT02425111|5534118|P1|STARTED|Part A: Treatment Period||101
2255047|NCT02425098|5534139|P2|NOT COMPLETED|Overall Study||16
2255048|NCT02425098|5534140|P1|NOT COMPLETED|Overall Study||13
2255049|NCT02425098|5534139|P2|COMPLETED|Overall Study||159
2255050|NCT02425098|5534140|P1|COMPLETED|Overall Study||163
2255051|NCT02425098|5534139|P2|STARTED|Overall Study||175
2255052|NCT02425098|5534140|P1|STARTED|Overall Study||176
2255053|NCT02424799|5534188|P6|NOT COMPLETED|Part C (Up to Day 23)||0
2255054|NCT02424799|5534189|P5|NOT COMPLETED|Part C (Up to Day 23)||0
2255055|NCT02424799|5534190|P4|NOT COMPLETED|Part C (Up to Day 23)||0
2255056|NCT02424799|5534191|P3|NOT COMPLETED|Part C (Up to Day 23)||0
2255057|NCT02424799|5534192|P2|NOT COMPLETED|Part C (Up to Day 23)||0
2255058|NCT02424799|5534193|P1|NOT COMPLETED|Part C (Up to Day 23)||0
2255059|NCT02424799|5534188|P6|COMPLETED|Part C (Up to Day 23)||4
2255060|NCT02424799|5534189|P5|COMPLETED|Part C (Up to Day 23)||1
2255061|NCT02424799|5534190|P4|COMPLETED|Part C (Up to Day 23)||0
2255062|NCT02424799|5534191|P3|COMPLETED|Part C (Up to Day 23)||0
2255063|NCT02424799|5534192|P2|COMPLETED|Part C (Up to Day 23)||0
2255064|NCT02424799|5534193|P1|COMPLETED|Part C (Up to Day 23)||0
2255065|NCT02424799|5534188|P6|STARTED|Part C (Up to Day 23)||4
2255066|NCT02424799|5534189|P5|STARTED|Part C (Up to Day 23)||1
2255067|NCT02424799|5534190|P4|STARTED|Part C (Up to Day 23)||0
2255068|NCT02424799|5534191|P3|STARTED|Part C (Up to Day 23)||0
2255069|NCT02424799|5534192|P2|STARTED|Part C (Up to Day 23)||0
2255070|NCT02424799|5534193|P1|STARTED|Part C (Up to Day 23)||0
2255071|NCT02424799|5534188|P6|NOT COMPLETED|Part B (Up to Day 19)||0
2255072|NCT02424799|5534189|P5|NOT COMPLETED|Part B (Up to Day 19)||0
2255073|NCT02424799|5534190|P4|NOT COMPLETED|Part B (Up to Day 19)||0
2255074|NCT02424799|5534191|P3|NOT COMPLETED|Part B (Up to Day 19)||0
2255075|NCT02424799|5534192|P2|NOT COMPLETED|Part B (Up to Day 19)||0
2255076|NCT02424799|5534193|P1|NOT COMPLETED|Part B (Up to Day 19)||0
2255077|NCT02424799|5534188|P6|COMPLETED|Part B (Up to Day 19)||0
2255078|NCT02424799|5534189|P5|COMPLETED|Part B (Up to Day 19)||0
2255079|NCT02424799|5534190|P4|COMPLETED|Part B (Up to Day 19)||9
2255080|NCT02424799|5534191|P3|COMPLETED|Part B (Up to Day 19)||3
2255081|NCT02424799|5534192|P2|COMPLETED|Part B (Up to Day 19)||0
2255082|NCT02424799|5534193|P1|COMPLETED|Part B (Up to Day 19)||0
2255083|NCT02424799|5534188|P6|STARTED|Part B (Up to Day 19)||0
2255084|NCT02424799|5534189|P5|STARTED|Part B (Up to Day 19)||0
2255085|NCT02424799|5534190|P4|STARTED|Part B (Up to Day 19)||9
2255086|NCT02424799|5534191|P3|STARTED|Part B (Up to Day 19)||3
2255087|NCT02424799|5534192|P2|STARTED|Part B (Up to Day 19)||0
2255088|NCT02424799|5534193|P1|STARTED|Part B (Up to Day 19)||0
2255089|NCT02424799|5534188|P6|NOT COMPLETED|Part A (Up to Day 11)||0
2255090|NCT02424799|5534189|P5|NOT COMPLETED|Part A (Up to Day 11)||0
2255091|NCT02424799|5534190|P4|NOT COMPLETED|Part A (Up to Day 11)||0
2255092|NCT02424799|5534191|P3|NOT COMPLETED|Part A (Up to Day 11)||0
2255093|NCT02424799|5534192|P2|NOT COMPLETED|Part A (Up to Day 11)||0
2255094|NCT02424799|5534193|P1|NOT COMPLETED|Part A (Up to Day 11)||0
2255095|NCT02424799|5534188|P6|COMPLETED|Part A (Up to Day 11)||0
2255096|NCT02424799|5534189|P5|COMPLETED|Part A (Up to Day 11)||0
2255097|NCT02424799|5534190|P4|COMPLETED|Part A (Up to Day 11)||0
2255098|NCT02424799|5534191|P3|COMPLETED|Part A (Up to Day 11)||0
2255099|NCT02424799|5534192|P2|COMPLETED|Part A (Up to Day 11)||8
2255100|NCT02424799|5534193|P1|COMPLETED|Part A (Up to Day 11)||9
2255101|NCT02424799|5534188|P6|STARTED|Part A (Up to Day 11)||0
2255102|NCT02424799|5534189|P5|STARTED|Part A (Up to Day 11)||0
2255103|NCT02424799|5534190|P4|STARTED|Part A (Up to Day 11)||0
2255104|NCT02424799|5534191|P3|STARTED|Part A (Up to Day 11)||0
2255105|NCT02424799|5534192|P2|STARTED|Part A (Up to Day 11)||8
2255106|NCT02424799|5534193|P1|STARTED|Part A (Up to Day 11)||9
2255107|NCT02424734|5534292|P3|NOT COMPLETED|Overall Study||0
2255108|NCT02424734|5534293|P2|NOT COMPLETED|Overall Study||2
2255109|NCT02424734|5534294|P1|NOT COMPLETED|Overall Study||2
2255110|NCT02424734|5534292|P3|COMPLETED|Overall Study||2
2255111|NCT02424734|5534293|P2|COMPLETED|Overall Study||3
2255112|NCT02424734|5534294|P1|COMPLETED|Overall Study||2
2255113|NCT02424734|5534292|P3|Treated|Overall Study||2
2255114|NCT02424734|5534293|P2|Treated|Overall Study||5
2255115|NCT02424734|5534294|P1|Treated|Overall Study||4
2255116|NCT02424734|5534292|P3|STARTED|Overall Study||2
2255117|NCT02424734|5534293|P2|STARTED|Overall Study||5
2255118|NCT02424734|5534294|P1|STARTED|Overall Study||4
2255119|NCT02424591|5534313|P2|NOT COMPLETED|Overall Study||3
2255120|NCT02424591|5534314|P1|NOT COMPLETED|Overall Study||2
2255121|NCT02424591|5534313|P2|COMPLETED|Overall Study||20
2255122|NCT02424591|5534314|P1|COMPLETED|Overall Study||20
2255123|NCT02424591|5534313|P2|STARTED|Overall Study||23
2255124|NCT02424591|5534314|P1|STARTED|Overall Study||22
2255125|NCT02424578|5534326|P2|NOT COMPLETED|Overall Study||1
2255126|NCT02424578|5534327|P1|NOT COMPLETED|Overall Study||0
2255127|NCT02424578|5534326|P2|COMPLETED|Overall Study||14
2255128|NCT02424578|5534327|P1|COMPLETED|Overall Study||15
2255129|NCT02424578|5534326|P2|STARTED|Overall Study||15
2255130|NCT02424578|5534327|P1|STARTED|Overall Study||15
2255131|NCT02424565|5534333|P2|NOT COMPLETED|Period 2 (D3)||0
2255132|NCT02424565|5534334|P1|NOT COMPLETED|Period 2 (D3)||0
2255133|NCT02424565|5534333|P2|COMPLETED|Period 2 (D3)||6
2255134|NCT02424565|5534334|P1|COMPLETED|Period 2 (D3)||8
2255135|NCT02424565|5534333|P2|STARTED|Period 2 (D3)||6
2255136|NCT02424565|5534334|P1|STARTED|Period 2 (D3)||8
2255137|NCT02424565|5534333|P2|NOT COMPLETED|Washout Period||0
2255138|NCT02424565|5534334|P1|NOT COMPLETED|Washout Period||0
2255139|NCT02424565|5534333|P2|COMPLETED|Washout Period||6
2255140|NCT02424565|5534334|P1|COMPLETED|Washout Period||8
2255141|NCT02424565|5534333|P2|STARTED|Washout Period||6
2255142|NCT02424565|5534334|P1|STARTED|Washout Period||8
2255143|NCT02424565|5534333|P2|NOT COMPLETED|Period 1 (D0)||1
2255144|NCT02424565|5534334|P1|NOT COMPLETED|Period 1 (D0)||0
2255145|NCT02424565|5534333|P2|COMPLETED|Period 1 (D0)||6
2255146|NCT02424565|5534334|P1|COMPLETED|Period 1 (D0)||8
2255147|NCT02424565|5534333|P2|STARTED|Period 1 (D0)||7
2255148|NCT02424565|5534334|P1|STARTED|Period 1 (D0)||8
2255149|NCT02424539|5534343|P3|NOT COMPLETED|Overall Study||8
2255150|NCT02424539|5534344|P2|NOT COMPLETED|Overall Study||8
2255151|NCT02424539|5534345|P1|NOT COMPLETED|Overall Study||14
2255152|NCT02424539|5534343|P3|COMPLETED|Overall Study||111
2255153|NCT02424539|5534344|P2|COMPLETED|Overall Study||111
2255154|NCT02424539|5534345|P1|COMPLETED|Overall Study||106
2255155|NCT02424539|5534343|P3|STARTED|Overall Study||119
2255156|NCT02424539|5534344|P2|STARTED|Overall Study||119
2255157|NCT02424539|5534345|P1|STARTED|Overall Study||120
2255158|NCT02424357|5534409|P2|NOT COMPLETED|Overall Study||0
2255159|NCT02424357|5534410|P1|NOT COMPLETED|Overall Study||0
2255160|NCT02424357|5534409|P2|COMPLETED|Overall Study||30
2255161|NCT02424357|5534410|P1|COMPLETED|Overall Study||35
2255162|NCT02424357|5534409|P2|STARTED|Overall Study||30
2255163|NCT02424357|5534410|P1|STARTED|Overall Study||35
2255164|NCT02424344|5534420|P2|NOT COMPLETED|Overall Study||10
2255165|NCT02424344|5534421|P1|NOT COMPLETED|Overall Study||7
2255166|NCT02424344|5534420|P2|COMPLETED|Overall Study||123
2255167|NCT02424344|5534421|P1|COMPLETED|Overall Study||127
2255168|NCT02424344|5534420|P2|STARTED|Overall Study||133
2255169|NCT02424344|5534421|P1|STARTED|Overall Study||134
2255170|NCT02424175|5534431|P1|NOT COMPLETED|Overall Study||0
2255171|NCT02424175|5534431|P1|COMPLETED|Overall Study||10
2255172|NCT02424175|5534431|P1|STARTED|Overall Study||10
2255173|NCT02424149|5534439|P2|NOT COMPLETED|Overall Study||1
2255174|NCT02424149|5534440|P1|NOT COMPLETED|Overall Study||2
2255175|NCT02424149|5534439|P2|COMPLETED|Overall Study||52
2255176|NCT02424149|5534440|P1|COMPLETED|Overall Study||52
2255177|NCT02424149|5534439|P2|STARTED|Overall Study||53
2255178|NCT02424149|5534440|P1|STARTED|Overall Study||54
2255179|NCT02424097|5534456|P2|NOT COMPLETED|Overall Study||2
2255180|NCT02424097|5534457|P1|NOT COMPLETED|Overall Study||1
2255181|NCT02424097|5534456|P2|COMPLETED|Overall Study||18
2255182|NCT02424097|5534457|P1|COMPLETED|Overall Study||19
2255183|NCT02424097|5534456|P2|STARTED|Overall Study||20
2255184|NCT02424097|5534457|P1|STARTED|Overall Study||20
2255185|NCT02423993|5534469|P4|NOT COMPLETED|Overall Study||0
2255186|NCT02423993|5534470|P3|NOT COMPLETED|Overall Study||0
2255187|NCT02423993|5534471|P2|NOT COMPLETED|Overall Study||0
2255188|NCT02423993|5534472|P1|NOT COMPLETED|Overall Study||0
2255189|NCT02423993|5534469|P4|COMPLETED|Overall Study||19
2255190|NCT02423993|5534470|P3|COMPLETED|Overall Study||23
2255191|NCT02423993|5534471|P2|COMPLETED|Overall Study||16
2255192|NCT02423993|5534472|P1|COMPLETED|Overall Study||19
2255193|NCT02423993|5534469|P4|STARTED|Overall Study||19
2255194|NCT02423993|5534470|P3|STARTED|Overall Study||23
2255195|NCT02423993|5534471|P2|STARTED|Overall Study||16
2255196|NCT02423993|5534472|P1|STARTED|Overall Study||19
2255197|NCT02423980|5534502|P1|NOT COMPLETED|Overall Study||0
2255198|NCT02423980|5534502|P1|COMPLETED|Overall Study||7
2255199|NCT02423980|5534502|P1|STARTED|Overall Study||7
2255200|NCT02423798|5534512|P1|NOT COMPLETED|Overall Study||3
2255201|NCT02423798|5534512|P1|COMPLETED|Overall Study||21
2255202|NCT02423798|5534512|P1|STARTED|Overall Study||24
2255203|NCT02423577|5534520|P2|NOT COMPLETED|Overall Study||0
2255204|NCT02423577|5534521|P1|NOT COMPLETED|Overall Study||0
2255205|NCT02423577|5534520|P2|COMPLETED|Overall Study||26
2255206|NCT02423577|5534521|P1|COMPLETED|Overall Study||53
2255207|NCT02423577|5534520|P2|STARTED|Overall Study||26
2255208|NCT02423577|5534521|P1|STARTED|Overall Study||53
2255209|NCT02423447|5534527|P2|NOT COMPLETED|Overall Study||0
2255210|NCT02423447|5534528|P1|NOT COMPLETED|Overall Study||0
2255211|NCT02423447|5534527|P2|COMPLETED|Overall Study||12
2255212|NCT02423447|5534528|P1|COMPLETED|Overall Study||13
2255213|NCT02423447|5534527|P2|STARTED|Overall Study||12
2255214|NCT02423447|5534528|P1|STARTED|Overall Study||13
2255215|NCT02423408|5534544|P2|NOT COMPLETED|Overall Study||2
2255216|NCT02423408|5534545|P1|NOT COMPLETED|Overall Study||1
2255217|NCT02423408|5534544|P2|COMPLETED|Overall Study||80
2255218|NCT02423408|5534545|P1|COMPLETED|Overall Study||82
2255219|NCT02423408|5534544|P2|STARTED|Overall Study||82
2255220|NCT02423408|5534545|P1|STARTED|Overall Study||83
2255221|NCT02423317|5534559|P2|NOT COMPLETED|Overall Study||0
2255222|NCT02423317|5534560|P1|NOT COMPLETED|Overall Study||0
2255223|NCT02423317|5534559|P2|COMPLETED|Overall Study||30
2255224|NCT02423317|5534560|P1|COMPLETED|Overall Study||30
2255225|NCT02423317|5534559|P2|STARTED|Overall Study||30
2255226|NCT02423317|5534560|P1|STARTED|Overall Study||30
2255227|NCT02423291|5534578|P1|NOT COMPLETED|Overall Study||15
2255228|NCT02423291|5534578|P1|COMPLETED|Overall Study|Patients that have completed therapy|0
2255229|NCT02423291|5534578|P1|STARTED|Overall Study|Patients enrolled|15
2255230|NCT02423200|5534584|P2|NOT COMPLETED|Overall Study||0
2255231|NCT02423200|5534585|P1|NOT COMPLETED|Overall Study||1
2255232|NCT02423200|5534584|P2|COMPLETED|Overall Study||1
2255233|NCT02423200|5534585|P1|COMPLETED|Overall Study||7
2255234|NCT02423200|5534584|P2|STARTED|Overall Study||1
2255235|NCT02423200|5534585|P1|STARTED|Overall Study||8
2255236|NCT02423122|5534595|P2|NOT COMPLETED|Overall Study||0
2255237|NCT02423122|5534596|P1|NOT COMPLETED|Overall Study||0
2255238|NCT02423122|5534595|P2|COMPLETED|Overall Study||7
2255239|NCT02423122|5534596|P1|COMPLETED|Overall Study||9
2255240|NCT02423122|5534595|P2|STARTED|Overall Study||7
2255241|NCT02423122|5534596|P1|STARTED|Overall Study||9
2255242|NCT02423109|5534608|P2|NOT COMPLETED|Lens 2||0
2255243|NCT02423109|5534609|P1|NOT COMPLETED|Lens 2||0
2255244|NCT02423109|5534608|P2|COMPLETED|Lens 2||14
2255245|NCT02423109|5534609|P1|COMPLETED|Lens 2||18
2255246|NCT02423109|5534608|P2|STARTED|Lens 2||14
2255247|NCT02423109|5534609|P1|STARTED|Lens 2||18
2255248|NCT02423109|5534608|P2|NOT COMPLETED|Lens 1||0
2255249|NCT02423109|5534609|P1|NOT COMPLETED|Lens 1||1
2255250|NCT02423109|5534608|P2|COMPLETED|Lens 1||14
2255251|NCT02423109|5534609|P1|COMPLETED|Lens 1||18
2255252|NCT02423109|5534608|P2|STARTED|Lens 1||14
2255253|NCT02423109|5534609|P1|STARTED|Lens 1||19
2255254|NCT02422940|5534619|P2|NOT COMPLETED|Overall Study||121
2255255|NCT02422940|5534620|P1|NOT COMPLETED|Overall Study||121
2255256|NCT02422940|5534619|P2|COMPLETED|Overall Study||21
2255257|NCT02422940|5534620|P1|COMPLETED|Overall Study||31
2255258|NCT02422940|5534619|P2|STARTED|Overall Study||142
2255259|NCT02422940|5534620|P1|STARTED|Overall Study||152
2255272|NCT02422615|5534731|P2|NOT COMPLETED|Overall Study||166
2255273|NCT02422615|5534732|P1|NOT COMPLETED|Overall Study||280
2255274|NCT02422615|5534731|P2|COMPLETED|Overall Study||76
2255275|NCT02422615|5534732|P1|COMPLETED|Overall Study||204
2255276|NCT02422615|5534731|P2|Untreated|Overall Study||1
2255277|NCT02422615|5534732|P1|Untreated|Overall Study||1
2255278|NCT02422615|5534731|P2|STARTED|Overall Study||242
2255279|NCT02422615|5534732|P1|STARTED|Overall Study||484
2255280|NCT02422446|5534740|P2|NOT COMPLETED|Overall Study||0
2255281|NCT02422446|5534741|P1|NOT COMPLETED|Overall Study||0
2255282|NCT02422446|5534740|P2|COMPLETED|Overall Study||1
2255283|NCT02422446|5534741|P1|COMPLETED|Overall Study||1
2255284|NCT02422446|5534740|P2|STARTED|Overall Study||1
2255285|NCT02422446|5534741|P1|STARTED|Overall Study||1
2255286|NCT02422303|5534749|P2|NOT COMPLETED|Overall Study||1
2255287|NCT02422303|5534750|P1|NOT COMPLETED|Overall Study||1
2255288|NCT02422303|5534749|P2|COMPLETED|Overall Study||5
2255289|NCT02422303|5534750|P1|COMPLETED|Overall Study||5
2255290|NCT02422303|5534749|P2|STARTED|Overall Study||6
2255291|NCT02422303|5534750|P1|STARTED|Overall Study||6
2255292|NCT02422264|5534758|P2|NOT COMPLETED|Overall Study||4
2255293|NCT02422264|5534759|P1|NOT COMPLETED|Overall Study||5
2255294|NCT02422264|5534758|P2|COMPLETED|Overall Study||301
2255295|NCT02422264|5534759|P1|COMPLETED|Overall Study||291
2255296|NCT02422264|5534758|P2|STARTED|Overall Study||305
2255297|NCT02422264|5534759|P1|STARTED|Overall Study||296
2255298|NCT02422186|5534805|P2|NOT COMPLETED|Follow-up Phase (2 Weeks)||0
2255299|NCT02422186|5534806|P1|NOT COMPLETED|Follow-up Phase (2 Weeks)||4
2255300|NCT02422186|5534805|P2|COMPLETED|Follow-up Phase (2 Weeks)||3
2255301|NCT02422186|5534806|P1|COMPLETED|Follow-up Phase (2 Weeks)||8
2255302|NCT02422186|5534805|P2|STARTED|Follow-up Phase (2 Weeks)||3
2255303|NCT02422186|5534806|P1|STARTED|Follow-up Phase (2 Weeks)||12
2255304|NCT02422186|5534805|P2|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
2255305|NCT02422186|5534806|P1|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||10
2255306|NCT02422186|5534805|P2|COMPLETED|Double-blind Induction Phase (4 Weeks)||60
2255307|NCT02422186|5534806|P1|COMPLETED|Double-blind Induction Phase (4 Weeks)||62
2255308|NCT02422186|5534805|P2|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||65
2255309|NCT02422186|5534806|P1|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||72
2255310|NCT02422186|5534805|P2|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||65
2255311|NCT02422186|5534806|P1|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||72
2255312|NCT02422186|5534805|P2|STARTED|Double-blind Induction Phase (4 Weeks)||66
2255313|NCT02422186|5534806|P1|STARTED|Double-blind Induction Phase (4 Weeks)||72
2255314|NCT02421939|5534830|P2|NOT COMPLETED|Overall Study||124
2255315|NCT02421939|5534831|P1|NOT COMPLETED|Overall Study||209
2255316|NCT02421939|5534830|P2|COMPLETED|Overall Study||0
2255317|NCT02421939|5534831|P1|COMPLETED|Overall Study||38
2255318|NCT02421939|5534830|P2|Treated|Overall Study||109
2255319|NCT02421939|5534831|P1|Treated|Overall Study||246
2255320|NCT02421939|5534830|P2|STARTED|Overall Study||124
2255321|NCT02421939|5534831|P1|STARTED|Overall Study||247
2255322|NCT02421887|5534859|P2|NOT COMPLETED|Overall Study||9
2255323|NCT02421887|5534860|P1|NOT COMPLETED|Overall Study||17
2255324|NCT02421887|5534859|P2|COMPLETED|Overall Study||77
2255325|NCT02421887|5534860|P1|COMPLETED|Overall Study||68
2255326|NCT02421887|5534859|P2|STARTED|Overall Study||86
2255327|NCT02421887|5534860|P1|STARTED|Overall Study||85
2255328|NCT02421510|5534887|P3|NOT COMPLETED|Overall Study||36
2255329|NCT02421510|5534888|P2|NOT COMPLETED|Overall Study||35
2255330|NCT02421510|5534889|P1|NOT COMPLETED|Overall Study||33
2255331|NCT02421510|5534887|P3|COMPLETED|Overall Study||227
2255332|NCT02421510|5534888|P2|COMPLETED|Overall Study||226
2255333|NCT02421510|5534889|P1|COMPLETED|Overall Study||225
2255334|NCT02421510|5534887|P3|Completed the 24 Week Treatment Period|Overall Study||240
2255335|NCT02421510|5534888|P2|Completed the 24 Week Treatment Period|Overall Study||239
2255336|NCT02421510|5534889|P1|Completed the 24 Week Treatment Period|Overall Study||236
2255337|NCT02421510|5534887|P3|STARTED|Overall Study||263
2255338|NCT02421510|5534888|P2|STARTED|Overall Study||261
2255339|NCT02421510|5534889|P1|STARTED|Overall Study||258
2255340|NCT02421419|5534921|P3|NOT COMPLETED|Overall Study||1
2255341|NCT02421419|5534922|P2|NOT COMPLETED|Overall Study||0
2255342|NCT02421419|5534923|P1|NOT COMPLETED|Overall Study||0
2255343|NCT02421419|5534921|P3|COMPLETED|Overall Study||8
2255344|NCT02421419|5534922|P2|COMPLETED|Overall Study||11
2255345|NCT02421419|5534923|P1|COMPLETED|Overall Study||6
2255346|NCT02421419|5534921|P3|STARTED|Overall Study||9
2255347|NCT02421419|5534922|P2|STARTED|Overall Study||11
2255348|NCT02421419|5534923|P1|STARTED|Overall Study||6
2255349|NCT02421354|5534940|P1|NOT COMPLETED|Overall Study||0
2255350|NCT02421354|5534940|P1|COMPLETED|Overall Study||8
2255351|NCT02421354|5534940|P1|STARTED|Overall Study||8
2255352|NCT02421211|5534946|P2|NOT COMPLETED|Overall Study||0
2255353|NCT02421211|5534947|P1|NOT COMPLETED|Overall Study||0
2255354|NCT02421211|5534946|P2|COMPLETED|Overall Study||20
2255355|NCT02421211|5534947|P1|COMPLETED|Overall Study||20
2255356|NCT02421211|5534946|P2|STARTED|Overall Study||20
2255357|NCT02421211|5534947|P1|STARTED|Overall Study||20
2255358|NCT02421172|5534993|P5|NOT COMPLETED|Period 2||1
2255359|NCT02421172|5534994|P4|NOT COMPLETED|Period 2||3
2255360|NCT02421172|5534995|P3|NOT COMPLETED|Period 2||7
2255361|NCT02421172|5534996|P2|NOT COMPLETED|Period 2||0
2255362|NCT02421172|5534997|P1|NOT COMPLETED|Period 2||0
2255363|NCT02421172|5534993|P5|COMPLETED|Period 2||14
2255364|NCT02421172|5534994|P4|COMPLETED|Period 2||13
2255365|NCT02421172|5534995|P3|COMPLETED|Period 2||22
2255366|NCT02421172|5534996|P2|COMPLETED|Period 2||0
2255367|NCT02421172|5534997|P1|COMPLETED|Period 2||0
2255368|NCT02421172|5534993|P5|STARTED|Period 2||15
2255369|NCT02421172|5534994|P4|STARTED|Period 2||16
2255370|NCT02421172|5534995|P3|STARTED|Period 2||29
2255371|NCT02421172|5534996|P2|STARTED|Period 2||0
2255372|NCT02421172|5534997|P1|STARTED|Period 2||0
2255373|NCT02421172|5534993|P5|NOT COMPLETED|Period 1||0
2255374|NCT02421172|5534994|P4|NOT COMPLETED|Period 1||0
2255375|NCT02421172|5534995|P3|NOT COMPLETED|Period 1||0
2255376|NCT02421172|5534996|P2|NOT COMPLETED|Period 1||2
2255377|NCT02421172|5534997|P1|NOT COMPLETED|Period 1||4
2255378|NCT02421172|5534993|P5|COMPLETED|Period 1||0
2255379|NCT02421172|5534994|P4|COMPLETED|Period 1||0
2255380|NCT02421172|5534995|P3|COMPLETED|Period 1||0
2255381|NCT02421172|5534996|P2|COMPLETED|Period 1||31
2255382|NCT02421172|5534997|P1|COMPLETED|Period 1||29
2255383|NCT02421172|5534993|P5|PK Analysis Set Period 1|Period 1||0
2255384|NCT02421172|5534994|P4|PK Analysis Set Period 1|Period 1||0
2255385|NCT02421172|5534995|P3|PK Analysis Set Period 1|Period 1||0
2255386|NCT02421172|5534996|P2|PK Analysis Set Period 1|Period 1||0
2255387|NCT02421172|5534997|P1|PK Analysis Set Period 1|Period 1||33
2255388|NCT02421172|5534993|P5|PD Analysis Set Period 1|Period 1||0
2255389|NCT02421172|5534994|P4|PD Analysis Set Period 1|Period 1||0
2255390|NCT02421172|5534995|P3|PD Analysis Set Period 1|Period 1||0
2255391|NCT02421172|5534996|P2|PD Analysis Set Period 1|Period 1||33
2255392|NCT02421172|5534997|P1|PD Analysis Set Period 1|Period 1||31
2255393|NCT02421172|5534993|P5|STARTED|Period 1||0
2255394|NCT02421172|5534994|P4|STARTED|Period 1||0
2255395|NCT02421172|5534995|P3|STARTED|Period 1||0
2255396|NCT02421172|5534996|P2|STARTED|Period 1||33
2255397|NCT02421172|5534997|P1|STARTED|Period 1||33
2255398|NCT02421146|5535024|P4|NOT COMPLETED|Overall Study||0
2255399|NCT02421146|5535025|P3|NOT COMPLETED|Overall Study||0
2255400|NCT02421146|5535026|P2|NOT COMPLETED|Overall Study||0
2255401|NCT02421146|5535027|P1|NOT COMPLETED|Overall Study||0
2255402|NCT02421146|5535024|P4|COMPLETED|Overall Study||3
2255403|NCT02421146|5535025|P3|COMPLETED|Overall Study||3
2255404|NCT02421146|5535026|P2|COMPLETED|Overall Study||4
2255405|NCT02421146|5535027|P1|COMPLETED|Overall Study||2
2255406|NCT02421146|5535024|P4|STARTED|Overall Study||3
2255407|NCT02421146|5535025|P3|STARTED|Overall Study||3
2255408|NCT02421146|5535026|P2|STARTED|Overall Study||4
2255409|NCT02421146|5535027|P1|STARTED|Overall Study||2
2255410|NCT02421120|5535041|P1|NOT COMPLETED|Overall Study||1
2255411|NCT02421120|5535041|P1|COMPLETED|Overall Study||20
2255412|NCT02421120|5535041|P1|STARTED|Overall Study||21
2255413|NCT02420951|5535051|P2|NOT COMPLETED|Overall Study||0
2255414|NCT02420951|5535052|P1|NOT COMPLETED|Overall Study||0
2255415|NCT02420951|5535051|P2|COMPLETED|Overall Study||25
2255416|NCT02420951|5535052|P1|COMPLETED|Overall Study||25
2255417|NCT02420951|5535051|P2|STARTED|Overall Study||25
2255418|NCT02420951|5535052|P1|STARTED|Overall Study||25
2255419|NCT02420873|5535071|P3|NOT COMPLETED|Overall Study||0
2255420|NCT02420873|5535072|P2|NOT COMPLETED|Overall Study||0
2255421|NCT02420873|5535073|P1|NOT COMPLETED|Overall Study||0
2255422|NCT02420873|5535071|P3|COMPLETED|Overall Study||0
2255423|NCT02420873|5535072|P2|COMPLETED|Overall Study||0
2255424|NCT02420873|5535073|P1|COMPLETED|Overall Study||9
2255425|NCT02420873|5535071|P3|STARTED|Overall Study||0
2255426|NCT02420873|5535072|P2|STARTED|Overall Study||0
2255427|NCT02420873|5535073|P1|STARTED|Overall Study||9
2255428|NCT02420821|5535083|P2|NOT COMPLETED|Overall Study||137
2255429|NCT02420821|5535084|P1|NOT COMPLETED|Overall Study||168
2255430|NCT02420821|5535083|P2|COMPLETED|Overall Study||317
2255431|NCT02420821|5535084|P1|COMPLETED|Overall Study||293
2255432|NCT02420821|5535083|P2|STARTED|Overall Study||454
2255433|NCT02420821|5535084|P1|STARTED|Overall Study||461
2255434|NCT02420353|5535154|P2|NOT COMPLETED|Overall Study||1
2255435|NCT02420353|5535155|P1|NOT COMPLETED|Overall Study||0
2255436|NCT02420353|5535154|P2|COMPLETED|Overall Study||9
2255437|NCT02420353|5535155|P1|COMPLETED|Overall Study||10
2255438|NCT02420353|5535154|P2|Allocation to Intervention|Overall Study||10
2255439|NCT02420353|5535155|P1|Allocation to Intervention|Overall Study||10
2255440|NCT02420353|5535154|P2|STARTED|Overall Study||10
2255441|NCT02420353|5535155|P1|STARTED|Overall Study||10
2255442|NCT02420327|5535247|P1|NOT COMPLETED|Overall Study||16
2255443|NCT02420327|5535247|P1|COMPLETED|Overall Study||27
2255444|NCT02420327|5535247|P1|STARTED|Overall Study||43
2255445|NCT02420262|5535283|P2|NOT COMPLETED|Overall Study||5
2255446|NCT02420262|5535284|P1|NOT COMPLETED|Overall Study||2
2255447|NCT02420262|5535283|P2|COMPLETED|Overall Study||249
2255448|NCT02420262|5535284|P1|COMPLETED|Overall Study||250
2255449|NCT02420262|5535283|P2|Exposed|Overall Study|One subject withdrew consent before exposure to trial product due to personal reasons.|253
2255450|NCT02420262|5535284|P1|Exposed|Overall Study||252
2255451|NCT02420262|5535283|P2|STARTED|Overall Study||254
2255452|NCT02420262|5535284|P1|STARTED|Overall Study||252
2255453|NCT02420210|5535298|P1|NOT COMPLETED|Overall Study||0
2255454|NCT02420210|5535298|P1|COMPLETED|Overall Study||2
2255455|NCT02420210|5535298|P1|STARTED|Overall Study||2
2255456|NCT02420093|5535310|P2|NOT COMPLETED|Overall Study||1
2255457|NCT02420093|5535311|P1|NOT COMPLETED|Overall Study||1
2255458|NCT02420093|5535310|P2|COMPLETED|Overall Study||7
2255459|NCT02420093|5535311|P1|COMPLETED|Overall Study||8
2255460|NCT02420093|5535310|P2|STARTED|Overall Study||8
2255461|NCT02420093|5535311|P1|STARTED|Overall Study||9
2255462|NCT02420041|5535327|P2|NOT COMPLETED|Overall Study||0
2255463|NCT02420041|5535328|P1|NOT COMPLETED|Overall Study||0
2255464|NCT02420041|5535327|P2|COMPLETED|Overall Study||14
2255465|NCT02420041|5535328|P1|COMPLETED|Overall Study||14
2255466|NCT02420041|5535327|P2|STARTED|Overall Study||14
2255467|NCT02420041|5535328|P1|STARTED|Overall Study||14
2255468|NCT02420015|5535354|P2|NOT COMPLETED|Overall Study||0
2255469|NCT02420015|5535355|P1|NOT COMPLETED|Overall Study||0
2255470|NCT02420015|5535354|P2|COMPLETED|Overall Study||13
2255471|NCT02420015|5535355|P1|COMPLETED|Overall Study||21
2255472|NCT02420015|5535354|P2|STARTED|Overall Study||13
2255473|NCT02420015|5535355|P1|STARTED|Overall Study||21
2255474|NCT02419937|5535373|P2|NOT COMPLETED|Overall Study||0
2255475|NCT02419937|5535374|P1|NOT COMPLETED|Overall Study||1
2255476|NCT02419937|5535373|P2|COMPLETED|Overall Study||16
2255477|NCT02419937|5535374|P1|COMPLETED|Overall Study||11
2255478|NCT02419937|5535373|P2|STARTED|Overall Study||16
2255479|NCT02419937|5535374|P1|STARTED|Overall Study||12
2255480|NCT02419755|5535382|P2|NOT COMPLETED|Overall Study||4
2255481|NCT02419755|5535383|P1|NOT COMPLETED|Overall Study||3
2255482|NCT02419755|5535382|P2|COMPLETED|Overall Study||2
2255483|NCT02419755|5535383|P1|COMPLETED|Overall Study||3
2255484|NCT02419755|5535382|P2|STARTED|Overall Study||6
2255485|NCT02419755|5535383|P1|STARTED|Overall Study||6
2255486|NCT02419612|5535409|P2|NOT COMPLETED|Overall Study||23
2255487|NCT02419612|5535410|P1|NOT COMPLETED|Overall Study||17
2255488|NCT02419612|5535409|P2|COMPLETED|Overall Study||194
2255489|NCT02419612|5535410|P1|COMPLETED|Overall Study||210
2255490|NCT02419612|5535409|P2|STARTED|Overall Study||217
2255491|NCT02419612|5535410|P1|STARTED|Overall Study||227
2255492|NCT02419573|5535426|P2|NOT COMPLETED|Overall Study||0
2255493|NCT02419573|5535427|P1|NOT COMPLETED|Overall Study||4
2255494|NCT02419573|5535426|P2|COMPLETED|Overall Study||1505
2255495|NCT02419573|5535427|P1|COMPLETED|Overall Study||1495
2255496|NCT02419573|5535426|P2|STARTED|Overall Study||1505
2255497|NCT02419573|5535427|P1|STARTED|Overall Study||1499
2255498|NCT02419547|5535439|P1|NOT COMPLETED|Overall Study||0
2255499|NCT02419547|5535439|P1|COMPLETED|Overall Study||11
2255500|NCT02419547|5535439|P1|STARTED|Overall Study||11
2255501|NCT02419521|5535443|P1|NOT COMPLETED|Overall Study||1
2255502|NCT02419521|5535443|P1|COMPLETED|Overall Study||74
2255503|NCT02419521|5535443|P1|STARTED|Overall Study||75
2255504|NCT02419508|5535457|P2|NOT COMPLETED|Overall Study||4
2255505|NCT02419508|5535458|P1|NOT COMPLETED|Overall Study||10
2255506|NCT02419508|5535457|P2|COMPLETED|Overall Study||88
2255507|NCT02419508|5535458|P1|COMPLETED|Overall Study||86
2255508|NCT02419508|5535457|P2|Safety Analysis Set|Overall Study||92
2255509|NCT02419508|5535458|P1|Safety Analysis Set|Overall Study||95
2255510|NCT02419508|5535457|P2|Full Analysis Set|Overall Study||92
2255511|NCT02419508|5535458|P1|Full Analysis Set|Overall Study||95
2255512|NCT02419508|5535457|P2|STARTED|Overall Study||92
2255513|NCT02419508|5535458|P1|STARTED|Overall Study||96
2255514|NCT02419469|5535476|P1|NOT COMPLETED|Overall Study||1
2255515|NCT02419469|5535476|P1|COMPLETED|Overall Study||0
2255516|NCT02419469|5535476|P1|STARTED|Overall Study||1
2255517|NCT02419313|5535480|P2|NOT COMPLETED|Second Intervention||0
2255518|NCT02419313|5535481|P1|NOT COMPLETED|Second Intervention||1
2255519|NCT02419313|5535480|P2|COMPLETED|Second Intervention||15
2255520|NCT02419313|5535481|P1|COMPLETED|Second Intervention||15
2255521|NCT02419313|5535480|P2|STARTED|Second Intervention||15
2255522|NCT02419313|5535481|P1|STARTED|Second Intervention||16
2255523|NCT02419313|5535480|P2|NOT COMPLETED|First Intervention||0
2255524|NCT02419313|5535481|P1|NOT COMPLETED|First Intervention||2
2255525|NCT02419313|5535480|P2|COMPLETED|First Intervention||15
2255526|NCT02419313|5535481|P1|COMPLETED|First Intervention||16
2255527|NCT02419313|5535480|P2|STARTED|First Intervention||15
2255528|NCT02419313|5535481|P1|STARTED|First Intervention||18
2255529|NCT02419001|5535493|P2|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
2255530|NCT02419001|5535494|P1|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
2255699|NCT02417935|5535854|P1|COMPLETED|Tapering Period||134
2255531|NCT02419001|5535493|P2|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
2255532|NCT02419001|5535494|P1|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
2255533|NCT02419001|5535493|P2|STARTED|Period 2- Ceftriaxone With SYN-004||5
2255534|NCT02419001|5535494|P1|STARTED|Period 2- Ceftriaxone With SYN-004||5
2255535|NCT02419001|5535493|P2|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||0
2255536|NCT02419001|5535494|P1|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||1
2255537|NCT02419001|5535493|P2|COMPLETED|Period 1- Ceftriaxone Without SYN-004||5
2255538|NCT02419001|5535494|P1|COMPLETED|Period 1- Ceftriaxone Without SYN-004|The Adverse Event (AE) was with ceftriaxone, not with Investigational Product (IP)|5
2255539|NCT02419001|5535493|P2|STARTED|Period 1- Ceftriaxone Without SYN-004||5
2255540|NCT02419001|5535494|P1|STARTED|Period 1- Ceftriaxone Without SYN-004||6
2255541|NCT02418910|5535504|P1|NOT COMPLETED|Overall Study||7
2255542|NCT02418910|5535504|P1|COMPLETED|Overall Study||43
2255543|NCT02418910|5535504|P1|STARTED|Overall Study||50
2255544|NCT02418819|5535512|P4|NOT COMPLETED|Overall Study||1
2255545|NCT02418819|5535513|P3|NOT COMPLETED|Overall Study||4
2255546|NCT02418819|5535514|P2|NOT COMPLETED|Overall Study||0
2255547|NCT02418819|5535515|P1|NOT COMPLETED|Overall Study||1
2255548|NCT02418819|5535512|P4|COMPLETED|Overall Study||28
2255549|NCT02418819|5535513|P3|COMPLETED|Overall Study||29
2255550|NCT02418819|5535514|P2|COMPLETED|Overall Study||16
2255551|NCT02418819|5535515|P1|COMPLETED|Overall Study||21
2255552|NCT02418819|5535512|P4|STARTED|Overall Study||29
2255553|NCT02418819|5535513|P3|STARTED|Overall Study||33
2255554|NCT02418819|5535514|P2|STARTED|Overall Study||16
2255555|NCT02418819|5535515|P1|STARTED|Overall Study||22
2255556|NCT02418676|5535558|P3|NOT COMPLETED|Overall Study||0
2255557|NCT02418676|5535559|P2|NOT COMPLETED|Overall Study||0
2255558|NCT02418676|5535560|P1|NOT COMPLETED|Overall Study||0
2255559|NCT02418676|5535558|P3|COMPLETED|Overall Study||5
2255560|NCT02418676|5535559|P2|COMPLETED|Overall Study||5
2255561|NCT02418676|5535560|P1|COMPLETED|Overall Study||5
2255562|NCT02418676|5535558|P3|STARTED|Overall Study||5
2255563|NCT02418676|5535559|P2|STARTED|Overall Study||5
2255564|NCT02418676|5535560|P1|STARTED|Overall Study||5
2255565|NCT02418585|5535573|P2|NOT COMPLETED|Follow-up Phase (24 Weeks)||25
2255566|NCT02418585|5535574|P1|NOT COMPLETED|Follow-up Phase (24 Weeks)||18
2255567|NCT02418585|5535573|P2|COMPLETED|Follow-up Phase (24 Weeks)||27
2255568|NCT02418585|5535574|P1|COMPLETED|Follow-up Phase (24 Weeks)||16
2255569|NCT02418585|5535573|P2|STARTED|Follow-up Phase (24 Weeks)||52
2255570|NCT02418585|5535574|P1|STARTED|Follow-up Phase (24 Weeks)||34
2255571|NCT02418585|5535573|P2|NOT COMPLETED|Double Blind (DB) Phase (4 Weeks)||12
2255572|NCT02418585|5535574|P1|NOT COMPLETED|Double Blind (DB) Phase (4 Weeks)||18
2255573|NCT02418585|5535573|P2|COMPLETED|Double Blind (DB) Phase (4 Weeks)||99
2255574|NCT02418585|5535574|P1|COMPLETED|Double Blind (DB) Phase (4 Weeks)||98
2255575|NCT02418585|5535573|P2|Full Analysis Set|Double Blind (DB) Phase (4 Weeks)||109
2255576|NCT02418585|5535574|P1|Full Analysis Set|Double Blind (DB) Phase (4 Weeks)||114
2255577|NCT02418585|5535573|P2|Safety Analysis Set|Double Blind (DB) Phase (4 Weeks)||109
2255578|NCT02418585|5535574|P1|Safety Analysis Set|Double Blind (DB) Phase (4 Weeks)||115
2255579|NCT02418585|5535573|P2|STARTED|Double Blind (DB) Phase (4 Weeks)||111
2255580|NCT02418585|5535574|P1|STARTED|Double Blind (DB) Phase (4 Weeks)||116
2255581|NCT02418468|5535614|P2|NOT COMPLETED|Overall Study||1
2255582|NCT02418468|5535615|P1|NOT COMPLETED|Overall Study||2
2255583|NCT02418468|5535614|P2|COMPLETED|Overall Study||10
2255584|NCT02418468|5535615|P1|COMPLETED|Overall Study||11
2255585|NCT02418468|5535614|P2|STARTED|Overall Study||11
2255586|NCT02418468|5535615|P1|STARTED|Overall Study||13
2255587|NCT02418455|5535621|P1|NOT COMPLETED|Continuation Period||7
2255588|NCT02418455|5535621|P1|COMPLETED|Continuation Period||0
2255589|NCT02418455|5535621|P1|STARTED|Continuation Period||7
2255590|NCT02418455|5535621|P1|NOT COMPLETED|48-Week Treatment Period||1
2255591|NCT02418455|5535621|P1|COMPLETED|48-Week Treatment Period||7
2255592|NCT02418455|5535621|P1|Emergency IND (eIND)|48-Week Treatment Period||1
2255593|NCT02418455|5535621|P1|STARTED|48-Week Treatment Period||8
2255594|NCT02418312|5535644|P2|NOT COMPLETED|Overall Study||0
2255595|NCT02418312|5535645|P1|NOT COMPLETED|Overall Study||0
2255596|NCT02418312|5535644|P2|COMPLETED|Overall Study||114
2255597|NCT02418312|5535645|P1|COMPLETED|Overall Study||114
2255598|NCT02418312|5535644|P2|STARTED|Overall Study||114
2255599|NCT02418312|5535645|P1|STARTED|Overall Study||114
2255600|NCT02418234|5535651|P1|NOT COMPLETED|Overall Study||0
2255601|NCT02418234|5535651|P1|COMPLETED|Overall Study||314
2255602|NCT02418234|5535651|P1|STARTED|Overall Study||314
2255609|NCT02418156|5535677|P1|NOT COMPLETED|Overall Study||17
2255610|NCT02418156|5535677|P1|COMPLETED|Overall Study||21
2255611|NCT02418156|5535677|P1|STARTED|Overall Study||38
2255612|NCT02418026|5535683|P2|NOT COMPLETED|Overall Study||0
2255613|NCT02418026|5535684|P1|NOT COMPLETED|Overall Study||0
2255614|NCT02418026|5535683|P2|COMPLETED|Overall Study||35
2255615|NCT02418026|5535684|P1|COMPLETED|Overall Study||44
2255616|NCT02418026|5535683|P2|STARTED|Overall Study||35
2255617|NCT02418026|5535684|P1|STARTED|Overall Study||44
2255618|NCT02418000|5535719|P5|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||4
2255619|NCT02418000|5535720|P4|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
2255620|NCT02418000|5535721|P3|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
2255621|NCT02418000|5535722|P2|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
2255622|NCT02418000|5535723|P1|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
2255623|NCT02418000|5535719|P5|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
2255624|NCT02418000|5535720|P4|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
2255625|NCT02418000|5535721|P3|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
2255626|NCT02418000|5535722|P2|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
2255627|NCT02418000|5535723|P1|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
2255628|NCT02418000|5535719|P5|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||4
2255629|NCT02418000|5535720|P4|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
2255630|NCT02418000|5535721|P3|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
2255631|NCT02418000|5535722|P2|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
2255632|NCT02418000|5535723|P1|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
2255633|NCT02418000|5535719|P5|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
2255634|NCT02418000|5535720|P4|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||3
2255635|NCT02418000|5535721|P3|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
2255636|NCT02418000|5535722|P2|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
2255637|NCT02418000|5535723|P1|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
2255638|NCT02418000|5535719|P5|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
2255639|NCT02418000|5535720|P4|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
2255640|NCT02418000|5535721|P3|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
2255641|NCT02418000|5535722|P2|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
2255642|NCT02418000|5535723|P1|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
2255643|NCT02418000|5535719|P5|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
2255644|NCT02418000|5535720|P4|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||3
2255645|NCT02418000|5535721|P3|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
2255646|NCT02418000|5535722|P2|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
2255647|NCT02418000|5535723|P1|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
2255648|NCT02418000|5535719|P5|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
2255649|NCT02418000|5535720|P4|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
2255650|NCT02418000|5535721|P3|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||3
2255651|NCT02418000|5535722|P2|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
2255652|NCT02418000|5535723|P1|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
2255653|NCT02418000|5535719|P5|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
2255654|NCT02418000|5535720|P4|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
2255655|NCT02418000|5535721|P3|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
2255656|NCT02418000|5535722|P2|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
2255657|NCT02418000|5535723|P1|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
2255658|NCT02418000|5535719|P5|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
2255659|NCT02418000|5535720|P4|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
2255660|NCT02418000|5535721|P3|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||3
2255661|NCT02418000|5535722|P2|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
2255662|NCT02418000|5535723|P1|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
2255663|NCT02418000|5535719|P5|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
2255664|NCT02418000|5535720|P4|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
2255665|NCT02418000|5535721|P3|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
2255666|NCT02418000|5535722|P2|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||10
2255667|NCT02418000|5535723|P1|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
2255668|NCT02418000|5535719|P5|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
2255669|NCT02418000|5535720|P4|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
2255670|NCT02418000|5535721|P3|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
2255671|NCT02418000|5535722|P2|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
2255672|NCT02418000|5535723|P1|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
2255673|NCT02418000|5535719|P5|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
2255674|NCT02418000|5535720|P4|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
2255675|NCT02418000|5535721|P3|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
2255676|NCT02418000|5535722|P2|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||10
2255677|NCT02418000|5535723|P1|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
2255678|NCT02418000|5535719|P5|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
2255679|NCT02418000|5535720|P4|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
2255680|NCT02418000|5535721|P3|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
2255681|NCT02418000|5535722|P2|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
2255682|NCT02418000|5535723|P1|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||7
2255683|NCT02418000|5535719|P5|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
2255684|NCT02418000|5535720|P4|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
2255685|NCT02418000|5535721|P3|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
2255686|NCT02418000|5535722|P2|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
2255687|NCT02418000|5535723|P1|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
2255688|NCT02418000|5535719|P5|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
2255689|NCT02418000|5535720|P4|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
2255690|NCT02418000|5535721|P3|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
2255691|NCT02418000|5535722|P2|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
2255692|NCT02418000|5535723|P1|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||7
2255693|NCT02417961|5535841|P1|NOT COMPLETED|Overall Study||4
2255694|NCT02417961|5535841|P1|COMPLETED|Overall Study||112
2255695|NCT02417961|5535841|P1|STARTED|Overall Study||116
2255696|NCT02417935|5535853|P2|NOT COMPLETED|Tapering Period||0
2255697|NCT02417935|5535854|P1|NOT COMPLETED|Tapering Period||0
2255698|NCT02417935|5535853|P2|COMPLETED|Tapering Period||142
2255700|NCT02417935|5535853|P2|STARTED|Tapering Period|Participants who discontinued treatment period had an option to enter the taper period|142
2255701|NCT02417935|5535854|P1|STARTED|Tapering Period|Participants who discontinued treatment period had an option to enter the taper period|134
2255702|NCT02417935|5535853|P2|NOT COMPLETED|Treatment Period||16
2255703|NCT02417935|5535854|P1|NOT COMPLETED|Treatment Period||21
2255704|NCT02417935|5535853|P2|COMPLETED|Treatment Period||137
2255705|NCT02417935|5535854|P1|COMPLETED|Treatment Period||130
2255706|NCT02417935|5535853|P2|Received at Least One Dose of Study Drug|Treatment Period||152
2255707|NCT02417935|5535854|P1|Received at Least One Dose of Study Drug|Treatment Period||151
2255708|NCT02417935|5535853|P2|STARTED|Treatment Period||153
2255709|NCT02417935|5535854|P1|STARTED|Treatment Period||151
2255710|NCT02417753|5535878|P1|NOT COMPLETED|Overall Study||1
2255711|NCT02417753|5535878|P1|COMPLETED|Overall Study||0
2255712|NCT02417753|5535878|P1|STARTED|Overall Study||1
2255713|NCT02417532|5535888|P1|NOT COMPLETED|Overall Study||0
2255714|NCT02417532|5535888|P1|COMPLETED|Overall Study||56
2255715|NCT02417532|5535888|P1|STARTED|Overall Study||56
2255716|NCT02417441|5535898|P2|NOT COMPLETED|Overall Study||19
2255717|NCT02417441|5535899|P1|NOT COMPLETED|Overall Study||52
2255718|NCT02417441|5535898|P2|COMPLETED|Overall Study||306
2255719|NCT02417441|5535899|P1|COMPLETED|Overall Study||593
2255720|NCT02417441|5535898|P2|STARTED|Overall Study||325
2255721|NCT02417441|5535899|P1|STARTED|Overall Study||645
2255722|NCT02417376|5535920|P2|NOT COMPLETED|Overall Study||10
2255723|NCT02417376|5535921|P1|NOT COMPLETED|Overall Study||5
2255724|NCT02417376|5535920|P2|COMPLETED|Overall Study||25
2255725|NCT02417376|5535921|P1|COMPLETED|Overall Study||30
2255726|NCT02417376|5535920|P2|STARTED|Overall Study||35
2255727|NCT02417376|5535921|P1|STARTED|Overall Study||35
2255728|NCT02417246|5535967|P2|NOT COMPLETED|Phase 4 2nd Generic Administered||0
2255729|NCT02417246|5535968|P1|NOT COMPLETED|Phase 4 2nd Generic Administered||0
2255730|NCT02417246|5535967|P2|COMPLETED|Phase 4 2nd Generic Administered||20
2255731|NCT02417246|5535968|P1|COMPLETED|Phase 4 2nd Generic Administered||18
2255732|NCT02417246|5535967|P2|STARTED|Phase 4 2nd Generic Administered||20
2255733|NCT02417246|5535968|P1|STARTED|Phase 4 2nd Generic Administered||18
2255734|NCT02417246|5535967|P2|NOT COMPLETED|Phase 3 Brand Name Metoprolol ER #2||0
2255735|NCT02417246|5535968|P1|NOT COMPLETED|Phase 3 Brand Name Metoprolol ER #2||1
2255736|NCT02417246|5535967|P2|COMPLETED|Phase 3 Brand Name Metoprolol ER #2||20
2255737|NCT02417246|5535968|P1|COMPLETED|Phase 3 Brand Name Metoprolol ER #2||18
2255738|NCT02417246|5535967|P2|STARTED|Phase 3 Brand Name Metoprolol ER #2||20
2255739|NCT02417246|5535968|P1|STARTED|Phase 3 Brand Name Metoprolol ER #2||19
2255740|NCT02417246|5535967|P2|NOT COMPLETED|Phase 2 1st Generic Administered||0
2255741|NCT02417246|5535968|P1|NOT COMPLETED|Phase 2 1st Generic Administered||1
2255742|NCT02417246|5535967|P2|COMPLETED|Phase 2 1st Generic Administered||20
2255743|NCT02417246|5535968|P1|COMPLETED|Phase 2 1st Generic Administered||19
2255744|NCT02417246|5535967|P2|STARTED|Phase 2 1st Generic Administered||20
2255745|NCT02417246|5535968|P1|STARTED|Phase 2 1st Generic Administered||20
2255746|NCT02417246|5535967|P2|NOT COMPLETED|Phase 1 Brand Name Metoprolol ER||4
2255747|NCT02417246|5535968|P1|NOT COMPLETED|Phase 1 Brand Name Metoprolol ER||4
2255748|NCT02417246|5535967|P2|COMPLETED|Phase 1 Brand Name Metoprolol ER||20
2255749|NCT02417246|5535968|P1|COMPLETED|Phase 1 Brand Name Metoprolol ER||20
2255750|NCT02417246|5535967|P2|STARTED|Phase 1 Brand Name Metoprolol ER||24
2255751|NCT02417246|5535968|P1|STARTED|Phase 1 Brand Name Metoprolol ER||24
2255752|NCT02417233|5535991|P3|NOT COMPLETED|Overall Study||59
2255753|NCT02417233|5535992|P2|NOT COMPLETED|Overall Study||51
2255754|NCT02417233|5535993|P1|NOT COMPLETED|Overall Study||36
2255755|NCT02417233|5535991|P3|COMPLETED|Overall Study||239
2255756|NCT02417233|5535992|P2|COMPLETED|Overall Study||238
2255757|NCT02417233|5535993|P1|COMPLETED|Overall Study||133
2255758|NCT02417233|5535991|P3|STARTED|Overall Study||298
2255759|NCT02417233|5535992|P2|STARTED|Overall Study||289
2255760|NCT02417233|5535993|P1|STARTED|Overall Study||169
2255761|NCT02417129|5536016|P2|NOT COMPLETED|Overall Study||0
2255762|NCT02417129|5536017|P1|NOT COMPLETED|Overall Study||0
2255763|NCT02417129|5536016|P2|COMPLETED|Overall Study||0
2255764|NCT02417129|5536017|P1|COMPLETED|Overall Study||2
2255765|NCT02417129|5536016|P2|STARTED|Overall Study||0
2255766|NCT02417129|5536017|P1|STARTED|Overall Study||2
2255767|NCT02417064|5536030|P3|NOT COMPLETED|Follow-up Phase (24 Weeks)||51
2255768|NCT02417064|5536031|P2|NOT COMPLETED|Follow-up Phase (24 Weeks)||42
2255769|NCT02417064|5536032|P1|NOT COMPLETED|Follow-up Phase (24 Weeks)||39
2255770|NCT02417064|5536030|P3|COMPLETED|Follow-up Phase (24 Weeks)||18
2255771|NCT02417064|5536031|P2|COMPLETED|Follow-up Phase (24 Weeks)||10
2255772|NCT02417064|5536032|P1|COMPLETED|Follow-up Phase (24 Weeks)||8
2255773|NCT02417064|5536030|P3|STARTED|Follow-up Phase (24 Weeks)||69
2255774|NCT02417064|5536031|P2|STARTED|Follow-up Phase (24 Weeks)||52
2255775|NCT02417064|5536032|P1|STARTED|Follow-up Phase (24 Weeks)||47
2255776|NCT02417064|5536030|P3|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
2255777|NCT02417064|5536031|P2|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||19
2255778|NCT02417064|5536032|P1|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
2255779|NCT02417064|5536030|P3|COMPLETED|Double-blind Induction Phase (4 Weeks)||107
2255780|NCT02417064|5536031|P2|COMPLETED|Double-blind Induction Phase (4 Weeks)||97
2255781|NCT02417064|5536032|P1|COMPLETED|Double-blind Induction Phase (4 Weeks)||111
2255782|NCT02417064|5536030|P3|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||113
2255783|NCT02417064|5536031|P2|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||116
2255784|NCT02417064|5536032|P1|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||115
2255785|NCT02417064|5536030|P3|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||113
2255786|NCT02417064|5536031|P2|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||114
2255787|NCT02417064|5536032|P1|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||115
2255788|NCT02417064|5536030|P3|STARTED|Double-blind Induction Phase (4 Weeks)||113
2255789|NCT02417064|5536031|P2|STARTED|Double-blind Induction Phase (4 Weeks)||116
2255790|NCT02417064|5536032|P1|STARTED|Double-blind Induction Phase (4 Weeks)||117
2255791|NCT02416973|5536091|P3|NOT COMPLETED|Overall Study||1
2255792|NCT02416973|5536092|P2|NOT COMPLETED|Overall Study||3
2255793|NCT02416973|5536093|P1|NOT COMPLETED|Overall Study||1
2255794|NCT02416973|5536091|P3|COMPLETED|Overall Study||13
2255795|NCT02416973|5536092|P2|COMPLETED|Overall Study||10
2255796|NCT02416973|5536093|P1|COMPLETED|Overall Study||13
2255797|NCT02416973|5536091|P3|STARTED|Overall Study||14
2255798|NCT02416973|5536092|P2|STARTED|Overall Study||13
2255799|NCT02416973|5536093|P1|STARTED|Overall Study||14
2255800|NCT02416934|5536103|P2|NOT COMPLETED|Overall Study||7
2255801|NCT02416934|5536104|P1|NOT COMPLETED|Overall Study||3
2255802|NCT02416934|5536103|P2|COMPLETED|Overall Study||31
2255803|NCT02416934|5536104|P1|COMPLETED|Overall Study||33
2255804|NCT02416934|5536103|P2|Last Participant Completed 1 yr|Overall Study||31
2255805|NCT02416934|5536104|P1|Last Participant Completed 1 yr|Overall Study||33
2255806|NCT02416934|5536103|P2|Double Blind (0-52 Weeks)|Overall Study||38
2255807|NCT02416934|5536104|P1|Double Blind (0-52 Weeks)|Overall Study||36
2255808|NCT02416934|5536103|P2|STARTED|Overall Study||38
2255809|NCT02416934|5536104|P1|STARTED|Overall Study||36
2255810|NCT02416713|5536120|P4|NOT COMPLETED|Overall Study||0
2255811|NCT02416713|5536121|P3|NOT COMPLETED|Overall Study||0
2255812|NCT02416713|5536122|P2|NOT COMPLETED|Overall Study||0
2255813|NCT02416713|5536123|P1|NOT COMPLETED|Overall Study||0
2255814|NCT02416713|5536120|P4|COMPLETED|Overall Study||10
2255815|NCT02416713|5536121|P3|COMPLETED|Overall Study||8
2255816|NCT02416713|5536122|P2|COMPLETED|Overall Study||9
2255817|NCT02416713|5536123|P1|COMPLETED|Overall Study||8
2255818|NCT02416713|5536120|P4|STARTED|Overall Study||10
2255819|NCT02416713|5536121|P3|STARTED|Overall Study||8
2255820|NCT02416713|5536122|P2|STARTED|Overall Study||9
2255821|NCT02416713|5536123|P1|STARTED|Overall Study||8
2255822|NCT02416180|5536133|P1|NOT COMPLETED|Overall Study||1
2255823|NCT02416180|5536133|P1|COMPLETED|Overall Study||110
2255824|NCT02416180|5536133|P1|STARTED|Overall Study||111
2255825|NCT02415959|5536145|P5|NOT COMPLETED|Overall Study||0
2255826|NCT02415959|5536146|P4|NOT COMPLETED|Overall Study||1
2255827|NCT02415959|5536147|P3|NOT COMPLETED|Overall Study||0
2255828|NCT02415959|5536148|P2|NOT COMPLETED|Overall Study||1
2255829|NCT02415959|5536149|P1|NOT COMPLETED|Overall Study||0
2255830|NCT02415959|5536145|P5|COMPLETED|Overall Study||14
2255831|NCT02415959|5536146|P4|COMPLETED|Overall Study||13
2255832|NCT02415959|5536147|P3|COMPLETED|Overall Study||14
2255833|NCT02415959|5536148|P2|COMPLETED|Overall Study||13
2255834|NCT02415959|5536149|P1|COMPLETED|Overall Study||14
2255835|NCT02415959|5536145|P5|STARTED|Overall Study||14
2255836|NCT02415959|5536146|P4|STARTED|Overall Study||14
2255837|NCT02415959|5536147|P3|STARTED|Overall Study||14
2255838|NCT02415959|5536148|P2|STARTED|Overall Study||14
2255839|NCT02415959|5536149|P1|STARTED|Overall Study||14
2255840|NCT02415842|5536194|P13|NOT COMPLETED|Overall Study||0
2255841|NCT02415842|5536195|P12|NOT COMPLETED|Overall Study||0
2255842|NCT02415842|5536196|P11|NOT COMPLETED|Overall Study||0
2255843|NCT02415842|5536197|P10|NOT COMPLETED|Overall Study||0
2255844|NCT02415842|5536198|P9|NOT COMPLETED|Overall Study||0
2255845|NCT02415842|5536199|P8|NOT COMPLETED|Overall Study||0
2255846|NCT02415842|5536200|P7|NOT COMPLETED|Overall Study||0
2255847|NCT02415842|5536201|P6|NOT COMPLETED|Overall Study||0
2255848|NCT02415842|5536202|P5|NOT COMPLETED|Overall Study||0
2255849|NCT02415842|5536203|P4|NOT COMPLETED|Overall Study||0
2255850|NCT02415842|5536204|P3|NOT COMPLETED|Overall Study||0
2255851|NCT02415842|5536205|P2|NOT COMPLETED|Overall Study||0
2255852|NCT02415842|5536206|P1|NOT COMPLETED|Overall Study||0
2255853|NCT02415842|5536194|P13|COMPLETED|Overall Study||20
2255854|NCT02415842|5536195|P12|COMPLETED|Overall Study||33
2255855|NCT02415842|5536196|P11|COMPLETED|Overall Study||49
2255856|NCT02415842|5536197|P10|COMPLETED|Overall Study||53
2255857|NCT02415842|5536198|P9|COMPLETED|Overall Study||29
2255858|NCT02415842|5536199|P8|COMPLETED|Overall Study||26
2255859|NCT02415842|5536200|P7|COMPLETED|Overall Study||30
2255860|NCT02415842|5536201|P6|COMPLETED|Overall Study||30
2255861|NCT02415842|5536202|P5|COMPLETED|Overall Study||30
2255862|NCT02415842|5536203|P4|COMPLETED|Overall Study||27
2255863|NCT02415842|5536204|P3|COMPLETED|Overall Study||29
2255864|NCT02415842|5536205|P2|COMPLETED|Overall Study||29
2255865|NCT02415842|5536206|P1|COMPLETED|Overall Study||29
2255866|NCT02415842|5536194|P13|STARTED|Overall Study||20
2255867|NCT02415842|5536195|P12|STARTED|Overall Study||33
2255868|NCT02415842|5536196|P11|STARTED|Overall Study||49
2255869|NCT02415842|5536197|P10|STARTED|Overall Study||53
2255870|NCT02415842|5536198|P9|STARTED|Overall Study||29
2255871|NCT02415842|5536199|P8|STARTED|Overall Study||26
2255872|NCT02415842|5536200|P7|STARTED|Overall Study||30
2255873|NCT02415842|5536201|P6|STARTED|Overall Study||30
2255874|NCT02415842|5536202|P5|STARTED|Overall Study||30
2255875|NCT02415842|5536203|P4|STARTED|Overall Study||27
2255876|NCT02415842|5536204|P3|STARTED|Overall Study||29
2255877|NCT02415842|5536205|P2|STARTED|Overall Study||29
2255878|NCT02415842|5536206|P1|STARTED|Overall Study||29
2255879|NCT02415608|5536547|P2|NOT COMPLETED|Overall Study||0
2255880|NCT02415608|5536548|P1|NOT COMPLETED|Overall Study||0
2255881|NCT02415608|5536547|P2|COMPLETED|Overall Study||1
2255882|NCT02415608|5536548|P1|COMPLETED|Overall Study||3
2255883|NCT02415608|5536547|P2|STARTED|Overall Study||1
2255884|NCT02415608|5536548|P1|STARTED|Overall Study||3
2255885|NCT02415595|5536578|P4|NOT COMPLETED|Overall Study||53
2255886|NCT02415595|5536579|P3|NOT COMPLETED|Overall Study||51
2255887|NCT02415595|5536580|P2|NOT COMPLETED|Overall Study||52
2255888|NCT02415595|5536581|P1|NOT COMPLETED|Overall Study||50
2255889|NCT02415595|5536578|P4|COMPLETED|Overall Study||0
2255890|NCT02415595|5536579|P3|COMPLETED|Overall Study||0
2255891|NCT02415595|5536580|P2|COMPLETED|Overall Study||0
2255892|NCT02415595|5536581|P1|COMPLETED|Overall Study||0
2255893|NCT02415595|5536578|P4|STARTED|Overall Study||53
2255894|NCT02415595|5536579|P3|STARTED|Overall Study||51
2255895|NCT02415595|5536580|P2|STARTED|Overall Study||52
2255896|NCT02415595|5536581|P1|STARTED|Overall Study||50
2255897|NCT02415439|5536653|P13|NOT COMPLETED|Overall Study||0
2255898|NCT02415439|5536654|P12|NOT COMPLETED|Overall Study||0
2255899|NCT02415439|5536655|P11|NOT COMPLETED|Overall Study||0
2255900|NCT02415439|5536656|P10|NOT COMPLETED|Overall Study||0
2255901|NCT02415439|5536657|P9|NOT COMPLETED|Overall Study||1
2255902|NCT02415439|5536658|P8|NOT COMPLETED|Overall Study||0
2255903|NCT02415439|5536659|P7|NOT COMPLETED|Overall Study||0
2255904|NCT02415439|5536660|P6|NOT COMPLETED|Overall Study||0
2255905|NCT02415439|5536661|P5|NOT COMPLETED|Overall Study||0
2255906|NCT02415439|5536662|P4|NOT COMPLETED|Overall Study||0
2255907|NCT02415439|5536663|P3|NOT COMPLETED|Overall Study||0
2255908|NCT02415439|5536664|P2|NOT COMPLETED|Overall Study||0
2255909|NCT02415439|5536665|P1|NOT COMPLETED|Overall Study||0
2255910|NCT02415439|5536653|P13|COMPLETED|Overall Study||8
2255911|NCT02415439|5536654|P12|COMPLETED|Overall Study||6
2255912|NCT02415439|5536655|P11|COMPLETED|Overall Study||6
2255913|NCT02415439|5536656|P10|COMPLETED|Overall Study||6
2255914|NCT02415439|5536657|P9|COMPLETED|Overall Study||5
2255915|NCT02415439|5536658|P8|COMPLETED|Overall Study||12
2255916|NCT02415439|5536659|P7|COMPLETED|Overall Study||6
2255917|NCT02415439|5536660|P6|COMPLETED|Overall Study||6
2255918|NCT02415439|5536661|P5|COMPLETED|Overall Study||6
2255919|NCT02415439|5536662|P4|COMPLETED|Overall Study||6
2255920|NCT02415439|5536663|P3|COMPLETED|Overall Study||6
2255921|NCT02415439|5536664|P2|COMPLETED|Overall Study||6
2255922|NCT02415439|5536665|P1|COMPLETED|Overall Study||6
2255923|NCT02415439|5536653|P13|STARTED|Overall Study||8
2255924|NCT02415439|5536654|P12|STARTED|Overall Study||6
2255925|NCT02415439|5536655|P11|STARTED|Overall Study||6
2255926|NCT02415439|5536656|P10|STARTED|Overall Study||6
2255927|NCT02415439|5536657|P9|STARTED|Overall Study||6
2255928|NCT02415439|5536658|P8|STARTED|Overall Study||12
2255929|NCT02415439|5536659|P7|STARTED|Overall Study||6
2255930|NCT02415439|5536660|P6|STARTED|Overall Study||6
2255931|NCT02415439|5536661|P5|STARTED|Overall Study||6
2255932|NCT02415439|5536662|P4|STARTED|Overall Study||6
2255933|NCT02415439|5536663|P3|STARTED|Overall Study||6
2255934|NCT02415439|5536664|P2|STARTED|Overall Study||6
2255935|NCT02415439|5536665|P1|STARTED|Overall Study||6
2255936|NCT02415400|5536723|P4|NOT COMPLETED|Overall Study||83
2255937|NCT02415400|5536724|P3|NOT COMPLETED|Overall Study||85
2255938|NCT02415400|5536725|P2|NOT COMPLETED|Overall Study||62
2255939|NCT02415400|5536726|P1|NOT COMPLETED|Overall Study||66
2255940|NCT02415400|5536723|P4|COMPLETED|Overall Study||1071
2255941|NCT02415400|5536724|P3|COMPLETED|Overall Study||1069
2255942|NCT02415400|5536725|P2|COMPLETED|Overall Study||1091
2255943|NCT02415400|5536726|P1|COMPLETED|Overall Study||1087
2255944|NCT02415400|5536723|P4|STARTED|Overall Study||1154
2255945|NCT02415400|5536724|P3|STARTED|Overall Study||1154
2255946|NCT02415400|5536725|P2|STARTED|Overall Study||1153
2255947|NCT02415400|5536726|P1|STARTED|Overall Study||1153
2255948|NCT02415244|5536752|P2|NOT COMPLETED|Overall Study||0
2255949|NCT02415244|5536753|P1|NOT COMPLETED|Overall Study||0
2255950|NCT02415244|5536752|P2|COMPLETED|Overall Study||25
2255951|NCT02415244|5536753|P1|COMPLETED|Overall Study||50
2255952|NCT02415244|5536752|P2|STARTED|Overall Study||25
2255953|NCT02415244|5536753|P1|STARTED|Overall Study||50
2255954|NCT02415166|5536763|P4|NOT COMPLETED|Overall Study||0
2255955|NCT02415166|5536764|P3|NOT COMPLETED|Overall Study||0
2255956|NCT02415166|5536765|P2|NOT COMPLETED|Overall Study||0
2255957|NCT02415166|5536766|P1|NOT COMPLETED|Overall Study||0
2255958|NCT02415166|5536763|P4|COMPLETED|Overall Study||0
2255959|NCT02415166|5536764|P3|COMPLETED|Overall Study||0
2255960|NCT02415166|5536765|P2|COMPLETED|Overall Study||0
2255961|NCT02415166|5536766|P1|COMPLETED|Overall Study||6
2255962|NCT02415166|5536763|P4|STARTED|Overall Study||0
2255963|NCT02415166|5536764|P3|STARTED|Overall Study||0
2255964|NCT02415166|5536765|P2|STARTED|Overall Study||0
2255965|NCT02415166|5536766|P1|STARTED|Overall Study||6
2255966|NCT02415127|5536794|P2|NOT COMPLETED|Overall Study||0
2255967|NCT02415127|5536795|P1|NOT COMPLETED|Overall Study||1
2255968|NCT02415127|5536794|P2|COMPLETED|Overall Study||45
2255969|NCT02415127|5536795|P1|COMPLETED|Overall Study||46
2255970|NCT02415127|5536794|P2|STARTED|Overall Study||45
2255971|NCT02415127|5536795|P1|STARTED|Overall Study||47
2255972|NCT02414958|5536812|P3|NOT COMPLETED|Overall Study||14
2255973|NCT02414958|5536813|P2|NOT COMPLETED|Overall Study||20
2255974|NCT02414958|5536814|P1|NOT COMPLETED|Overall Study||32
2255975|NCT02414958|5536812|P3|COMPLETED|Overall Study||230
2255976|NCT02414958|5536813|P2|COMPLETED|Overall Study||223
2255977|NCT02414958|5536814|P1|COMPLETED|Overall Study||211
2255978|NCT02414958|5536812|P3|STARTED|Overall Study||244
2255979|NCT02414958|5536813|P2|STARTED|Overall Study||243
2255980|NCT02414958|5536814|P1|STARTED|Overall Study||243
2255981|NCT02414854|5536847|P4|NOT COMPLETED|Overall Study||51
2255982|NCT02414854|5536848|P3|NOT COMPLETED|Overall Study||20
2255983|NCT02414854|5536849|P2|NOT COMPLETED|Overall Study||45
2255984|NCT02414854|5536850|P1|NOT COMPLETED|Overall Study||22
2255985|NCT02414854|5536847|P4|COMPLETED|Overall Study||582
2255986|NCT02414854|5536848|P3|COMPLETED|Overall Study||301
2255987|NCT02414854|5536849|P2|COMPLETED|Overall Study||586
2255988|NCT02414854|5536850|P1|COMPLETED|Overall Study||295
2255989|NCT02414854|5536847|P4|Treated|Overall Study|1 got other treatment (dupilumab 200) than assigned + was allocated to that in AE table|632
2255990|NCT02414854|5536848|P3|Treated|Overall Study||321
2255991|NCT02414854|5536849|P2|Treated|Overall Study||629
2255992|NCT02414854|5536850|P1|Treated|Overall Study|2 got other treatment (1 each dupilumab 200+300) than assigned + were allocated to those in AE table|315
2255993|NCT02414854|5536847|P4|STARTED|Overall Study||633
2255994|NCT02414854|5536848|P3|STARTED|Overall Study||321
2255995|NCT02414854|5536849|P2|STARTED|Overall Study||631
2255996|NCT02414854|5536850|P1|STARTED|Overall Study||317
2255997|NCT02414841|5537014|P2|NOT COMPLETED|Overall Study||33
2255998|NCT02414841|5537015|P1|NOT COMPLETED|Overall Study||56
2255999|NCT02414841|5537014|P2|COMPLETED|Overall Study||175
2256000|NCT02414841|5537015|P1|COMPLETED|Overall Study||349
2256001|NCT02414841|5537014|P2|STARTED|Overall Study||208
2256002|NCT02414841|5537015|P1|STARTED|Overall Study||405
2256003|NCT02414828|5537027|P4|NOT COMPLETED|Overall Study||2
2256004|NCT02414828|5537028|P3|NOT COMPLETED|Overall Study||1
2256005|NCT02414828|5537029|P2|NOT COMPLETED|Overall Study||1
2256006|NCT02414828|5537030|P1|NOT COMPLETED|Overall Study||0
2256007|NCT02414828|5537027|P4|COMPLETED|Overall Study||29
2256008|NCT02414828|5537028|P3|COMPLETED|Overall Study||19
2256009|NCT02414828|5537029|P2|COMPLETED|Overall Study||9
2256010|NCT02414828|5537030|P1|COMPLETED|Overall Study||11
2256011|NCT02414828|5537027|P4|STARTED|Overall Study||31
2256012|NCT02414828|5537028|P3|STARTED|Overall Study||20
2256013|NCT02414828|5537029|P2|STARTED|Overall Study||10
2256014|NCT02414828|5537030|P1|STARTED|Overall Study||11
2256015|NCT02414698|5537070|P2|NOT COMPLETED|Overall Study||0
2256016|NCT02414698|5537071|P1|NOT COMPLETED|Overall Study||0
2256017|NCT02414698|5537070|P2|COMPLETED|Overall Study||1
2256018|NCT02414698|5537071|P1|COMPLETED|Overall Study||3
2256019|NCT02414698|5537070|P2|STARTED|Overall Study||1
2256020|NCT02414698|5537071|P1|STARTED|Overall Study||3
2256021|NCT02414633|5537081|P1|NOT COMPLETED|Overall Study||0
2256022|NCT02414633|5537081|P1|COMPLETED|Overall Study||148
2256023|NCT02414633|5537081|P1|STARTED|Overall Study||148
2256024|NCT02414243|5537104|P2|NOT COMPLETED|Overall Study||4
2256025|NCT02414243|5537105|P1|NOT COMPLETED|Overall Study||6
2256026|NCT02414243|5537104|P2|COMPLETED|Overall Study||17
2256027|NCT02414243|5537105|P1|COMPLETED|Overall Study||13
2256028|NCT02414243|5537104|P2|Entered Open Challenge at Home|Overall Study||20
2256029|NCT02414243|5537105|P1|Entered Open Challenge at Home|Overall Study||17
2256030|NCT02414243|5537104|P2|Moved to the Other Group|Overall Study||20
2256031|NCT02414243|5537105|P1|Moved to the Other Group|Overall Study||17
2256032|NCT02414243|5537104|P2|STARTED|Overall Study||21
2256033|NCT02414243|5537105|P1|STARTED|Overall Study||19
2256034|NCT02414204|5537114|P2|NOT COMPLETED|Overall Study||0
2256035|NCT02414204|5537115|P1|NOT COMPLETED|Overall Study||0
2256036|NCT02414204|5537114|P2|COMPLETED|Overall Study||2
2256037|NCT02414204|5537115|P1|COMPLETED|Overall Study||2
2256038|NCT02414204|5537114|P2|STARTED|Overall Study||2
2256039|NCT02414204|5537115|P1|STARTED|Overall Study||2
2256040|NCT02414152|5537123|P1|NOT COMPLETED|Overall Study||2
2256041|NCT02414152|5537123|P1|COMPLETED|Overall Study|Both subjects completed 56 days of anakinra but did not complete all visits in observational period|0
2256042|NCT02414152|5537123|P1|STARTED|Overall Study||2
2256043|NCT02413996|5537129|P2|NOT COMPLETED|Overall Study||2
2256044|NCT02413996|5537130|P1|NOT COMPLETED|Overall Study||9
2256045|NCT02413996|5537129|P2|COMPLETED|Overall Study||39
2256046|NCT02413996|5537130|P1|COMPLETED|Overall Study||35
2256047|NCT02413996|5537129|P2|STARTED|Overall Study||41
2256048|NCT02413996|5537130|P1|STARTED|Overall Study||44
2256049|NCT02413918|5537152|P1|NOT COMPLETED|Overall Study||25
2256050|NCT02413918|5537152|P1|COMPLETED|Overall Study||16
2256051|NCT02413918|5537152|P1|STARTED|Overall Study||41
2256052|NCT02413879|5537159|P1|NOT COMPLETED|Overall Study||0
2256053|NCT02413879|5537159|P1|COMPLETED|Overall Study||86
2256054|NCT02413879|5537159|P1|STARTED|Overall Study||86
2256055|NCT02413684|5537165|P1|NOT COMPLETED|Overall Study||13
2256056|NCT02413684|5537165|P1|COMPLETED|Overall Study||40
2256057|NCT02413684|5537165|P1|STARTED|Overall Study||53
2256058|NCT02413593|5537175|P1|NOT COMPLETED|Overall Study||4
2256059|NCT02413593|5537175|P1|COMPLETED|Overall Study||107
2256060|NCT02413593|5537175|P1|STARTED|Overall Study||111
2256061|NCT02413489|5537187|P3|NOT COMPLETED|Overall Study||5
2256062|NCT02413489|5537188|P2|NOT COMPLETED|Overall Study||16
2256063|NCT02413489|5537189|P1|NOT COMPLETED|Overall Study||15
2256064|NCT02413489|5537187|P3|COMPLETED|Overall Study||0
2256065|NCT02413489|5537188|P2|COMPLETED|Overall Study||0
2256066|NCT02413489|5537189|P1|COMPLETED|Overall Study||0
2256067|NCT02413489|5537187|P3|STARTED|Overall Study||5
2256068|NCT02413489|5537188|P2|STARTED|Overall Study||16
2256069|NCT02413489|5537189|P1|STARTED|Overall Study||15
2256070|NCT02413463|5537211|P2|NOT COMPLETED|Overall Study||2
2256071|NCT02413463|5537212|P1|NOT COMPLETED|Overall Study||5
2256072|NCT02413463|5537211|P2|COMPLETED|Overall Study||28
2256073|NCT02413463|5537212|P1|COMPLETED|Overall Study||25
2256074|NCT02413463|5537211|P2|STARTED|Overall Study||30
2256075|NCT02413463|5537212|P1|STARTED|Overall Study||30
2256076|NCT02413398|5537230|P2|NOT COMPLETED|Overall Study||7
2256077|NCT02413398|5537231|P1|NOT COMPLETED|Overall Study||4
2256078|NCT02413398|5537230|P2|COMPLETED|Overall Study||154
2256079|NCT02413398|5537231|P1|COMPLETED|Overall Study||156
2256080|NCT02413398|5537230|P2|STARTED|Overall Study||161
2256081|NCT02413398|5537231|P1|STARTED|Overall Study||160
2256082|NCT02413372|5537246|P3|NOT COMPLETED|Follow-up||2
2256083|NCT02413372|5537247|P2|NOT COMPLETED|Follow-up||1
2256084|NCT02413372|5537248|P1|NOT COMPLETED|Follow-up||2
2256085|NCT02413372|5537246|P3|COMPLETED|Follow-up||23
2256086|NCT02413372|5537247|P2|COMPLETED|Follow-up||20
2256087|NCT02413372|5537248|P1|COMPLETED|Follow-up||20
2256088|NCT02413372|5537246|P3|STARTED|Follow-up||25
2256089|NCT02413372|5537247|P2|STARTED|Follow-up||21
2256090|NCT02413372|5537248|P1|STARTED|Follow-up||22
2256091|NCT02413372|5537246|P3|NOT COMPLETED|Treatment||1
2256092|NCT02413372|5537247|P2|NOT COMPLETED|Treatment||2
2256093|NCT02413372|5537248|P1|NOT COMPLETED|Treatment||1
2256094|NCT02413372|5537246|P3|COMPLETED|Treatment||25
2256095|NCT02413372|5537247|P2|COMPLETED|Treatment||22
2256096|NCT02413372|5537248|P1|COMPLETED|Treatment||24
2256097|NCT02413372|5537246|P3|STARTED|Treatment||26
2256098|NCT02413372|5537247|P2|STARTED|Treatment||24
2256099|NCT02413372|5537248|P1|STARTED|Treatment||25
2256100|NCT02413346|5537297|P2|NOT COMPLETED|Overall Study||70
2256101|NCT02413346|5537298|P1|NOT COMPLETED|Overall Study||59
2256102|NCT02413346|5537297|P2|COMPLETED|Overall Study||177
2256103|NCT02413346|5537298|P1|COMPLETED|Overall Study||177
2256104|NCT02413346|5537297|P2|STARTED|Overall Study||247
2256105|NCT02413346|5537298|P1|STARTED|Overall Study||236
2256106|NCT02413333|5537308|P2|NOT COMPLETED|Period 2||0
2256107|NCT02413333|5537309|P1|NOT COMPLETED|Period 2||1
2256108|NCT02413333|5537308|P2|COMPLETED|Period 2||65
2256109|NCT02413333|5537309|P1|COMPLETED|Period 2||64
2256110|NCT02413333|5537308|P2|STARTED|Period 2||65
2256111|NCT02413333|5537309|P1|STARTED|Period 2||65
2256112|NCT02413333|5537308|P2|NOT COMPLETED|Period 1||1
2256113|NCT02413333|5537309|P1|NOT COMPLETED|Period 1||1
2256114|NCT02413333|5537308|P2|COMPLETED|Period 1||65
2256115|NCT02413333|5537309|P1|COMPLETED|Period 1||65
2256116|NCT02413333|5537308|P2|Randomized and Treated|Period 1||66
2256117|NCT02413333|5537309|P1|Randomized and Treated|Period 1||66
2256118|NCT02413333|5537308|P2|STARTED|Period 1||66
2256119|NCT02413333|5537309|P1|STARTED|Period 1||66
2256120|NCT02413294|5537317|P1|NOT COMPLETED|Overall Study||1
2256121|NCT02413294|5537317|P1|COMPLETED|Overall Study||11
2256122|NCT02413294|5537317|P1|STARTED|Overall Study||12
2256123|NCT02413255|5537352|P17|NOT COMPLETED|Overall Study||0
2256124|NCT02413255|5537353|P16|NOT COMPLETED|Overall Study||0
2256125|NCT02413255|5537354|P15|NOT COMPLETED|Overall Study||1
2256126|NCT02413255|5537355|P14|NOT COMPLETED|Overall Study||0
2256127|NCT02413255|5537356|P13|NOT COMPLETED|Overall Study||0
2256128|NCT02413255|5537357|P12|NOT COMPLETED|Overall Study||0
2256129|NCT02413255|5537358|P11|NOT COMPLETED|Overall Study||0
2256130|NCT02413255|5537359|P10|NOT COMPLETED|Overall Study||0
2256131|NCT02413255|5537360|P9|NOT COMPLETED|Overall Study||0
2256132|NCT02413255|5537361|P8|NOT COMPLETED|Overall Study||0
2256133|NCT02413255|5537362|P7|NOT COMPLETED|Overall Study||0
2256134|NCT02413255|5537363|P6|NOT COMPLETED|Overall Study||0
2256135|NCT02413255|5537364|P5|NOT COMPLETED|Overall Study||0
2256136|NCT02413255|5537365|P4|NOT COMPLETED|Overall Study||0
2256137|NCT02413255|5537366|P3|NOT COMPLETED|Overall Study||0
2256138|NCT02413255|5537367|P2|NOT COMPLETED|Overall Study||0
2256139|NCT02413255|5537368|P1|NOT COMPLETED|Overall Study||0
2256140|NCT02413255|5537352|P17|COMPLETED|Overall Study||6
2256141|NCT02413255|5537353|P16|COMPLETED|Overall Study||6
2256142|NCT02413255|5537354|P15|COMPLETED|Overall Study||5
2256143|NCT02413255|5537355|P14|COMPLETED|Overall Study||6
2256144|NCT02413255|5537356|P13|COMPLETED|Overall Study||6
2256145|NCT02413255|5537357|P12|COMPLETED|Overall Study||6
2256146|NCT02413255|5537358|P11|COMPLETED|Overall Study||12
2256147|NCT02413255|5537359|P10|COMPLETED|Overall Study||6
2256148|NCT02413255|5537360|P9|COMPLETED|Overall Study||6
2256149|NCT02413255|5537361|P8|COMPLETED|Overall Study||6
2256150|NCT02413255|5537362|P7|COMPLETED|Overall Study||6
2256151|NCT02413255|5537363|P6|COMPLETED|Overall Study||6
2256152|NCT02413255|5537364|P5|COMPLETED|Overall Study||6
2256153|NCT02413255|5537365|P4|COMPLETED|Overall Study||6
2256154|NCT02413255|5537366|P3|COMPLETED|Overall Study||6
2256155|NCT02413255|5537367|P2|COMPLETED|Overall Study||6
2256156|NCT02413255|5537368|P1|COMPLETED|Overall Study||18
2256157|NCT02413255|5537352|P17|STARTED|Overall Study||6
2256158|NCT02413255|5537353|P16|STARTED|Overall Study||6
2256159|NCT02413255|5537354|P15|STARTED|Overall Study||6
2256160|NCT02413255|5537355|P14|STARTED|Overall Study||6
2256161|NCT02413255|5537356|P13|STARTED|Overall Study||6
2256162|NCT02413255|5537357|P12|STARTED|Overall Study||6
2256163|NCT02413255|5537358|P11|STARTED|Overall Study||12
2256164|NCT02413255|5537359|P10|STARTED|Overall Study||6
2256165|NCT02413255|5537360|P9|STARTED|Overall Study||6
2256166|NCT02413255|5537361|P8|STARTED|Overall Study||6
2256167|NCT02413255|5537362|P7|STARTED|Overall Study||6
2256168|NCT02413255|5537363|P6|STARTED|Overall Study||6
2256169|NCT02413255|5537364|P5|STARTED|Overall Study||6
2256170|NCT02413255|5537365|P4|STARTED|Overall Study||6
2256171|NCT02413255|5537366|P3|STARTED|Overall Study||6
2256172|NCT02413255|5537367|P2|STARTED|Overall Study||6
2256173|NCT02413255|5537368|P1|STARTED|Overall Study||18
2256174|NCT02413229|5537724|P8|NOT COMPLETED|Overall Study||4
2256175|NCT02413229|5537725|P7|NOT COMPLETED|Overall Study||0
2256176|NCT02413229|5537726|P6|NOT COMPLETED|Overall Study||0
2256177|NCT02413229|5537727|P5|NOT COMPLETED|Overall Study||3
2256178|NCT02413229|5537728|P4|NOT COMPLETED|Overall Study||1
2256179|NCT02413229|5537729|P3|NOT COMPLETED|Overall Study||1
2256180|NCT02413229|5537730|P2|NOT COMPLETED|Overall Study||1
2256181|NCT02413229|5537731|P1|NOT COMPLETED|Overall Study||1
2256182|NCT02413229|5537724|P8|COMPLETED|Overall Study||11
2256183|NCT02413229|5537725|P7|COMPLETED|Overall Study||25
2256184|NCT02413229|5537726|P6|COMPLETED|Overall Study||12
2256185|NCT02413229|5537727|P5|COMPLETED|Overall Study||21
2256186|NCT02413229|5537728|P4|COMPLETED|Overall Study||11
2256187|NCT02413229|5537729|P3|COMPLETED|Overall Study||25
2256188|NCT02413229|5537730|P2|COMPLETED|Overall Study||11
2256189|NCT02413229|5537731|P1|COMPLETED|Overall Study||24
2256190|NCT02413229|5537724|P8|STARTED|Overall Study||15
2256191|NCT02413229|5537725|P7|STARTED|Overall Study||25
2256192|NCT02413229|5537726|P6|STARTED|Overall Study||12
2256193|NCT02413229|5537727|P5|STARTED|Overall Study||24
2256194|NCT02413229|5537728|P4|STARTED|Overall Study||12
2256195|NCT02413229|5537729|P3|STARTED|Overall Study||26
2256196|NCT02413229|5537730|P2|STARTED|Overall Study||12
2256197|NCT02413229|5537731|P1|STARTED|Overall Study||25
2256198|NCT02413203|5537751|P2|NOT COMPLETED|Overall Study||0
2256199|NCT02413203|5537752|P1|NOT COMPLETED|Overall Study||0
2256200|NCT02413203|5537751|P2|COMPLETED|Overall Study||10
2256201|NCT02413203|5537752|P1|COMPLETED|Overall Study||10
2256202|NCT02413203|5537751|P2|STARTED|Overall Study||10
2256203|NCT02413203|5537752|P1|STARTED|Overall Study||10
2256204|NCT02413190|5537772|P1|NOT COMPLETED|Overall Study||0
2256205|NCT02413190|5537772|P1|COMPLETED|Overall Study||94
2256206|NCT02413190|5537772|P1|STARTED|Overall Study||94
2256207|NCT02413151|5537778|P2|NOT COMPLETED|Overall Study||2
2256208|NCT02413151|5537779|P1|NOT COMPLETED|Overall Study||10
2256209|NCT02413151|5537778|P2|COMPLETED|Overall Study||28
2256210|NCT02413151|5537779|P1|COMPLETED|Overall Study||22
2256211|NCT02413151|5537778|P2|STARTED|Overall Study||30
2256212|NCT02413151|5537779|P1|STARTED|Overall Study||32
2256213|NCT02413047|5537807|P1|NOT COMPLETED|Overall Study||0
2256214|NCT02413047|5537807|P1|COMPLETED|Overall Study||3
2256215|NCT02413047|5537807|P1|Participants on Adalimumab|Overall Study||1
2256216|NCT02413047|5537807|P1|Participants on Infliximab|Overall Study||2
2256217|NCT02413047|5537807|P1|STARTED|Overall Study||3
2256218|NCT02413034|5537820|P2|NOT COMPLETED|Overall Study||0
2256219|NCT02413034|5537821|P1|NOT COMPLETED|Overall Study||0
2256220|NCT02413034|5537820|P2|COMPLETED|Overall Study||14
2256221|NCT02413034|5537821|P1|COMPLETED|Overall Study||14
2256222|NCT02413034|5537820|P2|STARTED|Overall Study||14
2256223|NCT02413034|5537821|P1|STARTED|Overall Study||14
2256224|NCT02413008|5537831|P2|NOT COMPLETED|Overall Study||2
2256225|NCT02413008|5537832|P1|NOT COMPLETED|Overall Study||7
2256226|NCT02413008|5537831|P2|COMPLETED|Overall Study||9
2256227|NCT02413008|5537832|P1|COMPLETED|Overall Study||43
2256228|NCT02413008|5537831|P2|STARTED|Overall Study||11
2256229|NCT02413008|5537832|P1|STARTED|Overall Study||50
2256230|NCT02412878|5537870|P2|NOT COMPLETED|Overall Study||13
2256231|NCT02412878|5537871|P1|NOT COMPLETED|Overall Study||21
2256232|NCT02412878|5537870|P2|COMPLETED|Overall Study||227
2256233|NCT02412878|5537871|P1|COMPLETED|Overall Study||217
2256234|NCT02412878|5537870|P2|Received Carfilzomib|Overall Study||238
2256235|NCT02412878|5537871|P1|Received Carfilzomib|Overall Study||235
2256236|NCT02412878|5537870|P2|STARTED|Overall Study||240
2256237|NCT02412878|5537871|P1|STARTED|Overall Study||238
2256238|NCT02412761|5537885|P6|NOT COMPLETED|Third Intervention (2 Weeks)||0
2256239|NCT02412761|5537886|P5|NOT COMPLETED|Third Intervention (2 Weeks)||0
2256240|NCT02412761|5537887|P4|NOT COMPLETED|Third Intervention (2 Weeks)||0
2256241|NCT02412761|5537888|P3|NOT COMPLETED|Third Intervention (2 Weeks)||0
2256242|NCT02412761|5537889|P2|NOT COMPLETED|Third Intervention (2 Weeks)||0
2256243|NCT02412761|5537890|P1|NOT COMPLETED|Third Intervention (2 Weeks)||0
2256244|NCT02412761|5537885|P6|COMPLETED|Third Intervention (2 Weeks)||6
2256245|NCT02412761|5537886|P5|COMPLETED|Third Intervention (2 Weeks)||4
2256246|NCT02412761|5537887|P4|COMPLETED|Third Intervention (2 Weeks)||8
2256247|NCT02412761|5537888|P3|COMPLETED|Third Intervention (2 Weeks)||4
2256248|NCT02412761|5537889|P2|COMPLETED|Third Intervention (2 Weeks)||5
2256249|NCT02412761|5537890|P1|COMPLETED|Third Intervention (2 Weeks)||5
2256250|NCT02412761|5537885|P6|STARTED|Third Intervention (2 Weeks)||6
2256251|NCT02412761|5537886|P5|STARTED|Third Intervention (2 Weeks)||4
2256252|NCT02412761|5537887|P4|STARTED|Third Intervention (2 Weeks)||8
2256253|NCT02412761|5537888|P3|STARTED|Third Intervention (2 Weeks)||4
2256254|NCT02412761|5537889|P2|STARTED|Third Intervention (2 Weeks)||5
2256255|NCT02412761|5537890|P1|STARTED|Third Intervention (2 Weeks)||5
2256256|NCT02412761|5537885|P6|NOT COMPLETED|Second Intervention (2 Weeks)||0
2256257|NCT02412761|5537886|P5|NOT COMPLETED|Second Intervention (2 Weeks)||0
2256258|NCT02412761|5537887|P4|NOT COMPLETED|Second Intervention (2 Weeks)||0
2256259|NCT02412761|5537888|P3|NOT COMPLETED|Second Intervention (2 Weeks)||0
2256260|NCT02412761|5537889|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
2256261|NCT02412761|5537890|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
2256262|NCT02412761|5537885|P6|COMPLETED|Second Intervention (2 Weeks)||6
2256263|NCT02412761|5537886|P5|COMPLETED|Second Intervention (2 Weeks)||4
2256264|NCT02412761|5537887|P4|COMPLETED|Second Intervention (2 Weeks)||8
2256265|NCT02412761|5537888|P3|COMPLETED|Second Intervention (2 Weeks)||4
2256266|NCT02412761|5537889|P2|COMPLETED|Second Intervention (2 Weeks)||5
2256267|NCT02412761|5537890|P1|COMPLETED|Second Intervention (2 Weeks)||5
2256268|NCT02412761|5537885|P6|STARTED|Second Intervention (2 Weeks)||6
2256269|NCT02412761|5537886|P5|STARTED|Second Intervention (2 Weeks)||4
2256270|NCT02412761|5537887|P4|STARTED|Second Intervention (2 Weeks)||8
2256271|NCT02412761|5537888|P3|STARTED|Second Intervention (2 Weeks)||4
2256272|NCT02412761|5537889|P2|STARTED|Second Intervention (2 Weeks)||5
2256273|NCT02412761|5537890|P1|STARTED|Second Intervention (2 Weeks)||5
2256274|NCT02412761|5537885|P6|NOT COMPLETED|First Intervention (2 Weeks)||1
2256275|NCT02412761|5537886|P5|NOT COMPLETED|First Intervention (2 Weeks)||0
2256276|NCT02412761|5537887|P4|NOT COMPLETED|First Intervention (2 Weeks)||0
2256277|NCT02412761|5537888|P3|NOT COMPLETED|First Intervention (2 Weeks)||1
2256278|NCT02412761|5537889|P2|NOT COMPLETED|First Intervention (2 Weeks)||1
2256279|NCT02412761|5537890|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
2256280|NCT02412761|5537885|P6|COMPLETED|First Intervention (2 Weeks)||6
2256281|NCT02412761|5537886|P5|COMPLETED|First Intervention (2 Weeks)||4
2256282|NCT02412761|5537887|P4|COMPLETED|First Intervention (2 Weeks)||8
2256283|NCT02412761|5537888|P3|COMPLETED|First Intervention (2 Weeks)||4
2256284|NCT02412761|5537889|P2|COMPLETED|First Intervention (2 Weeks)||5
2256285|NCT02412761|5537890|P1|COMPLETED|First Intervention (2 Weeks)||5
2256286|NCT02412761|5537885|P6|STARTED|First Intervention (2 Weeks)||7
2256287|NCT02412761|5537886|P5|STARTED|First Intervention (2 Weeks)||4
2256288|NCT02412761|5537887|P4|STARTED|First Intervention (2 Weeks)||8
2256289|NCT02412761|5537888|P3|STARTED|First Intervention (2 Weeks)||5
2256290|NCT02412761|5537889|P2|STARTED|First Intervention (2 Weeks)||6
2256291|NCT02412761|5537890|P1|STARTED|First Intervention (2 Weeks)||5
2256292|NCT02412657|5537901|P3|NOT COMPLETED|Overall Study||3
2256293|NCT02412657|5537902|P2|NOT COMPLETED|Overall Study||2
2256294|NCT02412657|5537903|P1|NOT COMPLETED|Overall Study||1
2256295|NCT02412657|5537901|P3|COMPLETED|Overall Study||22
2256296|NCT02412657|5537902|P2|COMPLETED|Overall Study||23
2256297|NCT02412657|5537903|P1|COMPLETED|Overall Study||24
2256298|NCT02412657|5537901|P3|STARTED|Overall Study||25
2256299|NCT02412657|5537902|P2|STARTED|Overall Study||25
2256300|NCT02412657|5537903|P1|STARTED|Overall Study||25
2256301|NCT02412644|5537913|P2|NOT COMPLETED|Overall Study||4
2256302|NCT02412644|5537914|P1|NOT COMPLETED|Overall Study||15
2256303|NCT02412644|5537913|P2|COMPLETED|Overall Study||4
2256304|NCT02412644|5537914|P1|COMPLETED|Overall Study||6
2256305|NCT02412644|5537913|P2|STARTED|Overall Study||8
2256306|NCT02412644|5537914|P1|STARTED|Overall Study||21
2256307|NCT02412501|5537926|P1|NOT COMPLETED|Overall Study||0
2256308|NCT02412501|5537926|P1|COMPLETED|Overall Study||101
2256309|NCT02412501|5537926|P1|STARTED|Overall Study||101
2256310|NCT02412488|5537947|P1|NOT COMPLETED|Overall Study||18
2256311|NCT02412488|5537947|P1|COMPLETED|Overall Study||174
2256312|NCT02412488|5537947|P1|Reveal LINQ Implanted|Overall Study||191
2256313|NCT02412488|5537947|P1|STARTED|Overall Study||192
2256314|NCT02412436|5537951|P1|NOT COMPLETED|Overall Study||18
2256315|NCT02412436|5537951|P1|COMPLETED|Overall Study||44
2256316|NCT02412436|5537951|P1|STARTED|Overall Study||62
2256317|NCT02412306|5537970|P5|NOT COMPLETED|Overall Study||2
2256318|NCT02412306|5537971|P4|NOT COMPLETED|Overall Study||0
2256319|NCT02412306|5537972|P3|NOT COMPLETED|Overall Study||16
2256320|NCT02412306|5537973|P2|NOT COMPLETED|Overall Study||8
2256321|NCT02412306|5537974|P1|NOT COMPLETED|Overall Study||5
2256322|NCT02412306|5537970|P5|COMPLETED|Overall Study||15
2256323|NCT02412306|5537971|P4|COMPLETED|Overall Study||14
2256324|NCT02412306|5537972|P3|COMPLETED|Overall Study||5
2256325|NCT02412306|5537973|P2|COMPLETED|Overall Study||1
2256326|NCT02412306|5537974|P1|COMPLETED|Overall Study||0
2256327|NCT02412306|5537970|P5|STARTED|Overall Study||17
2256328|NCT02412306|5537971|P4|STARTED|Overall Study||14
2256329|NCT02412306|5537972|P3|STARTED|Overall Study||21
2256330|NCT02412306|5537973|P2|STARTED|Overall Study||9
2256331|NCT02412306|5537974|P1|STARTED|Overall Study||5
2256332|NCT02412111|5538036|P3|NOT COMPLETED|Active Comparator Period (8 Weeks)||6
2256333|NCT02412111|5538037|P2|NOT COMPLETED|Active Comparator Period (8 Weeks)||1
2256334|NCT02412111|5538038|P1|NOT COMPLETED|Active Comparator Period (8 Weeks)||0
2256335|NCT02412111|5538036|P3|COMPLETED|Active Comparator Period (8 Weeks)||69
2256336|NCT02412111|5538037|P2|COMPLETED|Active Comparator Period (8 Weeks)||75
2256337|NCT02412111|5538038|P1|COMPLETED|Active Comparator Period (8 Weeks)||0
2256338|NCT02412111|5538036|P3|Full Analysis Set|Active Comparator Period (8 Weeks)||74
2256339|NCT02412111|5538037|P2|Full Analysis Set|Active Comparator Period (8 Weeks)||76
2256340|NCT02412111|5538038|P1|Full Analysis Set|Active Comparator Period (8 Weeks)||0
2256341|NCT02412111|5538036|P3|STARTED|Active Comparator Period (8 Weeks)||75
2256342|NCT02412111|5538037|P2|STARTED|Active Comparator Period (8 Weeks)||76
2256343|NCT02412111|5538038|P1|STARTED|Active Comparator Period (8 Weeks)||0
2256344|NCT02412111|5538036|P3|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
2256345|NCT02412111|5538037|P2|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
2256346|NCT02412111|5538038|P1|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||3
2256347|NCT02412111|5538036|P3|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
2256348|NCT02412111|5538037|P2|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
2256349|NCT02412111|5538038|P1|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||153
2256350|NCT02412111|5538036|P3|STARTED|Ivacaftor Run-in Period (4 Weeks)||0
2256351|NCT02412111|5538037|P2|STARTED|Ivacaftor Run-in Period (4 Weeks)||0
2256352|NCT02412111|5538038|P1|STARTED|Ivacaftor Run-in Period (4 Weeks)||156
2256353|NCT02412098|5538060|P3|NOT COMPLETED|Overall Study||0
2256354|NCT02412098|5538061|P2|NOT COMPLETED|Overall Study||0
2256355|NCT02412098|5538062|P1|NOT COMPLETED|Overall Study||0
2256356|NCT02412098|5538060|P3|COMPLETED|Overall Study||21
2256357|NCT02412098|5538061|P2|COMPLETED|Overall Study||14
2256358|NCT02412098|5538062|P1|COMPLETED|Overall Study||14
2256359|NCT02412098|5538060|P3|STARTED|Overall Study||21
2256360|NCT02412098|5538061|P2|STARTED|Overall Study||14
2256361|NCT02412098|5538062|P1|STARTED|Overall Study||14
2256362|NCT02411929|5538089|P1|NOT COMPLETED|Period 2||0
2256363|NCT02411929|5538089|P1|COMPLETED|Period 2||8
2256364|NCT02411929|5538089|P1|STARTED|Period 2||8
2256365|NCT02411929|5538089|P1|NOT COMPLETED|Washout Period||0
2256366|NCT02411929|5538089|P1|COMPLETED|Washout Period||8
2256367|NCT02411929|5538089|P1|STARTED|Washout Period||8
2256368|NCT02411929|5538089|P1|NOT COMPLETED|Period 1||0
2256369|NCT02411929|5538089|P1|COMPLETED|Period 1||8
2256370|NCT02411929|5538089|P1|STARTED|Period 1||8
2256371|NCT02411747|5538121|P2|NOT COMPLETED|Overall Study||4
2256372|NCT02411747|5538122|P1|NOT COMPLETED|Overall Study||3
2256373|NCT02411747|5538121|P2|COMPLETED|Overall Study||12
2256374|NCT02411747|5538122|P1|COMPLETED|Overall Study||13
2256375|NCT02411747|5538121|P2|Simulation Training Completed|Overall Study||16
2256376|NCT02411747|5538122|P1|Simulation Training Completed|Overall Study||16
2256377|NCT02411747|5538121|P2|STARTED|Overall Study||16
2256378|NCT02411747|5538122|P1|STARTED|Overall Study||16
2256379|NCT02411643|5538128|P1|NOT COMPLETED|Overall Study||0
2256380|NCT02411643|5538128|P1|COMPLETED|Overall Study||2
2256381|NCT02411643|5538128|P1|STARTED|Overall Study||2
2256382|NCT02411578|5538137|P2|NOT COMPLETED|Extension Phase||0
2256383|NCT02411578|5538138|P1|NOT COMPLETED|Extension Phase||0
2256384|NCT02411578|5538137|P2|COMPLETED|Extension Phase||9
2256385|NCT02411578|5538138|P1|COMPLETED|Extension Phase||8
2256386|NCT02411578|5538137|P2|STARTED|Extension Phase|2 Crossover Trial participants could not continue due to study syringes expiration|9
2256387|NCT02411578|5538138|P1|STARTED|Extension Phase||8
2256388|NCT02411578|5538137|P2|NOT COMPLETED|Crossover Trial Phase||1
2256389|NCT02411578|5538138|P1|NOT COMPLETED|Crossover Trial Phase||0
2256390|NCT02411578|5538137|P2|COMPLETED|Crossover Trial Phase||11
2256391|NCT02411578|5538138|P1|COMPLETED|Crossover Trial Phase||8
2256392|NCT02411578|5538137|P2|STARTED|Crossover Trial Phase||12
2256393|NCT02411578|5538138|P1|STARTED|Crossover Trial Phase||8
2256394|NCT02411565|5538180|P2|NOT COMPLETED|Overall Study||0
2256395|NCT02411565|5538181|P1|NOT COMPLETED|Overall Study||0
2256396|NCT02411565|5538180|P2|COMPLETED|Overall Study||2
2256397|NCT02411565|5538181|P1|COMPLETED|Overall Study||1
2256398|NCT02411565|5538180|P2|STARTED|Overall Study||2
2256399|NCT02411565|5538181|P1|STARTED|Overall Study||1
2256400|NCT02411539|5538195|P2|NOT COMPLETED|Overall Study||1
2256401|NCT02411539|5538196|P1|NOT COMPLETED|Overall Study||2
2256402|NCT02411539|5538195|P2|COMPLETED|Overall Study||19
2256403|NCT02411539|5538196|P1|COMPLETED|Overall Study||18
2256404|NCT02411539|5538195|P2|STARTED|Overall Study||20
2256405|NCT02411539|5538196|P1|STARTED|Overall Study||20
2256406|NCT02411461|5538274|P3|NOT COMPLETED|Overall Study||0
2256407|NCT02411461|5538275|P2|NOT COMPLETED|Overall Study||0
2256408|NCT02411461|5538276|P1|NOT COMPLETED|Overall Study||0
2256409|NCT02411461|5538274|P3|COMPLETED|Overall Study||15
2256410|NCT02411461|5538275|P2|COMPLETED|Overall Study||8
2256411|NCT02411461|5538276|P1|COMPLETED|Overall Study||16
2256412|NCT02411461|5538274|P3|STARTED|Overall Study||15
2256413|NCT02411461|5538275|P2|STARTED|Overall Study||8
2256414|NCT02411461|5538276|P1|STARTED|Overall Study||16
2256415|NCT02411396|5538284|P1|NOT COMPLETED|Overall Study||41
2256416|NCT02411396|5538284|P1|COMPLETED|Overall Study||442
2256417|NCT02411396|5538284|P1|STARTED|Overall Study||483
2256418|NCT02411292|5538297|P1|NOT COMPLETED|Overall Study||21
2256419|NCT02411292|5538297|P1|COMPLETED|Overall Study||89
2256420|NCT02411292|5538297|P1|STARTED|Overall Study||110
2256421|NCT02411201|5538303|P1|NOT COMPLETED|Overall Study||6
2256422|NCT02411201|5538303|P1|COMPLETED|Overall Study||45
2256423|NCT02411201|5538303|P1|STARTED|Overall Study||51
2256424|NCT02411110|5538316|P2|NOT COMPLETED|Treatment Period 2||4
2256425|NCT02411110|5538317|P1|NOT COMPLETED|Treatment Period 2||1
2256426|NCT02411110|5538316|P2|COMPLETED|Treatment Period 2||44
2256427|NCT02411110|5538317|P1|COMPLETED|Treatment Period 2||49
2256428|NCT02411110|5538316|P2|STARTED|Treatment Period 2|Period 2 was optional.|48
2256429|NCT02411110|5538317|P1|STARTED|Treatment Period 2|Period 2 was optional.|50
2256430|NCT02411110|5538316|P2|NOT COMPLETED|Treatment Period 1||7
2256431|NCT02411110|5538317|P1|NOT COMPLETED|Treatment Period 1||9
2256432|NCT02411110|5538316|P2|COMPLETED|Treatment Period 1||59
2256433|NCT02411110|5538317|P1|COMPLETED|Treatment Period 1||56
2256434|NCT02411110|5538316|P2|STARTED|Treatment Period 1||66
2256435|NCT02411110|5538317|P1|STARTED|Treatment Period 1||65
2256436|NCT02411084|5538327|P2|NOT COMPLETED|Overall Study||13
2256437|NCT02411084|5538328|P1|NOT COMPLETED|Overall Study||13
2256438|NCT02411084|5538327|P2|COMPLETED|Overall Study||5
2256439|NCT02411084|5538328|P1|COMPLETED|Overall Study||5
2256440|NCT02411084|5538327|P2|STARTED|Overall Study||18
2256441|NCT02411084|5538328|P1|STARTED|Overall Study||18
2256442|NCT02410967|5538343|P2|NOT COMPLETED|Follow-up Phase (8 Weeks)||6
2256443|NCT02410967|5538344|P1|NOT COMPLETED|Follow-up Phase (8 Weeks)||4
2256444|NCT02410967|5538343|P2|COMPLETED|Follow-up Phase (8 Weeks)||16
2256445|NCT02410967|5538344|P1|COMPLETED|Follow-up Phase (8 Weeks)||22
2256446|NCT02410967|5538343|P2|STARTED|Follow-up Phase (8 Weeks)||22
2256447|NCT02410967|5538344|P1|STARTED|Follow-up Phase (8 Weeks)||26
2256448|NCT02410967|5538343|P2|NOT COMPLETED|Treatment Phase (4 Weeks)||4
2256449|NCT02410967|5538344|P1|NOT COMPLETED|Treatment Phase (4 Weeks)||1
2256450|NCT02410967|5538343|P2|COMPLETED|Treatment Phase (4 Weeks)||22
2256451|NCT02410967|5538344|P1|COMPLETED|Treatment Phase (4 Weeks)||26
2256452|NCT02410967|5538343|P2|STARTED|Treatment Phase (4 Weeks)||26
2256453|NCT02410967|5538344|P1|STARTED|Treatment Phase (4 Weeks)||27
2256454|NCT02410824|5538360|P2|NOT COMPLETED|Second Intervention (One Week)||0
2256455|NCT02410824|5538361|P1|NOT COMPLETED|Second Intervention (One Week)||0
2256456|NCT02410824|5538360|P2|COMPLETED|Second Intervention (One Week)||22
2256457|NCT02410824|5538361|P1|COMPLETED|Second Intervention (One Week)||22
2256458|NCT02410824|5538360|P2|STARTED|Second Intervention (One Week)||22
2256459|NCT02410824|5538361|P1|STARTED|Second Intervention (One Week)||22
2256460|NCT02410824|5538360|P2|NOT COMPLETED|First Intervention (One Week)||1
2256461|NCT02410824|5538361|P1|NOT COMPLETED|First Intervention (One Week)||0
2256462|NCT02410824|5538360|P2|COMPLETED|First Intervention (One Week)||22
2256463|NCT02410824|5538361|P1|COMPLETED|First Intervention (One Week)||22
2256464|NCT02410824|5538360|P2|STARTED|First Intervention (One Week)||23
2256465|NCT02410824|5538361|P1|STARTED|First Intervention (One Week)||22
2256466|NCT02410577|5538393|P1|NOT COMPLETED|Overall Study||0
2256467|NCT02410577|5538393|P1|COMPLETED|Overall Study||2
2256468|NCT02410577|5538393|P1|STARTED|Overall Study||2
2256469|NCT02410551|5538397|P1|NOT COMPLETED|Overall Study||4
2256470|NCT02410551|5538397|P1|COMPLETED|Overall Study||0
2256471|NCT02410551|5538397|P1|STARTED|Overall Study||4
2256472|NCT02410382|5538404|P2|NOT COMPLETED|Overall Study||0
2256473|NCT02410382|5538405|P1|NOT COMPLETED|Overall Study||0
2256474|NCT02410382|5538404|P2|COMPLETED|Overall Study||0
2256475|NCT02410382|5538405|P1|COMPLETED|Overall Study|Study was terminated by IRB - attempts made to obtain info were unsuccessful.|0
2256476|NCT02410382|5538404|P2|STARTED|Overall Study||0
2256477|NCT02410382|5538405|P1|STARTED|Overall Study||0
2256478|NCT02410343|5538415|P2|NOT COMPLETED|Extension Period (12 Months)||1
2256479|NCT02410343|5538416|P1|NOT COMPLETED|Extension Period (12 Months)||1
2256480|NCT02410343|5538415|P2|COMPLETED|Extension Period (12 Months)||0
2256481|NCT02410343|5538416|P1|COMPLETED|Extension Period (12 Months)||0
2256482|NCT02410343|5538415|P2|STARTED|Extension Period (12 Months)||1
2256483|NCT02410343|5538416|P1|STARTED|Extension Period (12 Months)||1
2256484|NCT02410343|5538415|P2|NOT COMPLETED|Core Period (24 Weeks)||7
2256485|NCT02410343|5538416|P1|NOT COMPLETED|Core Period (24 Weeks)||5
2256486|NCT02410343|5538415|P2|COMPLETED|Core Period (24 Weeks)||1
2256487|NCT02410343|5538416|P1|COMPLETED|Core Period (24 Weeks)||1
2256488|NCT02410343|5538415|P2|STARTED|Core Period (24 Weeks)||8
2256489|NCT02410343|5538416|P1|STARTED|Core Period (24 Weeks)||6
2256490|NCT02410291|5538453|P2|NOT COMPLETED|Overall Study||0
2256491|NCT02410291|5538454|P1|NOT COMPLETED|Overall Study||0
2256492|NCT02410291|5538453|P2|COMPLETED|Overall Study||29
2256493|NCT02410291|5538454|P1|COMPLETED|Overall Study||29
2256494|NCT02410291|5538453|P2|STARTED|Overall Study||29
2256495|NCT02410291|5538454|P1|STARTED|Overall Study||29
2256496|NCT02410278|5538462|P3|NOT COMPLETED|Study Treatment Period||4
2256497|NCT02410278|5538463|P2|NOT COMPLETED|Study Treatment Period||11
2256498|NCT02410278|5538464|P1|NOT COMPLETED|Study Treatment Period||0
2256499|NCT02410278|5538462|P3|COMPLETED|Study Treatment Period||29
2256500|NCT02410278|5538463|P2|COMPLETED|Study Treatment Period||20
2256501|NCT02410278|5538464|P1|COMPLETED|Study Treatment Period||0
2256502|NCT02410278|5538462|P3|Completed Randomized Study Treatment|Study Treatment Period||29
2256503|NCT02410278|5538463|P2|Completed Randomized Study Treatment|Study Treatment Period||20
2256504|NCT02410278|5538464|P1|Completed Randomized Study Treatment|Study Treatment Period||0
2256505|NCT02410278|5538462|P3|Modified Intent-to Treat(mITT)Population|Study Treatment Period||33
2256506|NCT02410278|5538463|P2|Modified Intent-to Treat(mITT)Population|Study Treatment Period||30
2256507|NCT02410278|5538464|P1|Modified Intent-to Treat(mITT)Population|Study Treatment Period||0
2256508|NCT02410278|5538462|P3|STARTED|Study Treatment Period||33
2256509|NCT02410278|5538463|P2|STARTED|Study Treatment Period||31
2256510|NCT02410278|5538464|P1|STARTED|Study Treatment Period||0
2256511|NCT02410278|5538462|P3|NOT COMPLETED|Run-in Period||0
2256512|NCT02410278|5538463|P2|NOT COMPLETED|Run-in Period||0
2256513|NCT02410278|5538464|P1|NOT COMPLETED|Run-in Period||38
2256514|NCT02410278|5538462|P3|COMPLETED|Run-in Period||0
2256515|NCT02410278|5538463|P2|COMPLETED|Run-in Period||0
2256516|NCT02410278|5538464|P1|COMPLETED|Run-in Period||64
2256517|NCT02410278|5538462|P3|Received at Least 1 Dose of DMF|Run-in Period||0
2256518|NCT02410278|5538463|P2|Received at Least 1 Dose of DMF|Run-in Period||0
2256519|NCT02410278|5538464|P1|Received at Least 1 Dose of DMF|Run-in Period||98
2256520|NCT02410278|5538462|P3|STARTED|Run-in Period||0
2256521|NCT02410278|5538463|P2|STARTED|Run-in Period||0
2256522|NCT02410278|5538464|P1|STARTED|Run-in Period||102
2256523|NCT02410252|5538489|P1|NOT COMPLETED|Overall Study||6
2256524|NCT02410252|5538489|P1|COMPLETED|Overall Study||19
2256525|NCT02410252|5538489|P1|STARTED|Overall Study||25
2256526|NCT02410213|5538495|P2|NOT COMPLETED|Overall Study||0
2256527|NCT02410213|5538496|P1|NOT COMPLETED|Overall Study||0
2256528|NCT02410213|5538495|P2|COMPLETED|Overall Study||19
2256529|NCT02410213|5538496|P1|COMPLETED|Overall Study||16
2256530|NCT02410213|5538495|P2|STARTED|Overall Study||19
2256531|NCT02410213|5538496|P1|STARTED|Overall Study||16
2256532|NCT02410200|5538502|P1|NOT COMPLETED|Overall Study||2
2256533|NCT02410200|5538502|P1|COMPLETED|Overall Study||20
2256534|NCT02410200|5538502|P1|STARTED|Overall Study||22
2256535|NCT02410161|5538515|P2|NOT COMPLETED|Overall Study||0
2256536|NCT02410161|5538516|P1|NOT COMPLETED|Overall Study||0
2256537|NCT02410161|5538515|P2|COMPLETED|Overall Study||10
2256538|NCT02410161|5538516|P1|COMPLETED|Overall Study||10
2256539|NCT02410161|5538515|P2|STARTED|Overall Study||10
2256540|NCT02410161|5538516|P1|STARTED|Overall Study||10
2256541|NCT02410018|5538532|P2|NOT COMPLETED|Overall Study||0
2256542|NCT02410018|5538533|P1|NOT COMPLETED|Overall Study||0
2256543|NCT02410018|5538532|P2|COMPLETED|Overall Study||1
2256544|NCT02410018|5538533|P1|COMPLETED|Overall Study||2
2256545|NCT02410018|5538532|P2|STARTED|Overall Study||1
2256546|NCT02410018|5538533|P1|STARTED|Overall Study||2
2256547|NCT02409927|5538553|P1|NOT COMPLETED|Overall Study||0
2256548|NCT02409927|5538553|P1|COMPLETED|Overall Study||10
2256549|NCT02409927|5538553|P1|STARTED|Overall Study||10
2256550|NCT02409914|5538561|P1|NOT COMPLETED|Overall Study||0
2256551|NCT02409914|5538561|P1|COMPLETED|Overall Study||7
2256552|NCT02409914|5538561|P1|STARTED|Overall Study||7
2256553|NCT02409784|5538567|P1|NOT COMPLETED|Overall Study||0
2256554|NCT02409784|5538567|P1|COMPLETED|Overall Study||10
2256555|NCT02409784|5538567|P1|STARTED|Overall Study||10
2256556|NCT02409732|5538572|P1|NOT COMPLETED|Overall Study||6
2256557|NCT02409732|5538572|P1|COMPLETED|Overall Study||14
2256558|NCT02409732|5538572|P1|STARTED|Overall Study|First patient consented on 4/23/15|20
2256559|NCT02409719|5538582|P2|NOT COMPLETED|Overall Study||3
2256560|NCT02409719|5538583|P1|NOT COMPLETED|Overall Study||3
2256561|NCT02409719|5538582|P2|COMPLETED|Overall Study||42
2256562|NCT02409719|5538583|P1|COMPLETED|Overall Study||28
2256563|NCT02409719|5538582|P2|12 Months|Overall Study||42
2256564|NCT02409719|5538583|P1|12 Months|Overall Study||28
2256565|NCT02409719|5538582|P2|6 Months|Overall Study||42
2256566|NCT02409719|5538583|P1|6 Months|Overall Study||28
2256567|NCT02409719|5538582|P2|3 Months|Overall Study||42
2256568|NCT02409719|5538583|P1|3 Months|Overall Study||28
2256569|NCT02409719|5538582|P2|6 Weeks|Overall Study||42
2256570|NCT02409719|5538583|P1|6 Weeks|Overall Study||28
2256571|NCT02409719|5538582|P2|4 Weeks|Overall Study||42
2256572|NCT02409719|5538583|P1|4 Weeks|Overall Study||28
2256573|NCT02409719|5538582|P2|2 Weeks|Overall Study||42
2256574|NCT02409719|5538583|P1|2 Weeks|Overall Study||28
2256575|NCT02409719|5538582|P2|STARTED|Overall Study||45
2256576|NCT02409719|5538583|P1|STARTED|Overall Study||31
2256577|NCT02409667|5538593|P5|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||3
2256578|NCT02409667|5538594|P4|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||8
2256579|NCT02409667|5538595|P3|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||21
2256580|NCT02409667|5538596|P2|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||23
2256581|NCT02409667|5538597|P1|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||0
2256582|NCT02409667|5538593|P5|COMPLETED|Treatment Period 2, Week 24 to Week 52)||90
2256583|NCT02409667|5538594|P4|COMPLETED|Treatment Period 2, Week 24 to Week 52)||106
2256584|NCT02409667|5538595|P3|COMPLETED|Treatment Period 2, Week 24 to Week 52)||641
2256585|NCT02409667|5538596|P2|COMPLETED|Treatment Period 2, Week 24 to Week 52)||621
2256586|NCT02409667|5538597|P1|COMPLETED|Treatment Period 2, Week 24 to Week 52)||0
2256587|NCT02409667|5538593|P5|STARTED|Treatment Period 2, Week 24 to Week 52)||93
2256588|NCT02409667|5538594|P4|STARTED|Treatment Period 2, Week 24 to Week 52)||114
2256589|NCT02409667|5538595|P3|STARTED|Treatment Period 2, Week 24 to Week 52)||662
2256590|NCT02409667|5538596|P2|STARTED|Treatment Period 2, Week 24 to Week 52)||644
2256591|NCT02409667|5538597|P1|STARTED|Treatment Period 2, Week 24 to Week 52)||0
2256592|NCT02409667|5538593|P5|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
2256593|NCT02409667|5538594|P4|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
2256594|NCT02409667|5538595|P3|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
2256595|NCT02409667|5538596|P2|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
2256596|NCT02409667|5538597|P1|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||121
2256597|NCT02409667|5538593|P5|COMPLETED|Treatment Period 1, Baseline to Week 24||0
2256598|NCT02409667|5538594|P4|COMPLETED|Treatment Period 1, Baseline to Week 24||0
2256599|NCT02409667|5538595|P3|COMPLETED|Treatment Period 1, Baseline to Week 24||0
2256600|NCT02409667|5538596|P2|COMPLETED|Treatment Period 1, Baseline to Week 24||0
2256601|NCT02409667|5538597|P1|COMPLETED|Treatment Period 1, Baseline to Week 24||1526
2256602|NCT02409667|5538593|P5|STARTED|Treatment Period 1, Baseline to Week 24||0
2256603|NCT02409667|5538594|P4|STARTED|Treatment Period 1, Baseline to Week 24||0
2256604|NCT02409667|5538595|P3|STARTED|Treatment Period 1, Baseline to Week 24||0
2256605|NCT02409667|5538596|P2|STARTED|Treatment Period 1, Baseline to Week 24||0
2256606|NCT02409667|5538597|P1|STARTED|Treatment Period 1, Baseline to Week 24||1647
2256607|NCT02409459|5538638|P2|NOT COMPLETED|Overall Study||1
2256608|NCT02409459|5538639|P1|NOT COMPLETED|Overall Study||1
2256609|NCT02409459|5538638|P2|COMPLETED|Overall Study||39
2256610|NCT02409459|5538639|P1|COMPLETED|Overall Study||40
2256611|NCT02409459|5538638|P2|STARTED|Overall Study||40
2256612|NCT02409459|5538639|P1|STARTED|Overall Study||41
2256613|NCT02409355|5538659|P2|NOT COMPLETED|Overall Study||4
2256614|NCT02409355|5538660|P1|NOT COMPLETED|Overall Study||4
2256615|NCT02409355|5538659|P2|COMPLETED|Overall Study||0
2256616|NCT02409355|5538660|P1|COMPLETED|Overall Study||0
2256617|NCT02409355|5538659|P2|STARTED|Overall Study||4
2256618|NCT02409355|5538660|P1|STARTED|Overall Study||4
2256619|NCT02409277|5538669|P3|NOT COMPLETED|Overall Study||0
2256620|NCT02409277|5538670|P2|NOT COMPLETED|Overall Study||17
2256621|NCT02409277|5538671|P1|NOT COMPLETED|Overall Study||100
2256622|NCT02409277|5538669|P3|COMPLETED|Overall Study||599
2256623|NCT02409277|5538670|P2|COMPLETED|Overall Study||43
2256624|NCT02409277|5538671|P1|COMPLETED|Overall Study||167
2256625|NCT02409277|5538669|P3|12 Months Follow-up|Overall Study||599
2256626|NCT02409277|5538670|P2|12 Months Follow-up|Overall Study||43
2256627|NCT02409277|5538671|P1|12 Months Follow-up|Overall Study||167
2256628|NCT02409277|5538669|P3|6 Months Follow-up|Overall Study||599
2256629|NCT02409277|5538670|P2|6 Months Follow-up|Overall Study||42
2256630|NCT02409277|5538671|P1|6 Months Follow-up|Overall Study||182
2256631|NCT02409277|5538669|P3|3 Months Follow-up|Overall Study||599
2256632|NCT02409277|5538670|P2|3 Months Follow-up|Overall Study||40
2256633|NCT02409277|5538671|P1|3 Months Follow-up|Overall Study||178
2256634|NCT02409277|5538669|P3|STARTED|Overall Study||599
2256635|NCT02409277|5538670|P2|STARTED|Overall Study||60
2256636|NCT02409277|5538671|P1|STARTED|Overall Study||267
2256637|NCT02408965|5538711|P2|NOT COMPLETED|Overall Study||0
2256638|NCT02408965|5538712|P1|NOT COMPLETED|Overall Study||0
2256639|NCT02408965|5538711|P2|COMPLETED|Overall Study||144
2256640|NCT02408965|5538712|P1|COMPLETED|Overall Study||140
2256641|NCT02408965|5538711|P2|STARTED|Overall Study||144
2256642|NCT02408965|5538712|P1|STARTED|Overall Study||140
2256643|NCT02408692|5538737|P3|NOT COMPLETED|Overall Study||0
2256644|NCT02408692|5538738|P2|NOT COMPLETED|Overall Study||0
2256645|NCT02408692|5538739|P1|NOT COMPLETED|Overall Study||0
2256646|NCT02408692|5538737|P3|COMPLETED|Overall Study||5
2256647|NCT02408692|5538738|P2|COMPLETED|Overall Study||5
2256648|NCT02408692|5538739|P1|COMPLETED|Overall Study||5
2256649|NCT02408692|5538737|P3|STARTED|Overall Study||5
2256650|NCT02408692|5538738|P2|STARTED|Overall Study||5
2256651|NCT02408692|5538739|P1|STARTED|Overall Study||5
2256652|NCT02408315|5538752|P2|NOT COMPLETED|Overall Study||0
2256653|NCT02408315|5538753|P1|NOT COMPLETED|Overall Study||0
2256654|NCT02408315|5538752|P2|COMPLETED|Overall Study||152
2256655|NCT02408315|5538753|P1|COMPLETED|Overall Study||148
2256656|NCT02408315|5538752|P2|STARTED|Overall Study||152
2256657|NCT02408315|5538753|P1|STARTED|Overall Study||148
2256658|NCT02408263|5538775|P2|NOT COMPLETED|Overall Study||0
2256659|NCT02408263|5538776|P1|NOT COMPLETED|Overall Study||0
2256660|NCT02408263|5538775|P2|COMPLETED|Overall Study||25
2256661|NCT02408263|5538776|P1|COMPLETED|Overall Study||25
2256662|NCT02408263|5538775|P2|STARTED|Overall Study||25
2256663|NCT02408263|5538776|P1|STARTED|Overall Study||25
2256670|NCT02408068|5538791|P6|NOT COMPLETED|Treatment 3 (1.5 Days)||0
2256671|NCT02408068|5538792|P5|NOT COMPLETED|Treatment 3 (1.5 Days)||0
2256672|NCT02408068|5538793|P4|NOT COMPLETED|Treatment 3 (1.5 Days)||0
2256673|NCT02408068|5538794|P3|NOT COMPLETED|Treatment 3 (1.5 Days)||1
2256674|NCT02408068|5538795|P2|NOT COMPLETED|Treatment 3 (1.5 Days)||0
2256675|NCT02408068|5538796|P1|NOT COMPLETED|Treatment 3 (1.5 Days)||0
2256676|NCT02408068|5538791|P6|COMPLETED|Treatment 3 (1.5 Days)||3
2256677|NCT02408068|5538792|P5|COMPLETED|Treatment 3 (1.5 Days)||3
2256678|NCT02408068|5538793|P4|COMPLETED|Treatment 3 (1.5 Days)||3
2256679|NCT02408068|5538794|P3|COMPLETED|Treatment 3 (1.5 Days)||2
2256680|NCT02408068|5538795|P2|COMPLETED|Treatment 3 (1.5 Days)||3
2256681|NCT02408068|5538796|P1|COMPLETED|Treatment 3 (1.5 Days)||3
2256682|NCT02408068|5538791|P6|STARTED|Treatment 3 (1.5 Days)||3
2256683|NCT02408068|5538792|P5|STARTED|Treatment 3 (1.5 Days)||3
2256684|NCT02408068|5538793|P4|STARTED|Treatment 3 (1.5 Days)||3
2256685|NCT02408068|5538794|P3|STARTED|Treatment 3 (1.5 Days)||3
2256686|NCT02408068|5538795|P2|STARTED|Treatment 3 (1.5 Days)||3
2256687|NCT02408068|5538796|P1|STARTED|Treatment 3 (1.5 Days)||3
2256688|NCT02408068|5538791|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
2256689|NCT02408068|5538792|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
2256690|NCT02408068|5538793|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
2256691|NCT02408068|5538794|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
2256692|NCT02408068|5538795|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
2256693|NCT02408068|5538796|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
2256694|NCT02408068|5538791|P6|COMPLETED|Washout Period 2 (7 Days)||3
2256695|NCT02408068|5538792|P5|COMPLETED|Washout Period 2 (7 Days)||3
2256696|NCT02408068|5538793|P4|COMPLETED|Washout Period 2 (7 Days)||3
2256697|NCT02408068|5538794|P3|COMPLETED|Washout Period 2 (7 Days)||3
2256698|NCT02408068|5538795|P2|COMPLETED|Washout Period 2 (7 Days)||3
2256699|NCT02408068|5538796|P1|COMPLETED|Washout Period 2 (7 Days)||3
2256700|NCT02408068|5538791|P6|STARTED|Washout Period 2 (7 Days)||3
2256701|NCT02408068|5538792|P5|STARTED|Washout Period 2 (7 Days)||3
2256702|NCT02408068|5538793|P4|STARTED|Washout Period 2 (7 Days)||3
2256703|NCT02408068|5538794|P3|STARTED|Washout Period 2 (7 Days)||3
2256704|NCT02408068|5538795|P2|STARTED|Washout Period 2 (7 Days)||3
2256705|NCT02408068|5538796|P1|STARTED|Washout Period 2 (7 Days)||3
2256706|NCT02408068|5538791|P6|NOT COMPLETED|Treatment 2 (1.5 Days)||0
2256707|NCT02408068|5538792|P5|NOT COMPLETED|Treatment 2 (1.5 Days)||0
2256708|NCT02408068|5538793|P4|NOT COMPLETED|Treatment 2 (1.5 Days)||0
2256709|NCT02408068|5538794|P3|NOT COMPLETED|Treatment 2 (1.5 Days)||0
2256710|NCT02408068|5538795|P2|NOT COMPLETED|Treatment 2 (1.5 Days)||0
2256711|NCT02408068|5538796|P1|NOT COMPLETED|Treatment 2 (1.5 Days)||0
2256712|NCT02408068|5538791|P6|COMPLETED|Treatment 2 (1.5 Days)||3
2256713|NCT02408068|5538792|P5|COMPLETED|Treatment 2 (1.5 Days)||3
2256714|NCT02408068|5538793|P4|COMPLETED|Treatment 2 (1.5 Days)||3
2256715|NCT02408068|5538794|P3|COMPLETED|Treatment 2 (1.5 Days)||3
2256716|NCT02408068|5538795|P2|COMPLETED|Treatment 2 (1.5 Days)||3
2256717|NCT02408068|5538796|P1|COMPLETED|Treatment 2 (1.5 Days)||3
2256718|NCT02408068|5538791|P6|STARTED|Treatment 2 (1.5 Days)||3
2256719|NCT02408068|5538792|P5|STARTED|Treatment 2 (1.5 Days)||3
2256720|NCT02408068|5538793|P4|STARTED|Treatment 2 (1.5 Days)||3
2256721|NCT02408068|5538794|P3|STARTED|Treatment 2 (1.5 Days)||3
2256722|NCT02408068|5538795|P2|STARTED|Treatment 2 (1.5 Days)||3
2256723|NCT02408068|5538796|P1|STARTED|Treatment 2 (1.5 Days)||3
2256724|NCT02408068|5538791|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
2256725|NCT02408068|5538792|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
2256726|NCT02408068|5538793|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
2256727|NCT02408068|5538794|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
2256728|NCT02408068|5538795|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
2256729|NCT02408068|5538796|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
2256730|NCT02408068|5538791|P6|COMPLETED|Washout Period 1 (7 Days)||3
2256731|NCT02408068|5538792|P5|COMPLETED|Washout Period 1 (7 Days)||3
2256732|NCT02408068|5538793|P4|COMPLETED|Washout Period 1 (7 Days)||3
2256733|NCT02408068|5538794|P3|COMPLETED|Washout Period 1 (7 Days)||3
2256734|NCT02408068|5538795|P2|COMPLETED|Washout Period 1 (7 Days)||3
2256735|NCT02408068|5538796|P1|COMPLETED|Washout Period 1 (7 Days)||3
2256736|NCT02408068|5538791|P6|STARTED|Washout Period 1 (7 Days)||3
2256737|NCT02408068|5538792|P5|STARTED|Washout Period 1 (7 Days)||3
2256738|NCT02408068|5538793|P4|STARTED|Washout Period 1 (7 Days)||3
2256739|NCT02408068|5538794|P3|STARTED|Washout Period 1 (7 Days)||3
2256740|NCT02408068|5538795|P2|STARTED|Washout Period 1 (7 Days)||3
2256741|NCT02408068|5538796|P1|STARTED|Washout Period 1 (7 Days)||3
2256742|NCT02408068|5538791|P6|NOT COMPLETED|Treatment 1 (1.5 Days)||0
2256743|NCT02408068|5538792|P5|NOT COMPLETED|Treatment 1 (1.5 Days)||0
2256744|NCT02408068|5538793|P4|NOT COMPLETED|Treatment 1 (1.5 Days)||0
2256745|NCT02408068|5538794|P3|NOT COMPLETED|Treatment 1 (1.5 Days)||0
2256746|NCT02408068|5538795|P2|NOT COMPLETED|Treatment 1 (1.5 Days)||0
2256747|NCT02408068|5538796|P1|NOT COMPLETED|Treatment 1 (1.5 Days)||0
2256748|NCT02408068|5538791|P6|COMPLETED|Treatment 1 (1.5 Days)||3
2256749|NCT02408068|5538792|P5|COMPLETED|Treatment 1 (1.5 Days)||3
2256750|NCT02408068|5538793|P4|COMPLETED|Treatment 1 (1.5 Days)||3
2256751|NCT02408068|5538794|P3|COMPLETED|Treatment 1 (1.5 Days)||3
2256752|NCT02408068|5538795|P2|COMPLETED|Treatment 1 (1.5 Days)||3
2256753|NCT02408068|5538796|P1|COMPLETED|Treatment 1 (1.5 Days)||3
2256754|NCT02408068|5538791|P6|STARTED|Treatment 1 (1.5 Days)||3
2256755|NCT02408068|5538792|P5|STARTED|Treatment 1 (1.5 Days)||3
2256756|NCT02408068|5538793|P4|STARTED|Treatment 1 (1.5 Days)||3
2256757|NCT02408068|5538794|P3|STARTED|Treatment 1 (1.5 Days)||3
2256758|NCT02408068|5538795|P2|STARTED|Treatment 1 (1.5 Days)||3
2256759|NCT02408068|5538796|P1|STARTED|Treatment 1 (1.5 Days)||3
2256760|NCT02407704|5538823|P4|NOT COMPLETED|Overall Study||3
2256761|NCT02407704|5538824|P3|NOT COMPLETED|Overall Study||1
2256762|NCT02407704|5538825|P2|NOT COMPLETED|Overall Study||0
2256763|NCT02407704|5538826|P1|NOT COMPLETED|Overall Study||0
2256764|NCT02407704|5538823|P4|COMPLETED|Overall Study||2
2256765|NCT02407704|5538824|P3|COMPLETED|Overall Study||4
2256766|NCT02407704|5538825|P2|COMPLETED|Overall Study||3
2256767|NCT02407704|5538826|P1|COMPLETED|Overall Study||2
2256768|NCT02407704|5538823|P4|STARTED|Overall Study||5
2256769|NCT02407704|5538824|P3|STARTED|Overall Study||5
2256770|NCT02407704|5538825|P2|STARTED|Overall Study||3
2256771|NCT02407704|5538826|P1|STARTED|Overall Study||2
2256772|NCT02407249|5538860|P1|NOT COMPLETED|Overall Study||26
2256773|NCT02407249|5538860|P1|COMPLETED|Overall Study||47
2256774|NCT02407249|5538860|P1|Treated|Overall Study||60
2256775|NCT02407249|5538860|P1|STARTED|Overall Study||73
2256864|NCT02407223|5539123|P3|NOT COMPLETED|Overall Study||122
2256865|NCT02407223|5539124|P2|NOT COMPLETED|Overall Study||118
2256866|NCT02407223|5539125|P1|NOT COMPLETED|Overall Study||116
2256867|NCT02407223|5539123|P3|COMPLETED|Overall Study||0
2256868|NCT02407223|5539124|P2|COMPLETED|Overall Study||0
2256869|NCT02407223|5539125|P1|COMPLETED|Overall Study||0
2256870|NCT02407223|5539123|P3|Qualified Re-randomization at Week 52|Overall Study||2
2256871|NCT02407223|5539124|P2|Qualified Re-randomization at Week 52|Overall Study||3
2256872|NCT02407223|5539125|P1|Qualified Re-randomization at Week 52|Overall Study||0
2256873|NCT02407223|5539123|P3|Cross Over at Week 24|Overall Study||0
2256874|NCT02407223|5539124|P2|Cross Over at Week 24|Overall Study||0
2256875|NCT02407223|5539125|P1|Cross Over at Week 24|Overall Study|Study discontinuation/completion reported under randomization group|60
2256876|NCT02407223|5539123|P3|Early Escape at Week 16|Overall Study||0
2256877|NCT02407223|5539124|P2|Early Escape at Week 16|Overall Study||0
2256878|NCT02407223|5539125|P1|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|22
2256879|NCT02407223|5539123|P3|STARTED|Overall Study||122
2256880|NCT02407223|5539124|P2|STARTED|Overall Study||118
2256881|NCT02407223|5539125|P1|STARTED|Overall Study||116
2256882|NCT02407132|5539170|P2|NOT COMPLETED|12 Months Post-intervention||2
2256883|NCT02407132|5539171|P1|NOT COMPLETED|12 Months Post-intervention||13
2256884|NCT02407132|5539170|P2|COMPLETED|12 Months Post-intervention||90
2256885|NCT02407132|5539171|P1|COMPLETED|12 Months Post-intervention||83
2256886|NCT02407132|5539170|P2|STARTED|12 Months Post-intervention||92
2256887|NCT02407132|5539171|P1|STARTED|12 Months Post-intervention||96
2256888|NCT02407132|5539170|P2|NOT COMPLETED|6 Months Post-intervention||9
2256889|NCT02407132|5539171|P1|NOT COMPLETED|6 Months Post-intervention||11
2256890|NCT02407132|5539170|P2|COMPLETED|6 Months Post-intervention||92
2256891|NCT02407132|5539171|P1|COMPLETED|6 Months Post-intervention||96
2256892|NCT02407132|5539170|P2|STARTED|6 Months Post-intervention||101
2256893|NCT02407132|5539171|P1|STARTED|6 Months Post-intervention||107
2256894|NCT02407132|5539170|P2|NOT COMPLETED|Immediate Post-intervention||10
2256895|NCT02407132|5539171|P1|NOT COMPLETED|Immediate Post-intervention||3
2256896|NCT02407132|5539170|P2|COMPLETED|Immediate Post-intervention||101
2256897|NCT02407132|5539171|P1|COMPLETED|Immediate Post-intervention||107
2256898|NCT02407132|5539170|P2|STARTED|Immediate Post-intervention||111
2256899|NCT02407132|5539171|P1|STARTED|Immediate Post-intervention||110
2256900|NCT02406937|5539198|P3|NOT COMPLETED|Overall Study||2
2256901|NCT02406937|5539199|P2|NOT COMPLETED|Overall Study||1
2256902|NCT02406937|5539200|P1|NOT COMPLETED|Overall Study||1
2256903|NCT02406937|5539198|P3|COMPLETED|Overall Study||58
2256904|NCT02406937|5539199|P2|COMPLETED|Overall Study||59
2256905|NCT02406937|5539200|P1|COMPLETED|Overall Study||59
2256906|NCT02406937|5539198|P3|STARTED|Overall Study||60
2256907|NCT02406937|5539199|P2|STARTED|Overall Study||60
2256908|NCT02406937|5539200|P1|STARTED|Overall Study||60
2256909|NCT02406677|5539258|P2|NOT COMPLETED|Overall Study||598
2256910|NCT02406677|5539259|P1|NOT COMPLETED|Overall Study||301
2256911|NCT02406677|5539258|P2|COMPLETED|Overall Study||3967
2256912|NCT02406677|5539259|P1|COMPLETED|Overall Study||6135
2256913|NCT02406677|5539258|P2|STARTED|Overall Study||4565
2256914|NCT02406677|5539259|P1|STARTED|Overall Study||6436
2256915|NCT02406612|5539273|P2|NOT COMPLETED|Overall Study||4
2256916|NCT02406612|5539274|P1|NOT COMPLETED|Overall Study||4
2256917|NCT02406612|5539273|P2|COMPLETED|Overall Study||17
2256918|NCT02406612|5539274|P1|COMPLETED|Overall Study||22
2256919|NCT02406612|5539273|P2|STARTED|Overall Study||21
2256920|NCT02406612|5539274|P1|STARTED|Overall Study||26
2256921|NCT02406586|5539289|P3|NOT COMPLETED|Overall Study||2
2256922|NCT02406586|5539290|P2|NOT COMPLETED|Overall Study||4
2256923|NCT02406586|5539291|P1|NOT COMPLETED|Overall Study||1
2256924|NCT02406586|5539289|P3|COMPLETED|Overall Study||10
2256925|NCT02406586|5539290|P2|COMPLETED|Overall Study||8
2256926|NCT02406586|5539291|P1|COMPLETED|Overall Study||11
2256927|NCT02406586|5539289|P3|STARTED|Overall Study||12
2256928|NCT02406586|5539290|P2|STARTED|Overall Study||12
2256929|NCT02406586|5539291|P1|STARTED|Overall Study||12
2256930|NCT02406573|5539365|P1|NOT COMPLETED|Overall Study||0
2256931|NCT02406573|5539365|P1|COMPLETED|Overall Study||30
2256932|NCT02406573|5539365|P1|STARTED|Overall Study||30
2256933|NCT02406495|5539371|P1|NOT COMPLETED|Overall Study||0
2256934|NCT02406495|5539371|P1|COMPLETED|Overall Study||40
2256935|NCT02406495|5539371|P1|STARTED|Overall Study||40
2256936|NCT02406443|5539412|P2|NOT COMPLETED|Overall Study||2
2256937|NCT02406443|5539413|P1|NOT COMPLETED|Overall Study||2
2256938|NCT02406443|5539412|P2|COMPLETED|Overall Study||16
2256939|NCT02406443|5539413|P1|COMPLETED|Overall Study||16
2256940|NCT02406443|5539412|P2|STARTED|Overall Study||18
2256941|NCT02406443|5539413|P1|STARTED|Overall Study||18
2256942|NCT02406261|5539433|P2|NOT COMPLETED|Period 2||3
2256943|NCT02406261|5539434|P1|NOT COMPLETED|Period 2||0
2256944|NCT02406261|5539433|P2|COMPLETED|Period 2||29
2256945|NCT02406261|5539434|P1|COMPLETED|Period 2||0
2256946|NCT02406261|5539433|P2|STARTED|Period 2||32
2256947|NCT02406261|5539434|P1|STARTED|Period 2|Cohort A participated in Period 1 only|0
2256948|NCT02406261|5539433|P2|NOT COMPLETED|Period 1||0
2256949|NCT02406261|5539434|P1|NOT COMPLETED|Period 1||3
2256950|NCT02406261|5539433|P2|COMPLETED|Period 1||32
2256951|NCT02406261|5539434|P1|COMPLETED|Period 1||47
2256952|NCT02406261|5539433|P2|Received at Least One Dose of Study Drug|Period 1||32
2256953|NCT02406261|5539434|P1|Received at Least One Dose of Study Drug|Period 1||50
2256954|NCT02406261|5539433|P2|STARTED|Period 1||32
2256955|NCT02406261|5539434|P1|STARTED|Period 1||50
2256956|NCT02406248|5539446|P1|NOT COMPLETED|Overall Study||9
2256957|NCT02406248|5539446|P1|COMPLETED|Overall Study||99
2256958|NCT02406248|5539446|P1|STARTED|Overall Study||108
2256959|NCT02406027|5539457|P7|NOT COMPLETED|Open-label Phase (Period 2)||22
2256960|NCT02406027|5539458|P6|NOT COMPLETED|Open-label Phase (Period 2)||26
2256961|NCT02406027|5539459|P5|NOT COMPLETED|Open-label Phase (Period 2)||14
2256962|NCT02406027|5539460|P4|NOT COMPLETED|Open-label Phase (Period 2)||15
2256963|NCT02406027|5539461|P3|NOT COMPLETED|Open-label Phase (Period 2)||0
2256964|NCT02406027|5539462|P2|NOT COMPLETED|Open-label Phase (Period 2)||0
2256965|NCT02406027|5539463|P1|NOT COMPLETED|Open-label Phase (Period 2)||0
2256966|NCT02406027|5539457|P7|COMPLETED|Open-label Phase (Period 2)||0
2256967|NCT02406027|5539458|P6|COMPLETED|Open-label Phase (Period 2)||0
2256968|NCT02406027|5539459|P5|COMPLETED|Open-label Phase (Period 2)||0
2256969|NCT02406027|5539460|P4|COMPLETED|Open-label Phase (Period 2)||0
2256970|NCT02406027|5539461|P3|COMPLETED|Open-label Phase (Period 2)||0
2256971|NCT02406027|5539462|P2|COMPLETED|Open-label Phase (Period 2)||0
2256972|NCT02406027|5539463|P1|COMPLETED|Open-label Phase (Period 2)||0
2256973|NCT02406027|5539457|P7|STARTED|Open-label Phase (Period 2)||22
2256974|NCT02406027|5539458|P6|STARTED|Open-label Phase (Period 2)||26
2256975|NCT02406027|5539459|P5|STARTED|Open-label Phase (Period 2)||14
2256976|NCT02406027|5539460|P4|STARTED|Open-label Phase (Period 2)||15
2256977|NCT02406027|5539461|P3|STARTED|Open-label Phase (Period 2)||0
2256978|NCT02406027|5539462|P2|STARTED|Open-label Phase (Period 2)||0
2256979|NCT02406027|5539463|P1|STARTED|Open-label Phase (Period 2)||0
2256980|NCT02406027|5539457|P7|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
2256981|NCT02406027|5539458|P6|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
2256982|NCT02406027|5539459|P5|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
2256983|NCT02406027|5539460|P4|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
2256984|NCT02406027|5539461|P3|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||4
2256985|NCT02406027|5539462|P2|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||3
2256986|NCT02406027|5539463|P1|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||6
2256987|NCT02406027|5539457|P7|COMPLETED|Double-blind Treatment Phase (Period 1)||0
2256988|NCT02406027|5539458|P6|COMPLETED|Double-blind Treatment Phase (Period 1)||0
2256989|NCT02406027|5539459|P5|COMPLETED|Double-blind Treatment Phase (Period 1)||0
2256990|NCT02406027|5539460|P4|COMPLETED|Double-blind Treatment Phase (Period 1)||0
2256991|NCT02406027|5539461|P3|COMPLETED|Double-blind Treatment Phase (Period 1)||22
2256992|NCT02406027|5539462|P2|COMPLETED|Double-blind Treatment Phase (Period 1)||26
2256993|NCT02406027|5539463|P1|COMPLETED|Double-blind Treatment Phase (Period 1)||29
2256994|NCT02406027|5539457|P7|Prodromal|Double-blind Treatment Phase (Period 1)||0
2256995|NCT02406027|5539458|P6|Prodromal|Double-blind Treatment Phase (Period 1)||0
2256996|NCT02406027|5539459|P5|Prodromal|Double-blind Treatment Phase (Period 1)||0
2256997|NCT02406027|5539460|P4|Prodromal|Double-blind Treatment Phase (Period 1)||0
2256998|NCT02406027|5539461|P3|Prodromal|Double-blind Treatment Phase (Period 1)||20
2256999|NCT02406027|5539462|P2|Prodromal|Double-blind Treatment Phase (Period 1)||21
2257000|NCT02406027|5539463|P1|Prodromal|Double-blind Treatment Phase (Period 1)||29
2257001|NCT02406027|5539457|P7|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
2257002|NCT02406027|5539458|P6|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
2257003|NCT02406027|5539459|P5|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
2257004|NCT02406027|5539460|P4|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
2257005|NCT02406027|5539461|P3|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||6
2257006|NCT02406027|5539462|P2|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||8
2257007|NCT02406027|5539463|P1|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||6
2257008|NCT02406027|5539457|P7|STARTED|Double-blind Treatment Phase (Period 1)||0
2257009|NCT02406027|5539458|P6|STARTED|Double-blind Treatment Phase (Period 1)||0
2257010|NCT02406027|5539459|P5|STARTED|Double-blind Treatment Phase (Period 1)||0
2257011|NCT02406027|5539460|P4|STARTED|Double-blind Treatment Phase (Period 1)||0
2257012|NCT02406027|5539461|P3|STARTED|Double-blind Treatment Phase (Period 1)||26
2257013|NCT02406027|5539462|P2|STARTED|Double-blind Treatment Phase (Period 1)||29
2257014|NCT02406027|5539463|P1|STARTED|Double-blind Treatment Phase (Period 1)||35
2257015|NCT02405962|5539493|P2|NOT COMPLETED|Overall Study||5
2257016|NCT02405962|5539494|P1|NOT COMPLETED|Overall Study||1
2257017|NCT02405962|5539493|P2|COMPLETED|Overall Study||79
2257018|NCT02405962|5539494|P1|COMPLETED|Overall Study||83
2257019|NCT02405962|5539493|P2|3 Months After the Intervention|Overall Study||79
2257020|NCT02405962|5539494|P1|3 Months After the Intervention|Overall Study||80
2257021|NCT02405962|5539493|P2|Post-intervention|Overall Study||81
2257022|NCT02405962|5539494|P1|Post-intervention|Overall Study||80
2257023|NCT02405962|5539493|P2|STARTED|Overall Study||84
2257024|NCT02405962|5539494|P1|STARTED|Overall Study||84
2257025|NCT02405780|5539532|P4|NOT COMPLETED|Period II||18
2257026|NCT02405780|5539533|P3|NOT COMPLETED|Period II||12
2257027|NCT02405780|5539534|P2|NOT COMPLETED|Period II||12
2257028|NCT02405780|5539535|P1|NOT COMPLETED|Period II||15
2257029|NCT02405780|5539532|P4|COMPLETED|Period II||172
2257030|NCT02405780|5539533|P3|COMPLETED|Period II||81
2257031|NCT02405780|5539534|P2|COMPLETED|Period II||88
2257032|NCT02405780|5539535|P1|COMPLETED|Period II||174
2257033|NCT02405780|5539532|P4|STARTED|Period II||190
2257034|NCT02405780|5539533|P3|STARTED|Period II||93
2257035|NCT02405780|5539534|P2|STARTED|Period II||100
2257036|NCT02405780|5539535|P1|STARTED|Period II||189
2257037|NCT02405780|5539532|P4|NOT COMPLETED|Period I||23
2257038|NCT02405780|5539533|P3|NOT COMPLETED|Period I||15
2257039|NCT02405780|5539534|P2|NOT COMPLETED|Period I||8
2257040|NCT02405780|5539535|P1|NOT COMPLETED|Period I||27
2257041|NCT02405780|5539532|P4|COMPLETED|Period I||190
2257042|NCT02405780|5539533|P3|COMPLETED|Period I||93
2257043|NCT02405780|5539534|P2|COMPLETED|Period I||100
2257044|NCT02405780|5539535|P1|COMPLETED|Period I||189
2257045|NCT02405780|5539532|P4|STARTED|Period I||213
2257046|NCT02405780|5539533|P3|STARTED|Period I||108
2257047|NCT02405780|5539534|P2|STARTED|Period I||108
2257048|NCT02405780|5539535|P1|STARTED|Period I||216
2257049|NCT02405442|5539598|P4|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
2257050|NCT02405442|5539599|P3|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
2257051|NCT02405442|5539600|P2|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
2257052|NCT02405442|5539601|P1|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||3
2257053|NCT02405442|5539598|P4|COMPLETED|Extended Treatment Phase(up to Week 208)||0
2257054|NCT02405442|5539599|P3|COMPLETED|Extended Treatment Phase(up to Week 208)||0
2257055|NCT02405442|5539600|P2|COMPLETED|Extended Treatment Phase(up to Week 208)||0
2257056|NCT02405442|5539601|P1|COMPLETED|Extended Treatment Phase(up to Week 208)||0
2257057|NCT02405442|5539598|P4|STARTED|Extended Treatment Phase(up to Week 208)||2
2257058|NCT02405442|5539599|P3|STARTED|Extended Treatment Phase(up to Week 208)||2
2257059|NCT02405442|5539600|P2|STARTED|Extended Treatment Phase(up to Week 208)|1 participant completed Open-Label Phase, but did not continue in Extended Treatment Phase.|2
2257060|NCT02405442|5539601|P1|STARTED|Extended Treatment Phase(up to Week 208)|1 participant completed Open-Label Phase, but did not continue in Extended Treatment Phase.|3
2257061|NCT02405442|5539598|P4|NOT COMPLETED|Open-Label Phase (up to Week 52)||24
2257062|NCT02405442|5539599|P3|NOT COMPLETED|Open-Label Phase (up to Week 52)||45
2257063|NCT02405442|5539600|P2|NOT COMPLETED|Open-Label Phase (up to Week 52)||45
2257064|NCT02405442|5539601|P1|NOT COMPLETED|Open-Label Phase (up to Week 52)||48
2257065|NCT02405442|5539598|P4|COMPLETED|Open-Label Phase (up to Week 52)||2
2257066|NCT02405442|5539599|P3|COMPLETED|Open-Label Phase (up to Week 52)||2
2257067|NCT02405442|5539600|P2|COMPLETED|Open-Label Phase (up to Week 52)||3
2257068|NCT02405442|5539601|P1|COMPLETED|Open-Label Phase (up to Week 52)||4
2257069|NCT02405442|5539598|P4|STARTED|Open-Label Phase (up to Week 52)|1 participant completed Double-Blind Phase, but did not continue in Open-Label Phase.|26
2257070|NCT02405442|5539599|P3|STARTED|Open-Label Phase (up to Week 52)||47
2257071|NCT02405442|5539600|P2|STARTED|Open-Label Phase (up to Week 52)||48
2257072|NCT02405442|5539601|P1|STARTED|Open-Label Phase (up to Week 52)||52
2257073|NCT02405442|5539598|P4|NOT COMPLETED|Double-Blind Phase (up to Week 8)||1
2257074|NCT02405442|5539599|P3|NOT COMPLETED|Double-Blind Phase (up to Week 8)||6
2257075|NCT02405442|5539600|P2|NOT COMPLETED|Double-Blind Phase (up to Week 8)||5
2257076|NCT02405442|5539601|P1|NOT COMPLETED|Double-Blind Phase (up to Week 8)||1
2257077|NCT02405442|5539598|P4|COMPLETED|Double-Blind Phase (up to Week 8)||27
2257078|NCT02405442|5539599|P3|COMPLETED|Double-Blind Phase (up to Week 8)||47
2257079|NCT02405442|5539600|P2|COMPLETED|Double-Blind Phase (up to Week 8)||48
2257080|NCT02405442|5539601|P1|COMPLETED|Double-Blind Phase (up to Week 8)||52
2257081|NCT02405442|5539598|P4|STARTED|Double-Blind Phase (up to Week 8)||28
2257082|NCT02405442|5539599|P3|STARTED|Double-Blind Phase (up to Week 8)||53
2257083|NCT02405442|5539600|P2|STARTED|Double-Blind Phase (up to Week 8)||53
2257084|NCT02405442|5539601|P1|STARTED|Double-Blind Phase (up to Week 8)||53
2257085|NCT02405429|5539627|P1|NOT COMPLETED|Overall Study||0
2257086|NCT02405429|5539627|P1|COMPLETED|Overall Study||49
2257087|NCT02405429|5539627|P1|STARTED|Overall Study||49
2257088|NCT02405390|5539637|P2|NOT COMPLETED|Overall Study||0
2257089|NCT02405390|5539638|P1|NOT COMPLETED|Overall Study||0
2257090|NCT02405390|5539637|P2|COMPLETED|Overall Study||46
2257091|NCT02405390|5539638|P1|COMPLETED|Overall Study||46
2257092|NCT02405390|5539637|P2|STARTED|Overall Study||46
2257093|NCT02405390|5539638|P1|STARTED|Overall Study||46
2257094|NCT02405195|5539646|P1|NOT COMPLETED|Overall Study||0
2257095|NCT02405195|5539646|P1|COMPLETED|Overall Study||18
2257096|NCT02405195|5539646|P1|STARTED|Overall Study||18
2257097|NCT02405091|5539655|P3|NOT COMPLETED|Overall Study||2
2257098|NCT02405091|5539656|P2|NOT COMPLETED|Overall Study||33
2257099|NCT02405091|5539657|P1|NOT COMPLETED|Overall Study||29
2257100|NCT02405091|5539655|P3|COMPLETED|Overall Study||9
2257101|NCT02405091|5539656|P2|COMPLETED|Overall Study||74
2257102|NCT02405091|5539657|P1|COMPLETED|Overall Study||20
2257103|NCT02405091|5539655|P3|STARTED|Overall Study||11
2257104|NCT02405091|5539656|P2|STARTED|Overall Study||107
2257105|NCT02405091|5539657|P1|STARTED|Overall Study||49
2257106|NCT02404792|5539680|P2|NOT COMPLETED|Overall Study||8
2257107|NCT02404792|5539681|P1|NOT COMPLETED|Overall Study||5
2257108|NCT02404792|5539680|P2|COMPLETED|Overall Study||29
2257109|NCT02404792|5539681|P1|COMPLETED|Overall Study||27
2257110|NCT02404792|5539680|P2|STARTED|Overall Study||37
2257111|NCT02404792|5539681|P1|STARTED|Overall Study||32
2257112|NCT02404649|5539693|P2|NOT COMPLETED|Overall Study||2
2257113|NCT02404649|5539694|P1|NOT COMPLETED|Overall Study||1
2257114|NCT02404649|5539693|P2|COMPLETED|Overall Study||14
2257115|NCT02404649|5539694|P1|COMPLETED|Overall Study||16
2257116|NCT02404649|5539693|P2|STARTED|Overall Study||16
2257117|NCT02404649|5539694|P1|STARTED|Overall Study||17
2257118|NCT02404610|5539702|P2|NOT COMPLETED|Overall Study||0
2257119|NCT02404610|5539703|P1|NOT COMPLETED|Overall Study||0
2257120|NCT02404610|5539702|P2|COMPLETED|Overall Study||53
2257121|NCT02404610|5539703|P1|COMPLETED|Overall Study||54
2257122|NCT02404610|5539702|P2|STARTED|Overall Study||53
2257123|NCT02404610|5539703|P1|STARTED|Overall Study||54
2257124|NCT02404545|5539711|P2|NOT COMPLETED|Overall Study||6
2257125|NCT02404545|5539712|P1|NOT COMPLETED|Overall Study||6
2257126|NCT02404545|5539711|P2|COMPLETED|Overall Study||0
2257127|NCT02404545|5539712|P1|COMPLETED|Overall Study||0
2257128|NCT02404545|5539711|P2|STARTED|Overall Study||6
2257129|NCT02404545|5539712|P1|STARTED|Overall Study||6
2257130|NCT02404532|5539719|P1|NOT COMPLETED|Overall Study||0
2257131|NCT02404532|5539719|P1|COMPLETED|Overall Study||29
2257132|NCT02404532|5539719|P1|STARTED|Overall Study||29
2257133|NCT02404493|5539731|P2|NOT COMPLETED|Overall Study||1
2257134|NCT02404493|5539732|P1|NOT COMPLETED|Overall Study||1
2257135|NCT02404493|5539731|P2|COMPLETED|Overall Study||5
2257136|NCT02404493|5539732|P1|COMPLETED|Overall Study||16
2257137|NCT02404493|5539731|P2|STARTED|Overall Study||6
2257138|NCT02404493|5539732|P1|STARTED|Overall Study||17
2257139|NCT02404389|5539977|P5|NOT COMPLETED|Overall Study||3
2257140|NCT02404389|5539978|P4|NOT COMPLETED|Overall Study||1
2257141|NCT02404389|5539979|P3|NOT COMPLETED|Overall Study||1
2257142|NCT02404389|5539980|P2|NOT COMPLETED|Overall Study||0
2257143|NCT02404389|5539981|P1|NOT COMPLETED|Overall Study||2
2257144|NCT02404389|5539977|P5|COMPLETED|Overall Study||18
2257145|NCT02404389|5539978|P4|COMPLETED|Overall Study||9
2257146|NCT02404389|5539979|P3|COMPLETED|Overall Study||10
2257147|NCT02404389|5539980|P2|COMPLETED|Overall Study||20
2257148|NCT02404389|5539981|P1|COMPLETED|Overall Study||18
2257149|NCT02404389|5539977|P5|STARTED|Overall Study||21
2257150|NCT02404389|5539978|P4|STARTED|Overall Study||10
2257151|NCT02404389|5539979|P3|STARTED|Overall Study||11
2257152|NCT02404389|5539980|P2|STARTED|Overall Study||20
2257153|NCT02404389|5539981|P1|STARTED|Overall Study||20
2257154|NCT02404350|5540021|P4|NOT COMPLETED|Overall Study||37
2257155|NCT02404350|5540022|P3|NOT COMPLETED|Overall Study||6
2257156|NCT02404350|5540023|P2|NOT COMPLETED|Overall Study||6
2257157|NCT02404350|5540024|P1|NOT COMPLETED|Overall Study||15
2257158|NCT02404350|5540021|P4|COMPLETED|Overall Study||295
2257159|NCT02404350|5540022|P3|COMPLETED|Overall Study||216
2257160|NCT02404350|5540023|P2|COMPLETED|Overall Study||214
2257161|NCT02404350|5540024|P1|COMPLETED|Overall Study||207
2257162|NCT02404350|5540021|P4|STARTED|Overall Study||332
2257163|NCT02404350|5540022|P3|STARTED|Overall Study||222
2257164|NCT02404350|5540023|P2|STARTED|Overall Study||220
2257165|NCT02404350|5540024|P1|STARTED|Overall Study||222
2257166|NCT02404285|5540041|P2|NOT COMPLETED|Overall Study||2
2257167|NCT02404285|5540042|P1|NOT COMPLETED|Overall Study||2
2257168|NCT02404285|5540041|P2|COMPLETED|Overall Study||33
2257169|NCT02404285|5540042|P1|COMPLETED|Overall Study||31
2257170|NCT02404285|5540041|P2|STARTED|Overall Study||35
2257171|NCT02404285|5540042|P1|STARTED|Overall Study||33
2257172|NCT02404220|5540078|P4|NOT COMPLETED|Overall Study||10
2257173|NCT02404220|5540079|P3|NOT COMPLETED|Overall Study||7
2257174|NCT02404220|5540080|P2|NOT COMPLETED|Overall Study||8
2257175|NCT02404220|5540081|P1|NOT COMPLETED|Overall Study||5
2257176|NCT02404220|5540078|P4|COMPLETED|Overall Study||0
2257177|NCT02404220|5540079|P3|COMPLETED|Overall Study||0
2257178|NCT02404220|5540080|P2|COMPLETED|Overall Study||0
2257179|NCT02404220|5540081|P1|COMPLETED|Overall Study||0
2257180|NCT02404220|5540078|P4|STARTED|Overall Study||10
2257181|NCT02404220|5540079|P3|STARTED|Overall Study||7
2257182|NCT02404220|5540080|P2|STARTED|Overall Study||8
2257183|NCT02404220|5540081|P1|STARTED|Overall Study||5
2257184|NCT02404168|5540107|P1|NOT COMPLETED|Overall Study||0
2257185|NCT02404168|5540107|P1|COMPLETED|Overall Study||4
2257186|NCT02404168|5540107|P1|STARTED|Overall Study||4
2257187|NCT02404103|5540117|P2|NOT COMPLETED|Overall Study||3
2257188|NCT02404103|5540118|P1|NOT COMPLETED|Overall Study||4
2257189|NCT02404103|5540117|P2|COMPLETED|Overall Study||9
2257190|NCT02404103|5540118|P1|COMPLETED|Overall Study||10
2257191|NCT02404103|5540117|P2|STARTED|Overall Study||12
2257192|NCT02404103|5540118|P1|STARTED|Overall Study||14
2257193|NCT02404025|5540138|P1|NOT COMPLETED|Overall Study||4
2257194|NCT02404025|5540138|P1|COMPLETED|Overall Study||6
2257195|NCT02404025|5540138|P1|STARTED|Overall Study||10
2257196|NCT02403999|5540170|P3|NOT COMPLETED|Overall Study||0
2257197|NCT02403999|5540171|P2|NOT COMPLETED|Overall Study||0
2257198|NCT02403999|5540172|P1|NOT COMPLETED|Overall Study||0
2257199|NCT02403999|5540170|P3|COMPLETED|Overall Study||11
2257200|NCT02403999|5540171|P2|COMPLETED|Overall Study||10
2257201|NCT02403999|5540172|P1|COMPLETED|Overall Study||10
2257202|NCT02403999|5540170|P3|STARTED|Overall Study||11
2257203|NCT02403999|5540171|P2|STARTED|Overall Study||10
2257204|NCT02403999|5540172|P1|STARTED|Overall Study||10
2257205|NCT02403986|5540185|P2|NOT COMPLETED|Overall Study||4
2257206|NCT02403986|5540186|P1|NOT COMPLETED|Overall Study||5
2257207|NCT02403986|5540185|P2|COMPLETED|Overall Study||23
2257208|NCT02403986|5540186|P1|COMPLETED|Overall Study||21
2257209|NCT02403986|5540185|P2|STARTED|Overall Study||27
2257210|NCT02403986|5540186|P1|STARTED|Overall Study||26
2257211|NCT02403895|5540194|P1|NOT COMPLETED|Overall Study||0
2257212|NCT02403895|5540194|P1|COMPLETED|Overall Study||11
2257213|NCT02403895|5540194|P1|STARTED|Overall Study||11
2257214|NCT02403830|5540207|P2|NOT COMPLETED|Visit 2||0
2257215|NCT02403830|5540208|P1|NOT COMPLETED|Visit 2||0
2257216|NCT02403830|5540207|P2|COMPLETED|Visit 2||15
2257217|NCT02403830|5540208|P1|COMPLETED|Visit 2||14
2257218|NCT02403830|5540207|P2|STARTED|Visit 2||15
2257219|NCT02403830|5540208|P1|STARTED|Visit 2|One subject completed visit 1 and then withdrew from the study for an adverse event (nausea).|14
2257220|NCT02403830|5540207|P2|NOT COMPLETED|Visit 1||0
2257221|NCT02403830|5540208|P1|NOT COMPLETED|Visit 1||0
2257222|NCT02403830|5540207|P2|COMPLETED|Visit 1||15
2257223|NCT02403830|5540208|P1|COMPLETED|Visit 1||15
2257224|NCT02403830|5540207|P2|STARTED|Visit 1||15
2257225|NCT02403830|5540208|P1|STARTED|Visit 1||15
2257226|NCT02403817|5540220|P2|NOT COMPLETED|Overall Study||0
2257227|NCT02403817|5540221|P1|NOT COMPLETED|Overall Study||5
2257228|NCT02403817|5540220|P2|COMPLETED|Overall Study||2
2257229|NCT02403817|5540221|P1|COMPLETED|Overall Study||23
2257230|NCT02403817|5540220|P2|STARTED|Overall Study||2
2257231|NCT02403817|5540221|P1|STARTED|Overall Study||28
2257232|NCT02403778|5540235|P2|NOT COMPLETED|Overall Study||0
2257233|NCT02403778|5540236|P1|NOT COMPLETED|Overall Study||0
2257234|NCT02403778|5540235|P2|COMPLETED|Overall Study||4
2257235|NCT02403778|5540236|P1|COMPLETED|Overall Study||6
2257236|NCT02403778|5540235|P2|STARTED|Overall Study||4
2257237|NCT02403778|5540236|P1|STARTED|Overall Study||6
2257238|NCT02403674|5540252|P2|NOT COMPLETED|Overall Study||63
2257239|NCT02403674|5540253|P1|NOT COMPLETED|Overall Study||55
2257240|NCT02403674|5540252|P2|COMPLETED|Overall Study||303
2257241|NCT02403674|5540253|P1|COMPLETED|Overall Study||313
2257242|NCT02403674|5540252|P2|Treated|Overall Study||364
2257243|NCT02403674|5540253|P1|Treated|Overall Study||364
2257244|NCT02403674|5540252|P2|STARTED|Overall Study||366
2257245|NCT02403674|5540253|P1|STARTED|Overall Study||368
2257246|NCT02403635|5540292|P1|NOT COMPLETED|Overall Study||9
2257247|NCT02403635|5540292|P1|COMPLETED|Overall Study||18
2257248|NCT02403635|5540292|P1|Received the First Dose|Overall Study||18
2257249|NCT02403635|5540292|P1|Screening (28 Days)|Overall Study||27
2257250|NCT02403635|5540292|P1|STARTED|Overall Study||27
2257251|NCT02403479|5540360|P2|NOT COMPLETED|Overall Study||0
2257252|NCT02403479|5540361|P1|NOT COMPLETED|Overall Study||2
2257253|NCT02403479|5540360|P2|COMPLETED|Overall Study||12
2257254|NCT02403479|5540361|P1|COMPLETED|Overall Study||8
2257255|NCT02403479|5540360|P2|STARTED|Overall Study||12
2257256|NCT02403479|5540361|P1|STARTED|Overall Study||10
2257257|NCT02403271|5540369|P2|NOT COMPLETED|Period 2||124
2257258|NCT02403271|5540370|P1|NOT COMPLETED|Period 2||0
2257259|NCT02403271|5540369|P2|COMPLETED|Period 2||0
2257260|NCT02403271|5540370|P1|COMPLETED|Period 2||0
2257261|NCT02403271|5540369|P2|STARTED|Period 2|Phase 2 includes all subjects who participated in Phase 1b.|124
2257262|NCT02403271|5540370|P1|STARTED|Period 2||0
2257263|NCT02403271|5540369|P2|NOT COMPLETED|Period 1||0
2257264|NCT02403271|5540370|P1|NOT COMPLETED|Period 1||1
2257265|NCT02403271|5540369|P2|COMPLETED|Period 1||0
2257266|NCT02403271|5540370|P1|COMPLETED|Period 1||6
2257267|NCT02403271|5540369|P2|STARTED|Period 1||0
2257268|NCT02403271|5540370|P1|STARTED|Period 1|All Phase 1b participants went on to participate in Phase 2.|7
2257269|NCT02403206|5540384|P2|NOT COMPLETED|Overall Study||10
2257270|NCT02403206|5540385|P1|NOT COMPLETED|Overall Study||11
2257271|NCT02403206|5540384|P2|COMPLETED|Overall Study||186
2257272|NCT02403206|5540385|P1|COMPLETED|Overall Study||183
2257273|NCT02403206|5540384|P2|Randomized and Treated|Overall Study||190
2257274|NCT02403206|5540385|P1|Randomized and Treated|Overall Study||188
2257275|NCT02403206|5540384|P2|Treated Prior to Randomization|Overall Study||1
2257276|NCT02403206|5540385|P1|Treated Prior to Randomization|Overall Study||0
2257277|NCT02403206|5540384|P2|STARTED|Overall Study||196
2257278|NCT02403206|5540385|P1|STARTED|Overall Study||194
2257279|NCT02403180|5540396|P2|NOT COMPLETED|Period 2 (5 Days)||1
2257280|NCT02403180|5540397|P1|NOT COMPLETED|Period 2 (5 Days)||0
2257281|NCT02403180|5540396|P2|COMPLETED|Period 2 (5 Days)||32
2257282|NCT02403180|5540397|P1|COMPLETED|Period 2 (5 Days)||36
2257283|NCT02403180|5540396|P2|STARTED|Period 2 (5 Days)||33
2257284|NCT02403180|5540397|P1|STARTED|Period 2 (5 Days)||36
2257285|NCT02403180|5540396|P2|NOT COMPLETED|Period 1 (5 Days)||0
2257286|NCT02403180|5540397|P1|NOT COMPLETED|Period 1 (5 Days)||0
2257287|NCT02403180|5540396|P2|COMPLETED|Period 1 (5 Days)||33
2257288|NCT02403180|5540397|P1|COMPLETED|Period 1 (5 Days)||36
2257289|NCT02403180|5540396|P2|Randomized|Period 1 (5 Days)||33
2257290|NCT02403180|5540397|P1|Randomized|Period 1 (5 Days)||36
2257291|NCT02403180|5540396|P2|STARTED|Period 1 (5 Days)||33
2257292|NCT02403180|5540397|P1|STARTED|Period 1 (5 Days)||36
2257293|NCT02403180|5540396|P2|NOT COMPLETED|Pre-Treatment Period||1
2257294|NCT02403180|5540397|P1|NOT COMPLETED|Pre-Treatment Period||0
2257295|NCT02403180|5540396|P2|COMPLETED|Pre-Treatment Period||33
2257296|NCT02403180|5540397|P1|COMPLETED|Pre-Treatment Period||36
2257297|NCT02403180|5540396|P2|STARTED|Pre-Treatment Period||34
2257298|NCT02403180|5540397|P1|STARTED|Pre-Treatment Period||36
2257299|NCT02403154|5540409|P4|NOT COMPLETED|Overall Study||1
2257300|NCT02403154|5540410|P3|NOT COMPLETED|Overall Study||1
2257301|NCT02403154|5540411|P2|NOT COMPLETED|Overall Study||0
2257302|NCT02403154|5540412|P1|NOT COMPLETED|Overall Study||2
2257303|NCT02403154|5540409|P4|COMPLETED|Overall Study||0
2257304|NCT02403154|5540410|P3|COMPLETED|Overall Study||0
2257305|NCT02403154|5540411|P2|COMPLETED|Overall Study||0
2257306|NCT02403154|5540412|P1|COMPLETED|Overall Study||0
2257307|NCT02403154|5540409|P4|STARTED|Overall Study||1
2257308|NCT02403154|5540410|P3|STARTED|Overall Study||1
2257309|NCT02403154|5540411|P2|STARTED|Overall Study||0
2257310|NCT02403154|5540412|P1|STARTED|Overall Study||2
2257311|NCT02402933|5540426|P1|NOT COMPLETED|Overall Study||14
2257312|NCT02402933|5540426|P1|COMPLETED|Overall Study||12
2257313|NCT02402933|5540426|P1|Received at Least One Dose of Study Drug|Overall Study||22
2257314|NCT02402933|5540426|P1|STARTED|Overall Study||26
2257315|NCT02402881|5540435|P2|NOT COMPLETED|Post-Intervention Study Period||0
2257316|NCT02402881|5540436|P1|NOT COMPLETED|Post-Intervention Study Period||0
2257317|NCT02402881|5540435|P2|COMPLETED|Post-Intervention Study Period||8662
2257318|NCT02402881|5540436|P1|COMPLETED|Post-Intervention Study Period||3111
2257319|NCT02402881|5540435|P2|STARTED|Post-Intervention Study Period||8662
2257320|NCT02402881|5540436|P1|STARTED|Post-Intervention Study Period||3111
2257321|NCT02402881|5540435|P2|NOT COMPLETED|Pre-Intervention Study Period||0
2257322|NCT02402881|5540436|P1|NOT COMPLETED|Pre-Intervention Study Period||0
2257323|NCT02402881|5540435|P2|COMPLETED|Pre-Intervention Study Period||5657
2257324|NCT02402881|5540436|P1|COMPLETED|Pre-Intervention Study Period||2222
2257325|NCT02402881|5540435|P2|STARTED|Pre-Intervention Study Period||5657
2257326|NCT02402881|5540436|P1|STARTED|Pre-Intervention Study Period||2222
2257327|NCT02402764|5540444|P1|NOT COMPLETED|Overall Study||0
2257328|NCT02402764|5540444|P1|COMPLETED|Overall Study||10
2257329|NCT02402764|5540444|P1|STARTED|Overall Study||10
2257330|NCT02402322|5540455|P3|NOT COMPLETED|Follow-up||24
2257331|NCT02402322|5540456|P2|NOT COMPLETED|Follow-up||3
2257332|NCT02402322|5540457|P1|NOT COMPLETED|Follow-up||6
2257333|NCT02402322|5540455|P3|COMPLETED|Follow-up||0
2257334|NCT02402322|5540456|P2|COMPLETED|Follow-up||21
2257335|NCT02402322|5540457|P1|COMPLETED|Follow-up||18
2257336|NCT02402322|5540455|P3|STARTED|Follow-up|These individuals were not evaluated at this follow-up as they started an alternative treatment.|24
2257337|NCT02402322|5540456|P2|STARTED|Follow-up||24
2257338|NCT02402322|5540457|P1|STARTED|Follow-up||24
2257339|NCT02402322|5540455|P3|NOT COMPLETED|Pretreatment||1
2257340|NCT02402322|5540456|P2|NOT COMPLETED|Pretreatment||1
2257341|NCT02402322|5540457|P1|NOT COMPLETED|Pretreatment||3
2257342|NCT02402322|5540455|P3|COMPLETED|Pretreatment||24
2257343|NCT02402322|5540456|P2|COMPLETED|Pretreatment||24
2257344|NCT02402322|5540457|P1|COMPLETED|Pretreatment||24
2257345|NCT02402322|5540455|P3|Posttreatment Measures|Pretreatment||24
2257346|NCT02402322|5540456|P2|Posttreatment Measures|Pretreatment||24
2257347|NCT02402322|5540457|P1|Posttreatment Measures|Pretreatment||24
2257348|NCT02402322|5540455|P3|STARTED|Pretreatment||25
2257349|NCT02402322|5540456|P2|STARTED|Pretreatment||25
2257350|NCT02402322|5540457|P1|STARTED|Pretreatment||27
2257351|NCT02402296|5540491|P2|NOT COMPLETED|Overall Study||0
2257352|NCT02402296|5540492|P1|NOT COMPLETED|Overall Study||0
2257353|NCT02402296|5540491|P2|COMPLETED|Overall Study||15
2257354|NCT02402296|5540492|P1|COMPLETED|Overall Study||15
2257355|NCT02402296|5540491|P2|STARTED|Overall Study||15
2257356|NCT02402296|5540492|P1|STARTED|Overall Study||15
2257357|NCT02402218|5540507|P3|NOT COMPLETED|Overall Study||17
2257358|NCT02402218|5540508|P2|NOT COMPLETED|Overall Study||13
2257359|NCT02402218|5540509|P1|NOT COMPLETED|Overall Study||14
2257360|NCT02402218|5540507|P3|COMPLETED|Overall Study||37
2257361|NCT02402218|5540508|P2|COMPLETED|Overall Study||41
2257362|NCT02402218|5540509|P1|COMPLETED|Overall Study||22
2257363|NCT02402218|5540507|P3|Achieved Sustained Virologic Response|Overall Study||37
2257364|NCT02402218|5540508|P2|Achieved Sustained Virologic Response|Overall Study||41
2257365|NCT02402218|5540509|P1|Achieved Sustained Virologic Response|Overall Study||22
2257366|NCT02402218|5540507|P3|Completed Treatment With LDV/SOF|Overall Study||39
2257367|NCT02402218|5540508|P2|Completed Treatment With LDV/SOF|Overall Study||42
2257368|NCT02402218|5540509|P1|Completed Treatment With LDV/SOF|Overall Study||23
2257369|NCT02402218|5540507|P3|Initiated Treatment With LDV/SOF|Overall Study||41
2257370|NCT02402218|5540508|P2|Initiated Treatment With LDV/SOF|Overall Study||45
2257371|NCT02402218|5540509|P1|Initiated Treatment With LDV/SOF|Overall Study||24
2257372|NCT02402218|5540507|P3|STARTED|Overall Study||54
2257373|NCT02402218|5540508|P2|STARTED|Overall Study||54
2257374|NCT02402218|5540509|P1|STARTED|Overall Study||36
2257375|NCT02402166|5540532|P1|NOT COMPLETED|Overall Study||5
2257376|NCT02402166|5540532|P1|COMPLETED|Overall Study||19
2257377|NCT02402166|5540532|P1|STARTED|Overall Study||24
2257378|NCT02402153|5540553|P1|NOT COMPLETED|Overall Study||0
2257379|NCT02402153|5540553|P1|COMPLETED|Overall Study||18
2257380|NCT02402153|5540553|P1|STARTED|Overall Study||18
2257381|NCT02402127|5540569|P6|NOT COMPLETED|Third Wear Period (1 Day)||0
2257382|NCT02402127|5540570|P5|NOT COMPLETED|Third Wear Period (1 Day)||0
2257383|NCT02402127|5540571|P4|NOT COMPLETED|Third Wear Period (1 Day)||0
2257384|NCT02402127|5540572|P3|NOT COMPLETED|Third Wear Period (1 Day)||0
2257385|NCT02402127|5540573|P2|NOT COMPLETED|Third Wear Period (1 Day)||0
2257386|NCT02402127|5540574|P1|NOT COMPLETED|Third Wear Period (1 Day)||0
2257387|NCT02402127|5540569|P6|COMPLETED|Third Wear Period (1 Day)||4
2257388|NCT02402127|5540570|P5|COMPLETED|Third Wear Period (1 Day)||4
2257389|NCT02402127|5540571|P4|COMPLETED|Third Wear Period (1 Day)||4
2257390|NCT02402127|5540572|P3|COMPLETED|Third Wear Period (1 Day)||4
2257391|NCT02402127|5540573|P2|COMPLETED|Third Wear Period (1 Day)||4
2257392|NCT02402127|5540574|P1|COMPLETED|Third Wear Period (1 Day)||4
2257393|NCT02402127|5540569|P6|STARTED|Third Wear Period (1 Day)||4
2257394|NCT02402127|5540570|P5|STARTED|Third Wear Period (1 Day)||4
2257395|NCT02402127|5540571|P4|STARTED|Third Wear Period (1 Day)||4
2257396|NCT02402127|5540572|P3|STARTED|Third Wear Period (1 Day)||4
2257397|NCT02402127|5540573|P2|STARTED|Third Wear Period (1 Day)||4
2257398|NCT02402127|5540574|P1|STARTED|Third Wear Period (1 Day)||4
2257399|NCT02402127|5540569|P6|NOT COMPLETED|Second Wear Period (1 Day)||0
2257400|NCT02402127|5540570|P5|NOT COMPLETED|Second Wear Period (1 Day)||0
2257401|NCT02402127|5540571|P4|NOT COMPLETED|Second Wear Period (1 Day)||0
2257402|NCT02402127|5540572|P3|NOT COMPLETED|Second Wear Period (1 Day)||0
2257403|NCT02402127|5540573|P2|NOT COMPLETED|Second Wear Period (1 Day)||0
2257404|NCT02402127|5540574|P1|NOT COMPLETED|Second Wear Period (1 Day)||0
2257405|NCT02402127|5540569|P6|COMPLETED|Second Wear Period (1 Day)||4
2257406|NCT02402127|5540570|P5|COMPLETED|Second Wear Period (1 Day)||4
2257407|NCT02402127|5540571|P4|COMPLETED|Second Wear Period (1 Day)||4
2257408|NCT02402127|5540572|P3|COMPLETED|Second Wear Period (1 Day)||4
2257409|NCT02402127|5540573|P2|COMPLETED|Second Wear Period (1 Day)||4
2257410|NCT02402127|5540574|P1|COMPLETED|Second Wear Period (1 Day)||4
2257411|NCT02402127|5540569|P6|STARTED|Second Wear Period (1 Day)||4
2257412|NCT02402127|5540570|P5|STARTED|Second Wear Period (1 Day)||4
2257413|NCT02402127|5540571|P4|STARTED|Second Wear Period (1 Day)||4
2257414|NCT02402127|5540572|P3|STARTED|Second Wear Period (1 Day)||4
2257415|NCT02402127|5540573|P2|STARTED|Second Wear Period (1 Day)||4
2257416|NCT02402127|5540574|P1|STARTED|Second Wear Period (1 Day)||4
2257417|NCT02402127|5540569|P6|NOT COMPLETED|First Wear Period (1 Day)||0
2257418|NCT02402127|5540570|P5|NOT COMPLETED|First Wear Period (1 Day)||0
2257419|NCT02402127|5540571|P4|NOT COMPLETED|First Wear Period (1 Day)||0
2257420|NCT02402127|5540572|P3|NOT COMPLETED|First Wear Period (1 Day)||0
2257421|NCT02402127|5540573|P2|NOT COMPLETED|First Wear Period (1 Day)||0
2257422|NCT02402127|5540574|P1|NOT COMPLETED|First Wear Period (1 Day)||0
2257423|NCT02402127|5540569|P6|COMPLETED|First Wear Period (1 Day)||4
2257424|NCT02402127|5540570|P5|COMPLETED|First Wear Period (1 Day)||4
2257425|NCT02402127|5540571|P4|COMPLETED|First Wear Period (1 Day)||4
2257426|NCT02402127|5540572|P3|COMPLETED|First Wear Period (1 Day)||4
2257427|NCT02402127|5540573|P2|COMPLETED|First Wear Period (1 Day)||4
2257428|NCT02402127|5540574|P1|COMPLETED|First Wear Period (1 Day)||4
2257429|NCT02402127|5540569|P6|Randomized and Treated|First Wear Period (1 Day)||4
2257430|NCT02402127|5540570|P5|Randomized and Treated|First Wear Period (1 Day)||4
2257431|NCT02402127|5540571|P4|Randomized and Treated|First Wear Period (1 Day)||4
2257432|NCT02402127|5540572|P3|Randomized and Treated|First Wear Period (1 Day)||4
2257433|NCT02402127|5540573|P2|Randomized and Treated|First Wear Period (1 Day)||4
2257434|NCT02402127|5540574|P1|Randomized and Treated|First Wear Period (1 Day)||4
2257435|NCT02402127|5540569|P6|STARTED|First Wear Period (1 Day)||4
2257436|NCT02402127|5540570|P5|STARTED|First Wear Period (1 Day)||4
2257437|NCT02402127|5540571|P4|STARTED|First Wear Period (1 Day)||4
2257438|NCT02402127|5540572|P3|STARTED|First Wear Period (1 Day)||4
2257439|NCT02402127|5540573|P2|STARTED|First Wear Period (1 Day)||4
2257440|NCT02402127|5540574|P1|STARTED|First Wear Period (1 Day)||4
2257441|NCT02402036|5540585|P1|NOT COMPLETED|Overall Study||0
2257442|NCT02402036|5540585|P1|COMPLETED|Overall Study||10
2257443|NCT02402036|5540585|P1|STARTED|Overall Study||10
2257444|NCT02401867|5540589|P1|NOT COMPLETED|Analysis||9
2257445|NCT02401867|5540589|P1|COMPLETED|Analysis|Comparative analysis of vaginal HPV DNA results and cervical HPV DNA results|131
2257446|NCT02401867|5540589|P1|STARTED|Analysis||140
2257447|NCT02401867|5540589|P1|NOT COMPLETED|Specimen Collection||10
2257448|NCT02401867|5540589|P1|COMPLETED|Specimen Collection|Completed both vaginal self-swab and provider-collected cervical swab|140
2257449|NCT02401867|5540589|P1|STARTED|Specimen Collection||150
2257450|NCT02401867|5540589|P1|NOT COMPLETED|Enrolled||0
2257451|NCT02401867|5540589|P1|COMPLETED|Enrolled||150
2257452|NCT02401867|5540589|P1|STARTED|Enrolled||150
2257453|NCT02401555|5540597|P3|NOT COMPLETED|Overall Study||0
2257454|NCT02401555|5540598|P2|NOT COMPLETED|Overall Study||0
2257455|NCT02401555|5540599|P1|NOT COMPLETED|Overall Study||0
2257456|NCT02401555|5540597|P3|COMPLETED|Overall Study||120
2257457|NCT02401555|5540598|P2|COMPLETED|Overall Study||212
2257458|NCT02401555|5540599|P1|COMPLETED|Overall Study||87
2257459|NCT02401555|5540597|P3|STARTED|Overall Study||120
2257460|NCT02401555|5540598|P2|STARTED|Overall Study||212
2257461|NCT02401555|5540599|P1|STARTED|Overall Study||87
2257471|NCT02401529|5540624|P2|NOT COMPLETED|Overall Study||7
2257472|NCT02401529|5540625|P1|NOT COMPLETED|Overall Study||9
2257473|NCT02401529|5540624|P2|COMPLETED|Overall Study||50
2257474|NCT02401529|5540625|P1|COMPLETED|Overall Study||50
2257475|NCT02401529|5540624|P2|STARTED|Overall Study||57
2257476|NCT02401529|5540625|P1|STARTED|Overall Study||59
2257477|NCT02401464|5540653|P4|NOT COMPLETED|Intervention Period 2 (6 Days)||0
2257478|NCT02401464|5540654|P3|NOT COMPLETED|Intervention Period 2 (6 Days)||0
2257479|NCT02401464|5540655|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
2257480|NCT02401464|5540656|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
2257481|NCT02401464|5540653|P4|COMPLETED|Intervention Period 2 (6 Days)||13
2257482|NCT02401464|5540654|P3|COMPLETED|Intervention Period 2 (6 Days)||13
2257483|NCT02401464|5540655|P2|COMPLETED|Intervention Period 2 (6 Days)||13
2257484|NCT02401464|5540656|P1|COMPLETED|Intervention Period 2 (6 Days)||13
2257485|NCT02401464|5540653|P4|STARTED|Intervention Period 2 (6 Days)||13
2257486|NCT02401464|5540654|P3|STARTED|Intervention Period 2 (6 Days)||13
2257487|NCT02401464|5540655|P2|STARTED|Intervention Period 2 (6 Days)||13
2257488|NCT02401464|5540656|P1|STARTED|Intervention Period 2 (6 Days)||13
2257489|NCT02401464|5540653|P4|NOT COMPLETED|Washout Period (At Least 6 Days)||0
2257490|NCT02401464|5540654|P3|NOT COMPLETED|Washout Period (At Least 6 Days)||0
2257491|NCT02401464|5540655|P2|NOT COMPLETED|Washout Period (At Least 6 Days)||0
2257492|NCT02401464|5540656|P1|NOT COMPLETED|Washout Period (At Least 6 Days)||0
2257493|NCT02401464|5540653|P4|COMPLETED|Washout Period (At Least 6 Days)||13
2257494|NCT02401464|5540654|P3|COMPLETED|Washout Period (At Least 6 Days)||13
2257495|NCT02401464|5540655|P2|COMPLETED|Washout Period (At Least 6 Days)||13
2257496|NCT02401464|5540656|P1|COMPLETED|Washout Period (At Least 6 Days)||13
2257497|NCT02401464|5540653|P4|STARTED|Washout Period (At Least 6 Days)||13
2257498|NCT02401464|5540654|P3|STARTED|Washout Period (At Least 6 Days)||13
2257499|NCT02401464|5540655|P2|STARTED|Washout Period (At Least 6 Days)||13
2257500|NCT02401464|5540656|P1|STARTED|Washout Period (At Least 6 Days)||13
2257501|NCT02401464|5540653|P4|NOT COMPLETED|Intervention Period 1 (6 Days)||0
2257502|NCT02401464|5540654|P3|NOT COMPLETED|Intervention Period 1 (6 Days)||0
2257503|NCT02401464|5540655|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
2257504|NCT02401464|5540656|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
2257505|NCT02401464|5540653|P4|COMPLETED|Intervention Period 1 (6 Days)||13
2257506|NCT02401464|5540654|P3|COMPLETED|Intervention Period 1 (6 Days)||13
2257507|NCT02401464|5540655|P2|COMPLETED|Intervention Period 1 (6 Days)||13
2257508|NCT02401464|5540656|P1|COMPLETED|Intervention Period 1 (6 Days)||13
2257509|NCT02401464|5540653|P4|STARTED|Intervention Period 1 (6 Days)||13
2257510|NCT02401464|5540654|P3|STARTED|Intervention Period 1 (6 Days)||13
2257511|NCT02401464|5540655|P2|STARTED|Intervention Period 1 (6 Days)||13
2257512|NCT02401464|5540656|P1|STARTED|Intervention Period 1 (6 Days)||13
2257513|NCT02401412|5540692|P2|NOT COMPLETED|Overall Study||32
2257514|NCT02401412|5540693|P1|NOT COMPLETED|Overall Study||30
2257515|NCT02401412|5540692|P2|COMPLETED|Overall Study||49
2257516|NCT02401412|5540693|P1|COMPLETED|Overall Study||59
2257517|NCT02401412|5540692|P2|Received Study Device|Overall Study||80
2257518|NCT02401412|5540693|P1|Received Study Device|Overall Study||89
2257519|NCT02401412|5540692|P2|STARTED|Overall Study||81
2257520|NCT02401412|5540693|P1|STARTED|Overall Study||89
2257521|NCT02401256|5540701|P1|NOT COMPLETED|Overall Study||17
2257522|NCT02401256|5540701|P1|COMPLETED|Overall Study||53
2257523|NCT02401256|5540701|P1|Analysed|Overall Study|Volunteers that completed at least until Phase 2 inpatient visit (Volunteers with Efavirenz PK data)|61
2257524|NCT02401256|5540701|P1|Finished Phase 3|Overall Study||53
2257525|NCT02401256|5540701|P1|Finished Phase 2|Overall Study||58
2257526|NCT02401256|5540701|P1|Finished Phase 1|Overall Study||64
2257527|NCT02401256|5540701|P1|STARTED|Overall Study||70
2257528|NCT02401230|5540710|P3|NOT COMPLETED|Overall Study||4
2257529|NCT02401230|5540711|P2|NOT COMPLETED|Overall Study||6
2257530|NCT02401230|5540712|P1|NOT COMPLETED|Overall Study||6
2257531|NCT02401230|5540710|P3|COMPLETED|Overall Study||21
2257532|NCT02401230|5540711|P2|COMPLETED|Overall Study||19
2257533|NCT02401230|5540712|P1|COMPLETED|Overall Study||20
2257534|NCT02401230|5540710|P3|STARTED|Overall Study||25
2257535|NCT02401230|5540711|P2|STARTED|Overall Study||25
2257536|NCT02401230|5540712|P1|STARTED|Overall Study||26
2257537|NCT02401048|5540747|P2|NOT COMPLETED|Overall Study||30
2257538|NCT02401048|5540748|P1|NOT COMPLETED|Overall Study||22
2257539|NCT02401048|5540747|P2|COMPLETED|Overall Study||4
2257540|NCT02401048|5540748|P1|COMPLETED|Overall Study||5
2257541|NCT02401048|5540747|P2|STARTED|Overall Study||34
2257542|NCT02401048|5540748|P1|STARTED|Overall Study||27
2257543|NCT02401022|5540780|P2|NOT COMPLETED|Overall Study||20
2257544|NCT02401022|5540781|P1|NOT COMPLETED|Overall Study||15
2257545|NCT02401022|5540780|P2|COMPLETED|Overall Study||90
2257546|NCT02401022|5540781|P1|COMPLETED|Overall Study||89
2257547|NCT02401022|5540780|P2|STARTED|Overall Study||110
2257548|NCT02401022|5540781|P1|STARTED|Overall Study||104
2257549|NCT02400996|5540787|P1|NOT COMPLETED|Overall Study||0
2257550|NCT02400996|5540787|P1|COMPLETED|Overall Study||40
2257551|NCT02400996|5540787|P1|STARTED|Overall Study||40
2257552|NCT02400905|5540791|P1|NOT COMPLETED|Overall Study||271
2257553|NCT02400905|5540791|P1|COMPLETED|Overall Study||0
2257554|NCT02400905|5540791|P1|12-month Follow-up|Overall Study||256
2257555|NCT02400905|5540791|P1|STARTED|Overall Study||271
2257556|NCT02400749|5540801|P2|NOT COMPLETED|Week 17 - 32||3
2257557|NCT02400749|5540802|P1|NOT COMPLETED|Week 17 - 32||5
2257558|NCT02400749|5540801|P2|COMPLETED|Week 17 - 32||41
2257559|NCT02400749|5540802|P1|COMPLETED|Week 17 - 32||34
2257560|NCT02400749|5540801|P2|STARTED|Week 17 - 32||44
2257561|NCT02400749|5540802|P1|STARTED|Week 17 - 32||39
2257562|NCT02400749|5540801|P2|NOT COMPLETED|Week 0 -16||6
2257563|NCT02400749|5540802|P1|NOT COMPLETED|Week 0 -16||11
2257564|NCT02400749|5540801|P2|COMPLETED|Week 0 -16||44
2257565|NCT02400749|5540802|P1|COMPLETED|Week 0 -16||39
2257566|NCT02400749|5540801|P2|STARTED|Week 0 -16||50
2257567|NCT02400749|5540802|P1|STARTED|Week 0 -16||50
2257568|NCT02400710|5540818|P2|NOT COMPLETED|Overall Study||0
2257569|NCT02400710|5540819|P1|NOT COMPLETED|Overall Study||0
2257570|NCT02400710|5540818|P2|COMPLETED|Overall Study||10
2257571|NCT02400710|5540819|P1|COMPLETED|Overall Study||10
2257572|NCT02400710|5540818|P2|STARTED|Overall Study||10
2257573|NCT02400710|5540819|P1|STARTED|Overall Study||10
2257574|NCT02400580|5540829|P2|NOT COMPLETED|Overall Study||1
2257575|NCT02400580|5540830|P1|NOT COMPLETED|Overall Study||2
2257576|NCT02400580|5540829|P2|COMPLETED|Overall Study||91
2257577|NCT02400580|5540830|P1|COMPLETED|Overall Study||89
2257578|NCT02400580|5540829|P2|STARTED|Overall Study||92
2257579|NCT02400580|5540830|P1|STARTED|Overall Study||91
2257580|NCT02400346|5540846|P1|NOT COMPLETED|Overall Study||44
2257581|NCT02400346|5540846|P1|COMPLETED|Overall Study||88
2257582|NCT02400346|5540846|P1|STARTED|Overall Study||132
2257583|NCT02400333|5540854|P4|NOT COMPLETED|Overall Study||2
2257584|NCT02400333|5540855|P3|NOT COMPLETED|Overall Study||2
2257585|NCT02400333|5540856|P2|NOT COMPLETED|Overall Study||1
2257586|NCT02400333|5540857|P1|NOT COMPLETED|Overall Study||1
2257587|NCT02400333|5540854|P4|COMPLETED|Overall Study||7
2257588|NCT02400333|5540855|P3|COMPLETED|Overall Study||7
2257589|NCT02400333|5540856|P2|COMPLETED|Overall Study||8
2257590|NCT02400333|5540857|P1|COMPLETED|Overall Study||8
2257591|NCT02400333|5540854|P4|STARTED|Overall Study||9
2257592|NCT02400333|5540855|P3|STARTED|Overall Study||9
2257593|NCT02400333|5540856|P2|STARTED|Overall Study||9
2257594|NCT02400333|5540857|P1|STARTED|Overall Study||9
2257595|NCT02400307|5540917|P2|NOT COMPLETED|Overall Study||0
2257596|NCT02400307|5540918|P1|NOT COMPLETED|Overall Study||1
2257597|NCT02400307|5540917|P2|COMPLETED|Overall Study||8
2257598|NCT02400307|5540918|P1|COMPLETED|Overall Study||10
2257599|NCT02400307|5540917|P2|STARTED|Overall Study||8
2257600|NCT02400307|5540918|P1|STARTED|Overall Study||11
2257601|NCT02400073|5540938|P1|NOT COMPLETED|Overall Study||11
2257602|NCT02400073|5540938|P1|COMPLETED|Overall Study||111
2257603|NCT02400073|5540938|P1|STARTED|Overall Study||122
2257604|NCT02399917|5540946|P3|NOT COMPLETED|Overall Study||0
2257605|NCT02399917|5540947|P2|NOT COMPLETED|Overall Study||0
2257606|NCT02399917|5540948|P1|NOT COMPLETED|Overall Study||0
2257607|NCT02399917|5540946|P3|COMPLETED|Overall Study||24
2257608|NCT02399917|5540947|P2|COMPLETED|Overall Study||6
2257609|NCT02399917|5540948|P1|COMPLETED|Overall Study||6
2257610|NCT02399917|5540946|P3|STARTED|Overall Study||24
2257611|NCT02399917|5540947|P2|STARTED|Overall Study||6
2257612|NCT02399917|5540948|P1|STARTED|Overall Study||6
2257613|NCT02399345|5540966|P1|NOT COMPLETED|Overall Study||0
2257614|NCT02399345|5540966|P1|COMPLETED|Overall Study||10
2257615|NCT02399345|5540966|P1|STARTED|Overall Study||10
2257616|NCT02399254|5540972|P1|NOT COMPLETED|Overall Study||2
2257617|NCT02399254|5540972|P1|COMPLETED|Overall Study||19
2257618|NCT02399254|5540972|P1|STARTED|Overall Study||21
2257619|NCT02399163|5540979|P1|NOT COMPLETED|Overall Study||9
2257620|NCT02399163|5540979|P1|COMPLETED|Overall Study||53
2257621|NCT02399163|5540979|P1|STARTED|Overall Study||62
2257622|NCT02399111|5541007|P4|NOT COMPLETED|Overall Study||0
2257623|NCT02399111|5541008|P3|NOT COMPLETED|Overall Study||0
2257624|NCT02399111|5541009|P2|NOT COMPLETED|Overall Study||0
2257625|NCT02399111|5541010|P1|NOT COMPLETED|Overall Study||0
2257626|NCT02399111|5541007|P4|COMPLETED|Overall Study||0
2257627|NCT02399111|5541008|P3|COMPLETED|Overall Study||4
2257628|NCT02399111|5541009|P2|COMPLETED|Overall Study||1
2257629|NCT02399111|5541010|P1|COMPLETED|Overall Study||4
2257630|NCT02399111|5541007|P4|STARTED|Overall Study||0
2257631|NCT02399111|5541008|P3|STARTED|Overall Study||4
2257632|NCT02399111|5541009|P2|STARTED|Overall Study||1
2257633|NCT02399111|5541010|P1|STARTED|Overall Study||4
2257634|NCT02399085|5541024|P1|NOT COMPLETED|Overall Study||51
2257635|NCT02399085|5541024|P1|COMPLETED|Overall Study|30 patients completed the combination treatment on both study drugs (12 cycles).|30
2257636|NCT02399085|5541024|P1|STARTED|Overall Study||81
2257637|NCT02398227|5541034|P2|NOT COMPLETED|Overall Study||18
2257638|NCT02398227|5541035|P1|NOT COMPLETED|Overall Study||27
2257639|NCT02398227|5541034|P2|COMPLETED|Overall Study||71
2257640|NCT02398227|5541035|P1|COMPLETED|Overall Study||56
2257641|NCT02398227|5541034|P2|STARTED|Overall Study||89
2257642|NCT02398227|5541035|P1|STARTED|Overall Study||83
2257643|NCT02398188|5541045|P2|NOT COMPLETED|Overall Study||34
2257644|NCT02398188|5541046|P1|NOT COMPLETED|Overall Study||27
2257645|NCT02398188|5541045|P2|COMPLETED|Overall Study||361
2257646|NCT02398188|5541046|P1|COMPLETED|Overall Study||371
2257647|NCT02398188|5541045|P2|STARTED|Overall Study||395
2257648|NCT02398188|5541046|P1|STARTED|Overall Study||398
2257649|NCT02397954|5541056|P1|NOT COMPLETED|Overall Study||0
2257650|NCT02397954|5541056|P1|COMPLETED|Overall Study||4
2257651|NCT02397954|5541056|P1|STARTED|Overall Study||4
2257652|NCT02397915|5541064|P4|NOT COMPLETED|Period 2||0
2257653|NCT02397915|5541065|P3|NOT COMPLETED|Period 2||0
2257654|NCT02397915|5541066|P2|NOT COMPLETED|Period 2||0
2257655|NCT02397915|5541067|P1|NOT COMPLETED|Period 2||0
2257656|NCT02397915|5541064|P4|COMPLETED|Period 2||149
2257657|NCT02397915|5541065|P3|COMPLETED|Period 2||149
2257658|NCT02397915|5541066|P2|COMPLETED|Period 2||0
2257659|NCT02397915|5541067|P1|COMPLETED|Period 2||0
2257660|NCT02397915|5541064|P4|STARTED|Period 2||149
2257661|NCT02397915|5541065|P3|STARTED|Period 2||149
2257662|NCT02397915|5541066|P2|STARTED|Period 2||0
2257663|NCT02397915|5541067|P1|STARTED|Period 2||0
2257664|NCT02397915|5541064|P4|NOT COMPLETED|Period 1||0
2257665|NCT02397915|5541065|P3|NOT COMPLETED|Period 1||0
2257666|NCT02397915|5541066|P2|NOT COMPLETED|Period 1||1
2257667|NCT02397915|5541067|P1|NOT COMPLETED|Period 1||1
2257668|NCT02397915|5541064|P4|COMPLETED|Period 1||0
2257669|NCT02397915|5541065|P3|COMPLETED|Period 1||0
2257670|NCT02397915|5541066|P2|COMPLETED|Period 1||149
2257671|NCT02397915|5541067|P1|COMPLETED|Period 1||149
2257672|NCT02397915|5541064|P4|STARTED|Period 1||0
2257673|NCT02397915|5541065|P3|STARTED|Period 1||0
2257674|NCT02397915|5541066|P2|STARTED|Period 1||150
2257675|NCT02397915|5541067|P1|STARTED|Period 1||150
2257676|NCT02397785|5541119|P2|NOT COMPLETED|Overall Study||9
2257677|NCT02397785|5541120|P1|NOT COMPLETED|Overall Study||2
2257678|NCT02397785|5541119|P2|COMPLETED|Overall Study||25
2257679|NCT02397785|5541120|P1|COMPLETED|Overall Study||22
2257680|NCT02397785|5541119|P2|STARTED|Overall Study||34
2257681|NCT02397785|5541120|P1|STARTED|Overall Study||24
2257682|NCT02397694|5541166|P2|NOT COMPLETED|Open Label Extension Phase||30
2257683|NCT02397694|5541167|P1|NOT COMPLETED|Open Label Extension Phase||62
2257684|NCT02397694|5541166|P2|COMPLETED|Open Label Extension Phase||0
2257685|NCT02397694|5541167|P1|COMPLETED|Open Label Extension Phase||0
2257686|NCT02397694|5541166|P2|STARTED|Open Label Extension Phase||30
2257687|NCT02397694|5541167|P1|STARTED|Open Label Extension Phase||62
2257688|NCT02397694|5541166|P2|NOT COMPLETED|Double-Blinded Phase||3
2257689|NCT02397694|5541167|P1|NOT COMPLETED|Double-Blinded Phase||3
2257690|NCT02397694|5541166|P2|COMPLETED|Double-Blinded Phase||30
2257691|NCT02397694|5541167|P1|COMPLETED|Double-Blinded Phase||62
2257692|NCT02397694|5541166|P2|STARTED|Double-Blinded Phase||33
2257693|NCT02397694|5541167|P1|STARTED|Double-Blinded Phase||65
2257694|NCT02397655|5541205|P1|NOT COMPLETED|Overall Study||1301
2257695|NCT02397655|5541205|P1|COMPLETED|Overall Study||10711
2257696|NCT02397655|5541205|P1|STARTED|Overall Study||12012
2257697|NCT02397564|5541209|P1|NOT COMPLETED|Overall Study||4
2257698|NCT02397564|5541209|P1|COMPLETED|Overall Study||16
2257699|NCT02397564|5541209|P1|STARTED|Overall Study||20
2257700|NCT02397473|5541216|P2|NOT COMPLETED|Post Treatment Follow-up Phase||2
2257701|NCT02397473|5541217|P1|NOT COMPLETED|Post Treatment Follow-up Phase||3
2257702|NCT02397473|5541216|P2|COMPLETED|Post Treatment Follow-up Phase||45
2257703|NCT02397473|5541217|P1|COMPLETED|Post Treatment Follow-up Phase||47
2257704|NCT02397473|5541216|P2|STARTED|Post Treatment Follow-up Phase||47
2257705|NCT02397473|5541217|P1|STARTED|Post Treatment Follow-up Phase|Participants who discontinued treatment period had an option to enter post treatment phase.|50
2257706|NCT02397473|5541216|P2|NOT COMPLETED|Treatment Phase||7
2257707|NCT02397473|5541217|P1|NOT COMPLETED|Treatment Phase||12
2257708|NCT02397473|5541216|P2|COMPLETED|Treatment Phase||45
2257709|NCT02397473|5541217|P1|COMPLETED|Treatment Phase||45
2257710|NCT02397473|5541216|P2|Received at Least One Dose of Study Drug|Treatment Phase||49
2257711|NCT02397473|5541217|P1|Received at Least One Dose of Study Drug|Treatment Phase||57
2257712|NCT02397473|5541216|P2|STARTED|Treatment Phase||52
2257713|NCT02397473|5541217|P1|STARTED|Treatment Phase||57
2257714|NCT02397265|5541245|P3|NOT COMPLETED|Third Intervention of Three||0
2257715|NCT02397265|5541246|P2|NOT COMPLETED|Third Intervention of Three||0
2257716|NCT02397265|5541247|P1|NOT COMPLETED|Third Intervention of Three||0
2257717|NCT02397265|5541245|P3|COMPLETED|Third Intervention of Three||2
2257718|NCT02397265|5541246|P2|COMPLETED|Third Intervention of Three||2
2257719|NCT02397265|5541247|P1|COMPLETED|Third Intervention of Three||2
2257720|NCT02397265|5541245|P3|STARTED|Third Intervention of Three||2
2257721|NCT02397265|5541246|P2|STARTED|Third Intervention of Three||2
2257722|NCT02397265|5541247|P1|STARTED|Third Intervention of Three||2
2257723|NCT02397265|5541245|P3|NOT COMPLETED|Second Intervention of Three||0
2257724|NCT02397265|5541246|P2|NOT COMPLETED|Second Intervention of Three||0
2257725|NCT02397265|5541247|P1|NOT COMPLETED|Second Intervention of Three||0
2257726|NCT02397265|5541245|P3|COMPLETED|Second Intervention of Three||2
2257727|NCT02397265|5541246|P2|COMPLETED|Second Intervention of Three||2
2257728|NCT02397265|5541247|P1|COMPLETED|Second Intervention of Three||2
2257729|NCT02397265|5541245|P3|STARTED|Second Intervention of Three||2
2257730|NCT02397265|5541246|P2|STARTED|Second Intervention of Three||2
2257731|NCT02397265|5541247|P1|STARTED|Second Intervention of Three||2
2257732|NCT02397265|5541245|P3|NOT COMPLETED|First Intervention of Three||0
2257733|NCT02397265|5541246|P2|NOT COMPLETED|First Intervention of Three||0
2257734|NCT02397265|5541247|P1|NOT COMPLETED|First Intervention of Three||0
2257735|NCT02397265|5541245|P3|COMPLETED|First Intervention of Three||2
2257736|NCT02397265|5541246|P2|COMPLETED|First Intervention of Three||2
2257737|NCT02397265|5541247|P1|COMPLETED|First Intervention of Three||2
2257738|NCT02397265|5541245|P3|STARTED|First Intervention of Three||2
2257739|NCT02397265|5541246|P2|STARTED|First Intervention of Three||2
2257740|NCT02397265|5541247|P1|STARTED|First Intervention of Three||2
2257741|NCT02397122|5541257|P2|NOT COMPLETED|Overall Study||0
2257742|NCT02397122|5541258|P1|NOT COMPLETED|Overall Study||0
2257743|NCT02397122|5541257|P2|COMPLETED|Overall Study||20
2257744|NCT02397122|5541258|P1|COMPLETED|Overall Study||20
2257745|NCT02397122|5541257|P2|STARTED|Overall Study||20
2257746|NCT02397122|5541258|P1|STARTED|Overall Study||20
2257747|NCT02397096|5541276|P2|NOT COMPLETED|Study Extensions||202
2257748|NCT02397096|5541277|P1|NOT COMPLETED|Study Extensions||399
2257749|NCT02397096|5541276|P2|COMPLETED|Study Extensions|The extension study is ongoing.|0
2257750|NCT02397096|5541277|P1|COMPLETED|Study Extensions|The extension study is ongoing.|0
2257751|NCT02397096|5541276|P2|STARTED|Study Extensions|The extension study is optional; not all eligible participants enrolled.|202
2257752|NCT02397096|5541277|P1|STARTED|Study Extensions|The extension study is optional; not all eligible participants enrolled.|399
2257753|NCT02397096|5541276|P2|NOT COMPLETED|Week 24 to Week 48||7
2257754|NCT02397096|5541277|P1|NOT COMPLETED|Week 24 to Week 48||20
2257755|NCT02397096|5541276|P2|COMPLETED|Week 24 to Week 48||202
2257756|NCT02397096|5541277|P1|COMPLETED|Week 24 to Week 48||407
2257757|NCT02397096|5541276|P2|STARTED|Week 24 to Week 48||209
2257758|NCT02397096|5541277|P1|STARTED|Week 24 to Week 48||427
2257759|NCT02397096|5541276|P2|NOT COMPLETED|Day 1 to Week 24||14
2257760|NCT02397096|5541277|P1|NOT COMPLETED|Day 1 to Week 24||20
2257761|NCT02397096|5541276|P2|COMPLETED|Day 1 to Week 24||209
2257762|NCT02397096|5541277|P1|COMPLETED|Day 1 to Week 24||427
2257763|NCT02397096|5541276|P2|STARTED|Day 1 to Week 24||223
2257764|NCT02397096|5541277|P1|STARTED|Day 1 to Week 24||447
2257765|NCT02396953|5541310|P3|NOT COMPLETED|Overall Study||3
2257766|NCT02396953|5541311|P2|NOT COMPLETED|Overall Study||3
2257767|NCT02396953|5541312|P1|NOT COMPLETED|Overall Study||4
2257768|NCT02396953|5541310|P3|COMPLETED|Overall Study||7
2257769|NCT02396953|5541311|P2|COMPLETED|Overall Study||6
2257770|NCT02396953|5541312|P1|COMPLETED|Overall Study||5
2257771|NCT02396953|5541310|P3|STARTED|Overall Study||10
2257772|NCT02396953|5541311|P2|STARTED|Overall Study||9
2257773|NCT02396953|5541312|P1|STARTED|Overall Study||9
2257774|NCT02396745|5541362|P1|NOT COMPLETED|Overall Study||0
2257775|NCT02396745|5541362|P1|COMPLETED|Overall Study||1
2257776|NCT02396745|5541362|P1|STARTED|Overall Study||1
2257777|NCT02396732|5541374|P2|NOT COMPLETED|Overall Study||0
2257778|NCT02396732|5541375|P1|NOT COMPLETED|Overall Study||0
2257779|NCT02396732|5541374|P2|COMPLETED|Overall Study||17
2257780|NCT02396732|5541375|P1|COMPLETED|Overall Study||14
2257781|NCT02396732|5541374|P2|STARTED|Overall Study||17
2257782|NCT02396732|5541375|P1|STARTED|Overall Study||14
2257783|NCT02396537|5541387|P2|NOT COMPLETED|Overall Study||1
2257784|NCT02396537|5541388|P1|NOT COMPLETED|Overall Study||0
2257785|NCT02396537|5541387|P2|COMPLETED|Overall Study||36
2257786|NCT02396537|5541388|P1|COMPLETED|Overall Study||40
2257787|NCT02396537|5541387|P2|STARTED|Overall Study||37
2257788|NCT02396537|5541388|P1|STARTED|Overall Study||40
2257789|NCT02396511|5541394|P1|NOT COMPLETED|Overall Study||0
2257790|NCT02396511|5541394|P1|COMPLETED|Overall Study||2
2257791|NCT02396511|5541394|P1|STARTED|Overall Study||2
2257792|NCT02396420|5541400|P1|NOT COMPLETED|Overall Study||1
2257793|NCT02396420|5541400|P1|COMPLETED|Overall Study||1
2257794|NCT02396420|5541400|P1|6 Months Post PAE|Overall Study||2
2257795|NCT02396420|5541400|P1|3 Months Post PAE|Overall Study||2
2257796|NCT02396420|5541400|P1|1 Month Post PAE|Overall Study||2
2257797|NCT02396420|5541400|P1|STARTED|Overall Study||2
2257798|NCT02396381|5541424|P2|NOT COMPLETED|Overall Study||74
2257799|NCT02396381|5541425|P1|NOT COMPLETED|Overall Study||107
2257800|NCT02396381|5541424|P2|COMPLETED|Overall Study||422
2257801|NCT02396381|5541425|P1|COMPLETED|Overall Study||381
2257802|NCT02396381|5541424|P2|Full Analysis Set - As Exposed (FAS-EX)|Overall Study||443
2257803|NCT02396381|5541425|P1|Full Analysis Set - As Exposed (FAS-EX)|Overall Study||414
2257804|NCT02396381|5541424|P2|STARTED|Overall Study||496
2257805|NCT02396381|5541425|P1|STARTED|Overall Study||488
2257806|NCT02396316|5541464|P2|NOT COMPLETED|Overall Study||5
2257807|NCT02396316|5541465|P1|NOT COMPLETED|Overall Study||7
2257808|NCT02396316|5541464|P2|COMPLETED|Overall Study||22
2257809|NCT02396316|5541465|P1|COMPLETED|Overall Study||20
2257810|NCT02396316|5541464|P2|Received Active Injection at Week 9|Overall Study||1
2257811|NCT02396316|5541465|P1|Received Active Injection at Week 9|Overall Study||2
2257812|NCT02396316|5541464|P2|Received Active Injection at Week 5|Overall Study||4
2257813|NCT02396316|5541465|P1|Received Active Injection at Week 5|Overall Study||4
2257814|NCT02396316|5541464|P2|Received AFL Injection at Week 1|Overall Study||22
2257815|NCT02396316|5541465|P1|Received AFL Injection at Week 1|Overall Study||0
2257816|NCT02396316|5541464|P2|Received Sham Injection at Week 1|Overall Study||0
2257817|NCT02396316|5541465|P1|Received Sham Injection at Week 1|Overall Study||10
2257818|NCT02396316|5541464|P2|Treated|Overall Study||27
2257819|NCT02396316|5541465|P1|Treated|Overall Study||27
2257820|NCT02396316|5541464|P2|STARTED|Overall Study||27
2257821|NCT02396316|5541465|P1|STARTED|Overall Study||27
2257822|NCT02396251|5541477|P2|NOT COMPLETED|Overall Study||5
2257823|NCT02396251|5541478|P1|NOT COMPLETED|Overall Study||13
2257824|NCT02396251|5541477|P2|COMPLETED|Overall Study||7
2257825|NCT02396251|5541478|P1|COMPLETED|Overall Study||23
2257826|NCT02396251|5541477|P2|STARTED|Overall Study||12
2257827|NCT02396251|5541478|P1|STARTED|Overall Study||36
2257828|NCT02396212|5541484|P1|NOT COMPLETED|Overall Study||3
2257829|NCT02396212|5541484|P1|COMPLETED|Overall Study||16
2257830|NCT02396212|5541484|P1|STARTED|Overall Study||19
2257831|NCT02396160|5541505|P2|NOT COMPLETED|Overall Study||2
2257832|NCT02396160|5541506|P1|NOT COMPLETED|Overall Study||6
2257833|NCT02396160|5541505|P2|COMPLETED|Overall Study||73
2257834|NCT02396160|5541506|P1|COMPLETED|Overall Study||69
2257835|NCT02396160|5541505|P2|STARTED|Overall Study||75
2257836|NCT02396160|5541506|P1|STARTED|Overall Study||75
2257837|NCT02396147|5541522|P2|NOT COMPLETED|Period 3||0
2257838|NCT02396147|5541523|P1|NOT COMPLETED|Period 3||0
2257839|NCT02396147|5541522|P2|COMPLETED|Period 3||27
2257840|NCT02396147|5541523|P1|COMPLETED|Period 3||27
2257841|NCT02396147|5541522|P2|STARTED|Period 3||27
2257842|NCT02396147|5541523|P1|STARTED|Period 3||27
2257843|NCT02396147|5541522|P2|NOT COMPLETED|Period 2||0
2257844|NCT02396147|5541523|P1|NOT COMPLETED|Period 2||0
2257845|NCT02396147|5541522|P2|COMPLETED|Period 2||27
2257846|NCT02396147|5541523|P1|COMPLETED|Period 2||27
2257847|NCT02396147|5541522|P2|STARTED|Period 2||27
2257848|NCT02396147|5541523|P1|STARTED|Period 2||27
2257849|NCT02396147|5541522|P2|NOT COMPLETED|Period 1||0
2257850|NCT02396147|5541523|P1|NOT COMPLETED|Period 1||0
2257851|NCT02396147|5541522|P2|COMPLETED|Period 1||27
2257852|NCT02396147|5541523|P1|COMPLETED|Period 1||27
2257853|NCT02396147|5541522|P2|STARTED|Period 1||27
2257854|NCT02396147|5541523|P1|STARTED|Period 1||27
2257855|NCT02395822|5541591|P1|NOT COMPLETED|Overall Study||2
2257856|NCT02395822|5541591|P1|COMPLETED|Overall Study||15
2257857|NCT02395822|5541591|P1|STARTED|Overall Study||17
2257858|NCT02395692|5541599|P2|NOT COMPLETED|Overall Study||0
2257859|NCT02395692|5541600|P1|NOT COMPLETED|Overall Study||0
2257860|NCT02395692|5541599|P2|COMPLETED|Overall Study||0
2257861|NCT02395692|5541600|P1|COMPLETED|Overall Study||19
2257862|NCT02395692|5541599|P2|STARTED|Overall Study||0
2257863|NCT02395692|5541600|P1|STARTED|Overall Study||19
2257864|NCT02395653|5541610|P1|NOT COMPLETED|Overall Study||12
2257865|NCT02395653|5541610|P1|COMPLETED|Overall Study||59
2257866|NCT02395653|5541610|P1|Received at Least 1 Dose of Study Drug|Overall Study||61
2257867|NCT02395653|5541610|P1|STARTED|Overall Study||71
2257868|NCT02395536|5541619|P2|NOT COMPLETED|Overall Study||30
2257869|NCT02395536|5541620|P1|NOT COMPLETED|Overall Study||20
2257870|NCT02395536|5541619|P2|COMPLETED|Overall Study||227
2257871|NCT02395536|5541620|P1|COMPLETED|Overall Study||244
2257872|NCT02395536|5541619|P2|REVEAL LINQ Insertion|Overall Study||231
2257873|NCT02395536|5541620|P1|REVEAL LINQ Insertion|Overall Study||251
2257874|NCT02395536|5541619|P2|STARTED|Overall Study||257
2257875|NCT02395536|5541620|P1|STARTED|Overall Study||264
2257876|NCT02395471|5541628|P2|NOT COMPLETED|Overall Study||3
2257877|NCT02395471|5541629|P1|NOT COMPLETED|Overall Study||7
2257878|NCT02395471|5541628|P2|COMPLETED|Overall Study||59
2257879|NCT02395471|5541629|P1|COMPLETED|Overall Study||122
2257880|NCT02395471|5541628|P2|STARTED|Overall Study||62
2257881|NCT02395471|5541629|P1|STARTED|Overall Study||129
2257882|NCT02395302|5541644|P1|NOT COMPLETED|Overall Study||14
2257883|NCT02395302|5541644|P1|COMPLETED|Overall Study||14
2257884|NCT02395302|5541644|P1|STARTED|Overall Study||28
2257885|NCT02395185|5541648|P1|NOT COMPLETED|Overall Study||0
2257886|NCT02395185|5541648|P1|COMPLETED|Overall Study||33
2257887|NCT02395185|5541648|P1|Sequence 18 (m,w,m,s,w,s)|Overall Study||1
2257888|NCT02395185|5541648|P1|Sequence 17 (w,m,s,w,s,m)|Overall Study||1
2257889|NCT02395185|5541648|P1|Sequence 16 (m,s,w,s,m,w)|Overall Study||1
2257890|NCT02395185|5541648|P1|Sequence 15 (s,w,s,m,w,m)|Overall Study||2
2257891|NCT02395185|5541648|P1|Sequence 14 (w,s,m,w,m,s)|Overall Study||2
2257892|NCT02395185|5541648|P1|Sequence 13 (s,m,w,m,s,w)|Overall Study||2
2257893|NCT02395185|5541648|P1|Sequence 12 (s,w,w,m,m,s)|Overall Study||2
2257894|NCT02395185|5541648|P1|Sequence 11 (w,w,m,m,s,s)|Overall Study||2
2257895|NCT02395185|5541648|P1|Sequence 10 (w,m,m,s,s,w)|Overall Study||2
2257896|NCT02395185|5541648|P1|Sequence 9 (m,m,s,s,w,w)|Overall Study||2
2257897|NCT02395185|5541648|P1|Sequence 8 (m,s,s,w,w,m)|Overall Study||2
2257898|NCT02395185|5541648|P1|Sequence 7 (s,s,w,w,m,m)|Overall Study||2
2257899|NCT02395185|5541648|P1|Sequence 6 (s,m,m,w,w,s)|Overall Study||2
2257900|NCT02395185|5541648|P1|Sequence 5 (m,m,w,w,s,s)|Overall Study||2
2257901|NCT02395185|5541648|P1|Sequence 4 (m,w,w,s,s,m)|Overall Study||2
2257902|NCT02395185|5541648|P1|Sequence 3 (w,w,s,s,m,m)|Overall Study||2
2257903|NCT02395185|5541648|P1|Sequence 2 (w,s,s,m,m,w)|Overall Study||2
2257904|NCT02395185|5541648|P1|Sequence 1 (s,s,m,m,w,w)|Overall Study|one of the participants in this milestone did not have a guardian enrolled due to age.|2
2257905|NCT02395185|5541648|P1|STARTED|Overall Study|32 guardians participated with these infants. one infant did not have a guardian participate.|33
2257906|NCT02395172|5541664|P2|NOT COMPLETED|Overall Study||36
2257907|NCT02395172|5541665|P1|NOT COMPLETED|Overall Study||52
2257908|NCT02395172|5541664|P2|COMPLETED|Overall Study||360
2257909|NCT02395172|5541665|P1|COMPLETED|Overall Study||344
2257910|NCT02395172|5541664|P2|Treated|Overall Study||365
2257911|NCT02395172|5541665|P1|Treated|Overall Study||393
2257912|NCT02395172|5541664|P2|STARTED|Overall Study||396
2257913|NCT02395172|5541665|P1|STARTED|Overall Study||396
2257914|NCT02395133|5541704|P4|NOT COMPLETED|Overall Study||14
2257915|NCT02395133|5541705|P3|NOT COMPLETED|Overall Study||10
2257916|NCT02395133|5541706|P2|NOT COMPLETED|Overall Study||9
2257917|NCT02395133|5541707|P1|NOT COMPLETED|Overall Study||14
2257918|NCT02395133|5541704|P4|COMPLETED|Overall Study||155
2257919|NCT02395133|5541705|P3|COMPLETED|Overall Study||76
2257920|NCT02395133|5541706|P2|COMPLETED|Overall Study||75
2257921|NCT02395133|5541707|P1|COMPLETED|Overall Study||69
2257922|NCT02395133|5541704|P4|STARTED|Overall Study||169
2257923|NCT02395133|5541705|P3|STARTED|Overall Study||86
2257924|NCT02395133|5541706|P2|STARTED|Overall Study||84
2257925|NCT02395133|5541707|P1|STARTED|Overall Study||83
2257926|NCT02395055|5541795|P2|NOT COMPLETED|Overall Study||3
2257927|NCT02395055|5541796|P1|NOT COMPLETED|Overall Study||7
2257928|NCT02395055|5541795|P2|COMPLETED|Overall Study||44
2257929|NCT02395055|5541796|P1|COMPLETED|Overall Study||40
2257930|NCT02395055|5541795|P2|STARTED|Overall Study||47
2257931|NCT02395055|5541796|P1|STARTED|Overall Study||47
2257932|NCT02395042|5541809|P3|NOT COMPLETED|Treatment 2 Period||0
2257933|NCT02395042|5541810|P2|NOT COMPLETED|Treatment 2 Period||1
2257934|NCT02395042|5541811|P1|NOT COMPLETED|Treatment 2 Period||1
2257935|NCT02395042|5541809|P3|COMPLETED|Treatment 2 Period||13
2257936|NCT02395042|5541810|P2|COMPLETED|Treatment 2 Period||23
2257937|NCT02395042|5541811|P1|COMPLETED|Treatment 2 Period||9
2257938|NCT02395042|5541809|P3|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|13
2257939|NCT02395042|5541810|P2|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|24
2257940|NCT02395042|5541811|P1|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|10
2257941|NCT02395042|5541809|P3|NOT COMPLETED|Treatment 1 Period||2
2257942|NCT02395042|5541810|P2|NOT COMPLETED|Treatment 1 Period||6
2257943|NCT02395042|5541811|P1|NOT COMPLETED|Treatment 1 Period||3
2257944|NCT02395042|5541809|P3|COMPLETED|Treatment 1 Period||14
2257945|NCT02395042|5541810|P2|COMPLETED|Treatment 1 Period||25
2257946|NCT02395042|5541811|P1|COMPLETED|Treatment 1 Period||9
2257947|NCT02395042|5541809|P3|STARTED|Treatment 1 Period||16
2257948|NCT02395042|5541810|P2|STARTED|Treatment 1 Period||31
2257949|NCT02395042|5541811|P1|STARTED|Treatment 1 Period||12
2257950|NCT02394951|5541830|P2|NOT COMPLETED|Period II||4
2257951|NCT02394951|5541831|P1|NOT COMPLETED|Period II||0
2257952|NCT02394951|5541830|P2|COMPLETED|Period II||9
2257953|NCT02394951|5541831|P1|COMPLETED|Period II||11
2257954|NCT02394951|5541830|P2|STARTED|Period II||13
2257955|NCT02394951|5541831|P1|STARTED|Period II||11
2257956|NCT02394951|5541830|P2|NOT COMPLETED|Period I||1
2257957|NCT02394951|5541831|P1|NOT COMPLETED|Period I||1
2257958|NCT02394951|5541830|P2|COMPLETED|Period I||13
2257959|NCT02394951|5541831|P1|COMPLETED|Period I||11
2257960|NCT02394951|5541830|P2|STARTED|Period I||14
2257961|NCT02394951|5541831|P1|STARTED|Period I||12
2257962|NCT02394925|5541849|P1|NOT COMPLETED|Overall Study||29
2257963|NCT02394925|5541849|P1|COMPLETED|Overall Study||79
2257964|NCT02394925|5541849|P1|STARTED|Overall Study||108
2257965|NCT02394912|5541853|P1|NOT COMPLETED|Overall Study||0
2257966|NCT02394912|5541853|P1|COMPLETED|Overall Study||21
2257967|NCT02394912|5541853|P1|STARTED|Overall Study||21
2257968|NCT02394808|5541859|P2|NOT COMPLETED|Period 2||0
2257969|NCT02394808|5541860|P1|NOT COMPLETED|Period 2||1
2257970|NCT02394808|5541859|P2|COMPLETED|Period 2||28
2257971|NCT02394808|5541860|P1|COMPLETED|Period 2||24
2257972|NCT02394808|5541859|P2|STARTED|Period 2||28
2257973|NCT02394808|5541860|P1|STARTED|Period 2||25
2257974|NCT02394808|5541859|P2|NOT COMPLETED|Period 1||1
2257975|NCT02394808|5541860|P1|NOT COMPLETED|Period 1||0
2257976|NCT02394808|5541859|P2|COMPLETED|Period 1||28
2257977|NCT02394808|5541860|P1|COMPLETED|Period 1||25
2257978|NCT02394808|5541859|P2|STARTED|Period 1||29
2257979|NCT02394808|5541860|P1|STARTED|Period 1||25
2257980|NCT02394756|5541868|P6|NOT COMPLETED|Period 3||0
2257981|NCT02394756|5541869|P5|NOT COMPLETED|Period 3||0
2257982|NCT02394756|5541870|P4|NOT COMPLETED|Period 3||0
2257983|NCT02394756|5541871|P3|NOT COMPLETED|Period 3||0
2257984|NCT02394756|5541872|P2|NOT COMPLETED|Period 3||0
2257985|NCT02394756|5541873|P1|NOT COMPLETED|Period 3||0
2257986|NCT02394756|5541868|P6|COMPLETED|Period 3||6
2257987|NCT02394756|5541869|P5|COMPLETED|Period 3||6
2257988|NCT02394756|5541870|P4|COMPLETED|Period 3||6
2257989|NCT02394756|5541871|P3|COMPLETED|Period 3||6
2257990|NCT02394756|5541872|P2|COMPLETED|Period 3||6
2257991|NCT02394756|5541873|P1|COMPLETED|Period 3||7
2257992|NCT02394756|5541868|P6|STARTED|Period 3||6
2257993|NCT02394756|5541869|P5|STARTED|Period 3||6
2257994|NCT02394756|5541870|P4|STARTED|Period 3||6
2257995|NCT02394756|5541871|P3|STARTED|Period 3||6
2257996|NCT02394756|5541872|P2|STARTED|Period 3||6
2257997|NCT02394756|5541873|P1|STARTED|Period 3||7
2257998|NCT02394756|5541868|P6|NOT COMPLETED|Period 2||0
2257999|NCT02394756|5541869|P5|NOT COMPLETED|Period 2||1
2258000|NCT02394756|5541870|P4|NOT COMPLETED|Period 2||0
2258001|NCT02394756|5541871|P3|NOT COMPLETED|Period 2||0
2258002|NCT02394756|5541872|P2|NOT COMPLETED|Period 2||0
2258003|NCT02394756|5541873|P1|NOT COMPLETED|Period 2||0
2258004|NCT02394756|5541868|P6|COMPLETED|Period 2||6
2258005|NCT02394756|5541869|P5|COMPLETED|Period 2||6
2258006|NCT02394756|5541870|P4|COMPLETED|Period 2||6
2258007|NCT02394756|5541871|P3|COMPLETED|Period 2||6
2258008|NCT02394756|5541872|P2|COMPLETED|Period 2||6
2258009|NCT02394756|5541873|P1|COMPLETED|Period 2||7
2258010|NCT02394756|5541868|P6|STARTED|Period 2||6
2258011|NCT02394756|5541869|P5|STARTED|Period 2||7
2258012|NCT02394756|5541870|P4|STARTED|Period 2||6
2258013|NCT02394756|5541871|P3|STARTED|Period 2||6
2258014|NCT02394756|5541872|P2|STARTED|Period 2||6
2258015|NCT02394756|5541873|P1|STARTED|Period 2||7
2258016|NCT02394756|5541868|P6|NOT COMPLETED|Period 1||1
2258017|NCT02394756|5541869|P5|NOT COMPLETED|Period 1||0
2258018|NCT02394756|5541870|P4|NOT COMPLETED|Period 1||1
2258019|NCT02394756|5541871|P3|NOT COMPLETED|Period 1||1
2258020|NCT02394756|5541872|P2|NOT COMPLETED|Period 1||1
2258021|NCT02394756|5541873|P1|NOT COMPLETED|Period 1||0
2258022|NCT02394756|5541868|P6|COMPLETED|Period 1||6
2258023|NCT02394756|5541869|P5|COMPLETED|Period 1||7
2258024|NCT02394756|5541870|P4|COMPLETED|Period 1||6
2258025|NCT02394756|5541871|P3|COMPLETED|Period 1||6
2258026|NCT02394756|5541872|P2|COMPLETED|Period 1||6
2258027|NCT02394756|5541873|P1|COMPLETED|Period 1||7
2258028|NCT02394756|5541868|P6|STARTED|Period 1||7
2258029|NCT02394756|5541869|P5|STARTED|Period 1||7
2258030|NCT02394756|5541870|P4|STARTED|Period 1||7
2258031|NCT02394756|5541871|P3|STARTED|Period 1||7
2258032|NCT02394756|5541872|P2|STARTED|Period 1||7
2258033|NCT02394756|5541873|P1|STARTED|Period 1||7
2258034|NCT02394730|5541886|P2|NOT COMPLETED|Overall Study||1
2258035|NCT02394730|5541887|P1|NOT COMPLETED|Overall Study||1
2258036|NCT02394730|5541886|P2|COMPLETED|Overall Study||30
2258037|NCT02394730|5541887|P1|COMPLETED|Overall Study||33
2258038|NCT02394730|5541886|P2|STARTED|Overall Study||31
2258039|NCT02394730|5541887|P1|STARTED|Overall Study||34
2258040|NCT02394665|5541924|P3|NOT COMPLETED|Overall Study||0
2258041|NCT02394665|5541925|P2|NOT COMPLETED|Overall Study||0
2258042|NCT02394665|5541926|P1|NOT COMPLETED|Overall Study||1
2258043|NCT02394665|5541924|P3|COMPLETED|Overall Study||0
2258044|NCT02394665|5541925|P2|COMPLETED|Overall Study||0
2258045|NCT02394665|5541926|P1|COMPLETED|Overall Study||0
2258046|NCT02394665|5541924|P3|STARTED|Overall Study||0
2258047|NCT02394665|5541925|P2|STARTED|Overall Study||0
2258048|NCT02394665|5541926|P1|STARTED|Overall Study||1
2258049|NCT02394600|5541948|P2|NOT COMPLETED|Overall Study||2
2258050|NCT02394600|5541949|P1|NOT COMPLETED|Overall Study||4
2258051|NCT02394600|5541948|P2|COMPLETED|Overall Study||44
2258052|NCT02394600|5541949|P1|COMPLETED|Overall Study||43
2258053|NCT02394600|5541948|P2|STARTED|Overall Study||46
2258054|NCT02394600|5541949|P1|STARTED|Overall Study||47
2258055|NCT02394561|5541959|P2|NOT COMPLETED|Extension Phase||12
2258056|NCT02394561|5541960|P1|NOT COMPLETED|Extension Phase||11
2258057|NCT02394561|5541959|P2|COMPLETED|Extension Phase||207
2258058|NCT02394561|5541960|P1|COMPLETED|Extension Phase||151
2258059|NCT02394561|5541959|P2|STARTED|Extension Phase||219
2258060|NCT02394561|5541960|P1|STARTED|Extension Phase||162
2258061|NCT02394561|5541959|P2|NOT COMPLETED|CORE Phase||19
2258062|NCT02394561|5541960|P1|NOT COMPLETED|CORE Phase||13
2258063|NCT02394561|5541959|P2|COMPLETED|CORE Phase||227
2258064|NCT02394561|5541960|P1|COMPLETED|CORE Phase||172
2258065|NCT02394561|5541959|P2|ITT Set|CORE Phase||246
2258066|NCT02394561|5541960|P1|ITT Set|CORE Phase||184
2258067|NCT02394561|5541959|P2|Safety Set|CORE Phase||246
2258068|NCT02394561|5541960|P1|Safety Set|CORE Phase||185
2258069|NCT02394561|5541959|P2|Full Analysis Set|CORE Phase||246
2258070|NCT02394561|5541960|P1|Full Analysis Set|CORE Phase||185
2258071|NCT02394561|5541959|P2|STARTED|CORE Phase||246
2258072|NCT02394561|5541960|P1|STARTED|CORE Phase||185
2258076|NCT02394457|5541990|P2|NOT COMPLETED|Overall Study||0
2258077|NCT02394457|5541991|P1|NOT COMPLETED|Overall Study||0
2258078|NCT02394457|5541990|P2|COMPLETED|Overall Study||13
2258079|NCT02394457|5541991|P1|COMPLETED|Overall Study||15
2258080|NCT02394457|5541990|P2|STARTED|Overall Study||13
2258081|NCT02394457|5541991|P1|STARTED|Overall Study||15
2258082|NCT02394340|5542007|P1|NOT COMPLETED|Overall Study||2
2258083|NCT02394340|5542007|P1|COMPLETED|Overall Study||18
2258084|NCT02394340|5542007|P1|Received at Least 1 Dose of Study Drug|Overall Study||20
2258085|NCT02394340|5542007|P1|STARTED|Overall Study||20
2258086|NCT02393950|5542014|P2|NOT COMPLETED|Overall Study||1
2258087|NCT02393950|5542015|P1|NOT COMPLETED|Overall Study||1
2258088|NCT02393950|5542014|P2|COMPLETED|Overall Study||8
2258089|NCT02393950|5542015|P1|COMPLETED|Overall Study||8
2258090|NCT02393950|5542014|P2|Period 4|Overall Study|6 subjects ODM-106 Capsule A 100 mg (10 x 10mg) and 2 subjects on placebo|8
2258091|NCT02393950|5542015|P1|Period 4|Overall Study|6 subjects ODM-106 Capsule B 50 mg and 2 subjects on placebo|8
2258092|NCT02393950|5542014|P2|Period 3|Overall Study|6 subjects ODM-106 Capsule B 200 mg (20 x 10mg) and 2 subjects on placebo|8
2258093|NCT02393950|5542015|P1|Period 3|Overall Study|6 subjects ODM-106 Capsule B 25 mg and 2 subjects on placebo|8
2258094|NCT02393950|5542014|P2|Period 2|Overall Study|6 subjects ODM-106 Capsule B 100 mg (10 x 10mg) and 2 subjects on placebo|8
2258095|NCT02393950|5542015|P1|Period 2|Overall Study|6 subjects ODM-106 Capsule B 10 mg and 2 subjects on placebo|8
2258096|NCT02393950|5542014|P2|Period 1|Overall Study|6 subjects ODM-106 Capsule B 100 mg (1 x 100mg) and 2 subjects on placebo|8
2258097|NCT02393950|5542015|P1|Period 1|Overall Study|6 subjects ODM-106 Capsule B 2 mg and 2 subjects on placebo|8
2258098|NCT02393950|5542014|P2|STARTED|Overall Study||9
2258099|NCT02393950|5542015|P1|STARTED|Overall Study||9
2258100|NCT02393677|5542082|P2|NOT COMPLETED|Overall Study||0
2258101|NCT02393677|5542083|P1|NOT COMPLETED|Overall Study||0
2258102|NCT02393677|5542082|P2|COMPLETED|Overall Study||40
2258103|NCT02393677|5542083|P1|COMPLETED|Overall Study||40
2258104|NCT02393677|5542082|P2|STARTED|Overall Study||40
2258105|NCT02393677|5542083|P1|STARTED|Overall Study||40
2258106|NCT02393547|5542089|P1|NOT COMPLETED|Overall Study||6
2258107|NCT02393547|5542089|P1|COMPLETED|Overall Study||14
2258108|NCT02393547|5542089|P1|STARTED|Overall Study||20
2258109|NCT02393417|5542100|P4|NOT COMPLETED|Overall Study||12
2258110|NCT02393417|5542101|P3|NOT COMPLETED|Overall Study||10
2258111|NCT02393417|5542102|P2|NOT COMPLETED|Overall Study||13
2258112|NCT02393417|5542103|P1|NOT COMPLETED|Overall Study||15
2258113|NCT02393417|5542100|P4|COMPLETED|Overall Study||29
2258114|NCT02393417|5542101|P3|COMPLETED|Overall Study||30
2258115|NCT02393417|5542102|P2|COMPLETED|Overall Study||32
2258116|NCT02393417|5542103|P1|COMPLETED|Overall Study||28
2258117|NCT02393417|5542100|P4|Completed Treatment|Overall Study||30
2258118|NCT02393417|5542101|P3|Completed Treatment|Overall Study||32
2258119|NCT02393417|5542102|P2|Completed Treatment|Overall Study||34
2258120|NCT02393417|5542103|P1|Completed Treatment|Overall Study||30
2258121|NCT02393417|5542100|P4|STARTED|Overall Study||41
2258122|NCT02393417|5542101|P3|STARTED|Overall Study||40
2258123|NCT02393417|5542102|P2|STARTED|Overall Study||45
2258124|NCT02393417|5542103|P1|STARTED|Overall Study||43
2258125|NCT02393378|5542161|P2|NOT COMPLETED|Overall Study||0
2258126|NCT02393378|5542162|P1|NOT COMPLETED|Overall Study||0
2258127|NCT02393378|5542161|P2|COMPLETED|Overall Study||4
2258128|NCT02393378|5542162|P1|COMPLETED|Overall Study||3
2258129|NCT02393378|5542161|P2|STARTED|Overall Study||4
2258130|NCT02393378|5542162|P1|STARTED|Overall Study||3
2258131|NCT02393209|5542180|P4|NOT COMPLETED|Overall Study||0
2258132|NCT02393209|5542181|P3|NOT COMPLETED|Overall Study||0
2258133|NCT02393209|5542182|P2|NOT COMPLETED|Overall Study||8
2258134|NCT02393209|5542183|P1|NOT COMPLETED|Overall Study||6
2258135|NCT02393209|5542180|P4|COMPLETED|Overall Study||0
2258136|NCT02393209|5542181|P3|COMPLETED|Overall Study||0
2258137|NCT02393209|5542182|P2|COMPLETED|Overall Study||0
2258138|NCT02393209|5542183|P1|COMPLETED|Overall Study||0
2258139|NCT02393209|5542180|P4|STARTED|Overall Study||0
2258140|NCT02393209|5542181|P3|STARTED|Overall Study||0
2258141|NCT02393209|5542182|P2|STARTED|Overall Study||8
2258142|NCT02393209|5542183|P1|STARTED|Overall Study||6
2258143|NCT02392806|5542241|P2|NOT COMPLETED|Overall Study||0
2258144|NCT02392806|5542242|P1|NOT COMPLETED|Overall Study||0
2258145|NCT02392806|5542241|P2|COMPLETED|Overall Study||21
2258146|NCT02392806|5542242|P1|COMPLETED|Overall Study||22
2258147|NCT02392806|5542241|P2|STARTED|Overall Study||21
2258148|NCT02392806|5542242|P1|STARTED|Overall Study||22
2258149|NCT02392767|5542252|P2|NOT COMPLETED|Overall Study||0
2258150|NCT02392767|5542253|P1|NOT COMPLETED|Overall Study||0
2258151|NCT02392767|5542252|P2|COMPLETED|Overall Study||13
2258152|NCT02392767|5542253|P1|COMPLETED|Overall Study||12
2258153|NCT02392767|5542252|P2|STARTED|Overall Study||13
2258154|NCT02392767|5542253|P1|STARTED|Overall Study||12
2258155|NCT02392624|5542272|P3|NOT COMPLETED|Overall Study||13
2258156|NCT02392624|5542273|P2|NOT COMPLETED|Overall Study||15
2258157|NCT02392624|5542274|P1|NOT COMPLETED|Overall Study||71
2258158|NCT02392624|5542272|P3|COMPLETED|Overall Study||40
2258159|NCT02392624|5542273|P2|COMPLETED|Overall Study||66
2258160|NCT02392624|5542274|P1|COMPLETED|Overall Study||0
2258161|NCT02392624|5542272|P3|STARTED|Overall Study||53
2258162|NCT02392624|5542273|P2|STARTED|Overall Study||81
2258163|NCT02392624|5542274|P1|STARTED|Overall Study||71
2258164|NCT02392507|5542287|P1|NOT COMPLETED|Maintenance Regimen||12
2258165|NCT02392507|5542287|P1|COMPLETED|Maintenance Regimen||22
2258166|NCT02392507|5542287|P1|STARTED|Maintenance Regimen|After induction regimen participants with disease response are eligible for maintenance regimen.|34
2258167|NCT02392507|5542287|P1|NOT COMPLETED|Induction Regimen||17
2258168|NCT02392507|5542287|P1|COMPLETED|Induction Regimen||37
2258169|NCT02392507|5542287|P1|Received at Least 1 Dose of Study Drug|Induction Regimen||54
2258170|NCT02392507|5542287|P1|STARTED|Induction Regimen||54
2258171|NCT02392494|5542305|P4|NOT COMPLETED|Overall Study||0
2258172|NCT02392494|5542306|P3|NOT COMPLETED|Overall Study||0
2258173|NCT02392494|5542307|P2|NOT COMPLETED|Overall Study||0
2258174|NCT02392494|5542308|P1|NOT COMPLETED|Overall Study||0
2258175|NCT02392494|5542305|P4|COMPLETED|Overall Study||0
2258176|NCT02392494|5542306|P3|COMPLETED|Overall Study||3
2258177|NCT02392494|5542307|P2|COMPLETED|Overall Study||3
2258178|NCT02392494|5542308|P1|COMPLETED|Overall Study||3
2258179|NCT02392494|5542305|P4|STARTED|Overall Study||0
2258180|NCT02392494|5542306|P3|STARTED|Overall Study||3
2258181|NCT02392494|5542307|P2|STARTED|Overall Study||3
2258182|NCT02392494|5542308|P1|STARTED|Overall Study||3
2258183|NCT02392481|5542326|P4|NOT COMPLETED|Overall Study||2
2258184|NCT02392481|5542327|P3|NOT COMPLETED|Overall Study||2
2258185|NCT02392481|5542328|P2|NOT COMPLETED|Overall Study||0
2258186|NCT02392481|5542329|P1|NOT COMPLETED|Overall Study||0
2258187|NCT02392481|5542326|P4|COMPLETED|Overall Study||25
2258188|NCT02392481|5542327|P3|COMPLETED|Overall Study||18
2258189|NCT02392481|5542328|P2|COMPLETED|Overall Study||12
2258190|NCT02392481|5542329|P1|COMPLETED|Overall Study||10
2258191|NCT02392481|5542326|P4|STARTED|Overall Study||27
2258192|NCT02392481|5542327|P3|STARTED|Overall Study||20
2258193|NCT02392481|5542328|P2|STARTED|Overall Study||12
2258194|NCT02392481|5542329|P1|STARTED|Overall Study||10
2258195|NCT02392403|5542351|P1|NOT COMPLETED|Overall Study||3
2258196|NCT02392403|5542351|P1|COMPLETED|Overall Study||42
2258197|NCT02392403|5542351|P1|STARTED|Overall Study||45
2258198|NCT02392377|5542365|P2|NOT COMPLETED|Overall Study||1
2258199|NCT02392377|5542366|P1|NOT COMPLETED|Overall Study||0
2258200|NCT02392377|5542365|P2|COMPLETED|Overall Study||0
2258201|NCT02392377|5542366|P1|COMPLETED|Overall Study||0
2258202|NCT02392377|5542365|P2|STARTED|Overall Study||1
2258203|NCT02392377|5542366|P1|STARTED|Overall Study||0
2258210|NCT02392286|5542441|P2|NOT COMPLETED|Overall Study||2
2258211|NCT02392286|5542442|P1|NOT COMPLETED|Overall Study||3
2258212|NCT02392286|5542441|P2|COMPLETED|Overall Study||6
2258213|NCT02392286|5542442|P1|COMPLETED|Overall Study||4
2258214|NCT02392286|5542441|P2|STARTED|Overall Study||8
2258215|NCT02392286|5542442|P1|STARTED|Overall Study||7
2258216|NCT02392247|5542458|P1|NOT COMPLETED|Overall Study||2
2258217|NCT02392247|5542458|P1|COMPLETED|Overall Study||50
2258218|NCT02392247|5542458|P1|STARTED|Overall Study||52
2258219|NCT02392234|5542469|P6|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
2258220|NCT02392234|5542470|P5|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
2258221|NCT02392234|5542471|P4|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
2258222|NCT02392234|5542472|P3|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
2258223|NCT02392234|5542473|P2|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
2258224|NCT02392234|5542474|P1|NOT COMPLETED|Treatment Period 2 (8 Weeks)||1
2258225|NCT02392234|5542469|P6|COMPLETED|Treatment Period 2 (8 Weeks)||38
2258226|NCT02392234|5542470|P5|COMPLETED|Treatment Period 2 (8 Weeks)||37
2258227|NCT02392234|5542471|P4|COMPLETED|Treatment Period 2 (8 Weeks)||41
2258228|NCT02392234|5542472|P3|COMPLETED|Treatment Period 2 (8 Weeks)||38
2258229|NCT02392234|5542473|P2|COMPLETED|Treatment Period 2 (8 Weeks)||43
2258230|NCT02392234|5542474|P1|COMPLETED|Treatment Period 2 (8 Weeks)||37
2258231|NCT02392234|5542469|P6|STARTED|Treatment Period 2 (8 Weeks)||38
2258232|NCT02392234|5542470|P5|STARTED|Treatment Period 2 (8 Weeks)||37
2258233|NCT02392234|5542471|P4|STARTED|Treatment Period 2 (8 Weeks)||41
2258234|NCT02392234|5542472|P3|STARTED|Treatment Period 2 (8 Weeks)||38
2258235|NCT02392234|5542473|P2|STARTED|Treatment Period 2 (8 Weeks)||43
2258236|NCT02392234|5542474|P1|STARTED|Treatment Period 2 (8 Weeks)||38
2258237|NCT02392234|5542469|P6|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3
2258238|NCT02392234|5542470|P5|NOT COMPLETED|Treatment Period 1 (8 Weeks)||4
2258239|NCT02392234|5542471|P4|NOT COMPLETED|Treatment Period 1 (8 Weeks)||1
2258240|NCT02392234|5542472|P3|NOT COMPLETED|Treatment Period 1 (8 Weeks)||2
2258241|NCT02392234|5542473|P2|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
2258242|NCT02392234|5542474|P1|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3
2258243|NCT02392234|5542469|P6|COMPLETED|Treatment Period 1 (8 Weeks)||38
2258244|NCT02392234|5542470|P5|COMPLETED|Treatment Period 1 (8 Weeks)||37
2258245|NCT02392234|5542471|P4|COMPLETED|Treatment Period 1 (8 Weeks)||41
2258246|NCT02392234|5542472|P3|COMPLETED|Treatment Period 1 (8 Weeks)||38
2258247|NCT02392234|5542473|P2|COMPLETED|Treatment Period 1 (8 Weeks)||43
2258248|NCT02392234|5542474|P1|COMPLETED|Treatment Period 1 (8 Weeks)||38
2258249|NCT02392234|5542469|P6|Treated|Treatment Period 1 (8 Weeks)||41
2258250|NCT02392234|5542470|P5|Treated|Treatment Period 1 (8 Weeks)||40
2258251|NCT02392234|5542471|P4|Treated|Treatment Period 1 (8 Weeks)||42
2258252|NCT02392234|5542472|P3|Treated|Treatment Period 1 (8 Weeks)||39
2258253|NCT02392234|5542473|P2|Treated|Treatment Period 1 (8 Weeks)||43
2258254|NCT02392234|5542474|P1|Treated|Treatment Period 1 (8 Weeks)||41
2258255|NCT02392234|5542469|P6|STARTED|Treatment Period 1 (8 Weeks)||41
2258256|NCT02392234|5542470|P5|STARTED|Treatment Period 1 (8 Weeks)||41
2258257|NCT02392234|5542471|P4|STARTED|Treatment Period 1 (8 Weeks)||42
2258258|NCT02392234|5542472|P3|STARTED|Treatment Period 1 (8 Weeks)||40
2258259|NCT02392234|5542473|P2|STARTED|Treatment Period 1 (8 Weeks)||43
2258260|NCT02392234|5542474|P1|STARTED|Treatment Period 1 (8 Weeks)||41
2258261|NCT02392208|5542496|P1|NOT COMPLETED|Telavancin After Hemodialysis||0
2258262|NCT02392208|5542496|P1|COMPLETED|Telavancin After Hemodialysis||8
2258263|NCT02392208|5542496|P1|STARTED|Telavancin After Hemodialysis||8
2258264|NCT02392208|5542496|P1|NOT COMPLETED|Telavancin Before Hemodialysis||0
2258265|NCT02392208|5542496|P1|COMPLETED|Telavancin Before Hemodialysis||8
2258266|NCT02392208|5542496|P1|STARTED|Telavancin Before Hemodialysis||8
2258267|NCT02392104|5542506|P1|NOT COMPLETED|Overall Study||11
2258268|NCT02392104|5542506|P1|COMPLETED|Overall Study||39
2258269|NCT02392104|5542506|P1|STARTED|Overall Study|one participant enrolled but was removed prior to starting study protocol|50
2258270|NCT02392000|5542517|P1|NOT COMPLETED|Overall Study||27
2258271|NCT02392000|5542517|P1|COMPLETED|Overall Study||11
2258272|NCT02392000|5542517|P1|STARTED|Overall Study||38
2258273|NCT02391987|5542527|P2|NOT COMPLETED|Overall Study||0
2258274|NCT02391987|5542528|P1|NOT COMPLETED|Overall Study||0
2258275|NCT02391987|5542527|P2|COMPLETED|Overall Study||58
2258276|NCT02391987|5542528|P1|COMPLETED|Overall Study||54
2258277|NCT02391987|5542527|P2|STARTED|Overall Study||58
2258278|NCT02391987|5542528|P1|STARTED|Overall Study||54
2258279|NCT02391948|5542543|P5|NOT COMPLETED|24-month Assessment||10
2258280|NCT02391948|5542544|P4|NOT COMPLETED|24-month Assessment||9
2258281|NCT02391948|5542545|P3|NOT COMPLETED|24-month Assessment||3
2258282|NCT02391948|5542546|P2|NOT COMPLETED|24-month Assessment||10
2258283|NCT02391948|5542547|P1|NOT COMPLETED|24-month Assessment||14
2258284|NCT02391948|5542543|P5|COMPLETED|24-month Assessment||69
2258285|NCT02391948|5542544|P4|COMPLETED|24-month Assessment||75
2258286|NCT02391948|5542545|P3|COMPLETED|24-month Assessment||48
2258287|NCT02391948|5542546|P2|COMPLETED|24-month Assessment||97
2258288|NCT02391948|5542547|P1|COMPLETED|24-month Assessment||135
2258289|NCT02391948|5542543|P5|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 4 of the Not Completed remained active.|79
2258290|NCT02391948|5542544|P4|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 1 of the Not Completed remained active.|84
2258291|NCT02391948|5542545|P3|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 3 of the Not Completed remained active.|51
2258292|NCT02391948|5542546|P2|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 6 of the Not Completed remained active.|107
2258293|NCT02391948|5542547|P1|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 2 of the Not Completed remained active.|149
2258294|NCT02391948|5542543|P5|NOT COMPLETED|18-month Assessment||30
2258295|NCT02391948|5542544|P4|NOT COMPLETED|18-month Assessment||36
2258296|NCT02391948|5542545|P3|NOT COMPLETED|18-month Assessment||26
2258297|NCT02391948|5542546|P2|NOT COMPLETED|18-month Assessment||50
2258298|NCT02391948|5542547|P1|NOT COMPLETED|18-month Assessment||72
2258299|NCT02391948|5542543|P5|COMPLETED|18-month Assessment||75
2258300|NCT02391948|5542544|P4|COMPLETED|18-month Assessment||83
2258301|NCT02391948|5542545|P3|COMPLETED|18-month Assessment||48
2258302|NCT02391948|5542546|P2|COMPLETED|18-month Assessment||101
2258303|NCT02391948|5542547|P1|COMPLETED|18-month Assessment||147
2258304|NCT02391948|5542543|P5|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 2 of the Not Completed remained active.|105
2258305|NCT02391948|5542544|P4|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 3 of the Not Completed remained active.|119
2258306|NCT02391948|5542545|P3|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 1 of the Not Completed remained active.|74
2258307|NCT02391948|5542546|P2|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 4 of the Not Completed remained active.|151
2258308|NCT02391948|5542547|P1|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 2 of the Not Completed remained active.|219
2258309|NCT02391948|5542543|P5|NOT COMPLETED|12-month Assessment||6
2258310|NCT02391948|5542544|P4|NOT COMPLETED|12-month Assessment||9
2258311|NCT02391948|5542545|P3|NOT COMPLETED|12-month Assessment||4
2258312|NCT02391948|5542546|P2|NOT COMPLETED|12-month Assessment||9
2258313|NCT02391948|5542547|P1|NOT COMPLETED|12-month Assessment||8
2258314|NCT02391948|5542543|P5|COMPLETED|12-month Assessment||103
2258315|NCT02391948|5542544|P4|COMPLETED|12-month Assessment||116
2258316|NCT02391948|5542545|P3|COMPLETED|12-month Assessment||73
2258317|NCT02391948|5542546|P2|COMPLETED|12-month Assessment||147
2258318|NCT02391948|5542547|P1|COMPLETED|12-month Assessment||217
2258319|NCT02391948|5542543|P5|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 24 of the Not Completed remained active.|109
2258320|NCT02391948|5542544|P4|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 41 of the Not Completed remained active.|125
2258321|NCT02391948|5542545|P3|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 28 of the Not Completed remained active.|77
2258322|NCT02391948|5542546|P2|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 51 of the Not Completed remained active.|156
2258323|NCT02391948|5542547|P1|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 77 of the Not Completed remained active.|225
2258324|NCT02391948|5542543|P5|NOT COMPLETED|6-month Assessment||26
2258325|NCT02391948|5542544|P4|NOT COMPLETED|6-month Assessment||45
2258326|NCT02391948|5542545|P3|NOT COMPLETED|6-month Assessment||31
2258327|NCT02391948|5542546|P2|NOT COMPLETED|6-month Assessment||56
2258328|NCT02391948|5542547|P1|NOT COMPLETED|6-month Assessment||79
2258329|NCT02391948|5542543|P5|COMPLETED|6-month Assessment||85
2258330|NCT02391948|5542544|P4|COMPLETED|6-month Assessment||84
2258331|NCT02391948|5542545|P3|COMPLETED|6-month Assessment||49
2258332|NCT02391948|5542546|P2|COMPLETED|6-month Assessment||105
2258333|NCT02391948|5542547|P1|COMPLETED|6-month Assessment||148
2258334|NCT02391948|5542543|P5|STARTED|6-month Assessment||111
2258335|NCT02391948|5542544|P4|STARTED|6-month Assessment||129
2258336|NCT02391948|5542545|P3|STARTED|6-month Assessment||80
2258337|NCT02391948|5542546|P2|STARTED|6-month Assessment||161
2258338|NCT02391948|5542547|P1|STARTED|6-month Assessment||227
2258339|NCT02391948|5542543|P5|NOT COMPLETED|Baseline||0
2258340|NCT02391948|5542544|P4|NOT COMPLETED|Baseline||0
2258341|NCT02391948|5542545|P3|NOT COMPLETED|Baseline||0
2258342|NCT02391948|5542546|P2|NOT COMPLETED|Baseline||0
2258343|NCT02391948|5542547|P1|NOT COMPLETED|Baseline||0
2258344|NCT02391948|5542543|P5|COMPLETED|Baseline||111
2258345|NCT02391948|5542544|P4|COMPLETED|Baseline||129
2258346|NCT02391948|5542545|P3|COMPLETED|Baseline||80
2258347|NCT02391948|5542546|P2|COMPLETED|Baseline||161
2258348|NCT02391948|5542547|P1|COMPLETED|Baseline||227
2258349|NCT02391948|5542543|P5|STARTED|Baseline||111
2258350|NCT02391948|5542544|P4|STARTED|Baseline||129
2258351|NCT02391948|5542545|P3|STARTED|Baseline||80
2258352|NCT02391948|5542546|P2|STARTED|Baseline||161
2258353|NCT02391948|5542547|P1|STARTED|Baseline||227
2258354|NCT02391714|5542641|P2|NOT COMPLETED|Overall Study||0
2258355|NCT02391714|5542642|P1|NOT COMPLETED|Overall Study||0
2258356|NCT02391714|5542641|P2|COMPLETED|Overall Study||40
2258357|NCT02391714|5542642|P1|COMPLETED|Overall Study||40
2258358|NCT02391714|5542641|P2|STARTED|Overall Study||40
2258359|NCT02391714|5542642|P1|STARTED|Overall Study||40
2258360|NCT02391584|5542654|P2|NOT COMPLETED|12 Month (End of Study)||0
2258361|NCT02391584|5542655|P1|NOT COMPLETED|12 Month (End of Study)||2
2258362|NCT02391584|5542654|P2|COMPLETED|12 Month (End of Study)||0
2258363|NCT02391584|5542655|P1|COMPLETED|12 Month (End of Study)||49
2258364|NCT02391584|5542654|P2|STARTED|12 Month (End of Study)||0
2258365|NCT02391584|5542655|P1|STARTED|12 Month (End of Study)||51
2258366|NCT02391584|5542654|P2|NOT COMPLETED|6 Month||0
2258367|NCT02391584|5542655|P1|NOT COMPLETED|6 Month||1
2258368|NCT02391584|5542654|P2|COMPLETED|6 Month||0
2258369|NCT02391584|5542655|P1|COMPLETED|6 Month||51
2258370|NCT02391584|5542654|P2|STARTED|6 Month||0
2258371|NCT02391584|5542655|P1|STARTED|6 Month||52
2258372|NCT02391584|5542654|P2|NOT COMPLETED|3 Month||0
2258373|NCT02391584|5542655|P1|NOT COMPLETED|3 Month||1
2258374|NCT02391584|5542654|P2|COMPLETED|3 Month||0
2258375|NCT02391584|5542655|P1|COMPLETED|3 Month||52
2258376|NCT02391584|5542654|P2|STARTED|3 Month|23 Crossover participants are included in balloon dilation arm for remainder of study visits.|0
2258377|NCT02391584|5542655|P1|STARTED|3 Month|Includes 30 balloon dilation and 23 crossover participants|53
2258378|NCT02391584|5542654|P2|NOT COMPLETED|Primary Endpoint (6-weeks)||2
2258379|NCT02391584|5542655|P1|NOT COMPLETED|Primary Endpoint (6-weeks)||2
2258380|NCT02391584|5542654|P2|COMPLETED|Primary Endpoint (6-weeks)||27
2258381|NCT02391584|5542655|P1|COMPLETED|Primary Endpoint (6-weeks)||29
2258382|NCT02391584|5542654|P2|STARTED|Primary Endpoint (6-weeks)||29
2258383|NCT02391584|5542655|P1|STARTED|Primary Endpoint (6-weeks)||31
2258384|NCT02391545|5542672|P2|NOT COMPLETED|Overall Study||28
2258385|NCT02391545|5542673|P1|NOT COMPLETED|Overall Study||26
2258386|NCT02391545|5542672|P2|COMPLETED|Overall Study||0
2258387|NCT02391545|5542673|P1|COMPLETED|Overall Study||1
2258388|NCT02391545|5542672|P2|STARTED|Overall Study||28
2258389|NCT02391545|5542673|P1|STARTED|Overall Study||27
2258390|NCT02391363|5542693|P2|NOT COMPLETED|Overall Study||8
2258391|NCT02391363|5542694|P1|NOT COMPLETED|Overall Study||11
2258392|NCT02391363|5542693|P2|COMPLETED|Overall Study||56
2258393|NCT02391363|5542694|P1|COMPLETED|Overall Study||59
2258394|NCT02391363|5542693|P2|STARTED|Overall Study||64
2258395|NCT02391363|5542694|P1|STARTED|Overall Study||70
2258396|NCT02391311|5542760|P2|NOT COMPLETED|Overall Study||2
2258397|NCT02391311|5542761|P1|NOT COMPLETED|Overall Study||3
2258398|NCT02391311|5542760|P2|COMPLETED|Overall Study||19
2258399|NCT02391311|5542761|P1|COMPLETED|Overall Study||18
2258400|NCT02391311|5542760|P2|STARTED|Overall Study||21
2258401|NCT02391311|5542761|P1|STARTED|Overall Study||21
2258402|NCT02391116|5542769|P1|NOT COMPLETED|Survival Follow-up||4
2258403|NCT02391116|5542769|P1|COMPLETED|Survival Follow-up|Reason for completed in this period included death (35) and clinical endpoint reached (7)|42
2258404|NCT02391116|5542769|P1|STARTED|Survival Follow-up|21 participants discontinued from treatment didn't enter due to withdrawal by subject (3) and death|46
2258405|NCT02391116|5542769|P1|NOT COMPLETED|Active Follow-up||3
2258406|NCT02391116|5542769|P1|COMPLETED|Active Follow-up|Reasons for completion in this period included death (2) and PD (4)|6
2258407|NCT02391116|5542769|P1|STARTED|Active Follow-up|This period incorporates safety follow-up with radiological|9
2258408|NCT02391116|5542769|P1|NOT COMPLETED|Safety Follow-up||13
2258409|NCT02391116|5542769|P1|COMPLETED|Safety Follow-up|14 participants were considered completed due to death|43
2258410|NCT02391116|5542769|P1|STARTED|Safety Follow-up|This period excludes 2 deaths on treatment and 9 participants entering active follow-up|56
2258411|NCT02391116|5542769|P1|NOT COMPLETED|Treatment||14
2258412|NCT02391116|5542769|P1|COMPLETED|Treatment|Reasons for completion in this period included death (2), PD (50) and lack of efficacy (1)|53
2258413|NCT02391116|5542769|P1|Included in Per Protocol Set|Treatment||40
2258414|NCT02391116|5542769|P1|STARTED|Treatment||67
2258415|NCT02391038|5542823|P3|NOT COMPLETED|Overall Study||6
2258416|NCT02391038|5542824|P2|NOT COMPLETED|Overall Study||3
2258417|NCT02391038|5542825|P1|NOT COMPLETED|Overall Study||3
2258418|NCT02391038|5542823|P3|COMPLETED|Overall Study||0
2258419|NCT02391038|5542824|P2|COMPLETED|Overall Study||0
2258420|NCT02391038|5542825|P1|COMPLETED|Overall Study||0
2258421|NCT02391038|5542823|P3|STARTED|Overall Study||6
2258422|NCT02391038|5542824|P2|STARTED|Overall Study||3
2258423|NCT02391038|5542825|P1|STARTED|Overall Study||3
2258424|NCT02390791|5542941|P2|NOT COMPLETED|Overall Study||0
2258425|NCT02390791|5542942|P1|NOT COMPLETED|Overall Study||0
2258426|NCT02390791|5542941|P2|COMPLETED|Overall Study||45
2258427|NCT02390791|5542942|P1|COMPLETED|Overall Study||40
2258428|NCT02390791|5542941|P2|STARTED|Overall Study||45
2258429|NCT02390791|5542942|P1|STARTED|Overall Study||40
2258430|NCT02390557|5542969|P3|NOT COMPLETED|Wave 2||23
2258431|NCT02390557|5542970|P2|NOT COMPLETED|Wave 2||41
2258432|NCT02390557|5542971|P1|NOT COMPLETED|Wave 2||72
2258433|NCT02390557|5542969|P3|COMPLETED|Wave 2||112
2258434|NCT02390557|5542970|P2|COMPLETED|Wave 2||115
2258435|NCT02390557|5542971|P1|COMPLETED|Wave 2||88
2258436|NCT02390557|5542969|P3|STARTED|Wave 2||135
2258437|NCT02390557|5542970|P2|STARTED|Wave 2||156
2258438|NCT02390557|5542971|P1|STARTED|Wave 2||160
2258439|NCT02390557|5542969|P3|NOT COMPLETED|Wave 1||0
2258440|NCT02390557|5542970|P2|NOT COMPLETED|Wave 1||0
2258441|NCT02390557|5542971|P1|NOT COMPLETED|Wave 1||0
2258442|NCT02390557|5542969|P3|COMPLETED|Wave 1||135
2258443|NCT02390557|5542970|P2|COMPLETED|Wave 1||156
2258444|NCT02390557|5542971|P1|COMPLETED|Wave 1||160
2258445|NCT02390557|5542969|P3|STARTED|Wave 1||135
2258446|NCT02390557|5542970|P2|STARTED|Wave 1||156
2258447|NCT02390557|5542971|P1|STARTED|Wave 1||160
2258448|NCT02390362|5542981|P2|NOT COMPLETED|Overall Study||1
2258449|NCT02390362|5542982|P1|NOT COMPLETED|Overall Study||0
2258450|NCT02390362|5542981|P2|COMPLETED|Overall Study||1
2258451|NCT02390362|5542982|P1|COMPLETED|Overall Study||1
2258452|NCT02390362|5542981|P2|STARTED|Overall Study||2
2258453|NCT02390362|5542982|P1|STARTED|Overall Study|1 subject enrolled in this arm. completed 2 doses of Rituximab.|1
2258454|NCT02390219|5542990|P1|NOT COMPLETED|Overall Study||13
2258455|NCT02390219|5542990|P1|COMPLETED|Overall Study||33
2258456|NCT02390219|5542990|P1|STARTED|Overall Study||46
2258457|NCT02390167|5543000|P1|NOT COMPLETED|Overall Study||1
2258458|NCT02390167|5543000|P1|COMPLETED|Overall Study||375
2258459|NCT02390167|5543000|P1|Without Diabetes|Overall Study||43
2258460|NCT02390167|5543000|P1|With Diabetes|Overall Study||333
2258461|NCT02390167|5543000|P1|STARTED|Overall Study||376
2258462|NCT02390076|5543022|P3|NOT COMPLETED|Overall Study||4
2258463|NCT02390076|5543023|P2|NOT COMPLETED|Overall Study||1
2258464|NCT02390076|5543024|P1|NOT COMPLETED|Overall Study||2
2258465|NCT02390076|5543022|P3|COMPLETED|Overall Study||11
2258466|NCT02390076|5543023|P2|COMPLETED|Overall Study||17
2258467|NCT02390076|5543024|P1|COMPLETED|Overall Study||16
2258468|NCT02390076|5543022|P3|STARTED|Overall Study||15
2258469|NCT02390076|5543023|P2|STARTED|Overall Study||18
2258470|NCT02390076|5543024|P1|STARTED|Overall Study||18
2258471|NCT02389946|5543037|P2|NOT COMPLETED|Overall Study||15
2258472|NCT02389946|5543038|P1|NOT COMPLETED|Overall Study||24
2258473|NCT02389946|5543037|P2|COMPLETED|Overall Study||435
2258474|NCT02389946|5543038|P1|COMPLETED|Overall Study||860
2258475|NCT02389946|5543037|P2|STARTED|Overall Study||450
2258476|NCT02389946|5543038|P1|STARTED|Overall Study||884
2258477|NCT02389894|5543053|P3|NOT COMPLETED|Overall Study||9
2258478|NCT02389894|5543054|P2|NOT COMPLETED|Overall Study||10
2258479|NCT02389894|5543055|P1|NOT COMPLETED|Overall Study||8
2258480|NCT02389894|5543053|P3|COMPLETED|Overall Study||123
2258481|NCT02389894|5543054|P2|COMPLETED|Overall Study||108
2258482|NCT02389894|5543055|P1|COMPLETED|Overall Study||125
2258483|NCT02389894|5543053|P3|STARTED|Overall Study||132
2258484|NCT02389894|5543054|P2|STARTED|Overall Study||118
2258485|NCT02389894|5543055|P1|STARTED|Overall Study||133
2258486|NCT02389881|5543130|P7|NOT COMPLETED|Overall Study||0
2258487|NCT02389881|5543131|P6|NOT COMPLETED|Overall Study||0
2258488|NCT02389881|5543132|P5|NOT COMPLETED|Overall Study||0
2258489|NCT02389881|5543133|P4|NOT COMPLETED|Overall Study||0
2258490|NCT02389881|5543134|P3|NOT COMPLETED|Overall Study||0
2258491|NCT02389881|5543135|P2|NOT COMPLETED|Overall Study||0
2258492|NCT02389881|5543136|P1|NOT COMPLETED|Overall Study||0
2258493|NCT02389881|5543130|P7|COMPLETED|Overall Study||2
2258494|NCT02389881|5543131|P6|COMPLETED|Overall Study||8
2258495|NCT02389881|5543132|P5|COMPLETED|Overall Study||6
2258496|NCT02389881|5543133|P4|COMPLETED|Overall Study||6
2258497|NCT02389881|5543134|P3|COMPLETED|Overall Study||6
2258498|NCT02389881|5543135|P2|COMPLETED|Overall Study||6
2258499|NCT02389881|5543136|P1|COMPLETED|Overall Study||6
2258500|NCT02389881|5543130|P7|STARTED|Overall Study||2
2258501|NCT02389881|5543131|P6|STARTED|Overall Study||8
2258502|NCT02389881|5543132|P5|STARTED|Overall Study||6
2258503|NCT02389881|5543133|P4|STARTED|Overall Study||6
2258504|NCT02389881|5543134|P3|STARTED|Overall Study||6
2258505|NCT02389881|5543135|P2|STARTED|Overall Study||6
2258506|NCT02389881|5543136|P1|STARTED|Overall Study||6
2258507|NCT02389829|5543187|P2|NOT COMPLETED|Overall Study||1
2258508|NCT02389829|5543188|P1|NOT COMPLETED|Overall Study||0
2258509|NCT02389829|5543187|P2|COMPLETED|Overall Study||62
2258510|NCT02389829|5543188|P1|COMPLETED|Overall Study||64
2258511|NCT02389829|5543187|P2|STARTED|Overall Study||63
2258512|NCT02389829|5543188|P1|STARTED|Overall Study||64
2258513|NCT02389816|5543203|P3|NOT COMPLETED|Overall Study||12
2258514|NCT02389816|5543204|P2|NOT COMPLETED|Overall Study||13
2258515|NCT02389816|5543205|P1|NOT COMPLETED|Overall Study||15
2258516|NCT02389816|5543203|P3|COMPLETED|Overall Study||152
2258517|NCT02389816|5543204|P2|COMPLETED|Overall Study||152
2258518|NCT02389816|5543205|P1|COMPLETED|Overall Study||149
2258519|NCT02389816|5543203|P3|STARTED|Overall Study||164
2258520|NCT02389816|5543204|P2|STARTED|Overall Study||165
2258521|NCT02389816|5543205|P1|STARTED|Overall Study||164
2258522|NCT02389764|5543237|P1|NOT COMPLETED|Overall Study||9
2258523|NCT02389764|5543237|P1|COMPLETED|Overall Study||0
2258524|NCT02389764|5543237|P1|STARTED|Overall Study||9
2258525|NCT02389738|5543242|P1|NOT COMPLETED|Overall Study||1
2258526|NCT02389738|5543242|P1|COMPLETED|Overall Study||5
2258527|NCT02389738|5543242|P1|STARTED|Overall Study||6
2258528|NCT02389725|5543248|P2|NOT COMPLETED|Overall Study||0
2258529|NCT02389725|5543249|P1|NOT COMPLETED|Overall Study||0
2258530|NCT02389725|5543248|P2|COMPLETED|Overall Study||60
2258531|NCT02389725|5543249|P1|COMPLETED|Overall Study||59
2258532|NCT02389725|5543248|P2|STARTED|Overall Study||60
2258533|NCT02389725|5543249|P1|STARTED|Overall Study||59
2258534|NCT02389712|5543263|P2|NOT COMPLETED|Overall Study||0
2258535|NCT02389712|5543264|P1|NOT COMPLETED|Overall Study||0
2258536|NCT02389712|5543263|P2|COMPLETED|Overall Study||1
2258537|NCT02389712|5543264|P1|COMPLETED|Overall Study||1
2258538|NCT02389712|5543263|P2|STARTED|Overall Study||1
2258539|NCT02389712|5543264|P1|STARTED|Overall Study||1
2258540|NCT02389621|5543272|P2|NOT COMPLETED|Posttreatment Period||4
2258541|NCT02389621|5543273|P1|NOT COMPLETED|Posttreatment Period||9
2258542|NCT02389621|5543272|P2|COMPLETED|Posttreatment Period||102
2258543|NCT02389621|5543273|P1|COMPLETED|Posttreatment Period||98
2258544|NCT02389621|5543272|P2|STARTED|Posttreatment Period||106
2258545|NCT02389621|5543273|P1|STARTED|Posttreatment Period||107
2258546|NCT02389621|5543272|P2|NOT COMPLETED|Treatment Period||1
2258547|NCT02389621|5543273|P1|NOT COMPLETED|Treatment Period||1
2258548|NCT02389621|5543272|P2|COMPLETED|Treatment Period||106
2258549|NCT02389621|5543273|P1|COMPLETED|Treatment Period||107
2258550|NCT02389621|5543272|P2|Received Study Drug|Treatment Period||107
2258551|NCT02389621|5543273|P1|Received Study Drug|Treatment Period||107
2258552|NCT02389621|5543272|P2|STARTED|Treatment Period||107
2258553|NCT02389621|5543273|P1|STARTED|Treatment Period||108
2258554|NCT02389452|5543303|P1|NOT COMPLETED|Overall Study||25
2258555|NCT02389452|5543303|P1|COMPLETED|Overall Study||369
2258556|NCT02389452|5543303|P1|Participants Received Repeat Injection|Overall Study|Repeat injection based on physician's assessment of efficacy and safety at Week 26, 39 or 52.|11
2258557|NCT02389452|5543303|P1|STARTED|Overall Study||394
2258558|NCT02389374|5543324|P3|NOT COMPLETED|Overall Study||1
2258559|NCT02389374|5543325|P2|NOT COMPLETED|Overall Study||28
2258560|NCT02389374|5543326|P1|NOT COMPLETED|Overall Study||9
2258561|NCT02389374|5543324|P3|COMPLETED|Overall Study||10
2258562|NCT02389374|5543325|P2|COMPLETED|Overall Study||87
2258563|NCT02389374|5543326|P1|COMPLETED|Overall Study||46
2258564|NCT02389374|5543324|P3|STARTED|Overall Study||11
2258565|NCT02389374|5543325|P2|STARTED|Overall Study||115
2258566|NCT02389374|5543326|P1|STARTED|Overall Study||55
2258567|NCT02389361|5543358|P2|NOT COMPLETED|Overall Study||0
2258568|NCT02389361|5543359|P1|NOT COMPLETED|Overall Study||0
2258569|NCT02389361|5543358|P2|COMPLETED|Overall Study||27
2258570|NCT02389361|5543359|P1|COMPLETED|Overall Study||24
2258571|NCT02389361|5543358|P2|STARTED|Overall Study||27
2258572|NCT02389361|5543359|P1|STARTED|Overall Study||24
2258573|NCT02389101|5543365|P1|NOT COMPLETED|Overall Study||0
2258574|NCT02389101|5543365|P1|COMPLETED|Overall Study||21
2258575|NCT02389101|5543365|P1|STARTED|Overall Study||21
2258576|NCT02389088|5543369|P1|NOT COMPLETED|Phase II - All Study Participants||0
2258577|NCT02389088|5543369|P1|COMPLETED|Phase II - All Study Participants||9
2258578|NCT02389088|5543369|P1|STARTED|Phase II - All Study Participants||9
2258579|NCT02389088|5543369|P1|NOT COMPLETED|Overall Study - Phase I||0
2258580|NCT02389088|5543369|P1|COMPLETED|Overall Study - Phase I||9
2258581|NCT02389088|5543369|P1|STARTED|Overall Study - Phase I||9
2258582|NCT02388997|5543415|P2|NOT COMPLETED|Overall Study||6
2258583|NCT02388997|5543416|P1|NOT COMPLETED|Overall Study||3
2258584|NCT02388997|5543415|P2|COMPLETED|Overall Study||10
2258585|NCT02388997|5543416|P1|COMPLETED|Overall Study||12
2258586|NCT02388997|5543415|P2|STARTED|Overall Study||16
2258587|NCT02388997|5543416|P1|STARTED|Overall Study||15
2258588|NCT02388932|5543434|P1|NOT COMPLETED|Overall Study||1
2258589|NCT02388932|5543434|P1|COMPLETED|Overall Study||2
2258590|NCT02388932|5543434|P1|STARTED|Overall Study||3
2258591|NCT02388880|5543444|P1|NOT COMPLETED|Overall Study||0
2258592|NCT02388880|5543444|P1|COMPLETED|Overall Study||3
2258593|NCT02388880|5543444|P1|STARTED|Overall Study||3
2258594|NCT02388815|5543451|P1|NOT COMPLETED|Overall Study||4
2258595|NCT02388815|5543451|P1|COMPLETED|Overall Study||85
2258596|NCT02388815|5543451|P1|STARTED|Overall Study||89
2258597|NCT02388776|5543455|P1|NOT COMPLETED|Overall Study||2
2258598|NCT02388776|5543455|P1|COMPLETED|Overall Study||0
2258599|NCT02388776|5543455|P1|STARTED|Overall Study||2
2258600|NCT02388763|5543460|P2|NOT COMPLETED|Period 2, 10 Days of Wear||0
2258601|NCT02388763|5543461|P1|NOT COMPLETED|Period 2, 10 Days of Wear||0
2258602|NCT02388763|5543460|P2|COMPLETED|Period 2, 10 Days of Wear||30
2258603|NCT02388763|5543461|P1|COMPLETED|Period 2, 10 Days of Wear||30
2258604|NCT02388763|5543460|P2|STARTED|Period 2, 10 Days of Wear||30
2258605|NCT02388763|5543461|P1|STARTED|Period 2, 10 Days of Wear||30
2258606|NCT02388763|5543460|P2|NOT COMPLETED|Period 1, 10 Days of Wear||1
2258607|NCT02388763|5543461|P1|NOT COMPLETED|Period 1, 10 Days of Wear||1
2258608|NCT02388763|5543460|P2|COMPLETED|Period 1, 10 Days of Wear||30
2258609|NCT02388763|5543461|P1|COMPLETED|Period 1, 10 Days of Wear||30
2258610|NCT02388763|5543460|P2|STARTED|Period 1, 10 Days of Wear||31
2258611|NCT02388763|5543461|P1|STARTED|Period 1, 10 Days of Wear||31
2258612|NCT02388763|5543460|P2|NOT COMPLETED|Habitual, 10 Days of Wear||1
2258613|NCT02388763|5543461|P1|NOT COMPLETED|Habitual, 10 Days of Wear||1
2258614|NCT02388763|5543460|P2|COMPLETED|Habitual, 10 Days of Wear||31
2258615|NCT02388763|5543461|P1|COMPLETED|Habitual, 10 Days of Wear||31
2258616|NCT02388763|5543460|P2|STARTED|Habitual, 10 Days of Wear||32
2258617|NCT02388763|5543461|P1|STARTED|Habitual, 10 Days of Wear||32
2258627|NCT02388724|5543511|P2|NOT COMPLETED|Overall Study||13
2258628|NCT02388724|5543512|P1|NOT COMPLETED|Overall Study||12
2258629|NCT02388724|5543511|P2|COMPLETED|Overall Study||224
2258630|NCT02388724|5543512|P1|COMPLETED|Overall Study||232
2258631|NCT02388724|5543511|P2|Safety Set: Randomized But Not Treated|Overall Study||2
2258632|NCT02388724|5543512|P1|Safety Set: Randomized But Not Treated|Overall Study||0
2258633|NCT02388724|5543511|P2|STARTED|Overall Study||237
2258634|NCT02388724|5543512|P1|STARTED|Overall Study||244
2258635|NCT02388568|5543536|P2|NOT COMPLETED|Overall Study||15
2258636|NCT02388568|5543537|P1|NOT COMPLETED|Overall Study||10
2258637|NCT02388568|5543536|P2|COMPLETED|Overall Study||53
2258638|NCT02388568|5543537|P1|COMPLETED|Overall Study||59
2258639|NCT02388568|5543536|P2|STARTED|Overall Study||68
2258640|NCT02388568|5543537|P1|STARTED|Overall Study||69
2258641|NCT02388347|5543558|P5|NOT COMPLETED|Overall Study||0
2258642|NCT02388347|5543559|P4|NOT COMPLETED|Overall Study||0
2258643|NCT02388347|5543560|P3|NOT COMPLETED|Overall Study||1
2258644|NCT02388347|5543561|P2|NOT COMPLETED|Overall Study||0
2258645|NCT02388347|5543562|P1|NOT COMPLETED|Overall Study||0
2258646|NCT02388347|5543558|P5|COMPLETED|Overall Study||6
2258647|NCT02388347|5543559|P4|COMPLETED|Overall Study||6
2258648|NCT02388347|5543560|P3|COMPLETED|Overall Study||5
2258649|NCT02388347|5543561|P2|COMPLETED|Overall Study||6
2258650|NCT02388347|5543562|P1|COMPLETED|Overall Study||8
2258651|NCT02388347|5543558|P5|STARTED|Overall Study||6
2258652|NCT02388347|5543559|P4|STARTED|Overall Study||6
2258653|NCT02388347|5543560|P3|STARTED|Overall Study||6
2258654|NCT02388347|5543561|P2|STARTED|Overall Study||6
2258655|NCT02388347|5543562|P1|STARTED|Overall Study||8
2258656|NCT02388321|5543629|P2|NOT COMPLETED|Overall Study||0
2258657|NCT02388321|5543630|P1|NOT COMPLETED|Overall Study||0
2258658|NCT02388321|5543629|P2|COMPLETED|Overall Study||11
2258659|NCT02388321|5543630|P1|COMPLETED|Overall Study||11
2258660|NCT02388321|5543629|P2|STARTED|Overall Study||11
2258661|NCT02388321|5543630|P1|STARTED|Overall Study||11
2258662|NCT02388295|5543641|P3|NOT COMPLETED|Treatment Weeks 3 to 12||0
2258663|NCT02388295|5543642|P2|NOT COMPLETED|Treatment Weeks 3 to 12||1
2258664|NCT02388295|5543643|P1|NOT COMPLETED|Treatment Weeks 3 to 12||1
2258665|NCT02388295|5543641|P3|COMPLETED|Treatment Weeks 3 to 12||17
2258666|NCT02388295|5543642|P2|COMPLETED|Treatment Weeks 3 to 12||13
2258667|NCT02388295|5543643|P1|COMPLETED|Treatment Weeks 3 to 12||15
2258668|NCT02388295|5543641|P3|STARTED|Treatment Weeks 3 to 12||17
2258669|NCT02388295|5543642|P2|STARTED|Treatment Weeks 3 to 12||14
2258670|NCT02388295|5543643|P1|STARTED|Treatment Weeks 3 to 12||16
2258671|NCT02388295|5543641|P3|NOT COMPLETED|Dose Escalation Week 2||1
2258672|NCT02388295|5543642|P2|NOT COMPLETED|Dose Escalation Week 2||2
2258673|NCT02388295|5543643|P1|NOT COMPLETED|Dose Escalation Week 2||1
2258674|NCT02388295|5543641|P3|COMPLETED|Dose Escalation Week 2||17
2258675|NCT02388295|5543642|P2|COMPLETED|Dose Escalation Week 2||14
2258676|NCT02388295|5543643|P1|COMPLETED|Dose Escalation Week 2||16
2258677|NCT02388295|5543641|P3|STARTED|Dose Escalation Week 2||18
2258678|NCT02388295|5543642|P2|STARTED|Dose Escalation Week 2||16
2258679|NCT02388295|5543643|P1|STARTED|Dose Escalation Week 2||17
2258680|NCT02388295|5543641|P3|NOT COMPLETED|Dose Escalation Week 1||2
2258681|NCT02388295|5543642|P2|NOT COMPLETED|Dose Escalation Week 1||3
2258682|NCT02388295|5543643|P1|NOT COMPLETED|Dose Escalation Week 1||2
2258683|NCT02388295|5543641|P3|COMPLETED|Dose Escalation Week 1||18
2258684|NCT02388295|5543642|P2|COMPLETED|Dose Escalation Week 1||16
2258685|NCT02388295|5543643|P1|COMPLETED|Dose Escalation Week 1||17
2258686|NCT02388295|5543641|P3|STARTED|Dose Escalation Week 1|Number randomized to treatment|20
2258687|NCT02388295|5543642|P2|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
2258688|NCT02388295|5543643|P1|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
2258689|NCT02388269|5543661|P3|NOT COMPLETED|Overall Study||10
2258690|NCT02388269|5543662|P2|NOT COMPLETED|Overall Study||2
2258691|NCT02388269|5543663|P1|NOT COMPLETED|Overall Study||9
2258692|NCT02388269|5543661|P3|COMPLETED|Overall Study||0
2258693|NCT02388269|5543662|P2|COMPLETED|Overall Study||38
2258694|NCT02388269|5543663|P1|COMPLETED|Overall Study||32
2258695|NCT02388269|5543661|P3|Open Label|Overall Study||0
2258696|NCT02388269|5543662|P2|Open Label|Overall Study||38
2258697|NCT02388269|5543663|P1|Open Label|Overall Study||37
2258698|NCT02388269|5543661|P3|Randomised Period|Overall Study||0
2258699|NCT02388269|5543662|P2|Randomised Period|Overall Study||40
2258700|NCT02388269|5543663|P1|Randomised Period|Overall Study||41
2258701|NCT02388269|5543661|P3|STARTED|Overall Study||10
2258702|NCT02388269|5543662|P2|STARTED|Overall Study||40
2258703|NCT02388269|5543663|P1|STARTED|Overall Study||41
2258704|NCT02388191|5543695|P2|NOT COMPLETED|Overall Study||0
2258705|NCT02388191|5543696|P1|NOT COMPLETED|Overall Study||1
2258706|NCT02388191|5543695|P2|COMPLETED|Overall Study||60
2258707|NCT02388191|5543696|P1|COMPLETED|Overall Study||58
2258708|NCT02388191|5543695|P2|STARTED|Overall Study||60
2258709|NCT02388191|5543696|P1|STARTED|Overall Study||59
2258710|NCT02388074|5543710|P1|NOT COMPLETED|Overall Study||3
2258711|NCT02388074|5543710|P1|COMPLETED|Overall Study||22
2258712|NCT02388074|5543710|P1|STARTED|Overall Study||25
2258713|NCT02387996|5543714|P1|NOT COMPLETED|Overall Study||204
2258714|NCT02387996|5543714|P1|COMPLETED|Overall Study|Completed equals continuing in the Treatment Period|66
2258715|NCT02387996|5543714|P1|STARTED|Overall Study||270
2258716|NCT02387983|5543725|P1|NOT COMPLETED|Overall Study||7
2258717|NCT02387983|5543725|P1|COMPLETED|Overall Study||58
2258718|NCT02387983|5543725|P1|STARTED|Overall Study||65
2258725|NCT02387957|5543761|P3|NOT COMPLETED|Overall Study||20
2258726|NCT02387957|5543762|P2|NOT COMPLETED|Overall Study||21
2258727|NCT02387957|5543763|P1|NOT COMPLETED|Overall Study||21
2258728|NCT02387957|5543761|P3|COMPLETED|Overall Study|The study was discontinued|1
2258729|NCT02387957|5543762|P2|COMPLETED|Overall Study|The study was discontinued|0
2258730|NCT02387957|5543763|P1|COMPLETED|Overall Study|The study was discontinued|0
2258731|NCT02387957|5543761|P3|STARTED|Overall Study||21
2258732|NCT02387957|5543762|P2|STARTED|Overall Study||21
2258733|NCT02387957|5543763|P1|STARTED|Overall Study||21
2258734|NCT02387853|5543774|P1|NOT COMPLETED|Overall Study||3
2258735|NCT02387853|5543774|P1|COMPLETED|Overall Study||103
2258736|NCT02387853|5543774|P1|STARTED|Overall Study||106
2258737|NCT02387814|5543794|P4|NOT COMPLETED|Overall Study||0
2258738|NCT02387814|5543795|P3|NOT COMPLETED|Overall Study||0
2258739|NCT02387814|5543796|P2|NOT COMPLETED|Overall Study||0
2258740|NCT02387814|5543797|P1|NOT COMPLETED|Overall Study||0
2258741|NCT02387814|5543794|P4|COMPLETED|Overall Study||6
2258742|NCT02387814|5543795|P3|COMPLETED|Overall Study||10
2258743|NCT02387814|5543796|P2|COMPLETED|Overall Study||9
2258744|NCT02387814|5543797|P1|COMPLETED|Overall Study||10
2258745|NCT02387814|5543794|P4|Received Abemaciclib|Overall Study||6
2258746|NCT02387814|5543795|P3|Received Abemaciclib|Overall Study||10
2258747|NCT02387814|5543796|P2|Received Abemaciclib|Overall Study||9
2258748|NCT02387814|5543797|P1|Received Abemaciclib|Overall Study||10
2258749|NCT02387814|5543794|P4|STARTED|Overall Study||6
2258750|NCT02387814|5543795|P3|STARTED|Overall Study||10
2258751|NCT02387814|5543796|P2|STARTED|Overall Study||9
2258752|NCT02387814|5543797|P1|STARTED|Overall Study||10
2258753|NCT02387801|5543813|P2|NOT COMPLETED|Post-Treatment Follow-up||0
2258754|NCT02387801|5543814|P1|NOT COMPLETED|Post-Treatment Follow-up||0
2258755|NCT02387801|5543813|P2|COMPLETED|Post-Treatment Follow-up||12
2258756|NCT02387801|5543814|P1|COMPLETED|Post-Treatment Follow-up||0
2258757|NCT02387801|5543813|P2|STARTED|Post-Treatment Follow-up||12
2258758|NCT02387801|5543814|P1|STARTED|Post-Treatment Follow-up||0
2258759|NCT02387801|5543813|P2|NOT COMPLETED|Maintenance Dosing Period||0
2258760|NCT02387801|5543814|P1|NOT COMPLETED|Maintenance Dosing Period||0
2258761|NCT02387801|5543813|P2|COMPLETED|Maintenance Dosing Period||12
2258762|NCT02387801|5543814|P1|COMPLETED|Maintenance Dosing Period||0
2258763|NCT02387801|5543813|P2|STARTED|Maintenance Dosing Period||12
2258764|NCT02387801|5543814|P1|STARTED|Maintenance Dosing Period|All participants from Induction Dosing Period went to ixe Q4W arm during Maintenance Dosing Period.|0
2258765|NCT02387801|5543813|P2|NOT COMPLETED|Induction Dosing Period||0
2258766|NCT02387801|5543814|P1|NOT COMPLETED|Induction Dosing Period||0
2258767|NCT02387801|5543813|P2|COMPLETED|Induction Dosing Period||6
2258768|NCT02387801|5543814|P1|COMPLETED|Induction Dosing Period||6
2258769|NCT02387801|5543813|P2|STARTED|Induction Dosing Period||6
2258770|NCT02387801|5543814|P1|STARTED|Induction Dosing Period||6
2258771|NCT02387762|5543834|P2|NOT COMPLETED|Overall Study||0
2258772|NCT02387762|5543835|P1|NOT COMPLETED|Overall Study||1
2258773|NCT02387762|5543834|P2|COMPLETED|Overall Study||15
2258774|NCT02387762|5543835|P1|COMPLETED|Overall Study||15
2258775|NCT02387762|5543834|P2|STARTED|Overall Study||15
2258776|NCT02387762|5543835|P1|STARTED|Overall Study||16
2258777|NCT02387749|5543841|P1|NOT COMPLETED|Overall Study||0
2258778|NCT02387749|5543841|P1|COMPLETED|Overall Study||10
2258779|NCT02387749|5543841|P1|STARTED|Overall Study||10
2258780|NCT02387710|5543850|P2|NOT COMPLETED|Second Study Night||0
2258781|NCT02387710|5543851|P1|NOT COMPLETED|Second Study Night||0
2258782|NCT02387710|5543850|P2|COMPLETED|Second Study Night||7
2258783|NCT02387710|5543851|P1|COMPLETED|Second Study Night||9
2258784|NCT02387710|5543850|P2|STARTED|Second Study Night|2 patients did not come back for excessive sleep disruption due to the equipment|7
2258785|NCT02387710|5543851|P1|STARTED|Second Study Night||9
2258786|NCT02387710|5543850|P2|NOT COMPLETED|First Study Night||0
2258787|NCT02387710|5543851|P1|NOT COMPLETED|First Study Night||0
2258788|NCT02387710|5543850|P2|COMPLETED|First Study Night||9
2258789|NCT02387710|5543851|P1|COMPLETED|First Study Night||9
2258790|NCT02387710|5543850|P2|STARTED|First Study Night||9
2258791|NCT02387710|5543851|P1|STARTED|First Study Night||9
2258792|NCT02387580|5543867|P6|NOT COMPLETED|Overall Study||0
2258793|NCT02387580|5543868|P5|NOT COMPLETED|Overall Study||0
2258794|NCT02387580|5543869|P4|NOT COMPLETED|Overall Study||1
2258795|NCT02387580|5543870|P3|NOT COMPLETED|Overall Study||0
2258796|NCT02387580|5543871|P2|NOT COMPLETED|Overall Study||0
2258797|NCT02387580|5543872|P1|NOT COMPLETED|Overall Study||0
2258798|NCT02387580|5543867|P6|COMPLETED|Overall Study||8
2258799|NCT02387580|5543868|P5|COMPLETED|Overall Study||8
2258800|NCT02387580|5543869|P4|COMPLETED|Overall Study||7
2258801|NCT02387580|5543870|P3|COMPLETED|Overall Study||8
2258802|NCT02387580|5543871|P2|COMPLETED|Overall Study||8
2258803|NCT02387580|5543872|P1|COMPLETED|Overall Study||8
2258804|NCT02387580|5543867|P6|STARTED|Overall Study||8
2258805|NCT02387580|5543868|P5|STARTED|Overall Study||8
2258806|NCT02387580|5543869|P4|STARTED|Overall Study||8
2258807|NCT02387580|5543870|P3|STARTED|Overall Study||8
2258808|NCT02387580|5543871|P2|STARTED|Overall Study||8
2258809|NCT02387580|5543872|P1|STARTED|Overall Study||8
2258810|NCT02387554|5543908|P4|NOT COMPLETED|Overall Study||2
2258811|NCT02387554|5543909|P3|NOT COMPLETED|Overall Study||2
2258812|NCT02387554|5543910|P2|NOT COMPLETED|Overall Study||0
2258813|NCT02387554|5543911|P1|NOT COMPLETED|Overall Study||3
2258814|NCT02387554|5543908|P4|COMPLETED|Overall Study||6
2258815|NCT02387554|5543909|P3|COMPLETED|Overall Study||6
2258816|NCT02387554|5543910|P2|COMPLETED|Overall Study||7
2258817|NCT02387554|5543911|P1|COMPLETED|Overall Study||7
2258818|NCT02387554|5543908|P4|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
2258819|NCT02387554|5543909|P3|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
2258820|NCT02387554|5543910|P2|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|7
2258821|NCT02387554|5543911|P1|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|10
2258822|NCT02387502|5543924|P3|NOT COMPLETED|Overall Study||0
2258823|NCT02387502|5543925|P2|NOT COMPLETED|Overall Study||0
2258824|NCT02387502|5543926|P1|NOT COMPLETED|Overall Study||0
2258825|NCT02387502|5543924|P3|COMPLETED|Overall Study||40
2258826|NCT02387502|5543925|P2|COMPLETED|Overall Study||40
2258827|NCT02387502|5543926|P1|COMPLETED|Overall Study||40
2258828|NCT02387502|5543924|P3|STARTED|Overall Study||40
2258829|NCT02387502|5543925|P2|STARTED|Overall Study||40
2258830|NCT02387502|5543926|P1|STARTED|Overall Study||40
2258831|NCT02387476|5543936|P2|NOT COMPLETED|Overall Study||5
2258832|NCT02387476|5543937|P1|NOT COMPLETED|Overall Study||6
2258833|NCT02387476|5543936|P2|COMPLETED|Overall Study||17
2258834|NCT02387476|5543937|P1|COMPLETED|Overall Study||19
2258835|NCT02387476|5543936|P2|STARTED|Overall Study||22
2258836|NCT02387476|5543937|P1|STARTED|Overall Study||25
2258837|NCT02387372|5543965|P2|NOT COMPLETED|Overall Study||0
2258838|NCT02387372|5543966|P1|NOT COMPLETED|Overall Study||1
2258839|NCT02387372|5543965|P2|COMPLETED|Overall Study||10
2258840|NCT02387372|5543966|P1|COMPLETED|Overall Study||26
2258841|NCT02387372|5543965|P2|Treated|Overall Study||10
2258842|NCT02387372|5543966|P1|Treated|Overall Study||26
2258843|NCT02387372|5543965|P2|STARTED|Overall Study||10
2258844|NCT02387372|5543966|P1|STARTED|Overall Study||27
2258845|NCT02387359|5544015|P3|NOT COMPLETED|Overall Study||56
2258846|NCT02387359|5544016|P2|NOT COMPLETED|Overall Study||42
2258847|NCT02387359|5544017|P1|NOT COMPLETED|Overall Study||59
2258848|NCT02387359|5544015|P3|COMPLETED|Overall Study||293
2258849|NCT02387359|5544016|P2|COMPLETED|Overall Study||309
2258850|NCT02387359|5544017|P1|COMPLETED|Overall Study||295
2258851|NCT02387359|5544015|P3|STARTED|Overall Study||349
2258852|NCT02387359|5544016|P2|STARTED|Overall Study||351
2258853|NCT02387359|5544017|P1|STARTED|Overall Study||354
2258854|NCT02387268|5544049|P1|NOT COMPLETED|Overall Study||1
2258855|NCT02387268|5544049|P1|COMPLETED|Overall Study||9
2258856|NCT02387268|5544049|P1|STARTED|Overall Study||10
2258857|NCT02387008|5544057|P3|NOT COMPLETED|Overall Study||0
2258858|NCT02387008|5544058|P2|NOT COMPLETED|Overall Study||0
2258859|NCT02387008|5544059|P1|NOT COMPLETED|Overall Study||0
2258860|NCT02387008|5544057|P3|COMPLETED|Overall Study||4
2258861|NCT02387008|5544058|P2|COMPLETED|Overall Study||0
2258862|NCT02387008|5544059|P1|COMPLETED|Overall Study||2
2258863|NCT02387008|5544057|P3|STARTED|Overall Study||4
2258864|NCT02387008|5544058|P2|STARTED|Overall Study||0
2258865|NCT02387008|5544059|P1|STARTED|Overall Study||2
2258866|NCT02386345|5544076|P1|NOT COMPLETED|Overall Study||102
2258867|NCT02386345|5544076|P1|COMPLETED|Overall Study||197
2258868|NCT02386345|5544076|P1|STARTED|Overall Study||299
2258869|NCT02386189|5544086|P2|NOT COMPLETED|Overall Study||3
2258870|NCT02386189|5544087|P1|NOT COMPLETED|Overall Study||4
2258871|NCT02386189|5544086|P2|COMPLETED|Overall Study||30
2258872|NCT02386189|5544087|P1|COMPLETED|Overall Study||26
2258873|NCT02386189|5544086|P2|STARTED|Overall Study||33
2258874|NCT02386189|5544087|P1|STARTED|Overall Study||30
2258875|NCT02386098|5544110|P5|NOT COMPLETED|Stage 2 (96 Weeks)||0
2258876|NCT02386098|5544111|P4|NOT COMPLETED|Stage 2 (96 Weeks)||0
2258877|NCT02386098|5544112|P3|NOT COMPLETED|Stage 2 (96 Weeks)||0
2258878|NCT02386098|5544113|P2|NOT COMPLETED|Stage 2 (96 Weeks)||0
2258879|NCT02386098|5544114|P1|NOT COMPLETED|Stage 2 (96 Weeks)||0
2258880|NCT02386098|5544110|P5|COMPLETED|Stage 2 (96 Weeks)||0
2258881|NCT02386098|5544111|P4|COMPLETED|Stage 2 (96 Weeks)||0
2258882|NCT02386098|5544112|P3|COMPLETED|Stage 2 (96 Weeks)||0
2258883|NCT02386098|5544113|P2|COMPLETED|Stage 2 (96 Weeks)||0
2258884|NCT02386098|5544114|P1|COMPLETED|Stage 2 (96 Weeks)||0
2258885|NCT02386098|5544110|P5|STARTED|Stage 2 (96 Weeks)||0
2258886|NCT02386098|5544111|P4|STARTED|Stage 2 (96 Weeks)||0
2258887|NCT02386098|5544112|P3|STARTED|Stage 2 (96 Weeks)||0
2258888|NCT02386098|5544113|P2|STARTED|Stage 2 (96 Weeks)||0
2258889|NCT02386098|5544114|P1|STARTED|Stage 2 (96 Weeks)||0
2258890|NCT02386098|5544110|P5|NOT COMPLETED|Stage 1 (96 Weeks)||0
2258891|NCT02386098|5544111|P4|NOT COMPLETED|Stage 1 (96 Weeks)||0
2258892|NCT02386098|5544112|P3|NOT COMPLETED|Stage 1 (96 Weeks)||0
2258893|NCT02386098|5544113|P2|NOT COMPLETED|Stage 1 (96 Weeks)||43
2258894|NCT02386098|5544114|P1|NOT COMPLETED|Stage 1 (96 Weeks)||43
2258895|NCT02386098|5544110|P5|COMPLETED|Stage 1 (96 Weeks)||0
2258896|NCT02386098|5544111|P4|COMPLETED|Stage 1 (96 Weeks)||0
2258897|NCT02386098|5544112|P3|COMPLETED|Stage 1 (96 Weeks)||0
2258898|NCT02386098|5544113|P2|COMPLETED|Stage 1 (96 Weeks)||0
2258899|NCT02386098|5544114|P1|COMPLETED|Stage 1 (96 Weeks)||0
2258900|NCT02386098|5544110|P5|STARTED|Stage 1 (96 Weeks)||0
2258901|NCT02386098|5544111|P4|STARTED|Stage 1 (96 Weeks)||0
2258902|NCT02386098|5544112|P3|STARTED|Stage 1 (96 Weeks)||0
2258903|NCT02386098|5544113|P2|STARTED|Stage 1 (96 Weeks)||43
2258904|NCT02386098|5544114|P1|STARTED|Stage 1 (96 Weeks)||43
2258905|NCT02385799|5544193|P2|NOT COMPLETED|Overall Study||8
2258906|NCT02385799|5544194|P1|NOT COMPLETED|Overall Study||5
2258907|NCT02385799|5544193|P2|COMPLETED|Overall Study||24
2258908|NCT02385799|5544194|P1|COMPLETED|Overall Study||21
2258909|NCT02385799|5544193|P2|Completed End-of-Treatment Visit|Overall Study||26
2258910|NCT02385799|5544194|P1|Completed End-of-Treatment Visit|Overall Study||21
2258911|NCT02385799|5544193|P2|STARTED|Overall Study||32
2258912|NCT02385799|5544194|P1|STARTED|Overall Study||26
2258913|NCT02385721|5544228|P1|NOT COMPLETED|Overall Study||230
2258914|NCT02385721|5544228|P1|COMPLETED|Overall Study||371
2258915|NCT02385721|5544228|P1|STARTED|Overall Study||601
2258916|NCT02385708|5544235|P2|NOT COMPLETED|Overall Study||15
2258917|NCT02385708|5544236|P1|NOT COMPLETED|Overall Study||8
2258918|NCT02385708|5544235|P2|COMPLETED|Overall Study||67
2258919|NCT02385708|5544236|P1|COMPLETED|Overall Study||73
2258920|NCT02385708|5544235|P2|Intervention Started|Overall Study||82
2258921|NCT02385708|5544236|P1|Intervention Started|Overall Study||81
2258922|NCT02385708|5544235|P2|STARTED|Overall Study||82
2258923|NCT02385708|5544236|P1|STARTED|Overall Study||81
2258924|NCT02385669|5544242|P1|NOT COMPLETED|Overall Study||2
2258925|NCT02385669|5544242|P1|COMPLETED|Overall Study||1
2258926|NCT02385669|5544242|P1|STARTED|Overall Study||3
2258927|NCT02385526|5544250|P3|NOT COMPLETED|Overall Study||0
2258928|NCT02385526|5544251|P2|NOT COMPLETED|Overall Study||3
2258929|NCT02385526|5544252|P1|NOT COMPLETED|Overall Study||2
2258930|NCT02385526|5544250|P3|COMPLETED|Overall Study||20
2258931|NCT02385526|5544251|P2|COMPLETED|Overall Study||17
2258932|NCT02385526|5544252|P1|COMPLETED|Overall Study||20
2258933|NCT02385526|5544250|P3|STARTED|Overall Study||20
2258934|NCT02385526|5544251|P2|STARTED|Overall Study||20
2258935|NCT02385526|5544252|P1|STARTED|Overall Study||22
2258936|NCT02385084|5544260|P6|NOT COMPLETED|Period 3||0
2258937|NCT02385084|5544261|P5|NOT COMPLETED|Period 3||0
2258938|NCT02385084|5544262|P4|NOT COMPLETED|Period 3||0
2258939|NCT02385084|5544263|P3|NOT COMPLETED|Period 3||0
2258940|NCT02385084|5544264|P2|NOT COMPLETED|Period 3||0
2258941|NCT02385084|5544265|P1|NOT COMPLETED|Period 3||0
2258942|NCT02385084|5544260|P6|COMPLETED|Period 3||3
2258943|NCT02385084|5544261|P5|COMPLETED|Period 3||2
2258944|NCT02385084|5544262|P4|COMPLETED|Period 3||3
2258945|NCT02385084|5544263|P3|COMPLETED|Period 3||1
2258946|NCT02385084|5544264|P2|COMPLETED|Period 3||3
2258947|NCT02385084|5544265|P1|COMPLETED|Period 3||2
2258948|NCT02385084|5544260|P6|Washout|Period 3||3
2258949|NCT02385084|5544261|P5|Washout|Period 3||2
2258950|NCT02385084|5544262|P4|Washout|Period 3||3
2258951|NCT02385084|5544263|P3|Washout|Period 3||1
2258952|NCT02385084|5544264|P2|Washout|Period 3||3
2258953|NCT02385084|5544265|P1|Washout|Period 3||2
2258954|NCT02385084|5544260|P6|Received LY2409021|Period 3||3
2258955|NCT02385084|5544261|P5|Received LY2409021|Period 3||2
2258956|NCT02385084|5544262|P4|Received LY2409021|Period 3||3
2258957|NCT02385084|5544263|P3|Received LY2409021|Period 3||1
2258958|NCT02385084|5544264|P2|Received LY2409021|Period 3||3
2258959|NCT02385084|5544265|P1|Received LY2409021|Period 3||2
2258960|NCT02385084|5544260|P6|STARTED|Period 3||3
2258961|NCT02385084|5544261|P5|STARTED|Period 3|1 participant discontinued after Period 2 - adverse event. Did not enter Period 3.|2
2258962|NCT02385084|5544262|P4|STARTED|Period 3||3
2258963|NCT02385084|5544263|P3|STARTED|Period 3|1 participant discontinued after Period 2 - adverse event. Did not enter Period 3.|1
2258964|NCT02385084|5544264|P2|STARTED|Period 3||3
2258965|NCT02385084|5544265|P1|STARTED|Period 3||2
2258966|NCT02385084|5544260|P6|NOT COMPLETED|Period 2||0
2258967|NCT02385084|5544261|P5|NOT COMPLETED|Period 2||0
2258968|NCT02385084|5544262|P4|NOT COMPLETED|Period 2||0
2258969|NCT02385084|5544263|P3|NOT COMPLETED|Period 2||1
2258970|NCT02385084|5544264|P2|NOT COMPLETED|Period 2||0
2258971|NCT02385084|5544265|P1|NOT COMPLETED|Period 2||0
2258972|NCT02385084|5544260|P6|COMPLETED|Period 2||3
2258973|NCT02385084|5544261|P5|COMPLETED|Period 2||3
2258974|NCT02385084|5544262|P4|COMPLETED|Period 2||3
2258975|NCT02385084|5544263|P3|COMPLETED|Period 2||2
2258976|NCT02385084|5544264|P2|COMPLETED|Period 2||3
2258977|NCT02385084|5544265|P1|COMPLETED|Period 2||2
2258978|NCT02385084|5544260|P6|Washout|Period 2||3
2258979|NCT02385084|5544261|P5|Washout|Period 2||3
2258980|NCT02385084|5544262|P4|Washout|Period 2||3
2258981|NCT02385084|5544263|P3|Washout|Period 2||3
2258982|NCT02385084|5544264|P2|Washout|Period 2||3
2258983|NCT02385084|5544265|P1|Washout|Period 2||2
2258984|NCT02385084|5544260|P6|Received LY2409021|Period 2||3
2258985|NCT02385084|5544261|P5|Received LY2409021|Period 2||3
2258986|NCT02385084|5544262|P4|Received LY2409021|Period 2||3
2258987|NCT02385084|5544263|P3|Received LY2409021|Period 2||3
2258988|NCT02385084|5544264|P2|Received LY2409021|Period 2||3
2258989|NCT02385084|5544265|P1|Received LY2409021|Period 2||2
2258990|NCT02385084|5544260|P6|STARTED|Period 2||3
2258991|NCT02385084|5544261|P5|STARTED|Period 2||3
2258992|NCT02385084|5544262|P4|STARTED|Period 2||3
2258993|NCT02385084|5544263|P3|STARTED|Period 2||3
2258994|NCT02385084|5544264|P2|STARTED|Period 2||3
2258995|NCT02385084|5544265|P1|STARTED|Period 2|1 participant discontinued after Period 1 - physician decision. Did not enter Period 2.|2
2258996|NCT02385084|5544260|P6|NOT COMPLETED|Period 1||0
2258997|NCT02385084|5544261|P5|NOT COMPLETED|Period 1||0
2258998|NCT02385084|5544262|P4|NOT COMPLETED|Period 1||0
2258999|NCT02385084|5544263|P3|NOT COMPLETED|Period 1||0
2259000|NCT02385084|5544264|P2|NOT COMPLETED|Period 1||0
2259001|NCT02385084|5544265|P1|NOT COMPLETED|Period 1||0
2259002|NCT02385084|5544260|P6|COMPLETED|Period 1||3
2259003|NCT02385084|5544261|P5|COMPLETED|Period 1||3
2259004|NCT02385084|5544262|P4|COMPLETED|Period 1||3
2259005|NCT02385084|5544263|P3|COMPLETED|Period 1||3
2259006|NCT02385084|5544264|P2|COMPLETED|Period 1||3
2259007|NCT02385084|5544265|P1|COMPLETED|Period 1||3
2259008|NCT02385084|5544260|P6|Washout|Period 1||3
2259009|NCT02385084|5544261|P5|Washout|Period 1||3
2259010|NCT02385084|5544262|P4|Washout|Period 1||3
2259011|NCT02385084|5544263|P3|Washout|Period 1||3
2259012|NCT02385084|5544264|P2|Washout|Period 1||3
2259013|NCT02385084|5544265|P1|Washout|Period 1||3
2259014|NCT02385084|5544260|P6|Received LY2409021|Period 1||3
2259015|NCT02385084|5544261|P5|Received LY2409021|Period 1||3
2259016|NCT02385084|5544262|P4|Received LY2409021|Period 1||3
2259017|NCT02385084|5544263|P3|Received LY2409021|Period 1||3
2259018|NCT02385084|5544264|P2|Received LY2409021|Period 1||3
2259019|NCT02385084|5544265|P1|Received LY2409021|Period 1||3
2259020|NCT02385084|5544260|P6|STARTED|Period 1||3
2259021|NCT02385084|5544261|P5|STARTED|Period 1||3
2259022|NCT02385084|5544262|P4|STARTED|Period 1||3
2259023|NCT02385084|5544263|P3|STARTED|Period 1||3
2259024|NCT02385084|5544264|P2|STARTED|Period 1||3
2259025|NCT02385084|5544265|P1|STARTED|Period 1||3
2259026|NCT02384941|5544279|P3|NOT COMPLETED|Overall Study||41
2259027|NCT02384941|5544280|P2|NOT COMPLETED|Overall Study||35
2259028|NCT02384941|5544281|P1|NOT COMPLETED|Overall Study||50
2259029|NCT02384941|5544279|P3|COMPLETED|Overall Study||221
2259030|NCT02384941|5544280|P2|COMPLETED|Overall Study||228
2259031|NCT02384941|5544281|P1|COMPLETED|Overall Study||218
2259032|NCT02384941|5544279|P3|STARTED|Overall Study||262
2259033|NCT02384941|5544280|P2|STARTED|Overall Study||263
2259034|NCT02384941|5544281|P1|STARTED|Overall Study||268
2259035|NCT02384538|5544312|P2|NOT COMPLETED|Overall Study||15
2259036|NCT02384538|5544313|P1|NOT COMPLETED|Overall Study||6
2259037|NCT02384538|5544312|P2|COMPLETED|Overall Study||49
2259038|NCT02384538|5544313|P1|COMPLETED|Overall Study||61
2259039|NCT02384538|5544312|P2|STARTED|Overall Study||64
2259040|NCT02384538|5544313|P1|STARTED|Overall Study||67
2259041|NCT02384460|5544333|P2|NOT COMPLETED|Overall Study||7
2259042|NCT02384460|5544334|P1|NOT COMPLETED|Overall Study||7
2259043|NCT02384460|5544333|P2|COMPLETED|Overall Study||80
2259044|NCT02384460|5544334|P1|COMPLETED|Overall Study||75
2259045|NCT02384460|5544333|P2|Received at Least 1 Dose of Study Drug|Overall Study||87
2259046|NCT02384460|5544334|P1|Received at Least 1 Dose of Study Drug|Overall Study||82
2259047|NCT02384460|5544333|P2|STARTED|Overall Study||87
2259048|NCT02384460|5544334|P1|STARTED|Overall Study||82
2259049|NCT02384200|5544354|P2|NOT COMPLETED|Overall Study||0
2259050|NCT02384200|5544355|P1|NOT COMPLETED|Overall Study||0
2259051|NCT02384200|5544354|P2|COMPLETED|Overall Study||43
2259052|NCT02384200|5544355|P1|COMPLETED|Overall Study||43
2259053|NCT02384200|5544354|P2|STARTED|Overall Study||43
2259054|NCT02384200|5544355|P1|STARTED|Overall Study||43
2259055|NCT02384096|5544381|P2|NOT COMPLETED|Second Intervention (7 Days)||1
2259056|NCT02384096|5544382|P1|NOT COMPLETED|Second Intervention (7 Days)||0
2259057|NCT02384096|5544381|P2|COMPLETED|Second Intervention (7 Days)||6
2259058|NCT02384096|5544382|P1|COMPLETED|Second Intervention (7 Days)||4
2259059|NCT02384096|5544381|P2|STARTED|Second Intervention (7 Days)||7
2259060|NCT02384096|5544382|P1|STARTED|Second Intervention (7 Days)||4
2259061|NCT02384096|5544381|P2|NOT COMPLETED|First Intervention (7 Days)||0
2259062|NCT02384096|5544382|P1|NOT COMPLETED|First Intervention (7 Days)||1
2259063|NCT02384096|5544381|P2|COMPLETED|First Intervention (7 Days)||7
2259064|NCT02384096|5544382|P1|COMPLETED|First Intervention (7 Days)||4
2259065|NCT02384096|5544381|P2|STARTED|First Intervention (7 Days)||7
2259066|NCT02384096|5544382|P1|STARTED|First Intervention (7 Days)||5
2259067|NCT02384070|5544390|P3|NOT COMPLETED|Overall Study||0
2259068|NCT02384070|5544391|P2|NOT COMPLETED|Overall Study||0
2259069|NCT02384070|5544392|P1|NOT COMPLETED|Overall Study||0
2259070|NCT02384070|5544390|P3|COMPLETED|Overall Study||100
2259071|NCT02384070|5544391|P2|COMPLETED|Overall Study||100
2259072|NCT02384070|5544392|P1|COMPLETED|Overall Study||100
2259073|NCT02384070|5544390|P3|STARTED|Overall Study||100
2259074|NCT02384070|5544391|P2|STARTED|Overall Study||100
2259075|NCT02384070|5544392|P1|STARTED|Overall Study||100
2259076|NCT02384044|5544408|P2|NOT COMPLETED|Overall Study||0
2259077|NCT02384044|5544409|P1|NOT COMPLETED|Overall Study||0
2259078|NCT02384044|5544408|P2|COMPLETED|Overall Study||15
2259079|NCT02384044|5544409|P1|COMPLETED|Overall Study||15
2259080|NCT02384044|5544408|P2|STARTED|Overall Study||15
2259081|NCT02384044|5544409|P1|STARTED|Overall Study||15
2259082|NCT02383966|5544419|P2|NOT COMPLETED|Overall Study||7
2259083|NCT02383966|5544420|P1|NOT COMPLETED|Overall Study||26
2259084|NCT02383966|5544419|P2|COMPLETED|Overall Study||72
2259085|NCT02383966|5544420|P1|COMPLETED|Overall Study||138
2259086|NCT02383966|5544419|P2|STARTED|Overall Study||79
2259087|NCT02383966|5544420|P1|STARTED|Overall Study||164
2259088|NCT02383940|5544440|P2|NOT COMPLETED|Overall Study||3
2259089|NCT02383940|5544441|P1|NOT COMPLETED|Overall Study||9
2259090|NCT02383940|5544440|P2|COMPLETED|Overall Study||40
2259091|NCT02383940|5544441|P1|COMPLETED|Overall Study||35
2259092|NCT02383940|5544440|P2|Treated|Overall Study||43
2259093|NCT02383940|5544441|P1|Treated|Overall Study||42
2259094|NCT02383940|5544440|P2|STARTED|Overall Study||43
2259095|NCT02383940|5544441|P1|STARTED|Overall Study||44
2259096|NCT02383862|5544457|P2|NOT COMPLETED|3 Month Follow up||21
2259097|NCT02383862|5544458|P1|NOT COMPLETED|3 Month Follow up||23
2259098|NCT02383862|5544457|P2|COMPLETED|3 Month Follow up||128
2259099|NCT02383862|5544458|P1|COMPLETED|3 Month Follow up||128
2259100|NCT02383862|5544457|P2|STARTED|3 Month Follow up||149
2259101|NCT02383862|5544458|P1|STARTED|3 Month Follow up||151
2259102|NCT02383862|5544457|P2|NOT COMPLETED|Baseline||0
2259103|NCT02383862|5544458|P1|NOT COMPLETED|Baseline||0
2259104|NCT02383862|5544457|P2|COMPLETED|Baseline||149
2259105|NCT02383862|5544458|P1|COMPLETED|Baseline||151
2259106|NCT02383862|5544457|P2|STARTED|Baseline||149
2259107|NCT02383862|5544458|P1|STARTED|Baseline||151
2259108|NCT02383758|5544491|P2|NOT COMPLETED|Overall Study||2
2259109|NCT02383758|5544492|P1|NOT COMPLETED|Overall Study||0
2259110|NCT02383758|5544491|P2|COMPLETED|Overall Study||8
2259111|NCT02383758|5544492|P1|COMPLETED|Overall Study||10
2259112|NCT02383758|5544491|P2|STARTED|Overall Study||10
2259113|NCT02383758|5544492|P1|STARTED|Overall Study||10
2259114|NCT02383719|5544504|P1|NOT COMPLETED|Overall Study||0
2259115|NCT02383719|5544504|P1|COMPLETED|Overall Study||18
2259116|NCT02383719|5544504|P1|STARTED|Overall Study||18
2259117|NCT02383706|5544508|P1|NOT COMPLETED|Overall Study||28
2259118|NCT02383706|5544508|P1|COMPLETED|Overall Study||80
2259119|NCT02383706|5544508|P1|STARTED|Overall Study||108
2259120|NCT02383667|5544514|P1|NOT COMPLETED|Overall Study||0
2259121|NCT02383667|5544514|P1|COMPLETED|Overall Study||20
2259122|NCT02383667|5544514|P1|STARTED|Overall Study||20
2259123|NCT02383589|5544520|P2|NOT COMPLETED|Overall Study||10
2259124|NCT02383589|5544521|P1|NOT COMPLETED|Overall Study||1
2259125|NCT02383589|5544520|P2|COMPLETED|Overall Study||58
2259126|NCT02383589|5544521|P1|COMPLETED|Overall Study||66
2259127|NCT02383589|5544520|P2|STARTED|Overall Study||68
2259128|NCT02383589|5544521|P1|STARTED|Overall Study||67
2259129|NCT02383576|5544544|P2|NOT COMPLETED|Overall Study||45
2259130|NCT02383576|5544545|P1|NOT COMPLETED|Overall Study||63
2259131|NCT02383576|5544544|P2|COMPLETED|Overall Study||46
2259132|NCT02383576|5544545|P1|COMPLETED|Overall Study||31
2259133|NCT02383576|5544544|P2|STARTED|Overall Study||91
2259134|NCT02383576|5544545|P1|STARTED|Overall Study||94
2259135|NCT02383472|5544561|P2|NOT COMPLETED|Overall Study||1
2259136|NCT02383472|5544562|P1|NOT COMPLETED|Overall Study||1
2259137|NCT02383472|5544561|P2|COMPLETED|Overall Study||29
2259138|NCT02383472|5544562|P1|COMPLETED|Overall Study||22
2259139|NCT02383472|5544561|P2|STARTED|Overall Study||30
2259140|NCT02383472|5544562|P1|STARTED|Overall Study||23
2259141|NCT02383433|5544576|P1|NOT COMPLETED|Overall Study||2
2259142|NCT02383433|5544576|P1|COMPLETED|Overall Study||0
2259143|NCT02383433|5544576|P1|STARTED|Overall Study||2
2259144|NCT02383420|5544583|P3|NOT COMPLETED|Overall Study||0
2259145|NCT02383420|5544584|P2|NOT COMPLETED|Overall Study||0
2259146|NCT02383420|5544585|P1|NOT COMPLETED|Overall Study||2
2259147|NCT02383420|5544583|P3|COMPLETED|Overall Study||3
2259148|NCT02383420|5544584|P2|COMPLETED|Overall Study||10
2259149|NCT02383420|5544585|P1|COMPLETED|Overall Study||8
2259150|NCT02383420|5544583|P3|STARTED|Overall Study||3
2259151|NCT02383420|5544584|P2|STARTED|Overall Study||10
2259152|NCT02383420|5544585|P1|STARTED|Overall Study||10
2259153|NCT02383355|5544595|P2|NOT COMPLETED|Overall Study||0
2259154|NCT02383355|5544596|P1|NOT COMPLETED|Overall Study||2
2259155|NCT02383355|5544595|P2|COMPLETED|Overall Study||21
2259156|NCT02383355|5544596|P1|COMPLETED|Overall Study||17
2259157|NCT02383355|5544595|P2|STARTED|Overall Study||21
2259158|NCT02383355|5544596|P1|STARTED|Overall Study||19
2259159|NCT02383056|5544612|P2|NOT COMPLETED|Overall Study||2
2259160|NCT02383056|5544613|P1|NOT COMPLETED|Overall Study||1
2259161|NCT02383056|5544612|P2|COMPLETED|Overall Study||5
2259162|NCT02383056|5544613|P1|COMPLETED|Overall Study||6
2259163|NCT02383056|5544612|P2|STARTED|Overall Study||7
2259164|NCT02383056|5544613|P1|STARTED|Overall Study||7
2259165|NCT02383043|5544626|P3|NOT COMPLETED|Overall Study||0
2259166|NCT02383043|5544627|P2|NOT COMPLETED|Overall Study||0
2259167|NCT02383043|5544628|P1|NOT COMPLETED|Overall Study||2
2259168|NCT02383043|5544626|P3|COMPLETED|Overall Study||4
2259169|NCT02383043|5544627|P2|COMPLETED|Overall Study||5
2259170|NCT02383043|5544628|P1|COMPLETED|Overall Study||7
2259171|NCT02383043|5544626|P3|STARTED|Overall Study||4
2259172|NCT02383043|5544627|P2|STARTED|Overall Study||5
2259173|NCT02383043|5544628|P1|STARTED|Overall Study||9
2259174|NCT02382991|5544639|P2|NOT COMPLETED|Overall Study||3
2259175|NCT02382991|5544640|P1|NOT COMPLETED|Overall Study||2
2259176|NCT02382991|5544639|P2|COMPLETED|Overall Study||15
2259177|NCT02382991|5544640|P1|COMPLETED|Overall Study||15
2259178|NCT02382991|5544639|P2|STARTED|Overall Study||18
2259179|NCT02382991|5544640|P1|STARTED|Overall Study||17
2259180|NCT02382913|5544660|P10|NOT COMPLETED|Overall Study||0
2259181|NCT02382913|5544661|P9|NOT COMPLETED|Overall Study||0
2259182|NCT02382913|5544662|P8|NOT COMPLETED|Overall Study||0
2259183|NCT02382913|5544663|P7|NOT COMPLETED|Overall Study||0
2259184|NCT02382913|5544664|P6|NOT COMPLETED|Overall Study||0
2259185|NCT02382913|5544665|P5|NOT COMPLETED|Overall Study||0
2259186|NCT02382913|5544666|P4|NOT COMPLETED|Overall Study||0
2259187|NCT02382913|5544667|P3|NOT COMPLETED|Overall Study||0
2259188|NCT02382913|5544668|P2|NOT COMPLETED|Overall Study||0
2259189|NCT02382913|5544669|P1|NOT COMPLETED|Overall Study||0
2259190|NCT02382913|5544660|P10|COMPLETED|Overall Study||33
2259191|NCT02382913|5544661|P9|COMPLETED|Overall Study||30
2259192|NCT02382913|5544662|P8|COMPLETED|Overall Study||30
2259193|NCT02382913|5544663|P7|COMPLETED|Overall Study||37
2259194|NCT02382913|5544664|P6|COMPLETED|Overall Study||30
2259195|NCT02382913|5544665|P5|COMPLETED|Overall Study||33
2259196|NCT02382913|5544666|P4|COMPLETED|Overall Study||27
2259197|NCT02382913|5544667|P3|COMPLETED|Overall Study||32
2259198|NCT02382913|5544668|P2|COMPLETED|Overall Study||36
2259199|NCT02382913|5544669|P1|COMPLETED|Overall Study||27
2259200|NCT02382913|5544660|P10|STARTED|Overall Study||33
2259201|NCT02382913|5544661|P9|STARTED|Overall Study||30
2259202|NCT02382913|5544662|P8|STARTED|Overall Study||30
2259203|NCT02382913|5544663|P7|STARTED|Overall Study||37
2259204|NCT02382913|5544664|P6|STARTED|Overall Study||30
2259205|NCT02382913|5544665|P5|STARTED|Overall Study||33
2259206|NCT02382913|5544666|P4|STARTED|Overall Study||27
2259207|NCT02382913|5544667|P3|STARTED|Overall Study||32
2259208|NCT02382913|5544668|P2|STARTED|Overall Study||36
2259209|NCT02382913|5544669|P1|STARTED|Overall Study||27
2259210|NCT02382848|5544705|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
2259211|NCT02382848|5544706|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
2259212|NCT02382848|5544705|P2|COMPLETED|Second Intervention (3 Weeks)||5
2259213|NCT02382848|5544706|P1|COMPLETED|Second Intervention (3 Weeks)||3
2259214|NCT02382848|5544705|P2|STARTED|Second Intervention (3 Weeks)||5
2259215|NCT02382848|5544706|P1|STARTED|Second Intervention (3 Weeks)||3
2259216|NCT02382848|5544705|P2|NOT COMPLETED|Washout (1 Week)||0
2259217|NCT02382848|5544706|P1|NOT COMPLETED|Washout (1 Week)||0
2259218|NCT02382848|5544705|P2|COMPLETED|Washout (1 Week)||5
2259219|NCT02382848|5544706|P1|COMPLETED|Washout (1 Week)||3
2259220|NCT02382848|5544705|P2|STARTED|Washout (1 Week)||5
2259221|NCT02382848|5544706|P1|STARTED|Washout (1 Week)||3
2259222|NCT02382848|5544705|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
2259223|NCT02382848|5544706|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
2259224|NCT02382848|5544705|P2|COMPLETED|First Intervention (3 Weeks)||5
2259225|NCT02382848|5544706|P1|COMPLETED|First Intervention (3 Weeks)||3
2259226|NCT02382848|5544705|P2|STARTED|First Intervention (3 Weeks)||5
2259227|NCT02382848|5544706|P1|STARTED|First Intervention (3 Weeks)||3
2259228|NCT02382744|5544724|P2|NOT COMPLETED|Overall Study||0
2259229|NCT02382744|5544725|P1|NOT COMPLETED|Overall Study||0
2259230|NCT02382744|5544724|P2|COMPLETED|Overall Study||40
2259231|NCT02382744|5544725|P1|COMPLETED|Overall Study||40
2259232|NCT02382744|5544724|P2|Analyzed|Overall Study||40
2259233|NCT02382744|5544725|P1|Analyzed|Overall Study||40
2259234|NCT02382744|5544724|P2|Allocated|Overall Study||40
2259235|NCT02382744|5544725|P1|Allocated|Overall Study||40
2259236|NCT02382744|5544724|P2|STARTED|Overall Study||40
2259237|NCT02382744|5544725|P1|STARTED|Overall Study||40
2259238|NCT02382705|5544756|P1|NOT COMPLETED|Overall Study||24
2259239|NCT02382705|5544756|P1|COMPLETED|Overall Study||33
2259240|NCT02382705|5544756|P1|STARTED|Overall Study||57
2259241|NCT02382640|5544767|P4|NOT COMPLETED|Intervention Period 4 (3 Days)||0
2259242|NCT02382640|5544768|P3|NOT COMPLETED|Intervention Period 4 (3 Days)||0
2259243|NCT02382640|5544769|P2|NOT COMPLETED|Intervention Period 4 (3 Days)||0
2259244|NCT02382640|5544770|P1|NOT COMPLETED|Intervention Period 4 (3 Days)||1
2259245|NCT02382640|5544767|P4|COMPLETED|Intervention Period 4 (3 Days)||9
2259246|NCT02382640|5544768|P3|COMPLETED|Intervention Period 4 (3 Days)||9
2259247|NCT02382640|5544769|P2|COMPLETED|Intervention Period 4 (3 Days)||9
2259248|NCT02382640|5544770|P1|COMPLETED|Intervention Period 4 (3 Days)||8
2259249|NCT02382640|5544767|P4|STARTED|Intervention Period 4 (3 Days)||9
2259250|NCT02382640|5544768|P3|STARTED|Intervention Period 4 (3 Days)||9
2259251|NCT02382640|5544769|P2|STARTED|Intervention Period 4 (3 Days)||9
2259252|NCT02382640|5544770|P1|STARTED|Intervention Period 4 (3 Days)||9
2259253|NCT02382640|5544767|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
2259254|NCT02382640|5544768|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
2259255|NCT02382640|5544769|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
2259256|NCT02382640|5544770|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
2259257|NCT02382640|5544767|P4|COMPLETED|Washout Period 3 (7 Days)||9
2259258|NCT02382640|5544768|P3|COMPLETED|Washout Period 3 (7 Days)||9
2259259|NCT02382640|5544769|P2|COMPLETED|Washout Period 3 (7 Days)||9
2259260|NCT02382640|5544770|P1|COMPLETED|Washout Period 3 (7 Days)||9
2259261|NCT02382640|5544767|P4|STARTED|Washout Period 3 (7 Days)||9
2259262|NCT02382640|5544768|P3|STARTED|Washout Period 3 (7 Days)||9
2259263|NCT02382640|5544769|P2|STARTED|Washout Period 3 (7 Days)||9
2259264|NCT02382640|5544770|P1|STARTED|Washout Period 3 (7 Days)||9
2259265|NCT02382640|5544767|P4|NOT COMPLETED|Intervention Period 3 (3 Days)||0
2259266|NCT02382640|5544768|P3|NOT COMPLETED|Intervention Period 3 (3 Days)||0
2259267|NCT02382640|5544769|P2|NOT COMPLETED|Intervention Period 3 (3 Days)||0
2259268|NCT02382640|5544770|P1|NOT COMPLETED|Intervention Period 3 (3 Days)||0
2259269|NCT02382640|5544767|P4|COMPLETED|Intervention Period 3 (3 Days)||9
2259270|NCT02382640|5544768|P3|COMPLETED|Intervention Period 3 (3 Days)||9
2259271|NCT02382640|5544769|P2|COMPLETED|Intervention Period 3 (3 Days)||9
2259272|NCT02382640|5544770|P1|COMPLETED|Intervention Period 3 (3 Days)||9
2259273|NCT02382640|5544767|P4|STARTED|Intervention Period 3 (3 Days)||9
2259274|NCT02382640|5544768|P3|STARTED|Intervention Period 3 (3 Days)||9
2259275|NCT02382640|5544769|P2|STARTED|Intervention Period 3 (3 Days)||9
2259276|NCT02382640|5544770|P1|STARTED|Intervention Period 3 (3 Days)||9
2259277|NCT02382640|5544767|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
2259278|NCT02382640|5544768|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
2259279|NCT02382640|5544769|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
2259280|NCT02382640|5544770|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
2259281|NCT02382640|5544767|P4|COMPLETED|Washout Period 2 (7 Days)||9
2259282|NCT02382640|5544768|P3|COMPLETED|Washout Period 2 (7 Days)||9
2259283|NCT02382640|5544769|P2|COMPLETED|Washout Period 2 (7 Days)||9
2259284|NCT02382640|5544770|P1|COMPLETED|Washout Period 2 (7 Days)||9
2259285|NCT02382640|5544767|P4|STARTED|Washout Period 2 (7 Days)||9
2259286|NCT02382640|5544768|P3|STARTED|Washout Period 2 (7 Days)||9
2259287|NCT02382640|5544769|P2|STARTED|Washout Period 2 (7 Days)||9
2259288|NCT02382640|5544770|P1|STARTED|Washout Period 2 (7 Days)||9
2259289|NCT02382640|5544767|P4|NOT COMPLETED|Intervention Period 2 (3 Days)||0
2259290|NCT02382640|5544768|P3|NOT COMPLETED|Intervention Period 2 (3 Days)||0
2259291|NCT02382640|5544769|P2|NOT COMPLETED|Intervention Period 2 (3 Days)||0
2259292|NCT02382640|5544770|P1|NOT COMPLETED|Intervention Period 2 (3 Days)||0
2259293|NCT02382640|5544767|P4|COMPLETED|Intervention Period 2 (3 Days)||9
2259294|NCT02382640|5544768|P3|COMPLETED|Intervention Period 2 (3 Days)||9
2259295|NCT02382640|5544769|P2|COMPLETED|Intervention Period 2 (3 Days)||9
2259296|NCT02382640|5544770|P1|COMPLETED|Intervention Period 2 (3 Days)||9
2259297|NCT02382640|5544767|P4|STARTED|Intervention Period 2 (3 Days)||9
2259298|NCT02382640|5544768|P3|STARTED|Intervention Period 2 (3 Days)||9
2259299|NCT02382640|5544769|P2|STARTED|Intervention Period 2 (3 Days)||9
2259300|NCT02382640|5544770|P1|STARTED|Intervention Period 2 (3 Days)||9
2259301|NCT02382640|5544767|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
2259302|NCT02382640|5544768|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
2259303|NCT02382640|5544769|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
2259304|NCT02382640|5544770|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
2259305|NCT02382640|5544767|P4|COMPLETED|Washout Period 1 (7 Days)||9
2259306|NCT02382640|5544768|P3|COMPLETED|Washout Period 1 (7 Days)||9
2259307|NCT02382640|5544769|P2|COMPLETED|Washout Period 1 (7 Days)||9
2259308|NCT02382640|5544770|P1|COMPLETED|Washout Period 1 (7 Days)||9
2259309|NCT02382640|5544767|P4|STARTED|Washout Period 1 (7 Days)||9
2259310|NCT02382640|5544768|P3|STARTED|Washout Period 1 (7 Days)||9
2259311|NCT02382640|5544769|P2|STARTED|Washout Period 1 (7 Days)||9
2259312|NCT02382640|5544770|P1|STARTED|Washout Period 1 (7 Days)||9
2259313|NCT02382640|5544767|P4|NOT COMPLETED|Intervention Period 1 (3 Days)||0
2259314|NCT02382640|5544768|P3|NOT COMPLETED|Intervention Period 1 (3 Days)||0
2259315|NCT02382640|5544769|P2|NOT COMPLETED|Intervention Period 1 (3 Days)||0
2259316|NCT02382640|5544770|P1|NOT COMPLETED|Intervention Period 1 (3 Days)||0
2259317|NCT02382640|5544767|P4|COMPLETED|Intervention Period 1 (3 Days)||9
2259318|NCT02382640|5544768|P3|COMPLETED|Intervention Period 1 (3 Days)||9
2259319|NCT02382640|5544769|P2|COMPLETED|Intervention Period 1 (3 Days)||9
2259320|NCT02382640|5544770|P1|COMPLETED|Intervention Period 1 (3 Days)||9
2259321|NCT02382640|5544767|P4|STARTED|Intervention Period 1 (3 Days)||9
2259322|NCT02382640|5544768|P3|STARTED|Intervention Period 1 (3 Days)||9
2259323|NCT02382640|5544769|P2|STARTED|Intervention Period 1 (3 Days)||9
2259324|NCT02382640|5544770|P1|STARTED|Intervention Period 1 (3 Days)||9
2259325|NCT02382133|5544808|P1|NOT COMPLETED|Overall Study||33
2259326|NCT02382133|5544808|P1|COMPLETED|Overall Study||10
2259327|NCT02382133|5544808|P1|STARTED|Overall Study||43
2259328|NCT02382016|5544815|P2|NOT COMPLETED|OL Extension Period||0
2259329|NCT02382016|5544816|P1|NOT COMPLETED|OL Extension Period||6
2259330|NCT02382016|5544815|P2|COMPLETED|OL Extension Period||0
2259331|NCT02382016|5544816|P1|COMPLETED|OL Extension Period||27
2259332|NCT02382016|5544815|P2|STARTED|OL Extension Period||0
2259333|NCT02382016|5544816|P1|STARTED|OL Extension Period|Participants(French site) who completed DB,OL periods, consented receiving macitentan in OLE period.|33
2259334|NCT02382016|5544815|P2|NOT COMPLETED|Open-label (OL) Treatment Period||0
2259335|NCT02382016|5544816|P1|NOT COMPLETED|Open-label (OL) Treatment Period||9
2259336|NCT02382016|5544815|P2|COMPLETED|Open-label (OL) Treatment Period||0
2259337|NCT02382016|5544816|P1|COMPLETED|Open-label (OL) Treatment Period||71
2259338|NCT02382016|5544815|P2|STARTED|Open-label (OL) Treatment Period||0
2259339|NCT02382016|5544816|P1|STARTED|Open-label (OL) Treatment Period||80
2259340|NCT02382016|5544815|P2|NOT COMPLETED|Double-blind (DB) Treatment Period||1
2259341|NCT02382016|5544816|P1|NOT COMPLETED|Double-blind (DB) Treatment Period||4
2259342|NCT02382016|5544815|P2|COMPLETED|Double-blind (DB) Treatment Period||41
2259343|NCT02382016|5544816|P1|COMPLETED|Double-blind (DB) Treatment Period||39
2259344|NCT02382016|5544815|P2|STARTED|Double-blind (DB) Treatment Period||42
2259345|NCT02382016|5544816|P1|STARTED|Double-blind (DB) Treatment Period||43
2259346|NCT02381795|5544840|P1|NOT COMPLETED|Overall Study||3
2259347|NCT02381795|5544840|P1|COMPLETED|Overall Study||7
2259348|NCT02381795|5544840|P1|STARTED|Overall Study||10
2259349|NCT02381678|5544844|P3|NOT COMPLETED|Overall Study||0
2259350|NCT02381678|5544845|P2|NOT COMPLETED|Overall Study||0
2259351|NCT02381678|5544846|P1|NOT COMPLETED|Overall Study||0
2259352|NCT02381678|5544844|P3|COMPLETED|Overall Study||32
2259353|NCT02381678|5544845|P2|COMPLETED|Overall Study||139
2259354|NCT02381678|5544846|P1|COMPLETED|Overall Study||54
2259355|NCT02381678|5544844|P3|STARTED|Overall Study||32
2259356|NCT02381678|5544845|P2|STARTED|Overall Study||139
2259357|NCT02381678|5544846|P1|STARTED|Overall Study||54
2259358|NCT02381418|5544852|P1|NOT COMPLETED|Overall Study||0
2259359|NCT02381418|5544852|P1|COMPLETED|Overall Study||120
2259360|NCT02381418|5544852|P1|STARTED|Overall Study||120
2259361|NCT02381392|5544860|P2|NOT COMPLETED|Overall Study||0
2259362|NCT02381392|5544861|P1|NOT COMPLETED|Overall Study||0
2259363|NCT02381392|5544860|P2|COMPLETED|Overall Study||12
2259364|NCT02381392|5544861|P1|COMPLETED|Overall Study||11
2259365|NCT02381392|5544860|P2|STARTED|Overall Study||12
2259366|NCT02381392|5544861|P1|STARTED|Overall Study||11
2259367|NCT02381288|5544879|P4|NOT COMPLETED|Overall Study||0
2259368|NCT02381288|5544880|P3|NOT COMPLETED|Overall Study||0
2259369|NCT02381288|5544881|P2|NOT COMPLETED|Overall Study||0
2259370|NCT02381288|5544882|P1|NOT COMPLETED|Overall Study||0
2259371|NCT02381288|5544879|P4|COMPLETED|Overall Study||5
2259372|NCT02381288|5544880|P3|COMPLETED|Overall Study||5
2259373|NCT02381288|5544881|P2|COMPLETED|Overall Study||2
2259374|NCT02381288|5544882|P1|COMPLETED|Overall Study||5
2259375|NCT02381288|5544879|P4|STARTED|Overall Study||5
2259376|NCT02381288|5544880|P3|STARTED|Overall Study||5
2259377|NCT02381288|5544881|P2|STARTED|Overall Study||2
2259378|NCT02381288|5544882|P1|STARTED|Overall Study||5
2259379|NCT02381015|5544913|P4|NOT COMPLETED|Year 3 Chart Review||51
2259380|NCT02381015|5544914|P3|NOT COMPLETED|Year 3 Chart Review||58
2259381|NCT02381015|5544915|P2|NOT COMPLETED|Year 3 Chart Review||34
2259382|NCT02381015|5544916|P1|NOT COMPLETED|Year 3 Chart Review||47
2259383|NCT02381015|5544913|P4|COMPLETED|Year 3 Chart Review||118
2259384|NCT02381015|5544914|P3|COMPLETED|Year 3 Chart Review||115
2259385|NCT02381015|5544915|P2|COMPLETED|Year 3 Chart Review||134
2259386|NCT02381015|5544916|P1|COMPLETED|Year 3 Chart Review||125
2259387|NCT02381015|5544913|P4|STARTED|Year 3 Chart Review||169
2259388|NCT02381015|5544914|P3|STARTED|Year 3 Chart Review||173
2259389|NCT02381015|5544915|P2|STARTED|Year 3 Chart Review||168
2259390|NCT02381015|5544916|P1|STARTED|Year 3 Chart Review||172
2259391|NCT02381015|5544913|P4|NOT COMPLETED|Visit 3 - 3 Months Followup||0
2259392|NCT02381015|5544914|P3|NOT COMPLETED|Visit 3 - 3 Months Followup||0
2259393|NCT02381015|5544915|P2|NOT COMPLETED|Visit 3 - 3 Months Followup||0
2259394|NCT02381015|5544916|P1|NOT COMPLETED|Visit 3 - 3 Months Followup||0
2259395|NCT02381015|5544913|P4|COMPLETED|Visit 3 - 3 Months Followup||169
2259396|NCT02381015|5544914|P3|COMPLETED|Visit 3 - 3 Months Followup||173
2259397|NCT02381015|5544915|P2|COMPLETED|Visit 3 - 3 Months Followup||168
2259398|NCT02381015|5544916|P1|COMPLETED|Visit 3 - 3 Months Followup||172
2259399|NCT02381015|5544913|P4|STARTED|Visit 3 - 3 Months Followup||169
2259400|NCT02381015|5544914|P3|STARTED|Visit 3 - 3 Months Followup||173
2259401|NCT02381015|5544915|P2|STARTED|Visit 3 - 3 Months Followup||168
2259402|NCT02381015|5544916|P1|STARTED|Visit 3 - 3 Months Followup||172
2259403|NCT02381015|5544913|P4|NOT COMPLETED|Visit 2 - Results DIsclosure||3
2259404|NCT02381015|5544914|P3|NOT COMPLETED|Visit 2 - Results DIsclosure||2
2259405|NCT02381015|5544915|P2|NOT COMPLETED|Visit 2 - Results DIsclosure||5
2259406|NCT02381015|5544916|P1|NOT COMPLETED|Visit 2 - Results DIsclosure||3
2259407|NCT02381015|5544913|P4|COMPLETED|Visit 2 - Results DIsclosure||169
2259408|NCT02381015|5544914|P3|COMPLETED|Visit 2 - Results DIsclosure||173
2259409|NCT02381015|5544915|P2|COMPLETED|Visit 2 - Results DIsclosure||168
2259410|NCT02381015|5544916|P1|COMPLETED|Visit 2 - Results DIsclosure||172
2259411|NCT02381015|5544913|P4|STARTED|Visit 2 - Results DIsclosure||172
2259412|NCT02381015|5544914|P3|STARTED|Visit 2 - Results DIsclosure||175
2259413|NCT02381015|5544915|P2|STARTED|Visit 2 - Results DIsclosure||173
2259414|NCT02381015|5544916|P1|STARTED|Visit 2 - Results DIsclosure||175
2259415|NCT02381015|5544913|P4|NOT COMPLETED|Visit 1 - Enrollment||3
2259416|NCT02381015|5544914|P3|NOT COMPLETED|Visit 1 - Enrollment||0
2259417|NCT02381015|5544915|P2|NOT COMPLETED|Visit 1 - Enrollment||2
2259418|NCT02381015|5544916|P1|NOT COMPLETED|Visit 1 - Enrollment||0
2259419|NCT02381015|5544913|P4|COMPLETED|Visit 1 - Enrollment||172
2259420|NCT02381015|5544914|P3|COMPLETED|Visit 1 - Enrollment||175
2259421|NCT02381015|5544915|P2|COMPLETED|Visit 1 - Enrollment||173
2259422|NCT02381015|5544916|P1|COMPLETED|Visit 1 - Enrollment||175
2259423|NCT02381015|5544913|P4|STARTED|Visit 1 - Enrollment||175
2259424|NCT02381015|5544914|P3|STARTED|Visit 1 - Enrollment||175
2259425|NCT02381015|5544915|P2|STARTED|Visit 1 - Enrollment||175
2259426|NCT02381015|5544916|P1|STARTED|Visit 1 - Enrollment||175
2259427|NCT02380859|5544948|P2|NOT COMPLETED|Overall Study||0
2259428|NCT02380859|5544949|P1|NOT COMPLETED|Overall Study||2
2259429|NCT02380859|5544948|P2|COMPLETED|Overall Study||13
2259430|NCT02380859|5544949|P1|COMPLETED|Overall Study||17
2259431|NCT02380859|5544948|P2|STARTED|Overall Study||13
2259432|NCT02380859|5544949|P1|STARTED|Overall Study||19
2259433|NCT02380742|5544985|P2|NOT COMPLETED|Overall Study||0
2259434|NCT02380742|5544986|P1|NOT COMPLETED|Overall Study||1
2259435|NCT02380742|5544985|P2|COMPLETED|Overall Study||26
2259436|NCT02380742|5544986|P1|COMPLETED|Overall Study||27
2259437|NCT02380742|5544985|P2|STARTED|Overall Study||26
2259438|NCT02380742|5544986|P1|STARTED|Overall Study||28
2259439|NCT02380287|5545006|P8|NOT COMPLETED|Overall Study||0
2259440|NCT02380287|5545007|P7|NOT COMPLETED|Overall Study||0
2259441|NCT02380287|5545008|P6|NOT COMPLETED|Overall Study||0
2259442|NCT02380287|5545009|P5|NOT COMPLETED|Overall Study||0
2259443|NCT02380287|5545010|P4|NOT COMPLETED|Overall Study||0
2259444|NCT02380287|5545011|P3|NOT COMPLETED|Overall Study||1
2259445|NCT02380287|5545012|P2|NOT COMPLETED|Overall Study||0
2259446|NCT02380287|5545013|P1|NOT COMPLETED|Overall Study||0
2259447|NCT02380287|5545006|P8|COMPLETED|Overall Study||3
2259448|NCT02380287|5545007|P7|COMPLETED|Overall Study||3
2259449|NCT02380287|5545008|P6|COMPLETED|Overall Study||3
2259450|NCT02380287|5545009|P5|COMPLETED|Overall Study||3
2259451|NCT02380287|5545010|P4|COMPLETED|Overall Study||3
2259452|NCT02380287|5545011|P3|COMPLETED|Overall Study||2
2259453|NCT02380287|5545012|P2|COMPLETED|Overall Study||3
2259454|NCT02380287|5545013|P1|COMPLETED|Overall Study||1
2259455|NCT02380287|5545006|P8|STARTED|Overall Study||3
2259456|NCT02380287|5545007|P7|STARTED|Overall Study||3
2259457|NCT02380287|5545008|P6|STARTED|Overall Study||3
2259458|NCT02380287|5545009|P5|STARTED|Overall Study||3
2259459|NCT02380287|5545010|P4|STARTED|Overall Study||3
2259460|NCT02380287|5545011|P3|STARTED|Overall Study||3
2259461|NCT02380287|5545012|P2|STARTED|Overall Study||3
2259462|NCT02380287|5545013|P1|STARTED|Overall Study||1
2259463|NCT02380261|5545024|P1|NOT COMPLETED|Overall Study||0
2259464|NCT02380261|5545024|P1|COMPLETED|Overall Study||35
2259465|NCT02380261|5545024|P1|STARTED|Overall Study||35
2259466|NCT02380248|5545029|P1|NOT COMPLETED|Overall Study||14
2259467|NCT02380248|5545029|P1|COMPLETED|Overall Study||186
2259468|NCT02380248|5545029|P1|STARTED|Overall Study||200
2259469|NCT02380183|5545036|P2|NOT COMPLETED|Overall Study||0
2259470|NCT02380183|5545037|P1|NOT COMPLETED|Overall Study||0
2259471|NCT02380183|5545036|P2|COMPLETED|Overall Study||34
2259472|NCT02380183|5545037|P1|COMPLETED|Overall Study||36
2259473|NCT02380183|5545036|P2|STARTED|Overall Study||34
2259474|NCT02380183|5545037|P1|STARTED|Overall Study||36
2259475|NCT02379923|5545045|P1|NOT COMPLETED|Overall Study||5
2259476|NCT02379923|5545045|P1|COMPLETED|Overall Study||158
2259477|NCT02379923|5545045|P1|STARTED|Overall Study||163
2259478|NCT02379858|5545061|P2|NOT COMPLETED|Overall Study||0
2259479|NCT02379858|5545062|P1|NOT COMPLETED|Overall Study||0
2259480|NCT02379858|5545061|P2|COMPLETED|Overall Study||4
2259481|NCT02379858|5545062|P1|COMPLETED|Overall Study||6
2259482|NCT02379858|5545061|P2|STARTED|Overall Study||4
2259483|NCT02379858|5545062|P1|STARTED|Overall Study||6
2259484|NCT02379637|5545074|P2|NOT COMPLETED|Overall Study||1
2259485|NCT02379637|5545075|P1|NOT COMPLETED|Overall Study||2
2259486|NCT02379637|5545074|P2|COMPLETED|Overall Study||34
2259487|NCT02379637|5545075|P1|COMPLETED|Overall Study||33
2259488|NCT02379637|5545074|P2|STARTED|Overall Study||35
2259489|NCT02379637|5545075|P1|STARTED|Overall Study||35
2259490|NCT02379585|5545085|P2|NOT COMPLETED|Overall Study||5
2259491|NCT02379585|5545086|P1|NOT COMPLETED|Overall Study||3
2259492|NCT02379585|5545085|P2|COMPLETED|Overall Study||0
2259493|NCT02379585|5545086|P1|COMPLETED|Overall Study||0
2259494|NCT02379585|5545085|P2|STARTED|Overall Study||5
2259495|NCT02379585|5545086|P1|STARTED|Overall Study||3
2259496|NCT02379442|5545108|P1|NOT COMPLETED|Overall Study||0
2259497|NCT02379442|5545108|P1|COMPLETED|Overall Study||1
2259498|NCT02379442|5545108|P1|STARTED|Overall Study||1
2259499|NCT02379390|5545114|P2|NOT COMPLETED|Overall Study||2
2259500|NCT02379390|5545115|P1|NOT COMPLETED|Overall Study||2
2259501|NCT02379390|5545114|P2|COMPLETED|Overall Study||2
2259502|NCT02379390|5545115|P1|COMPLETED|Overall Study||2
2259503|NCT02379390|5545114|P2|STARTED|Overall Study||4
2259504|NCT02379390|5545115|P1|STARTED|Overall Study||4
2259505|NCT02379221|5545143|P1|NOT COMPLETED|Overall Study||1
2259506|NCT02379221|5545143|P1|COMPLETED|Overall Study||48
2259507|NCT02379221|5545143|P1|STARTED|Overall Study||49
2259508|NCT02379195|5545158|P1|NOT COMPLETED|Overall Study||0
2259509|NCT02379195|5545158|P1|COMPLETED|Overall Study||12
2259510|NCT02379195|5545158|P1|STARTED|Overall Study||12
2259511|NCT02379117|5545168|P2|NOT COMPLETED|Overall Study||0
2259512|NCT02379117|5545169|P1|NOT COMPLETED|Overall Study||0
2259513|NCT02379117|5545168|P2|COMPLETED|Overall Study||31
2259514|NCT02379117|5545169|P1|COMPLETED|Overall Study||30
2259515|NCT02379117|5545168|P2|STARTED|Overall Study||31
2259516|NCT02379117|5545169|P1|STARTED|Overall Study||30
2259517|NCT02379091|5545179|P4|NOT COMPLETED|Overall Study||14
2259518|NCT02379091|5545180|P3|NOT COMPLETED|Overall Study||7
2259519|NCT02379091|5545181|P2|NOT COMPLETED|Overall Study||10
2259520|NCT02379091|5545182|P1|NOT COMPLETED|Overall Study||12
2259521|NCT02379091|5545179|P4|COMPLETED|Overall Study||14
2259522|NCT02379091|5545180|P3|COMPLETED|Overall Study||18
2259523|NCT02379091|5545181|P2|COMPLETED|Overall Study||18
2259524|NCT02379091|5545182|P1|COMPLETED|Overall Study||15
2259525|NCT02379091|5545179|P4|Full Analysis Set|Overall Study||28
2259526|NCT02379091|5545180|P3|Full Analysis Set|Overall Study|One participant was excluded because of data collection issues.|24
2259527|NCT02379091|5545181|P2|Full Analysis Set|Overall Study||28
2259528|NCT02379091|5545182|P1|Full Analysis Set|Overall Study|One participant was excluded because of data collection issues.|26
2259529|NCT02379091|5545179|P4|STARTED|Overall Study||28
2259530|NCT02379091|5545180|P3|STARTED|Overall Study||25
2259531|NCT02379091|5545181|P2|STARTED|Overall Study||28
2259532|NCT02379091|5545182|P1|STARTED|Overall Study||27
2259533|NCT02378961|5545222|P4|NOT COMPLETED|Overall Study||1
2259534|NCT02378961|5545223|P3|NOT COMPLETED|Overall Study||1
2259535|NCT02378961|5545224|P2|NOT COMPLETED|Overall Study||2
2259536|NCT02378961|5545225|P1|NOT COMPLETED|Overall Study||4
2259537|NCT02378961|5545222|P4|COMPLETED|Overall Study||28
2259538|NCT02378961|5545223|P3|COMPLETED|Overall Study||35
2259539|NCT02378961|5545224|P2|COMPLETED|Overall Study||28
2259540|NCT02378961|5545225|P1|COMPLETED|Overall Study||29
2259541|NCT02378961|5545222|P4|STARTED|Overall Study||29
2259542|NCT02378961|5545223|P3|STARTED|Overall Study||36
2259543|NCT02378961|5545224|P2|STARTED|Overall Study||30
2259544|NCT02378961|5545225|P1|STARTED|Overall Study||33
2259545|NCT02378935|5545262|P7|NOT COMPLETED|Overall Study||0
2259546|NCT02378935|5545263|P6|NOT COMPLETED|Overall Study||0
2259547|NCT02378935|5545264|P5|NOT COMPLETED|Overall Study||0
2259548|NCT02378935|5545265|P4|NOT COMPLETED|Overall Study||6
2259549|NCT02378935|5545266|P3|NOT COMPLETED|Overall Study||3
2259550|NCT02378935|5545267|P2|NOT COMPLETED|Overall Study||0
2259551|NCT02378935|5545268|P1|NOT COMPLETED|Overall Study||10
2259552|NCT02378935|5545262|P7|COMPLETED|Overall Study||8
2259553|NCT02378935|5545263|P6|COMPLETED|Overall Study||32
2259554|NCT02378935|5545264|P5|COMPLETED|Overall Study||31
2259555|NCT02378935|5545265|P4|COMPLETED|Overall Study||25
2259556|NCT02378935|5545266|P3|COMPLETED|Overall Study||30
2259557|NCT02378935|5545267|P2|COMPLETED|Overall Study||36
2259558|NCT02378935|5545268|P1|COMPLETED|Overall Study||24
2259559|NCT02378935|5545262|P7|STARTED|Overall Study||8
2259560|NCT02378935|5545263|P6|STARTED|Overall Study||32
2259561|NCT02378935|5545264|P5|STARTED|Overall Study||31
2259562|NCT02378935|5545265|P4|STARTED|Overall Study||31
2259563|NCT02378935|5545266|P3|STARTED|Overall Study||33
2259564|NCT02378935|5545267|P2|STARTED|Overall Study||36
2259565|NCT02378935|5545268|P1|STARTED|Overall Study||34
2259566|NCT02378883|5545319|P1|NOT COMPLETED|12 Months Follow-Up||5
2259567|NCT02378883|5545319|P1|COMPLETED|12 Months Follow-Up||41
2259568|NCT02378883|5545319|P1|STARTED|12 Months Follow-Up|Two deaths occurred between 30 day FU and prior to 12 month FU.|46
2259569|NCT02378883|5545319|P1|NOT COMPLETED|30 Day Follow-Up||6
2259570|NCT02378883|5545319|P1|COMPLETED|30 Day Follow-Up||106
2259571|NCT02378883|5545319|P1|STARTED|30 Day Follow-Up||112
2259572|NCT02378883|5545319|P1|NOT COMPLETED|Discharge||0
2259573|NCT02378883|5545319|P1|COMPLETED|Discharge||112
2259574|NCT02378883|5545319|P1|STARTED|Discharge||112
2259575|NCT02378883|5545319|P1|NOT COMPLETED|Enrollment||9
2259576|NCT02378883|5545319|P1|COMPLETED|Enrollment|Attempted with study device - intent to treat population|112
2259577|NCT02378883|5545319|P1|STARTED|Enrollment|Participants consented and assessed for eligibility|121
2259578|NCT02378844|5545332|P3|NOT COMPLETED|Open Label Period||0
2259579|NCT02378844|5545333|P2|NOT COMPLETED|Open Label Period||48
2259580|NCT02378844|5545334|P1|NOT COMPLETED|Open Label Period||43
2259581|NCT02378844|5545332|P3|COMPLETED|Open Label Period||0
2259582|NCT02378844|5545333|P2|COMPLETED|Open Label Period||87
2259583|NCT02378844|5545334|P1|COMPLETED|Open Label Period||99
2259584|NCT02378844|5545332|P3|STARTED|Open Label Period||0
2259585|NCT02378844|5545333|P2|STARTED|Open Label Period||135
2259586|NCT02378844|5545334|P1|STARTED|Open Label Period||142
2259587|NCT02378844|5545332|P3|NOT COMPLETED|Randomized Period (Double Blind)||0
2259588|NCT02378844|5545333|P2|NOT COMPLETED|Randomized Period (Double Blind)||32
2259589|NCT02378844|5545334|P1|NOT COMPLETED|Randomized Period (Double Blind)||23
2259590|NCT02378844|5545332|P3|COMPLETED|Randomized Period (Double Blind)||0
2259591|NCT02378844|5545333|P2|COMPLETED|Randomized Period (Double Blind)||135
2259592|NCT02378844|5545334|P1|COMPLETED|Randomized Period (Double Blind)||142
2259593|NCT02378844|5545332|P3|STARTED|Randomized Period (Double Blind)||0
2259594|NCT02378844|5545333|P2|STARTED|Randomized Period (Double Blind)||167
2259595|NCT02378844|5545334|P1|STARTED|Randomized Period (Double Blind)||165
2259596|NCT02378844|5545332|P3|NOT COMPLETED|Run-in Period||136
2259597|NCT02378844|5545333|P2|NOT COMPLETED|Run-in Period||5
2259598|NCT02378844|5545334|P1|NOT COMPLETED|Run-in Period||4
2259599|NCT02378844|5545332|P3|COMPLETED|Run-in Period||0
2259600|NCT02378844|5545333|P2|COMPLETED|Run-in Period||167
2259601|NCT02378844|5545334|P1|COMPLETED|Run-in Period||165
2259602|NCT02378844|5545332|P3|STARTED|Run-in Period||136
2259603|NCT02378844|5545333|P2|STARTED|Run-in Period||172
2259604|NCT02378844|5545334|P1|STARTED|Run-in Period||169
2259605|NCT02378753|5545364|P2|NOT COMPLETED|Overall Study||695
2259606|NCT02378753|5545365|P1|NOT COMPLETED|Overall Study||218
2259607|NCT02378753|5545364|P2|COMPLETED|Overall Study||3637
2259608|NCT02378753|5545365|P1|COMPLETED|Overall Study||4101
2259609|NCT02378753|5545364|P2|STARTED|Overall Study||4332
2259610|NCT02378753|5545365|P1|STARTED|Overall Study||4319
2259611|NCT02378662|5545385|P2|NOT COMPLETED|Overall Study||0
2259612|NCT02378662|5545386|P1|NOT COMPLETED|Overall Study||2
2259613|NCT02378662|5545385|P2|COMPLETED|Overall Study||0
2259614|NCT02378662|5545386|P1|COMPLETED|Overall Study||0
2259615|NCT02378662|5545385|P2|Implantation|Overall Study||0
2259616|NCT02378662|5545386|P1|Implantation|Overall Study||2
2259617|NCT02378662|5545385|P2|Harvesting|Overall Study||0
2259618|NCT02378662|5545386|P1|Harvesting|Overall Study||2
2259619|NCT02378662|5545385|P2|STARTED|Overall Study||0
2259620|NCT02378662|5545386|P1|STARTED|Overall Study||2
2259621|NCT02378506|5545392|P1|NOT COMPLETED|Overall Study||25
2259622|NCT02378506|5545392|P1|COMPLETED|Overall Study||163
2259623|NCT02378506|5545392|P1|Treated|Overall Study||187
2259624|NCT02378506|5545392|P1|STARTED|Overall Study||188
2259625|NCT02378480|5545411|P2|NOT COMPLETED|Overall Study||32
2259626|NCT02378480|5545412|P1|NOT COMPLETED|Overall Study||28
2259627|NCT02378480|5545411|P2|COMPLETED|Overall Study||294
2259628|NCT02378480|5545412|P1|COMPLETED|Overall Study||301
2259629|NCT02378480|5545411|P2|STARTED|Overall Study||326
2259630|NCT02378480|5545412|P1|STARTED|Overall Study||329
2259631|NCT02378402|5545427|P3|NOT COMPLETED|Overall Study||0
2259632|NCT02378402|5545428|P2|NOT COMPLETED|Overall Study||2
2259633|NCT02378402|5545429|P1|NOT COMPLETED|Overall Study||0
2259634|NCT02378402|5545427|P3|COMPLETED|Overall Study||21
2259635|NCT02378402|5545428|P2|COMPLETED|Overall Study||23
2259636|NCT02378402|5545429|P1|COMPLETED|Overall Study||25
2259637|NCT02378402|5545427|P3|STARTED|Overall Study||21
2259638|NCT02378402|5545428|P2|STARTED|Overall Study||25
2259639|NCT02378402|5545429|P1|STARTED|Overall Study||25
2259640|NCT02378220|5545439|P2|NOT COMPLETED|Overall Study||1
2259641|NCT02378220|5545440|P1|NOT COMPLETED|Overall Study||6
2259642|NCT02378220|5545439|P2|COMPLETED|Overall Study||56
2259643|NCT02378220|5545440|P1|COMPLETED|Overall Study||47
2259644|NCT02378220|5545439|P2|STARTED|Overall Study||57
2259645|NCT02378220|5545440|P1|STARTED|Overall Study||53
2259646|NCT02378207|5545474|P4|NOT COMPLETED|Overall Study||1
2259647|NCT02378207|5545475|P3|NOT COMPLETED|Overall Study||2
2259648|NCT02378207|5545476|P2|NOT COMPLETED|Overall Study||3
2259649|NCT02378207|5545477|P1|NOT COMPLETED|Overall Study||0
2259650|NCT02378207|5545474|P4|COMPLETED|Overall Study||11
2259651|NCT02378207|5545475|P3|COMPLETED|Overall Study||22
2259652|NCT02378207|5545476|P2|COMPLETED|Overall Study||21
2259653|NCT02378207|5545477|P1|COMPLETED|Overall Study||24
2259654|NCT02378207|5545474|P4|STARTED|Overall Study||12
2259655|NCT02378207|5545475|P3|STARTED|Overall Study||24
2259656|NCT02378207|5545476|P2|STARTED|Overall Study||24
2259657|NCT02378207|5545477|P1|STARTED|Overall Study||24
2259658|NCT02377986|5545491|P1|NOT COMPLETED|Overall Study||0
2259659|NCT02377986|5545491|P1|COMPLETED|Overall Study||5
2259660|NCT02377986|5545491|P1|STARTED|Overall Study||5
2259661|NCT02377947|5545496|P1|NOT COMPLETED|Overall Study||0
2259662|NCT02377947|5545496|P1|COMPLETED|Overall Study||50
2259663|NCT02377947|5545496|P1|STARTED|Overall Study||50
2259664|NCT02377921|5545509|P2|NOT COMPLETED|Overall Study||1
2259665|NCT02377921|5545510|P1|NOT COMPLETED|Overall Study||1
2259666|NCT02377921|5545509|P2|COMPLETED|Overall Study||43
2259667|NCT02377921|5545510|P1|COMPLETED|Overall Study||44
2259668|NCT02377921|5545509|P2|STARTED|Overall Study||44
2259669|NCT02377921|5545510|P1|STARTED|Overall Study||45
2259670|NCT02377466|5545534|P2|NOT COMPLETED|Overall Study||2
2259671|NCT02377466|5545535|P1|NOT COMPLETED|Overall Study||0
2259672|NCT02377466|5545534|P2|COMPLETED|Overall Study||10
2259673|NCT02377466|5545535|P1|COMPLETED|Overall Study||13
2259674|NCT02377466|5545534|P2|Treated|Overall Study||10
2259675|NCT02377466|5545535|P1|Treated|Overall Study||13
2259676|NCT02377466|5545534|P2|STARTED|Overall Study||12
2259677|NCT02377466|5545535|P1|STARTED|Overall Study||13
2259678|NCT02377427|5545653|P5|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
2259679|NCT02377427|5545654|P4|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
2259680|NCT02377427|5545655|P3|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||1
2259681|NCT02377427|5545656|P2|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
2259682|NCT02377427|5545657|P1|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
2259683|NCT02377427|5545653|P5|COMPLETED|Part B (From Week 20 and up to Week 80)||4
2259684|NCT02377427|5545654|P4|COMPLETED|Part B (From Week 20 and up to Week 80)||10
2259685|NCT02377427|5545655|P3|COMPLETED|Part B (From Week 20 and up to Week 80)||15
2259686|NCT02377427|5545656|P2|COMPLETED|Part B (From Week 20 and up to Week 80)||0
2259687|NCT02377427|5545657|P1|COMPLETED|Part B (From Week 20 and up to Week 80)||0
2259688|NCT02377427|5545653|P5|STARTED|Part B (From Week 20 and up to Week 80)||4
2259689|NCT02377427|5545654|P4|STARTED|Part B (From Week 20 and up to Week 80)||10
2259690|NCT02377427|5545655|P3|STARTED|Part B (From Week 20 and up to Week 80)|Two participants of PartA chose not to continue in PartB;4 shifted to PartB Mepolizumab 40/100mg arm|16
2259691|NCT02377427|5545656|P2|STARTED|Part B (From Week 20 and up to Week 80)||0
2259692|NCT02377427|5545657|P1|STARTED|Part B (From Week 20 and up to Week 80)||0
2259693|NCT02377427|5545653|P5|NOT COMPLETED|Part A (Up to Week 20)||0
2259694|NCT02377427|5545654|P4|NOT COMPLETED|Part A (Up to Week 20)||0
2259695|NCT02377427|5545655|P3|NOT COMPLETED|Part A (Up to Week 20)||0
2259696|NCT02377427|5545656|P2|NOT COMPLETED|Part A (Up to Week 20)||0
2259697|NCT02377427|5545657|P1|NOT COMPLETED|Part A (Up to Week 20)||4
2259698|NCT02377427|5545653|P5|COMPLETED|Part A (Up to Week 20)||0
2259699|NCT02377427|5545654|P4|COMPLETED|Part A (Up to Week 20)||0
2259700|NCT02377427|5545655|P3|COMPLETED|Part A (Up to Week 20)||0
2259701|NCT02377427|5545656|P2|COMPLETED|Part A (Up to Week 20)||10
2259702|NCT02377427|5545657|P1|COMPLETED|Part A (Up to Week 20)||22
2259703|NCT02377427|5545653|P5|STARTED|Part A (Up to Week 20)||0
2259704|NCT02377427|5545654|P4|STARTED|Part A (Up to Week 20)||0
2259705|NCT02377427|5545655|P3|STARTED|Part A (Up to Week 20)||0
2259706|NCT02377427|5545656|P2|STARTED|Part A (Up to Week 20)||10
2259707|NCT02377427|5545657|P1|STARTED|Part A (Up to Week 20)||26
2259708|NCT02377362|5545730|P13|NOT COMPLETED|Part B Overall||0
2259709|NCT02377362|5545731|P12|NOT COMPLETED|Part B Overall||1
2259710|NCT02377362|5545732|P11|NOT COMPLETED|Part B Overall||0
2259711|NCT02377362|5545733|P10|NOT COMPLETED|Part B Overall||1
2259712|NCT02377362|5545734|P9|NOT COMPLETED|Part B Overall||0
2259713|NCT02377362|5545735|P8|NOT COMPLETED|Part B Overall||1
2259714|NCT02377362|5545736|P7|NOT COMPLETED|Part B Overall||2
2259715|NCT02377362|5545737|P6|NOT COMPLETED|Part B Overall||0
2259716|NCT02377362|5545738|P5|NOT COMPLETED|Part B Overall||0
2259717|NCT02377362|5545739|P4|NOT COMPLETED|Part B Overall||0
2259718|NCT02377362|5545740|P3|NOT COMPLETED|Part B Overall||0
2259719|NCT02377362|5545741|P2|NOT COMPLETED|Part B Overall||0
2259720|NCT02377362|5545742|P1|NOT COMPLETED|Part B Overall||0
2259721|NCT02377362|5545730|P13|COMPLETED|Part B Overall||12
2259722|NCT02377362|5545731|P12|COMPLETED|Part B Overall||6
2259723|NCT02377362|5545732|P11|COMPLETED|Part B Overall||6
2259724|NCT02377362|5545733|P10|COMPLETED|Part B Overall||6
2259725|NCT02377362|5545734|P9|COMPLETED|Part B Overall||6
2259726|NCT02377362|5545735|P8|COMPLETED|Part B Overall||5
2259727|NCT02377362|5545736|P7|COMPLETED|Part B Overall||4
2259728|NCT02377362|5545737|P6|COMPLETED|Part B Overall||0
2259729|NCT02377362|5545738|P5|COMPLETED|Part B Overall||0
2259730|NCT02377362|5545739|P4|COMPLETED|Part B Overall||0
2259731|NCT02377362|5545740|P3|COMPLETED|Part B Overall||0
2259732|NCT02377362|5545741|P2|COMPLETED|Part B Overall||0
2259733|NCT02377362|5545742|P1|COMPLETED|Part B Overall||0
2259734|NCT02377362|5545730|P13|STARTED|Part B Overall||12
2259735|NCT02377362|5545731|P12|STARTED|Part B Overall||7
2259736|NCT02377362|5545732|P11|STARTED|Part B Overall||6
2259737|NCT02377362|5545733|P10|STARTED|Part B Overall||7
2259738|NCT02377362|5545734|P9|STARTED|Part B Overall||6
2259739|NCT02377362|5545735|P8|STARTED|Part B Overall||6
2259740|NCT02377362|5545736|P7|STARTED|Part B Overall||6
2259741|NCT02377362|5545737|P6|STARTED|Part B Overall||0
2259742|NCT02377362|5545738|P5|STARTED|Part B Overall||0
2259743|NCT02377362|5545739|P4|STARTED|Part B Overall||0
2259744|NCT02377362|5545740|P3|STARTED|Part B Overall||0
2259745|NCT02377362|5545741|P2|STARTED|Part B Overall||0
2259746|NCT02377362|5545742|P1|STARTED|Part B Overall||0
2259747|NCT02377362|5545730|P13|NOT COMPLETED|Part A Third Treatment||0
2259748|NCT02377362|5545731|P12|NOT COMPLETED|Part A Third Treatment||0
2259749|NCT02377362|5545732|P11|NOT COMPLETED|Part A Third Treatment||0
2259750|NCT02377362|5545733|P10|NOT COMPLETED|Part A Third Treatment||0
2259751|NCT02377362|5545734|P9|NOT COMPLETED|Part A Third Treatment||0
2259752|NCT02377362|5545735|P8|NOT COMPLETED|Part A Third Treatment||0
2259753|NCT02377362|5545736|P7|NOT COMPLETED|Part A Third Treatment||0
2259754|NCT02377362|5545737|P6|NOT COMPLETED|Part A Third Treatment||4
2259755|NCT02377362|5545738|P5|NOT COMPLETED|Part A Third Treatment||3
2259756|NCT02377362|5545739|P4|NOT COMPLETED|Part A Third Treatment||4
2259757|NCT02377362|5545740|P3|NOT COMPLETED|Part A Third Treatment||0
2259758|NCT02377362|5545741|P2|NOT COMPLETED|Part A Third Treatment||0
2259759|NCT02377362|5545742|P1|NOT COMPLETED|Part A Third Treatment||0
2259760|NCT02377362|5545730|P13|COMPLETED|Part A Third Treatment||0
2259761|NCT02377362|5545731|P12|COMPLETED|Part A Third Treatment||0
2259762|NCT02377362|5545732|P11|COMPLETED|Part A Third Treatment||0
2259763|NCT02377362|5545733|P10|COMPLETED|Part A Third Treatment||0
2259764|NCT02377362|5545734|P9|COMPLETED|Part A Third Treatment||0
2259765|NCT02377362|5545735|P8|COMPLETED|Part A Third Treatment||0
2259766|NCT02377362|5545736|P7|COMPLETED|Part A Third Treatment||0
2259767|NCT02377362|5545737|P6|COMPLETED|Part A Third Treatment||0
2259768|NCT02377362|5545738|P5|COMPLETED|Part A Third Treatment||0
2259769|NCT02377362|5545739|P4|COMPLETED|Part A Third Treatment||0
2259770|NCT02377362|5545740|P3|COMPLETED|Part A Third Treatment||4
2259771|NCT02377362|5545741|P2|COMPLETED|Part A Third Treatment||4
2259772|NCT02377362|5545742|P1|COMPLETED|Part A Third Treatment||4
2259773|NCT02377362|5545730|P13|STARTED|Part A Third Treatment||0
2259774|NCT02377362|5545731|P12|STARTED|Part A Third Treatment||0
2259775|NCT02377362|5545732|P11|STARTED|Part A Third Treatment||0
2259776|NCT02377362|5545733|P10|STARTED|Part A Third Treatment||0
2259777|NCT02377362|5545734|P9|STARTED|Part A Third Treatment||0
2259778|NCT02377362|5545735|P8|STARTED|Part A Third Treatment||0
2259779|NCT02377362|5545736|P7|STARTED|Part A Third Treatment||0
2259780|NCT02377362|5545737|P6|STARTED|Part A Third Treatment||4
2259781|NCT02377362|5545738|P5|STARTED|Part A Third Treatment||3
2259782|NCT02377362|5545739|P4|STARTED|Part A Third Treatment||4
2259783|NCT02377362|5545740|P3|STARTED|Part A Third Treatment||4
2259784|NCT02377362|5545741|P2|STARTED|Part A Third Treatment||4
2259785|NCT02377362|5545742|P1|STARTED|Part A Third Treatment||4
2259786|NCT02377362|5545730|P13|NOT COMPLETED|Part A Second Treatment||0
2259787|NCT02377362|5545731|P12|NOT COMPLETED|Part A Second Treatment||0
2259788|NCT02377362|5545732|P11|NOT COMPLETED|Part A Second Treatment||0
2259789|NCT02377362|5545733|P10|NOT COMPLETED|Part A Second Treatment||0
2259790|NCT02377362|5545734|P9|NOT COMPLETED|Part A Second Treatment||0
2259791|NCT02377362|5545735|P8|NOT COMPLETED|Part A Second Treatment||0
2259792|NCT02377362|5545736|P7|NOT COMPLETED|Part A Second Treatment||0
2259793|NCT02377362|5545737|P6|NOT COMPLETED|Part A Second Treatment||0
2259794|NCT02377362|5545738|P5|NOT COMPLETED|Part A Second Treatment||1
2259795|NCT02377362|5545739|P4|NOT COMPLETED|Part A Second Treatment||0
2259796|NCT02377362|5545740|P3|NOT COMPLETED|Part A Second Treatment||0
2259797|NCT02377362|5545741|P2|NOT COMPLETED|Part A Second Treatment||0
2259798|NCT02377362|5545742|P1|NOT COMPLETED|Part A Second Treatment||0
2259799|NCT02377362|5545730|P13|COMPLETED|Part A Second Treatment||0
2259800|NCT02377362|5545731|P12|COMPLETED|Part A Second Treatment||0
2259801|NCT02377362|5545732|P11|COMPLETED|Part A Second Treatment||0
2259802|NCT02377362|5545733|P10|COMPLETED|Part A Second Treatment||0
2259803|NCT02377362|5545734|P9|COMPLETED|Part A Second Treatment||0
2259804|NCT02377362|5545735|P8|COMPLETED|Part A Second Treatment||0
2259805|NCT02377362|5545736|P7|COMPLETED|Part A Second Treatment||0
2259806|NCT02377362|5545737|P6|COMPLETED|Part A Second Treatment||4
2259807|NCT02377362|5545738|P5|COMPLETED|Part A Second Treatment||3
2259808|NCT02377362|5545739|P4|COMPLETED|Part A Second Treatment||4
2259809|NCT02377362|5545740|P3|COMPLETED|Part A Second Treatment||4
2259810|NCT02377362|5545741|P2|COMPLETED|Part A Second Treatment||4
2259811|NCT02377362|5545742|P1|COMPLETED|Part A Second Treatment||4
2259812|NCT02377362|5545730|P13|STARTED|Part A Second Treatment||0
2259813|NCT02377362|5545731|P12|STARTED|Part A Second Treatment||0
2259814|NCT02377362|5545732|P11|STARTED|Part A Second Treatment||0
2259815|NCT02377362|5545733|P10|STARTED|Part A Second Treatment||0
2259816|NCT02377362|5545734|P9|STARTED|Part A Second Treatment||0
2259817|NCT02377362|5545735|P8|STARTED|Part A Second Treatment||0
2259818|NCT02377362|5545736|P7|STARTED|Part A Second Treatment||0
2259819|NCT02377362|5545737|P6|STARTED|Part A Second Treatment||4
2259820|NCT02377362|5545738|P5|STARTED|Part A Second Treatment||4
2259821|NCT02377362|5545739|P4|STARTED|Part A Second Treatment||4
2259822|NCT02377362|5545740|P3|STARTED|Part A Second Treatment||4
2259823|NCT02377362|5545741|P2|STARTED|Part A Second Treatment||4
2259824|NCT02377362|5545742|P1|STARTED|Part A Second Treatment||4
2259825|NCT02377362|5545730|P13|NOT COMPLETED|Part A First Treatment||0
2259826|NCT02377362|5545731|P12|NOT COMPLETED|Part A First Treatment||0
2259827|NCT02377362|5545732|P11|NOT COMPLETED|Part A First Treatment||0
2259828|NCT02377362|5545733|P10|NOT COMPLETED|Part A First Treatment||0
2259829|NCT02377362|5545734|P9|NOT COMPLETED|Part A First Treatment||0
2259830|NCT02377362|5545735|P8|NOT COMPLETED|Part A First Treatment||0
2259831|NCT02377362|5545736|P7|NOT COMPLETED|Part A First Treatment||0
2259832|NCT02377362|5545737|P6|NOT COMPLETED|Part A First Treatment||0
2259833|NCT02377362|5545738|P5|NOT COMPLETED|Part A First Treatment||0
2259834|NCT02377362|5545739|P4|NOT COMPLETED|Part A First Treatment||0
2259835|NCT02377362|5545740|P3|NOT COMPLETED|Part A First Treatment||0
2259836|NCT02377362|5545741|P2|NOT COMPLETED|Part A First Treatment||0
2259837|NCT02377362|5545742|P1|NOT COMPLETED|Part A First Treatment||0
2259838|NCT02377362|5545730|P13|COMPLETED|Part A First Treatment||0
2259839|NCT02377362|5545731|P12|COMPLETED|Part A First Treatment||0
2259840|NCT02377362|5545732|P11|COMPLETED|Part A First Treatment||0
2259841|NCT02377362|5545733|P10|COMPLETED|Part A First Treatment||0
2259842|NCT02377362|5545734|P9|COMPLETED|Part A First Treatment||0
2259843|NCT02377362|5545735|P8|COMPLETED|Part A First Treatment||0
2259844|NCT02377362|5545736|P7|COMPLETED|Part A First Treatment||0
2259845|NCT02377362|5545737|P6|COMPLETED|Part A First Treatment||4
2259846|NCT02377362|5545738|P5|COMPLETED|Part A First Treatment||4
2259847|NCT02377362|5545739|P4|COMPLETED|Part A First Treatment||4
2259848|NCT02377362|5545740|P3|COMPLETED|Part A First Treatment||4
2259849|NCT02377362|5545741|P2|COMPLETED|Part A First Treatment||4
2259850|NCT02377362|5545742|P1|COMPLETED|Part A First Treatment||4
2259851|NCT02377362|5545730|P13|STARTED|Part A First Treatment||0
2259852|NCT02377362|5545731|P12|STARTED|Part A First Treatment||0
2259853|NCT02377362|5545732|P11|STARTED|Part A First Treatment||0
2259854|NCT02377362|5545733|P10|STARTED|Part A First Treatment||0
2259855|NCT02377362|5545734|P9|STARTED|Part A First Treatment||0
2259856|NCT02377362|5545735|P8|STARTED|Part A First Treatment||0
2259857|NCT02377362|5545736|P7|STARTED|Part A First Treatment||0
2259858|NCT02377362|5545737|P6|STARTED|Part A First Treatment||4
2259859|NCT02377362|5545738|P5|STARTED|Part A First Treatment||4
2259860|NCT02377362|5545739|P4|STARTED|Part A First Treatment||4
2259861|NCT02377362|5545740|P3|STARTED|Part A First Treatment||4
2259862|NCT02377362|5545741|P2|STARTED|Part A First Treatment||4
2259863|NCT02377362|5545742|P1|STARTED|Part A First Treatment||4
2259864|NCT02377349|5545951|P2|NOT COMPLETED|Overall Study||11
2259865|NCT02377349|5545952|P1|NOT COMPLETED|Overall Study||16
2259866|NCT02377349|5545951|P2|COMPLETED|Overall Study||335
2259867|NCT02377349|5545952|P1|COMPLETED|Overall Study||325
2259868|NCT02377349|5545951|P2|STARTED|Overall Study||346
2259869|NCT02377349|5545952|P1|STARTED|Overall Study||341
2259870|NCT02377063|5545990|P1|NOT COMPLETED|Overall Study||5
2259871|NCT02377063|5545990|P1|COMPLETED|Overall Study||20
2259872|NCT02377063|5545990|P1|STARTED|Overall Study||25
2259873|NCT02376998|5545994|P1|NOT COMPLETED|Overall Study||9
2259874|NCT02376998|5545994|P1|COMPLETED|Overall Study||11
2259875|NCT02376998|5545994|P1|STARTED|Overall Study||20
2259876|NCT02376933|5545998|P1|NOT COMPLETED|Overall Study||2
2259877|NCT02376933|5545998|P1|COMPLETED|Overall Study||8
2259878|NCT02376933|5545998|P1|STARTED|Overall Study||10
2259879|NCT02376790|5546008|P3|NOT COMPLETED|Overall Study||53
2259880|NCT02376790|5546009|P2|NOT COMPLETED|Overall Study||47
2259881|NCT02376790|5546010|P1|NOT COMPLETED|Overall Study||60
2259882|NCT02376790|5546008|P3|COMPLETED|Overall Study||230
2259883|NCT02376790|5546009|P2|COMPLETED|Overall Study||237
2259884|NCT02376790|5546010|P1|COMPLETED|Overall Study||224
2259885|NCT02376790|5546008|P3|Received Treatment|Overall Study||282
2259886|NCT02376790|5546009|P2|Received Treatment|Overall Study||284
2259887|NCT02376790|5546010|P1|Received Treatment|Overall Study||282
2259888|NCT02376790|5546008|P3|STARTED|Overall Study||283
2259889|NCT02376790|5546009|P2|STARTED|Overall Study||284
2259890|NCT02376790|5546010|P1|STARTED|Overall Study||284
2259891|NCT02376530|5546130|P4|NOT COMPLETED|Overall Study||0
2259892|NCT02376530|5546131|P3|NOT COMPLETED|Overall Study||0
2259893|NCT02376530|5546132|P2|NOT COMPLETED|Overall Study||0
2259894|NCT02376530|5546133|P1|NOT COMPLETED|Overall Study||0
2259895|NCT02376530|5546130|P4|COMPLETED|Overall Study||197
2259896|NCT02376530|5546131|P3|COMPLETED|Overall Study||197
2259897|NCT02376530|5546132|P2|COMPLETED|Overall Study||198
2259898|NCT02376530|5546133|P1|COMPLETED|Overall Study||196
2259899|NCT02376530|5546130|P4|STARTED|Overall Study||197
2259900|NCT02376530|5546131|P3|STARTED|Overall Study||197
2259901|NCT02376530|5546132|P2|STARTED|Overall Study||198
2259902|NCT02376530|5546133|P1|STARTED|Overall Study||196
2259903|NCT02376283|5546146|P3|NOT COMPLETED|Overall Study||0
2259904|NCT02376283|5546147|P2|NOT COMPLETED|Overall Study||0
2259905|NCT02376283|5546148|P1|NOT COMPLETED|Overall Study||0
2259906|NCT02376283|5546146|P3|COMPLETED|Overall Study||30
2259907|NCT02376283|5546147|P2|COMPLETED|Overall Study||30
2259908|NCT02376283|5546148|P1|COMPLETED|Overall Study||27
2259909|NCT02376283|5546146|P3|STARTED|Overall Study||30
2259910|NCT02376283|5546147|P2|STARTED|Overall Study||30
2259911|NCT02376283|5546148|P1|STARTED|Overall Study||27
2259912|NCT02376257|5546166|P3|NOT COMPLETED|Overall Study||0
2259913|NCT02376257|5546167|P2|NOT COMPLETED|Overall Study||0
2259914|NCT02376257|5546168|P1|NOT COMPLETED|Overall Study||0
2259915|NCT02376257|5546166|P3|COMPLETED|Overall Study||11
2259916|NCT02376257|5546167|P2|COMPLETED|Overall Study||12
2259917|NCT02376257|5546168|P1|COMPLETED|Overall Study||13
2259918|NCT02376257|5546166|P3|STARTED|Overall Study||11
2259919|NCT02376257|5546167|P2|STARTED|Overall Study||12
2259920|NCT02376257|5546168|P1|STARTED|Overall Study||13
2259921|NCT02376179|5546197|P1|NOT COMPLETED|Overall Study||0
2259922|NCT02376179|5546197|P1|COMPLETED|Overall Study||84
2259923|NCT02376179|5546197|P1|STARTED|Overall Study||84
2259924|NCT02376166|5546201|P1|NOT COMPLETED|Overall Study||3
2259925|NCT02376166|5546201|P1|COMPLETED|Overall Study||12
2259926|NCT02376166|5546201|P1|STARTED|Overall Study||15
2259927|NCT02375971|5546229|P3|NOT COMPLETED|Follow-Up Phase (up to Day 169)||5
2259928|NCT02375971|5546230|P2|NOT COMPLETED|Follow-Up Phase (up to Day 169)||5
2259929|NCT02375971|5546231|P1|NOT COMPLETED|Follow-Up Phase (up to Day 169)||7
2259930|NCT02375971|5546229|P3|COMPLETED|Follow-Up Phase (up to Day 169)||64
2259931|NCT02375971|5546230|P2|COMPLETED|Follow-Up Phase (up to Day 169)||71
2259932|NCT02375971|5546231|P1|COMPLETED|Follow-Up Phase (up to Day 169)||66
2259933|NCT02375971|5546229|P3|STARTED|Follow-Up Phase (up to Day 169)||69
2259934|NCT02375971|5546230|P2|STARTED|Follow-Up Phase (up to Day 169)||76
2259935|NCT02375971|5546231|P1|STARTED|Follow-Up Phase (up to Day 169)||73
2259936|NCT02375971|5546229|P3|NOT COMPLETED|Treatment (Day 1 - Baseline)||5
2259937|NCT02375971|5546230|P2|NOT COMPLETED|Treatment (Day 1 - Baseline)||1
2259938|NCT02375971|5546231|P1|NOT COMPLETED|Treatment (Day 1 - Baseline)||1
2259939|NCT02375971|5546229|P3|COMPLETED|Treatment (Day 1 - Baseline)||69
2259940|NCT02375971|5546230|P2|COMPLETED|Treatment (Day 1 - Baseline)||76
2259941|NCT02375971|5546231|P1|COMPLETED|Treatment (Day 1 - Baseline)||73
2259942|NCT02375971|5546229|P3|PK Set|Treatment (Day 1 - Baseline)||0
2259943|NCT02375971|5546230|P2|PK Set|Treatment (Day 1 - Baseline)||46
2259944|NCT02375971|5546231|P1|PK Set|Treatment (Day 1 - Baseline)||49
2259945|NCT02375971|5546229|P3|VEGF Set|Treatment (Day 1 - Baseline)||51
2259946|NCT02375971|5546230|P2|VEGF Set|Treatment (Day 1 - Baseline)||26
2259947|NCT02375971|5546231|P1|VEGF Set|Treatment (Day 1 - Baseline)||19
2259948|NCT02375971|5546229|P3|Safety Set|Treatment (Day 1 - Baseline)||69
2259949|NCT02375971|5546230|P2|Safety Set|Treatment (Day 1 - Baseline)||76
2259950|NCT02375971|5546231|P1|Safety Set|Treatment (Day 1 - Baseline)||73
2259951|NCT02375971|5546229|P3|STARTED|Treatment (Day 1 - Baseline)||74
2259952|NCT02375971|5546230|P2|STARTED|Treatment (Day 1 - Baseline)||77
2259953|NCT02375971|5546231|P1|STARTED|Treatment (Day 1 - Baseline)||74
2259954|NCT02375724|5546273|P2|NOT COMPLETED|Overall Study||6
2259955|NCT02375724|5546274|P1|NOT COMPLETED|Overall Study||6
2259956|NCT02375724|5546273|P2|COMPLETED|Overall Study||128
2259957|NCT02375724|5546274|P1|COMPLETED|Overall Study||129
2259958|NCT02375724|5546273|P2|STARTED|Overall Study||134
2259959|NCT02375724|5546274|P1|STARTED|Overall Study||135
2259960|NCT02375698|5546286|P2|NOT COMPLETED|Overall Study||2
2259961|NCT02375698|5546287|P1|NOT COMPLETED|Overall Study||2
2259962|NCT02375698|5546286|P2|COMPLETED|Overall Study||4
2259963|NCT02375698|5546287|P1|COMPLETED|Overall Study||14
2259964|NCT02375698|5546286|P2|STARTED|Overall Study||6
2259965|NCT02375698|5546287|P1|STARTED|Overall Study||16
2259966|NCT02375373|5546295|P1|NOT COMPLETED|Overall Study||11
2259967|NCT02375373|5546295|P1|COMPLETED|Overall Study||1
2259968|NCT02375373|5546295|P1|STARTED|Overall Study||12
2259969|NCT02375347|5546299|P1|NOT COMPLETED|Overall Study||1
2259970|NCT02375347|5546299|P1|COMPLETED|Overall Study||12
2259971|NCT02375347|5546299|P1|STARTED|Overall Study||13
2259972|NCT02374957|5546305|P2|NOT COMPLETED|Overall Study||0
2259973|NCT02374957|5546306|P1|NOT COMPLETED|Overall Study||1
2259974|NCT02374957|5546305|P2|COMPLETED|Overall Study||9
2259975|NCT02374957|5546306|P1|COMPLETED|Overall Study||10
2259976|NCT02374957|5546305|P2|STARTED|Overall Study||9
2259977|NCT02374957|5546306|P1|STARTED|Overall Study||11
2259978|NCT02374671|5546335|P3|NOT COMPLETED|Implantation- Nonrandomized & Randomized||3
2259979|NCT02374671|5546336|P2|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
2259980|NCT02374671|5546337|P1|NOT COMPLETED|Implantation- Nonrandomized & Randomized||25
2259981|NCT02374671|5546335|P3|COMPLETED|Implantation- Nonrandomized & Randomized|(1) unilaterally implanted subject discontinued (1 eye)|23
2259982|NCT02374671|5546336|P2|COMPLETED|Implantation- Nonrandomized & Randomized||27
2259983|NCT02374671|5546337|P1|COMPLETED|Implantation- Nonrandomized & Randomized||281
2259984|NCT02374671|5546335|P3|STARTED|Implantation- Nonrandomized & Randomized|(3) subjects were unilaterally implanted|26
2259985|NCT02374671|5546336|P2|STARTED|Implantation- Nonrandomized & Randomized|(1) subject was unilaterally implanted|28
2259986|NCT02374671|5546337|P1|STARTED|Implantation- Nonrandomized & Randomized|(8) subjects were unilaterally implanted|306
2259987|NCT02374671|5546335|P3|NOT COMPLETED|Observation (Deferred Implantation)||5
2259988|NCT02374671|5546336|P2|NOT COMPLETED|Observation (Deferred Implantation)||0
2259989|NCT02374671|5546337|P1|NOT COMPLETED|Observation (Deferred Implantation)||0
2259990|NCT02374671|5546335|P3|COMPLETED|Observation (Deferred Implantation)||26
2259991|NCT02374671|5546336|P2|COMPLETED|Observation (Deferred Implantation)||0
2259992|NCT02374671|5546337|P1|COMPLETED|Observation (Deferred Implantation)||0
2259993|NCT02374671|5546335|P3|STARTED|Observation (Deferred Implantation)||31
2259994|NCT02374671|5546336|P2|STARTED|Observation (Deferred Implantation)||0
2259995|NCT02374671|5546337|P1|STARTED|Observation (Deferred Implantation)||0
2259996|NCT02374593|5546345|P2|NOT COMPLETED|Overall Study||0
2259997|NCT02374593|5546346|P1|NOT COMPLETED|Overall Study||2
2259998|NCT02374593|5546345|P2|COMPLETED|Overall Study||44
2259999|NCT02374593|5546346|P1|COMPLETED|Overall Study||22
2260000|NCT02374593|5546345|P2|STARTED|Overall Study||44
2260001|NCT02374593|5546346|P1|STARTED|Overall Study||24
2260002|NCT02374398|5546360|P4|NOT COMPLETED|Overall Study||0
2260003|NCT02374398|5546361|P3|NOT COMPLETED|Overall Study||3
2260004|NCT02374398|5546362|P2|NOT COMPLETED|Overall Study||1
2260005|NCT02374398|5546363|P1|NOT COMPLETED|Overall Study||2
2260006|NCT02374398|5546360|P4|COMPLETED|Overall Study||32
2260007|NCT02374398|5546361|P3|COMPLETED|Overall Study||29
2260008|NCT02374398|5546362|P2|COMPLETED|Overall Study||31
2260009|NCT02374398|5546363|P1|COMPLETED|Overall Study||29
2260010|NCT02374398|5546360|P4|STARTED|Overall Study||32
2260011|NCT02374398|5546361|P3|STARTED|Overall Study||32
2260012|NCT02374398|5546362|P2|STARTED|Overall Study||32
2260013|NCT02374398|5546363|P1|STARTED|Overall Study||31
2260014|NCT02374346|5546389|P1|NOT COMPLETED|Overall Study||48
2260015|NCT02374346|5546389|P1|COMPLETED|Overall Study||446
2260016|NCT02374346|5546389|P1|STARTED|Overall Study||494
2260017|NCT02374307|5546397|P2|NOT COMPLETED|6-months Follow-up||6
2260018|NCT02374307|5546398|P1|NOT COMPLETED|6-months Follow-up||3
2260019|NCT02374307|5546397|P2|COMPLETED|6-months Follow-up||64
2260020|NCT02374307|5546398|P1|COMPLETED|6-months Follow-up||71
2260021|NCT02374307|5546397|P2|STARTED|6-months Follow-up|1 subject missed the first follow-up, but continued the study and was assessed at 6 months.|70
2260022|NCT02374307|5546398|P1|STARTED|6-months Follow-up|5 subjects missed the first follow-up, but continued the study and were assessed at 6 months.|74
2260023|NCT02374307|5546397|P2|NOT COMPLETED|3-months Follow-up||9
2260024|NCT02374307|5546398|P1|NOT COMPLETED|3-months Follow-up||8
2260025|NCT02374307|5546397|P2|COMPLETED|3-months Follow-up||69
2260026|NCT02374307|5546398|P1|COMPLETED|3-months Follow-up||69
2260027|NCT02374307|5546397|P2|STARTED|3-months Follow-up||78
2260028|NCT02374307|5546398|P1|STARTED|3-months Follow-up||77
2260029|NCT02374255|5546429|P4|NOT COMPLETED|Overall Study||0
2260030|NCT02374255|5546430|P3|NOT COMPLETED|Overall Study||0
2260031|NCT02374255|5546431|P2|NOT COMPLETED|Overall Study||0
2260032|NCT02374255|5546432|P1|NOT COMPLETED|Overall Study||2
2260033|NCT02374255|5546429|P4|COMPLETED|Overall Study||11
2260034|NCT02374255|5546430|P3|COMPLETED|Overall Study||11
2260035|NCT02374255|5546431|P2|COMPLETED|Overall Study||110
2260036|NCT02374255|5546432|P1|COMPLETED|Overall Study||153
2260037|NCT02374255|5546429|P4|STARTED|Overall Study||11
2260038|NCT02374255|5546430|P3|STARTED|Overall Study||11
2260039|NCT02374255|5546431|P2|STARTED|Overall Study||110
2260040|NCT02374255|5546432|P1|STARTED|Overall Study||155
2260041|NCT02374164|5546453|P3|NOT COMPLETED|Treatment Period 3||0
2260042|NCT02374164|5546454|P2|NOT COMPLETED|Treatment Period 3||0
2260043|NCT02374164|5546455|P1|NOT COMPLETED|Treatment Period 3||0
2260044|NCT02374164|5546453|P3|COMPLETED|Treatment Period 3||12
2260045|NCT02374164|5546454|P2|COMPLETED|Treatment Period 3||11
2260046|NCT02374164|5546455|P1|COMPLETED|Treatment Period 3||12
2260047|NCT02374164|5546453|P3|STARTED|Treatment Period 3||12
2260048|NCT02374164|5546454|P2|STARTED|Treatment Period 3|One participant was Lost-to-Follow-Up prior to treatment A.|11
2260049|NCT02374164|5546455|P1|STARTED|Treatment Period 3||12
2260050|NCT02374164|5546453|P3|NOT COMPLETED|Treatment Period 2||0
2260051|NCT02374164|5546454|P2|NOT COMPLETED|Treatment Period 2||0
2260052|NCT02374164|5546455|P1|NOT COMPLETED|Treatment Period 2||0
2260053|NCT02374164|5546453|P3|COMPLETED|Treatment Period 2||12
2260054|NCT02374164|5546454|P2|COMPLETED|Treatment Period 2||12
2260055|NCT02374164|5546455|P1|COMPLETED|Treatment Period 2||12
2260056|NCT02374164|5546453|P3|STARTED|Treatment Period 2||12
2260057|NCT02374164|5546454|P2|STARTED|Treatment Period 2||12
2260058|NCT02374164|5546455|P1|STARTED|Treatment Period 2||12
2260059|NCT02374164|5546453|P3|NOT COMPLETED|Treatment Period 1||0
2260060|NCT02374164|5546454|P2|NOT COMPLETED|Treatment Period 1||0
2260061|NCT02374164|5546455|P1|NOT COMPLETED|Treatment Period 1||0
2260062|NCT02374164|5546453|P3|COMPLETED|Treatment Period 1||12
2260063|NCT02374164|5546454|P2|COMPLETED|Treatment Period 1||12
2260064|NCT02374164|5546455|P1|COMPLETED|Treatment Period 1||12
2260065|NCT02374164|5546453|P3|STARTED|Treatment Period 1||12
2260066|NCT02374164|5546454|P2|STARTED|Treatment Period 1||12
2260067|NCT02374164|5546455|P1|STARTED|Treatment Period 1||12
2260068|NCT02374138|5546474|P2|NOT COMPLETED|Twelve Month FollowUp||12
2260069|NCT02374138|5546475|P1|NOT COMPLETED|Twelve Month FollowUp||9
2260070|NCT02374138|5546474|P2|COMPLETED|Twelve Month FollowUp||95
2260071|NCT02374138|5546475|P1|COMPLETED|Twelve Month FollowUp||101
2260072|NCT02374138|5546474|P2|STARTED|Twelve Month FollowUp||107
2260073|NCT02374138|5546475|P1|STARTED|Twelve Month FollowUp||110
2260074|NCT02374138|5546474|P2|NOT COMPLETED|Six Month Follow Up||14
2260075|NCT02374138|5546475|P1|NOT COMPLETED|Six Month Follow Up||8
2260076|NCT02374138|5546474|P2|COMPLETED|Six Month Follow Up|6 Month Follow Up|93
2260077|NCT02374138|5546475|P1|COMPLETED|Six Month Follow Up|6 Month Follow Up|102
2260078|NCT02374138|5546474|P2|STARTED|Six Month Follow Up||107
2260079|NCT02374138|5546475|P1|STARTED|Six Month Follow Up||110
2260080|NCT02374099|5546533|P2|NOT COMPLETED|Overall Study||49
2260081|NCT02374099|5546534|P1|NOT COMPLETED|Overall Study||48
2260082|NCT02374099|5546533|P2|COMPLETED|Overall Study||0
2260083|NCT02374099|5546534|P1|COMPLETED|Overall Study||0
2260084|NCT02374099|5546533|P2|Participants Treated|Overall Study|1 participant randomized, but not treated|48
2260085|NCT02374099|5546534|P1|Participants Treated|Overall Study|2 participants randomized, but not treated|46
2260086|NCT02374099|5546533|P2|STARTED|Overall Study||49
2260087|NCT02374099|5546534|P1|STARTED|Overall Study||48
2260088|NCT02374060|5546553|P3|NOT COMPLETED|Overall Study||3
2260089|NCT02374060|5546554|P2|NOT COMPLETED|Overall Study||1
2260090|NCT02374060|5546555|P1|NOT COMPLETED|Overall Study||2
2260091|NCT02374060|5546553|P3|COMPLETED|Overall Study||61
2260092|NCT02374060|5546554|P2|COMPLETED|Overall Study||62
2260093|NCT02374060|5546555|P1|COMPLETED|Overall Study||63
2260094|NCT02374060|5546553|P3|STARTED|Overall Study||64
2260095|NCT02374060|5546554|P2|STARTED|Overall Study||63
2260096|NCT02374060|5546555|P1|STARTED|Overall Study||65
2260097|NCT02373865|5546607|P2|NOT COMPLETED|Overall Study||0
2260098|NCT02373865|5546608|P1|NOT COMPLETED|Overall Study||0
2260099|NCT02373865|5546607|P2|COMPLETED|Overall Study||2
2260100|NCT02373865|5546608|P1|COMPLETED|Overall Study||2
2260101|NCT02373865|5546607|P2|STARTED|Overall Study||2
2260102|NCT02373865|5546608|P1|STARTED|Overall Study||2
2260103|NCT02373852|5546618|P1|NOT COMPLETED|Overall Study||1
2260104|NCT02373852|5546618|P1|COMPLETED|Overall Study||11
2260105|NCT02373852|5546618|P1|STARTED|Overall Study|Includes patients from a previous retrospective study NCT01042444|12
2260106|NCT02373371|5546625|P2|NOT COMPLETED|Overall Study||0
2260107|NCT02373371|5546626|P1|NOT COMPLETED|Overall Study||0
2260108|NCT02373371|5546625|P2|COMPLETED|Overall Study||13
2260109|NCT02373371|5546626|P1|COMPLETED|Overall Study||13
2260110|NCT02373371|5546625|P2|STARTED|Overall Study||13
2260111|NCT02373371|5546626|P1|STARTED|Overall Study||13
2260112|NCT02373202|5546642|P4|NOT COMPLETED|Overall Study||1
2260113|NCT02373202|5546643|P3|NOT COMPLETED|Overall Study||3
2260114|NCT02373202|5546644|P2|NOT COMPLETED|Overall Study||6
2260115|NCT02373202|5546645|P1|NOT COMPLETED|Overall Study||2
2260116|NCT02373202|5546642|P4|COMPLETED|Overall Study||30
2260117|NCT02373202|5546643|P3|COMPLETED|Overall Study||27
2260118|NCT02373202|5546644|P2|COMPLETED|Overall Study||9
2260119|NCT02373202|5546645|P1|COMPLETED|Overall Study||13
2260120|NCT02373202|5546642|P4|STARTED|Overall Study||31
2260121|NCT02373202|5546643|P3|STARTED|Overall Study||30
2260122|NCT02373202|5546644|P2|STARTED|Overall Study||15
2260123|NCT02373202|5546645|P1|STARTED|Overall Study||15
2260124|NCT02373137|5546697|P2|NOT COMPLETED|Overall Study||1
2260125|NCT02373137|5546698|P1|NOT COMPLETED|Overall Study||1
2260126|NCT02373137|5546697|P2|COMPLETED|Overall Study||18
2260127|NCT02373137|5546698|P1|COMPLETED|Overall Study||18
2260128|NCT02373137|5546697|P2|12-Month Follow-Up|Overall Study||19
2260129|NCT02373137|5546698|P1|12-Month Follow-Up|Overall Study||19
2260130|NCT02373137|5546697|P2|6-Month Follow-Up|Overall Study||18
2260131|NCT02373137|5546698|P1|6-Month Follow-Up|Overall Study||19
2260132|NCT02373137|5546697|P2|3-Month Follow-Up|Overall Study||19
2260133|NCT02373137|5546698|P1|3-Month Follow-Up|Overall Study||19
2260134|NCT02373137|5546697|P2|STARTED|Overall Study||19
2260135|NCT02373137|5546698|P1|STARTED|Overall Study||19
2260136|NCT02373124|5546714|P1|NOT COMPLETED|Overall Study||1
2260137|NCT02373124|5546714|P1|COMPLETED|Overall Study||3
2260138|NCT02373124|5546714|P1|STARTED|Overall Study||4
2260139|NCT02373098|5546720|P2|NOT COMPLETED|Overall Study||0
2260140|NCT02373098|5546721|P1|NOT COMPLETED|Overall Study||12
2260141|NCT02373098|5546720|P2|COMPLETED|Overall Study||60
2260142|NCT02373098|5546721|P1|COMPLETED|Overall Study||54
2260143|NCT02373098|5546720|P2|STARTED|Overall Study||60
2260144|NCT02373098|5546721|P1|STARTED|Overall Study||66
2260145|NCT02372799|5546749|P3|NOT COMPLETED|Down-taper Period||2
2260146|NCT02372799|5546750|P2|NOT COMPLETED|Down-taper Period||2
2260147|NCT02372799|5546751|P1|NOT COMPLETED|Down-taper Period||1
2260148|NCT02372799|5546749|P3|COMPLETED|Down-taper Period||80
2260149|NCT02372799|5546750|P2|COMPLETED|Down-taper Period||157
2260150|NCT02372799|5546751|P1|COMPLETED|Down-taper Period||151
2260151|NCT02372799|5546749|P3|STARTED|Down-taper Period||82
2260152|NCT02372799|5546750|P2|STARTED|Down-taper Period||159
2260153|NCT02372799|5546751|P1|STARTED|Down-taper Period||152
2260154|NCT02372799|5546749|P3|NOT COMPLETED|Treatment Period||15
2260155|NCT02372799|5546750|P2|NOT COMPLETED|Treatment Period||32
2260156|NCT02372799|5546751|P1|NOT COMPLETED|Treatment Period||34
2260157|NCT02372799|5546749|P3|COMPLETED|Treatment Period||82
2260158|NCT02372799|5546750|P2|COMPLETED|Treatment Period||155
2260159|NCT02372799|5546751|P1|COMPLETED|Treatment Period||152
2260160|NCT02372799|5546749|P3|STARTED|Treatment Period||97
2260161|NCT02372799|5546750|P2|STARTED|Treatment Period||187
2260162|NCT02372799|5546751|P1|STARTED|Treatment Period||186
2260163|NCT02372682|5546764|P2|NOT COMPLETED|Overall Study||14
2260164|NCT02372682|5546765|P1|NOT COMPLETED|Overall Study||8
2260165|NCT02372682|5546764|P2|COMPLETED|Overall Study||79
2260166|NCT02372682|5546765|P1|COMPLETED|Overall Study||70
2260167|NCT02372682|5546764|P2|STARTED|Overall Study||93
2260168|NCT02372682|5546765|P1|STARTED|Overall Study||78
2260169|NCT02372396|5546780|P2|NOT COMPLETED|Overall Study||9
2260170|NCT02372396|5546781|P1|NOT COMPLETED|Overall Study||7
2260171|NCT02372396|5546780|P2|COMPLETED|Overall Study||11
2260172|NCT02372396|5546781|P1|COMPLETED|Overall Study||10
2260173|NCT02372396|5546780|P2|Began Intervention|Overall Study||14
2260174|NCT02372396|5546781|P1|Began Intervention|Overall Study||14
2260175|NCT02372396|5546780|P2|STARTED|Overall Study||20
2260176|NCT02372396|5546781|P1|STARTED|Overall Study||17
2260177|NCT02372344|5546787|P3|NOT COMPLETED|Period 3 (Visit 4)||0
2260178|NCT02372344|5546788|P2|NOT COMPLETED|Period 3 (Visit 4)||0
2260179|NCT02372344|5546789|P1|NOT COMPLETED|Period 3 (Visit 4)||0
2260180|NCT02372344|5546787|P3|COMPLETED|Period 3 (Visit 4)||14
2260181|NCT02372344|5546788|P2|COMPLETED|Period 3 (Visit 4)||14
2260182|NCT02372344|5546789|P1|COMPLETED|Period 3 (Visit 4)||14
2260183|NCT02372344|5546787|P3|STARTED|Period 3 (Visit 4)||14
2260184|NCT02372344|5546788|P2|STARTED|Period 3 (Visit 4)||14
2260185|NCT02372344|5546789|P1|STARTED|Period 3 (Visit 4)||14
2260186|NCT02372344|5546787|P3|NOT COMPLETED|Period 2 (Visit 3)||0
2260187|NCT02372344|5546788|P2|NOT COMPLETED|Period 2 (Visit 3)||0
2260188|NCT02372344|5546789|P1|NOT COMPLETED|Period 2 (Visit 3)||0
2260189|NCT02372344|5546787|P3|COMPLETED|Period 2 (Visit 3)||14
2260190|NCT02372344|5546788|P2|COMPLETED|Period 2 (Visit 3)||14
2260191|NCT02372344|5546789|P1|COMPLETED|Period 2 (Visit 3)||14
2260192|NCT02372344|5546787|P3|STARTED|Period 2 (Visit 3)||14
2260193|NCT02372344|5546788|P2|STARTED|Period 2 (Visit 3)||14
2260194|NCT02372344|5546789|P1|STARTED|Period 2 (Visit 3)||14
2260195|NCT02372344|5546787|P3|NOT COMPLETED|Period 1 (Visit 2)||0
2260196|NCT02372344|5546788|P2|NOT COMPLETED|Period 1 (Visit 2)||0
2260197|NCT02372344|5546789|P1|NOT COMPLETED|Period 1 (Visit 2)||0
2260198|NCT02372344|5546787|P3|COMPLETED|Period 1 (Visit 2)||14
2260199|NCT02372344|5546788|P2|COMPLETED|Period 1 (Visit 2)||14
2260200|NCT02372344|5546789|P1|COMPLETED|Period 1 (Visit 2)||14
2260201|NCT02372344|5546787|P3|STARTED|Period 1 (Visit 2)||14
2260202|NCT02372344|5546788|P2|STARTED|Period 1 (Visit 2)||14
2260203|NCT02372344|5546789|P1|STARTED|Period 1 (Visit 2)||14
2260204|NCT02372253|5546805|P2|NOT COMPLETED|Overall Study||0
2260205|NCT02372253|5546806|P1|NOT COMPLETED|Overall Study||2
2260206|NCT02372253|5546805|P2|COMPLETED|Overall Study||13
2260207|NCT02372253|5546806|P1|COMPLETED|Overall Study||11
2260208|NCT02372253|5546805|P2|STARTED|Overall Study||13
2260209|NCT02372253|5546806|P1|STARTED|Overall Study||13
2260210|NCT02372097|5546824|P2|NOT COMPLETED|Second Intervention Period (8 Days)||0
2260211|NCT02372097|5546825|P1|NOT COMPLETED|Second Intervention Period (8 Days)||0
2260212|NCT02372097|5546824|P2|COMPLETED|Second Intervention Period (8 Days)||12
2260213|NCT02372097|5546825|P1|COMPLETED|Second Intervention Period (8 Days)||12
2260214|NCT02372097|5546824|P2|STARTED|Second Intervention Period (8 Days)||12
2260215|NCT02372097|5546825|P1|STARTED|Second Intervention Period (8 Days)||12
2260216|NCT02372097|5546824|P2|NOT COMPLETED|Wash Out Period (13 Days)||0
2260217|NCT02372097|5546825|P1|NOT COMPLETED|Wash Out Period (13 Days)||0
2260218|NCT02372097|5546824|P2|COMPLETED|Wash Out Period (13 Days)||12
2260219|NCT02372097|5546825|P1|COMPLETED|Wash Out Period (13 Days)||12
2260220|NCT02372097|5546824|P2|STARTED|Wash Out Period (13 Days)||12
2260221|NCT02372097|5546825|P1|STARTED|Wash Out Period (13 Days)||12
2260222|NCT02372097|5546824|P2|NOT COMPLETED|First Intervention Period (8 Days)||0
2260223|NCT02372097|5546825|P1|NOT COMPLETED|First Intervention Period (8 Days)||0
2260224|NCT02372097|5546824|P2|COMPLETED|First Intervention Period (8 Days)||12
2260225|NCT02372097|5546825|P1|COMPLETED|First Intervention Period (8 Days)||12
2260226|NCT02372097|5546824|P2|STARTED|First Intervention Period (8 Days)||12
2260227|NCT02372097|5546825|P1|STARTED|First Intervention Period (8 Days)||12
2260228|NCT02372071|5546851|P1|NOT COMPLETED|Overall Study||18
2260229|NCT02372071|5546851|P1|COMPLETED|Overall Study||93
2260230|NCT02372071|5546851|P1|STARTED|Overall Study||111
2260231|NCT02372058|5546856|P1|NOT COMPLETED|Overall Study||3
2260232|NCT02372058|5546856|P1|COMPLETED|Overall Study||100
2260233|NCT02372058|5546856|P1|STARTED|Overall Study||103
2260234|NCT02371876|5546862|P1|NOT COMPLETED|Overall Study||0
2260235|NCT02371876|5546862|P1|COMPLETED|Overall Study||134
2260236|NCT02371876|5546862|P1|STARTED|Overall Study||134
2260237|NCT02371850|5546872|P1|NOT COMPLETED|Overall Study||0
2260238|NCT02371850|5546872|P1|COMPLETED|Overall Study||10
2260239|NCT02371850|5546872|P1|STARTED|Overall Study||10
2260240|NCT02371785|5546877|P1|NOT COMPLETED|Overall Study||0
2260241|NCT02371785|5546877|P1|COMPLETED|Overall Study||20
2260242|NCT02371785|5546877|P1|STARTED|Overall Study||20
2260243|NCT02371759|5546895|P8|NOT COMPLETED|Overall Study||4
2260244|NCT02371759|5546896|P7|NOT COMPLETED|Overall Study||0
2260245|NCT02371759|5546897|P6|NOT COMPLETED|Overall Study||1
2260246|NCT02371759|5546898|P5|NOT COMPLETED|Overall Study||3
2260247|NCT02371759|5546899|P4|NOT COMPLETED|Overall Study||0
2260248|NCT02371759|5546900|P3|NOT COMPLETED|Overall Study||1
2260249|NCT02371759|5546901|P2|NOT COMPLETED|Overall Study||1
2260250|NCT02371759|5546902|P1|NOT COMPLETED|Overall Study||3
2260251|NCT02371759|5546895|P8|COMPLETED|Overall Study||24
2260252|NCT02371759|5546896|P7|COMPLETED|Overall Study||25
2260253|NCT02371759|5546897|P6|COMPLETED|Overall Study||25
2260254|NCT02371759|5546898|P5|COMPLETED|Overall Study||24
2260255|NCT02371759|5546899|P4|COMPLETED|Overall Study||31
2260256|NCT02371759|5546900|P3|COMPLETED|Overall Study||32
2260257|NCT02371759|5546901|P2|COMPLETED|Overall Study||30
2260258|NCT02371759|5546902|P1|COMPLETED|Overall Study||29
2260259|NCT02371759|5546895|P8|STARTED|Overall Study||28
2260260|NCT02371759|5546896|P7|STARTED|Overall Study||25
2260261|NCT02371759|5546897|P6|STARTED|Overall Study||26
2260262|NCT02371759|5546898|P5|STARTED|Overall Study||27
2260263|NCT02371759|5546899|P4|STARTED|Overall Study||31
2260264|NCT02371759|5546900|P3|STARTED|Overall Study||33
2260265|NCT02371759|5546901|P2|STARTED|Overall Study||31
2260266|NCT02371759|5546902|P1|STARTED|Overall Study||32
2260267|NCT02371746|5547119|P7|NOT COMPLETED|Overall Study||1
2260268|NCT02371746|5547120|P6|NOT COMPLETED|Overall Study||0
2260269|NCT02371746|5547121|P5|NOT COMPLETED|Overall Study||0
2260270|NCT02371746|5547122|P4|NOT COMPLETED|Overall Study||0
2260271|NCT02371746|5547123|P3|NOT COMPLETED|Overall Study||0
2260272|NCT02371746|5547124|P2|NOT COMPLETED|Overall Study||0
2260273|NCT02371746|5547125|P1|NOT COMPLETED|Overall Study||0
2260274|NCT02371746|5547119|P7|COMPLETED|Overall Study||8
2260275|NCT02371746|5547120|P6|COMPLETED|Overall Study||6
2260276|NCT02371746|5547121|P5|COMPLETED|Overall Study||5
2260277|NCT02371746|5547122|P4|COMPLETED|Overall Study||2
2260278|NCT02371746|5547123|P3|COMPLETED|Overall Study||2
2260279|NCT02371746|5547124|P2|COMPLETED|Overall Study||10
2260280|NCT02371746|5547125|P1|COMPLETED|Overall Study||7
2260281|NCT02371746|5547119|P7|STARTED|Overall Study||9
2260282|NCT02371746|5547120|P6|STARTED|Overall Study||6
2260283|NCT02371746|5547121|P5|STARTED|Overall Study||5
2260284|NCT02371746|5547122|P4|STARTED|Overall Study||2
2260285|NCT02371746|5547123|P3|STARTED|Overall Study||2
2260286|NCT02371746|5547124|P2|STARTED|Overall Study||10
2260287|NCT02371746|5547125|P1|STARTED|Overall Study||7
2260294|NCT02371629|5547168|P2|NOT COMPLETED|Overall Study||25
2260295|NCT02371629|5547169|P1|NOT COMPLETED|Overall Study||26
2260296|NCT02371629|5547168|P2|COMPLETED|Overall Study||363
2260297|NCT02371629|5547169|P1|COMPLETED|Overall Study||362
2260298|NCT02371629|5547168|P2|STARTED|Overall Study||388
2260299|NCT02371629|5547169|P1|STARTED|Overall Study||388
2260300|NCT02371616|5547205|P2|NOT COMPLETED|Overall Study||7
2260301|NCT02371616|5547206|P1|NOT COMPLETED|Overall Study||4
2260302|NCT02371616|5547205|P2|COMPLETED|Overall Study||147
2260303|NCT02371616|5547206|P1|COMPLETED|Overall Study||146
2260304|NCT02371616|5547205|P2|STARTED|Overall Study||154
2260305|NCT02371616|5547206|P1|STARTED|Overall Study||150
2260306|NCT02371395|5547218|P1|NOT COMPLETED|Overall Study||0
2260307|NCT02371395|5547218|P1|COMPLETED|Overall Study||1000
2260308|NCT02371395|5547218|P1|STARTED|Overall Study||1000
2260309|NCT02371369|5547224|P2|NOT COMPLETED|Part 2||4
2260310|NCT02371369|5547225|P1|NOT COMPLETED|Part 2||9
2260311|NCT02371369|5547224|P2|COMPLETED|Part 2||26
2260312|NCT02371369|5547225|P1|COMPLETED|Part 2||39
2260313|NCT02371369|5547224|P2|STARTED|Part 2|N=30; Only participants who were eligible to receive treatment in Part 2.|30
2260314|NCT02371369|5547225|P1|STARTED|Part 2|N=48; Only participants who were eligible to receive treatment in Part 2.|48
2260315|NCT02371369|5547224|P2|NOT COMPLETED|Part 1||11
2260316|NCT02371369|5547225|P1|NOT COMPLETED|Part 1||9
2260317|NCT02371369|5547224|P2|COMPLETED|Part 1||48
2260318|NCT02371369|5547225|P1|COMPLETED|Part 1||52
2260319|NCT02371369|5547224|P2|STARTED|Part 1||59
2260320|NCT02371369|5547225|P1|STARTED|Part 1||61
2260321|NCT02371187|5547275|P2|NOT COMPLETED|Overall Study||4
2260322|NCT02371187|5547276|P1|NOT COMPLETED|Overall Study||3
2260323|NCT02371187|5547275|P2|COMPLETED|Overall Study||15
2260324|NCT02371187|5547276|P1|COMPLETED|Overall Study||15
2260325|NCT02371187|5547275|P2|STARTED|Overall Study||19
2260326|NCT02371187|5547276|P1|STARTED|Overall Study||18
2260327|NCT02370914|5547290|P1|NOT COMPLETED|Overall Study||2
2260328|NCT02370914|5547290|P1|COMPLETED|Overall Study||82
2260329|NCT02370914|5547290|P1|STARTED|Overall Study||84
2260330|NCT02370888|5547298|P1|NOT COMPLETED|Overall Study||8
2260331|NCT02370888|5547298|P1|COMPLETED|Overall Study||1
2260332|NCT02370888|5547298|P1|Proceed to Treatment|Overall Study||3
2260333|NCT02370888|5547298|P1|STARTED|Overall Study||9
2260334|NCT02370667|5547309|P3|NOT COMPLETED|Overall Study||0
2260335|NCT02370667|5547310|P2|NOT COMPLETED|Overall Study||1
2260336|NCT02370667|5547311|P1|NOT COMPLETED|Overall Study||0
2260337|NCT02370667|5547309|P3|COMPLETED|Overall Study||10
2260338|NCT02370667|5547310|P2|COMPLETED|Overall Study||10
2260339|NCT02370667|5547311|P1|COMPLETED|Overall Study||10
2260340|NCT02370667|5547309|P3|STARTED|Overall Study||10
2260341|NCT02370667|5547310|P2|STARTED|Overall Study||11
2260342|NCT02370667|5547311|P1|STARTED|Overall Study||10
2260343|NCT02370641|5547375|P2|NOT COMPLETED|Overall Study||2
2260344|NCT02370641|5547376|P1|NOT COMPLETED|Overall Study||4
2260345|NCT02370641|5547375|P2|COMPLETED|Overall Study||6
2260346|NCT02370641|5547376|P1|COMPLETED|Overall Study||14
2260347|NCT02370641|5547375|P2|STARTED|Overall Study||8
2260348|NCT02370641|5547376|P1|STARTED|Overall Study||18
2260349|NCT02370615|5547384|P2|NOT COMPLETED|Overall Study||0
2260350|NCT02370615|5547385|P1|NOT COMPLETED|Overall Study||1
2260351|NCT02370615|5547384|P2|COMPLETED|Overall Study||18
2260352|NCT02370615|5547385|P1|COMPLETED|Overall Study||15
2260353|NCT02370615|5547384|P2|STARTED|Overall Study||18
2260354|NCT02370615|5547385|P1|STARTED|Overall Study||16
2260355|NCT02370602|5547428|P6|NOT COMPLETED|Overall Study||0
2260356|NCT02370602|5547429|P5|NOT COMPLETED|Overall Study||0
2260357|NCT02370602|5547430|P4|NOT COMPLETED|Overall Study||0
2260358|NCT02370602|5547431|P3|NOT COMPLETED|Overall Study||0
2260359|NCT02370602|5547432|P2|NOT COMPLETED|Overall Study||0
2260360|NCT02370602|5547433|P1|NOT COMPLETED|Overall Study||1
2260361|NCT02370602|5547428|P6|COMPLETED|Overall Study||2
2260362|NCT02370602|5547429|P5|COMPLETED|Overall Study||3
2260363|NCT02370602|5547430|P4|COMPLETED|Overall Study||3
2260364|NCT02370602|5547431|P3|COMPLETED|Overall Study||2
2260365|NCT02370602|5547432|P2|COMPLETED|Overall Study||2
2260366|NCT02370602|5547433|P1|COMPLETED|Overall Study||0
2260367|NCT02370602|5547428|P6|STARTED|Overall Study||2
2260368|NCT02370602|5547429|P5|STARTED|Overall Study||3
2260369|NCT02370602|5547430|P4|STARTED|Overall Study||3
2260370|NCT02370602|5547431|P3|STARTED|Overall Study||2
2260371|NCT02370602|5547432|P2|STARTED|Overall Study||2
2260372|NCT02370602|5547433|P1|STARTED|Overall Study||1
2260373|NCT02370537|5547527|P3|NOT COMPLETED|Part B||259
2260374|NCT02370537|5547528|P2|NOT COMPLETED|Part B||3
2260375|NCT02370537|5547529|P1|NOT COMPLETED|Part B||1
2260376|NCT02370537|5547527|P3|COMPLETED|Part B||23
2260377|NCT02370537|5547528|P2|COMPLETED|Part B||12
2260378|NCT02370537|5547529|P1|COMPLETED|Part B||15
2260379|NCT02370537|5547527|P3|Period 2 Sequence BA|Part B||12
2260380|NCT02370537|5547528|P2|Period 2 Sequence BA|Part B||7
2260381|NCT02370537|5547529|P1|Period 2 Sequence BA|Part B||7
2260382|NCT02370537|5547527|P3|Period 2 Sequence AB|Part B||11
2260383|NCT02370537|5547528|P2|Period 2 Sequence AB|Part B||5
2260384|NCT02370537|5547529|P1|Period 2 Sequence AB|Part B||8
2260385|NCT02370537|5547527|P3|Period 1 Sequence BA|Part B||12
2260386|NCT02370537|5547528|P2|Period 1 Sequence BA|Part B||7
2260387|NCT02370537|5547529|P1|Period 1 Sequence BA|Part B||7
2260388|NCT02370537|5547527|P3|Period 1 Sequence AB|Part B||11
2260389|NCT02370537|5547528|P2|Period 1 Sequence AB|Part B||6
2260390|NCT02370537|5547529|P1|Period 1 Sequence AB|Part B||8
2260391|NCT02370537|5547527|P3|Eligible for Randomisation|Part B||23
2260392|NCT02370537|5547528|P2|Eligible for Randomisation|Part B||13
2260393|NCT02370537|5547529|P1|Eligible for Randomisation|Part B||15
2260394|NCT02370537|5547527|P3|STARTED|Part B||282
2260395|NCT02370537|5547528|P2|STARTED|Part B||15
2260396|NCT02370537|5547529|P1|STARTED|Part B||16
2260397|NCT02370537|5547527|P3|NOT COMPLETED|Part A (Open-label Recruitment)||1
2260398|NCT02370537|5547528|P2|NOT COMPLETED|Part A (Open-label Recruitment)||1
2260399|NCT02370537|5547529|P1|NOT COMPLETED|Part A (Open-label Recruitment)||0
2260400|NCT02370537|5547527|P3|COMPLETED|Part A (Open-label Recruitment)||282
2260401|NCT02370537|5547528|P2|COMPLETED|Part A (Open-label Recruitment)||15
2260402|NCT02370537|5547529|P1|COMPLETED|Part A (Open-label Recruitment)||16
2260403|NCT02370537|5547527|P3|STARTED|Part A (Open-label Recruitment)||283
2260404|NCT02370537|5547528|P2|STARTED|Part A (Open-label Recruitment)||16
2260405|NCT02370537|5547529|P1|STARTED|Part A (Open-label Recruitment)||16
2260406|NCT02370498|5547578|P2|NOT COMPLETED|Overall Study||296
2260407|NCT02370498|5547579|P1|NOT COMPLETED|Overall Study||296
2260408|NCT02370498|5547578|P2|COMPLETED|Overall Study||0
2260409|NCT02370498|5547579|P1|COMPLETED|Overall Study||0
2260410|NCT02370498|5547578|P2|PD-L1 Positive Participants|Overall Study||199
2260411|NCT02370498|5547579|P1|PD-L1 Positive Participants|Overall Study||196
2260412|NCT02370498|5547578|P2|Treated|Overall Study||276
2260413|NCT02370498|5547579|P1|Treated|Overall Study||294
2260414|NCT02370498|5547578|P2|STARTED|Overall Study||296
2260415|NCT02370498|5547579|P1|STARTED|Overall Study||296
2260416|NCT02370420|5547633|P2|NOT COMPLETED|Overall Study||12
2260417|NCT02370420|5547634|P1|NOT COMPLETED|Overall Study||14
2260418|NCT02370420|5547633|P2|COMPLETED|Overall Study||15
2260419|NCT02370420|5547634|P1|COMPLETED|Overall Study||15
2260420|NCT02370420|5547633|P2|STARTED|Overall Study||27
2260421|NCT02370420|5547634|P1|STARTED|Overall Study||29
2260422|NCT02370407|5547646|P2|NOT COMPLETED|Overall Study||0
2260423|NCT02370407|5547647|P1|NOT COMPLETED|Overall Study||0
2260424|NCT02370407|5547646|P2|COMPLETED|Overall Study||20
2260425|NCT02370407|5547647|P1|COMPLETED|Overall Study||20
2260426|NCT02370407|5547646|P2|STARTED|Overall Study||20
2260427|NCT02370407|5547647|P1|STARTED|Overall Study||20
2260428|NCT02370394|5547671|P2|NOT COMPLETED|Overall Study||2
2260429|NCT02370394|5547672|P1|NOT COMPLETED|Overall Study||2
2260430|NCT02370394|5547671|P2|COMPLETED|Overall Study||23
2260431|NCT02370394|5547672|P1|COMPLETED|Overall Study||26
2260432|NCT02370394|5547671|P2|STARTED|Overall Study||25
2260433|NCT02370394|5547672|P1|STARTED|Overall Study||28
2260434|NCT02370251|5547686|P1|NOT COMPLETED|Overall Study||11
2260435|NCT02370251|5547686|P1|COMPLETED|Overall Study||52
2260436|NCT02370251|5547686|P1|STARTED|Overall Study||63
2260437|NCT02370160|5547692|P3|NOT COMPLETED|Overall Study||1
2260438|NCT02370160|5547693|P2|NOT COMPLETED|Overall Study||4
2260439|NCT02370160|5547694|P1|NOT COMPLETED|Overall Study||3
2260440|NCT02370160|5547692|P3|COMPLETED|Overall Study||2
2260441|NCT02370160|5547693|P2|COMPLETED|Overall Study||2
2260442|NCT02370160|5547694|P1|COMPLETED|Overall Study||6
2260443|NCT02370160|5547692|P3|STARTED|Overall Study||3
2260444|NCT02370160|5547693|P2|STARTED|Overall Study||6
2260445|NCT02370160|5547694|P1|STARTED|Overall Study||9
2260446|NCT02370121|5547718|P2|NOT COMPLETED|Overall Study||1
2260447|NCT02370121|5547719|P1|NOT COMPLETED|Overall Study||1
2260448|NCT02370121|5547718|P2|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
2260449|NCT02370121|5547719|P1|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
2260450|NCT02370121|5547718|P2|STARTED|Overall Study||12
2260451|NCT02370121|5547719|P1|STARTED|Overall Study||12
2260452|NCT02370095|5547759|P2|NOT COMPLETED|Overall Study||1
2260453|NCT02370095|5547760|P1|NOT COMPLETED|Overall Study||0
2260454|NCT02370095|5547759|P2|COMPLETED|Overall Study||3
2260455|NCT02370095|5547760|P1|COMPLETED|Overall Study||10
2260456|NCT02370095|5547759|P2|STARTED|Overall Study||4
2260457|NCT02370095|5547760|P1|STARTED|Overall Study||10
2260458|NCT02370043|5547790|P6|NOT COMPLETED|Overall Study||1
2260459|NCT02370043|5547791|P5|NOT COMPLETED|Overall Study||1
2260460|NCT02370043|5547792|P4|NOT COMPLETED|Overall Study||0
2260461|NCT02370043|5547793|P3|NOT COMPLETED|Overall Study||0
2260462|NCT02370043|5547794|P2|NOT COMPLETED|Overall Study||0
2260463|NCT02370043|5547795|P1|NOT COMPLETED|Overall Study||0
2260464|NCT02370043|5547790|P6|COMPLETED|Overall Study||3
2260465|NCT02370043|5547791|P5|COMPLETED|Overall Study||2
2260466|NCT02370043|5547792|P4|COMPLETED|Overall Study||3
2260467|NCT02370043|5547793|P3|COMPLETED|Overall Study||3
2260468|NCT02370043|5547794|P2|COMPLETED|Overall Study||3
2260469|NCT02370043|5547795|P1|COMPLETED|Overall Study||3
2260470|NCT02370043|5547790|P6|STARTED|Overall Study||4
2260471|NCT02370043|5547791|P5|STARTED|Overall Study||3
2260472|NCT02370043|5547792|P4|STARTED|Overall Study||3
2260473|NCT02370043|5547793|P3|STARTED|Overall Study||3
2260474|NCT02370043|5547794|P2|STARTED|Overall Study||3
2260475|NCT02370043|5547795|P1|STARTED|Overall Study||3
2260476|NCT02369874|5547927|P3|NOT COMPLETED|Overall Study||61
2260477|NCT02369874|5547928|P2|NOT COMPLETED|Overall Study||57
2260478|NCT02369874|5547929|P1|NOT COMPLETED|Overall Study||44
2260479|NCT02369874|5547927|P3|COMPLETED|Overall Study||188
2260480|NCT02369874|5547928|P2|COMPLETED|Overall Study||183
2260481|NCT02369874|5547929|P1|COMPLETED|Overall Study||203
2260482|NCT02369874|5547927|P3|Received Treatment|Overall Study||240
2260483|NCT02369874|5547928|P2|Received Treatment|Overall Study||237
2260484|NCT02369874|5547929|P1|Received Treatment|Overall Study||246
2260485|NCT02369874|5547927|P3|STARTED|Overall Study||249
2260486|NCT02369874|5547928|P2|STARTED|Overall Study||240
2260487|NCT02369874|5547929|P1|STARTED|Overall Study||247
2260488|NCT02369848|5547976|P1|NOT COMPLETED|Overall Study||4
2260489|NCT02369848|5547976|P1|COMPLETED|Overall Study||56
2260490|NCT02369848|5547976|P1|12 Month Primary Endpoint|Overall Study||30
2260491|NCT02369848|5547976|P1|30 Day Primary Safety Endpoint|Overall Study||58
2260492|NCT02369848|5547976|P1|STARTED|Overall Study||60
2260493|NCT02369835|5547992|P2|NOT COMPLETED|Overall Study||13
2260494|NCT02369835|5547993|P1|NOT COMPLETED|Overall Study||11
2260495|NCT02369835|5547992|P2|COMPLETED|Overall Study|Reasons that participants did not complete for the Primary Outcome are not available.|55
2260496|NCT02369835|5547993|P1|COMPLETED|Overall Study|Reasons that participants did not complete for the Primary Outcome are not available.|53
2260497|NCT02369835|5547992|P2|STARTED|Overall Study||68
2260498|NCT02369835|5547993|P1|STARTED|Overall Study||64
2260499|NCT02369796|5548008|P5|NOT COMPLETED|Overall Study||0
2260500|NCT02369796|5548009|P4|NOT COMPLETED|Overall Study||0
2260501|NCT02369796|5548010|P3|NOT COMPLETED|Overall Study||0
2260502|NCT02369796|5548011|P2|NOT COMPLETED|Overall Study||0
2260503|NCT02369796|5548012|P1|NOT COMPLETED|Overall Study||0
2260504|NCT02369796|5548008|P5|COMPLETED|Overall Study||3
2260505|NCT02369796|5548009|P4|COMPLETED|Overall Study||3
2260506|NCT02369796|5548010|P3|COMPLETED|Overall Study||3
2260507|NCT02369796|5548011|P2|COMPLETED|Overall Study||3
2260508|NCT02369796|5548012|P1|COMPLETED|Overall Study||3
2260509|NCT02369796|5548008|P5|STARTED|Overall Study||3
2260510|NCT02369796|5548009|P4|STARTED|Overall Study||3
2260511|NCT02369796|5548010|P3|STARTED|Overall Study||3
2260512|NCT02369796|5548011|P2|STARTED|Overall Study||3
2260513|NCT02369796|5548012|P1|STARTED|Overall Study||3
2260514|NCT02369510|5548054|P3|NOT COMPLETED|Overall Study||6
2260515|NCT02369510|5548055|P2|NOT COMPLETED|Overall Study||3
2260516|NCT02369510|5548056|P1|NOT COMPLETED|Overall Study||2
2260517|NCT02369510|5548054|P3|COMPLETED|Overall Study||17
2260518|NCT02369510|5548055|P2|COMPLETED|Overall Study||19
2260519|NCT02369510|5548056|P1|COMPLETED|Overall Study||21
2260520|NCT02369510|5548054|P3|STARTED|Overall Study||23
2260521|NCT02369510|5548055|P2|STARTED|Overall Study||22
2260522|NCT02369510|5548056|P1|STARTED|Overall Study||23
2260523|NCT02369484|5548085|P1|NOT COMPLETED|Overall Study||0
2260524|NCT02369484|5548085|P1|COMPLETED|Overall Study||13
2260525|NCT02369484|5548085|P1|STARTED|Overall Study||13
2260526|NCT02369341|5548095|P2|NOT COMPLETED|Overall Study||0
2260527|NCT02369341|5548096|P1|NOT COMPLETED|Overall Study||1
2260528|NCT02369341|5548095|P2|COMPLETED|Overall Study||57
2260529|NCT02369341|5548096|P1|COMPLETED|Overall Study||62
2260530|NCT02369341|5548095|P2|STARTED|Overall Study||57
2260531|NCT02369341|5548096|P1|STARTED|Overall Study||63
2260532|NCT02369211|5548152|P2|NOT COMPLETED|Overall Study||2
2260533|NCT02369211|5548153|P1|NOT COMPLETED|Overall Study||0
2260534|NCT02369211|5548152|P2|COMPLETED|Overall Study||41
2260535|NCT02369211|5548153|P1|COMPLETED|Overall Study||43
2260536|NCT02369211|5548152|P2|STARTED|Overall Study||43
2260537|NCT02369211|5548153|P1|STARTED|Overall Study||43
2260538|NCT02369172|5548165|P1|NOT COMPLETED|Overall Study||0
2260539|NCT02369172|5548165|P1|COMPLETED|Overall Study||24
2260540|NCT02369172|5548165|P1|STARTED|Overall Study||24
2260541|NCT02369068|5548239|P2|NOT COMPLETED|6 Months||1
2260542|NCT02369068|5548240|P1|NOT COMPLETED|6 Months||0
2260543|NCT02369068|5548239|P2|COMPLETED|6 Months||7
2260544|NCT02369068|5548240|P1|COMPLETED|6 Months||9
2260545|NCT02369068|5548239|P2|STARTED|6 Months||8
2260546|NCT02369068|5548240|P1|STARTED|6 Months||9
2260547|NCT02369068|5548239|P2|NOT COMPLETED|3 Months||2
2260548|NCT02369068|5548240|P1|NOT COMPLETED|3 Months||0
2260549|NCT02369068|5548239|P2|COMPLETED|3 Months||8
2260550|NCT02369068|5548240|P1|COMPLETED|3 Months||9
2260551|NCT02369068|5548239|P2|STARTED|3 Months||10
2260552|NCT02369068|5548240|P1|STARTED|3 Months||9
2260553|NCT02369068|5548239|P2|NOT COMPLETED|1 Month||1
2260554|NCT02369068|5548240|P1|NOT COMPLETED|1 Month||1
2260555|NCT02369068|5548239|P2|COMPLETED|1 Month||10
2260556|NCT02369068|5548240|P1|COMPLETED|1 Month||9
2260557|NCT02369068|5548239|P2|STARTED|1 Month||11
2260558|NCT02369068|5548240|P1|STARTED|1 Month||10
2260559|NCT02368886|5548272|P4|NOT COMPLETED|Overall Study||4
2260560|NCT02368886|5548273|P3|NOT COMPLETED|Overall Study||1
2260561|NCT02368886|5548274|P2|NOT COMPLETED|Overall Study||1
2260562|NCT02368886|5548275|P1|NOT COMPLETED|Overall Study||1
2260563|NCT02368886|5548272|P4|COMPLETED|Overall Study||29
2260564|NCT02368886|5548273|P3|COMPLETED|Overall Study||33
2260565|NCT02368886|5548274|P2|COMPLETED|Overall Study||26
2260566|NCT02368886|5548275|P1|COMPLETED|Overall Study||28
2260567|NCT02368886|5548272|P4|STARTED|Overall Study||33
2260568|NCT02368886|5548273|P3|STARTED|Overall Study||34
2260569|NCT02368886|5548274|P2|STARTED|Overall Study||27
2260570|NCT02368886|5548275|P1|STARTED|Overall Study||29
2260571|NCT02368457|5548295|P2|NOT COMPLETED|Overall Study||0
2260572|NCT02368457|5548296|P1|NOT COMPLETED|Overall Study||0
2260573|NCT02368457|5548295|P2|COMPLETED|Overall Study||12
2260574|NCT02368457|5548296|P1|COMPLETED|Overall Study||12
2260575|NCT02368457|5548295|P2|STARTED|Overall Study||12
2260576|NCT02368457|5548296|P1|STARTED|Overall Study||12
2260577|NCT02368314|5548306|P2|NOT COMPLETED|Overall Study||3
2260578|NCT02368314|5548307|P1|NOT COMPLETED|Overall Study||3
2260579|NCT02368314|5548306|P2|COMPLETED|Overall Study||57
2260580|NCT02368314|5548307|P1|COMPLETED|Overall Study||61
2260581|NCT02368314|5548306|P2|STARTED|Overall Study||60
2260582|NCT02368314|5548307|P1|STARTED|Overall Study||64
2260583|NCT02368210|5548319|P2|NOT COMPLETED|Overall Study||1
2260584|NCT02368210|5548320|P1|NOT COMPLETED|Overall Study||1
2260585|NCT02368210|5548319|P2|COMPLETED|Overall Study||75
2260586|NCT02368210|5548320|P1|COMPLETED|Overall Study||74
2260587|NCT02368210|5548319|P2|STARTED|Overall Study||76
2260588|NCT02368210|5548320|P1|STARTED|Overall Study||75
2260589|NCT02368093|5548338|P2|NOT COMPLETED|Overall Study||0
2260590|NCT02368093|5548339|P1|NOT COMPLETED|Overall Study||0
2260591|NCT02368093|5548338|P2|COMPLETED|Overall Study||24
2260592|NCT02368093|5548339|P1|COMPLETED|Overall Study||24
2260593|NCT02368093|5548338|P2|STARTED|Overall Study||24
2260594|NCT02368093|5548339|P1|STARTED|Overall Study||24
2260595|NCT02367911|5548347|P2|NOT COMPLETED|Overall Study||4
2260596|NCT02367911|5548348|P1|NOT COMPLETED|Overall Study||5
2260597|NCT02367911|5548347|P2|COMPLETED|Overall Study||69
2260598|NCT02367911|5548348|P1|COMPLETED|Overall Study||66
2260599|NCT02367911|5548347|P2|STARTED|Overall Study||73
2260600|NCT02367911|5548348|P1|STARTED|Overall Study||71
2260601|NCT02367885|5548359|P3|NOT COMPLETED|Overall Study||0
2260602|NCT02367885|5548360|P2|NOT COMPLETED|Overall Study||0
2260603|NCT02367885|5548361|P1|NOT COMPLETED|Overall Study||2
2260604|NCT02367885|5548359|P3|COMPLETED|Overall Study||33
2260605|NCT02367885|5548360|P2|COMPLETED|Overall Study||33
2260606|NCT02367885|5548361|P1|COMPLETED|Overall Study||31
2260607|NCT02367885|5548359|P3|STARTED|Overall Study||33
2260608|NCT02367885|5548360|P2|STARTED|Overall Study||33
2260609|NCT02367885|5548361|P1|STARTED|Overall Study||33
2260610|NCT02367872|5548434|P8|NOT COMPLETED|Overall Study||0
2260611|NCT02367872|5548435|P7|NOT COMPLETED|Overall Study||0
2260612|NCT02367872|5548436|P6|NOT COMPLETED|Overall Study||0
2260613|NCT02367872|5548437|P5|NOT COMPLETED|Overall Study||0
2260614|NCT02367872|5548438|P4|NOT COMPLETED|Overall Study||0
2260615|NCT02367872|5548439|P3|NOT COMPLETED|Overall Study||0
2260616|NCT02367872|5548440|P2|NOT COMPLETED|Overall Study||0
2260617|NCT02367872|5548441|P1|NOT COMPLETED|Overall Study||0
2260618|NCT02367872|5548434|P8|COMPLETED|Overall Study||6
2260619|NCT02367872|5548435|P7|COMPLETED|Overall Study||6
2260620|NCT02367872|5548436|P6|COMPLETED|Overall Study||6
2260621|NCT02367872|5548437|P5|COMPLETED|Overall Study||6
2260622|NCT02367872|5548438|P4|COMPLETED|Overall Study||6
2260623|NCT02367872|5548439|P3|COMPLETED|Overall Study||6
2260624|NCT02367872|5548440|P2|COMPLETED|Overall Study||6
2260625|NCT02367872|5548441|P1|COMPLETED|Overall Study||6
2260626|NCT02367872|5548434|P8|STARTED|Overall Study||6
2260627|NCT02367872|5548435|P7|STARTED|Overall Study||6
2260628|NCT02367872|5548436|P6|STARTED|Overall Study||6
2260629|NCT02367872|5548437|P5|STARTED|Overall Study||6
2260630|NCT02367872|5548438|P4|STARTED|Overall Study||6
2260631|NCT02367872|5548439|P3|STARTED|Overall Study||6
2260632|NCT02367872|5548440|P2|STARTED|Overall Study||6
2260633|NCT02367872|5548441|P1|STARTED|Overall Study||6
2260634|NCT02367859|5548594|P1|NOT COMPLETED|Overall Study||0
2260635|NCT02367859|5548594|P1|COMPLETED|Overall Study||1
2260636|NCT02367859|5548594|P1|STARTED|Overall Study||1
2260637|NCT02367833|5548604|P3|NOT COMPLETED|Overall Study||0
2260638|NCT02367833|5548605|P2|NOT COMPLETED|Overall Study||1
2260639|NCT02367833|5548606|P1|NOT COMPLETED|Overall Study||1
2260640|NCT02367833|5548604|P3|COMPLETED|Overall Study||8
2260641|NCT02367833|5548605|P2|COMPLETED|Overall Study||8
2260642|NCT02367833|5548606|P1|COMPLETED|Overall Study||8
2260643|NCT02367833|5548604|P3|STARTED|Overall Study||8
2260644|NCT02367833|5548605|P2|STARTED|Overall Study||9
2260645|NCT02367833|5548606|P1|STARTED|Overall Study||9
2260646|NCT02367794|5548620|P3|NOT COMPLETED|Overall Study||249
2260647|NCT02367794|5548621|P2|NOT COMPLETED|Overall Study||240
2260648|NCT02367794|5548622|P1|NOT COMPLETED|Overall Study||258
2260649|NCT02367794|5548620|P3|COMPLETED|Overall Study||89
2260650|NCT02367794|5548621|P2|COMPLETED|Overall Study||103
2260651|NCT02367794|5548622|P1|COMPLETED|Overall Study||82
2260652|NCT02367794|5548620|P3|STARTED|Overall Study||338
2260653|NCT02367794|5548621|P2|STARTED|Overall Study||343
2260654|NCT02367794|5548622|P1|STARTED|Overall Study||340
2260655|NCT02367781|5548635|P2|NOT COMPLETED|Overall Study||240
2260656|NCT02367781|5548636|P1|NOT COMPLETED|Overall Study||483
2260657|NCT02367781|5548635|P2|COMPLETED|Overall Study||0
2260658|NCT02367781|5548636|P1|COMPLETED|Overall Study||0
2260659|NCT02367781|5548635|P2|STARTED|Overall Study||240
2260660|NCT02367781|5548636|P1|STARTED|Overall Study||483
2260661|NCT02367729|5548646|P2|NOT COMPLETED|Overall Study||8
2260662|NCT02367729|5548647|P1|NOT COMPLETED|Overall Study||3
2260663|NCT02367729|5548646|P2|COMPLETED|Overall Study||47
2260664|NCT02367729|5548647|P1|COMPLETED|Overall Study||57
2260665|NCT02367729|5548646|P2|STARTED|Overall Study||55
2260666|NCT02367729|5548647|P1|STARTED|Overall Study||60
2260667|NCT02367521|5548665|P2|NOT COMPLETED|Overall Study||0
2260668|NCT02367521|5548666|P1|NOT COMPLETED|Overall Study||4
2260669|NCT02367521|5548665|P2|COMPLETED|Overall Study||17
2260670|NCT02367521|5548666|P1|COMPLETED|Overall Study||13
2260671|NCT02367521|5548665|P2|STARTED|Overall Study||17
2260672|NCT02367521|5548666|P1|STARTED|Overall Study||17
2260673|NCT02367430|5548718|P1|NOT COMPLETED|Overall Study||3
2260674|NCT02367430|5548718|P1|COMPLETED|Overall Study||11
2260675|NCT02367430|5548718|P1|STARTED|Overall Study||14
2260676|NCT02367391|5548725|P2|NOT COMPLETED|Overall Study||0
2260677|NCT02367391|5548726|P1|NOT COMPLETED|Overall Study||2
2260678|NCT02367391|5548725|P2|COMPLETED|Overall Study||76
2260679|NCT02367391|5548726|P1|COMPLETED|Overall Study||74
2260680|NCT02367391|5548725|P2|STARTED|Overall Study||76
2260681|NCT02367391|5548726|P1|STARTED|Overall Study||76
2260682|NCT02367352|5548744|P3|NOT COMPLETED|Overall Study||0
2260683|NCT02367352|5548745|P2|NOT COMPLETED|Overall Study||0
2260684|NCT02367352|5548746|P1|NOT COMPLETED|Overall Study||9
2260685|NCT02367352|5548744|P3|COMPLETED|Overall Study||0
2260686|NCT02367352|5548745|P2|COMPLETED|Overall Study||0
2260687|NCT02367352|5548746|P1|COMPLETED|Overall Study||0
2260688|NCT02367352|5548744|P3|STARTED|Overall Study||0
2260689|NCT02367352|5548745|P2|STARTED|Overall Study||0
2260690|NCT02367352|5548746|P1|STARTED|Overall Study||9
2260691|NCT02367170|5548785|P2|NOT COMPLETED|Overall Study||0
2260692|NCT02367170|5548786|P1|NOT COMPLETED|Overall Study||0
2260693|NCT02367170|5548785|P2|COMPLETED|Overall Study||0
2260694|NCT02367170|5548786|P1|COMPLETED|Overall Study||1
2260695|NCT02367170|5548785|P2|STARTED|Overall Study||0
2260696|NCT02367170|5548786|P1|STARTED|Overall Study||1
2260697|NCT02367131|5548796|P1|NOT COMPLETED|Overall Study||222
2260698|NCT02367131|5548796|P1|COMPLETED|Overall Study||201
2260699|NCT02367131|5548796|P1|STARTED|Overall Study|Started are the treated patients|423
2260700|NCT02367066|5548804|P2|NOT COMPLETED|Overall Study||0
2260701|NCT02367066|5548805|P1|NOT COMPLETED|Overall Study||0
2260702|NCT02367066|5548804|P2|COMPLETED|Overall Study||10
2260703|NCT02367066|5548805|P1|COMPLETED|Overall Study||10
2260704|NCT02367066|5548804|P2|STARTED|Overall Study||10
2260705|NCT02367066|5548805|P1|STARTED|Overall Study||10
2260706|NCT02367014|5548867|P4|NOT COMPLETED|Overall Study||0
2260707|NCT02367014|5548868|P3|NOT COMPLETED|Overall Study||0
2260708|NCT02367014|5548869|P2|NOT COMPLETED|Overall Study||0
2260709|NCT02367014|5548870|P1|NOT COMPLETED|Overall Study||0
2260710|NCT02367014|5548867|P4|COMPLETED|Overall Study||9
2260711|NCT02367014|5548868|P3|COMPLETED|Overall Study||9
2260712|NCT02367014|5548869|P2|COMPLETED|Overall Study||9
2260713|NCT02367014|5548870|P1|COMPLETED|Overall Study||9
2260714|NCT02367014|5548867|P4|STARTED|Overall Study||9
2260715|NCT02367014|5548868|P3|STARTED|Overall Study||9
2260716|NCT02367014|5548869|P2|STARTED|Overall Study||9
2260717|NCT02367014|5548870|P1|STARTED|Overall Study||9
2260718|NCT02366936|5548988|P1|NOT COMPLETED|Overall Study||8
2260719|NCT02366936|5548988|P1|COMPLETED|Overall Study||24
2260720|NCT02366936|5548988|P1|STARTED|Overall Study||32
2260721|NCT02366923|5548993|P1|NOT COMPLETED|Overall Study||6
2260722|NCT02366923|5548993|P1|COMPLETED|Overall Study||22
2260723|NCT02366923|5548993|P1|STARTED|Overall Study||28
2260724|NCT02366910|5549006|P1|NOT COMPLETED|Overall Study||5
2260725|NCT02366910|5549006|P1|COMPLETED|Overall Study||21
2260726|NCT02366910|5549006|P1|STARTED|Overall Study||26
2260727|NCT02366845|5549020|P2|NOT COMPLETED|Overall Study||0
2260728|NCT02366845|5549021|P1|NOT COMPLETED|Overall Study||0
2260729|NCT02366845|5549020|P2|COMPLETED|Overall Study||25
2260730|NCT02366845|5549021|P1|COMPLETED|Overall Study||25
2260731|NCT02366845|5549020|P2|STARTED|Overall Study||25
2260732|NCT02366845|5549021|P1|STARTED|Overall Study||25
2260733|NCT02366767|5549035|P2|NOT COMPLETED|Overall Study||0
2260734|NCT02366767|5549036|P1|NOT COMPLETED|Overall Study||1
2260735|NCT02366767|5549035|P2|COMPLETED|Overall Study||10
2260736|NCT02366767|5549036|P1|COMPLETED|Overall Study||10
2260737|NCT02366767|5549035|P2|STARTED|Overall Study||10
2260738|NCT02366767|5549036|P1|STARTED|Overall Study||11
2260739|NCT02366689|5549049|P3|NOT COMPLETED|Overall Study||2
2260740|NCT02366689|5549050|P2|NOT COMPLETED|Overall Study||3
2260741|NCT02366689|5549051|P1|NOT COMPLETED|Overall Study||4
2260742|NCT02366689|5549049|P3|COMPLETED|Overall Study||59
2260743|NCT02366689|5549050|P2|COMPLETED|Overall Study||55
2260744|NCT02366689|5549051|P1|COMPLETED|Overall Study||56
2260745|NCT02366689|5549049|P3|STARTED|Overall Study||61
2260746|NCT02366689|5549050|P2|STARTED|Overall Study||58
2260747|NCT02366689|5549051|P1|STARTED|Overall Study||60
2260748|NCT02366663|5549076|P2|NOT COMPLETED|Overall Study||0
2260749|NCT02366663|5549077|P1|NOT COMPLETED|Overall Study||0
2260750|NCT02366663|5549076|P2|COMPLETED|Overall Study||1
2260751|NCT02366663|5549077|P1|COMPLETED|Overall Study||2
2260752|NCT02366663|5549076|P2|STARTED|Overall Study||1
2260753|NCT02366663|5549077|P1|STARTED|Overall Study||2
2260754|NCT02366637|5549103|P2|NOT COMPLETED|Second Intervention Period||1
2260755|NCT02366637|5549104|P1|NOT COMPLETED|Second Intervention Period||1
2260756|NCT02366637|5549103|P2|COMPLETED|Second Intervention Period||0
2260757|NCT02366637|5549104|P1|COMPLETED|Second Intervention Period||0
2260758|NCT02366637|5549103|P2|STARTED|Second Intervention Period||1
2260759|NCT02366637|5549104|P1|STARTED|Second Intervention Period||1
2260760|NCT02366637|5549103|P2|NOT COMPLETED|Washout Period 28 to 49 Days||0
2260761|NCT02366637|5549104|P1|NOT COMPLETED|Washout Period 28 to 49 Days||0
2260762|NCT02366637|5549103|P2|COMPLETED|Washout Period 28 to 49 Days||1
2260763|NCT02366637|5549104|P1|COMPLETED|Washout Period 28 to 49 Days||1
2260764|NCT02366637|5549103|P2|STARTED|Washout Period 28 to 49 Days||1
2260765|NCT02366637|5549104|P1|STARTED|Washout Period 28 to 49 Days||1
2260766|NCT02366637|5549103|P2|NOT COMPLETED|First Intervention Period||5
2260767|NCT02366637|5549104|P1|NOT COMPLETED|First Intervention Period||6
2260768|NCT02366637|5549103|P2|COMPLETED|First Intervention Period||1
2260769|NCT02366637|5549104|P1|COMPLETED|First Intervention Period||1
2260770|NCT02366637|5549103|P2|STARTED|First Intervention Period||6
2260771|NCT02366637|5549104|P1|STARTED|First Intervention Period||7
2260772|NCT02366468|5549130|P2|NOT COMPLETED|Overall Study||9
2260773|NCT02366468|5549131|P1|NOT COMPLETED|Overall Study||6
2260774|NCT02366468|5549130|P2|COMPLETED|Overall Study||58
2260775|NCT02366468|5549131|P1|COMPLETED|Overall Study||62
2260776|NCT02366468|5549130|P2|Per Protocol Set (PPS)|Overall Study||61
2260777|NCT02366468|5549131|P1|Per Protocol Set (PPS)|Overall Study||62
2260778|NCT02366468|5549130|P2|Full Analysis Set (FAS)|Overall Study||66
2260779|NCT02366468|5549131|P1|Full Analysis Set (FAS)|Overall Study||67
2260780|NCT02366468|5549130|P2|STARTED|Overall Study||67
2260781|NCT02366468|5549131|P1|STARTED|Overall Study||68
2260782|NCT02366338|5549152|P3|NOT COMPLETED|Overall Study||0
2260783|NCT02366338|5549153|P2|NOT COMPLETED|Overall Study||0
2260784|NCT02366338|5549154|P1|NOT COMPLETED|Overall Study||0
2260785|NCT02366338|5549152|P3|COMPLETED|Overall Study||36
2260786|NCT02366338|5549153|P2|COMPLETED|Overall Study||39
2260787|NCT02366338|5549154|P1|COMPLETED|Overall Study||73
2260788|NCT02366338|5549152|P3|STARTED|Overall Study||36
2260789|NCT02366338|5549153|P2|STARTED|Overall Study||39
2260790|NCT02366338|5549154|P1|STARTED|Overall Study||73
2260791|NCT02366195|5549162|P1|NOT COMPLETED|Overall Study||112
2260792|NCT02366195|5549162|P1|COMPLETED|Overall Study||0
2260793|NCT02366195|5549162|P1|Received Study Drug|Overall Study||111
2260794|NCT02366195|5549162|P1|STARTED|Overall Study||112
2260795|NCT02365961|5549182|P2|NOT COMPLETED|Overall Study||0
2260796|NCT02365961|5549183|P1|NOT COMPLETED|Overall Study||0
2260797|NCT02365961|5549182|P2|COMPLETED|Overall Study||43
2260798|NCT02365961|5549183|P1|COMPLETED|Overall Study||41
2260799|NCT02365961|5549182|P2|STARTED|Overall Study||43
2260800|NCT02365961|5549183|P1|STARTED|Overall Study||41
2260801|NCT02365714|5549197|P1|NOT COMPLETED|Overall Study||0
2260802|NCT02365714|5549197|P1|COMPLETED|Overall Study||2
2260803|NCT02365714|5549197|P1|STARTED|Overall Study||2
2260804|NCT02365688|5549203|P1|NOT COMPLETED|Overall Study||0
2260805|NCT02365688|5549203|P1|COMPLETED|Overall Study|All subjects consented to an change in standard infusion volume pre-incision|18
2260806|NCT02365688|5549203|P1|STARTED|Overall Study|All subjects received a bolus of 500cc before first incision|18
2260807|NCT02365636|5549210|P3|NOT COMPLETED|Overall Study||3
2260808|NCT02365636|5549211|P2|NOT COMPLETED|Overall Study||7
2260809|NCT02365636|5549212|P1|NOT COMPLETED|Overall Study||6
2260810|NCT02365636|5549210|P3|COMPLETED|Overall Study||97
2260811|NCT02365636|5549211|P2|COMPLETED|Overall Study||93
2260812|NCT02365636|5549212|P1|COMPLETED|Overall Study||94
2260813|NCT02365636|5549210|P3|Full Analysis Set|Overall Study||100
2260814|NCT02365636|5549211|P2|Full Analysis Set|Overall Study||98
2260815|NCT02365636|5549212|P1|Full Analysis Set|Overall Study||100
2260816|NCT02365636|5549210|P3|Safety Population|Overall Study||100
2260817|NCT02365636|5549211|P2|Safety Population|Overall Study|2 terminated prior to treatment due to 1) prohibited concomitant medication 2) exclusion criteria|98
2260818|NCT02365636|5549212|P1|Safety Population|Overall Study||100
2260819|NCT02365636|5549210|P3|STARTED|Overall Study||100
2260820|NCT02365636|5549211|P2|STARTED|Overall Study||100
2260821|NCT02365636|5549212|P1|STARTED|Overall Study||100
2260822|NCT02365584|5549258|P2|NOT COMPLETED|Overall Study||14
2260823|NCT02365584|5549259|P1|NOT COMPLETED|Overall Study||12
2260824|NCT02365584|5549258|P2|COMPLETED|Overall Study||8
2260825|NCT02365584|5549259|P1|COMPLETED|Overall Study||9
2260826|NCT02365584|5549258|P2|STARTED|Overall Study||22
2260827|NCT02365584|5549259|P1|STARTED|Overall Study||21
2260828|NCT02365558|5549283|P2|NOT COMPLETED|Period 2 (Day 8 Through Day 20)||1
2260829|NCT02365558|5549284|P1|NOT COMPLETED|Period 2 (Day 8 Through Day 20)||0
2260830|NCT02365558|5549283|P2|COMPLETED|Period 2 (Day 8 Through Day 20)||32
2260831|NCT02365558|5549284|P1|COMPLETED|Period 2 (Day 8 Through Day 20)||0
2260832|NCT02365558|5549283|P2|STARTED|Period 2 (Day 8 Through Day 20)|Participants completed Period 1 and entered Evacetrapib + Omeprazole for Period 2.|33
2260833|NCT02365558|5549284|P1|STARTED|Period 2 (Day 8 Through Day 20)|Participants move to Evacetrapib + Omeprazole for Period 2.|0
2260834|NCT02365558|5549283|P2|NOT COMPLETED|Period 1 (Day 1 Through Day 7)||0
2260835|NCT02365558|5549284|P1|NOT COMPLETED|Period 1 (Day 1 Through Day 7)||1
2260836|NCT02365558|5549283|P2|COMPLETED|Period 1 (Day 1 Through Day 7)||0
2260837|NCT02365558|5549284|P1|COMPLETED|Period 1 (Day 1 Through Day 7)||33
2260838|NCT02365558|5549283|P2|Received at Least One Dose of Study Drug|Period 1 (Day 1 Through Day 7)||0
2260839|NCT02365558|5549284|P1|Received at Least One Dose of Study Drug|Period 1 (Day 1 Through Day 7)||34
2260840|NCT02365558|5549283|P2|STARTED|Period 1 (Day 1 Through Day 7)||0
2260841|NCT02365558|5549284|P1|STARTED|Period 1 (Day 1 Through Day 7)||34
2260842|NCT02365519|5549297|P3|NOT COMPLETED|Randomized and Treated||1
2260843|NCT02365519|5549298|P2|NOT COMPLETED|Randomized and Treated||2
2260844|NCT02365519|5549299|P1|NOT COMPLETED|Randomized and Treated||0
2260845|NCT02365519|5549297|P3|COMPLETED|Randomized and Treated||64
2260846|NCT02365519|5549298|P2|COMPLETED|Randomized and Treated||67
2260847|NCT02365519|5549299|P1|COMPLETED|Randomized and Treated||0
2260848|NCT02365519|5549297|P3|STARTED|Randomized and Treated||65
2260849|NCT02365519|5549298|P2|STARTED|Randomized and Treated||69
2260850|NCT02365519|5549299|P1|STARTED|Randomized and Treated||0
2260851|NCT02365519|5549297|P3|NOT COMPLETED|Vehicle Run-In||0
2260852|NCT02365519|5549298|P2|NOT COMPLETED|Vehicle Run-In||0
2260853|NCT02365519|5549299|P1|NOT COMPLETED|Vehicle Run-In||79
2260854|NCT02365519|5549297|P3|COMPLETED|Vehicle Run-In||0
2260855|NCT02365519|5549298|P2|COMPLETED|Vehicle Run-In||0
2260856|NCT02365519|5549299|P1|COMPLETED|Vehicle Run-In||134
2260857|NCT02365519|5549297|P3|STARTED|Vehicle Run-In||0
2260858|NCT02365519|5549298|P2|STARTED|Vehicle Run-In||0
2260859|NCT02365519|5549299|P1|STARTED|Vehicle Run-In||213
2260860|NCT02365298|5549320|P2|NOT COMPLETED|Period 2||2
2260861|NCT02365298|5549321|P1|NOT COMPLETED|Period 2||2
2260862|NCT02365298|5549320|P2|COMPLETED|Period 2||12
2260863|NCT02365298|5549321|P1|COMPLETED|Period 2||12
2260864|NCT02365298|5549320|P2|STARTED|Period 2||14
2260865|NCT02365298|5549321|P1|STARTED|Period 2||14
2260866|NCT02365298|5549320|P2|NOT COMPLETED|Period 1||0
2260867|NCT02365298|5549321|P1|NOT COMPLETED|Period 1||0
2260868|NCT02365298|5549320|P2|COMPLETED|Period 1||14
2260869|NCT02365298|5549321|P1|COMPLETED|Period 1||14
2260870|NCT02365298|5549320|P2|STARTED|Period 1||14
2260871|NCT02365298|5549321|P1|STARTED|Period 1||14
2260872|NCT02365285|5549341|P4|NOT COMPLETED|Overall Study||2
2260873|NCT02365285|5549342|P3|NOT COMPLETED|Overall Study||1
2260874|NCT02365285|5549343|P2|NOT COMPLETED|Overall Study||1
2260875|NCT02365285|5549344|P1|NOT COMPLETED|Overall Study||0
2260876|NCT02365285|5549341|P4|COMPLETED|Overall Study||1
2260877|NCT02365285|5549342|P3|COMPLETED|Overall Study||6
2260878|NCT02365285|5549343|P2|COMPLETED|Overall Study||5
2260879|NCT02365285|5549344|P1|COMPLETED|Overall Study||7
2260880|NCT02365285|5549341|P4|STARTED|Overall Study||3
2260881|NCT02365285|5549342|P3|STARTED|Overall Study||7
2260882|NCT02365285|5549343|P2|STARTED|Overall Study||6
2260883|NCT02365285|5549344|P1|STARTED|Overall Study||7
2260884|NCT02365233|5549361|P3|NOT COMPLETED|Overall Study||2
2260885|NCT02365233|5549362|P2|NOT COMPLETED|Overall Study||2
2260886|NCT02365233|5549363|P1|NOT COMPLETED|Overall Study||1
2260887|NCT02365233|5549361|P3|COMPLETED|Overall Study||0
2260888|NCT02365233|5549362|P2|COMPLETED|Overall Study||0
2260889|NCT02365233|5549363|P1|COMPLETED|Overall Study||0
2260890|NCT02365233|5549361|P3|STARTED|Overall Study||2
2260891|NCT02365233|5549362|P2|STARTED|Overall Study||2
2260892|NCT02365233|5549363|P1|STARTED|Overall Study||1
2260893|NCT02365207|5549371|P1|NOT COMPLETED|Overall Study||2
2260894|NCT02365207|5549371|P1|COMPLETED|Overall Study||4
2260895|NCT02365207|5549371|P1|STARTED|Overall Study||6
2260896|NCT02364999|5549377|P2|NOT COMPLETED|Overall Study||173
2260897|NCT02364999|5549378|P1|NOT COMPLETED|Overall Study||165
2260898|NCT02364999|5549377|P2|COMPLETED|Overall Study||188
2260899|NCT02364999|5549378|P1|COMPLETED|Overall Study||193
2260900|NCT02364999|5549377|P2|Received Treatment|Overall Study||358
2260901|NCT02364999|5549378|P1|Received Treatment|Overall Study||356
2260902|NCT02364999|5549377|P2|STARTED|Overall Study||361
2260903|NCT02364999|5549378|P1|STARTED|Overall Study||358
2260904|NCT02364947|5549404|P3|NOT COMPLETED|Overall Study||26
2260905|NCT02364947|5549405|P2|NOT COMPLETED|Overall Study||45
2260906|NCT02364947|5549406|P1|NOT COMPLETED|Overall Study||59
2260907|NCT02364947|5549404|P3|COMPLETED|Overall Study||219
2260908|NCT02364947|5549405|P2|COMPLETED|Overall Study||139
2260909|NCT02364947|5549406|P1|COMPLETED|Overall Study||189
2260910|NCT02364947|5549404|P3|STARTED|Overall Study||245
2260911|NCT02364947|5549405|P2|STARTED|Overall Study||184
2260912|NCT02364947|5549406|P1|STARTED|Overall Study||248
2260913|NCT02364778|5549473|P1|NOT COMPLETED|Overall Study||0
2260914|NCT02364778|5549473|P1|COMPLETED|Overall Study||30
2260915|NCT02364778|5549473|P1|STARTED|Overall Study||30
2260916|NCT02364700|5549485|P1|NOT COMPLETED|Overall Study||0
2260917|NCT02364700|5549485|P1|COMPLETED|Overall Study||12
2260918|NCT02364700|5549485|P1|STARTED|Overall Study||12
2260919|NCT02364570|5549494|P16|NOT COMPLETED|Overall Study||0
2260920|NCT02364570|5549495|P15|NOT COMPLETED|Overall Study||0
2260921|NCT02364570|5549496|P14|NOT COMPLETED|Overall Study||0
2260922|NCT02364570|5549497|P13|NOT COMPLETED|Overall Study||0
2260923|NCT02364570|5549498|P12|NOT COMPLETED|Overall Study||0
2260924|NCT02364570|5549499|P11|NOT COMPLETED|Overall Study||0
2260925|NCT02364570|5549500|P10|NOT COMPLETED|Overall Study||0
2260926|NCT02364570|5549501|P9|NOT COMPLETED|Overall Study||0
2260927|NCT02364570|5549502|P8|NOT COMPLETED|Overall Study||0
2260928|NCT02364570|5549503|P7|NOT COMPLETED|Overall Study||0
2260929|NCT02364570|5549504|P6|NOT COMPLETED|Overall Study||0
2260930|NCT02364570|5549505|P5|NOT COMPLETED|Overall Study||0
2260931|NCT02364570|5549506|P4|NOT COMPLETED|Overall Study||0
2260932|NCT02364570|5549507|P3|NOT COMPLETED|Overall Study||0
2260933|NCT02364570|5549508|P2|NOT COMPLETED|Overall Study||0
2260934|NCT02364570|5549509|P1|NOT COMPLETED|Overall Study||0
2260935|NCT02364570|5549494|P16|COMPLETED|Overall Study||1
2260936|NCT02364570|5549495|P15|COMPLETED|Overall Study||1
2260937|NCT02364570|5549496|P14|COMPLETED|Overall Study||2
2260938|NCT02364570|5549497|P13|COMPLETED|Overall Study||1
2260939|NCT02364570|5549498|P12|COMPLETED|Overall Study||1
2260940|NCT02364570|5549499|P11|COMPLETED|Overall Study||1
2260941|NCT02364570|5549500|P10|COMPLETED|Overall Study||1
2260942|NCT02364570|5549501|P9|COMPLETED|Overall Study||2
2260943|NCT02364570|5549502|P8|COMPLETED|Overall Study||1
2260944|NCT02364570|5549503|P7|COMPLETED|Overall Study||2
2260945|NCT02364570|5549504|P6|COMPLETED|Overall Study||1
2260946|NCT02364570|5549505|P5|COMPLETED|Overall Study||1
2260947|NCT02364570|5549506|P4|COMPLETED|Overall Study||1
2260948|NCT02364570|5549507|P3|COMPLETED|Overall Study||2
2260949|NCT02364570|5549508|P2|COMPLETED|Overall Study||1
2260950|NCT02364570|5549509|P1|COMPLETED|Overall Study||1
2260951|NCT02364570|5549494|P16|STARTED|Overall Study||1
2260952|NCT02364570|5549495|P15|STARTED|Overall Study||1
2260953|NCT02364570|5549496|P14|STARTED|Overall Study||2
2260954|NCT02364570|5549497|P13|STARTED|Overall Study||1
2260955|NCT02364570|5549498|P12|STARTED|Overall Study||1
2260956|NCT02364570|5549499|P11|STARTED|Overall Study||1
2260957|NCT02364570|5549500|P10|STARTED|Overall Study||1
2260958|NCT02364570|5549501|P9|STARTED|Overall Study||2
2260959|NCT02364570|5549502|P8|STARTED|Overall Study||1
2260960|NCT02364570|5549503|P7|STARTED|Overall Study||2
2260961|NCT02364570|5549504|P6|STARTED|Overall Study||1
2260962|NCT02364570|5549505|P5|STARTED|Overall Study||1
2260963|NCT02364570|5549506|P4|STARTED|Overall Study||1
2260964|NCT02364570|5549507|P3|STARTED|Overall Study||2
2260965|NCT02364570|5549508|P2|STARTED|Overall Study||1
2260966|NCT02364570|5549509|P1|STARTED|Overall Study||1
2260967|NCT02364336|5549577|P2|NOT COMPLETED|Overall Study||1
2260968|NCT02364336|5549578|P1|NOT COMPLETED|Overall Study||0
2260969|NCT02364336|5549577|P2|COMPLETED|Overall Study||11
2260970|NCT02364336|5549578|P1|COMPLETED|Overall Study||1
2260971|NCT02364336|5549577|P2|48 Weeks After End of Peginterferon|Overall Study||10
2260972|NCT02364336|5549578|P1|48 Weeks After End of Peginterferon|Overall Study||1
2260973|NCT02364336|5549577|P2|24 Weeks After End of Peginterferon|Overall Study||11
2260974|NCT02364336|5549578|P1|24 Weeks After End of Peginterferon|Overall Study||1
2260975|NCT02364336|5549577|P2|End of Peginterferon Treatment|Overall Study||11
2260976|NCT02364336|5549578|P1|End of Peginterferon Treatment|Overall Study||1
2260977|NCT02364336|5549577|P2|6 Hours Post First Peginterferon Inject|Overall Study||12
2260978|NCT02364336|5549578|P1|6 Hours Post First Peginterferon Inject|Overall Study||1
2260979|NCT02364336|5549577|P2|STARTED|Overall Study||12
2260980|NCT02364336|5549578|P1|STARTED|Overall Study||1
2260981|NCT02364180|5549591|P1|NOT COMPLETED|Overall Study||1
2260982|NCT02364180|5549591|P1|COMPLETED|Overall Study||10
2260983|NCT02364180|5549591|P1|STARTED|Overall Study||11
2260984|NCT02364076|5549595|P1|NOT COMPLETED|Overall Study||5
2260985|NCT02364076|5549595|P1|COMPLETED|Overall Study||40
2260986|NCT02364076|5549595|P1|STARTED|Overall Study||45
2260987|NCT02364037|5549604|P2|NOT COMPLETED|Overall Study||53
2260988|NCT02364037|5549605|P1|NOT COMPLETED|Overall Study||44
2260989|NCT02364037|5549604|P2|COMPLETED|Overall Study||453
2260990|NCT02364037|5549605|P1|COMPLETED|Overall Study||458
2260991|NCT02364037|5549604|P2|STARTED|Overall Study||506
2260992|NCT02364037|5549605|P1|STARTED|Overall Study||502
2260993|NCT02363959|5549619|P2|NOT COMPLETED|Overall Study||0
2260994|NCT02363959|5549620|P1|NOT COMPLETED|Overall Study||1
2260995|NCT02363959|5549619|P2|COMPLETED|Overall Study||10
2260996|NCT02363959|5549620|P1|COMPLETED|Overall Study||9
2260997|NCT02363959|5549619|P2|STARTED|Overall Study||10
2260998|NCT02363959|5549620|P1|STARTED|Overall Study||10
2260999|NCT02363946|5549649|P13|NOT COMPLETED|Overall Study||0
2261000|NCT02363946|5549650|P12|NOT COMPLETED|Overall Study||0
2261001|NCT02363946|5549651|P11|NOT COMPLETED|Overall Study||0
2261002|NCT02363946|5549652|P10|NOT COMPLETED|Overall Study||0
2261003|NCT02363946|5549653|P9|NOT COMPLETED|Overall Study||0
2261004|NCT02363946|5549654|P8|NOT COMPLETED|Overall Study||1
2261005|NCT02363946|5549655|P7|NOT COMPLETED|Overall Study||0
2261006|NCT02363946|5549656|P6|NOT COMPLETED|Overall Study||0
2261007|NCT02363946|5549657|P5|NOT COMPLETED|Overall Study||0
2261008|NCT02363946|5549658|P4|NOT COMPLETED|Overall Study||0
2261009|NCT02363946|5549659|P3|NOT COMPLETED|Overall Study||0
2261010|NCT02363946|5549660|P2|NOT COMPLETED|Overall Study||0
2261011|NCT02363946|5549661|P1|NOT COMPLETED|Overall Study||0
2261012|NCT02363946|5549649|P13|COMPLETED|Overall Study||4
2261013|NCT02363946|5549650|P12|COMPLETED|Overall Study||3
2261014|NCT02363946|5549651|P11|COMPLETED|Overall Study||4
2261015|NCT02363946|5549652|P10|COMPLETED|Overall Study||18
2261016|NCT02363946|5549653|P9|COMPLETED|Overall Study||4
2261017|NCT02363946|5549654|P8|COMPLETED|Overall Study||3
2261018|NCT02363946|5549655|P7|COMPLETED|Overall Study||4
2261019|NCT02363946|5549656|P6|COMPLETED|Overall Study||4
2261020|NCT02363946|5549657|P5|COMPLETED|Overall Study||4
2261021|NCT02363946|5549658|P4|COMPLETED|Overall Study||4
2261022|NCT02363946|5549659|P3|COMPLETED|Overall Study||4
2261023|NCT02363946|5549660|P2|COMPLETED|Overall Study||4
2261024|NCT02363946|5549661|P1|COMPLETED|Overall Study||4
2261025|NCT02363946|5549649|P13|STARTED|Overall Study||4
2261026|NCT02363946|5549650|P12|STARTED|Overall Study||3
2261027|NCT02363946|5549651|P11|STARTED|Overall Study||4
2261028|NCT02363946|5549652|P10|STARTED|Overall Study||18
2261029|NCT02363946|5549653|P9|STARTED|Overall Study||4
2261030|NCT02363946|5549654|P8|STARTED|Overall Study||4
2261031|NCT02363946|5549655|P7|STARTED|Overall Study||4
2261032|NCT02363946|5549656|P6|STARTED|Overall Study||4
2261033|NCT02363946|5549657|P5|STARTED|Overall Study||4
2261034|NCT02363946|5549658|P4|STARTED|Overall Study||4
2261035|NCT02363946|5549659|P3|STARTED|Overall Study||4
2261036|NCT02363946|5549660|P2|STARTED|Overall Study||4
2261037|NCT02363946|5549661|P1|STARTED|Overall Study||4
2261038|NCT02363933|5549847|P1|NOT COMPLETED|Overall Study||6
2261039|NCT02363933|5549847|P1|COMPLETED|Overall Study||2
2261040|NCT02363933|5549847|P1|STARTED|Overall Study||8
2261041|NCT02363907|5549852|P1|NOT COMPLETED|Overall Study||0
2261042|NCT02363907|5549852|P1|COMPLETED|Overall Study||30
2261043|NCT02363907|5549852|P1|STARTED|Overall Study||30
2261044|NCT02363803|5549858|P2|NOT COMPLETED|Period 2||0
2261045|NCT02363803|5549859|P1|NOT COMPLETED|Period 2||0
2261046|NCT02363803|5549858|P2|COMPLETED|Period 2||16
2261047|NCT02363803|5549859|P1|COMPLETED|Period 2||17
2261048|NCT02363803|5549858|P2|STARTED|Period 2|One participant did not return for Period 2 treatment|16
2261049|NCT02363803|5549859|P1|STARTED|Period 2||17
2261050|NCT02363803|5549858|P2|NOT COMPLETED|Period 1||0
2261051|NCT02363803|5549859|P1|NOT COMPLETED|Period 1||0
2261052|NCT02363803|5549858|P2|COMPLETED|Period 1||17
2261053|NCT02363803|5549859|P1|COMPLETED|Period 1||17
2261054|NCT02363803|5549858|P2|STARTED|Period 1||17
2261055|NCT02363803|5549859|P1|STARTED|Period 1||17
2261056|NCT02363621|5549879|P2|NOT COMPLETED|Overall Study||0
2261057|NCT02363621|5549880|P1|NOT COMPLETED|Overall Study||1
2261058|NCT02363621|5549879|P2|COMPLETED|Overall Study||50
2261059|NCT02363621|5549880|P1|COMPLETED|Overall Study||50
2261060|NCT02363621|5549879|P2|STARTED|Overall Study||50
2261061|NCT02363621|5549880|P1|STARTED|Overall Study||51
2261062|NCT02363478|5549890|P1|NOT COMPLETED|Overall Study||8
2261063|NCT02363478|5549890|P1|COMPLETED|Overall Study||22
2261064|NCT02363478|5549890|P1|STARTED|Overall Study||30
2261065|NCT02363439|5549897|P1|NOT COMPLETED|Overall Study||4
2261066|NCT02363439|5549897|P1|COMPLETED|Overall Study||1
2261067|NCT02363439|5549897|P1|STARTED|Overall Study||5
2261068|NCT02363322|5549903|P2|NOT COMPLETED|Overall Study||0
2261069|NCT02363322|5549904|P1|NOT COMPLETED|Overall Study||1
2261070|NCT02363322|5549903|P2|COMPLETED|Overall Study||36
2261071|NCT02363322|5549904|P1|COMPLETED|Overall Study||35
2261072|NCT02363322|5549903|P2|STARTED|Overall Study||36
2261073|NCT02363322|5549904|P1|STARTED|Overall Study||36
2261074|NCT02363270|5549916|P2|NOT COMPLETED|Overall Study||0
2261075|NCT02363270|5549917|P1|NOT COMPLETED|Overall Study||0
2261076|NCT02363270|5549916|P2|COMPLETED|Overall Study||24
2261077|NCT02363270|5549917|P1|COMPLETED|Overall Study||24
2261078|NCT02363270|5549916|P2|STARTED|Overall Study||24
2261079|NCT02363270|5549917|P1|STARTED|Overall Study||24
2261080|NCT02362789|5549925|P3|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||12
2261081|NCT02362789|5549926|P2|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||4
2261082|NCT02362789|5549927|P1|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||0
2261083|NCT02362789|5549925|P3|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||26
2261084|NCT02362789|5549926|P2|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||38
2261085|NCT02362789|5549927|P1|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||0
2261086|NCT02362789|5549925|P3|STARTED|Randomized Withdrawal (Wk 16 to 32)|Subjects achieving PASI reduction by 98-100% vs. baseline during Run-In|38
2261087|NCT02362789|5549926|P2|STARTED|Randomized Withdrawal (Wk 16 to 32)|Subjects achieving PASI reduction by 98-100% vs. baseline during Run-In|42
2261088|NCT02362789|5549927|P1|STARTED|Randomized Withdrawal (Wk 16 to 32)|N/A. Run-in phase completed.|0
2261089|NCT02362789|5549925|P3|NOT COMPLETED|Run-in Phase (Week 0 to 16)||0
2261090|NCT02362789|5549926|P2|NOT COMPLETED|Run-in Phase (Week 0 to 16)||0
2261091|NCT02362789|5549927|P1|NOT COMPLETED|Run-in Phase (Week 0 to 16)||2
2261092|NCT02362789|5549925|P3|COMPLETED|Run-in Phase (Week 0 to 16)||0
2261093|NCT02362789|5549926|P2|COMPLETED|Run-in Phase (Week 0 to 16)||0
2261094|NCT02362789|5549927|P1|COMPLETED|Run-in Phase (Week 0 to 16)||128
2261095|NCT02362789|5549925|P3|STARTED|Run-in Phase (Week 0 to 16)||0
2261096|NCT02362789|5549926|P2|STARTED|Run-in Phase (Week 0 to 16)||0
2261097|NCT02362789|5549927|P1|STARTED|Run-in Phase (Week 0 to 16)||130
2261098|NCT02362646|5549936|P2|NOT COMPLETED|Overall Study||24
2261099|NCT02362646|5549937|P1|NOT COMPLETED|Overall Study||38
2261100|NCT02362646|5549936|P2|COMPLETED|Overall Study||29
2261101|NCT02362646|5549937|P1|COMPLETED|Overall Study||68
2261102|NCT02362646|5549936|P2|STARTED|Overall Study||53
2261103|NCT02362646|5549937|P1|STARTED|Overall Study||106
2261104|NCT02362594|5549947|P2|NOT COMPLETED|Overall Study||225
2261105|NCT02362594|5549948|P1|NOT COMPLETED|Overall Study||250
2261106|NCT02362594|5549947|P2|COMPLETED|Overall Study||280
2261107|NCT02362594|5549948|P1|COMPLETED|Overall Study||264
2261108|NCT02362594|5549947|P2|Continuing Part 1 Adjuvant Therapy|Overall Study||21
2261109|NCT02362594|5549948|P1|Continuing Part 1 Adjuvant Therapy|Overall Study||41
2261110|NCT02362594|5549947|P2|Treated|Overall Study||502
2261111|NCT02362594|5549948|P1|Treated|Overall Study||509
2261112|NCT02362594|5549947|P2|STARTED|Overall Study||505
2261113|NCT02362594|5549948|P1|STARTED|Overall Study||514
2261132|NCT02362425|5550000|P4|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||3
2261133|NCT02362425|5550001|P3|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||1
2261134|NCT02362425|5550002|P2|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
2261135|NCT02362425|5550003|P1|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
2261136|NCT02362425|5550000|P4|COMPLETED|Phase 2 (up to 6 Months, Randomized)||14
2261137|NCT02362425|5550001|P3|COMPLETED|Phase 2 (up to 6 Months, Randomized)||15
2261138|NCT02362425|5550002|P2|COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
2261139|NCT02362425|5550003|P1|COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
2261140|NCT02362425|5550000|P4|STARTED|Phase 2 (up to 6 Months, Randomized)||17
2261141|NCT02362425|5550001|P3|STARTED|Phase 2 (up to 6 Months, Randomized)||16
2261142|NCT02362425|5550002|P2|STARTED|Phase 2 (up to 6 Months, Randomized)||0
2261143|NCT02362425|5550003|P1|STARTED|Phase 2 (up to 6 Months, Randomized)||0
2261144|NCT02362425|5550000|P4|NOT COMPLETED|Phase 1 (up to 6 Months)||0
2261145|NCT02362425|5550001|P3|NOT COMPLETED|Phase 1 (up to 6 Months)||0
2261146|NCT02362425|5550002|P2|NOT COMPLETED|Phase 1 (up to 6 Months)||0
2261147|NCT02362425|5550003|P1|NOT COMPLETED|Phase 1 (up to 6 Months)||16
2261148|NCT02362425|5550000|P4|COMPLETED|Phase 1 (up to 6 Months)||0
2261149|NCT02362425|5550001|P3|COMPLETED|Phase 1 (up to 6 Months)||0
2261150|NCT02362425|5550002|P2|COMPLETED|Phase 1 (up to 6 Months)||10
2261151|NCT02362425|5550003|P1|COMPLETED|Phase 1 (up to 6 Months)||37
2261152|NCT02362425|5550000|P4|STARTED|Phase 1 (up to 6 Months)||0
2261153|NCT02362425|5550001|P3|STARTED|Phase 1 (up to 6 Months)||0
2261154|NCT02362425|5550002|P2|STARTED|Phase 1 (up to 6 Months)||10
2261155|NCT02362425|5550003|P1|STARTED|Phase 1 (up to 6 Months)||53
2261156|NCT02362412|5550121|P2|NOT COMPLETED|Treatment Period III||1
2261157|NCT02362412|5550122|P1|NOT COMPLETED|Treatment Period III||0
2261158|NCT02362412|5550121|P2|COMPLETED|Treatment Period III||10
2261159|NCT02362412|5550122|P1|COMPLETED|Treatment Period III||9
2261160|NCT02362412|5550121|P2|TREATED|Treatment Period III||11
2261161|NCT02362412|5550122|P1|TREATED|Treatment Period III||9
2261162|NCT02362412|5550121|P2|STARTED|Treatment Period III||11
2261163|NCT02362412|5550122|P1|STARTED|Treatment Period III||9
2261164|NCT02362412|5550121|P2|NOT COMPLETED|Treatment Period II||0
2261165|NCT02362412|5550122|P1|NOT COMPLETED|Treatment Period II||0
2261166|NCT02362412|5550121|P2|COMPLETED|Treatment Period II||11
2261167|NCT02362412|5550122|P1|COMPLETED|Treatment Period II||9
2261168|NCT02362412|5550121|P2|TREATED|Treatment Period II||11
2261169|NCT02362412|5550122|P1|TREATED|Treatment Period II||9
2261170|NCT02362412|5550121|P2|STARTED|Treatment Period II||11
2261171|NCT02362412|5550122|P1|STARTED|Treatment Period II||9
2261172|NCT02362373|5550148|P1|NOT COMPLETED|Overall Study||0
2261173|NCT02362373|5550148|P1|COMPLETED|Overall Study||20
2261174|NCT02362373|5550148|P1|STARTED|Overall Study||20
2261175|NCT02362360|5550156|P2|NOT COMPLETED|Period 2||0
2261176|NCT02362360|5550157|P1|NOT COMPLETED|Period 2||0
2261177|NCT02362360|5550156|P2|COMPLETED|Period 2||25
2261178|NCT02362360|5550157|P1|COMPLETED|Period 2||23
2261179|NCT02362360|5550156|P2|STARTED|Period 2||25
2261180|NCT02362360|5550157|P1|STARTED|Period 2||23
2261181|NCT02362360|5550156|P2|NOT COMPLETED|Period 1||1
2261182|NCT02362360|5550157|P1|NOT COMPLETED|Period 1||3
2261183|NCT02362360|5550156|P2|COMPLETED|Period 1||25
2261184|NCT02362360|5550157|P1|COMPLETED|Period 1||23
2261185|NCT02362360|5550156|P2|STARTED|Period 1||26
2261186|NCT02362360|5550157|P1|STARTED|Period 1||26
2261187|NCT02362321|5550165|P2|NOT COMPLETED|Overall Study||0
2261188|NCT02362321|5550166|P1|NOT COMPLETED|Overall Study||4
2261189|NCT02362321|5550165|P2|COMPLETED|Overall Study||10
2261190|NCT02362321|5550166|P1|COMPLETED|Overall Study||6
2261191|NCT02362321|5550165|P2|STARTED|Overall Study||10
2261192|NCT02362321|5550166|P1|STARTED|Overall Study||10
2261193|NCT02362282|5550174|P2|NOT COMPLETED|Overall Study||0
2261194|NCT02362282|5550175|P1|NOT COMPLETED|Overall Study||1
2261195|NCT02362282|5550174|P2|COMPLETED|Overall Study||7
2261196|NCT02362282|5550175|P1|COMPLETED|Overall Study||4
2261197|NCT02362282|5550174|P2|STARTED|Overall Study||7
2261198|NCT02362282|5550175|P1|STARTED|Overall Study||5
2261199|NCT02362048|5550183|P2|NOT COMPLETED|Overall Study||40
2261200|NCT02362048|5550184|P1|NOT COMPLETED|Overall Study||37
2261201|NCT02362048|5550183|P2|COMPLETED|Overall Study||0
2261202|NCT02362048|5550184|P1|COMPLETED|Overall Study||0
2261203|NCT02362048|5550183|P2|Discontinued Study|Overall Study||40
2261204|NCT02362048|5550184|P1|Discontinued Study|Overall Study||37
2261205|NCT02362048|5550183|P2|Received Study Medication|Overall Study||38
2261206|NCT02362048|5550184|P1|Received Study Medication|Overall Study||35
2261207|NCT02362048|5550183|P2|Enrolled|Overall Study||40
2261208|NCT02362048|5550184|P1|Enrolled|Overall Study||37
2261209|NCT02362048|5550183|P2|STARTED|Overall Study|40 enrolled but only 38 received study medication.|40
2261210|NCT02362048|5550184|P1|STARTED|Overall Study|37 enrolled but only 35 received study medication.|37
2261211|NCT02361762|5550192|P2|NOT COMPLETED|Overall Study||2
2261212|NCT02361762|5550193|P1|NOT COMPLETED|Overall Study||0
2261213|NCT02361762|5550192|P2|COMPLETED|Overall Study||33
2261214|NCT02361762|5550193|P1|COMPLETED|Overall Study||35
2261215|NCT02361762|5550192|P2|STARTED|Overall Study||35
2261216|NCT02361762|5550193|P1|STARTED|Overall Study||35
2261217|NCT02361736|5550223|P2|NOT COMPLETED|Overall Study||1
2261218|NCT02361736|5550224|P1|NOT COMPLETED|Overall Study||1
2261219|NCT02361736|5550223|P2|COMPLETED|Overall Study||59
2261220|NCT02361736|5550224|P1|COMPLETED|Overall Study||59
2261221|NCT02361736|5550223|P2|STARTED|Overall Study||60
2261222|NCT02361736|5550224|P1|STARTED|Overall Study||60
2261223|NCT02361580|5550244|P2|NOT COMPLETED|Overall Study||3
2261224|NCT02361580|5550245|P1|NOT COMPLETED|Overall Study||6
2261225|NCT02361580|5550244|P2|COMPLETED|Overall Study||0
2261226|NCT02361580|5550245|P1|COMPLETED|Overall Study||0
2261227|NCT02361580|5550244|P2|STARTED|Overall Study||3
2261228|NCT02361580|5550245|P1|STARTED|Overall Study||6
2261229|NCT02361476|5550257|P2|NOT COMPLETED|Overall Study||0
2261230|NCT02361476|5550258|P1|NOT COMPLETED|Overall Study||0
2261231|NCT02361476|5550257|P2|COMPLETED|Overall Study||188
2261232|NCT02361476|5550258|P1|COMPLETED|Overall Study||191
2261233|NCT02361476|5550257|P2|STARTED|Overall Study||188
2261234|NCT02361476|5550258|P1|STARTED|Overall Study||191
2261235|NCT02361216|5550274|P2|NOT COMPLETED|12-month Follow-up||27
2261236|NCT02361216|5550275|P1|NOT COMPLETED|12-month Follow-up||52
2261237|NCT02361216|5550274|P2|COMPLETED|12-month Follow-up||130
2261238|NCT02361216|5550275|P1|COMPLETED|12-month Follow-up||489
2261239|NCT02361216|5550274|P2|STARTED|12-month Follow-up|1 of the 158 subjects did not receive treatment and was also excluded from the 12-month follow-up.|157
2261240|NCT02361216|5550275|P1|STARTED|12-month Follow-up||541
2261241|NCT02361216|5550274|P2|NOT COMPLETED|3 Day Treatment and 8 Week Follow/up||19
2261242|NCT02361216|5550275|P1|NOT COMPLETED|3 Day Treatment and 8 Week Follow/up||11
2261243|NCT02361216|5550274|P2|COMPLETED|3 Day Treatment and 8 Week Follow/up||158
2261244|NCT02361216|5550275|P1|COMPLETED|3 Day Treatment and 8 Week Follow/up||541
2261245|NCT02361216|5550274|P2|STARTED|3 Day Treatment and 8 Week Follow/up||177
2261246|NCT02361216|5550275|P1|STARTED|3 Day Treatment and 8 Week Follow/up||552
2261247|NCT02360995|5550290|P3|NOT COMPLETED|Overall Study||2
2261248|NCT02360995|5550291|P2|NOT COMPLETED|Overall Study||1
2261249|NCT02360995|5550292|P1|NOT COMPLETED|Overall Study||2
2261250|NCT02360995|5550290|P3|COMPLETED|Overall Study||41
2261251|NCT02360995|5550291|P2|COMPLETED|Overall Study||42
2261252|NCT02360995|5550292|P1|COMPLETED|Overall Study||41
2261253|NCT02360995|5550290|P3|STARTED|Overall Study||43
2261254|NCT02360995|5550291|P2|STARTED|Overall Study||43
2261255|NCT02360995|5550292|P1|STARTED|Overall Study||43
2261256|NCT02360774|5550317|P2|NOT COMPLETED|Overall Study||2
2261257|NCT02360774|5550318|P1|NOT COMPLETED|Overall Study||3
2261258|NCT02360774|5550317|P2|COMPLETED|Overall Study||13
2261259|NCT02360774|5550318|P1|COMPLETED|Overall Study||12
2261260|NCT02360774|5550317|P2|STARTED|Overall Study||15
2261261|NCT02360774|5550318|P1|STARTED|Overall Study||15
2261262|NCT02360631|5550332|P2|NOT COMPLETED|Overall Study||26
2261263|NCT02360631|5550333|P1|NOT COMPLETED|Overall Study||33
2261264|NCT02360631|5550332|P2|COMPLETED|Overall Study||174
2261265|NCT02360631|5550333|P1|COMPLETED|Overall Study||267
2261266|NCT02360631|5550332|P2|Week 12|Overall Study||165
2261267|NCT02360631|5550333|P1|Week 12|Overall Study||249
2261268|NCT02360631|5550332|P2|STARTED|Overall Study||200
2261269|NCT02360631|5550333|P1|STARTED|Overall Study||300
2261270|NCT02360475|5550347|P4|NOT COMPLETED|Overall Study||5
2261271|NCT02360475|5550348|P3|NOT COMPLETED|Overall Study||8
2261272|NCT02360475|5550349|P2|NOT COMPLETED|Overall Study||13
2261273|NCT02360475|5550350|P1|NOT COMPLETED|Overall Study||4
2261274|NCT02360475|5550347|P4|COMPLETED|Overall Study||120
2261275|NCT02360475|5550348|P3|COMPLETED|Overall Study||117
2261276|NCT02360475|5550349|P2|COMPLETED|Overall Study||111
2261277|NCT02360475|5550350|P1|COMPLETED|Overall Study||122
2261278|NCT02360475|5550347|P4|STARTED|Overall Study||125
2261279|NCT02360475|5550348|P3|STARTED|Overall Study||125
2261280|NCT02360475|5550349|P2|STARTED|Overall Study||124
2261281|NCT02360475|5550350|P1|STARTED|Overall Study||126
2261282|NCT02360397|5550408|P1|NOT COMPLETED|Overall Study||4
2261283|NCT02360397|5550408|P1|COMPLETED|Overall Study||2
2261284|NCT02360397|5550408|P1|STARTED|Overall Study||6
2261285|NCT02360293|5550417|P2|NOT COMPLETED|Overall Study||96
2261286|NCT02360293|5550418|P1|NOT COMPLETED|Overall Study||76
2261287|NCT02360293|5550417|P2|COMPLETED|Overall Study||83
2261288|NCT02360293|5550418|P1|COMPLETED|Overall Study||102
2261289|NCT02360293|5550417|P2|12month Physical Activity|Overall Study||59
2261290|NCT02360293|5550418|P1|12month Physical Activity|Overall Study||68
2261291|NCT02360293|5550417|P2|12month f/u Survey|Overall Study||83
2261292|NCT02360293|5550418|P1|12month f/u Survey|Overall Study||102
2261293|NCT02360293|5550417|P2|6month Physical Activity|Overall Study||108
2261294|NCT02360293|5550418|P1|6month Physical Activity|Overall Study||122
2261295|NCT02360293|5550417|P2|6month f/u Survey|Overall Study||105
2261296|NCT02360293|5550418|P1|6month f/u Survey|Overall Study||110
2261297|NCT02360293|5550417|P2|STARTED|Overall Study||179
2261298|NCT02360293|5550418|P1|STARTED|Overall Study||178
2261299|NCT02360280|5550432|P2|NOT COMPLETED|Overall Study||1
2261300|NCT02360280|5550433|P1|NOT COMPLETED|Overall Study||3
2261301|NCT02360280|5550432|P2|COMPLETED|Overall Study||29
2261302|NCT02360280|5550433|P1|COMPLETED|Overall Study||25
2261303|NCT02360280|5550432|P2|STARTED|Overall Study||30
2261304|NCT02360280|5550433|P1|STARTED|Overall Study||28
2261305|NCT02360228|5550448|P3|NOT COMPLETED|Overall Study||1
2261306|NCT02360228|5550449|P2|NOT COMPLETED|Overall Study||1
2261307|NCT02360228|5550450|P1|NOT COMPLETED|Overall Study||1
2261308|NCT02360228|5550448|P3|COMPLETED|Overall Study||7
2261309|NCT02360228|5550449|P2|COMPLETED|Overall Study||7
2261310|NCT02360228|5550450|P1|COMPLETED|Overall Study||8
2261311|NCT02360228|5550448|P3|STARTED|Overall Study||8
2261312|NCT02360228|5550449|P2|STARTED|Overall Study||8
2261313|NCT02360228|5550450|P1|STARTED|Overall Study||9
2261314|NCT02360124|5550479|P3|NOT COMPLETED|Overall Study||26
2261315|NCT02360124|5550480|P2|NOT COMPLETED|Overall Study||12
2261316|NCT02360124|5550481|P1|NOT COMPLETED|Overall Study||28
2261317|NCT02360124|5550479|P3|COMPLETED|Overall Study||82
2261318|NCT02360124|5550480|P2|COMPLETED|Overall Study||95
2261319|NCT02360124|5550481|P1|COMPLETED|Overall Study||80
2261320|NCT02360124|5550479|P3|STARTED|Overall Study||108
2261321|NCT02360124|5550480|P2|STARTED|Overall Study||107
2261322|NCT02360124|5550481|P1|STARTED|Overall Study||108
2261323|NCT02360111|5550492|P1|NOT COMPLETED|Overall Study||2
2261324|NCT02360111|5550492|P1|COMPLETED|Overall Study||1
2261325|NCT02360111|5550492|P1|STARTED|Overall Study||3
2261326|NCT02360059|5550502|P2|NOT COMPLETED|Overall Study||0
2261327|NCT02360059|5550503|P1|NOT COMPLETED|Overall Study||0
2261328|NCT02360059|5550502|P2|COMPLETED|Overall Study||0
2261329|NCT02360059|5550503|P1|COMPLETED|Overall Study||1
2261330|NCT02360059|5550502|P2|STARTED|Overall Study||0
2261331|NCT02360059|5550503|P1|STARTED|Overall Study||1
2261332|NCT02359955|5550511|P2|NOT COMPLETED|Overall Study||0
2261333|NCT02359955|5550512|P1|NOT COMPLETED|Overall Study||0
2261334|NCT02359955|5550511|P2|COMPLETED|Overall Study||10
2261335|NCT02359955|5550512|P1|COMPLETED|Overall Study||10
2261336|NCT02359955|5550511|P2|STARTED|Overall Study||10
2261337|NCT02359955|5550512|P1|STARTED|Overall Study||10
2261338|NCT02359916|5550535|P7|NOT COMPLETED|Overall Study||0
2261339|NCT02359916|5550536|P6|NOT COMPLETED|Overall Study||0
2261340|NCT02359916|5550537|P5|NOT COMPLETED|Overall Study||0
2261341|NCT02359916|5550538|P4|NOT COMPLETED|Overall Study||0
2261342|NCT02359916|5550539|P3|NOT COMPLETED|Overall Study||0
2261343|NCT02359916|5550540|P2|NOT COMPLETED|Overall Study||0
2261344|NCT02359916|5550541|P1|NOT COMPLETED|Overall Study||0
2261345|NCT02359916|5550535|P7|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
2261346|NCT02359916|5550536|P6|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
2261347|NCT02359916|5550537|P5|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
2261348|NCT02359916|5550538|P4|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
2261349|NCT02359916|5550539|P3|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
2261350|NCT02359916|5550540|P2|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
2261351|NCT02359916|5550541|P1|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
2261352|NCT02359916|5550535|P7|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
2261353|NCT02359916|5550536|P6|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
2261354|NCT02359916|5550537|P5|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
2261355|NCT02359916|5550538|P4|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
2261356|NCT02359916|5550539|P3|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
2261357|NCT02359916|5550540|P2|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
2261358|NCT02359916|5550541|P1|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
2261359|NCT02359903|5550563|P2|NOT COMPLETED|Overall Study||2
2261360|NCT02359903|5550564|P1|NOT COMPLETED|Overall Study||0
2261361|NCT02359903|5550563|P2|COMPLETED|Overall Study||43
2261362|NCT02359903|5550564|P1|COMPLETED|Overall Study||45
2261363|NCT02359903|5550563|P2|STARTED|Overall Study||45
2261364|NCT02359903|5550564|P1|STARTED|Overall Study||45
2261365|NCT02359890|5550572|P1|NOT COMPLETED|Overall Study||10
2261366|NCT02359890|5550572|P1|COMPLETED|Overall Study||155
2261367|NCT02359890|5550572|P1|Per-Protocol (PP) Population|Overall Study|Subjects part of mITT population who had undergone RF ablation.|155
2261368|NCT02359890|5550572|P1|mITT Population|Overall Study|Enrolled subjects who met the inclusion/exclusion criteria and had the study catheter inserted|155
2261369|NCT02359890|5550572|P1|Safety Population|Overall Study|Enrolled subjects who had the study catheter inserted|159
2261370|NCT02359890|5550572|P1|STARTED|Overall Study|Patients who enrolled in the study are those who signed informed consent forms.|165
2261371|NCT02359877|5550583|P4|NOT COMPLETED|Overall Study||3
2261372|NCT02359877|5550584|P3|NOT COMPLETED|Overall Study||0
2261373|NCT02359877|5550585|P2|NOT COMPLETED|Overall Study||0
2261374|NCT02359877|5550586|P1|NOT COMPLETED|Overall Study||1
2261375|NCT02359877|5550583|P4|COMPLETED|Overall Study||11
2261376|NCT02359877|5550584|P3|COMPLETED|Overall Study||6
2261377|NCT02359877|5550585|P2|COMPLETED|Overall Study||6
2261378|NCT02359877|5550586|P1|COMPLETED|Overall Study||33
2261379|NCT02359877|5550583|P4|STARTED|Overall Study||14
2261380|NCT02359877|5550584|P3|STARTED|Overall Study||6
2261381|NCT02359877|5550585|P2|STARTED|Overall Study||6
2261382|NCT02359877|5550586|P1|STARTED|Overall Study||34
2261383|NCT02359851|5550636|P1|NOT COMPLETED|Overall Study||2
2261384|NCT02359851|5550636|P1|COMPLETED|Overall Study||3
2261385|NCT02359851|5550636|P1|STARTED|Overall Study||5
2261386|NCT02359435|5550646|P2|NOT COMPLETED|Overall Study||4
2261387|NCT02359435|5550647|P1|NOT COMPLETED|Overall Study||4
2261388|NCT02359435|5550646|P2|COMPLETED|Overall Study||216
2261389|NCT02359435|5550647|P1|COMPLETED|Overall Study||216
2261390|NCT02359435|5550646|P2|STARTED|Overall Study||220
2261391|NCT02359435|5550647|P1|STARTED|Overall Study||220
2261392|NCT02359305|5550655|P2|NOT COMPLETED|Overall Study||0
2261393|NCT02359305|5550656|P1|NOT COMPLETED|Overall Study||0
2261394|NCT02359305|5550655|P2|COMPLETED|Overall Study||34
2261395|NCT02359305|5550656|P1|COMPLETED|Overall Study||34
2261396|NCT02359305|5550655|P2|STARTED|Overall Study||34
2261397|NCT02359305|5550656|P1|STARTED|Overall Study||34
2261398|NCT02359110|5550668|P2|NOT COMPLETED|Overall Study||0
2261399|NCT02359110|5550669|P1|NOT COMPLETED|Overall Study||0
2261400|NCT02359110|5550668|P2|COMPLETED|Overall Study||54
2261401|NCT02359110|5550669|P1|COMPLETED|Overall Study||55
2261402|NCT02359110|5550668|P2|STARTED|Overall Study||54
2261403|NCT02359110|5550669|P1|STARTED|Overall Study||55
2261404|NCT02359058|5550682|P3|NOT COMPLETED|Overall Study||0
2261405|NCT02359058|5550683|P2|NOT COMPLETED|Overall Study||0
2261406|NCT02359058|5550684|P1|NOT COMPLETED|Overall Study||0
2261407|NCT02359058|5550682|P3|COMPLETED|Overall Study||6
2261408|NCT02359058|5550683|P2|COMPLETED|Overall Study||6
2261409|NCT02359058|5550684|P1|COMPLETED|Overall Study||6
2261410|NCT02359058|5550682|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
2261411|NCT02359058|5550683|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
2261412|NCT02359058|5550684|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
2261413|NCT02359058|5550682|P3|STARTED|Overall Study||6
2261414|NCT02359058|5550683|P2|STARTED|Overall Study||6
2261415|NCT02359058|5550684|P1|STARTED|Overall Study||6
2261416|NCT02359045|5550707|P2|NOT COMPLETED|Overall Study||3
2261417|NCT02359045|5550708|P1|NOT COMPLETED|Overall Study||4
2261418|NCT02359045|5550707|P2|COMPLETED|Overall Study||39
2261419|NCT02359045|5550708|P1|COMPLETED|Overall Study||36
2261420|NCT02359045|5550707|P2|STARTED|Overall Study||42
2261421|NCT02359045|5550708|P1|STARTED|Overall Study||40
2261422|NCT02359006|5550943|P2|NOT COMPLETED|Overall Study||3
2261423|NCT02359006|5550944|P1|NOT COMPLETED|Overall Study||4
2261424|NCT02359006|5550943|P2|COMPLETED|Overall Study||10
2261425|NCT02359006|5550944|P1|COMPLETED|Overall Study||10
2261426|NCT02359006|5550943|P2|STARTED|Overall Study||13
2261427|NCT02359006|5550944|P1|STARTED|Overall Study||14
2261428|NCT02358876|5550984|P1|NOT COMPLETED|Overall Study||2
2261429|NCT02358876|5550984|P1|COMPLETED|Overall Study|All 32 participants completed the in-clinic portion and 30 out of the 32 completed the home portion.|30
2261430|NCT02358876|5550984|P1|STARTED|Overall Study||32
2261431|NCT02358863|5550988|P1|NOT COMPLETED|Overall Study||3
2261432|NCT02358863|5550988|P1|COMPLETED|Overall Study||10
2261433|NCT02358863|5550988|P1|STARTED|Overall Study||13
2261434|NCT02358668|5550995|P3|NOT COMPLETED|Overall Study||0
2261435|NCT02358668|5550996|P2|NOT COMPLETED|Overall Study||1
2261436|NCT02358668|5550997|P1|NOT COMPLETED|Overall Study||2
2261437|NCT02358668|5550995|P3|COMPLETED|Overall Study||12
2261438|NCT02358668|5550996|P2|COMPLETED|Overall Study||23
2261439|NCT02358668|5550997|P1|COMPLETED|Overall Study||22
2261440|NCT02358668|5550995|P3|STARTED|Overall Study||12
2261441|NCT02358668|5550996|P2|STARTED|Overall Study||24
2261442|NCT02358668|5550997|P1|STARTED|Overall Study||24
2261443|NCT02358603|5551139|P2|NOT COMPLETED|Overall Study||0
2261444|NCT02358603|5551140|P1|NOT COMPLETED|Overall Study||0
2261445|NCT02358603|5551139|P2|COMPLETED|Overall Study||8
2261446|NCT02358603|5551140|P1|COMPLETED|Overall Study||40
2261447|NCT02358603|5551139|P2|STARTED|Overall Study||8
2261448|NCT02358603|5551140|P1|STARTED|Overall Study||40
2261449|NCT02358473|5551146|P1|NOT COMPLETED|Overall Study||13
2261450|NCT02358473|5551146|P1|COMPLETED|Overall Study||0
2261451|NCT02358473|5551146|P1|STARTED|Overall Study||13
2261452|NCT02358343|5551160|P5|NOT COMPLETED|Comparative Efficacy Trial / Observation||2
2261453|NCT02358343|5551161|P4|NOT COMPLETED|Comparative Efficacy Trial / Observation||2
2261454|NCT02358343|5551162|P3|NOT COMPLETED|Comparative Efficacy Trial / Observation||5
2261455|NCT02358343|5551163|P2|NOT COMPLETED|Comparative Efficacy Trial / Observation||0
2261456|NCT02358343|5551164|P1|NOT COMPLETED|Comparative Efficacy Trial / Observation||0
2261457|NCT02358343|5551160|P5|COMPLETED|Comparative Efficacy Trial / Observation||18
2261458|NCT02358343|5551161|P4|COMPLETED|Comparative Efficacy Trial / Observation||58
2261459|NCT02358343|5551162|P3|COMPLETED|Comparative Efficacy Trial / Observation||55
2261460|NCT02358343|5551163|P2|COMPLETED|Comparative Efficacy Trial / Observation||0
2261461|NCT02358343|5551164|P1|COMPLETED|Comparative Efficacy Trial / Observation||0
2261462|NCT02358343|5551160|P5|STARTED|Comparative Efficacy Trial / Observation||20
2261463|NCT02358343|5551161|P4|STARTED|Comparative Efficacy Trial / Observation|47 completed treatment|60
2261464|NCT02358343|5551162|P3|STARTED|Comparative Efficacy Trial / Observation|44 completed treatment|60
2261465|NCT02358343|5551163|P2|STARTED|Comparative Efficacy Trial / Observation|Participants enrolled in screening intervention enrolled in comparative efficacy trial|0
2261466|NCT02358343|5551164|P1|STARTED|Comparative Efficacy Trial / Observation|Participants enrolled in screening intervention enrolled in comparative efficacy trial|0
2261467|NCT02358343|5551160|P5|NOT COMPLETED|Screening Intervention||0
2261468|NCT02358343|5551161|P4|NOT COMPLETED|Screening Intervention||0
2261469|NCT02358343|5551162|P3|NOT COMPLETED|Screening Intervention||0
2261470|NCT02358343|5551163|P2|NOT COMPLETED|Screening Intervention||8
2261471|NCT02358343|5551164|P1|NOT COMPLETED|Screening Intervention||6
2261472|NCT02358343|5551160|P5|COMPLETED|Screening Intervention||0
2261473|NCT02358343|5551161|P4|COMPLETED|Screening Intervention||0
2261474|NCT02358343|5551162|P3|COMPLETED|Screening Intervention||0
2261475|NCT02358343|5551163|P2|COMPLETED|Screening Intervention||84
2261476|NCT02358343|5551164|P1|COMPLETED|Screening Intervention||86
2261477|NCT02358343|5551160|P5|STARTED|Screening Intervention||0
2261478|NCT02358343|5551161|P4|STARTED|Screening Intervention||0
2261479|NCT02358343|5551162|P3|STARTED|Screening Intervention||0
2261480|NCT02358343|5551163|P2|STARTED|Screening Intervention|89 completed control visit|92
2261481|NCT02358343|5551164|P1|STARTED|Screening Intervention|90 completed engagement interview|92
2261482|NCT02358135|5551201|P2|NOT COMPLETED|Overall Study||19
2261483|NCT02358135|5551202|P1|NOT COMPLETED|Overall Study||15
2261484|NCT02358135|5551201|P2|COMPLETED|Overall Study||131
2261485|NCT02358135|5551202|P1|COMPLETED|Overall Study||135
2261486|NCT02358135|5551201|P2|Randomized|Overall Study||148
2261487|NCT02358135|5551202|P1|Randomized|Overall Study||148
2261488|NCT02358135|5551201|P2|STARTED|Overall Study||150
2261489|NCT02358135|5551202|P1|STARTED|Overall Study||150
2261490|NCT02358044|5551220|P2|NOT COMPLETED|Overall Study||7
2261491|NCT02358044|5551221|P1|NOT COMPLETED|Overall Study||2
2261492|NCT02358044|5551220|P2|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|121
2261493|NCT02358044|5551221|P1|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|127
2261494|NCT02358044|5551220|P2|Treated|Overall Study||126
2261495|NCT02358044|5551221|P1|Treated|Overall Study||129
2261496|NCT02358044|5551220|P2|STARTED|Overall Study||128
2261497|NCT02358044|5551221|P1|STARTED|Overall Study||129
2261516|NCT02357940|5551369|P2|NOT COMPLETED|Overall Study||2
2261517|NCT02357940|5551370|P1|NOT COMPLETED|Overall Study||0
2261518|NCT02357940|5551369|P2|COMPLETED|Overall Study||30
2261519|NCT02357940|5551370|P1|COMPLETED|Overall Study||9
2261520|NCT02357940|5551369|P2|STARTED|Overall Study||32
2261521|NCT02357940|5551370|P1|STARTED|Overall Study||9
2261522|NCT02357901|5551497|P4|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||66
2261523|NCT02357901|5551498|P3|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||72
2261524|NCT02357901|5551499|P2|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||78
2261525|NCT02357901|5551500|P1|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||0
2261526|NCT02357901|5551497|P4|COMPLETED|Treatment Period (Day 1 to Week 24)||34
2261527|NCT02357901|5551498|P3|COMPLETED|Treatment Period (Day 1 to Week 24)||129
2261528|NCT02357901|5551499|P2|COMPLETED|Treatment Period (Day 1 to Week 24)||125
2261529|NCT02357901|5551500|P1|COMPLETED|Treatment Period (Day 1 to Week 24)||0
2261530|NCT02357901|5551497|P4|Full Analysis Set|Treatment Period (Day 1 to Week 24)||99
2261531|NCT02357901|5551498|P3|Full Analysis Set|Treatment Period (Day 1 to Week 24)||196
2261532|NCT02357901|5551499|P2|Full Analysis Set|Treatment Period (Day 1 to Week 24)||194
2261533|NCT02357901|5551500|P1|Full Analysis Set|Treatment Period (Day 1 to Week 24)||0
2261534|NCT02357901|5551497|P4|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||100
2261535|NCT02357901|5551498|P3|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||201
2261536|NCT02357901|5551499|P2|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||203
2261537|NCT02357901|5551500|P1|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||0
2261538|NCT02357901|5551497|P4|STARTED|Treatment Period (Day 1 to Week 24)||100
2261539|NCT02357901|5551498|P3|STARTED|Treatment Period (Day 1 to Week 24)||201
2261540|NCT02357901|5551499|P2|STARTED|Treatment Period (Day 1 to Week 24)||203
2261541|NCT02357901|5551500|P1|STARTED|Treatment Period (Day 1 to Week 24)||0
2261542|NCT02357901|5551497|P4|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
2261543|NCT02357901|5551498|P3|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
2261544|NCT02357901|5551499|P2|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
2261545|NCT02357901|5551500|P1|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||161
2261546|NCT02357901|5551497|P4|COMPLETED|Run-In Period (Days -14 to Day -1)||0
2261547|NCT02357901|5551498|P3|COMPLETED|Run-In Period (Days -14 to Day -1)||0
2261548|NCT02357901|5551499|P2|COMPLETED|Run-In Period (Days -14 to Day -1)||0
2261549|NCT02357901|5551500|P1|COMPLETED|Run-In Period (Days -14 to Day -1)||504
2261550|NCT02357901|5551497|P4|STARTED|Run-In Period (Days -14 to Day -1)||0
2261551|NCT02357901|5551498|P3|STARTED|Run-In Period (Days -14 to Day -1)||0
2261552|NCT02357901|5551499|P2|STARTED|Run-In Period (Days -14 to Day -1)||0
2261553|NCT02357901|5551500|P1|STARTED|Run-In Period (Days -14 to Day -1)|Received at least one dose of SUBOXONE sublingual film.|665
2261554|NCT02357758|5551553|P3|NOT COMPLETED|Overall Study||7
2261555|NCT02357758|5551554|P2|NOT COMPLETED|Overall Study||0
2261556|NCT02357758|5551555|P1|NOT COMPLETED|Overall Study||16
2261557|NCT02357758|5551553|P3|COMPLETED|Overall Study||5
2261558|NCT02357758|5551554|P2|COMPLETED|Overall Study||20
2261559|NCT02357758|5551555|P1|COMPLETED|Overall Study||9
2261560|NCT02357758|5551553|P3|STARTED|Overall Study||12
2261561|NCT02357758|5551554|P2|STARTED|Overall Study||20
2261562|NCT02357758|5551555|P1|STARTED|Overall Study||25
2261563|NCT02357576|5551565|P2|NOT COMPLETED|Neurodevelopmental Outcome Follow Up||5
2261564|NCT02357576|5551566|P1|NOT COMPLETED|Neurodevelopmental Outcome Follow Up||5
2261565|NCT02357576|5551565|P2|COMPLETED|Neurodevelopmental Outcome Follow Up||2
2261566|NCT02357576|5551566|P1|COMPLETED|Neurodevelopmental Outcome Follow Up||6
2261567|NCT02357576|5551565|P2|STARTED|Neurodevelopmental Outcome Follow Up||7
2261568|NCT02357576|5551566|P1|STARTED|Neurodevelopmental Outcome Follow Up|1 patient exited the study after treatment completion and before returning for follow up visits.|11
2261569|NCT02357576|5551565|P2|NOT COMPLETED|Treatment Period||2
2261570|NCT02357576|5551566|P1|NOT COMPLETED|Treatment Period||0
2261571|NCT02357576|5551565|P2|COMPLETED|Treatment Period||7
2261572|NCT02357576|5551566|P1|COMPLETED|Treatment Period||12
2261573|NCT02357576|5551565|P2|STARTED|Treatment Period||9
2261574|NCT02357576|5551566|P1|STARTED|Treatment Period||12
2261575|NCT02357485|5551596|P1|NOT COMPLETED|Overall Study||0
2261576|NCT02357485|5551596|P1|COMPLETED|Overall Study||6
2261577|NCT02357485|5551596|P1|STARTED|Overall Study|6 subjects, 8 knees ( 2 bilateral & 4 unilateral)|6
2261578|NCT02357459|5551607|P3|NOT COMPLETED|Overall Study||12
2261579|NCT02357459|5551608|P2|NOT COMPLETED|Overall Study||14
2261580|NCT02357459|5551609|P1|NOT COMPLETED|Overall Study||17
2261581|NCT02357459|5551607|P3|COMPLETED|Overall Study||150
2261582|NCT02357459|5551608|P2|COMPLETED|Overall Study||149
2261583|NCT02357459|5551609|P1|COMPLETED|Overall Study||144
2261584|NCT02357459|5551607|P3|STARTED|Overall Study||162
2261585|NCT02357459|5551608|P2|STARTED|Overall Study||163
2261586|NCT02357459|5551609|P1|STARTED|Overall Study||161
2261587|NCT02357420|5551655|P4|NOT COMPLETED|Overall Study||19
2261588|NCT02357420|5551656|P3|NOT COMPLETED|Overall Study||16
2261589|NCT02357420|5551657|P2|NOT COMPLETED|Overall Study||12
2261590|NCT02357420|5551658|P1|NOT COMPLETED|Overall Study||12
2261591|NCT02357420|5551655|P4|COMPLETED|Overall Study||63
2261592|NCT02357420|5551656|P3|COMPLETED|Overall Study|1 participant who discontinued prematurely was included in completed as he/she fulfilled Visit 8.|93
2261593|NCT02357420|5551657|P2|COMPLETED|Overall Study|1 participant who discontinued prematurely was included in completed as he/she fulfilled Visit 8.|86
2261594|NCT02357420|5551658|P1|COMPLETED|Overall Study|3 participants who discontinued prematurely were included in completed as they fulfilled Visit 8.|92
2261595|NCT02357420|5551655|P4|Full Analysis Set (FAS)|Overall Study|1 participant from safety set did not enter FAS.|81
2261596|NCT02357420|5551656|P3|Full Analysis Set (FAS)|Overall Study||109
2261597|NCT02357420|5551657|P2|Full Analysis Set (FAS)|Overall Study||98
2261598|NCT02357420|5551658|P1|Full Analysis Set (FAS)|Overall Study||104
2261599|NCT02357420|5551655|P4|STARTED|Overall Study||82
2261600|NCT02357420|5551656|P3|STARTED|Overall Study||109
2261601|NCT02357420|5551657|P2|STARTED|Overall Study||98
2261602|NCT02357420|5551658|P1|STARTED|Overall Study||104
2261603|NCT02357394|5551678|P2|NOT COMPLETED|Overall Study||0
2261604|NCT02357394|5551679|P1|NOT COMPLETED|Overall Study||0
2261605|NCT02357394|5551678|P2|COMPLETED|Overall Study||3
2261606|NCT02357394|5551679|P1|COMPLETED|Overall Study||4
2261607|NCT02357394|5551678|P2|STARTED|Overall Study||3
2261608|NCT02357394|5551679|P1|STARTED|Overall Study||4
2261609|NCT02357342|5551719|P2|NOT COMPLETED|Extension Study||0
2261610|NCT02357342|5551720|P1|NOT COMPLETED|Extension Study||0
2261611|NCT02357342|5551719|P2|COMPLETED|Extension Study||9
2261612|NCT02357342|5551720|P1|COMPLETED|Extension Study||4
2261613|NCT02357342|5551719|P2|STARTED|Extension Study||9
2261614|NCT02357342|5551720|P1|STARTED|Extension Study||4
2261615|NCT02357342|5551719|P2|NOT COMPLETED|First 6 Months||0
2261616|NCT02357342|5551720|P1|NOT COMPLETED|First 6 Months||2
2261617|NCT02357342|5551719|P2|COMPLETED|First 6 Months||20
2261618|NCT02357342|5551720|P1|COMPLETED|First 6 Months|2 patients died. Neither deaths were study drug related.|18
2261619|NCT02357342|5551719|P2|STARTED|First 6 Months||20
2261620|NCT02357342|5551720|P1|STARTED|First 6 Months||20
2261621|NCT02357290|5551730|P1|NOT COMPLETED|Overall Study||26
2261622|NCT02357290|5551730|P1|COMPLETED|Overall Study||14
2261623|NCT02357290|5551730|P1|Exposed|Overall Study||26
2261624|NCT02357290|5551730|P1|STARTED|Overall Study||40
2261625|NCT02357264|5551737|P2|NOT COMPLETED|Overall Study||0
2261626|NCT02357264|5551738|P1|NOT COMPLETED|Overall Study||0
2261627|NCT02357264|5551737|P2|COMPLETED|Overall Study||130
2261628|NCT02357264|5551738|P1|COMPLETED|Overall Study||56
2261629|NCT02357264|5551737|P2|STARTED|Overall Study||130
2261630|NCT02357264|5551738|P1|STARTED|Overall Study||56
2261631|NCT02357173|5551747|P3|NOT COMPLETED|Overall Study||6
2261632|NCT02357173|5551748|P2|NOT COMPLETED|Overall Study||6
2261633|NCT02357173|5551749|P1|NOT COMPLETED|Overall Study||6
2261634|NCT02357173|5551747|P3|COMPLETED|Overall Study||16
2261635|NCT02357173|5551748|P2|COMPLETED|Overall Study||15
2261636|NCT02357173|5551749|P1|COMPLETED|Overall Study||19
2261637|NCT02357173|5551747|P3|STARTED|Overall Study||22
2261638|NCT02357173|5551748|P2|STARTED|Overall Study||21
2261639|NCT02357173|5551749|P1|STARTED|Overall Study||25
2261640|NCT02356900|5551768|P2|NOT COMPLETED|Overall Study||0
2261641|NCT02356900|5551769|P1|NOT COMPLETED|Overall Study||0
2261642|NCT02356900|5551768|P2|COMPLETED|Overall Study||10
2261643|NCT02356900|5551769|P1|COMPLETED|Overall Study||11
2261644|NCT02356900|5551768|P2|STARTED|Overall Study||10
2261645|NCT02356900|5551769|P1|STARTED|Overall Study||11
2261646|NCT02356783|5551789|P2|NOT COMPLETED|Overall Study||3
2261647|NCT02356783|5551790|P1|NOT COMPLETED|Overall Study||1
2261648|NCT02356783|5551789|P2|COMPLETED|Overall Study||14
2261649|NCT02356783|5551790|P1|COMPLETED|Overall Study||15
2261650|NCT02356783|5551789|P2|STARTED|Overall Study||17
2261651|NCT02356783|5551790|P1|STARTED|Overall Study||16
2261652|NCT02356588|5551800|P2|NOT COMPLETED|Overall Study||13
2261653|NCT02356588|5551801|P1|NOT COMPLETED|Overall Study||5
2261654|NCT02356588|5551800|P2|COMPLETED|Overall Study||41
2261655|NCT02356588|5551801|P1|COMPLETED|Overall Study||102
2261656|NCT02356588|5551800|P2|STARTED|Overall Study||54
2261657|NCT02356588|5551801|P1|STARTED|Overall Study||107
2261658|NCT02356575|5551835|P2|NOT COMPLETED|Overall Study||0
2261659|NCT02356575|5551836|P1|NOT COMPLETED|Overall Study||0
2261660|NCT02356575|5551835|P2|COMPLETED|Overall Study||80
2261661|NCT02356575|5551836|P1|COMPLETED|Overall Study||80
2261662|NCT02356575|5551835|P2|STARTED|Overall Study||80
2261663|NCT02356575|5551836|P1|STARTED|Overall Study||80
2261664|NCT02356562|5551918|P2|NOT COMPLETED|Overall Study||1
2261665|NCT02356562|5551919|P1|NOT COMPLETED|Overall Study||2
2261666|NCT02356562|5551918|P2|COMPLETED|Overall Study||6
2261667|NCT02356562|5551919|P1|COMPLETED|Overall Study||20
2261668|NCT02356562|5551918|P2|STARTED|Overall Study||7
2261669|NCT02356562|5551919|P1|STARTED|Overall Study||22
2261670|NCT02356471|5551929|P1|NOT COMPLETED|Overall Study||6
2261671|NCT02356471|5551929|P1|COMPLETED|Overall Study||28
2261672|NCT02356471|5551929|P1|STARTED|Overall Study||34
2261673|NCT02356211|5551945|P3|NOT COMPLETED|Overall Study||0
2261674|NCT02356211|5551946|P2|NOT COMPLETED|Overall Study||5
2261675|NCT02356211|5551947|P1|NOT COMPLETED|Overall Study||0
2261676|NCT02356211|5551945|P3|COMPLETED|Overall Study||51
2261677|NCT02356211|5551946|P2|COMPLETED|Overall Study|For 18 patients, phone call follow-up or EMR provided sufficient follow-up information.|18
2261678|NCT02356211|5551947|P1|COMPLETED|Overall Study||55
2261679|NCT02356211|5551945|P3|STARTED|Overall Study||51
2261680|NCT02356211|5551946|P2|STARTED|Overall Study||23
2261681|NCT02356211|5551947|P1|STARTED|Overall Study||55
2261682|NCT02356198|5551957|P2|NOT COMPLETED|Overall Study||7
2261683|NCT02356198|5551958|P1|NOT COMPLETED|Overall Study||2
2261684|NCT02356198|5551957|P2|COMPLETED|Overall Study||98
2261685|NCT02356198|5551958|P1|COMPLETED|Overall Study||102
2261686|NCT02356198|5551957|P2|STARTED|Overall Study||105
2261687|NCT02356198|5551958|P1|STARTED|Overall Study||104
2261688|NCT02356107|5551972|P1|NOT COMPLETED|Overall Study||3
2261689|NCT02356107|5551972|P1|COMPLETED|Overall Study||12
2261690|NCT02356107|5551972|P1|STARTED|Overall Study||15
2261691|NCT02355977|5551979|P3|NOT COMPLETED|Overall Study||0
2261692|NCT02355977|5551980|P2|NOT COMPLETED|Overall Study||0
2261693|NCT02355977|5551981|P1|NOT COMPLETED|Overall Study||0
2261694|NCT02355977|5551979|P3|COMPLETED|Overall Study||23
2261695|NCT02355977|5551980|P2|COMPLETED|Overall Study||26
2261696|NCT02355977|5551981|P1|COMPLETED|Overall Study||21
2261697|NCT02355977|5551979|P3|STARTED|Overall Study||23
2261698|NCT02355977|5551980|P2|STARTED|Overall Study||26
2261699|NCT02355977|5551981|P1|STARTED|Overall Study||21
2261700|NCT02355886|5551997|P2|NOT COMPLETED|Overall Study||0
2261701|NCT02355886|5551998|P1|NOT COMPLETED|Overall Study||0
2261702|NCT02355886|5551997|P2|COMPLETED|Overall Study||12
2261703|NCT02355886|5551998|P1|COMPLETED|Overall Study||13
2261704|NCT02355886|5551997|P2|STARTED|Overall Study||12
2261705|NCT02355886|5551998|P1|STARTED|Overall Study||13
2261706|NCT02355743|5552008|P1|NOT COMPLETED|Overall Study||2
2261707|NCT02355743|5552008|P1|COMPLETED|Overall Study||6
2261708|NCT02355743|5552008|P1|STARTED|Overall Study||8
2261709|NCT02355691|5552016|P2|NOT COMPLETED|Overall Study||9
2261710|NCT02355691|5552017|P1|NOT COMPLETED|Overall Study||7
2261711|NCT02355691|5552016|P2|COMPLETED|Overall Study||0
2261712|NCT02355691|5552017|P1|COMPLETED|Overall Study||0
2261713|NCT02355691|5552016|P2|2nd Postop Visit|Overall Study||9
2261714|NCT02355691|5552017|P1|2nd Postop Visit|Overall Study||7
2261715|NCT02355691|5552016|P2|1st Postop Visit|Overall Study||9
2261716|NCT02355691|5552017|P1|1st Postop Visit|Overall Study||7
2261717|NCT02355691|5552016|P2|STARTED|Overall Study||9
2261718|NCT02355691|5552017|P1|STARTED|Overall Study||7
2261719|NCT02355665|5552027|P2|NOT COMPLETED|Overall Study||232
2261720|NCT02355665|5552028|P1|NOT COMPLETED|Overall Study||249
2261721|NCT02355665|5552027|P2|COMPLETED|Overall Study||365
2261722|NCT02355665|5552028|P1|COMPLETED|Overall Study||352
2261723|NCT02355665|5552027|P2|STARTED|Overall Study||597
2261724|NCT02355665|5552028|P1|STARTED|Overall Study||601
2261725|NCT02355275|5552460|P1|NOT COMPLETED|Overall Study||8
2261726|NCT02355275|5552460|P1|COMPLETED|Overall Study||14
2261727|NCT02355275|5552460|P1|STARTED|Overall Study||22
2261728|NCT02355158|5552465|P1|NOT COMPLETED|Overall Study||150
2261729|NCT02355158|5552465|P1|COMPLETED|Overall Study||47
2261730|NCT02355158|5552465|P1|STARTED|Overall Study||197
2261731|NCT02355067|5552471|P2|NOT COMPLETED|Overall Study||8
2261732|NCT02355067|5552472|P1|NOT COMPLETED|Overall Study||8
2261733|NCT02355067|5552471|P2|COMPLETED|Overall Study||12
2261734|NCT02355067|5552472|P1|COMPLETED|Overall Study||12
2261735|NCT02355067|5552471|P2|STARTED|Overall Study||20
2261736|NCT02355067|5552472|P1|STARTED|Overall Study||20
2261737|NCT02355028|5552486|P2|NOT COMPLETED|Overall Study||5
2261738|NCT02355028|5552487|P1|NOT COMPLETED|Overall Study||11
2261739|NCT02355028|5552486|P2|COMPLETED|Overall Study||41
2261740|NCT02355028|5552487|P1|COMPLETED|Overall Study||36
2261741|NCT02355028|5552486|P2|Treated|Overall Study||45
2261742|NCT02355028|5552487|P1|Treated|Overall Study||46
2261743|NCT02355028|5552486|P2|STARTED|Overall Study||46
2261744|NCT02355028|5552487|P1|STARTED|Overall Study||47
2261745|NCT02354976|5552523|P3|NOT COMPLETED|Overall Study||3
2261746|NCT02354976|5552524|P2|NOT COMPLETED|Overall Study||1
2261747|NCT02354976|5552525|P1|NOT COMPLETED|Overall Study||2
2261748|NCT02354976|5552523|P3|COMPLETED|Overall Study||23
2261749|NCT02354976|5552524|P2|COMPLETED|Overall Study||26
2261750|NCT02354976|5552525|P1|COMPLETED|Overall Study||23
2261751|NCT02354976|5552523|P3|STARTED|Overall Study||26
2261752|NCT02354976|5552524|P2|STARTED|Overall Study||27
2261753|NCT02354976|5552525|P1|STARTED|Overall Study||25
2261754|NCT02354924|5552536|P2|NOT COMPLETED|Overall Study||0
2261755|NCT02354924|5552537|P1|NOT COMPLETED|Overall Study||0
2261756|NCT02354924|5552536|P2|COMPLETED|Overall Study||20
2261757|NCT02354924|5552537|P1|COMPLETED|Overall Study||40
2261758|NCT02354924|5552536|P2|STARTED|Overall Study||20
2261759|NCT02354924|5552537|P1|STARTED|Overall Study||40
2261760|NCT02354859|5552549|P2|NOT COMPLETED|Overall Study||2
2261761|NCT02354859|5552550|P1|NOT COMPLETED|Overall Study||0
2261762|NCT02354859|5552549|P2|COMPLETED|Overall Study||57
2261763|NCT02354859|5552550|P1|COMPLETED|Overall Study||60
2261764|NCT02354859|5552549|P2|STARTED|Overall Study||59
2261765|NCT02354859|5552550|P1|STARTED|Overall Study||60
2261766|NCT02354833|5552568|P2|NOT COMPLETED|Overall Study||0
2261767|NCT02354833|5552569|P1|NOT COMPLETED|Overall Study||0
2261768|NCT02354833|5552568|P2|COMPLETED|Overall Study||43
2261769|NCT02354833|5552569|P1|COMPLETED|Overall Study||38
2261770|NCT02354833|5552568|P2|STARTED|Overall Study||43
2261771|NCT02354833|5552569|P1|STARTED|Overall Study||38
2261775|NCT02354599|5552595|P6|NOT COMPLETED|Overall Study||1
2261776|NCT02354599|5552596|P5|NOT COMPLETED|Overall Study||0
2261777|NCT02354599|5552597|P4|NOT COMPLETED|Overall Study||0
2261778|NCT02354599|5552598|P3|NOT COMPLETED|Overall Study||0
2261779|NCT02354599|5552599|P2|NOT COMPLETED|Overall Study||1
2261780|NCT02354599|5552600|P1|NOT COMPLETED|Overall Study||1
2261781|NCT02354599|5552595|P6|COMPLETED|Overall Study||5
2261782|NCT02354599|5552596|P5|COMPLETED|Overall Study||2
2261783|NCT02354599|5552597|P4|COMPLETED|Overall Study||6
2261784|NCT02354599|5552598|P3|COMPLETED|Overall Study||6
2261785|NCT02354599|5552599|P2|COMPLETED|Overall Study||5
2261786|NCT02354599|5552600|P1|COMPLETED|Overall Study||5
2261787|NCT02354599|5552595|P6|STARTED|Overall Study||6
2261788|NCT02354599|5552596|P5|STARTED|Overall Study||2
2261789|NCT02354599|5552597|P4|STARTED|Overall Study||6
2261790|NCT02354599|5552598|P3|STARTED|Overall Study||6
2261791|NCT02354599|5552599|P2|STARTED|Overall Study||6
2261792|NCT02354599|5552600|P1|STARTED|Overall Study||6
2261793|NCT02354508|5552673|P3|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||3
2261794|NCT02354508|5552674|P2|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||3
2261795|NCT02354508|5552675|P1|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||4
2261796|NCT02354508|5552673|P3|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|36
2261797|NCT02354508|5552674|P2|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|20
2261798|NCT02354508|5552675|P1|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|22
2261799|NCT02354508|5552673|P3|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|3
2261800|NCT02354508|5552674|P2|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|3
2261801|NCT02354508|5552675|P1|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|4
2261802|NCT02354508|5552673|P3|STARTED|Period 3: Post-treatment Follow up Phase||39
2261803|NCT02354508|5552674|P2|STARTED|Period 3: Post-treatment Follow up Phase||23
2261804|NCT02354508|5552675|P1|STARTED|Period 3: Post-treatment Follow up Phase||26
2261805|NCT02354508|5552673|P3|NOT COMPLETED|Period 2: Extension Phase||3
2261806|NCT02354508|5552674|P2|NOT COMPLETED|Period 2: Extension Phase||4
2261807|NCT02354508|5552675|P1|NOT COMPLETED|Period 2: Extension Phase||6
2261808|NCT02354508|5552673|P3|COMPLETED|Period 2: Extension Phase||36
2261809|NCT02354508|5552674|P2|COMPLETED|Period 2: Extension Phase||19
2261810|NCT02354508|5552675|P1|COMPLETED|Period 2: Extension Phase||20
2261811|NCT02354508|5552673|P3|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|39
2261812|NCT02354508|5552674|P2|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|23
2261813|NCT02354508|5552675|P1|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|26
2261814|NCT02354508|5552673|P3|NOT COMPLETED|Period 1: Core Phase||6
2261815|NCT02354508|5552674|P2|NOT COMPLETED|Period 1: Core Phase||2
2261816|NCT02354508|5552675|P1|NOT COMPLETED|Period 1: Core Phase||2
2261817|NCT02354508|5552673|P3|COMPLETED|Period 1: Core Phase||47
2261818|NCT02354508|5552674|P2|COMPLETED|Period 1: Core Phase||27
2261819|NCT02354508|5552675|P1|COMPLETED|Period 1: Core Phase||39
2261820|NCT02354508|5552673|P3|STARTED|Period 1: Core Phase||53
2261821|NCT02354508|5552674|P2|STARTED|Period 1: Core Phase||29
2261822|NCT02354508|5552675|P1|STARTED|Period 1: Core Phase||41
2261823|NCT02354482|5552753|P1|NOT COMPLETED|Reference||0
2261824|NCT02354482|5552753|P1|COMPLETED|Reference||2042
2261825|NCT02354482|5552753|P1|STARTED|Reference||2042
2261826|NCT02354482|5552753|P1|NOT COMPLETED|Assessment and Teach Back||0
2261827|NCT02354482|5552753|P1|COMPLETED|Assessment and Teach Back||508
2261828|NCT02354482|5552753|P1|STARTED|Assessment and Teach Back||508
2261829|NCT02354482|5552753|P1|NOT COMPLETED|Patient/Family Caregiver Assessment||0
2261830|NCT02354482|5552753|P1|COMPLETED|Patient/Family Caregiver Assessment||3093
2261831|NCT02354482|5552753|P1|STARTED|Patient/Family Caregiver Assessment||3093
2261832|NCT02354482|5552753|P1|NOT COMPLETED|Hospital-Based Trust and Plain Language||0
2261833|NCT02354482|5552753|P1|COMPLETED|Hospital-Based Trust and Plain Language||2090
2261834|NCT02354482|5552753|P1|STARTED|Hospital-Based Trust and Plain Language||2090
2261835|NCT02354482|5552753|P1|NOT COMPLETED|Home-Based Trust and Plain Language||0
2261836|NCT02354482|5552753|P1|COMPLETED|Home-Based Trust and Plain Language||1979
2261837|NCT02354482|5552753|P1|STARTED|Home-Based Trust and Plain Language||1979
2261838|NCT02354482|5552753|P1|NOT COMPLETED|Patient Communication and Care||0
2261839|NCT02354482|5552753|P1|COMPLETED|Patient Communication and Care||2158
2261840|NCT02354482|5552753|P1|STARTED|Patient Communication and Care||2158
2261841|NCT02354443|5552773|P1|NOT COMPLETED|Overall Study||0
2261842|NCT02354443|5552773|P1|COMPLETED|Overall Study||1
2261843|NCT02354443|5552773|P1|STARTED|Overall Study||1
2261844|NCT02354417|5552777|P1|NOT COMPLETED|Overall Study||1
2261845|NCT02354417|5552777|P1|COMPLETED|Overall Study||2
2261846|NCT02354417|5552777|P1|STARTED|Overall Study||3
2261847|NCT02354378|5552783|P2|NOT COMPLETED|Overall Study||4
2261848|NCT02354378|5552784|P1|NOT COMPLETED|Overall Study||34
2261849|NCT02354378|5552783|P2|COMPLETED|Overall Study||16
2261850|NCT02354378|5552784|P1|COMPLETED|Overall Study||30
2261851|NCT02354378|5552783|P2|STARTED|Overall Study||20
2261852|NCT02354378|5552784|P1|STARTED|Overall Study||64
2261853|NCT02354352|5552794|P2|NOT COMPLETED|Overall Study||3
2261854|NCT02354352|5552795|P1|NOT COMPLETED|Overall Study||3
2261855|NCT02354352|5552794|P2|COMPLETED|Overall Study||23
2261856|NCT02354352|5552795|P1|COMPLETED|Overall Study||23
2261857|NCT02354352|5552794|P2|9 Months|Overall Study||23
2261858|NCT02354352|5552795|P1|9 Months|Overall Study||25
2261859|NCT02354352|5552794|P2|6 Months|Overall Study||23
2261860|NCT02354352|5552795|P1|6 Months|Overall Study||25
2261861|NCT02354352|5552794|P2|3 Months|Overall Study||23
2261862|NCT02354352|5552795|P1|3 Months|Overall Study||25
2261863|NCT02354352|5552794|P2|2 Months|Overall Study||22
2261864|NCT02354352|5552795|P1|2 Months|Overall Study||24
2261865|NCT02354352|5552794|P2|1 Month|Overall Study||23
2261866|NCT02354352|5552795|P1|1 Month|Overall Study||24
2261867|NCT02354352|5552794|P2|2 Weeks|Overall Study||25
2261868|NCT02354352|5552795|P1|2 Weeks|Overall Study||26
2261869|NCT02354352|5552794|P2|STARTED|Overall Study||26
2261870|NCT02354352|5552795|P1|STARTED|Overall Study||26
2261871|NCT02354235|5552803|P2|NOT COMPLETED|Overall Study||7
2261872|NCT02354235|5552804|P1|NOT COMPLETED|Overall Study||3
2261873|NCT02354235|5552803|P2|COMPLETED|Overall Study||61
2261874|NCT02354235|5552804|P1|COMPLETED|Overall Study||67
2261875|NCT02354235|5552803|P2|STARTED|Overall Study||68
2261876|NCT02354235|5552804|P1|STARTED|Overall Study||70
2261877|NCT02354222|5552820|P2|NOT COMPLETED|Overall Study||11
2261878|NCT02354222|5552821|P1|NOT COMPLETED|Overall Study||4
2261879|NCT02354222|5552820|P2|COMPLETED|Overall Study||66
2261880|NCT02354222|5552821|P1|COMPLETED|Overall Study||73
2261881|NCT02354222|5552820|P2|STARTED|Overall Study||77
2261882|NCT02354222|5552821|P1|STARTED|Overall Study||77
2261883|NCT02354092|5552837|P2|NOT COMPLETED|Overall Study||0
2261884|NCT02354092|5552838|P1|NOT COMPLETED|Overall Study||0
2261885|NCT02354092|5552837|P2|COMPLETED|Overall Study||7
2261886|NCT02354092|5552838|P1|COMPLETED|Overall Study||7
2261887|NCT02354092|5552837|P2|STARTED|Overall Study||7
2261888|NCT02354092|5552838|P1|STARTED|Overall Study||7
2261889|NCT02353871|5552852|P2|NOT COMPLETED|Overall Study||9
2261890|NCT02353871|5552853|P1|NOT COMPLETED|Overall Study||3
2261891|NCT02353871|5552852|P2|COMPLETED|Overall Study||51
2261892|NCT02353871|5552853|P1|COMPLETED|Overall Study||122
2261893|NCT02353871|5552852|P2|STARTED|Overall Study|Randomised. Included a subject who was randomised by mistake (excluded from mITT population).|60
2261894|NCT02353871|5552853|P1|STARTED|Overall Study|Randomised.|125
2261895|NCT02353832|5552873|P1|NOT COMPLETED|Overall Study||0
2261896|NCT02353832|5552873|P1|COMPLETED|Overall Study||44
2261897|NCT02353832|5552873|P1|STARTED|Overall Study||44
2261898|NCT02353806|5552878|P1|NOT COMPLETED|Overall Study||10
2261899|NCT02353806|5552878|P1|COMPLETED|Overall Study||6
2261900|NCT02353806|5552878|P1|STARTED|Overall Study||16
2261901|NCT02353754|5552895|P2|NOT COMPLETED|Overall Study||0
2261902|NCT02353754|5552896|P1|NOT COMPLETED|Overall Study||2
2261903|NCT02353754|5552895|P2|COMPLETED|Overall Study||0
2261904|NCT02353754|5552896|P1|COMPLETED|Overall Study||10
2261905|NCT02353754|5552895|P2|STARTED|Overall Study||0
2261906|NCT02353754|5552896|P1|STARTED|Overall Study||12
2261907|NCT02353572|5552906|P1|NOT COMPLETED|Overall Study||3
2261908|NCT02353572|5552906|P1|COMPLETED|Overall Study||0
2261909|NCT02353572|5552906|P1|STARTED|Overall Study||3
2261910|NCT02353468|5552910|P1|NOT COMPLETED|Overall Study||3
2261911|NCT02353468|5552910|P1|COMPLETED|Overall Study||0
2261912|NCT02353468|5552910|P1|STARTED|Overall Study||3
2261913|NCT02353442|5552916|P2|NOT COMPLETED|Overall Study||4
2261914|NCT02353442|5552917|P1|NOT COMPLETED|Overall Study||3
2261915|NCT02353442|5552916|P2|COMPLETED|Overall Study||27
2261916|NCT02353442|5552917|P1|COMPLETED|Overall Study||25
2261917|NCT02353442|5552916|P2|STARTED|Overall Study||31
2261918|NCT02353442|5552917|P1|STARTED|Overall Study||28
2261919|NCT02353299|5552931|P4|NOT COMPLETED|Fourth Intervention (1 Night)||0
2261920|NCT02353299|5552932|P3|NOT COMPLETED|Fourth Intervention (1 Night)||0
2261921|NCT02353299|5552933|P2|NOT COMPLETED|Fourth Intervention (1 Night)||0
2261922|NCT02353299|5552934|P1|NOT COMPLETED|Fourth Intervention (1 Night)||0
2261923|NCT02353299|5552931|P4|COMPLETED|Fourth Intervention (1 Night)||13
2261924|NCT02353299|5552932|P3|COMPLETED|Fourth Intervention (1 Night)||13
2261925|NCT02353299|5552933|P2|COMPLETED|Fourth Intervention (1 Night)||12
2261926|NCT02353299|5552934|P1|COMPLETED|Fourth Intervention (1 Night)||13
2261927|NCT02353299|5552931|P4|STARTED|Fourth Intervention (1 Night)||13
2261928|NCT02353299|5552932|P3|STARTED|Fourth Intervention (1 Night)||13
2261929|NCT02353299|5552933|P2|STARTED|Fourth Intervention (1 Night)|One patient withdrawn from study prior to start of fourth intervention.|12
2261930|NCT02353299|5552934|P1|STARTED|Fourth Intervention (1 Night)||13
2261931|NCT02353299|5552931|P4|NOT COMPLETED|Third Intervention (1 Night)||0
2261932|NCT02353299|5552932|P3|NOT COMPLETED|Third Intervention (1 Night)||0
2261933|NCT02353299|5552933|P2|NOT COMPLETED|Third Intervention (1 Night)||0
2261934|NCT02353299|5552934|P1|NOT COMPLETED|Third Intervention (1 Night)||0
2261935|NCT02353299|5552931|P4|COMPLETED|Third Intervention (1 Night)||13
2261936|NCT02353299|5552932|P3|COMPLETED|Third Intervention (1 Night)||13
2261937|NCT02353299|5552933|P2|COMPLETED|Third Intervention (1 Night)||13
2261938|NCT02353299|5552934|P1|COMPLETED|Third Intervention (1 Night)||13
2261939|NCT02353299|5552931|P4|STARTED|Third Intervention (1 Night)||13
2261940|NCT02353299|5552932|P3|STARTED|Third Intervention (1 Night)||13
2261941|NCT02353299|5552933|P2|STARTED|Third Intervention (1 Night)||13
2261942|NCT02353299|5552934|P1|STARTED|Third Intervention (1 Night)||13
2261943|NCT02353299|5552931|P4|NOT COMPLETED|Second Intervention (1 Night)||0
2261944|NCT02353299|5552932|P3|NOT COMPLETED|Second Intervention (1 Night)||0
2261945|NCT02353299|5552933|P2|NOT COMPLETED|Second Intervention (1 Night)||0
2261946|NCT02353299|5552934|P1|NOT COMPLETED|Second Intervention (1 Night)||0
2261947|NCT02353299|5552931|P4|COMPLETED|Second Intervention (1 Night)||13
2261948|NCT02353299|5552932|P3|COMPLETED|Second Intervention (1 Night)||13
2261949|NCT02353299|5552933|P2|COMPLETED|Second Intervention (1 Night)||13
2261950|NCT02353299|5552934|P1|COMPLETED|Second Intervention (1 Night)||13
2261951|NCT02353299|5552931|P4|STARTED|Second Intervention (1 Night)||13
2261952|NCT02353299|5552932|P3|STARTED|Second Intervention (1 Night)||13
2261953|NCT02353299|5552933|P2|STARTED|Second Intervention (1 Night)||13
2261954|NCT02353299|5552934|P1|STARTED|Second Intervention (1 Night)||13
2261955|NCT02353299|5552931|P4|NOT COMPLETED|First Intervention (1 Night)||0
2261956|NCT02353299|5552932|P3|NOT COMPLETED|First Intervention (1 Night)||0
2261957|NCT02353299|5552933|P2|NOT COMPLETED|First Intervention (1 Night)||0
2261958|NCT02353299|5552934|P1|NOT COMPLETED|First Intervention (1 Night)||0
2261959|NCT02353299|5552931|P4|COMPLETED|First Intervention (1 Night)||13
2261960|NCT02353299|5552932|P3|COMPLETED|First Intervention (1 Night)||13
2261961|NCT02353299|5552933|P2|COMPLETED|First Intervention (1 Night)||13
2261962|NCT02353299|5552934|P1|COMPLETED|First Intervention (1 Night)||13
2261963|NCT02353299|5552931|P4|STARTED|First Intervention (1 Night)||13
2261964|NCT02353299|5552932|P3|STARTED|First Intervention (1 Night)||13
2261965|NCT02353299|5552933|P2|STARTED|First Intervention (1 Night)||13
2261966|NCT02353299|5552934|P1|STARTED|First Intervention (1 Night)||13
2261967|NCT02353169|5552972|P4|NOT COMPLETED|Overall Study||3
2261968|NCT02353169|5552973|P3|NOT COMPLETED|Overall Study||4
2261969|NCT02353169|5552974|P2|NOT COMPLETED|Overall Study||6
2261970|NCT02353169|5552975|P1|NOT COMPLETED|Overall Study||3
2261971|NCT02353169|5552972|P4|COMPLETED|Overall Study||12
2261972|NCT02353169|5552973|P3|COMPLETED|Overall Study||12
2261973|NCT02353169|5552974|P2|COMPLETED|Overall Study||12
2261974|NCT02353169|5552975|P1|COMPLETED|Overall Study||12
2261975|NCT02353169|5552972|P4|STARTED|Overall Study||15
2261976|NCT02353169|5552973|P3|STARTED|Overall Study||16
2261977|NCT02353169|5552974|P2|STARTED|Overall Study||18
2261978|NCT02353169|5552975|P1|STARTED|Overall Study||15
2261979|NCT02352948|5552999|P6|NOT COMPLETED|Overall Study||49
2261980|NCT02352948|5553000|P5|NOT COMPLETED|Overall Study||88
2261981|NCT02352948|5553001|P4|NOT COMPLETED|Overall Study||99
2261982|NCT02352948|5553002|P3|NOT COMPLETED|Overall Study||129
2261983|NCT02352948|5553003|P2|NOT COMPLETED|Overall Study||59
2261984|NCT02352948|5553004|P1|NOT COMPLETED|Overall Study||49
2261985|NCT02352948|5552999|P6|COMPLETED|Overall Study||11
2261986|NCT02352948|5553000|P5|COMPLETED|Overall Study||29
2261987|NCT02352948|5553001|P4|COMPLETED|Overall Study||19
2261988|NCT02352948|5553002|P3|COMPLETED|Overall Study||45
2261989|NCT02352948|5553003|P2|COMPLETED|Overall Study||5
2261990|NCT02352948|5553004|P1|COMPLETED|Overall Study||13
2261991|NCT02352948|5552999|P6|Completed Study Treatment|Overall Study||4
2261992|NCT02352948|5553000|P5|Completed Study Treatment|Overall Study||23
2261993|NCT02352948|5553001|P4|Completed Study Treatment|Overall Study||0
2261994|NCT02352948|5553002|P3|Completed Study Treatment|Overall Study||36
2261995|NCT02352948|5553003|P2|Completed Study Treatment|Overall Study||0
2261996|NCT02352948|5553004|P1|Completed Study Treatment|Overall Study||15
2261997|NCT02352948|5552999|P6|Received Treatment|Overall Study||60
2261998|NCT02352948|5553000|P5|Received Treatment|Overall Study||117
2261999|NCT02352948|5553001|P4|Received Treatment|Overall Study||110
2262000|NCT02352948|5553002|P3|Received Treatment|Overall Study||173
2262001|NCT02352948|5553003|P2|Received Treatment|Overall Study||63
2262002|NCT02352948|5553004|P1|Received Treatment|Overall Study||62
2262003|NCT02352948|5552999|P6|STARTED|Overall Study||60
2262004|NCT02352948|5553000|P5|STARTED|Overall Study||117
2262005|NCT02352948|5553001|P4|STARTED|Overall Study||118
2262006|NCT02352948|5553002|P3|STARTED|Overall Study||174
2262007|NCT02352948|5553003|P2|STARTED|Overall Study||64
2262008|NCT02352948|5553004|P1|STARTED|Overall Study||62
2262009|NCT02352844|5553060|P1|NOT COMPLETED|Overall Study||0
2262010|NCT02352844|5553060|P1|COMPLETED|Overall Study||12
2262011|NCT02352844|5553060|P1|STARTED|Overall Study||12
2262012|NCT02352831|5553068|P2|NOT COMPLETED|Overall Study||0
2262013|NCT02352831|5553069|P1|NOT COMPLETED|Overall Study||0
2262014|NCT02352831|5553068|P2|COMPLETED|Overall Study||10
2262015|NCT02352831|5553069|P1|COMPLETED|Overall Study||6
2262016|NCT02352831|5553068|P2|STARTED|Overall Study||10
2262017|NCT02352831|5553069|P1|STARTED|Overall Study||6
2262018|NCT02352779|5553092|P3|NOT COMPLETED|Overall Study||2
2262019|NCT02352779|5553093|P2|NOT COMPLETED|Overall Study||1
2262020|NCT02352779|5553094|P1|NOT COMPLETED|Overall Study||8
2262021|NCT02352779|5553092|P3|COMPLETED|Overall Study||33
2262022|NCT02352779|5553093|P2|COMPLETED|Overall Study||35
2262023|NCT02352779|5553094|P1|COMPLETED|Overall Study||29
2262024|NCT02352779|5553092|P3|STARTED|Overall Study||35
2262025|NCT02352779|5553093|P2|STARTED|Overall Study||36
2262026|NCT02352779|5553094|P1|STARTED|Overall Study||37
2262027|NCT02352363|5553104|P2|NOT COMPLETED|Overall Study||3
2262028|NCT02352363|5553105|P1|NOT COMPLETED|Overall Study||7
2262029|NCT02352363|5553104|P2|COMPLETED|Overall Study||127
2262030|NCT02352363|5553105|P1|COMPLETED|Overall Study||271
2262031|NCT02352363|5553104|P2|STARTED|Overall Study||130
2262032|NCT02352363|5553105|P1|STARTED|Overall Study||278
2262033|NCT02352298|5553117|P1|NOT COMPLETED|Overall Study||0
2262034|NCT02352298|5553117|P1|COMPLETED|Overall Study||52
2262035|NCT02352298|5553117|P1|STARTED|Overall Study||52
2262036|NCT02352103|5553124|P2|NOT COMPLETED|Overall Study||1
2262037|NCT02352103|5553125|P1|NOT COMPLETED|Overall Study||0
2262038|NCT02352103|5553124|P2|COMPLETED|Overall Study||59
2262039|NCT02352103|5553125|P1|COMPLETED|Overall Study||60
2262040|NCT02352103|5553124|P2|STARTED|Overall Study||60
2262041|NCT02352103|5553125|P1|STARTED|Overall Study||60
2262042|NCT02351960|5553147|P2|NOT COMPLETED|Overall Study||12
2262043|NCT02351960|5553148|P1|NOT COMPLETED|Overall Study||11
2262044|NCT02351960|5553147|P2|COMPLETED|Overall Study||76
2262045|NCT02351960|5553148|P1|COMPLETED|Overall Study||197
2262046|NCT02351960|5553147|P2|STARTED|Overall Study||88
2262047|NCT02351960|5553148|P1|STARTED|Overall Study||208
2262048|NCT02351934|5553169|P2|NOT COMPLETED|Follow-Up||10
2262049|NCT02351934|5553170|P1|NOT COMPLETED|Follow-Up||12
2262050|NCT02351934|5553169|P2|COMPLETED|Follow-Up||51
2262051|NCT02351934|5553170|P1|COMPLETED|Follow-Up||44
2262052|NCT02351934|5553169|P2|STARTED|Follow-Up||61
2262053|NCT02351934|5553170|P1|STARTED|Follow-Up||56
2262054|NCT02351934|5553169|P2|NOT COMPLETED|Allocation||0
2262055|NCT02351934|5553170|P1|NOT COMPLETED|Allocation||6
2262056|NCT02351934|5553169|P2|COMPLETED|Allocation||61
2262057|NCT02351934|5553170|P1|COMPLETED|Allocation||56
2262058|NCT02351934|5553169|P2|Received Allocation|Allocation||61
2262059|NCT02351934|5553170|P1|Received Allocation|Allocation||56
2262060|NCT02351934|5553169|P2|STARTED|Allocation||61
2262061|NCT02351934|5553170|P1|STARTED|Allocation||62
2262062|NCT02351817|5553186|P2|NOT COMPLETED|Period 2||2
2262063|NCT02351817|5553187|P1|NOT COMPLETED|Period 2||1
2262064|NCT02351817|5553186|P2|COMPLETED|Period 2||3
2262065|NCT02351817|5553187|P1|COMPLETED|Period 2||4
2262066|NCT02351817|5553186|P2|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
2262067|NCT02351817|5553187|P1|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
2262068|NCT02351817|5553186|P2|NOT COMPLETED|Period 1||3
2262069|NCT02351817|5553187|P1|NOT COMPLETED|Period 1||1
2262070|NCT02351817|5553186|P2|COMPLETED|Period 1||2
2262071|NCT02351817|5553187|P1|COMPLETED|Period 1||4
2262072|NCT02351817|5553186|P2|STARTED|Period 1||5
2262073|NCT02351817|5553187|P1|STARTED|Period 1||5
2262074|NCT02351817|5553186|P2|NOT COMPLETED|Baseline Period||0
2262075|NCT02351817|5553187|P1|NOT COMPLETED|Baseline Period||0
2262076|NCT02351817|5553186|P2|COMPLETED|Baseline Period||5
2262077|NCT02351817|5553187|P1|COMPLETED|Baseline Period||5
2262078|NCT02351817|5553186|P2|STARTED|Baseline Period||5
2262079|NCT02351817|5553187|P1|STARTED|Baseline Period||5
2262080|NCT02351739|5553196|P2|NOT COMPLETED|Overall Study||40
2262081|NCT02351739|5553197|P1|NOT COMPLETED|Overall Study||38
2262082|NCT02351739|5553196|P2|COMPLETED|Overall Study||0
2262083|NCT02351739|5553197|P1|COMPLETED|Overall Study||0
2262084|NCT02351739|5553196|P2|Discontinued Study|Overall Study||40
2262085|NCT02351739|5553197|P1|Discontinued Study|Overall Study||38
2262086|NCT02351739|5553196|P2|Received Study Medication|Overall Study||40
2262087|NCT02351739|5553197|P1|Received Study Medication|Overall Study||35
2262088|NCT02351739|5553196|P2|Enrolled|Overall Study||40
2262089|NCT02351739|5553197|P1|Enrolled|Overall Study||38
2262090|NCT02351739|5553196|P2|STARTED|Overall Study||40
2262091|NCT02351739|5553197|P1|STARTED|Overall Study||38
2262092|NCT02351505|5553203|P1|NOT COMPLETED|Overall Study||0
2262093|NCT02351505|5553203|P1|COMPLETED|Overall Study||1
2262094|NCT02351505|5553203|P1|STARTED|Overall Study||1
2262095|NCT02351271|5553216|P2|NOT COMPLETED|Overall Study||0
2262096|NCT02351271|5553217|P1|NOT COMPLETED|Overall Study||0
2262097|NCT02351271|5553216|P2|COMPLETED|Overall Study||62
2262098|NCT02351271|5553217|P1|COMPLETED|Overall Study||68
2262099|NCT02351271|5553216|P2|STARTED|Overall Study||62
2262100|NCT02351271|5553217|P1|STARTED|Overall Study||68
2262101|NCT02351063|5553229|P1|NOT COMPLETED|Overall Study||0
2262102|NCT02351063|5553229|P1|COMPLETED|Overall Study|Study terminated. No study data collected.|1
2262103|NCT02351063|5553229|P1|STARTED|Overall Study||1
2262104|NCT02351037|5553236|P3|NOT COMPLETED|Overall Study||0
2262105|NCT02351037|5553237|P2|NOT COMPLETED|Overall Study||0
2262106|NCT02351037|5553238|P1|NOT COMPLETED|Overall Study||0
2262107|NCT02351037|5553236|P3|COMPLETED|Overall Study||8
2262108|NCT02351037|5553237|P2|COMPLETED|Overall Study||21
2262109|NCT02351037|5553238|P1|COMPLETED|Overall Study||7
2262110|NCT02351037|5553236|P3|STARTED|Overall Study||8
2262111|NCT02351037|5553237|P2|STARTED|Overall Study||21
2262112|NCT02351037|5553238|P1|STARTED|Overall Study||7
2262113|NCT02350881|5553246|P1|NOT COMPLETED|Overall Study||0
2262114|NCT02350881|5553246|P1|COMPLETED|Overall Study|64 patients were completed (6 bilateral)|64
2262115|NCT02350881|5553246|P1|STARTED|Overall Study|64 patients were included (6 bilateral)|64
2262116|NCT02350777|5553276|P2|NOT COMPLETED|Overall Study||0
2262117|NCT02350777|5553277|P1|NOT COMPLETED|Overall Study||0
2262118|NCT02350777|5553276|P2|COMPLETED|Overall Study||2
2262119|NCT02350777|5553277|P1|COMPLETED|Overall Study||2
2262120|NCT02350777|5553276|P2|STARTED|Overall Study||2
2262121|NCT02350777|5553277|P1|STARTED|Overall Study||2
2262122|NCT02350569|5553283|P1|NOT COMPLETED|Retreatment (LDV/SOF 12 Weeks)||0
2262123|NCT02350569|5553283|P1|COMPLETED|Retreatment (LDV/SOF 12 Weeks)||1
2262124|NCT02350569|5553283|P1|STARTED|Retreatment (LDV/SOF 12 Weeks)|1 completed treatment (Main Study), experienced virologic failure, and entered Retreatment Phase|1
2262125|NCT02350569|5553283|P1|NOT COMPLETED|Main Study (LDV/SOF 4 Weeks)||0
2262126|NCT02350569|5553283|P1|COMPLETED|Main Study (LDV/SOF 4 Weeks)|1 participant discontinued treatment, but completed follow-up visits and study.|16
2262127|NCT02350569|5553283|P1|STARTED|Main Study (LDV/SOF 4 Weeks)||16
2262128|NCT02350478|5553295|P2|NOT COMPLETED|Overall Study||1
2262129|NCT02350478|5553296|P1|NOT COMPLETED|Overall Study||5
2262130|NCT02350478|5553295|P2|COMPLETED|Overall Study||23
2262131|NCT02350478|5553296|P1|COMPLETED|Overall Study||20
2262132|NCT02350478|5553295|P2|STARTED|Overall Study||24
2262133|NCT02350478|5553296|P1|STARTED|Overall Study||25
2262134|NCT02350309|5553318|P6|NOT COMPLETED|Treatment Period 4 (2 Days)||1
2262135|NCT02350309|5553319|P5|NOT COMPLETED|Treatment Period 4 (2 Days)||0
2262136|NCT02350309|5553320|P4|NOT COMPLETED|Treatment Period 4 (2 Days)||0
2262137|NCT02350309|5553321|P3|NOT COMPLETED|Treatment Period 4 (2 Days)||0
2262138|NCT02350309|5553322|P2|NOT COMPLETED|Treatment Period 4 (2 Days)||0
2262139|NCT02350309|5553323|P1|NOT COMPLETED|Treatment Period 4 (2 Days)||0
2262140|NCT02350309|5553318|P6|COMPLETED|Treatment Period 4 (2 Days)||11
2262141|NCT02350309|5553319|P5|COMPLETED|Treatment Period 4 (2 Days)||12
2262142|NCT02350309|5553320|P4|COMPLETED|Treatment Period 4 (2 Days)||11
2262143|NCT02350309|5553321|P3|COMPLETED|Treatment Period 4 (2 Days)||10
2262144|NCT02350309|5553322|P2|COMPLETED|Treatment Period 4 (2 Days)||11
2262145|NCT02350309|5553323|P1|COMPLETED|Treatment Period 4 (2 Days)||12
2262146|NCT02350309|5553318|P6|STARTED|Treatment Period 4 (2 Days)||12
2262147|NCT02350309|5553319|P5|STARTED|Treatment Period 4 (2 Days)||12
2262148|NCT02350309|5553320|P4|STARTED|Treatment Period 4 (2 Days)||11
2262149|NCT02350309|5553321|P3|STARTED|Treatment Period 4 (2 Days)||10
2262150|NCT02350309|5553322|P2|STARTED|Treatment Period 4 (2 Days)||11
2262151|NCT02350309|5553323|P1|STARTED|Treatment Period 4 (2 Days)||12
2262152|NCT02350309|5553318|P6|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
2262153|NCT02350309|5553319|P5|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
2262154|NCT02350309|5553320|P4|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
2262155|NCT02350309|5553321|P3|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
2262156|NCT02350309|5553322|P2|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
2262157|NCT02350309|5553323|P1|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
2262158|NCT02350309|5553318|P6|COMPLETED|Washout Period 3 (12-16 Days)||12
2262159|NCT02350309|5553319|P5|COMPLETED|Washout Period 3 (12-16 Days)||12
2262160|NCT02350309|5553320|P4|COMPLETED|Washout Period 3 (12-16 Days)||11
2262161|NCT02350309|5553321|P3|COMPLETED|Washout Period 3 (12-16 Days)||10
2262162|NCT02350309|5553322|P2|COMPLETED|Washout Period 3 (12-16 Days)||11
2262163|NCT02350309|5553323|P1|COMPLETED|Washout Period 3 (12-16 Days)||12
2262164|NCT02350309|5553318|P6|STARTED|Washout Period 3 (12-16 Days)||12
2262165|NCT02350309|5553319|P5|STARTED|Washout Period 3 (12-16 Days)||12
2262166|NCT02350309|5553320|P4|STARTED|Washout Period 3 (12-16 Days)||11
2262167|NCT02350309|5553321|P3|STARTED|Washout Period 3 (12-16 Days)||10
2262168|NCT02350309|5553322|P2|STARTED|Washout Period 3 (12-16 Days)||11
2262169|NCT02350309|5553323|P1|STARTED|Washout Period 3 (12-16 Days)||12
2262170|NCT02350309|5553318|P6|NOT COMPLETED|Treatment Period 3 (2 Days)||0
2262171|NCT02350309|5553319|P5|NOT COMPLETED|Treatment Period 3 (2 Days)||0
2262172|NCT02350309|5553320|P4|NOT COMPLETED|Treatment Period 3 (2 Days)||0
2262173|NCT02350309|5553321|P3|NOT COMPLETED|Treatment Period 3 (2 Days)||0
2262174|NCT02350309|5553322|P2|NOT COMPLETED|Treatment Period 3 (2 Days)||0
2262175|NCT02350309|5553323|P1|NOT COMPLETED|Treatment Period 3 (2 Days)||0
2262176|NCT02350309|5553318|P6|COMPLETED|Treatment Period 3 (2 Days)||12
2262177|NCT02350309|5553319|P5|COMPLETED|Treatment Period 3 (2 Days)||12
2262178|NCT02350309|5553320|P4|COMPLETED|Treatment Period 3 (2 Days)||11
2262179|NCT02350309|5553321|P3|COMPLETED|Treatment Period 3 (2 Days)||10
2262180|NCT02350309|5553322|P2|COMPLETED|Treatment Period 3 (2 Days)||11
2262181|NCT02350309|5553323|P1|COMPLETED|Treatment Period 3 (2 Days)||12
2262182|NCT02350309|5553318|P6|STARTED|Treatment Period 3 (2 Days)||12
2262183|NCT02350309|5553319|P5|STARTED|Treatment Period 3 (2 Days)||12
2262184|NCT02350309|5553320|P4|STARTED|Treatment Period 3 (2 Days)||11
2262185|NCT02350309|5553321|P3|STARTED|Treatment Period 3 (2 Days)||10
2262186|NCT02350309|5553322|P2|STARTED|Treatment Period 3 (2 Days)||11
2262187|NCT02350309|5553323|P1|STARTED|Treatment Period 3 (2 Days)||12
2262188|NCT02350309|5553318|P6|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
2262189|NCT02350309|5553319|P5|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
2262190|NCT02350309|5553320|P4|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
2262191|NCT02350309|5553321|P3|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
2262192|NCT02350309|5553322|P2|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
2262193|NCT02350309|5553323|P1|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
2262194|NCT02350309|5553318|P6|COMPLETED|Washout Period 2 (12-16 Days)||12
2262195|NCT02350309|5553319|P5|COMPLETED|Washout Period 2 (12-16 Days)||12
2262196|NCT02350309|5553320|P4|COMPLETED|Washout Period 2 (12-16 Days)||11
2262197|NCT02350309|5553321|P3|COMPLETED|Washout Period 2 (12-16 Days)||10
2262198|NCT02350309|5553322|P2|COMPLETED|Washout Period 2 (12-16 Days)||11
2262199|NCT02350309|5553323|P1|COMPLETED|Washout Period 2 (12-16 Days)||12
2262200|NCT02350309|5553318|P6|STARTED|Washout Period 2 (12-16 Days)||12
2262201|NCT02350309|5553319|P5|STARTED|Washout Period 2 (12-16 Days)||12
2262202|NCT02350309|5553320|P4|STARTED|Washout Period 2 (12-16 Days)||11
2262203|NCT02350309|5553321|P3|STARTED|Washout Period 2 (12-16 Days)||10
2262204|NCT02350309|5553322|P2|STARTED|Washout Period 2 (12-16 Days)||11
2262205|NCT02350309|5553323|P1|STARTED|Washout Period 2 (12-16 Days)||12
2262206|NCT02350309|5553318|P6|NOT COMPLETED|Treatment Period 2 (2 Days)||0
2262207|NCT02350309|5553319|P5|NOT COMPLETED|Treatment Period 2 (2 Days)||0
2262208|NCT02350309|5553320|P4|NOT COMPLETED|Treatment Period 2 (2 Days)||0
2262209|NCT02350309|5553321|P3|NOT COMPLETED|Treatment Period 2 (2 Days)||0
2262210|NCT02350309|5553322|P2|NOT COMPLETED|Treatment Period 2 (2 Days)||0
2262211|NCT02350309|5553323|P1|NOT COMPLETED|Treatment Period 2 (2 Days)||0
2262212|NCT02350309|5553318|P6|COMPLETED|Treatment Period 2 (2 Days)||12
2262213|NCT02350309|5553319|P5|COMPLETED|Treatment Period 2 (2 Days)||12
2262214|NCT02350309|5553320|P4|COMPLETED|Treatment Period 2 (2 Days)||11
2262215|NCT02350309|5553321|P3|COMPLETED|Treatment Period 2 (2 Days)||10
2262216|NCT02350309|5553322|P2|COMPLETED|Treatment Period 2 (2 Days)||11
2262217|NCT02350309|5553323|P1|COMPLETED|Treatment Period 2 (2 Days)||12
2262218|NCT02350309|5553318|P6|STARTED|Treatment Period 2 (2 Days)||12
2262219|NCT02350309|5553319|P5|STARTED|Treatment Period 2 (2 Days)||12
2262220|NCT02350309|5553320|P4|STARTED|Treatment Period 2 (2 Days)||11
2262221|NCT02350309|5553321|P3|STARTED|Treatment Period 2 (2 Days)||10
2262222|NCT02350309|5553322|P2|STARTED|Treatment Period 2 (2 Days)||11
2262223|NCT02350309|5553323|P1|STARTED|Treatment Period 2 (2 Days)||12
2262224|NCT02350309|5553318|P6|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
2262225|NCT02350309|5553319|P5|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
2262226|NCT02350309|5553320|P4|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
2262227|NCT02350309|5553321|P3|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
2262228|NCT02350309|5553322|P2|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
2262229|NCT02350309|5553323|P1|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
2262230|NCT02350309|5553318|P6|COMPLETED|Washout Period 1 (12-16 Days)||12
2262231|NCT02350309|5553319|P5|COMPLETED|Washout Period 1 (12-16 Days)||12
2262232|NCT02350309|5553320|P4|COMPLETED|Washout Period 1 (12-16 Days)||11
2262233|NCT02350309|5553321|P3|COMPLETED|Washout Period 1 (12-16 Days)||10
2262234|NCT02350309|5553322|P2|COMPLETED|Washout Period 1 (12-16 Days)||11
2262235|NCT02350309|5553323|P1|COMPLETED|Washout Period 1 (12-16 Days)||12
2262236|NCT02350309|5553318|P6|STARTED|Washout Period 1 (12-16 Days)||12
2262237|NCT02350309|5553319|P5|STARTED|Washout Period 1 (12-16 Days)||12
2262238|NCT02350309|5553320|P4|STARTED|Washout Period 1 (12-16 Days)||11
2262239|NCT02350309|5553321|P3|STARTED|Washout Period 1 (12-16 Days)||10
2262240|NCT02350309|5553322|P2|STARTED|Washout Period 1 (12-16 Days)||11
2262241|NCT02350309|5553323|P1|STARTED|Washout Period 1 (12-16 Days)||12
2262242|NCT02350309|5553318|P6|NOT COMPLETED|Treatment Period 1 (2 Days)||0
2262243|NCT02350309|5553319|P5|NOT COMPLETED|Treatment Period 1 (2 Days)||0
2262244|NCT02350309|5553320|P4|NOT COMPLETED|Treatment Period 1 (2 Days)||0
2262245|NCT02350309|5553321|P3|NOT COMPLETED|Treatment Period 1 (2 Days)||1
2262246|NCT02350309|5553322|P2|NOT COMPLETED|Treatment Period 1 (2 Days)||0
2262247|NCT02350309|5553323|P1|NOT COMPLETED|Treatment Period 1 (2 Days)||0
2262248|NCT02350309|5553318|P6|COMPLETED|Treatment Period 1 (2 Days)||12
2262249|NCT02350309|5553319|P5|COMPLETED|Treatment Period 1 (2 Days)||12
2262250|NCT02350309|5553320|P4|COMPLETED|Treatment Period 1 (2 Days)||11
2262251|NCT02350309|5553321|P3|COMPLETED|Treatment Period 1 (2 Days)||10
2262252|NCT02350309|5553322|P2|COMPLETED|Treatment Period 1 (2 Days)||11
2262253|NCT02350309|5553323|P1|COMPLETED|Treatment Period 1 (2 Days)||12
2262254|NCT02350309|5553318|P6|STARTED|Treatment Period 1 (2 Days)||12
2262255|NCT02350309|5553319|P5|STARTED|Treatment Period 1 (2 Days)||12
2262256|NCT02350309|5553320|P4|STARTED|Treatment Period 1 (2 Days)||11
2262257|NCT02350309|5553321|P3|STARTED|Treatment Period 1 (2 Days)||11
2262258|NCT02350309|5553322|P2|STARTED|Treatment Period 1 (2 Days)||11
2262259|NCT02350309|5553323|P1|STARTED|Treatment Period 1 (2 Days)||12
2262260|NCT02349789|5553362|P1|NOT COMPLETED|Overall Study||2
2262261|NCT02349789|5553362|P1|COMPLETED|Overall Study||9
2262262|NCT02349789|5553362|P1|STARTED|Overall Study||11
2262263|NCT02349711|5553373|P2|NOT COMPLETED|Overall Study||2
2262264|NCT02349711|5553374|P1|NOT COMPLETED|Overall Study||3
2262265|NCT02349711|5553373|P2|COMPLETED|Overall Study||84
2262266|NCT02349711|5553374|P1|COMPLETED|Overall Study||84
2262267|NCT02349711|5553373|P2|STARTED|Overall Study||86
2262268|NCT02349711|5553374|P1|STARTED|Overall Study||87
2262269|NCT02349685|5553389|P3|NOT COMPLETED|Overall Study||4
2262270|NCT02349685|5553390|P2|NOT COMPLETED|Overall Study||2
2262271|NCT02349685|5553391|P1|NOT COMPLETED|Overall Study||5
2262272|NCT02349685|5553389|P3|COMPLETED|Overall Study||37
2262273|NCT02349685|5553390|P2|COMPLETED|Overall Study||87
2262274|NCT02349685|5553391|P1|COMPLETED|Overall Study||84
2262275|NCT02349685|5553389|P3|STARTED|Overall Study||41
2262276|NCT02349685|5553390|P2|STARTED|Overall Study||89
2262277|NCT02349685|5553391|P1|STARTED|Overall Study||89
2262278|NCT02349646|5553402|P1|NOT COMPLETED|Overall Study||17
2262279|NCT02349646|5553402|P1|COMPLETED|Overall Study||16
2262280|NCT02349646|5553402|P1|Receive Permanent System|Overall Study||27
2262281|NCT02349646|5553402|P1|Received Trial System|Overall Study||24
2262282|NCT02349646|5553402|P1|STARTED|Overall Study||33
2262283|NCT02349542|5553407|P1|NOT COMPLETED|Overall Study||5
2262284|NCT02349542|5553407|P1|COMPLETED|Overall Study||15
2262285|NCT02349542|5553407|P1|STARTED|Overall Study||20
2262286|NCT02349477|5553414|P2|NOT COMPLETED|Overall Study||18
2262287|NCT02349477|5553415|P1|NOT COMPLETED|Overall Study||13
2262288|NCT02349477|5553414|P2|COMPLETED|Overall Study||28
2262289|NCT02349477|5553415|P1|COMPLETED|Overall Study||31
2262290|NCT02349477|5553414|P2|STARTED|Overall Study||46
2262291|NCT02349477|5553415|P1|STARTED|Overall Study||44
2262292|NCT02349451|5553431|P4|NOT COMPLETED|Overall Study||1
2262293|NCT02349451|5553432|P3|NOT COMPLETED|Overall Study||2
2262294|NCT02349451|5553433|P2|NOT COMPLETED|Overall Study||1
2262295|NCT02349451|5553434|P1|NOT COMPLETED|Overall Study||0
2262296|NCT02349451|5553431|P4|COMPLETED|Overall Study||72
2262297|NCT02349451|5553432|P3|COMPLETED|Overall Study||69
2262298|NCT02349451|5553433|P2|COMPLETED|Overall Study||71
2262299|NCT02349451|5553434|P1|COMPLETED|Overall Study||24
2262300|NCT02349451|5553431|P4|STARTED|Overall Study||73
2262301|NCT02349451|5553432|P3|STARTED|Overall Study||71
2262302|NCT02349451|5553433|P2|STARTED|Overall Study||72
2262303|NCT02349451|5553434|P1|STARTED|Overall Study||24
2262304|NCT02349438|5553470|P2|NOT COMPLETED|Period 2||0
2262305|NCT02349438|5553471|P1|NOT COMPLETED|Period 2||0
2262306|NCT02349438|5553470|P2|COMPLETED|Period 2||10
2262307|NCT02349438|5553471|P1|COMPLETED|Period 2||11
2262308|NCT02349438|5553470|P2|STARTED|Period 2||10
2262309|NCT02349438|5553471|P1|STARTED|Period 2||11
2262310|NCT02349438|5553470|P2|NOT COMPLETED|Period 1||0
2262311|NCT02349438|5553471|P1|NOT COMPLETED|Period 1||0
2262312|NCT02349438|5553470|P2|COMPLETED|Period 1||10
2262313|NCT02349438|5553471|P1|COMPLETED|Period 1||11
2262314|NCT02349438|5553470|P2|STARTED|Period 1||10
2262315|NCT02349438|5553471|P1|STARTED|Period 1||11
2262316|NCT02349412|5553483|P2|NOT COMPLETED|Overall Study||7
2262317|NCT02349412|5553484|P1|NOT COMPLETED|Overall Study||7
2262318|NCT02349412|5553483|P2|COMPLETED|Overall Study||196
2262319|NCT02349412|5553484|P1|COMPLETED|Overall Study||195
2262320|NCT02349412|5553483|P2|Completed Week-24 QOL Assessment Measure|Overall Study||80
2262321|NCT02349412|5553484|P1|Completed Week-24 QOL Assessment Measure|Overall Study||68
2262322|NCT02349412|5553483|P2|Completed Week-12 QOL Assessment Measure|Overall Study||101
2262323|NCT02349412|5553484|P1|Completed Week-12 QOL Assessment Measure|Overall Study||92
2262324|NCT02349412|5553483|P2|STARTED|Overall Study||203
2262325|NCT02349412|5553484|P1|STARTED|Overall Study||202
2262326|NCT02349360|5553500|P2|NOT COMPLETED|Overall Study||1
2262327|NCT02349360|5553501|P1|NOT COMPLETED|Overall Study||0
2262328|NCT02349360|5553500|P2|COMPLETED|Overall Study||20
2262329|NCT02349360|5553501|P1|COMPLETED|Overall Study||21
2262330|NCT02349360|5553500|P2|STARTED|Overall Study||21
2262331|NCT02349360|5553501|P1|STARTED|Overall Study||21
2262332|NCT02349295|5553512|P5|NOT COMPLETED|IR (Week 16-24)||1
2262333|NCT02349295|5553513|P4|NOT COMPLETED|IR (Week 16-24)||0
2262334|NCT02349295|5553514|P3|NOT COMPLETED|IR (Week 16-24)||0
2262335|NCT02349295|5553515|P2|NOT COMPLETED|IR (Week 16-24)||0
2262336|NCT02349295|5553516|P1|NOT COMPLETED|IR (Week 16-24)||0
2262337|NCT02349295|5553512|P5|COMPLETED|IR (Week 16-24)||32
2262338|NCT02349295|5553513|P4|COMPLETED|IR (Week 16-24)||31
2262339|NCT02349295|5553514|P3|COMPLETED|IR (Week 16-24)||0
2262340|NCT02349295|5553515|P2|COMPLETED|IR (Week 16-24)||0
2262341|NCT02349295|5553516|P1|COMPLETED|IR (Week 16-24)||0
2262342|NCT02349295|5553512|P5|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q2W and IR from ixekizumab 80 mg Q2W.|33
2262343|NCT02349295|5553513|P4|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q4W and IR from ixekizumab 80 mg Q4W.|31
2262344|NCT02349295|5553514|P3|STARTED|IR (Week 16-24)|Only IR participants were included.|0
2262345|NCT02349295|5553515|P2|STARTED|IR (Week 16-24)|Only IR participants were included.|0
2262346|NCT02349295|5553516|P1|STARTED|IR (Week 16-24)|Only IR participants were included.|0
2262347|NCT02349295|5553512|P5|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
2262348|NCT02349295|5553513|P4|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
2262349|NCT02349295|5553514|P3|NOT COMPLETED|Double Blind Treatment (Week 0-24)||14
2262350|NCT02349295|5553515|P2|NOT COMPLETED|Double Blind Treatment (Week 0-24)||11
2262351|NCT02349295|5553516|P1|NOT COMPLETED|Double Blind Treatment (Week 0-24)||24
2262352|NCT02349295|5553512|P5|COMPLETED|Double Blind Treatment (Week 0-24)||0
2262353|NCT02349295|5553513|P4|COMPLETED|Double Blind Treatment (Week 0-24)||0
2262354|NCT02349295|5553514|P3|COMPLETED|Double Blind Treatment (Week 0-24)||109
2262355|NCT02349295|5553515|P2|COMPLETED|Double Blind Treatment (Week 0-24)||111
2262356|NCT02349295|5553516|P1|COMPLETED|Double Blind Treatment (Week 0-24)||94
2262357|NCT02349295|5553512|P5|STARTED|Double Blind Treatment (Week 0-24)||0
2262358|NCT02349295|5553513|P4|STARTED|Double Blind Treatment (Week 0-24)||0
2262359|NCT02349295|5553514|P3|STARTED|Double Blind Treatment (Week 0-24)||123
2262360|NCT02349295|5553515|P2|STARTED|Double Blind Treatment (Week 0-24)||122
2262361|NCT02349295|5553516|P1|STARTED|Double Blind Treatment (Week 0-24)||118
2262362|NCT02349178|5553590|P1|NOT COMPLETED|Overall Study||0
2262363|NCT02349178|5553590|P1|COMPLETED|Overall Study||6
2262364|NCT02349178|5553590|P1|STARTED|Overall Study||6
2262365|NCT02349152|5553596|P2|NOT COMPLETED|Overall Study||4
2262366|NCT02349152|5553597|P1|NOT COMPLETED|Overall Study||6
2262367|NCT02349152|5553596|P2|COMPLETED|Overall Study||52
2262368|NCT02349152|5553597|P1|COMPLETED|Overall Study||54
2262369|NCT02349152|5553596|P2|STARTED|Overall Study||56
2262370|NCT02349152|5553597|P1|STARTED|Overall Study||60
2262371|NCT02349061|5553633|P2|NOT COMPLETED|Overall Study||4
2262372|NCT02349061|5553634|P1|NOT COMPLETED|Overall Study||9
2262373|NCT02349061|5553633|P2|COMPLETED|Overall Study||56
2262374|NCT02349061|5553634|P1|COMPLETED|Overall Study||33
2262375|NCT02349061|5553633|P2|STARTED|Overall Study||60
2262376|NCT02349061|5553634|P1|STARTED|Overall Study||42
2262377|NCT02349048|5553642|P2|NOT COMPLETED|Overall Study||0
2262378|NCT02349048|5553643|P1|NOT COMPLETED|Overall Study||5
2262379|NCT02349048|5553642|P2|COMPLETED|Overall Study||9
2262380|NCT02349048|5553643|P1|COMPLETED|Overall Study||54
2262381|NCT02349048|5553642|P2|STARTED|Overall Study||9
2262382|NCT02349048|5553643|P1|STARTED|Overall Study||59
2262383|NCT02348918|5553672|P9|NOT COMPLETED|Overall Study||0
2262384|NCT02348918|5553673|P8|NOT COMPLETED|Overall Study||0
2262385|NCT02348918|5553674|P7|NOT COMPLETED|Overall Study||0
2262386|NCT02348918|5553675|P6|NOT COMPLETED|Overall Study||0
2262387|NCT02348918|5553676|P5|NOT COMPLETED|Overall Study||0
2262388|NCT02348918|5553677|P4|NOT COMPLETED|Overall Study||0
2262389|NCT02348918|5553678|P3|NOT COMPLETED|Overall Study||0
2262390|NCT02348918|5553679|P2|NOT COMPLETED|Overall Study||0
2262391|NCT02348918|5553680|P1|NOT COMPLETED|Overall Study||0
2262392|NCT02348918|5553672|P9|COMPLETED|Overall Study||15
2262393|NCT02348918|5553673|P8|COMPLETED|Overall Study||16
2262394|NCT02348918|5553674|P7|COMPLETED|Overall Study||13
2262395|NCT02348918|5553675|P6|COMPLETED|Overall Study||17
2262396|NCT02348918|5553676|P5|COMPLETED|Overall Study||19
2262397|NCT02348918|5553677|P4|COMPLETED|Overall Study||24
2262398|NCT02348918|5553678|P3|COMPLETED|Overall Study||42
2262399|NCT02348918|5553679|P2|COMPLETED|Overall Study||33
2262400|NCT02348918|5553680|P1|COMPLETED|Overall Study||39
2262401|NCT02348918|5553672|P9|STARTED|Overall Study||15
2262402|NCT02348918|5553673|P8|STARTED|Overall Study||16
2262403|NCT02348918|5553674|P7|STARTED|Overall Study||13
2262404|NCT02348918|5553675|P6|STARTED|Overall Study||17
2262405|NCT02348918|5553676|P5|STARTED|Overall Study||19
2262406|NCT02348918|5553677|P4|STARTED|Overall Study||24
2262407|NCT02348918|5553678|P3|STARTED|Overall Study||42
2262408|NCT02348918|5553679|P2|STARTED|Overall Study||33
2262409|NCT02348918|5553680|P1|STARTED|Overall Study||39
2262410|NCT02348840|5553704|P4|NOT COMPLETED|Overall Study||0
2262411|NCT02348840|5553705|P3|NOT COMPLETED|Overall Study||0
2262412|NCT02348840|5553706|P2|NOT COMPLETED|Overall Study||1
2262413|NCT02348840|5553707|P1|NOT COMPLETED|Overall Study||2
2262414|NCT02348840|5553704|P4|COMPLETED|Overall Study||374
2262415|NCT02348840|5553705|P3|COMPLETED|Overall Study||425
2262416|NCT02348840|5553706|P2|COMPLETED|Overall Study||20
2262417|NCT02348840|5553707|P1|COMPLETED|Overall Study||21
2262418|NCT02348840|5553704|P4|STARTED|Overall Study||374
2262419|NCT02348840|5553705|P3|STARTED|Overall Study||425
2262420|NCT02348840|5553706|P2|STARTED|Overall Study||21
2262421|NCT02348840|5553707|P1|STARTED|Overall Study||23
2262422|NCT02348723|5553721|P2|NOT COMPLETED|Overall Study||26
2262423|NCT02348723|5553722|P1|NOT COMPLETED|Overall Study||28
2262424|NCT02348723|5553721|P2|COMPLETED|Overall Study||312
2262425|NCT02348723|5553722|P1|COMPLETED|Overall Study||310
2262426|NCT02348723|5553721|P2|STARTED|Overall Study||338
2262427|NCT02348723|5553722|P1|STARTED|Overall Study||338
2262428|NCT02348684|5553734|P1|NOT COMPLETED|Overall Study||0
2262429|NCT02348684|5553734|P1|COMPLETED|Overall Study||20
2262430|NCT02348684|5553734|P1|STARTED|Overall Study||20
2262431|NCT02348658|5553738|P2|NOT COMPLETED|Period 2 (7 Days)||0
2262432|NCT02348658|5553739|P1|NOT COMPLETED|Period 2 (7 Days)||0
2262433|NCT02348658|5553738|P2|COMPLETED|Period 2 (7 Days)||6
2262434|NCT02348658|5553739|P1|COMPLETED|Period 2 (7 Days)||6
2262435|NCT02348658|5553738|P2|STARTED|Period 2 (7 Days)||6
2262436|NCT02348658|5553739|P1|STARTED|Period 2 (7 Days)||6
2262437|NCT02348658|5553738|P2|NOT COMPLETED|Washout Period (22 Days)||0
2262438|NCT02348658|5553739|P1|NOT COMPLETED|Washout Period (22 Days)||0
2262439|NCT02348658|5553738|P2|COMPLETED|Washout Period (22 Days)||6
2262440|NCT02348658|5553739|P1|COMPLETED|Washout Period (22 Days)||6
2262441|NCT02348658|5553738|P2|STARTED|Washout Period (22 Days)||6
2262442|NCT02348658|5553739|P1|STARTED|Washout Period (22 Days)||6
2262443|NCT02348658|5553738|P2|NOT COMPLETED|Period 1 (7 Days)||0
2262444|NCT02348658|5553739|P1|NOT COMPLETED|Period 1 (7 Days)||0
2262445|NCT02348658|5553738|P2|COMPLETED|Period 1 (7 Days)||6
2262446|NCT02348658|5553739|P1|COMPLETED|Period 1 (7 Days)||6
2262447|NCT02348658|5553738|P2|STARTED|Period 1 (7 Days)||6
2262448|NCT02348658|5553739|P1|STARTED|Period 1 (7 Days)||6
2262449|NCT02348632|5553773|P2|NOT COMPLETED|Randomized Withdrawal Period||1
2262450|NCT02348632|5553774|P1|NOT COMPLETED|Randomized Withdrawal Period||3
2262451|NCT02348632|5553773|P2|COMPLETED|Randomized Withdrawal Period||141
2262452|NCT02348632|5553774|P1|COMPLETED|Randomized Withdrawal Period||137
2262453|NCT02348632|5553773|P2|STARTED|Randomized Withdrawal Period||142
2262454|NCT02348632|5553774|P1|STARTED|Randomized Withdrawal Period||140
2262455|NCT02348632|5553773|P2|NOT COMPLETED|Open-label Period||0
2262456|NCT02348632|5553774|P1|NOT COMPLETED|Open-label Period||185
2262457|NCT02348632|5553773|P2|COMPLETED|Open-label Period||0
2262458|NCT02348632|5553774|P1|COMPLETED|Open-label Period||458
2262459|NCT02348632|5553773|P2|STARTED|Open-label Period||0
2262460|NCT02348632|5553774|P1|STARTED|Open-label Period||643
2262461|NCT02348619|5553784|P2|NOT COMPLETED|Double-Blind Withdrawal Phase||0
2262462|NCT02348619|5553785|P1|NOT COMPLETED|Double-Blind Withdrawal Phase||2
2262463|NCT02348619|5553784|P2|COMPLETED|Double-Blind Withdrawal Phase||62
2262464|NCT02348619|5553785|P1|COMPLETED|Double-Blind Withdrawal Phase||60
2262465|NCT02348619|5553784|P2|STARTED|Double-Blind Withdrawal Phase||62
2262466|NCT02348619|5553785|P1|STARTED|Double-Blind Withdrawal Phase||62
2262467|NCT02348619|5553784|P2|NOT COMPLETED|Stable-Dose Phase||0
2262468|NCT02348619|5553785|P1|NOT COMPLETED|Stable-Dose Phase||33
2262469|NCT02348619|5553784|P2|COMPLETED|Stable-Dose Phase||0
2262470|NCT02348619|5553785|P1|COMPLETED|Stable-Dose Phase||124
2262471|NCT02348619|5553784|P2|STARTED|Stable-Dose Phase||0
2262472|NCT02348619|5553785|P1|STARTED|Stable-Dose Phase||157
2262473|NCT02348619|5553784|P2|NOT COMPLETED|Titration Phase||0
2262474|NCT02348619|5553785|P1|NOT COMPLETED|Titration Phase||17
2262475|NCT02348619|5553784|P2|COMPLETED|Titration Phase||0
2262476|NCT02348619|5553785|P1|COMPLETED|Titration Phase||157
2262477|NCT02348619|5553784|P2|STARTED|Titration Phase||0
2262478|NCT02348619|5553785|P1|STARTED|Titration Phase||174
2262479|NCT02348606|5553804|P5|NOT COMPLETED|Overall Study||18
2262480|NCT02348606|5553805|P4|NOT COMPLETED|Overall Study||24
2262481|NCT02348606|5553806|P3|NOT COMPLETED|Overall Study||11
2262482|NCT02348606|5553807|P2|NOT COMPLETED|Overall Study||8
2262483|NCT02348606|5553808|P1|NOT COMPLETED|Overall Study||9
2262484|NCT02348606|5553804|P5|COMPLETED|Overall Study||101
2262485|NCT02348606|5553805|P4|COMPLETED|Overall Study||94
2262486|NCT02348606|5553806|P3|COMPLETED|Overall Study||106
2262487|NCT02348606|5553807|P2|COMPLETED|Overall Study||54
2262488|NCT02348606|5553808|P1|COMPLETED|Overall Study||49
2262489|NCT02348606|5553804|P5|STARTED|Overall Study||119
2262490|NCT02348606|5553805|P4|STARTED|Overall Study||118
2262491|NCT02348606|5553806|P3|STARTED|Overall Study||117
2262492|NCT02348606|5553807|P2|STARTED|Overall Study||62
2262493|NCT02348606|5553808|P1|STARTED|Overall Study||58
2262494|NCT02348593|5553864|P4|NOT COMPLETED|Overall Study||7
2262495|NCT02348593|5553865|P3|NOT COMPLETED|Overall Study||16
2262496|NCT02348593|5553866|P2|NOT COMPLETED|Overall Study||8
2262497|NCT02348593|5553867|P1|NOT COMPLETED|Overall Study||10
2262498|NCT02348593|5553864|P4|COMPLETED|Overall Study||52
2262499|NCT02348593|5553865|P3|COMPLETED|Overall Study||43
2262500|NCT02348593|5553866|P2|COMPLETED|Overall Study||51
2262501|NCT02348593|5553867|P1|COMPLETED|Overall Study||49
2262502|NCT02348593|5553864|P4|STARTED|Overall Study||59
2262503|NCT02348593|5553865|P3|STARTED|Overall Study||59
2262504|NCT02348593|5553866|P2|STARTED|Overall Study||59
2262505|NCT02348593|5553867|P1|STARTED|Overall Study||59
2262506|NCT02348359|5553913|P4|NOT COMPLETED|Overall Study||12
2262507|NCT02348359|5553914|P3|NOT COMPLETED|Overall Study||14
2262508|NCT02348359|5553915|P2|NOT COMPLETED|Overall Study||17
2262509|NCT02348359|5553916|P1|NOT COMPLETED|Overall Study||11
2262510|NCT02348359|5553913|P4|COMPLETED|Overall Study||27
2262511|NCT02348359|5553914|P3|COMPLETED|Overall Study||25
2262512|NCT02348359|5553915|P2|COMPLETED|Overall Study||22
2262513|NCT02348359|5553916|P1|COMPLETED|Overall Study||29
2262514|NCT02348359|5553913|P4|STARTED|Overall Study||39
2262515|NCT02348359|5553914|P3|STARTED|Overall Study||39
2262516|NCT02348359|5553915|P2|STARTED|Overall Study||39
2262517|NCT02348359|5553916|P1|STARTED|Overall Study||40
2262518|NCT02347943|5553929|P3|NOT COMPLETED|Overall Study||45
2262519|NCT02347943|5553930|P2|NOT COMPLETED|Overall Study||67
2262520|NCT02347943|5553931|P1|NOT COMPLETED|Overall Study||140
2262521|NCT02347943|5553929|P3|COMPLETED|Overall Study||0
2262522|NCT02347943|5553930|P2|COMPLETED|Overall Study||0
2262523|NCT02347943|5553931|P1|COMPLETED|Overall Study||0
2262524|NCT02347943|5553929|P3|STARTED|Overall Study||45
2262525|NCT02347943|5553930|P2|STARTED|Overall Study||67
2262526|NCT02347943|5553931|P1|STARTED|Overall Study||140
2262527|NCT02347787|5553941|P2|NOT COMPLETED|9 Month Follow-Up||71
2262528|NCT02347787|5553942|P1|NOT COMPLETED|9 Month Follow-Up||61
2262529|NCT02347787|5553941|P2|COMPLETED|9 Month Follow-Up||233
2262530|NCT02347787|5553942|P1|COMPLETED|9 Month Follow-Up||227
2262531|NCT02347787|5553941|P2|STARTED|9 Month Follow-Up||304
2262532|NCT02347787|5553942|P1|STARTED|9 Month Follow-Up||288
2262533|NCT02347787|5553941|P2|NOT COMPLETED|6 Month Follow-Up||56
2262534|NCT02347787|5553942|P1|NOT COMPLETED|6 Month Follow-Up||66
2262535|NCT02347787|5553941|P2|COMPLETED|6 Month Follow-Up||248
2262536|NCT02347787|5553942|P1|COMPLETED|6 Month Follow-Up||222
2262537|NCT02347787|5553941|P2|STARTED|6 Month Follow-Up||304
2262538|NCT02347787|5553942|P1|STARTED|6 Month Follow-Up||288
2262539|NCT02347774|5554004|P3|NOT COMPLETED|On Study Treatment||36
2262540|NCT02347774|5554005|P2|NOT COMPLETED|On Study Treatment||31
2262541|NCT02347774|5554006|P1|NOT COMPLETED|On Study Treatment||24
2262542|NCT02347774|5554004|P3|COMPLETED|On Study Treatment||177
2262543|NCT02347774|5554005|P2|COMPLETED|On Study Treatment||183
2262544|NCT02347774|5554006|P1|COMPLETED|On Study Treatment||190
2262545|NCT02347774|5554004|P3|STARTED|On Study Treatment|One subject randomized in error to the placebo arm was never dosed .|213
2262546|NCT02347774|5554005|P2|STARTED|On Study Treatment||214
2262547|NCT02347774|5554006|P1|STARTED|On Study Treatment||214
2262548|NCT02347774|5554004|P3|NOT COMPLETED|Study Participation||25
2262549|NCT02347774|5554005|P2|NOT COMPLETED|Study Participation||21
2262550|NCT02347774|5554006|P1|NOT COMPLETED|Study Participation||15
2262551|NCT02347774|5554004|P3|COMPLETED|Study Participation||188
2262552|NCT02347774|5554005|P2|COMPLETED|Study Participation||193
2262553|NCT02347774|5554006|P1|COMPLETED|Study Participation||199
2262554|NCT02347774|5554004|P3|STARTED|Study Participation|One subject randomized in error to the placebo arm was never dosed .|213
2262555|NCT02347774|5554005|P2|STARTED|Study Participation||214
2262556|NCT02347774|5554006|P1|STARTED|Study Participation||214
2262557|NCT02347761|5554062|P3|NOT COMPLETED|On Study Treatment||42
2262558|NCT02347761|5554063|P2|NOT COMPLETED|On Study Treatment||23
2262559|NCT02347761|5554064|P1|NOT COMPLETED|On Study Treatment||27
2262560|NCT02347761|5554062|P3|COMPLETED|On Study Treatment||176
2262561|NCT02347761|5554063|P2|COMPLETED|On Study Treatment||194
2262562|NCT02347761|5554064|P1|COMPLETED|On Study Treatment||191
2262563|NCT02347761|5554062|P3|STARTED|On Study Treatment||218
2262564|NCT02347761|5554063|P2|STARTED|On Study Treatment||217
2262565|NCT02347761|5554064|P1|STARTED|On Study Treatment||218
2262566|NCT02347761|5554062|P3|NOT COMPLETED|All Collected||27
2262567|NCT02347761|5554063|P2|NOT COMPLETED|All Collected||14
2262568|NCT02347761|5554064|P1|NOT COMPLETED|All Collected||17
2262569|NCT02347761|5554062|P3|COMPLETED|All Collected||191
2262570|NCT02347761|5554063|P2|COMPLETED|All Collected||203
2262571|NCT02347761|5554064|P1|COMPLETED|All Collected||201
2262572|NCT02347761|5554062|P3|STARTED|All Collected||218
2262573|NCT02347761|5554063|P2|STARTED|All Collected||217
2262574|NCT02347761|5554064|P1|STARTED|All Collected||218
2262575|NCT02347657|5554125|P2|NOT COMPLETED|Overall Study||15
2262576|NCT02347657|5554126|P1|NOT COMPLETED|Overall Study||18
2262577|NCT02347657|5554125|P2|COMPLETED|Overall Study||236
2262578|NCT02347657|5554126|P1|COMPLETED|Overall Study||241
2262579|NCT02347657|5554125|P2|Treated|Overall Study||251
2262580|NCT02347657|5554126|P1|Treated|Overall Study||258
2262581|NCT02347657|5554125|P2|STARTED|Overall Study||251
2262582|NCT02347657|5554126|P1|STARTED|Overall Study||259
2262583|NCT02347605|5554157|P6|NOT COMPLETED|Overall Study||2
2262584|NCT02347605|5554158|P5|NOT COMPLETED|Overall Study||3
2262585|NCT02347605|5554159|P4|NOT COMPLETED|Overall Study||4
2262586|NCT02347605|5554160|P3|NOT COMPLETED|Overall Study||1
2262587|NCT02347605|5554161|P2|NOT COMPLETED|Overall Study||3
2262588|NCT02347605|5554162|P1|NOT COMPLETED|Overall Study||3
2262589|NCT02347605|5554157|P6|COMPLETED|Overall Study||7
2262590|NCT02347605|5554158|P5|COMPLETED|Overall Study||6
2262591|NCT02347605|5554159|P4|COMPLETED|Overall Study||6
2262592|NCT02347605|5554160|P3|COMPLETED|Overall Study||7
2262593|NCT02347605|5554161|P2|COMPLETED|Overall Study||7
2262594|NCT02347605|5554162|P1|COMPLETED|Overall Study||7
2262595|NCT02347605|5554157|P6|Completed Lab 2|Overall Study||8
2262596|NCT02347605|5554158|P5|Completed Lab 2|Overall Study||6
2262597|NCT02347605|5554159|P4|Completed Lab 2|Overall Study||7
2262598|NCT02347605|5554160|P3|Completed Lab 2|Overall Study||7
2262599|NCT02347605|5554161|P2|Completed Lab 2|Overall Study||7
2262600|NCT02347605|5554162|P1|Completed Lab 2|Overall Study||7
2262601|NCT02347605|5554157|P6|Completed Lab 1|Overall Study||9
2262602|NCT02347605|5554158|P5|Completed Lab 1|Overall Study||8
2262603|NCT02347605|5554159|P4|Completed Lab 1|Overall Study||10
2262604|NCT02347605|5554160|P3|Completed Lab 1|Overall Study||8
2262605|NCT02347605|5554161|P2|Completed Lab 1|Overall Study||10
2262606|NCT02347605|5554162|P1|Completed Lab 1|Overall Study||10
2262607|NCT02347605|5554157|P6|STARTED|Overall Study||9
2262608|NCT02347605|5554158|P5|STARTED|Overall Study||9
2262609|NCT02347605|5554159|P4|STARTED|Overall Study||10
2262610|NCT02347605|5554160|P3|STARTED|Overall Study||8
2262611|NCT02347605|5554161|P2|STARTED|Overall Study||10
2262612|NCT02347605|5554162|P1|STARTED|Overall Study||10
2262613|NCT02347488|5554173|P1|NOT COMPLETED|Overall Study||0
2262614|NCT02347488|5554173|P1|COMPLETED|Overall Study||30
2262615|NCT02347488|5554173|P1|STARTED|Overall Study||30
2262616|NCT02347345|5554186|P3|NOT COMPLETED|Overall Study||0
2262617|NCT02347345|5554187|P2|NOT COMPLETED|Overall Study||0
2262618|NCT02347345|5554188|P1|NOT COMPLETED|Overall Study||0
2262619|NCT02347345|5554186|P3|COMPLETED|Overall Study||12
2262620|NCT02347345|5554187|P2|COMPLETED|Overall Study||12
2262621|NCT02347345|5554188|P1|COMPLETED|Overall Study||10
2262622|NCT02347345|5554186|P3|STARTED|Overall Study||12
2262623|NCT02347345|5554187|P2|STARTED|Overall Study||12
2262624|NCT02347345|5554188|P1|STARTED|Overall Study||10
2262625|NCT02347332|5554204|P2|NOT COMPLETED|Overall Study||229
2262626|NCT02347332|5554205|P1|NOT COMPLETED|Overall Study||230
2262627|NCT02347332|5554204|P2|COMPLETED|Overall Study|6 patients: unknown cause(2home), PDsuspect(1home+1hosp), sudden death(1home), hypercapnie(1hosp).|0
2262628|NCT02347332|5554205|P1|COMPLETED|Overall Study|6 patients: suicide(1), unknown cause(5 - 4 at home +1 in city hospital).|0
2262629|NCT02347332|5554204|P2|STARTED|Overall Study||229
2262630|NCT02347332|5554205|P1|STARTED|Overall Study||230
2262631|NCT02347189|5554219|P1|NOT COMPLETED|Overall Study||11
2262632|NCT02347189|5554219|P1|COMPLETED|Overall Study||28
2262633|NCT02347189|5554219|P1|Implanted > 24 Hours|Overall Study||30
2262634|NCT02347189|5554219|P1|Implanted|Overall Study||30
2262635|NCT02347189|5554219|P1|Catheterized|Overall Study||39
2262636|NCT02347189|5554219|P1|STARTED|Overall Study||39
2262637|NCT02347176|5554238|P4|NOT COMPLETED|Overall Study||4
2262638|NCT02347176|5554239|P3|NOT COMPLETED|Overall Study||8
2262639|NCT02347176|5554240|P2|NOT COMPLETED|Overall Study||10
2262640|NCT02347176|5554241|P1|NOT COMPLETED|Overall Study||12
2262641|NCT02347176|5554238|P4|COMPLETED|Overall Study||48
2262642|NCT02347176|5554239|P3|COMPLETED|Overall Study||43
2262643|NCT02347176|5554240|P2|COMPLETED|Overall Study||40
2262644|NCT02347176|5554241|P1|COMPLETED|Overall Study||39
2262645|NCT02347176|5554238|P4|STARTED|Overall Study||52
2262646|NCT02347176|5554239|P3|STARTED|Overall Study||51
2262647|NCT02347176|5554240|P2|STARTED|Overall Study||50
2262648|NCT02347176|5554241|P1|STARTED|Overall Study||51
2262649|NCT02347124|5554289|P2|NOT COMPLETED|Overall Study||99
2262650|NCT02347124|5554290|P1|NOT COMPLETED|Overall Study||93
2262651|NCT02347124|5554289|P2|COMPLETED|Overall Study||259
2262652|NCT02347124|5554290|P1|COMPLETED|Overall Study||267
2262653|NCT02347124|5554289|P2|2 Month Follow-up|Overall Study||275
2262654|NCT02347124|5554290|P1|2 Month Follow-up|Overall Study||298
2262655|NCT02347124|5554289|P2|STARTED|Overall Study||358
2262656|NCT02347124|5554290|P1|STARTED|Overall Study||360
2262657|NCT02347098|5554326|P2|NOT COMPLETED|Overall Study||8
2262658|NCT02347098|5554327|P1|NOT COMPLETED|Overall Study||7
2262659|NCT02347098|5554326|P2|COMPLETED|Overall Study||58
2262660|NCT02347098|5554327|P1|COMPLETED|Overall Study||56
2262661|NCT02347098|5554326|P2|STARTED|Overall Study||66
2262662|NCT02347098|5554327|P1|STARTED|Overall Study||63
2262663|NCT02347085|5554339|P1|NOT COMPLETED|Overall Study||10
2262664|NCT02347085|5554339|P1|COMPLETED|Overall Study||33
2262665|NCT02347085|5554339|P1|Placebo MDI|Overall Study||40
2262666|NCT02347085|5554339|P1|GFF MDI 14.4/9.6 µg|Overall Study||40
2262667|NCT02347085|5554339|P1|STARTED|Overall Study||43
2262668|NCT02347072|5554361|P1|NOT COMPLETED|Overall Study||18
2262669|NCT02347072|5554361|P1|COMPLETED|Overall Study||62
2262670|NCT02347072|5554361|P1|Spiriva Respimat 5 µg|Overall Study||73
2262671|NCT02347072|5554361|P1|Placebo MDI|Overall Study||72
2262672|NCT02347072|5554361|P1|GFF MDI 14.4/9.6 µg|Overall Study||75
2262673|NCT02347072|5554361|P1|STARTED|Overall Study||80
2262674|NCT02346877|5554395|P2|NOT COMPLETED|Overall Study||0
2262675|NCT02346877|5554396|P1|NOT COMPLETED|Overall Study||19
2262676|NCT02346877|5554395|P2|COMPLETED|Overall Study||0
2262677|NCT02346877|5554396|P1|COMPLETED|Overall Study||0
2262678|NCT02346877|5554395|P2|STARTED|Overall Study||0
2262679|NCT02346877|5554396|P1|STARTED|Overall Study||19
2262680|NCT02346721|5554406|P1|NOT COMPLETED|Overall Study||4
2262681|NCT02346721|5554406|P1|COMPLETED|Overall Study||107
2262682|NCT02346721|5554406|P1|STARTED|Overall Study||111
2262683|NCT02346643|5554415|P1|NOT COMPLETED|Overall Study||35
2262684|NCT02346643|5554415|P1|COMPLETED|Overall Study||6
2262685|NCT02346643|5554415|P1|Received Permanent System|Overall Study||31
2262686|NCT02346643|5554415|P1|Received Trial System|Overall Study||29
2262687|NCT02346643|5554415|P1|STARTED|Overall Study||41
2262688|NCT02346461|5554422|P2|NOT COMPLETED|Overall Study||0
2262689|NCT02346461|5554423|P1|NOT COMPLETED|Overall Study||0
2262690|NCT02346461|5554422|P2|COMPLETED|Overall Study||6
2262691|NCT02346461|5554423|P1|COMPLETED|Overall Study||6
2262692|NCT02346461|5554422|P2|STARTED|Overall Study||6
2262693|NCT02346461|5554423|P1|STARTED|Overall Study||6
2262694|NCT02346370|5554445|P3|NOT COMPLETED|Overall Study||4
2262695|NCT02346370|5554446|P2|NOT COMPLETED|Overall Study||4
2262696|NCT02346370|5554447|P1|NOT COMPLETED|Overall Study||8
2262697|NCT02346370|5554445|P3|COMPLETED|Overall Study||0
2262698|NCT02346370|5554446|P2|COMPLETED|Overall Study||0
2262699|NCT02346370|5554447|P1|COMPLETED|Overall Study||0
2262700|NCT02346370|5554445|P3|STARTED|Overall Study||4
2262701|NCT02346370|5554446|P2|STARTED|Overall Study||4
2262702|NCT02346370|5554447|P1|STARTED|Overall Study||8
2262703|NCT02346240|5554496|P17|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||6
2262704|NCT02346240|5554497|P16|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||13
2262705|NCT02346240|5554498|P15|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||14
2262706|NCT02346240|5554499|P14|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||7
2262707|NCT02346240|5554500|P13|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||0
2262708|NCT02346240|5554501|P12|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||3
2262709|NCT02346240|5554502|P11|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||2
2262710|NCT02346240|5554503|P10|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||1
2262711|NCT02346240|5554504|P9|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||4
2262712|NCT02346240|5554505|P8|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||2
2262713|NCT02346240|5554506|P7|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||2
2262714|NCT02346240|5554507|P6|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||1
2262715|NCT02346240|5554508|P5|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||0
2262716|NCT02346240|5554509|P4|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||0
2262717|NCT02346240|5554510|P3|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||0
2262718|NCT02346240|5554511|P2|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||0
2262719|NCT02346240|5554512|P1|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||0
2262720|NCT02346240|5554496|P17|COMPLETED|Finished Wk16 Entered Maintenance Period||30
2262721|NCT02346240|5554497|P16|COMPLETED|Finished Wk16 Entered Maintenance Period||36
2262722|NCT02346240|5554498|P15|COMPLETED|Finished Wk16 Entered Maintenance Period||71
2262723|NCT02346240|5554499|P14|COMPLETED|Finished Wk16 Entered Maintenance Period||46
2262724|NCT02346240|5554500|P13|COMPLETED|Finished Wk16 Entered Maintenance Period||49
2262725|NCT02346240|5554501|P12|COMPLETED|Finished Wk16 Entered Maintenance Period||47
2262726|NCT02346240|5554502|P11|COMPLETED|Finished Wk16 Entered Maintenance Period||23
2262727|NCT02346240|5554503|P10|COMPLETED|Finished Wk16 Entered Maintenance Period||43
2262728|NCT02346240|5554504|P9|COMPLETED|Finished Wk16 Entered Maintenance Period||40
2262729|NCT02346240|5554505|P8|COMPLETED|Finished Wk16 Entered Maintenance Period||20
2262730|NCT02346240|5554506|P7|COMPLETED|Finished Wk16 Entered Maintenance Period||48
2262731|NCT02346240|5554507|P6|COMPLETED|Finished Wk16 Entered Maintenance Period||23
2262732|NCT02346240|5554508|P5|COMPLETED|Finished Wk16 Entered Maintenance Period||2
2262733|NCT02346240|5554509|P4|COMPLETED|Finished Wk16 Entered Maintenance Period||0
2262734|NCT02346240|5554510|P3|COMPLETED|Finished Wk16 Entered Maintenance Period||0
2262735|NCT02346240|5554511|P2|COMPLETED|Finished Wk16 Entered Maintenance Period||0
2262736|NCT02346240|5554512|P1|COMPLETED|Finished Wk16 Entered Maintenance Period||0
2262737|NCT02346240|5554496|P17|STARTED|Finished Wk16 Entered Maintenance Period||36
2262738|NCT02346240|5554497|P16|STARTED|Finished Wk16 Entered Maintenance Period||49
2262739|NCT02346240|5554498|P15|STARTED|Finished Wk16 Entered Maintenance Period||85
2262740|NCT02346240|5554499|P14|STARTED|Finished Wk16 Entered Maintenance Period||53
2262741|NCT02346240|5554500|P13|STARTED|Finished Wk16 Entered Maintenance Period||49
2262742|NCT02346240|5554501|P12|STARTED|Finished Wk16 Entered Maintenance Period||50
2262743|NCT02346240|5554502|P11|STARTED|Finished Wk16 Entered Maintenance Period||25
2262744|NCT02346240|5554503|P10|STARTED|Finished Wk16 Entered Maintenance Period||44
2262745|NCT02346240|5554504|P9|STARTED|Finished Wk16 Entered Maintenance Period||44
2262746|NCT02346240|5554505|P8|STARTED|Finished Wk16 Entered Maintenance Period||22
2262747|NCT02346240|5554506|P7|STARTED|Finished Wk16 Entered Maintenance Period||50
2262748|NCT02346240|5554507|P6|STARTED|Finished Wk16 Entered Maintenance Period||24
2262749|NCT02346240|5554508|P5|STARTED|Finished Wk16 Entered Maintenance Period||2
2262750|NCT02346240|5554509|P4|STARTED|Finished Wk16 Entered Maintenance Period||0
2262751|NCT02346240|5554510|P3|STARTED|Finished Wk16 Entered Maintenance Period||0
2262752|NCT02346240|5554511|P2|STARTED|Finished Wk16 Entered Maintenance Period||0
2262753|NCT02346240|5554512|P1|STARTED|Finished Wk16 Entered Maintenance Period||0
2262754|NCT02346240|5554496|P17|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
2262755|NCT02346240|5554497|P16|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
2262756|NCT02346240|5554498|P15|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
2262757|NCT02346240|5554499|P14|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
2262758|NCT02346240|5554500|P13|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
2262759|NCT02346240|5554501|P12|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
2262760|NCT02346240|5554502|P11|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
2262761|NCT02346240|5554503|P10|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
2262762|NCT02346240|5554504|P9|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
2262763|NCT02346240|5554505|P8|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
2262764|NCT02346240|5554506|P7|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
2262765|NCT02346240|5554507|P6|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
2262766|NCT02346240|5554508|P5|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
2262767|NCT02346240|5554509|P4|NOT COMPLETED|Initial Period (Baseline to Week 16)||7
2262768|NCT02346240|5554510|P3|NOT COMPLETED|Initial Period (Baseline to Week 16)||6
2262769|NCT02346240|5554511|P2|NOT COMPLETED|Initial Period (Baseline to Week 16)||11
2262770|NCT02346240|5554512|P1|NOT COMPLETED|Initial Period (Baseline to Week 16)||2
2262771|NCT02346240|5554496|P17|COMPLETED|Initial Period (Baseline to Week 16)||0
2262772|NCT02346240|5554497|P16|COMPLETED|Initial Period (Baseline to Week 16)||0
2262773|NCT02346240|5554498|P15|COMPLETED|Initial Period (Baseline to Week 16)||0
2262774|NCT02346240|5554499|P14|COMPLETED|Initial Period (Baseline to Week 16)||0
2262775|NCT02346240|5554500|P13|COMPLETED|Initial Period (Baseline to Week 16)||0
2262776|NCT02346240|5554501|P12|COMPLETED|Initial Period (Baseline to Week 16)||0
2262777|NCT02346240|5554502|P11|COMPLETED|Initial Period (Baseline to Week 16)||0
2262778|NCT02346240|5554503|P10|COMPLETED|Initial Period (Baseline to Week 16)||0
2262779|NCT02346240|5554504|P9|COMPLETED|Initial Period (Baseline to Week 16)||0
2262780|NCT02346240|5554505|P8|COMPLETED|Initial Period (Baseline to Week 16)||0
2262781|NCT02346240|5554506|P7|COMPLETED|Initial Period (Baseline to Week 16)||0
2262782|NCT02346240|5554507|P6|COMPLETED|Initial Period (Baseline to Week 16)||0
2262783|NCT02346240|5554508|P5|COMPLETED|Initial Period (Baseline to Week 16)||0
2262784|NCT02346240|5554509|P4|COMPLETED|Initial Period (Baseline to Week 16)||160
2262785|NCT02346240|5554510|P3|COMPLETED|Initial Period (Baseline to Week 16)||159
2262786|NCT02346240|5554511|P2|COMPLETED|Initial Period (Baseline to Week 16)||159
2262787|NCT02346240|5554512|P1|COMPLETED|Initial Period (Baseline to Week 16)||55
2262788|NCT02346240|5554496|P17|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
2262789|NCT02346240|5554497|P16|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
2262790|NCT02346240|5554498|P15|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
2262791|NCT02346240|5554499|P14|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
2262792|NCT02346240|5554500|P13|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
2262870|NCT02345486|5554678|P1|NOT COMPLETED|Overall Study||0
2262793|NCT02346240|5554501|P12|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
2262794|NCT02346240|5554502|P11|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
2262795|NCT02346240|5554503|P10|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
2262796|NCT02346240|5554504|P9|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
2262797|NCT02346240|5554505|P8|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
2262798|NCT02346240|5554506|P7|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
2262799|NCT02346240|5554507|P6|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
2262800|NCT02346240|5554508|P5|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
2262801|NCT02346240|5554509|P4|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||160
2262802|NCT02346240|5554510|P3|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||159
2262803|NCT02346240|5554511|P2|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||159
2262804|NCT02346240|5554512|P1|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||55
2262805|NCT02346240|5554496|P17|Completed Week 16|Initial Period (Baseline to Week 16)||0
2262806|NCT02346240|5554497|P16|Completed Week 16|Initial Period (Baseline to Week 16)||0
2262807|NCT02346240|5554498|P15|Completed Week 16|Initial Period (Baseline to Week 16)||0
2262808|NCT02346240|5554499|P14|Completed Week 16|Initial Period (Baseline to Week 16)||0
2262809|NCT02346240|5554500|P13|Completed Week 16|Initial Period (Baseline to Week 16)||0
2262810|NCT02346240|5554501|P12|Completed Week 16|Initial Period (Baseline to Week 16)||0
2262811|NCT02346240|5554502|P11|Completed Week 16|Initial Period (Baseline to Week 16)||0
2262812|NCT02346240|5554503|P10|Completed Week 16|Initial Period (Baseline to Week 16)||0
2262813|NCT02346240|5554504|P9|Completed Week 16|Initial Period (Baseline to Week 16)||0
2262814|NCT02346240|5554505|P8|Completed Week 16|Initial Period (Baseline to Week 16)||0
2262815|NCT02346240|5554506|P7|Completed Week 16|Initial Period (Baseline to Week 16)||0
2262816|NCT02346240|5554507|P6|Completed Week 16|Initial Period (Baseline to Week 16)||0
2262817|NCT02346240|5554508|P5|Completed Week 16|Initial Period (Baseline to Week 16)||0
2262818|NCT02346240|5554509|P4|Completed Week 16|Initial Period (Baseline to Week 16)||162
2262819|NCT02346240|5554510|P3|Completed Week 16|Initial Period (Baseline to Week 16)||159
2262820|NCT02346240|5554511|P2|Completed Week 16|Initial Period (Baseline to Week 16)||159
2262821|NCT02346240|5554512|P1|Completed Week 16|Initial Period (Baseline to Week 16)||55
2262822|NCT02346240|5554496|P17|STARTED|Initial Period (Baseline to Week 16)||0
2262823|NCT02346240|5554497|P16|STARTED|Initial Period (Baseline to Week 16)||0
2262824|NCT02346240|5554498|P15|STARTED|Initial Period (Baseline to Week 16)||0
2262825|NCT02346240|5554499|P14|STARTED|Initial Period (Baseline to Week 16)||0
2262826|NCT02346240|5554500|P13|STARTED|Initial Period (Baseline to Week 16)||0
2262827|NCT02346240|5554501|P12|STARTED|Initial Period (Baseline to Week 16)||0
2262828|NCT02346240|5554502|P11|STARTED|Initial Period (Baseline to Week 16)||0
2262829|NCT02346240|5554503|P10|STARTED|Initial Period (Baseline to Week 16)||0
2262830|NCT02346240|5554504|P9|STARTED|Initial Period (Baseline to Week 16)||0
2262831|NCT02346240|5554505|P8|STARTED|Initial Period (Baseline to Week 16)||0
2262832|NCT02346240|5554506|P7|STARTED|Initial Period (Baseline to Week 16)||0
2262833|NCT02346240|5554507|P6|STARTED|Initial Period (Baseline to Week 16)||0
2262834|NCT02346240|5554508|P5|STARTED|Initial Period (Baseline to Week 16)||0
2262835|NCT02346240|5554509|P4|STARTED|Initial Period (Baseline to Week 16)||167
2262836|NCT02346240|5554510|P3|STARTED|Initial Period (Baseline to Week 16)||165
2262837|NCT02346240|5554511|P2|STARTED|Initial Period (Baseline to Week 16)||170
2262838|NCT02346240|5554512|P1|STARTED|Initial Period (Baseline to Week 16)||57
2262845|NCT02345889|5554585|P4|NOT COMPLETED|Overall Study||16
2262846|NCT02345889|5554586|P3|NOT COMPLETED|Overall Study||20
2262847|NCT02345889|5554587|P2|NOT COMPLETED|Overall Study||17
2262848|NCT02345889|5554588|P1|NOT COMPLETED|Overall Study||21
2262849|NCT02345889|5554585|P4|COMPLETED|Overall Study||299
2262850|NCT02345889|5554586|P3|COMPLETED|Overall Study||295
2262851|NCT02345889|5554587|P2|COMPLETED|Overall Study||299
2262852|NCT02345889|5554588|P1|COMPLETED|Overall Study||295
2262853|NCT02345889|5554585|P4|STARTED|Overall Study||315
2262854|NCT02345889|5554586|P3|STARTED|Overall Study||315
2262855|NCT02345889|5554587|P2|STARTED|Overall Study||316
2262856|NCT02345889|5554588|P1|STARTED|Overall Study||316
2262857|NCT02345772|5554654|P1|NOT COMPLETED|Overall Study||4
2262858|NCT02345772|5554654|P1|COMPLETED|Overall Study||0
2262859|NCT02345772|5554654|P1|STARTED|Overall Study||4
2262860|NCT02345720|5554660|P1|NOT COMPLETED|Overall Study||0
2262861|NCT02345720|5554660|P1|COMPLETED|Overall Study||20
2262862|NCT02345720|5554660|P1|STARTED|Overall Study||20
2262863|NCT02345642|5554668|P2|NOT COMPLETED|Overall Study||0
2262864|NCT02345642|5554669|P1|NOT COMPLETED|Overall Study||0
2262865|NCT02345642|5554668|P2|COMPLETED|Overall Study||10
2262866|NCT02345642|5554669|P1|COMPLETED|Overall Study||10
2262867|NCT02345642|5554668|P2|STARTED|Overall Study||10
2262868|NCT02345642|5554669|P1|STARTED|Overall Study||10
2262869|NCT02345486|5554677|P2|NOT COMPLETED|Overall Study||0
2262871|NCT02345486|5554677|P2|COMPLETED|Overall Study||520
2262872|NCT02345486|5554678|P1|COMPLETED|Overall Study||454
2262873|NCT02345486|5554677|P2|STARTED|Overall Study||520
2262874|NCT02345486|5554678|P1|STARTED|Overall Study||454
2262875|NCT02345460|5554726|P1|NOT COMPLETED|Overall Study||0
2262876|NCT02345460|5554726|P1|COMPLETED|Overall Study||1
2262877|NCT02345460|5554726|P1|STARTED|Overall Study||1
2262878|NCT02345369|5554739|P2|NOT COMPLETED|Overall Study||0
2262879|NCT02345369|5554740|P1|NOT COMPLETED|Overall Study||0
2262880|NCT02345369|5554739|P2|COMPLETED|Overall Study||0
2262881|NCT02345369|5554740|P1|COMPLETED|Overall Study||0
2262882|NCT02345369|5554739|P2|STARTED|Overall Study||0
2262883|NCT02345369|5554740|P1|STARTED|Overall Study||0
2262884|NCT02345330|5554750|P1|NOT COMPLETED|Overall Study||3
2262885|NCT02345330|5554750|P1|COMPLETED|Overall Study||1
2262886|NCT02345330|5554750|P1|STARTED|Overall Study||4
2262887|NCT02345252|5554762|P2|NOT COMPLETED|Open-Label Extension Phase||0
2262888|NCT02345252|5554763|P1|NOT COMPLETED|Open-Label Extension Phase||0
2262889|NCT02345252|5554762|P2|COMPLETED|Open-Label Extension Phase||17
2262890|NCT02345252|5554763|P1|COMPLETED|Open-Label Extension Phase||19
2262891|NCT02345252|5554762|P2|STARTED|Open-Label Extension Phase|250 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|17
2262892|NCT02345252|5554763|P1|STARTED|Open-Label Extension Phase|257 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|19
2262893|NCT02345252|5554762|P2|NOT COMPLETED|Double-Blind Phase||49
2262894|NCT02345252|5554763|P1|NOT COMPLETED|Double-Blind Phase||40
2262895|NCT02345252|5554762|P2|COMPLETED|Double-Blind Phase||267
2262896|NCT02345252|5554763|P1|COMPLETED|Double-Blind Phase||276
2262897|NCT02345252|5554762|P2|STARTED|Double-Blind Phase||316
2262898|NCT02345252|5554763|P1|STARTED|Double-Blind Phase||316
2262899|NCT02345226|5554791|P2|NOT COMPLETED|Open-Label Extension Phase||1
2262900|NCT02345226|5554792|P1|NOT COMPLETED|Open-Label Extension Phase||0
2262901|NCT02345226|5554791|P2|COMPLETED|Open-Label Extension Phase||20
2262902|NCT02345226|5554792|P1|COMPLETED|Open-Label Extension Phase||25
2262903|NCT02345226|5554791|P2|STARTED|Open-Label Extension Phase|349 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|21
2262904|NCT02345226|5554792|P1|STARTED|Open-Label Extension Phase|346 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|25
2262905|NCT02345226|5554791|P2|NOT COMPLETED|Double-Blind Phase||71
2262906|NCT02345226|5554792|P1|NOT COMPLETED|Double-Blind Phase||69
2262907|NCT02345226|5554791|P2|COMPLETED|Double-Blind Phase||370
2262908|NCT02345226|5554792|P1|COMPLETED|Double-Blind Phase||371
2262909|NCT02345226|5554791|P2|STARTED|Double-Blind Phase||441
2262910|NCT02345226|5554792|P1|STARTED|Double-Blind Phase||440
2262911|NCT02345161|5554824|P2|NOT COMPLETED|Overall Study||57
2262912|NCT02345161|5554825|P1|NOT COMPLETED|Overall Study||45
2262913|NCT02345161|5554824|P2|COMPLETED|Overall Study||842
2262914|NCT02345161|5554825|P1|COMPLETED|Overall Study||866
2262915|NCT02345161|5554824|P2|STARTED|Overall Study||899
2262916|NCT02345161|5554825|P1|STARTED|Overall Study||911
2262917|NCT02345031|5554929|P2|NOT COMPLETED|Overall Study||1
2262918|NCT02345031|5554930|P1|NOT COMPLETED|Overall Study||1
2262919|NCT02345031|5554929|P2|COMPLETED|Overall Study||39
2262920|NCT02345031|5554930|P1|COMPLETED|Overall Study||37
2262921|NCT02345031|5554929|P2|STARTED|Overall Study||40
2262922|NCT02345031|5554930|P1|STARTED|Overall Study||38
2262923|NCT02344745|5554946|P2|NOT COMPLETED|Overall Study||0
2262924|NCT02344745|5554947|P1|NOT COMPLETED|Overall Study||2
2262925|NCT02344745|5554946|P2|COMPLETED|Overall Study||40
2262926|NCT02344745|5554947|P1|COMPLETED|Overall Study||38
2262927|NCT02344745|5554946|P2|STARTED|Overall Study||40
2262928|NCT02344745|5554947|P1|STARTED|Overall Study||40
2262929|NCT02344628|5554961|P2|NOT COMPLETED|Overall Study||86
2262930|NCT02344628|5554962|P1|NOT COMPLETED|Overall Study||91
2262931|NCT02344628|5554961|P2|COMPLETED|Overall Study|4/52 clinical data was available for 286. Serological data 6/12 for 218. Both were available for 206|206
2262932|NCT02344628|5554962|P1|COMPLETED|Overall Study|4/52 clinical data was available for 283. Serological data 6/12 for 212. Both were available for 200|200
2262933|NCT02344628|5554961|P2|STARTED|Overall Study||292
2262934|NCT02344628|5554962|P1|STARTED|Overall Study||291
2262935|NCT02344407|5554975|P3|NOT COMPLETED|Overall Study||6
2262936|NCT02344407|5554976|P2|NOT COMPLETED|Overall Study||9
2262937|NCT02344407|5554977|P1|NOT COMPLETED|Overall Study||8
2262938|NCT02344407|5554975|P3|COMPLETED|Overall Study||494
2262939|NCT02344407|5554976|P2|COMPLETED|Overall Study||491
2262940|NCT02344407|5554977|P1|COMPLETED|Overall Study||492
2262941|NCT02344407|5554975|P3|STARTED|Overall Study||500
2262942|NCT02344407|5554976|P2|STARTED|Overall Study||500
2262943|NCT02344407|5554977|P1|STARTED|Overall Study||500
2262944|NCT02344342|5554992|P4|NOT COMPLETED|Overall Study||10
2262945|NCT02344342|5554993|P3|NOT COMPLETED|Overall Study||14
2262946|NCT02344342|5554994|P2|NOT COMPLETED|Overall Study||9
2262947|NCT02344342|5554995|P1|NOT COMPLETED|Overall Study||11
2262948|NCT02344342|5554992|P4|COMPLETED|Overall Study||3
2262949|NCT02344342|5554993|P3|COMPLETED|Overall Study||0
2262950|NCT02344342|5554994|P2|COMPLETED|Overall Study||2
2262951|NCT02344342|5554995|P1|COMPLETED|Overall Study||2
2262952|NCT02344342|5554992|P4|STARTED|Overall Study||13
2262953|NCT02344342|5554993|P3|STARTED|Overall Study||14
2262954|NCT02344342|5554994|P2|STARTED|Overall Study||11
2262955|NCT02344342|5554995|P1|STARTED|Overall Study||13
2262956|NCT02344251|5555019|P2|NOT COMPLETED|Overall Study||0
2262957|NCT02344251|5555020|P1|NOT COMPLETED|Overall Study||0
2262958|NCT02344251|5555019|P2|COMPLETED|Overall Study||20
2262959|NCT02344251|5555020|P1|COMPLETED|Overall Study||20
2262960|NCT02344251|5555019|P2|STARTED|Overall Study||20
2262961|NCT02344251|5555020|P1|STARTED|Overall Study||20
2262962|NCT02344238|5555031|P3|NOT COMPLETED|Overall Study||0
2262963|NCT02344238|5555032|P2|NOT COMPLETED|Overall Study||0
2262964|NCT02344238|5555033|P1|NOT COMPLETED|Overall Study||0
2262965|NCT02344238|5555031|P3|COMPLETED|Overall Study||20
2262966|NCT02344238|5555032|P2|COMPLETED|Overall Study||20
2262967|NCT02344238|5555033|P1|COMPLETED|Overall Study||20
2262968|NCT02344238|5555031|P3|STARTED|Overall Study||20
2262969|NCT02344238|5555032|P2|STARTED|Overall Study||20
2262970|NCT02344238|5555033|P1|STARTED|Overall Study||20
2262971|NCT02344173|5555042|P1|NOT COMPLETED|12-month Visit||96
2262972|NCT02344173|5555042|P1|COMPLETED|12-month Visit||1932
2262973|NCT02344173|5555042|P1|STARTED|12-month Visit||2028
2262974|NCT02344173|5555042|P1|NOT COMPLETED|Procedure||7
2262975|NCT02344173|5555042|P1|COMPLETED|Procedure||2028
2262976|NCT02344173|5555042|P1|STARTED|Procedure||2035
2262977|NCT02344173|5555042|P1|NOT COMPLETED|Enrollment||0
2262978|NCT02344173|5555042|P1|COMPLETED|Enrollment||2035
2262979|NCT02344173|5555042|P1|STARTED|Enrollment||2035
2262986|NCT02343939|5555078|P9|NOT COMPLETED|Overall Study||7
2262987|NCT02343939|5555079|P8|NOT COMPLETED|Overall Study||37
2262988|NCT02343939|5555080|P7|NOT COMPLETED|Overall Study||15
2262989|NCT02343939|5555081|P6|NOT COMPLETED|Overall Study||17
2262990|NCT02343939|5555082|P5|NOT COMPLETED|Overall Study||8
2262991|NCT02343939|5555083|P4|NOT COMPLETED|Overall Study||6
2262992|NCT02343939|5555084|P3|NOT COMPLETED|Overall Study||5
2262993|NCT02343939|5555085|P2|NOT COMPLETED|Overall Study||48
2262994|NCT02343939|5555086|P1|NOT COMPLETED|Overall Study||3
2262995|NCT02343939|5555078|P9|COMPLETED|Overall Study||0
2262996|NCT02343939|5555079|P8|COMPLETED|Overall Study||0
2262997|NCT02343939|5555080|P7|COMPLETED|Overall Study||0
2262998|NCT02343939|5555081|P6|COMPLETED|Overall Study||0
2262999|NCT02343939|5555082|P5|COMPLETED|Overall Study||0
2263000|NCT02343939|5555083|P4|COMPLETED|Overall Study||0
2263001|NCT02343939|5555084|P3|COMPLETED|Overall Study||0
2263002|NCT02343939|5555085|P2|COMPLETED|Overall Study||2
2263003|NCT02343939|5555086|P1|COMPLETED|Overall Study||0
2263004|NCT02343939|5555078|P9|STARTED|Overall Study||7
2263005|NCT02343939|5555079|P8|STARTED|Overall Study||37
2263006|NCT02343939|5555080|P7|STARTED|Overall Study||15
2263007|NCT02343939|5555081|P6|STARTED|Overall Study||17
2263008|NCT02343939|5555082|P5|STARTED|Overall Study||8
2263009|NCT02343939|5555083|P4|STARTED|Overall Study||6
2263010|NCT02343939|5555084|P3|STARTED|Overall Study||5
2263011|NCT02343939|5555085|P2|STARTED|Overall Study||50
2263012|NCT02343939|5555086|P1|STARTED|Overall Study||3
2263013|NCT02343627|5555198|P2|NOT COMPLETED|Overall Study||1
2263014|NCT02343627|5555199|P1|NOT COMPLETED|Overall Study||12
2263015|NCT02343627|5555198|P2|COMPLETED|Overall Study||11
2263016|NCT02343627|5555199|P1|COMPLETED|Overall Study||23
2263017|NCT02343627|5555198|P2|STARTED|Overall Study||12
2263018|NCT02343627|5555199|P1|STARTED|Overall Study||35
2263019|NCT02343575|5555207|P2|NOT COMPLETED|Overall Study||0
2263020|NCT02343575|5555208|P1|NOT COMPLETED|Overall Study||0
2263021|NCT02343575|5555207|P2|COMPLETED|Overall Study||2
2263022|NCT02343575|5555208|P1|COMPLETED|Overall Study||1
2263023|NCT02343575|5555207|P2|STARTED|Overall Study||2
2263024|NCT02343575|5555208|P1|STARTED|Overall Study||1
2263025|NCT02343458|5555228|P4|NOT COMPLETED|Overall Study||38
2263026|NCT02343458|5555229|P3|NOT COMPLETED|Overall Study||63
2263027|NCT02343458|5555230|P2|NOT COMPLETED|Overall Study||66
2263028|NCT02343458|5555231|P1|NOT COMPLETED|Overall Study||61
2263029|NCT02343458|5555228|P4|COMPLETED|Overall Study||200
2263030|NCT02343458|5555229|P3|COMPLETED|Overall Study||417
2263031|NCT02343458|5555230|P2|COMPLETED|Overall Study||417
2263032|NCT02343458|5555231|P1|COMPLETED|Overall Study||494
2263033|NCT02343458|5555228|P4|STARTED|Overall Study||238
2263034|NCT02343458|5555229|P3|STARTED|Overall Study||480
2263035|NCT02343458|5555230|P2|STARTED|Overall Study||483
2263036|NCT02343458|5555231|P1|STARTED|Overall Study||555
2263037|NCT02343380|5555307|P2|NOT COMPLETED|Overall Study||0
2263038|NCT02343380|5555308|P1|NOT COMPLETED|Overall Study||0
2263039|NCT02343380|5555307|P2|COMPLETED|Overall Study|Morning test (second week)|10
2263040|NCT02343380|5555308|P1|COMPLETED|Overall Study|Evening test (second week)|10
2263041|NCT02343380|5555307|P2|STARTED|Overall Study|Evening test (first week)|10
2263042|NCT02343380|5555308|P1|STARTED|Overall Study|Morning test (first week)|10
2263043|NCT02343276|5555326|P2|NOT COMPLETED|Overall Study||0
2263044|NCT02343276|5555327|P1|NOT COMPLETED|Overall Study||0
2263045|NCT02343276|5555326|P2|COMPLETED|Overall Study||164
2263046|NCT02343276|5555327|P1|COMPLETED|Overall Study||164
2263047|NCT02343276|5555326|P2|STARTED|Overall Study||164
2263048|NCT02343276|5555327|P1|STARTED|Overall Study||164
2263049|NCT02343263|5555340|P3|NOT COMPLETED|Overall Study||1
2263050|NCT02343263|5555341|P2|NOT COMPLETED|Overall Study||3
2263051|NCT02343263|5555342|P1|NOT COMPLETED|Overall Study||5
2263052|NCT02343263|5555340|P3|COMPLETED|Overall Study||0
2263053|NCT02343263|5555341|P2|COMPLETED|Overall Study||0
2263054|NCT02343263|5555342|P1|COMPLETED|Overall Study|Study closed due for administrative reasons|0
2263055|NCT02343263|5555340|P3|STARTED|Overall Study||1
2263056|NCT02343263|5555341|P2|STARTED|Overall Study||3
2263057|NCT02343263|5555342|P1|STARTED|Overall Study|Study closed due for administrative reasons|5
2263058|NCT02343159|5555371|P3|NOT COMPLETED|Overall Study||30
2263059|NCT02343159|5555372|P2|NOT COMPLETED|Overall Study||26
2263060|NCT02343159|5555373|P1|NOT COMPLETED|Overall Study||26
2263061|NCT02343159|5555371|P3|COMPLETED|Overall Study||0
2263062|NCT02343159|5555372|P2|COMPLETED|Overall Study||1
2263063|NCT02343159|5555373|P1|COMPLETED|Overall Study||1
2263064|NCT02343159|5555371|P3|STARTED|Overall Study||30
2263065|NCT02343159|5555372|P2|STARTED|Overall Study||27
2263066|NCT02343159|5555373|P1|STARTED|Overall Study||27
2263067|NCT02343081|5555400|P2|NOT COMPLETED|Second Intervention (Day 4)||0
2263068|NCT02343081|5555401|P1|NOT COMPLETED|Second Intervention (Day 4)||0
2263069|NCT02343081|5555400|P2|COMPLETED|Second Intervention (Day 4)||8
2263070|NCT02343081|5555401|P1|COMPLETED|Second Intervention (Day 4)||8
2263071|NCT02343081|5555400|P2|Received Intervention|Second Intervention (Day 4)||8
2263072|NCT02343081|5555401|P1|Received Intervention|Second Intervention (Day 4)||8
2263073|NCT02343081|5555400|P2|STARTED|Second Intervention (Day 4)||8
2263074|NCT02343081|5555401|P1|STARTED|Second Intervention (Day 4)||8
2263075|NCT02343081|5555400|P2|NOT COMPLETED|Washout (10 Hours)||0
2263076|NCT02343081|5555401|P1|NOT COMPLETED|Washout (10 Hours)||0
2263077|NCT02343081|5555400|P2|COMPLETED|Washout (10 Hours)||8
2263078|NCT02343081|5555401|P1|COMPLETED|Washout (10 Hours)||8
2263079|NCT02343081|5555400|P2|STARTED|Washout (10 Hours)||8
2263080|NCT02343081|5555401|P1|STARTED|Washout (10 Hours)||8
2263081|NCT02343081|5555400|P2|NOT COMPLETED|First Intervention (Day 3)||0
2263082|NCT02343081|5555401|P1|NOT COMPLETED|First Intervention (Day 3)||0
2263083|NCT02343081|5555400|P2|COMPLETED|First Intervention (Day 3)||8
2263084|NCT02343081|5555401|P1|COMPLETED|First Intervention (Day 3)||8
2263085|NCT02343081|5555400|P2|Received Intervention|First Intervention (Day 3)||8
2263086|NCT02343081|5555401|P1|Received Intervention|First Intervention (Day 3)||8
2263087|NCT02343081|5555400|P2|STARTED|First Intervention (Day 3)||8
2263088|NCT02343081|5555401|P1|STARTED|First Intervention (Day 3)||8
2263089|NCT02343003|5555417|P2|NOT COMPLETED|Overall Study||7
2263090|NCT02343003|5555418|P1|NOT COMPLETED|Overall Study||18
2263091|NCT02343003|5555417|P2|COMPLETED|Overall Study||68
2263092|NCT02343003|5555418|P1|COMPLETED|Overall Study||58
2263093|NCT02343003|5555417|P2|STARTED|Overall Study||75
2263094|NCT02343003|5555418|P1|STARTED|Overall Study||76
2263095|NCT02342886|5555439|P5|NOT COMPLETED|Overall Study||3
2263096|NCT02342886|5555440|P4|NOT COMPLETED|Overall Study||9
2263097|NCT02342886|5555441|P3|NOT COMPLETED|Overall Study||15
2263098|NCT02342886|5555442|P2|NOT COMPLETED|Overall Study||8
2263099|NCT02342886|5555443|P1|NOT COMPLETED|Overall Study||8
2263100|NCT02342886|5555439|P5|COMPLETED|Overall Study||10
2263101|NCT02342886|5555440|P4|COMPLETED|Overall Study||59
2263102|NCT02342886|5555441|P3|COMPLETED|Overall Study||52
2263103|NCT02342886|5555442|P2|COMPLETED|Overall Study||63
2263104|NCT02342886|5555443|P1|COMPLETED|Overall Study||57
2263105|NCT02342886|5555439|P5|Completed Month 24 Follow-Up|Overall Study||10
2263106|NCT02342886|5555440|P4|Completed Month 24 Follow-Up|Overall Study||53
2263107|NCT02342886|5555441|P3|Completed Month 24 Follow-Up|Overall Study||46
2263108|NCT02342886|5555442|P2|Completed Month 24 Follow-Up|Overall Study||47
2263109|NCT02342886|5555443|P1|Completed Month 24 Follow-Up|Overall Study||40
2263110|NCT02342886|5555439|P5|Completed Month 12 Follow-Up|Overall Study||10
2263111|NCT02342886|5555440|P4|Completed Month 12 Follow-Up|Overall Study||57
2263112|NCT02342886|5555441|P3|Completed Month 12 Follow-Up|Overall Study||49
2263113|NCT02342886|5555442|P2|Completed Month 12 Follow-Up|Overall Study||52
2263114|NCT02342886|5555443|P1|Completed Month 12 Follow-Up|Overall Study||43
2263115|NCT02342886|5555439|P5|STARTED|Overall Study||13
2263116|NCT02342886|5555440|P4|STARTED|Overall Study||68
2263117|NCT02342886|5555441|P3|STARTED|Overall Study||67
2263118|NCT02342886|5555442|P2|STARTED|Overall Study||71
2263119|NCT02342886|5555443|P1|STARTED|Overall Study||65
2263120|NCT02342743|5555460|P1|NOT COMPLETED|Treatment Period||11
2263121|NCT02342743|5555460|P1|COMPLETED|Treatment Period||47
2263122|NCT02342743|5555460|P1|STARTED|Treatment Period|7 patients didn't meet inclusion criteria for treatment period, evaluated at the end of the baseline|58
2263123|NCT02342743|5555460|P1|NOT COMPLETED|Baseline Period||15
2263124|NCT02342743|5555460|P1|COMPLETED|Baseline Period||58
2263125|NCT02342743|5555460|P1|STARTED|Baseline Period||73
2263126|NCT02342704|5555473|P2|NOT COMPLETED|Overall Study||51
2263127|NCT02342704|5555474|P1|NOT COMPLETED|Overall Study||53
2263128|NCT02342704|5555473|P2|COMPLETED|Overall Study||3
2263129|NCT02342704|5555474|P1|COMPLETED|Overall Study||1
2263130|NCT02342704|5555473|P2|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
2263131|NCT02342704|5555474|P1|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
2263132|NCT02342678|5555502|P2|NOT COMPLETED|Overall Study||5
2263133|NCT02342678|5555503|P1|NOT COMPLETED|Overall Study||1
2263134|NCT02342678|5555502|P2|COMPLETED|Overall Study||23
2263135|NCT02342678|5555503|P1|COMPLETED|Overall Study||27
2263136|NCT02342678|5555502|P2|STARTED|Overall Study||28
2263137|NCT02342678|5555503|P1|STARTED|Overall Study||28
2263138|NCT02342561|5555523|P1|NOT COMPLETED|Overall Study||0
2263139|NCT02342561|5555523|P1|COMPLETED|Overall Study||20
2263140|NCT02342561|5555523|P1|STARTED|Overall Study||20
2263141|NCT02342548|5555534|P3|NOT COMPLETED|Overall Study||43
2263142|NCT02342548|5555535|P2|NOT COMPLETED|Overall Study||62
2263143|NCT02342548|5555536|P1|NOT COMPLETED|Overall Study||34
2263144|NCT02342548|5555534|P3|COMPLETED|Overall Study||23
2263145|NCT02342548|5555535|P2|COMPLETED|Overall Study||9
2263146|NCT02342548|5555536|P1|COMPLETED|Overall Study||17
2263147|NCT02342548|5555534|P3|STARTED|Overall Study||66
2263148|NCT02342548|5555535|P2|STARTED|Overall Study||71
2263149|NCT02342548|5555536|P1|STARTED|Overall Study||51
2263150|NCT02342535|5555574|P1|NOT COMPLETED|Overall Study||0
2263151|NCT02342535|5555574|P1|COMPLETED|Overall Study|30 women in aerobic class and 38 kids in kids exercise class|68
2263152|NCT02342535|5555574|P1|STARTED|Overall Study|30 women who participated in the aerobic exercise class and 38 children.|68
2263153|NCT02342418|5555580|P2|NOT COMPLETED|Overall Study||1
2263154|NCT02342418|5555581|P1|NOT COMPLETED|Overall Study||0
2263155|NCT02342418|5555580|P2|COMPLETED|Overall Study||9
2263156|NCT02342418|5555581|P1|COMPLETED|Overall Study||9
2263157|NCT02342418|5555580|P2|STARTED|Overall Study||10
2263158|NCT02342418|5555581|P1|STARTED|Overall Study||9
2263159|NCT02342314|5555591|P17|NOT COMPLETED|Part B||0
2263160|NCT02342314|5555592|P16|NOT COMPLETED|Part B||0
2263161|NCT02342314|5555593|P15|NOT COMPLETED|Part B||0
2263162|NCT02342314|5555594|P14|NOT COMPLETED|Part B||0
2263163|NCT02342314|5555595|P13|NOT COMPLETED|Part B||0
2263164|NCT02342314|5555596|P12|NOT COMPLETED|Part B||0
2263165|NCT02342314|5555597|P11|NOT COMPLETED|Part B||0
2263166|NCT02342314|5555598|P10|NOT COMPLETED|Part B||0
2263167|NCT02342314|5555599|P9|NOT COMPLETED|Part B||0
2263168|NCT02342314|5555600|P8|NOT COMPLETED|Part B||0
2263169|NCT02342314|5555601|P7|NOT COMPLETED|Part B||0
2263170|NCT02342314|5555602|P6|NOT COMPLETED|Part B||0
2263171|NCT02342314|5555603|P5|NOT COMPLETED|Part B||0
2263172|NCT02342314|5555604|P4|NOT COMPLETED|Part B||0
2263173|NCT02342314|5555605|P3|NOT COMPLETED|Part B||0
2263174|NCT02342314|5555606|P2|NOT COMPLETED|Part B||0
2263175|NCT02342314|5555607|P1|NOT COMPLETED|Part B||0
2263176|NCT02342314|5555591|P17|COMPLETED|Part B||6
2263177|NCT02342314|5555592|P16|COMPLETED|Part B||3
2263178|NCT02342314|5555593|P15|COMPLETED|Part B||3
2263179|NCT02342314|5555594|P14|COMPLETED|Part B||3
2263180|NCT02342314|5555595|P13|COMPLETED|Part B||3
2263181|NCT02342314|5555596|P12|COMPLETED|Part B||3
2263182|NCT02342314|5555597|P11|COMPLETED|Part B||3
2263183|NCT02342314|5555598|P10|COMPLETED|Part B||3
2263184|NCT02342314|5555599|P9|COMPLETED|Part B||3
2263185|NCT02342314|5555600|P8|COMPLETED|Part B||3
2263186|NCT02342314|5555601|P7|COMPLETED|Part B||11
2263187|NCT02342314|5555602|P6|COMPLETED|Part B||0
2263188|NCT02342314|5555603|P5|COMPLETED|Part B||0
2263189|NCT02342314|5555604|P4|COMPLETED|Part B||0
2263190|NCT02342314|5555605|P3|COMPLETED|Part B||0
2263191|NCT02342314|5555606|P2|COMPLETED|Part B||0
2263192|NCT02342314|5555607|P1|COMPLETED|Part B||0
2263193|NCT02342314|5555591|P17|STARTED|Part B|Participants received rGlucagon in Part B.|6
2263194|NCT02342314|5555592|P16|STARTED|Part B|Participants received LY3185643 in Part B.|3
2263195|NCT02342314|5555593|P15|STARTED|Part B|Participants received LY3185643 in Part B.|3
2263196|NCT02342314|5555594|P14|STARTED|Part B|Participants received LY3185643 in Part B.|3
2263197|NCT02342314|5555595|P13|STARTED|Part B|Participants received LY3185643 in Part B.|3
2263198|NCT02342314|5555596|P12|STARTED|Part B|Participants received LY3185643 in Part B.|3
2263199|NCT02342314|5555597|P11|STARTED|Part B|Participants received LY3185643 in Part B.|3
2263200|NCT02342314|5555598|P10|STARTED|Part B|Participants received LY3185643 in Part B.|3
2263201|NCT02342314|5555599|P9|STARTED|Part B|Participants received LY3185643 in Part B.|3
2263202|NCT02342314|5555600|P8|STARTED|Part B|Participants received LY3185643 in Part B.|3
2263203|NCT02342314|5555601|P7|STARTED|Part B|Participants received placebo in Part B.|11
2263204|NCT02342314|5555602|P6|STARTED|Part B|Participants received LY3143753 in Part A.|0
2263205|NCT02342314|5555603|P5|STARTED|Part B|Participants received LY3143753 in Part A.|0
2263206|NCT02342314|5555604|P4|STARTED|Part B|Participants received LY3143753 in Part A.|0
2263207|NCT02342314|5555605|P3|STARTED|Part B|Participants received LY3143753 in Part A.|0
2263208|NCT02342314|5555606|P2|STARTED|Part B|Participants received LY3143753 in Part A.|0
2263209|NCT02342314|5555607|P1|STARTED|Part B|Participants received placebo in Part A.|0
2263210|NCT02342314|5555591|P17|NOT COMPLETED|Part A||0
2263211|NCT02342314|5555592|P16|NOT COMPLETED|Part A||0
2263212|NCT02342314|5555593|P15|NOT COMPLETED|Part A||0
2263213|NCT02342314|5555594|P14|NOT COMPLETED|Part A||0
2263214|NCT02342314|5555595|P13|NOT COMPLETED|Part A||0
2263215|NCT02342314|5555596|P12|NOT COMPLETED|Part A||0
2263216|NCT02342314|5555597|P11|NOT COMPLETED|Part A||0
2263217|NCT02342314|5555598|P10|NOT COMPLETED|Part A||0
2263218|NCT02342314|5555599|P9|NOT COMPLETED|Part A||0
2263219|NCT02342314|5555600|P8|NOT COMPLETED|Part A||0
2263220|NCT02342314|5555601|P7|NOT COMPLETED|Part A||0
2263221|NCT02342314|5555602|P6|NOT COMPLETED|Part A||0
2263222|NCT02342314|5555603|P5|NOT COMPLETED|Part A||0
2263223|NCT02342314|5555604|P4|NOT COMPLETED|Part A||0
2263224|NCT02342314|5555605|P3|NOT COMPLETED|Part A||0
2263225|NCT02342314|5555606|P2|NOT COMPLETED|Part A||0
2263226|NCT02342314|5555607|P1|NOT COMPLETED|Part A||0
2263227|NCT02342314|5555591|P17|COMPLETED|Part A||0
2263228|NCT02342314|5555592|P16|COMPLETED|Part A||0
2263229|NCT02342314|5555593|P15|COMPLETED|Part A||0
2263230|NCT02342314|5555594|P14|COMPLETED|Part A||0
2263231|NCT02342314|5555595|P13|COMPLETED|Part A||0
2263232|NCT02342314|5555596|P12|COMPLETED|Part A||0
2263233|NCT02342314|5555597|P11|COMPLETED|Part A||0
2263234|NCT02342314|5555598|P10|COMPLETED|Part A||0
2263235|NCT02342314|5555599|P9|COMPLETED|Part A||0
2263236|NCT02342314|5555600|P8|COMPLETED|Part A||0
2263237|NCT02342314|5555601|P7|COMPLETED|Part A||0
2263238|NCT02342314|5555602|P6|COMPLETED|Part A||3
2263239|NCT02342314|5555603|P5|COMPLETED|Part A||6
2263240|NCT02342314|5555604|P4|COMPLETED|Part A||3
2263241|NCT02342314|5555605|P3|COMPLETED|Part A||3
2263242|NCT02342314|5555606|P2|COMPLETED|Part A||3
2263243|NCT02342314|5555607|P1|COMPLETED|Part A||6
2263244|NCT02342314|5555591|P17|STARTED|Part A||0
2263245|NCT02342314|5555592|P16|STARTED|Part A||0
2263246|NCT02342314|5555593|P15|STARTED|Part A||0
2263247|NCT02342314|5555594|P14|STARTED|Part A||0
2263248|NCT02342314|5555595|P13|STARTED|Part A||0
2263249|NCT02342314|5555596|P12|STARTED|Part A||0
2263250|NCT02342314|5555597|P11|STARTED|Part A||0
2263251|NCT02342314|5555598|P10|STARTED|Part A||0
2263252|NCT02342314|5555599|P9|STARTED|Part A||0
2263253|NCT02342314|5555600|P8|STARTED|Part A||0
2263254|NCT02342314|5555601|P7|STARTED|Part A||0
2263255|NCT02342314|5555602|P6|STARTED|Part A||3
2263256|NCT02342314|5555603|P5|STARTED|Part A||6
2263257|NCT02342314|5555604|P4|STARTED|Part A||3
2263258|NCT02342314|5555605|P3|STARTED|Part A||3
2263259|NCT02342314|5555606|P2|STARTED|Part A||3
2263260|NCT02342314|5555607|P1|STARTED|Part A||6
2263261|NCT02342288|5555755|P2|NOT COMPLETED|Overall Study||6
2263262|NCT02342288|5555756|P1|NOT COMPLETED|Overall Study||5
2263263|NCT02342288|5555755|P2|COMPLETED|Overall Study||27
2263264|NCT02342288|5555756|P1|COMPLETED|Overall Study||25
2263265|NCT02342288|5555755|P2|STARTED|Overall Study|various issues listed below caused removal of subjects|33
2263266|NCT02342288|5555756|P1|STARTED|Overall Study|16 patients were not randomized to either arm.|30
2263267|NCT02342223|5555762|P1|NOT COMPLETED|Overall Study||1
2263268|NCT02342223|5555762|P1|COMPLETED|Overall Study||19
2263269|NCT02342223|5555762|P1|STARTED|Overall Study||20
2263270|NCT02342197|5555773|P2|NOT COMPLETED|Overall Study||2
2263271|NCT02342197|5555774|P1|NOT COMPLETED|Overall Study||3
2263272|NCT02342197|5555773|P2|COMPLETED|Overall Study||28
2263273|NCT02342197|5555774|P1|COMPLETED|Overall Study||27
2263274|NCT02342197|5555773|P2|STARTED|Overall Study||30
2263275|NCT02342197|5555774|P1|STARTED|Overall Study||30
2263276|NCT02342171|5555782|P2|NOT COMPLETED|Overall Study||89
2263277|NCT02342171|5555783|P1|NOT COMPLETED|Overall Study||15
2263278|NCT02342171|5555782|P2|COMPLETED|Overall Study||418
2263279|NCT02342171|5555783|P1|COMPLETED|Overall Study||84
2263280|NCT02342171|5555782|P2|STARTED|Overall Study||507
2263281|NCT02342171|5555783|P1|STARTED|Overall Study||99
2263282|NCT02341859|5555799|P2|NOT COMPLETED|Second Intervention (1 Day)||0
2263283|NCT02341859|5555800|P1|NOT COMPLETED|Second Intervention (1 Day)||0
2263284|NCT02341859|5555799|P2|COMPLETED|Second Intervention (1 Day)||9
2263285|NCT02341859|5555800|P1|COMPLETED|Second Intervention (1 Day)||10
2263286|NCT02341859|5555799|P2|STARTED|Second Intervention (1 Day)||9
2263287|NCT02341859|5555800|P1|STARTED|Second Intervention (1 Day)||10
2263288|NCT02341859|5555799|P2|NOT COMPLETED|First Intervention (1 Day)||0
2263289|NCT02341859|5555800|P1|NOT COMPLETED|First Intervention (1 Day)||0
2263290|NCT02341859|5555799|P2|COMPLETED|First Intervention (1 Day)||9
2263291|NCT02341859|5555800|P1|COMPLETED|First Intervention (1 Day)||10
2263292|NCT02341859|5555799|P2|STARTED|First Intervention (1 Day)||9
2263293|NCT02341859|5555800|P1|STARTED|First Intervention (1 Day)||10
2263294|NCT02341599|5555958|P5|NOT COMPLETED|Overall Study||0
2263295|NCT02341599|5555959|P4|NOT COMPLETED|Overall Study||0
2263296|NCT02341599|5555960|P3|NOT COMPLETED|Overall Study||0
2263297|NCT02341599|5555961|P2|NOT COMPLETED|Overall Study||0
2263298|NCT02341599|5555962|P1|NOT COMPLETED|Overall Study||0
2263299|NCT02341599|5555958|P5|COMPLETED|Overall Study||8
2263300|NCT02341599|5555959|P4|COMPLETED|Overall Study||8
2263301|NCT02341599|5555960|P3|COMPLETED|Overall Study||8
2263302|NCT02341599|5555961|P2|COMPLETED|Overall Study||8
2263303|NCT02341599|5555962|P1|COMPLETED|Overall Study||8
2263304|NCT02341599|5555958|P5|STARTED|Overall Study||8
2263305|NCT02341599|5555959|P4|STARTED|Overall Study||8
2263306|NCT02341599|5555960|P3|STARTED|Overall Study||8
2263307|NCT02341599|5555961|P2|STARTED|Overall Study||8
2263308|NCT02341599|5555962|P1|STARTED|Overall Study||8
2263309|NCT02341482|5556030|P1|NOT COMPLETED|Overall Study||1
2263310|NCT02341482|5556030|P1|COMPLETED|Overall Study||12
2263311|NCT02341482|5556030|P1|STARTED|Overall Study||13
2263312|NCT02341456|5556059|P3|NOT COMPLETED|Overall Study||4
2263313|NCT02341456|5556060|P2|NOT COMPLETED|Overall Study||6
2263314|NCT02341456|5556061|P1|NOT COMPLETED|Overall Study||4
2263315|NCT02341456|5556059|P3|COMPLETED|Overall Study||2
2263316|NCT02341456|5556060|P2|COMPLETED|Overall Study||0
2263317|NCT02341456|5556061|P1|COMPLETED|Overall Study||3
2263318|NCT02341456|5556059|P3|STARTED|Overall Study||6
2263319|NCT02341456|5556060|P2|STARTED|Overall Study||6
2263320|NCT02341456|5556061|P1|STARTED|Overall Study||7
2263321|NCT02341417|5556186|P3|NOT COMPLETED|Overall Study||1
2263322|NCT02341417|5556187|P2|NOT COMPLETED|Overall Study||2
2263323|NCT02341417|5556188|P1|NOT COMPLETED|Overall Study||2
2263324|NCT02341417|5556186|P3|COMPLETED|Overall Study||0
2263325|NCT02341417|5556187|P2|COMPLETED|Overall Study||12
2263326|NCT02341417|5556188|P1|COMPLETED|Overall Study||11
2263327|NCT02341417|5556186|P3|STARTED|Overall Study||1
2263328|NCT02341417|5556187|P2|STARTED|Overall Study||14
2263329|NCT02341417|5556188|P1|STARTED|Overall Study||13
2263330|NCT02341144|5556232|P2|NOT COMPLETED|Overall Study||1
2263331|NCT02341144|5556233|P1|NOT COMPLETED|Overall Study||2
2263332|NCT02341144|5556232|P2|COMPLETED|Overall Study||30
2263333|NCT02341144|5556233|P1|COMPLETED|Overall Study||28
2263334|NCT02341144|5556232|P2|STARTED|Overall Study||31
2263335|NCT02341144|5556233|P1|STARTED|Overall Study||30
2263336|NCT02340962|5556249|P2|NOT COMPLETED|Overall Study||0
2263337|NCT02340962|5556250|P1|NOT COMPLETED|Overall Study||1
2263338|NCT02340962|5556249|P2|COMPLETED|Overall Study||12
2263339|NCT02340962|5556250|P1|COMPLETED|Overall Study||12
2263340|NCT02340962|5556249|P2|STARTED|Overall Study||12
2263341|NCT02340962|5556250|P1|STARTED|Overall Study||13
2263342|NCT02340819|5556270|P1|NOT COMPLETED|Overall Study||4
2263343|NCT02340819|5556270|P1|COMPLETED|Overall Study||7
2263344|NCT02340819|5556270|P1|Completed Stage 4|Overall Study||7
2263345|NCT02340819|5556270|P1|Started Stage 4|Overall Study||7
2263346|NCT02340819|5556270|P1|Completed Stage 3|Overall Study||7
2263347|NCT02340819|5556270|P1|Started Stage 3|Overall Study||8
2263348|NCT02340819|5556270|P1|Completed Stage 2|Overall Study||9
2263349|NCT02340819|5556270|P1|Started Stage 2|Overall Study||11
2263350|NCT02340819|5556270|P1|STARTED|Overall Study||11
2263351|NCT02340806|5556299|P2|NOT COMPLETED|Overall Study||4
2263352|NCT02340806|5556300|P1|NOT COMPLETED|Overall Study||6
2263353|NCT02340806|5556299|P2|COMPLETED|Overall Study||108
2263354|NCT02340806|5556300|P1|COMPLETED|Overall Study||102
2263355|NCT02340806|5556299|P2|STARTED|Overall Study||112
2263356|NCT02340806|5556300|P1|STARTED|Overall Study||108
2263357|NCT02340780|5556326|P1|NOT COMPLETED|Overall Study||1
2263358|NCT02340780|5556326|P1|COMPLETED|Overall Study||13
2263359|NCT02340780|5556326|P1|STARTED|Overall Study|A total of 14 patients enrolled, one patient was found ineligible after the enrollment.|14
2263360|NCT02340767|5556340|P9|NOT COMPLETED|Overall Study||0
2263361|NCT02340767|5556341|P8|NOT COMPLETED|Overall Study||0
2263362|NCT02340767|5556342|P7|NOT COMPLETED|Overall Study||0
2263363|NCT02340767|5556343|P6|NOT COMPLETED|Overall Study||0
2263364|NCT02340767|5556344|P5|NOT COMPLETED|Overall Study||0
2263365|NCT02340767|5556345|P4|NOT COMPLETED|Overall Study||0
2263366|NCT02340767|5556346|P3|NOT COMPLETED|Overall Study||0
2263367|NCT02340767|5556347|P2|NOT COMPLETED|Overall Study||0
2263368|NCT02340767|5556348|P1|NOT COMPLETED|Overall Study||0
2263369|NCT02340767|5556340|P9|COMPLETED|Overall Study||531
2263370|NCT02340767|5556341|P8|COMPLETED|Overall Study||444
2263371|NCT02340767|5556342|P7|COMPLETED|Overall Study||525
2263372|NCT02340767|5556343|P6|COMPLETED|Overall Study||526
2263373|NCT02340767|5556344|P5|COMPLETED|Overall Study||474
2263374|NCT02340767|5556345|P4|COMPLETED|Overall Study||500
2263375|NCT02340767|5556346|P3|COMPLETED|Overall Study||29
2263376|NCT02340767|5556347|P2|COMPLETED|Overall Study||28
2263377|NCT02340767|5556348|P1|COMPLETED|Overall Study||28
2263378|NCT02340767|5556340|P9|STARTED|Overall Study||531
2263379|NCT02340767|5556341|P8|STARTED|Overall Study||444
2263380|NCT02340767|5556342|P7|STARTED|Overall Study||525
2263381|NCT02340767|5556343|P6|STARTED|Overall Study||526
2263382|NCT02340767|5556344|P5|STARTED|Overall Study||474
2263383|NCT02340767|5556345|P4|STARTED|Overall Study||500
2263384|NCT02340767|5556346|P3|STARTED|Overall Study||29
2263385|NCT02340767|5556347|P2|STARTED|Overall Study||28
2263386|NCT02340767|5556348|P1|STARTED|Overall Study||28
2263387|NCT02340715|5556364|P1|NOT COMPLETED|Overall Study||0
2263388|NCT02340715|5556364|P1|COMPLETED|Overall Study|158|158
2263389|NCT02340715|5556364|P1|STARTED|Overall Study|158|158
2263390|NCT02340676|5556368|P1|NOT COMPLETED|Overall Study||0
2263391|NCT02340676|5556368|P1|COMPLETED|Overall Study||25
2263392|NCT02340676|5556368|P1|STARTED|Overall Study||25
2263393|NCT02340663|5556381|P2|NOT COMPLETED|Overall Study||1
2263394|NCT02340663|5556382|P1|NOT COMPLETED|Overall Study||5
2263395|NCT02340663|5556381|P2|COMPLETED|Overall Study||31
2263396|NCT02340663|5556382|P1|COMPLETED|Overall Study||30
2263397|NCT02340663|5556381|P2|4 Month Follow-up, Assessments|Overall Study||31
2263398|NCT02340663|5556382|P1|4 Month Follow-up, Assessments|Overall Study||30
2263399|NCT02340663|5556381|P2|1 Week Follow-up, Assessments|Overall Study||31
2263400|NCT02340663|5556382|P1|1 Week Follow-up, Assessments|Overall Study||33
2263401|NCT02340663|5556381|P2|Splint Delivery, Assessments|Overall Study||31
2263402|NCT02340663|5556382|P1|Splint Delivery, Assessments|Overall Study||33
2263403|NCT02340663|5556381|P2|Clinical Exam, Impressions|Overall Study||32
2263404|NCT02340663|5556382|P1|Clinical Exam, Impressions|Overall Study||35
2263405|NCT02340663|5556381|P2|STARTED|Overall Study||32
2263406|NCT02340663|5556382|P1|STARTED|Overall Study||35
2263407|NCT02340520|5556438|P1|NOT COMPLETED|Overall Study||3
2263408|NCT02340520|5556438|P1|COMPLETED|Overall Study||8
2263409|NCT02340520|5556438|P1|STARTED|Overall Study||11
2263410|NCT02340338|5556450|P7|NOT COMPLETED|Overall Study||0
2263411|NCT02340338|5556451|P6|NOT COMPLETED|Overall Study||0
2263412|NCT02340338|5556452|P5|NOT COMPLETED|Overall Study||0
2263413|NCT02340338|5556453|P4|NOT COMPLETED|Overall Study||0
2263414|NCT02340338|5556454|P3|NOT COMPLETED|Overall Study||0
2263415|NCT02340338|5556455|P2|NOT COMPLETED|Overall Study||0
2263416|NCT02340338|5556456|P1|NOT COMPLETED|Overall Study||0
2263417|NCT02340338|5556450|P7|COMPLETED|Overall Study||12
2263418|NCT02340338|5556451|P6|COMPLETED|Overall Study|1 withdrew voluntarily after the first immunization; safety and serum assessment completed.|9
2263419|NCT02340338|5556452|P5|COMPLETED|Overall Study||9
2263420|NCT02340338|5556453|P4|COMPLETED|Overall Study||9
2263421|NCT02340338|5556454|P3|COMPLETED|Overall Study||3
2263422|NCT02340338|5556455|P2|COMPLETED|Overall Study||2
2263423|NCT02340338|5556456|P1|COMPLETED|Overall Study||2
2263424|NCT02340338|5556450|P7|STARTED|Overall Study|Placebos were randomly assigned to dose groups 1-6, included in the 46 participants.|12
2263425|NCT02340338|5556451|P6|STARTED|Overall Study|9 vaccine + 3 placebo|9
2263426|NCT02340338|5556452|P5|STARTED|Overall Study|9 vaccine + 3 placebo|9
2263427|NCT02340338|5556453|P4|STARTED|Overall Study|9 vaccine + 3 placebo|9
2263428|NCT02340338|5556454|P3|STARTED|Overall Study|3 vaccine + 1 placebo|3
2263429|NCT02340338|5556455|P2|STARTED|Overall Study|2 vaccine + 1 placebo|2
2263430|NCT02340338|5556456|P1|STARTED|Overall Study|2 vaccine + 1 placebo|2
2263431|NCT02340221|5556481|P2|NOT COMPLETED|Overall Study||417
2263432|NCT02340221|5556482|P1|NOT COMPLETED|Overall Study||214
2263433|NCT02340221|5556481|P2|COMPLETED|Overall Study||0
2263434|NCT02340221|5556482|P1|COMPLETED|Overall Study||0
2263435|NCT02340221|5556481|P2|STARTED|Overall Study||417
2263436|NCT02340221|5556482|P1|STARTED|Overall Study||214
2263437|NCT02340104|5556506|P1|NOT COMPLETED|Overall Study||0
2263438|NCT02340104|5556506|P1|COMPLETED|Overall Study||8
2263439|NCT02340104|5556506|P1|STARTED|Overall Study||8
2263440|NCT02340091|5556511|P1|NOT COMPLETED|Overall Study||2
2263441|NCT02340091|5556511|P1|COMPLETED|Overall Study||60
2263442|NCT02340091|5556511|P1|STARTED|Overall Study|All Study Participants|62
2263443|NCT02340078|5556516|P1|NOT COMPLETED|Overall Study||1
2263444|NCT02340078|5556516|P1|COMPLETED|Overall Study||61
2263445|NCT02340078|5556516|P1|STARTED|Overall Study||62
2263446|NCT02340000|5556523|P2|NOT COMPLETED|Time Period 2||15
2263447|NCT02340000|5556524|P1|NOT COMPLETED|Time Period 2||19
2263448|NCT02340000|5556523|P2|COMPLETED|Time Period 2||52
2263449|NCT02340000|5556524|P1|COMPLETED|Time Period 2||50
2263450|NCT02340000|5556523|P2|STARTED|Time Period 2||67
2263451|NCT02340000|5556524|P1|STARTED|Time Period 2||69
2263452|NCT02340000|5556523|P2|NOT COMPLETED|Time Period 1||15
2263453|NCT02340000|5556524|P1|NOT COMPLETED|Time Period 1||12
2263454|NCT02340000|5556523|P2|COMPLETED|Time Period 1||74
2263455|NCT02340000|5556524|P1|COMPLETED|Time Period 1||78
2263456|NCT02340000|5556523|P2|STARTED|Time Period 1||89
2263457|NCT02340000|5556524|P1|STARTED|Time Period 1||90
2263458|NCT02339909|5556554|P3|NOT COMPLETED|Overall Study||71
2263459|NCT02339909|5556555|P2|NOT COMPLETED|Overall Study||63
2263460|NCT02339909|5556556|P1|NOT COMPLETED|Overall Study||89
2263461|NCT02339909|5556554|P3|COMPLETED|Overall Study||304
2263462|NCT02339909|5556555|P2|COMPLETED|Overall Study||312
2263463|NCT02339909|5556556|P1|COMPLETED|Overall Study||435
2263464|NCT02339909|5556554|P3|STARTED|Overall Study||375
2263465|NCT02339909|5556555|P2|STARTED|Overall Study||375
2263466|NCT02339909|5556556|P1|STARTED|Overall Study||524
2263467|NCT02339831|5556569|P2|NOT COMPLETED|Overall Study||7
2263468|NCT02339831|5556570|P1|NOT COMPLETED|Overall Study||20
2263469|NCT02339831|5556569|P2|COMPLETED|Overall Study||45
2263470|NCT02339831|5556570|P1|COMPLETED|Overall Study||38
2263471|NCT02339831|5556569|P2|Lost to Follow Up|Overall Study||7
2263472|NCT02339831|5556570|P1|Lost to Follow Up|Overall Study||20
2263473|NCT02339831|5556569|P2|STARTED|Overall Study||52
2263474|NCT02339831|5556570|P1|STARTED|Overall Study||58
2263475|NCT02339584|5556594|P2|NOT COMPLETED|Overall Study||15
2263476|NCT02339584|5556595|P1|NOT COMPLETED|Overall Study||15
2263477|NCT02339584|5556594|P2|COMPLETED|Overall Study||176
2263478|NCT02339584|5556595|P1|COMPLETED|Overall Study||173
2263479|NCT02339584|5556594|P2|STARTED|Overall Study||191
2263480|NCT02339584|5556595|P1|STARTED|Overall Study||188
2263481|NCT02339558|5556601|P1|NOT COMPLETED|Overall Study||0
2263482|NCT02339558|5556601|P1|COMPLETED|Overall Study||45
2263483|NCT02339558|5556601|P1|STARTED|Overall Study||45
2263484|NCT02339545|5556610|P1|NOT COMPLETED|Overall Study||0
2263485|NCT02339545|5556610|P1|COMPLETED|Overall Study||15
2263486|NCT02339545|5556610|P1|STARTED|Overall Study||15
2263487|NCT02339506|5556615|P2|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0
2263488|NCT02339506|5556616|P1|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0
2263489|NCT02339506|5556615|P2|COMPLETED|Period 3 (Placebo or Cosyntropin)||10
2263490|NCT02339506|5556616|P1|COMPLETED|Period 3 (Placebo or Cosyntropin)||10
2263491|NCT02339506|5556615|P2|STARTED|Period 3 (Placebo or Cosyntropin)||10
2263492|NCT02339506|5556616|P1|STARTED|Period 3 (Placebo or Cosyntropin)||10
2263493|NCT02339506|5556615|P2|NOT COMPLETED|Washout (Period 2)||0
2263494|NCT02339506|5556616|P1|NOT COMPLETED|Washout (Period 2)||2
2263495|NCT02339506|5556615|P2|COMPLETED|Washout (Period 2)||10
2263496|NCT02339506|5556616|P1|COMPLETED|Washout (Period 2)||10
2263497|NCT02339506|5556615|P2|STARTED|Washout (Period 2)||10
2263498|NCT02339506|5556616|P1|STARTED|Washout (Period 2)||12
2263499|NCT02339506|5556615|P2|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||1
2263500|NCT02339506|5556616|P1|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||0
2263501|NCT02339506|5556615|P2|COMPLETED|Period 1 (Placebo or Cosyntropin)||10
2263502|NCT02339506|5556616|P1|COMPLETED|Period 1 (Placebo or Cosyntropin)||12
2263503|NCT02339506|5556615|P2|STARTED|Period 1 (Placebo or Cosyntropin)||11
2263504|NCT02339506|5556616|P1|STARTED|Period 1 (Placebo or Cosyntropin)||12
2263505|NCT02339415|5556624|P2|NOT COMPLETED|Second Period||2
2263506|NCT02339415|5556625|P1|NOT COMPLETED|Second Period||1
2263507|NCT02339415|5556624|P2|COMPLETED|Second Period||18
2263508|NCT02339415|5556625|P1|COMPLETED|Second Period||19
2263509|NCT02339415|5556624|P2|STARTED|Second Period||20
2263510|NCT02339415|5556625|P1|STARTED|Second Period||20
2263511|NCT02339415|5556624|P2|NOT COMPLETED|Washout||0
2263512|NCT02339415|5556625|P1|NOT COMPLETED|Washout||0
2263513|NCT02339415|5556624|P2|COMPLETED|Washout||20
2263514|NCT02339415|5556625|P1|COMPLETED|Washout||20
2263515|NCT02339415|5556624|P2|STARTED|Washout||20
2263516|NCT02339415|5556625|P1|STARTED|Washout||20
2263517|NCT02339415|5556624|P2|NOT COMPLETED|First Period||2
2263518|NCT02339415|5556625|P1|NOT COMPLETED|First Period||2
2263519|NCT02339415|5556624|P2|COMPLETED|First Period||20
2263520|NCT02339415|5556625|P1|COMPLETED|First Period||20
2263521|NCT02339415|5556624|P2|Received at Least One Dose|First Period||20
2263522|NCT02339415|5556625|P1|Received at Least One Dose|First Period||21
2263523|NCT02339415|5556624|P2|STARTED|First Period||22
2263524|NCT02339415|5556625|P1|STARTED|First Period||22
2263525|NCT02339389|5556635|P1|NOT COMPLETED|Overall Study||16
2263526|NCT02339389|5556635|P1|COMPLETED|Overall Study||41
2263527|NCT02339389|5556635|P1|STARTED|Overall Study||57
2263528|NCT02339285|5556643|P3|NOT COMPLETED|Overall Study||2
2263529|NCT02339285|5556644|P2|NOT COMPLETED|Overall Study||3
2263530|NCT02339285|5556645|P1|NOT COMPLETED|Overall Study||1
2263531|NCT02339285|5556643|P3|COMPLETED|Overall Study||9
2263532|NCT02339285|5556644|P2|COMPLETED|Overall Study||8
2263533|NCT02339285|5556645|P1|COMPLETED|Overall Study||9
2263534|NCT02339285|5556643|P3|4 Week Follow-up Visit|Overall Study||9
2263535|NCT02339285|5556644|P2|4 Week Follow-up Visit|Overall Study||8
2263536|NCT02339285|5556645|P1|4 Week Follow-up Visit|Overall Study||9
2263537|NCT02339285|5556643|P3|2 Week Follow-up|Overall Study||10
2263538|NCT02339285|5556644|P2|2 Week Follow-up|Overall Study||10
2263539|NCT02339285|5556645|P1|2 Week Follow-up|Overall Study||9
2263540|NCT02339285|5556643|P3|Completed Intervention|Overall Study||10
2263541|NCT02339285|5556644|P2|Completed Intervention|Overall Study||10
2263542|NCT02339285|5556645|P1|Completed Intervention|Overall Study||10
2263543|NCT02339285|5556643|P3|STARTED|Overall Study||11
2263544|NCT02339285|5556644|P2|STARTED|Overall Study||11
2263545|NCT02339285|5556645|P1|STARTED|Overall Study||10
2263546|NCT02339246|5556673|P3|NOT COMPLETED|Third Period (7 Days)||0
2263547|NCT02339246|5556674|P2|NOT COMPLETED|Third Period (7 Days)||0
2263548|NCT02339246|5556675|P1|NOT COMPLETED|Third Period (7 Days)||0
2263549|NCT02339246|5556673|P3|COMPLETED|Third Period (7 Days)||0
2263550|NCT02339246|5556674|P2|COMPLETED|Third Period (7 Days)||16
2263551|NCT02339246|5556675|P1|COMPLETED|Third Period (7 Days)||15
2263552|NCT02339246|5556673|P3|STARTED|Third Period (7 Days)||0
2263553|NCT02339246|5556674|P2|STARTED|Third Period (7 Days)||16
2263554|NCT02339246|5556675|P1|STARTED|Third Period (7 Days)||15
2263555|NCT02339246|5556673|P3|NOT COMPLETED|Second Intervention (7 Days)||0
2263556|NCT02339246|5556674|P2|NOT COMPLETED|Second Intervention (7 Days)||0
2263557|NCT02339246|5556675|P1|NOT COMPLETED|Second Intervention (7 Days)||0
2263558|NCT02339246|5556673|P3|COMPLETED|Second Intervention (7 Days)||0
2263559|NCT02339246|5556674|P2|COMPLETED|Second Intervention (7 Days)||15
2263560|NCT02339246|5556675|P1|COMPLETED|Second Intervention (7 Days)||16
2263561|NCT02339246|5556673|P3|STARTED|Second Intervention (7 Days)||0
2263562|NCT02339246|5556674|P2|STARTED|Second Intervention (7 Days)||15
2263563|NCT02339246|5556675|P1|STARTED|Second Intervention (7 Days)||16
2263564|NCT02339246|5556673|P3|NOT COMPLETED|First Intervention (7 Days)||0
2263565|NCT02339246|5556674|P2|NOT COMPLETED|First Intervention (7 Days)||0
2263566|NCT02339246|5556675|P1|NOT COMPLETED|First Intervention (7 Days)||0
2263567|NCT02339246|5556673|P3|COMPLETED|First Intervention (7 Days)||31
2263568|NCT02339246|5556674|P2|COMPLETED|First Intervention (7 Days)||0
2263569|NCT02339246|5556675|P1|COMPLETED|First Intervention (7 Days)||0
2263570|NCT02339246|5556673|P3|STARTED|First Intervention (7 Days)||31
2263571|NCT02339246|5556674|P2|STARTED|First Intervention (7 Days)||0
2263572|NCT02339246|5556675|P1|STARTED|First Intervention (7 Days)||0
2263573|NCT02339155|5556691|P2|NOT COMPLETED|Overall Study||21
2263574|NCT02339155|5556692|P1|NOT COMPLETED|Overall Study||15
2263575|NCT02339155|5556691|P2|COMPLETED|Overall Study||266
2263576|NCT02339155|5556692|P1|COMPLETED|Overall Study||271
2263577|NCT02339155|5556691|P2|Received Study Treatment|Overall Study||281
2263578|NCT02339155|5556692|P1|Received Study Treatment|Overall Study||285
2263579|NCT02339155|5556691|P2|STARTED|Overall Study||287
2263580|NCT02339155|5556692|P1|STARTED|Overall Study||286
2263581|NCT02339038|5556718|P1|NOT COMPLETED|Overall Study||600
2263582|NCT02339038|5556718|P1|COMPLETED|Overall Study||0
2263583|NCT02339038|5556718|P1|STARTED|Overall Study||600
2263584|NCT02338973|5556722|P1|NOT COMPLETED|Overall Study||0
2263585|NCT02338973|5556722|P1|COMPLETED|Overall Study||4
2263586|NCT02338973|5556722|P1|Enhanced S-Cone Syndrome (ESCS)|Overall Study||2
2263587|NCT02338973|5556722|P1|Rod-cone Dystrophy (RCD)|Overall Study||2
2263588|NCT02338973|5556722|P1|STARTED|Overall Study||4
2263589|NCT02338882|5556898|P2|NOT COMPLETED|Overall Study||3
2263590|NCT02338882|5556899|P1|NOT COMPLETED|Overall Study||7
2263591|NCT02338882|5556898|P2|COMPLETED|Overall Study||47
2263592|NCT02338882|5556899|P1|COMPLETED|Overall Study||43
2263593|NCT02338882|5556898|P2|STARTED|Overall Study||50
2263594|NCT02338882|5556899|P1|STARTED|Overall Study||50
2263595|NCT02338843|5556937|P2|NOT COMPLETED|Overall Study||58
2263596|NCT02338843|5556938|P1|NOT COMPLETED|Overall Study||44
2263597|NCT02338843|5556937|P2|COMPLETED|Overall Study||100
2263598|NCT02338843|5556938|P1|COMPLETED|Overall Study||119
2263599|NCT02338843|5556937|P2|STARTED|Overall Study||158
2263600|NCT02338843|5556938|P1|STARTED|Overall Study||163
2263601|NCT02338713|5556944|P1|NOT COMPLETED|Overall Study||0
2263602|NCT02338713|5556944|P1|COMPLETED|Overall Study||27
2263603|NCT02338713|5556944|P1|STARTED|Overall Study||27
2263604|NCT02338492|5556966|P1|NOT COMPLETED|Overall Study||45
2263605|NCT02338492|5556966|P1|COMPLETED|Overall Study||36
2263606|NCT02338492|5556966|P1|Treatment Failure|Overall Study||2
2263607|NCT02338492|5556966|P1|Device Implanted|Overall Study||79
2263608|NCT02338492|5556966|P1|Enrolled|Overall Study||81
2263609|NCT02338492|5556966|P1|STARTED|Overall Study||81
2263610|NCT02338362|5556982|P2|NOT COMPLETED|Overall Study||1
2263611|NCT02338362|5556983|P1|NOT COMPLETED|Overall Study||1
2263612|NCT02338362|5556982|P2|COMPLETED|Overall Study||10
2263613|NCT02338362|5556983|P1|COMPLETED|Overall Study||10
2263614|NCT02338362|5556982|P2|STARTED|Overall Study||11
2263615|NCT02338362|5556983|P1|STARTED|Overall Study||11
2263616|NCT02338336|5556999|P4|NOT COMPLETED|Overall Study||0
2263617|NCT02338336|5557000|P3|NOT COMPLETED|Overall Study||0
2263618|NCT02338336|5557001|P2|NOT COMPLETED|Overall Study||0
2263619|NCT02338336|5557002|P1|NOT COMPLETED|Overall Study||2
2263620|NCT02338336|5556999|P4|COMPLETED|Overall Study||4
2263621|NCT02338336|5557000|P3|COMPLETED|Overall Study||7
2263622|NCT02338336|5557001|P2|COMPLETED|Overall Study||17
2263623|NCT02338336|5557002|P1|COMPLETED|Overall Study||24
2263624|NCT02338336|5556999|P4|STARTED|Overall Study||4
2263625|NCT02338336|5557000|P3|STARTED|Overall Study||7
2263626|NCT02338336|5557001|P2|STARTED|Overall Study||17
2263627|NCT02338336|5557002|P1|STARTED|Overall Study||26
2263628|NCT02338193|5557013|P3|NOT COMPLETED|Overall Study||10
2263629|NCT02338193|5557014|P2|NOT COMPLETED|Overall Study||4
2263630|NCT02338193|5557015|P1|NOT COMPLETED|Overall Study||3
2263631|NCT02338193|5557013|P3|COMPLETED|Overall Study||15
2263632|NCT02338193|5557014|P2|COMPLETED|Overall Study||17
2263633|NCT02338193|5557015|P1|COMPLETED|Overall Study||17
2263634|NCT02338193|5557013|P3|STARTED|Overall Study||25
2263635|NCT02338193|5557014|P2|STARTED|Overall Study||21
2263636|NCT02338193|5557015|P1|STARTED|Overall Study||20
2263637|NCT02338154|5557068|P1|NOT COMPLETED|Overall Study||143
2263638|NCT02338154|5557068|P1|COMPLETED|Overall Study||373
2263639|NCT02338154|5557068|P1|INTUITY (Study Valve Cohort)|Overall Study||493
2263640|NCT02338154|5557068|P1|Enrolled Cohort (Intent to Treat)|Overall Study||516
2263641|NCT02338154|5557068|P1|STARTED|Overall Study||516
2263642|NCT02338076|5557164|P1|NOT COMPLETED|Overall Study||0
2263643|NCT02338076|5557164|P1|COMPLETED|Overall Study||20
2263644|NCT02338076|5557164|P1|STARTED|Overall Study||20
2263645|NCT02337959|5557182|P3|NOT COMPLETED|Overall Study||0
2263646|NCT02337959|5557183|P2|NOT COMPLETED|Overall Study||3
2263647|NCT02337959|5557184|P1|NOT COMPLETED|Overall Study||0
2263648|NCT02337959|5557182|P3|COMPLETED|Overall Study||7
2263649|NCT02337959|5557183|P2|COMPLETED|Overall Study||7
2263650|NCT02337959|5557184|P1|COMPLETED|Overall Study||10
2263651|NCT02337959|5557182|P3|STARTED|Overall Study||7
2263652|NCT02337959|5557183|P2|STARTED|Overall Study||10
2263653|NCT02337959|5557184|P1|STARTED|Overall Study||10
2263654|NCT02337946|5557192|P3|NOT COMPLETED|Protocol Treatment 2 Period||50
2263655|NCT02337946|5557193|P2|NOT COMPLETED|Protocol Treatment 2 Period||51
2263656|NCT02337946|5557194|P1|NOT COMPLETED|Protocol Treatment 2 Period||0
2263657|NCT02337946|5557192|P3|COMPLETED|Protocol Treatment 2 Period||7
2263658|NCT02337946|5557193|P2|COMPLETED|Protocol Treatment 2 Period||5
2263659|NCT02337946|5557194|P1|COMPLETED|Protocol Treatment 2 Period||0
2263660|NCT02337946|5557192|P3|Safety Population|Protocol Treatment 2 Period||54
2263661|NCT02337946|5557193|P2|Safety Population|Protocol Treatment 2 Period||56
2263662|NCT02337946|5557194|P1|Safety Population|Protocol Treatment 2 Period||0
2263663|NCT02337946|5557192|P3|STARTED|Protocol Treatment 2 Period||57
2263664|NCT02337946|5557193|P2|STARTED|Protocol Treatment 2 Period||56
2263665|NCT02337946|5557194|P1|STARTED|Protocol Treatment 2 Period||0
2263666|NCT02337946|5557192|P3|NOT COMPLETED|In-between Period||0
2263667|NCT02337946|5557193|P2|NOT COMPLETED|In-between Period||0
2263668|NCT02337946|5557194|P1|NOT COMPLETED|In-between Period||1
2263669|NCT02337946|5557192|P3|COMPLETED|In-between Period||0
2263670|NCT02337946|5557193|P2|COMPLETED|In-between Period||0
2263671|NCT02337946|5557194|P1|COMPLETED|In-between Period||113
2263672|NCT02337946|5557192|P3|STARTED|In-between Period||0
2263673|NCT02337946|5557193|P2|STARTED|In-between Period||0
2263674|NCT02337946|5557194|P1|STARTED|In-between Period||114
2263675|NCT02337946|5557192|P3|NOT COMPLETED|Protocol Treatment 1 Period||0
2263676|NCT02337946|5557193|P2|NOT COMPLETED|Protocol Treatment 1 Period||0
2263677|NCT02337946|5557194|P1|NOT COMPLETED|Protocol Treatment 1 Period||50
2263678|NCT02337946|5557192|P3|COMPLETED|Protocol Treatment 1 Period||0
2263679|NCT02337946|5557193|P2|COMPLETED|Protocol Treatment 1 Period||0
2263680|NCT02337946|5557194|P1|COMPLETED|Protocol Treatment 1 Period||114
2263681|NCT02337946|5557192|P3|STARTED|Protocol Treatment 1 Period||0
2263682|NCT02337946|5557193|P2|STARTED|Protocol Treatment 1 Period||0
2263683|NCT02337946|5557194|P1|STARTED|Protocol Treatment 1 Period||164
2263684|NCT02337907|5557222|P6|NOT COMPLETED|Overall Study||1
2263685|NCT02337907|5557223|P5|NOT COMPLETED|Overall Study||10
2263686|NCT02337907|5557224|P4|NOT COMPLETED|Overall Study||4
2263687|NCT02337907|5557225|P3|NOT COMPLETED|Overall Study||1
2263688|NCT02337907|5557226|P2|NOT COMPLETED|Overall Study||4
2263689|NCT02337907|5557227|P1|NOT COMPLETED|Overall Study||4
2263690|NCT02337907|5557222|P6|COMPLETED|Overall Study||4
2263691|NCT02337907|5557223|P5|COMPLETED|Overall Study||96
2263692|NCT02337907|5557224|P4|COMPLETED|Overall Study||51
2263693|NCT02337907|5557225|P3|COMPLETED|Overall Study||54
2263694|NCT02337907|5557226|P2|COMPLETED|Overall Study||49
2263695|NCT02337907|5557227|P1|COMPLETED|Overall Study||51
2263696|NCT02337907|5557222|P6|STARTED|Overall Study||5
2263697|NCT02337907|5557223|P5|STARTED|Overall Study||106
2263698|NCT02337907|5557224|P4|STARTED|Overall Study||55
2263699|NCT02337907|5557225|P3|STARTED|Overall Study||55
2263700|NCT02337907|5557226|P2|STARTED|Overall Study||53
2263701|NCT02337907|5557227|P1|STARTED|Overall Study||55
2263702|NCT02337764|5557262|P1|NOT COMPLETED|Overall Study||60
2263703|NCT02337764|5557262|P1|COMPLETED|Overall Study||162
2263704|NCT02337764|5557262|P1|STARTED|Overall Study||222
2263705|NCT02337751|5557275|P2|NOT COMPLETED|Overall Study||16
2263706|NCT02337751|5557276|P1|NOT COMPLETED|Overall Study||11
2263707|NCT02337751|5557275|P2|COMPLETED|Overall Study||87
2263708|NCT02337751|5557276|P1|COMPLETED|Overall Study||84
2263709|NCT02337751|5557275|P2|STARTED|Overall Study||103
2263710|NCT02337751|5557276|P1|STARTED|Overall Study||95
2263711|NCT02337738|5557295|P3|NOT COMPLETED|Overall Study||26
2263712|NCT02337738|5557296|P2|NOT COMPLETED|Overall Study||30
2263713|NCT02337738|5557297|P1|NOT COMPLETED|Overall Study||22
2263714|NCT02337738|5557295|P3|COMPLETED|Overall Study||103
2263715|NCT02337738|5557296|P2|COMPLETED|Overall Study||104
2263716|NCT02337738|5557297|P1|COMPLETED|Overall Study||119
2263717|NCT02337738|5557295|P3|STARTED|Overall Study||129
2263718|NCT02337738|5557296|P2|STARTED|Overall Study||134
2263719|NCT02337738|5557297|P1|STARTED|Overall Study||141
2263720|NCT02337725|5557337|P2|NOT COMPLETED|Overall Study||8
2263721|NCT02337725|5557338|P1|NOT COMPLETED|Overall Study||26
2263722|NCT02337725|5557337|P2|COMPLETED|Overall Study||110
2263723|NCT02337725|5557338|P1|COMPLETED|Overall Study||100
2263724|NCT02337725|5557337|P2|STARTED|Overall Study||118
2263725|NCT02337725|5557338|P1|STARTED|Overall Study||126
2263726|NCT02337491|5557362|P2|NOT COMPLETED|Overall Study||30
2263727|NCT02337491|5557363|P1|NOT COMPLETED|Overall Study||50
2263728|NCT02337491|5557362|P2|COMPLETED|Overall Study||0
2263729|NCT02337491|5557363|P1|COMPLETED|Overall Study||0
2263730|NCT02337491|5557362|P2|STARTED|Overall Study||30
2263731|NCT02337491|5557363|P1|STARTED|Overall Study||50
2263732|NCT02337478|5557377|P1|NOT COMPLETED|Overall Study||5
2263733|NCT02337478|5557377|P1|COMPLETED|Overall Study||0
2263734|NCT02337478|5557377|P1|STARTED|Overall Study||5
2263735|NCT02337387|5557387|P4|NOT COMPLETED|Overall Study||3
2263736|NCT02337387|5557388|P3|NOT COMPLETED|Overall Study||3
2263737|NCT02337387|5557389|P2|NOT COMPLETED|Overall Study||8
2263738|NCT02337387|5557390|P1|NOT COMPLETED|Overall Study||14
2263739|NCT02337387|5557387|P4|COMPLETED|Overall Study||0
2263740|NCT02337387|5557388|P3|COMPLETED|Overall Study||0
2263741|NCT02337387|5557389|P2|COMPLETED|Overall Study||0
2263742|NCT02337387|5557390|P1|COMPLETED|Overall Study||0
2263743|NCT02337387|5557387|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
2263744|NCT02337387|5557388|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
2263745|NCT02337387|5557389|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
2263746|NCT02337387|5557390|P1|Received at Least 1 Dose of Study Drug|Overall Study||14
2263747|NCT02337387|5557387|P4|STARTED|Overall Study||3
2263748|NCT02337387|5557388|P3|STARTED|Overall Study||3
2263749|NCT02337387|5557389|P2|STARTED|Overall Study||8
2263750|NCT02337387|5557390|P1|STARTED|Overall Study||14
2263751|NCT02337361|5557408|P2|NOT COMPLETED|6-month Follow-up||4
2263752|NCT02337361|5557409|P1|NOT COMPLETED|6-month Follow-up||2
2263753|NCT02337361|5557408|P2|COMPLETED|6-month Follow-up||68
2263754|NCT02337361|5557409|P1|COMPLETED|6-month Follow-up||78
2263755|NCT02337361|5557408|P2|STARTED|6-month Follow-up||72
2263756|NCT02337361|5557409|P1|STARTED|6-month Follow-up||80
2263757|NCT02337361|5557408|P2|NOT COMPLETED|3-month Follow-up||14
2263758|NCT02337361|5557409|P1|NOT COMPLETED|3-month Follow-up||19
2263759|NCT02337361|5557408|P2|COMPLETED|3-month Follow-up||72
2263760|NCT02337361|5557409|P1|COMPLETED|3-month Follow-up||80
2263761|NCT02337361|5557408|P2|STARTED|3-month Follow-up||86
2263762|NCT02337361|5557409|P1|STARTED|3-month Follow-up||99
2263763|NCT02337361|5557408|P2|NOT COMPLETED|Baseline Assessment||0
2263764|NCT02337361|5557409|P1|NOT COMPLETED|Baseline Assessment||0
2263765|NCT02337361|5557408|P2|COMPLETED|Baseline Assessment||86
2263766|NCT02337361|5557409|P1|COMPLETED|Baseline Assessment||99
2263767|NCT02337361|5557408|P2|STARTED|Baseline Assessment||86
2263768|NCT02337361|5557409|P1|STARTED|Baseline Assessment||99
2263769|NCT02337062|5557429|P2|NOT COMPLETED|Overall Study||19
2263770|NCT02337062|5557430|P1|NOT COMPLETED|Overall Study||17
2263771|NCT02337062|5557429|P2|COMPLETED|Overall Study||556
2263772|NCT02337062|5557430|P1|COMPLETED|Overall Study||555
2263773|NCT02337062|5557429|P2|STARTED|Overall Study||575
2263774|NCT02337062|5557430|P1|STARTED|Overall Study||572
2263775|NCT02336958|5557448|P2|NOT COMPLETED|Overall Study||0
2263776|NCT02336958|5557449|P1|NOT COMPLETED|Overall Study||0
2263777|NCT02336958|5557448|P2|COMPLETED|Overall Study||20
2263778|NCT02336958|5557449|P1|COMPLETED|Overall Study||20
2263779|NCT02336958|5557448|P2|STARTED|Overall Study||20
2263780|NCT02336958|5557449|P1|STARTED|Overall Study||20
2263781|NCT02336763|5557457|P1|NOT COMPLETED|Overall Study||0
2263782|NCT02336763|5557457|P1|COMPLETED|Overall Study||2
2263783|NCT02336763|5557457|P1|STARTED|Overall Study||2
2263784|NCT02336607|5557471|P4|NOT COMPLETED|Overall Study||87
2263785|NCT02336607|5557472|P3|NOT COMPLETED|Overall Study||6
2263786|NCT02336607|5557473|P2|NOT COMPLETED|Overall Study||10
2263787|NCT02336607|5557474|P1|NOT COMPLETED|Overall Study||4
2263788|NCT02336607|5557471|P4|COMPLETED|Overall Study||180
2263789|NCT02336607|5557472|P3|COMPLETED|Overall Study||86
2263790|NCT02336607|5557473|P2|COMPLETED|Overall Study||75
2263791|NCT02336607|5557474|P1|COMPLETED|Overall Study||81
2263792|NCT02336607|5557471|P4|Patients Included in Safety Population|Overall Study||260
2263793|NCT02336607|5557472|P3|Patients Included in Safety Population|Overall Study||92
2263794|NCT02336607|5557473|P2|Patients Included in Safety Population|Overall Study||85
2263795|NCT02336607|5557474|P1|Patients Included in Safety Population|Overall Study||85
2263796|NCT02336607|5557471|P4|Patients Included in PP Population|Overall Study||162
2263797|NCT02336607|5557472|P3|Patients Included in PP Population|Overall Study||75
2263798|NCT02336607|5557473|P2|Patients Included in PP Population|Overall Study||75
2263799|NCT02336607|5557474|P1|Patients Included in PP Population|Overall Study||78
2263800|NCT02336607|5557471|P4|Patients Included in ITT Population|Overall Study||222
2263801|NCT02336607|5557472|P3|Patients Included in ITT Population|Overall Study||91
2263802|NCT02336607|5557473|P2|Patients Included in ITT Population|Overall Study||84
2263803|NCT02336607|5557474|P1|Patients Included in ITT Population|Overall Study||84
2263804|NCT02336607|5557471|P4|STARTED|Overall Study||267
2263805|NCT02336607|5557472|P3|STARTED|Overall Study||92
2263806|NCT02336607|5557473|P2|STARTED|Overall Study||85
2263807|NCT02336607|5557474|P1|STARTED|Overall Study||85
2263808|NCT02336594|5557532|P4|NOT COMPLETED|Overall Study||0
2263809|NCT02336594|5557533|P3|NOT COMPLETED|Overall Study||0
2263810|NCT02336594|5557534|P2|NOT COMPLETED|Overall Study||0
2263811|NCT02336594|5557535|P1|NOT COMPLETED|Overall Study||0
2263812|NCT02336594|5557532|P4|COMPLETED|Overall Study||4
2263813|NCT02336594|5557533|P3|COMPLETED|Overall Study||4
2263814|NCT02336594|5557534|P2|COMPLETED|Overall Study||4
2263815|NCT02336594|5557535|P1|COMPLETED|Overall Study||3
2263816|NCT02336594|5557532|P4|STARTED|Overall Study||4
2263817|NCT02336594|5557533|P3|STARTED|Overall Study||4
2263818|NCT02336594|5557534|P2|STARTED|Overall Study||4
2263819|NCT02336594|5557535|P1|STARTED|Overall Study||3
2263820|NCT02336555|5557577|P2|NOT COMPLETED|Treatment Period 2 (28 Days)||1
2263821|NCT02336555|5557578|P1|NOT COMPLETED|Treatment Period 2 (28 Days)||0
2263822|NCT02336555|5557577|P2|COMPLETED|Treatment Period 2 (28 Days)||15
2263823|NCT02336555|5557578|P1|COMPLETED|Treatment Period 2 (28 Days)||16
2263824|NCT02336555|5557577|P2|STARTED|Treatment Period 2 (28 Days)||16
2263825|NCT02336555|5557578|P1|STARTED|Treatment Period 2 (28 Days)||16
2263826|NCT02336555|5557577|P2|NOT COMPLETED|Treatment Period 1 (28 Days)||1
2263827|NCT02336555|5557578|P1|NOT COMPLETED|Treatment Period 1 (28 Days)||2
2263828|NCT02336555|5557577|P2|COMPLETED|Treatment Period 1 (28 Days)||16
2263829|NCT02336555|5557578|P1|COMPLETED|Treatment Period 1 (28 Days)||16
2263830|NCT02336555|5557577|P2|STARTED|Treatment Period 1 (28 Days)||17
2263831|NCT02336555|5557578|P1|STARTED|Treatment Period 1 (28 Days)||18
2263847|NCT02336438|5557739|P1|NOT COMPLETED|Overall Study||1
2263848|NCT02336438|5557739|P1|COMPLETED|Overall Study||10
2263849|NCT02336438|5557739|P1|STARTED|Overall Study||11
2263850|NCT02336425|5557752|P4|NOT COMPLETED|Overall Study||3
2263851|NCT02336425|5557753|P3|NOT COMPLETED|Overall Study||3
2263852|NCT02336425|5557754|P2|NOT COMPLETED|Overall Study||2
2263853|NCT02336425|5557755|P1|NOT COMPLETED|Overall Study||2
2263854|NCT02336425|5557752|P4|COMPLETED|Overall Study||0
2263855|NCT02336425|5557753|P3|COMPLETED|Overall Study||0
2263856|NCT02336425|5557754|P2|COMPLETED|Overall Study||0
2263857|NCT02336425|5557755|P1|COMPLETED|Overall Study||0
2263858|NCT02336425|5557752|P4|STARTED|Overall Study||3
2263859|NCT02336425|5557753|P3|STARTED|Overall Study||3
2263860|NCT02336425|5557754|P2|STARTED|Overall Study||2
2263861|NCT02336425|5557755|P1|STARTED|Overall Study||2
2263862|NCT02336282|5557805|P1|NOT COMPLETED|Overall Study||5
2263863|NCT02336282|5557805|P1|COMPLETED|Overall Study||28
2263864|NCT02336282|5557805|P1|STARTED|Overall Study||33
2263865|NCT02336178|5557829|P1|NOT COMPLETED|Overall Study||4
2263866|NCT02336178|5557829|P1|COMPLETED|Overall Study||66
2263867|NCT02336178|5557829|P1|STARTED|Overall Study||70
2263868|NCT02336165|5557920|P5|NOT COMPLETED|Overall Study||22
2263869|NCT02336165|5557921|P4|NOT COMPLETED|Overall Study||31
2263870|NCT02336165|5557922|P3|NOT COMPLETED|Overall Study||31
2263871|NCT02336165|5557923|P2|NOT COMPLETED|Overall Study||25
2263872|NCT02336165|5557924|P1|NOT COMPLETED|Overall Study||34
2263873|NCT02336165|5557920|P5|COMPLETED|Overall Study||0
2263874|NCT02336165|5557921|P4|COMPLETED|Overall Study||2
2263875|NCT02336165|5557922|P3|COMPLETED|Overall Study||2
2263876|NCT02336165|5557923|P2|COMPLETED|Overall Study||6
2263877|NCT02336165|5557924|P1|COMPLETED|Overall Study||6
2263878|NCT02336165|5557920|P5|STARTED|Overall Study||22
2263879|NCT02336165|5557921|P4|STARTED|Overall Study||33
2263880|NCT02336165|5557922|P3|STARTED|Overall Study||33
2263881|NCT02336165|5557923|P2|STARTED|Overall Study||31
2263882|NCT02336165|5557924|P1|STARTED|Overall Study||40
2263883|NCT02336074|5557958|P2|NOT COMPLETED|Overall Study||2
2263884|NCT02336074|5557959|P1|NOT COMPLETED|Overall Study||0
2263885|NCT02336074|5557958|P2|COMPLETED|Overall Study||28
2263886|NCT02336074|5557959|P1|COMPLETED|Overall Study||30
2263887|NCT02336074|5557958|P2|STARTED|Overall Study||30
2263888|NCT02336074|5557959|P1|STARTED|Overall Study||30
2263889|NCT02335710|5557978|P2|NOT COMPLETED|Overall Study||0
2263890|NCT02335710|5557979|P1|NOT COMPLETED|Overall Study||0
2263891|NCT02335710|5557978|P2|COMPLETED|Overall Study||10
2263892|NCT02335710|5557979|P1|COMPLETED|Overall Study||40
2263893|NCT02335710|5557978|P2|STARTED|Overall Study||10
2263894|NCT02335710|5557979|P1|STARTED|Overall Study||40
2263895|NCT02335502|5557999|P1|NOT COMPLETED|Overall Study||17
2263896|NCT02335502|5557999|P1|COMPLETED|Overall Study||49
2263897|NCT02335502|5557999|P1|Receiving Permanent System|Overall Study||56
2263898|NCT02335502|5557999|P1|Received Trial System|Overall Study||65
2263899|NCT02335502|5557999|P1|STARTED|Overall Study||66
2263900|NCT02335489|5558004|P1|NOT COMPLETED|Overall Study||10
2263901|NCT02335489|5558004|P1|COMPLETED|Overall Study||0
2263902|NCT02335489|5558004|P1|Receiving Permanent System|Overall Study||8
2263903|NCT02335489|5558004|P1|Received Trial System|Overall Study||9
2263904|NCT02335489|5558004|P1|STARTED|Overall Study||10
2263905|NCT02335424|5558008|P1|NOT COMPLETED|Overall Study||374
2263906|NCT02335424|5558008|P1|COMPLETED|Overall Study||0
2263907|NCT02335424|5558008|P1|Treated|Overall Study||370
2263908|NCT02335424|5558008|P1|STARTED|Overall Study||374
2263909|NCT02335346|5558041|P1|NOT COMPLETED|Overall Study||12
2263910|NCT02335346|5558041|P1|COMPLETED|Overall Study||81
2263911|NCT02335346|5558041|P1|Received At Least 1 Dose of Study Drug|Overall Study||93
2263912|NCT02335346|5558041|P1|STARTED|Overall Study||93
2263913|NCT02335229|5558053|P1|NOT COMPLETED|Overall Study||7
2263914|NCT02335229|5558053|P1|COMPLETED|Overall Study||23
2263915|NCT02335229|5558053|P1|Received Permanent System|Overall Study||26
2263916|NCT02335229|5558053|P1|Received Trial System|Overall Study||10
2263917|NCT02335229|5558053|P1|STARTED|Overall Study||30
2263918|NCT02335216|5558058|P1|NOT COMPLETED|Overall Study||13
2263919|NCT02335216|5558058|P1|COMPLETED|Overall Study||9
2263920|NCT02335216|5558058|P1|Received Permanent System|Overall Study||13
2263921|NCT02335216|5558058|P1|Received Trial System|Overall Study||16
2263922|NCT02335216|5558058|P1|STARTED|Overall Study||22
2263923|NCT02334982|5558070|P7|NOT COMPLETED|Overall Study||0
2263924|NCT02334982|5558071|P6|NOT COMPLETED|Overall Study||0
2263925|NCT02334982|5558072|P5|NOT COMPLETED|Overall Study||0
2263926|NCT02334982|5558073|P4|NOT COMPLETED|Overall Study||0
2263927|NCT02334982|5558074|P3|NOT COMPLETED|Overall Study||0
2263928|NCT02334982|5558075|P2|NOT COMPLETED|Overall Study||0
2263929|NCT02334982|5558076|P1|NOT COMPLETED|Overall Study||0
2263930|NCT02334982|5558070|P7|COMPLETED|Overall Study||12
2263931|NCT02334982|5558071|P6|COMPLETED|Overall Study||6
2263932|NCT02334982|5558072|P5|COMPLETED|Overall Study||6
2263933|NCT02334982|5558073|P4|COMPLETED|Overall Study||6
2263934|NCT02334982|5558074|P3|COMPLETED|Overall Study||6
2263935|NCT02334982|5558075|P2|COMPLETED|Overall Study||5
2263936|NCT02334982|5558076|P1|COMPLETED|Overall Study||6
2263937|NCT02334982|5558070|P7|STARTED|Overall Study||12
2263938|NCT02334982|5558071|P6|STARTED|Overall Study||6
2263939|NCT02334982|5558072|P5|STARTED|Overall Study||6
2263940|NCT02334982|5558073|P4|STARTED|Overall Study||6
2263941|NCT02334982|5558074|P3|STARTED|Overall Study||6
2263942|NCT02334982|5558075|P2|STARTED|Overall Study||5
2263943|NCT02334982|5558076|P1|STARTED|Overall Study||6
2263944|NCT02334813|5558182|P2|NOT COMPLETED|Overall Study||1
2263945|NCT02334813|5558183|P1|NOT COMPLETED|Overall Study||3
2263946|NCT02334813|5558182|P2|COMPLETED|Overall Study||13
2263947|NCT02334813|5558183|P1|COMPLETED|Overall Study||9
2263948|NCT02334813|5558182|P2|STARTED|Overall Study||14
2263949|NCT02334813|5558183|P1|STARTED|Overall Study||12
2263950|NCT02334800|5558193|P4|NOT COMPLETED|Overall Study||0
2263951|NCT02334800|5558194|P3|NOT COMPLETED|Overall Study||0
2263952|NCT02334800|5558195|P2|NOT COMPLETED|Overall Study||0
2263953|NCT02334800|5558196|P1|NOT COMPLETED|Overall Study||0
2263954|NCT02334800|5558193|P4|COMPLETED|Overall Study||7
2263955|NCT02334800|5558194|P3|COMPLETED|Overall Study||7
2263956|NCT02334800|5558195|P2|COMPLETED|Overall Study||7
2263957|NCT02334800|5558196|P1|COMPLETED|Overall Study||7
2263958|NCT02334800|5558193|P4|Received Treatment|Overall Study||7
2263959|NCT02334800|5558194|P3|Received Treatment|Overall Study||7
2263960|NCT02334800|5558195|P2|Received Treatment|Overall Study||7
2263961|NCT02334800|5558196|P1|Received Treatment|Overall Study||7
2263962|NCT02334800|5558193|P4|STARTED|Overall Study||7
2263963|NCT02334800|5558194|P3|STARTED|Overall Study||7
2263964|NCT02334800|5558195|P2|STARTED|Overall Study||7
2263965|NCT02334800|5558196|P1|STARTED|Overall Study||7
2263966|NCT02334787|5558290|P4|NOT COMPLETED|Overall Study||0
2263967|NCT02334787|5558291|P3|NOT COMPLETED|Overall Study||0
2263968|NCT02334787|5558292|P2|NOT COMPLETED|Overall Study||0
2263969|NCT02334787|5558293|P1|NOT COMPLETED|Overall Study||0
2263970|NCT02334787|5558290|P4|COMPLETED|Overall Study||8
2263971|NCT02334787|5558291|P3|COMPLETED|Overall Study||8
2263972|NCT02334787|5558292|P2|COMPLETED|Overall Study||8
2263973|NCT02334787|5558293|P1|COMPLETED|Overall Study||8
2263974|NCT02334787|5558290|P4|STARTED|Overall Study||8
2263975|NCT02334787|5558291|P3|STARTED|Overall Study||8
2263976|NCT02334787|5558292|P2|STARTED|Overall Study||8
2263977|NCT02334787|5558293|P1|STARTED|Overall Study||8
2263978|NCT02334527|5558315|P1|NOT COMPLETED|Overall Study||0
2263979|NCT02334527|5558315|P1|COMPLETED|Overall Study||12
2263980|NCT02334527|5558315|P1|STARTED|Overall Study||12
2263981|NCT02334436|5558326|P2|NOT COMPLETED|Overall Study||1
2263982|NCT02334436|5558327|P1|NOT COMPLETED|Overall Study||9
2263983|NCT02334436|5558326|P2|COMPLETED|Overall Study||77
2263984|NCT02334436|5558327|P1|COMPLETED|Overall Study||237
2263985|NCT02334436|5558326|P2|STARTED|Overall Study||78
2263986|NCT02334436|5558327|P1|STARTED|Overall Study||246
2263987|NCT02334423|5558341|P2|NOT COMPLETED|Overall Study||3
2263988|NCT02334423|5558342|P1|NOT COMPLETED|Overall Study||10
2263989|NCT02334423|5558341|P2|COMPLETED|Overall Study||81
2263990|NCT02334423|5558342|P1|COMPLETED|Overall Study||236
2263991|NCT02334423|5558341|P2|STARTED|Overall Study||84
2263992|NCT02334423|5558342|P1|STARTED|Overall Study||246
2263993|NCT02334384|5558356|P2|NOT COMPLETED|Overall Study||1
2263994|NCT02334384|5558357|P1|NOT COMPLETED|Overall Study||1
2263995|NCT02334384|5558356|P2|COMPLETED|Overall Study||1
2263996|NCT02334384|5558357|P1|COMPLETED|Overall Study||3
2263997|NCT02334384|5558356|P2|STARTED|Overall Study||2
2263998|NCT02334384|5558357|P1|STARTED|Overall Study||4
2263999|NCT02334358|5558363|P1|NOT COMPLETED|Overall Study||9
2264000|NCT02334358|5558363|P1|COMPLETED|Overall Study||494
2264001|NCT02334358|5558363|P1|STARTED|Overall Study||503
2264002|NCT02334306|5558369|P2|NOT COMPLETED|Open-label Period||0
2264003|NCT02334306|5558370|P1|NOT COMPLETED|Open-label Period||0
2264004|NCT02334306|5558369|P2|COMPLETED|Open-label Period||14
2264005|NCT02334306|5558370|P1|COMPLETED|Open-label Period||15
2264006|NCT02334306|5558369|P2|STARTED|Open-label Period||14
2264007|NCT02334306|5558370|P1|STARTED|Open-label Period||15
2264008|NCT02334306|5558369|P2|NOT COMPLETED|Double-blind Period||2
2264009|NCT02334306|5558370|P1|NOT COMPLETED|Double-blind Period||1
2264010|NCT02334306|5558369|P2|COMPLETED|Double-blind Period||14
2264011|NCT02334306|5558370|P1|COMPLETED|Double-blind Period||15
2264012|NCT02334306|5558369|P2|STARTED|Double-blind Period||16
2264013|NCT02334306|5558370|P1|STARTED|Double-blind Period||16
2264014|NCT02334267|5558392|P2|NOT COMPLETED|Overall Study||0
2264015|NCT02334267|5558393|P1|NOT COMPLETED|Overall Study||1
2264016|NCT02334267|5558392|P2|COMPLETED|Overall Study||5
2264017|NCT02334267|5558393|P1|COMPLETED|Overall Study||5
2264018|NCT02334267|5558392|P2|STARTED|Overall Study||5
2264019|NCT02334267|5558393|P1|STARTED|Overall Study||6
2264020|NCT02334059|5558408|P3|NOT COMPLETED|Overall Study||0
2264021|NCT02334059|5558409|P2|NOT COMPLETED|Overall Study||0
2264022|NCT02334059|5558410|P1|NOT COMPLETED|Overall Study||0
2264023|NCT02334059|5558408|P3|COMPLETED|Overall Study||37
2264024|NCT02334059|5558409|P2|COMPLETED|Overall Study||34
2264025|NCT02334059|5558410|P1|COMPLETED|Overall Study||37
2264026|NCT02334059|5558408|P3|STARTED|Overall Study||37
2264027|NCT02334059|5558409|P2|STARTED|Overall Study||34
2264028|NCT02334059|5558410|P1|STARTED|Overall Study||37
2264029|NCT02333383|5558424|P1|NOT COMPLETED|Overall Study||41
2264030|NCT02333383|5558424|P1|COMPLETED|Overall Study||160
2264031|NCT02333383|5558424|P1|STARTED|Overall Study||201
2264032|NCT02333331|5558438|P4|NOT COMPLETED|Overall Study||3
2264033|NCT02333331|5558439|P3|NOT COMPLETED|Overall Study||18
2264034|NCT02333331|5558440|P2|NOT COMPLETED|Overall Study||6
2264035|NCT02333331|5558441|P1|NOT COMPLETED|Overall Study||2
2264036|NCT02333331|5558438|P4|COMPLETED|Overall Study||64
2264037|NCT02333331|5558439|P3|COMPLETED|Overall Study||95
2264038|NCT02333331|5558440|P2|COMPLETED|Overall Study||12
2264039|NCT02333331|5558441|P1|COMPLETED|Overall Study||17
2264040|NCT02333331|5558438|P4|STARTED|Overall Study||67
2264041|NCT02333331|5558439|P3|STARTED|Overall Study||113
2264042|NCT02333331|5558440|P2|STARTED|Overall Study||18
2264043|NCT02333331|5558441|P1|STARTED|Overall Study||19
2264044|NCT02333045|5558469|P2|NOT COMPLETED|Overall Study||0
2264045|NCT02333045|5558470|P1|NOT COMPLETED|Overall Study||0
2264046|NCT02333045|5558469|P2|COMPLETED|Overall Study||3
2264047|NCT02333045|5558470|P1|COMPLETED|Overall Study||1
2264048|NCT02333045|5558469|P2|STARTED|Overall Study||3
2264049|NCT02333045|5558470|P1|STARTED|Overall Study||1
2264050|NCT02332902|5558480|P1|NOT COMPLETED|Overall Study||7
2264051|NCT02332902|5558480|P1|COMPLETED|Overall Study||17
2264052|NCT02332902|5558480|P1|STARTED|Overall Study||24
2264053|NCT02332889|5558485|P1|NOT COMPLETED|Overall Study||1
2264054|NCT02332889|5558485|P1|COMPLETED|Overall Study||0
2264055|NCT02332889|5558485|P1|STARTED|Overall Study||1
2264056|NCT02332876|5558491|P2|NOT COMPLETED|Overall Study||1
2264057|NCT02332876|5558492|P1|NOT COMPLETED|Overall Study||1
2264058|NCT02332876|5558491|P2|COMPLETED|Overall Study||43
2264059|NCT02332876|5558492|P1|COMPLETED|Overall Study||42
2264060|NCT02332876|5558491|P2|STARTED|Overall Study||44
2264061|NCT02332876|5558492|P1|STARTED|Overall Study||43
2264062|NCT02332824|5558504|P6|NOT COMPLETED|Overall Study||1
2264063|NCT02332824|5558505|P5|NOT COMPLETED|Overall Study||4
2264064|NCT02332824|5558506|P4|NOT COMPLETED|Overall Study||2
2264065|NCT02332824|5558507|P3|NOT COMPLETED|Overall Study||2
2264066|NCT02332824|5558508|P2|NOT COMPLETED|Overall Study||1
2264067|NCT02332824|5558509|P1|NOT COMPLETED|Overall Study||6
2264068|NCT02332824|5558504|P6|COMPLETED|Overall Study||69
2264069|NCT02332824|5558505|P5|COMPLETED|Overall Study||65
2264070|NCT02332824|5558506|P4|COMPLETED|Overall Study||66
2264071|NCT02332824|5558507|P3|COMPLETED|Overall Study||72
2264072|NCT02332824|5558508|P2|COMPLETED|Overall Study||66
2264073|NCT02332824|5558509|P1|COMPLETED|Overall Study||61
2264074|NCT02332824|5558504|P6|STARTED|Overall Study||70
2264075|NCT02332824|5558505|P5|STARTED|Overall Study||69
2264076|NCT02332824|5558506|P4|STARTED|Overall Study||68
2264077|NCT02332824|5558507|P3|STARTED|Overall Study||74
2264078|NCT02332824|5558508|P2|STARTED|Overall Study||67
2264079|NCT02332824|5558509|P1|STARTED|Overall Study||67
2264080|NCT02332798|5558550|P3|NOT COMPLETED|Overall Study||1
2264081|NCT02332798|5558551|P2|NOT COMPLETED|Overall Study||2
2264082|NCT02332798|5558552|P1|NOT COMPLETED|Overall Study||1
2264083|NCT02332798|5558550|P3|COMPLETED|Overall Study||11
2264084|NCT02332798|5558551|P2|COMPLETED|Overall Study||12
2264085|NCT02332798|5558552|P1|COMPLETED|Overall Study||12
2264086|NCT02332798|5558550|P3|STARTED|Overall Study||12
2264087|NCT02332798|5558551|P2|STARTED|Overall Study||14
2264088|NCT02332798|5558552|P1|STARTED|Overall Study||13
2264089|NCT02332720|5558625|P23|NOT COMPLETED|Part C||0
2264090|NCT02332720|5558626|P22|NOT COMPLETED|Part C||0
2264091|NCT02332720|5558627|P21|NOT COMPLETED|Part C||0
2264092|NCT02332720|5558628|P20|NOT COMPLETED|Part C||0
2264093|NCT02332720|5558629|P19|NOT COMPLETED|Part C||0
2264094|NCT02332720|5558630|P18|NOT COMPLETED|Part C||0
2264095|NCT02332720|5558631|P17|NOT COMPLETED|Part C||0
2264096|NCT02332720|5558632|P16|NOT COMPLETED|Part C||0
2264097|NCT02332720|5558633|P15|NOT COMPLETED|Part C||0
2264098|NCT02332720|5558634|P14|NOT COMPLETED|Part C||0
2264099|NCT02332720|5558635|P13|NOT COMPLETED|Part C||0
2264100|NCT02332720|5558636|P12|NOT COMPLETED|Part C||0
2264101|NCT02332720|5558637|P11|NOT COMPLETED|Part C||0
2264102|NCT02332720|5558638|P10|NOT COMPLETED|Part C||0
2264103|NCT02332720|5558639|P9|NOT COMPLETED|Part C||0
2264104|NCT02332720|5558640|P8|NOT COMPLETED|Part C||0
2264105|NCT02332720|5558641|P7|NOT COMPLETED|Part C||0
2264106|NCT02332720|5558642|P6|NOT COMPLETED|Part C||0
2264107|NCT02332720|5558643|P5|NOT COMPLETED|Part C||0
2264108|NCT02332720|5558644|P4|NOT COMPLETED|Part C||0
2264109|NCT02332720|5558645|P3|NOT COMPLETED|Part C||0
2264110|NCT02332720|5558646|P2|NOT COMPLETED|Part C||0
2264111|NCT02332720|5558647|P1|NOT COMPLETED|Part C||0
2264112|NCT02332720|5558625|P23|COMPLETED|Part C||0
2264113|NCT02332720|5558626|P22|COMPLETED|Part C||0
2264114|NCT02332720|5558627|P21|COMPLETED|Part C||0
2264115|NCT02332720|5558628|P20|COMPLETED|Part C||0
2264116|NCT02332720|5558629|P19|COMPLETED|Part C||0
2264117|NCT02332720|5558630|P18|COMPLETED|Part C||0
2264118|NCT02332720|5558631|P17|COMPLETED|Part C||0
2264119|NCT02332720|5558632|P16|COMPLETED|Part C||0
2264120|NCT02332720|5558633|P15|COMPLETED|Part C||0
2264121|NCT02332720|5558634|P14|COMPLETED|Part C||0
2264122|NCT02332720|5558635|P13|COMPLETED|Part C||0
2264123|NCT02332720|5558636|P12|COMPLETED|Part C||0
2264124|NCT02332720|5558637|P11|COMPLETED|Part C||0
2264125|NCT02332720|5558638|P10|COMPLETED|Part C||0
2264126|NCT02332720|5558639|P9|COMPLETED|Part C||0
2264127|NCT02332720|5558640|P8|COMPLETED|Part C||0
2264128|NCT02332720|5558641|P7|COMPLETED|Part C||0
2264129|NCT02332720|5558642|P6|COMPLETED|Part C||0
2264130|NCT02332720|5558643|P5|COMPLETED|Part C||0
2264131|NCT02332720|5558644|P4|COMPLETED|Part C||2
2264132|NCT02332720|5558645|P3|COMPLETED|Part C||3
2264133|NCT02332720|5558646|P2|COMPLETED|Part C||1
2264134|NCT02332720|5558647|P1|COMPLETED|Part C||2
2264135|NCT02332720|5558625|P23|STARTED|Part C|Part B participants were not included in Part C.|0
2264136|NCT02332720|5558626|P22|STARTED|Part C||0
2264137|NCT02332720|5558627|P21|STARTED|Part C|Part B participants were not included in Part C.|0
2264138|NCT02332720|5558628|P20|STARTED|Part C|Part B participants were not included in Part C.|0
2264139|NCT02332720|5558629|P19|STARTED|Part C|Part B participants were not included in Part C.|0
2264140|NCT02332720|5558630|P18|STARTED|Part C|Part B participants were not included in Part C.|0
2264141|NCT02332720|5558631|P17|STARTED|Part C|Part B participants were not included in Part C.|0
2264142|NCT02332720|5558632|P16|STARTED|Part C|Part B participants were not included in Part C.|0
2264143|NCT02332720|5558633|P15|STARTED|Part C|Part B participants were not included in Part C.|0
2264144|NCT02332720|5558634|P14|STARTED|Part C|Part B participants were not included in Part C.|0
2264145|NCT02332720|5558635|P13|STARTED|Part C|Part B participants were not included in Part C.|0
2264146|NCT02332720|5558636|P12|STARTED|Part C|Part B participants were not included in Part C.|0
2264147|NCT02332720|5558637|P11|STARTED|Part C|Part B participants were not included in Part C.|0
2264148|NCT02332720|5558638|P10|STARTED|Part C|Part B participants were not included in Part C.|0
2264149|NCT02332720|5558639|P9|STARTED|Part C|Part B participants were not included in Part C.|0
2264150|NCT02332720|5558640|P8|STARTED|Part C|Part B participants were not included in Part C.|0
2264151|NCT02332720|5558641|P7|STARTED|Part C|Part B participants were not included in Part C.|0
2264152|NCT02332720|5558642|P6|STARTED|Part C|Part B participants were not included in Part C.|0
2264153|NCT02332720|5558643|P5|STARTED|Part C|Part B participants were not included in Part C.|0
2264154|NCT02332720|5558644|P4|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|2
2264155|NCT02332720|5558645|P3|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|3
2264156|NCT02332720|5558646|P2|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|1
2264157|NCT02332720|5558647|P1|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|2
2264158|NCT02332720|5558625|P23|NOT COMPLETED|Part A and Part B||0
2264159|NCT02332720|5558626|P22|NOT COMPLETED|Part A and Part B||0
2264160|NCT02332720|5558627|P21|NOT COMPLETED|Part A and Part B||0
2264161|NCT02332720|5558628|P20|NOT COMPLETED|Part A and Part B||1
2264162|NCT02332720|5558629|P19|NOT COMPLETED|Part A and Part B||1
2264163|NCT02332720|5558630|P18|NOT COMPLETED|Part A and Part B||1
2264164|NCT02332720|5558631|P17|NOT COMPLETED|Part A and Part B||0
2264165|NCT02332720|5558632|P16|NOT COMPLETED|Part A and Part B||1
2264166|NCT02332720|5558633|P15|NOT COMPLETED|Part A and Part B||0
2264167|NCT02332720|5558634|P14|NOT COMPLETED|Part A and Part B||0
2264168|NCT02332720|5558635|P13|NOT COMPLETED|Part A and Part B||0
2264169|NCT02332720|5558636|P12|NOT COMPLETED|Part A and Part B||0
2264170|NCT02332720|5558637|P11|NOT COMPLETED|Part A and Part B||0
2264171|NCT02332720|5558638|P10|NOT COMPLETED|Part A and Part B||0
2264172|NCT02332720|5558639|P9|NOT COMPLETED|Part A and Part B||0
2264173|NCT02332720|5558640|P8|NOT COMPLETED|Part A and Part B||1
2264174|NCT02332720|5558641|P7|NOT COMPLETED|Part A and Part B||1
2264175|NCT02332720|5558642|P6|NOT COMPLETED|Part A and Part B||3
2264176|NCT02332720|5558643|P5|NOT COMPLETED|Part A and Part B||0
2264177|NCT02332720|5558644|P4|NOT COMPLETED|Part A and Part B||0
2264178|NCT02332720|5558645|P3|NOT COMPLETED|Part A and Part B||0
2264179|NCT02332720|5558646|P2|NOT COMPLETED|Part A and Part B||0
2264180|NCT02332720|5558647|P1|NOT COMPLETED|Part A and Part B||1
2264181|NCT02332720|5558625|P23|COMPLETED|Part A and Part B||4
2264182|NCT02332720|5558626|P22|COMPLETED|Part A and Part B||0
2264183|NCT02332720|5558627|P21|COMPLETED|Part A and Part B||7
2264184|NCT02332720|5558628|P20|COMPLETED|Part A and Part B||24
2264185|NCT02332720|5558629|P19|COMPLETED|Part A and Part B||20
2264186|NCT02332720|5558630|P18|COMPLETED|Part A and Part B||13
2264187|NCT02332720|5558631|P17|COMPLETED|Part A and Part B||15
2264188|NCT02332720|5558632|P16|COMPLETED|Part A and Part B||13
2264189|NCT02332720|5558633|P15|COMPLETED|Part A and Part B||16
2264190|NCT02332720|5558634|P14|COMPLETED|Part A and Part B||13
2264191|NCT02332720|5558635|P13|COMPLETED|Part A and Part B||16
2264192|NCT02332720|5558636|P12|COMPLETED|Part A and Part B||15
2264193|NCT02332720|5558637|P11|COMPLETED|Part A and Part B||14
2264194|NCT02332720|5558638|P10|COMPLETED|Part A and Part B||14
2264195|NCT02332720|5558639|P9|COMPLETED|Part A and Part B||15
2264196|NCT02332720|5558640|P8|COMPLETED|Part A and Part B||34
2264197|NCT02332720|5558641|P7|COMPLETED|Part A and Part B||36
2264198|NCT02332720|5558642|P6|COMPLETED|Part A and Part B||33
2264199|NCT02332720|5558643|P5|COMPLETED|Part A and Part B||16
2264200|NCT02332720|5558644|P4|COMPLETED|Part A and Part B||22
2264201|NCT02332720|5558645|P3|COMPLETED|Part A and Part B||22
2264202|NCT02332720|5558646|P2|COMPLETED|Part A and Part B||21
2264203|NCT02332720|5558647|P1|COMPLETED|Part A and Part B||20
2264204|NCT02332720|5558625|P23|Treated|Part A and Part B||4
2264205|NCT02332720|5558626|P22|Treated|Part A and Part B||0
2264206|NCT02332720|5558627|P21|Treated|Part A and Part B||7
2264207|NCT02332720|5558628|P20|Treated|Part A and Part B||25
2264208|NCT02332720|5558629|P19|Treated|Part A and Part B||20
2264209|NCT02332720|5558630|P18|Treated|Part A and Part B||14
2264210|NCT02332720|5558631|P17|Treated|Part A and Part B||15
2264211|NCT02332720|5558632|P16|Treated|Part A and Part B||14
2264212|NCT02332720|5558633|P15|Treated|Part A and Part B||16
2264213|NCT02332720|5558634|P14|Treated|Part A and Part B||13
2264214|NCT02332720|5558635|P13|Treated|Part A and Part B||16
2264215|NCT02332720|5558636|P12|Treated|Part A and Part B||15
2264216|NCT02332720|5558637|P11|Treated|Part A and Part B||14
2264217|NCT02332720|5558638|P10|Treated|Part A and Part B||14
2264218|NCT02332720|5558639|P9|Treated|Part A and Part B||15
2264219|NCT02332720|5558640|P8|Treated|Part A and Part B||35
2264220|NCT02332720|5558641|P7|Treated|Part A and Part B||37
2264221|NCT02332720|5558642|P6|Treated|Part A and Part B||36
2264222|NCT02332720|5558643|P5|Treated|Part A and Part B||16
2264223|NCT02332720|5558644|P4|Treated|Part A and Part B||22
2264224|NCT02332720|5558645|P3|Treated|Part A and Part B||22
2264225|NCT02332720|5558646|P2|Treated|Part A and Part B||21
2264226|NCT02332720|5558647|P1|Treated|Part A and Part B||21
2264227|NCT02332720|5558625|P23|STARTED|Part A and Part B||4
2264228|NCT02332720|5558626|P22|STARTED|Part A and Part B||0
2264229|NCT02332720|5558627|P21|STARTED|Part A and Part B||7
2264230|NCT02332720|5558628|P20|STARTED|Part A and Part B||25
2264231|NCT02332720|5558629|P19|STARTED|Part A and Part B||21
2264232|NCT02332720|5558630|P18|STARTED|Part A and Part B||14
2264233|NCT02332720|5558631|P17|STARTED|Part A and Part B||15
2264234|NCT02332720|5558632|P16|STARTED|Part A and Part B||14
2264235|NCT02332720|5558633|P15|STARTED|Part A and Part B||16
2264236|NCT02332720|5558634|P14|STARTED|Part A and Part B||13
2264237|NCT02332720|5558635|P13|STARTED|Part A and Part B||16
2264238|NCT02332720|5558636|P12|STARTED|Part A and Part B||15
2264239|NCT02332720|5558637|P11|STARTED|Part A and Part B||14
2264240|NCT02332720|5558638|P10|STARTED|Part A and Part B||14
2264241|NCT02332720|5558639|P9|STARTED|Part A and Part B||15
2264242|NCT02332720|5558640|P8|STARTED|Part A and Part B||35
2264243|NCT02332720|5558641|P7|STARTED|Part A and Part B||37
2264244|NCT02332720|5558642|P6|STARTED|Part A and Part B||36
2264245|NCT02332720|5558643|P5|STARTED|Part A and Part B||16
2264246|NCT02332720|5558644|P4|STARTED|Part A and Part B||22
2264247|NCT02332720|5558645|P3|STARTED|Part A and Part B||22
2264248|NCT02332720|5558646|P2|STARTED|Part A and Part B||21
2264249|NCT02332720|5558647|P1|STARTED|Part A and Part B||21
2264250|NCT02332707|5558783|P18|NOT COMPLETED|Overall Study||0
2264251|NCT02332707|5558784|P17|NOT COMPLETED|Overall Study||0
2264252|NCT02332707|5558785|P16|NOT COMPLETED|Overall Study||0
2264253|NCT02332707|5558786|P15|NOT COMPLETED|Overall Study||0
2264254|NCT02332707|5558787|P14|NOT COMPLETED|Overall Study||0
2264255|NCT02332707|5558788|P13|NOT COMPLETED|Overall Study||5
2264256|NCT02332707|5558789|P12|NOT COMPLETED|Overall Study||0
2264257|NCT02332707|5558790|P11|NOT COMPLETED|Overall Study||2
2264258|NCT02332707|5558791|P10|NOT COMPLETED|Overall Study||3
2264259|NCT02332707|5558792|P9|NOT COMPLETED|Overall Study||0
2264260|NCT02332707|5558793|P8|NOT COMPLETED|Overall Study||0
2264261|NCT02332707|5558794|P7|NOT COMPLETED|Overall Study||0
2264262|NCT02332707|5558795|P6|NOT COMPLETED|Overall Study||1
2264263|NCT02332707|5558796|P5|NOT COMPLETED|Overall Study||0
2264264|NCT02332707|5558797|P4|NOT COMPLETED|Overall Study||1
2264265|NCT02332707|5558798|P3|NOT COMPLETED|Overall Study||1
2264266|NCT02332707|5558799|P2|NOT COMPLETED|Overall Study||0
2264267|NCT02332707|5558800|P1|NOT COMPLETED|Overall Study||0
2264268|NCT02332707|5558783|P18|COMPLETED|Overall Study||16
2264269|NCT02332707|5558784|P17|COMPLETED|Overall Study||30
2264270|NCT02332707|5558785|P16|COMPLETED|Overall Study||26
2264271|NCT02332707|5558786|P15|COMPLETED|Overall Study||16
2264272|NCT02332707|5558787|P14|COMPLETED|Overall Study||15
2264273|NCT02332707|5558788|P13|COMPLETED|Overall Study||35
2264274|NCT02332707|5558789|P12|COMPLETED|Overall Study||35
2264275|NCT02332707|5558790|P11|COMPLETED|Overall Study||29
2264276|NCT02332707|5558791|P10|COMPLETED|Overall Study||28
2264277|NCT02332707|5558792|P9|COMPLETED|Overall Study||48
2264278|NCT02332707|5558793|P8|COMPLETED|Overall Study||16
2264279|NCT02332707|5558794|P7|COMPLETED|Overall Study||15
2264280|NCT02332707|5558795|P6|COMPLETED|Overall Study||22
2264281|NCT02332707|5558796|P5|COMPLETED|Overall Study||23
2264282|NCT02332707|5558797|P4|COMPLETED|Overall Study||13
2264283|NCT02332707|5558798|P3|COMPLETED|Overall Study||15
2264284|NCT02332707|5558799|P2|COMPLETED|Overall Study||24
2264285|NCT02332707|5558800|P1|COMPLETED|Overall Study||23
2264286|NCT02332707|5558783|P18|STARTED|Overall Study||16
2264287|NCT02332707|5558784|P17|STARTED|Overall Study||30
2264288|NCT02332707|5558785|P16|STARTED|Overall Study||26
2264289|NCT02332707|5558786|P15|STARTED|Overall Study||16
2264290|NCT02332707|5558787|P14|STARTED|Overall Study||15
2264291|NCT02332707|5558788|P13|STARTED|Overall Study||40
2264292|NCT02332707|5558789|P12|STARTED|Overall Study||35
2264293|NCT02332707|5558790|P11|STARTED|Overall Study||31
2264294|NCT02332707|5558791|P10|STARTED|Overall Study||31
2264295|NCT02332707|5558792|P9|STARTED|Overall Study||48
2264296|NCT02332707|5558793|P8|STARTED|Overall Study||16
2264297|NCT02332707|5558794|P7|STARTED|Overall Study||15
2264298|NCT02332707|5558795|P6|STARTED|Overall Study||23
2264299|NCT02332707|5558796|P5|STARTED|Overall Study||23
2264300|NCT02332707|5558797|P4|STARTED|Overall Study||14
2264301|NCT02332707|5558798|P3|STARTED|Overall Study||16
2264302|NCT02332707|5558799|P2|STARTED|Overall Study||24
2264303|NCT02332707|5558800|P1|STARTED|Overall Study||23
2264304|NCT02332590|5558894|P2|NOT COMPLETED|Overall Study||19
2264305|NCT02332590|5558895|P1|NOT COMPLETED|Overall Study||29
2264306|NCT02332590|5558894|P2|COMPLETED|Overall Study|All 165 participants entered open-label treatment period.|165
2264307|NCT02332590|5558895|P1|COMPLETED|Overall Study|155 participants entered open-label treatment period and 1 did not enroll.|156
2264308|NCT02332590|5558894|P2|Treated|Overall Study||184
2264309|NCT02332590|5558895|P1|Treated|Overall Study||184
2264310|NCT02332590|5558894|P2|STARTED|Overall Study||184
2264311|NCT02332590|5558895|P1|STARTED|Overall Study||185
2264312|NCT02332239|5558959|P2|NOT COMPLETED|Overall Study||6
2264313|NCT02332239|5558960|P1|NOT COMPLETED|Overall Study||4
2264314|NCT02332239|5558959|P2|COMPLETED|Overall Study||52
2264315|NCT02332239|5558960|P1|COMPLETED|Overall Study||54
2264316|NCT02332239|5558959|P2|STARTED|Overall Study||58
2264317|NCT02332239|5558960|P1|STARTED|Overall Study||58
2264318|NCT02331992|5558973|P1|NOT COMPLETED|Overall Study||0
2264319|NCT02331992|5558973|P1|COMPLETED|Overall Study||34
2264320|NCT02331992|5558973|P1|STARTED|Overall Study||34
2264321|NCT02331940|5558980|P2|NOT COMPLETED|Overall Study||5
2264322|NCT02331940|5558981|P1|NOT COMPLETED|Overall Study||7
2264323|NCT02331940|5558980|P2|COMPLETED|Overall Study||95
2264324|NCT02331940|5558981|P1|COMPLETED|Overall Study||93
2264325|NCT02331940|5558980|P2|STARTED|Overall Study||100
2264326|NCT02331940|5558981|P1|STARTED|Overall Study||100
2264327|NCT02331680|5558996|P3|NOT COMPLETED|Overall Study||15
2264328|NCT02331680|5558997|P2|NOT COMPLETED|Overall Study||4
2264329|NCT02331680|5558998|P1|NOT COMPLETED|Overall Study||6
2264330|NCT02331680|5558996|P3|COMPLETED|Overall Study||29
2264331|NCT02331680|5558997|P2|COMPLETED|Overall Study||36
2264332|NCT02331680|5558998|P1|COMPLETED|Overall Study||34
2264333|NCT02331680|5558996|P3|STARTED|Overall Study||44
2264334|NCT02331680|5558997|P2|STARTED|Overall Study||40
2264335|NCT02331680|5558998|P1|STARTED|Overall Study||40
2264336|NCT02331589|5559011|P2|NOT COMPLETED|Overall Study||5
2264337|NCT02331589|5559012|P1|NOT COMPLETED|Overall Study||5
2264338|NCT02331589|5559011|P2|COMPLETED|Overall Study||31
2264339|NCT02331589|5559012|P1|COMPLETED|Overall Study||34
2264340|NCT02331589|5559011|P2|STARTED|Overall Study||36
2264341|NCT02331589|5559012|P1|STARTED|Overall Study||39
2264342|NCT02331446|5559028|P4|NOT COMPLETED|Overall Study||3
2264343|NCT02331446|5559029|P3|NOT COMPLETED|Overall Study||3
2264344|NCT02331446|5559030|P2|NOT COMPLETED|Overall Study||5
2264345|NCT02331446|5559031|P1|NOT COMPLETED|Overall Study||4
2264346|NCT02331446|5559028|P4|COMPLETED|Overall Study||8
2264347|NCT02331446|5559029|P3|COMPLETED|Overall Study||8
2264348|NCT02331446|5559030|P2|COMPLETED|Overall Study||6
2264349|NCT02331446|5559031|P1|COMPLETED|Overall Study||5
2264350|NCT02331446|5559028|P4|STARTED|Overall Study||11
2264351|NCT02331446|5559029|P3|STARTED|Overall Study||11
2264352|NCT02331446|5559030|P2|STARTED|Overall Study||11
2264353|NCT02331446|5559031|P1|STARTED|Overall Study||9
2264354|NCT02331407|5559101|P1|NOT COMPLETED|Overall Study||0
2264355|NCT02331407|5559101|P1|COMPLETED|Overall Study||9
2264356|NCT02331407|5559101|P1|STARTED|Overall Study||9
2264357|NCT02331368|5559107|P1|NOT COMPLETED|Overall Study||3
2264358|NCT02331368|5559107|P1|COMPLETED|Overall Study||29
2264359|NCT02331368|5559107|P1|STARTED|Overall Study||32
2264360|NCT02331108|5559119|P6|NOT COMPLETED|Overall Study||2
2264361|NCT02331108|5559120|P5|NOT COMPLETED|Overall Study||2
2264362|NCT02331108|5559121|P4|NOT COMPLETED|Overall Study||1
2264363|NCT02331108|5559122|P3|NOT COMPLETED|Overall Study||1
2264364|NCT02331108|5559123|P2|NOT COMPLETED|Overall Study||2
2264365|NCT02331108|5559124|P1|NOT COMPLETED|Overall Study||1
2264366|NCT02331108|5559119|P6|COMPLETED|Overall Study||50
2264367|NCT02331108|5559120|P5|COMPLETED|Overall Study||50
2264368|NCT02331108|5559121|P4|COMPLETED|Overall Study||50
2264369|NCT02331108|5559122|P3|COMPLETED|Overall Study||50
2264370|NCT02331108|5559123|P2|COMPLETED|Overall Study||50
2264371|NCT02331108|5559124|P1|COMPLETED|Overall Study||50
2264372|NCT02331108|5559119|P6|STARTED|Overall Study||52
2264373|NCT02331108|5559120|P5|STARTED|Overall Study||52
2264374|NCT02331108|5559121|P4|STARTED|Overall Study||51
2264375|NCT02331108|5559122|P3|STARTED|Overall Study||51
2264376|NCT02331108|5559123|P2|STARTED|Overall Study||52
2264377|NCT02331108|5559124|P1|STARTED|Overall Study||51
2264378|NCT02330978|5559146|P1|NOT COMPLETED|The Second Patient Included at Study||0
2264379|NCT02330978|5559146|P1|COMPLETED|The Second Patient Included at Study||1
2264380|NCT02330978|5559146|P1|STARTED|The Second Patient Included at Study||1
2264381|NCT02330978|5559146|P1|NOT COMPLETED|The First Patient Included at Study||0
2264382|NCT02330978|5559146|P1|COMPLETED|The First Patient Included at Study||1
2264383|NCT02330978|5559146|P1|STARTED|The First Patient Included at Study||1
2264384|NCT02330588|5559155|P5|NOT COMPLETED|Overall Study||19
2264385|NCT02330588|5559156|P4|NOT COMPLETED|Overall Study||22
2264386|NCT02330588|5559157|P3|NOT COMPLETED|Overall Study||15
2264387|NCT02330588|5559158|P2|NOT COMPLETED|Overall Study||18
2264388|NCT02330588|5559159|P1|NOT COMPLETED|Overall Study||16
2264389|NCT02330588|5559155|P5|COMPLETED|Overall Study||28
2264390|NCT02330588|5559156|P4|COMPLETED|Overall Study||24
2264391|NCT02330588|5559157|P3|COMPLETED|Overall Study||31
2264392|NCT02330588|5559158|P2|COMPLETED|Overall Study||25
2264393|NCT02330588|5559159|P1|COMPLETED|Overall Study||28
2264394|NCT02330588|5559155|P5|STARTED|Overall Study||47
2264395|NCT02330588|5559156|P4|STARTED|Overall Study||46
2264396|NCT02330588|5559157|P3|STARTED|Overall Study||46
2264397|NCT02330588|5559158|P2|STARTED|Overall Study||43
2264398|NCT02330588|5559159|P1|STARTED|Overall Study||44
2264399|NCT02330549|5559186|P2|NOT COMPLETED|Overall Study||1
2264400|NCT02330549|5559187|P1|NOT COMPLETED|Overall Study||4
2264401|NCT02330549|5559186|P2|COMPLETED|Overall Study||24
2264402|NCT02330549|5559187|P1|COMPLETED|Overall Study||16
2264403|NCT02330549|5559186|P2|STARTED|Overall Study||25
2264404|NCT02330549|5559187|P1|STARTED|Overall Study||20
2264405|NCT02330523|5559302|P2|NOT COMPLETED|Overall Study||0
2264406|NCT02330523|5559303|P1|NOT COMPLETED|Overall Study||0
2264407|NCT02330523|5559302|P2|COMPLETED|Overall Study||19
2264408|NCT02330523|5559303|P1|COMPLETED|Overall Study||21
2264409|NCT02330523|5559302|P2|STARTED|Overall Study||19
2264410|NCT02330523|5559303|P1|STARTED|Overall Study||21
2264411|NCT02330276|5559316|P3|NOT COMPLETED|Overall Study||0
2264412|NCT02330276|5559317|P2|NOT COMPLETED|Overall Study||0
2264413|NCT02330276|5559318|P1|NOT COMPLETED|Overall Study||0
2264414|NCT02330276|5559316|P3|COMPLETED|Overall Study||4
2264415|NCT02330276|5559317|P2|COMPLETED|Overall Study||4
2264416|NCT02330276|5559318|P1|COMPLETED|Overall Study||4
2264417|NCT02330276|5559316|P3|STARTED|Overall Study||4
2264418|NCT02330276|5559317|P2|STARTED|Overall Study||4
2264419|NCT02330276|5559318|P1|STARTED|Overall Study||4
2264420|NCT02330172|5559340|P2|NOT COMPLETED|Overall Study||1
2264421|NCT02330172|5559341|P1|NOT COMPLETED|Overall Study||3
2264422|NCT02330172|5559340|P2|COMPLETED|Overall Study||21
2264423|NCT02330172|5559341|P1|COMPLETED|Overall Study||19
2264424|NCT02330172|5559340|P2|STARTED|Overall Study||22
2264425|NCT02330172|5559341|P1|STARTED|Overall Study||22
2264426|NCT02330094|5559351|P2|NOT COMPLETED|Overall Study||0
2264427|NCT02330094|5559352|P1|NOT COMPLETED|Overall Study||0
2264428|NCT02330094|5559351|P2|COMPLETED|Overall Study||8
2264429|NCT02330094|5559352|P1|COMPLETED|Overall Study||8
2264430|NCT02330094|5559351|P2|STARTED|Overall Study||8
2264431|NCT02330094|5559352|P1|STARTED|Overall Study||8
2264432|NCT02330081|5559362|P1|NOT COMPLETED|Overall Study||8
2264433|NCT02330081|5559362|P1|COMPLETED|Overall Study||14
2264434|NCT02330081|5559362|P1|STARTED|Overall Study||22
2264435|NCT02330055|5559383|P2|NOT COMPLETED|Overall Study||9
2264436|NCT02330055|5559384|P1|NOT COMPLETED|Overall Study||10
2264437|NCT02330055|5559383|P2|COMPLETED|Overall Study||40
2264438|NCT02330055|5559384|P1|COMPLETED|Overall Study||40
2264439|NCT02330055|5559383|P2|STARTED|Overall Study||49
2264440|NCT02330055|5559384|P1|STARTED|Overall Study||50
2264441|NCT02329964|5559404|P2|NOT COMPLETED|Overall Study||0
2264442|NCT02329964|5559405|P1|NOT COMPLETED|Overall Study||0
2264443|NCT02329964|5559404|P2|COMPLETED|Overall Study||40
2264444|NCT02329964|5559405|P1|COMPLETED|Overall Study||40
2264445|NCT02329964|5559404|P2|STARTED|Overall Study||40
2264446|NCT02329964|5559405|P1|STARTED|Overall Study||40
2264447|NCT02329743|5559430|P3|NOT COMPLETED|Overall Study||8
2264448|NCT02329743|5559431|P2|NOT COMPLETED|Overall Study||7
2264449|NCT02329743|5559432|P1|NOT COMPLETED|Overall Study||6
2264450|NCT02329743|5559430|P3|COMPLETED|Overall Study||77
2264451|NCT02329743|5559431|P2|COMPLETED|Overall Study||80
2264452|NCT02329743|5559432|P1|COMPLETED|Overall Study||78
2264453|NCT02329743|5559430|P3|STARTED|Overall Study||85
2264454|NCT02329743|5559431|P2|STARTED|Overall Study||87
2264455|NCT02329743|5559432|P1|STARTED|Overall Study||84
2264456|NCT02329730|5559447|P12|NOT COMPLETED|Overall Study||0
2264457|NCT02329730|5559448|P11|NOT COMPLETED|Overall Study||0
2264458|NCT02329730|5559449|P10|NOT COMPLETED|Overall Study||1
2264459|NCT02329730|5559450|P9|NOT COMPLETED|Overall Study||1
2264460|NCT02329730|5559451|P8|NOT COMPLETED|Overall Study||1
2264461|NCT02329730|5559452|P7|NOT COMPLETED|Overall Study||1
2264462|NCT02329730|5559453|P6|NOT COMPLETED|Overall Study||2
2264463|NCT02329730|5559454|P5|NOT COMPLETED|Overall Study||3
2264464|NCT02329730|5559455|P4|NOT COMPLETED|Overall Study||0
2264465|NCT02329730|5559456|P3|NOT COMPLETED|Overall Study||0
2264466|NCT02329730|5559457|P2|NOT COMPLETED|Overall Study||0
2264467|NCT02329730|5559458|P1|NOT COMPLETED|Overall Study||0
2264468|NCT02329730|5559447|P12|COMPLETED|Overall Study||8
2264469|NCT02329730|5559448|P11|COMPLETED|Overall Study||8
2264470|NCT02329730|5559449|P10|COMPLETED|Overall Study||7
2264471|NCT02329730|5559450|P9|COMPLETED|Overall Study||7
2264472|NCT02329730|5559451|P8|COMPLETED|Overall Study||13
2264473|NCT02329730|5559452|P7|COMPLETED|Overall Study||13
2264474|NCT02329730|5559453|P6|COMPLETED|Overall Study||12
2264475|NCT02329730|5559454|P5|COMPLETED|Overall Study||11
2264476|NCT02329730|5559455|P4|COMPLETED|Overall Study||14
2264477|NCT02329730|5559456|P3|COMPLETED|Overall Study||14
2264478|NCT02329730|5559457|P2|COMPLETED|Overall Study||14
2264479|NCT02329730|5559458|P1|COMPLETED|Overall Study||14
2264480|NCT02329730|5559447|P12|STARTED|Overall Study||8
2264481|NCT02329730|5559448|P11|STARTED|Overall Study||8
2264482|NCT02329730|5559449|P10|STARTED|Overall Study||8
2264483|NCT02329730|5559450|P9|STARTED|Overall Study||8
2264484|NCT02329730|5559451|P8|STARTED|Overall Study||14
2264485|NCT02329730|5559452|P7|STARTED|Overall Study||14
2264486|NCT02329730|5559453|P6|STARTED|Overall Study||14
2264487|NCT02329730|5559454|P5|STARTED|Overall Study||14
2264488|NCT02329730|5559455|P4|STARTED|Overall Study||14
2264489|NCT02329730|5559456|P3|STARTED|Overall Study||14
2264490|NCT02329730|5559457|P2|STARTED|Overall Study||14
2264491|NCT02329730|5559458|P1|STARTED|Overall Study||14
2264492|NCT02329600|5559535|P3|NOT COMPLETED|Overall Study||0
2264493|NCT02329600|5559536|P2|NOT COMPLETED|Overall Study||0
2264494|NCT02329600|5559537|P1|NOT COMPLETED|Overall Study||0
2264495|NCT02329600|5559535|P3|COMPLETED|Overall Study||15
2264496|NCT02329600|5559536|P2|COMPLETED|Overall Study||15
2264497|NCT02329600|5559537|P1|COMPLETED|Overall Study||10
2264498|NCT02329600|5559535|P3|STARTED|Overall Study||15
2264499|NCT02329600|5559536|P2|STARTED|Overall Study||15
2264500|NCT02329600|5559537|P1|STARTED|Overall Study||10
2264501|NCT02329587|5559550|P2|NOT COMPLETED|1-month Follow-up||1
2264502|NCT02329587|5559551|P1|NOT COMPLETED|1-month Follow-up||0
2264503|NCT02329587|5559550|P2|COMPLETED|1-month Follow-up||5
2264504|NCT02329587|5559551|P1|COMPLETED|1-month Follow-up||4
2264505|NCT02329587|5559550|P2|STARTED|1-month Follow-up||6
2264506|NCT02329587|5559551|P1|STARTED|1-month Follow-up||4
2264507|NCT02329587|5559550|P2|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1
2264508|NCT02329587|5559551|P1|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1
2264509|NCT02329587|5559550|P2|COMPLETED|Baseline Thru Post-treatment Assessment||6
2264510|NCT02329587|5559551|P1|COMPLETED|Baseline Thru Post-treatment Assessment||4
2264511|NCT02329587|5559550|P2|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||4
2264512|NCT02329587|5559551|P1|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||3
2264513|NCT02329587|5559550|P2|STARTED|Baseline Thru Post-treatment Assessment||7
2264514|NCT02329587|5559551|P1|STARTED|Baseline Thru Post-treatment Assessment||5
2264515|NCT02329431|5559569|P2|NOT COMPLETED|Overall Study||13
2264516|NCT02329431|5559570|P1|NOT COMPLETED|Overall Study||20
2264517|NCT02329431|5559569|P2|COMPLETED|Overall Study||76
2264518|NCT02329431|5559570|P1|COMPLETED|Overall Study||72
2264519|NCT02329431|5559569|P2|Baseline Interview|Overall Study||85
2264520|NCT02329431|5559570|P1|Baseline Interview|Overall Study||87
2264521|NCT02329431|5559569|P2|STARTED|Overall Study||89
2264522|NCT02329431|5559570|P1|STARTED|Overall Study||92
2264523|NCT02329223|5559589|P3|NOT COMPLETED|Overall Study||6
2264524|NCT02329223|5559590|P2|NOT COMPLETED|Overall Study||3
2264525|NCT02329223|5559591|P1|NOT COMPLETED|Overall Study||1
2264526|NCT02329223|5559589|P3|COMPLETED|Overall Study||68
2264527|NCT02329223|5559590|P2|COMPLETED|Overall Study||68
2264528|NCT02329223|5559591|P1|COMPLETED|Overall Study||72
2264529|NCT02329223|5559589|P3|Safety Set|Overall Study||74
2264530|NCT02329223|5559590|P2|Safety Set|Overall Study||71
2264531|NCT02329223|5559591|P1|Safety Set|Overall Study||73
2264532|NCT02329223|5559589|P3|Full Analysis Set|Overall Study||74
2264533|NCT02329223|5559590|P2|Full Analysis Set|Overall Study||70
2264534|NCT02329223|5559591|P1|Full Analysis Set|Overall Study||73
2264535|NCT02329223|5559589|P3|STARTED|Overall Study||74
2264536|NCT02329223|5559590|P2|STARTED|Overall Study||71
2264537|NCT02329223|5559591|P1|STARTED|Overall Study||73
2264538|NCT02329015|5559624|P2|NOT COMPLETED|Overall Study||0
2264539|NCT02329015|5559625|P1|NOT COMPLETED|Overall Study||0
2264540|NCT02329015|5559624|P2|COMPLETED|Overall Study||64
2264541|NCT02329015|5559625|P1|COMPLETED|Overall Study||48
2264542|NCT02329015|5559624|P2|STARTED|Overall Study||64
2264543|NCT02329015|5559625|P1|STARTED|Overall Study||48
2264544|NCT02328937|5559641|P6|NOT COMPLETED|Period 3||0
2264545|NCT02328937|5559642|P5|NOT COMPLETED|Period 3||0
2264546|NCT02328937|5559643|P4|NOT COMPLETED|Period 3||0
2264547|NCT02328937|5559644|P3|NOT COMPLETED|Period 3||0
2264548|NCT02328937|5559645|P2|NOT COMPLETED|Period 3||0
2264549|NCT02328937|5559646|P1|NOT COMPLETED|Period 3||0
2264550|NCT02328937|5559641|P6|COMPLETED|Period 3||6
2264551|NCT02328937|5559642|P5|COMPLETED|Period 3||6
2264552|NCT02328937|5559643|P4|COMPLETED|Period 3||5
2264553|NCT02328937|5559644|P3|COMPLETED|Period 3||6
2264554|NCT02328937|5559645|P2|COMPLETED|Period 3||6
2264555|NCT02328937|5559646|P1|COMPLETED|Period 3||7
2264556|NCT02328937|5559641|P6|STARTED|Period 3||6
2264557|NCT02328937|5559642|P5|STARTED|Period 3||6
2264558|NCT02328937|5559643|P4|STARTED|Period 3||5
2264559|NCT02328937|5559644|P3|STARTED|Period 3||6
2264560|NCT02328937|5559645|P2|STARTED|Period 3||6
2264561|NCT02328937|5559646|P1|STARTED|Period 3||7
2264562|NCT02328937|5559641|P6|NOT COMPLETED|Period 2||0
2264563|NCT02328937|5559642|P5|NOT COMPLETED|Period 2||0
2264564|NCT02328937|5559643|P4|NOT COMPLETED|Period 2||0
2264565|NCT02328937|5559644|P3|NOT COMPLETED|Period 2||1
2264566|NCT02328937|5559645|P2|NOT COMPLETED|Period 2||0
2264567|NCT02328937|5559646|P1|NOT COMPLETED|Period 2||0
2264568|NCT02328937|5559641|P6|COMPLETED|Period 2||6
2264569|NCT02328937|5559642|P5|COMPLETED|Period 2||6
2264570|NCT02328937|5559643|P4|COMPLETED|Period 2||5
2264571|NCT02328937|5559644|P3|COMPLETED|Period 2||6
2264572|NCT02328937|5559645|P2|COMPLETED|Period 2||6
2264573|NCT02328937|5559646|P1|COMPLETED|Period 2||7
2264574|NCT02328937|5559641|P6|STARTED|Period 2||6
2264575|NCT02328937|5559642|P5|STARTED|Period 2||6
2264576|NCT02328937|5559643|P4|STARTED|Period 2||5
2264577|NCT02328937|5559644|P3|STARTED|Period 2||7
2264578|NCT02328937|5559645|P2|STARTED|Period 2||6
2264579|NCT02328937|5559646|P1|STARTED|Period 2||7
2264580|NCT02328937|5559641|P6|NOT COMPLETED|Period 1||0
2264581|NCT02328937|5559642|P5|NOT COMPLETED|Period 1||0
2264582|NCT02328937|5559643|P4|NOT COMPLETED|Period 1||1
2264583|NCT02328937|5559644|P3|NOT COMPLETED|Period 1||0
2264584|NCT02328937|5559645|P2|NOT COMPLETED|Period 1||0
2264585|NCT02328937|5559646|P1|NOT COMPLETED|Period 1||0
2264586|NCT02328937|5559641|P6|COMPLETED|Period 1||6
2264587|NCT02328937|5559642|P5|COMPLETED|Period 1||6
2264588|NCT02328937|5559643|P4|COMPLETED|Period 1||5
2264589|NCT02328937|5559644|P3|COMPLETED|Period 1||7
2264590|NCT02328937|5559645|P2|COMPLETED|Period 1||6
2264591|NCT02328937|5559646|P1|COMPLETED|Period 1||7
2264592|NCT02328937|5559641|P6|STARTED|Period 1||6
2264593|NCT02328937|5559642|P5|STARTED|Period 1||6
2264594|NCT02328937|5559643|P4|STARTED|Period 1||6
2264595|NCT02328937|5559644|P3|STARTED|Period 1||7
2264596|NCT02328937|5559645|P2|STARTED|Period 1||6
2264597|NCT02328937|5559646|P1|STARTED|Period 1||7
2264598|NCT02328807|5559657|P1|NOT COMPLETED|Overall Study||0
2264599|NCT02328807|5559657|P1|COMPLETED|Overall Study||6
2264600|NCT02328807|5559657|P1|STARTED|Overall Study||6
2264601|NCT02328547|5559666|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
2264602|NCT02328547|5559667|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
2264603|NCT02328547|5559666|P2|COMPLETED|Second Intervention (12 Weeks)||23
2264604|NCT02328547|5559667|P1|COMPLETED|Second Intervention (12 Weeks)||22
2264605|NCT02328547|5559666|P2|STARTED|Second Intervention (12 Weeks)||23
2264606|NCT02328547|5559667|P1|STARTED|Second Intervention (12 Weeks)||22
2264607|NCT02328547|5559666|P2|NOT COMPLETED|First Intervention (12 Weeks)||0
2264608|NCT02328547|5559667|P1|NOT COMPLETED|First Intervention (12 Weeks)||3
2264609|NCT02328547|5559666|P2|COMPLETED|First Intervention (12 Weeks)||23
2264610|NCT02328547|5559667|P1|COMPLETED|First Intervention (12 Weeks)||22
2264611|NCT02328547|5559666|P2|STARTED|First Intervention (12 Weeks)||23
2264612|NCT02328547|5559667|P1|STARTED|First Intervention (12 Weeks)||25
2264613|NCT02328404|5559707|P2|NOT COMPLETED|Overall Study||1
2264614|NCT02328404|5559708|P1|NOT COMPLETED|Overall Study||1
2264615|NCT02328404|5559707|P2|COMPLETED|Overall Study||29
2264616|NCT02328404|5559708|P1|COMPLETED|Overall Study||29
2264617|NCT02328404|5559707|P2|STARTED|Overall Study||30
2264618|NCT02328404|5559708|P1|STARTED|Overall Study||30
2264619|NCT02328105|5559742|P1|NOT COMPLETED|Overall Study||11
2264620|NCT02328105|5559742|P1|COMPLETED|Overall Study||0
2264621|NCT02328105|5559742|P1|STARTED|Overall Study||11
2264622|NCT02328040|5559747|P2|NOT COMPLETED|Second Intervention (2 Days)||0
2264623|NCT02328040|5559748|P1|NOT COMPLETED|Second Intervention (2 Days)||0
2264624|NCT02328040|5559747|P2|COMPLETED|Second Intervention (2 Days)||8
2264625|NCT02328040|5559748|P1|COMPLETED|Second Intervention (2 Days)||7
2264626|NCT02328040|5559747|P2|STARTED|Second Intervention (2 Days)||8
2264627|NCT02328040|5559748|P1|STARTED|Second Intervention (2 Days)||7
2264628|NCT02328040|5559747|P2|NOT COMPLETED|First Intervention (2 Days)||1
2264629|NCT02328040|5559748|P1|NOT COMPLETED|First Intervention (2 Days)||1
2264630|NCT02328040|5559747|P2|COMPLETED|First Intervention (2 Days)||8
2264631|NCT02328040|5559748|P1|COMPLETED|First Intervention (2 Days)||7
2264632|NCT02328040|5559747|P2|STARTED|First Intervention (2 Days)||9
2264633|NCT02328040|5559748|P1|STARTED|First Intervention (2 Days)||8
2264634|NCT02327429|5559756|P1|NOT COMPLETED|Overall Study||2
2264635|NCT02327429|5559756|P1|COMPLETED|Overall Study||17
2264636|NCT02327429|5559756|P1|STARTED|Overall Study||19
2264637|NCT02327325|5559779|P3|NOT COMPLETED|Overall Study||5
2264638|NCT02327325|5559780|P2|NOT COMPLETED|Overall Study||4
2264639|NCT02327325|5559781|P1|NOT COMPLETED|Overall Study||1
2264640|NCT02327325|5559779|P3|COMPLETED|Overall Study||15
2264641|NCT02327325|5559780|P2|COMPLETED|Overall Study||16
2264642|NCT02327325|5559781|P1|COMPLETED|Overall Study||19
2264643|NCT02327325|5559779|P3|STARTED|Overall Study||20
2264644|NCT02327325|5559780|P2|STARTED|Overall Study||20
2264645|NCT02327325|5559781|P1|STARTED|Overall Study||20
2264646|NCT02327260|5559804|P3|NOT COMPLETED|Overall Study||2
2264647|NCT02327260|5559805|P2|NOT COMPLETED|Overall Study||4
2264648|NCT02327260|5559806|P1|NOT COMPLETED|Overall Study||6
2264649|NCT02327260|5559804|P3|COMPLETED|Overall Study||15
2264650|NCT02327260|5559805|P2|COMPLETED|Overall Study||20
2264651|NCT02327260|5559806|P1|COMPLETED|Overall Study||14
2264652|NCT02327260|5559804|P3|STARTED|Overall Study||17
2264653|NCT02327260|5559805|P2|STARTED|Overall Study||24
2264654|NCT02327260|5559806|P1|STARTED|Overall Study||20
2264700|NCT02327143|5560088|P2|NOT COMPLETED|Day 1: Time 6 Hrs – to Day 9||0
2264701|NCT02327143|5560089|P1|NOT COMPLETED|Day 1: Time 6 Hrs – to Day 9||0
2264702|NCT02327143|5560088|P2|COMPLETED|Day 1: Time 6 Hrs – to Day 9||11
2264703|NCT02327143|5560089|P1|COMPLETED|Day 1: Time 6 Hrs – to Day 9||0
2264704|NCT02327143|5560088|P2|STARTED|Day 1: Time 6 Hrs – to Day 9||11
2264705|NCT02327143|5560089|P1|STARTED|Day 1: Time 6 Hrs – to Day 9||0
2264706|NCT02327143|5560088|P2|NOT COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
2264707|NCT02327143|5560089|P1|NOT COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
2264708|NCT02327143|5560088|P2|COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
2264709|NCT02327143|5560089|P1|COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||11
2264710|NCT02327143|5560088|P2|STARTED|Day 1: Time 0 Hrs to 6 Hrs||0
2264711|NCT02327143|5560089|P1|STARTED|Day 1: Time 0 Hrs to 6 Hrs||11
2264712|NCT02327130|5560097|P1|NOT COMPLETED|Overall Study||12
2264713|NCT02327130|5560097|P1|COMPLETED|Overall Study||20
2264714|NCT02327130|5560097|P1|STARTED|Overall Study||32
2264715|NCT02327117|5560106|P2|NOT COMPLETED|Overall Study||0
2264716|NCT02327117|5560107|P1|NOT COMPLETED|Overall Study||0
2264717|NCT02327117|5560106|P2|COMPLETED|Overall Study||45
2264718|NCT02327117|5560107|P1|COMPLETED|Overall Study||45
2264719|NCT02327117|5560106|P2|STARTED|Overall Study||45
2264720|NCT02327117|5560107|P1|STARTED|Overall Study||45
2264721|NCT02327013|5560116|P5|NOT COMPLETED|Overall Study||4
2264722|NCT02327013|5560117|P4|NOT COMPLETED|Overall Study||1
2264723|NCT02327013|5560118|P3|NOT COMPLETED|Overall Study||42
2264724|NCT02327013|5560119|P2|NOT COMPLETED|Overall Study||16
2264725|NCT02327013|5560120|P1|NOT COMPLETED|Overall Study||13
2264726|NCT02327013|5560116|P5|COMPLETED|Overall Study||12
2264727|NCT02327013|5560117|P4|COMPLETED|Overall Study||20
2264728|NCT02327013|5560118|P3|COMPLETED|Overall Study||54
2264729|NCT02327013|5560119|P2|COMPLETED|Overall Study||29
2264730|NCT02327013|5560120|P1|COMPLETED|Overall Study||36
2264731|NCT02327013|5560116|P5|STARTED|Overall Study||16
2264732|NCT02327013|5560117|P4|STARTED|Overall Study||21
2264733|NCT02327013|5560118|P3|STARTED|Overall Study||96
2264734|NCT02327013|5560119|P2|STARTED|Overall Study||45
2264735|NCT02327013|5560120|P1|STARTED|Overall Study||49
2264736|NCT02326844|5560293|P1|NOT COMPLETED|Overall Study||0
2264737|NCT02326844|5560293|P1|COMPLETED|Overall Study||3
2264738|NCT02326844|5560293|P1|STARTED|Overall Study||3
2264739|NCT02326649|5560300|P1|NOT COMPLETED|Overall Study||12
2264740|NCT02326649|5560300|P1|COMPLETED|Overall Study||21
2264741|NCT02326649|5560300|P1|STARTED|Overall Study||33
2264742|NCT02326597|5560306|P2|NOT COMPLETED|Overall Study||32
2264743|NCT02326597|5560307|P1|NOT COMPLETED|Overall Study||42
2264744|NCT02326597|5560306|P2|COMPLETED|Overall Study||28
2264745|NCT02326597|5560307|P1|COMPLETED|Overall Study||18
2264746|NCT02326597|5560306|P2|STARTED|Overall Study||60
2264747|NCT02326597|5560307|P1|STARTED|Overall Study||60
2264748|NCT02326298|5560328|P14|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||9
2264749|NCT02326298|5560329|P13|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||19
2264750|NCT02326298|5560330|P12|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||20
2264751|NCT02326298|5560331|P11|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264752|NCT02326298|5560332|P10|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264753|NCT02326298|5560333|P9|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264754|NCT02326298|5560334|P8|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264755|NCT02326298|5560335|P7|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264756|NCT02326298|5560336|P6|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264757|NCT02326298|5560337|P5|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264758|NCT02326298|5560338|P4|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264759|NCT02326298|5560339|P3|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264760|NCT02326298|5560340|P2|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264761|NCT02326298|5560341|P1|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264762|NCT02326298|5560328|P14|COMPLETED|Open-label Period (Week 48 to Week 144)||44
2264763|NCT02326298|5560329|P13|COMPLETED|Open-label Period (Week 48 to Week 144)||51
2264764|NCT02326298|5560330|P12|COMPLETED|Open-label Period (Week 48 to Week 144)||54
2264765|NCT02326298|5560331|P11|COMPLETED|Open-label Period (Week 48 to Week 144)||3
2264766|NCT02326298|5560332|P10|COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264767|NCT02326298|5560333|P9|COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264768|NCT02326298|5560334|P8|COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264769|NCT02326298|5560335|P7|COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264770|NCT02326298|5560336|P6|COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264771|NCT02326298|5560337|P5|COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264772|NCT02326298|5560338|P4|COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264773|NCT02326298|5560339|P3|COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264774|NCT02326298|5560340|P2|COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264775|NCT02326298|5560341|P1|COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264776|NCT02326298|5560328|P14|STARTED|Open-label Period (Week 48 to Week 144)||53
2264777|NCT02326298|5560329|P13|STARTED|Open-label Period (Week 48 to Week 144)||70
2264778|NCT02326298|5560330|P12|STARTED|Open-label Period (Week 48 to Week 144)||74
2264779|NCT02326298|5560331|P11|STARTED|Open-label Period (Week 48 to Week 144)||3
2264780|NCT02326298|5560332|P10|STARTED|Open-label Period (Week 48 to Week 144)||0
2264781|NCT02326298|5560333|P9|STARTED|Open-label Period (Week 48 to Week 144)||0
2264782|NCT02326298|5560334|P8|STARTED|Open-label Period (Week 48 to Week 144)||0
2264783|NCT02326298|5560335|P7|STARTED|Open-label Period (Week 48 to Week 144)||0
2264784|NCT02326298|5560336|P6|STARTED|Open-label Period (Week 48 to Week 144)||0
2264785|NCT02326298|5560337|P5|STARTED|Open-label Period (Week 48 to Week 144)||0
2264786|NCT02326298|5560338|P4|STARTED|Open-label Period (Week 48 to Week 144)||0
2264787|NCT02326298|5560339|P3|STARTED|Open-label Period (Week 48 to Week 144)||0
2264788|NCT02326298|5560340|P2|STARTED|Open-label Period (Week 48 to Week 144)||0
2264789|NCT02326298|5560341|P1|STARTED|Open-label Period (Week 48 to Week 144)||0
2264790|NCT02326298|5560328|P14|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
2264791|NCT02326298|5560329|P13|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
2264792|NCT02326298|5560330|P12|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
2264793|NCT02326298|5560331|P11|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
2264794|NCT02326298|5560332|P10|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
2264795|NCT02326298|5560333|P9|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
2264796|NCT02326298|5560334|P8|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
2264797|NCT02326298|5560335|P7|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
2264798|NCT02326298|5560336|P6|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
2264799|NCT02326298|5560337|P5|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
2264800|NCT02326298|5560338|P4|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
2264801|NCT02326298|5560339|P3|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
2264802|NCT02326298|5560340|P2|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
2264803|NCT02326298|5560341|P1|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
2264804|NCT02326298|5560328|P14|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
2264805|NCT02326298|5560329|P13|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
2264806|NCT02326298|5560330|P12|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
2264807|NCT02326298|5560331|P11|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
2264808|NCT02326298|5560332|P10|COMPLETED|Maintenance Period (Week 16 to Week 48)||7
2264809|NCT02326298|5560333|P9|COMPLETED|Maintenance Period (Week 16 to Week 48)||13
2264810|NCT02326298|5560334|P8|COMPLETED|Maintenance Period (Week 16 to Week 48)||33
2264811|NCT02326298|5560335|P7|COMPLETED|Maintenance Period (Week 16 to Week 48)||70
2264812|NCT02326298|5560336|P6|COMPLETED|Maintenance Period (Week 16 to Week 48)||69
2264813|NCT02326298|5560337|P5|COMPLETED|Maintenance Period (Week 16 to Week 48)||5
2264814|NCT02326298|5560338|P4|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
2264815|NCT02326298|5560339|P3|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
2264816|NCT02326298|5560340|P2|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
2264817|NCT02326298|5560341|P1|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
2264818|NCT02326298|5560328|P14|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
2264819|NCT02326298|5560329|P13|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
2264820|NCT02326298|5560330|P12|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
2264821|NCT02326298|5560331|P11|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
2264822|NCT02326298|5560332|P10|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||7
2264823|NCT02326298|5560333|P9|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||13
2264824|NCT02326298|5560334|P8|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||33
2264825|NCT02326298|5560335|P7|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||70
2264826|NCT02326298|5560336|P6|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||69
2264827|NCT02326298|5560337|P5|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||5
2264828|NCT02326298|5560338|P4|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
2264829|NCT02326298|5560339|P3|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
2264830|NCT02326298|5560340|P2|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
2264831|NCT02326298|5560341|P1|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
2264832|NCT02326298|5560328|P14|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
2264833|NCT02326298|5560329|P13|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
2264834|NCT02326298|5560330|P12|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
2264835|NCT02326298|5560331|P11|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
2264836|NCT02326298|5560332|P10|Completed Week 48|Maintenance Period (Week 16 to Week 48)||7
2264837|NCT02326298|5560333|P9|Completed Week 48|Maintenance Period (Week 16 to Week 48)||13
2264838|NCT02326298|5560334|P8|Completed Week 48|Maintenance Period (Week 16 to Week 48)||33
2264839|NCT02326298|5560335|P7|Completed Week 48|Maintenance Period (Week 16 to Week 48)||70
2264840|NCT02326298|5560336|P6|Completed Week 48|Maintenance Period (Week 16 to Week 48)||71
2264841|NCT02326298|5560337|P5|Completed Week 48|Maintenance Period (Week 16 to Week 48)||5
2264842|NCT02326298|5560338|P4|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
2264843|NCT02326298|5560339|P3|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
2264844|NCT02326298|5560340|P2|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
2264845|NCT02326298|5560341|P1|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
2264846|NCT02326298|5560328|P14|STARTED|Maintenance Period (Week 16 to Week 48)||0
2264847|NCT02326298|5560329|P13|STARTED|Maintenance Period (Week 16 to Week 48)||0
2264848|NCT02326298|5560330|P12|STARTED|Maintenance Period (Week 16 to Week 48)||0
2264849|NCT02326298|5560331|P11|STARTED|Maintenance Period (Week 16 to Week 48)||0
2264850|NCT02326298|5560332|P10|STARTED|Maintenance Period (Week 16 to Week 48)||8
2264851|NCT02326298|5560333|P9|STARTED|Maintenance Period (Week 16 to Week 48)||18
2264852|NCT02326298|5560334|P8|STARTED|Maintenance Period (Week 16 to Week 48)||38
2264853|NCT02326298|5560335|P7|STARTED|Maintenance Period (Week 16 to Week 48)||77
2264854|NCT02326298|5560336|P6|STARTED|Maintenance Period (Week 16 to Week 48)||74
2264855|NCT02326298|5560337|P5|STARTED|Maintenance Period (Week 16 to Week 48)||5
2264856|NCT02326298|5560338|P4|STARTED|Maintenance Period (Week 16 to Week 48)||3
2264857|NCT02326298|5560339|P3|STARTED|Maintenance Period (Week 16 to Week 48)||0
2264858|NCT02326298|5560340|P2|STARTED|Maintenance Period (Week 16 to Week 48)||0
2264859|NCT02326298|5560341|P1|STARTED|Maintenance Period (Week 16 to Week 48)||0
2264860|NCT02326298|5560328|P14|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
2264861|NCT02326298|5560329|P13|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
2264862|NCT02326298|5560330|P12|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
2264863|NCT02326298|5560331|P11|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
2264864|NCT02326298|5560332|P10|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
2264865|NCT02326298|5560333|P9|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
2264866|NCT02326298|5560334|P8|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
2264867|NCT02326298|5560335|P7|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
2264868|NCT02326298|5560336|P6|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
2264869|NCT02326298|5560337|P5|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
2264870|NCT02326298|5560338|P4|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
2264871|NCT02326298|5560339|P3|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
2264872|NCT02326298|5560340|P2|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
2264873|NCT02326298|5560341|P1|NOT COMPLETED|Initial Period (Week 0 to Week 16)||5
2264874|NCT02326298|5560328|P14|COMPLETED|Initial Period (Week 0 to Week 16)||0
2264875|NCT02326298|5560329|P13|COMPLETED|Initial Period (Week 0 to Week 16)||0
2264876|NCT02326298|5560330|P12|COMPLETED|Initial Period (Week 0 to Week 16)||0
2264877|NCT02326298|5560331|P11|COMPLETED|Initial Period (Week 0 to Week 16)||0
2264878|NCT02326298|5560332|P10|COMPLETED|Initial Period (Week 0 to Week 16)||0
2264879|NCT02326298|5560333|P9|COMPLETED|Initial Period (Week 0 to Week 16)||0
2264880|NCT02326298|5560334|P8|COMPLETED|Initial Period (Week 0 to Week 16)||0
2264881|NCT02326298|5560335|P7|COMPLETED|Initial Period (Week 0 to Week 16)||0
2264882|NCT02326298|5560336|P6|COMPLETED|Initial Period (Week 0 to Week 16)||0
2264883|NCT02326298|5560337|P5|COMPLETED|Initial Period (Week 0 to Week 16)||0
2264884|NCT02326298|5560338|P4|COMPLETED|Initial Period (Week 0 to Week 16)||0
2264885|NCT02326298|5560339|P3|COMPLETED|Initial Period (Week 0 to Week 16)||85
2264886|NCT02326298|5560340|P2|COMPLETED|Initial Period (Week 0 to Week 16)||92
2264887|NCT02326298|5560341|P1|COMPLETED|Initial Period (Week 0 to Week 16)||46
2264888|NCT02326298|5560328|P14|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
2264889|NCT02326298|5560329|P13|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
2264890|NCT02326298|5560330|P12|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
2264891|NCT02326298|5560331|P11|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
2264892|NCT02326298|5560332|P10|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
2264893|NCT02326298|5560333|P9|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
2264894|NCT02326298|5560334|P8|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
2264895|NCT02326298|5560335|P7|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
2264896|NCT02326298|5560336|P6|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
2264897|NCT02326298|5560337|P5|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
2264898|NCT02326298|5560338|P4|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
2264899|NCT02326298|5560339|P3|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||85
2264900|NCT02326298|5560340|P2|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||92
2264901|NCT02326298|5560341|P1|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||46
2264902|NCT02326298|5560328|P14|Completed Week 16|Initial Period (Week 0 to Week 16)||0
2264903|NCT02326298|5560329|P13|Completed Week 16|Initial Period (Week 0 to Week 16)||0
2264904|NCT02326298|5560330|P12|Completed Week 16|Initial Period (Week 0 to Week 16)||0
2264905|NCT02326298|5560331|P11|Completed Week 16|Initial Period (Week 0 to Week 16)||0
2264906|NCT02326298|5560332|P10|Completed Week 16|Initial Period (Week 0 to Week 16)||0
2264907|NCT02326298|5560333|P9|Completed Week 16|Initial Period (Week 0 to Week 16)||0
2264908|NCT02326298|5560334|P8|Completed Week 16|Initial Period (Week 0 to Week 16)||0
2264909|NCT02326298|5560335|P7|Completed Week 16|Initial Period (Week 0 to Week 16)||0
2264910|NCT02326298|5560336|P6|Completed Week 16|Initial Period (Week 0 to Week 16)||0
2264911|NCT02326298|5560337|P5|Completed Week 16|Initial Period (Week 0 to Week 16)||0
2264912|NCT02326298|5560338|P4|Completed Week 16|Initial Period (Week 0 to Week 16)||0
2264913|NCT02326298|5560339|P3|Completed Week 16|Initial Period (Week 0 to Week 16)||87
2264914|NCT02326298|5560340|P2|Completed Week 16|Initial Period (Week 0 to Week 16)||92
2264915|NCT02326298|5560341|P1|Completed Week 16|Initial Period (Week 0 to Week 16)||46
2264916|NCT02326298|5560328|P14|STARTED|Initial Period (Week 0 to Week 16)||0
2264917|NCT02326298|5560329|P13|STARTED|Initial Period (Week 0 to Week 16)||0
2264918|NCT02326298|5560330|P12|STARTED|Initial Period (Week 0 to Week 16)||0
2264919|NCT02326298|5560331|P11|STARTED|Initial Period (Week 0 to Week 16)||0
2264920|NCT02326298|5560332|P10|STARTED|Initial Period (Week 0 to Week 16)||0
2264921|NCT02326298|5560333|P9|STARTED|Initial Period (Week 0 to Week 16)||0
2264922|NCT02326298|5560334|P8|STARTED|Initial Period (Week 0 to Week 16)||0
2264923|NCT02326298|5560335|P7|STARTED|Initial Period (Week 0 to Week 16)||0
2264924|NCT02326298|5560336|P6|STARTED|Initial Period (Week 0 to Week 16)||0
2264925|NCT02326298|5560337|P5|STARTED|Initial Period (Week 0 to Week 16)||0
2264926|NCT02326298|5560338|P4|STARTED|Initial Period (Week 0 to Week 16)||0
2264927|NCT02326298|5560339|P3|STARTED|Initial Period (Week 0 to Week 16)||88
2264928|NCT02326298|5560340|P2|STARTED|Initial Period (Week 0 to Week 16)||95
2264929|NCT02326298|5560341|P1|STARTED|Initial Period (Week 0 to Week 16)||51
2264930|NCT02326272|5560364|P15|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||9
2264931|NCT02326272|5560365|P14|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264932|NCT02326272|5560366|P13|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||11
2264933|NCT02326272|5560367|P12|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||15
2264934|NCT02326272|5560368|P11|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||3
2264935|NCT02326272|5560369|P10|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264936|NCT02326272|5560370|P9|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264937|NCT02326272|5560371|P8|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264938|NCT02326272|5560372|P7|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264939|NCT02326272|5560373|P6|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264940|NCT02326272|5560374|P5|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264941|NCT02326272|5560375|P4|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264942|NCT02326272|5560376|P3|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264943|NCT02326272|5560377|P2|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264944|NCT02326272|5560378|P1|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264945|NCT02326272|5560364|P15|COMPLETED|Open-label Period (Week 48 to Week 144)||31
2264946|NCT02326272|5560365|P14|COMPLETED|Open-label Period (Week 48 to Week 144)||1
2264947|NCT02326272|5560366|P13|COMPLETED|Open-label Period (Week 48 to Week 144)||48
2264948|NCT02326272|5560367|P12|COMPLETED|Open-label Period (Week 48 to Week 144)||51
2264949|NCT02326272|5560368|P11|COMPLETED|Open-label Period (Week 48 to Week 144)||2
2264950|NCT02326272|5560369|P10|COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264951|NCT02326272|5560370|P9|COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264952|NCT02326272|5560371|P8|COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264953|NCT02326272|5560372|P7|COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264954|NCT02326272|5560373|P6|COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264955|NCT02326272|5560374|P5|COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264956|NCT02326272|5560375|P4|COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264957|NCT02326272|5560376|P3|COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264958|NCT02326272|5560377|P2|COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264959|NCT02326272|5560378|P1|COMPLETED|Open-label Period (Week 48 to Week 144)||0
2264960|NCT02326272|5560364|P15|STARTED|Open-label Period (Week 48 to Week 144)||40
2264961|NCT02326272|5560365|P14|STARTED|Open-label Period (Week 48 to Week 144)||1
2264962|NCT02326272|5560366|P13|STARTED|Open-label Period (Week 48 to Week 144)||59
2264963|NCT02326272|5560367|P12|STARTED|Open-label Period (Week 48 to Week 144)||66
2264964|NCT02326272|5560368|P11|STARTED|Open-label Period (Week 48 to Week 144)||5
2264965|NCT02326272|5560369|P10|STARTED|Open-label Period (Week 48 to Week 144)||0
2264966|NCT02326272|5560370|P9|STARTED|Open-label Period (Week 48 to Week 144)||0
2264967|NCT02326272|5560371|P8|STARTED|Open-label Period (Week 48 to Week 144)||0
2264968|NCT02326272|5560372|P7|STARTED|Open-label Period (Week 48 to Week 144)||0
2264969|NCT02326272|5560373|P6|STARTED|Open-label Period (Week 48 to Week 144)||0
2264970|NCT02326272|5560374|P5|STARTED|Open-label Period (Week 48 to Week 144)||0
2264971|NCT02326272|5560375|P4|STARTED|Open-label Period (Week 48 to Week 144)||0
2264972|NCT02326272|5560376|P3|STARTED|Open-label Period (Week 48 to Week 144)||0
2264973|NCT02326272|5560377|P2|STARTED|Open-label Period (Week 48 to Week 144)||0
2264974|NCT02326272|5560378|P1|STARTED|Open-label Period (Week 48 to Week 144)||0
2264975|NCT02326272|5560364|P15|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
2264976|NCT02326272|5560365|P14|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
2264977|NCT02326272|5560366|P13|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
2264978|NCT02326272|5560367|P12|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
2264979|NCT02326272|5560368|P11|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
2264980|NCT02326272|5560369|P10|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
2264981|NCT02326272|5560370|P9|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
2264982|NCT02326272|5560371|P8|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
2264983|NCT02326272|5560372|P7|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||9
2264984|NCT02326272|5560373|P6|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||13
2264985|NCT02326272|5560374|P5|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
2264986|NCT02326272|5560375|P4|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
2264987|NCT02326272|5560376|P3|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
2264988|NCT02326272|5560377|P2|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
2264989|NCT02326272|5560378|P1|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
2264990|NCT02326272|5560364|P15|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
2264991|NCT02326272|5560365|P14|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
2264992|NCT02326272|5560366|P13|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
2264993|NCT02326272|5560367|P12|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
2264994|NCT02326272|5560368|P11|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
2264995|NCT02326272|5560369|P10|COMPLETED|Maintenance Period (Week 16 to Week 48)||10
2264996|NCT02326272|5560370|P9|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
2264997|NCT02326272|5560371|P8|COMPLETED|Maintenance Period (Week 16 to Week 48)||27
2264998|NCT02326272|5560372|P7|COMPLETED|Maintenance Period (Week 16 to Week 48)||60
2264999|NCT02326272|5560373|P6|COMPLETED|Maintenance Period (Week 16 to Week 48)||63
2265000|NCT02326272|5560374|P5|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
2265001|NCT02326272|5560375|P4|COMPLETED|Maintenance Period (Week 16 to Week 48)||5
2265002|NCT02326272|5560376|P3|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
2265003|NCT02326272|5560377|P2|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
2265004|NCT02326272|5560378|P1|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
2265005|NCT02326272|5560364|P15|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
2265006|NCT02326272|5560365|P14|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
2265007|NCT02326272|5560366|P13|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
2265008|NCT02326272|5560367|P12|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
2265009|NCT02326272|5560368|P11|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
2265010|NCT02326272|5560369|P10|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||10
2265011|NCT02326272|5560370|P9|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
2265241|NCT02325713|5560505|P12|STARTED|Intervention Period 3 (2 Days)||2
2265012|NCT02326272|5560371|P8|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||27
2265013|NCT02326272|5560372|P7|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||60
2265014|NCT02326272|5560373|P6|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||63
2265015|NCT02326272|5560374|P5|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
2265016|NCT02326272|5560375|P4|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||5
2265017|NCT02326272|5560376|P3|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
2265018|NCT02326272|5560377|P2|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
2265019|NCT02326272|5560378|P1|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
2265020|NCT02326272|5560364|P15|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
2265021|NCT02326272|5560365|P14|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
2265022|NCT02326272|5560366|P13|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
2265023|NCT02326272|5560367|P12|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
2265024|NCT02326272|5560368|P11|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
2265025|NCT02326272|5560369|P10|Completed Week 48|Maintenance Period (Week 16 to Week 48)||10
2265026|NCT02326272|5560370|P9|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
2265027|NCT02326272|5560371|P8|Completed Week 48|Maintenance Period (Week 16 to Week 48)||27
2265028|NCT02326272|5560372|P7|Completed Week 48|Maintenance Period (Week 16 to Week 48)||61
2265029|NCT02326272|5560373|P6|Completed Week 48|Maintenance Period (Week 16 to Week 48)||64
2265030|NCT02326272|5560374|P5|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
2265031|NCT02326272|5560375|P4|Completed Week 48|Maintenance Period (Week 16 to Week 48)||5
2265032|NCT02326272|5560376|P3|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
2265033|NCT02326272|5560377|P2|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
2265034|NCT02326272|5560378|P1|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
2265035|NCT02326272|5560364|P15|STARTED|Maintenance Period (Week 16 to Week 48)||0
2265036|NCT02326272|5560365|P14|STARTED|Maintenance Period (Week 16 to Week 48)||0
2265037|NCT02326272|5560366|P13|STARTED|Maintenance Period (Week 16 to Week 48)||0
2265038|NCT02326272|5560367|P12|STARTED|Maintenance Period (Week 16 to Week 48)||0
2265039|NCT02326272|5560368|P11|STARTED|Maintenance Period (Week 16 to Week 48)||0
2265040|NCT02326272|5560369|P10|STARTED|Maintenance Period (Week 16 to Week 48)||12
2265041|NCT02326272|5560370|P9|STARTED|Maintenance Period (Week 16 to Week 48)||8
2265042|NCT02326272|5560371|P8|STARTED|Maintenance Period (Week 16 to Week 48)||34
2265043|NCT02326272|5560372|P7|STARTED|Maintenance Period (Week 16 to Week 48)||69
2265044|NCT02326272|5560373|P6|STARTED|Maintenance Period (Week 16 to Week 48)||76
2265045|NCT02326272|5560374|P5|STARTED|Maintenance Period (Week 16 to Week 48)||5
2265046|NCT02326272|5560375|P4|STARTED|Maintenance Period (Week 16 to Week 48)||6
2265047|NCT02326272|5560376|P3|STARTED|Maintenance Period (Week 16 to Week 48)||0
2265048|NCT02326272|5560377|P2|STARTED|Maintenance Period (Week 16 to Week 48)||0
2265049|NCT02326272|5560378|P1|STARTED|Maintenance Period (Week 16 to Week 48)||0
2265050|NCT02326272|5560364|P15|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
2265051|NCT02326272|5560365|P14|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
2265052|NCT02326272|5560366|P13|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
2265053|NCT02326272|5560367|P12|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
2265054|NCT02326272|5560368|P11|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
2265055|NCT02326272|5560369|P10|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
2265056|NCT02326272|5560370|P9|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
2265057|NCT02326272|5560371|P8|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
2265058|NCT02326272|5560372|P7|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
2265059|NCT02326272|5560373|P6|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
2265060|NCT02326272|5560374|P5|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
2265061|NCT02326272|5560375|P4|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
2265062|NCT02326272|5560376|P3|NOT COMPLETED|Initial Period (Week 0 to Week 16)||6
2265063|NCT02326272|5560377|P2|NOT COMPLETED|Initial Period (Week 0 to Week 16)||7
2265064|NCT02326272|5560378|P1|NOT COMPLETED|Initial Period (Week 0 to Week 16)||4
2265065|NCT02326272|5560364|P15|COMPLETED|Initial Period (Week 0 to Week 16)||0
2265066|NCT02326272|5560365|P14|COMPLETED|Initial Period (Week 0 to Week 16)||0
2265067|NCT02326272|5560366|P13|COMPLETED|Initial Period (Week 0 to Week 16)||0
2265068|NCT02326272|5560367|P12|COMPLETED|Initial Period (Week 0 to Week 16)||0
2265069|NCT02326272|5560368|P11|COMPLETED|Initial Period (Week 0 to Week 16)||0
2265070|NCT02326272|5560369|P10|COMPLETED|Initial Period (Week 0 to Week 16)||0
2265071|NCT02326272|5560370|P9|COMPLETED|Initial Period (Week 0 to Week 16)||0
2265072|NCT02326272|5560371|P8|COMPLETED|Initial Period (Week 0 to Week 16)||0
2265073|NCT02326272|5560372|P7|COMPLETED|Initial Period (Week 0 to Week 16)||0
2265074|NCT02326272|5560373|P6|COMPLETED|Initial Period (Week 0 to Week 16)||0
2265075|NCT02326272|5560374|P5|COMPLETED|Initial Period (Week 0 to Week 16)||0
2265076|NCT02326272|5560375|P4|COMPLETED|Initial Period (Week 0 to Week 16)||0
2265077|NCT02326272|5560376|P3|COMPLETED|Initial Period (Week 0 to Week 16)||81
2265078|NCT02326272|5560377|P2|COMPLETED|Initial Period (Week 0 to Week 16)||84
2265079|NCT02326272|5560378|P1|COMPLETED|Initial Period (Week 0 to Week 16)||45
2265080|NCT02326272|5560364|P15|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
2265081|NCT02326272|5560365|P14|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
2265082|NCT02326272|5560366|P13|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
2265083|NCT02326272|5560367|P12|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
2265084|NCT02326272|5560368|P11|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
2265085|NCT02326272|5560369|P10|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
2265086|NCT02326272|5560370|P9|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
2265087|NCT02326272|5560371|P8|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
2265088|NCT02326272|5560372|P7|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
2265089|NCT02326272|5560373|P6|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
2265090|NCT02326272|5560374|P5|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
2265091|NCT02326272|5560375|P4|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
2265092|NCT02326272|5560376|P3|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||81
2265093|NCT02326272|5560377|P2|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||84
2265094|NCT02326272|5560378|P1|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||45
2265095|NCT02326272|5560364|P15|Completed Week 16|Initial Period (Week 0 to Week 16)||0
2265096|NCT02326272|5560365|P14|Completed Week 16|Initial Period (Week 0 to Week 16)||0
2265097|NCT02326272|5560366|P13|Completed Week 16|Initial Period (Week 0 to Week 16)||0
2265098|NCT02326272|5560367|P12|Completed Week 16|Initial Period (Week 0 to Week 16)||0
2265099|NCT02326272|5560368|P11|Completed Week 16|Initial Period (Week 0 to Week 16)||0
2265100|NCT02326272|5560369|P10|Completed Week 16|Initial Period (Week 0 to Week 16)||0
2265101|NCT02326272|5560370|P9|Completed Week 16|Initial Period (Week 0 to Week 16)||0
2265102|NCT02326272|5560371|P8|Completed Week 16|Initial Period (Week 0 to Week 16)||0
2265103|NCT02326272|5560372|P7|Completed Week 16|Initial Period (Week 0 to Week 16)||0
2265104|NCT02326272|5560373|P6|Completed Week 16|Initial Period (Week 0 to Week 16)||0
2265105|NCT02326272|5560374|P5|Completed Week 16|Initial Period (Week 0 to Week 16)||0
2265106|NCT02326272|5560375|P4|Completed Week 16|Initial Period (Week 0 to Week 16)||0
2265107|NCT02326272|5560376|P3|Completed Week 16|Initial Period (Week 0 to Week 16)||83
2265108|NCT02326272|5560377|P2|Completed Week 16|Initial Period (Week 0 to Week 16)||84
2265109|NCT02326272|5560378|P1|Completed Week 16|Initial Period (Week 0 to Week 16)||45
2265110|NCT02326272|5560364|P15|STARTED|Initial Period (Week 0 to Week 16)||0
2265111|NCT02326272|5560365|P14|STARTED|Initial Period (Week 0 to Week 16)||0
2265112|NCT02326272|5560366|P13|STARTED|Initial Period (Week 0 to Week 16)||0
2265113|NCT02326272|5560367|P12|STARTED|Initial Period (Week 0 to Week 16)||0
2265114|NCT02326272|5560368|P11|STARTED|Initial Period (Week 0 to Week 16)||0
2265115|NCT02326272|5560369|P10|STARTED|Initial Period (Week 0 to Week 16)||0
2265116|NCT02326272|5560370|P9|STARTED|Initial Period (Week 0 to Week 16)||0
2265117|NCT02326272|5560371|P8|STARTED|Initial Period (Week 0 to Week 16)||0
2265118|NCT02326272|5560372|P7|STARTED|Initial Period (Week 0 to Week 16)||0
2265119|NCT02326272|5560373|P6|STARTED|Initial Period (Week 0 to Week 16)||0
2265120|NCT02326272|5560374|P5|STARTED|Initial Period (Week 0 to Week 16)||0
2265121|NCT02326272|5560375|P4|STARTED|Initial Period (Week 0 to Week 16)||0
2265122|NCT02326272|5560376|P3|STARTED|Initial Period (Week 0 to Week 16)||87
2265123|NCT02326272|5560377|P2|STARTED|Initial Period (Week 0 to Week 16)||91
2265124|NCT02326272|5560378|P1|STARTED|Initial Period (Week 0 to Week 16)||49
2265125|NCT02326233|5560400|P2|NOT COMPLETED|Overall Study||1
2265126|NCT02326233|5560401|P1|NOT COMPLETED|Overall Study||0
2265127|NCT02326233|5560400|P2|COMPLETED|Overall Study||94
2265128|NCT02326233|5560401|P1|COMPLETED|Overall Study||95
2265129|NCT02326233|5560400|P2|STARTED|Overall Study||95
2265130|NCT02326233|5560401|P1|STARTED|Overall Study||95
2265131|NCT02326025|5560415|P2|NOT COMPLETED|Overall Study||5
2265132|NCT02326025|5560416|P1|NOT COMPLETED|Overall Study||5
2265133|NCT02326025|5560415|P2|COMPLETED|Overall Study||19
2265134|NCT02326025|5560416|P1|COMPLETED|Overall Study||20
2265135|NCT02326025|5560415|P2|Received at Least 1 Dose of Study Drug|Overall Study||24
2265136|NCT02326025|5560416|P1|Received at Least 1 Dose of Study Drug|Overall Study||25
2265137|NCT02326025|5560415|P2|STARTED|Overall Study||24
2265138|NCT02326025|5560416|P1|STARTED|Overall Study||25
2265139|NCT02325856|5560450|P2|NOT COMPLETED|Overall Study||27
2265140|NCT02325856|5560451|P1|NOT COMPLETED|Overall Study||20
2265141|NCT02325856|5560450|P2|COMPLETED|Overall Study||123
2265142|NCT02325856|5560451|P1|COMPLETED|Overall Study||128
2265143|NCT02325856|5560450|P2|STARTED|Overall Study||150
2265144|NCT02325856|5560451|P1|STARTED|Overall Study||148
2265145|NCT02325791|5560463|P4|NOT COMPLETED|Overall Study||26
2265146|NCT02325791|5560464|P3|NOT COMPLETED|Overall Study||25
2265147|NCT02325791|5560465|P2|NOT COMPLETED|Overall Study||25
2265148|NCT02325791|5560466|P1|NOT COMPLETED|Overall Study||0
2265149|NCT02325791|5560463|P4|COMPLETED|Overall Study||355
2265150|NCT02325791|5560464|P3|COMPLETED|Overall Study||360
2265151|NCT02325791|5560465|P2|COMPLETED|Overall Study||358
2265152|NCT02325791|5560466|P1|COMPLETED|Overall Study||23
2265153|NCT02325791|5560463|P4|STARTED|Overall Study||381
2265154|NCT02325791|5560464|P3|STARTED|Overall Study||385
2265155|NCT02325791|5560465|P2|STARTED|Overall Study||383
2265156|NCT02325791|5560466|P1|STARTED|Overall Study||23
2265157|NCT02325713|5560501|P16|NOT COMPLETED|Intervention Period 4 (2 Days)||0
2265158|NCT02325713|5560502|P15|NOT COMPLETED|Intervention Period 4 (2 Days)||0
2265159|NCT02325713|5560503|P14|NOT COMPLETED|Intervention Period 4 (2 Days)||0
2265160|NCT02325713|5560504|P13|NOT COMPLETED|Intervention Period 4 (2 Days)||0
2265161|NCT02325713|5560505|P12|NOT COMPLETED|Intervention Period 4 (2 Days)||0
2265162|NCT02325713|5560506|P11|NOT COMPLETED|Intervention Period 4 (2 Days)||0
2265163|NCT02325713|5560507|P10|NOT COMPLETED|Intervention Period 4 (2 Days)||0
2265164|NCT02325713|5560508|P9|NOT COMPLETED|Intervention Period 4 (2 Days)||0
2265165|NCT02325713|5560509|P8|NOT COMPLETED|Intervention Period 4 (2 Days)||0
2265166|NCT02325713|5560510|P7|NOT COMPLETED|Intervention Period 4 (2 Days)||0
2265167|NCT02325713|5560511|P6|NOT COMPLETED|Intervention Period 4 (2 Days)||0
2265168|NCT02325713|5560512|P5|NOT COMPLETED|Intervention Period 4 (2 Days)||0
2265169|NCT02325713|5560513|P4|NOT COMPLETED|Intervention Period 4 (2 Days)||0
2265170|NCT02325713|5560514|P3|NOT COMPLETED|Intervention Period 4 (2 Days)||0
2265171|NCT02325713|5560515|P2|NOT COMPLETED|Intervention Period 4 (2 Days)||0
2265172|NCT02325713|5560516|P1|NOT COMPLETED|Intervention Period 4 (2 Days)||0
2265173|NCT02325713|5560501|P16|COMPLETED|Intervention Period 4 (2 Days)||2
2265174|NCT02325713|5560502|P15|COMPLETED|Intervention Period 4 (2 Days)||2
2265175|NCT02325713|5560503|P14|COMPLETED|Intervention Period 4 (2 Days)||2
2265176|NCT02325713|5560504|P13|COMPLETED|Intervention Period 4 (2 Days)||2
2265177|NCT02325713|5560505|P12|COMPLETED|Intervention Period 4 (2 Days)||2
2265178|NCT02325713|5560506|P11|COMPLETED|Intervention Period 4 (2 Days)||1
2265179|NCT02325713|5560507|P10|COMPLETED|Intervention Period 4 (2 Days)||1
2265180|NCT02325713|5560508|P9|COMPLETED|Intervention Period 4 (2 Days)||2
2265181|NCT02325713|5560509|P8|COMPLETED|Intervention Period 4 (2 Days)||2
2265182|NCT02325713|5560510|P7|COMPLETED|Intervention Period 4 (2 Days)||2
2265183|NCT02325713|5560511|P6|COMPLETED|Intervention Period 4 (2 Days)||2
2265184|NCT02325713|5560512|P5|COMPLETED|Intervention Period 4 (2 Days)||2
2265185|NCT02325713|5560513|P4|COMPLETED|Intervention Period 4 (2 Days)||2
2265186|NCT02325713|5560514|P3|COMPLETED|Intervention Period 4 (2 Days)||2
2265187|NCT02325713|5560515|P2|COMPLETED|Intervention Period 4 (2 Days)||2
2265188|NCT02325713|5560516|P1|COMPLETED|Intervention Period 4 (2 Days)||1
2265189|NCT02325713|5560501|P16|STARTED|Intervention Period 4 (2 Days)||2
2265190|NCT02325713|5560502|P15|STARTED|Intervention Period 4 (2 Days)||2
2265191|NCT02325713|5560503|P14|STARTED|Intervention Period 4 (2 Days)||2
2265192|NCT02325713|5560504|P13|STARTED|Intervention Period 4 (2 Days)||2
2265193|NCT02325713|5560505|P12|STARTED|Intervention Period 4 (2 Days)||2
2265194|NCT02325713|5560506|P11|STARTED|Intervention Period 4 (2 Days)||1
2265195|NCT02325713|5560507|P10|STARTED|Intervention Period 4 (2 Days)||1
2265196|NCT02325713|5560508|P9|STARTED|Intervention Period 4 (2 Days)||2
2265197|NCT02325713|5560509|P8|STARTED|Intervention Period 4 (2 Days)||2
2265198|NCT02325713|5560510|P7|STARTED|Intervention Period 4 (2 Days)||2
2265199|NCT02325713|5560511|P6|STARTED|Intervention Period 4 (2 Days)||2
2265200|NCT02325713|5560512|P5|STARTED|Intervention Period 4 (2 Days)||2
2265201|NCT02325713|5560513|P4|STARTED|Intervention Period 4 (2 Days)||2
2265202|NCT02325713|5560514|P3|STARTED|Intervention Period 4 (2 Days)||2
2265203|NCT02325713|5560515|P2|STARTED|Intervention Period 4 (2 Days)||2
2265204|NCT02325713|5560516|P1|STARTED|Intervention Period 4 (2 Days)||1
2265205|NCT02325713|5560501|P16|NOT COMPLETED|Intervention Period 3 (2 Days)||0
2265206|NCT02325713|5560502|P15|NOT COMPLETED|Intervention Period 3 (2 Days)||0
2265207|NCT02325713|5560503|P14|NOT COMPLETED|Intervention Period 3 (2 Days)||0
2265208|NCT02325713|5560504|P13|NOT COMPLETED|Intervention Period 3 (2 Days)||0
2265209|NCT02325713|5560505|P12|NOT COMPLETED|Intervention Period 3 (2 Days)||0
2265210|NCT02325713|5560506|P11|NOT COMPLETED|Intervention Period 3 (2 Days)||0
2265211|NCT02325713|5560507|P10|NOT COMPLETED|Intervention Period 3 (2 Days)||1
2265212|NCT02325713|5560508|P9|NOT COMPLETED|Intervention Period 3 (2 Days)||0
2265213|NCT02325713|5560509|P8|NOT COMPLETED|Intervention Period 3 (2 Days)||0
2265214|NCT02325713|5560510|P7|NOT COMPLETED|Intervention Period 3 (2 Days)||0
2265215|NCT02325713|5560511|P6|NOT COMPLETED|Intervention Period 3 (2 Days)||0
2265216|NCT02325713|5560512|P5|NOT COMPLETED|Intervention Period 3 (2 Days)||0
2265217|NCT02325713|5560513|P4|NOT COMPLETED|Intervention Period 3 (2 Days)||0
2265218|NCT02325713|5560514|P3|NOT COMPLETED|Intervention Period 3 (2 Days)||0
2265219|NCT02325713|5560515|P2|NOT COMPLETED|Intervention Period 3 (2 Days)||0
2265220|NCT02325713|5560516|P1|NOT COMPLETED|Intervention Period 3 (2 Days)||0
2265221|NCT02325713|5560501|P16|COMPLETED|Intervention Period 3 (2 Days)||2
2265222|NCT02325713|5560502|P15|COMPLETED|Intervention Period 3 (2 Days)||2
2265223|NCT02325713|5560503|P14|COMPLETED|Intervention Period 3 (2 Days)||2
2265224|NCT02325713|5560504|P13|COMPLETED|Intervention Period 3 (2 Days)||2
2265225|NCT02325713|5560505|P12|COMPLETED|Intervention Period 3 (2 Days)||2
2265226|NCT02325713|5560506|P11|COMPLETED|Intervention Period 3 (2 Days)||1
2265227|NCT02325713|5560507|P10|COMPLETED|Intervention Period 3 (2 Days)||1
2265228|NCT02325713|5560508|P9|COMPLETED|Intervention Period 3 (2 Days)||2
2265229|NCT02325713|5560509|P8|COMPLETED|Intervention Period 3 (2 Days)||2
2265230|NCT02325713|5560510|P7|COMPLETED|Intervention Period 3 (2 Days)||2
2265231|NCT02325713|5560511|P6|COMPLETED|Intervention Period 3 (2 Days)||2
2265232|NCT02325713|5560512|P5|COMPLETED|Intervention Period 3 (2 Days)||2
2265233|NCT02325713|5560513|P4|COMPLETED|Intervention Period 3 (2 Days)||2
2265234|NCT02325713|5560514|P3|COMPLETED|Intervention Period 3 (2 Days)||2
2265235|NCT02325713|5560515|P2|COMPLETED|Intervention Period 3 (2 Days)||2
2265236|NCT02325713|5560516|P1|COMPLETED|Intervention Period 3 (2 Days)||1
2265237|NCT02325713|5560501|P16|STARTED|Intervention Period 3 (2 Days)||2
2265238|NCT02325713|5560502|P15|STARTED|Intervention Period 3 (2 Days)||2
2265239|NCT02325713|5560503|P14|STARTED|Intervention Period 3 (2 Days)||2
2265240|NCT02325713|5560504|P13|STARTED|Intervention Period 3 (2 Days)||2
2265242|NCT02325713|5560506|P11|STARTED|Intervention Period 3 (2 Days)||1
2265243|NCT02325713|5560507|P10|STARTED|Intervention Period 3 (2 Days)||2
2265244|NCT02325713|5560508|P9|STARTED|Intervention Period 3 (2 Days)||2
2265245|NCT02325713|5560509|P8|STARTED|Intervention Period 3 (2 Days)||2
2265246|NCT02325713|5560510|P7|STARTED|Intervention Period 3 (2 Days)||2
2265247|NCT02325713|5560511|P6|STARTED|Intervention Period 3 (2 Days)||2
2265248|NCT02325713|5560512|P5|STARTED|Intervention Period 3 (2 Days)||2
2265249|NCT02325713|5560513|P4|STARTED|Intervention Period 3 (2 Days)||2
2265250|NCT02325713|5560514|P3|STARTED|Intervention Period 3 (2 Days)||2
2265251|NCT02325713|5560515|P2|STARTED|Intervention Period 3 (2 Days)||2
2265252|NCT02325713|5560516|P1|STARTED|Intervention Period 3 (2 Days)||1
2265253|NCT02325713|5560501|P16|NOT COMPLETED|Intervention Period 2 (2 Days)||0
2265254|NCT02325713|5560502|P15|NOT COMPLETED|Intervention Period 2 (2 Days)||0
2265255|NCT02325713|5560503|P14|NOT COMPLETED|Intervention Period 2 (2 Days)||0
2265256|NCT02325713|5560504|P13|NOT COMPLETED|Intervention Period 2 (2 Days)||0
2265257|NCT02325713|5560505|P12|NOT COMPLETED|Intervention Period 2 (2 Days)||0
2265258|NCT02325713|5560506|P11|NOT COMPLETED|Intervention Period 2 (2 Days)||0
2265259|NCT02325713|5560507|P10|NOT COMPLETED|Intervention Period 2 (2 Days)||0
2265260|NCT02325713|5560508|P9|NOT COMPLETED|Intervention Period 2 (2 Days)||0
2265261|NCT02325713|5560509|P8|NOT COMPLETED|Intervention Period 2 (2 Days)||0
2265262|NCT02325713|5560510|P7|NOT COMPLETED|Intervention Period 2 (2 Days)||0
2265263|NCT02325713|5560511|P6|NOT COMPLETED|Intervention Period 2 (2 Days)||0
2265264|NCT02325713|5560512|P5|NOT COMPLETED|Intervention Period 2 (2 Days)||0
2265265|NCT02325713|5560513|P4|NOT COMPLETED|Intervention Period 2 (2 Days)||0
2265266|NCT02325713|5560514|P3|NOT COMPLETED|Intervention Period 2 (2 Days)||0
2265267|NCT02325713|5560515|P2|NOT COMPLETED|Intervention Period 2 (2 Days)||0
2265268|NCT02325713|5560516|P1|NOT COMPLETED|Intervention Period 2 (2 Days)||1
2265269|NCT02325713|5560501|P16|COMPLETED|Intervention Period 2 (2 Days)||2
2265270|NCT02325713|5560502|P15|COMPLETED|Intervention Period 2 (2 Days)||2
2265271|NCT02325713|5560503|P14|COMPLETED|Intervention Period 2 (2 Days)||2
2265272|NCT02325713|5560504|P13|COMPLETED|Intervention Period 2 (2 Days)||2
2265273|NCT02325713|5560505|P12|COMPLETED|Intervention Period 2 (2 Days)||2
2265274|NCT02325713|5560506|P11|COMPLETED|Intervention Period 2 (2 Days)||1
2265275|NCT02325713|5560507|P10|COMPLETED|Intervention Period 2 (2 Days)||2
2265276|NCT02325713|5560508|P9|COMPLETED|Intervention Period 2 (2 Days)||2
2265277|NCT02325713|5560509|P8|COMPLETED|Intervention Period 2 (2 Days)||2
2265278|NCT02325713|5560510|P7|COMPLETED|Intervention Period 2 (2 Days)||2
2265279|NCT02325713|5560511|P6|COMPLETED|Intervention Period 2 (2 Days)||2
2265280|NCT02325713|5560512|P5|COMPLETED|Intervention Period 2 (2 Days)||2
2265281|NCT02325713|5560513|P4|COMPLETED|Intervention Period 2 (2 Days)||2
2265282|NCT02325713|5560514|P3|COMPLETED|Intervention Period 2 (2 Days)||2
2265283|NCT02325713|5560515|P2|COMPLETED|Intervention Period 2 (2 Days)||2
2265284|NCT02325713|5560516|P1|COMPLETED|Intervention Period 2 (2 Days)||1
2265285|NCT02325713|5560501|P16|STARTED|Intervention Period 2 (2 Days)||2
2265286|NCT02325713|5560502|P15|STARTED|Intervention Period 2 (2 Days)||2
2265287|NCT02325713|5560503|P14|STARTED|Intervention Period 2 (2 Days)||2
2265288|NCT02325713|5560504|P13|STARTED|Intervention Period 2 (2 Days)||2
2265289|NCT02325713|5560505|P12|STARTED|Intervention Period 2 (2 Days)||2
2265290|NCT02325713|5560506|P11|STARTED|Intervention Period 2 (2 Days)||1
2265291|NCT02325713|5560507|P10|STARTED|Intervention Period 2 (2 Days)||2
2265292|NCT02325713|5560508|P9|STARTED|Intervention Period 2 (2 Days)||2
2265293|NCT02325713|5560509|P8|STARTED|Intervention Period 2 (2 Days)||2
2265294|NCT02325713|5560510|P7|STARTED|Intervention Period 2 (2 Days)||2
2265295|NCT02325713|5560511|P6|STARTED|Intervention Period 2 (2 Days)||2
2265296|NCT02325713|5560512|P5|STARTED|Intervention Period 2 (2 Days)||2
2265297|NCT02325713|5560513|P4|STARTED|Intervention Period 2 (2 Days)||2
2265298|NCT02325713|5560514|P3|STARTED|Intervention Period 2 (2 Days)||2
2265299|NCT02325713|5560515|P2|STARTED|Intervention Period 2 (2 Days)||2
2265300|NCT02325713|5560516|P1|STARTED|Intervention Period 2 (2 Days)||2
2265301|NCT02325713|5560501|P16|NOT COMPLETED|Intervention Period 1 (2 Days)||0
2265302|NCT02325713|5560502|P15|NOT COMPLETED|Intervention Period 1 (2 Days)||0
2265303|NCT02325713|5560503|P14|NOT COMPLETED|Intervention Period 1 (2 Days)||0
2265304|NCT02325713|5560504|P13|NOT COMPLETED|Intervention Period 1 (2 Days)||0
2265305|NCT02325713|5560505|P12|NOT COMPLETED|Intervention Period 1 (2 Days)||0
2265306|NCT02325713|5560506|P11|NOT COMPLETED|Intervention Period 1 (2 Days)||1
2265307|NCT02325713|5560507|P10|NOT COMPLETED|Intervention Period 1 (2 Days)||0
2265308|NCT02325713|5560508|P9|NOT COMPLETED|Intervention Period 1 (2 Days)||0
2265309|NCT02325713|5560509|P8|NOT COMPLETED|Intervention Period 1 (2 Days)||0
2265310|NCT02325713|5560510|P7|NOT COMPLETED|Intervention Period 1 (2 Days)||0
2265311|NCT02325713|5560511|P6|NOT COMPLETED|Intervention Period 1 (2 Days)||0
2265312|NCT02325713|5560512|P5|NOT COMPLETED|Intervention Period 1 (2 Days)||0
2265313|NCT02325713|5560513|P4|NOT COMPLETED|Intervention Period 1 (2 Days)||0
2265314|NCT02325713|5560514|P3|NOT COMPLETED|Intervention Period 1 (2 Days)||0
2265315|NCT02325713|5560515|P2|NOT COMPLETED|Intervention Period 1 (2 Days)||0
2265316|NCT02325713|5560516|P1|NOT COMPLETED|Intervention Period 1 (2 Days)||0
2265317|NCT02325713|5560501|P16|COMPLETED|Intervention Period 1 (2 Days)||2
2265318|NCT02325713|5560502|P15|COMPLETED|Intervention Period 1 (2 Days)||2
2265319|NCT02325713|5560503|P14|COMPLETED|Intervention Period 1 (2 Days)||2
2265320|NCT02325713|5560504|P13|COMPLETED|Intervention Period 1 (2 Days)||2
2265321|NCT02325713|5560505|P12|COMPLETED|Intervention Period 1 (2 Days)||2
2265322|NCT02325713|5560506|P11|COMPLETED|Intervention Period 1 (2 Days)||1
2265323|NCT02325713|5560507|P10|COMPLETED|Intervention Period 1 (2 Days)||2
2265324|NCT02325713|5560508|P9|COMPLETED|Intervention Period 1 (2 Days)||2
2265325|NCT02325713|5560509|P8|COMPLETED|Intervention Period 1 (2 Days)||2
2265326|NCT02325713|5560510|P7|COMPLETED|Intervention Period 1 (2 Days)||2
2265327|NCT02325713|5560511|P6|COMPLETED|Intervention Period 1 (2 Days)||2
2265328|NCT02325713|5560512|P5|COMPLETED|Intervention Period 1 (2 Days)||2
2265329|NCT02325713|5560513|P4|COMPLETED|Intervention Period 1 (2 Days)||2
2265330|NCT02325713|5560514|P3|COMPLETED|Intervention Period 1 (2 Days)||2
2265331|NCT02325713|5560515|P2|COMPLETED|Intervention Period 1 (2 Days)||2
2265332|NCT02325713|5560516|P1|COMPLETED|Intervention Period 1 (2 Days)||2
2265333|NCT02325713|5560501|P16|STARTED|Intervention Period 1 (2 Days)||2
2265334|NCT02325713|5560502|P15|STARTED|Intervention Period 1 (2 Days)||2
2265335|NCT02325713|5560503|P14|STARTED|Intervention Period 1 (2 Days)||2
2265336|NCT02325713|5560504|P13|STARTED|Intervention Period 1 (2 Days)||2
2265337|NCT02325713|5560505|P12|STARTED|Intervention Period 1 (2 Days)||2
2265338|NCT02325713|5560506|P11|STARTED|Intervention Period 1 (2 Days)||2
2265339|NCT02325713|5560507|P10|STARTED|Intervention Period 1 (2 Days)||2
2265340|NCT02325713|5560508|P9|STARTED|Intervention Period 1 (2 Days)||2
2265341|NCT02325713|5560509|P8|STARTED|Intervention Period 1 (2 Days)||2
2265342|NCT02325713|5560510|P7|STARTED|Intervention Period 1 (2 Days)||2
2265343|NCT02325713|5560511|P6|STARTED|Intervention Period 1 (2 Days)||2
2265344|NCT02325713|5560512|P5|STARTED|Intervention Period 1 (2 Days)||2
2265345|NCT02325713|5560513|P4|STARTED|Intervention Period 1 (2 Days)||2
2265346|NCT02325713|5560514|P3|STARTED|Intervention Period 1 (2 Days)||2
2265347|NCT02325713|5560515|P2|STARTED|Intervention Period 1 (2 Days)||2
2265348|NCT02325713|5560516|P1|STARTED|Intervention Period 1 (2 Days)||2
2265349|NCT02325518|5560611|P2|NOT COMPLETED|Overall Study||3
2265350|NCT02325518|5560612|P1|NOT COMPLETED|Overall Study||4
2265351|NCT02325518|5560611|P2|COMPLETED|Overall Study||100
2265352|NCT02325518|5560612|P1|COMPLETED|Overall Study||94
2265353|NCT02325518|5560611|P2|Per Protocol Set (PPS)|Overall Study||97
2265354|NCT02325518|5560612|P1|Per Protocol Set (PPS)|Overall Study||92
2265355|NCT02325518|5560611|P2|Full Analysis Set (FAS)|Overall Study||101
2265356|NCT02325518|5560612|P1|Full Analysis Set (FAS)|Overall Study||98
2265357|NCT02325518|5560611|P2|Safety Set|Overall Study||103
2265358|NCT02325518|5560612|P1|Safety Set|Overall Study||98
2265359|NCT02325518|5560611|P2|STARTED|Overall Study||103
2265360|NCT02325518|5560612|P1|STARTED|Overall Study||98
2265361|NCT02324972|5560623|P2|NOT COMPLETED|Overall Study||5
2265362|NCT02324972|5560624|P1|NOT COMPLETED|Overall Study||7
2265363|NCT02324972|5560623|P2|COMPLETED|Overall Study||23
2265364|NCT02324972|5560624|P1|COMPLETED|Overall Study||19
2265365|NCT02324972|5560623|P2|STARTED|Overall Study||28
2265366|NCT02324972|5560624|P1|STARTED|Overall Study||26
2265367|NCT02324842|5560641|P3|NOT COMPLETED|Overall Study||2
2265368|NCT02324842|5560642|P2|NOT COMPLETED|Overall Study||1
2265369|NCT02324842|5560643|P1|NOT COMPLETED|Overall Study||1
2265370|NCT02324842|5560641|P3|COMPLETED|Overall Study||13
2265371|NCT02324842|5560642|P2|COMPLETED|Overall Study||14
2265372|NCT02324842|5560643|P1|COMPLETED|Overall Study||14
2265373|NCT02324842|5560641|P3|STARTED|Overall Study||15
2265374|NCT02324842|5560642|P2|STARTED|Overall Study||15
2265375|NCT02324842|5560643|P1|STARTED|Overall Study||15
2265376|NCT02324699|5560672|P1|NOT COMPLETED|Overall Study||1
2265377|NCT02324699|5560672|P1|COMPLETED|Overall Study||0
2265378|NCT02324699|5560672|P1|STARTED|Overall Study||1
2265379|NCT02324673|5560682|P3|NOT COMPLETED|Overall Study||0
2265380|NCT02324673|5560683|P2|NOT COMPLETED|Overall Study||0
2265381|NCT02324673|5560684|P1|NOT COMPLETED|Overall Study||0
2265382|NCT02324673|5560682|P3|COMPLETED|Overall Study||21
2265383|NCT02324673|5560683|P2|COMPLETED|Overall Study||20
2265384|NCT02324673|5560684|P1|COMPLETED|Overall Study||20
2265385|NCT02324673|5560682|P3|STARTED|Overall Study||21
2265386|NCT02324673|5560683|P2|STARTED|Overall Study||20
2265387|NCT02324673|5560684|P1|STARTED|Overall Study||20
2265388|NCT02324660|5560785|P1|NOT COMPLETED|Overall Study||32
2265389|NCT02324660|5560785|P1|COMPLETED|Overall Study||137
2265390|NCT02324660|5560785|P1|STARTED|Overall Study||169
2265391|NCT02324569|5560792|P2|NOT COMPLETED|Overall Study||21
2265392|NCT02324569|5560793|P1|NOT COMPLETED|Overall Study||16
2265393|NCT02324569|5560792|P2|COMPLETED|Overall Study||103
2265394|NCT02324569|5560793|P1|COMPLETED|Overall Study||100
2265395|NCT02324569|5560792|P2|STARTED|Overall Study||124
2265396|NCT02324569|5560793|P1|STARTED|Overall Study||116
2265400|NCT02324465|5560826|P2|NOT COMPLETED|Overall Study||1
2265401|NCT02324465|5560827|P1|NOT COMPLETED|Overall Study||0
2265402|NCT02324465|5560826|P2|COMPLETED|Overall Study||21
2265403|NCT02324465|5560827|P1|COMPLETED|Overall Study||18
2265404|NCT02324465|5560826|P2|STARTED|Overall Study||22
2265405|NCT02324465|5560827|P1|STARTED|Overall Study||18
2265406|NCT02324335|5560841|P2|NOT COMPLETED|Overall Study||9
2265407|NCT02324335|5560842|P1|NOT COMPLETED|Overall Study||9
2265408|NCT02324335|5560841|P2|COMPLETED|Overall Study||20
2265409|NCT02324335|5560842|P1|COMPLETED|Overall Study||21
2265410|NCT02324335|5560841|P2|STARTED|Overall Study||29
2265411|NCT02324335|5560842|P1|STARTED|Overall Study||30
2265412|NCT02324205|5560854|P1|NOT COMPLETED|Overall Study||37
2265413|NCT02324205|5560854|P1|COMPLETED|Overall Study||159
2265414|NCT02324205|5560854|P1|STARTED|Overall Study||196
2265415|NCT02324075|5560866|P2|NOT COMPLETED|Overall Study||9
2265416|NCT02324075|5560867|P1|NOT COMPLETED|Overall Study||3
2265417|NCT02324075|5560866|P2|COMPLETED|Overall Study||605
2265418|NCT02324075|5560867|P1|COMPLETED|Overall Study||609
2265419|NCT02324075|5560866|P2|STARTED|Overall Study||614
2265420|NCT02324075|5560867|P1|STARTED|Overall Study||612
2265421|NCT02324049|5560885|P1|NOT COMPLETED|Part C||11
2265422|NCT02324049|5560885|P1|COMPLETED|Part C||0
2265423|NCT02324049|5560885|P1|Safety Analysis Set|Part C||11
2265424|NCT02324049|5560885|P1|STARTED|Part C||11
2265425|NCT02324049|5560885|P1|NOT COMPLETED|Part B||0
2265426|NCT02324049|5560885|P1|COMPLETED|Part B||11
2265427|NCT02324049|5560885|P1|Safety Analysis Set|Part B||11
2265428|NCT02324049|5560885|P1|STARTED|Part B||11
2265429|NCT02324049|5560885|P1|NOT COMPLETED|Part A||0
2265430|NCT02324049|5560885|P1|COMPLETED|Part A||11
2265431|NCT02324049|5560885|P1|Safety Analysis Set|Part A|Participants with informed consent, confirmed MPS IIIB diagnosis, and received any amount of SBC-103|11
2265432|NCT02324049|5560885|P1|STARTED|Part A||11
2265433|NCT02323854|5560889|P1|NOT COMPLETED|Overall Study||0
2265434|NCT02323854|5560889|P1|COMPLETED|Overall Study||15
2265435|NCT02323854|5560889|P1|STARTED|Overall Study||15
2265436|NCT02323646|5560898|P3|NOT COMPLETED|Treatment Course 2||3
2265437|NCT02323646|5560899|P2|NOT COMPLETED|Treatment Course 2||1
2265438|NCT02323646|5560900|P1|NOT COMPLETED|Treatment Course 2||1
2265439|NCT02323646|5560898|P3|COMPLETED|Treatment Course 2||9
2265440|NCT02323646|5560899|P2|COMPLETED|Treatment Course 2||9
2265441|NCT02323646|5560900|P1|COMPLETED|Treatment Course 2||10
2265442|NCT02323646|5560898|P3|STARTED|Treatment Course 2||12
2265443|NCT02323646|5560899|P2|STARTED|Treatment Course 2||10
2265444|NCT02323646|5560900|P1|STARTED|Treatment Course 2||11
2265445|NCT02323646|5560898|P3|NOT COMPLETED|Treatment Course 1||3
2265446|NCT02323646|5560899|P2|NOT COMPLETED|Treatment Course 1||3
2265447|NCT02323646|5560900|P1|NOT COMPLETED|Treatment Course 1||3
2265448|NCT02323646|5560898|P3|COMPLETED|Treatment Course 1||12
2265449|NCT02323646|5560899|P2|COMPLETED|Treatment Course 1||10
2265450|NCT02323646|5560900|P1|COMPLETED|Treatment Course 1||11
2265451|NCT02323646|5560898|P3|STARTED|Treatment Course 1||15
2265452|NCT02323646|5560899|P2|STARTED|Treatment Course 1||13
2265453|NCT02323646|5560900|P1|STARTED|Treatment Course 1||14
2265454|NCT02323204|5560948|P4|NOT COMPLETED|6-month Follow-up Survey Completion||44
2265455|NCT02323204|5560949|P3|NOT COMPLETED|6-month Follow-up Survey Completion||41
2265456|NCT02323204|5560950|P2|NOT COMPLETED|6-month Follow-up Survey Completion||50
2265457|NCT02323204|5560951|P1|NOT COMPLETED|6-month Follow-up Survey Completion||49
2265458|NCT02323204|5560948|P4|COMPLETED|6-month Follow-up Survey Completion||112
2265459|NCT02323204|5560949|P3|COMPLETED|6-month Follow-up Survey Completion||113
2265460|NCT02323204|5560950|P2|COMPLETED|6-month Follow-up Survey Completion||96
2265461|NCT02323204|5560951|P1|COMPLETED|6-month Follow-up Survey Completion||96
2265462|NCT02323204|5560948|P4|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|156
2265463|NCT02323204|5560949|P3|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|154
2265464|NCT02323204|5560950|P2|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|146
2265465|NCT02323204|5560951|P1|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|145
2265466|NCT02323204|5560948|P4|NOT COMPLETED|3-month Follow-up Survey Completion||44
2265467|NCT02323204|5560949|P3|NOT COMPLETED|3-month Follow-up Survey Completion||41
2265468|NCT02323204|5560950|P2|NOT COMPLETED|3-month Follow-up Survey Completion||47
2265469|NCT02323204|5560951|P1|NOT COMPLETED|3-month Follow-up Survey Completion||54
2265470|NCT02323204|5560948|P4|COMPLETED|3-month Follow-up Survey Completion||112
2265471|NCT02323204|5560949|P3|COMPLETED|3-month Follow-up Survey Completion||113
2265472|NCT02323204|5560950|P2|COMPLETED|3-month Follow-up Survey Completion||99
2265473|NCT02323204|5560951|P1|COMPLETED|3-month Follow-up Survey Completion||91
2265474|NCT02323204|5560948|P4|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|156
2265475|NCT02323204|5560949|P3|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|154
2265476|NCT02323204|5560950|P2|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|146
2265477|NCT02323204|5560951|P1|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|145
2265478|NCT02323204|5560948|P4|NOT COMPLETED|6-week Follow-up Intervention Booster||36
2265479|NCT02323204|5560949|P3|NOT COMPLETED|6-week Follow-up Intervention Booster||0
2265480|NCT02323204|5560950|P2|NOT COMPLETED|6-week Follow-up Intervention Booster||43
2265481|NCT02323204|5560951|P1|NOT COMPLETED|6-week Follow-up Intervention Booster||0
2265482|NCT02323204|5560948|P4|COMPLETED|6-week Follow-up Intervention Booster||120
2265483|NCT02323204|5560949|P3|COMPLETED|6-week Follow-up Intervention Booster||0
2265484|NCT02323204|5560950|P2|COMPLETED|6-week Follow-up Intervention Booster||103
2265485|NCT02323204|5560951|P1|COMPLETED|6-week Follow-up Intervention Booster||0
2265486|NCT02323204|5560948|P4|STARTED|6-week Follow-up Intervention Booster|Received intervention-specific booster training via phone between 6-weeks and 1 year post-enrollment|156
2265487|NCT02323204|5560949|P3|STARTED|6-week Follow-up Intervention Booster|Child participants did not receive intervention booster training.|0
2265488|NCT02323204|5560950|P2|STARTED|6-week Follow-up Intervention Booster|Received intervention-specific booster training via phone between 6-weeks and 1 year post-enrollment|146
2265489|NCT02323204|5560951|P1|STARTED|6-week Follow-up Intervention Booster|Child participants did not receive intervention booster training.|0
2265490|NCT02323204|5560948|P4|NOT COMPLETED|6-week Follow-up Survey Completion||37
2265491|NCT02323204|5560949|P3|NOT COMPLETED|6-week Follow-up Survey Completion||42
2265492|NCT02323204|5560950|P2|NOT COMPLETED|6-week Follow-up Survey Completion||36
2265493|NCT02323204|5560951|P1|NOT COMPLETED|6-week Follow-up Survey Completion||41
2265494|NCT02323204|5560948|P4|COMPLETED|6-week Follow-up Survey Completion||119
2265495|NCT02323204|5560949|P3|COMPLETED|6-week Follow-up Survey Completion||112
2265496|NCT02323204|5560950|P2|COMPLETED|6-week Follow-up Survey Completion||110
2265497|NCT02323204|5560951|P1|COMPLETED|6-week Follow-up Survey Completion||104
2265498|NCT02323204|5560948|P4|STARTED|6-week Follow-up Survey Completion||156
2265499|NCT02323204|5560949|P3|STARTED|6-week Follow-up Survey Completion||154
2265500|NCT02323204|5560950|P2|STARTED|6-week Follow-up Survey Completion||146
2265501|NCT02323204|5560951|P1|STARTED|6-week Follow-up Survey Completion||145
2265502|NCT02323204|5560948|P4|NOT COMPLETED|Baseline Survey Completion||3
2265503|NCT02323204|5560949|P3|NOT COMPLETED|Baseline Survey Completion||5
2265504|NCT02323204|5560950|P2|NOT COMPLETED|Baseline Survey Completion||9
2265505|NCT02323204|5560951|P1|NOT COMPLETED|Baseline Survey Completion||10
2265506|NCT02323204|5560948|P4|COMPLETED|Baseline Survey Completion||156
2265507|NCT02323204|5560949|P3|COMPLETED|Baseline Survey Completion||154
2265508|NCT02323204|5560950|P2|COMPLETED|Baseline Survey Completion||146
2265509|NCT02323204|5560951|P1|COMPLETED|Baseline Survey Completion||145
2265510|NCT02323204|5560948|P4|STARTED|Baseline Survey Completion||159
2265511|NCT02323204|5560949|P3|STARTED|Baseline Survey Completion||159
2265512|NCT02323204|5560950|P2|STARTED|Baseline Survey Completion||155
2265513|NCT02323204|5560951|P1|STARTED|Baseline Survey Completion||155
2265514|NCT02323048|5561006|P5|NOT COMPLETED|Overall Study||0
2265515|NCT02323048|5561007|P4|NOT COMPLETED|Overall Study||0
2265516|NCT02323048|5561008|P3|NOT COMPLETED|Overall Study||0
2265517|NCT02323048|5561009|P2|NOT COMPLETED|Overall Study||2
2265518|NCT02323048|5561010|P1|NOT COMPLETED|Overall Study||1
2265519|NCT02323048|5561006|P5|COMPLETED|Overall Study||9
2265520|NCT02323048|5561007|P4|COMPLETED|Overall Study||7
2265521|NCT02323048|5561008|P3|COMPLETED|Overall Study||23
2265522|NCT02323048|5561009|P2|COMPLETED|Overall Study||24
2265523|NCT02323048|5561010|P1|COMPLETED|Overall Study||24
2265524|NCT02323048|5561006|P5|STARTED|Overall Study||9
2265525|NCT02323048|5561007|P4|STARTED|Overall Study||7
2265526|NCT02323048|5561008|P3|STARTED|Overall Study||23
2265527|NCT02323048|5561009|P2|STARTED|Overall Study||26
2265528|NCT02323048|5561010|P1|STARTED|Overall Study||25
2265529|NCT02322892|5561024|P2|NOT COMPLETED|Overall Study||3
2265530|NCT02322892|5561025|P1|NOT COMPLETED|Overall Study||2
2265531|NCT02322892|5561024|P2|COMPLETED|Overall Study|Received thiamine|31
2265532|NCT02322892|5561025|P1|COMPLETED|Overall Study|Received placebo|33
2265533|NCT02322892|5561024|P2|STARTED|Overall Study|Number randomized|34
2265534|NCT02322892|5561025|P1|STARTED|Overall Study|Number randomized|35
2265535|NCT02322879|5561041|P2|NOT COMPLETED|Second Intervention||0
2265536|NCT02322879|5561042|P1|NOT COMPLETED|Second Intervention||0
2265537|NCT02322879|5561041|P2|COMPLETED|Second Intervention||10
2265538|NCT02322879|5561042|P1|COMPLETED|Second Intervention||10
2265539|NCT02322879|5561041|P2|STARTED|Second Intervention||10
2265540|NCT02322879|5561042|P1|STARTED|Second Intervention||10
2265541|NCT02322879|5561041|P2|NOT COMPLETED|Washout||0
2265542|NCT02322879|5561042|P1|NOT COMPLETED|Washout||0
2265543|NCT02322879|5561041|P2|COMPLETED|Washout||10
2265544|NCT02322879|5561042|P1|COMPLETED|Washout||10
2265545|NCT02322879|5561041|P2|STARTED|Washout||10
2265546|NCT02322879|5561042|P1|STARTED|Washout||10
2265547|NCT02322879|5561041|P2|NOT COMPLETED|First Intervention||0
2265548|NCT02322879|5561042|P1|NOT COMPLETED|First Intervention||1
2265549|NCT02322879|5561041|P2|COMPLETED|First Intervention||10
2265550|NCT02322879|5561042|P1|COMPLETED|First Intervention||10
2265551|NCT02322879|5561041|P2|STARTED|First Intervention||10
2265552|NCT02322879|5561042|P1|STARTED|First Intervention||11
2265553|NCT02322866|5561050|P2|NOT COMPLETED|Overall Study||86
2265554|NCT02322866|5561051|P1|NOT COMPLETED|Overall Study||71
2265555|NCT02322866|5561050|P2|COMPLETED|Overall Study||433
2265556|NCT02322866|5561051|P1|COMPLETED|Overall Study||444
2265557|NCT02322866|5561050|P2|STARTED|Overall Study||519
2265558|NCT02322866|5561051|P1|STARTED|Overall Study||515
2265559|NCT02322814|5561078|P5|NOT COMPLETED|Overall Study||31
2265560|NCT02322814|5561079|P4|NOT COMPLETED|Overall Study||32
2265561|NCT02322814|5561080|P3|NOT COMPLETED|Overall Study||47
2265562|NCT02322814|5561081|P2|NOT COMPLETED|Overall Study||43
2265563|NCT02322814|5561082|P1|NOT COMPLETED|Overall Study||16
2265564|NCT02322814|5561078|P5|COMPLETED|Overall Study||0
2265565|NCT02322814|5561079|P4|COMPLETED|Overall Study||0
2265566|NCT02322814|5561080|P3|COMPLETED|Overall Study||0
2265567|NCT02322814|5561081|P2|COMPLETED|Overall Study||0
2265568|NCT02322814|5561082|P1|COMPLETED|Overall Study||0
2265569|NCT02322814|5561078|P5|STARTED|Overall Study||31
2265570|NCT02322814|5561079|P4|STARTED|Overall Study||32
2265571|NCT02322814|5561080|P3|STARTED|Overall Study||47
2265572|NCT02322814|5561081|P2|STARTED|Overall Study||43
2265573|NCT02322814|5561082|P1|STARTED|Overall Study||16
2265574|NCT02322788|5561093|P4|NOT COMPLETED|Visit 6||0
2265575|NCT02322788|5561094|P3|NOT COMPLETED|Visit 6||0
2265576|NCT02322788|5561095|P2|NOT COMPLETED|Visit 6||0
2265577|NCT02322788|5561096|P1|NOT COMPLETED|Visit 6||0
2265578|NCT02322788|5561093|P4|COMPLETED|Visit 6||15
2265579|NCT02322788|5561094|P3|COMPLETED|Visit 6||15
2265580|NCT02322788|5561095|P2|COMPLETED|Visit 6||16
2265581|NCT02322788|5561096|P1|COMPLETED|Visit 6||14
2265582|NCT02322788|5561093|P4|STARTED|Visit 6||15
2265583|NCT02322788|5561094|P3|STARTED|Visit 6||15
2265584|NCT02322788|5561095|P2|STARTED|Visit 6||16
2265585|NCT02322788|5561096|P1|STARTED|Visit 6||14
2265586|NCT02322788|5561093|P4|NOT COMPLETED|Visit 5||0
2265587|NCT02322788|5561094|P3|NOT COMPLETED|Visit 5||0
2265588|NCT02322788|5561095|P2|NOT COMPLETED|Visit 5||0
2265589|NCT02322788|5561096|P1|NOT COMPLETED|Visit 5||0
2265590|NCT02322788|5561093|P4|COMPLETED|Visit 5||14
2265591|NCT02322788|5561094|P3|COMPLETED|Visit 5||15
2265592|NCT02322788|5561095|P2|COMPLETED|Visit 5||15
2265593|NCT02322788|5561096|P1|COMPLETED|Visit 5||16
2265594|NCT02322788|5561093|P4|STARTED|Visit 5||14
2265595|NCT02322788|5561094|P3|STARTED|Visit 5||15
2265596|NCT02322788|5561095|P2|STARTED|Visit 5||15
2265597|NCT02322788|5561096|P1|STARTED|Visit 5||16
2265598|NCT02322788|5561093|P4|NOT COMPLETED|Visit 4||0
2265599|NCT02322788|5561094|P3|NOT COMPLETED|Visit 4||0
2265600|NCT02322788|5561095|P2|NOT COMPLETED|Visit 4||0
2265601|NCT02322788|5561096|P1|NOT COMPLETED|Visit 4||0
2265602|NCT02322788|5561093|P4|COMPLETED|Visit 4||15
2265603|NCT02322788|5561094|P3|COMPLETED|Visit 4||16
2265604|NCT02322788|5561095|P2|COMPLETED|Visit 4||14
2265605|NCT02322788|5561096|P1|COMPLETED|Visit 4||15
2265606|NCT02322788|5561093|P4|STARTED|Visit 4||15
2265607|NCT02322788|5561094|P3|STARTED|Visit 4||16
2265608|NCT02322788|5561095|P2|STARTED|Visit 4||14
2265609|NCT02322788|5561096|P1|STARTED|Visit 4||15
2265610|NCT02322788|5561093|P4|NOT COMPLETED|Visit 3||0
2265611|NCT02322788|5561094|P3|NOT COMPLETED|Visit 3||0
2265612|NCT02322788|5561095|P2|NOT COMPLETED|Visit 3||0
2265613|NCT02322788|5561096|P1|NOT COMPLETED|Visit 3||0
2265614|NCT02322788|5561093|P4|COMPLETED|Visit 3||16
2265615|NCT02322788|5561094|P3|COMPLETED|Visit 3||14
2265616|NCT02322788|5561095|P2|COMPLETED|Visit 3||15
2265617|NCT02322788|5561096|P1|COMPLETED|Visit 3||15
2265618|NCT02322788|5561093|P4|STARTED|Visit 3||16
2265619|NCT02322788|5561094|P3|STARTED|Visit 3||14
2265620|NCT02322788|5561095|P2|STARTED|Visit 3||15
2265621|NCT02322788|5561096|P1|STARTED|Visit 3||15
2265622|NCT02322775|5561108|P2|NOT COMPLETED|Overall Study||6
2265623|NCT02322775|5561109|P1|NOT COMPLETED|Overall Study||5
2265624|NCT02322775|5561108|P2|COMPLETED|Overall Study||99
2265625|NCT02322775|5561109|P1|COMPLETED|Overall Study||101
2265626|NCT02322775|5561108|P2|STARTED|Overall Study||105
2265627|NCT02322775|5561109|P1|STARTED|Overall Study||106
2265628|NCT02322749|5561135|P6|NOT COMPLETED|Period 3||0
2265629|NCT02322749|5561136|P5|NOT COMPLETED|Period 3||0
2265630|NCT02322749|5561137|P4|NOT COMPLETED|Period 3||0
2265631|NCT02322749|5561138|P3|NOT COMPLETED|Period 3||1
2265632|NCT02322749|5561139|P2|NOT COMPLETED|Period 3||0
2265633|NCT02322749|5561140|P1|NOT COMPLETED|Period 3||0
2265634|NCT02322749|5561135|P6|COMPLETED|Period 3||8
2265635|NCT02322749|5561136|P5|COMPLETED|Period 3||8
2265636|NCT02322749|5561137|P4|COMPLETED|Period 3||6
2265637|NCT02322749|5561138|P3|COMPLETED|Period 3||7
2265638|NCT02322749|5561139|P2|COMPLETED|Period 3||8
2265639|NCT02322749|5561140|P1|COMPLETED|Period 3||8
2265640|NCT02322749|5561135|P6|STARTED|Period 3||8
2265641|NCT02322749|5561136|P5|STARTED|Period 3||8
2265642|NCT02322749|5561137|P4|STARTED|Period 3||6
2265643|NCT02322749|5561138|P3|STARTED|Period 3||8
2265644|NCT02322749|5561139|P2|STARTED|Period 3||8
2265645|NCT02322749|5561140|P1|STARTED|Period 3||8
2265646|NCT02322749|5561135|P6|NOT COMPLETED|Period 2||0
2265647|NCT02322749|5561136|P5|NOT COMPLETED|Period 2||0
2265648|NCT02322749|5561137|P4|NOT COMPLETED|Period 2||2
2265649|NCT02322749|5561138|P3|NOT COMPLETED|Period 2||0
2265650|NCT02322749|5561139|P2|NOT COMPLETED|Period 2||0
2265651|NCT02322749|5561140|P1|NOT COMPLETED|Period 2||0
2265652|NCT02322749|5561135|P6|COMPLETED|Period 2||8
2265653|NCT02322749|5561136|P5|COMPLETED|Period 2||8
2265654|NCT02322749|5561137|P4|COMPLETED|Period 2||6
2265655|NCT02322749|5561138|P3|COMPLETED|Period 2||8
2265656|NCT02322749|5561139|P2|COMPLETED|Period 2||8
2265657|NCT02322749|5561140|P1|COMPLETED|Period 2||8
2265658|NCT02322749|5561135|P6|STARTED|Period 2||8
2265659|NCT02322749|5561136|P5|STARTED|Period 2||8
2265660|NCT02322749|5561137|P4|STARTED|Period 2||8
2265661|NCT02322749|5561138|P3|STARTED|Period 2||8
2265662|NCT02322749|5561139|P2|STARTED|Period 2||8
2265663|NCT02322749|5561140|P1|STARTED|Period 2||8
2265664|NCT02322749|5561135|P6|NOT COMPLETED|Period 1||0
2265665|NCT02322749|5561136|P5|NOT COMPLETED|Period 1||0
2265666|NCT02322749|5561137|P4|NOT COMPLETED|Period 1||0
2265667|NCT02322749|5561138|P3|NOT COMPLETED|Period 1||0
2265668|NCT02322749|5561139|P2|NOT COMPLETED|Period 1||0
2265669|NCT02322749|5561140|P1|NOT COMPLETED|Period 1||0
2265670|NCT02322749|5561135|P6|COMPLETED|Period 1||8
2265671|NCT02322749|5561136|P5|COMPLETED|Period 1||8
2265672|NCT02322749|5561137|P4|COMPLETED|Period 1||8
2265673|NCT02322749|5561138|P3|COMPLETED|Period 1||8
2265674|NCT02322749|5561139|P2|COMPLETED|Period 1||8
2265675|NCT02322749|5561140|P1|COMPLETED|Period 1||8
2265676|NCT02322749|5561135|P6|STARTED|Period 1||8
2265677|NCT02322749|5561136|P5|STARTED|Period 1||8
2265678|NCT02322749|5561137|P4|STARTED|Period 1||8
2265679|NCT02322749|5561138|P3|STARTED|Period 1||8
2265680|NCT02322749|5561139|P2|STARTED|Period 1||8
2265681|NCT02322749|5561140|P1|STARTED|Period 1||8
2265682|NCT02322710|5561165|P2|NOT COMPLETED|Overall Study||26
2265683|NCT02322710|5561166|P1|NOT COMPLETED|Overall Study||20
2265684|NCT02322710|5561165|P2|COMPLETED|Overall Study||73
2265685|NCT02322710|5561166|P1|COMPLETED|Overall Study||85
2265686|NCT02322710|5561165|P2|Full Analysis Population|Overall Study||98
2265687|NCT02322710|5561166|P1|Full Analysis Population|Overall Study||105
2265688|NCT02322710|5561165|P2|Safety Population|Overall Study||99
2265689|NCT02322710|5561166|P1|Safety Population|Overall Study||105
2265690|NCT02322710|5561165|P2|STARTED|Overall Study||99
2265691|NCT02322710|5561166|P1|STARTED|Overall Study||105
2265692|NCT02322528|5561172|P1|NOT COMPLETED|Overall Study||0
2265693|NCT02322528|5561172|P1|COMPLETED|Overall Study||10
2265694|NCT02322528|5561172|P1|STARTED|Overall Study||10
2265695|NCT02322411|5561179|P2|NOT COMPLETED|Overall Study||7
2265696|NCT02322411|5561180|P1|NOT COMPLETED|Overall Study||4
2265697|NCT02322411|5561179|P2|COMPLETED|Overall Study||9
2265698|NCT02322411|5561180|P1|COMPLETED|Overall Study||9
2265699|NCT02322411|5561179|P2|STARTED|Overall Study||16
2265700|NCT02322411|5561180|P1|STARTED|Overall Study||13
2265701|NCT02322281|5561199|P3|NOT COMPLETED|Overall Study||74
2265702|NCT02322281|5561200|P2|NOT COMPLETED|Overall Study||22
2265703|NCT02322281|5561201|P1|NOT COMPLETED|Overall Study||53
2265704|NCT02322281|5561199|P3|COMPLETED|Overall Study|Patients who are off study for any reason.|0
2265705|NCT02322281|5561200|P2|COMPLETED|Overall Study|Patients who are off study for any reason.|0
2265706|NCT02322281|5561201|P1|COMPLETED|Overall Study|Patients who are off study for any reason.|0
2265707|NCT02322281|5561199|P3|Crossed Over to Rociletinib 625 mg BID|Overall Study||3
2265708|NCT02322281|5561200|P2|Crossed Over to Rociletinib 625 mg BID|Overall Study||0
2265709|NCT02322281|5561201|P1|Crossed Over to Rociletinib 625 mg BID|Overall Study||0
2265710|NCT02322281|5561199|P3|Crossed Over to Rociletinib 500 mg BID|Overall Study||36
2265711|NCT02322281|5561200|P2|Crossed Over to Rociletinib 500 mg BID|Overall Study||0
2265712|NCT02322281|5561201|P1|Crossed Over to Rociletinib 500 mg BID|Overall Study||0
2265713|NCT02322281|5561199|P3|STARTED|Overall Study||74
2265714|NCT02322281|5561200|P2|STARTED|Overall Study||22
2265715|NCT02322281|5561201|P1|STARTED|Overall Study||53
2265716|NCT02322229|5561222|P1|NOT COMPLETED|Overall Study||2
2265717|NCT02322229|5561222|P1|COMPLETED|Overall Study||50
2265718|NCT02322229|5561222|P1|STARTED|Overall Study||52
2265719|NCT02322216|5561234|P2|NOT COMPLETED|Overall Study||4
2265720|NCT02322216|5561235|P1|NOT COMPLETED|Overall Study||2
2265721|NCT02322216|5561234|P2|COMPLETED|Overall Study||123
2265722|NCT02322216|5561235|P1|COMPLETED|Overall Study||124
2265723|NCT02322216|5561234|P2|Per Protocol Set (PPS)|Overall Study||122
2265724|NCT02322216|5561235|P1|Per Protocol Set (PPS)|Overall Study||123
2265725|NCT02322216|5561234|P2|Treated (Safety Set)|Overall Study||126
2265726|NCT02322216|5561235|P1|Treated (Safety Set)|Overall Study||126
2265727|NCT02322216|5561234|P2|STARTED|Overall Study||127
2265728|NCT02322216|5561235|P1|STARTED|Overall Study||126
2265729|NCT02321930|5561242|P1|NOT COMPLETED|Overall Study||1
2265730|NCT02321930|5561242|P1|COMPLETED|Overall Study||24
2265731|NCT02321930|5561242|P1|STARTED|Overall Study||25
2265732|NCT02321800|5561252|P2|NOT COMPLETED|Overall Study||11
2265733|NCT02321800|5561253|P1|NOT COMPLETED|Overall Study||20
2265734|NCT02321800|5561252|P2|COMPLETED|Overall Study||138
2265735|NCT02321800|5561253|P1|COMPLETED|Overall Study||283
2265736|NCT02321800|5561252|P2|Received Study Drug|Overall Study||148
2265737|NCT02321800|5561253|P1|Received Study Drug|Overall Study||300
2265738|NCT02321800|5561252|P2|STARTED|Overall Study||149
2265739|NCT02321800|5561253|P1|STARTED|Overall Study||303
2265740|NCT02321748|5561303|P2|NOT COMPLETED|Overall Study||0
2265741|NCT02321748|5561304|P1|NOT COMPLETED|Overall Study||0
2265742|NCT02321748|5561303|P2|COMPLETED|Overall Study||12
2265743|NCT02321748|5561304|P1|COMPLETED|Overall Study||12
2265744|NCT02321748|5561303|P2|Second Intervention (4 Days)|Overall Study||12
2265745|NCT02321748|5561304|P1|Second Intervention (4 Days)|Overall Study||12
2265746|NCT02321748|5561303|P2|Wasout (2weeks)|Overall Study||12
2265747|NCT02321748|5561304|P1|Wasout (2weeks)|Overall Study||12
2265748|NCT02321748|5561303|P2|First Intervention (4 Days)|Overall Study||12
2265749|NCT02321748|5561304|P1|First Intervention (4 Days)|Overall Study||12
2265750|NCT02321748|5561303|P2|STARTED|Overall Study||12
2265751|NCT02321748|5561304|P1|STARTED|Overall Study||12
2265752|NCT02321527|5561336|P1|NOT COMPLETED|Overall Study||1
2265753|NCT02321527|5561336|P1|COMPLETED|Overall Study||20
2265754|NCT02321527|5561336|P1|STARTED|Overall Study||21
2265755|NCT02321462|5561342|P2|NOT COMPLETED|Overall Study||3
2265756|NCT02321462|5561343|P1|NOT COMPLETED|Overall Study||6
2265757|NCT02321462|5561342|P2|COMPLETED|Overall Study||146
2265758|NCT02321462|5561343|P1|COMPLETED|Overall Study||141
2265759|NCT02321462|5561342|P2|Safety Population|Overall Study||147
2265760|NCT02321462|5561343|P1|Safety Population|Overall Study||147
2265761|NCT02321462|5561342|P2|Treated Patients|Overall Study||147
2265762|NCT02321462|5561343|P1|Treated Patients|Overall Study||147
2265763|NCT02321462|5561342|P2|ITT Population|Overall Study||148
2265764|NCT02321462|5561343|P1|ITT Population|Overall Study||146
2265765|NCT02321462|5561342|P2|STARTED|Overall Study||149
2265766|NCT02321462|5561343|P1|STARTED|Overall Study||147
2265767|NCT02321436|5561365|P2|NOT COMPLETED|Overall Study||1
2265768|NCT02321436|5561366|P1|NOT COMPLETED|Overall Study||1
2265769|NCT02321436|5561365|P2|COMPLETED|Overall Study||13
2265770|NCT02321436|5561366|P1|COMPLETED|Overall Study||27
2265771|NCT02321436|5561365|P2|STARTED|Overall Study||14
2265772|NCT02321436|5561366|P1|STARTED|Overall Study||28
2265773|NCT02321111|5561382|P6|NOT COMPLETED|Infusion3||0
2265774|NCT02321111|5561383|P5|NOT COMPLETED|Infusion3||0
2265775|NCT02321111|5561384|P4|NOT COMPLETED|Infusion3||0
2265776|NCT02321111|5561385|P3|NOT COMPLETED|Infusion3||0
2265777|NCT02321111|5561386|P2|NOT COMPLETED|Infusion3||0
2265778|NCT02321111|5561387|P1|NOT COMPLETED|Infusion3||0
2265779|NCT02321111|5561382|P6|COMPLETED|Infusion3||0
2265780|NCT02321111|5561383|P5|COMPLETED|Infusion3||0
2265781|NCT02321111|5561384|P4|COMPLETED|Infusion3||1
2265782|NCT02321111|5561385|P3|COMPLETED|Infusion3||4
2265783|NCT02321111|5561386|P2|COMPLETED|Infusion3||4
2265784|NCT02321111|5561387|P1|COMPLETED|Infusion3||1
2265785|NCT02321111|5561382|P6|STARTED|Infusion3||0
2265786|NCT02321111|5561383|P5|STARTED|Infusion3||0
2265787|NCT02321111|5561384|P4|STARTED|Infusion3||1
2265788|NCT02321111|5561385|P3|STARTED|Infusion3||4
2265789|NCT02321111|5561386|P2|STARTED|Infusion3||4
2265790|NCT02321111|5561387|P1|STARTED|Infusion3||1
2265791|NCT02321111|5561382|P6|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
2265792|NCT02321111|5561383|P5|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
2265793|NCT02321111|5561384|P4|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
2265794|NCT02321111|5561385|P3|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
2265795|NCT02321111|5561386|P2|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
2265796|NCT02321111|5561387|P1|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
2265797|NCT02321111|5561382|P6|COMPLETED|Washout2 (3-4weeks Between Infusions)||0
2265798|NCT02321111|5561383|P5|COMPLETED|Washout2 (3-4weeks Between Infusions)||0
2265799|NCT02321111|5561384|P4|COMPLETED|Washout2 (3-4weeks Between Infusions)||1
2265800|NCT02321111|5561385|P3|COMPLETED|Washout2 (3-4weeks Between Infusions)||4
2265801|NCT02321111|5561386|P2|COMPLETED|Washout2 (3-4weeks Between Infusions)||4
2265802|NCT02321111|5561387|P1|COMPLETED|Washout2 (3-4weeks Between Infusions)||1
2265803|NCT02321111|5561382|P6|STARTED|Washout2 (3-4weeks Between Infusions)||0
2265804|NCT02321111|5561383|P5|STARTED|Washout2 (3-4weeks Between Infusions)||0
2265805|NCT02321111|5561384|P4|STARTED|Washout2 (3-4weeks Between Infusions)||1
2265806|NCT02321111|5561385|P3|STARTED|Washout2 (3-4weeks Between Infusions)||4
2265807|NCT02321111|5561386|P2|STARTED|Washout2 (3-4weeks Between Infusions)||4
2265808|NCT02321111|5561387|P1|STARTED|Washout2 (3-4weeks Between Infusions)||1
2265809|NCT02321111|5561382|P6|NOT COMPLETED|Infusion2||0
2265810|NCT02321111|5561383|P5|NOT COMPLETED|Infusion2||0
2265811|NCT02321111|5561384|P4|NOT COMPLETED|Infusion2||0
2265812|NCT02321111|5561385|P3|NOT COMPLETED|Infusion2||0
2265813|NCT02321111|5561386|P2|NOT COMPLETED|Infusion2||0
2265814|NCT02321111|5561387|P1|NOT COMPLETED|Infusion2||0
2265815|NCT02321111|5561382|P6|COMPLETED|Infusion2||0
2265816|NCT02321111|5561383|P5|COMPLETED|Infusion2||0
2265817|NCT02321111|5561384|P4|COMPLETED|Infusion2||1
2265818|NCT02321111|5561385|P3|COMPLETED|Infusion2||4
2265819|NCT02321111|5561386|P2|COMPLETED|Infusion2||4
2265820|NCT02321111|5561387|P1|COMPLETED|Infusion2||1
2265821|NCT02321111|5561382|P6|STARTED|Infusion2||0
2265822|NCT02321111|5561383|P5|STARTED|Infusion2||0
2265823|NCT02321111|5561384|P4|STARTED|Infusion2||1
2265824|NCT02321111|5561385|P3|STARTED|Infusion2||4
2265825|NCT02321111|5561386|P2|STARTED|Infusion2||4
2265826|NCT02321111|5561387|P1|STARTED|Infusion2||1
2265827|NCT02321111|5561382|P6|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
2265828|NCT02321111|5561383|P5|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
2265829|NCT02321111|5561384|P4|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
2265830|NCT02321111|5561385|P3|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
2265831|NCT02321111|5561386|P2|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
2265832|NCT02321111|5561387|P1|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
2265833|NCT02321111|5561382|P6|COMPLETED|Washout1 (3-4weeks Between Infusions)||0
2265834|NCT02321111|5561383|P5|COMPLETED|Washout1 (3-4weeks Between Infusions)||0
2265835|NCT02321111|5561384|P4|COMPLETED|Washout1 (3-4weeks Between Infusions)||1
2265836|NCT02321111|5561385|P3|COMPLETED|Washout1 (3-4weeks Between Infusions)||4
2265837|NCT02321111|5561386|P2|COMPLETED|Washout1 (3-4weeks Between Infusions)||4
2265838|NCT02321111|5561387|P1|COMPLETED|Washout1 (3-4weeks Between Infusions)||1
2265839|NCT02321111|5561382|P6|STARTED|Washout1 (3-4weeks Between Infusions)||0
2265840|NCT02321111|5561383|P5|STARTED|Washout1 (3-4weeks Between Infusions)||0
2265841|NCT02321111|5561384|P4|STARTED|Washout1 (3-4weeks Between Infusions)||1
2265842|NCT02321111|5561385|P3|STARTED|Washout1 (3-4weeks Between Infusions)||4
2265843|NCT02321111|5561386|P2|STARTED|Washout1 (3-4weeks Between Infusions)||4
2265844|NCT02321111|5561387|P1|STARTED|Washout1 (3-4weeks Between Infusions)||1
2265845|NCT02321111|5561382|P6|NOT COMPLETED|Infusion1||0
2265846|NCT02321111|5561383|P5|NOT COMPLETED|Infusion1||0
2265847|NCT02321111|5561384|P4|NOT COMPLETED|Infusion1||0
2265848|NCT02321111|5561385|P3|NOT COMPLETED|Infusion1||0
2265849|NCT02321111|5561386|P2|NOT COMPLETED|Infusion1||0
2265850|NCT02321111|5561387|P1|NOT COMPLETED|Infusion1||0
2265851|NCT02321111|5561382|P6|COMPLETED|Infusion1||0
2265852|NCT02321111|5561383|P5|COMPLETED|Infusion1||0
2265853|NCT02321111|5561384|P4|COMPLETED|Infusion1||1
2265854|NCT02321111|5561385|P3|COMPLETED|Infusion1||4
2265855|NCT02321111|5561386|P2|COMPLETED|Infusion1||4
2265856|NCT02321111|5561387|P1|COMPLETED|Infusion1||1
2265857|NCT02321111|5561382|P6|STARTED|Infusion1||0
2265858|NCT02321111|5561383|P5|STARTED|Infusion1||0
2265859|NCT02321111|5561384|P4|STARTED|Infusion1||1
2265860|NCT02321111|5561385|P3|STARTED|Infusion1||4
2265861|NCT02321111|5561386|P2|STARTED|Infusion1||4
2265862|NCT02321111|5561387|P1|STARTED|Infusion1||1
2265863|NCT02321098|5561410|P3|NOT COMPLETED|Additional 15 Months Treatment||8
2265864|NCT02321098|5561411|P2|NOT COMPLETED|Additional 15 Months Treatment||0
2265865|NCT02321098|5561412|P1|NOT COMPLETED|Additional 15 Months Treatment||0
2265866|NCT02321098|5561410|P3|COMPLETED|Additional 15 Months Treatment||21
2265867|NCT02321098|5561411|P2|COMPLETED|Additional 15 Months Treatment||0
2265868|NCT02321098|5561412|P1|COMPLETED|Additional 15 Months Treatment||0
2265869|NCT02321098|5561410|P3|STARTED|Additional 15 Months Treatment||29
2265870|NCT02321098|5561411|P2|STARTED|Additional 15 Months Treatment||0
2265871|NCT02321098|5561412|P1|STARTED|Additional 15 Months Treatment||0
2265872|NCT02321098|5561410|P3|NOT COMPLETED|12 Weeks Treament||0
2265873|NCT02321098|5561411|P2|NOT COMPLETED|12 Weeks Treament||1
2265874|NCT02321098|5561412|P1|NOT COMPLETED|12 Weeks Treament||1
2265875|NCT02321098|5561410|P3|COMPLETED|12 Weeks Treament||0
2265876|NCT02321098|5561411|P2|COMPLETED|12 Weeks Treament||23
2265877|NCT02321098|5561412|P1|COMPLETED|12 Weeks Treament||25
2265878|NCT02321098|5561410|P3|STARTED|12 Weeks Treament||0
2265879|NCT02321098|5561411|P2|STARTED|12 Weeks Treament||24
2265880|NCT02321098|5561412|P1|STARTED|12 Weeks Treament||26
2265881|NCT02320903|5561424|P3|NOT COMPLETED|Overall Study||16
2265882|NCT02320903|5561425|P2|NOT COMPLETED|Overall Study||16
2265883|NCT02320903|5561426|P1|NOT COMPLETED|Overall Study||8
2265884|NCT02320903|5561424|P3|COMPLETED|Overall Study||16
2265885|NCT02320903|5561425|P2|COMPLETED|Overall Study||16
2265886|NCT02320903|5561426|P1|COMPLETED|Overall Study||16
2265887|NCT02320903|5561424|P3|STARTED|Overall Study||32
2265888|NCT02320903|5561425|P2|STARTED|Overall Study||32
2265889|NCT02320903|5561426|P1|STARTED|Overall Study||24
2265890|NCT02320838|5561459|P5|NOT COMPLETED|Third Intervention (1 Day)||0
2265891|NCT02320838|5561460|P4|NOT COMPLETED|Third Intervention (1 Day)||0
2265892|NCT02320838|5561461|P3|NOT COMPLETED|Third Intervention (1 Day)||0
2265893|NCT02320838|5561462|P2|NOT COMPLETED|Third Intervention (1 Day)||0
2265894|NCT02320838|5561463|P1|NOT COMPLETED|Third Intervention (1 Day)||0
2265895|NCT02320838|5561459|P5|COMPLETED|Third Intervention (1 Day)||7
2265896|NCT02320838|5561460|P4|COMPLETED|Third Intervention (1 Day)||7
2265897|NCT02320838|5561461|P3|COMPLETED|Third Intervention (1 Day)||8
2265898|NCT02320838|5561462|P2|COMPLETED|Third Intervention (1 Day)||8
2265899|NCT02320838|5561463|P1|COMPLETED|Third Intervention (1 Day)||8
2265900|NCT02320838|5561459|P5|STARTED|Third Intervention (1 Day)||7
2265901|NCT02320838|5561460|P4|STARTED|Third Intervention (1 Day)||7
2265902|NCT02320838|5561461|P3|STARTED|Third Intervention (1 Day)||8
2265903|NCT02320838|5561462|P2|STARTED|Third Intervention (1 Day)||8
2265904|NCT02320838|5561463|P1|STARTED|Third Intervention (1 Day)||8
2265905|NCT02320838|5561459|P5|NOT COMPLETED|Washout (1 Day)||0
2265906|NCT02320838|5561460|P4|NOT COMPLETED|Washout (1 Day)||0
2265907|NCT02320838|5561461|P3|NOT COMPLETED|Washout (1 Day)||0
2265908|NCT02320838|5561462|P2|NOT COMPLETED|Washout (1 Day)||0
2265909|NCT02320838|5561463|P1|NOT COMPLETED|Washout (1 Day)||0
2265910|NCT02320838|5561459|P5|COMPLETED|Washout (1 Day)||7
2265911|NCT02320838|5561460|P4|COMPLETED|Washout (1 Day)||7
2265912|NCT02320838|5561461|P3|COMPLETED|Washout (1 Day)||8
2265913|NCT02320838|5561462|P2|COMPLETED|Washout (1 Day)||8
2265914|NCT02320838|5561463|P1|COMPLETED|Washout (1 Day)||8
2265915|NCT02320838|5561459|P5|STARTED|Washout (1 Day)||7
2265916|NCT02320838|5561460|P4|STARTED|Washout (1 Day)||7
2265917|NCT02320838|5561461|P3|STARTED|Washout (1 Day)||8
2265918|NCT02320838|5561462|P2|STARTED|Washout (1 Day)||8
2265919|NCT02320838|5561463|P1|STARTED|Washout (1 Day)||8
2265920|NCT02320838|5561459|P5|NOT COMPLETED|Second Intervention (1 Day)||0
2265921|NCT02320838|5561460|P4|NOT COMPLETED|Second Intervention (1 Day)||0
2265922|NCT02320838|5561461|P3|NOT COMPLETED|Second Intervention (1 Day)||0
2265923|NCT02320838|5561462|P2|NOT COMPLETED|Second Intervention (1 Day)||0
2265924|NCT02320838|5561463|P1|NOT COMPLETED|Second Intervention (1 Day)||0
2265925|NCT02320838|5561459|P5|COMPLETED|Second Intervention (1 Day)||7
2265926|NCT02320838|5561460|P4|COMPLETED|Second Intervention (1 Day)||7
2265927|NCT02320838|5561461|P3|COMPLETED|Second Intervention (1 Day)||8
2265928|NCT02320838|5561462|P2|COMPLETED|Second Intervention (1 Day)||8
2265929|NCT02320838|5561463|P1|COMPLETED|Second Intervention (1 Day)||8
2265930|NCT02320838|5561459|P5|STARTED|Second Intervention (1 Day)||7
2265931|NCT02320838|5561460|P4|STARTED|Second Intervention (1 Day)||7
2265932|NCT02320838|5561461|P3|STARTED|Second Intervention (1 Day)||8
2265933|NCT02320838|5561462|P2|STARTED|Second Intervention (1 Day)||8
2265934|NCT02320838|5561463|P1|STARTED|Second Intervention (1 Day)||8
2265935|NCT02320838|5561459|P5|NOT COMPLETED|Washout (1 Day)||0
2265936|NCT02320838|5561460|P4|NOT COMPLETED|Washout (1 Day)||0
2265937|NCT02320838|5561461|P3|NOT COMPLETED|Washout (1 Day)||0
2265938|NCT02320838|5561462|P2|NOT COMPLETED|Washout (1 Day)||0
2265939|NCT02320838|5561463|P1|NOT COMPLETED|Washout (1 Day)||0
2265940|NCT02320838|5561459|P5|COMPLETED|Washout (1 Day)||7
2265941|NCT02320838|5561460|P4|COMPLETED|Washout (1 Day)||7
2265942|NCT02320838|5561461|P3|COMPLETED|Washout (1 Day)||8
2265943|NCT02320838|5561462|P2|COMPLETED|Washout (1 Day)||8
2265944|NCT02320838|5561463|P1|COMPLETED|Washout (1 Day)||8
2265945|NCT02320838|5561459|P5|STARTED|Washout (1 Day)||7
2265946|NCT02320838|5561460|P4|STARTED|Washout (1 Day)||7
2265947|NCT02320838|5561461|P3|STARTED|Washout (1 Day)||8
2265948|NCT02320838|5561462|P2|STARTED|Washout (1 Day)||8
2265949|NCT02320838|5561463|P1|STARTED|Washout (1 Day)||8
2265950|NCT02320838|5561459|P5|NOT COMPLETED|First Intervention (1 Day)||0
2265951|NCT02320838|5561460|P4|NOT COMPLETED|First Intervention (1 Day)||0
2265952|NCT02320838|5561461|P3|NOT COMPLETED|First Intervention (1 Day)||0
2265953|NCT02320838|5561462|P2|NOT COMPLETED|First Intervention (1 Day)||0
2265954|NCT02320838|5561463|P1|NOT COMPLETED|First Intervention (1 Day)||0
2265955|NCT02320838|5561459|P5|COMPLETED|First Intervention (1 Day)||7
2265956|NCT02320838|5561460|P4|COMPLETED|First Intervention (1 Day)||7
2265957|NCT02320838|5561461|P3|COMPLETED|First Intervention (1 Day)||8
2265958|NCT02320838|5561462|P2|COMPLETED|First Intervention (1 Day)||8
2265959|NCT02320838|5561463|P1|COMPLETED|First Intervention (1 Day)||8
2265960|NCT02320838|5561459|P5|STARTED|First Intervention (1 Day)||7
2265961|NCT02320838|5561460|P4|STARTED|First Intervention (1 Day)||7
2265962|NCT02320838|5561461|P3|STARTED|First Intervention (1 Day)||8
2265963|NCT02320838|5561462|P2|STARTED|First Intervention (1 Day)||8
2265964|NCT02320838|5561463|P1|STARTED|First Intervention (1 Day)||8
2265965|NCT02320825|5561530|P2|NOT COMPLETED|Overall Study||0
2265966|NCT02320825|5561531|P1|NOT COMPLETED|Overall Study||0
2265967|NCT02320825|5561530|P2|COMPLETED|Overall Study||8
2265968|NCT02320825|5561531|P1|COMPLETED|Overall Study||8
2265969|NCT02320825|5561530|P2|STARTED|Overall Study||8
2265970|NCT02320825|5561531|P1|STARTED|Overall Study||8
2265971|NCT02320812|5561541|P1|NOT COMPLETED|Overall Study||0
2265972|NCT02320812|5561541|P1|COMPLETED|Overall Study||28
2265973|NCT02320812|5561541|P1|STARTED|Overall Study||28
2265974|NCT02320721|5561551|P2|NOT COMPLETED|Overall Study||34
2265975|NCT02320721|5561552|P1|NOT COMPLETED|Overall Study||27
2265976|NCT02320721|5561551|P2|COMPLETED|Overall Study||472
2265977|NCT02320721|5561552|P1|COMPLETED|Overall Study||481
2265978|NCT02320721|5561551|P2|Treated (Safety Population)|Overall Study||505
2265979|NCT02320721|5561552|P1|Treated (Safety Population)|Overall Study||508
2265980|NCT02320721|5561551|P2|STARTED|Overall Study||506
2265981|NCT02320721|5561552|P1|STARTED|Overall Study||508
2265982|NCT02320695|5561580|P1|NOT COMPLETED|Overall Study||0
2265983|NCT02320695|5561580|P1|COMPLETED|Overall Study||60
2265984|NCT02320695|5561580|P1|Pain Relief Ointment|Overall Study||60
2265985|NCT02320695|5561580|P1|Original Ointment|Overall Study||60
2265986|NCT02320695|5561580|P1|Antibiotic/Pain Relieving Ointment|Overall Study||60
2265987|NCT02320695|5561580|P1|Pain Relieving Cream|Overall Study||59
2265988|NCT02320695|5561580|P1|Alcohol|Overall Study||60
2265989|NCT02320695|5561580|P1|Saline|Overall Study||60
2265990|NCT02320695|5561580|P1|STARTED|Overall Study||60
2265991|NCT02320487|5561607|P1|NOT COMPLETED|Overall Study||21
2265992|NCT02320487|5561607|P1|COMPLETED|Overall Study|Completed = completed the 6-cycle Treatment Period.|81
2265993|NCT02320487|5561607|P1|STARTED|Overall Study||102
2265994|NCT02320396|5561627|P2|NOT COMPLETED|Overall Study||4
2265995|NCT02320396|5561628|P1|NOT COMPLETED|Overall Study||4
2265996|NCT02320396|5561627|P2|COMPLETED|Overall Study||221
2265997|NCT02320396|5561628|P1|COMPLETED|Overall Study||220
2265998|NCT02320396|5561627|P2|Treated (Full Analysis Set)|Overall Study||225
2265999|NCT02320396|5561628|P1|Treated (Full Analysis Set)|Overall Study||223
2266000|NCT02320396|5561627|P2|STARTED|Overall Study||225
2266001|NCT02320396|5561628|P1|STARTED|Overall Study||224
2266002|NCT02320227|5561658|P1|NOT COMPLETED|Overall Study||0
2266003|NCT02320227|5561658|P1|COMPLETED|Overall Study||30
2266004|NCT02320227|5561658|P1|STARTED|Overall Study||30
2266005|NCT02320214|5561663|P1|NOT COMPLETED|Overall Study||0
2266006|NCT02320214|5561663|P1|COMPLETED|Overall Study||30
2266007|NCT02320214|5561663|P1|STARTED|Overall Study||30
2266008|NCT02320149|5561670|P2|NOT COMPLETED|Overall Study||80
2266009|NCT02320149|5561671|P1|NOT COMPLETED|Overall Study||63
2266010|NCT02320149|5561670|P2|COMPLETED|Overall Study||405
2266011|NCT02320149|5561671|P1|COMPLETED|Overall Study||420
2266012|NCT02320149|5561670|P2|STARTED|Overall Study||485
2266013|NCT02320149|5561671|P1|STARTED|Overall Study||483
2266014|NCT02319967|5561712|P3|NOT COMPLETED|Overall Study||45
2266015|NCT02319967|5561713|P2|NOT COMPLETED|Overall Study||44
2266016|NCT02319967|5561714|P1|NOT COMPLETED|Overall Study||48
2266017|NCT02319967|5561712|P3|COMPLETED|Overall Study||76
2266018|NCT02319967|5561713|P2|COMPLETED|Overall Study||82
2266019|NCT02319967|5561714|P1|COMPLETED|Overall Study||78
2266020|NCT02319967|5561712|P3|STARTED|Overall Study||121
2266021|NCT02319967|5561713|P2|STARTED|Overall Study||126
2266022|NCT02319967|5561714|P1|STARTED|Overall Study||126
2266023|NCT02319824|5561770|P1|NOT COMPLETED|Overall Study||0
2266024|NCT02319824|5561770|P1|COMPLETED|Overall Study||2
2266025|NCT02319824|5561770|P1|STARTED|Overall Study||2
2266026|NCT02319668|5561778|P2|NOT COMPLETED|Overall Study||2
2266027|NCT02319668|5561779|P1|NOT COMPLETED|Overall Study||0
2266028|NCT02319668|5561778|P2|COMPLETED|Overall Study||17
2266029|NCT02319668|5561779|P1|COMPLETED|Overall Study||19
2266030|NCT02319668|5561778|P2|STARTED|Overall Study||19
2266031|NCT02319668|5561779|P1|STARTED|Overall Study||19
2266032|NCT02319642|5561793|P2|NOT COMPLETED|Overall Study||6
2266033|NCT02319642|5561794|P1|NOT COMPLETED|Overall Study||4
2266034|NCT02319642|5561793|P2|COMPLETED|Overall Study||245
2266035|NCT02319642|5561794|P1|COMPLETED|Overall Study||91
2266036|NCT02319642|5561793|P2|STARTED|Overall Study||251
2266037|NCT02319642|5561794|P1|STARTED|Overall Study||95
2266038|NCT02319525|5561814|P2|NOT COMPLETED|Overall Study||1
2266039|NCT02319525|5561815|P1|NOT COMPLETED|Overall Study||2
2266040|NCT02319525|5561814|P2|COMPLETED|Overall Study||147
2266041|NCT02319525|5561815|P1|COMPLETED|Overall Study||151
2266042|NCT02319525|5561814|P2|Primary Research Completion|Overall Study||147
2266043|NCT02319525|5561815|P1|Primary Research Completion|Overall Study||151
2266044|NCT02319525|5561814|P2|STARTED|Overall Study||148
2266045|NCT02319525|5561815|P1|STARTED|Overall Study||153
2266046|NCT02319486|5561833|P1|NOT COMPLETED|Overall Study||0
2266047|NCT02319486|5561833|P1|COMPLETED|Overall Study||26
2266048|NCT02319486|5561833|P1|STARTED|Overall Study||26
2266049|NCT02319317|5561841|P2|NOT COMPLETED|Overall Study||0
2266050|NCT02319317|5561842|P1|NOT COMPLETED|Overall Study||0
2266051|NCT02319317|5561841|P2|COMPLETED|Overall Study||29
2266052|NCT02319317|5561842|P1|COMPLETED|Overall Study||31
2266053|NCT02319317|5561841|P2|STARTED|Overall Study||29
2266054|NCT02319317|5561842|P1|STARTED|Overall Study||31
2266055|NCT02319174|5561848|P1|NOT COMPLETED|Overall Study||1
2266056|NCT02319174|5561848|P1|COMPLETED|Overall Study||42
2266057|NCT02319174|5561848|P1|STARTED|Overall Study||43
2266058|NCT02319148|5561857|P4|NOT COMPLETED|Second Intervention Period||2
2266059|NCT02319148|5561858|P3|NOT COMPLETED|Second Intervention Period||1
2266060|NCT02319148|5561859|P2|NOT COMPLETED|Second Intervention Period||1
2266061|NCT02319148|5561860|P1|NOT COMPLETED|Second Intervention Period||0
2266062|NCT02319148|5561857|P4|COMPLETED|Second Intervention Period||6
2266063|NCT02319148|5561858|P3|COMPLETED|Second Intervention Period||6
2266064|NCT02319148|5561859|P2|COMPLETED|Second Intervention Period||6
2266065|NCT02319148|5561860|P1|COMPLETED|Second Intervention Period||0
2266066|NCT02319148|5561857|P4|STARTED|Second Intervention Period||8
2266067|NCT02319148|5561858|P3|STARTED|Second Intervention Period||7
2266068|NCT02319148|5561859|P2|STARTED|Second Intervention Period||7
2266069|NCT02319148|5561860|P1|STARTED|Second Intervention Period||0
2266070|NCT02319148|5561857|P4|NOT COMPLETED|Washout Period 4 Days||0
2266071|NCT02319148|5561858|P3|NOT COMPLETED|Washout Period 4 Days||0
2266072|NCT02319148|5561859|P2|NOT COMPLETED|Washout Period 4 Days||0
2266073|NCT02319148|5561860|P1|NOT COMPLETED|Washout Period 4 Days||0
2266074|NCT02319148|5561857|P4|COMPLETED|Washout Period 4 Days||0
2266075|NCT02319148|5561858|P3|COMPLETED|Washout Period 4 Days||0
2266076|NCT02319148|5561859|P2|COMPLETED|Washout Period 4 Days||0
2266077|NCT02319148|5561860|P1|COMPLETED|Washout Period 4 Days||22
2266078|NCT02319148|5561857|P4|STARTED|Washout Period 4 Days||0
2266079|NCT02319148|5561858|P3|STARTED|Washout Period 4 Days||0
2266080|NCT02319148|5561859|P2|STARTED|Washout Period 4 Days||0
2266081|NCT02319148|5561860|P1|STARTED|Washout Period 4 Days||22
2266082|NCT02319148|5561857|P4|NOT COMPLETED|First Intervention Period||0
2266083|NCT02319148|5561858|P3|NOT COMPLETED|First Intervention Period||0
2266084|NCT02319148|5561859|P2|NOT COMPLETED|First Intervention Period||0
2266085|NCT02319148|5561860|P1|NOT COMPLETED|First Intervention Period||0
2266086|NCT02319148|5561857|P4|COMPLETED|First Intervention Period||0
2266087|NCT02319148|5561858|P3|COMPLETED|First Intervention Period||0
2266088|NCT02319148|5561859|P2|COMPLETED|First Intervention Period||0
2266089|NCT02319148|5561860|P1|COMPLETED|First Intervention Period||22
2266090|NCT02319148|5561857|P4|STARTED|First Intervention Period||0
2266091|NCT02319148|5561858|P3|STARTED|First Intervention Period||0
2266092|NCT02319148|5561859|P2|STARTED|First Intervention Period||0
2266093|NCT02319148|5561860|P1|STARTED|First Intervention Period||22
2266103|NCT02319031|5561981|P2|NOT COMPLETED|Follow-Up Period||0
2266104|NCT02319031|5561982|P1|NOT COMPLETED|Follow-Up Period||0
2266105|NCT02319031|5561981|P2|COMPLETED|Follow-Up Period||26
2266106|NCT02319031|5561982|P1|COMPLETED|Follow-Up Period||23
2266107|NCT02319031|5561981|P2|STARTED|Follow-Up Period||26
2266108|NCT02319031|5561982|P1|STARTED|Follow-Up Period||23
2266109|NCT02319031|5561981|P2|NOT COMPLETED|Treatment Period||0
2266110|NCT02319031|5561982|P1|NOT COMPLETED|Treatment Period||1
2266111|NCT02319031|5561981|P2|COMPLETED|Treatment Period||26
2266112|NCT02319031|5561982|P1|COMPLETED|Treatment Period||23
2266113|NCT02319031|5561981|P2|STARTED|Treatment Period||26
2266114|NCT02319031|5561982|P1|STARTED|Treatment Period||24
2266115|NCT02319005|5561994|P2|NOT COMPLETED|Overall Study||15
2266116|NCT02319005|5561995|P1|NOT COMPLETED|Overall Study||48
2266117|NCT02319005|5561994|P2|COMPLETED|Overall Study||51
2266118|NCT02319005|5561995|P1|COMPLETED|Overall Study||92
2266119|NCT02319005|5561994|P2|STARTED|Overall Study||66
2266120|NCT02319005|5561995|P1|STARTED|Overall Study||140
2266121|NCT02318992|5562018|P3|NOT COMPLETED|Overall Study||4
2266122|NCT02318992|5562019|P2|NOT COMPLETED|Overall Study||2
2266123|NCT02318992|5562020|P1|NOT COMPLETED|Overall Study||2
2266124|NCT02318992|5562018|P3|COMPLETED|Overall Study||20
2266125|NCT02318992|5562019|P2|COMPLETED|Overall Study||25
2266126|NCT02318992|5562020|P1|COMPLETED|Overall Study||25
2266127|NCT02318992|5562018|P3|STARTED|Overall Study||24
2266128|NCT02318992|5562019|P2|STARTED|Overall Study||27
2266129|NCT02318992|5562020|P1|STARTED|Overall Study||27
2266130|NCT02318979|5562033|P2|NOT COMPLETED|Overall Study||0
2266131|NCT02318979|5562034|P1|NOT COMPLETED|Overall Study||0
2266132|NCT02318979|5562033|P2|COMPLETED|Overall Study||15
2266133|NCT02318979|5562034|P1|COMPLETED|Overall Study||15
2266134|NCT02318979|5562033|P2|STARTED|Overall Study||15
2266135|NCT02318979|5562034|P1|STARTED|Overall Study||15
2266136|NCT02318940|5562046|P2|NOT COMPLETED|Overall Study||0
2266137|NCT02318940|5562047|P1|NOT COMPLETED|Overall Study||1
2266138|NCT02318940|5562046|P2|COMPLETED|Overall Study||50
2266139|NCT02318940|5562047|P1|COMPLETED|Overall Study||49
2266140|NCT02318940|5562046|P2|STARTED|Overall Study||50
2266141|NCT02318940|5562047|P1|STARTED|Overall Study|in the last patient we lost the record.|50
2266142|NCT02318901|5562062|P3|NOT COMPLETED|Overall Study||10
2266143|NCT02318901|5562063|P2|NOT COMPLETED|Overall Study||1
2266144|NCT02318901|5562064|P1|NOT COMPLETED|Overall Study||5
2266145|NCT02318901|5562062|P3|COMPLETED|Overall Study||0
2266146|NCT02318901|5562063|P2|COMPLETED|Overall Study||0
2266147|NCT02318901|5562064|P1|COMPLETED|Overall Study||0
2266148|NCT02318901|5562062|P3|STARTED|Overall Study||10
2266149|NCT02318901|5562063|P2|STARTED|Overall Study||1
2266150|NCT02318901|5562064|P1|STARTED|Overall Study||5
2266151|NCT02318797|5562089|P2|NOT COMPLETED|Overall Study||102
2266152|NCT02318797|5562090|P1|NOT COMPLETED|Overall Study||88
2266153|NCT02318797|5562089|P2|COMPLETED|Overall Study||611
2266154|NCT02318797|5562090|P1|COMPLETED|Overall Study||428
2266155|NCT02318797|5562089|P2|STARTED|Overall Study||713
2266156|NCT02318797|5562090|P1|STARTED|Overall Study||516
2266157|NCT02318693|5562130|P2|NOT COMPLETED|Overall Study||1
2266158|NCT02318693|5562131|P1|NOT COMPLETED|Overall Study||0
2266159|NCT02318693|5562130|P2|COMPLETED|Overall Study||26
2266160|NCT02318693|5562131|P1|COMPLETED|Overall Study||26
2266161|NCT02318693|5562130|P2|Treated|Overall Study|1 randomized participant did not receive treatment.|26
2266162|NCT02318693|5562131|P1|Treated|Overall Study||26
2266163|NCT02318693|5562130|P2|STARTED|Overall Study||27
2266164|NCT02318693|5562131|P1|STARTED|Overall Study||26
2266165|NCT02318667|5562145|P1|NOT COMPLETED|Overall Study||9
2266166|NCT02318667|5562145|P1|COMPLETED|Overall Study||29
2266167|NCT02318667|5562145|P1|STARTED|Overall Study||38
2266168|NCT02318602|5562164|P3|NOT COMPLETED|Overall Study||2
2266169|NCT02318602|5562165|P2|NOT COMPLETED|Overall Study||4
2266170|NCT02318602|5562166|P1|NOT COMPLETED|Overall Study||1
2266171|NCT02318602|5562164|P3|COMPLETED|Overall Study||15
2266172|NCT02318602|5562165|P2|COMPLETED|Overall Study||22
2266173|NCT02318602|5562166|P1|COMPLETED|Overall Study||8
2266174|NCT02318602|5562164|P3|STARTED|Overall Study||17
2266175|NCT02318602|5562165|P2|STARTED|Overall Study||26
2266176|NCT02318602|5562166|P1|STARTED|Overall Study||9
2266177|NCT02318303|5562204|P7|NOT COMPLETED|Overall Study||2
2266178|NCT02318303|5562205|P6|NOT COMPLETED|Overall Study||6
2266179|NCT02318303|5562206|P5|NOT COMPLETED|Overall Study||5
2266180|NCT02318303|5562207|P4|NOT COMPLETED|Overall Study||3
2266181|NCT02318303|5562208|P3|NOT COMPLETED|Overall Study||3
2266182|NCT02318303|5562209|P2|NOT COMPLETED|Overall Study||3
2266183|NCT02318303|5562210|P1|NOT COMPLETED|Overall Study||4
2266184|NCT02318303|5562204|P7|COMPLETED|Overall Study||158
2266185|NCT02318303|5562205|P6|COMPLETED|Overall Study||153
2266186|NCT02318303|5562206|P5|COMPLETED|Overall Study||152
2266187|NCT02318303|5562207|P4|COMPLETED|Overall Study||155
2266188|NCT02318303|5562208|P3|COMPLETED|Overall Study||157
2266189|NCT02318303|5562209|P2|COMPLETED|Overall Study||155
2266190|NCT02318303|5562210|P1|COMPLETED|Overall Study||155
2266191|NCT02318303|5562204|P7|STARTED|Overall Study||160
2266192|NCT02318303|5562205|P6|STARTED|Overall Study||159
2266193|NCT02318303|5562206|P5|STARTED|Overall Study||157
2266194|NCT02318303|5562207|P4|STARTED|Overall Study||158
2266195|NCT02318303|5562208|P3|STARTED|Overall Study||160
2266196|NCT02318303|5562209|P2|STARTED|Overall Study||158
2266197|NCT02318303|5562210|P1|STARTED|Overall Study||159
2266198|NCT02317809|5562226|P2|NOT COMPLETED|Second Intervention Period (8 Days)||0
2266199|NCT02317809|5562227|P1|NOT COMPLETED|Second Intervention Period (8 Days)||0
2266200|NCT02317809|5562226|P2|COMPLETED|Second Intervention Period (8 Days)||17
2266201|NCT02317809|5562227|P1|COMPLETED|Second Intervention Period (8 Days)||14
2266202|NCT02317809|5562226|P2|STARTED|Second Intervention Period (8 Days)||17
2266203|NCT02317809|5562227|P1|STARTED|Second Intervention Period (8 Days)||14
2266204|NCT02317809|5562226|P2|NOT COMPLETED|First Intervention Period (8 Days)||0
2266205|NCT02317809|5562227|P1|NOT COMPLETED|First Intervention Period (8 Days)||3
2266206|NCT02317809|5562226|P2|COMPLETED|First Intervention Period (8 Days)||17
2266207|NCT02317809|5562227|P1|COMPLETED|First Intervention Period (8 Days)||14
2266208|NCT02317809|5562226|P2|STARTED|First Intervention Period (8 Days)||17
2266209|NCT02317809|5562227|P1|STARTED|First Intervention Period (8 Days)||17
2266210|NCT02317744|5562279|P2|NOT COMPLETED|Overall Study||2
2266211|NCT02317744|5562280|P1|NOT COMPLETED|Overall Study||1
2266212|NCT02317744|5562279|P2|COMPLETED|Overall Study|One Placebo participant stopped the treatment but completed assessments.|8
2266213|NCT02317744|5562280|P1|COMPLETED|Overall Study|One NB participant stopped the treatment but completed assessments.|11
2266214|NCT02317744|5562279|P2|Completed Treatment|Overall Study||7
2266215|NCT02317744|5562280|P1|Completed Treatment|Overall Study||10
2266216|NCT02317744|5562279|P2|STARTED|Overall Study||10
2266217|NCT02317744|5562280|P1|STARTED|Overall Study||12
2266218|NCT02317692|5562294|P2|NOT COMPLETED|Overall Study||0
2266219|NCT02317692|5562295|P1|NOT COMPLETED|Overall Study||6
2266220|NCT02317692|5562294|P2|COMPLETED|Overall Study||77
2266221|NCT02317692|5562295|P1|COMPLETED|Overall Study||63
2266222|NCT02317692|5562294|P2|STARTED|Overall Study||77
2266223|NCT02317692|5562295|P1|STARTED|Overall Study||69
2266224|NCT02317614|5562315|P2|NOT COMPLETED|Overall Study||2
2266225|NCT02317614|5562316|P1|NOT COMPLETED|Overall Study||3
2266226|NCT02317614|5562315|P2|COMPLETED|Overall Study||23
2266227|NCT02317614|5562316|P1|COMPLETED|Overall Study||23
2266228|NCT02317614|5562315|P2|STARTED|Overall Study||25
2266229|NCT02317614|5562316|P1|STARTED|Overall Study||26
2266230|NCT02317549|5562334|P2|NOT COMPLETED|Overall Study||0
2266231|NCT02317549|5562335|P1|NOT COMPLETED|Overall Study||0
2266232|NCT02317549|5562334|P2|COMPLETED|Overall Study||3
2266233|NCT02317549|5562335|P1|COMPLETED|Overall Study||5
2266234|NCT02317549|5562334|P2|STARTED|Overall Study||3
2266235|NCT02317549|5562335|P1|STARTED|Overall Study||5
2266236|NCT02317510|5562343|P2|NOT COMPLETED|Overall Study||1
2266237|NCT02317510|5562344|P1|NOT COMPLETED|Overall Study||0
2266238|NCT02317510|5562343|P2|COMPLETED|Overall Study||24
2266239|NCT02317510|5562344|P1|COMPLETED|Overall Study||25
2266240|NCT02317510|5562343|P2|STARTED|Overall Study||25
2266241|NCT02317510|5562344|P1|STARTED|Overall Study||25
2266242|NCT02317276|5562372|P1|NOT COMPLETED|Overall Study||6
2266243|NCT02317276|5562372|P1|COMPLETED|Overall Study||5
2266244|NCT02317276|5562372|P1|STARTED|Overall Study||11
2266245|NCT02317016|5562376|P1|NOT COMPLETED|Part B: Day 35 to End Part B (AZD9291)||31
2266246|NCT02317016|5562376|P1|COMPLETED|Part B: Day 35 to End Part B (AZD9291)||11
2266247|NCT02317016|5562376|P1|STARTED|Part B: Day 35 to End Part B (AZD9291)|41 completed Part A + 1 entered Part B without completing Part A (due to AE) = 42 started Part B|42
2266248|NCT02317016|5562376|P1|NOT COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||2
2266249|NCT02317016|5562376|P1|COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||41
2266250|NCT02317016|5562376|P1|STARTED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||43
2266251|NCT02317016|5562376|P1|NOT COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||1
2266252|NCT02317016|5562376|P1|COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||43
2266253|NCT02317016|5562376|P1|STARTED|Part A: Day 4-31 (AZD9291 Alone)||44
2266254|NCT02317016|5562376|P1|NOT COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||0
2266255|NCT02317016|5562376|P1|COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||44
2266256|NCT02317016|5562376|P1|STARTED|Part A: Day 1-3 (Rosuvastatin Alone)||44
2266257|NCT02316847|5562404|P2|NOT COMPLETED|Overall Study||86
2266258|NCT02316847|5562405|P1|NOT COMPLETED|Overall Study||9
2266259|NCT02316847|5562404|P2|COMPLETED|Overall Study||13
2266260|NCT02316847|5562405|P1|COMPLETED|Overall Study||0
2266261|NCT02316847|5562404|P2|STARTED|Overall Study||99
2266262|NCT02316847|5562405|P1|STARTED|Overall Study||9
2266263|NCT02316769|5562416|P2|NOT COMPLETED|Overall Study||0
2266264|NCT02316769|5562417|P1|NOT COMPLETED|Overall Study||2
2266265|NCT02316769|5562416|P2|COMPLETED|Overall Study||33
2266266|NCT02316769|5562417|P1|COMPLETED|Overall Study||31
2266267|NCT02316769|5562416|P2|STARTED|Overall Study||33
2266268|NCT02316769|5562417|P1|STARTED|Overall Study||33
2266278|NCT02316678|5562560|P2|NOT COMPLETED|Overall Study||0
2266279|NCT02316678|5562561|P1|NOT COMPLETED|Overall Study||0
2266280|NCT02316678|5562560|P2|COMPLETED|Overall Study||7694
2266281|NCT02316678|5562561|P1|COMPLETED|Overall Study||1879
2266282|NCT02316678|5562560|P2|STARTED|Overall Study||7694
2266283|NCT02316678|5562561|P1|STARTED|Overall Study||1879
2266284|NCT02316613|5562567|P1|NOT COMPLETED|Overall Study||104
2266285|NCT02316613|5562567|P1|COMPLETED|Overall Study||156
2266286|NCT02316613|5562567|P1|Overall Population|Overall Study||241
2266287|NCT02316613|5562567|P1|Safety Population|Overall Study||255
2266288|NCT02316613|5562567|P1|STARTED|Overall Study||260
2266289|NCT02316548|5562606|P2|NOT COMPLETED|Overall Study||1
2266290|NCT02316548|5562607|P1|NOT COMPLETED|Overall Study||0
2266291|NCT02316548|5562606|P2|COMPLETED|Overall Study|Eligible patients on study until study termination|6
2266292|NCT02316548|5562607|P1|COMPLETED|Overall Study|Eligible patients on study until study termination|6
2266293|NCT02316548|5562606|P2|Eligible With Adverse Event Data|Overall Study||2
2266294|NCT02316548|5562607|P1|Eligible With Adverse Event Data|Overall Study||4
2266295|NCT02316548|5562606|P2|Eligible With Disease Assessment|Overall Study||1
2266296|NCT02316548|5562607|P1|Eligible With Disease Assessment|Overall Study||4
2266297|NCT02316548|5562606|P2|Eligible Population|Overall Study||6
2266298|NCT02316548|5562607|P1|Eligible Population|Overall Study||6
2266299|NCT02316548|5562606|P2|STARTED|Overall Study|Randomized|7
2266300|NCT02316548|5562607|P1|STARTED|Overall Study|Randomized|6
2266301|NCT02316470|5562621|P4|NOT COMPLETED|Overall Study||2
2266302|NCT02316470|5562622|P3|NOT COMPLETED|Overall Study||5
2266303|NCT02316470|5562623|P2|NOT COMPLETED|Overall Study||6
2266304|NCT02316470|5562624|P1|NOT COMPLETED|Overall Study||5
2266305|NCT02316470|5562621|P4|COMPLETED|Overall Study||46
2266306|NCT02316470|5562622|P3|COMPLETED|Overall Study||147
2266307|NCT02316470|5562623|P2|COMPLETED|Overall Study||146
2266308|NCT02316470|5562624|P1|COMPLETED|Overall Study||143
2266309|NCT02316470|5562621|P4|STARTED|Overall Study||48
2266310|NCT02316470|5562622|P3|STARTED|Overall Study||152
2266311|NCT02316470|5562623|P2|STARTED|Overall Study||152
2266312|NCT02316470|5562624|P1|STARTED|Overall Study||148
2266313|NCT02316366|5562720|P2|NOT COMPLETED|Overall Study||0
2266314|NCT02316366|5562721|P1|NOT COMPLETED|Overall Study||0
2266315|NCT02316366|5562720|P2|COMPLETED|Overall Study||40
2266316|NCT02316366|5562721|P1|COMPLETED|Overall Study||40
2266317|NCT02316366|5562720|P2|STARTED|Overall Study||40
2266318|NCT02316366|5562721|P1|STARTED|Overall Study||40
2266319|NCT02316353|5562737|P2|NOT COMPLETED|Overall Study||8
2266320|NCT02316353|5562738|P1|NOT COMPLETED|Overall Study||8
2266321|NCT02316353|5562737|P2|COMPLETED|Overall Study||55
2266322|NCT02316353|5562738|P1|COMPLETED|Overall Study||55
2266323|NCT02316353|5562737|P2|STARTED|Overall Study||63
2266324|NCT02316353|5562738|P1|STARTED|Overall Study|7 subjects assigned to the CSL830 (40) Arm, were titrated up to the 60 IU/kg arm during the study|63
2266325|NCT02316171|5562758|P4|NOT COMPLETED|Overall Study||0
2266326|NCT02316171|5562759|P3|NOT COMPLETED|Overall Study||0
2266327|NCT02316171|5562760|P2|NOT COMPLETED|Overall Study||0
2266328|NCT02316171|5562761|P1|NOT COMPLETED|Overall Study||1
2266329|NCT02316171|5562758|P4|COMPLETED|Overall Study||3
2266330|NCT02316171|5562759|P3|COMPLETED|Overall Study||3
2266331|NCT02316171|5562760|P2|COMPLETED|Overall Study||6
2266332|NCT02316171|5562761|P1|COMPLETED|Overall Study||3
2266333|NCT02316171|5562758|P4|STARTED|Overall Study||3
2266334|NCT02316171|5562759|P3|STARTED|Overall Study||3
2266335|NCT02316171|5562760|P2|STARTED|Overall Study||6
2266336|NCT02316171|5562761|P1|STARTED|Overall Study||4
2266337|NCT02316002|5562767|P1|NOT COMPLETED|Overall Study||6
2266338|NCT02316002|5562767|P1|COMPLETED|Overall Study||45
2266339|NCT02316002|5562767|P1|STARTED|Overall Study||51
2266340|NCT02315989|5562771|P1|NOT COMPLETED|Overall Study||0
2266341|NCT02315989|5562771|P1|COMPLETED|Overall Study||6
2266342|NCT02315989|5562771|P1|STARTED|Overall Study||6
2266343|NCT02315872|5562781|P2|NOT COMPLETED|Overall Study||1
2266344|NCT02315872|5562782|P1|NOT COMPLETED|Overall Study||3
2266345|NCT02315872|5562781|P2|COMPLETED|Overall Study||3
2266346|NCT02315872|5562782|P1|COMPLETED|Overall Study||1
2266347|NCT02315872|5562781|P2|STARTED|Overall Study||4
2266348|NCT02315872|5562782|P1|STARTED|Overall Study||4
2266349|NCT02315755|5562794|P1|NOT COMPLETED|Overall Study||0
2266350|NCT02315755|5562794|P1|COMPLETED|Overall Study|Participants who died, were considered as 'completed'.|102
2266351|NCT02315755|5562794|P1|STARTED|Overall Study||102
2266352|NCT02315664|5562825|P2|NOT COMPLETED|Overall Study||4
2266353|NCT02315664|5562826|P1|NOT COMPLETED|Overall Study||1
2266354|NCT02315664|5562825|P2|COMPLETED|Overall Study||27
2266355|NCT02315664|5562826|P1|COMPLETED|Overall Study||29
2266356|NCT02315664|5562825|P2|STARTED|Overall Study||31
2266357|NCT02315664|5562826|P1|STARTED|Overall Study||30
2266358|NCT02315560|5562846|P1|NOT COMPLETED|Overall Study||3
2266359|NCT02315560|5562846|P1|COMPLETED|Overall Study||22
2266360|NCT02315560|5562846|P1|STARTED|Overall Study||25
2266361|NCT02315352|5562853|P8|NOT COMPLETED|Fifth Intervention (Day 2)||0
2266362|NCT02315352|5562854|P7|NOT COMPLETED|Fifth Intervention (Day 2)||0
2266363|NCT02315352|5562855|P6|NOT COMPLETED|Fifth Intervention (Day 2)||0
2266364|NCT02315352|5562856|P5|NOT COMPLETED|Fifth Intervention (Day 2)||0
2266365|NCT02315352|5562857|P4|NOT COMPLETED|Fifth Intervention (Day 2)||0
2266366|NCT02315352|5562858|P3|NOT COMPLETED|Fifth Intervention (Day 2)||0
2266367|NCT02315352|5562859|P2|NOT COMPLETED|Fifth Intervention (Day 2)||0
2266368|NCT02315352|5562860|P1|NOT COMPLETED|Fifth Intervention (Day 2)||0
2266369|NCT02315352|5562853|P8|COMPLETED|Fifth Intervention (Day 2)||8
2266370|NCT02315352|5562854|P7|COMPLETED|Fifth Intervention (Day 2)||9
2266371|NCT02315352|5562855|P6|COMPLETED|Fifth Intervention (Day 2)||7
2266372|NCT02315352|5562856|P5|COMPLETED|Fifth Intervention (Day 2)||8
2266373|NCT02315352|5562857|P4|COMPLETED|Fifth Intervention (Day 2)||8
2266374|NCT02315352|5562858|P3|COMPLETED|Fifth Intervention (Day 2)||7
2266375|NCT02315352|5562859|P2|COMPLETED|Fifth Intervention (Day 2)||0
2266376|NCT02315352|5562860|P1|COMPLETED|Fifth Intervention (Day 2)||0
2266377|NCT02315352|5562853|P8|STARTED|Fifth Intervention (Day 2)||8
2266378|NCT02315352|5562854|P7|STARTED|Fifth Intervention (Day 2)||9
2266379|NCT02315352|5562855|P6|STARTED|Fifth Intervention (Day 2)||7
2266380|NCT02315352|5562856|P5|STARTED|Fifth Intervention (Day 2)||8
2266381|NCT02315352|5562857|P4|STARTED|Fifth Intervention (Day 2)||8
2266382|NCT02315352|5562858|P3|STARTED|Fifth Intervention (Day 2)||7
2266383|NCT02315352|5562859|P2|STARTED|Fifth Intervention (Day 2)||0
2266384|NCT02315352|5562860|P1|STARTED|Fifth Intervention (Day 2)||0
2266385|NCT02315352|5562853|P8|NOT COMPLETED|Fourth Intervention (Day 2)||0
2266386|NCT02315352|5562854|P7|NOT COMPLETED|Fourth Intervention (Day 2)||0
2266387|NCT02315352|5562855|P6|NOT COMPLETED|Fourth Intervention (Day 2)||0
2266388|NCT02315352|5562856|P5|NOT COMPLETED|Fourth Intervention (Day 2)||0
2266389|NCT02315352|5562857|P4|NOT COMPLETED|Fourth Intervention (Day 2)||0
2266390|NCT02315352|5562858|P3|NOT COMPLETED|Fourth Intervention (Day 2)||0
2266391|NCT02315352|5562859|P2|NOT COMPLETED|Fourth Intervention (Day 2)||0
2266392|NCT02315352|5562860|P1|NOT COMPLETED|Fourth Intervention (Day 2)||0
2266393|NCT02315352|5562853|P8|COMPLETED|Fourth Intervention (Day 2)||8
2266394|NCT02315352|5562854|P7|COMPLETED|Fourth Intervention (Day 2)||9
2266395|NCT02315352|5562855|P6|COMPLETED|Fourth Intervention (Day 2)||7
2266396|NCT02315352|5562856|P5|COMPLETED|Fourth Intervention (Day 2)||8
2266397|NCT02315352|5562857|P4|COMPLETED|Fourth Intervention (Day 2)||8
2266398|NCT02315352|5562858|P3|COMPLETED|Fourth Intervention (Day 2)||7
2266399|NCT02315352|5562859|P2|COMPLETED|Fourth Intervention (Day 2)||0
2266400|NCT02315352|5562860|P1|COMPLETED|Fourth Intervention (Day 2)||0
2266401|NCT02315352|5562853|P8|STARTED|Fourth Intervention (Day 2)||8
2266402|NCT02315352|5562854|P7|STARTED|Fourth Intervention (Day 2)||9
2266403|NCT02315352|5562855|P6|STARTED|Fourth Intervention (Day 2)||7
2266404|NCT02315352|5562856|P5|STARTED|Fourth Intervention (Day 2)||8
2266405|NCT02315352|5562857|P4|STARTED|Fourth Intervention (Day 2)||8
2266406|NCT02315352|5562858|P3|STARTED|Fourth Intervention (Day 2)||7
2266407|NCT02315352|5562859|P2|STARTED|Fourth Intervention (Day 2)||0
2266408|NCT02315352|5562860|P1|STARTED|Fourth Intervention (Day 2)||0
2266409|NCT02315352|5562853|P8|NOT COMPLETED|Third Intervention (Day 2)||0
2266410|NCT02315352|5562854|P7|NOT COMPLETED|Third Intervention (Day 2)||0
2266411|NCT02315352|5562855|P6|NOT COMPLETED|Third Intervention (Day 2)||0
2266412|NCT02315352|5562856|P5|NOT COMPLETED|Third Intervention (Day 2)||0
2266413|NCT02315352|5562857|P4|NOT COMPLETED|Third Intervention (Day 2)||0
2266414|NCT02315352|5562858|P3|NOT COMPLETED|Third Intervention (Day 2)||0
2266415|NCT02315352|5562859|P2|NOT COMPLETED|Third Intervention (Day 2)||0
2266416|NCT02315352|5562860|P1|NOT COMPLETED|Third Intervention (Day 2)||0
2266417|NCT02315352|5562853|P8|COMPLETED|Third Intervention (Day 2)||8
2266418|NCT02315352|5562854|P7|COMPLETED|Third Intervention (Day 2)||9
2266419|NCT02315352|5562855|P6|COMPLETED|Third Intervention (Day 2)||7
2266420|NCT02315352|5562856|P5|COMPLETED|Third Intervention (Day 2)||8
2266421|NCT02315352|5562857|P4|COMPLETED|Third Intervention (Day 2)||8
2266422|NCT02315352|5562858|P3|COMPLETED|Third Intervention (Day 2)||7
2266423|NCT02315352|5562859|P2|COMPLETED|Third Intervention (Day 2)||0
2266424|NCT02315352|5562860|P1|COMPLETED|Third Intervention (Day 2)||0
2266425|NCT02315352|5562853|P8|STARTED|Third Intervention (Day 2)||8
2266426|NCT02315352|5562854|P7|STARTED|Third Intervention (Day 2)||9
2266427|NCT02315352|5562855|P6|STARTED|Third Intervention (Day 2)||7
2266428|NCT02315352|5562856|P5|STARTED|Third Intervention (Day 2)||8
2266429|NCT02315352|5562857|P4|STARTED|Third Intervention (Day 2)||8
2266430|NCT02315352|5562858|P3|STARTED|Third Intervention (Day 2)||7
2266431|NCT02315352|5562859|P2|STARTED|Third Intervention (Day 2)||0
2266432|NCT02315352|5562860|P1|STARTED|Third Intervention (Day 2)||0
2266433|NCT02315352|5562853|P8|NOT COMPLETED|Second Intervention (Day 1)||0
2266434|NCT02315352|5562854|P7|NOT COMPLETED|Second Intervention (Day 1)||0
2266435|NCT02315352|5562855|P6|NOT COMPLETED|Second Intervention (Day 1)||0
2266436|NCT02315352|5562856|P5|NOT COMPLETED|Second Intervention (Day 1)||0
2266437|NCT02315352|5562857|P4|NOT COMPLETED|Second Intervention (Day 1)||0
2266438|NCT02315352|5562858|P3|NOT COMPLETED|Second Intervention (Day 1)||0
2266439|NCT02315352|5562859|P2|NOT COMPLETED|Second Intervention (Day 1)||0
2266440|NCT02315352|5562860|P1|NOT COMPLETED|Second Intervention (Day 1)||0
2266441|NCT02315352|5562853|P8|COMPLETED|Second Intervention (Day 1)||0
2266442|NCT02315352|5562854|P7|COMPLETED|Second Intervention (Day 1)||0
2266443|NCT02315352|5562855|P6|COMPLETED|Second Intervention (Day 1)||0
2266444|NCT02315352|5562856|P5|COMPLETED|Second Intervention (Day 1)||0
2266445|NCT02315352|5562857|P4|COMPLETED|Second Intervention (Day 1)||0
2266446|NCT02315352|5562858|P3|COMPLETED|Second Intervention (Day 1)||0
2266447|NCT02315352|5562859|P2|COMPLETED|Second Intervention (Day 1)||24
2266448|NCT02315352|5562860|P1|COMPLETED|Second Intervention (Day 1)|Out of 24 subjects completing this period, 1 discontinued before assignment to any sequence on Day 2|24
2266449|NCT02315352|5562853|P8|STARTED|Second Intervention (Day 1)||0
2266450|NCT02315352|5562854|P7|STARTED|Second Intervention (Day 1)||0
2266451|NCT02315352|5562855|P6|STARTED|Second Intervention (Day 1)||0
2266452|NCT02315352|5562856|P5|STARTED|Second Intervention (Day 1)||0
2266453|NCT02315352|5562857|P4|STARTED|Second Intervention (Day 1)||0
2266454|NCT02315352|5562858|P3|STARTED|Second Intervention (Day 1)||0
2266455|NCT02315352|5562859|P2|STARTED|Second Intervention (Day 1)||24
2266456|NCT02315352|5562860|P1|STARTED|Second Intervention (Day 1)||24
2266457|NCT02315352|5562853|P8|NOT COMPLETED|First Intervention (Day 1)||0
2266458|NCT02315352|5562854|P7|NOT COMPLETED|First Intervention (Day 1)||0
2266459|NCT02315352|5562855|P6|NOT COMPLETED|First Intervention (Day 1)||0
2266460|NCT02315352|5562856|P5|NOT COMPLETED|First Intervention (Day 1)||0
2266461|NCT02315352|5562857|P4|NOT COMPLETED|First Intervention (Day 1)||0
2266462|NCT02315352|5562858|P3|NOT COMPLETED|First Intervention (Day 1)||0
2266463|NCT02315352|5562859|P2|NOT COMPLETED|First Intervention (Day 1)||0
2266464|NCT02315352|5562860|P1|NOT COMPLETED|First Intervention (Day 1)||0
2266465|NCT02315352|5562853|P8|COMPLETED|First Intervention (Day 1)||0
2266466|NCT02315352|5562854|P7|COMPLETED|First Intervention (Day 1)||0
2266467|NCT02315352|5562855|P6|COMPLETED|First Intervention (Day 1)||0
2266468|NCT02315352|5562856|P5|COMPLETED|First Intervention (Day 1)||0
2266469|NCT02315352|5562857|P4|COMPLETED|First Intervention (Day 1)||0
2266470|NCT02315352|5562858|P3|COMPLETED|First Intervention (Day 1)||0
2266471|NCT02315352|5562859|P2|COMPLETED|First Intervention (Day 1)||24
2266472|NCT02315352|5562860|P1|COMPLETED|First Intervention (Day 1)||24
2266473|NCT02315352|5562853|P8|STARTED|First Intervention (Day 1)||0
2266474|NCT02315352|5562854|P7|STARTED|First Intervention (Day 1)||0
2266475|NCT02315352|5562855|P6|STARTED|First Intervention (Day 1)||0
2266476|NCT02315352|5562856|P5|STARTED|First Intervention (Day 1)||0
2266477|NCT02315352|5562857|P4|STARTED|First Intervention (Day 1)||0
2266478|NCT02315352|5562858|P3|STARTED|First Intervention (Day 1)||0
2266479|NCT02315352|5562859|P2|STARTED|First Intervention (Day 1)||24
2266480|NCT02315352|5562860|P1|STARTED|First Intervention (Day 1)||24
2266481|NCT02315261|5562887|P1|NOT COMPLETED|Overall Study||0
2266482|NCT02315261|5562887|P1|COMPLETED|Overall Study||364
2266483|NCT02315261|5562887|P1|STARTED|Overall Study||364
2266484|NCT02314936|5562898|P4|NOT COMPLETED|Overall Study||0
2266485|NCT02314936|5562899|P3|NOT COMPLETED|Overall Study||2
2266486|NCT02314936|5562900|P2|NOT COMPLETED|Overall Study||0
2266487|NCT02314936|5562901|P1|NOT COMPLETED|Overall Study||0
2266488|NCT02314936|5562898|P4|COMPLETED|Overall Study||48
2266489|NCT02314936|5562899|P3|COMPLETED|Overall Study||46
2266490|NCT02314936|5562900|P2|COMPLETED|Overall Study||48
2266491|NCT02314936|5562901|P1|COMPLETED|Overall Study||48
2266492|NCT02314936|5562898|P4|STARTED|Overall Study||48
2266493|NCT02314936|5562899|P3|STARTED|Overall Study||48
2266494|NCT02314936|5562900|P2|STARTED|Overall Study||48
2266495|NCT02314936|5562901|P1|STARTED|Overall Study||48
2266496|NCT02314923|5563097|P10|NOT COMPLETED|Overall Study||0
2266497|NCT02314923|5563098|P9|NOT COMPLETED|Overall Study||2
2266498|NCT02314923|5563099|P8|NOT COMPLETED|Overall Study||5
2266499|NCT02314923|5563100|P7|NOT COMPLETED|Overall Study||5
2266500|NCT02314923|5563101|P6|NOT COMPLETED|Overall Study||1
2266501|NCT02314923|5563102|P5|NOT COMPLETED|Overall Study||1
2266502|NCT02314923|5563103|P4|NOT COMPLETED|Overall Study||1
2266503|NCT02314923|5563104|P3|NOT COMPLETED|Overall Study||2
2266504|NCT02314923|5563105|P2|NOT COMPLETED|Overall Study||4
2266505|NCT02314923|5563106|P1|NOT COMPLETED|Overall Study||3
2266506|NCT02314923|5563097|P10|COMPLETED|Overall Study||20
2266507|NCT02314923|5563098|P9|COMPLETED|Overall Study||46
2266508|NCT02314923|5563099|P8|COMPLETED|Overall Study||42
2266509|NCT02314923|5563100|P7|COMPLETED|Overall Study||43
2266510|NCT02314923|5563101|P6|COMPLETED|Overall Study||19
2266511|NCT02314923|5563102|P5|COMPLETED|Overall Study||73
2266512|NCT02314923|5563103|P4|COMPLETED|Overall Study||63
2266513|NCT02314923|5563104|P3|COMPLETED|Overall Study||62
2266514|NCT02314923|5563105|P2|COMPLETED|Overall Study||60
2266515|NCT02314923|5563106|P1|COMPLETED|Overall Study||61
2266516|NCT02314923|5563097|P10|Treated|Overall Study||20
2266517|NCT02314923|5563098|P9|Treated|Overall Study||48
2266518|NCT02314923|5563099|P8|Treated|Overall Study||47
2266519|NCT02314923|5563100|P7|Treated|Overall Study|One participant did not receive vaccination due to missing blood sample at randomization.|47
2266520|NCT02314923|5563101|P6|Treated|Overall Study||20
2266521|NCT02314923|5563102|P5|Treated|Overall Study||74
2266522|NCT02314923|5563103|P4|Treated|Overall Study||64
2266523|NCT02314923|5563104|P3|Treated|Overall Study||64
2266524|NCT02314923|5563105|P2|Treated|Overall Study||64
2266525|NCT02314923|5563106|P1|Treated|Overall Study||64
2266526|NCT02314923|5563097|P10|STARTED|Overall Study||20
2266527|NCT02314923|5563098|P9|STARTED|Overall Study||48
2266528|NCT02314923|5563099|P8|STARTED|Overall Study||47
2266529|NCT02314923|5563100|P7|STARTED|Overall Study||48
2266530|NCT02314923|5563101|P6|STARTED|Overall Study||20
2266531|NCT02314923|5563102|P5|STARTED|Overall Study||74
2266532|NCT02314923|5563103|P4|STARTED|Overall Study||64
2266533|NCT02314923|5563104|P3|STARTED|Overall Study||64
2266534|NCT02314923|5563105|P2|STARTED|Overall Study||64
2266535|NCT02314923|5563106|P1|STARTED|Overall Study||64
2266536|NCT02314689|5563199|P1|NOT COMPLETED|Overall Study||0
2266537|NCT02314689|5563199|P1|COMPLETED|Overall Study|Target citrulline level reached with first 4 subjects enrolled at initial IV citrulline of 20 mg/kg|4
2266538|NCT02314689|5563199|P1|STARTED|Overall Study||4
2266539|NCT02314637|5563205|P2|NOT COMPLETED|Overall Study||14
2266540|NCT02314637|5563206|P1|NOT COMPLETED|Overall Study||16
2266541|NCT02314637|5563205|P2|COMPLETED|Overall Study||75
2266542|NCT02314637|5563206|P1|COMPLETED|Overall Study||135
2266543|NCT02314637|5563205|P2|STARTED|Overall Study||89
2266544|NCT02314637|5563206|P1|STARTED|Overall Study||151
2266545|NCT02314598|5563216|P1|NOT COMPLETED|Overall Study||0
2266546|NCT02314598|5563216|P1|COMPLETED|Overall Study||46
2266547|NCT02314598|5563216|P1|STARTED|Overall Study||46
2266548|NCT02314546|5563225|P3|NOT COMPLETED|Overall Study||0
2266549|NCT02314546|5563226|P2|NOT COMPLETED|Overall Study||0
2266550|NCT02314546|5563227|P1|NOT COMPLETED|Overall Study||0
2266551|NCT02314546|5563225|P3|COMPLETED|Overall Study||5
2266552|NCT02314546|5563226|P2|COMPLETED|Overall Study||5
2266553|NCT02314546|5563227|P1|COMPLETED|Overall Study||5
2266554|NCT02314546|5563225|P3|STARTED|Overall Study||5
2266555|NCT02314546|5563226|P2|STARTED|Overall Study||5
2266556|NCT02314546|5563227|P1|STARTED|Overall Study||5
2266557|NCT02314520|5563255|P2|NOT COMPLETED|Overall Study||0
2266558|NCT02314520|5563256|P1|NOT COMPLETED|Overall Study||0
2266559|NCT02314520|5563255|P2|COMPLETED|Overall Study||80
2266560|NCT02314520|5563256|P1|COMPLETED|Overall Study||72
2266561|NCT02314520|5563255|P2|STARTED|Overall Study||80
2266562|NCT02314520|5563256|P1|STARTED|Overall Study||72
2266563|NCT02314260|5563268|P1|NOT COMPLETED|Overall Study||0
2266564|NCT02314260|5563268|P1|COMPLETED|Overall Study||80
2266565|NCT02314260|5563268|P1|STARTED|Overall Study||80
2266566|NCT02314247|5563277|P3|NOT COMPLETED|Overall Study||1
2266567|NCT02314247|5563278|P2|NOT COMPLETED|Overall Study||6
2266568|NCT02314247|5563279|P1|NOT COMPLETED|Overall Study||9
2266569|NCT02314247|5563277|P3|COMPLETED|Overall Study||0
2266570|NCT02314247|5563278|P2|COMPLETED|Overall Study||0
2266571|NCT02314247|5563279|P1|COMPLETED|Overall Study||0
2266572|NCT02314247|5563277|P3|STARTED|Overall Study||1
2266573|NCT02314247|5563278|P2|STARTED|Overall Study||6
2266574|NCT02314247|5563279|P1|STARTED|Overall Study||9
2266575|NCT02314143|5563304|P3|NOT COMPLETED|Overall Study||9
2266576|NCT02314143|5563305|P2|NOT COMPLETED|Overall Study||10
2266577|NCT02314143|5563306|P1|NOT COMPLETED|Overall Study||8
2266578|NCT02314143|5563304|P3|COMPLETED|Overall Study||7
2266579|NCT02314143|5563305|P2|COMPLETED|Overall Study||6
2266580|NCT02314143|5563306|P1|COMPLETED|Overall Study||8
2266581|NCT02314143|5563304|P3|STARTED|Overall Study||16
2266582|NCT02314143|5563305|P2|STARTED|Overall Study||16
2266583|NCT02314143|5563306|P1|STARTED|Overall Study||16
2266584|NCT02314117|5563352|P2|NOT COMPLETED|Overall Study||38
2266585|NCT02314117|5563353|P1|NOT COMPLETED|Overall Study||41
2266586|NCT02314117|5563352|P2|COMPLETED|Overall Study||281
2266587|NCT02314117|5563353|P1|COMPLETED|Overall Study||285
2266588|NCT02314117|5563352|P2|Alive But Off Treatment|Overall Study||50
2266589|NCT02314117|5563353|P1|Alive But Off Treatment|Overall Study||46
2266590|NCT02314117|5563352|P2|Death|Overall Study||231
2266591|NCT02314117|5563353|P1|Death|Overall Study||239
2266592|NCT02314117|5563352|P2|Received at Least One Dose of Study Drug|Overall Study||315
2266593|NCT02314117|5563353|P1|Received at Least One Dose of Study Drug|Overall Study||323
2266594|NCT02314117|5563352|P2|STARTED|Overall Study||319
2266595|NCT02314117|5563353|P1|STARTED|Overall Study||326
2266596|NCT02314104|5563384|P3|NOT COMPLETED|Overall Study||18
2266597|NCT02314104|5563385|P2|NOT COMPLETED|Overall Study||20
2266598|NCT02314104|5563386|P1|NOT COMPLETED|Overall Study||14
2266599|NCT02314104|5563384|P3|COMPLETED|Overall Study||53
2266600|NCT02314104|5563385|P2|COMPLETED|Overall Study||58
2266601|NCT02314104|5563386|P1|COMPLETED|Overall Study||57
2266602|NCT02314104|5563384|P3|STARTED|Overall Study||71
2266603|NCT02314104|5563385|P2|STARTED|Overall Study||78
2266604|NCT02314104|5563386|P1|STARTED|Overall Study||71
2266605|NCT02314052|5563406|P6|NOT COMPLETED|Cycles 6 -10.5||0
2266606|NCT02314052|5563407|P5|NOT COMPLETED|Cycles 6 -10.5||0
2266607|NCT02314052|5563408|P4|NOT COMPLETED|Cycles 6 -10.5||0
2266608|NCT02314052|5563409|P3|NOT COMPLETED|Cycles 6 -10.5||0
2266609|NCT02314052|5563410|P2|NOT COMPLETED|Cycles 6 -10.5||0
2266610|NCT02314052|5563411|P1|NOT COMPLETED|Cycles 6 -10.5||0
2266611|NCT02314052|5563406|P6|COMPLETED|Cycles 6 -10.5||0
2266612|NCT02314052|5563407|P5|COMPLETED|Cycles 6 -10.5|Subject 02-014 only completed 1 of 2 doses in cycle 6|2
2266613|NCT02314052|5563408|P4|COMPLETED|Cycles 6 -10.5||1
2266614|NCT02314052|5563409|P3|COMPLETED|Cycles 6 -10.5||0
2266615|NCT02314052|5563410|P2|COMPLETED|Cycles 6 -10.5||0
2266616|NCT02314052|5563411|P1|COMPLETED|Cycles 6 -10.5||0
2266617|NCT02314052|5563406|P6|STARTED|Cycles 6 -10.5||0
2266618|NCT02314052|5563407|P5|STARTED|Cycles 6 -10.5||2
2266619|NCT02314052|5563408|P4|STARTED|Cycles 6 -10.5||1
2266620|NCT02314052|5563409|P3|STARTED|Cycles 6 -10.5||0
2266621|NCT02314052|5563410|P2|STARTED|Cycles 6 -10.5||0
2266622|NCT02314052|5563411|P1|STARTED|Cycles 6 -10.5||0
2266623|NCT02314052|5563406|P6|NOT COMPLETED|Cycle Five||0
2266624|NCT02314052|5563407|P5|NOT COMPLETED|Cycle Five||0
2266625|NCT02314052|5563408|P4|NOT COMPLETED|Cycle Five||0
2266626|NCT02314052|5563409|P3|NOT COMPLETED|Cycle Five||1
2266627|NCT02314052|5563410|P2|NOT COMPLETED|Cycle Five||2
2266628|NCT02314052|5563411|P1|NOT COMPLETED|Cycle Five||0
2266629|NCT02314052|5563406|P6|COMPLETED|Cycle Five||0
2266630|NCT02314052|5563407|P5|COMPLETED|Cycle Five||2
2266631|NCT02314052|5563408|P4|COMPLETED|Cycle Five|subject missed cycle four but returned for cycle 5|1
2266632|NCT02314052|5563409|P3|COMPLETED|Cycle Five||0
2266633|NCT02314052|5563410|P2|COMPLETED|Cycle Five||0
2266634|NCT02314052|5563411|P1|COMPLETED|Cycle Five||0
2266635|NCT02314052|5563406|P6|STARTED|Cycle Five||0
2266636|NCT02314052|5563407|P5|STARTED|Cycle Five||2
2266637|NCT02314052|5563408|P4|STARTED|Cycle Five|subject missed cycle four but returned for cycle 5|1
2266638|NCT02314052|5563409|P3|STARTED|Cycle Five||1
2266639|NCT02314052|5563410|P2|STARTED|Cycle Five||2
2266640|NCT02314052|5563411|P1|STARTED|Cycle Five||0
2266641|NCT02314052|5563406|P6|NOT COMPLETED|Cycle Four||3
2266642|NCT02314052|5563407|P5|NOT COMPLETED|Cycle Four||0
2266643|NCT02314052|5563408|P4|NOT COMPLETED|Cycle Four||1
2266644|NCT02314052|5563409|P3|NOT COMPLETED|Cycle Four||1
2266645|NCT02314052|5563410|P2|NOT COMPLETED|Cycle Four||0
2266646|NCT02314052|5563411|P1|NOT COMPLETED|Cycle Four||3
2266647|NCT02314052|5563406|P6|COMPLETED|Cycle Four||0
2266648|NCT02314052|5563407|P5|COMPLETED|Cycle Four||2
2266649|NCT02314052|5563408|P4|COMPLETED|Cycle Four||0
2266650|NCT02314052|5563409|P3|COMPLETED|Cycle Four||1
2266651|NCT02314052|5563410|P2|COMPLETED|Cycle Four||2
2266652|NCT02314052|5563411|P1|COMPLETED|Cycle Four||0
2266653|NCT02314052|5563406|P6|STARTED|Cycle Four||3
2266654|NCT02314052|5563407|P5|STARTED|Cycle Four||2
2266655|NCT02314052|5563408|P4|STARTED|Cycle Four||1
2266656|NCT02314052|5563409|P3|STARTED|Cycle Four||2
2266657|NCT02314052|5563410|P2|STARTED|Cycle Four||2
2266658|NCT02314052|5563411|P1|STARTED|Cycle Four||3
2266659|NCT02314052|5563406|P6|NOT COMPLETED|Cycle Three||0
2266660|NCT02314052|5563407|P5|NOT COMPLETED|Cycle Three||0
2266661|NCT02314052|5563408|P4|NOT COMPLETED|Cycle Three||0
2266662|NCT02314052|5563409|P3|NOT COMPLETED|Cycle Three||0
2266663|NCT02314052|5563410|P2|NOT COMPLETED|Cycle Three||0
2266664|NCT02314052|5563411|P1|NOT COMPLETED|Cycle Three||0
2266665|NCT02314052|5563406|P6|COMPLETED|Cycle Three||3
2266666|NCT02314052|5563407|P5|COMPLETED|Cycle Three||2
2266667|NCT02314052|5563408|P4|COMPLETED|Cycle Three||1
2266668|NCT02314052|5563409|P3|COMPLETED|Cycle Three||2
2266669|NCT02314052|5563410|P2|COMPLETED|Cycle Three|1 of 2 completers in cohort 2 (subject 02-005) only completed 1 of 2 infusions during this cycle|2
2266670|NCT02314052|5563411|P1|COMPLETED|Cycle Three||3
2266671|NCT02314052|5563406|P6|STARTED|Cycle Three||3
2266672|NCT02314052|5563407|P5|STARTED|Cycle Three||2
2266673|NCT02314052|5563408|P4|STARTED|Cycle Three||1
2266674|NCT02314052|5563409|P3|STARTED|Cycle Three||2
2266675|NCT02314052|5563410|P2|STARTED|Cycle Three||2
2266676|NCT02314052|5563411|P1|STARTED|Cycle Three||3
2266677|NCT02314052|5563406|P6|NOT COMPLETED|Cycle Two||0
2266678|NCT02314052|5563407|P5|NOT COMPLETED|Cycle Two||4
2266679|NCT02314052|5563408|P4|NOT COMPLETED|Cycle Two||1
2266680|NCT02314052|5563409|P3|NOT COMPLETED|Cycle Two||1
2266681|NCT02314052|5563410|P2|NOT COMPLETED|Cycle Two||1
2266682|NCT02314052|5563411|P1|NOT COMPLETED|Cycle Two||0
2266683|NCT02314052|5563406|P6|COMPLETED|Cycle Two||3
2266684|NCT02314052|5563407|P5|COMPLETED|Cycle Two||2
2266685|NCT02314052|5563408|P4|COMPLETED|Cycle Two||1
2266686|NCT02314052|5563409|P3|COMPLETED|Cycle Two||2
2266687|NCT02314052|5563410|P2|COMPLETED|Cycle Two||2
2266688|NCT02314052|5563411|P1|COMPLETED|Cycle Two||3
2266689|NCT02314052|5563406|P6|STARTED|Cycle Two||3
2266690|NCT02314052|5563407|P5|STARTED|Cycle Two||6
2266691|NCT02314052|5563408|P4|STARTED|Cycle Two||2
2266692|NCT02314052|5563409|P3|STARTED|Cycle Two||3
2266693|NCT02314052|5563410|P2|STARTED|Cycle Two||3
2266694|NCT02314052|5563411|P1|STARTED|Cycle Two||3
2266695|NCT02314052|5563406|P6|NOT COMPLETED|Cycle One||0
2266696|NCT02314052|5563407|P5|NOT COMPLETED|Cycle One||0
2266697|NCT02314052|5563408|P4|NOT COMPLETED|Cycle One||1
2266698|NCT02314052|5563409|P3|NOT COMPLETED|Cycle One||0
2266699|NCT02314052|5563410|P2|NOT COMPLETED|Cycle One||0
2266700|NCT02314052|5563411|P1|NOT COMPLETED|Cycle One||0
2266701|NCT02314052|5563406|P6|COMPLETED|Cycle One||3
2266702|NCT02314052|5563407|P5|COMPLETED|Cycle One||6
2266703|NCT02314052|5563408|P4|COMPLETED|Cycle One||2
2266704|NCT02314052|5563409|P3|COMPLETED|Cycle One||3
2266705|NCT02314052|5563410|P2|COMPLETED|Cycle One||3
2266706|NCT02314052|5563411|P1|COMPLETED|Cycle One||3
2266707|NCT02314052|5563406|P6|STARTED|Cycle One||3
2266708|NCT02314052|5563407|P5|STARTED|Cycle One||6
2266709|NCT02314052|5563408|P4|STARTED|Cycle One||3
2266710|NCT02314052|5563409|P3|STARTED|Cycle One||3
2266711|NCT02314052|5563410|P2|STARTED|Cycle One||3
2266712|NCT02314052|5563411|P1|STARTED|Cycle One||3
2266713|NCT02314026|5563479|P1|NOT COMPLETED|Overall Study||28
2266714|NCT02314026|5563479|P1|COMPLETED|Overall Study||107
2266715|NCT02314026|5563479|P1|STARTED|Overall Study||135
2266716|NCT02314000|5563487|P2|NOT COMPLETED|Overall Study||8
2266717|NCT02314000|5563488|P1|NOT COMPLETED|Overall Study||13
2266718|NCT02314000|5563487|P2|COMPLETED|Overall Study||57
2266719|NCT02314000|5563488|P1|COMPLETED|Overall Study||62
2266720|NCT02314000|5563487|P2|STARTED|Overall Study||65
2266721|NCT02314000|5563488|P1|STARTED|Overall Study||75
2266722|NCT02313909|5563497|P2|NOT COMPLETED|Overall Study||50
2266723|NCT02313909|5563498|P1|NOT COMPLETED|Overall Study||57
2266724|NCT02313909|5563497|P2|COMPLETED|Overall Study||3554
2266725|NCT02313909|5563498|P1|COMPLETED|Overall Study||3552
2266726|NCT02313909|5563497|P2|Treated|Overall Study||3559
2266727|NCT02313909|5563498|P1|Treated|Overall Study||3562
2266728|NCT02313909|5563497|P2|STARTED|Overall Study||3604
2266729|NCT02313909|5563498|P1|STARTED|Overall Study||3609
2266730|NCT02313766|5563521|P3|NOT COMPLETED|Overall Study||0
2266731|NCT02313766|5563522|P2|NOT COMPLETED|Overall Study||3
2266732|NCT02313766|5563523|P1|NOT COMPLETED|Overall Study||1
2266733|NCT02313766|5563521|P3|COMPLETED|Overall Study||50
2266734|NCT02313766|5563522|P2|COMPLETED|Overall Study||47
2266735|NCT02313766|5563523|P1|COMPLETED|Overall Study||49
2266736|NCT02313766|5563521|P3|STARTED|Overall Study||50
2266737|NCT02313766|5563522|P2|STARTED|Overall Study||50
2266738|NCT02313766|5563523|P1|STARTED|Overall Study||50
2266739|NCT02313675|5563541|P4|NOT COMPLETED|Overall Study||0
2266740|NCT02313675|5563542|P3|NOT COMPLETED|Overall Study||0
2266741|NCT02313675|5563543|P2|NOT COMPLETED|Overall Study||0
2266742|NCT02313675|5563544|P1|NOT COMPLETED|Overall Study||0
2266743|NCT02313675|5563541|P4|COMPLETED|Overall Study||11
2266744|NCT02313675|5563542|P3|COMPLETED|Overall Study||11
2266745|NCT02313675|5563543|P2|COMPLETED|Overall Study||11
2266746|NCT02313675|5563544|P1|COMPLETED|Overall Study||11
2266747|NCT02313675|5563541|P4|STARTED|Overall Study||11
2266748|NCT02313675|5563542|P3|STARTED|Overall Study||11
2266749|NCT02313675|5563543|P2|STARTED|Overall Study||11
2266750|NCT02313675|5563544|P1|STARTED|Overall Study||11
2266751|NCT02313558|5563560|P2|NOT COMPLETED|Overall Study||4
2266752|NCT02313558|5563561|P1|NOT COMPLETED|Overall Study||6
2266753|NCT02313558|5563560|P2|COMPLETED|Overall Study||46
2266754|NCT02313558|5563561|P1|COMPLETED|Overall Study||44
2266755|NCT02313558|5563560|P2|STARTED|Overall Study||50
2266756|NCT02313558|5563561|P1|STARTED|Overall Study||50
2266757|NCT02313506|5563575|P2|NOT COMPLETED|Overall Study||0
2266758|NCT02313506|5563576|P1|NOT COMPLETED|Overall Study||0
2266759|NCT02313506|5563575|P2|COMPLETED|Overall Study||17
2266760|NCT02313506|5563576|P1|COMPLETED|Overall Study||17
2266761|NCT02313506|5563575|P2|STARTED|Overall Study||17
2266762|NCT02313506|5563576|P1|STARTED|Overall Study||17
2266763|NCT02313454|5563596|P2|NOT COMPLETED|Treatment 2||0
2266764|NCT02313454|5563597|P1|NOT COMPLETED|Treatment 2||0
2266765|NCT02313454|5563596|P2|COMPLETED|Treatment 2||10
2266766|NCT02313454|5563597|P1|COMPLETED|Treatment 2||8
2266767|NCT02313454|5563596|P2|STARTED|Treatment 2|1 participant did not receive the second application.|10
2266768|NCT02313454|5563597|P1|STARTED|Treatment 2|1 participant did not receive the second application.|8
2266769|NCT02313454|5563596|P2|NOT COMPLETED|Treatment 1||0
2266770|NCT02313454|5563597|P1|NOT COMPLETED|Treatment 1||0
2266771|NCT02313454|5563596|P2|COMPLETED|Treatment 1||11
2266772|NCT02313454|5563597|P1|COMPLETED|Treatment 1||9
2266773|NCT02313454|5563596|P2|STARTED|Treatment 1||11
2266774|NCT02313454|5563597|P1|STARTED|Treatment 1||9
2266775|NCT02313233|5563607|P2|NOT COMPLETED|Overall Study||3
2266776|NCT02313233|5563608|P1|NOT COMPLETED|Overall Study||2
2266777|NCT02313233|5563607|P2|COMPLETED|Overall Study||18
2266778|NCT02313233|5563608|P1|COMPLETED|Overall Study||18
2266779|NCT02313233|5563607|P2|STARTED|Overall Study||21
2266780|NCT02313233|5563608|P1|STARTED|Overall Study||20
2266781|NCT02313155|5563630|P2|NOT COMPLETED|Overall Study||1
2266782|NCT02313155|5563631|P1|NOT COMPLETED|Overall Study||0
2266783|NCT02313155|5563630|P2|COMPLETED|Overall Study||54
2266784|NCT02313155|5563631|P1|COMPLETED|Overall Study||55
2266785|NCT02313155|5563630|P2|STARTED|Overall Study||55
2266786|NCT02313155|5563631|P1|STARTED|Overall Study||55
2266787|NCT02312934|5563681|P2|NOT COMPLETED|Overall Study||0
2266788|NCT02312934|5563682|P1|NOT COMPLETED|Overall Study||2
2266789|NCT02312934|5563681|P2|COMPLETED|Overall Study||11
2266790|NCT02312934|5563682|P1|COMPLETED|Overall Study||9
2266791|NCT02312934|5563681|P2|STARTED|Overall Study||11
2266792|NCT02312934|5563682|P1|STARTED|Overall Study||11
2266793|NCT02312882|5563690|P1|NOT COMPLETED|Overall Study||4
2266794|NCT02312882|5563690|P1|COMPLETED|Overall Study||36
2266795|NCT02312882|5563690|P1|STARTED|Overall Study||40
2266796|NCT02312856|5563694|P1|NOT COMPLETED|Overall Study||4
2266797|NCT02312856|5563694|P1|COMPLETED|Overall Study||30
2266798|NCT02312856|5563694|P1|STARTED|Overall Study||34
2266799|NCT02312739|5563700|P2|NOT COMPLETED|Overall Study||2
2266800|NCT02312739|5563701|P1|NOT COMPLETED|Overall Study||6
2266801|NCT02312739|5563700|P2|COMPLETED|Overall Study||34
2266802|NCT02312739|5563701|P1|COMPLETED|Overall Study||30
2266803|NCT02312739|5563700|P2|Withdrawn Prior to Procedure|Overall Study||2
2266804|NCT02312739|5563701|P1|Withdrawn Prior to Procedure|Overall Study||6
2266805|NCT02312739|5563700|P2|STARTED|Overall Study||36
2266806|NCT02312739|5563701|P1|STARTED|Overall Study||36
2266807|NCT02312726|5563715|P3|NOT COMPLETED|Overall Study||67
2266808|NCT02312726|5563716|P2|NOT COMPLETED|Overall Study||0
2266809|NCT02312726|5563717|P1|NOT COMPLETED|Overall Study||0
2266810|NCT02312726|5563715|P3|COMPLETED|Overall Study||0
2266811|NCT02312726|5563716|P2|COMPLETED|Overall Study||30
2266812|NCT02312726|5563717|P1|COMPLETED|Overall Study||38
2266813|NCT02312726|5563715|P3|STARTED|Overall Study||67
2266814|NCT02312726|5563716|P2|STARTED|Overall Study||30
2266815|NCT02312726|5563717|P1|STARTED|Overall Study||38
2266816|NCT02312713|5563732|P3|NOT COMPLETED|Overall Study||5
2266817|NCT02312713|5563733|P2|NOT COMPLETED|Overall Study||30
2266818|NCT02312713|5563734|P1|NOT COMPLETED|Overall Study||11
2266819|NCT02312713|5563732|P3|COMPLETED|Overall Study||63
2266820|NCT02312713|5563733|P2|COMPLETED|Overall Study||112
2266821|NCT02312713|5563734|P1|COMPLETED|Overall Study||129
2266822|NCT02312713|5563732|P3|STARTED|Overall Study||68
2266823|NCT02312713|5563733|P2|STARTED|Overall Study||142
2266824|NCT02312713|5563734|P1|STARTED|Overall Study||140
2266825|NCT02312687|5563778|P1|NOT COMPLETED|Overall Study||1
2266826|NCT02312687|5563778|P1|COMPLETED|Overall Study||19
2266827|NCT02312687|5563778|P1|STARTED|Overall Study||20
2266828|NCT02312622|5563809|P3|NOT COMPLETED|Overall Study||0
2266829|NCT02312622|5563810|P2|NOT COMPLETED|Overall Study||0
2266830|NCT02312622|5563811|P1|NOT COMPLETED|Overall Study||0
2266831|NCT02312622|5563809|P3|COMPLETED|Overall Study||12
2266832|NCT02312622|5563810|P2|COMPLETED|Overall Study||3
2266833|NCT02312622|5563811|P1|COMPLETED|Overall Study||12
2266834|NCT02312622|5563809|P3|STARTED|Overall Study||12
2266835|NCT02312622|5563810|P2|STARTED|Overall Study||3
2266836|NCT02312622|5563811|P1|STARTED|Overall Study||12
2266837|NCT02312219|5563837|P2|NOT COMPLETED|Overall Study||6
2266838|NCT02312219|5563838|P1|NOT COMPLETED|Overall Study||1
2266839|NCT02312219|5563837|P2|COMPLETED|Overall Study||16
2266840|NCT02312219|5563838|P1|COMPLETED|Overall Study||12
2266841|NCT02312219|5563837|P2|STARTED|Overall Study||22
2266842|NCT02312219|5563838|P1|STARTED|Overall Study||13
2266843|NCT02312206|5563848|P2|NOT COMPLETED|Overall Study||130
2266844|NCT02312206|5563849|P1|NOT COMPLETED|Overall Study||130
2266845|NCT02312206|5563848|P2|COMPLETED|Overall Study||0
2266846|NCT02312206|5563849|P1|COMPLETED|Overall Study||0
2266847|NCT02312206|5563848|P2|Informed Consent Obtained|Overall Study||130
2266848|NCT02312206|5563849|P1|Informed Consent Obtained|Overall Study||130
2266849|NCT02312206|5563848|P2|STARTED|Overall Study||130
2266850|NCT02312206|5563849|P1|STARTED|Overall Study||130
2266851|NCT02312154|5563855|P1|NOT COMPLETED|Overall Study||1
2266852|NCT02312154|5563855|P1|COMPLETED|Overall Study||24
2266853|NCT02312154|5563855|P1|STARTED|Overall Study||25
2266854|NCT02312063|5563872|P2|NOT COMPLETED|Overall Study||1
2266855|NCT02312063|5563873|P1|NOT COMPLETED|Overall Study||0
2266856|NCT02312063|5563872|P2|COMPLETED|Overall Study||24
2266857|NCT02312063|5563873|P1|COMPLETED|Overall Study||23
2266858|NCT02312063|5563872|P2|STARTED|Overall Study||25
2266859|NCT02312063|5563873|P1|STARTED|Overall Study||23
2266860|NCT02311972|5563883|P2|NOT COMPLETED|Overall Study||0
2266861|NCT02311972|5563884|P1|NOT COMPLETED|Overall Study||0
2266862|NCT02311972|5563883|P2|COMPLETED|Overall Study||8
2266863|NCT02311972|5563884|P1|COMPLETED|Overall Study||12
2266864|NCT02311972|5563883|P2|STARTED|Overall Study||8
2266865|NCT02311972|5563884|P1|STARTED|Overall Study||12
2266866|NCT02311907|5563903|P2|NOT COMPLETED|Overall Study||0
2266867|NCT02311907|5563904|P1|NOT COMPLETED|Overall Study||0
2266868|NCT02311907|5563903|P2|COMPLETED|Overall Study||91
2266869|NCT02311907|5563904|P1|COMPLETED|Overall Study||94
2266870|NCT02311907|5563903|P2|STARTED|Overall Study||91
2266871|NCT02311907|5563904|P1|STARTED|Overall Study||94
2266872|NCT02311894|5563926|P1|NOT COMPLETED|Overall Study||4
2266873|NCT02311894|5563926|P1|COMPLETED|Overall Study||78
2266874|NCT02311894|5563926|P1|Modified ITT Population|Overall Study||81
2266875|NCT02311894|5563926|P1|STARTED|Overall Study||82
2266876|NCT02311881|5563938|P3|NOT COMPLETED|Overall Study||41
2266877|NCT02311881|5563939|P2|NOT COMPLETED|Overall Study||43
2266878|NCT02311881|5563940|P1|NOT COMPLETED|Overall Study||35
2266879|NCT02311881|5563938|P3|COMPLETED|Overall Study||196
2266880|NCT02311881|5563939|P2|COMPLETED|Overall Study||193
2266881|NCT02311881|5563940|P1|COMPLETED|Overall Study||200
2266882|NCT02311881|5563938|P3|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|237
2266883|NCT02311881|5563939|P2|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|236
2266884|NCT02311881|5563940|P1|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|234
2266885|NCT02311881|5563938|P3|STARTED|Overall Study|Started refers to all randomized participants.|237
2266886|NCT02311881|5563939|P2|STARTED|Overall Study|Started refers to all randomized participants.|236
2266887|NCT02311881|5563940|P1|STARTED|Overall Study|Started refers to all randomized participants.|235
2266888|NCT02311478|5563975|P1|NOT COMPLETED|Overall Study||7
2266889|NCT02311478|5563975|P1|COMPLETED|Overall Study||72
2266890|NCT02311478|5563975|P1|IUD Insertion|Overall Study||78
2266891|NCT02311478|5563975|P1|STARTED|Overall Study||79
2266892|NCT02311309|5563983|P3|NOT COMPLETED|Overall Study||0
2266893|NCT02311309|5563984|P2|NOT COMPLETED|Overall Study||0
2266894|NCT02311309|5563985|P1|NOT COMPLETED|Overall Study||0
2266895|NCT02311309|5563983|P3|COMPLETED|Overall Study||863
2266896|NCT02311309|5563984|P2|COMPLETED|Overall Study||35
2266897|NCT02311309|5563985|P1|COMPLETED|Overall Study||541
2266898|NCT02311309|5563983|P3|STARTED|Overall Study||863
2266899|NCT02311309|5563984|P2|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|35
2266900|NCT02311309|5563985|P1|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|541
2266901|NCT02311153|5563998|P2|NOT COMPLETED|Overall Study||7
2266902|NCT02311153|5563999|P1|NOT COMPLETED|Overall Study||5
2266903|NCT02311153|5563998|P2|COMPLETED|Overall Study||42
2266904|NCT02311153|5563999|P1|COMPLETED|Overall Study||48
2266905|NCT02311153|5563998|P2|STARTED|Overall Study||49
2266906|NCT02311153|5563999|P1|STARTED|Overall Study||53
2266907|NCT02310789|5564015|P1|NOT COMPLETED|Overall Study||1
2266908|NCT02310789|5564015|P1|COMPLETED|Overall Study||7
2266909|NCT02310789|5564015|P1|STARTED|Overall Study||8
2266910|NCT02310776|5564020|P1|NOT COMPLETED|Overall Study||0
2266911|NCT02310776|5564020|P1|COMPLETED|Overall Study||501
2266912|NCT02310776|5564020|P1|STARTED|Overall Study||501
2266913|NCT02310763|5564027|P3|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
2266914|NCT02310763|5564028|P2|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
2266915|NCT02310763|5564029|P1|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
2266916|NCT02310763|5564027|P3|COMPLETED|Period 2 (Weeks 49 to 96)||22
2266917|NCT02310763|5564028|P2|COMPLETED|Period 2 (Weeks 49 to 96)||21
2266918|NCT02310763|5564029|P1|COMPLETED|Period 2 (Weeks 49 to 96)||22
2266919|NCT02310763|5564027|P3|STARTED|Period 2 (Weeks 49 to 96)||38
2266920|NCT02310763|5564028|P2|STARTED|Period 2 (Weeks 49 to 96)||37
2266921|NCT02310763|5564029|P1|STARTED|Period 2 (Weeks 49 to 96)||38
2266922|NCT02310763|5564027|P3|NOT COMPLETED|Period 1 (Weeks 1 to 48)||2
2266923|NCT02310763|5564028|P2|NOT COMPLETED|Period 1 (Weeks 1 to 48)||2
2266924|NCT02310763|5564029|P1|NOT COMPLETED|Period 1 (Weeks 1 to 48)||3
2266925|NCT02310763|5564027|P3|COMPLETED|Period 1 (Weeks 1 to 48)||38
2266926|NCT02310763|5564028|P2|COMPLETED|Period 1 (Weeks 1 to 48)||37
2266927|NCT02310763|5564029|P1|COMPLETED|Period 1 (Weeks 1 to 48)||38
2266928|NCT02310763|5564027|P3|STARTED|Period 1 (Weeks 1 to 48)||40
2266929|NCT02310763|5564028|P2|STARTED|Period 1 (Weeks 1 to 48)||39
2266930|NCT02310763|5564029|P1|STARTED|Period 1 (Weeks 1 to 48)||41
2266931|NCT02310750|5564232|P16|NOT COMPLETED|HP MAD and Fasted/Fed||0
2266932|NCT02310750|5564233|P15|NOT COMPLETED|HP MAD and Fasted/Fed||0
2266933|NCT02310750|5564234|P14|NOT COMPLETED|HP MAD and Fasted/Fed||0
2266934|NCT02310750|5564235|P13|NOT COMPLETED|HP MAD and Fasted/Fed||0
2266935|NCT02310750|5564236|P12|NOT COMPLETED|HP MAD and Fasted/Fed||0
2266936|NCT02310750|5564237|P11|NOT COMPLETED|HP MAD and Fasted/Fed||0
2266937|NCT02310750|5564238|P10|NOT COMPLETED|HP MAD and Fasted/Fed||0
2266938|NCT02310750|5564239|P9|NOT COMPLETED|HP MAD and Fasted/Fed||0
2266939|NCT02310750|5564240|P8|NOT COMPLETED|HP MAD and Fasted/Fed||0
2266940|NCT02310750|5564241|P7|NOT COMPLETED|HP MAD and Fasted/Fed||0
2266941|NCT02310750|5564242|P6|NOT COMPLETED|HP MAD and Fasted/Fed||0
2266942|NCT02310750|5564243|P5|NOT COMPLETED|HP MAD and Fasted/Fed||1
2266943|NCT02310750|5564244|P4|NOT COMPLETED|HP MAD and Fasted/Fed||0
2266944|NCT02310750|5564245|P3|NOT COMPLETED|HP MAD and Fasted/Fed||0
2266945|NCT02310750|5564246|P2|NOT COMPLETED|HP MAD and Fasted/Fed||0
2266946|NCT02310750|5564247|P1|NOT COMPLETED|HP MAD and Fasted/Fed||0
2266947|NCT02310750|5564232|P16|COMPLETED|HP MAD and Fasted/Fed||2
2266948|NCT02310750|5564233|P15|COMPLETED|HP MAD and Fasted/Fed||2
2266949|NCT02310750|5564234|P14|COMPLETED|HP MAD and Fasted/Fed||2
2266950|NCT02310750|5564235|P13|COMPLETED|HP MAD and Fasted/Fed||2
2266951|NCT02310750|5564236|P12|COMPLETED|HP MAD and Fasted/Fed||2
2266952|NCT02310750|5564237|P11|COMPLETED|HP MAD and Fasted/Fed||2
2266953|NCT02310750|5564238|P10|COMPLETED|HP MAD and Fasted/Fed||0
2266954|NCT02310750|5564239|P9|COMPLETED|HP MAD and Fasted/Fed||0
2266955|NCT02310750|5564240|P8|COMPLETED|HP MAD and Fasted/Fed||0
2266956|NCT02310750|5564241|P7|COMPLETED|HP MAD and Fasted/Fed||2
2266957|NCT02310750|5564242|P6|COMPLETED|HP MAD and Fasted/Fed||0
2266958|NCT02310750|5564243|P5|COMPLETED|HP MAD and Fasted/Fed||4
2266959|NCT02310750|5564244|P4|COMPLETED|HP MAD and Fasted/Fed||0
2266960|NCT02310750|5564245|P3|COMPLETED|HP MAD and Fasted/Fed||0
2266961|NCT02310750|5564246|P2|COMPLETED|HP MAD and Fasted/Fed||0
2266962|NCT02310750|5564247|P1|COMPLETED|HP MAD and Fasted/Fed||0
2266963|NCT02310750|5564232|P16|STARTED|HP MAD and Fasted/Fed||2
2266964|NCT02310750|5564233|P15|STARTED|HP MAD and Fasted/Fed||2
2266965|NCT02310750|5564234|P14|STARTED|HP MAD and Fasted/Fed||2
2266966|NCT02310750|5564235|P13|STARTED|HP MAD and Fasted/Fed||2
2266967|NCT02310750|5564236|P12|STARTED|HP MAD and Fasted/Fed||2
2266968|NCT02310750|5564237|P11|STARTED|HP MAD and Fasted/Fed||2
2266969|NCT02310750|5564238|P10|STARTED|HP MAD and Fasted/Fed||0
2266970|NCT02310750|5564239|P9|STARTED|HP MAD and Fasted/Fed||0
2266971|NCT02310750|5564240|P8|STARTED|HP MAD and Fasted/Fed||0
2266972|NCT02310750|5564241|P7|STARTED|HP MAD and Fasted/Fed||2
2266973|NCT02310750|5564242|P6|STARTED|HP MAD and Fasted/Fed||0
2266974|NCT02310750|5564243|P5|STARTED|HP MAD and Fasted/Fed||5
2266975|NCT02310750|5564244|P4|STARTED|HP MAD and Fasted/Fed||0
2266976|NCT02310750|5564245|P3|STARTED|HP MAD and Fasted/Fed||0
2266977|NCT02310750|5564246|P2|STARTED|HP MAD and Fasted/Fed||0
2266978|NCT02310750|5564247|P1|STARTED|HP MAD and Fasted/Fed||0
2266979|NCT02310750|5564232|P16|NOT COMPLETED|HP Washout 2||0
2266980|NCT02310750|5564233|P15|NOT COMPLETED|HP Washout 2||0
2266981|NCT02310750|5564234|P14|NOT COMPLETED|HP Washout 2||0
2266982|NCT02310750|5564235|P13|NOT COMPLETED|HP Washout 2||0
2266983|NCT02310750|5564236|P12|NOT COMPLETED|HP Washout 2||0
2266984|NCT02310750|5564237|P11|NOT COMPLETED|HP Washout 2||0
2266985|NCT02310750|5564238|P10|NOT COMPLETED|HP Washout 2||0
2266986|NCT02310750|5564239|P9|NOT COMPLETED|HP Washout 2||0
2266987|NCT02310750|5564240|P8|NOT COMPLETED|HP Washout 2||0
2266988|NCT02310750|5564241|P7|NOT COMPLETED|HP Washout 2||7
2266989|NCT02310750|5564242|P6|NOT COMPLETED|HP Washout 2||0
2266990|NCT02310750|5564243|P5|NOT COMPLETED|HP Washout 2||1
2266991|NCT02310750|5564244|P4|NOT COMPLETED|HP Washout 2||0
2266992|NCT02310750|5564245|P3|NOT COMPLETED|HP Washout 2||0
2266993|NCT02310750|5564246|P2|NOT COMPLETED|HP Washout 2||0
2266994|NCT02310750|5564247|P1|NOT COMPLETED|HP Washout 2||0
2266995|NCT02310750|5564232|P16|COMPLETED|HP Washout 2||2
2266996|NCT02310750|5564233|P15|COMPLETED|HP Washout 2||2
2266997|NCT02310750|5564234|P14|COMPLETED|HP Washout 2||2
2266998|NCT02310750|5564235|P13|COMPLETED|HP Washout 2||2
2266999|NCT02310750|5564236|P12|COMPLETED|HP Washout 2||2
2267000|NCT02310750|5564237|P11|COMPLETED|HP Washout 2||2
2267001|NCT02310750|5564238|P10|COMPLETED|HP Washout 2||0
2267002|NCT02310750|5564239|P9|COMPLETED|HP Washout 2||0
2267003|NCT02310750|5564240|P8|COMPLETED|HP Washout 2||0
2267004|NCT02310750|5564241|P7|COMPLETED|HP Washout 2||2
2267005|NCT02310750|5564242|P6|COMPLETED|HP Washout 2||0
2267006|NCT02310750|5564243|P5|COMPLETED|HP Washout 2||5
2267007|NCT02310750|5564244|P4|COMPLETED|HP Washout 2||0
2267008|NCT02310750|5564245|P3|COMPLETED|HP Washout 2||0
2267009|NCT02310750|5564246|P2|COMPLETED|HP Washout 2||0
2267010|NCT02310750|5564247|P1|COMPLETED|HP Washout 2||0
2267011|NCT02310750|5564232|P16|STARTED|HP Washout 2||2
2267012|NCT02310750|5564233|P15|STARTED|HP Washout 2||2
2267013|NCT02310750|5564234|P14|STARTED|HP Washout 2||2
2267014|NCT02310750|5564235|P13|STARTED|HP Washout 2||2
2267015|NCT02310750|5564236|P12|STARTED|HP Washout 2||2
2267016|NCT02310750|5564237|P11|STARTED|HP Washout 2||2
2267017|NCT02310750|5564238|P10|STARTED|HP Washout 2||0
2267018|NCT02310750|5564239|P9|STARTED|HP Washout 2||0
2267019|NCT02310750|5564240|P8|STARTED|HP Washout 2||0
2267020|NCT02310750|5564241|P7|STARTED|HP Washout 2||9
2267021|NCT02310750|5564242|P6|STARTED|HP Washout 2||0
2267022|NCT02310750|5564243|P5|STARTED|HP Washout 2||6
2267023|NCT02310750|5564244|P4|STARTED|HP Washout 2||0
2267024|NCT02310750|5564245|P3|STARTED|HP Washout 2||0
2267025|NCT02310750|5564246|P2|STARTED|HP Washout 2||0
2267026|NCT02310750|5564247|P1|STARTED|HP Washout 2||0
2267027|NCT02310750|5564232|P16|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
2267028|NCT02310750|5564233|P15|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
2267029|NCT02310750|5564234|P14|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
2267030|NCT02310750|5564235|P13|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
2267031|NCT02310750|5564236|P12|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
2267032|NCT02310750|5564237|P11|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
2267033|NCT02310750|5564238|P10|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
2267034|NCT02310750|5564239|P9|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||8
2267035|NCT02310750|5564240|P8|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
2267036|NCT02310750|5564241|P7|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
2267037|NCT02310750|5564242|P6|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
2267038|NCT02310750|5564243|P5|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
2267039|NCT02310750|5564244|P4|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||1
2267040|NCT02310750|5564245|P3|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
2267041|NCT02310750|5564246|P2|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
2267042|NCT02310750|5564247|P1|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
2267043|NCT02310750|5564232|P16|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
2267044|NCT02310750|5564233|P15|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
2267045|NCT02310750|5564234|P14|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
2267046|NCT02310750|5564235|P13|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
2267047|NCT02310750|5564236|P12|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
2267048|NCT02310750|5564237|P11|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
2267049|NCT02310750|5564238|P10|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
2267050|NCT02310750|5564239|P9|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
2267051|NCT02310750|5564240|P8|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
2267052|NCT02310750|5564241|P7|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
2267053|NCT02310750|5564242|P6|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
2267054|NCT02310750|5564243|P5|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
2267055|NCT02310750|5564244|P4|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
2267056|NCT02310750|5564245|P3|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
2267057|NCT02310750|5564246|P2|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
2267058|NCT02310750|5564247|P1|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
2267059|NCT02310750|5564232|P16|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
2267060|NCT02310750|5564233|P15|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
2267061|NCT02310750|5564234|P14|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
2267062|NCT02310750|5564235|P13|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
2267063|NCT02310750|5564236|P12|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
2267064|NCT02310750|5564237|P11|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
2267065|NCT02310750|5564238|P10|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
2267066|NCT02310750|5564239|P9|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||14
2267067|NCT02310750|5564240|P8|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
2267068|NCT02310750|5564241|P7|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
2267069|NCT02310750|5564242|P6|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
2267070|NCT02310750|5564243|P5|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
2267071|NCT02310750|5564244|P4|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
2267072|NCT02310750|5564245|P3|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
2267073|NCT02310750|5564246|P2|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
2267074|NCT02310750|5564247|P1|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
2267075|NCT02310750|5564232|P16|NOT COMPLETED|HP Washout 1||0
2267076|NCT02310750|5564233|P15|NOT COMPLETED|HP Washout 1||0
2267077|NCT02310750|5564234|P14|NOT COMPLETED|HP Washout 1||0
2267078|NCT02310750|5564235|P13|NOT COMPLETED|HP Washout 1||0
2267079|NCT02310750|5564236|P12|NOT COMPLETED|HP Washout 1||0
2267080|NCT02310750|5564237|P11|NOT COMPLETED|HP Washout 1||0
2267081|NCT02310750|5564238|P10|NOT COMPLETED|HP Washout 1||0
2267082|NCT02310750|5564239|P9|NOT COMPLETED|HP Washout 1||0
2267083|NCT02310750|5564240|P8|NOT COMPLETED|HP Washout 1||0
2267084|NCT02310750|5564241|P7|NOT COMPLETED|HP Washout 1||3
2267085|NCT02310750|5564242|P6|NOT COMPLETED|HP Washout 1||2
2267086|NCT02310750|5564243|P5|NOT COMPLETED|HP Washout 1||2
2267087|NCT02310750|5564244|P4|NOT COMPLETED|HP Washout 1||1
2267088|NCT02310750|5564245|P3|NOT COMPLETED|HP Washout 1||1
2267089|NCT02310750|5564246|P2|NOT COMPLETED|HP Washout 1||0
2267090|NCT02310750|5564247|P1|NOT COMPLETED|HP Washout 1||0
2267091|NCT02310750|5564232|P16|COMPLETED|HP Washout 1||2
2267092|NCT02310750|5564233|P15|COMPLETED|HP Washout 1||2
2267093|NCT02310750|5564234|P14|COMPLETED|HP Washout 1||2
2267094|NCT02310750|5564235|P13|COMPLETED|HP Washout 1||2
2267095|NCT02310750|5564236|P12|COMPLETED|HP Washout 1||2
2267096|NCT02310750|5564237|P11|COMPLETED|HP Washout 1||2
2267097|NCT02310750|5564238|P10|COMPLETED|HP Washout 1||0
2267098|NCT02310750|5564239|P9|COMPLETED|HP Washout 1||0
2267099|NCT02310750|5564240|P8|COMPLETED|HP Washout 1||0
2267100|NCT02310750|5564241|P7|COMPLETED|HP Washout 1||9
2267101|NCT02310750|5564242|P6|COMPLETED|HP Washout 1||6
2267102|NCT02310750|5564243|P5|COMPLETED|HP Washout 1||6
2267103|NCT02310750|5564244|P4|COMPLETED|HP Washout 1||4
2267104|NCT02310750|5564245|P3|COMPLETED|HP Washout 1||5
2267105|NCT02310750|5564246|P2|COMPLETED|HP Washout 1||0
2267106|NCT02310750|5564247|P1|COMPLETED|HP Washout 1||0
2267107|NCT02310750|5564232|P16|STARTED|HP Washout 1||2
2267108|NCT02310750|5564233|P15|STARTED|HP Washout 1||2
2267109|NCT02310750|5564234|P14|STARTED|HP Washout 1||2
2267110|NCT02310750|5564235|P13|STARTED|HP Washout 1||2
2267111|NCT02310750|5564236|P12|STARTED|HP Washout 1||2
2267112|NCT02310750|5564237|P11|STARTED|HP Washout 1||2
2267113|NCT02310750|5564238|P10|STARTED|HP Washout 1||0
2267114|NCT02310750|5564239|P9|STARTED|HP Washout 1||0
2267115|NCT02310750|5564240|P8|STARTED|HP Washout 1||0
2267116|NCT02310750|5564241|P7|STARTED|HP Washout 1||12
2267117|NCT02310750|5564242|P6|STARTED|HP Washout 1||8
2267118|NCT02310750|5564243|P5|STARTED|HP Washout 1||8
2267119|NCT02310750|5564244|P4|STARTED|HP Washout 1||5
2267120|NCT02310750|5564245|P3|STARTED|HP Washout 1||6
2267121|NCT02310750|5564246|P2|STARTED|HP Washout 1||0
2267122|NCT02310750|5564247|P1|STARTED|HP Washout 1||0
2267123|NCT02310750|5564232|P16|NOT COMPLETED|HP Period 1||0
2267124|NCT02310750|5564233|P15|NOT COMPLETED|HP Period 1||0
2267125|NCT02310750|5564234|P14|NOT COMPLETED|HP Period 1||0
2267126|NCT02310750|5564235|P13|NOT COMPLETED|HP Period 1||0
2267127|NCT02310750|5564236|P12|NOT COMPLETED|HP Period 1||0
2267128|NCT02310750|5564237|P11|NOT COMPLETED|HP Period 1||0
2267129|NCT02310750|5564238|P10|NOT COMPLETED|HP Period 1||0
2267130|NCT02310750|5564239|P9|NOT COMPLETED|HP Period 1||0
2267131|NCT02310750|5564240|P8|NOT COMPLETED|HP Period 1||0
2267132|NCT02310750|5564241|P7|NOT COMPLETED|HP Period 1||1
2267133|NCT02310750|5564242|P6|NOT COMPLETED|HP Period 1||0
2267134|NCT02310750|5564243|P5|NOT COMPLETED|HP Period 1||0
2267135|NCT02310750|5564244|P4|NOT COMPLETED|HP Period 1||1
2267136|NCT02310750|5564245|P3|NOT COMPLETED|HP Period 1||0
2267137|NCT02310750|5564246|P2|NOT COMPLETED|HP Period 1||0
2267138|NCT02310750|5564247|P1|NOT COMPLETED|HP Period 1||1
2267139|NCT02310750|5564232|P16|COMPLETED|HP Period 1||2
2267140|NCT02310750|5564233|P15|COMPLETED|HP Period 1||2
2267141|NCT02310750|5564234|P14|COMPLETED|HP Period 1||2
2267142|NCT02310750|5564235|P13|COMPLETED|HP Period 1||2
2267143|NCT02310750|5564236|P12|COMPLETED|HP Period 1||2
2267144|NCT02310750|5564237|P11|COMPLETED|HP Period 1||2
2267145|NCT02310750|5564238|P10|COMPLETED|HP Period 1||0
2267146|NCT02310750|5564239|P9|COMPLETED|HP Period 1||0
2267147|NCT02310750|5564240|P8|COMPLETED|HP Period 1||0
2267148|NCT02310750|5564241|P7|COMPLETED|HP Period 1||12
2267149|NCT02310750|5564242|P6|COMPLETED|HP Period 1||8
2267150|NCT02310750|5564243|P5|COMPLETED|HP Period 1||8
2267151|NCT02310750|5564244|P4|COMPLETED|HP Period 1||5
2267152|NCT02310750|5564245|P3|COMPLETED|HP Period 1||6
2267153|NCT02310750|5564246|P2|COMPLETED|HP Period 1||6
2267154|NCT02310750|5564247|P1|COMPLETED|HP Period 1||6
2267155|NCT02310750|5564232|P16|STARTED|HP Period 1||2
2267156|NCT02310750|5564233|P15|STARTED|HP Period 1||2
2267157|NCT02310750|5564234|P14|STARTED|HP Period 1||2
2267158|NCT02310750|5564235|P13|STARTED|HP Period 1||2
2267159|NCT02310750|5564236|P12|STARTED|HP Period 1||2
2267160|NCT02310750|5564237|P11|STARTED|HP Period 1||2
2267161|NCT02310750|5564238|P10|STARTED|HP Period 1||0
2267162|NCT02310750|5564239|P9|STARTED|HP Period 1||0
2267163|NCT02310750|5564240|P8|STARTED|HP Period 1||0
2267164|NCT02310750|5564241|P7|STARTED|HP Period 1||13
2267165|NCT02310750|5564242|P6|STARTED|HP Period 1||8
2267166|NCT02310750|5564243|P5|STARTED|HP Period 1||8
2267167|NCT02310750|5564244|P4|STARTED|HP Period 1||6
2267168|NCT02310750|5564245|P3|STARTED|HP Period 1||6
2267169|NCT02310750|5564246|P2|STARTED|HP Period 1||6
2267170|NCT02310750|5564247|P1|STARTED|HP Period 1||7
2267171|NCT02310646|5564688|P2|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
2267172|NCT02310646|5564689|P1|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
2267173|NCT02310646|5564688|P2|COMPLETED|Second Intervention (Day 8 - Day 14)||104
2267174|NCT02310646|5564689|P1|COMPLETED|Second Intervention (Day 8 - Day 14)||107
2267175|NCT02310646|5564688|P2|STARTED|Second Intervention (Day 8 - Day 14)||104
2267176|NCT02310646|5564689|P1|STARTED|Second Intervention (Day 8 - Day 14)||107
2267177|NCT02310646|5564688|P2|NOT COMPLETED|First Intervention (Day 1 - Day 7)||0
2267178|NCT02310646|5564689|P1|NOT COMPLETED|First Intervention (Day 1 - Day 7)||2
2267179|NCT02310646|5564688|P2|COMPLETED|First Intervention (Day 1 - Day 7)||104
2267180|NCT02310646|5564689|P1|COMPLETED|First Intervention (Day 1 - Day 7)||107
2267181|NCT02310646|5564688|P2|STARTED|First Intervention (Day 1 - Day 7)||104
2267182|NCT02310646|5564689|P1|STARTED|First Intervention (Day 1 - Day 7)||109
2267183|NCT02310581|5564717|P4|NOT COMPLETED|Overall Study||1
2267184|NCT02310581|5564718|P3|NOT COMPLETED|Overall Study||1
2267185|NCT02310581|5564719|P2|NOT COMPLETED|Overall Study||2
2267186|NCT02310581|5564720|P1|NOT COMPLETED|Overall Study||3
2267187|NCT02310581|5564717|P4|COMPLETED|Overall Study||9
2267188|NCT02310581|5564718|P3|COMPLETED|Overall Study||9
2267189|NCT02310581|5564719|P2|COMPLETED|Overall Study||9
2267190|NCT02310581|5564720|P1|COMPLETED|Overall Study||6
2267191|NCT02310581|5564717|P4|STARTED|Overall Study||10
2267192|NCT02310581|5564718|P3|STARTED|Overall Study||10
2267193|NCT02310581|5564719|P2|STARTED|Overall Study||11
2267194|NCT02310581|5564720|P1|STARTED|Overall Study||9
2267195|NCT02310568|5564759|P5|NOT COMPLETED|Stage 2 (4 Weeks)||1
2267196|NCT02310568|5564760|P4|NOT COMPLETED|Stage 2 (4 Weeks)||5
2267197|NCT02310568|5564761|P3|NOT COMPLETED|Stage 2 (4 Weeks)||1
2267198|NCT02310568|5564762|P2|NOT COMPLETED|Stage 2 (4 Weeks)||1
2267199|NCT02310568|5564763|P1|NOT COMPLETED|Stage 2 (4 Weeks)||1
2267200|NCT02310568|5564759|P5|COMPLETED|Stage 2 (4 Weeks)||19
2267201|NCT02310568|5564760|P4|COMPLETED|Stage 2 (4 Weeks)||17
2267202|NCT02310568|5564761|P3|COMPLETED|Stage 2 (4 Weeks)||13
2267203|NCT02310568|5564762|P2|COMPLETED|Stage 2 (4 Weeks)||12
2267204|NCT02310568|5564763|P1|COMPLETED|Stage 2 (4 Weeks)||11
2267205|NCT02310568|5564759|P5|STARTED|Stage 2 (4 Weeks)||20
2267206|NCT02310568|5564760|P4|STARTED|Stage 2 (4 Weeks)||22
2267207|NCT02310568|5564761|P3|STARTED|Stage 2 (4 Weeks)||14
2267208|NCT02310568|5564762|P2|STARTED|Stage 2 (4 Weeks)||13
2267209|NCT02310568|5564763|P1|STARTED|Stage 2 (4 Weeks)||12
2267210|NCT02310568|5564759|P5|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
2267211|NCT02310568|5564760|P4|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
2267212|NCT02310568|5564761|P3|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
2267213|NCT02310568|5564762|P2|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
2267214|NCT02310568|5564763|P1|NOT COMPLETED|Stage 1 ( 4 Weeks)||3
2267215|NCT02310568|5564759|P5|COMPLETED|Stage 1 ( 4 Weeks)||20
2267216|NCT02310568|5564760|P4|COMPLETED|Stage 1 ( 4 Weeks)||22
2267217|NCT02310568|5564761|P3|COMPLETED|Stage 1 ( 4 Weeks)||14
2267218|NCT02310568|5564762|P2|COMPLETED|Stage 1 ( 4 Weeks)||13
2267219|NCT02310568|5564763|P1|COMPLETED|Stage 1 ( 4 Weeks)||12
2267220|NCT02310568|5564759|P5|STARTED|Stage 1 ( 4 Weeks)||21
2267221|NCT02310568|5564760|P4|STARTED|Stage 1 ( 4 Weeks)||24
2267222|NCT02310568|5564761|P3|STARTED|Stage 1 ( 4 Weeks)||15
2267223|NCT02310568|5564762|P2|STARTED|Stage 1 ( 4 Weeks)||15
2267224|NCT02310568|5564763|P1|STARTED|Stage 1 ( 4 Weeks)||15
2267225|NCT02310126|5564843|P2|NOT COMPLETED|Period 2 (15 Minutes)||0
2267226|NCT02310126|5564844|P1|NOT COMPLETED|Period 2 (15 Minutes)||0
2267227|NCT02310126|5564843|P2|COMPLETED|Period 2 (15 Minutes)||95
2267228|NCT02310126|5564844|P1|COMPLETED|Period 2 (15 Minutes)||94
2267229|NCT02310126|5564843|P2|Myopes|Period 2 (15 Minutes)||63
2267230|NCT02310126|5564844|P1|Myopes|Period 2 (15 Minutes)||56
2267231|NCT02310126|5564843|P2|Hyperopes|Period 2 (15 Minutes)||32
2267232|NCT02310126|5564844|P1|Hyperopes|Period 2 (15 Minutes)||38
2267233|NCT02310126|5564843|P2|STARTED|Period 2 (15 Minutes)||95
2267234|NCT02310126|5564844|P1|STARTED|Period 2 (15 Minutes)||94
2267235|NCT02310126|5564843|P2|NOT COMPLETED|Period 1 (15 Minutes)||2
2267236|NCT02310126|5564844|P1|NOT COMPLETED|Period 1 (15 Minutes)||0
2267237|NCT02310126|5564843|P2|COMPLETED|Period 1 (15 Minutes)||95
2267238|NCT02310126|5564844|P1|COMPLETED|Period 1 (15 Minutes)||94
2267239|NCT02310126|5564843|P2|Myopes|Period 1 (15 Minutes)||64
2267240|NCT02310126|5564844|P1|Myopes|Period 1 (15 Minutes)||56
2267241|NCT02310126|5564843|P2|Hyperopes|Period 1 (15 Minutes)||33
2267242|NCT02310126|5564844|P1|Hyperopes|Period 1 (15 Minutes)||38
2267243|NCT02310126|5564843|P2|STARTED|Period 1 (15 Minutes)||97
2267244|NCT02310126|5564844|P1|STARTED|Period 1 (15 Minutes)||94
2267245|NCT02310100|5564850|P1|NOT COMPLETED|Overall Study||18
2267246|NCT02310100|5564850|P1|COMPLETED|Overall Study||160
2267247|NCT02310100|5564850|P1|STARTED|Overall Study|First enrollment|178
2267248|NCT02309723|5564858|P3|NOT COMPLETED|Overall Study||24
2267249|NCT02309723|5564859|P2|NOT COMPLETED|Overall Study||23
2267250|NCT02309723|5564860|P1|NOT COMPLETED|Overall Study||24
2267251|NCT02309723|5564858|P3|COMPLETED|Overall Study||105
2267252|NCT02309723|5564859|P2|COMPLETED|Overall Study||105
2267253|NCT02309723|5564860|P1|COMPLETED|Overall Study||105
2267254|NCT02309723|5564858|P3|STARTED|Overall Study||129
2267255|NCT02309723|5564859|P2|STARTED|Overall Study||128
2267256|NCT02309723|5564860|P1|STARTED|Overall Study||129
2267257|NCT02309489|5564876|P2|NOT COMPLETED|Overall Study||14
2267258|NCT02309489|5564877|P1|NOT COMPLETED|Overall Study||15
2267259|NCT02309489|5564876|P2|COMPLETED|Overall Study||547
2267260|NCT02309489|5564877|P1|COMPLETED|Overall Study||568
2267261|NCT02309489|5564876|P2|Follow-up at 3 Months Postpartum|Overall Study||541
2267262|NCT02309489|5564877|P1|Follow-up at 3 Months Postpartum|Overall Study||560
2267263|NCT02309489|5564876|P2|STARTED|Overall Study||561
2267264|NCT02309489|5564877|P1|STARTED|Overall Study||583
2267265|NCT02309411|5564903|P3|NOT COMPLETED|Overall Study||0
2267266|NCT02309411|5564904|P2|NOT COMPLETED|Overall Study||1
2267267|NCT02309411|5564905|P1|NOT COMPLETED|Overall Study||2
2267268|NCT02309411|5564903|P3|COMPLETED|Overall Study||6
2267269|NCT02309411|5564904|P2|COMPLETED|Overall Study||14
2267270|NCT02309411|5564905|P1|COMPLETED|Overall Study||23
2267271|NCT02309411|5564903|P3|STARTED|Overall Study||6
2267272|NCT02309411|5564904|P2|STARTED|Overall Study||15
2267273|NCT02309411|5564905|P1|STARTED|Overall Study||25
2267274|NCT02309359|5564929|P5|NOT COMPLETED|Overall Study||9
2267275|NCT02309359|5564930|P4|NOT COMPLETED|Overall Study||12
2267276|NCT02309359|5564931|P3|NOT COMPLETED|Overall Study||11
2267277|NCT02309359|5564932|P2|NOT COMPLETED|Overall Study||8
2267278|NCT02309359|5564933|P1|NOT COMPLETED|Overall Study||12
2267279|NCT02309359|5564929|P5|COMPLETED|Overall Study||60
2267280|NCT02309359|5564930|P4|COMPLETED|Overall Study||57
2267281|NCT02309359|5564931|P3|COMPLETED|Overall Study||57
2267282|NCT02309359|5564932|P2|COMPLETED|Overall Study||62
2267283|NCT02309359|5564933|P1|COMPLETED|Overall Study||57
2267284|NCT02309359|5564929|P5|STARTED|Overall Study||69
2267285|NCT02309359|5564930|P4|STARTED|Overall Study||69
2267286|NCT02309359|5564931|P3|STARTED|Overall Study||68
2267287|NCT02309359|5564932|P2|STARTED|Overall Study||70
2267288|NCT02309359|5564933|P1|STARTED|Overall Study||69
2267289|NCT02309294|5565060|P1|NOT COMPLETED|Overall Study||2
2267290|NCT02309294|5565060|P1|COMPLETED|Overall Study||41
2267291|NCT02309294|5565060|P1|STARTED|Overall Study||43
2267292|NCT02309112|5565067|P3|NOT COMPLETED|Overall Study||1
2267293|NCT02309112|5565068|P2|NOT COMPLETED|Overall Study||1
2267294|NCT02309112|5565069|P1|NOT COMPLETED|Overall Study||1
2267295|NCT02309112|5565067|P3|COMPLETED|Overall Study||4
2267296|NCT02309112|5565068|P2|COMPLETED|Overall Study||4
2267297|NCT02309112|5565069|P1|COMPLETED|Overall Study||4
2267298|NCT02309112|5565067|P3|Completed Yoga Intervention|Overall Study||4
2267299|NCT02309112|5565068|P2|Completed Yoga Intervention|Overall Study||5
2267300|NCT02309112|5565069|P1|Completed Yoga Intervention|Overall Study||4
2267301|NCT02309112|5565067|P3|STARTED|Overall Study||5
2267302|NCT02309112|5565068|P2|STARTED|Overall Study||5
2267303|NCT02309112|5565069|P1|STARTED|Overall Study||5
2267304|NCT02309099|5565092|P2|NOT COMPLETED|Overall Study||0
2267305|NCT02309099|5565093|P1|NOT COMPLETED|Overall Study||2
2267306|NCT02309099|5565092|P2|COMPLETED|Overall Study||3
2267307|NCT02309099|5565093|P1|COMPLETED|Overall Study|5 participants completed the study (2 did not complete due to adverse event)|5
2267308|NCT02309099|5565092|P2|Cochlear Implant Use/Follow-Up|Overall Study||3
2267408|NCT02308748|5565163|P1|STARTED|Period 3||2
2267309|NCT02309099|5565093|P1|Cochlear Implant Use/Follow-Up|Overall Study|5 participants completed cochlear implant use/follow-up (2 did not complete due to adverse event)|5
2267310|NCT02309099|5565092|P2|Initial Activation|Overall Study||3
2267311|NCT02309099|5565093|P1|Initial Activation|Overall Study||7
2267312|NCT02309099|5565092|P2|Cochlear Implantation|Overall Study||3
2267313|NCT02309099|5565093|P1|Cochlear Implantation|Overall Study||7
2267314|NCT02309099|5565092|P2|STARTED|Overall Study||3
2267315|NCT02309099|5565093|P1|STARTED|Overall Study||7
2267316|NCT02308787|5565139|P1|NOT COMPLETED|Overall Study||0
2267317|NCT02308787|5565139|P1|COMPLETED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
2267318|NCT02308787|5565139|P1|STARTED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
2267319|NCT02308748|5565154|P10|NOT COMPLETED|Period 5||0
2267320|NCT02308748|5565155|P9|NOT COMPLETED|Period 5||1
2267321|NCT02308748|5565156|P8|NOT COMPLETED|Period 5||0
2267322|NCT02308748|5565157|P7|NOT COMPLETED|Period 5||0
2267323|NCT02308748|5565158|P6|NOT COMPLETED|Period 5||0
2267324|NCT02308748|5565159|P5|NOT COMPLETED|Period 5||0
2267325|NCT02308748|5565160|P4|NOT COMPLETED|Period 5||0
2267326|NCT02308748|5565161|P3|NOT COMPLETED|Period 5||0
2267327|NCT02308748|5565162|P2|NOT COMPLETED|Period 5||0
2267328|NCT02308748|5565163|P1|NOT COMPLETED|Period 5||1
2267329|NCT02308748|5565154|P10|COMPLETED|Period 5||2
2267330|NCT02308748|5565155|P9|COMPLETED|Period 5||1
2267331|NCT02308748|5565156|P8|COMPLETED|Period 5||1
2267332|NCT02308748|5565157|P7|COMPLETED|Period 5||2
2267333|NCT02308748|5565158|P6|COMPLETED|Period 5||3
2267334|NCT02308748|5565159|P5|COMPLETED|Period 5||2
2267335|NCT02308748|5565160|P4|COMPLETED|Period 5||2
2267336|NCT02308748|5565161|P3|COMPLETED|Period 5||1
2267337|NCT02308748|5565162|P2|COMPLETED|Period 5||2
2267338|NCT02308748|5565163|P1|COMPLETED|Period 5||1
2267339|NCT02308748|5565154|P10|STARTED|Period 5||2
2267340|NCT02308748|5565155|P9|STARTED|Period 5||2
2267341|NCT02308748|5565156|P8|STARTED|Period 5||1
2267342|NCT02308748|5565157|P7|STARTED|Period 5||2
2267343|NCT02308748|5565158|P6|STARTED|Period 5||3
2267344|NCT02308748|5565159|P5|STARTED|Period 5||2
2267345|NCT02308748|5565160|P4|STARTED|Period 5||2
2267346|NCT02308748|5565161|P3|STARTED|Period 5||1
2267347|NCT02308748|5565162|P2|STARTED|Period 5||2
2267348|NCT02308748|5565163|P1|STARTED|Period 5||2
2267349|NCT02308748|5565154|P10|NOT COMPLETED|Period 4||0
2267350|NCT02308748|5565155|P9|NOT COMPLETED|Period 4||0
2267351|NCT02308748|5565156|P8|NOT COMPLETED|Period 4||0
2267352|NCT02308748|5565157|P7|NOT COMPLETED|Period 4||0
2267353|NCT02308748|5565158|P6|NOT COMPLETED|Period 4||0
2267354|NCT02308748|5565159|P5|NOT COMPLETED|Period 4||0
2267355|NCT02308748|5565160|P4|NOT COMPLETED|Period 4||0
2267356|NCT02308748|5565161|P3|NOT COMPLETED|Period 4||0
2267357|NCT02308748|5565162|P2|NOT COMPLETED|Period 4||0
2267358|NCT02308748|5565163|P1|NOT COMPLETED|Period 4||0
2267359|NCT02308748|5565154|P10|COMPLETED|Period 4||2
2267360|NCT02308748|5565155|P9|COMPLETED|Period 4||2
2267361|NCT02308748|5565156|P8|COMPLETED|Period 4||1
2267362|NCT02308748|5565157|P7|COMPLETED|Period 4||2
2267363|NCT02308748|5565158|P6|COMPLETED|Period 4||3
2267364|NCT02308748|5565159|P5|COMPLETED|Period 4||2
2267365|NCT02308748|5565160|P4|COMPLETED|Period 4||2
2267366|NCT02308748|5565161|P3|COMPLETED|Period 4||1
2267367|NCT02308748|5565162|P2|COMPLETED|Period 4||2
2267368|NCT02308748|5565163|P1|COMPLETED|Period 4||2
2267369|NCT02308748|5565154|P10|STARTED|Period 4||2
2267370|NCT02308748|5565155|P9|STARTED|Period 4||2
2267371|NCT02308748|5565156|P8|STARTED|Period 4||1
2267372|NCT02308748|5565157|P7|STARTED|Period 4||2
2267373|NCT02308748|5565158|P6|STARTED|Period 4||3
2267374|NCT02308748|5565159|P5|STARTED|Period 4||2
2267375|NCT02308748|5565160|P4|STARTED|Period 4||2
2267376|NCT02308748|5565161|P3|STARTED|Period 4||1
2267377|NCT02308748|5565162|P2|STARTED|Period 4||2
2267378|NCT02308748|5565163|P1|STARTED|Period 4||2
2267379|NCT02308748|5565154|P10|NOT COMPLETED|Period 3||1
2267380|NCT02308748|5565155|P9|NOT COMPLETED|Period 3||0
2267381|NCT02308748|5565156|P8|NOT COMPLETED|Period 3||0
2267382|NCT02308748|5565157|P7|NOT COMPLETED|Period 3||0
2267383|NCT02308748|5565158|P6|NOT COMPLETED|Period 3||0
2267384|NCT02308748|5565159|P5|NOT COMPLETED|Period 3||0
2267385|NCT02308748|5565160|P4|NOT COMPLETED|Period 3||0
2267386|NCT02308748|5565161|P3|NOT COMPLETED|Period 3||0
2267387|NCT02308748|5565162|P2|NOT COMPLETED|Period 3||0
2267388|NCT02308748|5565163|P1|NOT COMPLETED|Period 3||0
2267389|NCT02308748|5565154|P10|COMPLETED|Period 3||2
2267390|NCT02308748|5565155|P9|COMPLETED|Period 3||2
2267391|NCT02308748|5565156|P8|COMPLETED|Period 3||1
2267392|NCT02308748|5565157|P7|COMPLETED|Period 3||2
2267393|NCT02308748|5565158|P6|COMPLETED|Period 3||3
2267394|NCT02308748|5565159|P5|COMPLETED|Period 3||2
2267395|NCT02308748|5565160|P4|COMPLETED|Period 3||2
2267396|NCT02308748|5565161|P3|COMPLETED|Period 3||1
2267397|NCT02308748|5565162|P2|COMPLETED|Period 3||2
2267398|NCT02308748|5565163|P1|COMPLETED|Period 3||2
2267399|NCT02308748|5565154|P10|STARTED|Period 3||3
2267400|NCT02308748|5565155|P9|STARTED|Period 3||2
2267401|NCT02308748|5565156|P8|STARTED|Period 3||1
2267402|NCT02308748|5565157|P7|STARTED|Period 3||2
2267403|NCT02308748|5565158|P6|STARTED|Period 3||3
2267404|NCT02308748|5565159|P5|STARTED|Period 3||2
2267405|NCT02308748|5565160|P4|STARTED|Period 3||2
2267406|NCT02308748|5565161|P3|STARTED|Period 3||1
2267407|NCT02308748|5565162|P2|STARTED|Period 3||2
2267409|NCT02308748|5565154|P10|NOT COMPLETED|Period 2||0
2267410|NCT02308748|5565155|P9|NOT COMPLETED|Period 2||0
2267411|NCT02308748|5565156|P8|NOT COMPLETED|Period 2||1
2267412|NCT02308748|5565157|P7|NOT COMPLETED|Period 2||0
2267413|NCT02308748|5565158|P6|NOT COMPLETED|Period 2||0
2267414|NCT02308748|5565159|P5|NOT COMPLETED|Period 2||0
2267415|NCT02308748|5565160|P4|NOT COMPLETED|Period 2||0
2267416|NCT02308748|5565161|P3|NOT COMPLETED|Period 2||0
2267417|NCT02308748|5565162|P2|NOT COMPLETED|Period 2||0
2267418|NCT02308748|5565163|P1|NOT COMPLETED|Period 2||0
2267419|NCT02308748|5565154|P10|COMPLETED|Period 2||3
2267420|NCT02308748|5565155|P9|COMPLETED|Period 2||2
2267421|NCT02308748|5565156|P8|COMPLETED|Period 2||1
2267422|NCT02308748|5565157|P7|COMPLETED|Period 2||2
2267423|NCT02308748|5565158|P6|COMPLETED|Period 2||3
2267424|NCT02308748|5565159|P5|COMPLETED|Period 2||2
2267425|NCT02308748|5565160|P4|COMPLETED|Period 2||2
2267426|NCT02308748|5565161|P3|COMPLETED|Period 2||1
2267427|NCT02308748|5565162|P2|COMPLETED|Period 2||2
2267428|NCT02308748|5565163|P1|COMPLETED|Period 2||2
2267429|NCT02308748|5565154|P10|STARTED|Period 2||3
2267430|NCT02308748|5565155|P9|STARTED|Period 2||2
2267431|NCT02308748|5565156|P8|STARTED|Period 2||2
2267432|NCT02308748|5565157|P7|STARTED|Period 2||2
2267433|NCT02308748|5565158|P6|STARTED|Period 2||3
2267434|NCT02308748|5565159|P5|STARTED|Period 2||2
2267435|NCT02308748|5565160|P4|STARTED|Period 2||2
2267436|NCT02308748|5565161|P3|STARTED|Period 2||1
2267437|NCT02308748|5565162|P2|STARTED|Period 2||2
2267438|NCT02308748|5565163|P1|STARTED|Period 2||2
2267439|NCT02308748|5565154|P10|NOT COMPLETED|Period 1||0
2267440|NCT02308748|5565155|P9|NOT COMPLETED|Period 1||0
2267441|NCT02308748|5565156|P8|NOT COMPLETED|Period 1||0
2267442|NCT02308748|5565157|P7|NOT COMPLETED|Period 1||0
2267443|NCT02308748|5565158|P6|NOT COMPLETED|Period 1||0
2267444|NCT02308748|5565159|P5|NOT COMPLETED|Period 1||0
2267445|NCT02308748|5565160|P4|NOT COMPLETED|Period 1||0
2267446|NCT02308748|5565161|P3|NOT COMPLETED|Period 1||1
2267447|NCT02308748|5565162|P2|NOT COMPLETED|Period 1||0
2267448|NCT02308748|5565163|P1|NOT COMPLETED|Period 1||0
2267449|NCT02308748|5565154|P10|COMPLETED|Period 1||3
2267450|NCT02308748|5565155|P9|COMPLETED|Period 1||2
2267451|NCT02308748|5565156|P8|COMPLETED|Period 1||2
2267452|NCT02308748|5565157|P7|COMPLETED|Period 1||2
2267453|NCT02308748|5565158|P6|COMPLETED|Period 1||3
2267454|NCT02308748|5565159|P5|COMPLETED|Period 1||2
2267455|NCT02308748|5565160|P4|COMPLETED|Period 1||2
2267456|NCT02308748|5565161|P3|COMPLETED|Period 1|One subject withdraw consent before starting Period 2|1
2267457|NCT02308748|5565162|P2|COMPLETED|Period 1||2
2267458|NCT02308748|5565163|P1|COMPLETED|Period 1||2
2267459|NCT02308748|5565154|P10|STARTED|Period 1||3
2267460|NCT02308748|5565155|P9|STARTED|Period 1||2
2267461|NCT02308748|5565156|P8|STARTED|Period 1||2
2267462|NCT02308748|5565157|P7|STARTED|Period 1||2
2267463|NCT02308748|5565158|P6|STARTED|Period 1||3
2267464|NCT02308748|5565159|P5|STARTED|Period 1||2
2267465|NCT02308748|5565160|P4|STARTED|Period 1||2
2267466|NCT02308748|5565161|P3|STARTED|Period 1||2
2267467|NCT02308748|5565162|P2|STARTED|Period 1||2
2267468|NCT02308748|5565163|P1|STARTED|Period 1||2
2267469|NCT02308696|5565177|P2|NOT COMPLETED|Overall Study||31
2267470|NCT02308696|5565178|P1|NOT COMPLETED|Overall Study||53
2267471|NCT02308696|5565177|P2|COMPLETED|Overall Study||203
2267472|NCT02308696|5565178|P1|COMPLETED|Overall Study||169
2267473|NCT02308696|5565177|P2|STARTED|Overall Study||234
2267474|NCT02308696|5565178|P1|STARTED|Overall Study||222
2267475|NCT02308540|5565212|P6|NOT COMPLETED|Overall Study||1
2267476|NCT02308540|5565213|P5|NOT COMPLETED|Overall Study||0
2267477|NCT02308540|5565214|P4|NOT COMPLETED|Overall Study||0
2267478|NCT02308540|5565215|P3|NOT COMPLETED|Overall Study||0
2267479|NCT02308540|5565216|P2|NOT COMPLETED|Overall Study||0
2267480|NCT02308540|5565217|P1|NOT COMPLETED|Overall Study||0
2267481|NCT02308540|5565212|P6|COMPLETED|Overall Study||99
2267482|NCT02308540|5565213|P5|COMPLETED|Overall Study||100
2267483|NCT02308540|5565214|P4|COMPLETED|Overall Study||56
2267484|NCT02308540|5565215|P3|COMPLETED|Overall Study||56
2267485|NCT02308540|5565216|P2|COMPLETED|Overall Study||17
2267486|NCT02308540|5565217|P1|COMPLETED|Overall Study||17
2267487|NCT02308540|5565212|P6|Vaccinated|Overall Study||100
2267488|NCT02308540|5565213|P5|Vaccinated|Overall Study||100
2267489|NCT02308540|5565214|P4|Vaccinated|Overall Study||56
2267490|NCT02308540|5565215|P3|Vaccinated|Overall Study||56
2267491|NCT02308540|5565216|P2|Vaccinated|Overall Study||17
2267492|NCT02308540|5565217|P1|Vaccinated|Overall Study||17
2267493|NCT02308540|5565212|P6|Randomized|Overall Study||100
2267494|NCT02308540|5565213|P5|Randomized|Overall Study||100
2267495|NCT02308540|5565214|P4|Randomized|Overall Study||56
2267496|NCT02308540|5565215|P3|Randomized|Overall Study||56
2267497|NCT02308540|5565216|P2|Randomized|Overall Study||17
2267498|NCT02308540|5565217|P1|Randomized|Overall Study||17
2267499|NCT02308540|5565212|P6|STARTED|Overall Study||100
2267500|NCT02308540|5565213|P5|STARTED|Overall Study||100
2267501|NCT02308540|5565214|P4|STARTED|Overall Study||56
2267502|NCT02308540|5565215|P3|STARTED|Overall Study||56
2267503|NCT02308540|5565216|P2|STARTED|Overall Study||17
2267504|NCT02308540|5565217|P1|STARTED|Overall Study||17
2267505|NCT02308475|5565281|P1|NOT COMPLETED|Overall Study||0
2267506|NCT02308475|5565281|P1|COMPLETED|Overall Study||2
2267507|NCT02308475|5565281|P1|STARTED|Overall Study||2
2267508|NCT02308371|5565289|P2|NOT COMPLETED|Overall Study||0
2267509|NCT02308371|5565290|P1|NOT COMPLETED|Overall Study||0
2267510|NCT02308371|5565289|P2|COMPLETED|Overall Study|Consider eligible for retrospective enrollment if admitted up until 10/15/2012|50
2267511|NCT02308371|5565290|P1|COMPLETED|Overall Study|Ended enrollment and recruitment 3/1/2016|50
2267512|NCT02308371|5565289|P2|STARTED|Overall Study|Consider eligible for retrospective enrollment if admitted after 4/1/2012|50
2267513|NCT02308371|5565290|P1|STARTED|Overall Study|Started enrollment and recruitment 11/26/2014|50
2267514|NCT02308228|5565306|P2|NOT COMPLETED|Overall Study||7
2267515|NCT02308228|5565307|P1|NOT COMPLETED|Overall Study||8
2267516|NCT02308228|5565306|P2|COMPLETED|Overall Study||48
2267517|NCT02308228|5565307|P1|COMPLETED|Overall Study||46
2267518|NCT02308228|5565306|P2|STARTED|Overall Study||55
2267519|NCT02308228|5565307|P1|STARTED|Overall Study||54
2267520|NCT02308189|5565321|P2|NOT COMPLETED|Overall Study||1
2267521|NCT02308189|5565322|P1|NOT COMPLETED|Overall Study||1
2267522|NCT02308189|5565321|P2|COMPLETED|Overall Study||14
2267523|NCT02308189|5565322|P1|COMPLETED|Overall Study||16
2267524|NCT02308189|5565321|P2|STARTED|Overall Study||15
2267525|NCT02308189|5565322|P1|STARTED|Overall Study||17
2267526|NCT02308124|5565335|P3|NOT COMPLETED|Overall Study||8
2267527|NCT02308124|5565336|P2|NOT COMPLETED|Overall Study||8
2267528|NCT02308124|5565337|P1|NOT COMPLETED|Overall Study||6
2267529|NCT02308124|5565335|P3|COMPLETED|Overall Study||21
2267530|NCT02308124|5565336|P2|COMPLETED|Overall Study||21
2267531|NCT02308124|5565337|P1|COMPLETED|Overall Study||23
2267532|NCT02308124|5565335|P3|STARTED|Overall Study||29
2267533|NCT02308124|5565336|P2|STARTED|Overall Study||29
2267534|NCT02308124|5565337|P1|STARTED|Overall Study||29
2267535|NCT02308020|5565363|P6|NOT COMPLETED|Overall Study||2
2267536|NCT02308020|5565364|P5|NOT COMPLETED|Overall Study||2
2267537|NCT02308020|5565365|P4|NOT COMPLETED|Overall Study||4
2267538|NCT02308020|5565366|P3|NOT COMPLETED|Overall Study||1
2267539|NCT02308020|5565367|P2|NOT COMPLETED|Overall Study||12
2267540|NCT02308020|5565368|P1|NOT COMPLETED|Overall Study||3
2267541|NCT02308020|5565363|P6|COMPLETED|Overall Study||15
2267542|NCT02308020|5565364|P5|COMPLETED|Overall Study||21
2267543|NCT02308020|5565365|P4|COMPLETED|Overall Study||24
2267544|NCT02308020|5565366|P3|COMPLETED|Overall Study||8
2267545|NCT02308020|5565367|P2|COMPLETED|Overall Study||46
2267546|NCT02308020|5565368|P1|COMPLETED|Overall Study||24
2267547|NCT02308020|5565363|P6|Progressive Disease|Overall Study||13
2267548|NCT02308020|5565364|P5|Progressive Disease|Overall Study||16
2267549|NCT02308020|5565365|P4|Progressive Disease|Overall Study||20
2267550|NCT02308020|5565366|P3|Progressive Disease|Overall Study||6
2267551|NCT02308020|5565367|P2|Progressive Disease|Overall Study||43
2267552|NCT02308020|5565368|P1|Progressive Disease|Overall Study||23
2267553|NCT02308020|5565363|P6|Received at Least One Dose of Study Drug|Overall Study||17
2267554|NCT02308020|5565364|P5|Received at Least One Dose of Study Drug|Overall Study||23
2267555|NCT02308020|5565365|P4|Received at Least One Dose of Study Drug|Overall Study||28
2267556|NCT02308020|5565366|P3|Received at Least One Dose of Study Drug|Overall Study||9
2267557|NCT02308020|5565367|P2|Received at Least One Dose of Study Drug|Overall Study||58
2267558|NCT02308020|5565368|P1|Received at Least One Dose of Study Drug|Overall Study||27
2267559|NCT02308020|5565363|P6|STARTED|Overall Study||17
2267560|NCT02308020|5565364|P5|STARTED|Overall Study||23
2267561|NCT02308020|5565365|P4|STARTED|Overall Study||28
2267562|NCT02308020|5565366|P3|STARTED|Overall Study||9
2267563|NCT02308020|5565367|P2|STARTED|Overall Study||58
2267564|NCT02308020|5565368|P1|STARTED|Overall Study||27
2267565|NCT02307838|5565421|P3|NOT COMPLETED|Overall Study||0
2267566|NCT02307838|5565422|P2|NOT COMPLETED|Overall Study||0
2267567|NCT02307838|5565423|P1|NOT COMPLETED|Overall Study||0
2267568|NCT02307838|5565421|P3|COMPLETED|Overall Study||55
2267569|NCT02307838|5565422|P2|COMPLETED|Overall Study||64
2267570|NCT02307838|5565423|P1|COMPLETED|Overall Study||56
2267571|NCT02307838|5565421|P3|STARTED|Overall Study||55
2267572|NCT02307838|5565422|P2|STARTED|Overall Study||64
2267573|NCT02307838|5565423|P1|STARTED|Overall Study||56
2267574|NCT02307682|5565469|P3|NOT COMPLETED|Overall Study||64
2267575|NCT02307682|5565470|P2|NOT COMPLETED|Overall Study||57
2267576|NCT02307682|5565471|P1|NOT COMPLETED|Overall Study||50
2267577|NCT02307682|5565469|P3|COMPLETED|Overall Study||297
2267578|NCT02307682|5565470|P2|COMPLETED|Overall Study||304
2267579|NCT02307682|5565471|P1|COMPLETED|Overall Study||310
2267580|NCT02307682|5565469|P3|Randomized and Treated|Overall Study||360
2267581|NCT02307682|5565470|P2|Randomized and Treated|Overall Study||360
2267582|NCT02307682|5565471|P1|Randomized and Treated|Overall Study||358
2267583|NCT02307682|5565469|P3|STARTED|Overall Study||361
2267584|NCT02307682|5565470|P2|STARTED|Overall Study||361
2267585|NCT02307682|5565471|P1|STARTED|Overall Study||360
2267586|NCT02307552|5565571|P1|NOT COMPLETED|Overall Study||0
2267587|NCT02307552|5565571|P1|COMPLETED|Overall Study||1
2267588|NCT02307552|5565571|P1|STARTED|Overall Study||1
2267589|NCT02307526|5565575|P1|NOT COMPLETED|Day 2 - 60 mg of Pyridostigmine||0
2267590|NCT02307526|5565575|P1|COMPLETED|Day 2 - 60 mg of Pyridostigmine||10
2267591|NCT02307526|5565575|P1|STARTED|Day 2 - 60 mg of Pyridostigmine||10
2267592|NCT02307526|5565575|P1|NOT COMPLETED|Day 1 - No Drug||0
2267593|NCT02307526|5565575|P1|COMPLETED|Day 1 - No Drug||10
2267594|NCT02307526|5565575|P1|STARTED|Day 1 - No Drug||10
2267595|NCT02307513|5565587|P2|NOT COMPLETED|Active Treatment Phase (Weeks 13-64)||15
2267596|NCT02307513|5565588|P1|NOT COMPLETED|Active Treatment Phase (Weeks 13-64)||20
2267597|NCT02307513|5565587|P2|COMPLETED|Active Treatment Phase (Weeks 13-64)||68
2267598|NCT02307513|5565588|P1|COMPLETED|Active Treatment Phase (Weeks 13-64)||75
2267599|NCT02307513|5565587|P2|STARTED|Active Treatment Phase (Weeks 13-64)||83
2267600|NCT02307513|5565588|P1|STARTED|Active Treatment Phase (Weeks 13-64)|1 participant completed Week 12; did not enter into active treatment|95
2267601|NCT02307513|5565587|P2|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-12)||20
2267602|NCT02307513|5565588|P1|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-12)||8
2267603|NCT02307513|5565587|P2|COMPLETED|Placebo Controlled Phase (Weeks 0-12)||83
2267604|NCT02307513|5565588|P1|COMPLETED|Placebo Controlled Phase (Weeks 0-12)||96
2267605|NCT02307513|5565587|P2|STARTED|Placebo Controlled Phase (Weeks 0-12)||103
2267606|NCT02307513|5565588|P1|STARTED|Placebo Controlled Phase (Weeks 0-12)||104
2267607|NCT02307318|5565629|P1|NOT COMPLETED|Overall Study||0
2267608|NCT02307318|5565629|P1|COMPLETED|Overall Study||51
2267609|NCT02307318|5565629|P1|STARTED|Overall Study||51
2267610|NCT02307266|5565639|P3|NOT COMPLETED|Overall Study||6
2267611|NCT02307266|5565640|P2|NOT COMPLETED|Overall Study||1
2267612|NCT02307266|5565641|P1|NOT COMPLETED|Overall Study||8
2267613|NCT02307266|5565639|P3|COMPLETED|Overall Study||25
2267614|NCT02307266|5565640|P2|COMPLETED|Overall Study||32
2267615|NCT02307266|5565641|P1|COMPLETED|Overall Study||25
2267616|NCT02307266|5565639|P3|STARTED|Overall Study||31
2267617|NCT02307266|5565640|P2|STARTED|Overall Study||33
2267618|NCT02307266|5565641|P1|STARTED|Overall Study||33
2267619|NCT02307188|5565649|P1|NOT COMPLETED|Overall Study||4
2267620|NCT02307188|5565649|P1|COMPLETED|Overall Study|Four of 5 patients did not meet required criteria to complete the study after they were enrolled.|1
2267621|NCT02307188|5565649|P1|STARTED|Overall Study||5
2267622|NCT02307123|5565653|P1|NOT COMPLETED|Overall Study||0
2267623|NCT02307123|5565653|P1|COMPLETED|Overall Study||483
2267624|NCT02307123|5565653|P1|STARTED|Overall Study||483
2267625|NCT02306928|5565658|P1|NOT COMPLETED|Overall Study||0
2267626|NCT02306928|5565658|P1|COMPLETED|Overall Study||15
2267627|NCT02306928|5565658|P1|STARTED|Overall Study||15
2267628|NCT02306850|5565666|P1|NOT COMPLETED|Overall Study||2
2267629|NCT02306850|5565666|P1|COMPLETED|Overall Study||8
2267630|NCT02306850|5565666|P1|STARTED|Overall Study||10
2267631|NCT02306759|5565673|P2|NOT COMPLETED|Overall Study||0
2267632|NCT02306759|5565674|P1|NOT COMPLETED|Overall Study||0
2267633|NCT02306759|5565673|P2|COMPLETED|Overall Study||30
2267634|NCT02306759|5565674|P1|COMPLETED|Overall Study||30
2267635|NCT02306759|5565673|P2|STARTED|Overall Study||30
2267636|NCT02306759|5565674|P1|STARTED|Overall Study||30
2267637|NCT02306265|5565688|P1|NOT COMPLETED|Overall Study||1
2267638|NCT02306265|5565688|P1|COMPLETED|Overall Study||249
2267639|NCT02306265|5565688|P1|STARTED|Overall Study||250
2267640|NCT02305888|5565697|P3|NOT COMPLETED|Overall Study||1
2267641|NCT02305888|5565698|P2|NOT COMPLETED|Overall Study||1
2267642|NCT02305888|5565699|P1|NOT COMPLETED|Overall Study||0
2267643|NCT02305888|5565697|P3|COMPLETED|Overall Study||62
2267644|NCT02305888|5565698|P2|COMPLETED|Overall Study||62
2267645|NCT02305888|5565699|P1|COMPLETED|Overall Study||63
2267646|NCT02305888|5565697|P3|STARTED|Overall Study||63
2267647|NCT02305888|5565698|P2|STARTED|Overall Study||63
2267648|NCT02305888|5565699|P1|STARTED|Overall Study||63
2267649|NCT02305797|5565718|P2|NOT COMPLETED|Overall Study||38
2267650|NCT02305797|5565719|P1|NOT COMPLETED|Overall Study||45
2267651|NCT02305797|5565718|P2|COMPLETED|Overall Study||210
2267652|NCT02305797|5565719|P1|COMPLETED|Overall Study||202
2267653|NCT02305797|5565718|P2|STARTED|Overall Study||248
2267654|NCT02305797|5565719|P1|STARTED|Overall Study||247
2267655|NCT02305758|5565729|P2|NOT COMPLETED|Overall Study||65
2267656|NCT02305758|5565730|P1|NOT COMPLETED|Overall Study||65
2267657|NCT02305758|5565729|P2|COMPLETED|Overall Study||0
2267658|NCT02305758|5565730|P1|COMPLETED|Overall Study||0
2267659|NCT02305758|5565729|P2|STARTED|Overall Study||65
2267660|NCT02305758|5565730|P1|STARTED|Overall Study||65
2267661|NCT02305732|5565740|P1|NOT COMPLETED|Overall Study||18
2267662|NCT02305732|5565740|P1|COMPLETED|Overall Study||72
2267663|NCT02305732|5565740|P1|STARTED|Overall Study||90
2267664|NCT02305446|5565748|P1|NOT COMPLETED|Overall Study||1
2267665|NCT02305446|5565748|P1|COMPLETED|Overall Study||54
2267666|NCT02305446|5565748|P1|STARTED|Overall Study||55
2267667|NCT02305381|5565756|P3|NOT COMPLETED|Overall Study||7
2267668|NCT02305381|5565757|P2|NOT COMPLETED|Overall Study||5
2267669|NCT02305381|5565758|P1|NOT COMPLETED|Overall Study||5
2267670|NCT02305381|5565756|P3|COMPLETED|Overall Study|Subjects who completed the trial.|126
2267671|NCT02305381|5565757|P2|COMPLETED|Overall Study|Subjects who completed the trial.|127
2267672|NCT02305381|5565758|P1|COMPLETED|Overall Study|Subjects who completed the trial.|127
2267673|NCT02305381|5565756|P3|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|13
2267674|NCT02305381|5565757|P2|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial|16
2267675|NCT02305381|5565758|P1|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|14
2267676|NCT02305381|5565756|P3|Exposed|Overall Study||133
2267677|NCT02305381|5565757|P2|Exposed|Overall Study||131
2267678|NCT02305381|5565758|P1|Exposed|Overall Study||132
2267679|NCT02305381|5565756|P3|STARTED|Overall Study||133
2267680|NCT02305381|5565757|P2|STARTED|Overall Study||132
2267681|NCT02305381|5565758|P1|STARTED|Overall Study||132
2267682|NCT02305329|5565791|P4|NOT COMPLETED|Overall Study||0
2267683|NCT02305329|5565792|P3|NOT COMPLETED|Overall Study||0
2267684|NCT02305329|5565793|P2|NOT COMPLETED|Overall Study||1
2267685|NCT02305329|5565794|P1|NOT COMPLETED|Overall Study||0
2267686|NCT02305329|5565791|P4|COMPLETED|Overall Study||14
2267687|NCT02305329|5565792|P3|COMPLETED|Overall Study||14
2267688|NCT02305329|5565793|P2|COMPLETED|Overall Study||13
2267689|NCT02305329|5565794|P1|COMPLETED|Overall Study||14
2267690|NCT02305329|5565791|P4|Period 2|Overall Study||14
2267691|NCT02305329|5565792|P3|Period 2|Overall Study||14
2267692|NCT02305329|5565793|P2|Period 2|Overall Study||13
2267693|NCT02305329|5565794|P1|Period 2|Overall Study||14
2267694|NCT02305329|5565791|P4|Period 1|Overall Study||14
2267695|NCT02305329|5565792|P3|Period 1|Overall Study||14
2267696|NCT02305329|5565793|P2|Period 1|Overall Study||14
2267697|NCT02305329|5565794|P1|Period 1|Overall Study||14
2267698|NCT02305329|5565791|P4|STARTED|Overall Study||14
2267699|NCT02305329|5565792|P3|STARTED|Overall Study||14
2267700|NCT02305329|5565793|P2|STARTED|Overall Study||14
2267701|NCT02305329|5565794|P1|STARTED|Overall Study||14
2267702|NCT02305316|5565818|P2|NOT COMPLETED|Overall Study||0
2267703|NCT02305316|5565819|P1|NOT COMPLETED|Overall Study||0
2267704|NCT02305316|5565818|P2|COMPLETED|Overall Study||14
2267705|NCT02305316|5565819|P1|COMPLETED|Overall Study||14
2267706|NCT02305316|5565818|P2|STARTED|Overall Study||14
2267707|NCT02305316|5565819|P1|STARTED|Overall Study||14
2267708|NCT02305277|5565837|P6|NOT COMPLETED|Overall Study||0
2267709|NCT02305277|5565838|P5|NOT COMPLETED|Overall Study||1
2267710|NCT02305277|5565839|P4|NOT COMPLETED|Overall Study||0
2267711|NCT02305277|5565840|P3|NOT COMPLETED|Overall Study||0
2267712|NCT02305277|5565841|P2|NOT COMPLETED|Overall Study||0
2267713|NCT02305277|5565842|P1|NOT COMPLETED|Overall Study||1
2267714|NCT02305277|5565837|P6|COMPLETED|Overall Study||14
2267715|NCT02305277|5565838|P5|COMPLETED|Overall Study||13
2267716|NCT02305277|5565839|P4|COMPLETED|Overall Study||14
2267717|NCT02305277|5565840|P3|COMPLETED|Overall Study||14
2267718|NCT02305277|5565841|P2|COMPLETED|Overall Study||14
2267719|NCT02305277|5565842|P1|COMPLETED|Overall Study||14
2267720|NCT02305277|5565837|P6|Received TBM|Overall Study||14
2267721|NCT02305277|5565838|P5|Received TBM|Overall Study||14
2267722|NCT02305277|5565839|P4|Received TBM|Overall Study||14
2267723|NCT02305277|5565840|P3|Received TBM|Overall Study||14
2267724|NCT02305277|5565841|P2|Received TBM|Overall Study||14
2267725|NCT02305277|5565842|P1|Received TBM|Overall Study||15
2267726|NCT02305277|5565837|P6|Received CM|Overall Study||14
2267727|NCT02305277|5565838|P5|Received CM|Overall Study||14
2267728|NCT02305277|5565839|P4|Received CM|Overall Study||14
2267729|NCT02305277|5565840|P3|Received CM|Overall Study||14
2267730|NCT02305277|5565841|P2|Received CM|Overall Study||14
2267731|NCT02305277|5565842|P1|Received CM|Overall Study||15
2267732|NCT02305277|5565837|P6|STARTED|Overall Study||14
2267733|NCT02305277|5565838|P5|STARTED|Overall Study||14
2267734|NCT02305277|5565839|P4|STARTED|Overall Study||14
2267735|NCT02305277|5565840|P3|STARTED|Overall Study||14
2267736|NCT02305277|5565841|P2|STARTED|Overall Study||14
2267737|NCT02305277|5565842|P1|STARTED|Overall Study||15
2267738|NCT02305238|5565871|P3|NOT COMPLETED|Overall Study||8
2267739|NCT02305238|5565872|P2|NOT COMPLETED|Overall Study||19
2267740|NCT02305238|5565873|P1|NOT COMPLETED|Overall Study||16
2267741|NCT02305238|5565871|P3|COMPLETED|Overall Study||0
2267742|NCT02305238|5565872|P2|COMPLETED|Overall Study||104
2267743|NCT02305238|5565873|P1|COMPLETED|Overall Study||108
2267744|NCT02305238|5565871|P3|BCVA Post-randomization Assessment|Overall Study||0
2267745|NCT02305238|5565872|P2|BCVA Post-randomization Assessment|Overall Study||123
2267746|NCT02305238|5565873|P1|BCVA Post-randomization Assessment|Overall Study||123
2267747|NCT02305238|5565871|P3|Randomized|Overall Study||0
2267748|NCT02305238|5565872|P2|Randomized|Overall Study||123
2267749|NCT02305238|5565873|P1|Randomized|Overall Study||124
2267750|NCT02305238|5565871|P3|Treated|Overall Study||7
2267751|NCT02305238|5565872|P2|Treated|Overall Study||123
2267752|NCT02305238|5565873|P1|Treated|Overall Study||124
2267753|NCT02305238|5565871|P3|STARTED|Overall Study||8
2267754|NCT02305238|5565872|P2|STARTED|Overall Study||123
2267755|NCT02305238|5565873|P1|STARTED|Overall Study||124
2267756|NCT02305017|5565890|P2|NOT COMPLETED|Overall Study||0
2267757|NCT02305017|5565891|P1|NOT COMPLETED|Overall Study||0
2267758|NCT02305017|5565890|P2|COMPLETED|Overall Study||14
2267759|NCT02305017|5565891|P1|COMPLETED|Overall Study||14
2267760|NCT02305017|5565890|P2|STARTED|Overall Study||14
2267761|NCT02305017|5565891|P1|STARTED|Overall Study||14
2267762|NCT02304926|5565905|P2|NOT COMPLETED|Overall Study||1
2267763|NCT02304926|5565906|P1|NOT COMPLETED|Overall Study||2
2267764|NCT02304926|5565905|P2|COMPLETED|Overall Study||19
2267765|NCT02304926|5565906|P1|COMPLETED|Overall Study||20
2267766|NCT02304926|5565905|P2|STARTED|Overall Study||20
2267767|NCT02304926|5565906|P1|STARTED|Overall Study||22
2267768|NCT02304705|5565952|P2|NOT COMPLETED|Overall Study||7
2267769|NCT02304705|5565953|P1|NOT COMPLETED|Overall Study||4
2267770|NCT02304705|5565952|P2|COMPLETED|Overall Study||10
2267771|NCT02304705|5565953|P1|COMPLETED|Overall Study||12
2267772|NCT02304705|5565952|P2|STARTED|Overall Study||17
2267773|NCT02304705|5565953|P1|STARTED|Overall Study||16
2267774|NCT02304484|5565959|P1|NOT COMPLETED|Overall Study||25
2267775|NCT02304484|5565959|P1|COMPLETED|Overall Study||745
2267776|NCT02304484|5565959|P1|STARTED|Overall Study||770
2267777|NCT02304432|5565964|P4|NOT COMPLETED|Second Open Label DCS||0
2267778|NCT02304432|5565965|P3|NOT COMPLETED|Second Open Label DCS||0
2267779|NCT02304432|5565966|P2|NOT COMPLETED|Second Open Label DCS||0
2267780|NCT02304432|5565967|P1|NOT COMPLETED|Second Open Label DCS||0
2267781|NCT02304432|5565964|P4|COMPLETED|Second Open Label DCS||2
2267782|NCT02304432|5565965|P3|COMPLETED|Second Open Label DCS||0
2267783|NCT02304432|5565966|P2|COMPLETED|Second Open Label DCS||0
2267784|NCT02304432|5565967|P1|COMPLETED|Second Open Label DCS||0
2267785|NCT02304432|5565964|P4|STARTED|Second Open Label DCS||2
2267786|NCT02304432|5565965|P3|STARTED|Second Open Label DCS||0
2267787|NCT02304432|5565966|P2|STARTED|Second Open Label DCS||0
2267788|NCT02304432|5565967|P1|STARTED|Second Open Label DCS||0
2267789|NCT02304432|5565964|P4|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
2267790|NCT02304432|5565965|P3|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
2267791|NCT02304432|5565966|P2|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
2267792|NCT02304432|5565967|P1|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
2267793|NCT02304432|5565964|P4|COMPLETED|Double-Blind DCS Placebo Crossover||0
2267794|NCT02304432|5565965|P3|COMPLETED|Double-Blind DCS Placebo Crossover||1
2267795|NCT02304432|5565966|P2|COMPLETED|Double-Blind DCS Placebo Crossover||1
2267796|NCT02304432|5565967|P1|COMPLETED|Double-Blind DCS Placebo Crossover||0
2267797|NCT02304432|5565964|P4|STARTED|Double-Blind DCS Placebo Crossover||0
2267798|NCT02304432|5565965|P3|STARTED|Double-Blind DCS Placebo Crossover||1
2267799|NCT02304432|5565966|P2|STARTED|Double-Blind DCS Placebo Crossover||1
2267800|NCT02304432|5565967|P1|STARTED|Double-Blind DCS Placebo Crossover||0
2267801|NCT02304432|5565964|P4|NOT COMPLETED|Open Label DCS||0
2267802|NCT02304432|5565965|P3|NOT COMPLETED|Open Label DCS||0
2267803|NCT02304432|5565966|P2|NOT COMPLETED|Open Label DCS||0
2267804|NCT02304432|5565967|P1|NOT COMPLETED|Open Label DCS||0
2267805|NCT02304432|5565964|P4|COMPLETED|Open Label DCS||0
2267806|NCT02304432|5565965|P3|COMPLETED|Open Label DCS||0
2267807|NCT02304432|5565966|P2|COMPLETED|Open Label DCS||0
2267808|NCT02304432|5565967|P1|COMPLETED|Open Label DCS||2
2267809|NCT02304432|5565964|P4|STARTED|Open Label DCS||0
2267810|NCT02304432|5565965|P3|STARTED|Open Label DCS||0
2267811|NCT02304432|5565966|P2|STARTED|Open Label DCS||0
2267812|NCT02304432|5565967|P1|STARTED|Open Label DCS||2
2267813|NCT02304406|5565999|P1|NOT COMPLETED|Overall Study||0
2267814|NCT02304406|5565999|P1|COMPLETED|Overall Study||449
2267815|NCT02304406|5565999|P1|STARTED|Overall Study||449
2267816|NCT02304159|5566018|P2|NOT COMPLETED|Overall Study||2
2267817|NCT02304159|5566019|P1|NOT COMPLETED|Overall Study||2
2267818|NCT02304159|5566018|P2|COMPLETED|Overall Study||16
2267819|NCT02304159|5566019|P1|COMPLETED|Overall Study||19
2267820|NCT02304159|5566018|P2|STARTED|Overall Study||18
2267821|NCT02304159|5566019|P1|STARTED|Overall Study||21
2267822|NCT02303743|5566031|P2|NOT COMPLETED|Overall Study||0
2267823|NCT02303743|5566032|P1|NOT COMPLETED|Overall Study||0
2267824|NCT02303743|5566031|P2|COMPLETED|Overall Study||152
2267825|NCT02303743|5566032|P1|COMPLETED|Overall Study||108
2267826|NCT02303743|5566031|P2|STARTED|Overall Study||152
2267827|NCT02303743|5566032|P1|STARTED|Overall Study||108
2267828|NCT02303704|5566042|P2|NOT COMPLETED|Overall Study||9
2267829|NCT02303704|5566043|P1|NOT COMPLETED|Overall Study||5
2267830|NCT02303704|5566042|P2|COMPLETED|Overall Study||219
2267831|NCT02303704|5566043|P1|COMPLETED|Overall Study||215
2267832|NCT02303704|5566042|P2|STARTED|Overall Study||228
2267833|NCT02303704|5566043|P1|STARTED|Overall Study||220
2267834|NCT02303574|5566071|P10|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
2267835|NCT02303574|5566072|P9|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
2267836|NCT02303574|5566073|P8|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||1
2267837|NCT02303574|5566074|P7|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
2267838|NCT02303574|5566075|P6|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
2267839|NCT02303574|5566076|P5|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
2267840|NCT02303574|5566077|P4|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
2267841|NCT02303574|5566078|P3|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
2267842|NCT02303574|5566079|P2|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
2267843|NCT02303574|5566080|P1|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
2267844|NCT02303574|5566071|P10|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||12
2267845|NCT02303574|5566072|P9|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||10
2267846|NCT02303574|5566073|P8|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||7
2267847|NCT02303574|5566074|P7|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||6
2267848|NCT02303574|5566075|P6|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
2267849|NCT02303574|5566076|P5|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
2267850|NCT02303574|5566077|P4|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
2267851|NCT02303574|5566078|P3|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
2267852|NCT02303574|5566079|P2|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
2267853|NCT02303574|5566080|P1|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
2267854|NCT02303574|5566071|P10|STARTED|Part 2 - Multiple Ascending Dose (MAD)|Participants took AZD7986 matching placebo for 28 days (fasted/fed state, based on part 1b results)|12
2267855|NCT02303574|5566072|P9|STARTED|Part 2 - Multiple Ascending Dose (MAD)||10
2267856|NCT02303574|5566073|P8|STARTED|Part 2 - Multiple Ascending Dose (MAD)||8
2267857|NCT02303574|5566074|P7|STARTED|Part 2 - Multiple Ascending Dose (MAD)||6
2267858|NCT02303574|5566075|P6|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
2267859|NCT02303574|5566076|P5|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
2267860|NCT02303574|5566077|P4|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
2267861|NCT02303574|5566078|P3|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
2267862|NCT02303574|5566079|P2|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
2267863|NCT02303574|5566080|P1|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
2267864|NCT02303574|5566071|P10|NOT COMPLETED|Part 1b (Fed State) - SAD||0
2267865|NCT02303574|5566072|P9|NOT COMPLETED|Part 1b (Fed State) - SAD||0
2267866|NCT02303574|5566073|P8|NOT COMPLETED|Part 1b (Fed State) - SAD||0
2267867|NCT02303574|5566074|P7|NOT COMPLETED|Part 1b (Fed State) - SAD||0
2267868|NCT02303574|5566075|P6|NOT COMPLETED|Part 1b (Fed State) - SAD||0
2267869|NCT02303574|5566076|P5|NOT COMPLETED|Part 1b (Fed State) - SAD||0
2267870|NCT02303574|5566077|P4|NOT COMPLETED|Part 1b (Fed State) - SAD||0
2267871|NCT02303574|5566078|P3|NOT COMPLETED|Part 1b (Fed State) - SAD||0
2267872|NCT02303574|5566079|P2|NOT COMPLETED|Part 1b (Fed State) - SAD||0
2267873|NCT02303574|5566080|P1|NOT COMPLETED|Part 1b (Fed State) - SAD||0
2267874|NCT02303574|5566071|P10|COMPLETED|Part 1b (Fed State) - SAD||3
2267875|NCT02303574|5566072|P9|COMPLETED|Part 1b (Fed State) - SAD||0
2267876|NCT02303574|5566073|P8|COMPLETED|Part 1b (Fed State) - SAD||0
2267877|NCT02303574|5566074|P7|COMPLETED|Part 1b (Fed State) - SAD||0
2267878|NCT02303574|5566075|P6|COMPLETED|Part 1b (Fed State) - SAD||5
2267879|NCT02303574|5566076|P5|COMPLETED|Part 1b (Fed State) - SAD||0
2267880|NCT02303574|5566077|P4|COMPLETED|Part 1b (Fed State) - SAD||0
2267881|NCT02303574|5566078|P3|COMPLETED|Part 1b (Fed State) - SAD||0
2267882|NCT02303574|5566079|P2|COMPLETED|Part 1b (Fed State) - SAD||0
2267883|NCT02303574|5566080|P1|COMPLETED|Part 1b (Fed State) - SAD||0
2267884|NCT02303574|5566071|P10|STARTED|Part 1b (Fed State) - SAD|Participants received AZD7986 matching placebo on Day 1 in fed state.|3
2267885|NCT02303574|5566072|P9|STARTED|Part 1b (Fed State) - SAD||0
2267886|NCT02303574|5566073|P8|STARTED|Part 1b (Fed State) - SAD||0
2267887|NCT02303574|5566074|P7|STARTED|Part 1b (Fed State) - SAD||0
2267888|NCT02303574|5566075|P6|STARTED|Part 1b (Fed State) - SAD||5
2267889|NCT02303574|5566076|P5|STARTED|Part 1b (Fed State) - SAD||0
2267890|NCT02303574|5566077|P4|STARTED|Part 1b (Fed State) - SAD||0
2267891|NCT02303574|5566078|P3|STARTED|Part 1b (Fed State) - SAD||0
2267892|NCT02303574|5566079|P2|STARTED|Part 1b (Fed State) - SAD||0
2267893|NCT02303574|5566080|P1|STARTED|Part 1b (Fed State) - SAD||0
2267894|NCT02303574|5566071|P10|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
2267895|NCT02303574|5566072|P9|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
2267896|NCT02303574|5566073|P8|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
2267897|NCT02303574|5566074|P7|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
2267898|NCT02303574|5566075|P6|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
2267899|NCT02303574|5566076|P5|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
2267900|NCT02303574|5566077|P4|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
2267901|NCT02303574|5566078|P3|NOT COMPLETED|Part 1a (Fasted State)- SAD||1
2267902|NCT02303574|5566079|P2|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
2267903|NCT02303574|5566080|P1|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
2267904|NCT02303574|5566071|P10|COMPLETED|Part 1a (Fasted State)- SAD||15
2267905|NCT02303574|5566072|P9|COMPLETED|Part 1a (Fasted State)- SAD||0
2267906|NCT02303574|5566073|P8|COMPLETED|Part 1a (Fasted State)- SAD||0
2267907|NCT02303574|5566074|P7|COMPLETED|Part 1a (Fasted State)- SAD||0
2267908|NCT02303574|5566075|P6|COMPLETED|Part 1a (Fasted State)- SAD||0
2267909|NCT02303574|5566076|P5|COMPLETED|Part 1a (Fasted State)- SAD||6
2267910|NCT02303574|5566077|P4|COMPLETED|Part 1a (Fasted State)- SAD||6
2267911|NCT02303574|5566078|P3|COMPLETED|Part 1a (Fasted State)- SAD||5
2267912|NCT02303574|5566079|P2|COMPLETED|Part 1a (Fasted State)- SAD||6
2267913|NCT02303574|5566080|P1|COMPLETED|Part 1a (Fasted State)- SAD||6
2267914|NCT02303574|5566071|P10|STARTED|Part 1a (Fasted State)- SAD|Participants received AZD7986 matching placebo on Day 1 in fasted state.|15
2267915|NCT02303574|5566072|P9|STARTED|Part 1a (Fasted State)- SAD||0
2267916|NCT02303574|5566073|P8|STARTED|Part 1a (Fasted State)- SAD||0
2267917|NCT02303574|5566074|P7|STARTED|Part 1a (Fasted State)- SAD||0
2267918|NCT02303574|5566075|P6|STARTED|Part 1a (Fasted State)- SAD||0
2267919|NCT02303574|5566076|P5|STARTED|Part 1a (Fasted State)- SAD||6
2267920|NCT02303574|5566077|P4|STARTED|Part 1a (Fasted State)- SAD||6
2267921|NCT02303574|5566078|P3|STARTED|Part 1a (Fasted State)- SAD||6
2267922|NCT02303574|5566079|P2|STARTED|Part 1a (Fasted State)- SAD||6
2267923|NCT02303574|5566080|P1|STARTED|Part 1a (Fasted State)- SAD||6
2267924|NCT02303548|5566294|P2|NOT COMPLETED|Overall Study||0
2267925|NCT02303548|5566295|P1|NOT COMPLETED|Overall Study||0
2267926|NCT02303548|5566294|P2|COMPLETED|Overall Study||25
2267927|NCT02303548|5566295|P1|COMPLETED|Overall Study||25
2267928|NCT02303548|5566294|P2|STARTED|Overall Study||25
2267929|NCT02303548|5566295|P1|STARTED|Overall Study||25
2267930|NCT02303262|5566301|P1|NOT COMPLETED|Overall Study||2
2267931|NCT02303262|5566301|P1|COMPLETED|Overall Study||18
2267932|NCT02303262|5566301|P1|STARTED|Overall Study||20
2267933|NCT02303041|5566309|P2|NOT COMPLETED|Overall Study||2
2267934|NCT02303041|5566310|P1|NOT COMPLETED|Overall Study||1
2267935|NCT02303041|5566309|P2|COMPLETED|Overall Study||4
2267936|NCT02303041|5566310|P1|COMPLETED|Overall Study||3
2267937|NCT02303041|5566309|P2|STARTED|Overall Study||6
2267938|NCT02303041|5566310|P1|STARTED|Overall Study||4
2267939|NCT02302859|5566326|P2|NOT COMPLETED|Overall Study||2
2267940|NCT02302859|5566327|P1|NOT COMPLETED|Overall Study||1
2267941|NCT02302859|5566326|P2|COMPLETED|Overall Study||4
2267942|NCT02302859|5566327|P1|COMPLETED|Overall Study||1
2267943|NCT02302859|5566326|P2|STARTED|Overall Study||6
2267944|NCT02302859|5566327|P1|STARTED|Overall Study||2
2267945|NCT02302846|5566333|P1|NOT COMPLETED|Overall Study||1
2267946|NCT02302846|5566333|P1|COMPLETED|Overall Study||4
2267947|NCT02302846|5566333|P1|STARTED|Overall Study||5
2267948|NCT02302807|5566339|P2|NOT COMPLETED|Overall Study||467
2267949|NCT02302807|5566340|P1|NOT COMPLETED|Overall Study||464
2267950|NCT02302807|5566339|P2|COMPLETED|Overall Study|Participants still receiving atezolizumab had opportunity to continue treatment in extension study.|0
2267951|NCT02302807|5566340|P1|COMPLETED|Overall Study|Participants still on chemotherapy were discontinued where that treatment was available locally.|0
2267952|NCT02302807|5566339|P2|Received Treatment|Overall Study||459
2267953|NCT02302807|5566340|P1|Received Treatment|Overall Study||443
2267954|NCT02302807|5566339|P2|STARTED|Overall Study||467
2267955|NCT02302807|5566340|P1|STARTED|Overall Study||464
2267956|NCT02302716|5566387|P2|NOT COMPLETED|Overall Study||19
2267957|NCT02302716|5566388|P1|NOT COMPLETED|Overall Study||19
2267958|NCT02302716|5566387|P2|COMPLETED|Overall Study||225
2267959|NCT02302716|5566388|P1|COMPLETED|Overall Study||230
2267960|NCT02302716|5566387|P2|Received at Least 1 Dose of Study Drug|Overall Study||244
2267961|NCT02302716|5566388|P1|Received at Least 1 Dose of Study Drug|Overall Study||249
2267962|NCT02302716|5566387|P2|STARTED|Overall Study||244
2267963|NCT02302716|5566388|P1|STARTED|Overall Study||249
2267964|NCT02302365|5566414|P1|NOT COMPLETED|0-24 Hour Period||0
2267965|NCT02302365|5566414|P1|COMPLETED|0-24 Hour Period||32
2267966|NCT02302365|5566414|P1|STARTED|0-24 Hour Period|2 of 3 study sites collected additional safety data; 32 pts. 0-24 hour data, 43 pts. 0-2 hour data|32
2267967|NCT02302365|5566414|P1|NOT COMPLETED|0-2 Hour Period||2
2267968|NCT02302365|5566414|P1|COMPLETED|0-2 Hour Period|The Per-protocol Analysis Set comprised 54 procedures performed in 41 subjects|41
2267969|NCT02302365|5566414|P1|STARTED|0-2 Hour Period|Data were collected from 58 WBCD procedures performed in 43 subjects - Full and Safety Analysis Sets|43
2267970|NCT02302339|5566436|P4|NOT COMPLETED|Overall Study||0
2267971|NCT02302339|5566437|P3|NOT COMPLETED|Overall Study||1
2267972|NCT02302339|5566438|P2|NOT COMPLETED|Overall Study||2
2267973|NCT02302339|5566439|P1|NOT COMPLETED|Overall Study||1
2267974|NCT02302339|5566436|P4|COMPLETED|Overall Study||7
2267975|NCT02302339|5566437|P3|COMPLETED|Overall Study||28
2267976|NCT02302339|5566438|P2|COMPLETED|Overall Study||32
2267977|NCT02302339|5566439|P1|COMPLETED|Overall Study||61
2267978|NCT02302339|5566436|P4|STARTED|Overall Study||7
2267979|NCT02302339|5566437|P3|STARTED|Overall Study||29
2267980|NCT02302339|5566438|P2|STARTED|Overall Study||34
2267981|NCT02302339|5566439|P1|STARTED|Overall Study||62
2267982|NCT02302222|5566472|P2|NOT COMPLETED|Overall Study||6
2267983|NCT02302222|5566473|P1|NOT COMPLETED|Overall Study||1
2267984|NCT02302222|5566472|P2|COMPLETED|Overall Study||31
2267985|NCT02302222|5566473|P1|COMPLETED|Overall Study||33
2267986|NCT02302222|5566472|P2|STARTED|Overall Study||37
2267987|NCT02302222|5566473|P1|STARTED|Overall Study||34
2267988|NCT02302092|5566481|P2|NOT COMPLETED|Overall Study||0
2267989|NCT02302092|5566482|P1|NOT COMPLETED|Overall Study||0
2267990|NCT02302092|5566481|P2|COMPLETED|Overall Study||7
2267991|NCT02302092|5566482|P1|COMPLETED|Overall Study||6
2267992|NCT02302092|5566481|P2|STARTED|Overall Study||7
2267993|NCT02302092|5566482|P1|STARTED|Overall Study||6
2268018|NCT02301988|5566559|P2|NOT COMPLETED|Overall Study||9
2268019|NCT02301988|5566560|P1|NOT COMPLETED|Overall Study||10
2268020|NCT02301988|5566559|P2|COMPLETED|Overall Study||66
2268021|NCT02301988|5566560|P1|COMPLETED|Overall Study||66
2268022|NCT02301988|5566559|P2|STARTED|Overall Study||75
2268023|NCT02301988|5566560|P1|STARTED|Overall Study||76
2268024|NCT02301975|5566593|P3|NOT COMPLETED|Overall Study||22
2268025|NCT02301975|5566594|P2|NOT COMPLETED|Overall Study||25
2268026|NCT02301975|5566595|P1|NOT COMPLETED|Overall Study||31
2268027|NCT02301975|5566593|P3|COMPLETED|Overall Study||477
2268028|NCT02301975|5566594|P2|COMPLETED|Overall Study||476
2268029|NCT02301975|5566595|P1|COMPLETED|Overall Study||473
2268030|NCT02301975|5566593|P3|STARTED|Overall Study||499
2268031|NCT02301975|5566594|P2|STARTED|Overall Study||501
2268032|NCT02301975|5566595|P1|STARTED|Overall Study||504
2268033|NCT02301936|5566623|P2|NOT COMPLETED|Overall Study||0
2268034|NCT02301936|5566624|P1|NOT COMPLETED|Overall Study||1
2268035|NCT02301936|5566623|P2|COMPLETED|Overall Study||1
2268036|NCT02301936|5566624|P1|COMPLETED|Overall Study||8
2268037|NCT02301936|5566623|P2|STARTED|Overall Study||1
2268038|NCT02301936|5566624|P1|STARTED|Overall Study||9
2268039|NCT02301897|5566649|P3|NOT COMPLETED|Treatment Course 2||1
2268040|NCT02301897|5566650|P2|NOT COMPLETED|Treatment Course 2||5
2268041|NCT02301897|5566651|P1|NOT COMPLETED|Treatment Course 2||1
2268042|NCT02301897|5566649|P3|COMPLETED|Treatment Course 2||7
2268043|NCT02301897|5566650|P2|COMPLETED|Treatment Course 2||9
2268044|NCT02301897|5566651|P1|COMPLETED|Treatment Course 2||8
2268045|NCT02301897|5566649|P3|STARTED|Treatment Course 2||8
2268046|NCT02301897|5566650|P2|STARTED|Treatment Course 2||14
2268047|NCT02301897|5566651|P1|STARTED|Treatment Course 2||9
2268048|NCT02301897|5566649|P3|NOT COMPLETED|Treatment Course 1||6
2268049|NCT02301897|5566650|P2|NOT COMPLETED|Treatment Course 1||3
2268050|NCT02301897|5566651|P1|NOT COMPLETED|Treatment Course 1||3
2268051|NCT02301897|5566649|P3|COMPLETED|Treatment Course 1||8
2268052|NCT02301897|5566650|P2|COMPLETED|Treatment Course 1||14
2268053|NCT02301897|5566651|P1|COMPLETED|Treatment Course 1||9
2268054|NCT02301897|5566649|P3|STARTED|Treatment Course 1||14
2268055|NCT02301897|5566650|P2|STARTED|Treatment Course 1||17
2268056|NCT02301897|5566651|P1|STARTED|Treatment Course 1||12
2268057|NCT02301793|5566700|P2|NOT COMPLETED|During and Post Education Study Period||49
2268058|NCT02301793|5566701|P1|NOT COMPLETED|During and Post Education Study Period||83
2268059|NCT02301793|5566700|P2|COMPLETED|During and Post Education Study Period||396
2268060|NCT02301793|5566701|P1|COMPLETED|During and Post Education Study Period||405
2268061|NCT02301793|5566700|P2|STARTED|During and Post Education Study Period||445
2268062|NCT02301793|5566701|P1|STARTED|During and Post Education Study Period||488
2268063|NCT02301793|5566700|P2|NOT COMPLETED|Pre Education Study Period||0
2268064|NCT02301793|5566701|P1|NOT COMPLETED|Pre Education Study Period||0
2268065|NCT02301793|5566700|P2|COMPLETED|Pre Education Study Period|Nurses had not been randomized|0
2268066|NCT02301793|5566701|P1|COMPLETED|Pre Education Study Period|Nurses had not been randomized|0
2268067|NCT02301793|5566700|P2|STARTED|Pre Education Study Period|Nurses had not been randomized|0
2268068|NCT02301793|5566701|P1|STARTED|Pre Education Study Period|Nurses had not been randomized|0
2268069|NCT02301624|5566717|P2|NOT COMPLETED|Open-label Maintenance Phase||17
2268070|NCT02301624|5566718|P1|NOT COMPLETED|Open-label Maintenance Phase||12
2268071|NCT02301624|5566717|P2|COMPLETED|Open-label Maintenance Phase||44
2268072|NCT02301624|5566718|P1|COMPLETED|Open-label Maintenance Phase||43
2268073|NCT02301624|5566717|P2|Received at Least 1 Dose of Study Drug|Open-label Maintenance Phase||61
2268074|NCT02301624|5566718|P1|Received at Least 1 Dose of Study Drug|Open-label Maintenance Phase||55
2268075|NCT02301624|5566717|P2|STARTED|Open-label Maintenance Phase||61
2268076|NCT02301624|5566718|P1|STARTED|Open-label Maintenance Phase||55
2268077|NCT02301624|5566717|P2|NOT COMPLETED|Blind Induction Phase||0
2268078|NCT02301624|5566718|P1|NOT COMPLETED|Blind Induction Phase||1
2268079|NCT02301624|5566717|P2|COMPLETED|Blind Induction Phase||61
2268080|NCT02301624|5566718|P1|COMPLETED|Blind Induction Phase||55
2268081|NCT02301624|5566717|P2|Received at Least 1 Dose of Study Drug|Blind Induction Phase||61
2268082|NCT02301624|5566718|P1|Received at Least 1 Dose of Study Drug|Blind Induction Phase||56
2268083|NCT02301624|5566717|P2|STARTED|Blind Induction Phase||61
2268084|NCT02301624|5566718|P1|STARTED|Blind Induction Phase||56
2268085|NCT02301429|5566727|P1|NOT COMPLETED|Overall Study||3
2268086|NCT02301429|5566727|P1|COMPLETED|Overall Study||13
2268087|NCT02301429|5566727|P1|STARTED|Overall Study||16
2268088|NCT02301416|5566733|P2|NOT COMPLETED|Overall Study||0
2268089|NCT02301416|5566734|P1|NOT COMPLETED|Overall Study||10
2268090|NCT02301416|5566733|P2|COMPLETED|Overall Study||40
2268091|NCT02301416|5566734|P1|COMPLETED|Overall Study||15
2268092|NCT02301416|5566733|P2|STARTED|Overall Study||40
2268093|NCT02301416|5566734|P1|STARTED|Overall Study||25
2268094|NCT02301403|5566773|P2|NOT COMPLETED|Overall Study||41
2268095|NCT02301403|5566774|P1|NOT COMPLETED|Overall Study||28
2268096|NCT02301403|5566773|P2|COMPLETED|Overall Study||267
2268097|NCT02301403|5566774|P1|COMPLETED|Overall Study||287
2268098|NCT02301403|5566773|P2|STARTED|Overall Study||308
2268099|NCT02301403|5566774|P1|STARTED|Overall Study||315
2268100|NCT02301390|5566782|P2|NOT COMPLETED|Overall Study||13
2268101|NCT02301390|5566783|P1|NOT COMPLETED|Overall Study||10
2268102|NCT02301390|5566782|P2|COMPLETED|Overall Study||13
2268103|NCT02301390|5566783|P1|COMPLETED|Overall Study||17
2268104|NCT02301390|5566782|P2|STARTED|Overall Study||26
2268105|NCT02301390|5566783|P1|STARTED|Overall Study||27
2268106|NCT02301377|5566797|P2|NOT COMPLETED|Overall Study||0
2268107|NCT02301377|5566798|P1|NOT COMPLETED|Overall Study||0
2268108|NCT02301377|5566797|P2|COMPLETED|Overall Study||2
2268109|NCT02301377|5566798|P1|COMPLETED|Overall Study||3
2268110|NCT02301377|5566797|P2|STARTED|Overall Study||2
2268111|NCT02301377|5566798|P1|STARTED|Overall Study||3
2268112|NCT02301364|5566808|P1|NOT COMPLETED|Overall Study||0
2268113|NCT02301364|5566808|P1|COMPLETED|Overall Study||4
2268114|NCT02301364|5566808|P1|STARTED|Overall Study||4
2268115|NCT02301299|5566815|P1|NOT COMPLETED|Overall Study||0
2268116|NCT02301299|5566815|P1|COMPLETED|Overall Study||1322
2268117|NCT02301299|5566815|P1|STARTED|Overall Study||1322
2268118|NCT02301169|5566824|P2|NOT COMPLETED|Overall Study||0
2268119|NCT02301169|5566825|P1|NOT COMPLETED|Overall Study||1
2268120|NCT02301169|5566824|P2|COMPLETED|Overall Study||21
2268121|NCT02301169|5566825|P1|COMPLETED|Overall Study||20
2268122|NCT02301169|5566824|P2|STARTED|Overall Study||21
2268123|NCT02301169|5566825|P1|STARTED|Overall Study||21
2268124|NCT02301143|5566839|P2|NOT COMPLETED|Investigator's Choice||10
2268125|NCT02301143|5566840|P1|NOT COMPLETED|Investigator's Choice||0
2268126|NCT02301143|5566839|P2|COMPLETED|Investigator's Choice|3 participants completed nab-Paclitaxel+Gemcitabine,18 completed chemoradiation,16 had surgery.|37
2268127|NCT02301143|5566840|P1|COMPLETED|Investigator's Choice||0
2268128|NCT02301143|5566839|P2|STARTED|Investigator's Choice|12 participants continued nab-Paclitaxel/Gemcitabine; 18 started chemoradiation;17 underwent surgery|47
2268129|NCT02301143|5566840|P1|STARTED|Investigator's Choice||0
2268130|NCT02301143|5566839|P2|NOT COMPLETED|Induction Period||0
2268131|NCT02301143|5566840|P1|NOT COMPLETED|Induction Period||45
2268132|NCT02301143|5566839|P2|COMPLETED|Induction Period||0
2268133|NCT02301143|5566840|P1|COMPLETED|Induction Period||62
2268134|NCT02301143|5566839|P2|STARTED|Induction Period||0
2268135|NCT02301143|5566840|P1|STARTED|Induction Period||107
2268136|NCT02300727|5566862|P6|NOT COMPLETED|Overall Study||0
2268137|NCT02300727|5566863|P5|NOT COMPLETED|Overall Study||0
2268138|NCT02300727|5566864|P4|NOT COMPLETED|Overall Study||1
2268139|NCT02300727|5566865|P3|NOT COMPLETED|Overall Study||0
2268140|NCT02300727|5566866|P2|NOT COMPLETED|Overall Study||0
2268141|NCT02300727|5566867|P1|NOT COMPLETED|Overall Study||0
2268142|NCT02300727|5566862|P6|COMPLETED|Overall Study||0
2268143|NCT02300727|5566863|P5|COMPLETED|Overall Study||0
2268144|NCT02300727|5566864|P4|COMPLETED|Overall Study||2
2268145|NCT02300727|5566865|P3|COMPLETED|Overall Study||3
2268146|NCT02300727|5566866|P2|COMPLETED|Overall Study||0
2268147|NCT02300727|5566867|P1|COMPLETED|Overall Study||0
2268148|NCT02300727|5566862|P6|STARTED|Overall Study||0
2268149|NCT02300727|5566863|P5|STARTED|Overall Study||0
2268150|NCT02300727|5566864|P4|STARTED|Overall Study||3
2268151|NCT02300727|5566865|P3|STARTED|Overall Study||3
2268152|NCT02300727|5566866|P2|STARTED|Overall Study||0
2268153|NCT02300727|5566867|P1|STARTED|Overall Study||0
2268154|NCT02300610|5566884|P3|NOT COMPLETED|Overall Study||1
2268155|NCT02300610|5566885|P2|NOT COMPLETED|Overall Study||0
2268156|NCT02300610|5566886|P1|NOT COMPLETED|Overall Study||1
2268157|NCT02300610|5566884|P3|COMPLETED|Overall Study||3
2268158|NCT02300610|5566885|P2|COMPLETED|Overall Study||3
2268159|NCT02300610|5566886|P1|COMPLETED|Overall Study||2
2268160|NCT02300610|5566884|P3|STARTED|Overall Study||4
2268161|NCT02300610|5566885|P2|STARTED|Overall Study||3
2268162|NCT02300610|5566886|P1|STARTED|Overall Study||3
2268163|NCT02300558|5566901|P1|NOT COMPLETED|Open-Label (OL) Extension Phase||32
2268164|NCT02300558|5566901|P1|COMPLETED|Open-Label (OL) Extension Phase||0
2268165|NCT02300558|5566901|P1|STARTED|Open-Label (OL) Extension Phase||32
2268166|NCT02300558|5566901|P1|NOT COMPLETED|Single Blind Phase (24 Weeks)||6
2268167|NCT02300558|5566901|P1|COMPLETED|Single Blind Phase (24 Weeks)||35
2268168|NCT02300558|5566901|P1|STARTED|Single Blind Phase (24 Weeks)||41
2268169|NCT02300311|5566914|P2|NOT COMPLETED|Overall Study||0
2268170|NCT02300311|5566915|P1|NOT COMPLETED|Overall Study||19
2268171|NCT02300311|5566914|P2|COMPLETED|Overall Study||69
2268172|NCT02300311|5566915|P1|COMPLETED|Overall Study||50
2268173|NCT02300311|5566914|P2|STARTED|Overall Study||69
2268174|NCT02300311|5566915|P1|STARTED|Overall Study||69
2268175|NCT02300298|5566927|P2|NOT COMPLETED|Disposition for Docetaxel||10
2268176|NCT02300298|5566928|P1|NOT COMPLETED|Disposition for Docetaxel||0
2268177|NCT02300298|5566927|P2|COMPLETED|Disposition for Docetaxel||0
2268178|NCT02300298|5566928|P1|COMPLETED|Disposition for Docetaxel||0
2268179|NCT02300298|5566927|P2|STARTED|Disposition for Docetaxel||10
2268180|NCT02300298|5566928|P1|STARTED|Disposition for Docetaxel||0
2268181|NCT02300298|5566927|P2|NOT COMPLETED|Disposition for Nintedanib||0
2268182|NCT02300298|5566928|P1|NOT COMPLETED|Disposition for Nintedanib||10
2268183|NCT02300298|5566927|P2|COMPLETED|Disposition for Nintedanib||0
2268184|NCT02300298|5566928|P1|COMPLETED|Disposition for Nintedanib||0
2268185|NCT02300298|5566927|P2|STARTED|Disposition for Nintedanib||0
2268186|NCT02300298|5566928|P1|STARTED|Disposition for Nintedanib||10
2268187|NCT02300129|5566938|P4|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
2268188|NCT02300129|5566939|P3|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
2268189|NCT02300129|5566940|P2|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
2268190|NCT02300129|5566941|P1|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
2268191|NCT02300129|5566938|P4|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
2268192|NCT02300129|5566939|P3|COMPLETED|Period 2 Treatment 2 (2 Weeks)||7
2268193|NCT02300129|5566940|P2|COMPLETED|Period 2 Treatment 2 (2 Weeks)||4
2268194|NCT02300129|5566941|P1|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
2268195|NCT02300129|5566938|P4|STARTED|Period 2 Treatment 2 (2 Weeks)||10
2268196|NCT02300129|5566939|P3|STARTED|Period 2 Treatment 2 (2 Weeks)||7
2268197|NCT02300129|5566940|P2|STARTED|Period 2 Treatment 2 (2 Weeks)||4
2268198|NCT02300129|5566941|P1|STARTED|Period 2 Treatment 2 (2 Weeks)||10
2268199|NCT02300129|5566938|P4|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
2268200|NCT02300129|5566939|P3|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
2268201|NCT02300129|5566940|P2|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
2268202|NCT02300129|5566941|P1|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
2268203|NCT02300129|5566938|P4|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
2268204|NCT02300129|5566939|P3|COMPLETED|Period 2 Treatment 1 (2 Weeks)||7
2268205|NCT02300129|5566940|P2|COMPLETED|Period 2 Treatment 1 (2 Weeks)||4
2268206|NCT02300129|5566941|P1|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
2268207|NCT02300129|5566938|P4|STARTED|Period 2 Treatment 1 (2 Weeks)|Withdrawal consent of 1 subject between the Period 1 and Period 2|11
2268208|NCT02300129|5566939|P3|STARTED|Period 2 Treatment 1 (2 Weeks)||7
2268209|NCT02300129|5566940|P2|STARTED|Period 2 Treatment 1 (2 Weeks)||4
2268210|NCT02300129|5566941|P1|STARTED|Period 2 Treatment 1 (2 Weeks)||11
2268211|NCT02300129|5566938|P4|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
2268212|NCT02300129|5566939|P3|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
2268213|NCT02300129|5566940|P2|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
2268214|NCT02300129|5566941|P1|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
2268215|NCT02300129|5566938|P4|COMPLETED|Period 1 Session 3 (Day 5)||11
2268216|NCT02300129|5566939|P3|COMPLETED|Period 1 Session 3 (Day 5)||7
2268217|NCT02300129|5566940|P2|COMPLETED|Period 1 Session 3 (Day 5)||4
2268218|NCT02300129|5566941|P1|COMPLETED|Period 1 Session 3 (Day 5)||11
2268219|NCT02300129|5566938|P4|STARTED|Period 1 Session 3 (Day 5)||11
2268220|NCT02300129|5566939|P3|STARTED|Period 1 Session 3 (Day 5)||7
2268221|NCT02300129|5566940|P2|STARTED|Period 1 Session 3 (Day 5)||4
2268222|NCT02300129|5566941|P1|STARTED|Period 1 Session 3 (Day 5)||11
2268223|NCT02300129|5566938|P4|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
2268224|NCT02300129|5566939|P3|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
2268225|NCT02300129|5566940|P2|NOT COMPLETED|Period 1 Session 2 (Day 3)||1
2268226|NCT02300129|5566941|P1|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
2268227|NCT02300129|5566938|P4|COMPLETED|Period 1 Session 2 (Day 3)||11
2268228|NCT02300129|5566939|P3|COMPLETED|Period 1 Session 2 (Day 3)||7
2268229|NCT02300129|5566940|P2|COMPLETED|Period 1 Session 2 (Day 3)||4
2268230|NCT02300129|5566941|P1|COMPLETED|Period 1 Session 2 (Day 3)||11
2268231|NCT02300129|5566938|P4|STARTED|Period 1 Session 2 (Day 3)||11
2268232|NCT02300129|5566939|P3|STARTED|Period 1 Session 2 (Day 3)||7
2268233|NCT02300129|5566940|P2|STARTED|Period 1 Session 2 (Day 3)|Withdrawal consent of 1 subject between Day 1 and Day 3|5
2268234|NCT02300129|5566941|P1|STARTED|Period 1 Session 2 (Day 3)||11
2268235|NCT02300129|5566938|P4|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
2268236|NCT02300129|5566939|P3|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
2268237|NCT02300129|5566940|P2|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
2268238|NCT02300129|5566941|P1|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
2268239|NCT02300129|5566938|P4|COMPLETED|Period 1 Session 1 (Day 1)||11
2268240|NCT02300129|5566939|P3|COMPLETED|Period 1 Session 1 (Day 1)||7
2268241|NCT02300129|5566940|P2|COMPLETED|Period 1 Session 1 (Day 1)||5
2268242|NCT02300129|5566941|P1|COMPLETED|Period 1 Session 1 (Day 1)||11
2268243|NCT02300129|5566938|P4|STARTED|Period 1 Session 1 (Day 1)||11
2268244|NCT02300129|5566939|P3|STARTED|Period 1 Session 1 (Day 1)||7
2268245|NCT02300129|5566940|P2|STARTED|Period 1 Session 1 (Day 1)||5
2268246|NCT02300129|5566941|P1|STARTED|Period 1 Session 1 (Day 1)||11
2268247|NCT02300103|5566951|P1|NOT COMPLETED|Overall Study||6
2268248|NCT02300103|5566951|P1|COMPLETED|Overall Study||63
2268249|NCT02300103|5566951|P1|STARTED|Overall Study||69
2268250|NCT02300077|5566963|P3|NOT COMPLETED|Overall Study||0
2268251|NCT02300077|5566964|P2|NOT COMPLETED|Overall Study||0
2268252|NCT02300077|5566965|P1|NOT COMPLETED|Overall Study||0
2268253|NCT02300077|5566963|P3|COMPLETED|Overall Study||21
2268254|NCT02300077|5566964|P2|COMPLETED|Overall Study||18
2268255|NCT02300077|5566965|P1|COMPLETED|Overall Study||21
2268256|NCT02300077|5566963|P3|STARTED|Overall Study||21
2268257|NCT02300077|5566964|P2|STARTED|Overall Study||18
2268258|NCT02300077|5566965|P1|STARTED|Overall Study||21
2268259|NCT02300025|5566986|P4|NOT COMPLETED|Overall Study||0
2268260|NCT02300025|5566987|P3|NOT COMPLETED|Overall Study||0
2268261|NCT02300025|5566988|P2|NOT COMPLETED|Overall Study||0
2268262|NCT02300025|5566989|P1|NOT COMPLETED|Overall Study||0
2268263|NCT02300025|5566986|P4|COMPLETED|Overall Study||6
2268264|NCT02300025|5566987|P3|COMPLETED|Overall Study||6
2268265|NCT02300025|5566988|P2|COMPLETED|Overall Study||6
2268266|NCT02300025|5566989|P1|COMPLETED|Overall Study||10
2268267|NCT02300025|5566986|P4|STARTED|Overall Study||6
2268268|NCT02300025|5566987|P3|STARTED|Overall Study||6
2268269|NCT02300025|5566988|P2|STARTED|Overall Study||6
2268270|NCT02300025|5566989|P1|STARTED|Overall Study||10
2268271|NCT02299934|5567031|P1|NOT COMPLETED|Overall Study||13
2268272|NCT02299934|5567031|P1|COMPLETED|Overall Study||0
2268273|NCT02299934|5567031|P1|STARTED|Overall Study||13
2268274|NCT02299869|5567046|P4|NOT COMPLETED|Overall Study||0
2268275|NCT02299869|5567047|P3|NOT COMPLETED|Overall Study||0
2268276|NCT02299869|5567048|P2|NOT COMPLETED|Overall Study||0
2268277|NCT02299869|5567049|P1|NOT COMPLETED|Overall Study||0
2268278|NCT02299869|5567046|P4|COMPLETED|Overall Study||10
2268279|NCT02299869|5567047|P3|COMPLETED|Overall Study||10
2268280|NCT02299869|5567048|P2|COMPLETED|Overall Study||10
2268281|NCT02299869|5567049|P1|COMPLETED|Overall Study||10
2268282|NCT02299869|5567046|P4|STARTED|Overall Study||10
2268283|NCT02299869|5567047|P3|STARTED|Overall Study||10
2268284|NCT02299869|5567048|P2|STARTED|Overall Study||10
2268285|NCT02299869|5567049|P1|STARTED|Overall Study||10
2268286|NCT02299791|5567074|P2|NOT COMPLETED|Overall Study||0
2268287|NCT02299791|5567075|P1|NOT COMPLETED|Overall Study||0
2268288|NCT02299791|5567074|P2|COMPLETED|Overall Study||2803
2268289|NCT02299791|5567075|P1|COMPLETED|Overall Study||2053
2268290|NCT02299791|5567074|P2|STARTED|Overall Study||2803
2268291|NCT02299791|5567075|P1|STARTED|Overall Study||2053
2268292|NCT02299635|5567081|P1|NOT COMPLETED|Overall Study||19
2268293|NCT02299635|5567081|P1|COMPLETED|Overall Study||0
2268294|NCT02299635|5567081|P1|STARTED|Overall Study||19
2268295|NCT02299570|5567103|P3|NOT COMPLETED|Overall Study||2
2268296|NCT02299570|5567104|P2|NOT COMPLETED|Overall Study||0
2268297|NCT02299570|5567105|P1|NOT COMPLETED|Overall Study||4
2268298|NCT02299570|5567103|P3|COMPLETED|Overall Study||42
2268299|NCT02299570|5567104|P2|COMPLETED|Overall Study||44
2268300|NCT02299570|5567105|P1|COMPLETED|Overall Study||41
2268301|NCT02299570|5567103|P3|STARTED|Overall Study||44
2268302|NCT02299570|5567104|P2|STARTED|Overall Study||44
2268303|NCT02299570|5567105|P1|STARTED|Overall Study||45
2268304|NCT02299479|5567113|P1|NOT COMPLETED|Overall Study||2
2268305|NCT02299479|5567113|P1|COMPLETED|Overall Study||18
2268306|NCT02299479|5567113|P1|STARTED|Overall Study||20
2268307|NCT02299427|5567121|P2|NOT COMPLETED|Overall Study||3
2268308|NCT02299427|5567122|P1|NOT COMPLETED|Overall Study||23
2268309|NCT02299427|5567121|P2|COMPLETED|Overall Study||31
2268310|NCT02299427|5567122|P1|COMPLETED|Overall Study||12
2268311|NCT02299427|5567121|P2|STARTED|Overall Study||34
2268312|NCT02299427|5567122|P1|STARTED|Overall Study||35
2268313|NCT02299388|5567132|P2|NOT COMPLETED|Overall Study||1
2268314|NCT02299388|5567133|P1|NOT COMPLETED|Overall Study||0
2268315|NCT02299388|5567132|P2|COMPLETED|Overall Study||4
2268316|NCT02299388|5567133|P1|COMPLETED|Overall Study||6
2268317|NCT02299388|5567132|P2|STARTED|Overall Study||5
2268318|NCT02299388|5567133|P1|STARTED|Overall Study||6
2268319|NCT02299375|5567143|P2|NOT COMPLETED|Overall Study||80
2268320|NCT02299375|5567144|P1|NOT COMPLETED|Overall Study||80
2268321|NCT02299375|5567143|P2|COMPLETED|Overall Study||10
2268322|NCT02299375|5567144|P1|COMPLETED|Overall Study||14
2268323|NCT02299375|5567143|P2|STARTED|Overall Study||90
2268324|NCT02299375|5567144|P1|STARTED|Overall Study||94
2268325|NCT02299349|5567194|P2|NOT COMPLETED|Overall Study||0
2268326|NCT02299349|5567195|P1|NOT COMPLETED|Overall Study||0
2268327|NCT02299349|5567194|P2|COMPLETED|Overall Study||35
2268328|NCT02299349|5567195|P1|COMPLETED|Overall Study||35
2268329|NCT02299349|5567194|P2|STARTED|Overall Study||35
2268330|NCT02299349|5567195|P1|STARTED|Overall Study||35
2268331|NCT02299336|5567203|P1|NOT COMPLETED|Overall Study||14
2268332|NCT02299336|5567203|P1|COMPLETED|Overall Study||46
2268333|NCT02299336|5567203|P1|STARTED|Overall Study||60
2268334|NCT02299297|5567219|P1|NOT COMPLETED|Overall Study||1
2268335|NCT02299297|5567219|P1|COMPLETED|Overall Study||11
2268336|NCT02299297|5567219|P1|STARTED|Overall Study||12
2268337|NCT02299258|5567229|P2|NOT COMPLETED|Overall Study||1
2268338|NCT02299258|5567230|P1|NOT COMPLETED|Overall Study||1
2268339|NCT02299258|5567229|P2|COMPLETED|Overall Study||30
2268340|NCT02299258|5567230|P1|COMPLETED|Overall Study||31
2268341|NCT02299258|5567229|P2|STARTED|Overall Study||31
2268342|NCT02299258|5567230|P1|STARTED|Overall Study||32
2268343|NCT02299206|5567238|P1|NOT COMPLETED|Overall Study||2
2268344|NCT02299206|5567238|P1|COMPLETED|Overall Study||2
2268345|NCT02299206|5567238|P1|STARTED|Overall Study||4
2268346|NCT02299089|5567250|P4|NOT COMPLETED|Overall Study||0
2268347|NCT02299089|5567251|P3|NOT COMPLETED|Overall Study||0
2268348|NCT02299089|5567252|P2|NOT COMPLETED|Overall Study||0
2268349|NCT02299089|5567253|P1|NOT COMPLETED|Overall Study||0
2268350|NCT02299089|5567250|P4|COMPLETED|Overall Study||4
2268351|NCT02299089|5567251|P3|COMPLETED|Overall Study||1
2268352|NCT02299089|5567252|P2|COMPLETED|Overall Study||4
2268353|NCT02299089|5567253|P1|COMPLETED|Overall Study||3
2268354|NCT02299089|5567250|P4|STARTED|Overall Study||4
2268355|NCT02299089|5567251|P3|STARTED|Overall Study||1
2268356|NCT02299089|5567252|P2|STARTED|Overall Study||4
2268357|NCT02299089|5567253|P1|STARTED|Overall Study||3
2268358|NCT02299076|5567299|P2|NOT COMPLETED|Overall Study||14
2268359|NCT02299076|5567300|P1|NOT COMPLETED|Overall Study||20
2268360|NCT02299076|5567299|P2|COMPLETED|Overall Study||212
2268361|NCT02299076|5567300|P1|COMPLETED|Overall Study||210
2268362|NCT02299076|5567299|P2|STARTED|Overall Study||226
2268363|NCT02299076|5567300|P1|STARTED|Overall Study||230
2268364|NCT02299050|5567308|P1|NOT COMPLETED|Overall Study||8
2268365|NCT02299050|5567308|P1|COMPLETED|Overall Study||15
2268366|NCT02299050|5567308|P1|STARTED|Overall Study||23
2268367|NCT02298946|5567321|P2|NOT COMPLETED|Overall Study||1
2268368|NCT02298946|5567322|P1|NOT COMPLETED|Overall Study||4
2268369|NCT02298946|5567321|P2|COMPLETED|Overall Study||8
2268370|NCT02298946|5567322|P1|COMPLETED|Overall Study||4
2268371|NCT02298946|5567321|P2|STARTED|Overall Study||9
2268372|NCT02298946|5567322|P1|STARTED|Overall Study||8
2268373|NCT02298933|5567346|P1|NOT COMPLETED|Overall Study||0
2268374|NCT02298933|5567346|P1|COMPLETED|Overall Study||10
2268375|NCT02298933|5567346|P1|STARTED|Overall Study||10
2268376|NCT02298868|5567350|P1|NOT COMPLETED|Overall Study||3
2268377|NCT02298868|5567350|P1|COMPLETED|Overall Study||7
2268378|NCT02298868|5567350|P1|STARTED|Overall Study||10
2268379|NCT02298842|5567364|P2|NOT COMPLETED|Second Platelet Donation (Day 6-8)||6
2268380|NCT02298842|5567365|P1|NOT COMPLETED|Second Platelet Donation (Day 6-8)||8
2268381|NCT02298842|5567364|P2|COMPLETED|Second Platelet Donation (Day 6-8)||30
2268382|NCT02298842|5567365|P1|COMPLETED|Second Platelet Donation (Day 6-8)||30
2268383|NCT02298842|5567364|P2|STARTED|Second Platelet Donation (Day 6-8)||36
2268384|NCT02298842|5567365|P1|STARTED|Second Platelet Donation (Day 6-8)||38
2268385|NCT02298842|5567364|P2|NOT COMPLETED|First Platelet Donation (Day 0)||5
2268386|NCT02298842|5567365|P1|NOT COMPLETED|First Platelet Donation (Day 0)||6
2268387|NCT02298842|5567364|P2|COMPLETED|First Platelet Donation (Day 0)||36
2268388|NCT02298842|5567365|P1|COMPLETED|First Platelet Donation (Day 0)||38
2268389|NCT02298842|5567364|P2|STARTED|First Platelet Donation (Day 0)||41
2268390|NCT02298842|5567365|P1|STARTED|First Platelet Donation (Day 0)||44
2268391|NCT02298803|5567391|P1|NOT COMPLETED|Overall Study||0
2268392|NCT02298803|5567391|P1|COMPLETED|Overall Study||30
2268393|NCT02298803|5567391|P1|STARTED|Overall Study||30
2268394|NCT02298361|5567403|P3|NOT COMPLETED|Overall Study||0
2268395|NCT02298361|5567404|P2|NOT COMPLETED|Overall Study||0
2268396|NCT02298361|5567405|P1|NOT COMPLETED|Overall Study||0
2268397|NCT02298361|5567403|P3|COMPLETED|Overall Study||12227
2268398|NCT02298361|5567404|P2|COMPLETED|Overall Study||12784
2268399|NCT02298361|5567405|P1|COMPLETED|Overall Study||2240
2268400|NCT02298361|5567403|P3|STARTED|Overall Study||12227
2268401|NCT02298361|5567404|P2|STARTED|Overall Study||12784
2268402|NCT02298361|5567405|P1|STARTED|Overall Study||2240
2268403|NCT02298192|5567421|P2|NOT COMPLETED|Overall Study||6
2268404|NCT02298192|5567422|P1|NOT COMPLETED|Overall Study||19
2268405|NCT02298192|5567421|P2|COMPLETED|Overall Study||204
2268406|NCT02298192|5567422|P1|COMPLETED|Overall Study||191
2268407|NCT02298192|5567421|P2|STARTED|Overall Study||210
2268408|NCT02298192|5567422|P1|STARTED|Overall Study||210
2268409|NCT02298179|5567446|P12|NOT COMPLETED|Overall Study||0
2268410|NCT02298179|5567447|P11|NOT COMPLETED|Overall Study||0
2268411|NCT02298179|5567448|P10|NOT COMPLETED|Overall Study||0
2268412|NCT02298179|5567449|P9|NOT COMPLETED|Overall Study||0
2268413|NCT02298179|5567450|P8|NOT COMPLETED|Overall Study||1
2268414|NCT02298179|5567451|P7|NOT COMPLETED|Overall Study||0
2268415|NCT02298179|5567452|P6|NOT COMPLETED|Overall Study||0
2268416|NCT02298179|5567453|P5|NOT COMPLETED|Overall Study||0
2268417|NCT02298179|5567454|P4|NOT COMPLETED|Overall Study||0
2268418|NCT02298179|5567455|P3|NOT COMPLETED|Overall Study||1
2268419|NCT02298179|5567456|P2|NOT COMPLETED|Overall Study||0
2268420|NCT02298179|5567457|P1|NOT COMPLETED|Overall Study||0
2268421|NCT02298179|5567446|P12|COMPLETED|Overall Study||24
2268422|NCT02298179|5567447|P11|COMPLETED|Overall Study||24
2268423|NCT02298179|5567448|P10|COMPLETED|Overall Study||24
2268424|NCT02298179|5567449|P9|COMPLETED|Overall Study||24
2268425|NCT02298179|5567450|P8|COMPLETED|Overall Study||23
2268426|NCT02298179|5567451|P7|COMPLETED|Overall Study||24
2268427|NCT02298179|5567452|P6|COMPLETED|Overall Study||24
2268428|NCT02298179|5567453|P5|COMPLETED|Overall Study||24
2268429|NCT02298179|5567454|P4|COMPLETED|Overall Study||24
2268430|NCT02298179|5567455|P3|COMPLETED|Overall Study||23
2268431|NCT02298179|5567456|P2|COMPLETED|Overall Study||24
2268432|NCT02298179|5567457|P1|COMPLETED|Overall Study||24
2268433|NCT02298179|5567446|P12|STARTED|Overall Study||24
2268434|NCT02298179|5567447|P11|STARTED|Overall Study||24
2268435|NCT02298179|5567448|P10|STARTED|Overall Study||24
2268436|NCT02298179|5567449|P9|STARTED|Overall Study||24
2268437|NCT02298179|5567450|P8|STARTED|Overall Study||24
2268438|NCT02298179|5567451|P7|STARTED|Overall Study||24
2268439|NCT02298179|5567452|P6|STARTED|Overall Study||24
2268440|NCT02298179|5567453|P5|STARTED|Overall Study||24
2268441|NCT02298179|5567454|P4|STARTED|Overall Study||24
2268442|NCT02298179|5567455|P3|STARTED|Overall Study||24
2268443|NCT02298179|5567456|P2|STARTED|Overall Study||24
2268444|NCT02298179|5567457|P1|STARTED|Overall Study||24
2268445|NCT02297841|5567699|P1|NOT COMPLETED|Overall Study||8
2268446|NCT02297841|5567699|P1|COMPLETED|Overall Study||201
2268447|NCT02297841|5567699|P1|Challenge Phase|Overall Study||201
2268448|NCT02297841|5567699|P1|Induction Phase|Overall Study||209
2268449|NCT02297841|5567699|P1|STARTED|Overall Study||209
2268450|NCT02297815|5567705|P2|NOT COMPLETED|Overall Study||140
2268451|NCT02297815|5567706|P1|NOT COMPLETED|Overall Study||236
2268452|NCT02297815|5567705|P2|COMPLETED|Overall Study||728
2268453|NCT02297815|5567706|P1|COMPLETED|Overall Study||1368
2268454|NCT02297815|5567705|P2|14-20 Day Interview|Overall Study||728
2268455|NCT02297815|5567706|P1|14-20 Day Interview|Overall Study||1368
2268456|NCT02297815|5567705|P2|5-10 Day Interview|Overall Study||868
2268457|NCT02297815|5567706|P1|5-10 Day Interview|Overall Study||1604
2268458|NCT02297815|5567705|P2|STARTED|Overall Study||868
2268459|NCT02297815|5567706|P1|STARTED|Overall Study||1604
2268460|NCT02297516|5567724|P2|NOT COMPLETED|Combination Treatment Phase (up to 18 m)||1
2268461|NCT02297516|5567725|P1|NOT COMPLETED|Combination Treatment Phase (up to 18 m)||0
2268462|NCT02297516|5567724|P2|COMPLETED|Combination Treatment Phase (up to 18 m)||30
2268463|NCT02297516|5567725|P1|COMPLETED|Combination Treatment Phase (up to 18 m)||31
2268464|NCT02297516|5567724|P2|STARTED|Combination Treatment Phase (up to 18 m)||31
2268465|NCT02297516|5567725|P1|STARTED|Combination Treatment Phase (up to 18 m)||31
2268466|NCT02297516|5567724|P2|NOT COMPLETED|Single Treatment Phase (6 Months)||2
2268467|NCT02297516|5567725|P1|NOT COMPLETED|Single Treatment Phase (6 Months)||1
2268468|NCT02297516|5567724|P2|COMPLETED|Single Treatment Phase (6 Months)||31
2268469|NCT02297516|5567725|P1|COMPLETED|Single Treatment Phase (6 Months)||31
2268470|NCT02297516|5567724|P2|STARTED|Single Treatment Phase (6 Months)||33
2268471|NCT02297516|5567725|P1|STARTED|Single Treatment Phase (6 Months)||32
2268472|NCT02297503|5567746|P2|NOT COMPLETED|Overall Study||4
2268473|NCT02297503|5567747|P1|NOT COMPLETED|Overall Study||2
2268474|NCT02297503|5567746|P2|COMPLETED|Overall Study||27
2268475|NCT02297503|5567747|P1|COMPLETED|Overall Study||28
2268476|NCT02297503|5567746|P2|Second Combined Treatment|Overall Study||28
2268477|NCT02297503|5567747|P1|Second Combined Treatment|Overall Study||28
2268478|NCT02297503|5567746|P2|First Combined Treatment|Overall Study||28
2268479|NCT02297503|5567747|P1|First Combined Treatment|Overall Study||28
2268480|NCT02297503|5567746|P2|Initial Single Treatment|Overall Study||31
2268481|NCT02297503|5567747|P1|Initial Single Treatment|Overall Study||29
2268482|NCT02297503|5567746|P2|STARTED|Overall Study||31
2268483|NCT02297503|5567747|P1|STARTED|Overall Study||30
2268484|NCT02297412|5567774|P2|NOT COMPLETED|Overall Study||1
2268485|NCT02297412|5567775|P1|NOT COMPLETED|Overall Study||1
2268486|NCT02297412|5567774|P2|COMPLETED|Overall Study||23
2268487|NCT02297412|5567775|P1|COMPLETED|Overall Study||22
2268488|NCT02297412|5567774|P2|STARTED|Overall Study||24
2268489|NCT02297412|5567775|P1|STARTED|Overall Study||23
2268490|NCT02297308|5567785|P1|NOT COMPLETED|Overall Study||0
2268491|NCT02297308|5567785|P1|COMPLETED|Overall Study||90
2268492|NCT02297308|5567785|P1|STARTED|Overall Study||90
2268493|NCT02297230|5567794|P4|NOT COMPLETED|Overall Study||0
2268494|NCT02297230|5567795|P3|NOT COMPLETED|Overall Study||0
2268495|NCT02297230|5567796|P2|NOT COMPLETED|Overall Study||0
2268496|NCT02297230|5567797|P1|NOT COMPLETED|Overall Study||0
2268497|NCT02297230|5567794|P4|COMPLETED|Overall Study||11
2268498|NCT02297230|5567795|P3|COMPLETED|Overall Study||11
2268499|NCT02297230|5567796|P2|COMPLETED|Overall Study||11
2268500|NCT02297230|5567797|P1|COMPLETED|Overall Study||11
2268501|NCT02297230|5567794|P4|STARTED|Overall Study||11
2268502|NCT02297230|5567795|P3|STARTED|Overall Study||11
2268503|NCT02297230|5567796|P2|STARTED|Overall Study||11
2268504|NCT02297230|5567797|P1|STARTED|Overall Study||11
2268505|NCT02297100|5567821|P2|NOT COMPLETED|Overall Study||0
2268506|NCT02297100|5567822|P1|NOT COMPLETED|Overall Study||0
2268507|NCT02297100|5567821|P2|COMPLETED|Overall Study||14
2268508|NCT02297100|5567822|P1|COMPLETED|Overall Study||13
2268509|NCT02297100|5567821|P2|STARTED|Overall Study||14
2268510|NCT02297100|5567822|P1|STARTED|Overall Study||13
2268511|NCT02296931|5567836|P2|NOT COMPLETED|Overall Study||2
2268512|NCT02296931|5567837|P1|NOT COMPLETED|Overall Study||0
2268513|NCT02296931|5567836|P2|COMPLETED|Overall Study||22
2268514|NCT02296931|5567837|P1|COMPLETED|Overall Study||10
2268515|NCT02296931|5567836|P2|STARTED|Overall Study||24
2268516|NCT02296931|5567837|P1|STARTED|Overall Study||10
2268517|NCT02296892|5567846|P3|NOT COMPLETED|Overall Study||5
2268518|NCT02296892|5567847|P2|NOT COMPLETED|Overall Study||4
2268519|NCT02296892|5567848|P1|NOT COMPLETED|Overall Study||12
2268520|NCT02296892|5567846|P3|COMPLETED|Overall Study||68
2268521|NCT02296892|5567847|P2|COMPLETED|Overall Study||59
2268522|NCT02296892|5567848|P1|COMPLETED|Overall Study||298
2268523|NCT02296892|5567846|P3|Complete Trial Treatment Period|Overall Study||69
2268524|NCT02296892|5567847|P2|Complete Trial Treatment Period|Overall Study||59
2268525|NCT02296892|5567848|P1|Complete Trial Treatment Period|Overall Study||303
2268526|NCT02296892|5567846|P3|Safety Population|Overall Study||69
2268527|NCT02296892|5567847|P2|Safety Population|Overall Study||59
2268528|NCT02296892|5567848|P1|Safety Population|Overall Study||303
2268529|NCT02296892|5567846|P3|STARTED|Overall Study||73
2268530|NCT02296892|5567847|P2|STARTED|Overall Study||63
2268531|NCT02296892|5567848|P1|STARTED|Overall Study||310
2268532|NCT02296840|5567867|P2|NOT COMPLETED|Overall Study||19
2268533|NCT02296840|5567868|P1|NOT COMPLETED|Overall Study||9
2268534|NCT02296840|5567867|P2|COMPLETED|Overall Study||8
2268535|NCT02296840|5567868|P1|COMPLETED|Overall Study||9
2268536|NCT02296840|5567867|P2|STARTED|Overall Study||27
2268537|NCT02296840|5567868|P1|STARTED|Overall Study||18
2268538|NCT02296775|5567879|P3|NOT COMPLETED|Recovery and Follow-up||4
2268539|NCT02296775|5567880|P2|NOT COMPLETED|Recovery and Follow-up||5
2268540|NCT02296775|5567881|P1|NOT COMPLETED|Recovery and Follow-up||5
2268541|NCT02296775|5567879|P3|COMPLETED|Recovery and Follow-up||79
2268542|NCT02296775|5567880|P2|COMPLETED|Recovery and Follow-up||79
2268543|NCT02296775|5567881|P1|COMPLETED|Recovery and Follow-up||82
2268544|NCT02296775|5567879|P3|STARTED|Recovery and Follow-up||83
2268545|NCT02296775|5567880|P2|STARTED|Recovery and Follow-up||84
2268546|NCT02296775|5567881|P1|STARTED|Recovery and Follow-up||87
2268547|NCT02296775|5567879|P3|NOT COMPLETED|Treatment and Evaluation||10
2268548|NCT02296775|5567880|P2|NOT COMPLETED|Treatment and Evaluation||8
2268549|NCT02296775|5567881|P1|NOT COMPLETED|Treatment and Evaluation||4
2268550|NCT02296775|5567879|P3|COMPLETED|Treatment and Evaluation||83
2268551|NCT02296775|5567880|P2|COMPLETED|Treatment and Evaluation||84
2268552|NCT02296775|5567881|P1|COMPLETED|Treatment and Evaluation||87
2268553|NCT02296775|5567879|P3|STARTED|Treatment and Evaluation||93
2268554|NCT02296775|5567880|P2|STARTED|Treatment and Evaluation||92
2268555|NCT02296775|5567881|P1|STARTED|Treatment and Evaluation||91
2268556|NCT02296606|5567949|P1|NOT COMPLETED|Overall Study||0
2268557|NCT02296606|5567949|P1|COMPLETED|Overall Study||127
2268558|NCT02296606|5567949|P1|STARTED|Overall Study||127
2268559|NCT02296502|5567957|P4|NOT COMPLETED|Overall Study||0
2268560|NCT02296502|5567958|P3|NOT COMPLETED|Overall Study||0
2268561|NCT02296502|5567959|P2|NOT COMPLETED|Overall Study||0
2268562|NCT02296502|5567960|P1|NOT COMPLETED|Overall Study||0
2268563|NCT02296502|5567957|P4|COMPLETED|Overall Study||160
2268564|NCT02296502|5567958|P3|COMPLETED|Overall Study||30
2268565|NCT02296502|5567959|P2|COMPLETED|Overall Study||1
2268566|NCT02296502|5567960|P1|COMPLETED|Overall Study||248
2268567|NCT02296502|5567957|P4|STARTED|Overall Study||160
2268568|NCT02296502|5567958|P3|STARTED|Overall Study||30
2268569|NCT02296502|5567959|P2|STARTED|Overall Study||1
2268570|NCT02296502|5567960|P1|STARTED|Overall Study||248
2268571|NCT02296476|5567976|P3|NOT COMPLETED|Overall Study||2
2268572|NCT02296476|5567977|P2|NOT COMPLETED|Overall Study||4
2268573|NCT02296476|5567978|P1|NOT COMPLETED|Overall Study||6
2268574|NCT02296476|5567976|P3|COMPLETED|Overall Study||0
2268575|NCT02296476|5567977|P2|COMPLETED|Overall Study||0
2268576|NCT02296476|5567978|P1|COMPLETED|Overall Study||0
2268577|NCT02296476|5567976|P3|STARTED|Overall Study||2
2268578|NCT02296476|5567977|P2|STARTED|Overall Study||4
2268579|NCT02296476|5567978|P1|STARTED|Overall Study||6
2268580|NCT02296424|5568033|P4|NOT COMPLETED|Part 2||0
2268581|NCT02296424|5568034|P3|NOT COMPLETED|Part 2||3
2268582|NCT02296424|5568035|P2|NOT COMPLETED|Part 2||0
2268583|NCT02296424|5568036|P1|NOT COMPLETED|Part 2||0
2268584|NCT02296424|5568033|P4|COMPLETED|Part 2||37
2268585|NCT02296424|5568034|P3|COMPLETED|Part 2||35
2268586|NCT02296424|5568035|P2|COMPLETED|Part 2||0
2268587|NCT02296424|5568036|P1|COMPLETED|Part 2||0
2268588|NCT02296424|5568033|P4|STARTED|Part 2||37
2268589|NCT02296424|5568034|P3|STARTED|Part 2||38
2268590|NCT02296424|5568035|P2|STARTED|Part 2||0
2268591|NCT02296424|5568036|P1|STARTED|Part 2||0
2268592|NCT02296424|5568033|P4|NOT COMPLETED|Part 1||0
2268593|NCT02296424|5568034|P3|NOT COMPLETED|Part 1||0
2268594|NCT02296424|5568035|P2|NOT COMPLETED|Part 1||33
2268595|NCT02296424|5568036|P1|NOT COMPLETED|Part 1||23
2268596|NCT02296424|5568033|P4|COMPLETED|Part 1||0
2268597|NCT02296424|5568034|P3|COMPLETED|Part 1||0
2268598|NCT02296424|5568035|P2|COMPLETED|Part 1||65
2268599|NCT02296424|5568036|P1|COMPLETED|Part 1||61
2268600|NCT02296424|5568033|P4|STARTED|Part 1||0
2268601|NCT02296424|5568034|P3|STARTED|Part 1||0
2268602|NCT02296424|5568035|P2|STARTED|Part 1||98
2268603|NCT02296424|5568036|P1|STARTED|Part 1|16 patients immediately went into Part II|84
2268604|NCT02296346|5568049|P2|NOT COMPLETED|Overall Study||6
2268605|NCT02296346|5568050|P1|NOT COMPLETED|Overall Study||5
2268606|NCT02296346|5568049|P2|COMPLETED|Overall Study||0
2268607|NCT02296346|5568050|P1|COMPLETED|Overall Study||2
2268608|NCT02296346|5568049|P2|STARTED|Overall Study||6
2268609|NCT02296346|5568050|P1|STARTED|Overall Study||7
2268610|NCT02296320|5568061|P3|NOT COMPLETED|Overall Study||37
2268611|NCT02296320|5568062|P2|NOT COMPLETED|Overall Study||5
2268612|NCT02296320|5568063|P1|NOT COMPLETED|Overall Study||35
2268613|NCT02296320|5568061|P3|COMPLETED|Overall Study||59
2268614|NCT02296320|5568062|P2|COMPLETED|Overall Study||10
2268615|NCT02296320|5568063|P1|COMPLETED|Overall Study||67
2268616|NCT02296320|5568061|P3|Treated|Overall Study||96
2268617|NCT02296320|5568062|P2|Treated|Overall Study||15
2268618|NCT02296320|5568063|P1|Treated|Overall Study||100
2268619|NCT02296320|5568061|P3|STARTED|Overall Study||96
2268620|NCT02296320|5568062|P2|STARTED|Overall Study||15
2268621|NCT02296320|5568063|P1|STARTED|Overall Study||102
2268622|NCT02296242|5568102|P5|NOT COMPLETED|Overall Study||21
2268623|NCT02296242|5568103|P4|NOT COMPLETED|Overall Study||14
2268624|NCT02296242|5568104|P3|NOT COMPLETED|Overall Study||7
2268625|NCT02296242|5568105|P2|NOT COMPLETED|Overall Study||6
2268626|NCT02296242|5568106|P1|NOT COMPLETED|Overall Study||5
2268627|NCT02296242|5568102|P5|COMPLETED|Overall Study||0
2268628|NCT02296242|5568103|P4|COMPLETED|Overall Study||0
2268629|NCT02296242|5568104|P3|COMPLETED|Overall Study||0
2268630|NCT02296242|5568105|P2|COMPLETED|Overall Study||0
2268631|NCT02296242|5568106|P1|COMPLETED|Overall Study||0
2268632|NCT02296242|5568102|P5|STARTED|Overall Study||21
2268633|NCT02296242|5568103|P4|STARTED|Overall Study||14
2268634|NCT02296242|5568104|P3|STARTED|Overall Study||7
2268635|NCT02296242|5568105|P2|STARTED|Overall Study||6
2268636|NCT02296242|5568106|P1|STARTED|Overall Study||5
2268637|NCT02296164|5568128|P1|NOT COMPLETED|Overall Study||110
2268638|NCT02296164|5568128|P1|COMPLETED|Overall Study||188
2268639|NCT02296164|5568128|P1|STARTED|Overall Study|2 patients not eligible as were not on Valchlor at time of study start|298
2268640|NCT02296138|5568134|P2|NOT COMPLETED|Overall Study||500
2268641|NCT02296138|5568135|P1|NOT COMPLETED|Overall Study||661
2268642|NCT02296138|5568134|P2|COMPLETED|Overall Study||3451
2268643|NCT02296138|5568135|P1|COMPLETED|Overall Study||3291
2268644|NCT02296138|5568134|P2|Treated|Overall Study||3939
2268645|NCT02296138|5568135|P1|Treated|Overall Study||3941
2268646|NCT02296138|5568134|P2|STARTED|Overall Study||3951
2268647|NCT02296138|5568135|P1|STARTED|Overall Study||3952
2268660|NCT02296112|5568206|P1|NOT COMPLETED|Overall Study||9
2268661|NCT02296112|5568206|P1|COMPLETED|Overall Study||0
2268662|NCT02296112|5568206|P1|STARTED|Overall Study||9
2268663|NCT02296099|5568221|P2|NOT COMPLETED|Overall Study||2
2268664|NCT02296099|5568222|P1|NOT COMPLETED|Overall Study||3
2268665|NCT02296099|5568221|P2|COMPLETED|Overall Study||55
2268666|NCT02296099|5568222|P1|COMPLETED|Overall Study||54
2268667|NCT02296099|5568221|P2|STARTED|Overall Study||57
2268668|NCT02296099|5568222|P1|STARTED|Overall Study||57
2268669|NCT02295995|5568248|P2|NOT COMPLETED|Overall Study||1
2268670|NCT02295995|5568249|P1|NOT COMPLETED|Overall Study||5
2268671|NCT02295995|5568248|P2|COMPLETED|Overall Study||17
2268672|NCT02295995|5568249|P1|COMPLETED|Overall Study||31
2268673|NCT02295995|5568248|P2|STARTED|Overall Study||18
2268674|NCT02295995|5568249|P1|STARTED|Overall Study||36
2268675|NCT02295774|5568260|P1|NOT COMPLETED|Overall Study||3
2268676|NCT02295774|5568260|P1|COMPLETED|Overall Study||10
2268677|NCT02295774|5568260|P1|STARTED|Overall Study||13
2268678|NCT02295644|5568269|P4|NOT COMPLETED|Overall Study||2
2268679|NCT02295644|5568270|P3|NOT COMPLETED|Overall Study||1
2268680|NCT02295644|5568271|P2|NOT COMPLETED|Overall Study||0
2268681|NCT02295644|5568272|P1|NOT COMPLETED|Overall Study||0
2268682|NCT02295644|5568269|P4|COMPLETED|Overall Study||5
2268683|NCT02295644|5568270|P3|COMPLETED|Overall Study||6
2268684|NCT02295644|5568271|P2|COMPLETED|Overall Study||7
2268685|NCT02295644|5568272|P1|COMPLETED|Overall Study||7
2268686|NCT02295644|5568269|P4|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
2268687|NCT02295644|5568270|P3|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
2268688|NCT02295644|5568271|P2|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
2268689|NCT02295644|5568272|P1|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
2268690|NCT02295553|5568294|P4|NOT COMPLETED|Overall Study||1
2268691|NCT02295553|5568295|P3|NOT COMPLETED|Overall Study||1
2268692|NCT02295553|5568296|P2|NOT COMPLETED|Overall Study||0
2268693|NCT02295553|5568297|P1|NOT COMPLETED|Overall Study||0
2268694|NCT02295553|5568294|P4|COMPLETED|Overall Study||13
2268695|NCT02295553|5568295|P3|COMPLETED|Overall Study||13
2268696|NCT02295553|5568296|P2|COMPLETED|Overall Study||14
2268697|NCT02295553|5568297|P1|COMPLETED|Overall Study||14
2268698|NCT02295553|5568294|P4|STARTED|Overall Study||14
2268699|NCT02295553|5568295|P3|STARTED|Overall Study||14
2268700|NCT02295553|5568296|P2|STARTED|Overall Study||14
2268701|NCT02295553|5568297|P1|STARTED|Overall Study||14
2268702|NCT02295280|5568321|P2|NOT COMPLETED|Overall Study||1
2268703|NCT02295280|5568322|P1|NOT COMPLETED|Overall Study||0
2268704|NCT02295280|5568321|P2|COMPLETED|Overall Study||34
2268705|NCT02295280|5568322|P1|COMPLETED|Overall Study||35
2268706|NCT02295280|5568321|P2|STARTED|Overall Study||35
2268707|NCT02295280|5568322|P1|STARTED|Overall Study||35
2268708|NCT02295020|5568330|P2|NOT COMPLETED|Overall Study||3
2268709|NCT02295020|5568331|P1|NOT COMPLETED|Overall Study||3
2268710|NCT02295020|5568330|P2|COMPLETED|Overall Study||17
2268711|NCT02295020|5568331|P1|COMPLETED|Overall Study||17
2268712|NCT02295020|5568330|P2|STARTED|Overall Study||20
2268713|NCT02295020|5568331|P1|STARTED|Overall Study||20
2268714|NCT02294786|5568363|P2|NOT COMPLETED|Overall Study||14
2268715|NCT02294786|5568364|P1|NOT COMPLETED|Overall Study||11
2268716|NCT02294786|5568363|P2|COMPLETED|Overall Study||18
2268717|NCT02294786|5568364|P1|COMPLETED|Overall Study||19
2268718|NCT02294786|5568363|P2|ITT Population|Overall Study||32
2268719|NCT02294786|5568364|P1|ITT Population|Overall Study||30
2268720|NCT02294786|5568363|P2|Safety Population|Overall Study|The subject was included in the No-Octreotide arm.|33
2268721|NCT02294786|5568364|P1|Safety Population|Overall Study|One subject randomized to Octreotide received only 0.1 mg dose.|29
2268722|NCT02294786|5568363|P2|STARTED|Overall Study||32
2268723|NCT02294786|5568364|P1|STARTED|Overall Study||30
2268724|NCT02294773|5568411|P2|NOT COMPLETED|Overall Study||2
2268725|NCT02294773|5568412|P1|NOT COMPLETED|Overall Study||0
2268726|NCT02294773|5568411|P2|COMPLETED|Overall Study||4
2268727|NCT02294773|5568412|P1|COMPLETED|Overall Study||7
2268728|NCT02294773|5568411|P2|STARTED|Overall Study||6
2268729|NCT02294773|5568412|P1|STARTED|Overall Study||7
2268730|NCT02294734|5568428|P2|NOT COMPLETED|Overall Study||8
2268731|NCT02294734|5568429|P1|NOT COMPLETED|Overall Study||14
2268732|NCT02294734|5568428|P2|COMPLETED|Overall Study||55
2268733|NCT02294734|5568429|P1|COMPLETED|Overall Study||49
2268734|NCT02294734|5568428|P2|STARTED|Overall Study||63
2268735|NCT02294734|5568429|P1|STARTED|Overall Study||63
2268736|NCT02294682|5568481|P2|NOT COMPLETED|Overall Study||0
2268737|NCT02294682|5568482|P1|NOT COMPLETED|Overall Study||1
2268738|NCT02294682|5568481|P2|COMPLETED|Overall Study||53
2268739|NCT02294682|5568482|P1|COMPLETED|Overall Study||52
2268740|NCT02294682|5568481|P2|STARTED|Overall Study||53
2268741|NCT02294682|5568482|P1|STARTED|Overall Study||53
2268742|NCT02294604|5568525|P3|NOT COMPLETED|Overall Study||0
2268743|NCT02294604|5568526|P2|NOT COMPLETED|Overall Study||3
2268744|NCT02294604|5568527|P1|NOT COMPLETED|Overall Study||1
2268745|NCT02294604|5568525|P3|COMPLETED|Overall Study||80
2268746|NCT02294604|5568526|P2|COMPLETED|Overall Study||77
2268747|NCT02294604|5568527|P1|COMPLETED|Overall Study||79
2268748|NCT02294604|5568525|P3|STARTED|Overall Study||80
2268749|NCT02294604|5568526|P2|STARTED|Overall Study||80
2268750|NCT02294604|5568527|P1|STARTED|Overall Study||80
2268751|NCT02294474|5568546|P2|NOT COMPLETED|Overall Study||22
2268752|NCT02294474|5568547|P1|NOT COMPLETED|Overall Study||25
2268753|NCT02294474|5568546|P2|COMPLETED|Overall Study||230
2268754|NCT02294474|5568547|P1|COMPLETED|Overall Study||228
2268755|NCT02294474|5568546|P2|STARTED|Overall Study||252
2268756|NCT02294474|5568547|P1|STARTED|Overall Study||253
2268757|NCT02294461|5568571|P2|NOT COMPLETED|Overall Study||131
2268758|NCT02294461|5568572|P1|NOT COMPLETED|Overall Study||62
2268759|NCT02294461|5568571|P2|COMPLETED|Overall Study||59
2268760|NCT02294461|5568572|P1|COMPLETED|Overall Study|Participants still receiving treatment as of 20 Sept 2016. Data cutoff date: 20 Sep 2015/20 Jan 2016|136
2268761|NCT02294461|5568571|P2|Treated/Received Study Drug|Overall Study||190
2268762|NCT02294461|5568572|P1|Treated/Received Study Drug|Overall Study||198
2268763|NCT02294461|5568571|P2|STARTED|Overall Study||190
2268764|NCT02294461|5568572|P1|STARTED|Overall Study||198
2268765|NCT02294396|5568628|P4|NOT COMPLETED|Overall Study||37
2268766|NCT02294396|5568629|P3|NOT COMPLETED|Overall Study||35
2268767|NCT02294396|5568630|P2|NOT COMPLETED|Overall Study||33
2268768|NCT02294396|5568631|P1|NOT COMPLETED|Overall Study||40
2268769|NCT02294396|5568628|P4|COMPLETED|Overall Study||123
2268770|NCT02294396|5568629|P3|COMPLETED|Overall Study||126
2268771|NCT02294396|5568630|P2|COMPLETED|Overall Study||128
2268772|NCT02294396|5568631|P1|COMPLETED|Overall Study||127
2268773|NCT02294396|5568628|P4|STARTED|Overall Study||160
2268774|NCT02294396|5568629|P3|STARTED|Overall Study||161
2268775|NCT02294396|5568630|P2|STARTED|Overall Study||161
2268776|NCT02294396|5568631|P1|STARTED|Overall Study||167
2268777|NCT02294318|5568703|P2|NOT COMPLETED|Overall Study||2
2268778|NCT02294318|5568704|P1|NOT COMPLETED|Overall Study||3
2268779|NCT02294318|5568703|P2|COMPLETED|Overall Study||21
2268780|NCT02294318|5568704|P1|COMPLETED|Overall Study||21
2268781|NCT02294318|5568703|P2|STARTED|Overall Study||23
2268782|NCT02294318|5568704|P1|STARTED|Overall Study||24
2268783|NCT02294227|5568719|P3|NOT COMPLETED|Overall Study||19
2268784|NCT02294227|5568720|P2|NOT COMPLETED|Overall Study||25
2268785|NCT02294227|5568721|P1|NOT COMPLETED|Overall Study||25
2268786|NCT02294227|5568719|P3|COMPLETED|Overall Study||95
2268787|NCT02294227|5568720|P2|COMPLETED|Overall Study||88
2268788|NCT02294227|5568721|P1|COMPLETED|Overall Study||89
2268789|NCT02294227|5568719|P3|STARTED|Overall Study||114
2268790|NCT02294227|5568720|P2|STARTED|Overall Study||113
2268791|NCT02294227|5568721|P1|STARTED|Overall Study||114
2268792|NCT02294019|5568745|P1|NOT COMPLETED|Overall Study||103
2268793|NCT02294019|5568745|P1|COMPLETED|Overall Study||635
2268794|NCT02294019|5568745|P1|STARTED|Overall Study||738
2268795|NCT02293902|5568753|P5|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||6
2268796|NCT02293902|5568754|P4|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||1
2268797|NCT02293902|5568755|P3|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||2
2268798|NCT02293902|5568756|P2|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||8
2268799|NCT02293902|5568757|P1|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||0
2268800|NCT02293902|5568753|P5|COMPLETED|Single-Blind Period (Week 25 to Week 52)|18 rescued and 13 not rescued completed.|31
2268801|NCT02293902|5568754|P4|COMPLETED|Single-Blind Period (Week 25 to Week 52)|20 rescued and 13 not rescued completed.|33
2268802|NCT02293902|5568755|P3|COMPLETED|Single-Blind Period (Week 25 to Week 52)|8 rescued and 60 not rescued completed.|68
2268803|NCT02293902|5568756|P2|COMPLETED|Single-Blind Period (Week 25 to Week 52)|5 rescued and 61 not rescued completed.|66
2268804|NCT02293902|5568757|P1|COMPLETED|Single-Blind Period (Week 25 to Week 52)||0
2268805|NCT02293902|5568753|P5|STARTED|Single-Blind Period (Week 25 to Week 52)|15 participants not rescued were switched and 22 rescued continued open label treatment.|37
2268806|NCT02293902|5568754|P4|STARTED|Single-Blind Period (Week 25 to Week 52)|14 participants not rescued were switched and 20 rescued continued open label treatment.|34
2268807|NCT02293902|5568755|P3|STARTED|Single-Blind Period (Week 25 to Week 52)|62 participants not rescued continued same treatment and 8 rescued continued open label treatment.|70
2268808|NCT02293902|5568756|P2|STARTED|Single-Blind Period (Week 25 to Week 52)|68 participants not rescued continued same treatment and 6 rescued continued open label treatment.|74
2268809|NCT02293902|5568757|P1|STARTED|Single-Blind Period (Week 25 to Week 52)||0
2268810|NCT02293902|5568753|P5|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0
2268811|NCT02293902|5568754|P4|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0
2268812|NCT02293902|5568755|P3|NOT COMPLETED|Double-Blind Period (Up to Week 24)||10
2268813|NCT02293902|5568756|P2|NOT COMPLETED|Double-Blind Period (Up to Week 24)||7
2268814|NCT02293902|5568757|P1|NOT COMPLETED|Double-Blind Period (Up to Week 24)||11
2268815|NCT02293902|5568753|P5|COMPLETED|Double-Blind Period (Up to Week 24)||0
2268816|NCT02293902|5568754|P4|COMPLETED|Double-Blind Period (Up to Week 24)||0
2268817|NCT02293902|5568755|P3|COMPLETED|Double-Blind Period (Up to Week 24)|8 rescued and 62 not rescued completed.|70
2268818|NCT02293902|5568756|P2|COMPLETED|Double-Blind Period (Up to Week 24)|6 rescued and 68 not rescued completed.|74
2268819|NCT02293902|5568757|P1|COMPLETED|Double-Blind Period (Up to Week 24)|42 rescued and 29 not rescued completed.|71
2268820|NCT02293902|5568753|P5|Rescued|Double-Blind Period (Up to Week 24)||0
2268821|NCT02293902|5568754|P4|Rescued|Double-Blind Period (Up to Week 24)||0
2268822|NCT02293902|5568755|P3|Rescued|Double-Blind Period (Up to Week 24)||8
2268823|NCT02293902|5568756|P2|Rescued|Double-Blind Period (Up to Week 24)||6
2268824|NCT02293902|5568757|P1|Rescued|Double-Blind Period (Up to Week 24)||44
2268825|NCT02293902|5568753|P5|Treated|Double-Blind Period (Up to Week 24)||0
2268826|NCT02293902|5568754|P4|Treated|Double-Blind Period (Up to Week 24)||0
2268827|NCT02293902|5568755|P3|Treated|Double-Blind Period (Up to Week 24)||80
2268828|NCT02293902|5568756|P2|Treated|Double-Blind Period (Up to Week 24)||81
2268829|NCT02293902|5568757|P1|Treated|Double-Blind Period (Up to Week 24)||81
2268830|NCT02293902|5568753|P5|STARTED|Double-Blind Period (Up to Week 24)||0
2268831|NCT02293902|5568754|P4|STARTED|Double-Blind Period (Up to Week 24)||0
2268832|NCT02293902|5568755|P3|STARTED|Double-Blind Period (Up to Week 24)||80
2268833|NCT02293902|5568756|P2|STARTED|Double-Blind Period (Up to Week 24)||81
2268834|NCT02293902|5568757|P1|STARTED|Double-Blind Period (Up to Week 24)||82
2268835|NCT02293863|5568819|P3|NOT COMPLETED|Overall Study||9
2268836|NCT02293863|5568820|P2|NOT COMPLETED|Overall Study||13
2268837|NCT02293863|5568821|P1|NOT COMPLETED|Overall Study||9
2268838|NCT02293863|5568819|P3|COMPLETED|Overall Study||38
2268839|NCT02293863|5568820|P2|COMPLETED|Overall Study||42
2268840|NCT02293863|5568821|P1|COMPLETED|Overall Study||47
2268841|NCT02293863|5568819|P3|STARTED|Overall Study||47
2268842|NCT02293863|5568820|P2|STARTED|Overall Study||55
2268843|NCT02293863|5568821|P1|STARTED|Overall Study||56
2268844|NCT02293798|5568884|P1|NOT COMPLETED|Overall Study||0
2268845|NCT02293798|5568884|P1|COMPLETED|Overall Study|2 units of SERI Mesh placed in each patient|13
2268846|NCT02293798|5568884|P1|STARTED|Overall Study|2 units of SERI Mesh placed in each patient|13
2268847|NCT02293538|5568890|P2|NOT COMPLETED|Overall Study||2
2268848|NCT02293538|5568891|P1|NOT COMPLETED|Overall Study||1
2268849|NCT02293538|5568890|P2|COMPLETED|Overall Study||69
2268850|NCT02293538|5568891|P1|COMPLETED|Overall Study||72
2268851|NCT02293538|5568890|P2|STARTED|Overall Study||71
2268852|NCT02293538|5568891|P1|STARTED|Overall Study||73
2268853|NCT02293512|5568908|P4|NOT COMPLETED|Overall Study||2
2268854|NCT02293512|5568909|P3|NOT COMPLETED|Overall Study||3
2268855|NCT02293512|5568910|P2|NOT COMPLETED|Overall Study||6
2268856|NCT02293512|5568911|P1|NOT COMPLETED|Overall Study||4
2268857|NCT02293512|5568908|P4|COMPLETED|Overall Study||8
2268858|NCT02293512|5568909|P3|COMPLETED|Overall Study||7
2268859|NCT02293512|5568910|P2|COMPLETED|Overall Study||4
2268860|NCT02293512|5568911|P1|COMPLETED|Overall Study||6
2268861|NCT02293512|5568908|P4|STARTED|Overall Study||10
2268862|NCT02293512|5568909|P3|STARTED|Overall Study||10
2268863|NCT02293512|5568910|P2|STARTED|Overall Study||10
2268864|NCT02293512|5568911|P1|STARTED|Overall Study||10
2268865|NCT02293395|5568923|P2|NOT COMPLETED|Overall Study||7
2268866|NCT02293395|5568924|P1|NOT COMPLETED|Overall Study||9
2268867|NCT02293395|5568923|P2|COMPLETED|Overall Study||1511
2268868|NCT02293395|5568924|P1|COMPLETED|Overall Study||1510
2268869|NCT02293395|5568923|P2|Treated|Overall Study||1506
2268870|NCT02293395|5568924|P1|Treated|Overall Study||1510
2268871|NCT02293395|5568923|P2|STARTED|Overall Study||1518
2268872|NCT02293395|5568924|P1|STARTED|Overall Study||1519
2268873|NCT02293044|5568930|P1|NOT COMPLETED|Overall Study||0
2268874|NCT02293044|5568930|P1|COMPLETED|Overall Study||15
2268875|NCT02293044|5568930|P1|STARTED|Overall Study||15
2268876|NCT02292927|5568937|P2|NOT COMPLETED|Overall Study||7
2268877|NCT02292927|5568938|P1|NOT COMPLETED|Overall Study||13
2268878|NCT02292927|5568937|P2|COMPLETED|Overall Study||5
2268879|NCT02292927|5568938|P1|COMPLETED|Overall Study||0
2268880|NCT02292927|5568937|P2|STARTED|Overall Study||12
2268881|NCT02292927|5568938|P1|STARTED|Overall Study||13
2268882|NCT02292849|5568955|P3|NOT COMPLETED|Overall Study||2
2268883|NCT02292849|5568956|P2|NOT COMPLETED|Overall Study||2
2268884|NCT02292849|5568957|P1|NOT COMPLETED|Overall Study||4
2268885|NCT02292849|5568955|P3|COMPLETED|Overall Study||8
2268886|NCT02292849|5568956|P2|COMPLETED|Overall Study||6
2268887|NCT02292849|5568957|P1|COMPLETED|Overall Study||7
2268888|NCT02292849|5568955|P3|STARTED|Overall Study||10
2268889|NCT02292849|5568956|P2|STARTED|Overall Study||8
2268890|NCT02292849|5568957|P1|STARTED|Overall Study||11
2268891|NCT02292771|5568967|P2|NOT COMPLETED|Overall Study||2
2268892|NCT02292771|5568968|P1|NOT COMPLETED|Overall Study||4
2268893|NCT02292771|5568967|P2|COMPLETED|Overall Study||48
2268894|NCT02292771|5568968|P1|COMPLETED|Overall Study||43
2268895|NCT02292771|5568967|P2|STARTED|Overall Study||50
2268896|NCT02292771|5568968|P1|STARTED|Overall Study||47
2268897|NCT02292719|5569064|P6|NOT COMPLETED|Overall Study||0
2268898|NCT02292719|5569065|P5|NOT COMPLETED|Overall Study||1
2268899|NCT02292719|5569066|P4|NOT COMPLETED|Overall Study||1
2268900|NCT02292719|5569067|P3|NOT COMPLETED|Overall Study||1
2268901|NCT02292719|5569068|P2|NOT COMPLETED|Overall Study||0
2268902|NCT02292719|5569069|P1|NOT COMPLETED|Overall Study||0
2268903|NCT02292719|5569064|P6|COMPLETED|Overall Study||10
2268904|NCT02292719|5569065|P5|COMPLETED|Overall Study||20
2268905|NCT02292719|5569066|P4|COMPLETED|Overall Study||8
2268906|NCT02292719|5569067|P3|COMPLETED|Overall Study||9
2268907|NCT02292719|5569068|P2|COMPLETED|Overall Study||11
2268908|NCT02292719|5569069|P1|COMPLETED|Overall Study||9
2268909|NCT02292719|5569064|P6|STARTED|Overall Study||10
2268910|NCT02292719|5569065|P5|STARTED|Overall Study||21
2268911|NCT02292719|5569066|P4|STARTED|Overall Study||9
2268912|NCT02292719|5569067|P3|STARTED|Overall Study||10
2268913|NCT02292719|5569068|P2|STARTED|Overall Study||11
2268914|NCT02292719|5569069|P1|STARTED|Overall Study||9
2268915|NCT02292537|5569097|P2|NOT COMPLETED|Overall Study||0
2268916|NCT02292537|5569098|P1|NOT COMPLETED|Overall Study||0
2268917|NCT02292537|5569097|P2|COMPLETED|Overall Study||84
2268918|NCT02292537|5569098|P1|COMPLETED|Overall Study||42
2268919|NCT02292537|5569097|P2|Completed Treatment|Overall Study|1 participant completed the study but did not complete treatments due to early study closure|83
2268920|NCT02292537|5569098|P1|Completed Treatment|Overall Study||42
2268921|NCT02292537|5569097|P2|STARTED|Overall Study||84
2268922|NCT02292537|5569098|P1|STARTED|Overall Study||42
2268923|NCT02292446|5569132|P1|NOT COMPLETED|Overall Study||20
2268924|NCT02292446|5569132|P1|COMPLETED|Overall Study||141
2268925|NCT02292446|5569132|P1|STARTED|Overall Study||161
2268926|NCT02292433|5569148|P3|NOT COMPLETED|Third Intervention Period (7 Days)||0
2268927|NCT02292433|5569149|P2|NOT COMPLETED|Third Intervention Period (7 Days)||0
2268928|NCT02292433|5569150|P1|NOT COMPLETED|Third Intervention Period (7 Days)||0
2268929|NCT02292433|5569148|P3|COMPLETED|Third Intervention Period (7 Days)||4
2268930|NCT02292433|5569149|P2|COMPLETED|Third Intervention Period (7 Days)||4
2268931|NCT02292433|5569150|P1|COMPLETED|Third Intervention Period (7 Days)||4
2268932|NCT02292433|5569148|P3|STARTED|Third Intervention Period (7 Days)||4
2268933|NCT02292433|5569149|P2|STARTED|Third Intervention Period (7 Days)||4
2268934|NCT02292433|5569150|P1|STARTED|Third Intervention Period (7 Days)||4
2268935|NCT02292433|5569148|P3|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
2268936|NCT02292433|5569149|P2|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
2268937|NCT02292433|5569150|P1|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
2268938|NCT02292433|5569148|P3|COMPLETED|Second Washout Period (7 to 14 Days)||4
2268939|NCT02292433|5569149|P2|COMPLETED|Second Washout Period (7 to 14 Days)||4
2268940|NCT02292433|5569150|P1|COMPLETED|Second Washout Period (7 to 14 Days)||4
2268941|NCT02292433|5569148|P3|STARTED|Second Washout Period (7 to 14 Days)||4
2268942|NCT02292433|5569149|P2|STARTED|Second Washout Period (7 to 14 Days)||4
2268943|NCT02292433|5569150|P1|STARTED|Second Washout Period (7 to 14 Days)||4
2268944|NCT02292433|5569148|P3|NOT COMPLETED|Second Intervention Period (7 Days)||0
2268945|NCT02292433|5569149|P2|NOT COMPLETED|Second Intervention Period (7 Days)||0
2268946|NCT02292433|5569150|P1|NOT COMPLETED|Second Intervention Period (7 Days)||0
2268947|NCT02292433|5569148|P3|COMPLETED|Second Intervention Period (7 Days)||4
2268948|NCT02292433|5569149|P2|COMPLETED|Second Intervention Period (7 Days)||4
2268949|NCT02292433|5569150|P1|COMPLETED|Second Intervention Period (7 Days)||4
2268950|NCT02292433|5569148|P3|STARTED|Second Intervention Period (7 Days)||4
2268951|NCT02292433|5569149|P2|STARTED|Second Intervention Period (7 Days)||4
2268952|NCT02292433|5569150|P1|STARTED|Second Intervention Period (7 Days)||4
2268953|NCT02292433|5569148|P3|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
2268954|NCT02292433|5569149|P2|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
2268955|NCT02292433|5569150|P1|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
2268956|NCT02292433|5569148|P3|COMPLETED|First Washout Period (7 to 14 Days)||4
2268957|NCT02292433|5569149|P2|COMPLETED|First Washout Period (7 to 14 Days)||4
2268958|NCT02292433|5569150|P1|COMPLETED|First Washout Period (7 to 14 Days)||4
2268959|NCT02292433|5569148|P3|STARTED|First Washout Period (7 to 14 Days)||4
2268960|NCT02292433|5569149|P2|STARTED|First Washout Period (7 to 14 Days)||4
2268961|NCT02292433|5569150|P1|STARTED|First Washout Period (7 to 14 Days)||4
2268962|NCT02292433|5569148|P3|NOT COMPLETED|First Intervention Period (7 Days)||0
2268963|NCT02292433|5569149|P2|NOT COMPLETED|First Intervention Period (7 Days)||0
2268964|NCT02292433|5569150|P1|NOT COMPLETED|First Intervention Period (7 Days)||0
2268965|NCT02292433|5569148|P3|COMPLETED|First Intervention Period (7 Days)||4
2268966|NCT02292433|5569149|P2|COMPLETED|First Intervention Period (7 Days)||4
2268967|NCT02292433|5569150|P1|COMPLETED|First Intervention Period (7 Days)||4
2268968|NCT02292433|5569148|P3|STARTED|First Intervention Period (7 Days)||4
2268969|NCT02292433|5569149|P2|STARTED|First Intervention Period (7 Days)||4
2268970|NCT02292433|5569150|P1|STARTED|First Intervention Period (7 Days)||4
2268971|NCT02292212|5569221|P1|NOT COMPLETED|Post-ViE Phase||0
2268972|NCT02292212|5569221|P1|COMPLETED|Post-ViE Phase||14
2268973|NCT02292212|5569221|P1|STARTED|Post-ViE Phase||14
2268974|NCT02292212|5569221|P1|NOT COMPLETED|ViE Phase||3
2268975|NCT02292212|5569221|P1|COMPLETED|ViE Phase||14
2268976|NCT02292212|5569221|P1|STARTED|ViE Phase||17
2268977|NCT02292212|5569221|P1|NOT COMPLETED|Pre-ViE Phase||0
2268978|NCT02292212|5569221|P1|COMPLETED|Pre-ViE Phase||17
2268979|NCT02292212|5569221|P1|STARTED|Pre-ViE Phase||17
2268980|NCT02292186|5569253|P1|NOT COMPLETED|Overall Study||18
2268981|NCT02292186|5569253|P1|COMPLETED|Overall Study||7
2268982|NCT02292186|5569253|P1|STARTED|Overall Study||25
2268983|NCT02292082|5569263|P2|NOT COMPLETED|Overall Study||0
2268984|NCT02292082|5569264|P1|NOT COMPLETED|Overall Study||0
2268985|NCT02292082|5569263|P2|COMPLETED|Overall Study||55
2268986|NCT02292082|5569264|P1|COMPLETED|Overall Study||56
2268987|NCT02292082|5569263|P2|STARTED|Overall Study||55
2268988|NCT02292082|5569264|P1|STARTED|Overall Study||56
2268992|NCT02291861|5569303|P4|NOT COMPLETED|Overall Study||10
2268993|NCT02291861|5569304|P3|NOT COMPLETED|Overall Study||9
2268994|NCT02291861|5569305|P2|NOT COMPLETED|Overall Study||8
2268995|NCT02291861|5569306|P1|NOT COMPLETED|Overall Study||7
2268996|NCT02291861|5569303|P4|COMPLETED|Overall Study||65
2268997|NCT02291861|5569304|P3|COMPLETED|Overall Study||65
2268998|NCT02291861|5569305|P2|COMPLETED|Overall Study||67
2268999|NCT02291861|5569306|P1|COMPLETED|Overall Study||67
2269000|NCT02291861|5569303|P4|Modified Intent to Treat Pop (mITT)|Overall Study||55
2269001|NCT02291861|5569304|P3|Modified Intent to Treat Pop (mITT)|Overall Study||49
2269002|NCT02291861|5569305|P2|Modified Intent to Treat Pop (mITT)|Overall Study||60
2269003|NCT02291861|5569306|P1|Modified Intent to Treat Pop (mITT)|Overall Study||58
2269004|NCT02291861|5569303|P4|Safety Population|Overall Study||74
2269005|NCT02291861|5569304|P3|Safety Population|Overall Study||73
2269006|NCT02291861|5569305|P2|Safety Population|Overall Study||74
2269007|NCT02291861|5569306|P1|Safety Population|Overall Study||72
2269008|NCT02291861|5569303|P4|STARTED|Overall Study||75
2269009|NCT02291861|5569304|P3|STARTED|Overall Study||74
2269010|NCT02291861|5569305|P2|STARTED|Overall Study||75
2269011|NCT02291861|5569306|P1|STARTED|Overall Study||74
2269012|NCT02291718|5569347|P3|NOT COMPLETED|Overall Study||0
2269013|NCT02291718|5569348|P2|NOT COMPLETED|Overall Study||0
2269014|NCT02291718|5569349|P1|NOT COMPLETED|Overall Study||0
2269015|NCT02291718|5569347|P3|COMPLETED|Overall Study||50
2269016|NCT02291718|5569348|P2|COMPLETED|Overall Study||50
2269017|NCT02291718|5569349|P1|COMPLETED|Overall Study||50
2269018|NCT02291718|5569347|P3|STARTED|Overall Study||50
2269019|NCT02291718|5569348|P2|STARTED|Overall Study||50
2269020|NCT02291718|5569349|P1|STARTED|Overall Study||50
2269021|NCT02291679|5569369|P3|NOT COMPLETED|Overall Study||59
2269022|NCT02291679|5569370|P2|NOT COMPLETED|Overall Study||42
2269023|NCT02291679|5569371|P1|NOT COMPLETED|Overall Study||44
2269024|NCT02291679|5569369|P3|COMPLETED|Overall Study||352
2269025|NCT02291679|5569370|P2|COMPLETED|Overall Study||369
2269026|NCT02291679|5569371|P1|COMPLETED|Overall Study||357
2269027|NCT02291679|5569369|P3|STARTED|Overall Study||411
2269028|NCT02291679|5569370|P2|STARTED|Overall Study||411
2269029|NCT02291679|5569371|P1|STARTED|Overall Study||401
2269030|NCT02291549|5569402|P2|NOT COMPLETED|Overall Study||1
2269031|NCT02291549|5569403|P1|NOT COMPLETED|Overall Study||1
2269032|NCT02291549|5569402|P2|COMPLETED|Overall Study||98
2269033|NCT02291549|5569403|P1|COMPLETED|Overall Study||200
2269034|NCT02291549|5569402|P2|STARTED|Overall Study||99
2269035|NCT02291549|5569403|P1|STARTED|Overall Study||201
2269036|NCT02291510|5569425|P4|NOT COMPLETED|Overall Study||1
2269037|NCT02291510|5569426|P3|NOT COMPLETED|Overall Study||0
2269038|NCT02291510|5569427|P2|NOT COMPLETED|Overall Study||0
2269039|NCT02291510|5569428|P1|NOT COMPLETED|Overall Study||0
2269040|NCT02291510|5569425|P4|COMPLETED|Overall Study||4
2269041|NCT02291510|5569426|P3|COMPLETED|Overall Study||5
2269042|NCT02291510|5569427|P2|COMPLETED|Overall Study||5
2269043|NCT02291510|5569428|P1|COMPLETED|Overall Study||5
2269044|NCT02291510|5569425|P4|Completed Treatment D|Overall Study||5
2269045|NCT02291510|5569426|P3|Completed Treatment D|Overall Study||5
2269046|NCT02291510|5569427|P2|Completed Treatment D|Overall Study||5
2269047|NCT02291510|5569428|P1|Completed Treatment D|Overall Study||5
2269048|NCT02291510|5569425|P4|Completed Treatment C|Overall Study||4
2269049|NCT02291510|5569426|P3|Completed Treatment C|Overall Study||5
2269050|NCT02291510|5569427|P2|Completed Treatment C|Overall Study||5
2269051|NCT02291510|5569428|P1|Completed Treatment C|Overall Study||5
2269052|NCT02291510|5569425|P4|Completed Treatment B|Overall Study||4
2269053|NCT02291510|5569426|P3|Completed Treatment B|Overall Study||5
2269054|NCT02291510|5569427|P2|Completed Treatment B|Overall Study||5
2269055|NCT02291510|5569428|P1|Completed Treatment B|Overall Study||5
2269056|NCT02291510|5569425|P4|Completed Treatment A|Overall Study||5
2269057|NCT02291510|5569426|P3|Completed Treatment A|Overall Study||5
2269058|NCT02291510|5569427|P2|Completed Treatment A|Overall Study||5
2269059|NCT02291510|5569428|P1|Completed Treatment A|Overall Study||5
2269060|NCT02291510|5569425|P4|STARTED|Overall Study||5
2269061|NCT02291510|5569426|P3|STARTED|Overall Study||5
2269062|NCT02291510|5569427|P2|STARTED|Overall Study||5
2269063|NCT02291510|5569428|P1|STARTED|Overall Study||5
2269064|NCT02291419|5569444|P2|NOT COMPLETED|Overall Study||5
2269065|NCT02291419|5569445|P1|NOT COMPLETED|Overall Study||1
2269066|NCT02291419|5569444|P2|COMPLETED|Overall Study||0
2269067|NCT02291419|5569445|P1|COMPLETED|Overall Study||0
2269068|NCT02291419|5569444|P2|STARTED|Overall Study||5
2269069|NCT02291419|5569445|P1|STARTED|Overall Study||1
2269070|NCT02291237|5569463|P2|NOT COMPLETED|Overall Study||86
2269071|NCT02291237|5569464|P1|NOT COMPLETED|Overall Study||86
2269072|NCT02291237|5569463|P2|COMPLETED|Overall Study||0
2269073|NCT02291237|5569464|P1|COMPLETED|Overall Study||0
2269074|NCT02291237|5569463|P2|STARTED|Overall Study||86
2269075|NCT02291237|5569464|P1|STARTED|Overall Study||86
2269076|NCT02291029|5569486|P6|NOT COMPLETED|Overall Study||0
2269077|NCT02291029|5569487|P5|NOT COMPLETED|Overall Study||0
2269078|NCT02291029|5569488|P4|NOT COMPLETED|Overall Study||0
2269079|NCT02291029|5569489|P3|NOT COMPLETED|Overall Study||1
2269080|NCT02291029|5569490|P2|NOT COMPLETED|Overall Study||1
2269081|NCT02291029|5569491|P1|NOT COMPLETED|Overall Study||0
2269082|NCT02291029|5569486|P6|COMPLETED|Overall Study||12
2269083|NCT02291029|5569487|P5|COMPLETED|Overall Study||13
2269084|NCT02291029|5569488|P4|COMPLETED|Overall Study||11
2269085|NCT02291029|5569489|P3|COMPLETED|Overall Study||20
2269086|NCT02291029|5569490|P2|COMPLETED|Overall Study||3
2269087|NCT02291029|5569491|P1|COMPLETED|Overall Study||8
2269088|NCT02291029|5569486|P6|STARTED|Overall Study||12
2269089|NCT02291029|5569487|P5|STARTED|Overall Study||13
2269090|NCT02291029|5569488|P4|STARTED|Overall Study||11
2269091|NCT02291029|5569489|P3|STARTED|Overall Study||21
2269092|NCT02291029|5569490|P2|STARTED|Overall Study||4
2269093|NCT02291029|5569491|P1|STARTED|Overall Study||8
2269094|NCT02291016|5569537|P2|NOT COMPLETED|Visit 2||0
2269095|NCT02291016|5569538|P1|NOT COMPLETED|Visit 2||1
2269096|NCT02291016|5569537|P2|COMPLETED|Visit 2||5
2269097|NCT02291016|5569538|P1|COMPLETED|Visit 2|Patients did not meet visit 2 FEV1 criteria ( 15% or closer to value at visit 1)|1
2269098|NCT02291016|5569537|P2|STARTED|Visit 2||5
2269099|NCT02291016|5569538|P1|STARTED|Visit 2||2
2269100|NCT02291016|5569537|P2|NOT COMPLETED|Visit 1||0
2269101|NCT02291016|5569538|P1|NOT COMPLETED|Visit 1||0
2269102|NCT02291016|5569537|P2|COMPLETED|Visit 1||5
2269103|NCT02291016|5569538|P1|COMPLETED|Visit 1||2
2269104|NCT02291016|5569537|P2|STARTED|Visit 1||5
2269105|NCT02291016|5569538|P1|STARTED|Visit 1||2
2269106|NCT02290925|5569562|P2|NOT COMPLETED|Second Period of 3 Months||4
2269107|NCT02290925|5569563|P1|NOT COMPLETED|Second Period of 3 Months||1
2269108|NCT02290925|5569562|P2|COMPLETED|Second Period of 3 Months||65
2269109|NCT02290925|5569563|P1|COMPLETED|Second Period of 3 Months||57
2269110|NCT02290925|5569562|P2|STARTED|Second Period of 3 Months||69
2269111|NCT02290925|5569563|P1|STARTED|Second Period of 3 Months||58
2269112|NCT02290925|5569562|P2|NOT COMPLETED|First Period of Three Months||2
2269113|NCT02290925|5569563|P1|NOT COMPLETED|First Period of Three Months||4
2269114|NCT02290925|5569562|P2|COMPLETED|First Period of Three Months||69
2269115|NCT02290925|5569563|P1|COMPLETED|First Period of Three Months||58
2269116|NCT02290925|5569562|P2|STARTED|First Period of Three Months||71
2269117|NCT02290925|5569563|P1|STARTED|First Period of Three Months||62
2269118|NCT02290873|5569578|P3|NOT COMPLETED|Overall Study||2
2269119|NCT02290873|5569579|P2|NOT COMPLETED|Overall Study||1
2269120|NCT02290873|5569580|P1|NOT COMPLETED|Overall Study||2
2269121|NCT02290873|5569578|P3|COMPLETED|Overall Study||101
2269122|NCT02290873|5569579|P2|COMPLETED|Overall Study||59
2269123|NCT02290873|5569580|P1|COMPLETED|Overall Study||296
2269124|NCT02290873|5569578|P3|Safety Population|Overall Study||102
2269125|NCT02290873|5569579|P2|Safety Population|Overall Study||60
2269126|NCT02290873|5569580|P1|Safety Population|Overall Study||296
2269127|NCT02290873|5569578|P3|Modified Intention to Treat (mITT)|Overall Study||102
2269128|NCT02290873|5569579|P2|Modified Intention to Treat (mITT)|Overall Study||60
2269129|NCT02290873|5569580|P1|Modified Intention to Treat (mITT)|Overall Study||296
2269130|NCT02290873|5569578|P3|STARTED|Overall Study||103
2269131|NCT02290873|5569579|P2|STARTED|Overall Study||60
2269132|NCT02290873|5569580|P1|STARTED|Overall Study||298
2269133|NCT02290821|5569599|P2|NOT COMPLETED|Overall Study||3
2269134|NCT02290821|5569600|P1|NOT COMPLETED|Overall Study||6
2269135|NCT02290821|5569599|P2|COMPLETED|Overall Study||103
2269136|NCT02290821|5569600|P1|COMPLETED|Overall Study||103
2269137|NCT02290821|5569599|P2|STARTED|Overall Study||106
2269138|NCT02290821|5569600|P1|STARTED|Overall Study||109
2269139|NCT02290691|5569608|P2|NOT COMPLETED|Overall Study||9
2269140|NCT02290691|5569609|P1|NOT COMPLETED|Overall Study||8
2269141|NCT02290691|5569608|P2|COMPLETED|Overall Study||479
2269142|NCT02290691|5569609|P1|COMPLETED|Overall Study||488
2269143|NCT02290691|5569608|P2|STARTED|Overall Study||488
2269144|NCT02290691|5569609|P1|STARTED|Overall Study||496
2269145|NCT02290574|5569623|P1|NOT COMPLETED|Overall Study||1
2269146|NCT02290574|5569623|P1|COMPLETED|Overall Study||13
2269147|NCT02290574|5569623|P1|STARTED|Overall Study||14
2269148|NCT02290509|5569633|P2|NOT COMPLETED|Overall Study||14
2269149|NCT02290509|5569634|P1|NOT COMPLETED|Overall Study||49
2269150|NCT02290509|5569633|P2|COMPLETED|Overall Study||325
2269151|NCT02290509|5569634|P1|COMPLETED|Overall Study||962
2269152|NCT02290509|5569633|P2|STARTED|Overall Study||339
2269153|NCT02290509|5569634|P1|STARTED|Overall Study||1011
2269154|NCT02290431|5569646|P1|NOT COMPLETED|Overall Study||27
2269155|NCT02290431|5569646|P1|COMPLETED|Overall Study||4
2269156|NCT02290431|5569646|P1|Entered Treatment Phase 2|Overall Study||17
2269157|NCT02290431|5569646|P1|Subjects Entered Survival f/u Phase|Overall Study||24
2269158|NCT02290431|5569646|P1|Subjs. Ntered Post-treatment Eval. Phase|Overall Study||31
2269159|NCT02290431|5569646|P1|Subjects Completed Study Per Protocol|Overall Study||8
2269160|NCT02290431|5569646|P1|Subjects. Discont. Prematurely|Overall Study||27
2269161|NCT02290431|5569646|P1|STARTED|Overall Study||31
2269162|NCT02290340|5569669|P4|NOT COMPLETED|Overall Study||2
2269163|NCT02290340|5569670|P3|NOT COMPLETED|Overall Study||0
2269164|NCT02290340|5569671|P2|NOT COMPLETED|Overall Study||0
2269165|NCT02290340|5569672|P1|NOT COMPLETED|Overall Study||2
2269166|NCT02290340|5569669|P4|COMPLETED|Overall Study||30
2269167|NCT02290340|5569670|P3|COMPLETED|Overall Study||31
2269168|NCT02290340|5569671|P2|COMPLETED|Overall Study||8
2269169|NCT02290340|5569672|P1|COMPLETED|Overall Study||16
2269170|NCT02290340|5569669|P4|STARTED|Overall Study||32
2269171|NCT02290340|5569670|P3|STARTED|Overall Study||31
2269172|NCT02290340|5569671|P2|STARTED|Overall Study||8
2269173|NCT02290340|5569672|P1|STARTED|Overall Study||18
2269174|NCT02290223|5569717|P2|NOT COMPLETED|12 Months||11
2269175|NCT02290223|5569718|P1|NOT COMPLETED|12 Months||16
2269176|NCT02290223|5569717|P2|COMPLETED|12 Months||176
2269177|NCT02290223|5569718|P1|COMPLETED|12 Months||166
2269178|NCT02290223|5569717|P2|STARTED|12 Months|All participants were contacted at 12 mo, unless deceased or withdrawn (n=0).|187
2269179|NCT02290223|5569718|P1|STARTED|12 Months|All participants were contacted at 12 mo, unless deceased or withdrawn (n=7).|182
2269180|NCT02290223|5569717|P2|NOT COMPLETED|6 Months||6
2269181|NCT02290223|5569718|P1|NOT COMPLETED|6 Months||16
2269182|NCT02290223|5569717|P2|COMPLETED|6 Months||181
2269183|NCT02290223|5569718|P1|COMPLETED|6 Months||173
2269184|NCT02290223|5569717|P2|STARTED|6 Months||187
2269185|NCT02290223|5569718|P1|STARTED|6 Months||189
2269186|NCT02290223|5569717|P2|NOT COMPLETED|Baseline||0
2269187|NCT02290223|5569718|P1|NOT COMPLETED|Baseline||0
2269188|NCT02290223|5569717|P2|COMPLETED|Baseline||187
2269189|NCT02290223|5569718|P1|COMPLETED|Baseline||189
2269190|NCT02290223|5569717|P2|STARTED|Baseline||187
2269191|NCT02290223|5569718|P1|STARTED|Baseline||189
2269192|NCT02290184|5569778|P2|NOT COMPLETED|Overall Study||0
2269193|NCT02290184|5569779|P1|NOT COMPLETED|Overall Study||0
2269194|NCT02290184|5569778|P2|COMPLETED|Overall Study|6-month follow up visit - completed 3-month intervention and competed study|23
2269195|NCT02290184|5569779|P1|COMPLETED|Overall Study|6-month follow-up visit - completed the 3-month maintenance phase and completed study|22
2269196|NCT02290184|5569778|P2|3-month Follow-up|Overall Study|Completed initial 3-month control period and transition to receive the 3-month intervention|23
2269197|NCT02290184|5569779|P1|3-month Follow-up|Overall Study|Completed initial 3-month intervention and now transition to a 3-month maintenance phase|22
2269198|NCT02290184|5569778|P2|STARTED|Overall Study||23
2269199|NCT02290184|5569779|P1|STARTED|Overall Study||22
2269200|NCT02290106|5569793|P2|NOT COMPLETED|Overall Study||2
2269201|NCT02290106|5569794|P1|NOT COMPLETED|Overall Study||1
2269202|NCT02290106|5569793|P2|COMPLETED|Overall Study||23
2269203|NCT02290106|5569794|P1|COMPLETED|Overall Study||24
2269204|NCT02290106|5569793|P2|STARTED|Overall Study||25
2269205|NCT02290106|5569794|P1|STARTED|Overall Study||25
2269206|NCT02289989|5569814|P2|NOT COMPLETED|Overall Study||0
2269207|NCT02289989|5569815|P1|NOT COMPLETED|Overall Study||0
2269208|NCT02289989|5569814|P2|COMPLETED|Overall Study||1
2269209|NCT02289989|5569815|P1|COMPLETED|Overall Study||0
2269210|NCT02289989|5569814|P2|STARTED|Overall Study||1
2269211|NCT02289989|5569815|P1|STARTED|Overall Study||0
2269212|NCT02289963|5569833|P2|NOT COMPLETED|Overall Study||10
2269213|NCT02289963|5569834|P1|NOT COMPLETED|Overall Study||5
2269214|NCT02289963|5569833|P2|COMPLETED|Overall Study||87
2269215|NCT02289963|5569834|P1|COMPLETED|Overall Study||97
2269216|NCT02289963|5569833|P2|Treated|Overall Study||97
2269217|NCT02289963|5569834|P1|Treated|Overall Study||102
2269218|NCT02289963|5569833|P2|STARTED|Overall Study|Randomized|97
2269219|NCT02289963|5569834|P1|STARTED|Overall Study|Randomized|102
2269220|NCT02289898|5569885|P3|NOT COMPLETED|Overall Study||56
2269221|NCT02289898|5569886|P2|NOT COMPLETED|Overall Study||53
2269222|NCT02289898|5569887|P1|NOT COMPLETED|Overall Study||52
2269223|NCT02289898|5569885|P3|COMPLETED|Overall Study||9
2269224|NCT02289898|5569886|P2|COMPLETED|Overall Study||18
2269225|NCT02289898|5569887|P1|COMPLETED|Overall Study||16
2269226|NCT02289898|5569885|P3|STARTED|Overall Study||65
2269227|NCT02289898|5569886|P2|STARTED|Overall Study||71
2269228|NCT02289898|5569887|P1|STARTED|Overall Study||68
2269229|NCT02289833|5569896|P2|NOT COMPLETED|Overall Study||17
2269230|NCT02289833|5569897|P1|NOT COMPLETED|Overall Study||27
2269231|NCT02289833|5569896|P2|COMPLETED|Overall Study||3
2269232|NCT02289833|5569897|P1|COMPLETED|Overall Study||2
2269233|NCT02289833|5569896|P2|STARTED|Overall Study||20
2269234|NCT02289833|5569897|P1|STARTED|Overall Study||29
2269235|NCT02289820|5569933|P7|NOT COMPLETED|Overall Study||2
2269236|NCT02289820|5569934|P6|NOT COMPLETED|Overall Study||1
2269237|NCT02289820|5569935|P5|NOT COMPLETED|Overall Study||0
2269238|NCT02289820|5569936|P4|NOT COMPLETED|Overall Study||2
2269239|NCT02289820|5569937|P3|NOT COMPLETED|Overall Study||6
2269240|NCT02289820|5569938|P2|NOT COMPLETED|Overall Study||2
2269241|NCT02289820|5569939|P1|NOT COMPLETED|Overall Study||2
2269242|NCT02289820|5569933|P7|COMPLETED|Overall Study||37
2269243|NCT02289820|5569934|P6|COMPLETED|Overall Study||39
2269244|NCT02289820|5569935|P5|COMPLETED|Overall Study||40
2269245|NCT02289820|5569936|P4|COMPLETED|Overall Study||37
2269246|NCT02289820|5569937|P3|COMPLETED|Overall Study||38
2269247|NCT02289820|5569938|P2|COMPLETED|Overall Study||18
2269248|NCT02289820|5569939|P1|COMPLETED|Overall Study||37
2269249|NCT02289820|5569933|P7|STARTED|Overall Study||39
2269250|NCT02289820|5569934|P6|STARTED|Overall Study||40
2269251|NCT02289820|5569935|P5|STARTED|Overall Study||40
2269252|NCT02289820|5569936|P4|STARTED|Overall Study||39
2269253|NCT02289820|5569937|P3|STARTED|Overall Study||44
2269254|NCT02289820|5569938|P2|STARTED|Overall Study||20
2269255|NCT02289820|5569939|P1|STARTED|Overall Study||39
2269256|NCT02289755|5570050|P1|NOT COMPLETED|Follow up Period [4 Days]||0
2269257|NCT02289755|5570050|P1|COMPLETED|Follow up Period [4 Days]||16
2269258|NCT02289755|5570050|P1|STARTED|Follow up Period [4 Days]||16
2269259|NCT02289755|5570050|P1|NOT COMPLETED|ALLN-177 Treatment Period [4 Days]||0
2269260|NCT02289755|5570050|P1|COMPLETED|ALLN-177 Treatment Period [4 Days]||16
2269261|NCT02289755|5570050|P1|STARTED|ALLN-177 Treatment Period [4 Days]||16
2269262|NCT02289755|5570050|P1|NOT COMPLETED|Baseline Period [No Treatment, 3 Days]||0
2269263|NCT02289755|5570050|P1|COMPLETED|Baseline Period [No Treatment, 3 Days]||16
2269264|NCT02289755|5570050|P1|STARTED|Baseline Period [No Treatment, 3 Days]||16
2269265|NCT02289742|5570057|P4|NOT COMPLETED|Third Wear Period||1
2269266|NCT02289742|5570058|P3|NOT COMPLETED|Third Wear Period||0
2269267|NCT02289742|5570059|P2|NOT COMPLETED|Third Wear Period||1
2269268|NCT02289742|5570060|P1|NOT COMPLETED|Third Wear Period||0
2269269|NCT02289742|5570057|P4|COMPLETED|Third Wear Period||8
2269270|NCT02289742|5570058|P3|COMPLETED|Third Wear Period||11
2269271|NCT02289742|5570059|P2|COMPLETED|Third Wear Period||10
2269272|NCT02289742|5570060|P1|COMPLETED|Third Wear Period||11
2269273|NCT02289742|5570057|P4|STARTED|Third Wear Period||9
2269274|NCT02289742|5570058|P3|STARTED|Third Wear Period||11
2269275|NCT02289742|5570059|P2|STARTED|Third Wear Period||11
2269276|NCT02289742|5570060|P1|STARTED|Third Wear Period||11
2269277|NCT02289742|5570057|P4|NOT COMPLETED|Second Wear Period||0
2269278|NCT02289742|5570058|P3|NOT COMPLETED|Second Wear Period||0
2269279|NCT02289742|5570059|P2|NOT COMPLETED|Second Wear Period||0
2269280|NCT02289742|5570060|P1|NOT COMPLETED|Second Wear Period||0
2269281|NCT02289742|5570057|P4|COMPLETED|Second Wear Period||9
2269282|NCT02289742|5570058|P3|COMPLETED|Second Wear Period||11
2269283|NCT02289742|5570059|P2|COMPLETED|Second Wear Period||11
2269284|NCT02289742|5570060|P1|COMPLETED|Second Wear Period||11
2269285|NCT02289742|5570057|P4|STARTED|Second Wear Period||9
2269286|NCT02289742|5570058|P3|STARTED|Second Wear Period||11
2269287|NCT02289742|5570059|P2|STARTED|Second Wear Period||11
2269288|NCT02289742|5570060|P1|STARTED|Second Wear Period||11
2269289|NCT02289742|5570057|P4|NOT COMPLETED|First Wear Period||1
2269290|NCT02289742|5570058|P3|NOT COMPLETED|First Wear Period||1
2269291|NCT02289742|5570059|P2|NOT COMPLETED|First Wear Period||1
2269292|NCT02289742|5570060|P1|NOT COMPLETED|First Wear Period||0
2269293|NCT02289742|5570057|P4|COMPLETED|First Wear Period||9
2269294|NCT02289742|5570058|P3|COMPLETED|First Wear Period||11
2269295|NCT02289742|5570059|P2|COMPLETED|First Wear Period||11
2269296|NCT02289742|5570060|P1|COMPLETED|First Wear Period||11
2269297|NCT02289742|5570057|P4|Treated|First Wear Period||9
2269298|NCT02289742|5570058|P3|Treated|First Wear Period||12
2269299|NCT02289742|5570059|P2|Treated|First Wear Period||11
2269300|NCT02289742|5570060|P1|Treated|First Wear Period||11
2269301|NCT02289742|5570057|P4|STARTED|First Wear Period||10
2269302|NCT02289742|5570058|P3|STARTED|First Wear Period||12
2269303|NCT02289742|5570059|P2|STARTED|First Wear Period||12
2269304|NCT02289742|5570060|P1|STARTED|First Wear Period||11
2269305|NCT02289729|5570077|P1|NOT COMPLETED|Overall Study||6
2269306|NCT02289729|5570077|P1|COMPLETED|Overall Study||53
2269307|NCT02289729|5570077|P1|STARTED|Overall Study||59
2269308|NCT02289469|5570133|P2|NOT COMPLETED|Overall Study||0
2269309|NCT02289469|5570134|P1|NOT COMPLETED|Overall Study||6
2269310|NCT02289469|5570133|P2|COMPLETED|Overall Study||244
2269311|NCT02289469|5570134|P1|COMPLETED|Overall Study||244
2269312|NCT02289469|5570133|P2|STARTED|Overall Study||244
2269313|NCT02289469|5570134|P1|STARTED|Overall Study||250
2269314|NCT02289456|5570142|P1|NOT COMPLETED|Monotherapy Period||16
2269315|NCT02289456|5570142|P1|COMPLETED|Monotherapy Period||0
2269316|NCT02289456|5570142|P1|STARTED|Monotherapy Period||16
2269317|NCT02289456|5570142|P1|NOT COMPLETED|Induction Period||24
2269318|NCT02289456|5570142|P1|COMPLETED|Induction Period||16
2269319|NCT02289456|5570142|P1|Treated Population|Induction Period||40
2269320|NCT02289456|5570142|P1|STARTED|Induction Period||40
2269321|NCT02289417|5570165|P3|NOT COMPLETED|Overall Study||3
2269322|NCT02289417|5570166|P2|NOT COMPLETED|Overall Study||4
2269323|NCT02289417|5570167|P1|NOT COMPLETED|Overall Study||7
2269324|NCT02289417|5570165|P3|COMPLETED|Overall Study||52
2269325|NCT02289417|5570166|P2|COMPLETED|Overall Study||53
2269326|NCT02289417|5570167|P1|COMPLETED|Overall Study||51
2269327|NCT02289417|5570165|P3|STARTED|Overall Study||55
2269328|NCT02289417|5570166|P2|STARTED|Overall Study||57
2269329|NCT02289417|5570167|P1|STARTED|Overall Study||58
2269330|NCT02289352|5570208|P3|NOT COMPLETED|Overall Study||0
2269331|NCT02289352|5570209|P2|NOT COMPLETED|Overall Study||1
2269332|NCT02289352|5570210|P1|NOT COMPLETED|Overall Study||1
2269333|NCT02289352|5570208|P3|COMPLETED|Overall Study||64
2269334|NCT02289352|5570209|P2|COMPLETED|Overall Study||198
2269335|NCT02289352|5570210|P1|COMPLETED|Overall Study||198
2269336|NCT02289352|5570208|P3|PP Population|Overall Study||54
2269337|NCT02289352|5570209|P2|PP Population|Overall Study||173
2269338|NCT02289352|5570210|P1|PP Population|Overall Study||173
2269339|NCT02289352|5570208|P3|mITT Population|Overall Study||58
2269340|NCT02289352|5570209|P2|mITT Population|Overall Study||193
2269341|NCT02289352|5570210|P1|mITT Population|Overall Study||191
2269342|NCT02289352|5570208|P3|Safety Population|Overall Study||64
2269343|NCT02289352|5570209|P2|Safety Population|Overall Study||199
2269344|NCT02289352|5570210|P1|Safety Population|Overall Study||199
2269345|NCT02289352|5570208|P3|STARTED|Overall Study||64
2269346|NCT02289352|5570209|P2|STARTED|Overall Study||199
2269347|NCT02289352|5570210|P1|STARTED|Overall Study||199
2269348|NCT02289222|5570221|P1|NOT COMPLETED|Overall Study||0
2269349|NCT02289222|5570221|P1|COMPLETED|Overall Study||48
2269350|NCT02289222|5570221|P1|STARTED|Overall Study||48
2269351|NCT02289157|5570229|P2|NOT COMPLETED|Overall Study||0
2269352|NCT02289157|5570230|P1|NOT COMPLETED|Overall Study||0
2269353|NCT02289157|5570229|P2|COMPLETED|Overall Study||219
2269354|NCT02289157|5570230|P1|COMPLETED|Overall Study||222
2269355|NCT02289157|5570229|P2|No Post op Check or Follow up Phone Call|Overall Study||4
2269356|NCT02289157|5570230|P1|No Post op Check or Follow up Phone Call|Overall Study||2
2269357|NCT02289157|5570229|P2|STARTED|Overall Study||219
2269358|NCT02289157|5570230|P1|STARTED|Overall Study||222
2269359|NCT02289105|5570264|P2|NOT COMPLETED|Overall Study||0
2269360|NCT02289105|5570265|P1|NOT COMPLETED|Overall Study||0
2269361|NCT02289105|5570264|P2|COMPLETED|Overall Study||637
2269362|NCT02289105|5570265|P1|COMPLETED|Overall Study||642
2269363|NCT02289105|5570264|P2|STARTED|Overall Study||637
2269364|NCT02289105|5570265|P1|STARTED|Overall Study||642
2269365|NCT02289079|5570277|P2|NOT COMPLETED|Overall Study||1
2269366|NCT02289079|5570278|P1|NOT COMPLETED|Overall Study||2
2269367|NCT02289079|5570277|P2|COMPLETED|Overall Study||29
2269368|NCT02289079|5570278|P1|COMPLETED|Overall Study||28
2269369|NCT02289079|5570277|P2|STARTED|Overall Study||30
2269370|NCT02289079|5570278|P1|STARTED|Overall Study||30
2269371|NCT02288819|5570290|P1|NOT COMPLETED|Overall Study||0
2269372|NCT02288819|5570290|P1|COMPLETED|Overall Study||50
2269373|NCT02288819|5570290|P1|STARTED|Overall Study||50
2269374|NCT02288559|5570307|P4|NOT COMPLETED|Overall Study||2
2269375|NCT02288559|5570308|P3|NOT COMPLETED|Overall Study||11
2269376|NCT02288559|5570309|P2|NOT COMPLETED|Overall Study||1
2269377|NCT02288559|5570310|P1|NOT COMPLETED|Overall Study||1
2269378|NCT02288559|5570307|P4|COMPLETED|Overall Study||20
2269379|NCT02288559|5570308|P3|COMPLETED|Overall Study||35
2269380|NCT02288559|5570309|P2|COMPLETED|Overall Study||10
2269381|NCT02288559|5570310|P1|COMPLETED|Overall Study||9
2269382|NCT02288559|5570307|P4|STARTED|Overall Study||22
2269383|NCT02288559|5570308|P3|STARTED|Overall Study||46
2269384|NCT02288559|5570309|P2|STARTED|Overall Study||11
2269385|NCT02288559|5570310|P1|STARTED|Overall Study||10
2269386|NCT02288364|5570336|P2|NOT COMPLETED|Overall Study||0
2269387|NCT02288364|5570337|P1|NOT COMPLETED|Overall Study||0
2269388|NCT02288364|5570336|P2|COMPLETED|Overall Study||44
2269389|NCT02288364|5570337|P1|COMPLETED|Overall Study||42
2269390|NCT02288364|5570336|P2|STARTED|Overall Study||44
2269391|NCT02288364|5570337|P1|STARTED|Overall Study||42
2269392|NCT02288325|5570361|P3|NOT COMPLETED|Double-blind Treatment Period||26
2269393|NCT02288325|5570362|P2|NOT COMPLETED|Double-blind Treatment Period||24
2269394|NCT02288325|5570363|P1|NOT COMPLETED|Double-blind Treatment Period||0
2269395|NCT02288325|5570361|P3|COMPLETED|Double-blind Treatment Period||139
2269396|NCT02288325|5570362|P2|COMPLETED|Double-blind Treatment Period||135
2269397|NCT02288325|5570363|P1|COMPLETED|Double-blind Treatment Period||0
2269398|NCT02288325|5570361|P3|STARTED|Double-blind Treatment Period|7 participants did not enter Double-Blind Period (2 did not meet entry criteria; 5 other reasons)|165
2269399|NCT02288325|5570362|P2|STARTED|Double-blind Treatment Period|7 participants did not enter Double-Blind Period (2 did not meet entry criteria; 5 other reasons)|159
2269400|NCT02288325|5570363|P1|STARTED|Double-blind Treatment Period||0
2269401|NCT02288325|5570361|P3|NOT COMPLETED|Stabilization Period||0
2269402|NCT02288325|5570362|P2|NOT COMPLETED|Stabilization Period||0
2269403|NCT02288325|5570363|P1|NOT COMPLETED|Stabilization Period||98
2269404|NCT02288325|5570361|P3|COMPLETED|Stabilization Period||0
2269405|NCT02288325|5570362|P2|COMPLETED|Stabilization Period||0
2269406|NCT02288325|5570363|P1|COMPLETED|Stabilization Period||331
2269407|NCT02288325|5570361|P3|STARTED|Stabilization Period||0
2269408|NCT02288325|5570362|P2|STARTED|Stabilization Period||0
2269409|NCT02288325|5570363|P1|STARTED|Stabilization Period|70 participants did not enter Stabilization Period (69 did not meet entry criteria; 1 other reason)|429
2269410|NCT02288325|5570361|P3|NOT COMPLETED|Run-in Period||0
2269411|NCT02288325|5570362|P2|NOT COMPLETED|Run-in Period||0
2269412|NCT02288325|5570363|P1|NOT COMPLETED|Run-in Period||145
2269413|NCT02288325|5570361|P3|COMPLETED|Run-in Period||0
2269414|NCT02288325|5570362|P2|COMPLETED|Run-in Period||0
2269415|NCT02288325|5570363|P1|COMPLETED|Run-in Period||499
2269416|NCT02288325|5570361|P3|STARTED|Run-in Period||0
2269417|NCT02288325|5570362|P2|STARTED|Run-in Period||0
2269418|NCT02288325|5570363|P1|STARTED|Run-in Period||644
2269419|NCT02288312|5570373|P3|NOT COMPLETED|Overall Study||0
2269420|NCT02288312|5570374|P2|NOT COMPLETED|Overall Study||0
2269421|NCT02288312|5570375|P1|NOT COMPLETED|Overall Study||1
2269422|NCT02288312|5570373|P3|COMPLETED|Overall Study||6
2269423|NCT02288312|5570374|P2|COMPLETED|Overall Study||6
2269424|NCT02288312|5570375|P1|COMPLETED|Overall Study||5
2269425|NCT02288312|5570373|P3|STARTED|Overall Study||6
2269426|NCT02288312|5570374|P2|STARTED|Overall Study||6
2269427|NCT02288312|5570375|P1|STARTED|Overall Study||6
2269428|NCT02288273|5570394|P2|NOT COMPLETED|Overall Study||8
2269429|NCT02288273|5570395|P1|NOT COMPLETED|Overall Study||8
2269430|NCT02288273|5570394|P2|COMPLETED|Overall Study||48
2269431|NCT02288273|5570395|P1|COMPLETED|Overall Study||53
2269432|NCT02288273|5570394|P2|STARTED|Overall Study||56
2269433|NCT02288273|5570395|P1|STARTED|Overall Study||61
2269434|NCT02288182|5570415|P2|NOT COMPLETED|Overall Study||2
2269435|NCT02288182|5570416|P1|NOT COMPLETED|Overall Study||0
2269436|NCT02288182|5570415|P2|COMPLETED|Overall Study||25
2269437|NCT02288182|5570416|P1|COMPLETED|Overall Study||25
2269438|NCT02288182|5570415|P2|STARTED|Overall Study||27
2269439|NCT02288182|5570416|P1|STARTED|Overall Study||25
2269440|NCT02288091|5570428|P1|NOT COMPLETED|Overall Study||8
2269441|NCT02288091|5570428|P1|COMPLETED|Overall Study||24
2269442|NCT02288091|5570428|P1|Randomized/Treated|Overall Study||25
2269443|NCT02288091|5570428|P1|STARTED|Overall Study||32
2269444|NCT02287922|5570440|P4|NOT COMPLETED|Overall Study||7
2269445|NCT02287922|5570441|P3|NOT COMPLETED|Overall Study||7
2269446|NCT02287922|5570442|P2|NOT COMPLETED|Overall Study||2
2269447|NCT02287922|5570443|P1|NOT COMPLETED|Overall Study||3
2269448|NCT02287922|5570440|P4|COMPLETED|Overall Study||57
2269449|NCT02287922|5570441|P3|COMPLETED|Overall Study||56
2269450|NCT02287922|5570442|P2|COMPLETED|Overall Study||60
2269451|NCT02287922|5570443|P1|COMPLETED|Overall Study||59
2269452|NCT02287922|5570440|P4|STARTED|Overall Study||64
2269453|NCT02287922|5570441|P3|STARTED|Overall Study||63
2269454|NCT02287922|5570442|P2|STARTED|Overall Study||62
2269455|NCT02287922|5570443|P1|STARTED|Overall Study||62
2269456|NCT02287896|5570534|P2|NOT COMPLETED|Second Injection Visit||1
2269457|NCT02287896|5570535|P1|NOT COMPLETED|Second Injection Visit||0
2269458|NCT02287896|5570534|P2|COMPLETED|Second Injection Visit||25
2269459|NCT02287896|5570535|P1|COMPLETED|Second Injection Visit||36
2269460|NCT02287896|5570534|P2|STARTED|Second Injection Visit||26
2269461|NCT02287896|5570535|P1|STARTED|Second Injection Visit||36
2269462|NCT02287896|5570534|P2|NOT COMPLETED|First Injection Visit||0
2269463|NCT02287896|5570535|P1|NOT COMPLETED|First Injection Visit||0
2269464|NCT02287896|5570534|P2|COMPLETED|First Injection Visit||26
2269465|NCT02287896|5570535|P1|COMPLETED|First Injection Visit||36
2269466|NCT02287896|5570534|P2|STARTED|First Injection Visit||26
2269467|NCT02287896|5570535|P1|STARTED|First Injection Visit||36
2269468|NCT02287896|5570534|P2|NOT COMPLETED|Screening Visit V1||0
2269469|NCT02287896|5570535|P1|NOT COMPLETED|Screening Visit V1||0
2269470|NCT02287896|5570534|P2|COMPLETED|Screening Visit V1||26
2269471|NCT02287896|5570535|P1|COMPLETED|Screening Visit V1||36
2269472|NCT02287896|5570534|P2|STARTED|Screening Visit V1||26
2269473|NCT02287896|5570535|P1|STARTED|Screening Visit V1||36
2269474|NCT02287883|5570553|P2|NOT COMPLETED|Overall Study||426
2269475|NCT02287883|5570554|P1|NOT COMPLETED|Overall Study||459
2269476|NCT02287883|5570553|P2|COMPLETED|Overall Study||669
2269477|NCT02287883|5570554|P1|COMPLETED|Overall Study||622
2269478|NCT02287883|5570553|P2|One-year Follow-up Survey|Overall Study||669
2269479|NCT02287883|5570554|P1|One-year Follow-up Survey|Overall Study||622
2269480|NCT02287883|5570553|P2|STARTED|Overall Study||1095
2269481|NCT02287883|5570554|P1|STARTED|Overall Study||1081
2269482|NCT02287779|5570572|P8|NOT COMPLETED|Overall Study||0
2269483|NCT02287779|5570573|P7|NOT COMPLETED|Overall Study||0
2269484|NCT02287779|5570574|P6|NOT COMPLETED|Overall Study||0
2269485|NCT02287779|5570575|P5|NOT COMPLETED|Overall Study||0
2269486|NCT02287779|5570576|P4|NOT COMPLETED|Overall Study||0
2269487|NCT02287779|5570577|P3|NOT COMPLETED|Overall Study||0
2269488|NCT02287779|5570578|P2|NOT COMPLETED|Overall Study||0
2269489|NCT02287779|5570579|P1|NOT COMPLETED|Overall Study||0
2269490|NCT02287779|5570572|P8|COMPLETED|Overall Study||9
2269491|NCT02287779|5570573|P7|COMPLETED|Overall Study||9
2269492|NCT02287779|5570574|P6|COMPLETED|Overall Study||9
2269493|NCT02287779|5570575|P5|COMPLETED|Overall Study||9
2269494|NCT02287779|5570576|P4|COMPLETED|Overall Study||9
2269495|NCT02287779|5570577|P3|COMPLETED|Overall Study||9
2269496|NCT02287779|5570578|P2|COMPLETED|Overall Study||9
2269497|NCT02287779|5570579|P1|COMPLETED|Overall Study||21
2269498|NCT02287779|5570572|P8|STARTED|Overall Study||9
2269499|NCT02287779|5570573|P7|STARTED|Overall Study||9
2269500|NCT02287779|5570574|P6|STARTED|Overall Study||9
2269501|NCT02287779|5570575|P5|STARTED|Overall Study||9
2269502|NCT02287779|5570576|P4|STARTED|Overall Study||9
2269503|NCT02287779|5570577|P3|STARTED|Overall Study||9
2269504|NCT02287779|5570578|P2|STARTED|Overall Study||9
2269505|NCT02287779|5570579|P1|STARTED|Overall Study||21
2269506|NCT02287688|5570717|P1|NOT COMPLETED|Overall Study||0
2269507|NCT02287688|5570717|P1|COMPLETED|Overall Study||138
2269508|NCT02287688|5570717|P1|STARTED|Overall Study||138
2269509|NCT02287675|5570728|P2|NOT COMPLETED|Overall Study||0
2269510|NCT02287675|5570729|P1|NOT COMPLETED|Overall Study||0
2269511|NCT02287675|5570728|P2|COMPLETED|Overall Study||18
2269512|NCT02287675|5570729|P1|COMPLETED|Overall Study||22
2269513|NCT02287675|5570728|P2|STARTED|Overall Study||18
2269514|NCT02287675|5570729|P1|STARTED|Overall Study||22
2269518|NCT02287623|5570756|P2|NOT COMPLETED|Overall Study||1
2269519|NCT02287623|5570757|P1|NOT COMPLETED|Overall Study||0
2269520|NCT02287623|5570756|P2|COMPLETED|Overall Study||29
2269521|NCT02287623|5570757|P1|COMPLETED|Overall Study||30
2269522|NCT02287623|5570756|P2|STARTED|Overall Study||30
2269523|NCT02287623|5570757|P1|STARTED|Overall Study||30
2269524|NCT02287610|5570773|P1|NOT COMPLETED|Overall Study||16
2269525|NCT02287610|5570773|P1|COMPLETED|Overall Study||48
2269526|NCT02287610|5570773|P1|Per Protocol Follow-Up|Overall Study||56
2269527|NCT02287610|5570773|P1|STARTED|Overall Study||64
2269528|NCT02287467|5570808|P2|NOT COMPLETED|Overall Study||9
2269529|NCT02287467|5570809|P1|NOT COMPLETED|Overall Study||12
2269530|NCT02287467|5570808|P2|COMPLETED|Overall Study||152
2269531|NCT02287467|5570809|P1|COMPLETED|Overall Study||156
2269532|NCT02287467|5570808|P2|STARTED|Overall Study||161
2269533|NCT02287467|5570809|P1|STARTED|Overall Study||168
2269534|NCT02287415|5570851|P1|NOT COMPLETED|Overall Study||0
2269535|NCT02287415|5570851|P1|COMPLETED|Overall Study||13
2269536|NCT02287415|5570851|P1|STARTED|Overall Study||13
2269537|NCT02287402|5570857|P1|NOT COMPLETED|Follow-up||3
2269538|NCT02287402|5570857|P1|COMPLETED|Follow-up||103
2269539|NCT02287402|5570857|P1|STARTED|Follow-up|64 participants who completed the Treatment Period did not continue to Follow-up.|106
2269540|NCT02287402|5570857|P1|NOT COMPLETED|Treatment Period||27
2269541|NCT02287402|5570857|P1|COMPLETED|Treatment Period||170
2269542|NCT02287402|5570857|P1|STARTED|Treatment Period||197
2269543|NCT02287376|5570872|P1|NOT COMPLETED|Overall Study||0
2269544|NCT02287376|5570872|P1|COMPLETED|Overall Study||25
2269545|NCT02287376|5570872|P1|STARTED|Overall Study||25
2269546|NCT02287350|5570915|P1|NOT COMPLETED|Overall Study||3
2269547|NCT02287350|5570915|P1|COMPLETED|Overall Study||48
2269548|NCT02287350|5570915|P1|STARTED|Overall Study||51
2269549|NCT02287038|5570962|P2|NOT COMPLETED|Overall Study||3
2269550|NCT02287038|5570963|P1|NOT COMPLETED|Overall Study||5
2269551|NCT02287038|5570962|P2|COMPLETED|Overall Study||18
2269552|NCT02287038|5570963|P1|COMPLETED|Overall Study||18
2269553|NCT02287038|5570962|P2|STARTED|Overall Study||21
2269554|NCT02287038|5570963|P1|STARTED|Overall Study||23
2269555|NCT02287025|5570973|P2|NOT COMPLETED|Overall Study||9
2269556|NCT02287025|5570974|P1|NOT COMPLETED|Overall Study||10
2269557|NCT02287025|5570973|P2|COMPLETED|Overall Study||2
2269558|NCT02287025|5570974|P1|COMPLETED|Overall Study||2
2269559|NCT02287025|5570973|P2|STARTED|Overall Study||11
2269560|NCT02287025|5570974|P1|STARTED|Overall Study||12
2269561|NCT02286947|5570983|P1|NOT COMPLETED|Overall Study||2
2269562|NCT02286947|5570983|P1|COMPLETED|Overall Study||22
2269563|NCT02286947|5570983|P1|STARTED|Overall Study||24
2269564|NCT02286921|5570994|P2|NOT COMPLETED|Overall Study||0
2269565|NCT02286921|5570995|P1|NOT COMPLETED|Overall Study||0
2269566|NCT02286921|5570994|P2|COMPLETED|Overall Study||101
2269567|NCT02286921|5570995|P1|COMPLETED|Overall Study||94
2269568|NCT02286921|5570994|P2|STARTED|Overall Study||101
2269569|NCT02286921|5570995|P1|STARTED|Overall Study||94
2269570|NCT02286895|5571025|P2|NOT COMPLETED|Assessed for Measles Seroconversion||39
2269571|NCT02286895|5571026|P1|NOT COMPLETED|Assessed for Measles Seroconversion||48
2269572|NCT02286895|5571025|P2|COMPLETED|Assessed for Measles Seroconversion||261
2269573|NCT02286895|5571026|P1|COMPLETED|Assessed for Measles Seroconversion||252
2269574|NCT02286895|5571025|P2|STARTED|Assessed for Measles Seroconversion||300
2269575|NCT02286895|5571026|P1|STARTED|Assessed for Measles Seroconversion||300
2269576|NCT02286895|5571025|P2|NOT COMPLETED|Randomized and Vaccinated||0
2269577|NCT02286895|5571026|P1|NOT COMPLETED|Randomized and Vaccinated||0
2269578|NCT02286895|5571025|P2|COMPLETED|Randomized and Vaccinated||300
2269579|NCT02286895|5571026|P1|COMPLETED|Randomized and Vaccinated||300
2269580|NCT02286895|5571025|P2|STARTED|Randomized and Vaccinated||300
2269581|NCT02286895|5571026|P1|STARTED|Randomized and Vaccinated||300
2269582|NCT02286713|5571070|P2|NOT COMPLETED|Six Month Follow-Up||27
2269583|NCT02286713|5571071|P1|NOT COMPLETED|Six Month Follow-Up||32
2269584|NCT02286713|5571070|P2|COMPLETED|Six Month Follow-Up||225
2269585|NCT02286713|5571071|P1|COMPLETED|Six Month Follow-Up||218
2269586|NCT02286713|5571070|P2|STARTED|Six Month Follow-Up||252
2269587|NCT02286713|5571071|P1|STARTED|Six Month Follow-Up||250
2269588|NCT02286713|5571070|P2|NOT COMPLETED|Three Month Follow-Up||26
2269589|NCT02286713|5571071|P1|NOT COMPLETED|Three Month Follow-Up||28
2269590|NCT02286713|5571070|P2|COMPLETED|Three Month Follow-Up||228
2269591|NCT02286713|5571071|P1|COMPLETED|Three Month Follow-Up||224
2269592|NCT02286713|5571070|P2|STARTED|Three Month Follow-Up||254
2269593|NCT02286713|5571071|P1|STARTED|Three Month Follow-Up||252
2269594|NCT02286713|5571070|P2|NOT COMPLETED|One Week Follow-Up||24
2269595|NCT02286713|5571071|P1|NOT COMPLETED|One Week Follow-Up||24
2269596|NCT02286713|5571070|P2|COMPLETED|One Week Follow-Up||233
2269597|NCT02286713|5571071|P1|COMPLETED|One Week Follow-Up||235
2269598|NCT02286713|5571070|P2|STARTED|One Week Follow-Up||257
2269599|NCT02286713|5571071|P1|STARTED|One Week Follow-Up||259
2269600|NCT02286518|5571097|P14|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
2269601|NCT02286518|5571098|P13|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
2269602|NCT02286518|5571099|P12|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
2269603|NCT02286518|5571100|P11|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
2269604|NCT02286518|5571101|P10|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
2269605|NCT02286518|5571102|P9|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
2269606|NCT02286518|5571103|P8|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
2269607|NCT02286518|5571104|P7|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
2269608|NCT02286518|5571105|P6|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
2269609|NCT02286518|5571106|P5|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
2269610|NCT02286518|5571107|P4|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
2269611|NCT02286518|5571108|P3|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
2269612|NCT02286518|5571109|P2|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
2269613|NCT02286518|5571110|P1|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
2269614|NCT02286518|5571097|P14|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
2269615|NCT02286518|5571098|P13|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
2269616|NCT02286518|5571099|P12|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
2269617|NCT02286518|5571100|P11|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
2269618|NCT02286518|5571101|P10|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
2269619|NCT02286518|5571102|P9|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
2269620|NCT02286518|5571103|P8|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
2269621|NCT02286518|5571104|P7|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
2269622|NCT02286518|5571105|P6|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
2269623|NCT02286518|5571106|P5|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
2269624|NCT02286518|5571107|P4|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
2269625|NCT02286518|5571108|P3|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
2269626|NCT02286518|5571109|P2|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
2269627|NCT02286518|5571110|P1|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
2269628|NCT02286518|5571097|P14|STARTED|Crossover Treatment (Part 2: 3 Days)||0
2269629|NCT02286518|5571098|P13|STARTED|Crossover Treatment (Part 2: 3 Days)||0
2269630|NCT02286518|5571099|P12|STARTED|Crossover Treatment (Part 2: 3 Days)||0
2269631|NCT02286518|5571100|P11|STARTED|Crossover Treatment (Part 2: 3 Days)||0
2269632|NCT02286518|5571101|P10|STARTED|Crossover Treatment (Part 2: 3 Days)||0
2269633|NCT02286518|5571102|P9|STARTED|Crossover Treatment (Part 2: 3 Days)||6
2269634|NCT02286518|5571103|P8|STARTED|Crossover Treatment (Part 2: 3 Days)||6
2269635|NCT02286518|5571104|P7|STARTED|Crossover Treatment (Part 2: 3 Days)||0
2269636|NCT02286518|5571105|P6|STARTED|Crossover Treatment (Part 2: 3 Days)||0
2269637|NCT02286518|5571106|P5|STARTED|Crossover Treatment (Part 2: 3 Days)||0
2269638|NCT02286518|5571107|P4|STARTED|Crossover Treatment (Part 2: 3 Days)||0
2269639|NCT02286518|5571108|P3|STARTED|Crossover Treatment (Part 2: 3 Days)||0
2269640|NCT02286518|5571109|P2|STARTED|Crossover Treatment (Part 2: 3 Days)||0
2269641|NCT02286518|5571110|P1|STARTED|Crossover Treatment (Part 2: 3 Days)||0
2269642|NCT02286518|5571097|P14|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
2269643|NCT02286518|5571098|P13|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
2269644|NCT02286518|5571099|P12|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
2269645|NCT02286518|5571100|P11|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
2269646|NCT02286518|5571101|P10|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
2269647|NCT02286518|5571102|P9|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
2269648|NCT02286518|5571103|P8|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
2269649|NCT02286518|5571104|P7|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
2269650|NCT02286518|5571105|P6|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
2269651|NCT02286518|5571106|P5|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
2269652|NCT02286518|5571107|P4|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
2269653|NCT02286518|5571108|P3|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
2269654|NCT02286518|5571109|P2|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
2269655|NCT02286518|5571110|P1|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
2269656|NCT02286518|5571097|P14|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
2269657|NCT02286518|5571098|P13|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
2269658|NCT02286518|5571099|P12|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
2269659|NCT02286518|5571100|P11|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
2269660|NCT02286518|5571101|P10|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
2269661|NCT02286518|5571102|P9|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
2269662|NCT02286518|5571103|P8|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
2269663|NCT02286518|5571104|P7|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
2269664|NCT02286518|5571105|P6|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
2269665|NCT02286518|5571106|P5|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
2269666|NCT02286518|5571107|P4|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
2269667|NCT02286518|5571108|P3|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
2269668|NCT02286518|5571109|P2|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
2269669|NCT02286518|5571110|P1|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
2269670|NCT02286518|5571097|P14|STARTED|Washout Crossover Period(Part 2:14 Days)||0
2269671|NCT02286518|5571098|P13|STARTED|Washout Crossover Period(Part 2:14 Days)||0
2269672|NCT02286518|5571099|P12|STARTED|Washout Crossover Period(Part 2:14 Days)||0
2269673|NCT02286518|5571100|P11|STARTED|Washout Crossover Period(Part 2:14 Days)||0
2269674|NCT02286518|5571101|P10|STARTED|Washout Crossover Period(Part 2:14 Days)||0
2269675|NCT02286518|5571102|P9|STARTED|Washout Crossover Period(Part 2:14 Days)||6
2269676|NCT02286518|5571103|P8|STARTED|Washout Crossover Period(Part 2:14 Days)||6
2269677|NCT02286518|5571104|P7|STARTED|Washout Crossover Period(Part 2:14 Days)||0
2269678|NCT02286518|5571105|P6|STARTED|Washout Crossover Period(Part 2:14 Days)||0
2269679|NCT02286518|5571106|P5|STARTED|Washout Crossover Period(Part 2:14 Days)||0
2269680|NCT02286518|5571107|P4|STARTED|Washout Crossover Period(Part 2:14 Days)||0
2269681|NCT02286518|5571108|P3|STARTED|Washout Crossover Period(Part 2:14 Days)||0
2269682|NCT02286518|5571109|P2|STARTED|Washout Crossover Period(Part 2:14 Days)||0
2269683|NCT02286518|5571110|P1|STARTED|Washout Crossover Period(Part 2:14 Days)||0
2269684|NCT02286518|5571097|P14|NOT COMPLETED|All Parts (16 Days)||0
2269685|NCT02286518|5571098|P13|NOT COMPLETED|All Parts (16 Days)||0
2269686|NCT02286518|5571099|P12|NOT COMPLETED|All Parts (16 Days)||0
2269687|NCT02286518|5571100|P11|NOT COMPLETED|All Parts (16 Days)||0
2269688|NCT02286518|5571101|P10|NOT COMPLETED|All Parts (16 Days)||0
2269689|NCT02286518|5571102|P9|NOT COMPLETED|All Parts (16 Days)||0
2269690|NCT02286518|5571103|P8|NOT COMPLETED|All Parts (16 Days)||0
2269691|NCT02286518|5571104|P7|NOT COMPLETED|All Parts (16 Days)||0
2269692|NCT02286518|5571105|P6|NOT COMPLETED|All Parts (16 Days)||0
2269693|NCT02286518|5571106|P5|NOT COMPLETED|All Parts (16 Days)||0
2269694|NCT02286518|5571107|P4|NOT COMPLETED|All Parts (16 Days)||0
2269695|NCT02286518|5571108|P3|NOT COMPLETED|All Parts (16 Days)||0
2269696|NCT02286518|5571109|P2|NOT COMPLETED|All Parts (16 Days)||0
2269697|NCT02286518|5571110|P1|NOT COMPLETED|All Parts (16 Days)||0
2269698|NCT02286518|5571097|P14|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
2269699|NCT02286518|5571098|P13|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
2269700|NCT02286518|5571099|P12|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
2269701|NCT02286518|5571100|P11|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
2269702|NCT02286518|5571101|P10|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|4
2269703|NCT02286518|5571102|P9|COMPLETED|All Parts (16 Days)|Only participants of Part 2 would continue in next period.|6
2269704|NCT02286518|5571103|P8|COMPLETED|All Parts (16 Days)|Only participants of Part 2 continued in next period.|6
2269705|NCT02286518|5571104|P7|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
2269706|NCT02286518|5571105|P6|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
2269707|NCT02286518|5571106|P5|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
2269708|NCT02286518|5571107|P4|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
2269709|NCT02286518|5571108|P3|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
2269710|NCT02286518|5571109|P2|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
2269711|NCT02286518|5571110|P1|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
2269712|NCT02286518|5571097|P14|STARTED|All Parts (16 Days)||6
2269713|NCT02286518|5571098|P13|STARTED|All Parts (16 Days)||6
2269714|NCT02286518|5571099|P12|STARTED|All Parts (16 Days)||6
2269715|NCT02286518|5571100|P11|STARTED|All Parts (16 Days)||6
2269716|NCT02286518|5571101|P10|STARTED|All Parts (16 Days)||4
2269717|NCT02286518|5571102|P9|STARTED|All Parts (16 Days)||6
2269718|NCT02286518|5571103|P8|STARTED|All Parts (16 Days)||6
2269719|NCT02286518|5571104|P7|STARTED|All Parts (16 Days)||6
2269720|NCT02286518|5571105|P6|STARTED|All Parts (16 Days)||6
2269721|NCT02286518|5571106|P5|STARTED|All Parts (16 Days)||6
2269722|NCT02286518|5571107|P4|STARTED|All Parts (16 Days)||6
2269723|NCT02286518|5571108|P3|STARTED|All Parts (16 Days)||6
2269724|NCT02286518|5571109|P2|STARTED|All Parts (16 Days)||6
2269725|NCT02286518|5571110|P1|STARTED|All Parts (16 Days)||6
2269726|NCT02286466|5571252|P2|NOT COMPLETED|Overall Study||10
2269727|NCT02286466|5571253|P1|NOT COMPLETED|Overall Study||7
2269728|NCT02286466|5571252|P2|COMPLETED|Overall Study||63
2269729|NCT02286466|5571253|P1|COMPLETED|Overall Study||65
2269730|NCT02286466|5571252|P2|Post Self-report|Overall Study||68
2269731|NCT02286466|5571253|P1|Post Self-report|Overall Study||67
2269732|NCT02286466|5571252|P2|Baseline Clinician Assessment|Overall Study||72
2269733|NCT02286466|5571253|P1|Baseline Clinician Assessment|Overall Study||72
2269734|NCT02286466|5571252|P2|STARTED|Overall Study||73
2269735|NCT02286466|5571253|P1|STARTED|Overall Study||72
2269736|NCT02286193|5571265|P1|NOT COMPLETED|Overall Study||204
2269737|NCT02286193|5571265|P1|COMPLETED|Overall Study||418
2269738|NCT02286193|5571265|P1|STARTED|Overall Study||622
2269739|NCT02286102|5571272|P2|NOT COMPLETED|Overall Study||1
2269740|NCT02286102|5571273|P1|NOT COMPLETED|Overall Study||1
2269741|NCT02286102|5571272|P2|COMPLETED|Overall Study||33
2269742|NCT02286102|5571273|P1|COMPLETED|Overall Study||35
2269743|NCT02286102|5571272|P2|STARTED|Overall Study||34
2269744|NCT02286102|5571273|P1|STARTED|Overall Study||36
2269745|NCT02285998|5571285|P2|NOT COMPLETED|Overall Study||253
2269746|NCT02285998|5571286|P1|NOT COMPLETED|Overall Study||246
2269747|NCT02285998|5571285|P2|COMPLETED|Overall Study||4236
2269748|NCT02285998|5571286|P1|COMPLETED|Overall Study||4228
2269749|NCT02285998|5571285|P2|STARTED|Overall Study||4489
2269750|NCT02285998|5571286|P1|STARTED|Overall Study||4474
2269751|NCT02285920|5571314|P4|NOT COMPLETED|Overall Study||1
2269752|NCT02285920|5571315|P3|NOT COMPLETED|Overall Study||5
2269753|NCT02285920|5571316|P2|NOT COMPLETED|Overall Study||4
2269754|NCT02285920|5571317|P1|NOT COMPLETED|Overall Study||4
2269755|NCT02285920|5571314|P4|COMPLETED|Overall Study||24
2269756|NCT02285920|5571315|P3|COMPLETED|Overall Study||21
2269757|NCT02285920|5571316|P2|COMPLETED|Overall Study||23
2269758|NCT02285920|5571317|P1|COMPLETED|Overall Study||47
2269759|NCT02285920|5571314|P4|STARTED|Overall Study||25
2269760|NCT02285920|5571315|P3|STARTED|Overall Study||26
2269761|NCT02285920|5571316|P2|STARTED|Overall Study||27
2269762|NCT02285920|5571317|P1|STARTED|Overall Study||51
2269763|NCT02285907|5571379|P1|NOT COMPLETED|Overall Study||0
2269764|NCT02285907|5571379|P1|COMPLETED|Overall Study||21
2269765|NCT02285907|5571379|P1|Began 4th Intervention|Overall Study||21
2269766|NCT02285907|5571379|P1|Began 3rd Intervention|Overall Study||21
2269767|NCT02285907|5571379|P1|Began 2nd Intervention|Overall Study||21
2269768|NCT02285907|5571379|P1|Began 1st Intervention|Overall Study||21
2269769|NCT02285907|5571379|P1|STARTED|Overall Study||21
2269770|NCT02285855|5571407|P2|NOT COMPLETED|Overall Study||1
2269771|NCT02285855|5571408|P1|NOT COMPLETED|Overall Study||2
2269772|NCT02285855|5571407|P2|COMPLETED|Overall Study||1
2269773|NCT02285855|5571408|P1|COMPLETED|Overall Study||14
2269774|NCT02285855|5571407|P2|Randomized|Overall Study||2
2269775|NCT02285855|5571408|P1|Randomized|Overall Study||16
2269776|NCT02285855|5571407|P2|STARTED|Overall Study||2
2269777|NCT02285855|5571408|P1|STARTED|Overall Study||16
2269778|NCT02285777|5571416|P2|NOT COMPLETED|Overall Study||3
2269779|NCT02285777|5571417|P1|NOT COMPLETED|Overall Study||5
2269780|NCT02285777|5571416|P2|COMPLETED|Overall Study||91
2269781|NCT02285777|5571417|P1|COMPLETED|Overall Study||90
2269782|NCT02285777|5571416|P2|STARTED|Overall Study||94
2269783|NCT02285777|5571417|P1|STARTED|Overall Study||95
2269784|NCT02285634|5571473|P4|NOT COMPLETED|Overall Study||1
2269785|NCT02285634|5571474|P3|NOT COMPLETED|Overall Study||4
2269786|NCT02285634|5571475|P2|NOT COMPLETED|Overall Study||0
2269787|NCT02285634|5571476|P1|NOT COMPLETED|Overall Study||0
2269788|NCT02285634|5571473|P4|COMPLETED|Overall Study||17
2269789|NCT02285634|5571474|P3|COMPLETED|Overall Study||11
2269790|NCT02285634|5571475|P2|COMPLETED|Overall Study||20
2269791|NCT02285634|5571476|P1|COMPLETED|Overall Study||15
2269792|NCT02285634|5571473|P4|STARTED|Overall Study||18
2269793|NCT02285634|5571474|P3|STARTED|Overall Study||15
2269794|NCT02285634|5571475|P2|STARTED|Overall Study||20
2269795|NCT02285634|5571476|P1|STARTED|Overall Study||15
2269796|NCT02285270|5571498|P1|NOT COMPLETED|Overall Study||5
2269797|NCT02285270|5571498|P1|COMPLETED|Overall Study||5
2269798|NCT02285270|5571498|P1|STARTED|Overall Study||10
2269799|NCT02285153|5571506|P2|NOT COMPLETED|Overall Study||0
2269800|NCT02285153|5571507|P1|NOT COMPLETED|Overall Study||1
2269801|NCT02285153|5571506|P2|COMPLETED|Overall Study||8
2269802|NCT02285153|5571507|P1|COMPLETED|Overall Study||6
2269803|NCT02285153|5571506|P2|STARTED|Overall Study||8
2269804|NCT02285153|5571507|P1|STARTED|Overall Study||7
2269805|NCT02285023|5571519|P1|NOT COMPLETED|Overall Study||0
2269806|NCT02285023|5571519|P1|COMPLETED|Overall Study||166
2269807|NCT02285023|5571519|P1|STARTED|Overall Study||166
2269808|NCT02285010|5571531|P2|NOT COMPLETED|Overall Study||1
2269809|NCT02285010|5571532|P1|NOT COMPLETED|Overall Study||5
2269810|NCT02285010|5571531|P2|COMPLETED|Overall Study||61
2269811|NCT02285010|5571532|P1|COMPLETED|Overall Study||58
2269812|NCT02285010|5571531|P2|STARTED|Overall Study||62
2269813|NCT02285010|5571532|P1|STARTED|Overall Study||63
2269814|NCT02284906|5571549|P3|NOT COMPLETED|Overall Study||19
2269815|NCT02284906|5571550|P2|NOT COMPLETED|Overall Study||18
2269816|NCT02284906|5571551|P1|NOT COMPLETED|Overall Study||3
2269817|NCT02284906|5571549|P3|COMPLETED|Overall Study||0
2269818|NCT02284906|5571550|P2|COMPLETED|Overall Study||0
2269819|NCT02284906|5571551|P1|COMPLETED|Overall Study||0
2269820|NCT02284906|5571549|P3|STARTED|Overall Study||19
2269821|NCT02284906|5571550|P2|STARTED|Overall Study||18
2269822|NCT02284906|5571551|P1|STARTED|Overall Study||3
2269823|NCT02284893|5571564|P2|NOT COMPLETED|52 Week (Long Term)||13
2269824|NCT02284893|5571565|P1|NOT COMPLETED|52 Week (Long Term)||11
2269825|NCT02284893|5571564|P2|COMPLETED|52 Week (Long Term)||180
2269826|NCT02284893|5571565|P1|COMPLETED|52 Week (Long Term)||198
2269827|NCT02284893|5571564|P2|STARTED|52 Week (Long Term)||193
2269828|NCT02284893|5571565|P1|STARTED|52 Week (Long Term)||209
2269829|NCT02284893|5571564|P2|NOT COMPLETED|26 Week (Short Term)||31
2269830|NCT02284893|5571565|P1|NOT COMPLETED|26 Week (Short Term)||19
2269831|NCT02284893|5571564|P2|COMPLETED|26 Week (Short Term)||198
2269832|NCT02284893|5571565|P1|COMPLETED|26 Week (Short Term)||213
2269833|NCT02284893|5571564|P2|STARTED|26 Week (Short Term)||229
2269834|NCT02284893|5571565|P1|STARTED|26 Week (Short Term)||232
2269835|NCT02284880|5571579|P4|NOT COMPLETED|Overall Study||0
2269836|NCT02284880|5571580|P3|NOT COMPLETED|Overall Study||2
2269837|NCT02284880|5571581|P2|NOT COMPLETED|Overall Study||0
2269838|NCT02284880|5571582|P1|NOT COMPLETED|Overall Study||0
2269839|NCT02284880|5571579|P4|COMPLETED|Overall Study||10
2269840|NCT02284880|5571580|P3|COMPLETED|Overall Study||8
2269841|NCT02284880|5571581|P2|COMPLETED|Overall Study||9
2269842|NCT02284880|5571582|P1|COMPLETED|Overall Study||11
2269843|NCT02284880|5571579|P4|Second Period (4 Days)|Overall Study||10
2269844|NCT02284880|5571580|P3|Second Period (4 Days)|Overall Study||8
2269845|NCT02284880|5571581|P2|Second Period (4 Days)|Overall Study||9
2269846|NCT02284880|5571582|P1|Second Period (4 Days)|Overall Study||11
2269847|NCT02284880|5571579|P4|Wash-out Period (7 Days)|Overall Study||10
2269848|NCT02284880|5571580|P3|Wash-out Period (7 Days)|Overall Study||10
2269849|NCT02284880|5571581|P2|Wash-out Period (7 Days)|Overall Study||9
2269850|NCT02284880|5571582|P1|Wash-out Period (7 Days)|Overall Study||11
2269851|NCT02284880|5571579|P4|First Period (4 Days)|Overall Study||10
2269852|NCT02284880|5571580|P3|First Period (4 Days)|Overall Study||10
2269853|NCT02284880|5571581|P2|First Period (4 Days)|Overall Study||9
2269854|NCT02284880|5571582|P1|First Period (4 Days)|Overall Study||11
2269855|NCT02284880|5571579|P4|STARTED|Overall Study||10
2269856|NCT02284880|5571580|P3|STARTED|Overall Study||10
2269857|NCT02284880|5571581|P2|STARTED|Overall Study||9
2269858|NCT02284880|5571582|P1|STARTED|Overall Study||11
2269859|NCT02284867|5571598|P2|NOT COMPLETED|Overall Study||0
2269860|NCT02284867|5571599|P1|NOT COMPLETED|Overall Study||0
2269861|NCT02284867|5571598|P2|COMPLETED|Overall Study||30
2269862|NCT02284867|5571599|P1|COMPLETED|Overall Study||30
2269863|NCT02284867|5571598|P2|STARTED|Overall Study||30
2269864|NCT02284867|5571599|P1|STARTED|Overall Study||30
2269865|NCT02284854|5571609|P2|NOT COMPLETED|Overall Study||0
2269866|NCT02284854|5571610|P1|NOT COMPLETED|Overall Study||5
2269867|NCT02284854|5571609|P2|COMPLETED|Overall Study||20
2269868|NCT02284854|5571610|P1|COMPLETED|Overall Study||18
2269869|NCT02284854|5571609|P2|STARTED|Overall Study||20
2269870|NCT02284854|5571610|P1|STARTED|Overall Study||23
2269871|NCT02284828|5571627|P1|NOT COMPLETED|Overall Study||4
2269872|NCT02284828|5571627|P1|COMPLETED|Overall Study||22
2269873|NCT02284828|5571627|P1|STARTED|Overall Study||26
2269874|NCT02284568|5571642|P3|NOT COMPLETED|Overall Study||95
2269875|NCT02284568|5571643|P2|NOT COMPLETED|Overall Study||46
2269876|NCT02284568|5571644|P1|NOT COMPLETED|Overall Study||31
2269877|NCT02284568|5571642|P3|COMPLETED|Overall Study||0
2269878|NCT02284568|5571643|P2|COMPLETED|Overall Study||93
2269879|NCT02284568|5571644|P1|COMPLETED|Overall Study||109
2269880|NCT02284568|5571642|P3|Completed Week 48 MRI - on Treatment|Overall Study||0
2269881|NCT02284568|5571643|P2|Completed Week 48 MRI - on Treatment|Overall Study||107
2269882|NCT02284568|5571644|P1|Completed Week 48 MRI - on Treatment|Overall Study||113
2269883|NCT02284568|5571642|P3|Safety Population|Overall Study||95
2269884|NCT02284568|5571643|P2|Safety Population|Overall Study||138
2269885|NCT02284568|5571644|P1|Safety Population|Overall Study||140
2269886|NCT02284568|5571642|P3|STARTED|Overall Study|Intent to treat (ITT) population|95
2269887|NCT02284568|5571643|P2|STARTED|Overall Study|Intent to treat (ITT) population|139
2269888|NCT02284568|5571644|P1|STARTED|Overall Study|Intent to treat (ITT) population|140
2269889|NCT02284555|5571670|P1|NOT COMPLETED|Overall Study||0
2269890|NCT02284555|5571670|P1|COMPLETED|Overall Study||12
2269891|NCT02284555|5571670|P1|STARTED|Overall Study||12
2269892|NCT02284516|5571677|P2|NOT COMPLETED|Overall Study||36
2269893|NCT02284516|5571678|P1|NOT COMPLETED|Overall Study||38
2269894|NCT02284516|5571677|P2|COMPLETED|Overall Study||319
2269895|NCT02284516|5571678|P1|COMPLETED|Overall Study||318
2269896|NCT02284516|5571677|P2|Safety Population|Overall Study|Two placebo participants were included in Lifitegrast arm for safety analysis set (N=357).|357
2269897|NCT02284516|5571678|P1|Safety Population|Overall Study|Two placebo participants were considered for Lifitegrast arm; Placebo safety analysis set (N= 354).|354
2269898|NCT02284516|5571677|P2|STARTED|Overall Study||355
2269899|NCT02284516|5571678|P1|STARTED|Overall Study||356
2269900|NCT02284399|5571688|P2|NOT COMPLETED|Overall Study||0
2269901|NCT02284399|5571689|P1|NOT COMPLETED|Overall Study||0
2269902|NCT02284399|5571688|P2|COMPLETED|Overall Study||3074
2269903|NCT02284399|5571689|P1|COMPLETED|Overall Study||1414
2269904|NCT02284399|5571688|P2|STARTED|Overall Study||3074
2269905|NCT02284399|5571689|P1|STARTED|Overall Study||1414
2269906|NCT02284386|5571697|P1|NOT COMPLETED|Overall Study||0
2269907|NCT02284386|5571697|P1|COMPLETED|Overall Study||15
2269908|NCT02284386|5571697|P1|STARTED|Overall Study||15
2269909|NCT02284347|5571706|P1|NOT COMPLETED|Overall Study||3
2269910|NCT02284347|5571706|P1|COMPLETED|Overall Study||48
2269911|NCT02284347|5571706|P1|STARTED|Overall Study||51
2269912|NCT02284243|5571714|P2|NOT COMPLETED|Overall Study||3
2269913|NCT02284243|5571715|P1|NOT COMPLETED|Overall Study||4
2269914|NCT02284243|5571714|P2|COMPLETED|Overall Study||81
2269915|NCT02284243|5571715|P1|COMPLETED|Overall Study||80
2269916|NCT02284243|5571714|P2|STARTED|Overall Study||84
2269917|NCT02284243|5571715|P1|STARTED|Overall Study||84
2269918|NCT02284178|5571735|P2|NOT COMPLETED|Overall Study||54
2269919|NCT02284178|5571736|P1|NOT COMPLETED|Overall Study||49
2269920|NCT02284178|5571735|P2|COMPLETED|Overall Study||204
2269921|NCT02284178|5571736|P1|COMPLETED|Overall Study||206
2269922|NCT02284178|5571735|P2|STARTED|Overall Study||258
2269923|NCT02284178|5571736|P1|STARTED|Overall Study||255
2269924|NCT02284165|5571759|P3|NOT COMPLETED|Overall Study||0
2269925|NCT02284165|5571760|P2|NOT COMPLETED|Overall Study||0
2269926|NCT02284165|5571761|P1|NOT COMPLETED|Overall Study||0
2269927|NCT02284165|5571759|P3|COMPLETED|Overall Study||70996
2269928|NCT02284165|5571760|P2|COMPLETED|Overall Study||40272
2269929|NCT02284165|5571761|P1|COMPLETED|Overall Study||36448
2269930|NCT02284165|5571759|P3|STARTED|Overall Study||70996
2269931|NCT02284165|5571760|P2|STARTED|Overall Study||40272
2269932|NCT02284165|5571761|P1|STARTED|Overall Study||36448
2269933|NCT02284009|5571779|P2|NOT COMPLETED|Overall Study||10
2269934|NCT02284009|5571780|P1|NOT COMPLETED|Overall Study||6
2269935|NCT02284009|5571779|P2|COMPLETED|Overall Study||40
2269936|NCT02284009|5571780|P1|COMPLETED|Overall Study||11
2269937|NCT02284009|5571779|P2|STARTED|Overall Study||50
2269938|NCT02284009|5571780|P1|STARTED|Overall Study||17
2269939|NCT02283840|5571825|P3|NOT COMPLETED|Overall Study||0
2269940|NCT02283840|5571826|P2|NOT COMPLETED|Overall Study||1
2269941|NCT02283840|5571827|P1|NOT COMPLETED|Overall Study||0
2269942|NCT02283840|5571825|P3|COMPLETED|Overall Study||20
2269943|NCT02283840|5571826|P2|COMPLETED|Overall Study||19
2269944|NCT02283840|5571827|P1|COMPLETED|Overall Study||20
2269945|NCT02283840|5571825|P3|STARTED|Overall Study||20
2269946|NCT02283840|5571826|P2|STARTED|Overall Study||20
2269947|NCT02283840|5571827|P1|STARTED|Overall Study||20
2269948|NCT02283827|5571846|P2|NOT COMPLETED|Overall Study||3
2269949|NCT02283827|5571847|P1|NOT COMPLETED|Overall Study||1
2269950|NCT02283827|5571846|P2|COMPLETED|Overall Study||13
2269951|NCT02283827|5571847|P1|COMPLETED|Overall Study||15
2269952|NCT02283827|5571846|P2|STARTED|Overall Study||16
2269953|NCT02283827|5571847|P1|STARTED|Overall Study||16
2269954|NCT02283814|5571864|P2|NOT COMPLETED|Overall Study||2
2269955|NCT02283814|5571865|P1|NOT COMPLETED|Overall Study||3
2269956|NCT02283814|5571864|P2|COMPLETED|Overall Study||14
2269957|NCT02283814|5571865|P1|COMPLETED|Overall Study||13
2269958|NCT02283814|5571864|P2|STARTED|Overall Study||16
2269959|NCT02283814|5571865|P1|STARTED|Overall Study||16
2269960|NCT02283788|5571879|P4|NOT COMPLETED|Overall Study||2
2269961|NCT02283788|5571880|P3|NOT COMPLETED|Overall Study||5
2269962|NCT02283788|5571881|P2|NOT COMPLETED|Overall Study||4
2269963|NCT02283788|5571882|P1|NOT COMPLETED|Overall Study||1
2269964|NCT02283788|5571879|P4|COMPLETED|Overall Study||14
2269965|NCT02283788|5571880|P3|COMPLETED|Overall Study||12
2269966|NCT02283788|5571881|P2|COMPLETED|Overall Study||13
2269967|NCT02283788|5571882|P1|COMPLETED|Overall Study||16
2269968|NCT02283788|5571879|P4|STARTED|Overall Study||16
2269969|NCT02283788|5571880|P3|STARTED|Overall Study||17
2269970|NCT02283788|5571881|P2|STARTED|Overall Study||17
2269971|NCT02283788|5571882|P1|STARTED|Overall Study||17
2269972|NCT02283762|5571894|P2|NOT COMPLETED|Long-term Extension Phase (LTE)||14
2269973|NCT02283762|5571895|P1|NOT COMPLETED|Long-term Extension Phase (LTE)||10
2269974|NCT02283762|5571894|P2|COMPLETED|Long-term Extension Phase (LTE)||31
2269975|NCT02283762|5571895|P1|COMPLETED|Long-term Extension Phase (LTE)||32
2269976|NCT02283762|5571894|P2|STARTED|Long-term Extension Phase (LTE)|Of the 46 patients who completed the main treatment phase, 1 patient did not enter the LTE phase|45
2269977|NCT02283762|5571895|P1|STARTED|Long-term Extension Phase (LTE)||42
2269978|NCT02283762|5571894|P2|NOT COMPLETED|Main Treatment Phase (MT)||15
2269979|NCT02283762|5571895|P1|NOT COMPLETED|Main Treatment Phase (MT)||18
2269980|NCT02283762|5571894|P2|COMPLETED|Main Treatment Phase (MT)||46
2269981|NCT02283762|5571895|P1|COMPLETED|Main Treatment Phase (MT)||42
2269982|NCT02283762|5571894|P2|STARTED|Main Treatment Phase (MT)||61
2269983|NCT02283762|5571895|P1|STARTED|Main Treatment Phase (MT)||60
2269984|NCT02283749|5571913|P1|NOT COMPLETED|Overall Study||0
2269985|NCT02283749|5571913|P1|COMPLETED|Overall Study||5
2269986|NCT02283749|5571913|P1|STARTED|Overall Study||5
2269987|NCT02283528|5571921|P2|NOT COMPLETED|Overall Study||0
2269988|NCT02283528|5571922|P1|NOT COMPLETED|Overall Study||0
2269989|NCT02283528|5571921|P2|COMPLETED|Overall Study||24
2269990|NCT02283528|5571922|P1|COMPLETED|Overall Study||26
2269991|NCT02283528|5571921|P2|STARTED|Overall Study||24
2269992|NCT02283528|5571922|P1|STARTED|Overall Study||26
2269993|NCT02283411|5571932|P1|NOT COMPLETED|Overall Study||31
2269994|NCT02283411|5571932|P1|COMPLETED|Overall Study||125
2269995|NCT02283411|5571932|P1|STARTED|Overall Study||156
2269996|NCT02283268|5571940|P1|NOT COMPLETED|Overall Study||1
2269997|NCT02283268|5571940|P1|COMPLETED|Overall Study||14
2269998|NCT02283268|5571940|P1|STARTED|Overall Study||15
2269999|NCT02282982|5572001|P1|NOT COMPLETED|Overall Study||206
2270000|NCT02282982|5572001|P1|COMPLETED|Overall Study||153
2270001|NCT02282982|5572001|P1|Attended Follow-up Visit|Overall Study||349
2270002|NCT02282982|5572001|P1|Attended Visit 5|Overall Study||83
2270003|NCT02282982|5572001|P1|Attended Visit 4|Overall Study||194
2270004|NCT02282982|5572001|P1|Attended Visit 3|Overall Study||298
2270005|NCT02282982|5572001|P1|Attended Visit 2|Overall Study||341
2270006|NCT02282982|5572001|P1|Attended Visit 1|Overall Study||359
2270007|NCT02282982|5572001|P1|STARTED|Overall Study||359
2270008|NCT02282930|5572016|P1|NOT COMPLETED|Overall Study||1
2270009|NCT02282930|5572016|P1|COMPLETED|Overall Study||19
2270010|NCT02282930|5572016|P1|STARTED|Overall Study||20
2270011|NCT02282813|5572024|P3|NOT COMPLETED|Overall Study||3
2270012|NCT02282813|5572025|P2|NOT COMPLETED|Overall Study||23
2270013|NCT02282813|5572026|P1|NOT COMPLETED|Overall Study||12
2270014|NCT02282813|5572024|P3|COMPLETED|Overall Study||39
2270015|NCT02282813|5572025|P2|COMPLETED|Overall Study||130
2270016|NCT02282813|5572026|P1|COMPLETED|Overall Study||91
2270017|NCT02282813|5572024|P3|STARTED|Overall Study|Randomization to take adjunctive treatment in addition to CTAP101 capsules began after week 12.|42
2270018|NCT02282813|5572025|P2|STARTED|Overall Study|ITT Population - not randomized or randomized to CTAP101 monotherapy|153
2270019|NCT02282813|5572026|P1|STARTED|Overall Study|ITT Population|103
2270020|NCT02282722|5572045|P2|NOT COMPLETED|Overall Study||19
2270021|NCT02282722|5572046|P1|NOT COMPLETED|Overall Study||23
2270022|NCT02282722|5572045|P2|COMPLETED|Overall Study||73
2270023|NCT02282722|5572046|P1|COMPLETED|Overall Study||71
2270024|NCT02282722|5572045|P2|3-month Assessment|Overall Study||73
2270025|NCT02282722|5572046|P1|3-month Assessment|Overall Study||71
2270026|NCT02282722|5572045|P2|2-week Assessment|Overall Study||75
2270027|NCT02282722|5572046|P1|2-week Assessment|Overall Study||79
2270028|NCT02282722|5572045|P2|STARTED|Overall Study||92
2270029|NCT02282722|5572046|P1|STARTED|Overall Study||94
2270030|NCT02282631|5572072|P2|NOT COMPLETED|Overall Study||0
2270031|NCT02282631|5572073|P1|NOT COMPLETED|Overall Study||2
2270032|NCT02282631|5572072|P2|COMPLETED|Overall Study||15
2270033|NCT02282631|5572073|P1|COMPLETED|Overall Study||12
2270034|NCT02282631|5572072|P2|STARTED|Overall Study||15
2270035|NCT02282631|5572073|P1|STARTED|Overall Study|The two dropouts happened on the 2nd and 3rd weeks post-baseline, respectively|14
2270036|NCT02282605|5572114|P3|NOT COMPLETED|Overall Study||0
2270037|NCT02282605|5572115|P2|NOT COMPLETED|Overall Study||0
2270038|NCT02282605|5572116|P1|NOT COMPLETED|Overall Study||3
2270039|NCT02282605|5572114|P3|COMPLETED|Overall Study||24
2270040|NCT02282605|5572115|P2|COMPLETED|Overall Study||12
2270041|NCT02282605|5572116|P1|COMPLETED|Overall Study||24
2270042|NCT02282605|5572114|P3|STARTED|Overall Study||24
2270043|NCT02282605|5572115|P2|STARTED|Overall Study||12
2270044|NCT02282605|5572116|P1|STARTED|Overall Study||27
2270045|NCT02282527|5572138|P2|NOT COMPLETED|Overall Study||1
2270046|NCT02282527|5572139|P1|NOT COMPLETED|Overall Study||1
2270047|NCT02282527|5572138|P2|COMPLETED|Overall Study||15
2270048|NCT02282527|5572139|P1|COMPLETED|Overall Study||15
2270049|NCT02282527|5572138|P2|STARTED|Overall Study||16
2270050|NCT02282527|5572139|P1|STARTED|Overall Study||16
2270051|NCT02282293|5572151|P2|NOT COMPLETED|Overall Study||3
2270052|NCT02282293|5572152|P1|NOT COMPLETED|Overall Study||3
2270053|NCT02282293|5572151|P2|COMPLETED|Overall Study||97
2270054|NCT02282293|5572152|P1|COMPLETED|Overall Study||97
2270055|NCT02282293|5572151|P2|STARTED|Overall Study||100
2270056|NCT02282293|5572152|P1|STARTED|Overall Study||100
2270057|NCT02282111|5572172|P2|NOT COMPLETED|Overall Study||8
2270058|NCT02282111|5572173|P1|NOT COMPLETED|Overall Study||7
2270059|NCT02282111|5572172|P2|COMPLETED|Overall Study||22
2270060|NCT02282111|5572173|P1|COMPLETED|Overall Study||19
2270061|NCT02282111|5572172|P2|STARTED|Overall Study||30
2270062|NCT02282111|5572173|P1|STARTED|Overall Study||26
2270063|NCT02282020|5572189|P2|NOT COMPLETED|Overall Study||87
2270064|NCT02282020|5572190|P1|NOT COMPLETED|Overall Study||135
2270065|NCT02282020|5572189|P2|COMPLETED|Overall Study||1
2270066|NCT02282020|5572190|P1|COMPLETED|Overall Study||43
2270067|NCT02282020|5572189|P2|Received Treatment|Overall Study||76
2270068|NCT02282020|5572190|P1|Received Treatment|Overall Study||178
2270069|NCT02282020|5572189|P2|STARTED|Overall Study||88
2270070|NCT02282020|5572190|P1|STARTED|Overall Study||178
2270071|NCT02281773|5572240|P5|NOT COMPLETED|Overall Study||30
2270072|NCT02281773|5572241|P4|NOT COMPLETED|Overall Study||21
2270073|NCT02281773|5572242|P3|NOT COMPLETED|Overall Study||18
2270074|NCT02281773|5572243|P2|NOT COMPLETED|Overall Study||15
2270075|NCT02281773|5572244|P1|NOT COMPLETED|Overall Study||11
2270076|NCT02281773|5572240|P5|COMPLETED|Overall Study||143
2270077|NCT02281773|5572241|P4|COMPLETED|Overall Study||65
2270078|NCT02281773|5572242|P3|COMPLETED|Overall Study||67
2270079|NCT02281773|5572243|P2|COMPLETED|Overall Study||70
2270080|NCT02281773|5572244|P1|COMPLETED|Overall Study||76
2270081|NCT02281773|5572240|P5|STARTED|Overall Study|Started are the treated patients|173
2270082|NCT02281773|5572241|P4|STARTED|Overall Study||86
2270083|NCT02281773|5572242|P3|STARTED|Overall Study||85
2270084|NCT02281773|5572243|P2|STARTED|Overall Study|Started are the treated patients|85
2270085|NCT02281773|5572244|P1|STARTED|Overall Study||87
2270086|NCT02281591|5572305|P4|NOT COMPLETED|Overall Study||0
2270087|NCT02281591|5572306|P3|NOT COMPLETED|Overall Study||0
2270088|NCT02281591|5572307|P2|NOT COMPLETED|Overall Study||0
2270089|NCT02281591|5572308|P1|NOT COMPLETED|Overall Study||0
2270090|NCT02281591|5572305|P4|COMPLETED|Overall Study||8
2270091|NCT02281591|5572306|P3|COMPLETED|Overall Study||8
2270092|NCT02281591|5572307|P2|COMPLETED|Overall Study||8
2270093|NCT02281591|5572308|P1|COMPLETED|Overall Study||8
2270094|NCT02281591|5572305|P4|STARTED|Overall Study||8
2270095|NCT02281591|5572306|P3|STARTED|Overall Study||8
2270096|NCT02281591|5572307|P2|STARTED|Overall Study||8
2270097|NCT02281591|5572308|P1|STARTED|Overall Study||8
2270098|NCT02281552|5572332|P2|NOT COMPLETED|Overall Study||10
2270099|NCT02281552|5572333|P1|NOT COMPLETED|Overall Study||4
2270100|NCT02281552|5572332|P2|COMPLETED|Overall Study||95
2270101|NCT02281552|5572333|P1|COMPLETED|Overall Study||100
2270102|NCT02281552|5572332|P2|STARTED|Overall Study||105
2270103|NCT02281552|5572333|P1|STARTED|Overall Study||104
2270104|NCT02281526|5572373|P2|NOT COMPLETED|Overall Study||0
2270105|NCT02281526|5572374|P1|NOT COMPLETED|Overall Study||1
2270106|NCT02281526|5572373|P2|COMPLETED|Overall Study||8
2270107|NCT02281526|5572374|P1|COMPLETED|Overall Study||8
2270108|NCT02281526|5572373|P2|STARTED|Overall Study||8
2270109|NCT02281526|5572374|P1|STARTED|Overall Study||9
2270110|NCT02281448|5572384|P2|NOT COMPLETED|Overall Study||1
2270111|NCT02281448|5572385|P1|NOT COMPLETED|Overall Study||2
2270112|NCT02281448|5572384|P2|COMPLETED|Overall Study||9
2270113|NCT02281448|5572385|P1|COMPLETED|Overall Study||8
2270114|NCT02281448|5572384|P2|STARTED|Overall Study||10
2270115|NCT02281448|5572385|P1|STARTED|Overall Study||10
2270116|NCT02281422|5572398|P5|NOT COMPLETED|Overall Study||0
2270117|NCT02281422|5572399|P4|NOT COMPLETED|Overall Study||0
2270118|NCT02281422|5572400|P3|NOT COMPLETED|Overall Study||0
2270119|NCT02281422|5572401|P2|NOT COMPLETED|Overall Study||0
2270120|NCT02281422|5572402|P1|NOT COMPLETED|Overall Study||0
2270121|NCT02281422|5572398|P5|COMPLETED|Overall Study||8
2270122|NCT02281422|5572399|P4|COMPLETED|Overall Study||8
2270123|NCT02281422|5572400|P3|COMPLETED|Overall Study||8
2270124|NCT02281422|5572401|P2|COMPLETED|Overall Study||8
2270125|NCT02281422|5572402|P1|COMPLETED|Overall Study||8
2270126|NCT02281422|5572398|P5|STARTED|Overall Study||8
2270127|NCT02281422|5572399|P4|STARTED|Overall Study||8
2270128|NCT02281422|5572400|P3|STARTED|Overall Study||8
2270129|NCT02281422|5572401|P2|STARTED|Overall Study||8
2270130|NCT02281422|5572402|P1|STARTED|Overall Study||8
2270131|NCT02281357|5572426|P2|NOT COMPLETED|Overall Study||4
2270132|NCT02281357|5572427|P1|NOT COMPLETED|Overall Study||7
2270133|NCT02281357|5572426|P2|COMPLETED|Overall Study||66
2270134|NCT02281357|5572427|P1|COMPLETED|Overall Study||63
2270135|NCT02281357|5572426|P2|STARTED|Overall Study||70
2270136|NCT02281357|5572427|P1|STARTED|Overall Study||70
2270137|NCT02281318|5572441|P2|NOT COMPLETED|Overall Study||5
2270138|NCT02281318|5572442|P1|NOT COMPLETED|Overall Study||14
2270139|NCT02281318|5572441|P2|COMPLETED|Overall Study||269
2270140|NCT02281318|5572442|P1|COMPLETED|Overall Study||263
2270141|NCT02281318|5572441|P2|STARTED|Overall Study||274
2270142|NCT02281318|5572442|P1|STARTED|Overall Study||277
2270143|NCT02281136|5572454|P1|NOT COMPLETED|Overall Study||0
2270144|NCT02281136|5572454|P1|COMPLETED|Overall Study||29
2270145|NCT02281136|5572454|P1|STARTED|Overall Study||29
2270146|NCT02280863|5572488|P2|NOT COMPLETED|Integrated Platform||1
2270147|NCT02280863|5572489|P1|NOT COMPLETED|Integrated Platform||0
2270148|NCT02280863|5572488|P2|COMPLETED|Integrated Platform||14
2270149|NCT02280863|5572489|P1|COMPLETED|Integrated Platform||9
2270150|NCT02280863|5572488|P2|STARTED|Integrated Platform||15
2270151|NCT02280863|5572489|P1|STARTED|Integrated Platform|One additional participant was enrolled for part 2.|9
2270152|NCT02280863|5572488|P2|NOT COMPLETED|Android Platform||0
2270153|NCT02280863|5572489|P1|NOT COMPLETED|Android Platform||0
2270154|NCT02280863|5572488|P2|COMPLETED|Android Platform||0
2270155|NCT02280863|5572489|P1|COMPLETED|Android Platform||8
2270156|NCT02280863|5572488|P2|STARTED|Android Platform||0
2270157|NCT02280863|5572489|P1|STARTED|Android Platform||8
2270158|NCT02280811|5572519|P5|NOT COMPLETED|Retreated at the MTD||0
2270159|NCT02280811|5572520|P4|NOT COMPLETED|Retreated at the MTD||0
2270160|NCT02280811|5572521|P3|NOT COMPLETED|Retreated at the MTD||0
2270161|NCT02280811|5572522|P2|NOT COMPLETED|Retreated at the MTD||0
2270162|NCT02280811|5572523|P1|NOT COMPLETED|Retreated at the MTD||0
2270163|NCT02280811|5572519|P5|COMPLETED|Retreated at the MTD||1
2270164|NCT02280811|5572520|P4|COMPLETED|Retreated at the MTD||0
2270165|NCT02280811|5572521|P3|COMPLETED|Retreated at the MTD||0
2270166|NCT02280811|5572522|P2|COMPLETED|Retreated at the MTD||0
2270167|NCT02280811|5572523|P1|COMPLETED|Retreated at the MTD||0
2270168|NCT02280811|5572519|P5|STARTED|Retreated at the MTD|Patient originally started in Grp1(HPV-16 E6mTCR PBL 1x10^9+HD IL-2) and was retreated at the MTD.|1
2270169|NCT02280811|5572520|P4|STARTED|Retreated at the MTD||0
2270170|NCT02280811|5572521|P3|STARTED|Retreated at the MTD||0
2270171|NCT02280811|5572522|P2|STARTED|Retreated at the MTD||0
2270172|NCT02280811|5572523|P1|STARTED|Retreated at the MTD||0
2270173|NCT02280811|5572519|P5|NOT COMPLETED|Drug Administration||0
2270174|NCT02280811|5572520|P4|NOT COMPLETED|Drug Administration||0
2270175|NCT02280811|5572521|P3|NOT COMPLETED|Drug Administration||0
2270176|NCT02280811|5572522|P2|NOT COMPLETED|Drug Administration||0
2270177|NCT02280811|5572523|P1|NOT COMPLETED|Drug Administration||0
2270178|NCT02280811|5572519|P5|COMPLETED|Drug Administration||2
2270179|NCT02280811|5572520|P4|COMPLETED|Drug Administration||6
2270180|NCT02280811|5572521|P3|COMPLETED|Drug Administration||1
2270181|NCT02280811|5572522|P2|COMPLETED|Drug Administration||2
2270182|NCT02280811|5572523|P1|COMPLETED|Drug Administration||1
2270183|NCT02280811|5572519|P5|STARTED|Drug Administration||2
2270184|NCT02280811|5572520|P4|STARTED|Drug Administration||6
2270185|NCT02280811|5572521|P3|STARTED|Drug Administration||1
2270186|NCT02280811|5572522|P2|STARTED|Drug Administration||2
2270187|NCT02280811|5572523|P1|STARTED|Drug Administration||1
2270188|NCT02280655|5572564|P2|NOT COMPLETED|Overall Study||0
2270189|NCT02280655|5572565|P1|NOT COMPLETED|Overall Study||0
2270190|NCT02280655|5572564|P2|COMPLETED|Overall Study||18
2270191|NCT02280655|5572565|P1|COMPLETED|Overall Study||25
2270192|NCT02280655|5572564|P2|STARTED|Overall Study||18
2270193|NCT02280655|5572565|P1|STARTED|Overall Study||25
2270194|NCT02280499|5572573|P1|NOT COMPLETED|Overall Study||61
2270195|NCT02280499|5572573|P1|COMPLETED|Overall Study||26
2270196|NCT02280499|5572573|P1|STARTED|Overall Study||87
2270197|NCT02280473|5572581|P2|NOT COMPLETED|Overall Study||3
2270198|NCT02280473|5572582|P1|NOT COMPLETED|Overall Study||1
2270199|NCT02280473|5572581|P2|COMPLETED|Overall Study||91
2270200|NCT02280473|5572582|P1|COMPLETED|Overall Study||93
2270201|NCT02280473|5572581|P2|STARTED|Overall Study||94
2270202|NCT02280473|5572582|P1|STARTED|Overall Study||94
2270203|NCT02280421|5572598|P2|NOT COMPLETED|Second Intervention(2 Weeks)||0
2270204|NCT02280421|5572599|P1|NOT COMPLETED|Second Intervention(2 Weeks)||0
2270205|NCT02280421|5572598|P2|COMPLETED|Second Intervention(2 Weeks)||12
2270206|NCT02280421|5572599|P1|COMPLETED|Second Intervention(2 Weeks)||12
2270207|NCT02280421|5572598|P2|Received Intervention|Second Intervention(2 Weeks)||12
2270208|NCT02280421|5572599|P1|Received Intervention|Second Intervention(2 Weeks)||12
2270209|NCT02280421|5572598|P2|STARTED|Second Intervention(2 Weeks)||12
2270210|NCT02280421|5572599|P1|STARTED|Second Intervention(2 Weeks)||12
2270211|NCT02280421|5572598|P2|NOT COMPLETED|Washout (2 Weeks)||1
2270212|NCT02280421|5572599|P1|NOT COMPLETED|Washout (2 Weeks)||1
2270213|NCT02280421|5572598|P2|COMPLETED|Washout (2 Weeks)||11
2270214|NCT02280421|5572599|P1|COMPLETED|Washout (2 Weeks)||11
2270215|NCT02280421|5572598|P2|STARTED|Washout (2 Weeks)||12
2270216|NCT02280421|5572599|P1|STARTED|Washout (2 Weeks)||12
2270217|NCT02280421|5572598|P2|NOT COMPLETED|First Intervention(2 Weeks)||0
2270218|NCT02280421|5572599|P1|NOT COMPLETED|First Intervention(2 Weeks)||0
2270219|NCT02280421|5572598|P2|COMPLETED|First Intervention(2 Weeks)||12
2270220|NCT02280421|5572599|P1|COMPLETED|First Intervention(2 Weeks)||12
2270221|NCT02280421|5572598|P2|Received Intervention|First Intervention(2 Weeks)||12
2270222|NCT02280421|5572599|P1|Received Intervention|First Intervention(2 Weeks)||12
2270223|NCT02280421|5572598|P2|STARTED|First Intervention(2 Weeks)||12
2270224|NCT02280421|5572599|P1|STARTED|First Intervention(2 Weeks)||12
2270225|NCT02280408|5572665|P4|NOT COMPLETED|Overall Study||0
2270226|NCT02280408|5572666|P3|NOT COMPLETED|Overall Study||0
2270227|NCT02280408|5572667|P2|NOT COMPLETED|Overall Study||2
2270228|NCT02280408|5572668|P1|NOT COMPLETED|Overall Study||0
2270229|NCT02280408|5572665|P4|COMPLETED|Overall Study||9
2270230|NCT02280408|5572666|P3|COMPLETED|Overall Study||10
2270231|NCT02280408|5572667|P2|COMPLETED|Overall Study||8
2270232|NCT02280408|5572668|P1|COMPLETED|Overall Study||10
2270233|NCT02280408|5572665|P4|Vaccination 2|Overall Study||9
2270234|NCT02280408|5572666|P3|Vaccination 2|Overall Study||10
2270235|NCT02280408|5572667|P2|Vaccination 2|Overall Study||10
2270236|NCT02280408|5572668|P1|Vaccination 2|Overall Study||10
2270237|NCT02280408|5572665|P4|Vaccination 1|Overall Study||9
2270238|NCT02280408|5572666|P3|Vaccination 1|Overall Study||10
2270239|NCT02280408|5572667|P2|Vaccination 1|Overall Study||10
2270240|NCT02280408|5572668|P1|Vaccination 1|Overall Study||10
2270241|NCT02280408|5572665|P4|STARTED|Overall Study||9
2270242|NCT02280408|5572666|P3|STARTED|Overall Study||10
2270243|NCT02280408|5572667|P2|STARTED|Overall Study||10
2270244|NCT02280408|5572668|P1|STARTED|Overall Study||10
2270245|NCT02280226|5572738|P1|NOT COMPLETED|Overall Study||0
2270246|NCT02280226|5572738|P1|COMPLETED|Overall Study||17
2270247|NCT02280226|5572738|P1|STARTED|Overall Study||17
2270248|NCT02280200|5572745|P2|NOT COMPLETED|Overall Study||3
2270249|NCT02280200|5572746|P1|NOT COMPLETED|Overall Study||3
2270250|NCT02280200|5572745|P2|COMPLETED|Overall Study||10
2270251|NCT02280200|5572746|P1|COMPLETED|Overall Study||12
2270252|NCT02280200|5572745|P2|STARTED|Overall Study||13
2270253|NCT02280200|5572746|P1|STARTED|Overall Study||15
2270254|NCT02280187|5572760|P1|NOT COMPLETED|Overall Study||218
2270255|NCT02280187|5572760|P1|COMPLETED|Overall Study||182
2270256|NCT02280187|5572760|P1|STARTED|Overall Study||400
2270257|NCT02280122|5572778|P3|NOT COMPLETED|Overall Study||0
2270258|NCT02280122|5572779|P2|NOT COMPLETED|Overall Study||0
2270259|NCT02280122|5572780|P1|NOT COMPLETED|Overall Study||0
2270260|NCT02280122|5572778|P3|COMPLETED|Overall Study||30
2270261|NCT02280122|5572779|P2|COMPLETED|Overall Study||15
2270262|NCT02280122|5572780|P1|COMPLETED|Overall Study||15
2270263|NCT02280122|5572778|P3|STARTED|Overall Study||30
2270264|NCT02280122|5572779|P2|STARTED|Overall Study||15
2270265|NCT02280122|5572780|P1|STARTED|Overall Study||15
2270266|NCT02280096|5572788|P2|NOT COMPLETED|Overall Study||1
2270267|NCT02280096|5572789|P1|NOT COMPLETED|Overall Study||2
2270268|NCT02280096|5572788|P2|COMPLETED|Overall Study||10
2270269|NCT02280096|5572789|P1|COMPLETED|Overall Study||11
2270270|NCT02280096|5572788|P2|STARTED|Overall Study||11
2270271|NCT02280096|5572789|P1|STARTED|Overall Study||13
2270272|NCT02280044|5572819|P2|NOT COMPLETED|Overall Study||2
2270273|NCT02280044|5572820|P1|NOT COMPLETED|Overall Study||0
2270274|NCT02280044|5572819|P2|COMPLETED|Overall Study||13
2270275|NCT02280044|5572820|P1|COMPLETED|Overall Study||15
2270276|NCT02280044|5572819|P2|STARTED|Overall Study||15
2270277|NCT02280044|5572820|P1|STARTED|Overall Study||15
2270278|NCT02279862|5572830|P2|NOT COMPLETED|Overall Study||25
2270279|NCT02279862|5572831|P1|NOT COMPLETED|Overall Study||26
2270280|NCT02279862|5572830|P2|COMPLETED|Overall Study|Completed treatment in induction period|2
2270281|NCT02279862|5572831|P1|COMPLETED|Overall Study|Completed treatment in induction period|0
2270282|NCT02279862|5572830|P2|Treated|Overall Study||26
2270283|NCT02279862|5572831|P1|Treated|Overall Study||25
2270284|NCT02279862|5572830|P2|STARTED|Overall Study||27
2270285|NCT02279862|5572831|P1|STARTED|Overall Study||26
2270286|NCT02279732|5572849|P2|NOT COMPLETED|Overall Study||106
2270287|NCT02279732|5572850|P1|NOT COMPLETED|Overall Study||98
2270288|NCT02279732|5572849|P2|COMPLETED|Overall Study||0
2270289|NCT02279732|5572850|P1|COMPLETED|Overall Study||0
2270290|NCT02279732|5572849|P2|STARTED|Overall Study||106
2270291|NCT02279732|5572850|P1|STARTED|Overall Study||98
2270292|NCT02279667|5572863|P3|NOT COMPLETED|Overall Study||0
2270293|NCT02279667|5572864|P2|NOT COMPLETED|Overall Study||0
2270294|NCT02279667|5572865|P1|NOT COMPLETED|Overall Study||0
2270295|NCT02279667|5572863|P3|COMPLETED|Overall Study||6
2270296|NCT02279667|5572864|P2|COMPLETED|Overall Study||6
2270297|NCT02279667|5572865|P1|COMPLETED|Overall Study||6
2270298|NCT02279667|5572863|P3|STARTED|Overall Study||6
2270299|NCT02279667|5572864|P2|STARTED|Overall Study||6
2270300|NCT02279667|5572865|P1|STARTED|Overall Study||6
2270301|NCT02279641|5572885|P2|NOT COMPLETED|Overall Study||0
2270302|NCT02279641|5572886|P1|NOT COMPLETED|Overall Study||0
2270303|NCT02279641|5572885|P2|COMPLETED|Overall Study||6
2270304|NCT02279641|5572886|P1|COMPLETED|Overall Study||6
2270305|NCT02279641|5572885|P2|STARTED|Overall Study||6
2270306|NCT02279641|5572886|P1|STARTED|Overall Study||6
2270307|NCT02279498|5572942|P2|NOT COMPLETED|Overall Study||4
2270308|NCT02279498|5572943|P1|NOT COMPLETED|Overall Study||18
2270309|NCT02279498|5572942|P2|COMPLETED|Overall Study||59
2270310|NCT02279498|5572943|P1|COMPLETED|Overall Study||47
2270311|NCT02279498|5572942|P2|STARTED|Overall Study||63
2270312|NCT02279498|5572943|P1|STARTED|Overall Study||65
2270313|NCT02279420|5572952|P1|NOT COMPLETED|Overall Study||23
2270314|NCT02279420|5572952|P1|COMPLETED|Overall Study||50
2270315|NCT02279420|5572952|P1|STARTED|Overall Study||73
2270316|NCT02279407|5572960|P4|NOT COMPLETED|Overall Study||1
2270317|NCT02279407|5572961|P3|NOT COMPLETED|Overall Study||5
2270318|NCT02279407|5572962|P2|NOT COMPLETED|Overall Study||1
2270319|NCT02279407|5572963|P1|NOT COMPLETED|Overall Study||2
2270320|NCT02279407|5572960|P4|COMPLETED|Overall Study||20
2270321|NCT02279407|5572961|P3|COMPLETED|Overall Study||15
2270322|NCT02279407|5572962|P2|COMPLETED|Overall Study||20
2270323|NCT02279407|5572963|P1|COMPLETED|Overall Study||20
2270324|NCT02279407|5572960|P4|STARTED|Overall Study||21
2270325|NCT02279407|5572961|P3|STARTED|Overall Study||20
2270326|NCT02279407|5572962|P2|STARTED|Overall Study||21
2270327|NCT02279407|5572963|P1|STARTED|Overall Study||22
2270328|NCT02279173|5572974|P1|NOT COMPLETED|Overall Study||167
2270329|NCT02279173|5572974|P1|COMPLETED|Overall Study||37
2270330|NCT02279173|5572974|P1|Enrolled Under Protocol Supplement|Overall Study||79
2270331|NCT02279173|5572974|P1|Received Treatment|Overall Study||203
2270332|NCT02279173|5572974|P1|STARTED|Overall Study||204
2270333|NCT02279108|5572993|P2|NOT COMPLETED|Overall Study||1
2270334|NCT02279108|5572994|P1|NOT COMPLETED|Overall Study||0
2270335|NCT02279108|5572993|P2|COMPLETED|Overall Study||49
2270336|NCT02279108|5572994|P1|COMPLETED|Overall Study||50
2270337|NCT02279108|5572993|P2|STARTED|Overall Study||50
2270338|NCT02279108|5572994|P1|STARTED|Overall Study||50
2270339|NCT02279082|5573016|P1|NOT COMPLETED|Overall Study||33
2270340|NCT02279082|5573016|P1|COMPLETED|Overall Study||134
2270341|NCT02279082|5573016|P1|STARTED|Overall Study|Intentions were to have 173 participants, but only 167 participants received study drug.|167
2270342|NCT02279043|5573023|P3|NOT COMPLETED|Overall Study||0
2270343|NCT02279043|5573024|P2|NOT COMPLETED|Overall Study||89
2270344|NCT02279043|5573025|P1|NOT COMPLETED|Overall Study||47
2270345|NCT02279043|5573023|P3|COMPLETED|Overall Study||140
2270346|NCT02279043|5573024|P2|COMPLETED|Overall Study||226
2270347|NCT02279043|5573025|P1|COMPLETED|Overall Study||128
2270348|NCT02279043|5573023|P3|STARTED|Overall Study||140
2270349|NCT02279043|5573024|P2|STARTED|Overall Study||315
2270350|NCT02279043|5573025|P1|STARTED|Overall Study||175
2270351|NCT02278952|5573055|P1|NOT COMPLETED|Overall Study||6
2270352|NCT02278952|5573055|P1|COMPLETED|Overall Study|The number of biopsy samples assayed during the time the patient was enrolled in the study.|44
2270353|NCT02278952|5573055|P1|STARTED|Overall Study|The number of biopsy procedures performed during the time the patient was enrolled in the study.|50
2270354|NCT02278939|5573067|P2|NOT COMPLETED|Overall Study||1
2270355|NCT02278939|5573068|P1|NOT COMPLETED|Overall Study||5
2270356|NCT02278939|5573067|P2|COMPLETED|Overall Study||33
2270357|NCT02278939|5573068|P1|COMPLETED|Overall Study||28
2270358|NCT02278939|5573067|P2|STARTED|Overall Study||34
2270359|NCT02278939|5573068|P1|STARTED|Overall Study||33
2270360|NCT02278783|5573080|P1|NOT COMPLETED|Overall Study||0
2270361|NCT02278783|5573080|P1|COMPLETED|Overall Study||1
2270362|NCT02278783|5573080|P1|STARTED|Overall Study||1
2270363|NCT02278640|5573087|P1|NOT COMPLETED|Overall Study||0
2270364|NCT02278640|5573087|P1|COMPLETED|Overall Study||40
2270365|NCT02278640|5573087|P1|STARTED|Overall Study||40
2270366|NCT02278614|5573096|P2|NOT COMPLETED|Overall Study||5
2270367|NCT02278614|5573097|P1|NOT COMPLETED|Overall Study||5
2270368|NCT02278614|5573096|P2|COMPLETED|Overall Study||110
2270369|NCT02278614|5573097|P1|COMPLETED|Overall Study||122
2270370|NCT02278614|5573096|P2|STARTED|Overall Study||115
2270371|NCT02278614|5573097|P1|STARTED|Overall Study||127
2270372|NCT02278562|5573106|P3|NOT COMPLETED|Overall Study||0
2270373|NCT02278562|5573107|P2|NOT COMPLETED|Overall Study||0
2270374|NCT02278562|5573108|P1|NOT COMPLETED|Overall Study||0
2270375|NCT02278562|5573106|P3|COMPLETED|Overall Study||8
2270376|NCT02278562|5573107|P2|COMPLETED|Overall Study||7
2270377|NCT02278562|5573108|P1|COMPLETED|Overall Study||9
2270378|NCT02278562|5573106|P3|STARTED|Overall Study||8
2270379|NCT02278562|5573107|P2|STARTED|Overall Study||7
2270380|NCT02278562|5573108|P1|STARTED|Overall Study||9
2270381|NCT02278484|5573122|P1|NOT COMPLETED|Overall Study||0
2270382|NCT02278484|5573122|P1|COMPLETED|Overall Study||50
2270383|NCT02278484|5573122|P1|STARTED|Overall Study||50
2270384|NCT02278471|5573131|P2|NOT COMPLETED|Overall Study||20
2270385|NCT02278471|5573132|P1|NOT COMPLETED|Overall Study||8
2270386|NCT02278471|5573131|P2|COMPLETED|Overall Study||128
2270387|NCT02278471|5573132|P1|COMPLETED|Overall Study||147
2270388|NCT02278471|5573131|P2|STARTED|Overall Study||148
2270389|NCT02278471|5573132|P1|STARTED|Overall Study||155
2270390|NCT02278328|5573148|P3|NOT COMPLETED|Third Washout (1 Week)||0
2270391|NCT02278328|5573149|P2|NOT COMPLETED|Third Washout (1 Week)||0
2270392|NCT02278328|5573150|P1|NOT COMPLETED|Third Washout (1 Week)||0
2270393|NCT02278328|5573148|P3|COMPLETED|Third Washout (1 Week)||6
2270394|NCT02278328|5573149|P2|COMPLETED|Third Washout (1 Week)||6
2270395|NCT02278328|5573150|P1|COMPLETED|Third Washout (1 Week)||9
2270396|NCT02278328|5573148|P3|STARTED|Third Washout (1 Week)||6
2270397|NCT02278328|5573149|P2|STARTED|Third Washout (1 Week)||6
2270398|NCT02278328|5573150|P1|STARTED|Third Washout (1 Week)||9
2270399|NCT02278328|5573148|P3|NOT COMPLETED|Third Intervention (1 Day)||0
2270400|NCT02278328|5573149|P2|NOT COMPLETED|Third Intervention (1 Day)||0
2270401|NCT02278328|5573150|P1|NOT COMPLETED|Third Intervention (1 Day)||0
2270402|NCT02278328|5573148|P3|COMPLETED|Third Intervention (1 Day)||6
2270403|NCT02278328|5573149|P2|COMPLETED|Third Intervention (1 Day)||6
2270404|NCT02278328|5573150|P1|COMPLETED|Third Intervention (1 Day)||9
2270405|NCT02278328|5573148|P3|STARTED|Third Intervention (1 Day)||6
2270406|NCT02278328|5573149|P2|STARTED|Third Intervention (1 Day)||6
2270407|NCT02278328|5573150|P1|STARTED|Third Intervention (1 Day)||9
2270408|NCT02278328|5573148|P3|NOT COMPLETED|Second Washout (1 Week)||0
2270409|NCT02278328|5573149|P2|NOT COMPLETED|Second Washout (1 Week)||0
2270410|NCT02278328|5573150|P1|NOT COMPLETED|Second Washout (1 Week)||0
2270411|NCT02278328|5573148|P3|COMPLETED|Second Washout (1 Week)||6
2270412|NCT02278328|5573149|P2|COMPLETED|Second Washout (1 Week)||6
2270413|NCT02278328|5573150|P1|COMPLETED|Second Washout (1 Week)||9
2270414|NCT02278328|5573148|P3|STARTED|Second Washout (1 Week)||6
2270415|NCT02278328|5573149|P2|STARTED|Second Washout (1 Week)||6
2270416|NCT02278328|5573150|P1|STARTED|Second Washout (1 Week)||9
2270417|NCT02278328|5573148|P3|NOT COMPLETED|Second Intervention (1 Day)||0
2270418|NCT02278328|5573149|P2|NOT COMPLETED|Second Intervention (1 Day)||0
2270419|NCT02278328|5573150|P1|NOT COMPLETED|Second Intervention (1 Day)||0
2270420|NCT02278328|5573148|P3|COMPLETED|Second Intervention (1 Day)||6
2270421|NCT02278328|5573149|P2|COMPLETED|Second Intervention (1 Day)||6
2270422|NCT02278328|5573150|P1|COMPLETED|Second Intervention (1 Day)||9
2270423|NCT02278328|5573148|P3|STARTED|Second Intervention (1 Day)||6
2270424|NCT02278328|5573149|P2|STARTED|Second Intervention (1 Day)||6
2270425|NCT02278328|5573150|P1|STARTED|Second Intervention (1 Day)||9
2270426|NCT02278328|5573148|P3|NOT COMPLETED|Washout (1 Week)||0
2270427|NCT02278328|5573149|P2|NOT COMPLETED|Washout (1 Week)||0
2270428|NCT02278328|5573150|P1|NOT COMPLETED|Washout (1 Week)||0
2270429|NCT02278328|5573148|P3|COMPLETED|Washout (1 Week)||6
2270430|NCT02278328|5573149|P2|COMPLETED|Washout (1 Week)||6
2270431|NCT02278328|5573150|P1|COMPLETED|Washout (1 Week)||9
2270432|NCT02278328|5573148|P3|STARTED|Washout (1 Week)||6
2270433|NCT02278328|5573149|P2|STARTED|Washout (1 Week)||6
2270434|NCT02278328|5573150|P1|STARTED|Washout (1 Week)||9
2270435|NCT02278328|5573148|P3|NOT COMPLETED|First Intervention (1 Day)||0
2270436|NCT02278328|5573149|P2|NOT COMPLETED|First Intervention (1 Day)||0
2270437|NCT02278328|5573150|P1|NOT COMPLETED|First Intervention (1 Day)||0
2270438|NCT02278328|5573148|P3|COMPLETED|First Intervention (1 Day)||6
2270439|NCT02278328|5573149|P2|COMPLETED|First Intervention (1 Day)||6
2270440|NCT02278328|5573150|P1|COMPLETED|First Intervention (1 Day)||9
2270441|NCT02278328|5573148|P3|STARTED|First Intervention (1 Day)||6
2270442|NCT02278328|5573149|P2|STARTED|First Intervention (1 Day)||6
2270443|NCT02278328|5573150|P1|STARTED|First Intervention (1 Day)||9
2270444|NCT02278328|5573148|P3|NOT COMPLETED|Neuropsych Screening||2
2270445|NCT02278328|5573149|P2|NOT COMPLETED|Neuropsych Screening||1
2270446|NCT02278328|5573150|P1|NOT COMPLETED|Neuropsych Screening||1
2270447|NCT02278328|5573148|P3|COMPLETED|Neuropsych Screening||6
2270448|NCT02278328|5573149|P2|COMPLETED|Neuropsych Screening||6
2270449|NCT02278328|5573150|P1|COMPLETED|Neuropsych Screening||9
2270450|NCT02278328|5573148|P3|STARTED|Neuropsych Screening||8
2270451|NCT02278328|5573149|P2|STARTED|Neuropsych Screening||7
2270452|NCT02278328|5573150|P1|STARTED|Neuropsych Screening||10
2270453|NCT02278237|5573160|P1|NOT COMPLETED|Overall Study||7
2270454|NCT02278237|5573160|P1|COMPLETED|Overall Study||83
2270455|NCT02278237|5573160|P1|STARTED|Overall Study||90
2270456|NCT02278146|5573166|P2|NOT COMPLETED|Overall Study||2
2270457|NCT02278146|5573167|P1|NOT COMPLETED|Overall Study||0
2270458|NCT02278146|5573166|P2|COMPLETED|Overall Study||8
2270459|NCT02278146|5573167|P1|COMPLETED|Overall Study||6
2270460|NCT02278146|5573166|P2|STARTED|Overall Study||10
2270461|NCT02278146|5573167|P1|STARTED|Overall Study||6
2270462|NCT02278120|5573179|P2|NOT COMPLETED|Overall Study||216
2270463|NCT02278120|5573180|P1|NOT COMPLETED|Overall Study||161
2270464|NCT02278120|5573179|P2|COMPLETED|Overall Study||121
2270465|NCT02278120|5573180|P1|COMPLETED|Overall Study||174
2270466|NCT02278120|5573179|P2|STARTED|Overall Study||337
2270467|NCT02278120|5573180|P1|STARTED|Overall Study||335
2270468|NCT02278003|5573196|P2|NOT COMPLETED|Overall Study||0
2270469|NCT02278003|5573197|P1|NOT COMPLETED|Overall Study||19
2270470|NCT02278003|5573196|P2|COMPLETED|Overall Study||20
2270471|NCT02278003|5573197|P1|COMPLETED|Overall Study||30
2270472|NCT02278003|5573196|P2|STARTED|Overall Study||20
2270473|NCT02278003|5573197|P1|STARTED|Overall Study||49
2270474|NCT02277990|5573207|P2|NOT COMPLETED|Overall Study||376
2270475|NCT02277990|5573208|P1|NOT COMPLETED|Overall Study||366
2270476|NCT02277990|5573207|P2|COMPLETED|Overall Study||3112
2270477|NCT02277990|5573208|P1|COMPLETED|Overall Study||3129
2270478|NCT02277990|5573207|P2|STARTED|Overall Study||3488
2270479|NCT02277990|5573208|P1|STARTED|Overall Study||3495
2270480|NCT02277925|5573222|P2|NOT COMPLETED|Overall Study||15
2270481|NCT02277925|5573223|P1|NOT COMPLETED|Overall Study||7
2270482|NCT02277925|5573222|P2|COMPLETED|Overall Study||87
2270483|NCT02277925|5573223|P1|COMPLETED|Overall Study||95
2270484|NCT02277925|5573222|P2|Surgery|Overall Study||101
2270485|NCT02277925|5573223|P1|Surgery|Overall Study||99
2270486|NCT02277925|5573222|P2|STARTED|Overall Study||102
2270487|NCT02277925|5573223|P1|STARTED|Overall Study||102
2270488|NCT02277769|5573236|P3|NOT COMPLETED|Overall Study||18
2270489|NCT02277769|5573237|P2|NOT COMPLETED|Overall Study||13
2270490|NCT02277769|5573238|P1|NOT COMPLETED|Overall Study||46
2270491|NCT02277769|5573236|P3|COMPLETED|Overall Study||221
2270492|NCT02277769|5573237|P2|COMPLETED|Overall Study||220
2270493|NCT02277769|5573238|P1|COMPLETED|Overall Study||190
2270494|NCT02277769|5573236|P3|Safety Population|Overall Study|2 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|237
2270495|NCT02277769|5573237|P2|Safety Population|Overall Study|3 participants (1 [placebo] + 2 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|236
2270496|NCT02277769|5573238|P1|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|234
2270497|NCT02277769|5573236|P3|Treated|Overall Study||239
2270498|NCT02277769|5573237|P2|Treated|Overall Study||233
2270499|NCT02277769|5573238|P1|Treated|Overall Study||235
2270500|NCT02277769|5573236|P3|STARTED|Overall Study||239
2270501|NCT02277769|5573237|P2|STARTED|Overall Study||233
2270502|NCT02277769|5573238|P1|STARTED|Overall Study||236
2270503|NCT02277743|5573309|P3|NOT COMPLETED|Overall Study||26
2270504|NCT02277743|5573310|P2|NOT COMPLETED|Overall Study||16
2270505|NCT02277743|5573311|P1|NOT COMPLETED|Overall Study||40
2270506|NCT02277743|5573309|P3|COMPLETED|Overall Study||197
2270507|NCT02277743|5573310|P2|COMPLETED|Overall Study||208
2270508|NCT02277743|5573311|P1|COMPLETED|Overall Study||184
2270509|NCT02277743|5573309|P3|Safety Population|Overall Study|5 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|218
2270510|NCT02277743|5573310|P2|Safety Population|Overall Study|6 participants (1 [placebo] + 5 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|229
2270511|NCT02277743|5573311|P1|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|222
2270512|NCT02277743|5573309|P3|Treated|Overall Study||223
2270513|NCT02277743|5573310|P2|Treated|Overall Study||223
2270514|NCT02277743|5573311|P1|Treated|Overall Study||223
2270515|NCT02277743|5573309|P3|STARTED|Overall Study||223
2270516|NCT02277743|5573310|P2|STARTED|Overall Study||224
2270517|NCT02277743|5573311|P1|STARTED|Overall Study||224
2270518|NCT02277691|5573379|P1|NOT COMPLETED|Overall Study||46
2270519|NCT02277691|5573379|P1|COMPLETED|Overall Study||295
2270520|NCT02277691|5573379|P1|STARTED|Overall Study||341
2270521|NCT02277665|5573391|P2|NOT COMPLETED|Overall Study||0
2270522|NCT02277665|5573392|P1|NOT COMPLETED|Overall Study||0
2270523|NCT02277665|5573391|P2|COMPLETED|Overall Study||34
2270524|NCT02277665|5573392|P1|COMPLETED|Overall Study||33
2270525|NCT02277665|5573391|P2|STARTED|Overall Study||34
2270526|NCT02277665|5573392|P1|STARTED|Overall Study||33
2270527|NCT02277639|5573410|P2|NOT COMPLETED|Overall Study||0
2270528|NCT02277639|5573411|P1|NOT COMPLETED|Overall Study||0
2270529|NCT02277639|5573410|P2|COMPLETED|Overall Study||2
2270530|NCT02277639|5573411|P1|COMPLETED|Overall Study||0
2270531|NCT02277639|5573410|P2|STARTED|Overall Study||2
2270532|NCT02277639|5573411|P1|STARTED|Overall Study||0
2270533|NCT02277626|5573417|P2|NOT COMPLETED|Overall Study||0
2270534|NCT02277626|5573418|P1|NOT COMPLETED|Overall Study||0
2270535|NCT02277626|5573417|P2|COMPLETED|Overall Study||9
2270536|NCT02277626|5573418|P1|COMPLETED|Overall Study||6
2270537|NCT02277626|5573417|P2|STARTED|Overall Study||9
2270538|NCT02277626|5573418|P1|STARTED|Overall Study||6
2270539|NCT02277548|5573434|P2|NOT COMPLETED|Overall Study||2
2270540|NCT02277548|5573435|P1|NOT COMPLETED|Overall Study||0
2270541|NCT02277548|5573434|P2|COMPLETED|Overall Study||9
2270542|NCT02277548|5573435|P1|COMPLETED|Overall Study||9
2270543|NCT02277548|5573434|P2|STARTED|Overall Study||11
2270544|NCT02277548|5573435|P1|STARTED|Overall Study||9
2270545|NCT02277249|5573443|P2|NOT COMPLETED|Overall Study||0
2270546|NCT02277249|5573444|P1|NOT COMPLETED|Overall Study||0
2270547|NCT02277249|5573443|P2|COMPLETED|Overall Study||30
2270548|NCT02277249|5573444|P1|COMPLETED|Overall Study||30
2270549|NCT02277249|5573443|P2|STARTED|Overall Study||30
2270550|NCT02277249|5573444|P1|STARTED|Overall Study||30
2270551|NCT02277119|5573453|P3|NOT COMPLETED|Overall Study||8
2270552|NCT02277119|5573454|P2|NOT COMPLETED|Overall Study||4
2270553|NCT02277119|5573455|P1|NOT COMPLETED|Overall Study||3
2270554|NCT02277119|5573453|P3|COMPLETED|Overall Study||19
2270555|NCT02277119|5573454|P2|COMPLETED|Overall Study||20
2270556|NCT02277119|5573455|P1|COMPLETED|Overall Study||55
2270557|NCT02277119|5573453|P3|STARTED|Overall Study||27
2270558|NCT02277119|5573454|P2|STARTED|Overall Study||24
2270559|NCT02277119|5573455|P1|STARTED|Overall Study||58
2270560|NCT02277093|5573472|P1|NOT COMPLETED|Overall Study||0
2270561|NCT02277093|5573472|P1|COMPLETED|Overall Study||11
2270562|NCT02277093|5573472|P1|STARTED|Overall Study||11
2270563|NCT02277054|5573480|P1|NOT COMPLETED|Overall Study||0
2270564|NCT02277054|5573480|P1|COMPLETED|Overall Study||5
2270565|NCT02277054|5573480|P1|STARTED|Overall Study||5
2270566|NCT02276963|5573486|P1|NOT COMPLETED|Overall Study||3
2270567|NCT02276963|5573486|P1|COMPLETED|Overall Study||3
2270568|NCT02276963|5573486|P1|STARTED|Overall Study||6
2270569|NCT02276872|5573493|P3|NOT COMPLETED|Overall Study||0
2270570|NCT02276872|5573494|P2|NOT COMPLETED|Overall Study||0
2270571|NCT02276872|5573495|P1|NOT COMPLETED|Overall Study||1
2270572|NCT02276872|5573493|P3|COMPLETED|Overall Study||12
2270573|NCT02276872|5573494|P2|COMPLETED|Overall Study||10
2270574|NCT02276872|5573495|P1|COMPLETED|Overall Study||9
2270575|NCT02276872|5573493|P3|STARTED|Overall Study||12
2270576|NCT02276872|5573494|P2|STARTED|Overall Study||10
2270577|NCT02276872|5573495|P1|STARTED|Overall Study||10
2270578|NCT02276807|5573571|P2|NOT COMPLETED|Overall Study||17
2270579|NCT02276807|5573572|P1|NOT COMPLETED|Overall Study||18
2270580|NCT02276807|5573571|P2|COMPLETED|Overall Study||55
2270581|NCT02276807|5573572|P1|COMPLETED|Overall Study||50
2270582|NCT02276807|5573571|P2|12-week Assessment|Overall Study||63
2270583|NCT02276807|5573572|P1|12-week Assessment|Overall Study||57
2270584|NCT02276807|5573571|P2|STARTED|Overall Study||72
2270585|NCT02276807|5573572|P1|STARTED|Overall Study||68
2270586|NCT02276638|5573589|P3|NOT COMPLETED|Overall Study||0
2270587|NCT02276638|5573590|P2|NOT COMPLETED|Overall Study||0
2270588|NCT02276638|5573591|P1|NOT COMPLETED|Overall Study||0
2270589|NCT02276638|5573589|P3|COMPLETED|Overall Study||23
2270590|NCT02276638|5573590|P2|COMPLETED|Overall Study||28
2270591|NCT02276638|5573591|P1|COMPLETED|Overall Study||28
2270592|NCT02276638|5573589|P3|STARTED|Overall Study||23
2270593|NCT02276638|5573590|P2|STARTED|Overall Study||28
2270594|NCT02276638|5573591|P1|STARTED|Overall Study||28
2270595|NCT02276612|5573607|P2|NOT COMPLETED|Overall Study||0
2270596|NCT02276612|5573608|P1|NOT COMPLETED|Overall Study||4
2270597|NCT02276612|5573607|P2|COMPLETED|Overall Study||10
2270598|NCT02276612|5573608|P1|COMPLETED|Overall Study||46
2270599|NCT02276612|5573607|P2|STARTED|Overall Study||10
2270600|NCT02276612|5573608|P1|STARTED|Overall Study||50
2270601|NCT02276560|5573631|P3|NOT COMPLETED|Overall Study||0
2270602|NCT02276560|5573632|P2|NOT COMPLETED|Overall Study||0
2270603|NCT02276560|5573633|P1|NOT COMPLETED|Overall Study||1
2270604|NCT02276560|5573631|P3|COMPLETED|Overall Study||0
2270605|NCT02276560|5573632|P2|COMPLETED|Overall Study||0
2270606|NCT02276560|5573633|P1|COMPLETED|Overall Study||0
2270607|NCT02276560|5573631|P3|STARTED|Overall Study||0
2270608|NCT02276560|5573632|P2|STARTED|Overall Study||0
2270609|NCT02276560|5573633|P1|STARTED|Overall Study||1
2270610|NCT02276482|5573643|P2|NOT COMPLETED|Overall Study||1
2270611|NCT02276482|5573644|P1|NOT COMPLETED|Overall Study||3
2270612|NCT02276482|5573643|P2|COMPLETED|Overall Study||28
2270613|NCT02276482|5573644|P1|COMPLETED|Overall Study||88
2270614|NCT02276482|5573643|P2|STARTED|Overall Study||29
2270615|NCT02276482|5573644|P1|STARTED|Overall Study||91
2270616|NCT02276274|5573668|P2|NOT COMPLETED|Second Intervention Period||0
2270617|NCT02276274|5573669|P1|NOT COMPLETED|Second Intervention Period||0
2270618|NCT02276274|5573668|P2|COMPLETED|Second Intervention Period||6
2270619|NCT02276274|5573669|P1|COMPLETED|Second Intervention Period||6
2270620|NCT02276274|5573668|P2|STARTED|Second Intervention Period||6
2270621|NCT02276274|5573669|P1|STARTED|Second Intervention Period||6
2270622|NCT02276274|5573668|P2|NOT COMPLETED|Washout Period (at Least 15 Days)||0
2270623|NCT02276274|5573669|P1|NOT COMPLETED|Washout Period (at Least 15 Days)||0
2270624|NCT02276274|5573668|P2|COMPLETED|Washout Period (at Least 15 Days)||6
2270625|NCT02276274|5573669|P1|COMPLETED|Washout Period (at Least 15 Days)||6
2270626|NCT02276274|5573668|P2|STARTED|Washout Period (at Least 15 Days)||6
2270627|NCT02276274|5573669|P1|STARTED|Washout Period (at Least 15 Days)||6
2270628|NCT02276274|5573668|P2|NOT COMPLETED|First Intervention Period||0
2270629|NCT02276274|5573669|P1|NOT COMPLETED|First Intervention Period||0
2270630|NCT02276274|5573668|P2|COMPLETED|First Intervention Period||6
2270631|NCT02276274|5573669|P1|COMPLETED|First Intervention Period||6
2270632|NCT02276274|5573668|P2|STARTED|First Intervention Period||6
2270633|NCT02276274|5573669|P1|STARTED|First Intervention Period||6
2270634|NCT02276222|5573779|P2|NOT COMPLETED|Overall Study||64
2270635|NCT02276222|5573780|P1|NOT COMPLETED|Overall Study||185
2270636|NCT02276222|5573779|P2|COMPLETED|Overall Study||402
2270726|NCT02275364|5573921|P2|NOT COMPLETED|Washout Period 2||0
2270637|NCT02276222|5573780|P1|COMPLETED|Overall Study|one subject withdrew at randomization due to a pre-treatment event prior to being dosed|436
2270638|NCT02276222|5573779|P2|STARTED|Overall Study||466
2270639|NCT02276222|5573780|P1|STARTED|Overall Study||621
2270640|NCT02276053|5573804|P1|NOT COMPLETED|Overall Study||14
2270641|NCT02276053|5573804|P1|COMPLETED|Overall Study||79
2270642|NCT02276053|5573804|P1|STARTED|Overall Study||93
2270643|NCT02276040|5573820|P1|NOT COMPLETED|Overall Study||15
2270644|NCT02276040|5573820|P1|COMPLETED|Overall Study||11
2270645|NCT02276040|5573820|P1|STARTED|Overall Study||26
2270646|NCT02275923|5573824|P1|NOT COMPLETED|Overall Study||2
2270647|NCT02275923|5573824|P1|COMPLETED|Overall Study||7
2270648|NCT02275923|5573824|P1|STARTED|Overall Study||9
2270649|NCT02275780|5573831|P2|NOT COMPLETED|Extension Study: up to 192 Weeks||233
2270650|NCT02275780|5573832|P1|NOT COMPLETED|Extension Study: up to 192 Weeks||260
2270651|NCT02275780|5573831|P2|COMPLETED|Extension Study: up to 192 Weeks|The extension study is ongoing|0
2270652|NCT02275780|5573832|P1|COMPLETED|Extension Study: up to 192 Weeks|The extension study is ongoing|0
2270653|NCT02275780|5573831|P2|STARTED|Extension Study: up to 192 Weeks|The extension study is optional; not all eligible participants enrolled|233
2270654|NCT02275780|5573832|P1|STARTED|Extension Study: up to 192 Weeks|The extension study is optional; not all eligible participants enrolled|260
2270655|NCT02275780|5573831|P2|NOT COMPLETED|Base Study: 96 Weeks||111
2270656|NCT02275780|5573832|P1|NOT COMPLETED|Base Study: 96 Weeks||93
2270657|NCT02275780|5573831|P2|COMPLETED|Base Study: 96 Weeks||273
2270658|NCT02275780|5573832|P1|COMPLETED|Base Study: 96 Weeks||292
2270659|NCT02275780|5573831|P2|Treated|Base Study: 96 Weeks||383
2270660|NCT02275780|5573832|P1|Treated|Base Study: 96 Weeks||383
2270661|NCT02275780|5573831|P2|STARTED|Base Study: 96 Weeks||384
2270662|NCT02275780|5573832|P1|STARTED|Base Study: 96 Weeks||385
2270663|NCT02275767|5573871|P3|NOT COMPLETED|Overall Study||3
2270664|NCT02275767|5573872|P2|NOT COMPLETED|Overall Study||4
2270665|NCT02275767|5573873|P1|NOT COMPLETED|Overall Study||2
2270666|NCT02275767|5573871|P3|COMPLETED|Overall Study||19
2270667|NCT02275767|5573872|P2|COMPLETED|Overall Study||18
2270668|NCT02275767|5573873|P1|COMPLETED|Overall Study||20
2270669|NCT02275767|5573871|P3|STARTED|Overall Study||22
2270670|NCT02275767|5573872|P2|STARTED|Overall Study||22
2270671|NCT02275767|5573873|P1|STARTED|Overall Study||22
2270672|NCT02275611|5573888|P4|NOT COMPLETED|Outpatient Drinking||0
2270673|NCT02275611|5573889|P3|NOT COMPLETED|Outpatient Drinking||0
2270674|NCT02275611|5573890|P2|NOT COMPLETED|Outpatient Drinking||0
2270675|NCT02275611|5573891|P1|NOT COMPLETED|Outpatient Drinking||0
2270676|NCT02275611|5573888|P4|COMPLETED|Outpatient Drinking||3
2270677|NCT02275611|5573889|P3|COMPLETED|Outpatient Drinking||6
2270678|NCT02275611|5573890|P2|COMPLETED|Outpatient Drinking||0
2270679|NCT02275611|5573891|P1|COMPLETED|Outpatient Drinking||0
2270680|NCT02275611|5573888|P4|STARTED|Outpatient Drinking||3
2270681|NCT02275611|5573889|P3|STARTED|Outpatient Drinking||6
2270682|NCT02275611|5573890|P2|STARTED|Outpatient Drinking||0
2270683|NCT02275611|5573891|P1|STARTED|Outpatient Drinking||0
2270684|NCT02275611|5573888|P4|NOT COMPLETED|Inpatient Withdrawal||0
2270685|NCT02275611|5573889|P3|NOT COMPLETED|Inpatient Withdrawal||0
2270686|NCT02275611|5573890|P2|NOT COMPLETED|Inpatient Withdrawal||0
2270687|NCT02275611|5573891|P1|NOT COMPLETED|Inpatient Withdrawal||1
2270688|NCT02275611|5573888|P4|COMPLETED|Inpatient Withdrawal||0
2270689|NCT02275611|5573889|P3|COMPLETED|Inpatient Withdrawal||0
2270690|NCT02275611|5573890|P2|COMPLETED|Inpatient Withdrawal||4
2270691|NCT02275611|5573891|P1|COMPLETED|Inpatient Withdrawal||4
2270692|NCT02275611|5573888|P4|STARTED|Inpatient Withdrawal||0
2270693|NCT02275611|5573889|P3|STARTED|Inpatient Withdrawal||0
2270694|NCT02275611|5573890|P2|STARTED|Inpatient Withdrawal||4
2270695|NCT02275611|5573891|P1|STARTED|Inpatient Withdrawal||5
2270696|NCT02275546|5573903|P2|NOT COMPLETED|Treatment Period 2||2
2270697|NCT02275546|5573904|P1|NOT COMPLETED|Treatment Period 2||2
2270698|NCT02275546|5573903|P2|COMPLETED|Treatment Period 2||81
2270699|NCT02275546|5573904|P1|COMPLETED|Treatment Period 2||79
2270700|NCT02275546|5573903|P2|STARTED|Treatment Period 2||83
2270701|NCT02275546|5573904|P1|STARTED|Treatment Period 2||81
2270702|NCT02275546|5573903|P2|NOT COMPLETED|Treatment Period 1||0
2270703|NCT02275546|5573904|P1|NOT COMPLETED|Treatment Period 1||0
2270704|NCT02275546|5573903|P2|COMPLETED|Treatment Period 1||83
2270705|NCT02275546|5573904|P1|COMPLETED|Treatment Period 1||81
2270706|NCT02275546|5573903|P2|STARTED|Treatment Period 1||83
2270707|NCT02275546|5573904|P1|STARTED|Treatment Period 1||81
2270708|NCT02275481|5573914|P2|NOT COMPLETED|Overall Study||3
2270709|NCT02275481|5573915|P1|NOT COMPLETED|Overall Study||9
2270710|NCT02275481|5573914|P2|COMPLETED|Overall Study||31
2270711|NCT02275481|5573915|P1|COMPLETED|Overall Study||23
2270712|NCT02275481|5573914|P2|STARTED|Overall Study||34
2270713|NCT02275481|5573915|P1|STARTED|Overall Study||32
2270714|NCT02275364|5573921|P2|NOT COMPLETED|Period 4||0
2270715|NCT02275364|5573922|P1|NOT COMPLETED|Period 4||0
2270716|NCT02275364|5573921|P2|COMPLETED|Period 4||14
2270717|NCT02275364|5573922|P1|COMPLETED|Period 4||12
2270718|NCT02275364|5573921|P2|STARTED|Period 4||14
2270719|NCT02275364|5573922|P1|STARTED|Period 4||12
2270720|NCT02275364|5573921|P2|NOT COMPLETED|Period 3||0
2270721|NCT02275364|5573922|P1|NOT COMPLETED|Period 3||0
2270722|NCT02275364|5573921|P2|COMPLETED|Period 3||14
2270723|NCT02275364|5573922|P1|COMPLETED|Period 3||12
2270724|NCT02275364|5573921|P2|STARTED|Period 3||14
2270725|NCT02275364|5573922|P1|STARTED|Period 3||12
2270727|NCT02275364|5573922|P1|NOT COMPLETED|Washout Period 2||0
2270728|NCT02275364|5573921|P2|COMPLETED|Washout Period 2||14
2270729|NCT02275364|5573922|P1|COMPLETED|Washout Period 2||12
2270730|NCT02275364|5573921|P2|STARTED|Washout Period 2||14
2270731|NCT02275364|5573922|P1|STARTED|Washout Period 2||12
2270732|NCT02275364|5573921|P2|NOT COMPLETED|Period 2||0
2270733|NCT02275364|5573922|P1|NOT COMPLETED|Period 2||0
2270734|NCT02275364|5573921|P2|COMPLETED|Period 2||14
2270735|NCT02275364|5573922|P1|COMPLETED|Period 2||12
2270736|NCT02275364|5573921|P2|STARTED|Period 2||14
2270737|NCT02275364|5573922|P1|STARTED|Period 2||12
2270738|NCT02275364|5573921|P2|NOT COMPLETED|Washout Period 1||0
2270739|NCT02275364|5573922|P1|NOT COMPLETED|Washout Period 1||0
2270740|NCT02275364|5573921|P2|COMPLETED|Washout Period 1||14
2270741|NCT02275364|5573922|P1|COMPLETED|Washout Period 1||12
2270742|NCT02275364|5573921|P2|STARTED|Washout Period 1||14
2270743|NCT02275364|5573922|P1|STARTED|Washout Period 1||12
2270744|NCT02275364|5573921|P2|NOT COMPLETED|Period 1||0
2270745|NCT02275364|5573922|P1|NOT COMPLETED|Period 1||2
2270746|NCT02275364|5573921|P2|COMPLETED|Period 1||14
2270747|NCT02275364|5573922|P1|COMPLETED|Period 1||12
2270748|NCT02275364|5573921|P2|STARTED|Period 1||14
2270749|NCT02275364|5573922|P1|STARTED|Period 1||14
2270750|NCT02275338|5573951|P1|NOT COMPLETED|Overall Study||33
2270751|NCT02275338|5573951|P1|COMPLETED|Overall Study||19
2270752|NCT02275338|5573951|P1|Started Phase 2|Overall Study||21
2270753|NCT02275338|5573951|P1|Completed Phase 1|Overall Study||25
2270754|NCT02275338|5573951|P1|STARTED|Overall Study||52
2270755|NCT02275156|5573966|P3|NOT COMPLETED|Overall Study||0
2270756|NCT02275156|5573967|P2|NOT COMPLETED|Overall Study||0
2270757|NCT02275156|5573968|P1|NOT COMPLETED|Overall Study||0
2270758|NCT02275156|5573966|P3|COMPLETED|Overall Study||6
2270759|NCT02275156|5573967|P2|COMPLETED|Overall Study||6
2270760|NCT02275156|5573968|P1|COMPLETED|Overall Study||6
2270761|NCT02275156|5573966|P3|STARTED|Overall Study||6
2270762|NCT02275156|5573967|P2|STARTED|Overall Study||6
2270763|NCT02275156|5573968|P1|STARTED|Overall Study||6
2270764|NCT02275052|5573995|P4|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||14
2270765|NCT02275052|5573996|P3|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||5
2270766|NCT02275052|5573997|P2|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
2270767|NCT02275052|5573998|P1|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
2270768|NCT02275052|5573995|P4|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||72
2270769|NCT02275052|5573996|P3|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||88
2270770|NCT02275052|5573997|P2|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
2270771|NCT02275052|5573998|P1|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
2270772|NCT02275052|5573995|P4|STARTED|Period 2: Treatment Period 2 (12 Weeks)||86
2270773|NCT02275052|5573996|P3|STARTED|Period 2: Treatment Period 2 (12 Weeks)||93
2270774|NCT02275052|5573997|P2|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
2270775|NCT02275052|5573998|P1|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
2270776|NCT02275052|5573995|P4|NOT COMPLETED|Washout Period (12-17 Days)||0
2270777|NCT02275052|5573996|P3|NOT COMPLETED|Washout Period (12-17 Days)||0
2270778|NCT02275052|5573997|P2|NOT COMPLETED|Washout Period (12-17 Days)||0
2270779|NCT02275052|5573998|P1|NOT COMPLETED|Washout Period (12-17 Days)||4
2270780|NCT02275052|5573995|P4|COMPLETED|Washout Period (12-17 Days)||0
2270781|NCT02275052|5573996|P3|COMPLETED|Washout Period (12-17 Days)||0
2270782|NCT02275052|5573997|P2|COMPLETED|Washout Period (12-17 Days)||93
2270783|NCT02275052|5573998|P1|COMPLETED|Washout Period (12-17 Days)||86
2270784|NCT02275052|5573995|P4|STARTED|Washout Period (12-17 Days)||0
2270785|NCT02275052|5573996|P3|STARTED|Washout Period (12-17 Days)||0
2270786|NCT02275052|5573997|P2|STARTED|Washout Period (12-17 Days)||93
2270787|NCT02275052|5573998|P1|STARTED|Washout Period (12-17 Days)||90
2270788|NCT02275052|5573995|P4|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
2270789|NCT02275052|5573996|P3|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
2270790|NCT02275052|5573997|P2|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||6
2270791|NCT02275052|5573998|P1|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||9
2270792|NCT02275052|5573995|P4|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
2270793|NCT02275052|5573996|P3|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
2270794|NCT02275052|5573997|P2|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||93
2270795|NCT02275052|5573998|P1|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||90
2270796|NCT02275052|5573995|P4|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
2270797|NCT02275052|5573996|P3|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
2270798|NCT02275052|5573997|P2|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
2270799|NCT02275052|5573998|P1|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
2270800|NCT02274948|5574012|P2|NOT COMPLETED|Overall Study||91
2270801|NCT02274948|5574013|P1|NOT COMPLETED|Overall Study||98
2270802|NCT02274948|5574012|P2|COMPLETED|Overall Study||82
2270803|NCT02274948|5574013|P1|COMPLETED|Overall Study||68
2270804|NCT02274948|5574012|P2|STARTED|Overall Study||173
2270805|NCT02274948|5574013|P1|STARTED|Overall Study||166
2270806|NCT02274870|5574029|P2|NOT COMPLETED|Overall Study||0
2270807|NCT02274870|5574030|P1|NOT COMPLETED|Overall Study||0
2270808|NCT02274870|5574029|P2|COMPLETED|Overall Study||33
2270809|NCT02274870|5574030|P1|COMPLETED|Overall Study||32
2270810|NCT02274870|5574029|P2|STARTED|Overall Study||33
2270811|NCT02274870|5574030|P1|STARTED|Overall Study||32
2270812|NCT02274857|5574056|P2|NOT COMPLETED|Overall Study||6
2270813|NCT02274857|5574057|P1|NOT COMPLETED|Overall Study||20
2270814|NCT02274857|5574056|P2|COMPLETED|Overall Study||165
2270815|NCT02274857|5574057|P1|COMPLETED|Overall Study||159
2270816|NCT02274857|5574056|P2|Completed Per Protocol|Overall Study||114
2270817|NCT02274857|5574057|P1|Completed Per Protocol|Overall Study||102
2270818|NCT02274857|5574056|P2|STARTED|Overall Study||171
2270819|NCT02274857|5574057|P1|STARTED|Overall Study||179
2270820|NCT02274792|5574070|P1|NOT COMPLETED|Overall Study||25
2270821|NCT02274792|5574070|P1|COMPLETED|Overall Study||107
2270822|NCT02274792|5574070|P1|Received Treatment|Overall Study||131
2270823|NCT02274792|5574070|P1|STARTED|Overall Study||132
2270824|NCT02274766|5574080|P2|NOT COMPLETED|Overall Study||9
2270825|NCT02274766|5574081|P1|NOT COMPLETED|Overall Study||4
2270826|NCT02274766|5574080|P2|COMPLETED|Overall Study||29
2270827|NCT02274766|5574081|P1|COMPLETED|Overall Study||35
2270828|NCT02274766|5574080|P2|Received Study Drug|Overall Study||37
2270829|NCT02274766|5574081|P1|Received Study Drug|Overall Study||38
2270830|NCT02274766|5574080|P2|STARTED|Overall Study||38
2270831|NCT02274766|5574081|P1|STARTED|Overall Study||39
2270832|NCT02274688|5574091|P2|NOT COMPLETED|Overall Study||13
2270833|NCT02274688|5574092|P1|NOT COMPLETED|Overall Study||14
2270834|NCT02274688|5574091|P2|COMPLETED|Overall Study||72
2270835|NCT02274688|5574092|P1|COMPLETED|Overall Study||72
2270836|NCT02274688|5574091|P2|STARTED|Overall Study||85
2270837|NCT02274688|5574092|P1|STARTED|Overall Study||86
2270838|NCT02274675|5574114|P1|NOT COMPLETED|Overall Study||0
2270839|NCT02274675|5574114|P1|COMPLETED|Overall Study||7
2270840|NCT02274675|5574114|P1|STARTED|Overall Study||7
2270841|NCT02274649|5574126|P2|NOT COMPLETED|Overall Study||12
2270842|NCT02274649|5574127|P1|NOT COMPLETED|Overall Study||24
2270843|NCT02274649|5574126|P2|COMPLETED|Overall Study||81
2270844|NCT02274649|5574127|P1|COMPLETED|Overall Study||77
2270845|NCT02274649|5574126|P2|STARTED|Overall Study||93
2270846|NCT02274649|5574127|P1|STARTED|Overall Study||101
2270847|NCT02274558|5574148|P3|NOT COMPLETED|Overall Study||9
2270848|NCT02274558|5574149|P2|NOT COMPLETED|Overall Study||13
2270849|NCT02274558|5574150|P1|NOT COMPLETED|Overall Study||7
2270850|NCT02274558|5574148|P3|COMPLETED|Overall Study||71
2270851|NCT02274558|5574149|P2|COMPLETED|Overall Study||63
2270852|NCT02274558|5574150|P1|COMPLETED|Overall Study||71
2270853|NCT02274558|5574148|P3|Included in the Safety Analysis Set|Overall Study||79
2270854|NCT02274558|5574149|P2|Included in the Safety Analysis Set|Overall Study||72
2270855|NCT02274558|5574150|P1|Included in the Safety Analysis Set|Overall Study||76
2270856|NCT02274558|5574148|P3|STARTED|Overall Study||80
2270857|NCT02274558|5574149|P2|STARTED|Overall Study||76
2270858|NCT02274558|5574150|P1|STARTED|Overall Study||78
2270859|NCT02274493|5574164|P1|NOT COMPLETED|Overall Study||1
2270860|NCT02274493|5574164|P1|COMPLETED|Overall Study||14
2270861|NCT02274493|5574164|P1|STARTED|Overall Study||15
2270862|NCT02274311|5574171|P1|NOT COMPLETED|Three Months of Clomiphene Wash-out||1
2270863|NCT02274311|5574171|P1|COMPLETED|Three Months of Clomiphene Wash-out||15
2270864|NCT02274311|5574171|P1|STARTED|Three Months of Clomiphene Wash-out||16
2270865|NCT02274311|5574171|P1|NOT COMPLETED|Three Months of Clomiphene Treatment||0
2270866|NCT02274311|5574171|P1|COMPLETED|Three Months of Clomiphene Treatment||16
2270867|NCT02274311|5574171|P1|STARTED|Three Months of Clomiphene Treatment||16
2270868|NCT02273973|5574179|P2|NOT COMPLETED|Overall Study||8
2270869|NCT02273973|5574180|P1|NOT COMPLETED|Overall Study||9
2270870|NCT02273973|5574179|P2|COMPLETED|Overall Study||160
2270871|NCT02273973|5574180|P1|COMPLETED|Overall Study||157
2270872|NCT02273973|5574179|P2|STARTED|Overall Study||168
2270873|NCT02273973|5574180|P1|STARTED|Overall Study||166
2270874|NCT02273960|5574224|P4|NOT COMPLETED|Long Term Extension||1
2270875|NCT02273960|5574225|P3|NOT COMPLETED|Long Term Extension||0
2270876|NCT02273960|5574226|P2|NOT COMPLETED|Long Term Extension||0
2270877|NCT02273960|5574227|P1|NOT COMPLETED|Long Term Extension||0
2270878|NCT02273960|5574224|P4|COMPLETED|Long Term Extension||3
2270879|NCT02273960|5574225|P3|COMPLETED|Long Term Extension||1
2270880|NCT02273960|5574226|P2|COMPLETED|Long Term Extension||0
2270881|NCT02273960|5574227|P1|COMPLETED|Long Term Extension||0
2270882|NCT02273960|5574224|P4|STARTED|Long Term Extension||4
2270883|NCT02273960|5574225|P3|STARTED|Long Term Extension||1
2270884|NCT02273960|5574226|P2|STARTED|Long Term Extension||0
2270885|NCT02273960|5574227|P1|STARTED|Long Term Extension||0
2270886|NCT02273960|5574224|P4|NOT COMPLETED|Short Term Period||6
2270887|NCT02273960|5574225|P3|NOT COMPLETED|Short Term Period||4
2270888|NCT02273960|5574226|P2|NOT COMPLETED|Short Term Period||6
2270889|NCT02273960|5574227|P1|NOT COMPLETED|Short Term Period||5
2270890|NCT02273960|5574224|P4|COMPLETED|Short Term Period||4
2270891|NCT02273960|5574225|P3|COMPLETED|Short Term Period||1
2270892|NCT02273960|5574226|P2|COMPLETED|Short Term Period||0
2270893|NCT02273960|5574227|P1|COMPLETED|Short Term Period||0
2270894|NCT02273960|5574224|P4|STARTED|Short Term Period||10
2270895|NCT02273960|5574225|P3|STARTED|Short Term Period||5
2270896|NCT02273960|5574226|P2|STARTED|Short Term Period||6
2270897|NCT02273960|5574227|P1|STARTED|Short Term Period||5
2270898|NCT02273908|5574271|P2|NOT COMPLETED|Overall Study||5
2270899|NCT02273908|5574272|P1|NOT COMPLETED|Overall Study||33
2270900|NCT02273908|5574271|P2|COMPLETED|Overall Study||169
2270901|NCT02273908|5574272|P1|COMPLETED|Overall Study||124
2270902|NCT02273908|5574271|P2|STARTED|Overall Study||174
2270903|NCT02273908|5574272|P1|STARTED|Overall Study||157
2270904|NCT02273752|5574294|P1|NOT COMPLETED|Overall Study||2
2270905|NCT02273752|5574294|P1|COMPLETED|Overall Study||0
2270906|NCT02273752|5574294|P1|STARTED|Overall Study||2
2270907|NCT02273323|5574305|P2|NOT COMPLETED|Overall Study||0
2270908|NCT02273323|5574306|P1|NOT COMPLETED|Overall Study||0
2270909|NCT02273323|5574305|P2|COMPLETED|Overall Study||15
2270910|NCT02273323|5574306|P1|COMPLETED|Overall Study||15
2270911|NCT02273323|5574305|P2|STARTED|Overall Study||15
2270912|NCT02273323|5574306|P1|STARTED|Overall Study||15
2270913|NCT02273310|5574324|P2|NOT COMPLETED|Overall Study||3
2270914|NCT02273310|5574325|P1|NOT COMPLETED|Overall Study||18
2270915|NCT02273310|5574324|P2|COMPLETED|Overall Study||38
2270916|NCT02273310|5574325|P1|COMPLETED|Overall Study||24
2270917|NCT02273310|5574324|P2|STARTED|Overall Study||41
2270918|NCT02273310|5574325|P1|STARTED|Overall Study||42
2270919|NCT02273180|5574338|P2|NOT COMPLETED|Overall Study||19
2270920|NCT02273180|5574339|P1|NOT COMPLETED|Overall Study||27
2270921|NCT02273180|5574338|P2|COMPLETED|Overall Study||235
2270922|NCT02273180|5574339|P1|COMPLETED|Overall Study||226
2270923|NCT02273180|5574338|P2|Treated|Overall Study||254
2270924|NCT02273180|5574339|P1|Treated|Overall Study||252
2270925|NCT02273180|5574338|P2|STARTED|Overall Study||254
2270926|NCT02273180|5574339|P1|STARTED|Overall Study||253
2270927|NCT02273167|5574364|P3|NOT COMPLETED|Overall Study||21
2270928|NCT02273167|5574365|P2|NOT COMPLETED|Overall Study||23
2270929|NCT02273167|5574366|P1|NOT COMPLETED|Overall Study||24
2270930|NCT02273167|5574364|P3|COMPLETED|Overall Study||262
2270931|NCT02273167|5574365|P2|COMPLETED|Overall Study||260
2270932|NCT02273167|5574366|P1|COMPLETED|Overall Study||259
2270933|NCT02273167|5574364|P3|STARTED|Overall Study||283
2270934|NCT02273167|5574365|P2|STARTED|Overall Study||283
2270935|NCT02273167|5574366|P1|STARTED|Overall Study||283
2270936|NCT02273141|5574391|P2|NOT COMPLETED|Overall Study||25
2270937|NCT02273141|5574392|P1|NOT COMPLETED|Overall Study||17
2270938|NCT02273141|5574391|P2|COMPLETED|Overall Study||233
2270939|NCT02273141|5574392|P1|COMPLETED|Overall Study||240
2270940|NCT02273141|5574391|P2|STARTED|Overall Study||258
2270941|NCT02273141|5574392|P1|STARTED|Overall Study||257
2270942|NCT02273115|5574412|P4|NOT COMPLETED|Overall Study||1
2270943|NCT02273115|5574413|P3|NOT COMPLETED|Overall Study||0
2270944|NCT02273115|5574414|P2|NOT COMPLETED|Overall Study||0
2270945|NCT02273115|5574415|P1|NOT COMPLETED|Overall Study||0
2270946|NCT02273115|5574412|P4|COMPLETED|Overall Study||71
2270947|NCT02273115|5574413|P3|COMPLETED|Overall Study||67
2270948|NCT02273115|5574414|P2|COMPLETED|Overall Study||90
2270949|NCT02273115|5574415|P1|COMPLETED|Overall Study||94
2270950|NCT02273115|5574412|P4|STARTED|Overall Study||72
2270951|NCT02273115|5574413|P3|STARTED|Overall Study||67
2270952|NCT02273115|5574414|P2|STARTED|Overall Study||90
2270953|NCT02273115|5574415|P1|STARTED|Overall Study||94
2270954|NCT02273063|5574457|P1|NOT COMPLETED|Overall Study||5
2270955|NCT02273063|5574457|P1|COMPLETED|Overall Study||35
2270956|NCT02273063|5574457|P1|STARTED|Overall Study||40
2270957|NCT02273050|5574465|P3|NOT COMPLETED|Overall Study||29
2270958|NCT02273050|5574466|P2|NOT COMPLETED|Overall Study||22
2270959|NCT02273050|5574467|P1|NOT COMPLETED|Overall Study||24
2270960|NCT02273050|5574465|P3|COMPLETED|Overall Study||185
2270961|NCT02273050|5574466|P2|COMPLETED|Overall Study||194
2270962|NCT02273050|5574467|P1|COMPLETED|Overall Study||186
2270963|NCT02273050|5574465|P3|STARTED|Overall Study||214
2270964|NCT02273050|5574466|P2|STARTED|Overall Study||216
2270965|NCT02273050|5574467|P1|STARTED|Overall Study||210
2270966|NCT02273037|5574495|P2|NOT COMPLETED|Overall Study||8
2270967|NCT02273037|5574496|P1|NOT COMPLETED|Overall Study||8
2270968|NCT02273037|5574495|P2|COMPLETED|Overall Study||992
2270969|NCT02273037|5574496|P1|COMPLETED|Overall Study||979
2270970|NCT02273037|5574495|P2|STARTED|Overall Study||1000
2270971|NCT02273037|5574496|P1|STARTED|Overall Study||987
2270972|NCT02272985|5574506|P1|NOT COMPLETED|Overall Study||3
2270973|NCT02272985|5574506|P1|COMPLETED|Overall Study||12
2270974|NCT02272985|5574506|P1|STARTED|Overall Study||15
2270975|NCT02272816|5574511|P1|NOT COMPLETED|Overall Study||1
2270976|NCT02272816|5574511|P1|COMPLETED|Overall Study||47
2270977|NCT02272816|5574511|P1|STARTED|Overall Study||48
2270978|NCT02272803|5574519|P2|NOT COMPLETED|Overall Study||17
2270979|NCT02272803|5574520|P1|NOT COMPLETED|Overall Study||9
2270980|NCT02272803|5574519|P2|COMPLETED|Overall Study|Completed = Still receiving treatment|25
2270981|NCT02272803|5574520|P1|COMPLETED|Overall Study|Completed = Still receiving treatment|31
2270982|NCT02272803|5574519|P2|STARTED|Overall Study||42
2270983|NCT02272803|5574520|P1|STARTED|Overall Study||40
2270984|NCT02272790|5574537|P6|NOT COMPLETED|Overall Study||0
2270985|NCT02272790|5574538|P5|NOT COMPLETED|Overall Study||0
2270986|NCT02272790|5574539|P4|NOT COMPLETED|Overall Study||0
2270987|NCT02272790|5574540|P3|NOT COMPLETED|Overall Study||0
2270988|NCT02272790|5574541|P2|NOT COMPLETED|Overall Study||1
2270989|NCT02272790|5574542|P1|NOT COMPLETED|Overall Study||0
2270990|NCT02272790|5574537|P6|COMPLETED|Overall Study||6
2270991|NCT02272790|5574538|P5|COMPLETED|Overall Study||6
2270992|NCT02272790|5574539|P4|COMPLETED|Overall Study||12
2270993|NCT02272790|5574540|P3|COMPLETED|Overall Study||23
2270994|NCT02272790|5574541|P2|COMPLETED|Overall Study||38
2270995|NCT02272790|5574542|P1|COMPLETED|Overall Study||9
2270996|NCT02272790|5574537|P6|STARTED|Overall Study||6
2270997|NCT02272790|5574538|P5|STARTED|Overall Study||6
2270998|NCT02272790|5574539|P4|STARTED|Overall Study||12
2270999|NCT02272790|5574540|P3|STARTED|Overall Study||23
2271000|NCT02272790|5574541|P2|STARTED|Overall Study||39
2271001|NCT02272790|5574542|P1|STARTED|Overall Study||9
2271002|NCT02272777|5574678|P2|NOT COMPLETED|Overall Study||4
2271003|NCT02272777|5574679|P1|NOT COMPLETED|Overall Study||4
2271004|NCT02272777|5574678|P2|COMPLETED|Overall Study||109
2271005|NCT02272777|5574679|P1|COMPLETED|Overall Study||108
2271006|NCT02272777|5574678|P2|STARTED|Overall Study||113
2271007|NCT02272777|5574679|P1|STARTED|Overall Study||112
2271008|NCT02272725|5574687|P2|NOT COMPLETED|Overall Study||0
2271009|NCT02272725|5574688|P1|NOT COMPLETED|Overall Study||2
2271010|NCT02272725|5574687|P2|COMPLETED|Overall Study||42
2271011|NCT02272725|5574688|P1|COMPLETED|Overall Study||47
2271012|NCT02272725|5574687|P2|STARTED|Overall Study||42
2271013|NCT02272725|5574688|P1|STARTED|Overall Study||49
2271014|NCT02272686|5574698|P1|NOT COMPLETED|Overall Study||0
2271015|NCT02272686|5574698|P1|COMPLETED|Overall Study||1
2271016|NCT02272686|5574698|P1|STARTED|Overall Study||1
2271017|NCT02272413|5574705|P2|NOT COMPLETED|Post-switch Period||46
2271018|NCT02272413|5574706|P1|NOT COMPLETED|Post-switch Period||42
2271019|NCT02272413|5574705|P2|COMPLETED|Post-switch Period||0
2271020|NCT02272413|5574706|P1|COMPLETED|Post-switch Period||0
2271021|NCT02272413|5574705|P2|STARTED|Post-switch Period|Started for this period|46
2271022|NCT02272413|5574706|P1|STARTED|Post-switch Period|Started for this period|42
2271023|NCT02272413|5574705|P2|NOT COMPLETED|Pre-switch Period||282
2271024|NCT02272413|5574706|P1|NOT COMPLETED|Pre-switch Period||293
2271025|NCT02272413|5574705|P2|COMPLETED|Pre-switch Period||46
2271026|NCT02272413|5574706|P1|COMPLETED|Pre-switch Period||42
2271027|NCT02272413|5574705|P2|STARTED|Pre-switch Period|Started for this period|328
2271028|NCT02272413|5574706|P1|STARTED|Pre-switch Period|Started for this period|335
2271029|NCT02272413|5574705|P2|NOT COMPLETED|Randomized Through Treatment Start||5
2271030|NCT02272413|5574706|P1|NOT COMPLETED|Randomized Through Treatment Start||3
2271031|NCT02272413|5574705|P2|COMPLETED|Randomized Through Treatment Start||328
2271032|NCT02272413|5574706|P1|COMPLETED|Randomized Through Treatment Start||335
2271033|NCT02272413|5574705|P2|Treated|Randomized Through Treatment Start||328
2271034|NCT02272413|5574706|P1|Treated|Randomized Through Treatment Start||335
2271035|NCT02272413|5574705|P2|STARTED|Randomized Through Treatment Start|Started for this period|333
2271036|NCT02272413|5574706|P1|STARTED|Randomized Through Treatment Start|Started for this period|338
2271037|NCT02272244|5574724|P2|NOT COMPLETED|Overall Study||0
2271038|NCT02272244|5574725|P1|NOT COMPLETED|Overall Study||0
2271039|NCT02272244|5574724|P2|COMPLETED|Overall Study||197
2271040|NCT02272244|5574725|P1|COMPLETED|Overall Study||203
2271041|NCT02272244|5574724|P2|STARTED|Overall Study||197
2271042|NCT02272244|5574725|P1|STARTED|Overall Study||203
2271043|NCT02271984|5574737|P12|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
2271044|NCT02271984|5574738|P11|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
2271045|NCT02271984|5574739|P10|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
2271046|NCT02271984|5574740|P9|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
2271047|NCT02271984|5574741|P8|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
2271048|NCT02271984|5574742|P7|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
2271049|NCT02271984|5574743|P6|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
2271050|NCT02271984|5574744|P5|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
2271051|NCT02271984|5574745|P4|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
2271052|NCT02271984|5574746|P3|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
2271053|NCT02271984|5574747|P2|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
2271054|NCT02271984|5574748|P1|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
2271055|NCT02271984|5574737|P12|COMPLETED|Fifth Intervention Period (1 Day)||3
2271056|NCT02271984|5574738|P11|COMPLETED|Fifth Intervention Period (1 Day)||3
2271057|NCT02271984|5574739|P10|COMPLETED|Fifth Intervention Period (1 Day)||3
2271058|NCT02271984|5574740|P9|COMPLETED|Fifth Intervention Period (1 Day)||3
2271059|NCT02271984|5574741|P8|COMPLETED|Fifth Intervention Period (1 Day)||2
2271060|NCT02271984|5574742|P7|COMPLETED|Fifth Intervention Period (1 Day)||3
2271061|NCT02271984|5574743|P6|COMPLETED|Fifth Intervention Period (1 Day)||2
2271062|NCT02271984|5574744|P5|COMPLETED|Fifth Intervention Period (1 Day)||3
2271063|NCT02271984|5574745|P4|COMPLETED|Fifth Intervention Period (1 Day)||3
2271064|NCT02271984|5574746|P3|COMPLETED|Fifth Intervention Period (1 Day)||3
2271065|NCT02271984|5574747|P2|COMPLETED|Fifth Intervention Period (1 Day)||3
2271066|NCT02271984|5574748|P1|COMPLETED|Fifth Intervention Period (1 Day)||3
2271067|NCT02271984|5574737|P12|STARTED|Fifth Intervention Period (1 Day)||3
2271068|NCT02271984|5574738|P11|STARTED|Fifth Intervention Period (1 Day)||3
2271069|NCT02271984|5574739|P10|STARTED|Fifth Intervention Period (1 Day)||3
2271070|NCT02271984|5574740|P9|STARTED|Fifth Intervention Period (1 Day)||3
2271071|NCT02271984|5574741|P8|STARTED|Fifth Intervention Period (1 Day)||2
2271072|NCT02271984|5574742|P7|STARTED|Fifth Intervention Period (1 Day)||3
2271073|NCT02271984|5574743|P6|STARTED|Fifth Intervention Period (1 Day)||2
2271074|NCT02271984|5574744|P5|STARTED|Fifth Intervention Period (1 Day)||3
2271075|NCT02271984|5574745|P4|STARTED|Fifth Intervention Period (1 Day)||3
2271076|NCT02271984|5574746|P3|STARTED|Fifth Intervention Period (1 Day)||3
2271077|NCT02271984|5574747|P2|STARTED|Fifth Intervention Period (1 Day)||3
2271078|NCT02271984|5574748|P1|STARTED|Fifth Intervention Period (1 Day)||3
2271079|NCT02271984|5574737|P12|NOT COMPLETED|Washout Period 4 (7 Days)||0
2271080|NCT02271984|5574738|P11|NOT COMPLETED|Washout Period 4 (7 Days)||0
2271081|NCT02271984|5574739|P10|NOT COMPLETED|Washout Period 4 (7 Days)||0
2271082|NCT02271984|5574740|P9|NOT COMPLETED|Washout Period 4 (7 Days)||0
2271083|NCT02271984|5574741|P8|NOT COMPLETED|Washout Period 4 (7 Days)||1
2271084|NCT02271984|5574742|P7|NOT COMPLETED|Washout Period 4 (7 Days)||0
2271085|NCT02271984|5574743|P6|NOT COMPLETED|Washout Period 4 (7 Days)||1
2271086|NCT02271984|5574744|P5|NOT COMPLETED|Washout Period 4 (7 Days)||0
2271087|NCT02271984|5574745|P4|NOT COMPLETED|Washout Period 4 (7 Days)||0
2271088|NCT02271984|5574746|P3|NOT COMPLETED|Washout Period 4 (7 Days)||0
2271089|NCT02271984|5574747|P2|NOT COMPLETED|Washout Period 4 (7 Days)||0
2271090|NCT02271984|5574748|P1|NOT COMPLETED|Washout Period 4 (7 Days)||0
2271091|NCT02271984|5574737|P12|COMPLETED|Washout Period 4 (7 Days)||3
2271092|NCT02271984|5574738|P11|COMPLETED|Washout Period 4 (7 Days)||3
2271093|NCT02271984|5574739|P10|COMPLETED|Washout Period 4 (7 Days)||3
2271094|NCT02271984|5574740|P9|COMPLETED|Washout Period 4 (7 Days)||3
2271095|NCT02271984|5574741|P8|COMPLETED|Washout Period 4 (7 Days)||2
2271096|NCT02271984|5574742|P7|COMPLETED|Washout Period 4 (7 Days)||3
2271097|NCT02271984|5574743|P6|COMPLETED|Washout Period 4 (7 Days)||2
2271098|NCT02271984|5574744|P5|COMPLETED|Washout Period 4 (7 Days)||3
2271099|NCT02271984|5574745|P4|COMPLETED|Washout Period 4 (7 Days)||3
2271100|NCT02271984|5574746|P3|COMPLETED|Washout Period 4 (7 Days)||3
2271101|NCT02271984|5574747|P2|COMPLETED|Washout Period 4 (7 Days)||3
2271102|NCT02271984|5574748|P1|COMPLETED|Washout Period 4 (7 Days)||3
2271103|NCT02271984|5574737|P12|STARTED|Washout Period 4 (7 Days)||3
2271104|NCT02271984|5574738|P11|STARTED|Washout Period 4 (7 Days)||3
2271105|NCT02271984|5574739|P10|STARTED|Washout Period 4 (7 Days)||3
2271106|NCT02271984|5574740|P9|STARTED|Washout Period 4 (7 Days)||3
2271107|NCT02271984|5574741|P8|STARTED|Washout Period 4 (7 Days)||3
2271108|NCT02271984|5574742|P7|STARTED|Washout Period 4 (7 Days)||3
2271109|NCT02271984|5574743|P6|STARTED|Washout Period 4 (7 Days)||3
2271110|NCT02271984|5574744|P5|STARTED|Washout Period 4 (7 Days)||3
2271111|NCT02271984|5574745|P4|STARTED|Washout Period 4 (7 Days)||3
2271112|NCT02271984|5574746|P3|STARTED|Washout Period 4 (7 Days)||3
2271113|NCT02271984|5574747|P2|STARTED|Washout Period 4 (7 Days)||3
2271114|NCT02271984|5574748|P1|STARTED|Washout Period 4 (7 Days)||3
2271115|NCT02271984|5574737|P12|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
2271116|NCT02271984|5574738|P11|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
2271117|NCT02271984|5574739|P10|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
2271118|NCT02271984|5574740|P9|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
2271119|NCT02271984|5574741|P8|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
2271120|NCT02271984|5574742|P7|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
2271121|NCT02271984|5574743|P6|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
2271122|NCT02271984|5574744|P5|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
2271123|NCT02271984|5574745|P4|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
2271124|NCT02271984|5574746|P3|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
2271125|NCT02271984|5574747|P2|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
2271126|NCT02271984|5574748|P1|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
2271127|NCT02271984|5574737|P12|COMPLETED|Fourth Intervention Period (Day 1)||3
2271128|NCT02271984|5574738|P11|COMPLETED|Fourth Intervention Period (Day 1)||3
2271129|NCT02271984|5574739|P10|COMPLETED|Fourth Intervention Period (Day 1)||3
2271130|NCT02271984|5574740|P9|COMPLETED|Fourth Intervention Period (Day 1)||3
2271131|NCT02271984|5574741|P8|COMPLETED|Fourth Intervention Period (Day 1)||3
2271132|NCT02271984|5574742|P7|COMPLETED|Fourth Intervention Period (Day 1)||3
2271133|NCT02271984|5574743|P6|COMPLETED|Fourth Intervention Period (Day 1)||3
2271134|NCT02271984|5574744|P5|COMPLETED|Fourth Intervention Period (Day 1)||3
2271135|NCT02271984|5574745|P4|COMPLETED|Fourth Intervention Period (Day 1)||3
2271136|NCT02271984|5574746|P3|COMPLETED|Fourth Intervention Period (Day 1)||3
2271137|NCT02271984|5574747|P2|COMPLETED|Fourth Intervention Period (Day 1)||3
2271138|NCT02271984|5574748|P1|COMPLETED|Fourth Intervention Period (Day 1)||3
2271139|NCT02271984|5574737|P12|STARTED|Fourth Intervention Period (Day 1)||3
2271140|NCT02271984|5574738|P11|STARTED|Fourth Intervention Period (Day 1)||3
2271141|NCT02271984|5574739|P10|STARTED|Fourth Intervention Period (Day 1)||3
2271142|NCT02271984|5574740|P9|STARTED|Fourth Intervention Period (Day 1)||3
2271143|NCT02271984|5574741|P8|STARTED|Fourth Intervention Period (Day 1)||3
2271144|NCT02271984|5574742|P7|STARTED|Fourth Intervention Period (Day 1)||3
2271145|NCT02271984|5574743|P6|STARTED|Fourth Intervention Period (Day 1)||3
2271146|NCT02271984|5574744|P5|STARTED|Fourth Intervention Period (Day 1)||3
2271147|NCT02271984|5574745|P4|STARTED|Fourth Intervention Period (Day 1)||3
2271148|NCT02271984|5574746|P3|STARTED|Fourth Intervention Period (Day 1)||3
2271149|NCT02271984|5574747|P2|STARTED|Fourth Intervention Period (Day 1)||3
2271150|NCT02271984|5574748|P1|STARTED|Fourth Intervention Period (Day 1)||3
2271151|NCT02271984|5574737|P12|NOT COMPLETED|Washout Period 3 (7 Days)||0
2271152|NCT02271984|5574738|P11|NOT COMPLETED|Washout Period 3 (7 Days)||0
2271153|NCT02271984|5574739|P10|NOT COMPLETED|Washout Period 3 (7 Days)||0
2271154|NCT02271984|5574740|P9|NOT COMPLETED|Washout Period 3 (7 Days)||0
2271155|NCT02271984|5574741|P8|NOT COMPLETED|Washout Period 3 (7 Days)||0
2271156|NCT02271984|5574742|P7|NOT COMPLETED|Washout Period 3 (7 Days)||0
2271157|NCT02271984|5574743|P6|NOT COMPLETED|Washout Period 3 (7 Days)||0
2271158|NCT02271984|5574744|P5|NOT COMPLETED|Washout Period 3 (7 Days)||0
2271159|NCT02271984|5574745|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
2271160|NCT02271984|5574746|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
2271161|NCT02271984|5574747|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
2271162|NCT02271984|5574748|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
2271163|NCT02271984|5574737|P12|COMPLETED|Washout Period 3 (7 Days)||3
2271164|NCT02271984|5574738|P11|COMPLETED|Washout Period 3 (7 Days)||3
2271165|NCT02271984|5574739|P10|COMPLETED|Washout Period 3 (7 Days)||3
2271166|NCT02271984|5574740|P9|COMPLETED|Washout Period 3 (7 Days)||3
2271167|NCT02271984|5574741|P8|COMPLETED|Washout Period 3 (7 Days)||3
2271168|NCT02271984|5574742|P7|COMPLETED|Washout Period 3 (7 Days)||3
2271169|NCT02271984|5574743|P6|COMPLETED|Washout Period 3 (7 Days)||3
2271170|NCT02271984|5574744|P5|COMPLETED|Washout Period 3 (7 Days)||3
2271171|NCT02271984|5574745|P4|COMPLETED|Washout Period 3 (7 Days)||3
2271172|NCT02271984|5574746|P3|COMPLETED|Washout Period 3 (7 Days)||3
2271173|NCT02271984|5574747|P2|COMPLETED|Washout Period 3 (7 Days)||3
2271174|NCT02271984|5574748|P1|COMPLETED|Washout Period 3 (7 Days)||3
2271175|NCT02271984|5574737|P12|STARTED|Washout Period 3 (7 Days)||3
2271176|NCT02271984|5574738|P11|STARTED|Washout Period 3 (7 Days)||3
2271177|NCT02271984|5574739|P10|STARTED|Washout Period 3 (7 Days)||3
2271178|NCT02271984|5574740|P9|STARTED|Washout Period 3 (7 Days)||3
2271179|NCT02271984|5574741|P8|STARTED|Washout Period 3 (7 Days)||3
2271180|NCT02271984|5574742|P7|STARTED|Washout Period 3 (7 Days)||3
2271181|NCT02271984|5574743|P6|STARTED|Washout Period 3 (7 Days)||3
2271182|NCT02271984|5574744|P5|STARTED|Washout Period 3 (7 Days)||3
2271183|NCT02271984|5574745|P4|STARTED|Washout Period 3 (7 Days)||3
2271184|NCT02271984|5574746|P3|STARTED|Washout Period 3 (7 Days)||3
2271185|NCT02271984|5574747|P2|STARTED|Washout Period 3 (7 Days)||3
2271186|NCT02271984|5574748|P1|STARTED|Washout Period 3 (7 Days)||3
2271187|NCT02271984|5574737|P12|NOT COMPLETED|Third Intervention Period (1 Day)||0
2271188|NCT02271984|5574738|P11|NOT COMPLETED|Third Intervention Period (1 Day)||0
2271189|NCT02271984|5574739|P10|NOT COMPLETED|Third Intervention Period (1 Day)||0
2271190|NCT02271984|5574740|P9|NOT COMPLETED|Third Intervention Period (1 Day)||0
2271191|NCT02271984|5574741|P8|NOT COMPLETED|Third Intervention Period (1 Day)||0
2271192|NCT02271984|5574742|P7|NOT COMPLETED|Third Intervention Period (1 Day)||0
2271193|NCT02271984|5574743|P6|NOT COMPLETED|Third Intervention Period (1 Day)||0
2271194|NCT02271984|5574744|P5|NOT COMPLETED|Third Intervention Period (1 Day)||0
2271195|NCT02271984|5574745|P4|NOT COMPLETED|Third Intervention Period (1 Day)||0
2271196|NCT02271984|5574746|P3|NOT COMPLETED|Third Intervention Period (1 Day)||0
2271197|NCT02271984|5574747|P2|NOT COMPLETED|Third Intervention Period (1 Day)||0
2271198|NCT02271984|5574748|P1|NOT COMPLETED|Third Intervention Period (1 Day)||0
2271199|NCT02271984|5574737|P12|COMPLETED|Third Intervention Period (1 Day)||3
2271200|NCT02271984|5574738|P11|COMPLETED|Third Intervention Period (1 Day)||3
2271201|NCT02271984|5574739|P10|COMPLETED|Third Intervention Period (1 Day)||3
2271202|NCT02271984|5574740|P9|COMPLETED|Third Intervention Period (1 Day)||3
2271203|NCT02271984|5574741|P8|COMPLETED|Third Intervention Period (1 Day)||3
2271204|NCT02271984|5574742|P7|COMPLETED|Third Intervention Period (1 Day)||3
2271205|NCT02271984|5574743|P6|COMPLETED|Third Intervention Period (1 Day)||3
2271206|NCT02271984|5574744|P5|COMPLETED|Third Intervention Period (1 Day)||3
2271207|NCT02271984|5574745|P4|COMPLETED|Third Intervention Period (1 Day)||3
2271208|NCT02271984|5574746|P3|COMPLETED|Third Intervention Period (1 Day)||3
2271209|NCT02271984|5574747|P2|COMPLETED|Third Intervention Period (1 Day)||3
2271210|NCT02271984|5574748|P1|COMPLETED|Third Intervention Period (1 Day)||3
2271211|NCT02271984|5574737|P12|STARTED|Third Intervention Period (1 Day)||3
2271212|NCT02271984|5574738|P11|STARTED|Third Intervention Period (1 Day)||3
2271213|NCT02271984|5574739|P10|STARTED|Third Intervention Period (1 Day)||3
2271214|NCT02271984|5574740|P9|STARTED|Third Intervention Period (1 Day)||3
2271215|NCT02271984|5574741|P8|STARTED|Third Intervention Period (1 Day)||3
2271216|NCT02271984|5574742|P7|STARTED|Third Intervention Period (1 Day)||3
2271217|NCT02271984|5574743|P6|STARTED|Third Intervention Period (1 Day)||3
2271218|NCT02271984|5574744|P5|STARTED|Third Intervention Period (1 Day)||3
2271219|NCT02271984|5574745|P4|STARTED|Third Intervention Period (1 Day)||3
2271220|NCT02271984|5574746|P3|STARTED|Third Intervention Period (1 Day)||3
2271221|NCT02271984|5574747|P2|STARTED|Third Intervention Period (1 Day)||3
2271222|NCT02271984|5574748|P1|STARTED|Third Intervention Period (1 Day)||3
2271223|NCT02271984|5574737|P12|NOT COMPLETED|Washout Period 2 (7 Days)||0
2271224|NCT02271984|5574738|P11|NOT COMPLETED|Washout Period 2 (7 Days)||0
2271225|NCT02271984|5574739|P10|NOT COMPLETED|Washout Period 2 (7 Days)||0
2271226|NCT02271984|5574740|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
2271227|NCT02271984|5574741|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
2271228|NCT02271984|5574742|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
2271229|NCT02271984|5574743|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
2271230|NCT02271984|5574744|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
2271231|NCT02271984|5574745|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
2271232|NCT02271984|5574746|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
2271233|NCT02271984|5574747|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
2271234|NCT02271984|5574748|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
2271235|NCT02271984|5574737|P12|COMPLETED|Washout Period 2 (7 Days)||3
2271236|NCT02271984|5574738|P11|COMPLETED|Washout Period 2 (7 Days)||3
2271237|NCT02271984|5574739|P10|COMPLETED|Washout Period 2 (7 Days)||3
2271238|NCT02271984|5574740|P9|COMPLETED|Washout Period 2 (7 Days)||3
2271239|NCT02271984|5574741|P8|COMPLETED|Washout Period 2 (7 Days)||3
2271240|NCT02271984|5574742|P7|COMPLETED|Washout Period 2 (7 Days)||3
2271241|NCT02271984|5574743|P6|COMPLETED|Washout Period 2 (7 Days)||3
2271242|NCT02271984|5574744|P5|COMPLETED|Washout Period 2 (7 Days)||3
2271243|NCT02271984|5574745|P4|COMPLETED|Washout Period 2 (7 Days)||3
2271244|NCT02271984|5574746|P3|COMPLETED|Washout Period 2 (7 Days)||3
2271245|NCT02271984|5574747|P2|COMPLETED|Washout Period 2 (7 Days)||3
2271246|NCT02271984|5574748|P1|COMPLETED|Washout Period 2 (7 Days)||3
2271247|NCT02271984|5574737|P12|STARTED|Washout Period 2 (7 Days)||3
2271248|NCT02271984|5574738|P11|STARTED|Washout Period 2 (7 Days)||3
2271249|NCT02271984|5574739|P10|STARTED|Washout Period 2 (7 Days)||3
2271250|NCT02271984|5574740|P9|STARTED|Washout Period 2 (7 Days)||3
2271251|NCT02271984|5574741|P8|STARTED|Washout Period 2 (7 Days)||3
2271252|NCT02271984|5574742|P7|STARTED|Washout Period 2 (7 Days)||3
2271253|NCT02271984|5574743|P6|STARTED|Washout Period 2 (7 Days)||3
2271254|NCT02271984|5574744|P5|STARTED|Washout Period 2 (7 Days)||3
2271255|NCT02271984|5574745|P4|STARTED|Washout Period 2 (7 Days)||3
2271256|NCT02271984|5574746|P3|STARTED|Washout Period 2 (7 Days)||3
2271257|NCT02271984|5574747|P2|STARTED|Washout Period 2 (7 Days)||3
2271258|NCT02271984|5574748|P1|STARTED|Washout Period 2 (7 Days)||3
2271259|NCT02271984|5574737|P12|NOT COMPLETED|Second Intervention Period (1 Day)||0
2271260|NCT02271984|5574738|P11|NOT COMPLETED|Second Intervention Period (1 Day)||0
2271261|NCT02271984|5574739|P10|NOT COMPLETED|Second Intervention Period (1 Day)||0
2271262|NCT02271984|5574740|P9|NOT COMPLETED|Second Intervention Period (1 Day)||0
2271263|NCT02271984|5574741|P8|NOT COMPLETED|Second Intervention Period (1 Day)||0
2271264|NCT02271984|5574742|P7|NOT COMPLETED|Second Intervention Period (1 Day)||0
2271265|NCT02271984|5574743|P6|NOT COMPLETED|Second Intervention Period (1 Day)||0
2271266|NCT02271984|5574744|P5|NOT COMPLETED|Second Intervention Period (1 Day)||0
2271267|NCT02271984|5574745|P4|NOT COMPLETED|Second Intervention Period (1 Day)||0
2271268|NCT02271984|5574746|P3|NOT COMPLETED|Second Intervention Period (1 Day)||0
2271269|NCT02271984|5574747|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
2271270|NCT02271984|5574748|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
2271271|NCT02271984|5574737|P12|COMPLETED|Second Intervention Period (1 Day)||3
2271272|NCT02271984|5574738|P11|COMPLETED|Second Intervention Period (1 Day)||3
2271273|NCT02271984|5574739|P10|COMPLETED|Second Intervention Period (1 Day)||3
2271274|NCT02271984|5574740|P9|COMPLETED|Second Intervention Period (1 Day)||3
2271275|NCT02271984|5574741|P8|COMPLETED|Second Intervention Period (1 Day)||3
2271276|NCT02271984|5574742|P7|COMPLETED|Second Intervention Period (1 Day)||3
2271277|NCT02271984|5574743|P6|COMPLETED|Second Intervention Period (1 Day)||3
2271278|NCT02271984|5574744|P5|COMPLETED|Second Intervention Period (1 Day)||3
2271279|NCT02271984|5574745|P4|COMPLETED|Second Intervention Period (1 Day)||3
2271280|NCT02271984|5574746|P3|COMPLETED|Second Intervention Period (1 Day)||3
2271281|NCT02271984|5574747|P2|COMPLETED|Second Intervention Period (1 Day)||3
2271282|NCT02271984|5574748|P1|COMPLETED|Second Intervention Period (1 Day)||3
2271283|NCT02271984|5574737|P12|STARTED|Second Intervention Period (1 Day)||3
2271284|NCT02271984|5574738|P11|STARTED|Second Intervention Period (1 Day)||3
2271285|NCT02271984|5574739|P10|STARTED|Second Intervention Period (1 Day)||3
2271286|NCT02271984|5574740|P9|STARTED|Second Intervention Period (1 Day)||3
2271287|NCT02271984|5574741|P8|STARTED|Second Intervention Period (1 Day)||3
2271288|NCT02271984|5574742|P7|STARTED|Second Intervention Period (1 Day)||3
2271289|NCT02271984|5574743|P6|STARTED|Second Intervention Period (1 Day)||3
2271290|NCT02271984|5574744|P5|STARTED|Second Intervention Period (1 Day)||3
2271291|NCT02271984|5574745|P4|STARTED|Second Intervention Period (1 Day)||3
2271292|NCT02271984|5574746|P3|STARTED|Second Intervention Period (1 Day)||3
2271293|NCT02271984|5574747|P2|STARTED|Second Intervention Period (1 Day)||3
2271294|NCT02271984|5574748|P1|STARTED|Second Intervention Period (1 Day)||3
2271295|NCT02271984|5574737|P12|NOT COMPLETED|Washout Period 1 (7 Days)||0
2271296|NCT02271984|5574738|P11|NOT COMPLETED|Washout Period 1 (7 Days)||0
2271297|NCT02271984|5574739|P10|NOT COMPLETED|Washout Period 1 (7 Days)||0
2271298|NCT02271984|5574740|P9|NOT COMPLETED|Washout Period 1 (7 Days)||0
2271299|NCT02271984|5574741|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
2271300|NCT02271984|5574742|P7|NOT COMPLETED|Washout Period 1 (7 Days)||0
2271301|NCT02271984|5574743|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
2271302|NCT02271984|5574744|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
2271303|NCT02271984|5574745|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
2271304|NCT02271984|5574746|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
2271305|NCT02271984|5574747|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
2271306|NCT02271984|5574748|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
2271307|NCT02271984|5574737|P12|COMPLETED|Washout Period 1 (7 Days)||3
2271308|NCT02271984|5574738|P11|COMPLETED|Washout Period 1 (7 Days)||3
2271309|NCT02271984|5574739|P10|COMPLETED|Washout Period 1 (7 Days)||3
2271310|NCT02271984|5574740|P9|COMPLETED|Washout Period 1 (7 Days)||3
2271311|NCT02271984|5574741|P8|COMPLETED|Washout Period 1 (7 Days)||3
2271312|NCT02271984|5574742|P7|COMPLETED|Washout Period 1 (7 Days)||3
2271313|NCT02271984|5574743|P6|COMPLETED|Washout Period 1 (7 Days)||3
2271314|NCT02271984|5574744|P5|COMPLETED|Washout Period 1 (7 Days)||3
2271315|NCT02271984|5574745|P4|COMPLETED|Washout Period 1 (7 Days)||3
2271316|NCT02271984|5574746|P3|COMPLETED|Washout Period 1 (7 Days)||3
2271317|NCT02271984|5574747|P2|COMPLETED|Washout Period 1 (7 Days)||3
2271318|NCT02271984|5574748|P1|COMPLETED|Washout Period 1 (7 Days)||3
2271319|NCT02271984|5574737|P12|STARTED|Washout Period 1 (7 Days)||3
2271320|NCT02271984|5574738|P11|STARTED|Washout Period 1 (7 Days)||3
2271321|NCT02271984|5574739|P10|STARTED|Washout Period 1 (7 Days)||3
2271322|NCT02271984|5574740|P9|STARTED|Washout Period 1 (7 Days)||3
2271323|NCT02271984|5574741|P8|STARTED|Washout Period 1 (7 Days)||3
2271324|NCT02271984|5574742|P7|STARTED|Washout Period 1 (7 Days)||3
2271325|NCT02271984|5574743|P6|STARTED|Washout Period 1 (7 Days)||3
2271326|NCT02271984|5574744|P5|STARTED|Washout Period 1 (7 Days)||3
2271327|NCT02271984|5574745|P4|STARTED|Washout Period 1 (7 Days)||3
2271328|NCT02271984|5574746|P3|STARTED|Washout Period 1 (7 Days)||3
2271329|NCT02271984|5574747|P2|STARTED|Washout Period 1 (7 Days)||3
2271330|NCT02271984|5574748|P1|STARTED|Washout Period 1 (7 Days)||3
2271331|NCT02271984|5574737|P12|NOT COMPLETED|First Intervention Period (1 Day)||0
2271332|NCT02271984|5574738|P11|NOT COMPLETED|First Intervention Period (1 Day)||0
2271333|NCT02271984|5574739|P10|NOT COMPLETED|First Intervention Period (1 Day)||0
2271334|NCT02271984|5574740|P9|NOT COMPLETED|First Intervention Period (1 Day)||0
2271335|NCT02271984|5574741|P8|NOT COMPLETED|First Intervention Period (1 Day)||0
2271336|NCT02271984|5574742|P7|NOT COMPLETED|First Intervention Period (1 Day)||0
2271337|NCT02271984|5574743|P6|NOT COMPLETED|First Intervention Period (1 Day)||0
2271338|NCT02271984|5574744|P5|NOT COMPLETED|First Intervention Period (1 Day)||0
2271339|NCT02271984|5574745|P4|NOT COMPLETED|First Intervention Period (1 Day)||0
2271340|NCT02271984|5574746|P3|NOT COMPLETED|First Intervention Period (1 Day)||0
2271341|NCT02271984|5574747|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
2271342|NCT02271984|5574748|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
2271343|NCT02271984|5574737|P12|COMPLETED|First Intervention Period (1 Day)||3
2271344|NCT02271984|5574738|P11|COMPLETED|First Intervention Period (1 Day)||3
2271345|NCT02271984|5574739|P10|COMPLETED|First Intervention Period (1 Day)||3
2271346|NCT02271984|5574740|P9|COMPLETED|First Intervention Period (1 Day)||3
2271347|NCT02271984|5574741|P8|COMPLETED|First Intervention Period (1 Day)||3
2271348|NCT02271984|5574742|P7|COMPLETED|First Intervention Period (1 Day)||3
2271349|NCT02271984|5574743|P6|COMPLETED|First Intervention Period (1 Day)||3
2271350|NCT02271984|5574744|P5|COMPLETED|First Intervention Period (1 Day)||3
2271351|NCT02271984|5574745|P4|COMPLETED|First Intervention Period (1 Day)||3
2271352|NCT02271984|5574746|P3|COMPLETED|First Intervention Period (1 Day)||3
2271353|NCT02271984|5574747|P2|COMPLETED|First Intervention Period (1 Day)||3
2271354|NCT02271984|5574748|P1|COMPLETED|First Intervention Period (1 Day)||3
2271355|NCT02271984|5574737|P12|STARTED|First Intervention Period (1 Day)||3
2271356|NCT02271984|5574738|P11|STARTED|First Intervention Period (1 Day)||3
2271357|NCT02271984|5574739|P10|STARTED|First Intervention Period (1 Day)||3
2271358|NCT02271984|5574740|P9|STARTED|First Intervention Period (1 Day)||3
2271359|NCT02271984|5574741|P8|STARTED|First Intervention Period (1 Day)||3
2271360|NCT02271984|5574742|P7|STARTED|First Intervention Period (1 Day)||3
2271361|NCT02271984|5574743|P6|STARTED|First Intervention Period (1 Day)||3
2271362|NCT02271984|5574744|P5|STARTED|First Intervention Period (1 Day)||3
2271363|NCT02271984|5574745|P4|STARTED|First Intervention Period (1 Day)||3
2271364|NCT02271984|5574746|P3|STARTED|First Intervention Period (1 Day)||3
2271365|NCT02271984|5574747|P2|STARTED|First Intervention Period (1 Day)||3
2271366|NCT02271984|5574748|P1|STARTED|First Intervention Period (1 Day)||3
2271367|NCT02271945|5574837|P2|NOT COMPLETED|Overall Study||5
2271368|NCT02271945|5574838|P1|NOT COMPLETED|Overall Study||5
2271369|NCT02271945|5574837|P2|COMPLETED|Overall Study||0
2271370|NCT02271945|5574838|P1|COMPLETED|Overall Study||0
2271371|NCT02271945|5574837|P2|STARTED|Overall Study||5
2271372|NCT02271945|5574838|P1|STARTED|Overall Study||5
2271373|NCT02271906|5574874|P1|NOT COMPLETED|Overall Study||0
2271374|NCT02271906|5574874|P1|COMPLETED|Overall Study||2
2271375|NCT02271906|5574874|P1|STARTED|Overall Study||2
2271376|NCT02271880|5574881|P2|NOT COMPLETED|Overall Study||4
2271377|NCT02271880|5574882|P1|NOT COMPLETED|Overall Study||3
2271378|NCT02271880|5574881|P2|COMPLETED|Overall Study||0
2271379|NCT02271880|5574882|P1|COMPLETED|Overall Study||0
2271380|NCT02271880|5574881|P2|STARTED|Overall Study||4
2271381|NCT02271880|5574882|P1|STARTED|Overall Study||3
2271382|NCT02271854|5574912|P1|NOT COMPLETED|Overall Study||4
2271383|NCT02271854|5574912|P1|COMPLETED|Overall Study||98
2271384|NCT02271854|5574912|P1|STARTED|Overall Study||102
2271385|NCT02271698|5574923|P4|NOT COMPLETED|Overall Study||0
2271386|NCT02271698|5574924|P3|NOT COMPLETED|Overall Study||0
2271387|NCT02271698|5574925|P2|NOT COMPLETED|Overall Study||0
2271388|NCT02271698|5574926|P1|NOT COMPLETED|Overall Study||0
2271389|NCT02271698|5574923|P4|COMPLETED|Overall Study||11
2271390|NCT02271698|5574924|P3|COMPLETED|Overall Study||10
2271391|NCT02271698|5574925|P2|COMPLETED|Overall Study||10
2271392|NCT02271698|5574926|P1|COMPLETED|Overall Study||11
2271393|NCT02271698|5574923|P4|STARTED|Overall Study||11
2271394|NCT02271698|5574924|P3|STARTED|Overall Study||10
2271395|NCT02271698|5574925|P2|STARTED|Overall Study||10
2271396|NCT02271698|5574926|P1|STARTED|Overall Study||11
2271397|NCT02271529|5574952|P1|NOT COMPLETED|Overall Study||1
2271398|NCT02271529|5574952|P1|COMPLETED|Overall Study||39
2271399|NCT02271529|5574952|P1|STARTED|Overall Study||40
2271400|NCT02271477|5574958|P2|NOT COMPLETED|Overall Study||0
2271401|NCT02271477|5574959|P1|NOT COMPLETED|Overall Study||0
2271402|NCT02271477|5574958|P2|COMPLETED|Overall Study||80
2271403|NCT02271477|5574959|P1|COMPLETED|Overall Study||80
2271404|NCT02271477|5574958|P2|STARTED|Overall Study||80
2271405|NCT02271477|5574959|P1|STARTED|Overall Study||80
2271406|NCT02271451|5574973|P2|NOT COMPLETED|Overall Study||1
2271407|NCT02271451|5574974|P1|NOT COMPLETED|Overall Study||0
2271408|NCT02271451|5574973|P2|COMPLETED|Overall Study|one subject does not have MRI data due to braces|7
2271409|NCT02271451|5574974|P1|COMPLETED|Overall Study||7
2271410|NCT02271451|5574973|P2|STARTED|Overall Study||8
2271411|NCT02271451|5574974|P1|STARTED|Overall Study||7
2271412|NCT02271425|5574980|P1|NOT COMPLETED|Overall Study||0
2271413|NCT02271425|5574980|P1|COMPLETED|Overall Study||8
2271414|NCT02271425|5574980|P1|STARTED|Overall Study||8
2271415|NCT02271386|5574989|P4|NOT COMPLETED|Intervention Period- 8 Months||0
2271416|NCT02271386|5574990|P3|NOT COMPLETED|Intervention Period- 8 Months||0
2271417|NCT02271386|5574991|P2|NOT COMPLETED|Intervention Period- 8 Months||0
2271418|NCT02271386|5574992|P1|NOT COMPLETED|Intervention Period- 8 Months||0
2271419|NCT02271386|5574989|P4|COMPLETED|Intervention Period- 8 Months||197
2271420|NCT02271386|5574990|P3|COMPLETED|Intervention Period- 8 Months||202
2271421|NCT02271386|5574991|P2|COMPLETED|Intervention Period- 8 Months||52
2271422|NCT02271386|5574992|P1|COMPLETED|Intervention Period- 8 Months||53
2271423|NCT02271386|5574989|P4|STARTED|Intervention Period- 8 Months||197
2271424|NCT02271386|5574990|P3|STARTED|Intervention Period- 8 Months||202
2271425|NCT02271386|5574991|P2|STARTED|Intervention Period- 8 Months||52
2271426|NCT02271386|5574992|P1|STARTED|Intervention Period- 8 Months||53
2271427|NCT02271386|5574989|P4|NOT COMPLETED|Baseline Period- 8 Months||0
2271428|NCT02271386|5574990|P3|NOT COMPLETED|Baseline Period- 8 Months||0
2271429|NCT02271386|5574991|P2|NOT COMPLETED|Baseline Period- 8 Months||0
2271430|NCT02271386|5574992|P1|NOT COMPLETED|Baseline Period- 8 Months||0
2271431|NCT02271386|5574989|P4|COMPLETED|Baseline Period- 8 Months||191
2271432|NCT02271386|5574990|P3|COMPLETED|Baseline Period- 8 Months||200
2271433|NCT02271386|5574991|P2|COMPLETED|Baseline Period- 8 Months||52
2271434|NCT02271386|5574992|P1|COMPLETED|Baseline Period- 8 Months||53
2271435|NCT02271386|5574989|P4|STARTED|Baseline Period- 8 Months||191
2271436|NCT02271386|5574990|P3|STARTED|Baseline Period- 8 Months||200
2271437|NCT02271386|5574991|P2|STARTED|Baseline Period- 8 Months||52
2271438|NCT02271386|5574992|P1|STARTED|Baseline Period- 8 Months||53
2271439|NCT02271217|5575057|P3|NOT COMPLETED|Overall Study||12
2271440|NCT02271217|5575058|P2|NOT COMPLETED|Overall Study||13
2271441|NCT02271217|5575059|P1|NOT COMPLETED|Overall Study||11
2271442|NCT02271217|5575057|P3|COMPLETED|Overall Study||113
2271443|NCT02271217|5575058|P2|COMPLETED|Overall Study||113
2271444|NCT02271217|5575059|P1|COMPLETED|Overall Study||115
2271445|NCT02271217|5575057|P3|STARTED|Overall Study||125
2271446|NCT02271217|5575058|P2|STARTED|Overall Study||126
2271447|NCT02271217|5575059|P1|STARTED|Overall Study||126
2271448|NCT02270983|5575073|P3|NOT COMPLETED|Overall Study||12
2271449|NCT02270983|5575074|P2|NOT COMPLETED|Overall Study||7
2271450|NCT02270983|5575075|P1|NOT COMPLETED|Overall Study||9
2271451|NCT02270983|5575073|P3|COMPLETED|Overall Study||76
2271452|NCT02270983|5575074|P2|COMPLETED|Overall Study||80
2271453|NCT02270983|5575075|P1|COMPLETED|Overall Study||70
2271454|NCT02270983|5575073|P3|STARTED|Overall Study||88
2271455|NCT02270983|5575074|P2|STARTED|Overall Study||87
2271456|NCT02270983|5575075|P1|STARTED|Overall Study||79
2271457|NCT02270944|5575100|P2|NOT COMPLETED|Overall Study||5
2271458|NCT02270944|5575101|P1|NOT COMPLETED|Overall Study||11
2271459|NCT02270944|5575100|P2|COMPLETED|Overall Study||516
2271460|NCT02270944|5575101|P1|COMPLETED|Overall Study||518
2271461|NCT02270944|5575100|P2|STARTED|Overall Study||521
2271462|NCT02270944|5575101|P1|STARTED|Overall Study||529
2271463|NCT02270684|5575119|P2|NOT COMPLETED|Overall Study||3
2271464|NCT02270684|5575120|P1|NOT COMPLETED|Overall Study||1
2271465|NCT02270684|5575119|P2|COMPLETED|Overall Study||0
2271466|NCT02270684|5575120|P1|COMPLETED|Overall Study||0
2271467|NCT02270684|5575119|P2|STARTED|Overall Study||3
2271468|NCT02270684|5575120|P1|STARTED|Overall Study||1
2271469|NCT02270671|5575128|P2|NOT COMPLETED|Overall Study||5
2271470|NCT02270671|5575129|P1|NOT COMPLETED|Overall Study||5
2271471|NCT02270671|5575128|P2|COMPLETED|Overall Study||61
2271472|NCT02270671|5575129|P1|COMPLETED|Overall Study||59
2271473|NCT02270671|5575128|P2|STARTED|Overall Study||66
2271474|NCT02270671|5575129|P1|STARTED|Overall Study||64
2271475|NCT02270645|5575145|P2|NOT COMPLETED|Overall Study||0
2271476|NCT02270645|5575146|P1|NOT COMPLETED|Overall Study||2
2271477|NCT02270645|5575145|P2|COMPLETED|Overall Study||4
2271478|NCT02270645|5575146|P1|COMPLETED|Overall Study||6
2271479|NCT02270645|5575145|P2|STARTED|Overall Study||4
2271480|NCT02270645|5575146|P1|STARTED|Overall Study||8
2271481|NCT02270515|5575154|P1|NOT COMPLETED|Intervention Period 3: 12-18 Months||24
2271482|NCT02270515|5575154|P1|COMPLETED|Intervention Period 3: 12-18 Months||103
2271483|NCT02270515|5575154|P1|STARTED|Intervention Period 3: 12-18 Months||127
2271484|NCT02270515|5575154|P1|NOT COMPLETED|Intervention Period 2: 6-12 Months||32
2271485|NCT02270515|5575154|P1|COMPLETED|Intervention Period 2: 6-12 Months||127
2271486|NCT02270515|5575154|P1|STARTED|Intervention Period 2: 6-12 Months||159
2271487|NCT02270515|5575154|P1|NOT COMPLETED|Intervention Period 1: 0-6 Months||16
2271488|NCT02270515|5575154|P1|COMPLETED|Intervention Period 1: 0-6 Months||159
2271489|NCT02270515|5575154|P1|STARTED|Intervention Period 1: 0-6 Months||175
2271490|NCT02270255|5575171|P2|NOT COMPLETED|Overall Study||0
2271491|NCT02270255|5575172|P1|NOT COMPLETED|Overall Study||1
2271492|NCT02270255|5575171|P2|COMPLETED|Overall Study||22
2271493|NCT02270255|5575172|P1|COMPLETED|Overall Study||21
2271494|NCT02270255|5575171|P2|Complete Data From Home Survey|Overall Study||22
2271495|NCT02270255|5575172|P1|Complete Data From Home Survey|Overall Study||21
2271496|NCT02270255|5575171|P2|Complete Data at Discharge PACU|Overall Study||22
2271497|NCT02270255|5575172|P1|Complete Data at Discharge PACU|Overall Study||22
2271498|NCT02270255|5575171|P2|STARTED|Overall Study||22
2271499|NCT02270255|5575172|P1|STARTED|Overall Study||22
2271500|NCT02270060|5575183|P3|NOT COMPLETED|Overall Study||0
2271501|NCT02270060|5575184|P2|NOT COMPLETED|Overall Study||0
2271502|NCT02270060|5575185|P1|NOT COMPLETED|Overall Study||0
2271503|NCT02270060|5575183|P3|COMPLETED|Overall Study||20
2271504|NCT02270060|5575184|P2|COMPLETED|Overall Study||20
2271505|NCT02270060|5575185|P1|COMPLETED|Overall Study||20
2271506|NCT02270060|5575183|P3|STARTED|Overall Study||20
2271507|NCT02270060|5575184|P2|STARTED|Overall Study||20
2271508|NCT02270060|5575185|P1|STARTED|Overall Study||20
2271509|NCT02269943|5575213|P2|NOT COMPLETED|Follow-Up Survival Period||26
2271510|NCT02269943|5575214|P1|NOT COMPLETED|Follow-Up Survival Period||5
2271511|NCT02269943|5575213|P2|COMPLETED|Follow-Up Survival Period|Not applicable according to the study design.|0
2271512|NCT02269943|5575214|P1|COMPLETED|Follow-Up Survival Period|Not applicable according to the study design.|0
2271513|NCT02269943|5575213|P2|STARTED|Follow-Up Survival Period||26
2271514|NCT02269943|5575214|P1|STARTED|Follow-Up Survival Period||5
2271515|NCT02269943|5575213|P2|NOT COMPLETED|Treatment Period||30
2271516|NCT02269943|5575214|P1|NOT COMPLETED|Treatment Period||6
2271517|NCT02269943|5575213|P2|COMPLETED|Treatment Period|Not applicable according to the study design|0
2271518|NCT02269943|5575214|P1|COMPLETED|Treatment Period|Not applicable according to the study design|0
2271519|NCT02269943|5575213|P2|Investigational Product (IP) Stopped|Treatment Period||30
2271520|NCT02269943|5575214|P1|Investigational Product (IP) Stopped|Treatment Period||6
2271521|NCT02269943|5575213|P2|STARTED|Treatment Period||30
2271522|NCT02269943|5575214|P1|STARTED|Treatment Period||6
2271531|NCT02269787|5575298|P2|NOT COMPLETED|Overall Study||10
2271532|NCT02269787|5575299|P1|NOT COMPLETED|Overall Study||22
2271533|NCT02269787|5575298|P2|COMPLETED|Overall Study||140
2271534|NCT02269787|5575299|P1|COMPLETED|Overall Study||126
2271535|NCT02269787|5575298|P2|STARTED|Overall Study||150
2271536|NCT02269787|5575299|P1|STARTED|Overall Study||148
2271537|NCT02269709|5575305|P1|NOT COMPLETED|Six Month Follow-up||12
2271538|NCT02269709|5575305|P1|COMPLETED|Six Month Follow-up||5
2271539|NCT02269709|5575305|P1|STARTED|Six Month Follow-up||17
2271540|NCT02269709|5575305|P1|NOT COMPLETED|Prior to Hospital Discharge||0
2271541|NCT02269709|5575305|P1|COMPLETED|Prior to Hospital Discharge||17
2271542|NCT02269709|5575305|P1|STARTED|Prior to Hospital Discharge||17
2271543|NCT02269709|5575305|P1|NOT COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||1
2271544|NCT02269709|5575305|P1|COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||17
2271545|NCT02269709|5575305|P1|STARTED|Follow-up #1 (24-72 Hours Post-surgery)||18
2271546|NCT02269709|5575305|P1|NOT COMPLETED|Time of Enrollment||3
2271547|NCT02269709|5575305|P1|COMPLETED|Time of Enrollment||18
2271548|NCT02269709|5575305|P1|STARTED|Time of Enrollment||21
2271549|NCT02269657|5575310|P1|NOT COMPLETED|Overall Study||3
2271550|NCT02269657|5575310|P1|COMPLETED|Overall Study||37
2271551|NCT02269657|5575310|P1|STARTED|Overall Study||40
2271552|NCT02269631|5575326|P2|NOT COMPLETED|Overall Study||0
2271553|NCT02269631|5575327|P1|NOT COMPLETED|Overall Study||0
2271554|NCT02269631|5575326|P2|COMPLETED|Overall Study||5
2271555|NCT02269631|5575327|P1|COMPLETED|Overall Study||7
2271556|NCT02269631|5575326|P2|STARTED|Overall Study||5
2271557|NCT02269631|5575327|P1|STARTED|Overall Study||7
2271558|NCT02269488|5575341|P1|NOT COMPLETED|Overall Study||0
2271559|NCT02269488|5575341|P1|COMPLETED|Overall Study||100
2271560|NCT02269488|5575341|P1|STARTED|Overall Study||100
2271561|NCT02269475|5575347|P2|NOT COMPLETED|Overall Study||1
2271562|NCT02269475|5575348|P1|NOT COMPLETED|Overall Study||3
2271563|NCT02269475|5575347|P2|COMPLETED|Overall Study||432
2271564|NCT02269475|5575348|P1|COMPLETED|Overall Study||865
2271565|NCT02269475|5575347|P2|Per Protocol Population|Overall Study||430
2271566|NCT02269475|5575348|P1|Per Protocol Population|Overall Study||849
2271567|NCT02269475|5575347|P2|Received IP (Safety Population)|Overall Study||433
2271568|NCT02269475|5575348|P1|Received IP (Safety Population)|Overall Study||868
2271569|NCT02269475|5575347|P2|STARTED|Overall Study||433
2271570|NCT02269475|5575348|P1|STARTED|Overall Study||868
2271571|NCT02269423|5575363|P4|NOT COMPLETED|Overall Study||1
2271572|NCT02269423|5575364|P3|NOT COMPLETED|Overall Study||0
2271573|NCT02269423|5575365|P2|NOT COMPLETED|Overall Study||1
2271574|NCT02269423|5575366|P1|NOT COMPLETED|Overall Study||0
2271575|NCT02269423|5575363|P4|COMPLETED|Overall Study||8
2271576|NCT02269423|5575364|P3|COMPLETED|Overall Study||10
2271577|NCT02269423|5575365|P2|COMPLETED|Overall Study||9
2271578|NCT02269423|5575366|P1|COMPLETED|Overall Study||10
2271579|NCT02269423|5575363|P4|STARTED|Overall Study||9
2271580|NCT02269423|5575364|P3|STARTED|Overall Study||10
2271581|NCT02269423|5575365|P2|STARTED|Overall Study||10
2271582|NCT02269423|5575366|P1|STARTED|Overall Study||10
2271583|NCT02269241|5575428|P1|NOT COMPLETED|Overall Study||1200
2271584|NCT02269241|5575428|P1|COMPLETED|Overall Study||352
2271585|NCT02269241|5575428|P1|STARTED|Overall Study||1552
2271586|NCT02269098|5575442|P2|NOT COMPLETED|Overall Study||9
2271587|NCT02269098|5575443|P1|NOT COMPLETED|Overall Study||14
2271588|NCT02269098|5575442|P2|COMPLETED|Overall Study||41
2271589|NCT02269098|5575443|P1|COMPLETED|Overall Study||37
2271590|NCT02269098|5575442|P2|STARTED|Overall Study||50
2271591|NCT02269098|5575443|P1|STARTED|Overall Study||51
2271592|NCT02268994|5575459|P2|NOT COMPLETED|Overall Study||35
2271593|NCT02268994|5575460|P1|NOT COMPLETED|Overall Study||31
2271594|NCT02268994|5575459|P2|COMPLETED|Overall Study||81
2271595|NCT02268994|5575460|P1|COMPLETED|Overall Study||86
2271596|NCT02268994|5575459|P2|STARTED|Overall Study||116
2271597|NCT02268994|5575460|P1|STARTED|Overall Study||117
2271598|NCT02268955|5575478|P2|NOT COMPLETED|Overall Study||2
2271599|NCT02268955|5575479|P1|NOT COMPLETED|Overall Study||2
2271600|NCT02268955|5575478|P2|COMPLETED|Overall Study||9
2271601|NCT02268955|5575479|P1|COMPLETED|Overall Study||9
2271602|NCT02268955|5575478|P2|STARTED|Overall Study||11
2271603|NCT02268955|5575479|P1|STARTED|Overall Study||11
2271604|NCT02268942|5575485|P1|NOT COMPLETED|Overall Study||0
2271605|NCT02268942|5575485|P1|COMPLETED|Overall Study||144
2271606|NCT02268942|5575485|P1|STARTED|Overall Study||144
2271607|NCT02268877|5575492|P2|NOT COMPLETED|Overall Study||5
2271608|NCT02268877|5575493|P1|NOT COMPLETED|Overall Study||4
2271609|NCT02268877|5575492|P2|COMPLETED|Overall Study|106 patients received the intervention.|106
2271610|NCT02268877|5575493|P1|COMPLETED|Overall Study||118
2271611|NCT02268877|5575492|P2|STARTED|Overall Study|111 patients were randomized to this arm.|111
2271612|NCT02268877|5575493|P1|STARTED|Overall Study||122
2271613|NCT02268864|5575504|P3|NOT COMPLETED|Overall Study||0
2271614|NCT02268864|5575505|P2|NOT COMPLETED|Overall Study||1
2271615|NCT02268864|5575506|P1|NOT COMPLETED|Overall Study||2
2271616|NCT02268864|5575504|P3|COMPLETED|Overall Study||64
2271617|NCT02268864|5575505|P2|COMPLETED|Overall Study||24
2271618|NCT02268864|5575506|P1|COMPLETED|Overall Study||15
2271619|NCT02268864|5575504|P3|STARTED|Overall Study||64
2271620|NCT02268864|5575505|P2|STARTED|Overall Study||25
2271621|NCT02268864|5575506|P1|STARTED|Overall Study||17
2271622|NCT02268812|5575532|P4|NOT COMPLETED|Overall Study||14
2271623|NCT02268812|5575533|P3|NOT COMPLETED|Overall Study||9
2271624|NCT02268812|5575534|P2|NOT COMPLETED|Overall Study||32
2271625|NCT02268812|5575535|P1|NOT COMPLETED|Overall Study||16
2271626|NCT02268812|5575532|P4|COMPLETED|Overall Study||26
2271627|NCT02268812|5575533|P3|COMPLETED|Overall Study||21
2271628|NCT02268812|5575534|P2|COMPLETED|Overall Study||40
2271629|NCT02268812|5575535|P1|COMPLETED|Overall Study||61
2271630|NCT02268812|5575532|P4|STARTED|Overall Study||40
2271631|NCT02268812|5575533|P3|STARTED|Overall Study||30
2271632|NCT02268812|5575534|P2|STARTED|Overall Study||72
2271633|NCT02268812|5575535|P1|STARTED|Overall Study||77
2271634|NCT02268526|5575568|P3|NOT COMPLETED|Overall Study||5
2271635|NCT02268526|5575569|P2|NOT COMPLETED|Overall Study||21
2271636|NCT02268526|5575570|P1|NOT COMPLETED|Overall Study||1
2271637|NCT02268526|5575568|P3|COMPLETED|Overall Study||16
2271638|NCT02268526|5575569|P2|COMPLETED|Overall Study||38
2271639|NCT02268526|5575570|P1|COMPLETED|Overall Study||5
2271640|NCT02268526|5575568|P3|PD Analysis Set (Cohort 2)|Overall Study||17
2271641|NCT02268526|5575569|P2|PD Analysis Set (Cohort 2)|Overall Study||42
2271642|NCT02268526|5575570|P1|PD Analysis Set (Cohort 2)|Overall Study||0
2271643|NCT02268526|5575568|P3|STARTED|Overall Study||21
2271644|NCT02268526|5575569|P2|STARTED|Overall Study||59
2271645|NCT02268526|5575570|P1|STARTED|Overall Study||6
2271646|NCT02268396|5575591|P1|NOT COMPLETED|Overall Study||12
2271647|NCT02268396|5575591|P1|COMPLETED|Overall Study||126
2271648|NCT02268396|5575591|P1|STARTED|Overall Study||138
2271649|NCT02268214|5575603|P3|NOT COMPLETED|Overall Study||42
2271650|NCT02268214|5575604|P2|NOT COMPLETED|Overall Study||41
2271651|NCT02268214|5575605|P1|NOT COMPLETED|Overall Study||42
2271652|NCT02268214|5575603|P3|COMPLETED|Overall Study||218
2271653|NCT02268214|5575604|P2|COMPLETED|Overall Study||255
2271654|NCT02268214|5575605|P1|COMPLETED|Overall Study||235
2271655|NCT02268214|5575603|P3|COMPLETED 24 WEEK PERIOD|Overall Study||232
2271656|NCT02268214|5575604|P2|COMPLETED 24 WEEK PERIOD|Overall Study||273
2271657|NCT02268214|5575605|P1|COMPLETED 24 WEEK PERIOD|Overall Study||252
2271658|NCT02268214|5575603|P3|STARTED|Overall Study||260
2271659|NCT02268214|5575604|P2|STARTED|Overall Study||296
2271660|NCT02268214|5575605|P1|STARTED|Overall Study||277
2271661|NCT02268175|5575633|P2|NOT COMPLETED|Overall Study||0
2271662|NCT02268175|5575634|P1|NOT COMPLETED|Overall Study||0
2271663|NCT02268175|5575633|P2|COMPLETED|Overall Study||25
2271664|NCT02268175|5575634|P1|COMPLETED|Overall Study||50
2271665|NCT02268175|5575633|P2|STARTED|Overall Study||25
2271666|NCT02268175|5575634|P1|STARTED|Overall Study||50
2271667|NCT02268058|5575652|P4|NOT COMPLETED|Overall Study||0
2271668|NCT02268058|5575653|P3|NOT COMPLETED|Overall Study||0
2271669|NCT02268058|5575654|P2|NOT COMPLETED|Overall Study||0
2271670|NCT02268058|5575655|P1|NOT COMPLETED|Overall Study||1
2271671|NCT02268058|5575652|P4|COMPLETED|Overall Study||20
2271672|NCT02268058|5575653|P3|COMPLETED|Overall Study||20
2271673|NCT02268058|5575654|P2|COMPLETED|Overall Study||20
2271674|NCT02268058|5575655|P1|COMPLETED|Overall Study||19
2271675|NCT02268058|5575652|P4|STARTED|Overall Study||20
2271676|NCT02268058|5575653|P3|STARTED|Overall Study||20
2271677|NCT02268058|5575654|P2|STARTED|Overall Study||20
2271678|NCT02268058|5575655|P1|STARTED|Overall Study||20
2271679|NCT02268045|5575679|P2|NOT COMPLETED|Overall Study||20
2271680|NCT02268045|5575680|P1|NOT COMPLETED|Overall Study||16
2271681|NCT02268045|5575679|P2|COMPLETED|Overall Study||116
2271682|NCT02268045|5575680|P1|COMPLETED|Overall Study||120
2271683|NCT02268045|5575679|P2|STARTED|Overall Study||136
2271684|NCT02268045|5575680|P1|STARTED|Overall Study||136
2271685|NCT02267850|5575704|P2|NOT COMPLETED|Overall Study||2
2271686|NCT02267850|5575705|P1|NOT COMPLETED|Overall Study||1
2271687|NCT02267850|5575704|P2|COMPLETED|Overall Study||12
2271688|NCT02267850|5575705|P1|COMPLETED|Overall Study||14
2271689|NCT02267850|5575704|P2|STARTED|Overall Study||14
2271690|NCT02267850|5575705|P1|STARTED|Overall Study||15
2271691|NCT02267837|5575713|P2|NOT COMPLETED|Overall Study||0
2271692|NCT02267837|5575714|P1|NOT COMPLETED|Overall Study||0
2271693|NCT02267837|5575713|P2|COMPLETED|Overall Study||9
2271694|NCT02267837|5575714|P1|COMPLETED|Overall Study||11
2271695|NCT02267837|5575713|P2|STARTED|Overall Study||9
2271696|NCT02267837|5575714|P1|STARTED|Overall Study||11
2271697|NCT02267824|5575722|P2|NOT COMPLETED|Overall Study||1
2271698|NCT02267824|5575723|P1|NOT COMPLETED|Overall Study||10
2271699|NCT02267824|5575722|P2|COMPLETED|Overall Study||17
2271700|NCT02267824|5575723|P1|COMPLETED|Overall Study||73
2271701|NCT02267824|5575722|P2|STARTED|Overall Study||18
2271702|NCT02267824|5575723|P1|STARTED|Overall Study||83
2271703|NCT02267811|5575731|P2|NOT COMPLETED|Overall Study||2
2271704|NCT02267811|5575732|P1|NOT COMPLETED|Overall Study||1
2271705|NCT02267811|5575731|P2|COMPLETED|Overall Study||15
2271706|NCT02267811|5575732|P1|COMPLETED|Overall Study||15
2271707|NCT02267811|5575731|P2|STARTED|Overall Study||17
2271708|NCT02267811|5575732|P1|STARTED|Overall Study||16
2271709|NCT02267629|5575742|P1|NOT COMPLETED|Overall Study||0
2271710|NCT02267629|5575742|P1|COMPLETED|Overall Study||7
2271711|NCT02267629|5575742|P1|STARTED|Overall Study||7
2271712|NCT02267603|5575747|P1|NOT COMPLETED|Overall Study||44
2271713|NCT02267603|5575747|P1|COMPLETED|Overall Study||6
2271714|NCT02267603|5575747|P1|STARTED|Overall Study||50
2271715|NCT02267577|5575751|P1|NOT COMPLETED|Overall Study||4
2271716|NCT02267577|5575751|P1|COMPLETED|Overall Study||81
2271717|NCT02267577|5575751|P1|STARTED|Overall Study||85
2271718|NCT02267538|5575758|P2|NOT COMPLETED|Overall Study||0
2271719|NCT02267538|5575759|P1|NOT COMPLETED|Overall Study||0
2271720|NCT02267538|5575758|P2|COMPLETED|Overall Study||143
2271721|NCT02267538|5575759|P1|COMPLETED|Overall Study||142
2271722|NCT02267538|5575758|P2|STARTED|Overall Study||143
2271723|NCT02267538|5575759|P1|STARTED|Overall Study||142
2271724|NCT02267447|5575779|P2|NOT COMPLETED|Overall Study||0
2271725|NCT02267447|5575780|P1|NOT COMPLETED|Overall Study||0
2271726|NCT02267447|5575779|P2|COMPLETED|Overall Study||26968
2271727|NCT02267447|5575780|P1|COMPLETED|Overall Study||77251
2271728|NCT02267447|5575779|P2|STARTED|Overall Study||26968
2271729|NCT02267447|5575780|P1|STARTED|Overall Study||77251
2271730|NCT02267382|5575793|P5|NOT COMPLETED|Overall Study||7
2271731|NCT02267382|5575794|P4|NOT COMPLETED|Overall Study||6
2271732|NCT02267382|5575795|P3|NOT COMPLETED|Overall Study||9
2271733|NCT02267382|5575796|P2|NOT COMPLETED|Overall Study||10
2271734|NCT02267382|5575797|P1|NOT COMPLETED|Overall Study||7
2271735|NCT02267382|5575793|P5|COMPLETED|Overall Study||39
2271736|NCT02267382|5575794|P4|COMPLETED|Overall Study||35
2271737|NCT02267382|5575795|P3|COMPLETED|Overall Study||34
2271738|NCT02267382|5575796|P2|COMPLETED|Overall Study||33
2271739|NCT02267382|5575797|P1|COMPLETED|Overall Study||35
2271740|NCT02267382|5575793|P5|STARTED|Overall Study||46
2271741|NCT02267382|5575794|P4|STARTED|Overall Study||41
2271742|NCT02267382|5575795|P3|STARTED|Overall Study||43
2271743|NCT02267382|5575796|P2|STARTED|Overall Study||43
2271744|NCT02267382|5575797|P1|STARTED|Overall Study||42
2271745|NCT02267278|5575809|P1|NOT COMPLETED|Overall Study||5
2271746|NCT02267278|5575809|P1|COMPLETED|Overall Study||20
2271747|NCT02267278|5575809|P1|STARTED|Overall Study||25
2271748|NCT02267226|5575814|P1|NOT COMPLETED|Overall Study||7
2271749|NCT02267226|5575814|P1|COMPLETED|Overall Study||18
2271750|NCT02267226|5575814|P1|Surgical Prophylaxis Population|Overall Study||9
2271751|NCT02267226|5575814|P1|FAS-Bleeding Population|Overall Study||24
2271752|NCT02267226|5575814|P1|SAFETY Population|Overall Study||25
2271753|NCT02267226|5575814|P1|STARTED|Overall Study||25
2271754|NCT02267187|5575833|P1|NOT COMPLETED|Overall Study||5
2271755|NCT02267187|5575833|P1|COMPLETED|Overall Study||10
2271756|NCT02267187|5575833|P1|STARTED|Overall Study||15
2271757|NCT02267135|5575841|P2|NOT COMPLETED|Period 2 (Randomized Set)||1
2271758|NCT02267135|5575842|P1|NOT COMPLETED|Period 2 (Randomized Set)||4
2271759|NCT02267135|5575841|P2|COMPLETED|Period 2 (Randomized Set)||46
2271760|NCT02267135|5575842|P1|COMPLETED|Period 2 (Randomized Set)||46
2271761|NCT02267135|5575841|P2|STARTED|Period 2 (Randomized Set)||47
2271762|NCT02267135|5575842|P1|STARTED|Period 2 (Randomized Set)||50
2271763|NCT02267135|5575841|P2|NOT COMPLETED|Period 1 (Randomized Set)||4
2271764|NCT02267135|5575842|P1|NOT COMPLETED|Period 1 (Randomized Set)||1
2271765|NCT02267135|5575841|P2|COMPLETED|Period 1 (Randomized Set)||47
2271766|NCT02267135|5575842|P1|COMPLETED|Period 1 (Randomized Set)||50
2271767|NCT02267135|5575841|P2|STARTED|Period 1 (Randomized Set)||51
2271768|NCT02267135|5575842|P1|STARTED|Period 1 (Randomized Set)||51
2271769|NCT02267083|5575873|P1|NOT COMPLETED|Overall Study||19
2271770|NCT02267083|5575873|P1|COMPLETED|Overall Study||3
2271771|NCT02267083|5575873|P1|STARTED|Overall Study||22
2271772|NCT02266914|5575880|P1|NOT COMPLETED|Overall Study||9
2271773|NCT02266914|5575880|P1|COMPLETED|Overall Study||0
2271774|NCT02266914|5575880|P1|STARTED|Overall Study||9
2271775|NCT02266875|5575886|P2|NOT COMPLETED|Overall Study||0
2271776|NCT02266875|5575887|P1|NOT COMPLETED|Overall Study||11
2271777|NCT02266875|5575886|P2|COMPLETED|Overall Study||30
2271778|NCT02266875|5575887|P1|COMPLETED|Overall Study||29
2271779|NCT02266875|5575886|P2|STARTED|Overall Study||30
2271780|NCT02266875|5575887|P1|STARTED|Overall Study||40
2271781|NCT02266810|5575899|P2|NOT COMPLETED|Overall Study||1
2271782|NCT02266810|5575900|P1|NOT COMPLETED|Overall Study||1
2271783|NCT02266810|5575899|P2|COMPLETED|Overall Study|sinus sides|79
2271784|NCT02266810|5575900|P1|COMPLETED|Overall Study|sinus sides|79
2271785|NCT02266810|5575899|P2|STARTED|Overall Study|sinus sides|80
2271786|NCT02266810|5575900|P1|STARTED|Overall Study|sinus sides|80
2271787|NCT02266797|5575926|P2|NOT COMPLETED|Overall Study||1
2271788|NCT02266797|5575927|P1|NOT COMPLETED|Overall Study||0
2271789|NCT02266797|5575926|P2|COMPLETED|Overall Study||2
2271790|NCT02266797|5575927|P1|COMPLETED|Overall Study||1
2271791|NCT02266797|5575926|P2|STARTED|Overall Study||3
2271792|NCT02266797|5575927|P1|STARTED|Overall Study||1
2271793|NCT02266706|5575952|P9|NOT COMPLETED|Overall Study||0
2271794|NCT02266706|5575953|P8|NOT COMPLETED|Overall Study||0
2271795|NCT02266706|5575954|P7|NOT COMPLETED|Overall Study||1
2271796|NCT02266706|5575955|P6|NOT COMPLETED|Overall Study||2
2271797|NCT02266706|5575956|P5|NOT COMPLETED|Overall Study||0
2271798|NCT02266706|5575957|P4|NOT COMPLETED|Overall Study||1
2271799|NCT02266706|5575958|P3|NOT COMPLETED|Overall Study||1
2271800|NCT02266706|5575959|P2|NOT COMPLETED|Overall Study||1
2271801|NCT02266706|5575960|P1|NOT COMPLETED|Overall Study||0
2271802|NCT02266706|5575952|P9|COMPLETED|Overall Study||4
2271803|NCT02266706|5575953|P8|COMPLETED|Overall Study||2
2271804|NCT02266706|5575954|P7|COMPLETED|Overall Study||7
2271805|NCT02266706|5575955|P6|COMPLETED|Overall Study||5
2271806|NCT02266706|5575956|P5|COMPLETED|Overall Study||1
2271807|NCT02266706|5575957|P4|COMPLETED|Overall Study||3
2271808|NCT02266706|5575958|P3|COMPLETED|Overall Study||3
2271809|NCT02266706|5575959|P2|COMPLETED|Overall Study||6
2271810|NCT02266706|5575960|P1|COMPLETED|Overall Study||6
2271811|NCT02266706|5575952|P9|Treated|Overall Study||4
2271812|NCT02266706|5575953|P8|Treated|Overall Study||2
2271813|NCT02266706|5575954|P7|Treated|Overall Study||7
2271814|NCT02266706|5575955|P6|Treated|Overall Study||5
2271815|NCT02266706|5575956|P5|Treated|Overall Study||1
2271816|NCT02266706|5575957|P4|Treated|Overall Study||3
2271817|NCT02266706|5575958|P3|Treated|Overall Study||3
2271818|NCT02266706|5575959|P2|Treated|Overall Study||6
2271819|NCT02266706|5575960|P1|Treated|Overall Study||6
2271820|NCT02266706|5575952|P9|STARTED|Overall Study||4
2271821|NCT02266706|5575953|P8|STARTED|Overall Study||2
2271822|NCT02266706|5575954|P7|STARTED|Overall Study||8
2271823|NCT02266706|5575955|P6|STARTED|Overall Study||7
2271824|NCT02266706|5575956|P5|STARTED|Overall Study||1
2271825|NCT02266706|5575957|P4|STARTED|Overall Study||4
2271826|NCT02266706|5575958|P3|STARTED|Overall Study||4
2271827|NCT02266706|5575959|P2|STARTED|Overall Study||7
2271828|NCT02266706|5575960|P1|STARTED|Overall Study||6
2271829|NCT02266576|5576153|P2|NOT COMPLETED|Overall Study||15
2271830|NCT02266576|5576154|P1|NOT COMPLETED|Overall Study||17
2271831|NCT02266576|5576153|P2|COMPLETED|Overall Study||90
2271832|NCT02266576|5576154|P1|COMPLETED|Overall Study||85
2271833|NCT02266576|5576153|P2|STARTED|Overall Study||105
2271834|NCT02266576|5576154|P1|STARTED|Overall Study||102
2271835|NCT02266472|5576172|P2|NOT COMPLETED|Period 2+ Washout||0
2271836|NCT02266472|5576173|P1|NOT COMPLETED|Period 2+ Washout||0
2271837|NCT02266472|5576172|P2|COMPLETED|Period 2+ Washout||15
2271838|NCT02266472|5576173|P1|COMPLETED|Period 2+ Washout||15
2271839|NCT02266472|5576172|P2|STARTED|Period 2+ Washout||15
2271840|NCT02266472|5576173|P1|STARTED|Period 2+ Washout||15
2271841|NCT02266472|5576172|P2|NOT COMPLETED|Period 1+ Washout||0
2271842|NCT02266472|5576173|P1|NOT COMPLETED|Period 1+ Washout||0
2271843|NCT02266472|5576172|P2|COMPLETED|Period 1+ Washout||15
2271844|NCT02266472|5576173|P1|COMPLETED|Period 1+ Washout||15
2271845|NCT02266472|5576172|P2|STARTED|Period 1+ Washout||15
2271846|NCT02266472|5576173|P1|STARTED|Period 1+ Washout||15
2271847|NCT02266381|5576192|P3|NOT COMPLETED|Overall Study||4
2271848|NCT02266381|5576193|P2|NOT COMPLETED|Overall Study||5
2271849|NCT02266381|5576194|P1|NOT COMPLETED|Overall Study||3
2271850|NCT02266381|5576192|P3|COMPLETED|Overall Study||146
2271851|NCT02266381|5576193|P2|COMPLETED|Overall Study||145
2271852|NCT02266381|5576194|P1|COMPLETED|Overall Study||147
2271853|NCT02266381|5576192|P3|STARTED|Overall Study||150
2271854|NCT02266381|5576193|P2|STARTED|Overall Study||150
2271855|NCT02266381|5576194|P1|STARTED|Overall Study||150
2271856|NCT02266277|5576217|P6|NOT COMPLETED|Overall Study||0
2271857|NCT02266277|5576218|P5|NOT COMPLETED|Overall Study||0
2271858|NCT02266277|5576219|P4|NOT COMPLETED|Overall Study||0
2271859|NCT02266277|5576220|P3|NOT COMPLETED|Overall Study||0
2271860|NCT02266277|5576221|P2|NOT COMPLETED|Overall Study||0
2271861|NCT02266277|5576222|P1|NOT COMPLETED|Overall Study||0
2271862|NCT02266277|5576217|P6|COMPLETED|Overall Study||5000
2271863|NCT02266277|5576218|P5|COMPLETED|Overall Study||5000
2271864|NCT02266277|5576219|P4|COMPLETED|Overall Study||5000
2271865|NCT02266277|5576220|P3|COMPLETED|Overall Study||5000
2271866|NCT02266277|5576221|P2|COMPLETED|Overall Study||5000
2271867|NCT02266277|5576222|P1|COMPLETED|Overall Study||5000
2271868|NCT02266277|5576217|P6|STARTED|Overall Study||5000
2271869|NCT02266277|5576218|P5|STARTED|Overall Study||5000
2271870|NCT02266277|5576219|P4|STARTED|Overall Study||5000
2271871|NCT02266277|5576220|P3|STARTED|Overall Study||5000
2271872|NCT02266277|5576221|P2|STARTED|Overall Study||5000
2271873|NCT02266277|5576222|P1|STARTED|Overall Study||5000
2271874|NCT02266225|5576244|P1|NOT COMPLETED|Overall Study||16
2271875|NCT02266225|5576244|P1|COMPLETED|Overall Study||32
2271876|NCT02266225|5576244|P1|Enrolled in Intervention|Overall Study||44
2271877|NCT02266225|5576244|P1|STARTED|Overall Study||48
2271878|NCT02266108|5576267|P2|NOT COMPLETED|Overall Study||0
2271879|NCT02266108|5576268|P1|NOT COMPLETED|Overall Study||0
2271880|NCT02266108|5576267|P2|COMPLETED|Overall Study||71
2271881|NCT02266108|5576268|P1|COMPLETED|Overall Study||80
2271882|NCT02266108|5576267|P2|STARTED|Overall Study||71
2271883|NCT02266108|5576268|P1|STARTED|Overall Study||80
2271884|NCT02265952|5576278|P2|NOT COMPLETED|Open Label Extension (OLE) Period||8
2271885|NCT02265952|5576279|P1|NOT COMPLETED|Open Label Extension (OLE) Period||0
2271886|NCT02265952|5576278|P2|COMPLETED|Open Label Extension (OLE) Period||0
2271887|NCT02265952|5576279|P1|COMPLETED|Open Label Extension (OLE) Period||0
2271888|NCT02265952|5576278|P2|STARTED|Open Label Extension (OLE) Period||8
2271889|NCT02265952|5576279|P1|STARTED|Open Label Extension (OLE) Period||0
2271890|NCT02265952|5576278|P2|NOT COMPLETED|Main Study Period||0
2271891|NCT02265952|5576279|P1|NOT COMPLETED|Main Study Period||0
2271892|NCT02265952|5576278|P2|COMPLETED|Main Study Period||0
2271893|NCT02265952|5576279|P1|COMPLETED|Main Study Period||9
2271894|NCT02265952|5576278|P2|STARTED|Main Study Period||0
2271895|NCT02265952|5576279|P1|STARTED|Main Study Period||9
2271896|NCT02265848|5576307|P2|NOT COMPLETED|Overall Study||0
2271897|NCT02265848|5576308|P1|NOT COMPLETED|Overall Study||0
2271898|NCT02265848|5576307|P2|COMPLETED|Overall Study|Last subject for this study completed the visit on December 24, 2014|11
2271899|NCT02265848|5576308|P1|COMPLETED|Overall Study||11
2271900|NCT02265848|5576307|P2|STARTED|Overall Study||11
2271901|NCT02265848|5576308|P1|STARTED|Overall Study|First subject for this study was randomized on October 1st 2014|11
2271902|NCT02265796|5576322|P2|NOT COMPLETED|Overall Study||1
2271903|NCT02265796|5576323|P1|NOT COMPLETED|Overall Study||3
2271904|NCT02265796|5576322|P2|COMPLETED|Overall Study||24
2271905|NCT02265796|5576323|P1|COMPLETED|Overall Study||22
2271906|NCT02265796|5576322|P2|STARTED|Overall Study||25
2271907|NCT02265796|5576323|P1|STARTED|Overall Study||25
2271908|NCT02265783|5576333|P1|NOT COMPLETED|Overall Study||0
2271909|NCT02265783|5576333|P1|COMPLETED|Overall Study|All subjects completed, one excluded from the analysis due to an issue with the data collection|20
2271910|NCT02265783|5576333|P1|STARTED|Overall Study||20
2271911|NCT02265744|5576342|P5|NOT COMPLETED|Overall Study||13
2271912|NCT02265744|5576343|P4|NOT COMPLETED|Overall Study||23
2271913|NCT02265744|5576344|P3|NOT COMPLETED|Overall Study||17
2271914|NCT02265744|5576345|P2|NOT COMPLETED|Overall Study||15
2271915|NCT02265744|5576346|P1|NOT COMPLETED|Overall Study||20
2271916|NCT02265744|5576342|P5|COMPLETED|Overall Study||58
2271917|NCT02265744|5576343|P4|COMPLETED|Overall Study||47
2271918|NCT02265744|5576344|P3|COMPLETED|Overall Study||51
2271919|NCT02265744|5576345|P2|COMPLETED|Overall Study||53
2271920|NCT02265744|5576346|P1|COMPLETED|Overall Study||49
2271921|NCT02265744|5576342|P5|STARTED|Overall Study||71
2271922|NCT02265744|5576343|P4|STARTED|Overall Study||70
2271923|NCT02265744|5576344|P3|STARTED|Overall Study||68
2271924|NCT02265744|5576345|P2|STARTED|Overall Study||68
2271925|NCT02265744|5576346|P1|STARTED|Overall Study||69
2271926|NCT02265705|5576525|P7|NOT COMPLETED|Follow-up Period||11
2271927|NCT02265705|5576526|P6|NOT COMPLETED|Follow-up Period||1
2271928|NCT02265705|5576527|P5|NOT COMPLETED|Follow-up Period||0
2271929|NCT02265705|5576528|P4|NOT COMPLETED|Follow-up Period||0
2271930|NCT02265705|5576529|P3|NOT COMPLETED|Follow-up Period||0
2271931|NCT02265705|5576530|P2|NOT COMPLETED|Follow-up Period||0
2271932|NCT02265705|5576531|P1|NOT COMPLETED|Follow-up Period||0
2271933|NCT02265705|5576525|P7|COMPLETED|Follow-up Period||47
2271934|NCT02265705|5576526|P6|COMPLETED|Follow-up Period||1
2271935|NCT02265705|5576527|P5|COMPLETED|Follow-up Period||0
2271936|NCT02265705|5576528|P4|COMPLETED|Follow-up Period||0
2271937|NCT02265705|5576529|P3|COMPLETED|Follow-up Period||0
2271938|NCT02265705|5576530|P2|COMPLETED|Follow-up Period||0
2271939|NCT02265705|5576531|P1|COMPLETED|Follow-up Period||0
2271940|NCT02265705|5576525|P7|STARTED|Follow-up Period|Participants who ever took baricitinib and entered the post-treatment follow-up period.|58
2271941|NCT02265705|5576526|P6|STARTED|Follow-up Period|Participants from placebo who never rescued or switched and entered post-treatment follow-up period.|2
2271942|NCT02265705|5576527|P5|STARTED|Follow-up Period||0
2271943|NCT02265705|5576528|P4|STARTED|Follow-up Period||0
2271944|NCT02265705|5576529|P3|STARTED|Follow-up Period||0
2271945|NCT02265705|5576530|P2|STARTED|Follow-up Period||0
2271946|NCT02265705|5576531|P1|STARTED|Follow-up Period||0
2271947|NCT02265705|5576525|P7|NOT COMPLETED|Open Label Period||0
2271948|NCT02265705|5576526|P6|NOT COMPLETED|Open Label Period||0
2271949|NCT02265705|5576527|P5|NOT COMPLETED|Open Label Period||5
2271950|NCT02265705|5576528|P4|NOT COMPLETED|Open Label Period||2
2271951|NCT02265705|5576529|P3|NOT COMPLETED|Open Label Period||0
2271952|NCT02265705|5576530|P2|NOT COMPLETED|Open Label Period||0
2271953|NCT02265705|5576531|P1|NOT COMPLETED|Open Label Period||0
2271954|NCT02265705|5576525|P7|COMPLETED|Open Label Period||0
2271955|NCT02265705|5576526|P6|COMPLETED|Open Label Period||0
2271956|NCT02265705|5576527|P5|COMPLETED|Open Label Period||115
2271957|NCT02265705|5576528|P4|COMPLETED|Open Label Period||72
2271958|NCT02265705|5576529|P3|COMPLETED|Open Label Period||0
2271959|NCT02265705|5576530|P2|COMPLETED|Open Label Period||0
2271960|NCT02265705|5576531|P1|COMPLETED|Open Label Period||0
2271961|NCT02265705|5576525|P7|STARTED|Open Label Period||0
2271962|NCT02265705|5576526|P6|STARTED|Open Label Period||0
2271963|NCT02265705|5576527|P5|STARTED|Open Label Period|Completed Wk 24 w/o rescue Tx, switched to or remained on active Tx, and entered Open Label Period.|120
2271964|NCT02265705|5576528|P4|STARTED|Open Label Period|Completed Wk 24 w/o rescue Tx, switched to or remained on active Tx, and entered Open Label Period.|74
2271965|NCT02265705|5576529|P3|STARTED|Open Label Period||0
2271966|NCT02265705|5576530|P2|STARTED|Open Label Period||0
2271967|NCT02265705|5576531|P1|STARTED|Open Label Period||0
2271968|NCT02265705|5576525|P7|NOT COMPLETED|Rescue Period||0
2271969|NCT02265705|5576526|P6|NOT COMPLETED|Rescue Period||0
2271970|NCT02265705|5576527|P5|NOT COMPLETED|Rescue Period||0
2271971|NCT02265705|5576528|P4|NOT COMPLETED|Rescue Period||0
2271972|NCT02265705|5576529|P3|NOT COMPLETED|Rescue Period||3
2271973|NCT02265705|5576530|P2|NOT COMPLETED|Rescue Period||0
2271974|NCT02265705|5576531|P1|NOT COMPLETED|Rescue Period||0
2271975|NCT02265705|5576525|P7|COMPLETED|Rescue Period||0
2271976|NCT02265705|5576526|P6|COMPLETED|Rescue Period||0
2271977|NCT02265705|5576527|P5|COMPLETED|Rescue Period||0
2271978|NCT02265705|5576528|P4|COMPLETED|Rescue Period||0
2271979|NCT02265705|5576529|P3|COMPLETED|Rescue Period||74
2271980|NCT02265705|5576530|P2|COMPLETED|Rescue Period||0
2271981|NCT02265705|5576531|P1|COMPLETED|Rescue Period||0
2271982|NCT02265705|5576525|P7|STARTED|Rescue Period||0
2271983|NCT02265705|5576526|P6|STARTED|Rescue Period||0
2271984|NCT02265705|5576527|P5|STARTED|Rescue Period||0
2271985|NCT02265705|5576528|P4|STARTED|Rescue Period||0
2271986|NCT02265705|5576529|P3|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|77
2271987|NCT02265705|5576530|P2|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
2271988|NCT02265705|5576531|P1|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
2271989|NCT02265705|5576525|P7|NOT COMPLETED|Treatment Period Week 0-24||0
2271990|NCT02265705|5576526|P6|NOT COMPLETED|Treatment Period Week 0-24||0
2271991|NCT02265705|5576527|P5|NOT COMPLETED|Treatment Period Week 0-24||0
2271992|NCT02265705|5576528|P4|NOT COMPLETED|Treatment Period Week 0-24||0
2271993|NCT02265705|5576529|P3|NOT COMPLETED|Treatment Period Week 0-24||0
2271994|NCT02265705|5576530|P2|NOT COMPLETED|Treatment Period Week 0-24||9
2271995|NCT02265705|5576531|P1|NOT COMPLETED|Treatment Period Week 0-24||12
2271996|NCT02265705|5576525|P7|COMPLETED|Treatment Period Week 0-24||0
2271997|NCT02265705|5576526|P6|COMPLETED|Treatment Period Week 0-24||0
2271998|NCT02265705|5576527|P5|COMPLETED|Treatment Period Week 0-24||0
2271999|NCT02265705|5576528|P4|COMPLETED|Treatment Period Week 0-24||0
2272000|NCT02265705|5576529|P3|COMPLETED|Treatment Period Week 0-24||0
2272001|NCT02265705|5576530|P2|COMPLETED|Treatment Period Week 0-24|"Completers include rescued participants."|136
2272002|NCT02265705|5576531|P1|COMPLETED|Treatment Period Week 0-24|"Completers include rescued participants."|133
2272003|NCT02265705|5576525|P7|Rescued|Treatment Period Week 0-24||0
2272004|NCT02265705|5576526|P6|Rescued|Treatment Period Week 0-24||0
2272005|NCT02265705|5576527|P5|Rescued|Treatment Period Week 0-24||0
2272006|NCT02265705|5576528|P4|Rescued|Treatment Period Week 0-24||0
2272007|NCT02265705|5576529|P3|Rescued|Treatment Period Week 0-24||0
2272008|NCT02265705|5576530|P2|Rescued|Treatment Period Week 0-24||17
2272009|NCT02265705|5576531|P1|Rescued|Treatment Period Week 0-24||59
2272010|NCT02265705|5576525|P7|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
2272011|NCT02265705|5576526|P6|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
2272012|NCT02265705|5576527|P5|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
2272013|NCT02265705|5576528|P4|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
2272014|NCT02265705|5576529|P3|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
2272015|NCT02265705|5576530|P2|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||145
2272016|NCT02265705|5576531|P1|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||145
2272017|NCT02265705|5576525|P7|STARTED|Treatment Period Week 0-24||0
2272018|NCT02265705|5576526|P6|STARTED|Treatment Period Week 0-24||0
2272019|NCT02265705|5576527|P5|STARTED|Treatment Period Week 0-24||0
2272020|NCT02265705|5576528|P4|STARTED|Treatment Period Week 0-24||0
2272021|NCT02265705|5576529|P3|STARTED|Treatment Period Week 0-24||0
2272022|NCT02265705|5576530|P2|STARTED|Treatment Period Week 0-24||145
2272023|NCT02265705|5576531|P1|STARTED|Treatment Period Week 0-24||145
2272024|NCT02265341|5576556|P1|NOT COMPLETED|Overall Study||0
2272025|NCT02265341|5576556|P1|COMPLETED|Overall Study||12
2272026|NCT02265341|5576556|P1|STARTED|Overall Study||12
2272027|NCT02265237|5576568|P4|NOT COMPLETED|As Treated (Overall Study)||1
2272028|NCT02265237|5576569|P3|NOT COMPLETED|As Treated (Overall Study)||10
2272029|NCT02265237|5576570|P2|NOT COMPLETED|As Treated (Overall Study)||3
2272030|NCT02265237|5576571|P1|NOT COMPLETED|As Treated (Overall Study)||5
2272031|NCT02265237|5576568|P4|COMPLETED|As Treated (Overall Study)||2
2272032|NCT02265237|5576569|P3|COMPLETED|As Treated (Overall Study)||51
2272033|NCT02265237|5576570|P2|COMPLETED|As Treated (Overall Study)||57
2272034|NCT02265237|5576571|P1|COMPLETED|As Treated (Overall Study)||55
2272035|NCT02265237|5576568|P4|STARTED|As Treated (Overall Study)||3
2272036|NCT02265237|5576569|P3|STARTED|As Treated (Overall Study)||61
2272037|NCT02265237|5576570|P2|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
2272038|NCT02265237|5576571|P1|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
2272039|NCT02265237|5576568|P4|NOT COMPLETED|As Enrolled (Overall Study)||1
2272040|NCT02265237|5576569|P3|NOT COMPLETED|As Enrolled (Overall Study)||10
2272041|NCT02265237|5576570|P2|NOT COMPLETED|As Enrolled (Overall Study)||3
2272042|NCT02265237|5576571|P1|NOT COMPLETED|As Enrolled (Overall Study)||5
2272043|NCT02265237|5576568|P4|COMPLETED|As Enrolled (Overall Study)||2
2272044|NCT02265237|5576569|P3|COMPLETED|As Enrolled (Overall Study)||51
2272045|NCT02265237|5576570|P2|COMPLETED|As Enrolled (Overall Study)||58
2272046|NCT02265237|5576571|P1|COMPLETED|As Enrolled (Overall Study)||54
2272047|NCT02265237|5576568|P4|STARTED|As Enrolled (Overall Study)||3
2272048|NCT02265237|5576569|P3|STARTED|As Enrolled (Overall Study)||61
2272049|NCT02265237|5576570|P2|STARTED|As Enrolled (Overall Study)||61
2272050|NCT02265237|5576571|P1|STARTED|As Enrolled (Overall Study)||59
2272051|NCT02264977|5576590|P1|NOT COMPLETED|Overall Study||6
2272052|NCT02264977|5576590|P1|COMPLETED|Overall Study||3
2272053|NCT02264977|5576590|P1|STARTED|Overall Study||9
2272054|NCT02264821|5576601|P3|NOT COMPLETED|Overall Study||6
2272055|NCT02264821|5576602|P2|NOT COMPLETED|Overall Study||3
2272056|NCT02264821|5576603|P1|NOT COMPLETED|Overall Study||1
2272057|NCT02264821|5576601|P3|COMPLETED|Overall Study||58
2272058|NCT02264821|5576602|P2|COMPLETED|Overall Study||61
2272059|NCT02264821|5576603|P1|COMPLETED|Overall Study||63
2272060|NCT02264821|5576601|P3|STARTED|Overall Study|Double Blind|64
2272061|NCT02264821|5576602|P2|STARTED|Overall Study|Double Blind|64
2272062|NCT02264821|5576603|P1|STARTED|Overall Study|Double Blind|64
2272063|NCT02264574|5576616|P2|NOT COMPLETED|Overall Study||8
2272064|NCT02264574|5576617|P1|NOT COMPLETED|Overall Study||6
2272065|NCT02264574|5576616|P2|COMPLETED|Overall Study||108
2272066|NCT02264574|5576617|P1|COMPLETED|Overall Study||107
2272067|NCT02264574|5576616|P2|STARTED|Overall Study||116
2272068|NCT02264574|5576617|P1|STARTED|Overall Study||113
2272069|NCT02264353|5576627|P2|NOT COMPLETED|Overall Study||0
2272070|NCT02264353|5576628|P1|NOT COMPLETED|Overall Study||3
2272071|NCT02264353|5576627|P2|COMPLETED|Overall Study||24
2272072|NCT02264353|5576628|P1|COMPLETED|Overall Study||17
2272073|NCT02264353|5576627|P2|STARTED|Overall Study||24
2272074|NCT02264353|5576628|P1|STARTED|Overall Study||20
2272075|NCT02264249|5576641|P3|NOT COMPLETED|Overall Study||0
2272076|NCT02264249|5576642|P2|NOT COMPLETED|Overall Study||0
2272077|NCT02264249|5576643|P1|NOT COMPLETED|Overall Study||0
2272078|NCT02264249|5576641|P3|COMPLETED|Overall Study||241
2272079|NCT02264249|5576642|P2|COMPLETED|Overall Study||187
2272080|NCT02264249|5576643|P1|COMPLETED|Overall Study||21
2272081|NCT02264249|5576641|P3|STARTED|Overall Study||241
2272082|NCT02264249|5576642|P2|STARTED|Overall Study||187
2272083|NCT02264249|5576643|P1|STARTED|Overall Study||21
2272084|NCT02263911|5576657|P4|NOT COMPLETED|Period 5||0
2272085|NCT02263911|5576658|P3|NOT COMPLETED|Period 5||0
2272086|NCT02263911|5576659|P2|NOT COMPLETED|Period 5||0
2272087|NCT02263911|5576660|P1|NOT COMPLETED|Period 5||0
2272088|NCT02263911|5576657|P4|COMPLETED|Period 5||4
2272089|NCT02263911|5576658|P3|COMPLETED|Period 5||4
2272090|NCT02263911|5576659|P2|COMPLETED|Period 5||4
2272091|NCT02263911|5576660|P1|COMPLETED|Period 5||4
2272092|NCT02263911|5576657|P4|STARTED|Period 5||4
2272093|NCT02263911|5576658|P3|STARTED|Period 5||4
2272094|NCT02263911|5576659|P2|STARTED|Period 5||4
2272095|NCT02263911|5576660|P1|STARTED|Period 5||4
2272096|NCT02263911|5576657|P4|NOT COMPLETED|Period 4 Washout||0
2272097|NCT02263911|5576658|P3|NOT COMPLETED|Period 4 Washout||0
2272098|NCT02263911|5576659|P2|NOT COMPLETED|Period 4 Washout||0
2272099|NCT02263911|5576660|P1|NOT COMPLETED|Period 4 Washout||0
2272100|NCT02263911|5576657|P4|COMPLETED|Period 4 Washout||4
2272101|NCT02263911|5576658|P3|COMPLETED|Period 4 Washout||4
2272102|NCT02263911|5576659|P2|COMPLETED|Period 4 Washout||4
2272103|NCT02263911|5576660|P1|COMPLETED|Period 4 Washout||4
2272104|NCT02263911|5576657|P4|STARTED|Period 4 Washout||4
2272105|NCT02263911|5576658|P3|STARTED|Period 4 Washout||4
2272106|NCT02263911|5576659|P2|STARTED|Period 4 Washout||4
2272107|NCT02263911|5576660|P1|STARTED|Period 4 Washout||4
2272108|NCT02263911|5576657|P4|NOT COMPLETED|Period 4||0
2272109|NCT02263911|5576658|P3|NOT COMPLETED|Period 4||0
2272110|NCT02263911|5576659|P2|NOT COMPLETED|Period 4||0
2272111|NCT02263911|5576660|P1|NOT COMPLETED|Period 4||0
2272112|NCT02263911|5576657|P4|COMPLETED|Period 4||4
2272113|NCT02263911|5576658|P3|COMPLETED|Period 4||4
2272114|NCT02263911|5576659|P2|COMPLETED|Period 4||4
2272115|NCT02263911|5576660|P1|COMPLETED|Period 4||4
2272116|NCT02263911|5576657|P4|STARTED|Period 4||4
2272117|NCT02263911|5576658|P3|STARTED|Period 4||4
2272118|NCT02263911|5576659|P2|STARTED|Period 4||4
2272119|NCT02263911|5576660|P1|STARTED|Period 4||4
2272120|NCT02263911|5576657|P4|NOT COMPLETED|Period 3 Washout||0
2272121|NCT02263911|5576658|P3|NOT COMPLETED|Period 3 Washout||0
2272122|NCT02263911|5576659|P2|NOT COMPLETED|Period 3 Washout||0
2272123|NCT02263911|5576660|P1|NOT COMPLETED|Period 3 Washout||0
2272124|NCT02263911|5576657|P4|COMPLETED|Period 3 Washout||4
2272125|NCT02263911|5576658|P3|COMPLETED|Period 3 Washout||4
2272126|NCT02263911|5576659|P2|COMPLETED|Period 3 Washout||4
2272127|NCT02263911|5576660|P1|COMPLETED|Period 3 Washout||4
2272128|NCT02263911|5576657|P4|STARTED|Period 3 Washout||4
2272129|NCT02263911|5576658|P3|STARTED|Period 3 Washout||4
2272130|NCT02263911|5576659|P2|STARTED|Period 3 Washout||4
2272131|NCT02263911|5576660|P1|STARTED|Period 3 Washout||4
2272132|NCT02263911|5576657|P4|NOT COMPLETED|Period 3||0
2272133|NCT02263911|5576658|P3|NOT COMPLETED|Period 3||0
2272134|NCT02263911|5576659|P2|NOT COMPLETED|Period 3||0
2272135|NCT02263911|5576660|P1|NOT COMPLETED|Period 3||0
2272136|NCT02263911|5576657|P4|COMPLETED|Period 3||4
2272137|NCT02263911|5576658|P3|COMPLETED|Period 3||4
2272138|NCT02263911|5576659|P2|COMPLETED|Period 3||4
2272139|NCT02263911|5576660|P1|COMPLETED|Period 3||4
2272140|NCT02263911|5576657|P4|STARTED|Period 3||4
2272141|NCT02263911|5576658|P3|STARTED|Period 3||4
2272142|NCT02263911|5576659|P2|STARTED|Period 3||4
2272143|NCT02263911|5576660|P1|STARTED|Period 3||4
2272144|NCT02263911|5576657|P4|NOT COMPLETED|Period 2 Washout||0
2272145|NCT02263911|5576658|P3|NOT COMPLETED|Period 2 Washout||0
2272146|NCT02263911|5576659|P2|NOT COMPLETED|Period 2 Washout||0
2272147|NCT02263911|5576660|P1|NOT COMPLETED|Period 2 Washout||0
2272148|NCT02263911|5576657|P4|COMPLETED|Period 2 Washout||4
2272149|NCT02263911|5576658|P3|COMPLETED|Period 2 Washout||4
2272150|NCT02263911|5576659|P2|COMPLETED|Period 2 Washout||4
2272151|NCT02263911|5576660|P1|COMPLETED|Period 2 Washout||4
2272152|NCT02263911|5576657|P4|STARTED|Period 2 Washout||4
2272153|NCT02263911|5576658|P3|STARTED|Period 2 Washout||4
2272154|NCT02263911|5576659|P2|STARTED|Period 2 Washout||4
2272155|NCT02263911|5576660|P1|STARTED|Period 2 Washout||4
2272156|NCT02263911|5576657|P4|NOT COMPLETED|Period 2||0
2272157|NCT02263911|5576658|P3|NOT COMPLETED|Period 2||0
2272158|NCT02263911|5576659|P2|NOT COMPLETED|Period 2||0
2272159|NCT02263911|5576660|P1|NOT COMPLETED|Period 2||0
2272160|NCT02263911|5576657|P4|COMPLETED|Period 2||4
2272161|NCT02263911|5576658|P3|COMPLETED|Period 2||4
2272162|NCT02263911|5576659|P2|COMPLETED|Period 2||4
2272163|NCT02263911|5576660|P1|COMPLETED|Period 2||4
2272164|NCT02263911|5576657|P4|STARTED|Period 2||4
2272165|NCT02263911|5576658|P3|STARTED|Period 2||4
2272166|NCT02263911|5576659|P2|STARTED|Period 2||4
2272167|NCT02263911|5576660|P1|STARTED|Period 2||4
2272168|NCT02263911|5576657|P4|NOT COMPLETED|Period 1 Washout||0
2272169|NCT02263911|5576658|P3|NOT COMPLETED|Period 1 Washout||0
2272170|NCT02263911|5576659|P2|NOT COMPLETED|Period 1 Washout||0
2272171|NCT02263911|5576660|P1|NOT COMPLETED|Period 1 Washout||0
2272172|NCT02263911|5576657|P4|COMPLETED|Period 1 Washout||4
2272173|NCT02263911|5576658|P3|COMPLETED|Period 1 Washout||4
2272174|NCT02263911|5576659|P2|COMPLETED|Period 1 Washout||4
2272175|NCT02263911|5576660|P1|COMPLETED|Period 1 Washout||4
2272176|NCT02263911|5576657|P4|STARTED|Period 1 Washout||4
2272177|NCT02263911|5576658|P3|STARTED|Period 1 Washout||4
2272178|NCT02263911|5576659|P2|STARTED|Period 1 Washout||4
2272179|NCT02263911|5576660|P1|STARTED|Period 1 Washout||4
2272180|NCT02263911|5576657|P4|NOT COMPLETED|Period 1||0
2272181|NCT02263911|5576658|P3|NOT COMPLETED|Period 1||0
2272182|NCT02263911|5576659|P2|NOT COMPLETED|Period 1||0
2272183|NCT02263911|5576660|P1|NOT COMPLETED|Period 1||0
2272184|NCT02263911|5576657|P4|COMPLETED|Period 1||4
2272185|NCT02263911|5576658|P3|COMPLETED|Period 1||4
2272186|NCT02263911|5576659|P2|COMPLETED|Period 1||4
2272187|NCT02263911|5576660|P1|COMPLETED|Period 1||4
2272188|NCT02263911|5576657|P4|STARTED|Period 1||4
2272189|NCT02263911|5576658|P3|STARTED|Period 1||4
2272190|NCT02263911|5576659|P2|STARTED|Period 1||4
2272191|NCT02263911|5576660|P1|STARTED|Period 1||4
2272192|NCT02263833|5576682|P1|NOT COMPLETED|Overall Study||0
2272193|NCT02263833|5576682|P1|COMPLETED|Overall Study||742
2272194|NCT02263833|5576682|P1|STARTED|Overall Study||742
2272195|NCT02263547|5576687|P1|NOT COMPLETED|Overall Study||3
2272196|NCT02263547|5576687|P1|COMPLETED|Overall Study||11
2272197|NCT02263547|5576687|P1|STARTED|Overall Study||14
2272198|NCT02263365|5576694|P2|NOT COMPLETED|Overall Study||18
2272199|NCT02263365|5576695|P1|NOT COMPLETED|Overall Study||22
2272200|NCT02263365|5576694|P2|COMPLETED|Overall Study||0
2272201|NCT02263365|5576695|P1|COMPLETED|Overall Study||0
2272202|NCT02263365|5576694|P2|STARTED|Overall Study||18
2272203|NCT02263365|5576695|P1|STARTED|Overall Study||22
2272204|NCT02263326|5576709|P2|NOT COMPLETED|Overall Study||1
2272205|NCT02263326|5576710|P1|NOT COMPLETED|Overall Study||1
2272206|NCT02263326|5576709|P2|COMPLETED|Overall Study||44
2272207|NCT02263326|5576710|P1|COMPLETED|Overall Study||43
2272208|NCT02263326|5576709|P2|STARTED|Overall Study||45
2272209|NCT02263326|5576710|P1|STARTED|Overall Study||44
2272210|NCT02263131|5576732|P2|NOT COMPLETED|Overall Study||1
2272211|NCT02263131|5576733|P1|NOT COMPLETED|Overall Study||10
2272212|NCT02263131|5576732|P2|COMPLETED|Overall Study||68
2272213|NCT02263131|5576733|P1|COMPLETED|Overall Study||337
2272214|NCT02263131|5576732|P2|STARTED|Overall Study||69
2272215|NCT02263131|5576733|P1|STARTED|Overall Study||347
2272216|NCT02263118|5576745|P4|NOT COMPLETED|Overall Study||2
2272217|NCT02263118|5576746|P3|NOT COMPLETED|Overall Study||8
2272218|NCT02263118|5576747|P2|NOT COMPLETED|Overall Study||8
2272219|NCT02263118|5576748|P1|NOT COMPLETED|Overall Study||4
2272220|NCT02263118|5576745|P4|COMPLETED|Overall Study||12
2272221|NCT02263118|5576746|P3|COMPLETED|Overall Study||22
2272222|NCT02263118|5576747|P2|COMPLETED|Overall Study||24
2272223|NCT02263118|5576748|P1|COMPLETED|Overall Study||20
2272224|NCT02263118|5576745|P4|STARTED|Overall Study||14
2272225|NCT02263118|5576746|P3|STARTED|Overall Study||30
2272226|NCT02263118|5576747|P2|STARTED|Overall Study||32
2272227|NCT02263118|5576748|P1|STARTED|Overall Study||24
2272228|NCT02263040|5576772|P2|NOT COMPLETED|Overall Study||0
2272229|NCT02263040|5576773|P1|NOT COMPLETED|Overall Study||0
2272230|NCT02263040|5576772|P2|COMPLETED|Overall Study||83
2272231|NCT02263040|5576773|P1|COMPLETED|Overall Study||87
2272232|NCT02263040|5576772|P2|STARTED|Overall Study||83
2272233|NCT02263040|5576773|P1|STARTED|Overall Study||87
2272234|NCT02262754|5576804|P3|NOT COMPLETED|Overall Study||9
2272235|NCT02262754|5576805|P2|NOT COMPLETED|Overall Study||9
2272236|NCT02262754|5576806|P1|NOT COMPLETED|Overall Study||16
2272237|NCT02262754|5576804|P3|COMPLETED|Overall Study||65
2272238|NCT02262754|5576805|P2|COMPLETED|Overall Study||65
2272239|NCT02262754|5576806|P1|COMPLETED|Overall Study||58
2272240|NCT02262754|5576804|P3|STARTED|Overall Study||74
2272241|NCT02262754|5576805|P2|STARTED|Overall Study||74
2272242|NCT02262754|5576806|P1|STARTED|Overall Study||74
2272243|NCT02262728|5576881|P2|NOT COMPLETED|Follow-up Phase (3 Years)||3
2272244|NCT02262728|5576882|P1|NOT COMPLETED|Follow-up Phase (3 Years)||4
2272245|NCT02262728|5576881|P2|COMPLETED|Follow-up Phase (3 Years)||18
2272246|NCT02262728|5576882|P1|COMPLETED|Follow-up Phase (3 Years)||15
2272247|NCT02262728|5576881|P2|STARTED|Follow-up Phase (3 Years)||21
2272248|NCT02262728|5576882|P1|STARTED|Follow-up Phase (3 Years)||19
2272249|NCT02262728|5576881|P2|NOT COMPLETED|Treatment Period (12 Weeks)||0
2272250|NCT02262728|5576882|P1|NOT COMPLETED|Treatment Period (12 Weeks)||0
2272251|NCT02262728|5576881|P2|COMPLETED|Treatment Period (12 Weeks)|Participants who completed continued follow-up phase.|21
2272252|NCT02262728|5576882|P1|COMPLETED|Treatment Period (12 Weeks)|Participants who completed continued follow-up phase.|19
2272253|NCT02262728|5576881|P2|STARTED|Treatment Period (12 Weeks)||21
2272254|NCT02262728|5576882|P1|STARTED|Treatment Period (12 Weeks)||19
2272255|NCT02262377|5576914|P2|NOT COMPLETED|Overall Study||6
2272256|NCT02262377|5576915|P1|NOT COMPLETED|Overall Study||12
2272257|NCT02262377|5576914|P2|COMPLETED|Overall Study||73
2272258|NCT02262377|5576915|P1|COMPLETED|Overall Study||68
2272259|NCT02262377|5576914|P2|STARTED|Overall Study||79
2272260|NCT02262377|5576915|P1|STARTED|Overall Study||80
2272261|NCT02262364|5576930|P1|NOT COMPLETED|Follow-Up Through 12 Months||0
2272262|NCT02262364|5576930|P1|COMPLETED|Follow-Up Through 12 Months||10
2272263|NCT02262364|5576930|P1|STARTED|Follow-Up Through 12 Months||10
2272264|NCT02262364|5576930|P1|NOT COMPLETED|Injection With APS||0
2272265|NCT02262364|5576930|P1|COMPLETED|Injection With APS||10
2272266|NCT02262364|5576930|P1|STARTED|Injection With APS||10
2272267|NCT02262364|5576930|P1|NOT COMPLETED|Blood Draw for Device Processing||1
2272268|NCT02262364|5576930|P1|COMPLETED|Blood Draw for Device Processing||10
2272269|NCT02262364|5576930|P1|STARTED|Blood Draw for Device Processing||11
2272270|NCT02262364|5576930|P1|NOT COMPLETED|Study Enrollment||0
2272271|NCT02262364|5576930|P1|COMPLETED|Study Enrollment||11
2272272|NCT02262364|5576930|P1|STARTED|Study Enrollment||11
2272273|NCT02262260|5576939|P2|NOT COMPLETED|Overall Study||10
2272274|NCT02262260|5576940|P1|NOT COMPLETED|Overall Study||11
2272275|NCT02262260|5576939|P2|COMPLETED|Overall Study||32
2272276|NCT02262260|5576940|P1|COMPLETED|Overall Study||34
2272277|NCT02262260|5576939|P2|STARTED|Overall Study||42
2272278|NCT02262260|5576940|P1|STARTED|Overall Study||45
2272279|NCT02262130|5576958|P1|NOT COMPLETED|Overall Study||0
2272280|NCT02262130|5576958|P1|COMPLETED|Overall Study||10
2272281|NCT02262130|5576958|P1|STARTED|Overall Study||10
2272282|NCT02262078|5576968|P2|NOT COMPLETED|Overall Study||0
2272283|NCT02262078|5576969|P1|NOT COMPLETED|Overall Study||0
2272284|NCT02262078|5576968|P2|COMPLETED|Overall Study||13
2272285|NCT02262078|5576969|P1|COMPLETED|Overall Study||13
2272286|NCT02262078|5576968|P2|STARTED|Overall Study||13
2272287|NCT02262078|5576969|P1|STARTED|Overall Study||13
2272288|NCT02262039|5576977|P2|NOT COMPLETED|Overall Study||0
2272289|NCT02262039|5576978|P1|NOT COMPLETED|Overall Study||0
2272290|NCT02262039|5576977|P2|COMPLETED|Overall Study||27
2272291|NCT02262039|5576978|P1|COMPLETED|Overall Study||14
2272292|NCT02262039|5576977|P2|STARTED|Overall Study||27
2272293|NCT02262039|5576978|P1|STARTED|Overall Study||14
2272294|NCT02261974|5576998|P2|NOT COMPLETED|Overall Study||7
2272295|NCT02261974|5576999|P1|NOT COMPLETED|Overall Study||15
2272296|NCT02261974|5576998|P2|COMPLETED|Overall Study||56
2272297|NCT02261974|5576999|P1|COMPLETED|Overall Study||108
2272298|NCT02261974|5576998|P2|Treated|Overall Study||57
2272299|NCT02261974|5576999|P1|Treated|Overall Study||117
2272300|NCT02261974|5576998|P2|STARTED|Overall Study||63
2272301|NCT02261974|5576999|P1|STARTED|Overall Study||123
2272302|NCT02261948|5577015|P2|NOT COMPLETED|Overall Study||0
2272303|NCT02261948|5577016|P1|NOT COMPLETED|Overall Study||0
2272304|NCT02261948|5577015|P2|COMPLETED|Overall Study||19
2272305|NCT02261948|5577016|P1|COMPLETED|Overall Study||23
2272306|NCT02261948|5577015|P2|STARTED|Overall Study||19
2272307|NCT02261948|5577016|P1|STARTED|Overall Study||23
2272308|NCT02261818|5577026|P1|NOT COMPLETED|Overall Study||3
2272309|NCT02261818|5577026|P1|COMPLETED|Overall Study||27
2272310|NCT02261818|5577026|P1|STARTED|Overall Study||30
2272311|NCT02261805|5577030|P3|NOT COMPLETED|Overall Study||0
2272312|NCT02261805|5577031|P2|NOT COMPLETED|Overall Study||0
2272313|NCT02261805|5577032|P1|NOT COMPLETED|Overall Study||0
2272314|NCT02261805|5577030|P3|COMPLETED|Overall Study||2
2272315|NCT02261805|5577031|P2|COMPLETED|Overall Study||6
2272316|NCT02261805|5577032|P1|COMPLETED|Overall Study||3
2272317|NCT02261805|5577030|P3|STARTED|Overall Study||2
2272318|NCT02261805|5577031|P2|STARTED|Overall Study||6
2272319|NCT02261805|5577032|P1|STARTED|Overall Study||3
2272320|NCT02261597|5577042|P2|NOT COMPLETED|Overall Study||0
2272321|NCT02261597|5577043|P1|NOT COMPLETED|Overall Study||0
2272322|NCT02261597|5577042|P2|COMPLETED|Overall Study||22
2272323|NCT02261597|5577043|P1|COMPLETED|Overall Study||22
2272324|NCT02261597|5577042|P2|STARTED|Overall Study||22
2272325|NCT02261597|5577043|P1|STARTED|Overall Study||22
2272326|NCT02261493|5577056|P3|NOT COMPLETED|Overall Study||26
2272327|NCT02261493|5577057|P2|NOT COMPLETED|Overall Study||47
2272328|NCT02261493|5577058|P1|NOT COMPLETED|Overall Study||30
2272329|NCT02261493|5577056|P3|COMPLETED|Overall Study||287
2272330|NCT02261493|5577057|P2|COMPLETED|Overall Study||271
2272331|NCT02261493|5577058|P1|COMPLETED|Overall Study||126
2272332|NCT02261493|5577056|P3|STARTED|Overall Study||313
2272333|NCT02261493|5577057|P2|STARTED|Overall Study||318
2272334|NCT02261493|5577058|P1|STARTED|Overall Study||156
2272335|NCT02261467|5577086|P2|NOT COMPLETED|Overall Study||37
2272336|NCT02261467|5577087|P1|NOT COMPLETED|Overall Study||21
2272337|NCT02261467|5577086|P2|COMPLETED|Overall Study||253
2272338|NCT02261467|5577087|P1|COMPLETED|Overall Study||80
2272339|NCT02261467|5577086|P2|STARTED|Overall Study||290
2272340|NCT02261467|5577087|P1|STARTED|Overall Study||101
2272341|NCT02261428|5577107|P2|NOT COMPLETED|Overall Study||0
2272342|NCT02261428|5577108|P1|NOT COMPLETED|Overall Study||0
2272343|NCT02261428|5577107|P2|COMPLETED|Overall Study||10
2272344|NCT02261428|5577108|P1|COMPLETED|Overall Study||10
2272345|NCT02261428|5577107|P2|STARTED|Overall Study|Washout (30 minutes)|10
2272346|NCT02261428|5577108|P1|STARTED|Overall Study|Washout (30 minutes)|10
2272347|NCT02260986|5577129|P3|NOT COMPLETED|Overall Study||41
2272348|NCT02260986|5577130|P2|NOT COMPLETED|Overall Study||13
2272349|NCT02260986|5577131|P1|NOT COMPLETED|Overall Study||90
2272350|NCT02260986|5577129|P3|COMPLETED|Overall Study||278
2272351|NCT02260986|5577130|P2|COMPLETED|Overall Study||93
2272352|NCT02260986|5577131|P1|COMPLETED|Overall Study||225
2272353|NCT02260986|5577129|P3|Safety Population|Overall Study|4 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|315
2272354|NCT02260986|5577130|P2|Safety Population|Overall Study|4 participants from Dupilumab 300 mg qw arm analyzed in Dupilumab 300 mg q2w arm|110
2272355|NCT02260986|5577131|P1|Safety Population|Overall Study||315
2272356|NCT02260986|5577129|P3|STARTED|Overall Study||319
2272357|NCT02260986|5577130|P2|STARTED|Overall Study||106
2272358|NCT02260986|5577131|P1|STARTED|Overall Study||315
2272359|NCT02260934|5577249|P2|NOT COMPLETED|Overall Study||14
2272360|NCT02260934|5577250|P1|NOT COMPLETED|Overall Study||13
2272361|NCT02260934|5577249|P2|COMPLETED|Overall Study|At primary outcome timepoint: Eleven participants engaged in ongoing scheduled study visits.|7
2272362|NCT02260934|5577250|P1|COMPLETED|Overall Study|At primary outcome timepoint: Ten participants engaged in ongoing scheduled study visits.|9
2272363|NCT02260934|5577249|P2|STARTED|Overall Study||21
2272364|NCT02260934|5577250|P1|STARTED|Overall Study||22
2272365|NCT02260882|5577260|P2|NOT COMPLETED|Overall Study||1
2272366|NCT02260882|5577261|P1|NOT COMPLETED|Overall Study||0
2272367|NCT02260882|5577260|P2|COMPLETED|Overall Study||81
2272368|NCT02260882|5577261|P1|COMPLETED|Overall Study||161
2272369|NCT02260882|5577260|P2|STARTED|Overall Study||82
2272370|NCT02260882|5577261|P1|STARTED|Overall Study||161
2272371|NCT02260817|5577285|P2|NOT COMPLETED|Overall Study||37
2272372|NCT02260817|5577286|P1|NOT COMPLETED|Overall Study||0
2272373|NCT02260817|5577285|P2|COMPLETED|Overall Study||58
2272374|NCT02260817|5577286|P1|COMPLETED|Overall Study||14
2272375|NCT02260817|5577285|P2|STARTED|Overall Study||95
2272376|NCT02260817|5577286|P1|STARTED|Overall Study||14
2272377|NCT02260791|5577334|P2|NOT COMPLETED|Overall Study||34
2272378|NCT02260791|5577335|P1|NOT COMPLETED|Overall Study||33
2272379|NCT02260791|5577334|P2|COMPLETED|Overall Study||328
2272380|NCT02260791|5577335|P1|COMPLETED|Overall Study||333
2272381|NCT02260791|5577334|P2|STARTED|Overall Study||362
2272382|NCT02260791|5577335|P1|STARTED|Overall Study||366
2272383|NCT02260648|5577374|P3|NOT COMPLETED|Overall Study||8
2272384|NCT02260648|5577375|P2|NOT COMPLETED|Overall Study||13
2272385|NCT02260648|5577376|P1|NOT COMPLETED|Overall Study||18
2272386|NCT02260648|5577374|P3|COMPLETED|Overall Study||42
2272387|NCT02260648|5577375|P2|COMPLETED|Overall Study||33
2272388|NCT02260648|5577376|P1|COMPLETED|Overall Study||35
2272389|NCT02260648|5577374|P3|Received at Least One Dose of Study Drug|Overall Study||50
2272390|NCT02260648|5577375|P2|Received at Least One Dose of Study Drug|Overall Study||46
2272391|NCT02260648|5577376|P1|Received at Least One Dose of Study Drug|Overall Study||53
2272392|NCT02260648|5577374|P3|STARTED|Overall Study||50
2272393|NCT02260648|5577375|P2|STARTED|Overall Study||46
2272394|NCT02260648|5577376|P1|STARTED|Overall Study||53
2272395|NCT02260635|5577404|P2|NOT COMPLETED|Open-Label Extension||25
2272396|NCT02260635|5577405|P1|NOT COMPLETED|Open-Label Extension||26
2272397|NCT02260635|5577404|P2|COMPLETED|Open-Label Extension||0
2272398|NCT02260635|5577405|P1|COMPLETED|Open-Label Extension||0
2272399|NCT02260635|5577404|P2|Received at Least One Dose of Study Drug|Open-Label Extension||25
2272400|NCT02260635|5577405|P1|Received at Least One Dose of Study Drug|Open-Label Extension||26
2272401|NCT02260635|5577404|P2|STARTED|Open-Label Extension||25
2272402|NCT02260635|5577405|P1|STARTED|Open-Label Extension||26
2272403|NCT02260635|5577404|P2|NOT COMPLETED|Double-Blind Treatment Period||2
2272404|NCT02260635|5577405|P1|NOT COMPLETED|Double-Blind Treatment Period||1
2272405|NCT02260635|5577404|P2|COMPLETED|Double-Blind Treatment Period||25
2272406|NCT02260635|5577405|P1|COMPLETED|Double-Blind Treatment Period||26
2272407|NCT02260635|5577404|P2|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||26
2272408|NCT02260635|5577405|P1|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||27
2272409|NCT02260635|5577404|P2|STARTED|Double-Blind Treatment Period||27
2272410|NCT02260635|5577405|P1|STARTED|Double-Blind Treatment Period||27
2272411|NCT02260622|5577427|P2|NOT COMPLETED|Overall Study||0
2272412|NCT02260622|5577428|P1|NOT COMPLETED|Overall Study||0
2272413|NCT02260622|5577427|P2|COMPLETED|Overall Study||9
2272414|NCT02260622|5577428|P1|COMPLETED|Overall Study||11
2272415|NCT02260622|5577427|P2|STARTED|Overall Study||9
2272416|NCT02260622|5577428|P1|STARTED|Overall Study||11
2272417|NCT02260492|5577457|P3|NOT COMPLETED|Overall Study||5
2272418|NCT02260492|5577458|P2|NOT COMPLETED|Overall Study||13
2272419|NCT02260492|5577459|P1|NOT COMPLETED|Overall Study||23
2272420|NCT02260492|5577457|P3|COMPLETED|Overall Study||37
2272421|NCT02260492|5577458|P2|COMPLETED|Overall Study||406
2272422|NCT02260492|5577459|P1|COMPLETED|Overall Study||395
2272423|NCT02260492|5577457|P3|Completed Day 1|Overall Study||42
2272424|NCT02260492|5577458|P2|Completed Day 1|Overall Study||419
2272425|NCT02260492|5577459|P1|Completed Day 1|Overall Study||418
2272426|NCT02260492|5577457|P3|STARTED|Overall Study||42
2272427|NCT02260492|5577458|P2|STARTED|Overall Study||419
2272428|NCT02260492|5577459|P1|STARTED|Overall Study||418
2272429|NCT02260440|5577473|P1|NOT COMPLETED|Overall Study||0
2272430|NCT02260440|5577473|P1|COMPLETED|Overall Study||31
2272431|NCT02260440|5577473|P1|STARTED|Overall Study||31
2272432|NCT02260401|5577481|P2|NOT COMPLETED|Overall Study||12
2272433|NCT02260401|5577482|P1|NOT COMPLETED|Overall Study||5
2272434|NCT02260401|5577481|P2|COMPLETED|Overall Study||73
2272435|NCT02260401|5577482|P1|COMPLETED|Overall Study||75
2272436|NCT02260401|5577481|P2|STARTED|Overall Study||85
2272437|NCT02260401|5577482|P1|STARTED|Overall Study||80
2272438|NCT02260388|5577492|P4|NOT COMPLETED|Overall Study||4
2272439|NCT02260388|5577493|P3|NOT COMPLETED|Overall Study||3
2272440|NCT02260388|5577494|P2|NOT COMPLETED|Overall Study||8
2272441|NCT02260388|5577495|P1|NOT COMPLETED|Overall Study||2
2272442|NCT02260388|5577492|P4|COMPLETED|Overall Study||65
2272443|NCT02260388|5577493|P3|COMPLETED|Overall Study||70
2272444|NCT02260388|5577494|P2|COMPLETED|Overall Study||118
2272445|NCT02260388|5577495|P1|COMPLETED|Overall Study||132
2272446|NCT02260388|5577492|P4|STARTED|Overall Study||69
2272447|NCT02260388|5577493|P3|STARTED|Overall Study||73
2272448|NCT02260388|5577494|P2|STARTED|Overall Study||126
2272449|NCT02260388|5577495|P1|STARTED|Overall Study||134
2272450|NCT02260180|5577524|P3|NOT COMPLETED|Overall Study||1
2272451|NCT02260180|5577525|P2|NOT COMPLETED|Overall Study||0
2272452|NCT02260180|5577526|P1|NOT COMPLETED|Overall Study||2
2272453|NCT02260180|5577524|P3|COMPLETED|Overall Study||40
2272454|NCT02260180|5577525|P2|COMPLETED|Overall Study||39
2272455|NCT02260180|5577526|P1|COMPLETED|Overall Study||37
2272456|NCT02260180|5577524|P3|STARTED|Overall Study||41
2272457|NCT02260180|5577525|P2|STARTED|Overall Study||39
2272458|NCT02260180|5577526|P1|STARTED|Overall Study||39
2272459|NCT02260154|5577537|P1|NOT COMPLETED|Overall Study||2
2272460|NCT02260154|5577537|P1|COMPLETED|Overall Study||218
2272461|NCT02260154|5577537|P1|STARTED|Overall Study||220
2272462|NCT02259699|5577553|P2|NOT COMPLETED|Overall Study||20
2272463|NCT02259699|5577554|P1|NOT COMPLETED|Overall Study||27
2272464|NCT02259699|5577553|P2|COMPLETED|Overall Study||40
2272465|NCT02259699|5577554|P1|COMPLETED|Overall Study||37
2272466|NCT02259699|5577553|P2|STARTED|Overall Study||60
2272467|NCT02259699|5577554|P1|STARTED|Overall Study||64
2272468|NCT02259608|5577569|P1|NOT COMPLETED|Overall Study||0
2272469|NCT02259608|5577569|P1|COMPLETED|Overall Study||15
2272470|NCT02259608|5577569|P1|STARTED|Overall Study||15
2272471|NCT02259582|5577577|P3|NOT COMPLETED|Overall Study||21
2272472|NCT02259582|5577578|P2|NOT COMPLETED|Overall Study||17
2272473|NCT02259582|5577579|P1|NOT COMPLETED|Overall Study||16
2272474|NCT02259582|5577577|P3|COMPLETED|Overall Study||8
2272475|NCT02259582|5577578|P2|COMPLETED|Overall Study||11
2272476|NCT02259582|5577579|P1|COMPLETED|Overall Study||9
2272477|NCT02259582|5577577|P3|STARTED|Overall Study||29
2272478|NCT02259582|5577578|P2|STARTED|Overall Study||28
2272479|NCT02259582|5577579|P1|STARTED|Overall Study||25
2272480|NCT02259400|5577589|P2|NOT COMPLETED|Overall Study||2
2272481|NCT02259400|5577590|P1|NOT COMPLETED|Overall Study||0
2272482|NCT02259400|5577589|P2|COMPLETED|Overall Study||60
2272483|NCT02259400|5577590|P1|COMPLETED|Overall Study||62
2272484|NCT02259400|5577589|P2|STARTED|Overall Study||62
2272485|NCT02259400|5577590|P1|STARTED|Overall Study||62
2272486|NCT02259348|5577622|P1|NOT COMPLETED|Overall Study||10
2272487|NCT02259348|5577622|P1|COMPLETED|Overall Study||2
2272488|NCT02259348|5577622|P1|One Year Post-transplant|Overall Study||2
2272489|NCT02259348|5577622|P1|STARTED|Overall Study||12
2272490|NCT02259114|5577639|P5|NOT COMPLETED|Overall Study||6
2272491|NCT02259114|5577640|P4|NOT COMPLETED|Overall Study||3
2272492|NCT02259114|5577641|P3|NOT COMPLETED|Overall Study||13
2272493|NCT02259114|5577642|P2|NOT COMPLETED|Overall Study||4
2272494|NCT02259114|5577643|P1|NOT COMPLETED|Overall Study||21
2272495|NCT02259114|5577639|P5|COMPLETED|Overall Study||0
2272496|NCT02259114|5577640|P4|COMPLETED|Overall Study||0
2272497|NCT02259114|5577641|P3|COMPLETED|Overall Study||0
2272498|NCT02259114|5577642|P2|COMPLETED|Overall Study||0
2272499|NCT02259114|5577643|P1|COMPLETED|Overall Study||0
2272500|NCT02259114|5577639|P5|Treated|Overall Study||6
2272501|NCT02259114|5577640|P4|Treated|Overall Study||3
2272502|NCT02259114|5577641|P3|Treated|Overall Study||13
2272503|NCT02259114|5577642|P2|Treated|Overall Study||4
2272504|NCT02259114|5577643|P1|Treated|Overall Study|One participant was randomized but did not receive treatment due to a protocol violation.|20
2272505|NCT02259114|5577639|P5|STARTED|Overall Study||6
2272506|NCT02259114|5577640|P4|STARTED|Overall Study||3
2272507|NCT02259114|5577641|P3|STARTED|Overall Study||13
2272508|NCT02259114|5577642|P2|STARTED|Overall Study||4
2272509|NCT02259114|5577643|P1|STARTED|Overall Study||21
2272510|NCT02259088|5577702|P2|NOT COMPLETED|Overall Study||14
2272511|NCT02259088|5577703|P1|NOT COMPLETED|Overall Study||28
2272512|NCT02259088|5577702|P2|COMPLETED|Overall Study||63
2272513|NCT02259088|5577703|P1|COMPLETED|Overall Study||279
2272514|NCT02259088|5577702|P2|Treated (Safety Analysis Set)|Overall Study||75
2272515|NCT02259088|5577703|P1|Treated (Safety Analysis Set)|Overall Study||307
2272516|NCT02259088|5577702|P2|Full Analysis Set|Overall Study||77
2272517|NCT02259088|5577703|P1|Full Analysis Set|Overall Study||307
2272518|NCT02259088|5577702|P2|STARTED|Overall Study||77
2272519|NCT02259088|5577703|P1|STARTED|Overall Study||307
2272520|NCT02259010|5577748|P1|NOT COMPLETED|Overall Study||5
2272521|NCT02259010|5577748|P1|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK assessment.|19
2272522|NCT02259010|5577748|P1|STARTED|Overall Study||24
2272523|NCT02258542|5577777|P4|NOT COMPLETED|Overall Study||5
2272524|NCT02258542|5577778|P3|NOT COMPLETED|Overall Study||8
2272525|NCT02258542|5577779|P2|NOT COMPLETED|Overall Study||49
2272526|NCT02258542|5577780|P1|NOT COMPLETED|Overall Study||42
2272527|NCT02258542|5577777|P4|COMPLETED|Overall Study|48 enrolled into study MELTEMI|92
2272528|NCT02258542|5577778|P3|COMPLETED|Overall Study|51 enrolled into study MELTEMI|92
2272529|NCT02258542|5577779|P2|COMPLETED|Overall Study|178 enrolled into study MELTEMI|924
2272530|NCT02258542|5577780|P1|COMPLETED|Overall Study|170 enrolled into study MELTEMI|911
2272531|NCT02258542|5577777|P4|Adolescents Only|Overall Study||0
2272532|NCT02258542|5577778|P3|Adolescents Only|Overall Study||0
2272533|NCT02258542|5577779|P2|Adolescents Only|Overall Study||61
2272534|NCT02258542|5577780|P1|Adolescents Only|Overall Study||25
2272535|NCT02258542|5577777|P4|Treated|Overall Study||97
2272536|NCT02258542|5577778|P3|Treated|Overall Study||100
2272537|NCT02258542|5577779|P2|Treated|Overall Study||971
2272538|NCT02258542|5577780|P1|Treated|Overall Study||953
2272539|NCT02258542|5577777|P4|STARTED|Overall Study||97
2272540|NCT02258542|5577778|P3|STARTED|Overall Study||100
2272541|NCT02258542|5577779|P2|STARTED|Overall Study||973
2272542|NCT02258542|5577780|P1|STARTED|Overall Study||953
2272543|NCT02258529|5578004|P1|NOT COMPLETED|Overall Study||10
2272544|NCT02258529|5578004|P1|COMPLETED|Overall Study||0
2272545|NCT02258529|5578004|P1|STARTED|Overall Study||10
2272546|NCT02258477|5578016|P4|NOT COMPLETED|Fourth Intervention (1 Week)||0
2272547|NCT02258477|5578017|P3|NOT COMPLETED|Fourth Intervention (1 Week)||0
2272548|NCT02258477|5578018|P2|NOT COMPLETED|Fourth Intervention (1 Week)||0
2272549|NCT02258477|5578019|P1|NOT COMPLETED|Fourth Intervention (1 Week)||0
2272550|NCT02258477|5578016|P4|COMPLETED|Fourth Intervention (1 Week)||8
2272551|NCT02258477|5578017|P3|COMPLETED|Fourth Intervention (1 Week)||8
2272552|NCT02258477|5578018|P2|COMPLETED|Fourth Intervention (1 Week)||8
2272553|NCT02258477|5578019|P1|COMPLETED|Fourth Intervention (1 Week)||9
2272554|NCT02258477|5578016|P4|STARTED|Fourth Intervention (1 Week)||8
2272555|NCT02258477|5578017|P3|STARTED|Fourth Intervention (1 Week)||8
2272556|NCT02258477|5578018|P2|STARTED|Fourth Intervention (1 Week)||8
2272557|NCT02258477|5578019|P1|STARTED|Fourth Intervention (1 Week)||9
2272558|NCT02258477|5578016|P4|NOT COMPLETED|Third Intervention (1 Week)||0
2272559|NCT02258477|5578017|P3|NOT COMPLETED|Third Intervention (1 Week)||0
2272560|NCT02258477|5578018|P2|NOT COMPLETED|Third Intervention (1 Week)||0
2272561|NCT02258477|5578019|P1|NOT COMPLETED|Third Intervention (1 Week)||0
2272562|NCT02258477|5578016|P4|COMPLETED|Third Intervention (1 Week)||8
2272563|NCT02258477|5578017|P3|COMPLETED|Third Intervention (1 Week)||8
2272564|NCT02258477|5578018|P2|COMPLETED|Third Intervention (1 Week)||8
2272565|NCT02258477|5578019|P1|COMPLETED|Third Intervention (1 Week)||9
2272566|NCT02258477|5578016|P4|STARTED|Third Intervention (1 Week)||8
2272567|NCT02258477|5578017|P3|STARTED|Third Intervention (1 Week)||8
2272568|NCT02258477|5578018|P2|STARTED|Third Intervention (1 Week)||8
2272569|NCT02258477|5578019|P1|STARTED|Third Intervention (1 Week)||9
2272570|NCT02258477|5578016|P4|NOT COMPLETED|Second Intervention (1 Week)||1
2272571|NCT02258477|5578017|P3|NOT COMPLETED|Second Intervention (1 Week)||1
2272572|NCT02258477|5578018|P2|NOT COMPLETED|Second Intervention (1 Week)||0
2272573|NCT02258477|5578019|P1|NOT COMPLETED|Second Intervention (1 Week)||0
2272574|NCT02258477|5578016|P4|COMPLETED|Second Intervention (1 Week)||8
2272575|NCT02258477|5578017|P3|COMPLETED|Second Intervention (1 Week)||8
2272576|NCT02258477|5578018|P2|COMPLETED|Second Intervention (1 Week)||8
2272577|NCT02258477|5578019|P1|COMPLETED|Second Intervention (1 Week)||9
2272578|NCT02258477|5578016|P4|STARTED|Second Intervention (1 Week)||9
2272579|NCT02258477|5578017|P3|STARTED|Second Intervention (1 Week)||9
2272580|NCT02258477|5578018|P2|STARTED|Second Intervention (1 Week)||8
2272581|NCT02258477|5578019|P1|STARTED|Second Intervention (1 Week)||9
2272582|NCT02258477|5578016|P4|NOT COMPLETED|First Intervention (1 Week)||0
2272583|NCT02258477|5578017|P3|NOT COMPLETED|First Intervention (1 Week)||0
2272584|NCT02258477|5578018|P2|NOT COMPLETED|First Intervention (1 Week)||1
2272585|NCT02258477|5578019|P1|NOT COMPLETED|First Intervention (1 Week)||1
2272586|NCT02258477|5578016|P4|COMPLETED|First Intervention (1 Week)||9
2272587|NCT02258477|5578017|P3|COMPLETED|First Intervention (1 Week)||9
2272588|NCT02258477|5578018|P2|COMPLETED|First Intervention (1 Week)||8
2272589|NCT02258477|5578019|P1|COMPLETED|First Intervention (1 Week)||9
2272590|NCT02258477|5578016|P4|STARTED|First Intervention (1 Week)||9
2272591|NCT02258477|5578017|P3|STARTED|First Intervention (1 Week)||9
2272592|NCT02258477|5578018|P2|STARTED|First Intervention (1 Week)||9
2272593|NCT02258477|5578019|P1|STARTED|First Intervention (1 Week)||10
2272594|NCT02258412|5578037|P3|NOT COMPLETED|Overall Study||0
2272595|NCT02258412|5578038|P2|NOT COMPLETED|Overall Study||0
2272596|NCT02258412|5578039|P1|NOT COMPLETED|Overall Study||0
2272597|NCT02258412|5578037|P3|COMPLETED|Overall Study||61
2272598|NCT02258412|5578038|P2|COMPLETED|Overall Study||25
2272599|NCT02258412|5578039|P1|COMPLETED|Overall Study||26
2272600|NCT02258412|5578037|P3|STARTED|Overall Study||61
2272601|NCT02258412|5578038|P2|STARTED|Overall Study||25
2272602|NCT02258412|5578039|P1|STARTED|Overall Study||26
2272603|NCT02258373|5578048|P2|NOT COMPLETED|Overall Study||2
2272604|NCT02258373|5578049|P1|NOT COMPLETED|Overall Study||7
2272605|NCT02258373|5578048|P2|COMPLETED|Overall Study||75
2272606|NCT02258373|5578049|P1|COMPLETED|Overall Study||142
2272607|NCT02258373|5578048|P2|STARTED|Overall Study||77
2272608|NCT02258373|5578049|P1|STARTED|Overall Study||149
2272609|NCT02258334|5578093|P4|NOT COMPLETED|Overall Study||0
2272610|NCT02258334|5578094|P3|NOT COMPLETED|Overall Study||0
2272611|NCT02258334|5578095|P2|NOT COMPLETED|Overall Study||0
2272612|NCT02258334|5578096|P1|NOT COMPLETED|Overall Study||1
2272613|NCT02258334|5578093|P4|COMPLETED|Overall Study||52
2272614|NCT02258334|5578094|P3|COMPLETED|Overall Study||52
2272615|NCT02258334|5578095|P2|COMPLETED|Overall Study||54
2272616|NCT02258334|5578096|P1|COMPLETED|Overall Study||49
2272617|NCT02258334|5578093|P4|STARTED|Overall Study||52
2272618|NCT02258334|5578094|P3|STARTED|Overall Study||52
2272619|NCT02258334|5578095|P2|STARTED|Overall Study||54
2272620|NCT02258334|5578096|P1|STARTED|Overall Study||50
2272621|NCT02258256|5578122|P1|NOT COMPLETED|Overall Study||0
2272622|NCT02258256|5578122|P1|COMPLETED|Overall Study||11
2272623|NCT02258256|5578122|P1|STARTED|Overall Study||11
2272624|NCT02258152|5578128|P2|NOT COMPLETED|Overall Study||4
2272625|NCT02258152|5578129|P1|NOT COMPLETED|Overall Study||6
2272626|NCT02258152|5578128|P2|COMPLETED|Overall Study||34
2272627|NCT02258152|5578129|P1|COMPLETED|Overall Study||38
2272628|NCT02258152|5578128|P2|STARTED|Overall Study||38
2272629|NCT02258152|5578129|P1|STARTED|Overall Study||44
2272630|NCT02257970|5578141|P4|NOT COMPLETED|Part 3||7
2272631|NCT02257970|5578142|P3|NOT COMPLETED|Part 3||7
2272632|NCT02257970|5578143|P2|NOT COMPLETED|Part 3||0
2272633|NCT02257970|5578144|P1|NOT COMPLETED|Part 3||0
2272634|NCT02257970|5578141|P4|COMPLETED|Part 3||14
2272635|NCT02257970|5578142|P3|COMPLETED|Part 3||16
2272636|NCT02257970|5578143|P2|COMPLETED|Part 3||0
2272637|NCT02257970|5578144|P1|COMPLETED|Part 3||0
2272638|NCT02257970|5578141|P4|STARTED|Part 3||21
2272639|NCT02257970|5578142|P3|STARTED|Part 3||23
2272640|NCT02257970|5578143|P2|STARTED|Part 3||0
2272641|NCT02257970|5578144|P1|STARTED|Part 3||0
2272642|NCT02257970|5578141|P4|NOT COMPLETED|Part 2||0
2272643|NCT02257970|5578142|P3|NOT COMPLETED|Part 2||0
2272644|NCT02257970|5578143|P2|NOT COMPLETED|Part 2||7
2272645|NCT02257970|5578144|P1|NOT COMPLETED|Part 2||0
2272646|NCT02257970|5578141|P4|COMPLETED|Part 2||0
2272647|NCT02257970|5578142|P3|COMPLETED|Part 2||0
2272648|NCT02257970|5578143|P2|COMPLETED|Part 2||16
2272649|NCT02257970|5578144|P1|COMPLETED|Part 2||0
2272650|NCT02257970|5578141|P4|STARTED|Part 2||0
2272651|NCT02257970|5578142|P3|STARTED|Part 2||0
2272652|NCT02257970|5578143|P2|STARTED|Part 2||23
2272653|NCT02257970|5578144|P1|STARTED|Part 2||0
2272654|NCT02257970|5578141|P4|NOT COMPLETED|Part 1||0
2272655|NCT02257970|5578142|P3|NOT COMPLETED|Part 1||0
2272656|NCT02257970|5578143|P2|NOT COMPLETED|Part 1||0
2272657|NCT02257970|5578144|P1|NOT COMPLETED|Part 1||0
2272658|NCT02257970|5578141|P4|COMPLETED|Part 1||0
2272659|NCT02257970|5578142|P3|COMPLETED|Part 1||0
2272660|NCT02257970|5578143|P2|COMPLETED|Part 1||0
2272661|NCT02257970|5578144|P1|COMPLETED|Part 1||50
2272662|NCT02257970|5578141|P4|STARTED|Part 1||0
2272663|NCT02257970|5578142|P3|STARTED|Part 1||0
2272664|NCT02257970|5578143|P2|STARTED|Part 1||0
2272665|NCT02257970|5578144|P1|STARTED|Part 1||50
2272666|NCT02257918|5578170|P3|NOT COMPLETED|Overall Study||2
2272667|NCT02257918|5578171|P2|NOT COMPLETED|Overall Study||1
2272668|NCT02257918|5578172|P1|NOT COMPLETED|Overall Study||4
2272669|NCT02257918|5578170|P3|COMPLETED|Overall Study||39
2272670|NCT02257918|5578171|P2|COMPLETED|Overall Study||66
2272671|NCT02257918|5578172|P1|COMPLETED|Overall Study||68
2272672|NCT02257918|5578170|P3|Test of Cure Visit|Overall Study||40
2272673|NCT02257918|5578171|P2|Test of Cure Visit|Overall Study||67
2272674|NCT02257918|5578172|P1|Test of Cure Visit|Overall Study||72
2272675|NCT02257918|5578170|P3|STARTED|Overall Study||41
2272676|NCT02257918|5578171|P2|STARTED|Overall Study||67
2272677|NCT02257918|5578172|P1|STARTED|Overall Study||72
2272678|NCT02257684|5578222|P1|NOT COMPLETED|Overall Study||4
2272679|NCT02257684|5578222|P1|COMPLETED|Overall Study||0
2272680|NCT02257684|5578222|P1|STARTED|Overall Study||4
2272681|NCT02257632|5578232|P2|NOT COMPLETED|Overall Study||3
2272682|NCT02257632|5578233|P1|NOT COMPLETED|Overall Study||1
2272683|NCT02257632|5578232|P2|COMPLETED|Overall Study||19
2272684|NCT02257632|5578233|P1|COMPLETED|Overall Study||18
2272685|NCT02257632|5578232|P2|Per-Protocol Set (PPS)|Overall Study||20
2272686|NCT02257632|5578233|P1|Per-Protocol Set (PPS)|Overall Study||17
2272687|NCT02257632|5578232|P2|Safety Set (SAF)|Overall Study||21
2272688|NCT02257632|5578233|P1|Safety Set (SAF)|Overall Study||19
2272689|NCT02257632|5578232|P2|Full Analysis Set (FAS)|Overall Study||21
2272690|NCT02257632|5578233|P1|Full Analysis Set (FAS)|Overall Study||19
2272691|NCT02257632|5578232|P2|STARTED|Overall Study||22
2272692|NCT02257632|5578233|P1|STARTED|Overall Study||19
2272693|NCT02257489|5578254|P9|NOT COMPLETED|Overall Study||0
2272694|NCT02257489|5578255|P8|NOT COMPLETED|Overall Study||0
2272695|NCT02257489|5578256|P7|NOT COMPLETED|Overall Study||0
2272696|NCT02257489|5578257|P6|NOT COMPLETED|Overall Study||0
2272697|NCT02257489|5578258|P5|NOT COMPLETED|Overall Study||0
2272698|NCT02257489|5578259|P4|NOT COMPLETED|Overall Study||1
2272699|NCT02257489|5578260|P3|NOT COMPLETED|Overall Study||0
2272700|NCT02257489|5578261|P2|NOT COMPLETED|Overall Study||0
2272701|NCT02257489|5578262|P1|NOT COMPLETED|Overall Study||0
2272702|NCT02257489|5578254|P9|COMPLETED|Overall Study||6
2272703|NCT02257489|5578255|P8|COMPLETED|Overall Study||10
2272704|NCT02257489|5578256|P7|COMPLETED|Overall Study||6
2272705|NCT02257489|5578257|P6|COMPLETED|Overall Study||6
2272706|NCT02257489|5578258|P5|COMPLETED|Overall Study||6
2272707|NCT02257489|5578259|P4|COMPLETED|Overall Study||5
2272708|NCT02257489|5578260|P3|COMPLETED|Overall Study||6
2272709|NCT02257489|5578261|P2|COMPLETED|Overall Study||6
2272710|NCT02257489|5578262|P1|COMPLETED|Overall Study||6
2272711|NCT02257489|5578254|P9|STARTED|Overall Study||6
2272712|NCT02257489|5578255|P8|STARTED|Overall Study||10
2272713|NCT02257489|5578256|P7|STARTED|Overall Study||6
2272714|NCT02257489|5578257|P6|STARTED|Overall Study||6
2272715|NCT02257489|5578258|P5|STARTED|Overall Study||6
2272716|NCT02257489|5578259|P4|STARTED|Overall Study||6
2272717|NCT02257489|5578260|P3|STARTED|Overall Study||6
2272718|NCT02257489|5578261|P2|STARTED|Overall Study||6
2272719|NCT02257489|5578262|P1|STARTED|Overall Study||6
2272720|NCT02257385|5578298|P2|NOT COMPLETED|Overall Study||22
2272721|NCT02257385|5578299|P1|NOT COMPLETED|Overall Study||22
2272722|NCT02257385|5578298|P2|COMPLETED|Overall Study||457
2272723|NCT02257385|5578299|P1|COMPLETED|Overall Study||460
2272724|NCT02257385|5578298|P2|STARTED|Overall Study||479
2272725|NCT02257385|5578299|P1|STARTED|Overall Study||482
2272726|NCT02257372|5578309|P2|NOT COMPLETED|Overall Study||10
2272727|NCT02257372|5578310|P1|NOT COMPLETED|Overall Study||7
2272728|NCT02257372|5578309|P2|COMPLETED|Overall Study||109
2272729|NCT02257372|5578310|P1|COMPLETED|Overall Study||110
2272730|NCT02257372|5578309|P2|STARTED|Overall Study||119
2272731|NCT02257372|5578310|P1|STARTED|Overall Study||117
2272732|NCT02257099|5578318|P1|NOT COMPLETED|Overall Study||0
2272733|NCT02257099|5578318|P1|COMPLETED|Overall Study||20
2272734|NCT02257099|5578318|P1|STARTED|Overall Study||20
2272735|NCT02256982|5578327|P2|NOT COMPLETED|Overall Study||1
2272736|NCT02256982|5578328|P1|NOT COMPLETED|Overall Study||0
2272737|NCT02256982|5578327|P2|COMPLETED|Overall Study||1
2272738|NCT02256982|5578328|P1|COMPLETED|Overall Study||1
2272739|NCT02256982|5578327|P2|STARTED|Overall Study||2
2272740|NCT02256982|5578328|P1|STARTED|Overall Study||1
2272741|NCT02256969|5578337|P3|NOT COMPLETED|Overall Study||1
2272742|NCT02256969|5578338|P2|NOT COMPLETED|Overall Study||1
2272743|NCT02256969|5578339|P1|NOT COMPLETED|Overall Study||2
2272744|NCT02256969|5578337|P3|COMPLETED|Overall Study||14
2272745|NCT02256969|5578338|P2|COMPLETED|Overall Study||14
2272746|NCT02256969|5578339|P1|COMPLETED|Overall Study||13
2272747|NCT02256969|5578337|P3|STARTED|Overall Study||15
2272748|NCT02256969|5578338|P2|STARTED|Overall Study||15
2272749|NCT02256969|5578339|P1|STARTED|Overall Study||15
2272750|NCT02256917|5578356|P1|NOT COMPLETED|Prophylactic Treatment Phase II||4
2272751|NCT02256917|5578356|P1|COMPLETED|Prophylactic Treatment Phase II||52
2272752|NCT02256917|5578356|P1|STARTED|Prophylactic Treatment Phase II||56
2272753|NCT02256917|5578356|P1|NOT COMPLETED|Prophylactic Treatment Phase I||1
2272754|NCT02256917|5578356|P1|COMPLETED|Prophylactic Treatment Phase I||56
2272755|NCT02256917|5578356|P1|STARTED|Prophylactic Treatment Phase I||57
2272756|NCT02256917|5578356|P1|NOT COMPLETED|Pharmacokinetic (PK) Evaluation Phase||0
2272757|NCT02256917|5578356|P1|COMPLETED|Pharmacokinetic (PK) Evaluation Phase||58
2272758|NCT02256917|5578356|P1|STARTED|Pharmacokinetic (PK) Evaluation Phase||58
2272759|NCT02256891|5578377|P2|NOT COMPLETED|Overall Study||13
2272760|NCT02256891|5578378|P1|NOT COMPLETED|Overall Study||12
2272761|NCT02256891|5578377|P2|COMPLETED|Overall Study||29
2272762|NCT02256891|5578378|P1|COMPLETED|Overall Study||43
2272763|NCT02256891|5578377|P2|STARTED|Overall Study||42
2272764|NCT02256891|5578378|P1|STARTED|Overall Study||55
2272765|NCT02256839|5578404|P2|NOT COMPLETED|Overall Study||3
2272766|NCT02256839|5578405|P1|NOT COMPLETED|Overall Study||2
2272767|NCT02256839|5578404|P2|COMPLETED|Overall Study||212
2272768|NCT02256839|5578405|P1|COMPLETED|Overall Study||51
2272769|NCT02256839|5578404|P2|STARTED|Overall Study||215
2272770|NCT02256839|5578405|P1|STARTED|Overall Study||53
2272771|NCT02256553|5578411|P1|NOT COMPLETED|Period III||3
2272772|NCT02256553|5578411|P1|COMPLETED|Period III||91
2272773|NCT02256553|5578411|P1|STARTED|Period III||94
2272774|NCT02256553|5578411|P1|NOT COMPLETED|Period II||2
2272775|NCT02256553|5578411|P1|COMPLETED|Period II||94
2272776|NCT02256553|5578411|P1|STARTED|Period II||96
2272777|NCT02256553|5578411|P1|NOT COMPLETED|Period I||6
2272778|NCT02256553|5578411|P1|COMPLETED|Period I||96
2272779|NCT02256553|5578411|P1|STARTED|Period I||102
2272780|NCT02256488|5578424|P4|NOT COMPLETED|Overall Study||6
2272781|NCT02256488|5578425|P3|NOT COMPLETED|Overall Study||10
2272782|NCT02256488|5578426|P2|NOT COMPLETED|Overall Study||6
2272783|NCT02256488|5578427|P1|NOT COMPLETED|Overall Study||8
2272784|NCT02256488|5578424|P4|COMPLETED|Overall Study||384
2272785|NCT02256488|5578425|P3|COMPLETED|Overall Study||382
2272786|NCT02256488|5578426|P2|COMPLETED|Overall Study||386
2272787|NCT02256488|5578427|P1|COMPLETED|Overall Study||379
2272788|NCT02256488|5578424|P4|STARTED|Overall Study||390
2272789|NCT02256488|5578425|P3|STARTED|Overall Study||392
2272790|NCT02256488|5578426|P2|STARTED|Overall Study||392
2272791|NCT02256488|5578427|P1|STARTED|Overall Study||387
2272792|NCT02256436|5578443|P2|NOT COMPLETED|Overall Study||272
2272793|NCT02256436|5578444|P1|NOT COMPLETED|Overall Study||270
2272794|NCT02256436|5578443|P2|COMPLETED|Overall Study||0
2272795|NCT02256436|5578444|P1|COMPLETED|Overall Study||0
2272796|NCT02256436|5578443|P2|Treated|Overall Study||255
2272797|NCT02256436|5578444|P1|Treated|Overall Study||266
2272798|NCT02256436|5578443|P2|STARTED|Overall Study||272
2272799|NCT02256436|5578444|P1|STARTED|Overall Study||270
2272800|NCT02256358|5578482|P2|NOT COMPLETED|Overall Study||1
2272801|NCT02256358|5578483|P1|NOT COMPLETED|Overall Study||0
2272802|NCT02256358|5578482|P2|COMPLETED|Overall Study||33
2272803|NCT02256358|5578483|P1|COMPLETED|Overall Study||34
2272804|NCT02256358|5578482|P2|STARTED|Overall Study||34
2272805|NCT02256358|5578483|P1|STARTED|Overall Study||34
2272806|NCT02256345|5578491|P2|NOT COMPLETED|Overall Study||0
2272807|NCT02256345|5578492|P1|NOT COMPLETED|Overall Study||0
2272808|NCT02256345|5578491|P2|COMPLETED|Overall Study||3
2272809|NCT02256345|5578492|P1|COMPLETED|Overall Study||9
2272810|NCT02256345|5578491|P2|STARTED|Overall Study||3
2272811|NCT02256345|5578492|P1|STARTED|Overall Study||9
2272812|NCT02256267|5578504|P1|NOT COMPLETED|Period 2 (Day 7 to Day 14)||1
2272813|NCT02256267|5578504|P1|COMPLETED|Period 2 (Day 7 to Day 14)||22
2272814|NCT02256267|5578504|P1|Received LY2835219 + Rifampin|Period 2 (Day 7 to Day 14)||23
2272815|NCT02256267|5578504|P1|STARTED|Period 2 (Day 7 to Day 14)||23
2272816|NCT02256267|5578504|P1|NOT COMPLETED|Period 2 (Day 1 to Day 6)||0
2272817|NCT02256267|5578504|P1|COMPLETED|Period 2 (Day 1 to Day 6)||23
2272818|NCT02256267|5578504|P1|Received at Least 1 Dose of Rifampin|Period 2 (Day 1 to Day 6)||23
2272819|NCT02256267|5578504|P1|STARTED|Period 2 (Day 1 to Day 6)||23
2272820|NCT02256267|5578504|P1|NOT COMPLETED|Period 1 (Day 1; Day 2 to Day 9 Washout)||1
2272821|NCT02256267|5578504|P1|COMPLETED|Period 1 (Day 1; Day 2 to Day 9 Washout)||23
2272822|NCT02256267|5578504|P1|Received at Least 1 Dose of LY2835219|Period 1 (Day 1; Day 2 to Day 9 Washout)||24
2272823|NCT02256267|5578504|P1|STARTED|Period 1 (Day 1; Day 2 to Day 9 Washout)||24
2272824|NCT02256189|5578515|P2|NOT COMPLETED|Overall Study||0
2272825|NCT02256189|5578516|P1|NOT COMPLETED|Overall Study||0
2272826|NCT02256189|5578515|P2|COMPLETED|Overall Study||13
2272827|NCT02256189|5578516|P1|COMPLETED|Overall Study||15
2272828|NCT02256189|5578515|P2|STARTED|Overall Study||13
2272829|NCT02256189|5578516|P1|STARTED|Overall Study||15
2272830|NCT02256111|5578526|P2|NOT COMPLETED|Overall Study||0
2272831|NCT02256111|5578527|P1|NOT COMPLETED|Overall Study||0
2272832|NCT02256111|5578526|P2|COMPLETED|Overall Study||13
2272833|NCT02256111|5578527|P1|COMPLETED|Overall Study||13
2272834|NCT02256111|5578526|P2|STARTED|Overall Study||13
2272835|NCT02256111|5578527|P1|STARTED|Overall Study||13
2272836|NCT02256072|5578562|P2|NOT COMPLETED|Overall Study||29
2272837|NCT02256072|5578563|P1|NOT COMPLETED|Overall Study||42
2272838|NCT02256072|5578562|P2|COMPLETED|Overall Study||162
2272839|NCT02256072|5578563|P1|COMPLETED|Overall Study|Completed the 3-month follow-up|152
2272840|NCT02256072|5578562|P2|Completed 1 Month Follow-Up|Overall Study||179
2272841|NCT02256072|5578563|P1|Completed 1 Month Follow-Up|Overall Study|Completed the 1-month follow-up|167
2272842|NCT02256072|5578562|P2|STARTED|Overall Study||191
2272843|NCT02256072|5578563|P1|STARTED|Overall Study||194
2272844|NCT02255760|5578582|P5|NOT COMPLETED|Overall Study||0
2272845|NCT02255760|5578583|P4|NOT COMPLETED|Overall Study||0
2272846|NCT02255760|5578584|P3|NOT COMPLETED|Overall Study||0
2272847|NCT02255760|5578585|P2|NOT COMPLETED|Overall Study||1
2272848|NCT02255760|5578586|P1|NOT COMPLETED|Overall Study||0
2272849|NCT02255760|5578582|P5|COMPLETED|Overall Study||9
2272850|NCT02255760|5578583|P4|COMPLETED|Overall Study||15
2272851|NCT02255760|5578584|P3|COMPLETED|Overall Study||15
2272852|NCT02255760|5578585|P2|COMPLETED|Overall Study||2
2272853|NCT02255760|5578586|P1|COMPLETED|Overall Study||14
2272854|NCT02255760|5578582|P5|STARTED|Overall Study||9
2272855|NCT02255760|5578583|P4|STARTED|Overall Study||15
2272856|NCT02255760|5578584|P3|STARTED|Overall Study||15
2272857|NCT02255760|5578585|P2|STARTED|Overall Study||3
2272858|NCT02255760|5578586|P1|STARTED|Overall Study||14
2272859|NCT02255565|5578641|P3|NOT COMPLETED|Overall Study||0
2272860|NCT02255565|5578642|P2|NOT COMPLETED|Overall Study||1
2272861|NCT02255565|5578643|P1|NOT COMPLETED|Overall Study||0
2272862|NCT02255565|5578641|P3|COMPLETED|Overall Study||9
2272863|NCT02255565|5578642|P2|COMPLETED|Overall Study||8
2272864|NCT02255565|5578643|P1|COMPLETED|Overall Study||9
2272865|NCT02255565|5578641|P3|STARTED|Overall Study||9
2272866|NCT02255565|5578642|P2|STARTED|Overall Study||9
2272867|NCT02255565|5578643|P1|STARTED|Overall Study||9
2272868|NCT02255357|5578704|P2|NOT COMPLETED|Overall Study||10
2272869|NCT02255357|5578705|P1|NOT COMPLETED|Overall Study||7
2272870|NCT02255357|5578704|P2|COMPLETED|Overall Study||5
2272871|NCT02255357|5578705|P1|COMPLETED|Overall Study||4
2272872|NCT02255357|5578704|P2|STARTED|Overall Study||15
2272873|NCT02255357|5578705|P1|STARTED|Overall Study||11
2272874|NCT02255279|5578713|P2|NOT COMPLETED|Overall Study||9
2272875|NCT02255279|5578714|P1|NOT COMPLETED|Overall Study||5
2272876|NCT02255279|5578713|P2|COMPLETED|Overall Study||134
2272877|NCT02255279|5578714|P1|COMPLETED|Overall Study||139
2272878|NCT02255279|5578713|P2|STARTED|Overall Study||143
2272879|NCT02255279|5578714|P1|STARTED|Overall Study||144
2272880|NCT02255175|5578742|P2|NOT COMPLETED|Overall Study||12
2272881|NCT02255175|5578743|P1|NOT COMPLETED|Overall Study||17
2272882|NCT02255175|5578742|P2|COMPLETED|Overall Study||19
2272883|NCT02255175|5578743|P1|COMPLETED|Overall Study||16
2272884|NCT02255175|5578742|P2|STARTED|Overall Study||31
2272885|NCT02255175|5578743|P1|STARTED|Overall Study||33
2272886|NCT02255149|5578767|P1|NOT COMPLETED|Overall Study||5
2272887|NCT02255149|5578767|P1|COMPLETED|Overall Study||5
2272888|NCT02255149|5578767|P1|STARTED|Overall Study||10
2272889|NCT02255110|5578771|P1|NOT COMPLETED|Overall Study||0
2272890|NCT02255110|5578771|P1|COMPLETED|Overall Study||6
2272891|NCT02255110|5578771|P1|STARTED|Overall Study||6
2272892|NCT02255097|5578783|P1|NOT COMPLETED|Overall Study||172
2272893|NCT02255097|5578783|P1|COMPLETED|Overall Study||0
2272894|NCT02255097|5578783|P1|Treated|Overall Study||171
2272895|NCT02255097|5578783|P1|STARTED|Overall Study||172
2272896|NCT02254772|5578804|P1|NOT COMPLETED|Overall Study||2
2272897|NCT02254772|5578804|P1|COMPLETED|Overall Study||7
2272898|NCT02254772|5578804|P1|STARTED|Overall Study||9
2272899|NCT02254681|5578810|P1|NOT COMPLETED|Overall Study||6
2272900|NCT02254681|5578810|P1|COMPLETED|Overall Study||0
2272901|NCT02254681|5578810|P1|STARTED|Overall Study||6
2272902|NCT02254551|5578820|P1|NOT COMPLETED|Maintenance||0
2272903|NCT02254551|5578820|P1|COMPLETED|Maintenance||0
2272904|NCT02254551|5578820|P1|STARTED|Maintenance||0
2272905|NCT02254551|5578820|P1|NOT COMPLETED|Expansion||0
2272906|NCT02254551|5578820|P1|COMPLETED|Expansion||0
2272907|NCT02254551|5578820|P1|STARTED|Expansion||0
2272908|NCT02254551|5578820|P1|NOT COMPLETED|Dose Escalation||3
2272909|NCT02254551|5578820|P1|COMPLETED|Dose Escalation|Due to toxicity and lack of efficacy, no other dose levels were examined.|4
2272910|NCT02254551|5578820|P1|Cohort 3: LDE225 800mg|Dose Escalation||0
2272911|NCT02254551|5578820|P1|Cohort 2: LDE225 600mg|Dose Escalation||0
2272912|NCT02254551|5578820|P1|Cohort 1: LDE225 400mg|Dose Escalation|1 patient was found to be refractory to bortezomib and deemed ineligible.|7
2272913|NCT02254551|5578820|P1|STARTED|Dose Escalation||7
2272914|NCT02254486|5578830|P2|NOT COMPLETED|Overall Study||55
2272915|NCT02254486|5578831|P1|NOT COMPLETED|Overall Study||50
2272916|NCT02254486|5578830|P2|COMPLETED|Overall Study||255
2272917|NCT02254486|5578831|P1|COMPLETED|Overall Study||261
2272918|NCT02254486|5578830|P2|STARTED|Overall Study||310
2272919|NCT02254486|5578831|P1|STARTED|Overall Study||311
2272920|NCT02254473|5578849|P2|NOT COMPLETED|Overall Study||1
2272921|NCT02254473|5578850|P1|NOT COMPLETED|Overall Study||2
2272922|NCT02254473|5578849|P2|COMPLETED|Overall Study||2
2272923|NCT02254473|5578850|P1|COMPLETED|Overall Study||7
2272924|NCT02254473|5578849|P2|STARTED|Overall Study||3
2272925|NCT02254473|5578850|P1|STARTED|Overall Study||9
2272926|NCT02254460|5578870|P2|NOT COMPLETED|Overall Study||0
2272927|NCT02254460|5578871|P1|NOT COMPLETED|Overall Study||1
2272928|NCT02254460|5578870|P2|COMPLETED|Overall Study||12
2272929|NCT02254460|5578871|P1|COMPLETED|Overall Study||12
2272930|NCT02254460|5578870|P2|STARTED|Overall Study||12
2272931|NCT02254460|5578871|P1|STARTED|Overall Study||13
2272932|NCT02254421|5578879|P2|NOT COMPLETED|Overall Study||3
2272933|NCT02254421|5578880|P1|NOT COMPLETED|Overall Study||2
2272934|NCT02254421|5578879|P2|COMPLETED|Overall Study||26
2272935|NCT02254421|5578880|P1|COMPLETED|Overall Study||29
2272936|NCT02254421|5578879|P2|STARTED|Overall Study||29
2272937|NCT02254421|5578880|P1|STARTED|Overall Study||31
2272938|NCT02254408|5578894|P2|NOT COMPLETED|Overall Study||10
2272939|NCT02254408|5578895|P1|NOT COMPLETED|Overall Study||8
2272940|NCT02254408|5578894|P2|COMPLETED|Overall Study||83
2272941|NCT02254408|5578895|P1|COMPLETED|Overall Study||88
2272942|NCT02254408|5578894|P2|STARTED|Overall Study||93
2272943|NCT02254408|5578895|P1|STARTED|Overall Study||96
2272944|NCT02254304|5578907|P2|NOT COMPLETED|Overall Study||4
2272945|NCT02254304|5578908|P1|NOT COMPLETED|Overall Study||14
2272946|NCT02254304|5578907|P2|COMPLETED|Overall Study||13
2272947|NCT02254304|5578908|P1|COMPLETED|Overall Study||75
2272948|NCT02254304|5578907|P2|STARTED|Overall Study||17
2272949|NCT02254304|5578908|P1|STARTED|Overall Study||89
2272950|NCT02254291|5578968|P3|NOT COMPLETED|Overall Study||2
2272951|NCT02254291|5578969|P2|NOT COMPLETED|Overall Study||3
2272952|NCT02254291|5578970|P1|NOT COMPLETED|Overall Study||0
2272953|NCT02254291|5578968|P3|COMPLETED|Overall Study||101
2272954|NCT02254291|5578969|P2|COMPLETED|Overall Study||99
2272955|NCT02254291|5578970|P1|COMPLETED|Overall Study||103
2272956|NCT02254291|5578968|P3|Exposed|Overall Study||103
2272957|NCT02254291|5578969|P2|Exposed|Overall Study||102
2272958|NCT02254291|5578970|P1|Exposed|Overall Study||103
2272959|NCT02254291|5578968|P3|STARTED|Overall Study||103
2272960|NCT02254291|5578969|P2|STARTED|Overall Study||102
2272961|NCT02254291|5578970|P1|STARTED|Overall Study||103
2272962|NCT02254265|5578987|P3|NOT COMPLETED|Overall Study||8
2272963|NCT02254265|5578988|P2|NOT COMPLETED|Overall Study||12
2272964|NCT02254265|5578989|P1|NOT COMPLETED|Overall Study||9
2272965|NCT02254265|5578987|P3|COMPLETED|Overall Study||144
2272966|NCT02254265|5578988|P2|COMPLETED|Overall Study||140
2272967|NCT02254265|5578989|P1|COMPLETED|Overall Study||142
2272968|NCT02254265|5578987|P3|STARTED|Overall Study||152
2272969|NCT02254265|5578988|P2|STARTED|Overall Study||152
2272970|NCT02254265|5578989|P1|STARTED|Overall Study||151
2272971|NCT02254252|5579014|P2|NOT COMPLETED|Overall Study||2
2272972|NCT02254252|5579015|P1|NOT COMPLETED|Overall Study||3
2272973|NCT02254252|5579014|P2|COMPLETED|Overall Study||25
2272974|NCT02254252|5579015|P1|COMPLETED|Overall Study||24
2272975|NCT02254252|5579014|P2|STARTED|Overall Study||27
2272976|NCT02254252|5579015|P1|STARTED|Overall Study||27
2272977|NCT02253654|5579027|P2|NOT COMPLETED|Overall Study||18
2272978|NCT02253654|5579028|P1|NOT COMPLETED|Overall Study||23
2272979|NCT02253654|5579027|P2|COMPLETED|Overall Study||90
2272980|NCT02253654|5579028|P1|COMPLETED|Overall Study||85
2272981|NCT02253654|5579027|P2|Received Treatment|Overall Study||107
2272982|NCT02253654|5579028|P1|Received Treatment|Overall Study||104
2272983|NCT02253654|5579027|P2|STARTED|Overall Study||108
2272984|NCT02253654|5579028|P1|STARTED|Overall Study||108
2272985|NCT02253537|5579048|P1|NOT COMPLETED|Overall Study||0
2272986|NCT02253537|5579048|P1|COMPLETED|Overall Study||15
2272987|NCT02253537|5579048|P1|STARTED|Overall Study||15
2272988|NCT02253433|5579054|P2|NOT COMPLETED|Overall Study||55
2272989|NCT02253433|5579055|P1|NOT COMPLETED|Overall Study||16
2272990|NCT02253433|5579054|P2|COMPLETED|Overall Study||79
2272991|NCT02253433|5579055|P1|COMPLETED|Overall Study||114
2272992|NCT02253433|5579054|P2|STARTED|Overall Study||134
2272993|NCT02253433|5579055|P1|STARTED|Overall Study||130
2272994|NCT02253394|5579065|P2|NOT COMPLETED|Overall Study||0
2272995|NCT02253394|5579066|P1|NOT COMPLETED|Overall Study||0
2272996|NCT02253394|5579065|P2|COMPLETED|Overall Study||2
2272997|NCT02253394|5579066|P1|COMPLETED|Overall Study||0
2272998|NCT02253394|5579065|P2|STARTED|Overall Study|Ambrisentan 5 or 10 mg QD + placebo (90 d) first, then washout (21 d), then +Spiro 50 mg QD (90 d).|2
2272999|NCT02253394|5579066|P1|STARTED|Overall Study||0
2273000|NCT02253173|5579076|P4|NOT COMPLETED|Overall Study||14
2273001|NCT02253173|5579077|P3|NOT COMPLETED|Overall Study||13
2273002|NCT02253173|5579078|P2|NOT COMPLETED|Overall Study||17
2273003|NCT02253173|5579079|P1|NOT COMPLETED|Overall Study||16
2273004|NCT02253173|5579076|P4|COMPLETED|Overall Study||178
2273005|NCT02253173|5579077|P3|COMPLETED|Overall Study||177
2273006|NCT02253173|5579078|P2|COMPLETED|Overall Study||174
2273007|NCT02253173|5579079|P1|COMPLETED|Overall Study||175
2273008|NCT02253173|5579076|P4|STARTED|Overall Study||192
2273009|NCT02253173|5579077|P3|STARTED|Overall Study||190
2273010|NCT02253173|5579078|P2|STARTED|Overall Study||191
2273011|NCT02253173|5579079|P1|STARTED|Overall Study||191
2273012|NCT02253160|5579276|P3|NOT COMPLETED|Overall Study||0
2273013|NCT02253160|5579277|P2|NOT COMPLETED|Overall Study||0
2273014|NCT02253160|5579278|P1|NOT COMPLETED|Overall Study||0
2273015|NCT02253160|5579276|P3|COMPLETED|Overall Study||10
2273016|NCT02253160|5579277|P2|COMPLETED|Overall Study||12
2273017|NCT02253160|5579278|P1|COMPLETED|Overall Study||1
2273018|NCT02253160|5579276|P3|STARTED|Overall Study||10
2273019|NCT02253160|5579277|P2|STARTED|Overall Study||12
2273020|NCT02253160|5579278|P1|STARTED|Overall Study||1
2273021|NCT02253147|5579314|P1|NOT COMPLETED|Overall Study||47
2273022|NCT02253147|5579314|P1|COMPLETED|Overall Study||71
2273023|NCT02253147|5579314|P1|N Patients at W52|Overall Study||84
2273024|NCT02253147|5579314|P1|N Patients at W36|Overall Study||86
2273025|NCT02253147|5579314|P1|N Patients at W24 (Primary Outcome)|Overall Study||88
2273026|NCT02253147|5579314|P1|STARTED|Overall Study||118
2273027|NCT02252965|5579348|P2|NOT COMPLETED|Overall Study||43
2273028|NCT02252965|5579349|P1|NOT COMPLETED|Overall Study||40
2273029|NCT02252965|5579348|P2|COMPLETED|Overall Study||222
2273030|NCT02252965|5579349|P1|COMPLETED|Overall Study||227
2273031|NCT02252965|5579348|P2|Safety Population|Overall Study||264
2273032|NCT02252965|5579349|P1|Safety Population|Overall Study|Out of 261, 12 subjects intolerant to the Metformin IR switched to Metformin XR group.|261
2273033|NCT02252965|5579348|P2|STARTED|Overall Study||265
2273034|NCT02252965|5579349|P1|STARTED|Overall Study||267
2273035|NCT02252939|5579376|P1|NOT COMPLETED|Overall Study||3
2273036|NCT02252939|5579376|P1|COMPLETED|Overall Study||59
2273037|NCT02252939|5579376|P1|STARTED|Overall Study||62
2273038|NCT02252744|5579385|P1|NOT COMPLETED|Overall Study||0
2273039|NCT02252744|5579385|P1|COMPLETED|Overall Study||286
2273040|NCT02252744|5579385|P1|STARTED|Overall Study||286
2273041|NCT02252718|5579389|P1|NOT COMPLETED|Overall Study||0
2273042|NCT02252718|5579389|P1|COMPLETED|Overall Study||100
2273043|NCT02252718|5579389|P1|STARTED|Overall Study||100
2273044|NCT02252666|5579393|P1|NOT COMPLETED|Overall Study||0
2273045|NCT02252666|5579393|P1|COMPLETED|Overall Study||6
2273046|NCT02252666|5579393|P1|STARTED|Overall Study||6
2273047|NCT02252562|5579417|P2|NOT COMPLETED|Overall Study||0
2273048|NCT02252562|5579418|P1|NOT COMPLETED|Overall Study||0
2273049|NCT02252562|5579417|P2|COMPLETED|Overall Study||1636
2273050|NCT02252562|5579418|P1|COMPLETED|Overall Study||1620
2273051|NCT02252562|5579417|P2|STARTED|Overall Study||1636
2273052|NCT02252562|5579418|P1|STARTED|Overall Study||1620
2273053|NCT02252536|5579433|P2|NOT COMPLETED|Overall Study||3
2273054|NCT02252536|5579434|P1|NOT COMPLETED|Overall Study||5
2273055|NCT02252536|5579433|P2|COMPLETED|Overall Study||170
2273056|NCT02252536|5579434|P1|COMPLETED|Overall Study||168
2273057|NCT02252536|5579433|P2|STARTED|Overall Study||173
2273058|NCT02252536|5579434|P1|STARTED|Overall Study||173
2273059|NCT02252445|5579468|P2|NOT COMPLETED|Overall Study||0
2273060|NCT02252445|5579469|P1|NOT COMPLETED|Overall Study||0
2273061|NCT02252445|5579468|P2|COMPLETED|Overall Study||41
2273062|NCT02252445|5579469|P1|COMPLETED|Overall Study||41
2273063|NCT02252445|5579468|P2|STARTED|Overall Study||41
2273064|NCT02252445|5579469|P1|STARTED|Overall Study||41
2273065|NCT02252354|5579495|P2|NOT COMPLETED|Overall Study||0
2273066|NCT02252354|5579496|P1|NOT COMPLETED|Overall Study||0
2273067|NCT02252354|5579495|P2|COMPLETED|Overall Study||6
2273068|NCT02252354|5579496|P1|COMPLETED|Overall Study||6
2273069|NCT02252354|5579495|P2|STARTED|Overall Study||6
2273070|NCT02252354|5579496|P1|STARTED|Overall Study||6
2273071|NCT02252211|5579543|P3|NOT COMPLETED|Overall Study||1
2273072|NCT02252211|5579544|P2|NOT COMPLETED|Overall Study||3
2273073|NCT02252211|5579545|P1|NOT COMPLETED|Overall Study||5
2273074|NCT02252211|5579543|P3|COMPLETED|Overall Study||0
2273075|NCT02252211|5579544|P2|COMPLETED|Overall Study||0
2273076|NCT02252211|5579545|P1|COMPLETED|Overall Study||0
2273077|NCT02252211|5579543|P3|Received Further Doses (Through Dose 24)|Overall Study||0
2273078|NCT02252211|5579544|P2|Received Further Doses (Through Dose 24)|Overall Study||0
2273079|NCT02252211|5579545|P1|Received Further Doses (Through Dose 24)|Overall Study||1
2273080|NCT02252211|5579543|P3|Received Dose 4 (Day 36)|Overall Study||0
2273081|NCT02252211|5579544|P2|Received Dose 4 (Day 36)|Overall Study||1
2273082|NCT02252211|5579545|P1|Received Dose 4 (Day 36)|Overall Study||1
2273083|NCT02252211|5579543|P3|Received Dose 3 (Day 22)|Overall Study||0
2273084|NCT02252211|5579544|P2|Received Dose 3 (Day 22)|Overall Study||3
2273085|NCT02252211|5579545|P1|Received Dose 3 (Day 22)|Overall Study||3
2273086|NCT02252211|5579543|P3|Received Dose 2 (Day 8)|Overall Study||0
2273087|NCT02252211|5579544|P2|Received Dose 2 (Day 8)|Overall Study||3
2273088|NCT02252211|5579545|P1|Received Dose 2 (Day 8)|Overall Study||4
2273089|NCT02252211|5579543|P3|Received Dose 1 (Day 1)|Overall Study||0
2273090|NCT02252211|5579544|P2|Received Dose 1 (Day 1)|Overall Study||3
2273091|NCT02252211|5579545|P1|Received Dose 1 (Day 1)|Overall Study||4
2273092|NCT02252211|5579543|P3|STARTED|Overall Study||1
2273093|NCT02252211|5579544|P2|STARTED|Overall Study||3
2273094|NCT02252211|5579545|P1|STARTED|Overall Study||5
2273095|NCT02252172|5579582|P2|NOT COMPLETED|Overall Study||299
2273096|NCT02252172|5579583|P1|NOT COMPLETED|Overall Study||279
2273097|NCT02252172|5579582|P2|COMPLETED|Overall Study||69
2273098|NCT02252172|5579583|P1|COMPLETED|Overall Study||90
2273099|NCT02252172|5579582|P2|Treated|Overall Study||364
2273100|NCT02252172|5579583|P1|Treated|Overall Study||365
2273101|NCT02252172|5579582|P2|STARTED|Overall Study||368
2273102|NCT02252172|5579583|P1|STARTED|Overall Study||369
2273103|NCT02252146|5579595|P1|NOT COMPLETED|Overall Study||6
2273104|NCT02252146|5579595|P1|COMPLETED|Overall Study||0
2273105|NCT02252146|5579595|P1|STARTED|Overall Study||6
2273106|NCT02252133|5579599|P2|NOT COMPLETED|Period 2||0
2273107|NCT02252133|5579600|P1|NOT COMPLETED|Period 2||0
2273108|NCT02252133|5579599|P2|COMPLETED|Period 2||24
2273109|NCT02252133|5579600|P1|COMPLETED|Period 2||23
2273110|NCT02252133|5579599|P2|STARTED|Period 2||24
2273111|NCT02252133|5579600|P1|STARTED|Period 2||23
2273112|NCT02252133|5579599|P2|NOT COMPLETED|Period 1||0
2273113|NCT02252133|5579600|P1|NOT COMPLETED|Period 1||0
2273114|NCT02252133|5579599|P2|COMPLETED|Period 1||24
2273115|NCT02252133|5579600|P1|COMPLETED|Period 1||23
2273116|NCT02252133|5579599|P2|STARTED|Period 1||24
2273117|NCT02252133|5579600|P1|STARTED|Period 1||23
2273118|NCT02252042|5579608|P2|NOT COMPLETED|Overall Study||248
2273119|NCT02252042|5579609|P1|NOT COMPLETED|Overall Study||247
2273120|NCT02252042|5579608|P2|COMPLETED|Overall Study||0
2273121|NCT02252042|5579609|P1|COMPLETED|Overall Study||0
2273122|NCT02252042|5579608|P2|Treated|Overall Study|14 participants were randomized but did not receive study treatment.|234
2273123|NCT02252042|5579609|P1|Treated|Overall Study|1 participant was randomized but did not receive study treatment.|246
2273124|NCT02252042|5579608|P2|STARTED|Overall Study||248
2273125|NCT02252042|5579609|P1|STARTED|Overall Study||247
2273126|NCT02252016|5579649|P2|NOT COMPLETED|Overall Study||3
2273127|NCT02252016|5579650|P1|NOT COMPLETED|Overall Study||3
2273128|NCT02252016|5579649|P2|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|49
2273129|NCT02252016|5579650|P1|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|104
2273130|NCT02252016|5579649|P2|STARTED|Overall Study||52
2273131|NCT02252016|5579650|P1|STARTED|Overall Study||107
2273132|NCT02251990|5579664|P2|NOT COMPLETED|Period 3 (DTG Follow-up)||0
2273133|NCT02251990|5579665|P1|NOT COMPLETED|Period 3 (DTG Follow-up)||0
2273134|NCT02251990|5579664|P2|COMPLETED|Period 3 (DTG Follow-up)|Completed 24 weeks of follow-up|121
2273135|NCT02251990|5579665|P1|COMPLETED|Period 3 (DTG Follow-up)||0
2273136|NCT02251990|5579664|P2|STARTED|Period 3 (DTG Follow-up)|3 participants that discontinued treatment in Period 2 were included in Follow-up.|121
2273137|NCT02251990|5579665|P1|STARTED|Period 3 (DTG Follow-up)|The ITG completed the study with Period 2|0
2273138|NCT02251990|5579664|P2|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||3
2273139|NCT02251990|5579665|P1|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||0
2273140|NCT02251990|5579664|P2|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 12 weeks of Grazoprevir/Elbasvir|118
2273141|NCT02251990|5579665|P1|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 24 weeks of follow-up|360
2273142|NCT02251990|5579664|P2|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|1 participant completing Period 1 was not eligible for Period 2 and was not treated.|121
2273143|NCT02251990|5579665|P1|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|2 participants that did not complete Period 1 treatment were included in Follow-up.|360
2273144|NCT02251990|5579664|P2|NOT COMPLETED|Period 1 (Double-blind [DB])||1
2273145|NCT02251990|5579665|P1|NOT COMPLETED|Period 1 (Double-blind [DB])||8
2273146|NCT02251990|5579664|P2|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Placebo|122
2273147|NCT02251990|5579665|P1|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Grazoprevir/Elbasvir|358
2273148|NCT02251990|5579664|P2|Treated|Period 1 (Double-blind [DB])|Started Placebo|123
2273149|NCT02251990|5579665|P1|Treated|Period 1 (Double-blind [DB])|Started Grazoprevir/Elbasvir|365
2273150|NCT02251990|5579664|P2|STARTED|Period 1 (Double-blind [DB])||123
2273151|NCT02251990|5579665|P1|STARTED|Period 1 (Double-blind [DB])||366
2273152|NCT02251938|5579680|P1|NOT COMPLETED|Overall Study||17
2273153|NCT02251938|5579680|P1|COMPLETED|Overall Study||43
2273154|NCT02251938|5579680|P1|STARTED|Overall Study||60
2273155|NCT02251912|5579693|P2|NOT COMPLETED|Overall Study||5
2273156|NCT02251912|5579694|P1|NOT COMPLETED|Overall Study||2
2273157|NCT02251912|5579693|P2|COMPLETED|Overall Study||5
2273158|NCT02251912|5579694|P1|COMPLETED|Overall Study||10
2273159|NCT02251912|5579693|P2|STARTED|Overall Study||10
2273160|NCT02251912|5579694|P1|STARTED|Overall Study||12
2273161|NCT02251886|5579708|P4|NOT COMPLETED|Overall Study||0
2273162|NCT02251886|5579709|P3|NOT COMPLETED|Overall Study||0
2273163|NCT02251886|5579710|P2|NOT COMPLETED|Overall Study||0
2273164|NCT02251886|5579711|P1|NOT COMPLETED|Overall Study||0
2273165|NCT02251886|5579708|P4|COMPLETED|Overall Study||54
2273166|NCT02251886|5579709|P3|COMPLETED|Overall Study||44
2273167|NCT02251886|5579710|P2|COMPLETED|Overall Study||54
2273168|NCT02251886|5579711|P1|COMPLETED|Overall Study||48
2273169|NCT02251886|5579708|P4|STARTED|Overall Study||54
2273170|NCT02251886|5579709|P3|STARTED|Overall Study||44
2273171|NCT02251886|5579710|P2|STARTED|Overall Study||54
2273172|NCT02251886|5579711|P1|STARTED|Overall Study||48
2273173|NCT02251717|5579723|P2|NOT COMPLETED|Overall Study||1
2273174|NCT02251717|5579724|P1|NOT COMPLETED|Overall Study||1
2273175|NCT02251717|5579723|P2|COMPLETED|Overall Study||56
2273176|NCT02251717|5579724|P1|COMPLETED|Overall Study||56
2273177|NCT02251717|5579723|P2|STARTED|Overall Study||57
2273178|NCT02251717|5579724|P1|STARTED|Overall Study||57
2273179|NCT02251652|5579736|P1|NOT COMPLETED|Overall Study||1
2273180|NCT02251652|5579736|P1|COMPLETED|Overall Study||16
2273181|NCT02251652|5579736|P1|STARTED|Overall Study||17
2273182|NCT02251613|5579746|P1|NOT COMPLETED|Overall Study||0
2273183|NCT02251613|5579746|P1|COMPLETED|Overall Study||50
2273184|NCT02251613|5579746|P1|STARTED|Overall Study||50
2273185|NCT02251561|5579754|P1|NOT COMPLETED|Overall Study||0
2273186|NCT02251561|5579754|P1|COMPLETED|Overall Study||28
2273187|NCT02251561|5579754|P1|STARTED|Overall Study||28
2273188|NCT02251379|5579764|P2|NOT COMPLETED|Overall Study||20
2273189|NCT02251379|5579765|P1|NOT COMPLETED|Overall Study||20
2273190|NCT02251379|5579764|P2|COMPLETED|Overall Study||58
2273191|NCT02251379|5579765|P1|COMPLETED|Overall Study||57
2273192|NCT02251379|5579764|P2|STARTED|Overall Study||78
2273193|NCT02251379|5579765|P1|STARTED|Overall Study||77
2273194|NCT02251275|5579786|P5|NOT COMPLETED|Overall Study||1
2273195|NCT02251275|5579787|P4|NOT COMPLETED|Overall Study||1
2273196|NCT02251275|5579788|P3|NOT COMPLETED|Overall Study||94
2273197|NCT02251275|5579789|P2|NOT COMPLETED|Overall Study||147
2273198|NCT02251275|5579790|P1|NOT COMPLETED|Overall Study||72
2273199|NCT02251275|5579786|P5|COMPLETED|Overall Study||2
2273200|NCT02251275|5579787|P4|COMPLETED|Overall Study||5
2273201|NCT02251275|5579788|P3|COMPLETED|Overall Study||624
2273202|NCT02251275|5579789|P2|COMPLETED|Overall Study||423
2273203|NCT02251275|5579790|P1|COMPLETED|Overall Study||434
2273204|NCT02251275|5579786|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
2273205|NCT02251275|5579787|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
2273206|NCT02251275|5579788|P3|Received at Least 1 Dose of Study Drug|Overall Study||717
2273207|NCT02251275|5579789|P2|Received at Least 1 Dose of Study Drug|Overall Study||569
2273208|NCT02251275|5579790|P1|Received at Least 1 Dose of Study Drug|Overall Study||505
2273209|NCT02251275|5579786|P5|STARTED|Overall Study|From trials 156-04-251 and 156-09-290|3
2273210|NCT02251275|5579787|P4|STARTED|Overall Study|From trials 156-04-251 and 156-09-290|6
2273211|NCT02251275|5579788|P3|STARTED|Overall Study||718
2273212|NCT02251275|5579789|P2|STARTED|Overall Study||570
2273213|NCT02251275|5579790|P1|STARTED|Overall Study||506
2273214|NCT02251236|5579805|P3|NOT COMPLETED|Overall Study||0
2273215|NCT02251236|5579806|P2|NOT COMPLETED|Overall Study||0
2273216|NCT02251236|5579807|P1|NOT COMPLETED|Overall Study||0
2273217|NCT02251236|5579805|P3|COMPLETED|Overall Study||0
2273218|NCT02251236|5579806|P2|COMPLETED|Overall Study||5
2273219|NCT02251236|5579807|P1|COMPLETED|Overall Study||9
2273220|NCT02251236|5579805|P3|STARTED|Overall Study||0
2273221|NCT02251236|5579806|P2|STARTED|Overall Study||5
2273222|NCT02251236|5579807|P1|STARTED|Overall Study||9
2273223|NCT02250807|5579824|P1|NOT COMPLETED|Overall Study||0
2273224|NCT02250807|5579824|P1|COMPLETED|Overall Study||40
2273225|NCT02250807|5579824|P1|STARTED|Overall Study||40
2273226|NCT02250703|5579836|P2|NOT COMPLETED|Overall Study||1
2273227|NCT02250703|5579837|P1|NOT COMPLETED|Overall Study||1
2273228|NCT02250703|5579836|P2|COMPLETED|Overall Study||36
2273229|NCT02250703|5579837|P1|COMPLETED|Overall Study||37
2273230|NCT02250703|5579836|P2|STARTED|Overall Study||37
2273231|NCT02250703|5579837|P1|STARTED|Overall Study||38
2273232|NCT02250521|5579849|P1|NOT COMPLETED|Overall Study||1
2273233|NCT02250521|5579849|P1|COMPLETED|Overall Study||99
2273234|NCT02250521|5579849|P1|STARTED|Overall Study||100
2273235|NCT02250443|5579863|P1|NOT COMPLETED|Overall Study||10
2273236|NCT02250443|5579863|P1|COMPLETED|Overall Study||0
2273237|NCT02250443|5579863|P1|STARTED|Overall Study||10
2273238|NCT02250417|5579876|P2|NOT COMPLETED|Second Intervention (1 Night)||0
2273239|NCT02250417|5579877|P1|NOT COMPLETED|Second Intervention (1 Night)||0
2273240|NCT02250417|5579876|P2|COMPLETED|Second Intervention (1 Night)||6
2273241|NCT02250417|5579877|P1|COMPLETED|Second Intervention (1 Night)||6
2273242|NCT02250417|5579876|P2|STARTED|Second Intervention (1 Night)||6
2273243|NCT02250417|5579877|P1|STARTED|Second Intervention (1 Night)||6
2273244|NCT02250417|5579876|P2|NOT COMPLETED|First Intervention (1 Night)||0
2273245|NCT02250417|5579877|P1|NOT COMPLETED|First Intervention (1 Night)||0
2273246|NCT02250417|5579876|P2|COMPLETED|First Intervention (1 Night)||6
2273247|NCT02250417|5579877|P1|COMPLETED|First Intervention (1 Night)||6
2273248|NCT02250417|5579876|P2|STARTED|First Intervention (1 Night)||6
2273249|NCT02250417|5579877|P1|STARTED|First Intervention (1 Night)||6
2273250|NCT02250326|5579892|P3|NOT COMPLETED|Follow-Up Period||38
2273251|NCT02250326|5579893|P2|NOT COMPLETED|Follow-Up Period||30
2273252|NCT02250326|5579894|P1|NOT COMPLETED|Follow-Up Period||49
2273253|NCT02250326|5579892|P3|COMPLETED|Follow-Up Period||26
2273254|NCT02250326|5579893|P2|COMPLETED|Follow-Up Period||13
2273255|NCT02250326|5579894|P1|COMPLETED|Follow-Up Period||18
2273256|NCT02250326|5579892|P3|STARTED|Follow-Up Period||64
2273257|NCT02250326|5579893|P2|STARTED|Follow-Up Period||43
2273258|NCT02250326|5579894|P1|STARTED|Follow-Up Period||67
2273259|NCT02250326|5579892|P3|NOT COMPLETED|Treatment Period||77
2273260|NCT02250326|5579893|P2|NOT COMPLETED|Treatment Period||64
2273261|NCT02250326|5579894|P1|NOT COMPLETED|Treatment Period||81
2273262|NCT02250326|5579892|P3|COMPLETED|Treatment Period|Data Cut-off Date = 30 August 2017|3
2273263|NCT02250326|5579893|P2|COMPLETED|Treatment Period|Data Cut-off Date = 23 December 2017|15
2273264|NCT02250326|5579894|P1|COMPLETED|Treatment Period|Data Cut-off Date = 30 August 2017|0
2273265|NCT02250326|5579892|P3|Treated Population|Treatment Period||79
2273266|NCT02250326|5579893|P2|Treated Population|Treatment Period||78
2273267|NCT02250326|5579894|P1|Treated Population|Treatment Period||79
2273268|NCT02250326|5579892|P3|STARTED|Treatment Period||80
2273269|NCT02250326|5579893|P2|STARTED|Treatment Period||79
2273270|NCT02250326|5579894|P1|STARTED|Treatment Period||81
2273271|NCT02250274|5579927|P2|NOT COMPLETED|Overall Study||6
2273272|NCT02250274|5579928|P1|NOT COMPLETED|Overall Study||7
2273273|NCT02250274|5579927|P2|COMPLETED|Overall Study||40
2273274|NCT02250274|5579928|P1|COMPLETED|Overall Study||78
2273275|NCT02250274|5579927|P2|STARTED|Overall Study||46
2273276|NCT02250274|5579928|P1|STARTED|Overall Study||85
2273277|NCT02250183|5579944|P1|NOT COMPLETED|Overall Study||8
2273278|NCT02250183|5579944|P1|COMPLETED|Overall Study||13
2273279|NCT02250183|5579944|P1|STARTED|Overall Study||21
2273280|NCT02249949|5579953|P1|NOT COMPLETED|Overall Study||2
2273281|NCT02249949|5579953|P1|COMPLETED|Overall Study||11
2273282|NCT02249949|5579953|P1|STARTED|Overall Study||13
2273283|NCT02249832|5579960|P1|NOT COMPLETED|Overall Study||13
2273284|NCT02249832|5579960|P1|COMPLETED|Overall Study||42
2273285|NCT02249832|5579960|P1|STARTED|Overall Study||55
2273286|NCT02249819|5579972|P2|NOT COMPLETED|Overall Study||0
2273287|NCT02249819|5579973|P1|NOT COMPLETED|Overall Study||0
2273288|NCT02249819|5579972|P2|COMPLETED|Overall Study||7
2273289|NCT02249819|5579973|P1|COMPLETED|Overall Study||8
2273290|NCT02249819|5579972|P2|STARTED|Overall Study||7
2273291|NCT02249819|5579973|P1|STARTED|Overall Study||8
2273292|NCT02249793|5579979|P1|NOT COMPLETED|Session 2, 48-Hours Healthy Volunteers||0
2273293|NCT02249793|5579979|P1|COMPLETED|Session 2, 48-Hours Healthy Volunteers||6
2273294|NCT02249793|5579979|P1|STARTED|Session 2, 48-Hours Healthy Volunteers||6
2273295|NCT02249793|5579979|P1|NOT COMPLETED|Session 1, 48-hours Healthy Volunteers||0
2273296|NCT02249793|5579979|P1|COMPLETED|Session 1, 48-hours Healthy Volunteers||6
2273297|NCT02249793|5579979|P1|STARTED|Session 1, 48-hours Healthy Volunteers||6
2273298|NCT02249767|5580004|P3|NOT COMPLETED|Overall Study||8
2273299|NCT02249767|5580005|P2|NOT COMPLETED|Overall Study||9
2273300|NCT02249767|5580006|P1|NOT COMPLETED|Overall Study||8
2273301|NCT02249767|5580004|P3|COMPLETED|Overall Study||107
2273302|NCT02249767|5580005|P2|COMPLETED|Overall Study||220
2273303|NCT02249767|5580006|P1|COMPLETED|Overall Study||222
2273304|NCT02249767|5580004|P3|STARTED|Overall Study||115
2273305|NCT02249767|5580005|P2|STARTED|Overall Study||229
2273306|NCT02249767|5580006|P1|STARTED|Overall Study||230
2273307|NCT02249728|5580014|P1|NOT COMPLETED|Part Two (up to 6 Days)||0
2273308|NCT02249728|5580014|P1|COMPLETED|Part Two (up to 6 Days)||6
2273309|NCT02249728|5580014|P1|STARTED|Part Two (up to 6 Days)||6
2273310|NCT02249728|5580014|P1|NOT COMPLETED|Part One (4 Days)||0
2273311|NCT02249728|5580014|P1|COMPLETED|Part One (4 Days)||6
2273312|NCT02249728|5580014|P1|STARTED|Part One (4 Days)||6
2273313|NCT02249585|5580027|P3|NOT COMPLETED|Overall Study||0
2273314|NCT02249585|5580028|P2|NOT COMPLETED|Overall Study||0
2273315|NCT02249585|5580029|P1|NOT COMPLETED|Overall Study||0
2273316|NCT02249585|5580027|P3|COMPLETED|Overall Study||44
2273317|NCT02249585|5580028|P2|COMPLETED|Overall Study||44
2273318|NCT02249585|5580029|P1|COMPLETED|Overall Study||43
2273319|NCT02249585|5580027|P3|STARTED|Overall Study||44
2273320|NCT02249585|5580028|P2|STARTED|Overall Study||44
2273321|NCT02249585|5580029|P1|STARTED|Overall Study||43
2273322|NCT02249182|5580057|P5|NOT COMPLETED|Treatment Phase||0
2273323|NCT02249182|5580058|P4|NOT COMPLETED|Treatment Phase||0
2273324|NCT02249182|5580059|P3|NOT COMPLETED|Treatment Phase||0
2273325|NCT02249182|5580060|P2|NOT COMPLETED|Treatment Phase||0
2273326|NCT02249182|5580061|P1|NOT COMPLETED|Treatment Phase||4
2273327|NCT02249182|5580057|P5|COMPLETED|Treatment Phase||34
2273328|NCT02249182|5580058|P4|COMPLETED|Treatment Phase||2
2273329|NCT02249182|5580059|P3|COMPLETED|Treatment Phase||1
2273330|NCT02249182|5580060|P2|COMPLETED|Treatment Phase||89
2273331|NCT02249182|5580061|P1|COMPLETED|Treatment Phase||96
2273332|NCT02249182|5580057|P5|STARTED|Treatment Phase|17 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|34
2273333|NCT02249182|5580058|P4|STARTED|Treatment Phase|2 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|2
2273334|NCT02249182|5580059|P3|STARTED|Treatment Phase|1 participant enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|1
2273335|NCT02249182|5580060|P2|STARTED|Treatment Phase|77 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|89
2273336|NCT02249182|5580061|P1|STARTED|Treatment Phase|90 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|100
2273337|NCT02249182|5580057|P5|NOT COMPLETED|PK Lead-In Phase||0
2273338|NCT02249182|5580058|P4|NOT COMPLETED|PK Lead-In Phase||0
2273339|NCT02249182|5580059|P3|NOT COMPLETED|PK Lead-In Phase||0
2273340|NCT02249182|5580060|P2|NOT COMPLETED|PK Lead-In Phase||0
2273341|NCT02249182|5580061|P1|NOT COMPLETED|PK Lead-In Phase||0
2273342|NCT02249182|5580057|P5|COMPLETED|PK Lead-In Phase||17
2273343|NCT02249182|5580058|P4|COMPLETED|PK Lead-In Phase||0
2273344|NCT02249182|5580059|P3|COMPLETED|PK Lead-In Phase||0
2273345|NCT02249182|5580060|P2|COMPLETED|PK Lead-In Phase||12
2273346|NCT02249182|5580061|P1|COMPLETED|PK Lead-In Phase||10
2273347|NCT02249182|5580057|P5|STARTED|PK Lead-In Phase||17
2273348|NCT02249182|5580058|P4|STARTED|PK Lead-In Phase||0
2273349|NCT02249182|5580059|P3|STARTED|PK Lead-In Phase||0
2273350|NCT02249182|5580060|P2|STARTED|PK Lead-In Phase||12
2273351|NCT02249182|5580061|P1|STARTED|PK Lead-In Phase||10
2273352|NCT02249143|5580149|P2|NOT COMPLETED|Overall Study||4
2273353|NCT02249143|5580150|P1|NOT COMPLETED|Overall Study||2
2273354|NCT02249143|5580149|P2|COMPLETED|Overall Study|with technically acceptable pulmonary function tests in the neonatal intensive care unit|22
2273355|NCT02249143|5580150|P1|COMPLETED|Overall Study|with technically acceptable pulmonary function tests in the neonatal intensive care unit|22
2273356|NCT02249143|5580149|P2|STARTED|Overall Study|randomized|26
2273357|NCT02249143|5580150|P1|STARTED|Overall Study||24
2273358|NCT02249104|5580176|P1|NOT COMPLETED|Overall Study||3
2273359|NCT02249104|5580176|P1|COMPLETED|Overall Study||25
2273360|NCT02249104|5580176|P1|STARTED|Overall Study||28
2273361|NCT02249065|5580185|P1|NOT COMPLETED|Overall Study||29
2273362|NCT02249065|5580185|P1|COMPLETED|Overall Study||176
2273363|NCT02249065|5580185|P1|Treated|Overall Study||181
2273364|NCT02249065|5580185|P1|STARTED|Overall Study||205
2273365|NCT02249052|5580193|P1|NOT COMPLETED|Overall Study||0
2273366|NCT02249052|5580193|P1|COMPLETED|Overall Study||19
2273367|NCT02249052|5580193|P1|STARTED|Overall Study||19
2273368|NCT02248974|5580211|P2|NOT COMPLETED|1-Month Follow-Up||3
2273369|NCT02248974|5580212|P1|NOT COMPLETED|1-Month Follow-Up||2
2273370|NCT02248974|5580211|P2|COMPLETED|1-Month Follow-Up||31
2273371|NCT02248974|5580212|P1|COMPLETED|1-Month Follow-Up||27
2273372|NCT02248974|5580211|P2|STARTED|1-Month Follow-Up||34
2273373|NCT02248974|5580212|P1|STARTED|1-Month Follow-Up||29
2273374|NCT02248974|5580211|P2|NOT COMPLETED|1-Week Follow-Up||17
2273375|NCT02248974|5580212|P1|NOT COMPLETED|1-Week Follow-Up||8
2273376|NCT02248974|5580211|P2|COMPLETED|1-Week Follow-Up||34
2273377|NCT02248974|5580212|P1|COMPLETED|1-Week Follow-Up||29
2273378|NCT02248974|5580211|P2|STARTED|1-Week Follow-Up||51
2273379|NCT02248974|5580212|P1|STARTED|1-Week Follow-Up||37
2273380|NCT02248974|5580211|P2|NOT COMPLETED|1-Day Follow-Up||0
2273381|NCT02248974|5580212|P1|NOT COMPLETED|1-Day Follow-Up||10
2273382|NCT02248974|5580211|P2|COMPLETED|1-Day Follow-Up|"No DA group did not receive 1-Day Follow-up survey."|0
2273383|NCT02248974|5580212|P1|COMPLETED|1-Day Follow-Up||37
2273384|NCT02248974|5580211|P2|STARTED|1-Day Follow-Up|"No DA group did not receive 1-Day Follow-up survey."|0
2273385|NCT02248974|5580212|P1|STARTED|1-Day Follow-Up||47
2273386|NCT02248974|5580211|P2|NOT COMPLETED|Baseline||0
2273387|NCT02248974|5580212|P1|NOT COMPLETED|Baseline||0
2273388|NCT02248974|5580211|P2|COMPLETED|Baseline||51
2273389|NCT02248974|5580212|P1|COMPLETED|Baseline||47
2273390|NCT02248974|5580211|P2|STARTED|Baseline||51
2273391|NCT02248974|5580212|P1|STARTED|Baseline||47
2273392|NCT02248961|5580290|P2|NOT COMPLETED|Overall Study||2
2273393|NCT02248961|5580291|P1|NOT COMPLETED|Overall Study||3
2273394|NCT02248961|5580290|P2|COMPLETED|Overall Study||88
2273395|NCT02248961|5580291|P1|COMPLETED|Overall Study||86
2273396|NCT02248961|5580290|P2|STARTED|Overall Study||90
2273397|NCT02248961|5580291|P1|STARTED|Overall Study||89
2273398|NCT02248922|5580311|P2|NOT COMPLETED|Overall Study||0
2273399|NCT02248922|5580312|P1|NOT COMPLETED|Overall Study||0
2273400|NCT02248922|5580311|P2|COMPLETED|Overall Study||12
2273401|NCT02248922|5580312|P1|COMPLETED|Overall Study||5
2273402|NCT02248922|5580311|P2|STARTED|Overall Study||12
2273403|NCT02248922|5580312|P1|STARTED|Overall Study||5
2273404|NCT02248857|5580326|P3|NOT COMPLETED|6 Month||17
2273405|NCT02248857|5580327|P2|NOT COMPLETED|6 Month||29
2273406|NCT02248857|5580328|P1|NOT COMPLETED|6 Month||28
2273407|NCT02248857|5580326|P3|COMPLETED|6 Month||106
2273408|NCT02248857|5580327|P2|COMPLETED|6 Month||136
2273409|NCT02248857|5580328|P1|COMPLETED|6 Month||120
2273410|NCT02248857|5580326|P3|STARTED|6 Month|127 baseline - 4 who withdrew = 123|123
2273411|NCT02248857|5580327|P2|STARTED|6 Month|168 baseline - 3 who withdrew = 165|165
2273412|NCT02248857|5580328|P1|STARTED|6 Month|157 baseline - 9 who withdrew = 148|148
2273413|NCT02248857|5580326|P3|NOT COMPLETED|3 Month||31
2273414|NCT02248857|5580327|P2|NOT COMPLETED|3 Month||34
2273415|NCT02248857|5580328|P1|NOT COMPLETED|3 Month||46
2273416|NCT02248857|5580326|P3|COMPLETED|3 Month||96
2273417|NCT02248857|5580327|P2|COMPLETED|3 Month||134
2273418|NCT02248857|5580328|P1|COMPLETED|3 Month||111
2273419|NCT02248857|5580326|P3|STARTED|3 Month||127
2273420|NCT02248857|5580327|P2|STARTED|3 Month||168
2273421|NCT02248857|5580328|P1|STARTED|3 Month||157
2273422|NCT02248857|5580326|P3|NOT COMPLETED|Baseline||0
2273423|NCT02248857|5580327|P2|NOT COMPLETED|Baseline||0
2273424|NCT02248857|5580328|P1|NOT COMPLETED|Baseline||0
2273425|NCT02248857|5580326|P3|COMPLETED|Baseline||127
2273426|NCT02248857|5580327|P2|COMPLETED|Baseline||168
2273427|NCT02248857|5580328|P1|COMPLETED|Baseline||157
2273428|NCT02248857|5580326|P3|STARTED|Baseline||127
2273429|NCT02248857|5580327|P2|STARTED|Baseline||168
2273430|NCT02248857|5580328|P1|STARTED|Baseline||157
2273431|NCT02248818|5580365|P9|NOT COMPLETED|Randomised Study||0
2273432|NCT02248818|5580366|P8|NOT COMPLETED|Randomised Study||0
2273433|NCT02248818|5580367|P7|NOT COMPLETED|Randomised Study||0
2273434|NCT02248818|5580368|P6|NOT COMPLETED|Randomised Study||8
2273435|NCT02248818|5580369|P5|NOT COMPLETED|Randomised Study||0
2273436|NCT02248818|5580370|P4|NOT COMPLETED|Randomised Study||0
2273437|NCT02248818|5580371|P3|NOT COMPLETED|Randomised Study||0
2273438|NCT02248818|5580372|P2|NOT COMPLETED|Randomised Study||0
2273439|NCT02248818|5580373|P1|NOT COMPLETED|Randomised Study||0
2273440|NCT02248818|5580365|P9|COMPLETED|Randomised Study||0
2273441|NCT02248818|5580366|P8|COMPLETED|Randomised Study||4
2273442|NCT02248818|5580367|P7|COMPLETED|Randomised Study||6
2273443|NCT02248818|5580368|P6|COMPLETED|Randomised Study||0
2273444|NCT02248818|5580369|P5|COMPLETED|Randomised Study||6
2273445|NCT02248818|5580370|P4|COMPLETED|Randomised Study||6
2273446|NCT02248818|5580371|P3|COMPLETED|Randomised Study||6
2273447|NCT02248818|5580372|P2|COMPLETED|Randomised Study||6
2273448|NCT02248818|5580373|P1|COMPLETED|Randomised Study||6
2273449|NCT02248818|5580365|P9|STARTED|Randomised Study||0
2273450|NCT02248818|5580366|P8|STARTED|Randomised Study||4
2273451|NCT02248818|5580367|P7|STARTED|Randomised Study||6
2273452|NCT02248818|5580368|P6|STARTED|Randomised Study||8
2273453|NCT02248818|5580369|P5|STARTED|Randomised Study||6
2273454|NCT02248818|5580370|P4|STARTED|Randomised Study||6
2273455|NCT02248818|5580371|P3|STARTED|Randomised Study||6
2273456|NCT02248818|5580372|P2|STARTED|Randomised Study||6
2273457|NCT02248818|5580373|P1|STARTED|Randomised Study||6
2273458|NCT02248818|5580365|P9|NOT COMPLETED|Screening||107
2273459|NCT02248818|5580366|P8|NOT COMPLETED|Screening||0
2273460|NCT02248818|5580367|P7|NOT COMPLETED|Screening||0
2273461|NCT02248818|5580368|P6|NOT COMPLETED|Screening||0
2273462|NCT02248818|5580369|P5|NOT COMPLETED|Screening||0
2273463|NCT02248818|5580370|P4|NOT COMPLETED|Screening||0
2273464|NCT02248818|5580371|P3|NOT COMPLETED|Screening||0
2273465|NCT02248818|5580372|P2|NOT COMPLETED|Screening||0
2273466|NCT02248818|5580373|P1|NOT COMPLETED|Screening||0
2273467|NCT02248818|5580365|P9|COMPLETED|Screening||48
2273468|NCT02248818|5580366|P8|COMPLETED|Screening||0
2273469|NCT02248818|5580367|P7|COMPLETED|Screening||0
2273470|NCT02248818|5580368|P6|COMPLETED|Screening||0
2273471|NCT02248818|5580369|P5|COMPLETED|Screening||0
2273472|NCT02248818|5580370|P4|COMPLETED|Screening||0
2273473|NCT02248818|5580371|P3|COMPLETED|Screening||0
2273474|NCT02248818|5580372|P2|COMPLETED|Screening||0
2273475|NCT02248818|5580373|P1|COMPLETED|Screening||0
2273476|NCT02248818|5580365|P9|STARTED|Screening||155
2273477|NCT02248818|5580366|P8|STARTED|Screening||0
2273478|NCT02248818|5580367|P7|STARTED|Screening||0
2273479|NCT02248818|5580368|P6|STARTED|Screening||0
2273480|NCT02248818|5580369|P5|STARTED|Screening||0
2273481|NCT02248818|5580370|P4|STARTED|Screening||0
2273482|NCT02248818|5580371|P3|STARTED|Screening||0
2273483|NCT02248818|5580372|P2|STARTED|Screening||0
2273484|NCT02248818|5580373|P1|STARTED|Screening||0
2273485|NCT02248766|5580511|P1|NOT COMPLETED|Overall Study||0
2273486|NCT02248766|5580511|P1|COMPLETED|Overall Study||30
2273487|NCT02248766|5580511|P1|STARTED|Overall Study||30
2273488|NCT02248740|5580525|P2|NOT COMPLETED|Overall Study||18
2273489|NCT02248740|5580526|P1|NOT COMPLETED|Overall Study||18
2273490|NCT02248740|5580525|P2|COMPLETED|Overall Study||0
2273491|NCT02248740|5580526|P1|COMPLETED|Overall Study||0
2273492|NCT02248740|5580525|P2|STARTED|Overall Study||18
2273493|NCT02248740|5580526|P1|STARTED|Overall Study||18
2273494|NCT02248727|5580536|P1|NOT COMPLETED|Overall Study||0
2273495|NCT02248727|5580536|P1|COMPLETED|Overall Study||30
2273496|NCT02248727|5580536|P1|STARTED|Overall Study||30
2273497|NCT02248714|5580549|P2|NOT COMPLETED|Overall Study||4
2273498|NCT02248714|5580550|P1|NOT COMPLETED|Overall Study||4
2273499|NCT02248714|5580549|P2|COMPLETED|Overall Study||61
2273500|NCT02248714|5580550|P1|COMPLETED|Overall Study||62
2273501|NCT02248714|5580549|P2|STARTED|Overall Study||65
2273502|NCT02248714|5580550|P1|STARTED|Overall Study||66
2273503|NCT02248675|5580588|P2|NOT COMPLETED|Overall Study||1
2273504|NCT02248675|5580589|P1|NOT COMPLETED|Overall Study||3
2273505|NCT02248675|5580588|P2|COMPLETED|Overall Study||27
2273506|NCT02248675|5580589|P1|COMPLETED|Overall Study||23
2273507|NCT02248675|5580588|P2|STARTED|Overall Study||28
2273508|NCT02248675|5580589|P1|STARTED|Overall Study||26
2273509|NCT02248662|5580603|P2|NOT COMPLETED|Overall Study||30515
2273510|NCT02248662|5580604|P1|NOT COMPLETED|Overall Study||4563
2273511|NCT02248662|5580603|P2|COMPLETED|Overall Study||2679
2273512|NCT02248662|5580604|P1|COMPLETED|Overall Study||757
2273513|NCT02248662|5580603|P2|STARTED|Overall Study||33194
2273514|NCT02248662|5580604|P1|STARTED|Overall Study||5320
2273515|NCT02248649|5580616|P2|NOT COMPLETED|Overall Study||21
2273516|NCT02248649|5580617|P1|NOT COMPLETED|Overall Study||21
2273517|NCT02248649|5580616|P2|COMPLETED|Overall Study||59
2273518|NCT02248649|5580617|P1|COMPLETED|Overall Study||59
2273519|NCT02248649|5580616|P2|STARTED|Overall Study||80
2273520|NCT02248649|5580617|P1|STARTED|Overall Study||80
2273521|NCT02248558|5580629|P2|NOT COMPLETED|Overall Study||45
2273522|NCT02248558|5580630|P1|NOT COMPLETED|Overall Study||52
2273523|NCT02248558|5580629|P2|COMPLETED|Overall Study||307
2273524|NCT02248558|5580630|P1|COMPLETED|Overall Study||317
2273525|NCT02248558|5580629|P2|STARTED|Overall Study||352
2273526|NCT02248558|5580630|P1|STARTED|Overall Study||369
2273527|NCT02248480|5580642|P2|NOT COMPLETED|Overall Study||14
2273528|NCT02248480|5580643|P1|NOT COMPLETED|Overall Study||17
2273529|NCT02248480|5580642|P2|COMPLETED|Overall Study||162
2273530|NCT02248480|5580643|P1|COMPLETED|Overall Study||161
2273531|NCT02248480|5580642|P2|Efficacy Population|Overall Study||176
2273532|NCT02248480|5580643|P1|Efficacy Population|Overall Study||177
2273533|NCT02248480|5580642|P2|STARTED|Overall Study||176
2273534|NCT02248480|5580643|P1|STARTED|Overall Study||178
2273535|NCT02248285|5580683|P2|NOT COMPLETED|Overall Study||287
2273536|NCT02248285|5580684|P1|NOT COMPLETED|Overall Study||101
2273537|NCT02248285|5580683|P2|COMPLETED|Overall Study||571
2273538|NCT02248285|5580684|P1|COMPLETED|Overall Study||586
2273539|NCT02248285|5580683|P2|STARTED|Overall Study||858
2273540|NCT02248285|5580684|P1|STARTED|Overall Study||687
2273541|NCT02248246|5580690|P1|NOT COMPLETED|Overall Study||0
2273542|NCT02248246|5580690|P1|COMPLETED|Overall Study||40
2273543|NCT02248246|5580690|P1|STARTED|Overall Study||40
2273544|NCT02248103|5580697|P2|NOT COMPLETED|Overall Study||0
2273545|NCT02248103|5580698|P1|NOT COMPLETED|Overall Study||0
2273546|NCT02248103|5580697|P2|COMPLETED|Overall Study||10
2273547|NCT02248103|5580698|P1|COMPLETED|Overall Study||10
2273548|NCT02248103|5580697|P2|STARTED|Overall Study||10
2273549|NCT02248103|5580698|P1|STARTED|Overall Study||10
2273550|NCT02247960|5580710|P2|NOT COMPLETED|Catheter Removed||10
2273551|NCT02247960|5580711|P1|NOT COMPLETED|Catheter Removed||7
2273552|NCT02247960|5580710|P2|COMPLETED|Catheter Removed||74
2273553|NCT02247960|5580711|P1|COMPLETED|Catheter Removed||76
2273554|NCT02247960|5580710|P2|STARTED|Catheter Removed||84
2273555|NCT02247960|5580711|P1|STARTED|Catheter Removed||83
2273556|NCT02247960|5580710|P2|NOT COMPLETED|Patient Consent and Randomization||6
2273557|NCT02247960|5580711|P1|NOT COMPLETED|Patient Consent and Randomization||2
2273558|NCT02247960|5580710|P2|COMPLETED|Patient Consent and Randomization||84
2273559|NCT02247960|5580711|P1|COMPLETED|Patient Consent and Randomization||83
2273560|NCT02247960|5580710|P2|STARTED|Patient Consent and Randomization||90
2273561|NCT02247960|5580711|P1|STARTED|Patient Consent and Randomization||85
2273562|NCT02247765|5580721|P1|NOT COMPLETED|Overall Study||0
2273563|NCT02247765|5580721|P1|COMPLETED|Overall Study||18
2273564|NCT02247765|5580721|P1|STARTED|Overall Study||18
2273565|NCT02247739|5580726|P6|NOT COMPLETED|Overall Study||1
2273566|NCT02247739|5580727|P5|NOT COMPLETED|Overall Study||1
2273567|NCT02247739|5580728|P4|NOT COMPLETED|Overall Study||0
2273568|NCT02247739|5580729|P3|NOT COMPLETED|Overall Study||1
2273569|NCT02247739|5580730|P2|NOT COMPLETED|Overall Study||3
2273570|NCT02247739|5580731|P1|NOT COMPLETED|Overall Study||0
2273571|NCT02247739|5580726|P6|COMPLETED|Overall Study||4
2273572|NCT02247739|5580727|P5|COMPLETED|Overall Study||5
2273573|NCT02247739|5580728|P4|COMPLETED|Overall Study||5
2273574|NCT02247739|5580729|P3|COMPLETED|Overall Study||4
2273575|NCT02247739|5580730|P2|COMPLETED|Overall Study||3
2273576|NCT02247739|5580731|P1|COMPLETED|Overall Study||5
2273577|NCT02247739|5580726|P6|STARTED|Overall Study||5
2273578|NCT02247739|5580727|P5|STARTED|Overall Study||6
2273579|NCT02247739|5580728|P4|STARTED|Overall Study||5
2273580|NCT02247739|5580729|P3|STARTED|Overall Study||5
2273581|NCT02247739|5580730|P2|STARTED|Overall Study||6
2273582|NCT02247739|5580731|P1|STARTED|Overall Study||5
2273583|NCT02247531|5580750|P3|NOT COMPLETED|Overall Study||110
2273584|NCT02247531|5580751|P2|NOT COMPLETED|Overall Study||125
2273585|NCT02247531|5580752|P1|NOT COMPLETED|Overall Study||106
2273586|NCT02247531|5580750|P3|COMPLETED|Overall Study||214
2273587|NCT02247531|5580751|P2|COMPLETED|Overall Study||205
2273588|NCT02247531|5580752|P1|COMPLETED|Overall Study||215
2273589|NCT02247531|5580750|P3|STARTED|Overall Study||324
2273590|NCT02247531|5580751|P2|STARTED|Overall Study||330
2273591|NCT02247531|5580752|P1|STARTED|Overall Study||321
2273592|NCT02247479|5580802|P3|NOT COMPLETED|Overall Study||138
2273593|NCT02247479|5580803|P2|NOT COMPLETED|Overall Study||138
2273594|NCT02247479|5580804|P1|NOT COMPLETED|Overall Study||142
2273595|NCT02247479|5580802|P3|COMPLETED|Overall Study||165
2273596|NCT02247479|5580803|P2|COMPLETED|Overall Study||160
2273597|NCT02247479|5580804|P1|COMPLETED|Overall Study||163
2273598|NCT02247479|5580802|P3|STARTED|Overall Study||303
2273599|NCT02247479|5580803|P2|STARTED|Overall Study||298
2273600|NCT02247479|5580804|P1|STARTED|Overall Study||305
2273601|NCT02247466|5580853|P2|NOT COMPLETED|Overall Study||3
2273602|NCT02247466|5580854|P1|NOT COMPLETED|Overall Study||0
2273603|NCT02247466|5580853|P2|COMPLETED|Overall Study||15
2273604|NCT02247466|5580854|P1|COMPLETED|Overall Study||19
2273605|NCT02247466|5580853|P2|STARTED|Overall Study||18
2273606|NCT02247466|5580854|P1|STARTED|Overall Study||19
2273607|NCT02247440|5580872|P1|NOT COMPLETED|Overall Study||4
2273608|NCT02247440|5580872|P1|COMPLETED|Overall Study||14
2273609|NCT02247440|5580872|P1|STARTED|Overall Study||18
2273610|NCT02247401|5580885|P3|NOT COMPLETED|Overall Study||2
2273611|NCT02247401|5580886|P2|NOT COMPLETED|Overall Study||2
2273612|NCT02247401|5580887|P1|NOT COMPLETED|Overall Study||6
2273613|NCT02247401|5580885|P3|COMPLETED|Overall Study||27
2273614|NCT02247401|5580886|P2|COMPLETED|Overall Study||29
2273615|NCT02247401|5580887|P1|COMPLETED|Overall Study||94
2273616|NCT02247401|5580885|P3|STARTED|Overall Study||29
2273617|NCT02247401|5580886|P2|STARTED|Overall Study||31
2273618|NCT02247401|5580887|P1|STARTED|Overall Study||100
2273619|NCT02247245|5580908|P4|NOT COMPLETED|Overall Study||0
2273620|NCT02247245|5580909|P3|NOT COMPLETED|Overall Study||0
2273621|NCT02247245|5580910|P2|NOT COMPLETED|Overall Study||0
2273622|NCT02247245|5580911|P1|NOT COMPLETED|Overall Study||0
2273623|NCT02247245|5580908|P4|COMPLETED|Overall Study||7
2273624|NCT02247245|5580909|P3|COMPLETED|Overall Study||7
2273625|NCT02247245|5580910|P2|COMPLETED|Overall Study||13
2273626|NCT02247245|5580911|P1|COMPLETED|Overall Study||13
2273627|NCT02247245|5580908|P4|STARTED|Overall Study||7
2273628|NCT02247245|5580909|P3|STARTED|Overall Study||7
2273629|NCT02247245|5580910|P2|STARTED|Overall Study||13
2273630|NCT02247245|5580911|P1|STARTED|Overall Study||13
2273631|NCT02247063|5580923|P2|NOT COMPLETED|Overall Study||0
2273632|NCT02247063|5580924|P1|NOT COMPLETED|Overall Study||0
2273633|NCT02247063|5580923|P2|COMPLETED|Overall Study||12
2273634|NCT02247063|5580924|P1|COMPLETED|Overall Study||12
2273635|NCT02247063|5580923|P2|STARTED|Overall Study||12
2273636|NCT02247063|5580924|P1|STARTED|Overall Study||12
2273637|NCT02247011|5580934|P1|NOT COMPLETED|Overall Study||125
2273638|NCT02247011|5580934|P1|COMPLETED|Overall Study||975
2273639|NCT02247011|5580934|P1|STARTED|Overall Study||1100
2273640|NCT02246998|5580955|P4|NOT COMPLETED|Overall Study||2
2273641|NCT02246998|5580956|P3|NOT COMPLETED|Overall Study||3
2273642|NCT02246998|5580957|P2|NOT COMPLETED|Overall Study||3
2273643|NCT02246998|5580958|P1|NOT COMPLETED|Overall Study||2
2273644|NCT02246998|5580955|P4|COMPLETED|Overall Study||16
2273645|NCT02246998|5580956|P3|COMPLETED|Overall Study||15
2273646|NCT02246998|5580957|P2|COMPLETED|Overall Study||15
2273647|NCT02246998|5580958|P1|COMPLETED|Overall Study||16
2273648|NCT02246998|5580955|P4|STARTED|Overall Study||18
2273649|NCT02246998|5580956|P3|STARTED|Overall Study||18
2273650|NCT02246998|5580957|P2|STARTED|Overall Study||18
2273651|NCT02246998|5580958|P1|STARTED|Overall Study||18
2273652|NCT02246777|5581068|P1|NOT COMPLETED|Overall Study||3
2273653|NCT02246777|5581068|P1|COMPLETED|Overall Study||29
2273654|NCT02246777|5581068|P1|STARTED|Overall Study||32
2273655|NCT02246764|5581084|P3|NOT COMPLETED|Overall Study||4
2273656|NCT02246764|5581085|P2|NOT COMPLETED|Overall Study||32
2273657|NCT02246764|5581086|P1|NOT COMPLETED|Overall Study||18
2273658|NCT02246764|5581084|P3|COMPLETED|Overall Study||19
2273659|NCT02246764|5581085|P2|COMPLETED|Overall Study||4
2273660|NCT02246764|5581086|P1|COMPLETED|Overall Study||16
2273661|NCT02246764|5581084|P3|STARTED|Overall Study||23
2273662|NCT02246764|5581085|P2|STARTED|Overall Study||36
2273663|NCT02246764|5581086|P1|STARTED|Overall Study||34
2273664|NCT02246673|5581099|P5|NOT COMPLETED|Overall Study||1
2273665|NCT02246673|5581100|P4|NOT COMPLETED|Overall Study||2
2273666|NCT02246673|5581101|P3|NOT COMPLETED|Overall Study||0
2273667|NCT02246673|5581102|P2|NOT COMPLETED|Overall Study||0
2273668|NCT02246673|5581103|P1|NOT COMPLETED|Overall Study||1
2273669|NCT02246673|5581099|P5|COMPLETED|Overall Study||11
2273670|NCT02246673|5581100|P4|COMPLETED|Overall Study||12
2273671|NCT02246673|5581101|P3|COMPLETED|Overall Study||12
2273672|NCT02246673|5581102|P2|COMPLETED|Overall Study||12
2273673|NCT02246673|5581103|P1|COMPLETED|Overall Study||13
2273674|NCT02246673|5581099|P5|STARTED|Overall Study||12
2273675|NCT02246673|5581100|P4|STARTED|Overall Study||14
2273676|NCT02246673|5581101|P3|STARTED|Overall Study||12
2273677|NCT02246673|5581102|P2|STARTED|Overall Study||12
2273678|NCT02246673|5581103|P1|STARTED|Overall Study||14
2273679|NCT02246660|5581211|P3|NOT COMPLETED|Overall Study||1
2273680|NCT02246660|5581212|P2|NOT COMPLETED|Overall Study||1
2273681|NCT02246660|5581213|P1|NOT COMPLETED|Overall Study||0
2273682|NCT02246660|5581211|P3|COMPLETED|Overall Study||21
2273683|NCT02246660|5581212|P2|COMPLETED|Overall Study||20
2273684|NCT02246660|5581213|P1|COMPLETED|Overall Study||23
2273685|NCT02246660|5581211|P3|STARTED|Overall Study||22
2273686|NCT02246660|5581212|P2|STARTED|Overall Study||21
2273687|NCT02246660|5581213|P1|STARTED|Overall Study||23
2273688|NCT02246647|5581223|P2|NOT COMPLETED|Overall Study||1
2273689|NCT02246647|5581224|P1|NOT COMPLETED|Overall Study||1
2273690|NCT02246647|5581223|P2|COMPLETED|Overall Study||19
2273691|NCT02246647|5581224|P1|COMPLETED|Overall Study||18
2273692|NCT02246647|5581223|P2|STARTED|Overall Study||20
2273693|NCT02246647|5581224|P1|STARTED|Overall Study||19
2273694|NCT02246621|5581258|P2|NOT COMPLETED|Overall Study||148
2273695|NCT02246621|5581259|P1|NOT COMPLETED|Overall Study||296
2273696|NCT02246621|5581258|P2|COMPLETED|Overall Study||17
2273697|NCT02246621|5581259|P1|COMPLETED|Overall Study||32
2273698|NCT02246621|5581258|P2|Received At Least One Dose of Study Drug|Overall Study||162
2273699|NCT02246621|5581259|P1|Received At Least One Dose of Study Drug|Overall Study||326
2273700|NCT02246621|5581258|P2|STARTED|Overall Study||165
2273701|NCT02246621|5581259|P1|STARTED|Overall Study||328
2273702|NCT02246608|5581287|P2|NOT COMPLETED|Overall Study||10
2273703|NCT02246608|5581288|P1|NOT COMPLETED|Overall Study||12
2273704|NCT02246608|5581287|P2|COMPLETED|Overall Study||11
2273705|NCT02246608|5581288|P1|COMPLETED|Overall Study||10
2273706|NCT02246608|5581287|P2|STARTED|Overall Study||21
2273707|NCT02246608|5581288|P1|STARTED|Overall Study||22
2273708|NCT02246582|5581296|P2|NOT COMPLETED|Overall Study||4
2273709|NCT02246582|5581297|P1|NOT COMPLETED|Overall Study||3
2273710|NCT02246582|5581296|P2|COMPLETED|Overall Study||41
2273711|NCT02246582|5581297|P1|COMPLETED|Overall Study||41
2273712|NCT02246582|5581296|P2|STARTED|Overall Study||45
2273713|NCT02246582|5581297|P1|STARTED|Overall Study||44
2273714|NCT02246439|5581305|P2|NOT COMPLETED|Overall Study||11
2273715|NCT02246439|5581306|P1|NOT COMPLETED|Overall Study||12
2273716|NCT02246439|5581305|P2|COMPLETED|Overall Study||118
2273717|NCT02246439|5581306|P1|COMPLETED|Overall Study||180
2273718|NCT02246439|5581305|P2|Randomized|Overall Study||132
2273719|NCT02246439|5581306|P1|Randomized|Overall Study||198
2273720|NCT02246439|5581305|P2|STARTED|Overall Study|3 participants that enrolled in the study did not receive allocated intervention.|129
2273721|NCT02246439|5581306|P1|STARTED|Overall Study|6 participants that enrolled in the study did not receive allocated intervention.|192
2273722|NCT02246309|5581344|P2|NOT COMPLETED|Overall Study||0
2273723|NCT02246309|5581345|P1|NOT COMPLETED|Overall Study||0
2273724|NCT02246309|5581344|P2|COMPLETED|Overall Study||15
2273725|NCT02246309|5581345|P1|COMPLETED|Overall Study||16
2273726|NCT02246309|5581344|P2|STARTED|Overall Study||15
2273727|NCT02246309|5581345|P1|STARTED|Overall Study|16 patients going through Time Lapse System and 15 through Standard Embryo Culture.|16
2273728|NCT02246218|5581357|P2|NOT COMPLETED|Overall Study||6
2273729|NCT02246218|5581358|P1|NOT COMPLETED|Overall Study||4
2273730|NCT02246218|5581357|P2|COMPLETED|Overall Study||10
2273731|NCT02246218|5581358|P1|COMPLETED|Overall Study||6
2273732|NCT02246218|5581357|P2|STARTED|Overall Study||16
2273733|NCT02246218|5581358|P1|STARTED|Overall Study||10
2273734|NCT02246166|5581418|P2|NOT COMPLETED|Overall Study||0
2273735|NCT02246166|5581419|P1|NOT COMPLETED|Overall Study||1
2273736|NCT02246166|5581418|P2|COMPLETED|Overall Study||27
2273737|NCT02246166|5581419|P1|COMPLETED|Overall Study||25
2273738|NCT02246166|5581418|P2|STARTED|Overall Study||27
2273739|NCT02246166|5581419|P1|STARTED|Overall Study||26
2273740|NCT02246114|5581455|P2|NOT COMPLETED|Overall Study||0
2273741|NCT02246114|5581456|P1|NOT COMPLETED|Overall Study||1
2273742|NCT02246114|5581455|P2|COMPLETED|Overall Study||0
2273743|NCT02246114|5581456|P1|COMPLETED|Overall Study||0
2273744|NCT02246114|5581455|P2|STARTED|Overall Study||0
2273745|NCT02246114|5581456|P1|STARTED|Overall Study||1
2273746|NCT02246062|5581466|P4|NOT COMPLETED|Overall Study||0
2273747|NCT02246062|5581467|P3|NOT COMPLETED|Overall Study||0
2273748|NCT02246062|5581468|P2|NOT COMPLETED|Overall Study||0
2273749|NCT02246062|5581469|P1|NOT COMPLETED|Overall Study||0
2273750|NCT02246062|5581466|P4|COMPLETED|Overall Study||21
2273751|NCT02246062|5581467|P3|COMPLETED|Overall Study||21
2273752|NCT02246062|5581468|P2|COMPLETED|Overall Study||21
2273753|NCT02246062|5581469|P1|COMPLETED|Overall Study||21
2273754|NCT02246062|5581466|P4|STARTED|Overall Study||21
2273755|NCT02246062|5581467|P3|STARTED|Overall Study||21
2273756|NCT02246062|5581468|P2|STARTED|Overall Study||21
2273757|NCT02246062|5581469|P1|STARTED|Overall Study||21
2273758|NCT02246010|5581489|P2|NOT COMPLETED|Overall Study||0
2273759|NCT02246010|5581490|P1|NOT COMPLETED|Overall Study||0
2273760|NCT02246010|5581489|P2|COMPLETED|Overall Study||2
2273761|NCT02246010|5581490|P1|COMPLETED|Overall Study||4
2273762|NCT02246010|5581489|P2|STARTED|Overall Study||2
2273763|NCT02246010|5581490|P1|STARTED|Overall Study||4
2273764|NCT02245737|5581507|P3|NOT COMPLETED|Overall Study||571
2273765|NCT02245737|5581508|P2|NOT COMPLETED|Overall Study||555
2273766|NCT02245737|5581509|P1|NOT COMPLETED|Overall Study||553
2273767|NCT02245737|5581507|P3|COMPLETED|Overall Study||168
2273768|NCT02245737|5581508|P2|COMPLETED|Overall Study||184
2273769|NCT02245737|5581509|P1|COMPLETED|Overall Study||187
2273770|NCT02245737|5581507|P3|Received at Least 1 Dose of Study Drug|Overall Study||735
2273771|NCT02245737|5581508|P2|Received at Least 1 Dose of Study Drug|Overall Study||736
2273772|NCT02245737|5581509|P1|Received at Least 1 Dose of Study Drug|Overall Study||738
2273773|NCT02245737|5581507|P3|STARTED|Overall Study||739
2273774|NCT02245737|5581508|P2|STARTED|Overall Study||739
2273775|NCT02245737|5581509|P1|STARTED|Overall Study||740
2273776|NCT02245412|5581567|P3|NOT COMPLETED|Follow-Up Period||2
2273777|NCT02245412|5581568|P2|NOT COMPLETED|Follow-Up Period||2
2273778|NCT02245412|5581569|P1|NOT COMPLETED|Follow-Up Period||5
2273779|NCT02245412|5581567|P3|COMPLETED|Follow-Up Period||0
2273780|NCT02245412|5581568|P2|COMPLETED|Follow-Up Period||2
2273781|NCT02245412|5581569|P1|COMPLETED|Follow-Up Period||8
2273782|NCT02245412|5581567|P3|STARTED|Follow-Up Period||2
2273783|NCT02245412|5581568|P2|STARTED|Follow-Up Period|One participant who discontinued Study Drug in Treatment Period continued to Follow-Up Period.|4
2273784|NCT02245412|5581569|P1|STARTED|Follow-Up Period|One participant who discontinued Study Drug in Treatment Period continued to Follow-Up Period.|13
2273785|NCT02245412|5581567|P3|NOT COMPLETED|Treatment Period||0
2273786|NCT02245412|5581568|P2|NOT COMPLETED|Treatment Period||3
2273787|NCT02245412|5581569|P1|NOT COMPLETED|Treatment Period||5
2273788|NCT02245412|5581567|P3|COMPLETED|Treatment Period||2
2273789|NCT02245412|5581568|P2|COMPLETED|Treatment Period||3
2273790|NCT02245412|5581569|P1|COMPLETED|Treatment Period||12
2273791|NCT02245412|5581567|P3|Modified Full Analysis Set (mFAS)|Treatment Period||2
2273792|NCT02245412|5581568|P2|Modified Full Analysis Set (mFAS)|Treatment Period||6
2273793|NCT02245412|5581569|P1|Modified Full Analysis Set (mFAS)|Treatment Period||16
2273794|NCT02245412|5581567|P3|Received at Least 1 Dose of Study Drug|Treatment Period||2
2273795|NCT02245412|5581568|P2|Received at Least 1 Dose of Study Drug|Treatment Period||6
2273796|NCT02245412|5581569|P1|Received at Least 1 Dose of Study Drug|Treatment Period||17
2273797|NCT02245412|5581567|P3|STARTED|Treatment Period||2
2273798|NCT02245412|5581568|P2|STARTED|Treatment Period||6
2273799|NCT02245412|5581569|P1|STARTED|Treatment Period||17
2273800|NCT02245360|5581588|P2|NOT COMPLETED|Overall Study||2
2273801|NCT02245360|5581589|P1|NOT COMPLETED|Overall Study||5
2273802|NCT02245360|5581588|P2|COMPLETED|Overall Study||52
2273803|NCT02245360|5581589|P1|COMPLETED|Overall Study||48
2273804|NCT02245360|5581588|P2|STARTED|Overall Study||54
2273805|NCT02245360|5581589|P1|STARTED|Overall Study||53
2273806|NCT02245308|5581599|P2|NOT COMPLETED|Overall Study||0
2273807|NCT02245308|5581600|P1|NOT COMPLETED|Overall Study||0
2273808|NCT02245308|5581599|P2|COMPLETED|Overall Study|Using intent-to-treat analyses, i.e., missing=smoking|64
2273809|NCT02245308|5581600|P1|COMPLETED|Overall Study|Using intent-to-treat analyses, i.e., missing=smoking|63
2273810|NCT02245308|5581599|P2|STARTED|Overall Study||64
2273811|NCT02245308|5581600|P1|STARTED|Overall Study||63
2273812|NCT02245217|5581608|P1|NOT COMPLETED|Overall Study||2
2273813|NCT02245217|5581608|P1|COMPLETED|Overall Study||7
2273814|NCT02245217|5581608|P1|STARTED|Overall Study||9
2273815|NCT02244996|5581616|P2|NOT COMPLETED|Overall Study||6
2273816|NCT02244996|5581617|P1|NOT COMPLETED|Overall Study||2
2273817|NCT02244996|5581616|P2|COMPLETED|Overall Study||19
2273818|NCT02244996|5581617|P1|COMPLETED|Overall Study||23
2273819|NCT02244996|5581616|P2|STARTED|Overall Study||25
2273820|NCT02244996|5581617|P1|STARTED|Overall Study||25
2273821|NCT02244944|5581629|P1|NOT COMPLETED|Overall Study||2
2273822|NCT02244944|5581629|P1|COMPLETED|Overall Study||0
2273823|NCT02244944|5581629|P1|STARTED|Overall Study||2
2273824|NCT02244918|5581637|P2|NOT COMPLETED|Overall Study||0
2273825|NCT02244918|5581638|P1|NOT COMPLETED|Overall Study||0
2273826|NCT02244918|5581637|P2|COMPLETED|Overall Study||93
2273827|NCT02244918|5581638|P1|COMPLETED|Overall Study||185
2273828|NCT02244918|5581637|P2|Week 12|Overall Study||83
2273829|NCT02244918|5581638|P1|Week 12|Overall Study||160
2273830|NCT02244918|5581637|P2|STARTED|Overall Study||93
2273831|NCT02244918|5581638|P1|STARTED|Overall Study||185
2273832|NCT02244840|5581654|P1|NOT COMPLETED|Overall Study||0
2273833|NCT02244840|5581654|P1|COMPLETED|Overall Study||40
2273834|NCT02244840|5581654|P1|STARTED|Overall Study||40
2273835|NCT02244619|5581660|P2|NOT COMPLETED|Overall Study||21
2273836|NCT02244619|5581661|P1|NOT COMPLETED|Overall Study||8
2273837|NCT02244619|5581660|P2|COMPLETED|Overall Study||245
2273838|NCT02244619|5581661|P1|COMPLETED|Overall Study||241
2273839|NCT02244619|5581660|P2|STARTED|Overall Study||266
2273840|NCT02244619|5581661|P1|STARTED|Overall Study||249
2273841|NCT02244580|5581679|P1|NOT COMPLETED|Overall Study||241
2273842|NCT02244580|5581679|P1|COMPLETED|Overall Study|An RT-qPCR assay was performed from breast cancer tissues of 769 out of the 1010 patients.|769
2273843|NCT02244580|5581679|P1|STARTED|Overall Study||1010
2273844|NCT02244424|5581689|P2|NOT COMPLETED|Overall Study||10
2273845|NCT02244424|5581690|P1|NOT COMPLETED|Overall Study||20
2273846|NCT02244424|5581689|P2|COMPLETED|Overall Study|Data were collected on all of the infants of teen moms (n = 26).|52
2273847|NCT02244424|5581690|P1|COMPLETED|Overall Study|Data were collected on all of the infants of the teen moms (n = 41).|82
2273848|NCT02244424|5581689|P2|Mothers|Overall Study||31
2273849|NCT02244424|5581690|P1|Mothers|Overall Study||51
2273850|NCT02244424|5581689|P2|Infants|Overall Study|Infants of participants included in the study for collection of demographic and weight data.|31
2273851|NCT02244424|5581690|P1|Infants|Overall Study|Infants of participants included in the study for collection of demographic and weight data.|51
2273852|NCT02244424|5581689|P2|STARTED|Overall Study|Teen participants received the MIHP standard care. Data were collected on infants.|62
2273853|NCT02244424|5581690|P1|STARTED|Overall Study|Teens were the participants who received the intervention. Data were collected on the infants.|102
2273854|NCT02243943|5581698|P2|NOT COMPLETED|Overall Study||0
2273855|NCT02243943|5581699|P1|NOT COMPLETED|Overall Study||0
2273856|NCT02243943|5581698|P2|COMPLETED|Overall Study||50
2273857|NCT02243943|5581699|P1|COMPLETED|Overall Study||50
2273858|NCT02243943|5581698|P2|STARTED|Overall Study||50
2273859|NCT02243943|5581699|P1|STARTED|Overall Study||50
2273860|NCT02243579|5581709|P1|NOT COMPLETED|Overall Study||20
2273861|NCT02243579|5581709|P1|COMPLETED|Overall Study||4
2273862|NCT02243579|5581709|P1|STARTED|Overall Study||24
2273863|NCT02243527|5581720|P2|NOT COMPLETED|Overall Study||0
2273864|NCT02243527|5581721|P1|NOT COMPLETED|Overall Study||0
2273865|NCT02243527|5581720|P2|COMPLETED|Overall Study||13
2273866|NCT02243527|5581721|P1|COMPLETED|Overall Study||12
2273867|NCT02243527|5581720|P2|STARTED|Overall Study||13
2273868|NCT02243527|5581721|P1|STARTED|Overall Study||12
2273869|NCT02243371|5581735|P2|NOT COMPLETED|Overall Study||32
2273870|NCT02243371|5581736|P1|NOT COMPLETED|Overall Study||37
2273871|NCT02243371|5581735|P2|COMPLETED|Overall Study||10
2273872|NCT02243371|5581736|P1|COMPLETED|Overall Study||14
2273873|NCT02243371|5581735|P2|STARTED|Overall Study||42
2273874|NCT02243371|5581736|P1|STARTED|Overall Study||51
2273875|NCT02243306|5581756|P2|NOT COMPLETED|Overall Study||3
2273876|NCT02243306|5581757|P1|NOT COMPLETED|Overall Study||0
2273877|NCT02243306|5581756|P2|COMPLETED|Overall Study||4
2273878|NCT02243306|5581757|P1|COMPLETED|Overall Study||1
2273879|NCT02243306|5581756|P2|STARTED|Overall Study||7
2273880|NCT02243306|5581757|P1|STARTED|Overall Study||1
2273881|NCT02243293|5581832|P22|NOT COMPLETED|Overall Study||3
2273882|NCT02243293|5581833|P21|NOT COMPLETED|Overall Study||2
2273883|NCT02243293|5581834|P20|NOT COMPLETED|Overall Study||1
2273884|NCT02243293|5581835|P19|NOT COMPLETED|Overall Study||0
2273885|NCT02243293|5581836|P18|NOT COMPLETED|Overall Study||1
2273886|NCT02243293|5581837|P17|NOT COMPLETED|Overall Study||3
2273887|NCT02243293|5581838|P16|NOT COMPLETED|Overall Study||1
2273888|NCT02243293|5581839|P15|NOT COMPLETED|Overall Study||1
2273889|NCT02243293|5581840|P14|NOT COMPLETED|Overall Study||0
2273890|NCT02243293|5581841|P13|NOT COMPLETED|Overall Study||0
2273891|NCT02243293|5581842|P12|NOT COMPLETED|Overall Study||3
2273892|NCT02243293|5581843|P11|NOT COMPLETED|Overall Study||0
2273893|NCT02243293|5581844|P10|NOT COMPLETED|Overall Study||2
2273894|NCT02243293|5581845|P9|NOT COMPLETED|Overall Study||0
2273895|NCT02243293|5581846|P8|NOT COMPLETED|Overall Study||0
2273896|NCT02243293|5581847|P7|NOT COMPLETED|Overall Study||3
2273897|NCT02243293|5581848|P6|NOT COMPLETED|Overall Study||0
2273898|NCT02243293|5581849|P5|NOT COMPLETED|Overall Study||1
2273899|NCT02243293|5581850|P4|NOT COMPLETED|Overall Study||1
2273900|NCT02243293|5581851|P3|NOT COMPLETED|Overall Study||1
2273901|NCT02243293|5581852|P2|NOT COMPLETED|Overall Study||1
2273902|NCT02243293|5581853|P1|NOT COMPLETED|Overall Study||2
2273903|NCT02243293|5581832|P22|COMPLETED|Overall Study||55
2273904|NCT02243293|5581833|P21|COMPLETED|Overall Study||143
2273905|NCT02243293|5581834|P20|COMPLETED|Overall Study||47
2273906|NCT02243293|5581835|P19|COMPLETED|Overall Study||22
2273907|NCT02243293|5581836|P18|COMPLETED|Overall Study||21
2273908|NCT02243293|5581837|P17|COMPLETED|Overall Study||37
2273909|NCT02243293|5581838|P16|COMPLETED|Overall Study||26
2273910|NCT02243293|5581839|P15|COMPLETED|Overall Study||27
2273911|NCT02243293|5581840|P14|COMPLETED|Overall Study||0
2273912|NCT02243293|5581841|P13|COMPLETED|Overall Study||0
2273913|NCT02243293|5581842|P12|COMPLETED|Overall Study||50
2273914|NCT02243293|5581843|P11|COMPLETED|Overall Study||0
2273915|NCT02243293|5581844|P10|COMPLETED|Overall Study||53
2273916|NCT02243293|5581845|P9|COMPLETED|Overall Study||0
2273917|NCT02243293|5581846|P8|COMPLETED|Overall Study||0
2273918|NCT02243293|5581847|P7|COMPLETED|Overall Study||27
2273919|NCT02243293|5581848|P6|COMPLETED|Overall Study||31
2273920|NCT02243293|5581849|P5|COMPLETED|Overall Study||30
2273921|NCT02243293|5581850|P4|COMPLETED|Overall Study||29
2273922|NCT02243293|5581851|P3|COMPLETED|Overall Study||24
2273923|NCT02243293|5581852|P2|COMPLETED|Overall Study||23
2273924|NCT02243293|5581853|P1|COMPLETED|Overall Study||23
2273925|NCT02243293|5581832|P22|STARTED|Overall Study||58
2273926|NCT02243293|5581833|P21|STARTED|Overall Study||145
2273927|NCT02243293|5581834|P20|STARTED|Overall Study||48
2273928|NCT02243293|5581835|P19|STARTED|Overall Study||22
2273929|NCT02243293|5581836|P18|STARTED|Overall Study||22
2273930|NCT02243293|5581837|P17|STARTED|Overall Study||40
2273931|NCT02243293|5581838|P16|STARTED|Overall Study||27
2273932|NCT02243293|5581839|P15|STARTED|Overall Study||28
2273933|NCT02243293|5581840|P14|STARTED|Overall Study||0
2273934|NCT02243293|5581841|P13|STARTED|Overall Study||0
2273935|NCT02243293|5581842|P12|STARTED|Overall Study||53
2273936|NCT02243293|5581843|P11|STARTED|Overall Study||0
2273937|NCT02243293|5581844|P10|STARTED|Overall Study||55
2273938|NCT02243293|5581845|P9|STARTED|Overall Study||0
2273939|NCT02243293|5581846|P8|STARTED|Overall Study||0
2273940|NCT02243293|5581847|P7|STARTED|Overall Study||30
2273941|NCT02243293|5581848|P6|STARTED|Overall Study||31
2273942|NCT02243293|5581849|P5|STARTED|Overall Study||31
2273943|NCT02243293|5581850|P4|STARTED|Overall Study||30
2273944|NCT02243293|5581851|P3|STARTED|Overall Study||25
2273945|NCT02243293|5581852|P2|STARTED|Overall Study||24
2273946|NCT02243293|5581853|P1|STARTED|Overall Study||25
2273947|NCT02243280|5581952|P11|NOT COMPLETED|Treated||3
2273948|NCT02243280|5581953|P10|NOT COMPLETED|Treated||0
2273949|NCT02243280|5581954|P9|NOT COMPLETED|Treated||1
2273950|NCT02243280|5581955|P8|NOT COMPLETED|Treated||0
2273951|NCT02243280|5581956|P7|NOT COMPLETED|Treated||0
2273952|NCT02243280|5581957|P6|NOT COMPLETED|Treated||0
2273953|NCT02243280|5581958|P5|NOT COMPLETED|Treated||0
2273954|NCT02243280|5581959|P4|NOT COMPLETED|Treated||0
2273955|NCT02243280|5581960|P3|NOT COMPLETED|Treated||0
2273956|NCT02243280|5581961|P2|NOT COMPLETED|Treated||0
2273957|NCT02243280|5581962|P1|NOT COMPLETED|Treated||1
2273958|NCT02243280|5581952|P11|COMPLETED|Treated||31
2273959|NCT02243280|5581953|P10|COMPLETED|Treated||0
2273960|NCT02243280|5581954|P9|COMPLETED|Treated||31
2273961|NCT02243280|5581955|P8|COMPLETED|Treated||0
2273962|NCT02243280|5581956|P7|COMPLETED|Treated||0
2273963|NCT02243280|5581957|P6|COMPLETED|Treated||27
2273964|NCT02243280|5581958|P5|COMPLETED|Treated||0
2273965|NCT02243280|5581959|P4|COMPLETED|Treated||0
2273966|NCT02243280|5581960|P3|COMPLETED|Treated||0
2273967|NCT02243280|5581961|P2|COMPLETED|Treated||39
2273968|NCT02243280|5581962|P1|COMPLETED|Treated||41
2273969|NCT02243280|5581952|P11|Completed Treatment|Treated||33
2273970|NCT02243280|5581953|P10|Completed Treatment|Treated||0
2273971|NCT02243280|5581954|P9|Completed Treatment|Treated||32
2273972|NCT02243280|5581955|P8|Completed Treatment|Treated||0
2273973|NCT02243280|5581956|P7|Completed Treatment|Treated||0
2273974|NCT02243280|5581957|P6|Completed Treatment|Treated||27
2273975|NCT02243280|5581958|P5|Completed Treatment|Treated||0
2273976|NCT02243280|5581959|P4|Completed Treatment|Treated||0
2273977|NCT02243280|5581960|P3|Completed Treatment|Treated||0
2273978|NCT02243280|5581961|P2|Completed Treatment|Treated||38
2273979|NCT02243280|5581962|P1|Completed Treatment|Treated||42
2273980|NCT02243280|5581952|P11|STARTED|Treated||34
2273981|NCT02243280|5581953|P10|STARTED|Treated||0
2273982|NCT02243280|5581954|P9|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|32
2273983|NCT02243280|5581955|P8|STARTED|Treated||0
2273984|NCT02243280|5581956|P7|STARTED|Treated||0
2273985|NCT02243280|5581957|P6|STARTED|Treated||27
2273986|NCT02243280|5581958|P5|STARTED|Treated||0
2273987|NCT02243280|5581959|P4|STARTED|Treated||0
2273988|NCT02243280|5581960|P3|STARTED|Treated||0
2273989|NCT02243280|5581961|P2|STARTED|Treated||39
2273990|NCT02243280|5581962|P1|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|42
2273991|NCT02243280|5581952|P11|NOT COMPLETED|Enrolled||0
2273992|NCT02243280|5581953|P10|NOT COMPLETED|Enrolled||0
2273993|NCT02243280|5581954|P9|NOT COMPLETED|Enrolled||0
2273994|NCT02243280|5581955|P8|NOT COMPLETED|Enrolled||0
2273995|NCT02243280|5581956|P7|NOT COMPLETED|Enrolled||0
2273996|NCT02243280|5581957|P6|NOT COMPLETED|Enrolled||0
2273997|NCT02243280|5581958|P5|NOT COMPLETED|Enrolled||0
2273998|NCT02243280|5581959|P4|NOT COMPLETED|Enrolled||0
2273999|NCT02243280|5581960|P3|NOT COMPLETED|Enrolled||0
2274000|NCT02243280|5581961|P2|NOT COMPLETED|Enrolled||0
2274001|NCT02243280|5581962|P1|NOT COMPLETED|Enrolled||0
2274002|NCT02243280|5581952|P11|COMPLETED|Enrolled||34
2274003|NCT02243280|5581953|P10|COMPLETED|Enrolled||0
2274004|NCT02243280|5581954|P9|COMPLETED|Enrolled||34
2274005|NCT02243280|5581955|P8|COMPLETED|Enrolled||0
2274006|NCT02243280|5581956|P7|COMPLETED|Enrolled||0
2274007|NCT02243280|5581957|P6|COMPLETED|Enrolled||27
2274008|NCT02243280|5581958|P5|COMPLETED|Enrolled||0
2274009|NCT02243280|5581959|P4|COMPLETED|Enrolled||0
2274010|NCT02243280|5581960|P3|COMPLETED|Enrolled||0
2274011|NCT02243280|5581961|P2|COMPLETED|Enrolled||39
2274012|NCT02243280|5581962|P1|COMPLETED|Enrolled||40
2274013|NCT02243280|5581952|P11|STARTED|Enrolled||34
2274014|NCT02243280|5581953|P10|STARTED|Enrolled||0
2274015|NCT02243280|5581954|P9|STARTED|Enrolled||34
2274016|NCT02243280|5581955|P8|STARTED|Enrolled||0
2274017|NCT02243280|5581956|P7|STARTED|Enrolled||0
2274018|NCT02243280|5581957|P6|STARTED|Enrolled||27
2274019|NCT02243280|5581958|P5|STARTED|Enrolled||0
2274020|NCT02243280|5581959|P4|STARTED|Enrolled||0
2274021|NCT02243280|5581960|P3|STARTED|Enrolled||0
2274022|NCT02243280|5581961|P2|STARTED|Enrolled||39
2274023|NCT02243280|5581962|P1|STARTED|Enrolled||40
2274024|NCT02243202|5582017|P4|NOT COMPLETED|Overall Study||23
2274025|NCT02243202|5582018|P3|NOT COMPLETED|Overall Study||31
2274026|NCT02243202|5582019|P2|NOT COMPLETED|Overall Study||25
2274027|NCT02243202|5582020|P1|NOT COMPLETED|Overall Study||25
2274028|NCT02243202|5582017|P4|COMPLETED|Overall Study||61
2274029|NCT02243202|5582018|P3|COMPLETED|Overall Study||53
2274030|NCT02243202|5582019|P2|COMPLETED|Overall Study||60
2274031|NCT02243202|5582020|P1|COMPLETED|Overall Study||57
2274032|NCT02243202|5582017|P4|Treated|Overall Study||83
2274033|NCT02243202|5582018|P3|Treated|Overall Study||84
2274034|NCT02243202|5582019|P2|Treated|Overall Study||85
2274035|NCT02243202|5582020|P1|Treated|Overall Study||82
2274036|NCT02243202|5582017|P4|STARTED|Overall Study||84
2274037|NCT02243202|5582018|P3|STARTED|Overall Study||84
2274038|NCT02243202|5582019|P2|STARTED|Overall Study||85
2274039|NCT02243202|5582020|P1|STARTED|Overall Study||82
2274040|NCT02243176|5582056|P2|NOT COMPLETED|Overall Study||15
2274041|NCT02243176|5582057|P1|NOT COMPLETED|Overall Study||14
2274042|NCT02243176|5582056|P2|COMPLETED|Overall Study||229
2274043|NCT02243176|5582057|P1|COMPLETED|Overall Study||230
2274044|NCT02243176|5582056|P2|STARTED|Overall Study||244
2274045|NCT02243176|5582057|P1|STARTED|Overall Study|3 of the randomized subjects withdrew before taking any medication|244
2274046|NCT02243046|5582082|P3|NOT COMPLETED|Overall Study||4
2274047|NCT02243046|5582083|P2|NOT COMPLETED|Overall Study||1
2274048|NCT02243046|5582084|P1|NOT COMPLETED|Overall Study||1
2274049|NCT02243046|5582082|P3|COMPLETED|Overall Study||49
2274050|NCT02243046|5582083|P2|COMPLETED|Overall Study||53
2274051|NCT02243046|5582084|P1|COMPLETED|Overall Study||54
2274052|NCT02243046|5582082|P3|6 Month|Overall Study|2 subjects didn't return for 6 month clinic visit|49
2274053|NCT02243046|5582083|P2|6 Month|Overall Study||53
2274054|NCT02243046|5582084|P1|6 Month|Overall Study||54
2274055|NCT02243046|5582082|P3|3 Month|Overall Study|2 subjects didn't return for 3 month clinic visit|51
2274056|NCT02243046|5582083|P2|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|53
2274057|NCT02243046|5582084|P1|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|54
2274058|NCT02243046|5582082|P3|STARTED|Overall Study||53
2274059|NCT02243046|5582083|P2|STARTED|Overall Study||54
2274060|NCT02243046|5582084|P1|STARTED|Overall Study||55
2274061|NCT02243020|5582109|P2|NOT COMPLETED|Overall Study||0
2274062|NCT02243020|5582110|P1|NOT COMPLETED|Overall Study||0
2274063|NCT02243020|5582109|P2|COMPLETED|Overall Study||9
2274064|NCT02243020|5582110|P1|COMPLETED|Overall Study||8
2274065|NCT02243020|5582109|P2|STARTED|Overall Study||9
2274066|NCT02243020|5582110|P1|STARTED|Overall Study||8
2274067|NCT02243007|5582120|P2|NOT COMPLETED|Overall Study||0
2274068|NCT02243007|5582121|P1|NOT COMPLETED|Overall Study||0
2274069|NCT02243007|5582120|P2|COMPLETED|Overall Study||3
2274070|NCT02243007|5582121|P1|COMPLETED|Overall Study||4
2274071|NCT02243007|5582120|P2|STARTED|Overall Study||3
2274072|NCT02243007|5582121|P1|STARTED|Overall Study||4
2274073|NCT02242994|5582143|P1|NOT COMPLETED|Overall Study||0
2274074|NCT02242994|5582143|P1|COMPLETED|Overall Study||5
2274075|NCT02242994|5582143|P1|STARTED|Overall Study||5
2274076|NCT02242942|5582151|P3|NOT COMPLETED|Overall Study||13
2274077|NCT02242942|5582152|P2|NOT COMPLETED|Overall Study||216
2274078|NCT02242942|5582153|P1|NOT COMPLETED|Overall Study||216
2274079|NCT02242942|5582151|P3|COMPLETED|Overall Study||0
2274080|NCT02242942|5582152|P2|COMPLETED|Overall Study||0
2274081|NCT02242942|5582153|P1|COMPLETED|Overall Study||0
2274082|NCT02242942|5582151|P3|Treated|Overall Study||13
2274083|NCT02242942|5582152|P2|Treated|Overall Study||212
2274084|NCT02242942|5582153|P1|Treated|Overall Study||214
2274085|NCT02242942|5582151|P3|STARTED|Overall Study||13
2274086|NCT02242942|5582152|P2|STARTED|Overall Study||216
2274087|NCT02242942|5582153|P1|STARTED|Overall Study||216
2274088|NCT02242903|5582187|P7|NOT COMPLETED|Overall Study||0
2274089|NCT02242903|5582188|P6|NOT COMPLETED|Overall Study||0
2274090|NCT02242903|5582189|P5|NOT COMPLETED|Overall Study||0
2274091|NCT02242903|5582190|P4|NOT COMPLETED|Overall Study||0
2274092|NCT02242903|5582191|P3|NOT COMPLETED|Overall Study||0
2274093|NCT02242903|5582192|P2|NOT COMPLETED|Overall Study||0
2274094|NCT02242903|5582193|P1|NOT COMPLETED|Overall Study||1
2274095|NCT02242903|5582187|P7|COMPLETED|Overall Study||6
2274096|NCT02242903|5582188|P6|COMPLETED|Overall Study||6
2274097|NCT02242903|5582189|P5|COMPLETED|Overall Study||6
2274098|NCT02242903|5582190|P4|COMPLETED|Overall Study||6
2274099|NCT02242903|5582191|P3|COMPLETED|Overall Study||6
2274100|NCT02242903|5582192|P2|COMPLETED|Overall Study||6
2274101|NCT02242903|5582193|P1|COMPLETED|Overall Study||11
2274102|NCT02242903|5582187|P7|Received at Least One Dose of Study Drug|Overall Study||6
2274103|NCT02242903|5582188|P6|Received at Least One Dose of Study Drug|Overall Study||6
2274104|NCT02242903|5582189|P5|Received at Least One Dose of Study Drug|Overall Study||6
2274105|NCT02242903|5582190|P4|Received at Least One Dose of Study Drug|Overall Study||6
2274106|NCT02242903|5582191|P3|Received at Least One Dose of Study Drug|Overall Study||6
2274107|NCT02242903|5582192|P2|Received at Least One Dose of Study Drug|Overall Study||6
2274108|NCT02242903|5582193|P1|Received at Least One Dose of Study Drug|Overall Study||12
2274109|NCT02242903|5582187|P7|STARTED|Overall Study||6
2274110|NCT02242903|5582188|P6|STARTED|Overall Study||6
2274111|NCT02242903|5582189|P5|STARTED|Overall Study||6
2274112|NCT02242903|5582190|P4|STARTED|Overall Study||6
2274113|NCT02242903|5582191|P3|STARTED|Overall Study||6
2274114|NCT02242903|5582192|P2|STARTED|Overall Study||6
2274115|NCT02242903|5582193|P1|STARTED|Overall Study||12
2274116|NCT02242643|5582223|P2|NOT COMPLETED|Overall Study||78
2274117|NCT02242643|5582224|P1|NOT COMPLETED|Overall Study||75
2274118|NCT02242643|5582223|P2|COMPLETED|Overall Study||1139
2274119|NCT02242643|5582224|P1|COMPLETED|Overall Study||1132
2274120|NCT02242643|5582223|P2|STARTED|Overall Study||1217
2274121|NCT02242643|5582224|P1|STARTED|Overall Study||1207
2274122|NCT02242630|5582260|P4|NOT COMPLETED|Overall Study||0
2274123|NCT02242630|5582261|P3|NOT COMPLETED|Overall Study||0
2274124|NCT02242630|5582262|P2|NOT COMPLETED|Overall Study||0
2274125|NCT02242630|5582263|P1|NOT COMPLETED|Overall Study||0
2274126|NCT02242630|5582260|P4|COMPLETED|Overall Study||16
2274127|NCT02242630|5582261|P3|COMPLETED|Overall Study||15
2274128|NCT02242630|5582262|P2|COMPLETED|Overall Study||15
2274129|NCT02242630|5582263|P1|COMPLETED|Overall Study||15
2274130|NCT02242630|5582260|P4|STARTED|Overall Study||16
2274131|NCT02242630|5582261|P3|STARTED|Overall Study||15
2274132|NCT02242630|5582262|P2|STARTED|Overall Study||15
2274133|NCT02242630|5582263|P1|STARTED|Overall Study||15
2274134|NCT02242487|5582279|P2|NOT COMPLETED|Overall Study||47
2274135|NCT02242487|5582280|P1|NOT COMPLETED|Overall Study||62
2274136|NCT02242487|5582279|P2|COMPLETED|Overall Study||117
2274137|NCT02242487|5582280|P1|COMPLETED|Overall Study||99
2274138|NCT02242487|5582279|P2|STARTED|Overall Study||164
2274139|NCT02242487|5582280|P1|STARTED|Overall Study||161
2274140|NCT02242305|5582296|P2|NOT COMPLETED|Overall Study||10
2274141|NCT02242305|5582297|P1|NOT COMPLETED|Overall Study||6
2274142|NCT02242305|5582296|P2|COMPLETED|Overall Study||141
2274143|NCT02242305|5582297|P1|COMPLETED|Overall Study||145
2274144|NCT02242305|5582296|P2|STARTED|Overall Study||151
2274145|NCT02242305|5582297|P1|STARTED|Overall Study||151
2274146|NCT02242201|5582318|P3|NOT COMPLETED|Overall Study||1
2274147|NCT02242201|5582319|P2|NOT COMPLETED|Overall Study||1
2274148|NCT02242201|5582320|P1|NOT COMPLETED|Overall Study||4
2274149|NCT02242201|5582318|P3|COMPLETED|Overall Study||54
2274150|NCT02242201|5582319|P2|COMPLETED|Overall Study||54
2274151|NCT02242201|5582320|P1|COMPLETED|Overall Study||51
2274152|NCT02242201|5582318|P3|STARTED|Overall Study||55
2274153|NCT02242201|5582319|P2|STARTED|Overall Study||55
2274154|NCT02242201|5582320|P1|STARTED|Overall Study||55
2274155|NCT02242019|5582352|P1|NOT COMPLETED|Overall Study||0
2274156|NCT02242019|5582352|P1|COMPLETED|Overall Study||109
2274157|NCT02242019|5582352|P1|STARTED|Overall Study||109
2274158|NCT02241889|5582358|P6|NOT COMPLETED|Overall Study||1
2274159|NCT02241889|5582359|P5|NOT COMPLETED|Overall Study||0
2274160|NCT02241889|5582360|P4|NOT COMPLETED|Overall Study||0
2274161|NCT02241889|5582361|P3|NOT COMPLETED|Overall Study||1
2274162|NCT02241889|5582362|P2|NOT COMPLETED|Overall Study||0
2274163|NCT02241889|5582363|P1|NOT COMPLETED|Overall Study||0
2274164|NCT02241889|5582358|P6|COMPLETED|Overall Study||3
2274165|NCT02241889|5582359|P5|COMPLETED|Overall Study||5
2274166|NCT02241889|5582360|P4|COMPLETED|Overall Study||3
2274167|NCT02241889|5582361|P3|COMPLETED|Overall Study||2
2274168|NCT02241889|5582362|P2|COMPLETED|Overall Study||4
2274169|NCT02241889|5582363|P1|COMPLETED|Overall Study||4
2274170|NCT02241889|5582358|P6|STARTED|Overall Study||4
2274171|NCT02241889|5582359|P5|STARTED|Overall Study||5
2274172|NCT02241889|5582360|P4|STARTED|Overall Study||3
2274173|NCT02241889|5582361|P3|STARTED|Overall Study||3
2274174|NCT02241889|5582362|P2|STARTED|Overall Study||4
2274175|NCT02241889|5582363|P1|STARTED|Overall Study||4
2274176|NCT02241785|5582398|P1|NOT COMPLETED|Overall Study||47
2274177|NCT02241785|5582398|P1|COMPLETED|Overall Study||0
2274178|NCT02241785|5582398|P1|STARTED|Overall Study||47
2274179|NCT02241733|5582408|P2|NOT COMPLETED|Overall Study||10
2274180|NCT02241733|5582409|P1|NOT COMPLETED|Overall Study||15
2274181|NCT02241733|5582408|P2|COMPLETED|Overall Study||30
2274182|NCT02241733|5582409|P1|COMPLETED|Overall Study||25
2274183|NCT02241733|5582408|P2|STARTED|Overall Study||40
2274184|NCT02241733|5582409|P1|STARTED|Overall Study||40
2274185|NCT02241720|5582421|P1|NOT COMPLETED|Overall Study||4
2274186|NCT02241720|5582421|P1|COMPLETED|Overall Study||1
2274187|NCT02241720|5582421|P1|STARTED|Overall Study||5
2274188|NCT02241655|5582427|P2|NOT COMPLETED|Overall Study||0
2274189|NCT02241655|5582428|P1|NOT COMPLETED|Overall Study||0
2274190|NCT02241655|5582427|P2|COMPLETED|Overall Study||618
2274191|NCT02241655|5582428|P1|COMPLETED|Overall Study||614
2274192|NCT02241655|5582427|P2|STARTED|Overall Study||618
2274193|NCT02241655|5582428|P1|STARTED|Overall Study||614
2274194|NCT02241551|5582448|P2|NOT COMPLETED|Overall Study||0
2274195|NCT02241551|5582449|P1|NOT COMPLETED|Overall Study||1
2274196|NCT02241551|5582448|P2|COMPLETED|Overall Study||0
2274197|NCT02241551|5582449|P1|COMPLETED|Overall Study||0
2274198|NCT02241551|5582448|P2|STARTED|Overall Study||0
2274199|NCT02241551|5582449|P1|STARTED|Overall Study||1
2274206|NCT02241486|5582484|P1|NOT COMPLETED|Overall Study||0
2274207|NCT02241486|5582484|P1|COMPLETED|Overall Study||2
2274208|NCT02241486|5582484|P1|STARTED|Overall Study||2
2274209|NCT02241187|5582488|P1|NOT COMPLETED|Overall Study||2
2274210|NCT02241187|5582488|P1|COMPLETED|Overall Study||0
2274211|NCT02241187|5582488|P1|STARTED|Overall Study||2
2274212|NCT02240810|5582495|P2|NOT COMPLETED|Overall Study||60
2274213|NCT02240810|5582496|P1|NOT COMPLETED|Overall Study||60
2274214|NCT02240810|5582495|P2|COMPLETED|Overall Study||2621
2274215|NCT02240810|5582496|P1|COMPLETED|Overall Study||1441
2274216|NCT02240810|5582495|P2|STARTED|Overall Study|correct typo|2681
2274217|NCT02240810|5582496|P1|STARTED|Overall Study||1501
2274218|NCT02240693|5582520|P5|NOT COMPLETED|Overall Study||1
2274219|NCT02240693|5582521|P4|NOT COMPLETED|Overall Study||1
2274220|NCT02240693|5582522|P3|NOT COMPLETED|Overall Study||4
2274221|NCT02240693|5582523|P2|NOT COMPLETED|Overall Study||0
2274222|NCT02240693|5582524|P1|NOT COMPLETED|Overall Study||0
2274223|NCT02240693|5582520|P5|COMPLETED|Overall Study||42
2274224|NCT02240693|5582521|P4|COMPLETED|Overall Study||20
2274225|NCT02240693|5582522|P3|COMPLETED|Overall Study||17
2274226|NCT02240693|5582523|P2|COMPLETED|Overall Study||21
2274227|NCT02240693|5582524|P1|COMPLETED|Overall Study||22
2274228|NCT02240693|5582520|P5|STARTED|Overall Study||43
2274229|NCT02240693|5582521|P4|STARTED|Overall Study||21
2274230|NCT02240693|5582522|P3|STARTED|Overall Study||21
2274231|NCT02240693|5582523|P2|STARTED|Overall Study||21
2274232|NCT02240693|5582524|P1|STARTED|Overall Study||22
2274233|NCT02240680|5582560|P4|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||7
2274234|NCT02240680|5582561|P3|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||8
2274235|NCT02240680|5582562|P2|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||0
2274236|NCT02240680|5582563|P1|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||0
2274237|NCT02240680|5582560|P4|COMPLETED|Japanese Patients (Up to 52 Weeks)||45
2274238|NCT02240680|5582561|P3|COMPLETED|Japanese Patients (Up to 52 Weeks)||42
2274239|NCT02240680|5582562|P2|COMPLETED|Japanese Patients (Up to 52 Weeks)||0
2274240|NCT02240680|5582563|P1|COMPLETED|Japanese Patients (Up to 52 Weeks)||0
2274241|NCT02240680|5582560|P4|STARTED|Japanese Patients (Up to 52 Weeks)||52
2274242|NCT02240680|5582561|P3|STARTED|Japanese Patients (Up to 52 Weeks)||50
2274243|NCT02240680|5582562|P2|STARTED|Japanese Patients (Up to 52 Weeks)||0
2274244|NCT02240680|5582563|P1|STARTED|Japanese Patients (Up to 52 Weeks)||0
2274245|NCT02240680|5582560|P4|NOT COMPLETED|Overall Study (Up to 24 Weeks)||0
2274246|NCT02240680|5582561|P3|NOT COMPLETED|Overall Study (Up to 24 Weeks)||0
2274247|NCT02240680|5582562|P2|NOT COMPLETED|Overall Study (Up to 24 Weeks)||8
2274248|NCT02240680|5582563|P1|NOT COMPLETED|Overall Study (Up to 24 Weeks)||15
2274249|NCT02240680|5582560|P4|COMPLETED|Overall Study (Up to 24 Weeks)||0
2274250|NCT02240680|5582561|P3|COMPLETED|Overall Study (Up to 24 Weeks)||0
2274251|NCT02240680|5582562|P2|COMPLETED|Overall Study (Up to 24 Weeks)||143
2274252|NCT02240680|5582563|P1|COMPLETED|Overall Study (Up to 24 Weeks)||136
2274253|NCT02240680|5582560|P4|STARTED|Overall Study (Up to 24 Weeks)||0
2274254|NCT02240680|5582561|P3|STARTED|Overall Study (Up to 24 Weeks)||0
2274255|NCT02240680|5582562|P2|STARTED|Overall Study (Up to 24 Weeks)||151
2274256|NCT02240680|5582563|P1|STARTED|Overall Study (Up to 24 Weeks)||151
2274257|NCT02240667|5582583|P2|NOT COMPLETED|Overall Study||0
2274258|NCT02240667|5582584|P1|NOT COMPLETED|Overall Study||0
2274259|NCT02240667|5582583|P2|COMPLETED|Overall Study||650
2274260|NCT02240667|5582584|P1|COMPLETED|Overall Study||771
2274261|NCT02240667|5582583|P2|STARTED|Overall Study||650
2274262|NCT02240667|5582584|P1|STARTED|Overall Study||771
2274263|NCT02240654|5582599|P5|NOT COMPLETED|Overall Study||0
2274264|NCT02240654|5582600|P4|NOT COMPLETED|Overall Study||0
2274265|NCT02240654|5582601|P3|NOT COMPLETED|Overall Study||0
2274266|NCT02240654|5582602|P2|NOT COMPLETED|Overall Study||0
2274267|NCT02240654|5582603|P1|NOT COMPLETED|Overall Study||0
2274268|NCT02240654|5582599|P5|COMPLETED|Overall Study||1285
2274269|NCT02240654|5582600|P4|COMPLETED|Overall Study||2150
2274270|NCT02240654|5582601|P3|COMPLETED|Overall Study||28619
2274271|NCT02240654|5582602|P2|COMPLETED|Overall Study||2813
2274272|NCT02240654|5582603|P1|COMPLETED|Overall Study||1706
2274273|NCT02240654|5582599|P5|STARTED|Overall Study||1285
2274274|NCT02240654|5582600|P4|STARTED|Overall Study||2150
2274275|NCT02240654|5582601|P3|STARTED|Overall Study||28619
2274276|NCT02240654|5582602|P2|STARTED|Overall Study||2813
2274277|NCT02240654|5582603|P1|STARTED|Overall Study||1706
2274278|NCT02240628|5582617|P2|NOT COMPLETED|Overall Study||5
2274279|NCT02240628|5582618|P1|NOT COMPLETED|Overall Study||6
2274280|NCT02240628|5582617|P2|COMPLETED|Overall Study||33
2274281|NCT02240628|5582618|P1|COMPLETED|Overall Study||32
2274282|NCT02240628|5582617|P2|STARTED|Overall Study||38
2274283|NCT02240628|5582618|P1|STARTED|Overall Study||38
2274284|NCT02240589|5582628|P2|NOT COMPLETED|Overall Study||2
2274285|NCT02240589|5582629|P1|NOT COMPLETED|Overall Study||2
2274286|NCT02240589|5582628|P2|COMPLETED|Overall Study||4
2274287|NCT02240589|5582629|P1|COMPLETED|Overall Study||3
2274288|NCT02240589|5582628|P2|STARTED|Overall Study||6
2274289|NCT02240589|5582629|P1|STARTED|Overall Study||5
2274290|NCT02240368|5582652|P3|NOT COMPLETED|Overall Study||1
2274291|NCT02240368|5582653|P2|NOT COMPLETED|Overall Study||0
2274292|NCT02240368|5582654|P1|NOT COMPLETED|Overall Study||1
2274293|NCT02240368|5582652|P3|COMPLETED|Overall Study||18
2274294|NCT02240368|5582653|P2|COMPLETED|Overall Study||22
2274295|NCT02240368|5582654|P1|COMPLETED|Overall Study||8
2274296|NCT02240368|5582652|P3|STARTED|Overall Study||19
2274297|NCT02240368|5582653|P2|STARTED|Overall Study||22
2274298|NCT02240368|5582654|P1|STARTED|Overall Study||9
2274299|NCT02240329|5582671|P1|NOT COMPLETED|Overall Study||0
2274300|NCT02240329|5582671|P1|COMPLETED|Overall Study||4
2274301|NCT02240329|5582671|P1|Determination of Urge to Cough|Overall Study||4
2274302|NCT02240329|5582671|P1|STARTED|Overall Study||4
2274303|NCT02240186|5582676|P1|NOT COMPLETED|Overall Study||27
2274304|NCT02240186|5582676|P1|COMPLETED|Overall Study||23
2274305|NCT02240186|5582676|P1|STARTED|Overall Study||50
2274306|NCT02240121|5582686|P2|NOT COMPLETED|Overall Study||20
2274307|NCT02240121|5582687|P1|NOT COMPLETED|Overall Study||18
2274308|NCT02240121|5582686|P2|COMPLETED|Overall Study||20
2274309|NCT02240121|5582687|P1|COMPLETED|Overall Study||22
2274310|NCT02240121|5582686|P2|STARTED|Overall Study||40
2274311|NCT02240121|5582687|P1|STARTED|Overall Study||40
2274312|NCT02240108|5582715|P2|NOT COMPLETED|Overall Study||25
2274313|NCT02240108|5582716|P1|NOT COMPLETED|Overall Study||14
2274314|NCT02240108|5582715|P2|COMPLETED|Overall Study||21
2274315|NCT02240108|5582716|P1|COMPLETED|Overall Study||21
2274316|NCT02240108|5582715|P2|Intent-to-treat (ITT) Population|Overall Study||45
2274317|NCT02240108|5582716|P1|Intent-to-treat (ITT) Population|Overall Study||35
2274318|NCT02240108|5582715|P2|STARTED|Overall Study||46
2274319|NCT02240108|5582716|P1|STARTED|Overall Study||35
2274320|NCT02240030|5582745|P3|NOT COMPLETED|Overall Study||15
2274321|NCT02240030|5582746|P2|NOT COMPLETED|Overall Study||17
2274322|NCT02240030|5582747|P1|NOT COMPLETED|Overall Study||17
2274323|NCT02240030|5582745|P3|COMPLETED|Overall Study||97
2274324|NCT02240030|5582746|P2|COMPLETED|Overall Study||97
2274325|NCT02240030|5582747|P1|COMPLETED|Overall Study||96
2274326|NCT02240030|5582745|P3|STARTED|Overall Study||112
2274327|NCT02240030|5582746|P2|STARTED|Overall Study||114
2274328|NCT02240030|5582747|P1|STARTED|Overall Study||113
2274329|NCT02239978|5582771|P2|NOT COMPLETED|Overall Study||0
2274330|NCT02239978|5582772|P1|NOT COMPLETED|Overall Study||2
2274331|NCT02239978|5582771|P2|COMPLETED|Overall Study||12
2274332|NCT02239978|5582772|P1|COMPLETED|Overall Study||28
2274333|NCT02239978|5582771|P2|STARTED|Overall Study||12
2274334|NCT02239978|5582772|P1|STARTED|Overall Study||30
2274335|NCT02239939|5582789|P2|NOT COMPLETED|Overall Study||2
2274336|NCT02239939|5582790|P1|NOT COMPLETED|Overall Study||2
2274337|NCT02239939|5582789|P2|COMPLETED|Overall Study||15
2274338|NCT02239939|5582790|P1|COMPLETED|Overall Study||18
2274339|NCT02239939|5582789|P2|STARTED|Overall Study||17
2274340|NCT02239939|5582790|P1|STARTED|Overall Study||20
2274341|NCT02239926|5582806|P2|NOT COMPLETED|Overall Study||1
2274342|NCT02239926|5582807|P1|NOT COMPLETED|Overall Study||0
2274343|NCT02239926|5582806|P2|COMPLETED|Overall Study||1
2274344|NCT02239926|5582807|P1|COMPLETED|Overall Study||0
2274345|NCT02239926|5582806|P2|STARTED|Overall Study||2
2274346|NCT02239926|5582807|P1|STARTED|Overall Study||0
2274347|NCT02239770|5582821|P6|NOT COMPLETED|Part 2||0
2274348|NCT02239770|5582822|P5|NOT COMPLETED|Part 2||0
2274349|NCT02239770|5582823|P4|NOT COMPLETED|Part 2||0
2274350|NCT02239770|5582824|P3|NOT COMPLETED|Part 2||0
2274351|NCT02239770|5582825|P2|NOT COMPLETED|Part 2||0
2274352|NCT02239770|5582826|P1|NOT COMPLETED|Part 2||0
2274353|NCT02239770|5582821|P6|COMPLETED|Part 2||4
2274354|NCT02239770|5582822|P5|COMPLETED|Part 2||4
2274355|NCT02239770|5582823|P4|COMPLETED|Part 2||4
2274356|NCT02239770|5582824|P3|COMPLETED|Part 2||0
2274357|NCT02239770|5582825|P2|COMPLETED|Part 2||0
2274358|NCT02239770|5582826|P1|COMPLETED|Part 2||0
2274359|NCT02239770|5582821|P6|STARTED|Part 2||4
2274360|NCT02239770|5582822|P5|STARTED|Part 2||4
2274361|NCT02239770|5582823|P4|STARTED|Part 2||4
2274362|NCT02239770|5582824|P3|STARTED|Part 2||0
2274363|NCT02239770|5582825|P2|STARTED|Part 2||0
2274364|NCT02239770|5582826|P1|STARTED|Part 2||0
2274365|NCT02239770|5582821|P6|NOT COMPLETED|Part 1||0
2274366|NCT02239770|5582822|P5|NOT COMPLETED|Part 1||0
2274367|NCT02239770|5582823|P4|NOT COMPLETED|Part 1||0
2274368|NCT02239770|5582824|P3|NOT COMPLETED|Part 1||0
2274369|NCT02239770|5582825|P2|NOT COMPLETED|Part 1||0
2274370|NCT02239770|5582826|P1|NOT COMPLETED|Part 1||0
2274371|NCT02239770|5582821|P6|COMPLETED|Part 1||0
2274372|NCT02239770|5582822|P5|COMPLETED|Part 1||0
2274373|NCT02239770|5582823|P4|COMPLETED|Part 1||0
2274374|NCT02239770|5582824|P3|COMPLETED|Part 1||4
2274375|NCT02239770|5582825|P2|COMPLETED|Part 1||4
2274376|NCT02239770|5582826|P1|COMPLETED|Part 1||4
2274377|NCT02239770|5582821|P6|STARTED|Part 1||0
2274378|NCT02239770|5582822|P5|STARTED|Part 1||0
2274379|NCT02239770|5582823|P4|STARTED|Part 1||0
2274380|NCT02239770|5582824|P3|STARTED|Part 1||4
2274381|NCT02239770|5582825|P2|STARTED|Part 1||4
2274382|NCT02239770|5582826|P1|STARTED|Part 1||4
2274383|NCT02239744|5582854|P2|NOT COMPLETED|Period 2||0
2274384|NCT02239744|5582855|P1|NOT COMPLETED|Period 2||0
2274385|NCT02239744|5582854|P2|COMPLETED|Period 2||18
2274386|NCT02239744|5582855|P1|COMPLETED|Period 2||17
2274387|NCT02239744|5582854|P2|STARTED|Period 2||18
2274388|NCT02239744|5582855|P1|STARTED|Period 2||17
2274389|NCT02239744|5582854|P2|NOT COMPLETED|Period 1||0
2274390|NCT02239744|5582855|P1|NOT COMPLETED|Period 1||0
2274391|NCT02239744|5582854|P2|COMPLETED|Period 1||18
2274392|NCT02239744|5582855|P1|COMPLETED|Period 1||17
2274393|NCT02239744|5582854|P2|STARTED|Period 1||18
2274394|NCT02239744|5582855|P1|STARTED|Period 1||17
2274395|NCT02239692|5582869|P2|NOT COMPLETED|Overall Study||13
2274396|NCT02239692|5582870|P1|NOT COMPLETED|Overall Study||6
2274397|NCT02239692|5582869|P2|COMPLETED|Overall Study||118
2274398|NCT02239692|5582870|P1|COMPLETED|Overall Study||67
2274399|NCT02239692|5582869|P2|Safety Analysis Set|Overall Study||125
2274400|NCT02239692|5582870|P1|Safety Analysis Set|Overall Study||70
2274401|NCT02239692|5582869|P2|Per-protocol Analysis Set|Overall Study||120
2274402|NCT02239692|5582870|P1|Per-protocol Analysis Set|Overall Study||66
2274403|NCT02239692|5582869|P2|Intention-to-treat Analysis Set|Overall Study||131
2274404|NCT02239692|5582870|P1|Intention-to-treat Analysis Set|Overall Study||73
2274405|NCT02239692|5582869|P2|STARTED|Overall Study||131
2274406|NCT02239692|5582870|P1|STARTED|Overall Study||73
2274407|NCT02239679|5582889|P3|NOT COMPLETED|Overall Study||1
2274408|NCT02239679|5582890|P2|NOT COMPLETED|Overall Study||3
2274409|NCT02239679|5582891|P1|NOT COMPLETED|Overall Study||3
2274410|NCT02239679|5582889|P3|COMPLETED|Overall Study||53
2274411|NCT02239679|5582890|P2|COMPLETED|Overall Study||56
2274412|NCT02239679|5582891|P1|COMPLETED|Overall Study||50
2274413|NCT02239679|5582889|P3|STARTED|Overall Study||54
2274414|NCT02239679|5582890|P2|STARTED|Overall Study||59
2274415|NCT02239679|5582891|P1|STARTED|Overall Study||53
2274416|NCT02239640|5583103|P1|NOT COMPLETED|Overall Study||217
2274417|NCT02239640|5583103|P1|COMPLETED|Overall Study||767
2274418|NCT02239640|5583103|P1|STARTED|Overall Study||984
2274419|NCT02239601|5583115|P2|NOT COMPLETED|Overall Study||6
2274420|NCT02239601|5583116|P1|NOT COMPLETED|Overall Study||7
2274421|NCT02239601|5583115|P2|COMPLETED|Overall Study||26
2274422|NCT02239601|5583116|P1|COMPLETED|Overall Study||22
2274423|NCT02239601|5583115|P2|STARTED|Overall Study||32
2274424|NCT02239601|5583116|P1|STARTED|Overall Study||29
2274425|NCT02239562|5583140|P6|NOT COMPLETED|Overall Study||0
2274426|NCT02239562|5583141|P5|NOT COMPLETED|Overall Study||0
2274427|NCT02239562|5583142|P4|NOT COMPLETED|Overall Study||0
2274428|NCT02239562|5583143|P3|NOT COMPLETED|Overall Study||0
2274429|NCT02239562|5583144|P2|NOT COMPLETED|Overall Study||0
2274430|NCT02239562|5583145|P1|NOT COMPLETED|Overall Study||0
2274431|NCT02239562|5583140|P6|COMPLETED|Overall Study||6
2274432|NCT02239562|5583141|P5|COMPLETED|Overall Study||6
2274433|NCT02239562|5583142|P4|COMPLETED|Overall Study||6
2274434|NCT02239562|5583143|P3|COMPLETED|Overall Study||6
2274435|NCT02239562|5583144|P2|COMPLETED|Overall Study||6
2274436|NCT02239562|5583145|P1|COMPLETED|Overall Study||6
2274437|NCT02239562|5583140|P6|STARTED|Overall Study||6
2274438|NCT02239562|5583141|P5|STARTED|Overall Study||6
2274439|NCT02239562|5583142|P4|STARTED|Overall Study||6
2274440|NCT02239562|5583143|P3|STARTED|Overall Study||6
2274441|NCT02239562|5583144|P2|STARTED|Overall Study||6
2274442|NCT02239562|5583145|P1|STARTED|Overall Study||6
2274443|NCT02239510|5583169|P2|NOT COMPLETED|Overall Study||1
2274444|NCT02239510|5583170|P1|NOT COMPLETED|Overall Study||2
2274445|NCT02239510|5583169|P2|COMPLETED|Overall Study||3
2274446|NCT02239510|5583170|P1|COMPLETED|Overall Study||3
2274447|NCT02239510|5583169|P2|STARTED|Overall Study||4
2274448|NCT02239510|5583170|P1|STARTED|Overall Study||5
2274449|NCT02239380|5583182|P1|NOT COMPLETED|Overall Study||0
2274450|NCT02239380|5583182|P1|COMPLETED|Overall Study||26
2274451|NCT02239380|5583182|P1|STARTED|Overall Study||26
2274452|NCT02239328|5583192|P1|NOT COMPLETED|Overall Study||8
2274453|NCT02239328|5583192|P1|COMPLETED|Overall Study||174
2274454|NCT02239328|5583192|P1|STARTED|Overall Study||182
2274455|NCT02239289|5583196|P1|NOT COMPLETED|Overall Study||0
2274456|NCT02239289|5583196|P1|COMPLETED|Overall Study||21
2274457|NCT02239289|5583196|P1|STARTED|Overall Study||21
2274458|NCT02239120|5583217|P2|NOT COMPLETED|Overall Study||72
2274459|NCT02239120|5583218|P1|NOT COMPLETED|Overall Study||75
2274460|NCT02239120|5583217|P2|COMPLETED|Overall Study||2623
2274461|NCT02239120|5583218|P1|COMPLETED|Overall Study||2620
2274462|NCT02239120|5583217|P2|STARTED|Overall Study||2695
2274463|NCT02239120|5583218|P1|STARTED|Overall Study||2695
2274464|NCT02239094|5583242|P1|NOT COMPLETED|Overall Study||2
2274465|NCT02239094|5583242|P1|COMPLETED|Overall Study||18
2274466|NCT02239094|5583242|P1|STARTED|Overall Study||20
2274467|NCT02238977|5583249|P2|NOT COMPLETED|Overall Study||0
2274468|NCT02238977|5583250|P1|NOT COMPLETED|Overall Study||0
2274469|NCT02238977|5583249|P2|COMPLETED|Overall Study||1
2274470|NCT02238977|5583250|P1|COMPLETED|Overall Study||0
2274471|NCT02238977|5583249|P2|STARTED|Overall Study||1
2274472|NCT02238977|5583250|P1|STARTED|Overall Study||0
2274473|NCT02238925|5583256|P1|NOT COMPLETED|Overall Study||25
2274474|NCT02238925|5583256|P1|COMPLETED|Overall Study||1
2274475|NCT02238925|5583256|P1|STARTED|Overall Study||26
2274482|NCT02238782|5583291|P1|NOT COMPLETED|Overall Study||0
2274483|NCT02238782|5583291|P1|COMPLETED|Overall Study||12
2274484|NCT02238782|5583291|P1|Subjects Treated|Overall Study||12
2274485|NCT02238782|5583291|P1|STARTED|Overall Study||12
2274486|NCT02238483|5583297|P2|NOT COMPLETED|Overall Study||14
2274487|NCT02238483|5583298|P1|NOT COMPLETED|Overall Study||15
2274488|NCT02238483|5583297|P2|COMPLETED|Overall Study||91
2274489|NCT02238483|5583298|P1|COMPLETED|Overall Study||93
2274490|NCT02238483|5583297|P2|STARTED|Overall Study||105
2274491|NCT02238483|5583298|P1|STARTED|Overall Study||108
2274492|NCT02238379|5583336|P2|NOT COMPLETED|Overall Study||0
2274493|NCT02238379|5583337|P1|NOT COMPLETED|Overall Study||1
2274494|NCT02238379|5583336|P2|COMPLETED|Overall Study||14
2274495|NCT02238379|5583337|P1|COMPLETED|Overall Study||11
2274496|NCT02238379|5583336|P2|STARTED|Overall Study||14
2274497|NCT02238379|5583337|P1|STARTED|Overall Study||12
2274498|NCT02238080|5583363|P1|NOT COMPLETED|Overall Study||25
2274499|NCT02238080|5583363|P1|COMPLETED|Overall Study||172
2274500|NCT02238080|5583363|P1|STARTED|Overall Study||197
2274501|NCT02238067|5583377|P1|NOT COMPLETED|Overall Study||45
2274502|NCT02238067|5583377|P1|COMPLETED|Overall Study||151
2274503|NCT02238067|5583377|P1|STARTED|Overall Study||196
2274504|NCT02238028|5583400|P2|NOT COMPLETED|Overall Study||2
2274505|NCT02238028|5583401|P1|NOT COMPLETED|Overall Study||2
2274506|NCT02238028|5583400|P2|COMPLETED|Overall Study||12
2274507|NCT02238028|5583401|P1|COMPLETED|Overall Study||12
2274508|NCT02238028|5583400|P2|STARTED|Overall Study||14
2274509|NCT02238028|5583401|P1|STARTED|Overall Study||14
2274510|NCT02237950|5583422|P2|NOT COMPLETED|Overall Study||48
2274511|NCT02237950|5583423|P1|NOT COMPLETED|Overall Study||48
2274512|NCT02237950|5583422|P2|COMPLETED|Overall Study||243
2274513|NCT02237950|5583423|P1|COMPLETED|Overall Study||247
2274514|NCT02237950|5583422|P2|STARTED|Overall Study||291
2274515|NCT02237950|5583423|P1|STARTED|Overall Study||295
2274516|NCT02237911|5583448|P3|NOT COMPLETED|Overall Study||3
2274517|NCT02237911|5583449|P2|NOT COMPLETED|Overall Study||8
2274518|NCT02237911|5583450|P1|NOT COMPLETED|Overall Study||7
2274519|NCT02237911|5583448|P3|COMPLETED|Overall Study||45
2274520|NCT02237911|5583449|P2|COMPLETED|Overall Study||88
2274521|NCT02237911|5583450|P1|COMPLETED|Overall Study||89
2274522|NCT02237911|5583448|P3|6 Months|Overall Study||45
2274523|NCT02237911|5583449|P2|6 Months|Overall Study||88
2274524|NCT02237911|5583450|P1|6 Months|Overall Study||89
2274525|NCT02237911|5583448|P3|3 Months|Overall Study||44
2274526|NCT02237911|5583449|P2|3 Months|Overall Study||87
2274527|NCT02237911|5583450|P1|3 Months|Overall Study||90
2274528|NCT02237911|5583448|P3|STARTED|Overall Study||48
2274529|NCT02237911|5583449|P2|STARTED|Overall Study||96
2274530|NCT02237911|5583450|P1|STARTED|Overall Study||96
2274531|NCT02237118|5583466|P2|NOT COMPLETED|Overall Study||1
2274532|NCT02237118|5583467|P1|NOT COMPLETED|Overall Study||1
2274533|NCT02237118|5583466|P2|COMPLETED|Overall Study||62
2274534|NCT02237118|5583467|P1|COMPLETED|Overall Study||59
2274535|NCT02237118|5583466|P2|STARTED|Overall Study||63
2274536|NCT02237118|5583467|P1|STARTED|Overall Study||60
2274537|NCT02237092|5583481|P1|NOT COMPLETED|Overall Study||0
2274538|NCT02237092|5583481|P1|COMPLETED|Overall Study||196
2274539|NCT02237092|5583481|P1|STARTED|Overall Study||196
2274540|NCT02236767|5583498|P1|NOT COMPLETED|Overall Study||0
2274541|NCT02236767|5583498|P1|COMPLETED|Overall Study||1
2274542|NCT02236767|5583498|P1|STARTED|Overall Study||1
2274543|NCT02236611|5583504|P2|NOT COMPLETED|Overall Study||34
2274544|NCT02236611|5583505|P1|NOT COMPLETED|Overall Study||26
2274545|NCT02236611|5583504|P2|COMPLETED|Overall Study||484
2274546|NCT02236611|5583505|P1|COMPLETED|Overall Study||490
2274547|NCT02236611|5583504|P2|STARTED|Overall Study||518
2274548|NCT02236611|5583505|P1|STARTED|Overall Study||516
2274549|NCT02236598|5583513|P2|NOT COMPLETED|Overall Study||2
2274550|NCT02236598|5583514|P1|NOT COMPLETED|Overall Study||0
2274551|NCT02236598|5583513|P2|COMPLETED|Overall Study||12
2274552|NCT02236598|5583514|P1|COMPLETED|Overall Study||15
2274553|NCT02236598|5583513|P2|STARTED|Overall Study||14
2274554|NCT02236598|5583514|P1|STARTED|Overall Study||15
2274555|NCT02236559|5583528|P2|NOT COMPLETED|Overall Study||12
2274556|NCT02236559|5583529|P1|NOT COMPLETED|Overall Study||12
2274557|NCT02236559|5583528|P2|COMPLETED|Overall Study||104
2274558|NCT02236559|5583529|P1|COMPLETED|Overall Study||100
2274559|NCT02236559|5583528|P2|STARTED|Overall Study||116
2274560|NCT02236559|5583529|P1|STARTED|Overall Study||112
2274561|NCT02236546|5583555|P1|NOT COMPLETED|Overall Study||0
2274562|NCT02236546|5583555|P1|COMPLETED|Overall Study||3
2274563|NCT02236546|5583555|P1|STARTED|Overall Study||3
2274564|NCT02236520|5583566|P4|NOT COMPLETED|Overall Study||1
2274565|NCT02236520|5583567|P3|NOT COMPLETED|Overall Study||0
2274566|NCT02236520|5583568|P2|NOT COMPLETED|Overall Study||5
2274567|NCT02236520|5583569|P1|NOT COMPLETED|Overall Study||2
2274568|NCT02236520|5583566|P4|COMPLETED|Overall Study||14
2274569|NCT02236520|5583567|P3|COMPLETED|Overall Study||15
2274570|NCT02236520|5583568|P2|COMPLETED|Overall Study||8
2274571|NCT02236520|5583569|P1|COMPLETED|Overall Study||14
2274572|NCT02236520|5583566|P4|STARTED|Overall Study||15
2274573|NCT02236520|5583567|P3|STARTED|Overall Study||15
2274574|NCT02236520|5583568|P2|STARTED|Overall Study||13
2274575|NCT02236520|5583569|P1|STARTED|Overall Study||16
2274576|NCT02236338|5583581|P2|NOT COMPLETED|Overall Study||0
2274577|NCT02236338|5583582|P1|NOT COMPLETED|Overall Study||0
2274578|NCT02236338|5583581|P2|COMPLETED|Overall Study||100
2274579|NCT02236338|5583582|P1|COMPLETED|Overall Study||100
2274580|NCT02236338|5583581|P2|STARTED|Overall Study||100
2274581|NCT02236338|5583582|P1|STARTED|Overall Study||100
2274582|NCT02236130|5583596|P2|NOT COMPLETED|Overall Study||12
2274583|NCT02236130|5583597|P1|NOT COMPLETED|Overall Study||7
2274584|NCT02236130|5583596|P2|COMPLETED|Overall Study||15
2274585|NCT02236130|5583597|P1|COMPLETED|Overall Study||15
2274586|NCT02236130|5583596|P2|STARTED|Overall Study||27
2274587|NCT02236130|5583597|P1|STARTED|Overall Study||22
2274588|NCT02235987|5583605|P1|NOT COMPLETED|Overall Study||1
2274589|NCT02235987|5583605|P1|COMPLETED|Overall Study||19
2274590|NCT02235987|5583605|P1|Received 1800 µg DG3173|Overall Study||19
2274591|NCT02235987|5583605|P1|Received 900 µg DG3173|Overall Study||19
2274592|NCT02235987|5583605|P1|Received 300 µg DG3173|Overall Study||20
2274593|NCT02235987|5583605|P1|Received 100 µg DG3173|Overall Study||20
2274594|NCT02235987|5583605|P1|Received Octreotide|Overall Study||20
2274595|NCT02235987|5583605|P1|STARTED|Overall Study||20
2274596|NCT02235870|5583620|P2|NOT COMPLETED|Overall Study||61
2274597|NCT02235870|5583621|P1|NOT COMPLETED|Overall Study||38
2274598|NCT02235870|5583620|P2|COMPLETED|Overall Study||128
2274599|NCT02235870|5583621|P1|COMPLETED|Overall Study||160
2274600|NCT02235870|5583620|P2|Crossover (Week 24)|Overall Study||138
2274601|NCT02235870|5583621|P1|Crossover (Week 24)|Overall Study||170
2274602|NCT02235870|5583620|P2|Completed Phase I (Week 24)|Overall Study||179
2274603|NCT02235870|5583621|P1|Completed Phase I (Week 24)|Overall Study||182
2274604|NCT02235870|5583620|P2|STARTED|Overall Study||189
2274605|NCT02235870|5583621|P1|STARTED|Overall Study||198
2274606|NCT02235831|5583630|P6|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
2274607|NCT02235831|5583631|P5|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
2274608|NCT02235831|5583632|P4|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
2274609|NCT02235831|5583633|P3|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
2274610|NCT02235831|5583634|P2|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
2274611|NCT02235831|5583635|P1|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
2274612|NCT02235831|5583630|P6|COMPLETED|Period 3, Third 5 Days of Wear||4
2274613|NCT02235831|5583631|P5|COMPLETED|Period 3, Third 5 Days of Wear||4
2274614|NCT02235831|5583632|P4|COMPLETED|Period 3, Third 5 Days of Wear||4
2274615|NCT02235831|5583633|P3|COMPLETED|Period 3, Third 5 Days of Wear||4
2274616|NCT02235831|5583634|P2|COMPLETED|Period 3, Third 5 Days of Wear||4
2274617|NCT02235831|5583635|P1|COMPLETED|Period 3, Third 5 Days of Wear||4
2274618|NCT02235831|5583630|P6|STARTED|Period 3, Third 5 Days of Wear||4
2274619|NCT02235831|5583631|P5|STARTED|Period 3, Third 5 Days of Wear||4
2274620|NCT02235831|5583632|P4|STARTED|Period 3, Third 5 Days of Wear||4
2274621|NCT02235831|5583633|P3|STARTED|Period 3, Third 5 Days of Wear||4
2274622|NCT02235831|5583634|P2|STARTED|Period 3, Third 5 Days of Wear||4
2274623|NCT02235831|5583635|P1|STARTED|Period 3, Third 5 Days of Wear||4
2274624|NCT02235831|5583630|P6|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
2274625|NCT02235831|5583631|P5|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
2274626|NCT02235831|5583632|P4|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
2274627|NCT02235831|5583633|P3|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
2274628|NCT02235831|5583634|P2|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
2274629|NCT02235831|5583635|P1|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
2274630|NCT02235831|5583630|P6|COMPLETED|Period 2, Second 5 Days of Wear||4
2274631|NCT02235831|5583631|P5|COMPLETED|Period 2, Second 5 Days of Wear||4
2274632|NCT02235831|5583632|P4|COMPLETED|Period 2, Second 5 Days of Wear||4
2274633|NCT02235831|5583633|P3|COMPLETED|Period 2, Second 5 Days of Wear||4
2274634|NCT02235831|5583634|P2|COMPLETED|Period 2, Second 5 Days of Wear||4
2274635|NCT02235831|5583635|P1|COMPLETED|Period 2, Second 5 Days of Wear||4
2274636|NCT02235831|5583630|P6|STARTED|Period 2, Second 5 Days of Wear||4
2274637|NCT02235831|5583631|P5|STARTED|Period 2, Second 5 Days of Wear||4
2274638|NCT02235831|5583632|P4|STARTED|Period 2, Second 5 Days of Wear||4
2274639|NCT02235831|5583633|P3|STARTED|Period 2, Second 5 Days of Wear||4
2274640|NCT02235831|5583634|P2|STARTED|Period 2, Second 5 Days of Wear||4
2274641|NCT02235831|5583635|P1|STARTED|Period 2, Second 5 Days of Wear||4
2274642|NCT02235831|5583630|P6|NOT COMPLETED|Period 1, First 5 Days of Wear||0
2274643|NCT02235831|5583631|P5|NOT COMPLETED|Period 1, First 5 Days of Wear||0
2274644|NCT02235831|5583632|P4|NOT COMPLETED|Period 1, First 5 Days of Wear||0
2274645|NCT02235831|5583633|P3|NOT COMPLETED|Period 1, First 5 Days of Wear||0
2274646|NCT02235831|5583634|P2|NOT COMPLETED|Period 1, First 5 Days of Wear||0
2274647|NCT02235831|5583635|P1|NOT COMPLETED|Period 1, First 5 Days of Wear||0
2274648|NCT02235831|5583630|P6|COMPLETED|Period 1, First 5 Days of Wear||4
2274649|NCT02235831|5583631|P5|COMPLETED|Period 1, First 5 Days of Wear||4
2274650|NCT02235831|5583632|P4|COMPLETED|Period 1, First 5 Days of Wear||4
2274651|NCT02235831|5583633|P3|COMPLETED|Period 1, First 5 Days of Wear||4
2274652|NCT02235831|5583634|P2|COMPLETED|Period 1, First 5 Days of Wear||4
2274653|NCT02235831|5583635|P1|COMPLETED|Period 1, First 5 Days of Wear||4
2274654|NCT02235831|5583630|P6|STARTED|Period 1, First 5 Days of Wear||4
2274655|NCT02235831|5583631|P5|STARTED|Period 1, First 5 Days of Wear||4
2274656|NCT02235831|5583632|P4|STARTED|Period 1, First 5 Days of Wear||4
2274657|NCT02235831|5583633|P3|STARTED|Period 1, First 5 Days of Wear||4
2274658|NCT02235831|5583634|P2|STARTED|Period 1, First 5 Days of Wear||4
2274659|NCT02235831|5583635|P1|STARTED|Period 1, First 5 Days of Wear||4
2274660|NCT02235493|5583642|P1|NOT COMPLETED|Overall Study||0
2274661|NCT02235493|5583642|P1|COMPLETED|Overall Study||6
2274662|NCT02235493|5583642|P1|STARTED|Overall Study||6
2274663|NCT02235454|5583647|P1|NOT COMPLETED|Overall Study||2
2274664|NCT02235454|5583647|P1|COMPLETED|Overall Study||55
2274665|NCT02235454|5583647|P1|STARTED|Overall Study||57
2274666|NCT02235311|5583653|P2|NOT COMPLETED|Overall Study||2
2274667|NCT02235311|5583654|P1|NOT COMPLETED|Overall Study||0
2274668|NCT02235311|5583653|P2|COMPLETED|Overall Study||0
2274669|NCT02235311|5583654|P1|COMPLETED|Overall Study||1
2274670|NCT02235311|5583653|P2|STARTED|Overall Study||2
2274671|NCT02235311|5583654|P1|STARTED|Overall Study||1
2274672|NCT02235285|5583666|P1|NOT COMPLETED|Overall Study||13
2274673|NCT02235285|5583666|P1|COMPLETED|Overall Study||149
2274674|NCT02235285|5583666|P1|STARTED|Overall Study||162
2274675|NCT02235077|5583672|P2|NOT COMPLETED|Overall Study||19
2274676|NCT02235077|5583673|P1|NOT COMPLETED|Overall Study||18
2274677|NCT02235077|5583672|P2|COMPLETED|Overall Study||159
2274678|NCT02235077|5583673|P1|COMPLETED|Overall Study||164
2274679|NCT02235077|5583672|P2|STARTED|Overall Study||178
2274680|NCT02235077|5583673|P1|STARTED|Overall Study||182
2274681|NCT02235064|5583701|P2|NOT COMPLETED|Overall Study||0
2274682|NCT02235064|5583702|P1|NOT COMPLETED|Overall Study||0
2274683|NCT02235064|5583701|P2|COMPLETED|Overall Study||1
2274684|NCT02235064|5583702|P1|COMPLETED|Overall Study||1
2274685|NCT02235064|5583701|P2|STARTED|Overall Study||1
2274686|NCT02235064|5583702|P1|STARTED|Overall Study||1
2274687|NCT02234752|5583728|P1|NOT COMPLETED|Overall Study||1
2274688|NCT02234752|5583728|P1|COMPLETED|Overall Study||2
2274689|NCT02234752|5583728|P1|STARTED|Overall Study||3
2274690|NCT02234713|5583741|P2|NOT COMPLETED|Overall Study||5
2274691|NCT02234713|5583742|P1|NOT COMPLETED|Overall Study||6
2274692|NCT02234713|5583741|P2|COMPLETED|Overall Study||27
2274693|NCT02234713|5583742|P1|COMPLETED|Overall Study||25
2274694|NCT02234713|5583741|P2|STARTED|Overall Study||32
2274695|NCT02234713|5583742|P1|STARTED|Overall Study||31
2274696|NCT02234687|5583767|P3|NOT COMPLETED|Overall Study||4
2274697|NCT02234687|5583768|P2|NOT COMPLETED|Overall Study||4
2274698|NCT02234687|5583769|P1|NOT COMPLETED|Overall Study||6
2274699|NCT02234687|5583767|P3|COMPLETED|Overall Study||0
2274700|NCT02234687|5583768|P2|COMPLETED|Overall Study||0
2274701|NCT02234687|5583769|P1|COMPLETED|Overall Study|Study Terminated. No outcome measures were analyzed|0
2274702|NCT02234687|5583767|P3|STARTED|Overall Study||4
2274703|NCT02234687|5583768|P2|STARTED|Overall Study||4
2274704|NCT02234687|5583769|P1|STARTED|Overall Study|Study Terminated. No outcome measures were analyzed|6
2274705|NCT02234570|5583785|P8|NOT COMPLETED|Overall Study||0
2274706|NCT02234570|5583786|P7|NOT COMPLETED|Overall Study||0
2274707|NCT02234570|5583787|P6|NOT COMPLETED|Overall Study||0
2274708|NCT02234570|5583788|P5|NOT COMPLETED|Overall Study||0
2274709|NCT02234570|5583789|P4|NOT COMPLETED|Overall Study||0
2274710|NCT02234570|5583790|P3|NOT COMPLETED|Overall Study||0
2274711|NCT02234570|5583791|P2|NOT COMPLETED|Overall Study||0
2274712|NCT02234570|5583792|P1|NOT COMPLETED|Overall Study||0
2274713|NCT02234570|5583785|P8|COMPLETED|Overall Study||14
2274714|NCT02234570|5583786|P7|COMPLETED|Overall Study||8
2274715|NCT02234570|5583787|P6|COMPLETED|Overall Study||8
2274716|NCT02234570|5583788|P5|COMPLETED|Overall Study||8
2274717|NCT02234570|5583789|P4|COMPLETED|Overall Study||8
2274718|NCT02234570|5583790|P3|COMPLETED|Overall Study||8
2274719|NCT02234570|5583791|P2|COMPLETED|Overall Study||8
2274720|NCT02234570|5583792|P1|COMPLETED|Overall Study||8
2274721|NCT02234570|5583785|P8|STARTED|Overall Study||14
2274722|NCT02234570|5583786|P7|STARTED|Overall Study||8
2274723|NCT02234570|5583787|P6|STARTED|Overall Study||8
2274724|NCT02234570|5583788|P5|STARTED|Overall Study||8
2274725|NCT02234570|5583789|P4|STARTED|Overall Study||8
2274726|NCT02234570|5583790|P3|STARTED|Overall Study||8
2274727|NCT02234570|5583791|P2|STARTED|Overall Study||8
2274728|NCT02234570|5583792|P1|STARTED|Overall Study||8
2274729|NCT02234479|5583868|P2|NOT COMPLETED|Overall Study||3
2274730|NCT02234479|5583869|P1|NOT COMPLETED|Overall Study||1
2274731|NCT02234479|5583868|P2|COMPLETED|Overall Study||15
2274732|NCT02234479|5583869|P1|COMPLETED|Overall Study||15
2274733|NCT02234479|5583868|P2|STARTED|Overall Study||18
2274734|NCT02234479|5583869|P1|STARTED|Overall Study||16
2274735|NCT02234427|5583875|P1|NOT COMPLETED|Overall Study||1
2274736|NCT02234427|5583875|P1|COMPLETED|Overall Study|One individual withdrew after first visit|33
2274737|NCT02234427|5583875|P1|STARTED|Overall Study||34
2274738|NCT02234362|5583879|P1|NOT COMPLETED|Overall Study||26
2274739|NCT02234362|5583879|P1|COMPLETED|Overall Study||21
2274740|NCT02234362|5583879|P1|Received at Least One Dose of Medication|Overall Study||27
2274741|NCT02234362|5583879|P1|STARTED|Overall Study||47
2274742|NCT02234284|5583898|P2|NOT COMPLETED|Overall Study||9
2274743|NCT02234284|5583899|P1|NOT COMPLETED|Overall Study||25
2274744|NCT02234284|5583898|P2|COMPLETED|Overall Study||83
2274745|NCT02234284|5583899|P1|COMPLETED|Overall Study||75
2274746|NCT02234284|5583898|P2|STARTED|Overall Study||92
2274747|NCT02234284|5583899|P1|STARTED|Overall Study||100
2274748|NCT02234180|5583947|P2|NOT COMPLETED|Overall Study||0
2274749|NCT02234180|5583948|P1|NOT COMPLETED|Overall Study||0
2274750|NCT02234180|5583947|P2|COMPLETED|Overall Study||1
2274751|NCT02234180|5583948|P1|COMPLETED|Overall Study||2
2274752|NCT02234180|5583947|P2|STARTED|Overall Study||1
2274753|NCT02234180|5583948|P1|STARTED|Overall Study||2
2274754|NCT02234141|5583958|P7|NOT COMPLETED|Long-Term Treatment Period||10
2274755|NCT02234141|5583959|P6|NOT COMPLETED|Long-Term Treatment Period||12
2274756|NCT02234141|5583960|P5|NOT COMPLETED|Long-Term Treatment Period||10
2274757|NCT02234141|5583961|P4|NOT COMPLETED|Long-Term Treatment Period||0
2274758|NCT02234141|5583962|P3|NOT COMPLETED|Long-Term Treatment Period||33
2274759|NCT02234141|5583963|P2|NOT COMPLETED|Long-Term Treatment Period||31
2274760|NCT02234141|5583964|P1|NOT COMPLETED|Long-Term Treatment Period||33
2274761|NCT02234141|5583958|P7|COMPLETED|Long-Term Treatment Period||0
2274762|NCT02234141|5583959|P6|COMPLETED|Long-Term Treatment Period||0
2274763|NCT02234141|5583960|P5|COMPLETED|Long-Term Treatment Period||0
2274764|NCT02234141|5583961|P4|COMPLETED|Long-Term Treatment Period||0
2274765|NCT02234141|5583962|P3|COMPLETED|Long-Term Treatment Period||0
2274766|NCT02234141|5583963|P2|COMPLETED|Long-Term Treatment Period||0
2274767|NCT02234141|5583964|P1|COMPLETED|Long-Term Treatment Period||0
2274768|NCT02234141|5583958|P7|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|10
2274769|NCT02234141|5583959|P6|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|12
2274770|NCT02234141|5583960|P5|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|10
2274771|NCT02234141|5583961|P4|STARTED|Long-Term Treatment Period|Participants were rerandomized to receive selonsertib during the Long-Term Treatment Phase.|0
2274772|NCT02234141|5583962|P3|STARTED|Long-Term Treatment Period|2 participants who completed Period 1 did not continue into the Long-Term Treatment Phase.|33
2274773|NCT02234141|5583963|P2|STARTED|Long-Term Treatment Period|1 participant who completed the Period 1 did not continue into the Long-Term Treatment Phase.|31
2274774|NCT02234141|5583964|P1|STARTED|Long-Term Treatment Period|2 participants who completed Period 1 did not continue into the Long-Term Treatment Phase.|33
2274775|NCT02234141|5583958|P7|NOT COMPLETED|Treatment Period (24 Weeks)||0
2274776|NCT02234141|5583959|P6|NOT COMPLETED|Treatment Period (24 Weeks)||0
2274777|NCT02234141|5583960|P5|NOT COMPLETED|Treatment Period (24 Weeks)||0
2274778|NCT02234141|5583961|P4|NOT COMPLETED|Treatment Period (24 Weeks)||5
2274779|NCT02234141|5583962|P3|NOT COMPLETED|Treatment Period (24 Weeks)||2
2274780|NCT02234141|5583963|P2|NOT COMPLETED|Treatment Period (24 Weeks)||6
2274781|NCT02234141|5583964|P1|NOT COMPLETED|Treatment Period (24 Weeks)||4
2274782|NCT02234141|5583958|P7|COMPLETED|Treatment Period (24 Weeks)||0
2274783|NCT02234141|5583959|P6|COMPLETED|Treatment Period (24 Weeks)||0
2274784|NCT02234141|5583960|P5|COMPLETED|Treatment Period (24 Weeks)||0
2274785|NCT02234141|5583961|P4|COMPLETED|Treatment Period (24 Weeks)||32
2274786|NCT02234141|5583962|P3|COMPLETED|Treatment Period (24 Weeks)||35
2274787|NCT02234141|5583963|P2|COMPLETED|Treatment Period (24 Weeks)||32
2274788|NCT02234141|5583964|P1|COMPLETED|Treatment Period (24 Weeks)||35
2274789|NCT02234141|5583958|P7|STARTED|Treatment Period (24 Weeks)||0
2274790|NCT02234141|5583959|P6|STARTED|Treatment Period (24 Weeks)||0
2274791|NCT02234141|5583960|P5|STARTED|Treatment Period (24 Weeks)||0
2274792|NCT02234141|5583961|P4|STARTED|Treatment Period (24 Weeks)||37
2274793|NCT02234141|5583962|P3|STARTED|Treatment Period (24 Weeks)||37
2274794|NCT02234141|5583963|P2|STARTED|Treatment Period (24 Weeks)||38
2274795|NCT02234141|5583964|P1|STARTED|Treatment Period (24 Weeks)||39
2274796|NCT02234115|5584046|P1|NOT COMPLETED|Overall Study||15
2274797|NCT02234115|5584046|P1|COMPLETED|Overall Study||122
2274798|NCT02234115|5584046|P1|PK Subgroup|Overall Study||31
2274799|NCT02234115|5584046|P1|PP|Overall Study||124
2274800|NCT02234115|5584046|P1|ITT|Overall Study||137
2274801|NCT02234115|5584046|P1|STARTED|Overall Study||137
2274802|NCT02234011|5584051|P1|NOT COMPLETED|Overall Study||0
2274803|NCT02234011|5584051|P1|COMPLETED|Overall Study||0
2274804|NCT02234011|5584051|P1|STARTED|Overall Study||0
2274805|NCT02233998|5584058|P3|NOT COMPLETED|Overall Study||0
2274806|NCT02233998|5584059|P2|NOT COMPLETED|Overall Study||0
2274807|NCT02233998|5584060|P1|NOT COMPLETED|Overall Study||0
2274808|NCT02233998|5584058|P3|COMPLETED|Overall Study||53
2274809|NCT02233998|5584059|P2|COMPLETED|Overall Study||52
2274810|NCT02233998|5584060|P1|COMPLETED|Overall Study||53
2274811|NCT02233998|5584058|P3|STARTED|Overall Study||53
2274812|NCT02233998|5584059|P2|STARTED|Overall Study||52
2274813|NCT02233998|5584060|P1|STARTED|Overall Study||53
2274814|NCT02233985|5584094|P2|NOT COMPLETED|Overall Study||0
2274815|NCT02233985|5584095|P1|NOT COMPLETED|Overall Study||0
2274816|NCT02233985|5584094|P2|COMPLETED|Overall Study||31
2274817|NCT02233985|5584095|P1|COMPLETED|Overall Study||33
2274818|NCT02233985|5584094|P2|STARTED|Overall Study||31
2274819|NCT02233985|5584095|P1|STARTED|Overall Study||33
2274820|NCT02233842|5584103|P1|NOT COMPLETED|Questionnaire 3 Version 2||0
2274821|NCT02233842|5584103|P1|COMPLETED|Questionnaire 3 Version 2||5
2274822|NCT02233842|5584103|P1|STARTED|Questionnaire 3 Version 2||5
2274823|NCT02233842|5584103|P1|NOT COMPLETED|Questionnaire 3 Version 1||0
2274824|NCT02233842|5584103|P1|COMPLETED|Questionnaire 3 Version 1||5
2274825|NCT02233842|5584103|P1|STARTED|Questionnaire 3 Version 1||5
2274826|NCT02233842|5584103|P1|NOT COMPLETED|Questionnaire 2 Version 2||0
2274827|NCT02233842|5584103|P1|COMPLETED|Questionnaire 2 Version 2||5
2274828|NCT02233842|5584103|P1|STARTED|Questionnaire 2 Version 2||5
2274829|NCT02233842|5584103|P1|NOT COMPLETED|Questionnaire 2 Version 1||0
2274830|NCT02233842|5584103|P1|COMPLETED|Questionnaire 2 Version 1||5
2274831|NCT02233842|5584103|P1|STARTED|Questionnaire 2 Version 1||5
2274832|NCT02233842|5584103|P1|NOT COMPLETED|Questionnaire 1 Version 2||0
2274833|NCT02233842|5584103|P1|COMPLETED|Questionnaire 1 Version 2||5
2274834|NCT02233842|5584103|P1|STARTED|Questionnaire 1 Version 2||5
2274835|NCT02233842|5584103|P1|NOT COMPLETED|Questionnaire 1 Version 1||0
2274836|NCT02233842|5584103|P1|COMPLETED|Questionnaire 1 Version 1||5
2274837|NCT02233842|5584103|P1|STARTED|Questionnaire 1 Version 1||5
2274838|NCT02233803|5584110|P2|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
2274839|NCT02233803|5584111|P1|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
2274840|NCT02233803|5584110|P2|COMPLETED|Treatment Period 2 (4-Wks)||91
2274841|NCT02233803|5584111|P1|COMPLETED|Treatment Period 2 (4-Wks)||93
2274842|NCT02233803|5584110|P2|STARTED|Treatment Period 2 (4-Wks)||93
2274843|NCT02233803|5584111|P1|STARTED|Treatment Period 2 (4-Wks)||95
2274844|NCT02233803|5584110|P2|NOT COMPLETED|Washout Period (4-Wks)||2
2274845|NCT02233803|5584111|P1|NOT COMPLETED|Washout Period (4-Wks)||2
2274846|NCT02233803|5584110|P2|COMPLETED|Washout Period (4-Wks)||93
2274847|NCT02233803|5584111|P1|COMPLETED|Washout Period (4-Wks)||95
2274848|NCT02233803|5584110|P2|STARTED|Washout Period (4-Wks)||95
2274849|NCT02233803|5584111|P1|STARTED|Washout Period (4-Wks)||97
2274850|NCT02233803|5584110|P2|NOT COMPLETED|Treatment Period 1 (4-Wks)||4
2274851|NCT02233803|5584111|P1|NOT COMPLETED|Treatment Period 1 (4-Wks)||3
2274852|NCT02233803|5584110|P2|COMPLETED|Treatment Period 1 (4-Wks)||95
2274853|NCT02233803|5584111|P1|COMPLETED|Treatment Period 1 (4-Wks)||97
2274854|NCT02233803|5584110|P2|STARTED|Treatment Period 1 (4-Wks)||99
2274855|NCT02233803|5584111|P1|STARTED|Treatment Period 1 (4-Wks)||100
2274856|NCT02233751|5584123|P2|NOT COMPLETED|Overall Study||0
2274857|NCT02233751|5584124|P1|NOT COMPLETED|Overall Study||0
2274858|NCT02233751|5584123|P2|COMPLETED|Overall Study||6
2274859|NCT02233751|5584124|P1|COMPLETED|Overall Study||6
2274860|NCT02233751|5584123|P2|STARTED|Overall Study||6
2274861|NCT02233751|5584124|P1|STARTED|Overall Study||6
2274862|NCT02233738|5584144|P2|NOT COMPLETED|Overall Study||16
2274863|NCT02233738|5584145|P1|NOT COMPLETED|Overall Study||8
2274864|NCT02233738|5584144|P2|COMPLETED|Overall Study||75
2274865|NCT02233738|5584145|P1|COMPLETED|Overall Study||85
2274866|NCT02233738|5584144|P2|6 Month Follow-Up|Overall Study||75
2274867|NCT02233738|5584145|P1|6 Month Follow-Up|Overall Study||85
2274868|NCT02233738|5584144|P2|3 Month Follow-Up|Overall Study||77
2274869|NCT02233738|5584145|P1|3 Month Follow-Up|Overall Study||87
2274870|NCT02233738|5584144|P2|1 Month Follow-Up|Overall Study||82
2274871|NCT02233738|5584145|P1|1 Month Follow-Up|Overall Study||89
2274872|NCT02233738|5584144|P2|STARTED|Overall Study||91
2274873|NCT02233738|5584145|P1|STARTED|Overall Study||93
2274874|NCT02233647|5584315|P1|NOT COMPLETED|Overall Study||1
2274875|NCT02233647|5584315|P1|COMPLETED|Overall Study||10
2274876|NCT02233647|5584315|P1|80 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
2274877|NCT02233647|5584315|P1|40 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
2274878|NCT02233647|5584315|P1|20 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
2274879|NCT02233647|5584315|P1|10 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
2274880|NCT02233647|5584315|P1|0 mg Cocaine With 210 mg Phendimetrazine|Overall Study||10
2274881|NCT02233647|5584315|P1|80 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
2274882|NCT02233647|5584315|P1|40 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
2274883|NCT02233647|5584315|P1|20 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
2274884|NCT02233647|5584315|P1|10 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
2274885|NCT02233647|5584315|P1|0 mg Cocaine With 140 mg Phendimetrazine|Overall Study||10
2274886|NCT02233647|5584315|P1|80 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
2274887|NCT02233647|5584315|P1|40 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
2274888|NCT02233647|5584315|P1|20 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
2274889|NCT02233647|5584315|P1|10 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
2274890|NCT02233647|5584315|P1|0 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
2274891|NCT02233647|5584315|P1|80 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
2274892|NCT02233647|5584315|P1|40 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
2274893|NCT02233647|5584315|P1|20 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
2274894|NCT02233647|5584315|P1|10 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
2274895|NCT02233647|5584315|P1|0 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
2274896|NCT02233647|5584315|P1|STARTED|Overall Study||11
2274897|NCT02233543|5584344|P2|NOT COMPLETED|Period 2||1
2274898|NCT02233543|5584345|P1|NOT COMPLETED|Period 2||2
2274899|NCT02233543|5584344|P2|COMPLETED|Period 2||12
2274900|NCT02233543|5584345|P1|COMPLETED|Period 2|1 participant erroneously received QVA149 during both periods.|17
2274901|NCT02233543|5584344|P2|STARTED|Period 2||13
2274902|NCT02233543|5584345|P1|STARTED|Period 2||19
2274903|NCT02233543|5584344|P2|NOT COMPLETED|Period 1||3
2274904|NCT02233543|5584345|P1|NOT COMPLETED|Period 1||3
2274905|NCT02233543|5584344|P2|COMPLETED|Period 1||13
2274906|NCT02233543|5584345|P1|COMPLETED|Period 1||19
2274907|NCT02233543|5584344|P2|STARTED|Period 1||16
2274908|NCT02233543|5584345|P1|STARTED|Period 1||22
2274909|NCT02233517|5584355|P2|NOT COMPLETED|Overall Study||4
2274910|NCT02233517|5584356|P1|NOT COMPLETED|Overall Study||7
2274911|NCT02233517|5584355|P2|COMPLETED|Overall Study||13
2274912|NCT02233517|5584356|P1|COMPLETED|Overall Study||12
2274913|NCT02233517|5584355|P2|STARTED|Overall Study||17
2274914|NCT02233517|5584356|P1|STARTED|Overall Study||19
2274915|NCT02233478|5584382|P6|NOT COMPLETED|Third Intervention (1 Day)||0
2274916|NCT02233478|5584383|P5|NOT COMPLETED|Third Intervention (1 Day)||0
2274917|NCT02233478|5584384|P4|NOT COMPLETED|Third Intervention (1 Day)||0
2274918|NCT02233478|5584385|P3|NOT COMPLETED|Third Intervention (1 Day)||0
2274919|NCT02233478|5584386|P2|NOT COMPLETED|Third Intervention (1 Day)||0
2274920|NCT02233478|5584387|P1|NOT COMPLETED|Third Intervention (1 Day)||0
2274921|NCT02233478|5584382|P6|COMPLETED|Third Intervention (1 Day)||3
2274922|NCT02233478|5584383|P5|COMPLETED|Third Intervention (1 Day)||3
2274923|NCT02233478|5584384|P4|COMPLETED|Third Intervention (1 Day)||3
2274924|NCT02233478|5584385|P3|COMPLETED|Third Intervention (1 Day)||3
2274925|NCT02233478|5584386|P2|COMPLETED|Third Intervention (1 Day)||3
2274926|NCT02233478|5584387|P1|COMPLETED|Third Intervention (1 Day)||3
2274927|NCT02233478|5584382|P6|STARTED|Third Intervention (1 Day)||3
2274928|NCT02233478|5584383|P5|STARTED|Third Intervention (1 Day)||3
2274929|NCT02233478|5584384|P4|STARTED|Third Intervention (1 Day)||3
2274930|NCT02233478|5584385|P3|STARTED|Third Intervention (1 Day)||3
2274931|NCT02233478|5584386|P2|STARTED|Third Intervention (1 Day)||3
2274932|NCT02233478|5584387|P1|STARTED|Third Intervention (1 Day)||3
2274933|NCT02233478|5584382|P6|NOT COMPLETED|Washout (7 Days)||0
2274934|NCT02233478|5584383|P5|NOT COMPLETED|Washout (7 Days)||0
2274935|NCT02233478|5584384|P4|NOT COMPLETED|Washout (7 Days)||0
2274936|NCT02233478|5584385|P3|NOT COMPLETED|Washout (7 Days)||0
2274937|NCT02233478|5584386|P2|NOT COMPLETED|Washout (7 Days)||0
2274938|NCT02233478|5584387|P1|NOT COMPLETED|Washout (7 Days)||0
2274939|NCT02233478|5584382|P6|COMPLETED|Washout (7 Days)||3
2274940|NCT02233478|5584383|P5|COMPLETED|Washout (7 Days)||3
2274941|NCT02233478|5584384|P4|COMPLETED|Washout (7 Days)||3
2274942|NCT02233478|5584385|P3|COMPLETED|Washout (7 Days)||3
2274943|NCT02233478|5584386|P2|COMPLETED|Washout (7 Days)||3
2274944|NCT02233478|5584387|P1|COMPLETED|Washout (7 Days)||3
2274945|NCT02233478|5584382|P6|STARTED|Washout (7 Days)||3
2274946|NCT02233478|5584383|P5|STARTED|Washout (7 Days)||3
2274947|NCT02233478|5584384|P4|STARTED|Washout (7 Days)||3
2274948|NCT02233478|5584385|P3|STARTED|Washout (7 Days)||3
2274949|NCT02233478|5584386|P2|STARTED|Washout (7 Days)||3
2274950|NCT02233478|5584387|P1|STARTED|Washout (7 Days)||3
2274951|NCT02233478|5584382|P6|NOT COMPLETED|Second Intervention (1 Day)||0
2274952|NCT02233478|5584383|P5|NOT COMPLETED|Second Intervention (1 Day)||0
2274953|NCT02233478|5584384|P4|NOT COMPLETED|Second Intervention (1 Day)||0
2274954|NCT02233478|5584385|P3|NOT COMPLETED|Second Intervention (1 Day)||0
2274955|NCT02233478|5584386|P2|NOT COMPLETED|Second Intervention (1 Day)||0
2274956|NCT02233478|5584387|P1|NOT COMPLETED|Second Intervention (1 Day)||0
2274957|NCT02233478|5584382|P6|COMPLETED|Second Intervention (1 Day)||3
2274958|NCT02233478|5584383|P5|COMPLETED|Second Intervention (1 Day)||3
2274959|NCT02233478|5584384|P4|COMPLETED|Second Intervention (1 Day)||3
2274960|NCT02233478|5584385|P3|COMPLETED|Second Intervention (1 Day)||3
2274961|NCT02233478|5584386|P2|COMPLETED|Second Intervention (1 Day)||3
2274962|NCT02233478|5584387|P1|COMPLETED|Second Intervention (1 Day)||3
2274963|NCT02233478|5584382|P6|STARTED|Second Intervention (1 Day)||3
2274964|NCT02233478|5584383|P5|STARTED|Second Intervention (1 Day)||3
2274965|NCT02233478|5584384|P4|STARTED|Second Intervention (1 Day)||3
2274966|NCT02233478|5584385|P3|STARTED|Second Intervention (1 Day)||3
2274967|NCT02233478|5584386|P2|STARTED|Second Intervention (1 Day)||3
2274968|NCT02233478|5584387|P1|STARTED|Second Intervention (1 Day)||3
2274969|NCT02233478|5584382|P6|NOT COMPLETED|Washout (7 Days)||0
2274970|NCT02233478|5584383|P5|NOT COMPLETED|Washout (7 Days)||0
2274971|NCT02233478|5584384|P4|NOT COMPLETED|Washout (7 Days)||0
2274972|NCT02233478|5584385|P3|NOT COMPLETED|Washout (7 Days)||0
2274973|NCT02233478|5584386|P2|NOT COMPLETED|Washout (7 Days)||0
2274974|NCT02233478|5584387|P1|NOT COMPLETED|Washout (7 Days)||0
2274975|NCT02233478|5584382|P6|COMPLETED|Washout (7 Days)||3
2274976|NCT02233478|5584383|P5|COMPLETED|Washout (7 Days)||3
2274977|NCT02233478|5584384|P4|COMPLETED|Washout (7 Days)||3
2274978|NCT02233478|5584385|P3|COMPLETED|Washout (7 Days)||3
2274979|NCT02233478|5584386|P2|COMPLETED|Washout (7 Days)||3
2274980|NCT02233478|5584387|P1|COMPLETED|Washout (7 Days)||3
2274981|NCT02233478|5584382|P6|STARTED|Washout (7 Days)||3
2274982|NCT02233478|5584383|P5|STARTED|Washout (7 Days)||3
2274983|NCT02233478|5584384|P4|STARTED|Washout (7 Days)||3
2274984|NCT02233478|5584385|P3|STARTED|Washout (7 Days)||3
2274985|NCT02233478|5584386|P2|STARTED|Washout (7 Days)||3
2274986|NCT02233478|5584387|P1|STARTED|Washout (7 Days)||3
2274987|NCT02233478|5584382|P6|NOT COMPLETED|First Intervention (1 Day)||0
2274988|NCT02233478|5584383|P5|NOT COMPLETED|First Intervention (1 Day)||0
2274989|NCT02233478|5584384|P4|NOT COMPLETED|First Intervention (1 Day)||0
2274990|NCT02233478|5584385|P3|NOT COMPLETED|First Intervention (1 Day)||0
2274991|NCT02233478|5584386|P2|NOT COMPLETED|First Intervention (1 Day)||0
2274992|NCT02233478|5584387|P1|NOT COMPLETED|First Intervention (1 Day)||0
2274993|NCT02233478|5584382|P6|COMPLETED|First Intervention (1 Day)||3
2274994|NCT02233478|5584383|P5|COMPLETED|First Intervention (1 Day)||3
2274995|NCT02233478|5584384|P4|COMPLETED|First Intervention (1 Day)||3
2274996|NCT02233478|5584385|P3|COMPLETED|First Intervention (1 Day)||3
2274997|NCT02233478|5584386|P2|COMPLETED|First Intervention (1 Day)||3
2274998|NCT02233478|5584387|P1|COMPLETED|First Intervention (1 Day)||3
2274999|NCT02233478|5584382|P6|STARTED|First Intervention (1 Day)||3
2275000|NCT02233478|5584383|P5|STARTED|First Intervention (1 Day)||3
2275001|NCT02233478|5584384|P4|STARTED|First Intervention (1 Day)||3
2275002|NCT02233478|5584385|P3|STARTED|First Intervention (1 Day)||3
2275003|NCT02233478|5584386|P2|STARTED|First Intervention (1 Day)||3
2275004|NCT02233478|5584387|P1|STARTED|First Intervention (1 Day)||3
2275005|NCT02233309|5584395|P1|NOT COMPLETED|Overall Study||5
2275006|NCT02233309|5584395|P1|COMPLETED|Overall Study||31
2275007|NCT02233309|5584395|P1|STARTED|Overall Study||36
2275008|NCT02233296|5584401|P2|NOT COMPLETED|Overall Study||0
2275009|NCT02233296|5584402|P1|NOT COMPLETED|Overall Study||0
2275010|NCT02233296|5584401|P2|COMPLETED|Overall Study||14
2275011|NCT02233296|5584402|P1|COMPLETED|Overall Study||16
2275012|NCT02233296|5584401|P2|STARTED|Overall Study||14
2275013|NCT02233296|5584402|P1|STARTED|Overall Study||16
2275014|NCT02233101|5584420|P2|NOT COMPLETED|Overall Study||1
2275015|NCT02233101|5584421|P1|NOT COMPLETED|Overall Study||12
2275016|NCT02233101|5584420|P2|COMPLETED|Overall Study||80
2275017|NCT02233101|5584421|P1|COMPLETED|Overall Study||74
2275018|NCT02233101|5584420|P2|STARTED|Overall Study||81
2275019|NCT02233101|5584421|P1|STARTED|Overall Study||86
2275020|NCT02232984|5584429|P1|NOT COMPLETED|Overall Study||77
2275021|NCT02232984|5584429|P1|COMPLETED|Overall Study|Total number of subjects who completed study|672
2275022|NCT02232984|5584429|P1|Successfully Implanted|Overall Study|Successfully implanted subjects|675
2275023|NCT02232984|5584429|P1|STARTED|Overall Study|Enrolled subjects|749
2275024|NCT02232880|5584438|P1|NOT COMPLETED|Overall Study||1
2275025|NCT02232880|5584438|P1|COMPLETED|Overall Study||0
2275026|NCT02232880|5584438|P1|STARTED|Overall Study||1
2275027|NCT02232698|5584447|P2|NOT COMPLETED|Overall Study||20
2275028|NCT02232698|5584448|P1|NOT COMPLETED|Overall Study||10
2275029|NCT02232698|5584447|P2|COMPLETED|Overall Study||101
2275030|NCT02232698|5584448|P1|COMPLETED|Overall Study||110
2275031|NCT02232698|5584447|P2|STARTED|Overall Study||121
2275032|NCT02232698|5584448|P1|STARTED|Overall Study||120
2275033|NCT02232425|5584471|P2|NOT COMPLETED|Overall Study||8
2275034|NCT02232425|5584472|P1|NOT COMPLETED|Overall Study||14
2275035|NCT02232425|5584471|P2|COMPLETED|Overall Study||22
2275036|NCT02232425|5584472|P1|COMPLETED|Overall Study||44
2275037|NCT02232425|5584471|P2|STARTED|Overall Study||30
2275038|NCT02232425|5584472|P1|STARTED|Overall Study||58
2275039|NCT02232243|5584505|P3|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
2275040|NCT02232243|5584506|P2|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
2275041|NCT02232243|5584507|P1|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
2275042|NCT02232243|5584505|P3|COMPLETED|Third Dose(200mg HCQ Twice Daily)||3
2275043|NCT02232243|5584506|P2|COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
2275044|NCT02232243|5584507|P1|COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
2275045|NCT02232243|5584505|P3|STARTED|Third Dose(200mg HCQ Twice Daily)||3
2275046|NCT02232243|5584506|P2|STARTED|Third Dose(200mg HCQ Twice Daily)||0
2275047|NCT02232243|5584507|P1|STARTED|Third Dose(200mg HCQ Twice Daily)||0
2275048|NCT02232243|5584505|P3|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
2275049|NCT02232243|5584506|P2|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||1
2275050|NCT02232243|5584507|P1|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
2275051|NCT02232243|5584505|P3|COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
2275052|NCT02232243|5584506|P2|COMPLETED|Second Dose (400mg HCQ Twice Daily)||3
2275053|NCT02232243|5584507|P1|COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
2275054|NCT02232243|5584505|P3|STARTED|Second Dose (400mg HCQ Twice Daily)||0
2275055|NCT02232243|5584506|P2|STARTED|Second Dose (400mg HCQ Twice Daily)||4
2275056|NCT02232243|5584507|P1|STARTED|Second Dose (400mg HCQ Twice Daily)||0
2275057|NCT02232243|5584505|P3|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
2275058|NCT02232243|5584506|P2|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
2275059|NCT02232243|5584507|P1|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
2275060|NCT02232243|5584505|P3|COMPLETED|First Dose (200mg HCQ Twice Daily)||0
2275061|NCT02232243|5584506|P2|COMPLETED|First Dose (200mg HCQ Twice Daily)||0
2275062|NCT02232243|5584507|P1|COMPLETED|First Dose (200mg HCQ Twice Daily)||3
2275063|NCT02232243|5584505|P3|STARTED|First Dose (200mg HCQ Twice Daily)||0
2275064|NCT02232243|5584506|P2|STARTED|First Dose (200mg HCQ Twice Daily)||0
2275065|NCT02232243|5584507|P1|STARTED|First Dose (200mg HCQ Twice Daily)||3
2275066|NCT02232178|5584519|P3|NOT COMPLETED|Overall Study||1
2275067|NCT02232178|5584520|P2|NOT COMPLETED|Overall Study||1
2275068|NCT02232178|5584521|P1|NOT COMPLETED|Overall Study||1
2275069|NCT02232178|5584519|P3|COMPLETED|Overall Study||12
2275070|NCT02232178|5584520|P2|COMPLETED|Overall Study||24
2275071|NCT02232178|5584521|P1|COMPLETED|Overall Study||25
2275072|NCT02232178|5584519|P3|Safety Population|Overall Study||12
2275073|NCT02232178|5584520|P2|Safety Population|Overall Study||24
2275074|NCT02232178|5584521|P1|Safety Population|Overall Study||26
2275075|NCT02232178|5584519|P3|Per Protocol PK Population|Overall Study||11
2275076|NCT02232178|5584520|P2|Per Protocol PK Population|Overall Study||24
2275077|NCT02232178|5584521|P1|Per Protocol PK Population|Overall Study||26
2275078|NCT02232178|5584519|P3|STARTED|Overall Study||13
2275079|NCT02232178|5584520|P2|STARTED|Overall Study||25
2275080|NCT02232178|5584521|P1|STARTED|Overall Study||26
2275081|NCT02232126|5584540|P2|NOT COMPLETED|Overall Study||0
2275082|NCT02232126|5584541|P1|NOT COMPLETED|Overall Study||0
2275083|NCT02232126|5584540|P2|COMPLETED|Overall Study||90
2275084|NCT02232126|5584541|P1|COMPLETED|Overall Study||91
2275085|NCT02232126|5584540|P2|STARTED|Overall Study||90
2275086|NCT02232126|5584541|P1|STARTED|Overall Study||91
2275087|NCT02232074|5584551|P2|NOT COMPLETED|Overall Study||45
2275088|NCT02232074|5584552|P1|NOT COMPLETED|Overall Study||41
2275089|NCT02232074|5584551|P2|COMPLETED|Overall Study||107
2275090|NCT02232074|5584552|P1|COMPLETED|Overall Study||113
2275091|NCT02232074|5584551|P2|STARTED|Overall Study||152
2275092|NCT02232074|5584552|P1|STARTED|Overall Study||154
2275093|NCT02232022|5584598|P1|NOT COMPLETED|Overall Study||2
2275094|NCT02232022|5584598|P1|COMPLETED|Overall Study||51
2275095|NCT02232022|5584598|P1|STARTED|Overall Study||53
2275096|NCT02232009|5584607|P1|NOT COMPLETED|Overall Study||0
2275097|NCT02232009|5584607|P1|COMPLETED|Overall Study||9
2275098|NCT02232009|5584607|P1|STARTED|Overall Study||9
2275099|NCT02231918|5584619|P3|NOT COMPLETED|Overall Study||1
2275100|NCT02231918|5584620|P2|NOT COMPLETED|Overall Study||1
2275101|NCT02231918|5584621|P1|NOT COMPLETED|Overall Study||0
2275102|NCT02231918|5584619|P3|COMPLETED|Overall Study||1
2275103|NCT02231918|5584620|P2|COMPLETED|Overall Study||14
2275104|NCT02231918|5584621|P1|COMPLETED|Overall Study||9
2275105|NCT02231918|5584619|P3|STARTED|Overall Study||2
2275106|NCT02231918|5584620|P2|STARTED|Overall Study||15
2275107|NCT02231918|5584621|P1|STARTED|Overall Study||9
2275126|NCT02231762|5584705|P4|NOT COMPLETED|Maintenance Phase||5
2275127|NCT02231762|5584706|P3|NOT COMPLETED|Maintenance Phase||5
2275128|NCT02231762|5584707|P2|NOT COMPLETED|Maintenance Phase||3
2275129|NCT02231762|5584708|P1|NOT COMPLETED|Maintenance Phase||0
2275130|NCT02231762|5584705|P4|COMPLETED|Maintenance Phase||7
2275131|NCT02231762|5584706|P3|COMPLETED|Maintenance Phase||9
2275132|NCT02231762|5584707|P2|COMPLETED|Maintenance Phase||8
2275133|NCT02231762|5584708|P1|COMPLETED|Maintenance Phase||0
2275134|NCT02231762|5584705|P4|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|12
2275135|NCT02231762|5584706|P3|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|14
2275136|NCT02231762|5584707|P2|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|11
2275137|NCT02231762|5584708|P1|STARTED|Maintenance Phase|This arm was not included in period 2 (maintenance phase).|0
2275138|NCT02231762|5584705|P4|NOT COMPLETED|Combination Phase||0
2275139|NCT02231762|5584706|P3|NOT COMPLETED|Combination Phase||0
2275140|NCT02231762|5584707|P2|NOT COMPLETED|Combination Phase||0
2275141|NCT02231762|5584708|P1|NOT COMPLETED|Combination Phase||20
2275142|NCT02231762|5584705|P4|COMPLETED|Combination Phase||0
2275143|NCT02231762|5584706|P3|COMPLETED|Combination Phase||0
2275144|NCT02231762|5584707|P2|COMPLETED|Combination Phase||0
2275145|NCT02231762|5584708|P1|COMPLETED|Combination Phase||37
2275146|NCT02231762|5584705|P4|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
2275147|NCT02231762|5584706|P3|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
2275148|NCT02231762|5584707|P2|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
2275149|NCT02231762|5584708|P1|STARTED|Combination Phase||57
2275150|NCT02231749|5584741|P2|NOT COMPLETED|Overall Study||449
2275151|NCT02231749|5584742|P1|NOT COMPLETED|Overall Study||422
2275152|NCT02231749|5584741|P2|COMPLETED|Overall Study||97
2275153|NCT02231749|5584742|P1|COMPLETED|Overall Study||128
2275154|NCT02231749|5584741|P2|Received Treatment|Overall Study||535
2275155|NCT02231749|5584742|P1|Received Treatment|Overall Study||547
2275156|NCT02231749|5584741|P2|STARTED|Overall Study||546
2275157|NCT02231749|5584742|P1|STARTED|Overall Study||550
2275158|NCT02231580|5584760|P2|NOT COMPLETED|Overall Study||0
2275159|NCT02231580|5584761|P1|NOT COMPLETED|Overall Study||5
2275160|NCT02231580|5584760|P2|COMPLETED|Overall Study||3
2275161|NCT02231580|5584761|P1|COMPLETED|Overall Study||9
2275162|NCT02231580|5584760|P2|Cohort 2|Overall Study||1
2275163|NCT02231580|5584761|P1|Cohort 2|Overall Study||6
2275164|NCT02231580|5584760|P2|Cohort 1|Overall Study||2
2275165|NCT02231580|5584761|P1|Cohort 1|Overall Study||8
2275166|NCT02231580|5584760|P2|STARTED|Overall Study||3
2275167|NCT02231580|5584761|P1|STARTED|Overall Study||14
2275168|NCT02231177|5584817|P6|NOT COMPLETED|Treatment Period 3 (21 Days)||0
2275169|NCT02231177|5584818|P5|NOT COMPLETED|Treatment Period 3 (21 Days)||0
2275170|NCT02231177|5584819|P4|NOT COMPLETED|Treatment Period 3 (21 Days)||0
2275171|NCT02231177|5584820|P3|NOT COMPLETED|Treatment Period 3 (21 Days)||0
2275172|NCT02231177|5584821|P2|NOT COMPLETED|Treatment Period 3 (21 Days)||0
2275173|NCT02231177|5584822|P1|NOT COMPLETED|Treatment Period 3 (21 Days)||0
2275174|NCT02231177|5584817|P6|COMPLETED|Treatment Period 3 (21 Days)||9
2275175|NCT02231177|5584818|P5|COMPLETED|Treatment Period 3 (21 Days)||8
2275176|NCT02231177|5584819|P4|COMPLETED|Treatment Period 3 (21 Days)||7
2275177|NCT02231177|5584820|P3|COMPLETED|Treatment Period 3 (21 Days)||8
2275178|NCT02231177|5584821|P2|COMPLETED|Treatment Period 3 (21 Days)||7
2275179|NCT02231177|5584822|P1|COMPLETED|Treatment Period 3 (21 Days)||8
2275180|NCT02231177|5584817|P6|STARTED|Treatment Period 3 (21 Days)||9
2275181|NCT02231177|5584818|P5|STARTED|Treatment Period 3 (21 Days)||8
2275182|NCT02231177|5584819|P4|STARTED|Treatment Period 3 (21 Days)||7
2275183|NCT02231177|5584820|P3|STARTED|Treatment Period 3 (21 Days)||8
2275184|NCT02231177|5584821|P2|STARTED|Treatment Period 3 (21 Days)||7
2275185|NCT02231177|5584822|P1|STARTED|Treatment Period 3 (21 Days)||8
2275186|NCT02231177|5584817|P6|NOT COMPLETED|Treatment Period 2 (21 Days)||0
2275187|NCT02231177|5584818|P5|NOT COMPLETED|Treatment Period 2 (21 Days)||0
2275188|NCT02231177|5584819|P4|NOT COMPLETED|Treatment Period 2 (21 Days)||0
2275189|NCT02231177|5584820|P3|NOT COMPLETED|Treatment Period 2 (21 Days)||0
2275190|NCT02231177|5584821|P2|NOT COMPLETED|Treatment Period 2 (21 Days)||0
2275191|NCT02231177|5584822|P1|NOT COMPLETED|Treatment Period 2 (21 Days)||0
2275192|NCT02231177|5584817|P6|COMPLETED|Treatment Period 2 (21 Days)||9
2275193|NCT02231177|5584818|P5|COMPLETED|Treatment Period 2 (21 Days)||8
2275194|NCT02231177|5584819|P4|COMPLETED|Treatment Period 2 (21 Days)||7
2275195|NCT02231177|5584820|P3|COMPLETED|Treatment Period 2 (21 Days)||8
2275196|NCT02231177|5584821|P2|COMPLETED|Treatment Period 2 (21 Days)||7
2275197|NCT02231177|5584822|P1|COMPLETED|Treatment Period 2 (21 Days)||8
2275198|NCT02231177|5584817|P6|STARTED|Treatment Period 2 (21 Days)||9
2275199|NCT02231177|5584818|P5|STARTED|Treatment Period 2 (21 Days)||8
2275200|NCT02231177|5584819|P4|STARTED|Treatment Period 2 (21 Days)||7
2275201|NCT02231177|5584820|P3|STARTED|Treatment Period 2 (21 Days)||8
2275202|NCT02231177|5584821|P2|STARTED|Treatment Period 2 (21 Days)||7
2275203|NCT02231177|5584822|P1|STARTED|Treatment Period 2 (21 Days)||8
2275204|NCT02231177|5584817|P6|NOT COMPLETED|Treatment Period 1 (21 Days)||0
2275205|NCT02231177|5584818|P5|NOT COMPLETED|Treatment Period 1 (21 Days)||0
2275206|NCT02231177|5584819|P4|NOT COMPLETED|Treatment Period 1 (21 Days)||0
2275207|NCT02231177|5584820|P3|NOT COMPLETED|Treatment Period 1 (21 Days)||0
2275208|NCT02231177|5584821|P2|NOT COMPLETED|Treatment Period 1 (21 Days)||0
2275209|NCT02231177|5584822|P1|NOT COMPLETED|Treatment Period 1 (21 Days)||0
2275210|NCT02231177|5584817|P6|COMPLETED|Treatment Period 1 (21 Days)||9
2275211|NCT02231177|5584818|P5|COMPLETED|Treatment Period 1 (21 Days)||8
2275212|NCT02231177|5584819|P4|COMPLETED|Treatment Period 1 (21 Days)||7
2275213|NCT02231177|5584820|P3|COMPLETED|Treatment Period 1 (21 Days)||8
2275214|NCT02231177|5584821|P2|COMPLETED|Treatment Period 1 (21 Days)||7
2275215|NCT02231177|5584822|P1|COMPLETED|Treatment Period 1 (21 Days)||8
2275216|NCT02231177|5584817|P6|STARTED|Treatment Period 1 (21 Days)||9
2275217|NCT02231177|5584818|P5|STARTED|Treatment Period 1 (21 Days)||8
2275218|NCT02231177|5584819|P4|STARTED|Treatment Period 1 (21 Days)||7
2275219|NCT02231177|5584820|P3|STARTED|Treatment Period 1 (21 Days)||8
2275220|NCT02231177|5584821|P2|STARTED|Treatment Period 1 (21 Days)||7
2275221|NCT02231177|5584822|P1|STARTED|Treatment Period 1 (21 Days)||8
2275222|NCT02231164|5584878|P2|NOT COMPLETED|Overall Study||6
2275223|NCT02231164|5584879|P1|NOT COMPLETED|Overall Study||6
2275224|NCT02231164|5584878|P2|COMPLETED|Overall Study||0
2275225|NCT02231164|5584879|P1|COMPLETED|Overall Study||0
2275226|NCT02231164|5584878|P2|STARTED|Overall Study||6
2275227|NCT02231164|5584879|P1|STARTED|Overall Study||6
2275228|NCT02230995|5584887|P2|NOT COMPLETED|Period 2 + Washout||0
2275229|NCT02230995|5584888|P1|NOT COMPLETED|Period 2 + Washout||0
2275230|NCT02230995|5584887|P2|COMPLETED|Period 2 + Washout||15
2275231|NCT02230995|5584888|P1|COMPLETED|Period 2 + Washout||15
2275232|NCT02230995|5584887|P2|STARTED|Period 2 + Washout||15
2275233|NCT02230995|5584888|P1|STARTED|Period 2 + Washout||15
2275234|NCT02230995|5584887|P2|NOT COMPLETED|Period 1 + Washout||0
2275235|NCT02230995|5584888|P1|NOT COMPLETED|Period 1 + Washout||0
2275236|NCT02230995|5584887|P2|COMPLETED|Period 1 + Washout||15
2275237|NCT02230995|5584888|P1|COMPLETED|Period 1 + Washout||15
2275238|NCT02230995|5584887|P2|STARTED|Period 1 + Washout||15
2275239|NCT02230995|5584888|P1|STARTED|Period 1 + Washout||15
2275240|NCT02230956|5584907|P3|NOT COMPLETED|Overall Study||7
2275241|NCT02230956|5584908|P2|NOT COMPLETED|Overall Study||6
2275242|NCT02230956|5584909|P1|NOT COMPLETED|Overall Study||5
2275243|NCT02230956|5584907|P3|COMPLETED|Overall Study||82
2275244|NCT02230956|5584908|P2|COMPLETED|Overall Study||37
2275245|NCT02230956|5584909|P1|COMPLETED|Overall Study||39
2275246|NCT02230956|5584907|P3|STARTED|Overall Study||89
2275247|NCT02230956|5584908|P2|STARTED|Overall Study||43
2275248|NCT02230956|5584909|P1|STARTED|Overall Study||44
2275249|NCT02230904|5584931|P2|NOT COMPLETED|Overall Study||1
2275250|NCT02230904|5584932|P1|NOT COMPLETED|Overall Study||0
2275251|NCT02230904|5584931|P2|COMPLETED|Overall Study||27
2275252|NCT02230904|5584932|P1|COMPLETED|Overall Study||29
2275253|NCT02230904|5584931|P2|STARTED|Overall Study||28
2275254|NCT02230904|5584932|P1|STARTED|Overall Study||29
2275255|NCT02230761|5584954|P2|NOT COMPLETED|Overall Study||1
2275256|NCT02230761|5584955|P1|NOT COMPLETED|Overall Study||0
2275257|NCT02230761|5584954|P2|COMPLETED|Overall Study||29
2275258|NCT02230761|5584955|P1|COMPLETED|Overall Study||60
2275259|NCT02230761|5584954|P2|STARTED|Overall Study||30
2275260|NCT02230761|5584955|P1|STARTED|Overall Study||60
2275261|NCT02230683|5584965|P1|NOT COMPLETED|Overall Study||1
2275262|NCT02230683|5584965|P1|COMPLETED|Overall Study||22
2275263|NCT02230683|5584965|P1|STARTED|Overall Study||23
2275264|NCT02230670|5584982|P2|NOT COMPLETED|Overall Study||8
2275265|NCT02230670|5584983|P1|NOT COMPLETED|Overall Study||4
2275266|NCT02230670|5584982|P2|COMPLETED|Overall Study||34
2275267|NCT02230670|5584983|P1|COMPLETED|Overall Study||40
2275268|NCT02230670|5584982|P2|STARTED|Overall Study|One subject randomized to placebo withdrew from the study before receiving any study treatment.|42
2275269|NCT02230670|5584983|P1|STARTED|Overall Study||44
2275270|NCT02230579|5585000|P7|NOT COMPLETED|Overall Study||0
2275271|NCT02230579|5585001|P6|NOT COMPLETED|Overall Study||0
2275272|NCT02230579|5585002|P5|NOT COMPLETED|Overall Study||0
2275273|NCT02230579|5585003|P4|NOT COMPLETED|Overall Study||0
2275274|NCT02230579|5585004|P3|NOT COMPLETED|Overall Study||0
2275275|NCT02230579|5585005|P2|NOT COMPLETED|Overall Study||0
2275276|NCT02230579|5585006|P1|NOT COMPLETED|Overall Study||0
2275277|NCT02230579|5585000|P7|COMPLETED|Overall Study||12
2275278|NCT02230579|5585001|P6|COMPLETED|Overall Study||6
2275279|NCT02230579|5585002|P5|COMPLETED|Overall Study||6
2275280|NCT02230579|5585003|P4|COMPLETED|Overall Study||6
2275281|NCT02230579|5585004|P3|COMPLETED|Overall Study||6
2275282|NCT02230579|5585005|P2|COMPLETED|Overall Study||6
2275283|NCT02230579|5585006|P1|COMPLETED|Overall Study||6
2275284|NCT02230579|5585000|P7|STARTED|Overall Study||12
2275285|NCT02230579|5585001|P6|STARTED|Overall Study||6
2275286|NCT02230579|5585002|P5|STARTED|Overall Study||6
2275287|NCT02230579|5585003|P4|STARTED|Overall Study||6
2275288|NCT02230579|5585004|P3|STARTED|Overall Study||6
2275289|NCT02230579|5585005|P2|STARTED|Overall Study||6
2275290|NCT02230579|5585006|P1|STARTED|Overall Study||6
2275291|NCT02230566|5585044|P4|NOT COMPLETED|Overall Study||0
2275292|NCT02230566|5585045|P3|NOT COMPLETED|Overall Study||0
2275293|NCT02230566|5585046|P2|NOT COMPLETED|Overall Study||0
2275294|NCT02230566|5585047|P1|NOT COMPLETED|Overall Study||0
2275295|NCT02230566|5585044|P4|COMPLETED|Overall Study||3
2275296|NCT02230566|5585045|P3|COMPLETED|Overall Study||3
2275297|NCT02230566|5585046|P2|COMPLETED|Overall Study||3
2275298|NCT02230566|5585047|P1|COMPLETED|Overall Study||3
2275299|NCT02230566|5585044|P4|STARTED|Overall Study||3
2275300|NCT02230566|5585045|P3|STARTED|Overall Study||3
2275301|NCT02230566|5585046|P2|STARTED|Overall Study||3
2275302|NCT02230566|5585047|P1|STARTED|Overall Study||3
2275303|NCT02230540|5585062|P2|NOT COMPLETED|Overall Study||0
2275304|NCT02230540|5585063|P1|NOT COMPLETED|Overall Study||0
2275305|NCT02230540|5585062|P2|COMPLETED|Overall Study||0
2275306|NCT02230540|5585063|P1|COMPLETED|Overall Study||8
2275307|NCT02230540|5585062|P2|STARTED|Overall Study|The study was terminated before initiation of sequence B. Sequence B was therefore not initiated.|0
2275308|NCT02230540|5585063|P1|STARTED|Overall Study||8
2275309|NCT02230384|5585069|P2|NOT COMPLETED|Phase 2 Wash Out||0
2275310|NCT02230384|5585070|P1|NOT COMPLETED|Phase 2 Wash Out||0
2275311|NCT02230384|5585069|P2|COMPLETED|Phase 2 Wash Out||30
2275312|NCT02230384|5585070|P1|COMPLETED|Phase 2 Wash Out||26
2275313|NCT02230384|5585069|P2|STARTED|Phase 2 Wash Out||30
2275314|NCT02230384|5585070|P1|STARTED|Phase 2 Wash Out||26
2275315|NCT02230384|5585069|P2|NOT COMPLETED|Phase 2 - Switch||1
2275316|NCT02230384|5585070|P1|NOT COMPLETED|Phase 2 - Switch||3
2275317|NCT02230384|5585069|P2|COMPLETED|Phase 2 - Switch||30
2275318|NCT02230384|5585070|P1|COMPLETED|Phase 2 - Switch||26
2275319|NCT02230384|5585069|P2|STARTED|Phase 2 - Switch||31
2275320|NCT02230384|5585070|P1|STARTED|Phase 2 - Switch||29
2275321|NCT02230384|5585069|P2|NOT COMPLETED|Phase 1 Wash Out||0
2275322|NCT02230384|5585070|P1|NOT COMPLETED|Phase 1 Wash Out||0
2275323|NCT02230384|5585069|P2|COMPLETED|Phase 1 Wash Out||31
2275324|NCT02230384|5585070|P1|COMPLETED|Phase 1 Wash Out||29
2275325|NCT02230384|5585069|P2|STARTED|Phase 1 Wash Out||31
2275326|NCT02230384|5585070|P1|STARTED|Phase 1 Wash Out||29
2275327|NCT02230384|5585069|P2|NOT COMPLETED|Phase 1||1
2275328|NCT02230384|5585070|P1|NOT COMPLETED|Phase 1||1
2275329|NCT02230384|5585069|P2|COMPLETED|Phase 1||31
2275330|NCT02230384|5585070|P1|COMPLETED|Phase 1||29
2275331|NCT02230384|5585069|P2|STARTED|Phase 1||32
2275332|NCT02230384|5585070|P1|STARTED|Phase 1||30
2275333|NCT02230332|5585090|P2|NOT COMPLETED|Overall Study||1
2275334|NCT02230332|5585091|P1|NOT COMPLETED|Overall Study||4
2275335|NCT02230332|5585090|P2|COMPLETED|Overall Study||39
2275336|NCT02230332|5585091|P1|COMPLETED|Overall Study||34
2275337|NCT02230332|5585090|P2|STARTED|Overall Study||40
2275338|NCT02230332|5585091|P1|STARTED|Overall Study||38
2275339|NCT02230306|5585107|P1|NOT COMPLETED|Overall Study||1
2275340|NCT02230306|5585107|P1|COMPLETED|Overall Study||4
2275341|NCT02230306|5585107|P1|STARTED|Overall Study||5
2275342|NCT02230085|5585118|P1|NOT COMPLETED|Overall Study||4
2275343|NCT02230085|5585118|P1|COMPLETED|Overall Study||106
2275344|NCT02230085|5585118|P1|STARTED|Overall Study||110
2275345|NCT02229864|5585122|P1|NOT COMPLETED|3 - Year Visit||2
2275346|NCT02229864|5585122|P1|COMPLETED|3 - Year Visit||10
2275347|NCT02229864|5585122|P1|STARTED|3 - Year Visit|The missed visit participant in the 2nd year has joined the study for 3rd year follow-up.|12
2275348|NCT02229864|5585122|P1|NOT COMPLETED|2 - Year Visit||1
2275349|NCT02229864|5585122|P1|COMPLETED|2 - Year Visit||11
2275350|NCT02229864|5585122|P1|STARTED|2 - Year Visit||12
2275351|NCT02229864|5585122|P1|NOT COMPLETED|1 - Year Visit||0
2275352|NCT02229864|5585122|P1|COMPLETED|1 - Year Visit||12
2275353|NCT02229864|5585122|P1|STARTED|1 - Year Visit||12
2275354|NCT02229864|5585122|P1|NOT COMPLETED|6 - Month Visit||0
2275355|NCT02229864|5585122|P1|COMPLETED|6 - Month Visit||12
2275356|NCT02229864|5585122|P1|STARTED|6 - Month Visit||12
2275357|NCT02229864|5585122|P1|NOT COMPLETED|1 - Month Visit||0
2275358|NCT02229864|5585122|P1|COMPLETED|1 - Month Visit||12
2275359|NCT02229864|5585122|P1|STARTED|1 - Month Visit||12
2275360|NCT02229539|5585177|P3|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||10
2275361|NCT02229539|5585178|P2|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||7
2275362|NCT02229539|5585179|P1|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||9
2275363|NCT02229539|5585177|P3|COMPLETED|Cycle 2 (Optional Continuation Phase)||22
2275364|NCT02229539|5585178|P2|COMPLETED|Cycle 2 (Optional Continuation Phase)||29
2275365|NCT02229539|5585179|P1|COMPLETED|Cycle 2 (Optional Continuation Phase)||26
2275366|NCT02229539|5585177|P3|STARTED|Cycle 2 (Optional Continuation Phase)||32
2275367|NCT02229539|5585178|P2|STARTED|Cycle 2 (Optional Continuation Phase)||36
2275368|NCT02229539|5585179|P1|STARTED|Cycle 2 (Optional Continuation Phase)||35
2275369|NCT02229539|5585177|P3|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
2275370|NCT02229539|5585178|P2|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||5
2275371|NCT02229539|5585179|P1|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
2275372|NCT02229539|5585177|P3|COMPLETED|Cycle 1 (Treatment Per Protocol)||72
2275373|NCT02229539|5585178|P2|COMPLETED|Cycle 1 (Treatment Per Protocol)||71
2275374|NCT02229539|5585179|P1|COMPLETED|Cycle 1 (Treatment Per Protocol)||74
2275375|NCT02229539|5585177|P3|STARTED|Cycle 1 (Treatment Per Protocol)||75
2275376|NCT02229539|5585178|P2|STARTED|Cycle 1 (Treatment Per Protocol)||76
2275377|NCT02229539|5585179|P1|STARTED|Cycle 1 (Treatment Per Protocol)||77
2275378|NCT02229513|5585189|P2|NOT COMPLETED|Overall Study||0
2275379|NCT02229513|5585190|P1|NOT COMPLETED|Overall Study||0
2275380|NCT02229513|5585189|P2|COMPLETED|Overall Study||100
2275381|NCT02229513|5585190|P1|COMPLETED|Overall Study||100
2275382|NCT02229513|5585189|P2|STARTED|Overall Study||100
2275383|NCT02229513|5585190|P1|STARTED|Overall Study||100
2275384|NCT02229487|5585226|P2|NOT COMPLETED|Overall Study||0
2275385|NCT02229487|5585227|P1|NOT COMPLETED|Overall Study||0
2275386|NCT02229487|5585226|P2|COMPLETED|Overall Study||27
2275387|NCT02229487|5585227|P1|COMPLETED|Overall Study||24
2275388|NCT02229487|5585226|P2|STARTED|Overall Study||27
2275389|NCT02229487|5585227|P1|STARTED|Overall Study||24
2275390|NCT02229474|5585235|P2|NOT COMPLETED|Overall Study||3
2275391|NCT02229474|5585236|P1|NOT COMPLETED|Overall Study||0
2275392|NCT02229474|5585235|P2|COMPLETED|Overall Study||15
2275393|NCT02229474|5585236|P1|COMPLETED|Overall Study||16
2275394|NCT02229474|5585235|P2|STARTED|Overall Study||18
2275395|NCT02229474|5585236|P1|STARTED|Overall Study||16
2275396|NCT02229461|5585269|P6|NOT COMPLETED|Overall Study||0
2275397|NCT02229461|5585270|P5|NOT COMPLETED|Overall Study||0
2275398|NCT02229461|5585271|P4|NOT COMPLETED|Overall Study||0
2275399|NCT02229461|5585272|P3|NOT COMPLETED|Overall Study||0
2275400|NCT02229461|5585273|P2|NOT COMPLETED|Overall Study||0
2275401|NCT02229461|5585274|P1|NOT COMPLETED|Overall Study||0
2275402|NCT02229461|5585269|P6|COMPLETED|Overall Study||17
2275403|NCT02229461|5585270|P5|COMPLETED|Overall Study||17
2275404|NCT02229461|5585271|P4|COMPLETED|Overall Study||17
2275405|NCT02229461|5585272|P3|COMPLETED|Overall Study||17
2275406|NCT02229461|5585273|P2|COMPLETED|Overall Study||17
2275407|NCT02229461|5585274|P1|COMPLETED|Overall Study||17
2275408|NCT02229461|5585269|P6|STARTED|Overall Study|Randomized and received treatment|17
2275409|NCT02229461|5585270|P5|STARTED|Overall Study|Randomized and received treatment|17
2275410|NCT02229461|5585271|P4|STARTED|Overall Study|Randomized and received treatment|17
2275411|NCT02229461|5585272|P3|STARTED|Overall Study|Randomized and received treatment|17
2275412|NCT02229461|5585273|P2|STARTED|Overall Study|Randomized and received treatment|17
2275413|NCT02229461|5585274|P1|STARTED|Overall Study|Randomized and received treatment|17
2275414|NCT02229396|5585310|P3|NOT COMPLETED|Overall Study||95
2275415|NCT02229396|5585311|P2|NOT COMPLETED|Overall Study||77
2275416|NCT02229396|5585312|P1|NOT COMPLETED|Overall Study||78
2275417|NCT02229396|5585310|P3|COMPLETED|Overall Study||136
2275418|NCT02229396|5585311|P2|COMPLETED|Overall Study||154
2275419|NCT02229396|5585312|P1|COMPLETED|Overall Study||155
2275420|NCT02229396|5585310|P3|Completed 52-Week Study Period|Overall Study||177
2275421|NCT02229396|5585311|P2|Completed 52-Week Study Period|Overall Study||193
2275422|NCT02229396|5585312|P1|Completed 52-Week Study Period|Overall Study||194
2275423|NCT02229396|5585310|P3|Completed 28-Week Study Period|Overall Study||193
2275424|NCT02229396|5585311|P2|Completed 28-Week Study Period|Overall Study||202
2275425|NCT02229396|5585312|P1|Completed 28-Week Study Period|Overall Study||208
2275426|NCT02229396|5585310|P3|Intent-to-Treat (ITT) Analysis Set|Overall Study||227
2275427|NCT02229396|5585311|P2|Intent-to-Treat (ITT) Analysis Set|Overall Study||228
2275428|NCT02229396|5585312|P1|Intent-to-Treat (ITT) Analysis Set|Overall Study||230
2275429|NCT02229396|5585310|P3|Safety Analysis Set|Overall Study||230
2275430|NCT02229396|5585311|P2|Safety Analysis Set|Overall Study||231
2275431|NCT02229396|5585312|P1|Safety Analysis Set|Overall Study||233
2275432|NCT02229396|5585310|P3|Randomization Code Allocated|Overall Study||231
2275433|NCT02229396|5585311|P2|Randomization Code Allocated|Overall Study||231
2275434|NCT02229396|5585312|P1|Randomization Code Allocated|Overall Study||233
2275435|NCT02229396|5585310|P3|STARTED|Overall Study||231
2275436|NCT02229396|5585311|P2|STARTED|Overall Study||231
2275437|NCT02229396|5585312|P1|STARTED|Overall Study||233
2275438|NCT02229383|5585343|P2|NOT COMPLETED|Overall Study||22
2275439|NCT02229383|5585344|P1|NOT COMPLETED|Overall Study||20
2275440|NCT02229383|5585343|P2|COMPLETED|Overall Study||207
2275441|NCT02229383|5585344|P1|COMPLETED|Overall Study||212
2275442|NCT02229383|5585343|P2|Intent-to-treat (ITT) Analysis Set|Overall Study||228
2275443|NCT02229383|5585344|P1|Intent-to-treat (ITT) Analysis Set|Overall Study||230
2275444|NCT02229383|5585343|P2|Safety Analysis Set|Overall Study||229
2275445|NCT02229383|5585344|P1|Safety Analysis Set|Overall Study||231
2275446|NCT02229383|5585343|P2|Received Treatment|Overall Study||229
2275447|NCT02229383|5585344|P1|Received Treatment|Overall Study||231
2275448|NCT02229383|5585343|P2|STARTED|Overall Study||229
2275449|NCT02229383|5585344|P1|STARTED|Overall Study||232
2275450|NCT02229318|5585362|P1|NOT COMPLETED|Overall Study||0
2275451|NCT02229318|5585362|P1|COMPLETED|Overall Study|September 15th 2014 11 completed|11
2275452|NCT02229318|5585362|P1|STARTED|Overall Study|September 6th 2014 11 enrolled|11
2275453|NCT02229227|5585369|P2|NOT COMPLETED|Overall Study||62
2275454|NCT02229227|5585370|P1|NOT COMPLETED|Overall Study||51
2275455|NCT02229227|5585369|P2|COMPLETED|Overall Study||350
2275456|NCT02229227|5585370|P1|COMPLETED|Overall Study||351
2275457|NCT02229227|5585369|P2|STARTED|Overall Study||412
2275458|NCT02229227|5585370|P1|STARTED|Overall Study||402
2275459|NCT02229214|5585455|P2|NOT COMPLETED|Overall Study||0
2275460|NCT02229214|5585456|P1|NOT COMPLETED|Overall Study||6
2275461|NCT02229214|5585455|P2|COMPLETED|Overall Study||10
2275462|NCT02229214|5585456|P1|COMPLETED|Overall Study||35
2275463|NCT02229214|5585455|P2|STARTED|Overall Study||10
2275464|NCT02229214|5585456|P1|STARTED|Overall Study||41
2275465|NCT02228980|5585480|P4|NOT COMPLETED|Overall Study||3
2275466|NCT02228980|5585481|P3|NOT COMPLETED|Overall Study||2
2275467|NCT02228980|5585482|P2|NOT COMPLETED|Overall Study||3
2275468|NCT02228980|5585483|P1|NOT COMPLETED|Overall Study||24
2275469|NCT02228980|5585480|P4|COMPLETED|Overall Study||148
2275470|NCT02228980|5585481|P3|COMPLETED|Overall Study||149
2275471|NCT02228980|5585482|P2|COMPLETED|Overall Study||147
2275472|NCT02228980|5585483|P1|COMPLETED|Overall Study||126
2275473|NCT02228980|5585480|P4|STARTED|Overall Study||151
2275474|NCT02228980|5585481|P3|STARTED|Overall Study||151
2275475|NCT02228980|5585482|P2|STARTED|Overall Study||150
2275476|NCT02228980|5585483|P1|STARTED|Overall Study||150
2275477|NCT02228967|5585507|P2|NOT COMPLETED|Overall Study||160
2275478|NCT02228967|5585508|P1|NOT COMPLETED|Overall Study||159
2275479|NCT02228967|5585507|P2|COMPLETED|Overall Study||228
2275480|NCT02228967|5585508|P1|COMPLETED|Overall Study||244
2275481|NCT02228967|5585507|P2|STARTED|Overall Study||388
2275482|NCT02228967|5585508|P1|STARTED|Overall Study||403
2275483|NCT02228824|5585530|P2|NOT COMPLETED|Overall Study||22
2275484|NCT02228824|5585531|P1|NOT COMPLETED|Overall Study||29
2275485|NCT02228824|5585530|P2|COMPLETED|Overall Study||98
2275486|NCT02228824|5585531|P1|COMPLETED|Overall Study||89
2275487|NCT02228824|5585530|P2|STARTED|Overall Study||120
2275488|NCT02228824|5585531|P1|STARTED|Overall Study||118
2275489|NCT02228720|5585545|P1|NOT COMPLETED|Open Label - Day 90||0
2275490|NCT02228720|5585545|P1|COMPLETED|Open Label - Day 90||14
2275491|NCT02228720|5585545|P1|STARTED|Open Label - Day 90||14
2275492|NCT02228720|5585545|P1|NOT COMPLETED|Open Label - Day 30||1
2275493|NCT02228720|5585545|P1|COMPLETED|Open Label - Day 30||14
2275494|NCT02228720|5585545|P1|STARTED|Open Label - Day 30||15
2275495|NCT02228720|5585545|P1|NOT COMPLETED|Open Label - Baseline||0
2275496|NCT02228720|5585545|P1|COMPLETED|Open Label - Baseline||15
2275497|NCT02228720|5585545|P1|STARTED|Open Label - Baseline||15
2275498|NCT02228681|5585555|P2|NOT COMPLETED|Overall Study||0
2275499|NCT02228681|5585556|P1|NOT COMPLETED|Overall Study||0
2275500|NCT02228681|5585555|P2|COMPLETED|Overall Study||37
2275501|NCT02228681|5585556|P1|COMPLETED|Overall Study||37
2275502|NCT02228681|5585555|P2|STARTED|Overall Study||37
2275503|NCT02228681|5585556|P1|STARTED|Overall Study||37
2275504|NCT02228499|5585570|P2|NOT COMPLETED|Overall Study||26
2275505|NCT02228499|5585571|P1|NOT COMPLETED|Overall Study||23
2275506|NCT02228499|5585570|P2|COMPLETED|Overall Study||10
2275507|NCT02228499|5585571|P1|COMPLETED|Overall Study||7
2275508|NCT02228499|5585570|P2|STARTED|Overall Study||36
2275509|NCT02228499|5585571|P1|STARTED|Overall Study||30
2275510|NCT02228460|5585577|P1|NOT COMPLETED|Overall Study||2
2275511|NCT02228460|5585577|P1|COMPLETED|Overall Study||9
2275512|NCT02228460|5585577|P1|STARTED|Overall Study||11
2275513|NCT02228395|5585600|P3|NOT COMPLETED|Third Intervention Period||0
2275514|NCT02228395|5585601|P2|NOT COMPLETED|Third Intervention Period||0
2275515|NCT02228395|5585602|P1|NOT COMPLETED|Third Intervention Period||0
2275516|NCT02228395|5585600|P3|COMPLETED|Third Intervention Period||3
2275517|NCT02228395|5585601|P2|COMPLETED|Third Intervention Period||3
2275518|NCT02228395|5585602|P1|COMPLETED|Third Intervention Period||3
2275519|NCT02228395|5585600|P3|STARTED|Third Intervention Period||3
2275520|NCT02228395|5585601|P2|STARTED|Third Intervention Period||3
2275521|NCT02228395|5585602|P1|STARTED|Third Intervention Period||3
2275522|NCT02228395|5585600|P3|NOT COMPLETED|Washout Period (at Least 10 Days)||0
2275523|NCT02228395|5585601|P2|NOT COMPLETED|Washout Period (at Least 10 Days)||0
2275524|NCT02228395|5585602|P1|NOT COMPLETED|Washout Period (at Least 10 Days)||0
2275525|NCT02228395|5585600|P3|COMPLETED|Washout Period (at Least 10 Days)||3
2275526|NCT02228395|5585601|P2|COMPLETED|Washout Period (at Least 10 Days)||3
2275527|NCT02228395|5585602|P1|COMPLETED|Washout Period (at Least 10 Days)||3
2275528|NCT02228395|5585600|P3|STARTED|Washout Period (at Least 10 Days)||3
2275529|NCT02228395|5585601|P2|STARTED|Washout Period (at Least 10 Days)||3
2275530|NCT02228395|5585602|P1|STARTED|Washout Period (at Least 10 Days)||3
2275531|NCT02228395|5585600|P3|NOT COMPLETED|Second Intervention Period||0
2275532|NCT02228395|5585601|P2|NOT COMPLETED|Second Intervention Period||0
2275533|NCT02228395|5585602|P1|NOT COMPLETED|Second Intervention Period||0
2275534|NCT02228395|5585600|P3|COMPLETED|Second Intervention Period||3
2275535|NCT02228395|5585601|P2|COMPLETED|Second Intervention Period||3
2275536|NCT02228395|5585602|P1|COMPLETED|Second Intervention Period||3
2275537|NCT02228395|5585600|P3|STARTED|Second Intervention Period||3
2275538|NCT02228395|5585601|P2|STARTED|Second Intervention Period||3
2275539|NCT02228395|5585602|P1|STARTED|Second Intervention Period||3
2275540|NCT02228395|5585600|P3|NOT COMPLETED|Washout Period (at Least 10 Days)||0
2275541|NCT02228395|5585601|P2|NOT COMPLETED|Washout Period (at Least 10 Days)||0
2275542|NCT02228395|5585602|P1|NOT COMPLETED|Washout Period (at Least 10 Days)||0
2275543|NCT02228395|5585600|P3|COMPLETED|Washout Period (at Least 10 Days)||3
2275544|NCT02228395|5585601|P2|COMPLETED|Washout Period (at Least 10 Days)||3
2275545|NCT02228395|5585602|P1|COMPLETED|Washout Period (at Least 10 Days)||3
2275546|NCT02228395|5585600|P3|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
2275547|NCT02228395|5585601|P2|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
2275548|NCT02228395|5585602|P1|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
2275549|NCT02228395|5585600|P3|NOT COMPLETED|First Intervention Period||1
2275550|NCT02228395|5585601|P2|NOT COMPLETED|First Intervention Period||1
2275551|NCT02228395|5585602|P1|NOT COMPLETED|First Intervention Period||1
2275552|NCT02228395|5585600|P3|COMPLETED|First Intervention Period||2
2275553|NCT02228395|5585601|P2|COMPLETED|First Intervention Period||2
2275554|NCT02228395|5585602|P1|COMPLETED|First Intervention Period||2
2275555|NCT02228395|5585600|P3|STARTED|First Intervention Period||3
2275556|NCT02228395|5585601|P2|STARTED|First Intervention Period||3
2275557|NCT02228395|5585602|P1|STARTED|First Intervention Period||3
2275558|NCT02228174|5585666|P1|NOT COMPLETED|Overall Study||5
2275559|NCT02228174|5585666|P1|COMPLETED|Overall Study||142
2275560|NCT02228174|5585666|P1|Full Analysis Population|Overall Study|Subjects who didn't become pregnant or diagnosed with an interfering medical condition at 12-months|143
2275561|NCT02228174|5585666|P1|STARTED|Overall Study||147
2275562|NCT02227849|5585686|P1|NOT COMPLETED|Overall Study||8
2275563|NCT02227849|5585686|P1|COMPLETED|Overall Study||63
2275564|NCT02227849|5585686|P1|STARTED|Overall Study||71
2275565|NCT02227836|5585694|P1|NOT COMPLETED|Overall Study||0
2275566|NCT02227836|5585694|P1|COMPLETED|Overall Study||8
2275567|NCT02227836|5585694|P1|STARTED|Overall Study||8
2275568|NCT02227810|5585700|P2|NOT COMPLETED|Overall Study||5
2275569|NCT02227810|5585701|P1|NOT COMPLETED|Overall Study||2
2275570|NCT02227810|5585700|P2|COMPLETED|Overall Study||29
2275571|NCT02227810|5585701|P1|COMPLETED|Overall Study||17
2275572|NCT02227810|5585700|P2|STARTED|Overall Study||34
2275573|NCT02227810|5585701|P1|STARTED|Overall Study||19
2275574|NCT02227784|5585717|P5|NOT COMPLETED|Open-Label Extension Phase (OLE)||248
2275575|NCT02227784|5585718|P4|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
2275576|NCT02227784|5585719|P3|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
2275577|NCT02227784|5585720|P2|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
2275578|NCT02227784|5585721|P1|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
2275579|NCT02227784|5585717|P5|COMPLETED|Open-Label Extension Phase (OLE)||0
2275580|NCT02227784|5585718|P4|COMPLETED|Open-Label Extension Phase (OLE)||0
2275581|NCT02227784|5585719|P3|COMPLETED|Open-Label Extension Phase (OLE)||0
2275582|NCT02227784|5585720|P2|COMPLETED|Open-Label Extension Phase (OLE)||0
2275583|NCT02227784|5585721|P1|COMPLETED|Open-Label Extension Phase (OLE)||0
2275584|NCT02227784|5585717|P5|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||247
2275585|NCT02227784|5585718|P4|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
2275586|NCT02227784|5585719|P3|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
2275587|NCT02227784|5585720|P2|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
2275588|NCT02227784|5585721|P1|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
2275589|NCT02227784|5585717|P5|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|248
2275590|NCT02227784|5585718|P4|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
2275591|NCT02227784|5585719|P3|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
2275592|NCT02227784|5585720|P2|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
2275593|NCT02227784|5585721|P1|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
2275594|NCT02227784|5585717|P5|NOT COMPLETED|Double-Blind Phase||0
2275595|NCT02227784|5585718|P4|NOT COMPLETED|Double-Blind Phase||39
2275596|NCT02227784|5585719|P3|NOT COMPLETED|Double-Blind Phase||21
2275597|NCT02227784|5585720|P2|NOT COMPLETED|Double-Blind Phase||18
2275598|NCT02227784|5585721|P1|NOT COMPLETED|Double-Blind Phase||40
2275599|NCT02227784|5585717|P5|COMPLETED|Double-Blind Phase||0
2275600|NCT02227784|5585718|P4|COMPLETED|Double-Blind Phase||88
2275601|NCT02227784|5585719|P3|COMPLETED|Double-Blind Phase||41
2275602|NCT02227784|5585720|P2|COMPLETED|Double-Blind Phase||36
2275603|NCT02227784|5585721|P1|COMPLETED|Double-Blind Phase||83
2275604|NCT02227784|5585717|P5|STARTED|Double-Blind Phase||0
2275605|NCT02227784|5585718|P4|STARTED|Double-Blind Phase||127
2275606|NCT02227784|5585719|P3|STARTED|Double-Blind Phase||62
2275607|NCT02227784|5585720|P2|STARTED|Double-Blind Phase||54
2275608|NCT02227784|5585721|P1|STARTED|Double-Blind Phase||123
2275609|NCT02227758|5585756|P1|NOT COMPLETED|Overall Study||67
2275610|NCT02227758|5585756|P1|COMPLETED|Overall Study||45
2275611|NCT02227758|5585756|P1|STARTED|Overall Study||112
2275612|NCT02227693|5585772|P4|NOT COMPLETED|Overall Study||0
2275613|NCT02227693|5585773|P3|NOT COMPLETED|Overall Study||0
2275614|NCT02227693|5585774|P2|NOT COMPLETED|Overall Study||0
2275615|NCT02227693|5585775|P1|NOT COMPLETED|Overall Study||0
2275616|NCT02227693|5585772|P4|COMPLETED|Overall Study||10
2275617|NCT02227693|5585773|P3|COMPLETED|Overall Study||11
2275618|NCT02227693|5585774|P2|COMPLETED|Overall Study||7
2275619|NCT02227693|5585775|P1|COMPLETED|Overall Study||11
2275620|NCT02227693|5585772|P4|STARTED|Overall Study||10
2275621|NCT02227693|5585773|P3|STARTED|Overall Study||11
2275622|NCT02227693|5585774|P2|STARTED|Overall Study||7
2275623|NCT02227693|5585775|P1|STARTED|Overall Study||11
2275624|NCT02227485|5585831|P2|NOT COMPLETED|Second Follow-up||2
2275625|NCT02227485|5585832|P1|NOT COMPLETED|Second Follow-up||2
2275626|NCT02227485|5585831|P2|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|36
2275627|NCT02227485|5585832|P1|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|34
2275628|NCT02227485|5585831|P2|STARTED|Second Follow-up||38
2275629|NCT02227485|5585832|P1|STARTED|Second Follow-up||36
2275630|NCT02227485|5585831|P2|NOT COMPLETED|First Follow-up||2
2275631|NCT02227485|5585832|P1|NOT COMPLETED|First Follow-up||4
2275632|NCT02227485|5585831|P2|COMPLETED|First Follow-up|After 2 weeks, 2 patients had withdrew the study.|38
2275633|NCT02227485|5585832|P1|COMPLETED|First Follow-up|At the first follow-up we lost 4 patients.|36
2275634|NCT02227485|5585831|P2|STARTED|First Follow-up||40
2275635|NCT02227485|5585832|P1|STARTED|First Follow-up||40
2275636|NCT02227368|5585850|P2|NOT COMPLETED|Overall Study||4
2275637|NCT02227368|5585851|P1|NOT COMPLETED|Overall Study||2
2275638|NCT02227368|5585850|P2|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|20
2275639|NCT02227368|5585851|P1|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|14
2275640|NCT02227368|5585850|P2|Sujects Who Completed Treatment|Overall Study||17
2275641|NCT02227368|5585851|P1|Sujects Who Completed Treatment|Overall Study||10
2275642|NCT02227368|5585850|P2|Sujects Who Received Treatment|Overall Study||24
2275643|NCT02227368|5585851|P1|Sujects Who Received Treatment|Overall Study||16
2275644|NCT02227368|5585850|P2|STARTED|Overall Study||24
2275645|NCT02227368|5585851|P1|STARTED|Overall Study||16
2275646|NCT02227329|5585861|P2|NOT COMPLETED|Overall Study||0
2275647|NCT02227329|5585862|P1|NOT COMPLETED|Overall Study||0
2275648|NCT02227329|5585861|P2|COMPLETED|Overall Study||20
2275649|NCT02227329|5585862|P1|COMPLETED|Overall Study||18
2275650|NCT02227329|5585861|P2|STARTED|Overall Study||20
2275651|NCT02227329|5585862|P1|STARTED|Overall Study||18
2275652|NCT02227316|5585872|P4|NOT COMPLETED|Overall Study||0
2275653|NCT02227316|5585873|P3|NOT COMPLETED|Overall Study||0
2275654|NCT02227316|5585874|P2|NOT COMPLETED|Overall Study||0
2275655|NCT02227316|5585875|P1|NOT COMPLETED|Overall Study||0
2275656|NCT02227316|5585872|P4|COMPLETED|Overall Study||16
2275657|NCT02227316|5585873|P3|COMPLETED|Overall Study||16
2275658|NCT02227316|5585874|P2|COMPLETED|Overall Study||4
2275659|NCT02227316|5585875|P1|COMPLETED|Overall Study||4
2275660|NCT02227316|5585872|P4|STARTED|Overall Study||16
2275661|NCT02227316|5585873|P3|STARTED|Overall Study||16
2275662|NCT02227316|5585874|P2|STARTED|Overall Study||4
2275663|NCT02227316|5585875|P1|STARTED|Overall Study||4
2275664|NCT02227238|5585907|P2|NOT COMPLETED|Overall Study||67
2275665|NCT02227238|5585908|P1|NOT COMPLETED|Overall Study||37
2275666|NCT02227238|5585907|P2|COMPLETED|Overall Study||245
2275667|NCT02227238|5585908|P1|COMPLETED|Overall Study||275
2275668|NCT02227238|5585907|P2|STARTED|Overall Study||312
2275669|NCT02227238|5585908|P1|STARTED|Overall Study||312
2275670|NCT02227147|5585974|P2|NOT COMPLETED|Follow-up Period||5
2275671|NCT02227147|5585975|P1|NOT COMPLETED|Follow-up Period||3
2275672|NCT02227147|5585974|P2|COMPLETED|Follow-up Period||16
2275673|NCT02227147|5585975|P1|COMPLETED|Follow-up Period||15
2275674|NCT02227147|5585974|P2|STARTED|Follow-up Period||21
2275675|NCT02227147|5585975|P1|STARTED|Follow-up Period||18
2275676|NCT02227147|5585974|P2|NOT COMPLETED|Controlled Treatment Period||3
2275677|NCT02227147|5585975|P1|NOT COMPLETED|Controlled Treatment Period||6
2275678|NCT02227147|5585974|P2|COMPLETED|Controlled Treatment Period||21
2275679|NCT02227147|5585975|P1|COMPLETED|Controlled Treatment Period||18
2275680|NCT02227147|5585974|P2|STARTED|Controlled Treatment Period||24
2275681|NCT02227147|5585975|P1|STARTED|Controlled Treatment Period||24
2275682|NCT02227121|5585998|P1|NOT COMPLETED|Overall Study||0
2275683|NCT02227121|5585998|P1|COMPLETED|Overall Study||16
2275684|NCT02227121|5585998|P1|STARTED|Overall Study||16
2275685|NCT02227108|5586002|P1|NOT COMPLETED|Overall Study||31
2275686|NCT02227108|5586002|P1|COMPLETED|Overall Study||1
2275687|NCT02227108|5586002|P1|Treated|Overall Study||30
2275688|NCT02227108|5586002|P1|STARTED|Overall Study||32
2275689|NCT02226653|5586031|P2|NOT COMPLETED|Washout Period 5 (at Least 21 Days)||0
2275690|NCT02226653|5586032|P1|NOT COMPLETED|Washout Period 5 (at Least 21 Days)||0
2275691|NCT02226653|5586031|P2|COMPLETED|Washout Period 5 (at Least 21 Days)||23
2275692|NCT02226653|5586032|P1|COMPLETED|Washout Period 5 (at Least 21 Days)||23
2275693|NCT02226653|5586031|P2|STARTED|Washout Period 5 (at Least 21 Days)||23
2275694|NCT02226653|5586032|P1|STARTED|Washout Period 5 (at Least 21 Days)||23
2275695|NCT02226653|5586031|P2|NOT COMPLETED|Treatment Period 5 Fed State||1
2275696|NCT02226653|5586032|P1|NOT COMPLETED|Treatment Period 5 Fed State||0
2275697|NCT02226653|5586031|P2|COMPLETED|Treatment Period 5 Fed State||23
2275698|NCT02226653|5586032|P1|COMPLETED|Treatment Period 5 Fed State||23
2275699|NCT02226653|5586031|P2|Received at Least 1 Dose of Study Drug|Treatment Period 5 Fed State||24
2275700|NCT02226653|5586032|P1|Received at Least 1 Dose of Study Drug|Treatment Period 5 Fed State||23
2275701|NCT02226653|5586031|P2|STARTED|Treatment Period 5 Fed State||24
2275702|NCT02226653|5586032|P1|STARTED|Treatment Period 5 Fed State||23
2275703|NCT02226653|5586031|P2|NOT COMPLETED|Washout Period 4 (at Least 21 Days)||0
2275704|NCT02226653|5586032|P1|NOT COMPLETED|Washout Period 4 (at Least 21 Days)||0
2275705|NCT02226653|5586031|P2|COMPLETED|Washout Period 4 (at Least 21 Days)||24
2275706|NCT02226653|5586032|P1|COMPLETED|Washout Period 4 (at Least 21 Days)||23
2275707|NCT02226653|5586031|P2|STARTED|Washout Period 4 (at Least 21 Days)||24
2275708|NCT02226653|5586032|P1|STARTED|Washout Period 4 (at Least 21 Days)||23
2275709|NCT02226653|5586031|P2|NOT COMPLETED|Treatment Period 4 Fasted State||0
2275710|NCT02226653|5586032|P1|NOT COMPLETED|Treatment Period 4 Fasted State||0
2275711|NCT02226653|5586031|P2|COMPLETED|Treatment Period 4 Fasted State||24
2275712|NCT02226653|5586032|P1|COMPLETED|Treatment Period 4 Fasted State||23
2275713|NCT02226653|5586031|P2|Received at Least 1 Dose of Study Drug|Treatment Period 4 Fasted State||24
2275714|NCT02226653|5586032|P1|Received at Least 1 Dose of Study Drug|Treatment Period 4 Fasted State||23
2275715|NCT02226653|5586031|P2|STARTED|Treatment Period 4 Fasted State||24
2275716|NCT02226653|5586032|P1|STARTED|Treatment Period 4 Fasted State||23
2275717|NCT02226653|5586031|P2|NOT COMPLETED|Washout Period 3 (at Least 21 Days)||0
2275718|NCT02226653|5586032|P1|NOT COMPLETED|Washout Period 3 (at Least 21 Days)||0
2275719|NCT02226653|5586031|P2|COMPLETED|Washout Period 3 (at Least 21 Days)||24
2275720|NCT02226653|5586032|P1|COMPLETED|Washout Period 3 (at Least 21 Days)||23
2275721|NCT02226653|5586031|P2|STARTED|Washout Period 3 (at Least 21 Days)||24
2275722|NCT02226653|5586032|P1|STARTED|Washout Period 3 (at Least 21 Days)||23
2275723|NCT02226653|5586031|P2|NOT COMPLETED|Treatment Period 3 Fasted State||0
2275724|NCT02226653|5586032|P1|NOT COMPLETED|Treatment Period 3 Fasted State||0
2275725|NCT02226653|5586031|P2|COMPLETED|Treatment Period 3 Fasted State||24
2275726|NCT02226653|5586032|P1|COMPLETED|Treatment Period 3 Fasted State||23
2275727|NCT02226653|5586031|P2|Received at Least 1 Dose of Study Drug|Treatment Period 3 Fasted State||24
2275728|NCT02226653|5586032|P1|Received at Least 1 Dose of Study Drug|Treatment Period 3 Fasted State||23
2275729|NCT02226653|5586031|P2|STARTED|Treatment Period 3 Fasted State||24
2275730|NCT02226653|5586032|P1|STARTED|Treatment Period 3 Fasted State||23
2275731|NCT02226653|5586031|P2|NOT COMPLETED|Washout Period 2 (at Least 21 Days)||0
2275732|NCT02226653|5586032|P1|NOT COMPLETED|Washout Period 2 (at Least 21 Days)||0
2275733|NCT02226653|5586031|P2|COMPLETED|Washout Period 2 (at Least 21 Days)||24
2275734|NCT02226653|5586032|P1|COMPLETED|Washout Period 2 (at Least 21 Days)||23
2275735|NCT02226653|5586031|P2|STARTED|Washout Period 2 (at Least 21 Days)||24
2275736|NCT02226653|5586032|P1|STARTED|Washout Period 2 (at Least 21 Days)||23
2275737|NCT02226653|5586031|P2|NOT COMPLETED|Treatment Period 2 Fasted State||0
2275738|NCT02226653|5586032|P1|NOT COMPLETED|Treatment Period 2 Fasted State||1
2275739|NCT02226653|5586031|P2|COMPLETED|Treatment Period 2 Fasted State||24
2275740|NCT02226653|5586032|P1|COMPLETED|Treatment Period 2 Fasted State||23
2275741|NCT02226653|5586031|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2 Fasted State||24
2275742|NCT02226653|5586032|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2 Fasted State||24
2275743|NCT02226653|5586031|P2|STARTED|Treatment Period 2 Fasted State||24
2275744|NCT02226653|5586032|P1|STARTED|Treatment Period 2 Fasted State||24
2275745|NCT02226653|5586031|P2|NOT COMPLETED|Washout Period 1 (at Least 21 Days)||0
2275746|NCT02226653|5586032|P1|NOT COMPLETED|Washout Period 1 (at Least 21 Days)||0
2275747|NCT02226653|5586031|P2|COMPLETED|Washout Period 1 (at Least 21 Days)||24
2275748|NCT02226653|5586032|P1|COMPLETED|Washout Period 1 (at Least 21 Days)||24
2275749|NCT02226653|5586031|P2|STARTED|Washout Period 1 (at Least 21 Days)||24
2275750|NCT02226653|5586032|P1|STARTED|Washout Period 1 (at Least 21 Days)||24
2275751|NCT02226653|5586031|P2|NOT COMPLETED|Treatment Period 1 Fasted State||0
2275752|NCT02226653|5586032|P1|NOT COMPLETED|Treatment Period 1 Fasted State||0
2275753|NCT02226653|5586031|P2|COMPLETED|Treatment Period 1 Fasted State||24
2275754|NCT02226653|5586032|P1|COMPLETED|Treatment Period 1 Fasted State||24
2275755|NCT02226653|5586031|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 Fasted State||24
2275756|NCT02226653|5586032|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 Fasted State||24
2275757|NCT02226653|5586031|P2|STARTED|Treatment Period 1 Fasted State||24
2275758|NCT02226653|5586032|P1|STARTED|Treatment Period 1 Fasted State||24
2275759|NCT02226562|5586056|P2|NOT COMPLETED|Overall Study||1
2275760|NCT02226562|5586057|P1|NOT COMPLETED|Overall Study||0
2275761|NCT02226562|5586056|P2|COMPLETED|Overall Study|Lost to follow up|95
2275762|NCT02226562|5586057|P1|COMPLETED|Overall Study||95
2275763|NCT02226562|5586056|P2|STARTED|Overall Study||96
2275764|NCT02226562|5586057|P1|STARTED|Overall Study||95
2275765|NCT02226549|5586075|P2|NOT COMPLETED|Overall Study||1
2275766|NCT02226549|5586076|P1|NOT COMPLETED|Overall Study||1
2275767|NCT02226549|5586075|P2|COMPLETED|Overall Study||23
2275768|NCT02226549|5586076|P1|COMPLETED|Overall Study||22
2275769|NCT02226549|5586075|P2|STARTED|Overall Study||24
2275770|NCT02226549|5586076|P1|STARTED|Overall Study||23
2275771|NCT02226198|5586086|P3|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
2275772|NCT02226198|5586087|P2|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
2275773|NCT02226198|5586088|P1|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
2275774|NCT02226198|5586086|P3|COMPLETED|Maintenance Phase (12 Weeks)||0
2275775|NCT02226198|5586087|P2|COMPLETED|Maintenance Phase (12 Weeks)||0
2275776|NCT02226198|5586088|P1|COMPLETED|Maintenance Phase (12 Weeks)||13
2275777|NCT02226198|5586086|P3|STARTED|Maintenance Phase (12 Weeks)||0
2275778|NCT02226198|5586087|P2|STARTED|Maintenance Phase (12 Weeks)||0
2275779|NCT02226198|5586088|P1|STARTED|Maintenance Phase (12 Weeks)||13
2275780|NCT02226198|5586086|P3|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
2275781|NCT02226198|5586087|P2|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
2275782|NCT02226198|5586088|P1|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
2275783|NCT02226198|5586086|P3|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||7
2275784|NCT02226198|5586087|P2|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||6
2275785|NCT02226198|5586088|P1|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
2275786|NCT02226198|5586086|P3|STARTED|Cross-Over: Second Interv. (6 Weeks)||7
2275787|NCT02226198|5586087|P2|STARTED|Cross-Over: Second Interv. (6 Weeks)||6
2275788|NCT02226198|5586088|P1|STARTED|Cross-Over: Second Interv. (6 Weeks)||0
2275789|NCT02226198|5586086|P3|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
2275790|NCT02226198|5586087|P2|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||1
2275791|NCT02226198|5586088|P1|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
2275792|NCT02226198|5586086|P3|COMPLETED|Cross-Over: First Intervention (6 Weeks)||7
2275793|NCT02226198|5586087|P2|COMPLETED|Cross-Over: First Intervention (6 Weeks)||6
2275794|NCT02226198|5586088|P1|COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
2275795|NCT02226198|5586086|P3|STARTED|Cross-Over: First Intervention (6 Weeks)||7
2275796|NCT02226198|5586087|P2|STARTED|Cross-Over: First Intervention (6 Weeks)||7
2275797|NCT02226198|5586088|P1|STARTED|Cross-Over: First Intervention (6 Weeks)||0
2275798|NCT02226198|5586086|P3|NOT COMPLETED|Lead-in Phase||0
2275799|NCT02226198|5586087|P2|NOT COMPLETED|Lead-in Phase||0
2275800|NCT02226198|5586088|P1|NOT COMPLETED|Lead-in Phase||1
2275801|NCT02226198|5586086|P3|COMPLETED|Lead-in Phase||0
2275802|NCT02226198|5586087|P2|COMPLETED|Lead-in Phase||0
2275803|NCT02226198|5586088|P1|COMPLETED|Lead-in Phase||10
2275804|NCT02226198|5586086|P3|STARTED|Lead-in Phase||0
2275805|NCT02226198|5586087|P2|STARTED|Lead-in Phase||0
2275806|NCT02226198|5586088|P1|STARTED|Lead-in Phase||11
2275807|NCT02226172|5586161|P1|NOT COMPLETED|Overall Study||17
2275808|NCT02226172|5586161|P1|COMPLETED|Overall Study||4
2275809|NCT02226172|5586161|P1|STARTED|Overall Study||21
2275810|NCT02226120|5586192|P1|NOT COMPLETED|Overall Study||320
2275811|NCT02226120|5586192|P1|COMPLETED|Overall Study||1660
2275812|NCT02226120|5586192|P1|STARTED|Overall Study||1980
2275813|NCT02226003|5586199|P3|NOT COMPLETED|Overall Study||6
2275814|NCT02226003|5586200|P2|NOT COMPLETED|Overall Study||1
2275815|NCT02226003|5586201|P1|NOT COMPLETED|Overall Study||2
2275816|NCT02226003|5586199|P3|COMPLETED|Overall Study||91
2275817|NCT02226003|5586200|P2|COMPLETED|Overall Study||95
2275818|NCT02226003|5586201|P1|COMPLETED|Overall Study||96
2275819|NCT02226003|5586199|P3|STARTED|Overall Study||97
2275820|NCT02226003|5586200|P2|STARTED|Overall Study||96
2275821|NCT02226003|5586201|P1|STARTED|Overall Study||98
2275825|NCT02225860|5586246|P2|NOT COMPLETED|Overall Study||0
2275826|NCT02225860|5586247|P1|NOT COMPLETED|Overall Study||1
2275827|NCT02225860|5586246|P2|COMPLETED|Overall Study||17
2275828|NCT02225860|5586247|P1|COMPLETED|Overall Study||16
2275829|NCT02225860|5586246|P2|STARTED|Overall Study||17
2275830|NCT02225860|5586247|P1|STARTED|Overall Study||17
2275831|NCT02225743|5586257|P1|NOT COMPLETED|Overall Study||18
2275832|NCT02225743|5586257|P1|COMPLETED|Overall Study|18 patients chose not to participate on the day of surgery.|102
2275833|NCT02225743|5586257|P1|STARTED|Overall Study||120
2275834|NCT02225587|5586263|P2|NOT COMPLETED|Overall Study||38
2275835|NCT02225587|5586264|P1|NOT COMPLETED|Overall Study||28
2275836|NCT02225587|5586263|P2|COMPLETED|Overall Study||162
2275837|NCT02225587|5586264|P1|COMPLETED|Overall Study||172
2275838|NCT02225587|5586263|P2|Vaccination 3|Overall Study||164
2275839|NCT02225587|5586264|P1|Vaccination 3|Overall Study||172
2275840|NCT02225587|5586263|P2|Vaccination 2|Overall Study||185
2275841|NCT02225587|5586264|P1|Vaccination 2|Overall Study||188
2275842|NCT02225587|5586263|P2|STARTED|Overall Study||200
2275843|NCT02225587|5586264|P1|STARTED|Overall Study||200
2275844|NCT02225353|5586293|P3|NOT COMPLETED|Overall Study||15
2275845|NCT02225353|5586294|P2|NOT COMPLETED|Overall Study||6
2275846|NCT02225353|5586295|P1|NOT COMPLETED|Overall Study||4
2275847|NCT02225353|5586293|P3|COMPLETED|Overall Study||75
2275848|NCT02225353|5586294|P2|COMPLETED|Overall Study||84
2275849|NCT02225353|5586295|P1|COMPLETED|Overall Study||87
2275850|NCT02225353|5586293|P3|STARTED|Overall Study||90
2275851|NCT02225353|5586294|P2|STARTED|Overall Study||90
2275852|NCT02225353|5586295|P1|STARTED|Overall Study||91
2275853|NCT02225132|5586318|P1|NOT COMPLETED|Overall Study||0
2275854|NCT02225132|5586318|P1|COMPLETED|Overall Study||10
2275855|NCT02225132|5586318|P1|STARTED|Overall Study||10
2275856|NCT02225106|5586323|P1|NOT COMPLETED|Overall Study||0
2275857|NCT02225106|5586323|P1|COMPLETED|Overall Study||11
2275858|NCT02225106|5586323|P1|STARTED|Overall Study||11
2275859|NCT02225080|5586327|P1|NOT COMPLETED|Overall Study||0
2275860|NCT02225080|5586327|P1|COMPLETED|Overall Study||100
2275861|NCT02225080|5586327|P1|STARTED|Overall Study||100
2275862|NCT02224846|5586336|P2|NOT COMPLETED|Period 2 (Month 12 to Month 24)||74
2275863|NCT02224846|5586337|P1|NOT COMPLETED|Period 2 (Month 12 to Month 24)||42
2275864|NCT02224846|5586336|P2|COMPLETED|Period 2 (Month 12 to Month 24)||283
2275865|NCT02224846|5586337|P1|COMPLETED|Period 2 (Month 12 to Month 24)||131
2275866|NCT02224846|5586336|P2|STARTED|Period 2 (Month 12 to Month 24)||357
2275867|NCT02224846|5586337|P1|STARTED|Period 2 (Month 12 to Month 24)||173
2275868|NCT02224846|5586336|P2|NOT COMPLETED|Period 2 (Month 3 to Month 12)||31
2275869|NCT02224846|5586337|P1|NOT COMPLETED|Period 2 (Month 3 to Month 12)||19
2275870|NCT02224846|5586336|P2|COMPLETED|Period 2 (Month 3 to Month 12)||357
2275871|NCT02224846|5586337|P1|COMPLETED|Period 2 (Month 3 to Month 12)||173
2275872|NCT02224846|5586336|P2|STARTED|Period 2 (Month 3 to Month 12)||388
2275873|NCT02224846|5586337|P1|STARTED|Period 2 (Month 3 to Month 12)||192
2275874|NCT02224846|5586336|P2|NOT COMPLETED|Period 1 (Month 3)||36
2275875|NCT02224846|5586337|P1|NOT COMPLETED|Period 1 (Month 3)||19
2275876|NCT02224846|5586336|P2|COMPLETED|Period 1 (Month 3)||388
2275877|NCT02224846|5586337|P1|COMPLETED|Period 1 (Month 3)||192
2275878|NCT02224846|5586336|P2|Received at Least One Dose of Study Drug|Period 1 (Month 3)||421
2275879|NCT02224846|5586337|P1|Received at Least One Dose of Study Drug|Period 1 (Month 3)||210
2275880|NCT02224846|5586336|P2|STARTED|Period 1 (Month 3)||424
2275881|NCT02224846|5586337|P1|STARTED|Period 1 (Month 3)||211
2275882|NCT02224820|5586357|P1|NOT COMPLETED|Overall Study||0
2275883|NCT02224820|5586357|P1|COMPLETED|Overall Study|One patient did not receive full dose|8
2275884|NCT02224820|5586357|P1|STARTED|Overall Study||8
2275885|NCT02224755|5586367|P2|NOT COMPLETED|Two Year Follow up Post-implant||226
2275886|NCT02224755|5586368|P1|NOT COMPLETED|Two Year Follow up Post-implant||258
2275887|NCT02224755|5586367|P2|COMPLETED|Two Year Follow up Post-implant||289
2275888|NCT02224755|5586368|P1|COMPLETED|Two Year Follow up Post-implant||247
2275889|NCT02224755|5586367|P2|STARTED|Two Year Follow up Post-implant||515
2275890|NCT02224755|5586368|P1|STARTED|Two Year Follow up Post-implant||505
2275891|NCT02224755|5586367|P2|NOT COMPLETED|Randomization to Device Implant||1
2275892|NCT02224755|5586368|P1|NOT COMPLETED|Randomization to Device Implant||7
2275893|NCT02224755|5586367|P2|COMPLETED|Randomization to Device Implant|Patients who underwent HeartMate 3 LVAS implant|515
2275894|NCT02224755|5586368|P1|COMPLETED|Randomization to Device Implant|Patients who underwent HeartMate II LVAS implant|505
2275895|NCT02224755|5586367|P2|STARTED|Randomization to Device Implant|Patients in the Full Study Cohort (n=1028) who were randomized to HeartMate 3|516
2275896|NCT02224755|5586368|P1|STARTED|Randomization to Device Implant|Patients in the Full Study Cohort (n=1028) who were randomized to HeartMate II|512
2275897|NCT02224729|5586392|P1|NOT COMPLETED|Overall Study||0
2275898|NCT02224729|5586392|P1|COMPLETED|Overall Study||24
2275899|NCT02224729|5586392|P1|STARTED|Overall Study||24
2275900|NCT02224703|5586403|P3|NOT COMPLETED|Overall Study||0
2275901|NCT02224703|5586404|P2|NOT COMPLETED|Overall Study||6
2275902|NCT02224703|5586405|P1|NOT COMPLETED|Overall Study||3
2275903|NCT02224703|5586403|P3|COMPLETED|Overall Study||65
2275904|NCT02224703|5586404|P2|COMPLETED|Overall Study||61
2275905|NCT02224703|5586405|P1|COMPLETED|Overall Study||64
2275906|NCT02224703|5586403|P3|Intent to Treat (ITT) Analysis Set|Overall Study||65
2275907|NCT02224703|5586404|P2|Intent to Treat (ITT) Analysis Set|Overall Study||67
2275908|NCT02224703|5586405|P1|Intent to Treat (ITT) Analysis Set|Overall Study||66
2275909|NCT02224703|5586403|P3|Safety Analysis Set|Overall Study||65
2275910|NCT02224703|5586404|P2|Safety Analysis Set|Overall Study|Two participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group|69
2275911|NCT02224703|5586405|P1|Safety Analysis Set|Overall Study|Two participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group|64
2275912|NCT02224703|5586403|P3|Received at Least 1 Dose of Study Drug|Overall Study||65
2275913|NCT02224703|5586404|P2|Received at Least 1 Dose of Study Drug|Overall Study||67
2275914|NCT02224703|5586405|P1|Received at Least 1 Dose of Study Drug|Overall Study||66
2275915|NCT02224703|5586403|P3|STARTED|Overall Study||65
2275916|NCT02224703|5586404|P2|STARTED|Overall Study||67
2275917|NCT02224703|5586405|P1|STARTED|Overall Study||67
2275918|NCT02224690|5586424|P2|NOT COMPLETED|Overall Study||1
2275919|NCT02224690|5586425|P1|NOT COMPLETED|Overall Study||14
2275920|NCT02224690|5586424|P2|COMPLETED|Overall Study||84
2275921|NCT02224690|5586425|P1|COMPLETED|Overall Study||72
2275922|NCT02224690|5586424|P2|Intent to Treat (ITT) Analysis Set|Overall Study||85
2275923|NCT02224690|5586425|P1|Intent to Treat (ITT) Analysis Set|Overall Study||86
2275924|NCT02224690|5586424|P2|Safety Analysis Set|Overall Study||85
2275925|NCT02224690|5586425|P1|Safety Analysis Set|Overall Study||86
2275926|NCT02224690|5586424|P2|STARTED|Overall Study||85
2275927|NCT02224690|5586425|P1|STARTED|Overall Study||86
2275928|NCT02224664|5586437|P5|NOT COMPLETED|Dose Escalation Period (21 Days)||11
2275929|NCT02224664|5586438|P4|NOT COMPLETED|Dose Escalation Period (21 Days)||3
2275930|NCT02224664|5586439|P3|NOT COMPLETED|Dose Escalation Period (21 Days)||2
2275931|NCT02224664|5586440|P2|NOT COMPLETED|Dose Escalation Period (21 Days)||0
2275932|NCT02224664|5586441|P1|NOT COMPLETED|Dose Escalation Period (21 Days)||0
2275933|NCT02224664|5586437|P5|COMPLETED|Dose Escalation Period (21 Days)||8
2275934|NCT02224664|5586438|P4|COMPLETED|Dose Escalation Period (21 Days)||3
2275935|NCT02224664|5586439|P3|COMPLETED|Dose Escalation Period (21 Days)||9
2275936|NCT02224664|5586440|P2|COMPLETED|Dose Escalation Period (21 Days)||9
2275937|NCT02224664|5586441|P1|COMPLETED|Dose Escalation Period (21 Days)||0
2275938|NCT02224664|5586437|P5|STARTED|Dose Escalation Period (21 Days)||19
2275939|NCT02224664|5586438|P4|STARTED|Dose Escalation Period (21 Days)||6
2275940|NCT02224664|5586439|P3|STARTED|Dose Escalation Period (21 Days)||11
2275941|NCT02224664|5586440|P2|STARTED|Dose Escalation Period (21 Days)||9
2275942|NCT02224664|5586441|P1|STARTED|Dose Escalation Period (21 Days)||0
2275943|NCT02224664|5586437|P5|NOT COMPLETED|Lead-in Period (3 Days)||0
2275944|NCT02224664|5586438|P4|NOT COMPLETED|Lead-in Period (3 Days)||0
2275945|NCT02224664|5586439|P3|NOT COMPLETED|Lead-in Period (3 Days)||0
2275946|NCT02224664|5586440|P2|NOT COMPLETED|Lead-in Period (3 Days)||0
2275947|NCT02224664|5586441|P1|NOT COMPLETED|Lead-in Period (3 Days)||5
2275948|NCT02224664|5586437|P5|COMPLETED|Lead-in Period (3 Days)||0
2275949|NCT02224664|5586438|P4|COMPLETED|Lead-in Period (3 Days)||0
2275950|NCT02224664|5586439|P3|COMPLETED|Lead-in Period (3 Days)||0
2275951|NCT02224664|5586440|P2|COMPLETED|Lead-in Period (3 Days)||0
2275952|NCT02224664|5586441|P1|COMPLETED|Lead-in Period (3 Days)||45
2275953|NCT02224664|5586437|P5|STARTED|Lead-in Period (3 Days)||0
2275954|NCT02224664|5586438|P4|STARTED|Lead-in Period (3 Days)||0
2275955|NCT02224664|5586439|P3|STARTED|Lead-in Period (3 Days)||0
2275956|NCT02224664|5586440|P2|STARTED|Lead-in Period (3 Days)||0
2275957|NCT02224664|5586441|P1|STARTED|Lead-in Period (3 Days)||50
2275958|NCT02224638|5586523|P2|NOT COMPLETED|Overall Study||1
2275959|NCT02224638|5586524|P1|NOT COMPLETED|Overall Study||1
2275960|NCT02224638|5586523|P2|COMPLETED|Overall Study||9
2275961|NCT02224638|5586524|P1|COMPLETED|Overall Study||10
2275962|NCT02224638|5586523|P2|STARTED|Overall Study||10
2275963|NCT02224638|5586524|P1|STARTED|Overall Study||11
2275964|NCT02224625|5586532|P1|NOT COMPLETED|Sensitization||55
2275965|NCT02224625|5586532|P1|COMPLETED|Sensitization||194
2275966|NCT02224625|5586532|P1|STARTED|Sensitization|Subjects from Irritation study also participated in Sensitization Study|249
2275967|NCT02224625|5586532|P1|NOT COMPLETED|Irritation||6
2275968|NCT02224625|5586532|P1|COMPLETED|Irritation||33
2275969|NCT02224625|5586532|P1|STARTED|Irritation||39
2275970|NCT02224612|5586544|P2|NOT COMPLETED|Overall Study||0
2275971|NCT02224612|5586545|P1|NOT COMPLETED|Overall Study||0
2275972|NCT02224612|5586544|P2|COMPLETED|Overall Study||48
2275973|NCT02224612|5586545|P1|COMPLETED|Overall Study||48
2275974|NCT02224612|5586544|P2|STARTED|Overall Study||48
2275975|NCT02224612|5586545|P1|STARTED|Overall Study||48
2275976|NCT02224560|5586556|P3|NOT COMPLETED|Overall Study||2
2275977|NCT02224560|5586557|P2|NOT COMPLETED|Overall Study||2
2275978|NCT02224560|5586558|P1|NOT COMPLETED|Overall Study||9
2275979|NCT02224560|5586556|P3|COMPLETED|Overall Study||74
2275980|NCT02224560|5586557|P2|COMPLETED|Overall Study||71
2275981|NCT02224560|5586558|P1|COMPLETED|Overall Study||67
2275982|NCT02224560|5586556|P3|Intent to Treat (ITT) Analysis Set|Overall Study||76
2275983|NCT02224560|5586557|P2|Intent to Treat (ITT) Analysis Set|Overall Study||73
2275984|NCT02224560|5586558|P1|Intent to Treat (ITT) Analysis Set|Overall Study||76
2275985|NCT02224560|5586556|P3|Safety Analysis Set|Overall Study||76
2275986|NCT02224560|5586557|P2|Safety Analysis Set|Overall Study|Six participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group.|67
2275987|NCT02224560|5586558|P1|Safety Analysis Set|Overall Study|Six participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group.|82
2275988|NCT02224560|5586556|P3|STARTED|Overall Study||76
2275989|NCT02224560|5586557|P2|STARTED|Overall Study||73
2275990|NCT02224560|5586558|P1|STARTED|Overall Study||76
2275991|NCT02224508|5586577|P2|NOT COMPLETED|Overall Study||0
2275992|NCT02224508|5586578|P1|NOT COMPLETED|Overall Study||0
2275993|NCT02224508|5586577|P2|COMPLETED|Overall Study||653
2275994|NCT02224508|5586578|P1|COMPLETED|Overall Study||935
2275995|NCT02224508|5586577|P2|STARTED|Overall Study|Number of patients surveyed in the control segment of the health plan (contracted care).|653
2275996|NCT02224508|5586578|P1|STARTED|Overall Study|Number of patients surveyed in intervention segment of the health plan (group practice).|935
2275997|NCT02224404|5586588|P1|NOT COMPLETED|Overall Study||0
2275998|NCT02224404|5586588|P1|COMPLETED|Overall Study||21
2275999|NCT02224404|5586588|P1|STARTED|Overall Study||21
2276000|NCT02224274|5586595|P2|NOT COMPLETED|Overall Study||0
2276001|NCT02224274|5586596|P1|NOT COMPLETED|Overall Study||1
2276002|NCT02224274|5586595|P2|COMPLETED|Overall Study||20
2276003|NCT02224274|5586596|P1|COMPLETED|Overall Study||16
2276004|NCT02224274|5586595|P2|STARTED|Overall Study||20
2276005|NCT02224274|5586596|P1|STARTED|Overall Study||17
2276006|NCT02224157|5586608|P2|NOT COMPLETED|Overall Study||111
2276007|NCT02224157|5586609|P1|NOT COMPLETED|Overall Study||110
2276008|NCT02224157|5586608|P2|COMPLETED|Overall Study||1983
2276009|NCT02224157|5586609|P1|COMPLETED|Overall Study||1985
2276010|NCT02224157|5586608|P2|Patients Who Completed Treatment|Overall Study||1903
2276011|NCT02224157|5586609|P1|Patients Who Completed Treatment|Overall Study||1924
2276012|NCT02224157|5586608|P2|STARTED|Overall Study||2094
2276013|NCT02224157|5586609|P1|STARTED|Overall Study||2095
2276014|NCT02224053|5586633|P1|NOT COMPLETED|AZD9291 Alone||0
2276015|NCT02224053|5586633|P1|COMPLETED|AZD9291 Alone||47
2276016|NCT02224053|5586633|P1|STARTED|AZD9291 Alone||47
2276017|NCT02224053|5586633|P1|NOT COMPLETED|AZD9291 and Omeprazole Co-administration||21
2276018|NCT02224053|5586633|P1|COMPLETED|AZD9291 and Omeprazole Co-administration||47
2276019|NCT02224053|5586633|P1|STARTED|AZD9291 and Omeprazole Co-administration||68
2276020|NCT02223871|5586665|P1|NOT COMPLETED|Overall Study||0
2276021|NCT02223871|5586665|P1|COMPLETED|Overall Study||8
2276022|NCT02223871|5586665|P1|STARTED|Overall Study||8
2276023|NCT02223858|5586679|P2|NOT COMPLETED|Overall Study||26
2276024|NCT02223858|5586680|P1|NOT COMPLETED|Overall Study||24
2276025|NCT02223858|5586679|P2|COMPLETED|Overall Study||154
2276026|NCT02223858|5586680|P1|COMPLETED|Overall Study||156
2276027|NCT02223858|5586679|P2|6-month Follow-up|Overall Study||154
2276028|NCT02223858|5586680|P1|6-month Follow-up|Overall Study||156
2276029|NCT02223858|5586679|P2|3-month Follow-up|Overall Study||154
2276030|NCT02223858|5586680|P1|3-month Follow-up|Overall Study||155
2276031|NCT02223858|5586679|P2|1-month Follow-up|Overall Study||150
2276032|NCT02223858|5586680|P1|1-month Follow-up|Overall Study||156
2276033|NCT02223858|5586679|P2|STARTED|Overall Study||180
2276034|NCT02223858|5586680|P1|STARTED|Overall Study||180
2276035|NCT02223793|5586693|P3|NOT COMPLETED|Overall Study||13
2276036|NCT02223793|5586694|P2|NOT COMPLETED|Overall Study||9
2276037|NCT02223793|5586695|P1|NOT COMPLETED|Overall Study||17
2276038|NCT02223793|5586693|P3|COMPLETED|Overall Study||185
2276039|NCT02223793|5586694|P2|COMPLETED|Overall Study||190
2276040|NCT02223793|5586695|P1|COMPLETED|Overall Study||168
2276041|NCT02223793|5586693|P3|STARTED|Overall Study||198
2276042|NCT02223793|5586694|P2|STARTED|Overall Study||199
2276043|NCT02223793|5586695|P1|STARTED|Overall Study||185
2276044|NCT02223754|5586708|P2|NOT COMPLETED|Period 2||3
2276045|NCT02223754|5586709|P1|NOT COMPLETED|Period 2||3
2276046|NCT02223754|5586708|P2|COMPLETED|Period 2||141
2276047|NCT02223754|5586709|P1|COMPLETED|Period 2||156
2276048|NCT02223754|5586708|P2|STARTED|Period 2||144
2276049|NCT02223754|5586709|P1|STARTED|Period 2||159
2276050|NCT02223754|5586708|P2|NOT COMPLETED|Period 1||15
2276051|NCT02223754|5586709|P1|NOT COMPLETED|Period 1||4
2276052|NCT02223754|5586708|P2|COMPLETED|Period 1||144
2276053|NCT02223754|5586709|P1|COMPLETED|Period 1||159
2276054|NCT02223754|5586708|P2|STARTED|Period 1||159
2276055|NCT02223754|5586709|P1|STARTED|Period 1||163
2276056|NCT02223715|5586729|P1|NOT COMPLETED|Overall Study||104
2276057|NCT02223715|5586729|P1|COMPLETED|Overall Study||496
2276058|NCT02223715|5586729|P1|STARTED|Overall Study||600
2276059|NCT02223702|5586738|P2|NOT COMPLETED|Overall Study||4
2276060|NCT02223702|5586739|P1|NOT COMPLETED|Overall Study||1
2276061|NCT02223702|5586738|P2|COMPLETED|Overall Study||15
2276062|NCT02223702|5586739|P1|COMPLETED|Overall Study||19
2276063|NCT02223702|5586738|P2|STARTED|Overall Study||19
2276064|NCT02223702|5586739|P1|STARTED|Overall Study||20
2276065|NCT02223689|5586747|P1|NOT COMPLETED|Overall Study||0
2276066|NCT02223689|5586747|P1|COMPLETED|Overall Study||35
2276067|NCT02223689|5586747|P1|STARTED|Overall Study||35
2276068|NCT02223650|5586754|P2|NOT COMPLETED|Overall Study||0
2276069|NCT02223650|5586755|P1|NOT COMPLETED|Overall Study||0
2276070|NCT02223650|5586754|P2|COMPLETED|Overall Study||31
2276071|NCT02223650|5586755|P1|COMPLETED|Overall Study||27
2276072|NCT02223650|5586754|P2|STARTED|Overall Study||31
2276073|NCT02223650|5586755|P1|STARTED|Overall Study||27
2276074|NCT02223637|5586785|P1|NOT COMPLETED|Overall Study||0
2276075|NCT02223637|5586785|P1|COMPLETED|Overall Study||82
2276076|NCT02223637|5586785|P1|STARTED|Overall Study||82
2276077|NCT02223455|5586811|P3|NOT COMPLETED|Overall Study||0
2276078|NCT02223455|5586812|P2|NOT COMPLETED|Overall Study||0
2276079|NCT02223455|5586813|P1|NOT COMPLETED|Overall Study||0
2276080|NCT02223455|5586811|P3|COMPLETED|Overall Study|Participant level data not collected.|0
2276081|NCT02223455|5586812|P2|COMPLETED|Overall Study|Participant level data not collected.|0
2276082|NCT02223455|5586813|P1|COMPLETED|Overall Study|Participant level data not collected.|0
2276083|NCT02223455|5586811|P3|STARTED|Overall Study|Participant level data not collected.|0
2276084|NCT02223455|5586812|P2|STARTED|Overall Study|Participant level data not collected.|0
2276085|NCT02223455|5586813|P1|STARTED|Overall Study|Participant level data not collected.|0
2276086|NCT02223429|5586825|P4|NOT COMPLETED|Overall Study||0
2276087|NCT02223429|5586826|P3|NOT COMPLETED|Overall Study||0
2276088|NCT02223429|5586827|P2|NOT COMPLETED|Overall Study||0
2276089|NCT02223429|5586828|P1|NOT COMPLETED|Overall Study||1
2276090|NCT02223429|5586825|P4|COMPLETED|Overall Study||8
2276091|NCT02223429|5586826|P3|COMPLETED|Overall Study||8
2276092|NCT02223429|5586827|P2|COMPLETED|Overall Study||8
2276093|NCT02223429|5586828|P1|COMPLETED|Overall Study||7
2276094|NCT02223429|5586825|P4|STARTED|Overall Study||8
2276095|NCT02223429|5586826|P3|STARTED|Overall Study||8
2276096|NCT02223429|5586827|P2|STARTED|Overall Study||8
2276097|NCT02223429|5586828|P1|STARTED|Overall Study||8
2276098|NCT02223390|5586858|P2|NOT COMPLETED|Overall Study||4
2276099|NCT02223390|5586859|P1|NOT COMPLETED|Overall Study||9
2276100|NCT02223390|5586858|P2|COMPLETED|Overall Study||28
2276101|NCT02223390|5586859|P1|COMPLETED|Overall Study||23
2276102|NCT02223390|5586858|P2|STARTED|Overall Study||32
2276103|NCT02223390|5586859|P1|STARTED|Overall Study||32
2276104|NCT02223364|5586870|P3|NOT COMPLETED|Overall Study||3
2276105|NCT02223364|5586871|P2|NOT COMPLETED|Overall Study||0
2276106|NCT02223364|5586872|P1|NOT COMPLETED|Overall Study||5
2276107|NCT02223364|5586870|P3|COMPLETED|Overall Study||52
2276108|NCT02223364|5586871|P2|COMPLETED|Overall Study||55
2276109|NCT02223364|5586872|P1|COMPLETED|Overall Study||50
2276110|NCT02223364|5586870|P3|STARTED|Overall Study||55
2276111|NCT02223364|5586871|P2|STARTED|Overall Study||55
2276112|NCT02223364|5586872|P1|STARTED|Overall Study||55
2276113|NCT02223351|5586924|P2|NOT COMPLETED|Overall Study||0
2276114|NCT02223351|5586925|P1|NOT COMPLETED|Overall Study||0
2276115|NCT02223351|5586924|P2|COMPLETED|Overall Study||24
2276116|NCT02223351|5586925|P1|COMPLETED|Overall Study||24
2276117|NCT02223351|5586924|P2|Second Intervention (8 Days)|Overall Study||24
2276118|NCT02223351|5586925|P1|Second Intervention (8 Days)|Overall Study||24
2276119|NCT02223351|5586924|P2|Wasout (2weeks)|Overall Study||24
2276120|NCT02223351|5586925|P1|Wasout (2weeks)|Overall Study||24
2276121|NCT02223351|5586924|P2|First Intervention (8 Days)|Overall Study||24
2276122|NCT02223351|5586925|P1|First Intervention (8 Days)|Overall Study||24
2276123|NCT02223351|5586924|P2|STARTED|Overall Study||24
2276124|NCT02223351|5586925|P1|STARTED|Overall Study||24
2276125|NCT02223338|5586985|P2|NOT COMPLETED|Overall Study||0
2276126|NCT02223338|5586986|P1|NOT COMPLETED|Overall Study||0
2276127|NCT02223338|5586985|P2|COMPLETED|Overall Study||60
2276128|NCT02223338|5586986|P1|COMPLETED|Overall Study||60
2276129|NCT02223338|5586985|P2|STARTED|Overall Study||60
2276130|NCT02223338|5586986|P1|STARTED|Overall Study||60
2276131|NCT02223260|5586994|P1|NOT COMPLETED|Overall Study||0
2276132|NCT02223260|5586994|P1|COMPLETED|Overall Study||8
2276133|NCT02223260|5586994|P1|STARTED|Overall Study||8
2276134|NCT02223065|5587012|P2|NOT COMPLETED|Overall Study||0
2276135|NCT02223065|5587013|P1|NOT COMPLETED|Overall Study||0
2276136|NCT02223065|5587012|P2|COMPLETED|Overall Study||18
2276137|NCT02223065|5587013|P1|COMPLETED|Overall Study||18
2276138|NCT02223065|5587012|P2|STARTED|Overall Study||18
2276139|NCT02223065|5587013|P1|STARTED|Overall Study||18
2276140|NCT02222870|5587031|P2|NOT COMPLETED|Overall Study||0
2276141|NCT02222870|5587032|P1|NOT COMPLETED|Overall Study||0
2276142|NCT02222870|5587031|P2|COMPLETED|Overall Study||30
2276143|NCT02222870|5587032|P1|COMPLETED|Overall Study||30
2276144|NCT02222870|5587031|P2|STARTED|Overall Study||30
2276145|NCT02222870|5587032|P1|STARTED|Overall Study||30
2276146|NCT02222818|5587048|P2|NOT COMPLETED|Period 2||0
2276147|NCT02222818|5587049|P1|NOT COMPLETED|Period 2||0
2276148|NCT02222818|5587048|P2|COMPLETED|Period 2|End of CAFR evaluation period|30
2276149|NCT02222818|5587049|P1|COMPLETED|Period 2|End of CAFRPlus evaluation period|33
2276150|NCT02222818|5587048|P2|STARTED|Period 2|Start of CAFR evaluation period|30
2276151|NCT02222818|5587049|P1|STARTED|Period 2|Start of CAFRPlus evaluation period|33
2276152|NCT02222818|5587048|P2|NOT COMPLETED|Period 1||3
2276153|NCT02222818|5587049|P1|NOT COMPLETED|Period 1||0
2276154|NCT02222818|5587048|P2|COMPLETED|Period 1|End of CAFRPlus evaluation period|30
2276155|NCT02222818|5587049|P1|COMPLETED|Period 1|End of CAFR evaluation period|33
2276156|NCT02222818|5587048|P2|STARTED|Period 1|Start of CAFRPlus evaluation period|33
2276157|NCT02222818|5587049|P1|STARTED|Period 1|Start of CAFR evaluation period|33
2276158|NCT02222714|5587061|P5|NOT COMPLETED|Overall Study||7
2276159|NCT02222714|5587062|P4|NOT COMPLETED|Overall Study||4
2276160|NCT02222714|5587063|P3|NOT COMPLETED|Overall Study||4
2276161|NCT02222714|5587064|P2|NOT COMPLETED|Overall Study||2
2276162|NCT02222714|5587065|P1|NOT COMPLETED|Overall Study||0
2276163|NCT02222714|5587061|P5|COMPLETED|Overall Study||37
2276164|NCT02222714|5587062|P4|COMPLETED|Overall Study||11
2276165|NCT02222714|5587063|P3|COMPLETED|Overall Study||8
2276166|NCT02222714|5587064|P2|COMPLETED|Overall Study||22
2276167|NCT02222714|5587065|P1|COMPLETED|Overall Study||15
2276168|NCT02222714|5587061|P5|STARTED|Overall Study||44
2276169|NCT02222714|5587062|P4|STARTED|Overall Study||15
2276170|NCT02222714|5587063|P3|STARTED|Overall Study||12
2276171|NCT02222714|5587064|P2|STARTED|Overall Study||24
2276172|NCT02222714|5587065|P1|STARTED|Overall Study||15
2276173|NCT02222558|5587104|P6|NOT COMPLETED|Period 3||1
2276174|NCT02222558|5587105|P5|NOT COMPLETED|Period 3||0
2276175|NCT02222558|5587106|P4|NOT COMPLETED|Period 3||0
2276176|NCT02222558|5587107|P3|NOT COMPLETED|Period 3||0
2276177|NCT02222558|5587108|P2|NOT COMPLETED|Period 3||0
2276178|NCT02222558|5587109|P1|NOT COMPLETED|Period 3||0
2276179|NCT02222558|5587104|P6|COMPLETED|Period 3||7
2276180|NCT02222558|5587105|P5|COMPLETED|Period 3||8
2276181|NCT02222558|5587106|P4|COMPLETED|Period 3||1
2276182|NCT02222558|5587107|P3|COMPLETED|Period 3||4
2276183|NCT02222558|5587108|P2|COMPLETED|Period 3||0
2276184|NCT02222558|5587109|P1|COMPLETED|Period 3||0
2276185|NCT02222558|5587104|P6|STARTED|Period 3||8
2276186|NCT02222558|5587105|P5|STARTED|Period 3||8
2276187|NCT02222558|5587106|P4|STARTED|Period 3||1
2276188|NCT02222558|5587107|P3|STARTED|Period 3||4
2276189|NCT02222558|5587108|P2|STARTED|Period 3||0
2276190|NCT02222558|5587109|P1|STARTED|Period 3||0
2276191|NCT02222558|5587104|P6|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
2276192|NCT02222558|5587105|P5|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
2276193|NCT02222558|5587106|P4|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
2276194|NCT02222558|5587107|P3|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
2276195|NCT02222558|5587108|P2|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
2276196|NCT02222558|5587109|P1|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
2276197|NCT02222558|5587104|P6|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
2276198|NCT02222558|5587105|P5|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
2276199|NCT02222558|5587106|P4|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
2276200|NCT02222558|5587107|P3|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
2276201|NCT02222558|5587108|P2|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||21
2276202|NCT02222558|5587109|P1|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
2276203|NCT02222558|5587104|P6|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
2276204|NCT02222558|5587105|P5|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
2276205|NCT02222558|5587106|P4|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
2276206|NCT02222558|5587107|P3|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
2276207|NCT02222558|5587108|P2|STARTED|Period 2: Two Times Daily Dosing 90 mg||21
2276208|NCT02222558|5587109|P1|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
2276209|NCT02222558|5587104|P6|NOT COMPLETED|Period 1: Single Dose||0
2276210|NCT02222558|5587105|P5|NOT COMPLETED|Period 1: Single Dose||0
2276211|NCT02222558|5587106|P4|NOT COMPLETED|Period 1: Single Dose||0
2276212|NCT02222558|5587107|P3|NOT COMPLETED|Period 1: Single Dose||0
2276213|NCT02222558|5587108|P2|NOT COMPLETED|Period 1: Single Dose||0
2276214|NCT02222558|5587109|P1|NOT COMPLETED|Period 1: Single Dose||4
2276215|NCT02222558|5587104|P6|COMPLETED|Period 1: Single Dose||0
2276216|NCT02222558|5587105|P5|COMPLETED|Period 1: Single Dose||0
2276217|NCT02222558|5587106|P4|COMPLETED|Period 1: Single Dose||0
2276218|NCT02222558|5587107|P3|COMPLETED|Period 1: Single Dose||0
2276219|NCT02222558|5587108|P2|COMPLETED|Period 1: Single Dose||0
2276220|NCT02222558|5587109|P1|COMPLETED|Period 1: Single Dose||21
2276221|NCT02222558|5587104|P6|STARTED|Period 1: Single Dose||0
2276222|NCT02222558|5587105|P5|STARTED|Period 1: Single Dose||0
2276223|NCT02222558|5587106|P4|STARTED|Period 1: Single Dose||0
2276224|NCT02222558|5587107|P3|STARTED|Period 1: Single Dose||0
2276225|NCT02222558|5587108|P2|STARTED|Period 1: Single Dose||0
2276226|NCT02222558|5587109|P1|STARTED|Period 1: Single Dose||25
2276227|NCT02222493|5587125|P2|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0
2276228|NCT02222493|5587126|P1|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||31
2276229|NCT02222493|5587125|P2|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0
2276230|NCT02222493|5587126|P1|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||474
2276231|NCT02222493|5587125|P2|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||0
2276232|NCT02222493|5587126|P1|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||505
2276233|NCT02222493|5587125|P2|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||17
2276234|NCT02222493|5587126|P1|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||43
2276235|NCT02222493|5587125|P2|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||126
2276236|NCT02222493|5587126|P1|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||380
2276237|NCT02222493|5587125|P2|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||143
2276238|NCT02222493|5587126|P1|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||423
2276239|NCT02222493|5587125|P2|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||40
2276240|NCT02222493|5587126|P1|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||44
2276241|NCT02222493|5587125|P2|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||286
2276242|NCT02222493|5587126|P1|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||280
2276243|NCT02222493|5587125|P2|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||326
2276244|NCT02222493|5587126|P1|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||323
2276245|NCT02222493|5587125|P2|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||326
2276246|NCT02222493|5587126|P1|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||324
2276247|NCT02222337|5587244|P2|NOT COMPLETED|Overall Study||24
2276248|NCT02222337|5587245|P1|NOT COMPLETED|Overall Study||26
2276249|NCT02222337|5587244|P2|COMPLETED|Overall Study||108
2276250|NCT02222337|5587245|P1|COMPLETED|Overall Study||114
2276251|NCT02222337|5587244|P2|STARTED|Overall Study|132 participants were enrolled but 2 withdrew and never provided any data.|132
2276252|NCT02222337|5587245|P1|STARTED|Overall Study||140
2276253|NCT02222246|5587277|P2|NOT COMPLETED|Overall Study||27
2276254|NCT02222246|5587278|P1|NOT COMPLETED|Overall Study||27
2276255|NCT02222246|5587277|P2|COMPLETED|Overall Study||26
2276256|NCT02222246|5587278|P1|COMPLETED|Overall Study||26
2276257|NCT02222246|5587277|P2|STARTED|Overall Study||53
2276258|NCT02222246|5587278|P1|STARTED|Overall Study||53
2276259|NCT02222207|5587306|P1|NOT COMPLETED|Overall Study||4
2276260|NCT02222207|5587306|P1|COMPLETED|Overall Study||48
2276261|NCT02222207|5587306|P1|Treated and Valid for Full Analysis Set|Overall Study||51
2276262|NCT02222207|5587306|P1|STARTED|Overall Study||52
2276263|NCT02222181|5587313|P1|NOT COMPLETED|Overall Study||108
2276264|NCT02222181|5587313|P1|COMPLETED|Overall Study||55
2276265|NCT02222181|5587313|P1|STARTED|Overall Study||163
2276266|NCT02222129|5587325|P2|NOT COMPLETED|Overall Study||0
2276267|NCT02222129|5587326|P1|NOT COMPLETED|Overall Study||0
2276268|NCT02222129|5587325|P2|COMPLETED|Overall Study||106
2276269|NCT02222129|5587326|P1|COMPLETED|Overall Study||100
2276270|NCT02222129|5587325|P2|STARTED|Overall Study||106
2276271|NCT02222129|5587326|P1|STARTED|Overall Study||100
2276272|NCT02221947|5587334|P2|NOT COMPLETED|Overall Study||0
2276273|NCT02221947|5587335|P1|NOT COMPLETED|Overall Study||0
2276274|NCT02221947|5587334|P2|COMPLETED|Overall Study||3
2276275|NCT02221947|5587335|P1|COMPLETED|Overall Study||6
2276276|NCT02221947|5587334|P2|STARTED|Overall Study||3
2276277|NCT02221947|5587335|P1|STARTED|Overall Study||6
2276278|NCT02221882|5587353|P6|NOT COMPLETED|Overall Study||2
2276279|NCT02221882|5587354|P5|NOT COMPLETED|Overall Study||2
2276280|NCT02221882|5587355|P4|NOT COMPLETED|Overall Study||2
2276281|NCT02221882|5587356|P3|NOT COMPLETED|Overall Study||4
2276282|NCT02221882|5587357|P2|NOT COMPLETED|Overall Study||1
2276283|NCT02221882|5587358|P1|NOT COMPLETED|Overall Study||0
2276284|NCT02221882|5587353|P6|COMPLETED|Overall Study||2
2276285|NCT02221882|5587354|P5|COMPLETED|Overall Study||3
2276286|NCT02221882|5587355|P4|COMPLETED|Overall Study||1
2276287|NCT02221882|5587356|P3|COMPLETED|Overall Study||7
2276288|NCT02221882|5587357|P2|COMPLETED|Overall Study||2
2276289|NCT02221882|5587358|P1|COMPLETED|Overall Study||3
2276290|NCT02221882|5587353|P6|Received at Least One Dose of Study Drug|Overall Study||4
2276291|NCT02221882|5587354|P5|Received at Least One Dose of Study Drug|Overall Study||5
2276292|NCT02221882|5587355|P4|Received at Least One Dose of Study Drug|Overall Study||3
2276293|NCT02221882|5587356|P3|Received at Least One Dose of Study Drug|Overall Study||11
2276389|NCT02220725|5587680|P2|STARTED|Overall Study||27
2276294|NCT02221882|5587357|P2|Received at Least One Dose of Study Drug|Overall Study||3
2276295|NCT02221882|5587358|P1|Received at Least One Dose of Study Drug|Overall Study||3
2276296|NCT02221882|5587353|P6|STARTED|Overall Study||4
2276297|NCT02221882|5587354|P5|STARTED|Overall Study||5
2276298|NCT02221882|5587355|P4|STARTED|Overall Study||3
2276299|NCT02221882|5587356|P3|STARTED|Overall Study||11
2276300|NCT02221882|5587357|P2|STARTED|Overall Study||3
2276301|NCT02221882|5587358|P1|STARTED|Overall Study||3
2276302|NCT02221869|5587401|P3|NOT COMPLETED|Overall Study||10
2276303|NCT02221869|5587402|P2|NOT COMPLETED|Overall Study||0
2276304|NCT02221869|5587403|P1|NOT COMPLETED|Overall Study||1
2276305|NCT02221869|5587401|P3|COMPLETED|Overall Study||33
2276306|NCT02221869|5587402|P2|COMPLETED|Overall Study||32
2276307|NCT02221869|5587403|P1|COMPLETED|Overall Study||30
2276308|NCT02221869|5587401|P3|STARTED|Overall Study||43
2276309|NCT02221869|5587402|P2|STARTED|Overall Study||32
2276310|NCT02221869|5587403|P1|STARTED|Overall Study||31
2276311|NCT02221739|5587417|P1|NOT COMPLETED|Overall Study||18
2276312|NCT02221739|5587417|P1|COMPLETED|Overall Study||21
2276313|NCT02221739|5587417|P1|STARTED|Overall Study||39
2276314|NCT02221674|5587425|P3|NOT COMPLETED|Overall Study||0
2276315|NCT02221674|5587426|P2|NOT COMPLETED|Overall Study||0
2276316|NCT02221674|5587427|P1|NOT COMPLETED|Overall Study||1
2276317|NCT02221674|5587425|P3|COMPLETED|Overall Study||5
2276318|NCT02221674|5587426|P2|COMPLETED|Overall Study||6
2276319|NCT02221674|5587427|P1|COMPLETED|Overall Study||7
2276320|NCT02221674|5587425|P3|STARTED|Overall Study||5
2276321|NCT02221674|5587426|P2|STARTED|Overall Study||6
2276322|NCT02221674|5587427|P1|STARTED|Overall Study||8
2276323|NCT02221648|5587443|P2|NOT COMPLETED|Overall Study||3
2276324|NCT02221648|5587444|P1|NOT COMPLETED|Overall Study||3
2276325|NCT02221648|5587443|P2|COMPLETED|Overall Study||18
2276326|NCT02221648|5587444|P1|COMPLETED|Overall Study||19
2276327|NCT02221648|5587443|P2|STARTED|Overall Study||21
2276328|NCT02221648|5587444|P1|STARTED|Overall Study||22
2276329|NCT02221557|5587454|P1|NOT COMPLETED|Overall Study||3
2276330|NCT02221557|5587454|P1|COMPLETED|Overall Study||5
2276331|NCT02221557|5587454|P1|STARTED|Overall Study||8
2276332|NCT02221284|5587462|P1|NOT COMPLETED|Overall Study||61
2276333|NCT02221284|5587462|P1|COMPLETED|Overall Study||903
2276334|NCT02221284|5587462|P1|STARTED|Overall Study||964
2276335|NCT02221037|5587494|P4|NOT COMPLETED|Overall Study||0
2276336|NCT02221037|5587495|P3|NOT COMPLETED|Overall Study||1
2276337|NCT02221037|5587496|P2|NOT COMPLETED|Overall Study||0
2276338|NCT02221037|5587497|P1|NOT COMPLETED|Overall Study||0
2276339|NCT02221037|5587494|P4|COMPLETED|Overall Study||9
2276340|NCT02221037|5587495|P3|COMPLETED|Overall Study||7
2276341|NCT02221037|5587496|P2|COMPLETED|Overall Study||11
2276342|NCT02221037|5587497|P1|COMPLETED|Overall Study||5
2276343|NCT02221037|5587494|P4|STARTED|Overall Study||9
2276344|NCT02221037|5587495|P3|STARTED|Overall Study||8
2276345|NCT02221037|5587496|P2|STARTED|Overall Study||11
2276346|NCT02221037|5587497|P1|STARTED|Overall Study||5
2276347|NCT02220998|5587583|P2|NOT COMPLETED|Overall Study||11
2276348|NCT02220998|5587584|P1|NOT COMPLETED|Overall Study||7
2276349|NCT02220998|5587583|P2|COMPLETED|Overall Study||123
2276350|NCT02220998|5587584|P1|COMPLETED|Overall Study||128
2276351|NCT02220998|5587583|P2|STARTED|Overall Study||134
2276352|NCT02220998|5587584|P1|STARTED|Overall Study||135
2276353|NCT02220920|5587602|P2|NOT COMPLETED|Overall Study||3
2276354|NCT02220920|5587603|P1|NOT COMPLETED|Overall Study||3
2276355|NCT02220920|5587602|P2|COMPLETED|Overall Study||67
2276356|NCT02220920|5587603|P1|COMPLETED|Overall Study||73
2276357|NCT02220920|5587602|P2|STARTED|Overall Study||70
2276358|NCT02220920|5587603|P1|STARTED|Overall Study||76
2276359|NCT02220907|5587617|P1|NOT COMPLETED|Overall Study||11
2276360|NCT02220907|5587617|P1|COMPLETED|Overall Study||142
2276361|NCT02220907|5587617|P1|STARTED|Overall Study||153
2276370|NCT02220855|5587653|P1|NOT COMPLETED|Overall Study||14
2276371|NCT02220855|5587653|P1|COMPLETED|Overall Study||0
2276372|NCT02220855|5587653|P1|STARTED|Overall Study||14
2276373|NCT02220764|5587663|P2|NOT COMPLETED|Overall Study||1
2276374|NCT02220764|5587664|P1|NOT COMPLETED|Overall Study||4
2276375|NCT02220764|5587663|P2|COMPLETED|Overall Study||7
2276376|NCT02220764|5587664|P1|COMPLETED|Overall Study||20
2276377|NCT02220764|5587663|P2|STARTED|Overall Study||8
2276378|NCT02220764|5587664|P1|STARTED|Overall Study||24
2276379|NCT02220725|5587678|P4|NOT COMPLETED|Overall Study||2
2276380|NCT02220725|5587679|P3|NOT COMPLETED|Overall Study||0
2276381|NCT02220725|5587680|P2|NOT COMPLETED|Overall Study||0
2276382|NCT02220725|5587681|P1|NOT COMPLETED|Overall Study||0
2276383|NCT02220725|5587678|P4|COMPLETED|Overall Study||24
2276384|NCT02220725|5587679|P3|COMPLETED|Overall Study||13
2276385|NCT02220725|5587680|P2|COMPLETED|Overall Study||27
2276386|NCT02220725|5587681|P1|COMPLETED|Overall Study||14
2276387|NCT02220725|5587678|P4|STARTED|Overall Study||26
2276388|NCT02220725|5587679|P3|STARTED|Overall Study||13
2276390|NCT02220725|5587681|P1|STARTED|Overall Study||14
2276391|NCT02220205|5587711|P2|NOT COMPLETED|Overall Study||0
2276392|NCT02220205|5587712|P1|NOT COMPLETED|Overall Study||1
2276393|NCT02220205|5587711|P2|COMPLETED|Overall Study||30
2276394|NCT02220205|5587712|P1|COMPLETED|Overall Study||29
2276395|NCT02220205|5587711|P2|STARTED|Overall Study||30
2276396|NCT02220205|5587712|P1|STARTED|Overall Study||30
2276397|NCT02219997|5587722|P3|NOT COMPLETED|Second Filter||0
2276398|NCT02219997|5587723|P2|NOT COMPLETED|Second Filter||0
2276399|NCT02219997|5587724|P1|NOT COMPLETED|Second Filter||0
2276400|NCT02219997|5587722|P3|COMPLETED|Second Filter||18
2276401|NCT02219997|5587723|P2|COMPLETED|Second Filter||17
2276402|NCT02219997|5587724|P1|COMPLETED|Second Filter||0
2276403|NCT02219997|5587722|P3|STARTED|Second Filter||18
2276404|NCT02219997|5587723|P2|STARTED|Second Filter||17
2276405|NCT02219997|5587724|P1|STARTED|Second Filter||0
2276406|NCT02219997|5587722|P3|NOT COMPLETED|First Filter||0
2276407|NCT02219997|5587723|P2|NOT COMPLETED|First Filter||0
2276408|NCT02219997|5587724|P1|NOT COMPLETED|First Filter||0
2276409|NCT02219997|5587722|P3|COMPLETED|First Filter||18
2276410|NCT02219997|5587723|P2|COMPLETED|First Filter||17
2276411|NCT02219997|5587724|P1|COMPLETED|First Filter||33
2276412|NCT02219997|5587722|P3|STARTED|First Filter||18
2276413|NCT02219997|5587723|P2|STARTED|First Filter||17
2276414|NCT02219997|5587724|P1|STARTED|First Filter||33
2276415|NCT02219932|5587737|P2|NOT COMPLETED|Overall Study||51
2276416|NCT02219932|5587738|P1|NOT COMPLETED|Overall Study||65
2276417|NCT02219932|5587737|P2|COMPLETED|Overall Study||266
2276418|NCT02219932|5587738|P1|COMPLETED|Overall Study||254
2276419|NCT02219932|5587737|P2|Randomized, Not Treated|Overall Study||1
2276420|NCT02219932|5587738|P1|Randomized, Not Treated|Overall Study||0
2276421|NCT02219932|5587737|P2|STARTED|Overall Study||317
2276422|NCT02219932|5587738|P1|STARTED|Overall Study||319
2276423|NCT02219685|5587754|P2|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
2276424|NCT02219685|5587755|P1|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
2276425|NCT02219685|5587754|P2|COMPLETED|Open-Label (After Posttreatment Week 4)||14
2276426|NCT02219685|5587755|P1|COMPLETED|Open-Label (After Posttreatment Week 4)||0
2276427|NCT02219685|5587754|P2|STARTED|Open-Label (After Posttreatment Week 4)||14
2276428|NCT02219685|5587755|P1|STARTED|Open-Label (After Posttreatment Week 4)|Only participants from the Placebo arm were eligible to enroll in the Open-Label Phase.|0
2276429|NCT02219685|5587754|P2|NOT COMPLETED|Blinded Treatment Phase||0
2276430|NCT02219685|5587755|P1|NOT COMPLETED|Blinded Treatment Phase||2
2276431|NCT02219685|5587754|P2|COMPLETED|Blinded Treatment Phase||14
2276432|NCT02219685|5587755|P1|COMPLETED|Blinded Treatment Phase||24
2276433|NCT02219685|5587754|P2|STARTED|Blinded Treatment Phase||14
2276434|NCT02219685|5587755|P1|STARTED|Blinded Treatment Phase||26
2276435|NCT02219516|5587803|P4|NOT COMPLETED|Overall Study||0
2276436|NCT02219516|5587804|P3|NOT COMPLETED|Overall Study||0
2276437|NCT02219516|5587805|P2|NOT COMPLETED|Overall Study||0
2276438|NCT02219516|5587806|P1|NOT COMPLETED|Overall Study||0
2276439|NCT02219516|5587803|P4|COMPLETED|Overall Study||8
2276440|NCT02219516|5587804|P3|COMPLETED|Overall Study||7
2276441|NCT02219516|5587805|P2|COMPLETED|Overall Study||8
2276442|NCT02219516|5587806|P1|COMPLETED|Overall Study||8
2276443|NCT02219516|5587803|P4|STARTED|Overall Study||8
2276444|NCT02219516|5587804|P3|STARTED|Overall Study||7
2276445|NCT02219516|5587805|P2|STARTED|Overall Study||8
2276446|NCT02219516|5587806|P1|STARTED|Overall Study||8
2276447|NCT02219503|5587852|P1|NOT COMPLETED|Overall Study||0
2276448|NCT02219503|5587852|P1|COMPLETED|Overall Study||60
2276449|NCT02219503|5587852|P1|STARTED|Overall Study||60
2276450|NCT02219477|5587861|P3|NOT COMPLETED|Overall Study||1
2276451|NCT02219477|5587862|P2|NOT COMPLETED|Overall Study||2
2276452|NCT02219477|5587863|P1|NOT COMPLETED|Overall Study||0
2276453|NCT02219477|5587861|P3|COMPLETED|Overall Study||2
2276454|NCT02219477|5587862|P2|COMPLETED|Overall Study||22
2276455|NCT02219477|5587863|P1|COMPLETED|Overall Study||9
2276456|NCT02219477|5587861|P3|STARTED|Overall Study||3
2276457|NCT02219477|5587862|P2|STARTED|Overall Study||24
2276458|NCT02219477|5587863|P1|STARTED|Overall Study||9
2276459|NCT02219464|5587891|P2|NOT COMPLETED|Overall Study||0
2276460|NCT02219464|5587892|P1|NOT COMPLETED|Overall Study||3
2276461|NCT02219464|5587891|P2|COMPLETED|Overall Study||30
2276462|NCT02219464|5587892|P1|COMPLETED|Overall Study||27
2276463|NCT02219464|5587891|P2|STARTED|Overall Study||30
2276464|NCT02219464|5587892|P1|STARTED|Overall Study||30
2276465|NCT02219308|5587902|P2|NOT COMPLETED|Overall Study||2
2276466|NCT02219308|5587903|P1|NOT COMPLETED|Overall Study||1
2276467|NCT02219308|5587902|P2|COMPLETED|Overall Study||33
2276468|NCT02219308|5587903|P1|COMPLETED|Overall Study||31
2276469|NCT02219308|5587902|P2|STARTED|Overall Study||35
2276470|NCT02219308|5587903|P1|STARTED|Overall Study||32
2276471|NCT02219282|5587913|P2|NOT COMPLETED|Overall Study||1
2276472|NCT02219282|5587914|P1|NOT COMPLETED|Overall Study||1
2276473|NCT02219282|5587913|P2|COMPLETED|Overall Study||32
2276474|NCT02219282|5587914|P1|COMPLETED|Overall Study||32
2276475|NCT02219282|5587913|P2|STARTED|Overall Study||33
2276476|NCT02219282|5587914|P1|STARTED|Overall Study||33
2276477|NCT02219256|5587940|P12|NOT COMPLETED|Overall Study||0
2276478|NCT02219256|5587941|P11|NOT COMPLETED|Overall Study||0
2276479|NCT02219256|5587942|P10|NOT COMPLETED|Overall Study||0
2276480|NCT02219256|5587943|P9|NOT COMPLETED|Overall Study||0
2276481|NCT02219256|5587944|P8|NOT COMPLETED|Overall Study||0
2276482|NCT02219256|5587945|P7|NOT COMPLETED|Overall Study||0
2276483|NCT02219256|5587946|P6|NOT COMPLETED|Overall Study||0
2276484|NCT02219256|5587947|P5|NOT COMPLETED|Overall Study||0
2276485|NCT02219256|5587948|P4|NOT COMPLETED|Overall Study||0
2276486|NCT02219256|5587949|P3|NOT COMPLETED|Overall Study||0
2276487|NCT02219256|5587950|P2|NOT COMPLETED|Overall Study||0
2276488|NCT02219256|5587951|P1|NOT COMPLETED|Overall Study||0
2276489|NCT02219256|5587940|P12|COMPLETED|Overall Study||6
2276490|NCT02219256|5587941|P11|COMPLETED|Overall Study||6
2276491|NCT02219256|5587942|P10|COMPLETED|Overall Study||6
2276492|NCT02219256|5587943|P9|COMPLETED|Overall Study||6
2276493|NCT02219256|5587944|P8|COMPLETED|Overall Study||8
2276494|NCT02219256|5587945|P7|COMPLETED|Overall Study||6
2276495|NCT02219256|5587946|P6|COMPLETED|Overall Study||6
2276496|NCT02219256|5587947|P5|COMPLETED|Overall Study||6
2276497|NCT02219256|5587948|P4|COMPLETED|Overall Study||4
2276498|NCT02219256|5587949|P3|COMPLETED|Overall Study||4
2276499|NCT02219256|5587950|P2|COMPLETED|Overall Study||4
2276500|NCT02219256|5587951|P1|COMPLETED|Overall Study||12
2276501|NCT02219256|5587940|P12|STARTED|Overall Study||6
2276502|NCT02219256|5587941|P11|STARTED|Overall Study||6
2276503|NCT02219256|5587942|P10|STARTED|Overall Study||6
2276504|NCT02219256|5587943|P9|STARTED|Overall Study||6
2276505|NCT02219256|5587944|P8|STARTED|Overall Study||8
2276506|NCT02219256|5587945|P7|STARTED|Overall Study||6
2276507|NCT02219256|5587946|P6|STARTED|Overall Study||6
2276508|NCT02219256|5587947|P5|STARTED|Overall Study||6
2276509|NCT02219256|5587948|P4|STARTED|Overall Study||4
2276510|NCT02219256|5587949|P3|STARTED|Overall Study||4
2276511|NCT02219256|5587950|P2|STARTED|Overall Study||4
2276512|NCT02219256|5587951|P1|STARTED|Overall Study||12
2276513|NCT02219087|5588063|P2|NOT COMPLETED|Overall Study||1
2276514|NCT02219087|5588064|P1|NOT COMPLETED|Overall Study||0
2276515|NCT02219087|5588063|P2|COMPLETED|Overall Study|Randomization envelope pulled out of sequence for consented patient. Excluded by request of IRB|29
2276516|NCT02219087|5588064|P1|COMPLETED|Overall Study||30
2276517|NCT02219087|5588063|P2|STARTED|Overall Study||30
2276518|NCT02219087|5588064|P1|STARTED|Overall Study||30
2276519|NCT02219048|5588084|P2|NOT COMPLETED|Overall Study||21
2276520|NCT02219048|5588085|P1|NOT COMPLETED|Overall Study||21
2276521|NCT02219048|5588084|P2|COMPLETED|Overall Study||4
2276522|NCT02219048|5588085|P1|COMPLETED|Overall Study||5
2276523|NCT02219048|5588084|P2|STARTED|Overall Study||25
2276524|NCT02219048|5588085|P1|STARTED|Overall Study||26
2276525|NCT02219009|5588111|P2|NOT COMPLETED|Overall Study||8
2276526|NCT02219009|5588112|P1|NOT COMPLETED|Overall Study||10
2276527|NCT02219009|5588111|P2|COMPLETED|Overall Study||22
2276528|NCT02219009|5588112|P1|COMPLETED|Overall Study||27
2276529|NCT02219009|5588111|P2|STARTED|Overall Study||30
2276530|NCT02219009|5588112|P1|STARTED|Overall Study||37
2276531|NCT02218736|5588124|P2|NOT COMPLETED|Overall Study||9
2276532|NCT02218736|5588125|P1|NOT COMPLETED|Overall Study||12
2276533|NCT02218736|5588124|P2|COMPLETED|Overall Study||35
2276534|NCT02218736|5588125|P1|COMPLETED|Overall Study||33
2276535|NCT02218736|5588124|P2|STARTED|Overall Study||44
2276536|NCT02218736|5588125|P1|STARTED|Overall Study||45
2276537|NCT02218697|5588137|P2|NOT COMPLETED|Overall Study||6
2276538|NCT02218697|5588138|P1|NOT COMPLETED|Overall Study||2
2276539|NCT02218697|5588137|P2|COMPLETED|Overall Study||171
2276540|NCT02218697|5588138|P1|COMPLETED|Overall Study||177
2276541|NCT02218697|5588137|P2|STARTED|Overall Study||177
2276542|NCT02218697|5588138|P1|STARTED|Overall Study||179
2276543|NCT02218541|5588178|P2|NOT COMPLETED|Overall Study||2
2276544|NCT02218541|5588179|P1|NOT COMPLETED|Overall Study||6
2276545|NCT02218541|5588178|P2|COMPLETED|Overall Study||9
2276546|NCT02218541|5588179|P1|COMPLETED|Overall Study||5
2276547|NCT02218541|5588178|P2|STARTED|Overall Study||11
2276548|NCT02218541|5588179|P1|STARTED|Overall Study||11
2276549|NCT02218463|5588191|P2|NOT COMPLETED|Overall Study||3
2276550|NCT02218463|5588192|P1|NOT COMPLETED|Overall Study||3
2276551|NCT02218463|5588191|P2|COMPLETED|Overall Study||19
2276552|NCT02218463|5588192|P1|COMPLETED|Overall Study||18
2276553|NCT02218463|5588191|P2|STARTED|Overall Study||22
2276554|NCT02218463|5588192|P1|STARTED|Overall Study||21
2276555|NCT02218424|5588202|P2|NOT COMPLETED|Overall Study||0
2276556|NCT02218424|5588203|P1|NOT COMPLETED|Overall Study||0
2276557|NCT02218424|5588202|P2|COMPLETED|Overall Study||30
2276558|NCT02218424|5588203|P1|COMPLETED|Overall Study||30
2276559|NCT02218424|5588202|P2|STARTED|Overall Study||30
2276560|NCT02218424|5588203|P1|STARTED|Overall Study||30
2276561|NCT02218372|5588225|P2|NOT COMPLETED|Overall Study||6
2276562|NCT02218372|5588226|P1|NOT COMPLETED|Overall Study||5
2276563|NCT02218372|5588225|P2|COMPLETED|Overall Study||42
2276564|NCT02218372|5588226|P1|COMPLETED|Overall Study||95
2276565|NCT02218372|5588225|P2|Treated|Overall Study||44
2276566|NCT02218372|5588226|P1|Treated|Overall Study||98
2276567|NCT02218372|5588225|P2|STARTED|Overall Study||48
2276568|NCT02218372|5588226|P1|STARTED|Overall Study||100
2276569|NCT02218320|5588284|P2|NOT COMPLETED|Overall Study||0
2276570|NCT02218320|5588285|P1|NOT COMPLETED|Overall Study||0
2276571|NCT02218320|5588284|P2|COMPLETED|Overall Study|Last participant contact on this arm was October 2015|10
2276572|NCT02218320|5588285|P1|COMPLETED|Overall Study|Last participant contact on this arm was June 2015|10
2276573|NCT02218320|5588284|P2|STARTED|Overall Study|First participant contact on this arm was December 2014|10
2276574|NCT02218320|5588285|P1|STARTED|Overall Study|First participant visit on this arm Dec 2014|10
2276575|NCT02218307|5588297|P2|NOT COMPLETED|Overall Study||1
2276576|NCT02218307|5588298|P1|NOT COMPLETED|Overall Study||9
2276577|NCT02218307|5588297|P2|COMPLETED|Overall Study||33
2276578|NCT02218307|5588298|P1|COMPLETED|Overall Study||25
2276579|NCT02218307|5588297|P2|STARTED|Overall Study||34
2276580|NCT02218307|5588298|P1|STARTED|Overall Study||34
2276581|NCT02218268|5588306|P2|NOT COMPLETED|Final Phase (2 Hours)||0
2276582|NCT02218268|5588307|P1|NOT COMPLETED|Final Phase (2 Hours)||0
2276583|NCT02218268|5588306|P2|COMPLETED|Final Phase (2 Hours)||21
2276584|NCT02218268|5588307|P1|COMPLETED|Final Phase (2 Hours)||19
2276585|NCT02218268|5588306|P2|STARTED|Final Phase (2 Hours)||21
2276586|NCT02218268|5588307|P1|STARTED|Final Phase (2 Hours)||19
2276587|NCT02218268|5588306|P2|NOT COMPLETED|24 Hour Washout||9
2276588|NCT02218268|5588307|P1|NOT COMPLETED|24 Hour Washout||11
2276589|NCT02218268|5588306|P2|COMPLETED|24 Hour Washout||21
2276590|NCT02218268|5588307|P1|COMPLETED|24 Hour Washout||19
2276591|NCT02218268|5588306|P2|STARTED|24 Hour Washout||30
2276592|NCT02218268|5588307|P1|STARTED|24 Hour Washout||30
2276593|NCT02218268|5588306|P2|NOT COMPLETED|First Phase (2 Hours)||0
2276594|NCT02218268|5588307|P1|NOT COMPLETED|First Phase (2 Hours)||0
2276595|NCT02218268|5588306|P2|COMPLETED|First Phase (2 Hours)||30
2276596|NCT02218268|5588307|P1|COMPLETED|First Phase (2 Hours)||30
2276597|NCT02218268|5588306|P2|STARTED|First Phase (2 Hours)||30
2276598|NCT02218268|5588307|P1|STARTED|First Phase (2 Hours)||30
2276599|NCT02218242|5588313|P1|NOT COMPLETED|Overall Study||0
2276600|NCT02218242|5588313|P1|COMPLETED|Overall Study||9
2276601|NCT02218242|5588313|P1|STARTED|Overall Study||9
2276602|NCT02218216|5588319|P3|NOT COMPLETED|Overall Study||0
2276603|NCT02218216|5588320|P2|NOT COMPLETED|Overall Study||0
2276604|NCT02218216|5588321|P1|NOT COMPLETED|Overall Study||6
2276605|NCT02218216|5588319|P3|COMPLETED|Overall Study||3
2276606|NCT02218216|5588320|P2|COMPLETED|Overall Study||2
2276607|NCT02218216|5588321|P1|COMPLETED|Overall Study||8
2276608|NCT02218216|5588319|P3|STARTED|Overall Study||3
2276609|NCT02218216|5588320|P2|STARTED|Overall Study||2
2276610|NCT02218216|5588321|P1|STARTED|Overall Study||14
2276611|NCT02218203|5588329|P1|NOT COMPLETED|Overall Study||0
2276612|NCT02218203|5588329|P1|COMPLETED|Overall Study|2 subjects did not complete the placebo, medium dose, and high dose dex/lido combination arms.|26
2276613|NCT02218203|5588329|P1|High Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24
2276614|NCT02218203|5588329|P1|High Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24
2276615|NCT02218203|5588329|P1|High Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24
2276616|NCT02218203|5588329|P1|High Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24
2276617|NCT02218203|5588329|P1|Medium Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24
2276618|NCT02218203|5588329|P1|Medium Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24
2276619|NCT02218203|5588329|P1|Medium Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24
2276620|NCT02218203|5588329|P1|Medium Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24
2276621|NCT02218203|5588329|P1|Low Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||26
2276622|NCT02218203|5588329|P1|Low Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||26
2276623|NCT02218203|5588329|P1|Low Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||26
2276624|NCT02218203|5588329|P1|Low Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||26
2276625|NCT02218203|5588329|P1|Placebo Dex v. 4mg/km LBM Lidocaine|Overall Study||24
2276626|NCT02218203|5588329|P1|Placebo Dex v. 2mg/km LBM Lidocaine|Overall Study||24
2276627|NCT02218203|5588329|P1|Placebo Dex v. 1mg/km LBM Lidocaine|Overall Study||24
2276628|NCT02218203|5588329|P1|Placebo Dex v. 0mg/km LBM Lidocaine|Overall Study||24
2276629|NCT02218203|5588329|P1|STARTED|Overall Study||26
2276630|NCT02218190|5588353|P2|NOT COMPLETED|Overall Study||0
2276631|NCT02218190|5588354|P1|NOT COMPLETED|Overall Study||0
2276632|NCT02218190|5588353|P2|COMPLETED|Overall Study||13
2276633|NCT02218190|5588354|P1|COMPLETED|Overall Study||13
2276634|NCT02218190|5588353|P2|STARTED|Overall Study||13
2276635|NCT02218190|5588354|P1|STARTED|Overall Study||13
2276636|NCT02218164|5588364|P1|NOT COMPLETED|Overall Study||0
2276637|NCT02218164|5588364|P1|COMPLETED|Overall Study||8
2276638|NCT02218164|5588364|P1|STARTED|Overall Study||8
2276639|NCT02218008|5588374|P6|NOT COMPLETED|Stage 2 (S2)||6
2276640|NCT02218008|5588375|P5|NOT COMPLETED|Stage 2 (S2)||4
2276641|NCT02218008|5588376|P4|NOT COMPLETED|Stage 2 (S2)||4
2276642|NCT02218008|5588377|P3|NOT COMPLETED|Stage 2 (S2)||0
2276643|NCT02218008|5588378|P2|NOT COMPLETED|Stage 2 (S2)||0
2276644|NCT02218008|5588379|P1|NOT COMPLETED|Stage 2 (S2)||0
2276645|NCT02218008|5588374|P6|COMPLETED|Stage 2 (S2)||57
2276646|NCT02218008|5588375|P5|COMPLETED|Stage 2 (S2)||58
2276647|NCT02218008|5588376|P4|COMPLETED|Stage 2 (S2)||58
2276648|NCT02218008|5588377|P3|COMPLETED|Stage 2 (S2)||0
2276649|NCT02218008|5588378|P2|COMPLETED|Stage 2 (S2)||0
2276650|NCT02218008|5588379|P1|COMPLETED|Stage 2 (S2)||0
2276651|NCT02218008|5588374|P6|STARTED|Stage 2 (S2)||63
2276652|NCT02218008|5588375|P5|STARTED|Stage 2 (S2)||62
2276653|NCT02218008|5588376|P4|STARTED|Stage 2 (S2)||62
2276654|NCT02218008|5588377|P3|STARTED|Stage 2 (S2)||0
2276655|NCT02218008|5588378|P2|STARTED|Stage 2 (S2)||0
2276656|NCT02218008|5588379|P1|STARTED|Stage 2 (S2)||0
2276657|NCT02218008|5588374|P6|NOT COMPLETED|Stage 1 (S1)||0
2276658|NCT02218008|5588375|P5|NOT COMPLETED|Stage 1 (S1)||0
2276659|NCT02218008|5588376|P4|NOT COMPLETED|Stage 1 (S1)||0
2276660|NCT02218008|5588377|P3|NOT COMPLETED|Stage 1 (S1)||15
2276661|NCT02218008|5588378|P2|NOT COMPLETED|Stage 1 (S1)||7
2276662|NCT02218008|5588379|P1|NOT COMPLETED|Stage 1 (S1)||22
2276663|NCT02218008|5588374|P6|COMPLETED|Stage 1 (S1)||0
2276664|NCT02218008|5588375|P5|COMPLETED|Stage 1 (S1)||0
2276665|NCT02218008|5588376|P4|COMPLETED|Stage 1 (S1)||0
2276666|NCT02218008|5588377|P3|COMPLETED|Stage 1 (S1)||48
2276667|NCT02218008|5588378|P2|COMPLETED|Stage 1 (S1)||56
2276668|NCT02218008|5588379|P1|COMPLETED|Stage 1 (S1)||258
2276669|NCT02218008|5588374|P6|STARTED|Stage 1 (S1)||0
2276670|NCT02218008|5588375|P5|STARTED|Stage 1 (S1)||0
2276671|NCT02218008|5588376|P4|STARTED|Stage 1 (S1)||0
2276672|NCT02218008|5588377|P3|STARTED|Stage 1 (S1)||63
2276673|NCT02218008|5588378|P2|STARTED|Stage 1 (S1)||63
2276674|NCT02218008|5588379|P1|STARTED|Stage 1 (S1)||280
2276675|NCT02217982|5588425|P2|NOT COMPLETED|Overall Study||1
2276676|NCT02217982|5588426|P1|NOT COMPLETED|Overall Study||1
2276677|NCT02217982|5588425|P2|COMPLETED|Overall Study||3
2276678|NCT02217982|5588426|P1|COMPLETED|Overall Study|Trial closed before patient finished|0
2276679|NCT02217982|5588425|P2|STARTED|Overall Study||4
2276680|NCT02217982|5588426|P1|STARTED|Overall Study||1
2276681|NCT02217904|5588439|P7|NOT COMPLETED|Overall Study||0
2276682|NCT02217904|5588440|P6|NOT COMPLETED|Overall Study||0
2276683|NCT02217904|5588441|P5|NOT COMPLETED|Overall Study||0
2276684|NCT02217904|5588442|P4|NOT COMPLETED|Overall Study||0
2276685|NCT02217904|5588443|P3|NOT COMPLETED|Overall Study||0
2276686|NCT02217904|5588444|P2|NOT COMPLETED|Overall Study||0
2276687|NCT02217904|5588445|P1|NOT COMPLETED|Overall Study||0
2276688|NCT02217904|5588439|P7|COMPLETED|Overall Study||0
2276689|NCT02217904|5588440|P6|COMPLETED|Overall Study||0
2276690|NCT02217904|5588441|P5|COMPLETED|Overall Study||6
2276691|NCT02217904|5588442|P4|COMPLETED|Overall Study||6
2276692|NCT02217904|5588443|P3|COMPLETED|Overall Study||6
2276693|NCT02217904|5588444|P2|COMPLETED|Overall Study||6
2276694|NCT02217904|5588445|P1|COMPLETED|Overall Study||6
2276695|NCT02217904|5588439|P7|STARTED|Overall Study||0
2276696|NCT02217904|5588440|P6|STARTED|Overall Study||0
2276697|NCT02217904|5588441|P5|STARTED|Overall Study||6
2276698|NCT02217904|5588442|P4|STARTED|Overall Study||6
2276699|NCT02217904|5588443|P3|STARTED|Overall Study||6
2276700|NCT02217904|5588444|P2|STARTED|Overall Study||6
2276701|NCT02217904|5588445|P1|STARTED|Overall Study||6
2276702|NCT02217878|5588509|P2|NOT COMPLETED|Overall Study||2
2276703|NCT02217878|5588510|P1|NOT COMPLETED|Overall Study||2
2276704|NCT02217878|5588509|P2|COMPLETED|Overall Study||35
2276705|NCT02217878|5588510|P1|COMPLETED|Overall Study||35
2276706|NCT02217878|5588509|P2|STARTED|Overall Study||37
2276707|NCT02217878|5588510|P1|STARTED|Overall Study||37
2276708|NCT02217800|5588590|P1|NOT COMPLETED|Overall Study||0
2276709|NCT02217800|5588590|P1|COMPLETED|Overall Study||8
2276710|NCT02217800|5588590|P1|STARTED|Overall Study||8
2276711|NCT02217618|5588602|P1|NOT COMPLETED|Overall Study||0
2276712|NCT02217618|5588602|P1|COMPLETED|Overall Study||16
2276713|NCT02217618|5588602|P1|Received Study Drug|Overall Study||16
2276714|NCT02217618|5588602|P1|STARTED|Overall Study||16
2276715|NCT02217566|5588608|P1|NOT COMPLETED|Overall Study||11
2276716|NCT02217566|5588608|P1|COMPLETED|Overall Study||35
2276717|NCT02217566|5588608|P1|STARTED|Overall Study||46
2276718|NCT02217527|5588619|P2|NOT COMPLETED|Drug Condition 2: Second Study Phase||1
2276719|NCT02217527|5588620|P1|NOT COMPLETED|Drug Condition 2: Second Study Phase||0
2276720|NCT02217527|5588619|P2|COMPLETED|Drug Condition 2: Second Study Phase||14
2276721|NCT02217527|5588620|P1|COMPLETED|Drug Condition 2: Second Study Phase||17
2276722|NCT02217527|5588619|P2|STARTED|Drug Condition 2: Second Study Phase||15
2276723|NCT02217527|5588620|P1|STARTED|Drug Condition 2: Second Study Phase||17
2276724|NCT02217527|5588619|P2|NOT COMPLETED|Drug Condition 1: First Study Phase||3
2276725|NCT02217527|5588620|P1|NOT COMPLETED|Drug Condition 1: First Study Phase||1
2276726|NCT02217527|5588619|P2|COMPLETED|Drug Condition 1: First Study Phase||15
2276727|NCT02217527|5588620|P1|COMPLETED|Drug Condition 1: First Study Phase||17
2276728|NCT02217527|5588619|P2|STARTED|Drug Condition 1: First Study Phase||18
2276729|NCT02217527|5588620|P1|STARTED|Drug Condition 1: First Study Phase||18
2276730|NCT02217475|5588633|P3|NOT COMPLETED|Treatment Period 2 (Year 2)||12
2276731|NCT02217475|5588634|P2|NOT COMPLETED|Treatment Period 2 (Year 2)||2
2276732|NCT02217475|5588635|P1|NOT COMPLETED|Treatment Period 2 (Year 2)||2
2276733|NCT02217475|5588633|P3|COMPLETED|Treatment Period 2 (Year 2)||109
2276734|NCT02217475|5588634|P2|COMPLETED|Treatment Period 2 (Year 2)||59
2276735|NCT02217475|5588635|P1|COMPLETED|Treatment Period 2 (Year 2)||58
2276736|NCT02217475|5588633|P3|STARTED|Treatment Period 2 (Year 2)||121
2276737|NCT02217475|5588634|P2|STARTED|Treatment Period 2 (Year 2)||61
2276738|NCT02217475|5588635|P1|STARTED|Treatment Period 2 (Year 2)||60
2276739|NCT02217475|5588633|P3|NOT COMPLETED|Discontinued After Period 1||3
2276740|NCT02217475|5588634|P2|NOT COMPLETED|Discontinued After Period 1||3
2276741|NCT02217475|5588635|P1|NOT COMPLETED|Discontinued After Period 1||2
2276742|NCT02217475|5588633|P3|COMPLETED|Discontinued After Period 1||121
2276743|NCT02217475|5588634|P2|COMPLETED|Discontinued After Period 1||61
2276744|NCT02217475|5588635|P1|COMPLETED|Discontinued After Period 1||60
2276745|NCT02217475|5588633|P3|STARTED|Discontinued After Period 1||124
2276746|NCT02217475|5588634|P2|STARTED|Discontinued After Period 1||64
2276747|NCT02217475|5588635|P1|STARTED|Discontinued After Period 1||62
2276748|NCT02217475|5588633|P3|NOT COMPLETED|Treatment Period 1 (Year 1)||21
2276749|NCT02217475|5588634|P2|NOT COMPLETED|Treatment Period 1 (Year 1)||8
2276750|NCT02217475|5588635|P1|NOT COMPLETED|Treatment Period 1 (Year 1)||10
2276751|NCT02217475|5588633|P3|COMPLETED|Treatment Period 1 (Year 1)||124
2276752|NCT02217475|5588634|P2|COMPLETED|Treatment Period 1 (Year 1)||64
2276753|NCT02217475|5588635|P1|COMPLETED|Treatment Period 1 (Year 1)||62
2276754|NCT02217475|5588633|P3|Safety Analysis Set|Treatment Period 1 (Year 1)||144
2276755|NCT02217475|5588634|P2|Safety Analysis Set|Treatment Period 1 (Year 1)||72
2276756|NCT02217475|5588635|P1|Safety Analysis Set|Treatment Period 1 (Year 1)||72
2276757|NCT02217475|5588633|P3|STARTED|Treatment Period 1 (Year 1)||145
2276758|NCT02217475|5588634|P2|STARTED|Treatment Period 1 (Year 1)||72
2276759|NCT02217475|5588635|P1|STARTED|Treatment Period 1 (Year 1)||72
2276760|NCT02217436|5588752|P2|NOT COMPLETED|Overall Study||2
2276761|NCT02217436|5588753|P1|NOT COMPLETED|Overall Study||1
2276762|NCT02217436|5588752|P2|COMPLETED|Overall Study||38
2276763|NCT02217436|5588753|P1|COMPLETED|Overall Study||39
2276764|NCT02217436|5588752|P2|STARTED|Overall Study||40
2276765|NCT02217436|5588753|P1|STARTED|Overall Study||40
2276766|NCT02217410|5588764|P3|NOT COMPLETED|Overall Study||5
2276767|NCT02217410|5588765|P2|NOT COMPLETED|Overall Study||4
2276768|NCT02217410|5588766|P1|NOT COMPLETED|Overall Study||1
2276769|NCT02217410|5588764|P3|COMPLETED|Overall Study||13
2276770|NCT02217410|5588765|P2|COMPLETED|Overall Study||30
2276771|NCT02217410|5588766|P1|COMPLETED|Overall Study||6
2276772|NCT02217410|5588764|P3|STARTED|Overall Study||18
2276773|NCT02217410|5588765|P2|STARTED|Overall Study||34
2276774|NCT02217410|5588766|P1|STARTED|Overall Study||7
2276775|NCT02217280|5588789|P1|NOT COMPLETED|Overall Study||4
2276776|NCT02217280|5588789|P1|COMPLETED|Overall Study||16
2276777|NCT02217280|5588789|P1|STARTED|Overall Study||20
2276778|NCT02216812|5588796|P2|NOT COMPLETED|Overall Study||5
2276779|NCT02216812|5588797|P1|NOT COMPLETED|Overall Study||10
2276780|NCT02216812|5588796|P2|COMPLETED|Overall Study||62
2276781|NCT02216812|5588797|P1|COMPLETED|Overall Study||57
2276782|NCT02216812|5588796|P2|STARTED|Overall Study||67
2276783|NCT02216812|5588797|P1|STARTED|Overall Study||67
2276784|NCT02216773|5588813|P2|NOT COMPLETED|Overall Study||5
2276785|NCT02216773|5588814|P1|NOT COMPLETED|Overall Study||12
2276786|NCT02216773|5588813|P2|COMPLETED|Overall Study||24
2276787|NCT02216773|5588814|P1|COMPLETED|Overall Study||16
2276788|NCT02216773|5588813|P2|Underwent Procedure (PVE/RALPPS)|Overall Study||26
2276789|NCT02216773|5588814|P1|Underwent Procedure (PVE/RALPPS)|Overall Study||24
2276790|NCT02216773|5588813|P2|STARTED|Overall Study||29
2276791|NCT02216773|5588814|P1|STARTED|Overall Study||28
2276792|NCT02216695|5588824|P1|NOT COMPLETED|Overall Study||0
2276793|NCT02216695|5588824|P1|COMPLETED|Overall Study|This is a database study and hence, 64882 patients were finally included|64882
2276794|NCT02216695|5588824|P1|STARTED|Overall Study||64882
2276795|NCT02216591|5588835|P2|NOT COMPLETED|Overall Study||1
2276796|NCT02216591|5588836|P1|NOT COMPLETED|Overall Study||0
2276797|NCT02216591|5588835|P2|COMPLETED|Overall Study||9
2276798|NCT02216591|5588836|P1|COMPLETED|Overall Study||11
2276799|NCT02216591|5588835|P2|STARTED|Overall Study||10
2276800|NCT02216591|5588836|P1|STARTED|Overall Study||11
2276801|NCT02216526|5588849|P3|NOT COMPLETED|Overall Study||8
2276802|NCT02216526|5588850|P2|NOT COMPLETED|Overall Study||3
2276803|NCT02216526|5588851|P1|NOT COMPLETED|Overall Study||5
2276804|NCT02216526|5588849|P3|COMPLETED|Overall Study||36
2276805|NCT02216526|5588850|P2|COMPLETED|Overall Study||41
2276806|NCT02216526|5588851|P1|COMPLETED|Overall Study||40
2276807|NCT02216526|5588849|P3|STARTED|Overall Study||44
2276808|NCT02216526|5588850|P2|STARTED|Overall Study||44
2276809|NCT02216526|5588851|P1|STARTED|Overall Study||45
2276810|NCT02216422|5588961|P1|NOT COMPLETED|Overall Study||0
2276811|NCT02216422|5588961|P1|COMPLETED|Overall Study||36
2276812|NCT02216422|5588961|P1|STARTED|Overall Study||36
2276813|NCT02216357|5588969|P2|NOT COMPLETED|Overall Study||1
2276814|NCT02216357|5588970|P1|NOT COMPLETED|Overall Study||2
2276815|NCT02216357|5588969|P2|COMPLETED|Overall Study||4
2276816|NCT02216357|5588970|P1|COMPLETED|Overall Study||12
2276817|NCT02216357|5588969|P2|STARTED|Overall Study||5
2276818|NCT02216357|5588970|P1|STARTED|Overall Study||14
2276819|NCT02216214|5588996|P2|NOT COMPLETED|Overall Study||36
2276820|NCT02216214|5588997|P1|NOT COMPLETED|Overall Study||43
2276821|NCT02216214|5588996|P2|COMPLETED|Overall Study||409
2276822|NCT02216214|5588997|P1|COMPLETED|Overall Study||400
2276823|NCT02216214|5588996|P2|Treated|Overall Study||445
2276824|NCT02216214|5588997|P1|Treated|Overall Study||442
2276825|NCT02216214|5588996|P2|STARTED|Overall Study||445
2276826|NCT02216214|5588997|P1|STARTED|Overall Study||443
2276827|NCT02216136|5589056|P3|NOT COMPLETED|Overall Study||0
2276828|NCT02216136|5589057|P2|NOT COMPLETED|Overall Study||0
2276829|NCT02216136|5589058|P1|NOT COMPLETED|Overall Study||0
2276830|NCT02216136|5589056|P3|COMPLETED|Overall Study||0
2276831|NCT02216136|5589057|P2|COMPLETED|Overall Study||90
2276832|NCT02216136|5589058|P1|COMPLETED|Overall Study||72
2276833|NCT02216136|5589056|P3|STARTED|Overall Study||0
2276834|NCT02216136|5589057|P2|STARTED|Overall Study||90
2276835|NCT02216136|5589058|P1|STARTED|Overall Study||72
2276836|NCT02216123|5589068|P2|NOT COMPLETED|Overall Study||2
2276837|NCT02216123|5589069|P1|NOT COMPLETED|Overall Study||6
2276838|NCT02216123|5589068|P2|COMPLETED|Overall Study||83
2276839|NCT02216123|5589069|P1|COMPLETED|Overall Study||160
2276840|NCT02216123|5589068|P2|STARTED|Overall Study||85
2276841|NCT02216123|5589069|P1|STARTED|Overall Study||166
2276842|NCT02216097|5589135|P2|NOT COMPLETED|Overall Study||0
2276843|NCT02216097|5589136|P1|NOT COMPLETED|Overall Study||0
2276844|NCT02216097|5589135|P2|COMPLETED|Overall Study||6
2276845|NCT02216097|5589136|P1|COMPLETED|Overall Study||8
2276846|NCT02216097|5589135|P2|STARTED|Overall Study||6
2276847|NCT02216097|5589136|P1|STARTED|Overall Study||8
2276848|NCT02215967|5589162|P4|NOT COMPLETED|Overall Study||3
2276849|NCT02215967|5589163|P3|NOT COMPLETED|Overall Study||1
2276850|NCT02215967|5589164|P2|NOT COMPLETED|Overall Study||0
2276851|NCT02215967|5589165|P1|NOT COMPLETED|Overall Study||0
2276852|NCT02215967|5589162|P4|COMPLETED|Overall Study||16
2276853|NCT02215967|5589163|P3|COMPLETED|Overall Study||4
2276854|NCT02215967|5589164|P2|COMPLETED|Overall Study||3
2276855|NCT02215967|5589165|P1|COMPLETED|Overall Study||3
2276856|NCT02215967|5589162|P4|STARTED|Overall Study||19
2276857|NCT02215967|5589163|P3|STARTED|Overall Study||5
2276858|NCT02215967|5589164|P2|STARTED|Overall Study||3
2276859|NCT02215967|5589165|P1|STARTED|Overall Study||3
2276860|NCT02215954|5589186|P3|NOT COMPLETED|Overall Study||6
2276861|NCT02215954|5589187|P2|NOT COMPLETED|Overall Study||1
2276862|NCT02215954|5589188|P1|NOT COMPLETED|Overall Study||1
2276863|NCT02215954|5589186|P3|COMPLETED|Overall Study||205
2276864|NCT02215954|5589187|P2|COMPLETED|Overall Study||211
2276865|NCT02215954|5589188|P1|COMPLETED|Overall Study||213
2276866|NCT02215954|5589186|P3|Safety Analysis Set|Overall Study||208
2276867|NCT02215954|5589187|P2|Safety Analysis Set|Overall Study||211
2276868|NCT02215954|5589188|P1|Safety Analysis Set|Overall Study||213
2276869|NCT02215954|5589186|P3|Per Protocol (PP) Analysis Set|Overall Study||205
2276870|NCT02215954|5589187|P2|Per Protocol (PP) Analysis Set|Overall Study||208
2276871|NCT02215954|5589188|P1|Per Protocol (PP) Analysis Set|Overall Study||212
2276872|NCT02215954|5589186|P3|Intention-To-Treat (ITT) Analysis Set|Overall Study||211
2276873|NCT02215954|5589187|P2|Intention-To-Treat (ITT) Analysis Set|Overall Study||212
2276874|NCT02215954|5589188|P1|Intention-To-Treat (ITT) Analysis Set|Overall Study||214
2276875|NCT02215954|5589186|P3|STARTED|Overall Study||211
2276876|NCT02215954|5589187|P2|STARTED|Overall Study||212
2276877|NCT02215954|5589188|P1|STARTED|Overall Study||214
2276878|NCT02215616|5589212|P4|NOT COMPLETED|Overall Study||13
2276879|NCT02215616|5589213|P3|NOT COMPLETED|Overall Study||14
2276880|NCT02215616|5589214|P2|NOT COMPLETED|Overall Study||17
2276881|NCT02215616|5589215|P1|NOT COMPLETED|Overall Study||11
2276882|NCT02215616|5589212|P4|COMPLETED|Overall Study||17
2276883|NCT02215616|5589213|P3|COMPLETED|Overall Study||93
2276884|NCT02215616|5589214|P2|COMPLETED|Overall Study||90
2276885|NCT02215616|5589215|P1|COMPLETED|Overall Study||97
2276886|NCT02215616|5589212|P4|Received at Least 1 Dose of Study Drug|Overall Study||29
2276887|NCT02215616|5589213|P3|Received at Least 1 Dose of Study Drug|Overall Study||106
2276888|NCT02215616|5589214|P2|Received at Least 1 Dose of Study Drug|Overall Study||107
2276889|NCT02215616|5589215|P1|Received at Least 1 Dose of Study Drug|Overall Study||108
2276890|NCT02215616|5589212|P4|STARTED|Overall Study||30
2276891|NCT02215616|5589213|P3|STARTED|Overall Study||107
2276892|NCT02215616|5589214|P2|STARTED|Overall Study||107
2276893|NCT02215616|5589215|P1|STARTED|Overall Study||108
2276894|NCT02215252|5589232|P3|NOT COMPLETED|Overall Study||4
2276895|NCT02215252|5589233|P2|NOT COMPLETED|Overall Study||8
2276896|NCT02215252|5589234|P1|NOT COMPLETED|Overall Study||2
2276897|NCT02215252|5589232|P3|COMPLETED|Overall Study||41
2276898|NCT02215252|5589233|P2|COMPLETED|Overall Study||38
2276899|NCT02215252|5589234|P1|COMPLETED|Overall Study||42
2276900|NCT02215252|5589232|P3|STARTED|Overall Study||45
2276901|NCT02215252|5589233|P2|STARTED|Overall Study||46
2276902|NCT02215252|5589234|P1|STARTED|Overall Study||44
2276903|NCT02215161|5589291|P1|NOT COMPLETED|Overall Study||0
2276904|NCT02215161|5589291|P1|COMPLETED|Overall Study||14
2276905|NCT02215161|5589291|P1|STARTED|Overall Study||14
2276906|NCT02214628|5589311|P2|NOT COMPLETED|Overall Study||29
2276907|NCT02214628|5589312|P1|NOT COMPLETED|Overall Study||27
2276908|NCT02214628|5589311|P2|COMPLETED|Overall Study||9
2276909|NCT02214628|5589312|P1|COMPLETED|Overall Study||36
2276910|NCT02214628|5589311|P2|STARTED|Overall Study||38
2276911|NCT02214628|5589312|P1|STARTED|Overall Study||63
2276912|NCT02214615|5589322|P2|NOT COMPLETED|Second Intervention||0
2276913|NCT02214615|5589323|P1|NOT COMPLETED|Second Intervention||0
2276914|NCT02214615|5589322|P2|COMPLETED|Second Intervention||1
2276915|NCT02214615|5589323|P1|COMPLETED|Second Intervention||1
2276916|NCT02214615|5589322|P2|STARTED|Second Intervention||1
2276917|NCT02214615|5589323|P1|STARTED|Second Intervention||1
2276918|NCT02214615|5589322|P2|NOT COMPLETED|Washout||0
2276919|NCT02214615|5589323|P1|NOT COMPLETED|Washout||0
2276920|NCT02214615|5589322|P2|COMPLETED|Washout||1
2276921|NCT02214615|5589323|P1|COMPLETED|Washout||1
2276922|NCT02214615|5589322|P2|STARTED|Washout||1
2276923|NCT02214615|5589323|P1|STARTED|Washout||1
2276924|NCT02214615|5589322|P2|NOT COMPLETED|First Intervention||0
2276925|NCT02214615|5589323|P1|NOT COMPLETED|First Intervention||0
2276926|NCT02214615|5589322|P2|COMPLETED|First Intervention||1
2276927|NCT02214615|5589323|P1|COMPLETED|First Intervention||1
2276928|NCT02214615|5589322|P2|STARTED|First Intervention||1
2276929|NCT02214615|5589323|P1|STARTED|First Intervention||1
2276930|NCT02214420|5589333|P2|NOT COMPLETED|Overall Study||0
2276931|NCT02214420|5589334|P1|NOT COMPLETED|Overall Study||1
2276932|NCT02214420|5589333|P2|COMPLETED|Overall Study||10
2276933|NCT02214420|5589334|P1|COMPLETED|Overall Study||13
2276934|NCT02214420|5589333|P2|STARTED|Overall Study||10
2276935|NCT02214420|5589334|P1|STARTED|Overall Study||14
2276936|NCT02214277|5589343|P3|NOT COMPLETED|Overall Study||34
2276937|NCT02214277|5589344|P2|NOT COMPLETED|Overall Study||25
2276938|NCT02214277|5589345|P1|NOT COMPLETED|Overall Study||19
2276939|NCT02214277|5589343|P3|COMPLETED|Overall Study||85
2276940|NCT02214277|5589344|P2|COMPLETED|Overall Study||96
2276941|NCT02214277|5589345|P1|COMPLETED|Overall Study||104
2276942|NCT02214277|5589343|P3|STARTED|Overall Study||119
2276943|NCT02214277|5589344|P2|STARTED|Overall Study||121
2276944|NCT02214277|5589345|P1|STARTED|Overall Study||123
2276945|NCT02214238|5589355|P2|NOT COMPLETED|Overall Study||6
2276946|NCT02214238|5589356|P1|NOT COMPLETED|Overall Study||6
2276947|NCT02214238|5589355|P2|COMPLETED|Overall Study||17
2276948|NCT02214238|5589356|P1|COMPLETED|Overall Study||20
2276949|NCT02214238|5589355|P2|STARTED|Overall Study||23
2276950|NCT02214238|5589356|P1|STARTED|Overall Study||26
2276951|NCT02214225|5589369|P3|NOT COMPLETED|Overall Study||22
2276952|NCT02214225|5589370|P2|NOT COMPLETED|Overall Study||19
2276953|NCT02214225|5589371|P1|NOT COMPLETED|Overall Study||55
2276954|NCT02214225|5589369|P3|COMPLETED|Overall Study||850
2276955|NCT02214225|5589370|P2|COMPLETED|Overall Study||852
2276956|NCT02214225|5589371|P1|COMPLETED|Overall Study||1686
2276957|NCT02214225|5589369|P3|STARTED|Overall Study||872
2276958|NCT02214225|5589370|P2|STARTED|Overall Study||871
2276959|NCT02214225|5589371|P1|STARTED|Overall Study||1741
2276960|NCT02214186|5589430|P2|NOT COMPLETED|Overall Study||2
2276961|NCT02214186|5589431|P1|NOT COMPLETED|Overall Study||2
2276962|NCT02214186|5589430|P2|COMPLETED|Overall Study||21
2276963|NCT02214186|5589431|P1|COMPLETED|Overall Study||21
2276964|NCT02214186|5589430|P2|STARTED|Overall Study||23
2276965|NCT02214186|5589431|P1|STARTED|Overall Study||23
2276966|NCT02214147|5589456|P3|NOT COMPLETED|Overall Study||0
2276967|NCT02214147|5589457|P2|NOT COMPLETED|Overall Study||0
2276968|NCT02214147|5589458|P1|NOT COMPLETED|Overall Study||0
2276969|NCT02214147|5589456|P3|COMPLETED|Overall Study||8
2276970|NCT02214147|5589457|P2|COMPLETED|Overall Study||12
2276971|NCT02214147|5589458|P1|COMPLETED|Overall Study||16
2276972|NCT02214147|5589456|P3|STARTED|Overall Study||8
2276973|NCT02214147|5589457|P2|STARTED|Overall Study||12
2276974|NCT02214147|5589458|P1|STARTED|Overall Study||16
2276975|NCT02214121|5589499|P3|NOT COMPLETED|Part B||1
2276976|NCT02214121|5589500|P2|NOT COMPLETED|Part B||3
2276977|NCT02214121|5589501|P1|NOT COMPLETED|Part B||0
2276978|NCT02214121|5589499|P3|COMPLETED|Part B||7
2276979|NCT02214121|5589500|P2|COMPLETED|Part B||14
2276980|NCT02214121|5589501|P1|COMPLETED|Part B||0
2276981|NCT02214121|5589499|P3|STARTED|Part B||8
2276982|NCT02214121|5589500|P2|STARTED|Part B||17
2276983|NCT02214121|5589501|P1|STARTED|Part B||0
2276984|NCT02214121|5589499|P3|NOT COMPLETED|Part A||0
2276985|NCT02214121|5589500|P2|NOT COMPLETED|Part A||0
2276986|NCT02214121|5589501|P1|NOT COMPLETED|Part A||7
2276987|NCT02214121|5589499|P3|COMPLETED|Part A||0
2276988|NCT02214121|5589500|P2|COMPLETED|Part A||0
2276989|NCT02214121|5589501|P1|COMPLETED|Part A||39
2276990|NCT02214121|5589499|P3|STARTED|Part A||0
2276991|NCT02214121|5589500|P2|STARTED|Part A||0
2276992|NCT02214121|5589501|P1|STARTED|Part A||46
2276993|NCT02214017|5589580|P2|NOT COMPLETED|Overall Study||0
2276994|NCT02214017|5589581|P1|NOT COMPLETED|Overall Study||0
2276995|NCT02214017|5589580|P2|COMPLETED|Overall Study||18
2276996|NCT02214017|5589581|P1|COMPLETED|Overall Study||22
2276997|NCT02214017|5589580|P2|STARTED|Overall Study||18
2276998|NCT02214017|5589581|P1|STARTED|Overall Study||22
2276999|NCT02213926|5589591|P1|NOT COMPLETED|Overall Study||70
2277000|NCT02213926|5589591|P1|COMPLETED|Overall Study||54
2277001|NCT02213926|5589591|P1|STARTED|Overall Study||124
2277002|NCT02213900|5589597|P2|NOT COMPLETED|Overall Study||0
2277003|NCT02213900|5589598|P1|NOT COMPLETED|Overall Study||0
2277004|NCT02213900|5589597|P2|COMPLETED|Overall Study||67
2277005|NCT02213900|5589598|P1|COMPLETED|Overall Study||68
2277006|NCT02213900|5589597|P2|STARTED|Overall Study||67
2277007|NCT02213900|5589598|P1|STARTED|Overall Study||68
2277008|NCT02213666|5589610|P1|NOT COMPLETED|Overall Study||1
2277009|NCT02213666|5589610|P1|COMPLETED|Overall Study||71
2277010|NCT02213666|5589610|P1|STARTED|Overall Study||72
2277011|NCT02213510|5589616|P2|NOT COMPLETED|Overall Study||1
2277012|NCT02213510|5589617|P1|NOT COMPLETED|Overall Study||1
2277013|NCT02213510|5589616|P2|COMPLETED|Overall Study||18
2277014|NCT02213510|5589617|P1|COMPLETED|Overall Study||20
2277015|NCT02213510|5589616|P2|STARTED|Overall Study||19
2277016|NCT02213510|5589617|P1|STARTED|Overall Study||21
2277017|NCT02213263|5589645|P2|NOT COMPLETED|Overall Study||26
2277018|NCT02213263|5589646|P1|NOT COMPLETED|Overall Study||28
2277019|NCT02213263|5589645|P2|COMPLETED|Overall Study||170
2277020|NCT02213263|5589646|P1|COMPLETED|Overall Study||170
2277021|NCT02213263|5589645|P2|Treated|Overall Study||196
2277022|NCT02213263|5589646|P1|Treated|Overall Study||197
2277023|NCT02213263|5589645|P2|STARTED|Overall Study||196
2277024|NCT02213263|5589646|P1|STARTED|Overall Study||198
2277025|NCT02213250|5589682|P2|NOT COMPLETED|Overall Study||0
2277026|NCT02213250|5589683|P1|NOT COMPLETED|Overall Study||0
2277027|NCT02213250|5589682|P2|COMPLETED|Overall Study||8
2277028|NCT02213250|5589683|P1|COMPLETED|Overall Study||4
2277029|NCT02213250|5589682|P2|STARTED|Overall Study||8
2277030|NCT02213250|5589683|P1|STARTED|Overall Study||4
2277031|NCT02213198|5589714|P2|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||7
2277032|NCT02213198|5589715|P1|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||23
2277033|NCT02213198|5589714|P2|COMPLETED|Follow up 2 6 Months Post TCC Treatment||60
2277034|NCT02213198|5589715|P1|COMPLETED|Follow up 2 6 Months Post TCC Treatment||102
2277035|NCT02213198|5589714|P2|STARTED|Follow up 2 6 Months Post TCC Treatment||67
2277036|NCT02213198|5589715|P1|STARTED|Follow up 2 6 Months Post TCC Treatment||125
2277037|NCT02213198|5589714|P2|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||41
2277038|NCT02213198|5589715|P1|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||93
2277039|NCT02213198|5589714|P2|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||67
2277040|NCT02213198|5589715|P1|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||125
2277041|NCT02213198|5589714|P2|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||108
2277042|NCT02213198|5589715|P1|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||218
2277043|NCT02213198|5589714|P2|NOT COMPLETED|Baseline||51
2277044|NCT02213198|5589715|P1|NOT COMPLETED|Baseline||88
2277045|NCT02213198|5589714|P2|COMPLETED|Baseline||108
2277046|NCT02213198|5589715|P1|COMPLETED|Baseline||218
2277047|NCT02213198|5589714|P2|STARTED|Baseline||159
2277048|NCT02213198|5589715|P1|STARTED|Baseline||306
2277049|NCT02213094|5589725|P2|NOT COMPLETED|Overall Study||0
2277050|NCT02213094|5589726|P1|NOT COMPLETED|Overall Study||1
2277051|NCT02213094|5589725|P2|COMPLETED|Overall Study||5
2277052|NCT02213094|5589726|P1|COMPLETED|Overall Study|One subject stopped study agent early because of elevation in LFTs > 3x ULN|4
2277053|NCT02213094|5589725|P2|STARTED|Overall Study||5
2277054|NCT02213094|5589726|P1|STARTED|Overall Study||5
2277055|NCT02213055|5589734|P2|NOT COMPLETED|Overall Study||0
2277056|NCT02213055|5589735|P1|NOT COMPLETED|Overall Study||39
2277057|NCT02213055|5589734|P2|COMPLETED|Overall Study||0
2277058|NCT02213055|5589735|P1|COMPLETED|Overall Study||58
2277059|NCT02213055|5589734|P2|STARTED|Overall Study||0
2277060|NCT02213055|5589735|P1|STARTED|Overall Study||97
2277061|NCT02212977|5589743|P2|NOT COMPLETED|Overall Study||6
2277062|NCT02212977|5589744|P1|NOT COMPLETED|Overall Study||5
2277063|NCT02212977|5589743|P2|COMPLETED|Overall Study||48
2277064|NCT02212977|5589744|P1|COMPLETED|Overall Study||50
2277065|NCT02212977|5589743|P2|STARTED|Overall Study||54
2277066|NCT02212977|5589744|P1|STARTED|Overall Study||55
2277067|NCT02212834|5589760|P2|NOT COMPLETED|Overall Study||0
2277068|NCT02212834|5589761|P1|NOT COMPLETED|Overall Study||0
2277069|NCT02212834|5589760|P2|COMPLETED|Overall Study||2506
2277070|NCT02212834|5589761|P1|COMPLETED|Overall Study||33938
2277071|NCT02212834|5589760|P2|STARTED|Overall Study||2506
2277072|NCT02212834|5589761|P1|STARTED|Overall Study||33938
2277073|NCT02212678|5589767|P1|NOT COMPLETED|Overall Study||1
2277074|NCT02212678|5589767|P1|COMPLETED|Overall Study||7
2277075|NCT02212678|5589767|P1|STARTED|Overall Study||8
2277076|NCT02212457|5589777|P6|NOT COMPLETED|Overall Study||13
2277077|NCT02212457|5589778|P5|NOT COMPLETED|Overall Study||15
2277078|NCT02212457|5589779|P4|NOT COMPLETED|Overall Study||11
2277079|NCT02212457|5589780|P3|NOT COMPLETED|Overall Study||16
2277080|NCT02212457|5589781|P2|NOT COMPLETED|Overall Study||21
2277081|NCT02212457|5589782|P1|NOT COMPLETED|Overall Study||19
2277082|NCT02212457|5589777|P6|COMPLETED|Overall Study||147
2277083|NCT02212457|5589778|P5|COMPLETED|Overall Study||137
2277084|NCT02212457|5589779|P4|COMPLETED|Overall Study||123
2277085|NCT02212457|5589780|P3|COMPLETED|Overall Study||141
2277086|NCT02212457|5589781|P2|COMPLETED|Overall Study||211
2277087|NCT02212457|5589782|P1|COMPLETED|Overall Study||209
2277088|NCT02212457|5589777|P6|STARTED|Overall Study||160
2277089|NCT02212457|5589778|P5|STARTED|Overall Study||152
2277090|NCT02212457|5589779|P4|STARTED|Overall Study||134
2277091|NCT02212457|5589780|P3|STARTED|Overall Study||157
2277092|NCT02212457|5589781|P2|STARTED|Overall Study||232
2277093|NCT02212457|5589782|P1|STARTED|Overall Study||228
2277094|NCT02212301|5589906|P2|NOT COMPLETED|Period 2||0
2277095|NCT02212301|5589907|P1|NOT COMPLETED|Period 2||0
2277096|NCT02212301|5589906|P2|COMPLETED|Period 2||21
2277097|NCT02212301|5589907|P1|COMPLETED|Period 2||21
2277098|NCT02212301|5589906|P2|STARTED|Period 2||21
2277099|NCT02212301|5589907|P1|STARTED|Period 2||21
2277100|NCT02212301|5589906|P2|NOT COMPLETED|Period 1||1
2277101|NCT02212301|5589907|P1|NOT COMPLETED|Period 1||0
2277102|NCT02212301|5589906|P2|COMPLETED|Period 1||21
2277103|NCT02212301|5589907|P1|COMPLETED|Period 1||21
2277104|NCT02212301|5589906|P2|STARTED|Period 1||22
2277105|NCT02212301|5589907|P1|STARTED|Period 1||21
2277106|NCT02212197|5589918|P3|NOT COMPLETED|Overall Study||0
2277107|NCT02212197|5589919|P2|NOT COMPLETED|Overall Study||0
2277108|NCT02212197|5589920|P1|NOT COMPLETED|Overall Study||1
2277109|NCT02212197|5589918|P3|COMPLETED|Overall Study||17
2277110|NCT02212197|5589919|P2|COMPLETED|Overall Study||15
2277111|NCT02212197|5589920|P1|COMPLETED|Overall Study||18
2277112|NCT02212197|5589918|P3|STARTED|Overall Study||17
2277113|NCT02212197|5589919|P2|STARTED|Overall Study||15
2277114|NCT02212197|5589920|P1|STARTED|Overall Study||19
2277115|NCT02212106|5589945|P2|NOT COMPLETED|Overall Study||4
2277116|NCT02212106|5589946|P1|NOT COMPLETED|Overall Study||10
2277117|NCT02212106|5589945|P2|COMPLETED|Overall Study||96
2277118|NCT02212106|5589946|P1|COMPLETED|Overall Study||292
2277119|NCT02212106|5589945|P2|STARTED|Overall Study||100
2277120|NCT02212106|5589946|P1|STARTED|Overall Study||302
2277121|NCT02212028|5589964|P2|NOT COMPLETED|Overall Study||0
2277122|NCT02212028|5589965|P1|NOT COMPLETED|Overall Study||0
2277123|NCT02212028|5589964|P2|COMPLETED|Overall Study||26
2277124|NCT02212028|5589965|P1|COMPLETED|Overall Study||26
2277125|NCT02212028|5589964|P2|STARTED|Overall Study||26
2277126|NCT02212028|5589965|P1|STARTED|Overall Study||26
2277127|NCT02211638|5589973|P1|NOT COMPLETED|Overall Study||983
2277128|NCT02211638|5589973|P1|COMPLETED|Overall Study||17130
2277129|NCT02211638|5589973|P1|STARTED|Overall Study||18113
2277130|NCT02211534|5589984|P2|NOT COMPLETED|Overall Study||5
2277131|NCT02211534|5589985|P1|NOT COMPLETED|Overall Study||13
2277132|NCT02211534|5589984|P2|COMPLETED|Overall Study||6
2277133|NCT02211534|5589985|P1|COMPLETED|Overall Study||11
2277134|NCT02211534|5589984|P2|STARTED|Overall Study||11
2277135|NCT02211534|5589985|P1|STARTED|Overall Study||24
2277136|NCT02211313|5590007|P2|NOT COMPLETED|Overall Study||3
2277137|NCT02211313|5590008|P1|NOT COMPLETED|Overall Study||6
2277138|NCT02211313|5590007|P2|COMPLETED|Overall Study||20
2277139|NCT02211313|5590008|P1|COMPLETED|Overall Study||12
2277140|NCT02211313|5590007|P2|STARTED|Overall Study||23
2277141|NCT02211313|5590008|P1|STARTED|Overall Study||18
2277142|NCT02211261|5590025|P11|NOT COMPLETED|Overall Study||0
2277143|NCT02211261|5590026|P10|NOT COMPLETED|Overall Study||2
2277144|NCT02211261|5590027|P9|NOT COMPLETED|Overall Study||0
2277145|NCT02211261|5590028|P8|NOT COMPLETED|Overall Study||1
2277146|NCT02211261|5590029|P7|NOT COMPLETED|Overall Study||0
2277147|NCT02211261|5590030|P6|NOT COMPLETED|Overall Study||1
2277148|NCT02211261|5590031|P5|NOT COMPLETED|Overall Study||2
2277149|NCT02211261|5590032|P4|NOT COMPLETED|Overall Study||0
2277150|NCT02211261|5590033|P3|NOT COMPLETED|Overall Study||1
2277151|NCT02211261|5590034|P2|NOT COMPLETED|Overall Study||0
2277152|NCT02211261|5590035|P1|NOT COMPLETED|Overall Study||0
2277153|NCT02211261|5590025|P11|COMPLETED|Overall Study||8
2277154|NCT02211261|5590026|P10|COMPLETED|Overall Study||14
2277155|NCT02211261|5590027|P9|COMPLETED|Overall Study||8
2277156|NCT02211261|5590028|P8|COMPLETED|Overall Study||7
2277157|NCT02211261|5590029|P7|COMPLETED|Overall Study||6
2277158|NCT02211261|5590030|P6|COMPLETED|Overall Study||1
2277159|NCT02211261|5590031|P5|COMPLETED|Overall Study||7
2277160|NCT02211261|5590032|P4|COMPLETED|Overall Study||6
2277161|NCT02211261|5590033|P3|COMPLETED|Overall Study||5
2277162|NCT02211261|5590034|P2|COMPLETED|Overall Study||6
2277163|NCT02211261|5590035|P1|COMPLETED|Overall Study||9
2277164|NCT02211261|5590025|P11|STARTED|Overall Study||8
2277165|NCT02211261|5590026|P10|STARTED|Overall Study||16
2277166|NCT02211261|5590027|P9|STARTED|Overall Study||8
2277167|NCT02211261|5590028|P8|STARTED|Overall Study||8
2277168|NCT02211261|5590029|P7|STARTED|Overall Study||6
2277169|NCT02211261|5590030|P6|STARTED|Overall Study||2
2277170|NCT02211261|5590031|P5|STARTED|Overall Study||9
2277171|NCT02211261|5590032|P4|STARTED|Overall Study||6
2277172|NCT02211261|5590033|P3|STARTED|Overall Study||6
2277173|NCT02211261|5590034|P2|STARTED|Overall Study||6
2277174|NCT02211261|5590035|P1|STARTED|Overall Study||9
2277175|NCT02210689|5590159|P3|NOT COMPLETED|Overall Study||23
2277176|NCT02210689|5590160|P2|NOT COMPLETED|Overall Study||47
2277177|NCT02210689|5590161|P1|NOT COMPLETED|Overall Study||52
2277178|NCT02210689|5590159|P3|COMPLETED|Overall Study||99
2277179|NCT02210689|5590160|P2|COMPLETED|Overall Study||193
2277180|NCT02210689|5590161|P1|COMPLETED|Overall Study||190
2277181|NCT02210689|5590159|P3|PP Population|Overall Study||84
2277182|NCT02210689|5590160|P2|PP Population|Overall Study||169
2277183|NCT02210689|5590161|P1|PP Population|Overall Study||164
2277184|NCT02210689|5590159|P3|mITT Population|Overall Study||107
2277185|NCT02210689|5590160|P2|mITT Population|Overall Study||207
2277186|NCT02210689|5590161|P1|mITT Population|Overall Study||199
2277187|NCT02210689|5590159|P3|Safety Population|Overall Study||122
2277188|NCT02210689|5590160|P2|Safety Population|Overall Study||236
2277189|NCT02210689|5590161|P1|Safety Population|Overall Study||233
2277190|NCT02210689|5590159|P3|STARTED|Overall Study||122
2277191|NCT02210689|5590160|P2|STARTED|Overall Study||240
2277192|NCT02210689|5590161|P1|STARTED|Overall Study||242
2277193|NCT02210208|5590169|P1|NOT COMPLETED|Period B (Donor Site)||7
2277194|NCT02210208|5590169|P1|COMPLETED|Period B (Donor Site)||12
2277195|NCT02210208|5590169|P1|STARTED|Period B (Donor Site)|6 subjects was decided by the Physician not to be included in the Part B.|19
2277196|NCT02210208|5590169|P1|NOT COMPLETED|Period A (Graft Site)||2
2277197|NCT02210208|5590169|P1|COMPLETED|Period A (Graft Site)||23
2277198|NCT02210208|5590169|P1|STARTED|Period A (Graft Site)||25
2277199|NCT02210195|5590178|P2|NOT COMPLETED|Overall Study||0
2277200|NCT02210195|5590179|P1|NOT COMPLETED|Overall Study||4
2277201|NCT02210195|5590178|P2|COMPLETED|Overall Study||10
2277202|NCT02210195|5590179|P1|COMPLETED|Overall Study||6
2277203|NCT02210195|5590178|P2|STARTED|Overall Study||10
2277204|NCT02210195|5590179|P1|STARTED|Overall Study||10
2277205|NCT02210091|5590189|P2|NOT COMPLETED|Overall Study||2
2277206|NCT02210091|5590190|P1|NOT COMPLETED|Overall Study||0
2277207|NCT02210091|5590189|P2|COMPLETED|Overall Study||32
2277208|NCT02210091|5590190|P1|COMPLETED|Overall Study||32
2277209|NCT02210091|5590189|P2|STARTED|Overall Study||34
2277210|NCT02210091|5590190|P1|STARTED|Overall Study||32
2277211|NCT02210052|5590262|P1|NOT COMPLETED|Overall Study||0
2277212|NCT02210052|5590262|P1|COMPLETED|Overall Study||6
2277213|NCT02210052|5590262|P1|STARTED|Overall Study||6
2277214|NCT02210039|5590266|P1|NOT COMPLETED|Overall Study||0
2277215|NCT02210039|5590266|P1|COMPLETED|Overall Study||6
2277216|NCT02210039|5590266|P1|STARTED|Overall Study||6
2277217|NCT02210000|5590272|P2|NOT COMPLETED|Overall Study||21
2277218|NCT02210000|5590273|P1|NOT COMPLETED|Overall Study||19
2277219|NCT02210000|5590272|P2|COMPLETED|Overall Study||36
2277220|NCT02210000|5590273|P1|COMPLETED|Overall Study||38
2277221|NCT02210000|5590272|P2|STARTED|Overall Study||57
2277222|NCT02210000|5590273|P1|STARTED|Overall Study||57
2277223|NCT02209766|5590299|P5|NOT COMPLETED|Overall Study||0
2277224|NCT02209766|5590300|P4|NOT COMPLETED|Overall Study||1
2277225|NCT02209766|5590301|P3|NOT COMPLETED|Overall Study||0
2277226|NCT02209766|5590302|P2|NOT COMPLETED|Overall Study||0
2277227|NCT02209766|5590303|P1|NOT COMPLETED|Overall Study||0
2277228|NCT02209766|5590299|P5|COMPLETED|Overall Study||6
2277229|NCT02209766|5590300|P4|COMPLETED|Overall Study||2
2277230|NCT02209766|5590301|P3|COMPLETED|Overall Study||6
2277231|NCT02209766|5590302|P2|COMPLETED|Overall Study||3
2277232|NCT02209766|5590303|P1|COMPLETED|Overall Study||6
2277233|NCT02209766|5590299|P5|STARTED|Overall Study||6
2277234|NCT02209766|5590300|P4|STARTED|Overall Study||3
2277235|NCT02209766|5590301|P3|STARTED|Overall Study||6
2277236|NCT02209766|5590302|P2|STARTED|Overall Study||3
2277237|NCT02209766|5590303|P1|STARTED|Overall Study||6
2277238|NCT02209610|5590351|P2|NOT COMPLETED|Overall Study||0
2277239|NCT02209610|5590352|P1|NOT COMPLETED|Overall Study||0
2277240|NCT02209610|5590351|P2|COMPLETED|Overall Study||16
2277241|NCT02209610|5590352|P1|COMPLETED|Overall Study||16
2277242|NCT02209610|5590351|P2|STARTED|Overall Study||16
2277243|NCT02209610|5590352|P1|STARTED|Overall Study||16
2277244|NCT02209532|5590364|P2|NOT COMPLETED|Overall Study||1
2277245|NCT02209532|5590365|P1|NOT COMPLETED|Overall Study||3
2277246|NCT02209532|5590364|P2|COMPLETED|Overall Study||89
2277247|NCT02209532|5590365|P1|COMPLETED|Overall Study||87
2277248|NCT02209532|5590364|P2|STARTED|Overall Study||90
2277249|NCT02209532|5590365|P1|STARTED|Overall Study||90
2277250|NCT02209506|5590386|P5|NOT COMPLETED|Overall Study||1
2277251|NCT02209506|5590387|P4|NOT COMPLETED|Overall Study||0
2277252|NCT02209506|5590388|P3|NOT COMPLETED|Overall Study||0
2277253|NCT02209506|5590389|P2|NOT COMPLETED|Overall Study||0
2277254|NCT02209506|5590390|P1|NOT COMPLETED|Overall Study||0
2277255|NCT02209506|5590386|P5|COMPLETED|Overall Study||5
2277256|NCT02209506|5590387|P4|COMPLETED|Overall Study||2
2277257|NCT02209506|5590388|P3|COMPLETED|Overall Study||6
2277258|NCT02209506|5590389|P2|COMPLETED|Overall Study||6
2277259|NCT02209506|5590390|P1|COMPLETED|Overall Study||3
2277260|NCT02209506|5590386|P5|STARTED|Overall Study||6
2277261|NCT02209506|5590387|P4|STARTED|Overall Study||2
2277262|NCT02209506|5590388|P3|STARTED|Overall Study||6
2277263|NCT02209506|5590389|P2|STARTED|Overall Study||6
2277264|NCT02209506|5590390|P1|STARTED|Overall Study||3
2277265|NCT02209454|5590465|P2|NOT COMPLETED|Second Period||0
2277266|NCT02209454|5590466|P1|NOT COMPLETED|Second Period||1
2277267|NCT02209454|5590465|P2|COMPLETED|Second Period||13
2277268|NCT02209454|5590466|P1|COMPLETED|Second Period||12
2277269|NCT02209454|5590465|P2|STARTED|Second Period||13
2277270|NCT02209454|5590466|P1|STARTED|Second Period||13
2277271|NCT02209454|5590465|P2|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
2277272|NCT02209454|5590466|P1|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
2277273|NCT02209454|5590465|P2|COMPLETED|Washout Period a Minimum of a 7 Day||13
2277274|NCT02209454|5590466|P1|COMPLETED|Washout Period a Minimum of a 7 Day||13
2277275|NCT02209454|5590465|P2|STARTED|Washout Period a Minimum of a 7 Day||13
2277276|NCT02209454|5590466|P1|STARTED|Washout Period a Minimum of a 7 Day||13
2277277|NCT02209454|5590465|P2|NOT COMPLETED|First Period||0
2277278|NCT02209454|5590466|P1|NOT COMPLETED|First Period||0
2277279|NCT02209454|5590465|P2|COMPLETED|First Period||13
2277280|NCT02209454|5590466|P1|COMPLETED|First Period||13
2277281|NCT02209454|5590465|P2|STARTED|First Period||13
2277282|NCT02209454|5590466|P1|STARTED|First Period||13
2277283|NCT02209272|5590482|P2|NOT COMPLETED|Overall Study||0
2277284|NCT02209272|5590483|P1|NOT COMPLETED|Overall Study||0
2277285|NCT02209272|5590482|P2|COMPLETED|Overall Study||36
2277286|NCT02209272|5590483|P1|COMPLETED|Overall Study||32
2277287|NCT02209272|5590482|P2|STARTED|Overall Study||36
2277288|NCT02209272|5590483|P1|STARTED|Overall Study||32
2277289|NCT02209259|5590496|P3|NOT COMPLETED|Overall Study||0
2277290|NCT02209259|5590497|P2|NOT COMPLETED|Overall Study||0
2277291|NCT02209259|5590498|P1|NOT COMPLETED|Overall Study||0
2277292|NCT02209259|5590496|P3|COMPLETED|Overall Study||56
2277293|NCT02209259|5590497|P2|COMPLETED|Overall Study||56
2277294|NCT02209259|5590498|P1|COMPLETED|Overall Study||56
2277295|NCT02209259|5590496|P3|STARTED|Overall Study||56
2277296|NCT02209259|5590497|P2|STARTED|Overall Study||56
2277297|NCT02209259|5590498|P1|STARTED|Overall Study||56
2277298|NCT02209181|5590516|P4|NOT COMPLETED|Overall Study||0
2277299|NCT02209181|5590517|P3|NOT COMPLETED|Overall Study||1
2277300|NCT02209181|5590518|P2|NOT COMPLETED|Overall Study||1
2277301|NCT02209181|5590519|P1|NOT COMPLETED|Overall Study||1
2277302|NCT02209181|5590516|P4|COMPLETED|Overall Study||66
2277303|NCT02209181|5590517|P3|COMPLETED|Overall Study||68
2277304|NCT02209181|5590518|P2|COMPLETED|Overall Study||66
2277305|NCT02209181|5590519|P1|COMPLETED|Overall Study||66
2277306|NCT02209181|5590516|P4|STARTED|Overall Study||66
2277307|NCT02209181|5590517|P3|STARTED|Overall Study||69
2277308|NCT02209181|5590518|P2|STARTED|Overall Study||67
2277309|NCT02209181|5590519|P1|STARTED|Overall Study||67
2277310|NCT02209064|5590681|P1|NOT COMPLETED|Overall Study||0
2277311|NCT02209064|5590681|P1|COMPLETED|Overall Study||25
2277312|NCT02209064|5590681|P1|STARTED|Overall Study||25
2277313|NCT02208999|5590690|P1|NOT COMPLETED|Overall Study||1
2277314|NCT02208999|5590690|P1|COMPLETED|Overall Study||105
2277315|NCT02208999|5590690|P1|STARTED|Overall Study||106
2277316|NCT02208843|5590712|P1|NOT COMPLETED|Overall Study||60
2277317|NCT02208843|5590712|P1|COMPLETED|Overall Study||0
2277318|NCT02208843|5590712|P1|STARTED|Overall Study||60
2277319|NCT02208349|5590720|P2|NOT COMPLETED|Sixth 6 Month||0
2277320|NCT02208349|5590721|P1|NOT COMPLETED|Sixth 6 Month||0
2277321|NCT02208349|5590720|P2|COMPLETED|Sixth 6 Month||2
2277322|NCT02208349|5590721|P1|COMPLETED|Sixth 6 Month||3
2277323|NCT02208349|5590720|P2|STARTED|Sixth 6 Month||2
2277324|NCT02208349|5590721|P1|STARTED|Sixth 6 Month||3
2277325|NCT02208349|5590720|P2|NOT COMPLETED|Fifth 6 Month||0
2277326|NCT02208349|5590721|P1|NOT COMPLETED|Fifth 6 Month||0
2277327|NCT02208349|5590720|P2|COMPLETED|Fifth 6 Month||2
2277328|NCT02208349|5590721|P1|COMPLETED|Fifth 6 Month||7
2277329|NCT02208349|5590720|P2|STARTED|Fifth 6 Month||2
2277330|NCT02208349|5590721|P1|STARTED|Fifth 6 Month||7
2277331|NCT02208349|5590720|P2|NOT COMPLETED|Fourth 6 Month||0
2277332|NCT02208349|5590721|P1|NOT COMPLETED|Fourth 6 Month||0
2277333|NCT02208349|5590720|P2|COMPLETED|Fourth 6 Month||2
2277334|NCT02208349|5590721|P1|COMPLETED|Fourth 6 Month||14
2277335|NCT02208349|5590720|P2|STARTED|Fourth 6 Month||2
2277336|NCT02208349|5590721|P1|STARTED|Fourth 6 Month||14
2277337|NCT02208349|5590720|P2|NOT COMPLETED|Third 6 Month||0
2277338|NCT02208349|5590721|P1|NOT COMPLETED|Third 6 Month||0
2277339|NCT02208349|5590720|P2|COMPLETED|Third 6 Month||3
2277340|NCT02208349|5590721|P1|COMPLETED|Third 6 Month||6
2277341|NCT02208349|5590720|P2|STARTED|Third 6 Month||3
2277342|NCT02208349|5590721|P1|STARTED|Third 6 Month||6
2277343|NCT02208349|5590720|P2|NOT COMPLETED|Second 6 Months||0
2277344|NCT02208349|5590721|P1|NOT COMPLETED|Second 6 Months||0
2277345|NCT02208349|5590720|P2|COMPLETED|Second 6 Months||7
2277346|NCT02208349|5590721|P1|COMPLETED|Second 6 Months||11
2277347|NCT02208349|5590720|P2|STARTED|Second 6 Months||7
2277348|NCT02208349|5590721|P1|STARTED|Second 6 Months||11
2277349|NCT02208349|5590720|P2|NOT COMPLETED|Initial 6 Months||0
2277350|NCT02208349|5590721|P1|NOT COMPLETED|Initial 6 Months||0
2277351|NCT02208349|5590720|P2|COMPLETED|Initial 6 Months||9
2277352|NCT02208349|5590721|P1|COMPLETED|Initial 6 Months||16
2277353|NCT02208349|5590720|P2|STARTED|Initial 6 Months||9
2277354|NCT02208349|5590721|P1|STARTED|Initial 6 Months||16
2277355|NCT02208310|5590731|P2|NOT COMPLETED|Overall Study||5
2277356|NCT02208310|5590732|P1|NOT COMPLETED|Overall Study||6
2277357|NCT02208310|5590731|P2|COMPLETED|Overall Study||0
2277358|NCT02208310|5590732|P1|COMPLETED|Overall Study||0
2277359|NCT02208310|5590731|P2|Day 180|Overall Study||1
2277360|NCT02208310|5590732|P1|Day 180|Overall Study||0
2277361|NCT02208310|5590731|P2|STARTED|Overall Study||5
2277362|NCT02208310|5590732|P1|STARTED|Overall Study||6
2277363|NCT02208089|5590764|P2|NOT COMPLETED|Overall Study||0
2277364|NCT02208089|5590765|P1|NOT COMPLETED|Overall Study||7
2277365|NCT02208089|5590764|P2|COMPLETED|Overall Study||47
2277366|NCT02208089|5590765|P1|COMPLETED|Overall Study||40
2277367|NCT02208089|5590764|P2|STARTED|Overall Study||47
2277368|NCT02208089|5590765|P1|STARTED|Overall Study||47
2277379|NCT02208037|5590797|P3|NOT COMPLETED|Overall Study||1
2277380|NCT02208037|5590798|P2|NOT COMPLETED|Overall Study||1
2277381|NCT02208037|5590799|P1|NOT COMPLETED|Overall Study||4
2277382|NCT02208037|5590797|P3|COMPLETED|Overall Study||92
2277383|NCT02208037|5590798|P2|COMPLETED|Overall Study||92
2277384|NCT02208037|5590799|P1|COMPLETED|Overall Study||89
2277385|NCT02208037|5590797|P3|STARTED|Overall Study||93
2277386|NCT02208037|5590798|P2|STARTED|Overall Study||93
2277387|NCT02208037|5590799|P1|STARTED|Overall Study||93
2277388|NCT02207972|5590848|P2|NOT COMPLETED|Overall Study||0
2277389|NCT02207972|5590849|P1|NOT COMPLETED|Overall Study||0
2277390|NCT02207972|5590848|P2|COMPLETED|Overall Study||24
2277391|NCT02207972|5590849|P1|COMPLETED|Overall Study||22
2277392|NCT02207972|5590848|P2|STARTED|Overall Study||24
2277393|NCT02207972|5590849|P1|STARTED|Overall Study||22
2277394|NCT02207907|5590861|P2|NOT COMPLETED|Overall Study||8
2277395|NCT02207907|5590862|P1|NOT COMPLETED|Overall Study||11
2277396|NCT02207907|5590861|P2|COMPLETED|Overall Study||115
2277397|NCT02207907|5590862|P1|COMPLETED|Overall Study||113
2277398|NCT02207907|5590861|P2|STARTED|Overall Study||123
2277399|NCT02207907|5590862|P1|STARTED|Overall Study||124
2277400|NCT02207829|5590880|P2|NOT COMPLETED|Overall Study||34
2277401|NCT02207829|5590881|P1|NOT COMPLETED|Overall Study||42
2277402|NCT02207829|5590880|P2|COMPLETED|Overall Study||474
2277403|NCT02207829|5590881|P1|COMPLETED|Overall Study||467
2277404|NCT02207829|5590880|P2|STARTED|Overall Study||508
2277405|NCT02207829|5590881|P1|STARTED|Overall Study||509
2277406|NCT02207816|5590890|P3|NOT COMPLETED|Overall Study||67
2277407|NCT02207816|5590891|P2|NOT COMPLETED|Overall Study||86
2277408|NCT02207816|5590892|P1|NOT COMPLETED|Overall Study||51
2277409|NCT02207816|5590890|P3|COMPLETED|Overall Study||961
2277410|NCT02207816|5590891|P2|COMPLETED|Overall Study||924
2277411|NCT02207816|5590892|P1|COMPLETED|Overall Study||995
2277412|NCT02207816|5590890|P3|STARTED|Overall Study||1028
2277413|NCT02207816|5590891|P2|STARTED|Overall Study||1010
2277414|NCT02207816|5590892|P1|STARTED|Overall Study||1046
2277415|NCT02207803|5591037|P2|NOT COMPLETED|Overall Study||17
2277416|NCT02207803|5591038|P1|NOT COMPLETED|Overall Study||15
2277417|NCT02207803|5591037|P2|COMPLETED|Overall Study||108
2277418|NCT02207803|5591038|P1|COMPLETED|Overall Study||110
2277419|NCT02207803|5591037|P2|STARTED|Overall Study||125
2277420|NCT02207803|5591038|P1|STARTED|Overall Study||125
2277421|NCT02207725|5591050|P4|NOT COMPLETED|Overall Study||1
2277422|NCT02207725|5591051|P3|NOT COMPLETED|Overall Study||1
2277423|NCT02207725|5591052|P2|NOT COMPLETED|Overall Study||1
2277424|NCT02207725|5591053|P1|NOT COMPLETED|Overall Study||0
2277425|NCT02207725|5591050|P4|COMPLETED|Overall Study||24
2277426|NCT02207725|5591051|P3|COMPLETED|Overall Study||8
2277427|NCT02207725|5591052|P2|COMPLETED|Overall Study||24
2277428|NCT02207725|5591053|P1|COMPLETED|Overall Study||9
2277429|NCT02207725|5591050|P4|STARTED|Overall Study||25
2277430|NCT02207725|5591051|P3|STARTED|Overall Study||9
2277431|NCT02207725|5591052|P2|STARTED|Overall Study||25
2277432|NCT02207725|5591053|P1|STARTED|Overall Study||9
2277433|NCT02207634|5591083|P2|NOT COMPLETED|Overall Study||31
2277434|NCT02207634|5591084|P1|NOT COMPLETED|Overall Study||22
2277435|NCT02207634|5591083|P2|COMPLETED|Overall Study||953
2277436|NCT02207634|5591084|P1|COMPLETED|Overall Study||968
2277437|NCT02207634|5591083|P2|Received Treatment|Overall Study||983
2277438|NCT02207634|5591084|P1|Received Treatment|Overall Study||990
2277439|NCT02207634|5591083|P2|STARTED|Overall Study||984
2277440|NCT02207634|5591084|P1|STARTED|Overall Study||990
2277441|NCT02207621|5591099|P3|NOT COMPLETED|Overall Study||168
2277442|NCT02207621|5591100|P2|NOT COMPLETED|Overall Study||47
2277443|NCT02207621|5591101|P1|NOT COMPLETED|Overall Study||105
2277444|NCT02207621|5591099|P3|COMPLETED|Overall Study||86
2277445|NCT02207621|5591100|P2|COMPLETED|Overall Study||204
2277446|NCT02207621|5591101|P1|COMPLETED|Overall Study||146
2277447|NCT02207621|5591099|P3|STARTED|Overall Study||254
2277448|NCT02207621|5591100|P2|STARTED|Overall Study||251
2277449|NCT02207621|5591101|P1|STARTED|Overall Study||251
2277450|NCT02207608|5591114|P2|NOT COMPLETED|Overall Study||0
2277451|NCT02207608|5591115|P1|NOT COMPLETED|Overall Study||1
2277452|NCT02207608|5591114|P2|COMPLETED|Overall Study||15
2277453|NCT02207608|5591115|P1|COMPLETED|Overall Study||14
2277454|NCT02207608|5591114|P2|STARTED|Overall Study||15
2277455|NCT02207608|5591115|P1|STARTED|Overall Study||15
2277456|NCT02207569|5591121|P1|NOT COMPLETED|6 Months - 1 Year||9
2277457|NCT02207569|5591121|P1|COMPLETED|6 Months - 1 Year||213
2277458|NCT02207569|5591121|P1|STARTED|6 Months - 1 Year||222
2277459|NCT02207569|5591121|P1|NOT COMPLETED|30 Days to 6 Months||11
2277460|NCT02207569|5591121|P1|COMPLETED|30 Days to 6 Months||222
2277461|NCT02207569|5591121|P1|STARTED|30 Days to 6 Months||233
2277462|NCT02207569|5591121|P1|NOT COMPLETED|Implant to 30 Days||4
2277463|NCT02207569|5591121|P1|COMPLETED|Implant to 30 Days||233
2277464|NCT02207569|5591121|P1|STARTED|Implant to 30 Days||237
2277465|NCT02207569|5591121|P1|NOT COMPLETED|Enrolled to Implant||4
2277466|NCT02207569|5591121|P1|COMPLETED|Enrolled to Implant|237 actual implants|237
2277467|NCT02207569|5591121|P1|STARTED|Enrolled to Implant|241 entered procedure room for implant|241
2277468|NCT02207556|5591141|P2|NOT COMPLETED|Overall Study||5
2277469|NCT02207556|5591142|P1|NOT COMPLETED|Overall Study||2
2277470|NCT02207556|5591141|P2|COMPLETED|Overall Study||20
2277471|NCT02207556|5591142|P1|COMPLETED|Overall Study||5
2277472|NCT02207556|5591141|P2|STARTED|Overall Study||25
2277473|NCT02207556|5591142|P1|STARTED|Overall Study||7
2277477|NCT02207491|5591161|P2|NOT COMPLETED|Overall Study||13
2277478|NCT02207491|5591162|P1|NOT COMPLETED|Overall Study||31
2277479|NCT02207491|5591161|P2|COMPLETED|Overall Study||196
2277480|NCT02207491|5591162|P1|COMPLETED|Overall Study||171
2277481|NCT02207491|5591161|P2|STARTED|Overall Study||209
2277482|NCT02207491|5591162|P1|STARTED|Overall Study||202
2277483|NCT02207478|5591172|P2|NOT COMPLETED|Overall Study||0
2277484|NCT02207478|5591173|P1|NOT COMPLETED|Overall Study||0
2277485|NCT02207478|5591172|P2|COMPLETED|Overall Study||46
2277486|NCT02207478|5591173|P1|COMPLETED|Overall Study||40
2277487|NCT02207478|5591172|P2|STARTED|Overall Study||46
2277488|NCT02207478|5591173|P1|STARTED|Overall Study||40
2277489|NCT02207413|5591187|P6|NOT COMPLETED|Overall Study||13
2277490|NCT02207413|5591188|P5|NOT COMPLETED|Overall Study||7
2277491|NCT02207413|5591189|P4|NOT COMPLETED|Overall Study||1
2277492|NCT02207413|5591190|P3|NOT COMPLETED|Overall Study||0
2277493|NCT02207413|5591191|P2|NOT COMPLETED|Overall Study||0
2277494|NCT02207413|5591192|P1|NOT COMPLETED|Overall Study||1
2277495|NCT02207413|5591187|P6|COMPLETED|Overall Study|Primed subjects: 41; Unprimed subjects: 420|461
2277496|NCT02207413|5591188|P5|COMPLETED|Overall Study|Primed subjects: 40; Unprimed subjects: 419|459
2277497|NCT02207413|5591189|P4|COMPLETED|Overall Study|Primed subjects: 312; Unprimed subjects: 98|410
2277498|NCT02207413|5591190|P3|COMPLETED|Overall Study|Primed subjects: 309; Unprimed subjects: 101|410
2277499|NCT02207413|5591191|P2|COMPLETED|Overall Study||60
2277500|NCT02207413|5591192|P1|COMPLETED|Overall Study||59
2277501|NCT02207413|5591187|P6|STARTED|Overall Study||474
2277502|NCT02207413|5591188|P5|STARTED|Overall Study||466
2277503|NCT02207413|5591189|P4|STARTED|Overall Study||411
2277504|NCT02207413|5591190|P3|STARTED|Overall Study||410
2277505|NCT02207413|5591191|P2|STARTED|Overall Study||60
2277506|NCT02207413|5591192|P1|STARTED|Overall Study||60
2277507|NCT02207400|5591288|P2|NOT COMPLETED|Overall Study||14
2277508|NCT02207400|5591289|P1|NOT COMPLETED|Overall Study||16
2277509|NCT02207400|5591288|P2|COMPLETED|Overall Study||109
2277510|NCT02207400|5591289|P1|COMPLETED|Overall Study||107
2277511|NCT02207400|5591288|P2|STARTED|Overall Study||123
2277512|NCT02207400|5591289|P1|STARTED|Overall Study||123
2277513|NCT02207374|5591310|P3|NOT COMPLETED|Overall Study||6
2277514|NCT02207374|5591311|P2|NOT COMPLETED|Overall Study||10
2277515|NCT02207374|5591312|P1|NOT COMPLETED|Overall Study||6
2277516|NCT02207374|5591310|P3|COMPLETED|Overall Study||115
2277517|NCT02207374|5591311|P2|COMPLETED|Overall Study||231
2277518|NCT02207374|5591312|P1|COMPLETED|Overall Study||233
2277519|NCT02207374|5591310|P3|Exposed|Overall Study||120
2277520|NCT02207374|5591311|P2|Exposed|Overall Study||241
2277521|NCT02207374|5591312|P1|Exposed|Overall Study||239
2277522|NCT02207374|5591310|P3|STARTED|Overall Study||121
2277523|NCT02207374|5591311|P2|STARTED|Overall Study||241
2277524|NCT02207374|5591312|P1|STARTED|Overall Study||239
2277525|NCT02207322|5591328|P2|NOT COMPLETED|Overall Study||10
2277526|NCT02207322|5591329|P1|NOT COMPLETED|Overall Study||9
2277527|NCT02207322|5591328|P2|COMPLETED|Overall Study|6-month|71
2277528|NCT02207322|5591329|P1|COMPLETED|Overall Study|6-month|70
2277529|NCT02207322|5591328|P2|3-month|Overall Study||75
2277530|NCT02207322|5591329|P1|3-month|Overall Study||74
2277531|NCT02207322|5591328|P2|Week-2|Overall Study||80
2277532|NCT02207322|5591329|P1|Week-2|Overall Study||77
2277533|NCT02207322|5591328|P2|STARTED|Overall Study||81
2277534|NCT02207322|5591329|P1|STARTED|Overall Study||79
2277535|NCT02207244|5591376|P9|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||8
2277536|NCT02207244|5591377|P8|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||13
2277537|NCT02207244|5591378|P7|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||8
2277538|NCT02207244|5591379|P6|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
2277539|NCT02207244|5591380|P5|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
2277540|NCT02207244|5591381|P4|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
2277541|NCT02207244|5591382|P3|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
2277542|NCT02207244|5591383|P2|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
2277543|NCT02207244|5591384|P1|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
2277544|NCT02207244|5591376|P9|COMPLETED|Withdrawal, Retreatment Period:Week28-48||220
2277545|NCT02207244|5591377|P8|COMPLETED|Withdrawal, Retreatment Period:Week28-48||457
2277546|NCT02207244|5591378|P7|COMPLETED|Withdrawal, Retreatment Period:Week28-48||219
2277547|NCT02207244|5591379|P6|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
2277548|NCT02207244|5591380|P5|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
2277549|NCT02207244|5591381|P4|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
2277550|NCT02207244|5591382|P3|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
2277551|NCT02207244|5591383|P2|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
2277552|NCT02207244|5591384|P1|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
2277553|NCT02207244|5591376|P9|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||34
2277554|NCT02207244|5591377|P8|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||16
2277555|NCT02207244|5591378|P7|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||4
2277556|NCT02207244|5591379|P6|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
2277557|NCT02207244|5591380|P5|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
2277558|NCT02207244|5591381|P4|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
2277559|NCT02207244|5591382|P3|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
2277560|NCT02207244|5591383|P2|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
2277561|NCT02207244|5591384|P1|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
2277562|NCT02207244|5591376|P9|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
2277563|NCT02207244|5591377|P8|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||193
2277564|NCT02207244|5591378|P7|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
2277565|NCT02207244|5591379|P6|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
2277566|NCT02207244|5591380|P5|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
2277567|NCT02207244|5591381|P4|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
2277568|NCT02207244|5591382|P3|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
2277569|NCT02207244|5591383|P2|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
2277570|NCT02207244|5591384|P1|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
2277571|NCT02207244|5591376|P9|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||82
2277572|NCT02207244|5591377|P8|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||166
2277573|NCT02207244|5591378|P7|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||143
2277574|NCT02207244|5591379|P6|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
2277575|NCT02207244|5591380|P5|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
2277576|NCT02207244|5591381|P4|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
2277577|NCT02207244|5591382|P3|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
2277578|NCT02207244|5591383|P2|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
2277579|NCT02207244|5591384|P1|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
2277580|NCT02207244|5591376|P9|Non-Responders|Withdrawal, Retreatment Period:Week28-48||112
2277581|NCT02207244|5591377|P8|Non-Responders|Withdrawal, Retreatment Period:Week28-48||95
2277582|NCT02207244|5591378|P7|Non-Responders|Withdrawal, Retreatment Period:Week28-48||80
2277583|NCT02207244|5591379|P6|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
2277584|NCT02207244|5591380|P5|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
2277585|NCT02207244|5591381|P4|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
2277586|NCT02207244|5591382|P3|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
2277587|NCT02207244|5591383|P2|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
2277588|NCT02207244|5591384|P1|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
2277589|NCT02207244|5591376|P9|STARTED|Withdrawal, Retreatment Period:Week28-48||228
2277590|NCT02207244|5591377|P8|STARTED|Withdrawal, Retreatment Period:Week28-48||470
2277591|NCT02207244|5591378|P7|STARTED|Withdrawal, Retreatment Period:Week28-48||227
2277592|NCT02207244|5591379|P6|STARTED|Withdrawal, Retreatment Period:Week28-48||0
2277593|NCT02207244|5591380|P5|STARTED|Withdrawal, Retreatment Period:Week28-48||0
2277594|NCT02207244|5591381|P4|STARTED|Withdrawal, Retreatment Period:Week28-48||0
2277595|NCT02207244|5591382|P3|STARTED|Withdrawal, Retreatment Period:Week28-48||0
2277596|NCT02207244|5591383|P2|STARTED|Withdrawal, Retreatment Period:Week28-48||0
2277597|NCT02207244|5591384|P1|STARTED|Withdrawal, Retreatment Period:Week28-48||0
2277598|NCT02207244|5591376|P9|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
2277599|NCT02207244|5591377|P8|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
2277600|NCT02207244|5591378|P7|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
2277601|NCT02207244|5591379|P6|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||9
2277602|NCT02207244|5591380|P5|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||8
2277603|NCT02207244|5591381|P4|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||6
2277604|NCT02207244|5591382|P3|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
2277605|NCT02207244|5591383|P2|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
2277606|NCT02207244|5591384|P1|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
2277607|NCT02207244|5591376|P9|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
2277608|NCT02207244|5591377|P8|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
2277609|NCT02207244|5591378|P7|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
2277610|NCT02207244|5591379|P6|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||228
2277611|NCT02207244|5591380|P5|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||470
2277612|NCT02207244|5591381|P4|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||227
2277613|NCT02207244|5591382|P3|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
2277614|NCT02207244|5591383|P2|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
2277615|NCT02207244|5591384|P1|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
2277616|NCT02207244|5591376|P9|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
2277617|NCT02207244|5591377|P8|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
2277618|NCT02207244|5591378|P7|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
2277619|NCT02207244|5591379|P6|STARTED|Placebo Crossover and ACP: Week 16 - 28||237
2277620|NCT02207244|5591380|P5|STARTED|Placebo Crossover and ACP: Week 16 - 28||478
2277621|NCT02207244|5591381|P4|STARTED|Placebo Crossover and ACP: Week 16 - 28||233
2277622|NCT02207244|5591382|P3|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
2277623|NCT02207244|5591383|P2|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
2277624|NCT02207244|5591384|P1|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
2277625|NCT02207244|5591376|P9|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
2277626|NCT02207244|5591377|P8|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
2277627|NCT02207244|5591378|P7|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
2277628|NCT02207244|5591379|P6|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
2277629|NCT02207244|5591380|P5|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
2277630|NCT02207244|5591381|P4|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
2277631|NCT02207244|5591382|P3|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||11
2277632|NCT02207244|5591383|P2|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||18
2277633|NCT02207244|5591384|P1|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||15
2277634|NCT02207244|5591376|P9|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
2277635|NCT02207244|5591377|P8|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
2277636|NCT02207244|5591378|P7|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
2277637|NCT02207244|5591379|P6|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
2277638|NCT02207244|5591380|P5|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
2277639|NCT02207244|5591381|P4|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
2277640|NCT02207244|5591382|P3|COMPLETED|Placebo Controlled Period: Week 0 - 16||237
2277641|NCT02207244|5591383|P2|COMPLETED|Placebo Controlled Period: Week 0 - 16||478
2277642|NCT02207244|5591384|P1|COMPLETED|Placebo Controlled Period: Week 0 - 16||233
2277643|NCT02207244|5591376|P9|Treated|Placebo Controlled Period: Week 0 - 16||0
2277644|NCT02207244|5591377|P8|Treated|Placebo Controlled Period: Week 0 - 16||0
2277645|NCT02207244|5591378|P7|Treated|Placebo Controlled Period: Week 0 - 16||0
2277646|NCT02207244|5591379|P6|Treated|Placebo Controlled Period: Week 0 - 16||0
2277647|NCT02207244|5591380|P5|Treated|Placebo Controlled Period: Week 0 - 16||0
2277648|NCT02207244|5591381|P4|Treated|Placebo Controlled Period: Week 0 - 16||0
2277649|NCT02207244|5591382|P3|Treated|Placebo Controlled Period: Week 0 - 16||248
2277650|NCT02207244|5591383|P2|Treated|Placebo Controlled Period: Week 0 - 16||494
2277651|NCT02207244|5591384|P1|Treated|Placebo Controlled Period: Week 0 - 16||248
2277652|NCT02207244|5591376|P9|STARTED|Placebo Controlled Period: Week 0 - 16||0
2277653|NCT02207244|5591377|P8|STARTED|Placebo Controlled Period: Week 0 - 16||0
2277654|NCT02207244|5591378|P7|STARTED|Placebo Controlled Period: Week 0 - 16||0
2277655|NCT02207244|5591379|P6|STARTED|Placebo Controlled Period: Week 0 - 16||0
2277656|NCT02207244|5591380|P5|STARTED|Placebo Controlled Period: Week 0 - 16||0
2277657|NCT02207244|5591381|P4|STARTED|Placebo Controlled Period: Week 0 - 16||0
2277658|NCT02207244|5591382|P3|STARTED|Placebo Controlled Period: Week 0 - 16||248
2277659|NCT02207244|5591383|P2|STARTED|Placebo Controlled Period: Week 0 - 16||496
2277660|NCT02207244|5591384|P1|STARTED|Placebo Controlled Period: Week 0 - 16||248
2277661|NCT02207231|5591425|P3|NOT COMPLETED|Active Controlled Period: Week 16 - 48||42
2277662|NCT02207231|5591426|P2|NOT COMPLETED|Active Controlled Period: Week 16 - 48||21
2277663|NCT02207231|5591427|P1|NOT COMPLETED|Active Controlled Period: Week 16 - 48||3
2277664|NCT02207231|5591425|P3|COMPLETED|Active Controlled Period: Week 16 - 48||282
2277665|NCT02207231|5591426|P2|COMPLETED|Active Controlled Period: Week 16 - 48||301
2277666|NCT02207231|5591427|P1|COMPLETED|Active Controlled Period: Week 16 - 48||162
2277667|NCT02207231|5591425|P3|STARTED|Active Controlled Period: Week 16 - 48||324
2277668|NCT02207231|5591426|P2|STARTED|Active Controlled Period: Week 16 - 48||322
2277669|NCT02207231|5591427|P1|STARTED|Active Controlled Period: Week 16 - 48|2 participants did not cross-over.|165
2277670|NCT02207231|5591425|P3|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||10
2277671|NCT02207231|5591426|P2|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
2277672|NCT02207231|5591427|P1|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
2277673|NCT02207231|5591425|P3|COMPLETED|Placebo Controlled Period: Week 0 - 16||324
2277674|NCT02207231|5591426|P2|COMPLETED|Placebo Controlled Period: Week 0 - 16||322
2277675|NCT02207231|5591427|P1|COMPLETED|Placebo Controlled Period: Week 0 - 16||167
2277676|NCT02207231|5591425|P3|Treated|Placebo Controlled Period: Week 0 - 16||333
2277677|NCT02207231|5591426|P2|Treated|Placebo Controlled Period: Week 0 - 16||329
2277678|NCT02207231|5591427|P1|Treated|Placebo Controlled Period: Week 0 - 16||174
2277679|NCT02207231|5591425|P3|STARTED|Placebo Controlled Period: Week 0 - 16||334
2277680|NCT02207231|5591426|P2|STARTED|Placebo Controlled Period: Week 0 - 16||329
2277681|NCT02207231|5591427|P1|STARTED|Placebo Controlled Period: Week 0 - 16||174
2277682|NCT02207088|5591459|P1|NOT COMPLETED|Overall Study||2
2277683|NCT02207088|5591459|P1|COMPLETED|Overall Study||66
2277684|NCT02207088|5591459|P1|STARTED|Overall Study||68
2277685|NCT02206828|5591465|P1|NOT COMPLETED|Overall Study||7
2277686|NCT02206828|5591465|P1|COMPLETED|Overall Study||93
2277687|NCT02206828|5591465|P1|STARTED|Overall Study||100
2277688|NCT02206776|5591494|P2|NOT COMPLETED|Overall Study||0
2277689|NCT02206776|5591495|P1|NOT COMPLETED|Overall Study||0
2277690|NCT02206776|5591494|P2|COMPLETED|Overall Study||1
2277691|NCT02206776|5591495|P1|COMPLETED|Overall Study||1
2277692|NCT02206776|5591494|P2|STARTED|Overall Study||1
2277693|NCT02206776|5591495|P1|STARTED|Overall Study||1
2277694|NCT02206620|5591501|P2|NOT COMPLETED|Phase II - Second Intervention (6 Weeks)||2
2277695|NCT02206620|5591502|P1|NOT COMPLETED|Phase II - Second Intervention (6 Weeks)||0
2277696|NCT02206620|5591501|P2|COMPLETED|Phase II - Second Intervention (6 Weeks)||24
2277697|NCT02206620|5591502|P1|COMPLETED|Phase II - Second Intervention (6 Weeks)||21
2277698|NCT02206620|5591501|P2|STARTED|Phase II - Second Intervention (6 Weeks)||26
2277699|NCT02206620|5591502|P1|STARTED|Phase II - Second Intervention (6 Weeks)||21
2277700|NCT02206620|5591501|P2|NOT COMPLETED|Washout (6 Weeks)||0
2277701|NCT02206620|5591502|P1|NOT COMPLETED|Washout (6 Weeks)||0
2277702|NCT02206620|5591501|P2|COMPLETED|Washout (6 Weeks)||26
2277703|NCT02206620|5591502|P1|COMPLETED|Washout (6 Weeks)||21
2277704|NCT02206620|5591501|P2|STARTED|Washout (6 Weeks)||26
2277705|NCT02206620|5591502|P1|STARTED|Washout (6 Weeks)||21
2277706|NCT02206620|5591501|P2|NOT COMPLETED|Phase I - First Intervention (6 Weeks)||1
2277707|NCT02206620|5591502|P1|NOT COMPLETED|Phase I - First Intervention (6 Weeks)||1
2277708|NCT02206620|5591501|P2|COMPLETED|Phase I - First Intervention (6 Weeks)||26
2277709|NCT02206620|5591502|P1|COMPLETED|Phase I - First Intervention (6 Weeks)||21
2277710|NCT02206620|5591501|P2|STARTED|Phase I - First Intervention (6 Weeks)||27
2277711|NCT02206620|5591502|P1|STARTED|Phase I - First Intervention (6 Weeks)||22
2277712|NCT02206607|5591518|P5|NOT COMPLETED|Fourth Intervention Period||0
2277713|NCT02206607|5591519|P4|NOT COMPLETED|Fourth Intervention Period||0
2277714|NCT02206607|5591520|P3|NOT COMPLETED|Fourth Intervention Period||0
2277715|NCT02206607|5591521|P2|NOT COMPLETED|Fourth Intervention Period||0
2277716|NCT02206607|5591522|P1|NOT COMPLETED|Fourth Intervention Period||0
2277717|NCT02206607|5591518|P5|COMPLETED|Fourth Intervention Period||10
2277718|NCT02206607|5591519|P4|COMPLETED|Fourth Intervention Period||10
2277719|NCT02206607|5591520|P3|COMPLETED|Fourth Intervention Period||9
2277720|NCT02206607|5591521|P2|COMPLETED|Fourth Intervention Period||9
2277721|NCT02206607|5591522|P1|COMPLETED|Fourth Intervention Period||0
2277722|NCT02206607|5591518|P5|STARTED|Fourth Intervention Period||10
2277723|NCT02206607|5591519|P4|STARTED|Fourth Intervention Period||10
2277724|NCT02206607|5591520|P3|STARTED|Fourth Intervention Period||9
2277725|NCT02206607|5591521|P2|STARTED|Fourth Intervention Period||9
2277726|NCT02206607|5591522|P1|STARTED|Fourth Intervention Period||0
2277727|NCT02206607|5591518|P5|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
2277728|NCT02206607|5591519|P4|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
2277729|NCT02206607|5591520|P3|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
2277730|NCT02206607|5591521|P2|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
2277731|NCT02206607|5591522|P1|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
2277732|NCT02206607|5591518|P5|COMPLETED|Third Washout Period 5 to 10 Days||10
2277733|NCT02206607|5591519|P4|COMPLETED|Third Washout Period 5 to 10 Days||10
2277734|NCT02206607|5591520|P3|COMPLETED|Third Washout Period 5 to 10 Days||9
2277735|NCT02206607|5591521|P2|COMPLETED|Third Washout Period 5 to 10 Days||9
2277736|NCT02206607|5591522|P1|COMPLETED|Third Washout Period 5 to 10 Days||0
2277737|NCT02206607|5591518|P5|STARTED|Third Washout Period 5 to 10 Days||10
2277738|NCT02206607|5591519|P4|STARTED|Third Washout Period 5 to 10 Days||10
2277739|NCT02206607|5591520|P3|STARTED|Third Washout Period 5 to 10 Days||9
2277740|NCT02206607|5591521|P2|STARTED|Third Washout Period 5 to 10 Days||9
2277741|NCT02206607|5591522|P1|STARTED|Third Washout Period 5 to 10 Days||0
2277742|NCT02206607|5591518|P5|NOT COMPLETED|Third Intervention Period||0
2277743|NCT02206607|5591519|P4|NOT COMPLETED|Third Intervention Period||0
2277744|NCT02206607|5591520|P3|NOT COMPLETED|Third Intervention Period||0
2277745|NCT02206607|5591521|P2|NOT COMPLETED|Third Intervention Period||0
2277746|NCT02206607|5591522|P1|NOT COMPLETED|Third Intervention Period||0
2277747|NCT02206607|5591518|P5|COMPLETED|Third Intervention Period||10
2277748|NCT02206607|5591519|P4|COMPLETED|Third Intervention Period||10
2277749|NCT02206607|5591520|P3|COMPLETED|Third Intervention Period||9
2277750|NCT02206607|5591521|P2|COMPLETED|Third Intervention Period||9
2277751|NCT02206607|5591522|P1|COMPLETED|Third Intervention Period||0
2277752|NCT02206607|5591518|P5|STARTED|Third Intervention Period||10
2277753|NCT02206607|5591519|P4|STARTED|Third Intervention Period||10
2277754|NCT02206607|5591520|P3|STARTED|Third Intervention Period||9
2277755|NCT02206607|5591521|P2|STARTED|Third Intervention Period||9
2277756|NCT02206607|5591522|P1|STARTED|Third Intervention Period||0
2277757|NCT02206607|5591518|P5|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
2277758|NCT02206607|5591519|P4|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
2277759|NCT02206607|5591520|P3|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
2277760|NCT02206607|5591521|P2|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
2277761|NCT02206607|5591522|P1|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
2277762|NCT02206607|5591518|P5|COMPLETED|Second Washout Period 5 to 10 Days||10
2277763|NCT02206607|5591519|P4|COMPLETED|Second Washout Period 5 to 10 Days||10
2277764|NCT02206607|5591520|P3|COMPLETED|Second Washout Period 5 to 10 Days||9
2277765|NCT02206607|5591521|P2|COMPLETED|Second Washout Period 5 to 10 Days||9
2277766|NCT02206607|5591522|P1|COMPLETED|Second Washout Period 5 to 10 Days||0
2277767|NCT02206607|5591518|P5|STARTED|Second Washout Period 5 to 10 Days||10
2277768|NCT02206607|5591519|P4|STARTED|Second Washout Period 5 to 10 Days||10
2277769|NCT02206607|5591520|P3|STARTED|Second Washout Period 5 to 10 Days||9
2277770|NCT02206607|5591521|P2|STARTED|Second Washout Period 5 to 10 Days||9
2277771|NCT02206607|5591522|P1|STARTED|Second Washout Period 5 to 10 Days||0
2277772|NCT02206607|5591518|P5|NOT COMPLETED|Second Intervention Period||0
2277773|NCT02206607|5591519|P4|NOT COMPLETED|Second Intervention Period||1
2277774|NCT02206607|5591520|P3|NOT COMPLETED|Second Intervention Period||0
2277775|NCT02206607|5591521|P2|NOT COMPLETED|Second Intervention Period||0
2277776|NCT02206607|5591522|P1|NOT COMPLETED|Second Intervention Period||0
2277777|NCT02206607|5591518|P5|COMPLETED|Second Intervention Period||10
2277778|NCT02206607|5591519|P4|COMPLETED|Second Intervention Period||10
2277779|NCT02206607|5591520|P3|COMPLETED|Second Intervention Period||9
2277780|NCT02206607|5591521|P2|COMPLETED|Second Intervention Period||9
2277781|NCT02206607|5591522|P1|COMPLETED|Second Intervention Period||0
2277782|NCT02206607|5591518|P5|STARTED|Second Intervention Period||10
2277783|NCT02206607|5591519|P4|STARTED|Second Intervention Period||11
2277784|NCT02206607|5591520|P3|STARTED|Second Intervention Period||9
2277785|NCT02206607|5591521|P2|STARTED|Second Intervention Period||9
2277786|NCT02206607|5591522|P1|STARTED|Second Intervention Period||0
2277787|NCT02206607|5591518|P5|NOT COMPLETED|First Washout Period 5 to 10 Days||0
2277788|NCT02206607|5591519|P4|NOT COMPLETED|First Washout Period 5 to 10 Days||0
2277789|NCT02206607|5591520|P3|NOT COMPLETED|First Washout Period 5 to 10 Days||0
2277790|NCT02206607|5591521|P2|NOT COMPLETED|First Washout Period 5 to 10 Days||0
2277791|NCT02206607|5591522|P1|NOT COMPLETED|First Washout Period 5 to 10 Days||0
2277792|NCT02206607|5591518|P5|COMPLETED|First Washout Period 5 to 10 Days||10
2277793|NCT02206607|5591519|P4|COMPLETED|First Washout Period 5 to 10 Days||11
2277794|NCT02206607|5591520|P3|COMPLETED|First Washout Period 5 to 10 Days||9
2277795|NCT02206607|5591521|P2|COMPLETED|First Washout Period 5 to 10 Days||9
2277796|NCT02206607|5591522|P1|COMPLETED|First Washout Period 5 to 10 Days||0
2277797|NCT02206607|5591518|P5|STARTED|First Washout Period 5 to 10 Days||10
2277798|NCT02206607|5591519|P4|STARTED|First Washout Period 5 to 10 Days||11
2277799|NCT02206607|5591520|P3|STARTED|First Washout Period 5 to 10 Days||9
2277800|NCT02206607|5591521|P2|STARTED|First Washout Period 5 to 10 Days||9
2277801|NCT02206607|5591522|P1|STARTED|First Washout Period 5 to 10 Days||0
2277802|NCT02206607|5591518|P5|NOT COMPLETED|First Intervention Period||0
2277803|NCT02206607|5591519|P4|NOT COMPLETED|First Intervention Period||0
2277804|NCT02206607|5591520|P3|NOT COMPLETED|First Intervention Period||0
2277805|NCT02206607|5591521|P2|NOT COMPLETED|First Intervention Period||0
2277806|NCT02206607|5591522|P1|NOT COMPLETED|First Intervention Period||0
2277807|NCT02206607|5591518|P5|COMPLETED|First Intervention Period||10
2277808|NCT02206607|5591519|P4|COMPLETED|First Intervention Period||11
2277809|NCT02206607|5591520|P3|COMPLETED|First Intervention Period||9
2277810|NCT02206607|5591521|P2|COMPLETED|First Intervention Period||9
2277811|NCT02206607|5591522|P1|COMPLETED|First Intervention Period||0
2277812|NCT02206607|5591518|P5|STARTED|First Intervention Period||10
2277813|NCT02206607|5591519|P4|STARTED|First Intervention Period||11
2277814|NCT02206607|5591520|P3|STARTED|First Intervention Period||9
2277815|NCT02206607|5591521|P2|STARTED|First Intervention Period||9
2277816|NCT02206607|5591522|P1|STARTED|First Intervention Period||0
2277817|NCT02206607|5591518|P5|NOT COMPLETED|Open-Label Run-In||0
2277818|NCT02206607|5591519|P4|NOT COMPLETED|Open-Label Run-In||0
2277819|NCT02206607|5591520|P3|NOT COMPLETED|Open-Label Run-In||0
2277820|NCT02206607|5591521|P2|NOT COMPLETED|Open-Label Run-In||0
2277821|NCT02206607|5591522|P1|NOT COMPLETED|Open-Label Run-In||3
2277822|NCT02206607|5591518|P5|COMPLETED|Open-Label Run-In||0
2277823|NCT02206607|5591519|P4|COMPLETED|Open-Label Run-In||0
2277824|NCT02206607|5591520|P3|COMPLETED|Open-Label Run-In||0
2277825|NCT02206607|5591521|P2|COMPLETED|Open-Label Run-In||0
2277826|NCT02206607|5591522|P1|COMPLETED|Open-Label Run-In||39
2277827|NCT02206607|5591518|P5|STARTED|Open-Label Run-In||0
2277828|NCT02206607|5591519|P4|STARTED|Open-Label Run-In||0
2277829|NCT02206607|5591520|P3|STARTED|Open-Label Run-In||0
2277830|NCT02206607|5591521|P2|STARTED|Open-Label Run-In||0
2277831|NCT02206607|5591522|P1|STARTED|Open-Label Run-In||42
2277832|NCT02206217|5591576|P2|NOT COMPLETED|Overall Study||14
2277833|NCT02206217|5591577|P1|NOT COMPLETED|Overall Study||9
2277834|NCT02206217|5591576|P2|COMPLETED|Overall Study||79
2277835|NCT02206217|5591577|P1|COMPLETED|Overall Study||81
2277836|NCT02206217|5591576|P2|STARTED|Overall Study||93
2277837|NCT02206217|5591577|P1|STARTED|Overall Study||90
2277838|NCT02206152|5591585|P1|NOT COMPLETED|NAC, Then Placebo||0
2277839|NCT02206152|5591585|P1|COMPLETED|NAC, Then Placebo||10
2277840|NCT02206152|5591585|P1|STARTED|NAC, Then Placebo||10
2277841|NCT02206152|5591585|P1|NOT COMPLETED|Placebo, Then NAC||0
2277842|NCT02206152|5591585|P1|COMPLETED|Placebo, Then NAC||10
2277843|NCT02206152|5591585|P1|STARTED|Placebo, Then NAC||10
2277844|NCT02206152|5591585|P1|NOT COMPLETED|Pre-Randomization||2
2277845|NCT02206152|5591585|P1|COMPLETED|Pre-Randomization||20
2277846|NCT02206152|5591585|P1|STARTED|Pre-Randomization||22
2277847|NCT02205983|5591595|P4|NOT COMPLETED|Overall Study||0
2277848|NCT02205983|5591596|P3|NOT COMPLETED|Overall Study||0
2277849|NCT02205983|5591597|P2|NOT COMPLETED|Overall Study||0
2277850|NCT02205983|5591598|P1|NOT COMPLETED|Overall Study||0
2277851|NCT02205983|5591595|P4|COMPLETED|Overall Study||13
2277852|NCT02205983|5591596|P3|COMPLETED|Overall Study||13
2277853|NCT02205983|5591597|P2|COMPLETED|Overall Study||12
2277854|NCT02205983|5591598|P1|COMPLETED|Overall Study||12
2277855|NCT02205983|5591595|P4|STARTED|Overall Study||13
2277856|NCT02205983|5591596|P3|STARTED|Overall Study||13
2277857|NCT02205983|5591597|P2|STARTED|Overall Study||12
2277858|NCT02205983|5591598|P1|STARTED|Overall Study||12
2277859|NCT02205814|5591612|P4|NOT COMPLETED|Overall Study||4
2277860|NCT02205814|5591613|P3|NOT COMPLETED|Overall Study||5
2277861|NCT02205814|5591614|P2|NOT COMPLETED|Overall Study||1
2277862|NCT02205814|5591615|P1|NOT COMPLETED|Overall Study||2
2277863|NCT02205814|5591612|P4|COMPLETED|Overall Study||104
2277864|NCT02205814|5591613|P3|COMPLETED|Overall Study||103
2277865|NCT02205814|5591614|P2|COMPLETED|Overall Study||109
2277866|NCT02205814|5591615|P1|COMPLETED|Overall Study||108
2277867|NCT02205814|5591612|P4|STARTED|Overall Study||108
2277868|NCT02205814|5591613|P3|STARTED|Overall Study||108
2277869|NCT02205814|5591614|P2|STARTED|Overall Study||110
2277870|NCT02205814|5591615|P1|STARTED|Overall Study||110
2277871|NCT02205801|5591641|P4|NOT COMPLETED|Overall Study||0
2277872|NCT02205801|5591642|P3|NOT COMPLETED|Overall Study||0
2277873|NCT02205801|5591643|P2|NOT COMPLETED|Overall Study||0
2277874|NCT02205801|5591644|P1|NOT COMPLETED|Overall Study||0
2277875|NCT02205801|5591641|P4|COMPLETED|Overall Study||8
2277876|NCT02205801|5591642|P3|COMPLETED|Overall Study||9
2277877|NCT02205801|5591643|P2|COMPLETED|Overall Study||8
2277878|NCT02205801|5591644|P1|COMPLETED|Overall Study||11
2277879|NCT02205801|5591641|P4|STARTED|Overall Study||8
2277880|NCT02205801|5591642|P3|STARTED|Overall Study||9
2277881|NCT02205801|5591643|P2|STARTED|Overall Study||8
2277882|NCT02205801|5591644|P1|STARTED|Overall Study||11
2277883|NCT02205476|5591668|P2|NOT COMPLETED|Overall Study||3
2277884|NCT02205476|5591669|P1|NOT COMPLETED|Overall Study||7
2277885|NCT02205476|5591668|P2|COMPLETED|Overall Study||0
2277886|NCT02205476|5591669|P1|COMPLETED|Overall Study||0
2277887|NCT02205476|5591668|P2|STARTED|Overall Study||3
2277888|NCT02205476|5591669|P1|STARTED|Overall Study||7
2277889|NCT02205333|5591708|P9|NOT COMPLETED|Overall Study||0
2277890|NCT02205333|5591709|P8|NOT COMPLETED|Overall Study||2
2277891|NCT02205333|5591710|P7|NOT COMPLETED|Overall Study||5
2277892|NCT02205333|5591711|P6|NOT COMPLETED|Overall Study||3
2277893|NCT02205333|5591712|P5|NOT COMPLETED|Overall Study||5
2277894|NCT02205333|5591713|P4|NOT COMPLETED|Overall Study||7
2277895|NCT02205333|5591714|P3|NOT COMPLETED|Overall Study||2
2277896|NCT02205333|5591715|P2|NOT COMPLETED|Overall Study||6
2277897|NCT02205333|5591716|P1|NOT COMPLETED|Overall Study||6
2277898|NCT02205333|5591708|P9|COMPLETED|Overall Study||1
2277899|NCT02205333|5591709|P8|COMPLETED|Overall Study||1
2277900|NCT02205333|5591710|P7|COMPLETED|Overall Study||2
2277901|NCT02205333|5591711|P6|COMPLETED|Overall Study||4
2277902|NCT02205333|5591712|P5|COMPLETED|Overall Study||1
2277903|NCT02205333|5591713|P4|COMPLETED|Overall Study||0
2277904|NCT02205333|5591714|P3|COMPLETED|Overall Study||1
2277905|NCT02205333|5591715|P2|COMPLETED|Overall Study||0
2277906|NCT02205333|5591716|P1|COMPLETED|Overall Study||2
2277907|NCT02205333|5591708|P9|STARTED|Overall Study||1
2277908|NCT02205333|5591709|P8|STARTED|Overall Study||3
2277909|NCT02205333|5591710|P7|STARTED|Overall Study||7
2277910|NCT02205333|5591711|P6|STARTED|Overall Study||7
2277911|NCT02205333|5591712|P5|STARTED|Overall Study||6
2277912|NCT02205333|5591713|P4|STARTED|Overall Study||7
2277913|NCT02205333|5591714|P3|STARTED|Overall Study||3
2277914|NCT02205333|5591715|P2|STARTED|Overall Study||6
2277915|NCT02205333|5591716|P1|STARTED|Overall Study||8
2277916|NCT02205177|5591891|P2|NOT COMPLETED|Overall Study||0
2277917|NCT02205177|5591892|P1|NOT COMPLETED|Overall Study||2
2277918|NCT02205177|5591891|P2|COMPLETED|Overall Study||2
2277919|NCT02205177|5591892|P1|COMPLETED|Overall Study||6
2277920|NCT02205177|5591891|P2|STARTED|Overall Study||2
2277921|NCT02205177|5591892|P1|STARTED|Overall Study||8
2277922|NCT02204982|5591902|P2|NOT COMPLETED|Overall Study||7
2277923|NCT02204982|5591903|P1|NOT COMPLETED|Overall Study||4
2277924|NCT02204982|5591902|P2|COMPLETED|Overall Study||0
2277925|NCT02204982|5591903|P1|COMPLETED|Overall Study||2
2277926|NCT02204982|5591902|P2|STARTED|Overall Study||7
2277927|NCT02204982|5591903|P1|STARTED|Overall Study||6
2277928|NCT02204917|5591911|P1|NOT COMPLETED|Overall Study||1
2277929|NCT02204917|5591911|P1|COMPLETED|Overall Study||30
2277930|NCT02204917|5591911|P1|STARTED|Overall Study||31
2277931|NCT02204761|5591918|P1|NOT COMPLETED|Overall Study||0
2277932|NCT02204761|5591918|P1|COMPLETED|Overall Study||6
2277933|NCT02204761|5591918|P1|STARTED|Overall Study||6
2277934|NCT02204748|5591925|P1|NOT COMPLETED|Overall Study||0
2277935|NCT02204748|5591925|P1|COMPLETED|Overall Study||5
2277936|NCT02204748|5591925|P1|STARTED|Overall Study||5
2277937|NCT02204657|5591939|P2|NOT COMPLETED|Overall Study||0
2277938|NCT02204657|5591940|P1|NOT COMPLETED|Overall Study||7
2277939|NCT02204657|5591939|P2|COMPLETED|Overall Study||25
2277940|NCT02204657|5591940|P1|COMPLETED|Overall Study||25
2277941|NCT02204657|5591939|P2|STARTED|Overall Study||25
2277942|NCT02204657|5591940|P1|STARTED|Overall Study||32
2277943|NCT02204579|5591948|P1|NOT COMPLETED|Overall Study||2
2277944|NCT02204579|5591948|P1|COMPLETED|Overall Study||5
2277945|NCT02204579|5591948|P1|Treated|Overall Study||5
2277946|NCT02204579|5591948|P1|Participants Started in Post-Amendment|Overall Study|Two participants from pre-amendment were re-enrolled with different identification numbers.|5
2277947|NCT02204579|5591948|P1|Participants Started in Pre-Amendment|Overall Study|Two participants completed treatment in pre-amendment and were re-enrolled in post-amendment.|2
2277948|NCT02204579|5591948|P1|STARTED|Overall Study||7
2277949|NCT02204566|5592000|P1|NOT COMPLETED|Overall Study||4
2277950|NCT02204566|5592000|P1|COMPLETED|Overall Study||1
2277951|NCT02204566|5592000|P1|STARTED|Overall Study||5
2277952|NCT02204449|5592006|P2|NOT COMPLETED|Overall Study||11
2277953|NCT02204449|5592007|P1|NOT COMPLETED|Overall Study||7
2277954|NCT02204449|5592006|P2|COMPLETED|Overall Study||37
2277955|NCT02204449|5592007|P1|COMPLETED|Overall Study||39
2277956|NCT02204449|5592006|P2|STARTED|Overall Study||48
2277957|NCT02204449|5592007|P1|STARTED|Overall Study||46
2277958|NCT02204410|5592017|P1|NOT COMPLETED|Overall Study||11
2277959|NCT02204410|5592017|P1|COMPLETED|Overall Study||10
2277960|NCT02204410|5592017|P1|STARTED|Overall Study||21
2277961|NCT02204371|5592022|P1|NOT COMPLETED|Overall Study||1
2277962|NCT02204371|5592022|P1|COMPLETED|Overall Study||6
2277963|NCT02204371|5592022|P1|STARTED|Overall Study||7
2277964|NCT02204319|5592045|P1|NOT COMPLETED|Overall Study||3
2277965|NCT02204319|5592045|P1|COMPLETED|Overall Study|3 did not complete study.|7
2277966|NCT02204319|5592045|P1|STARTED|Overall Study||10
2277967|NCT02204176|5592054|P3|NOT COMPLETED|Overall Study||16
2277968|NCT02204176|5592055|P2|NOT COMPLETED|Overall Study||12
2277969|NCT02204176|5592056|P1|NOT COMPLETED|Overall Study||10
2277970|NCT02204176|5592054|P3|COMPLETED|Overall Study||58
2277971|NCT02204176|5592055|P2|COMPLETED|Overall Study||61
2277972|NCT02204176|5592056|P1|COMPLETED|Overall Study||64
2277973|NCT02204176|5592054|P3|STARTED|Overall Study||74
2277974|NCT02204176|5592055|P2|STARTED|Overall Study||73
2277975|NCT02204176|5592056|P1|STARTED|Overall Study||74
2277976|NCT02204150|5592079|P1|NOT COMPLETED|Overall Study||0
2277977|NCT02204150|5592079|P1|COMPLETED|Overall Study||56
2277978|NCT02204150|5592079|P1|STARTED|Overall Study||56
2277979|NCT02204124|5592085|P2|NOT COMPLETED|Overall Study||0
2277980|NCT02204124|5592086|P1|NOT COMPLETED|Overall Study||0
2277981|NCT02204124|5592085|P2|COMPLETED|Overall Study||19
2277982|NCT02204124|5592086|P1|COMPLETED|Overall Study||13
2277983|NCT02204124|5592085|P2|STARTED|Overall Study||19
2277984|NCT02204124|5592086|P1|STARTED|Overall Study||13
2277985|NCT02204007|5592106|P2|NOT COMPLETED|Overall Study||1
2277986|NCT02204007|5592107|P1|NOT COMPLETED|Overall Study||1
2277987|NCT02204007|5592106|P2|COMPLETED|Overall Study||17
2277988|NCT02204007|5592107|P1|COMPLETED|Overall Study||17
2277989|NCT02204007|5592106|P2|STARTED|Overall Study||18
2277990|NCT02204007|5592107|P1|STARTED|Overall Study||18
2277991|NCT02203916|5592118|P3|NOT COMPLETED|Overall Study||11
2277992|NCT02203916|5592119|P2|NOT COMPLETED|Overall Study||10
2277993|NCT02203916|5592120|P1|NOT COMPLETED|Overall Study||8
2277994|NCT02203916|5592118|P3|COMPLETED|Overall Study||120
2277995|NCT02203916|5592119|P2|COMPLETED|Overall Study||122
2277996|NCT02203916|5592120|P1|COMPLETED|Overall Study||57
2277997|NCT02203916|5592118|P3|Safety Analysis Set (SAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the SAS.|130
2277998|NCT02203916|5592119|P2|Safety Analysis Set (SAS)|Overall Study||132
2277999|NCT02203916|5592120|P1|Safety Analysis Set (SAS)|Overall Study||65
2278000|NCT02203916|5592118|P3|Full Analysis Set (FAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the FAS.|130
2278001|NCT02203916|5592119|P2|Full Analysis Set (FAS)|Overall Study||132
2278002|NCT02203916|5592120|P1|Full Analysis Set (FAS)|Overall Study||65
2278003|NCT02203916|5592118|P3|STARTED|Overall Study|1 participant was randomized twice and counted only once.|131
2278004|NCT02203916|5592119|P2|STARTED|Overall Study||132
2278005|NCT02203916|5592120|P1|STARTED|Overall Study||65
2278006|NCT02203851|5592140|P1|NOT COMPLETED|Overall Study||11
2278007|NCT02203851|5592140|P1|COMPLETED|Overall Study||99
2278008|NCT02203851|5592140|P1|STARTED|Overall Study||110
2278009|NCT02203838|5592178|P4|NOT COMPLETED|Overall Study||18
2278010|NCT02203838|5592179|P3|NOT COMPLETED|Overall Study||16
2278011|NCT02203838|5592180|P2|NOT COMPLETED|Overall Study||22
2278012|NCT02203838|5592181|P1|NOT COMPLETED|Overall Study||210
2278013|NCT02203838|5592178|P4|COMPLETED|Overall Study||15
2278014|NCT02203838|5592179|P3|COMPLETED|Overall Study||15
2278015|NCT02203838|5592180|P2|COMPLETED|Overall Study||6
2278016|NCT02203838|5592181|P1|COMPLETED|Overall Study||198
2278017|NCT02203838|5592178|P4|STARTED|Overall Study||33
2278018|NCT02203838|5592179|P3|STARTED|Overall Study||31
2278019|NCT02203838|5592180|P2|STARTED|Overall Study||28
2278020|NCT02203838|5592181|P1|STARTED|Overall Study||408
2278021|NCT02203786|5592215|P4|NOT COMPLETED|Overall Study||0
2278022|NCT02203786|5592216|P3|NOT COMPLETED|Overall Study||2
2278023|NCT02203786|5592217|P2|NOT COMPLETED|Overall Study||0
2278024|NCT02203786|5592218|P1|NOT COMPLETED|Overall Study||0
2278025|NCT02203786|5592215|P4|COMPLETED|Overall Study||15
2278026|NCT02203786|5592216|P3|COMPLETED|Overall Study||15
2278027|NCT02203786|5592217|P2|COMPLETED|Overall Study||15
2278028|NCT02203786|5592218|P1|COMPLETED|Overall Study||15
2278029|NCT02203786|5592215|P4|STARTED|Overall Study||15
2278030|NCT02203786|5592216|P3|STARTED|Overall Study||17
2278031|NCT02203786|5592217|P2|STARTED|Overall Study||15
2278032|NCT02203786|5592218|P1|STARTED|Overall Study||15
2278033|NCT02203747|5592250|P2|NOT COMPLETED|Overall Study||0
2278034|NCT02203747|5592251|P1|NOT COMPLETED|Overall Study||0
2278035|NCT02203747|5592250|P2|COMPLETED|Overall Study||34
2278036|NCT02203747|5592251|P1|COMPLETED|Overall Study||45
2278037|NCT02203747|5592250|P2|STARTED|Overall Study||34
2278038|NCT02203747|5592251|P1|STARTED|Overall Study||45
2278039|NCT02203721|5592261|P2|NOT COMPLETED|Overall Study||3
2278040|NCT02203721|5592262|P1|NOT COMPLETED|Overall Study||1
2278041|NCT02203721|5592261|P2|COMPLETED|Overall Study||148
2278042|NCT02203721|5592262|P1|COMPLETED|Overall Study||147
2278043|NCT02203721|5592261|P2|STARTED|Overall Study||151
2278044|NCT02203721|5592262|P1|STARTED|Overall Study||148
2278045|NCT02203630|5592272|P2|NOT COMPLETED|Overall Study||0
2278046|NCT02203630|5592273|P1|NOT COMPLETED|Overall Study||0
2278047|NCT02203630|5592272|P2|COMPLETED|Overall Study||9
2278048|NCT02203630|5592273|P1|COMPLETED|Overall Study||8
2278049|NCT02203630|5592272|P2|STARTED|Overall Study||9
2278050|NCT02203630|5592273|P1|STARTED|Overall Study||8
2278051|NCT02203578|5592343|P1|NOT COMPLETED|Overall Study||0
2278052|NCT02203578|5592343|P1|COMPLETED|Overall Study||1
2278053|NCT02203578|5592343|P1|STARTED|Overall Study||1
2278054|NCT02203565|5592355|P1|NOT COMPLETED|Overall Study||1
2278055|NCT02203565|5592355|P1|COMPLETED|Overall Study||19
2278056|NCT02203565|5592355|P1|STARTED|Overall Study||20
2278057|NCT02203357|5592362|P3|NOT COMPLETED|Overall Study||70
2278058|NCT02203357|5592363|P2|NOT COMPLETED|Overall Study||66
2278059|NCT02203357|5592364|P1|NOT COMPLETED|Overall Study||58
2278060|NCT02203357|5592362|P3|COMPLETED|Overall Study||55
2278061|NCT02203357|5592363|P2|COMPLETED|Overall Study||45
2278062|NCT02203357|5592364|P1|COMPLETED|Overall Study||59
2278063|NCT02203357|5592362|P3|mon24|Overall Study||55
2278064|NCT02203357|5592363|P2|mon24|Overall Study||45
2278065|NCT02203357|5592364|P1|mon24|Overall Study||59
2278066|NCT02203357|5592362|P3|mon12|Overall Study||122
2278067|NCT02203357|5592363|P2|mon12|Overall Study||101
2278068|NCT02203357|5592364|P1|mon12|Overall Study||113
2278069|NCT02203357|5592362|P3|mon7/2/3|Overall Study||124
2278070|NCT02203357|5592363|P2|mon7/2/3|Overall Study||110
2278071|NCT02203357|5592364|P1|mon7/2/3|Overall Study||114
2278072|NCT02203357|5592362|P3|STARTED|Overall Study||125
2278073|NCT02203357|5592363|P2|STARTED|Overall Study||111
2278074|NCT02203357|5592364|P1|STARTED|Overall Study||117
2278075|NCT02203331|5592387|P6|NOT COMPLETED|Overall Study||7
2278076|NCT02203331|5592388|P5|NOT COMPLETED|Overall Study||7
2278077|NCT02203331|5592389|P4|NOT COMPLETED|Overall Study||7
2278078|NCT02203331|5592390|P3|NOT COMPLETED|Overall Study||5
2278079|NCT02203331|5592391|P2|NOT COMPLETED|Overall Study||14
2278080|NCT02203331|5592392|P1|NOT COMPLETED|Overall Study||7
2278081|NCT02203331|5592387|P6|COMPLETED|Overall Study||46
2278082|NCT02203331|5592388|P5|COMPLETED|Overall Study||46
2278083|NCT02203331|5592389|P4|COMPLETED|Overall Study||46
2278084|NCT02203331|5592390|P3|COMPLETED|Overall Study||50
2278085|NCT02203331|5592391|P2|COMPLETED|Overall Study||39
2278086|NCT02203331|5592392|P1|COMPLETED|Overall Study||45
2278087|NCT02203331|5592387|P6|Treated|Overall Study||53
2278088|NCT02203331|5592388|P5|Treated|Overall Study||50
2278089|NCT02203331|5592389|P4|Treated|Overall Study||49
2278090|NCT02203331|5592390|P3|Treated|Overall Study||54
2278091|NCT02203331|5592391|P2|Treated|Overall Study||50
2278092|NCT02203331|5592392|P1|Treated|Overall Study||49
2278093|NCT02203331|5592387|P6|STARTED|Overall Study||53
2278094|NCT02203331|5592388|P5|STARTED|Overall Study||53
2278095|NCT02203331|5592389|P4|STARTED|Overall Study||53
2278096|NCT02203331|5592390|P3|STARTED|Overall Study||55
2278097|NCT02203331|5592391|P2|STARTED|Overall Study||53
2278098|NCT02203331|5592392|P1|STARTED|Overall Study||52
2278099|NCT02203162|5592442|P1|NOT COMPLETED|Overall Study||0
2278100|NCT02203162|5592442|P1|COMPLETED|Overall Study||30
2278101|NCT02203162|5592442|P1|STARTED|Overall Study||30
2278102|NCT02203149|5592451|P5|NOT COMPLETED|Part 2||1
2278103|NCT02203149|5592452|P4|NOT COMPLETED|Part 2||3
2278104|NCT02203149|5592453|P3|NOT COMPLETED|Part 2||1
2278105|NCT02203149|5592454|P2|NOT COMPLETED|Part 2||0
2278106|NCT02203149|5592455|P1|NOT COMPLETED|Part 2||0
2278107|NCT02203149|5592451|P5|COMPLETED|Part 2||34
2278108|NCT02203149|5592452|P4|COMPLETED|Part 2||71
2278109|NCT02203149|5592453|P3|COMPLETED|Part 2||226
2278110|NCT02203149|5592454|P2|COMPLETED|Part 2||0
2278111|NCT02203149|5592455|P1|COMPLETED|Part 2||0
2278112|NCT02203149|5592451|P5|Started Deferred Active Treatment|Part 2||0
2278113|NCT02203149|5592452|P4|Started Deferred Active Treatment|Part 2|1 participant in Deferred Treatment Arm receiving Placebo did not receive Deferred Active Treatment.|73
2278114|NCT02203149|5592453|P3|Started Deferred Active Treatment|Part 2||0
2278115|NCT02203149|5592454|P2|Started Deferred Active Treatment|Part 2||0
2278116|NCT02203149|5592455|P1|Started Deferred Active Treatment|Part 2||0
2278117|NCT02203149|5592451|P5|STARTED|Part 2||35
2278118|NCT02203149|5592452|P4|STARTED|Part 2||74
2278119|NCT02203149|5592453|P3|STARTED|Part 2||227
2278120|NCT02203149|5592454|P2|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
2278121|NCT02203149|5592455|P1|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
2278122|NCT02203149|5592451|P5|NOT COMPLETED|Part 1||0
2278123|NCT02203149|5592452|P4|NOT COMPLETED|Part 1||0
2278124|NCT02203149|5592453|P3|NOT COMPLETED|Part 1||0
2278125|NCT02203149|5592454|P2|NOT COMPLETED|Part 1||1
2278126|NCT02203149|5592455|P1|NOT COMPLETED|Part 1||0
2278127|NCT02203149|5592451|P5|COMPLETED|Part 1||0
2278128|NCT02203149|5592452|P4|COMPLETED|Part 1||0
2278129|NCT02203149|5592453|P3|COMPLETED|Part 1||0
2278130|NCT02203149|5592454|P2|COMPLETED|Part 1||31
2278131|NCT02203149|5592455|P1|COMPLETED|Part 1||31
2278132|NCT02203149|5592451|P5|STARTED|Part 1||0
2278133|NCT02203149|5592452|P4|STARTED|Part 1||0
2278134|NCT02203149|5592453|P3|STARTED|Part 1||0
2278135|NCT02203149|5592454|P2|STARTED|Part 1||32
2278136|NCT02203149|5592455|P1|STARTED|Part 1||31
2278137|NCT02203032|5592488|P4|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||46
2278138|NCT02203032|5592489|P3|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||26
2278139|NCT02203032|5592490|P2|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||15
2278140|NCT02203032|5592491|P1|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||0
2278141|NCT02203032|5592488|P4|COMPLETED|Blinded Phase (Week 16 to Week 44)||539
2278142|NCT02203032|5592489|P3|COMPLETED|Blinded Phase (Week 16 to Week 44)||107
2278143|NCT02203032|5592490|P2|COMPLETED|Blinded Phase (Week 16 to Week 44)||120
2278144|NCT02203032|5592491|P1|COMPLETED|Blinded Phase (Week 16 to Week 44)||0
2278145|NCT02203032|5592488|P4|STARTED|Blinded Phase (Week 16 to Week 44)||585
2278146|NCT02203032|5592489|P3|STARTED|Blinded Phase (Week 16 to Week 44)||133
2278147|NCT02203032|5592490|P2|STARTED|Blinded Phase (Week 16 to Week 44)||135
2278148|NCT02203032|5592491|P1|STARTED|Blinded Phase (Week 16 to Week 44)||0
2278149|NCT02203032|5592488|P4|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
2278150|NCT02203032|5592489|P3|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
2278151|NCT02203032|5592490|P2|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
2278152|NCT02203032|5592491|P1|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||19
2278153|NCT02203032|5592488|P4|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
2278154|NCT02203032|5592489|P3|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
2278155|NCT02203032|5592490|P2|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
2278156|NCT02203032|5592491|P1|COMPLETED|Open Label Run-in (Week 0 to Week 16)||853
2278157|NCT02203032|5592488|P4|Treated|Open Label Run-in (Week 0 to Week 16)||0
2278158|NCT02203032|5592489|P3|Treated|Open Label Run-in (Week 0 to Week 16)||0
2278159|NCT02203032|5592490|P2|Treated|Open Label Run-in (Week 0 to Week 16)||0
2278160|NCT02203032|5592491|P1|Treated|Open Label Run-in (Week 0 to Week 16)||871
2278161|NCT02203032|5592488|P4|STARTED|Open Label Run-in (Week 0 to Week 16)||0
2278162|NCT02203032|5592489|P3|STARTED|Open Label Run-in (Week 0 to Week 16)||0
2278163|NCT02203032|5592490|P2|STARTED|Open Label Run-in (Week 0 to Week 16)||0
2278164|NCT02203032|5592491|P1|STARTED|Open Label Run-in (Week 0 to Week 16)||872
2278165|NCT02202980|5592519|P14|NOT COMPLETED|Overall Study||0
2278166|NCT02202980|5592520|P13|NOT COMPLETED|Overall Study||11
2278167|NCT02202980|5592521|P12|NOT COMPLETED|Overall Study||3
2278168|NCT02202980|5592522|P11|NOT COMPLETED|Overall Study||0
2278169|NCT02202980|5592523|P10|NOT COMPLETED|Overall Study||0
2278170|NCT02202980|5592524|P9|NOT COMPLETED|Overall Study||4
2278171|NCT02202980|5592525|P8|NOT COMPLETED|Overall Study||3
2278172|NCT02202980|5592526|P7|NOT COMPLETED|Overall Study||11
2278173|NCT02202980|5592527|P6|NOT COMPLETED|Overall Study||1
2278174|NCT02202980|5592528|P5|NOT COMPLETED|Overall Study||6
2278175|NCT02202980|5592529|P4|NOT COMPLETED|Overall Study||4
2278176|NCT02202980|5592530|P3|NOT COMPLETED|Overall Study||10
2278177|NCT02202980|5592531|P2|NOT COMPLETED|Overall Study||2
2278178|NCT02202980|5592532|P1|NOT COMPLETED|Overall Study||1
2278179|NCT02202980|5592519|P14|COMPLETED|Overall Study||4
2278180|NCT02202980|5592520|P13|COMPLETED|Overall Study||19
2278181|NCT02202980|5592521|P12|COMPLETED|Overall Study||25
2278182|NCT02202980|5592522|P11|COMPLETED|Overall Study||19
2278183|NCT02202980|5592523|P10|COMPLETED|Overall Study||17
2278184|NCT02202980|5592524|P9|COMPLETED|Overall Study||14
2278185|NCT02202980|5592525|P8|COMPLETED|Overall Study||12
2278186|NCT02202980|5592526|P7|COMPLETED|Overall Study||4
2278187|NCT02202980|5592527|P6|COMPLETED|Overall Study||14
2278188|NCT02202980|5592528|P5|COMPLETED|Overall Study||7
2278189|NCT02202980|5592529|P4|COMPLETED|Overall Study||28
2278190|NCT02202980|5592530|P3|COMPLETED|Overall Study||17
2278191|NCT02202980|5592531|P2|COMPLETED|Overall Study||24
2278192|NCT02202980|5592532|P1|COMPLETED|Overall Study||13
2278193|NCT02202980|5592519|P14|STARTED|Overall Study||4
2278194|NCT02202980|5592520|P13|STARTED|Overall Study||30
2278195|NCT02202980|5592521|P12|STARTED|Overall Study||28
2278196|NCT02202980|5592522|P11|STARTED|Overall Study||19
2278197|NCT02202980|5592523|P10|STARTED|Overall Study||17
2278198|NCT02202980|5592524|P9|STARTED|Overall Study||18
2278199|NCT02202980|5592525|P8|STARTED|Overall Study||15
2278200|NCT02202980|5592526|P7|STARTED|Overall Study||15
2278201|NCT02202980|5592527|P6|STARTED|Overall Study||15
2278202|NCT02202980|5592528|P5|STARTED|Overall Study||13
2278203|NCT02202980|5592529|P4|STARTED|Overall Study||32
2278204|NCT02202980|5592530|P3|STARTED|Overall Study||27
2278205|NCT02202980|5592531|P2|STARTED|Overall Study||26
2278206|NCT02202980|5592532|P1|STARTED|Overall Study||14
2278207|NCT02202850|5592620|P2|NOT COMPLETED|Overall Study||6
2278208|NCT02202850|5592621|P1|NOT COMPLETED|Overall Study||24
2278209|NCT02202850|5592620|P2|COMPLETED|Overall Study||8
2278210|NCT02202850|5592621|P1|COMPLETED|Overall Study||46
2278211|NCT02202850|5592620|P2|STARTED|Overall Study||14
2278212|NCT02202850|5592621|P1|STARTED|Overall Study||70
2278213|NCT02202837|5592673|P2|NOT COMPLETED|Overall Study||5
2278214|NCT02202837|5592674|P1|NOT COMPLETED|Overall Study||53
2278215|NCT02202837|5592673|P2|COMPLETED|Overall Study||12
2278216|NCT02202837|5592674|P1|COMPLETED|Overall Study||87
2278217|NCT02202837|5592673|P2|STARTED|Overall Study||17
2278218|NCT02202837|5592674|P1|STARTED|Overall Study||140
2278219|NCT02202785|5592725|P3|NOT COMPLETED|Overall Study||17
2278220|NCT02202785|5592726|P2|NOT COMPLETED|Overall Study||15
2278221|NCT02202785|5592727|P1|NOT COMPLETED|Overall Study||11
2278222|NCT02202785|5592725|P3|COMPLETED|Overall Study||0
2278223|NCT02202785|5592726|P2|COMPLETED|Overall Study||0
2278224|NCT02202785|5592727|P1|COMPLETED|Overall Study||0
2278225|NCT02202785|5592725|P3|STARTED|Overall Study||17
2278226|NCT02202785|5592726|P2|STARTED|Overall Study||15
2278227|NCT02202785|5592727|P1|STARTED|Overall Study||11
2278228|NCT02202759|5592764|P3|NOT COMPLETED|Overall Study||14
2278229|NCT02202759|5592765|P2|NOT COMPLETED|Overall Study||15
2278230|NCT02202759|5592766|P1|NOT COMPLETED|Overall Study||9
2278231|NCT02202759|5592764|P3|COMPLETED|Overall Study||0
2278232|NCT02202759|5592765|P2|COMPLETED|Overall Study||0
2278233|NCT02202759|5592766|P1|COMPLETED|Overall Study||0
2278234|NCT02202759|5592764|P3|STARTED|Overall Study||14
2278235|NCT02202759|5592765|P2|STARTED|Overall Study||15
2278236|NCT02202759|5592766|P1|STARTED|Overall Study||9
2278237|NCT02202616|5592800|P1|NOT COMPLETED|Overall Study||100
2278238|NCT02202616|5592800|P1|COMPLETED|Overall Study||301
2278239|NCT02202616|5592800|P1|Intent to Treat Set (ITT)|Overall Study||338
2278240|NCT02202616|5592800|P1|STARTED|Overall Study||401
2278241|NCT02202538|5592811|P1|NOT COMPLETED|Overall Study||8
2278242|NCT02202538|5592811|P1|COMPLETED|Overall Study||45
2278243|NCT02202538|5592811|P1|Screen Failure|Overall Study||2
2278244|NCT02202538|5592811|P1|STARTED|Overall Study||53
2278245|NCT02202499|5592825|P3|NOT COMPLETED|Overall Study||2
2278246|NCT02202499|5592826|P2|NOT COMPLETED|Overall Study||0
2278247|NCT02202499|5592827|P1|NOT COMPLETED|Overall Study||2
2278248|NCT02202499|5592825|P3|COMPLETED|Overall Study||19
2278249|NCT02202499|5592826|P2|COMPLETED|Overall Study||20
2278250|NCT02202499|5592827|P1|COMPLETED|Overall Study||19
2278251|NCT02202499|5592825|P3|STARTED|Overall Study||21
2278252|NCT02202499|5592826|P2|STARTED|Overall Study||20
2278253|NCT02202499|5592827|P1|STARTED|Overall Study||21
2278254|NCT02202434|5592854|P4|NOT COMPLETED|Overall Study||37
2278255|NCT02202434|5592855|P3|NOT COMPLETED|Overall Study||15
2278256|NCT02202434|5592856|P2|NOT COMPLETED|Overall Study||69
2278257|NCT02202434|5592857|P1|NOT COMPLETED|Overall Study||109
2278258|NCT02202434|5592854|P4|COMPLETED|Overall Study||258
2278259|NCT02202434|5592855|P3|COMPLETED|Overall Study||87
2278260|NCT02202434|5592856|P2|COMPLETED|Overall Study||236
2278261|NCT02202434|5592857|P1|COMPLETED|Overall Study||498
2278262|NCT02202434|5592854|P4|STARTED|Overall Study||295
2278263|NCT02202434|5592855|P3|STARTED|Overall Study||102
2278264|NCT02202434|5592856|P2|STARTED|Overall Study||305
2278265|NCT02202434|5592857|P1|STARTED|Overall Study||607
2278266|NCT02202317|5592981|P1|NOT COMPLETED|Overall Study||1
2278267|NCT02202317|5592981|P1|COMPLETED|Overall Study||8
2278268|NCT02202317|5592981|P1|STARTED|Overall Study||9
2278269|NCT02202252|5592989|P2|NOT COMPLETED|Overall Study||0
2278270|NCT02202252|5592990|P1|NOT COMPLETED|Overall Study||0
2278271|NCT02202252|5592989|P2|COMPLETED|Overall Study||30
2278272|NCT02202252|5592990|P1|COMPLETED|Overall Study||30
2278273|NCT02202252|5592989|P2|STARTED|Overall Study||30
2278274|NCT02202252|5592990|P1|STARTED|Overall Study||30
2278275|NCT02202161|5593008|P8|NOT COMPLETED|Overall Study||6
2278276|NCT02202161|5593009|P7|NOT COMPLETED|Overall Study||0
2278277|NCT02202161|5593010|P6|NOT COMPLETED|Overall Study||1
2278278|NCT02202161|5593011|P5|NOT COMPLETED|Overall Study||1
2278279|NCT02202161|5593012|P4|NOT COMPLETED|Overall Study||0
2278280|NCT02202161|5593013|P3|NOT COMPLETED|Overall Study||0
2278281|NCT02202161|5593014|P2|NOT COMPLETED|Overall Study||1
2278282|NCT02202161|5593015|P1|NOT COMPLETED|Overall Study||1
2278283|NCT02202161|5593008|P8|COMPLETED|Overall Study||0
2278284|NCT02202161|5593009|P7|COMPLETED|Overall Study||13
2278285|NCT02202161|5593010|P6|COMPLETED|Overall Study||9
2278286|NCT02202161|5593011|P5|COMPLETED|Overall Study||8
2278287|NCT02202161|5593012|P4|COMPLETED|Overall Study||9
2278288|NCT02202161|5593013|P3|COMPLETED|Overall Study||5
2278289|NCT02202161|5593014|P2|COMPLETED|Overall Study||4
2278290|NCT02202161|5593015|P1|COMPLETED|Overall Study||12
2278291|NCT02202161|5593008|P8|STARTED|Overall Study||6
2278292|NCT02202161|5593009|P7|STARTED|Overall Study||13
2278293|NCT02202161|5593010|P6|STARTED|Overall Study||10
2278294|NCT02202161|5593011|P5|STARTED|Overall Study||9
2278295|NCT02202161|5593012|P4|STARTED|Overall Study||9
2278296|NCT02202161|5593013|P3|STARTED|Overall Study||5
2278297|NCT02202161|5593014|P2|STARTED|Overall Study||5
2278298|NCT02202161|5593015|P1|STARTED|Overall Study||13
2278299|NCT02202135|5593169|P1|NOT COMPLETED|Overall Study||0
2278300|NCT02202135|5593169|P1|COMPLETED|Overall Study||4
2278301|NCT02202135|5593169|P1|STARTED|Overall Study||4
2278302|NCT02202109|5593175|P2|NOT COMPLETED|Overall Study||87
2278303|NCT02202109|5593176|P1|NOT COMPLETED|Overall Study||90
2278304|NCT02202109|5593175|P2|COMPLETED|Overall Study||213
2278305|NCT02202109|5593176|P1|COMPLETED|Overall Study||212
2278306|NCT02202109|5593175|P2|STARTED|Overall Study||300
2278307|NCT02202109|5593176|P1|STARTED|Overall Study||302
2278308|NCT02202044|5593186|P1|NOT COMPLETED|Overall Study||0
2278309|NCT02202044|5593186|P1|COMPLETED|Overall Study||0
2278310|NCT02202044|5593186|P1|STARTED|Overall Study||0
2278311|NCT02202031|5593193|P2|NOT COMPLETED|Overall Study||5
2278312|NCT02202031|5593194|P1|NOT COMPLETED|Overall Study||5
2278313|NCT02202031|5593193|P2|COMPLETED|Overall Study||74
2278314|NCT02202031|5593194|P1|COMPLETED|Overall Study||77
2278315|NCT02202031|5593193|P2|STARTED|Overall Study||79
2278316|NCT02202031|5593194|P1|STARTED|Overall Study||82
2278317|NCT02201953|5593242|P2|NOT COMPLETED|Overall Study||56
2278318|NCT02201953|5593243|P1|NOT COMPLETED|Overall Study||20
2278319|NCT02201953|5593242|P2|COMPLETED|Overall Study||224
2278320|NCT02201953|5593243|P1|COMPLETED|Overall Study||258
2278321|NCT02201953|5593242|P2|STARTED|Overall Study||280
2278322|NCT02201953|5593243|P1|STARTED|Overall Study||278
2278323|NCT02201940|5593261|P2|NOT COMPLETED|Overall Study||116
2278324|NCT02201940|5593262|P1|NOT COMPLETED|Overall Study||12
2278325|NCT02201940|5593261|P2|COMPLETED|Overall Study||0
2278326|NCT02201940|5593262|P1|COMPLETED|Overall Study||613
2278327|NCT02201940|5593261|P2|STARTED|Overall Study||116
2278328|NCT02201940|5593262|P1|STARTED|Overall Study||625
2278329|NCT02201901|5593281|P3|NOT COMPLETED|Overall Study||13
2278330|NCT02201901|5593282|P2|NOT COMPLETED|Overall Study||9
2278331|NCT02201901|5593283|P1|NOT COMPLETED|Overall Study||15
2278332|NCT02201901|5593281|P3|COMPLETED|Overall Study||77
2278333|NCT02201901|5593282|P2|COMPLETED|Overall Study||79
2278334|NCT02201901|5593283|P1|COMPLETED|Overall Study||75
2278335|NCT02201901|5593281|P3|STARTED|Overall Study||90
2278336|NCT02201901|5593282|P2|STARTED|Overall Study||88
2278337|NCT02201901|5593283|P1|STARTED|Overall Study||90
2278338|NCT02201784|5593314|P2|NOT COMPLETED|Overall Study||0
2278339|NCT02201784|5593315|P1|NOT COMPLETED|Overall Study||2
2278340|NCT02201784|5593314|P2|COMPLETED|Overall Study||30
2278341|NCT02201784|5593315|P1|COMPLETED|Overall Study||28
2278342|NCT02201784|5593314|P2|STARTED|Overall Study||30
2278343|NCT02201784|5593315|P1|STARTED|Overall Study||30
2278344|NCT02201771|5593332|P3|NOT COMPLETED|Overall Study||10
2278345|NCT02201771|5593333|P2|NOT COMPLETED|Overall Study||10
2278346|NCT02201771|5593334|P1|NOT COMPLETED|Overall Study||13
2278347|NCT02201771|5593332|P3|COMPLETED|Overall Study||156
2278348|NCT02201771|5593333|P2|COMPLETED|Overall Study||158
2278349|NCT02201771|5593334|P1|COMPLETED|Overall Study||153
2278350|NCT02201771|5593332|P3|STARTED|Overall Study||166
2278351|NCT02201771|5593333|P2|STARTED|Overall Study||168
2278352|NCT02201771|5593334|P1|STARTED|Overall Study||166
2278353|NCT02201524|5593361|P4|NOT COMPLETED|Overall Study||4
2278354|NCT02201524|5593362|P3|NOT COMPLETED|Overall Study||4
2278355|NCT02201524|5593363|P2|NOT COMPLETED|Overall Study||3
2278356|NCT02201524|5593364|P1|NOT COMPLETED|Overall Study||2
2278357|NCT02201524|5593361|P4|COMPLETED|Overall Study||10
2278358|NCT02201524|5593362|P3|COMPLETED|Overall Study||12
2278359|NCT02201524|5593363|P2|COMPLETED|Overall Study||12
2278360|NCT02201524|5593364|P1|COMPLETED|Overall Study||12
2278361|NCT02201524|5593361|P4|STARTED|Overall Study||14
2278362|NCT02201524|5593362|P3|STARTED|Overall Study||16
2278363|NCT02201524|5593363|P2|STARTED|Overall Study||15
2278364|NCT02201524|5593364|P1|STARTED|Overall Study||14
2278365|NCT02201446|5593448|P2|NOT COMPLETED|Overall Study||0
2278366|NCT02201446|5593449|P1|NOT COMPLETED|Overall Study||0
2278367|NCT02201446|5593448|P2|COMPLETED|Overall Study||58
2278368|NCT02201446|5593449|P1|COMPLETED|Overall Study||81
2278369|NCT02201446|5593448|P2|STARTED|Overall Study||58
2278370|NCT02201446|5593449|P1|STARTED|Overall Study||81
2278371|NCT02201420|5593477|P1|NOT COMPLETED|Overall Study||0
2278372|NCT02201420|5593477|P1|COMPLETED|Overall Study||5
2278373|NCT02201420|5593477|P1|STARTED|Overall Study||5
2278374|NCT02201394|5593482|P1|NOT COMPLETED|Maintenance Dose||0
2278375|NCT02201394|5593482|P1|COMPLETED|Maintenance Dose||20
2278376|NCT02201394|5593482|P1|STARTED|Maintenance Dose||20
2278377|NCT02201394|5593482|P1|NOT COMPLETED|Loading Dose||0
2278378|NCT02201394|5593482|P1|COMPLETED|Loading Dose||20
2278379|NCT02201394|5593482|P1|STARTED|Loading Dose||20
2278380|NCT02201329|5593489|P1|NOT COMPLETED|Overall Study||5
2278381|NCT02201329|5593489|P1|COMPLETED|Overall Study||0
2278382|NCT02201329|5593489|P1|STARTED|Overall Study||5
2278383|NCT02201290|5593497|P1|NOT COMPLETED|Overall Study||5
2278384|NCT02201290|5593497|P1|COMPLETED|Overall Study||4
2278385|NCT02201290|5593497|P1|STARTED|Overall Study||9
2278386|NCT02201277|5593503|P2|NOT COMPLETED|Overall Study||5
2278387|NCT02201277|5593504|P1|NOT COMPLETED|Overall Study||7
2278388|NCT02201277|5593503|P2|COMPLETED|Overall Study||16
2278389|NCT02201277|5593504|P1|COMPLETED|Overall Study||17
2278390|NCT02201277|5593503|P2|Failed Retrieval (Referred Elsewhere)|Overall Study||0
2278391|NCT02201277|5593504|P1|Failed Retrieval (Referred Elsewhere)|Overall Study||1
2278392|NCT02201277|5593503|P2|Complicated Retrieval|Overall Study||0
2278393|NCT02201277|5593504|P1|Complicated Retrieval|Overall Study||2
2278394|NCT02201277|5593503|P2|Death (Before Removal)|Overall Study||4
2278395|NCT02201277|5593504|P1|Death (Before Removal)|Overall Study||3
2278396|NCT02201277|5593503|P2|Lost to Follow up|Overall Study||1
2278397|NCT02201277|5593504|P1|Lost to Follow up|Overall Study||2
2278398|NCT02201277|5593503|P2|Filter Ruled to be Permanent|Overall Study||2
2278399|NCT02201277|5593504|P1|Filter Ruled to be Permanent|Overall Study||2
2278400|NCT02201277|5593503|P2|Signed ICF But Did Not Enroll|Overall Study||1
2278401|NCT02201277|5593504|P1|Signed ICF But Did Not Enroll|Overall Study|Physician had preference for a specific filter so patient not randomized.|0
2278402|NCT02201277|5593503|P2|Filter Retrieval|Overall Study||16
2278403|NCT02201277|5593504|P1|Filter Retrieval|Overall Study||17
2278404|NCT02201277|5593503|P2|STARTED|Overall Study|1 patient was withdrawn after signing consent due to physician preference for the option filter.|21
2278405|NCT02201277|5593504|P1|STARTED|Overall Study|24 patients were consented but 1 patient had denali filter placed twice.|24
2278406|NCT02201056|5593531|P7|NOT COMPLETED|Overall Study||0
2278407|NCT02201056|5593532|P6|NOT COMPLETED|Overall Study||0
2278408|NCT02201056|5593533|P5|NOT COMPLETED|Overall Study||0
2278409|NCT02201056|5593534|P4|NOT COMPLETED|Overall Study||0
2278410|NCT02201056|5593535|P3|NOT COMPLETED|Overall Study||0
2278411|NCT02201056|5593536|P2|NOT COMPLETED|Overall Study||0
2278412|NCT02201056|5593537|P1|NOT COMPLETED|Overall Study||0
2278413|NCT02201056|5593531|P7|COMPLETED|Overall Study||6
2278414|NCT02201056|5593532|P6|COMPLETED|Overall Study||6
2278415|NCT02201056|5593533|P5|COMPLETED|Overall Study||6
2278416|NCT02201056|5593534|P4|COMPLETED|Overall Study||6
2278417|NCT02201056|5593535|P3|COMPLETED|Overall Study||6
2278418|NCT02201056|5593536|P2|COMPLETED|Overall Study||6
2278419|NCT02201056|5593537|P1|COMPLETED|Overall Study||12
2278420|NCT02201056|5593531|P7|STARTED|Overall Study||6
2278421|NCT02201056|5593532|P6|STARTED|Overall Study||6
2278422|NCT02201056|5593533|P5|STARTED|Overall Study||6
2278423|NCT02201056|5593534|P4|STARTED|Overall Study||6
2278424|NCT02201056|5593535|P3|STARTED|Overall Study||6
2278425|NCT02201056|5593536|P2|STARTED|Overall Study||6
2278426|NCT02201056|5593537|P1|STARTED|Overall Study||12
2278427|NCT02200770|5593594|P2|NOT COMPLETED|Open-label Period (OLP)||162
2278428|NCT02200770|5593595|P1|NOT COMPLETED|Open-label Period (OLP)||51
2278429|NCT02200770|5593594|P2|COMPLETED|Open-label Period (OLP)||0
2278430|NCT02200770|5593595|P1|COMPLETED|Open-label Period (OLP)||0
2278431|NCT02200770|5593594|P2|STARTED|Open-label Period (OLP)|Enrolment into OLP was optional; out of 169 participants who completed RCP, only 162 entered in OLP.|162
2278432|NCT02200770|5593595|P1|STARTED|Open-label Period (OLP)|Enrolment into OLP was optional; out of 54 participants who completed RCP, only 51 entered in OLP.|51
2278433|NCT02200770|5593594|P2|NOT COMPLETED|Randomized-controlled Period (RCP)||6
2278434|NCT02200770|5593595|P1|NOT COMPLETED|Randomized-controlled Period (RCP)||2
2278435|NCT02200770|5593594|P2|COMPLETED|Randomized-controlled Period (RCP)||169
2278436|NCT02200770|5593595|P1|COMPLETED|Randomized-controlled Period (RCP)||54
2278437|NCT02200770|5593594|P2|Treated|Randomized-controlled Period (RCP)||174
2278438|NCT02200770|5593595|P1|Treated|Randomized-controlled Period (RCP)||56
2278439|NCT02200770|5593594|P2|STARTED|Randomized-controlled Period (RCP)||175
2278440|NCT02200770|5593595|P1|STARTED|Randomized-controlled Period (RCP)||56
2278457|NCT02200536|5593644|P3|NOT COMPLETED|Overall Study||0
2278458|NCT02200536|5593645|P2|NOT COMPLETED|Overall Study||0
2278459|NCT02200536|5593646|P1|NOT COMPLETED|Overall Study||0
2278460|NCT02200536|5593644|P3|COMPLETED|Overall Study||30
2278461|NCT02200536|5593645|P2|COMPLETED|Overall Study||30
2278462|NCT02200536|5593646|P1|COMPLETED|Overall Study||32
2278463|NCT02200536|5593644|P3|STARTED|Overall Study||30
2278464|NCT02200536|5593645|P2|STARTED|Overall Study||30
2278465|NCT02200536|5593646|P1|STARTED|Overall Study||32
2278466|NCT02200510|5593659|P2|NOT COMPLETED|Overall Study||3
2278467|NCT02200510|5593660|P1|NOT COMPLETED|Overall Study||9
2278468|NCT02200510|5593659|P2|COMPLETED|Overall Study|This number is the number of participants with both baseline and post data.|44
2278469|NCT02200510|5593660|P1|COMPLETED|Overall Study|This is the number of participants with baseline and post data.|22
2278470|NCT02200510|5593659|P2|STARTED|Overall Study|Number who only completed portal or completed it before self-management (could do 6 months later).|47
2278471|NCT02200510|5593660|P1|STARTED|Overall Study|Number who only completed self-management or completed it before portal (could do 6 months later).|31
2278472|NCT02200458|5593666|P1|NOT COMPLETED|Overall Study||0
2278473|NCT02200458|5593666|P1|COMPLETED|Overall Study||62
2278474|NCT02200458|5593666|P1|STARTED|Overall Study||62
2278475|NCT02200328|5593672|P2|NOT COMPLETED|Overall Study||33
2278476|NCT02200328|5593673|P1|NOT COMPLETED|Overall Study||43
2278477|NCT02200328|5593672|P2|COMPLETED|Overall Study||0
2278478|NCT02200328|5593673|P1|COMPLETED|Overall Study||0
2278479|NCT02200328|5593672|P2|STARTED|Overall Study||33
2278480|NCT02200328|5593673|P1|STARTED|Overall Study||43
2278481|NCT02200211|5593685|P4|NOT COMPLETED|Overall Study||2
2278482|NCT02200211|5593686|P3|NOT COMPLETED|Overall Study||1
2278483|NCT02200211|5593687|P2|NOT COMPLETED|Overall Study||7
2278484|NCT02200211|5593688|P1|NOT COMPLETED|Overall Study||8
2278485|NCT02200211|5593685|P4|COMPLETED|Overall Study||58
2278486|NCT02200211|5593686|P3|COMPLETED|Overall Study||39
2278487|NCT02200211|5593687|P2|COMPLETED|Overall Study||188
2278488|NCT02200211|5593688|P1|COMPLETED|Overall Study||182
2278489|NCT02200211|5593685|P4|Included in 16-week Primary Analysis|Overall Study||56
2278490|NCT02200211|5593686|P3|Included in 16-week Primary Analysis|Overall Study||39
2278491|NCT02200211|5593687|P2|Included in 16-week Primary Analysis|Overall Study||186
2278492|NCT02200211|5593688|P1|Included in 16-week Primary Analysis|Overall Study||177
2278493|NCT02200211|5593685|P4|STARTED|Overall Study||60
2278494|NCT02200211|5593686|P3|STARTED|Overall Study||40
2278495|NCT02200211|5593687|P2|STARTED|Overall Study||195
2278496|NCT02200211|5593688|P1|STARTED|Overall Study||190
2278497|NCT02200055|5593784|P1|NOT COMPLETED|Overall Study||0
2278498|NCT02200055|5593784|P1|COMPLETED|Overall Study||86
2278499|NCT02200055|5593784|P1|STARTED|Overall Study||86
2278500|NCT02200042|5593801|P2|NOT COMPLETED|Overall Study||1
2278501|NCT02200042|5593802|P1|NOT COMPLETED|Overall Study||0
2278502|NCT02200042|5593801|P2|COMPLETED|Overall Study||0
2278503|NCT02200042|5593802|P1|COMPLETED|Overall Study||0
2278504|NCT02200042|5593801|P2|STARTED|Overall Study||1
2278505|NCT02200042|5593802|P1|STARTED|Overall Study||0
2278512|NCT02199795|5593831|P2|NOT COMPLETED|Overall Study||0
2278513|NCT02199795|5593832|P1|NOT COMPLETED|Overall Study||2
2278514|NCT02199795|5593831|P2|COMPLETED|Overall Study||3
2278515|NCT02199795|5593832|P1|COMPLETED|Overall Study||2
2278516|NCT02199795|5593831|P2|STARTED|Overall Study||3
2278517|NCT02199795|5593832|P1|STARTED|Overall Study||4
2278518|NCT02199717|5593844|P1|NOT COMPLETED|Overall Study||0
2278519|NCT02199717|5593844|P1|COMPLETED|Overall Study||66
2278520|NCT02199717|5593844|P1|STARTED|Overall Study||66
2278521|NCT02199652|5593853|P2|NOT COMPLETED|Overall Study||7
2278522|NCT02199652|5593854|P1|NOT COMPLETED|Overall Study||7
2278523|NCT02199652|5593853|P2|COMPLETED|Overall Study||3
2278524|NCT02199652|5593854|P1|COMPLETED|Overall Study||3
2278525|NCT02199652|5593853|P2|STARTED|Overall Study||10
2278526|NCT02199652|5593854|P1|STARTED|Overall Study||10
2278527|NCT02199574|5593864|P1|NOT COMPLETED|Overall Study||0
2278528|NCT02199574|5593864|P1|COMPLETED|Overall Study||12
2278529|NCT02199574|5593864|P1|STARTED|Overall Study||12
2278530|NCT02199509|5593873|P2|NOT COMPLETED|Overall Study||1
2278531|NCT02199509|5593874|P1|NOT COMPLETED|Overall Study||1
2278532|NCT02199509|5593873|P2|COMPLETED|Overall Study||3
2278533|NCT02199509|5593874|P1|COMPLETED|Overall Study||2
2278534|NCT02199509|5593873|P2|STARTED|Overall Study||4
2278535|NCT02199509|5593874|P1|STARTED|Overall Study||3
2278536|NCT02199197|5593888|P2|NOT COMPLETED|Overall Study||2
2278537|NCT02199197|5593889|P1|NOT COMPLETED|Overall Study||0
2278538|NCT02199197|5593888|P2|COMPLETED|Overall Study||12
2278539|NCT02199197|5593889|P1|COMPLETED|Overall Study||35
2278540|NCT02199197|5593888|P2|STARTED|Overall Study||14
2278541|NCT02199197|5593889|P1|STARTED|Overall Study||35
2278542|NCT02199080|5593897|P1|NOT COMPLETED|Overall Study||12
2278543|NCT02199080|5593897|P1|COMPLETED|Overall Study||2494
2278544|NCT02199080|5593897|P1|STARTED|Overall Study||2506
2278545|NCT02199041|5593907|P1|NOT COMPLETED|Overall Study||0
2278546|NCT02199041|5593907|P1|COMPLETED|Overall Study||12
2278547|NCT02199041|5593907|P1|STARTED|Overall Study||12
2278548|NCT02199028|5593922|P2|NOT COMPLETED|Week 4||0
2278549|NCT02199028|5593923|P1|NOT COMPLETED|Week 4||0
2278550|NCT02199028|5593922|P2|COMPLETED|Week 4||15
2278551|NCT02199028|5593923|P1|COMPLETED|Week 4||13
2278552|NCT02199028|5593922|P2|STARTED|Week 4||15
2278553|NCT02199028|5593923|P1|STARTED|Week 4||13
2278554|NCT02199028|5593922|P2|NOT COMPLETED|Week 3||0
2278555|NCT02199028|5593923|P1|NOT COMPLETED|Week 3||1
2278556|NCT02199028|5593922|P2|COMPLETED|Week 3||15
2278557|NCT02199028|5593923|P1|COMPLETED|Week 3||13
2278558|NCT02199028|5593922|P2|STARTED|Week 3||15
2278559|NCT02199028|5593923|P1|STARTED|Week 3||14
2278560|NCT02199028|5593922|P2|NOT COMPLETED|Week 2||0
2278561|NCT02199028|5593923|P1|NOT COMPLETED|Week 2||0
2278562|NCT02199028|5593922|P2|COMPLETED|Week 2||15
2278563|NCT02199028|5593923|P1|COMPLETED|Week 2||14
2278564|NCT02199028|5593922|P2|STARTED|Week 2||15
2278565|NCT02199028|5593923|P1|STARTED|Week 2||14
2278566|NCT02199028|5593922|P2|NOT COMPLETED|Week 1||0
2278567|NCT02199028|5593923|P1|NOT COMPLETED|Week 1||1
2278568|NCT02199028|5593922|P2|COMPLETED|Week 1||15
2278569|NCT02199028|5593923|P1|COMPLETED|Week 1||14
2278570|NCT02199028|5593922|P2|STARTED|Week 1||15
2278571|NCT02199028|5593923|P1|STARTED|Week 1||15
2278572|NCT02198963|5593932|P1|NOT COMPLETED|Overall Study||7
2278573|NCT02198963|5593932|P1|COMPLETED|Overall Study||36
2278574|NCT02198963|5593932|P1|STARTED|Overall Study||43
2278575|NCT02198833|5593943|P2|NOT COMPLETED|Overall Study||0
2278576|NCT02198833|5593944|P1|NOT COMPLETED|Overall Study||0
2278577|NCT02198833|5593943|P2|COMPLETED|Overall Study||1
2278578|NCT02198833|5593944|P1|COMPLETED|Overall Study||1
2278579|NCT02198833|5593943|P2|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed.|1
2278580|NCT02198833|5593944|P1|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed|1
2278581|NCT02198651|5593956|P5|NOT COMPLETED|Open-label Rescue Period||0
2278582|NCT02198651|5593957|P4|NOT COMPLETED|Open-label Rescue Period||3
2278583|NCT02198651|5593958|P3|NOT COMPLETED|Open-label Rescue Period||0
2278584|NCT02198651|5593959|P2|NOT COMPLETED|Open-label Rescue Period||0
2278585|NCT02198651|5593960|P1|NOT COMPLETED|Open-label Rescue Period||0
2278586|NCT02198651|5593956|P5|COMPLETED|Open-label Rescue Period||8
2278587|NCT02198651|5593957|P4|COMPLETED|Open-label Rescue Period||28
2278588|NCT02198651|5593958|P3|COMPLETED|Open-label Rescue Period||0
2278589|NCT02198651|5593959|P2|COMPLETED|Open-label Rescue Period||0
2278590|NCT02198651|5593960|P1|COMPLETED|Open-label Rescue Period||0
2278591|NCT02198651|5593956|P5|Correctly Entered Open-label Rescue|Open-label Rescue Period||8
2278592|NCT02198651|5593957|P4|Correctly Entered Open-label Rescue|Open-label Rescue Period||30
2278593|NCT02198651|5593958|P3|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
2278594|NCT02198651|5593959|P2|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
2278595|NCT02198651|5593960|P1|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
2278596|NCT02198651|5593956|P5|STARTED|Open-label Rescue Period||8
2278597|NCT02198651|5593957|P4|STARTED|Open-label Rescue Period||31
2278598|NCT02198651|5593958|P3|STARTED|Open-label Rescue Period||0
2278599|NCT02198651|5593959|P2|STARTED|Open-label Rescue Period||0
2278600|NCT02198651|5593960|P1|STARTED|Open-label Rescue Period||0
2278601|NCT02198651|5593956|P5|NOT COMPLETED|Double-blind Period||0
2278602|NCT02198651|5593957|P4|NOT COMPLETED|Double-blind Period||0
2278603|NCT02198651|5593958|P3|NOT COMPLETED|Double-blind Period||1
2278604|NCT02198651|5593959|P2|NOT COMPLETED|Double-blind Period||9
2278605|NCT02198651|5593960|P1|NOT COMPLETED|Double-blind Period||0
2278606|NCT02198651|5593956|P5|COMPLETED|Double-blind Period||0
2278607|NCT02198651|5593957|P4|COMPLETED|Double-blind Period||0
2278608|NCT02198651|5593958|P3|COMPLETED|Double-blind Period||19
2278609|NCT02198651|5593959|P2|COMPLETED|Double-blind Period||93
2278610|NCT02198651|5593960|P1|COMPLETED|Double-blind Period||0
2278611|NCT02198651|5593956|P5|STARTED|Double-blind Period||0
2278612|NCT02198651|5593957|P4|STARTED|Double-blind Period||0
2278613|NCT02198651|5593958|P3|STARTED|Double-blind Period||20
2278614|NCT02198651|5593959|P2|STARTED|Double-blind Period||102
2278615|NCT02198651|5593960|P1|STARTED|Double-blind Period||0
2278616|NCT02198651|5593956|P5|NOT COMPLETED|Lead-in Period||0
2278617|NCT02198651|5593957|P4|NOT COMPLETED|Lead-in Period||0
2278618|NCT02198651|5593958|P3|NOT COMPLETED|Lead-in Period||0
2278619|NCT02198651|5593959|P2|NOT COMPLETED|Lead-in Period||0
2278620|NCT02198651|5593960|P1|NOT COMPLETED|Lead-in Period||37
2278621|NCT02198651|5593956|P5|COMPLETED|Lead-in Period||0
2278622|NCT02198651|5593957|P4|COMPLETED|Lead-in Period||0
2278623|NCT02198651|5593958|P3|COMPLETED|Lead-in Period||0
2278624|NCT02198651|5593959|P2|COMPLETED|Lead-in Period||0
2278625|NCT02198651|5593960|P1|COMPLETED|Lead-in Period||112
2278626|NCT02198651|5593956|P5|Participants Treated in Lead-In Period|Lead-in Period||0
2278627|NCT02198651|5593957|P4|Participants Treated in Lead-In Period|Lead-in Period||0
2278628|NCT02198651|5593958|P3|Participants Treated in Lead-In Period|Lead-in Period||0
2278629|NCT02198651|5593959|P2|Participants Treated in Lead-In Period|Lead-in Period||0
2278630|NCT02198651|5593960|P1|Participants Treated in Lead-In Period|Lead-in Period||146
2278631|NCT02198651|5593956|P5|STARTED|Lead-in Period||0
2278632|NCT02198651|5593957|P4|STARTED|Lead-in Period||0
2278633|NCT02198651|5593958|P3|STARTED|Lead-in Period||0
2278634|NCT02198651|5593959|P2|STARTED|Lead-in Period||0
2278635|NCT02198651|5593960|P1|STARTED|Lead-in Period||149
2278636|NCT02198430|5594045|P2|NOT COMPLETED|Overall Study||0
2278637|NCT02198430|5594046|P1|NOT COMPLETED|Overall Study||0
2278638|NCT02198430|5594045|P2|COMPLETED|Overall Study||51
2278639|NCT02198430|5594046|P1|COMPLETED|Overall Study||53
2278640|NCT02198430|5594045|P2|STARTED|Overall Study||51
2278641|NCT02198430|5594046|P1|STARTED|Overall Study||53
2278642|NCT02198235|5594061|P3|NOT COMPLETED|Overall Study||2
2278643|NCT02198235|5594062|P2|NOT COMPLETED|Overall Study||2
2278644|NCT02198235|5594063|P1|NOT COMPLETED|Overall Study||3
2278645|NCT02198235|5594061|P3|COMPLETED|Overall Study||28
2278646|NCT02198235|5594062|P2|COMPLETED|Overall Study||28
2278647|NCT02198235|5594063|P1|COMPLETED|Overall Study||27
2278648|NCT02198235|5594061|P3|STARTED|Overall Study||30
2278649|NCT02198235|5594062|P2|STARTED|Overall Study||30
2278650|NCT02198235|5594063|P1|STARTED|Overall Study||30
2278651|NCT02198040|5594083|P3|NOT COMPLETED|Overall Study||1
2278652|NCT02198040|5594084|P2|NOT COMPLETED|Overall Study||1
2278653|NCT02198040|5594085|P1|NOT COMPLETED|Overall Study||0
2278654|NCT02198040|5594083|P3|COMPLETED|Overall Study||8
2278655|NCT02198040|5594084|P2|COMPLETED|Overall Study||8
2278656|NCT02198040|5594085|P1|COMPLETED|Overall Study||9
2278657|NCT02198040|5594083|P3|STARTED|Overall Study||9
2278658|NCT02198040|5594084|P2|STARTED|Overall Study||9
2278659|NCT02198040|5594085|P1|STARTED|Overall Study||9
2278660|NCT02197806|5594115|P4|NOT COMPLETED|Overall Study||1
2278661|NCT02197806|5594116|P3|NOT COMPLETED|Overall Study||0
2278662|NCT02197806|5594117|P2|NOT COMPLETED|Overall Study||1
2278663|NCT02197806|5594118|P1|NOT COMPLETED|Overall Study||0
2278664|NCT02197806|5594115|P4|COMPLETED|Overall Study||16
2278665|NCT02197806|5594116|P3|COMPLETED|Overall Study||16
2278666|NCT02197806|5594117|P2|COMPLETED|Overall Study||16
2278667|NCT02197806|5594118|P1|COMPLETED|Overall Study||15
2278668|NCT02197806|5594115|P4|STARTED|Overall Study||17
2278669|NCT02197806|5594116|P3|STARTED|Overall Study||16
2278670|NCT02197806|5594117|P2|STARTED|Overall Study||17
2278671|NCT02197806|5594118|P1|STARTED|Overall Study||15
2278672|NCT02197767|5594128|P1|NOT COMPLETED|Overall Study||0
2278673|NCT02197767|5594128|P1|COMPLETED|Overall Study||11
2278674|NCT02197767|5594128|P1|STARTED|Overall Study||11
2278675|NCT02197520|5594133|P2|NOT COMPLETED|Period 2||2
2278676|NCT02197520|5594134|P1|NOT COMPLETED|Period 2||1
2278677|NCT02197520|5594133|P2|COMPLETED|Period 2||10
2278678|NCT02197520|5594134|P1|COMPLETED|Period 2||10
2278679|NCT02197520|5594133|P2|STARTED|Period 2||12
2278680|NCT02197520|5594134|P1|STARTED|Period 2||11
2278681|NCT02197520|5594133|P2|NOT COMPLETED|Period 1||0
2278682|NCT02197520|5594134|P1|NOT COMPLETED|Period 1||1
2278683|NCT02197520|5594133|P2|COMPLETED|Period 1||12
2278684|NCT02197520|5594134|P1|COMPLETED|Period 1||11
2278685|NCT02197520|5594133|P2|STARTED|Period 1||12
2278686|NCT02197520|5594134|P1|STARTED|Period 1||12
2278687|NCT02197481|5594152|P2|NOT COMPLETED|Overall Study||0
2278688|NCT02197481|5594153|P1|NOT COMPLETED|Overall Study||0
2278689|NCT02197481|5594152|P2|COMPLETED|Overall Study||43
2278690|NCT02197481|5594153|P1|COMPLETED|Overall Study|February 2016|43
2278691|NCT02197481|5594152|P2|STARTED|Overall Study||43
2278692|NCT02197481|5594153|P1|STARTED|Overall Study|October 2014|43
2278693|NCT02197455|5594173|P1|NOT COMPLETED|Overall Study||0
2278694|NCT02197455|5594173|P1|COMPLETED|Overall Study||30
2278695|NCT02197455|5594173|P1|STARTED|Overall Study||30
2278696|NCT02197377|5594180|P2|NOT COMPLETED|Overall Study||3
2278697|NCT02197377|5594181|P1|NOT COMPLETED|Overall Study||0
2278698|NCT02197377|5594180|P2|COMPLETED|Overall Study||27
2278699|NCT02197377|5594181|P1|COMPLETED|Overall Study||30
2278700|NCT02197377|5594180|P2|STARTED|Overall Study||30
2278701|NCT02197377|5594181|P1|STARTED|Overall Study||30
2278702|NCT02197273|5594191|P2|NOT COMPLETED|Overall Study||0
2278703|NCT02197273|5594192|P1|NOT COMPLETED|Overall Study||0
2278704|NCT02197273|5594191|P2|COMPLETED|Overall Study||104
2278705|NCT02197273|5594192|P1|COMPLETED|Overall Study||107
2278706|NCT02197273|5594191|P2|STARTED|Overall Study||104
2278707|NCT02197273|5594192|P1|STARTED|Overall Study||107
2278708|NCT02197247|5594202|P1|NOT COMPLETED|Part B: Day 78 to End Part B (AZD9291)||15
2278709|NCT02197247|5594202|P1|COMPLETED|Part B: Day 78 to End Part B (AZD9291)||19
2278710|NCT02197247|5594202|P1|STARTED|Part B: Day 78 to End Part B (AZD9291)|32 completed Part A + 2 entered Part B without completing Part A (both due to AE) =34 started Part B|34
2278711|NCT02197247|5594202|P1|NOT COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||5
2278712|NCT02197247|5594202|P1|COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||32
2278713|NCT02197247|5594202|P1|STARTED|Part A: Day 50-77 (AZD9291 Alone)||37
2278714|NCT02197247|5594202|P1|NOT COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||4
2278715|NCT02197247|5594202|P1|COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||37
2278716|NCT02197247|5594202|P1|STARTED|Part A: Day 29-49 (AZD9291+Rifampicin)||41
2278717|NCT02197247|5594202|P1|NOT COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||0
2278718|NCT02197247|5594202|P1|COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||41
2278719|NCT02197247|5594202|P1|STARTED|Part A: Day 1-28 (AZD9291 Alone)||41
2278720|NCT02197234|5594247|P1|NOT COMPLETED|Part B: Day 33 to End Part B (AZD9291)||30
2278721|NCT02197234|5594247|P1|COMPLETED|Part B: Day 33 to End Part B (AZD9291)||20
2278722|NCT02197234|5594247|P1|STARTED|Part B: Day 33 to End Part B (AZD9291)|49 completed Part A + 1 entered Part B without completing Part A (due to AE) = 50 started Part B|50
2278723|NCT02197234|5594247|P1|NOT COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||0
2278724|NCT02197234|5594247|P1|COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
2278725|NCT02197234|5594247|P1|STARTED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
2278726|NCT02197234|5594247|P1|NOT COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||3
2278727|NCT02197234|5594247|P1|COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||49
2278728|NCT02197234|5594247|P1|STARTED|Part A: Day 3-30 (AZD9291 Alone)||52
2278729|NCT02197234|5594247|P1|NOT COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||0
2278730|NCT02197234|5594247|P1|COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||52
2278731|NCT02197234|5594247|P1|STARTED|Part A: Day 1-2 (Simvastatin Alone)||52
2278732|NCT02197130|5594269|P3|NOT COMPLETED|Overall Study||32
2278733|NCT02197130|5594270|P2|NOT COMPLETED|Overall Study||8
2278734|NCT02197130|5594271|P1|NOT COMPLETED|Overall Study||16
2278735|NCT02197130|5594269|P3|COMPLETED|Overall Study||56
2278736|NCT02197130|5594270|P2|COMPLETED|Overall Study||81
2278737|NCT02197130|5594271|P1|COMPLETED|Overall Study||79
2278738|NCT02197130|5594269|P3|Received Treatment|Overall Study||87
2278739|NCT02197130|5594270|P2|Received Treatment|Overall Study||88
2278740|NCT02197130|5594271|P1|Received Treatment|Overall Study||95
2278741|NCT02197130|5594269|P3|STARTED|Overall Study||88
2278742|NCT02197130|5594270|P2|STARTED|Overall Study||89
2278743|NCT02197130|5594271|P1|STARTED|Overall Study||95
2278744|NCT02197065|5594323|P2|NOT COMPLETED|Overall Study||0
2278745|NCT02197065|5594324|P1|NOT COMPLETED|Overall Study||0
2278746|NCT02197065|5594323|P2|COMPLETED|Overall Study||10
2278747|NCT02197065|5594324|P1|COMPLETED|Overall Study||10
2278748|NCT02197065|5594323|P2|STARTED|Overall Study||10
2278749|NCT02197065|5594324|P1|STARTED|Overall Study||10
2278750|NCT02196922|5594335|P2|NOT COMPLETED|Overall Study||0
2278751|NCT02196922|5594336|P1|NOT COMPLETED|Overall Study||0
2278752|NCT02196922|5594335|P2|COMPLETED|Overall Study||46
2278753|NCT02196922|5594336|P1|COMPLETED|Overall Study||58
2278754|NCT02196922|5594335|P2|STARTED|Overall Study||46
2278755|NCT02196922|5594336|P1|STARTED|Overall Study||58
2278756|NCT02196857|5594346|P1|NOT COMPLETED|Overall Study||0
2278757|NCT02196857|5594346|P1|COMPLETED|Overall Study||16
2278758|NCT02196857|5594346|P1|STARTED|Overall Study||16
2278759|NCT02196831|5594353|P2|NOT COMPLETED|Overall Study||4
2278760|NCT02196831|5594354|P1|NOT COMPLETED|Overall Study||9
2278761|NCT02196831|5594353|P2|COMPLETED|Overall Study||26
2278762|NCT02196831|5594354|P1|COMPLETED|Overall Study||21
2278763|NCT02196831|5594353|P2|Received Follow-up Imaging|Overall Study||28
2278764|NCT02196831|5594354|P1|Received Follow-up Imaging|Overall Study||26
2278765|NCT02196831|5594353|P2|STARTED|Overall Study||30
2278766|NCT02196831|5594354|P1|STARTED|Overall Study||30
2278767|NCT02196766|5594367|P2|NOT COMPLETED|Second Intervention (7 Days)||0
2278768|NCT02196766|5594368|P1|NOT COMPLETED|Second Intervention (7 Days)||0
2278769|NCT02196766|5594367|P2|COMPLETED|Second Intervention (7 Days)||15
2278770|NCT02196766|5594368|P1|COMPLETED|Second Intervention (7 Days)||15
2278771|NCT02196766|5594367|P2|STARTED|Second Intervention (7 Days)||15
2278772|NCT02196766|5594368|P1|STARTED|Second Intervention (7 Days)||15
2278773|NCT02196766|5594367|P2|NOT COMPLETED|First Intervention (7 Days)||0
2278774|NCT02196766|5594368|P1|NOT COMPLETED|First Intervention (7 Days)||0
2278775|NCT02196766|5594367|P2|COMPLETED|First Intervention (7 Days)||15
2278776|NCT02196766|5594368|P1|COMPLETED|First Intervention (7 Days)||15
2278777|NCT02196766|5594367|P2|STARTED|First Intervention (7 Days)||15
2278778|NCT02196766|5594368|P1|STARTED|First Intervention (7 Days)||15
2278779|NCT02196714|5594384|P4|NOT COMPLETED|Overall Study||0
2278780|NCT02196714|5594385|P3|NOT COMPLETED|Overall Study||1
2278781|NCT02196714|5594386|P2|NOT COMPLETED|Overall Study||0
2278782|NCT02196714|5594387|P1|NOT COMPLETED|Overall Study||0
2278783|NCT02196714|5594384|P4|COMPLETED|Overall Study||24
2278784|NCT02196714|5594385|P3|COMPLETED|Overall Study||23
2278785|NCT02196714|5594386|P2|COMPLETED|Overall Study||23
2278786|NCT02196714|5594387|P1|COMPLETED|Overall Study||24
2278787|NCT02196714|5594384|P4|STARTED|Overall Study||24
2278788|NCT02196714|5594385|P3|STARTED|Overall Study||24
2278789|NCT02196714|5594386|P2|STARTED|Overall Study||23
2278790|NCT02196714|5594387|P1|STARTED|Overall Study||24
2278791|NCT02196701|5594509|P1|NOT COMPLETED|Overall Study||3
2278792|NCT02196701|5594509|P1|COMPLETED|Overall Study||43
2278793|NCT02196701|5594509|P1|STARTED|Overall Study||46
2278794|NCT02196688|5594567|P2|NOT COMPLETED|Overall Study||1
2278795|NCT02196688|5594568|P1|NOT COMPLETED|Overall Study||7
2278796|NCT02196688|5594567|P2|COMPLETED|Overall Study||23
2278797|NCT02196688|5594568|P1|COMPLETED|Overall Study||40
2278798|NCT02196688|5594567|P2|STARTED|Overall Study||24
2278799|NCT02196688|5594568|P1|STARTED|Overall Study||47
2278800|NCT02196675|5594583|P3|NOT COMPLETED|Overall Study||1
2278801|NCT02196675|5594584|P2|NOT COMPLETED|Overall Study||2
2278802|NCT02196675|5594585|P1|NOT COMPLETED|Overall Study||2
2278803|NCT02196675|5594583|P3|COMPLETED|Overall Study||7
2278804|NCT02196675|5594584|P2|COMPLETED|Overall Study||68
2278805|NCT02196675|5594585|P1|COMPLETED|Overall Study||25
2278806|NCT02196675|5594583|P3|STARTED|Overall Study||8
2278807|NCT02196675|5594584|P2|STARTED|Overall Study||70
2278808|NCT02196675|5594585|P1|STARTED|Overall Study||27
2278809|NCT02196506|5594607|P4|NOT COMPLETED|Phase A+||14
2278810|NCT02196506|5594608|P3|NOT COMPLETED|Phase A+||0
2278811|NCT02196506|5594609|P2|NOT COMPLETED|Phase A+||0
2278812|NCT02196506|5594610|P1|NOT COMPLETED|Phase A+||0
2278813|NCT02196506|5594607|P4|COMPLETED|Phase A+||308
2278814|NCT02196506|5594608|P3|COMPLETED|Phase A+||0
2278815|NCT02196506|5594609|P2|COMPLETED|Phase A+||0
2278816|NCT02196506|5594610|P1|COMPLETED|Phase A+||0
2278817|NCT02196506|5594607|P4|STARTED|Phase A+||322
2278818|NCT02196506|5594608|P3|STARTED|Phase A+||0
2278819|NCT02196506|5594609|P2|STARTED|Phase A+||0
2278820|NCT02196506|5594610|P1|STARTED|Phase A+||0
2278821|NCT02196506|5594607|P4|NOT COMPLETED|Phase B||0
2278822|NCT02196506|5594608|P3|NOT COMPLETED|Phase B||6
2278823|NCT02196506|5594609|P2|NOT COMPLETED|Phase B||15
2278824|NCT02196506|5594610|P1|NOT COMPLETED|Phase B||0
2278825|NCT02196506|5594607|P4|COMPLETED|Phase B||0
2278826|NCT02196506|5594608|P3|COMPLETED|Phase B||196
2278827|NCT02196506|5594609|P2|COMPLETED|Phase B||177
2278828|NCT02196506|5594610|P1|COMPLETED|Phase B||0
2278829|NCT02196506|5594607|P4|STARTED|Phase B||0
2278830|NCT02196506|5594608|P3|STARTED|Phase B||202
2278831|NCT02196506|5594609|P2|STARTED|Phase B||192
2278832|NCT02196506|5594610|P1|STARTED|Phase B||0
2278833|NCT02196506|5594607|P4|NOT COMPLETED|Phase A||0
2278834|NCT02196506|5594608|P3|NOT COMPLETED|Phase A||0
2278835|NCT02196506|5594609|P2|NOT COMPLETED|Phase A||0
2278836|NCT02196506|5594610|P1|NOT COMPLETED|Phase A||121
2278837|NCT02196506|5594607|P4|COMPLETED|Phase A||0
2278838|NCT02196506|5594608|P3|COMPLETED|Phase A||0
2278839|NCT02196506|5594609|P2|COMPLETED|Phase A||0
2278840|NCT02196506|5594610|P1|COMPLETED|Phase A||716
2278841|NCT02196506|5594607|P4|STARTED|Phase A||0
2278842|NCT02196506|5594608|P3|STARTED|Phase A||0
2278843|NCT02196506|5594609|P2|STARTED|Phase A||0
2278844|NCT02196506|5594610|P1|STARTED|Phase A||837
2278845|NCT02196259|5594625|P3|NOT COMPLETED|Overall Study||1
2278846|NCT02196259|5594626|P2|NOT COMPLETED|Overall Study||3
2278847|NCT02196259|5594627|P1|NOT COMPLETED|Overall Study||0
2278848|NCT02196259|5594625|P3|COMPLETED|Overall Study||2
2278849|NCT02196259|5594626|P2|COMPLETED|Overall Study||4
2278850|NCT02196259|5594627|P1|COMPLETED|Overall Study||3
2278851|NCT02196259|5594625|P3|STARTED|Overall Study||3
2278852|NCT02196259|5594626|P2|STARTED|Overall Study||7
2278853|NCT02196259|5594627|P1|STARTED|Overall Study||3
2278854|NCT02196168|5594636|P2|NOT COMPLETED|Overall Study||0
2278855|NCT02196168|5594637|P1|NOT COMPLETED|Overall Study||0
2278856|NCT02196168|5594636|P2|COMPLETED|Overall Study||0
2278857|NCT02196168|5594637|P1|COMPLETED|Overall Study||6
2278858|NCT02196168|5594636|P2|STARTED|Overall Study||0
2278859|NCT02196168|5594637|P1|STARTED|Overall Study||6
2278860|NCT02196077|5594655|P1|NOT COMPLETED|Overall Study||47
2278861|NCT02196077|5594655|P1|COMPLETED|Overall Study||133
2278862|NCT02196077|5594655|P1|FF MDI 9.6 μg|Overall Study||157
2278863|NCT02196077|5594655|P1|BD MDI 320 μg|Overall Study||108
2278864|NCT02196077|5594655|P1|BFF MDI 80/9.6 μg|Overall Study||103
2278865|NCT02196077|5594655|P1|BFF MDI 160/9.6 μg|Overall Study||106
2278866|NCT02196077|5594655|P1|BFF MDI 320/9.6 μg|Overall Study||155
2278867|NCT02196077|5594655|P1|STARTED|Overall Study||180
2278868|NCT02195986|5594705|P3|NOT COMPLETED|Overall Study||2
2278869|NCT02195986|5594706|P2|NOT COMPLETED|Overall Study||5
2278870|NCT02195986|5594707|P1|NOT COMPLETED|Overall Study||3
2278871|NCT02195986|5594705|P3|COMPLETED|Overall Study||71
2278872|NCT02195986|5594706|P2|COMPLETED|Overall Study||142
2278873|NCT02195986|5594707|P1|COMPLETED|Overall Study||143
2278874|NCT02195986|5594705|P3|STARTED|Overall Study||73
2278875|NCT02195986|5594706|P2|STARTED|Overall Study||147
2278876|NCT02195986|5594707|P1|STARTED|Overall Study||146
2278877|NCT02195895|5594722|P1|NOT COMPLETED|Overall Study||0
2278878|NCT02195895|5594722|P1|COMPLETED|Overall Study||17
2278879|NCT02195895|5594722|P1|STARTED|Overall Study||17
2278880|NCT02195869|5594730|P1|NOT COMPLETED|Overall Study||42
2278881|NCT02195869|5594730|P1|COMPLETED|Overall Study||0
2278882|NCT02195869|5594730|P1|All-Treated Population|Overall Study||42
2278883|NCT02195869|5594730|P1|STARTED|Overall Study|Phase 1b: 6 patients, 420 mg, no DLT observed. Phase 2: 42 patients, 420 mg|42
2278884|NCT02195713|5594743|P2|NOT COMPLETED|Overall Study||0
2278885|NCT02195713|5594744|P1|NOT COMPLETED|Overall Study||0
2278886|NCT02195713|5594743|P2|COMPLETED|Overall Study||10
2278887|NCT02195713|5594744|P1|COMPLETED|Overall Study||10
2278888|NCT02195713|5594743|P2|STARTED|Overall Study||10
2278889|NCT02195713|5594744|P1|STARTED|Overall Study||10
2278890|NCT02195700|5594752|P2|NOT COMPLETED|Overall Study||7
2278891|NCT02195700|5594753|P1|NOT COMPLETED|Overall Study||6
2278892|NCT02195700|5594752|P2|COMPLETED|Overall Study||52
2278893|NCT02195700|5594753|P1|COMPLETED|Overall Study||52
2278894|NCT02195700|5594752|P2|Maintenance Period|Overall Study||54
2278895|NCT02195700|5594753|P1|Maintenance Period|Overall Study||53
2278896|NCT02195700|5594752|P2|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|57
2278897|NCT02195700|5594753|P1|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|56
2278898|NCT02195700|5594752|P2|Safety and ITT Populations|Overall Study||59
2278899|NCT02195700|5594753|P1|Safety and ITT Populations|Overall Study||58
2278900|NCT02195700|5594752|P2|STARTED|Overall Study||59
2278901|NCT02195700|5594753|P1|STARTED|Overall Study||58
2278902|NCT02195687|5594775|P2|NOT COMPLETED|Overall Study||2
2278903|NCT02195687|5594776|P1|NOT COMPLETED|Overall Study||5
2278904|NCT02195687|5594775|P2|COMPLETED|Overall Study||99
2278905|NCT02195687|5594776|P1|COMPLETED|Overall Study||311
2278906|NCT02195687|5594775|P2|STARTED|Overall Study||101
2278907|NCT02195687|5594776|P1|STARTED|Overall Study||316
2278908|NCT02195622|5594794|P2|NOT COMPLETED|Overall Study||0
2278909|NCT02195622|5594795|P1|NOT COMPLETED|Overall Study||0
2278910|NCT02195622|5594794|P2|COMPLETED|Overall Study||37
2278911|NCT02195622|5594795|P1|COMPLETED|Overall Study||37
2278912|NCT02195622|5594794|P2|STARTED|Overall Study||37
2278913|NCT02195622|5594795|P1|STARTED|Overall Study||37
2278914|NCT02195583|5594801|P1|NOT COMPLETED|Overall Study||9
2278915|NCT02195583|5594801|P1|COMPLETED|Overall Study||53
2278916|NCT02195583|5594801|P1|Sodium Fluoride (1426 Ppm) + Zinc Base B|Overall Study|Discontinuations: 1 withdrawal of consent in Period 2;1 adverse event each in Period 3 and Period 4|60
2278917|NCT02195583|5594801|P1|Sodium Fluoride (1426 Ppm)|Overall Study|Discontinuation:1 lost to follow up, 1 withdrawal of consent in Period 2, 1 other reason in Period 5|59
2278918|NCT02195583|5594801|P1|Sodium Fluoride (250 Ppm)|Overall Study||55
2278919|NCT02195583|5594801|P1|Sodium Fluoride (1426 Ppm) + Zinc Base A|Overall Study|Discontinuations: 1 withdrawal of consent in Period 3 and 1 withdrawal of consent in Period 4|58
2278920|NCT02195583|5594801|P1|Sodium Fluoride (0 Ppm)|Overall Study||59
2278921|NCT02195583|5594801|P1|Sodium Fluoride (1150 Ppm)|Overall Study|Discontinuations: 1 due to other reason in Period 5|57
2278922|NCT02195583|5594801|P1|STARTED|Overall Study||62
2278923|NCT02195531|5594836|P3|NOT COMPLETED|Overall Study||1
2278924|NCT02195531|5594837|P2|NOT COMPLETED|Overall Study||1
2278925|NCT02195531|5594838|P1|NOT COMPLETED|Overall Study||1
2278926|NCT02195531|5594836|P3|COMPLETED|Overall Study||55
2278927|NCT02195531|5594837|P2|COMPLETED|Overall Study||48
2278928|NCT02195531|5594838|P1|COMPLETED|Overall Study||63
2278929|NCT02195531|5594836|P3|STARTED|Overall Study||56
2278930|NCT02195531|5594837|P2|STARTED|Overall Study||49
2278931|NCT02195531|5594838|P1|STARTED|Overall Study||64
2278932|NCT02195518|5594863|P1|NOT COMPLETED|Overall Study||9
2278933|NCT02195518|5594863|P1|COMPLETED|Overall Study||204
2278934|NCT02195518|5594863|P1|STARTED|Overall Study||213
2278935|NCT02195479|5594886|P2|NOT COMPLETED|Overall Study||350
2278936|NCT02195479|5594887|P1|NOT COMPLETED|Overall Study||356
2278937|NCT02195479|5594886|P2|COMPLETED|Overall Study|None of the participants completed the study as the study is still on-going.|0
2278938|NCT02195479|5594887|P1|COMPLETED|Overall Study|None of the participants completed the study as the study is still on-going.|0
2278939|NCT02195479|5594886|P2|Treated|Overall Study||346
2278940|NCT02195479|5594887|P1|Treated|Overall Study||354
2278941|NCT02195479|5594886|P2|STARTED|Overall Study||350
2278942|NCT02195479|5594887|P1|STARTED|Overall Study||356
2278943|NCT02195427|5594925|P2|NOT COMPLETED|Overall Study||27
2278944|NCT02195427|5594926|P1|NOT COMPLETED|Overall Study||26
2278945|NCT02195427|5594925|P2|COMPLETED|Overall Study||47
2278946|NCT02195427|5594926|P1|COMPLETED|Overall Study||47
2278947|NCT02195427|5594925|P2|N Patients at W52|Overall Study||56
2278948|NCT02195427|5594926|P1|N Patients at W52|Overall Study||63
2278949|NCT02195427|5594925|P2|N Patients at W36|Overall Study||59
2278950|NCT02195427|5594926|P1|N Patients at W36|Overall Study||65
2278951|NCT02195427|5594925|P2|N Patients at W24 (Primary Outcome)|Overall Study||62
2278952|NCT02195427|5594926|P1|N Patients at W24 (Primary Outcome)|Overall Study||67
2278953|NCT02195427|5594925|P2|STARTED|Overall Study||74
2278954|NCT02195427|5594926|P1|STARTED|Overall Study||73
2278955|NCT02195414|5594988|P1|NOT COMPLETED|Overall Study||0
2278956|NCT02195414|5594988|P1|COMPLETED|Overall Study||31
2278957|NCT02195414|5594988|P1|Primary Endpoint|Overall Study||31
2278958|NCT02195414|5594988|P1|STARTED|Overall Study||31
2278959|NCT02195349|5595006|P11|NOT COMPLETED|Overall Study||0
2278960|NCT02195349|5595007|P10|NOT COMPLETED|Overall Study||0
2278961|NCT02195349|5595008|P9|NOT COMPLETED|Overall Study||0
2278962|NCT02195349|5595009|P8|NOT COMPLETED|Overall Study||0
2278963|NCT02195349|5595010|P7|NOT COMPLETED|Overall Study||0
2278964|NCT02195349|5595011|P6|NOT COMPLETED|Overall Study||0
2278965|NCT02195349|5595012|P5|NOT COMPLETED|Overall Study||0
2278966|NCT02195349|5595013|P4|NOT COMPLETED|Overall Study||0
2278967|NCT02195349|5595014|P3|NOT COMPLETED|Overall Study||0
2278968|NCT02195349|5595015|P2|NOT COMPLETED|Overall Study||0
2278969|NCT02195349|5595016|P1|NOT COMPLETED|Overall Study||0
2278970|NCT02195349|5595006|P11|COMPLETED|Overall Study||6
2278971|NCT02195349|5595007|P10|COMPLETED|Overall Study||6
2278972|NCT02195349|5595008|P9|COMPLETED|Overall Study||6
2278973|NCT02195349|5595009|P8|COMPLETED|Overall Study||9
2278974|NCT02195349|5595010|P7|COMPLETED|Overall Study||6
2278975|NCT02195349|5595011|P6|COMPLETED|Overall Study||6
2278976|NCT02195349|5595012|P5|COMPLETED|Overall Study||6
2278977|NCT02195349|5595013|P4|COMPLETED|Overall Study||6
2278978|NCT02195349|5595014|P3|COMPLETED|Overall Study||1
2278979|NCT02195349|5595015|P2|COMPLETED|Overall Study||1
2278980|NCT02195349|5595016|P1|COMPLETED|Overall Study||14
2278981|NCT02195349|5595006|P11|STARTED|Overall Study||6
2278982|NCT02195349|5595007|P10|STARTED|Overall Study||6
2278983|NCT02195349|5595008|P9|STARTED|Overall Study||6
2278984|NCT02195349|5595009|P8|STARTED|Overall Study||9
2278985|NCT02195349|5595010|P7|STARTED|Overall Study||6
2278986|NCT02195349|5595011|P6|STARTED|Overall Study||6
2278987|NCT02195349|5595012|P5|STARTED|Overall Study||6
2278988|NCT02195349|5595013|P4|STARTED|Overall Study||6
2278989|NCT02195349|5595014|P3|STARTED|Overall Study||1
2278990|NCT02195349|5595015|P2|STARTED|Overall Study||1
2278991|NCT02195349|5595016|P1|STARTED|Overall Study||14
2278992|NCT02195310|5595269|P2|NOT COMPLETED|Overall Study||16
2278993|NCT02195310|5595270|P1|NOT COMPLETED|Overall Study||20
2278994|NCT02195310|5595269|P2|COMPLETED|Overall Study||153
2278995|NCT02195310|5595270|P1|COMPLETED|Overall Study||153
2278996|NCT02195310|5595269|P2|STARTED|Overall Study||169
2278997|NCT02195310|5595270|P1|STARTED|Overall Study||173
2278998|NCT02195232|5595278|P2|NOT COMPLETED|Overall Study||3
2278999|NCT02195232|5595279|P1|NOT COMPLETED|Overall Study||4
2279000|NCT02195232|5595278|P2|COMPLETED|Overall Study|Evaluated for VTE and safety|29
2279001|NCT02195232|5595279|P1|COMPLETED|Overall Study|Evaluated for VTE and safety|28
2279002|NCT02195232|5595278|P2|STARTED|Overall Study|patients consented|32
2279003|NCT02195232|5595279|P1|STARTED|Overall Study|patients consented|32
2279004|NCT02195011|5595291|P2|NOT COMPLETED|Overall Study||1
2279005|NCT02195011|5595292|P1|NOT COMPLETED|Overall Study||25
2279006|NCT02195011|5595291|P2|COMPLETED|Overall Study||0
2279007|NCT02195011|5595292|P1|COMPLETED|Overall Study||0
2279008|NCT02195011|5595291|P2|STARTED|Overall Study||1
2279009|NCT02195011|5595292|P1|STARTED|Overall Study||25
2279010|NCT02194998|5595308|P4|NOT COMPLETED|Post-HCV Treatment Follow-Up||0
2279011|NCT02194998|5595309|P3|NOT COMPLETED|Post-HCV Treatment Follow-Up||1
2279012|NCT02194998|5595310|P2|NOT COMPLETED|Post-HCV Treatment Follow-Up||0
2279013|NCT02194998|5595311|P1|NOT COMPLETED|Post-HCV Treatment Follow-Up||1
2279014|NCT02194998|5595308|P4|COMPLETED|Post-HCV Treatment Follow-Up||4
2279015|NCT02194998|5595309|P3|COMPLETED|Post-HCV Treatment Follow-Up||14
2279016|NCT02194998|5595310|P2|COMPLETED|Post-HCV Treatment Follow-Up||5
2279017|NCT02194998|5595311|P1|COMPLETED|Post-HCV Treatment Follow-Up||20
2279018|NCT02194998|5595308|P4|STARTED|Post-HCV Treatment Follow-Up||4
2279019|NCT02194998|5595309|P3|STARTED|Post-HCV Treatment Follow-Up||15
2279020|NCT02194998|5595310|P2|STARTED|Post-HCV Treatment Follow-Up||5
2279021|NCT02194998|5595311|P1|STARTED|Post-HCV Treatment Follow-Up||21
2279022|NCT02194998|5595308|P4|NOT COMPLETED|On-HCV Treatment||0
2279023|NCT02194998|5595309|P3|NOT COMPLETED|On-HCV Treatment||0
2279024|NCT02194998|5595310|P2|NOT COMPLETED|On-HCV Treatment||1
2279025|NCT02194998|5595311|P1|NOT COMPLETED|On-HCV Treatment||0
2279026|NCT02194998|5595308|P4|COMPLETED|On-HCV Treatment||4
2279027|NCT02194998|5595309|P3|COMPLETED|On-HCV Treatment||15
2279028|NCT02194998|5595310|P2|COMPLETED|On-HCV Treatment||5
2279029|NCT02194998|5595311|P1|COMPLETED|On-HCV Treatment||21
2279030|NCT02194998|5595308|P4|STARTED|On-HCV Treatment||4
2279031|NCT02194998|5595309|P3|STARTED|On-HCV Treatment||15
2279032|NCT02194998|5595310|P2|STARTED|On-HCV Treatment||6
2279033|NCT02194998|5595311|P1|STARTED|On-HCV Treatment||21
2279034|NCT02194933|5595375|P2|NOT COMPLETED|Overall Study||9
2279035|NCT02194933|5595376|P1|NOT COMPLETED|Overall Study||3
2279036|NCT02194933|5595375|P2|COMPLETED|Overall Study||10
2279037|NCT02194933|5595376|P1|COMPLETED|Overall Study||16
2279038|NCT02194933|5595375|P2|STARTED|Overall Study||19
2279039|NCT02194933|5595376|P1|STARTED|Overall Study||19
2279040|NCT02194699|5595430|P2|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||52
2279041|NCT02194699|5595431|P1|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||50
2279042|NCT02194699|5595430|P2|COMPLETED|With Potential to Receive 52 Weeks of IP||365
2279043|NCT02194699|5595431|P1|COMPLETED|With Potential to Receive 52 Weeks of IP||370
2279044|NCT02194699|5595430|P2|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|417
2279045|NCT02194699|5595431|P1|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|420
2279046|NCT02194699|5595430|P2|NOT COMPLETED|Randomised||11
2279047|NCT02194699|5595431|P1|NOT COMPLETED|Randomised||8
2279048|NCT02194699|5595430|P2|COMPLETED|Randomised||417
2279049|NCT02194699|5595431|P1|COMPLETED|Randomised||420
2279050|NCT02194699|5595430|P2|STARTED|Randomised||428
2279051|NCT02194699|5595431|P1|STARTED|Randomised||428
2279052|NCT02194621|5595539|P3|NOT COMPLETED|Overall Study||9
2279053|NCT02194621|5595540|P2|NOT COMPLETED|Overall Study||6
2279054|NCT02194621|5595541|P1|NOT COMPLETED|Overall Study||6
2279055|NCT02194621|5595539|P3|COMPLETED|Overall Study||34
2279056|NCT02194621|5595540|P2|COMPLETED|Overall Study||36
2279057|NCT02194621|5595541|P1|COMPLETED|Overall Study||37
2279058|NCT02194621|5595539|P3|STARTED|Overall Study||43
2279059|NCT02194621|5595540|P2|STARTED|Overall Study||42
2279060|NCT02194621|5595541|P1|STARTED|Overall Study||43
2279061|NCT02194088|5595560|P2|NOT COMPLETED|Overall Study||0
2279062|NCT02194088|5595561|P1|NOT COMPLETED|Overall Study||0
2279063|NCT02194088|5595560|P2|COMPLETED|Overall Study||25
2279064|NCT02194088|5595561|P1|COMPLETED|Overall Study||75
2279065|NCT02194088|5595560|P2|STARTED|Overall Study||25
2279066|NCT02194088|5595561|P1|STARTED|Overall Study||75
2279067|NCT02194062|5595574|P3|NOT COMPLETED|Overall Study||5
2279068|NCT02194062|5595575|P2|NOT COMPLETED|Overall Study||2
2279069|NCT02194062|5595576|P1|NOT COMPLETED|Overall Study||2
2279070|NCT02194062|5595574|P3|COMPLETED|Overall Study||7
2279071|NCT02194062|5595575|P2|COMPLETED|Overall Study||8
2279072|NCT02194062|5595576|P1|COMPLETED|Overall Study||8
2279073|NCT02194062|5595574|P3|STARTED|Overall Study||12
2279074|NCT02194062|5595575|P2|STARTED|Overall Study||10
2279075|NCT02194062|5595576|P1|STARTED|Overall Study||10
2279076|NCT02193880|5595587|P1|NOT COMPLETED|Overall Study||3
2279077|NCT02193880|5595587|P1|COMPLETED|Overall Study||4
2279078|NCT02193880|5595587|P1|STARTED|Overall Study||7
2279079|NCT02193867|5595592|P1|NOT COMPLETED|Overall Study||4
2279080|NCT02193867|5595592|P1|COMPLETED|Overall Study||6
2279081|NCT02193867|5595592|P1|Completed 18 Months Of Treatment|Overall Study||8
2279082|NCT02193867|5595592|P1|Received At Least 1 Dose Of Study Drug|Overall Study||10
2279083|NCT02193867|5595592|P1|STARTED|Overall Study||10
2279084|NCT02193828|5595610|P4|NOT COMPLETED|Overall Study||1
2279085|NCT02193828|5595611|P3|NOT COMPLETED|Overall Study||1
2279086|NCT02193828|5595612|P2|NOT COMPLETED|Overall Study||0
2279087|NCT02193828|5595613|P1|NOT COMPLETED|Overall Study||0
2279088|NCT02193828|5595610|P4|COMPLETED|Overall Study||16
2279089|NCT02193828|5595611|P3|COMPLETED|Overall Study||22
2279090|NCT02193828|5595612|P2|COMPLETED|Overall Study||18
2279091|NCT02193828|5595613|P1|COMPLETED|Overall Study||18
2279092|NCT02193828|5595610|P4|STARTED|Overall Study||17
2279093|NCT02193828|5595611|P3|STARTED|Overall Study||23
2279094|NCT02193828|5595612|P2|STARTED|Overall Study||18
2279095|NCT02193828|5595613|P1|STARTED|Overall Study||18
2279096|NCT02193815|5595651|P1|NOT COMPLETED|Overall Study||0
2279097|NCT02193815|5595651|P1|COMPLETED|Overall Study||15
2279098|NCT02193815|5595651|P1|STARTED|Overall Study||15
2279099|NCT02193776|5595690|P4|NOT COMPLETED|Overall Study||2
2279100|NCT02193776|5595691|P3|NOT COMPLETED|Overall Study||2
2279101|NCT02193776|5595692|P2|NOT COMPLETED|Overall Study||7
2279102|NCT02193776|5595693|P1|NOT COMPLETED|Overall Study||8
2279103|NCT02193776|5595690|P4|COMPLETED|Overall Study||58
2279104|NCT02193776|5595691|P3|COMPLETED|Overall Study||59
2279105|NCT02193776|5595692|P2|COMPLETED|Overall Study||53
2279106|NCT02193776|5595693|P1|COMPLETED|Overall Study||51
2279107|NCT02193776|5595690|P4|Completed Day 140 Follow-up|Overall Study||58
2279108|NCT02193776|5595691|P3|Completed Day 140 Follow-up|Overall Study||58
2279109|NCT02193776|5595692|P2|Completed Day 140 Follow-up|Overall Study||52
2279110|NCT02193776|5595693|P1|Completed Day 140 Follow-up|Overall Study||52
2279111|NCT02193776|5595690|P4|Completed Day 70 Follow-up|Overall Study||60
2279112|NCT02193776|5595691|P3|Completed Day 70 Follow-up|Overall Study||60
2279113|NCT02193776|5595692|P2|Completed Day 70 Follow-up|Overall Study||56
2279114|NCT02193776|5595693|P1|Completed Day 70 Follow-up|Overall Study||54
2279115|NCT02193776|5595690|P4|STARTED|Overall Study||60
2279116|NCT02193776|5595691|P3|STARTED|Overall Study||61
2279117|NCT02193776|5595692|P2|STARTED|Overall Study||60
2279118|NCT02193776|5595693|P1|STARTED|Overall Study||59
2279119|NCT02193490|5595709|P2|NOT COMPLETED|Overall Study||2
2279120|NCT02193490|5595710|P1|NOT COMPLETED|Overall Study||4
2279121|NCT02193490|5595709|P2|COMPLETED|Overall Study||20
2279122|NCT02193490|5595710|P1|COMPLETED|Overall Study||21
2279123|NCT02193490|5595709|P2|STARTED|Overall Study||22
2279124|NCT02193490|5595710|P1|STARTED|Overall Study||25
2279125|NCT02193178|5595720|P1|NOT COMPLETED|Overall Study||2
2279126|NCT02193178|5595720|P1|COMPLETED|Overall Study||13
2279127|NCT02193178|5595720|P1|STARTED|Overall Study||15
2279128|NCT02193165|5595770|P3|NOT COMPLETED|6 Week Product Use||0
2279129|NCT02193165|5595771|P2|NOT COMPLETED|6 Week Product Use||1
2279130|NCT02193165|5595772|P1|NOT COMPLETED|6 Week Product Use||0
2279131|NCT02193165|5595770|P3|COMPLETED|6 Week Product Use||39
2279132|NCT02193165|5595771|P2|COMPLETED|6 Week Product Use|1 subject failed to keep appointment time and didn't return to clinical site.|38
2279133|NCT02193165|5595772|P1|COMPLETED|6 Week Product Use||39
2279134|NCT02193165|5595770|P3|STARTED|6 Week Product Use||39
2279135|NCT02193165|5595771|P2|STARTED|6 Week Product Use||39
2279136|NCT02193165|5595772|P1|STARTED|6 Week Product Use||39
2279137|NCT02193165|5595770|P3|NOT COMPLETED|4 Week Product Use||1
2279138|NCT02193165|5595771|P2|NOT COMPLETED|4 Week Product Use||1
2279139|NCT02193165|5595772|P1|NOT COMPLETED|4 Week Product Use||1
2279140|NCT02193165|5595770|P3|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
2279141|NCT02193165|5595771|P2|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
2279142|NCT02193165|5595772|P1|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
2279143|NCT02193165|5595770|P3|STARTED|4 Week Product Use||40
2279144|NCT02193165|5595771|P2|STARTED|4 Week Product Use||40
2279145|NCT02193165|5595772|P1|STARTED|4 Week Product Use||40
2279146|NCT02193087|5595799|P4|NOT COMPLETED|Overall Study||79
2279147|NCT02193087|5595800|P3|NOT COMPLETED|Overall Study||7
2279148|NCT02193087|5595801|P2|NOT COMPLETED|Overall Study||14
2279149|NCT02193087|5595802|P1|NOT COMPLETED|Overall Study||37
2279150|NCT02193087|5595799|P4|COMPLETED|Overall Study||524
2279151|NCT02193087|5595800|P3|COMPLETED|Overall Study||93
2279152|NCT02193087|5595801|P2|COMPLETED|Overall Study||86
2279153|NCT02193087|5595802|P1|COMPLETED|Overall Study||162
2279154|NCT02193087|5595799|P4|Received Vaccination|Overall Study||602
2279155|NCT02193087|5595800|P3|Received Vaccination|Overall Study||100
2279156|NCT02193087|5595801|P2|Received Vaccination|Overall Study||97
2279157|NCT02193087|5595802|P1|Received Vaccination|Overall Study||197
2279158|NCT02193087|5595799|P4|STARTED|Overall Study||603
2279159|NCT02193087|5595800|P3|STARTED|Overall Study||100
2279160|NCT02193087|5595801|P2|STARTED|Overall Study||100
2279161|NCT02193087|5595802|P1|STARTED|Overall Study||199
2279162|NCT02193074|5595847|P2|NOT COMPLETED|Overall Study||15
2279163|NCT02193074|5595848|P1|NOT COMPLETED|Overall Study||17
2279164|NCT02193074|5595847|P2|COMPLETED|Overall Study||65
2279165|NCT02193074|5595848|P1|COMPLETED|Overall Study||24
2279166|NCT02193074|5595847|P2|Completed Due to Early Study Termination|Overall Study||39
2279167|NCT02193074|5595848|P1|Completed Due to Early Study Termination|Overall Study||13
2279168|NCT02193074|5595847|P2|Completed During Follow-Up Period|Overall Study||26
2279169|NCT02193074|5595848|P1|Completed During Follow-Up Period|Overall Study||11
2279170|NCT02193074|5595847|P2|STARTED|Overall Study|Randomized and received double-blind treatment.|80
2279171|NCT02193074|5595848|P1|STARTED|Overall Study|Randomized and received double-blind treatment.|41
2279172|NCT02192905|5595880|P1|NOT COMPLETED|Overall Study||1
2279173|NCT02192905|5595880|P1|COMPLETED|Overall Study|Reporting a minimum of current weight at 16-week follow-up|42
2279174|NCT02192905|5595880|P1|STARTED|Overall Study||43
2279175|NCT02192879|5595894|P3|NOT COMPLETED|Overall Study||0
2279176|NCT02192879|5595895|P2|NOT COMPLETED|Overall Study||0
2279177|NCT02192879|5595896|P1|NOT COMPLETED|Overall Study||0
2279178|NCT02192879|5595894|P3|COMPLETED|Overall Study||3
2279179|NCT02192879|5595895|P2|COMPLETED|Overall Study||4
2279180|NCT02192879|5595896|P1|COMPLETED|Overall Study||3
2279181|NCT02192879|5595894|P3|STARTED|Overall Study||3
2279182|NCT02192879|5595895|P2|STARTED|Overall Study||4
2279183|NCT02192879|5595896|P1|STARTED|Overall Study||3
2279184|NCT02192814|5595922|P1|NOT COMPLETED|Overall Study||0
2279185|NCT02192814|5595922|P1|COMPLETED|Overall Study||9
2279186|NCT02192814|5595922|P1|STARTED|Overall Study||9
2279187|NCT02192684|5595935|P2|NOT COMPLETED|Overall Study||0
2279188|NCT02192684|5595936|P1|NOT COMPLETED|Overall Study||0
2279189|NCT02192684|5595935|P2|COMPLETED|Overall Study||15
2279190|NCT02192684|5595936|P1|COMPLETED|Overall Study||30
2279191|NCT02192684|5595935|P2|STARTED|Overall Study||15
2279192|NCT02192684|5595936|P1|STARTED|Overall Study||30
2279193|NCT02192606|5595944|P2|NOT COMPLETED|Overall Study||4
2279194|NCT02192606|5595945|P1|NOT COMPLETED|Overall Study||2
2279195|NCT02192606|5595944|P2|COMPLETED|Overall Study||24
2279196|NCT02192606|5595945|P1|COMPLETED|Overall Study||27
2279197|NCT02192606|5595944|P2|STARTED|Overall Study||28
2279198|NCT02192606|5595945|P1|STARTED|Overall Study||29
2279199|NCT02192541|5595955|P2|NOT COMPLETED|Overall Study||0
2279200|NCT02192541|5595956|P1|NOT COMPLETED|Overall Study||0
2279201|NCT02192541|5595955|P2|COMPLETED|Overall Study||3
2279202|NCT02192541|5595956|P1|COMPLETED|Overall Study||2
2279203|NCT02192541|5595955|P2|Evaluable for Response|Overall Study||3
2279204|NCT02192541|5595956|P1|Evaluable for Response|Overall Study||1
2279205|NCT02192541|5595955|P2|Treated|Overall Study||3
2279206|NCT02192541|5595956|P1|Treated|Overall Study||2
2279207|NCT02192541|5595955|P2|STARTED|Overall Study||3
2279208|NCT02192541|5595956|P1|STARTED|Overall Study||2
2279209|NCT02192307|5595978|P2|NOT COMPLETED|Overall Study||0
2279210|NCT02192307|5595979|P1|NOT COMPLETED|Overall Study||0
2279211|NCT02192307|5595978|P2|COMPLETED|Overall Study||30
2279212|NCT02192307|5595979|P1|COMPLETED|Overall Study||30
2279213|NCT02192307|5595978|P2|STARTED|Overall Study||30
2279214|NCT02192307|5595979|P1|STARTED|Overall Study||30
2279215|NCT02192190|5595993|P6|NOT COMPLETED|Overall Study||29
2279216|NCT02192190|5595994|P5|NOT COMPLETED|Overall Study||30
2279217|NCT02192190|5595995|P4|NOT COMPLETED|Overall Study||26
2279218|NCT02192190|5595996|P3|NOT COMPLETED|Overall Study||25
2279219|NCT02192190|5595997|P2|NOT COMPLETED|Overall Study||29
2279220|NCT02192190|5595998|P1|NOT COMPLETED|Overall Study||54
2279221|NCT02192190|5595993|P6|COMPLETED|Overall Study||9
2279222|NCT02192190|5595994|P5|COMPLETED|Overall Study||9
2279223|NCT02192190|5595995|P4|COMPLETED|Overall Study||12
2279224|NCT02192190|5595996|P3|COMPLETED|Overall Study||13
2279225|NCT02192190|5595997|P2|COMPLETED|Overall Study||10
2279226|NCT02192190|5595998|P1|COMPLETED|Overall Study||22
2279227|NCT02192190|5595993|P6|Received at Least 1 Dose of Study Drug|Overall Study||37
2279228|NCT02192190|5595994|P5|Received at Least 1 Dose of Study Drug|Overall Study||38
2279229|NCT02192190|5595995|P4|Received at Least 1 Dose of Study Drug|Overall Study||38
2279230|NCT02192190|5595996|P3|Received at Least 1 Dose of Study Drug|Overall Study||38
2279231|NCT02192190|5595997|P2|Received at Least 1 Dose of Study Drug|Overall Study||39
2279232|NCT02192190|5595998|P1|Received at Least 1 Dose of Study Drug|Overall Study||76
2279233|NCT02192190|5595993|P6|STARTED|Overall Study||38
2279234|NCT02192190|5595994|P5|STARTED|Overall Study||39
2279235|NCT02192190|5595995|P4|STARTED|Overall Study||38
2279236|NCT02192190|5595996|P3|STARTED|Overall Study||38
2279237|NCT02192190|5595997|P2|STARTED|Overall Study||39
2279238|NCT02192190|5595998|P1|STARTED|Overall Study||76
2279239|NCT02192164|5596042|P1|NOT COMPLETED|Overall Study||14
2279240|NCT02192164|5596042|P1|COMPLETED|Overall Study||112
2279241|NCT02192164|5596042|P1|Etanercept Treated Population|Overall Study||112
2279242|NCT02192164|5596042|P1|STARTED|Overall Study||126
2279243|NCT02192099|5596058|P1|NOT COMPLETED|Overall Study||61
2279244|NCT02192099|5596058|P1|COMPLETED|Overall Study||0
2279245|NCT02192099|5596058|P1|STARTED|Overall Study||61
2279246|NCT02191865|5596065|P3|NOT COMPLETED|Overall Study||0
2279247|NCT02191865|5596066|P2|NOT COMPLETED|Overall Study||0
2279248|NCT02191865|5596067|P1|NOT COMPLETED|Overall Study||0
2279249|NCT02191865|5596065|P3|COMPLETED|Overall Study||17
2279250|NCT02191865|5596066|P2|COMPLETED|Overall Study||8
2279251|NCT02191865|5596067|P1|COMPLETED|Overall Study||8
2279252|NCT02191865|5596065|P3|STARTED|Overall Study||17
2279253|NCT02191865|5596066|P2|STARTED|Overall Study||8
2279254|NCT02191865|5596067|P1|STARTED|Overall Study||8
2279255|NCT02191605|5596092|P5|NOT COMPLETED|Overall Study||4
2279256|NCT02191605|5596093|P4|NOT COMPLETED|Overall Study||3
2279257|NCT02191605|5596094|P3|NOT COMPLETED|Overall Study||7
2279258|NCT02191605|5596095|P2|NOT COMPLETED|Overall Study||4
2279259|NCT02191605|5596096|P1|NOT COMPLETED|Overall Study||9
2279260|NCT02191605|5596092|P5|COMPLETED|Overall Study||3
2279261|NCT02191605|5596093|P4|COMPLETED|Overall Study||5
2279262|NCT02191605|5596094|P3|COMPLETED|Overall Study||8
2279263|NCT02191605|5596095|P2|COMPLETED|Overall Study||11
2279264|NCT02191605|5596096|P1|COMPLETED|Overall Study||6
2279265|NCT02191605|5596092|P5|Completed Intervention Portion|Overall Study||7
2279266|NCT02191605|5596093|P4|Completed Intervention Portion|Overall Study||8
2279267|NCT02191605|5596094|P3|Completed Intervention Portion|Overall Study||15
2279268|NCT02191605|5596095|P2|Completed Intervention Portion|Overall Study||15
2279269|NCT02191605|5596096|P1|Completed Intervention Portion|Overall Study||15
2279270|NCT02191605|5596092|P5|STARTED|Overall Study||7
2279271|NCT02191605|5596093|P4|STARTED|Overall Study||8
2279272|NCT02191605|5596094|P3|STARTED|Overall Study||15
2279273|NCT02191605|5596095|P2|STARTED|Overall Study||15
2279274|NCT02191605|5596096|P1|STARTED|Overall Study||15
2279275|NCT02191579|5596115|P2|NOT COMPLETED|Treatment 2||25
2279276|NCT02191579|5596116|P1|NOT COMPLETED|Treatment 2||0
2279277|NCT02191579|5596115|P2|COMPLETED|Treatment 2||55
2279278|NCT02191579|5596116|P1|COMPLETED|Treatment 2||0
2279279|NCT02191579|5596115|P2|STARTED|Treatment 2||80
2279280|NCT02191579|5596116|P1|STARTED|Treatment 2||0
2279281|NCT02191579|5596115|P2|NOT COMPLETED|Treatment 1||58
2279282|NCT02191579|5596116|P1|NOT COMPLETED|Treatment 1||27
2279283|NCT02191579|5596115|P2|COMPLETED|Treatment 1||84
2279284|NCT02191579|5596116|P1|COMPLETED|Treatment 1||113
2279285|NCT02191579|5596115|P2|STARTED|Treatment 1||142
2279286|NCT02191579|5596116|P1|STARTED|Treatment 1||140
2279293|NCT02191267|5596192|P3|NOT COMPLETED|Overall Study||0
2279294|NCT02191267|5596193|P2|NOT COMPLETED|Overall Study||0
2279295|NCT02191267|5596194|P1|NOT COMPLETED|Overall Study||1
2279296|NCT02191267|5596192|P3|COMPLETED|Overall Study||4
2279297|NCT02191267|5596193|P2|COMPLETED|Overall Study||6
2279298|NCT02191267|5596194|P1|COMPLETED|Overall Study||19
2279299|NCT02191267|5596192|P3|STARTED|Overall Study||4
2279300|NCT02191267|5596193|P2|STARTED|Overall Study||6
2279301|NCT02191267|5596194|P1|STARTED|Overall Study||20
2279302|NCT02191137|5596205|P1|NOT COMPLETED|Follow-up||5
2279303|NCT02191137|5596205|P1|COMPLETED|Follow-up||60
2279304|NCT02191137|5596205|P1|STARTED|Follow-up||65
2279305|NCT02191137|5596205|P1|NOT COMPLETED|Treatment||10
2279306|NCT02191137|5596205|P1|COMPLETED|Treatment||65
2279307|NCT02191137|5596205|P1|STARTED|Treatment||75
2279308|NCT02191046|5596235|P2|NOT COMPLETED|Overall Study||1
2279309|NCT02191046|5596236|P1|NOT COMPLETED|Overall Study||5
2279310|NCT02191046|5596235|P2|COMPLETED|Overall Study|exclude 1 patient because low compliance|38
2279311|NCT02191046|5596236|P1|COMPLETED|Overall Study|exclude 5 patients because low compliance|36
2279312|NCT02191046|5596235|P2|STARTED|Overall Study||39
2279313|NCT02191046|5596236|P1|STARTED|Overall Study||41
2279314|NCT02191033|5596244|P2|NOT COMPLETED|Overall Study||1
2279315|NCT02191033|5596245|P1|NOT COMPLETED|Overall Study||2
2279316|NCT02191033|5596244|P2|COMPLETED|Overall Study||19
2279317|NCT02191033|5596245|P1|COMPLETED|Overall Study||18
2279318|NCT02191033|5596244|P2|STARTED|Overall Study||20
2279319|NCT02191033|5596245|P1|STARTED|Overall Study||20
2279320|NCT02190903|5596257|P2|NOT COMPLETED|Overall Study||0
2279321|NCT02190903|5596258|P1|NOT COMPLETED|Overall Study||0
2279322|NCT02190903|5596257|P2|COMPLETED|Overall Study||6
2279323|NCT02190903|5596258|P1|COMPLETED|Overall Study||6
2279324|NCT02190903|5596257|P2|STARTED|Overall Study||6
2279325|NCT02190903|5596258|P1|STARTED|Overall Study||6
2279326|NCT02190721|5596267|P3|NOT COMPLETED|Overall Study||0
2279327|NCT02190721|5596268|P2|NOT COMPLETED|Overall Study||1
2279328|NCT02190721|5596269|P1|NOT COMPLETED|Overall Study||0
2279329|NCT02190721|5596267|P3|COMPLETED|Overall Study||18
2279330|NCT02190721|5596268|P2|COMPLETED|Overall Study||29
2279331|NCT02190721|5596269|P1|COMPLETED|Overall Study||2
2279332|NCT02190721|5596267|P3|Completed 90 Day Follow-up|Overall Study||18
2279333|NCT02190721|5596268|P2|Completed 90 Day Follow-up|Overall Study||29
2279334|NCT02190721|5596269|P1|Completed 90 Day Follow-up|Overall Study||2
2279335|NCT02190721|5596267|P3|Completed 30 Day Follow-up|Overall Study||18
2279336|NCT02190721|5596268|P2|Completed 30 Day Follow-up|Overall Study||29
2279337|NCT02190721|5596269|P1|Completed 30 Day Follow-up|Overall Study||2
2279338|NCT02190721|5596267|P3|Completed Treatment|Overall Study||18
2279339|NCT02190721|5596268|P2|Completed Treatment|Overall Study||30
2279340|NCT02190721|5596269|P1|Completed Treatment|Overall Study||2
2279341|NCT02190721|5596267|P3|STARTED|Overall Study||18
2279342|NCT02190721|5596268|P2|STARTED|Overall Study||30
2279343|NCT02190721|5596269|P1|STARTED|Overall Study||2
2279344|NCT02190604|5596392|P19|NOT COMPLETED|Part 3 (Patients)||0
2279345|NCT02190604|5596393|P18|NOT COMPLETED|Part 3 (Patients)||0
2279346|NCT02190604|5596394|P17|NOT COMPLETED|Part 3 (Patients)||0
2279347|NCT02190604|5596395|P16|NOT COMPLETED|Part 3 (Patients)||0
2279348|NCT02190604|5596396|P15|NOT COMPLETED|Part 3 (Patients)||0
2279349|NCT02190604|5596397|P14|NOT COMPLETED|Part 3 (Patients)||0
2279350|NCT02190604|5596398|P13|NOT COMPLETED|Part 3 (Patients)||0
2279351|NCT02190604|5596399|P12|NOT COMPLETED|Part 3 (Patients)||0
2279352|NCT02190604|5596400|P11|NOT COMPLETED|Part 3 (Patients)||0
2279353|NCT02190604|5596401|P10|NOT COMPLETED|Part 3 (Patients)||0
2279354|NCT02190604|5596402|P9|NOT COMPLETED|Part 3 (Patients)||0
2279355|NCT02190604|5596403|P8|NOT COMPLETED|Part 3 (Patients)||0
2279356|NCT02190604|5596404|P7|NOT COMPLETED|Part 3 (Patients)||0
2279357|NCT02190604|5596405|P6|NOT COMPLETED|Part 3 (Patients)||0
2279358|NCT02190604|5596406|P5|NOT COMPLETED|Part 3 (Patients)||0
2279359|NCT02190604|5596407|P4|NOT COMPLETED|Part 3 (Patients)||0
2279360|NCT02190604|5596408|P3|NOT COMPLETED|Part 3 (Patients)||0
2279361|NCT02190604|5596409|P2|NOT COMPLETED|Part 3 (Patients)||0
2279362|NCT02190604|5596410|P1|NOT COMPLETED|Part 3 (Patients)||0
2279363|NCT02190604|5596392|P19|COMPLETED|Part 3 (Patients)||12
2279364|NCT02190604|5596393|P18|COMPLETED|Part 3 (Patients)||19
2279365|NCT02190604|5596394|P17|COMPLETED|Part 3 (Patients)||12
2279366|NCT02190604|5596395|P16|COMPLETED|Part 3 (Patients)||6
2279367|NCT02190604|5596396|P15|COMPLETED|Part 3 (Patients)||0
2279368|NCT02190604|5596397|P14|COMPLETED|Part 3 (Patients)||0
2279369|NCT02190604|5596398|P13|COMPLETED|Part 3 (Patients)||0
2279370|NCT02190604|5596399|P12|COMPLETED|Part 3 (Patients)||0
2279371|NCT02190604|5596400|P11|COMPLETED|Part 3 (Patients)||0
2279372|NCT02190604|5596401|P10|COMPLETED|Part 3 (Patients)||0
2279373|NCT02190604|5596402|P9|COMPLETED|Part 3 (Patients)||0
2279374|NCT02190604|5596403|P8|COMPLETED|Part 3 (Patients)||0
2279375|NCT02190604|5596404|P7|COMPLETED|Part 3 (Patients)||0
2279376|NCT02190604|5596405|P6|COMPLETED|Part 3 (Patients)||0
2279377|NCT02190604|5596406|P5|COMPLETED|Part 3 (Patients)||0
2279378|NCT02190604|5596407|P4|COMPLETED|Part 3 (Patients)||0
2279379|NCT02190604|5596408|P3|COMPLETED|Part 3 (Patients)||0
2279380|NCT02190604|5596409|P2|COMPLETED|Part 3 (Patients)||0
2279381|NCT02190604|5596410|P1|COMPLETED|Part 3 (Patients)||0
2279382|NCT02190604|5596392|P19|STARTED|Part 3 (Patients)||12
2279383|NCT02190604|5596393|P18|STARTED|Part 3 (Patients)||19
2279384|NCT02190604|5596394|P17|STARTED|Part 3 (Patients)||12
2279385|NCT02190604|5596395|P16|STARTED|Part 3 (Patients)||6
2279386|NCT02190604|5596396|P15|STARTED|Part 3 (Patients)||0
2279387|NCT02190604|5596397|P14|STARTED|Part 3 (Patients)||0
2279388|NCT02190604|5596398|P13|STARTED|Part 3 (Patients)||0
2279389|NCT02190604|5596399|P12|STARTED|Part 3 (Patients)||0
2279390|NCT02190604|5596400|P11|STARTED|Part 3 (Patients)||0
2279391|NCT02190604|5596401|P10|STARTED|Part 3 (Patients)||0
2279392|NCT02190604|5596402|P9|STARTED|Part 3 (Patients)||0
2279393|NCT02190604|5596403|P8|STARTED|Part 3 (Patients)||0
2279394|NCT02190604|5596404|P7|STARTED|Part 3 (Patients)||0
2279395|NCT02190604|5596405|P6|STARTED|Part 3 (Patients)||0
2279396|NCT02190604|5596406|P5|STARTED|Part 3 (Patients)||0
2279397|NCT02190604|5596407|P4|STARTED|Part 3 (Patients)||0
2279398|NCT02190604|5596408|P3|STARTED|Part 3 (Patients)||0
2279399|NCT02190604|5596409|P2|STARTED|Part 3 (Patients)||0
2279400|NCT02190604|5596410|P1|STARTED|Part 3 (Patients)||0
2279401|NCT02190604|5596392|P19|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
2279402|NCT02190604|5596393|P18|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
2279403|NCT02190604|5596394|P17|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
2279404|NCT02190604|5596395|P16|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
2279405|NCT02190604|5596396|P15|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||2
2279406|NCT02190604|5596397|P14|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||1
2279407|NCT02190604|5596398|P13|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
2279408|NCT02190604|5596399|P12|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
2279409|NCT02190604|5596400|P11|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
2279410|NCT02190604|5596401|P10|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
2279411|NCT02190604|5596402|P9|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
2279412|NCT02190604|5596403|P8|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
2279413|NCT02190604|5596404|P7|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
2279414|NCT02190604|5596405|P6|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
2279415|NCT02190604|5596406|P5|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
2279416|NCT02190604|5596407|P4|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
2279417|NCT02190604|5596408|P3|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
2279418|NCT02190604|5596409|P2|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
2279419|NCT02190604|5596410|P1|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
2279420|NCT02190604|5596392|P19|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
2279421|NCT02190604|5596393|P18|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
2279422|NCT02190604|5596394|P17|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
2279423|NCT02190604|5596395|P16|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
2279424|NCT02190604|5596396|P15|COMPLETED|Part 1 and 2 (Healthy Volunteers)||8
2279425|NCT02190604|5596397|P14|COMPLETED|Part 1 and 2 (Healthy Volunteers)||5
2279426|NCT02190604|5596398|P13|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
2279427|NCT02190604|5596399|P12|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
2279428|NCT02190604|5596400|P11|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
2279429|NCT02190604|5596401|P10|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
2279430|NCT02190604|5596402|P9|COMPLETED|Part 1 and 2 (Healthy Volunteers)||16
2279431|NCT02190604|5596403|P8|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
2279432|NCT02190604|5596404|P7|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
2279433|NCT02190604|5596405|P6|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
2279434|NCT02190604|5596406|P5|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
2279435|NCT02190604|5596407|P4|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
2279436|NCT02190604|5596408|P3|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
2279437|NCT02190604|5596409|P2|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
2279438|NCT02190604|5596410|P1|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
2279439|NCT02190604|5596392|P19|STARTED|Part 1 and 2 (Healthy Volunteers)||0
2279440|NCT02190604|5596393|P18|STARTED|Part 1 and 2 (Healthy Volunteers)||0
2279441|NCT02190604|5596394|P17|STARTED|Part 1 and 2 (Healthy Volunteers)||0
2279442|NCT02190604|5596395|P16|STARTED|Part 1 and 2 (Healthy Volunteers)||0
2279443|NCT02190604|5596396|P15|STARTED|Part 1 and 2 (Healthy Volunteers)||10
2279444|NCT02190604|5596397|P14|STARTED|Part 1 and 2 (Healthy Volunteers)||6
2279445|NCT02190604|5596398|P13|STARTED|Part 1 and 2 (Healthy Volunteers)||6
2279446|NCT02190604|5596399|P12|STARTED|Part 1 and 2 (Healthy Volunteers)||6
2279447|NCT02190604|5596400|P11|STARTED|Part 1 and 2 (Healthy Volunteers)||6
2279448|NCT02190604|5596401|P10|STARTED|Part 1 and 2 (Healthy Volunteers)||6
2279449|NCT02190604|5596402|P9|STARTED|Part 1 and 2 (Healthy Volunteers)||16
2279450|NCT02190604|5596403|P8|STARTED|Part 1 and 2 (Healthy Volunteers)||6
2279451|NCT02190604|5596404|P7|STARTED|Part 1 and 2 (Healthy Volunteers)||6
2279452|NCT02190604|5596405|P6|STARTED|Part 1 and 2 (Healthy Volunteers)||6
2279453|NCT02190604|5596406|P5|STARTED|Part 1 and 2 (Healthy Volunteers)||6
2279454|NCT02190604|5596407|P4|STARTED|Part 1 and 2 (Healthy Volunteers)||6
2279455|NCT02190604|5596408|P3|STARTED|Part 1 and 2 (Healthy Volunteers)||6
2279456|NCT02190604|5596409|P2|STARTED|Part 1 and 2 (Healthy Volunteers)||6
2279457|NCT02190604|5596410|P1|STARTED|Part 1 and 2 (Healthy Volunteers)||6
2279458|NCT02190591|5596601|P2|NOT COMPLETED|Overall Study||11
2279459|NCT02190591|5596602|P1|NOT COMPLETED|Overall Study||2
2279460|NCT02190591|5596601|P2|COMPLETED|Overall Study||91
2279461|NCT02190591|5596602|P1|COMPLETED|Overall Study||100
2279462|NCT02190591|5596601|P2|STARTED|Overall Study||102
2279463|NCT02190591|5596602|P1|STARTED|Overall Study||102
2279464|NCT02190552|5596612|P1|NOT COMPLETED|Overall Study||4
2279465|NCT02190552|5596612|P1|COMPLETED|Overall Study||36
2279466|NCT02190552|5596612|P1|STARTED|Overall Study||40
2279467|NCT02190435|5596625|P2|NOT COMPLETED|Overall Study||0
2279468|NCT02190435|5596626|P1|NOT COMPLETED|Overall Study||15
2279469|NCT02190435|5596625|P2|COMPLETED|Overall Study||24
2279470|NCT02190435|5596626|P1|COMPLETED|Overall Study||26
2279471|NCT02190435|5596625|P2|STARTED|Overall Study||24
2279472|NCT02190435|5596626|P1|STARTED|Overall Study||41
2279473|NCT02190279|5596637|P3|NOT COMPLETED|Overall Study||3
2279474|NCT02190279|5596638|P2|NOT COMPLETED|Overall Study||0
2279475|NCT02190279|5596639|P1|NOT COMPLETED|Overall Study||3
2279476|NCT02190279|5596637|P3|COMPLETED|Overall Study||28
2279477|NCT02190279|5596638|P2|COMPLETED|Overall Study||69
2279478|NCT02190279|5596639|P1|COMPLETED|Overall Study||13
2279479|NCT02190279|5596637|P3|STARTED|Overall Study||31
2279480|NCT02190279|5596638|P2|STARTED|Overall Study||69
2279481|NCT02190279|5596639|P1|STARTED|Overall Study||16
2279482|NCT02190045|5596660|P2|NOT COMPLETED|Overall Study||0
2279483|NCT02190045|5596661|P1|NOT COMPLETED|Overall Study||3
2279484|NCT02190045|5596660|P2|COMPLETED|Overall Study||15
2279485|NCT02190045|5596661|P1|COMPLETED|Overall Study||12
2279486|NCT02190045|5596660|P2|STARTED|Overall Study||15
2279487|NCT02190045|5596661|P1|STARTED|Overall Study||15
2279488|NCT02189954|5596669|P2|NOT COMPLETED|Overall Study||0
2279489|NCT02189954|5596670|P1|NOT COMPLETED|Overall Study||0
2279490|NCT02189954|5596669|P2|COMPLETED|Overall Study||45
2279491|NCT02189954|5596670|P1|COMPLETED|Overall Study||45
2279492|NCT02189954|5596669|P2|STARTED|Overall Study||45
2279493|NCT02189954|5596670|P1|STARTED|Overall Study||45
2279494|NCT02189941|5596678|P3|NOT COMPLETED|Overall Study||1
2279495|NCT02189941|5596679|P2|NOT COMPLETED|Overall Study||0
2279496|NCT02189941|5596680|P1|NOT COMPLETED|Overall Study||0
2279497|NCT02189941|5596678|P3|COMPLETED|Overall Study||2
2279498|NCT02189941|5596679|P2|COMPLETED|Overall Study||4
2279499|NCT02189941|5596680|P1|COMPLETED|Overall Study||4
2279500|NCT02189941|5596678|P3|STARTED|Overall Study||3
2279501|NCT02189941|5596679|P2|STARTED|Overall Study||4
2279502|NCT02189941|5596680|P1|STARTED|Overall Study||4
2279503|NCT02189915|5596703|P1|NOT COMPLETED|Overall Study||3
2279504|NCT02189915|5596703|P1|COMPLETED|Overall Study||11
2279505|NCT02189915|5596703|P1|STARTED|Overall Study||14
2279506|NCT02189863|5596708|P2|NOT COMPLETED|Second 2 Weeks||0
2279507|NCT02189863|5596709|P1|NOT COMPLETED|Second 2 Weeks||0
2279508|NCT02189863|5596708|P2|COMPLETED|Second 2 Weeks||13
2279509|NCT02189863|5596709|P1|COMPLETED|Second 2 Weeks||8
2279510|NCT02189863|5596708|P2|STARTED|Second 2 Weeks||13
2279511|NCT02189863|5596709|P1|STARTED|Second 2 Weeks||8
2279512|NCT02189863|5596708|P2|NOT COMPLETED|First 2 Weeks||2
2279513|NCT02189863|5596709|P1|NOT COMPLETED|First 2 Weeks||4
2279514|NCT02189863|5596708|P2|COMPLETED|First 2 Weeks||13
2279515|NCT02189863|5596709|P1|COMPLETED|First 2 Weeks||8
2279516|NCT02189863|5596708|P2|STARTED|First 2 Weeks||15
2279517|NCT02189863|5596709|P1|STARTED|First 2 Weeks||12
2279518|NCT02189837|5596724|P4|NOT COMPLETED|Overall Study||2
2279519|NCT02189837|5596725|P3|NOT COMPLETED|Overall Study||3
2279520|NCT02189837|5596726|P2|NOT COMPLETED|Overall Study||1
2279521|NCT02189837|5596727|P1|NOT COMPLETED|Overall Study||2
2279522|NCT02189837|5596724|P4|COMPLETED|Overall Study||19
2279523|NCT02189837|5596725|P3|COMPLETED|Overall Study||20
2279524|NCT02189837|5596726|P2|COMPLETED|Overall Study||22
2279525|NCT02189837|5596727|P1|COMPLETED|Overall Study||20
2279526|NCT02189837|5596724|P4|Received Treatment|Overall Study||20
2279527|NCT02189837|5596725|P3|Received Treatment|Overall Study||22
2279528|NCT02189837|5596726|P2|Received Treatment|Overall Study||22
2279529|NCT02189837|5596727|P1|Received Treatment|Overall Study||21
2279530|NCT02189837|5596724|P4|STARTED|Overall Study||21
2279531|NCT02189837|5596725|P3|STARTED|Overall Study||23
2279532|NCT02189837|5596726|P2|STARTED|Overall Study||23
2279533|NCT02189837|5596727|P1|STARTED|Overall Study||22
2279534|NCT02189759|5596757|P4|NOT COMPLETED|Overall Study||5
2279535|NCT02189759|5596758|P3|NOT COMPLETED|Overall Study||2
2279536|NCT02189759|5596759|P2|NOT COMPLETED|Overall Study||0
2279537|NCT02189759|5596760|P1|NOT COMPLETED|Overall Study||0
2279538|NCT02189759|5596757|P4|COMPLETED|Overall Study||84
2279539|NCT02189759|5596758|P3|COMPLETED|Overall Study||81
2279540|NCT02189759|5596759|P2|COMPLETED|Overall Study||101
2279541|NCT02189759|5596760|P1|COMPLETED|Overall Study||102
2279542|NCT02189759|5596757|P4|STARTED|Overall Study||89
2279543|NCT02189759|5596758|P3|STARTED|Overall Study||83
2279544|NCT02189759|5596759|P2|STARTED|Overall Study||101
2279545|NCT02189759|5596760|P1|STARTED|Overall Study||102
2279546|NCT02189668|5596780|P2|NOT COMPLETED|Overall Study||0
2279547|NCT02189668|5596781|P1|NOT COMPLETED|Overall Study||0
2279548|NCT02189668|5596780|P2|COMPLETED|Overall Study||9
2279549|NCT02189668|5596781|P1|COMPLETED|Overall Study||5
2279550|NCT02189668|5596780|P2|STARTED|Overall Study||9
2279551|NCT02189668|5596781|P1|STARTED|Overall Study||5
2279552|NCT02189629|5596789|P1|NOT COMPLETED|Overall Study||105
2279553|NCT02189629|5596789|P1|COMPLETED|Overall Study||348
2279554|NCT02189629|5596789|P1|STARTED|Overall Study||453
2279561|NCT02189382|5596819|P2|NOT COMPLETED|Overall Study||0
2279562|NCT02189382|5596820|P1|NOT COMPLETED|Overall Study||0
2279563|NCT02189382|5596819|P2|COMPLETED|Overall Study||35
2279564|NCT02189382|5596820|P1|COMPLETED|Overall Study||35
2279565|NCT02189382|5596819|P2|STARTED|Overall Study||35
2279566|NCT02189382|5596820|P1|STARTED|Overall Study||35
2279567|NCT02189317|5596830|P2|NOT COMPLETED|Overall Study||0
2279568|NCT02189317|5596831|P1|NOT COMPLETED|Overall Study||0
2279569|NCT02189317|5596830|P2|COMPLETED|Overall Study||16
2279570|NCT02189317|5596831|P1|COMPLETED|Overall Study||16
2279571|NCT02189317|5596830|P2|STARTED|Overall Study||16
2279572|NCT02189317|5596831|P1|STARTED|Overall Study||16
2279573|NCT02189252|5596845|P4|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
2279574|NCT02189252|5596846|P3|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
2279575|NCT02189252|5596847|P2|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
2279576|NCT02189252|5596848|P1|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
2279577|NCT02189252|5596845|P4|COMPLETED|Period 2 (Visit6b, Week 12)||4
2279578|NCT02189252|5596846|P3|COMPLETED|Period 2 (Visit6b, Week 12)||3
2279579|NCT02189252|5596847|P2|COMPLETED|Period 2 (Visit6b, Week 12)||2
2279580|NCT02189252|5596848|P1|COMPLETED|Period 2 (Visit6b, Week 12)||4
2279581|NCT02189252|5596845|P4|STARTED|Period 2 (Visit6b, Week 12)||4
2279582|NCT02189252|5596846|P3|STARTED|Period 2 (Visit6b, Week 12)||3
2279583|NCT02189252|5596847|P2|STARTED|Period 2 (Visit6b, Week 12)||2
2279584|NCT02189252|5596848|P1|STARTED|Period 2 (Visit6b, Week 12)||4
2279585|NCT02189252|5596845|P4|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
2279586|NCT02189252|5596846|P3|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
2279587|NCT02189252|5596847|P2|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||2
2279588|NCT02189252|5596848|P1|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
2279589|NCT02189252|5596845|P4|COMPLETED|Period 1 (Visit 4b, Week 4)||4
2279590|NCT02189252|5596846|P3|COMPLETED|Period 1 (Visit 4b, Week 4)||3
2279591|NCT02189252|5596847|P2|COMPLETED|Period 1 (Visit 4b, Week 4)||2
2279592|NCT02189252|5596848|P1|COMPLETED|Period 1 (Visit 4b, Week 4)||4
2279593|NCT02189252|5596845|P4|STARTED|Period 1 (Visit 4b, Week 4)||4
2279594|NCT02189252|5596846|P3|STARTED|Period 1 (Visit 4b, Week 4)||3
2279595|NCT02189252|5596847|P2|STARTED|Period 1 (Visit 4b, Week 4)||4
2279596|NCT02189252|5596848|P1|STARTED|Period 1 (Visit 4b, Week 4)||4
2279597|NCT02189161|5596880|P1|NOT COMPLETED|Overall Study||0
2279598|NCT02189161|5596880|P1|COMPLETED|Overall Study||10
2279599|NCT02189161|5596880|P1|STARTED|Overall Study||10
2279600|NCT02189122|5596888|P2|NOT COMPLETED|Overall Study||0
2279601|NCT02189122|5596889|P1|NOT COMPLETED|Overall Study||0
2279602|NCT02189122|5596888|P2|COMPLETED|Overall Study||18
2279603|NCT02189122|5596889|P1|COMPLETED|Overall Study||18
2279604|NCT02189122|5596888|P2|STARTED|Overall Study||18
2279605|NCT02189122|5596889|P1|STARTED|Overall Study||18
2279606|NCT02188849|5596907|P2|NOT COMPLETED|Overall Study||8
2279607|NCT02188849|5596908|P1|NOT COMPLETED|Overall Study||3
2279608|NCT02188849|5596907|P2|COMPLETED|Overall Study||17
2279609|NCT02188849|5596908|P1|COMPLETED|Overall Study||22
2279610|NCT02188849|5596907|P2|STARTED|Overall Study||25
2279611|NCT02188849|5596908|P1|STARTED|Overall Study||25
2279612|NCT02188784|5596922|P2|NOT COMPLETED|Overall Study||13
2279613|NCT02188784|5596923|P1|NOT COMPLETED|Overall Study||9
2279614|NCT02188784|5596922|P2|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|101
2279615|NCT02188784|5596923|P1|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|102
2279616|NCT02188784|5596922|P2|STARTED|Overall Study||114
2279617|NCT02188784|5596923|P1|STARTED|Overall Study||111
2279618|NCT02188589|5596939|P1|NOT COMPLETED|Overall Study||5
2279619|NCT02188589|5596939|P1|COMPLETED|Overall Study||25
2279620|NCT02188589|5596939|P1|24 Months|Overall Study||25
2279621|NCT02188589|5596939|P1|12 Months|Overall Study||30
2279622|NCT02188589|5596939|P1|6 Months|Overall Study||30
2279623|NCT02188589|5596939|P1|STARTED|Overall Study||30
2279624|NCT02188576|5596947|P2|NOT COMPLETED|Overall Study||0
2279625|NCT02188576|5596948|P1|NOT COMPLETED|Overall Study||0
2279626|NCT02188576|5596947|P2|COMPLETED|Overall Study||34
2279627|NCT02188576|5596948|P1|COMPLETED|Overall Study||32
2279628|NCT02188576|5596947|P2|STARTED|Overall Study||34
2279629|NCT02188576|5596948|P1|STARTED|Overall Study||32
2279630|NCT02187887|5596958|P2|NOT COMPLETED|Overall Study||4
2279631|NCT02187887|5596959|P1|NOT COMPLETED|Overall Study||5
2279632|NCT02187887|5596958|P2|COMPLETED|Overall Study||396
2279633|NCT02187887|5596959|P1|COMPLETED|Overall Study||388
2279634|NCT02187887|5596958|P2|STARTED|Overall Study||400
2279635|NCT02187887|5596959|P1|STARTED|Overall Study||393
2279636|NCT02187861|5596971|P4|NOT COMPLETED|Overall Study||32
2279637|NCT02187861|5596972|P3|NOT COMPLETED|Overall Study||32
2279638|NCT02187861|5596973|P2|NOT COMPLETED|Overall Study||48
2279639|NCT02187861|5596974|P1|NOT COMPLETED|Overall Study||6
2279640|NCT02187861|5596971|P4|COMPLETED|Overall Study||19
2279641|NCT02187861|5596972|P3|COMPLETED|Overall Study||19
2279642|NCT02187861|5596973|P2|COMPLETED|Overall Study||4
2279643|NCT02187861|5596974|P1|COMPLETED|Overall Study||3
2279644|NCT02187861|5596971|P4|Treated|Overall Study||50
2279645|NCT02187861|5596972|P3|Treated|Overall Study||49
2279646|NCT02187861|5596973|P2|Treated|Overall Study||52
2279647|NCT02187861|5596974|P1|Treated|Overall Study||9
2279648|NCT02187861|5596971|P4|STARTED|Overall Study||51
2279649|NCT02187861|5596972|P3|STARTED|Overall Study||51
2279650|NCT02187861|5596973|P2|STARTED|Overall Study||52
2279651|NCT02187861|5596974|P1|STARTED|Overall Study||9
2279652|NCT02187809|5597070|P1|NOT COMPLETED|Overall Study||3
2279653|NCT02187809|5597070|P1|COMPLETED|Overall Study||0
2279654|NCT02187809|5597070|P1|Treated|Overall Study||1
2279655|NCT02187809|5597070|P1|STARTED|Overall Study||3
2279656|NCT02187783|5597080|P1|NOT COMPLETED|Overall Study||106
2279657|NCT02187783|5597080|P1|COMPLETED|Overall Study||0
2279658|NCT02187783|5597080|P1|Patients With Solid Tumors|Overall Study||105
2279659|NCT02187783|5597080|P1|STARTED|Overall Study||106
2279660|NCT02187744|5597091|P2|NOT COMPLETED|Treatment||5
2279661|NCT02187744|5597092|P1|NOT COMPLETED|Treatment||4
2279662|NCT02187744|5597091|P2|COMPLETED|Treatment||107
2279663|NCT02187744|5597092|P1|COMPLETED|Treatment||109
2279664|NCT02187744|5597091|P2|STARTED|Treatment||112
2279665|NCT02187744|5597092|P1|STARTED|Treatment||113
2279666|NCT02187744|5597091|P2|NOT COMPLETED|Study||6
2279667|NCT02187744|5597092|P1|NOT COMPLETED|Study||4
2279668|NCT02187744|5597091|P2|COMPLETED|Study||106
2279669|NCT02187744|5597092|P1|COMPLETED|Study||109
2279670|NCT02187744|5597091|P2|STARTED|Study|Received treatment|112
2279671|NCT02187744|5597092|P1|STARTED|Study|Received treatment|113
2279672|NCT02187172|5597110|P2|NOT COMPLETED|Overall Study||6
2279673|NCT02187172|5597111|P1|NOT COMPLETED|Overall Study||3
2279674|NCT02187172|5597110|P2|COMPLETED|Overall Study||15
2279675|NCT02187172|5597111|P1|COMPLETED|Overall Study||19
2279676|NCT02187172|5597110|P2|RCT Phase Completed|Overall Study||19
2279677|NCT02187172|5597111|P1|RCT Phase Completed|Overall Study||22
2279678|NCT02187172|5597110|P2|STARTED|Overall Study||21
2279679|NCT02187172|5597111|P1|STARTED|Overall Study||22
2279680|NCT02187055|5597278|P3|NOT COMPLETED|Overall Study||74
2279681|NCT02187055|5597279|P2|NOT COMPLETED|Overall Study||73
2279682|NCT02187055|5597280|P1|NOT COMPLETED|Overall Study||69
2279683|NCT02187055|5597278|P3|COMPLETED|Overall Study||312
2279684|NCT02187055|5597279|P2|COMPLETED|Overall Study||303
2279685|NCT02187055|5597280|P1|COMPLETED|Overall Study||315
2279686|NCT02187055|5597278|P3|STARTED|Overall Study|Treated|386
2279687|NCT02187055|5597279|P2|STARTED|Overall Study|Treated|376
2279688|NCT02187055|5597280|P1|STARTED|Overall Study|Treated|384
2279689|NCT02187042|5597380|P2|NOT COMPLETED|Overall Study||14
2279690|NCT02187042|5597381|P1|NOT COMPLETED|Overall Study||13
2279691|NCT02187042|5597380|P2|COMPLETED|Overall Study||13
2279692|NCT02187042|5597381|P1|COMPLETED|Overall Study||29
2279693|NCT02187042|5597380|P2|STARTED|Overall Study||27
2279694|NCT02187042|5597381|P1|STARTED|Overall Study||42
2279695|NCT02187029|5597427|P4|NOT COMPLETED|Overall Study||3
2279696|NCT02187029|5597428|P3|NOT COMPLETED|Overall Study||11
2279697|NCT02187029|5597429|P2|NOT COMPLETED|Overall Study||1
2279698|NCT02187029|5597430|P1|NOT COMPLETED|Overall Study||1
2279699|NCT02187029|5597427|P4|COMPLETED|Overall Study||6
2279700|NCT02187029|5597428|P3|COMPLETED|Overall Study||0
2279701|NCT02187029|5597429|P2|COMPLETED|Overall Study||2
2279702|NCT02187029|5597430|P1|COMPLETED|Overall Study||6
2279703|NCT02187029|5597427|P4|STARTED|Overall Study||9
2279704|NCT02187029|5597428|P3|STARTED|Overall Study||11
2279705|NCT02187029|5597429|P2|STARTED|Overall Study||3
2279706|NCT02187029|5597430|P1|STARTED|Overall Study||7
2279707|NCT02187016|5597506|P4|NOT COMPLETED|Overall Study||0
2279708|NCT02187016|5597507|P3|NOT COMPLETED|Overall Study||1
2279709|NCT02187016|5597508|P2|NOT COMPLETED|Overall Study||2
2279710|NCT02187016|5597509|P1|NOT COMPLETED|Overall Study||1
2279711|NCT02187016|5597506|P4|COMPLETED|Overall Study||51
2279712|NCT02187016|5597507|P3|COMPLETED|Overall Study||78
2279713|NCT02187016|5597508|P2|COMPLETED|Overall Study||78
2279714|NCT02187016|5597509|P1|COMPLETED|Overall Study||79
2279715|NCT02187016|5597506|P4|STARTED|Overall Study||51
2279716|NCT02187016|5597507|P3|STARTED|Overall Study||79
2279717|NCT02187016|5597508|P2|STARTED|Overall Study||80
2279718|NCT02187016|5597509|P1|STARTED|Overall Study||80
2279719|NCT02186938|5597541|P2|NOT COMPLETED|Overall Study||3
2279720|NCT02186938|5597542|P1|NOT COMPLETED|Overall Study||9
2279721|NCT02186938|5597541|P2|COMPLETED|Overall Study||44
2279722|NCT02186938|5597542|P1|COMPLETED|Overall Study||38
2279723|NCT02186938|5597541|P2|STARTED|Overall Study||47
2279724|NCT02186938|5597542|P1|STARTED|Overall Study|2012|47
2279725|NCT02186873|5597552|P2|NOT COMPLETED|Overall Study||8
2279726|NCT02186873|5597553|P1|NOT COMPLETED|Overall Study||9
2279727|NCT02186873|5597552|P2|COMPLETED|Overall Study||97
2279728|NCT02186873|5597553|P1|COMPLETED|Overall Study||94
2279729|NCT02186873|5597552|P2|End of Control Period|Overall Study|Participants continued to receive golimumab|105
2279730|NCT02186873|5597553|P1|End of Control Period|Overall Study|Participants taking placebo crossed over to golimumab|99
2279731|NCT02186873|5597552|P2|STARTED|Overall Study||105
2279732|NCT02186873|5597553|P1|STARTED|Overall Study||103
2279733|NCT02186834|5597576|P6|NOT COMPLETED|Treatment at RP2D||1
2279734|NCT02186834|5597577|P5|NOT COMPLETED|Treatment at RP2D||0
2279735|NCT02186834|5597578|P4|NOT COMPLETED|Treatment at RP2D||0
2279736|NCT02186834|5597579|P3|NOT COMPLETED|Treatment at RP2D||0
2279737|NCT02186834|5597580|P2|NOT COMPLETED|Treatment at RP2D||0
2279738|NCT02186834|5597581|P1|NOT COMPLETED|Treatment at RP2D||0
2279739|NCT02186834|5597576|P6|COMPLETED|Treatment at RP2D||13
2279740|NCT02186834|5597577|P5|COMPLETED|Treatment at RP2D||0
2279741|NCT02186834|5597578|P4|COMPLETED|Treatment at RP2D||0
2279742|NCT02186834|5597579|P3|COMPLETED|Treatment at RP2D||0
2279743|NCT02186834|5597580|P2|COMPLETED|Treatment at RP2D||0
2279744|NCT02186834|5597581|P1|COMPLETED|Treatment at RP2D||0
2279745|NCT02186834|5597576|P6|STARTED|Treatment at RP2D||14
2279746|NCT02186834|5597577|P5|STARTED|Treatment at RP2D||0
2279747|NCT02186834|5597578|P4|STARTED|Treatment at RP2D||0
2279748|NCT02186834|5597579|P3|STARTED|Treatment at RP2D||0
2279749|NCT02186834|5597580|P2|STARTED|Treatment at RP2D||0
2279750|NCT02186834|5597581|P1|STARTED|Treatment at RP2D||0
2279751|NCT02186834|5597576|P6|NOT COMPLETED|Dose Escalation||0
2279752|NCT02186834|5597577|P5|NOT COMPLETED|Dose Escalation||0
2279753|NCT02186834|5597578|P4|NOT COMPLETED|Dose Escalation||1
2279754|NCT02186834|5597579|P3|NOT COMPLETED|Dose Escalation||0
2279755|NCT02186834|5597580|P2|NOT COMPLETED|Dose Escalation||0
2279756|NCT02186834|5597581|P1|NOT COMPLETED|Dose Escalation||0
2279757|NCT02186834|5597576|P6|COMPLETED|Dose Escalation||0
2279758|NCT02186834|5597577|P5|COMPLETED|Dose Escalation||4
2279759|NCT02186834|5597578|P4|COMPLETED|Dose Escalation||6
2279760|NCT02186834|5597579|P3|COMPLETED|Dose Escalation||0
2279761|NCT02186834|5597580|P2|COMPLETED|Dose Escalation||3
2279762|NCT02186834|5597581|P1|COMPLETED|Dose Escalation||6
2279763|NCT02186834|5597576|P6|STARTED|Dose Escalation||0
2279764|NCT02186834|5597577|P5|STARTED|Dose Escalation||4
2279765|NCT02186834|5597578|P4|STARTED|Dose Escalation||7
2279766|NCT02186834|5597579|P3|STARTED|Dose Escalation||0
2279767|NCT02186834|5597580|P2|STARTED|Dose Escalation||3
2279768|NCT02186834|5597581|P1|STARTED|Dose Escalation||6
2279769|NCT02186808|5597592|P1|NOT COMPLETED|Overall Study||13
2279770|NCT02186808|5597592|P1|COMPLETED|Overall Study||67
2279771|NCT02186808|5597592|P1|STARTED|Overall Study||80
2279772|NCT02186795|5597599|P2|NOT COMPLETED|Overall Study||0
2279773|NCT02186795|5597600|P1|NOT COMPLETED|Overall Study||0
2279774|NCT02186795|5597599|P2|COMPLETED|Overall Study||24
2279775|NCT02186795|5597600|P1|COMPLETED|Overall Study||24
2279776|NCT02186795|5597599|P2|STARTED|Overall Study||24
2279777|NCT02186795|5597600|P1|STARTED|Overall Study||24
2279778|NCT02186665|5597608|P2|NOT COMPLETED|Overall Study||1
2279779|NCT02186665|5597609|P1|NOT COMPLETED|Overall Study||0
2279780|NCT02186665|5597608|P2|COMPLETED|Overall Study||10
2279781|NCT02186665|5597609|P1|COMPLETED|Overall Study||8
2279782|NCT02186665|5597608|P2|STARTED|Overall Study||11
2279783|NCT02186665|5597609|P1|STARTED|Overall Study||8
2279784|NCT02186652|5597617|P2|NOT COMPLETED|Overall Study||0
2279785|NCT02186652|5597618|P1|NOT COMPLETED|Overall Study||2
2279786|NCT02186652|5597617|P2|COMPLETED|Overall Study||22
2279787|NCT02186652|5597618|P1|COMPLETED|Overall Study||17
2279788|NCT02186652|5597617|P2|STARTED|Overall Study||22
2279789|NCT02186652|5597618|P1|STARTED|Overall Study||19
2279790|NCT02186587|5597645|P2|NOT COMPLETED|Overall Study||0
2279791|NCT02186587|5597646|P1|NOT COMPLETED|Overall Study||5
2279792|NCT02186587|5597645|P2|COMPLETED|Overall Study||0
2279793|NCT02186587|5597646|P1|COMPLETED|Overall Study||23
2279794|NCT02186587|5597645|P2|STARTED|Overall Study||0
2279795|NCT02186587|5597646|P1|STARTED|Overall Study||28
2279796|NCT02186561|5597651|P1|NOT COMPLETED|3 - Year Post Index Procedure Visit||13
2279797|NCT02186561|5597651|P1|COMPLETED|3 - Year Post Index Procedure Visit||128
2279798|NCT02186561|5597651|P1|STARTED|3 - Year Post Index Procedure Visit||141
2279799|NCT02186561|5597651|P1|NOT COMPLETED|2 - Year Post Index Procedure Visit||7
2279800|NCT02186561|5597651|P1|COMPLETED|2 - Year Post Index Procedure Visit||134
2279801|NCT02186561|5597651|P1|STARTED|2 - Year Post Index Procedure Visit||141
2279802|NCT02186561|5597651|P1|NOT COMPLETED|1- Year Post Index Procedure Visit||2
2279803|NCT02186561|5597651|P1|COMPLETED|1- Year Post Index Procedure Visit||139
2279804|NCT02186561|5597651|P1|STARTED|1- Year Post Index Procedure Visit||141
2279805|NCT02186561|5597651|P1|NOT COMPLETED|180- Day Post Index Procedure Visit||7
2279806|NCT02186561|5597651|P1|COMPLETED|180- Day Post Index Procedure Visit||134
2279807|NCT02186561|5597651|P1|STARTED|180- Day Post Index Procedure Visit||141
2279808|NCT02186561|5597651|P1|NOT COMPLETED|30-Day Post Index Procedure Visit||1
2279809|NCT02186561|5597651|P1|COMPLETED|30-Day Post Index Procedure Visit||140
2279810|NCT02186561|5597651|P1|STARTED|30-Day Post Index Procedure Visit||141
2279811|NCT02186561|5597651|P1|NOT COMPLETED|Subjects Implanted With Device||0
2279812|NCT02186561|5597651|P1|COMPLETED|Subjects Implanted With Device||141
2279813|NCT02186561|5597651|P1|STARTED|Subjects Implanted With Device||141
2279814|NCT02186561|5597651|P1|NOT COMPLETED|Enrollment||56
2279815|NCT02186561|5597651|P1|COMPLETED|Enrollment||141
2279816|NCT02186561|5597651|P1|STARTED|Enrollment||197
2279817|NCT02186509|5597661|P1|NOT COMPLETED|Overall Study||0
2279818|NCT02186509|5597661|P1|COMPLETED|Overall Study||17
2279819|NCT02186509|5597661|P1|STARTED|Overall Study||17
2279820|NCT02186301|5597671|P3|NOT COMPLETED|Overall Study||50
2279821|NCT02186301|5597672|P2|NOT COMPLETED|Overall Study||30
2279822|NCT02186301|5597673|P1|NOT COMPLETED|Overall Study||20
2279823|NCT02186301|5597671|P3|COMPLETED|Overall Study|Patients who are off study for any reason.|0
2279824|NCT02186301|5597672|P2|COMPLETED|Overall Study|Patients who are off study for any reason.|0
2279825|NCT02186301|5597673|P1|COMPLETED|Overall Study|Patients who are off study for any reason.|0
2279826|NCT02186301|5597671|P3|STARTED|Overall Study||50
2279827|NCT02186301|5597672|P2|STARTED|Overall Study||30
2279828|NCT02186301|5597673|P1|STARTED|Overall Study||20
2279829|NCT02186223|5597689|P1|NOT COMPLETED|Overall Study||21
2279830|NCT02186223|5597689|P1|COMPLETED|Overall Study||151
2279831|NCT02186223|5597689|P1|Device Placed|Overall Study||163
2279832|NCT02186223|5597689|P1|STARTED|Overall Study||172
2279833|NCT02186210|5597700|P2|NOT COMPLETED|Overall Study||0
2279834|NCT02186210|5597701|P1|NOT COMPLETED|Overall Study||0
2279835|NCT02186210|5597700|P2|COMPLETED|Overall Study||20
2279836|NCT02186210|5597701|P1|COMPLETED|Overall Study||20
2279837|NCT02186210|5597700|P2|STARTED|Overall Study||20
2279838|NCT02186210|5597701|P1|STARTED|Overall Study||20
2279839|NCT02186171|5597711|P2|NOT COMPLETED|Overall Study||15
2279840|NCT02186171|5597712|P1|NOT COMPLETED|Overall Study||4
2279841|NCT02186171|5597711|P2|COMPLETED|Overall Study||148
2279842|NCT02186171|5597712|P1|COMPLETED|Overall Study||78
2279843|NCT02186171|5597711|P2|Received Treatment|Overall Study||163
2279844|NCT02186171|5597712|P1|Received Treatment|Overall Study||81
2279845|NCT02186171|5597711|P2|STARTED|Overall Study||163
2279846|NCT02186171|5597712|P1|STARTED|Overall Study||82
2279847|NCT02185729|5597728|P1|NOT COMPLETED|24 Hours Into Dextrose Infusion||0
2279848|NCT02185729|5597728|P1|COMPLETED|24 Hours Into Dextrose Infusion||12
2279849|NCT02185729|5597728|P1|STARTED|24 Hours Into Dextrose Infusion||12
2279850|NCT02185729|5597728|P1|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
2279851|NCT02185729|5597728|P1|COMPLETED|4 Hours Into Dextrose Infusion||12
2279852|NCT02185729|5597728|P1|STARTED|4 Hours Into Dextrose Infusion||12
2279853|NCT02185729|5597728|P1|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
2279854|NCT02185729|5597728|P1|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
2279855|NCT02185729|5597728|P1|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
2279856|NCT02185729|5597728|P1|NOT COMPLETED|24 Hours Into ClinOleic Infusion||0
2279857|NCT02185729|5597728|P1|COMPLETED|24 Hours Into ClinOleic Infusion||12
2279858|NCT02185729|5597728|P1|STARTED|24 Hours Into ClinOleic Infusion||12
2279859|NCT02185729|5597728|P1|NOT COMPLETED|4 Hours Into ClinOleic Infusion||0
2279860|NCT02185729|5597728|P1|COMPLETED|4 Hours Into ClinOleic Infusion||12
2279861|NCT02185729|5597728|P1|STARTED|4 Hours Into ClinOleic Infusion||12
2279862|NCT02185729|5597728|P1|NOT COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||0
2279863|NCT02185729|5597728|P1|COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||12
2279864|NCT02185729|5597728|P1|STARTED|0 Hour (Baseline) of ClinOleic Infusion||12
2279865|NCT02185729|5597728|P1|NOT COMPLETED|24 Hours Into Intralipid Infusion||0
2279866|NCT02185729|5597728|P1|COMPLETED|24 Hours Into Intralipid Infusion||12
2279867|NCT02185729|5597728|P1|STARTED|24 Hours Into Intralipid Infusion||12
2279868|NCT02185729|5597728|P1|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
2279869|NCT02185729|5597728|P1|COMPLETED|4 Hours Into Intralipid Infusion||12
2279870|NCT02185729|5597728|P1|STARTED|4 Hours Into Intralipid Infusion||12
2279871|NCT02185729|5597728|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
2279872|NCT02185729|5597728|P1|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
2279873|NCT02185729|5597728|P1|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
2279874|NCT02185729|5597728|P1|NOT COMPLETED|24 Hours Into Saline Infusion||0
2279875|NCT02185729|5597728|P1|COMPLETED|24 Hours Into Saline Infusion||12
2279876|NCT02185729|5597728|P1|STARTED|24 Hours Into Saline Infusion||12
2279877|NCT02185729|5597728|P1|NOT COMPLETED|4 Hours Into Saline Infusion||0
2279878|NCT02185729|5597728|P1|COMPLETED|4 Hours Into Saline Infusion||12
2279879|NCT02185729|5597728|P1|STARTED|4 Hours Into Saline Infusion||12
2279880|NCT02185729|5597728|P1|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
2279881|NCT02185729|5597728|P1|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
2279882|NCT02185729|5597728|P1|STARTED|0 Hour (Baseline) of Saline Infusion||12
2279883|NCT02185534|5597749|P6|NOT COMPLETED|Third Period||0
2279884|NCT02185534|5597750|P5|NOT COMPLETED|Third Period||0
2279885|NCT02185534|5597751|P4|NOT COMPLETED|Third Period||0
2279886|NCT02185534|5597752|P3|NOT COMPLETED|Third Period||0
2279887|NCT02185534|5597753|P2|NOT COMPLETED|Third Period||0
2279888|NCT02185534|5597754|P1|NOT COMPLETED|Third Period||0
2279889|NCT02185534|5597749|P6|COMPLETED|Third Period||13
2279890|NCT02185534|5597750|P5|COMPLETED|Third Period||13
2279891|NCT02185534|5597751|P4|COMPLETED|Third Period||13
2279892|NCT02185534|5597752|P3|COMPLETED|Third Period||14
2279893|NCT02185534|5597753|P2|COMPLETED|Third Period||14
2279894|NCT02185534|5597754|P1|COMPLETED|Third Period||13
2279895|NCT02185534|5597749|P6|STARTED|Third Period||13
2279896|NCT02185534|5597750|P5|STARTED|Third Period||13
2279897|NCT02185534|5597751|P4|STARTED|Third Period||13
2279898|NCT02185534|5597752|P3|STARTED|Third Period||14
2279899|NCT02185534|5597753|P2|STARTED|Third Period||14
2279900|NCT02185534|5597754|P1|STARTED|Third Period||13
2279901|NCT02185534|5597749|P6|NOT COMPLETED|Second Washout Period||0
2279902|NCT02185534|5597750|P5|NOT COMPLETED|Second Washout Period||0
2279903|NCT02185534|5597751|P4|NOT COMPLETED|Second Washout Period||0
2279904|NCT02185534|5597752|P3|NOT COMPLETED|Second Washout Period||0
2279905|NCT02185534|5597753|P2|NOT COMPLETED|Second Washout Period||0
2279906|NCT02185534|5597754|P1|NOT COMPLETED|Second Washout Period||0
2279907|NCT02185534|5597749|P6|COMPLETED|Second Washout Period||13
2279908|NCT02185534|5597750|P5|COMPLETED|Second Washout Period||13
2279909|NCT02185534|5597751|P4|COMPLETED|Second Washout Period||13
2279910|NCT02185534|5597752|P3|COMPLETED|Second Washout Period||14
2279911|NCT02185534|5597753|P2|COMPLETED|Second Washout Period||14
2279912|NCT02185534|5597754|P1|COMPLETED|Second Washout Period||13
2279913|NCT02185534|5597749|P6|STARTED|Second Washout Period||13
2279914|NCT02185534|5597750|P5|STARTED|Second Washout Period||13
2279915|NCT02185534|5597751|P4|STARTED|Second Washout Period||13
2279916|NCT02185534|5597752|P3|STARTED|Second Washout Period||14
2279917|NCT02185534|5597753|P2|STARTED|Second Washout Period||14
2279918|NCT02185534|5597754|P1|STARTED|Second Washout Period||13
2279919|NCT02185534|5597749|P6|NOT COMPLETED|Second Period||0
2279920|NCT02185534|5597750|P5|NOT COMPLETED|Second Period||0
2279921|NCT02185534|5597751|P4|NOT COMPLETED|Second Period||0
2279922|NCT02185534|5597752|P3|NOT COMPLETED|Second Period||0
2279923|NCT02185534|5597753|P2|NOT COMPLETED|Second Period||0
2279924|NCT02185534|5597754|P1|NOT COMPLETED|Second Period||0
2279925|NCT02185534|5597749|P6|COMPLETED|Second Period||13
2279926|NCT02185534|5597750|P5|COMPLETED|Second Period||13
2279927|NCT02185534|5597751|P4|COMPLETED|Second Period||13
2279928|NCT02185534|5597752|P3|COMPLETED|Second Period||14
2279929|NCT02185534|5597753|P2|COMPLETED|Second Period||14
2279930|NCT02185534|5597754|P1|COMPLETED|Second Period||13
2279931|NCT02185534|5597749|P6|STARTED|Second Period||13
2279932|NCT02185534|5597750|P5|STARTED|Second Period||13
2279933|NCT02185534|5597751|P4|STARTED|Second Period||13
2279934|NCT02185534|5597752|P3|STARTED|Second Period||14
2279935|NCT02185534|5597753|P2|STARTED|Second Period||14
2279936|NCT02185534|5597754|P1|STARTED|Second Period||13
2279937|NCT02185534|5597749|P6|NOT COMPLETED|First Washout Period||1
2279938|NCT02185534|5597750|P5|NOT COMPLETED|First Washout Period||1
2279939|NCT02185534|5597751|P4|NOT COMPLETED|First Washout Period||0
2279940|NCT02185534|5597752|P3|NOT COMPLETED|First Washout Period||0
2279941|NCT02185534|5597753|P2|NOT COMPLETED|First Washout Period||0
2279942|NCT02185534|5597754|P1|NOT COMPLETED|First Washout Period||1
2279943|NCT02185534|5597749|P6|COMPLETED|First Washout Period||13
2279944|NCT02185534|5597750|P5|COMPLETED|First Washout Period||13
2279945|NCT02185534|5597751|P4|COMPLETED|First Washout Period||13
2279946|NCT02185534|5597752|P3|COMPLETED|First Washout Period||14
2279947|NCT02185534|5597753|P2|COMPLETED|First Washout Period||14
2279948|NCT02185534|5597754|P1|COMPLETED|First Washout Period||13
2279949|NCT02185534|5597749|P6|STARTED|First Washout Period||14
2279950|NCT02185534|5597750|P5|STARTED|First Washout Period||14
2279951|NCT02185534|5597751|P4|STARTED|First Washout Period||13
2279952|NCT02185534|5597752|P3|STARTED|First Washout Period||14
2279953|NCT02185534|5597753|P2|STARTED|First Washout Period||14
2279954|NCT02185534|5597754|P1|STARTED|First Washout Period||14
2279955|NCT02185534|5597749|P6|NOT COMPLETED|First Period||0
2279956|NCT02185534|5597750|P5|NOT COMPLETED|First Period||0
2279957|NCT02185534|5597751|P4|NOT COMPLETED|First Period||1
2279958|NCT02185534|5597752|P3|NOT COMPLETED|First Period||0
2279959|NCT02185534|5597753|P2|NOT COMPLETED|First Period||0
2279960|NCT02185534|5597754|P1|NOT COMPLETED|First Period||0
2279961|NCT02185534|5597749|P6|COMPLETED|First Period||14
2279962|NCT02185534|5597750|P5|COMPLETED|First Period||14
2279963|NCT02185534|5597751|P4|COMPLETED|First Period||13
2279964|NCT02185534|5597752|P3|COMPLETED|First Period||14
2279965|NCT02185534|5597753|P2|COMPLETED|First Period||14
2279966|NCT02185534|5597754|P1|COMPLETED|First Period||14
2279967|NCT02185534|5597749|P6|STARTED|First Period||14
2279968|NCT02185534|5597750|P5|STARTED|First Period||14
2279969|NCT02185534|5597751|P4|STARTED|First Period||14
2279970|NCT02185534|5597752|P3|STARTED|First Period||14
2279971|NCT02185534|5597753|P2|STARTED|First Period||14
2279972|NCT02185534|5597754|P1|STARTED|First Period||14
2279973|NCT02185521|5597769|P1|NOT COMPLETED|Overall Study||2
2279974|NCT02185521|5597769|P1|COMPLETED|Overall Study||125
2279975|NCT02185521|5597769|P1|STARTED|Overall Study||127
2279976|NCT02185339|5597776|P2|NOT COMPLETED|Overall Study||1
2279977|NCT02185339|5597777|P1|NOT COMPLETED|Overall Study||0
2279978|NCT02185339|5597776|P2|COMPLETED|Overall Study||30
2279979|NCT02185339|5597777|P1|COMPLETED|Overall Study||30
2279980|NCT02185339|5597776|P2|STARTED|Overall Study||31
2279981|NCT02185339|5597777|P1|STARTED|Overall Study||30
2279982|NCT02185183|5597799|P1|NOT COMPLETED|Overall Study||0
2279983|NCT02185183|5597799|P1|COMPLETED|Overall Study||14
2279984|NCT02185183|5597799|P1|STARTED|Overall Study||14
2279985|NCT02185131|5597805|P2|NOT COMPLETED|Overall Study||1
2279986|NCT02185131|5597806|P1|NOT COMPLETED|Overall Study||1
2279987|NCT02185131|5597805|P2|COMPLETED|Overall Study||8
2279988|NCT02185131|5597806|P1|COMPLETED|Overall Study||6
2279989|NCT02185131|5597805|P2|STARTED|Overall Study||9
2279990|NCT02185131|5597806|P1|STARTED|Overall Study||7
2279991|NCT02185105|5597814|P1|NOT COMPLETED|Overall Study||0
2279992|NCT02185105|5597814|P1|COMPLETED|Overall Study||30
2279993|NCT02185105|5597814|P1|STARTED|Overall Study||30
2279994|NCT02185014|5597857|P1|NOT COMPLETED|Overall Study||54
2279995|NCT02185014|5597857|P1|COMPLETED|Overall Study||198
2279996|NCT02185014|5597857|P1|STARTED|Overall Study||252
2279997|NCT02184988|5597861|P1|NOT COMPLETED|Overall Study||55
2279998|NCT02184988|5597861|P1|COMPLETED|Overall Study||297
2279999|NCT02184988|5597861|P1|STARTED|Overall Study||352
2280000|NCT02184624|5597871|P5|NOT COMPLETED|Overall Study||0
2280001|NCT02184624|5597872|P4|NOT COMPLETED|Overall Study||0
2280002|NCT02184624|5597873|P3|NOT COMPLETED|Overall Study||0
2280003|NCT02184624|5597874|P2|NOT COMPLETED|Overall Study||0
2280004|NCT02184624|5597875|P1|NOT COMPLETED|Overall Study||0
2280005|NCT02184624|5597871|P5|COMPLETED|Overall Study||98
2280006|NCT02184624|5597872|P4|COMPLETED|Overall Study||118
2280007|NCT02184624|5597873|P3|COMPLETED|Overall Study||100
2280008|NCT02184624|5597874|P2|COMPLETED|Overall Study||80
2280009|NCT02184624|5597875|P1|COMPLETED|Overall Study||171
2280010|NCT02184624|5597871|P5|STARTED|Overall Study||98
2280011|NCT02184624|5597872|P4|STARTED|Overall Study||118
2280012|NCT02184624|5597873|P3|STARTED|Overall Study||100
2280013|NCT02184624|5597874|P2|STARTED|Overall Study||80
2280014|NCT02184624|5597875|P1|STARTED|Overall Study||171
2280015|NCT02184611|5597919|P2|NOT COMPLETED|Overall Study||28
2280016|NCT02184611|5597920|P1|NOT COMPLETED|Overall Study||21
2280017|NCT02184611|5597919|P2|COMPLETED|Overall Study||177
2280018|NCT02184611|5597920|P1|COMPLETED|Overall Study||80
2280019|NCT02184611|5597919|P2|STARTED|Overall Study||205
2280020|NCT02184611|5597920|P1|STARTED|Overall Study||101
2280021|NCT02184572|5597956|P2|NOT COMPLETED|Overall Study||30
2280022|NCT02184572|5597957|P1|NOT COMPLETED|Overall Study||47
2280023|NCT02184572|5597956|P2|COMPLETED|Overall Study||542
2280024|NCT02184572|5597957|P1|COMPLETED|Overall Study||1117
2280025|NCT02184572|5597956|P2|STARTED|Overall Study||572
2280026|NCT02184572|5597957|P1|STARTED|Overall Study||1164
2280027|NCT02184494|5597996|P3|NOT COMPLETED|Overall Study||0
2280028|NCT02184494|5597997|P2|NOT COMPLETED|Overall Study||2
2280029|NCT02184494|5597998|P1|NOT COMPLETED|Overall Study||1
2280030|NCT02184494|5597996|P3|COMPLETED|Overall Study||8
2280031|NCT02184494|5597997|P2|COMPLETED|Overall Study||11
2280032|NCT02184494|5597998|P1|COMPLETED|Overall Study||12
2280033|NCT02184494|5597996|P3|STARTED|Overall Study||8
2280034|NCT02184494|5597997|P2|STARTED|Overall Study||13
2280035|NCT02184494|5597998|P1|STARTED|Overall Study||13
2280036|NCT02184455|5598018|P1|NOT COMPLETED|Overall Study||1
2280037|NCT02184455|5598018|P1|COMPLETED|Overall Study||10
2280038|NCT02184455|5598018|P1|STARTED|Overall Study||11
2280039|NCT02184442|5598029|P2|NOT COMPLETED|Overall Study||76
2280040|NCT02184442|5598030|P1|NOT COMPLETED|Overall Study||64
2280041|NCT02184442|5598029|P2|COMPLETED|Overall Study||200
2280042|NCT02184442|5598030|P1|COMPLETED|Overall Study||220
2280043|NCT02184442|5598029|P2|Valve-Implant|Overall Study||263
2280044|NCT02184442|5598030|P1|Valve-Implant|Overall Study||280
2280045|NCT02184442|5598029|P2|As-Treated|Overall Study||271
2280046|NCT02184442|5598030|P1|As-Treated|Overall Study||282
2280047|NCT02184442|5598029|P2|STARTED|Overall Study||276
2280048|NCT02184442|5598030|P1|STARTED|Overall Study||284
2280049|NCT02184208|5598042|P1|NOT COMPLETED|Overall Study||56
2280050|NCT02184208|5598042|P1|COMPLETED|Overall Study||222
2280051|NCT02184208|5598042|P1|STARTED|Overall Study||278
2280052|NCT02184195|5598050|P2|NOT COMPLETED|Overall Study||35
2280053|NCT02184195|5598051|P1|NOT COMPLETED|Overall Study||43
2280054|NCT02184195|5598050|P2|COMPLETED|Overall Study||27
2280055|NCT02184195|5598051|P1|COMPLETED|Overall Study||49
2280056|NCT02184195|5598050|P2|STARTED|Overall Study||62
2280057|NCT02184195|5598051|P1|STARTED|Overall Study||92
2280058|NCT02184143|5598077|P2|NOT COMPLETED|Overall Study||7
2280059|NCT02184143|5598078|P1|NOT COMPLETED|Overall Study||10
2280060|NCT02184143|5598077|P2|COMPLETED|Overall Study|117 patients completed PROs. 100 actigraph valid wear time.|117
2280061|NCT02184143|5598078|P1|COMPLETED|Overall Study|114 patients completed PROs. 98 actigraph valid wear time.|114
2280062|NCT02184143|5598077|P2|STARTED|Overall Study|124 participants randomized; 121 received intervention|124
2280063|NCT02184143|5598078|P1|STARTED|Overall Study|124 participants randomized; 118 participant received intervention|124
2280064|NCT02183792|5598092|P2|NOT COMPLETED|Overall Study||0
2280065|NCT02183792|5598093|P1|NOT COMPLETED|Overall Study||0
2280066|NCT02183792|5598092|P2|COMPLETED|Overall Study||15
2280067|NCT02183792|5598093|P1|COMPLETED|Overall Study||18
2280068|NCT02183792|5598092|P2|STARTED|Overall Study||15
2280069|NCT02183792|5598093|P1|STARTED|Overall Study||18
2280070|NCT02183675|5598107|P6|NOT COMPLETED|Treatment Period 3 (10 Days)||0
2280071|NCT02183675|5598108|P5|NOT COMPLETED|Treatment Period 3 (10 Days)||0
2280072|NCT02183675|5598109|P4|NOT COMPLETED|Treatment Period 3 (10 Days)||0
2280073|NCT02183675|5598110|P3|NOT COMPLETED|Treatment Period 3 (10 Days)||0
2280074|NCT02183675|5598111|P2|NOT COMPLETED|Treatment Period 3 (10 Days)||0
2280075|NCT02183675|5598112|P1|NOT COMPLETED|Treatment Period 3 (10 Days)||0
2280076|NCT02183675|5598107|P6|COMPLETED|Treatment Period 3 (10 Days)||4
2280077|NCT02183675|5598108|P5|COMPLETED|Treatment Period 3 (10 Days)||6
2280078|NCT02183675|5598109|P4|COMPLETED|Treatment Period 3 (10 Days)||6
2280079|NCT02183675|5598110|P3|COMPLETED|Treatment Period 3 (10 Days)||6
2280080|NCT02183675|5598111|P2|COMPLETED|Treatment Period 3 (10 Days)||6
2280081|NCT02183675|5598112|P1|COMPLETED|Treatment Period 3 (10 Days)||6
2280082|NCT02183675|5598107|P6|STARTED|Treatment Period 3 (10 Days)||4
2280083|NCT02183675|5598108|P5|STARTED|Treatment Period 3 (10 Days)||6
2280084|NCT02183675|5598109|P4|STARTED|Treatment Period 3 (10 Days)||6
2280085|NCT02183675|5598110|P3|STARTED|Treatment Period 3 (10 Days)||6
2280086|NCT02183675|5598111|P2|STARTED|Treatment Period 3 (10 Days)||6
2280087|NCT02183675|5598112|P1|STARTED|Treatment Period 3 (10 Days)||6
2280088|NCT02183675|5598107|P6|NOT COMPLETED|Treatment Period 2 (10 Days)||2
2280089|NCT02183675|5598108|P5|NOT COMPLETED|Treatment Period 2 (10 Days)||0
2280090|NCT02183675|5598109|P4|NOT COMPLETED|Treatment Period 2 (10 Days)||0
2280091|NCT02183675|5598110|P3|NOT COMPLETED|Treatment Period 2 (10 Days)||0
2280092|NCT02183675|5598111|P2|NOT COMPLETED|Treatment Period 2 (10 Days)||0
2280093|NCT02183675|5598112|P1|NOT COMPLETED|Treatment Period 2 (10 Days)||0
2280094|NCT02183675|5598107|P6|COMPLETED|Treatment Period 2 (10 Days)|Patients withdrew after completion of treatment period 2 but before beginning of treatment period 3|4
2280095|NCT02183675|5598108|P5|COMPLETED|Treatment Period 2 (10 Days)||6
2280096|NCT02183675|5598109|P4|COMPLETED|Treatment Period 2 (10 Days)||6
2280097|NCT02183675|5598110|P3|COMPLETED|Treatment Period 2 (10 Days)||6
2280098|NCT02183675|5598111|P2|COMPLETED|Treatment Period 2 (10 Days)||6
2280099|NCT02183675|5598112|P1|COMPLETED|Treatment Period 2 (10 Days)||6
2280100|NCT02183675|5598107|P6|STARTED|Treatment Period 2 (10 Days)||6
2280101|NCT02183675|5598108|P5|STARTED|Treatment Period 2 (10 Days)||6
2280102|NCT02183675|5598109|P4|STARTED|Treatment Period 2 (10 Days)||6
2280103|NCT02183675|5598110|P3|STARTED|Treatment Period 2 (10 Days)||6
2280104|NCT02183675|5598111|P2|STARTED|Treatment Period 2 (10 Days)||6
2280105|NCT02183675|5598112|P1|STARTED|Treatment Period 2 (10 Days)||6
2280106|NCT02183675|5598107|P6|NOT COMPLETED|Treatment Period 1 (10 Days)||0
2280107|NCT02183675|5598108|P5|NOT COMPLETED|Treatment Period 1 (10 Days)||0
2280108|NCT02183675|5598109|P4|NOT COMPLETED|Treatment Period 1 (10 Days)||0
2280109|NCT02183675|5598110|P3|NOT COMPLETED|Treatment Period 1 (10 Days)||0
2280110|NCT02183675|5598111|P2|NOT COMPLETED|Treatment Period 1 (10 Days)||0
2280111|NCT02183675|5598112|P1|NOT COMPLETED|Treatment Period 1 (10 Days)||0
2280112|NCT02183675|5598107|P6|COMPLETED|Treatment Period 1 (10 Days)||6
2280113|NCT02183675|5598108|P5|COMPLETED|Treatment Period 1 (10 Days)||6
2280114|NCT02183675|5598109|P4|COMPLETED|Treatment Period 1 (10 Days)||6
2280115|NCT02183675|5598110|P3|COMPLETED|Treatment Period 1 (10 Days)||6
2280116|NCT02183675|5598111|P2|COMPLETED|Treatment Period 1 (10 Days)||6
2280117|NCT02183675|5598112|P1|COMPLETED|Treatment Period 1 (10 Days)||6
2280118|NCT02183675|5598107|P6|STARTED|Treatment Period 1 (10 Days)||6
2280119|NCT02183675|5598108|P5|STARTED|Treatment Period 1 (10 Days)||6
2280120|NCT02183675|5598109|P4|STARTED|Treatment Period 1 (10 Days)||6
2280121|NCT02183675|5598110|P3|STARTED|Treatment Period 1 (10 Days)||6
2280122|NCT02183675|5598111|P2|STARTED|Treatment Period 1 (10 Days)||6
2280123|NCT02183675|5598112|P1|STARTED|Treatment Period 1 (10 Days)||6
2280124|NCT02183519|5598136|P2|NOT COMPLETED|Overall Study||3
2280125|NCT02183519|5598137|P1|NOT COMPLETED|Overall Study||3
2280126|NCT02183519|5598136|P2|COMPLETED|Overall Study||13
2280127|NCT02183519|5598137|P1|COMPLETED|Overall Study||25
2280128|NCT02183519|5598136|P2|STARTED|Overall Study||16
2280129|NCT02183519|5598137|P1|STARTED|Overall Study||28
2280130|NCT02182999|5598145|P2|NOT COMPLETED|Overall Study||3
2280131|NCT02182999|5598146|P1|NOT COMPLETED|Overall Study||5
2280132|NCT02182999|5598145|P2|COMPLETED|Overall Study||22
2280133|NCT02182999|5598146|P1|COMPLETED|Overall Study||20
2280134|NCT02182999|5598145|P2|STARTED|Overall Study||25
2280135|NCT02182999|5598146|P1|STARTED|Overall Study||25
2280136|NCT02182973|5598162|P2|NOT COMPLETED|Overall Study||0
2280137|NCT02182973|5598163|P1|NOT COMPLETED|Overall Study||3
2280138|NCT02182973|5598162|P2|COMPLETED|Overall Study||9
2280139|NCT02182973|5598163|P1|COMPLETED|Overall Study||9
2280140|NCT02182973|5598162|P2|STARTED|Overall Study||9
2280141|NCT02182973|5598163|P1|STARTED|Overall Study||12
2280142|NCT02182895|5598175|P2|NOT COMPLETED|Overall Study||4
2280143|NCT02182895|5598176|P1|NOT COMPLETED|Overall Study||2
2280144|NCT02182895|5598175|P2|COMPLETED|Overall Study||33
2280145|NCT02182895|5598176|P1|COMPLETED|Overall Study||33
2280146|NCT02182895|5598175|P2|STARTED|Overall Study||37
2280147|NCT02182895|5598176|P1|STARTED|Overall Study||35
2280148|NCT02182843|5598196|P1|NOT COMPLETED|Overall Study||10
2280149|NCT02182843|5598196|P1|COMPLETED|Overall Study||71
2280150|NCT02182843|5598196|P1|STARTED|Overall Study||81
2280151|NCT02182830|5598203|P2|NOT COMPLETED|Overall Study||15
2280152|NCT02182830|5598204|P1|NOT COMPLETED|Overall Study||15
2280153|NCT02182830|5598203|P2|COMPLETED|Overall Study||68
2280154|NCT02182830|5598204|P1|COMPLETED|Overall Study||68
2280155|NCT02182830|5598203|P2|Treated Set (TS)|Overall Study|From RS, 1 duplicate patient and 1 non treated patient was removed|80
2280156|NCT02182830|5598204|P1|Treated Set (TS)|Overall Study|From RS, 1 duplicate patient and 1 non treated patient was removed|77
2280157|NCT02182830|5598203|P2|Randomised Set (RS)|Overall Study|From started, 1 patient from one site was removed|82
2280158|NCT02182830|5598204|P1|Randomised Set (RS)|Overall Study|From started, 2 duplicate patients and 2 patients from one site were removed|79
2280159|NCT02182830|5598203|P2|STARTED|Overall Study||83
2280160|NCT02182830|5598204|P1|STARTED|Overall Study||83
2280161|NCT02182492|5598232|P2|NOT COMPLETED|Overall Study||8
2280162|NCT02182492|5598233|P1|NOT COMPLETED|Overall Study||7
2280163|NCT02182492|5598232|P2|COMPLETED|Overall Study|CRSsNP: 29; Non-Eos CRSwNP: 28; Eos CRSwNP: 29|86
2280164|NCT02182492|5598233|P1|COMPLETED|Overall Study|CRSsNP: 27; Non-Eos CRSwNP: 31; Eos CRSwNP: 28|86
2280165|NCT02182492|5598232|P2|STARTED|Overall Study|CRSsNP: 30; Non-Eos CRSwNP: 32; Eos CRSwNP: 32|94
2280166|NCT02182492|5598233|P1|STARTED|Overall Study|CRSsNP: 28; Non-Eos CRSwNP: 34; Eos CRSwNP: 31|93
2280167|NCT02182115|5598243|P2|NOT COMPLETED|Overall Study||0
2280168|NCT02182115|5598244|P1|NOT COMPLETED|Overall Study||0
2280169|NCT02182115|5598243|P2|COMPLETED|Overall Study||57
2280170|NCT02182115|5598244|P1|COMPLETED|Overall Study||53
2280171|NCT02182115|5598243|P2|STARTED|Overall Study||57
2280172|NCT02182115|5598244|P1|STARTED|Overall Study||53
2280173|NCT02181842|5598250|P1|NOT COMPLETED|Overall Study||2
2280174|NCT02181842|5598250|P1|COMPLETED|Overall Study||244
2280175|NCT02181842|5598250|P1|STARTED|Overall Study||246
2280176|NCT02181816|5598267|P1|NOT COMPLETED|Overall Study||59
2280177|NCT02181816|5598267|P1|COMPLETED|Overall Study||1031
2280178|NCT02181816|5598267|P1|STARTED|Overall Study||1090
2280179|NCT02181790|5598275|P2|NOT COMPLETED|Overall Study||0
2280180|NCT02181790|5598276|P1|NOT COMPLETED|Overall Study||2
2280181|NCT02181790|5598275|P2|COMPLETED|Overall Study||0
2280182|NCT02181790|5598276|P1|COMPLETED|Overall Study||0
2280183|NCT02181790|5598275|P2|STARTED|Overall Study||0
2280184|NCT02181790|5598276|P1|STARTED|Overall Study||2
2280185|NCT02181738|5598288|P4|NOT COMPLETED|Overall Study||2
2280186|NCT02181738|5598289|P3|NOT COMPLETED|Overall Study||10
2280187|NCT02181738|5598290|P2|NOT COMPLETED|Overall Study||9
2280188|NCT02181738|5598291|P1|NOT COMPLETED|Overall Study||2
2280189|NCT02181738|5598288|P4|COMPLETED|Overall Study||49
2280190|NCT02181738|5598289|P3|COMPLETED|Overall Study||90
2280191|NCT02181738|5598290|P2|COMPLETED|Overall Study||71
2280192|NCT02181738|5598291|P1|COMPLETED|Overall Study||61
2280193|NCT02181738|5598288|P4|STARTED|Overall Study||51
2280194|NCT02181738|5598289|P3|STARTED|Overall Study||100
2280195|NCT02181738|5598290|P2|STARTED|Overall Study||80
2280196|NCT02181738|5598291|P1|STARTED|Overall Study||63
2280197|NCT02181673|5598332|P3|NOT COMPLETED|Week 24-Week 60||17
2280198|NCT02181673|5598333|P2|NOT COMPLETED|Week 24-Week 60||8
2280199|NCT02181673|5598334|P1|NOT COMPLETED|Week 24-Week 60||0
2280200|NCT02181673|5598332|P3|COMPLETED|Week 24-Week 60||213
2280201|NCT02181673|5598333|P2|COMPLETED|Week 24-Week 60||214
2280202|NCT02181673|5598334|P1|COMPLETED|Week 24-Week 60||0
2280203|NCT02181673|5598332|P3|Treated|Week 24-Week 60||230
2280204|NCT02181673|5598333|P2|Treated|Week 24-Week 60||220
2280205|NCT02181673|5598334|P1|Treated|Week 24-Week 60||0
2280206|NCT02181673|5598332|P3|STARTED|Week 24-Week 60||230
2280207|NCT02181673|5598333|P2|STARTED|Week 24-Week 60||222
2280208|NCT02181673|5598334|P1|STARTED|Week 24-Week 60||0
2280209|NCT02181673|5598332|P3|NOT COMPLETED|Up to Week 24||11
2280210|NCT02181673|5598333|P2|NOT COMPLETED|Up to Week 24||0
2280211|NCT02181673|5598334|P1|NOT COMPLETED|Up to Week 24||17
2280212|NCT02181673|5598332|P3|COMPLETED|Up to Week 24||230
2280213|NCT02181673|5598333|P2|COMPLETED|Up to Week 24||0
2280214|NCT02181673|5598334|P1|COMPLETED|Up to Week 24||222
2280215|NCT02181673|5598332|P3|Treated|Up to Week 24||240
2280216|NCT02181673|5598333|P2|Treated|Up to Week 24||0
2280217|NCT02181673|5598334|P1|Treated|Up to Week 24||239
2280218|NCT02181673|5598332|P3|STARTED|Up to Week 24||241
2280219|NCT02181673|5598333|P2|STARTED|Up to Week 24||0
2280220|NCT02181673|5598334|P1|STARTED|Up to Week 24||239
2280221|NCT02181634|5598361|P1|NOT COMPLETED|Overall Study||72
2280222|NCT02181634|5598361|P1|COMPLETED|Overall Study||2
2280223|NCT02181634|5598361|P1|Eligible and Treated|Overall Study||73
2280224|NCT02181634|5598361|P1|STARTED|Overall Study||74
2280225|NCT02181530|5598372|P1|NOT COMPLETED|Overall Study||0
2280226|NCT02181530|5598372|P1|COMPLETED|Overall Study||43
2280227|NCT02181530|5598372|P1|STARTED|Overall Study||43
2280228|NCT02181517|5598385|P3|NOT COMPLETED|Overall Study||0
2280229|NCT02181517|5598386|P2|NOT COMPLETED|Overall Study||0
2280230|NCT02181517|5598387|P1|NOT COMPLETED|Overall Study||0
2280231|NCT02181517|5598385|P3|COMPLETED|Overall Study||5
2280232|NCT02181517|5598386|P2|COMPLETED|Overall Study||10
2280233|NCT02181517|5598387|P1|COMPLETED|Overall Study||10
2280234|NCT02181517|5598385|P3|STARTED|Overall Study||5
2280235|NCT02181517|5598386|P2|STARTED|Overall Study||10
2280236|NCT02181517|5598387|P1|STARTED|Overall Study||10
2280237|NCT02181504|5598410|P3|NOT COMPLETED|Overall Study||1
2280238|NCT02181504|5598411|P2|NOT COMPLETED|Overall Study||1
2280239|NCT02181504|5598412|P1|NOT COMPLETED|Overall Study||1
2280240|NCT02181504|5598410|P3|COMPLETED|Overall Study||4
2280241|NCT02181504|5598411|P2|COMPLETED|Overall Study||9
2280242|NCT02181504|5598412|P1|COMPLETED|Overall Study||9
2280243|NCT02181504|5598410|P3|STARTED|Overall Study||5
2280244|NCT02181504|5598411|P2|STARTED|Overall Study||10
2280245|NCT02181504|5598412|P1|STARTED|Overall Study||10
2280246|NCT02181426|5598436|P4|NOT COMPLETED|Overall Study||0
2280247|NCT02181426|5598437|P3|NOT COMPLETED|Overall Study||0
2280248|NCT02181426|5598438|P2|NOT COMPLETED|Overall Study||0
2280249|NCT02181426|5598439|P1|NOT COMPLETED|Overall Study||0
2280250|NCT02181426|5598436|P4|COMPLETED|Overall Study||28
2280251|NCT02181426|5598437|P3|COMPLETED|Overall Study||28
2280252|NCT02181426|5598438|P2|COMPLETED|Overall Study||28
2280253|NCT02181426|5598439|P1|COMPLETED|Overall Study||28
2280254|NCT02181426|5598436|P4|STARTED|Overall Study||28
2280255|NCT02181426|5598437|P3|STARTED|Overall Study||28
2280256|NCT02181426|5598438|P2|STARTED|Overall Study||28
2280257|NCT02181426|5598439|P1|STARTED|Overall Study||28
2280258|NCT02181413|5598451|P2|NOT COMPLETED|Overall Study||197
2280259|NCT02181413|5598452|P1|NOT COMPLETED|Overall Study||152
2280260|NCT02181413|5598451|P2|COMPLETED|Overall Study||198
2280261|NCT02181413|5598452|P1|COMPLETED|Overall Study||109
2280262|NCT02181413|5598451|P2|Per Protocol (PP) Population|Overall Study||387
2280263|NCT02181413|5598452|P1|Per Protocol (PP) Population|Overall Study||256
2280264|NCT02181413|5598451|P2|Safety Population|Overall Study||394
2280265|NCT02181413|5598452|P1|Safety Population|Overall Study||259
2280266|NCT02181413|5598451|P2|Intent-to-Treat (ITT) Population|Overall Study||395
2280267|NCT02181413|5598452|P1|Intent-to-Treat (ITT) Population|Overall Study||261
2280268|NCT02181413|5598451|P2|STARTED|Overall Study||395
2280269|NCT02181413|5598452|P1|STARTED|Overall Study||261
2280270|NCT02181400|5598461|P3|NOT COMPLETED|Overall Study||0
2280271|NCT02181400|5598462|P2|NOT COMPLETED|Overall Study||0
2280272|NCT02181400|5598463|P1|NOT COMPLETED|Overall Study||0
2280273|NCT02181400|5598461|P3|COMPLETED|Overall Study||7
2280274|NCT02181400|5598462|P2|COMPLETED|Overall Study||7
2280275|NCT02181400|5598463|P1|COMPLETED|Overall Study||7
2280276|NCT02181400|5598461|P3|STARTED|Overall Study||7
2280277|NCT02181400|5598462|P2|STARTED|Overall Study||7
2280278|NCT02181400|5598463|P1|STARTED|Overall Study||7
2280279|NCT02181387|5598488|P2|NOT COMPLETED|Overall Study||4
2280280|NCT02181387|5598489|P1|NOT COMPLETED|Overall Study||2
2280281|NCT02181387|5598488|P2|COMPLETED|Overall Study||15
2280282|NCT02181387|5598489|P1|COMPLETED|Overall Study||12
2280283|NCT02181387|5598488|P2|STARTED|Overall Study||19
2280284|NCT02181387|5598489|P1|STARTED|Overall Study||14
2280285|NCT02181296|5598497|P2|NOT COMPLETED|Overall Study||6
2280286|NCT02181296|5598498|P1|NOT COMPLETED|Overall Study||7
2280287|NCT02181296|5598497|P2|COMPLETED|Overall Study||19
2280288|NCT02181296|5598498|P1|COMPLETED|Overall Study||18
2280289|NCT02181296|5598497|P2|STARTED|Overall Study||25
2280290|NCT02181296|5598498|P1|STARTED|Overall Study||25
2280291|NCT02181231|5598512|P2|NOT COMPLETED|Overall Study||0
2280292|NCT02181231|5598513|P1|NOT COMPLETED|Overall Study||2
2280293|NCT02181231|5598512|P2|COMPLETED|Overall Study||6
2280294|NCT02181231|5598513|P1|COMPLETED|Overall Study||10
2280295|NCT02181231|5598512|P2|STARTED|Overall Study||6
2280296|NCT02181231|5598513|P1|STARTED|Overall Study||12
2280297|NCT02181140|5598529|P1|NOT COMPLETED|Overall Study||0
2280298|NCT02181140|5598529|P1|COMPLETED|Overall Study||56
2280299|NCT02181140|5598529|P1|STARTED|Overall Study||56
2280300|NCT02181127|5598535|P1|NOT COMPLETED|Overall Study||0
2280301|NCT02181127|5598535|P1|COMPLETED|Overall Study||22
2280302|NCT02181127|5598535|P1|STARTED|Overall Study||22
2280303|NCT02181075|5598581|P2|NOT COMPLETED|Overall Study||0
2280304|NCT02181075|5598582|P1|NOT COMPLETED|Overall Study||0
2280305|NCT02181075|5598581|P2|COMPLETED|Overall Study||4
2280306|NCT02181075|5598582|P1|COMPLETED|Overall Study||6
2280307|NCT02181075|5598581|P2|STARTED|Overall Study||4
2280308|NCT02181075|5598582|P1|STARTED|Overall Study||6
2280309|NCT02180893|5598600|P2|NOT COMPLETED|Overall Study||7
2280310|NCT02180893|5598601|P1|NOT COMPLETED|Overall Study||3
2280311|NCT02180893|5598600|P2|COMPLETED|Overall Study||23
2280312|NCT02180893|5598601|P1|COMPLETED|Overall Study||27
2280313|NCT02180893|5598600|P2|STARTED|Overall Study||30
2280314|NCT02180893|5598601|P1|STARTED|Overall Study||30
2280315|NCT02180828|5598615|P2|NOT COMPLETED|Overall Study||7
2280316|NCT02180828|5598616|P1|NOT COMPLETED|Overall Study||5
2280317|NCT02180828|5598615|P2|COMPLETED|Overall Study||113
2280318|NCT02180828|5598616|P1|COMPLETED|Overall Study||115
2280319|NCT02180828|5598615|P2|STARTED|Overall Study||120
2280320|NCT02180828|5598616|P1|STARTED|Overall Study||120
2280321|NCT02180659|5598640|P2|NOT COMPLETED|Overall Study||5
2280322|NCT02180659|5598641|P1|NOT COMPLETED|Overall Study||6
2280323|NCT02180659|5598640|P2|COMPLETED|Overall Study||84
2280324|NCT02180659|5598641|P1|COMPLETED|Overall Study||81
2280325|NCT02180659|5598640|P2|STARTED|Overall Study|N=90 randomized, however N=89 received study medication|89
2280326|NCT02180659|5598641|P1|STARTED|Overall Study||87
2280327|NCT02180646|5598663|P2|NOT COMPLETED|Second Intervention (7 Days)||0
2280328|NCT02180646|5598664|P1|NOT COMPLETED|Second Intervention (7 Days)||0
2280329|NCT02180646|5598663|P2|COMPLETED|Second Intervention (7 Days)||6
2280330|NCT02180646|5598664|P1|COMPLETED|Second Intervention (7 Days)||6
2280331|NCT02180646|5598663|P2|STARTED|Second Intervention (7 Days)||6
2280332|NCT02180646|5598664|P1|STARTED|Second Intervention (7 Days)||6
2280333|NCT02180646|5598663|P2|NOT COMPLETED|Washout (7 Days)||0
2280334|NCT02180646|5598664|P1|NOT COMPLETED|Washout (7 Days)||0
2280335|NCT02180646|5598663|P2|COMPLETED|Washout (7 Days)||6
2280336|NCT02180646|5598664|P1|COMPLETED|Washout (7 Days)||6
2280337|NCT02180646|5598663|P2|STARTED|Washout (7 Days)||6
2280338|NCT02180646|5598664|P1|STARTED|Washout (7 Days)||6
2280339|NCT02180646|5598663|P2|NOT COMPLETED|First Intervention (7 Days)||0
2280340|NCT02180646|5598664|P1|NOT COMPLETED|First Intervention (7 Days)||0
2280341|NCT02180646|5598663|P2|COMPLETED|First Intervention (7 Days)||6
2280342|NCT02180646|5598664|P1|COMPLETED|First Intervention (7 Days)||6
2280343|NCT02180646|5598663|P2|STARTED|First Intervention (7 Days)||6
2280344|NCT02180646|5598664|P1|STARTED|First Intervention (7 Days)||6
2280345|NCT02180438|5598676|P1|NOT COMPLETED|Overall Study||1
2280346|NCT02180438|5598676|P1|COMPLETED|Overall Study||29
2280347|NCT02180438|5598676|P1|STARTED|Overall Study||30
2280348|NCT02180230|5598691|P1|NOT COMPLETED|Overall Study||7
2280349|NCT02180230|5598691|P1|COMPLETED|Overall Study||31
2280350|NCT02180230|5598691|P1|STARTED|Overall Study||38
2280351|NCT02180165|5598700|P4|NOT COMPLETED|Overall Study||6
2280352|NCT02180165|5598701|P3|NOT COMPLETED|Overall Study||29
2280353|NCT02180165|5598702|P2|NOT COMPLETED|Overall Study||1
2280354|NCT02180165|5598703|P1|NOT COMPLETED|Overall Study||11
2280355|NCT02180165|5598700|P4|COMPLETED|Overall Study||25
2280356|NCT02180165|5598701|P3|COMPLETED|Overall Study||34
2280357|NCT02180165|5598702|P2|COMPLETED|Overall Study||6
2280358|NCT02180165|5598703|P1|COMPLETED|Overall Study||4
2280359|NCT02180165|5598700|P4|Type of Aspergillosis|Overall Study|Invasive Aspergillosis and Chronic Pulmonary Aspergillosis|27
2280360|NCT02180165|5598701|P3|Type of Aspergillosis|Overall Study|Invasive Aspergillosis and Chronic Pulmonary Aspergillosis|57
2280361|NCT02180165|5598702|P2|Type of Aspergillosis|Overall Study|Chronic Pulmonary Aspergillosis|7
2280362|NCT02180165|5598703|P1|Type of Aspergillosis|Overall Study|Chronic Pulmonary Aspergillosis|15
2280363|NCT02180165|5598700|P4|Treated Participants|Overall Study||31
2280364|NCT02180165|5598701|P3|Treated Participants|Overall Study||62
2280365|NCT02180165|5598702|P2|Treated Participants|Overall Study||7
2280366|NCT02180165|5598703|P1|Treated Participants|Overall Study||15
2280367|NCT02180165|5598700|P4|STARTED|Overall Study||31
2280368|NCT02180165|5598701|P3|STARTED|Overall Study||63
2280369|NCT02180165|5598702|P2|STARTED|Overall Study||7
2280370|NCT02180165|5598703|P1|STARTED|Overall Study||15
2280371|NCT02180061|5598791|P2|NOT COMPLETED|Overall Study||8
2280372|NCT02180061|5598792|P1|NOT COMPLETED|Overall Study||25
2280373|NCT02180061|5598791|P2|COMPLETED|Overall Study||0
2280374|NCT02180061|5598792|P1|COMPLETED|Overall Study||9
2280375|NCT02180061|5598791|P2|STARTED|Overall Study||8
2280376|NCT02180061|5598792|P1|STARTED|Overall Study||34
2280377|NCT02179918|5598811|P5|NOT COMPLETED|Overall Study||8
2280378|NCT02179918|5598812|P4|NOT COMPLETED|Overall Study||3
2280379|NCT02179918|5598813|P3|NOT COMPLETED|Overall Study||2
2280380|NCT02179918|5598814|P2|NOT COMPLETED|Overall Study||3
2280381|NCT02179918|5598815|P1|NOT COMPLETED|Overall Study||4
2280382|NCT02179918|5598811|P5|COMPLETED|Overall Study||1
2280383|NCT02179918|5598812|P4|COMPLETED|Overall Study||0
2280384|NCT02179918|5598813|P3|COMPLETED|Overall Study||1
2280385|NCT02179918|5598814|P2|COMPLETED|Overall Study||0
2280386|NCT02179918|5598815|P1|COMPLETED|Overall Study||1
2280387|NCT02179918|5598811|P5|STARTED|Overall Study||9
2280388|NCT02179918|5598812|P4|STARTED|Overall Study||3
2280389|NCT02179918|5598813|P3|STARTED|Overall Study||3
2280390|NCT02179918|5598814|P2|STARTED|Overall Study||3
2280391|NCT02179918|5598815|P1|STARTED|Overall Study||5
2280392|NCT02179892|5598941|P2|NOT COMPLETED|Overall Study||0
2280393|NCT02179892|5598942|P1|NOT COMPLETED|Overall Study||0
2280394|NCT02179892|5598941|P2|COMPLETED|Overall Study||4
2280395|NCT02179892|5598942|P1|COMPLETED|Overall Study||5
2280396|NCT02179892|5598941|P2|STARTED|Overall Study||4
2280397|NCT02179892|5598942|P1|STARTED|Overall Study||5
2280398|NCT02179671|5598959|P5|NOT COMPLETED|Overall Study||13
2280399|NCT02179671|5598960|P4|NOT COMPLETED|Overall Study||13
2280400|NCT02179671|5598961|P3|NOT COMPLETED|Overall Study||1
2280401|NCT02179671|5598962|P2|NOT COMPLETED|Overall Study||1
2280402|NCT02179671|5598963|P1|NOT COMPLETED|Overall Study||1
2280403|NCT02179671|5598959|P5|COMPLETED|Overall Study||1
2280404|NCT02179671|5598960|P4|COMPLETED|Overall Study||1
2280405|NCT02179671|5598961|P3|COMPLETED|Overall Study||1
2280406|NCT02179671|5598962|P2|COMPLETED|Overall Study||0
2280407|NCT02179671|5598963|P1|COMPLETED|Overall Study||0
2280408|NCT02179671|5598959|P5|STARTED|Overall Study||14
2280409|NCT02179671|5598960|P4|STARTED|Overall Study||14
2280410|NCT02179671|5598961|P3|STARTED|Overall Study||2
2280411|NCT02179671|5598962|P2|STARTED|Overall Study||1
2280412|NCT02179671|5598963|P1|STARTED|Overall Study||1
2280413|NCT02179424|5598999|P4|NOT COMPLETED|Overall Study||0
2280414|NCT02179424|5599000|P3|NOT COMPLETED|Overall Study||0
2280415|NCT02179424|5599001|P2|NOT COMPLETED|Overall Study||0
2280416|NCT02179424|5599002|P1|NOT COMPLETED|Overall Study||0
2280417|NCT02179424|5598999|P4|COMPLETED|Overall Study||39
2280418|NCT02179424|5599000|P3|COMPLETED|Overall Study||516
2280419|NCT02179424|5599001|P2|COMPLETED|Overall Study||11
2280420|NCT02179424|5599002|P1|COMPLETED|Overall Study||76
2280421|NCT02179424|5598999|P4|STARTED|Overall Study||39
2280422|NCT02179424|5599000|P3|STARTED|Overall Study||516
2280423|NCT02179424|5599001|P2|STARTED|Overall Study||11
2280424|NCT02179424|5599002|P1|STARTED|Overall Study||76
2280425|NCT02179398|5599019|P2|NOT COMPLETED|Overall Study||4
2280426|NCT02179398|5599020|P1|NOT COMPLETED|Overall Study||3
2280427|NCT02179398|5599019|P2|COMPLETED|Overall Study||140
2280428|NCT02179398|5599020|P1|COMPLETED|Overall Study||131
2280429|NCT02179398|5599019|P2|STARTED|Overall Study||144
2280430|NCT02179398|5599020|P1|STARTED|Overall Study||134
2280431|NCT02179190|5599038|P1|NOT COMPLETED|Follow-Up Post Barrel VRD Implanted||9
2280432|NCT02179190|5599038|P1|COMPLETED|Follow-Up Post Barrel VRD Implanted||111
2280433|NCT02179190|5599038|P1|STARTED|Follow-Up Post Barrel VRD Implanted||120
2280434|NCT02179190|5599038|P1|NOT COMPLETED|Index Procedure With Barrel VRD Attempt||7
2280435|NCT02179190|5599038|P1|COMPLETED|Index Procedure With Barrel VRD Attempt||120
2280436|NCT02179190|5599038|P1|STARTED|Index Procedure With Barrel VRD Attempt||127
2280437|NCT02179190|5599038|P1|NOT COMPLETED|Enrollment||11
2280438|NCT02179190|5599038|P1|COMPLETED|Enrollment||127
2280439|NCT02179190|5599038|P1|STARTED|Enrollment||138
2280446|NCT02178995|5599077|P9|NOT COMPLETED|Open Label||0
2280447|NCT02178995|5599078|P8|NOT COMPLETED|Open Label||0
2280448|NCT02178995|5599079|P7|NOT COMPLETED|Open Label||0
2280449|NCT02178995|5599080|P6|NOT COMPLETED|Open Label||0
2280450|NCT02178995|5599081|P5|NOT COMPLETED|Open Label||0
2280451|NCT02178995|5599082|P4|NOT COMPLETED|Open Label||0
2280452|NCT02178995|5599083|P3|NOT COMPLETED|Open Label||0
2280453|NCT02178995|5599084|P2|NOT COMPLETED|Open Label||0
2280454|NCT02178995|5599085|P1|NOT COMPLETED|Open Label||2
2280455|NCT02178995|5599077|P9|COMPLETED|Open Label||0
2280456|NCT02178995|5599078|P8|COMPLETED|Open Label||0
2280457|NCT02178995|5599079|P7|COMPLETED|Open Label||0
2280458|NCT02178995|5599080|P6|COMPLETED|Open Label||0
2280459|NCT02178995|5599081|P5|COMPLETED|Open Label||0
2280460|NCT02178995|5599082|P4|COMPLETED|Open Label||0
2280461|NCT02178995|5599083|P3|COMPLETED|Open Label||0
2280462|NCT02178995|5599084|P2|COMPLETED|Open Label||14
2280463|NCT02178995|5599085|P1|COMPLETED|Open Label||28
2280464|NCT02178995|5599077|P9|STARTED|Open Label||0
2280465|NCT02178995|5599078|P8|STARTED|Open Label||0
2280466|NCT02178995|5599079|P7|STARTED|Open Label||0
2280467|NCT02178995|5599080|P6|STARTED|Open Label||0
2280468|NCT02178995|5599081|P5|STARTED|Open Label||0
2280469|NCT02178995|5599082|P4|STARTED|Open Label||0
2280470|NCT02178995|5599083|P3|STARTED|Open Label||0
2280471|NCT02178995|5599084|P2|STARTED|Open Label|One was lost to follow-up after completion of visit 4.|14
2280472|NCT02178995|5599085|P1|STARTED|Open Label|2 declined to join open-label. 1 withdrew from double-blind but rejoined open-label due to benefit.|30
2280473|NCT02178995|5599077|P9|NOT COMPLETED|Double Blind||1
2280474|NCT02178995|5599078|P8|NOT COMPLETED|Double Blind||2
2280475|NCT02178995|5599079|P7|NOT COMPLETED|Double Blind||0
2280476|NCT02178995|5599080|P6|NOT COMPLETED|Double Blind||1
2280477|NCT02178995|5599081|P5|NOT COMPLETED|Double Blind||0
2280478|NCT02178995|5599082|P4|NOT COMPLETED|Double Blind||0
2280479|NCT02178995|5599083|P3|NOT COMPLETED|Double Blind||0
2280480|NCT02178995|5599084|P2|NOT COMPLETED|Double Blind||1
2280481|NCT02178995|5599085|P1|NOT COMPLETED|Double Blind||0
2280482|NCT02178995|5599077|P9|COMPLETED|Double Blind||0
2280483|NCT02178995|5599078|P8|COMPLETED|Double Blind||4
2280484|NCT02178995|5599079|P7|COMPLETED|Double Blind||5
2280485|NCT02178995|5599080|P6|COMPLETED|Double Blind||5
2280486|NCT02178995|5599081|P5|COMPLETED|Double Blind||6
2280487|NCT02178995|5599082|P4|COMPLETED|Double Blind||6
2280488|NCT02178995|5599083|P3|COMPLETED|Double Blind||5
2280489|NCT02178995|5599084|P2|COMPLETED|Double Blind||15
2280490|NCT02178995|5599085|P1|COMPLETED|Double Blind||0
2280491|NCT02178995|5599077|P9|STARTED|Double Blind||1
2280492|NCT02178995|5599078|P8|STARTED|Double Blind||6
2280493|NCT02178995|5599079|P7|STARTED|Double Blind||5
2280494|NCT02178995|5599080|P6|STARTED|Double Blind||6
2280495|NCT02178995|5599081|P5|STARTED|Double Blind||6
2280496|NCT02178995|5599082|P4|STARTED|Double Blind||6
2280497|NCT02178995|5599083|P3|STARTED|Double Blind||5
2280498|NCT02178995|5599084|P2|STARTED|Double Blind||16
2280499|NCT02178995|5599085|P1|STARTED|Double Blind||0
2280500|NCT02178800|5599158|P2|NOT COMPLETED|Overall Study||6
2280501|NCT02178800|5599159|P1|NOT COMPLETED|Overall Study||20
2280502|NCT02178800|5599158|P2|COMPLETED|Overall Study|Number of participants who weren't terminated at week 41|42
2280503|NCT02178800|5599159|P1|COMPLETED|Overall Study|Number of participants who weren't terminated at week 41|131
2280504|NCT02178800|5599158|P2|STARTED|Overall Study||48
2280505|NCT02178800|5599159|P1|STARTED|Overall Study||151
2280506|NCT02178787|5599192|P2|NOT COMPLETED|Overall Study||9
2280507|NCT02178787|5599193|P1|NOT COMPLETED|Overall Study||5
2280508|NCT02178787|5599192|P2|COMPLETED|Overall Study||30
2280509|NCT02178787|5599193|P1|COMPLETED|Overall Study||30
2280510|NCT02178787|5599192|P2|STARTED|Overall Study||39
2280511|NCT02178787|5599193|P1|STARTED|Overall Study||35
2280512|NCT02178722|5599206|P5|NOT COMPLETED|Overall Study||382
2280513|NCT02178722|5599207|P4|NOT COMPLETED|Overall Study||20
2280514|NCT02178722|5599208|P3|NOT COMPLETED|Overall Study||18
2280515|NCT02178722|5599209|P2|NOT COMPLETED|Overall Study||20
2280516|NCT02178722|5599210|P1|NOT COMPLETED|Overall Study||4
2280517|NCT02178722|5599206|P5|COMPLETED|Overall Study||0
2280518|NCT02178722|5599207|P4|COMPLETED|Overall Study||0
2280519|NCT02178722|5599208|P3|COMPLETED|Overall Study||0
2280520|NCT02178722|5599209|P2|COMPLETED|Overall Study||0
2280521|NCT02178722|5599210|P1|COMPLETED|Overall Study||0
2280522|NCT02178722|5599206|P5|STARTED|Overall Study||382
2280523|NCT02178722|5599207|P4|STARTED|Overall Study||20
2280524|NCT02178722|5599208|P3|STARTED|Overall Study||18
2280525|NCT02178722|5599209|P2|STARTED|Overall Study||20
2280526|NCT02178722|5599210|P1|STARTED|Overall Study||4
2280530|NCT02178696|5599233|P2|NOT COMPLETED|Open-label Antidepressant||7
2280531|NCT02178696|5599234|P1|NOT COMPLETED|Open-label Antidepressant||6
2280532|NCT02178696|5599233|P2|COMPLETED|Open-label Antidepressant||13
2280533|NCT02178696|5599234|P1|COMPLETED|Open-label Antidepressant||14
2280534|NCT02178696|5599233|P2|STARTED|Open-label Antidepressant||20
2280535|NCT02178696|5599234|P1|STARTED|Open-label Antidepressant||20
2280536|NCT02178696|5599233|P2|NOT COMPLETED|Second Assignment After Crossover||0
2280537|NCT02178696|5599234|P1|NOT COMPLETED|Second Assignment After Crossover||0
2280538|NCT02178696|5599233|P2|COMPLETED|Second Assignment After Crossover||20
2280539|NCT02178696|5599234|P1|COMPLETED|Second Assignment After Crossover||20
2280540|NCT02178696|5599233|P2|STARTED|Second Assignment After Crossover||20
2280541|NCT02178696|5599234|P1|STARTED|Second Assignment After Crossover||20
2280542|NCT02178696|5599233|P2|NOT COMPLETED|First Assignment and Washout||0
2280543|NCT02178696|5599234|P1|NOT COMPLETED|First Assignment and Washout||0
2280544|NCT02178696|5599233|P2|COMPLETED|First Assignment and Washout||20
2280545|NCT02178696|5599234|P1|COMPLETED|First Assignment and Washout||20
2280546|NCT02178696|5599233|P2|STARTED|First Assignment and Washout||20
2280547|NCT02178696|5599234|P1|STARTED|First Assignment and Washout||20
2280548|NCT02178592|5599249|P2|NOT COMPLETED|Overall Study||9
2280549|NCT02178592|5599250|P1|NOT COMPLETED|Overall Study||19
2280550|NCT02178592|5599249|P2|COMPLETED|Overall Study||35
2280551|NCT02178592|5599250|P1|COMPLETED|Overall Study||50
2280552|NCT02178592|5599249|P2|STARTED|Overall Study||44
2280553|NCT02178592|5599250|P1|STARTED|Overall Study||69
2280554|NCT02178553|5599278|P2|NOT COMPLETED|Overall Study||10
2280555|NCT02178553|5599279|P1|NOT COMPLETED|Overall Study||8
2280556|NCT02178553|5599278|P2|COMPLETED|Overall Study||39
2280557|NCT02178553|5599279|P1|COMPLETED|Overall Study||45
2280558|NCT02178553|5599278|P2|STARTED|Overall Study||49
2280559|NCT02178553|5599279|P1|STARTED|Overall Study||53
2280560|NCT02178540|5599291|P1|NOT COMPLETED|Overall Study||0
2280561|NCT02178540|5599291|P1|COMPLETED|Overall Study||45
2280562|NCT02178540|5599291|P1|STARTED|Overall Study||45
2280563|NCT02178475|5599298|P1|NOT COMPLETED|Overall Study||129
2280564|NCT02178475|5599298|P1|COMPLETED|Overall Study||814
2280565|NCT02178475|5599298|P1|Primary Analysis Set|Overall Study|All enrolled participants who met eligibility criteria|844
2280566|NCT02178475|5599298|P1|STARTED|Overall Study||943
2280567|NCT02178241|5599318|P1|NOT COMPLETED|Overall Study||0
2280568|NCT02178241|5599318|P1|COMPLETED|Overall Study||24
2280569|NCT02178241|5599318|P1|STARTED|Overall Study||24
2280570|NCT02178059|5599325|P2|NOT COMPLETED|Second Intervention||0
2280571|NCT02178059|5599326|P1|NOT COMPLETED|Second Intervention||0
2280572|NCT02178059|5599325|P2|COMPLETED|Second Intervention||17
2280573|NCT02178059|5599326|P1|COMPLETED|Second Intervention||16
2280574|NCT02178059|5599325|P2|STARTED|Second Intervention||17
2280575|NCT02178059|5599326|P1|STARTED|Second Intervention||16
2280576|NCT02178059|5599325|P2|NOT COMPLETED|Washout||0
2280577|NCT02178059|5599326|P1|NOT COMPLETED|Washout||1
2280578|NCT02178059|5599325|P2|COMPLETED|Washout||17
2280579|NCT02178059|5599326|P1|COMPLETED|Washout||16
2280580|NCT02178059|5599325|P2|STARTED|Washout||17
2280581|NCT02178059|5599326|P1|STARTED|Washout||17
2280582|NCT02178059|5599325|P2|NOT COMPLETED|First Intervention||0
2280583|NCT02178059|5599326|P1|NOT COMPLETED|First Intervention||0
2280584|NCT02178059|5599325|P2|COMPLETED|First Intervention||17
2280585|NCT02178059|5599326|P1|COMPLETED|First Intervention||17
2280586|NCT02178059|5599325|P2|STARTED|First Intervention||17
2280587|NCT02178059|5599326|P1|STARTED|First Intervention||17
2280588|NCT02177942|5599344|P2|NOT COMPLETED|Overall Study||88
2280589|NCT02177942|5599345|P1|NOT COMPLETED|Overall Study||77
2280590|NCT02177942|5599344|P2|COMPLETED|Overall Study||178
2280591|NCT02177942|5599345|P1|COMPLETED|Overall Study||185
2280592|NCT02177942|5599344|P2|STARTED|Overall Study||266
2280593|NCT02177942|5599345|P1|STARTED|Overall Study||262
2280594|NCT02177812|5599376|P9|NOT COMPLETED|Part 2 (Up to 14 Months)||0
2280595|NCT02177812|5599377|P8|NOT COMPLETED|Part 2 (Up to 14 Months)||0
2280596|NCT02177812|5599378|P7|NOT COMPLETED|Part 2 (Up to 14 Months)||0
2280597|NCT02177812|5599379|P6|NOT COMPLETED|Part 2 (Up to 14 Months)||0
2280598|NCT02177812|5599380|P5|NOT COMPLETED|Part 2 (Up to 14 Months)||0
2280599|NCT02177812|5599381|P4|NOT COMPLETED|Part 2 (Up to 14 Months)||0
2280600|NCT02177812|5599382|P3|NOT COMPLETED|Part 2 (Up to 14 Months)||0
2280601|NCT02177812|5599383|P2|NOT COMPLETED|Part 2 (Up to 14 Months)||0
2280602|NCT02177812|5599384|P1|NOT COMPLETED|Part 2 (Up to 14 Months)||0
2280603|NCT02177812|5599376|P9|COMPLETED|Part 2 (Up to 14 Months)||0
2280604|NCT02177812|5599377|P8|COMPLETED|Part 2 (Up to 14 Months)||0
2280605|NCT02177812|5599378|P7|COMPLETED|Part 2 (Up to 14 Months)||0
2280606|NCT02177812|5599379|P6|COMPLETED|Part 2 (Up to 14 Months)||0
2280607|NCT02177812|5599380|P5|COMPLETED|Part 2 (Up to 14 Months)||0
2280608|NCT02177812|5599381|P4|COMPLETED|Part 2 (Up to 14 Months)||0
2280609|NCT02177812|5599382|P3|COMPLETED|Part 2 (Up to 14 Months)||0
2280610|NCT02177812|5599383|P2|COMPLETED|Part 2 (Up to 14 Months)||0
2280611|NCT02177812|5599384|P1|COMPLETED|Part 2 (Up to 14 Months)||0
2280612|NCT02177812|5599376|P9|STARTED|Part 2 (Up to 14 Months)||0
2280613|NCT02177812|5599377|P8|STARTED|Part 2 (Up to 14 Months)||0
2280614|NCT02177812|5599378|P7|STARTED|Part 2 (Up to 14 Months)||0
2280615|NCT02177812|5599379|P6|STARTED|Part 2 (Up to 14 Months)||0
2280616|NCT02177812|5599380|P5|STARTED|Part 2 (Up to 14 Months)||0
2280617|NCT02177812|5599381|P4|STARTED|Part 2 (Up to 14 Months)||0
2280618|NCT02177812|5599382|P3|STARTED|Part 2 (Up to 14 Months)||0
2280619|NCT02177812|5599383|P2|STARTED|Part 2 (Up to 14 Months)||0
2280620|NCT02177812|5599384|P1|STARTED|Part 2 (Up to 14 Months)||0
2280621|NCT02177812|5599376|P9|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
2280622|NCT02177812|5599377|P8|NOT COMPLETED|Part 1 (Median of 4 Weeks)||2
2280623|NCT02177812|5599378|P7|NOT COMPLETED|Part 1 (Median of 4 Weeks)||9
2280624|NCT02177812|5599379|P6|NOT COMPLETED|Part 1 (Median of 4 Weeks)||3
2280625|NCT02177812|5599380|P5|NOT COMPLETED|Part 1 (Median of 4 Weeks)||1
2280626|NCT02177812|5599381|P4|NOT COMPLETED|Part 1 (Median of 4 Weeks)||1
2280627|NCT02177812|5599382|P3|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
2280628|NCT02177812|5599383|P2|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
2280629|NCT02177812|5599384|P1|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
2280630|NCT02177812|5599376|P9|COMPLETED|Part 1 (Median of 4 Weeks)||0
2280631|NCT02177812|5599377|P8|COMPLETED|Part 1 (Median of 4 Weeks)||4
2280632|NCT02177812|5599378|P7|COMPLETED|Part 1 (Median of 4 Weeks)||1
2280633|NCT02177812|5599379|P6|COMPLETED|Part 1 (Median of 4 Weeks)||1
2280634|NCT02177812|5599380|P5|COMPLETED|Part 1 (Median of 4 Weeks)||5
2280635|NCT02177812|5599381|P4|COMPLETED|Part 1 (Median of 4 Weeks)||4
2280636|NCT02177812|5599382|P3|COMPLETED|Part 1 (Median of 4 Weeks)||7
2280637|NCT02177812|5599383|P2|COMPLETED|Part 1 (Median of 4 Weeks)||2
2280638|NCT02177812|5599384|P1|COMPLETED|Part 1 (Median of 4 Weeks)||1
2280639|NCT02177812|5599376|P9|STARTED|Part 1 (Median of 4 Weeks)||0
2280640|NCT02177812|5599377|P8|STARTED|Part 1 (Median of 4 Weeks)||6
2280641|NCT02177812|5599378|P7|STARTED|Part 1 (Median of 4 Weeks)||10
2280642|NCT02177812|5599379|P6|STARTED|Part 1 (Median of 4 Weeks)||4
2280643|NCT02177812|5599380|P5|STARTED|Part 1 (Median of 4 Weeks)||6
2280644|NCT02177812|5599381|P4|STARTED|Part 1 (Median of 4 Weeks)||5
2280645|NCT02177812|5599382|P3|STARTED|Part 1 (Median of 4 Weeks)||7
2280646|NCT02177812|5599383|P2|STARTED|Part 1 (Median of 4 Weeks)||2
2280647|NCT02177812|5599384|P1|STARTED|Part 1 (Median of 4 Weeks)||1
2280648|NCT02177786|5599601|P4|NOT COMPLETED|Overall Study||13
2280649|NCT02177786|5599602|P3|NOT COMPLETED|Overall Study||18
2280650|NCT02177786|5599603|P2|NOT COMPLETED|Overall Study||14
2280651|NCT02177786|5599604|P1|NOT COMPLETED|Overall Study||6
2280652|NCT02177786|5599601|P4|COMPLETED|Overall Study||72
2280653|NCT02177786|5599602|P3|COMPLETED|Overall Study||66
2280654|NCT02177786|5599603|P2|COMPLETED|Overall Study||70
2280655|NCT02177786|5599604|P1|COMPLETED|Overall Study||75
2280656|NCT02177786|5599601|P4|Randomized and Treated|Overall Study||85
2280657|NCT02177786|5599602|P3|Randomized and Treated|Overall Study||83
2280658|NCT02177786|5599603|P2|Randomized and Treated|Overall Study||84
2280659|NCT02177786|5599604|P1|Randomized and Treated|Overall Study||81
2280660|NCT02177786|5599601|P4|STARTED|Overall Study||85
2280661|NCT02177786|5599602|P3|STARTED|Overall Study||84
2280662|NCT02177786|5599603|P2|STARTED|Overall Study||84
2280663|NCT02177786|5599604|P1|STARTED|Overall Study||81
2280664|NCT02177773|5599618|P1|NOT COMPLETED|Overall Study||0
2280665|NCT02177773|5599618|P1|COMPLETED|Overall Study||300
2280666|NCT02177773|5599618|P1|STARTED|Overall Study||300
2280667|NCT02177266|5599627|P2|NOT COMPLETED|Overall Study||1
2280668|NCT02177266|5599628|P1|NOT COMPLETED|Overall Study||1
2280669|NCT02177266|5599627|P2|COMPLETED|Overall Study||0
2280670|NCT02177266|5599628|P1|COMPLETED|Overall Study||0
2280671|NCT02177266|5599627|P2|STARTED|Overall Study||1
2280672|NCT02177266|5599628|P1|STARTED|Overall Study||1
2280673|NCT02177201|5599640|P2|NOT COMPLETED|Overall Study||3
2280674|NCT02177201|5599641|P1|NOT COMPLETED|Overall Study||3
2280675|NCT02177201|5599640|P2|COMPLETED|Overall Study||77
2280676|NCT02177201|5599641|P1|COMPLETED|Overall Study||77
2280677|NCT02177201|5599640|P2|STARTED|Overall Study||80
2280678|NCT02177201|5599641|P1|STARTED|Overall Study||80
2280679|NCT02177136|5599650|P3|NOT COMPLETED|Overall Study||4
2280680|NCT02177136|5599651|P2|NOT COMPLETED|Overall Study||5
2280681|NCT02177136|5599652|P1|NOT COMPLETED|Overall Study||6
2280682|NCT02177136|5599650|P3|COMPLETED|Overall Study||21
2280683|NCT02177136|5599651|P2|COMPLETED|Overall Study||21
2280684|NCT02177136|5599652|P1|COMPLETED|Overall Study||19
2280685|NCT02177136|5599650|P3|STARTED|Overall Study||25
2280686|NCT02177136|5599651|P2|STARTED|Overall Study||26
2280687|NCT02177136|5599652|P1|STARTED|Overall Study||25
2280688|NCT02177032|5599685|P4|NOT COMPLETED|Overall Study||0
2280689|NCT02177032|5599686|P3|NOT COMPLETED|Overall Study||3
2280690|NCT02177032|5599687|P2|NOT COMPLETED|Overall Study||2
2280691|NCT02177032|5599688|P1|NOT COMPLETED|Overall Study||5
2280692|NCT02177032|5599685|P4|COMPLETED|Overall Study||88
2280693|NCT02177032|5599686|P3|COMPLETED|Overall Study||351
2280694|NCT02177032|5599687|P2|COMPLETED|Overall Study||86
2280695|NCT02177032|5599688|P1|COMPLETED|Overall Study||350
2280696|NCT02177032|5599685|P4|STARTED|Overall Study||88
2280697|NCT02177032|5599686|P3|STARTED|Overall Study||354
2280698|NCT02177032|5599687|P2|STARTED|Overall Study||88
2280699|NCT02177032|5599688|P1|STARTED|Overall Study||355
2280700|NCT02176837|5599722|P1|NOT COMPLETED|Overall Study||6
2280701|NCT02176837|5599722|P1|COMPLETED|Overall Study||0
2280702|NCT02176837|5599722|P1|STARTED|Overall Study||6
2280703|NCT02176655|5599726|P1|NOT COMPLETED|Overall Study||6
2280704|NCT02176655|5599726|P1|COMPLETED|Overall Study||25
2280705|NCT02176655|5599726|P1|STARTED|Overall Study||31
2280706|NCT02176642|5599749|P2|NOT COMPLETED|Overall Study||1
2280707|NCT02176642|5599750|P1|NOT COMPLETED|Overall Study||0
2280708|NCT02176642|5599749|P2|COMPLETED|Overall Study||16
2280709|NCT02176642|5599750|P1|COMPLETED|Overall Study||18
2280710|NCT02176642|5599749|P2|STARTED|Overall Study||17
2280711|NCT02176642|5599750|P1|STARTED|Overall Study||18
2280712|NCT02176525|5599780|P8|NOT COMPLETED|Overall Study||0
2280713|NCT02176525|5599781|P7|NOT COMPLETED|Overall Study||1
2280714|NCT02176525|5599782|P6|NOT COMPLETED|Overall Study||1
2280715|NCT02176525|5599783|P5|NOT COMPLETED|Overall Study||1
2280716|NCT02176525|5599784|P4|NOT COMPLETED|Overall Study||1
2280717|NCT02176525|5599785|P3|NOT COMPLETED|Overall Study||0
2280718|NCT02176525|5599786|P2|NOT COMPLETED|Overall Study||0
2280719|NCT02176525|5599787|P1|NOT COMPLETED|Overall Study||1
2280720|NCT02176525|5599780|P8|COMPLETED|Overall Study||10
2280721|NCT02176525|5599781|P7|COMPLETED|Overall Study||8
2280722|NCT02176525|5599782|P6|COMPLETED|Overall Study||5
2280723|NCT02176525|5599783|P5|COMPLETED|Overall Study||7
2280724|NCT02176525|5599784|P4|COMPLETED|Overall Study||8
2280725|NCT02176525|5599785|P3|COMPLETED|Overall Study||9
2280726|NCT02176525|5599786|P2|COMPLETED|Overall Study||9
2280727|NCT02176525|5599787|P1|COMPLETED|Overall Study||14
2280728|NCT02176525|5599780|P8|STARTED|Overall Study||10
2280729|NCT02176525|5599781|P7|STARTED|Overall Study||9
2280730|NCT02176525|5599782|P6|STARTED|Overall Study|6 subjects randomized, 5 subjects treated with at least one dose, 1 subject was not treated|6
2280731|NCT02176525|5599783|P5|STARTED|Overall Study||8
2280732|NCT02176525|5599784|P4|STARTED|Overall Study||9
2280733|NCT02176525|5599785|P3|STARTED|Overall Study||9
2280734|NCT02176525|5599786|P2|STARTED|Overall Study||9
2280735|NCT02176525|5599787|P1|STARTED|Overall Study|15 subjects randomized, 14 subjects treated with at least one dose, 1 subject was not treated|15
2280736|NCT02176486|5599967|P3|NOT COMPLETED|Overall Study||0
2280737|NCT02176486|5599968|P2|NOT COMPLETED|Overall Study||0
2280738|NCT02176486|5599969|P1|NOT COMPLETED|Overall Study||0
2280739|NCT02176486|5599967|P3|COMPLETED|Overall Study||4
2280740|NCT02176486|5599968|P2|COMPLETED|Overall Study||5
2280741|NCT02176486|5599969|P1|COMPLETED|Overall Study||3
2280742|NCT02176486|5599967|P3|STARTED|Overall Study||4
2280743|NCT02176486|5599968|P2|STARTED|Overall Study||5
2280744|NCT02176486|5599969|P1|STARTED|Overall Study||3
2280745|NCT02176421|5600003|P1|NOT COMPLETED|Overall Study||5
2280746|NCT02176421|5600003|P1|COMPLETED|Overall Study||75
2280747|NCT02176421|5600003|P1|STARTED|Overall Study||80
2280748|NCT02176408|5600014|P2|NOT COMPLETED|Overall Study||4
2280749|NCT02176408|5600015|P1|NOT COMPLETED|Overall Study||6
2280750|NCT02176408|5600014|P2|COMPLETED|Overall Study||12
2280751|NCT02176408|5600015|P1|COMPLETED|Overall Study||9
2280752|NCT02176408|5600014|P2|STARTED|Overall Study||16
2280753|NCT02176408|5600015|P1|STARTED|Overall Study||15
2280754|NCT02176356|5600035|P1|NOT COMPLETED|Overall Study||23
2280755|NCT02176356|5600035|P1|COMPLETED|Overall Study||93
2280756|NCT02176356|5600035|P1|Eligible and Received Treatment|Overall Study||100
2280757|NCT02176356|5600035|P1|STARTED|Overall Study||116
2280758|NCT02176343|5600052|P1|NOT COMPLETED|Overall Study||0
2280759|NCT02176343|5600052|P1|COMPLETED|Overall Study||31
2280760|NCT02176343|5600052|P1|STARTED|Overall Study||31
2280761|NCT02176291|5600065|P2|NOT COMPLETED|Overall Study||0
2280762|NCT02176291|5600066|P1|NOT COMPLETED|Overall Study||5
2280763|NCT02176291|5600065|P2|COMPLETED|Overall Study||11
2280764|NCT02176291|5600066|P1|COMPLETED|Overall Study||15
2280765|NCT02176291|5600065|P2|STARTED|Overall Study||11
2280766|NCT02176291|5600066|P1|STARTED|Overall Study||20
2280767|NCT02176226|5600074|P1|NOT COMPLETED|Overall Study||9
2280768|NCT02176226|5600074|P1|COMPLETED|Overall Study||96
2280769|NCT02176226|5600074|P1|STARTED|Overall Study||105
2280770|NCT02176018|5600082|P2|NOT COMPLETED|Overall Study||6
2280771|NCT02176018|5600083|P1|NOT COMPLETED|Overall Study||5
2280772|NCT02176018|5600082|P2|COMPLETED|Overall Study||17
2280773|NCT02176018|5600083|P1|COMPLETED|Overall Study||17
2280774|NCT02176018|5600082|P2|STARTED|Overall Study||23
2280775|NCT02176018|5600083|P1|STARTED|Overall Study||22
2280776|NCT02175979|5600109|P2|NOT COMPLETED|Overall Study||8
2280777|NCT02175979|5600110|P1|NOT COMPLETED|Overall Study||7
2280778|NCT02175979|5600109|P2|COMPLETED|Overall Study||132
2280779|NCT02175979|5600110|P1|COMPLETED|Overall Study||133
2280780|NCT02175979|5600109|P2|STARTED|Overall Study||140
2280781|NCT02175979|5600110|P1|STARTED|Overall Study||140
2280782|NCT02175966|5600134|P2|NOT COMPLETED|Follow-up Period||6
2280783|NCT02175966|5600135|P1|NOT COMPLETED|Follow-up Period||10
2280784|NCT02175966|5600134|P2|COMPLETED|Follow-up Period||8
2280785|NCT02175966|5600135|P1|COMPLETED|Follow-up Period||4
2280786|NCT02175966|5600134|P2|STARTED|Follow-up Period||14
2280787|NCT02175966|5600135|P1|STARTED|Follow-up Period||14
2280788|NCT02175966|5600134|P2|NOT COMPLETED|Treatment Period||0
2280789|NCT02175966|5600135|P1|NOT COMPLETED|Treatment Period||0
2280790|NCT02175966|5600134|P2|COMPLETED|Treatment Period||14
2280791|NCT02175966|5600135|P1|COMPLETED|Treatment Period||14
2280792|NCT02175966|5600134|P2|STARTED|Treatment Period||14
2280793|NCT02175966|5600135|P1|STARTED|Treatment Period||14
2280794|NCT02175771|5600163|P9|NOT COMPLETED|Treatment Period||6
2280795|NCT02175771|5600164|P8|NOT COMPLETED|Treatment Period||17
2280796|NCT02175771|5600165|P7|NOT COMPLETED|Treatment Period||5
2280797|NCT02175771|5600166|P6|NOT COMPLETED|Treatment Period||10
2280798|NCT02175771|5600167|P5|NOT COMPLETED|Treatment Period||5
2280799|NCT02175771|5600168|P4|NOT COMPLETED|Treatment Period||13
2280800|NCT02175771|5600169|P3|NOT COMPLETED|Treatment Period||7
2280801|NCT02175771|5600170|P2|NOT COMPLETED|Treatment Period||16
2280802|NCT02175771|5600171|P1|NOT COMPLETED|Treatment Period||0
2280803|NCT02175771|5600163|P9|COMPLETED|Treatment Period||38
2280804|NCT02175771|5600164|P8|COMPLETED|Treatment Period||116
2280805|NCT02175771|5600165|P7|COMPLETED|Treatment Period||36
2280806|NCT02175771|5600166|P6|COMPLETED|Treatment Period||110
2280807|NCT02175771|5600167|P5|COMPLETED|Treatment Period||36
2280808|NCT02175771|5600168|P4|COMPLETED|Treatment Period||113
2280809|NCT02175771|5600169|P3|COMPLETED|Treatment Period||35
2280810|NCT02175771|5600170|P2|COMPLETED|Treatment Period||111
2280811|NCT02175771|5600171|P1|COMPLETED|Treatment Period||0
2280812|NCT02175771|5600163|P9|STARTED|Treatment Period||44
2280813|NCT02175771|5600164|P8|STARTED|Treatment Period||133
2280814|NCT02175771|5600165|P7|STARTED|Treatment Period||41
2280815|NCT02175771|5600166|P6|STARTED|Treatment Period||120
2280816|NCT02175771|5600167|P5|STARTED|Treatment Period||41
2280817|NCT02175771|5600168|P4|STARTED|Treatment Period||126
2280818|NCT02175771|5600169|P3|STARTED|Treatment Period||42
2280819|NCT02175771|5600170|P2|STARTED|Treatment Period||127
2280820|NCT02175771|5600171|P1|STARTED|Treatment Period||0
2280821|NCT02175771|5600163|P9|NOT COMPLETED|Run-In Period (Pre-assignment)||0
2280822|NCT02175771|5600164|P8|NOT COMPLETED|Run-In Period (Pre-assignment)||0
2280823|NCT02175771|5600165|P7|NOT COMPLETED|Run-In Period (Pre-assignment)||0
2280824|NCT02175771|5600166|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
2280825|NCT02175771|5600167|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
2280826|NCT02175771|5600168|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
2280827|NCT02175771|5600169|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
2280828|NCT02175771|5600170|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
2280829|NCT02175771|5600171|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||84
2280830|NCT02175771|5600163|P9|COMPLETED|Run-In Period (Pre-assignment)||0
2280831|NCT02175771|5600164|P8|COMPLETED|Run-In Period (Pre-assignment)||0
2280832|NCT02175771|5600165|P7|COMPLETED|Run-In Period (Pre-assignment)||0
2280833|NCT02175771|5600166|P6|COMPLETED|Run-In Period (Pre-assignment)||0
2280834|NCT02175771|5600167|P5|COMPLETED|Run-In Period (Pre-assignment)||0
2280835|NCT02175771|5600168|P4|COMPLETED|Run-In Period (Pre-assignment)||0
2280836|NCT02175771|5600169|P3|COMPLETED|Run-In Period (Pre-assignment)||0
2280837|NCT02175771|5600170|P2|COMPLETED|Run-In Period (Pre-assignment)||0
2280838|NCT02175771|5600171|P1|COMPLETED|Run-In Period (Pre-assignment)||674
2280839|NCT02175771|5600163|P9|STARTED|Run-In Period (Pre-assignment)||0
2280840|NCT02175771|5600164|P8|STARTED|Run-In Period (Pre-assignment)||0
2280841|NCT02175771|5600165|P7|STARTED|Run-In Period (Pre-assignment)||0
2280842|NCT02175771|5600166|P6|STARTED|Run-In Period (Pre-assignment)||0
2280843|NCT02175771|5600167|P5|STARTED|Run-In Period (Pre-assignment)||0
2280844|NCT02175771|5600168|P4|STARTED|Run-In Period (Pre-assignment)||0
2280845|NCT02175771|5600169|P3|STARTED|Run-In Period (Pre-assignment)||0
2280846|NCT02175771|5600170|P2|STARTED|Run-In Period (Pre-assignment)||0
2280847|NCT02175771|5600171|P1|STARTED|Run-In Period (Pre-assignment)|Enrolled; two participants were enrolled but had no enrollment date in their records.|758
2280848|NCT02175758|5600235|P6|NOT COMPLETED|Treatment Phase||0
2280849|NCT02175758|5600236|P5|NOT COMPLETED|Treatment Phase||1
2280850|NCT02175758|5600237|P4|NOT COMPLETED|Treatment Phase||0
2280851|NCT02175758|5600238|P3|NOT COMPLETED|Treatment Phase||0
2280852|NCT02175758|5600239|P2|NOT COMPLETED|Treatment Phase||1
2280853|NCT02175758|5600240|P1|NOT COMPLETED|Treatment Phase||0
2280854|NCT02175758|5600235|P6|COMPLETED|Treatment Phase||8
2280855|NCT02175758|5600236|P5|COMPLETED|Treatment Phase||4
2280856|NCT02175758|5600237|P4|COMPLETED|Treatment Phase||28
2280857|NCT02175758|5600238|P3|COMPLETED|Treatment Phase||13
2280858|NCT02175758|5600239|P2|COMPLETED|Treatment Phase||38
2280859|NCT02175758|5600240|P1|COMPLETED|Treatment Phase||13
2280860|NCT02175758|5600235|P6|STARTED|Treatment Phase||8
2280861|NCT02175758|5600236|P5|STARTED|Treatment Phase|1 participant enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|5
2280862|NCT02175758|5600237|P4|STARTED|Treatment Phase|18 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|28
2280863|NCT02175758|5600238|P3|STARTED|Treatment Phase|11 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|13
2280864|NCT02175758|5600239|P2|STARTED|Treatment Phase|33 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|39
2280865|NCT02175758|5600240|P1|STARTED|Treatment Phase|9 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|13
2280866|NCT02175758|5600235|P6|NOT COMPLETED|PK Lead-in Phase||0
2280867|NCT02175758|5600236|P5|NOT COMPLETED|PK Lead-in Phase||0
2280868|NCT02175758|5600237|P4|NOT COMPLETED|PK Lead-in Phase||0
2280869|NCT02175758|5600238|P3|NOT COMPLETED|PK Lead-in Phase||0
2280870|NCT02175758|5600239|P2|NOT COMPLETED|PK Lead-in Phase||0
2280871|NCT02175758|5600240|P1|NOT COMPLETED|PK Lead-in Phase||0
2280872|NCT02175758|5600235|P6|COMPLETED|PK Lead-in Phase||8
2280873|NCT02175758|5600236|P5|COMPLETED|PK Lead-in Phase||4
2280874|NCT02175758|5600237|P4|COMPLETED|PK Lead-in Phase||10
2280875|NCT02175758|5600238|P3|COMPLETED|PK Lead-in Phase||2
2280876|NCT02175758|5600239|P2|COMPLETED|PK Lead-in Phase||6
2280877|NCT02175758|5600240|P1|COMPLETED|PK Lead-in Phase||4
2280878|NCT02175758|5600235|P6|STARTED|PK Lead-in Phase||8
2280879|NCT02175758|5600236|P5|STARTED|PK Lead-in Phase||4
2280880|NCT02175758|5600237|P4|STARTED|PK Lead-in Phase||10
2280881|NCT02175758|5600238|P3|STARTED|PK Lead-in Phase||2
2280882|NCT02175758|5600239|P2|STARTED|PK Lead-in Phase||6
2280883|NCT02175758|5600240|P1|STARTED|PK Lead-in Phase||4
2280884|NCT02175745|5600343|P1|NOT COMPLETED|Overall Study||1
2280885|NCT02175745|5600343|P1|COMPLETED|Overall Study||1
2280886|NCT02175745|5600343|P1|STARTED|Overall Study||2
2280887|NCT02175628|5600350|P2|NOT COMPLETED|Overall Study||0
2280888|NCT02175628|5600351|P1|NOT COMPLETED|Overall Study||0
2280889|NCT02175628|5600350|P2|COMPLETED|Overall Study||17
2280890|NCT02175628|5600351|P1|COMPLETED|Overall Study||6
2280891|NCT02175628|5600350|P2|STARTED|Overall Study||17
2280892|NCT02175628|5600351|P1|STARTED|Overall Study||6
2280893|NCT02175472|5600367|P2|NOT COMPLETED|Overall Study||2
2280894|NCT02175472|5600368|P1|NOT COMPLETED|Overall Study||7
2280895|NCT02175472|5600367|P2|COMPLETED|Overall Study||45
2280896|NCT02175472|5600368|P1|COMPLETED|Overall Study||38
2280897|NCT02175472|5600367|P2|STARTED|Overall Study||47
2280898|NCT02175472|5600368|P1|STARTED|Overall Study||45
2280899|NCT02175368|5600382|P1|NOT COMPLETED|Overall Study||1
2280900|NCT02175368|5600382|P1|COMPLETED|Overall Study||27
2280901|NCT02175368|5600382|P1|STARTED|Overall Study||28
2280902|NCT02175277|5600387|P1|NOT COMPLETED|Overall Study||1
2280903|NCT02175277|5600387|P1|COMPLETED|Overall Study||8
2280904|NCT02175277|5600387|P1|STARTED|Overall Study||9
2280905|NCT02175225|5600393|P2|NOT COMPLETED|Overall Study||11
2280906|NCT02175225|5600394|P1|NOT COMPLETED|Overall Study||8
2280907|NCT02175225|5600393|P2|COMPLETED|Overall Study||138
2280908|NCT02175225|5600394|P1|COMPLETED|Overall Study||137
2280909|NCT02175225|5600393|P2|180 Day Outcome Obtained|Overall Study||135
2280910|NCT02175225|5600394|P1|180 Day Outcome Obtained|Overall Study||135
2280911|NCT02175225|5600393|P2|90 Day Outcome Obtained|Overall Study||143
2280912|NCT02175225|5600394|P1|90 Day Outcome Obtained|Overall Study||140
2280913|NCT02175225|5600393|P2|Initiated Study Drug|Overall Study|Subjects in whom study drug was not initiated are not subsequently followed per the protocol.|147
2280914|NCT02175225|5600394|P1|Initiated Study Drug|Overall Study|Subjects in whom study drug was not initiated are not subsequently followed per the protocol.|144
2280915|NCT02175225|5600393|P2|STARTED|Overall Study||149
2280916|NCT02175225|5600394|P1|STARTED|Overall Study||145
2280917|NCT02175212|5600428|P2|NOT COMPLETED|Overall Study||147
2280918|NCT02175212|5600429|P1|NOT COMPLETED|Overall Study||163
2280919|NCT02175212|5600428|P2|COMPLETED|Overall Study||31
2280920|NCT02175212|5600429|P1|COMPLETED|Overall Study||14
2280921|NCT02175212|5600428|P2|STARTED|Overall Study||178
2280922|NCT02175212|5600429|P1|STARTED|Overall Study||177
2280923|NCT02175199|5600445|P2|NOT COMPLETED|Overall Study||5
2280924|NCT02175199|5600446|P1|NOT COMPLETED|Overall Study||3
2280925|NCT02175199|5600445|P2|COMPLETED|Overall Study||71
2280926|NCT02175199|5600446|P1|COMPLETED|Overall Study||71
2280927|NCT02175199|5600445|P2|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|74
2280928|NCT02175199|5600446|P1|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|72
2280929|NCT02175199|5600445|P2|STARTED|Overall Study||76
2280930|NCT02175199|5600446|P1|STARTED|Overall Study||74
2280931|NCT02175121|5600460|P5|NOT COMPLETED|Overall Study||1
2280932|NCT02175121|5600461|P4|NOT COMPLETED|Overall Study||1
2280933|NCT02175121|5600462|P3|NOT COMPLETED|Overall Study||2
2280934|NCT02175121|5600463|P2|NOT COMPLETED|Overall Study||1
2280935|NCT02175121|5600464|P1|NOT COMPLETED|Overall Study||1
2280936|NCT02175121|5600460|P5|COMPLETED|Overall Study||33
2280937|NCT02175121|5600461|P4|COMPLETED|Overall Study||34
2280938|NCT02175121|5600462|P3|COMPLETED|Overall Study||32
2280939|NCT02175121|5600463|P2|COMPLETED|Overall Study||34
2280940|NCT02175121|5600464|P1|COMPLETED|Overall Study||33
2280941|NCT02175121|5600460|P5|STARTED|Overall Study||34
2280942|NCT02175121|5600461|P4|STARTED|Overall Study||35
2280943|NCT02175121|5600462|P3|STARTED|Overall Study||34
2280944|NCT02175121|5600463|P2|STARTED|Overall Study||35
2280945|NCT02175121|5600464|P1|STARTED|Overall Study||34
2280946|NCT02174861|5600591|P1|NOT COMPLETED|Overall Study||158
2280947|NCT02174861|5600591|P1|COMPLETED|Overall Study||451
2280948|NCT02174861|5600591|P1|Enrolled in CHU Substudy|Overall Study||53
2280949|NCT02174861|5600591|P1|STARTED|Overall Study||609
2280950|NCT02174848|5600605|P2|NOT COMPLETED|Overall Study||6
2280951|NCT02174848|5600606|P1|NOT COMPLETED|Overall Study||7
2280952|NCT02174848|5600605|P2|COMPLETED|Overall Study||38
2280953|NCT02174848|5600606|P1|COMPLETED|Overall Study||17
2280954|NCT02174848|5600605|P2|Provided Post-baseline Efficacy Data|Overall Study||43
2280955|NCT02174848|5600606|P1|Provided Post-baseline Efficacy Data|Overall Study||19
2280956|NCT02174848|5600605|P2|STARTED|Overall Study||44
2280957|NCT02174848|5600606|P1|STARTED|Overall Study||24
2280958|NCT02174731|5600627|P2|NOT COMPLETED|Overall Study||65
2280959|NCT02174731|5600628|P1|NOT COMPLETED|Overall Study||69
2280960|NCT02174731|5600627|P2|COMPLETED|Overall Study||990
2280961|NCT02174731|5600628|P1|COMPLETED|Overall Study||982
2280962|NCT02174731|5600627|P2|Received Treatment|Overall Study||1053
2280963|NCT02174731|5600628|P1|Received Treatment|Overall Study||1048
2280964|NCT02174731|5600627|P2|STARTED|Overall Study||1055
2280965|NCT02174731|5600628|P1|STARTED|Overall Study||1051
2280966|NCT02174627|5600650|P2|NOT COMPLETED|Overall Study||130
2280967|NCT02174627|5600651|P1|NOT COMPLETED|Overall Study||84
2280968|NCT02174627|5600650|P2|COMPLETED|Overall Study||1247
2280969|NCT02174627|5600651|P1|COMPLETED|Overall Study||1300
2280970|NCT02174627|5600650|P2|Discontinued Treatment|Overall Study||801
2280971|NCT02174627|5600651|P1|Discontinued Treatment|Overall Study||499
2280972|NCT02174627|5600650|P2|Received Treatment|Overall Study||1376
2280973|NCT02174627|5600651|P1|Received Treatment|Overall Study||1384
2280974|NCT02174627|5600650|P2|STARTED|Overall Study||1377
2280975|NCT02174627|5600651|P1|STARTED|Overall Study||1384
2280976|NCT02174523|5600679|P2|NOT COMPLETED|Overall Study||0
2280977|NCT02174523|5600680|P1|NOT COMPLETED|Overall Study||1
2280978|NCT02174523|5600679|P2|COMPLETED|Overall Study||4
2280979|NCT02174523|5600680|P1|COMPLETED|Overall Study||9
2280980|NCT02174523|5600679|P2|STARTED|Overall Study||4
2280981|NCT02174523|5600680|P1|STARTED|Overall Study||10
2280982|NCT02174510|5600711|P4|NOT COMPLETED|Overall Study||0
2280983|NCT02174510|5600712|P3|NOT COMPLETED|Overall Study||0
2280984|NCT02174510|5600713|P2|NOT COMPLETED|Overall Study||0
2280985|NCT02174510|5600714|P1|NOT COMPLETED|Overall Study||0
2280986|NCT02174510|5600711|P4|COMPLETED|Overall Study||9
2280987|NCT02174510|5600712|P3|COMPLETED|Overall Study||12
2280988|NCT02174510|5600713|P2|COMPLETED|Overall Study||8
2280989|NCT02174510|5600714|P1|COMPLETED|Overall Study||8
2280990|NCT02174510|5600711|P4|STARTED|Overall Study||9
2280991|NCT02174510|5600712|P3|STARTED|Overall Study||12
2280992|NCT02174510|5600713|P2|STARTED|Overall Study||8
2280993|NCT02174510|5600714|P1|STARTED|Overall Study||8
2280994|NCT02174276|5600748|P4|NOT COMPLETED|OTEP (Weeks 48 to 144)||2
2280995|NCT02174276|5600749|P3|NOT COMPLETED|OTEP (Weeks 48 to 144)||3
2280996|NCT02174276|5600750|P2|NOT COMPLETED|OTEP (Weeks 48 to 144)||0
2280997|NCT02174276|5600751|P1|NOT COMPLETED|OTEP (Weeks 48 to 144)||1
2280998|NCT02174276|5600748|P4|COMPLETED|OTEP (Weeks 48 to 144)||50
2280999|NCT02174276|5600749|P3|COMPLETED|OTEP (Weeks 48 to 144)||48
2281000|NCT02174276|5600750|P2|COMPLETED|OTEP (Weeks 48 to 144)||54
2281001|NCT02174276|5600751|P1|COMPLETED|OTEP (Weeks 48 to 144)||25
2281002|NCT02174276|5600748|P4|STARTED|OTEP (Weeks 48 to 144)|3 Participants completed the study treatment phase but did not continue in OTEP.|52
2281003|NCT02174276|5600749|P3|STARTED|OTEP (Weeks 48 to 144)|2 Participants completed the study treatment phase but did not continue in OTEP.|51
2281004|NCT02174276|5600750|P2|STARTED|OTEP (Weeks 48 to 144)|2 Participants completed the study treatment phase but did not continue in OTEP.|54
2281005|NCT02174276|5600751|P1|STARTED|OTEP (Weeks 48 to 144)||26
2281006|NCT02174276|5600748|P4|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||0
2281007|NCT02174276|5600749|P3|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||3
2281008|NCT02174276|5600750|P2|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||1
2281009|NCT02174276|5600751|P1|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||1
2281010|NCT02174276|5600748|P4|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||55
2281011|NCT02174276|5600749|P3|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||53
2281012|NCT02174276|5600750|P2|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||56
2281013|NCT02174276|5600751|P1|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||26
2281014|NCT02174276|5600748|P4|STARTED|Study Treatment Phase (Weeks 1 to 48)||55
2281015|NCT02174276|5600749|P3|STARTED|Study Treatment Phase (Weeks 1 to 48)||56
2281016|NCT02174276|5600750|P2|STARTED|Study Treatment Phase (Weeks 1 to 48)||57
2281017|NCT02174276|5600751|P1|STARTED|Study Treatment Phase (Weeks 1 to 48)||27
2281018|NCT02174198|5600835|P2|NOT COMPLETED|Overall Study||0
2281019|NCT02174198|5600836|P1|NOT COMPLETED|Overall Study||0
2281020|NCT02174198|5600835|P2|COMPLETED|Overall Study||16
2281021|NCT02174198|5600836|P1|COMPLETED|Overall Study||16
2281022|NCT02174198|5600835|P2|STARTED|Overall Study||16
2281023|NCT02174198|5600836|P1|STARTED|Overall Study||16
2281024|NCT02173769|5600858|P1|NOT COMPLETED|Overall Study||4
2281025|NCT02173769|5600858|P1|COMPLETED|Overall Study||1854
2281026|NCT02173769|5600858|P1|STARTED|Overall Study||1858
2281027|NCT02173704|5600871|P2|NOT COMPLETED|Overall Study||4
2281028|NCT02173704|5600872|P1|NOT COMPLETED|Overall Study||13
2281029|NCT02173704|5600871|P2|COMPLETED|Overall Study||71
2281030|NCT02173704|5600872|P1|COMPLETED|Overall Study||137
2281031|NCT02173704|5600871|P2|STARTED|Overall Study||75
2281032|NCT02173704|5600872|P1|STARTED|Overall Study||150
2281033|NCT02173548|5600898|P2|NOT COMPLETED|Overall Study||2
2281034|NCT02173548|5600899|P1|NOT COMPLETED|Overall Study||1
2281035|NCT02173548|5600898|P2|COMPLETED|Overall Study||8
2281036|NCT02173548|5600899|P1|COMPLETED|Overall Study||20
2281037|NCT02173548|5600898|P2|STARTED|Overall Study||10
2281038|NCT02173548|5600899|P1|STARTED|Overall Study||21
2281039|NCT02173535|5600939|P20|NOT COMPLETED|Period 5||0
2281040|NCT02173535|5600940|P19|NOT COMPLETED|Period 5||0
2281041|NCT02173535|5600941|P18|NOT COMPLETED|Period 5||0
2281042|NCT02173535|5600942|P17|NOT COMPLETED|Period 5||0
2281043|NCT02173535|5600943|P16|NOT COMPLETED|Period 5||0
2281044|NCT02173535|5600944|P15|NOT COMPLETED|Period 5||0
2281045|NCT02173535|5600945|P14|NOT COMPLETED|Period 5||0
2281046|NCT02173535|5600946|P13|NOT COMPLETED|Period 5||0
2281047|NCT02173535|5600947|P12|NOT COMPLETED|Period 5||0
2281048|NCT02173535|5600948|P11|NOT COMPLETED|Period 5||0
2281049|NCT02173535|5600949|P10|NOT COMPLETED|Period 5||0
2281050|NCT02173535|5600950|P9|NOT COMPLETED|Period 5||0
2281051|NCT02173535|5600951|P8|NOT COMPLETED|Period 5||0
2281052|NCT02173535|5600952|P7|NOT COMPLETED|Period 5||0
2281053|NCT02173535|5600953|P6|NOT COMPLETED|Period 5||0
2281054|NCT02173535|5600954|P5|NOT COMPLETED|Period 5||0
2281055|NCT02173535|5600955|P4|NOT COMPLETED|Period 5||0
2281056|NCT02173535|5600956|P3|NOT COMPLETED|Period 5||0
2281057|NCT02173535|5600957|P2|NOT COMPLETED|Period 5||0
2281058|NCT02173535|5600958|P1|NOT COMPLETED|Period 5||0
2281059|NCT02173535|5600939|P20|COMPLETED|Period 5||12
2281060|NCT02173535|5600940|P19|COMPLETED|Period 5||12
2281061|NCT02173535|5600941|P18|COMPLETED|Period 5||12
2281062|NCT02173535|5600942|P17|COMPLETED|Period 5||12
2281063|NCT02173535|5600943|P16|COMPLETED|Period 5||12
2281064|NCT02173535|5600944|P15|COMPLETED|Period 5||12
2281065|NCT02173535|5600945|P14|COMPLETED|Period 5||12
2281066|NCT02173535|5600946|P13|COMPLETED|Period 5||12
2281067|NCT02173535|5600947|P12|COMPLETED|Period 5||12
2281068|NCT02173535|5600948|P11|COMPLETED|Period 5||12
2281069|NCT02173535|5600949|P10|COMPLETED|Period 5||12
2281070|NCT02173535|5600950|P9|COMPLETED|Period 5||12
2281071|NCT02173535|5600951|P8|COMPLETED|Period 5||12
2281072|NCT02173535|5600952|P7|COMPLETED|Period 5||12
2281073|NCT02173535|5600953|P6|COMPLETED|Period 5||12
2281074|NCT02173535|5600954|P5|COMPLETED|Period 5||12
2281075|NCT02173535|5600955|P4|COMPLETED|Period 5||12
2281076|NCT02173535|5600956|P3|COMPLETED|Period 5||12
2281077|NCT02173535|5600957|P2|COMPLETED|Period 5||12
2281078|NCT02173535|5600958|P1|COMPLETED|Period 5||12
2281079|NCT02173535|5600939|P20|STARTED|Period 5||12
2281080|NCT02173535|5600940|P19|STARTED|Period 5||12
2281081|NCT02173535|5600941|P18|STARTED|Period 5||12
2281082|NCT02173535|5600942|P17|STARTED|Period 5||12
2281083|NCT02173535|5600943|P16|STARTED|Period 5||12
2281084|NCT02173535|5600944|P15|STARTED|Period 5||12
2281085|NCT02173535|5600945|P14|STARTED|Period 5||12
2281086|NCT02173535|5600946|P13|STARTED|Period 5||12
2281087|NCT02173535|5600947|P12|STARTED|Period 5||12
2281088|NCT02173535|5600948|P11|STARTED|Period 5||12
2281089|NCT02173535|5600949|P10|STARTED|Period 5||12
2281090|NCT02173535|5600950|P9|STARTED|Period 5||12
2281091|NCT02173535|5600951|P8|STARTED|Period 5||12
2281092|NCT02173535|5600952|P7|STARTED|Period 5||12
2281093|NCT02173535|5600953|P6|STARTED|Period 5||12
2281094|NCT02173535|5600954|P5|STARTED|Period 5||12
2281095|NCT02173535|5600955|P4|STARTED|Period 5||12
2281096|NCT02173535|5600956|P3|STARTED|Period 5||12
2281097|NCT02173535|5600957|P2|STARTED|Period 5||12
2281098|NCT02173535|5600958|P1|STARTED|Period 5||12
2281099|NCT02173535|5600939|P20|NOT COMPLETED|Period 4||0
2281100|NCT02173535|5600940|P19|NOT COMPLETED|Period 4||0
2281101|NCT02173535|5600941|P18|NOT COMPLETED|Period 4||0
2281102|NCT02173535|5600942|P17|NOT COMPLETED|Period 4||0
2281103|NCT02173535|5600943|P16|NOT COMPLETED|Period 4||0
2281104|NCT02173535|5600944|P15|NOT COMPLETED|Period 4||0
2281105|NCT02173535|5600945|P14|NOT COMPLETED|Period 4||0
2281106|NCT02173535|5600946|P13|NOT COMPLETED|Period 4||0
2281107|NCT02173535|5600947|P12|NOT COMPLETED|Period 4||0
2281108|NCT02173535|5600948|P11|NOT COMPLETED|Period 4||0
2281109|NCT02173535|5600949|P10|NOT COMPLETED|Period 4||0
2281110|NCT02173535|5600950|P9|NOT COMPLETED|Period 4||0
2281111|NCT02173535|5600951|P8|NOT COMPLETED|Period 4||0
2281112|NCT02173535|5600952|P7|NOT COMPLETED|Period 4||0
2281113|NCT02173535|5600953|P6|NOT COMPLETED|Period 4||0
2281114|NCT02173535|5600954|P5|NOT COMPLETED|Period 4||0
2281115|NCT02173535|5600955|P4|NOT COMPLETED|Period 4||0
2281116|NCT02173535|5600956|P3|NOT COMPLETED|Period 4||0
2281117|NCT02173535|5600957|P2|NOT COMPLETED|Period 4||0
2281118|NCT02173535|5600958|P1|NOT COMPLETED|Period 4||0
2281119|NCT02173535|5600939|P20|COMPLETED|Period 4||12
2281120|NCT02173535|5600940|P19|COMPLETED|Period 4||12
2281121|NCT02173535|5600941|P18|COMPLETED|Period 4||12
2281122|NCT02173535|5600942|P17|COMPLETED|Period 4||12
2281123|NCT02173535|5600943|P16|COMPLETED|Period 4||12
2281124|NCT02173535|5600944|P15|COMPLETED|Period 4||12
2281125|NCT02173535|5600945|P14|COMPLETED|Period 4||12
2281126|NCT02173535|5600946|P13|COMPLETED|Period 4||12
2281127|NCT02173535|5600947|P12|COMPLETED|Period 4||12
2281128|NCT02173535|5600948|P11|COMPLETED|Period 4||12
2281129|NCT02173535|5600949|P10|COMPLETED|Period 4||12
2281130|NCT02173535|5600950|P9|COMPLETED|Period 4||12
2281131|NCT02173535|5600951|P8|COMPLETED|Period 4||12
2281132|NCT02173535|5600952|P7|COMPLETED|Period 4||12
2281133|NCT02173535|5600953|P6|COMPLETED|Period 4||12
2281134|NCT02173535|5600954|P5|COMPLETED|Period 4||12
2281135|NCT02173535|5600955|P4|COMPLETED|Period 4||12
2281136|NCT02173535|5600956|P3|COMPLETED|Period 4||12
2281137|NCT02173535|5600957|P2|COMPLETED|Period 4||12
2281138|NCT02173535|5600958|P1|COMPLETED|Period 4||12
2281139|NCT02173535|5600939|P20|STARTED|Period 4||12
2281140|NCT02173535|5600940|P19|STARTED|Period 4||12
2281141|NCT02173535|5600941|P18|STARTED|Period 4||12
2281142|NCT02173535|5600942|P17|STARTED|Period 4||12
2281143|NCT02173535|5600943|P16|STARTED|Period 4||12
2281144|NCT02173535|5600944|P15|STARTED|Period 4||12
2281145|NCT02173535|5600945|P14|STARTED|Period 4||12
2281146|NCT02173535|5600946|P13|STARTED|Period 4||12
2281147|NCT02173535|5600947|P12|STARTED|Period 4||12
2281148|NCT02173535|5600948|P11|STARTED|Period 4||12
2281149|NCT02173535|5600949|P10|STARTED|Period 4||12
2281150|NCT02173535|5600950|P9|STARTED|Period 4||12
2281151|NCT02173535|5600951|P8|STARTED|Period 4||12
2281152|NCT02173535|5600952|P7|STARTED|Period 4||12
2281153|NCT02173535|5600953|P6|STARTED|Period 4||12
2281154|NCT02173535|5600954|P5|STARTED|Period 4||12
2281155|NCT02173535|5600955|P4|STARTED|Period 4||12
2281156|NCT02173535|5600956|P3|STARTED|Period 4||12
2281157|NCT02173535|5600957|P2|STARTED|Period 4||12
2281158|NCT02173535|5600958|P1|STARTED|Period 4||12
2281159|NCT02173535|5600939|P20|NOT COMPLETED|Period 3||0
2281160|NCT02173535|5600940|P19|NOT COMPLETED|Period 3||0
2281161|NCT02173535|5600941|P18|NOT COMPLETED|Period 3||0
2281162|NCT02173535|5600942|P17|NOT COMPLETED|Period 3||0
2281163|NCT02173535|5600943|P16|NOT COMPLETED|Period 3||0
2281164|NCT02173535|5600944|P15|NOT COMPLETED|Period 3||0
2281165|NCT02173535|5600945|P14|NOT COMPLETED|Period 3||0
2281166|NCT02173535|5600946|P13|NOT COMPLETED|Period 3||0
2281167|NCT02173535|5600947|P12|NOT COMPLETED|Period 3||0
2281168|NCT02173535|5600948|P11|NOT COMPLETED|Period 3||0
2281169|NCT02173535|5600949|P10|NOT COMPLETED|Period 3||0
2281170|NCT02173535|5600950|P9|NOT COMPLETED|Period 3||0
2281171|NCT02173535|5600951|P8|NOT COMPLETED|Period 3||0
2281172|NCT02173535|5600952|P7|NOT COMPLETED|Period 3||0
2281173|NCT02173535|5600953|P6|NOT COMPLETED|Period 3||0
2281174|NCT02173535|5600954|P5|NOT COMPLETED|Period 3||0
2281175|NCT02173535|5600955|P4|NOT COMPLETED|Period 3||0
2281176|NCT02173535|5600956|P3|NOT COMPLETED|Period 3||0
2281177|NCT02173535|5600957|P2|NOT COMPLETED|Period 3||0
2281178|NCT02173535|5600958|P1|NOT COMPLETED|Period 3||0
2281179|NCT02173535|5600939|P20|COMPLETED|Period 3||12
2281180|NCT02173535|5600940|P19|COMPLETED|Period 3||12
2281181|NCT02173535|5600941|P18|COMPLETED|Period 3||12
2281182|NCT02173535|5600942|P17|COMPLETED|Period 3||12
2281183|NCT02173535|5600943|P16|COMPLETED|Period 3||12
2281184|NCT02173535|5600944|P15|COMPLETED|Period 3||12
2281185|NCT02173535|5600945|P14|COMPLETED|Period 3||12
2281186|NCT02173535|5600946|P13|COMPLETED|Period 3||12
2281187|NCT02173535|5600947|P12|COMPLETED|Period 3||12
2281188|NCT02173535|5600948|P11|COMPLETED|Period 3||12
2281189|NCT02173535|5600949|P10|COMPLETED|Period 3||12
2281190|NCT02173535|5600950|P9|COMPLETED|Period 3||12
2281191|NCT02173535|5600951|P8|COMPLETED|Period 3||12
2281192|NCT02173535|5600952|P7|COMPLETED|Period 3||12
2281193|NCT02173535|5600953|P6|COMPLETED|Period 3||12
2281194|NCT02173535|5600954|P5|COMPLETED|Period 3||12
2281195|NCT02173535|5600955|P4|COMPLETED|Period 3||12
2281196|NCT02173535|5600956|P3|COMPLETED|Period 3||12
2281197|NCT02173535|5600957|P2|COMPLETED|Period 3||12
2281198|NCT02173535|5600958|P1|COMPLETED|Period 3||12
2281199|NCT02173535|5600939|P20|STARTED|Period 3||12
2281200|NCT02173535|5600940|P19|STARTED|Period 3||12
2281201|NCT02173535|5600941|P18|STARTED|Period 3||12
2281202|NCT02173535|5600942|P17|STARTED|Period 3||12
2281203|NCT02173535|5600943|P16|STARTED|Period 3||12
2281204|NCT02173535|5600944|P15|STARTED|Period 3||12
2281205|NCT02173535|5600945|P14|STARTED|Period 3||12
2281206|NCT02173535|5600946|P13|STARTED|Period 3||12
2281207|NCT02173535|5600947|P12|STARTED|Period 3||12
2281208|NCT02173535|5600948|P11|STARTED|Period 3||12
2281209|NCT02173535|5600949|P10|STARTED|Period 3||12
2281210|NCT02173535|5600950|P9|STARTED|Period 3||12
2281211|NCT02173535|5600951|P8|STARTED|Period 3||12
2281212|NCT02173535|5600952|P7|STARTED|Period 3||12
2281213|NCT02173535|5600953|P6|STARTED|Period 3||12
2281214|NCT02173535|5600954|P5|STARTED|Period 3||12
2281215|NCT02173535|5600955|P4|STARTED|Period 3||12
2281216|NCT02173535|5600956|P3|STARTED|Period 3||12
2281217|NCT02173535|5600957|P2|STARTED|Period 3||12
2281218|NCT02173535|5600958|P1|STARTED|Period 3||12
2281219|NCT02173535|5600939|P20|NOT COMPLETED|Period 2||0
2281220|NCT02173535|5600940|P19|NOT COMPLETED|Period 2||0
2281221|NCT02173535|5600941|P18|NOT COMPLETED|Period 2||0
2281222|NCT02173535|5600942|P17|NOT COMPLETED|Period 2||0
2281223|NCT02173535|5600943|P16|NOT COMPLETED|Period 2||0
2281224|NCT02173535|5600944|P15|NOT COMPLETED|Period 2||0
2281225|NCT02173535|5600945|P14|NOT COMPLETED|Period 2||0
2281226|NCT02173535|5600946|P13|NOT COMPLETED|Period 2||0
2281227|NCT02173535|5600947|P12|NOT COMPLETED|Period 2||0
2281228|NCT02173535|5600948|P11|NOT COMPLETED|Period 2||0
2281229|NCT02173535|5600949|P10|NOT COMPLETED|Period 2||0
2281230|NCT02173535|5600950|P9|NOT COMPLETED|Period 2||0
2281231|NCT02173535|5600951|P8|NOT COMPLETED|Period 2||0
2281232|NCT02173535|5600952|P7|NOT COMPLETED|Period 2||0
2281233|NCT02173535|5600953|P6|NOT COMPLETED|Period 2||0
2281234|NCT02173535|5600954|P5|NOT COMPLETED|Period 2||0
2281235|NCT02173535|5600955|P4|NOT COMPLETED|Period 2||0
2281236|NCT02173535|5600956|P3|NOT COMPLETED|Period 2||0
2281237|NCT02173535|5600957|P2|NOT COMPLETED|Period 2||0
2281238|NCT02173535|5600958|P1|NOT COMPLETED|Period 2||0
2281239|NCT02173535|5600939|P20|COMPLETED|Period 2||12
2281240|NCT02173535|5600940|P19|COMPLETED|Period 2||12
2281241|NCT02173535|5600941|P18|COMPLETED|Period 2||12
2281242|NCT02173535|5600942|P17|COMPLETED|Period 2||12
2281243|NCT02173535|5600943|P16|COMPLETED|Period 2||12
2281244|NCT02173535|5600944|P15|COMPLETED|Period 2||12
2281245|NCT02173535|5600945|P14|COMPLETED|Period 2||12
2281246|NCT02173535|5600946|P13|COMPLETED|Period 2||12
2281247|NCT02173535|5600947|P12|COMPLETED|Period 2||12
2281248|NCT02173535|5600948|P11|COMPLETED|Period 2||12
2281249|NCT02173535|5600949|P10|COMPLETED|Period 2||12
2281250|NCT02173535|5600950|P9|COMPLETED|Period 2||12
2281251|NCT02173535|5600951|P8|COMPLETED|Period 2||12
2281252|NCT02173535|5600952|P7|COMPLETED|Period 2||12
2281253|NCT02173535|5600953|P6|COMPLETED|Period 2||12
2281254|NCT02173535|5600954|P5|COMPLETED|Period 2||12
2281255|NCT02173535|5600955|P4|COMPLETED|Period 2||12
2281256|NCT02173535|5600956|P3|COMPLETED|Period 2||12
2281257|NCT02173535|5600957|P2|COMPLETED|Period 2||12
2281258|NCT02173535|5600958|P1|COMPLETED|Period 2||12
2281259|NCT02173535|5600939|P20|STARTED|Period 2||12
2281260|NCT02173535|5600940|P19|STARTED|Period 2||12
2281261|NCT02173535|5600941|P18|STARTED|Period 2||12
2281262|NCT02173535|5600942|P17|STARTED|Period 2||12
2281263|NCT02173535|5600943|P16|STARTED|Period 2||12
2281264|NCT02173535|5600944|P15|STARTED|Period 2||12
2281265|NCT02173535|5600945|P14|STARTED|Period 2||12
2281266|NCT02173535|5600946|P13|STARTED|Period 2||12
2281267|NCT02173535|5600947|P12|STARTED|Period 2||12
2281268|NCT02173535|5600948|P11|STARTED|Period 2||12
2281269|NCT02173535|5600949|P10|STARTED|Period 2||12
2281270|NCT02173535|5600950|P9|STARTED|Period 2||12
2281271|NCT02173535|5600951|P8|STARTED|Period 2||12
2281272|NCT02173535|5600952|P7|STARTED|Period 2||12
2281273|NCT02173535|5600953|P6|STARTED|Period 2||12
2281274|NCT02173535|5600954|P5|STARTED|Period 2||12
2281275|NCT02173535|5600955|P4|STARTED|Period 2||12
2281276|NCT02173535|5600956|P3|STARTED|Period 2||12
2281277|NCT02173535|5600957|P2|STARTED|Period 2||12
2281278|NCT02173535|5600958|P1|STARTED|Period 2||12
2281279|NCT02173535|5600939|P20|NOT COMPLETED|Period 1||0
2281280|NCT02173535|5600940|P19|NOT COMPLETED|Period 1||0
2281281|NCT02173535|5600941|P18|NOT COMPLETED|Period 1||0
2281282|NCT02173535|5600942|P17|NOT COMPLETED|Period 1||0
2281283|NCT02173535|5600943|P16|NOT COMPLETED|Period 1||0
2281284|NCT02173535|5600944|P15|NOT COMPLETED|Period 1||0
2281285|NCT02173535|5600945|P14|NOT COMPLETED|Period 1||0
2281286|NCT02173535|5600946|P13|NOT COMPLETED|Period 1||0
2281287|NCT02173535|5600947|P12|NOT COMPLETED|Period 1||0
2281288|NCT02173535|5600948|P11|NOT COMPLETED|Period 1||0
2281289|NCT02173535|5600949|P10|NOT COMPLETED|Period 1||0
2281290|NCT02173535|5600950|P9|NOT COMPLETED|Period 1||0
2281291|NCT02173535|5600951|P8|NOT COMPLETED|Period 1||0
2281292|NCT02173535|5600952|P7|NOT COMPLETED|Period 1||0
2281293|NCT02173535|5600953|P6|NOT COMPLETED|Period 1||0
2281294|NCT02173535|5600954|P5|NOT COMPLETED|Period 1||0
2281295|NCT02173535|5600955|P4|NOT COMPLETED|Period 1||0
2281296|NCT02173535|5600956|P3|NOT COMPLETED|Period 1||0
2281297|NCT02173535|5600957|P2|NOT COMPLETED|Period 1||0
2281298|NCT02173535|5600958|P1|NOT COMPLETED|Period 1||0
2281299|NCT02173535|5600939|P20|COMPLETED|Period 1||12
2281300|NCT02173535|5600940|P19|COMPLETED|Period 1||12
2281301|NCT02173535|5600941|P18|COMPLETED|Period 1||12
2281302|NCT02173535|5600942|P17|COMPLETED|Period 1||12
2281303|NCT02173535|5600943|P16|COMPLETED|Period 1||12
2281304|NCT02173535|5600944|P15|COMPLETED|Period 1||12
2281305|NCT02173535|5600945|P14|COMPLETED|Period 1||12
2281306|NCT02173535|5600946|P13|COMPLETED|Period 1||12
2281307|NCT02173535|5600947|P12|COMPLETED|Period 1||12
2281308|NCT02173535|5600948|P11|COMPLETED|Period 1||12
2281309|NCT02173535|5600949|P10|COMPLETED|Period 1||12
2281310|NCT02173535|5600950|P9|COMPLETED|Period 1||12
2281311|NCT02173535|5600951|P8|COMPLETED|Period 1||12
2281312|NCT02173535|5600952|P7|COMPLETED|Period 1||12
2281313|NCT02173535|5600953|P6|COMPLETED|Period 1||12
2281314|NCT02173535|5600954|P5|COMPLETED|Period 1||12
2281315|NCT02173535|5600955|P4|COMPLETED|Period 1||12
2281316|NCT02173535|5600956|P3|COMPLETED|Period 1||12
2281317|NCT02173535|5600957|P2|COMPLETED|Period 1||12
2281318|NCT02173535|5600958|P1|COMPLETED|Period 1||12
2281319|NCT02173535|5600939|P20|STARTED|Period 1||12
2281320|NCT02173535|5600940|P19|STARTED|Period 1||12
2281321|NCT02173535|5600941|P18|STARTED|Period 1||12
2281322|NCT02173535|5600942|P17|STARTED|Period 1||12
2281323|NCT02173535|5600943|P16|STARTED|Period 1||12
2281324|NCT02173535|5600944|P15|STARTED|Period 1||12
2281325|NCT02173535|5600945|P14|STARTED|Period 1||12
2281326|NCT02173535|5600946|P13|STARTED|Period 1||12
2281327|NCT02173535|5600947|P12|STARTED|Period 1||12
2281328|NCT02173535|5600948|P11|STARTED|Period 1||12
2281329|NCT02173535|5600949|P10|STARTED|Period 1||12
2281330|NCT02173535|5600950|P9|STARTED|Period 1||12
2281331|NCT02173535|5600951|P8|STARTED|Period 1||12
2281332|NCT02173535|5600952|P7|STARTED|Period 1||12
2281333|NCT02173535|5600953|P6|STARTED|Period 1||12
2281334|NCT02173535|5600954|P5|STARTED|Period 1||12
2281335|NCT02173535|5600955|P4|STARTED|Period 1||12
2281336|NCT02173535|5600956|P3|STARTED|Period 1||12
2281337|NCT02173535|5600957|P2|STARTED|Period 1||12
2281338|NCT02173535|5600958|P1|STARTED|Period 1||12
2281339|NCT02173522|5600997|P2|NOT COMPLETED|Overall Study||0
2281340|NCT02173522|5600998|P1|NOT COMPLETED|Overall Study||0
2281341|NCT02173522|5600997|P2|COMPLETED|Overall Study||0
2281342|NCT02173522|5600998|P1|COMPLETED|Overall Study||4
2281343|NCT02173522|5600997|P2|STARTED|Overall Study||0
2281344|NCT02173522|5600998|P1|STARTED|Overall Study||4
2281345|NCT02173392|5601018|P2|NOT COMPLETED|Overall Study||4
2281346|NCT02173392|5601019|P1|NOT COMPLETED|Overall Study||14
2281347|NCT02173392|5601018|P2|COMPLETED|Overall Study||68
2281348|NCT02173392|5601019|P1|COMPLETED|Overall Study||59
2281349|NCT02173392|5601018|P2|STARTED|Overall Study||72
2281350|NCT02173392|5601019|P1|STARTED|Overall Study||73
2281351|NCT02173379|5601031|P2|NOT COMPLETED|Overall Study||7
2281352|NCT02173379|5601032|P1|NOT COMPLETED|Overall Study||9
2281353|NCT02173379|5601031|P2|COMPLETED|Overall Study||1301
2281354|NCT02173379|5601032|P1|COMPLETED|Overall Study||1287
2281355|NCT02173379|5601031|P2|STARTED|Overall Study||1308
2281356|NCT02173379|5601032|P1|STARTED|Overall Study||1296
2281357|NCT02173158|5601098|P1|NOT COMPLETED|Safety Phase||0
2281358|NCT02173158|5601098|P1|COMPLETED|Safety Phase||8
2281359|NCT02173158|5601098|P1|STARTED|Safety Phase||8
2281360|NCT02173158|5601098|P1|NOT COMPLETED|Efficacy Phase||1
2281361|NCT02173158|5601098|P1|COMPLETED|Efficacy Phase||8
2281362|NCT02173158|5601098|P1|STARTED|Efficacy Phase||9
2281363|NCT02173054|5601115|P3|NOT COMPLETED|Overall Study||1
2281364|NCT02173054|5601116|P2|NOT COMPLETED|Overall Study||0
2281365|NCT02173054|5601117|P1|NOT COMPLETED|Overall Study||1
2281366|NCT02173054|5601115|P3|COMPLETED|Overall Study||39
2281367|NCT02173054|5601116|P2|COMPLETED|Overall Study||40
2281368|NCT02173054|5601117|P1|COMPLETED|Overall Study||39
2281369|NCT02173054|5601115|P3|STARTED|Overall Study||40
2281370|NCT02173054|5601116|P2|STARTED|Overall Study||40
2281371|NCT02173054|5601117|P1|STARTED|Overall Study||40
2281372|NCT02172820|5601139|P2|NOT COMPLETED|Overall Study||0
2281373|NCT02172820|5601140|P1|NOT COMPLETED|Overall Study||0
2281374|NCT02172820|5601139|P2|COMPLETED|Overall Study||65
2281375|NCT02172820|5601140|P1|COMPLETED|Overall Study||65
2281376|NCT02172820|5601139|P2|STARTED|Overall Study||65
2281377|NCT02172820|5601140|P1|STARTED|Overall Study||65
2281378|NCT02172755|5601152|P2|NOT COMPLETED|Overall Study||4
2281379|NCT02172755|5601153|P1|NOT COMPLETED|Overall Study||2
2281380|NCT02172755|5601152|P2|COMPLETED|Overall Study||12
2281381|NCT02172755|5601153|P1|COMPLETED|Overall Study||12
2281382|NCT02172755|5601152|P2|STARTED|Overall Study||16
2281383|NCT02172755|5601153|P1|STARTED|Overall Study||14
2281384|NCT02172742|5601165|P2|NOT COMPLETED|Overall Study||0
2281385|NCT02172742|5601166|P1|NOT COMPLETED|Overall Study||1
2281386|NCT02172742|5601165|P2|COMPLETED|Overall Study||6
2281387|NCT02172742|5601166|P1|COMPLETED|Overall Study||6
2281388|NCT02172742|5601165|P2|STARTED|Overall Study||6
2281389|NCT02172742|5601166|P1|STARTED|Overall Study||7
2281390|NCT02172664|5601173|P2|NOT COMPLETED|Overall Study||6
2281391|NCT02172664|5601174|P1|NOT COMPLETED|Overall Study||6
2281392|NCT02172664|5601173|P2|COMPLETED|Overall Study||27
2281393|NCT02172664|5601174|P1|COMPLETED|Overall Study||27
2281394|NCT02172664|5601173|P2|STARTED|Overall Study||33
2281395|NCT02172664|5601174|P1|STARTED|Overall Study||33
2281396|NCT02172625|5601183|P2|NOT COMPLETED|Overall Study||3
2281397|NCT02172625|5601184|P1|NOT COMPLETED|Overall Study||0
2281398|NCT02172625|5601183|P2|COMPLETED|Overall Study||16
2281399|NCT02172625|5601184|P1|COMPLETED|Overall Study||19
2281400|NCT02172625|5601183|P2|STARTED|Overall Study||19
2281401|NCT02172625|5601184|P1|STARTED|Overall Study||19
2281402|NCT02172040|5601206|P4|NOT COMPLETED|Overall Study||1
2281403|NCT02172040|5601207|P3|NOT COMPLETED|Overall Study||2
2281404|NCT02172040|5601208|P2|NOT COMPLETED|Overall Study||3
2281405|NCT02172040|5601209|P1|NOT COMPLETED|Overall Study||0
2281406|NCT02172040|5601206|P4|COMPLETED|Overall Study||26
2281407|NCT02172040|5601207|P3|COMPLETED|Overall Study||29
2281408|NCT02172040|5601208|P2|COMPLETED|Overall Study||42
2281409|NCT02172040|5601209|P1|COMPLETED|Overall Study||49
2281410|NCT02172040|5601206|P4|STARTED|Overall Study||27
2281411|NCT02172040|5601207|P3|STARTED|Overall Study||31
2281412|NCT02172040|5601208|P2|STARTED|Overall Study||45
2281413|NCT02172040|5601209|P1|STARTED|Overall Study||49
2281414|NCT02171819|5601258|P3|NOT COMPLETED|Overall Study||0
2281415|NCT02171819|5601259|P2|NOT COMPLETED|Overall Study||0
2281416|NCT02171819|5601260|P1|NOT COMPLETED|Overall Study||0
2281417|NCT02171819|5601258|P3|COMPLETED|Overall Study||12
2281418|NCT02171819|5601259|P2|COMPLETED|Overall Study||32
2281419|NCT02171819|5601260|P1|COMPLETED|Overall Study||31
2281420|NCT02171819|5601258|P3|STARTED|Overall Study||12
2281421|NCT02171819|5601259|P2|STARTED|Overall Study||32
2281422|NCT02171819|5601260|P1|STARTED|Overall Study||31
2281423|NCT02171611|5601295|P6|NOT COMPLETED|Overall Study||0
2281424|NCT02171611|5601296|P5|NOT COMPLETED|Overall Study||0
2281425|NCT02171611|5601297|P4|NOT COMPLETED|Overall Study||0
2281426|NCT02171611|5601298|P3|NOT COMPLETED|Overall Study||0
2281427|NCT02171611|5601299|P2|NOT COMPLETED|Overall Study||0
2281428|NCT02171611|5601300|P1|NOT COMPLETED|Overall Study||0
2281429|NCT02171611|5601295|P6|COMPLETED|Overall Study||5
2281430|NCT02171611|5601296|P5|COMPLETED|Overall Study||5
2281431|NCT02171611|5601297|P4|COMPLETED|Overall Study||5
2281432|NCT02171611|5601298|P3|COMPLETED|Overall Study||5
2281433|NCT02171611|5601299|P2|COMPLETED|Overall Study||5
2281434|NCT02171611|5601300|P1|COMPLETED|Overall Study||5
2281435|NCT02171611|5601295|P6|STARTED|Overall Study||5
2281436|NCT02171611|5601296|P5|STARTED|Overall Study||5
2281437|NCT02171611|5601297|P4|STARTED|Overall Study||5
2281438|NCT02171611|5601298|P3|STARTED|Overall Study||5
2281439|NCT02171611|5601299|P2|STARTED|Overall Study||5
2281440|NCT02171611|5601300|P1|STARTED|Overall Study||5
2281441|NCT02171260|5601372|P4|NOT COMPLETED|Overall Study||5
2281442|NCT02171260|5601373|P3|NOT COMPLETED|Overall Study||5
2281443|NCT02171260|5601374|P2|NOT COMPLETED|Overall Study||6
2281444|NCT02171260|5601375|P1|NOT COMPLETED|Overall Study||6
2281445|NCT02171260|5601372|P4|COMPLETED|Overall Study||0
2281446|NCT02171260|5601373|P3|COMPLETED|Overall Study||0
2281447|NCT02171260|5601374|P2|COMPLETED|Overall Study||0
2281448|NCT02171260|5601375|P1|COMPLETED|Overall Study||0
2281449|NCT02171260|5601372|P4|STARTED|Overall Study||5
2281450|NCT02171260|5601373|P3|STARTED|Overall Study||5
2281451|NCT02171260|5601374|P2|STARTED|Overall Study||6
2281452|NCT02171260|5601375|P1|STARTED|Overall Study||6
2281453|NCT02171247|5601432|P2|NOT COMPLETED|Overall Study||0
2281454|NCT02171247|5601433|P1|NOT COMPLETED|Overall Study||0
2281455|NCT02171247|5601432|P2|COMPLETED|Overall Study||17
2281456|NCT02171247|5601433|P1|COMPLETED|Overall Study||16
2281457|NCT02171247|5601432|P2|STARTED|Overall Study||17
2281458|NCT02171247|5601433|P1|STARTED|Overall Study||16
2281459|NCT02171234|5601450|P5|NOT COMPLETED|Overall Study||0
2281460|NCT02171234|5601451|P4|NOT COMPLETED|Overall Study||0
2281461|NCT02171234|5601452|P3|NOT COMPLETED|Overall Study||0
2281462|NCT02171234|5601453|P2|NOT COMPLETED|Overall Study||0
2281463|NCT02171234|5601454|P1|NOT COMPLETED|Overall Study||0
2281464|NCT02171234|5601450|P5|COMPLETED|Overall Study||6
2281465|NCT02171234|5601451|P4|COMPLETED|Overall Study||6
2281466|NCT02171234|5601452|P3|COMPLETED|Overall Study||6
2281467|NCT02171234|5601453|P2|COMPLETED|Overall Study||6
2281468|NCT02171234|5601454|P1|COMPLETED|Overall Study||8
2281469|NCT02171234|5601450|P5|STARTED|Overall Study||6
2281470|NCT02171234|5601451|P4|STARTED|Overall Study||6
2281471|NCT02171234|5601452|P3|STARTED|Overall Study||6
2281472|NCT02171234|5601453|P2|STARTED|Overall Study||6
2281473|NCT02171234|5601454|P1|STARTED|Overall Study||8
2281474|NCT02171195|5601483|P9|NOT COMPLETED|Overall Study||0
2281475|NCT02171195|5601484|P8|NOT COMPLETED|Overall Study||0
2281476|NCT02171195|5601485|P7|NOT COMPLETED|Overall Study||0
2281477|NCT02171195|5601486|P6|NOT COMPLETED|Overall Study||0
2281478|NCT02171195|5601487|P5|NOT COMPLETED|Overall Study||0
2281479|NCT02171195|5601488|P4|NOT COMPLETED|Overall Study||0
2281480|NCT02171195|5601489|P3|NOT COMPLETED|Overall Study||0
2281481|NCT02171195|5601490|P2|NOT COMPLETED|Overall Study||0
2281482|NCT02171195|5601491|P1|NOT COMPLETED|Overall Study||0
2281483|NCT02171195|5601483|P9|COMPLETED|Overall Study||6
2281484|NCT02171195|5601484|P8|COMPLETED|Overall Study||6
2281485|NCT02171195|5601485|P7|COMPLETED|Overall Study||6
2281486|NCT02171195|5601486|P6|COMPLETED|Overall Study||6
2281487|NCT02171195|5601487|P5|COMPLETED|Overall Study||6
2281488|NCT02171195|5601488|P4|COMPLETED|Overall Study||6
2281489|NCT02171195|5601489|P3|COMPLETED|Overall Study||6
2281490|NCT02171195|5601490|P2|COMPLETED|Overall Study||6
2281491|NCT02171195|5601491|P1|COMPLETED|Overall Study||16
2281492|NCT02171195|5601483|P9|STARTED|Overall Study||6
2281493|NCT02171195|5601484|P8|STARTED|Overall Study||6
2281494|NCT02171195|5601485|P7|STARTED|Overall Study||6
2281495|NCT02171195|5601486|P6|STARTED|Overall Study||6
2281496|NCT02171195|5601487|P5|STARTED|Overall Study||6
2281497|NCT02171195|5601488|P4|STARTED|Overall Study||6
2281498|NCT02171195|5601489|P3|STARTED|Overall Study||6
2281499|NCT02171195|5601490|P2|STARTED|Overall Study||6
2281500|NCT02171195|5601491|P1|STARTED|Overall Study||16
2281501|NCT02171130|5601511|P1|NOT COMPLETED|Overall Study||28
2281502|NCT02171130|5601511|P1|COMPLETED|Overall Study|Including participants who completed the 6-month study but did not experience any hypoglycemia event|101
2281503|NCT02171130|5601511|P1|Experienced Hypoglycemic Event|Overall Study|Experienced at least one hypoglycemic event and received at least one dose of study drug.|87
2281504|NCT02171130|5601511|P1|Received at Least One Dose of Study Drug|Overall Study||87
2281505|NCT02171130|5601511|P1|STARTED|Overall Study||129
2281506|NCT02170870|5601525|P6|NOT COMPLETED|Overall Study||0
2281507|NCT02170870|5601526|P5|NOT COMPLETED|Overall Study||0
2281508|NCT02170870|5601527|P4|NOT COMPLETED|Overall Study||0
2281509|NCT02170870|5601528|P3|NOT COMPLETED|Overall Study||0
2281510|NCT02170870|5601529|P2|NOT COMPLETED|Overall Study||0
2281511|NCT02170870|5601530|P1|NOT COMPLETED|Overall Study||0
2281512|NCT02170870|5601525|P6|COMPLETED|Overall Study||20
2281513|NCT02170870|5601526|P5|COMPLETED|Overall Study||20
2281514|NCT02170870|5601527|P4|COMPLETED|Overall Study||20
2281515|NCT02170870|5601528|P3|COMPLETED|Overall Study||20
2281516|NCT02170870|5601529|P2|COMPLETED|Overall Study||11
2281517|NCT02170870|5601530|P1|COMPLETED|Overall Study||13
2281518|NCT02170870|5601525|P6|STARTED|Overall Study||20
2281519|NCT02170870|5601526|P5|STARTED|Overall Study||20
2281520|NCT02170870|5601527|P4|STARTED|Overall Study||20
2281521|NCT02170870|5601528|P3|STARTED|Overall Study||20
2281522|NCT02170870|5601529|P2|STARTED|Overall Study||11
2281523|NCT02170870|5601530|P1|STARTED|Overall Study||13
2281524|NCT02170779|5601552|P2|NOT COMPLETED|Overall Study||1
2281525|NCT02170779|5601553|P1|NOT COMPLETED|Overall Study||1
2281526|NCT02170779|5601552|P2|COMPLETED|Overall Study||19
2281527|NCT02170779|5601553|P1|COMPLETED|Overall Study||19
2281528|NCT02170779|5601552|P2|STARTED|Overall Study||20
2281529|NCT02170779|5601553|P1|STARTED|Overall Study||20
2281530|NCT02170727|5601577|P2|NOT COMPLETED|Overall Study||0
2281531|NCT02170727|5601578|P1|NOT COMPLETED|Overall Study||3
2281532|NCT02170727|5601577|P2|COMPLETED|Overall Study||31
2281533|NCT02170727|5601578|P1|COMPLETED|Overall Study||135
2281534|NCT02170727|5601577|P2|STARTED|Overall Study||31
2281535|NCT02170727|5601578|P1|STARTED|Overall Study||138
2281536|NCT02170688|5601609|P5|NOT COMPLETED|Overall Study||0
2281537|NCT02170688|5601610|P4|NOT COMPLETED|Overall Study||2
2281538|NCT02170688|5601611|P3|NOT COMPLETED|Overall Study||4
2281539|NCT02170688|5601612|P2|NOT COMPLETED|Overall Study||3
2281540|NCT02170688|5601613|P1|NOT COMPLETED|Overall Study||4
2281541|NCT02170688|5601609|P5|COMPLETED|Overall Study||25
2281542|NCT02170688|5601610|P4|COMPLETED|Overall Study||25
2281543|NCT02170688|5601611|P3|COMPLETED|Overall Study||25
2281544|NCT02170688|5601612|P2|COMPLETED|Overall Study||26
2281545|NCT02170688|5601613|P1|COMPLETED|Overall Study||25
2281546|NCT02170688|5601609|P5|STARTED|Overall Study||25
2281547|NCT02170688|5601610|P4|STARTED|Overall Study||27
2281548|NCT02170688|5601611|P3|STARTED|Overall Study||29
2281549|NCT02170688|5601612|P2|STARTED|Overall Study||29
2281550|NCT02170688|5601613|P1|STARTED|Overall Study||29
2281551|NCT02170662|5601632|P2|NOT COMPLETED|Overall Study||0
2281552|NCT02170662|5601633|P1|NOT COMPLETED|Overall Study||0
2281553|NCT02170662|5601632|P2|COMPLETED|Overall Study||6
2281554|NCT02170662|5601633|P1|COMPLETED|Overall Study||3
2281555|NCT02170662|5601632|P2|STARTED|Overall Study||6
2281556|NCT02170662|5601633|P1|STARTED|Overall Study||3
2281557|NCT02170649|5601645|P1|NOT COMPLETED|Fed Period||0
2281558|NCT02170649|5601645|P1|COMPLETED|Fed Period||12
2281559|NCT02170649|5601645|P1|STARTED|Fed Period||12
2281560|NCT02170649|5601645|P1|NOT COMPLETED|Fasting Period||0
2281561|NCT02170649|5601645|P1|COMPLETED|Fasting Period||12
2281562|NCT02170649|5601645|P1|STARTED|Fasting Period||12
2281563|NCT02170532|5601652|P1|NOT COMPLETED|Overall Study||0
2281564|NCT02170532|5601652|P1|COMPLETED|Overall Study||10
2281565|NCT02170532|5601652|P1|STARTED|Overall Study||10
2281566|NCT02170519|5601682|P2|NOT COMPLETED|Overall Study||0
2281567|NCT02170519|5601683|P1|NOT COMPLETED|Overall Study||0
2281568|NCT02170519|5601682|P2|COMPLETED|Overall Study||5
2281569|NCT02170519|5601683|P1|COMPLETED|Overall Study||22
2281570|NCT02170519|5601682|P2|STARTED|Overall Study||5
2281571|NCT02170519|5601683|P1|STARTED|Overall Study||22
2281572|NCT02170389|5601699|P1|NOT COMPLETED|Overall Study||1
2281573|NCT02170389|5601699|P1|COMPLETED|Overall Study||4
2281574|NCT02170389|5601699|P1|STARTED|Overall Study||5
2281575|NCT02170376|5601709|P5|NOT COMPLETED|Overall Study||0
2281576|NCT02170376|5601710|P4|NOT COMPLETED|Overall Study||0
2281577|NCT02170376|5601711|P3|NOT COMPLETED|Overall Study||0
2281578|NCT02170376|5601712|P2|NOT COMPLETED|Overall Study||1
2281579|NCT02170376|5601713|P1|NOT COMPLETED|Overall Study||0
2281580|NCT02170376|5601709|P5|COMPLETED|Overall Study||16
2281581|NCT02170376|5601710|P4|COMPLETED|Overall Study||16
2281582|NCT02170376|5601711|P3|COMPLETED|Overall Study||16
2281583|NCT02170376|5601712|P2|COMPLETED|Overall Study||15
2281584|NCT02170376|5601713|P1|COMPLETED|Overall Study||16
2281585|NCT02170376|5601709|P5|Pharmacokinetic Population|Overall Study||16
2281586|NCT02170376|5601710|P4|Pharmacokinetic Population|Overall Study||16
2281587|NCT02170376|5601711|P3|Pharmacokinetic Population|Overall Study||16
2281588|NCT02170376|5601712|P2|Pharmacokinetic Population|Overall Study||15
2281589|NCT02170376|5601713|P1|Pharmacokinetic Population|Overall Study||16
2281590|NCT02170376|5601709|P5|STARTED|Overall Study||16
2281591|NCT02170376|5601710|P4|STARTED|Overall Study||16
2281592|NCT02170376|5601711|P3|STARTED|Overall Study||16
2281593|NCT02170376|5601712|P2|STARTED|Overall Study||16
2281594|NCT02170376|5601713|P1|STARTED|Overall Study||16
2281595|NCT02170363|5601750|P1|NOT COMPLETED|Overall Study||0
2281596|NCT02170363|5601750|P1|COMPLETED|Overall Study|Followed to the 6-Month Primary Endpoint|50
2281597|NCT02170363|5601750|P1|STARTED|Overall Study||50
2281598|NCT02170298|5601764|P2|NOT COMPLETED|Overall Study||1
2281599|NCT02170298|5601765|P1|NOT COMPLETED|Overall Study||1
2281600|NCT02170298|5601764|P2|COMPLETED|Overall Study||4
2281601|NCT02170298|5601765|P1|COMPLETED|Overall Study||0
2281602|NCT02170298|5601764|P2|STARTED|Overall Study||5
2281603|NCT02170298|5601765|P1|STARTED|Overall Study||1
2281604|NCT02170220|5601775|P2|NOT COMPLETED|Overall Study||0
2281605|NCT02170220|5601776|P1|NOT COMPLETED|Overall Study||0
2281606|NCT02170220|5601775|P2|COMPLETED|Overall Study||6
2281607|NCT02170220|5601776|P1|COMPLETED|Overall Study||6
2281608|NCT02170220|5601775|P2|STARTED|Overall Study||6
2281609|NCT02170220|5601776|P1|STARTED|Overall Study||6
2281610|NCT02170207|5601802|P1|NOT COMPLETED|Overall Study||5
2281611|NCT02170207|5601802|P1|COMPLETED|Overall Study||58
2281612|NCT02170207|5601802|P1|STARTED|Overall Study||63
2281613|NCT02170077|5601813|P3|NOT COMPLETED|Overall Study||12
2281614|NCT02170077|5601814|P2|NOT COMPLETED|Overall Study||13
2281615|NCT02170077|5601815|P1|NOT COMPLETED|Overall Study||9
2281616|NCT02170077|5601813|P3|COMPLETED|Overall Study||35
2281617|NCT02170077|5601814|P2|COMPLETED|Overall Study||34
2281618|NCT02170077|5601815|P1|COMPLETED|Overall Study||41
2281619|NCT02170077|5601813|P3|Intent to Treat (ITT) Population|Overall Study||47
2281620|NCT02170077|5601814|P2|Intent to Treat (ITT) Population|Overall Study||46
2281621|NCT02170077|5601815|P1|Intent to Treat (ITT) Population|Overall Study||50
2281622|NCT02170077|5601813|P3|STARTED|Overall Study||47
2281623|NCT02170077|5601814|P2|STARTED|Overall Study||47
2281624|NCT02170077|5601815|P1|STARTED|Overall Study||50
2281625|NCT02170064|5601826|P3|NOT COMPLETED|Overall Study||1
2281626|NCT02170064|5601827|P2|NOT COMPLETED|Overall Study||2
2281627|NCT02170064|5601828|P1|NOT COMPLETED|Overall Study||6
2281628|NCT02170064|5601826|P3|COMPLETED|Overall Study||10
2281629|NCT02170064|5601827|P2|COMPLETED|Overall Study||7
2281630|NCT02170064|5601828|P1|COMPLETED|Overall Study||9
2281631|NCT02170064|5601826|P3|Efficacy Population (EP)|Overall Study||10
2281632|NCT02170064|5601827|P2|Efficacy Population (EP)|Overall Study||8
2281633|NCT02170064|5601828|P1|Efficacy Population (EP)|Overall Study||11
2281634|NCT02170064|5601826|P3|Pharmacokinetic Population (PKP)|Overall Study||10
2281635|NCT02170064|5601827|P2|Pharmacokinetic Population (PKP)|Overall Study||8
2281636|NCT02170064|5601828|P1|Pharmacokinetic Population (PKP)|Overall Study||11
2281637|NCT02170064|5601826|P3|Safety Population (SP)|Overall Study||11
2281638|NCT02170064|5601827|P2|Safety Population (SP)|Overall Study||8
2281639|NCT02170064|5601828|P1|Safety Population (SP)|Overall Study||12
2281640|NCT02170064|5601826|P3|STARTED|Overall Study||11
2281641|NCT02170064|5601827|P2|STARTED|Overall Study||9
2281642|NCT02170064|5601828|P1|STARTED|Overall Study||15
2281643|NCT02170025|5601844|P2|NOT COMPLETED|Overall Study||0
2281644|NCT02170025|5601845|P1|NOT COMPLETED|Overall Study||2
2281645|NCT02170025|5601844|P2|COMPLETED|Overall Study||7
2281646|NCT02170025|5601845|P1|COMPLETED|Overall Study||12
2281647|NCT02170025|5601844|P2|STARTED|Overall Study||7
2281648|NCT02170025|5601845|P1|STARTED|Overall Study||14
2281649|NCT02169895|5601857|P4|NOT COMPLETED|Overall Study||2
2281650|NCT02169895|5601858|P3|NOT COMPLETED|Overall Study||0
2281651|NCT02169895|5601859|P2|NOT COMPLETED|Overall Study||0
2281652|NCT02169895|5601860|P1|NOT COMPLETED|Overall Study||0
2281653|NCT02169895|5601857|P4|COMPLETED|Overall Study||2
2281654|NCT02169895|5601858|P3|COMPLETED|Overall Study||4
2281655|NCT02169895|5601859|P2|COMPLETED|Overall Study||4
2281656|NCT02169895|5601860|P1|COMPLETED|Overall Study||4
2281657|NCT02169895|5601857|P4|Placebo|Overall Study||4
2281658|NCT02169895|5601858|P3|Placebo|Overall Study||4
2281659|NCT02169895|5601859|P2|Placebo|Overall Study||4
2281660|NCT02169895|5601860|P1|Placebo|Overall Study||4
2281661|NCT02169895|5601857|P4|100 mg BIA 9-1067|Overall Study||2
2281662|NCT02169895|5601858|P3|100 mg BIA 9-1067|Overall Study||4
2281663|NCT02169895|5601859|P2|100 mg BIA 9-1067|Overall Study||4
2281664|NCT02169895|5601860|P1|100 mg BIA 9-1067|Overall Study||4
2281665|NCT02169895|5601857|P4|50 mg BIA 9-1067|Overall Study||4
2281666|NCT02169895|5601858|P3|50 mg BIA 9-1067|Overall Study||4
2281667|NCT02169895|5601859|P2|50 mg BIA 9-1067|Overall Study||4
2281668|NCT02169895|5601860|P1|50 mg BIA 9-1067|Overall Study||4
2281669|NCT02169895|5601857|P4|25 mg BIA 9-1067|Overall Study||4
2281670|NCT02169895|5601858|P3|25 mg BIA 9-1067|Overall Study||4
2281671|NCT02169895|5601859|P2|25 mg BIA 9-1067|Overall Study||4
2281672|NCT02169895|5601860|P1|25 mg BIA 9-1067|Overall Study||4
2281673|NCT02169895|5601857|P4|STARTED|Overall Study||4
2281674|NCT02169895|5601858|P3|STARTED|Overall Study||4
2281675|NCT02169895|5601859|P2|STARTED|Overall Study||4
2281676|NCT02169895|5601860|P1|STARTED|Overall Study||4
2281677|NCT02169869|5601880|P2|NOT COMPLETED|Overall Study||0
2281678|NCT02169869|5601881|P1|NOT COMPLETED|Overall Study||0
2281679|NCT02169869|5601880|P2|COMPLETED|Overall Study||16
2281680|NCT02169869|5601881|P1|COMPLETED|Overall Study||17
2281681|NCT02169869|5601880|P2|STARTED|Overall Study||16
2281682|NCT02169869|5601881|P1|STARTED|Overall Study||17
2281683|NCT02169674|5601889|P2|NOT COMPLETED|Overall Study||78
2281684|NCT02169674|5601890|P1|NOT COMPLETED|Overall Study||32
2281685|NCT02169674|5601889|P2|COMPLETED|Overall Study||135
2281686|NCT02169674|5601890|P1|COMPLETED|Overall Study||105
2281687|NCT02169674|5601889|P2|STARTED|Overall Study||213
2281688|NCT02169674|5601890|P1|STARTED|Overall Study||137
2281689|NCT02169505|5601904|P1|NOT COMPLETED|Overall Study||1
2281690|NCT02169505|5601904|P1|COMPLETED|Overall Study||1
2281691|NCT02169505|5601904|P1|STARTED|Overall Study||2
2281692|NCT02169479|5601919|P4|NOT COMPLETED|Overall Study||0
2281693|NCT02169479|5601920|P3|NOT COMPLETED|Overall Study||0
2281694|NCT02169479|5601921|P2|NOT COMPLETED|Overall Study||1
2281695|NCT02169479|5601922|P1|NOT COMPLETED|Overall Study||1
2281696|NCT02169479|5601919|P4|COMPLETED|Overall Study||4
2281697|NCT02169479|5601920|P3|COMPLETED|Overall Study||4
2281698|NCT02169479|5601921|P2|COMPLETED|Overall Study||3
2281699|NCT02169479|5601922|P1|COMPLETED|Overall Study||3
2281700|NCT02169479|5601919|P4|Placebo|Overall Study||4
2281701|NCT02169479|5601920|P3|Placebo|Overall Study||4
2281702|NCT02169479|5601921|P2|Placebo|Overall Study||3
2281703|NCT02169479|5601922|P1|Placebo|Overall Study||3
2281704|NCT02169479|5601919|P4|100 mg BIA 9-1067|Overall Study||4
2281705|NCT02169479|5601920|P3|100 mg BIA 9-1067|Overall Study||4
2281706|NCT02169479|5601921|P2|100 mg BIA 9-1067|Overall Study||4
2281707|NCT02169479|5601922|P1|100 mg BIA 9-1067|Overall Study||3
2281708|NCT02169479|5601919|P4|50 mg BIA 9-1067|Overall Study||4
2281709|NCT02169479|5601920|P3|50 mg BIA 9-1067|Overall Study||4
2281710|NCT02169479|5601921|P2|50 mg BIA 9-1067|Overall Study||4
2281711|NCT02169479|5601922|P1|50 mg BIA 9-1067|Overall Study||4
2281712|NCT02169479|5601919|P4|25 mg BIA 9-1067|Overall Study||4
2281713|NCT02169479|5601920|P3|25 mg BIA 9-1067|Overall Study||4
2281714|NCT02169479|5601921|P2|25 mg BIA 9-1067|Overall Study||3
2281715|NCT02169479|5601922|P1|25 mg BIA 9-1067|Overall Study||4
2281716|NCT02169479|5601919|P4|STARTED|Overall Study||4
2281717|NCT02169479|5601920|P3|STARTED|Overall Study||4
2281718|NCT02169479|5601921|P2|STARTED|Overall Study||4
2281719|NCT02169479|5601922|P1|STARTED|Overall Study||4
2281720|NCT02169466|5601944|P4|NOT COMPLETED|Overall Study||0
2281721|NCT02169466|5601945|P3|NOT COMPLETED|Overall Study||0
2281722|NCT02169466|5601946|P2|NOT COMPLETED|Overall Study||1
2281723|NCT02169466|5601947|P1|NOT COMPLETED|Overall Study||1
2281724|NCT02169466|5601944|P4|COMPLETED|Overall Study||5
2281725|NCT02169466|5601945|P3|COMPLETED|Overall Study||5
2281726|NCT02169466|5601946|P2|COMPLETED|Overall Study||5
2281727|NCT02169466|5601947|P1|COMPLETED|Overall Study||5
2281728|NCT02169466|5601944|P4|Placebo|Overall Study||5
2281729|NCT02169466|5601945|P3|Placebo|Overall Study||5
2281730|NCT02169466|5601946|P2|Placebo|Overall Study||6
2281731|NCT02169466|5601947|P1|Placebo|Overall Study||5
2281732|NCT02169466|5601944|P4|100 mg BIA 9-1067|Overall Study||5
2281733|NCT02169466|5601945|P3|100 mg BIA 9-1067|Overall Study||5
2281734|NCT02169466|5601946|P2|100 mg BIA 9-1067|Overall Study||6
2281735|NCT02169466|5601947|P1|100 mg BIA 9-1067|Overall Study||6
2281736|NCT02169466|5601944|P4|50 mg BIA 9-1067|Overall Study||5
2281737|NCT02169466|5601945|P3|50 mg BIA 9-1067|Overall Study||5
2281738|NCT02169466|5601946|P2|50 mg BIA 9-1067|Overall Study||6
2281739|NCT02169466|5601947|P1|50 mg BIA 9-1067|Overall Study||6
2281740|NCT02169466|5601944|P4|25 mg BIA 9-1067|Overall Study||5
2281741|NCT02169466|5601945|P3|25 mg BIA 9-1067|Overall Study||5
2281742|NCT02169466|5601946|P2|25 mg BIA 9-1067|Overall Study||5
2281743|NCT02169466|5601947|P1|25 mg BIA 9-1067|Overall Study||6
2281744|NCT02169466|5601944|P4|STARTED|Overall Study||5
2281745|NCT02169466|5601945|P3|STARTED|Overall Study||5
2281746|NCT02169466|5601946|P2|STARTED|Overall Study||6
2281747|NCT02169466|5601947|P1|STARTED|Overall Study||6
2281748|NCT02169453|5601973|P4|NOT COMPLETED|Overall Study||0
2281749|NCT02169453|5601974|P3|NOT COMPLETED|Overall Study||1
2281750|NCT02169453|5601975|P2|NOT COMPLETED|Overall Study||0
2281751|NCT02169453|5601976|P1|NOT COMPLETED|Overall Study||0
2281752|NCT02169453|5601973|P4|COMPLETED|Overall Study||3
2281753|NCT02169453|5601974|P3|COMPLETED|Overall Study||2
2281754|NCT02169453|5601975|P2|COMPLETED|Overall Study||3
2281755|NCT02169453|5601976|P1|COMPLETED|Overall Study||3
2281756|NCT02169453|5601973|P4|Placebo|Overall Study||3
2281757|NCT02169453|5601974|P3|Placebo|Overall Study||3
2281758|NCT02169453|5601975|P2|Placebo|Overall Study||3
2281759|NCT02169453|5601976|P1|Placebo|Overall Study||3
2281760|NCT02169453|5601973|P4|100 mg BIA 9-1067|Overall Study||3
2281761|NCT02169453|5601974|P3|100 mg BIA 9-1067|Overall Study||3
2281762|NCT02169453|5601975|P2|100 mg BIA 9-1067|Overall Study||3
2281763|NCT02169453|5601976|P1|100 mg BIA 9-1067|Overall Study||3
2281764|NCT02169453|5601973|P4|50 mg BIA 9-1067|Overall Study||3
2281765|NCT02169453|5601974|P3|50 mg BIA 9-1067|Overall Study||2
2281766|NCT02169453|5601975|P2|50 mg BIA 9-1067|Overall Study||3
2281767|NCT02169453|5601976|P1|50 mg BIA 9-1067|Overall Study||3
2281768|NCT02169453|5601973|P4|25 mg BIA 9-1067|Overall Study||3
2281769|NCT02169453|5601974|P3|25 mg BIA 9-1067|Overall Study||3
2281770|NCT02169453|5601975|P2|25 mg BIA 9-1067|Overall Study||3
2281771|NCT02169453|5601976|P1|25 mg BIA 9-1067|Overall Study||3
2281772|NCT02169453|5601973|P4|STARTED|Overall Study||3
2281773|NCT02169453|5601974|P3|STARTED|Overall Study||3
2281774|NCT02169453|5601975|P2|STARTED|Overall Study||3
2281775|NCT02169453|5601976|P1|STARTED|Overall Study||3
2281776|NCT02169440|5602008|P2|NOT COMPLETED|Overall Study||0
2281777|NCT02169440|5602009|P1|NOT COMPLETED|Overall Study||0
2281778|NCT02169440|5602008|P2|COMPLETED|Overall Study||10
2281779|NCT02169440|5602009|P1|COMPLETED|Overall Study||10
2281780|NCT02169440|5602008|P2|STARTED|Overall Study||10
2281781|NCT02169440|5602009|P1|STARTED|Overall Study||10
2281782|NCT02169427|5602022|P1|NOT COMPLETED|Overall Study||0
2281783|NCT02169427|5602022|P1|COMPLETED|Overall Study||6
2281784|NCT02169427|5602022|P1|STARTED|Overall Study||6
2281785|NCT02169414|5602032|P4|NOT COMPLETED|Overall Study||0
2281786|NCT02169414|5602033|P3|NOT COMPLETED|Overall Study||0
2281787|NCT02169414|5602034|P2|NOT COMPLETED|Overall Study||1
2281788|NCT02169414|5602035|P1|NOT COMPLETED|Overall Study||1
2281789|NCT02169414|5602032|P4|COMPLETED|Overall Study||18
2281790|NCT02169414|5602033|P3|COMPLETED|Overall Study||18
2281791|NCT02169414|5602034|P2|COMPLETED|Overall Study||18
2281792|NCT02169414|5602035|P1|COMPLETED|Overall Study||18
2281793|NCT02169414|5602032|P4|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
2281794|NCT02169414|5602033|P3|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
2281795|NCT02169414|5602034|P2|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
2281796|NCT02169414|5602035|P1|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
2281797|NCT02169414|5602032|P4|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
2281798|NCT02169414|5602033|P3|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
2281799|NCT02169414|5602034|P2|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||19
2281800|NCT02169414|5602035|P1|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
2281801|NCT02169414|5602032|P4|STARTED|Overall Study||18
2281802|NCT02169414|5602033|P3|STARTED|Overall Study||18
2281803|NCT02169414|5602034|P2|STARTED|Overall Study||19
2281804|NCT02169414|5602035|P1|STARTED|Overall Study||19
2281805|NCT02169336|5602076|P3|NOT COMPLETED|Overall Study||3
2281806|NCT02169336|5602077|P2|NOT COMPLETED|Overall Study||4
2281807|NCT02169336|5602078|P1|NOT COMPLETED|Overall Study||4
2281808|NCT02169336|5602076|P3|COMPLETED|Overall Study||29
2281809|NCT02169336|5602077|P2|COMPLETED|Overall Study||28
2281810|NCT02169336|5602078|P1|COMPLETED|Overall Study||27
2281811|NCT02169336|5602076|P3|STARTED|Overall Study||32
2281812|NCT02169336|5602077|P2|STARTED|Overall Study||32
2281813|NCT02169336|5602078|P1|STARTED|Overall Study||31
2281814|NCT02169219|5602086|P1|NOT COMPLETED|Overall Study||6
2281815|NCT02169219|5602086|P1|COMPLETED|Overall Study||14
2281816|NCT02169219|5602086|P1|STARTED|Overall Study||20
2281817|NCT02169115|5602100|P3|NOT COMPLETED|Overall Study||0
2281818|NCT02169115|5602101|P2|NOT COMPLETED|Overall Study||0
2281819|NCT02169115|5602102|P1|NOT COMPLETED|Overall Study||0
2281820|NCT02169115|5602100|P3|COMPLETED|Overall Study||21
2281821|NCT02169115|5602101|P2|COMPLETED|Overall Study||21
2281822|NCT02169115|5602102|P1|COMPLETED|Overall Study||19
2281823|NCT02169115|5602100|P3|STARTED|Overall Study||21
2281824|NCT02169115|5602101|P2|STARTED|Overall Study||21
2281825|NCT02169115|5602102|P1|STARTED|Overall Study||19
2281826|NCT02168946|5602112|P2|NOT COMPLETED|Overall Study||5
2281827|NCT02168946|5602113|P1|NOT COMPLETED|Overall Study||12
2281828|NCT02168946|5602112|P2|COMPLETED|Overall Study||20
2281829|NCT02168946|5602113|P1|COMPLETED|Overall Study||38
2281830|NCT02168946|5602112|P2|STARTED|Overall Study||25
2281831|NCT02168946|5602113|P1|STARTED|Overall Study|2 additional subjects were randomized to Vabomere but did not receive study drug|50
2281832|NCT02168933|5602149|P1|NOT COMPLETED|Overall Study||1
2281833|NCT02168933|5602149|P1|COMPLETED|Overall Study||7
2281834|NCT02168933|5602149|P1|STARTED|Overall Study||8
2281835|NCT02168842|5602159|P2|NOT COMPLETED|Overall Study||8
2281836|NCT02168842|5602160|P1|NOT COMPLETED|Overall Study||8
2281837|NCT02168842|5602159|P2|COMPLETED|Overall Study||158
2281838|NCT02168842|5602160|P1|COMPLETED|Overall Study||162
2281839|NCT02168842|5602159|P2|STARTED|Overall Study||166
2281840|NCT02168842|5602160|P1|STARTED|Overall Study||170
2281841|NCT02168816|5602218|P2|NOT COMPLETED|Overall Study||2
2281842|NCT02168816|5602219|P1|NOT COMPLETED|Overall Study||2
2281843|NCT02168816|5602218|P2|COMPLETED|Overall Study||5
2281844|NCT02168816|5602219|P1|COMPLETED|Overall Study||3
2281845|NCT02168816|5602218|P2|STARTED|Overall Study||7
2281846|NCT02168816|5602219|P1|STARTED|Overall Study||5
2281847|NCT02168803|5602230|P3|NOT COMPLETED|Overall Study||6
2281848|NCT02168803|5602231|P2|NOT COMPLETED|Overall Study||3
2281849|NCT02168803|5602232|P1|NOT COMPLETED|Overall Study||2
2281850|NCT02168803|5602230|P3|COMPLETED|Overall Study||33
2281851|NCT02168803|5602231|P2|COMPLETED|Overall Study||29
2281852|NCT02168803|5602232|P1|COMPLETED|Overall Study||28
2281853|NCT02168803|5602230|P3|Received at Least 1 Dose of Study Drug|Overall Study||39
2281854|NCT02168803|5602231|P2|Received at Least 1 Dose of Study Drug|Overall Study||32
2281855|NCT02168803|5602232|P1|Received at Least 1 Dose of Study Drug|Overall Study||30
2281856|NCT02168803|5602230|P3|STARTED|Overall Study||39
2281857|NCT02168803|5602231|P2|STARTED|Overall Study||32
2281858|NCT02168803|5602232|P1|STARTED|Overall Study||30
2281859|NCT02168777|5602262|P3|NOT COMPLETED|Overall Study||11
2281860|NCT02168777|5602263|P2|NOT COMPLETED|Overall Study||7
2281861|NCT02168777|5602264|P1|NOT COMPLETED|Overall Study||2
2281862|NCT02168777|5602262|P3|COMPLETED|Overall Study||0
2281863|NCT02168777|5602263|P2|COMPLETED|Overall Study||0
2281864|NCT02168777|5602264|P1|COMPLETED|Overall Study||0
2281865|NCT02168777|5602262|P3|STARTED|Overall Study||11
2281866|NCT02168777|5602263|P2|STARTED|Overall Study||7
2281867|NCT02168777|5602264|P1|STARTED|Overall Study||2
2281868|NCT02168660|5602344|P3|NOT COMPLETED|Overall Study||15
2281869|NCT02168660|5602345|P2|NOT COMPLETED|Overall Study||17
2281870|NCT02168660|5602346|P1|NOT COMPLETED|Overall Study||16
2281871|NCT02168660|5602344|P3|COMPLETED|Overall Study||21
2281872|NCT02168660|5602345|P2|COMPLETED|Overall Study||18
2281873|NCT02168660|5602346|P1|COMPLETED|Overall Study||22
2281874|NCT02168660|5602344|P3|STARTED|Overall Study||36
2281875|NCT02168660|5602345|P2|STARTED|Overall Study||35
2281876|NCT02168660|5602346|P1|STARTED|Overall Study||38
2281877|NCT02168491|5602360|P1|NOT COMPLETED|Overall Study||1
2281878|NCT02168491|5602360|P1|COMPLETED|Overall Study||8
2281879|NCT02168491|5602360|P1|STARTED|Overall Study||9
2281880|NCT02168478|5602366|P1|NOT COMPLETED|Overall Study||4
2281881|NCT02168478|5602366|P1|COMPLETED|Overall Study||202
2281882|NCT02168478|5602366|P1|STARTED|Overall Study||206
2281883|NCT02168439|5602372|P2|NOT COMPLETED|Overall Study||2
2281884|NCT02168439|5602373|P1|NOT COMPLETED|Overall Study||0
2281885|NCT02168439|5602372|P2|COMPLETED|Overall Study||18
2281886|NCT02168439|5602373|P1|COMPLETED|Overall Study||20
2281887|NCT02168439|5602372|P2|STARTED|Overall Study||20
2281888|NCT02168439|5602373|P1|STARTED|Overall Study||20
2281889|NCT02168387|5602391|P2|NOT COMPLETED|Overall Study||3
2281890|NCT02168387|5602392|P1|NOT COMPLETED|Overall Study||7
2281891|NCT02168387|5602391|P2|COMPLETED|Overall Study||16
2281892|NCT02168387|5602392|P1|COMPLETED|Overall Study||13
2281893|NCT02168387|5602391|P2|STARTED|Overall Study||19
2281894|NCT02168387|5602392|P1|STARTED|Overall Study||20
2281895|NCT02168361|5602404|P2|NOT COMPLETED|Overall Study||10
2281896|NCT02168361|5602405|P1|NOT COMPLETED|Overall Study||5
2281897|NCT02168361|5602404|P2|COMPLETED|Overall Study||21
2281898|NCT02168361|5602405|P1|COMPLETED|Overall Study||57
2281899|NCT02168361|5602404|P2|STARTED|Overall Study||31
2281900|NCT02168361|5602405|P1|STARTED|Overall Study||62
2281901|NCT02168309|5602415|P2|NOT COMPLETED|Overall Study||0
2281902|NCT02168309|5602416|P1|NOT COMPLETED|Overall Study||0
2281903|NCT02168309|5602415|P2|COMPLETED|Overall Study||25
2281904|NCT02168309|5602416|P1|COMPLETED|Overall Study||25
2281905|NCT02168309|5602415|P2|STARTED|Overall Study||25
2281906|NCT02168309|5602416|P1|STARTED|Overall Study||25
2281907|NCT02168270|5602424|P1|NOT COMPLETED|Overall Study||4
2281908|NCT02168270|5602424|P1|COMPLETED|Overall Study||0
2281909|NCT02168270|5602424|P1|STARTED|Overall Study||4
2281910|NCT02168153|5602433|P2|NOT COMPLETED|Overall Study||0
2281911|NCT02168153|5602434|P1|NOT COMPLETED|Overall Study||3
2281912|NCT02168153|5602433|P2|COMPLETED|Overall Study||60
2281913|NCT02168153|5602434|P1|COMPLETED|Overall Study||57
2281914|NCT02168153|5602433|P2|STARTED|Overall Study||60
2281915|NCT02168153|5602434|P1|STARTED|Overall Study||60
2281916|NCT02167893|5602448|P1|NOT COMPLETED|Overall Study||163
2281917|NCT02167893|5602448|P1|COMPLETED|Overall Study||11125
2281918|NCT02167893|5602448|P1|STARTED|Overall Study||11288
2281919|NCT02167867|5602459|P2|NOT COMPLETED|Overall Study||0
2281920|NCT02167867|5602460|P1|NOT COMPLETED|Overall Study||0
2281921|NCT02167867|5602459|P2|COMPLETED|Overall Study||22
2281922|NCT02167867|5602460|P1|COMPLETED|Overall Study||22
2281923|NCT02167867|5602459|P2|STARTED|Overall Study||22
2281924|NCT02167867|5602460|P1|STARTED|Overall Study||22
2281925|NCT02167815|5602468|P2|NOT COMPLETED|Overall Study||0
2281926|NCT02167815|5602469|P1|NOT COMPLETED|Overall Study||0
2281927|NCT02167815|5602468|P2|COMPLETED|Overall Study||21
2281928|NCT02167815|5602469|P1|COMPLETED|Overall Study||9
2281929|NCT02167815|5602468|P2|STARTED|Overall Study||21
2281930|NCT02167815|5602469|P1|STARTED|Overall Study||9
2281931|NCT02167256|5602482|P2|NOT COMPLETED|Overall Study||10
2281932|NCT02167256|5602483|P1|NOT COMPLETED|Overall Study||21
2281933|NCT02167256|5602482|P2|COMPLETED|Overall Study||70
2281934|NCT02167256|5602483|P1|COMPLETED|Overall Study||58
2281935|NCT02167256|5602482|P2|STARTED|Overall Study||80
2281936|NCT02167256|5602483|P1|STARTED|Overall Study||79
2281937|NCT02167217|5602499|P1|NOT COMPLETED|Overall Study||2
2281938|NCT02167217|5602499|P1|COMPLETED|Overall Study||23
2281939|NCT02167217|5602499|P1|STARTED|Overall Study||25
2281940|NCT02167204|5602503|P1|NOT COMPLETED|Overall Study||0
2281941|NCT02167204|5602503|P1|COMPLETED|Overall Study||9
2281942|NCT02167204|5602503|P1|STARTED|Overall Study||9
2281943|NCT02167139|5602516|P4|NOT COMPLETED|Transition-extension||5
2281944|NCT02167139|5602517|P3|NOT COMPLETED|Transition-extension||8
2281945|NCT02167139|5602518|P2|NOT COMPLETED|Transition-extension||0
2281946|NCT02167139|5602519|P1|NOT COMPLETED|Transition-extension||6
2281947|NCT02167139|5602516|P4|COMPLETED|Transition-extension||124
2281948|NCT02167139|5602517|P3|COMPLETED|Transition-extension||117
2281949|NCT02167139|5602518|P2|COMPLETED|Transition-extension||0
2281950|NCT02167139|5602519|P1|COMPLETED|Transition-extension||248
2281951|NCT02167139|5602516|P4|STARTED|Transition-extension||129
2281952|NCT02167139|5602517|P3|STARTED|Transition-extension||125
2281953|NCT02167139|5602518|P2|STARTED|Transition-extension||0
2281954|NCT02167139|5602519|P1|STARTED|Transition-extension||254
2281955|NCT02167139|5602516|P4|NOT COMPLETED|Randomised, Double-blind||0
2281956|NCT02167139|5602517|P3|NOT COMPLETED|Randomised, Double-blind||0
2281957|NCT02167139|5602518|P2|NOT COMPLETED|Randomised, Double-blind||19
2281958|NCT02167139|5602519|P1|NOT COMPLETED|Randomised, Double-blind||17
2281959|NCT02167139|5602516|P4|COMPLETED|Randomised, Double-blind||0
2281960|NCT02167139|5602517|P3|COMPLETED|Randomised, Double-blind||0
2281961|NCT02167139|5602518|P2|COMPLETED|Randomised, Double-blind||254
2281962|NCT02167139|5602519|P1|COMPLETED|Randomised, Double-blind||254
2281963|NCT02167139|5602516|P4|STARTED|Randomised, Double-blind||0
2281964|NCT02167139|5602517|P3|STARTED|Randomised, Double-blind||0
2281965|NCT02167139|5602518|P2|STARTED|Randomised, Double-blind||273
2281966|NCT02167139|5602519|P1|STARTED|Randomised, Double-blind||271
2281967|NCT02167035|5602535|P2|NOT COMPLETED|Overall Study||6
2281968|NCT02167035|5602536|P1|NOT COMPLETED|Overall Study||5
2281969|NCT02167035|5602535|P2|COMPLETED|Overall Study||16
2281970|NCT02167035|5602536|P1|COMPLETED|Overall Study||16
2281971|NCT02167035|5602535|P2|STARTED|Overall Study||22
2281972|NCT02167035|5602536|P1|STARTED|Overall Study||21
2281973|NCT02166697|5602544|P1|NOT COMPLETED|Overall Study||347
2281974|NCT02166697|5602544|P1|COMPLETED|Overall Study||13804
2281975|NCT02166697|5602544|P1|STARTED|Overall Study||14151
2281976|NCT02166606|5602553|P1|NOT COMPLETED|Overall Study||78
2281977|NCT02166606|5602553|P1|COMPLETED|Overall Study||1106
2281978|NCT02166606|5602553|P1|Consent Eligible|Overall Study||1174
2281979|NCT02166606|5602553|P1|Actively Enrolled|Overall Study||1180
2281980|NCT02166606|5602553|P1|STARTED|Overall Study||1184
2281981|NCT02166476|5602560|P2|NOT COMPLETED|Overall Study||23
2281982|NCT02166476|5602561|P1|NOT COMPLETED|Overall Study||14
2281983|NCT02166476|5602560|P2|COMPLETED|Overall Study||250
2281984|NCT02166476|5602561|P1|COMPLETED|Overall Study||258
2281985|NCT02166476|5602560|P2|Received at Least 1 Dose of Study Drug|Overall Study||273
2281986|NCT02166476|5602561|P1|Received at Least 1 Dose of Study Drug|Overall Study||272
2281987|NCT02166476|5602560|P2|STARTED|Overall Study||273
2281988|NCT02166476|5602561|P1|STARTED|Overall Study||272
2281989|NCT02166346|5602594|P2|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||0
2281990|NCT02166346|5602595|P1|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||1
2281991|NCT02166346|5602594|P2|COMPLETED|Intervention - Phase 2 (After Crossover)||6
2281992|NCT02166346|5602595|P1|COMPLETED|Intervention - Phase 2 (After Crossover)||7
2281993|NCT02166346|5602594|P2|STARTED|Intervention - Phase 2 (After Crossover)||6
2281994|NCT02166346|5602595|P1|STARTED|Intervention - Phase 2 (After Crossover)||8
2281995|NCT02166346|5602594|P2|NOT COMPLETED|Intervention - Phase 1||2
2281996|NCT02166346|5602595|P1|NOT COMPLETED|Intervention - Phase 1||0
2281997|NCT02166346|5602594|P2|COMPLETED|Intervention - Phase 1||6
2281998|NCT02166346|5602595|P1|COMPLETED|Intervention - Phase 1||8
2281999|NCT02166346|5602594|P2|STARTED|Intervention - Phase 1||8
2282000|NCT02166346|5602595|P1|STARTED|Intervention - Phase 1||8
2282001|NCT02166346|5602594|P2|NOT COMPLETED|Screening and Randomization||4
2282002|NCT02166346|5602595|P1|NOT COMPLETED|Screening and Randomization||4
2282003|NCT02166346|5602594|P2|COMPLETED|Screening and Randomization||8
2282004|NCT02166346|5602595|P1|COMPLETED|Screening and Randomization||8
2282005|NCT02166346|5602594|P2|STARTED|Screening and Randomization||12
2282006|NCT02166346|5602595|P1|STARTED|Screening and Randomization||12
2282007|NCT02165904|5602603|P1|NOT COMPLETED|Overall Study||0
2282008|NCT02165904|5602603|P1|COMPLETED|Overall Study||10
2282009|NCT02165904|5602603|P1|STARTED|Overall Study||10
2282010|NCT02165826|5602625|P3|NOT COMPLETED|Down-Titration Period||7
2282011|NCT02165826|5602626|P2|NOT COMPLETED|Down-Titration Period||11
2282012|NCT02165826|5602627|P1|NOT COMPLETED|Down-Titration Period||7
2282013|NCT02165826|5602625|P3|COMPLETED|Down-Titration Period||31
2282014|NCT02165826|5602626|P2|COMPLETED|Down-Titration Period||28
2282015|NCT02165826|5602627|P1|COMPLETED|Down-Titration Period||20
2282016|NCT02165826|5602625|P3|Safety Analysis Set: Received Study Drug|Down-Titration Period||38
2282017|NCT02165826|5602626|P2|Safety Analysis Set: Received Study Drug|Down-Titration Period||39
2282018|NCT02165826|5602627|P1|Safety Analysis Set: Received Study Drug|Down-Titration Period||27
2282019|NCT02165826|5602625|P3|STARTED|Down-Titration Period||38
2282020|NCT02165826|5602626|P2|STARTED|Down-Titration Period||39
2282021|NCT02165826|5602627|P1|STARTED|Down-Titration Period||27
2282022|NCT02165826|5602625|P3|NOT COMPLETED|Main Treatment Period||109
2282023|NCT02165826|5602626|P2|NOT COMPLETED|Main Treatment Period||90
2282024|NCT02165826|5602627|P1|NOT COMPLETED|Main Treatment Period||81
2282025|NCT02165826|5602625|P3|COMPLETED|Main Treatment Period||334
2282026|NCT02165826|5602626|P2|COMPLETED|Main Treatment Period||349
2282027|NCT02165826|5602627|P1|COMPLETED|Main Treatment Period||360
2282028|NCT02165826|5602625|P3|Safety Analysis Set: Received Study Drug|Main Treatment Period||443
2282029|NCT02165826|5602626|P2|Safety Analysis Set: Received Study Drug|Main Treatment Period||437
2282030|NCT02165826|5602627|P1|Safety Analysis Set: Received Study Drug|Main Treatment Period||441
2282031|NCT02165826|5602625|P3|STARTED|Main Treatment Period||443
2282032|NCT02165826|5602626|P2|STARTED|Main Treatment Period||439
2282033|NCT02165826|5602627|P1|STARTED|Main Treatment Period||441
2282034|NCT02165761|5602686|P2|NOT COMPLETED|Overall Study||14
2282035|NCT02165761|5602687|P1|NOT COMPLETED|Overall Study||19
2282036|NCT02165761|5602686|P2|COMPLETED|Overall Study||5
2282037|NCT02165761|5602687|P1|COMPLETED|Overall Study||4
2282038|NCT02165761|5602686|P2|STARTED|Overall Study||19
2282039|NCT02165761|5602687|P1|STARTED|Overall Study||23
2282040|NCT02165735|5602695|P2|NOT COMPLETED|Overall Study||14
2282041|NCT02165735|5602696|P1|NOT COMPLETED|Overall Study||16
2282042|NCT02165735|5602695|P2|COMPLETED|Overall Study||166
2282043|NCT02165735|5602696|P1|COMPLETED|Overall Study||164
2282044|NCT02165735|5602695|P2|STARTED|Overall Study||180
2282045|NCT02165735|5602696|P1|STARTED|Overall Study||180
2282046|NCT02165722|5602724|P2|NOT COMPLETED|Overall Study||0
2282047|NCT02165722|5602725|P1|NOT COMPLETED|Overall Study||0
2282048|NCT02165722|5602724|P2|COMPLETED|Overall Study|Started and completed participants reflect the longitudinal analytic data set of patients used|2202
2282049|NCT02165722|5602725|P1|COMPLETED|Overall Study|Started and completed participants reflect the longitudinal analytic data set of patients used|1971
2282050|NCT02165722|5602724|P2|STARTED|Overall Study||2202
2282051|NCT02165722|5602725|P1|STARTED|Overall Study||1971
2282052|NCT02165462|5602737|P1|NOT COMPLETED|Overall Study||0
2282053|NCT02165462|5602737|P1|COMPLETED|Overall Study||17
2282054|NCT02165462|5602737|P1|STARTED|Overall Study||17
2282055|NCT02165384|5602754|P1|NOT COMPLETED|Overall Study||0
2282056|NCT02165384|5602754|P1|COMPLETED|Overall Study||199
2282057|NCT02165384|5602754|P1|STARTED|Overall Study||199
2282058|NCT02165202|5602761|P2|NOT COMPLETED|Injection Phase||6
2282059|NCT02165202|5602762|P1|NOT COMPLETED|Injection Phase||10
2282060|NCT02165202|5602761|P2|COMPLETED|Injection Phase||36
2282061|NCT02165202|5602762|P1|COMPLETED|Injection Phase||70
2282062|NCT02165202|5602761|P2|STARTED|Injection Phase|Participants who received at least one injection.|42
2282063|NCT02165202|5602762|P1|STARTED|Injection Phase|Participants who received at least one injection.|80
2282064|NCT02165202|5602761|P2|NOT COMPLETED|Oral Phase||3
2282065|NCT02165202|5602762|P1|NOT COMPLETED|Oral Phase||11
2282066|NCT02165202|5602761|P2|COMPLETED|Oral Phase||42
2282067|NCT02165202|5602762|P1|COMPLETED|Oral Phase||80
2282068|NCT02165202|5602761|P2|STARTED|Oral Phase|Participants Enrolled in the study|45
2282069|NCT02165202|5602762|P1|STARTED|Oral Phase|Participants Enrolled in the study|91
2282070|NCT02165124|5602768|P1|NOT COMPLETED|Overall Study||5
2282071|NCT02165124|5602768|P1|COMPLETED|Overall Study||15
2282072|NCT02165124|5602768|P1|STARTED|Overall Study||20
2282073|NCT02165111|5602774|P2|NOT COMPLETED|Overall Study||0
2282074|NCT02165111|5602775|P1|NOT COMPLETED|Overall Study||0
2282075|NCT02165111|5602774|P2|COMPLETED|Overall Study||40
2282076|NCT02165111|5602775|P1|COMPLETED|Overall Study||40
2282077|NCT02165111|5602774|P2|STARTED|Overall Study||40
2282078|NCT02165111|5602775|P1|STARTED|Overall Study||40
2282079|NCT02165072|5602791|P1|NOT COMPLETED|Overall Study||0
2282080|NCT02165072|5602791|P1|COMPLETED|Overall Study||30
2282081|NCT02165072|5602791|P1|STARTED|Overall Study||30
2282082|NCT02164981|5602799|P3|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||0
2282083|NCT02164981|5602800|P2|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||2
2282084|NCT02164981|5602801|P1|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||2
2282085|NCT02164981|5602799|P3|COMPLETED|Phase 2 (Day 14 - Day 28)||18
2282086|NCT02164981|5602800|P2|COMPLETED|Phase 2 (Day 14 - Day 28)||12
2282087|NCT02164981|5602801|P1|COMPLETED|Phase 2 (Day 14 - Day 28)||16
2282088|NCT02164981|5602799|P3|STARTED|Phase 2 (Day 14 - Day 28)||18
2282089|NCT02164981|5602800|P2|STARTED|Phase 2 (Day 14 - Day 28)||14
2282090|NCT02164981|5602801|P1|STARTED|Phase 2 (Day 14 - Day 28)||18
2282091|NCT02164981|5602799|P3|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||0
2282092|NCT02164981|5602800|P2|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||2
2282093|NCT02164981|5602801|P1|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||0
2282094|NCT02164981|5602799|P3|COMPLETED|Phase 1 (Day 0 - Day 14)||18
2282095|NCT02164981|5602800|P2|COMPLETED|Phase 1 (Day 0 - Day 14)||14
2282096|NCT02164981|5602801|P1|COMPLETED|Phase 1 (Day 0 - Day 14)||18
2282097|NCT02164981|5602799|P3|STARTED|Phase 1 (Day 0 - Day 14)||18
2282098|NCT02164981|5602800|P2|STARTED|Phase 1 (Day 0 - Day 14)||16
2282099|NCT02164981|5602801|P1|STARTED|Phase 1 (Day 0 - Day 14)||18
2282100|NCT02164981|5602799|P3|NOT COMPLETED|Started||0
2282101|NCT02164981|5602800|P2|NOT COMPLETED|Started||3
2282102|NCT02164981|5602801|P1|NOT COMPLETED|Started||5
2282103|NCT02164981|5602799|P3|COMPLETED|Started||18
2282104|NCT02164981|5602800|P2|COMPLETED|Started||16
2282105|NCT02164981|5602801|P1|COMPLETED|Started||18
2282106|NCT02164981|5602799|P3|STARTED|Started||18
2282107|NCT02164981|5602800|P2|STARTED|Started||19
2282108|NCT02164981|5602801|P1|STARTED|Started||23
2282109|NCT02164929|5602874|P4|NOT COMPLETED|Overall Study||2
2282110|NCT02164929|5602875|P3|NOT COMPLETED|Overall Study||1
2282111|NCT02164929|5602876|P2|NOT COMPLETED|Overall Study||0
2282112|NCT02164929|5602877|P1|NOT COMPLETED|Overall Study||1
2282113|NCT02164929|5602874|P4|COMPLETED|Overall Study||2
2282114|NCT02164929|5602875|P3|COMPLETED|Overall Study||4
2282115|NCT02164929|5602876|P2|COMPLETED|Overall Study||3
2282116|NCT02164929|5602877|P1|COMPLETED|Overall Study||3
2282117|NCT02164929|5602874|P4|STARTED|Overall Study||4
2282118|NCT02164929|5602875|P3|STARTED|Overall Study||5
2282119|NCT02164929|5602876|P2|STARTED|Overall Study||3
2282120|NCT02164929|5602877|P1|STARTED|Overall Study||4
2282121|NCT02164916|5602921|P2|NOT COMPLETED|Overall Study||54
2282122|NCT02164916|5602922|P1|NOT COMPLETED|Overall Study||52
2282123|NCT02164916|5602921|P2|COMPLETED|Overall Study||0
2282124|NCT02164916|5602922|P1|COMPLETED|Overall Study||0
2282125|NCT02164916|5602921|P2|Cross-over to Arm II|Overall Study||0
2282126|NCT02164916|5602922|P1|Cross-over to Arm II|Overall Study|Following disease progression on Arm 1. Note: these patients are also counted in 'Not Completed'.|24
2282127|NCT02164916|5602921|P2|Eligible|Overall Study||49
2282128|NCT02164916|5602922|P1|Eligible|Overall Study||50
2282129|NCT02164916|5602921|P2|STARTED|Overall Study||54
2282130|NCT02164916|5602922|P1|STARTED|Overall Study||52
2282131|NCT02164864|5602942|P3|NOT COMPLETED|Overall Study||132
2282132|NCT02164864|5602943|P2|NOT COMPLETED|Overall Study||60
2282133|NCT02164864|5602944|P1|NOT COMPLETED|Overall Study||95
2282134|NCT02164864|5602942|P3|COMPLETED|Overall Study||849
2282135|NCT02164864|5602943|P2|COMPLETED|Overall Study||703
2282136|NCT02164864|5602944|P1|COMPLETED|Overall Study||886
2282137|NCT02164864|5602942|P3|STARTED|Overall Study|Started are the Randomised/entered patients.|981
2282138|NCT02164864|5602943|P2|STARTED|Overall Study|Started are the Randomised/entered patients.|763
2282139|NCT02164864|5602944|P1|STARTED|Overall Study|Started are the Randomised/entered patients.|981
2282140|NCT02164539|5603009|P7|NOT COMPLETED|Treatment Phase C (1 Week)||2
2282141|NCT02164539|5603010|P6|NOT COMPLETED|Treatment Phase C (1 Week)||0
2282142|NCT02164539|5603011|P5|NOT COMPLETED|Treatment Phase C (1 Week)||0
2282143|NCT02164539|5603012|P4|NOT COMPLETED|Treatment Phase C (1 Week)||0
2282144|NCT02164539|5603013|P3|NOT COMPLETED|Treatment Phase C (1 Week)||0
2282145|NCT02164539|5603014|P2|NOT COMPLETED|Treatment Phase C (1 Week)||0
2282146|NCT02164539|5603015|P1|NOT COMPLETED|Treatment Phase C (1 Week)||1
2282147|NCT02164539|5603009|P7|COMPLETED|Treatment Phase C (1 Week)||78
2282148|NCT02164539|5603010|P6|COMPLETED|Treatment Phase C (1 Week)||82
2282149|NCT02164539|5603011|P5|COMPLETED|Treatment Phase C (1 Week)||84
2282150|NCT02164539|5603012|P4|COMPLETED|Treatment Phase C (1 Week)||0
2282151|NCT02164539|5603013|P3|COMPLETED|Treatment Phase C (1 Week)||0
2282152|NCT02164539|5603014|P2|COMPLETED|Treatment Phase C (1 Week)||0
2282153|NCT02164539|5603015|P1|COMPLETED|Treatment Phase C (1 Week)||78
2282154|NCT02164539|5603009|P7|STARTED|Treatment Phase C (1 Week)||80
2282155|NCT02164539|5603010|P6|STARTED|Treatment Phase C (1 Week)||82
2282156|NCT02164539|5603011|P5|STARTED|Treatment Phase C (1 Week)||84
2282157|NCT02164539|5603012|P4|STARTED|Treatment Phase C (1 Week)||0
2282158|NCT02164539|5603013|P3|STARTED|Treatment Phase C (1 Week)||0
2282159|NCT02164539|5603014|P2|STARTED|Treatment Phase C (1 Week)||0
2282160|NCT02164539|5603015|P1|STARTED|Treatment Phase C (1 Week)||79
2282161|NCT02164539|5603009|P7|NOT COMPLETED|Treatment Phase B (1 Week)||1
2282162|NCT02164539|5603010|P6|NOT COMPLETED|Treatment Phase B (1 Week)||0
2282163|NCT02164539|5603011|P5|NOT COMPLETED|Treatment Phase B (1 Week)||3
2282164|NCT02164539|5603012|P4|NOT COMPLETED|Treatment Phase B (1 Week)||0
2282165|NCT02164539|5603013|P3|NOT COMPLETED|Treatment Phase B (1 Week)||0
2282166|NCT02164539|5603014|P2|NOT COMPLETED|Treatment Phase B (1 Week)||0
2282167|NCT02164539|5603015|P1|NOT COMPLETED|Treatment Phase B (1 Week)||0
2282168|NCT02164539|5603009|P7|COMPLETED|Treatment Phase B (1 Week)||162
2282169|NCT02164539|5603010|P6|COMPLETED|Treatment Phase B (1 Week)||0
2282170|NCT02164539|5603011|P5|COMPLETED|Treatment Phase B (1 Week)||163
2282171|NCT02164539|5603012|P4|COMPLETED|Treatment Phase B (1 Week)||0
2282172|NCT02164539|5603013|P3|COMPLETED|Treatment Phase B (1 Week)||0
2282173|NCT02164539|5603014|P2|COMPLETED|Treatment Phase B (1 Week)||0
2282174|NCT02164539|5603015|P1|COMPLETED|Treatment Phase B (1 Week)||0
2282175|NCT02164539|5603009|P7|STARTED|Treatment Phase B (1 Week)||163
2282176|NCT02164539|5603010|P6|STARTED|Treatment Phase B (1 Week)||0
2282177|NCT02164539|5603011|P5|STARTED|Treatment Phase B (1 Week)||166
2282178|NCT02164539|5603012|P4|STARTED|Treatment Phase B (1 Week)||0
2282179|NCT02164539|5603013|P3|STARTED|Treatment Phase B (1 Week)||0
2282180|NCT02164539|5603014|P2|STARTED|Treatment Phase B (1 Week)||0
2282181|NCT02164539|5603015|P1|STARTED|Treatment Phase B (1 Week)||0
2282182|NCT02164539|5603009|P7|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
2282183|NCT02164539|5603010|P6|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
2282184|NCT02164539|5603011|P5|NOT COMPLETED|Treatment Phase A (4 Weeks)||3
2282185|NCT02164539|5603012|P4|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
2282186|NCT02164539|5603013|P3|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
2282187|NCT02164539|5603014|P2|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
2282188|NCT02164539|5603015|P1|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
2282189|NCT02164539|5603009|P7|COMPLETED|Treatment Phase A (4 Weeks)||0
2282190|NCT02164539|5603010|P6|COMPLETED|Treatment Phase A (4 Weeks)||83
2282191|NCT02164539|5603011|P5|COMPLETED|Treatment Phase A (4 Weeks)||82
2282192|NCT02164539|5603012|P4|COMPLETED|Treatment Phase A (4 Weeks)||44
2282193|NCT02164539|5603013|P3|COMPLETED|Treatment Phase A (4 Weeks)||39
2282194|NCT02164539|5603014|P2|COMPLETED|Treatment Phase A (4 Weeks)||42
2282195|NCT02164539|5603015|P1|COMPLETED|Treatment Phase A (4 Weeks)||39
2282196|NCT02164539|5603009|P7|STARTED|Treatment Phase A (4 Weeks)||0
2282197|NCT02164539|5603010|P6|STARTED|Treatment Phase A (4 Weeks)||84
2282198|NCT02164539|5603011|P5|STARTED|Treatment Phase A (4 Weeks)||85
2282199|NCT02164539|5603012|P4|STARTED|Treatment Phase A (4 Weeks)||46
2282200|NCT02164539|5603013|P3|STARTED|Treatment Phase A (4 Weeks)||40
2282201|NCT02164539|5603014|P2|STARTED|Treatment Phase A (4 Weeks)||42
2282202|NCT02164539|5603015|P1|STARTED|Treatment Phase A (4 Weeks)||41
2282203|NCT02164513|5603063|P3|NOT COMPLETED|Overall Study||295
2282204|NCT02164513|5603064|P2|NOT COMPLETED|Overall Study||536
2282205|NCT02164513|5603065|P1|NOT COMPLETED|Overall Study||437
2282206|NCT02164513|5603063|P3|COMPLETED|Overall Study||1775
2282207|NCT02164513|5603064|P2|COMPLETED|Overall Study||3598
2282208|NCT02164513|5603065|P1|COMPLETED|Overall Study||3714
2282209|NCT02164513|5603063|P3|WIP :Did Not Complete Study Treatment|Overall Study||0
2282210|NCT02164513|5603064|P2|WIP :Did Not Complete Study Treatment|Overall Study||1
2282211|NCT02164513|5603065|P1|WIP :Did Not Complete Study Treatment|Overall Study||1
2282212|NCT02164513|5603063|P3|WIP: Withdrawal by Participant|Overall Study||153
2282213|NCT02164513|5603064|P2|WIP: Withdrawal by Participant|Overall Study||296
2282214|NCT02164513|5603065|P1|WIP: Withdrawal by Participant|Overall Study||250
2282215|NCT02164513|5603063|P3|WIP: Investigator Discretion|Overall Study||15
2282216|NCT02164513|5603064|P2|WIP: Investigator Discretion|Overall Study||36
2282217|NCT02164513|5603065|P1|WIP: Investigator Discretion|Overall Study||33
2282218|NCT02164513|5603063|P3|WIP: Lost to Follow-up|Overall Study||14
2282219|NCT02164513|5603064|P2|WIP: Lost to Follow-up|Overall Study||25
2282220|NCT02164513|5603065|P1|WIP: Lost to Follow-up|Overall Study||21
2282221|NCT02164513|5603063|P3|WIP: Study Closed/Terminated|Overall Study||5
2282222|NCT02164513|5603064|P2|WIP: Study Closed/Terminated|Overall Study||2
2282223|NCT02164513|5603065|P1|WIP: Study Closed/Terminated|Overall Study||5
2282224|NCT02164513|5603063|P3|WIP (Other): Stopping Criteria Reached|Overall Study||2
2282225|NCT02164513|5603064|P2|WIP (Other): Stopping Criteria Reached|Overall Study||1
2282226|NCT02164513|5603065|P1|WIP (Other): Stopping Criteria Reached|Overall Study||4
2282227|NCT02164513|5603063|P3|Withdrew IP: Protocol Deviation|Overall Study||19
2282228|NCT02164513|5603064|P2|Withdrew IP: Protocol Deviation|Overall Study||41
2282229|NCT02164513|5603065|P1|Withdrew IP: Protocol Deviation|Overall Study||32
2282230|NCT02164513|5603063|P3|WIP: Lack of Efficacy|Overall Study||172
2282231|NCT02164513|5603064|P2|WIP: Lack of Efficacy|Overall Study||313
2282232|NCT02164513|5603065|P1|WIP: Lack of Efficacy|Overall Study||163
2282233|NCT02164513|5603063|P3|Withdrew IP (WIP): Adverse Event|Overall Study||186
2282234|NCT02164513|5603064|P2|Withdrew IP (WIP): Adverse Event|Overall Study||325
2282235|NCT02164513|5603065|P1|Withdrew IP (WIP): Adverse Event|Overall Study||249
2282236|NCT02164513|5603063|P3|Not Completed IP|Overall Study||566
2282237|NCT02164513|5603064|P2|Not Completed IP|Overall Study||1040
2282238|NCT02164513|5603065|P1|Not Completed IP|Overall Study||758
2282239|NCT02164513|5603063|P3|Completed Investigational Product (IP)|Overall Study||1504
2282240|NCT02164513|5603064|P2|Completed Investigational Product (IP)|Overall Study||3094
2282241|NCT02164513|5603065|P1|Completed Investigational Product (IP)|Overall Study||3393
2282242|NCT02164513|5603063|P3|STARTED|Overall Study||2070
2282243|NCT02164513|5603064|P2|STARTED|Overall Study||4134
2282244|NCT02164513|5603065|P1|STARTED|Overall Study||4151
2282245|NCT02164396|5603090|P3|NOT COMPLETED|Overall Study||0
2282246|NCT02164396|5603091|P2|NOT COMPLETED|Overall Study||0
2282247|NCT02164396|5603092|P1|NOT COMPLETED|Overall Study||0
2282248|NCT02164396|5603090|P3|COMPLETED|Overall Study||10
2282249|NCT02164396|5603091|P2|COMPLETED|Overall Study||10
2282250|NCT02164396|5603092|P1|COMPLETED|Overall Study||10
2282251|NCT02164396|5603090|P3|STARTED|Overall Study||10
2282252|NCT02164396|5603091|P2|STARTED|Overall Study||10
2282253|NCT02164396|5603092|P1|STARTED|Overall Study||10
2282254|NCT02164383|5603102|P2|NOT COMPLETED|Overall Study||0
2282255|NCT02164383|5603103|P1|NOT COMPLETED|Overall Study||1
2282256|NCT02164383|5603102|P2|COMPLETED|Overall Study||14
2282257|NCT02164383|5603103|P1|COMPLETED|Overall Study||15
2282258|NCT02164383|5603102|P2|STARTED|Overall Study||14
2282259|NCT02164383|5603103|P1|STARTED|Overall Study||16
2282260|NCT02164318|5603113|P4|NOT COMPLETED|Overall Study||1
2282261|NCT02164318|5603114|P3|NOT COMPLETED|Overall Study||0
2282262|NCT02164318|5603115|P2|NOT COMPLETED|Overall Study||1
2282263|NCT02164318|5603116|P1|NOT COMPLETED|Overall Study||0
2282264|NCT02164318|5603113|P4|COMPLETED|Overall Study||2
2282265|NCT02164318|5603114|P3|COMPLETED|Overall Study||1
2282266|NCT02164318|5603115|P2|COMPLETED|Overall Study||2
2282267|NCT02164318|5603116|P1|COMPLETED|Overall Study||4
2282268|NCT02164318|5603113|P4|STARTED|Overall Study||3
2282269|NCT02164318|5603114|P3|STARTED|Overall Study||1
2282270|NCT02164318|5603115|P2|STARTED|Overall Study||3
2282271|NCT02164318|5603116|P1|STARTED|Overall Study||4
2282272|NCT02164240|5603134|P3|NOT COMPLETED|Overall Study||0
2282273|NCT02164240|5603135|P2|NOT COMPLETED|Overall Study||0
2282274|NCT02164240|5603136|P1|NOT COMPLETED|Overall Study||0
2282275|NCT02164240|5603134|P3|COMPLETED|Overall Study||4
2282276|NCT02164240|5603135|P2|COMPLETED|Overall Study||5
2282277|NCT02164240|5603136|P1|COMPLETED|Overall Study||5
2282278|NCT02164240|5603134|P3|STARTED|Overall Study||4
2282279|NCT02164240|5603135|P2|STARTED|Overall Study||5
2282280|NCT02164240|5603136|P1|STARTED|Overall Study||5
2282281|NCT02163993|5603151|P5|NOT COMPLETED|Post-treatment Period||3
2282282|NCT02163993|5603152|P4|NOT COMPLETED|Post-treatment Period||2
2282283|NCT02163993|5603153|P3|NOT COMPLETED|Post-treatment Period||4
2282284|NCT02163993|5603154|P2|NOT COMPLETED|Post-treatment Period||6
2282285|NCT02163993|5603155|P1|NOT COMPLETED|Post-treatment Period||4
2282286|NCT02163993|5603151|P5|COMPLETED|Post-treatment Period||62
2282287|NCT02163993|5603152|P4|COMPLETED|Post-treatment Period||61
2282288|NCT02163993|5603153|P3|COMPLETED|Post-treatment Period||62
2282289|NCT02163993|5603154|P2|COMPLETED|Post-treatment Period||55
2282290|NCT02163993|5603155|P1|COMPLETED|Post-treatment Period||121
2282291|NCT02163993|5603151|P5|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|65
2282292|NCT02163993|5603152|P4|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|63
2282293|NCT02163993|5603153|P3|STARTED|Post-treatment Period||66
2282294|NCT02163993|5603154|P2|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|61
2282295|NCT02163993|5603155|P1|STARTED|Post-treatment Period|One participant discontinued after Treatment Period. Did not enter into Post-treatment Period.|125
2282296|NCT02163993|5603151|P5|NOT COMPLETED|Treatment Period||7
2282297|NCT02163993|5603152|P4|NOT COMPLETED|Treatment Period||9
2282298|NCT02163993|5603153|P3|NOT COMPLETED|Treatment Period||2
2282299|NCT02163993|5603154|P2|NOT COMPLETED|Treatment Period||9
2282300|NCT02163993|5603155|P1|NOT COMPLETED|Treatment Period||12
2282301|NCT02163993|5603151|P5|COMPLETED|Treatment Period||62
2282302|NCT02163993|5603152|P4|COMPLETED|Treatment Period||62
2282303|NCT02163993|5603153|P3|COMPLETED|Treatment Period||66
2282304|NCT02163993|5603154|P2|COMPLETED|Treatment Period||59
2282305|NCT02163993|5603155|P1|COMPLETED|Treatment Period||126
2282306|NCT02163993|5603151|P5|Received at Least 1 Dose of Study Drug|Treatment Period||67
2282307|NCT02163993|5603152|P4|Received at Least 1 Dose of Study Drug|Treatment Period||70
2282308|NCT02163993|5603153|P3|Received at Least 1 Dose of Study Drug|Treatment Period||68
2282309|NCT02163993|5603154|P2|Received at Least 1 Dose of Study Drug|Treatment Period||68
2282310|NCT02163993|5603155|P1|Received at Least 1 Dose of Study Drug|Treatment Period||137
2282311|NCT02163993|5603151|P5|STARTED|Treatment Period||69
2282312|NCT02163993|5603152|P4|STARTED|Treatment Period||71
2282313|NCT02163993|5603153|P3|STARTED|Treatment Period||68
2282314|NCT02163993|5603154|P2|STARTED|Treatment Period||68
2282315|NCT02163993|5603155|P1|STARTED|Treatment Period||138
2282316|NCT02163967|5603231|P6|NOT COMPLETED|Third Intervention/Day 3||0
2282317|NCT02163967|5603232|P5|NOT COMPLETED|Third Intervention/Day 3||0
2282318|NCT02163967|5603233|P4|NOT COMPLETED|Third Intervention/Day 3||0
2282319|NCT02163967|5603234|P3|NOT COMPLETED|Third Intervention/Day 3||0
2282320|NCT02163967|5603235|P2|NOT COMPLETED|Third Intervention/Day 3||0
2282321|NCT02163967|5603236|P1|NOT COMPLETED|Third Intervention/Day 3||0
2282322|NCT02163967|5603231|P6|COMPLETED|Third Intervention/Day 3||3
2282323|NCT02163967|5603232|P5|COMPLETED|Third Intervention/Day 3||3
2282324|NCT02163967|5603233|P4|COMPLETED|Third Intervention/Day 3||4
2282325|NCT02163967|5603234|P3|COMPLETED|Third Intervention/Day 3||2
2282326|NCT02163967|5603235|P2|COMPLETED|Third Intervention/Day 3||3
2282327|NCT02163967|5603236|P1|COMPLETED|Third Intervention/Day 3||3
2282328|NCT02163967|5603231|P6|STARTED|Third Intervention/Day 3||3
2282329|NCT02163967|5603232|P5|STARTED|Third Intervention/Day 3||3
2282330|NCT02163967|5603233|P4|STARTED|Third Intervention/Day 3||4
2282331|NCT02163967|5603234|P3|STARTED|Third Intervention/Day 3||2
2282332|NCT02163967|5603235|P2|STARTED|Third Intervention/Day 3||3
2282333|NCT02163967|5603236|P1|STARTED|Third Intervention/Day 3||3
2282334|NCT02163967|5603231|P6|NOT COMPLETED|Second Intevention/Day 2||0
2282335|NCT02163967|5603232|P5|NOT COMPLETED|Second Intevention/Day 2||0
2282336|NCT02163967|5603233|P4|NOT COMPLETED|Second Intevention/Day 2||0
2282337|NCT02163967|5603234|P3|NOT COMPLETED|Second Intevention/Day 2||0
2282338|NCT02163967|5603235|P2|NOT COMPLETED|Second Intevention/Day 2||0
2282339|NCT02163967|5603236|P1|NOT COMPLETED|Second Intevention/Day 2||0
2282340|NCT02163967|5603231|P6|COMPLETED|Second Intevention/Day 2||3
2282341|NCT02163967|5603232|P5|COMPLETED|Second Intevention/Day 2||3
2282342|NCT02163967|5603233|P4|COMPLETED|Second Intevention/Day 2||4
2282343|NCT02163967|5603234|P3|COMPLETED|Second Intevention/Day 2||2
2282344|NCT02163967|5603235|P2|COMPLETED|Second Intevention/Day 2||4
2282345|NCT02163967|5603236|P1|COMPLETED|Second Intevention/Day 2||3
2282346|NCT02163967|5603231|P6|STARTED|Second Intevention/Day 2||3
2282347|NCT02163967|5603232|P5|STARTED|Second Intevention/Day 2||3
2282348|NCT02163967|5603233|P4|STARTED|Second Intevention/Day 2||4
2282349|NCT02163967|5603234|P3|STARTED|Second Intevention/Day 2||2
2282350|NCT02163967|5603235|P2|STARTED|Second Intevention/Day 2||4
2282351|NCT02163967|5603236|P1|STARTED|Second Intevention/Day 2||3
2282352|NCT02163967|5603231|P6|NOT COMPLETED|First Intervention/ Day 1||0
2282353|NCT02163967|5603232|P5|NOT COMPLETED|First Intervention/ Day 1||0
2282354|NCT02163967|5603233|P4|NOT COMPLETED|First Intervention/ Day 1||0
2282355|NCT02163967|5603234|P3|NOT COMPLETED|First Intervention/ Day 1||0
2282356|NCT02163967|5603235|P2|NOT COMPLETED|First Intervention/ Day 1||0
2282357|NCT02163967|5603236|P1|NOT COMPLETED|First Intervention/ Day 1||0
2282358|NCT02163967|5603231|P6|COMPLETED|First Intervention/ Day 1||3
2282359|NCT02163967|5603232|P5|COMPLETED|First Intervention/ Day 1||3
2282360|NCT02163967|5603233|P4|COMPLETED|First Intervention/ Day 1||4
2282361|NCT02163967|5603234|P3|COMPLETED|First Intervention/ Day 1||3
2282362|NCT02163967|5603235|P2|COMPLETED|First Intervention/ Day 1||4
2282363|NCT02163967|5603236|P1|COMPLETED|First Intervention/ Day 1||4
2282364|NCT02163967|5603231|P6|STARTED|First Intervention/ Day 1||3
2282365|NCT02163967|5603232|P5|STARTED|First Intervention/ Day 1||3
2282366|NCT02163967|5603233|P4|STARTED|First Intervention/ Day 1||4
2282367|NCT02163967|5603234|P3|STARTED|First Intervention/ Day 1||3
2282368|NCT02163967|5603235|P2|STARTED|First Intervention/ Day 1||4
2282369|NCT02163967|5603236|P1|STARTED|First Intervention/ Day 1||4
2282370|NCT02163915|5603258|P5|NOT COMPLETED|Overall Study||4
2282371|NCT02163915|5603259|P4|NOT COMPLETED|Overall Study||3
2282372|NCT02163915|5603260|P3|NOT COMPLETED|Overall Study||2
2282373|NCT02163915|5603261|P2|NOT COMPLETED|Overall Study||0
2282374|NCT02163915|5603262|P1|NOT COMPLETED|Overall Study||3
2282375|NCT02163915|5603258|P5|COMPLETED|Overall Study||6
2282376|NCT02163915|5603259|P4|COMPLETED|Overall Study||6
2282377|NCT02163915|5603260|P3|COMPLETED|Overall Study||8
2282378|NCT02163915|5603261|P2|COMPLETED|Overall Study||8
2282379|NCT02163915|5603262|P1|COMPLETED|Overall Study||7
2282380|NCT02163915|5603258|P5|STARTED|Overall Study||10
2282381|NCT02163915|5603259|P4|STARTED|Overall Study||9
2282382|NCT02163915|5603260|P3|STARTED|Overall Study||10
2282383|NCT02163915|5603261|P2|STARTED|Overall Study||8
2282384|NCT02163915|5603262|P1|STARTED|Overall Study||10
2282391|NCT02163837|5603334|P1|NOT COMPLETED|Day 28 of Rifaximin Treatment||0
2282392|NCT02163837|5603334|P1|COMPLETED|Day 28 of Rifaximin Treatment||15
2282393|NCT02163837|5603334|P1|STARTED|Day 28 of Rifaximin Treatment||15
2282394|NCT02163837|5603334|P1|NOT COMPLETED|Before Rifaximin||0
2282395|NCT02163837|5603334|P1|COMPLETED|Before Rifaximin||15
2282396|NCT02163837|5603334|P1|STARTED|Before Rifaximin||15
2282397|NCT02163733|5603344|P3|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||24
2282398|NCT02163733|5603345|P2|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
2282399|NCT02163733|5603346|P1|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
2282400|NCT02163733|5603344|P3|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||14
2282401|NCT02163733|5603345|P2|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
2282402|NCT02163733|5603346|P1|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
2282403|NCT02163733|5603344|P3|STARTED|Part B: Day 15 to End Part B (AZD9291)|No patients completed previous period as relates to Part A and arm is applicable only for Part B.|38
2282404|NCT02163733|5603345|P2|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
2282405|NCT02163733|5603346|P1|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
2282406|NCT02163733|5603344|P3|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
2282407|NCT02163733|5603345|P2|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
2282408|NCT02163733|5603346|P1|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
2282409|NCT02163733|5603344|P3|COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
2282410|NCT02163733|5603345|P2|COMPLETED|Part A: Day 10-15 (2nd Intervention)||20
2282411|NCT02163733|5603346|P1|COMPLETED|Part A: Day 10-15 (2nd Intervention)||18
2282412|NCT02163733|5603344|P3|STARTED|Part A: Day 10-15 (2nd Intervention)||0
2282413|NCT02163733|5603345|P2|STARTED|Part A: Day 10-15 (2nd Intervention)||20
2282414|NCT02163733|5603346|P1|STARTED|Part A: Day 10-15 (2nd Intervention)||18
2282415|NCT02163733|5603344|P3|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
2282416|NCT02163733|5603345|P2|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
2282417|NCT02163733|5603346|P1|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
2282418|NCT02163733|5603344|P3|COMPLETED|Part A: Day 1-9 (1st Intervention)||0
2282419|NCT02163733|5603345|P2|COMPLETED|Part A: Day 1-9 (1st Intervention)||20
2282420|NCT02163733|5603346|P1|COMPLETED|Part A: Day 1-9 (1st Intervention)||18
2282421|NCT02163733|5603344|P3|STARTED|Part A: Day 1-9 (1st Intervention)||0
2282422|NCT02163733|5603345|P2|STARTED|Part A: Day 1-9 (1st Intervention)||20
2282423|NCT02163733|5603346|P1|STARTED|Part A: Day 1-9 (1st Intervention)||18
2282424|NCT02163577|5603383|P2|NOT COMPLETED|Overall Study||0
2282425|NCT02163577|5603384|P1|NOT COMPLETED|Overall Study||0
2282426|NCT02163577|5603383|P2|COMPLETED|Overall Study||26
2282427|NCT02163577|5603384|P1|COMPLETED|Overall Study||26
2282428|NCT02163577|5603383|P2|STARTED|Overall Study||26
2282429|NCT02163577|5603384|P1|STARTED|Overall Study||26
2282430|NCT02163538|5603448|P2|NOT COMPLETED|Overall Study||1
2282431|NCT02163538|5603449|P1|NOT COMPLETED|Overall Study||1
2282432|NCT02163538|5603448|P2|COMPLETED|Overall Study||70
2282433|NCT02163538|5603449|P1|COMPLETED|Overall Study||70
2282434|NCT02163538|5603448|P2|STARTED|Overall Study||71
2282435|NCT02163538|5603449|P1|STARTED|Overall Study||71
2282436|NCT02163499|5603465|P1|NOT COMPLETED|Extended Dosing Phase: ZS||280
2282437|NCT02163499|5603465|P1|COMPLETED|Extended Dosing Phase: ZS||466
2282438|NCT02163499|5603465|P1|STARTED|Extended Dosing Phase: ZS||746
2282439|NCT02163499|5603465|P1|NOT COMPLETED|Acute Phase: ZS 10 g TID||5
2282440|NCT02163499|5603465|P1|COMPLETED|Acute Phase: ZS 10 g TID||746
2282441|NCT02163499|5603465|P1|STARTED|Acute Phase: ZS 10 g TID||751
2282442|NCT02163486|5603475|P2|NOT COMPLETED|Overall Study||2
2282443|NCT02163486|5603476|P1|NOT COMPLETED|Overall Study||1
2282444|NCT02163486|5603475|P2|COMPLETED|Overall Study||50
2282445|NCT02163486|5603476|P1|COMPLETED|Overall Study||50
2282446|NCT02163486|5603475|P2|STARTED|Overall Study||52
2282447|NCT02163486|5603476|P1|STARTED|Overall Study||51
2282448|NCT02163447|5603493|P3|NOT COMPLETED|Overall Study||3
2282449|NCT02163447|5603494|P2|NOT COMPLETED|Overall Study||6
2282450|NCT02163447|5603495|P1|NOT COMPLETED|Overall Study||6
2282451|NCT02163447|5603493|P3|COMPLETED|Overall Study||97
2282452|NCT02163447|5603494|P2|COMPLETED|Overall Study||88
2282453|NCT02163447|5603495|P1|COMPLETED|Overall Study||100
2282454|NCT02163447|5603493|P3|STARTED|Overall Study||100
2282455|NCT02163447|5603494|P2|STARTED|Overall Study||94
2282456|NCT02163447|5603495|P1|STARTED|Overall Study||106
2282457|NCT02163421|5603525|P4|NOT COMPLETED|Overall Study||0
2282458|NCT02163421|5603526|P3|NOT COMPLETED|Overall Study||0
2282459|NCT02163421|5603527|P2|NOT COMPLETED|Overall Study||0
2282460|NCT02163421|5603528|P1|NOT COMPLETED|Overall Study||0
2282461|NCT02163421|5603525|P4|COMPLETED|Overall Study||12
2282462|NCT02163421|5603526|P3|COMPLETED|Overall Study||12
2282463|NCT02163421|5603527|P2|COMPLETED|Overall Study||12
2282464|NCT02163421|5603528|P1|COMPLETED|Overall Study||12
2282465|NCT02163421|5603525|P4|STARTED|Overall Study||12
2282466|NCT02163421|5603526|P3|STARTED|Overall Study||12
2282467|NCT02163421|5603527|P2|STARTED|Overall Study||12
2282468|NCT02163421|5603528|P1|STARTED|Overall Study||12
2282469|NCT02163395|5603535|P1|NOT COMPLETED|Overall Study||5
2282470|NCT02163395|5603535|P1|COMPLETED|Overall Study||39
2282471|NCT02163395|5603535|P1|STARTED|Overall Study||44
2282472|NCT02163187|5603544|P2|NOT COMPLETED|Overall Study||0
2282473|NCT02163187|5603545|P1|NOT COMPLETED|Overall Study||2
2282474|NCT02163187|5603544|P2|COMPLETED|Overall Study||0
2282475|NCT02163187|5603545|P1|COMPLETED|Overall Study||2
2282476|NCT02163187|5603544|P2|Treatment|Overall Study||0
2282477|NCT02163187|5603545|P1|Treatment|Overall Study||2
2282478|NCT02163187|5603544|P2|STARTED|Overall Study||0
2282479|NCT02163187|5603545|P1|STARTED|Overall Study||4
2282480|NCT02162992|5603555|P2|NOT COMPLETED|Overall Study||1
2282481|NCT02162992|5603556|P1|NOT COMPLETED|Overall Study||5
2282482|NCT02162992|5603555|P2|COMPLETED|Overall Study||99
2282483|NCT02162992|5603556|P1|COMPLETED|Overall Study||46
2282484|NCT02162992|5603555|P2|STARTED|Overall Study||100
2282485|NCT02162992|5603556|P1|STARTED|Overall Study||51
2282486|NCT02162979|5603566|P2|NOT COMPLETED|Overall Study||0
2282487|NCT02162979|5603567|P1|NOT COMPLETED|Overall Study||0
2282488|NCT02162979|5603566|P2|COMPLETED|Overall Study||0
2282489|NCT02162979|5603567|P1|COMPLETED|Overall Study||0
2282490|NCT02162979|5603566|P2|STARTED|Overall Study||0
2282491|NCT02162979|5603567|P1|STARTED|Overall Study||0
2282492|NCT02162862|5603580|P3|NOT COMPLETED|Overall Study||4
2282493|NCT02162862|5603581|P2|NOT COMPLETED|Overall Study||11
2282494|NCT02162862|5603582|P1|NOT COMPLETED|Overall Study||0
2282495|NCT02162862|5603580|P3|COMPLETED|Overall Study||29
2282496|NCT02162862|5603581|P2|COMPLETED|Overall Study||24
2282497|NCT02162862|5603582|P1|COMPLETED|Overall Study||31
2282498|NCT02162862|5603580|P3|STARTED|Overall Study||33
2282499|NCT02162862|5603581|P2|STARTED|Overall Study||35
2282500|NCT02162862|5603582|P1|STARTED|Overall Study||31
2282501|NCT02162771|5603595|P2|NOT COMPLETED|Maintenance Study Period (Part 2)||22
2282502|NCT02162771|5603596|P1|NOT COMPLETED|Maintenance Study Period (Part 2)||16
2282503|NCT02162771|5603595|P2|COMPLETED|Maintenance Study Period (Part 2)||38
2282504|NCT02162771|5603596|P1|COMPLETED|Maintenance Study Period (Part 2)||46
2282505|NCT02162771|5603595|P2|STARTED|Maintenance Study Period (Part 2)|Two subjects did not enter this period due to Withdrawal by subject and Non-responder, 1 for each.|60
2282506|NCT02162771|5603596|P1|STARTED|Maintenance Study Period (Part 2)||62
2282507|NCT02162771|5603595|P2|NOT COMPLETED|Core Study Period (Part 2)||8
2282508|NCT02162771|5603596|P1|NOT COMPLETED|Core Study Period (Part 2)||8
2282509|NCT02162771|5603595|P2|COMPLETED|Core Study Period (Part 2)||62
2282510|NCT02162771|5603596|P1|COMPLETED|Core Study Period (Part 2)||62
2282511|NCT02162771|5603595|P2|STARTED|Core Study Period (Part 2)||70
2282512|NCT02162771|5603596|P1|STARTED|Core Study Period (Part 2)||70
2282513|NCT02162758|5603610|P2|NOT COMPLETED|Overall Study||1
2282514|NCT02162758|5603611|P1|NOT COMPLETED|Overall Study||0
2282515|NCT02162758|5603610|P2|COMPLETED|Overall Study||2
2282516|NCT02162758|5603611|P1|COMPLETED|Overall Study||3
2282517|NCT02162758|5603610|P2|STARTED|Overall Study||3
2282518|NCT02162758|5603611|P1|STARTED|Overall Study||3
2282519|NCT02162680|5603626|P3|NOT COMPLETED|Overall Study||0
2282520|NCT02162680|5603627|P2|NOT COMPLETED|Overall Study||0
2282521|NCT02162680|5603628|P1|NOT COMPLETED|Overall Study||0
2282522|NCT02162680|5603626|P3|COMPLETED|Overall Study||32
2282523|NCT02162680|5603627|P2|COMPLETED|Overall Study||33
2282524|NCT02162680|5603628|P1|COMPLETED|Overall Study||33
2282525|NCT02162680|5603626|P3|STARTED|Overall Study||32
2282526|NCT02162680|5603627|P2|STARTED|Overall Study||33
2282527|NCT02162680|5603628|P1|STARTED|Overall Study||33
2282528|NCT02162667|5603638|P2|NOT COMPLETED|Adjuvant Period||13
2282529|NCT02162667|5603639|P1|NOT COMPLETED|Adjuvant Period||12
2282530|NCT02162667|5603638|P2|COMPLETED|Adjuvant Period||255
2282531|NCT02162667|5603639|P1|COMPLETED|Adjuvant Period||248
2282532|NCT02162667|5603638|P2|STARTED|Adjuvant Period||268
2282533|NCT02162667|5603639|P1|STARTED|Adjuvant Period||260
2282534|NCT02162667|5603638|P2|NOT COMPLETED|Neoadjuvant Period||17
2282535|NCT02162667|5603639|P1|NOT COMPLETED|Neoadjuvant Period||14
2282536|NCT02162667|5603638|P2|COMPLETED|Neoadjuvant Period||267
2282537|NCT02162667|5603639|P1|COMPLETED|Neoadjuvant Period||264
2282538|NCT02162667|5603638|P2|STARTED|Neoadjuvant Period||284
2282539|NCT02162667|5603639|P1|STARTED|Neoadjuvant Period||278
2282540|NCT02162576|5603665|P1|NOT COMPLETED|Overall Study||0
2282541|NCT02162576|5603665|P1|COMPLETED|Overall Study||95
2282542|NCT02162576|5603665|P1|STARTED|Overall Study||95
2282543|NCT02162446|5603671|P1|NOT COMPLETED|Overall Study||0
2282544|NCT02162446|5603671|P1|COMPLETED|Overall Study||12
2282545|NCT02162446|5603671|P1|STARTED|Overall Study||12
2282546|NCT02161757|5603705|P3|NOT COMPLETED|Treatment Through Study Completion||39
2282547|NCT02161757|5603706|P2|NOT COMPLETED|Treatment Through Study Completion||43
2282548|NCT02161757|5603707|P1|NOT COMPLETED|Treatment Through Study Completion||57
2282549|NCT02161757|5603705|P3|COMPLETED|Treatment Through Study Completion||361
2282550|NCT02161757|5603706|P2|COMPLETED|Treatment Through Study Completion||361
2282551|NCT02161757|5603707|P1|COMPLETED|Treatment Through Study Completion||341
2282552|NCT02161757|5603705|P3|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||360
2282553|NCT02161757|5603706|P2|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||355
2282554|NCT02161757|5603707|P1|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||332
2282555|NCT02161757|5603705|P3|STARTED|Treatment Through Study Completion||400
2282556|NCT02161757|5603706|P2|STARTED|Treatment Through Study Completion||404
2282557|NCT02161757|5603707|P1|STARTED|Treatment Through Study Completion||398
2282558|NCT02161757|5603705|P3|NOT COMPLETED|Randomised Through Start Treatment||0
2282559|NCT02161757|5603706|P2|NOT COMPLETED|Randomised Through Start Treatment||2
2282560|NCT02161757|5603707|P1|NOT COMPLETED|Randomised Through Start Treatment||3
2282561|NCT02161757|5603705|P3|COMPLETED|Randomised Through Start Treatment||400
2282562|NCT02161757|5603706|P2|COMPLETED|Randomised Through Start Treatment||404
2282563|NCT02161757|5603707|P1|COMPLETED|Randomised Through Start Treatment||398
2282564|NCT02161757|5603705|P3|STARTED|Randomised Through Start Treatment||400
2282565|NCT02161757|5603706|P2|STARTED|Randomised Through Start Treatment||406
2282566|NCT02161757|5603707|P1|STARTED|Randomised Through Start Treatment||401
2282567|NCT02161731|5603765|P2|NOT COMPLETED|Period 2 (Day 7 Dosing to Day 23)||2
2282568|NCT02161731|5603766|P1|NOT COMPLETED|Period 2 (Day 7 Dosing to Day 23)||0
2282569|NCT02161731|5603765|P2|COMPLETED|Period 2 (Day 7 Dosing to Day 23)||22
2282570|NCT02161731|5603766|P1|COMPLETED|Period 2 (Day 7 Dosing to Day 23)||0
2282571|NCT02161731|5603765|P2|Received 1 Dose of Study Drug|Period 2 (Day 7 Dosing to Day 23)||24
2282572|NCT02161731|5603766|P1|Received 1 Dose of Study Drug|Period 2 (Day 7 Dosing to Day 23)||0
2282573|NCT02161731|5603765|P2|STARTED|Period 2 (Day 7 Dosing to Day 23)||24
2282574|NCT02161731|5603766|P1|STARTED|Period 2 (Day 7 Dosing to Day 23)||0
2282575|NCT02161731|5603765|P2|NOT COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
2282576|NCT02161731|5603766|P1|NOT COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
2282577|NCT02161731|5603765|P2|COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
2282578|NCT02161731|5603766|P1|COMPLETED|Period 1 (Day -1 to Day 7 Predose)||24
2282579|NCT02161731|5603765|P2|Received 1 Dose of Study Drug|Period 1 (Day -1 to Day 7 Predose)||0
2282580|NCT02161731|5603766|P1|Received 1 Dose of Study Drug|Period 1 (Day -1 to Day 7 Predose)||24
2282581|NCT02161731|5603765|P2|STARTED|Period 1 (Day -1 to Day 7 Predose)||0
2282582|NCT02161731|5603766|P1|STARTED|Period 1 (Day -1 to Day 7 Predose)||24
2282583|NCT02161575|5603783|P1|NOT COMPLETED|Overall Study||11
2282584|NCT02161575|5603783|P1|COMPLETED|Overall Study||92
2282585|NCT02161575|5603783|P1|Safety (SAF) Population|Overall Study||100
2282586|NCT02161575|5603783|P1|Full Analysis Set (FAS) Population|Overall Study||100
2282587|NCT02161575|5603783|P1|STARTED|Overall Study||103
2282588|NCT02161562|5603803|P2|NOT COMPLETED|Overall Study||17
2282589|NCT02161562|5603804|P1|NOT COMPLETED|Overall Study||26
2282590|NCT02161562|5603803|P2|COMPLETED|Overall Study||119
2282591|NCT02161562|5603804|P1|COMPLETED|Overall Study||152
2282592|NCT02161562|5603803|P2|STARTED|Overall Study||136
2282593|NCT02161562|5603804|P1|STARTED|Overall Study||178
2282594|NCT02161549|5603832|P2|NOT COMPLETED|Overall Study||2
2282595|NCT02161549|5603833|P1|NOT COMPLETED|Overall Study||6
2282596|NCT02161549|5603832|P2|COMPLETED|Overall Study||29
2282597|NCT02161549|5603833|P1|COMPLETED|Overall Study||34
2282598|NCT02161549|5603832|P2|STARTED|Overall Study||31
2282599|NCT02161549|5603833|P1|STARTED|Overall Study||40
2282600|NCT02161536|5603842|P3|NOT COMPLETED|Overall Study||0
2282601|NCT02161536|5603843|P2|NOT COMPLETED|Overall Study||0
2282602|NCT02161536|5603844|P1|NOT COMPLETED|Overall Study||0
2282603|NCT02161536|5603842|P3|COMPLETED|Overall Study||20
2282604|NCT02161536|5603843|P2|COMPLETED|Overall Study||21
2282605|NCT02161536|5603844|P1|COMPLETED|Overall Study||6
2282606|NCT02161536|5603842|P3|STARTED|Overall Study||20
2282607|NCT02161536|5603843|P2|STARTED|Overall Study||21
2282608|NCT02161536|5603844|P1|STARTED|Overall Study||6
2282609|NCT02161484|5603854|P2|NOT COMPLETED|Overall Study||3
2282610|NCT02161484|5603855|P1|NOT COMPLETED|Overall Study||4
2282611|NCT02161484|5603854|P2|COMPLETED|Overall Study||2
2282612|NCT02161484|5603855|P1|COMPLETED|Overall Study||1
2282613|NCT02161484|5603854|P2|STARTED|Overall Study||5
2282614|NCT02161484|5603855|P1|STARTED|Overall Study||5
2282615|NCT02161458|5603881|P4|NOT COMPLETED|Overall Study||0
2282616|NCT02161458|5603882|P3|NOT COMPLETED|Overall Study||5
2282617|NCT02161458|5603883|P2|NOT COMPLETED|Overall Study||6
2282618|NCT02161458|5603884|P1|NOT COMPLETED|Overall Study||0
2282619|NCT02161458|5603881|P4|COMPLETED|Overall Study||8
2282620|NCT02161458|5603882|P3|COMPLETED|Overall Study||28
2282621|NCT02161458|5603883|P2|COMPLETED|Overall Study||29
2282622|NCT02161458|5603884|P1|COMPLETED|Overall Study||22
2282623|NCT02161458|5603881|P4|STARTED|Overall Study||8
2282624|NCT02161458|5603882|P3|STARTED|Overall Study||33
2282625|NCT02161458|5603883|P2|STARTED|Overall Study||35
2282626|NCT02161458|5603884|P1|STARTED|Overall Study||22
2282633|NCT02161185|5603971|P1|NOT COMPLETED|Treatment Phase||7
2282634|NCT02161185|5603971|P1|COMPLETED|Treatment Phase||0
2282635|NCT02161185|5603971|P1|STARTED|Treatment Phase||7
2282636|NCT02161185|5603971|P1|NOT COMPLETED|Test Dose Phase||0
2282637|NCT02161185|5603971|P1|COMPLETED|Test Dose Phase||7
2282638|NCT02161185|5603971|P1|STARTED|Test Dose Phase||7
2282639|NCT02161146|5603981|P5|NOT COMPLETED|Overall Study||1
2282640|NCT02161146|5603982|P4|NOT COMPLETED|Overall Study||3
2282641|NCT02161146|5603983|P3|NOT COMPLETED|Overall Study||0
2282642|NCT02161146|5603984|P2|NOT COMPLETED|Overall Study||4
2282643|NCT02161146|5603985|P1|NOT COMPLETED|Overall Study||1
2282644|NCT02161146|5603981|P5|COMPLETED|Overall Study||48
2282645|NCT02161146|5603982|P4|COMPLETED|Overall Study||45
2282646|NCT02161146|5603983|P3|COMPLETED|Overall Study||49
2282647|NCT02161146|5603984|P2|COMPLETED|Overall Study||43
2282648|NCT02161146|5603985|P1|COMPLETED|Overall Study||46
2282649|NCT02161146|5603981|P5|STARTED|Overall Study||49
2282650|NCT02161146|5603982|P4|STARTED|Overall Study||48
2282651|NCT02161146|5603983|P3|STARTED|Overall Study||49
2282652|NCT02161146|5603984|P2|STARTED|Overall Study||47
2282653|NCT02161146|5603985|P1|STARTED|Overall Study||47
2282654|NCT02161016|5603998|P1|NOT COMPLETED|Overall Study||1
2282655|NCT02161016|5603998|P1|COMPLETED|Overall Study||0
2282656|NCT02161016|5603998|P1|STARTED|Overall Study||1
2282657|NCT02160990|5604008|P2|NOT COMPLETED|Overall Study||0
2282658|NCT02160990|5604009|P1|NOT COMPLETED|Overall Study||0
2282659|NCT02160990|5604008|P2|COMPLETED|Overall Study||10
2282660|NCT02160990|5604009|P1|COMPLETED|Overall Study||10
2282661|NCT02160990|5604008|P2|STARTED|Overall Study||10
2282662|NCT02160990|5604009|P1|STARTED|Overall Study||10
2282663|NCT02160977|5604029|P2|NOT COMPLETED|Six Months After Surgery||1
2282664|NCT02160977|5604030|P1|NOT COMPLETED|Six Months After Surgery||2
2282665|NCT02160977|5604029|P2|COMPLETED|Six Months After Surgery||42
2282666|NCT02160977|5604030|P1|COMPLETED|Six Months After Surgery||42
2282667|NCT02160977|5604029|P2|STARTED|Six Months After Surgery||43
2282668|NCT02160977|5604030|P1|STARTED|Six Months After Surgery||44
2282669|NCT02160977|5604029|P2|NOT COMPLETED|Three Months After Surgery||2
2282670|NCT02160977|5604030|P1|NOT COMPLETED|Three Months After Surgery||0
2282671|NCT02160977|5604029|P2|COMPLETED|Three Months After Surgery||43
2282672|NCT02160977|5604030|P1|COMPLETED|Three Months After Surgery||44
2282673|NCT02160977|5604029|P2|STARTED|Three Months After Surgery||45
2282674|NCT02160977|5604030|P1|STARTED|Three Months After Surgery||44
2282675|NCT02160977|5604029|P2|NOT COMPLETED|Six Weeks After Surgery||0
2282676|NCT02160977|5604030|P1|NOT COMPLETED|Six Weeks After Surgery||1
2282677|NCT02160977|5604029|P2|COMPLETED|Six Weeks After Surgery||45
2282678|NCT02160977|5604030|P1|COMPLETED|Six Weeks After Surgery||44
2282679|NCT02160977|5604029|P2|STARTED|Six Weeks After Surgery||45
2282680|NCT02160977|5604030|P1|STARTED|Six Weeks After Surgery||45
2282681|NCT02160977|5604029|P2|NOT COMPLETED|One Week After Surgery||0
2282682|NCT02160977|5604030|P1|NOT COMPLETED|One Week After Surgery||0
2282683|NCT02160977|5604029|P2|COMPLETED|One Week After Surgery||45
2282684|NCT02160977|5604030|P1|COMPLETED|One Week After Surgery||45
2282685|NCT02160977|5604029|P2|STARTED|One Week After Surgery||45
2282686|NCT02160977|5604030|P1|STARTED|One Week After Surgery||45
2282687|NCT02160899|5604046|P6|NOT COMPLETED|Overall Study||0
2282688|NCT02160899|5604047|P5|NOT COMPLETED|Overall Study||2
2282689|NCT02160899|5604048|P4|NOT COMPLETED|Overall Study||1
2282690|NCT02160899|5604049|P3|NOT COMPLETED|Overall Study||0
2282691|NCT02160899|5604050|P2|NOT COMPLETED|Overall Study||1
2282692|NCT02160899|5604051|P1|NOT COMPLETED|Overall Study||0
2282693|NCT02160899|5604046|P6|COMPLETED|Overall Study||8
2282694|NCT02160899|5604047|P5|COMPLETED|Overall Study||0
2282695|NCT02160899|5604048|P4|COMPLETED|Overall Study||2
2282696|NCT02160899|5604049|P3|COMPLETED|Overall Study||21
2282697|NCT02160899|5604050|P2|COMPLETED|Overall Study||3
2282698|NCT02160899|5604051|P1|COMPLETED|Overall Study||26
2282699|NCT02160899|5604046|P6|STARTED|Overall Study||8
2282700|NCT02160899|5604047|P5|STARTED|Overall Study||2
2282701|NCT02160899|5604048|P4|STARTED|Overall Study||3
2282702|NCT02160899|5604049|P3|STARTED|Overall Study||21
2282703|NCT02160899|5604050|P2|STARTED|Overall Study||4
2282704|NCT02160899|5604051|P1|STARTED|Overall Study||26
2282705|NCT02160873|5604073|P2|NOT COMPLETED|Overall Study||0
2282706|NCT02160873|5604074|P1|NOT COMPLETED|Overall Study||0
2282707|NCT02160873|5604073|P2|COMPLETED|Overall Study||6
2282708|NCT02160873|5604074|P1|COMPLETED|Overall Study||6
2282709|NCT02160873|5604073|P2|STARTED|Overall Study||6
2282710|NCT02160873|5604074|P1|STARTED|Overall Study||6
2282711|NCT02160847|5604088|P2|NOT COMPLETED|Overall Study||0
2282712|NCT02160847|5604089|P1|NOT COMPLETED|Overall Study||0
2282713|NCT02160847|5604088|P2|COMPLETED|Overall Study||16
2282714|NCT02160847|5604089|P1|COMPLETED|Overall Study||16
2282715|NCT02160847|5604088|P2|STARTED|Overall Study||16
2282716|NCT02160847|5604089|P1|STARTED|Overall Study||16
2282717|NCT02160626|5604100|P3|NOT COMPLETED|Overall Study||1
2282718|NCT02160626|5604101|P2|NOT COMPLETED|Overall Study||1
2282719|NCT02160626|5604102|P1|NOT COMPLETED|Overall Study||1
2282720|NCT02160626|5604100|P3|COMPLETED|Overall Study||56
2282721|NCT02160626|5604101|P2|COMPLETED|Overall Study||56
2282722|NCT02160626|5604102|P1|COMPLETED|Overall Study||57
2282723|NCT02160626|5604100|P3|STARTED|Overall Study||57
2282724|NCT02160626|5604101|P2|STARTED|Overall Study||57
2282725|NCT02160626|5604102|P1|STARTED|Overall Study||58
2282726|NCT02160535|5604116|P1|NOT COMPLETED|Overall Study||3
2282727|NCT02160535|5604116|P1|COMPLETED|Overall Study||10
2282728|NCT02160535|5604116|P1|STARTED|Overall Study||13
2282729|NCT02160314|5604125|P2|NOT COMPLETED|Overall Study||13
2282730|NCT02160314|5604126|P1|NOT COMPLETED|Overall Study||1
2282731|NCT02160314|5604125|P2|COMPLETED|Overall Study||59
2282732|NCT02160314|5604126|P1|COMPLETED|Overall Study||72
2282733|NCT02160314|5604125|P2|STARTED|Overall Study||72
2282734|NCT02160314|5604126|P1|STARTED|Overall Study||73
2282735|NCT02160145|5604134|P3|NOT COMPLETED|Randomized Double-blind Period||28
2282736|NCT02160145|5604135|P2|NOT COMPLETED|Randomized Double-blind Period||29
2282737|NCT02160145|5604136|P1|NOT COMPLETED|Randomized Double-blind Period||0
2282738|NCT02160145|5604134|P3|COMPLETED|Randomized Double-blind Period||659
2282739|NCT02160145|5604135|P2|COMPLETED|Randomized Double-blind Period||654
2282740|NCT02160145|5604136|P1|COMPLETED|Randomized Double-blind Period||0
2282741|NCT02160145|5604134|P3|Off-treatment Completers|Randomized Double-blind Period||22
2282742|NCT02160145|5604135|P2|Off-treatment Completers|Randomized Double-blind Period||76
2282743|NCT02160145|5604136|P1|Off-treatment Completers|Randomized Double-blind Period||0
2282744|NCT02160145|5604134|P3|On-treatment Completers|Randomized Double-blind Period||637
2282745|NCT02160145|5604135|P2|On-treatment Completers|Randomized Double-blind Period||578
2282746|NCT02160145|5604136|P1|On-treatment Completers|Randomized Double-blind Period||0
2282747|NCT02160145|5604134|P3|STARTED|Randomized Double-blind Period|Subjects completed the single-blind period and were randomized to receive placebo.|687
2282748|NCT02160145|5604135|P2|STARTED|Randomized Double-blind Period|Subjects completed the single-blind period and were randomized to receive tolvaptan.|683
2282749|NCT02160145|5604136|P1|STARTED|Randomized Double-blind Period|1370 subjects were randomized to receive tolvaptan or placebo in the double-blind period.|0
2282750|NCT02160145|5604134|P3|NOT COMPLETED|Prerandomization Single-blind Period||0
2282751|NCT02160145|5604135|P2|NOT COMPLETED|Prerandomization Single-blind Period||0
2282752|NCT02160145|5604136|P1|NOT COMPLETED|Prerandomization Single-blind Period||149
2282753|NCT02160145|5604134|P3|COMPLETED|Prerandomization Single-blind Period||0
2282754|NCT02160145|5604135|P2|COMPLETED|Prerandomization Single-blind Period||0
2282755|NCT02160145|5604136|P1|COMPLETED|Prerandomization Single-blind Period||1370
2282756|NCT02160145|5604134|P3|Randomized|Prerandomization Single-blind Period||0
2282757|NCT02160145|5604135|P2|Randomized|Prerandomization Single-blind Period||0
2282758|NCT02160145|5604136|P1|Randomized|Prerandomization Single-blind Period||1370
2282759|NCT02160145|5604134|P3|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||0
2282760|NCT02160145|5604135|P2|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||0
2282761|NCT02160145|5604136|P1|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||1491
2282762|NCT02160145|5604134|P3|Treated in Placebo Run-in|Prerandomization Single-blind Period||0
2282763|NCT02160145|5604135|P2|Treated in Placebo Run-in|Prerandomization Single-blind Period||0
2282764|NCT02160145|5604136|P1|Treated in Placebo Run-in|Prerandomization Single-blind Period||1514
2282765|NCT02160145|5604134|P3|STARTED|Prerandomization Single-blind Period||0
2282766|NCT02160145|5604135|P2|STARTED|Prerandomization Single-blind Period||0
2282767|NCT02160145|5604136|P1|STARTED|Prerandomization Single-blind Period||1519
2282768|NCT02160041|5604149|P1|NOT COMPLETED|Overall Study||84
2282769|NCT02160041|5604149|P1|COMPLETED|Overall Study||0
2282770|NCT02160041|5604149|P1|STARTED|Overall Study||84
2282771|NCT02160002|5604161|P2|NOT COMPLETED|Overall Study||1
2282772|NCT02160002|5604162|P1|NOT COMPLETED|Overall Study||2
2282773|NCT02160002|5604161|P2|COMPLETED|Overall Study||178
2282774|NCT02160002|5604162|P1|COMPLETED|Overall Study||185
2282775|NCT02160002|5604161|P2|Primary Outcome|Overall Study||178
2282776|NCT02160002|5604162|P1|Primary Outcome|Overall Study||185
2282777|NCT02160002|5604161|P2|STARTED|Overall Study||179
2282778|NCT02160002|5604162|P1|STARTED|Overall Study||187
2282779|NCT02159976|5604194|P2|NOT COMPLETED|Overall Study||25
2282780|NCT02159976|5604195|P1|NOT COMPLETED|Overall Study||30
2282781|NCT02159976|5604194|P2|COMPLETED|Overall Study||170
2282782|NCT02159976|5604195|P1|COMPLETED|Overall Study||165
2282783|NCT02159976|5604194|P2|STARTED|Overall Study||195
2282784|NCT02159976|5604195|P1|STARTED|Overall Study||195
2282785|NCT02159950|5604209|P2|NOT COMPLETED|Overall Study||2
2282786|NCT02159950|5604210|P1|NOT COMPLETED|Overall Study||0
2282787|NCT02159950|5604209|P2|COMPLETED|Overall Study||0
2282788|NCT02159950|5604210|P1|COMPLETED|Overall Study||0
2282789|NCT02159950|5604209|P2|STARTED|Overall Study||2
2282790|NCT02159950|5604210|P1|STARTED|Overall Study||0
2282791|NCT02159898|5604244|P2|NOT COMPLETED|Overall Study||0
2282792|NCT02159898|5604245|P1|NOT COMPLETED|Overall Study||1
2282793|NCT02159898|5604244|P2|COMPLETED|Overall Study||30
2282794|NCT02159898|5604245|P1|COMPLETED|Overall Study||29
2282795|NCT02159898|5604244|P2|STARTED|Overall Study||30
2282796|NCT02159898|5604245|P1|STARTED|Overall Study||30
2282797|NCT02159859|5604253|P1|NOT COMPLETED|Overall Study||0
2282798|NCT02159859|5604253|P1|COMPLETED|Overall Study||7
2282799|NCT02159859|5604253|P1|STARTED|Overall Study||7
2282800|NCT02159807|5604269|P3|NOT COMPLETED|Overall Study||3
2282801|NCT02159807|5604270|P2|NOT COMPLETED|Overall Study||1
2282802|NCT02159807|5604271|P1|NOT COMPLETED|Overall Study||1
2282803|NCT02159807|5604269|P3|COMPLETED|Overall Study||48
2282804|NCT02159807|5604270|P2|COMPLETED|Overall Study||51
2282805|NCT02159807|5604271|P1|COMPLETED|Overall Study||66
2282806|NCT02159807|5604269|P3|STARTED|Overall Study||51
2282807|NCT02159807|5604270|P2|STARTED|Overall Study||52
2282808|NCT02159807|5604271|P1|STARTED|Overall Study||67
2282809|NCT02159768|5604285|P1|NOT COMPLETED|Overall Study||0
2282810|NCT02159768|5604285|P1|COMPLETED|Overall Study|Completed 27 July 2015|30
2282811|NCT02159768|5604285|P1|STARTED|Overall Study|Started 16 July 2014|30
2282818|NCT02159703|5604305|P1|NOT COMPLETED|Overall Study||0
2282819|NCT02159703|5604305|P1|COMPLETED|Overall Study||60
2282820|NCT02159703|5604305|P1|STARTED|Overall Study||60
2282821|NCT02159547|5604311|P2|NOT COMPLETED|Overall Study||0
2282822|NCT02159547|5604312|P1|NOT COMPLETED|Overall Study||0
2282823|NCT02159547|5604311|P2|COMPLETED|Overall Study||112
2282824|NCT02159547|5604312|P1|COMPLETED|Overall Study||112
2282825|NCT02159547|5604311|P2|STARTED|Overall Study||112
2282826|NCT02159547|5604312|P1|STARTED|Overall Study||112
2282831|NCT02159482|5604341|P1|NOT COMPLETED|Overall Study||5
2282832|NCT02159482|5604341|P1|COMPLETED|Overall Study||6
2282833|NCT02159482|5604341|P1|STARTED|Overall Study||11
2282834|NCT02159469|5604346|P1|NOT COMPLETED|Overall Study||53
2282835|NCT02159469|5604346|P1|COMPLETED|Overall Study||97
2282836|NCT02159469|5604346|P1|Completed 12 Week|Overall Study||137
2282837|NCT02159469|5604346|P1|STARTED|Overall Study||150
2282838|NCT02159365|5604351|P1|NOT COMPLETED|Overall Study||70
2282839|NCT02159365|5604351|P1|COMPLETED|Overall Study|Completed = Still on treatment|0
2282840|NCT02159365|5604351|P1|STARTED|Overall Study||70
2282841|NCT02159352|5604358|P2|NOT COMPLETED|Overall Study||2
2282842|NCT02159352|5604359|P1|NOT COMPLETED|Overall Study||3
2282843|NCT02159352|5604358|P2|COMPLETED|Overall Study||12
2282844|NCT02159352|5604359|P1|COMPLETED|Overall Study||11
2282845|NCT02159352|5604358|P2|Phase 2 (Day 5-14)|Overall Study||12
2282846|NCT02159352|5604359|P1|Phase 2 (Day 5-14)|Overall Study||11
2282847|NCT02159352|5604358|P2|Phase 1 (Day 1- 4)|Overall Study||14
2282848|NCT02159352|5604359|P1|Phase 1 (Day 1- 4)|Overall Study||14
2282849|NCT02159352|5604358|P2|STARTED|Overall Study||14
2282850|NCT02159352|5604359|P1|STARTED|Overall Study||14
2282851|NCT02159183|5604411|P2|NOT COMPLETED|Analysis of Primary Endpoint (12 Mts)||1
2282852|NCT02159183|5604412|P1|NOT COMPLETED|Analysis of Primary Endpoint (12 Mts)||3
2282853|NCT02159183|5604411|P2|COMPLETED|Analysis of Primary Endpoint (12 Mts)||20
2282854|NCT02159183|5604412|P1|COMPLETED|Analysis of Primary Endpoint (12 Mts)||19
2282855|NCT02159183|5604411|P2|STARTED|Analysis of Primary Endpoint (12 Mts)||21
2282856|NCT02159183|5604412|P1|STARTED|Analysis of Primary Endpoint (12 Mts)||22
2282857|NCT02159183|5604411|P2|NOT COMPLETED|Analysis After the 36 Months Follow-up||2
2282858|NCT02159183|5604412|P1|NOT COMPLETED|Analysis After the 36 Months Follow-up||3
2282859|NCT02159183|5604411|P2|COMPLETED|Analysis After the 36 Months Follow-up||19
2282860|NCT02159183|5604412|P1|COMPLETED|Analysis After the 36 Months Follow-up||19
2282861|NCT02159183|5604411|P2|STARTED|Analysis After the 36 Months Follow-up||21
2282862|NCT02159183|5604412|P1|STARTED|Analysis After the 36 Months Follow-up||22
2282863|NCT02159118|5604438|P2|NOT COMPLETED|Overall Study||0
2282864|NCT02159118|5604439|P1|NOT COMPLETED|Overall Study||0
2282865|NCT02159118|5604438|P2|COMPLETED|Overall Study||22
2282866|NCT02159118|5604439|P1|COMPLETED|Overall Study||22
2282867|NCT02159118|5604438|P2|STARTED|Overall Study||22
2282868|NCT02159118|5604439|P1|STARTED|Overall Study||22
2282869|NCT02159079|5604463|P2|NOT COMPLETED|Overall Study||0
2282870|NCT02159079|5604464|P1|NOT COMPLETED|Overall Study||0
2282871|NCT02159079|5604463|P2|COMPLETED|Overall Study||15
2282872|NCT02159079|5604464|P1|COMPLETED|Overall Study||15
2282873|NCT02159079|5604463|P2|STARTED|Overall Study||15
2282874|NCT02159079|5604464|P1|STARTED|Overall Study||15
2282875|NCT02159053|5604485|P3|NOT COMPLETED|Overall Study||20
2282876|NCT02159053|5604486|P2|NOT COMPLETED|Overall Study||21
2282877|NCT02159053|5604487|P1|NOT COMPLETED|Overall Study||20
2282878|NCT02159053|5604485|P3|COMPLETED|Overall Study||97
2282879|NCT02159053|5604486|P2|COMPLETED|Overall Study||96
2282880|NCT02159053|5604487|P1|COMPLETED|Overall Study||96
2282881|NCT02159053|5604485|P3|Paticipants Week 16 Onwards|Overall Study||113
2282882|NCT02159053|5604486|P2|Paticipants Week 16 Onwards|Overall Study||117
2282883|NCT02159053|5604487|P1|Paticipants Week 16 Onwards|Overall Study||116
2282884|NCT02159053|5604485|P3|STARTED|Overall Study||117
2282885|NCT02159053|5604486|P2|STARTED|Overall Study||117
2282886|NCT02159053|5604487|P1|STARTED|Overall Study||116
2282887|NCT02159040|5604524|P1|NOT COMPLETED|Overall Study||1
2282888|NCT02159040|5604524|P1|COMPLETED|Overall Study||0
2282889|NCT02159040|5604524|P1|STARTED|Overall Study||1
2282890|NCT02158975|5604537|P1|NOT COMPLETED|Overall Study||1
2282891|NCT02158975|5604537|P1|COMPLETED|Overall Study||12
2282892|NCT02158975|5604537|P1|STARTED|Overall Study||13
2282893|NCT02158936|5604547|P2|NOT COMPLETED|Overall Study||177
2282894|NCT02158936|5604548|P1|NOT COMPLETED|Overall Study||179
2282895|NCT02158936|5604547|P2|COMPLETED|Overall Study||0
2282896|NCT02158936|5604548|P1|COMPLETED|Overall Study||0
2282897|NCT02158936|5604547|P2|Untreated|Overall Study||0
2282898|NCT02158936|5604548|P1|Untreated|Overall Study||2
2282899|NCT02158936|5604547|P2|Treated|Overall Study||177
2282900|NCT02158936|5604548|P1|Treated|Overall Study||177
2282901|NCT02158936|5604547|P2|STARTED|Overall Study||177
2282902|NCT02158936|5604548|P1|STARTED|Overall Study||179
2282903|NCT02158884|5604590|P1|NOT COMPLETED|12 Month Assessment||17
2282904|NCT02158884|5604590|P1|COMPLETED|12 Month Assessment||64
2282905|NCT02158884|5604590|P1|STARTED|12 Month Assessment||81
2282906|NCT02158884|5604590|P1|NOT COMPLETED|6 Month Assessment||20
2282907|NCT02158884|5604590|P1|COMPLETED|6 Month Assessment||61
2282908|NCT02158884|5604590|P1|STARTED|6 Month Assessment||81
2282909|NCT02158884|5604590|P1|NOT COMPLETED|Post Intervention (~4 Weeks)||10
2282910|NCT02158884|5604590|P1|COMPLETED|Post Intervention (~4 Weeks)||71
2282911|NCT02158884|5604590|P1|STARTED|Post Intervention (~4 Weeks)||81
2282912|NCT02158884|5604590|P1|NOT COMPLETED|Intervention: IDEO and PT Program||6
2282913|NCT02158884|5604590|P1|COMPLETED|Intervention: IDEO and PT Program||81
2282914|NCT02158884|5604590|P1|STARTED|Intervention: IDEO and PT Program||87
2282915|NCT02158884|5604590|P1|NOT COMPLETED|Baseline Assessment||4
2282916|NCT02158884|5604590|P1|COMPLETED|Baseline Assessment||87
2282917|NCT02158884|5604590|P1|STARTED|Baseline Assessment||91
2282918|NCT02158806|5604625|P2|NOT COMPLETED|Overall Study||5
2282919|NCT02158806|5604626|P1|NOT COMPLETED|Overall Study||4
2282920|NCT02158806|5604625|P2|COMPLETED|Overall Study|We had information on all participants for the primary outcome (time to complete healing).|121
2282921|NCT02158806|5604626|P1|COMPLETED|Overall Study|We had information on all participants for the primary outcome (time to complete healing).|121
2282922|NCT02158806|5604625|P2|STARTED|Overall Study||126
2282923|NCT02158806|5604626|P1|STARTED|Overall Study||125
2282924|NCT02158728|5604646|P1|NOT COMPLETED|Overall Study||27
2282925|NCT02158728|5604646|P1|COMPLETED|Overall Study||53
2282926|NCT02158728|5604646|P1|STARTED|Overall Study||80
2282927|NCT02158572|5604650|P1|NOT COMPLETED|Overall Study||1043
2282928|NCT02158572|5604650|P1|COMPLETED|Overall Study||989
2282929|NCT02158572|5604650|P1|STARTED|Overall Study||2032
2282930|NCT02158546|5604665|P4|NOT COMPLETED|Overall Study||6
2282931|NCT02158546|5604666|P3|NOT COMPLETED|Overall Study||4
2282932|NCT02158546|5604667|P2|NOT COMPLETED|Overall Study||17
2282933|NCT02158546|5604668|P1|NOT COMPLETED|Overall Study||19
2282934|NCT02158546|5604665|P4|COMPLETED|Overall Study||13
2282935|NCT02158546|5604666|P3|COMPLETED|Overall Study||14
2282936|NCT02158546|5604667|P2|COMPLETED|Overall Study||136
2282937|NCT02158546|5604668|P1|COMPLETED|Overall Study||133
2282938|NCT02158546|5604665|P4|STARTED|Overall Study||19
2282939|NCT02158546|5604666|P3|STARTED|Overall Study||18
2282940|NCT02158546|5604667|P2|STARTED|Overall Study||153
2282941|NCT02158546|5604668|P1|STARTED|Overall Study||152
2282942|NCT02158533|5604687|P6|NOT COMPLETED|Stage 2||6
2282943|NCT02158533|5604688|P5|NOT COMPLETED|Stage 2||4
2282944|NCT02158533|5604689|P4|NOT COMPLETED|Stage 2||3
2282945|NCT02158533|5604690|P3|NOT COMPLETED|Stage 2||0
2282946|NCT02158533|5604691|P2|NOT COMPLETED|Stage 2||0
2282947|NCT02158533|5604692|P1|NOT COMPLETED|Stage 2||0
2282948|NCT02158533|5604687|P6|COMPLETED|Stage 2||50
2282949|NCT02158533|5604688|P5|COMPLETED|Stage 2||52
2282950|NCT02158533|5604689|P4|COMPLETED|Stage 2||53
2282951|NCT02158533|5604690|P3|COMPLETED|Stage 2||0
2282952|NCT02158533|5604691|P2|COMPLETED|Stage 2||0
2282953|NCT02158533|5604692|P1|COMPLETED|Stage 2||0
2282954|NCT02158533|5604687|P6|STARTED|Stage 2||56
2282955|NCT02158533|5604688|P5|STARTED|Stage 2||56
2282956|NCT02158533|5604689|P4|STARTED|Stage 2||56
2282957|NCT02158533|5604690|P3|STARTED|Stage 2||0
2282958|NCT02158533|5604691|P2|STARTED|Stage 2||0
2282959|NCT02158533|5604692|P1|STARTED|Stage 2||0
2282960|NCT02158533|5604687|P6|NOT COMPLETED|Stage 1||0
2282961|NCT02158533|5604688|P5|NOT COMPLETED|Stage 1||0
2282962|NCT02158533|5604689|P4|NOT COMPLETED|Stage 1||0
2282963|NCT02158533|5604690|P3|NOT COMPLETED|Stage 1||8
2282964|NCT02158533|5604691|P2|NOT COMPLETED|Stage 1||8
2282965|NCT02158533|5604692|P1|NOT COMPLETED|Stage 1||14
2282966|NCT02158533|5604687|P6|COMPLETED|Stage 1||0
2282967|NCT02158533|5604688|P5|COMPLETED|Stage 1||0
2282968|NCT02158533|5604689|P4|COMPLETED|Stage 1||0
2282969|NCT02158533|5604690|P3|COMPLETED|Stage 1||52
2282970|NCT02158533|5604691|P2|COMPLETED|Stage 1||51
2282971|NCT02158533|5604692|P1|COMPLETED|Stage 1||251
2282972|NCT02158533|5604687|P6|STARTED|Stage 1||0
2282973|NCT02158533|5604688|P5|STARTED|Stage 1||0
2282974|NCT02158533|5604689|P4|STARTED|Stage 1||0
2282975|NCT02158533|5604690|P3|STARTED|Stage 1||60
2282976|NCT02158533|5604691|P2|STARTED|Stage 1||59
2282977|NCT02158533|5604692|P1|STARTED|Stage 1||265
2282978|NCT02158520|5604726|P2|NOT COMPLETED|Overall Study||0
2282979|NCT02158520|5604727|P1|NOT COMPLETED|Overall Study||0
2282980|NCT02158520|5604726|P2|COMPLETED|Overall Study||12
2282981|NCT02158520|5604727|P1|COMPLETED|Overall Study||12
2282982|NCT02158520|5604726|P2|Crossover Cohort|Overall Study||6
2282983|NCT02158520|5604727|P1|Crossover Cohort|Overall Study||4
2282984|NCT02158520|5604726|P2|Eligible for Crossover With AE Evaluated|Overall Study||7
2282985|NCT02158520|5604727|P1|Eligible for Crossover With AE Evaluated|Overall Study||7
2282986|NCT02158520|5604726|P2|Eligible for Crossover|Overall Study||8
2282987|NCT02158520|5604727|P1|Eligible for Crossover|Overall Study||8
2282988|NCT02158520|5604726|P2|AE Evaluated Prior to Crossover|Overall Study||12
2282989|NCT02158520|5604727|P1|AE Evaluated Prior to Crossover|Overall Study||12
2282990|NCT02158520|5604726|P2|STARTED|Overall Study||12
2282991|NCT02158520|5604727|P1|STARTED|Overall Study||12
2282992|NCT02158494|5604743|P2|NOT COMPLETED|Overall Study||1
2282993|NCT02158494|5604744|P1|NOT COMPLETED|Overall Study||0
2282994|NCT02158494|5604743|P2|COMPLETED|Overall Study||21
2282995|NCT02158494|5604744|P1|COMPLETED|Overall Study||22
2282996|NCT02158494|5604743|P2|STARTED|Overall Study||22
2282997|NCT02158494|5604744|P1|STARTED|Overall Study||22
2282998|NCT02158442|5604768|P2|NOT COMPLETED|Overall Study||0
2282999|NCT02158442|5604769|P1|NOT COMPLETED|Overall Study||2
2283000|NCT02158442|5604768|P2|COMPLETED|Overall Study||7
2283001|NCT02158442|5604769|P1|COMPLETED|Overall Study||6
2283002|NCT02158442|5604768|P2|STARTED|Overall Study||7
2283003|NCT02158442|5604769|P1|STARTED|Overall Study||8
2283004|NCT02158364|5604775|P1|NOT COMPLETED|Overall Study||60
2283005|NCT02158364|5604775|P1|COMPLETED|Overall Study||3271
2283006|NCT02158364|5604775|P1|STARTED|Overall Study||3331
2283007|NCT02158273|5604782|P2|NOT COMPLETED|Overall Study||3
2283008|NCT02158273|5604783|P1|NOT COMPLETED|Overall Study||3
2283009|NCT02158273|5604782|P2|COMPLETED|Overall Study||22
2283010|NCT02158273|5604783|P1|COMPLETED|Overall Study||22
2283011|NCT02158273|5604782|P2|STARTED|Overall Study||25
2283012|NCT02158273|5604783|P1|STARTED|Overall Study||25
2283013|NCT02158247|5604793|P1|NOT COMPLETED|Overall Study||5
2283014|NCT02158247|5604793|P1|COMPLETED|Overall Study||176
2283015|NCT02158247|5604793|P1|STARTED|Overall Study||181
2283016|NCT02158091|5604812|P3|NOT COMPLETED|Overall Study||0
2283017|NCT02158091|5604813|P2|NOT COMPLETED|Overall Study||1
2283018|NCT02158091|5604814|P1|NOT COMPLETED|Overall Study||2
2283019|NCT02158091|5604812|P3|COMPLETED|Overall Study||20
2283020|NCT02158091|5604813|P2|COMPLETED|Overall Study||5
2283021|NCT02158091|5604814|P1|COMPLETED|Overall Study||4
2283022|NCT02158091|5604812|P3|STARTED|Overall Study||20
2283023|NCT02158091|5604813|P2|STARTED|Overall Study||6
2283024|NCT02158091|5604814|P1|STARTED|Overall Study||6
2283025|NCT02158039|5604822|P1|NOT COMPLETED|Overall Study||10
2283026|NCT02158039|5604822|P1|COMPLETED|Overall Study||23
2283027|NCT02158039|5604822|P1|STARTED|Overall Study||33
2283028|NCT02157948|5604829|P2|NOT COMPLETED|Overall Study||9
2283029|NCT02157948|5604830|P1|NOT COMPLETED|Overall Study||9
2283030|NCT02157948|5604829|P2|COMPLETED|Overall Study||188
2283031|NCT02157948|5604830|P1|COMPLETED|Overall Study||188
2283032|NCT02157948|5604829|P2|Received Treatment|Overall Study||196
2283033|NCT02157948|5604830|P1|Received Treatment|Overall Study||196
2283034|NCT02157948|5604829|P2|STARTED|Overall Study||197
2283035|NCT02157948|5604830|P1|STARTED|Overall Study||197
2283036|NCT02157935|5604842|P2|NOT COMPLETED|Overall Study||65
2283037|NCT02157935|5604843|P1|NOT COMPLETED|Overall Study||39
2283038|NCT02157935|5604842|P2|COMPLETED|Overall Study||548
2283039|NCT02157935|5604843|P1|COMPLETED|Overall Study||567
2283040|NCT02157935|5604842|P2|STARTED|Overall Study||613
2283041|NCT02157935|5604843|P1|STARTED|Overall Study||606
2283042|NCT02157909|5604861|P2|NOT COMPLETED|Overall Study||0
2283043|NCT02157909|5604862|P1|NOT COMPLETED|Overall Study||0
2283044|NCT02157909|5604861|P2|COMPLETED|Overall Study||66
2283045|NCT02157909|5604862|P1|COMPLETED|Overall Study||66
2283046|NCT02157909|5604861|P2|STARTED|Overall Study||66
2283047|NCT02157909|5604862|P1|STARTED|Overall Study||66
2283048|NCT02157883|5604869|P1|NOT COMPLETED|Part B: Day 19 to End Part B (AZD9291)||22
2283049|NCT02157883|5604869|P1|COMPLETED|Part B: Day 19 to End Part B (AZD9291)||16
2283050|NCT02157883|5604869|P1|STARTED|Part B: Day 19 to End Part B (AZD9291)||38
2283051|NCT02157883|5604869|P1|NOT COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||1
2283052|NCT02157883|5604869|P1|COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||38
2283053|NCT02157883|5604869|P1|STARTED|Part A: Day 6-18 (AZD9291+Itraconozole)||39
2283054|NCT02157883|5604869|P1|NOT COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||0
2283055|NCT02157883|5604869|P1|COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||39
2283056|NCT02157883|5604869|P1|STARTED|Part A: Day 1-5 (AZD9291 Alone)||39
2283057|NCT02157623|5604900|P2|NOT COMPLETED|Overall Study||3
2283058|NCT02157623|5604901|P1|NOT COMPLETED|Overall Study||4
2283059|NCT02157623|5604900|P2|COMPLETED|Overall Study||0
2283060|NCT02157623|5604901|P1|COMPLETED|Overall Study||0
2283061|NCT02157623|5604900|P2|STARTED|Overall Study||3
2283062|NCT02157623|5604901|P1|STARTED|Overall Study||4
2283063|NCT02157519|5604909|P2|NOT COMPLETED|Overall Study||1
2283064|NCT02157519|5604910|P1|NOT COMPLETED|Overall Study||11
2283065|NCT02157519|5604909|P2|COMPLETED|Overall Study||89
2283066|NCT02157519|5604910|P1|COMPLETED|Overall Study||80
2283067|NCT02157519|5604909|P2|MEMScap Collected|Overall Study||86
2283068|NCT02157519|5604910|P1|MEMScap Collected|Overall Study||84
2283069|NCT02157519|5604909|P2|STARTED|Overall Study||90
2283070|NCT02157519|5604910|P1|STARTED|Overall Study||91
2283071|NCT02157506|5604933|P5|NOT COMPLETED|Overall Study||0
2283072|NCT02157506|5604934|P4|NOT COMPLETED|Overall Study||0
2283073|NCT02157506|5604935|P3|NOT COMPLETED|Overall Study||1
2283074|NCT02157506|5604936|P2|NOT COMPLETED|Overall Study||1
2283075|NCT02157506|5604937|P1|NOT COMPLETED|Overall Study||0
2283076|NCT02157506|5604933|P5|COMPLETED|Overall Study||7
2283077|NCT02157506|5604934|P4|COMPLETED|Overall Study||12
2283078|NCT02157506|5604935|P3|COMPLETED|Overall Study||8
2283079|NCT02157506|5604936|P2|COMPLETED|Overall Study||5
2283080|NCT02157506|5604937|P1|COMPLETED|Overall Study||12
2283081|NCT02157506|5604933|P5|STARTED|Overall Study||7
2283082|NCT02157506|5604934|P4|STARTED|Overall Study||12
2283083|NCT02157506|5604935|P3|STARTED|Overall Study||9
2283084|NCT02157506|5604936|P2|STARTED|Overall Study||6
2283085|NCT02157506|5604937|P1|STARTED|Overall Study||12
2283086|NCT02157376|5604996|P2|NOT COMPLETED|Overall Study||18
2283087|NCT02157376|5604997|P1|NOT COMPLETED|Overall Study||22
2283088|NCT02157376|5604996|P2|COMPLETED|Overall Study||138
2283089|NCT02157376|5604997|P1|COMPLETED|Overall Study||133
2283090|NCT02157376|5604996|P2|STARTED|Overall Study||156
2283091|NCT02157376|5604997|P1|STARTED|Overall Study||155
2283092|NCT02157298|5605007|P2|NOT COMPLETED|Overall Study||2
2283093|NCT02157298|5605008|P1|NOT COMPLETED|Overall Study||4
2283094|NCT02157298|5605007|P2|COMPLETED|Overall Study||58
2283095|NCT02157298|5605008|P1|COMPLETED|Overall Study||119
2283096|NCT02157298|5605007|P2|STARTED|Overall Study||60
2283097|NCT02157298|5605008|P1|STARTED|Overall Study||123
2283098|NCT02157168|5605025|P3|NOT COMPLETED|Overall Study||0
2283099|NCT02157168|5605026|P2|NOT COMPLETED|Overall Study||0
2283100|NCT02157168|5605027|P1|NOT COMPLETED|Overall Study||0
2283101|NCT02157168|5605025|P3|COMPLETED|Overall Study||1362
2283102|NCT02157168|5605026|P2|COMPLETED|Overall Study||159
2283103|NCT02157168|5605027|P1|COMPLETED|Overall Study||746
2283104|NCT02157168|5605025|P3|STARTED|Overall Study||1362
2283105|NCT02157168|5605026|P2|STARTED|Overall Study||159
2283106|NCT02157168|5605027|P1|STARTED|Overall Study||746
2283107|NCT02157116|5605047|P1|NOT COMPLETED|Overall Study||9
2283108|NCT02157116|5605047|P1|COMPLETED|Overall Study||4
2283109|NCT02157116|5605047|P1|STARTED|Overall Study|signed consent form|13
2283110|NCT02157103|5605056|P1|NOT COMPLETED|Overall Study||0
2283111|NCT02157103|5605056|P1|COMPLETED|Overall Study||3
2283112|NCT02157103|5605056|P1|STARTED|Overall Study||3
2283116|NCT02156492|5605073|P3|NOT COMPLETED|Period 3||0
2283117|NCT02156492|5605074|P2|NOT COMPLETED|Period 3||1
2283118|NCT02156492|5605075|P1|NOT COMPLETED|Period 3||0
2283119|NCT02156492|5605073|P3|COMPLETED|Period 3||22
2283120|NCT02156492|5605074|P2|COMPLETED|Period 3||22
2283121|NCT02156492|5605075|P1|COMPLETED|Period 3||0
2283122|NCT02156492|5605073|P3|STARTED|Period 3||22
2283123|NCT02156492|5605074|P2|STARTED|Period 3||23
2283124|NCT02156492|5605075|P1|STARTED|Period 3|Cohort A participated in Period 1 and Period 2 only.|0
2283125|NCT02156492|5605073|P3|NOT COMPLETED|Period 2||0
2283126|NCT02156492|5605074|P2|NOT COMPLETED|Period 2||0
2283127|NCT02156492|5605075|P1|NOT COMPLETED|Period 2||0
2283128|NCT02156492|5605073|P3|COMPLETED|Period 2||22
2283129|NCT02156492|5605074|P2|COMPLETED|Period 2||23
2283130|NCT02156492|5605075|P1|COMPLETED|Period 2||16
2283131|NCT02156492|5605073|P3|STARTED|Period 2||22
2283132|NCT02156492|5605074|P2|STARTED|Period 2||23
2283133|NCT02156492|5605075|P1|STARTED|Period 2||16
2283134|NCT02156492|5605073|P3|NOT COMPLETED|Period 1||0
2283135|NCT02156492|5605074|P2|NOT COMPLETED|Period 1||1
2283136|NCT02156492|5605075|P1|NOT COMPLETED|Period 1||0
2283137|NCT02156492|5605073|P3|COMPLETED|Period 1||22
2283138|NCT02156492|5605074|P2|COMPLETED|Period 1||23
2283139|NCT02156492|5605075|P1|COMPLETED|Period 1||16
2283140|NCT02156492|5605073|P3|Received at Least One Dose of Study Drug|Period 1||22
2283141|NCT02156492|5605074|P2|Received at Least One Dose of Study Drug|Period 1||24
2283142|NCT02156492|5605075|P1|Received at Least One Dose of Study Drug|Period 1||16
2283143|NCT02156492|5605073|P3|STARTED|Period 1||22
2283144|NCT02156492|5605074|P2|STARTED|Period 1||24
2283145|NCT02156492|5605075|P1|STARTED|Period 1||16
2283146|NCT02156466|5605101|P5|NOT COMPLETED|Overall Study||0
2283147|NCT02156466|5605102|P4|NOT COMPLETED|Overall Study||2
2283148|NCT02156466|5605103|P3|NOT COMPLETED|Overall Study||1
2283149|NCT02156466|5605104|P2|NOT COMPLETED|Overall Study||0
2283150|NCT02156466|5605105|P1|NOT COMPLETED|Overall Study||0
2283151|NCT02156466|5605101|P5|COMPLETED|Overall Study||8
2283152|NCT02156466|5605102|P4|COMPLETED|Overall Study||7
2283153|NCT02156466|5605103|P3|COMPLETED|Overall Study||7
2283154|NCT02156466|5605104|P2|COMPLETED|Overall Study||8
2283155|NCT02156466|5605105|P1|COMPLETED|Overall Study||8
2283156|NCT02156466|5605101|P5|STARTED|Overall Study||8
2283157|NCT02156466|5605102|P4|STARTED|Overall Study||9
2283158|NCT02156466|5605103|P3|STARTED|Overall Study||8
2283159|NCT02156466|5605104|P2|STARTED|Overall Study||8
2283160|NCT02156466|5605105|P1|STARTED|Overall Study||8
2283161|NCT02156271|5605286|P2|NOT COMPLETED|Overall Study||3
2283162|NCT02156271|5605287|P1|NOT COMPLETED|Overall Study||4
2283163|NCT02156271|5605286|P2|COMPLETED|Overall Study||10
2283164|NCT02156271|5605287|P1|COMPLETED|Overall Study||22
2283165|NCT02156271|5605286|P2|STARTED|Overall Study||13
2283166|NCT02156271|5605287|P1|STARTED|Overall Study||26
2283167|NCT02156167|5605319|P1|NOT COMPLETED|Overall Study||0
2283168|NCT02156167|5605319|P1|COMPLETED|Overall Study||15
2283169|NCT02156167|5605319|P1|STARTED|Overall Study||15
2283170|NCT02156076|5605327|P4|NOT COMPLETED|Follow-up Period||0
2283171|NCT02156076|5605328|P3|NOT COMPLETED|Follow-up Period||0
2283172|NCT02156076|5605329|P2|NOT COMPLETED|Follow-up Period||0
2283173|NCT02156076|5605330|P1|NOT COMPLETED|Follow-up Period||1
2283174|NCT02156076|5605327|P4|COMPLETED|Follow-up Period||4
2283175|NCT02156076|5605328|P3|COMPLETED|Follow-up Period||4
2283176|NCT02156076|5605329|P2|COMPLETED|Follow-up Period||5
2283177|NCT02156076|5605330|P1|COMPLETED|Follow-up Period||6
2283178|NCT02156076|5605327|P4|STARTED|Follow-up Period||4
2283179|NCT02156076|5605328|P3|STARTED|Follow-up Period||4
2283180|NCT02156076|5605329|P2|STARTED|Follow-up Period||5
2283181|NCT02156076|5605330|P1|STARTED|Follow-up Period||7
2283182|NCT02156076|5605327|P4|NOT COMPLETED|Treatment Period||2
2283183|NCT02156076|5605328|P3|NOT COMPLETED|Treatment Period||2
2283184|NCT02156076|5605329|P2|NOT COMPLETED|Treatment Period||2
2283185|NCT02156076|5605330|P1|NOT COMPLETED|Treatment Period||0
2283186|NCT02156076|5605327|P4|COMPLETED|Treatment Period||4
2283187|NCT02156076|5605328|P3|COMPLETED|Treatment Period||4
2283188|NCT02156076|5605329|P2|COMPLETED|Treatment Period||5
2283189|NCT02156076|5605330|P1|COMPLETED|Treatment Period||7
2283190|NCT02156076|5605327|P4|STARTED|Treatment Period||6
2283191|NCT02156076|5605328|P3|STARTED|Treatment Period||6
2283192|NCT02156076|5605329|P2|STARTED|Treatment Period||7
2283193|NCT02156076|5605330|P1|STARTED|Treatment Period||7
2283194|NCT02155985|5605387|P3|NOT COMPLETED|Overall Study||1
2283195|NCT02155985|5605388|P2|NOT COMPLETED|Overall Study||0
2283196|NCT02155985|5605389|P1|NOT COMPLETED|Overall Study||1
2283197|NCT02155985|5605387|P3|COMPLETED|Overall Study||39
2283198|NCT02155985|5605388|P2|COMPLETED|Overall Study||41
2283199|NCT02155985|5605389|P1|COMPLETED|Overall Study||39
2283200|NCT02155985|5605387|P3|STARTED|Overall Study||40
2283201|NCT02155985|5605388|P2|STARTED|Overall Study||41
2283202|NCT02155985|5605389|P1|STARTED|Overall Study||40
2283203|NCT02155881|5605456|P2|NOT COMPLETED|Overall Study||4
2283204|NCT02155881|5605457|P1|NOT COMPLETED|Overall Study||2
2283205|NCT02155881|5605456|P2|COMPLETED|Overall Study||36
2283206|NCT02155881|5605457|P1|COMPLETED|Overall Study||38
2283207|NCT02155881|5605456|P2|STARTED|Overall Study||40
2283208|NCT02155881|5605457|P1|STARTED|Overall Study||40
2283209|NCT02155738|5605481|P4|NOT COMPLETED|Overall Study||1
2283210|NCT02155738|5605482|P3|NOT COMPLETED|Overall Study||0
2283211|NCT02155738|5605483|P2|NOT COMPLETED|Overall Study||0
2283212|NCT02155738|5605484|P1|NOT COMPLETED|Overall Study||1
2283213|NCT02155738|5605481|P4|COMPLETED|Overall Study||50
2283214|NCT02155738|5605482|P3|COMPLETED|Overall Study||51
2283215|NCT02155738|5605483|P2|COMPLETED|Overall Study||52
2283216|NCT02155738|5605484|P1|COMPLETED|Overall Study||49
2283217|NCT02155738|5605481|P4|STARTED|Overall Study||51
2283218|NCT02155738|5605482|P3|STARTED|Overall Study||51
2283219|NCT02155738|5605483|P2|STARTED|Overall Study||52
2283220|NCT02155738|5605484|P1|STARTED|Overall Study||50
2283221|NCT02155712|5605504|P2|NOT COMPLETED|Secondary Objectives||134
2283222|NCT02155712|5605505|P1|NOT COMPLETED|Secondary Objectives||319
2283223|NCT02155712|5605504|P2|COMPLETED|Secondary Objectives||0
2283224|NCT02155712|5605505|P1|COMPLETED|Secondary Objectives||0
2283225|NCT02155712|5605504|P2|STARTED|Secondary Objectives|This period will be updated when posting secondary objective results.|134
2283226|NCT02155712|5605505|P1|STARTED|Secondary Objectives||319
2283227|NCT02155712|5605504|P2|NOT COMPLETED|Primary Objective||0
2283228|NCT02155712|5605505|P1|NOT COMPLETED|Primary Objective||60
2283229|NCT02155712|5605504|P2|COMPLETED|Primary Objective||0
2283230|NCT02155712|5605505|P1|COMPLETED|Primary Objective||259
2283231|NCT02155712|5605504|P2|STARTED|Primary Objective|Cohort 2 isn't included in primary obj analysis|0
2283232|NCT02155712|5605505|P1|STARTED|Primary Objective||319
2283233|NCT02155660|5605515|P4|NOT COMPLETED|Overall Study||61
2283234|NCT02155660|5605516|P3|NOT COMPLETED|Overall Study||60
2283235|NCT02155660|5605517|P2|NOT COMPLETED|Overall Study||73
2283236|NCT02155660|5605518|P1|NOT COMPLETED|Overall Study||58
2283237|NCT02155660|5605515|P4|COMPLETED|Overall Study||507
2283238|NCT02155660|5605516|P3|COMPLETED|Overall Study||502
2283239|NCT02155660|5605517|P2|COMPLETED|Overall Study||489
2283240|NCT02155660|5605518|P1|COMPLETED|Overall Study||504
2283241|NCT02155660|5605515|P4|STARTED|Overall Study||568
2283242|NCT02155660|5605516|P3|STARTED|Overall Study||562
2283243|NCT02155660|5605517|P2|STARTED|Overall Study||562
2283244|NCT02155660|5605518|P1|STARTED|Overall Study||562
2283245|NCT02155608|5605601|P2|NOT COMPLETED|1b: 1 Week Blinded Post Treatment||1
2283246|NCT02155608|5605602|P1|NOT COMPLETED|1b: 1 Week Blinded Post Treatment||1
2283247|NCT02155608|5605601|P2|COMPLETED|1b: 1 Week Blinded Post Treatment||28
2283248|NCT02155608|5605602|P1|COMPLETED|1b: 1 Week Blinded Post Treatment||31
2283249|NCT02155608|5605601|P2|STARTED|1b: 1 Week Blinded Post Treatment||29
2283250|NCT02155608|5605602|P1|STARTED|1b: 1 Week Blinded Post Treatment||32
2283251|NCT02155608|5605601|P2|NOT COMPLETED|1a: 4 Week Double Blind Sham Controlled||1
2283252|NCT02155608|5605602|P1|NOT COMPLETED|1a: 4 Week Double Blind Sham Controlled||0
2283253|NCT02155608|5605601|P2|COMPLETED|1a: 4 Week Double Blind Sham Controlled||29
2283254|NCT02155608|5605602|P1|COMPLETED|1a: 4 Week Double Blind Sham Controlled||32
2283255|NCT02155608|5605601|P2|STARTED|1a: 4 Week Double Blind Sham Controlled||30
2283256|NCT02155608|5605602|P1|STARTED|1a: 4 Week Double Blind Sham Controlled||32
2283257|NCT02155543|5605641|P7|NOT COMPLETED|Overall Study||0
2283258|NCT02155543|5605642|P6|NOT COMPLETED|Overall Study||0
2283259|NCT02155543|5605643|P5|NOT COMPLETED|Overall Study||0
2283260|NCT02155543|5605644|P4|NOT COMPLETED|Overall Study||0
2283261|NCT02155543|5605645|P3|NOT COMPLETED|Overall Study||0
2283262|NCT02155543|5605646|P2|NOT COMPLETED|Overall Study||0
2283263|NCT02155543|5605647|P1|NOT COMPLETED|Overall Study||0
2283264|NCT02155543|5605641|P7|COMPLETED|Overall Study||9
2283265|NCT02155543|5605642|P6|COMPLETED|Overall Study||3
2283266|NCT02155543|5605643|P5|COMPLETED|Overall Study||3
2283267|NCT02155543|5605644|P4|COMPLETED|Overall Study||9
2283268|NCT02155543|5605645|P3|COMPLETED|Overall Study||9
2283269|NCT02155543|5605646|P2|COMPLETED|Overall Study||9
2283270|NCT02155543|5605647|P1|COMPLETED|Overall Study||9
2283271|NCT02155543|5605641|P7|STARTED|Overall Study||9
2283272|NCT02155543|5605642|P6|STARTED|Overall Study||3
2283273|NCT02155543|5605643|P5|STARTED|Overall Study||3
2283274|NCT02155543|5605644|P4|STARTED|Overall Study||9
2283275|NCT02155543|5605645|P3|STARTED|Overall Study||9
2283276|NCT02155543|5605646|P2|STARTED|Overall Study||9
2283277|NCT02155543|5605647|P1|STARTED|Overall Study||9
2283278|NCT02155465|5605667|P7|NOT COMPLETED|Overall Study||0
2283279|NCT02155465|5605668|P6|NOT COMPLETED|Overall Study||0
2283280|NCT02155465|5605669|P5|NOT COMPLETED|Overall Study||0
2283281|NCT02155465|5605670|P4|NOT COMPLETED|Overall Study||0
2283282|NCT02155465|5605671|P3|NOT COMPLETED|Overall Study||0
2283283|NCT02155465|5605672|P2|NOT COMPLETED|Overall Study||0
2283284|NCT02155465|5605673|P1|NOT COMPLETED|Overall Study||0
2283285|NCT02155465|5605667|P7|COMPLETED|Overall Study||5
2283286|NCT02155465|5605668|P6|COMPLETED|Overall Study||2
2283287|NCT02155465|5605669|P5|COMPLETED|Overall Study||1
2283288|NCT02155465|5605670|P4|COMPLETED|Overall Study||2
2283289|NCT02155465|5605671|P3|COMPLETED|Overall Study||6
2283290|NCT02155465|5605672|P2|COMPLETED|Overall Study||3
2283291|NCT02155465|5605673|P1|COMPLETED|Overall Study||3
2283292|NCT02155465|5605667|P7|STARTED|Overall Study||5
2283293|NCT02155465|5605668|P6|STARTED|Overall Study||2
2283294|NCT02155465|5605669|P5|STARTED|Overall Study||1
2283295|NCT02155465|5605670|P4|STARTED|Overall Study||2
2283296|NCT02155465|5605671|P3|STARTED|Overall Study||6
2283297|NCT02155465|5605672|P2|STARTED|Overall Study||3
2283298|NCT02155465|5605673|P1|STARTED|Overall Study||3
2283299|NCT02155335|5605693|P2|NOT COMPLETED|Period 2||0
2283300|NCT02155335|5605694|P1|NOT COMPLETED|Period 2||0
2283301|NCT02155335|5605693|P2|COMPLETED|Period 2||49
2283302|NCT02155335|5605694|P1|COMPLETED|Period 2||50
2283303|NCT02155335|5605693|P2|STARTED|Period 2||49
2283304|NCT02155335|5605694|P1|STARTED|Period 2||50
2283305|NCT02155335|5605693|P2|NOT COMPLETED|Period 1||1
2283306|NCT02155335|5605694|P1|NOT COMPLETED|Period 1||0
2283307|NCT02155335|5605693|P2|COMPLETED|Period 1||49
2283308|NCT02155335|5605694|P1|COMPLETED|Period 1||50
2283309|NCT02155335|5605693|P2|Treated|Period 1||49
2283310|NCT02155335|5605694|P1|Treated|Period 1||50
2283311|NCT02155335|5605693|P2|STARTED|Period 1||50
2283312|NCT02155335|5605694|P1|STARTED|Period 1||50
2283313|NCT02155322|5605699|P1|NOT COMPLETED|Overall Study||14
2283314|NCT02155322|5605699|P1|COMPLETED|Overall Study||19
2283315|NCT02155322|5605699|P1|Treated|Overall Study|32 of 33 participants treated. 1 participant not treated at the discretion of the investigator.|32
2283316|NCT02155322|5605699|P1|STARTED|Overall Study||33
2283317|NCT02155309|5605706|P3|NOT COMPLETED|Overall Study||1
2283318|NCT02155309|5605707|P2|NOT COMPLETED|Overall Study||0
2283319|NCT02155309|5605708|P1|NOT COMPLETED|Overall Study||0
2283320|NCT02155309|5605706|P3|COMPLETED|Overall Study||12
2283321|NCT02155309|5605707|P2|COMPLETED|Overall Study||10
2283322|NCT02155309|5605708|P1|COMPLETED|Overall Study||13
2283323|NCT02155309|5605706|P3|STARTED|Overall Study||13
2283324|NCT02155309|5605707|P2|STARTED|Overall Study||10
2283325|NCT02155309|5605708|P1|STARTED|Overall Study||13
2283326|NCT02155283|5605715|P1|NOT COMPLETED|Overall Study||7
2283327|NCT02155283|5605715|P1|COMPLETED|Overall Study||9
2283328|NCT02155283|5605715|P1|STARTED|Overall Study||16
2283329|NCT02155257|5605723|P3|NOT COMPLETED|Overall Study||0
2283330|NCT02155257|5605724|P2|NOT COMPLETED|Overall Study||0
2283331|NCT02155257|5605725|P1|NOT COMPLETED|Overall Study||0
2283332|NCT02155257|5605723|P3|COMPLETED|Overall Study||10
2283333|NCT02155257|5605724|P2|COMPLETED|Overall Study||10
2283334|NCT02155257|5605725|P1|COMPLETED|Overall Study||10
2283335|NCT02155257|5605723|P3|STARTED|Overall Study||10
2283336|NCT02155257|5605724|P2|STARTED|Overall Study||10
2283337|NCT02155257|5605725|P1|STARTED|Overall Study||10
2283338|NCT02155101|5605741|P2|NOT COMPLETED|Overall Study||1
2283339|NCT02155101|5605742|P1|NOT COMPLETED|Overall Study||0
2283340|NCT02155101|5605741|P2|COMPLETED|Overall Study||80
2283341|NCT02155101|5605742|P1|COMPLETED|Overall Study||39
2283342|NCT02155101|5605741|P2|STARTED|Overall Study||81
2283343|NCT02155101|5605742|P1|STARTED|Overall Study||39
2283344|NCT02155010|5605754|P2|NOT COMPLETED|Overall Study||6
2283345|NCT02155010|5605755|P1|NOT COMPLETED|Overall Study||6
2283346|NCT02155010|5605754|P2|COMPLETED|Overall Study||31
2283347|NCT02155010|5605755|P1|COMPLETED|Overall Study||31
2283348|NCT02155010|5605754|P2|STARTED|Overall Study||37
2283349|NCT02155010|5605755|P1|STARTED|Overall Study||37
2283350|NCT02154906|5605765|P2|NOT COMPLETED|Overall Study||3
2283351|NCT02154906|5605766|P1|NOT COMPLETED|Overall Study||2
2283352|NCT02154906|5605765|P2|COMPLETED|Overall Study||17
2283353|NCT02154906|5605766|P1|COMPLETED|Overall Study||19
2283354|NCT02154906|5605765|P2|STARTED|Overall Study||20
2283355|NCT02154906|5605766|P1|STARTED|Overall Study||21
2283356|NCT02154763|5605776|P2|NOT COMPLETED|Overall Study||14
2283357|NCT02154763|5605777|P1|NOT COMPLETED|Overall Study||14
2283358|NCT02154763|5605776|P2|COMPLETED|Overall Study||46
2283359|NCT02154763|5605777|P1|COMPLETED|Overall Study||46
2283360|NCT02154763|5605776|P2|STARTED|Overall Study||60
2283361|NCT02154763|5605777|P1|STARTED|Overall Study||60
2283362|NCT02154581|5605891|P2|NOT COMPLETED|Overall Study||8
2283363|NCT02154581|5605892|P1|NOT COMPLETED|Overall Study||7
2283364|NCT02154581|5605891|P2|COMPLETED|Overall Study||12
2283365|NCT02154581|5605892|P1|COMPLETED|Overall Study||14
2283366|NCT02154581|5605891|P2|STARTED|Overall Study||20
2283367|NCT02154581|5605892|P1|STARTED|Overall Study||21
2283368|NCT02154477|5605910|P2|NOT COMPLETED|Overall Study||0
2283369|NCT02154477|5605911|P1|NOT COMPLETED|Overall Study||0
2283370|NCT02154477|5605910|P2|COMPLETED|Overall Study||8
2283371|NCT02154477|5605911|P1|COMPLETED|Overall Study||6
2283372|NCT02154477|5605910|P2|STARTED|Overall Study||8
2283373|NCT02154477|5605911|P1|STARTED|Overall Study||6
2283374|NCT02154425|5605917|P1|NOT COMPLETED|Sampling Period||0
2283375|NCT02154425|5605917|P1|COMPLETED|Sampling Period||17
2283376|NCT02154425|5605917|P1|STARTED|Sampling Period||17
2283377|NCT02154425|5605917|P1|NOT COMPLETED|Screening Period||1
2283378|NCT02154425|5605917|P1|COMPLETED|Screening Period||17
2283379|NCT02154425|5605917|P1|STARTED|Screening Period||18
2283380|NCT02154386|5605949|P2|NOT COMPLETED|Overall Study||2
2283381|NCT02154386|5605950|P1|NOT COMPLETED|Overall Study||1
2283382|NCT02154386|5605949|P2|COMPLETED|Overall Study||21
2283383|NCT02154386|5605950|P1|COMPLETED|Overall Study||22
2283384|NCT02154386|5605949|P2|STARTED|Overall Study||23
2283385|NCT02154386|5605950|P1|STARTED|Overall Study||23
2283386|NCT02154347|5605962|P2|NOT COMPLETED|Open-label Period||25
2283387|NCT02154347|5605963|P1|NOT COMPLETED|Open-label Period||7
2283388|NCT02154347|5605962|P2|COMPLETED|Open-label Period||88
2283389|NCT02154347|5605963|P1|COMPLETED|Open-label Period||50
2283390|NCT02154347|5605962|P2|STARTED|Open-label Period||113
2283391|NCT02154347|5605963|P1|STARTED|Open-label Period||57
2283392|NCT02154347|5605962|P2|NOT COMPLETED|Double-blind Period||4
2283393|NCT02154347|5605963|P1|NOT COMPLETED|Double-blind Period||3
2283394|NCT02154347|5605962|P2|COMPLETED|Double-blind Period||114
2283395|NCT02154347|5605963|P1|COMPLETED|Double-blind Period||57
2283396|NCT02154347|5605962|P2|STARTED|Double-blind Period||118
2283397|NCT02154347|5605963|P1|STARTED|Double-blind Period||60
2283398|NCT02154243|5605973|P3|NOT COMPLETED|Overall Study||0
2283399|NCT02154243|5605974|P2|NOT COMPLETED|Overall Study||0
2283400|NCT02154243|5605975|P1|NOT COMPLETED|Overall Study||0
2283401|NCT02154243|5605973|P3|COMPLETED|Overall Study||4
2283402|NCT02154243|5605974|P2|COMPLETED|Overall Study||4
2283403|NCT02154243|5605975|P1|COMPLETED|Overall Study||5
2283404|NCT02154243|5605973|P3|STARTED|Overall Study||4
2283405|NCT02154243|5605974|P2|STARTED|Overall Study||4
2283406|NCT02154243|5605975|P1|STARTED|Overall Study||5
2283407|NCT02154139|5605986|P1|NOT COMPLETED|Overall Study||7
2283408|NCT02154139|5605986|P1|COMPLETED|Overall Study||644
2283409|NCT02154139|5605986|P1|STARTED|Overall Study||651
2283410|NCT02154087|5605994|P1|NOT COMPLETED|Overall Study||1
2283411|NCT02154087|5605994|P1|COMPLETED|Overall Study||0
2283412|NCT02154087|5605994|P1|STARTED|Overall Study||1
2283413|NCT02154061|5606000|P2|NOT COMPLETED|Overall Study||0
2283414|NCT02154061|5606001|P1|NOT COMPLETED|Overall Study||2
2283415|NCT02154061|5606000|P2|COMPLETED|Overall Study||17
2283416|NCT02154061|5606001|P1|COMPLETED|Overall Study||14
2283417|NCT02154061|5606000|P2|STARTED|Overall Study||17
2283418|NCT02154061|5606001|P1|STARTED|Overall Study||16
2283419|NCT02154048|5606010|P3|NOT COMPLETED|Overall Study||0
2283420|NCT02154048|5606011|P2|NOT COMPLETED|Overall Study||0
2283421|NCT02154048|5606012|P1|NOT COMPLETED|Overall Study||0
2283422|NCT02154048|5606010|P3|COMPLETED|Overall Study||1
2283423|NCT02154048|5606011|P2|COMPLETED|Overall Study||2
2283424|NCT02154048|5606012|P1|COMPLETED|Overall Study||2
2283425|NCT02154048|5606010|P3|STARTED|Overall Study||1
2283426|NCT02154048|5606011|P2|STARTED|Overall Study||2
2283427|NCT02154048|5606012|P1|STARTED|Overall Study||2
2283428|NCT02153983|5606026|P6|NOT COMPLETED|Overall Study||0
2283429|NCT02153983|5606027|P5|NOT COMPLETED|Overall Study||0
2283430|NCT02153983|5606028|P4|NOT COMPLETED|Overall Study||0
2283431|NCT02153983|5606029|P3|NOT COMPLETED|Overall Study||2
2283432|NCT02153983|5606030|P2|NOT COMPLETED|Overall Study||3
2283433|NCT02153983|5606031|P1|NOT COMPLETED|Overall Study||0
2283434|NCT02153983|5606026|P6|COMPLETED|Overall Study||1
2283435|NCT02153983|5606027|P5|COMPLETED|Overall Study||19
2283436|NCT02153983|5606028|P4|COMPLETED|Overall Study||13
2283437|NCT02153983|5606029|P3|COMPLETED|Overall Study||2
2283438|NCT02153983|5606030|P2|COMPLETED|Overall Study||18
2283439|NCT02153983|5606031|P1|COMPLETED|Overall Study||19
2283440|NCT02153983|5606026|P6|STARTED|Overall Study||1
2283441|NCT02153983|5606027|P5|STARTED|Overall Study||19
2283442|NCT02153983|5606028|P4|STARTED|Overall Study||13
2283443|NCT02153983|5606029|P3|STARTED|Overall Study||4
2283444|NCT02153983|5606030|P2|STARTED|Overall Study||21
2283445|NCT02153983|5606031|P1|STARTED|Overall Study||19
2283446|NCT02153918|5606048|P1|NOT COMPLETED|Overall Study||1
2283447|NCT02153918|5606048|P1|COMPLETED|Overall Study||26
2283448|NCT02153918|5606048|P1|STARTED|Overall Study||27
2283449|NCT02153905|5606059|P2|NOT COMPLETED|Overall Study||0
2283450|NCT02153905|5606060|P1|NOT COMPLETED|Overall Study||1
2283451|NCT02153905|5606059|P2|COMPLETED|Overall Study||2
2283452|NCT02153905|5606060|P1|COMPLETED|Overall Study||0
2283453|NCT02153905|5606059|P2|STARTED|Overall Study||2
2283454|NCT02153905|5606060|P1|STARTED|Overall Study||1
2283455|NCT02153827|5606078|P2|NOT COMPLETED|Overall Study||9
2283456|NCT02153827|5606079|P1|NOT COMPLETED|Overall Study||3
2283457|NCT02153827|5606078|P2|COMPLETED|Overall Study||14
2283458|NCT02153827|5606079|P1|COMPLETED|Overall Study||22
2283459|NCT02153827|5606078|P2|STARTED|Overall Study||23
2283460|NCT02153827|5606079|P1|STARTED|Overall Study||25
2283461|NCT02153788|5606095|P2|NOT COMPLETED|Overall Study||1
2283462|NCT02153788|5606096|P1|NOT COMPLETED|Overall Study||2
2283463|NCT02153788|5606095|P2|COMPLETED|Overall Study||18
2283464|NCT02153788|5606096|P1|COMPLETED|Overall Study||23
2283465|NCT02153788|5606095|P2|STARTED|Overall Study||19
2283466|NCT02153788|5606096|P1|STARTED|Overall Study||25
2283467|NCT02153736|5606116|P2|NOT COMPLETED|Overall Study||2
2283468|NCT02153736|5606117|P1|NOT COMPLETED|Overall Study||2
2283469|NCT02153736|5606116|P2|COMPLETED|Overall Study||5
2283470|NCT02153736|5606117|P1|COMPLETED|Overall Study||5
2283471|NCT02153736|5606116|P2|STARTED|Overall Study||7
2283472|NCT02153736|5606117|P1|STARTED|Overall Study||7
2283473|NCT02153723|5606133|P1|NOT COMPLETED|Overall Study||0
2283474|NCT02153723|5606133|P1|COMPLETED|Overall Study||10
2283475|NCT02153723|5606133|P1|STARTED|Overall Study||10
2283476|NCT02153710|5606144|P2|NOT COMPLETED|Overall Study||0
2283477|NCT02153710|5606145|P1|NOT COMPLETED|Overall Study||0
2283478|NCT02153710|5606144|P2|COMPLETED|Overall Study||30
2283479|NCT02153710|5606145|P1|COMPLETED|Overall Study||28
2283480|NCT02153710|5606144|P2|STARTED|Overall Study||30
2283481|NCT02153710|5606145|P1|STARTED|Overall Study||28
2283482|NCT02153671|5606157|P2|NOT COMPLETED|Overall Study||0
2283483|NCT02153671|5606158|P1|NOT COMPLETED|Overall Study||0
2283484|NCT02153671|5606157|P2|COMPLETED|Overall Study||24
2283485|NCT02153671|5606158|P1|COMPLETED|Overall Study||19
2283486|NCT02153671|5606157|P2|STARTED|Overall Study||24
2283487|NCT02153671|5606158|P1|STARTED|Overall Study||19
2283488|NCT02153645|5606237|P3|NOT COMPLETED|Overall Study||10
2283489|NCT02153645|5606238|P2|NOT COMPLETED|Overall Study||10
2283490|NCT02153645|5606239|P1|NOT COMPLETED|Overall Study||13
2283491|NCT02153645|5606237|P3|COMPLETED|Overall Study||18
2283492|NCT02153645|5606238|P2|COMPLETED|Overall Study||19
2283493|NCT02153645|5606239|P1|COMPLETED|Overall Study||17
2283494|NCT02153645|5606237|P3|STARTED|Overall Study||28
2283495|NCT02153645|5606238|P2|STARTED|Overall Study||29
2283496|NCT02153645|5606239|P1|STARTED|Overall Study||30
2283497|NCT02153632|5606253|P3|NOT COMPLETED|Overall Study||19
2283498|NCT02153632|5606254|P2|NOT COMPLETED|Overall Study||19
2283499|NCT02153632|5606255|P1|NOT COMPLETED|Overall Study||18
2283500|NCT02153632|5606253|P3|COMPLETED|Overall Study||25
2283501|NCT02153632|5606254|P2|COMPLETED|Overall Study||27
2283502|NCT02153632|5606255|P1|COMPLETED|Overall Study||27
2283503|NCT02153632|5606253|P3|STARTED|Overall Study||44
2283504|NCT02153632|5606254|P2|STARTED|Overall Study||46
2283505|NCT02153632|5606255|P1|STARTED|Overall Study||45
2283506|NCT02153528|5606268|P2|NOT COMPLETED|Overall Study||0
2283507|NCT02153528|5606269|P1|NOT COMPLETED|Overall Study||0
2283508|NCT02153528|5606268|P2|COMPLETED|Overall Study||353
2283509|NCT02153528|5606269|P1|COMPLETED|Overall Study||348
2283510|NCT02153528|5606268|P2|STARTED|Overall Study||353
2283511|NCT02153528|5606269|P1|STARTED|Overall Study||348
2283512|NCT02153489|5606291|P2|NOT COMPLETED|Period 2||0
2283513|NCT02153489|5606292|P1|NOT COMPLETED|Period 2||0
2283514|NCT02153489|5606291|P2|COMPLETED|Period 2||15
2283515|NCT02153489|5606292|P1|COMPLETED|Period 2||15
2283516|NCT02153489|5606291|P2|STARTED|Period 2||15
2283517|NCT02153489|5606292|P1|STARTED|Period 2||15
2283518|NCT02153489|5606291|P2|NOT COMPLETED|Period 1||0
2283519|NCT02153489|5606292|P1|NOT COMPLETED|Period 1||0
2283520|NCT02153489|5606291|P2|COMPLETED|Period 1||15
2283521|NCT02153489|5606292|P1|COMPLETED|Period 1||15
2283522|NCT02153489|5606291|P2|STARTED|Period 1||15
2283523|NCT02153489|5606292|P1|STARTED|Period 1||15
2283524|NCT02153476|5606332|P2|NOT COMPLETED|Overall Study||0
2283525|NCT02153476|5606333|P1|NOT COMPLETED|Overall Study||1
2283526|NCT02153476|5606332|P2|COMPLETED|Overall Study||22
2283527|NCT02153476|5606333|P1|COMPLETED|Overall Study||22
2283528|NCT02153476|5606332|P2|STARTED|Overall Study||22
2283529|NCT02153476|5606333|P1|STARTED|Overall Study||23
2283530|NCT02153398|5606344|P5|NOT COMPLETED|Overall Study||0
2283531|NCT02153398|5606345|P4|NOT COMPLETED|Overall Study||1
2283532|NCT02153398|5606346|P3|NOT COMPLETED|Overall Study||1
2283533|NCT02153398|5606347|P2|NOT COMPLETED|Overall Study||0
2283534|NCT02153398|5606348|P1|NOT COMPLETED|Overall Study||1
2283535|NCT02153398|5606344|P5|COMPLETED|Overall Study||10
2283536|NCT02153398|5606345|P4|COMPLETED|Overall Study||9
2283537|NCT02153398|5606346|P3|COMPLETED|Overall Study||9
2283538|NCT02153398|5606347|P2|COMPLETED|Overall Study||10
2283539|NCT02153398|5606348|P1|COMPLETED|Overall Study||9
2283540|NCT02153398|5606344|P5|STARTED|Overall Study||10
2283541|NCT02153398|5606345|P4|STARTED|Overall Study||10
2283542|NCT02153398|5606346|P3|STARTED|Overall Study||10
2283543|NCT02153398|5606347|P2|STARTED|Overall Study||10
2283544|NCT02153398|5606348|P1|STARTED|Overall Study||10
2283545|NCT02153359|5606470|P2|NOT COMPLETED|Intervention 2 (1 Month)||2
2283546|NCT02153359|5606471|P1|NOT COMPLETED|Intervention 2 (1 Month)||0
2283547|NCT02153359|5606470|P2|COMPLETED|Intervention 2 (1 Month)||10
2283548|NCT02153359|5606471|P1|COMPLETED|Intervention 2 (1 Month)||11
2283549|NCT02153359|5606470|P2|STARTED|Intervention 2 (1 Month)||12
2283550|NCT02153359|5606471|P1|STARTED|Intervention 2 (1 Month)||11
2283551|NCT02153359|5606470|P2|NOT COMPLETED|Washout (at Least 1 Month)||0
2283552|NCT02153359|5606471|P1|NOT COMPLETED|Washout (at Least 1 Month)||0
2283553|NCT02153359|5606470|P2|COMPLETED|Washout (at Least 1 Month)||12
2283554|NCT02153359|5606471|P1|COMPLETED|Washout (at Least 1 Month)||11
2283555|NCT02153359|5606470|P2|STARTED|Washout (at Least 1 Month)||12
2283556|NCT02153359|5606471|P1|STARTED|Washout (at Least 1 Month)||11
2283557|NCT02153359|5606470|P2|NOT COMPLETED|Intervention 1 (1 Month)||0
2283558|NCT02153359|5606471|P1|NOT COMPLETED|Intervention 1 (1 Month)||0
2283559|NCT02153359|5606470|P2|COMPLETED|Intervention 1 (1 Month)||12
2283560|NCT02153359|5606471|P1|COMPLETED|Intervention 1 (1 Month)||11
2283561|NCT02153359|5606470|P2|STARTED|Intervention 1 (1 Month)||12
2283562|NCT02153359|5606471|P1|STARTED|Intervention 1 (1 Month)||11
2283563|NCT02153346|5606505|P1|NOT COMPLETED|Overall Study||11
2283564|NCT02153346|5606505|P1|COMPLETED|Overall Study||90
2283565|NCT02153346|5606505|P1|STARTED|Overall Study||101
2283566|NCT02153112|5606522|P10|NOT COMPLETED|Overall Study||14
2283567|NCT02153112|5606523|P9|NOT COMPLETED|Overall Study||15
2283568|NCT02153112|5606524|P8|NOT COMPLETED|Overall Study||2
2283569|NCT02153112|5606525|P7|NOT COMPLETED|Overall Study||8
2283570|NCT02153112|5606526|P6|NOT COMPLETED|Overall Study||2
2283571|NCT02153112|5606527|P5|NOT COMPLETED|Overall Study||3
2283572|NCT02153112|5606528|P4|NOT COMPLETED|Overall Study||2
2283573|NCT02153112|5606529|P3|NOT COMPLETED|Overall Study||3
2283574|NCT02153112|5606530|P2|NOT COMPLETED|Overall Study||2
2283575|NCT02153112|5606531|P1|NOT COMPLETED|Overall Study||4
2283576|NCT02153112|5606522|P10|COMPLETED|Overall Study||166
2283577|NCT02153112|5606523|P9|COMPLETED|Overall Study||165
2283578|NCT02153112|5606524|P8|COMPLETED|Overall Study||58
2283579|NCT02153112|5606525|P7|COMPLETED|Overall Study||52
2283580|NCT02153112|5606526|P6|COMPLETED|Overall Study||58
2283581|NCT02153112|5606527|P5|COMPLETED|Overall Study||57
2283582|NCT02153112|5606528|P4|COMPLETED|Overall Study||57
2283583|NCT02153112|5606529|P3|COMPLETED|Overall Study||58
2283584|NCT02153112|5606530|P2|COMPLETED|Overall Study||57
2283585|NCT02153112|5606531|P1|COMPLETED|Overall Study||57
2283586|NCT02153112|5606522|P10|STARTED|Overall Study||180
2283587|NCT02153112|5606523|P9|STARTED|Overall Study||180
2283588|NCT02153112|5606524|P8|STARTED|Overall Study||60
2283589|NCT02153112|5606525|P7|STARTED|Overall Study||60
2283590|NCT02153112|5606526|P6|STARTED|Overall Study||60
2283591|NCT02153112|5606527|P5|STARTED|Overall Study||60
2283592|NCT02153112|5606528|P4|STARTED|Overall Study||59
2283593|NCT02153112|5606529|P3|STARTED|Overall Study||61
2283594|NCT02153112|5606530|P2|STARTED|Overall Study||59
2283595|NCT02153112|5606531|P1|STARTED|Overall Study||61
2283596|NCT02153099|5606810|P7|NOT COMPLETED|Overall Study||0
2283597|NCT02153099|5606811|P6|NOT COMPLETED|Overall Study||0
2283598|NCT02153099|5606812|P5|NOT COMPLETED|Overall Study||0
2283599|NCT02153099|5606813|P4|NOT COMPLETED|Overall Study||0
2283600|NCT02153099|5606814|P3|NOT COMPLETED|Overall Study||0
2283601|NCT02153099|5606815|P2|NOT COMPLETED|Overall Study||0
2283602|NCT02153099|5606816|P1|NOT COMPLETED|Overall Study||0
2283603|NCT02153099|5606810|P7|COMPLETED|Overall Study||12
2283604|NCT02153099|5606811|P6|COMPLETED|Overall Study||6
2283605|NCT02153099|5606812|P5|COMPLETED|Overall Study||6
2283606|NCT02153099|5606813|P4|COMPLETED|Overall Study||6
2283607|NCT02153099|5606814|P3|COMPLETED|Overall Study||6
2283608|NCT02153099|5606815|P2|COMPLETED|Overall Study||6
2283609|NCT02153099|5606816|P1|COMPLETED|Overall Study||6
2283610|NCT02153099|5606810|P7|STARTED|Overall Study||12
2283611|NCT02153099|5606811|P6|STARTED|Overall Study||6
2283612|NCT02153099|5606812|P5|STARTED|Overall Study||6
2283613|NCT02153099|5606813|P4|STARTED|Overall Study||6
2283614|NCT02153099|5606814|P3|STARTED|Overall Study||6
2283615|NCT02153099|5606815|P2|STARTED|Overall Study||6
2283616|NCT02153099|5606816|P1|STARTED|Overall Study||6
2283617|NCT02153086|5606870|P1|NOT COMPLETED|Overall Study||4
2283618|NCT02153086|5606870|P1|COMPLETED|Overall Study||232
2283619|NCT02153086|5606870|P1|STARTED|Overall Study||236
2283620|NCT02153073|5606884|P1|NOT COMPLETED|Overall Study||298
2283621|NCT02153073|5606884|P1|COMPLETED|Overall Study||2786
2283622|NCT02153073|5606884|P1|STARTED|Overall Study||3084
2283623|NCT02152631|5606899|P2|NOT COMPLETED|Overall Study||26
2283624|NCT02152631|5606900|P1|NOT COMPLETED|Overall Study||66
2283625|NCT02152631|5606899|P2|COMPLETED|Overall Study||157
2283626|NCT02152631|5606900|P1|COMPLETED|Overall Study||204
2283627|NCT02152631|5606899|P2|Progressive Disease|Overall Study||137
2283628|NCT02152631|5606900|P1|Progressive Disease|Overall Study||174
2283629|NCT02152631|5606899|P2|Death Due to Any Cause|Overall Study||20
2283630|NCT02152631|5606900|P1|Death Due to Any Cause|Overall Study||30
2283631|NCT02152631|5606899|P2|Off Treatment|Overall Study||172
2283632|NCT02152631|5606900|P1|Off Treatment|Overall Study||246
2283633|NCT02152631|5606899|P2|Received at Least One Dose of Study Drug|Overall Study||175
2283634|NCT02152631|5606900|P1|Received at Least One Dose of Study Drug|Overall Study||265
2283635|NCT02152631|5606899|P2|STARTED|Overall Study||183
2283636|NCT02152631|5606900|P1|STARTED|Overall Study||270
2283637|NCT02152605|5606919|P2|NOT COMPLETED|Overall Study||18
2283638|NCT02152605|5606920|P1|NOT COMPLETED|Overall Study||19
2283639|NCT02152605|5606919|P2|COMPLETED|Overall Study||230
2283640|NCT02152605|5606920|P1|COMPLETED|Overall Study||229
2283641|NCT02152605|5606919|P2|STARTED|Overall Study||248
2283642|NCT02152605|5606920|P1|STARTED|Overall Study||248
2283643|NCT02152566|5606930|P1|NOT COMPLETED|Overall Study||3
2283644|NCT02152566|5606930|P1|COMPLETED|Overall Study||3
2283645|NCT02152566|5606930|P1|STARTED|Overall Study||6
2283646|NCT02152540|5606936|P2|NOT COMPLETED|Overall Study||0
2283647|NCT02152540|5606937|P1|NOT COMPLETED|Overall Study||0
2283648|NCT02152540|5606936|P2|COMPLETED|Overall Study||16
2283649|NCT02152540|5606937|P1|COMPLETED|Overall Study||17
2283650|NCT02152540|5606936|P2|STARTED|Overall Study||16
2283651|NCT02152540|5606937|P1|STARTED|Overall Study||17
2283652|NCT02152384|5606943|P2|NOT COMPLETED|Period 2||0
2283653|NCT02152384|5606944|P1|NOT COMPLETED|Period 2||0
2283654|NCT02152384|5606943|P2|COMPLETED|Period 2||12
2283655|NCT02152384|5606944|P1|COMPLETED|Period 2||13
2283656|NCT02152384|5606943|P2|STARTED|Period 2||12
2283657|NCT02152384|5606944|P1|STARTED|Period 2||13
2283658|NCT02152384|5606943|P2|NOT COMPLETED|Period 1||2
2283659|NCT02152384|5606944|P1|NOT COMPLETED|Period 1||1
2283660|NCT02152384|5606943|P2|COMPLETED|Period 1||12
2283661|NCT02152384|5606944|P1|COMPLETED|Period 1||13
2283662|NCT02152384|5606943|P2|Received at Least 1 Dose of Study Drug|Period 1||14
2283663|NCT02152384|5606944|P1|Received at Least 1 Dose of Study Drug|Period 1||14
2283664|NCT02152384|5606943|P2|STARTED|Period 1||14
2283665|NCT02152384|5606944|P1|STARTED|Period 1||14
2283666|NCT02152384|5606943|P2|NOT COMPLETED|Run In (1-5 Week Transition)||0
2283667|NCT02152384|5606944|P1|NOT COMPLETED|Run In (1-5 Week Transition)||0
2283668|NCT02152384|5606943|P2|COMPLETED|Run In (1-5 Week Transition)||14
2283669|NCT02152384|5606944|P1|COMPLETED|Run In (1-5 Week Transition)||14
2283670|NCT02152384|5606943|P2|STARTED|Run In (1-5 Week Transition)||14
2283671|NCT02152384|5606944|P1|STARTED|Run In (1-5 Week Transition)||14
2283672|NCT02152371|5606964|P2|NOT COMPLETED|Overall Study||16
2283673|NCT02152371|5606965|P1|NOT COMPLETED|Overall Study||12
2283674|NCT02152371|5606964|P2|COMPLETED|Overall Study||134
2283675|NCT02152371|5606965|P1|COMPLETED|Overall Study||138
2283676|NCT02152371|5606964|P2|Received at Least 1 Dose of Study Drug.|Overall Study||150
2283677|NCT02152371|5606965|P1|Received at Least 1 Dose of Study Drug.|Overall Study||150
2283678|NCT02152371|5606964|P2|STARTED|Overall Study||150
2283679|NCT02152371|5606965|P1|STARTED|Overall Study||150
2283680|NCT02152345|5607003|P2|NOT COMPLETED|Overall Study||5
2283681|NCT02152345|5607004|P1|NOT COMPLETED|Overall Study||4
2283682|NCT02152345|5607003|P2|COMPLETED|Overall Study|The last subject randomized to Standard Immunosuppression was on 25-Dec-2016.|24
2283683|NCT02152345|5607004|P1|COMPLETED|Overall Study|The last subject randomized to Belatacept was on 29-Dec-2016.|24
2283684|NCT02152345|5607003|P2|STARTED|Overall Study|The first subject randomized to Standard Immunosuppression was on 14-Jun-2014.|29
2283685|NCT02152345|5607004|P1|STARTED|Overall Study|The first subject randomized to Belatacept was on 15-Sep-2014.|28
2283686|NCT02152137|5607016|P1|NOT COMPLETED|Overall Study||4
2283687|NCT02152137|5607016|P1|COMPLETED|Overall Study||15
2283688|NCT02152137|5607016|P1|Originally Assigned to Arm B|Overall Study|With update #2, Arm B is closed and all patients should receive paclitaxel and efatutazone.|3
2283689|NCT02152137|5607016|P1|Originally Assigned to Arm A|Overall Study||16
2283690|NCT02152137|5607016|P1|STARTED|Overall Study||19
2283691|NCT02152007|5607024|P1|NOT COMPLETED|Overall Study||1
2283692|NCT02152007|5607024|P1|COMPLETED|Overall Study||14
2283693|NCT02152007|5607024|P1|STARTED|Overall Study||15
2283694|NCT02151994|5607033|P13|NOT COMPLETED|Food Effect (FE): Fed||0
2283695|NCT02151994|5607034|P12|NOT COMPLETED|Food Effect (FE): Fed||0
2283696|NCT02151994|5607035|P11|NOT COMPLETED|Food Effect (FE): Fed||0
2283697|NCT02151994|5607036|P10|NOT COMPLETED|Food Effect (FE): Fed||0
2283698|NCT02151994|5607037|P9|NOT COMPLETED|Food Effect (FE): Fed||0
2283699|NCT02151994|5607038|P8|NOT COMPLETED|Food Effect (FE): Fed||0
2283700|NCT02151994|5607039|P7|NOT COMPLETED|Food Effect (FE): Fed||0
2283701|NCT02151994|5607040|P6|NOT COMPLETED|Food Effect (FE): Fed||0
2283702|NCT02151994|5607041|P5|NOT COMPLETED|Food Effect (FE): Fed||0
2283703|NCT02151994|5607042|P4|NOT COMPLETED|Food Effect (FE): Fed||0
2283704|NCT02151994|5607043|P3|NOT COMPLETED|Food Effect (FE): Fed||0
2283705|NCT02151994|5607044|P2|NOT COMPLETED|Food Effect (FE): Fed||0
2283706|NCT02151994|5607045|P1|NOT COMPLETED|Food Effect (FE): Fed||0
2283707|NCT02151994|5607033|P13|COMPLETED|Food Effect (FE): Fed||12
2283708|NCT02151994|5607034|P12|COMPLETED|Food Effect (FE): Fed||0
2283709|NCT02151994|5607035|P11|COMPLETED|Food Effect (FE): Fed||0
2283710|NCT02151994|5607036|P10|COMPLETED|Food Effect (FE): Fed||0
2283711|NCT02151994|5607037|P9|COMPLETED|Food Effect (FE): Fed||0
2283712|NCT02151994|5607038|P8|COMPLETED|Food Effect (FE): Fed||0
2283713|NCT02151994|5607039|P7|COMPLETED|Food Effect (FE): Fed||0
2283714|NCT02151994|5607040|P6|COMPLETED|Food Effect (FE): Fed||0
2283715|NCT02151994|5607041|P5|COMPLETED|Food Effect (FE): Fed||0
2283716|NCT02151994|5607042|P4|COMPLETED|Food Effect (FE): Fed||0
2283717|NCT02151994|5607043|P3|COMPLETED|Food Effect (FE): Fed||0
2283718|NCT02151994|5607044|P2|COMPLETED|Food Effect (FE): Fed||0
2283719|NCT02151994|5607045|P1|COMPLETED|Food Effect (FE): Fed||0
2283720|NCT02151994|5607033|P13|STARTED|Food Effect (FE): Fed||12
2283721|NCT02151994|5607034|P12|STARTED|Food Effect (FE): Fed||0
2283722|NCT02151994|5607035|P11|STARTED|Food Effect (FE): Fed||0
2283723|NCT02151994|5607036|P10|STARTED|Food Effect (FE): Fed||0
2283724|NCT02151994|5607037|P9|STARTED|Food Effect (FE): Fed||0
2283725|NCT02151994|5607038|P8|STARTED|Food Effect (FE): Fed||0
2283726|NCT02151994|5607039|P7|STARTED|Food Effect (FE): Fed||0
2283727|NCT02151994|5607040|P6|STARTED|Food Effect (FE): Fed||0
2283728|NCT02151994|5607041|P5|STARTED|Food Effect (FE): Fed||0
2283729|NCT02151994|5607042|P4|STARTED|Food Effect (FE): Fed||0
2283730|NCT02151994|5607043|P3|STARTED|Food Effect (FE): Fed||0
2283731|NCT02151994|5607044|P2|STARTED|Food Effect (FE): Fed||0
2283732|NCT02151994|5607045|P1|STARTED|Food Effect (FE): Fed||0
2283733|NCT02151994|5607033|P13|NOT COMPLETED|Food Effect (FE): Fasted||0
2283734|NCT02151994|5607034|P12|NOT COMPLETED|Food Effect (FE): Fasted||0
2283735|NCT02151994|5607035|P11|NOT COMPLETED|Food Effect (FE): Fasted||0
2283736|NCT02151994|5607036|P10|NOT COMPLETED|Food Effect (FE): Fasted||0
2283737|NCT02151994|5607037|P9|NOT COMPLETED|Food Effect (FE): Fasted||0
2283738|NCT02151994|5607038|P8|NOT COMPLETED|Food Effect (FE): Fasted||0
2283739|NCT02151994|5607039|P7|NOT COMPLETED|Food Effect (FE): Fasted||0
2283740|NCT02151994|5607040|P6|NOT COMPLETED|Food Effect (FE): Fasted||0
2283741|NCT02151994|5607041|P5|NOT COMPLETED|Food Effect (FE): Fasted||0
2283742|NCT02151994|5607042|P4|NOT COMPLETED|Food Effect (FE): Fasted||0
2283743|NCT02151994|5607043|P3|NOT COMPLETED|Food Effect (FE): Fasted||0
2283744|NCT02151994|5607044|P2|NOT COMPLETED|Food Effect (FE): Fasted||0
2283745|NCT02151994|5607045|P1|NOT COMPLETED|Food Effect (FE): Fasted||0
2283746|NCT02151994|5607033|P13|COMPLETED|Food Effect (FE): Fasted||0
2283747|NCT02151994|5607034|P12|COMPLETED|Food Effect (FE): Fasted||12
2283748|NCT02151994|5607035|P11|COMPLETED|Food Effect (FE): Fasted||0
2283749|NCT02151994|5607036|P10|COMPLETED|Food Effect (FE): Fasted||0
2283750|NCT02151994|5607037|P9|COMPLETED|Food Effect (FE): Fasted||0
2283751|NCT02151994|5607038|P8|COMPLETED|Food Effect (FE): Fasted||0
2283752|NCT02151994|5607039|P7|COMPLETED|Food Effect (FE): Fasted||0
2283753|NCT02151994|5607040|P6|COMPLETED|Food Effect (FE): Fasted||0
2283754|NCT02151994|5607041|P5|COMPLETED|Food Effect (FE): Fasted||0
2283755|NCT02151994|5607042|P4|COMPLETED|Food Effect (FE): Fasted||0
2283756|NCT02151994|5607043|P3|COMPLETED|Food Effect (FE): Fasted||0
2283757|NCT02151994|5607044|P2|COMPLETED|Food Effect (FE): Fasted||0
2283758|NCT02151994|5607045|P1|COMPLETED|Food Effect (FE): Fasted||0
2283759|NCT02151994|5607033|P13|STARTED|Food Effect (FE): Fasted||0
2283760|NCT02151994|5607034|P12|STARTED|Food Effect (FE): Fasted||12
2283761|NCT02151994|5607035|P11|STARTED|Food Effect (FE): Fasted||0
2283762|NCT02151994|5607036|P10|STARTED|Food Effect (FE): Fasted||0
2283763|NCT02151994|5607037|P9|STARTED|Food Effect (FE): Fasted||0
2283764|NCT02151994|5607038|P8|STARTED|Food Effect (FE): Fasted||0
2283765|NCT02151994|5607039|P7|STARTED|Food Effect (FE): Fasted||0
2283766|NCT02151994|5607040|P6|STARTED|Food Effect (FE): Fasted||0
2283767|NCT02151994|5607041|P5|STARTED|Food Effect (FE): Fasted||0
2283768|NCT02151994|5607042|P4|STARTED|Food Effect (FE): Fasted||0
2283769|NCT02151994|5607043|P3|STARTED|Food Effect (FE): Fasted||0
2283770|NCT02151994|5607044|P2|STARTED|Food Effect (FE): Fasted||0
2283771|NCT02151994|5607045|P1|STARTED|Food Effect (FE): Fasted||0
2283772|NCT02151994|5607033|P13|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
2283773|NCT02151994|5607034|P12|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
2283774|NCT02151994|5607035|P11|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
2283775|NCT02151994|5607036|P10|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
2283776|NCT02151994|5607037|P9|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
2283777|NCT02151994|5607038|P8|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
2283778|NCT02151994|5607039|P7|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
2283779|NCT02151994|5607040|P6|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
2283780|NCT02151994|5607041|P5|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
2283781|NCT02151994|5607042|P4|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
2283782|NCT02151994|5607043|P3|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
2283783|NCT02151994|5607044|P2|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
2283784|NCT02151994|5607045|P1|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
2283785|NCT02151994|5607033|P13|COMPLETED|Multiple Ascending Dose (MAD)||0
2283786|NCT02151994|5607034|P12|COMPLETED|Multiple Ascending Dose (MAD)||0
2283787|NCT02151994|5607035|P11|COMPLETED|Multiple Ascending Dose (MAD)||0
2283788|NCT02151994|5607036|P10|COMPLETED|Multiple Ascending Dose (MAD)||0
2283789|NCT02151994|5607037|P9|COMPLETED|Multiple Ascending Dose (MAD)||6
2283790|NCT02151994|5607038|P8|COMPLETED|Multiple Ascending Dose (MAD)||0
2283791|NCT02151994|5607039|P7|COMPLETED|Multiple Ascending Dose (MAD)||6
2283792|NCT02151994|5607040|P6|COMPLETED|Multiple Ascending Dose (MAD)||6
2283793|NCT02151994|5607041|P5|COMPLETED|Multiple Ascending Dose (MAD)||6
2283794|NCT02151994|5607042|P4|COMPLETED|Multiple Ascending Dose (MAD)||6
2283795|NCT02151994|5607043|P3|COMPLETED|Multiple Ascending Dose (MAD)||0
2283796|NCT02151994|5607044|P2|COMPLETED|Multiple Ascending Dose (MAD)||0
2283797|NCT02151994|5607045|P1|COMPLETED|Multiple Ascending Dose (MAD)||10
2283798|NCT02151994|5607033|P13|STARTED|Multiple Ascending Dose (MAD)||0
2283799|NCT02151994|5607034|P12|STARTED|Multiple Ascending Dose (MAD)||0
2283800|NCT02151994|5607035|P11|STARTED|Multiple Ascending Dose (MAD)||0
2283801|NCT02151994|5607036|P10|STARTED|Multiple Ascending Dose (MAD)||0
2283802|NCT02151994|5607037|P9|STARTED|Multiple Ascending Dose (MAD)||6
2283803|NCT02151994|5607038|P8|STARTED|Multiple Ascending Dose (MAD)||0
2283804|NCT02151994|5607039|P7|STARTED|Multiple Ascending Dose (MAD)||6
2283805|NCT02151994|5607040|P6|STARTED|Multiple Ascending Dose (MAD)||6
2283806|NCT02151994|5607041|P5|STARTED|Multiple Ascending Dose (MAD)||6
2283807|NCT02151994|5607042|P4|STARTED|Multiple Ascending Dose (MAD)||6
2283808|NCT02151994|5607043|P3|STARTED|Multiple Ascending Dose (MAD)||0
2283809|NCT02151994|5607044|P2|STARTED|Multiple Ascending Dose (MAD)||0
2283810|NCT02151994|5607045|P1|STARTED|Multiple Ascending Dose (MAD)||10
2283811|NCT02151994|5607033|P13|NOT COMPLETED|Single Ascending Dose (SAD)||0
2283812|NCT02151994|5607034|P12|NOT COMPLETED|Single Ascending Dose (SAD)||0
2283813|NCT02151994|5607035|P11|NOT COMPLETED|Single Ascending Dose (SAD)||0
2283814|NCT02151994|5607036|P10|NOT COMPLETED|Single Ascending Dose (SAD)||0
2283815|NCT02151994|5607037|P9|NOT COMPLETED|Single Ascending Dose (SAD)||0
2283816|NCT02151994|5607038|P8|NOT COMPLETED|Single Ascending Dose (SAD)||0
2283817|NCT02151994|5607039|P7|NOT COMPLETED|Single Ascending Dose (SAD)||0
2283818|NCT02151994|5607040|P6|NOT COMPLETED|Single Ascending Dose (SAD)||0
2283819|NCT02151994|5607041|P5|NOT COMPLETED|Single Ascending Dose (SAD)||0
2283820|NCT02151994|5607042|P4|NOT COMPLETED|Single Ascending Dose (SAD)||0
2283821|NCT02151994|5607043|P3|NOT COMPLETED|Single Ascending Dose (SAD)||0
2283822|NCT02151994|5607044|P2|NOT COMPLETED|Single Ascending Dose (SAD)||0
2283823|NCT02151994|5607045|P1|NOT COMPLETED|Single Ascending Dose (SAD)||0
2283824|NCT02151994|5607033|P13|COMPLETED|Single Ascending Dose (SAD)||0
2283825|NCT02151994|5607034|P12|COMPLETED|Single Ascending Dose (SAD)||0
2283826|NCT02151994|5607035|P11|COMPLETED|Single Ascending Dose (SAD)||6
2283827|NCT02151994|5607036|P10|COMPLETED|Single Ascending Dose (SAD)||6
2283828|NCT02151994|5607037|P9|COMPLETED|Single Ascending Dose (SAD)||0
2283829|NCT02151994|5607038|P8|COMPLETED|Single Ascending Dose (SAD)||6
2283830|NCT02151994|5607039|P7|COMPLETED|Single Ascending Dose (SAD)||6
2283831|NCT02151994|5607040|P6|COMPLETED|Single Ascending Dose (SAD)||6
2283832|NCT02151994|5607041|P5|COMPLETED|Single Ascending Dose (SAD)||6
2283833|NCT02151994|5607042|P4|COMPLETED|Single Ascending Dose (SAD)||6
2283834|NCT02151994|5607043|P3|COMPLETED|Single Ascending Dose (SAD)||6
2283835|NCT02151994|5607044|P2|COMPLETED|Single Ascending Dose (SAD)||6
2283836|NCT02151994|5607045|P1|COMPLETED|Single Ascending Dose (SAD)||18
2283837|NCT02151994|5607033|P13|STARTED|Single Ascending Dose (SAD)||0
2283838|NCT02151994|5607034|P12|STARTED|Single Ascending Dose (SAD)||0
2283839|NCT02151994|5607035|P11|STARTED|Single Ascending Dose (SAD)||6
2283840|NCT02151994|5607036|P10|STARTED|Single Ascending Dose (SAD)||6
2283841|NCT02151994|5607037|P9|STARTED|Single Ascending Dose (SAD)||0
2283842|NCT02151994|5607038|P8|STARTED|Single Ascending Dose (SAD)||6
2283843|NCT02151994|5607039|P7|STARTED|Single Ascending Dose (SAD)||6
2283844|NCT02151994|5607040|P6|STARTED|Single Ascending Dose (SAD)||6
2283845|NCT02151994|5607041|P5|STARTED|Single Ascending Dose (SAD)||6
2283846|NCT02151994|5607042|P4|STARTED|Single Ascending Dose (SAD)||6
2283847|NCT02151994|5607043|P3|STARTED|Single Ascending Dose (SAD)||6
2283848|NCT02151994|5607044|P2|STARTED|Single Ascending Dose (SAD)||6
2283849|NCT02151994|5607045|P1|STARTED|Single Ascending Dose (SAD)||18
2283862|NCT02151851|5607104|P2|NOT COMPLETED|Overall Study||130
2283863|NCT02151851|5607105|P1|NOT COMPLETED|Overall Study||76
2283864|NCT02151851|5607104|P2|COMPLETED|Overall Study||186
2283865|NCT02151851|5607105|P1|COMPLETED|Overall Study||38
2283866|NCT02151851|5607104|P2|Included in the Safety Set|Overall Study||316
2283867|NCT02151851|5607105|P1|Included in the Safety Set|Overall Study||113
2283868|NCT02151851|5607104|P2|STARTED|Overall Study||316
2283869|NCT02151851|5607105|P1|STARTED|Overall Study||114
2283870|NCT02151786|5607117|P1|NOT COMPLETED|Overall Study||36
2283871|NCT02151786|5607117|P1|COMPLETED|Overall Study||1084
2283872|NCT02151786|5607117|P1|STARTED|Overall Study||1120
2283873|NCT02151773|5607128|P1|NOT COMPLETED|Overall Study||64
2283874|NCT02151773|5607128|P1|COMPLETED|Overall Study||3429
2283875|NCT02151773|5607128|P1|STARTED|Overall Study||3493
2283876|NCT02151682|5607135|P6|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||7
2283877|NCT02151682|5607136|P5|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
2283878|NCT02151682|5607137|P4|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
2283879|NCT02151682|5607138|P3|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
2283880|NCT02151682|5607139|P2|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
2283881|NCT02151682|5607140|P1|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
2283882|NCT02151682|5607135|P6|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||19
2283883|NCT02151682|5607136|P5|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
2283884|NCT02151682|5607137|P4|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
2283885|NCT02151682|5607138|P3|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
2283886|NCT02151682|5607139|P2|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
2283887|NCT02151682|5607140|P1|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
2283888|NCT02151682|5607135|P6|STARTED|Part 2: Observ. Aft. Tapent. Extension|19 tapentadol and 7 morphine completers (Part 1) who discontinued from tapentadol treatm. in Part 2.|26
2283889|NCT02151682|5607136|P5|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
2283890|NCT02151682|5607137|P4|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
2283891|NCT02151682|5607138|P3|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
2283892|NCT02151682|5607139|P2|STARTED|Part 2: Observ. Aft. Tapent. Extension|Group not defined for Part 2.|0
2283893|NCT02151682|5607140|P1|STARTED|Part 2: Observ. Aft. Tapent. Extension|Group not defined for Part 2.|0
2283894|NCT02151682|5607135|P6|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
2283895|NCT02151682|5607136|P5|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
2283896|NCT02151682|5607137|P4|NOT COMPLETED|Part 2: Tapent. Extension or Observation||4
2283897|NCT02151682|5607138|P3|NOT COMPLETED|Part 2: Tapent. Extension or Observation||28
2283898|NCT02151682|5607139|P2|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
2283899|NCT02151682|5607140|P1|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
2283900|NCT02151682|5607135|P6|COMPLETED|Part 2: Tapent. Extension or Observation||0
2283901|NCT02151682|5607136|P5|COMPLETED|Part 2: Tapent. Extension or Observation||14
2283902|NCT02151682|5607137|P4|COMPLETED|Part 2: Tapent. Extension or Observation||14
2283903|NCT02151682|5607138|P3|COMPLETED|Part 2: Tapent. Extension or Observation|12 Month of tapentadol treatment completed and final visit of Part 2 performed.|8
2283904|NCT02151682|5607139|P2|COMPLETED|Part 2: Tapent. Extension or Observation||0
2283905|NCT02151682|5607140|P1|COMPLETED|Part 2: Tapent. Extension or Observation||0
2283906|NCT02151682|5607135|P6|STARTED|Part 2: Tapent. Extension or Observation||0
2283907|NCT02151682|5607136|P5|STARTED|Part 2: Tapent. Extension or Observation|12 Completers and 2 non-completers from morphine treatment in Part 1.|14
2283908|NCT02151682|5607137|P4|STARTED|Part 2: Tapent. Extension or Observation|14 Completers and 4 of 5 non-completers on tapentadol in Part 1.|18
2283909|NCT02151682|5607138|P3|STARTED|Part 2: Tapent. Extension or Observation|26 Completers on tapentadol PR and 10 completers on morphine PR from Part 1.|36
2283910|NCT02151682|5607139|P2|STARTED|Part 2: Tapent. Extension or Observation|Group not defined for Part 2.|0
2283911|NCT02151682|5607140|P1|STARTED|Part 2: Tapent. Extension or Observation|Group not defined for Part 2.|0
2283912|NCT02151682|5607135|P6|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
2283913|NCT02151682|5607136|P5|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
2283914|NCT02151682|5607137|P4|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
2283915|NCT02151682|5607138|P3|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
2283916|NCT02151682|5607139|P2|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||5
2283917|NCT02151682|5607140|P1|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||2
2283918|NCT02151682|5607135|P6|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
2283919|NCT02151682|5607136|P5|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
2283920|NCT02151682|5607137|P4|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
2283921|NCT02151682|5607138|P3|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
2283922|NCT02151682|5607139|P2|COMPLETED|Part 1: 14 Days Morphine or Tapentadol|14-Day treatment and final post-treatment visit completed or tapentadol treatment in Part 2 entered.|40
2283923|NCT02151682|5607140|P1|COMPLETED|Part 1: 14 Days Morphine or Tapentadol|14-Day treatment and final post-treatment visit completed or tapentadol treatment in Part 2 entered.|22
2283924|NCT02151682|5607135|P6|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
2283925|NCT02151682|5607136|P5|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
2283926|NCT02151682|5607137|P4|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
2283927|NCT02151682|5607138|P3|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
2283928|NCT02151682|5607139|P2|STARTED|Part 1: 14 Days Morphine or Tapentadol||45
2283929|NCT02151682|5607140|P1|STARTED|Part 1: 14 Days Morphine or Tapentadol||24
2283930|NCT02151643|5607190|P5|NOT COMPLETED|Overall Study||3
2283931|NCT02151643|5607191|P4|NOT COMPLETED|Overall Study||7
2283932|NCT02151643|5607192|P3|NOT COMPLETED|Overall Study||4
2283933|NCT02151643|5607193|P2|NOT COMPLETED|Overall Study||4
2283934|NCT02151643|5607194|P1|NOT COMPLETED|Overall Study||6
2283935|NCT02151643|5607190|P5|COMPLETED|Overall Study||35
2283936|NCT02151643|5607191|P4|COMPLETED|Overall Study||32
2283937|NCT02151643|5607192|P3|COMPLETED|Overall Study||21
2283938|NCT02151643|5607193|P2|COMPLETED|Overall Study||21
2283939|NCT02151643|5607194|P1|COMPLETED|Overall Study||20
2283940|NCT02151643|5607190|P5|STARTED|Overall Study||38
2283941|NCT02151643|5607191|P4|STARTED|Overall Study||39
2283942|NCT02151643|5607192|P3|STARTED|Overall Study||25
2283943|NCT02151643|5607193|P2|STARTED|Overall Study||25
2283944|NCT02151643|5607194|P1|STARTED|Overall Study||26
2283951|NCT02151487|5607248|P4|NOT COMPLETED|Overall Study||3
2283952|NCT02151487|5607249|P3|NOT COMPLETED|Overall Study||4
2283953|NCT02151487|5607250|P2|NOT COMPLETED|Overall Study||5
2283954|NCT02151487|5607251|P1|NOT COMPLETED|Overall Study||2
2283955|NCT02151487|5607248|P4|COMPLETED|Overall Study||20
2283956|NCT02151487|5607249|P3|COMPLETED|Overall Study||16
2283957|NCT02151487|5607250|P2|COMPLETED|Overall Study||22
2283958|NCT02151487|5607251|P1|COMPLETED|Overall Study||25
2283959|NCT02151487|5607248|P4|STARTED|Overall Study||23
2283960|NCT02151487|5607249|P3|STARTED|Overall Study||20
2283961|NCT02151487|5607250|P2|STARTED|Overall Study||27
2283962|NCT02151487|5607251|P1|STARTED|Overall Study||27
2283963|NCT02151461|5607269|P4|NOT COMPLETED|Overall Study||4
2283964|NCT02151461|5607270|P3|NOT COMPLETED|Overall Study||3
2283965|NCT02151461|5607271|P2|NOT COMPLETED|Overall Study||1
2283966|NCT02151461|5607272|P1|NOT COMPLETED|Overall Study||6
2283967|NCT02151461|5607269|P4|COMPLETED|Overall Study||19
2283968|NCT02151461|5607270|P3|COMPLETED|Overall Study||21
2283969|NCT02151461|5607271|P2|COMPLETED|Overall Study||24
2283970|NCT02151461|5607272|P1|COMPLETED|Overall Study||18
2283971|NCT02151461|5607269|P4|STARTED|Overall Study||23
2283972|NCT02151461|5607270|P3|STARTED|Overall Study||24
2283973|NCT02151461|5607271|P2|STARTED|Overall Study||25
2283974|NCT02151461|5607272|P1|STARTED|Overall Study||24
2283975|NCT02151448|5607310|P1|NOT COMPLETED|Phase 2||0
2283976|NCT02151448|5607310|P1|COMPLETED|Phase 2||55
2283977|NCT02151448|5607310|P1|STARTED|Phase 2||55
2283978|NCT02151448|5607310|P1|NOT COMPLETED|Phase 1||0
2283979|NCT02151448|5607310|P1|COMPLETED|Phase 1||9
2283980|NCT02151448|5607310|P1|STARTED|Phase 1||9
2283981|NCT02151383|5607328|P3|NOT COMPLETED|Overall Study||0
2283982|NCT02151383|5607329|P2|NOT COMPLETED|Overall Study||0
2283983|NCT02151383|5607330|P1|NOT COMPLETED|Overall Study||0
2283984|NCT02151383|5607328|P3|COMPLETED|Overall Study||1
2283985|NCT02151383|5607329|P2|COMPLETED|Overall Study||3
2283986|NCT02151383|5607330|P1|COMPLETED|Overall Study||8
2283987|NCT02151383|5607328|P3|High-dose|Overall Study||0
2283988|NCT02151383|5607329|P2|High-dose|Overall Study||0
2283989|NCT02151383|5607330|P1|High-dose|Overall Study||6
2283990|NCT02151383|5607328|P3|Low-dose|Overall Study||1
2283991|NCT02151383|5607329|P2|Low-dose|Overall Study||3
2283992|NCT02151383|5607330|P1|Low-dose|Overall Study||2
2283993|NCT02151383|5607328|P3|STARTED|Overall Study||1
2283994|NCT02151383|5607329|P2|STARTED|Overall Study||3
2283995|NCT02151383|5607330|P1|STARTED|Overall Study||8
2283996|NCT02151331|5607388|P2|NOT COMPLETED|Overall Study||40
2283997|NCT02151331|5607389|P1|NOT COMPLETED|Overall Study||32
2283998|NCT02151331|5607388|P2|COMPLETED|Overall Study||52
2283999|NCT02151331|5607389|P1|COMPLETED|Overall Study||45
2284000|NCT02151331|5607388|P2|STARTED|Overall Study||92
2284001|NCT02151331|5607389|P1|STARTED|Overall Study||77
2284002|NCT02151266|5607404|P3|NOT COMPLETED|Overall Study||7
2284003|NCT02151266|5607405|P2|NOT COMPLETED|Overall Study||15
2284004|NCT02151266|5607406|P1|NOT COMPLETED|Overall Study||8
2284005|NCT02151266|5607404|P3|COMPLETED|Overall Study||14
2284006|NCT02151266|5607405|P2|COMPLETED|Overall Study||14
2284007|NCT02151266|5607406|P1|COMPLETED|Overall Study||11
2284008|NCT02151266|5607404|P3|STARTED|Overall Study||21
2284009|NCT02151266|5607405|P2|STARTED|Overall Study||29
2284010|NCT02151266|5607406|P1|STARTED|Overall Study||19
2284011|NCT02151253|5607432|P2|NOT COMPLETED|Overall Study||0
2284012|NCT02151253|5607433|P1|NOT COMPLETED|Overall Study||0
2284013|NCT02151253|5607432|P2|COMPLETED|Overall Study||15
2284014|NCT02151253|5607433|P1|COMPLETED|Overall Study||13
2284015|NCT02151253|5607432|P2|STARTED|Overall Study||15
2284016|NCT02151253|5607433|P1|STARTED|Overall Study||13
2284017|NCT02151149|5607449|P2|NOT COMPLETED|Follow-Up Period||37
2284018|NCT02151149|5607450|P1|NOT COMPLETED|Follow-Up Period||39
2284019|NCT02151149|5607449|P2|COMPLETED|Follow-Up Period|Completed = participants alive at final data cut-off date|18
2284020|NCT02151149|5607450|P1|COMPLETED|Follow-Up Period|Completed = participants alive at final data cut-off date|19
2284021|NCT02151149|5607449|P2|STARTED|Follow-Up Period||55
2284022|NCT02151149|5607450|P1|STARTED|Follow-Up Period||58
2284023|NCT02151149|5607449|P2|NOT COMPLETED|Treatment Period||71
2284024|NCT02151149|5607450|P1|NOT COMPLETED|Treatment Period||70
2284025|NCT02151149|5607449|P2|COMPLETED|Treatment Period||1
2284026|NCT02151149|5607450|P1|COMPLETED|Treatment Period||1
2284027|NCT02151149|5607449|P2|Treated Population|Treatment Period||70
2284028|NCT02151149|5607450|P1|Treated Population|Treatment Period||68
2284029|NCT02151149|5607449|P2|STARTED|Treatment Period|2 participants did not receive treatment|72
2284030|NCT02151149|5607450|P1|STARTED|Treatment Period|3 participants did not receive treatment|71
2284031|NCT02151110|5607482|P8|NOT COMPLETED|Overall Study||3
2284032|NCT02151110|5607483|P7|NOT COMPLETED|Overall Study||0
2284033|NCT02151110|5607484|P6|NOT COMPLETED|Overall Study||0
2284034|NCT02151110|5607485|P5|NOT COMPLETED|Overall Study||0
2284035|NCT02151110|5607486|P4|NOT COMPLETED|Overall Study||0
2284036|NCT02151110|5607487|P3|NOT COMPLETED|Overall Study||0
2284037|NCT02151110|5607488|P2|NOT COMPLETED|Overall Study||0
2284038|NCT02151110|5607489|P1|NOT COMPLETED|Overall Study||0
2284039|NCT02151110|5607482|P8|COMPLETED|Overall Study||5
2284040|NCT02151110|5607483|P7|COMPLETED|Overall Study||8
2284041|NCT02151110|5607484|P6|COMPLETED|Overall Study||8
2284042|NCT02151110|5607485|P5|COMPLETED|Overall Study||8
2284043|NCT02151110|5607486|P4|COMPLETED|Overall Study||8
2284044|NCT02151110|5607487|P3|COMPLETED|Overall Study||2
2284045|NCT02151110|5607488|P2|COMPLETED|Overall Study||2
2284046|NCT02151110|5607489|P1|COMPLETED|Overall Study||12
2284047|NCT02151110|5607482|P8|STARTED|Overall Study||8
2284048|NCT02151110|5607483|P7|STARTED|Overall Study||8
2284049|NCT02151110|5607484|P6|STARTED|Overall Study||8
2284050|NCT02151110|5607485|P5|STARTED|Overall Study||8
2284051|NCT02151110|5607486|P4|STARTED|Overall Study||8
2284052|NCT02151110|5607487|P3|STARTED|Overall Study||2
2284053|NCT02151110|5607488|P2|STARTED|Overall Study||2
2284054|NCT02151110|5607489|P1|STARTED|Overall Study||12
2284055|NCT02151058|5607582|P3|NOT COMPLETED|Overall Study||5
2284056|NCT02151058|5607583|P2|NOT COMPLETED|Overall Study||1
2284057|NCT02151058|5607584|P1|NOT COMPLETED|Overall Study||2
2284058|NCT02151058|5607582|P3|COMPLETED|Overall Study||86
2284059|NCT02151058|5607583|P2|COMPLETED|Overall Study||90
2284060|NCT02151058|5607584|P1|COMPLETED|Overall Study||43
2284061|NCT02151058|5607582|P3|STARTED|Overall Study||91
2284062|NCT02151058|5607583|P2|STARTED|Overall Study||91
2284063|NCT02151058|5607584|P1|STARTED|Overall Study||45
2284064|NCT02150954|5607618|P2|NOT COMPLETED|Overall Study||0
2284065|NCT02150954|5607619|P1|NOT COMPLETED|Overall Study||1
2284066|NCT02150954|5607618|P2|COMPLETED|Overall Study||59
2284067|NCT02150954|5607619|P1|COMPLETED|Overall Study||57
2284068|NCT02150954|5607618|P2|STARTED|Overall Study||59
2284069|NCT02150954|5607619|P1|STARTED|Overall Study||58
2284070|NCT02150863|5607644|P3|NOT COMPLETED|Overall Study||0
2284071|NCT02150863|5607645|P2|NOT COMPLETED|Overall Study||1
2284072|NCT02150863|5607646|P1|NOT COMPLETED|Overall Study||0
2284073|NCT02150863|5607644|P3|COMPLETED|Overall Study||0
2284074|NCT02150863|5607645|P2|COMPLETED|Overall Study||0
2284075|NCT02150863|5607646|P1|COMPLETED|Overall Study||0
2284076|NCT02150863|5607644|P3|STARTED|Overall Study||0
2284077|NCT02150863|5607645|P2|STARTED|Overall Study||1
2284078|NCT02150863|5607646|P1|STARTED|Overall Study||0
2284079|NCT02150837|5607656|P2|NOT COMPLETED|Overall Study||125
2284080|NCT02150837|5607657|P1|NOT COMPLETED|Overall Study||25
2284081|NCT02150837|5607656|P2|COMPLETED|Overall Study|There was no predefined study period to complete. 185 remained through the 12 wk primary endpoint.|185
2284082|NCT02150837|5607657|P1|COMPLETED|Overall Study|There was no predefined study period to complete. 37 remained through the 12 wk primary endpoint.|37
2284083|NCT02150837|5607656|P2|STARTED|Overall Study|478 charts were screened with 168 screen failures due to exclusion criteria.|310
2284084|NCT02150837|5607657|P1|STARTED|Overall Study|87 Charts were screened with 25 screen failures due to exclusion criteria.|62
2284085|NCT02150759|5607829|P2|NOT COMPLETED|Overall Study||2
2284086|NCT02150759|5607830|P1|NOT COMPLETED|Overall Study||1
2284087|NCT02150759|5607829|P2|COMPLETED|Overall Study||21
2284088|NCT02150759|5607830|P1|COMPLETED|Overall Study||22
2284089|NCT02150759|5607829|P2|STARTED|Overall Study||23
2284090|NCT02150759|5607830|P1|STARTED|Overall Study||23
2284091|NCT02150499|5607840|P2|NOT COMPLETED|Overall Study||0
2284092|NCT02150499|5607841|P1|NOT COMPLETED|Overall Study||0
2284093|NCT02150499|5607840|P2|COMPLETED|Overall Study||9
2284094|NCT02150499|5607841|P1|COMPLETED|Overall Study||9
2284095|NCT02150499|5607840|P2|STARTED|Overall Study||9
2284096|NCT02150499|5607841|P1|STARTED|Overall Study||9
2284097|NCT02150460|5607863|P2|NOT COMPLETED|Overall Study||0
2284098|NCT02150460|5607864|P1|NOT COMPLETED|Overall Study||0
2284099|NCT02150460|5607863|P2|COMPLETED|Overall Study||50
2284100|NCT02150460|5607864|P1|COMPLETED|Overall Study||50
2284101|NCT02150460|5607863|P2|STARTED|Overall Study||50
2284102|NCT02150460|5607864|P1|STARTED|Overall Study||50
2284103|NCT02150343|5607892|P4|NOT COMPLETED|Overall Study||10
2284104|NCT02150343|5607893|P3|NOT COMPLETED|Overall Study||12
2284105|NCT02150343|5607894|P2|NOT COMPLETED|Overall Study||20
2284106|NCT02150343|5607895|P1|NOT COMPLETED|Overall Study||21
2284107|NCT02150343|5607892|P4|COMPLETED|Overall Study||168
2284108|NCT02150343|5607893|P3|COMPLETED|Overall Study||166
2284109|NCT02150343|5607894|P2|COMPLETED|Overall Study||158
2284110|NCT02150343|5607895|P1|COMPLETED|Overall Study||159
2284111|NCT02150343|5607892|P4|STARTED|Overall Study||178
2284112|NCT02150343|5607893|P3|STARTED|Overall Study||178
2284113|NCT02150343|5607894|P2|STARTED|Overall Study||178
2284114|NCT02150343|5607895|P1|STARTED|Overall Study||180
2284115|NCT02150213|5607933|P1|NOT COMPLETED|Overall Study||2
2284116|NCT02150213|5607933|P1|COMPLETED|Overall Study||57
2284117|NCT02150213|5607933|P1|STARTED|Overall Study||59
2284118|NCT02150109|5607938|P1|NOT COMPLETED|Overall Study||0
2284119|NCT02150109|5607938|P1|COMPLETED|Overall Study||372
2284120|NCT02150109|5607938|P1|STARTED|Overall Study||372
2284121|NCT02150057|5607952|P2|NOT COMPLETED|Overall Study||4
2284122|NCT02150057|5607953|P1|NOT COMPLETED|Overall Study||6
2284123|NCT02150057|5607952|P2|COMPLETED|Overall Study||22
2284124|NCT02150057|5607953|P1|COMPLETED|Overall Study||19
2284125|NCT02150057|5607952|P2|STARTED|Overall Study||26
2284126|NCT02150057|5607953|P1|STARTED|Overall Study||25
2284127|NCT02150044|5607959|P1|NOT COMPLETED|Overall Study||0
2284128|NCT02150044|5607959|P1|COMPLETED|Overall Study||29
2284129|NCT02150044|5607959|P1|Study Cohort|Overall Study||13
2284130|NCT02150044|5607959|P1|Lead-In Subjects|Overall Study||16
2284131|NCT02150044|5607959|P1|STARTED|Overall Study||29
2284132|NCT02149875|5607968|P3|NOT COMPLETED|Overall Study||9
2284133|NCT02149875|5607969|P2|NOT COMPLETED|Overall Study||8
2284134|NCT02149875|5607970|P1|NOT COMPLETED|Overall Study||7
2284135|NCT02149875|5607968|P3|COMPLETED|Overall Study||20
2284136|NCT02149875|5607969|P2|COMPLETED|Overall Study||20
2284137|NCT02149875|5607970|P1|COMPLETED|Overall Study||20
2284138|NCT02149875|5607968|P3|STARTED|Overall Study||29
2284139|NCT02149875|5607969|P2|STARTED|Overall Study||28
2284140|NCT02149875|5607970|P1|STARTED|Overall Study||27
2284141|NCT02149836|5607981|P1|NOT COMPLETED|Overall Study||1
2284142|NCT02149836|5607981|P1|COMPLETED|Overall Study||17
2284143|NCT02149836|5607981|P1|STARTED|Overall Study||18
2284144|NCT02149524|5607990|P2|NOT COMPLETED|Overall Study||57
2284145|NCT02149524|5607991|P1|NOT COMPLETED|Overall Study||54
2284146|NCT02149524|5607990|P2|COMPLETED|Overall Study||380
2284147|NCT02149524|5607991|P1|COMPLETED|Overall Study||384
2284148|NCT02149524|5607990|P2|STARTED|Overall Study||437
2284149|NCT02149524|5607991|P1|STARTED|Overall Study||438
2284150|NCT02149420|5608008|P3|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||0
2284151|NCT02149420|5608009|P2|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||0
2284152|NCT02149420|5608010|P1|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||1
2284153|NCT02149420|5608008|P3|COMPLETED|Open Label VAY736 10 mg/kg Extension||0
2284154|NCT02149420|5608009|P2|COMPLETED|Open Label VAY736 10 mg/kg Extension||0
2284155|NCT02149420|5608010|P1|COMPLETED|Open Label VAY736 10 mg/kg Extension||4
2284156|NCT02149420|5608008|P3|STARTED|Open Label VAY736 10 mg/kg Extension|Only patients origianally randomized to Placebo were allowed to enter this Period.|0
2284157|NCT02149420|5608009|P2|STARTED|Open Label VAY736 10 mg/kg Extension|Only patients origianally randomized to Placebo were allowed to enter this Period.|0
2284158|NCT02149420|5608010|P1|STARTED|Open Label VAY736 10 mg/kg Extension|Patients received single dose of VAY736 10mg/kg at Week 24.|5
2284159|NCT02149420|5608008|P3|NOT COMPLETED|Core Study||2
2284160|NCT02149420|5608009|P2|NOT COMPLETED|Core Study||1
2284161|NCT02149420|5608010|P1|NOT COMPLETED|Core Study||0
2284162|NCT02149420|5608008|P3|COMPLETED|Core Study||10
2284163|NCT02149420|5608009|P2|COMPLETED|Core Study||5
2284164|NCT02149420|5608010|P1|COMPLETED|Core Study||9
2284165|NCT02149420|5608008|P3|PD (Pharmacodynamics) Analysis Set|Core Study||12
2284166|NCT02149420|5608009|P2|PD (Pharmacodynamics) Analysis Set|Core Study||6
2284167|NCT02149420|5608010|P1|PD (Pharmacodynamics) Analysis Set|Core Study||9
2284168|NCT02149420|5608008|P3|PK Analysis Set|Core Study||12
2284169|NCT02149420|5608009|P2|PK Analysis Set|Core Study||6
2284170|NCT02149420|5608010|P1|PK Analysis Set|Core Study|for patients entering open label VAY736 10 mg/kg at Week 24|5
2284171|NCT02149420|5608008|P3|Safety Analysis Set|Core Study||12
2284172|NCT02149420|5608009|P2|Safety Analysis Set|Core Study||6
2284173|NCT02149420|5608010|P1|Safety Analysis Set|Core Study||9
2284174|NCT02149420|5608008|P3|STARTED|Core Study||12
2284175|NCT02149420|5608009|P2|STARTED|Core Study||6
2284176|NCT02149420|5608010|P1|STARTED|Core Study||9
2284177|NCT02149342|5608060|P1|NOT COMPLETED|Overall Study||0
2284178|NCT02149342|5608060|P1|COMPLETED|Overall Study|14 patients|14
2284179|NCT02149342|5608060|P1|STARTED|Overall Study|14 patients|14
2284180|NCT02149303|5608072|P1|NOT COMPLETED|Overall Study||0
2284181|NCT02149303|5608072|P1|COMPLETED|Overall Study||191
2284182|NCT02149303|5608072|P1|STARTED|Overall Study||191
2284183|NCT02149264|5608078|P1|NOT COMPLETED|Overall Study||20
2284184|NCT02149264|5608078|P1|COMPLETED|Overall Study||139
2284185|NCT02149264|5608078|P1|STARTED|Overall Study|Of the 160 enrolled subjects, one discontinued before receiving treatment.|159
2284186|NCT02149199|5608094|P3|NOT COMPLETED|Overall Study||147
2284187|NCT02149199|5608095|P2|NOT COMPLETED|Overall Study||193
2284188|NCT02149199|5608096|P1|NOT COMPLETED|Overall Study||133
2284189|NCT02149199|5608094|P3|COMPLETED|Overall Study||1135
2284190|NCT02149199|5608095|P2|COMPLETED|Overall Study||1084
2284191|NCT02149199|5608096|P1|COMPLETED|Overall Study||1144
2284192|NCT02149199|5608094|P3|STARTED|Overall Study||1282
2284193|NCT02149199|5608095|P2|STARTED|Overall Study||1277
2284194|NCT02149199|5608096|P1|STARTED|Overall Study||1277
2284195|NCT02149173|5608161|P1|NOT COMPLETED|Overall Study||0
2284196|NCT02149173|5608161|P1|COMPLETED|Overall Study||29
2284197|NCT02149173|5608161|P1|STARTED|Overall Study||29
2284198|NCT02149108|5608175|P2|NOT COMPLETED|Overall Study||383
2284199|NCT02149108|5608176|P1|NOT COMPLETED|Overall Study||380
2284200|NCT02149108|5608175|P2|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|3
2284201|NCT02149108|5608176|P1|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|2
2284202|NCT02149108|5608175|P2|STARTED|Overall Study|Randomised patients.|386
2284203|NCT02149108|5608176|P1|STARTED|Overall Study|Randomised patients.|382
2284204|NCT02148952|5608190|P2|NOT COMPLETED|Follow-Up||279
2284205|NCT02148952|5608191|P1|NOT COMPLETED|Follow-Up||265
2284206|NCT02148952|5608190|P2|COMPLETED|Follow-Up||77347
2284207|NCT02148952|5608191|P1|COMPLETED|Follow-Up||79798
2284208|NCT02148952|5608190|P2|STARTED|Follow-Up||77626
2284209|NCT02148952|5608191|P1|STARTED|Follow-Up||80063
2284210|NCT02148952|5608190|P2|NOT COMPLETED|Assessing Eligibility and Consent||3147
2284211|NCT02148952|5608191|P1|NOT COMPLETED|Assessing Eligibility and Consent||3103
2284212|NCT02148952|5608190|P2|COMPLETED|Assessing Eligibility and Consent||77626
2284213|NCT02148952|5608191|P1|COMPLETED|Assessing Eligibility and Consent||80063
2284214|NCT02148952|5608190|P2|STARTED|Assessing Eligibility and Consent||80773
2284215|NCT02148952|5608191|P1|STARTED|Assessing Eligibility and Consent||83166
2284216|NCT02148874|5608249|P2|NOT COMPLETED|Overall Study||2
2284217|NCT02148874|5608250|P1|NOT COMPLETED|Overall Study||7
2284218|NCT02148874|5608249|P2|COMPLETED|Overall Study||84
2284219|NCT02148874|5608250|P1|COMPLETED|Overall Study||194
2284220|NCT02148874|5608249|P2|STARTED|Overall Study||86
2284221|NCT02148874|5608250|P1|STARTED|Overall Study||201
2284222|NCT02148835|5608262|P2|NOT COMPLETED|Overall Study||0
2284223|NCT02148835|5608263|P1|NOT COMPLETED|Overall Study||0
2284224|NCT02148835|5608262|P2|COMPLETED|Overall Study||22
2284225|NCT02148835|5608263|P1|COMPLETED|Overall Study||22
2284226|NCT02148835|5608262|P2|STARTED|Overall Study||22
2284227|NCT02148835|5608263|P1|STARTED|Overall Study||22
2284228|NCT02148809|5608269|P1|NOT COMPLETED|Overall Study||0
2284229|NCT02148809|5608269|P1|COMPLETED|Overall Study||14
2284230|NCT02148809|5608269|P1|STARTED|Overall Study||14
2284231|NCT02148718|5608274|P1|NOT COMPLETED|Overall Study||31
2284232|NCT02148718|5608274|P1|COMPLETED|Overall Study||55
2284233|NCT02148718|5608274|P1|STARTED|Overall Study||86
2284234|NCT02148588|5608295|P1|NOT COMPLETED|Overall Study||0
2284235|NCT02148588|5608295|P1|COMPLETED|Overall Study||8
2284236|NCT02148588|5608295|P1|STARTED|Overall Study||8
2284237|NCT02148523|5608307|P3|NOT COMPLETED|Overall Study||0
2284238|NCT02148523|5608308|P2|NOT COMPLETED|Overall Study||0
2284239|NCT02148523|5608309|P1|NOT COMPLETED|Overall Study||0
2284240|NCT02148523|5608307|P3|COMPLETED|Overall Study||67
2284241|NCT02148523|5608308|P2|COMPLETED|Overall Study||67
2284242|NCT02148523|5608309|P1|COMPLETED|Overall Study||67
2284243|NCT02148523|5608307|P3|STARTED|Overall Study||67
2284244|NCT02148523|5608308|P2|STARTED|Overall Study||67
2284245|NCT02148523|5608309|P1|STARTED|Overall Study||67
2284246|NCT02148445|5608322|P2|NOT COMPLETED|Overall Study||3
2284247|NCT02148445|5608323|P1|NOT COMPLETED|Overall Study||1
2284248|NCT02148445|5608322|P2|COMPLETED|Overall Study||197
2284249|NCT02148445|5608323|P1|COMPLETED|Overall Study||197
2284250|NCT02148445|5608322|P2|STARTED|Overall Study||200
2284251|NCT02148445|5608323|P1|STARTED|Overall Study||198
2284252|NCT02148133|5608359|P1|NOT COMPLETED|Overall Study||5
2284253|NCT02148133|5608359|P1|COMPLETED|Overall Study||16
2284254|NCT02148133|5608359|P1|Pharmacokinetic Analysis Set (PAS)|Overall Study||21
2284255|NCT02148133|5608359|P1|Safety Set (SS)|Overall Study||21
2284256|NCT02148133|5608359|P1|STARTED|Overall Study||21
2284257|NCT02148107|5608381|P3|NOT COMPLETED|Overall Study||0
2284258|NCT02148107|5608382|P2|NOT COMPLETED|Overall Study||0
2284259|NCT02148107|5608383|P1|NOT COMPLETED|Overall Study||0
2284260|NCT02148107|5608381|P3|COMPLETED|Overall Study||3
2284261|NCT02148107|5608382|P2|COMPLETED|Overall Study||7
2284262|NCT02148107|5608383|P1|COMPLETED|Overall Study||8
2284263|NCT02148107|5608381|P3|STARTED|Overall Study||3
2284264|NCT02148107|5608382|P2|STARTED|Overall Study||7
2284265|NCT02148107|5608383|P1|STARTED|Overall Study||8
2284266|NCT02147899|5608402|P3|NOT COMPLETED|Overall Study||0
2284267|NCT02147899|5608403|P2|NOT COMPLETED|Overall Study||0
2284268|NCT02147899|5608404|P1|NOT COMPLETED|Overall Study||0
2284269|NCT02147899|5608402|P3|COMPLETED|Overall Study||72
2284270|NCT02147899|5608403|P2|COMPLETED|Overall Study||72
2284271|NCT02147899|5608404|P1|COMPLETED|Overall Study||71
2284272|NCT02147899|5608402|P3|STARTED|Overall Study||72
2284273|NCT02147899|5608403|P2|STARTED|Overall Study||72
2284274|NCT02147899|5608404|P1|STARTED|Overall Study||71
2284275|NCT02147834|5608417|P2|NOT COMPLETED|Overall Study||0
2284276|NCT02147834|5608418|P1|NOT COMPLETED|Overall Study||0
2284277|NCT02147834|5608417|P2|COMPLETED|Overall Study||2
2284278|NCT02147834|5608418|P1|COMPLETED|Overall Study||3
2284279|NCT02147834|5608417|P2|STARTED|Overall Study||2
2284280|NCT02147834|5608418|P1|STARTED|Overall Study||3
2284281|NCT02147691|5608430|P2|NOT COMPLETED|Overall Study||1
2284282|NCT02147691|5608431|P1|NOT COMPLETED|Overall Study||4
2284283|NCT02147691|5608430|P2|COMPLETED|Overall Study||11
2284284|NCT02147691|5608431|P1|COMPLETED|Overall Study||6
2284285|NCT02147691|5608430|P2|STARTED|Overall Study||12
2284286|NCT02147691|5608431|P1|STARTED|Overall Study||10
2284287|NCT02147613|5608477|P2|NOT COMPLETED|Overall Study||3
2284288|NCT02147613|5608478|P1|NOT COMPLETED|Overall Study||1
2284289|NCT02147613|5608477|P2|COMPLETED|Overall Study||6
2284290|NCT02147613|5608478|P1|COMPLETED|Overall Study||9
2284291|NCT02147613|5608477|P2|STARTED|Overall Study||9
2284292|NCT02147613|5608478|P1|STARTED|Overall Study||10
2284293|NCT02147587|5608490|P2|NOT COMPLETED|Overall Study||5
2284294|NCT02147587|5608491|P1|NOT COMPLETED|Overall Study||11
2284295|NCT02147587|5608490|P2|COMPLETED|Overall Study||50
2284296|NCT02147587|5608491|P1|COMPLETED|Overall Study||46
2284297|NCT02147587|5608490|P2|STARTED|Overall Study||55
2284298|NCT02147587|5608491|P1|STARTED|Overall Study||57
2284299|NCT02147561|5608511|P1|NOT COMPLETED|Overall Study||4
2284300|NCT02147561|5608511|P1|COMPLETED|Overall Study||276
2284301|NCT02147561|5608511|P1|STARTED|Overall Study||280
2284302|NCT02147522|5608519|P2|NOT COMPLETED|Overall Study||48
2284303|NCT02147522|5608520|P1|NOT COMPLETED|Overall Study||56
2284304|NCT02147522|5608519|P2|COMPLETED|Overall Study||122
2284305|NCT02147522|5608520|P1|COMPLETED|Overall Study||122
2284306|NCT02147522|5608519|P2|STARTED|Overall Study||170
2284307|NCT02147522|5608520|P1|STARTED|Overall Study||178
2284308|NCT02147353|5608532|P2|NOT COMPLETED|Overall Study||0
2284309|NCT02147353|5608533|P1|NOT COMPLETED|Overall Study||9
2284310|NCT02147353|5608532|P2|COMPLETED|Overall Study||21
2284311|NCT02147353|5608533|P1|COMPLETED|Overall Study||12
2284312|NCT02147353|5608532|P2|STARTED|Overall Study||21
2284313|NCT02147353|5608533|P1|STARTED|Overall Study||21
2284314|NCT02147301|5608551|P1|NOT COMPLETED|Overall Study||0
2284315|NCT02147301|5608551|P1|COMPLETED|Overall Study||17
2284316|NCT02147301|5608551|P1|STARTED|Overall Study||17
2284317|NCT02147288|5608566|P10|NOT COMPLETED|Overall Study||0
2284318|NCT02147288|5608567|P9|NOT COMPLETED|Overall Study||0
2284319|NCT02147288|5608568|P8|NOT COMPLETED|Overall Study||0
2284320|NCT02147288|5608569|P7|NOT COMPLETED|Overall Study||0
2284321|NCT02147288|5608570|P6|NOT COMPLETED|Overall Study||0
2284322|NCT02147288|5608571|P5|NOT COMPLETED|Overall Study||0
2284323|NCT02147288|5608572|P4|NOT COMPLETED|Overall Study||0
2284324|NCT02147288|5608573|P3|NOT COMPLETED|Overall Study||0
2284325|NCT02147288|5608574|P2|NOT COMPLETED|Overall Study||2
2284326|NCT02147288|5608575|P1|NOT COMPLETED|Overall Study||1
2284327|NCT02147288|5608566|P10|COMPLETED|Overall Study||0
2284328|NCT02147288|5608567|P9|COMPLETED|Overall Study||0
2284329|NCT02147288|5608568|P8|COMPLETED|Overall Study||0
2284330|NCT02147288|5608569|P7|COMPLETED|Overall Study||0
2284331|NCT02147288|5608570|P6|COMPLETED|Overall Study||0
2284332|NCT02147288|5608571|P5|COMPLETED|Overall Study||0
2284333|NCT02147288|5608572|P4|COMPLETED|Overall Study||0
2284334|NCT02147288|5608573|P3|COMPLETED|Overall Study||0
2284335|NCT02147288|5608574|P2|COMPLETED|Overall Study||22
2284336|NCT02147288|5608575|P1|COMPLETED|Overall Study||21
2284337|NCT02147288|5608566|P10|STARTED|Overall Study||0
2284338|NCT02147288|5608567|P9|STARTED|Overall Study||0
2284339|NCT02147288|5608568|P8|STARTED|Overall Study||0
2284340|NCT02147288|5608569|P7|STARTED|Overall Study||0
2284341|NCT02147288|5608570|P6|STARTED|Overall Study||0
2284342|NCT02147288|5608571|P5|STARTED|Overall Study||0
2284343|NCT02147288|5608572|P4|STARTED|Overall Study||0
2284344|NCT02147288|5608573|P3|STARTED|Overall Study||0
2284345|NCT02147288|5608574|P2|STARTED|Overall Study||24
2284346|NCT02147288|5608575|P1|STARTED|Overall Study||22
2284347|NCT02147197|5608584|P3|NOT COMPLETED|Overall Study||9
2284348|NCT02147197|5608585|P2|NOT COMPLETED|Overall Study||6
2284349|NCT02147197|5608586|P1|NOT COMPLETED|Overall Study||9
2284350|NCT02147197|5608584|P3|COMPLETED|Overall Study||39
2284351|NCT02147197|5608585|P2|COMPLETED|Overall Study||47
2284352|NCT02147197|5608586|P1|COMPLETED|Overall Study||47
2284353|NCT02147197|5608584|P3|STARTED|Overall Study||48
2284354|NCT02147197|5608585|P2|STARTED|Overall Study||53
2284355|NCT02147197|5608586|P1|STARTED|Overall Study||56
2284356|NCT02147184|5608605|P2|NOT COMPLETED|Overall Study||27
2284357|NCT02147184|5608606|P1|NOT COMPLETED|Overall Study||49
2284358|NCT02147184|5608605|P2|COMPLETED|Overall Study||110
2284359|NCT02147184|5608606|P1|COMPLETED|Overall Study||78
2284360|NCT02147184|5608605|P2|STARTED|Overall Study||137
2284361|NCT02147184|5608606|P1|STARTED|Overall Study||127
2284362|NCT02147158|5608630|P6|NOT COMPLETED|Off-Treatment Interval 2||4
2284363|NCT02147158|5608631|P5|NOT COMPLETED|Off-Treatment Interval 2||2
2284364|NCT02147158|5608632|P4|NOT COMPLETED|Off-Treatment Interval 2||11
2284365|NCT02147158|5608633|P3|NOT COMPLETED|Off-Treatment Interval 2||10
2284366|NCT02147158|5608634|P2|NOT COMPLETED|Off-Treatment Interval 2||4
2284367|NCT02147158|5608635|P1|NOT COMPLETED|Off-Treatment Interval 2||4
2284368|NCT02147158|5608630|P6|COMPLETED|Off-Treatment Interval 2||39
2284369|NCT02147158|5608631|P5|COMPLETED|Off-Treatment Interval 2||39
2284370|NCT02147158|5608632|P4|COMPLETED|Off-Treatment Interval 2||66
2284371|NCT02147158|5608633|P3|COMPLETED|Off-Treatment Interval 2||69
2284372|NCT02147158|5608634|P2|COMPLETED|Off-Treatment Interval 2||25
2284373|NCT02147158|5608635|P1|COMPLETED|Off-Treatment Interval 2||36
2284374|NCT02147158|5608630|P6|STARTED|Off-Treatment Interval 2||43
2284375|NCT02147158|5608631|P5|STARTED|Off-Treatment Interval 2||41
2284376|NCT02147158|5608632|P4|STARTED|Off-Treatment Interval 2||77
2284377|NCT02147158|5608633|P3|STARTED|Off-Treatment Interval 2||79
2284378|NCT02147158|5608634|P2|STARTED|Off-Treatment Interval 2||29
2284379|NCT02147158|5608635|P1|STARTED|Off-Treatment Interval 2||40
2284380|NCT02147158|5608630|P6|NOT COMPLETED|Treatment Course 2||2
2284381|NCT02147158|5608631|P5|NOT COMPLETED|Treatment Course 2||0
2284382|NCT02147158|5608632|P4|NOT COMPLETED|Treatment Course 2||5
2284383|NCT02147158|5608633|P3|NOT COMPLETED|Treatment Course 2||5
2284384|NCT02147158|5608634|P2|NOT COMPLETED|Treatment Course 2||5
2284385|NCT02147158|5608635|P1|NOT COMPLETED|Treatment Course 2||1
2284386|NCT02147158|5608630|P6|COMPLETED|Treatment Course 2||43
2284387|NCT02147158|5608631|P5|COMPLETED|Treatment Course 2||41
2284388|NCT02147158|5608632|P4|COMPLETED|Treatment Course 2||77
2284389|NCT02147158|5608633|P3|COMPLETED|Treatment Course 2||79
2284390|NCT02147158|5608634|P2|COMPLETED|Treatment Course 2||29
2284391|NCT02147158|5608635|P1|COMPLETED|Treatment Course 2||40
2284392|NCT02147158|5608630|P6|STARTED|Treatment Course 2||45
2284393|NCT02147158|5608631|P5|STARTED|Treatment Course 2||41
2284394|NCT02147158|5608632|P4|STARTED|Treatment Course 2||82
2284395|NCT02147158|5608633|P3|STARTED|Treatment Course 2||84
2284396|NCT02147158|5608634|P2|STARTED|Treatment Course 2||34
2284397|NCT02147158|5608635|P1|STARTED|Treatment Course 2||41
2284398|NCT02147158|5608630|P6|NOT COMPLETED|Off-Treatment Interval 1||5
2284399|NCT02147158|5608631|P5|NOT COMPLETED|Off-Treatment Interval 1||8
2284400|NCT02147158|5608632|P4|NOT COMPLETED|Off-Treatment Interval 1||15
2284401|NCT02147158|5608633|P3|NOT COMPLETED|Off-Treatment Interval 1||15
2284402|NCT02147158|5608634|P2|NOT COMPLETED|Off-Treatment Interval 1||4
2284403|NCT02147158|5608635|P1|NOT COMPLETED|Off-Treatment Interval 1||10
2284404|NCT02147158|5608630|P6|COMPLETED|Off-Treatment Interval 1||45
2284405|NCT02147158|5608631|P5|COMPLETED|Off-Treatment Interval 1||41
2284406|NCT02147158|5608632|P4|COMPLETED|Off-Treatment Interval 1||82
2284407|NCT02147158|5608633|P3|COMPLETED|Off-Treatment Interval 1||84
2284408|NCT02147158|5608634|P2|COMPLETED|Off-Treatment Interval 1||34
2284409|NCT02147158|5608635|P1|COMPLETED|Off-Treatment Interval 1||41
2284410|NCT02147158|5608630|P6|STARTED|Off-Treatment Interval 1||50
2284411|NCT02147158|5608631|P5|STARTED|Off-Treatment Interval 1||49
2284412|NCT02147158|5608632|P4|STARTED|Off-Treatment Interval 1||97
2284413|NCT02147158|5608633|P3|STARTED|Off-Treatment Interval 1||99
2284414|NCT02147158|5608634|P2|STARTED|Off-Treatment Interval 1||38
2284415|NCT02147158|5608635|P1|STARTED|Off-Treatment Interval 1||51
2284416|NCT02147158|5608630|P6|NOT COMPLETED|Treatment Course 1||8
2284417|NCT02147158|5608631|P5|NOT COMPLETED|Treatment Course 1||6
2284418|NCT02147158|5608632|P4|NOT COMPLETED|Treatment Course 1||13
2284419|NCT02147158|5608633|P3|NOT COMPLETED|Treatment Course 1||8
2284420|NCT02147158|5608634|P2|NOT COMPLETED|Treatment Course 1||9
2284421|NCT02147158|5608635|P1|NOT COMPLETED|Treatment Course 1||4
2284422|NCT02147158|5608630|P6|COMPLETED|Treatment Course 1||50
2284423|NCT02147158|5608631|P5|COMPLETED|Treatment Course 1||49
2284424|NCT02147158|5608632|P4|COMPLETED|Treatment Course 1||97
2284425|NCT02147158|5608633|P3|COMPLETED|Treatment Course 1||99
2284426|NCT02147158|5608634|P2|COMPLETED|Treatment Course 1||38
2284427|NCT02147158|5608635|P1|COMPLETED|Treatment Course 1||51
2284428|NCT02147158|5608630|P6|STARTED|Treatment Course 1||58
2284429|NCT02147158|5608631|P5|STARTED|Treatment Course 1||55
2284430|NCT02147158|5608632|P4|STARTED|Treatment Course 1||110
2284431|NCT02147158|5608633|P3|STARTED|Treatment Course 1||107
2284432|NCT02147158|5608634|P2|STARTED|Treatment Course 1||47
2284433|NCT02147158|5608635|P1|STARTED|Treatment Course 1||55
2284434|NCT02147132|5608664|P4|NOT COMPLETED|Overall Study||0
2284435|NCT02147132|5608665|P3|NOT COMPLETED|Overall Study||0
2284436|NCT02147132|5608666|P2|NOT COMPLETED|Overall Study||0
2284437|NCT02147132|5608667|P1|NOT COMPLETED|Overall Study||1
2284438|NCT02147132|5608664|P4|COMPLETED|Overall Study||2
2284439|NCT02147132|5608665|P3|COMPLETED|Overall Study||1
2284440|NCT02147132|5608666|P2|COMPLETED|Overall Study||2
2284441|NCT02147132|5608667|P1|COMPLETED|Overall Study||1
2284442|NCT02147132|5608664|P4|STARTED|Overall Study||2
2284443|NCT02147132|5608665|P3|STARTED|Overall Study||1
2284444|NCT02147132|5608666|P2|STARTED|Overall Study||2
2284445|NCT02147132|5608667|P1|STARTED|Overall Study||2
2284446|NCT02147093|5608687|P2|NOT COMPLETED|Period 2||0
2284447|NCT02147093|5608688|P1|NOT COMPLETED|Period 2||2
2284448|NCT02147093|5608687|P2|COMPLETED|Period 2||19
2284449|NCT02147093|5608688|P1|COMPLETED|Period 2||18
2284450|NCT02147093|5608687|P2|STARTED|Period 2||19
2284451|NCT02147093|5608688|P1|STARTED|Period 2||20
2284452|NCT02147093|5608687|P2|NOT COMPLETED|Period 1||1
2284453|NCT02147093|5608688|P1|NOT COMPLETED|Period 1||0
2284454|NCT02147093|5608687|P2|COMPLETED|Period 1||19
2284455|NCT02147093|5608688|P1|COMPLETED|Period 1||20
2284456|NCT02147093|5608687|P2|STARTED|Period 1||20
2284457|NCT02147093|5608688|P1|STARTED|Period 1||20
2284458|NCT02147067|5608698|P2|NOT COMPLETED|Overall Study||2
2284459|NCT02147067|5608699|P1|NOT COMPLETED|Overall Study||2
2284460|NCT02147067|5608698|P2|COMPLETED|Overall Study||11
2284461|NCT02147067|5608699|P1|COMPLETED|Overall Study||11
2284462|NCT02147067|5608698|P2|STARTED|Overall Study||13
2284463|NCT02147067|5608699|P1|STARTED|Overall Study||13
2284464|NCT02146599|5608725|P1|NOT COMPLETED|Overall Study||5
2284465|NCT02146599|5608725|P1|COMPLETED|Overall Study||296
2284466|NCT02146599|5608725|P1|STARTED|Overall Study||301
2284467|NCT02146482|5608731|P2|NOT COMPLETED|Overall Study||0
2284468|NCT02146482|5608732|P1|NOT COMPLETED|Overall Study||0
2284469|NCT02146482|5608731|P2|COMPLETED|Overall Study||25
2284470|NCT02146482|5608732|P1|COMPLETED|Overall Study||21
2284471|NCT02146482|5608731|P2|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|25
2284472|NCT02146482|5608732|P1|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|21
2284497|NCT02146352|5608877|P1|NOT COMPLETED|Overall Study||2
2284498|NCT02146352|5608877|P1|COMPLETED|Overall Study||28
2284499|NCT02146352|5608877|P1|7 Days Post-stent Removal|Overall Study||28
2284500|NCT02146352|5608877|P1|30 or 60 Days Post-procedure|Overall Study||30
2284501|NCT02146352|5608877|P1|STARTED|Overall Study||30
2284502|NCT02146326|5608895|P4|NOT COMPLETED|Overall Study||48
2284503|NCT02146326|5608896|P3|NOT COMPLETED|Overall Study||43
2284504|NCT02146326|5608897|P2|NOT COMPLETED|Overall Study||37
2284505|NCT02146326|5608898|P1|NOT COMPLETED|Overall Study||28
2284506|NCT02146326|5608895|P4|COMPLETED|Overall Study||210
2284507|NCT02146326|5608896|P3|COMPLETED|Overall Study||168
2284508|NCT02146326|5608897|P2|COMPLETED|Overall Study||66
2284509|NCT02146326|5608898|P1|COMPLETED|Overall Study||61
2284510|NCT02146326|5608895|P4|12 Months|Overall Study||210
2284511|NCT02146326|5608896|P3|12 Months|Overall Study||168
2284512|NCT02146326|5608897|P2|12 Months|Overall Study||66
2284513|NCT02146326|5608898|P1|12 Months|Overall Study||61
2284514|NCT02146326|5608895|P4|6 Months|Overall Study||235
2284515|NCT02146326|5608896|P3|6 Months|Overall Study||186
2284516|NCT02146326|5608897|P2|6 Months|Overall Study||71
2284517|NCT02146326|5608898|P1|6 Months|Overall Study||71
2284518|NCT02146326|5608895|P4|3 Months|Overall Study||0
2284519|NCT02146326|5608896|P3|3 Months|Overall Study||0
2284520|NCT02146326|5608897|P2|3 Months|Overall Study||83
2284521|NCT02146326|5608898|P1|3 Months|Overall Study||71
2284522|NCT02146326|5608895|P4|Baseline|Overall Study||258
2284523|NCT02146326|5608896|P3|Baseline|Overall Study||211
2284524|NCT02146326|5608897|P2|Baseline|Overall Study||103
2284525|NCT02146326|5608898|P1|Baseline|Overall Study||89
2284526|NCT02146326|5608895|P4|STARTED|Overall Study||258
2284527|NCT02146326|5608896|P3|STARTED|Overall Study||211
2284528|NCT02146326|5608897|P2|STARTED|Overall Study||103
2284529|NCT02146326|5608898|P1|STARTED|Overall Study||89
2284530|NCT02146274|5609060|P1|NOT COMPLETED|Overall Study||73
2284531|NCT02146274|5609060|P1|COMPLETED|Overall Study||1804
2284532|NCT02146274|5609060|P1|STARTED|Overall Study||1877
2284533|NCT02146248|5609067|P1|NOT COMPLETED|Overall Study||2
2284534|NCT02146248|5609067|P1|COMPLETED|Overall Study||9
2284535|NCT02146248|5609067|P1|HSG 5|Overall Study||1
2284536|NCT02146248|5609067|P1|HSG 4|Overall Study||7
2284537|NCT02146248|5609067|P1|HSG 3|Overall Study||9
2284538|NCT02146248|5609067|P1|HSG 2|Overall Study||10
2284539|NCT02146248|5609067|P1|HSG 1|Overall Study||10
2284540|NCT02146248|5609067|P1|Uterine Sounding|Overall Study|one subject dropped out after uterine sound before HSG #1|11
2284541|NCT02146248|5609067|P1|Enrolled|Overall Study||11
2284542|NCT02146248|5609067|P1|STARTED|Overall Study||11
2284543|NCT02146131|5609077|P2|NOT COMPLETED|Overall Study||56
2284544|NCT02146131|5609078|P1|NOT COMPLETED|Overall Study||61
2284545|NCT02146131|5609077|P2|COMPLETED|Overall Study||113
2284546|NCT02146131|5609078|P1|COMPLETED|Overall Study||109
2284547|NCT02146131|5609077|P2|STARTED|Overall Study||169
2284548|NCT02146131|5609078|P1|STARTED|Overall Study||170
2284549|NCT02146105|5609084|P1|NOT COMPLETED|Overall Study||6
2284550|NCT02146105|5609084|P1|COMPLETED|Overall Study||39
2284551|NCT02146105|5609084|P1|STARTED|Overall Study||45
2284552|NCT02146001|5609090|P2|NOT COMPLETED|Overall Study||0
2284553|NCT02146001|5609091|P1|NOT COMPLETED|Overall Study||0
2284554|NCT02146001|5609090|P2|COMPLETED|Overall Study||19
2284555|NCT02146001|5609091|P1|COMPLETED|Overall Study||19
2284556|NCT02146001|5609090|P2|STARTED|Overall Study||19
2284557|NCT02146001|5609091|P1|STARTED|Overall Study||19
2284558|NCT02145754|5609101|P1|NOT COMPLETED|Overall Study||0
2284559|NCT02145754|5609101|P1|COMPLETED|Overall Study||235
2284560|NCT02145754|5609101|P1|STARTED|Overall Study||235
2284561|NCT02145676|5609108|P3|NOT COMPLETED|Overall Study||0
2284562|NCT02145676|5609109|P2|NOT COMPLETED|Overall Study||0
2284563|NCT02145676|5609110|P1|NOT COMPLETED|Overall Study||0
2284564|NCT02145676|5609108|P3|COMPLETED|Overall Study||18
2284565|NCT02145676|5609109|P2|COMPLETED|Overall Study||18
2284566|NCT02145676|5609110|P1|COMPLETED|Overall Study||17
2284567|NCT02145676|5609108|P3|STARTED|Overall Study||18
2284568|NCT02145676|5609109|P2|STARTED|Overall Study||18
2284569|NCT02145676|5609110|P1|STARTED|Overall Study||17
2284570|NCT02145468|5609135|P2|NOT COMPLETED|Overall Study||8
2284571|NCT02145468|5609136|P1|NOT COMPLETED|Overall Study||5
2284572|NCT02145468|5609135|P2|COMPLETED|Overall Study||1723
2284573|NCT02145468|5609136|P1|COMPLETED|Overall Study||1753
2284574|NCT02145468|5609135|P2|STARTED|Overall Study||1731
2284575|NCT02145468|5609136|P1|STARTED|Overall Study||1758
2284576|NCT02145429|5609194|P2|NOT COMPLETED|Overall Study||11
2284577|NCT02145429|5609195|P1|NOT COMPLETED|Overall Study||16
2284578|NCT02145429|5609194|P2|COMPLETED|Overall Study||79
2284579|NCT02145429|5609195|P1|COMPLETED|Overall Study||75
2284580|NCT02145429|5609194|P2|STARTED|Overall Study||90
2284581|NCT02145429|5609195|P1|STARTED|Overall Study||91
2284582|NCT02145403|5609209|P4|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
2284583|NCT02145403|5609210|P3|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||1
2284584|NCT02145403|5609211|P2|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
2284585|NCT02145403|5609212|P1|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
2284586|NCT02145403|5609209|P4|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
2284587|NCT02145403|5609210|P3|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||36
2284588|NCT02145403|5609211|P2|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
2284589|NCT02145403|5609212|P1|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
2284590|NCT02145403|5609209|P4|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
2284591|NCT02145403|5609210|P3|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||37
2284592|NCT02145403|5609211|P2|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
2284593|NCT02145403|5609212|P1|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
2284594|NCT02145403|5609209|P4|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||2
2284595|NCT02145403|5609210|P3|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
2284596|NCT02145403|5609211|P2|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
2284597|NCT02145403|5609212|P1|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
2284598|NCT02145403|5609209|P4|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||2
2284599|NCT02145403|5609210|P3|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
2284600|NCT02145403|5609211|P2|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
2284601|NCT02145403|5609212|P1|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
2284602|NCT02145403|5609209|P4|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||4
2284603|NCT02145403|5609210|P3|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
2284604|NCT02145403|5609211|P2|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
2284605|NCT02145403|5609212|P1|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
2284606|NCT02145403|5609209|P4|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
2284607|NCT02145403|5609210|P3|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||1
2284608|NCT02145403|5609211|P2|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
2284609|NCT02145403|5609212|P1|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
2284610|NCT02145403|5609209|P4|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
2284611|NCT02145403|5609210|P3|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||3
2284612|NCT02145403|5609211|P2|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
2284613|NCT02145403|5609212|P1|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
2284614|NCT02145403|5609209|P4|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
2284615|NCT02145403|5609210|P3|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||4
2284616|NCT02145403|5609211|P2|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
2284617|NCT02145403|5609212|P1|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
2284618|NCT02145403|5609209|P4|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
2284619|NCT02145403|5609210|P3|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
2284620|NCT02145403|5609211|P2|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
2284621|NCT02145403|5609212|P1|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
2284622|NCT02145403|5609209|P4|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
2284623|NCT02145403|5609210|P3|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
2284624|NCT02145403|5609211|P2|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||3
2284625|NCT02145403|5609212|P1|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
2284626|NCT02145403|5609209|P4|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
2284627|NCT02145403|5609210|P3|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
2284628|NCT02145403|5609211|P2|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||3
2284629|NCT02145403|5609212|P1|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
2284630|NCT02145403|5609209|P4|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
2284631|NCT02145403|5609210|P3|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
2284632|NCT02145403|5609211|P2|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
2284633|NCT02145403|5609212|P1|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
2284634|NCT02145403|5609209|P4|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
2284635|NCT02145403|5609210|P3|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
2284636|NCT02145403|5609211|P2|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
2284637|NCT02145403|5609212|P1|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||3
2284638|NCT02145403|5609209|P4|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
2284639|NCT02145403|5609210|P3|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
2284640|NCT02145403|5609211|P2|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
2284641|NCT02145403|5609212|P1|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||3
2284642|NCT02145390|5609226|P1|NOT COMPLETED|Overall Study||1
2284643|NCT02145390|5609226|P1|COMPLETED|Overall Study||0
2284644|NCT02145390|5609226|P1|STARTED|Overall Study||1
2284645|NCT02145299|5609237|P2|NOT COMPLETED|Overall Study||0
2284646|NCT02145299|5609238|P1|NOT COMPLETED|Overall Study||0
2284647|NCT02145299|5609237|P2|COMPLETED|Overall Study||2
2284648|NCT02145299|5609238|P1|COMPLETED|Overall Study||6
2284649|NCT02145299|5609237|P2|STARTED|Overall Study||2
2284650|NCT02145299|5609238|P1|STARTED|Overall Study||6
2284651|NCT02145247|5609266|P2|NOT COMPLETED|Overall Study||0
2284652|NCT02145247|5609267|P1|NOT COMPLETED|Overall Study||0
2284653|NCT02145247|5609266|P2|COMPLETED|Overall Study||19
2284654|NCT02145247|5609267|P1|COMPLETED|Overall Study||20
2284655|NCT02145247|5609266|P2|STARTED|Overall Study||19
2284656|NCT02145247|5609267|P1|STARTED|Overall Study||20
2284657|NCT02145182|5609275|P2|NOT COMPLETED|Overall Study||16
2284658|NCT02145182|5609276|P1|NOT COMPLETED|Overall Study||18
2284659|NCT02145182|5609275|P2|COMPLETED|Overall Study||130
2284660|NCT02145182|5609276|P1|COMPLETED|Overall Study||124
2284661|NCT02145182|5609275|P2|Received at Least 1 Dose of Study Drug|Overall Study||146
2284662|NCT02145182|5609276|P1|Received at Least 1 Dose of Study Drug|Overall Study||142
2284663|NCT02145182|5609275|P2|STARTED|Overall Study||146
2284664|NCT02145182|5609276|P1|STARTED|Overall Study||142
2284665|NCT02145156|5609293|P3|NOT COMPLETED|Overall Study||41
2284666|NCT02145156|5609294|P2|NOT COMPLETED|Overall Study||52
2284667|NCT02145156|5609295|P1|NOT COMPLETED|Overall Study||60
2284668|NCT02145156|5609293|P3|COMPLETED|Overall Study||398
2284669|NCT02145156|5609294|P2|COMPLETED|Overall Study||373
2284670|NCT02145156|5609295|P1|COMPLETED|Overall Study||370
2284671|NCT02145156|5609293|P3|STARTED|Overall Study||439
2284672|NCT02145156|5609294|P2|STARTED|Overall Study||425
2284673|NCT02145156|5609295|P1|STARTED|Overall Study||430
2284674|NCT02145039|5609336|P1|NOT COMPLETED|Overall Study||0
2284675|NCT02145039|5609336|P1|COMPLETED|Overall Study||2
2284676|NCT02145039|5609336|P1|STARTED|Overall Study||2
2284677|NCT02144714|5609348|P3|NOT COMPLETED|Overall Study||0
2284678|NCT02144714|5609349|P2|NOT COMPLETED|Overall Study||0
2284679|NCT02144714|5609350|P1|NOT COMPLETED|Overall Study||0
2284680|NCT02144714|5609348|P3|COMPLETED|Overall Study||63
2284681|NCT02144714|5609349|P2|COMPLETED|Overall Study||63
2284682|NCT02144714|5609350|P1|COMPLETED|Overall Study||63
2284683|NCT02144714|5609348|P3|STARTED|Overall Study||63
2284684|NCT02144714|5609349|P2|STARTED|Overall Study||63
2284685|NCT02144714|5609350|P1|STARTED|Overall Study||63
2284686|NCT02144701|5609369|P2|NOT COMPLETED|Overall Study||3
2284687|NCT02144701|5609370|P1|NOT COMPLETED|Overall Study||9
2284688|NCT02144701|5609369|P2|COMPLETED|Overall Study||8
2284689|NCT02144701|5609370|P1|COMPLETED|Overall Study||13
2284690|NCT02144701|5609369|P2|STARTED|Overall Study||11
2284691|NCT02144701|5609370|P1|STARTED|Overall Study||22
2284692|NCT02144675|5609388|P2|NOT COMPLETED|Overall Study||0
2284693|NCT02144675|5609389|P1|NOT COMPLETED|Overall Study||0
2284694|NCT02144675|5609388|P2|COMPLETED|Overall Study||14
2284695|NCT02144675|5609389|P1|COMPLETED|Overall Study||13
2284696|NCT02144675|5609388|P2|STARTED|Overall Study||14
2284697|NCT02144675|5609389|P1|STARTED|Overall Study||13
2284698|NCT02144610|5609397|P2|NOT COMPLETED|Overall Study||22
2284699|NCT02144610|5609398|P1|NOT COMPLETED|Overall Study||23
2284700|NCT02144610|5609397|P2|COMPLETED|Overall Study||1
2284701|NCT02144610|5609398|P1|COMPLETED|Overall Study||0
2284702|NCT02144610|5609397|P2|STARTED|Overall Study||23
2284703|NCT02144610|5609398|P1|STARTED|Overall Study||23
2284704|NCT02144519|5609428|P2|NOT COMPLETED|Year 3||0
2284705|NCT02144519|5609429|P1|NOT COMPLETED|Year 3||0
2284706|NCT02144519|5609428|P2|COMPLETED|Year 3||760
2284707|NCT02144519|5609429|P1|COMPLETED|Year 3||894
2284708|NCT02144519|5609428|P2|STARTED|Year 3||760
2284709|NCT02144519|5609429|P1|STARTED|Year 3||894
2284710|NCT02144519|5609428|P2|NOT COMPLETED|Year 2||0
2284711|NCT02144519|5609429|P1|NOT COMPLETED|Year 2||0
2284712|NCT02144519|5609428|P2|COMPLETED|Year 2||864
2284713|NCT02144519|5609429|P1|COMPLETED|Year 2||763
2284714|NCT02144519|5609428|P2|STARTED|Year 2||864
2284715|NCT02144519|5609429|P1|STARTED|Year 2||763
2284716|NCT02144519|5609428|P2|NOT COMPLETED|Year 1||0
2284717|NCT02144519|5609429|P1|NOT COMPLETED|Year 1||0
2284718|NCT02144519|5609428|P2|COMPLETED|Year 1||870
2284719|NCT02144519|5609429|P1|COMPLETED|Year 1||895
2284720|NCT02144519|5609428|P2|STARTED|Year 1||870
2284721|NCT02144519|5609429|P1|STARTED|Year 1||895
2284722|NCT02144337|5609439|P2|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||0
2284723|NCT02144337|5609440|P1|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||3
2284724|NCT02144337|5609439|P2|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
2284725|NCT02144337|5609440|P1|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
2284814|NCT02143843|5609647|P1|COMPLETED|Overall Study||63
2284815|NCT02143843|5609647|P1|STARTED|Overall Study||75
2284726|NCT02144337|5609439|P2|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|5
2284727|NCT02144337|5609440|P1|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|8
2284728|NCT02144337|5609439|P2|NOT COMPLETED|T2 Follow-up (Post-intervention)||1
2284729|NCT02144337|5609440|P1|NOT COMPLETED|T2 Follow-up (Post-intervention)||4
2284730|NCT02144337|5609439|P2|COMPLETED|T2 Follow-up (Post-intervention)||4
2284731|NCT02144337|5609440|P1|COMPLETED|T2 Follow-up (Post-intervention)||4
2284732|NCT02144337|5609439|P2|STARTED|T2 Follow-up (Post-intervention)||5
2284733|NCT02144337|5609440|P1|STARTED|T2 Follow-up (Post-intervention)||8
2284734|NCT02144337|5609439|P2|NOT COMPLETED|Baseline 0 Months||0
2284735|NCT02144337|5609440|P1|NOT COMPLETED|Baseline 0 Months||0
2284736|NCT02144337|5609439|P2|COMPLETED|Baseline 0 Months||5
2284737|NCT02144337|5609440|P1|COMPLETED|Baseline 0 Months||8
2284738|NCT02144337|5609439|P2|STARTED|Baseline 0 Months||5
2284739|NCT02144337|5609440|P1|STARTED|Baseline 0 Months||8
2284740|NCT02144285|5609460|P10|NOT COMPLETED|Overall Study||0
2284741|NCT02144285|5609461|P9|NOT COMPLETED|Overall Study||0
2284742|NCT02144285|5609462|P8|NOT COMPLETED|Overall Study||0
2284743|NCT02144285|5609463|P7|NOT COMPLETED|Overall Study||0
2284744|NCT02144285|5609464|P6|NOT COMPLETED|Overall Study||0
2284745|NCT02144285|5609465|P5|NOT COMPLETED|Overall Study||1
2284746|NCT02144285|5609466|P4|NOT COMPLETED|Overall Study||0
2284747|NCT02144285|5609467|P3|NOT COMPLETED|Overall Study||0
2284748|NCT02144285|5609468|P2|NOT COMPLETED|Overall Study||0
2284749|NCT02144285|5609469|P1|NOT COMPLETED|Overall Study||0
2284750|NCT02144285|5609460|P10|COMPLETED|Overall Study||6
2284751|NCT02144285|5609461|P9|COMPLETED|Overall Study||2
2284752|NCT02144285|5609462|P8|COMPLETED|Overall Study||6
2284753|NCT02144285|5609463|P7|COMPLETED|Overall Study||6
2284754|NCT02144285|5609464|P6|COMPLETED|Overall Study||6
2284755|NCT02144285|5609465|P5|COMPLETED|Overall Study||5
2284756|NCT02144285|5609466|P4|COMPLETED|Overall Study||6
2284757|NCT02144285|5609467|P3|COMPLETED|Overall Study||6
2284758|NCT02144285|5609468|P2|COMPLETED|Overall Study||6
2284759|NCT02144285|5609469|P1|COMPLETED|Overall Study||14
2284760|NCT02144285|5609460|P10|Received At Least One Dose of Study Drug|Overall Study||6
2284761|NCT02144285|5609461|P9|Received At Least One Dose of Study Drug|Overall Study||2
2284762|NCT02144285|5609462|P8|Received At Least One Dose of Study Drug|Overall Study||6
2284763|NCT02144285|5609463|P7|Received At Least One Dose of Study Drug|Overall Study||6
2284764|NCT02144285|5609464|P6|Received At Least One Dose of Study Drug|Overall Study||6
2284765|NCT02144285|5609465|P5|Received At Least One Dose of Study Drug|Overall Study||6
2284766|NCT02144285|5609466|P4|Received At Least One Dose of Study Drug|Overall Study||6
2284767|NCT02144285|5609467|P3|Received At Least One Dose of Study Drug|Overall Study||6
2284768|NCT02144285|5609468|P2|Received At Least One Dose of Study Drug|Overall Study||6
2284769|NCT02144285|5609469|P1|Received At Least One Dose of Study Drug|Overall Study||14
2284770|NCT02144285|5609460|P10|STARTED|Overall Study||6
2284771|NCT02144285|5609461|P9|STARTED|Overall Study||2
2284772|NCT02144285|5609462|P8|STARTED|Overall Study||6
2284773|NCT02144285|5609463|P7|STARTED|Overall Study||6
2284774|NCT02144285|5609464|P6|STARTED|Overall Study||6
2284775|NCT02144285|5609465|P5|STARTED|Overall Study||6
2284776|NCT02144285|5609466|P4|STARTED|Overall Study||6
2284777|NCT02144285|5609467|P3|STARTED|Overall Study||6
2284778|NCT02144285|5609468|P2|STARTED|Overall Study||6
2284779|NCT02144285|5609469|P1|STARTED|Overall Study||14
2284780|NCT02144259|5609542|P3|NOT COMPLETED|Overall Study||18
2284781|NCT02144259|5609543|P2|NOT COMPLETED|Overall Study||5
2284782|NCT02144259|5609544|P1|NOT COMPLETED|Overall Study||10
2284783|NCT02144259|5609542|P3|COMPLETED|Overall Study||16
2284784|NCT02144259|5609543|P2|COMPLETED|Overall Study||28
2284785|NCT02144259|5609544|P1|COMPLETED|Overall Study||23
2284786|NCT02144259|5609542|P3|STARTED|Overall Study||34
2284787|NCT02144259|5609543|P2|STARTED|Overall Study||33
2284788|NCT02144259|5609544|P1|STARTED|Overall Study||33
2284789|NCT02144220|5609558|P1|NOT COMPLETED|Overall Study||19
2284790|NCT02144220|5609558|P1|COMPLETED|Overall Study||258
2284791|NCT02144220|5609558|P1|STARTED|Overall Study||277
2284792|NCT02144155|5609566|P1|NOT COMPLETED|Overall Study||0
2284793|NCT02144155|5609566|P1|COMPLETED|Overall Study||14
2284794|NCT02144155|5609566|P1|STARTED|Overall Study||14
2284795|NCT02144077|5609577|P2|NOT COMPLETED|Overall Study||11
2284796|NCT02144077|5609578|P1|NOT COMPLETED|Overall Study||10
2284797|NCT02144077|5609577|P2|COMPLETED|Overall Study||132
2284798|NCT02144077|5609578|P1|COMPLETED|Overall Study||128
2284799|NCT02144077|5609577|P2|STARTED|Overall Study||143
2284800|NCT02144077|5609578|P1|STARTED|Overall Study||138
2284801|NCT02144012|5609596|P2|NOT COMPLETED|Overall Study||15
2284802|NCT02144012|5609597|P1|NOT COMPLETED|Overall Study||34
2284803|NCT02144012|5609596|P2|COMPLETED|Overall Study||0
2284804|NCT02144012|5609597|P1|COMPLETED|Overall Study||0
2284805|NCT02144012|5609596|P2|STARTED|Overall Study||15
2284806|NCT02144012|5609597|P1|STARTED|Overall Study||34
2284807|NCT02143947|5609634|P2|NOT COMPLETED|Overall Study||2
2284808|NCT02143947|5609635|P1|NOT COMPLETED|Overall Study||4
2284809|NCT02143947|5609634|P2|COMPLETED|Overall Study||42
2284810|NCT02143947|5609635|P1|COMPLETED|Overall Study||32
2284811|NCT02143947|5609634|P2|STARTED|Overall Study||44
2284812|NCT02143947|5609635|P1|STARTED|Overall Study||36
2284813|NCT02143843|5609647|P1|NOT COMPLETED|Overall Study||12
2284816|NCT02143778|5609652|P1|NOT COMPLETED|Overall Study||3
2284817|NCT02143778|5609652|P1|COMPLETED|Overall Study||243
2284818|NCT02143778|5609652|P1|STARTED|Overall Study||246
2284819|NCT02143713|5609661|P4|NOT COMPLETED|Post-treatment Follow-up (12 Months)||27
2284820|NCT02143713|5609662|P3|NOT COMPLETED|Post-treatment Follow-up (12 Months)||29
2284821|NCT02143713|5609663|P2|NOT COMPLETED|Post-treatment Follow-up (12 Months)||24
2284822|NCT02143713|5609664|P1|NOT COMPLETED|Post-treatment Follow-up (12 Months)||12
2284823|NCT02143713|5609661|P4|COMPLETED|Post-treatment Follow-up (12 Months)||95
2284824|NCT02143713|5609662|P3|COMPLETED|Post-treatment Follow-up (12 Months)||96
2284825|NCT02143713|5609663|P2|COMPLETED|Post-treatment Follow-up (12 Months)||81
2284826|NCT02143713|5609664|P1|COMPLETED|Post-treatment Follow-up (12 Months)||73
2284827|NCT02143713|5609661|P4|STARTED|Post-treatment Follow-up (12 Months)||122
2284828|NCT02143713|5609662|P3|STARTED|Post-treatment Follow-up (12 Months)||125
2284829|NCT02143713|5609663|P2|STARTED|Post-treatment Follow-up (12 Months)||105
2284830|NCT02143713|5609664|P1|STARTED|Post-treatment Follow-up (12 Months)||85
2284831|NCT02143713|5609661|P4|NOT COMPLETED|Treatment Period (6 Months)||28
2284832|NCT02143713|5609662|P3|NOT COMPLETED|Treatment Period (6 Months)||22
2284833|NCT02143713|5609663|P2|NOT COMPLETED|Treatment Period (6 Months)||12
2284834|NCT02143713|5609664|P1|NOT COMPLETED|Treatment Period (6 Months)||20
2284835|NCT02143713|5609661|P4|COMPLETED|Treatment Period (6 Months)||112
2284836|NCT02143713|5609662|P3|COMPLETED|Treatment Period (6 Months)||120
2284837|NCT02143713|5609663|P2|COMPLETED|Treatment Period (6 Months)||99
2284838|NCT02143713|5609664|P1|COMPLETED|Treatment Period (6 Months)||82
2284839|NCT02143713|5609661|P4|Received Elagolix|Treatment Period (6 Months)||140
2284840|NCT02143713|5609662|P3|Received Elagolix|Treatment Period (6 Months)||142
2284841|NCT02143713|5609663|P2|Received Elagolix|Treatment Period (6 Months)||111
2284842|NCT02143713|5609664|P1|Received Elagolix|Treatment Period (6 Months)||102
2284843|NCT02143713|5609661|P4|STARTED|Treatment Period (6 Months)||140
2284844|NCT02143713|5609662|P3|STARTED|Treatment Period (6 Months)||142
2284845|NCT02143713|5609663|P2|STARTED|Treatment Period (6 Months)||111
2284846|NCT02143713|5609664|P1|STARTED|Treatment Period (6 Months)||102
2284847|NCT02143583|5609745|P3|NOT COMPLETED|Overall Study||2
2284848|NCT02143583|5609746|P2|NOT COMPLETED|Overall Study||0
2284849|NCT02143583|5609747|P1|NOT COMPLETED|Overall Study||1
2284850|NCT02143583|5609745|P3|COMPLETED|Overall Study||66
2284851|NCT02143583|5609746|P2|COMPLETED|Overall Study||66
2284852|NCT02143583|5609747|P1|COMPLETED|Overall Study||61
2284853|NCT02143583|5609745|P3|STARTED|Overall Study||68
2284854|NCT02143583|5609746|P2|STARTED|Overall Study||66
2284855|NCT02143583|5609747|P1|STARTED|Overall Study||62
2284856|NCT02143310|5609758|P1|NOT COMPLETED|Overall Study||107
2284857|NCT02143310|5609758|P1|COMPLETED|Overall Study||102
2284858|NCT02143310|5609758|P1|STARTED|Overall Study||209
2284859|NCT02143141|5609770|P2|NOT COMPLETED|Overall Study||0
2284860|NCT02143141|5609771|P1|NOT COMPLETED|Overall Study||1
2284861|NCT02143141|5609770|P2|COMPLETED|Overall Study||6
2284862|NCT02143141|5609771|P1|COMPLETED|Overall Study||6
2284863|NCT02143141|5609770|P2|STARTED|Overall Study||6
2284864|NCT02143141|5609771|P1|STARTED|Overall Study||7
2284865|NCT02143102|5609783|P2|NOT COMPLETED|Overall Study||0
2284866|NCT02143102|5609784|P1|NOT COMPLETED|Overall Study||11
2284867|NCT02143102|5609783|P2|COMPLETED|Overall Study||28
2284868|NCT02143102|5609784|P1|COMPLETED|Overall Study||86
2284869|NCT02143102|5609783|P2|STARTED|Overall Study||28
2284870|NCT02143102|5609784|P1|STARTED|Overall Study||97
2284871|NCT02143024|5609794|P2|NOT COMPLETED|Overall Study||1
2284872|NCT02143024|5609795|P1|NOT COMPLETED|Overall Study||2
2284873|NCT02143024|5609794|P2|COMPLETED|Overall Study||7
2284874|NCT02143024|5609795|P1|COMPLETED|Overall Study||13
2284875|NCT02143024|5609794|P2|Received Treatment|Overall Study||7
2284876|NCT02143024|5609795|P1|Received Treatment|Overall Study||13
2284877|NCT02143024|5609794|P2|STARTED|Overall Study||8
2284878|NCT02143024|5609795|P1|STARTED|Overall Study||15
2284879|NCT02142894|5609801|P1|NOT COMPLETED|Overall Study||8
2284880|NCT02142894|5609801|P1|COMPLETED|Overall Study||25
2284881|NCT02142894|5609801|P1|STARTED|Overall Study||33
2284882|NCT02142738|5609807|P2|NOT COMPLETED|Overall Study||151
2284883|NCT02142738|5609808|P1|NOT COMPLETED|Overall Study||154
2284884|NCT02142738|5609807|P2|COMPLETED|Overall Study||0
2284885|NCT02142738|5609808|P1|COMPLETED|Overall Study||0
2284886|NCT02142738|5609807|P2|Treated|Overall Study||150
2284887|NCT02142738|5609808|P1|Treated|Overall Study||154
2284888|NCT02142738|5609807|P2|STARTED|Overall Study||151
2284889|NCT02142738|5609808|P1|STARTED|Overall Study||154
2284890|NCT02142712|5609821|P4|NOT COMPLETED|Overall Study||0
2284891|NCT02142712|5609822|P3|NOT COMPLETED|Overall Study||1
2284892|NCT02142712|5609823|P2|NOT COMPLETED|Overall Study||1
2284893|NCT02142712|5609824|P1|NOT COMPLETED|Overall Study||1
2284894|NCT02142712|5609821|P4|COMPLETED|Overall Study||0
2284895|NCT02142712|5609822|P3|COMPLETED|Overall Study||0
2284896|NCT02142712|5609823|P2|COMPLETED|Overall Study||0
2284897|NCT02142712|5609824|P1|COMPLETED|Overall Study||0
2284898|NCT02142712|5609821|P4|STARTED|Overall Study||0
2284899|NCT02142712|5609822|P3|STARTED|Overall Study||1
2284900|NCT02142712|5609823|P2|STARTED|Overall Study||1
2284901|NCT02142712|5609824|P1|STARTED|Overall Study||1
2284902|NCT02142504|5609847|P3|NOT COMPLETED|Overall Study||43
2284903|NCT02142504|5609848|P2|NOT COMPLETED|Overall Study||42
2284904|NCT02142504|5609849|P1|NOT COMPLETED|Overall Study||31
2284905|NCT02142504|5609847|P3|COMPLETED|Overall Study||111
2284906|NCT02142504|5609848|P2|COMPLETED|Overall Study||105
2284907|NCT02142504|5609849|P1|COMPLETED|Overall Study||122
2284908|NCT02142504|5609847|P3|Received Booster (Second Vaccination)|Overall Study||116
2284909|NCT02142504|5609848|P2|Received Booster (Second Vaccination)|Overall Study||109
2284910|NCT02142504|5609849|P1|Received Booster (Second Vaccination)|Overall Study||126
2284911|NCT02142504|5609847|P3|Randomized and Received Treatment|Overall Study||154
2284912|NCT02142504|5609848|P2|Randomized and Received Treatment|Overall Study||145
2284913|NCT02142504|5609849|P1|Randomized and Received Treatment|Overall Study||153
2284914|NCT02142504|5609847|P3|STARTED|Overall Study||154
2284915|NCT02142504|5609848|P2|STARTED|Overall Study||147
2284916|NCT02142504|5609849|P1|STARTED|Overall Study||153
2284917|NCT02142361|5609935|P3|NOT COMPLETED|Overall Study||0
2284918|NCT02142361|5609936|P2|NOT COMPLETED|Overall Study||0
2284919|NCT02142361|5609937|P1|NOT COMPLETED|Overall Study||0
2284920|NCT02142361|5609935|P3|COMPLETED|Overall Study||20
2284921|NCT02142361|5609936|P2|COMPLETED|Overall Study||20
2284922|NCT02142361|5609937|P1|COMPLETED|Overall Study||20
2284923|NCT02142361|5609935|P3|STARTED|Overall Study||20
2284924|NCT02142361|5609936|P2|STARTED|Overall Study||20
2284925|NCT02142361|5609937|P1|STARTED|Overall Study||20
2284926|NCT02142283|5610038|P2|NOT COMPLETED|Overall Study||21
2284927|NCT02142283|5610039|P1|NOT COMPLETED|Overall Study||21
2284928|NCT02142283|5610038|P2|COMPLETED|Overall Study||78
2284929|NCT02142283|5610039|P1|COMPLETED|Overall Study||86
2284930|NCT02142283|5610038|P2|STARTED|Overall Study||99
2284931|NCT02142283|5610039|P1|STARTED|Overall Study||107
2284932|NCT02142153|5610069|P10|NOT COMPLETED|Overall Study||0
2284933|NCT02142153|5610070|P9|NOT COMPLETED|Overall Study||0
2284934|NCT02142153|5610071|P8|NOT COMPLETED|Overall Study||0
2284935|NCT02142153|5610072|P7|NOT COMPLETED|Overall Study||0
2284936|NCT02142153|5610073|P6|NOT COMPLETED|Overall Study||0
2284937|NCT02142153|5610074|P5|NOT COMPLETED|Overall Study||0
2284938|NCT02142153|5610075|P4|NOT COMPLETED|Overall Study||0
2284939|NCT02142153|5610076|P3|NOT COMPLETED|Overall Study||0
2284940|NCT02142153|5610077|P2|NOT COMPLETED|Overall Study||0
2284941|NCT02142153|5610078|P1|NOT COMPLETED|Overall Study||0
2284942|NCT02142153|5610069|P10|COMPLETED|Overall Study||2
2284943|NCT02142153|5610070|P9|COMPLETED|Overall Study||6
2284944|NCT02142153|5610071|P8|COMPLETED|Overall Study||2
2284945|NCT02142153|5610072|P7|COMPLETED|Overall Study||6
2284946|NCT02142153|5610073|P6|COMPLETED|Overall Study||2
2284947|NCT02142153|5610074|P5|COMPLETED|Overall Study||6
2284948|NCT02142153|5610075|P4|COMPLETED|Overall Study||2
2284949|NCT02142153|5610076|P3|COMPLETED|Overall Study||6
2284950|NCT02142153|5610077|P2|COMPLETED|Overall Study||2
2284951|NCT02142153|5610078|P1|COMPLETED|Overall Study||6
2284952|NCT02142153|5610069|P10|STARTED|Overall Study||2
2284953|NCT02142153|5610070|P9|STARTED|Overall Study||6
2284954|NCT02142153|5610071|P8|STARTED|Overall Study||2
2284955|NCT02142153|5610072|P7|STARTED|Overall Study||6
2284956|NCT02142153|5610073|P6|STARTED|Overall Study||2
2284957|NCT02142153|5610074|P5|STARTED|Overall Study||6
2284958|NCT02142153|5610075|P4|STARTED|Overall Study||2
2284959|NCT02142153|5610076|P3|STARTED|Overall Study||6
2284960|NCT02142153|5610077|P2|STARTED|Overall Study||2
2284961|NCT02142153|5610078|P1|STARTED|Overall Study||6
2284962|NCT02142049|5610115|P5|NOT COMPLETED|Overall Study||0
2284963|NCT02142049|5610116|P4|NOT COMPLETED|Overall Study||0
2284964|NCT02142049|5610117|P3|NOT COMPLETED|Overall Study||0
2284965|NCT02142049|5610118|P2|NOT COMPLETED|Overall Study||0
2284966|NCT02142049|5610119|P1|NOT COMPLETED|Overall Study||0
2284967|NCT02142049|5610115|P5|COMPLETED|Overall Study||20
2284968|NCT02142049|5610116|P4|COMPLETED|Overall Study||6
2284969|NCT02142049|5610117|P3|COMPLETED|Overall Study||3
2284970|NCT02142049|5610118|P2|COMPLETED|Overall Study||3
2284971|NCT02142049|5610119|P1|COMPLETED|Overall Study||3
2284972|NCT02142049|5610115|P5|STARTED|Overall Study||20
2284973|NCT02142049|5610116|P4|STARTED|Overall Study||6
2284974|NCT02142049|5610117|P3|STARTED|Overall Study||3
2284975|NCT02142049|5610118|P2|STARTED|Overall Study||3
2284976|NCT02142049|5610119|P1|STARTED|Overall Study||3
2284977|NCT02141997|5610148|P4|NOT COMPLETED|Overall Study||1
2284978|NCT02141997|5610149|P3|NOT COMPLETED|Overall Study||3
2284979|NCT02141997|5610150|P2|NOT COMPLETED|Overall Study||6
2284980|NCT02141997|5610151|P1|NOT COMPLETED|Overall Study||3
2284981|NCT02141997|5610148|P4|COMPLETED|Overall Study||54
2284982|NCT02141997|5610149|P3|COMPLETED|Overall Study||53
2284983|NCT02141997|5610150|P2|COMPLETED|Overall Study||49
2284984|NCT02141997|5610151|P1|COMPLETED|Overall Study||53
2284985|NCT02141997|5610148|P4|STARTED|Overall Study||55
2284986|NCT02141997|5610149|P3|STARTED|Overall Study||56
2284987|NCT02141997|5610150|P2|STARTED|Overall Study||55
2284988|NCT02141997|5610151|P1|STARTED|Overall Study||56
2284989|NCT02141984|5610189|P1|NOT COMPLETED|Overall Study||2
2284990|NCT02141984|5610189|P1|COMPLETED|Overall Study||26
2284991|NCT02141984|5610189|P1|STARTED|Overall Study||28
2284992|NCT02141867|5610196|P1|NOT COMPLETED|Overall Study||94
2284993|NCT02141867|5610196|P1|COMPLETED|Overall Study||3927
2284994|NCT02141867|5610196|P1|STARTED|Overall Study||4021
2284995|NCT02141854|5610208|P6|NOT COMPLETED|Treatment Period||38
2284996|NCT02141854|5610209|P5|NOT COMPLETED|Treatment Period||10
2284997|NCT02141854|5610210|P4|NOT COMPLETED|Treatment Period||11
2284998|NCT02141854|5610211|P3|NOT COMPLETED|Treatment Period||9
2284999|NCT02141854|5610212|P2|NOT COMPLETED|Treatment Period||10
2285000|NCT02141854|5610213|P1|NOT COMPLETED|Treatment Period||0
2285001|NCT02141854|5610208|P6|COMPLETED|Treatment Period||107
2285002|NCT02141854|5610209|P5|COMPLETED|Treatment Period||136
2285003|NCT02141854|5610210|P4|COMPLETED|Treatment Period||135
2285004|NCT02141854|5610211|P3|COMPLETED|Treatment Period||136
2285005|NCT02141854|5610212|P2|COMPLETED|Treatment Period||136
2285006|NCT02141854|5610213|P1|COMPLETED|Treatment Period||0
2285007|NCT02141854|5610208|P6|Full Analysis Set|Treatment Period||143
2285008|NCT02141854|5610209|P5|Full Analysis Set|Treatment Period||145
2285009|NCT02141854|5610210|P4|Full Analysis Set|Treatment Period||146
2285010|NCT02141854|5610211|P3|Full Analysis Set|Treatment Period||141
2285011|NCT02141854|5610212|P2|Full Analysis Set|Treatment Period||145
2285012|NCT02141854|5610213|P1|Full Analysis Set|Treatment Period||0
2285013|NCT02141854|5610208|P6|Safety Population|Treatment Period||144
2285014|NCT02141854|5610209|P5|Safety Population|Treatment Period||145
2285015|NCT02141854|5610210|P4|Safety Population|Treatment Period||146
2285016|NCT02141854|5610211|P3|Safety Population|Treatment Period||143
2285017|NCT02141854|5610212|P2|Safety Population|Treatment Period||145
2285018|NCT02141854|5610213|P1|Safety Population|Treatment Period||0
2285019|NCT02141854|5610208|P6|Intent to Treat Population|Treatment Period||145
2285020|NCT02141854|5610209|P5|Intent to Treat Population|Treatment Period||146
2285021|NCT02141854|5610210|P4|Intent to Treat Population|Treatment Period||146
2285022|NCT02141854|5610211|P3|Intent to Treat Population|Treatment Period||145
2285023|NCT02141854|5610212|P2|Intent to Treat Population|Treatment Period||146
2285024|NCT02141854|5610213|P1|Intent to Treat Population|Treatment Period||0
2285025|NCT02141854|5610208|P6|STARTED|Treatment Period||145
2285026|NCT02141854|5610209|P5|STARTED|Treatment Period||146
2285027|NCT02141854|5610210|P4|STARTED|Treatment Period||146
2285028|NCT02141854|5610211|P3|STARTED|Treatment Period||145
2285029|NCT02141854|5610212|P2|STARTED|Treatment Period||146
2285030|NCT02141854|5610213|P1|STARTED|Treatment Period||0
2285031|NCT02141854|5610208|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
2285032|NCT02141854|5610209|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
2285033|NCT02141854|5610210|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
2285034|NCT02141854|5610211|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
2285035|NCT02141854|5610212|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
2285036|NCT02141854|5610213|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||154
2285037|NCT02141854|5610208|P6|COMPLETED|Run-In Period (Pre-assignment)||0
2285038|NCT02141854|5610209|P5|COMPLETED|Run-In Period (Pre-assignment)||0
2285039|NCT02141854|5610210|P4|COMPLETED|Run-In Period (Pre-assignment)||0
2285040|NCT02141854|5610211|P3|COMPLETED|Run-In Period (Pre-assignment)||0
2285041|NCT02141854|5610212|P2|COMPLETED|Run-In Period (Pre-assignment)||0
2285042|NCT02141854|5610213|P1|COMPLETED|Run-In Period (Pre-assignment)||728
2285043|NCT02141854|5610208|P6|STARTED|Run-In Period (Pre-assignment)||0
2285044|NCT02141854|5610209|P5|STARTED|Run-In Period (Pre-assignment)||0
2285045|NCT02141854|5610210|P4|STARTED|Run-In Period (Pre-assignment)||0
2285046|NCT02141854|5610211|P3|STARTED|Run-In Period (Pre-assignment)||0
2285047|NCT02141854|5610212|P2|STARTED|Run-In Period (Pre-assignment)||0
2285048|NCT02141854|5610213|P1|STARTED|Run-In Period (Pre-assignment)||882
2285049|NCT02141659|5610271|P6|NOT COMPLETED|Overall Study||2
2285050|NCT02141659|5610272|P5|NOT COMPLETED|Overall Study||2
2285051|NCT02141659|5610273|P4|NOT COMPLETED|Overall Study||0
2285052|NCT02141659|5610274|P3|NOT COMPLETED|Overall Study||0
2285053|NCT02141659|5610275|P2|NOT COMPLETED|Overall Study||1
2285054|NCT02141659|5610276|P1|NOT COMPLETED|Overall Study||0
2285055|NCT02141659|5610271|P6|COMPLETED|Overall Study||13
2285056|NCT02141659|5610272|P5|COMPLETED|Overall Study||13
2285057|NCT02141659|5610273|P4|COMPLETED|Overall Study||3
2285058|NCT02141659|5610274|P3|COMPLETED|Overall Study||3
2285059|NCT02141659|5610275|P2|COMPLETED|Overall Study||3
2285060|NCT02141659|5610276|P1|COMPLETED|Overall Study||3
2285061|NCT02141659|5610271|P6|STARTED|Overall Study||15
2285062|NCT02141659|5610272|P5|STARTED|Overall Study||15
2285063|NCT02141659|5610273|P4|STARTED|Overall Study||3
2285064|NCT02141659|5610274|P3|STARTED|Overall Study||3
2285065|NCT02141659|5610275|P2|STARTED|Overall Study||4
2285066|NCT02141659|5610276|P1|STARTED|Overall Study||3
2285067|NCT02141633|5610332|P2|NOT COMPLETED|Overall Study||0
2285068|NCT02141633|5610333|P1|NOT COMPLETED|Overall Study||1
2285069|NCT02141633|5610332|P2|COMPLETED|Overall Study||15
2285070|NCT02141633|5610333|P1|COMPLETED|Overall Study||15
2285071|NCT02141633|5610332|P2|STARTED|Overall Study||15
2285072|NCT02141633|5610333|P1|STARTED|Overall Study||16
2285073|NCT02141620|5610341|P2|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
2285074|NCT02141620|5610342|P1|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
2285075|NCT02141620|5610341|P2|COMPLETED|Treatment Condition 2 (7 Days)||7
2285076|NCT02141620|5610342|P1|COMPLETED|Treatment Condition 2 (7 Days)||7
2285077|NCT02141620|5610341|P2|STARTED|Treatment Condition 2 (7 Days)||7
2285078|NCT02141620|5610342|P1|STARTED|Treatment Condition 2 (7 Days)||7
2285079|NCT02141620|5610341|P2|NOT COMPLETED|Treatment Condition 1 (7 Days)||0
2285080|NCT02141620|5610342|P1|NOT COMPLETED|Treatment Condition 1 (7 Days)||1
2285081|NCT02141620|5610341|P2|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to placebo for Condition 2.|7
2285082|NCT02141620|5610342|P1|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to n-acetylcysteine for Condition 2.|7
2285083|NCT02141620|5610341|P2|STARTED|Treatment Condition 1 (7 Days)||7
2285084|NCT02141620|5610342|P1|STARTED|Treatment Condition 1 (7 Days)||8
2285085|NCT02141581|5610403|P3|NOT COMPLETED|Overall Study||0
2285086|NCT02141581|5610404|P2|NOT COMPLETED|Overall Study||0
2285087|NCT02141581|5610405|P1|NOT COMPLETED|Overall Study||0
2285088|NCT02141581|5610403|P3|COMPLETED|Overall Study||25
2285089|NCT02141581|5610404|P2|COMPLETED|Overall Study||19
2285090|NCT02141581|5610405|P1|COMPLETED|Overall Study||42
2285091|NCT02141581|5610403|P3|STARTED|Overall Study||25
2285092|NCT02141581|5610404|P2|STARTED|Overall Study||19
2285093|NCT02141581|5610405|P1|STARTED|Overall Study||42
2285094|NCT02141555|5610418|P2|NOT COMPLETED|Overall Study||0
2285095|NCT02141555|5610419|P1|NOT COMPLETED|Overall Study||0
2285096|NCT02141555|5610418|P2|COMPLETED|Overall Study||2
2285097|NCT02141555|5610419|P1|COMPLETED|Overall Study||2
2285098|NCT02141555|5610418|P2|STARTED|Overall Study||2
2285099|NCT02141555|5610419|P1|STARTED|Overall Study||2
2285100|NCT02141516|5610434|P3|NOT COMPLETED|Overall Study||0
2285101|NCT02141516|5610435|P2|NOT COMPLETED|Overall Study||5
2285102|NCT02141516|5610436|P1|NOT COMPLETED|Overall Study||0
2285103|NCT02141516|5610434|P3|COMPLETED|Overall Study||87
2285104|NCT02141516|5610435|P2|COMPLETED|Overall Study||107
2285105|NCT02141516|5610436|P1|COMPLETED|Overall Study||40
2285106|NCT02141516|5610434|P3|STARTED|Overall Study||87
2285107|NCT02141516|5610435|P2|STARTED|Overall Study||112
2285108|NCT02141516|5610436|P1|STARTED|Overall Study||40
2285109|NCT02141490|5610487|P3|NOT COMPLETED|Overall Study||0
2285110|NCT02141490|5610488|P2|NOT COMPLETED|Overall Study||0
2285111|NCT02141490|5610489|P1|NOT COMPLETED|Overall Study||4
2285112|NCT02141490|5610487|P3|COMPLETED|Overall Study||3
2285113|NCT02141490|5610488|P2|COMPLETED|Overall Study||6
2285114|NCT02141490|5610489|P1|COMPLETED|Overall Study||30
2285115|NCT02141490|5610487|P3|STARTED|Overall Study||3
2285116|NCT02141490|5610488|P2|STARTED|Overall Study||6
2285117|NCT02141490|5610489|P1|STARTED|Overall Study||34
2285130|NCT02141399|5610534|P1|NOT COMPLETED|Overall Study||744
2285131|NCT02141399|5610534|P1|COMPLETED|Overall Study||741
2285132|NCT02141399|5610534|P1|STARTED|Overall Study||1485
2285133|NCT02141360|5610540|P3|NOT COMPLETED|Overall Study||0
2285134|NCT02141360|5610541|P2|NOT COMPLETED|Overall Study||0
2285135|NCT02141360|5610542|P1|NOT COMPLETED|Overall Study||7
2285136|NCT02141360|5610540|P3|COMPLETED|Overall Study||6
2285137|NCT02141360|5610541|P2|COMPLETED|Overall Study||6
2285138|NCT02141360|5610542|P1|COMPLETED|Overall Study||4
2285139|NCT02141360|5610540|P3|STARTED|Overall Study||6
2285140|NCT02141360|5610541|P2|STARTED|Overall Study||6
2285141|NCT02141360|5610542|P1|STARTED|Overall Study||11
2285142|NCT02141217|5610552|P2|NOT COMPLETED|Overall Study||8
2285143|NCT02141217|5610553|P1|NOT COMPLETED|Overall Study||11
2285144|NCT02141217|5610552|P2|COMPLETED|Overall Study||229
2285145|NCT02141217|5610553|P1|COMPLETED|Overall Study||223
2285146|NCT02141217|5610552|P2|ITT Population-Actual Treatment Received|Overall Study||235
2285147|NCT02141217|5610553|P1|ITT Population-Actual Treatment Received|Overall Study||236
2285148|NCT02141217|5610552|P2|ITT Population-Randomized Treatment Arm|Overall Study||237
2285149|NCT02141217|5610553|P1|ITT Population-Randomized Treatment Arm|Overall Study||234
2285150|NCT02141217|5610552|P2|STARTED|Overall Study||237
2285151|NCT02141217|5610553|P1|STARTED|Overall Study||234
2285152|NCT02140957|5610573|P2|NOT COMPLETED|Overall Study||23
2285153|NCT02140957|5610574|P1|NOT COMPLETED|Overall Study||27
2285154|NCT02140957|5610573|P2|COMPLETED|Overall Study||99
2285155|NCT02140957|5610574|P1|COMPLETED|Overall Study||102
2285156|NCT02140957|5610573|P2|STARTED|Overall Study||122
2285157|NCT02140957|5610574|P1|STARTED|Overall Study||129
2285158|NCT02140788|5610584|P4|NOT COMPLETED|Overall Study||0
2285159|NCT02140788|5610585|P3|NOT COMPLETED|Overall Study||0
2285160|NCT02140788|5610586|P2|NOT COMPLETED|Overall Study||0
2285161|NCT02140788|5610587|P1|NOT COMPLETED|Overall Study||0
2285162|NCT02140788|5610584|P4|COMPLETED|Overall Study||0
2285163|NCT02140788|5610585|P3|COMPLETED|Overall Study||0
2285164|NCT02140788|5610586|P2|COMPLETED|Overall Study||0
2285165|NCT02140788|5610587|P1|COMPLETED|Overall Study||0
2285166|NCT02140788|5610584|P4|STARTED|Overall Study||0
2285167|NCT02140788|5610585|P3|STARTED|Overall Study||0
2285168|NCT02140788|5610586|P2|STARTED|Overall Study||0
2285169|NCT02140788|5610587|P1|STARTED|Overall Study||0
2285170|NCT02140762|5610615|P2|NOT COMPLETED|Overall Study||12
2285171|NCT02140762|5610616|P1|NOT COMPLETED|Overall Study||17
2285172|NCT02140762|5610615|P2|COMPLETED|Overall Study||139
2285173|NCT02140762|5610616|P1|COMPLETED|Overall Study||137
2285174|NCT02140762|5610615|P2|STARTED|Overall Study||151
2285175|NCT02140762|5610616|P1|STARTED|Overall Study||154
2285176|NCT02140645|5610682|P6|NOT COMPLETED|Overall Study||70896
2285177|NCT02140645|5610683|P5|NOT COMPLETED|Overall Study||3286
2285178|NCT02140645|5610684|P4|NOT COMPLETED|Overall Study||13833
2285179|NCT02140645|5610685|P3|NOT COMPLETED|Overall Study||4236
2285180|NCT02140645|5610686|P2|NOT COMPLETED|Overall Study||61654
2285181|NCT02140645|5610687|P1|NOT COMPLETED|Overall Study||5489
2285182|NCT02140645|5610682|P6|COMPLETED|Overall Study||3050
2285183|NCT02140645|5610683|P5|COMPLETED|Overall Study||150
2285184|NCT02140645|5610684|P4|COMPLETED|Overall Study||530
2285185|NCT02140645|5610685|P3|COMPLETED|Overall Study||205
2285186|NCT02140645|5610686|P2|COMPLETED|Overall Study||3041
2285187|NCT02140645|5610687|P1|COMPLETED|Overall Study||243
2285188|NCT02140645|5610682|P6|STARTED|Overall Study||73946
2285189|NCT02140645|5610683|P5|STARTED|Overall Study||3436
2285190|NCT02140645|5610684|P4|STARTED|Overall Study||14363
2285191|NCT02140645|5610685|P3|STARTED|Overall Study||4441
2285192|NCT02140645|5610686|P2|STARTED|Overall Study||64695
2285193|NCT02140645|5610687|P1|STARTED|Overall Study||5732
2285194|NCT02140593|5610776|P2|NOT COMPLETED|Overall Study||0
2285195|NCT02140593|5610777|P1|NOT COMPLETED|Overall Study||0
2285196|NCT02140593|5610776|P2|COMPLETED|Overall Study||65
2285197|NCT02140593|5610777|P1|COMPLETED|Overall Study||63
2285198|NCT02140593|5610776|P2|STARTED|Overall Study||65
2285199|NCT02140593|5610777|P1|STARTED|Overall Study||63
2285200|NCT02140567|5610785|P1|NOT COMPLETED|Overall Study||6
2285201|NCT02140567|5610785|P1|COMPLETED|Overall Study||134
2285202|NCT02140567|5610785|P1|STARTED|Overall Study||140
2285203|NCT02140411|5610790|P1|NOT COMPLETED|Overall Study||1
2285204|NCT02140411|5610790|P1|COMPLETED|Overall Study||20
2285205|NCT02140411|5610790|P1|STARTED|Overall Study||21
2285206|NCT02140372|5610799|P1|NOT COMPLETED|Overall Study||0
2285207|NCT02140372|5610799|P1|COMPLETED|Overall Study||10
2285208|NCT02140372|5610799|P1|STARTED|Overall Study||10
2285209|NCT02140164|5610810|P1|NOT COMPLETED|Overall Study||2
2285210|NCT02140164|5610810|P1|COMPLETED|Overall Study||5
2285211|NCT02140164|5610810|P1|STARTED|Overall Study||7
2285212|NCT02140060|5610831|P6|NOT COMPLETED|Overall Study||1
2285213|NCT02140060|5610832|P5|NOT COMPLETED|Overall Study||1
2285214|NCT02140060|5610833|P4|NOT COMPLETED|Overall Study||2
2285215|NCT02140060|5610834|P3|NOT COMPLETED|Overall Study||0
2285216|NCT02140060|5610835|P2|NOT COMPLETED|Overall Study||0
2285217|NCT02140060|5610836|P1|NOT COMPLETED|Overall Study||0
2285218|NCT02140060|5610831|P6|COMPLETED|Overall Study||43
2285219|NCT02140060|5610832|P5|COMPLETED|Overall Study||44
2285220|NCT02140060|5610833|P4|COMPLETED|Overall Study||43
2285221|NCT02140060|5610834|P3|COMPLETED|Overall Study||44
2285222|NCT02140060|5610835|P2|COMPLETED|Overall Study||44
2285223|NCT02140060|5610836|P1|COMPLETED|Overall Study||44
2285224|NCT02140060|5610831|P6|STARTED|Overall Study||44
2285225|NCT02140060|5610832|P5|STARTED|Overall Study||45
2285226|NCT02140060|5610833|P4|STARTED|Overall Study||45
2285227|NCT02140060|5610834|P3|STARTED|Overall Study||44
2285228|NCT02140060|5610835|P2|STARTED|Overall Study||44
2285229|NCT02140060|5610836|P1|STARTED|Overall Study||44
2285230|NCT02139982|5610861|P10|NOT COMPLETED|Overall Study||0
2285231|NCT02139982|5610862|P9|NOT COMPLETED|Overall Study||0
2285232|NCT02139982|5610863|P8|NOT COMPLETED|Overall Study||0
2285233|NCT02139982|5610864|P7|NOT COMPLETED|Overall Study||0
2285234|NCT02139982|5610865|P6|NOT COMPLETED|Overall Study||0
2285235|NCT02139982|5610866|P5|NOT COMPLETED|Overall Study||0
2285236|NCT02139982|5610867|P4|NOT COMPLETED|Overall Study||1
2285237|NCT02139982|5610868|P3|NOT COMPLETED|Overall Study||0
2285238|NCT02139982|5610869|P2|NOT COMPLETED|Overall Study||1
2285239|NCT02139982|5610870|P1|NOT COMPLETED|Overall Study||0
2285240|NCT02139982|5610861|P10|COMPLETED|Overall Study||13
2285241|NCT02139982|5610862|P9|COMPLETED|Overall Study||13
2285242|NCT02139982|5610863|P8|COMPLETED|Overall Study||13
2285243|NCT02139982|5610864|P7|COMPLETED|Overall Study||13
2285244|NCT02139982|5610865|P6|COMPLETED|Overall Study||13
2285245|NCT02139982|5610866|P5|COMPLETED|Overall Study||13
2285246|NCT02139982|5610867|P4|COMPLETED|Overall Study||7
2285247|NCT02139982|5610868|P3|COMPLETED|Overall Study||8
2285248|NCT02139982|5610869|P2|COMPLETED|Overall Study||7
2285249|NCT02139982|5610870|P1|COMPLETED|Overall Study||8
2285250|NCT02139982|5610861|P10|STARTED|Overall Study||13
2285251|NCT02139982|5610862|P9|STARTED|Overall Study||13
2285252|NCT02139982|5610863|P8|STARTED|Overall Study||13
2285253|NCT02139982|5610864|P7|STARTED|Overall Study||13
2285254|NCT02139982|5610865|P6|STARTED|Overall Study||13
2285255|NCT02139982|5610866|P5|STARTED|Overall Study||13
2285256|NCT02139982|5610867|P4|STARTED|Overall Study||8
2285257|NCT02139982|5610868|P3|STARTED|Overall Study||8
2285258|NCT02139982|5610869|P2|STARTED|Overall Study||8
2285259|NCT02139982|5610870|P1|STARTED|Overall Study||8
2285260|NCT02139943|5610915|P3|NOT COMPLETED|Overall Study||7
2285261|NCT02139943|5610916|P2|NOT COMPLETED|Overall Study||6
2285262|NCT02139943|5610917|P1|NOT COMPLETED|Overall Study||10
2285263|NCT02139943|5610915|P3|COMPLETED|Overall Study||110
2285264|NCT02139943|5610916|P2|COMPLETED|Overall Study||111
2285265|NCT02139943|5610917|P1|COMPLETED|Overall Study||107
2285266|NCT02139943|5610915|P3|STARTED|Overall Study||117
2285267|NCT02139943|5610916|P2|STARTED|Overall Study||117
2285268|NCT02139943|5610917|P1|STARTED|Overall Study||117
2285269|NCT02139878|5610928|P2|NOT COMPLETED|Second Intervention (7 Days)||0
2285270|NCT02139878|5610929|P1|NOT COMPLETED|Second Intervention (7 Days)||0
2285271|NCT02139878|5610928|P2|COMPLETED|Second Intervention (7 Days)||10
2285272|NCT02139878|5610929|P1|COMPLETED|Second Intervention (7 Days)||9
2285273|NCT02139878|5610928|P2|STARTED|Second Intervention (7 Days)||10
2285274|NCT02139878|5610929|P1|STARTED|Second Intervention (7 Days)||9
2285275|NCT02139878|5610928|P2|NOT COMPLETED|Washout Period (8 Days)||0
2285276|NCT02139878|5610929|P1|NOT COMPLETED|Washout Period (8 Days)||0
2285277|NCT02139878|5610928|P2|COMPLETED|Washout Period (8 Days)||10
2285278|NCT02139878|5610929|P1|COMPLETED|Washout Period (8 Days)||9
2285279|NCT02139878|5610928|P2|STARTED|Washout Period (8 Days)||10
2285280|NCT02139878|5610929|P1|STARTED|Washout Period (8 Days)||9
2285281|NCT02139878|5610928|P2|NOT COMPLETED|First Intervention (7 Days)||0
2285282|NCT02139878|5610929|P1|NOT COMPLETED|First Intervention (7 Days)||1
2285283|NCT02139878|5610928|P2|COMPLETED|First Intervention (7 Days)||10
2285284|NCT02139878|5610929|P1|COMPLETED|First Intervention (7 Days)||9
2285285|NCT02139878|5610928|P2|STARTED|First Intervention (7 Days)||10
2285286|NCT02139878|5610929|P1|STARTED|First Intervention (7 Days)||10
2285287|NCT02139644|5610942|P6|NOT COMPLETED|Treatment Period||17
2285288|NCT02139644|5610943|P5|NOT COMPLETED|Treatment Period||8
2285289|NCT02139644|5610944|P4|NOT COMPLETED|Treatment Period||9
2285290|NCT02139644|5610945|P3|NOT COMPLETED|Treatment Period||8
2285291|NCT02139644|5610946|P2|NOT COMPLETED|Treatment Period||3
2285292|NCT02139644|5610947|P1|NOT COMPLETED|Treatment Period||0
2285293|NCT02139644|5610942|P6|COMPLETED|Treatment Period||113
2285294|NCT02139644|5610943|P5|COMPLETED|Treatment Period||121
2285295|NCT02139644|5610944|P4|COMPLETED|Treatment Period||121
2285296|NCT02139644|5610945|P3|COMPLETED|Treatment Period||121
2285297|NCT02139644|5610946|P2|COMPLETED|Treatment Period||126
2285298|NCT02139644|5610947|P1|COMPLETED|Treatment Period||0
2285299|NCT02139644|5610942|P6|STARTED|Treatment Period|Randomized|130
2285300|NCT02139644|5610943|P5|STARTED|Treatment Period|Randomized|129
2285301|NCT02139644|5610944|P4|STARTED|Treatment Period|Randomized|130
2285302|NCT02139644|5610945|P3|STARTED|Treatment Period|Randomized|129
2285303|NCT02139644|5610946|P2|STARTED|Treatment Period|Randomized|129
2285304|NCT02139644|5610947|P1|STARTED|Treatment Period||0
2285305|NCT02139644|5610942|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
2285306|NCT02139644|5610943|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
2285307|NCT02139644|5610944|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
2285308|NCT02139644|5610945|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
2285309|NCT02139644|5610946|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
2285310|NCT02139644|5610947|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||140
2285311|NCT02139644|5610942|P6|COMPLETED|Run-In Period (Pre-assignment)||0
2285312|NCT02139644|5610943|P5|COMPLETED|Run-In Period (Pre-assignment)||0
2285313|NCT02139644|5610944|P4|COMPLETED|Run-In Period (Pre-assignment)||0
2285314|NCT02139644|5610945|P3|COMPLETED|Run-In Period (Pre-assignment)||0
2285315|NCT02139644|5610946|P2|COMPLETED|Run-In Period (Pre-assignment)||0
2285316|NCT02139644|5610947|P1|COMPLETED|Run-In Period (Pre-assignment)||647
2285317|NCT02139644|5610942|P6|STARTED|Run-In Period (Pre-assignment)||0
2285318|NCT02139644|5610943|P5|STARTED|Run-In Period (Pre-assignment)||0
2285319|NCT02139644|5610944|P4|STARTED|Run-In Period (Pre-assignment)||0
2285320|NCT02139644|5610945|P3|STARTED|Run-In Period (Pre-assignment)||0
2285321|NCT02139644|5610946|P2|STARTED|Run-In Period (Pre-assignment)||0
2285322|NCT02139644|5610947|P1|STARTED|Run-In Period (Pre-assignment)|Enrolled|787
2285323|NCT02139592|5610999|P1|NOT COMPLETED|Overall Study||8
2285324|NCT02139592|5610999|P1|COMPLETED|Overall Study||284
2285325|NCT02139592|5610999|P1|STARTED|Overall Study||292
2285326|NCT02139540|5611007|P2|NOT COMPLETED|Overall Study||0
2285327|NCT02139540|5611008|P1|NOT COMPLETED|Overall Study||1
2285328|NCT02139540|5611007|P2|COMPLETED|Overall Study||10
2285329|NCT02139540|5611008|P1|COMPLETED|Overall Study||10
2285330|NCT02139540|5611007|P2|STARTED|Overall Study||10
2285331|NCT02139540|5611008|P1|STARTED|Overall Study||11
2285332|NCT02139358|5611016|P1|NOT COMPLETED|Overall Study||0
2285333|NCT02139358|5611016|P1|COMPLETED|Overall Study||15
2285334|NCT02139358|5611016|P1|STARTED|Overall Study||15
2285335|NCT02139228|5611025|P2|NOT COMPLETED|Overall Study||0
2285336|NCT02139228|5611026|P1|NOT COMPLETED|Overall Study||0
2285337|NCT02139228|5611025|P2|COMPLETED|Overall Study||211
2285338|NCT02139228|5611026|P1|COMPLETED|Overall Study||215
2285339|NCT02139228|5611025|P2|STARTED|Overall Study||211
2285340|NCT02139228|5611026|P1|STARTED|Overall Study||215
2285341|NCT02139176|5611036|P2|NOT COMPLETED|Overall Study||0
2285342|NCT02139176|5611037|P1|NOT COMPLETED|Overall Study||0
2285343|NCT02139176|5611036|P2|COMPLETED|Overall Study||100
2285344|NCT02139176|5611037|P1|COMPLETED|Overall Study||100
2285345|NCT02139176|5611036|P2|STARTED|Overall Study||100
2285346|NCT02139176|5611037|P1|STARTED|Overall Study||100
2285347|NCT02139137|5611049|P2|NOT COMPLETED|Overall Study||10
2285348|NCT02139137|5611050|P1|NOT COMPLETED|Overall Study||7
2285349|NCT02139137|5611049|P2|COMPLETED|Overall Study||10
2285350|NCT02139137|5611050|P1|COMPLETED|Overall Study||15
2285351|NCT02139137|5611049|P2|STARTED|Overall Study||20
2285352|NCT02139137|5611050|P1|STARTED|Overall Study||22
2285353|NCT02139124|5611069|P5|NOT COMPLETED|Overall Study||13
2285354|NCT02139124|5611070|P4|NOT COMPLETED|Overall Study||12
2285355|NCT02139124|5611071|P3|NOT COMPLETED|Overall Study||4
2285356|NCT02139124|5611072|P2|NOT COMPLETED|Overall Study||4
2285357|NCT02139124|5611073|P1|NOT COMPLETED|Overall Study||9
2285358|NCT02139124|5611069|P5|COMPLETED|Overall Study||61
2285359|NCT02139124|5611070|P4|COMPLETED|Overall Study||61
2285360|NCT02139124|5611071|P3|COMPLETED|Overall Study||69
2285361|NCT02139124|5611072|P2|COMPLETED|Overall Study||73
2285362|NCT02139124|5611073|P1|COMPLETED|Overall Study||69
2285363|NCT02139124|5611069|P5|STARTED|Overall Study||74
2285364|NCT02139124|5611070|P4|STARTED|Overall Study||73
2285365|NCT02139124|5611071|P3|STARTED|Overall Study||73
2285366|NCT02139124|5611072|P2|STARTED|Overall Study||77
2285367|NCT02139124|5611073|P1|STARTED|Overall Study||78
2285368|NCT02139046|5611090|P5|NOT COMPLETED|Overall Study||57
2285369|NCT02139046|5611091|P4|NOT COMPLETED|Overall Study||68
2285370|NCT02139046|5611092|P3|NOT COMPLETED|Overall Study||59
2285371|NCT02139046|5611093|P2|NOT COMPLETED|Overall Study||54
2285372|NCT02139046|5611094|P1|NOT COMPLETED|Overall Study||62
2285373|NCT02139046|5611090|P5|COMPLETED|Overall Study||301
2285374|NCT02139046|5611091|P4|COMPLETED|Overall Study||290
2285375|NCT02139046|5611092|P3|COMPLETED|Overall Study||298
2285376|NCT02139046|5611093|P2|COMPLETED|Overall Study||305
2285377|NCT02139046|5611094|P1|COMPLETED|Overall Study|Completed=Completed Study Drug|296
2285378|NCT02139046|5611090|P5|Full Analysis Set|Overall Study||357
2285379|NCT02139046|5611091|P4|Full Analysis Set|Overall Study||357
2285380|NCT02139046|5611092|P3|Full Analysis Set|Overall Study||355
2285381|NCT02139046|5611093|P2|Full Analysis Set|Overall Study||357
2285382|NCT02139046|5611094|P1|Full Analysis Set|Overall Study||357
2285383|NCT02139046|5611090|P5|Safety Analysis Set|Overall Study||357
2285384|NCT02139046|5611091|P4|Safety Analysis Set|Overall Study||357
2285385|NCT02139046|5611092|P3|Safety Analysis Set|Overall Study||355
2285386|NCT02139046|5611093|P2|Safety Analysis Set|Overall Study||358
2285387|NCT02139046|5611094|P1|Safety Analysis Set|Overall Study||356
2285388|NCT02139046|5611090|P5|STARTED|Overall Study||358
2285389|NCT02139046|5611091|P4|STARTED|Overall Study||358
2285390|NCT02139046|5611092|P3|STARTED|Overall Study||357
2285391|NCT02139046|5611093|P2|STARTED|Overall Study||359
2285392|NCT02139046|5611094|P1|STARTED|Overall Study||358
2285393|NCT02139007|5611118|P2|NOT COMPLETED|Patient Participant Recruitment||1
2285394|NCT02139007|5611119|P1|NOT COMPLETED|Patient Participant Recruitment||2
2285395|NCT02139007|5611118|P2|COMPLETED|Patient Participant Recruitment||13
2285396|NCT02139007|5611119|P1|COMPLETED|Patient Participant Recruitment||11
2285397|NCT02139007|5611118|P2|STARTED|Patient Participant Recruitment||14
2285398|NCT02139007|5611119|P1|STARTED|Patient Participant Recruitment||13
2285399|NCT02139007|5611118|P2|NOT COMPLETED|Study Site Recruitment||4
2285400|NCT02139007|5611119|P1|NOT COMPLETED|Study Site Recruitment||3
2285401|NCT02139007|5611118|P2|COMPLETED|Study Site Recruitment||1
2285402|NCT02139007|5611119|P1|COMPLETED|Study Site Recruitment||1
2285403|NCT02139007|5611118|P2|STARTED|Study Site Recruitment||5
2285404|NCT02139007|5611119|P1|STARTED|Study Site Recruitment||4
2285405|NCT02138916|5611135|P3|NOT COMPLETED|Overall Study||59
2285406|NCT02138916|5611136|P2|NOT COMPLETED|Overall Study||60
2285407|NCT02138916|5611137|P1|NOT COMPLETED|Overall Study||57
2285408|NCT02138916|5611135|P3|COMPLETED|Overall Study||491
2285409|NCT02138916|5611136|P2|COMPLETED|Overall Study||492
2285410|NCT02138916|5611137|P1|COMPLETED|Overall Study||497
2285411|NCT02138916|5611135|P3|STARTED|Overall Study||550
2285412|NCT02138916|5611136|P2|STARTED|Overall Study||552
2285413|NCT02138916|5611137|P1|STARTED|Overall Study||554
2285414|NCT02138890|5611200|P2|NOT COMPLETED|Overall Study||0
2285415|NCT02138890|5611201|P1|NOT COMPLETED|Overall Study||1
2285416|NCT02138890|5611200|P2|COMPLETED|Overall Study||15
2285417|NCT02138890|5611201|P1|COMPLETED|Overall Study||30
2285418|NCT02138890|5611200|P2|STARTED|Overall Study||15
2285419|NCT02138890|5611201|P1|STARTED|Overall Study||31
2285420|NCT02138838|5611243|P2|NOT COMPLETED|Overall Study||11
2285421|NCT02138838|5611244|P1|NOT COMPLETED|Overall Study||8
2285422|NCT02138838|5611243|P2|COMPLETED|Overall Study||16
2285423|NCT02138838|5611244|P1|COMPLETED|Overall Study||20
2285424|NCT02138838|5611243|P2|Received Study Drug|Overall Study||25
2285425|NCT02138838|5611244|P1|Received Study Drug|Overall Study||28
2285426|NCT02138838|5611243|P2|STARTED|Overall Study||27
2285427|NCT02138838|5611244|P1|STARTED|Overall Study||28
2285428|NCT02138825|5611262|P2|NOT COMPLETED|Safety Follow-up||17
2285429|NCT02138825|5611263|P1|NOT COMPLETED|Safety Follow-up||22
2285430|NCT02138825|5611262|P2|COMPLETED|Safety Follow-up||47
2285431|NCT02138825|5611263|P1|COMPLETED|Safety Follow-up||50
2285432|NCT02138825|5611262|P2|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|64
2285433|NCT02138825|5611263|P1|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|72
2285434|NCT02138825|5611262|P2|NOT COMPLETED|Long-term Extension||38
2285435|NCT02138825|5611263|P1|NOT COMPLETED|Long-term Extension||32
2285436|NCT02138825|5611262|P2|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0
2285437|NCT02138825|5611263|P1|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0
2285438|NCT02138825|5611262|P2|STARTED|Long-term Extension||38
2285439|NCT02138825|5611263|P1|STARTED|Long-term Extension||32
2285440|NCT02138825|5611262|P2|NOT COMPLETED|Main Study Treatment||35
2285441|NCT02138825|5611263|P1|NOT COMPLETED|Main Study Treatment||40
2285442|NCT02138825|5611262|P2|COMPLETED|Main Study Treatment||39
2285443|NCT02138825|5611263|P1|COMPLETED|Main Study Treatment||33
2285444|NCT02138825|5611262|P2|STARTED|Main Study Treatment|safety population|74
2285445|NCT02138825|5611263|P1|STARTED|Main Study Treatment|safety population|73
2285446|NCT02138786|5611280|P3|NOT COMPLETED|Overall Study||8
2285447|NCT02138786|5611281|P2|NOT COMPLETED|Overall Study||15
2285448|NCT02138786|5611282|P1|NOT COMPLETED|Overall Study||3
2285449|NCT02138786|5611280|P3|COMPLETED|Overall Study||0
2285450|NCT02138786|5611281|P2|COMPLETED|Overall Study||0
2285451|NCT02138786|5611282|P1|COMPLETED|Overall Study||0
2285452|NCT02138786|5611280|P3|STARTED|Overall Study||8
2285453|NCT02138786|5611281|P2|STARTED|Overall Study||15
2285454|NCT02138786|5611282|P1|STARTED|Overall Study||3
2285479|NCT02138578|5611337|P3|NOT COMPLETED|Overall Study||0
2285480|NCT02138578|5611338|P2|NOT COMPLETED|Overall Study||0
2285481|NCT02138578|5611339|P1|NOT COMPLETED|Overall Study||0
2285482|NCT02138578|5611337|P3|COMPLETED|Overall Study||3
2285483|NCT02138578|5611338|P2|COMPLETED|Overall Study||0
2285484|NCT02138578|5611339|P1|COMPLETED|Overall Study||1
2285485|NCT02138578|5611337|P3|STARTED|Overall Study||3
2285486|NCT02138578|5611338|P2|STARTED|Overall Study||0
2285487|NCT02138578|5611339|P1|STARTED|Overall Study||1
2285488|NCT02138461|5611367|P2|NOT COMPLETED|Overall Study||0
2285489|NCT02138461|5611368|P1|NOT COMPLETED|Overall Study||0
2285490|NCT02138461|5611367|P2|COMPLETED|Overall Study||110
2285491|NCT02138461|5611368|P1|COMPLETED|Overall Study||101
2285492|NCT02138461|5611367|P2|STARTED|Overall Study||110
2285493|NCT02138461|5611368|P1|STARTED|Overall Study||101
2285494|NCT02138253|5611376|P2|NOT COMPLETED|Overall Study||4
2285495|NCT02138253|5611377|P1|NOT COMPLETED|Overall Study||9
2285496|NCT02138253|5611376|P2|COMPLETED|Overall Study||19
2285497|NCT02138253|5611377|P1|COMPLETED|Overall Study||32
2285498|NCT02138253|5611376|P2|STARTED|Overall Study||23
2285499|NCT02138253|5611377|P1|STARTED|Overall Study||41
2285500|NCT02138240|5611405|P1|NOT COMPLETED|Overall Study||0
2285501|NCT02138240|5611405|P1|COMPLETED|Overall Study||34
2285502|NCT02138240|5611405|P1|STARTED|Overall Study||34
2285503|NCT02138227|5611417|P2|NOT COMPLETED|Overall Study||0
2285504|NCT02138227|5611418|P1|NOT COMPLETED|Overall Study||0
2285505|NCT02138227|5611417|P2|COMPLETED|Overall Study||218
2285506|NCT02138227|5611418|P1|COMPLETED|Overall Study||55
2285507|NCT02138227|5611417|P2|STARTED|Overall Study||218
2285508|NCT02138227|5611418|P1|STARTED|Overall Study||55
2285509|NCT02138136|5611449|P1|NOT COMPLETED|Overall Study||139
2285510|NCT02138136|5611449|P1|COMPLETED|Overall Study||280
2285511|NCT02138136|5611449|P1|Modified Intent to Treat (mITT)|Overall Study||418
2285512|NCT02138136|5611449|P1|Safety Analysis Set|Overall Study||419
2285513|NCT02138136|5611449|P1|STARTED|Overall Study||419
2285514|NCT02138110|5611456|P1|NOT COMPLETED|Overall Scaffold Implantation||3
2285515|NCT02138110|5611456|P1|COMPLETED|Overall Scaffold Implantation||16
2285516|NCT02138110|5611456|P1|6-month Follow-Up|Overall Scaffold Implantation||16
2285517|NCT02138110|5611456|P1|STARTED|Overall Scaffold Implantation||19
2285518|NCT02138110|5611456|P1|NOT COMPLETED|Enrolled for Scaffold Implantation||1
2285519|NCT02138110|5611456|P1|COMPLETED|Enrolled for Scaffold Implantation||19
2285520|NCT02138110|5611456|P1|STARTED|Enrolled for Scaffold Implantation||20
2285521|NCT02138110|5611456|P1|NOT COMPLETED|Enrolled in Study||0
2285522|NCT02138110|5611456|P1|COMPLETED|Enrolled in Study||20
2285523|NCT02138110|5611456|P1|STARTED|Enrolled in Study||20
2285524|NCT02138097|5611484|P2|NOT COMPLETED|Overall Study||0
2285525|NCT02138097|5611485|P1|NOT COMPLETED|Overall Study||0
2285526|NCT02138097|5611484|P2|COMPLETED|Overall Study||459722
2285527|NCT02138097|5611485|P1|COMPLETED|Overall Study||155345
2285528|NCT02138097|5611484|P2|STARTED|Overall Study||459722
2285529|NCT02138097|5611485|P1|STARTED|Overall Study||155345
2285530|NCT02138006|5611677|P2|NOT COMPLETED|Overall Study||0
2285531|NCT02138006|5611678|P1|NOT COMPLETED|Overall Study||0
2285532|NCT02138006|5611677|P2|COMPLETED|Overall Study||54
2285533|NCT02138006|5611678|P1|COMPLETED|Overall Study||48
2285534|NCT02138006|5611677|P2|STARTED|Overall Study||54
2285535|NCT02138006|5611678|P1|STARTED|Overall Study||48
2285536|NCT02137785|5611688|P2|NOT COMPLETED|Overall Study||4
2285537|NCT02137785|5611689|P1|NOT COMPLETED|Overall Study||3
2285538|NCT02137785|5611688|P2|COMPLETED|Overall Study||130
2285539|NCT02137785|5611689|P1|COMPLETED|Overall Study||132
2285540|NCT02137785|5611688|P2|STARTED|Overall Study||134
2285541|NCT02137785|5611689|P1|STARTED|Overall Study||135
2285542|NCT02137772|5611797|P2|NOT COMPLETED|Overall Study||75
2285543|NCT02137772|5611798|P1|NOT COMPLETED|Overall Study||132
2285544|NCT02137772|5611797|P2|COMPLETED|Overall Study||119
2285545|NCT02137772|5611798|P1|COMPLETED|Overall Study||244
2285546|NCT02137772|5611797|P2|Treated Participants|Overall Study||192
2285547|NCT02137772|5611798|P1|Treated Participants|Overall Study||373
2285548|NCT02137772|5611797|P2|STARTED|Overall Study|Randomized participants|194
2285549|NCT02137772|5611798|P1|STARTED|Overall Study|Randomized participants|376
2285550|NCT02137603|5611824|P2|NOT COMPLETED|Overall Study||0
2285551|NCT02137603|5611825|P1|NOT COMPLETED|Overall Study||2
2285552|NCT02137603|5611824|P2|COMPLETED|Overall Study||18
2285553|NCT02137603|5611825|P1|COMPLETED|Overall Study||16
2285554|NCT02137603|5611824|P2|STARTED|Overall Study||18
2285555|NCT02137603|5611825|P1|STARTED|Overall Study||18
2285556|NCT02137512|5611833|P1|NOT COMPLETED|5-Month 24/7 Closed-Loop||0
2285557|NCT02137512|5611833|P1|COMPLETED|5-Month 24/7 Closed-Loop||14
2285558|NCT02137512|5611833|P1|STARTED|5-Month 24/7 Closed-Loop||14
2285559|NCT02137512|5611833|P1|NOT COMPLETED|2-Week 24/7 Closed-Loop||0
2285560|NCT02137512|5611833|P1|COMPLETED|2-Week 24/7 Closed-Loop||30
2285561|NCT02137512|5611833|P1|STARTED|2-Week 24/7 Closed-Loop||30
2285562|NCT02137512|5611833|P1|NOT COMPLETED|2-Week Overnight-Only Closed-Loop||0
2285563|NCT02137512|5611833|P1|COMPLETED|2-Week Overnight-Only Closed-Loop||30
2285564|NCT02137512|5611833|P1|STARTED|2-Week Overnight-Only Closed-Loop||30
2285565|NCT02137512|5611833|P1|NOT COMPLETED|2-Week Baseline Sensor-Augmented Pump||0
2285566|NCT02137512|5611833|P1|COMPLETED|2-Week Baseline Sensor-Augmented Pump||30
2285567|NCT02137512|5611833|P1|STARTED|2-Week Baseline Sensor-Augmented Pump||30
2285568|NCT02137499|5611990|P4|NOT COMPLETED|Overall Study||0
2285569|NCT02137499|5611991|P3|NOT COMPLETED|Overall Study||0
2285570|NCT02137499|5611992|P2|NOT COMPLETED|Overall Study||0
2285571|NCT02137499|5611993|P1|NOT COMPLETED|Overall Study||0
2285572|NCT02137499|5611990|P4|COMPLETED|Overall Study||10
2285573|NCT02137499|5611991|P3|COMPLETED|Overall Study||10
2285574|NCT02137499|5611992|P2|COMPLETED|Overall Study||10
2285575|NCT02137499|5611993|P1|COMPLETED|Overall Study||10
2285576|NCT02137499|5611990|P4|STARTED|Overall Study||10
2285577|NCT02137499|5611991|P3|STARTED|Overall Study||10
2285578|NCT02137499|5611992|P2|STARTED|Overall Study||10
2285579|NCT02137499|5611993|P1|STARTED|Overall Study||10
2285580|NCT02137486|5612013|P2|NOT COMPLETED|Overall Study||0
2285581|NCT02137486|5612014|P1|NOT COMPLETED|Overall Study||0
2285582|NCT02137486|5612013|P2|COMPLETED|Overall Study||102
2285583|NCT02137486|5612014|P1|COMPLETED|Overall Study||112
2285584|NCT02137486|5612013|P2|STARTED|Overall Study||102
2285585|NCT02137486|5612014|P1|STARTED|Overall Study||112
2285586|NCT02137447|5612030|P1|NOT COMPLETED|Overall Study||0
2285587|NCT02137447|5612030|P1|COMPLETED|Overall Study||10
2285588|NCT02137447|5612030|P1|STARTED|Overall Study||10
2285589|NCT02137382|5612035|P2|NOT COMPLETED|Cross-over Period 2||0
2285590|NCT02137382|5612036|P1|NOT COMPLETED|Cross-over Period 2||0
2285591|NCT02137382|5612035|P2|COMPLETED|Cross-over Period 2||21
2285592|NCT02137382|5612036|P1|COMPLETED|Cross-over Period 2||18
2285593|NCT02137382|5612035|P2|STARTED|Cross-over Period 2||21
2285594|NCT02137382|5612036|P1|STARTED|Cross-over Period 2||18
2285595|NCT02137382|5612035|P2|NOT COMPLETED|Wash Out||0
2285596|NCT02137382|5612036|P1|NOT COMPLETED|Wash Out||0
2285597|NCT02137382|5612035|P2|COMPLETED|Wash Out||21
2285598|NCT02137382|5612036|P1|COMPLETED|Wash Out||18
2285599|NCT02137382|5612035|P2|STARTED|Wash Out||21
2285600|NCT02137382|5612036|P1|STARTED|Wash Out||18
2285601|NCT02137382|5612035|P2|NOT COMPLETED|Cross-over Period 1||0
2285602|NCT02137382|5612036|P1|NOT COMPLETED|Cross-over Period 1||2
2285603|NCT02137382|5612035|P2|COMPLETED|Cross-over Period 1||21
2285604|NCT02137382|5612036|P1|COMPLETED|Cross-over Period 1||18
2285605|NCT02137382|5612035|P2|STARTED|Cross-over Period 1||21
2285606|NCT02137382|5612036|P1|STARTED|Cross-over Period 1||20
2285607|NCT02137226|5612056|P5|NOT COMPLETED|Period 2 (Re - Randomization)||9
2285608|NCT02137226|5612057|P4|NOT COMPLETED|Period 2 (Re - Randomization)||8
2285609|NCT02137226|5612058|P3|NOT COMPLETED|Period 2 (Re - Randomization)||17
2285610|NCT02137226|5612059|P2|NOT COMPLETED|Period 2 (Re - Randomization)||0
2285611|NCT02137226|5612060|P1|NOT COMPLETED|Period 2 (Re - Randomization)||0
2285612|NCT02137226|5612056|P5|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|138
2285613|NCT02137226|5612057|P4|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|140
2285614|NCT02137226|5612058|P3|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|281
2285615|NCT02137226|5612059|P2|COMPLETED|Period 2 (Re - Randomization)||0
2285616|NCT02137226|5612060|P1|COMPLETED|Period 2 (Re - Randomization)||0
2285617|NCT02137226|5612056|P5|STARTED|Period 2 (Re - Randomization)||147
2285618|NCT02137226|5612057|P4|STARTED|Period 2 (Re - Randomization)||148
2285619|NCT02137226|5612058|P3|STARTED|Period 2 (Re - Randomization)||298
2285620|NCT02137226|5612059|P2|STARTED|Period 2 (Re - Randomization)||0
2285621|NCT02137226|5612060|P1|STARTED|Period 2 (Re - Randomization)||0
2285622|NCT02137226|5612056|P5|NOT COMPLETED|Period 1 (Initial Randomization)||0
2285623|NCT02137226|5612057|P4|NOT COMPLETED|Period 1 (Initial Randomization)||0
2285624|NCT02137226|5612058|P3|NOT COMPLETED|Period 1 (Initial Randomization)||0
2285625|NCT02137226|5612059|P2|NOT COMPLETED|Period 1 (Initial Randomization)||16
2285626|NCT02137226|5612060|P1|NOT COMPLETED|Period 1 (Initial Randomization)||20
2285627|NCT02137226|5612056|P5|COMPLETED|Period 1 (Initial Randomization)||0
2285628|NCT02137226|5612057|P4|COMPLETED|Period 1 (Initial Randomization)||0
2285629|NCT02137226|5612058|P3|COMPLETED|Period 1 (Initial Randomization)||0
2285630|NCT02137226|5612059|P2|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|305
2285631|NCT02137226|5612060|P1|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|304
2285632|NCT02137226|5612056|P5|STARTED|Period 1 (Initial Randomization)||0
2285633|NCT02137226|5612057|P4|STARTED|Period 1 (Initial Randomization)||0
2285634|NCT02137226|5612058|P3|STARTED|Period 1 (Initial Randomization)||0
2285635|NCT02137226|5612059|P2|STARTED|Period 1 (Initial Randomization)||321
2285636|NCT02137226|5612060|P1|STARTED|Period 1 (Initial Randomization)||324
2285637|NCT02137096|5612072|P1|NOT COMPLETED|Overall Study||0
2285638|NCT02137096|5612072|P1|COMPLETED|Overall Study||1
2285639|NCT02137096|5612072|P1|STARTED|Overall Study||1
2285640|NCT02136914|5612078|P2|NOT COMPLETED|Overall Study||21
2285641|NCT02136914|5612079|P1|NOT COMPLETED|Overall Study||21
2285642|NCT02136914|5612078|P2|COMPLETED|Overall Study||42
2285643|NCT02136914|5612079|P1|COMPLETED|Overall Study||42
2285644|NCT02136914|5612078|P2|Received Study Drug|Overall Study||63
2285645|NCT02136914|5612079|P1|Received Study Drug|Overall Study||60
2285646|NCT02136914|5612078|P2|STARTED|Overall Study||63
2285647|NCT02136914|5612079|P1|STARTED|Overall Study||63
2285648|NCT02136810|5612093|P1|NOT COMPLETED|Overall Study||0
2285649|NCT02136810|5612093|P1|COMPLETED|Overall Study||200
2285650|NCT02136810|5612093|P1|STARTED|Overall Study||200
2285651|NCT02136680|5612099|P2|NOT COMPLETED|Overall Study||29
2285652|NCT02136680|5612100|P1|NOT COMPLETED|Overall Study||32
2285653|NCT02136680|5612099|P2|COMPLETED|Overall Study||56
2285654|NCT02136680|5612100|P1|COMPLETED|Overall Study||80
2285655|NCT02136680|5612099|P2|Interview 3|Overall Study||56
2285656|NCT02136680|5612100|P1|Interview 3|Overall Study||80
2285657|NCT02136680|5612099|P2|Interview 2|Overall Study||70
2285658|NCT02136680|5612100|P1|Interview 2|Overall Study||97
2285659|NCT02136680|5612099|P2|Interview 1|Overall Study||85
2285660|NCT02136680|5612100|P1|Interview 1|Overall Study||112
2285661|NCT02136680|5612099|P2|STARTED|Overall Study||85
2285662|NCT02136680|5612100|P1|STARTED|Overall Study||112
2285663|NCT02136498|5612116|P2|NOT COMPLETED|Overall Study||0
2285664|NCT02136498|5612117|P1|NOT COMPLETED|Overall Study||0
2285665|NCT02136498|5612116|P2|COMPLETED|Overall Study||33
2285666|NCT02136498|5612117|P1|COMPLETED|Overall Study||33
2285667|NCT02136498|5612116|P2|STARTED|Overall Study||33
2285668|NCT02136498|5612117|P1|STARTED|Overall Study||33
2285669|NCT02136420|5612129|P10|NOT COMPLETED|Overall Study||0
2285670|NCT02136420|5612130|P9|NOT COMPLETED|Overall Study||0
2285671|NCT02136420|5612131|P8|NOT COMPLETED|Overall Study||0
2285672|NCT02136420|5612132|P7|NOT COMPLETED|Overall Study||0
2285673|NCT02136420|5612133|P6|NOT COMPLETED|Overall Study||0
2285674|NCT02136420|5612134|P5|NOT COMPLETED|Overall Study||0
2285675|NCT02136420|5612135|P4|NOT COMPLETED|Overall Study||0
2285676|NCT02136420|5612136|P3|NOT COMPLETED|Overall Study||0
2285677|NCT02136420|5612137|P2|NOT COMPLETED|Overall Study||0
2285678|NCT02136420|5612138|P1|NOT COMPLETED|Overall Study||1
2285679|NCT02136420|5612129|P10|COMPLETED|Overall Study||5
2285680|NCT02136420|5612130|P9|COMPLETED|Overall Study||5
2285681|NCT02136420|5612131|P8|COMPLETED|Overall Study||0
2285682|NCT02136420|5612132|P7|COMPLETED|Overall Study||0
2285683|NCT02136420|5612133|P6|COMPLETED|Overall Study||0
2285684|NCT02136420|5612134|P5|COMPLETED|Overall Study||10
2285685|NCT02136420|5612135|P4|COMPLETED|Overall Study||0
2285686|NCT02136420|5612136|P3|COMPLETED|Overall Study||0
2285687|NCT02136420|5612137|P2|COMPLETED|Overall Study||0
2285688|NCT02136420|5612138|P1|COMPLETED|Overall Study||9
2285689|NCT02136420|5612129|P10|STARTED|Overall Study||5
2285690|NCT02136420|5612130|P9|STARTED|Overall Study||5
2285691|NCT02136420|5612131|P8|STARTED|Overall Study||0
2285692|NCT02136420|5612132|P7|STARTED|Overall Study||0
2285693|NCT02136420|5612133|P6|STARTED|Overall Study||0
2285694|NCT02136420|5612134|P5|STARTED|Overall Study||10
2285695|NCT02136420|5612135|P4|STARTED|Overall Study||0
2285696|NCT02136420|5612136|P3|STARTED|Overall Study||0
2285697|NCT02136420|5612137|P2|STARTED|Overall Study||0
2285698|NCT02136420|5612138|P1|STARTED|Overall Study||10
2285699|NCT02136238|5612160|P3|NOT COMPLETED|Overall Study||0
2285700|NCT02136238|5612161|P2|NOT COMPLETED|Overall Study||0
2285701|NCT02136238|5612162|P1|NOT COMPLETED|Overall Study||0
2285702|NCT02136238|5612160|P3|COMPLETED|Overall Study||10
2285703|NCT02136238|5612161|P2|COMPLETED|Overall Study||4
2285704|NCT02136238|5612162|P1|COMPLETED|Overall Study||4
2285705|NCT02136238|5612160|P3|STARTED|Overall Study||10
2285706|NCT02136238|5612161|P2|STARTED|Overall Study||4
2285707|NCT02136238|5612162|P1|STARTED|Overall Study||4
2285708|NCT02136134|5612175|P2|NOT COMPLETED|Overall Study||251
2285709|NCT02136134|5612176|P1|NOT COMPLETED|Overall Study||247
2285710|NCT02136134|5612175|P2|COMPLETED|Overall Study||0
2285711|NCT02136134|5612176|P1|COMPLETED|Overall Study||0
2285712|NCT02136134|5612175|P2|Treated|Overall Study||243
2285713|NCT02136134|5612176|P1|Treated|Overall Study||237
2285714|NCT02136134|5612175|P2|STARTED|Overall Study||251
2285715|NCT02136134|5612176|P1|STARTED|Overall Study||247
2285716|NCT02136004|5612194|P1|NOT COMPLETED|Overall Study||1
2285717|NCT02136004|5612194|P1|COMPLETED|Overall Study||219
2285718|NCT02136004|5612194|P1|STARTED|Overall Study|Enrollment commenced on May 20, 2014 and the last subject completed follow-up on February 28, 2015|220
2285719|NCT02135900|5612205|P1|NOT COMPLETED|Overall Study||0
2285720|NCT02135900|5612205|P1|COMPLETED|Overall Study||32
2285721|NCT02135900|5612205|P1|STARTED|Overall Study|32 subjects started the study. 50 subjects were screened.|32
2285722|NCT02135861|5612215|P3|NOT COMPLETED|Overall Study||0
2285723|NCT02135861|5612216|P2|NOT COMPLETED|Overall Study||0
2285724|NCT02135861|5612217|P1|NOT COMPLETED|Overall Study||0
2285725|NCT02135861|5612215|P3|COMPLETED|Overall Study||3
2285726|NCT02135861|5612216|P2|COMPLETED|Overall Study||12
2285727|NCT02135861|5612217|P1|COMPLETED|Overall Study||21
2285728|NCT02135861|5612215|P3|STARTED|Overall Study||3
2285729|NCT02135861|5612216|P2|STARTED|Overall Study||12
2285730|NCT02135861|5612217|P1|STARTED|Overall Study||21
2285731|NCT02135848|5612238|P2|NOT COMPLETED|Overall Study||1
2285732|NCT02135848|5612239|P1|NOT COMPLETED|Overall Study||3
2285733|NCT02135848|5612238|P2|COMPLETED|Overall Study||19
2285734|NCT02135848|5612239|P1|COMPLETED|Overall Study||23
2285735|NCT02135848|5612238|P2|STARTED|Overall Study||20
2285736|NCT02135848|5612239|P1|STARTED|Overall Study||26
2285737|NCT02135692|5612297|P1|NOT COMPLETED|Overall Study||339
2285738|NCT02135692|5612297|P1|COMPLETED|Overall Study||0
2285739|NCT02135692|5612297|P1|STARTED|Overall Study||339
2285740|NCT02135614|5612316|P2|NOT COMPLETED|Overall Study||5
2285741|NCT02135614|5612317|P1|NOT COMPLETED|Overall Study||8
2285742|NCT02135614|5612316|P2|COMPLETED|Overall Study||90
2285743|NCT02135614|5612317|P1|COMPLETED|Overall Study||86
2285744|NCT02135614|5612316|P2|STARTED|Overall Study||95
2285745|NCT02135614|5612317|P1|STARTED|Overall Study||94
2285746|NCT02135445|5612331|P2|NOT COMPLETED|Overall Study||0
2285747|NCT02135445|5612332|P1|NOT COMPLETED|Overall Study||2
2285748|NCT02135445|5612331|P2|COMPLETED|Overall Study||38
2285749|NCT02135445|5612332|P1|COMPLETED|Overall Study||63
2285750|NCT02135445|5612331|P2|STARTED|Overall Study||38
2285751|NCT02135445|5612332|P1|STARTED|Overall Study||65
2285752|NCT02135432|5612383|P2|NOT COMPLETED|Overall Study||0
2285753|NCT02135432|5612384|P1|NOT COMPLETED|Overall Study||0
2285754|NCT02135432|5612383|P2|COMPLETED|Overall Study||4
2285755|NCT02135432|5612384|P1|COMPLETED|Overall Study||8
2285756|NCT02135432|5612383|P2|STARTED|Overall Study||4
2285757|NCT02135432|5612384|P1|STARTED|Overall Study||8
2285758|NCT02135107|5612398|P4|NOT COMPLETED|Maintenance Therapy Period||20
2285759|NCT02135107|5612399|P3|NOT COMPLETED|Maintenance Therapy Period||15
2285760|NCT02135107|5612400|P2|NOT COMPLETED|Maintenance Therapy Period||0
2285761|NCT02135107|5612401|P1|NOT COMPLETED|Maintenance Therapy Period||0
2285762|NCT02135107|5612398|P4|COMPLETED|Maintenance Therapy Period||161
2285763|NCT02135107|5612399|P3|COMPLETED|Maintenance Therapy Period||163
2285764|NCT02135107|5612400|P2|COMPLETED|Maintenance Therapy Period||0
2285765|NCT02135107|5612401|P1|COMPLETED|Maintenance Therapy Period||0
2285766|NCT02135107|5612398|P4|STARTED|Maintenance Therapy Period|Only eligible participants entered into the Maintenance Therapy Period|181
2285767|NCT02135107|5612399|P3|STARTED|Maintenance Therapy Period|Only eligible participants entered into the Maintenance Therapy Period|178
2285768|NCT02135107|5612400|P2|STARTED|Maintenance Therapy Period|Treatment Phase only|0
2285769|NCT02135107|5612401|P1|STARTED|Maintenance Therapy Period|Treatment Phase only|0
2285770|NCT02135107|5612398|P4|NOT COMPLETED|Treatment Period||0
2285771|NCT02135107|5612399|P3|NOT COMPLETED|Treatment Period||0
2285772|NCT02135107|5612400|P2|NOT COMPLETED|Treatment Period||26
2285773|NCT02135107|5612401|P1|NOT COMPLETED|Treatment Period||132
2285774|NCT02135107|5612398|P4|COMPLETED|Treatment Period||0
2285775|NCT02135107|5612399|P3|COMPLETED|Treatment Period||0
2285776|NCT02135107|5612400|P2|COMPLETED|Treatment Period||54
2285777|NCT02135107|5612401|P1|COMPLETED|Treatment Period||305
2285778|NCT02135107|5612398|P4|STARTED|Treatment Period||0
2285779|NCT02135107|5612399|P3|STARTED|Treatment Period||0
2285780|NCT02135107|5612400|P2|STARTED|Treatment Period||80
2285781|NCT02135107|5612401|P1|STARTED|Treatment Period||437
2285782|NCT02135094|5612429|P2|NOT COMPLETED|Overall Study||0
2285783|NCT02135094|5612430|P1|NOT COMPLETED|Overall Study||0
2285784|NCT02135094|5612429|P2|COMPLETED|Overall Study||8
2285785|NCT02135094|5612430|P1|COMPLETED|Overall Study||25
2285786|NCT02135094|5612429|P2|Week 4|Overall Study||8
2285787|NCT02135094|5612430|P1|Week 4|Overall Study||25
2285788|NCT02135094|5612429|P2|Week 3|Overall Study||8
2285789|NCT02135094|5612430|P1|Week 3|Overall Study||25
2285790|NCT02135094|5612429|P2|Week 2|Overall Study||8
2285791|NCT02135094|5612430|P1|Week 2|Overall Study||25
2285792|NCT02135094|5612429|P2|STARTED|Overall Study||8
2285793|NCT02135094|5612430|P1|STARTED|Overall Study||25
2285794|NCT02135029|5612447|P3|NOT COMPLETED|Overall Study||3
2285795|NCT02135029|5612448|P2|NOT COMPLETED|Overall Study||5
2285796|NCT02135029|5612449|P1|NOT COMPLETED|Overall Study||4
2285797|NCT02135029|5612447|P3|COMPLETED|Overall Study||34
2285798|NCT02135029|5612448|P2|COMPLETED|Overall Study||69
2285799|NCT02135029|5612449|P1|COMPLETED|Overall Study||69
2285800|NCT02135029|5612447|P3|Treated|Overall Study||36
2285801|NCT02135029|5612448|P2|Treated|Overall Study||74
2285802|NCT02135029|5612449|P1|Treated|Overall Study||73
2285803|NCT02135029|5612447|P3|STARTED|Overall Study||37
2285804|NCT02135029|5612448|P2|STARTED|Overall Study||74
2285805|NCT02135029|5612449|P1|STARTED|Overall Study||73
2285806|NCT02135016|5612532|P3|NOT COMPLETED|Overall Study||0
2285807|NCT02135016|5612533|P2|NOT COMPLETED|Overall Study||0
2285808|NCT02135016|5612534|P1|NOT COMPLETED|Overall Study||0
2285809|NCT02135016|5612532|P3|COMPLETED|Overall Study||15
2285810|NCT02135016|5612533|P2|COMPLETED|Overall Study||15
2285811|NCT02135016|5612534|P1|COMPLETED|Overall Study||15
2285812|NCT02135016|5612532|P3|STARTED|Overall Study||15
2285813|NCT02135016|5612533|P2|STARTED|Overall Study||15
2285814|NCT02135016|5612534|P1|STARTED|Overall Study||15
2285815|NCT02134977|5612554|P1|NOT COMPLETED|Overall Study||102
2285816|NCT02134977|5612554|P1|COMPLETED|Overall Study||2714
2285817|NCT02134977|5612554|P1|STARTED|Overall Study||2816
2285818|NCT02134951|5612577|P2|NOT COMPLETED|Overall Study||0
2285819|NCT02134951|5612578|P1|NOT COMPLETED|Overall Study||0
2285820|NCT02134951|5612577|P2|COMPLETED|Overall Study|number of subjects with at least one valid scan|20
2285821|NCT02134951|5612578|P1|COMPLETED|Overall Study|number of subjects with at least one valid scan|39
2285822|NCT02134951|5612577|P2|STARTED|Overall Study||20
2285823|NCT02134951|5612578|P1|STARTED|Overall Study||39
2285824|NCT02134925|5612588|P2|NOT COMPLETED|Overall Study||6
2285825|NCT02134925|5612589|P1|NOT COMPLETED|Overall Study||2
2285826|NCT02134925|5612588|P2|COMPLETED|Overall Study||50
2285827|NCT02134925|5612589|P1|COMPLETED|Overall Study||52
2285828|NCT02134925|5612588|P2|STARTED|Overall Study||56
2285829|NCT02134925|5612589|P1|STARTED|Overall Study||54
2285836|NCT02134717|5612616|P1|NOT COMPLETED|Overall Study||0
2285837|NCT02134717|5612616|P1|COMPLETED|Overall Study||3
2285838|NCT02134717|5612616|P1|STARTED|Overall Study||3
2285839|NCT02134587|5612622|P1|NOT COMPLETED|Overall Study||30
2285840|NCT02134587|5612622|P1|COMPLETED|Overall Study||173
2285841|NCT02134587|5612622|P1|STARTED|Overall Study||203
2285842|NCT02134522|5612631|P1|NOT COMPLETED|Overall Study||0
2285843|NCT02134522|5612631|P1|COMPLETED|Overall Study||1
2285844|NCT02134522|5612631|P1|STARTED|Overall Study||1
2285845|NCT02134314|5612638|P2|NOT COMPLETED|Overall Study||1
2285846|NCT02134314|5612639|P1|NOT COMPLETED|Overall Study||1
2285847|NCT02134314|5612638|P2|COMPLETED|Overall Study||34
2285848|NCT02134314|5612639|P1|COMPLETED|Overall Study||34
2285849|NCT02134314|5612638|P2|STARTED|Overall Study||35
2285850|NCT02134314|5612639|P1|STARTED|Overall Study||35
2285851|NCT02134210|5612671|P2|NOT COMPLETED|Part Two: Weeks 13-48||28
2285852|NCT02134210|5612672|P1|NOT COMPLETED|Part Two: Weeks 13-48||30
2285853|NCT02134210|5612671|P2|COMPLETED|Part Two: Weeks 13-48||227
2285854|NCT02134210|5612672|P1|COMPLETED|Part Two: Weeks 13-48||211
2285855|NCT02134210|5612671|P2|STARTED|Part Two: Weeks 13-48||255
2285856|NCT02134210|5612672|P1|STARTED|Part Two: Weeks 13-48||241
2285857|NCT02134210|5612671|P2|NOT COMPLETED|Part One: Weeks 0-12||6
2285858|NCT02134210|5612672|P1|NOT COMPLETED|Part One: Weeks 0-12||19
2285859|NCT02134210|5612671|P2|COMPLETED|Part One: Weeks 0-12||255
2285860|NCT02134210|5612672|P1|COMPLETED|Part One: Weeks 0-12||241
2285861|NCT02134210|5612671|P2|STARTED|Part One: Weeks 0-12||261
2285862|NCT02134210|5612672|P1|STARTED|Part One: Weeks 0-12||260
2285863|NCT02134184|5612705|P3|NOT COMPLETED|Overall Study||0
2285864|NCT02134184|5612706|P2|NOT COMPLETED|Overall Study||0
2285865|NCT02134184|5612707|P1|NOT COMPLETED|Overall Study||0
2285866|NCT02134184|5612705|P3|COMPLETED|Overall Study||8
2285867|NCT02134184|5612706|P2|COMPLETED|Overall Study||37
2285868|NCT02134184|5612707|P1|COMPLETED|Overall Study||33
2285869|NCT02134184|5612705|P3|STARTED|Overall Study||8
2285870|NCT02134184|5612706|P2|STARTED|Overall Study||37
2285871|NCT02134184|5612707|P1|STARTED|Overall Study||33
2285872|NCT02134119|5612720|P2|NOT COMPLETED|Overall Study||0
2285873|NCT02134119|5612721|P1|NOT COMPLETED|Overall Study||0
2285874|NCT02134119|5612720|P2|COMPLETED|Overall Study||15
2285875|NCT02134119|5612721|P1|COMPLETED|Overall Study||30
2285876|NCT02134119|5612720|P2|STARTED|Overall Study||15
2285877|NCT02134119|5612721|P1|STARTED|Overall Study||30
2285878|NCT02134015|5612761|P2|NOT COMPLETED|Overall Study||74
2285879|NCT02134015|5612762|P1|NOT COMPLETED|Overall Study||71
2285880|NCT02134015|5612761|P2|COMPLETED|Overall Study||0
2285881|NCT02134015|5612762|P1|COMPLETED|Overall Study||0
2285882|NCT02134015|5612761|P2|STARTED|Overall Study||74
2285883|NCT02134015|5612762|P1|STARTED|Overall Study||71
2285884|NCT02133781|5612785|P3|NOT COMPLETED|Overall Study||0
2285885|NCT02133781|5612786|P2|NOT COMPLETED|Overall Study||0
2285886|NCT02133781|5612787|P1|NOT COMPLETED|Overall Study||0
2285887|NCT02133781|5612785|P3|COMPLETED|Overall Study||21
2285888|NCT02133781|5612786|P2|COMPLETED|Overall Study||24
2285889|NCT02133781|5612787|P1|COMPLETED|Overall Study||6
2285890|NCT02133781|5612785|P3|STARTED|Overall Study||21
2285891|NCT02133781|5612786|P2|STARTED|Overall Study||24
2285892|NCT02133781|5612787|P1|STARTED|Overall Study||6
2285899|NCT02133664|5612817|P2|NOT COMPLETED|Overall Study||7
2285900|NCT02133664|5612818|P1|NOT COMPLETED|Overall Study||5
2285901|NCT02133664|5612817|P2|COMPLETED|Overall Study||21
2285902|NCT02133664|5612818|P1|COMPLETED|Overall Study||21
2285903|NCT02133664|5612817|P2|STARTED|Overall Study||28
2285904|NCT02133664|5612818|P1|STARTED|Overall Study||26
2285905|NCT02133534|5612830|P1|NOT COMPLETED|Overall Study||0
2285906|NCT02133534|5612830|P1|COMPLETED|Overall Study||1
2285907|NCT02133534|5612830|P1|STARTED|Overall Study||1
2285908|NCT02133508|5612834|P1|NOT COMPLETED|Overall Study||15
2285909|NCT02133508|5612834|P1|COMPLETED|Overall Study||141
2285910|NCT02133508|5612834|P1|STARTED|Overall Study||156
2285911|NCT02133352|5612842|P1|NOT COMPLETED|Longer Term Extension||6
2285912|NCT02133352|5612842|P1|COMPLETED|Longer Term Extension||4
2285913|NCT02133352|5612842|P1|STARTED|Longer Term Extension||10
2285914|NCT02133352|5612842|P1|NOT COMPLETED|Main Study (180 Day)||0
2285915|NCT02133352|5612842|P1|COMPLETED|Main Study (180 Day)||10
2285916|NCT02133352|5612842|P1|STARTED|Main Study (180 Day)||10
2285917|NCT02133235|5612853|P2|NOT COMPLETED|Overall Study||0
2285918|NCT02133235|5612854|P1|NOT COMPLETED|Overall Study||0
2285919|NCT02133235|5612853|P2|COMPLETED|Overall Study||57
2285920|NCT02133235|5612854|P1|COMPLETED|Overall Study||55
2285921|NCT02133235|5612853|P2|STARTED|Overall Study||57
2285922|NCT02133235|5612854|P1|STARTED|Overall Study||55
2285923|NCT02133131|5612873|P7|NOT COMPLETED|Overall Study||12
2285924|NCT02133131|5612874|P6|NOT COMPLETED|Overall Study||14
2285925|NCT02133131|5612875|P5|NOT COMPLETED|Overall Study||15
2285926|NCT02133131|5612876|P4|NOT COMPLETED|Overall Study||6
2285927|NCT02133131|5612877|P3|NOT COMPLETED|Overall Study||1
2285928|NCT02133131|5612878|P2|NOT COMPLETED|Overall Study||5
2285929|NCT02133131|5612879|P1|NOT COMPLETED|Overall Study||5
2285930|NCT02133131|5612873|P7|COMPLETED|Overall Study||0
2285931|NCT02133131|5612874|P6|COMPLETED|Overall Study||0
2285932|NCT02133131|5612875|P5|COMPLETED|Overall Study||0
2285933|NCT02133131|5612876|P4|COMPLETED|Overall Study||15
2285934|NCT02133131|5612877|P3|COMPLETED|Overall Study||19
2285935|NCT02133131|5612878|P2|COMPLETED|Overall Study||25
2285936|NCT02133131|5612879|P1|COMPLETED|Overall Study||26
2285937|NCT02133131|5612873|P7|STARTED|Overall Study||12
2285938|NCT02133131|5612874|P6|STARTED|Overall Study||14
2285939|NCT02133131|5612875|P5|STARTED|Overall Study||15
2285940|NCT02133131|5612876|P4|STARTED|Overall Study||21
2285941|NCT02133131|5612877|P3|STARTED|Overall Study||20
2285942|NCT02133131|5612878|P2|STARTED|Overall Study||30
2285943|NCT02133131|5612879|P1|STARTED|Overall Study||31
2285944|NCT02133066|5612918|P2|NOT COMPLETED|Overall Study||0
2285945|NCT02133066|5612919|P1|NOT COMPLETED|Overall Study||0
2285946|NCT02133066|5612918|P2|COMPLETED|Overall Study||64
2285947|NCT02133066|5612919|P1|COMPLETED|Overall Study||64
2285948|NCT02133066|5612918|P2|STARTED|Overall Study||64
2285949|NCT02133066|5612919|P1|STARTED|Overall Study||64
2285950|NCT02133001|5612933|P2|NOT COMPLETED|Follow-Up Phase (Day 26-81)||3
2285951|NCT02133001|5612934|P1|NOT COMPLETED|Follow-Up Phase (Day 26-81)||2
2285952|NCT02133001|5612933|P2|COMPLETED|Follow-Up Phase (Day 26-81)||24
2285953|NCT02133001|5612934|P1|COMPLETED|Follow-Up Phase (Day 26-81)||20
2285954|NCT02133001|5612933|P2|STARTED|Follow-Up Phase (Day 26-81)||27
2285955|NCT02133001|5612934|P1|STARTED|Follow-Up Phase (Day 26-81)||22
2285956|NCT02133001|5612933|P2|NOT COMPLETED|Double Blind (Day 1-25)||9
2285957|NCT02133001|5612934|P1|NOT COMPLETED|Double Blind (Day 1-25)||10
2285958|NCT02133001|5612933|P2|COMPLETED|Double Blind (Day 1-25)|Participants who completed continued to follow-up phase.|27
2285959|NCT02133001|5612934|P1|COMPLETED|Double Blind (Day 1-25)|Participants who completed continued to follow-up phase.|22
2285960|NCT02133001|5612933|P2|Safety|Double Blind (Day 1-25)||35
2285961|NCT02133001|5612934|P1|Safety|Double Blind (Day 1-25)||31
2285962|NCT02133001|5612933|P2|STARTED|Double Blind (Day 1-25)||36
2285963|NCT02133001|5612934|P1|STARTED|Double Blind (Day 1-25)||32
2285964|NCT02132949|5612982|P2|NOT COMPLETED|Adjuvant Treatment Period||167
2285965|NCT02132949|5612983|P1|NOT COMPLETED|Adjuvant Treatment Period||149
2285966|NCT02132949|5612982|P2|COMPLETED|Adjuvant Treatment Period||23
2285967|NCT02132949|5612983|P1|COMPLETED|Adjuvant Treatment Period||29
2285968|NCT02132949|5612982|P2|STARTED|Adjuvant Treatment Period|Includes a participant who did not complete neoadjuvant treatment but started adjuvant treatment.|190
2285969|NCT02132949|5612983|P1|STARTED|Adjuvant Treatment Period|At clinical cutoff (03 March 2016), some participants had not yet received adjuvant treatment.|178
2285970|NCT02132949|5612982|P2|NOT COMPLETED|Neoadjuvant Treatment Period||12
2285971|NCT02132949|5612983|P1|NOT COMPLETED|Neoadjuvant Treatment Period||17
2285972|NCT02132949|5612982|P2|COMPLETED|Neoadjuvant Treatment Period||189
2285973|NCT02132949|5612983|P1|COMPLETED|Neoadjuvant Treatment Period||182
2285974|NCT02132949|5612982|P2|No Treatment|Neoadjuvant Treatment Period||3
2285975|NCT02132949|5612983|P1|No Treatment|Neoadjuvant Treatment Period||1
2285976|NCT02132949|5612982|P2|STARTED|Neoadjuvant Treatment Period||201
2285977|NCT02132949|5612983|P1|STARTED|Neoadjuvant Treatment Period|A participant enrolled in Cohort B received Cohort A treatment, hence counted under Cohort A.|199
2285978|NCT02132936|5613015|P4|NOT COMPLETED|Overall Study||14
2285979|NCT02132936|5613016|P3|NOT COMPLETED|Overall Study||14
2285980|NCT02132936|5613017|P2|NOT COMPLETED|Overall Study||9
2285981|NCT02132936|5613018|P1|NOT COMPLETED|Overall Study||10
2285982|NCT02132936|5613015|P4|COMPLETED|Overall Study||29
2285983|NCT02132936|5613016|P3|COMPLETED|Overall Study||174
2285984|NCT02132936|5613017|P2|COMPLETED|Overall Study||38
2285985|NCT02132936|5613018|P1|COMPLETED|Overall Study||175
2285986|NCT02132936|5613015|P4|STARTED|Overall Study||43
2285987|NCT02132936|5613016|P3|STARTED|Overall Study||188
2285988|NCT02132936|5613017|P2|STARTED|Overall Study||47
2285989|NCT02132936|5613018|P1|STARTED|Overall Study||185
2285990|NCT02132910|5613036|P2|NOT COMPLETED|Overall Study||0
2285991|NCT02132910|5613037|P1|NOT COMPLETED|Overall Study||0
2285992|NCT02132910|5613036|P2|COMPLETED|Overall Study||34
2285993|NCT02132910|5613037|P1|COMPLETED|Overall Study||34
2285994|NCT02132910|5613036|P2|STARTED|Overall Study||34
2285995|NCT02132910|5613037|P1|STARTED|Overall Study||34
2285996|NCT02132884|5613051|P2|NOT COMPLETED|Overall Study||0
2285997|NCT02132884|5613052|P1|NOT COMPLETED|Overall Study||0
2285998|NCT02132884|5613051|P2|COMPLETED|Overall Study||0
2285999|NCT02132884|5613052|P1|COMPLETED|Overall Study||0
2286000|NCT02132884|5613051|P2|STARTED|Overall Study||0
2286001|NCT02132884|5613052|P1|STARTED|Overall Study||0
2286002|NCT02132832|5613064|P2|NOT COMPLETED|Overall Study||7
2286003|NCT02132832|5613065|P1|NOT COMPLETED|Overall Study||3
2286004|NCT02132832|5613064|P2|COMPLETED|Overall Study||16
2286005|NCT02132832|5613065|P1|COMPLETED|Overall Study||16
2286006|NCT02132832|5613064|P2|STARTED|Overall Study||23
2286007|NCT02132832|5613065|P1|STARTED|Overall Study||19
2286008|NCT02132767|5613095|P2|NOT COMPLETED|Overall Study||15
2286009|NCT02132767|5613096|P1|NOT COMPLETED|Overall Study||17
2286010|NCT02132767|5613095|P2|COMPLETED|Overall Study||246
2286011|NCT02132767|5613096|P1|COMPLETED|Overall Study||245
2286012|NCT02132767|5613095|P2|STARTED|Overall Study||261
2286013|NCT02132767|5613096|P1|STARTED|Overall Study||262
2286014|NCT02132637|5613118|P2|NOT COMPLETED|Study Period 2 (Crossover)||1
2286015|NCT02132637|5613119|P1|NOT COMPLETED|Study Period 2 (Crossover)||2
2286016|NCT02132637|5613118|P2|COMPLETED|Study Period 2 (Crossover)||29
2286017|NCT02132637|5613119|P1|COMPLETED|Study Period 2 (Crossover)||31
2286018|NCT02132637|5613118|P2|STARTED|Study Period 2 (Crossover)||30
2286019|NCT02132637|5613119|P1|STARTED|Study Period 2 (Crossover)||33
2286020|NCT02132637|5613118|P2|NOT COMPLETED|Study Period 1||4
2286021|NCT02132637|5613119|P1|NOT COMPLETED|Study Period 1||1
2286022|NCT02132637|5613118|P2|COMPLETED|Study Period 1||30
2286023|NCT02132637|5613119|P1|COMPLETED|Study Period 1||33
2286024|NCT02132637|5613118|P2|Received at Least One Dose of Study Drug|Study Period 1||34
2286025|NCT02132637|5613119|P1|Received at Least One Dose of Study Drug|Study Period 1||34
2286026|NCT02132637|5613118|P2|STARTED|Study Period 1||34
2286027|NCT02132637|5613119|P1|STARTED|Study Period 1||34
2286028|NCT02132611|5613143|P1|NOT COMPLETED|Overall Study||2
2286029|NCT02132611|5613143|P1|COMPLETED|Overall Study||98
2286030|NCT02132611|5613143|P1|STARTED|Overall Study||100
2286031|NCT02132572|5613148|P1|NOT COMPLETED|Overall Study||0
2286032|NCT02132572|5613148|P1|COMPLETED|Overall Study||201
2286033|NCT02132572|5613148|P1|STARTED|Overall Study||201
2286040|NCT02132520|5613170|P3|NOT COMPLETED|Overall Study||0
2286041|NCT02132520|5613171|P2|NOT COMPLETED|Overall Study||0
2286042|NCT02132520|5613172|P1|NOT COMPLETED|Overall Study||0
2286043|NCT02132520|5613170|P3|COMPLETED|Overall Study||2
2286044|NCT02132520|5613171|P2|COMPLETED|Overall Study||1
2286045|NCT02132520|5613172|P1|COMPLETED|Overall Study||0
2286046|NCT02132520|5613170|P3|STARTED|Overall Study||2
2286047|NCT02132520|5613171|P2|STARTED|Overall Study||1
2286048|NCT02132520|5613172|P1|STARTED|Overall Study||0
2286049|NCT02132468|5613185|P1|NOT COMPLETED|Overall Study||7
2286050|NCT02132468|5613185|P1|COMPLETED|Overall Study||11
2286051|NCT02132468|5613185|P1|STARTED|Overall Study||18
2286052|NCT02132247|5613194|P2|NOT COMPLETED|Overall Study||0
2286053|NCT02132247|5613195|P1|NOT COMPLETED|Overall Study||1
2286054|NCT02132247|5613194|P2|COMPLETED|Overall Study||52
2286055|NCT02132247|5613195|P1|COMPLETED|Overall Study||51
2286056|NCT02132247|5613194|P2|STARTED|Overall Study||52
2286057|NCT02132247|5613195|P1|STARTED|Overall Study||52
2286058|NCT02132195|5613210|P3|NOT COMPLETED|Rescue Therapy||11
2286059|NCT02132195|5613211|P2|NOT COMPLETED|Rescue Therapy||0
2286060|NCT02132195|5613212|P1|NOT COMPLETED|Rescue Therapy||0
2286061|NCT02132195|5613210|P3|COMPLETED|Rescue Therapy||2
2286062|NCT02132195|5613211|P2|COMPLETED|Rescue Therapy||0
2286063|NCT02132195|5613212|P1|COMPLETED|Rescue Therapy||0
2286064|NCT02132195|5613210|P3|STARTED|Rescue Therapy||13
2286065|NCT02132195|5613211|P2|STARTED|Rescue Therapy||0
2286066|NCT02132195|5613212|P1|STARTED|Rescue Therapy||0
2286067|NCT02132195|5613210|P3|NOT COMPLETED|Initial Assignment||0
2286068|NCT02132195|5613211|P2|NOT COMPLETED|Initial Assignment||0
2286069|NCT02132195|5613212|P1|NOT COMPLETED|Initial Assignment||14
2286070|NCT02132195|5613210|P3|COMPLETED|Initial Assignment||0
2286071|NCT02132195|5613211|P2|COMPLETED|Initial Assignment||16
2286072|NCT02132195|5613212|P1|COMPLETED|Initial Assignment||1
2286073|NCT02132195|5613210|P3|STARTED|Initial Assignment||0
2286074|NCT02132195|5613211|P2|STARTED|Initial Assignment||16
2286075|NCT02132195|5613212|P1|STARTED|Initial Assignment||15
2286076|NCT02132169|5613228|P2|NOT COMPLETED|Overall Study||9
2286077|NCT02132169|5613229|P1|NOT COMPLETED|Overall Study||15
2286078|NCT02132169|5613228|P2|COMPLETED|Overall Study||162
2286079|NCT02132169|5613229|P1|COMPLETED|Overall Study||326
2286080|NCT02132169|5613228|P2|STARTED|Overall Study||171
2286081|NCT02132169|5613229|P1|STARTED|Overall Study||341
2286082|NCT02132117|5613243|P2|NOT COMPLETED|Overall Study||5
2286083|NCT02132117|5613244|P1|NOT COMPLETED|Overall Study||11
2286084|NCT02132117|5613243|P2|COMPLETED|Overall Study||216
2286085|NCT02132117|5613244|P1|COMPLETED|Overall Study||213
2286086|NCT02132117|5613243|P2|STARTED|Overall Study||221
2286087|NCT02132117|5613244|P1|STARTED|Overall Study||224
2286088|NCT02131662|5613265|P5|NOT COMPLETED|Overall Study||18
2286089|NCT02131662|5613266|P4|NOT COMPLETED|Overall Study||21
2286090|NCT02131662|5613267|P3|NOT COMPLETED|Overall Study||7
2286091|NCT02131662|5613268|P2|NOT COMPLETED|Overall Study||14
2286092|NCT02131662|5613269|P1|NOT COMPLETED|Overall Study||8
2286093|NCT02131662|5613265|P5|COMPLETED|Overall Study||43
2286094|NCT02131662|5613266|P4|COMPLETED|Overall Study||41
2286095|NCT02131662|5613267|P3|COMPLETED|Overall Study||56
2286096|NCT02131662|5613268|P2|COMPLETED|Overall Study||47
2286097|NCT02131662|5613269|P1|COMPLETED|Overall Study||54
2286098|NCT02131662|5613265|P5|Completed Follow-up|Overall Study||44
2286099|NCT02131662|5613266|P4|Completed Follow-up|Overall Study||42
2286100|NCT02131662|5613267|P3|Completed Follow-up|Overall Study||56
2286101|NCT02131662|5613268|P2|Completed Follow-up|Overall Study||47
2286102|NCT02131662|5613269|P1|Completed Follow-up|Overall Study||54
2286103|NCT02131662|5613265|P5|Completed Treatment|Overall Study||52
2286104|NCT02131662|5613266|P4|Completed Treatment|Overall Study||56
2286105|NCT02131662|5613267|P3|Completed Treatment|Overall Study||61
2286106|NCT02131662|5613268|P2|Completed Treatment|Overall Study||60
2286107|NCT02131662|5613269|P1|Completed Treatment|Overall Study||57
2286108|NCT02131662|5613265|P5|Treated|Overall Study||58
2286109|NCT02131662|5613266|P4|Treated|Overall Study||60
2286110|NCT02131662|5613267|P3|Treated|Overall Study||61
2286111|NCT02131662|5613268|P2|Treated|Overall Study||61
2286112|NCT02131662|5613269|P1|Treated|Overall Study||60
2286113|NCT02131662|5613265|P5|STARTED|Overall Study||61
2286114|NCT02131662|5613266|P4|STARTED|Overall Study||62
2286115|NCT02131662|5613267|P3|STARTED|Overall Study||63
2286116|NCT02131662|5613268|P2|STARTED|Overall Study||61
2286117|NCT02131662|5613269|P1|STARTED|Overall Study||62
2286118|NCT02131636|5613315|P2|NOT COMPLETED|Overall Study||5
2286119|NCT02131636|5613316|P1|NOT COMPLETED|Overall Study||12
2286120|NCT02131636|5613315|P2|COMPLETED|Overall Study||213
2286121|NCT02131636|5613316|P1|COMPLETED|Overall Study||210
2286122|NCT02131636|5613315|P2|STARTED|Overall Study||218
2286123|NCT02131636|5613316|P1|STARTED|Overall Study||222
2286124|NCT02131532|5613332|P1|NOT COMPLETED|Overall Study||4
2286125|NCT02131532|5613332|P1|COMPLETED|Overall Study||8
2286126|NCT02131532|5613332|P1|STARTED|Overall Study||12
2286127|NCT02131402|5613351|P1|NOT COMPLETED|Overall Study||0
2286128|NCT02131402|5613351|P1|COMPLETED|Overall Study||60
2286129|NCT02131402|5613351|P1|STARTED|Overall Study||60
2286130|NCT02131324|5613424|P2|NOT COMPLETED|Overall Study||3
2286131|NCT02131324|5613425|P1|NOT COMPLETED|Overall Study||2
2286132|NCT02131324|5613424|P2|COMPLETED|Overall Study||23
2286133|NCT02131324|5613425|P1|COMPLETED|Overall Study||22
2286134|NCT02131324|5613424|P2|Analyzed|Overall Study||24
2286135|NCT02131324|5613425|P1|Analyzed|Overall Study||22
2286136|NCT02131324|5613424|P2|STARTED|Overall Study|2 subjects randomized into DFD-06 not included in analysis as there was no post-baseline information|26
2286137|NCT02131324|5613425|P1|STARTED|Overall Study|2 subjects randomized into Comp01 not included in analysis as there was no post-baseline information|24
2286138|NCT02131311|5613431|P1|NOT COMPLETED|Overall Study||4
2286139|NCT02131311|5613431|P1|COMPLETED|Overall Study||86
2286140|NCT02131311|5613431|P1|STARTED|Overall Study||90
2286141|NCT02131272|5613443|P2|NOT COMPLETED|Overall Study||2
2286142|NCT02131272|5613444|P1|NOT COMPLETED|Overall Study||1
2286143|NCT02131272|5613443|P2|COMPLETED|Overall Study||20
2286144|NCT02131272|5613444|P1|COMPLETED|Overall Study||19
2286145|NCT02131272|5613443|P2|STARTED|Overall Study||22
2286146|NCT02131272|5613444|P1|STARTED|Overall Study||20
2286147|NCT02131259|5613462|P1|NOT COMPLETED|Overall Study||1225
2286148|NCT02131259|5613462|P1|COMPLETED|Overall Study|Completed is defined as 52 weeks follow-up after starting administration of GIOTRIF® tablets.|377
2286149|NCT02131259|5613462|P1|STARTED|Overall Study|Patients received treatment of GIOTRIF® Tablets|1602
2286150|NCT02131233|5613469|P2|NOT COMPLETED|Overall Study||42
2286151|NCT02131233|5613470|P1|NOT COMPLETED|Overall Study||66
2286152|NCT02131233|5613469|P2|COMPLETED|Overall Study|Completed to Week 96|227
2286153|NCT02131233|5613470|P1|COMPLETED|Overall Study|Completed to Week 96|467
2286154|NCT02131233|5613469|P2|Treated|Overall Study||266
2286155|NCT02131233|5613470|P1|Treated|Overall Study||531
2286156|NCT02131233|5613469|P2|STARTED|Overall Study|Enrolled participants|269
2286157|NCT02131233|5613470|P1|STARTED|Overall Study|Enrolled participants|533
2286158|NCT02131155|5613504|P2|NOT COMPLETED|Overall Study||11
2286159|NCT02131155|5613505|P1|NOT COMPLETED|Overall Study||25
2286160|NCT02131155|5613504|P2|COMPLETED|Overall Study|Completed are patients who completed study procedures as protocol requires.|0
2286161|NCT02131155|5613505|P1|COMPLETED|Overall Study|Completed are patients who completed study procedures as protocol requires.|0
2286162|NCT02131155|5613504|P2|STARTED|Overall Study|Started are treated patients.|11
2286163|NCT02131155|5613505|P1|STARTED|Overall Study|Started are treated patients.|25
2286164|NCT02131129|5613519|P2|NOT COMPLETED|Overall Study||0
2286165|NCT02131129|5613520|P1|NOT COMPLETED|Overall Study||1
2286166|NCT02131129|5613519|P2|COMPLETED|Overall Study||10
2286167|NCT02131129|5613520|P1|COMPLETED|Overall Study||9
2286168|NCT02131129|5613519|P2|STARTED|Overall Study||10
2286169|NCT02131129|5613520|P1|STARTED|Overall Study||10
2286170|NCT02131064|5613538|P2|NOT COMPLETED|Overall Study||34
2286171|NCT02131064|5613539|P1|NOT COMPLETED|Overall Study||25
2286172|NCT02131064|5613538|P2|COMPLETED|Overall Study||189
2286173|NCT02131064|5613539|P1|COMPLETED|Overall Study||196
2286174|NCT02131064|5613538|P2|STARTED|Overall Study||223
2286175|NCT02131064|5613539|P1|STARTED|Overall Study||221
2286176|NCT02130999|5613579|P2|NOT COMPLETED|Overall Study||0
2286177|NCT02130999|5613580|P1|NOT COMPLETED|Overall Study||0
2286178|NCT02130999|5613579|P2|COMPLETED|Overall Study||8
2286179|NCT02130999|5613580|P1|COMPLETED|Overall Study||6
2286180|NCT02130999|5613579|P2|STARTED|Overall Study||8
2286181|NCT02130999|5613580|P1|STARTED|Overall Study||6
2286182|NCT02130986|5613608|P2|NOT COMPLETED|Overall Study||164
2286183|NCT02130986|5613609|P1|NOT COMPLETED|Overall Study||155
2286184|NCT02130986|5613608|P2|COMPLETED|Overall Study||670
2286185|NCT02130986|5613609|P1|COMPLETED|Overall Study||675
2286186|NCT02130986|5613608|P2|STARTED|Overall Study||834
2286187|NCT02130986|5613609|P1|STARTED|Overall Study||830
2286188|NCT02130765|5613623|P4|NOT COMPLETED|Overall Study||0
2286189|NCT02130765|5613624|P3|NOT COMPLETED|Overall Study||0
2286190|NCT02130765|5613625|P2|NOT COMPLETED|Overall Study||0
2286191|NCT02130765|5613626|P1|NOT COMPLETED|Overall Study||4
2286192|NCT02130765|5613623|P4|COMPLETED|Overall Study||19
2286193|NCT02130765|5613624|P3|COMPLETED|Overall Study||26
2286194|NCT02130765|5613625|P2|COMPLETED|Overall Study||8
2286195|NCT02130765|5613626|P1|COMPLETED|Overall Study||7
2286196|NCT02130765|5613623|P4|STARTED|Overall Study||19
2286197|NCT02130765|5613624|P3|STARTED|Overall Study||26
2286198|NCT02130765|5613625|P2|STARTED|Overall Study||8
2286199|NCT02130765|5613626|P1|STARTED|Overall Study||11
2286200|NCT02130635|5613654|P9|NOT COMPLETED|Part B-Dose-Response Relationship||0
2286201|NCT02130635|5613655|P8|NOT COMPLETED|Part B-Dose-Response Relationship||0
2286202|NCT02130635|5613656|P7|NOT COMPLETED|Part B-Dose-Response Relationship||0
2286203|NCT02130635|5613657|P6|NOT COMPLETED|Part B-Dose-Response Relationship||0
2286204|NCT02130635|5613658|P5|NOT COMPLETED|Part B-Dose-Response Relationship||0
2286205|NCT02130635|5613659|P4|NOT COMPLETED|Part B-Dose-Response Relationship||0
2286206|NCT02130635|5613660|P3|NOT COMPLETED|Part B-Dose-Response Relationship||0
2286207|NCT02130635|5613661|P2|NOT COMPLETED|Part B-Dose-Response Relationship||0
2286208|NCT02130635|5613662|P1|NOT COMPLETED|Part B-Dose-Response Relationship||0
2286209|NCT02130635|5613654|P9|COMPLETED|Part B-Dose-Response Relationship||5
2286210|NCT02130635|5613655|P8|COMPLETED|Part B-Dose-Response Relationship||5
2286211|NCT02130635|5613656|P7|COMPLETED|Part B-Dose-Response Relationship||6
2286212|NCT02130635|5613657|P6|COMPLETED|Part B-Dose-Response Relationship||5
2286213|NCT02130635|5613658|P5|COMPLETED|Part B-Dose-Response Relationship||5
2286214|NCT02130635|5613659|P4|COMPLETED|Part B-Dose-Response Relationship||5
2286215|NCT02130635|5613660|P3|COMPLETED|Part B-Dose-Response Relationship||5
2286216|NCT02130635|5613661|P2|COMPLETED|Part B-Dose-Response Relationship||0
2286217|NCT02130635|5613662|P1|COMPLETED|Part B-Dose-Response Relationship||0
2286218|NCT02130635|5613654|P9|STARTED|Part B-Dose-Response Relationship||5
2286219|NCT02130635|5613655|P8|STARTED|Part B-Dose-Response Relationship||5
2286220|NCT02130635|5613656|P7|STARTED|Part B-Dose-Response Relationship||6
2286221|NCT02130635|5613657|P6|STARTED|Part B-Dose-Response Relationship||5
2286222|NCT02130635|5613658|P5|STARTED|Part B-Dose-Response Relationship||5
2286223|NCT02130635|5613659|P4|STARTED|Part B-Dose-Response Relationship||5
2286224|NCT02130635|5613660|P3|STARTED|Part B-Dose-Response Relationship||5
2286225|NCT02130635|5613661|P2|STARTED|Part B-Dose-Response Relationship||0
2286226|NCT02130635|5613662|P1|STARTED|Part B-Dose-Response Relationship||0
2286227|NCT02130635|5613654|P9|NOT COMPLETED|Part A-Safety and Tolerability||0
2286228|NCT02130635|5613655|P8|NOT COMPLETED|Part A-Safety and Tolerability||0
2286229|NCT02130635|5613656|P7|NOT COMPLETED|Part A-Safety and Tolerability||0
2286230|NCT02130635|5613657|P6|NOT COMPLETED|Part A-Safety and Tolerability||0
2286231|NCT02130635|5613658|P5|NOT COMPLETED|Part A-Safety and Tolerability||0
2286232|NCT02130635|5613659|P4|NOT COMPLETED|Part A-Safety and Tolerability||0
2286233|NCT02130635|5613660|P3|NOT COMPLETED|Part A-Safety and Tolerability||0
2286234|NCT02130635|5613661|P2|NOT COMPLETED|Part A-Safety and Tolerability||0
2286235|NCT02130635|5613662|P1|NOT COMPLETED|Part A-Safety and Tolerability||0
2286236|NCT02130635|5613654|P9|COMPLETED|Part A-Safety and Tolerability||0
2286237|NCT02130635|5613655|P8|COMPLETED|Part A-Safety and Tolerability||0
2286238|NCT02130635|5613656|P7|COMPLETED|Part A-Safety and Tolerability||0
2286239|NCT02130635|5613657|P6|COMPLETED|Part A-Safety and Tolerability||0
2286240|NCT02130635|5613658|P5|COMPLETED|Part A-Safety and Tolerability||0
2286241|NCT02130635|5613659|P4|COMPLETED|Part A-Safety and Tolerability||0
2286242|NCT02130635|5613660|P3|COMPLETED|Part A-Safety and Tolerability||0
2286243|NCT02130635|5613661|P2|COMPLETED|Part A-Safety and Tolerability||21
2286244|NCT02130635|5613662|P1|COMPLETED|Part A-Safety and Tolerability||7
2286245|NCT02130635|5613654|P9|STARTED|Part A-Safety and Tolerability||0
2286246|NCT02130635|5613655|P8|STARTED|Part A-Safety and Tolerability||0
2286247|NCT02130635|5613656|P7|STARTED|Part A-Safety and Tolerability||0
2286248|NCT02130635|5613657|P6|STARTED|Part A-Safety and Tolerability||0
2286249|NCT02130635|5613658|P5|STARTED|Part A-Safety and Tolerability||0
2286250|NCT02130635|5613659|P4|STARTED|Part A-Safety and Tolerability||0
2286251|NCT02130635|5613660|P3|STARTED|Part A-Safety and Tolerability||0
2286252|NCT02130635|5613661|P2|STARTED|Part A-Safety and Tolerability||21
2286253|NCT02130635|5613662|P1|STARTED|Part A-Safety and Tolerability||7
2286254|NCT02130622|5613836|P2|NOT COMPLETED|Overall Study||0
2286255|NCT02130622|5613837|P1|NOT COMPLETED|Overall Study||0
2286256|NCT02130622|5613836|P2|COMPLETED|Overall Study||1
2286257|NCT02130622|5613837|P1|COMPLETED|Overall Study||2
2286258|NCT02130622|5613836|P2|STARTED|Overall Study||1
2286259|NCT02130622|5613837|P1|STARTED|Overall Study||2
2286260|NCT02130583|5613851|P2|NOT COMPLETED|Overall Study||7
2286261|NCT02130583|5613852|P1|NOT COMPLETED|Overall Study||9
2286262|NCT02130583|5613851|P2|COMPLETED|Overall Study||19
2286263|NCT02130583|5613852|P1|COMPLETED|Overall Study||17
2286264|NCT02130583|5613851|P2|STARTED|Overall Study||26
2286265|NCT02130583|5613852|P1|STARTED|Overall Study||26
2286266|NCT02130570|5613872|P2|NOT COMPLETED|Overall Study||13
2286267|NCT02130570|5613873|P1|NOT COMPLETED|Overall Study||9
2286268|NCT02130570|5613872|P2|COMPLETED|Overall Study|Participants enrolled, did not die during index admission, did not withdraw consent|679
2286269|NCT02130570|5613873|P1|COMPLETED|Overall Study|Participants enrolled, did not die during index admission, did not withdraw consent|978
2286270|NCT02130570|5613872|P2|STARTED|Overall Study||692
2286271|NCT02130570|5613873|P1|STARTED|Overall Study||987
2286272|NCT02130557|5613891|P2|NOT COMPLETED|Overall Study||268
2286273|NCT02130557|5613892|P1|NOT COMPLETED|Overall Study||268
2286274|NCT02130557|5613891|P2|COMPLETED|Overall Study||0
2286275|NCT02130557|5613892|P1|COMPLETED|Overall Study||0
2286276|NCT02130557|5613891|P2|mITT Population|Overall Study||241
2286277|NCT02130557|5613892|P1|mITT Population|Overall Study||246
2286278|NCT02130557|5613891|P2|Treated|Overall Study||265
2286279|NCT02130557|5613892|P1|Treated|Overall Study||268
2286280|NCT02130557|5613891|P2|STARTED|Overall Study||268
2286281|NCT02130557|5613892|P1|STARTED|Overall Study||268
2286282|NCT02130284|5613924|P1|NOT COMPLETED|Overall Study||9
2286283|NCT02130284|5613924|P1|COMPLETED|Overall Study||71
2286284|NCT02130284|5613924|P1|STARTED|Overall Study||80
2286285|NCT02130258|5613937|P2|NOT COMPLETED|Overall Study||0
2286286|NCT02130258|5613938|P1|NOT COMPLETED|Overall Study||0
2286287|NCT02130258|5613937|P2|COMPLETED|Overall Study||11
2286288|NCT02130258|5613938|P1|COMPLETED|Overall Study||9
2286289|NCT02130258|5613937|P2|STARTED|Overall Study||11
2286290|NCT02130258|5613938|P1|STARTED|Overall Study||9
2286291|NCT02130193|5613950|P3|NOT COMPLETED|Part B: 52-week Double-blind Period||8
2286292|NCT02130193|5613951|P2|NOT COMPLETED|Part B: 52-week Double-blind Period||10
2286293|NCT02130193|5613952|P1|NOT COMPLETED|Part B: 52-week Double-blind Period||0
2286294|NCT02130193|5613950|P3|COMPLETED|Part B: 52-week Double-blind Period||37
2286295|NCT02130193|5613951|P2|COMPLETED|Part B: 52-week Double-blind Period||38
2286296|NCT02130193|5613952|P1|COMPLETED|Part B: 52-week Double-blind Period||0
2286297|NCT02130193|5613950|P3|STARTED|Part B: 52-week Double-blind Period||45
2286298|NCT02130193|5613951|P2|STARTED|Part B: 52-week Double-blind Period||48
2286299|NCT02130193|5613952|P1|STARTED|Part B: 52-week Double-blind Period||0
2286300|NCT02130193|5613950|P3|NOT COMPLETED|Part A: 4-week Open-label Period||0
2286301|NCT02130193|5613951|P2|NOT COMPLETED|Part A: 4-week Open-label Period||0
2286302|NCT02130193|5613952|P1|NOT COMPLETED|Part A: 4-week Open-label Period||0
2286303|NCT02130193|5613950|P3|COMPLETED|Part A: 4-week Open-label Period||0
2286304|NCT02130193|5613951|P2|COMPLETED|Part A: 4-week Open-label Period||0
2286305|NCT02130193|5613952|P1|COMPLETED|Part A: 4-week Open-label Period||9
2286306|NCT02130193|5613950|P3|STARTED|Part A: 4-week Open-label Period||0
2286307|NCT02130193|5613951|P2|STARTED|Part A: 4-week Open-label Period||0
2286308|NCT02130193|5613952|P1|STARTED|Part A: 4-week Open-label Period||9
2286309|NCT02130063|5614018|P2|NOT COMPLETED|Overall Study||17
2286310|NCT02130063|5614019|P1|NOT COMPLETED|Overall Study||25
2286311|NCT02130063|5614018|P2|COMPLETED|Overall Study||152
2286312|NCT02130063|5614019|P1|COMPLETED|Overall Study||317
2286313|NCT02130063|5614018|P2|STARTED|Overall Study||169
2286314|NCT02130063|5614019|P1|STARTED|Overall Study||342
2286315|NCT02130024|5614033|P2|NOT COMPLETED|Overall Study||31
2286316|NCT02130024|5614034|P1|NOT COMPLETED|Overall Study||25
2286317|NCT02130024|5614033|P2|COMPLETED|Overall Study||108
2286318|NCT02130024|5614034|P1|COMPLETED|Overall Study||117
2286319|NCT02130024|5614033|P2|Full Analysis Set (FAS)|Overall Study|2 patients had no post Baseline geographic atrophy (GA) data|137
2286320|NCT02130024|5614034|P1|Full Analysis Set (FAS)|Overall Study||141
2286321|NCT02130024|5614033|P2|Safety Set|Overall Study||139
2286322|NCT02130024|5614034|P1|Safety Set|Overall Study|One randomized patient did not receive treatment|141
2286323|NCT02130024|5614033|P2|STARTED|Overall Study||139
2286324|NCT02130024|5614034|P1|STARTED|Overall Study||142
2286325|NCT02129777|5614071|P7|NOT COMPLETED|Open-Label Period||48
2286326|NCT02129777|5614072|P6|NOT COMPLETED|Open-Label Period||12
2286327|NCT02129777|5614073|P5|NOT COMPLETED|Open-Label Period||0
2286328|NCT02129777|5614074|P4|NOT COMPLETED|Open-Label Period||0
2286329|NCT02129777|5614075|P3|NOT COMPLETED|Open-Label Period||0
2286330|NCT02129777|5614076|P2|NOT COMPLETED|Open-Label Period||0
2286331|NCT02129777|5614077|P1|NOT COMPLETED|Open-Label Period||0
2286332|NCT02129777|5614071|P7|COMPLETED|Open-Label Period||0
2286333|NCT02129777|5614072|P6|COMPLETED|Open-Label Period||0
2286334|NCT02129777|5614073|P5|COMPLETED|Open-Label Period||0
2286335|NCT02129777|5614074|P4|COMPLETED|Open-Label Period||0
2286336|NCT02129777|5614075|P3|COMPLETED|Open-Label Period||0
2286337|NCT02129777|5614076|P2|COMPLETED|Open-Label Period||0
2286338|NCT02129777|5614077|P1|COMPLETED|Open-Label Period||0
2286339|NCT02129777|5614071|P7|STARTED|Open-Label Period||48
2286340|NCT02129777|5614072|P6|STARTED|Open-Label Period||12
2286341|NCT02129777|5614073|P5|STARTED|Open-Label Period||0
2286342|NCT02129777|5614074|P4|STARTED|Open-Label Period||0
2286343|NCT02129777|5614075|P3|STARTED|Open-Label Period||0
2286344|NCT02129777|5614076|P2|STARTED|Open-Label Period||0
2286345|NCT02129777|5614077|P1|STARTED|Open-Label Period||0
2286346|NCT02129777|5614071|P7|NOT COMPLETED|Double-Blind Period||0
2286347|NCT02129777|5614072|P6|NOT COMPLETED|Double-Blind Period||0
2286348|NCT02129777|5614073|P5|NOT COMPLETED|Double-Blind Period||7
2286349|NCT02129777|5614074|P4|NOT COMPLETED|Double-Blind Period||7
2286350|NCT02129777|5614075|P3|NOT COMPLETED|Double-Blind Period||4
2286351|NCT02129777|5614076|P2|NOT COMPLETED|Double-Blind Period||8
2286352|NCT02129777|5614077|P1|NOT COMPLETED|Double-Blind Period||7
2286353|NCT02129777|5614071|P7|COMPLETED|Double-Blind Period||0
2286354|NCT02129777|5614072|P6|COMPLETED|Double-Blind Period||0
2286355|NCT02129777|5614073|P5|COMPLETED|Double-Blind Period||18
2286356|NCT02129777|5614074|P4|COMPLETED|Double-Blind Period||18
2286357|NCT02129777|5614075|P3|COMPLETED|Double-Blind Period||20
2286358|NCT02129777|5614076|P2|COMPLETED|Double-Blind Period||16
2286359|NCT02129777|5614077|P1|COMPLETED|Double-Blind Period||17
2286360|NCT02129777|5614071|P7|STARTED|Double-Blind Period||0
2286361|NCT02129777|5614072|P6|STARTED|Double-Blind Period||0
2286362|NCT02129777|5614073|P5|STARTED|Double-Blind Period||25
2286363|NCT02129777|5614074|P4|STARTED|Double-Blind Period||25
2286364|NCT02129777|5614075|P3|STARTED|Double-Blind Period||24
2286365|NCT02129777|5614076|P2|STARTED|Double-Blind Period||24
2286366|NCT02129777|5614077|P1|STARTED|Double-Blind Period||24
2286367|NCT02129725|5614183|P2|NOT COMPLETED|Overall Study||3
2286368|NCT02129725|5614184|P1|NOT COMPLETED|Overall Study||2
2286369|NCT02129725|5614183|P2|COMPLETED|Overall Study||4
2286370|NCT02129725|5614184|P1|COMPLETED|Overall Study||6
2286371|NCT02129725|5614183|P2|STARTED|Overall Study||7
2286372|NCT02129725|5614184|P1|STARTED|Overall Study||8
2286373|NCT02129660|5614195|P5|NOT COMPLETED|Overall Study||2
2286374|NCT02129660|5614196|P4|NOT COMPLETED|Overall Study||0
2286375|NCT02129660|5614197|P3|NOT COMPLETED|Overall Study||1
2286376|NCT02129660|5614198|P2|NOT COMPLETED|Overall Study||0
2286377|NCT02129660|5614199|P1|NOT COMPLETED|Overall Study||2
2286378|NCT02129660|5614195|P5|COMPLETED|Overall Study||20
2286379|NCT02129660|5614196|P4|COMPLETED|Overall Study||20
2286380|NCT02129660|5614197|P3|COMPLETED|Overall Study||21
2286381|NCT02129660|5614198|P2|COMPLETED|Overall Study||20
2286382|NCT02129660|5614199|P1|COMPLETED|Overall Study||19
2286383|NCT02129660|5614195|P5|STARTED|Overall Study||22
2286384|NCT02129660|5614196|P4|STARTED|Overall Study||20
2286385|NCT02129660|5614197|P3|STARTED|Overall Study||22
2286386|NCT02129660|5614198|P2|STARTED|Overall Study||20
2286387|NCT02129660|5614199|P1|STARTED|Overall Study||21
2286388|NCT02129608|5614244|P3|NOT COMPLETED|Overall Study||3
2286389|NCT02129608|5614245|P2|NOT COMPLETED|Overall Study||1
2286390|NCT02129608|5614246|P1|NOT COMPLETED|Overall Study||0
2286391|NCT02129608|5614244|P3|COMPLETED|Overall Study||12
2286392|NCT02129608|5614245|P2|COMPLETED|Overall Study||13
2286393|NCT02129608|5614246|P1|COMPLETED|Overall Study||15
2286394|NCT02129608|5614244|P3|End of Treatment|Overall Study||12
2286395|NCT02129608|5614245|P2|End of Treatment|Overall Study||13
2286396|NCT02129608|5614246|P1|End of Treatment|Overall Study||15
2286397|NCT02129608|5614244|P3|STARTED|Overall Study||15
2286398|NCT02129608|5614245|P2|STARTED|Overall Study||14
2286399|NCT02129608|5614246|P1|STARTED|Overall Study||15
2286400|NCT02129556|5614260|P4|NOT COMPLETED|Overall Study||0
2286401|NCT02129556|5614261|P3|NOT COMPLETED|Overall Study||3
2286402|NCT02129556|5614262|P2|NOT COMPLETED|Overall Study||0
2286403|NCT02129556|5614263|P1|NOT COMPLETED|Overall Study||0
2286404|NCT02129556|5614260|P4|COMPLETED|Overall Study||12
2286405|NCT02129556|5614261|P3|COMPLETED|Overall Study||37
2286406|NCT02129556|5614262|P2|COMPLETED|Overall Study||3
2286407|NCT02129556|5614263|P1|COMPLETED|Overall Study||3
2286408|NCT02129556|5614260|P4|STARTED|Overall Study||12
2286409|NCT02129556|5614261|P3|STARTED|Overall Study||40
2286410|NCT02129556|5614262|P2|STARTED|Overall Study||3
2286411|NCT02129556|5614263|P1|STARTED|Overall Study||3
2286412|NCT02129205|5614297|P10|NOT COMPLETED|Overall Study||0
2286413|NCT02129205|5614298|P9|NOT COMPLETED|Overall Study||2
2286414|NCT02129205|5614299|P8|NOT COMPLETED|Overall Study||2
2286415|NCT02129205|5614300|P7|NOT COMPLETED|Overall Study||4
2286416|NCT02129205|5614301|P6|NOT COMPLETED|Overall Study||4
2286417|NCT02129205|5614302|P5|NOT COMPLETED|Overall Study||3
2286418|NCT02129205|5614303|P4|NOT COMPLETED|Overall Study||0
2286419|NCT02129205|5614304|P3|NOT COMPLETED|Overall Study||0
2286420|NCT02129205|5614305|P2|NOT COMPLETED|Overall Study||0
2286421|NCT02129205|5614306|P1|NOT COMPLETED|Overall Study||1
2286422|NCT02129205|5614297|P10|COMPLETED|Overall Study||0
2286423|NCT02129205|5614298|P9|COMPLETED|Overall Study||0
2286424|NCT02129205|5614299|P8|COMPLETED|Overall Study||4
2286425|NCT02129205|5614300|P7|COMPLETED|Overall Study||2
2286426|NCT02129205|5614301|P6|COMPLETED|Overall Study||7
2286427|NCT02129205|5614302|P5|COMPLETED|Overall Study||4
2286428|NCT02129205|5614303|P4|COMPLETED|Overall Study||2
2286429|NCT02129205|5614304|P3|COMPLETED|Overall Study||2
2286430|NCT02129205|5614305|P2|COMPLETED|Overall Study||2
2286431|NCT02129205|5614306|P1|COMPLETED|Overall Study||1
2286432|NCT02129205|5614297|P10|STARTED|Overall Study||0
2286433|NCT02129205|5614298|P9|STARTED|Overall Study||2
2286434|NCT02129205|5614299|P8|STARTED|Overall Study||6
2286435|NCT02129205|5614300|P7|STARTED|Overall Study||6
2286436|NCT02129205|5614301|P6|STARTED|Overall Study||11
2286437|NCT02129205|5614302|P5|STARTED|Overall Study||7
2286438|NCT02129205|5614303|P4|STARTED|Overall Study||2
2286439|NCT02129205|5614304|P3|STARTED|Overall Study||2
2286440|NCT02129205|5614305|P2|STARTED|Overall Study||2
2286441|NCT02129205|5614306|P1|STARTED|Overall Study||2
2286442|NCT02129192|5614459|P2|NOT COMPLETED|Period 5||0
2286443|NCT02129192|5614460|P1|NOT COMPLETED|Period 5||0
2286444|NCT02129192|5614459|P2|COMPLETED|Period 5||0
2286445|NCT02129192|5614460|P1|COMPLETED|Period 5||36
2286446|NCT02129192|5614459|P2|STARTED|Period 5|This sequence consists of only 4 periods.|0
2286447|NCT02129192|5614460|P1|STARTED|Period 5||36
2286448|NCT02129192|5614459|P2|NOT COMPLETED|Period 4 Including Washout Period||0
2286449|NCT02129192|5614460|P1|NOT COMPLETED|Period 4 Including Washout Period||0
2286450|NCT02129192|5614459|P2|COMPLETED|Period 4 Including Washout Period||35
2286451|NCT02129192|5614460|P1|COMPLETED|Period 4 Including Washout Period||36
2286452|NCT02129192|5614459|P2|STARTED|Period 4 Including Washout Period||35
2286453|NCT02129192|5614460|P1|STARTED|Period 4 Including Washout Period||36
2286454|NCT02129192|5614459|P2|NOT COMPLETED|Period 3 Including Washout Period||0
2286455|NCT02129192|5614460|P1|NOT COMPLETED|Period 3 Including Washout Period||0
2286456|NCT02129192|5614459|P2|COMPLETED|Period 3 Including Washout Period||35
2286457|NCT02129192|5614460|P1|COMPLETED|Period 3 Including Washout Period||36
2286458|NCT02129192|5614459|P2|STARTED|Period 3 Including Washout Period||35
2286459|NCT02129192|5614460|P1|STARTED|Period 3 Including Washout Period||36
2286460|NCT02129192|5614459|P2|NOT COMPLETED|Period 2 Including Washout Period||0
2286461|NCT02129192|5614460|P1|NOT COMPLETED|Period 2 Including Washout Period||0
2286462|NCT02129192|5614459|P2|COMPLETED|Period 2 Including Washout Period||35
2286463|NCT02129192|5614460|P1|COMPLETED|Period 2 Including Washout Period||36
2286464|NCT02129192|5614459|P2|STARTED|Period 2 Including Washout Period||35
2286465|NCT02129192|5614460|P1|STARTED|Period 2 Including Washout Period||36
2286466|NCT02129192|5614459|P2|NOT COMPLETED|Period 1 Including Washout Period||1
2286467|NCT02129192|5614460|P1|NOT COMPLETED|Period 1 Including Washout Period||0
2286468|NCT02129192|5614459|P2|COMPLETED|Period 1 Including Washout Period|Withdrawal by one subject in washout period|35
2286469|NCT02129192|5614460|P1|COMPLETED|Period 1 Including Washout Period||36
2286470|NCT02129192|5614459|P2|STARTED|Period 1 Including Washout Period||36
2286471|NCT02129192|5614460|P1|STARTED|Period 1 Including Washout Period||36
2286472|NCT02129062|5614477|P1|NOT COMPLETED|Overall Study||3
2286473|NCT02129062|5614477|P1|COMPLETED|Overall Study||0
2286474|NCT02129062|5614477|P1|STARTED|Overall Study||3
2286475|NCT02128997|5614484|P2|NOT COMPLETED|Overall Study||11
2286476|NCT02128997|5614485|P1|NOT COMPLETED|Overall Study||6
2286477|NCT02128997|5614484|P2|COMPLETED|Overall Study||58
2286478|NCT02128997|5614485|P1|COMPLETED|Overall Study||61
2286479|NCT02128997|5614484|P2|STARTED|Overall Study||69
2286480|NCT02128997|5614485|P1|STARTED|Overall Study||67
2286481|NCT02128932|5614500|P3|NOT COMPLETED|Overall Study||18
2286482|NCT02128932|5614501|P2|NOT COMPLETED|Overall Study||19
2286483|NCT02128932|5614502|P1|NOT COMPLETED|Overall Study||27
2286484|NCT02128932|5614500|P3|COMPLETED|Overall Study||342
2286485|NCT02128932|5614501|P2|COMPLETED|Overall Study||341
2286486|NCT02128932|5614502|P1|COMPLETED|Overall Study||335
2286487|NCT02128932|5614500|P3|STARTED|Overall Study||360
2286488|NCT02128932|5614501|P2|STARTED|Overall Study||360
2286489|NCT02128932|5614502|P1|STARTED|Overall Study||362
2286490|NCT02128919|5614533|P2|NOT COMPLETED|Overall Study||1
2286491|NCT02128919|5614534|P1|NOT COMPLETED|Overall Study||3
2286492|NCT02128919|5614533|P2|COMPLETED|Overall Study||15
2286493|NCT02128919|5614534|P1|COMPLETED|Overall Study||14
2286494|NCT02128919|5614533|P2|STARTED|Overall Study||16
2286495|NCT02128919|5614534|P1|STARTED|Overall Study||17
2286496|NCT02128867|5614547|P3|NOT COMPLETED|Overall Study||4
2286497|NCT02128867|5614548|P2|NOT COMPLETED|Overall Study||2
2286498|NCT02128867|5614549|P1|NOT COMPLETED|Overall Study||3
2286499|NCT02128867|5614547|P3|COMPLETED|Overall Study||50
2286500|NCT02128867|5614548|P2|COMPLETED|Overall Study||50
2286501|NCT02128867|5614549|P1|COMPLETED|Overall Study||50
2286502|NCT02128867|5614547|P3|STARTED|Overall Study||54
2286503|NCT02128867|5614548|P2|STARTED|Overall Study||52
2286504|NCT02128867|5614549|P1|STARTED|Overall Study||53
2286505|NCT02128763|5614559|P2|NOT COMPLETED|Overall Study||16
2286506|NCT02128763|5614560|P1|NOT COMPLETED|Overall Study||20
2286507|NCT02128763|5614559|P2|COMPLETED|Overall Study||170
2286508|NCT02128763|5614560|P1|COMPLETED|Overall Study||329
2286509|NCT02128763|5614559|P2|STARTED|Overall Study||186
2286510|NCT02128763|5614560|P1|STARTED|Overall Study||349
2286511|NCT02128724|5614606|P4|NOT COMPLETED|Overall Study||3
2286512|NCT02128724|5614607|P3|NOT COMPLETED|Overall Study||0
2286513|NCT02128724|5614608|P2|NOT COMPLETED|Overall Study||1
2286514|NCT02128724|5614609|P1|NOT COMPLETED|Overall Study||1
2286515|NCT02128724|5614606|P4|COMPLETED|Overall Study||7
2286516|NCT02128724|5614607|P3|COMPLETED|Overall Study||3
2286517|NCT02128724|5614608|P2|COMPLETED|Overall Study||3
2286518|NCT02128724|5614609|P1|COMPLETED|Overall Study||3
2286519|NCT02128724|5614606|P4|STARTED|Overall Study||10
2286520|NCT02128724|5614607|P3|STARTED|Overall Study||3
2286521|NCT02128724|5614608|P2|STARTED|Overall Study||4
2286522|NCT02128724|5614609|P1|STARTED|Overall Study||4
2286523|NCT02128542|5614664|P2|NOT COMPLETED|Overall Study||0
2286524|NCT02128542|5614665|P1|NOT COMPLETED|Overall Study||4
2286525|NCT02128542|5614664|P2|COMPLETED|Overall Study||19
2286526|NCT02128542|5614665|P1|COMPLETED|Overall Study||43
2286527|NCT02128542|5614664|P2|STARTED|Overall Study||19
2286528|NCT02128542|5614665|P1|STARTED|Overall Study||47
2286529|NCT02128490|5614683|P5|NOT COMPLETED|Overall Study||7
2286530|NCT02128490|5614684|P4|NOT COMPLETED|Overall Study||6
2286531|NCT02128490|5614685|P3|NOT COMPLETED|Overall Study||5
2286532|NCT02128490|5614686|P2|NOT COMPLETED|Overall Study||6
2286533|NCT02128490|5614687|P1|NOT COMPLETED|Overall Study||5
2286534|NCT02128490|5614683|P5|COMPLETED|Overall Study||31
2286535|NCT02128490|5614684|P4|COMPLETED|Overall Study||31
2286536|NCT02128490|5614685|P3|COMPLETED|Overall Study||34
2286537|NCT02128490|5614686|P2|COMPLETED|Overall Study||31
2286538|NCT02128490|5614687|P1|COMPLETED|Overall Study||33
2286539|NCT02128490|5614683|P5|STARTED|Overall Study||38
2286540|NCT02128490|5614684|P4|STARTED|Overall Study||37
2286541|NCT02128490|5614685|P3|STARTED|Overall Study||39
2286542|NCT02128490|5614686|P2|STARTED|Overall Study||37
2286543|NCT02128490|5614687|P1|STARTED|Overall Study||38
2286544|NCT02128269|5614709|P1|NOT COMPLETED|Follow-up||0
2286545|NCT02128269|5614709|P1|COMPLETED|Follow-up||9
2286546|NCT02128269|5614709|P1|STARTED|Follow-up|All enrolled patients were followed for 12 weeks after their last infusion of ALXN1007.|9
2286547|NCT02128269|5614709|P1|NOT COMPLETED|Treatment Period||2
2286548|NCT02128269|5614709|P1|COMPLETED|Treatment Period||7
2286549|NCT02128269|5614709|P1|STARTED|Treatment Period||9
2286550|NCT02128217|5614715|P2|NOT COMPLETED|Overall Study||1
2286551|NCT02128217|5614716|P1|NOT COMPLETED|Overall Study||0
2286552|NCT02128217|5614715|P2|COMPLETED|Overall Study||26
2286553|NCT02128217|5614716|P1|COMPLETED|Overall Study||17
2286554|NCT02128217|5614715|P2|STARTED|Overall Study||27
2286555|NCT02128217|5614716|P1|STARTED|Overall Study||17
2286556|NCT02128074|5614758|P1|NOT COMPLETED|Overall Study||6
2286557|NCT02128074|5614758|P1|COMPLETED|Overall Study||26
2286558|NCT02128074|5614758|P1|STARTED|Overall Study||32
2286559|NCT02127970|5614764|P2|NOT COMPLETED|Overall Study||27
2286560|NCT02127970|5614765|P1|NOT COMPLETED|Overall Study||26
2286561|NCT02127970|5614764|P2|COMPLETED|Overall Study||322
2286562|NCT02127970|5614765|P1|COMPLETED|Overall Study||323
2286563|NCT02127970|5614764|P2|STARTED|Overall Study||349
2286564|NCT02127970|5614765|P1|STARTED|Overall Study||349
2286565|NCT02127931|5614787|P1|NOT COMPLETED|Overall Study||1
2286566|NCT02127931|5614787|P1|COMPLETED|Overall Study||17
2286567|NCT02127931|5614787|P1|STARTED|Overall Study||18
2286568|NCT02127892|5614797|P4|NOT COMPLETED|Overall Study||0
2286569|NCT02127892|5614798|P3|NOT COMPLETED|Overall Study||0
2286570|NCT02127892|5614799|P2|NOT COMPLETED|Overall Study||1
2286571|NCT02127892|5614800|P1|NOT COMPLETED|Overall Study||1
2286572|NCT02127892|5614797|P4|COMPLETED|Overall Study||0
2286573|NCT02127892|5614798|P3|COMPLETED|Overall Study||0
2286574|NCT02127892|5614799|P2|COMPLETED|Overall Study||1
2286575|NCT02127892|5614800|P1|COMPLETED|Overall Study||6
2286576|NCT02127892|5614797|P4|STARTED|Overall Study||0
2286577|NCT02127892|5614798|P3|STARTED|Overall Study||0
2286578|NCT02127892|5614799|P2|STARTED|Overall Study||2
2286579|NCT02127892|5614800|P1|STARTED|Overall Study||7
2286589|NCT02127632|5614873|P2|NOT COMPLETED|Overall Study||0
2286590|NCT02127632|5614874|P1|NOT COMPLETED|Overall Study||0
2286591|NCT02127632|5614873|P2|COMPLETED|Overall Study||50
2286592|NCT02127632|5614874|P1|COMPLETED|Overall Study||50
2286593|NCT02127632|5614873|P2|STARTED|Overall Study||50
2286594|NCT02127632|5614874|P1|STARTED|Overall Study||50
2286595|NCT02127567|5614884|P1|NOT COMPLETED|Overall Study||0
2286596|NCT02127567|5614884|P1|COMPLETED|Overall Study||41
2286597|NCT02127567|5614884|P1|STARTED|Overall Study|41 participants completed 123 domains, 3 domains were completed with the tool per participant|41
2286598|NCT02127372|5614906|P2|NOT COMPLETED|Overall Study||0
2286599|NCT02127372|5614907|P1|NOT COMPLETED|Overall Study||1
2286600|NCT02127372|5614906|P2|COMPLETED|Overall Study||28
2286601|NCT02127372|5614907|P1|COMPLETED|Overall Study|Completed at least one cycle and were available for dose limiting toxicity (DLT) evaluation.|14
2286602|NCT02127372|5614906|P2|Started Study Treatment|Overall Study||28
2286603|NCT02127372|5614907|P1|Started Study Treatment|Overall Study||15
2286604|NCT02127372|5614906|P2|STARTED|Overall Study|Signed Consent|28
2286605|NCT02127372|5614907|P1|STARTED|Overall Study|Signed Consent|15
2286606|NCT02127307|5614917|P1|NOT COMPLETED|Overall Study||308
2286607|NCT02127307|5614917|P1|COMPLETED|Overall Study||656
2286608|NCT02127307|5614917|P1|STARTED|Overall Study||964
2286609|NCT02127281|5614923|P2|NOT COMPLETED|Overall Study||0
2286610|NCT02127281|5614924|P1|NOT COMPLETED|Overall Study||1
2286611|NCT02127281|5614923|P2|COMPLETED|Overall Study||80
2286612|NCT02127281|5614924|P1|COMPLETED|Overall Study||79
2286613|NCT02127281|5614923|P2|STARTED|Overall Study||80
2286614|NCT02127281|5614924|P1|STARTED|Overall Study||80
2286615|NCT02126969|5614952|P2|NOT COMPLETED|Overall Study||2
2286616|NCT02126969|5614953|P1|NOT COMPLETED|Overall Study||1
2286617|NCT02126969|5614952|P2|COMPLETED|Overall Study||20
2286618|NCT02126969|5614953|P1|COMPLETED|Overall Study||22
2286619|NCT02126969|5614952|P2|STARTED|Overall Study||22
2286620|NCT02126969|5614953|P1|STARTED|Overall Study||23
2286621|NCT02126839|5614963|P2|NOT COMPLETED|Overall Study||14
2286622|NCT02126839|5614964|P1|NOT COMPLETED|Overall Study||10
2286623|NCT02126839|5614963|P2|COMPLETED|Overall Study||80
2286624|NCT02126839|5614964|P1|COMPLETED|Overall Study||82
2286625|NCT02126839|5614963|P2|Full Analysis Set|Overall Study||92
2286626|NCT02126839|5614964|P1|Full Analysis Set|Overall Study||92
2286627|NCT02126839|5614963|P2|Safety Population|Overall Study||93
2286628|NCT02126839|5614964|P1|Safety Population|Overall Study||92
2286629|NCT02126839|5614963|P2|STARTED|Overall Study||94
2286630|NCT02126839|5614964|P1|STARTED|Overall Study||92
2286631|NCT02126826|5614981|P7|NOT COMPLETED|Overall Study||0
2286632|NCT02126826|5614982|P6|NOT COMPLETED|Overall Study||0
2286633|NCT02126826|5614983|P5|NOT COMPLETED|Overall Study||0
2286634|NCT02126826|5614984|P4|NOT COMPLETED|Overall Study||1
2286635|NCT02126826|5614985|P3|NOT COMPLETED|Overall Study||0
2286636|NCT02126826|5614986|P2|NOT COMPLETED|Overall Study||0
2286637|NCT02126826|5614987|P1|NOT COMPLETED|Overall Study||0
2286638|NCT02126826|5614981|P7|COMPLETED|Overall Study||8
2286639|NCT02126826|5614982|P6|COMPLETED|Overall Study||9
2286640|NCT02126826|5614983|P5|COMPLETED|Overall Study||5
2286641|NCT02126826|5614984|P4|COMPLETED|Overall Study||8
2286642|NCT02126826|5614985|P3|COMPLETED|Overall Study||9
2286643|NCT02126826|5614986|P2|COMPLETED|Overall Study||9
2286644|NCT02126826|5614987|P1|COMPLETED|Overall Study||9
2286645|NCT02126826|5614981|P7|STARTED|Overall Study||8
2286646|NCT02126826|5614982|P6|STARTED|Overall Study||9
2286647|NCT02126826|5614983|P5|STARTED|Overall Study||5
2286648|NCT02126826|5614984|P4|STARTED|Overall Study||9
2286649|NCT02126826|5614985|P3|STARTED|Overall Study||9
2286650|NCT02126826|5614986|P2|STARTED|Overall Study||9
2286651|NCT02126826|5614987|P1|STARTED|Overall Study||9
2286652|NCT02126748|5615041|P3|NOT COMPLETED|Overall Study||5
2286653|NCT02126748|5615042|P2|NOT COMPLETED|Overall Study||3
2286654|NCT02126748|5615043|P1|NOT COMPLETED|Overall Study||2
2286655|NCT02126748|5615041|P3|COMPLETED|Overall Study||31
2286656|NCT02126748|5615042|P2|COMPLETED|Overall Study||31
2286657|NCT02126748|5615043|P1|COMPLETED|Overall Study||31
2286658|NCT02126748|5615041|P3|STARTED|Overall Study||36
2286659|NCT02126748|5615042|P2|STARTED|Overall Study||34
2286660|NCT02126748|5615043|P1|STARTED|Overall Study||33
2286661|NCT02126670|5615055|P4|NOT COMPLETED|Overall Study||1
2286662|NCT02126670|5615056|P3|NOT COMPLETED|Overall Study||0
2286663|NCT02126670|5615057|P2|NOT COMPLETED|Overall Study||0
2286664|NCT02126670|5615058|P1|NOT COMPLETED|Overall Study||1
2286665|NCT02126670|5615055|P4|COMPLETED|Overall Study||24
2286666|NCT02126670|5615056|P3|COMPLETED|Overall Study||25
2286667|NCT02126670|5615057|P2|COMPLETED|Overall Study||24
2286668|NCT02126670|5615058|P1|COMPLETED|Overall Study||25
2286669|NCT02126670|5615055|P4|STARTED|Overall Study||25
2286670|NCT02126670|5615056|P3|STARTED|Overall Study||25
2286671|NCT02126670|5615057|P2|STARTED|Overall Study||24
2286672|NCT02126670|5615058|P1|STARTED|Overall Study||26
2286673|NCT02126319|5615074|P2|NOT COMPLETED|Overall Study||24
2286674|NCT02126319|5615075|P1|NOT COMPLETED|Overall Study||21
2286675|NCT02126319|5615074|P2|COMPLETED|Overall Study||43
2286676|NCT02126319|5615075|P1|COMPLETED|Overall Study||40
2286677|NCT02126319|5615074|P2|STARTED|Overall Study||67
2286678|NCT02126319|5615075|P1|STARTED|Overall Study||61
2286679|NCT02126306|5615101|P2|NOT COMPLETED|Overall Study||0
2286680|NCT02126306|5615102|P1|NOT COMPLETED|Overall Study||0
2286681|NCT02126306|5615101|P2|COMPLETED|Overall Study||13
2286682|NCT02126306|5615102|P1|COMPLETED|Overall Study||10
2286683|NCT02126306|5615101|P2|STARTED|Overall Study||13
2286684|NCT02126306|5615102|P1|STARTED|Overall Study||10
2286685|NCT02125877|5615110|P2|NOT COMPLETED|Overall Study||10
2286686|NCT02125877|5615111|P1|NOT COMPLETED|Overall Study||13
2286687|NCT02125877|5615110|P2|COMPLETED|Overall Study||77
2286688|NCT02125877|5615111|P1|COMPLETED|Overall Study||73
2286689|NCT02125877|5615110|P2|Safety Set|Overall Study||87
2286690|NCT02125877|5615111|P1|Safety Set|Overall Study||86
2286691|NCT02125877|5615110|P2|Pharmacokinetic Subset A|Overall Study||15
2286692|NCT02125877|5615111|P1|Pharmacokinetic Subset A|Overall Study||16
2286693|NCT02125877|5615110|P2|Pharmacokinetic Analysis Set|Overall Study||83
2286694|NCT02125877|5615111|P1|Pharmacokinetic Analysis Set|Overall Study||83
2286695|NCT02125877|5615110|P2|STARTED|Overall Study||87
2286696|NCT02125877|5615111|P1|STARTED|Overall Study||86
2286697|NCT02125838|5615141|P2|NOT COMPLETED|Overall Study||4
2286698|NCT02125838|5615142|P1|NOT COMPLETED|Overall Study||4
2286699|NCT02125838|5615141|P2|COMPLETED|Overall Study|Analysed (n=50 )|50
2286700|NCT02125838|5615142|P1|COMPLETED|Overall Study|Analysed (n=50 )|50
2286701|NCT02125838|5615141|P2|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions) (n= 2) NBA used (n= 2)|54
2286702|NCT02125838|5615142|P1|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions)(n= 2) NBA used (n= 2)|54
2286703|NCT02125734|5615160|P2|NOT COMPLETED|Period 2||1
2286704|NCT02125734|5615161|P1|NOT COMPLETED|Period 2||0
2286705|NCT02125734|5615160|P2|COMPLETED|Period 2||47
2286706|NCT02125734|5615161|P1|COMPLETED|Period 2||40
2286707|NCT02125734|5615160|P2|STARTED|Period 2||48
2286708|NCT02125734|5615161|P1|STARTED|Period 2||40
2286709|NCT02125734|5615160|P2|NOT COMPLETED|Period 1||0
2286710|NCT02125734|5615161|P1|NOT COMPLETED|Period 1||0
2286711|NCT02125734|5615160|P2|COMPLETED|Period 1||48
2286712|NCT02125734|5615161|P1|COMPLETED|Period 1||40
2286713|NCT02125734|5615160|P2|STARTED|Period 1||48
2286714|NCT02125734|5615161|P1|STARTED|Period 1||40
2286715|NCT02125604|5615171|P1|NOT COMPLETED|Overall Study||31
2286716|NCT02125604|5615171|P1|COMPLETED|Overall Study||180
2286717|NCT02125604|5615171|P1|STARTED|Overall Study|enrolled and received at least 1 dose of study drug|211
2286718|NCT02125461|5615187|P2|NOT COMPLETED|Overall Study||129
2286719|NCT02125461|5615188|P1|NOT COMPLETED|Overall Study||203
2286720|NCT02125461|5615187|P2|COMPLETED|Overall Study||108
2286721|NCT02125461|5615188|P1|COMPLETED|Overall Study||273
2286722|NCT02125461|5615187|P2|Completed 12 Months of Treatment|Overall Study||82
2286723|NCT02125461|5615188|P1|Completed 12 Months of Treatment|Overall Study||232
2286724|NCT02125461|5615187|P2|Safety Analysis Set|Overall Study||234
2286725|NCT02125461|5615188|P1|Safety Analysis Set|Overall Study||475
2286726|NCT02125461|5615187|P2|Receieved Treatment|Overall Study||236
2286727|NCT02125461|5615188|P1|Receieved Treatment|Overall Study||473
2286728|NCT02125461|5615187|P2|Full Analysis Set (FAS)|Overall Study||237
2286729|NCT02125461|5615188|P1|Full Analysis Set (FAS)|Overall Study||476
2286730|NCT02125461|5615187|P2|STARTED|Overall Study||237
2286731|NCT02125461|5615188|P1|STARTED|Overall Study||476
2286732|NCT02125292|5615217|P6|NOT COMPLETED|Third Intervention (1 Hour)||0
2286733|NCT02125292|5615218|P5|NOT COMPLETED|Third Intervention (1 Hour)||0
2286734|NCT02125292|5615219|P4|NOT COMPLETED|Third Intervention (1 Hour)||0
2286735|NCT02125292|5615220|P3|NOT COMPLETED|Third Intervention (1 Hour)||0
2286736|NCT02125292|5615221|P2|NOT COMPLETED|Third Intervention (1 Hour)||0
2286737|NCT02125292|5615222|P1|NOT COMPLETED|Third Intervention (1 Hour)||0
2286738|NCT02125292|5615217|P6|COMPLETED|Third Intervention (1 Hour)||3
2286739|NCT02125292|5615218|P5|COMPLETED|Third Intervention (1 Hour)||3
2286740|NCT02125292|5615219|P4|COMPLETED|Third Intervention (1 Hour)||3
2286741|NCT02125292|5615220|P3|COMPLETED|Third Intervention (1 Hour)||3
2286742|NCT02125292|5615221|P2|COMPLETED|Third Intervention (1 Hour)||3
2286743|NCT02125292|5615222|P1|COMPLETED|Third Intervention (1 Hour)||3
2286744|NCT02125292|5615217|P6|STARTED|Third Intervention (1 Hour)||3
2286745|NCT02125292|5615218|P5|STARTED|Third Intervention (1 Hour)||3
2286746|NCT02125292|5615219|P4|STARTED|Third Intervention (1 Hour)||3
2286747|NCT02125292|5615220|P3|STARTED|Third Intervention (1 Hour)||3
2286748|NCT02125292|5615221|P2|STARTED|Third Intervention (1 Hour)||3
2286749|NCT02125292|5615222|P1|STARTED|Third Intervention (1 Hour)||3
2286750|NCT02125292|5615217|P6|NOT COMPLETED|Washout (2 Hours)||0
2286751|NCT02125292|5615218|P5|NOT COMPLETED|Washout (2 Hours)||0
2286752|NCT02125292|5615219|P4|NOT COMPLETED|Washout (2 Hours)||0
2286753|NCT02125292|5615220|P3|NOT COMPLETED|Washout (2 Hours)||0
2286754|NCT02125292|5615221|P2|NOT COMPLETED|Washout (2 Hours)||0
2286755|NCT02125292|5615222|P1|NOT COMPLETED|Washout (2 Hours)||0
2286756|NCT02125292|5615217|P6|COMPLETED|Washout (2 Hours)||3
2286757|NCT02125292|5615218|P5|COMPLETED|Washout (2 Hours)||3
2286758|NCT02125292|5615219|P4|COMPLETED|Washout (2 Hours)||3
2286759|NCT02125292|5615220|P3|COMPLETED|Washout (2 Hours)||3
2286760|NCT02125292|5615221|P2|COMPLETED|Washout (2 Hours)||3
2286761|NCT02125292|5615222|P1|COMPLETED|Washout (2 Hours)||3
2286762|NCT02125292|5615217|P6|STARTED|Washout (2 Hours)||3
2286763|NCT02125292|5615218|P5|STARTED|Washout (2 Hours)||3
2286764|NCT02125292|5615219|P4|STARTED|Washout (2 Hours)||3
2286765|NCT02125292|5615220|P3|STARTED|Washout (2 Hours)||3
2286766|NCT02125292|5615221|P2|STARTED|Washout (2 Hours)||3
2286767|NCT02125292|5615222|P1|STARTED|Washout (2 Hours)||3
2286768|NCT02125292|5615217|P6|NOT COMPLETED|Second Intervention (1 Hour)||0
2286769|NCT02125292|5615218|P5|NOT COMPLETED|Second Intervention (1 Hour)||0
2286770|NCT02125292|5615219|P4|NOT COMPLETED|Second Intervention (1 Hour)||0
2286771|NCT02125292|5615220|P3|NOT COMPLETED|Second Intervention (1 Hour)||0
2286772|NCT02125292|5615221|P2|NOT COMPLETED|Second Intervention (1 Hour)||0
2286773|NCT02125292|5615222|P1|NOT COMPLETED|Second Intervention (1 Hour)||0
2286774|NCT02125292|5615217|P6|COMPLETED|Second Intervention (1 Hour)||3
2286775|NCT02125292|5615218|P5|COMPLETED|Second Intervention (1 Hour)||3
2286776|NCT02125292|5615219|P4|COMPLETED|Second Intervention (1 Hour)||3
2286777|NCT02125292|5615220|P3|COMPLETED|Second Intervention (1 Hour)||3
2286778|NCT02125292|5615221|P2|COMPLETED|Second Intervention (1 Hour)||3
2286779|NCT02125292|5615222|P1|COMPLETED|Second Intervention (1 Hour)||3
2286780|NCT02125292|5615217|P6|STARTED|Second Intervention (1 Hour)||3
2286781|NCT02125292|5615218|P5|STARTED|Second Intervention (1 Hour)||3
2286782|NCT02125292|5615219|P4|STARTED|Second Intervention (1 Hour)||3
2286783|NCT02125292|5615220|P3|STARTED|Second Intervention (1 Hour)||3
2286784|NCT02125292|5615221|P2|STARTED|Second Intervention (1 Hour)||3
2286785|NCT02125292|5615222|P1|STARTED|Second Intervention (1 Hour)||3
2286786|NCT02125292|5615217|P6|NOT COMPLETED|Washout (2 Hours)||0
2286787|NCT02125292|5615218|P5|NOT COMPLETED|Washout (2 Hours)||0
2286788|NCT02125292|5615219|P4|NOT COMPLETED|Washout (2 Hours)||0
2286789|NCT02125292|5615220|P3|NOT COMPLETED|Washout (2 Hours)||0
2286790|NCT02125292|5615221|P2|NOT COMPLETED|Washout (2 Hours)||0
2286791|NCT02125292|5615222|P1|NOT COMPLETED|Washout (2 Hours)||0
2286792|NCT02125292|5615217|P6|COMPLETED|Washout (2 Hours)||3
2286793|NCT02125292|5615218|P5|COMPLETED|Washout (2 Hours)||3
2286794|NCT02125292|5615219|P4|COMPLETED|Washout (2 Hours)||3
2286795|NCT02125292|5615220|P3|COMPLETED|Washout (2 Hours)||3
2286796|NCT02125292|5615221|P2|COMPLETED|Washout (2 Hours)||3
2286797|NCT02125292|5615222|P1|COMPLETED|Washout (2 Hours)||3
2286798|NCT02125292|5615217|P6|STARTED|Washout (2 Hours)||3
2286799|NCT02125292|5615218|P5|STARTED|Washout (2 Hours)||3
2286800|NCT02125292|5615219|P4|STARTED|Washout (2 Hours)||3
2286801|NCT02125292|5615220|P3|STARTED|Washout (2 Hours)||3
2286802|NCT02125292|5615221|P2|STARTED|Washout (2 Hours)||3
2286803|NCT02125292|5615222|P1|STARTED|Washout (2 Hours)||3
2286804|NCT02125292|5615217|P6|NOT COMPLETED|First Intervention (1 Hour)||0
2286805|NCT02125292|5615218|P5|NOT COMPLETED|First Intervention (1 Hour)||0
2286806|NCT02125292|5615219|P4|NOT COMPLETED|First Intervention (1 Hour)||0
2286807|NCT02125292|5615220|P3|NOT COMPLETED|First Intervention (1 Hour)||0
2286808|NCT02125292|5615221|P2|NOT COMPLETED|First Intervention (1 Hour)||0
2286809|NCT02125292|5615222|P1|NOT COMPLETED|First Intervention (1 Hour)||0
2286810|NCT02125292|5615217|P6|COMPLETED|First Intervention (1 Hour)||3
2286811|NCT02125292|5615218|P5|COMPLETED|First Intervention (1 Hour)||3
2286812|NCT02125292|5615219|P4|COMPLETED|First Intervention (1 Hour)||3
2286813|NCT02125292|5615220|P3|COMPLETED|First Intervention (1 Hour)||3
2286814|NCT02125292|5615221|P2|COMPLETED|First Intervention (1 Hour)||3
2286815|NCT02125292|5615222|P1|COMPLETED|First Intervention (1 Hour)||3
2286816|NCT02125292|5615217|P6|STARTED|First Intervention (1 Hour)||3
2286817|NCT02125292|5615218|P5|STARTED|First Intervention (1 Hour)||3
2286818|NCT02125292|5615219|P4|STARTED|First Intervention (1 Hour)||3
2286819|NCT02125292|5615220|P3|STARTED|First Intervention (1 Hour)||3
2286820|NCT02125292|5615221|P2|STARTED|First Intervention (1 Hour)||3
2286821|NCT02125292|5615222|P1|STARTED|First Intervention (1 Hour)||3
2286822|NCT02125279|5615243|P1|NOT COMPLETED|Overall Study||13
2286823|NCT02125279|5615243|P1|COMPLETED|Overall Study||41
2286824|NCT02125279|5615243|P1|STARTED|Overall Study||54
2286825|NCT02124889|5615272|P2|NOT COMPLETED|Overall Study||0
2286826|NCT02124889|5615273|P1|NOT COMPLETED|Overall Study||0
2286827|NCT02124889|5615272|P2|COMPLETED|Overall Study||12
2286828|NCT02124889|5615273|P1|COMPLETED|Overall Study||12
2286829|NCT02124889|5615272|P2|STARTED|Overall Study||12
2286830|NCT02124889|5615273|P1|STARTED|Overall Study||12
2286831|NCT02124863|5615279|P1|NOT COMPLETED|Overall Study||17
2286832|NCT02124863|5615279|P1|COMPLETED|Overall Study||50
2286833|NCT02124863|5615279|P1|STARTED|Overall Study||67
2286834|NCT02124811|5615287|P2|NOT COMPLETED|Overall Study||2
2286835|NCT02124811|5615288|P1|NOT COMPLETED|Overall Study||3
2286836|NCT02124811|5615287|P2|COMPLETED|Overall Study||3
2286837|NCT02124811|5615288|P1|COMPLETED|Overall Study||2
2286838|NCT02124811|5615287|P2|STARTED|Overall Study||5
2286839|NCT02124811|5615288|P1|STARTED|Overall Study||5
2286840|NCT02124798|5615304|P1|NOT COMPLETED|Overall Study||4
2286841|NCT02124798|5615304|P1|COMPLETED|Overall Study||91
2286842|NCT02124798|5615304|P1|STARTED|Overall Study||95
2286843|NCT02124603|5615310|P1|NOT COMPLETED|Overall Study||0
2286844|NCT02124603|5615310|P1|COMPLETED|Overall Study||120
2286845|NCT02124603|5615310|P1|STARTED|Overall Study||120
2286846|NCT02124564|5615316|P1|NOT COMPLETED|Taper Period||0
2286847|NCT02124564|5615316|P1|COMPLETED|Taper Period||2
2286848|NCT02124564|5615316|P1|STARTED|Taper Period||2
2286849|NCT02124564|5615316|P1|NOT COMPLETED|Treatment Period||7
2286850|NCT02124564|5615316|P1|COMPLETED|Treatment Period||12
2286851|NCT02124564|5615316|P1|Started Follow-Up Period|Treatment Period||13
2286852|NCT02124564|5615316|P1|Started Evaluation Period|Treatment Period||17
2286853|NCT02124564|5615316|P1|Started Monotherapy Period|Treatment Period||17
2286854|NCT02124564|5615316|P1|Started AED Withdrawal Period|Treatment Period||19
2286855|NCT02124564|5615316|P1|Started Titration Period|Treatment Period||19
2286856|NCT02124564|5615316|P1|Started Treatment Period|Treatment Period||19
2286857|NCT02124564|5615316|P1|STARTED|Treatment Period||19
2286858|NCT02124512|5615328|P2|NOT COMPLETED|Overall Study||0
2286859|NCT02124512|5615329|P1|NOT COMPLETED|Overall Study||0
2286860|NCT02124512|5615328|P2|COMPLETED|Overall Study||6
2286861|NCT02124512|5615329|P1|COMPLETED|Overall Study||6
2286862|NCT02124512|5615328|P2|STARTED|Overall Study||6
2286863|NCT02124512|5615329|P1|STARTED|Overall Study||6
2286864|NCT02124460|5615339|P2|NOT COMPLETED|Overall Study||24
2286865|NCT02124460|5615340|P1|NOT COMPLETED|Overall Study||33
2286866|NCT02124460|5615339|P2|COMPLETED|Overall Study||336
2286867|NCT02124460|5615340|P1|COMPLETED|Overall Study||328
2286868|NCT02124460|5615339|P2|STARTED|Overall Study||360
2286869|NCT02124460|5615340|P1|STARTED|Overall Study||361
2286870|NCT02124304|5615372|P2|NOT COMPLETED|Overall Study||0
2286871|NCT02124304|5615373|P1|NOT COMPLETED|Overall Study||0
2286872|NCT02124304|5615372|P2|COMPLETED|Overall Study||15
2286873|NCT02124304|5615373|P1|COMPLETED|Overall Study||15
2286874|NCT02124304|5615372|P2|STARTED|Overall Study||15
2286875|NCT02124304|5615373|P1|STARTED|Overall Study||15
2286876|NCT02124265|5615381|P1|NOT COMPLETED|Overall Study||1
2286877|NCT02124265|5615381|P1|COMPLETED|Overall Study||2
2286878|NCT02124265|5615381|P1|STARTED|Overall Study||3
2286879|NCT02124161|5615387|P2|NOT COMPLETED|Overall Study||15
2286880|NCT02124161|5615388|P1|NOT COMPLETED|Overall Study||16
2286881|NCT02124161|5615387|P2|COMPLETED|Overall Study||426
2286882|NCT02124161|5615388|P1|COMPLETED|Overall Study||425
2286883|NCT02124161|5615387|P2|Vaccination 2|Overall Study||432
2286884|NCT02124161|5615388|P1|Vaccination 2|Overall Study||431
2286885|NCT02124161|5615387|P2|Vaccination 1|Overall Study||437
2286886|NCT02124161|5615388|P1|Vaccination 1|Overall Study||439
2286887|NCT02124161|5615387|P2|STARTED|Overall Study||441
2286888|NCT02124161|5615388|P1|STARTED|Overall Study||441
2286889|NCT02124122|5615420|P2|NOT COMPLETED|Overall Study||0
2286890|NCT02124122|5615421|P1|NOT COMPLETED|Overall Study||0
2286891|NCT02124122|5615420|P2|COMPLETED|Overall Study||19
2286892|NCT02124122|5615421|P1|COMPLETED|Overall Study||41
2286893|NCT02124122|5615420|P2|STARTED|Overall Study||19
2286894|NCT02124122|5615421|P1|STARTED|Overall Study||41
2286895|NCT02124083|5615429|P1|NOT COMPLETED|Overall Study||1
2286896|NCT02124083|5615429|P1|COMPLETED|Overall Study||11
2286897|NCT02124083|5615429|P1|STARTED|Overall Study||12
2286898|NCT02124044|5615440|P2|NOT COMPLETED|Overall Study||1
2286899|NCT02124044|5615441|P1|NOT COMPLETED|Overall Study||0
2286900|NCT02124044|5615440|P2|COMPLETED|Overall Study||9
2286901|NCT02124044|5615441|P1|COMPLETED|Overall Study||20
2286902|NCT02124044|5615440|P2|STARTED|Overall Study||10
2286903|NCT02124044|5615441|P1|STARTED|Overall Study||20
2286904|NCT02124018|5615450|P3|NOT COMPLETED|Overall Study||0
2286905|NCT02124018|5615451|P2|NOT COMPLETED|Overall Study||0
2286906|NCT02124018|5615452|P1|NOT COMPLETED|Overall Study||0
2286907|NCT02124018|5615450|P3|COMPLETED|Overall Study|Numbers do not add up to 575 (enrolled) due to refusals of programmed ventricular stimulation|41
2286908|NCT02124018|5615451|P2|COMPLETED|Overall Study||111
2286909|NCT02124018|5615452|P1|COMPLETED|Overall Study||371
2286910|NCT02124018|5615450|P3|STARTED|Overall Study||41
2286911|NCT02124018|5615451|P2|STARTED|Overall Study||111
2286912|NCT02124018|5615452|P1|STARTED|Overall Study||371
2286913|NCT02123966|5615463|P1|NOT COMPLETED|Overall Study||1
2286914|NCT02123966|5615463|P1|COMPLETED|Overall Study||9
2286915|NCT02123966|5615463|P1|STARTED|Overall Study||10
2286916|NCT02123849|5615470|P2|NOT COMPLETED|Overall Study||9
2286917|NCT02123849|5615471|P1|NOT COMPLETED|Overall Study||4
2286918|NCT02123849|5615470|P2|COMPLETED|Overall Study||18
2286919|NCT02123849|5615471|P1|COMPLETED|Overall Study||23
2286920|NCT02123849|5615470|P2|STARTED|Overall Study||27
2286921|NCT02123849|5615471|P1|STARTED|Overall Study||27
2286922|NCT02123745|5615495|P1|NOT COMPLETED|Overall Study||0
2286923|NCT02123745|5615495|P1|COMPLETED|Overall Study||71
2286924|NCT02123745|5615495|P1|STARTED|Overall Study||71
2286925|NCT02123576|5615505|P2|NOT COMPLETED|Overall Study||0
2286926|NCT02123576|5615506|P1|NOT COMPLETED|Overall Study||1
2286927|NCT02123576|5615505|P2|COMPLETED|Overall Study||6
2286928|NCT02123576|5615506|P1|COMPLETED|Overall Study||5
2286929|NCT02123576|5615505|P2|STARTED|Overall Study||6
2286930|NCT02123576|5615506|P1|STARTED|Overall Study||6
2286931|NCT02123511|5615524|P2|NOT COMPLETED|Overall Study||4
2286932|NCT02123511|5615525|P1|NOT COMPLETED|Overall Study||2
2286933|NCT02123511|5615524|P2|COMPLETED|Overall Study||12
2286934|NCT02123511|5615525|P1|COMPLETED|Overall Study||16
2286935|NCT02123511|5615524|P2|Eligible Patients|Overall Study||15
2286936|NCT02123511|5615525|P1|Eligible Patients|Overall Study||17
2286937|NCT02123511|5615524|P2|STARTED|Overall Study||16
2286938|NCT02123511|5615525|P1|STARTED|Overall Study||18
2286939|NCT02123472|5615549|P2|NOT COMPLETED|Period 2 (7 Days)||1
2286940|NCT02123472|5615550|P1|NOT COMPLETED|Period 2 (7 Days)||0
2286941|NCT02123472|5615549|P2|COMPLETED|Period 2 (7 Days)||13
2286942|NCT02123472|5615550|P1|COMPLETED|Period 2 (7 Days)||14
2286943|NCT02123472|5615549|P2|STARTED|Period 2 (7 Days)||14
2286944|NCT02123472|5615550|P1|STARTED|Period 2 (7 Days)||14
2286945|NCT02123472|5615549|P2|NOT COMPLETED|Washout Period (1 Day)||0
2286946|NCT02123472|5615550|P1|NOT COMPLETED|Washout Period (1 Day)||0
2286947|NCT02123472|5615549|P2|COMPLETED|Washout Period (1 Day)||14
2286948|NCT02123472|5615550|P1|COMPLETED|Washout Period (1 Day)||14
2286949|NCT02123472|5615549|P2|STARTED|Washout Period (1 Day)||14
2286950|NCT02123472|5615550|P1|STARTED|Washout Period (1 Day)||14
2286951|NCT02123472|5615549|P2|NOT COMPLETED|Period 1 (7 Days)||0
2286952|NCT02123472|5615550|P1|NOT COMPLETED|Period 1 (7 Days)||0
2286953|NCT02123472|5615549|P2|COMPLETED|Period 1 (7 Days)||14
2286954|NCT02123472|5615550|P1|COMPLETED|Period 1 (7 Days)||14
2286955|NCT02123472|5615549|P2|STARTED|Period 1 (7 Days)||14
2286956|NCT02123472|5615550|P1|STARTED|Period 1 (7 Days)||14
2286957|NCT02123459|5615560|P2|NOT COMPLETED|Period 2 (7 Days)||0
2286958|NCT02123459|5615561|P1|NOT COMPLETED|Period 2 (7 Days)||0
2286959|NCT02123459|5615560|P2|COMPLETED|Period 2 (7 Days)||14
2286960|NCT02123459|5615561|P1|COMPLETED|Period 2 (7 Days)||13
2286961|NCT02123459|5615560|P2|STARTED|Period 2 (7 Days)||14
2286962|NCT02123459|5615561|P1|STARTED|Period 2 (7 Days)||13
2286963|NCT02123459|5615560|P2|NOT COMPLETED|Washout Period (1 Day)||0
2286964|NCT02123459|5615561|P1|NOT COMPLETED|Washout Period (1 Day)||1
2286965|NCT02123459|5615560|P2|COMPLETED|Washout Period (1 Day)||14
2286966|NCT02123459|5615561|P1|COMPLETED|Washout Period (1 Day)||13
2286967|NCT02123459|5615560|P2|STARTED|Washout Period (1 Day)||14
2286968|NCT02123459|5615561|P1|STARTED|Washout Period (1 Day)||14
2286969|NCT02123459|5615560|P2|NOT COMPLETED|Period 1 (7 Days)||0
2286970|NCT02123459|5615561|P1|NOT COMPLETED|Period 1 (7 Days)||0
2286971|NCT02123459|5615560|P2|COMPLETED|Period 1 (7 Days)||14
2286972|NCT02123459|5615561|P1|COMPLETED|Period 1 (7 Days)||14
2286973|NCT02123459|5615560|P2|STARTED|Period 1 (7 Days)||14
2286974|NCT02123459|5615561|P1|STARTED|Period 1 (7 Days)||14
2286975|NCT02123446|5615571|P2|NOT COMPLETED|Period 2 (7 Days)||0
2286976|NCT02123446|5615572|P1|NOT COMPLETED|Period 2 (7 Days)||0
2286977|NCT02123446|5615571|P2|COMPLETED|Period 2 (7 Days)||14
2286978|NCT02123446|5615572|P1|COMPLETED|Period 2 (7 Days)||13
2286979|NCT02123446|5615571|P2|STARTED|Period 2 (7 Days)||14
2286980|NCT02123446|5615572|P1|STARTED|Period 2 (7 Days)||13
2286981|NCT02123446|5615571|P2|NOT COMPLETED|Washout Period (1 Day)||0
2286982|NCT02123446|5615572|P1|NOT COMPLETED|Washout Period (1 Day)||1
2286983|NCT02123446|5615571|P2|COMPLETED|Washout Period (1 Day)||14
2286984|NCT02123446|5615572|P1|COMPLETED|Washout Period (1 Day)||13
2286985|NCT02123446|5615571|P2|STARTED|Washout Period (1 Day)||14
2286986|NCT02123446|5615572|P1|STARTED|Washout Period (1 Day)||14
2286987|NCT02123446|5615571|P2|NOT COMPLETED|Period 1 (7 Days)||0
2286988|NCT02123446|5615572|P1|NOT COMPLETED|Period 1 (7 Days)||0
2286989|NCT02123446|5615571|P2|COMPLETED|Period 1 (7 Days)||14
2286990|NCT02123446|5615572|P1|COMPLETED|Period 1 (7 Days)||14
2286991|NCT02123446|5615571|P2|STARTED|Period 1 (7 Days)||14
2286992|NCT02123446|5615572|P1|STARTED|Period 1 (7 Days)||14
2286993|NCT02123329|5615584|P2|NOT COMPLETED|12 Month Outcome Measure||79
2286994|NCT02123329|5615585|P1|NOT COMPLETED|12 Month Outcome Measure||64
2286995|NCT02123329|5615584|P2|COMPLETED|12 Month Outcome Measure||88
2286996|NCT02123329|5615585|P1|COMPLETED|12 Month Outcome Measure||83
2286997|NCT02123329|5615584|P2|STARTED|12 Month Outcome Measure||167
2286998|NCT02123329|5615585|P1|STARTED|12 Month Outcome Measure||147
2286999|NCT02123329|5615584|P2|NOT COMPLETED|6 Month Outcome Measure||67
2287000|NCT02123329|5615585|P1|NOT COMPLETED|6 Month Outcome Measure||48
2287001|NCT02123329|5615584|P2|COMPLETED|6 Month Outcome Measure||100
2287002|NCT02123329|5615585|P1|COMPLETED|6 Month Outcome Measure||99
2287003|NCT02123329|5615584|P2|STARTED|6 Month Outcome Measure||167
2287004|NCT02123329|5615585|P1|STARTED|6 Month Outcome Measure||147
2287005|NCT02123329|5615584|P2|NOT COMPLETED|3 Month Outcome Measure||66
2287006|NCT02123329|5615585|P1|NOT COMPLETED|3 Month Outcome Measure||49
2287007|NCT02123329|5615584|P2|COMPLETED|3 Month Outcome Measure||101
2287008|NCT02123329|5615585|P1|COMPLETED|3 Month Outcome Measure||98
2287009|NCT02123329|5615584|P2|STARTED|3 Month Outcome Measure||167
2287010|NCT02123329|5615585|P1|STARTED|3 Month Outcome Measure||147
2287011|NCT02123251|5615613|P2|NOT COMPLETED|Overall Study||30
2287012|NCT02123251|5615614|P1|NOT COMPLETED|Overall Study||34
2287013|NCT02123251|5615613|P2|COMPLETED|Overall Study||131
2287014|NCT02123251|5615614|P1|COMPLETED|Overall Study||125
2287015|NCT02123251|5615613|P2|STARTED|Overall Study||161
2287016|NCT02123251|5615614|P1|STARTED|Overall Study||159
2287023|NCT02123017|5615662|P3|NOT COMPLETED|Overall Study||0
2287024|NCT02123017|5615663|P2|NOT COMPLETED|Overall Study||0
2287025|NCT02123017|5615664|P1|NOT COMPLETED|Overall Study||0
2287026|NCT02123017|5615662|P3|COMPLETED|Overall Study||12
2287027|NCT02123017|5615663|P2|COMPLETED|Overall Study||12
2287028|NCT02123017|5615664|P1|COMPLETED|Overall Study||8
2287029|NCT02123017|5615662|P3|STARTED|Overall Study||12
2287030|NCT02123017|5615663|P2|STARTED|Overall Study||12
2287031|NCT02123017|5615664|P1|STARTED|Overall Study||8
2287032|NCT02122952|5615683|P2|NOT COMPLETED|Overall Study||0
2287033|NCT02122952|5615684|P1|NOT COMPLETED|Overall Study||0
2287034|NCT02122952|5615683|P2|COMPLETED|Overall Study||12
2287035|NCT02122952|5615684|P1|COMPLETED|Overall Study||3
2287036|NCT02122952|5615683|P2|STARTED|Overall Study||12
2287037|NCT02122952|5615684|P1|STARTED|Overall Study||3
2287038|NCT02122887|5615698|P2|NOT COMPLETED|Overall Study||2
2287039|NCT02122887|5615699|P1|NOT COMPLETED|Overall Study||20
2287040|NCT02122887|5615698|P2|COMPLETED|Overall Study||39
2287041|NCT02122887|5615699|P1|COMPLETED|Overall Study||40
2287042|NCT02122887|5615698|P2|STARTED|Overall Study||41
2287043|NCT02122887|5615699|P1|STARTED|Overall Study||60
2287044|NCT02122796|5615717|P2|NOT COMPLETED|Visit 2||1
2287045|NCT02122796|5615718|P1|NOT COMPLETED|Visit 2||3
2287046|NCT02122796|5615717|P2|COMPLETED|Visit 2||14
2287047|NCT02122796|5615718|P1|COMPLETED|Visit 2||12
2287048|NCT02122796|5615717|P2|STARTED|Visit 2||15
2287049|NCT02122796|5615718|P1|STARTED|Visit 2||15
2287050|NCT02122796|5615717|P2|NOT COMPLETED|Visit 1||0
2287051|NCT02122796|5615718|P1|NOT COMPLETED|Visit 1||0
2287052|NCT02122796|5615717|P2|COMPLETED|Visit 1||15
2287053|NCT02122796|5615718|P1|COMPLETED|Visit 1||15
2287054|NCT02122796|5615717|P2|STARTED|Visit 1||15
2287055|NCT02122796|5615718|P1|STARTED|Visit 1||15
2287056|NCT02122770|5615735|P6|NOT COMPLETED|Part B: Standard of Care||13
2287057|NCT02122770|5615736|P5|NOT COMPLETED|Part B: Standard of Care||23
2287058|NCT02122770|5615737|P4|NOT COMPLETED|Part B: Standard of Care||0
2287059|NCT02122770|5615738|P3|NOT COMPLETED|Part B: Standard of Care||0
2287060|NCT02122770|5615739|P2|NOT COMPLETED|Part B: Standard of Care||0
2287061|NCT02122770|5615740|P1|NOT COMPLETED|Part B: Standard of Care||0
2287062|NCT02122770|5615735|P6|COMPLETED|Part B: Standard of Care||0
2287063|NCT02122770|5615736|P5|COMPLETED|Part B: Standard of Care||0
2287064|NCT02122770|5615737|P4|COMPLETED|Part B: Standard of Care||0
2287065|NCT02122770|5615738|P3|COMPLETED|Part B: Standard of Care||0
2287066|NCT02122770|5615739|P2|COMPLETED|Part B: Standard of Care||0
2287067|NCT02122770|5615740|P1|COMPLETED|Part B: Standard of Care||0
2287068|NCT02122770|5615735|P6|STARTED|Part B: Standard of Care||13
2287069|NCT02122770|5615736|P5|STARTED|Part B: Standard of Care||23
2287070|NCT02122770|5615737|P4|STARTED|Part B: Standard of Care||0
2287071|NCT02122770|5615738|P3|STARTED|Part B: Standard of Care||0
2287072|NCT02122770|5615739|P2|STARTED|Part B: Standard of Care||0
2287073|NCT02122770|5615740|P1|STARTED|Part B: Standard of Care||0
2287074|NCT02122770|5615735|P6|NOT COMPLETED|Part A: Drug-drug Interaction 2||0
2287075|NCT02122770|5615736|P5|NOT COMPLETED|Part A: Drug-drug Interaction 2||0
2287076|NCT02122770|5615737|P4|NOT COMPLETED|Part A: Drug-drug Interaction 2||3
2287077|NCT02122770|5615738|P3|NOT COMPLETED|Part A: Drug-drug Interaction 2||2
2287078|NCT02122770|5615739|P2|NOT COMPLETED|Part A: Drug-drug Interaction 2||6
2287079|NCT02122770|5615740|P1|NOT COMPLETED|Part A: Drug-drug Interaction 2||4
2287080|NCT02122770|5615735|P6|COMPLETED|Part A: Drug-drug Interaction 2||0
2287081|NCT02122770|5615736|P5|COMPLETED|Part A: Drug-drug Interaction 2||0
2287082|NCT02122770|5615737|P4|COMPLETED|Part A: Drug-drug Interaction 2||16
2287083|NCT02122770|5615738|P3|COMPLETED|Part A: Drug-drug Interaction 2||4
2287084|NCT02122770|5615739|P2|COMPLETED|Part A: Drug-drug Interaction 2||7
2287085|NCT02122770|5615740|P1|COMPLETED|Part A: Drug-drug Interaction 2||9
2287086|NCT02122770|5615735|P6|STARTED|Part A: Drug-drug Interaction 2||0
2287087|NCT02122770|5615736|P5|STARTED|Part A: Drug-drug Interaction 2||0
2287088|NCT02122770|5615737|P4|STARTED|Part A: Drug-drug Interaction 2||19
2287089|NCT02122770|5615738|P3|STARTED|Part A: Drug-drug Interaction 2||6
2287090|NCT02122770|5615739|P2|STARTED|Part A: Drug-drug Interaction 2||13
2287091|NCT02122770|5615740|P1|STARTED|Part A: Drug-drug Interaction 2||13
2287092|NCT02122549|5615820|P1|NOT COMPLETED|Overall Study||0
2287093|NCT02122549|5615820|P1|COMPLETED|Overall Study||59
2287094|NCT02122549|5615820|P1|STARTED|Overall Study||59
2287095|NCT02122471|5615827|P3|NOT COMPLETED|Overall Study||44
2287096|NCT02122471|5615828|P2|NOT COMPLETED|Overall Study||51
2287097|NCT02122471|5615829|P1|NOT COMPLETED|Overall Study||39
2287098|NCT02122471|5615827|P3|COMPLETED|Overall Study||405
2287099|NCT02122471|5615828|P2|COMPLETED|Overall Study||392
2287100|NCT02122471|5615829|P1|COMPLETED|Overall Study||406
2287101|NCT02122471|5615827|P3|STARTED|Overall Study||449
2287102|NCT02122471|5615828|P2|STARTED|Overall Study||443
2287103|NCT02122471|5615829|P1|STARTED|Overall Study||445
2287104|NCT02122445|5615849|P1|NOT COMPLETED|Overall Study||0
2287105|NCT02122445|5615849|P1|COMPLETED|Overall Study||20
2287106|NCT02122445|5615849|P1|STARTED|Overall Study||20
2287107|NCT02122406|5615854|P1|NOT COMPLETED|Overall Study||0
2287108|NCT02122406|5615854|P1|COMPLETED|Overall Study||200
2287109|NCT02122406|5615854|P1|STARTED|Overall Study||200
2287110|NCT02122341|5615860|P2|NOT COMPLETED|Overall Study||0
2287111|NCT02122341|5615861|P1|NOT COMPLETED|Overall Study||0
2287112|NCT02122341|5615860|P2|COMPLETED|Overall Study||18
2287113|NCT02122341|5615861|P1|COMPLETED|Overall Study||17
2287114|NCT02122341|5615860|P2|STARTED|Overall Study||18
2287115|NCT02122341|5615861|P1|STARTED|Overall Study||17
2287116|NCT02122146|5615883|P8|NOT COMPLETED|Part 3: Expansion||0
2287117|NCT02122146|5615884|P7|NOT COMPLETED|Part 3: Expansion||0
2287118|NCT02122146|5615885|P6|NOT COMPLETED|Part 3: Expansion||0
2287119|NCT02122146|5615886|P5|NOT COMPLETED|Part 3: Expansion||0
2287120|NCT02122146|5615887|P4|NOT COMPLETED|Part 3: Expansion||0
2287121|NCT02122146|5615888|P3|NOT COMPLETED|Part 3: Expansion||0
2287122|NCT02122146|5615889|P2|NOT COMPLETED|Part 3: Expansion||0
2287123|NCT02122146|5615890|P1|NOT COMPLETED|Part 3: Expansion||0
2287124|NCT02122146|5615883|P8|COMPLETED|Part 3: Expansion||0
2287125|NCT02122146|5615884|P7|COMPLETED|Part 3: Expansion||0
2287126|NCT02122146|5615885|P6|COMPLETED|Part 3: Expansion||0
2287127|NCT02122146|5615886|P5|COMPLETED|Part 3: Expansion||0
2287128|NCT02122146|5615887|P4|COMPLETED|Part 3: Expansion||0
2287129|NCT02122146|5615888|P3|COMPLETED|Part 3: Expansion||0
2287130|NCT02122146|5615889|P2|COMPLETED|Part 3: Expansion||0
2287131|NCT02122146|5615890|P1|COMPLETED|Part 3: Expansion||0
2287132|NCT02122146|5615883|P8|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
2287133|NCT02122146|5615884|P7|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
2287134|NCT02122146|5615885|P6|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
2287135|NCT02122146|5615886|P5|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
2287136|NCT02122146|5615887|P4|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
2287137|NCT02122146|5615888|P3|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
2287138|NCT02122146|5615889|P2|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
2287139|NCT02122146|5615890|P1|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
2287140|NCT02122146|5615883|P8|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
2287141|NCT02122146|5615884|P7|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
2287142|NCT02122146|5615885|P6|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
2287143|NCT02122146|5615886|P5|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
2287144|NCT02122146|5615887|P4|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
2287145|NCT02122146|5615888|P3|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
2287146|NCT02122146|5615889|P2|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
2287147|NCT02122146|5615890|P1|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
2287148|NCT02122146|5615883|P8|COMPLETED|Part 2: Maximum Tolerated Dose||0
2287149|NCT02122146|5615884|P7|COMPLETED|Part 2: Maximum Tolerated Dose||0
2287150|NCT02122146|5615885|P6|COMPLETED|Part 2: Maximum Tolerated Dose||0
2287151|NCT02122146|5615886|P5|COMPLETED|Part 2: Maximum Tolerated Dose||0
2287152|NCT02122146|5615887|P4|COMPLETED|Part 2: Maximum Tolerated Dose||0
2287153|NCT02122146|5615888|P3|COMPLETED|Part 2: Maximum Tolerated Dose||0
2287154|NCT02122146|5615889|P2|COMPLETED|Part 2: Maximum Tolerated Dose||0
2287155|NCT02122146|5615890|P1|COMPLETED|Part 2: Maximum Tolerated Dose||0
2287156|NCT02122146|5615883|P8|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
2287157|NCT02122146|5615884|P7|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
2287158|NCT02122146|5615885|P6|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
2287159|NCT02122146|5615886|P5|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
2287160|NCT02122146|5615887|P4|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
2287161|NCT02122146|5615888|P3|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
2287162|NCT02122146|5615889|P2|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
2287163|NCT02122146|5615890|P1|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
2287164|NCT02122146|5615883|P8|NOT COMPLETED|Part 1: Dose Escalation||2
2287165|NCT02122146|5615884|P7|NOT COMPLETED|Part 1: Dose Escalation||1
2287166|NCT02122146|5615885|P6|NOT COMPLETED|Part 1: Dose Escalation||1
2287167|NCT02122146|5615886|P5|NOT COMPLETED|Part 1: Dose Escalation||1
2287168|NCT02122146|5615887|P4|NOT COMPLETED|Part 1: Dose Escalation||1
2287169|NCT02122146|5615888|P3|NOT COMPLETED|Part 1: Dose Escalation||2
2287170|NCT02122146|5615889|P2|NOT COMPLETED|Part 1: Dose Escalation||1
2287171|NCT02122146|5615890|P1|NOT COMPLETED|Part 1: Dose Escalation||1
2287172|NCT02122146|5615883|P8|COMPLETED|Part 1: Dose Escalation||6
2287173|NCT02122146|5615884|P7|COMPLETED|Part 1: Dose Escalation||0
2287174|NCT02122146|5615885|P6|COMPLETED|Part 1: Dose Escalation||5
2287175|NCT02122146|5615886|P5|COMPLETED|Part 1: Dose Escalation||3
2287176|NCT02122146|5615887|P4|COMPLETED|Part 1: Dose Escalation||3
2287177|NCT02122146|5615888|P3|COMPLETED|Part 1: Dose Escalation||2
2287178|NCT02122146|5615889|P2|COMPLETED|Part 1: Dose Escalation||1
2287179|NCT02122146|5615890|P1|COMPLETED|Part 1: Dose Escalation||1
2287180|NCT02122146|5615883|P8|STARTED|Part 1: Dose Escalation||8
2287181|NCT02122146|5615884|P7|STARTED|Part 1: Dose Escalation||1
2287182|NCT02122146|5615885|P6|STARTED|Part 1: Dose Escalation||6
2287183|NCT02122146|5615886|P5|STARTED|Part 1: Dose Escalation||4
2287184|NCT02122146|5615887|P4|STARTED|Part 1: Dose Escalation||4
2287185|NCT02122146|5615888|P3|STARTED|Part 1: Dose Escalation||4
2287186|NCT02122146|5615889|P2|STARTED|Part 1: Dose Escalation||2
2287187|NCT02122146|5615890|P1|STARTED|Part 1: Dose Escalation||2
2287188|NCT02121912|5616127|P2|NOT COMPLETED|Overall Study||0
2287189|NCT02121912|5616128|P1|NOT COMPLETED|Overall Study||4
2287190|NCT02121912|5616127|P2|COMPLETED|Overall Study||25
2287191|NCT02121912|5616128|P1|COMPLETED|Overall Study||21
2287192|NCT02121912|5616127|P2|STARTED|Overall Study||25
2287193|NCT02121912|5616128|P1|STARTED|Overall Study||25
2287194|NCT02121860|5616142|P4|NOT COMPLETED|Overall Study||0
2287195|NCT02121860|5616143|P3|NOT COMPLETED|Overall Study||0
2287196|NCT02121860|5616144|P2|NOT COMPLETED|Overall Study||0
2287197|NCT02121860|5616145|P1|NOT COMPLETED|Overall Study||0
2287198|NCT02121860|5616142|P4|COMPLETED|Overall Study||8
2287199|NCT02121860|5616143|P3|COMPLETED|Overall Study||8
2287200|NCT02121860|5616144|P2|COMPLETED|Overall Study||12
2287201|NCT02121860|5616145|P1|COMPLETED|Overall Study||8
2287202|NCT02121860|5616142|P4|STARTED|Overall Study||8
2287203|NCT02121860|5616143|P3|STARTED|Overall Study||8
2287204|NCT02121860|5616144|P2|STARTED|Overall Study||12
2287205|NCT02121860|5616145|P1|STARTED|Overall Study||8
2287206|NCT02121847|5616164|P1|NOT COMPLETED|Overall Study||3
2287207|NCT02121847|5616164|P1|COMPLETED|Overall Study||37
2287208|NCT02121847|5616164|P1|STARTED|Overall Study||40
2287209|NCT02121834|5616190|P7|NOT COMPLETED|Overall Study||0
2287210|NCT02121834|5616191|P6|NOT COMPLETED|Overall Study||0
2287211|NCT02121834|5616192|P5|NOT COMPLETED|Overall Study||0
2287212|NCT02121834|5616193|P4|NOT COMPLETED|Overall Study||0
2287213|NCT02121834|5616194|P3|NOT COMPLETED|Overall Study||2
2287214|NCT02121834|5616195|P2|NOT COMPLETED|Overall Study||2
2287215|NCT02121834|5616196|P1|NOT COMPLETED|Overall Study||0
2287216|NCT02121834|5616190|P7|COMPLETED|Overall Study||3
2287217|NCT02121834|5616191|P6|COMPLETED|Overall Study||9
2287218|NCT02121834|5616192|P5|COMPLETED|Overall Study||9
2287219|NCT02121834|5616193|P4|COMPLETED|Overall Study||10
2287220|NCT02121834|5616194|P3|COMPLETED|Overall Study||7
2287221|NCT02121834|5616195|P2|COMPLETED|Overall Study||9
2287222|NCT02121834|5616196|P1|COMPLETED|Overall Study||12
2287223|NCT02121834|5616190|P7|Received at Least One Dose of Study Drug|Overall Study||3
2287224|NCT02121834|5616191|P6|Received at Least One Dose of Study Drug|Overall Study||9
2287225|NCT02121834|5616192|P5|Received at Least One Dose of Study Drug|Overall Study||9
2287226|NCT02121834|5616193|P4|Received at Least One Dose of Study Drug|Overall Study||10
2287227|NCT02121834|5616194|P3|Received at Least One Dose of Study Drug|Overall Study||9
2287228|NCT02121834|5616195|P2|Received at Least One Dose of Study Drug|Overall Study||11
2287229|NCT02121834|5616196|P1|Received at Least One Dose of Study Drug|Overall Study||12
2287230|NCT02121834|5616190|P7|STARTED|Overall Study||3
2287231|NCT02121834|5616191|P6|STARTED|Overall Study||9
2287232|NCT02121834|5616192|P5|STARTED|Overall Study||9
2287233|NCT02121834|5616193|P4|STARTED|Overall Study||10
2287234|NCT02121834|5616194|P3|STARTED|Overall Study||9
2287235|NCT02121834|5616195|P2|STARTED|Overall Study||11
2287236|NCT02121834|5616196|P1|STARTED|Overall Study||12
2287237|NCT02121808|5616222|P1|NOT COMPLETED|Overall Study||3
2287238|NCT02121808|5616222|P1|COMPLETED|Overall Study||17
2287239|NCT02121808|5616222|P1|STARTED|Overall Study||20
2287240|NCT02121795|5616233|P2|NOT COMPLETED|Overall Study||334
2287241|NCT02121795|5616234|P1|NOT COMPLETED|Overall Study||334
2287242|NCT02121795|5616233|P2|COMPLETED|Overall Study||0
2287243|NCT02121795|5616234|P1|COMPLETED|Overall Study||0
2287244|NCT02121795|5616233|P2|STARTED|Overall Study||334
2287245|NCT02121795|5616234|P1|STARTED|Overall Study||334
2287246|NCT02121756|5616250|P2|NOT COMPLETED|Overall Study||2
2287247|NCT02121756|5616251|P1|NOT COMPLETED|Overall Study||6
2287248|NCT02121756|5616250|P2|COMPLETED|Overall Study||17
2287249|NCT02121756|5616251|P1|COMPLETED|Overall Study||15
2287250|NCT02121756|5616250|P2|STARTED|Overall Study||19
2287251|NCT02121756|5616251|P1|STARTED|Overall Study||21
2287252|NCT02121535|5616288|P2|NOT COMPLETED|Period 4 (8 Trial Days)||0
2287253|NCT02121535|5616289|P1|NOT COMPLETED|Period 4 (8 Trial Days)||0
2287254|NCT02121535|5616288|P2|COMPLETED|Period 4 (8 Trial Days)||35
2287255|NCT02121535|5616289|P1|COMPLETED|Period 4 (8 Trial Days)||35
2287256|NCT02121535|5616288|P2|STARTED|Period 4 (8 Trial Days)||35
2287257|NCT02121535|5616289|P1|STARTED|Period 4 (8 Trial Days)||35
2287258|NCT02121535|5616288|P2|NOT COMPLETED|Period 3 (8 Trial Days)||0
2287259|NCT02121535|5616289|P1|NOT COMPLETED|Period 3 (8 Trial Days)||1
2287260|NCT02121535|5616288|P2|COMPLETED|Period 3 (8 Trial Days)||35
2287261|NCT02121535|5616289|P1|COMPLETED|Period 3 (8 Trial Days)|1 subject withdrew consent during the washout period between Period 3 and 4.|35
2287262|NCT02121535|5616288|P2|STARTED|Period 3 (8 Trial Days)||35
2287263|NCT02121535|5616289|P1|STARTED|Period 3 (8 Trial Days)||36
2287264|NCT02121535|5616288|P2|NOT COMPLETED|Period 2 (8 Trial Days)||0
2287265|NCT02121535|5616289|P1|NOT COMPLETED|Period 2 (8 Trial Days)||0
2287266|NCT02121535|5616288|P2|COMPLETED|Period 2 (8 Trial Days)||35
2287267|NCT02121535|5616289|P1|COMPLETED|Period 2 (8 Trial Days)||36
2287268|NCT02121535|5616288|P2|STARTED|Period 2 (8 Trial Days)||35
2287269|NCT02121535|5616289|P1|STARTED|Period 2 (8 Trial Days)||36
2287270|NCT02121535|5616288|P2|NOT COMPLETED|Period 1 (8 Trial Days)||1
2287271|NCT02121535|5616289|P1|NOT COMPLETED|Period 1 (8 Trial Days)||0
2287272|NCT02121535|5616288|P2|COMPLETED|Period 1 (8 Trial Days)|1 subject withdrew his consent during the washout period between Period 1 and 2.|35
2287273|NCT02121535|5616289|P1|COMPLETED|Period 1 (8 Trial Days)||36
2287274|NCT02121535|5616288|P2|STARTED|Period 1 (8 Trial Days)||36
2287275|NCT02121535|5616289|P1|STARTED|Period 1 (8 Trial Days)||36
2287276|NCT02121522|5616312|P1|NOT COMPLETED|Overall Study||1
2287277|NCT02121522|5616312|P1|COMPLETED|Overall Study||13
2287278|NCT02121522|5616312|P1|STARTED|Overall Study||14
2287279|NCT02121509|5616319|P4|NOT COMPLETED|Treatment Period-2 (4 Days)||0
2287280|NCT02121509|5616320|P3|NOT COMPLETED|Treatment Period-2 (4 Days)||0
2287281|NCT02121509|5616321|P2|NOT COMPLETED|Treatment Period-2 (4 Days)||0
2287282|NCT02121509|5616322|P1|NOT COMPLETED|Treatment Period-2 (4 Days)||0
2287283|NCT02121509|5616319|P4|COMPLETED|Treatment Period-2 (4 Days)||8
2287284|NCT02121509|5616320|P3|COMPLETED|Treatment Period-2 (4 Days)||8
2287285|NCT02121509|5616321|P2|COMPLETED|Treatment Period-2 (4 Days)||24
2287286|NCT02121509|5616322|P1|COMPLETED|Treatment Period-2 (4 Days)||28
2287287|NCT02121509|5616319|P4|STARTED|Treatment Period-2 (4 Days)||8
2287288|NCT02121509|5616320|P3|STARTED|Treatment Period-2 (4 Days)||8
2287289|NCT02121509|5616321|P2|STARTED|Treatment Period-2 (4 Days)||24
2287290|NCT02121509|5616322|P1|STARTED|Treatment Period-2 (4 Days)||28
2287291|NCT02121509|5616319|P4|NOT COMPLETED|Washout Period (35 Days)||0
2287292|NCT02121509|5616320|P3|NOT COMPLETED|Washout Period (35 Days)||0
2287293|NCT02121509|5616321|P2|NOT COMPLETED|Washout Period (35 Days)||4
2287294|NCT02121509|5616322|P1|NOT COMPLETED|Washout Period (35 Days)||2
2287295|NCT02121509|5616319|P4|COMPLETED|Washout Period (35 Days)||8
2287296|NCT02121509|5616320|P3|COMPLETED|Washout Period (35 Days)||8
2287297|NCT02121509|5616321|P2|COMPLETED|Washout Period (35 Days)||24
2287298|NCT02121509|5616322|P1|COMPLETED|Washout Period (35 Days)||28
2287299|NCT02121509|5616319|P4|STARTED|Washout Period (35 Days)||8
2287300|NCT02121509|5616320|P3|STARTED|Washout Period (35 Days)||8
2287301|NCT02121509|5616321|P2|STARTED|Washout Period (35 Days)||28
2287302|NCT02121509|5616322|P1|STARTED|Washout Period (35 Days)||30
2287303|NCT02121509|5616319|P4|NOT COMPLETED|Treatment Period-1 (4 Days)||0
2287304|NCT02121509|5616320|P3|NOT COMPLETED|Treatment Period-1 (4 Days)||0
2287305|NCT02121509|5616321|P2|NOT COMPLETED|Treatment Period-1 (4 Days)||0
2287306|NCT02121509|5616322|P1|NOT COMPLETED|Treatment Period-1 (4 Days)||0
2287307|NCT02121509|5616319|P4|COMPLETED|Treatment Period-1 (4 Days)||8
2287308|NCT02121509|5616320|P3|COMPLETED|Treatment Period-1 (4 Days)||8
2287309|NCT02121509|5616321|P2|COMPLETED|Treatment Period-1 (4 Days)||28
2287310|NCT02121509|5616322|P1|COMPLETED|Treatment Period-1 (4 Days)||30
2287311|NCT02121509|5616319|P4|STARTED|Treatment Period-1 (4 Days)||8
2287312|NCT02121509|5616320|P3|STARTED|Treatment Period-1 (4 Days)||8
2287313|NCT02121509|5616321|P2|STARTED|Treatment Period-1 (4 Days)||28
2287314|NCT02121509|5616322|P1|STARTED|Treatment Period-1 (4 Days)||30
2287315|NCT02121483|5616355|P3|NOT COMPLETED|Overall Study||0
2287316|NCT02121483|5616356|P2|NOT COMPLETED|Overall Study||0
2287317|NCT02121483|5616357|P1|NOT COMPLETED|Overall Study||0
2287318|NCT02121483|5616355|P3|COMPLETED|Overall Study||10
2287319|NCT02121483|5616356|P2|COMPLETED|Overall Study||8
2287320|NCT02121483|5616357|P1|COMPLETED|Overall Study||9
2287321|NCT02121483|5616355|P3|STARTED|Overall Study||10
2287322|NCT02121483|5616356|P2|STARTED|Overall Study||8
2287323|NCT02121483|5616357|P1|STARTED|Overall Study||9
2287324|NCT02121418|5616386|P1|NOT COMPLETED|Overall Study||0
2287325|NCT02121418|5616386|P1|COMPLETED|Overall Study||12
2287326|NCT02121418|5616386|P1|STARTED|Overall Study||12
2287327|NCT02121210|5616393|P2|NOT COMPLETED|Overall Study||9
2287328|NCT02121210|5616394|P1|NOT COMPLETED|Overall Study||7
2287329|NCT02121210|5616393|P2|COMPLETED|Overall Study||58
2287330|NCT02121210|5616394|P1|COMPLETED|Overall Study||58
2287331|NCT02121210|5616393|P2|STARTED|Overall Study||67
2287332|NCT02121210|5616394|P1|STARTED|Overall Study||65
2287333|NCT02121067|5616402|P1|NOT COMPLETED|Overall Study||0
2287334|NCT02121067|5616402|P1|COMPLETED|Overall Study||50
2287335|NCT02121067|5616402|P1|STARTED|Overall Study||50
2287336|NCT02121041|5616410|P2|NOT COMPLETED|Overall Study||6
2287337|NCT02121041|5616411|P1|NOT COMPLETED|Overall Study||1
2287338|NCT02121041|5616410|P2|COMPLETED|Overall Study||8
2287339|NCT02121041|5616411|P1|COMPLETED|Overall Study||13
2287340|NCT02121041|5616410|P2|STARTED|Overall Study||14
2287341|NCT02121041|5616411|P1|STARTED|Overall Study||14
2287342|NCT02120950|5616419|P3|NOT COMPLETED|Overall Study||15
2287343|NCT02120950|5616420|P2|NOT COMPLETED|Overall Study||14
2287344|NCT02120950|5616421|P1|NOT COMPLETED|Overall Study||20
2287345|NCT02120950|5616419|P3|COMPLETED|Overall Study||0
2287346|NCT02120950|5616420|P2|COMPLETED|Overall Study|Completed Treatment (Week 96)|147
2287347|NCT02120950|5616421|P1|COMPLETED|Overall Study|Completed Treatment (Week 96)|137
2287348|NCT02120950|5616419|P3|STARTED|Overall Study||15
2287349|NCT02120950|5616420|P2|STARTED|Overall Study||161
2287350|NCT02120950|5616421|P1|STARTED|Overall Study||157
2287351|NCT02120898|5616457|P3|NOT COMPLETED|Overall Study||4
2287352|NCT02120898|5616458|P2|NOT COMPLETED|Overall Study||6
2287353|NCT02120898|5616459|P1|NOT COMPLETED|Overall Study||9
2287354|NCT02120898|5616457|P3|COMPLETED|Overall Study||89
2287355|NCT02120898|5616458|P2|COMPLETED|Overall Study||181
2287356|NCT02120898|5616459|P1|COMPLETED|Overall Study||178
2287357|NCT02120898|5616457|P3|Intent-to-Treat (ITT) Population|Overall Study||93
2287358|NCT02120898|5616458|P2|Intent-to-Treat (ITT) Population|Overall Study||185
2287359|NCT02120898|5616459|P1|Intent-to-Treat (ITT) Population|Overall Study||183
2287360|NCT02120898|5616457|P3|Safety Population|Overall Study||93
2287361|NCT02120898|5616458|P2|Safety Population|Overall Study||187
2287362|NCT02120898|5616459|P1|Safety Population|Overall Study||187
2287363|NCT02120898|5616457|P3|STARTED|Overall Study||93
2287364|NCT02120898|5616458|P2|STARTED|Overall Study||187
2287365|NCT02120898|5616459|P1|STARTED|Overall Study||187
2287366|NCT02120833|5616481|P2|NOT COMPLETED|Overall Study||1
2287367|NCT02120833|5616482|P1|NOT COMPLETED|Overall Study||4
2287368|NCT02120833|5616481|P2|COMPLETED|Overall Study||11
2287369|NCT02120833|5616482|P1|COMPLETED|Overall Study||35
2287370|NCT02120833|5616481|P2|STARTED|Overall Study||12
2287371|NCT02120833|5616482|P1|STARTED|Overall Study||39
2287372|NCT02120794|5616636|P1|NOT COMPLETED|Overall Study||58
2287373|NCT02120794|5616636|P1|COMPLETED|Overall Study||136
2287374|NCT02120794|5616636|P1|STARTED|Overall Study||194
2287375|NCT02120716|5616645|P2|NOT COMPLETED|Overall Study||0
2287376|NCT02120716|5616646|P1|NOT COMPLETED|Overall Study||1
2287377|NCT02120716|5616645|P2|COMPLETED|Overall Study||19
2287378|NCT02120716|5616646|P1|COMPLETED|Overall Study||30
2287379|NCT02120716|5616645|P2|STARTED|Overall Study||19
2287380|NCT02120716|5616646|P1|STARTED|Overall Study||31
2287381|NCT02120664|5616660|P5|NOT COMPLETED|Overall Study||0
2287382|NCT02120664|5616661|P4|NOT COMPLETED|Overall Study||1
2287383|NCT02120664|5616662|P3|NOT COMPLETED|Overall Study||0
2287384|NCT02120664|5616663|P2|NOT COMPLETED|Overall Study||0
2287385|NCT02120664|5616664|P1|NOT COMPLETED|Overall Study||0
2287386|NCT02120664|5616660|P5|COMPLETED|Overall Study||10
2287387|NCT02120664|5616661|P4|COMPLETED|Overall Study||3
2287388|NCT02120664|5616662|P3|COMPLETED|Overall Study||7
2287389|NCT02120664|5616663|P2|COMPLETED|Overall Study||4
2287390|NCT02120664|5616664|P1|COMPLETED|Overall Study||10
2287391|NCT02120664|5616660|P5|STARTED|Overall Study||10
2287392|NCT02120664|5616661|P4|STARTED|Overall Study||4
2287393|NCT02120664|5616662|P3|STARTED|Overall Study||7
2287394|NCT02120664|5616663|P2|STARTED|Overall Study||4
2287395|NCT02120664|5616664|P1|STARTED|Overall Study||10
2287396|NCT02120625|5616682|P1|NOT COMPLETED|Overall Study||2
2287397|NCT02120625|5616682|P1|COMPLETED|Overall Study||6
2287398|NCT02120625|5616682|P1|STARTED|Overall Study||8
2287399|NCT02120456|5616698|P9|NOT COMPLETED|Part 2 Double-blind Phase||1
2287400|NCT02120456|5616699|P8|NOT COMPLETED|Part 2 Double-blind Phase||0
2287401|NCT02120456|5616700|P7|NOT COMPLETED|Part 2 Double-blind Phase||2
2287402|NCT02120456|5616701|P6|NOT COMPLETED|Part 2 Double-blind Phase||0
2287403|NCT02120456|5616702|P5|NOT COMPLETED|Part 2 Double-blind Phase||0
2287404|NCT02120456|5616703|P4|NOT COMPLETED|Part 2 Double-blind Phase||0
2287405|NCT02120456|5616704|P3|NOT COMPLETED|Part 2 Double-blind Phase||0
2287406|NCT02120456|5616705|P2|NOT COMPLETED|Part 2 Double-blind Phase||0
2287407|NCT02120456|5616706|P1|NOT COMPLETED|Part 2 Double-blind Phase||0
2287408|NCT02120456|5616698|P9|COMPLETED|Part 2 Double-blind Phase||62
2287409|NCT02120456|5616699|P8|COMPLETED|Part 2 Double-blind Phase||60
2287410|NCT02120456|5616700|P7|COMPLETED|Part 2 Double-blind Phase||30
2287411|NCT02120456|5616701|P6|COMPLETED|Part 2 Double-blind Phase||0
2287412|NCT02120456|5616702|P5|COMPLETED|Part 2 Double-blind Phase||0
2287413|NCT02120456|5616703|P4|COMPLETED|Part 2 Double-blind Phase||0
2287414|NCT02120456|5616704|P3|COMPLETED|Part 2 Double-blind Phase||0
2287415|NCT02120456|5616705|P2|COMPLETED|Part 2 Double-blind Phase||0
2287416|NCT02120456|5616706|P1|COMPLETED|Part 2 Double-blind Phase||0
2287417|NCT02120456|5616698|P9|STARTED|Part 2 Double-blind Phase||63
2287418|NCT02120456|5616699|P8|STARTED|Part 2 Double-blind Phase||60
2287419|NCT02120456|5616700|P7|STARTED|Part 2 Double-blind Phase||32
2287420|NCT02120456|5616701|P6|STARTED|Part 2 Double-blind Phase||0
2287421|NCT02120456|5616702|P5|STARTED|Part 2 Double-blind Phase||0
2287422|NCT02120456|5616703|P4|STARTED|Part 2 Double-blind Phase||0
2287423|NCT02120456|5616704|P3|STARTED|Part 2 Double-blind Phase||0
2287424|NCT02120456|5616705|P2|STARTED|Part 2 Double-blind Phase||0
2287425|NCT02120456|5616706|P1|STARTED|Part 2 Double-blind Phase||0
2287426|NCT02120456|5616698|P9|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
2287427|NCT02120456|5616699|P8|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
2287428|NCT02120456|5616700|P7|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
2287429|NCT02120456|5616701|P6|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
2287430|NCT02120456|5616702|P5|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
2287431|NCT02120456|5616703|P4|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
2287432|NCT02120456|5616704|P3|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
2287433|NCT02120456|5616705|P2|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
2287434|NCT02120456|5616706|P1|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
2287435|NCT02120456|5616698|P9|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
2287436|NCT02120456|5616699|P8|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
2287437|NCT02120456|5616700|P7|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
2287438|NCT02120456|5616701|P6|COMPLETED|Part 1 Open-label, Dose-escalation Phase||9
2287439|NCT02120456|5616702|P5|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
2287440|NCT02120456|5616703|P4|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
2287441|NCT02120456|5616704|P3|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
2287442|NCT02120456|5616705|P2|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
2287443|NCT02120456|5616706|P1|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
2287444|NCT02120456|5616698|P9|STARTED|Part 1 Open-label, Dose-escalation Phase||0
2287445|NCT02120456|5616699|P8|STARTED|Part 1 Open-label, Dose-escalation Phase||0
2287446|NCT02120456|5616700|P7|STARTED|Part 1 Open-label, Dose-escalation Phase||0
2287447|NCT02120456|5616701|P6|STARTED|Part 1 Open-label, Dose-escalation Phase||9
2287448|NCT02120456|5616702|P5|STARTED|Part 1 Open-label, Dose-escalation Phase||12
2287449|NCT02120456|5616703|P4|STARTED|Part 1 Open-label, Dose-escalation Phase||12
2287450|NCT02120456|5616704|P3|STARTED|Part 1 Open-label, Dose-escalation Phase||12
2287451|NCT02120456|5616705|P2|STARTED|Part 1 Open-label, Dose-escalation Phase||12
2287452|NCT02120456|5616706|P1|STARTED|Part 1 Open-label, Dose-escalation Phase||12
2287453|NCT02120443|5616732|P1|NOT COMPLETED|Overall Study||0
2287454|NCT02120443|5616732|P1|COMPLETED|Overall Study||43
2287455|NCT02120443|5616732|P1|STARTED|Overall Study||43
2287456|NCT02120417|5616740|P2|NOT COMPLETED|Overall Study||68
2287457|NCT02120417|5616741|P1|NOT COMPLETED|Overall Study||60
2287458|NCT02120417|5616740|P2|COMPLETED|Overall Study||5
2287459|NCT02120417|5616741|P1|COMPLETED|Overall Study||16
2287460|NCT02120417|5616740|P2|STARTED|Overall Study||73
2287461|NCT02120417|5616741|P1|STARTED|Overall Study||76
2287462|NCT02120300|5616763|P4|NOT COMPLETED|Overall Study||1
2287463|NCT02120300|5616764|P3|NOT COMPLETED|Overall Study||0
2287464|NCT02120300|5616765|P2|NOT COMPLETED|Overall Study||0
2287465|NCT02120300|5616766|P1|NOT COMPLETED|Overall Study||3
2287466|NCT02120300|5616763|P4|COMPLETED|Overall Study||5
2287467|NCT02120300|5616764|P3|COMPLETED|Overall Study||10
2287468|NCT02120300|5616765|P2|COMPLETED|Overall Study||5
2287469|NCT02120300|5616766|P1|COMPLETED|Overall Study||98
2287470|NCT02120300|5616763|P4|STARTED|Overall Study||6
2287471|NCT02120300|5616764|P3|STARTED|Overall Study||10
2287472|NCT02120300|5616765|P2|STARTED|Overall Study||5
2287473|NCT02120300|5616766|P1|STARTED|Overall Study||101
2287474|NCT02120287|5616802|P1|NOT COMPLETED|Overall Study||0
2287475|NCT02120287|5616802|P1|COMPLETED|Overall Study||16
2287476|NCT02120287|5616802|P1|STARTED|Overall Study||16
2287477|NCT02120261|5616822|P2|NOT COMPLETED|Overall Study||0
2287478|NCT02120261|5616823|P1|NOT COMPLETED|Overall Study||0
2287479|NCT02120261|5616822|P2|COMPLETED|Overall Study||25
2287480|NCT02120261|5616823|P1|COMPLETED|Overall Study||23
2287481|NCT02120261|5616822|P2|STARTED|Overall Study||25
2287482|NCT02120261|5616823|P1|STARTED|Overall Study||23
2287483|NCT02120157|5616837|P2|NOT COMPLETED|Overall Study||2
2287484|NCT02120157|5616838|P1|NOT COMPLETED|Overall Study||6
2287485|NCT02120157|5616837|P2|COMPLETED|Overall Study||11
2287486|NCT02120157|5616838|P1|COMPLETED|Overall Study||13
2287487|NCT02120157|5616837|P2|Undergoing Follow-up|Overall Study||8
2287488|NCT02120157|5616838|P1|Undergoing Follow-up|Overall Study||7
2287489|NCT02120157|5616837|P2|Completed 180 Days|Overall Study||3
2287490|NCT02120157|5616838|P1|Completed 180 Days|Overall Study||5
2287491|NCT02120157|5616837|P2|STARTED|Overall Study||13
2287492|NCT02120157|5616838|P1|STARTED|Overall Study||19
2287493|NCT02120027|5616848|P2|NOT COMPLETED|Overall Study||119
2287494|NCT02120027|5616849|P1|NOT COMPLETED|Overall Study||116
2287495|NCT02120027|5616848|P2|COMPLETED|Overall Study||160
2287496|NCT02120027|5616849|P1|COMPLETED|Overall Study||161
2287497|NCT02120027|5616848|P2|STARTED|Overall Study||279
2287498|NCT02120027|5616849|P1|STARTED|Overall Study||277
2287499|NCT02120001|5616865|P2|NOT COMPLETED|Overall Study||0
2287500|NCT02120001|5616866|P1|NOT COMPLETED|Overall Study||0
2287501|NCT02120001|5616865|P2|COMPLETED|Overall Study||19
2287502|NCT02120001|5616866|P1|COMPLETED|Overall Study||17
2287503|NCT02120001|5616865|P2|STARTED|Overall Study||19
2287504|NCT02120001|5616866|P1|STARTED|Overall Study||17
2287505|NCT02119936|5616874|P1|NOT COMPLETED|Overall Study||10
2287506|NCT02119936|5616874|P1|COMPLETED|Overall Study||0
2287507|NCT02119936|5616874|P1|STARTED|Overall Study||10
2287508|NCT02119871|5616885|P2|NOT COMPLETED|Overall Study||0
2287509|NCT02119871|5616886|P1|NOT COMPLETED|Overall Study||0
2287510|NCT02119871|5616885|P2|COMPLETED|Overall Study||10
2287511|NCT02119871|5616886|P1|COMPLETED|Overall Study||10
2287512|NCT02119871|5616885|P2|STARTED|Overall Study||10
2287513|NCT02119871|5616886|P1|STARTED|Overall Study||10
2287514|NCT02119676|5616908|P4|NOT COMPLETED|Overall Study||101
2287515|NCT02119676|5616909|P3|NOT COMPLETED|Overall Study||97
2287516|NCT02119676|5616910|P2|NOT COMPLETED|Overall Study||86
2287517|NCT02119676|5616911|P1|NOT COMPLETED|Overall Study||83
2287518|NCT02119676|5616908|P4|COMPLETED|Overall Study||10
2287519|NCT02119676|5616909|P3|COMPLETED|Overall Study||13
2287520|NCT02119676|5616910|P2|COMPLETED|Overall Study||2
2287521|NCT02119676|5616911|P1|COMPLETED|Overall Study||4
2287522|NCT02119676|5616908|P4|Treated Patients|Overall Study||106
2287523|NCT02119676|5616909|P3|Treated Patients|Overall Study||106
2287524|NCT02119676|5616910|P2|Treated Patients|Overall Study||86
2287525|NCT02119676|5616911|P1|Treated Patients|Overall Study||85
2287526|NCT02119676|5616908|P4|STARTED|Overall Study||111
2287527|NCT02119676|5616909|P3|STARTED|Overall Study||110
2287528|NCT02119676|5616910|P2|STARTED|Overall Study||88
2287529|NCT02119676|5616911|P1|STARTED|Overall Study||87
2287530|NCT02119663|5616943|P2|NOT COMPLETED|Overall Study||41
2287531|NCT02119663|5616944|P1|NOT COMPLETED|Overall Study||40
2287532|NCT02119663|5616943|P2|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|2
2287533|NCT02119663|5616944|P1|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|3
2287534|NCT02119663|5616943|P2|STARTED|Overall Study||43
2287535|NCT02119663|5616944|P1|STARTED|Overall Study||43
2287536|NCT02119650|5616962|P2|NOT COMPLETED|Overall Study||26
2287537|NCT02119650|5616963|P1|NOT COMPLETED|Overall Study||25
2287538|NCT02119650|5616962|P2|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|11
2287539|NCT02119650|5616963|P1|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|14
2287540|NCT02119650|5616962|P2|STARTED|Overall Study||37
2287541|NCT02119650|5616963|P1|STARTED|Overall Study||39
2287542|NCT02119455|5616979|P2|NOT COMPLETED|Overall Study||3
2287543|NCT02119455|5616980|P1|NOT COMPLETED|Overall Study||0
2287544|NCT02119455|5616979|P2|COMPLETED|Overall Study||17
2287545|NCT02119455|5616980|P1|COMPLETED|Overall Study||20
2287546|NCT02119455|5616979|P2|STARTED|Overall Study||20
2287547|NCT02119455|5616980|P1|STARTED|Overall Study||20
2287548|NCT02119442|5616994|P1|NOT COMPLETED|Overall Study||0
2287549|NCT02119442|5616994|P1|COMPLETED|Overall Study||90
2287550|NCT02119442|5616994|P1|STARTED|Overall Study||90
2287551|NCT02119325|5616998|P2|NOT COMPLETED|Period 2||0
2287552|NCT02119325|5616999|P1|NOT COMPLETED|Period 2||0
2287553|NCT02119325|5616998|P2|COMPLETED|Period 2||47
2287554|NCT02119325|5616999|P1|COMPLETED|Period 2||48
2287555|NCT02119325|5616998|P2|STARTED|Period 2||47
2287556|NCT02119325|5616999|P1|STARTED|Period 2||48
2287557|NCT02119325|5616998|P2|NOT COMPLETED|Washout Period 1||1
2287558|NCT02119325|5616999|P1|NOT COMPLETED|Washout Period 1||0
2287559|NCT02119325|5616998|P2|COMPLETED|Washout Period 1||47
2287560|NCT02119325|5616999|P1|COMPLETED|Washout Period 1||48
2287561|NCT02119325|5616998|P2|STARTED|Washout Period 1||48
2287562|NCT02119325|5616999|P1|STARTED|Washout Period 1||48
2287563|NCT02119325|5616998|P2|NOT COMPLETED|Period 1||0
2287564|NCT02119325|5616999|P1|NOT COMPLETED|Period 1||0
2287565|NCT02119325|5616998|P2|COMPLETED|Period 1||48
2287566|NCT02119325|5616999|P1|COMPLETED|Period 1||48
2287567|NCT02119325|5616998|P2|STARTED|Period 1||48
2287568|NCT02119325|5616999|P1|STARTED|Period 1||48
2287569|NCT02119299|5617043|P1|NOT COMPLETED|Overall Study||9
2287570|NCT02119299|5617043|P1|COMPLETED|Overall Study||67
2287571|NCT02119299|5617043|P1|STARTED|Overall Study||76
2287572|NCT02119286|5617057|P3|NOT COMPLETED|Overall Study||7
2287573|NCT02119286|5617058|P2|NOT COMPLETED|Overall Study||11
2287574|NCT02119286|5617059|P1|NOT COMPLETED|Overall Study||26
2287575|NCT02119286|5617057|P3|COMPLETED|Overall Study||200
2287576|NCT02119286|5617058|P2|COMPLETED|Overall Study||195
2287577|NCT02119286|5617059|P1|COMPLETED|Overall Study||180
2287578|NCT02119286|5617057|P3|STARTED|Overall Study||207
2287579|NCT02119286|5617058|P2|STARTED|Overall Study||206
2287580|NCT02119286|5617059|P1|STARTED|Overall Study||206
2287581|NCT02119260|5617077|P7|NOT COMPLETED|Overall Study||0
2287582|NCT02119260|5617078|P6|NOT COMPLETED|Overall Study||0
2287583|NCT02119260|5617079|P5|NOT COMPLETED|Overall Study||0
2287584|NCT02119260|5617080|P4|NOT COMPLETED|Overall Study||0
2287585|NCT02119260|5617081|P3|NOT COMPLETED|Overall Study||1
2287586|NCT02119260|5617082|P2|NOT COMPLETED|Overall Study||1
2287587|NCT02119260|5617083|P1|NOT COMPLETED|Overall Study||1
2287588|NCT02119260|5617077|P7|COMPLETED|Overall Study||2
2287589|NCT02119260|5617078|P6|COMPLETED|Overall Study||6
2287590|NCT02119260|5617079|P5|COMPLETED|Overall Study||13
2287591|NCT02119260|5617080|P4|COMPLETED|Overall Study||10
2287592|NCT02119260|5617081|P3|COMPLETED|Overall Study||7
2287593|NCT02119260|5617082|P2|COMPLETED|Overall Study||11
2287594|NCT02119260|5617083|P1|COMPLETED|Overall Study||8
2287595|NCT02119260|5617077|P7|STARTED|Overall Study||2
2287596|NCT02119260|5617078|P6|STARTED|Overall Study||6
2287597|NCT02119260|5617079|P5|STARTED|Overall Study||13
2287598|NCT02119260|5617080|P4|STARTED|Overall Study||10
2287599|NCT02119260|5617081|P3|STARTED|Overall Study||8
2287600|NCT02119260|5617082|P2|STARTED|Overall Study||12
2287601|NCT02119260|5617083|P1|STARTED|Overall Study||9
2287602|NCT02119156|5617156|P3|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||7
2287603|NCT02119156|5617157|P2|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||10
2287604|NCT02119156|5617158|P1|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||0
2287605|NCT02119156|5617156|P3|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||3
2287606|NCT02119156|5617157|P2|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||6
2287607|NCT02119156|5617158|P1|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||0
2287608|NCT02119156|5617156|P3|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Eligible participants of Treatment control and holiday group on completion of 52-weeks were included|10
2287609|NCT02119156|5617157|P2|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Eligible participants of Treatment control and holiday group on completion of 52-weeks were included|16
2287610|NCT02119156|5617158|P1|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Long-term discontinuation participants were not allowed in Maintenance period|0
2287611|NCT02119156|5617156|P3|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||1
2287612|NCT02119156|5617157|P2|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||2
2287613|NCT02119156|5617158|P1|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||6
2287614|NCT02119156|5617156|P3|COMPLETED|Treatment Phase (Up to 52 Weeks)||11
2287615|NCT02119156|5617157|P2|COMPLETED|Treatment Phase (Up to 52 Weeks)||27
2287616|NCT02119156|5617158|P1|COMPLETED|Treatment Phase (Up to 52 Weeks)||33
2287617|NCT02119156|5617156|P3|STARTED|Treatment Phase (Up to 52 Weeks)||12
2287618|NCT02119156|5617157|P2|STARTED|Treatment Phase (Up to 52 Weeks)||29
2287619|NCT02119156|5617158|P1|STARTED|Treatment Phase (Up to 52 Weeks)||39
2287620|NCT02119104|5617216|P1|NOT COMPLETED|Overall Study||16
2287621|NCT02119104|5617216|P1|COMPLETED|Overall Study||1071
2287622|NCT02119104|5617216|P1|STARTED|Overall Study||1087
2287623|NCT02119026|5617222|P2|NOT COMPLETED|2nd-line Treatment||2
2287624|NCT02119026|5617223|P1|NOT COMPLETED|2nd-line Treatment||9
2287625|NCT02119026|5617222|P2|COMPLETED|2nd-line Treatment||22
2287626|NCT02119026|5617223|P1|COMPLETED|2nd-line Treatment||23
2287627|NCT02119026|5617222|P2|STARTED|2nd-line Treatment||24
2287628|NCT02119026|5617223|P1|STARTED|2nd-line Treatment||32
2287629|NCT02119026|5617222|P2|NOT COMPLETED|1st-line Treatment||38
2287630|NCT02119026|5617223|P1|NOT COMPLETED|1st-line Treatment||26
2287631|NCT02119026|5617222|P2|COMPLETED|1st-line Treatment||24
2287632|NCT02119026|5617223|P1|COMPLETED|1st-line Treatment||32
2287633|NCT02119026|5617222|P2|STARTED|1st-line Treatment||62
2287634|NCT02119026|5617223|P1|STARTED|1st-line Treatment||58
2287635|NCT02118961|5617247|P2|NOT COMPLETED|Overall Study||0
2287636|NCT02118961|5617248|P1|NOT COMPLETED|Overall Study||1
2287637|NCT02118961|5617247|P2|COMPLETED|Overall Study||222
2287638|NCT02118961|5617248|P1|COMPLETED|Overall Study||223
2287639|NCT02118961|5617247|P2|STARTED|Overall Study||222
2287640|NCT02118961|5617248|P1|STARTED|Overall Study||224
2287641|NCT02118896|5617276|P10|NOT COMPLETED|Overall Study||2
2287642|NCT02118896|5617277|P9|NOT COMPLETED|Overall Study||4
2287643|NCT02118896|5617278|P8|NOT COMPLETED|Overall Study||2
2287644|NCT02118896|5617279|P7|NOT COMPLETED|Overall Study||2
2287645|NCT02118896|5617280|P6|NOT COMPLETED|Overall Study||28
2287646|NCT02118896|5617281|P5|NOT COMPLETED|Overall Study||17
2287647|NCT02118896|5617282|P4|NOT COMPLETED|Overall Study||24
2287648|NCT02118896|5617283|P3|NOT COMPLETED|Overall Study||14
2287649|NCT02118896|5617284|P2|NOT COMPLETED|Overall Study||15
2287650|NCT02118896|5617285|P1|NOT COMPLETED|Overall Study||17
2287651|NCT02118896|5617276|P10|COMPLETED|Overall Study||7
2287652|NCT02118896|5617277|P9|COMPLETED|Overall Study||84
2287653|NCT02118896|5617278|P8|COMPLETED|Overall Study||105
2287654|NCT02118896|5617279|P7|COMPLETED|Overall Study||83
2287655|NCT02118896|5617280|P6|COMPLETED|Overall Study||163
2287656|NCT02118896|5617281|P5|COMPLETED|Overall Study||113
2287657|NCT02118896|5617282|P4|COMPLETED|Overall Study||55
2287658|NCT02118896|5617283|P3|COMPLETED|Overall Study||53
2287659|NCT02118896|5617284|P2|COMPLETED|Overall Study||32
2287660|NCT02118896|5617285|P1|COMPLETED|Overall Study||30
2287661|NCT02118896|5617276|P10|STARTED|Overall Study||9
2287662|NCT02118896|5617277|P9|STARTED|Overall Study||88
2287663|NCT02118896|5617278|P8|STARTED|Overall Study||107
2287664|NCT02118896|5617279|P7|STARTED|Overall Study||85
2287665|NCT02118896|5617280|P6|STARTED|Overall Study||191
2287666|NCT02118896|5617281|P5|STARTED|Overall Study||130
2287667|NCT02118896|5617282|P4|STARTED|Overall Study||79
2287668|NCT02118896|5617283|P3|STARTED|Overall Study||67
2287669|NCT02118896|5617284|P2|STARTED|Overall Study||47
2287670|NCT02118896|5617285|P1|STARTED|Overall Study||47
2287671|NCT02118831|5617360|P3|NOT COMPLETED|Overall Study||0
2287672|NCT02118831|5617361|P2|NOT COMPLETED|Overall Study||0
2287673|NCT02118831|5617362|P1|NOT COMPLETED|Overall Study||0
2287674|NCT02118831|5617360|P3|COMPLETED|Overall Study||20
2287675|NCT02118831|5617361|P2|COMPLETED|Overall Study||15
2287676|NCT02118831|5617362|P1|COMPLETED|Overall Study||21
2287677|NCT02118831|5617360|P3|STARTED|Overall Study||20
2287678|NCT02118831|5617361|P2|STARTED|Overall Study||15
2287679|NCT02118831|5617362|P1|STARTED|Overall Study||21
2287680|NCT02118792|5617375|P2|NOT COMPLETED|Overall Study||37
2287681|NCT02118792|5617376|P1|NOT COMPLETED|Overall Study||31
2287682|NCT02118792|5617375|P2|COMPLETED|Overall Study||213
2287683|NCT02118792|5617376|P1|COMPLETED|Overall Study||483
2287684|NCT02118792|5617375|P2|Treated|Overall Study||250
2287685|NCT02118792|5617376|P1|Treated|Overall Study||513
2287686|NCT02118792|5617375|P2|STARTED|Overall Study||250
2287687|NCT02118792|5617376|P1|STARTED|Overall Study||514
2287688|NCT02118766|5617418|P2|NOT COMPLETED|Overall Study||31
2287689|NCT02118766|5617419|P1|NOT COMPLETED|Overall Study||30
2287690|NCT02118766|5617418|P2|COMPLETED|Overall Study||225
2287691|NCT02118766|5617419|P1|COMPLETED|Overall Study||477
2287692|NCT02118766|5617418|P2|Treated|Overall Study||256
2287693|NCT02118766|5617419|P1|Treated|Overall Study||503
2287694|NCT02118766|5617418|P2|STARTED|Overall Study||256
2287695|NCT02118766|5617419|P1|STARTED|Overall Study||507
2287696|NCT02118714|5617441|P1|NOT COMPLETED|Overall Study||3
2287697|NCT02118714|5617441|P1|COMPLETED|Overall Study||17
2287698|NCT02118714|5617441|P1|STARTED|Overall Study||20
2287699|NCT02118597|5617455|P1|NOT COMPLETED|Overall Study||16
2287700|NCT02118597|5617455|P1|COMPLETED|Overall Study||3
2287701|NCT02118597|5617455|P1|STARTED|Overall Study||19
2287702|NCT02118441|5617471|P2|NOT COMPLETED|Overall Study||1
2287703|NCT02118441|5617472|P1|NOT COMPLETED|Overall Study||3
2287704|NCT02118441|5617471|P2|COMPLETED|Overall Study||63
2287705|NCT02118441|5617472|P1|COMPLETED|Overall Study||62
2287706|NCT02118441|5617471|P2|STARTED|Overall Study||64
2287707|NCT02118441|5617472|P1|STARTED|Overall Study||65
2287708|NCT02118428|5617486|P3|NOT COMPLETED|Overall Study||1
2287709|NCT02118428|5617487|P2|NOT COMPLETED|Overall Study||9
2287710|NCT02118428|5617488|P1|NOT COMPLETED|Overall Study||13
2287711|NCT02118428|5617486|P3|COMPLETED|Overall Study||0
2287712|NCT02118428|5617487|P2|COMPLETED|Overall Study||104
2287713|NCT02118428|5617488|P1|COMPLETED|Overall Study||100
2287714|NCT02118428|5617486|P3|Received Study Transfusion|Overall Study||0
2287715|NCT02118428|5617487|P2|Received Study Transfusion|Overall Study||112
2287716|NCT02118428|5617488|P1|Received Study Transfusion|Overall Study||111
2287717|NCT02118428|5617486|P3|STARTED|Overall Study||1
2287718|NCT02118428|5617487|P2|STARTED|Overall Study||113
2287719|NCT02118428|5617488|P1|STARTED|Overall Study||113
2287720|NCT02117999|5617528|P2|NOT COMPLETED|Overall Study||0
2287721|NCT02117999|5617529|P1|NOT COMPLETED|Overall Study||0
2287722|NCT02117999|5617528|P2|COMPLETED|Overall Study||10
2287723|NCT02117999|5617529|P1|COMPLETED|Overall Study||20
2287724|NCT02117999|5617528|P2|Mean Kmax Change in Corneal Topography|Overall Study||10
2287725|NCT02117999|5617529|P1|Mean Kmax Change in Corneal Topography|Overall Study||20
2287726|NCT02117999|5617528|P2|STARTED|Overall Study||10
2287727|NCT02117999|5617529|P1|STARTED|Overall Study||20
2287728|NCT02117934|5617547|P2|NOT COMPLETED|Overall Study||215
2287729|NCT02117934|5617548|P1|NOT COMPLETED|Overall Study||500
2287730|NCT02117934|5617547|P2|COMPLETED|Overall Study||2567
2287731|NCT02117934|5617548|P1|COMPLETED|Overall Study||5092
2287732|NCT02117934|5617547|P2|STARTED|Overall Study||2782
2287733|NCT02117934|5617548|P1|STARTED|Overall Study||5592
2287734|NCT02117687|5617558|P2|NOT COMPLETED|Overall Study||4
2287735|NCT02117687|5617559|P1|NOT COMPLETED|Overall Study||1
2287736|NCT02117687|5617558|P2|COMPLETED|Overall Study||36
2287737|NCT02117687|5617559|P1|COMPLETED|Overall Study||39
2287738|NCT02117687|5617558|P2|STARTED|Overall Study||40
2287739|NCT02117687|5617559|P1|STARTED|Overall Study||40
2287740|NCT02117648|5617591|P1|NOT COMPLETED|Abemaciclib Safety-Extension Phase||20
2287741|NCT02117648|5617591|P1|COMPLETED|Abemaciclib Safety-Extension Phase||0
2287742|NCT02117648|5617591|P1|STARTED|Abemaciclib Safety-Extension Phase||20
2287743|NCT02117648|5617591|P1|NOT COMPLETED|Abemaciclib + Clarithromycin Period 2||4
2287744|NCT02117648|5617591|P1|COMPLETED|Abemaciclib + Clarithromycin Period 2||20
2287745|NCT02117648|5617591|P1|Received at Least 1 Dose of Study Drug|Abemaciclib + Clarithromycin Period 2||21
2287746|NCT02117648|5617591|P1|STARTED|Abemaciclib + Clarithromycin Period 2||24
2287747|NCT02117648|5617591|P1|NOT COMPLETED|Abemaciclib Alone Period 1||2
2287748|NCT02117648|5617591|P1|COMPLETED|Abemaciclib Alone Period 1||24
2287749|NCT02117648|5617591|P1|Received at Least 1 Dose of Study Drug|Abemaciclib Alone Period 1||26
2287750|NCT02117648|5617591|P1|STARTED|Abemaciclib Alone Period 1||26
2287751|NCT02117570|5617604|P3|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||6
2287752|NCT02117570|5617605|P2|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||3
2287753|NCT02117570|5617606|P1|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||1
2287754|NCT02117570|5617604|P3|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||54
2287755|NCT02117570|5617605|P2|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||59
2287756|NCT02117570|5617606|P1|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||20
2287757|NCT02117570|5617604|P3|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
2287758|NCT02117570|5617605|P2|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
2287759|NCT02117570|5617606|P1|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||4
2287760|NCT02117570|5617604|P3|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||50
2287761|NCT02117570|5617605|P2|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||53
2287762|NCT02117570|5617606|P1|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||17
2287763|NCT02117570|5617604|P3|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||60
2287764|NCT02117570|5617605|P2|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||61
2287765|NCT02117570|5617606|P1|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||21
2287766|NCT02117570|5617604|P3|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|60
2287767|NCT02117570|5617605|P2|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|62
2287768|NCT02117570|5617606|P1|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|21
2287769|NCT02117570|5617604|P3|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
2287770|NCT02117570|5617605|P2|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||3
2287771|NCT02117570|5617606|P1|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
2287772|NCT02117570|5617604|P3|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||17
2287773|NCT02117570|5617605|P2|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||15
2287774|NCT02117570|5617606|P1|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||5
2287775|NCT02117570|5617604|P3|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||18
2287776|NCT02117570|5617605|P2|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||17
2287777|NCT02117570|5617606|P1|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||6
2287778|NCT02117570|5617604|P3|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
2287779|NCT02117570|5617605|P2|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
2287780|NCT02117570|5617606|P1|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||6
2287781|NCT02117570|5617604|P3|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
2287782|NCT02117570|5617605|P2|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
2287783|NCT02117570|5617606|P1|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||6
2287784|NCT02117570|5617604|P3|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
2287785|NCT02117570|5617605|P2|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
2287786|NCT02117570|5617606|P1|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|6
2287787|NCT02117544|5617656|P2|NOT COMPLETED|Period 2||0
2287788|NCT02117544|5617657|P1|NOT COMPLETED|Period 2||0
2287789|NCT02117544|5617656|P2|COMPLETED|Period 2||55
2287790|NCT02117544|5617657|P1|COMPLETED|Period 2||52
2287791|NCT02117544|5617656|P2|STARTED|Period 2||55
2287792|NCT02117544|5617657|P1|STARTED|Period 2||52
2287793|NCT02117544|5617656|P2|NOT COMPLETED|Period 1||0
2287794|NCT02117544|5617657|P1|NOT COMPLETED|Period 1||2
2287795|NCT02117544|5617656|P2|COMPLETED|Period 1||55
2287796|NCT02117544|5617657|P1|COMPLETED|Period 1||52
2287797|NCT02117544|5617656|P2|Treated|Period 1||55
2287798|NCT02117544|5617657|P1|Treated|Period 1||52
2287799|NCT02117544|5617656|P2|STARTED|Period 1||55
2287800|NCT02117544|5617657|P1|STARTED|Period 1||54
2287801|NCT02117479|5617672|P2|NOT COMPLETED|Overall Study||156
2287802|NCT02117479|5617673|P1|NOT COMPLETED|Overall Study||156
2287803|NCT02117479|5617672|P2|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|4
2287804|NCT02117479|5617673|P1|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|5
2287805|NCT02117479|5617672|P2|STARTED|Overall Study||160
2287806|NCT02117479|5617673|P1|STARTED|Overall Study||161
2287807|NCT02117427|5617692|P3|NOT COMPLETED|Overall Study||0
2287808|NCT02117427|5617693|P2|NOT COMPLETED|Overall Study||5
2287809|NCT02117427|5617694|P1|NOT COMPLETED|Overall Study||5
2287810|NCT02117427|5617692|P3|COMPLETED|Overall Study||0
2287811|NCT02117427|5617693|P2|COMPLETED|Overall Study||0
2287812|NCT02117427|5617694|P1|COMPLETED|Overall Study||1
2287813|NCT02117427|5617692|P3|Long Term Safety Follow-up|Overall Study||0
2287814|NCT02117427|5617693|P2|Long Term Safety Follow-up|Overall Study||0
2287815|NCT02117427|5617694|P1|Long Term Safety Follow-up|Overall Study||1
2287816|NCT02117427|5617692|P3|Safety Follow-up|Overall Study||0
2287817|NCT02117427|5617693|P2|Safety Follow-up|Overall Study||0
2287818|NCT02117427|5617694|P1|Safety Follow-up|Overall Study||1
2287819|NCT02117427|5617692|P3|Implantation & Efficacy|Overall Study||0
2287820|NCT02117427|5617693|P2|Implantation & Efficacy|Overall Study||4
2287821|NCT02117427|5617694|P1|Implantation & Efficacy|Overall Study||6
2287822|NCT02117427|5617692|P3|Run in Phase & Harvest|Overall Study||0
2287823|NCT02117427|5617693|P2|Run in Phase & Harvest|Overall Study||4
2287824|NCT02117427|5617694|P1|Run in Phase & Harvest|Overall Study||6
2287825|NCT02117427|5617692|P3|STARTED|Overall Study||0
2287826|NCT02117427|5617693|P2|STARTED|Overall Study||5
2287827|NCT02117427|5617694|P1|STARTED|Overall Study||6
2287828|NCT02117414|5617704|P2|NOT COMPLETED|Overall Study||6
2287829|NCT02117414|5617705|P1|NOT COMPLETED|Overall Study||15
2287830|NCT02117414|5617704|P2|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the Control group.|82
2287831|NCT02117414|5617705|P1|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the MRI group.|160
2287832|NCT02117414|5617704|P2|STARTED|Overall Study|Subjects randomized to the Control group.|88
2287833|NCT02117414|5617705|P1|STARTED|Overall Study|Subjects randomized to the MRI group.|175
2287834|NCT02117349|5617725|P2|NOT COMPLETED|Overall Study||1
2287835|NCT02117349|5617726|P1|NOT COMPLETED|Overall Study||3
2287836|NCT02117349|5617725|P2|COMPLETED|Overall Study||17
2287837|NCT02117349|5617726|P1|COMPLETED|Overall Study||34
2287838|NCT02117349|5617725|P2|Modified Intent-to-treat (mITT)|Overall Study||18
2287839|NCT02117349|5617726|P1|Modified Intent-to-treat (mITT)|Overall Study||36
2287840|NCT02117349|5617725|P2|Safety Population|Overall Study||18
2287841|NCT02117349|5617726|P1|Safety Population|Overall Study||36
2287842|NCT02117349|5617725|P2|Intent-to-treat Population|Overall Study||18
2287843|NCT02117349|5617726|P1|Intent-to-treat Population|Overall Study||37
2287844|NCT02117349|5617725|P2|STARTED|Overall Study||18
2287845|NCT02117349|5617726|P1|STARTED|Overall Study||37
2287846|NCT02117310|5617736|P1|NOT COMPLETED|Overall Study||0
2287847|NCT02117310|5617736|P1|COMPLETED|Overall Study||5
2287848|NCT02117310|5617736|P1|STARTED|Overall Study||5
2287849|NCT02117193|5617740|P1|NOT COMPLETED|Overall Study||0
2287850|NCT02117193|5617740|P1|COMPLETED|Overall Study||10
2287851|NCT02117193|5617740|P1|Placebo Intake + Sleep Deprivation|Overall Study||10
2287852|NCT02117193|5617740|P1|Alcohol Intake + Sleep Deprivation|Overall Study||10
2287853|NCT02117193|5617740|P1|Placebo Intake + Normal Sleep|Overall Study||10
2287854|NCT02117193|5617740|P1|Alcohol Intake + Normal Sleep|Overall Study||10
2287855|NCT02117193|5617740|P1|STARTED|Overall Study||10
2287856|NCT02117050|5617762|P1|NOT COMPLETED|Overall Study||1
2287857|NCT02117050|5617762|P1|COMPLETED|Overall Study||0
2287858|NCT02117050|5617762|P1|STARTED|Overall Study||1
2287859|NCT02117024|5617776|P2|NOT COMPLETED|Overall Study||20
2287860|NCT02117024|5617777|P1|NOT COMPLETED|Overall Study||44
2287861|NCT02117024|5617776|P2|COMPLETED|Overall Study||1
2287862|NCT02117024|5617777|P1|COMPLETED|Overall Study||1
2287863|NCT02117024|5617776|P2|STARTED|Overall Study||21
2287864|NCT02117024|5617777|P1|STARTED|Overall Study||45
2287865|NCT02116972|5617804|P3|NOT COMPLETED|Overall Study||19
2287866|NCT02116972|5617805|P2|NOT COMPLETED|Overall Study||17
2287867|NCT02116972|5617806|P1|NOT COMPLETED|Overall Study||19
2287868|NCT02116972|5617804|P3|COMPLETED|Overall Study||85
2287869|NCT02116972|5617805|P2|COMPLETED|Overall Study||87
2287870|NCT02116972|5617806|P1|COMPLETED|Overall Study||83
2287871|NCT02116972|5617804|P3|STARTED|Overall Study||104
2287872|NCT02116972|5617805|P2|STARTED|Overall Study||104
2287873|NCT02116972|5617806|P1|STARTED|Overall Study||102
2287874|NCT02116803|5617838|P2|NOT COMPLETED|Overall Study||2
2287875|NCT02116803|5617839|P1|NOT COMPLETED|Overall Study||10
2287876|NCT02116803|5617838|P2|COMPLETED|Overall Study||0
2287877|NCT02116803|5617839|P1|COMPLETED|Overall Study||0
2287878|NCT02116803|5617838|P2|STARTED|Overall Study||2
2287879|NCT02116803|5617839|P1|STARTED|Overall Study||10
2287880|NCT02116660|5617847|P2|NOT COMPLETED|Overall Study||4
2287881|NCT02116660|5617848|P1|NOT COMPLETED|Overall Study||2
2287882|NCT02116660|5617847|P2|COMPLETED|Overall Study||1
2287883|NCT02116660|5617848|P1|COMPLETED|Overall Study||4
2287884|NCT02116660|5617847|P2|STARTED|Overall Study||5
2287885|NCT02116660|5617848|P1|STARTED|Overall Study||6
2287886|NCT02116621|5617892|P2|NOT COMPLETED|Twelve Month Follow-up||12
2287887|NCT02116621|5617893|P1|NOT COMPLETED|Twelve Month Follow-up||16
2287888|NCT02116621|5617892|P2|COMPLETED|Twelve Month Follow-up||86
2287889|NCT02116621|5617893|P1|COMPLETED|Twelve Month Follow-up||84
2287890|NCT02116621|5617892|P2|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|98
2287891|NCT02116621|5617893|P1|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|100
2287892|NCT02116621|5617892|P2|NOT COMPLETED|Six Month Follow-up||3
2287893|NCT02116621|5617893|P1|NOT COMPLETED|Six Month Follow-up||4
2287894|NCT02116621|5617892|P2|COMPLETED|Six Month Follow-up||97
2287895|NCT02116621|5617893|P1|COMPLETED|Six Month Follow-up||99
2287896|NCT02116621|5617892|P2|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up|100
2287897|NCT02116621|5617893|P1|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up.|103
2287898|NCT02116621|5617892|P2|NOT COMPLETED|Three Month Follow-up||7
2287899|NCT02116621|5617893|P1|NOT COMPLETED|Three Month Follow-up||19
2287900|NCT02116621|5617892|P2|COMPLETED|Three Month Follow-up||96
2287901|NCT02116621|5617893|P1|COMPLETED|Three Month Follow-up||89
2287902|NCT02116621|5617892|P2|STARTED|Three Month Follow-up||103
2287903|NCT02116621|5617893|P1|STARTED|Three Month Follow-up||108
2287904|NCT02116621|5617892|P2|NOT COMPLETED|Baseline||4
2287905|NCT02116621|5617893|P1|NOT COMPLETED|Baseline||0
2287906|NCT02116621|5617892|P2|COMPLETED|Baseline||103
2287907|NCT02116621|5617893|P1|COMPLETED|Baseline||108
2287908|NCT02116621|5617892|P2|Completed Intervention Period|Baseline||103
2287909|NCT02116621|5617893|P1|Completed Intervention Period|Baseline||95
2287910|NCT02116621|5617892|P2|Completed Baseline Visit|Baseline||103
2287911|NCT02116621|5617893|P1|Completed Baseline Visit|Baseline||108
2287912|NCT02116621|5617892|P2|STARTED|Baseline||107
2287913|NCT02116621|5617893|P1|STARTED|Baseline||108
2287914|NCT02116582|5617981|P1|NOT COMPLETED|Overall Study||215
2287915|NCT02116582|5617981|P1|COMPLETED|Overall Study||0
2287916|NCT02116582|5617981|P1|Treated|Overall Study||214
2287917|NCT02116582|5617981|P1|STARTED|Overall Study||215
2287918|NCT02116530|5617991|P2|NOT COMPLETED|Overall Study||4
2287919|NCT02116530|5617992|P1|NOT COMPLETED|Overall Study||9
2287920|NCT02116530|5617991|P2|COMPLETED|Overall Study||184
2287921|NCT02116530|5617992|P1|COMPLETED|Overall Study||183
2287922|NCT02116530|5617991|P2|STARTED|Overall Study||188
2287923|NCT02116530|5617992|P1|STARTED|Overall Study||192
2287924|NCT02116361|5618010|P4|NOT COMPLETED|Overall Study||31
2287925|NCT02116361|5618011|P3|NOT COMPLETED|Overall Study||26
2287926|NCT02116361|5618012|P2|NOT COMPLETED|Overall Study||31
2287927|NCT02116361|5618013|P1|NOT COMPLETED|Overall Study||31
2287928|NCT02116361|5618010|P4|COMPLETED|Overall Study||34
2287929|NCT02116361|5618011|P3|COMPLETED|Overall Study||33
2287930|NCT02116361|5618012|P2|COMPLETED|Overall Study||34
2287931|NCT02116361|5618013|P1|COMPLETED|Overall Study||38
2287932|NCT02116361|5618010|P4|STARTED|Overall Study||65
2287933|NCT02116361|5618011|P3|STARTED|Overall Study||59
2287934|NCT02116361|5618012|P2|STARTED|Overall Study||65
2287935|NCT02116361|5618013|P1|STARTED|Overall Study||69
2287936|NCT02116322|5618043|P1|NOT COMPLETED|Overall Study||0
2287937|NCT02116322|5618043|P1|COMPLETED|Overall Study||1
2287938|NCT02116322|5618043|P1|STARTED|Overall Study||1
2287939|NCT02116309|5618050|P2|NOT COMPLETED|Overall Study||1
2287940|NCT02116309|5618051|P1|NOT COMPLETED|Overall Study||0
2287941|NCT02116309|5618050|P2|COMPLETED|Overall Study||477
2287942|NCT02116309|5618051|P1|COMPLETED|Overall Study||482
2287943|NCT02116309|5618050|P2|STARTED|Overall Study||478
2287944|NCT02116309|5618051|P1|STARTED|Overall Study||482
2287945|NCT02115984|5618061|P2|NOT COMPLETED|Overall Study||7
2287946|NCT02115984|5618062|P1|NOT COMPLETED|Overall Study||6
2287947|NCT02115984|5618061|P2|COMPLETED|Overall Study||16
2287948|NCT02115984|5618062|P1|COMPLETED|Overall Study||51
2287949|NCT02115984|5618061|P2|STARTED|Overall Study||23
2287950|NCT02115984|5618062|P1|STARTED|Overall Study||57
2287951|NCT02115828|5618068|P1|NOT COMPLETED|Overall Study||0
2287952|NCT02115828|5618068|P1|COMPLETED|Overall Study||9
2287953|NCT02115828|5618068|P1|STARTED|Overall Study||9
2287954|NCT02115815|5618083|P7|NOT COMPLETED|Overall Study||0
2287955|NCT02115815|5618084|P6|NOT COMPLETED|Overall Study||2
2287956|NCT02115815|5618085|P5|NOT COMPLETED|Overall Study||0
2287957|NCT02115815|5618086|P4|NOT COMPLETED|Overall Study||0
2287958|NCT02115815|5618087|P3|NOT COMPLETED|Overall Study||0
2287959|NCT02115815|5618088|P2|NOT COMPLETED|Overall Study||0
2287960|NCT02115815|5618089|P1|NOT COMPLETED|Overall Study||2
2287961|NCT02115815|5618083|P7|COMPLETED|Overall Study||20
2287962|NCT02115815|5618084|P6|COMPLETED|Overall Study||20
2287963|NCT02115815|5618085|P5|COMPLETED|Overall Study||20
2287964|NCT02115815|5618086|P4|COMPLETED|Overall Study||20
2287965|NCT02115815|5618087|P3|COMPLETED|Overall Study||20
2287966|NCT02115815|5618088|P2|COMPLETED|Overall Study||20
2287967|NCT02115815|5618089|P1|COMPLETED|Overall Study||22
2287968|NCT02115815|5618083|P7|STARTED|Overall Study||20
2287969|NCT02115815|5618084|P6|STARTED|Overall Study||22
2287970|NCT02115815|5618085|P5|STARTED|Overall Study||20
2287971|NCT02115815|5618086|P4|STARTED|Overall Study||20
2287972|NCT02115815|5618087|P3|STARTED|Overall Study||20
2287973|NCT02115815|5618088|P2|STARTED|Overall Study||20
2287974|NCT02115815|5618089|P1|STARTED|Overall Study||24
2287975|NCT02115750|5618184|P2|NOT COMPLETED|Part 2: All Subjects Receive CHS-0214||12
2287976|NCT02115750|5618185|P1|NOT COMPLETED|Part 2: All Subjects Receive CHS-0214||11
2287977|NCT02115750|5618184|P2|COMPLETED|Part 2: All Subjects Receive CHS-0214||272
2287978|NCT02115750|5618185|P1|COMPLETED|Part 2: All Subjects Receive CHS-0214||269
2287979|NCT02115750|5618184|P2|STARTED|Part 2: All Subjects Receive CHS-0214||284
2287980|NCT02115750|5618185|P1|STARTED|Part 2: All Subjects Receive CHS-0214||280
2287981|NCT02115750|5618184|P2|NOT COMPLETED|Part 1||12
2287982|NCT02115750|5618185|P1|NOT COMPLETED|Part 1||22
2287983|NCT02115750|5618184|P2|COMPLETED|Part 1||312
2287984|NCT02115750|5618185|P1|COMPLETED|Part 1||301
2287985|NCT02115750|5618184|P2|STARTED|Part 1||324
2287986|NCT02115750|5618185|P1|STARTED|Part 1||323
2287987|NCT02115646|5618203|P1|NOT COMPLETED|Overall Study||7
2287988|NCT02115646|5618203|P1|COMPLETED|Overall Study||22
2287989|NCT02115646|5618203|P1|STARTED|Overall Study||29
2287990|NCT02115633|5618218|P2|NOT COMPLETED|Overall Study||0
2287991|NCT02115633|5618219|P1|NOT COMPLETED|Overall Study||0
2287992|NCT02115633|5618218|P2|COMPLETED|Overall Study||16
2287993|NCT02115633|5618219|P1|COMPLETED|Overall Study||15
2287994|NCT02115633|5618218|P2|STARTED|Overall Study||16
2287995|NCT02115633|5618219|P1|STARTED|Overall Study||15
2287996|NCT02115607|5618231|P1|NOT COMPLETED|Overall Study||1
2287997|NCT02115607|5618231|P1|COMPLETED|Overall Study||16
2287998|NCT02115607|5618231|P1|STARTED|Overall Study||17
2287999|NCT02115581|5618240|P2|NOT COMPLETED|Overall Study||0
2288000|NCT02115581|5618241|P1|NOT COMPLETED|Overall Study||0
2288001|NCT02115581|5618240|P2|COMPLETED|Overall Study||21
2288002|NCT02115581|5618241|P1|COMPLETED|Overall Study||17
2288003|NCT02115581|5618240|P2|STARTED|Overall Study||21
2288004|NCT02115581|5618241|P1|STARTED|Overall Study||17
2288005|NCT02115542|5618251|P1|NOT COMPLETED|Overall Study||0
2288006|NCT02115542|5618251|P1|COMPLETED|Overall Study||39
2288007|NCT02115542|5618251|P1|STARTED|Overall Study||39
2288008|NCT02115386|5618257|P1|NOT COMPLETED|Overall Study||7
2288009|NCT02115386|5618257|P1|COMPLETED|Overall Study||0
2288010|NCT02115386|5618257|P1|STARTED|Overall Study||7
2288011|NCT02115373|5618270|P3|NOT COMPLETED|Overall Study||0
2288012|NCT02115373|5618271|P2|NOT COMPLETED|Overall Study||0
2288013|NCT02115373|5618272|P1|NOT COMPLETED|Overall Study||0
2288014|NCT02115373|5618270|P3|COMPLETED|Overall Study||49
2288015|NCT02115373|5618271|P2|COMPLETED|Overall Study||13
2288016|NCT02115373|5618272|P1|COMPLETED|Overall Study||4
2288017|NCT02115373|5618270|P3|STARTED|Overall Study||49
2288018|NCT02115373|5618271|P2|STARTED|Overall Study||13
2288019|NCT02115373|5618272|P1|STARTED|Overall Study||4
2288020|NCT02115347|5618338|P3|NOT COMPLETED|Overall Study||0
2288021|NCT02115347|5618339|P2|NOT COMPLETED|Overall Study||0
2288022|NCT02115347|5618340|P1|NOT COMPLETED|Overall Study||0
2288023|NCT02115347|5618338|P3|COMPLETED|Overall Study||0
2288024|NCT02115347|5618339|P2|COMPLETED|Overall Study||8
2288025|NCT02115347|5618340|P1|COMPLETED|Overall Study||8
2288026|NCT02115347|5618338|P3|STARTED|Overall Study||0
2288027|NCT02115347|5618339|P2|STARTED|Overall Study||8
2288028|NCT02115347|5618340|P1|STARTED|Overall Study||8
2288029|NCT02115321|5618360|P2|NOT COMPLETED|Overall Study||0
2288030|NCT02115321|5618361|P1|NOT COMPLETED|Overall Study||1
2288031|NCT02115321|5618360|P2|COMPLETED|Overall Study||10
2288032|NCT02115321|5618361|P1|COMPLETED|Overall Study||29
2288033|NCT02115321|5618360|P2|STARTED|Overall Study||10
2288034|NCT02115321|5618361|P1|STARTED|Overall Study||30
2288035|NCT02115308|5618383|P2|NOT COMPLETED|Overall Study||2
2288036|NCT02115308|5618384|P1|NOT COMPLETED|Overall Study||2
2288037|NCT02115308|5618383|P2|COMPLETED|Overall Study|Number of subjects recruited to the CAD group meeting all inclusion criteria.|23
2288038|NCT02115308|5618384|P1|COMPLETED|Overall Study|Number of subjects recruited to the Control group meeting all inclusion criteria.|13
2288039|NCT02115308|5618383|P2|STARTED|Overall Study|Number of subjects recruited for the CAD group.|25
2288040|NCT02115308|5618384|P1|STARTED|Overall Study|Number of subjects recruited for the CONTROL group.|15
2288041|NCT02115269|5618400|P1|NOT COMPLETED|Overall Study||57
2288042|NCT02115269|5618400|P1|COMPLETED|Overall Study||702
2288043|NCT02115269|5618400|P1|STARTED|Overall Study||759
2288044|NCT02115256|5618420|P2|NOT COMPLETED|Overall Study||1
2288045|NCT02115256|5618421|P1|NOT COMPLETED|Overall Study||0
2288046|NCT02115256|5618420|P2|COMPLETED|Overall Study||2
2288047|NCT02115256|5618421|P1|COMPLETED|Overall Study||3
2288048|NCT02115256|5618420|P2|STARTED|Overall Study||3
2288049|NCT02115256|5618421|P1|STARTED|Overall Study||3
2288050|NCT02115113|5618433|P3|NOT COMPLETED|Participants Randomized||0
2288051|NCT02115113|5618434|P2|NOT COMPLETED|Participants Randomized||0
2288052|NCT02115113|5618435|P1|NOT COMPLETED|Participants Randomized||2
2288053|NCT02115113|5618433|P3|COMPLETED|Participants Randomized||0
2288054|NCT02115113|5618434|P2|COMPLETED|Participants Randomized||26
2288055|NCT02115113|5618435|P1|COMPLETED|Participants Randomized||22
2288056|NCT02115113|5618433|P3|STARTED|Participants Randomized||0
2288057|NCT02115113|5618434|P2|STARTED|Participants Randomized||26
2288058|NCT02115113|5618435|P1|STARTED|Participants Randomized||24
2288059|NCT02115113|5618433|P3|NOT COMPLETED|Participants in Run-in Period||10
2288060|NCT02115113|5618434|P2|NOT COMPLETED|Participants in Run-in Period||0
2288061|NCT02115113|5618435|P1|NOT COMPLETED|Participants in Run-in Period||0
2288062|NCT02115113|5618433|P3|COMPLETED|Participants in Run-in Period||68
2288063|NCT02115113|5618434|P2|COMPLETED|Participants in Run-in Period||0
2288064|NCT02115113|5618435|P1|COMPLETED|Participants in Run-in Period||0
2288065|NCT02115113|5618433|P3|STARTED|Participants in Run-in Period||78
2288066|NCT02115113|5618434|P2|STARTED|Participants in Run-in Period||0
2288067|NCT02115113|5618435|P1|STARTED|Participants in Run-in Period||0
2288068|NCT02115048|5618450|P2|NOT COMPLETED|Overall Study||0
2288069|NCT02115048|5618451|P1|NOT COMPLETED|Overall Study||0
2288070|NCT02115048|5618450|P2|COMPLETED|Overall Study||21
2288071|NCT02115048|5618451|P1|COMPLETED|Overall Study||23
2288072|NCT02115048|5618450|P2|STARTED|Overall Study||21
2288073|NCT02115048|5618451|P1|STARTED|Overall Study||23
2288074|NCT02114931|5618467|P2|NOT COMPLETED|Overall Study||30
2288075|NCT02114931|5618468|P1|NOT COMPLETED|Overall Study||25
2288076|NCT02114931|5618467|P2|COMPLETED|Overall Study||207
2288077|NCT02114931|5618468|P1|COMPLETED|Overall Study||205
2288078|NCT02114931|5618467|P2|Received Treatment|Overall Study||237
2288079|NCT02114931|5618468|P1|Received Treatment|Overall Study|One participant was enrolled in error and did not receive treatment in the extension study|229
2288080|NCT02114931|5618467|P2|STARTED|Overall Study||237
2288081|NCT02114931|5618468|P1|STARTED|Overall Study||230
2288082|NCT02114892|5618484|P2|NOT COMPLETED|Overall Study||2
2288083|NCT02114892|5618485|P1|NOT COMPLETED|Overall Study||1
2288084|NCT02114892|5618484|P2|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawl|10
2288085|NCT02114892|5618485|P1|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
2288086|NCT02114892|5618484|P2|STARTED|Overall Study||12
2288087|NCT02114892|5618485|P1|STARTED|Overall Study||12
2288088|NCT02114697|5618521|P2|NOT COMPLETED|Overall Study||4
2288089|NCT02114697|5618522|P1|NOT COMPLETED|Overall Study||5
2288090|NCT02114697|5618521|P2|COMPLETED|Overall Study||0
2288091|NCT02114697|5618522|P1|COMPLETED|Overall Study||0
2288092|NCT02114697|5618521|P2|Completed Month 18 Visit|Overall Study||1
2288093|NCT02114697|5618522|P1|Completed Month 18 Visit|Overall Study||0
2288094|NCT02114697|5618521|P2|STARTED|Overall Study||4
2288095|NCT02114697|5618522|P1|STARTED|Overall Study||5
2288096|NCT02114684|5618530|P2|NOT COMPLETED|Overall Study||10
2288097|NCT02114684|5618531|P1|NOT COMPLETED|Overall Study||12
2288098|NCT02114684|5618530|P2|COMPLETED|Overall Study||88
2288099|NCT02114684|5618531|P1|COMPLETED|Overall Study||86
2288100|NCT02114684|5618530|P2|STARTED|Overall Study||98
2288101|NCT02114684|5618531|P1|STARTED|Overall Study||98
2288102|NCT02114515|5618549|P2|NOT COMPLETED|Overall Study||150
2288103|NCT02114515|5618550|P1|NOT COMPLETED|Overall Study||133
2288104|NCT02114515|5618549|P2|COMPLETED|Overall Study||368
2288105|NCT02114515|5618550|P1|COMPLETED|Overall Study||378
2288106|NCT02114515|5618549|P2|STARTED|Overall Study||518
2288107|NCT02114515|5618550|P1|STARTED|Overall Study||511
2288108|NCT02114385|5618596|P2|NOT COMPLETED|Overall Study||8
2288109|NCT02114385|5618597|P1|NOT COMPLETED|Overall Study||3
2288110|NCT02114385|5618596|P2|COMPLETED|Overall Study||243
2288111|NCT02114385|5618597|P1|COMPLETED|Overall Study||246
2288112|NCT02114385|5618596|P2|Vaccinated|Overall Study||251
2288113|NCT02114385|5618597|P1|Vaccinated|Overall Study||249
2288114|NCT02114385|5618596|P2|STARTED|Overall Study||251
2288115|NCT02114385|5618597|P1|STARTED|Overall Study||249
2288116|NCT02114307|5618621|P2|NOT COMPLETED|Overall Study||0
2288117|NCT02114307|5618622|P1|NOT COMPLETED|Overall Study||1
2288118|NCT02114307|5618621|P2|COMPLETED|Overall Study||11
2288119|NCT02114307|5618622|P1|COMPLETED|Overall Study||10
2288120|NCT02114307|5618621|P2|STARTED|Overall Study||11
2288121|NCT02114307|5618622|P1|STARTED|Overall Study||11
2288122|NCT02114268|5618638|P6|NOT COMPLETED|Overall Study||3
2288123|NCT02114268|5618639|P5|NOT COMPLETED|Overall Study||0
2288124|NCT02114268|5618640|P4|NOT COMPLETED|Overall Study||0
2288125|NCT02114268|5618641|P3|NOT COMPLETED|Overall Study||1
2288126|NCT02114268|5618642|P2|NOT COMPLETED|Overall Study||1
2288127|NCT02114268|5618643|P1|NOT COMPLETED|Overall Study||6
2288128|NCT02114268|5618638|P6|COMPLETED|Overall Study||75
2288129|NCT02114268|5618639|P5|COMPLETED|Overall Study||6
2288130|NCT02114268|5618640|P4|COMPLETED|Overall Study||6
2288131|NCT02114268|5618641|P3|COMPLETED|Overall Study||5
2288132|NCT02114268|5618642|P2|COMPLETED|Overall Study||5
2288133|NCT02114268|5618643|P1|COMPLETED|Overall Study||28
2288134|NCT02114268|5618638|P6|STARTED|Overall Study||78
2288135|NCT02114268|5618639|P5|STARTED|Overall Study||6
2288136|NCT02114268|5618640|P4|STARTED|Overall Study||6
2288137|NCT02114268|5618641|P3|STARTED|Overall Study||6
2288138|NCT02114268|5618642|P2|STARTED|Overall Study||6
2288139|NCT02114268|5618643|P1|STARTED|Overall Study||34
2288140|NCT02114216|5618696|P3|NOT COMPLETED|Overall Study||0
2288141|NCT02114216|5618697|P2|NOT COMPLETED|Overall Study||0
2288142|NCT02114216|5618698|P1|NOT COMPLETED|Overall Study||0
2288143|NCT02114216|5618696|P3|COMPLETED|Overall Study||14
2288144|NCT02114216|5618697|P2|COMPLETED|Overall Study||45
2288145|NCT02114216|5618698|P1|COMPLETED|Overall Study||16
2288146|NCT02114216|5618696|P3|STARTED|Overall Study||14
2288147|NCT02114216|5618697|P2|STARTED|Overall Study||45
2288148|NCT02114216|5618698|P1|STARTED|Overall Study||16
2288149|NCT02114203|5618712|P3|NOT COMPLETED|Overall Study||0
2288150|NCT02114203|5618713|P2|NOT COMPLETED|Overall Study||2
2288151|NCT02114203|5618714|P1|NOT COMPLETED|Overall Study||0
2288152|NCT02114203|5618712|P3|COMPLETED|Overall Study||7
2288153|NCT02114203|5618713|P2|COMPLETED|Overall Study||14
2288154|NCT02114203|5618714|P1|COMPLETED|Overall Study||7
2288155|NCT02114203|5618712|P3|STARTED|Overall Study||7
2288156|NCT02114203|5618713|P2|STARTED|Overall Study||16
2288157|NCT02114203|5618714|P1|STARTED|Overall Study||7
2288158|NCT02114177|5618748|P2|NOT COMPLETED|Overall Study||4
2288159|NCT02114177|5618749|P1|NOT COMPLETED|Overall Study||9
2288160|NCT02114177|5618748|P2|COMPLETED|Overall Study||151
2288161|NCT02114177|5618749|P1|COMPLETED|Overall Study||146
2288162|NCT02114177|5618748|P2|STARTED|Overall Study||155
2288163|NCT02114177|5618749|P1|STARTED|Overall Study||155
2288164|NCT02114151|5618773|P1|NOT COMPLETED|Overall Study||7
2288165|NCT02114151|5618773|P1|COMPLETED|Overall Study||96
2288166|NCT02114151|5618773|P1|STARTED|Overall Study||103
2288167|NCT02113956|5618790|P2|NOT COMPLETED|3 Month Post-intervention||2
2288168|NCT02113956|5618791|P1|NOT COMPLETED|3 Month Post-intervention||4
2288169|NCT02113956|5618790|P2|COMPLETED|3 Month Post-intervention||146
2288170|NCT02113956|5618791|P1|COMPLETED|3 Month Post-intervention||137
2288171|NCT02113956|5618790|P2|STARTED|3 Month Post-intervention||148
2288172|NCT02113956|5618791|P1|STARTED|3 Month Post-intervention||141
2288173|NCT02113956|5618790|P2|NOT COMPLETED|Intervention End (5 Weeks Post Baseline)||4
2288174|NCT02113956|5618791|P1|NOT COMPLETED|Intervention End (5 Weeks Post Baseline)||9
2288175|NCT02113956|5618790|P2|COMPLETED|Intervention End (5 Weeks Post Baseline)||148
2288176|NCT02113956|5618791|P1|COMPLETED|Intervention End (5 Weeks Post Baseline)||141
2288177|NCT02113956|5618790|P2|STARTED|Intervention End (5 Weeks Post Baseline)||152
2288178|NCT02113956|5618791|P1|STARTED|Intervention End (5 Weeks Post Baseline)||150
2288179|NCT02113579|5618825|P2|NOT COMPLETED|Overall Study||4
2288180|NCT02113579|5618826|P1|NOT COMPLETED|Overall Study||10
2288181|NCT02113579|5618825|P2|COMPLETED|Overall Study||185
2288182|NCT02113579|5618826|P1|COMPLETED|Overall Study||176
2288183|NCT02113579|5618825|P2|STARTED|Overall Study||189
2288184|NCT02113579|5618826|P1|STARTED|Overall Study||186
2288185|NCT02113449|5618850|P1|NOT COMPLETED|Overall Study||4
2288186|NCT02113449|5618850|P1|COMPLETED|Overall Study||143
2288187|NCT02113449|5618850|P1|STARTED|Overall Study||147
2288188|NCT02113436|5618866|P4|NOT COMPLETED|Period 2: 16 Weeks||11
2288189|NCT02113436|5618867|P3|NOT COMPLETED|Period 2: 16 Weeks||9
2288190|NCT02113436|5618868|P2|NOT COMPLETED|Period 2: 16 Weeks||0
2288191|NCT02113436|5618869|P1|NOT COMPLETED|Period 2: 16 Weeks||0
2288192|NCT02113436|5618866|P4|COMPLETED|Period 2: 16 Weeks||136
2288193|NCT02113436|5618867|P3|COMPLETED|Period 2: 16 Weeks||132
2288194|NCT02113436|5618868|P2|COMPLETED|Period 2: 16 Weeks||0
2288195|NCT02113436|5618869|P1|COMPLETED|Period 2: 16 Weeks||0
2288196|NCT02113436|5618866|P4|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn’t transfer to TP2.|147
2288197|NCT02113436|5618867|P3|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn’t transfer to TP2.|141
2288198|NCT02113436|5618868|P2|STARTED|Period 2: 16 Weeks||0
2288199|NCT02113436|5618869|P1|STARTED|Period 2: 16 Weeks||0
2288200|NCT02113436|5618866|P4|NOT COMPLETED|Period 1: 8 Weeks||0
2288201|NCT02113436|5618867|P3|NOT COMPLETED|Period 1: 8 Weeks||0
2288202|NCT02113436|5618868|P2|NOT COMPLETED|Period 1: 8 Weeks||2
2288203|NCT02113436|5618869|P1|NOT COMPLETED|Period 1: 8 Weeks||8
2288204|NCT02113436|5618866|P4|COMPLETED|Period 1: 8 Weeks||0
2288205|NCT02113436|5618867|P3|COMPLETED|Period 1: 8 Weeks||0
2288206|NCT02113436|5618868|P2|COMPLETED|Period 1: 8 Weeks||148
2288207|NCT02113436|5618869|P1|COMPLETED|Period 1: 8 Weeks||142
2288208|NCT02113436|5618866|P4|STARTED|Period 1: 8 Weeks||0
2288209|NCT02113436|5618867|P3|STARTED|Period 1: 8 Weeks||0
2288210|NCT02113436|5618868|P2|STARTED|Period 1: 8 Weeks||150
2288211|NCT02113436|5618869|P1|STARTED|Period 1: 8 Weeks||150
2288212|NCT02113410|5618892|P2|NOT COMPLETED|Overall Study||3
2288213|NCT02113410|5618893|P1|NOT COMPLETED|Overall Study||16
2288214|NCT02113410|5618892|P2|COMPLETED|Overall Study||63
2288215|NCT02113410|5618893|P1|COMPLETED|Overall Study||49
2288216|NCT02113410|5618892|P2|STARTED|Overall Study||66
2288217|NCT02113410|5618893|P1|STARTED|Overall Study||65
2288218|NCT02113189|5618920|P3|NOT COMPLETED|Overall Study||3
2288219|NCT02113189|5618921|P2|NOT COMPLETED|Overall Study||1
2288220|NCT02113189|5618922|P1|NOT COMPLETED|Overall Study||2
2288221|NCT02113189|5618920|P3|COMPLETED|Overall Study||2
2288222|NCT02113189|5618921|P2|COMPLETED|Overall Study||3
2288223|NCT02113189|5618922|P1|COMPLETED|Overall Study||2
2288224|NCT02113189|5618920|P3|STARTED|Overall Study||5
2288225|NCT02113189|5618921|P2|STARTED|Overall Study||4
2288226|NCT02113189|5618922|P1|STARTED|Overall Study||4
2288227|NCT02113124|5618938|P2|NOT COMPLETED|Overall Study||1
2288228|NCT02113124|5618939|P1|NOT COMPLETED|Overall Study||1
2288229|NCT02113124|5618938|P2|COMPLETED|Overall Study||24
2288230|NCT02113124|5618939|P1|COMPLETED|Overall Study||17
2288231|NCT02113124|5618938|P2|STARTED|Overall Study||25
2288232|NCT02113124|5618939|P1|STARTED|Overall Study||18
2288233|NCT02113007|5618945|P1|NOT COMPLETED|Overall Study||2
2288234|NCT02113007|5618945|P1|COMPLETED|Overall Study||0
2288235|NCT02113007|5618945|P1|STARTED|Overall Study||2
2288236|NCT02112994|5618951|P3|NOT COMPLETED|Overall Study||3
2288237|NCT02112994|5618952|P2|NOT COMPLETED|Overall Study||2
2288238|NCT02112994|5618953|P1|NOT COMPLETED|Overall Study||0
2288239|NCT02112994|5618951|P3|COMPLETED|Overall Study||6
2288240|NCT02112994|5618952|P2|COMPLETED|Overall Study||14
2288241|NCT02112994|5618953|P1|COMPLETED|Overall Study||6
2288242|NCT02112994|5618951|P3|Completed 96-week Treatment Period|Overall Study||8
2288243|NCT02112994|5618952|P2|Completed 96-week Treatment Period|Overall Study||14
2288244|NCT02112994|5618953|P1|Completed 96-week Treatment Period|Overall Study||6
2288245|NCT02112994|5618951|P3|Received 3 mg/kg QW|Overall Study||1
2288246|NCT02112994|5618952|P2|Received 3 mg/kg QW|Overall Study||1
2288247|NCT02112994|5618953|P1|Received 3 mg/kg QW|Overall Study||2
2288248|NCT02112994|5618951|P3|Received 3 mg/kg QOW|Overall Study||3
2288249|NCT02112994|5618952|P2|Received 3 mg/kg QOW|Overall Study||5
2288250|NCT02112994|5618953|P1|Received 3 mg/kg QOW|Overall Study||3
2288251|NCT02112994|5618951|P3|Received 1 mg/kg QW|Overall Study||0
2288252|NCT02112994|5618952|P2|Received 1 mg/kg QW|Overall Study||1
2288253|NCT02112994|5618953|P1|Received 1 mg/kg QW|Overall Study||1
2288254|NCT02112994|5618951|P3|Received 1 mg/kg QOW|Overall Study||9
2288255|NCT02112994|5618952|P2|Received 1 mg/kg QOW|Overall Study||16
2288256|NCT02112994|5618953|P1|Received 1 mg/kg QOW|Overall Study||6
2288257|NCT02112994|5618951|P3|Received 0.35 mg/kg QOW|Overall Study||1
2288258|NCT02112994|5618952|P2|Received 0.35 mg/kg QOW|Overall Study||0
2288259|NCT02112994|5618953|P1|Received 0.35 mg/kg QOW|Overall Study||0
2288260|NCT02112994|5618951|P3|Received at Least 1 Dose of Study Drug|Overall Study||9
2288261|NCT02112994|5618952|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
2288262|NCT02112994|5618953|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
2288263|NCT02112994|5618951|P3|STARTED|Overall Study||9
2288264|NCT02112994|5618952|P2|STARTED|Overall Study||16
2288265|NCT02112994|5618953|P1|STARTED|Overall Study||6
2288266|NCT02112877|5618971|P2|NOT COMPLETED|Overall Study||13
2288267|NCT02112877|5618972|P1|NOT COMPLETED|Overall Study||2
2288268|NCT02112877|5618971|P2|COMPLETED|Overall Study||157
2288269|NCT02112877|5618972|P1|COMPLETED|Overall Study||28
2288270|NCT02112877|5618971|P2|STARTED|Overall Study||170
2288271|NCT02112877|5618972|P1|STARTED|Overall Study||30
2288272|NCT02112838|5618997|P3|NOT COMPLETED|Overall Study||1
2288273|NCT02112838|5618998|P2|NOT COMPLETED|Overall Study||2
2288274|NCT02112838|5618999|P1|NOT COMPLETED|Overall Study||5
2288275|NCT02112838|5618997|P3|COMPLETED|Overall Study||24
2288276|NCT02112838|5618998|P2|COMPLETED|Overall Study||24
2288277|NCT02112838|5618999|P1|COMPLETED|Overall Study||20
2288278|NCT02112838|5618997|P3|STARTED|Overall Study||25
2288279|NCT02112838|5618998|P2|STARTED|Overall Study||26
2288280|NCT02112838|5618999|P1|STARTED|Overall Study||25
2288281|NCT02112448|5619051|P2|NOT COMPLETED|Overall Study||10
2288282|NCT02112448|5619052|P1|NOT COMPLETED|Overall Study||8
2288283|NCT02112448|5619051|P2|COMPLETED|Overall Study||30
2288284|NCT02112448|5619052|P1|COMPLETED|Overall Study||30
2288285|NCT02112448|5619051|P2|STARTED|Overall Study||40
2288286|NCT02112448|5619052|P1|STARTED|Overall Study||38
2288287|NCT02112370|5619062|P2|NOT COMPLETED|Overall Study||0
2288288|NCT02112370|5619063|P1|NOT COMPLETED|Overall Study||0
2288289|NCT02112370|5619062|P2|COMPLETED|Overall Study||74
2288290|NCT02112370|5619063|P1|COMPLETED|Overall Study||74
2288291|NCT02112370|5619062|P2|STARTED|Overall Study||74
2288292|NCT02112370|5619063|P1|STARTED|Overall Study||74
2288293|NCT02112045|5619085|P2|NOT COMPLETED|Overall Study||0
2288294|NCT02112045|5619086|P1|NOT COMPLETED|Overall Study||1
2288295|NCT02112045|5619085|P2|COMPLETED|Overall Study||45
2288296|NCT02112045|5619086|P1|COMPLETED|Overall Study||44
2288297|NCT02112045|5619085|P2|STARTED|Overall Study||45
2288298|NCT02112045|5619086|P1|STARTED|Overall Study||45
2288299|NCT02111993|5619106|P2|NOT COMPLETED|Overall Study||4
2288300|NCT02111993|5619107|P1|NOT COMPLETED|Overall Study||5
2288301|NCT02111993|5619106|P2|COMPLETED|Overall Study||26
2288302|NCT02111993|5619107|P1|COMPLETED|Overall Study||25
2288303|NCT02111993|5619106|P2|STARTED|Overall Study||30
2288304|NCT02111993|5619107|P1|STARTED|Overall Study||30
2288305|NCT02111980|5619117|P1|NOT COMPLETED|Overall Study||0
2288306|NCT02111980|5619117|P1|COMPLETED|Overall Study||50
2288307|NCT02111980|5619117|P1|STARTED|Overall Study||50
2288308|NCT02111863|5619140|P1|NOT COMPLETED|Overall Study||0
2288309|NCT02111863|5619140|P1|COMPLETED|Overall Study||6
2288310|NCT02111863|5619140|P1|STARTED|Overall Study||6
2288311|NCT02111785|5619150|P4|NOT COMPLETED|Overall Study||0
2288312|NCT02111785|5619151|P3|NOT COMPLETED|Overall Study||0
2288313|NCT02111785|5619152|P2|NOT COMPLETED|Overall Study||1
2288314|NCT02111785|5619153|P1|NOT COMPLETED|Overall Study||0
2288315|NCT02111785|5619150|P4|COMPLETED|Overall Study||1
2288316|NCT02111785|5619151|P3|COMPLETED|Overall Study||1
2288317|NCT02111785|5619152|P2|COMPLETED|Overall Study||4
2288318|NCT02111785|5619153|P1|COMPLETED|Overall Study||3
2288319|NCT02111785|5619150|P4|STARTED|Overall Study||1
2288320|NCT02111785|5619151|P3|STARTED|Overall Study||1
2288321|NCT02111785|5619152|P2|STARTED|Overall Study||5
2288322|NCT02111785|5619153|P1|STARTED|Overall Study||3
2288323|NCT02111772|5619181|P2|NOT COMPLETED|Overall Study||0
2288324|NCT02111772|5619182|P1|NOT COMPLETED|Overall Study||0
2288325|NCT02111772|5619181|P2|COMPLETED|Overall Study||14
2288326|NCT02111772|5619182|P1|COMPLETED|Overall Study||12
2288327|NCT02111772|5619181|P2|STARTED|Overall Study||14
2288328|NCT02111772|5619182|P1|STARTED|Overall Study||12
2288329|NCT02111746|5619192|P2|NOT COMPLETED|Overall Study||2
2288330|NCT02111746|5619193|P1|NOT COMPLETED|Overall Study||3
2288331|NCT02111746|5619192|P2|COMPLETED|Overall Study||169
2288332|NCT02111746|5619193|P1|COMPLETED|Overall Study||169
2288333|NCT02111746|5619192|P2|STARTED|Overall Study||171
2288334|NCT02111746|5619193|P1|STARTED|Overall Study||172
2288335|NCT02111603|5619215|P1|NOT COMPLETED|Overall Study||1
2288336|NCT02111603|5619215|P1|COMPLETED|Overall Study||12
2288337|NCT02111603|5619215|P1|STARTED|Overall Study||13
2288338|NCT02111564|5619226|P2|NOT COMPLETED|Overall Study||143
2288339|NCT02111564|5619227|P1|NOT COMPLETED|Overall Study||131
2288340|NCT02111564|5619226|P2|COMPLETED|Overall Study||5869
2288341|NCT02111564|5619227|P1|COMPLETED|Overall Study||5876
2288342|NCT02111564|5619226|P2|Treated|Overall Study||5980
2288343|NCT02111564|5619227|P1|Treated|Overall Study||5982
2288344|NCT02111564|5619226|P2|STARTED|Overall Study||6012
2288345|NCT02111564|5619227|P1|STARTED|Overall Study||6007
2288346|NCT02111447|5619249|P4|NOT COMPLETED|Overall Study||0
2288347|NCT02111447|5619250|P3|NOT COMPLETED|Overall Study||0
2288348|NCT02111447|5619251|P2|NOT COMPLETED|Overall Study||0
2288349|NCT02111447|5619252|P1|NOT COMPLETED|Overall Study||0
2288350|NCT02111447|5619249|P4|COMPLETED|Overall Study||0
2288351|NCT02111447|5619250|P3|COMPLETED|Overall Study||1
2288352|NCT02111447|5619251|P2|COMPLETED|Overall Study||5
2288353|NCT02111447|5619252|P1|COMPLETED|Overall Study||0
2288354|NCT02111447|5619249|P4|STARTED|Overall Study||0
2288355|NCT02111447|5619250|P3|STARTED|Overall Study||1
2288356|NCT02111447|5619251|P2|STARTED|Overall Study||5
2288357|NCT02111447|5619252|P1|STARTED|Overall Study||0
2288358|NCT02111369|5619266|P1|NOT COMPLETED|Overall Study||3
2288359|NCT02111369|5619266|P1|COMPLETED|Overall Study||15
2288360|NCT02111369|5619266|P1|STARTED|Overall Study||18
2288361|NCT02111252|5619274|P1|NOT COMPLETED|Overall Study||0
2288362|NCT02111252|5619274|P1|COMPLETED|Overall Study||55
2288363|NCT02111252|5619274|P1|STARTED|Overall Study||55
2288364|NCT02111213|5619290|P2|NOT COMPLETED|Overall Study||6
2288365|NCT02111213|5619291|P1|NOT COMPLETED|Overall Study||6
2288366|NCT02111213|5619290|P2|COMPLETED|Overall Study||117
2288367|NCT02111213|5619291|P1|COMPLETED|Overall Study||116
2288368|NCT02111213|5619290|P2|STARTED|Overall Study||123
2288369|NCT02111213|5619291|P1|STARTED|Overall Study||122
2288370|NCT02111200|5619301|P4|NOT COMPLETED|Overall Study||0
2288371|NCT02111200|5619302|P3|NOT COMPLETED|Overall Study||0
2288372|NCT02111200|5619303|P2|NOT COMPLETED|Overall Study||0
2288373|NCT02111200|5619304|P1|NOT COMPLETED|Overall Study||0
2288374|NCT02111200|5619301|P4|COMPLETED|Overall Study||1
2288375|NCT02111200|5619302|P3|COMPLETED|Overall Study||1
2288376|NCT02111200|5619303|P2|COMPLETED|Overall Study||2
2288377|NCT02111200|5619304|P1|COMPLETED|Overall Study||3
2288378|NCT02111200|5619301|P4|STARTED|Overall Study||1
2288379|NCT02111200|5619302|P3|STARTED|Overall Study||1
2288380|NCT02111200|5619303|P2|STARTED|Overall Study||2
2288381|NCT02111200|5619304|P1|STARTED|Overall Study||3
2288382|NCT02111187|5619320|P2|NOT COMPLETED|Overall Study||0
2288383|NCT02111187|5619321|P1|NOT COMPLETED|Overall Study||0
2288384|NCT02111187|5619320|P2|COMPLETED|Overall Study||7
2288385|NCT02111187|5619321|P1|COMPLETED|Overall Study||7
2288386|NCT02111187|5619320|P2|STARTED|Overall Study||7
2288387|NCT02111187|5619321|P1|STARTED|Overall Study||7
2288388|NCT02111174|5619335|P2|NOT COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||7
2288389|NCT02111174|5619336|P1|NOT COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||8
2288390|NCT02111174|5619335|P2|COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||9
2288391|NCT02111174|5619336|P1|COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||7
2288392|NCT02111174|5619335|P2|2 Month Follow up Complete|Secondary Outcomes (2 and 3 Month f/u)||11
2288393|NCT02111174|5619336|P1|2 Month Follow up Complete|Secondary Outcomes (2 and 3 Month f/u)||8
2288394|NCT02111174|5619335|P2|STARTED|Secondary Outcomes (2 and 3 Month f/u)||16
2288395|NCT02111174|5619336|P1|STARTED|Secondary Outcomes (2 and 3 Month f/u)||15
2288396|NCT02111174|5619335|P2|NOT COMPLETED|Treatment and Primary Outcome||2
2288397|NCT02111174|5619336|P1|NOT COMPLETED|Treatment and Primary Outcome||3
2288398|NCT02111174|5619335|P2|COMPLETED|Treatment and Primary Outcome||16
2288399|NCT02111174|5619336|P1|COMPLETED|Treatment and Primary Outcome||15
2288400|NCT02111174|5619335|P2|STARTED|Treatment and Primary Outcome||18
2288401|NCT02111174|5619336|P1|STARTED|Treatment and Primary Outcome||18
2288402|NCT02111096|5619365|P3|NOT COMPLETED|Overall Study||66
2288403|NCT02111096|5619366|P2|NOT COMPLETED|Overall Study||41
2288404|NCT02111096|5619367|P1|NOT COMPLETED|Overall Study||64
2288405|NCT02111096|5619365|P3|COMPLETED|Overall Study||2
2288406|NCT02111096|5619366|P2|COMPLETED|Overall Study||0
2288407|NCT02111096|5619367|P1|COMPLETED|Overall Study||1
2288408|NCT02111096|5619365|P3|Received at Least 1 Dose of Study Drug|Overall Study||68
2288409|NCT02111096|5619366|P2|Received at Least 1 Dose of Study Drug|Overall Study||41
2288410|NCT02111096|5619367|P1|Received at Least 1 Dose of Study Drug|Overall Study||65
2288411|NCT02111096|5619365|P3|STARTED|Overall Study||68
2288412|NCT02111096|5619366|P2|STARTED|Overall Study||41
2288413|NCT02111096|5619367|P1|STARTED|Overall Study||65
2288414|NCT02111083|5619415|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
2288415|NCT02111083|5619416|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
2288416|NCT02111083|5619415|P2|COMPLETED|Fourth Intervention (1 Day)||18
2288417|NCT02111083|5619416|P1|COMPLETED|Fourth Intervention (1 Day)||18
2288418|NCT02111083|5619415|P2|STARTED|Fourth Intervention (1 Day)||18
2288419|NCT02111083|5619416|P1|STARTED|Fourth Intervention (1 Day)||18
2288420|NCT02111083|5619415|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
2288421|NCT02111083|5619416|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
2288422|NCT02111083|5619415|P2|COMPLETED|Interval Between Dosing (7-8 Days)||18
2288423|NCT02111083|5619416|P1|COMPLETED|Interval Between Dosing (7-8 Days)||18
2288424|NCT02111083|5619415|P2|STARTED|Interval Between Dosing (7-8 Days)||19
2288425|NCT02111083|5619416|P1|STARTED|Interval Between Dosing (7-8 Days)||19
2288426|NCT02111083|5619415|P2|NOT COMPLETED|Third Intervention (1 Day)||0
2288427|NCT02111083|5619416|P1|NOT COMPLETED|Third Intervention (1 Day)||0
2288428|NCT02111083|5619415|P2|COMPLETED|Third Intervention (1 Day)||19
2288429|NCT02111083|5619416|P1|COMPLETED|Third Intervention (1 Day)||19
2288430|NCT02111083|5619415|P2|STARTED|Third Intervention (1 Day)||19
2288431|NCT02111083|5619416|P1|STARTED|Third Intervention (1 Day)||19
2288432|NCT02111083|5619415|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
2288433|NCT02111083|5619416|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
2288434|NCT02111083|5619415|P2|COMPLETED|Interval Between Dosing (7-8 Days)||19
2288435|NCT02111083|5619416|P1|COMPLETED|Interval Between Dosing (7-8 Days)||19
2288436|NCT02111083|5619415|P2|STARTED|Interval Between Dosing (7-8 Days)||19
2288437|NCT02111083|5619416|P1|STARTED|Interval Between Dosing (7-8 Days)||19
2288438|NCT02111083|5619415|P2|NOT COMPLETED|Second Intervention (1 Day)||0
2288439|NCT02111083|5619416|P1|NOT COMPLETED|Second Intervention (1 Day)||0
2288440|NCT02111083|5619415|P2|COMPLETED|Second Intervention (1 Day)||19
2288441|NCT02111083|5619416|P1|COMPLETED|Second Intervention (1 Day)||19
2288442|NCT02111083|5619415|P2|STARTED|Second Intervention (1 Day)||19
2288443|NCT02111083|5619416|P1|STARTED|Second Intervention (1 Day)||19
2288444|NCT02111083|5619415|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
2288445|NCT02111083|5619416|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
2288446|NCT02111083|5619415|P2|COMPLETED|Interval Between Dosing (7-8 Days)||19
2288447|NCT02111083|5619416|P1|COMPLETED|Interval Between Dosing (7-8 Days)||19
2288448|NCT02111083|5619415|P2|STARTED|Interval Between Dosing (7-8 Days)||19
2288449|NCT02111083|5619416|P1|STARTED|Interval Between Dosing (7-8 Days)||19
2288450|NCT02111083|5619415|P2|NOT COMPLETED|First Intervention (1 Day)||0
2288451|NCT02111083|5619416|P1|NOT COMPLETED|First Intervention (1 Day)||0
2288452|NCT02111083|5619415|P2|COMPLETED|First Intervention (1 Day)||19
2288453|NCT02111083|5619416|P1|COMPLETED|First Intervention (1 Day)||19
2288454|NCT02111083|5619415|P2|STARTED|First Intervention (1 Day)||19
2288455|NCT02111083|5619416|P1|STARTED|First Intervention (1 Day)||19
2288456|NCT02110901|5619436|P2|NOT COMPLETED|Overall Study||14
2288457|NCT02110901|5619437|P1|NOT COMPLETED|Overall Study||30
2288458|NCT02110901|5619436|P2|COMPLETED|Overall Study||88
2288459|NCT02110901|5619437|P1|COMPLETED|Overall Study||179
2288460|NCT02110901|5619436|P2|STARTED|Overall Study||102
2288461|NCT02110901|5619437|P1|STARTED|Overall Study||209
2288462|NCT02110706|5619451|P2|NOT COMPLETED|Overall Study||4
2288463|NCT02110706|5619452|P1|NOT COMPLETED|Overall Study||5
2288464|NCT02110706|5619451|P2|COMPLETED|Overall Study||23
2288465|NCT02110706|5619452|P1|COMPLETED|Overall Study||20
2288466|NCT02110706|5619451|P2|No. Completing Study Through Week 52|Overall Study||24
2288467|NCT02110706|5619452|P1|No. Completing Study Through Week 52|Overall Study||23
2288468|NCT02110706|5619451|P2|STARTED|Overall Study||27
2288469|NCT02110706|5619452|P1|STARTED|Overall Study||25
2288470|NCT02110693|5619464|P2|NOT COMPLETED|Overall Study||29
2288471|NCT02110693|5619465|P1|NOT COMPLETED|Overall Study||28
2288472|NCT02110693|5619464|P2|COMPLETED|Overall Study||1002
2288473|NCT02110693|5619465|P1|COMPLETED|Overall Study||998
2288474|NCT02110693|5619464|P2|STARTED|Overall Study||1031
2288475|NCT02110693|5619465|P1|STARTED|Overall Study||1026
2288476|NCT02110485|5619492|P2|NOT COMPLETED|Overall Study||19
2288477|NCT02110485|5619493|P1|NOT COMPLETED|Overall Study||7
2288478|NCT02110485|5619492|P2|COMPLETED|Overall Study||83
2288479|NCT02110485|5619493|P1|COMPLETED|Overall Study||91
2288480|NCT02110485|5619492|P2|STARTED|Overall Study||102
2288481|NCT02110485|5619493|P1|STARTED|Overall Study||98
2288482|NCT02110381|5619511|P2|NOT COMPLETED|Dual Modality||1
2288483|NCT02110381|5619512|P1|NOT COMPLETED|Dual Modality||2
2288484|NCT02110381|5619511|P2|COMPLETED|Dual Modality||7
2288485|NCT02110381|5619512|P1|COMPLETED|Dual Modality||5
2288486|NCT02110381|5619511|P2|Began Active Treatment|Dual Modality||7
2288487|NCT02110381|5619512|P1|Began Active Treatment|Dual Modality||7
2288488|NCT02110381|5619511|P2|STARTED|Dual Modality||8
2288489|NCT02110381|5619512|P1|STARTED|Dual Modality||7
2288490|NCT02110381|5619511|P2|NOT COMPLETED|Single Modality||1
2288491|NCT02110381|5619512|P1|NOT COMPLETED|Single Modality||2
2288492|NCT02110381|5619511|P2|COMPLETED|Single Modality||8
2288493|NCT02110381|5619512|P1|COMPLETED|Single Modality||7
2288494|NCT02110381|5619511|P2|STARTED|Single Modality||9
2288495|NCT02110381|5619512|P1|STARTED|Single Modality||9
2288496|NCT02110277|5619523|P1|NOT COMPLETED|Overall Study||2
2288497|NCT02110277|5619523|P1|COMPLETED|Overall Study||0
2288498|NCT02110277|5619523|P1|STARTED|Overall Study||2
2288499|NCT02110264|5619531|P3|NOT COMPLETED|Overall Study||9
2288500|NCT02110264|5619532|P2|NOT COMPLETED|Overall Study||12
2288501|NCT02110264|5619533|P1|NOT COMPLETED|Overall Study||18
2288502|NCT02110264|5619531|P3|COMPLETED|Overall Study||39
2288503|NCT02110264|5619532|P2|COMPLETED|Overall Study||38
2288504|NCT02110264|5619533|P1|COMPLETED|Overall Study||35
2288505|NCT02110264|5619531|P3|STARTED|Overall Study||48
2288506|NCT02110264|5619532|P2|STARTED|Overall Study||50
2288507|NCT02110264|5619533|P1|STARTED|Overall Study||53
2288508|NCT02110238|5619546|P2|NOT COMPLETED|14 Week Blinded Extension Phase||12
2288509|NCT02110238|5619547|P1|NOT COMPLETED|14 Week Blinded Extension Phase||12
2288510|NCT02110238|5619546|P2|COMPLETED|14 Week Blinded Extension Phase||188
2288511|NCT02110238|5619547|P1|COMPLETED|14 Week Blinded Extension Phase||190
2288512|NCT02110238|5619546|P2|STARTED|14 Week Blinded Extension Phase||200
2288513|NCT02110238|5619547|P1|STARTED|14 Week Blinded Extension Phase||202
2288514|NCT02110238|5619546|P2|NOT COMPLETED|12 Week Pivotal Phase||9
2288515|NCT02110238|5619547|P1|NOT COMPLETED|12 Week Pivotal Phase||10
2288516|NCT02110238|5619546|P2|COMPLETED|12 Week Pivotal Phase||200
2288517|NCT02110238|5619547|P1|COMPLETED|12 Week Pivotal Phase||202
2288518|NCT02110238|5619546|P2|STARTED|12 Week Pivotal Phase||209
2288519|NCT02110238|5619547|P1|STARTED|12 Week Pivotal Phase|One subject was randomized but not treated. As a result there were 211 safety subjects|212
2288520|NCT02110225|5619556|P3|NOT COMPLETED|Overall Study||0
2288521|NCT02110225|5619557|P2|NOT COMPLETED|Overall Study||1
2288522|NCT02110225|5619558|P1|NOT COMPLETED|Overall Study||0
2288523|NCT02110225|5619556|P3|COMPLETED|Overall Study||10
2288524|NCT02110225|5619557|P2|COMPLETED|Overall Study||19
2288525|NCT02110225|5619558|P1|COMPLETED|Overall Study||20
2288526|NCT02110225|5619556|P3|STARTED|Overall Study||10
2288527|NCT02110225|5619557|P2|STARTED|Overall Study||20
2288528|NCT02110225|5619558|P1|STARTED|Overall Study||20
2288529|NCT02110147|5619610|P1|NOT COMPLETED|Overall Study||0
2288530|NCT02110147|5619610|P1|COMPLETED|Overall Study||4
2288531|NCT02110147|5619610|P1|STARTED|Overall Study||4
2288532|NCT02109939|5619618|P2|NOT COMPLETED|Overall Study||110
2288533|NCT02109939|5619619|P1|NOT COMPLETED|Overall Study||121
2288534|NCT02109939|5619618|P2|COMPLETED|Overall Study||607
2288535|NCT02109939|5619619|P1|COMPLETED|Overall Study||560
2288536|NCT02109939|5619618|P2|STARTED|Overall Study||717
2288537|NCT02109939|5619619|P1|STARTED|Overall Study||681
2288538|NCT02109809|5619642|P1|NOT COMPLETED|Overall Study||3
2288539|NCT02109809|5619642|P1|COMPLETED|Overall Study||1
2288540|NCT02109809|5619642|P1|STARTED|Overall Study||4
2288541|NCT02109731|5619648|P1|NOT COMPLETED|Overall Study||0
2288542|NCT02109731|5619648|P1|COMPLETED|Overall Study||15
2288543|NCT02109731|5619648|P1|STARTED|Overall Study||15
2288544|NCT02109640|5619654|P2|NOT COMPLETED|Overall Study||0
2288545|NCT02109640|5619655|P1|NOT COMPLETED|Overall Study||0
2288546|NCT02109640|5619654|P2|COMPLETED|Overall Study||23
2288547|NCT02109640|5619655|P1|COMPLETED|Overall Study||27
2288548|NCT02109640|5619654|P2|STARTED|Overall Study||23
2288549|NCT02109640|5619655|P1|STARTED|Overall Study||27
2288550|NCT02109562|5619668|P3|NOT COMPLETED|Overall Study||35
2288551|NCT02109562|5619669|P2|NOT COMPLETED|Overall Study||34
2288552|NCT02109562|5619670|P1|NOT COMPLETED|Overall Study||26
2288553|NCT02109562|5619668|P3|COMPLETED|Overall Study||84
2288554|NCT02109562|5619669|P2|COMPLETED|Overall Study||85
2288555|NCT02109562|5619670|P1|COMPLETED|Overall Study||90
2288556|NCT02109562|5619668|P3|Intent to Treat (ITT)|Overall Study||112
2288557|NCT02109562|5619669|P2|Intent to Treat (ITT)|Overall Study||114
2288558|NCT02109562|5619670|P1|Intent to Treat (ITT)|Overall Study||111
2288559|NCT02109562|5619668|P3|Safety|Overall Study||118
2288560|NCT02109562|5619669|P2|Safety|Overall Study||117
2288561|NCT02109562|5619670|P1|Safety|Overall Study||115
2288562|NCT02109562|5619668|P3|STARTED|Overall Study||119
2288563|NCT02109562|5619669|P2|STARTED|Overall Study||119
2288564|NCT02109562|5619670|P1|STARTED|Overall Study||116
2288565|NCT02109497|5619684|P1|NOT COMPLETED|Overall Study||1
2288566|NCT02109497|5619684|P1|COMPLETED|Overall Study|One participant completed the safety assessments but did not complete all doses of the study drugs.|17
2288567|NCT02109497|5619684|P1|STARTED|Overall Study||18
2288568|NCT02109484|5619697|P8|NOT COMPLETED|Overall Study||3
2288569|NCT02109484|5619698|P7|NOT COMPLETED|Overall Study||3
2288570|NCT02109484|5619699|P6|NOT COMPLETED|Overall Study||1
2288571|NCT02109484|5619700|P5|NOT COMPLETED|Overall Study||4
2288572|NCT02109484|5619701|P4|NOT COMPLETED|Overall Study||1
2288573|NCT02109484|5619702|P3|NOT COMPLETED|Overall Study||0
2288574|NCT02109484|5619703|P2|NOT COMPLETED|Overall Study||0
2288575|NCT02109484|5619704|P1|NOT COMPLETED|Overall Study||0
2288576|NCT02109484|5619697|P8|COMPLETED|Overall Study||47
2288577|NCT02109484|5619698|P7|COMPLETED|Overall Study||47
2288578|NCT02109484|5619699|P6|COMPLETED|Overall Study||11
2288579|NCT02109484|5619700|P5|COMPLETED|Overall Study||46
2288580|NCT02109484|5619701|P4|COMPLETED|Overall Study||11
2288581|NCT02109484|5619702|P3|COMPLETED|Overall Study||12
2288582|NCT02109484|5619703|P2|COMPLETED|Overall Study||13
2288583|NCT02109484|5619704|P1|COMPLETED|Overall Study||5
2288584|NCT02109484|5619697|P8|STARTED|Overall Study||50
2288585|NCT02109484|5619698|P7|STARTED|Overall Study||50
2288586|NCT02109484|5619699|P6|STARTED|Overall Study||12
2288587|NCT02109484|5619700|P5|STARTED|Overall Study||50
2288588|NCT02109484|5619701|P4|STARTED|Overall Study||12
2288589|NCT02109484|5619702|P3|STARTED|Overall Study||12
2288590|NCT02109484|5619703|P2|STARTED|Overall Study||13
2288591|NCT02109484|5619704|P1|STARTED|Overall Study||5
2288592|NCT02109458|5619753|P1|NOT COMPLETED|Overall Study||0
2288593|NCT02109458|5619753|P1|COMPLETED|Overall Study||24
2288594|NCT02109458|5619753|P1|STARTED|Overall Study||24
2288595|NCT02109445|5619760|P1|NOT COMPLETED|Overall Study||3
2288596|NCT02109445|5619760|P1|COMPLETED|Overall Study||0
2288597|NCT02109445|5619760|P1|STARTED|Overall Study||3
2288598|NCT02109432|5619793|P1|NOT COMPLETED|Overall Study||1
2288599|NCT02109432|5619793|P1|COMPLETED|Overall Study||6
2288600|NCT02109432|5619793|P1|STARTED|Overall Study||7
2288601|NCT02109419|5619797|P1|NOT COMPLETED|Overall Study||0
2288602|NCT02109419|5619797|P1|COMPLETED|Overall Study||57
2288603|NCT02109419|5619797|P1|STARTED|Overall Study||57
2288604|NCT02109172|5619803|P6|NOT COMPLETED|Overall Study||1
2288605|NCT02109172|5619804|P5|NOT COMPLETED|Overall Study||1
2288606|NCT02109172|5619805|P4|NOT COMPLETED|Overall Study||1
2288607|NCT02109172|5619806|P3|NOT COMPLETED|Overall Study||1
2288608|NCT02109172|5619807|P2|NOT COMPLETED|Overall Study||0
2288609|NCT02109172|5619808|P1|NOT COMPLETED|Overall Study||1
2288610|NCT02109172|5619803|P6|COMPLETED|Overall Study||10
2288611|NCT02109172|5619804|P5|COMPLETED|Overall Study||9
2288612|NCT02109172|5619805|P4|COMPLETED|Overall Study||10
2288613|NCT02109172|5619806|P3|COMPLETED|Overall Study||9
2288614|NCT02109172|5619807|P2|COMPLETED|Overall Study||11
2288615|NCT02109172|5619808|P1|COMPLETED|Overall Study||10
2288616|NCT02109172|5619803|P6|STARTED|Overall Study||11
2288617|NCT02109172|5619804|P5|STARTED|Overall Study||10
2288618|NCT02109172|5619805|P4|STARTED|Overall Study||11
2288619|NCT02109172|5619806|P3|STARTED|Overall Study||10
2288620|NCT02109172|5619807|P2|STARTED|Overall Study||11
2288621|NCT02109172|5619808|P1|STARTED|Overall Study||11
2288622|NCT02109159|5619818|P2|NOT COMPLETED|Overall Study||0
2288623|NCT02109159|5619819|P1|NOT COMPLETED|Overall Study||0
2288624|NCT02109159|5619818|P2|COMPLETED|Overall Study||4175
2288625|NCT02109159|5619819|P1|COMPLETED|Overall Study||4178
2288626|NCT02109159|5619818|P2|STARTED|Overall Study||4175
2288627|NCT02109159|5619819|P1|STARTED|Overall Study||4178
2288628|NCT02109133|5619829|P2|NOT COMPLETED|Overall Study||0
2288629|NCT02109133|5619830|P1|NOT COMPLETED|Overall Study||1
2288630|NCT02109133|5619829|P2|COMPLETED|Overall Study||34
2288631|NCT02109133|5619830|P1|COMPLETED|Overall Study||32
2288632|NCT02109133|5619829|P2|STARTED|Overall Study||34
2288633|NCT02109133|5619830|P1|STARTED|Overall Study||33
2288634|NCT02109107|5619842|P1|NOT COMPLETED|Overall Study||2
2288635|NCT02109107|5619842|P1|COMPLETED|Overall Study||52
2288636|NCT02109107|5619842|P1|STARTED|Overall Study||54
2288637|NCT02109042|5619849|P1|NOT COMPLETED|Overall Study||15
2288638|NCT02109042|5619849|P1|COMPLETED|Overall Study||0
2288639|NCT02109042|5619849|P1|Receive at Least 1 Subsequent 90 mg Dose|Overall Study||15
2288640|NCT02109042|5619849|P1|Received 180 mg Loading Dose|Overall Study||15
2288641|NCT02109042|5619849|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
2288642|NCT02109042|5619849|P1|STARTED|Overall Study||15
2288643|NCT02109029|5619858|P6|NOT COMPLETED|Part B||1
2288644|NCT02109029|5619859|P5|NOT COMPLETED|Part B||1
2288645|NCT02109029|5619860|P4|NOT COMPLETED|Part B||0
2288646|NCT02109029|5619861|P3|NOT COMPLETED|Part B||0
2288647|NCT02109029|5619862|P2|NOT COMPLETED|Part B||0
2288648|NCT02109029|5619863|P1|NOT COMPLETED|Part B||0
2288649|NCT02109029|5619858|P6|COMPLETED|Part B||5
2288650|NCT02109029|5619859|P5|COMPLETED|Part B||5
2288651|NCT02109029|5619860|P4|COMPLETED|Part B||0
2288652|NCT02109029|5619861|P3|COMPLETED|Part B||0
2288653|NCT02109029|5619862|P2|COMPLETED|Part B||0
2288654|NCT02109029|5619863|P1|COMPLETED|Part B||0
2288655|NCT02109029|5619858|P6|Received at Least One Dose of Study Drug|Part B||6
2288656|NCT02109029|5619859|P5|Received at Least One Dose of Study Drug|Part B||6
2288657|NCT02109029|5619860|P4|Received at Least One Dose of Study Drug|Part B||0
2288658|NCT02109029|5619861|P3|Received at Least One Dose of Study Drug|Part B||0
2288659|NCT02109029|5619862|P2|Received at Least One Dose of Study Drug|Part B||0
2288660|NCT02109029|5619863|P1|Received at Least One Dose of Study Drug|Part B||0
2288661|NCT02109029|5619858|P6|STARTED|Part B|New participants entered Part B.|6
2288662|NCT02109029|5619859|P5|STARTED|Part B|New participants entered Part B.|6
2288663|NCT02109029|5619860|P4|STARTED|Part B||0
2288664|NCT02109029|5619861|P3|STARTED|Part B||0
2288665|NCT02109029|5619862|P2|STARTED|Part B||0
2288666|NCT02109029|5619863|P1|STARTED|Part B||0
2288667|NCT02109029|5619858|P6|NOT COMPLETED|Part A||0
2288668|NCT02109029|5619859|P5|NOT COMPLETED|Part A||0
2288669|NCT02109029|5619860|P4|NOT COMPLETED|Part A||0
2288670|NCT02109029|5619861|P3|NOT COMPLETED|Part A||0
2288671|NCT02109029|5619862|P2|NOT COMPLETED|Part A||0
2288672|NCT02109029|5619863|P1|NOT COMPLETED|Part A||0
2288673|NCT02109029|5619858|P6|COMPLETED|Part A||0
2288674|NCT02109029|5619859|P5|COMPLETED|Part A||0
2288675|NCT02109029|5619860|P4|COMPLETED|Part A|Participants from Part A did not move on to Part B.|4
2288676|NCT02109029|5619861|P3|COMPLETED|Part A|Participants from Part A did not move on to Part B.|4
2288677|NCT02109029|5619862|P2|COMPLETED|Part A|Participants from Part A did not move on to Part B.|2
2288678|NCT02109029|5619863|P1|COMPLETED|Part A|Participants from Part A did not move on to Part B.|2
2288679|NCT02109029|5619858|P6|Received One Dose of Study Drug|Part A||0
2288680|NCT02109029|5619859|P5|Received One Dose of Study Drug|Part A||0
2288681|NCT02109029|5619860|P4|Received One Dose of Study Drug|Part A||4
2288682|NCT02109029|5619861|P3|Received One Dose of Study Drug|Part A||4
2288683|NCT02109029|5619862|P2|Received One Dose of Study Drug|Part A||2
2288684|NCT02109029|5619863|P1|Received One Dose of Study Drug|Part A||2
2288685|NCT02109029|5619858|P6|STARTED|Part A||0
2288686|NCT02109029|5619859|P5|STARTED|Part A||0
2288687|NCT02109029|5619860|P4|STARTED|Part A||4
2288688|NCT02109029|5619861|P3|STARTED|Part A||4
2288689|NCT02109029|5619862|P2|STARTED|Part A||2
2288690|NCT02109029|5619863|P1|STARTED|Part A||2
2288691|NCT02108977|5619877|P2|NOT COMPLETED|Overall Study||1
2288692|NCT02108977|5619878|P1|NOT COMPLETED|Overall Study||10
2288693|NCT02108977|5619877|P2|COMPLETED|Overall Study||19
2288694|NCT02108977|5619878|P1|COMPLETED|Overall Study||8
2288695|NCT02108977|5619877|P2|STARTED|Overall Study||20
2288696|NCT02108977|5619878|P1|STARTED|Overall Study||18
2288697|NCT02108951|5619892|P1|NOT COMPLETED|Overall Study||16
2288698|NCT02108951|5619892|P1|COMPLETED|Overall Study||4
2288699|NCT02108951|5619892|P1|STARTED|Overall Study|Indicates patients in enrolled, full analysis and safety set|20
2288700|NCT02108912|5619911|P2|NOT COMPLETED|Overall Study||1
2288701|NCT02108912|5619912|P1|NOT COMPLETED|Overall Study||3
2288702|NCT02108912|5619911|P2|COMPLETED|Overall Study||6
2288703|NCT02108912|5619912|P1|COMPLETED|Overall Study||6
2288704|NCT02108912|5619911|P2|STARTED|Overall Study||7
2288705|NCT02108912|5619912|P1|STARTED|Overall Study||9
2288706|NCT02108691|5619922|P2|NOT COMPLETED|Overall Study||9
2288707|NCT02108691|5619923|P1|NOT COMPLETED|Overall Study||8
2288708|NCT02108691|5619922|P2|COMPLETED|Overall Study||31
2288709|NCT02108691|5619923|P1|COMPLETED|Overall Study||32
2288710|NCT02108691|5619922|P2|STARTED|Overall Study||40
2288711|NCT02108691|5619923|P1|STARTED|Overall Study||40
2288712|NCT02108652|5619941|P1|NOT COMPLETED|Overall Study||310
2288713|NCT02108652|5619941|P1|COMPLETED|Overall Study||0
2288714|NCT02108652|5619941|P1|STARTED|Overall Study||310
2288715|NCT02108457|5619964|P2|NOT COMPLETED|Overall Study||2
2288716|NCT02108457|5619965|P1|NOT COMPLETED|Overall Study||0
2288717|NCT02108457|5619964|P2|COMPLETED|Overall Study||10
2288718|NCT02108457|5619965|P1|COMPLETED|Overall Study||3
2288719|NCT02108457|5619964|P2|STARTED|Overall Study||12
2288720|NCT02108457|5619965|P1|STARTED|Overall Study||3
2288721|NCT02108288|5619974|P3|NOT COMPLETED|Overall Study||0
2288722|NCT02108288|5619975|P2|NOT COMPLETED|Overall Study||0
2288723|NCT02108288|5619976|P1|NOT COMPLETED|Overall Study||0
2288724|NCT02108288|5619974|P3|COMPLETED|Overall Study||10
2288725|NCT02108288|5619975|P2|COMPLETED|Overall Study||10
2288726|NCT02108288|5619976|P1|COMPLETED|Overall Study||10
2288727|NCT02108288|5619974|P3|STARTED|Overall Study||10
2288728|NCT02108288|5619975|P2|STARTED|Overall Study||10
2288729|NCT02108288|5619976|P1|STARTED|Overall Study||10
2288730|NCT02108223|5619992|P3|NOT COMPLETED|Overall Study||0
2288731|NCT02108223|5619993|P2|NOT COMPLETED|Overall Study||0
2288732|NCT02108223|5619994|P1|NOT COMPLETED|Overall Study||0
2288733|NCT02108223|5619992|P3|COMPLETED|Overall Study||35
2288734|NCT02108223|5619993|P2|COMPLETED|Overall Study||50
2288735|NCT02108223|5619994|P1|COMPLETED|Overall Study||52
2288736|NCT02108223|5619992|P3|STARTED|Overall Study||35
2288737|NCT02108223|5619993|P2|STARTED|Overall Study||50
2288738|NCT02108223|5619994|P1|STARTED|Overall Study||52
2288739|NCT02108171|5620016|P2|NOT COMPLETED|Overall Study||0
2288740|NCT02108171|5620017|P1|NOT COMPLETED|Overall Study||0
2288741|NCT02108171|5620016|P2|COMPLETED|Overall Study||41
2288742|NCT02108171|5620017|P1|COMPLETED|Overall Study||40
2288743|NCT02108171|5620016|P2|STARTED|Overall Study||41
2288744|NCT02108171|5620017|P1|STARTED|Overall Study||40
2288745|NCT02107898|5620119|P2|NOT COMPLETED|Overall Study||12
2288746|NCT02107898|5620120|P1|NOT COMPLETED|Overall Study||6
2288747|NCT02107898|5620119|P2|COMPLETED|Overall Study||132
2288748|NCT02107898|5620120|P1|COMPLETED|Overall Study||66
2288749|NCT02107898|5620119|P2|Treated|Overall Study||143
2288750|NCT02107898|5620120|P1|Treated|Overall Study||72
2288751|NCT02107898|5620119|P2|STARTED|Overall Study|Randomized|144
2288752|NCT02107898|5620120|P1|STARTED|Overall Study|Randomized|72
2288753|NCT02107703|5620174|P2|NOT COMPLETED|Overall Study||175
2288754|NCT02107703|5620175|P1|NOT COMPLETED|Overall Study||361
2288755|NCT02107703|5620174|P2|COMPLETED|Overall Study||48
2288756|NCT02107703|5620175|P1|COMPLETED|Overall Study||85
2288757|NCT02107703|5620174|P2|Received at Least 1 Dose of Study Drug|Overall Study||223
2288758|NCT02107703|5620175|P1|Received at Least 1 Dose of Study Drug|Overall Study||441
2288759|NCT02107703|5620174|P2|STARTED|Overall Study||223
2288760|NCT02107703|5620175|P1|STARTED|Overall Study||446
2288761|NCT02107599|5620200|P1|NOT COMPLETED|Overall Study||0
2288762|NCT02107599|5620200|P1|COMPLETED|Overall Study||96
2288763|NCT02107599|5620200|P1|STARTED|Overall Study||96
2288764|NCT02107482|5620207|P1|NOT COMPLETED|Overall Study||4
2288765|NCT02107482|5620207|P1|COMPLETED|Overall Study||17
2288766|NCT02107482|5620207|P1|STARTED|Overall Study|21 participants enrolled. Total of 21 participants recvd both active and sham|21
2288767|NCT02107443|5620215|P2|NOT COMPLETED|Overall Study||83
2288768|NCT02107443|5620216|P1|NOT COMPLETED|Overall Study||98
2288769|NCT02107443|5620215|P2|COMPLETED|Overall Study||167
2288770|NCT02107443|5620216|P1|COMPLETED|Overall Study||198
2288771|NCT02107443|5620215|P2|STARTED|Overall Study||250
2288772|NCT02107443|5620216|P1|STARTED|Overall Study||296
2288773|NCT02107339|5620226|P2|NOT COMPLETED|Overall Study||4
2288774|NCT02107339|5620227|P1|NOT COMPLETED|Overall Study||1
2288775|NCT02107339|5620226|P2|COMPLETED|Overall Study||53
2288776|NCT02107339|5620227|P1|COMPLETED|Overall Study||62
2288777|NCT02107339|5620226|P2|STARTED|Overall Study||57
2288778|NCT02107339|5620227|P1|STARTED|Overall Study||63
2288779|NCT02107313|5620263|P2|NOT COMPLETED|Overall Study||1
2288780|NCT02107313|5620264|P1|NOT COMPLETED|Overall Study||0
2288781|NCT02107313|5620263|P2|COMPLETED|Overall Study||8
2288782|NCT02107313|5620264|P1|COMPLETED|Overall Study||9
2288783|NCT02107313|5620263|P2|STARTED|Overall Study|One participant from the study did not cross over and participate in the FED cohort|9
2288784|NCT02107313|5620264|P1|STARTED|Overall Study||9
2288785|NCT02107300|5620274|P2|NOT COMPLETED|Overall Study||0
2288786|NCT02107300|5620275|P1|NOT COMPLETED|Overall Study||0
2288787|NCT02107300|5620274|P2|COMPLETED|Overall Study||15
2288788|NCT02107300|5620275|P1|COMPLETED|Overall Study||16
2288789|NCT02107300|5620274|P2|STARTED|Overall Study||15
2288790|NCT02107300|5620275|P1|STARTED|Overall Study||16
2288791|NCT02107274|5620285|P2|NOT COMPLETED|Control Phase||2
2288792|NCT02107274|5620286|P1|NOT COMPLETED|Control Phase||3
2288793|NCT02107274|5620285|P2|COMPLETED|Control Phase||35
2288794|NCT02107274|5620286|P1|COMPLETED|Control Phase||33
2288795|NCT02107274|5620285|P2|STARTED|Control Phase||37
2288796|NCT02107274|5620286|P1|STARTED|Control Phase||36
2288797|NCT02107274|5620285|P2|NOT COMPLETED|Treatment vs. Placebo||2
2288798|NCT02107274|5620286|P1|NOT COMPLETED|Treatment vs. Placebo||3
2288799|NCT02107274|5620285|P2|COMPLETED|Treatment vs. Placebo||37
2288800|NCT02107274|5620286|P1|COMPLETED|Treatment vs. Placebo||36
2288801|NCT02107274|5620285|P2|STARTED|Treatment vs. Placebo||39
2288802|NCT02107274|5620286|P1|STARTED|Treatment vs. Placebo||39
2288803|NCT02107196|5620300|P2|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||5
2288804|NCT02107196|5620301|P1|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||23
2288805|NCT02107196|5620300|P2|COMPLETED|4-week Randomized Withdrawal (RW) Period||109
2288806|NCT02107196|5620301|P1|COMPLETED|4-week Randomized Withdrawal (RW) Period||315
2288807|NCT02107196|5620300|P2|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|90
2288808|NCT02107196|5620301|P1|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|272
2288809|NCT02107196|5620300|P2|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of placebo during RW period|114
2288810|NCT02107196|5620301|P1|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of ibodutant during RW period|338
2288811|NCT02107196|5620300|P2|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|114
2288812|NCT02107196|5620301|P1|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|338
2288813|NCT02107196|5620300|P2|NOT COMPLETED|12-week Treatment Period||39
2288814|NCT02107196|5620301|P1|NOT COMPLETED|12-week Treatment Period||44
2288815|NCT02107196|5620300|P2|COMPLETED|12-week Treatment Period||225
2288816|NCT02107196|5620301|P1|COMPLETED|12-week Treatment Period||227
2288817|NCT02107196|5620300|P2|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|216
2288818|NCT02107196|5620301|P1|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|221
2288819|NCT02107196|5620300|P2|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|264
2288820|NCT02107196|5620301|P1|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|271
2288821|NCT02107196|5620300|P2|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|264
2288822|NCT02107196|5620301|P1|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|271
2288823|NCT02107131|5620316|P2|NOT COMPLETED|Overall Study||9
2288824|NCT02107131|5620317|P1|NOT COMPLETED|Overall Study||8
2288825|NCT02107131|5620316|P2|COMPLETED|Overall Study||11
2288826|NCT02107131|5620317|P1|COMPLETED|Overall Study||12
2288827|NCT02107131|5620316|P2|STARTED|Overall Study||20
2288828|NCT02107131|5620317|P1|STARTED|Overall Study||20
2288829|NCT02107092|5620329|P1|NOT COMPLETED|Overall Study||44
2288830|NCT02107092|5620329|P1|COMPLETED|Overall Study||79
2288831|NCT02107092|5620329|P1|STARTED|Overall Study||123
2288832|NCT02107014|5620334|P1|NOT COMPLETED|Overall Study||1
2288833|NCT02107014|5620334|P1|COMPLETED|Overall Study||8
2288834|NCT02107014|5620334|P1|STARTED|Overall Study||9
2288835|NCT02106975|5620404|P2|NOT COMPLETED|Overall Study||39
2288836|NCT02106975|5620405|P1|NOT COMPLETED|Overall Study||25
2288837|NCT02106975|5620404|P2|COMPLETED|Overall Study||44
2288838|NCT02106975|5620405|P1|COMPLETED|Overall Study||59
2288839|NCT02106975|5620404|P2|STARTED|Overall Study||83
2288840|NCT02106975|5620405|P1|STARTED|Overall Study||84
2288841|NCT02106962|5620453|P2|NOT COMPLETED|Overall Study||0
2288842|NCT02106962|5620454|P1|NOT COMPLETED|Overall Study||0
2288843|NCT02106962|5620453|P2|COMPLETED|Overall Study||9
2288844|NCT02106962|5620454|P1|COMPLETED|Overall Study||8
2288845|NCT02106962|5620453|P2|STARTED|Overall Study||9
2288846|NCT02106962|5620454|P1|STARTED|Overall Study||8
2288847|NCT02106923|5620465|P6|NOT COMPLETED|Overall Study||1
2288848|NCT02106923|5620466|P5|NOT COMPLETED|Overall Study||0
2288849|NCT02106923|5620467|P4|NOT COMPLETED|Overall Study||0
2288850|NCT02106923|5620468|P3|NOT COMPLETED|Overall Study||0
2288851|NCT02106923|5620469|P2|NOT COMPLETED|Overall Study||0
2288852|NCT02106923|5620470|P1|NOT COMPLETED|Overall Study||0
2288853|NCT02106923|5620465|P6|COMPLETED|Overall Study||11
2288854|NCT02106923|5620466|P5|COMPLETED|Overall Study||12
2288855|NCT02106923|5620467|P4|COMPLETED|Overall Study||12
2288856|NCT02106923|5620468|P3|COMPLETED|Overall Study||12
2288857|NCT02106923|5620469|P2|COMPLETED|Overall Study||12
2288858|NCT02106923|5620470|P1|COMPLETED|Overall Study||12
2288859|NCT02106923|5620465|P6|STARTED|Overall Study||12
2288860|NCT02106923|5620466|P5|STARTED|Overall Study||12
2288861|NCT02106923|5620467|P4|STARTED|Overall Study||12
2288862|NCT02106923|5620468|P3|STARTED|Overall Study||12
2288863|NCT02106923|5620469|P2|STARTED|Overall Study||12
2288864|NCT02106923|5620470|P1|STARTED|Overall Study||12
2288865|NCT02106884|5620516|P2|NOT COMPLETED|Overall Study||1
2288866|NCT02106884|5620517|P1|NOT COMPLETED|Overall Study||0
2288867|NCT02106884|5620516|P2|COMPLETED|Overall Study|ITT analysis based on treatment assigned at baseline.|73
2288868|NCT02106884|5620517|P1|COMPLETED|Overall Study||72
2288869|NCT02106884|5620516|P2|STARTED|Overall Study||74
2288870|NCT02106884|5620517|P1|STARTED|Overall Study||72
2288871|NCT02106832|5620541|P4|NOT COMPLETED|Overall Study||15
2288872|NCT02106832|5620542|P3|NOT COMPLETED|Overall Study||16
2288873|NCT02106832|5620543|P2|NOT COMPLETED|Overall Study||25
2288874|NCT02106832|5620544|P1|NOT COMPLETED|Overall Study||23
2288875|NCT02106832|5620541|P4|COMPLETED|Overall Study||73
2288876|NCT02106832|5620542|P3|COMPLETED|Overall Study||70
2288877|NCT02106832|5620543|P2|COMPLETED|Overall Study||151
2288878|NCT02106832|5620544|P1|COMPLETED|Overall Study||148
2288879|NCT02106832|5620541|P4|Participants Received Treatment|Overall Study||88
2288880|NCT02106832|5620542|P3|Participants Received Treatment|Overall Study||86
2288881|NCT02106832|5620543|P2|Participants Received Treatment|Overall Study||174
2288882|NCT02106832|5620544|P1|Participants Received Treatment|Overall Study||171
2288883|NCT02106832|5620541|P4|STARTED|Overall Study||88
2288884|NCT02106832|5620542|P3|STARTED|Overall Study||86
2288885|NCT02106832|5620543|P2|STARTED|Overall Study||176
2288886|NCT02106832|5620544|P1|STARTED|Overall Study||171
2288887|NCT02106728|5620579|P2|NOT COMPLETED|Overall Study||0
2288888|NCT02106728|5620580|P1|NOT COMPLETED|Overall Study||0
2288889|NCT02106728|5620579|P2|COMPLETED|Overall Study||47
2288890|NCT02106728|5620580|P1|COMPLETED|Overall Study||70
2288891|NCT02106728|5620579|P2|STARTED|Overall Study||47
2288892|NCT02106728|5620580|P1|STARTED|Overall Study||70
2288893|NCT02106494|5620596|P2|NOT COMPLETED|Overall Study||25
2288894|NCT02106494|5620597|P1|NOT COMPLETED|Overall Study||26
2288895|NCT02106494|5620596|P2|COMPLETED|Overall Study||446
2288896|NCT02106494|5620597|P1|COMPLETED|Overall Study||445
2288897|NCT02106494|5620596|P2|Efficacy Population|Overall Study||452
2288898|NCT02106494|5620597|P1|Efficacy Population|Overall Study||450
2288899|NCT02106494|5620596|P2|Safety Population|Overall Study||459
2288900|NCT02106494|5620597|P1|Safety Population|Overall Study||456
2288901|NCT02106494|5620596|P2|STARTED|Overall Study||471
2288902|NCT02106494|5620597|P1|STARTED|Overall Study||471
2288903|NCT02106455|5620611|P1|NOT COMPLETED|Overall Study||8
2288904|NCT02106455|5620611|P1|COMPLETED|Overall Study||307
2288905|NCT02106455|5620611|P1|STARTED|Overall Study||315
2288906|NCT02106442|5620625|P1|NOT COMPLETED|Overall Study||37
2288907|NCT02106442|5620625|P1|COMPLETED|Overall Study||542
2288908|NCT02106442|5620625|P1|STARTED|Overall Study||579
2288909|NCT02106403|5620643|P6|NOT COMPLETED|Follow-Up Visit 3||1
2288910|NCT02106403|5620644|P5|NOT COMPLETED|Follow-Up Visit 3||0
2288911|NCT02106403|5620645|P4|NOT COMPLETED|Follow-Up Visit 3||0
2288912|NCT02106403|5620646|P3|NOT COMPLETED|Follow-Up Visit 3||0
2288913|NCT02106403|5620647|P2|NOT COMPLETED|Follow-Up Visit 3||0
2288914|NCT02106403|5620648|P1|NOT COMPLETED|Follow-Up Visit 3||0
2288915|NCT02106403|5620643|P6|COMPLETED|Follow-Up Visit 3||8
2288916|NCT02106403|5620644|P5|COMPLETED|Follow-Up Visit 3||8
2288917|NCT02106403|5620645|P4|COMPLETED|Follow-Up Visit 3||8
2288918|NCT02106403|5620646|P3|COMPLETED|Follow-Up Visit 3||9
2288919|NCT02106403|5620647|P2|COMPLETED|Follow-Up Visit 3||8
2288920|NCT02106403|5620648|P1|COMPLETED|Follow-Up Visit 3||8
2288921|NCT02106403|5620643|P6|STARTED|Follow-Up Visit 3||9
2288922|NCT02106403|5620644|P5|STARTED|Follow-Up Visit 3||8
2288923|NCT02106403|5620645|P4|STARTED|Follow-Up Visit 3||8
2288924|NCT02106403|5620646|P3|STARTED|Follow-Up Visit 3||9
2288925|NCT02106403|5620647|P2|STARTED|Follow-Up Visit 3||8
2288926|NCT02106403|5620648|P1|STARTED|Follow-Up Visit 3||8
2288927|NCT02106403|5620643|P6|NOT COMPLETED|Follow-Up Visit 2||0
2288928|NCT02106403|5620644|P5|NOT COMPLETED|Follow-Up Visit 2||0
2288929|NCT02106403|5620645|P4|NOT COMPLETED|Follow-Up Visit 2||0
2288930|NCT02106403|5620646|P3|NOT COMPLETED|Follow-Up Visit 2||0
2288931|NCT02106403|5620647|P2|NOT COMPLETED|Follow-Up Visit 2||0
2288932|NCT02106403|5620648|P1|NOT COMPLETED|Follow-Up Visit 2||0
2288933|NCT02106403|5620643|P6|COMPLETED|Follow-Up Visit 2||9
2288934|NCT02106403|5620644|P5|COMPLETED|Follow-Up Visit 2||8
2288935|NCT02106403|5620645|P4|COMPLETED|Follow-Up Visit 2||8
2288936|NCT02106403|5620646|P3|COMPLETED|Follow-Up Visit 2||9
2288937|NCT02106403|5620647|P2|COMPLETED|Follow-Up Visit 2||8
2288938|NCT02106403|5620648|P1|COMPLETED|Follow-Up Visit 2||8
2288939|NCT02106403|5620643|P6|STARTED|Follow-Up Visit 2||9
2288940|NCT02106403|5620644|P5|STARTED|Follow-Up Visit 2||8
2288941|NCT02106403|5620645|P4|STARTED|Follow-Up Visit 2||8
2288942|NCT02106403|5620646|P3|STARTED|Follow-Up Visit 2||9
2288943|NCT02106403|5620647|P2|STARTED|Follow-Up Visit 2||8
2288944|NCT02106403|5620648|P1|STARTED|Follow-Up Visit 2||8
2288945|NCT02106403|5620643|P6|NOT COMPLETED|Visit 1, Treatment Period 3||0
2288946|NCT02106403|5620644|P5|NOT COMPLETED|Visit 1, Treatment Period 3||0
2288947|NCT02106403|5620645|P4|NOT COMPLETED|Visit 1, Treatment Period 3||0
2288948|NCT02106403|5620646|P3|NOT COMPLETED|Visit 1, Treatment Period 3||0
2288949|NCT02106403|5620647|P2|NOT COMPLETED|Visit 1, Treatment Period 3||0
2288950|NCT02106403|5620648|P1|NOT COMPLETED|Visit 1, Treatment Period 3||0
2288951|NCT02106403|5620643|P6|COMPLETED|Visit 1, Treatment Period 3||9
2288952|NCT02106403|5620644|P5|COMPLETED|Visit 1, Treatment Period 3||8
2288953|NCT02106403|5620645|P4|COMPLETED|Visit 1, Treatment Period 3||8
2288954|NCT02106403|5620646|P3|COMPLETED|Visit 1, Treatment Period 3||9
2288955|NCT02106403|5620647|P2|COMPLETED|Visit 1, Treatment Period 3||8
2288956|NCT02106403|5620648|P1|COMPLETED|Visit 1, Treatment Period 3||8
2288957|NCT02106403|5620643|P6|STARTED|Visit 1, Treatment Period 3||9
2288958|NCT02106403|5620644|P5|STARTED|Visit 1, Treatment Period 3||8
2288959|NCT02106403|5620645|P4|STARTED|Visit 1, Treatment Period 3||8
2288960|NCT02106403|5620646|P3|STARTED|Visit 1, Treatment Period 3||9
2288961|NCT02106403|5620647|P2|STARTED|Visit 1, Treatment Period 3||8
2288962|NCT02106403|5620648|P1|STARTED|Visit 1, Treatment Period 3||8
2288963|NCT02106403|5620643|P6|NOT COMPLETED|Visit 1, Treatment Period 2||0
2288964|NCT02106403|5620644|P5|NOT COMPLETED|Visit 1, Treatment Period 2||0
2288965|NCT02106403|5620645|P4|NOT COMPLETED|Visit 1, Treatment Period 2||0
2288966|NCT02106403|5620646|P3|NOT COMPLETED|Visit 1, Treatment Period 2||0
2288967|NCT02106403|5620647|P2|NOT COMPLETED|Visit 1, Treatment Period 2||0
2288968|NCT02106403|5620648|P1|NOT COMPLETED|Visit 1, Treatment Period 2||0
2288969|NCT02106403|5620643|P6|COMPLETED|Visit 1, Treatment Period 2||9
2288970|NCT02106403|5620644|P5|COMPLETED|Visit 1, Treatment Period 2||8
2288971|NCT02106403|5620645|P4|COMPLETED|Visit 1, Treatment Period 2||8
2288972|NCT02106403|5620646|P3|COMPLETED|Visit 1, Treatment Period 2||9
2288973|NCT02106403|5620647|P2|COMPLETED|Visit 1, Treatment Period 2||8
2288974|NCT02106403|5620648|P1|COMPLETED|Visit 1, Treatment Period 2||8
2288975|NCT02106403|5620643|P6|STARTED|Visit 1, Treatment Period 2||9
2288976|NCT02106403|5620644|P5|STARTED|Visit 1, Treatment Period 2||8
2288977|NCT02106403|5620645|P4|STARTED|Visit 1, Treatment Period 2||8
2288978|NCT02106403|5620646|P3|STARTED|Visit 1, Treatment Period 2||9
2288979|NCT02106403|5620647|P2|STARTED|Visit 1, Treatment Period 2||8
2288980|NCT02106403|5620648|P1|STARTED|Visit 1, Treatment Period 2||8
2288981|NCT02106403|5620643|P6|NOT COMPLETED|Visit 1, Treatment Period 1||0
2288982|NCT02106403|5620644|P5|NOT COMPLETED|Visit 1, Treatment Period 1||0
2288983|NCT02106403|5620645|P4|NOT COMPLETED|Visit 1, Treatment Period 1||0
2288984|NCT02106403|5620646|P3|NOT COMPLETED|Visit 1, Treatment Period 1||0
2288985|NCT02106403|5620647|P2|NOT COMPLETED|Visit 1, Treatment Period 1||0
2288986|NCT02106403|5620648|P1|NOT COMPLETED|Visit 1, Treatment Period 1||0
2288987|NCT02106403|5620643|P6|COMPLETED|Visit 1, Treatment Period 1||9
2288988|NCT02106403|5620644|P5|COMPLETED|Visit 1, Treatment Period 1||8
2288989|NCT02106403|5620645|P4|COMPLETED|Visit 1, Treatment Period 1||8
2288990|NCT02106403|5620646|P3|COMPLETED|Visit 1, Treatment Period 1||9
2288991|NCT02106403|5620647|P2|COMPLETED|Visit 1, Treatment Period 1||8
2288992|NCT02106403|5620648|P1|COMPLETED|Visit 1, Treatment Period 1||8
2288993|NCT02106403|5620643|P6|STARTED|Visit 1, Treatment Period 1||9
2288994|NCT02106403|5620644|P5|STARTED|Visit 1, Treatment Period 1||8
2288995|NCT02106403|5620645|P4|STARTED|Visit 1, Treatment Period 1||8
2288996|NCT02106403|5620646|P3|STARTED|Visit 1, Treatment Period 1||9
2288997|NCT02106403|5620647|P2|STARTED|Visit 1, Treatment Period 1||8
2288998|NCT02106403|5620648|P1|STARTED|Visit 1, Treatment Period 1||8
2288999|NCT02106390|5620671|P3|NOT COMPLETED|Overall Study||43
2289000|NCT02106390|5620672|P2|NOT COMPLETED|Overall Study||48
2289001|NCT02106390|5620673|P1|NOT COMPLETED|Overall Study||49
2289002|NCT02106390|5620671|P3|COMPLETED|Overall Study||205
2289003|NCT02106390|5620672|P2|COMPLETED|Overall Study||202
2289004|NCT02106390|5620673|P1|COMPLETED|Overall Study||203
2289005|NCT02106390|5620671|P3|STARTED|Overall Study||248
2289006|NCT02106390|5620672|P2|STARTED|Overall Study||250
2289007|NCT02106390|5620673|P1|STARTED|Overall Study||252
2289008|NCT02106351|5620750|P3|NOT COMPLETED|Treatment Cycle 4||2
2289009|NCT02106351|5620751|P2|NOT COMPLETED|Treatment Cycle 4||1
2289010|NCT02106351|5620752|P1|NOT COMPLETED|Treatment Cycle 4||0
2289011|NCT02106351|5620750|P3|COMPLETED|Treatment Cycle 4||31
2289012|NCT02106351|5620751|P2|COMPLETED|Treatment Cycle 4||21
2289013|NCT02106351|5620752|P1|COMPLETED|Treatment Cycle 4||0
2289014|NCT02106351|5620750|P3|STARTED|Treatment Cycle 4|Not all subjects who completed TC 3 required retreatment in TC 4.|33
2289015|NCT02106351|5620751|P2|STARTED|Treatment Cycle 4|Not all subjects who completed TC 3 required retreatment in TC 4.|22
2289016|NCT02106351|5620752|P1|STARTED|Treatment Cycle 4||0
2289017|NCT02106351|5620750|P3|NOT COMPLETED|Treatment Cycle 3||5
2289018|NCT02106351|5620751|P2|NOT COMPLETED|Treatment Cycle 3||4
2289019|NCT02106351|5620752|P1|NOT COMPLETED|Treatment Cycle 3||0
2289020|NCT02106351|5620750|P3|COMPLETED|Treatment Cycle 3||53
2289021|NCT02106351|5620751|P2|COMPLETED|Treatment Cycle 3||45
2289022|NCT02106351|5620752|P1|COMPLETED|Treatment Cycle 3||0
2289023|NCT02106351|5620750|P3|STARTED|Treatment Cycle 3|Not all subjects who completed TC 2 required retreatment in TC 3.|58
2289024|NCT02106351|5620751|P2|STARTED|Treatment Cycle 3|Not all subjects who completed TC 2 required retreatment in TC 3.|49
2289025|NCT02106351|5620752|P1|STARTED|Treatment Cycle 3||0
2289026|NCT02106351|5620750|P3|NOT COMPLETED|Treatment Cycle 2||3
2289027|NCT02106351|5620751|P2|NOT COMPLETED|Treatment Cycle 2||5
2289028|NCT02106351|5620752|P1|NOT COMPLETED|Treatment Cycle 2||0
2289029|NCT02106351|5620750|P3|COMPLETED|Treatment Cycle 2||87
2289030|NCT02106351|5620751|P2|COMPLETED|Treatment Cycle 2||83
2289031|NCT02106351|5620752|P1|COMPLETED|Treatment Cycle 2||0
2289032|NCT02106351|5620750|P3|STARTED|Treatment Cycle 2|Not all subjects who completed TC 1 required retreatment in TC 2.|90
2289033|NCT02106351|5620751|P2|STARTED|Treatment Cycle 2|Not all subjects who completed TC 1 required retreatment in TC 2.|88
2289034|NCT02106351|5620752|P1|STARTED|Treatment Cycle 2|Subjects who received Dysport 2 U/kg in TC 1 were randomised to receive 8 or 16 U/kg in TCs 2-4.|0
2289035|NCT02106351|5620750|P3|NOT COMPLETED|Treatment Cycle 1||4
2289036|NCT02106351|5620751|P2|NOT COMPLETED|Treatment Cycle 1||3
2289037|NCT02106351|5620752|P1|NOT COMPLETED|Treatment Cycle 1||5
2289038|NCT02106351|5620750|P3|COMPLETED|Treatment Cycle 1||67
2289039|NCT02106351|5620751|P2|COMPLETED|Treatment Cycle 1||67
2289040|NCT02106351|5620752|P1|COMPLETED|Treatment Cycle 1||66
2289041|NCT02106351|5620750|P3|Received Treatment in TC 1|Treatment Cycle 1||70
2289042|NCT02106351|5620751|P2|Received Treatment in TC 1|Treatment Cycle 1||70
2289043|NCT02106351|5620752|P1|Received Treatment in TC 1|Treatment Cycle 1||70
2289044|NCT02106351|5620750|P3|STARTED|Treatment Cycle 1||71
2289045|NCT02106351|5620751|P2|STARTED|Treatment Cycle 1||70
2289046|NCT02106351|5620752|P1|STARTED|Treatment Cycle 1||71
2289047|NCT02106325|5620795|P2|NOT COMPLETED|Phase 3||1
2289048|NCT02106325|5620796|P1|NOT COMPLETED|Phase 3||2
2289049|NCT02106325|5620795|P2|COMPLETED|Phase 3||2
2289050|NCT02106325|5620796|P1|COMPLETED|Phase 3||0
2289051|NCT02106325|5620795|P2|STARTED|Phase 3||3
2289052|NCT02106325|5620796|P1|STARTED|Phase 3||2
2289053|NCT02106325|5620795|P2|NOT COMPLETED|Phase 2||3
2289054|NCT02106325|5620796|P1|NOT COMPLETED|Phase 2||2
2289055|NCT02106325|5620795|P2|COMPLETED|Phase 2||1
2289056|NCT02106325|5620796|P1|COMPLETED|Phase 2||2
2289057|NCT02106325|5620795|P2|STARTED|Phase 2||4
2289058|NCT02106325|5620796|P1|STARTED|Phase 2||4
2289059|NCT02106325|5620795|P2|NOT COMPLETED|Phase 1||2
2289060|NCT02106325|5620796|P1|NOT COMPLETED|Phase 1||2
2289061|NCT02106325|5620795|P2|COMPLETED|Phase 1||1
2289062|NCT02106325|5620796|P1|COMPLETED|Phase 1||3
2289063|NCT02106325|5620795|P2|STARTED|Phase 1||3
2289064|NCT02106325|5620796|P1|STARTED|Phase 1||5
2289065|NCT02106156|5620821|P3|NOT COMPLETED|Overall Study||0
2289066|NCT02106156|5620822|P2|NOT COMPLETED|Overall Study||40
2289067|NCT02106156|5620823|P1|NOT COMPLETED|Overall Study||2549
2289068|NCT02106156|5620821|P3|COMPLETED|Overall Study||518
2289069|NCT02106156|5620822|P2|COMPLETED|Overall Study||50
2289070|NCT02106156|5620823|P1|COMPLETED|Overall Study||7071
2289071|NCT02106156|5620821|P3|STARTED|Overall Study||518
2289072|NCT02106156|5620822|P2|STARTED|Overall Study||90
2289073|NCT02106156|5620823|P1|STARTED|Overall Study||9620
2289074|NCT02105987|5620847|P6|NOT COMPLETED|Continuation Phase||0
2289075|NCT02105987|5620848|P5|NOT COMPLETED|Continuation Phase||1
2289076|NCT02105987|5620849|P4|NOT COMPLETED|Continuation Phase||0
2289077|NCT02105987|5620850|P3|NOT COMPLETED|Continuation Phase||0
2289078|NCT02105987|5620851|P2|NOT COMPLETED|Continuation Phase||0
2289079|NCT02105987|5620852|P1|NOT COMPLETED|Continuation Phase||0
2289080|NCT02105987|5620847|P6|COMPLETED|Continuation Phase||23
2289081|NCT02105987|5620848|P5|COMPLETED|Continuation Phase||13
2289082|NCT02105987|5620849|P4|COMPLETED|Continuation Phase||0
2289083|NCT02105987|5620850|P3|COMPLETED|Continuation Phase||0
2289084|NCT02105987|5620851|P2|COMPLETED|Continuation Phase||0
2289085|NCT02105987|5620852|P1|COMPLETED|Continuation Phase||0
2289086|NCT02105987|5620847|P6|STARTED|Continuation Phase||23
2289087|NCT02105987|5620848|P5|STARTED|Continuation Phase||14
2289088|NCT02105987|5620849|P4|STARTED|Continuation Phase||0
2289089|NCT02105987|5620850|P3|STARTED|Continuation Phase||0
2289090|NCT02105987|5620851|P2|STARTED|Continuation Phase||0
2289091|NCT02105987|5620852|P1|STARTED|Continuation Phase||0
2289092|NCT02105987|5620847|P6|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
2289093|NCT02105987|5620848|P5|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
2289094|NCT02105987|5620849|P4|NOT COMPLETED|Late Switch Phase (24 Weeks)||14
2289095|NCT02105987|5620850|P3|NOT COMPLETED|Late Switch Phase (24 Weeks)||45
2289096|NCT02105987|5620851|P2|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
2289097|NCT02105987|5620852|P1|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
2289098|NCT02105987|5620847|P6|COMPLETED|Late Switch Phase (24 Weeks)||0
2289099|NCT02105987|5620848|P5|COMPLETED|Late Switch Phase (24 Weeks)||0
2289100|NCT02105987|5620849|P4|COMPLETED|Late Switch Phase (24 Weeks)||230
2289101|NCT02105987|5620850|P3|COMPLETED|Late Switch Phase (24 Weeks)||230
2289102|NCT02105987|5620851|P2|COMPLETED|Late Switch Phase (24 Weeks)||0
2289103|NCT02105987|5620852|P1|COMPLETED|Late Switch Phase (24 Weeks)||0
2289104|NCT02105987|5620847|P6|STARTED|Late Switch Phase (24 Weeks)||0
2289105|NCT02105987|5620848|P5|STARTED|Late Switch Phase (24 Weeks)||0
2289106|NCT02105987|5620849|P4|STARTED|Late Switch Phase (24 Weeks)||244
2289107|NCT02105987|5620850|P3|STARTED|Late Switch Phase (24 Weeks)||275
2289108|NCT02105987|5620851|P2|STARTED|Late Switch Phase (24 Weeks)||0
2289109|NCT02105987|5620852|P1|STARTED|Late Switch Phase (24 Weeks)||0
2289110|NCT02105987|5620847|P6|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
2289111|NCT02105987|5620848|P5|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
2289112|NCT02105987|5620849|P4|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
2289113|NCT02105987|5620850|P3|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
2289114|NCT02105987|5620851|P2|NOT COMPLETED|Early Switch Phase (24 Weeks)||34
2289115|NCT02105987|5620852|P1|NOT COMPLETED|Early Switch Phase (24 Weeks)||36
2289116|NCT02105987|5620847|P6|COMPLETED|Early Switch Phase (24 Weeks)||0
2289117|NCT02105987|5620848|P5|COMPLETED|Early Switch Phase (24 Weeks)||0
2289118|NCT02105987|5620849|P4|COMPLETED|Early Switch Phase (24 Weeks)||0
2289119|NCT02105987|5620850|P3|COMPLETED|Early Switch Phase (24 Weeks)||0
2289120|NCT02105987|5620851|P2|COMPLETED|Early Switch Phase (24 Weeks)||244
2289121|NCT02105987|5620852|P1|COMPLETED|Early Switch Phase (24 Weeks)||239
2289122|NCT02105987|5620847|P6|STARTED|Early Switch Phase (24 Weeks)||0
2289123|NCT02105987|5620848|P5|STARTED|Early Switch Phase (24 Weeks)||0
2289124|NCT02105987|5620849|P4|STARTED|Early Switch Phase (24 Weeks)||0
2289125|NCT02105987|5620850|P3|STARTED|Early Switch Phase (24 Weeks)||0
2289200|NCT02105948|5620947|P4|Withdrew IP Due to: Physician Decision|Overall Study||2
2289126|NCT02105987|5620851|P2|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|278
2289127|NCT02105987|5620852|P1|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|275
2289128|NCT02105974|5620906|P3|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||58
2289129|NCT02105974|5620907|P2|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||42
2289130|NCT02105974|5620908|P1|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||0
2289131|NCT02105974|5620906|P3|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|756
2289132|NCT02105974|5620907|P2|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|764
2289133|NCT02105974|5620908|P1|COMPLETED|12 Week (Wk) Treatment Period (TP)||0
2289134|NCT02105974|5620906|P3|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|754
2289135|NCT02105974|5620907|P2|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|764
2289136|NCT02105974|5620908|P1|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)||0
2289137|NCT02105974|5620906|P3|STARTED|12 Week (Wk) Treatment Period (TP)||814
2289138|NCT02105974|5620907|P2|STARTED|12 Week (Wk) Treatment Period (TP)||806
2289139|NCT02105974|5620908|P1|STARTED|12 Week (Wk) Treatment Period (TP)||0
2289140|NCT02105974|5620906|P3|NOT COMPLETED|2 Week Run-in Period||0
2289141|NCT02105974|5620907|P2|NOT COMPLETED|2 Week Run-in Period||0
2289142|NCT02105974|5620908|P1|NOT COMPLETED|2 Week Run-in Period||801
2289143|NCT02105974|5620906|P3|COMPLETED|2 Week Run-in Period||0
2289144|NCT02105974|5620907|P2|COMPLETED|2 Week Run-in Period||0
2289145|NCT02105974|5620908|P1|COMPLETED|2 Week Run-in Period||1622
2289146|NCT02105974|5620906|P3|STARTED|2 Week Run-in Period||0
2289147|NCT02105974|5620907|P2|STARTED|2 Week Run-in Period||0
2289148|NCT02105974|5620908|P1|STARTED|2 Week Run-in Period||2423
2289149|NCT02105961|5620921|P3|NOT COMPLETED|Overall Study||30
2289150|NCT02105961|5620922|P2|NOT COMPLETED|Overall Study||17
2289151|NCT02105961|5620923|P1|NOT COMPLETED|Overall Study||41
2289152|NCT02105961|5620921|P3|COMPLETED|Overall Study||195
2289153|NCT02105961|5620922|P2|COMPLETED|Overall Study||206
2289154|NCT02105961|5620923|P1|COMPLETED|Overall Study||185
2289155|NCT02105961|5620921|P3|Withdrew IP Due to: Site Closed|Overall Study||1
2289156|NCT02105961|5620922|P2|Withdrew IP Due to: Site Closed|Overall Study||0
2289157|NCT02105961|5620923|P1|Withdrew IP Due to: Site Closed|Overall Study||1
2289158|NCT02105961|5620921|P3|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
2289159|NCT02105961|5620922|P2|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
2289160|NCT02105961|5620923|P1|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16
2289161|NCT02105961|5620921|P3|Withdrew IP Due to: Physician Decision|Overall Study||1
2289162|NCT02105961|5620922|P2|Withdrew IP Due to: Physician Decision|Overall Study||3
2289163|NCT02105961|5620923|P1|Withdrew IP Due to: Physician Decision|Overall Study||2
2289164|NCT02105961|5620921|P3|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
2289165|NCT02105961|5620922|P2|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
2289166|NCT02105961|5620923|P1|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
2289167|NCT02105961|5620921|P3|Withdrew IP Due to: Protocol Deviation|Overall Study||1
2289168|NCT02105961|5620922|P2|Withdrew IP Due to: Protocol Deviation|Overall Study||0
2289169|NCT02105961|5620923|P1|Withdrew IP Due to: Protocol Deviation|Overall Study||2
2289170|NCT02105961|5620921|P3|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
2289171|NCT02105961|5620922|P2|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
2289172|NCT02105961|5620923|P1|Withdrew IP Due to: Lack of Efficacy|Overall Study||6
2289173|NCT02105961|5620921|P3|Withdrew IP Due to: Stopping Criteria|Overall Study||0
2289174|NCT02105961|5620922|P2|Withdrew IP Due to: Stopping Criteria|Overall Study||1
2289175|NCT02105961|5620923|P1|Withdrew IP Due to: Stopping Criteria|Overall Study||1
2289176|NCT02105961|5620921|P3|Withdrew IP Due to: Adverse Event|Overall Study||25
2289177|NCT02105961|5620922|P2|Withdrew IP Due to: Adverse Event|Overall Study||9
2289178|NCT02105961|5620923|P1|Withdrew IP Due to: Adverse Event|Overall Study||27
2289179|NCT02105961|5620921|P3|Not Completed IP|Overall Study||42
2289180|NCT02105961|5620922|P2|Not Completed IP|Overall Study||27
2289181|NCT02105961|5620923|P1|Not Completed IP|Overall Study||56
2289182|NCT02105961|5620921|P3|Completed Investigational Product (IP)|Overall Study||183
2289183|NCT02105961|5620922|P2|Completed Investigational Product (IP)|Overall Study||196
2289184|NCT02105961|5620923|P1|Completed Investigational Product (IP)|Overall Study||170
2289185|NCT02105961|5620921|P3|STARTED|Overall Study||225
2289186|NCT02105961|5620922|P2|STARTED|Overall Study||223
2289187|NCT02105961|5620923|P1|STARTED|Overall Study||226
2289188|NCT02105948|5620947|P4|NOT COMPLETED|Overall Study||27
2289189|NCT02105948|5620948|P3|NOT COMPLETED|Overall Study||28
2289190|NCT02105948|5620949|P2|NOT COMPLETED|Overall Study||20
2289191|NCT02105948|5620950|P1|NOT COMPLETED|Overall Study||27
2289192|NCT02105948|5620947|P4|COMPLETED|Overall Study||157
2289193|NCT02105948|5620948|P3|COMPLETED|Overall Study||162
2289194|NCT02105948|5620949|P2|COMPLETED|Overall Study||213
2289195|NCT02105948|5620950|P1|COMPLETED|Overall Study||202
2289196|NCT02105948|5620947|P4|Withdrew IP Due to: Stopping Criteria|Overall Study||1
2289197|NCT02105948|5620948|P3|Withdrew IP Due to: Stopping Criteria|Overall Study||0
2289198|NCT02105948|5620949|P2|Withdrew IP Due to: Stopping Criteria|Overall Study||0
2289199|NCT02105948|5620950|P1|Withdrew IP Due to: Stopping Criteria|Overall Study||0
2289280|NCT02105558|5621055|P1|COMPLETED|Overall Study||15
2289201|NCT02105948|5620948|P3|Withdrew IP Due to: Physician Decision|Overall Study||4
2289202|NCT02105948|5620949|P2|Withdrew IP Due to: Physician Decision|Overall Study||1
2289203|NCT02105948|5620950|P1|Withdrew IP Due to: Physician Decision|Overall Study||2
2289204|NCT02105948|5620947|P4|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||15
2289205|NCT02105948|5620948|P3|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
2289206|NCT02105948|5620949|P2|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||8
2289207|NCT02105948|5620950|P1|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16
2289208|NCT02105948|5620947|P4|Withdrew IP Due to: Lost to Follow-up|Overall Study||2
2289209|NCT02105948|5620948|P3|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
2289210|NCT02105948|5620949|P2|Withdrew IP Due to: Lost to Follow-up|Overall Study||0
2289211|NCT02105948|5620950|P1|Withdrew IP Due to: Lost to Follow-up|Overall Study||0
2289212|NCT02105948|5620947|P4|Withdrew IP Due to: Protocol Deviation|Overall Study||0
2289213|NCT02105948|5620948|P3|Withdrew IP Due to: Protocol Deviation|Overall Study||3
2289214|NCT02105948|5620949|P2|Withdrew IP Due to: Protocol Deviation|Overall Study||3
2289215|NCT02105948|5620950|P1|Withdrew IP Due to: Protocol Deviation|Overall Study||1
2289216|NCT02105948|5620947|P4|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
2289217|NCT02105948|5620948|P3|Withdrew IP Due to: Lack of Efficacy|Overall Study||8
2289218|NCT02105948|5620949|P2|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
2289219|NCT02105948|5620950|P1|Withdrew IP Due to: Lack of Efficacy|Overall Study||5
2289220|NCT02105948|5620947|P4|Withdrew IP Due to: Adverse Event|Overall Study||13
2289221|NCT02105948|5620948|P3|Withdrew IP Due to: Adverse Event|Overall Study||15
2289222|NCT02105948|5620949|P2|Withdrew IP Due to: Adverse Event|Overall Study||16
2289223|NCT02105948|5620950|P1|Withdrew IP Due to: Adverse Event|Overall Study||20
2289224|NCT02105948|5620947|P4|Not Completed IP|Overall Study||35
2289225|NCT02105948|5620948|P3|Not Completed IP|Overall Study||42
2289226|NCT02105948|5620949|P2|Not Completed IP|Overall Study||30
2289227|NCT02105948|5620950|P1|Not Completed IP|Overall Study||44
2289228|NCT02105948|5620947|P4|Completed Investigational Product (IP)|Overall Study||149
2289229|NCT02105948|5620948|P3|Completed Investigational Product (IP)|Overall Study||148
2289230|NCT02105948|5620949|P2|Completed Investigational Product (IP)|Overall Study||203
2289231|NCT02105948|5620950|P1|Completed Investigational Product (IP)|Overall Study||185
2289232|NCT02105948|5620947|P4|STARTED|Overall Study||184
2289233|NCT02105948|5620948|P3|STARTED|Overall Study||190
2289234|NCT02105948|5620949|P2|STARTED|Overall Study||233
2289235|NCT02105948|5620950|P1|STARTED|Overall Study||229
2289236|NCT02105740|5620978|P2|NOT COMPLETED|Overall Study||1
2289237|NCT02105740|5620979|P1|NOT COMPLETED|Overall Study||0
2289238|NCT02105740|5620978|P2|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|11
2289239|NCT02105740|5620979|P1|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|12
2289240|NCT02105740|5620978|P2|Second|Overall Study|Application of EVA and HADS scales. One accompanying lost|11
2289241|NCT02105740|5620979|P1|Second|Overall Study|Intervention with hypnosis and application of EVA scales and HADS (n = 12)|12
2289242|NCT02105740|5620978|P2|STARTED|Overall Study|Application of EVA and HADS scales|12
2289243|NCT02105740|5620979|P1|STARTED|Overall Study|Application of EVA and HADS scales and after that application of hypnosis intervention|12
2289244|NCT02105701|5620991|P4|NOT COMPLETED|Overall Study||2
2289245|NCT02105701|5620992|P3|NOT COMPLETED|Overall Study||3
2289246|NCT02105701|5620993|P2|NOT COMPLETED|Overall Study||1
2289247|NCT02105701|5620994|P1|NOT COMPLETED|Overall Study||4
2289248|NCT02105701|5620991|P4|COMPLETED|Overall Study||104
2289249|NCT02105701|5620992|P3|COMPLETED|Overall Study||102
2289250|NCT02105701|5620993|P2|COMPLETED|Overall Study||103
2289251|NCT02105701|5620994|P1|COMPLETED|Overall Study||101
2289252|NCT02105701|5620991|P4|STARTED|Overall Study||106
2289253|NCT02105701|5620992|P3|STARTED|Overall Study||105
2289254|NCT02105701|5620993|P2|STARTED|Overall Study||104
2289255|NCT02105701|5620994|P1|STARTED|Overall Study||105
2289256|NCT02105688|5621018|P2|NOT COMPLETED|Part B: Observational Follow-up||20
2289257|NCT02105688|5621019|P1|NOT COMPLETED|Part B: Observational Follow-up||37
2289258|NCT02105688|5621018|P2|COMPLETED|Part B: Observational Follow-up|Completed Part B extension|48
2289259|NCT02105688|5621019|P1|COMPLETED|Part B: Observational Follow-up|Completed Part B extension|94
2289260|NCT02105688|5621018|P2|STARTED|Part B: Observational Follow-up|Completed Part A and met Part B Extension criteria|68
2289261|NCT02105688|5621019|P1|STARTED|Part B: Observational Follow-up|Completed Part A and met Part B Extension criteria|131
2289262|NCT02105688|5621018|P2|NOT COMPLETED|Part A: Double-Blind||17
2289263|NCT02105688|5621019|P1|NOT COMPLETED|Part A: Double-Blind||20
2289264|NCT02105688|5621018|P2|COMPLETED|Part A: Double-Blind|Completed Part A|83
2289265|NCT02105688|5621019|P1|COMPLETED|Part A: Double-Blind|Completed Part A|181
2289266|NCT02105688|5621018|P2|STARTED|Part A: Double-Blind||100
2289267|NCT02105688|5621019|P1|STARTED|Part A: Double-Blind||201
2289268|NCT02105662|5621032|P1|NOT COMPLETED|Overall Study||6
2289269|NCT02105662|5621032|P1|COMPLETED|Overall Study||212
2289270|NCT02105662|5621032|P1|STARTED|Overall Study||218
2289271|NCT02105636|5621041|P2|NOT COMPLETED|Overall Study||108
2289272|NCT02105636|5621042|P1|NOT COMPLETED|Overall Study||195
2289273|NCT02105636|5621041|P2|COMPLETED|Overall Study|Completed=Still on Treatment|3
2289274|NCT02105636|5621042|P1|COMPLETED|Overall Study|Completed=Still on Treatment|41
2289275|NCT02105636|5621041|P2|STARTED|Overall Study||111
2289276|NCT02105636|5621042|P1|STARTED|Overall Study||236
2289277|NCT02105558|5621054|P2|NOT COMPLETED|Overall Study||0
2289278|NCT02105558|5621055|P1|NOT COMPLETED|Overall Study||0
2289279|NCT02105558|5621054|P2|COMPLETED|Overall Study||28
2289281|NCT02105558|5621054|P2|STARTED|Overall Study||28
2289282|NCT02105558|5621055|P1|STARTED|Overall Study||15
2289283|NCT02105467|5621085|P2|NOT COMPLETED|Period 3||1
2289284|NCT02105467|5621086|P1|NOT COMPLETED|Period 3||0
2289285|NCT02105467|5621085|P2|COMPLETED|Period 3||102
2289286|NCT02105467|5621086|P1|COMPLETED|Period 3||0
2289287|NCT02105467|5621085|P2|STARTED|Period 3|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|103
2289288|NCT02105467|5621086|P1|STARTED|Period 3|The Immediate Treatment Group completed the study with Period 2|0
2289289|NCT02105467|5621085|P2|NOT COMPLETED|Period 2||2
2289290|NCT02105467|5621086|P1|NOT COMPLETED|Period 2||2
2289291|NCT02105467|5621085|P2|COMPLETED|Period 2||102
2289292|NCT02105467|5621086|P1|COMPLETED|Period 2||312
2289293|NCT02105467|5621085|P2|STARTED|Period 2|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|104
2289294|NCT02105467|5621086|P1|STARTED|Period 2||314
2289295|NCT02105467|5621085|P2|NOT COMPLETED|Period 1||0
2289296|NCT02105467|5621086|P1|NOT COMPLETED|Period 1||2
2289297|NCT02105467|5621085|P2|COMPLETED|Period 1||105
2289298|NCT02105467|5621086|P1|COMPLETED|Period 1||314
2289299|NCT02105467|5621085|P2|STARTED|Period 1||105
2289300|NCT02105467|5621086|P1|STARTED|Period 1||316
2289301|NCT02105454|5621098|P1|NOT COMPLETED|Overall Study||1
2289302|NCT02105454|5621098|P1|COMPLETED|Overall Study||78
2289303|NCT02105454|5621098|P1|STARTED|Overall Study||79
2289304|NCT02105415|5621107|P2|NOT COMPLETED|Overall Study||5
2289305|NCT02105415|5621108|P1|NOT COMPLETED|Overall Study||3
2289306|NCT02105415|5621107|P2|COMPLETED|Overall Study||79
2289307|NCT02105415|5621108|P1|COMPLETED|Overall Study||73
2289308|NCT02105415|5621107|P2|STARTED|Overall Study||84
2289309|NCT02105415|5621108|P1|STARTED|Overall Study||76
2289310|NCT02105324|5621130|P2|NOT COMPLETED|Period 2||0
2289311|NCT02105324|5621131|P1|NOT COMPLETED|Period 2||0
2289312|NCT02105324|5621130|P2|COMPLETED|Period 2||10
2289313|NCT02105324|5621131|P1|COMPLETED|Period 2||9
2289314|NCT02105324|5621130|P2|STARTED|Period 2||10
2289315|NCT02105324|5621131|P1|STARTED|Period 2||9
2289316|NCT02105324|5621130|P2|NOT COMPLETED|Period 1||0
2289317|NCT02105324|5621131|P1|NOT COMPLETED|Period 1||0
2289318|NCT02105324|5621130|P2|COMPLETED|Period 1||10
2289319|NCT02105324|5621131|P1|COMPLETED|Period 1||9
2289320|NCT02105324|5621130|P2|STARTED|Period 1||10
2289321|NCT02105324|5621131|P1|STARTED|Period 1||9
2289322|NCT02105285|5621210|P3|NOT COMPLETED|Overall Study||0
2289323|NCT02105285|5621211|P2|NOT COMPLETED|Overall Study||2
2289324|NCT02105285|5621212|P1|NOT COMPLETED|Overall Study||2
2289325|NCT02105285|5621210|P3|COMPLETED|Overall Study||37
2289326|NCT02105285|5621211|P2|COMPLETED|Overall Study||76
2289327|NCT02105285|5621212|P1|COMPLETED|Overall Study||76
2289328|NCT02105285|5621210|P3|STARTED|Overall Study||37
2289329|NCT02105285|5621211|P2|STARTED|Overall Study||78
2289330|NCT02105285|5621212|P1|STARTED|Overall Study||78
2289331|NCT02105272|5621231|P2|NOT COMPLETED|Overall Study||3
2289332|NCT02105272|5621232|P1|NOT COMPLETED|Overall Study||5
2289333|NCT02105272|5621231|P2|COMPLETED|Overall Study||116
2289334|NCT02105272|5621232|P1|COMPLETED|Overall Study||113
2289335|NCT02105272|5621231|P2|STARTED|Overall Study||119
2289336|NCT02105272|5621232|P1|STARTED|Overall Study||118
2289337|NCT02105246|5621250|P2|NOT COMPLETED|Overall Study||0
2289338|NCT02105246|5621251|P1|NOT COMPLETED|Overall Study||0
2289339|NCT02105246|5621250|P2|COMPLETED|Overall Study||597
2289340|NCT02105246|5621251|P1|COMPLETED|Overall Study||557
2289341|NCT02105246|5621250|P2|STARTED|Overall Study||597
2289342|NCT02105246|5621251|P1|STARTED|Overall Study||557
2289343|NCT02105116|5621261|P1|NOT COMPLETED|Overall Study||6
2289344|NCT02105116|5621261|P1|COMPLETED|Overall Study||0
2289345|NCT02105116|5621261|P1|STARTED|Overall Study||6
2289346|NCT02105012|5621268|P1|NOT COMPLETED|Overall Study||33
2289347|NCT02105012|5621268|P1|COMPLETED|Overall Study||114
2289348|NCT02105012|5621268|P1|Placebo MDI|Overall Study||127
2289349|NCT02105012|5621268|P1|BD MDI 40 µg|Overall Study||63
2289350|NCT02105012|5621268|P1|BD MDI 80 µg|Overall Study||64
2289351|NCT02105012|5621268|P1|BD MDI 160 µg|Overall Study||132
2289352|NCT02105012|5621268|P1|BD MDI 320 µg|Overall Study||124
2289353|NCT02105012|5621268|P1|STARTED|Overall Study||147
2289354|NCT02104947|5621302|P2|NOT COMPLETED|Overall Study||56
2289355|NCT02104947|5621303|P1|NOT COMPLETED|Overall Study||79
2289356|NCT02104947|5621302|P2|COMPLETED|Overall Study||146
2289357|NCT02104947|5621303|P1|COMPLETED|Overall Study||222
2289358|NCT02104947|5621302|P2|STARTED|Overall Study||202
2289359|NCT02104947|5621303|P1|STARTED|Overall Study||301
2289360|NCT02104895|5621321|P2|NOT COMPLETED|Overall Study||14
2289361|NCT02104895|5621322|P1|NOT COMPLETED|Overall Study||0
2289362|NCT02104895|5621321|P2|COMPLETED|Overall Study||246
2289363|NCT02104895|5621322|P1|COMPLETED|Overall Study||260
2289364|NCT02104895|5621321|P2|STARTED|Overall Study||260
2289365|NCT02104895|5621322|P1|STARTED|Overall Study||260
2289366|NCT02104830|5621335|P3|NOT COMPLETED|Overall Study||7
2289367|NCT02104830|5621336|P2|NOT COMPLETED|Overall Study||7
2289368|NCT02104830|5621337|P1|NOT COMPLETED|Overall Study||4
2289369|NCT02104830|5621335|P3|COMPLETED|Overall Study||36
2289370|NCT02104830|5621336|P2|COMPLETED|Overall Study||36
2289371|NCT02104830|5621337|P1|COMPLETED|Overall Study||38
2289372|NCT02104830|5621335|P3|STARTED|Overall Study||43
2289373|NCT02104830|5621336|P2|STARTED|Overall Study||43
2289374|NCT02104830|5621337|P1|STARTED|Overall Study||42
2289375|NCT02104804|5621362|P2|NOT COMPLETED|Overall Study||19
2289376|NCT02104804|5621363|P1|NOT COMPLETED|Overall Study||16
2289377|NCT02104804|5621362|P2|COMPLETED|Overall Study|Of the 19 who did not complete, 1 did not take study medication after randomization.|213
2289378|NCT02104804|5621363|P1|COMPLETED|Overall Study|Number of patients who completed 24 weeks of treatment|218
2289379|NCT02104804|5621362|P2|STARTED|Overall Study|Number of patients who were randomized|232
2289380|NCT02104804|5621363|P1|STARTED|Overall Study|Number of patients who were randomized|234
2289381|NCT02104765|5621386|P7|NOT COMPLETED|Overall Study||1
2289382|NCT02104765|5621387|P6|NOT COMPLETED|Overall Study||0
2289383|NCT02104765|5621388|P5|NOT COMPLETED|Overall Study||1
2289384|NCT02104765|5621389|P4|NOT COMPLETED|Overall Study||1
2289385|NCT02104765|5621390|P3|NOT COMPLETED|Overall Study||1
2289386|NCT02104765|5621391|P2|NOT COMPLETED|Overall Study||0
2289387|NCT02104765|5621392|P1|NOT COMPLETED|Overall Study||0
2289388|NCT02104765|5621386|P7|COMPLETED|Overall Study||7
2289389|NCT02104765|5621387|P6|COMPLETED|Overall Study||2
2289390|NCT02104765|5621388|P5|COMPLETED|Overall Study||7
2289391|NCT02104765|5621389|P4|COMPLETED|Overall Study||6
2289392|NCT02104765|5621390|P3|COMPLETED|Overall Study||5
2289393|NCT02104765|5621391|P2|COMPLETED|Overall Study||6
2289394|NCT02104765|5621392|P1|COMPLETED|Overall Study||8
2289395|NCT02104765|5621386|P7|Received at Least 1 Dose of Study Drug|Overall Study||8
2289396|NCT02104765|5621387|P6|Received at Least 1 Dose of Study Drug|Overall Study||2
2289397|NCT02104765|5621388|P5|Received at Least 1 Dose of Study Drug|Overall Study||8
2289398|NCT02104765|5621389|P4|Received at Least 1 Dose of Study Drug|Overall Study||7
2289399|NCT02104765|5621390|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
2289400|NCT02104765|5621391|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
2289401|NCT02104765|5621392|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
2289402|NCT02104765|5621386|P7|STARTED|Overall Study||8
2289403|NCT02104765|5621387|P6|STARTED|Overall Study||2
2289404|NCT02104765|5621388|P5|STARTED|Overall Study||8
2289405|NCT02104765|5621389|P4|STARTED|Overall Study||7
2289406|NCT02104765|5621390|P3|STARTED|Overall Study||6
2289407|NCT02104765|5621391|P2|STARTED|Overall Study||6
2289408|NCT02104765|5621392|P1|STARTED|Overall Study||8
2289409|NCT02104752|5621420|P2|NOT COMPLETED|Overall Study||2
2289410|NCT02104752|5621421|P1|NOT COMPLETED|Overall Study||1
2289411|NCT02104752|5621420|P2|COMPLETED|Overall Study||19
2289412|NCT02104752|5621421|P1|COMPLETED|Overall Study||17
2289413|NCT02104752|5621420|P2|STARTED|Overall Study||21
2289414|NCT02104752|5621421|P1|STARTED|Overall Study||18
2289415|NCT02104739|5621435|P7|NOT COMPLETED|Extension Phase (6 Weeks)||1
2289416|NCT02104739|5621436|P6|NOT COMPLETED|Extension Phase (6 Weeks)||0
2289417|NCT02104739|5621437|P5|NOT COMPLETED|Extension Phase (6 Weeks)||0
2289418|NCT02104739|5621438|P4|NOT COMPLETED|Extension Phase (6 Weeks)||0
2289419|NCT02104739|5621439|P3|NOT COMPLETED|Extension Phase (6 Weeks)||0
2289420|NCT02104739|5621440|P2|NOT COMPLETED|Extension Phase (6 Weeks)||0
2289421|NCT02104739|5621441|P1|NOT COMPLETED|Extension Phase (6 Weeks)||0
2289422|NCT02104739|5621435|P7|COMPLETED|Extension Phase (6 Weeks)||7
2289423|NCT02104739|5621436|P6|COMPLETED|Extension Phase (6 Weeks)||0
2289424|NCT02104739|5621437|P5|COMPLETED|Extension Phase (6 Weeks)||0
2289425|NCT02104739|5621438|P4|COMPLETED|Extension Phase (6 Weeks)||0
2289426|NCT02104739|5621439|P3|COMPLETED|Extension Phase (6 Weeks)||0
2289427|NCT02104739|5621440|P2|COMPLETED|Extension Phase (6 Weeks)||0
2289428|NCT02104739|5621441|P1|COMPLETED|Extension Phase (6 Weeks)||0
2289429|NCT02104739|5621435|P7|STARTED|Extension Phase (6 Weeks)||8
2289430|NCT02104739|5621436|P6|STARTED|Extension Phase (6 Weeks)||0
2289431|NCT02104739|5621437|P5|STARTED|Extension Phase (6 Weeks)||0
2289432|NCT02104739|5621438|P4|STARTED|Extension Phase (6 Weeks)||0
2289433|NCT02104739|5621439|P3|STARTED|Extension Phase (6 Weeks)||0
2289434|NCT02104739|5621440|P2|STARTED|Extension Phase (6 Weeks)||0
2289435|NCT02104739|5621441|P1|STARTED|Extension Phase (6 Weeks)||0
2289436|NCT02104739|5621435|P7|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||1
2289437|NCT02104739|5621436|P6|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
2289438|NCT02104739|5621437|P5|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
2289439|NCT02104739|5621438|P4|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
2289440|NCT02104739|5621439|P3|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
2289441|NCT02104739|5621440|P2|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
2289442|NCT02104739|5621441|P1|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
2289443|NCT02104739|5621435|P7|COMPLETED|Washout (Min of 10 and Max of 323 Days)||7
2289444|NCT02104739|5621436|P6|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
2289445|NCT02104739|5621437|P5|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
2289446|NCT02104739|5621438|P4|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
2289447|NCT02104739|5621439|P3|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
2289448|NCT02104739|5621440|P2|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
2289449|NCT02104739|5621441|P1|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
2289450|NCT02104739|5621435|P7|STARTED|Washout (Min of 10 and Max of 323 Days)||8
2289451|NCT02104739|5621436|P6|STARTED|Washout (Min of 10 and Max of 323 Days)||0
2289452|NCT02104739|5621437|P5|STARTED|Washout (Min of 10 and Max of 323 Days)||0
2289453|NCT02104739|5621438|P4|STARTED|Washout (Min of 10 and Max of 323 Days)||0
2289454|NCT02104739|5621439|P3|STARTED|Washout (Min of 10 and Max of 323 Days)||0
2289455|NCT02104739|5621440|P2|STARTED|Washout (Min of 10 and Max of 323 Days)||0
2289456|NCT02104739|5621441|P1|STARTED|Washout (Min of 10 and Max of 323 Days)||0
2289457|NCT02104739|5621435|P7|NOT COMPLETED|Third Intervention (1 Day)||0
2289458|NCT02104739|5621436|P6|NOT COMPLETED|Third Intervention (1 Day)||0
2289459|NCT02104739|5621437|P5|NOT COMPLETED|Third Intervention (1 Day)||0
2289460|NCT02104739|5621438|P4|NOT COMPLETED|Third Intervention (1 Day)||0
2289461|NCT02104739|5621439|P3|NOT COMPLETED|Third Intervention (1 Day)||0
2289462|NCT02104739|5621440|P2|NOT COMPLETED|Third Intervention (1 Day)||0
2289463|NCT02104739|5621441|P1|NOT COMPLETED|Third Intervention (1 Day)||0
2289464|NCT02104739|5621435|P7|COMPLETED|Third Intervention (1 Day)||0
2289465|NCT02104739|5621436|P6|COMPLETED|Third Intervention (1 Day)||2
2289466|NCT02104739|5621437|P5|COMPLETED|Third Intervention (1 Day)||0
2289467|NCT02104739|5621438|P4|COMPLETED|Third Intervention (1 Day)||7
2289468|NCT02104739|5621439|P3|COMPLETED|Third Intervention (1 Day)||2
2289469|NCT02104739|5621440|P2|COMPLETED|Third Intervention (1 Day)||4
2289470|NCT02104739|5621441|P1|COMPLETED|Third Intervention (1 Day)||1
2289471|NCT02104739|5621435|P7|STARTED|Third Intervention (1 Day)||0
2289472|NCT02104739|5621436|P6|STARTED|Third Intervention (1 Day)||2
2289473|NCT02104739|5621437|P5|STARTED|Third Intervention (1 Day)||0
2289474|NCT02104739|5621438|P4|STARTED|Third Intervention (1 Day)||7
2289475|NCT02104739|5621439|P3|STARTED|Third Intervention (1 Day)||2
2289476|NCT02104739|5621440|P2|STARTED|Third Intervention (1 Day)||4
2289477|NCT02104739|5621441|P1|STARTED|Third Intervention (1 Day)||1
2289478|NCT02104739|5621435|P7|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
2289479|NCT02104739|5621436|P6|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
2289480|NCT02104739|5621437|P5|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
2289481|NCT02104739|5621438|P4|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
2289482|NCT02104739|5621439|P3|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
2289483|NCT02104739|5621440|P2|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
2289484|NCT02104739|5621441|P1|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
2289485|NCT02104739|5621435|P7|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
2289486|NCT02104739|5621436|P6|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
2289487|NCT02104739|5621437|P5|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
2289488|NCT02104739|5621438|P4|COMPLETED|Washout (Min of 10 and Max of 107 Days)||7
2289489|NCT02104739|5621439|P3|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
2289490|NCT02104739|5621440|P2|COMPLETED|Washout (Min of 10 and Max of 107 Days)||4
2289491|NCT02104739|5621441|P1|COMPLETED|Washout (Min of 10 and Max of 107 Days)||1
2289492|NCT02104739|5621435|P7|STARTED|Washout (Min of 10 and Max of 107 Days)||0
2289493|NCT02104739|5621436|P6|STARTED|Washout (Min of 10 and Max of 107 Days)||2
2289494|NCT02104739|5621437|P5|STARTED|Washout (Min of 10 and Max of 107 Days)||0
2289495|NCT02104739|5621438|P4|STARTED|Washout (Min of 10 and Max of 107 Days)||7
2289496|NCT02104739|5621439|P3|STARTED|Washout (Min of 10 and Max of 107 Days)||2
2289497|NCT02104739|5621440|P2|STARTED|Washout (Min of 10 and Max of 107 Days)||4
2289498|NCT02104739|5621441|P1|STARTED|Washout (Min of 10 and Max of 107 Days)||1
2289499|NCT02104739|5621435|P7|NOT COMPLETED|Second Intervention (1 Day)||0
2289500|NCT02104739|5621436|P6|NOT COMPLETED|Second Intervention (1 Day)||0
2289501|NCT02104739|5621437|P5|NOT COMPLETED|Second Intervention (1 Day)||0
2289502|NCT02104739|5621438|P4|NOT COMPLETED|Second Intervention (1 Day)||0
2289503|NCT02104739|5621439|P3|NOT COMPLETED|Second Intervention (1 Day)||0
2289504|NCT02104739|5621440|P2|NOT COMPLETED|Second Intervention (1 Day)||0
2289505|NCT02104739|5621441|P1|NOT COMPLETED|Second Intervention (1 Day)||0
2289506|NCT02104739|5621435|P7|COMPLETED|Second Intervention (1 Day)||0
2289507|NCT02104739|5621436|P6|COMPLETED|Second Intervention (1 Day)||2
2289508|NCT02104739|5621437|P5|COMPLETED|Second Intervention (1 Day)||0
2289509|NCT02104739|5621438|P4|COMPLETED|Second Intervention (1 Day)||7
2289510|NCT02104739|5621439|P3|COMPLETED|Second Intervention (1 Day)||2
2289511|NCT02104739|5621440|P2|COMPLETED|Second Intervention (1 Day)||4
2289512|NCT02104739|5621441|P1|COMPLETED|Second Intervention (1 Day)||1
2289513|NCT02104739|5621435|P7|STARTED|Second Intervention (1 Day)||0
2289514|NCT02104739|5621436|P6|STARTED|Second Intervention (1 Day)||2
2289515|NCT02104739|5621437|P5|STARTED|Second Intervention (1 Day)||0
2289516|NCT02104739|5621438|P4|STARTED|Second Intervention (1 Day)||7
2289517|NCT02104739|5621439|P3|STARTED|Second Intervention (1 Day)||2
2289518|NCT02104739|5621440|P2|STARTED|Second Intervention (1 Day)||4
2289519|NCT02104739|5621441|P1|STARTED|Second Intervention (1 Day)||1
2289520|NCT02104739|5621435|P7|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
2289521|NCT02104739|5621436|P6|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
2289522|NCT02104739|5621437|P5|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
2289523|NCT02104739|5621438|P4|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
2289524|NCT02104739|5621439|P3|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
2289525|NCT02104739|5621440|P2|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
2289526|NCT02104739|5621441|P1|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
2289527|NCT02104739|5621435|P7|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
2289528|NCT02104739|5621436|P6|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
2289529|NCT02104739|5621437|P5|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
2289530|NCT02104739|5621438|P4|COMPLETED|Washout (Min of 10 and Max of 107 Days)||7
2289531|NCT02104739|5621439|P3|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
2289532|NCT02104739|5621440|P2|COMPLETED|Washout (Min of 10 and Max of 107 Days)||4
2289533|NCT02104739|5621441|P1|COMPLETED|Washout (Min of 10 and Max of 107 Days)||1
2289534|NCT02104739|5621435|P7|STARTED|Washout (Min of 10 and Max of 107 Days)||0
2289535|NCT02104739|5621436|P6|STARTED|Washout (Min of 10 and Max of 107 Days)||2
2289536|NCT02104739|5621437|P5|STARTED|Washout (Min of 10 and Max of 107 Days)||0
2289537|NCT02104739|5621438|P4|STARTED|Washout (Min of 10 and Max of 107 Days)||7
2289538|NCT02104739|5621439|P3|STARTED|Washout (Min of 10 and Max of 107 Days)||2
2289539|NCT02104739|5621440|P2|STARTED|Washout (Min of 10 and Max of 107 Days)||4
2289540|NCT02104739|5621441|P1|STARTED|Washout (Min of 10 and Max of 107 Days)||1
2289541|NCT02104739|5621435|P7|NOT COMPLETED|First Intervention (1 Day)||0
2289542|NCT02104739|5621436|P6|NOT COMPLETED|First Intervention (1 Day)||0
2289543|NCT02104739|5621437|P5|NOT COMPLETED|First Intervention (1 Day)||0
2289544|NCT02104739|5621438|P4|NOT COMPLETED|First Intervention (1 Day)||1
2289545|NCT02104739|5621439|P3|NOT COMPLETED|First Intervention (1 Day)||0
2289546|NCT02104739|5621440|P2|NOT COMPLETED|First Intervention (1 Day)||1
2289547|NCT02104739|5621441|P1|NOT COMPLETED|First Intervention (1 Day)||0
2289548|NCT02104739|5621435|P7|COMPLETED|First Intervention (1 Day)||0
2289549|NCT02104739|5621436|P6|COMPLETED|First Intervention (1 Day)||3
2289550|NCT02104739|5621437|P5|COMPLETED|First Intervention (1 Day)||0
2289551|NCT02104739|5621438|P4|COMPLETED|First Intervention (1 Day)||7
2289552|NCT02104739|5621439|P3|COMPLETED|First Intervention (1 Day)||2
2289553|NCT02104739|5621440|P2|COMPLETED|First Intervention (1 Day)||4
2289554|NCT02104739|5621441|P1|COMPLETED|First Intervention (1 Day)||2
2289555|NCT02104739|5621435|P7|STARTED|First Intervention (1 Day)||0
2289556|NCT02104739|5621436|P6|STARTED|First Intervention (1 Day)||3
2289557|NCT02104739|5621437|P5|STARTED|First Intervention (1 Day)||0
2289558|NCT02104739|5621438|P4|STARTED|First Intervention (1 Day)||8
2289559|NCT02104739|5621439|P3|STARTED|First Intervention (1 Day)||2
2289560|NCT02104739|5621440|P2|STARTED|First Intervention (1 Day)||5
2289561|NCT02104739|5621441|P1|STARTED|First Intervention (1 Day)||2
2289562|NCT02104583|5621504|P5|NOT COMPLETED|Overall Study||12
2289563|NCT02104583|5621505|P4|NOT COMPLETED|Overall Study||17
2289564|NCT02104583|5621506|P3|NOT COMPLETED|Overall Study||16
2289565|NCT02104583|5621507|P2|NOT COMPLETED|Overall Study||11
2289566|NCT02104583|5621508|P1|NOT COMPLETED|Overall Study||18
2289567|NCT02104583|5621504|P5|COMPLETED|Overall Study||63
2289568|NCT02104583|5621505|P4|COMPLETED|Overall Study||57
2289569|NCT02104583|5621506|P3|COMPLETED|Overall Study||54
2289570|NCT02104583|5621507|P2|COMPLETED|Overall Study||35
2289571|NCT02104583|5621508|P1|COMPLETED|Overall Study||30
2289572|NCT02104583|5621504|P5|STARTED|Overall Study||75
2289573|NCT02104583|5621505|P4|STARTED|Overall Study||74
2289574|NCT02104583|5621506|P3|STARTED|Overall Study||70
2289575|NCT02104583|5621507|P2|STARTED|Overall Study||46
2289576|NCT02104583|5621508|P1|STARTED|Overall Study||48
2289577|NCT02104505|5621571|P2|NOT COMPLETED|Second Intervention (14 Days)||1
2289578|NCT02104505|5621572|P1|NOT COMPLETED|Second Intervention (14 Days)||2
2289579|NCT02104505|5621571|P2|COMPLETED|Second Intervention (14 Days)||7
2289580|NCT02104505|5621572|P1|COMPLETED|Second Intervention (14 Days)||8
2289581|NCT02104505|5621571|P2|STARTED|Second Intervention (14 Days)||8
2289582|NCT02104505|5621572|P1|STARTED|Second Intervention (14 Days)||10
2289583|NCT02104505|5621571|P2|NOT COMPLETED|Washout (Minimum 3 Weeks)||0
2289584|NCT02104505|5621572|P1|NOT COMPLETED|Washout (Minimum 3 Weeks)||0
2289585|NCT02104505|5621571|P2|COMPLETED|Washout (Minimum 3 Weeks)||8
2289586|NCT02104505|5621572|P1|COMPLETED|Washout (Minimum 3 Weeks)||10
2289587|NCT02104505|5621571|P2|STARTED|Washout (Minimum 3 Weeks)||8
2289588|NCT02104505|5621572|P1|STARTED|Washout (Minimum 3 Weeks)||10
2289589|NCT02104505|5621571|P2|NOT COMPLETED|First Intervention (14 Days)||3
2289590|NCT02104505|5621572|P1|NOT COMPLETED|First Intervention (14 Days)||2
2289591|NCT02104505|5621571|P2|COMPLETED|First Intervention (14 Days)||8
2289592|NCT02104505|5621572|P1|COMPLETED|First Intervention (14 Days)||10
2289593|NCT02104505|5621571|P2|STARTED|First Intervention (14 Days)|one participant withdrew prior to receiving study drug|11
2289594|NCT02104505|5621572|P1|STARTED|First Intervention (14 Days)||12
2289595|NCT02104427|5621584|P1|NOT COMPLETED|Overall Study||0
2289596|NCT02104427|5621584|P1|COMPLETED|Overall Study||12
2289597|NCT02104427|5621584|P1|STARTED|Overall Study||12
2289598|NCT02104414|5621610|P3|NOT COMPLETED|Overall Study||0
2289599|NCT02104414|5621611|P2|NOT COMPLETED|Overall Study||0
2289600|NCT02104414|5621612|P1|NOT COMPLETED|Overall Study||0
2289601|NCT02104414|5621610|P3|COMPLETED|Overall Study||2
2289602|NCT02104414|5621611|P2|COMPLETED|Overall Study||4
2289603|NCT02104414|5621612|P1|COMPLETED|Overall Study||5
2289604|NCT02104414|5621610|P3|STARTED|Overall Study||2
2289605|NCT02104414|5621611|P2|STARTED|Overall Study||4
2289606|NCT02104414|5621612|P1|STARTED|Overall Study||5
2289607|NCT02104219|5621635|P1|NOT COMPLETED|Overall Study||0
2289608|NCT02104219|5621635|P1|COMPLETED|Overall Study||32
2289609|NCT02104219|5621635|P1|STARTED|Overall Study||32
2289610|NCT02104180|5621644|P2|NOT COMPLETED|Overall Study||0
2289611|NCT02104180|5621645|P1|NOT COMPLETED|Overall Study||1
2289612|NCT02104180|5621644|P2|COMPLETED|Overall Study||31
2289613|NCT02104180|5621645|P1|COMPLETED|Overall Study||30
2289614|NCT02104180|5621644|P2|STARTED|Overall Study||31
2289615|NCT02104180|5621645|P1|STARTED|Overall Study||31
2289616|NCT02104167|5621651|P1|NOT COMPLETED|Overall Study||0
2289617|NCT02104167|5621651|P1|COMPLETED|Overall Study||110
2289618|NCT02104167|5621651|P1|STARTED|Overall Study||110
2289619|NCT02104141|5621656|P1|NOT COMPLETED|Overall Study||0
2289620|NCT02104141|5621656|P1|COMPLETED|Overall Study||51
2289621|NCT02104141|5621656|P1|STARTED|Overall Study||51
2289622|NCT02103855|5621661|P1|NOT COMPLETED|Overall Study||2
2289623|NCT02103855|5621661|P1|COMPLETED|Overall Study||4
2289624|NCT02103855|5621661|P1|STARTED|Overall Study||6
2289625|NCT02103608|5621669|P1|NOT COMPLETED|Overall Study||2
2289626|NCT02103608|5621669|P1|COMPLETED|Overall Study||15
2289627|NCT02103608|5621669|P1|STARTED|Overall Study||17
2289628|NCT02103439|5621675|P2|NOT COMPLETED|Overall Study||3
2289629|NCT02103439|5621676|P1|NOT COMPLETED|Overall Study||3
2289630|NCT02103439|5621675|P2|COMPLETED|Overall Study||67
2289631|NCT02103439|5621676|P1|COMPLETED|Overall Study||67
2289632|NCT02103439|5621675|P2|STARTED|Overall Study||70
2289633|NCT02103439|5621676|P1|STARTED|Overall Study||70
2289634|NCT02103309|5621696|P2|NOT COMPLETED|Overall Study||0
2289635|NCT02103309|5621697|P1|NOT COMPLETED|Overall Study||0
2289636|NCT02103309|5621696|P2|COMPLETED|Overall Study||22
2289637|NCT02103309|5621697|P1|COMPLETED|Overall Study||20
2289638|NCT02103309|5621696|P2|STARTED|Overall Study||22
2289639|NCT02103309|5621697|P1|STARTED|Overall Study||20
2289640|NCT02103270|5621712|P3|NOT COMPLETED|Overall Study||24
2289641|NCT02103270|5621713|P2|NOT COMPLETED|Overall Study||6
2289642|NCT02103270|5621714|P1|NOT COMPLETED|Overall Study||9
2289643|NCT02103270|5621712|P3|COMPLETED|Overall Study||1
2289644|NCT02103270|5621713|P2|COMPLETED|Overall Study||29
2289645|NCT02103270|5621714|P1|COMPLETED|Overall Study||51
2289646|NCT02103270|5621712|P3|STARTED|Overall Study||25
2289647|NCT02103270|5621713|P2|STARTED|Overall Study||35
2289648|NCT02103270|5621714|P1|STARTED|Overall Study||60
2289649|NCT02103218|5621729|P4|NOT COMPLETED|Overall Study||7
2289650|NCT02103218|5621730|P3|NOT COMPLETED|Overall Study||4
2289651|NCT02103218|5621731|P2|NOT COMPLETED|Overall Study||8
2289652|NCT02103218|5621732|P1|NOT COMPLETED|Overall Study||5
2289653|NCT02103218|5621729|P4|COMPLETED|Overall Study||47
2289654|NCT02103218|5621730|P3|COMPLETED|Overall Study||44
2289655|NCT02103218|5621731|P2|COMPLETED|Overall Study||51
2289656|NCT02103218|5621732|P1|COMPLETED|Overall Study||46
2289657|NCT02103218|5621729|P4|STARTED|Overall Study||54
2289658|NCT02103218|5621730|P3|STARTED|Overall Study||48
2289659|NCT02103218|5621731|P2|STARTED|Overall Study||59
2289660|NCT02103218|5621732|P1|STARTED|Overall Study||51
2289661|NCT02103114|5621778|P2|NOT COMPLETED|Overall Study||1
2289662|NCT02103114|5621779|P1|NOT COMPLETED|Overall Study||0
2289663|NCT02103114|5621778|P2|COMPLETED|Overall Study||19
2289664|NCT02103114|5621779|P1|COMPLETED|Overall Study||20
2289665|NCT02103114|5621778|P2|STARTED|Overall Study||20
2289666|NCT02103114|5621779|P1|STARTED|Overall Study||20
2289667|NCT02103062|5621835|P2|NOT COMPLETED|Overall Study||23
2289668|NCT02103062|5621836|P1|NOT COMPLETED|Overall Study||18
2289669|NCT02103062|5621835|P2|COMPLETED|Overall Study||0
2289670|NCT02103062|5621836|P1|COMPLETED|Overall Study||0
2289671|NCT02103062|5621835|P2|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|20
2289672|NCT02103062|5621836|P1|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|17
2289673|NCT02103062|5621835|P2|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|23
2289674|NCT02103062|5621836|P1|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|18
2289675|NCT02103062|5621835|P2|STARTED|Overall Study||23
2289676|NCT02103062|5621836|P1|STARTED|Overall Study||18
2289677|NCT02102932|5621862|P8|NOT COMPLETED|Overall Study||0
2289678|NCT02102932|5621863|P7|NOT COMPLETED|Overall Study||0
2289679|NCT02102932|5621864|P6|NOT COMPLETED|Overall Study||0
2289680|NCT02102932|5621865|P5|NOT COMPLETED|Overall Study||0
2289681|NCT02102932|5621866|P4|NOT COMPLETED|Overall Study||0
2289682|NCT02102932|5621867|P3|NOT COMPLETED|Overall Study||0
2289683|NCT02102932|5621868|P2|NOT COMPLETED|Overall Study||0
2289684|NCT02102932|5621869|P1|NOT COMPLETED|Overall Study||0
2289685|NCT02102932|5621862|P8|COMPLETED|Overall Study||12
2289686|NCT02102932|5621863|P7|COMPLETED|Overall Study||12
2289687|NCT02102932|5621864|P6|COMPLETED|Overall Study||12
2289688|NCT02102932|5621865|P5|COMPLETED|Overall Study||12
2289689|NCT02102932|5621866|P4|COMPLETED|Overall Study||12
2289690|NCT02102932|5621867|P3|COMPLETED|Overall Study||12
2289691|NCT02102932|5621868|P2|COMPLETED|Overall Study||12
2289692|NCT02102932|5621869|P1|COMPLETED|Overall Study||12
2289693|NCT02102932|5621862|P8|STARTED|Overall Study||12
2289694|NCT02102932|5621863|P7|STARTED|Overall Study||12
2289695|NCT02102932|5621864|P6|STARTED|Overall Study||12
2289696|NCT02102932|5621865|P5|STARTED|Overall Study||12
2289697|NCT02102932|5621866|P4|STARTED|Overall Study||12
2289698|NCT02102932|5621867|P3|STARTED|Overall Study||12
2289699|NCT02102932|5621868|P2|STARTED|Overall Study||12
2289700|NCT02102932|5621869|P1|STARTED|Overall Study||12
2289701|NCT02102724|5621929|P2|NOT COMPLETED|Overall Study||1
2289702|NCT02102724|5621930|P1|NOT COMPLETED|Overall Study||2
2289703|NCT02102724|5621929|P2|COMPLETED|Overall Study||18
2289704|NCT02102724|5621930|P1|COMPLETED|Overall Study||16
2289705|NCT02102724|5621929|P2|STARTED|Overall Study||19
2289706|NCT02102724|5621930|P1|STARTED|Overall Study||18
2289707|NCT02102490|5621936|P1|NOT COMPLETED|Overall Study||7
2289708|NCT02102490|5621936|P1|COMPLETED|Overall Study||125
2289709|NCT02102490|5621936|P1|Received at Least 1 Dose of Study Drug|Overall Study||132
2289710|NCT02102490|5621936|P1|STARTED|Overall Study||132
2289711|NCT02102464|5621950|P3|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
2289712|NCT02102464|5621951|P2|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
2289713|NCT02102464|5621952|P1|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
2289714|NCT02102464|5621950|P3|COMPLETED|Crossover LipiFlow Treatment of Control||25
2289715|NCT02102464|5621951|P2|COMPLETED|Crossover LipiFlow Treatment of Control||0
2289716|NCT02102464|5621952|P1|COMPLETED|Crossover LipiFlow Treatment of Control||0
2289717|NCT02102464|5621950|P3|STARTED|Crossover LipiFlow Treatment of Control||25
2289718|NCT02102464|5621951|P2|STARTED|Crossover LipiFlow Treatment of Control||0
2289719|NCT02102464|5621952|P1|STARTED|Crossover LipiFlow Treatment of Control||0
2289720|NCT02102464|5621950|P3|NOT COMPLETED|Randomized Study||0
2289721|NCT02102464|5621951|P2|NOT COMPLETED|Randomized Study||1
2289722|NCT02102464|5621952|P1|NOT COMPLETED|Randomized Study||0
2289723|NCT02102464|5621950|P3|COMPLETED|Randomized Study||0
2289724|NCT02102464|5621951|P2|COMPLETED|Randomized Study||25
2289725|NCT02102464|5621952|P1|COMPLETED|Randomized Study||29
2289726|NCT02102464|5621950|P3|STARTED|Randomized Study||0
2289727|NCT02102464|5621951|P2|STARTED|Randomized Study||26
2289728|NCT02102464|5621952|P1|STARTED|Randomized Study||29
2289729|NCT02102399|5621971|P2|NOT COMPLETED|Overall Study||4
2289730|NCT02102399|5621972|P1|NOT COMPLETED|Overall Study||6
2289731|NCT02102399|5621971|P2|COMPLETED|Overall Study||17
2289732|NCT02102399|5621972|P1|COMPLETED|Overall Study||14
2289733|NCT02102399|5621971|P2|STARTED|Overall Study||21
2289734|NCT02102399|5621972|P1|STARTED|Overall Study||20
2289735|NCT02102230|5622023|P3|NOT COMPLETED|Overall Study||17
2289736|NCT02102230|5622024|P2|NOT COMPLETED|Overall Study||17
2289737|NCT02102230|5622025|P1|NOT COMPLETED|Overall Study||17
2289738|NCT02102230|5622023|P3|COMPLETED|Overall Study||24
2289739|NCT02102230|5622024|P2|COMPLETED|Overall Study||11
2289740|NCT02102230|5622025|P1|COMPLETED|Overall Study||25
2289741|NCT02102230|5622023|P3|STARTED|Overall Study||41
2289742|NCT02102230|5622024|P2|STARTED|Overall Study||28
2289743|NCT02102230|5622025|P1|STARTED|Overall Study||42
2289744|NCT02102204|5622042|P1|NOT COMPLETED|Overall Study||304
2289745|NCT02102204|5622042|P1|COMPLETED|Overall Study||598
2289746|NCT02102204|5622042|P1|Received Etelcalcetide|Overall Study||884
2289747|NCT02102204|5622042|P1|STARTED|Overall Study||902
2289748|NCT02102100|5622053|P2|NOT COMPLETED|Overall Study||7
2289749|NCT02102100|5622054|P1|NOT COMPLETED|Overall Study||9
2289750|NCT02102100|5622053|P2|COMPLETED|Overall Study||18
2289751|NCT02102100|5622054|P1|COMPLETED|Overall Study||23
2289752|NCT02102100|5622053|P2|STARTED|Overall Study||25
2289753|NCT02102100|5622054|P1|STARTED|Overall Study||32
2289754|NCT02101983|5622062|P2|NOT COMPLETED|Overall Study||0
2289755|NCT02101983|5622063|P1|NOT COMPLETED|Overall Study||1
2289756|NCT02101983|5622062|P2|COMPLETED|Overall Study||6
2289757|NCT02101983|5622063|P1|COMPLETED|Overall Study||4
2289758|NCT02101983|5622062|P2|STARTED|Overall Study||6
2289759|NCT02101983|5622063|P1|STARTED|Overall Study||5
2289760|NCT02101515|5622075|P2|NOT COMPLETED|Overall Study||0
2289761|NCT02101515|5622076|P1|NOT COMPLETED|Overall Study||0
2289762|NCT02101515|5622075|P2|COMPLETED|Overall Study||41
2289763|NCT02101515|5622076|P1|COMPLETED|Overall Study||37
2289764|NCT02101515|5622075|P2|STARTED|Overall Study||41
2289765|NCT02101515|5622076|P1|STARTED|Overall Study||37
2289766|NCT02101437|5622118|P4|NOT COMPLETED|Overall Study||0
2289767|NCT02101437|5622119|P3|NOT COMPLETED|Overall Study||0
2289768|NCT02101437|5622120|P2|NOT COMPLETED|Overall Study||0
2289769|NCT02101437|5622121|P1|NOT COMPLETED|Overall Study||0
2289770|NCT02101437|5622118|P4|COMPLETED|Overall Study||49
2289771|NCT02101437|5622119|P3|COMPLETED|Overall Study||52
2289772|NCT02101437|5622120|P2|COMPLETED|Overall Study||54
2289773|NCT02101437|5622121|P1|COMPLETED|Overall Study||20
2289774|NCT02101437|5622118|P4|STARTED|Overall Study||49
2289775|NCT02101437|5622119|P3|STARTED|Overall Study||52
2289776|NCT02101437|5622120|P2|STARTED|Overall Study||54
2289777|NCT02101437|5622121|P1|STARTED|Overall Study||20
2289778|NCT02101411|5622134|P3|NOT COMPLETED|Overall Study||10
2289779|NCT02101411|5622135|P2|NOT COMPLETED|Overall Study||7
2289780|NCT02101411|5622136|P1|NOT COMPLETED|Overall Study||4
2289781|NCT02101411|5622134|P3|COMPLETED|Overall Study||104
2289782|NCT02101411|5622135|P2|COMPLETED|Overall Study||102
2289783|NCT02101411|5622136|P1|COMPLETED|Overall Study||107
2289784|NCT02101411|5622134|P3|STARTED|Overall Study||114
2289785|NCT02101411|5622135|P2|STARTED|Overall Study||109
2289786|NCT02101411|5622136|P1|STARTED|Overall Study||111
2289787|NCT02101359|5622146|P2|NOT COMPLETED|Overall Study||19
2289788|NCT02101359|5622147|P1|NOT COMPLETED|Overall Study||29
2289789|NCT02101359|5622146|P2|COMPLETED|Overall Study||277
2289790|NCT02101359|5622147|P1|COMPLETED|Overall Study||266
2289791|NCT02101359|5622146|P2|STARTED|Overall Study||296
2289792|NCT02101359|5622147|P1|STARTED|Overall Study||295
2289793|NCT02101294|5622153|P1|NOT COMPLETED|Overall Study||11
2289794|NCT02101294|5622153|P1|COMPLETED|Overall Study||20
2289795|NCT02101294|5622153|P1|STARTED|Overall Study||31
2289796|NCT02101281|5622162|P2|NOT COMPLETED|Overall Study||1
2289797|NCT02101281|5622163|P1|NOT COMPLETED|Overall Study||0
2289798|NCT02101281|5622162|P2|COMPLETED|Overall Study||19
2289799|NCT02101281|5622163|P1|COMPLETED|Overall Study||20
2289800|NCT02101281|5622162|P2|STARTED|Overall Study||20
2289801|NCT02101281|5622163|P1|STARTED|Overall Study||20
2289802|NCT02101190|5622205|P2|NOT COMPLETED|Overall Study||0
2289803|NCT02101190|5622206|P1|NOT COMPLETED|Overall Study||0
2289804|NCT02101190|5622205|P2|COMPLETED|Overall Study||8
2289805|NCT02101190|5622206|P1|COMPLETED|Overall Study||8
2289806|NCT02101190|5622205|P2|STARTED|Overall Study||8
2289807|NCT02101190|5622206|P1|STARTED|Overall Study||8
2289808|NCT02101112|5622216|P6|NOT COMPLETED|Overall Study||0
2289809|NCT02101112|5622217|P5|NOT COMPLETED|Overall Study||1
2289810|NCT02101112|5622218|P4|NOT COMPLETED|Overall Study||0
2289811|NCT02101112|5622219|P3|NOT COMPLETED|Overall Study||1
2289812|NCT02101112|5622220|P2|NOT COMPLETED|Overall Study||0
2289813|NCT02101112|5622221|P1|NOT COMPLETED|Overall Study||0
2289814|NCT02101112|5622216|P6|COMPLETED|Overall Study||5
2289815|NCT02101112|5622217|P5|COMPLETED|Overall Study||5
2289816|NCT02101112|5622218|P4|COMPLETED|Overall Study||5
2289817|NCT02101112|5622219|P3|COMPLETED|Overall Study||5
2289818|NCT02101112|5622220|P2|COMPLETED|Overall Study||5
2289819|NCT02101112|5622221|P1|COMPLETED|Overall Study||6
2289820|NCT02101112|5622216|P6|STARTED|Overall Study||5
2289821|NCT02101112|5622217|P5|STARTED|Overall Study||6
2289822|NCT02101112|5622218|P4|STARTED|Overall Study||5
2289823|NCT02101112|5622219|P3|STARTED|Overall Study||6
2289824|NCT02101112|5622220|P2|STARTED|Overall Study||5
2289825|NCT02101112|5622221|P1|STARTED|Overall Study||6
2289826|NCT02101021|5622251|P5|NOT COMPLETED|Overall Study||4
2289827|NCT02101021|5622252|P4|NOT COMPLETED|Overall Study||3
2289828|NCT02101021|5622253|P3|NOT COMPLETED|Overall Study||7
2289829|NCT02101021|5622254|P2|NOT COMPLETED|Overall Study||4
2289830|NCT02101021|5622255|P1|NOT COMPLETED|Overall Study||7
2289831|NCT02101021|5622251|P5|COMPLETED|Overall Study||0
2289832|NCT02101021|5622252|P4|COMPLETED|Overall Study||0
2289833|NCT02101021|5622253|P3|COMPLETED|Overall Study||0
2289834|NCT02101021|5622254|P2|COMPLETED|Overall Study||0
2289835|NCT02101021|5622255|P1|COMPLETED|Overall Study||0
2289836|NCT02101021|5622251|P5|STARTED|Overall Study||4
2289837|NCT02101021|5622252|P4|STARTED|Overall Study||3
2289838|NCT02101021|5622253|P3|STARTED|Overall Study||7
2289839|NCT02101021|5622254|P2|STARTED|Overall Study||4
2289840|NCT02101021|5622255|P1|STARTED|Overall Study||7
2289841|NCT02101008|5622297|P1|NOT COMPLETED|Overall Study||0
2289842|NCT02101008|5622297|P1|COMPLETED|Overall Study||12
2289843|NCT02101008|5622297|P1|STARTED|Overall Study||12
2289844|NCT02100969|5622302|P1|NOT COMPLETED|Overall Study||1
2289845|NCT02100969|5622302|P1|COMPLETED|Overall Study||22
2289846|NCT02100969|5622302|P1|STARTED|Overall Study||23
2289847|NCT02100839|5622316|P2|NOT COMPLETED|Multiple Ascending Dose||0
2289848|NCT02100839|5622317|P1|NOT COMPLETED|Multiple Ascending Dose||4
2289849|NCT02100839|5622316|P2|COMPLETED|Multiple Ascending Dose||3
2289850|NCT02100839|5622317|P1|COMPLETED|Multiple Ascending Dose||9
2289851|NCT02100839|5622316|P2|STARTED|Multiple Ascending Dose||3
2289852|NCT02100839|5622317|P1|STARTED|Multiple Ascending Dose||13
2289853|NCT02100839|5622316|P2|NOT COMPLETED|Single Ascending Dose||0
2289854|NCT02100839|5622317|P1|NOT COMPLETED|Single Ascending Dose||0
2289855|NCT02100839|5622316|P2|COMPLETED|Single Ascending Dose||12
2289856|NCT02100839|5622317|P1|COMPLETED|Single Ascending Dose||24
2289857|NCT02100839|5622316|P2|STARTED|Single Ascending Dose||12
2289858|NCT02100839|5622317|P1|STARTED|Single Ascending Dose||24
2289859|NCT02100826|5622329|P2|NOT COMPLETED|Period 2 (7 Days)||0
2289860|NCT02100826|5622330|P1|NOT COMPLETED|Period 2 (7 Days)||0
2289861|NCT02100826|5622329|P2|COMPLETED|Period 2 (7 Days)||14
2289862|NCT02100826|5622330|P1|COMPLETED|Period 2 (7 Days)||14
2289863|NCT02100826|5622329|P2|STARTED|Period 2 (7 Days)||14
2289864|NCT02100826|5622330|P1|STARTED|Period 2 (7 Days)||14
2289865|NCT02100826|5622329|P2|NOT COMPLETED|Washout Period (1 Day)||0
2289866|NCT02100826|5622330|P1|NOT COMPLETED|Washout Period (1 Day)||0
2289867|NCT02100826|5622329|P2|COMPLETED|Washout Period (1 Day)||14
2289868|NCT02100826|5622330|P1|COMPLETED|Washout Period (1 Day)||14
2289869|NCT02100826|5622329|P2|STARTED|Washout Period (1 Day)||14
2289870|NCT02100826|5622330|P1|STARTED|Washout Period (1 Day)||14
2289871|NCT02100826|5622329|P2|NOT COMPLETED|Period 1 (7 Days)||0
2289872|NCT02100826|5622330|P1|NOT COMPLETED|Period 1 (7 Days)||0
2289873|NCT02100826|5622329|P2|COMPLETED|Period 1 (7 Days)||14
2289874|NCT02100826|5622330|P1|COMPLETED|Period 1 (7 Days)||14
2289875|NCT02100826|5622329|P2|STARTED|Period 1 (7 Days)||14
2289876|NCT02100826|5622330|P1|STARTED|Period 1 (7 Days)||14
2289877|NCT02100813|5622348|P8|NOT COMPLETED|Overall Study||1
2289878|NCT02100813|5622349|P7|NOT COMPLETED|Overall Study||0
2289879|NCT02100813|5622350|P6|NOT COMPLETED|Overall Study||0
2289880|NCT02100813|5622351|P5|NOT COMPLETED|Overall Study||0
2289881|NCT02100813|5622352|P4|NOT COMPLETED|Overall Study||0
2289882|NCT02100813|5622353|P3|NOT COMPLETED|Overall Study||0
2289883|NCT02100813|5622354|P2|NOT COMPLETED|Overall Study||0
2289884|NCT02100813|5622355|P1|NOT COMPLETED|Overall Study||0
2289885|NCT02100813|5622348|P8|COMPLETED|Overall Study||66
2289886|NCT02100813|5622349|P7|COMPLETED|Overall Study||64
2289887|NCT02100813|5622350|P6|COMPLETED|Overall Study||32
2289888|NCT02100813|5622351|P5|COMPLETED|Overall Study||12
2289889|NCT02100813|5622352|P4|COMPLETED|Overall Study||12
2289890|NCT02100813|5622353|P3|COMPLETED|Overall Study||12
2289891|NCT02100813|5622354|P2|COMPLETED|Overall Study||11
2289892|NCT02100813|5622355|P1|COMPLETED|Overall Study||10
2289893|NCT02100813|5622348|P8|STARTED|Overall Study||67
2289894|NCT02100813|5622349|P7|STARTED|Overall Study||64
2289895|NCT02100813|5622350|P6|STARTED|Overall Study||32
2289896|NCT02100813|5622351|P5|STARTED|Overall Study||12
2289897|NCT02100813|5622352|P4|STARTED|Overall Study||12
2289898|NCT02100813|5622353|P3|STARTED|Overall Study||12
2289899|NCT02100813|5622354|P2|STARTED|Overall Study||11
2289900|NCT02100813|5622355|P1|STARTED|Overall Study||10
2289901|NCT02100670|5622383|P4|NOT COMPLETED|Overall Study||1
2289902|NCT02100670|5622384|P3|NOT COMPLETED|Overall Study||4
2289903|NCT02100670|5622385|P2|NOT COMPLETED|Overall Study||7
2289904|NCT02100670|5622386|P1|NOT COMPLETED|Overall Study||13
2289905|NCT02100670|5622383|P4|COMPLETED|Overall Study||75
2289906|NCT02100670|5622384|P3|COMPLETED|Overall Study||74
2289907|NCT02100670|5622385|P2|COMPLETED|Overall Study||106
2289908|NCT02100670|5622386|P1|COMPLETED|Overall Study||105
2289909|NCT02100670|5622383|P4|STARTED|Overall Study||76
2289910|NCT02100670|5622384|P3|STARTED|Overall Study||78
2289911|NCT02100670|5622385|P2|STARTED|Overall Study||113
2289912|NCT02100670|5622386|P1|STARTED|Overall Study||118
2289913|NCT02100644|5622446|P3|NOT COMPLETED|LTG and VPA Maintenance Phase||0
2289914|NCT02100644|5622447|P2|NOT COMPLETED|LTG and VPA Maintenance Phase||0
2289915|NCT02100644|5622448|P1|NOT COMPLETED|LTG and VPA Maintenance Phase||0
2289916|NCT02100644|5622446|P3|COMPLETED|LTG and VPA Maintenance Phase||20
2289917|NCT02100644|5622447|P2|COMPLETED|LTG and VPA Maintenance Phase||0
2289918|NCT02100644|5622448|P1|COMPLETED|LTG and VPA Maintenance Phase||0
2289919|NCT02100644|5622446|P3|STARTED|LTG and VPA Maintenance Phase||20
2289920|NCT02100644|5622447|P2|STARTED|LTG and VPA Maintenance Phase||0
2289921|NCT02100644|5622448|P1|STARTED|LTG and VPA Maintenance Phase||0
2289922|NCT02100644|5622446|P3|NOT COMPLETED|VPA Reduction Phase||0
2289923|NCT02100644|5622447|P2|NOT COMPLETED|VPA Reduction Phase||0
2289924|NCT02100644|5622448|P1|NOT COMPLETED|VPA Reduction Phase||0
2289925|NCT02100644|5622446|P3|COMPLETED|VPA Reduction Phase||0
2289926|NCT02100644|5622447|P2|COMPLETED|VPA Reduction Phase||20
2289927|NCT02100644|5622448|P1|COMPLETED|VPA Reduction Phase||0
2289928|NCT02100644|5622446|P3|STARTED|VPA Reduction Phase||0
2289929|NCT02100644|5622447|P2|STARTED|VPA Reduction Phase||20
2289930|NCT02100644|5622448|P1|STARTED|VPA Reduction Phase||0
2289931|NCT02100644|5622446|P3|NOT COMPLETED|LTG Escalation Phase||0
2289932|NCT02100644|5622447|P2|NOT COMPLETED|LTG Escalation Phase||0
2289933|NCT02100644|5622448|P1|NOT COMPLETED|LTG Escalation Phase||13
2289934|NCT02100644|5622446|P3|COMPLETED|LTG Escalation Phase||0
2289935|NCT02100644|5622447|P2|COMPLETED|LTG Escalation Phase||0
2289936|NCT02100644|5622448|P1|COMPLETED|LTG Escalation Phase||20
2289937|NCT02100644|5622446|P3|STARTED|LTG Escalation Phase||0
2289938|NCT02100644|5622447|P2|STARTED|LTG Escalation Phase||0
2289939|NCT02100644|5622448|P1|STARTED|LTG Escalation Phase||33
2289940|NCT02100579|5622460|P2|NOT COMPLETED|Overall Study||0
2289941|NCT02100579|5622461|P1|NOT COMPLETED|Overall Study||0
2289942|NCT02100579|5622460|P2|COMPLETED|Overall Study||20
2289943|NCT02100579|5622461|P1|COMPLETED|Overall Study||20
2289944|NCT02100579|5622460|P2|STARTED|Overall Study||20
2289945|NCT02100579|5622461|P1|STARTED|Overall Study||20
2289946|NCT02100514|5622473|P5|NOT COMPLETED|Extension Period||0
2289947|NCT02100514|5622474|P4|NOT COMPLETED|Extension Period||0
2289948|NCT02100514|5622475|P3|NOT COMPLETED|Extension Period||2
2289949|NCT02100514|5622476|P2|NOT COMPLETED|Extension Period||0
2289950|NCT02100514|5622477|P1|NOT COMPLETED|Extension Period||0
2289951|NCT02100514|5622473|P5|COMPLETED|Extension Period||56
2289952|NCT02100514|5622474|P4|COMPLETED|Extension Period||33
2289953|NCT02100514|5622475|P3|COMPLETED|Extension Period||42
2289954|NCT02100514|5622476|P2|COMPLETED|Extension Period||0
2289955|NCT02100514|5622477|P1|COMPLETED|Extension Period||0
2289956|NCT02100514|5622473|P5|STARTED|Extension Period||56
2289957|NCT02100514|5622474|P4|STARTED|Extension Period||33
2289958|NCT02100514|5622475|P3|STARTED|Extension Period||44
2289959|NCT02100514|5622476|P2|STARTED|Extension Period||0
2289960|NCT02100514|5622477|P1|STARTED|Extension Period||0
2289961|NCT02100514|5622473|P5|NOT COMPLETED|Treatment Period||0
2289962|NCT02100514|5622474|P4|NOT COMPLETED|Treatment Period||0
2289963|NCT02100514|5622475|P3|NOT COMPLETED|Treatment Period||0
2289964|NCT02100514|5622476|P2|NOT COMPLETED|Treatment Period||74
2289965|NCT02100514|5622477|P1|NOT COMPLETED|Treatment Period||29
2289966|NCT02100514|5622473|P5|COMPLETED|Treatment Period||0
2289967|NCT02100514|5622474|P4|COMPLETED|Treatment Period||0
2289968|NCT02100514|5622475|P3|COMPLETED|Treatment Period||0
2289969|NCT02100514|5622476|P2|COMPLETED|Treatment Period||425
2289970|NCT02100514|5622477|P1|COMPLETED|Treatment Period||218
2289971|NCT02100514|5622473|P5|STARTED|Treatment Period||0
2289972|NCT02100514|5622474|P4|STARTED|Treatment Period||0
2289973|NCT02100514|5622475|P3|STARTED|Treatment Period||0
2289974|NCT02100514|5622476|P2|STARTED|Treatment Period||499
2289975|NCT02100514|5622477|P1|STARTED|Treatment Period||247
2289976|NCT02100475|5622545|P2|NOT COMPLETED|Overall Study||2
2289977|NCT02100475|5622546|P1|NOT COMPLETED|Overall Study||2
2289978|NCT02100475|5622545|P2|COMPLETED|Overall Study||13
2289979|NCT02100475|5622546|P1|COMPLETED|Overall Study||14
2289980|NCT02100475|5622545|P2|STARTED|Overall Study||15
2289981|NCT02100475|5622546|P1|STARTED|Overall Study||16
2289982|NCT02100410|5622556|P6|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
2289983|NCT02100410|5622557|P5|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
2289984|NCT02100410|5622558|P4|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
2289985|NCT02100410|5622559|P3|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
2289986|NCT02100410|5622560|P2|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
2289987|NCT02100410|5622561|P1|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
2289988|NCT02100410|5622556|P6|COMPLETED|Exposure Pair 3, 30 Minutes||9
2289989|NCT02100410|5622557|P5|COMPLETED|Exposure Pair 3, 30 Minutes||8
2289990|NCT02100410|5622558|P4|COMPLETED|Exposure Pair 3, 30 Minutes||8
2289991|NCT02100410|5622559|P3|COMPLETED|Exposure Pair 3, 30 Minutes||8
2289992|NCT02100410|5622560|P2|COMPLETED|Exposure Pair 3, 30 Minutes||8
2289993|NCT02100410|5622561|P1|COMPLETED|Exposure Pair 3, 30 Minutes||8
2289994|NCT02100410|5622556|P6|STARTED|Exposure Pair 3, 30 Minutes||9
2289995|NCT02100410|5622557|P5|STARTED|Exposure Pair 3, 30 Minutes||8
2289996|NCT02100410|5622558|P4|STARTED|Exposure Pair 3, 30 Minutes||8
2289997|NCT02100410|5622559|P3|STARTED|Exposure Pair 3, 30 Minutes||8
2289998|NCT02100410|5622560|P2|STARTED|Exposure Pair 3, 30 Minutes||8
2289999|NCT02100410|5622561|P1|STARTED|Exposure Pair 3, 30 Minutes||8
2290000|NCT02100410|5622556|P6|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
2290001|NCT02100410|5622557|P5|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
2290002|NCT02100410|5622558|P4|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
2290003|NCT02100410|5622559|P3|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
2290004|NCT02100410|5622560|P2|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
2290005|NCT02100410|5622561|P1|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
2290006|NCT02100410|5622556|P6|COMPLETED|Exposure Pair 2, 30 Minutes||9
2290007|NCT02100410|5622557|P5|COMPLETED|Exposure Pair 2, 30 Minutes||8
2290008|NCT02100410|5622558|P4|COMPLETED|Exposure Pair 2, 30 Minutes||8
2290009|NCT02100410|5622559|P3|COMPLETED|Exposure Pair 2, 30 Minutes||8
2290010|NCT02100410|5622560|P2|COMPLETED|Exposure Pair 2, 30 Minutes||8
2290011|NCT02100410|5622561|P1|COMPLETED|Exposure Pair 2, 30 Minutes||8
2290012|NCT02100410|5622556|P6|STARTED|Exposure Pair 2, 30 Minutes||9
2290013|NCT02100410|5622557|P5|STARTED|Exposure Pair 2, 30 Minutes||8
2290014|NCT02100410|5622558|P4|STARTED|Exposure Pair 2, 30 Minutes||8
2290015|NCT02100410|5622559|P3|STARTED|Exposure Pair 2, 30 Minutes||8
2290016|NCT02100410|5622560|P2|STARTED|Exposure Pair 2, 30 Minutes||8
2290017|NCT02100410|5622561|P1|STARTED|Exposure Pair 2, 30 Minutes||8
2290018|NCT02100410|5622556|P6|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
2290019|NCT02100410|5622557|P5|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
2290020|NCT02100410|5622558|P4|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
2290021|NCT02100410|5622559|P3|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
2290022|NCT02100410|5622560|P2|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
2290023|NCT02100410|5622561|P1|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
2290024|NCT02100410|5622556|P6|COMPLETED|Exposure Pair 1, 30 Minutes||9
2290025|NCT02100410|5622557|P5|COMPLETED|Exposure Pair 1, 30 Minutes||8
2290026|NCT02100410|5622558|P4|COMPLETED|Exposure Pair 1, 30 Minutes||8
2290027|NCT02100410|5622559|P3|COMPLETED|Exposure Pair 1, 30 Minutes||8
2290028|NCT02100410|5622560|P2|COMPLETED|Exposure Pair 1, 30 Minutes||8
2290029|NCT02100410|5622561|P1|COMPLETED|Exposure Pair 1, 30 Minutes||8
2290030|NCT02100410|5622556|P6|STARTED|Exposure Pair 1, 30 Minutes||9
2290031|NCT02100410|5622557|P5|STARTED|Exposure Pair 1, 30 Minutes||8
2290032|NCT02100410|5622558|P4|STARTED|Exposure Pair 1, 30 Minutes||8
2290033|NCT02100410|5622559|P3|STARTED|Exposure Pair 1, 30 Minutes||8
2290034|NCT02100410|5622560|P2|STARTED|Exposure Pair 1, 30 Minutes||8
2290035|NCT02100410|5622561|P1|STARTED|Exposure Pair 1, 30 Minutes||8
2290036|NCT02100319|5622577|P1|NOT COMPLETED|Overall Study||16
2290037|NCT02100319|5622577|P1|COMPLETED|Overall Study||371
2290038|NCT02100319|5622577|P1|STARTED|Overall Study||387
2290039|NCT02100280|5622588|P2|NOT COMPLETED|Overall Study||4
2290040|NCT02100280|5622589|P1|NOT COMPLETED|Overall Study||4
2290041|NCT02100280|5622588|P2|COMPLETED|Overall Study||44
2290042|NCT02100280|5622589|P1|COMPLETED|Overall Study||44
2290043|NCT02100280|5622588|P2|STARTED|Overall Study||48
2290044|NCT02100280|5622589|P1|STARTED|Overall Study||48
2290045|NCT02100228|5622605|P2|NOT COMPLETED|Overall Study||90
2290046|NCT02100228|5622606|P1|NOT COMPLETED|Overall Study||75
2290047|NCT02100228|5622605|P2|COMPLETED|Overall Study||657
2290048|NCT02100228|5622606|P1|COMPLETED|Overall Study||678
2290049|NCT02100228|5622605|P2|STARTED|Overall Study|721 treated with Usual Care|747
2290050|NCT02100228|5622606|P1|STARTED|Overall Study|735 treated with Apixaban|753
2290051|NCT02100189|5622632|P1|NOT COMPLETED|Overall Study||0
2290052|NCT02100189|5622632|P1|COMPLETED|Overall Study||50
2290053|NCT02100189|5622632|P1|STARTED|Overall Study||50
2290054|NCT02100124|5622642|P3|NOT COMPLETED|Overall Study||3
2290055|NCT02100124|5622643|P2|NOT COMPLETED|Overall Study||11
2290056|NCT02100124|5622644|P1|NOT COMPLETED|Overall Study||6
2290057|NCT02100124|5622642|P3|COMPLETED|Overall Study||323
2290058|NCT02100124|5622643|P2|COMPLETED|Overall Study||318
2290059|NCT02100124|5622644|P1|COMPLETED|Overall Study||323
2290060|NCT02100124|5622642|P3|STARTED|Overall Study||326
2290061|NCT02100124|5622643|P2|STARTED|Overall Study||329
2290062|NCT02100124|5622644|P1|STARTED|Overall Study||329
2290063|NCT02100007|5622661|P1|NOT COMPLETED|Overall Study||0
2290064|NCT02100007|5622661|P1|COMPLETED|Overall Study||46
2290065|NCT02100007|5622661|P1|STARTED|Overall Study||46
2290066|NCT02099838|5622674|P2|NOT COMPLETED|Overall Study||2
2290067|NCT02099838|5622675|P1|NOT COMPLETED|Overall Study||4
2290068|NCT02099838|5622674|P2|COMPLETED|Overall Study||49
2290069|NCT02099838|5622675|P1|COMPLETED|Overall Study||43
2290070|NCT02099838|5622674|P2|STARTED|Overall Study||51
2290071|NCT02099838|5622675|P1|STARTED|Overall Study||47
2290072|NCT02099786|5622707|P2|NOT COMPLETED|Overall Study||8
2290073|NCT02099786|5622708|P1|NOT COMPLETED|Overall Study||3
2290074|NCT02099786|5622707|P2|COMPLETED|Overall Study||15
2290075|NCT02099786|5622708|P1|COMPLETED|Overall Study||21
2290076|NCT02099786|5622707|P2|Program Eval 3|Overall Study|One year post randomization|15
2290077|NCT02099786|5622708|P1|Program Eval 3|Overall Study|One year post randomization|21
2290078|NCT02099786|5622707|P2|Program Eval 2|Overall Study|One month post randomization|19
2290079|NCT02099786|5622708|P1|Program Eval 2|Overall Study|One month post randomization|23
2290171|NCT02098746|5622900|P1|STARTED|Overall Study||294
2290080|NCT02099786|5622707|P2|Program Eval 1|Overall Study|Baseline (prior to randomization and first cisplatin dose)|23
2290081|NCT02099786|5622708|P1|Program Eval 1|Overall Study|Baseline (prior to randomization and first cisplatin dose)|24
2290082|NCT02099786|5622707|P2|STARTED|Overall Study||23
2290083|NCT02099786|5622708|P1|STARTED|Overall Study||24
2290084|NCT02099708|5622720|P1|NOT COMPLETED|Overall Study||200
2290085|NCT02099708|5622720|P1|COMPLETED|Overall Study||3302
2290086|NCT02099708|5622720|P1|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3302
2290087|NCT02099708|5622720|P1|STARTED|Overall Study|Number of cases.|3502
2290088|NCT02099682|5622731|P1|NOT COMPLETED|Overall Study||111
2290089|NCT02099682|5622731|P1|COMPLETED|Overall Study||3255
2290090|NCT02099682|5622731|P1|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3255
2290091|NCT02099682|5622731|P1|STARTED|Overall Study|Number of cases.|3366
2290092|NCT02099461|5622745|P3|NOT COMPLETED|Overall Study||0
2290093|NCT02099461|5622746|P2|NOT COMPLETED|Overall Study||0
2290094|NCT02099461|5622747|P1|NOT COMPLETED|Overall Study||0
2290095|NCT02099461|5622745|P3|COMPLETED|Overall Study||28
2290096|NCT02099461|5622746|P2|COMPLETED|Overall Study||27
2290097|NCT02099461|5622747|P1|COMPLETED|Overall Study||27
2290098|NCT02099461|5622745|P3|STARTED|Overall Study||28
2290099|NCT02099461|5622746|P2|STARTED|Overall Study||27
2290100|NCT02099461|5622747|P1|STARTED|Overall Study||27
2290101|NCT02099344|5622757|P2|NOT COMPLETED|Overall Study||0
2290102|NCT02099344|5622758|P1|NOT COMPLETED|Overall Study||1
2290103|NCT02099344|5622757|P2|COMPLETED|Overall Study||0
2290104|NCT02099344|5622758|P1|COMPLETED|Overall Study||0
2290105|NCT02099344|5622757|P2|STARTED|Overall Study||0
2290106|NCT02099344|5622758|P1|STARTED|Overall Study||1
2290107|NCT02099318|5622768|P2|NOT COMPLETED|Overall Study||0
2290108|NCT02099318|5622769|P1|NOT COMPLETED|Overall Study||0
2290109|NCT02099318|5622768|P2|COMPLETED|Overall Study||20
2290110|NCT02099318|5622769|P1|COMPLETED|Overall Study||20
2290111|NCT02099318|5622768|P2|STARTED|Overall Study||20
2290112|NCT02099318|5622769|P1|STARTED|Overall Study||20
2290113|NCT02099266|5622783|P1|NOT COMPLETED|Overall Study||0
2290114|NCT02099266|5622783|P1|COMPLETED|Overall Study||15
2290115|NCT02099266|5622783|P1|STARTED|Overall Study||15
2290116|NCT02099110|5622795|P5|NOT COMPLETED|Overall Study||27
2290117|NCT02099110|5622796|P4|NOT COMPLETED|Overall Study||22
2290118|NCT02099110|5622797|P3|NOT COMPLETED|Overall Study||28
2290119|NCT02099110|5622798|P2|NOT COMPLETED|Overall Study||31
2290120|NCT02099110|5622799|P1|NOT COMPLETED|Overall Study||24
2290121|NCT02099110|5622795|P5|COMPLETED|Overall Study||218
2290122|NCT02099110|5622796|P4|COMPLETED|Overall Study||221
2290123|NCT02099110|5622797|P3|COMPLETED|Overall Study||219
2290124|NCT02099110|5622798|P2|COMPLETED|Overall Study||217
2290125|NCT02099110|5622799|P1|COMPLETED|Overall Study||226
2290126|NCT02099110|5622795|P5|Treated|Overall Study||244
2290127|NCT02099110|5622796|P4|Treated|Overall Study||243
2290128|NCT02099110|5622797|P3|Treated|Overall Study||247
2290129|NCT02099110|5622798|P2|Treated|Overall Study||248
2290130|NCT02099110|5622799|P1|Treated|Overall Study||250
2290131|NCT02099110|5622795|P5|STARTED|Overall Study||245
2290132|NCT02099110|5622796|P4|STARTED|Overall Study||243
2290133|NCT02099110|5622797|P3|STARTED|Overall Study||247
2290134|NCT02099110|5622798|P2|STARTED|Overall Study||248
2290135|NCT02099110|5622799|P1|STARTED|Overall Study||250
2290136|NCT02099084|5622846|P2|NOT COMPLETED|Second Intervention||0
2290137|NCT02099084|5622847|P1|NOT COMPLETED|Second Intervention||0
2290138|NCT02099084|5622846|P2|COMPLETED|Second Intervention||4
2290139|NCT02099084|5622847|P1|COMPLETED|Second Intervention||4
2290140|NCT02099084|5622846|P2|STARTED|Second Intervention||4
2290141|NCT02099084|5622847|P1|STARTED|Second Intervention||4
2290142|NCT02099084|5622846|P2|NOT COMPLETED|Washout Period of 14 Days||0
2290143|NCT02099084|5622847|P1|NOT COMPLETED|Washout Period of 14 Days||0
2290144|NCT02099084|5622846|P2|COMPLETED|Washout Period of 14 Days||4
2290145|NCT02099084|5622847|P1|COMPLETED|Washout Period of 14 Days||4
2290146|NCT02099084|5622846|P2|STARTED|Washout Period of 14 Days||4
2290147|NCT02099084|5622847|P1|STARTED|Washout Period of 14 Days||4
2290148|NCT02099084|5622846|P2|NOT COMPLETED|First Intervention||0
2290149|NCT02099084|5622847|P1|NOT COMPLETED|First Intervention||0
2290150|NCT02099084|5622846|P2|COMPLETED|First Intervention||4
2290151|NCT02099084|5622847|P1|COMPLETED|First Intervention||4
2290152|NCT02099084|5622846|P2|STARTED|First Intervention||4
2290153|NCT02099084|5622847|P1|STARTED|First Intervention||4
2290154|NCT02099006|5622865|P1|NOT COMPLETED|Overall Study||1
2290155|NCT02099006|5622865|P1|COMPLETED|Overall Study||8
2290156|NCT02099006|5622865|P1|Received Gabapentin|Overall Study||8
2290157|NCT02099006|5622865|P1|Received Ketamine|Overall Study||6
2290158|NCT02099006|5622865|P1|Received Loperamide|Overall Study||7
2290159|NCT02099006|5622865|P1|Received Ketoprofen|Overall Study||3
2290160|NCT02099006|5622865|P1|Received Amitriptyline/ Baclofen|Overall Study||7
2290161|NCT02099006|5622865|P1|Received Placebo|Overall Study||9
2290162|NCT02099006|5622865|P1|STARTED|Overall Study||9
2290163|NCT02098993|5622875|P2|NOT COMPLETED|Overall Study||0
2290164|NCT02098993|5622876|P1|NOT COMPLETED|Overall Study||0
2290165|NCT02098993|5622875|P2|COMPLETED|Overall Study||3
2290166|NCT02098993|5622876|P1|COMPLETED|Overall Study||4
2290167|NCT02098993|5622875|P2|STARTED|Overall Study||3
2290168|NCT02098993|5622876|P1|STARTED|Overall Study||4
2290169|NCT02098746|5622900|P1|NOT COMPLETED|Overall Study||5
2290170|NCT02098746|5622900|P1|COMPLETED|Overall Study||289
2290172|NCT02098733|5622908|P1|NOT COMPLETED|Overall Study||10
2290173|NCT02098733|5622908|P1|COMPLETED|Overall Study||1158
2290174|NCT02098733|5622908|P1|STARTED|Overall Study||1168
2290175|NCT02098395|5622922|P4|NOT COMPLETED|Overall Study||27
2290176|NCT02098395|5622923|P3|NOT COMPLETED|Overall Study||42
2290177|NCT02098395|5622924|P2|NOT COMPLETED|Overall Study||32
2290178|NCT02098395|5622925|P1|NOT COMPLETED|Overall Study||26
2290179|NCT02098395|5622922|P4|COMPLETED|Overall Study||180
2290180|NCT02098395|5622923|P3|COMPLETED|Overall Study||165
2290181|NCT02098395|5622924|P2|COMPLETED|Overall Study||177
2290182|NCT02098395|5622925|P1|COMPLETED|Overall Study||186
2290183|NCT02098395|5622922|P4|Exposed|Overall Study||206
2290184|NCT02098395|5622923|P3|Exposed|Overall Study||206
2290185|NCT02098395|5622924|P2|Exposed|Overall Study||209
2290186|NCT02098395|5622925|P1|Exposed|Overall Study||211
2290187|NCT02098395|5622922|P4|STARTED|Overall Study||207
2290188|NCT02098395|5622923|P3|STARTED|Overall Study||207
2290189|NCT02098395|5622924|P2|STARTED|Overall Study||209
2290190|NCT02098395|5622925|P1|STARTED|Overall Study||212
2290191|NCT02098369|5622946|P3|NOT COMPLETED|Overall Study||5
2290192|NCT02098369|5622947|P2|NOT COMPLETED|Overall Study||9
2290193|NCT02098369|5622948|P1|NOT COMPLETED|Overall Study||7
2290194|NCT02098369|5622946|P3|COMPLETED|Overall Study||143
2290195|NCT02098369|5622947|P2|COMPLETED|Overall Study||145
2290196|NCT02098369|5622948|P1|COMPLETED|Overall Study||135
2290197|NCT02098369|5622946|P3|STARTED|Overall Study||148
2290198|NCT02098369|5622947|P2|STARTED|Overall Study||154
2290199|NCT02098369|5622948|P1|STARTED|Overall Study||142
2290200|NCT02098304|5622977|P1|NOT COMPLETED|Overall Study||0
2290201|NCT02098304|5622977|P1|COMPLETED|Overall Study||42
2290202|NCT02098304|5622977|P1|STARTED|Overall Study||42
2290203|NCT02098109|5622986|P2|NOT COMPLETED|Overall Study||0
2290204|NCT02098109|5622987|P1|NOT COMPLETED|Overall Study||3
2290205|NCT02098109|5622986|P2|COMPLETED|Overall Study||51
2290206|NCT02098109|5622987|P1|COMPLETED|Overall Study||46
2290207|NCT02098109|5622986|P2|STARTED|Overall Study||51
2290208|NCT02098109|5622987|P1|STARTED|Overall Study||49
2290209|NCT02097992|5623013|P4|NOT COMPLETED|Treatment 3 (4 Weeks)||0
2290210|NCT02097992|5623014|P3|NOT COMPLETED|Treatment 3 (4 Weeks)||0
2290211|NCT02097992|5623015|P2|NOT COMPLETED|Treatment 3 (4 Weeks)||0
2290212|NCT02097992|5623016|P1|NOT COMPLETED|Treatment 3 (4 Weeks)||0
2290213|NCT02097992|5623013|P4|COMPLETED|Treatment 3 (4 Weeks)||2
2290214|NCT02097992|5623014|P3|COMPLETED|Treatment 3 (4 Weeks)||4
2290215|NCT02097992|5623015|P2|COMPLETED|Treatment 3 (4 Weeks)||3
2290216|NCT02097992|5623016|P1|COMPLETED|Treatment 3 (4 Weeks)||2
2290217|NCT02097992|5623013|P4|STARTED|Treatment 3 (4 Weeks)||2
2290218|NCT02097992|5623014|P3|STARTED|Treatment 3 (4 Weeks)||4
2290219|NCT02097992|5623015|P2|STARTED|Treatment 3 (4 Weeks)||3
2290220|NCT02097992|5623016|P1|STARTED|Treatment 3 (4 Weeks)||2
2290221|NCT02097992|5623013|P4|NOT COMPLETED|Washout (4 Weeks)||0
2290222|NCT02097992|5623014|P3|NOT COMPLETED|Washout (4 Weeks)||0
2290223|NCT02097992|5623015|P2|NOT COMPLETED|Washout (4 Weeks)||0
2290224|NCT02097992|5623016|P1|NOT COMPLETED|Washout (4 Weeks)||0
2290225|NCT02097992|5623013|P4|COMPLETED|Washout (4 Weeks)||2
2290226|NCT02097992|5623014|P3|COMPLETED|Washout (4 Weeks)||4
2290227|NCT02097992|5623015|P2|COMPLETED|Washout (4 Weeks)||3
2290228|NCT02097992|5623016|P1|COMPLETED|Washout (4 Weeks)||2
2290229|NCT02097992|5623013|P4|STARTED|Washout (4 Weeks)||2
2290230|NCT02097992|5623014|P3|STARTED|Washout (4 Weeks)||4
2290231|NCT02097992|5623015|P2|STARTED|Washout (4 Weeks)||3
2290232|NCT02097992|5623016|P1|STARTED|Washout (4 Weeks)||2
2290233|NCT02097992|5623013|P4|NOT COMPLETED|Treatment 2 (4 Weeks)||0
2290234|NCT02097992|5623014|P3|NOT COMPLETED|Treatment 2 (4 Weeks)||0
2290235|NCT02097992|5623015|P2|NOT COMPLETED|Treatment 2 (4 Weeks)||0
2290236|NCT02097992|5623016|P1|NOT COMPLETED|Treatment 2 (4 Weeks)||0
2290237|NCT02097992|5623013|P4|COMPLETED|Treatment 2 (4 Weeks)||2
2290238|NCT02097992|5623014|P3|COMPLETED|Treatment 2 (4 Weeks)||4
2290239|NCT02097992|5623015|P2|COMPLETED|Treatment 2 (4 Weeks)||3
2290240|NCT02097992|5623016|P1|COMPLETED|Treatment 2 (4 Weeks)||2
2290241|NCT02097992|5623013|P4|STARTED|Treatment 2 (4 Weeks)||2
2290242|NCT02097992|5623014|P3|STARTED|Treatment 2 (4 Weeks)||4
2290243|NCT02097992|5623015|P2|STARTED|Treatment 2 (4 Weeks)||3
2290244|NCT02097992|5623016|P1|STARTED|Treatment 2 (4 Weeks)||2
2290245|NCT02097992|5623013|P4|NOT COMPLETED|Treatment 1 (1 Day)||0
2290246|NCT02097992|5623014|P3|NOT COMPLETED|Treatment 1 (1 Day)||0
2290247|NCT02097992|5623015|P2|NOT COMPLETED|Treatment 1 (1 Day)||0
2290248|NCT02097992|5623016|P1|NOT COMPLETED|Treatment 1 (1 Day)||0
2290249|NCT02097992|5623013|P4|COMPLETED|Treatment 1 (1 Day)||2
2290250|NCT02097992|5623014|P3|COMPLETED|Treatment 1 (1 Day)||4
2290251|NCT02097992|5623015|P2|COMPLETED|Treatment 1 (1 Day)||3
2290252|NCT02097992|5623016|P1|COMPLETED|Treatment 1 (1 Day)||2
2290253|NCT02097992|5623013|P4|STARTED|Treatment 1 (1 Day)||2
2290254|NCT02097992|5623014|P3|STARTED|Treatment 1 (1 Day)||4
2290255|NCT02097992|5623015|P2|STARTED|Treatment 1 (1 Day)||3
2290256|NCT02097992|5623016|P1|STARTED|Treatment 1 (1 Day)||2
2290257|NCT02097849|5623026|P2|NOT COMPLETED|Overall Study||0
2290258|NCT02097849|5623027|P1|NOT COMPLETED|Overall Study||0
2290259|NCT02097849|5623026|P2|COMPLETED|Overall Study||38
2290260|NCT02097849|5623027|P1|COMPLETED|Overall Study||33
2290261|NCT02097849|5623026|P2|STARTED|Overall Study||38
2290262|NCT02097849|5623027|P1|STARTED|Overall Study||33
2290263|NCT02097823|5623065|P2|NOT COMPLETED|Overall Study||1
2290264|NCT02097823|5623066|P1|NOT COMPLETED|Overall Study||1
2290265|NCT02097823|5623065|P2|COMPLETED|Overall Study||3
2290266|NCT02097823|5623066|P1|COMPLETED|Overall Study||10
2290267|NCT02097823|5623065|P2|STARTED|Overall Study||4
2290268|NCT02097823|5623066|P1|STARTED|Overall Study||11
2290269|NCT02097745|5623081|P1|NOT COMPLETED|Overall Study||178
2290270|NCT02097745|5623081|P1|COMPLETED|Overall Study||157
2290271|NCT02097745|5623081|P1|STARTED|Overall Study|Six participants did not receive any treatment and were not included in any analyses.|335
2290272|NCT02097732|5623105|P2|NOT COMPLETED|Overall Study||0
2290273|NCT02097732|5623106|P1|NOT COMPLETED|Overall Study||0
2290274|NCT02097732|5623105|P2|COMPLETED|Overall Study||3
2290275|NCT02097732|5623106|P1|COMPLETED|Overall Study||1
2290276|NCT02097732|5623105|P2|STARTED|Overall Study||3
2290277|NCT02097732|5623106|P1|STARTED|Overall Study||1
2290278|NCT02097719|5623119|P2|NOT COMPLETED|Overall Study||1
2290279|NCT02097719|5623120|P1|NOT COMPLETED|Overall Study||3
2290280|NCT02097719|5623119|P2|COMPLETED|Overall Study||50
2290281|NCT02097719|5623120|P1|COMPLETED|Overall Study||46
2290282|NCT02097719|5623119|P2|STARTED|Overall Study||51
2290283|NCT02097719|5623120|P1|STARTED|Overall Study||49
2290284|NCT02097641|5623128|P2|NOT COMPLETED|Overall Study||0
2290285|NCT02097641|5623129|P1|NOT COMPLETED|Overall Study||0
2290286|NCT02097641|5623128|P2|COMPLETED|Overall Study||20
2290287|NCT02097641|5623129|P1|COMPLETED|Overall Study||40
2290288|NCT02097641|5623128|P2|STARTED|Overall Study||20
2290289|NCT02097641|5623129|P1|STARTED|Overall Study||40
2290290|NCT02097537|5623171|P1|NOT COMPLETED|Overall Study||0
2290291|NCT02097537|5623171|P1|COMPLETED|Overall Study||10
2290292|NCT02097537|5623171|P1|Follow-Up|Overall Study||10
2290293|NCT02097537|5623171|P1|Enrollment|Overall Study|Inhalation of Methacholine Chloride|10
2290294|NCT02097537|5623171|P1|STARTED|Overall Study||10
2290295|NCT02097472|5623185|P8|NOT COMPLETED|Assessed for Immunogenicity||1
2290296|NCT02097472|5623186|P7|NOT COMPLETED|Assessed for Immunogenicity||2
2290297|NCT02097472|5623187|P6|NOT COMPLETED|Assessed for Immunogenicity||2
2290298|NCT02097472|5623188|P5|NOT COMPLETED|Assessed for Immunogenicity||0
2290299|NCT02097472|5623189|P4|NOT COMPLETED|Assessed for Immunogenicity||2
2290300|NCT02097472|5623190|P3|NOT COMPLETED|Assessed for Immunogenicity||1
2290301|NCT02097472|5623191|P2|NOT COMPLETED|Assessed for Immunogenicity||0
2290302|NCT02097472|5623192|P1|NOT COMPLETED|Assessed for Immunogenicity||0
2290303|NCT02097472|5623185|P8|COMPLETED|Assessed for Immunogenicity||49
2290304|NCT02097472|5623186|P7|COMPLETED|Assessed for Immunogenicity||47
2290305|NCT02097472|5623187|P6|COMPLETED|Assessed for Immunogenicity||48
2290306|NCT02097472|5623188|P5|COMPLETED|Assessed for Immunogenicity||50
2290307|NCT02097472|5623189|P4|COMPLETED|Assessed for Immunogenicity||48
2290308|NCT02097472|5623190|P3|COMPLETED|Assessed for Immunogenicity||17
2290309|NCT02097472|5623191|P2|COMPLETED|Assessed for Immunogenicity||18
2290310|NCT02097472|5623192|P1|COMPLETED|Assessed for Immunogenicity||18
2290311|NCT02097472|5623185|P8|STARTED|Assessed for Immunogenicity||50
2290312|NCT02097472|5623186|P7|STARTED|Assessed for Immunogenicity||49
2290313|NCT02097472|5623187|P6|STARTED|Assessed for Immunogenicity||50
2290314|NCT02097472|5623188|P5|STARTED|Assessed for Immunogenicity||50
2290315|NCT02097472|5623189|P4|STARTED|Assessed for Immunogenicity||50
2290316|NCT02097472|5623190|P3|STARTED|Assessed for Immunogenicity||18
2290317|NCT02097472|5623191|P2|STARTED|Assessed for Immunogenicity||18
2290318|NCT02097472|5623192|P1|STARTED|Assessed for Immunogenicity||18
2290319|NCT02097472|5623185|P8|NOT COMPLETED|Received Vaccination 2||0
2290320|NCT02097472|5623186|P7|NOT COMPLETED|Received Vaccination 2||1
2290321|NCT02097472|5623187|P6|NOT COMPLETED|Received Vaccination 2||0
2290322|NCT02097472|5623188|P5|NOT COMPLETED|Received Vaccination 2||0
2290323|NCT02097472|5623189|P4|NOT COMPLETED|Received Vaccination 2||0
2290324|NCT02097472|5623190|P3|NOT COMPLETED|Received Vaccination 2||0
2290325|NCT02097472|5623191|P2|NOT COMPLETED|Received Vaccination 2||0
2290326|NCT02097472|5623192|P1|NOT COMPLETED|Received Vaccination 2||0
2290327|NCT02097472|5623185|P8|COMPLETED|Received Vaccination 2||50
2290328|NCT02097472|5623186|P7|COMPLETED|Received Vaccination 2||49
2290329|NCT02097472|5623187|P6|COMPLETED|Received Vaccination 2||50
2290330|NCT02097472|5623188|P5|COMPLETED|Received Vaccination 2||50
2290331|NCT02097472|5623189|P4|COMPLETED|Received Vaccination 2||50
2290332|NCT02097472|5623190|P3|COMPLETED|Received Vaccination 2||18
2290333|NCT02097472|5623191|P2|COMPLETED|Received Vaccination 2||18
2290334|NCT02097472|5623192|P1|COMPLETED|Received Vaccination 2||18
2290335|NCT02097472|5623185|P8|STARTED|Received Vaccination 2||50
2290336|NCT02097472|5623186|P7|STARTED|Received Vaccination 2||50
2290337|NCT02097472|5623187|P6|STARTED|Received Vaccination 2||50
2290338|NCT02097472|5623188|P5|STARTED|Received Vaccination 2||50
2290339|NCT02097472|5623189|P4|STARTED|Received Vaccination 2||50
2290340|NCT02097472|5623190|P3|STARTED|Received Vaccination 2||18
2290341|NCT02097472|5623191|P2|STARTED|Received Vaccination 2||18
2290342|NCT02097472|5623192|P1|STARTED|Received Vaccination 2||18
2290343|NCT02097472|5623185|P8|NOT COMPLETED|Received Vaccination 1||0
2290344|NCT02097472|5623186|P7|NOT COMPLETED|Received Vaccination 1||0
2290345|NCT02097472|5623187|P6|NOT COMPLETED|Received Vaccination 1||0
2290346|NCT02097472|5623188|P5|NOT COMPLETED|Received Vaccination 1||0
2290347|NCT02097472|5623189|P4|NOT COMPLETED|Received Vaccination 1||0
2290348|NCT02097472|5623190|P3|NOT COMPLETED|Received Vaccination 1||0
2290349|NCT02097472|5623191|P2|NOT COMPLETED|Received Vaccination 1||0
2290350|NCT02097472|5623192|P1|NOT COMPLETED|Received Vaccination 1||0
2290351|NCT02097472|5623185|P8|COMPLETED|Received Vaccination 1||50
2290352|NCT02097472|5623186|P7|COMPLETED|Received Vaccination 1||50
2290353|NCT02097472|5623187|P6|COMPLETED|Received Vaccination 1||50
2290354|NCT02097472|5623188|P5|COMPLETED|Received Vaccination 1||50
2290355|NCT02097472|5623189|P4|COMPLETED|Received Vaccination 1||50
2290356|NCT02097472|5623190|P3|COMPLETED|Received Vaccination 1||18
2290357|NCT02097472|5623191|P2|COMPLETED|Received Vaccination 1||18
2290358|NCT02097472|5623192|P1|COMPLETED|Received Vaccination 1||18
2290359|NCT02097472|5623185|P8|STARTED|Received Vaccination 1||50
2290360|NCT02097472|5623186|P7|STARTED|Received Vaccination 1||50
2290361|NCT02097472|5623187|P6|STARTED|Received Vaccination 1||50
2290362|NCT02097472|5623188|P5|STARTED|Received Vaccination 1||50
2290363|NCT02097472|5623189|P4|STARTED|Received Vaccination 1||50
2290364|NCT02097472|5623190|P3|STARTED|Received Vaccination 1||18
2290365|NCT02097472|5623191|P2|STARTED|Received Vaccination 1||18
2290366|NCT02097472|5623192|P1|STARTED|Received Vaccination 1||18
2290367|NCT02097303|5623613|P1|NOT COMPLETED|Overall Study||5
2290368|NCT02097303|5623613|P1|COMPLETED|Overall Study||31
2290369|NCT02097303|5623613|P1|STARTED|Overall Study||36
2290370|NCT02097290|5623623|P1|NOT COMPLETED|Overall Study||17
2290371|NCT02097290|5623623|P1|COMPLETED|Overall Study|Active subjects at the end of 3 month follow up visit for primary end point data collection|193
2290372|NCT02097290|5623623|P1|STARTED|Overall Study||210
2290373|NCT02097277|5623638|P5|NOT COMPLETED|Overall Study||1
2290374|NCT02097277|5623639|P4|NOT COMPLETED|Overall Study||4
2290375|NCT02097277|5623640|P3|NOT COMPLETED|Overall Study||2
2290376|NCT02097277|5623641|P2|NOT COMPLETED|Overall Study||3
2290377|NCT02097277|5623642|P1|NOT COMPLETED|Overall Study||2
2290378|NCT02097277|5623638|P5|COMPLETED|Overall Study||23
2290379|NCT02097277|5623639|P4|COMPLETED|Overall Study||20
2290380|NCT02097277|5623640|P3|COMPLETED|Overall Study||22
2290381|NCT02097277|5623641|P2|COMPLETED|Overall Study||21
2290382|NCT02097277|5623642|P1|COMPLETED|Overall Study||22
2290383|NCT02097277|5623638|P5|STARTED|Overall Study||24
2290384|NCT02097277|5623639|P4|STARTED|Overall Study||24
2290385|NCT02097277|5623640|P3|STARTED|Overall Study||24
2290386|NCT02097277|5623641|P2|STARTED|Overall Study||24
2290387|NCT02097277|5623642|P1|STARTED|Overall Study||24
2290388|NCT02097238|5623725|P1|NOT COMPLETED|Overall Study||19
2290389|NCT02097238|5623725|P1|COMPLETED|Overall Study||0
2290390|NCT02097238|5623725|P1|STARTED|Overall Study||19
2290391|NCT02097134|5623731|P1|NOT COMPLETED|Overall Study||9
2290392|NCT02097134|5623731|P1|COMPLETED|Overall Study||5
2290393|NCT02097134|5623731|P1|STARTED|Overall Study||14
2290394|NCT02097108|5623739|P1|NOT COMPLETED|Overall Study||2
2290395|NCT02097108|5623739|P1|COMPLETED|Overall Study||9
2290396|NCT02097108|5623739|P1|STARTED|Overall Study||11
2290397|NCT02097056|5623746|P1|NOT COMPLETED|Overall Study||58
2290398|NCT02097056|5623746|P1|COMPLETED|Overall Study||113
2290399|NCT02097056|5623746|P1|ParticipantsTreated|Overall Study||170
2290400|NCT02097056|5623746|P1|STARTED|Overall Study||171
2290401|NCT02097030|5623754|P2|NOT COMPLETED|Second Intervention (3 Days)||0
2290402|NCT02097030|5623755|P1|NOT COMPLETED|Second Intervention (3 Days)||0
2290403|NCT02097030|5623754|P2|COMPLETED|Second Intervention (3 Days)||16
2290404|NCT02097030|5623755|P1|COMPLETED|Second Intervention (3 Days)||14
2290405|NCT02097030|5623754|P2|STARTED|Second Intervention (3 Days)||16
2290406|NCT02097030|5623755|P1|STARTED|Second Intervention (3 Days)||14
2290407|NCT02097030|5623754|P2|NOT COMPLETED|First Intervention (3 Days)||1
2290408|NCT02097030|5623755|P1|NOT COMPLETED|First Intervention (3 Days)||1
2290409|NCT02097030|5623754|P2|COMPLETED|First Intervention (3 Days)||16
2290410|NCT02097030|5623755|P1|COMPLETED|First Intervention (3 Days)||14
2290411|NCT02097030|5623754|P2|STARTED|First Intervention (3 Days)||17
2290412|NCT02097030|5623755|P1|STARTED|First Intervention (3 Days)||15
2290413|NCT02096952|5623816|P1|NOT COMPLETED|Overall Study||1
2290414|NCT02096952|5623816|P1|COMPLETED|Overall Study||14
2290415|NCT02096952|5623816|P1|STARTED|Overall Study||15
2290416|NCT02096900|5623822|P2|NOT COMPLETED|Overall Study||2
2290417|NCT02096900|5623823|P1|NOT COMPLETED|Overall Study||4
2290418|NCT02096900|5623822|P2|COMPLETED|Overall Study||42
2290419|NCT02096900|5623823|P1|COMPLETED|Overall Study||38
2290420|NCT02096900|5623822|P2|STARTED|Overall Study|Allocated to Zolpidem|44
2290421|NCT02096900|5623823|P1|STARTED|Overall Study|Allocated to Midazolam|42
2290422|NCT02096861|5623841|P4|NOT COMPLETED|Overall Study||10
2290423|NCT02096861|5623842|P3|NOT COMPLETED|Overall Study||17
2290424|NCT02096861|5623843|P2|NOT COMPLETED|Overall Study||15
2290425|NCT02096861|5623844|P1|NOT COMPLETED|Overall Study||12
2290426|NCT02096861|5623841|P4|COMPLETED|Overall Study||45
2290427|NCT02096861|5623842|P3|COMPLETED|Overall Study||37
2290428|NCT02096861|5623843|P2|COMPLETED|Overall Study||40
2290429|NCT02096861|5623844|P1|COMPLETED|Overall Study||44
2290430|NCT02096861|5623841|P4|Drug Switching at Week 30|Overall Study||47
2290431|NCT02096861|5623842|P3|Drug Switching at Week 30|Overall Study||41
2290432|NCT02096861|5623843|P2|Drug Switching at Week 30|Overall Study||44
2290433|NCT02096861|5623844|P1|Drug Switching at Week 30|Overall Study||48
2290434|NCT02096861|5623841|P4|STARTED|Overall Study|Remicade followed by CT-P13 from Week 30|55
2290435|NCT02096861|5623842|P3|STARTED|Overall Study|Remicade followed by Remicade from Week 30|54
2290436|NCT02096861|5623843|P2|STARTED|Overall Study|CT-P13 followed by Remicade from Week 30|55
2290437|NCT02096861|5623844|P1|STARTED|Overall Study|CT-P13 followed by CT-P13 from Week 30|56
2290438|NCT02096835|5623875|P3|NOT COMPLETED|Overall Study||1
2290439|NCT02096835|5623876|P2|NOT COMPLETED|Overall Study||0
2290440|NCT02096835|5623877|P1|NOT COMPLETED|Overall Study||3
2290441|NCT02096835|5623875|P3|COMPLETED|Overall Study||50
2290442|NCT02096835|5623876|P2|COMPLETED|Overall Study||53
2290443|NCT02096835|5623877|P1|COMPLETED|Overall Study||50
2290444|NCT02096835|5623875|P3|STARTED|Overall Study||51
2290445|NCT02096835|5623876|P2|STARTED|Overall Study||53
2290446|NCT02096835|5623877|P1|STARTED|Overall Study||53
2290447|NCT02096744|5623894|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||1
2290448|NCT02096744|5623895|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
2290449|NCT02096744|5623894|P2|COMPLETED|Treatment Period 3 (7 Days)||27
2290450|NCT02096744|5623895|P1|COMPLETED|Treatment Period 3 (7 Days)||28
2290451|NCT02096744|5623894|P2|STARTED|Treatment Period 3 (7 Days)||28
2290452|NCT02096744|5623895|P1|STARTED|Treatment Period 3 (7 Days)||28
2290453|NCT02096744|5623894|P2|NOT COMPLETED|Washout Period 2 (3 Days)||0
2290454|NCT02096744|5623895|P1|NOT COMPLETED|Washout Period 2 (3 Days)||0
2290455|NCT02096744|5623894|P2|COMPLETED|Washout Period 2 (3 Days)||28
2290456|NCT02096744|5623895|P1|COMPLETED|Washout Period 2 (3 Days)||28
2290457|NCT02096744|5623894|P2|STARTED|Washout Period 2 (3 Days)||28
2290458|NCT02096744|5623895|P1|STARTED|Washout Period 2 (3 Days)||28
2290459|NCT02096744|5623894|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||0
2290460|NCT02096744|5623895|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
2290461|NCT02096744|5623894|P2|COMPLETED|Treatment Period 2 (7 Days)||28
2290462|NCT02096744|5623895|P1|COMPLETED|Treatment Period 2 (7 Days)||28
2290463|NCT02096744|5623894|P2|STARTED|Treatment Period 2 (7 Days)||28
2290464|NCT02096744|5623895|P1|STARTED|Treatment Period 2 (7 Days)||28
2290465|NCT02096744|5623894|P2|NOT COMPLETED|Washout Period 1(7 Days)||0
2290466|NCT02096744|5623895|P1|NOT COMPLETED|Washout Period 1(7 Days)||0
2290467|NCT02096744|5623894|P2|COMPLETED|Washout Period 1(7 Days)||28
2290468|NCT02096744|5623895|P1|COMPLETED|Washout Period 1(7 Days)||28
2290469|NCT02096744|5623894|P2|STARTED|Washout Period 1(7 Days)||28
2290470|NCT02096744|5623895|P1|STARTED|Washout Period 1(7 Days)||28
2290471|NCT02096744|5623894|P2|NOT COMPLETED|Treatment Period 1(7 Days)||1
2290472|NCT02096744|5623895|P1|NOT COMPLETED|Treatment Period 1(7 Days)||1
2290473|NCT02096744|5623894|P2|COMPLETED|Treatment Period 1(7 Days)||28
2290474|NCT02096744|5623895|P1|COMPLETED|Treatment Period 1(7 Days)||28
2290475|NCT02096744|5623894|P2|STARTED|Treatment Period 1(7 Days)||29
2290476|NCT02096744|5623895|P1|STARTED|Treatment Period 1(7 Days)||29
2290477|NCT02096731|5623910|P2|NOT COMPLETED|Overall Study||0
2290478|NCT02096731|5623911|P1|NOT COMPLETED|Overall Study||0
2290479|NCT02096731|5623910|P2|COMPLETED|Overall Study||88955
2290480|NCT02096731|5623911|P1|COMPLETED|Overall Study||26442
2290481|NCT02096731|5623910|P2|STARTED|Overall Study||88955
2290482|NCT02096731|5623911|P1|STARTED|Overall Study||26442
2290483|NCT02096718|5623928|P3|NOT COMPLETED|Overall Study||0
2290484|NCT02096718|5623929|P2|NOT COMPLETED|Overall Study||0
2290485|NCT02096718|5623930|P1|NOT COMPLETED|Overall Study||0
2290486|NCT02096718|5623928|P3|COMPLETED|Overall Study||14
2290487|NCT02096718|5623929|P2|COMPLETED|Overall Study||8
2290488|NCT02096718|5623930|P1|COMPLETED|Overall Study||8
2290489|NCT02096718|5623928|P3|STARTED|Overall Study||14
2290490|NCT02096718|5623929|P2|STARTED|Overall Study||8
2290491|NCT02096718|5623930|P1|STARTED|Overall Study||8
2290492|NCT02096705|5623949|P2|NOT COMPLETED|Follow-up||4
2290493|NCT02096705|5623950|P1|NOT COMPLETED|Follow-up||4
2290494|NCT02096705|5623949|P2|COMPLETED|Follow-up||135
2290495|NCT02096705|5623950|P1|COMPLETED|Follow-up||125
2290496|NCT02096705|5623949|P2|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|139
2290497|NCT02096705|5623950|P1|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|129
2290498|NCT02096705|5623949|P2|NOT COMPLETED|Treatment||5
2290499|NCT02096705|5623950|P1|NOT COMPLETED|Treatment||9
2290500|NCT02096705|5623949|P2|COMPLETED|Treatment||134
2290501|NCT02096705|5623950|P1|COMPLETED|Treatment||124
2290502|NCT02096705|5623949|P2|STARTED|Treatment||139
2290503|NCT02096705|5623950|P1|STARTED|Treatment||133
2290504|NCT02096692|5623962|P1|NOT COMPLETED|Overall Study||4
2290505|NCT02096692|5623962|P1|COMPLETED|Overall Study||150
2290506|NCT02096692|5623962|P1|STARTED|Overall Study||154
2290507|NCT02096679|5623968|P1|NOT COMPLETED|Overall Study||0
2290508|NCT02096679|5623968|P1|COMPLETED|Overall Study||8
2290509|NCT02096679|5623968|P1|STARTED|Overall Study||8
2290510|NCT02096588|5623993|P2|NOT COMPLETED|Overall Study||1
2290511|NCT02096588|5623994|P1|NOT COMPLETED|Overall Study||2
2290512|NCT02096588|5623993|P2|COMPLETED|Overall Study||15
2290513|NCT02096588|5623994|P1|COMPLETED|Overall Study||13
2290514|NCT02096588|5623993|P2|STARTED|Overall Study||16
2290515|NCT02096588|5623994|P1|STARTED|Overall Study||15
2290516|NCT02096575|5624004|P3|NOT COMPLETED|Overall Study||5
2290517|NCT02096575|5624005|P2|NOT COMPLETED|Overall Study||0
2290518|NCT02096575|5624006|P1|NOT COMPLETED|Overall Study||0
2290519|NCT02096575|5624004|P3|COMPLETED|Overall Study||0
2290520|NCT02096575|5624005|P2|COMPLETED|Overall Study||67
2290521|NCT02096575|5624006|P1|COMPLETED|Overall Study||68
2290522|NCT02096575|5624004|P3|STARTED|Overall Study||5
2290523|NCT02096575|5624005|P2|STARTED|Overall Study||67
2290524|NCT02096575|5624006|P1|STARTED|Overall Study||68
2290525|NCT02096471|5624020|P1|NOT COMPLETED|Overall Study||13
2290526|NCT02096471|5624020|P1|COMPLETED|Overall Study|Participants terminated the study if a partial response was not achieved and/or maintained.|6
2290527|NCT02096471|5624020|P1|STARTED|Overall Study||19
2290528|NCT02096458|5624031|P1|NOT COMPLETED|Overall Study||0
2290529|NCT02096458|5624031|P1|COMPLETED|Overall Study||8
2290530|NCT02096458|5624031|P1|STARTED|Overall Study||8
2290531|NCT02096263|5624038|P3|NOT COMPLETED|Overall Study||39
2290532|NCT02096263|5624039|P2|NOT COMPLETED|Overall Study||36
2290533|NCT02096263|5624040|P1|NOT COMPLETED|Overall Study||34
2290534|NCT02096263|5624038|P3|COMPLETED|Overall Study||157
2290535|NCT02096263|5624039|P2|COMPLETED|Overall Study||158
2290536|NCT02096263|5624040|P1|COMPLETED|Overall Study||161
2290537|NCT02096263|5624038|P3|STARTED|Overall Study||196
2290538|NCT02096263|5624039|P2|STARTED|Overall Study||194
2290539|NCT02096263|5624040|P1|STARTED|Overall Study||195
2290540|NCT02096107|5624176|P2|NOT COMPLETED|Overall Study||0
2290541|NCT02096107|5624177|P1|NOT COMPLETED|Overall Study||0
2290542|NCT02096107|5624176|P2|COMPLETED|Overall Study||30
2290543|NCT02096107|5624177|P1|COMPLETED|Overall Study||30
2290544|NCT02096107|5624176|P2|STARTED|Overall Study||30
2290545|NCT02096107|5624177|P1|STARTED|Overall Study||30
2290546|NCT02096081|5624195|P2|NOT COMPLETED|Overall Study||4
2290547|NCT02096081|5624196|P1|NOT COMPLETED|Overall Study||3
2290548|NCT02096081|5624195|P2|COMPLETED|Overall Study||124
2290549|NCT02096081|5624196|P1|COMPLETED|Overall Study||119
2290550|NCT02096081|5624195|P2|STARTED|Overall Study||128
2290551|NCT02096081|5624196|P1|STARTED|Overall Study||122
2290552|NCT02096042|5624228|P3|NOT COMPLETED|Overall Study||0
2290553|NCT02096042|5624229|P2|NOT COMPLETED|Overall Study||0
2290554|NCT02096042|5624230|P1|NOT COMPLETED|Overall Study||1
2290555|NCT02096042|5624228|P3|COMPLETED|Overall Study||0
2290556|NCT02096042|5624229|P2|COMPLETED|Overall Study||0
2290557|NCT02096042|5624230|P1|COMPLETED|Overall Study||0
2290558|NCT02096042|5624228|P3|STARTED|Overall Study||0
2290559|NCT02096042|5624229|P2|STARTED|Overall Study||0
2290560|NCT02096042|5624230|P1|STARTED|Overall Study||1
2290561|NCT02096029|5624239|P2|NOT COMPLETED|Overall Study||0
2290562|NCT02096029|5624240|P1|NOT COMPLETED|Overall Study||0
2290563|NCT02096029|5624239|P2|COMPLETED|Overall Study||593
2290564|NCT02096029|5624240|P1|COMPLETED|Overall Study||652
2290565|NCT02096029|5624239|P2|STARTED|Overall Study||593
2290566|NCT02096029|5624240|P1|STARTED|Overall Study||652
2290567|NCT02096003|5624252|P2|NOT COMPLETED|Overall Study||3
2290568|NCT02096003|5624253|P1|NOT COMPLETED|Overall Study||2
2290569|NCT02096003|5624252|P2|COMPLETED|Overall Study||37
2290570|NCT02096003|5624253|P1|COMPLETED|Overall Study||38
2290571|NCT02096003|5624252|P2|STARTED|Overall Study||40
2290572|NCT02096003|5624253|P1|STARTED|Overall Study||40
2290573|NCT02095951|5624269|P2|NOT COMPLETED|Overall Study||6
2290574|NCT02095951|5624270|P1|NOT COMPLETED|Overall Study||9
2290575|NCT02095951|5624269|P2|COMPLETED|Overall Study||8
2290576|NCT02095951|5624270|P1|COMPLETED|Overall Study||4
2290577|NCT02095951|5624269|P2|STARTED|Overall Study|1 participant with 2 episodes of catheter infection was enrolled twice in this group.|14
2290578|NCT02095951|5624270|P1|STARTED|Overall Study|2 participants with 4 episodes of catheter infection was enrolled twice in this group.|13
2290579|NCT02095873|5624290|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
2290580|NCT02095873|5624291|P1|NOT COMPLETED|Second Intervention (8 Weeks)||2
2290581|NCT02095873|5624290|P2|COMPLETED|Second Intervention (8 Weeks)||16
2290582|NCT02095873|5624291|P1|COMPLETED|Second Intervention (8 Weeks)||13
2290583|NCT02095873|5624290|P2|STARTED|Second Intervention (8 Weeks)||16
2290584|NCT02095873|5624291|P1|STARTED|Second Intervention (8 Weeks)||15
2290585|NCT02095873|5624290|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
2290586|NCT02095873|5624291|P1|NOT COMPLETED|First Intervention (8 Weeks)||1
2290587|NCT02095873|5624290|P2|COMPLETED|First Intervention (8 Weeks)||16
2290588|NCT02095873|5624291|P1|COMPLETED|First Intervention (8 Weeks)||15
2290589|NCT02095873|5624290|P2|STARTED|First Intervention (8 Weeks)||16
2290590|NCT02095873|5624291|P1|STARTED|First Intervention (8 Weeks)||16
2290591|NCT02095691|5624303|P1|NOT COMPLETED|Overall Study||1
2290592|NCT02095691|5624303|P1|COMPLETED|Overall Study|Subjects with follow up available at 12 months.|18
2290593|NCT02095691|5624303|P1|STARTED|Overall Study|Subjects who were consented and treated with study ablation catheter.|19
2290594|NCT02095561|5624322|P2|NOT COMPLETED|Overall Study||0
2290595|NCT02095561|5624323|P1|NOT COMPLETED|Overall Study||0
2290596|NCT02095561|5624322|P2|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|2964
2290597|NCT02095561|5624323|P1|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|3049
2290598|NCT02095561|5624322|P2|HPV Tested at Health Centers|Overall Study||599
2290599|NCT02095561|5624323|P1|HPV Tested at Health Centers|Overall Study||99
2290600|NCT02095561|5624322|P2|HPV Self-tested Women|Overall Study|HPV self-testing only applies to the HPV self-testing arm|0
2290601|NCT02095561|5624323|P1|HPV Self-tested Women|Overall Study||2519
2290602|NCT02095561|5624322|P2|Self-testing Acceptability|Overall Study|Acceptablity only applies to the group of women being offered self-testing.|0
2290603|NCT02095561|5624323|P1|Self-testing Acceptability|Overall Study||2616
2290604|NCT02095561|5624322|P2|STARTED|Overall Study||2964
2290605|NCT02095561|5624323|P1|STARTED|Overall Study||3049
2290606|NCT02095535|5624335|P1|NOT COMPLETED|Analysis||0
2290607|NCT02095535|5624335|P1|COMPLETED|Analysis||18
2290608|NCT02095535|5624335|P1|STARTED|Analysis||18
2290609|NCT02095535|5624335|P1|NOT COMPLETED|Recruitment||2
2290610|NCT02095535|5624335|P1|COMPLETED|Recruitment||18
2290611|NCT02095535|5624335|P1|STARTED|Recruitment||20
2290612|NCT02095223|5624341|P2|NOT COMPLETED|Overall Study||0
2290613|NCT02095223|5624342|P1|NOT COMPLETED|Overall Study||1
2290614|NCT02095223|5624341|P2|COMPLETED|Overall Study||2
2290615|NCT02095223|5624342|P1|COMPLETED|Overall Study|1 participant dropped out of this study due to the time commitment associated with participation.|1
2290616|NCT02095223|5624341|P2|STARTED|Overall Study||2
2290617|NCT02095223|5624342|P1|STARTED|Overall Study||2
2290618|NCT02095197|5624352|P2|NOT COMPLETED|Overall Study||3
2290619|NCT02095197|5624353|P1|NOT COMPLETED|Overall Study||0
2290620|NCT02095197|5624352|P2|COMPLETED|Overall Study||36
2290621|NCT02095197|5624353|P1|COMPLETED|Overall Study||40
2290622|NCT02095197|5624352|P2|STARTED|Overall Study||39
2290623|NCT02095197|5624353|P1|STARTED|Overall Study||40
2290624|NCT02095158|5624365|P1|NOT COMPLETED|Overall Study||75
2290625|NCT02095158|5624365|P1|COMPLETED|Overall Study||365
2290626|NCT02095158|5624365|P1|STARTED|Overall Study||440
2290627|NCT02095145|5624372|P2|NOT COMPLETED|Overall Study||0
2290628|NCT02095145|5624373|P1|NOT COMPLETED|Overall Study||1
2290629|NCT02095145|5624372|P2|COMPLETED|Overall Study||15
2290630|NCT02095145|5624373|P1|COMPLETED|Overall Study||14
2290631|NCT02095145|5624372|P2|STARTED|Overall Study||15
2290632|NCT02095145|5624373|P1|STARTED|Overall Study||15
2290633|NCT02095106|5624419|P2|NOT COMPLETED|Second Intervention (14 Days)||1
2290634|NCT02095106|5624420|P1|NOT COMPLETED|Second Intervention (14 Days)||0
2290635|NCT02095106|5624419|P2|COMPLETED|Second Intervention (14 Days)||12
2290636|NCT02095106|5624420|P1|COMPLETED|Second Intervention (14 Days)||14
2290637|NCT02095106|5624419|P2|STARTED|Second Intervention (14 Days)||13
2290638|NCT02095106|5624420|P1|STARTED|Second Intervention (14 Days)||14
2290639|NCT02095106|5624419|P2|NOT COMPLETED|First Intervention (14 Days)||0
2290640|NCT02095106|5624420|P1|NOT COMPLETED|First Intervention (14 Days)||0
2290641|NCT02095106|5624419|P2|COMPLETED|First Intervention (14 Days)||13
2290642|NCT02095106|5624420|P1|COMPLETED|First Intervention (14 Days)||14
2290643|NCT02095106|5624419|P2|STARTED|First Intervention (14 Days)||13
2290644|NCT02095106|5624420|P1|STARTED|First Intervention (14 Days)||14
2290645|NCT02094937|5624436|P4|NOT COMPLETED|12 Weeks in Period 2||12
2290646|NCT02094937|5624437|P3|NOT COMPLETED|12 Weeks in Period 2||12
2290647|NCT02094937|5624438|P2|NOT COMPLETED|12 Weeks in Period 2||11
2290648|NCT02094937|5624439|P1|NOT COMPLETED|12 Weeks in Period 2||0
2290649|NCT02094937|5624436|P4|COMPLETED|12 Weeks in Period 2||112
2290650|NCT02094937|5624437|P3|COMPLETED|12 Weeks in Period 2||112
2290651|NCT02094937|5624438|P2|COMPLETED|12 Weeks in Period 2||112
2290652|NCT02094937|5624439|P1|COMPLETED|12 Weeks in Period 2||0
2290653|NCT02094937|5624436|P4|STARTED|12 Weeks in Period 2||124
2290654|NCT02094937|5624437|P3|STARTED|12 Weeks in Period 2||124
2290655|NCT02094937|5624438|P2|STARTED|12 Weeks in Period 2||123
2290656|NCT02094937|5624439|P1|STARTED|12 Weeks in Period 2||0
2290657|NCT02094937|5624436|P4|NOT COMPLETED|8 Weeks in Period 1||0
2290658|NCT02094937|5624437|P3|NOT COMPLETED|8 Weeks in Period 1||0
2290659|NCT02094937|5624438|P2|NOT COMPLETED|8 Weeks in Period 1||0
2290660|NCT02094937|5624439|P1|NOT COMPLETED|8 Weeks in Period 1||60
2290661|NCT02094937|5624436|P4|COMPLETED|8 Weeks in Period 1||0
2290662|NCT02094937|5624437|P3|COMPLETED|8 Weeks in Period 1||0
2290663|NCT02094937|5624438|P2|COMPLETED|8 Weeks in Period 1||0
2290664|NCT02094937|5624439|P1|COMPLETED|8 Weeks in Period 1||370
2290665|NCT02094937|5624436|P4|STARTED|8 Weeks in Period 1||0
2290666|NCT02094937|5624437|P3|STARTED|8 Weeks in Period 1||0
2290667|NCT02094937|5624438|P2|STARTED|8 Weeks in Period 1||0
2290668|NCT02094937|5624439|P1|STARTED|8 Weeks in Period 1||430
2290669|NCT02094898|5624469|P1|NOT COMPLETED|Overall Study||5
2290670|NCT02094898|5624469|P1|COMPLETED|Overall Study||7
2290671|NCT02094898|5624469|P1|STARTED|Overall Study||12
2290672|NCT02094885|5624516|P2|NOT COMPLETED|Overall Study||5
2290673|NCT02094885|5624517|P1|NOT COMPLETED|Overall Study||2
2290674|NCT02094885|5624516|P2|COMPLETED|Overall Study||122
2290675|NCT02094885|5624517|P1|COMPLETED|Overall Study||123
2290676|NCT02094885|5624516|P2|STARTED|Overall Study||127
2290677|NCT02094885|5624517|P1|STARTED|Overall Study||125
2290678|NCT02094872|5624529|P1|NOT COMPLETED|Overall Study||29
2290679|NCT02094872|5624529|P1|COMPLETED|Overall Study||20
2290680|NCT02094872|5624529|P1|Patients Treated With MEK162|Overall Study||20
2290681|NCT02094872|5624529|P1|Received Standard of Care|Overall Study|7 standard-of-care patients crossed-over and received targeted therapy.|9
2290682|NCT02094872|5624529|P1|Received Targeted Therapy|Overall Study||20
2290683|NCT02094872|5624529|P1|Received Tumor-board Recommendation|Overall Study|1 individual withdrew consent after biopsy.|36
2290684|NCT02094872|5624529|P1|Received Biopsy|Overall Study||37
2290685|NCT02094872|5624529|P1|STARTED|Overall Study||49
2290686|NCT02094755|5624534|P1|NOT COMPLETED|Overall Study||0
2290687|NCT02094755|5624534|P1|COMPLETED|Overall Study||100
2290688|NCT02094755|5624534|P1|STARTED|Overall Study||100
2290689|NCT02094677|5624540|P2|NOT COMPLETED|Overall Study||1
2290690|NCT02094677|5624541|P1|NOT COMPLETED|Overall Study||3
2290691|NCT02094677|5624540|P2|COMPLETED|Overall Study||30
2290692|NCT02094677|5624541|P1|COMPLETED|Overall Study||40
2290693|NCT02094677|5624540|P2|STARTED|Overall Study||31
2290694|NCT02094677|5624541|P1|STARTED|Overall Study||43
2290695|NCT02094664|5624605|P2|NOT COMPLETED|Overall Study||0
2290696|NCT02094664|5624606|P1|NOT COMPLETED|Overall Study||0
2290697|NCT02094664|5624605|P2|COMPLETED|Overall Study||16
2290698|NCT02094664|5624606|P1|COMPLETED|Overall Study||16
2290699|NCT02094664|5624605|P2|STARTED|Overall Study||16
2290700|NCT02094664|5624606|P1|STARTED|Overall Study||16
2290701|NCT02094612|5624620|P2|NOT COMPLETED|Overall Study||70
2290702|NCT02094612|5624621|P1|NOT COMPLETED|Overall Study||79
2290703|NCT02094612|5624620|P2|COMPLETED|Overall Study||25
2290704|NCT02094612|5624621|P1|COMPLETED|Overall Study||33
2290705|NCT02094612|5624620|P2|6 Month Follow up|Overall Study||25
2290706|NCT02094612|5624621|P1|6 Month Follow up|Overall Study||33
2290707|NCT02094612|5624620|P2|3 Month Follow up|Overall Study||43
2290708|NCT02094612|5624621|P1|3 Month Follow up|Overall Study||50
2290709|NCT02094612|5624620|P2|1 Month Follow up|Overall Study||50
2290710|NCT02094612|5624621|P1|1 Month Follow up|Overall Study||67
2290711|NCT02094612|5624620|P2|STARTED|Overall Study||95
2290712|NCT02094612|5624621|P1|STARTED|Overall Study||112
2290713|NCT02094573|5624641|P2|NOT COMPLETED|Overall Study||110
2290714|NCT02094573|5624642|P1|NOT COMPLETED|Overall Study||112
2290715|NCT02094573|5624641|P2|COMPLETED|Overall Study||0
2290716|NCT02094573|5624642|P1|COMPLETED|Overall Study||0
2290717|NCT02094573|5624641|P2|Treated|Overall Study||110
2290718|NCT02094573|5624642|P1|Treated|Overall Study||109
2290719|NCT02094573|5624641|P2|STARTED|Overall Study||110
2290720|NCT02094573|5624642|P1|STARTED|Overall Study||112
2290721|NCT02094534|5624676|P2|NOT COMPLETED|Overall Study||0
2290722|NCT02094534|5624677|P1|NOT COMPLETED|Overall Study||0
2290723|NCT02094534|5624676|P2|COMPLETED|Overall Study||10
2290724|NCT02094534|5624677|P1|COMPLETED|Overall Study||15
2290725|NCT02094534|5624676|P2|STARTED|Overall Study||10
2290726|NCT02094534|5624677|P1|STARTED|Overall Study||15
2290727|NCT02094443|5624687|P2|NOT COMPLETED|Overall Study||17
2290728|NCT02094443|5624688|P1|NOT COMPLETED|Overall Study||15
2290729|NCT02094443|5624687|P2|COMPLETED|Overall Study||9
2290730|NCT02094443|5624688|P1|COMPLETED|Overall Study||11
2290731|NCT02094443|5624687|P2|Completed at Week 24|Overall Study||8
2290732|NCT02094443|5624688|P1|Completed at Week 24|Overall Study||11
2290733|NCT02094443|5624687|P2|Completed at Week 12|Overall Study||1
2290734|NCT02094443|5624688|P1|Completed at Week 12|Overall Study||0
2290735|NCT02094443|5624687|P2|STARTED|Overall Study||26
2290736|NCT02094443|5624688|P1|STARTED|Overall Study||26
2290737|NCT02094352|5624708|P2|NOT COMPLETED|Overall Study||0
2290738|NCT02094352|5624709|P1|NOT COMPLETED|Overall Study||0
2290739|NCT02094352|5624708|P2|COMPLETED|Overall Study||1
2290740|NCT02094352|5624709|P1|COMPLETED|Overall Study||2
2290741|NCT02094352|5624708|P2|STARTED|Overall Study||1
2290742|NCT02094352|5624709|P1|STARTED|Overall Study||2
2290743|NCT02094326|5624715|P1|NOT COMPLETED|Overall Study||0
2290744|NCT02094326|5624715|P1|COMPLETED|Overall Study||301
2290745|NCT02094326|5624715|P1|STARTED|Overall Study||301
2290746|NCT02094300|5624724|P1|NOT COMPLETED|Overall Study||20
2290747|NCT02094300|5624724|P1|COMPLETED|Overall Study||6
2290748|NCT02094300|5624724|P1|30 Days|Overall Study||24
2290749|NCT02094300|5624724|P1|STARTED|Overall Study||26
2290750|NCT02094261|5624728|P1|NOT COMPLETED|Overall Study||210
2290751|NCT02094261|5624728|P1|COMPLETED|Overall Study||0
2290752|NCT02094261|5624728|P1|STARTED|Overall Study||210
2290753|NCT02093962|5624737|P2|NOT COMPLETED|Overall Study||131
2290754|NCT02093962|5624738|P1|NOT COMPLETED|Overall Study||134
2290755|NCT02093962|5624737|P2|COMPLETED|Overall Study||0
2290756|NCT02093962|5624738|P1|COMPLETED|Overall Study||0
2290757|NCT02093962|5624737|P2|Received Treatment|Overall Study||130
2290758|NCT02093962|5624738|P1|Received Treatment|Overall Study||130
2290759|NCT02093962|5624737|P2|STARTED|Overall Study||131
2290760|NCT02093962|5624738|P1|STARTED|Overall Study||134
2290761|NCT02093949|5624746|P2|NOT COMPLETED|Overall Study||0
2290762|NCT02093949|5624747|P1|NOT COMPLETED|Overall Study||0
2290763|NCT02093949|5624746|P2|COMPLETED|Overall Study||47
2290764|NCT02093949|5624747|P1|COMPLETED|Overall Study||105
2290765|NCT02093949|5624746|P2|STARTED|Overall Study||47
2290766|NCT02093949|5624747|P1|STARTED|Overall Study||105
2290767|NCT02093923|5624770|P5|NOT COMPLETED|Overall Study||0
2290768|NCT02093923|5624771|P4|NOT COMPLETED|Overall Study||2
2290769|NCT02093923|5624772|P3|NOT COMPLETED|Overall Study||0
2290770|NCT02093923|5624773|P2|NOT COMPLETED|Overall Study||0
2290771|NCT02093923|5624774|P1|NOT COMPLETED|Overall Study||0
2290772|NCT02093923|5624770|P5|COMPLETED|Overall Study||13
2290773|NCT02093923|5624771|P4|COMPLETED|Overall Study||10
2290774|NCT02093923|5624772|P3|COMPLETED|Overall Study||5
2290775|NCT02093923|5624773|P2|COMPLETED|Overall Study||4
2290776|NCT02093923|5624774|P1|COMPLETED|Overall Study||4
2290777|NCT02093923|5624770|P5|Treated - 2 Doses:|Overall Study||13
2290778|NCT02093923|5624771|P4|Treated - 2 Doses:|Overall Study||10
2290779|NCT02093923|5624772|P3|Treated - 2 Doses:|Overall Study||5
2290780|NCT02093923|5624773|P2|Treated - 2 Doses:|Overall Study||4
2290781|NCT02093923|5624774|P1|Treated - 2 Doses:|Overall Study||4
2290782|NCT02093923|5624770|P5|Treated - 1 Dose Only:|Overall Study||0
2290783|NCT02093923|5624771|P4|Treated - 1 Dose Only:|Overall Study||1
2290784|NCT02093923|5624772|P3|Treated - 1 Dose Only:|Overall Study||0
2290785|NCT02093923|5624773|P2|Treated - 1 Dose Only:|Overall Study||0
2290786|NCT02093923|5624774|P1|Treated - 1 Dose Only:|Overall Study||0
2290787|NCT02093923|5624770|P5|Total Treated|Overall Study||13
2290788|NCT02093923|5624771|P4|Total Treated|Overall Study||11
2290789|NCT02093923|5624772|P3|Total Treated|Overall Study||5
2290790|NCT02093923|5624773|P2|Total Treated|Overall Study||4
2290791|NCT02093923|5624774|P1|Total Treated|Overall Study||4
2290792|NCT02093923|5624770|P5|STARTED|Overall Study||13
2290793|NCT02093923|5624771|P4|STARTED|Overall Study||12
2290794|NCT02093923|5624772|P3|STARTED|Overall Study||5
2290795|NCT02093923|5624773|P2|STARTED|Overall Study||4
2290796|NCT02093923|5624774|P1|STARTED|Overall Study||4
2290797|NCT02093897|5624829|P1|NOT COMPLETED|Overall Study||19
2290798|NCT02093897|5624829|P1|COMPLETED|Overall Study||65
2290799|NCT02093897|5624829|P1|STARTED|Overall Study||84
2290800|NCT02093819|5624857|P8|NOT COMPLETED|Overall Study||0
2290801|NCT02093819|5624858|P7|NOT COMPLETED|Overall Study||0
2290802|NCT02093819|5624859|P6|NOT COMPLETED|Overall Study||0
2290803|NCT02093819|5624860|P5|NOT COMPLETED|Overall Study||0
2290804|NCT02093819|5624861|P4|NOT COMPLETED|Overall Study||0
2290805|NCT02093819|5624862|P3|NOT COMPLETED|Overall Study||0
2290806|NCT02093819|5624863|P2|NOT COMPLETED|Overall Study||0
2290807|NCT02093819|5624864|P1|NOT COMPLETED|Overall Study||0
2290808|NCT02093819|5624857|P8|COMPLETED|Overall Study||6
2290809|NCT02093819|5624858|P7|COMPLETED|Overall Study||5
2290810|NCT02093819|5624859|P6|COMPLETED|Overall Study||6
2290811|NCT02093819|5624860|P5|COMPLETED|Overall Study||6
2290812|NCT02093819|5624861|P4|COMPLETED|Overall Study||6
2290813|NCT02093819|5624862|P3|COMPLETED|Overall Study||10
2290814|NCT02093819|5624863|P2|COMPLETED|Overall Study||6
2290815|NCT02093819|5624864|P1|COMPLETED|Overall Study||15
2290816|NCT02093819|5624857|P8|STARTED|Overall Study||6
2290817|NCT02093819|5624858|P7|STARTED|Overall Study||5
2290818|NCT02093819|5624859|P6|STARTED|Overall Study||6
2290819|NCT02093819|5624860|P5|STARTED|Overall Study||6
2290820|NCT02093819|5624861|P4|STARTED|Overall Study||6
2290821|NCT02093819|5624862|P3|STARTED|Overall Study||10
2290822|NCT02093819|5624863|P2|STARTED|Overall Study||6
2290823|NCT02093819|5624864|P1|STARTED|Overall Study||15
2290824|NCT02093702|5624900|P2|NOT COMPLETED|Overall Study||0
2290825|NCT02093702|5624901|P1|NOT COMPLETED|Overall Study||0
2290826|NCT02093702|5624900|P2|COMPLETED|Overall Study||3
2290827|NCT02093702|5624901|P1|COMPLETED|Overall Study||2
2290828|NCT02093702|5624900|P2|STARTED|Overall Study||3
2290829|NCT02093702|5624901|P1|STARTED|Overall Study||2
2290830|NCT02093689|5624932|P3|NOT COMPLETED|Overall Study||0
2290831|NCT02093689|5624933|P2|NOT COMPLETED|Overall Study||0
2290832|NCT02093689|5624934|P1|NOT COMPLETED|Overall Study||4
2290833|NCT02093689|5624932|P3|COMPLETED|Overall Study||0
2290834|NCT02093689|5624933|P2|COMPLETED|Overall Study||0
2290835|NCT02093689|5624934|P1|COMPLETED|Overall Study||14
2290836|NCT02093689|5624932|P3|STARTED|Overall Study||0
2290837|NCT02093689|5624933|P2|STARTED|Overall Study||0
2290838|NCT02093689|5624934|P1|STARTED|Overall Study||18
2290839|NCT02093663|5624940|P5|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||11
2290840|NCT02093663|5624941|P4|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||10
2290841|NCT02093663|5624942|P3|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
2290842|NCT02093663|5624943|P2|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
2290843|NCT02093663|5624944|P1|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
2290844|NCT02093663|5624940|P5|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||34
2290845|NCT02093663|5624941|P4|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||32
2290846|NCT02093663|5624942|P3|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
2290847|NCT02093663|5624943|P2|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
2290848|NCT02093663|5624944|P1|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
2290849|NCT02093663|5624940|P5|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||4
2290850|NCT02093663|5624941|P4|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||4
2290851|NCT02093663|5624942|P3|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
2290852|NCT02093663|5624943|P2|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
2290853|NCT02093663|5624944|P1|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
2290854|NCT02093663|5624940|P5|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||15
2290855|NCT02093663|5624941|P4|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||12
2290856|NCT02093663|5624942|P3|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
2290857|NCT02093663|5624943|P2|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
2290858|NCT02093663|5624944|P1|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
2290859|NCT02093663|5624940|P5|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||26
2290860|NCT02093663|5624941|P4|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||26
2290861|NCT02093663|5624942|P3|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
2290862|NCT02093663|5624943|P2|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
2290863|NCT02093663|5624944|P1|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
2290864|NCT02093663|5624940|P5|STARTED|Double Blind Maintenance Phase(26 Weeks)||45
2290865|NCT02093663|5624941|P4|STARTED|Double Blind Maintenance Phase(26 Weeks)||42
2290866|NCT02093663|5624942|P3|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
2290867|NCT02093663|5624943|P2|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
2290868|NCT02093663|5624944|P1|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
2290869|NCT02093663|5624940|P5|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
2290870|NCT02093663|5624941|P4|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
2290871|NCT02093663|5624942|P3|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||6
2290872|NCT02093663|5624943|P2|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
2290873|NCT02093663|5624944|P1|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
2290874|NCT02093663|5624940|P5|COMPLETED|Open Label Acute Phase (8 Weeks)||0
2290875|NCT02093663|5624941|P4|COMPLETED|Open Label Acute Phase (8 Weeks)||0
2290876|NCT02093663|5624942|P3|COMPLETED|Open Label Acute Phase (8 Weeks)||12
2290877|NCT02093663|5624943|P2|COMPLETED|Open Label Acute Phase (8 Weeks)||0
2290878|NCT02093663|5624944|P1|COMPLETED|Open Label Acute Phase (8 Weeks)||0
2290879|NCT02093663|5624940|P5|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
2290880|NCT02093663|5624941|P4|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
2290881|NCT02093663|5624942|P3|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||18
2290882|NCT02093663|5624943|P2|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
2290883|NCT02093663|5624944|P1|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
2290884|NCT02093663|5624940|P5|STARTED|Open Label Acute Phase (8 Weeks)||0
2290885|NCT02093663|5624941|P4|STARTED|Open Label Acute Phase (8 Weeks)||0
2290886|NCT02093663|5624942|P3|STARTED|Open Label Acute Phase (8 Weeks)||18
2290887|NCT02093663|5624943|P2|STARTED|Open Label Acute Phase (8 Weeks)||0
2290888|NCT02093663|5624944|P1|STARTED|Open Label Acute Phase (8 Weeks)||0
2290889|NCT02093663|5624940|P5|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
2290890|NCT02093663|5624941|P4|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
2290891|NCT02093663|5624942|P3|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
2290892|NCT02093663|5624943|P2|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||4
2290893|NCT02093663|5624944|P1|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||8
2290894|NCT02093663|5624940|P5|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
2290895|NCT02093663|5624941|P4|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
2290896|NCT02093663|5624942|P3|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
2290897|NCT02093663|5624943|P2|COMPLETED|Double Blind Acute Phase (8 Weeks)||22
2290898|NCT02093663|5624944|P1|COMPLETED|Double Blind Acute Phase (8 Weeks)||19
2290899|NCT02093663|5624940|P5|STARTED|Double Blind Acute Phase (8 Weeks)||0
2290900|NCT02093663|5624941|P4|STARTED|Double Blind Acute Phase (8 Weeks)||0
2290901|NCT02093663|5624942|P3|STARTED|Double Blind Acute Phase (8 Weeks)||0
2290902|NCT02093663|5624943|P2|STARTED|Double Blind Acute Phase (8 Weeks)||26
2290903|NCT02093663|5624944|P1|STARTED|Double Blind Acute Phase (8 Weeks)||27
2290904|NCT02093520|5624973|P2|NOT COMPLETED|Overall Study||22
2290905|NCT02093520|5624974|P1|NOT COMPLETED|Overall Study||6
2290906|NCT02093520|5624973|P2|COMPLETED|Overall Study||131
2290907|NCT02093520|5624974|P1|COMPLETED|Overall Study||143
2290908|NCT02093520|5624973|P2|STARTED|Overall Study||153
2290909|NCT02093520|5624974|P1|STARTED|Overall Study||149
2290910|NCT02093390|5624986|P2|NOT COMPLETED|Overall Study||1
2290911|NCT02093390|5624987|P1|NOT COMPLETED|Overall Study||0
2290912|NCT02093390|5624986|P2|COMPLETED|Overall Study||19
2290913|NCT02093390|5624987|P1|COMPLETED|Overall Study||20
2290914|NCT02093390|5624986|P2|STARTED|Overall Study||20
2290915|NCT02093390|5624987|P1|STARTED|Overall Study||20
2290916|NCT02093351|5625026|P4|NOT COMPLETED|Part B||63
2290917|NCT02093351|5625027|P3|NOT COMPLETED|Part B||0
2290918|NCT02093351|5625028|P2|NOT COMPLETED|Part B||0
2290919|NCT02093351|5625029|P1|NOT COMPLETED|Part B||0
2290920|NCT02093351|5625026|P4|COMPLETED|Part B||6
2290921|NCT02093351|5625027|P3|COMPLETED|Part B||0
2290922|NCT02093351|5625028|P2|COMPLETED|Part B||0
2290923|NCT02093351|5625029|P1|COMPLETED|Part B||0
2290924|NCT02093351|5625026|P4|STARTED|Part B|Eligible patients completing Part A entered Part B for continued access to olaparib.|69
2290925|NCT02093351|5625027|P3|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
2290926|NCT02093351|5625028|P2|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
2290927|NCT02093351|5625029|P1|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
2290928|NCT02093351|5625026|P4|NOT COMPLETED|Part A||0
2290929|NCT02093351|5625027|P3|NOT COMPLETED|Part A||3
2290930|NCT02093351|5625028|P2|NOT COMPLETED|Part A||2
2290931|NCT02093351|5625029|P1|NOT COMPLETED|Part A||2
2290932|NCT02093351|5625026|P4|COMPLETED|Part A||0
2290933|NCT02093351|5625027|P3|COMPLETED|Part A||23
2290934|NCT02093351|5625028|P2|COMPLETED|Part A||21
2290935|NCT02093351|5625029|P1|COMPLETED|Part A||28
2290936|NCT02093351|5625026|P4|Completing Treatment Period 3|Part A||0
2290937|NCT02093351|5625027|P3|Completing Treatment Period 3|Part A||23
2290938|NCT02093351|5625028|P2|Completing Treatment Period 3|Part A||21
2290939|NCT02093351|5625029|P1|Completing Treatment Period 3|Part A||28
2290940|NCT02093351|5625026|P4|Completing Treatment Period 2|Part A||0
2290941|NCT02093351|5625027|P3|Completing Treatment Period 2|Part A||23
2290942|NCT02093351|5625028|P2|Completing Treatment Period 2|Part A||21
2290943|NCT02093351|5625029|P1|Completing Treatment Period 2|Part A||29
2290944|NCT02093351|5625026|P4|Completing Treatment Period 1|Part A||0
2290945|NCT02093351|5625027|P3|Completing Treatment Period 1|Part A||23
2290946|NCT02093351|5625028|P2|Completing Treatment Period 1|Part A||22
2290947|NCT02093351|5625029|P1|Completing Treatment Period 1|Part A||29
2290948|NCT02093351|5625026|P4|STARTED|Part A||0
2290949|NCT02093351|5625027|P3|STARTED|Part A||26
2290950|NCT02093351|5625028|P2|STARTED|Part A||23
2290951|NCT02093351|5625029|P1|STARTED|Part A||30
2290952|NCT02093234|5625062|P3|NOT COMPLETED|Overall Study||4
2290953|NCT02093234|5625063|P2|NOT COMPLETED|Overall Study||4
2290954|NCT02093234|5625064|P1|NOT COMPLETED|Overall Study||3
2290955|NCT02093234|5625062|P3|COMPLETED|Overall Study||50
2290956|NCT02093234|5625063|P2|COMPLETED|Overall Study||52
2290957|NCT02093234|5625064|P1|COMPLETED|Overall Study||53
2290958|NCT02093234|5625062|P3|STARTED|Overall Study||54
2290959|NCT02093234|5625063|P2|STARTED|Overall Study||56
2290960|NCT02093234|5625064|P1|STARTED|Overall Study||56
2290961|NCT02093221|5625086|P5|NOT COMPLETED|Overall Study||8
2290962|NCT02093221|5625087|P4|NOT COMPLETED|Overall Study||8
2290963|NCT02093221|5625088|P3|NOT COMPLETED|Overall Study||9
2290964|NCT02093221|5625089|P2|NOT COMPLETED|Overall Study||8
2290965|NCT02093221|5625090|P1|NOT COMPLETED|Overall Study||10
2290966|NCT02093221|5625086|P5|COMPLETED|Overall Study||7
2290967|NCT02093221|5625087|P4|COMPLETED|Overall Study||7
2290968|NCT02093221|5625088|P3|COMPLETED|Overall Study||6
2290969|NCT02093221|5625089|P2|COMPLETED|Overall Study||8
2290970|NCT02093221|5625090|P1|COMPLETED|Overall Study||5
2290971|NCT02093221|5625086|P5|STARTED|Overall Study||15
2290972|NCT02093221|5625087|P4|STARTED|Overall Study||15
2290973|NCT02093221|5625088|P3|STARTED|Overall Study||15
2290974|NCT02093221|5625089|P2|STARTED|Overall Study||16
2290975|NCT02093221|5625090|P1|STARTED|Overall Study||15
2290976|NCT02093026|5625127|P1|NOT COMPLETED|Overall Study||193
2290977|NCT02093026|5625127|P1|COMPLETED|Overall Study|At predefined end-of-treatment date, 272 ongoing participants were designated as completed study.|272
2290978|NCT02093026|5625127|P1|STARTED|Overall Study||465
2290979|NCT02092961|5625149|P3|NOT COMPLETED|Overall Study||16
2290980|NCT02092961|5625150|P2|NOT COMPLETED|Overall Study||14
2290981|NCT02092961|5625151|P1|NOT COMPLETED|Overall Study||21
2290982|NCT02092961|5625149|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|13
2290983|NCT02092961|5625150|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|14
2290984|NCT02092961|5625151|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|12
2290985|NCT02092961|5625149|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
2290986|NCT02092961|5625150|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/study stopped|5
2290987|NCT02092961|5625151|P1|Randomised But Did Not Receive Treatment|Overall Study|Study stopped|1
2290988|NCT02092961|5625149|P3|STARTED|Overall Study|Patients who received treatment|29
2290989|NCT02092961|5625150|P2|STARTED|Overall Study|Patients who received treatment|28
2290990|NCT02092961|5625151|P1|STARTED|Overall Study|Patients who received treatment|33
2290991|NCT02092909|5625176|P4|NOT COMPLETED|Overall Study||6
2290992|NCT02092909|5625177|P3|NOT COMPLETED|Overall Study||9
2290993|NCT02092909|5625178|P2|NOT COMPLETED|Overall Study||3
2290994|NCT02092909|5625179|P1|NOT COMPLETED|Overall Study||1
2290995|NCT02092909|5625176|P4|COMPLETED|Overall Study||0
2290996|NCT02092909|5625177|P3|COMPLETED|Overall Study||5
2290997|NCT02092909|5625178|P2|COMPLETED|Overall Study||2
2290998|NCT02092909|5625179|P1|COMPLETED|Overall Study||5
2290999|NCT02092909|5625176|P4|STARTED|Overall Study||6
2291000|NCT02092909|5625177|P3|STARTED|Overall Study||14
2291001|NCT02092909|5625178|P2|STARTED|Overall Study||5
2291002|NCT02092909|5625179|P1|STARTED|Overall Study||6
2291003|NCT02092857|5625208|P3|NOT COMPLETED|Overall Study||13
2291004|NCT02092857|5625209|P2|NOT COMPLETED|Overall Study||12
2291005|NCT02092857|5625210|P1|NOT COMPLETED|Overall Study||10
2291006|NCT02092857|5625208|P3|COMPLETED|Overall Study||16
2291007|NCT02092857|5625209|P2|COMPLETED|Overall Study||18
2291008|NCT02092857|5625210|P1|COMPLETED|Overall Study||20
2291009|NCT02092857|5625208|P3|STARTED|Overall Study||29
2291010|NCT02092857|5625209|P2|STARTED|Overall Study||30
2291011|NCT02092857|5625210|P1|STARTED|Overall Study||30
2291012|NCT02092662|5625220|P2|NOT COMPLETED|Overall Study||0
2291013|NCT02092662|5625221|P1|NOT COMPLETED|Overall Study||13
2291014|NCT02092662|5625220|P2|COMPLETED|Overall Study||19
2291015|NCT02092662|5625221|P1|COMPLETED|Overall Study||25
2291016|NCT02092662|5625220|P2|Recruited|Overall Study||19
2291017|NCT02092662|5625221|P1|Recruited|Overall Study||38
2291018|NCT02092662|5625220|P2|STARTED|Overall Study||19
2291019|NCT02092662|5625221|P1|STARTED|Overall Study||38
2291020|NCT02092649|5625230|P2|NOT COMPLETED|Overall Study||0
2291021|NCT02092649|5625231|P1|NOT COMPLETED|Overall Study||0
2291022|NCT02092649|5625230|P2|COMPLETED|Overall Study|13 participants finished study|13
2291023|NCT02092649|5625231|P1|COMPLETED|Overall Study|13 participants finished study|13
2291024|NCT02092649|5625230|P2|STARTED|Overall Study|13 participants recruited|13
2291025|NCT02092649|5625231|P1|STARTED|Overall Study|13 participants recruited|13
2291026|NCT02092610|5625249|P2|NOT COMPLETED|Overall Study||12
2291027|NCT02092610|5625250|P1|NOT COMPLETED|Overall Study||8
2291028|NCT02092610|5625249|P2|COMPLETED|Overall Study||40
2291029|NCT02092610|5625250|P1|COMPLETED|Overall Study||17
2291030|NCT02092610|5625249|P2|STARTED|Overall Study||52
2291031|NCT02092610|5625250|P1|STARTED|Overall Study||25
2291032|NCT02092441|5625264|P2|NOT COMPLETED|Overall Study||0
2291033|NCT02092441|5625265|P1|NOT COMPLETED|Overall Study||0
2291034|NCT02092441|5625264|P2|COMPLETED|Overall Study||43
2291035|NCT02092441|5625265|P1|COMPLETED|Overall Study||37
2291036|NCT02092441|5625264|P2|STARTED|Overall Study||43
2291037|NCT02092441|5625265|P1|STARTED|Overall Study||37
2291038|NCT02092415|5625275|P1|NOT COMPLETED|Overall Study||0
2291039|NCT02092415|5625275|P1|COMPLETED|Overall Study||10
2291040|NCT02092415|5625275|P1|STARTED|Overall Study||10
2291041|NCT02092389|5625280|P1|NOT COMPLETED|Overall Study||6
2291042|NCT02092389|5625280|P1|COMPLETED|Overall Study||4
2291043|NCT02092389|5625280|P1|STARTED|Overall Study||10
2291044|NCT02092350|5625292|P2|NOT COMPLETED|Overall Study||12
2291045|NCT02092350|5625293|P1|NOT COMPLETED|Overall Study||10
2291046|NCT02092350|5625292|P2|COMPLETED|Overall Study||102
2291047|NCT02092350|5625293|P1|COMPLETED|Overall Study||113
2291048|NCT02092350|5625292|P2|STARTED|Overall Study||114
2291049|NCT02092350|5625293|P1|STARTED|Overall Study||123
2291050|NCT02092311|5625310|P2|NOT COMPLETED|Overall Study||0
2291051|NCT02092311|5625311|P1|NOT COMPLETED|Overall Study||0
2291052|NCT02092311|5625310|P2|COMPLETED|Overall Study||285
2291053|NCT02092311|5625311|P1|COMPLETED|Overall Study||285
2291054|NCT02092311|5625310|P2|STARTED|Overall Study||285
2291055|NCT02092311|5625311|P1|STARTED|Overall Study||285
2291056|NCT02092285|5625321|P1|NOT COMPLETED|Maintenance Phase & Follow-up||110
2291057|NCT02092285|5625321|P1|COMPLETED|Maintenance Phase & Follow-up||60
2291058|NCT02092285|5625321|P1|STARTED|Maintenance Phase & Follow-up||170
2291059|NCT02092285|5625321|P1|NOT COMPLETED|Induction Phase||35
2291060|NCT02092285|5625321|P1|COMPLETED|Induction Phase||170
2291061|NCT02092285|5625321|P1|STARTED|Induction Phase||205
2291062|NCT02092220|5625325|P2|NOT COMPLETED|Period 2||1
2291063|NCT02092220|5625326|P1|NOT COMPLETED|Period 2||1
2291064|NCT02092220|5625325|P2|COMPLETED|Period 2||19
2291065|NCT02092220|5625326|P1|COMPLETED|Period 2||20
2291066|NCT02092220|5625325|P2|STARTED|Period 2||20
2291067|NCT02092220|5625326|P1|STARTED|Period 2||21
2291068|NCT02092220|5625325|P2|NOT COMPLETED|Period 1||2
2291069|NCT02092220|5625326|P1|NOT COMPLETED|Period 1||0
2291070|NCT02092220|5625325|P2|COMPLETED|Period 1||20
2291071|NCT02092220|5625326|P1|COMPLETED|Period 1||21
2291072|NCT02092220|5625325|P2|STARTED|Period 1||22
2291073|NCT02092220|5625326|P1|STARTED|Period 1||21
2291074|NCT02092168|5625386|P2|NOT COMPLETED|Overall Study||0
2291075|NCT02092168|5625387|P1|NOT COMPLETED|Overall Study||0
2291076|NCT02092168|5625386|P2|COMPLETED|Overall Study||12
2291077|NCT02092168|5625387|P1|COMPLETED|Overall Study||12
2291078|NCT02092168|5625386|P2|STARTED|Overall Study||12
2291079|NCT02092168|5625387|P1|STARTED|Overall Study||12
2291080|NCT02092116|5625399|P2|NOT COMPLETED|Overall Study||4
2291081|NCT02092116|5625400|P1|NOT COMPLETED|Overall Study||0
2291082|NCT02092116|5625399|P2|COMPLETED|Overall Study||16
2291083|NCT02092116|5625400|P1|COMPLETED|Overall Study||6
2291084|NCT02092116|5625399|P2|STARTED|Overall Study||20
2291085|NCT02092116|5625400|P1|STARTED|Overall Study||6
2291086|NCT02092025|5625409|P1|NOT COMPLETED|Overall Study||68
2291087|NCT02092025|5625409|P1|COMPLETED|Overall Study||3369
2291088|NCT02092025|5625409|P1|STARTED|Overall Study||3437
2291089|NCT02091986|5625418|P3|NOT COMPLETED|Overall Study||8
2291090|NCT02091986|5625419|P2|NOT COMPLETED|Overall Study||11
2291091|NCT02091986|5625420|P1|NOT COMPLETED|Overall Study||7
2291092|NCT02091986|5625418|P3|COMPLETED|Overall Study||84
2291093|NCT02091986|5625419|P2|COMPLETED|Overall Study||84
2291094|NCT02091986|5625420|P1|COMPLETED|Overall Study||85
2291095|NCT02091986|5625418|P3|STARTED|Overall Study||92
2291096|NCT02091986|5625419|P2|STARTED|Overall Study||95
2291097|NCT02091986|5625420|P1|STARTED|Overall Study||92
2291098|NCT02091960|5625467|P1|NOT COMPLETED|Overall Study||51
2291099|NCT02091960|5625467|P1|COMPLETED|Overall Study|Completed indicates participants with disease progression|52
2291100|NCT02091960|5625467|P1|Received Treatment|Overall Study||103
2291101|NCT02091960|5625467|P1|STARTED|Overall Study||103
2291102|NCT02091921|5625478|P1|NOT COMPLETED|Overall Study||3
2291103|NCT02091921|5625478|P1|COMPLETED|Overall Study||50
2291104|NCT02091921|5625478|P1|STARTED|Overall Study||53
2291105|NCT02091869|5625487|P2|NOT COMPLETED|Overall Study||3
2291106|NCT02091869|5625488|P1|NOT COMPLETED|Overall Study||0
2291107|NCT02091869|5625487|P2|COMPLETED|Overall Study||14
2291108|NCT02091869|5625488|P1|COMPLETED|Overall Study||17
2291109|NCT02091869|5625487|P2|STARTED|Overall Study||17
2291110|NCT02091869|5625488|P1|STARTED|Overall Study||17
2291111|NCT02091856|5625503|P3|NOT COMPLETED|Follow-up Assessment||0
2291112|NCT02091856|5625504|P2|NOT COMPLETED|Follow-up Assessment||3
2291113|NCT02091856|5625505|P1|NOT COMPLETED|Follow-up Assessment||5
2291114|NCT02091856|5625503|P3|COMPLETED|Follow-up Assessment||0
2291115|NCT02091856|5625504|P2|COMPLETED|Follow-up Assessment||9
2291116|NCT02091856|5625505|P1|COMPLETED|Follow-up Assessment||10
2291117|NCT02091856|5625503|P3|STARTED|Follow-up Assessment|WLCG participants were lost at follow-up.|0
2291118|NCT02091856|5625504|P2|STARTED|Follow-up Assessment|Only a subset of R-CBT participants responded to our request to complete the follow-up assessment.|12
2291119|NCT02091856|5625505|P1|STARTED|Follow-up Assessment|Only a subset of C-CBT participants responded to our request to complete the follow-up assessment.|15
2291120|NCT02091856|5625503|P3|NOT COMPLETED|Active Intervention Interval||7
2291121|NCT02091856|5625504|P2|NOT COMPLETED|Active Intervention Interval||7
2291122|NCT02091856|5625505|P1|NOT COMPLETED|Active Intervention Interval||19
2291123|NCT02091856|5625503|P3|COMPLETED|Active Intervention Interval||19
2291124|NCT02091856|5625504|P2|COMPLETED|Active Intervention Interval||12
2291125|NCT02091856|5625505|P1|COMPLETED|Active Intervention Interval||15
2291126|NCT02091856|5625503|P3|STARTED|Active Intervention Interval||26
2291127|NCT02091856|5625504|P2|STARTED|Active Intervention Interval||19
2291128|NCT02091856|5625505|P1|STARTED|Active Intervention Interval||34
2291129|NCT02091778|5625525|P1|NOT COMPLETED|Overall Study||1
2291130|NCT02091778|5625525|P1|COMPLETED|Overall Study||20
2291131|NCT02091778|5625525|P1|STARTED|Overall Study||21
2291132|NCT02091752|5625529|P1|NOT COMPLETED|Overall Study||3
2291133|NCT02091752|5625529|P1|COMPLETED|Overall Study||0
2291134|NCT02091752|5625529|P1|STARTED|Overall Study||3
2291135|NCT02091739|5625543|P5|NOT COMPLETED|EP: 48 Weeks||14
2291136|NCT02091739|5625544|P4|NOT COMPLETED|EP: 48 Weeks||8
2291137|NCT02091739|5625545|P3|NOT COMPLETED|EP: 48 Weeks||0
2291138|NCT02091739|5625546|P2|NOT COMPLETED|EP: 48 Weeks||0
2291139|NCT02091739|5625547|P1|NOT COMPLETED|EP: 48 Weeks||0
2291140|NCT02091739|5625543|P5|COMPLETED|EP: 48 Weeks||75
2291141|NCT02091739|5625544|P4|COMPLETED|EP: 48 Weeks||76
2291142|NCT02091739|5625545|P3|COMPLETED|EP: 48 Weeks||0
2291143|NCT02091739|5625546|P2|COMPLETED|EP: 48 Weeks||0
2291144|NCT02091739|5625547|P1|COMPLETED|EP: 48 Weeks||0
2291145|NCT02091739|5625543|P5|STARTED|EP: 48 Weeks||89
2291146|NCT02091739|5625544|P4|STARTED|EP: 48 Weeks||84
2291147|NCT02091739|5625545|P3|STARTED|EP: 48 Weeks||0
2291148|NCT02091739|5625546|P2|STARTED|EP: 48 Weeks||0
2291149|NCT02091739|5625547|P1|STARTED|EP: 48 Weeks||0
2291150|NCT02091739|5625543|P5|NOT COMPLETED|MP: 16 Weeks||0
2291151|NCT02091739|5625544|P4|NOT COMPLETED|MP: 16 Weeks||0
2291152|NCT02091739|5625545|P3|NOT COMPLETED|MP: 16 Weeks||2
2291153|NCT02091739|5625546|P2|NOT COMPLETED|MP: 16 Weeks||5
2291154|NCT02091739|5625547|P1|NOT COMPLETED|MP: 16 Weeks||4
2291155|NCT02091739|5625543|P5|COMPLETED|MP: 16 Weeks||0
2291156|NCT02091739|5625544|P4|COMPLETED|MP: 16 Weeks||0
2291157|NCT02091739|5625545|P3|COMPLETED|MP: 16 Weeks||72
2291158|NCT02091739|5625546|P2|COMPLETED|MP: 16 Weeks||69
2291159|NCT02091739|5625547|P1|COMPLETED|MP: 16 Weeks||32
2291160|NCT02091739|5625543|P5|STARTED|MP: 16 Weeks||0
2291161|NCT02091739|5625544|P4|STARTED|MP: 16 Weeks||0
2291162|NCT02091739|5625545|P3|STARTED|MP: 16 Weeks||74
2291163|NCT02091739|5625546|P2|STARTED|MP: 16 Weeks||74
2291164|NCT02091739|5625547|P1|STARTED|MP: 16 Weeks||36
2291165|NCT02091726|5625566|P1|NOT COMPLETED|Overall Study||6
2291166|NCT02091726|5625566|P1|COMPLETED|Overall Study||104
2291167|NCT02091726|5625566|P1|4 Week Followup|Overall Study||104
2291168|NCT02091726|5625566|P1|1 Week Followup|Overall Study||110
2291169|NCT02091726|5625566|P1|STARTED|Overall Study||110
2291170|NCT02091531|5625574|P1|NOT COMPLETED|Overall Study||0
2291171|NCT02091531|5625574|P1|COMPLETED|Overall Study||9
2291172|NCT02091531|5625574|P1|STARTED|Overall Study||9
2291173|NCT02091466|5625582|P2|NOT COMPLETED|Overall Study||0
2291174|NCT02091466|5625583|P1|NOT COMPLETED|Overall Study||0
2291175|NCT02091466|5625582|P2|COMPLETED|Overall Study||20
2291176|NCT02091466|5625583|P1|COMPLETED|Overall Study||20
2291177|NCT02091466|5625582|P2|STARTED|Overall Study||20
2291178|NCT02091466|5625583|P1|STARTED|Overall Study||20
2291179|NCT02091440|5625589|P1|NOT COMPLETED|Overall Study||2
2291180|NCT02091440|5625589|P1|COMPLETED|Overall Study||4
2291181|NCT02091440|5625589|P1|Overall Survival at 180 Days|Overall Study||6
2291182|NCT02091440|5625589|P1|Primary Endpoint (Success at 180 Days)|Overall Study||6
2291183|NCT02091440|5625589|P1|STARTED|Overall Study||6
2291184|NCT02091414|5625599|P1|NOT COMPLETED|Overall Study||4
2291185|NCT02091414|5625599|P1|COMPLETED|Overall Study||32
2291186|NCT02091414|5625599|P1|STARTED|Overall Study||36
2291187|NCT02091375|5625613|P2|NOT COMPLETED|Overall Study||3
2291188|NCT02091375|5625614|P1|NOT COMPLETED|Overall Study||9
2291189|NCT02091375|5625613|P2|COMPLETED|Overall Study||56
2291190|NCT02091375|5625614|P1|COMPLETED|Overall Study||52
2291191|NCT02091375|5625613|P2|Intention to Treat (ITT) Analysis Set|Overall Study||59
2291192|NCT02091375|5625614|P1|Intention to Treat (ITT) Analysis Set|Overall Study||61
2291193|NCT02091375|5625613|P2|Safety Analysis Set|Overall Study||59
2291194|NCT02091375|5625614|P1|Safety Analysis Set|Overall Study||61
2291195|NCT02091375|5625613|P2|STARTED|Overall Study||59
2291196|NCT02091375|5625614|P1|STARTED|Overall Study||61
2291197|NCT02091362|5625644|P2|NOT COMPLETED|Period 2||2
2291198|NCT02091362|5625645|P1|NOT COMPLETED|Period 2||2
2291199|NCT02091362|5625644|P2|COMPLETED|Period 2||128
2291200|NCT02091362|5625645|P1|COMPLETED|Period 2||125
2291201|NCT02091362|5625644|P2|STARTED|Period 2||130
2291202|NCT02091362|5625645|P1|STARTED|Period 2||127
2291203|NCT02091362|5625644|P2|NOT COMPLETED|Wash-out||3
2291204|NCT02091362|5625645|P1|NOT COMPLETED|Wash-out||1
2291205|NCT02091362|5625644|P2|COMPLETED|Wash-out||130
2291206|NCT02091362|5625645|P1|COMPLETED|Wash-out||127
2291207|NCT02091362|5625644|P2|STARTED|Wash-out||133
2291208|NCT02091362|5625645|P1|STARTED|Wash-out||128
2291209|NCT02091362|5625644|P2|NOT COMPLETED|Period 1||4
2291210|NCT02091362|5625645|P1|NOT COMPLETED|Period 1||5
2291211|NCT02091362|5625644|P2|COMPLETED|Period 1||133
2291212|NCT02091362|5625645|P1|COMPLETED|Period 1||128
2291213|NCT02091362|5625644|P2|STARTED|Period 1||137
2291214|NCT02091362|5625645|P1|STARTED|Period 1||133
2291215|NCT02091284|5625667|P2|NOT COMPLETED|Overall Study||1
2291216|NCT02091284|5625668|P1|NOT COMPLETED|Overall Study||3
2291217|NCT02091284|5625667|P2|COMPLETED|Overall Study||22
2291218|NCT02091284|5625668|P1|COMPLETED|Overall Study||23
2291219|NCT02091284|5625667|P2|STARTED|Overall Study|One subject from this group discontinued the protocol|23
2291220|NCT02091284|5625668|P1|STARTED|Overall Study|Two subjects from this group discontinued the protocol, data from one subject could not be included.|26
2291221|NCT02091206|5625690|P4|NOT COMPLETED|Taper Period||2
2291222|NCT02091206|5625691|P3|NOT COMPLETED|Taper Period||0
2291223|NCT02091206|5625692|P2|NOT COMPLETED|Taper Period||0
2291224|NCT02091206|5625693|P1|NOT COMPLETED|Taper Period||1
2291225|NCT02091206|5625690|P4|COMPLETED|Taper Period||5
2291226|NCT02091206|5625691|P3|COMPLETED|Taper Period||8
2291227|NCT02091206|5625692|P2|COMPLETED|Taper Period||7
2291228|NCT02091206|5625693|P1|COMPLETED|Taper Period||9
2291229|NCT02091206|5625690|P4|STARTED|Taper Period||7
2291230|NCT02091206|5625691|P3|STARTED|Taper Period||8
2291231|NCT02091206|5625692|P2|STARTED|Taper Period||7
2291232|NCT02091206|5625693|P1|STARTED|Taper Period||10
2291233|NCT02091206|5625690|P4|NOT COMPLETED|Treatment Period||0
2291234|NCT02091206|5625691|P3|NOT COMPLETED|Treatment Period||1
2291235|NCT02091206|5625692|P2|NOT COMPLETED|Treatment Period||1
2291236|NCT02091206|5625693|P1|NOT COMPLETED|Treatment Period||0
2291237|NCT02091206|5625690|P4|COMPLETED|Treatment Period||7
2291238|NCT02091206|5625691|P3|COMPLETED|Treatment Period||8
2291239|NCT02091206|5625692|P2|COMPLETED|Treatment Period||7
2291240|NCT02091206|5625693|P1|COMPLETED|Treatment Period||10
2291241|NCT02091206|5625690|P4|Safety Analysis Set|Treatment Period||7
2291242|NCT02091206|5625691|P3|Safety Analysis Set|Treatment Period||9
2291243|NCT02091206|5625692|P2|Safety Analysis Set|Treatment Period||8
2291244|NCT02091206|5625693|P1|Safety Analysis Set|Treatment Period||10
2291245|NCT02091206|5625690|P4|STARTED|Treatment Period||7
2291246|NCT02091206|5625691|P3|STARTED|Treatment Period||9
2291247|NCT02091206|5625692|P2|STARTED|Treatment Period||8
2291248|NCT02091206|5625693|P1|STARTED|Treatment Period||10
2291249|NCT02091167|5625712|P2|NOT COMPLETED|Overall Study||2
2291250|NCT02091167|5625713|P1|NOT COMPLETED|Overall Study||0
2291251|NCT02091167|5625712|P2|COMPLETED|Overall Study||14
2291252|NCT02091167|5625713|P1|COMPLETED|Overall Study||19
2291253|NCT02091167|5625712|P2|STARTED|Overall Study||16
2291254|NCT02091167|5625713|P1|STARTED|Overall Study||19
2291255|NCT02090894|5625721|P1|NOT COMPLETED|Overall Study||0
2291256|NCT02090894|5625721|P1|COMPLETED|Overall Study||11
2291257|NCT02090894|5625721|P1|STARTED|Overall Study||11
2291258|NCT02090855|5625726|P1|NOT COMPLETED|Overall Study||2
2291259|NCT02090855|5625726|P1|COMPLETED|Overall Study||106
2291260|NCT02090855|5625726|P1|STARTED|Overall Study||108
2291261|NCT02090777|5625733|P1|NOT COMPLETED|Overall Study||0
2291262|NCT02090777|5625733|P1|COMPLETED|Overall Study||4
2291263|NCT02090777|5625733|P1|STARTED|Overall Study||4
2291264|NCT02090764|5625739|P2|NOT COMPLETED|Overall Study||20
2291265|NCT02090764|5625740|P1|NOT COMPLETED|Overall Study||6
2291266|NCT02090764|5625739|P2|COMPLETED|Overall Study||186
2291267|NCT02090764|5625740|P1|COMPLETED|Overall Study||200
2291268|NCT02090764|5625739|P2|STARTED|Overall Study||206
2291269|NCT02090764|5625740|P1|STARTED|Overall Study||206
2291270|NCT02090725|5625746|P1|NOT COMPLETED|Overall Study||4
2291271|NCT02090725|5625746|P1|COMPLETED|Overall Study||0
2291272|NCT02090725|5625746|P1|STARTED|Overall Study||4
2291273|NCT02090413|5625753|P3|NOT COMPLETED|Overall Study||23
2291274|NCT02090413|5625754|P2|NOT COMPLETED|Overall Study||20
2291275|NCT02090413|5625755|P1|NOT COMPLETED|Overall Study||19
2291276|NCT02090413|5625753|P3|COMPLETED|Overall Study||57
2291277|NCT02090413|5625754|P2|COMPLETED|Overall Study||60
2291278|NCT02090413|5625755|P1|COMPLETED|Overall Study||62
2291279|NCT02090413|5625753|P3|STARTED|Overall Study||80
2291280|NCT02090413|5625754|P2|STARTED|Overall Study||80
2291281|NCT02090413|5625755|P1|STARTED|Overall Study||81
2291282|NCT02090283|5625832|P3|NOT COMPLETED|Overall Study||10
2291283|NCT02090283|5625833|P2|NOT COMPLETED|Overall Study||15
2291284|NCT02090283|5625834|P1|NOT COMPLETED|Overall Study||17
2291285|NCT02090283|5625832|P3|COMPLETED|Overall Study||0
2291286|NCT02090283|5625833|P2|COMPLETED|Overall Study||0
2291287|NCT02090283|5625834|P1|COMPLETED|Overall Study||0
2291288|NCT02090283|5625832|P3|Received At Least 1 Dose Of Study Drug|Overall Study||10
2291289|NCT02090283|5625833|P2|Received At Least 1 Dose Of Study Drug|Overall Study||15
2291290|NCT02090283|5625834|P1|Received At Least 1 Dose Of Study Drug|Overall Study||17
2291291|NCT02090283|5625832|P3|STARTED|Overall Study||10
2291292|NCT02090283|5625833|P2|STARTED|Overall Study||15
2291293|NCT02090283|5625834|P1|STARTED|Overall Study||17
2291294|NCT02090088|5625845|P1|NOT COMPLETED|Overall Study||0
2291295|NCT02090088|5625845|P1|COMPLETED|Overall Study||4
2291296|NCT02090088|5625845|P1|Gave Birth|Overall Study||4
2291297|NCT02090088|5625845|P1|STARTED|Overall Study||4
2291298|NCT02090075|5625859|P2|NOT COMPLETED|Overall Study||3
2291299|NCT02090075|5625860|P1|NOT COMPLETED|Overall Study||7
2291300|NCT02090075|5625859|P2|COMPLETED|Overall Study||30
2291301|NCT02090075|5625860|P1|COMPLETED|Overall Study||26
2291302|NCT02090075|5625859|P2|STARTED|Overall Study||33
2291303|NCT02090075|5625860|P1|STARTED|Overall Study||33
2291304|NCT02089997|5625868|P1|NOT COMPLETED|Overall Study||246
2291305|NCT02089997|5625868|P1|COMPLETED|Overall Study||3058
2291306|NCT02089997|5625868|P1|STARTED|Overall Study||3304
2291307|NCT02089737|5625883|P1|NOT COMPLETED|Overall Study||6
2291308|NCT02089737|5625883|P1|COMPLETED|Overall Study||3085
2291309|NCT02089737|5625883|P1|STARTED|Overall Study||3091
2291310|NCT02089659|5625892|P3|NOT COMPLETED|Overall Study||0
2291311|NCT02089659|5625893|P2|NOT COMPLETED|Overall Study||0
2291312|NCT02089659|5625894|P1|NOT COMPLETED|Overall Study||0
2291313|NCT02089659|5625892|P3|COMPLETED|Overall Study||0
2291314|NCT02089659|5625893|P2|COMPLETED|Overall Study||8
2291315|NCT02089659|5625894|P1|COMPLETED|Overall Study||8
2291316|NCT02089659|5625892|P3|STARTED|Overall Study||0
2291317|NCT02089659|5625893|P2|STARTED|Overall Study||8
2291318|NCT02089659|5625894|P1|STARTED|Overall Study||8
2291319|NCT02089347|5625908|P2|NOT COMPLETED|Overall Study||0
2291320|NCT02089347|5625909|P1|NOT COMPLETED|Overall Study||1
2291321|NCT02089347|5625908|P2|COMPLETED|Overall Study||178
2291322|NCT02089347|5625909|P1|COMPLETED|Overall Study||355
2291323|NCT02089347|5625908|P2|STARTED|Overall Study||178
2291324|NCT02089347|5625909|P1|STARTED|Overall Study||356
2291325|NCT02089191|5625931|P2|NOT COMPLETED|Period 2, Second 12 Hours||0
2291326|NCT02089191|5625932|P1|NOT COMPLETED|Period 2, Second 12 Hours||0
2291327|NCT02089191|5625931|P2|COMPLETED|Period 2, Second 12 Hours||15
2291328|NCT02089191|5625932|P1|COMPLETED|Period 2, Second 12 Hours||15
2291329|NCT02089191|5625931|P2|STARTED|Period 2, Second 12 Hours||15
2291330|NCT02089191|5625932|P1|STARTED|Period 2, Second 12 Hours|One participant discontinued between Period 1 and Period 2 due to availability|15
2291331|NCT02089191|5625931|P2|NOT COMPLETED|Period 1, First 12 Hours||0
2291332|NCT02089191|5625932|P1|NOT COMPLETED|Period 1, First 12 Hours||0
2291333|NCT02089191|5625931|P2|COMPLETED|Period 1, First 12 Hours||15
2291334|NCT02089191|5625932|P1|COMPLETED|Period 1, First 12 Hours||16
2291335|NCT02089191|5625931|P2|STARTED|Period 1, First 12 Hours||15
2291336|NCT02089191|5625932|P1|STARTED|Period 1, First 12 Hours||16
2291337|NCT02089113|5625942|P2|NOT COMPLETED|Overall Study||0
2291338|NCT02089113|5625943|P1|NOT COMPLETED|Overall Study||1
2291339|NCT02089113|5625942|P2|COMPLETED|Overall Study||80
2291340|NCT02089113|5625943|P1|COMPLETED|Overall Study||160
2291341|NCT02089113|5625942|P2|STARTED|Overall Study||80
2291342|NCT02089113|5625943|P1|STARTED|Overall Study||161
2291343|NCT02088957|5625951|P2|NOT COMPLETED|Overall Study||0
2291344|NCT02088957|5625952|P1|NOT COMPLETED|Overall Study||1
2291345|NCT02088957|5625951|P2|COMPLETED|Overall Study||0
2291346|NCT02088957|5625952|P1|COMPLETED|Overall Study||0
2291347|NCT02088957|5625951|P2|STARTED|Overall Study||0
2291348|NCT02088957|5625952|P1|STARTED|Overall Study||1
2291349|NCT02088905|5625970|P2|NOT COMPLETED|Overall Study||1
2291350|NCT02088905|5625971|P1|NOT COMPLETED|Overall Study||5
2291351|NCT02088905|5625970|P2|COMPLETED|Overall Study||9
2291352|NCT02088905|5625971|P1|COMPLETED|Overall Study||8
2291353|NCT02088905|5625970|P2|Week 9|Overall Study||9
2291354|NCT02088905|5625971|P1|Week 9|Overall Study||10
2291355|NCT02088905|5625970|P2|STARTED|Overall Study||10
2291356|NCT02088905|5625971|P1|STARTED|Overall Study||13
2291357|NCT02088788|5625993|P2|NOT COMPLETED|Overall Study||41
2291358|NCT02088788|5625994|P1|NOT COMPLETED|Overall Study||30
2291359|NCT02088788|5625993|P2|COMPLETED|Overall Study||89
2291360|NCT02088788|5625994|P1|COMPLETED|Overall Study||105
2291361|NCT02088788|5625993|P2|STARTED|Overall Study||130
2291362|NCT02088788|5625994|P1|STARTED|Overall Study||135
2291363|NCT02088385|5626004|P2|NOT COMPLETED|Overall Study||0
2291364|NCT02088385|5626005|P1|NOT COMPLETED|Overall Study||0
2291365|NCT02088385|5626004|P2|COMPLETED|Overall Study||10
2291366|NCT02088385|5626005|P1|COMPLETED|Overall Study||10
2291367|NCT02088385|5626004|P2|STARTED|Overall Study||10
2291368|NCT02088385|5626005|P1|STARTED|Overall Study||10
2291369|NCT02088216|5626015|P2|NOT COMPLETED|Overall Study||10
2291370|NCT02088216|5626016|P1|NOT COMPLETED|Overall Study||12
2291371|NCT02088216|5626015|P2|COMPLETED|Overall Study||70
2291372|NCT02088216|5626016|P1|COMPLETED|Overall Study||69
2291373|NCT02088216|5626015|P2|STARTED|Overall Study||80
2291374|NCT02088216|5626016|P1|STARTED|Overall Study||81
2291375|NCT02088177|5626042|P1|NOT COMPLETED|Overall Study||3
2291376|NCT02088177|5626042|P1|COMPLETED|Overall Study||9
2291377|NCT02088177|5626042|P1|STARTED|Overall Study||12
2291378|NCT02088073|5626052|P5|NOT COMPLETED|Maintanance Phase||7
2291379|NCT02088073|5626053|P4|NOT COMPLETED|Maintanance Phase||7
2291380|NCT02088073|5626054|P3|NOT COMPLETED|Maintanance Phase||5
2291381|NCT02088073|5626055|P2|NOT COMPLETED|Maintanance Phase||10
2291382|NCT02088073|5626056|P1|NOT COMPLETED|Maintanance Phase||0
2291383|NCT02088073|5626052|P5|COMPLETED|Maintanance Phase||49
2291384|NCT02088073|5626053|P4|COMPLETED|Maintanance Phase||44
2291385|NCT02088073|5626054|P3|COMPLETED|Maintanance Phase||40
2291386|NCT02088073|5626055|P2|COMPLETED|Maintanance Phase||75
2291387|NCT02088073|5626056|P1|COMPLETED|Maintanance Phase|251 subjects completed the AP; 240 were eligible to enter the MP. 237 entered the MP.|0
2291388|NCT02088073|5626052|P5|STARTED|Maintanance Phase||56
2291389|NCT02088073|5626053|P4|STARTED|Maintanance Phase||51
2291390|NCT02088073|5626054|P3|STARTED|Maintanance Phase||45
2291391|NCT02088073|5626055|P2|STARTED|Maintanance Phase||85
2291392|NCT02088073|5626056|P1|STARTED|Maintanance Phase||0
2291393|NCT02088073|5626052|P5|NOT COMPLETED|Acute Phase||0
2291394|NCT02088073|5626053|P4|NOT COMPLETED|Acute Phase||0
2291395|NCT02088073|5626054|P3|NOT COMPLETED|Acute Phase||0
2291396|NCT02088073|5626055|P2|NOT COMPLETED|Acute Phase||0
2291397|NCT02088073|5626056|P1|NOT COMPLETED|Acute Phase||7
2291398|NCT02088073|5626052|P5|COMPLETED|Acute Phase||0
2291399|NCT02088073|5626053|P4|COMPLETED|Acute Phase||0
2291400|NCT02088073|5626054|P3|COMPLETED|Acute Phase||0
2291401|NCT02088073|5626055|P2|COMPLETED|Acute Phase||0
2291402|NCT02088073|5626056|P1|COMPLETED|Acute Phase||251
2291403|NCT02088073|5626052|P5|STARTED|Acute Phase||0
2291404|NCT02088073|5626053|P4|STARTED|Acute Phase||0
2291405|NCT02088073|5626054|P3|STARTED|Acute Phase||0
2291406|NCT02088073|5626055|P2|STARTED|Acute Phase||0
2291407|NCT02088073|5626056|P1|STARTED|Acute Phase||258
2291408|NCT02087995|5626108|P1|NOT COMPLETED|Overall Study||0
2291409|NCT02087995|5626108|P1|COMPLETED|Overall Study||51
2291410|NCT02087995|5626108|P1|STARTED|Overall Study||51
2291411|NCT02087956|5626114|P2|NOT COMPLETED|Overall Study||5
2291412|NCT02087956|5626115|P1|NOT COMPLETED|Overall Study||6
2291413|NCT02087956|5626114|P2|COMPLETED|Overall Study||107
2291414|NCT02087956|5626115|P1|COMPLETED|Overall Study||105
2291415|NCT02087956|5626114|P2|STARTED|Overall Study||112
2291416|NCT02087956|5626115|P1|STARTED|Overall Study||111
2291417|NCT02087943|5626130|P5|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
2291418|NCT02087943|5626131|P4|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
2291419|NCT02087943|5626132|P3|NOT COMPLETED|Observational Follow-up Phase Week 24-30||3
2291420|NCT02087943|5626133|P2|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
2291421|NCT02087943|5626134|P1|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
2291422|NCT02087943|5626130|P5|COMPLETED|Observational Follow-up Phase Week 24-30||22
2291423|NCT02087943|5626131|P4|COMPLETED|Observational Follow-up Phase Week 24-30||23
2291424|NCT02087943|5626132|P3|COMPLETED|Observational Follow-up Phase Week 24-30||45
2291425|NCT02087943|5626133|P2|COMPLETED|Observational Follow-up Phase Week 24-30||46
2291426|NCT02087943|5626134|P1|COMPLETED|Observational Follow-up Phase Week 24-30||0
2291427|NCT02087943|5626130|P5|STARTED|Observational Follow-up Phase Week 24-30||23
2291428|NCT02087943|5626131|P4|STARTED|Observational Follow-up Phase Week 24-30||24
2291429|NCT02087943|5626132|P3|STARTED|Observational Follow-up Phase Week 24-30||48
2291430|NCT02087943|5626133|P2|STARTED|Observational Follow-up Phase Week 24-30||46
2291431|NCT02087943|5626134|P1|STARTED|Observational Follow-up Phase Week 24-30||0
2291432|NCT02087943|5626130|P5|NOT COMPLETED|Active Treatment Phase Week 12-24||2
2291433|NCT02087943|5626131|P4|NOT COMPLETED|Active Treatment Phase Week 12-24||2
2291434|NCT02087943|5626132|P3|NOT COMPLETED|Active Treatment Phase Week 12-24||5
2291435|NCT02087943|5626133|P2|NOT COMPLETED|Active Treatment Phase Week 12-24||4
2291436|NCT02087943|5626134|P1|NOT COMPLETED|Active Treatment Phase Week 12-24||0
2291437|NCT02087943|5626130|P5|COMPLETED|Active Treatment Phase Week 12-24||21
2291438|NCT02087943|5626131|P4|COMPLETED|Active Treatment Phase Week 12-24||22
2291439|NCT02087943|5626132|P3|COMPLETED|Active Treatment Phase Week 12-24||44
2291440|NCT02087943|5626133|P2|COMPLETED|Active Treatment Phase Week 12-24||42
2291441|NCT02087943|5626134|P1|COMPLETED|Active Treatment Phase Week 12-24||0
2291442|NCT02087943|5626130|P5|STARTED|Active Treatment Phase Week 12-24||23
2291443|NCT02087943|5626131|P4|STARTED|Active Treatment Phase Week 12-24||24
2291444|NCT02087943|5626132|P3|STARTED|Active Treatment Phase Week 12-24||49
2291445|NCT02087943|5626133|P2|STARTED|Active Treatment Phase Week 12-24||46
2291446|NCT02087943|5626134|P1|STARTED|Active Treatment Phase Week 12-24||0
2291447|NCT02087943|5626130|P5|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
2291448|NCT02087943|5626131|P4|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
2291449|NCT02087943|5626132|P3|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||13
2291450|NCT02087943|5626133|P2|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||12
2291451|NCT02087943|5626134|P1|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||14
2291452|NCT02087943|5626130|P5|COMPLETED|Placebo-Controlled Phase Week 0-12||0
2291453|NCT02087943|5626131|P4|COMPLETED|Placebo-Controlled Phase Week 0-12||0
2291454|NCT02087943|5626132|P3|COMPLETED|Placebo-Controlled Phase Week 0-12|1 participant who completed week 12 did not enter the active treatment phase.|50
2291455|NCT02087943|5626133|P2|COMPLETED|Placebo-Controlled Phase Week 0-12||46
2291456|NCT02087943|5626134|P1|COMPLETED|Placebo-Controlled Phase Week 0-12|3 participants who completed week 12 did not enter the active treatment phase.|50
2291457|NCT02087943|5626130|P5|Safety Population|Placebo-Controlled Phase Week 0-12||0
2291458|NCT02087943|5626131|P4|Safety Population|Placebo-Controlled Phase Week 0-12||0
2291459|NCT02087943|5626132|P3|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|63
2291460|NCT02087943|5626133|P2|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|58
2291461|NCT02087943|5626134|P1|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|64
2291462|NCT02087943|5626130|P5|STARTED|Placebo-Controlled Phase Week 0-12||0
2291463|NCT02087943|5626131|P4|STARTED|Placebo-Controlled Phase Week 0-12||0
2291464|NCT02087943|5626132|P3|STARTED|Placebo-Controlled Phase Week 0-12||63
2291465|NCT02087943|5626133|P2|STARTED|Placebo-Controlled Phase Week 0-12||58
2291466|NCT02087943|5626134|P1|STARTED|Placebo-Controlled Phase Week 0-12||64
2291467|NCT02087904|5626162|P4|NOT COMPLETED|Overall Study||25
2291468|NCT02087904|5626163|P3|NOT COMPLETED|Overall Study||22
2291469|NCT02087904|5626164|P2|NOT COMPLETED|Overall Study||19
2291470|NCT02087904|5626165|P1|NOT COMPLETED|Overall Study||25
2291471|NCT02087904|5626162|P4|COMPLETED|Overall Study||64
2291472|NCT02087904|5626163|P3|COMPLETED|Overall Study||65
2291473|NCT02087904|5626164|P2|COMPLETED|Overall Study||70
2291474|NCT02087904|5626165|P1|COMPLETED|Overall Study||60
2291475|NCT02087904|5626162|P4|STARTED|Overall Study||89
2291476|NCT02087904|5626163|P3|STARTED|Overall Study||87
2291477|NCT02087904|5626164|P2|STARTED|Overall Study||89
2291478|NCT02087904|5626165|P1|STARTED|Overall Study||85
2291479|NCT02087774|5626281|P2|NOT COMPLETED|Overall Study||20
2291480|NCT02087774|5626282|P1|NOT COMPLETED|Overall Study||8
2291481|NCT02087774|5626281|P2|COMPLETED|Overall Study||130
2291482|NCT02087774|5626282|P1|COMPLETED|Overall Study||142
2291483|NCT02087774|5626281|P2|STARTED|Overall Study||150
2291484|NCT02087774|5626282|P1|STARTED|Overall Study||150
2291485|NCT02087748|5626290|P1|NOT COMPLETED|Overall Study||0
2291486|NCT02087748|5626290|P1|COMPLETED|Overall Study||24
2291487|NCT02087748|5626290|P1|STARTED|Overall Study||24
2291488|NCT02087670|5626302|P2|NOT COMPLETED|Overall Study||2
2291489|NCT02087670|5626303|P1|NOT COMPLETED|Overall Study||3
2291490|NCT02087670|5626302|P2|COMPLETED|Overall Study||20
2291491|NCT02087670|5626303|P1|COMPLETED|Overall Study||17
2291492|NCT02087670|5626302|P2|STARTED|Overall Study||22
2291493|NCT02087670|5626303|P1|STARTED|Overall Study||20
2291494|NCT02087514|5626317|P6|NOT COMPLETED|Overall Study||1
2291495|NCT02087514|5626318|P5|NOT COMPLETED|Overall Study||0
2291496|NCT02087514|5626319|P4|NOT COMPLETED|Overall Study||2
2291497|NCT02087514|5626320|P3|NOT COMPLETED|Overall Study||3
2291498|NCT02087514|5626321|P2|NOT COMPLETED|Overall Study||0
2291499|NCT02087514|5626322|P1|NOT COMPLETED|Overall Study||2
2291500|NCT02087514|5626317|P6|COMPLETED|Overall Study||9
2291501|NCT02087514|5626318|P5|COMPLETED|Overall Study||10
2291502|NCT02087514|5626319|P4|COMPLETED|Overall Study||8
2291503|NCT02087514|5626320|P3|COMPLETED|Overall Study||7
2291504|NCT02087514|5626321|P2|COMPLETED|Overall Study||10
2291505|NCT02087514|5626322|P1|COMPLETED|Overall Study||8
2291506|NCT02087514|5626317|P6|STARTED|Overall Study||10
2291507|NCT02087514|5626318|P5|STARTED|Overall Study||10
2291508|NCT02087514|5626319|P4|STARTED|Overall Study||10
2291509|NCT02087514|5626320|P3|STARTED|Overall Study||10
2291510|NCT02087514|5626321|P2|STARTED|Overall Study||10
2291511|NCT02087514|5626322|P1|STARTED|Overall Study||10
2291512|NCT02087423|5626339|P3|NOT COMPLETED|Overall Study||68
2291513|NCT02087423|5626340|P2|NOT COMPLETED|Overall Study||265
2291514|NCT02087423|5626341|P1|NOT COMPLETED|Overall Study||111
2291515|NCT02087423|5626339|P3|COMPLETED|Overall Study||0
2291516|NCT02087423|5626340|P2|COMPLETED|Overall Study||0
2291517|NCT02087423|5626341|P1|COMPLETED|Overall Study||0
2291518|NCT02087423|5626339|P3|Completed 12 Months of Treatment|Overall Study||26
2291519|NCT02087423|5626340|P2|Completed 12 Months of Treatment|Overall Study||60
2291520|NCT02087423|5626341|P1|Completed 12 Months of Treatment|Overall Study||18
2291521|NCT02087423|5626339|P3|STARTED|Overall Study|Treated|68
2291522|NCT02087423|5626340|P2|STARTED|Overall Study|Treated|265
2291523|NCT02087423|5626341|P1|STARTED|Overall Study|Treated|111
2291524|NCT02087241|5626370|P4|NOT COMPLETED|Overall Study||7
2291525|NCT02087241|5626371|P3|NOT COMPLETED|Overall Study||1
2291526|NCT02087241|5626372|P2|NOT COMPLETED|Overall Study||3
2291527|NCT02087241|5626373|P1|NOT COMPLETED|Overall Study||3
2291528|NCT02087241|5626370|P4|COMPLETED|Overall Study||0
2291529|NCT02087241|5626371|P3|COMPLETED|Overall Study||0
2291530|NCT02087241|5626372|P2|COMPLETED|Overall Study||0
2291531|NCT02087241|5626373|P1|COMPLETED|Overall Study||0
2291532|NCT02087241|5626370|P4|STARTED|Overall Study||7
2291533|NCT02087241|5626371|P3|STARTED|Overall Study||1
2291534|NCT02087241|5626372|P2|STARTED|Overall Study||3
2291535|NCT02087241|5626373|P1|STARTED|Overall Study||3
2291536|NCT02087176|5626399|P1|NOT COMPLETED|Overall Study||32
2291537|NCT02087176|5626399|P1|COMPLETED|Overall Study|The sponsor terminated the study early.|0
2291538|NCT02087176|5626399|P1|STARTED|Overall Study||32
2291539|NCT02087163|5626404|P1|NOT COMPLETED|Overall Study||17
2291540|NCT02087163|5626404|P1|COMPLETED|Overall Study||73
2291541|NCT02087163|5626404|P1|STARTED|Overall Study||90
2291542|NCT02087150|5626412|P3|NOT COMPLETED|Overall Study||11
2291543|NCT02087150|5626413|P2|NOT COMPLETED|Overall Study||34
2291544|NCT02087150|5626414|P1|NOT COMPLETED|Overall Study||10
2291545|NCT02087150|5626412|P3|COMPLETED|Overall Study||69
2291546|NCT02087150|5626413|P2|COMPLETED|Overall Study||128
2291547|NCT02087150|5626414|P1|COMPLETED|Overall Study||71
2291548|NCT02087150|5626412|P3|Received a Crossover MM ETBC Procedure|Overall Study||70
2291549|NCT02087150|5626413|P2|Received a Crossover MM ETBC Procedure|Overall Study||0
2291550|NCT02087150|5626414|P1|Received a Crossover MM ETBC Procedure|Overall Study||0
2291551|NCT02087150|5626412|P3|Had a Lead-in or Randomized ETBC Proc|Overall Study||0
2291552|NCT02087150|5626413|P2|Had a Lead-in or Randomized ETBC Proc|Overall Study||149
2291553|NCT02087150|5626414|P1|Had a Lead-in or Randomized ETBC Proc|Overall Study||80
2291554|NCT02087150|5626412|P3|STARTED|Overall Study||80
2291555|NCT02087150|5626413|P2|STARTED|Overall Study||162
2291556|NCT02087150|5626414|P1|STARTED|Overall Study||81
2291557|NCT02087085|5626433|P2|NOT COMPLETED|Overall Study||116
2291558|NCT02087085|5626434|P1|NOT COMPLETED|Overall Study||120
2291559|NCT02087085|5626433|P2|COMPLETED|Overall Study||40
2291560|NCT02087085|5626434|P1|COMPLETED|Overall Study||34
2291561|NCT02087085|5626433|P2|STARTED|Overall Study||156
2291562|NCT02087085|5626434|P1|STARTED|Overall Study||154
2291563|NCT02087059|5626444|P1|NOT COMPLETED|Overall Study||7
2291564|NCT02087059|5626444|P1|COMPLETED|Overall Study||44
2291565|NCT02087059|5626444|P1|STARTED|Overall Study||51
2291566|NCT02086786|5626454|P2|NOT COMPLETED|Overall Study||16
2291567|NCT02086786|5626455|P1|NOT COMPLETED|Overall Study||18
2291568|NCT02086786|5626454|P2|COMPLETED|Overall Study||19
2291569|NCT02086786|5626455|P1|COMPLETED|Overall Study||17
2291570|NCT02086786|5626454|P2|STARTED|Overall Study||35
2291571|NCT02086786|5626455|P1|STARTED|Overall Study||35
2291572|NCT02086708|5626479|P1|NOT COMPLETED|Overall Study||0
2291573|NCT02086708|5626479|P1|COMPLETED|Overall Study||24
2291574|NCT02086708|5626479|P1|STARTED|Overall Study||24
2291575|NCT02086682|5626493|P2|NOT COMPLETED|Overall Study||0
2291576|NCT02086682|5626494|P1|NOT COMPLETED|Overall Study||0
2291577|NCT02086682|5626493|P2|COMPLETED|Overall Study||182
2291578|NCT02086682|5626494|P1|COMPLETED|Overall Study||156
2291579|NCT02086682|5626493|P2|STARTED|Overall Study||182
2291580|NCT02086682|5626494|P1|STARTED|Overall Study||156
2291581|NCT02086591|5626500|P1|NOT COMPLETED|Overall Study||5
2291582|NCT02086591|5626500|P1|COMPLETED|Overall Study||2
2291583|NCT02086591|5626500|P1|STARTED|Overall Study||7
2291584|NCT02086565|5626508|P2|NOT COMPLETED|Overall Study||12
2291585|NCT02086565|5626509|P1|NOT COMPLETED|Overall Study||16
2291586|NCT02086565|5626508|P2|COMPLETED|Overall Study||138
2291587|NCT02086565|5626509|P1|COMPLETED|Overall Study||135
2291588|NCT02086565|5626508|P2|STARTED|Overall Study||150
2291589|NCT02086565|5626509|P1|STARTED|Overall Study||151
2291590|NCT02086552|5626523|P1|NOT COMPLETED|Overall Study||1
2291591|NCT02086552|5626523|P1|COMPLETED|Overall Study||27
2291592|NCT02086552|5626523|P1|STARTED|Overall Study||28
2291593|NCT02086162|5626532|P2|NOT COMPLETED|Overall Study||7
2291594|NCT02086162|5626533|P1|NOT COMPLETED|Overall Study||10
2291595|NCT02086162|5626532|P2|COMPLETED|Overall Study||77
2291596|NCT02086162|5626533|P1|COMPLETED|Overall Study||68
2291597|NCT02086162|5626532|P2|STARTED|Overall Study||84
2291598|NCT02086162|5626533|P1|STARTED|Overall Study||78
2291599|NCT02086110|5626545|P2|NOT COMPLETED|Overall Study||1
2291600|NCT02086110|5626546|P1|NOT COMPLETED|Overall Study||1
2291601|NCT02086110|5626545|P2|COMPLETED|Overall Study||5
2291602|NCT02086110|5626546|P1|COMPLETED|Overall Study||4
2291603|NCT02086110|5626545|P2|STARTED|Overall Study||6
2291604|NCT02086110|5626546|P1|STARTED|Overall Study||5
2291605|NCT02085785|5626557|P2|NOT COMPLETED|Overall Study||2
2291606|NCT02085785|5626558|P1|NOT COMPLETED|Overall Study||2
2291607|NCT02085785|5626557|P2|COMPLETED|Overall Study||6
2291608|NCT02085785|5626558|P1|COMPLETED|Overall Study||5
2291609|NCT02085785|5626557|P2|STARTED|Overall Study||8
2291610|NCT02085785|5626558|P1|STARTED|Overall Study||7
2291611|NCT02085720|5626570|P1|NOT COMPLETED|Overall Study||0
2291612|NCT02085720|5626570|P1|COMPLETED|Overall Study||819
2291613|NCT02085720|5626570|P1|STARTED|Overall Study||819
2291614|NCT02085473|5626582|P4|NOT COMPLETED|Overall Study||0
2291615|NCT02085473|5626583|P3|NOT COMPLETED|Overall Study||0
2291616|NCT02085473|5626584|P2|NOT COMPLETED|Overall Study||0
2291617|NCT02085473|5626585|P1|NOT COMPLETED|Overall Study||0
2291618|NCT02085473|5626582|P4|COMPLETED|Overall Study||15
2291619|NCT02085473|5626583|P3|COMPLETED|Overall Study||15
2291620|NCT02085473|5626584|P2|COMPLETED|Overall Study||15
2291621|NCT02085473|5626585|P1|COMPLETED|Overall Study||15
2291622|NCT02085473|5626582|P4|STARTED|Overall Study||15
2291623|NCT02085473|5626583|P3|STARTED|Overall Study||15
2291624|NCT02085473|5626584|P2|STARTED|Overall Study||15
2291625|NCT02085473|5626585|P1|STARTED|Overall Study||15
2291626|NCT02085447|5626647|P1|NOT COMPLETED|Overall Study||4
2291627|NCT02085447|5626647|P1|COMPLETED|Overall Study||26
2291628|NCT02085447|5626647|P1|STARTED|Overall Study||30
2291629|NCT02085356|5626676|P4|NOT COMPLETED|Overall Study||0
2291630|NCT02085356|5626677|P3|NOT COMPLETED|Overall Study||0
2291631|NCT02085356|5626678|P2|NOT COMPLETED|Overall Study||0
2291632|NCT02085356|5626679|P1|NOT COMPLETED|Overall Study||0
2291633|NCT02085356|5626676|P4|COMPLETED|Overall Study||361
2291634|NCT02085356|5626677|P3|COMPLETED|Overall Study||681
2291635|NCT02085356|5626678|P2|COMPLETED|Overall Study||348
2291636|NCT02085356|5626679|P1|COMPLETED|Overall Study||577
2291637|NCT02085356|5626676|P4|STARTED|Overall Study||361
2291638|NCT02085356|5626677|P3|STARTED|Overall Study||681
2291639|NCT02085356|5626678|P2|STARTED|Overall Study||348
2291640|NCT02085356|5626679|P1|STARTED|Overall Study||577
2291641|NCT02085252|5626707|P2|NOT COMPLETED|Overall Study||4
2291642|NCT02085252|5626708|P1|NOT COMPLETED|Overall Study||1
2291643|NCT02085252|5626707|P2|COMPLETED|Overall Study||53
2291644|NCT02085252|5626708|P1|COMPLETED|Overall Study||57
2291645|NCT02085252|5626707|P2|STARTED|Overall Study||57
2291646|NCT02085252|5626708|P1|STARTED|Overall Study||58
2291647|NCT02085161|5626732|P4|NOT COMPLETED|Overall Study||10
2291648|NCT02085161|5626733|P3|NOT COMPLETED|Overall Study||5
2291649|NCT02085161|5626734|P2|NOT COMPLETED|Overall Study||10
2291650|NCT02085161|5626735|P1|NOT COMPLETED|Overall Study||12
2291651|NCT02085161|5626732|P4|COMPLETED|Overall Study||66
2291652|NCT02085161|5626733|P3|COMPLETED|Overall Study||71
2291653|NCT02085161|5626734|P2|COMPLETED|Overall Study||66
2291654|NCT02085161|5626735|P1|COMPLETED|Overall Study||64
2291655|NCT02085161|5626732|P4|STARTED|Overall Study||76
2291656|NCT02085161|5626733|P3|STARTED|Overall Study||76
2291657|NCT02085161|5626734|P2|STARTED|Overall Study||76
2291658|NCT02085161|5626735|P1|STARTED|Overall Study||76
2291659|NCT02085135|5626776|P2|NOT COMPLETED|Overall Study||9
2291660|NCT02085135|5626777|P1|NOT COMPLETED|Overall Study||11
2291661|NCT02085135|5626776|P2|COMPLETED|Overall Study||23
2291662|NCT02085135|5626777|P1|COMPLETED|Overall Study||23
2291663|NCT02085135|5626776|P2|STARTED|Overall Study||32
2291664|NCT02085135|5626777|P1|STARTED|Overall Study||34
2291665|NCT02084797|5626783|P1|NOT COMPLETED|Overall Study||0
2291666|NCT02084797|5626783|P1|COMPLETED|Overall Study||10
2291667|NCT02084797|5626783|P1|STARTED|Overall Study||10
2291668|NCT02084706|5626792|P2|NOT COMPLETED|Overall Study||0
2291669|NCT02084706|5626793|P1|NOT COMPLETED|Overall Study||0
2291670|NCT02084706|5626792|P2|COMPLETED|Overall Study||31
2291671|NCT02084706|5626793|P1|COMPLETED|Overall Study||29
2291672|NCT02084706|5626792|P2|STARTED|Overall Study||31
2291673|NCT02084706|5626793|P1|STARTED|Overall Study||29
2291674|NCT02084628|5626799|P1|NOT COMPLETED|Overall Study||0
2291675|NCT02084628|5626799|P1|COMPLETED|Overall Study||1
2291676|NCT02084628|5626799|P1|STARTED|Overall Study||1
2291677|NCT02084511|5626816|P4|NOT COMPLETED|Overall Study||0
2291678|NCT02084511|5626817|P3|NOT COMPLETED|Overall Study||0
2291679|NCT02084511|5626818|P2|NOT COMPLETED|Overall Study||0
2291680|NCT02084511|5626819|P1|NOT COMPLETED|Overall Study||0
2291681|NCT02084511|5626816|P4|COMPLETED|Overall Study||20
2291682|NCT02084511|5626817|P3|COMPLETED|Overall Study||20
2291683|NCT02084511|5626818|P2|COMPLETED|Overall Study||20
2291684|NCT02084511|5626819|P1|COMPLETED|Overall Study||20
2291685|NCT02084511|5626816|P4|STARTED|Overall Study||20
2291686|NCT02084511|5626817|P3|STARTED|Overall Study||20
2291687|NCT02084511|5626818|P2|STARTED|Overall Study||20
2291688|NCT02084511|5626819|P1|STARTED|Overall Study||20
2291689|NCT02084238|5626849|P1|NOT COMPLETED|Overall Study||2
2291690|NCT02084238|5626849|P1|COMPLETED|Overall Study||38
2291691|NCT02084238|5626849|P1|STARTED|Overall Study||40
2291692|NCT02084160|5626860|P1|NOT COMPLETED|Overall Study||0
2291693|NCT02084160|5626860|P1|COMPLETED|Overall Study||579
2291694|NCT02084160|5626860|P1|STARTED|Overall Study||579
2291695|NCT02084147|5626864|P1|NOT COMPLETED|Overall Study||0
2291696|NCT02084147|5626864|P1|COMPLETED|Overall Study||72
2291697|NCT02084147|5626864|P1|STARTED|Overall Study||72
2291698|NCT02084134|5626874|P2|NOT COMPLETED|Overall Study||3
2291699|NCT02084134|5626875|P1|NOT COMPLETED|Overall Study||4
2291700|NCT02084134|5626874|P2|COMPLETED|Overall Study||17
2291701|NCT02084134|5626875|P1|COMPLETED|Overall Study||19
2291702|NCT02084134|5626874|P2|STARTED|Overall Study||20
2291703|NCT02084134|5626875|P1|STARTED|Overall Study||23
2291704|NCT02084082|5626885|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
2291705|NCT02084082|5626886|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
2291706|NCT02084082|5626887|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
2291707|NCT02084082|5626888|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
2291708|NCT02084082|5626885|P4|COMPLETED|Treatment Period 2 (4 Days)||6
2291709|NCT02084082|5626886|P3|COMPLETED|Treatment Period 2 (4 Days)||7
2291710|NCT02084082|5626887|P2|COMPLETED|Treatment Period 2 (4 Days)||26
2291711|NCT02084082|5626888|P1|COMPLETED|Treatment Period 2 (4 Days)||26
2291712|NCT02084082|5626885|P4|STARTED|Treatment Period 2 (4 Days)||6
2291713|NCT02084082|5626886|P3|STARTED|Treatment Period 2 (4 Days)||7
2291714|NCT02084082|5626887|P2|STARTED|Treatment Period 2 (4 Days)||26
2291715|NCT02084082|5626888|P1|STARTED|Treatment Period 2 (4 Days)||26
2291716|NCT02084082|5626885|P4|NOT COMPLETED|Washout Period 1 (35 Days)||2
2291717|NCT02084082|5626886|P3|NOT COMPLETED|Washout Period 1 (35 Days)||1
2291718|NCT02084082|5626887|P2|NOT COMPLETED|Washout Period 1 (35 Days)||0
2291719|NCT02084082|5626888|P1|NOT COMPLETED|Washout Period 1 (35 Days)||0
2291720|NCT02084082|5626885|P4|COMPLETED|Washout Period 1 (35 Days)||6
2291721|NCT02084082|5626886|P3|COMPLETED|Washout Period 1 (35 Days)||7
2291722|NCT02084082|5626887|P2|COMPLETED|Washout Period 1 (35 Days)||26
2291723|NCT02084082|5626888|P1|COMPLETED|Washout Period 1 (35 Days)||26
2291724|NCT02084082|5626885|P4|STARTED|Washout Period 1 (35 Days)||8
2291725|NCT02084082|5626886|P3|STARTED|Washout Period 1 (35 Days)||8
2291726|NCT02084082|5626887|P2|STARTED|Washout Period 1 (35 Days)||26
2291727|NCT02084082|5626888|P1|STARTED|Washout Period 1 (35 Days)||26
2291728|NCT02084082|5626885|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
2291729|NCT02084082|5626886|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
2291730|NCT02084082|5626887|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
2291731|NCT02084082|5626888|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
2291732|NCT02084082|5626885|P4|COMPLETED|Treatment Period 1 (4 Days)||8
2291733|NCT02084082|5626886|P3|COMPLETED|Treatment Period 1 (4 Days)||8
2291734|NCT02084082|5626887|P2|COMPLETED|Treatment Period 1 (4 Days)||26
2291735|NCT02084082|5626888|P1|COMPLETED|Treatment Period 1 (4 Days)||26
2291736|NCT02084082|5626885|P4|STARTED|Treatment Period 1 (4 Days)||8
2291737|NCT02084082|5626886|P3|STARTED|Treatment Period 1 (4 Days)||8
2291738|NCT02084082|5626887|P2|STARTED|Treatment Period 1 (4 Days)||26
2291739|NCT02084082|5626888|P1|STARTED|Treatment Period 1 (4 Days)||26
2291740|NCT02084069|5626920|P2|NOT COMPLETED|Overall Study||0
2291741|NCT02084069|5626921|P1|NOT COMPLETED|Overall Study||0
2291742|NCT02084069|5626920|P2|COMPLETED|Overall Study||29
2291743|NCT02084069|5626921|P1|COMPLETED|Overall Study||29
2291744|NCT02084069|5626920|P2|STARTED|Overall Study||29
2291745|NCT02084069|5626921|P1|STARTED|Overall Study||29
2291746|NCT02084056|5626929|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
2291747|NCT02084056|5626930|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
2291748|NCT02084056|5626931|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
2291749|NCT02084056|5626932|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
2291750|NCT02084056|5626929|P4|COMPLETED|Treatment Period 2 (4 Days)||8
2291751|NCT02084056|5626930|P3|COMPLETED|Treatment Period 2 (4 Days)||8
2291752|NCT02084056|5626931|P2|COMPLETED|Treatment Period 2 (4 Days)||30
2291753|NCT02084056|5626932|P1|COMPLETED|Treatment Period 2 (4 Days)||26
2291754|NCT02084056|5626929|P4|STARTED|Treatment Period 2 (4 Days)||8
2291755|NCT02084056|5626930|P3|STARTED|Treatment Period 2 (4 Days)||8
2291756|NCT02084056|5626931|P2|STARTED|Treatment Period 2 (4 Days)||30
2291757|NCT02084056|5626932|P1|STARTED|Treatment Period 2 (4 Days)||26
2291758|NCT02084056|5626929|P4|NOT COMPLETED|Washout Period 1 (35 Days)||0
2291759|NCT02084056|5626930|P3|NOT COMPLETED|Washout Period 1 (35 Days)||0
2291760|NCT02084056|5626931|P2|NOT COMPLETED|Washout Period 1 (35 Days)||0
2291761|NCT02084056|5626932|P1|NOT COMPLETED|Washout Period 1 (35 Days)||1
2291762|NCT02084056|5626929|P4|COMPLETED|Washout Period 1 (35 Days)||8
2291763|NCT02084056|5626930|P3|COMPLETED|Washout Period 1 (35 Days)||8
2291764|NCT02084056|5626931|P2|COMPLETED|Washout Period 1 (35 Days)||30
2291765|NCT02084056|5626932|P1|COMPLETED|Washout Period 1 (35 Days)||26
2291766|NCT02084056|5626929|P4|STARTED|Washout Period 1 (35 Days)||8
2291767|NCT02084056|5626930|P3|STARTED|Washout Period 1 (35 Days)||8
2291768|NCT02084056|5626931|P2|STARTED|Washout Period 1 (35 Days)||30
2291769|NCT02084056|5626932|P1|STARTED|Washout Period 1 (35 Days)||27
2291770|NCT02084056|5626929|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
2291771|NCT02084056|5626930|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
2291772|NCT02084056|5626931|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
2291773|NCT02084056|5626932|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||1
2291774|NCT02084056|5626929|P4|COMPLETED|Treatment Period 1 (4 Days)||8
2291775|NCT02084056|5626930|P3|COMPLETED|Treatment Period 1 (4 Days)||8
2291776|NCT02084056|5626931|P2|COMPLETED|Treatment Period 1 (4 Days)||30
2291777|NCT02084056|5626932|P1|COMPLETED|Treatment Period 1 (4 Days)||27
2291778|NCT02084056|5626929|P4|STARTED|Treatment Period 1 (4 Days)||8
2291779|NCT02084056|5626930|P3|STARTED|Treatment Period 1 (4 Days)||8
2291780|NCT02084056|5626931|P2|STARTED|Treatment Period 1 (4 Days)||30
2291781|NCT02084056|5626932|P1|STARTED|Treatment Period 1 (4 Days)||28
2291782|NCT02083965|5626964|P2|NOT COMPLETED|Treatment Period||0
2291783|NCT02083965|5626965|P1|NOT COMPLETED|Treatment Period||1
2291784|NCT02083965|5626964|P2|COMPLETED|Treatment Period||8
2291785|NCT02083965|5626965|P1|COMPLETED|Treatment Period||9
2291786|NCT02083965|5626964|P2|STARTED|Treatment Period|1 participant completed PK period 1 and 2, then chose to withdraw and did not enter treatment period|8
2291787|NCT02083965|5626965|P1|STARTED|Treatment Period||10
2291788|NCT02083965|5626964|P2|NOT COMPLETED|PK Period 2||0
2291789|NCT02083965|5626965|P1|NOT COMPLETED|PK Period 2||0
2291790|NCT02083965|5626964|P2|COMPLETED|PK Period 2||9
2291791|NCT02083965|5626965|P1|COMPLETED|PK Period 2||10
2291792|NCT02083965|5626964|P2|STARTED|PK Period 2||9
2291793|NCT02083965|5626965|P1|STARTED|PK Period 2||10
2291794|NCT02083965|5626964|P2|NOT COMPLETED|Washout Period||0
2291795|NCT02083965|5626965|P1|NOT COMPLETED|Washout Period||0
2291796|NCT02083965|5626964|P2|COMPLETED|Washout Period||9
2291797|NCT02083965|5626965|P1|COMPLETED|Washout Period||10
2291798|NCT02083965|5626964|P2|STARTED|Washout Period||9
2291799|NCT02083965|5626965|P1|STARTED|Washout Period||10
2291800|NCT02083965|5626964|P2|NOT COMPLETED|PK Period 1||0
2291801|NCT02083965|5626965|P1|NOT COMPLETED|PK Period 1||0
2291802|NCT02083965|5626964|P2|COMPLETED|PK Period 1||9
2291803|NCT02083965|5626965|P1|COMPLETED|PK Period 1||10
2291804|NCT02083965|5626964|P2|STARTED|PK Period 1||9
2291805|NCT02083965|5626965|P1|STARTED|PK Period 1||10
2291806|NCT02083861|5627023|P2|NOT COMPLETED|Overall Study||3
2291807|NCT02083861|5627024|P1|NOT COMPLETED|Overall Study||6
2291808|NCT02083861|5627023|P2|COMPLETED|Overall Study||33
2291809|NCT02083861|5627024|P1|COMPLETED|Overall Study||51
2291810|NCT02083861|5627023|P2|Treated|Overall Study||35
2291811|NCT02083861|5627024|P1|Treated|Overall Study||55
2291812|NCT02083861|5627023|P2|STARTED|Overall Study||36
2291813|NCT02083861|5627024|P1|STARTED|Overall Study||57
2291814|NCT02083679|5627040|P4|NOT COMPLETED|Overall Study||0
2291815|NCT02083679|5627041|P3|NOT COMPLETED|Overall Study||0
2291816|NCT02083679|5627042|P2|NOT COMPLETED|Overall Study||0
2291817|NCT02083679|5627043|P1|NOT COMPLETED|Overall Study||0
2291818|NCT02083679|5627040|P4|COMPLETED|Overall Study||3
2291819|NCT02083679|5627041|P3|COMPLETED|Overall Study||3
2291820|NCT02083679|5627042|P2|COMPLETED|Overall Study||6
2291821|NCT02083679|5627043|P1|COMPLETED|Overall Study||3
2291822|NCT02083679|5627040|P4|STARTED|Overall Study||3
2291823|NCT02083679|5627041|P3|STARTED|Overall Study||3
2291824|NCT02083679|5627042|P2|STARTED|Overall Study||6
2291825|NCT02083679|5627043|P1|STARTED|Overall Study||3
2291826|NCT02083653|5627060|P3|NOT COMPLETED|Overall Study||84
2291827|NCT02083653|5627061|P2|NOT COMPLETED|Overall Study||85
2291828|NCT02083653|5627062|P1|NOT COMPLETED|Overall Study||82
2291829|NCT02083653|5627060|P3|COMPLETED|Overall Study||1
2291830|NCT02083653|5627061|P2|COMPLETED|Overall Study||1
2291831|NCT02083653|5627062|P1|COMPLETED|Overall Study||1
2291832|NCT02083653|5627060|P3|STARTED|Overall Study||85
2291833|NCT02083653|5627061|P2|STARTED|Overall Study||86
2291834|NCT02083653|5627062|P1|STARTED|Overall Study||83
2291835|NCT02083406|5627108|P3|NOT COMPLETED|Overall Study||0
2291836|NCT02083406|5627109|P2|NOT COMPLETED|Overall Study||0
2291837|NCT02083406|5627110|P1|NOT COMPLETED|Overall Study||0
2291838|NCT02083406|5627108|P3|COMPLETED|Overall Study||7
2291839|NCT02083406|5627109|P2|COMPLETED|Overall Study||8
2291840|NCT02083406|5627110|P1|COMPLETED|Overall Study||7
2291841|NCT02083406|5627108|P3|STARTED|Overall Study||7
2291842|NCT02083406|5627109|P2|STARTED|Overall Study||8
2291843|NCT02083406|5627110|P1|STARTED|Overall Study||7
2291844|NCT02083380|5627130|P3|NOT COMPLETED|Overall Study||84
2291845|NCT02083380|5627131|P2|NOT COMPLETED|Overall Study||95
2291846|NCT02083380|5627132|P1|NOT COMPLETED|Overall Study||91
2291847|NCT02083380|5627130|P3|COMPLETED|Overall Study||65
2291848|NCT02083380|5627131|P2|COMPLETED|Overall Study||56
2291849|NCT02083380|5627132|P1|COMPLETED|Overall Study||57
2291850|NCT02083380|5627130|P3|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|149
2291851|NCT02083380|5627131|P2|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|151
2291852|NCT02083380|5627132|P1|STARTED|Overall Study|5 subjects excluded from safety / ITT population - no drug administered|148
2291853|NCT02083263|5627227|P2|NOT COMPLETED|Overall Study||0
2291854|NCT02083263|5627228|P1|NOT COMPLETED|Overall Study||0
2291855|NCT02083263|5627227|P2|COMPLETED|Overall Study||16
2291856|NCT02083263|5627228|P1|COMPLETED|Overall Study||16
2291857|NCT02083263|5627227|P2|STARTED|Overall Study||16
2291858|NCT02083263|5627228|P1|STARTED|Overall Study||16
2291859|NCT02083185|5627237|P3|NOT COMPLETED|Overall Study||7
2291860|NCT02083185|5627238|P2|NOT COMPLETED|Overall Study||29
2291861|NCT02083185|5627239|P1|NOT COMPLETED|Overall Study||20
2291862|NCT02083185|5627237|P3|COMPLETED|Overall Study||17
2291863|NCT02083185|5627238|P2|COMPLETED|Overall Study||27
2291864|NCT02083185|5627239|P1|COMPLETED|Overall Study||36
2291865|NCT02083185|5627237|P3|Safety Population|Overall Study||24
2291866|NCT02083185|5627238|P2|Safety Population|Overall Study||54
2291867|NCT02083185|5627239|P1|Safety Population|Overall Study||56
2291868|NCT02083185|5627237|P3|STARTED|Overall Study||24
2291869|NCT02083185|5627238|P2|STARTED|Overall Study||56
2291870|NCT02083185|5627239|P1|STARTED|Overall Study||56
2291871|NCT02083107|5627297|P3|NOT COMPLETED|Overall Study||0
2291872|NCT02083107|5627298|P2|NOT COMPLETED|Overall Study||0
2291873|NCT02083107|5627299|P1|NOT COMPLETED|Overall Study||0
2291874|NCT02083107|5627297|P3|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
2291875|NCT02083107|5627298|P2|COMPLETED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
2291876|NCT02083107|5627299|P1|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
2291877|NCT02083107|5627297|P3|STARTED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
2291878|NCT02083107|5627298|P2|STARTED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
2291879|NCT02083107|5627299|P1|STARTED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
2291940|NCT02082912|5627607|P2|NOT COMPLETED|Overall Study||1
2291941|NCT02082912|5627608|P1|NOT COMPLETED|Overall Study||0
2291942|NCT02082912|5627607|P2|COMPLETED|Overall Study||6
2291943|NCT02082912|5627608|P1|COMPLETED|Overall Study||7
2291944|NCT02082912|5627607|P2|STARTED|Overall Study||7
2291945|NCT02082912|5627608|P1|STARTED|Overall Study||7
2291946|NCT02082769|5627625|P3|NOT COMPLETED|Overall Study||36
2291947|NCT02082769|5627626|P2|NOT COMPLETED|Overall Study||27
2291948|NCT02082769|5627627|P1|NOT COMPLETED|Overall Study||24
2291949|NCT02082769|5627625|P3|COMPLETED|Overall Study||132
2291950|NCT02082769|5627626|P2|COMPLETED|Overall Study||141
2291951|NCT02082769|5627627|P1|COMPLETED|Overall Study||144
2291952|NCT02082769|5627625|P3|STARTED|Overall Study||168
2291953|NCT02082769|5627626|P2|STARTED|Overall Study||168
2291954|NCT02082769|5627627|P1|STARTED|Overall Study||168
2291955|NCT02082522|5627643|P2|NOT COMPLETED|Overall Study||13
2291956|NCT02082522|5627644|P1|NOT COMPLETED|Overall Study||15
2291957|NCT02082522|5627643|P2|COMPLETED|Overall Study||0
2291958|NCT02082522|5627644|P1|COMPLETED|Overall Study||0
2291959|NCT02082522|5627643|P2|STARTED|Overall Study||13
2291960|NCT02082522|5627644|P1|STARTED|Overall Study||15
2291961|NCT02082483|5627694|P2|NOT COMPLETED|Overall Study||6
2291962|NCT02082483|5627695|P1|NOT COMPLETED|Overall Study||6
2291963|NCT02082483|5627694|P2|COMPLETED|Overall Study||67
2291964|NCT02082483|5627695|P1|COMPLETED|Overall Study||65
2291965|NCT02082483|5627694|P2|STARTED|Overall Study||73
2291966|NCT02082483|5627695|P1|STARTED|Overall Study||71
2291967|NCT02082392|5627712|P2|NOT COMPLETED|Overall Study||0
2291968|NCT02082392|5627713|P1|NOT COMPLETED|Overall Study||0
2291969|NCT02082392|5627712|P2|COMPLETED|Overall Study||1
2291970|NCT02082392|5627713|P1|COMPLETED|Overall Study||2
2291971|NCT02082392|5627712|P2|STARTED|Overall Study||1
2291972|NCT02082392|5627713|P1|STARTED|Overall Study||2
2291979|NCT02082288|5627754|P1|NOT COMPLETED|Overall Study||0
2291980|NCT02082288|5627754|P1|COMPLETED|Overall Study||243
2291981|NCT02082288|5627754|P1|STARTED|Overall Study||243
2291982|NCT02082262|5627758|P1|NOT COMPLETED|Overall Study||51
2291983|NCT02082262|5627758|P1|COMPLETED|Overall Study||89
2291984|NCT02082262|5627758|P1|STARTED|Overall Study||140
2291985|NCT02082184|5627764|P2|NOT COMPLETED|Overall Study||13
2291986|NCT02082184|5627765|P1|NOT COMPLETED|Overall Study||10
2291987|NCT02082184|5627764|P2|COMPLETED|Overall Study||62
2291988|NCT02082184|5627765|P1|COMPLETED|Overall Study||139
2291989|NCT02082184|5627764|P2|STARTED|Overall Study||75
2291990|NCT02082184|5627765|P1|STARTED|Overall Study||149
2291991|NCT02082158|5627790|P6|NOT COMPLETED|Overall Study||7
2291992|NCT02082158|5627791|P5|NOT COMPLETED|Overall Study||4
2291993|NCT02082158|5627792|P4|NOT COMPLETED|Overall Study||4
2291994|NCT02082158|5627793|P3|NOT COMPLETED|Overall Study||14
2291995|NCT02082158|5627794|P2|NOT COMPLETED|Overall Study||8
2291996|NCT02082158|5627795|P1|NOT COMPLETED|Overall Study||8
2291997|NCT02082158|5627790|P6|COMPLETED|Overall Study||56
2291998|NCT02082158|5627791|P5|COMPLETED|Overall Study||64
2291999|NCT02082158|5627792|P4|COMPLETED|Overall Study|Includes completion with respirator from secondary randomization after fit-test failure of 1st model|68
2292000|NCT02082158|5627793|P3|COMPLETED|Overall Study||38
2292001|NCT02082158|5627794|P2|COMPLETED|Overall Study||53
2292002|NCT02082158|5627795|P1|COMPLETED|Overall Study||58
2292003|NCT02082158|5627790|P6|STARTED|Overall Study||63
2292004|NCT02082158|5627791|P5|STARTED|Overall Study||68
2292005|NCT02082158|5627792|P4|STARTED|Overall Study||72
2292006|NCT02082158|5627793|P3|STARTED|Overall Study||52
2292007|NCT02082158|5627794|P2|STARTED|Overall Study||61
2292008|NCT02082158|5627795|P1|STARTED|Overall Study||66
2292009|NCT02082145|5627817|P2|NOT COMPLETED|Overall Study||0
2292010|NCT02082145|5627818|P1|NOT COMPLETED|Overall Study||0
2292011|NCT02082145|5627817|P2|COMPLETED|Overall Study||9
2292012|NCT02082145|5627818|P1|COMPLETED|Overall Study||5
2292013|NCT02082145|5627817|P2|STARTED|Overall Study||9
2292014|NCT02082145|5627818|P1|STARTED|Overall Study||5
2292015|NCT02081963|5627832|P2|NOT COMPLETED|Overall Study||4
2292016|NCT02081963|5627833|P1|NOT COMPLETED|Overall Study||5
2292017|NCT02081963|5627832|P2|COMPLETED|Overall Study||69
2292018|NCT02081963|5627833|P1|COMPLETED|Overall Study||74
2292019|NCT02081963|5627832|P2|STARTED|Overall Study||73
2292020|NCT02081963|5627833|P1|STARTED|Overall Study||79
2292021|NCT02081859|5627849|P2|NOT COMPLETED|Overall Study||31
2292022|NCT02081859|5627850|P1|NOT COMPLETED|Overall Study||34
2292023|NCT02081859|5627849|P2|COMPLETED|Overall Study||119
2292024|NCT02081859|5627850|P1|COMPLETED|Overall Study||116
2292025|NCT02081859|5627849|P2|STARTED|Overall Study||150
2292026|NCT02081859|5627850|P1|STARTED|Overall Study||150
2292027|NCT02081846|5627860|P2|NOT COMPLETED|Overall Study||0
2292028|NCT02081846|5627861|P1|NOT COMPLETED|Overall Study||2
2292029|NCT02081846|5627860|P2|COMPLETED|Overall Study||749
2292030|NCT02081846|5627861|P1|COMPLETED|Overall Study||749
2292031|NCT02081846|5627860|P2|STARTED|Overall Study||749
2292032|NCT02081846|5627861|P1|STARTED|Overall Study||751
2292033|NCT02081807|5627887|P8|NOT COMPLETED|Overall Study||0
2292034|NCT02081807|5627888|P7|NOT COMPLETED|Overall Study||0
2292035|NCT02081807|5627889|P6|NOT COMPLETED|Overall Study||0
2292036|NCT02081807|5627890|P5|NOT COMPLETED|Overall Study||0
2292037|NCT02081807|5627891|P4|NOT COMPLETED|Overall Study||0
2292038|NCT02081807|5627892|P3|NOT COMPLETED|Overall Study||0
2292039|NCT02081807|5627893|P2|NOT COMPLETED|Overall Study||0
2292040|NCT02081807|5627894|P1|NOT COMPLETED|Overall Study||0
2292041|NCT02081807|5627887|P8|COMPLETED|Overall Study||19729
2292042|NCT02081807|5627888|P7|COMPLETED|Overall Study||40207
2292043|NCT02081807|5627889|P6|COMPLETED|Overall Study||76055
2292044|NCT02081807|5627890|P5|COMPLETED|Overall Study||27456
2292045|NCT02081807|5627891|P4|COMPLETED|Overall Study||9112
2292046|NCT02081807|5627892|P3|COMPLETED|Overall Study||14852
2292047|NCT02081807|5627893|P2|COMPLETED|Overall Study||26149
2292048|NCT02081807|5627894|P1|COMPLETED|Overall Study||7668
2292049|NCT02081807|5627887|P8|STARTED|Overall Study||19729
2292050|NCT02081807|5627888|P7|STARTED|Overall Study||40207
2292051|NCT02081807|5627889|P6|STARTED|Overall Study||76055
2292052|NCT02081807|5627890|P5|STARTED|Overall Study||27456
2292053|NCT02081807|5627891|P4|STARTED|Overall Study||9112
2292054|NCT02081807|5627892|P3|STARTED|Overall Study||14852
2292055|NCT02081807|5627893|P2|STARTED|Overall Study||26149
2292056|NCT02081807|5627894|P1|STARTED|Overall Study||7668
2292057|NCT02081690|5628030|P1|NOT COMPLETED|Overall Study||7
2292058|NCT02081690|5628030|P1|COMPLETED|Overall Study||81
2292059|NCT02081690|5628030|P1|STARTED|Overall Study||88
2292060|NCT02081677|5628041|P4|NOT COMPLETED|Overall Study||0
2292061|NCT02081677|5628042|P3|NOT COMPLETED|Overall Study||2
2292062|NCT02081677|5628043|P2|NOT COMPLETED|Overall Study||1
2292063|NCT02081677|5628044|P1|NOT COMPLETED|Overall Study||1
2292064|NCT02081677|5628041|P4|COMPLETED|Overall Study||19
2292065|NCT02081677|5628042|P3|COMPLETED|Overall Study||17
2292066|NCT02081677|5628043|P2|COMPLETED|Overall Study||18
2292067|NCT02081677|5628044|P1|COMPLETED|Overall Study||18
2292068|NCT02081677|5628041|P4|STARTED|Overall Study||19
2292069|NCT02081677|5628042|P3|STARTED|Overall Study||19
2292070|NCT02081677|5628043|P2|STARTED|Overall Study||19
2292071|NCT02081677|5628044|P1|STARTED|Overall Study||19
2292072|NCT02081599|5628136|P2|NOT COMPLETED|Period 2：Open-label Period||4
2292073|NCT02081599|5628137|P1|NOT COMPLETED|Period 2：Open-label Period||6
2292074|NCT02081599|5628136|P2|COMPLETED|Period 2：Open-label Period||71
2292075|NCT02081599|5628137|P1|COMPLETED|Period 2：Open-label Period||57
2292076|NCT02081599|5628136|P2|STARTED|Period 2：Open-label Period||75
2292077|NCT02081599|5628137|P1|STARTED|Period 2：Open-label Period||63
2292078|NCT02081599|5628136|P2|NOT COMPLETED|Period 1：Double-blind Period||2
2292079|NCT02081599|5628137|P1|NOT COMPLETED|Period 1：Double-blind Period||8
2292080|NCT02081599|5628136|P2|COMPLETED|Period 1：Double-blind Period||75
2292081|NCT02081599|5628137|P1|COMPLETED|Period 1：Double-blind Period||63
2292082|NCT02081599|5628136|P2|STARTED|Period 1：Double-blind Period||77
2292083|NCT02081599|5628137|P1|STARTED|Period 1：Double-blind Period||71
2292084|NCT02081586|5628155|P4|NOT COMPLETED|Overall Study||1
2292085|NCT02081586|5628156|P3|NOT COMPLETED|Overall Study||1
2292086|NCT02081586|5628157|P2|NOT COMPLETED|Overall Study||1
2292087|NCT02081586|5628158|P1|NOT COMPLETED|Overall Study||0
2292088|NCT02081586|5628155|P4|COMPLETED|Overall Study||2
2292089|NCT02081586|5628156|P3|COMPLETED|Overall Study||3
2292090|NCT02081586|5628157|P2|COMPLETED|Overall Study||2
2292091|NCT02081586|5628158|P1|COMPLETED|Overall Study||3
2292092|NCT02081586|5628155|P4|STARTED|Overall Study||3
2292093|NCT02081586|5628156|P3|STARTED|Overall Study||4
2292094|NCT02081586|5628157|P2|STARTED|Overall Study||3
2292095|NCT02081586|5628158|P1|STARTED|Overall Study||3
2292096|NCT02081573|5628185|P1|NOT COMPLETED|Overall Study||0
2292097|NCT02081573|5628185|P1|COMPLETED|Overall Study||10
2292098|NCT02081573|5628185|P1|STARTED|Overall Study||10
2292099|NCT02081456|5628196|P2|NOT COMPLETED|Overall Study||0
2292100|NCT02081456|5628197|P1|NOT COMPLETED|Overall Study||0
2292101|NCT02081456|5628196|P2|COMPLETED|Overall Study||12
2292102|NCT02081456|5628197|P1|COMPLETED|Overall Study||11
2292103|NCT02081456|5628196|P2|STARTED|Overall Study||12
2292104|NCT02081456|5628197|P1|STARTED|Overall Study||11
2292105|NCT02081443|5628211|P2|NOT COMPLETED|Overall Study||0
2292106|NCT02081443|5628212|P1|NOT COMPLETED|Overall Study||0
2292107|NCT02081443|5628211|P2|COMPLETED|Overall Study||30
2292108|NCT02081443|5628212|P1|COMPLETED|Overall Study||30
2292109|NCT02081443|5628211|P2|STARTED|Overall Study||30
2292110|NCT02081443|5628212|P1|STARTED|Overall Study||30
2292111|NCT02081417|5628224|P2|NOT COMPLETED|Overall Study||51
2292112|NCT02081417|5628225|P1|NOT COMPLETED|Overall Study||56
2292113|NCT02081417|5628224|P2|COMPLETED|Overall Study||115
2292114|NCT02081417|5628225|P1|COMPLETED|Overall Study||107
2292115|NCT02081417|5628224|P2|6-Month Follow-Up|Overall Study||92
2292116|NCT02081417|5628225|P1|6-Month Follow-Up|Overall Study||82
2292117|NCT02081417|5628224|P2|3-Month Follow-Up|Overall Study||95
2292118|NCT02081417|5628225|P1|3-Month Follow-Up|Overall Study||94
2292119|NCT02081417|5628224|P2|1st Interview Completed|Overall Study||145
2292120|NCT02081417|5628225|P1|1st Interview Completed|Overall Study||146
2292121|NCT02081417|5628224|P2|STARTED|Overall Study||166
2292122|NCT02081417|5628225|P1|STARTED|Overall Study|Randomized to intervention|163
2292123|NCT02081391|5628245|P4|NOT COMPLETED|24-hour Treatment and Trial Completion||0
2292124|NCT02081391|5628246|P3|NOT COMPLETED|24-hour Treatment and Trial Completion||1
2292125|NCT02081391|5628247|P2|NOT COMPLETED|24-hour Treatment and Trial Completion||18
2292126|NCT02081391|5628248|P1|NOT COMPLETED|24-hour Treatment and Trial Completion||27
2292127|NCT02081391|5628245|P4|COMPLETED|24-hour Treatment and Trial Completion||4
2292128|NCT02081391|5628246|P3|COMPLETED|24-hour Treatment and Trial Completion||9
2292129|NCT02081391|5628247|P2|COMPLETED|24-hour Treatment and Trial Completion||28
2292130|NCT02081391|5628248|P1|COMPLETED|24-hour Treatment and Trial Completion||63
2292131|NCT02081391|5628245|P4|STARTED|24-hour Treatment and Trial Completion||4
2292132|NCT02081391|5628246|P3|STARTED|24-hour Treatment and Trial Completion||10
2292133|NCT02081391|5628247|P2|STARTED|24-hour Treatment and Trial Completion||46
2292134|NCT02081391|5628248|P1|STARTED|24-hour Treatment and Trial Completion||90
2292135|NCT02081391|5628245|P4|NOT COMPLETED|12-hour Treatment||0
2292136|NCT02081391|5628246|P3|NOT COMPLETED|12-hour Treatment||1
2292137|NCT02081391|5628247|P2|NOT COMPLETED|12-hour Treatment||6
2292138|NCT02081391|5628248|P1|NOT COMPLETED|12-hour Treatment||18
2292139|NCT02081391|5628245|P4|COMPLETED|12-hour Treatment||4
2292140|NCT02081391|5628246|P3|COMPLETED|12-hour Treatment||10
2292141|NCT02081391|5628247|P2|COMPLETED|12-hour Treatment||46
2292142|NCT02081391|5628248|P1|COMPLETED|12-hour Treatment||90
2292143|NCT02081391|5628245|P4|STARTED|12-hour Treatment||4
2292144|NCT02081391|5628246|P3|STARTED|12-hour Treatment||11
2292145|NCT02081391|5628247|P2|STARTED|12-hour Treatment||52
2292146|NCT02081391|5628248|P1|STARTED|12-hour Treatment||108
2292147|NCT02081365|5628302|P2|NOT COMPLETED|Overall Study||23
2292148|NCT02081365|5628303|P1|NOT COMPLETED|Overall Study||30
2292149|NCT02081365|5628302|P2|COMPLETED|Overall Study||54
2292150|NCT02081365|5628303|P1|COMPLETED|Overall Study||44
2292151|NCT02081365|5628302|P2|Received Allocated Intervention|Overall Study||59
2292152|NCT02081365|5628303|P1|Received Allocated Intervention|Overall Study||46
2292153|NCT02081365|5628302|P2|STARTED|Overall Study||77
2292154|NCT02081365|5628303|P1|STARTED|Overall Study||74
2292155|NCT02081248|5628317|P2|NOT COMPLETED|Overall Study||13
2292156|NCT02081248|5628318|P1|NOT COMPLETED|Overall Study||22
2292157|NCT02081248|5628317|P2|COMPLETED|Overall Study||87
2292158|NCT02081248|5628318|P1|COMPLETED|Overall Study||76
2292159|NCT02081248|5628317|P2|STARTED|Overall Study||100
2292160|NCT02081248|5628318|P1|STARTED|Overall Study||98
2292161|NCT02081183|5628342|P2|NOT COMPLETED|Overall Study||4
2292162|NCT02081183|5628343|P1|NOT COMPLETED|Overall Study||4
2292163|NCT02081183|5628342|P2|COMPLETED|Overall Study||2
2292164|NCT02081183|5628343|P1|COMPLETED|Overall Study||1
2292165|NCT02081183|5628342|P2|STARTED|Overall Study||6
2292166|NCT02081183|5628343|P1|STARTED|Overall Study||5
2292167|NCT02081079|5628359|P2|NOT COMPLETED|Overall Study||2
2292168|NCT02081079|5628360|P1|NOT COMPLETED|Overall Study||4
2292169|NCT02081079|5628359|P2|COMPLETED|Overall Study||39
2292170|NCT02081079|5628360|P1|COMPLETED|Overall Study||40
2292171|NCT02081079|5628359|P2|STARTED|Overall Study||41
2292172|NCT02081079|5628360|P1|STARTED|Overall Study||44
2292173|NCT02081014|5628382|P6|NOT COMPLETED|Overall Study||0
2292174|NCT02081014|5628383|P5|NOT COMPLETED|Overall Study||0
2292175|NCT02081014|5628384|P4|NOT COMPLETED|Overall Study||0
2292176|NCT02081014|5628385|P3|NOT COMPLETED|Overall Study||0
2292177|NCT02081014|5628386|P2|NOT COMPLETED|Overall Study||0
2292178|NCT02081014|5628387|P1|NOT COMPLETED|Overall Study||0
2292179|NCT02081014|5628382|P6|COMPLETED|Overall Study||2
2292180|NCT02081014|5628383|P5|COMPLETED|Overall Study||2
2292181|NCT02081014|5628384|P4|COMPLETED|Overall Study||2
2292182|NCT02081014|5628385|P3|COMPLETED|Overall Study||2
2292183|NCT02081014|5628386|P2|COMPLETED|Overall Study||2
2292184|NCT02081014|5628387|P1|COMPLETED|Overall Study||2
2292185|NCT02081014|5628382|P6|STARTED|Overall Study||2
2292186|NCT02081014|5628383|P5|STARTED|Overall Study||2
2292187|NCT02081014|5628384|P4|STARTED|Overall Study||2
2292188|NCT02081014|5628385|P3|STARTED|Overall Study||2
2292189|NCT02081014|5628386|P2|STARTED|Overall Study||2
2292190|NCT02081014|5628387|P1|STARTED|Overall Study||2
2292191|NCT02081001|5628433|P12|NOT COMPLETED|Overall Study||0
2292192|NCT02081001|5628434|P11|NOT COMPLETED|Overall Study||0
2292193|NCT02081001|5628435|P10|NOT COMPLETED|Overall Study||0
2292194|NCT02081001|5628436|P9|NOT COMPLETED|Overall Study||0
2292195|NCT02081001|5628437|P8|NOT COMPLETED|Overall Study||0
2292196|NCT02081001|5628438|P7|NOT COMPLETED|Overall Study||0
2292197|NCT02081001|5628439|P6|NOT COMPLETED|Overall Study||0
2292198|NCT02081001|5628440|P5|NOT COMPLETED|Overall Study||1
2292199|NCT02081001|5628441|P4|NOT COMPLETED|Overall Study||0
2292200|NCT02081001|5628442|P3|NOT COMPLETED|Overall Study||0
2292201|NCT02081001|5628443|P2|NOT COMPLETED|Overall Study||0
2292202|NCT02081001|5628444|P1|NOT COMPLETED|Overall Study||0
2292203|NCT02081001|5628433|P12|COMPLETED|Overall Study||1
2292204|NCT02081001|5628434|P11|COMPLETED|Overall Study||2
2292205|NCT02081001|5628435|P10|COMPLETED|Overall Study||1
2292206|NCT02081001|5628436|P9|COMPLETED|Overall Study||2
2292207|NCT02081001|5628437|P8|COMPLETED|Overall Study||1
2292208|NCT02081001|5628438|P7|COMPLETED|Overall Study||2
2292209|NCT02081001|5628439|P6|COMPLETED|Overall Study||1
2292210|NCT02081001|5628440|P5|COMPLETED|Overall Study||2
2292211|NCT02081001|5628441|P4|COMPLETED|Overall Study||1
2292212|NCT02081001|5628442|P3|COMPLETED|Overall Study||2
2292213|NCT02081001|5628443|P2|COMPLETED|Overall Study||1
2292214|NCT02081001|5628444|P1|COMPLETED|Overall Study||2
2292215|NCT02081001|5628433|P12|STARTED|Overall Study||1
2292216|NCT02081001|5628434|P11|STARTED|Overall Study||2
2292217|NCT02081001|5628435|P10|STARTED|Overall Study||1
2292218|NCT02081001|5628436|P9|STARTED|Overall Study||2
2292219|NCT02081001|5628437|P8|STARTED|Overall Study||1
2292220|NCT02081001|5628438|P7|STARTED|Overall Study||2
2292221|NCT02081001|5628439|P6|STARTED|Overall Study||1
2292222|NCT02081001|5628440|P5|STARTED|Overall Study||3
2292223|NCT02081001|5628441|P4|STARTED|Overall Study||1
2292224|NCT02081001|5628442|P3|STARTED|Overall Study||2
2292225|NCT02081001|5628443|P2|STARTED|Overall Study||1
2292226|NCT02081001|5628444|P1|STARTED|Overall Study||2
2292227|NCT02080871|5628508|P1|NOT COMPLETED|Overall Study||2
2292228|NCT02080871|5628508|P1|COMPLETED|Overall Study||132
2292229|NCT02080871|5628508|P1|STARTED|Overall Study||134
2292230|NCT02080832|5628592|P3|NOT COMPLETED|Overall Study||16
2292231|NCT02080832|5628593|P2|NOT COMPLETED|Overall Study||12
2292232|NCT02080832|5628594|P1|NOT COMPLETED|Overall Study||9
2292233|NCT02080832|5628592|P3|COMPLETED|Overall Study||6
2292234|NCT02080832|5628593|P2|COMPLETED|Overall Study||5
2292235|NCT02080832|5628594|P1|COMPLETED|Overall Study||6
2292236|NCT02080832|5628592|P3|STARTED|Overall Study||22
2292237|NCT02080832|5628593|P2|STARTED|Overall Study||17
2292238|NCT02080832|5628594|P1|STARTED|Overall Study||15
2292239|NCT02080819|5628611|P3|NOT COMPLETED|Overall Study||22
2292240|NCT02080819|5628612|P2|NOT COMPLETED|Overall Study||26
2292241|NCT02080819|5628613|P1|NOT COMPLETED|Overall Study||25
2292242|NCT02080819|5628611|P3|COMPLETED|Overall Study||11
2292243|NCT02080819|5628612|P2|COMPLETED|Overall Study||9
2292244|NCT02080819|5628613|P1|COMPLETED|Overall Study||38
2292245|NCT02080819|5628611|P3|STARTED|Overall Study||33
2292246|NCT02080819|5628612|P2|STARTED|Overall Study||35
2292247|NCT02080819|5628613|P1|STARTED|Overall Study||63
2292248|NCT02080780|5628621|P1|NOT COMPLETED|Overall Study||0
2292249|NCT02080780|5628621|P1|COMPLETED|Overall Study||24
2292250|NCT02080780|5628621|P1|STARTED|Overall Study||24
2292251|NCT02080637|5628630|P2|NOT COMPLETED|Overall Study||0
2292252|NCT02080637|5628631|P1|NOT COMPLETED|Overall Study||0
2292253|NCT02080637|5628630|P2|COMPLETED|Overall Study||3
2292254|NCT02080637|5628631|P1|COMPLETED|Overall Study||13
2292255|NCT02080637|5628630|P2|STARTED|Overall Study||3
2292256|NCT02080637|5628631|P1|STARTED|Overall Study||13
2292257|NCT02080546|5628644|P2|NOT COMPLETED|Overall Study||11
2292258|NCT02080546|5628645|P1|NOT COMPLETED|Overall Study||8
2292259|NCT02080546|5628644|P2|COMPLETED|Overall Study||52
2292260|NCT02080546|5628645|P1|COMPLETED|Overall Study||49
2292261|NCT02080546|5628644|P2|STARTED|Overall Study||63
2292262|NCT02080546|5628645|P1|STARTED|Overall Study||57
2292263|NCT02080507|5628655|P2|NOT COMPLETED|Overall Study||0
2292264|NCT02080507|5628656|P1|NOT COMPLETED|Overall Study||0
2292265|NCT02080507|5628655|P2|COMPLETED|Overall Study||7
2292266|NCT02080507|5628656|P1|COMPLETED|Overall Study||5
2292267|NCT02080507|5628655|P2|STARTED|Overall Study||7
2292268|NCT02080507|5628656|P1|STARTED|Overall Study||5
2292269|NCT02080481|5628666|P2|NOT COMPLETED|Overall Study||0
2292270|NCT02080481|5628667|P1|NOT COMPLETED|Overall Study||1
2292271|NCT02080481|5628666|P2|COMPLETED|Overall Study||67
2292272|NCT02080481|5628667|P1|COMPLETED|Overall Study||67
2292273|NCT02080481|5628666|P2|STARTED|Overall Study||67
2292274|NCT02080481|5628667|P1|STARTED|Overall Study||68
2292275|NCT02080468|5628681|P2|NOT COMPLETED|Overall Study||2
2292276|NCT02080468|5628682|P1|NOT COMPLETED|Overall Study||2
2292277|NCT02080468|5628681|P2|COMPLETED|Overall Study||14
2292278|NCT02080468|5628682|P1|COMPLETED|Overall Study||14
2292279|NCT02080468|5628681|P2|STARTED|Overall Study||16
2292280|NCT02080468|5628682|P1|STARTED|Overall Study||16
2292281|NCT02080312|5628746|P1|NOT COMPLETED|Overall Study||0
2292282|NCT02080312|5628746|P1|COMPLETED|Overall Study||6
2292283|NCT02080312|5628746|P1|STARTED|Overall Study||6
2292284|NCT02080273|5628755|P3|NOT COMPLETED|Overall Study||0
2292285|NCT02080273|5628756|P2|NOT COMPLETED|Overall Study||0
2292286|NCT02080273|5628757|P1|NOT COMPLETED|Overall Study||0
2292287|NCT02080273|5628755|P3|COMPLETED|Overall Study||45
2292288|NCT02080273|5628756|P2|COMPLETED|Overall Study||45
2292289|NCT02080273|5628757|P1|COMPLETED|Overall Study||45
2292290|NCT02080273|5628755|P3|STARTED|Overall Study||45
2292291|NCT02080273|5628756|P2|STARTED|Overall Study||45
2292292|NCT02080273|5628757|P1|STARTED|Overall Study||45
2292293|NCT02080260|5628786|P1|NOT COMPLETED|Overall Study||19
2292294|NCT02080260|5628786|P1|COMPLETED|Overall Study|Defined as still alive in follow-up when the study was terminated and the database was locked.|1
2292295|NCT02080260|5628786|P1|STARTED|Overall Study||20
2292296|NCT02080195|5628794|P1|NOT COMPLETED|Overall Study||0
2292297|NCT02080195|5628794|P1|COMPLETED|Overall Study||1
2292298|NCT02080195|5628794|P1|STARTED|Overall Study||1
2292299|NCT02080091|5628803|P1|NOT COMPLETED|Overall Study||25
2292300|NCT02080091|5628803|P1|COMPLETED|Overall Study||0
2292301|NCT02080091|5628803|P1|STARTED|Overall Study||25
2292302|NCT02079987|5628811|P2|NOT COMPLETED|Overall Study||0
2292303|NCT02079987|5628812|P1|NOT COMPLETED|Overall Study||0
2292304|NCT02079987|5628811|P2|COMPLETED|Overall Study||544
2292305|NCT02079987|5628812|P1|COMPLETED|Overall Study||557
2292306|NCT02079987|5628811|P2|STARTED|Overall Study||544
2292307|NCT02079987|5628812|P1|STARTED|Overall Study||557
2292308|NCT02079909|5628831|P3|NOT COMPLETED|Overall Study||18
2292309|NCT02079909|5628832|P2|NOT COMPLETED|Overall Study||49
2292310|NCT02079909|5628833|P1|NOT COMPLETED|Overall Study||38
2292311|NCT02079909|5628831|P3|COMPLETED|Overall Study||140
2292312|NCT02079909|5628832|P2|COMPLETED|Overall Study||117
2292313|NCT02079909|5628833|P1|COMPLETED|Overall Study||120
2292314|NCT02079909|5628831|P3|STARTED|Overall Study||158
2292315|NCT02079909|5628832|P2|STARTED|Overall Study||166
2292316|NCT02079909|5628833|P1|STARTED|Overall Study||158
2292317|NCT02079844|5628850|P3|NOT COMPLETED|Treatment Period 3||0
2292318|NCT02079844|5628851|P2|NOT COMPLETED|Treatment Period 3||0
2292319|NCT02079844|5628852|P1|NOT COMPLETED|Treatment Period 3||0
2292320|NCT02079844|5628850|P3|COMPLETED|Treatment Period 3||5
2292321|NCT02079844|5628851|P2|COMPLETED|Treatment Period 3||5
2292322|NCT02079844|5628852|P1|COMPLETED|Treatment Period 3||5
2292323|NCT02079844|5628850|P3|STARTED|Treatment Period 3||5
2292324|NCT02079844|5628851|P2|STARTED|Treatment Period 3|1 Participant Voluntarily Withdrew after completing Period 2.|5
2292325|NCT02079844|5628852|P1|STARTED|Treatment Period 3||5
2292326|NCT02079844|5628850|P3|NOT COMPLETED|Treatment Period 2||0
2292327|NCT02079844|5628851|P2|NOT COMPLETED|Treatment Period 2||1
2292328|NCT02079844|5628852|P1|NOT COMPLETED|Treatment Period 2||0
2292329|NCT02079844|5628850|P3|COMPLETED|Treatment Period 2||5
2292330|NCT02079844|5628851|P2|COMPLETED|Treatment Period 2||6
2292331|NCT02079844|5628852|P1|COMPLETED|Treatment Period 2||5
2292332|NCT02079844|5628850|P3|STARTED|Treatment Period 2||5
2292333|NCT02079844|5628851|P2|STARTED|Treatment Period 2||7
2292334|NCT02079844|5628852|P1|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|5
2292335|NCT02079844|5628850|P3|NOT COMPLETED|Treatment Period 1||2
2292336|NCT02079844|5628851|P2|NOT COMPLETED|Treatment Period 1||0
2292337|NCT02079844|5628852|P1|NOT COMPLETED|Treatment Period 1||0
2292338|NCT02079844|5628850|P3|COMPLETED|Treatment Period 1||5
2292339|NCT02079844|5628851|P2|COMPLETED|Treatment Period 1||7
2292340|NCT02079844|5628852|P1|COMPLETED|Treatment Period 1||6
2292341|NCT02079844|5628850|P3|STARTED|Treatment Period 1||7
2292342|NCT02079844|5628851|P2|STARTED|Treatment Period 1||7
2292343|NCT02079844|5628852|P1|STARTED|Treatment Period 1||6
2292344|NCT02079805|5628910|P2|NOT COMPLETED|Overall Study||2
2292345|NCT02079805|5628911|P1|NOT COMPLETED|Overall Study||0
2292346|NCT02079805|5628910|P2|COMPLETED|Overall Study||15
2292347|NCT02079805|5628911|P1|COMPLETED|Overall Study||16
2292348|NCT02079805|5628910|P2|STARTED|Overall Study||17
2292349|NCT02079805|5628911|P1|STARTED|Overall Study||16
2292350|NCT02079649|5628933|P4|NOT COMPLETED|Overall Study||2
2292351|NCT02079649|5628934|P3|NOT COMPLETED|Overall Study||1
2292352|NCT02079649|5628935|P2|NOT COMPLETED|Overall Study||0
2292353|NCT02079649|5628936|P1|NOT COMPLETED|Overall Study||1
2292354|NCT02079649|5628933|P4|COMPLETED|Overall Study||38
2292355|NCT02079649|5628934|P3|COMPLETED|Overall Study||40
2292356|NCT02079649|5628935|P2|COMPLETED|Overall Study||41
2292357|NCT02079649|5628936|P1|COMPLETED|Overall Study||41
2292358|NCT02079649|5628933|P4|Treated|Overall Study||40
2292359|NCT02079649|5628934|P3|Treated|Overall Study||40
2292360|NCT02079649|5628935|P2|Treated|Overall Study||41
2292361|NCT02079649|5628936|P1|Treated|Overall Study||41
2292362|NCT02079649|5628933|P4|STARTED|Overall Study||40
2292363|NCT02079649|5628934|P3|STARTED|Overall Study||41
2292364|NCT02079649|5628935|P2|STARTED|Overall Study||41
2292365|NCT02079649|5628936|P1|STARTED|Overall Study||42
2292366|NCT02079610|5628953|P2|NOT COMPLETED|Overall Study||1
2292367|NCT02079610|5628954|P1|NOT COMPLETED|Overall Study||1
2292368|NCT02079610|5628953|P2|COMPLETED|Overall Study||16
2292369|NCT02079610|5628954|P1|COMPLETED|Overall Study||18
2292370|NCT02079610|5628953|P2|STARTED|Overall Study||17
2292371|NCT02079610|5628954|P1|STARTED|Overall Study||19
2292372|NCT02079532|5628964|P1|NOT COMPLETED|Overall Study||29
2292373|NCT02079532|5628964|P1|COMPLETED|Overall Study||273
2292374|NCT02079532|5628964|P1|STARTED|Overall Study||302
2292375|NCT02079519|5628986|P1|NOT COMPLETED|Overall Study||10
2292376|NCT02079519|5628986|P1|COMPLETED|Overall Study||0
2292377|NCT02079519|5628986|P1|STARTED|Overall Study||10
2292378|NCT02079311|5628992|P2|NOT COMPLETED|Overall Study||1
2292379|NCT02079311|5628993|P1|NOT COMPLETED|Overall Study||0
2292380|NCT02079311|5628992|P2|COMPLETED|Overall Study||26
2292381|NCT02079311|5628993|P1|COMPLETED|Overall Study||28
2292382|NCT02079311|5628992|P2|STARTED|Overall Study||27
2292383|NCT02079311|5628993|P1|STARTED|Overall Study||28
2292384|NCT02079246|5628999|P2|NOT COMPLETED|OLEX-MEM||19
2292385|NCT02079246|5629000|P1|NOT COMPLETED|OLEX-MEM||0
2292386|NCT02079246|5628999|P2|COMPLETED|OLEX-MEM||82
2292387|NCT02079246|5629000|P1|COMPLETED|OLEX-MEM||0
2292388|NCT02079246|5628999|P2|STARTED|OLEX-MEM||101
2292389|NCT02079246|5629000|P1|STARTED|OLEX-MEM||0
2292390|NCT02079246|5628999|P2|NOT COMPLETED|OLEX||0
2292391|NCT02079246|5629000|P1|NOT COMPLETED|OLEX||228
2292392|NCT02079246|5628999|P2|COMPLETED|OLEX||0
2292393|NCT02079246|5629000|P1|COMPLETED|OLEX||1235
2292394|NCT02079246|5628999|P2|STARTED|OLEX||0
2292395|NCT02079246|5629000|P1|STARTED|OLEX||1463
2292396|NCT02079077|5629019|P2|NOT COMPLETED|Overall Study||9
2292397|NCT02079077|5629020|P1|NOT COMPLETED|Overall Study||6
2292398|NCT02079077|5629019|P2|COMPLETED|Overall Study||39
2292399|NCT02079077|5629020|P1|COMPLETED|Overall Study||37
2292400|NCT02079077|5629019|P2|STARTED|Overall Study||48
2292401|NCT02079077|5629020|P1|STARTED|Overall Study||43
2292402|NCT02079025|5629030|P2|NOT COMPLETED|Overall Study||0
2292403|NCT02079025|5629031|P1|NOT COMPLETED|Overall Study||0
2292404|NCT02079025|5629030|P2|COMPLETED|Overall Study||837
2292405|NCT02079025|5629031|P1|COMPLETED|Overall Study||839
2292406|NCT02079025|5629030|P2|STARTED|Overall Study||837
2292407|NCT02079025|5629031|P1|STARTED|Overall Study||839
2292408|NCT02078960|5629043|P3|NOT COMPLETED|Follow-up Period||0
2292409|NCT02078960|5629044|P2|NOT COMPLETED|Follow-up Period||1
2292410|NCT02078960|5629045|P1|NOT COMPLETED|Follow-up Period||2
2292411|NCT02078960|5629043|P3|COMPLETED|Follow-up Period||1
2292412|NCT02078960|5629044|P2|COMPLETED|Follow-up Period||1
2292413|NCT02078960|5629045|P1|COMPLETED|Follow-up Period||0
2292414|NCT02078960|5629043|P3|STARTED|Follow-up Period||1
2292415|NCT02078960|5629044|P2|STARTED|Follow-up Period||2
2292416|NCT02078960|5629045|P1|STARTED|Follow-up Period||2
2292417|NCT02078960|5629043|P3|NOT COMPLETED|Treatment Period||3
2292418|NCT02078960|5629044|P2|NOT COMPLETED|Treatment Period||3
2292419|NCT02078960|5629045|P1|NOT COMPLETED|Treatment Period||2
2292420|NCT02078960|5629043|P3|COMPLETED|Treatment Period||1
2292421|NCT02078960|5629044|P2|COMPLETED|Treatment Period||1
2292422|NCT02078960|5629045|P1|COMPLETED|Treatment Period||0
2292423|NCT02078960|5629043|P3|STARTED|Treatment Period||4
2292424|NCT02078960|5629044|P2|STARTED|Treatment Period||4
2292425|NCT02078960|5629045|P1|STARTED|Treatment Period||2
2292426|NCT02078817|5629067|P1|NOT COMPLETED|Overall Study||1
2292427|NCT02078817|5629067|P1|COMPLETED|Overall Study||13
2292428|NCT02078817|5629067|P1|STARTED|Overall Study||14
2292429|NCT02078752|5629089|P10|NOT COMPLETED|Overall Study||10
2292430|NCT02078752|5629090|P9|NOT COMPLETED|Overall Study||0
2292431|NCT02078752|5629091|P8|NOT COMPLETED|Overall Study||3
2292432|NCT02078752|5629092|P7|NOT COMPLETED|Overall Study||2
2292433|NCT02078752|5629093|P6|NOT COMPLETED|Overall Study||4
2292434|NCT02078752|5629094|P5|NOT COMPLETED|Overall Study||1
2292435|NCT02078752|5629095|P4|NOT COMPLETED|Overall Study||2
2292436|NCT02078752|5629096|P3|NOT COMPLETED|Overall Study||1
2292437|NCT02078752|5629097|P2|NOT COMPLETED|Overall Study||7
2292438|NCT02078752|5629098|P1|NOT COMPLETED|Overall Study||2
2292439|NCT02078752|5629089|P10|COMPLETED|Overall Study||2
2292440|NCT02078752|5629090|P9|COMPLETED|Overall Study||2
2292441|NCT02078752|5629091|P8|COMPLETED|Overall Study||3
2292442|NCT02078752|5629092|P7|COMPLETED|Overall Study||1
2292443|NCT02078752|5629093|P6|COMPLETED|Overall Study||5
2292444|NCT02078752|5629094|P5|COMPLETED|Overall Study||2
2292445|NCT02078752|5629095|P4|COMPLETED|Overall Study||5
2292446|NCT02078752|5629096|P3|COMPLETED|Overall Study||1
2292447|NCT02078752|5629097|P2|COMPLETED|Overall Study||6
2292448|NCT02078752|5629098|P1|COMPLETED|Overall Study||1
2292449|NCT02078752|5629089|P10|STARTED|Overall Study||12
2292450|NCT02078752|5629090|P9|STARTED|Overall Study||2
2292451|NCT02078752|5629091|P8|STARTED|Overall Study||6
2292452|NCT02078752|5629092|P7|STARTED|Overall Study||3
2292453|NCT02078752|5629093|P6|STARTED|Overall Study||9
2292454|NCT02078752|5629094|P5|STARTED|Overall Study||3
2292455|NCT02078752|5629095|P4|STARTED|Overall Study||7
2292456|NCT02078752|5629096|P3|STARTED|Overall Study||2
2292457|NCT02078752|5629097|P2|STARTED|Overall Study||13
2292458|NCT02078752|5629098|P1|STARTED|Overall Study||3
2292459|NCT02078713|5629374|P4|NOT COMPLETED|Overall Study||0
2292460|NCT02078713|5629375|P3|NOT COMPLETED|Overall Study||0
2292461|NCT02078713|5629376|P2|NOT COMPLETED|Overall Study||61
2292462|NCT02078713|5629377|P1|NOT COMPLETED|Overall Study||52
2292463|NCT02078713|5629374|P4|COMPLETED|Overall Study||13
2292464|NCT02078713|5629375|P3|COMPLETED|Overall Study||15
2292465|NCT02078713|5629376|P2|COMPLETED|Overall Study||290
2292466|NCT02078713|5629377|P1|COMPLETED|Overall Study||355
2292467|NCT02078713|5629374|P4|STARTED|Overall Study||13
2292468|NCT02078713|5629375|P3|STARTED|Overall Study||15
2292469|NCT02078713|5629376|P2|STARTED|Overall Study||351
2292470|NCT02078713|5629377|P1|STARTED|Overall Study||407
2292471|NCT02078557|5629429|P1|NOT COMPLETED|Overall Study||0
2292472|NCT02078557|5629429|P1|COMPLETED|Overall Study||4
2292473|NCT02078557|5629429|P1|STARTED|Overall Study||4
2292474|NCT02078492|5629438|P3|NOT COMPLETED|Overall Study||0
2292475|NCT02078492|5629439|P2|NOT COMPLETED|Overall Study||0
2292476|NCT02078492|5629440|P1|NOT COMPLETED|Overall Study||0
2292477|NCT02078492|5629438|P3|COMPLETED|Overall Study||80
2292478|NCT02078492|5629439|P2|COMPLETED|Overall Study||80
2292479|NCT02078492|5629440|P1|COMPLETED|Overall Study||80
2292480|NCT02078492|5629438|P3|STARTED|Overall Study||80
2292481|NCT02078492|5629439|P2|STARTED|Overall Study||80
2292482|NCT02078492|5629440|P1|STARTED|Overall Study||80
2292483|NCT02078219|5629462|P5|NOT COMPLETED|Overall Study||2
2292484|NCT02078219|5629463|P4|NOT COMPLETED|Overall Study||4
2292485|NCT02078219|5629464|P3|NOT COMPLETED|Overall Study||6
2292486|NCT02078219|5629465|P2|NOT COMPLETED|Overall Study||4
2292487|NCT02078219|5629466|P1|NOT COMPLETED|Overall Study||3
2292488|NCT02078219|5629462|P5|COMPLETED|Overall Study||39
2292489|NCT02078219|5629463|P4|COMPLETED|Overall Study||37
2292490|NCT02078219|5629464|P3|COMPLETED|Overall Study||35
2292491|NCT02078219|5629465|P2|COMPLETED|Overall Study||36
2292492|NCT02078219|5629466|P1|COMPLETED|Overall Study||38
2292493|NCT02078219|5629462|P5|STARTED|Overall Study||41
2292494|NCT02078219|5629463|P4|STARTED|Overall Study||41
2292495|NCT02078219|5629464|P3|STARTED|Overall Study||41
2292496|NCT02078219|5629465|P2|STARTED|Overall Study||40
2292497|NCT02078219|5629466|P1|STARTED|Overall Study||41
2292498|NCT02078193|5629493|P1|NOT COMPLETED|Overall Study||0
2292499|NCT02078193|5629493|P1|COMPLETED|Overall Study||3
2292500|NCT02078193|5629493|P1|STARTED|Overall Study||3
2292501|NCT02078180|5629499|P1|NOT COMPLETED|Overall Study||5
2292502|NCT02078180|5629499|P1|COMPLETED|Overall Study||29
2292503|NCT02078180|5629499|P1|XL 300|Overall Study||32
2292504|NCT02078180|5629499|P1|XL 150|Overall Study||31
2292505|NCT02078180|5629499|P1|SR150|Overall Study||32
2292506|NCT02078180|5629499|P1|SR100|Overall Study||31
2292507|NCT02078180|5629499|P1|IR100|Overall Study||31
2292508|NCT02078180|5629499|P1|IR75|Overall Study||30
2292509|NCT02078180|5629499|P1|STARTED|Overall Study||34
2292510|NCT02077374|5629516|P2|NOT COMPLETED|Overall Study||2
2292511|NCT02077374|5629517|P1|NOT COMPLETED|Overall Study||0
2292512|NCT02077374|5629516|P2|COMPLETED|Overall Study||17
2292513|NCT02077374|5629517|P1|COMPLETED|Overall Study||19
2292514|NCT02077374|5629516|P2|STARTED|Overall Study||19
2292515|NCT02077374|5629517|P1|STARTED|Overall Study||19
2292516|NCT02077140|5629538|P5|NOT COMPLETED|Overall Study||5
2292517|NCT02077140|5629539|P4|NOT COMPLETED|Overall Study||4
2292518|NCT02077140|5629540|P3|NOT COMPLETED|Overall Study||2
2292519|NCT02077140|5629541|P2|NOT COMPLETED|Overall Study||2
2292520|NCT02077140|5629542|P1|NOT COMPLETED|Overall Study||4
2292521|NCT02077140|5629538|P5|COMPLETED|Overall Study||43
2292522|NCT02077140|5629539|P4|COMPLETED|Overall Study||32
2292523|NCT02077140|5629540|P3|COMPLETED|Overall Study||34
2292524|NCT02077140|5629541|P2|COMPLETED|Overall Study||34
2292525|NCT02077140|5629542|P1|COMPLETED|Overall Study||32
2292526|NCT02077140|5629538|P5|STARTED|Overall Study||48
2292527|NCT02077140|5629539|P4|STARTED|Overall Study||36
2292528|NCT02077140|5629540|P3|STARTED|Overall Study||36
2292529|NCT02077140|5629541|P2|STARTED|Overall Study||36
2292530|NCT02077140|5629542|P1|STARTED|Overall Study||36
2292531|NCT02076919|5629641|P4|NOT COMPLETED|Overall Study||0
2292532|NCT02076919|5629642|P3|NOT COMPLETED|Overall Study||0
2292533|NCT02076919|5629643|P2|NOT COMPLETED|Overall Study||0
2292534|NCT02076919|5629644|P1|NOT COMPLETED|Overall Study||0
2292535|NCT02076919|5629641|P4|COMPLETED|Overall Study||12
2292536|NCT02076919|5629642|P3|COMPLETED|Overall Study||36
2292537|NCT02076919|5629643|P2|COMPLETED|Overall Study||8
2292538|NCT02076919|5629644|P1|COMPLETED|Overall Study||24
2292539|NCT02076919|5629641|P4|STARTED|Overall Study||12
2292540|NCT02076919|5629642|P3|STARTED|Overall Study||36
2292541|NCT02076919|5629643|P2|STARTED|Overall Study||8
2292542|NCT02076919|5629644|P1|STARTED|Overall Study||24
2292543|NCT02076776|5629745|P3|NOT COMPLETED|Overall Study||0
2292544|NCT02076776|5629746|P2|NOT COMPLETED|Overall Study||2
2292545|NCT02076776|5629747|P1|NOT COMPLETED|Overall Study||1
2292546|NCT02076776|5629745|P3|COMPLETED|Overall Study||6
2292547|NCT02076776|5629746|P2|COMPLETED|Overall Study||6
2292548|NCT02076776|5629747|P1|COMPLETED|Overall Study||5
2292549|NCT02076776|5629745|P3|STARTED|Overall Study||6
2292550|NCT02076776|5629746|P2|STARTED|Overall Study||8
2292551|NCT02076776|5629747|P1|STARTED|Overall Study||6
2292552|NCT02076425|5629763|P2|NOT COMPLETED|Overall Study||24
2292553|NCT02076425|5629764|P1|NOT COMPLETED|Overall Study||14
2292554|NCT02076425|5629763|P2|COMPLETED|Overall Study||91
2292555|NCT02076425|5629764|P1|COMPLETED|Overall Study||100
2292556|NCT02076425|5629763|P2|STARTED|Overall Study||115
2292557|NCT02076425|5629764|P1|STARTED|Overall Study||114
2292558|NCT02076412|5629776|P2|NOT COMPLETED|Overall Study||22
2292559|NCT02076412|5629777|P1|NOT COMPLETED|Overall Study||37
2292560|NCT02076412|5629776|P2|COMPLETED|Overall Study||2
2292561|NCT02076412|5629777|P1|COMPLETED|Overall Study||13
2292562|NCT02076412|5629776|P2|STARTED|Overall Study||24
2292563|NCT02076412|5629777|P1|STARTED|Overall Study||50
2292564|NCT02076399|5629797|P2|NOT COMPLETED|Overall Study||24
2292565|NCT02076399|5629798|P1|NOT COMPLETED|Overall Study||39
2292566|NCT02076399|5629797|P2|COMPLETED|Overall Study||1
2292567|NCT02076399|5629798|P1|COMPLETED|Overall Study||12
2292568|NCT02076399|5629797|P2|STARTED|Overall Study||25
2292569|NCT02076399|5629798|P1|STARTED|Overall Study||51
2292570|NCT02076334|5629820|P4|NOT COMPLETED|Overall Study||1
2292571|NCT02076334|5629821|P3|NOT COMPLETED|Overall Study||1
2292572|NCT02076334|5629822|P2|NOT COMPLETED|Overall Study||1
2292573|NCT02076334|5629823|P1|NOT COMPLETED|Overall Study||1
2292574|NCT02076334|5629820|P4|COMPLETED|Overall Study||20
2292575|NCT02076334|5629821|P3|COMPLETED|Overall Study||20
2292576|NCT02076334|5629822|P2|COMPLETED|Overall Study||20
2292577|NCT02076334|5629823|P1|COMPLETED|Overall Study||20
2292578|NCT02076334|5629820|P4|STARTED|Overall Study||21
2292579|NCT02076334|5629821|P3|STARTED|Overall Study||21
2292580|NCT02076334|5629822|P2|STARTED|Overall Study||21
2292581|NCT02076334|5629823|P1|STARTED|Overall Study||21
2292582|NCT02076321|5629839|P2|NOT COMPLETED|Overall Study||2
2292583|NCT02076321|5629840|P1|NOT COMPLETED|Overall Study||5
2292584|NCT02076321|5629839|P2|COMPLETED|Overall Study||49
2292585|NCT02076321|5629840|P1|COMPLETED|Overall Study||46
2292586|NCT02076321|5629839|P2|STARTED|Overall Study||51
2292587|NCT02076321|5629840|P1|STARTED|Overall Study||51
2292588|NCT02076243|5629846|P1|NOT COMPLETED|Overall Study||2
2292589|NCT02076243|5629846|P1|COMPLETED|Overall Study||0
2292590|NCT02076243|5629846|P1|STARTED|Overall Study||2
2292591|NCT02076178|5629856|P2|NOT COMPLETED|Injection Phase||7
2292592|NCT02076178|5629857|P1|NOT COMPLETED|Injection Phase||1
2292593|NCT02076178|5629856|P2|COMPLETED|Injection Phase||87
2292594|NCT02076178|5629857|P1|COMPLETED|Injection Phase||20
2292595|NCT02076178|5629856|P2|STARTED|Injection Phase||94
2292596|NCT02076178|5629857|P1|STARTED|Injection Phase||21
2292597|NCT02076178|5629856|P2|NOT COMPLETED|Oral Phase||12
2292598|NCT02076178|5629857|P1|NOT COMPLETED|Oral Phase||0
2292599|NCT02076178|5629856|P2|COMPLETED|Oral Phase||94
2292600|NCT02076178|5629857|P1|COMPLETED|Oral Phase||21
2292601|NCT02076178|5629856|P2|STARTED|Oral Phase||106
2292602|NCT02076178|5629857|P1|STARTED|Oral Phase||21
2292603|NCT02076165|5629891|P2|NOT COMPLETED|Overall Study||6
2292604|NCT02076165|5629892|P1|NOT COMPLETED|Overall Study||8
2292605|NCT02076165|5629891|P2|COMPLETED|Overall Study||69
2292606|NCT02076165|5629892|P1|COMPLETED|Overall Study||66
2292607|NCT02076165|5629891|P2|STARTED|Overall Study||75
2292608|NCT02076165|5629892|P1|STARTED|Overall Study||74
2292609|NCT02076100|5629923|P7|NOT COMPLETED|Overall Study||0
2292610|NCT02076100|5629924|P6|NOT COMPLETED|Overall Study||0
2292611|NCT02076100|5629925|P5|NOT COMPLETED|Overall Study||0
2292612|NCT02076100|5629926|P4|NOT COMPLETED|Overall Study||0
2292613|NCT02076100|5629927|P3|NOT COMPLETED|Overall Study||0
2292614|NCT02076100|5629928|P2|NOT COMPLETED|Overall Study||0
2292615|NCT02076100|5629929|P1|NOT COMPLETED|Overall Study||0
2292616|NCT02076100|5629923|P7|COMPLETED|Overall Study||4
2292617|NCT02076100|5629924|P6|COMPLETED|Overall Study||3
2292618|NCT02076100|5629925|P5|COMPLETED|Overall Study||3
2292619|NCT02076100|5629926|P4|COMPLETED|Overall Study||3
2292620|NCT02076100|5629927|P3|COMPLETED|Overall Study||3
2292621|NCT02076100|5629928|P2|COMPLETED|Overall Study||3
2292622|NCT02076100|5629929|P1|COMPLETED|Overall Study||3
2292623|NCT02076100|5629923|P7|STARTED|Overall Study||4
2292624|NCT02076100|5629924|P6|STARTED|Overall Study||3
2292625|NCT02076100|5629925|P5|STARTED|Overall Study||3
2292626|NCT02076100|5629926|P4|STARTED|Overall Study||3
2292627|NCT02076100|5629927|P3|STARTED|Overall Study||3
2292628|NCT02076100|5629928|P2|STARTED|Overall Study||3
2292629|NCT02076100|5629929|P1|STARTED|Overall Study||3
2292630|NCT02076022|5629962|P2|NOT COMPLETED|Overall Study||0
2292631|NCT02076022|5629963|P1|NOT COMPLETED|Overall Study||2
2292632|NCT02076022|5629962|P2|COMPLETED|Overall Study||3
2292633|NCT02076022|5629963|P1|COMPLETED|Overall Study||5
2292634|NCT02076022|5629962|P2|STARTED|Overall Study||3
2292635|NCT02076022|5629963|P1|STARTED|Overall Study||7
2292636|NCT02076009|5629975|P2|NOT COMPLETED|Overall Study||286
2292637|NCT02076009|5629976|P1|NOT COMPLETED|Overall Study||283
2292638|NCT02076009|5629975|P2|COMPLETED|Overall Study||0
2292639|NCT02076009|5629976|P1|COMPLETED|Overall Study||0
2292640|NCT02076009|5629975|P2|Treated|Overall Study||283
2292641|NCT02076009|5629976|P1|Treated|Overall Study||281
2292642|NCT02076009|5629975|P2|STARTED|Overall Study||286
2292643|NCT02076009|5629976|P1|STARTED|Overall Study||283
2292644|NCT02075840|5629998|P2|NOT COMPLETED|Overall Study||151
2292645|NCT02075840|5629999|P1|NOT COMPLETED|Overall Study||152
2292646|NCT02075840|5629998|P2|COMPLETED|Overall Study||0
2292647|NCT02075840|5629999|P1|COMPLETED|Overall Study||0
2292648|NCT02075840|5629998|P2|STARTED|Overall Study||151
2292649|NCT02075840|5629999|P1|STARTED|Overall Study||152
2292650|NCT02075658|5630055|P2|NOT COMPLETED|Overall Study||2
2292651|NCT02075658|5630056|P1|NOT COMPLETED|Overall Study||2
2292652|NCT02075658|5630055|P2|COMPLETED|Overall Study||28
2292653|NCT02075658|5630056|P1|COMPLETED|Overall Study||28
2292654|NCT02075658|5630055|P2|STARTED|Overall Study||30
2292655|NCT02075658|5630056|P1|STARTED|Overall Study||30
2292656|NCT02075632|5630066|P2|NOT COMPLETED|Overall Study||5
2292657|NCT02075632|5630067|P1|NOT COMPLETED|Overall Study||1
2292658|NCT02075632|5630066|P2|COMPLETED|Overall Study||143
2292659|NCT02075632|5630067|P1|COMPLETED|Overall Study||161
2292660|NCT02075632|5630066|P2|STARTED|Overall Study||148
2292661|NCT02075632|5630067|P1|STARTED|Overall Study||162
2292662|NCT02075606|5630077|P1|NOT COMPLETED|Overall Study||10
2292663|NCT02075606|5630077|P1|COMPLETED|Overall Study||40
2292664|NCT02075606|5630077|P1|STARTED|Overall Study||50
2292665|NCT02075541|5630101|P2|NOT COMPLETED|Overall Study||8
2292666|NCT02075541|5630102|P1|NOT COMPLETED|Overall Study||4
2292667|NCT02075541|5630101|P2|COMPLETED|Overall Study||64
2292668|NCT02075541|5630102|P1|COMPLETED|Overall Study||69
2292669|NCT02075541|5630101|P2|STARTED|Overall Study||72
2292670|NCT02075541|5630102|P1|STARTED|Overall Study||73
2292671|NCT02075515|5630151|P3|NOT COMPLETED|Overall Study||8
2292672|NCT02075515|5630152|P2|NOT COMPLETED|Overall Study||5
2292673|NCT02075515|5630153|P1|NOT COMPLETED|Overall Study||4
2292674|NCT02075515|5630151|P3|COMPLETED|Overall Study||208
2292675|NCT02075515|5630152|P2|COMPLETED|Overall Study||212
2292676|NCT02075515|5630153|P1|COMPLETED|Overall Study||214
2292677|NCT02075515|5630151|P3|STARTED|Overall Study||216
2292678|NCT02075515|5630152|P2|STARTED|Overall Study||217
2292679|NCT02075515|5630153|P1|STARTED|Overall Study||218
2292680|NCT02075463|5630188|P1|NOT COMPLETED|Overall Study||8
2292681|NCT02075463|5630188|P1|COMPLETED|Overall Study||7
2292682|NCT02075463|5630188|P1|STARTED|Overall Study||15
2292683|NCT02075411|5630217|P4|NOT COMPLETED|Overall Study||0
2292684|NCT02075411|5630218|P3|NOT COMPLETED|Overall Study||0
2292685|NCT02075411|5630219|P2|NOT COMPLETED|Overall Study||0
2292686|NCT02075411|5630220|P1|NOT COMPLETED|Overall Study||0
2292687|NCT02075411|5630217|P4|COMPLETED|Overall Study||1
2292688|NCT02075411|5630218|P3|COMPLETED|Overall Study||0
2292689|NCT02075411|5630219|P2|COMPLETED|Overall Study||0
2292690|NCT02075411|5630220|P1|COMPLETED|Overall Study||0
2292691|NCT02075411|5630217|P4|STARTED|Overall Study||1
2292692|NCT02075411|5630218|P3|STARTED|Overall Study||0
2292693|NCT02075411|5630219|P2|STARTED|Overall Study||0
2292694|NCT02075411|5630220|P1|STARTED|Overall Study||0
2292695|NCT02075320|5630238|P1|NOT COMPLETED|Overall Study||2
2292696|NCT02075320|5630238|P1|COMPLETED|Overall Study||48
2292697|NCT02075320|5630238|P1|STARTED|Overall Study||50
2292698|NCT02075255|5630248|P3|NOT COMPLETED|Overall Study||3
2292699|NCT02075255|5630249|P2|NOT COMPLETED|Overall Study||4
2292700|NCT02075255|5630250|P1|NOT COMPLETED|Overall Study||4
2292701|NCT02075255|5630248|P3|COMPLETED|Overall Study||72
2292702|NCT02075255|5630249|P2|COMPLETED|Overall Study||69
2292703|NCT02075255|5630250|P1|COMPLETED|Overall Study||68
2292704|NCT02075255|5630248|P3|STARTED|Overall Study||75
2292705|NCT02075255|5630249|P2|STARTED|Overall Study||73
2292706|NCT02075255|5630250|P1|STARTED|Overall Study||72
2292707|NCT02075203|5630360|P3|NOT COMPLETED|Overall Study||1
2292708|NCT02075203|5630361|P2|NOT COMPLETED|Overall Study||0
2292709|NCT02075203|5630362|P1|NOT COMPLETED|Overall Study||3
2292710|NCT02075203|5630360|P3|COMPLETED|Overall Study||328
2292711|NCT02075203|5630361|P2|COMPLETED|Overall Study||330
2292712|NCT02075203|5630362|P1|COMPLETED|Overall Study||327
2292713|NCT02075203|5630360|P3|STARTED|Overall Study||329
2292714|NCT02075203|5630361|P2|STARTED|Overall Study||330
2292715|NCT02075203|5630362|P1|STARTED|Overall Study||330
2292716|NCT02075125|5630381|P2|NOT COMPLETED|Overall Study||1
2292717|NCT02075125|5630382|P1|NOT COMPLETED|Overall Study||0
2292718|NCT02075125|5630381|P2|COMPLETED|Overall Study|One patient switched to clopidogrel treatment after 18 days of ticagrelor treatment.|19
2292719|NCT02075125|5630382|P1|COMPLETED|Overall Study||19
2292720|NCT02075125|5630381|P2|STARTED|Overall Study||20
2292721|NCT02075125|5630382|P1|STARTED|Overall Study||19
2292722|NCT02075073|5630403|P3|NOT COMPLETED|Overall Study||0
2292723|NCT02075073|5630404|P2|NOT COMPLETED|Overall Study||1
2292724|NCT02075073|5630405|P1|NOT COMPLETED|Overall Study||0
2292725|NCT02075073|5630403|P3|COMPLETED|Overall Study||36
2292726|NCT02075073|5630404|P2|COMPLETED|Overall Study||36
2292727|NCT02075073|5630405|P1|COMPLETED|Overall Study||36
2292728|NCT02075073|5630403|P3|STARTED|Overall Study||36
2292729|NCT02075073|5630404|P2|STARTED|Overall Study||37
2292730|NCT02075073|5630405|P1|STARTED|Overall Study||36
2292731|NCT02075021|5630422|P1|NOT COMPLETED|Overall Study||0
2292732|NCT02075021|5630422|P1|COMPLETED|Overall Study||3
2292733|NCT02075021|5630422|P1|STARTED|Overall Study||3
2292734|NCT02075008|5630427|P1|NOT COMPLETED|Overall Study||176
2292735|NCT02075008|5630427|P1|COMPLETED|Overall Study||94
2292736|NCT02075008|5630427|P1|STARTED|Overall Study||270
2292737|NCT02074995|5630431|P3|NOT COMPLETED|Overall Study||0
2292738|NCT02074995|5630432|P2|NOT COMPLETED|Overall Study||0
2292739|NCT02074995|5630433|P1|NOT COMPLETED|Overall Study||0
2292740|NCT02074995|5630431|P3|COMPLETED|Overall Study||0
2292741|NCT02074995|5630432|P2|COMPLETED|Overall Study||0
2292742|NCT02074995|5630433|P1|COMPLETED|Overall Study||1
2292743|NCT02074995|5630431|P3|STARTED|Overall Study||0
2292744|NCT02074995|5630432|P2|STARTED|Overall Study||0
2292745|NCT02074995|5630433|P1|STARTED|Overall Study||1
2292746|NCT02074982|5630450|P2|NOT COMPLETED|Overall Study||54
2292747|NCT02074982|5630451|P1|NOT COMPLETED|Overall Study||51
2292748|NCT02074982|5630450|P2|COMPLETED|Overall Study||285
2292749|NCT02074982|5630451|P1|COMPLETED|Overall Study||286
2292750|NCT02074982|5630450|P2|Safety Set (SF)|Overall Study||336
2292751|NCT02074982|5630451|P1|Safety Set (SF)|Overall Study||335
2292752|NCT02074982|5630450|P2|Full Analysis Set (FAS)|Overall Study||339
2292753|NCT02074982|5630451|P1|Full Analysis Set (FAS)|Overall Study||336
2292754|NCT02074982|5630450|P2|STARTED|Overall Study||339
2292755|NCT02074982|5630451|P1|STARTED|Overall Study||337
2292756|NCT02074904|5630463|P2|NOT COMPLETED|Overall Study||0
2292757|NCT02074904|5630464|P1|NOT COMPLETED|Overall Study||0
2292758|NCT02074904|5630463|P2|COMPLETED|Overall Study||0
2292759|NCT02074904|5630464|P1|COMPLETED|Overall Study||1
2292760|NCT02074904|5630463|P2|STARTED|Overall Study||0
2292761|NCT02074904|5630464|P1|STARTED|Overall Study||1
2292762|NCT02074735|5630480|P2|NOT COMPLETED|Overall Study||4
2292763|NCT02074735|5630481|P1|NOT COMPLETED|Overall Study||3
2292764|NCT02074735|5630480|P2|COMPLETED|Overall Study||29
2292765|NCT02074735|5630481|P1|COMPLETED|Overall Study||26
2292766|NCT02074735|5630480|P2|STARTED|Overall Study||33
2292767|NCT02074735|5630481|P1|STARTED|Overall Study||29
2292768|NCT02074709|5630489|P2|NOT COMPLETED|Overall Study||1
2292769|NCT02074709|5630490|P1|NOT COMPLETED|Overall Study||1
2292770|NCT02074709|5630489|P2|COMPLETED|Overall Study||29
2292771|NCT02074709|5630490|P1|COMPLETED|Overall Study||29
2292772|NCT02074709|5630489|P2|STARTED|Overall Study||30
2292773|NCT02074709|5630490|P1|STARTED|Overall Study||30
2292774|NCT02074553|5630498|P8|NOT COMPLETED|Intervention Period 4||0
2292775|NCT02074553|5630499|P7|NOT COMPLETED|Intervention Period 4||0
2292776|NCT02074553|5630500|P6|NOT COMPLETED|Intervention Period 4||0
2292777|NCT02074553|5630501|P5|NOT COMPLETED|Intervention Period 4||0
2292778|NCT02074553|5630502|P4|NOT COMPLETED|Intervention Period 4||0
2292779|NCT02074553|5630503|P3|NOT COMPLETED|Intervention Period 4||0
2292780|NCT02074553|5630504|P2|NOT COMPLETED|Intervention Period 4||0
2292781|NCT02074553|5630505|P1|NOT COMPLETED|Intervention Period 4||0
2292782|NCT02074553|5630498|P8|COMPLETED|Intervention Period 4||11
2292783|NCT02074553|5630499|P7|COMPLETED|Intervention Period 4||11
2292784|NCT02074553|5630500|P6|COMPLETED|Intervention Period 4||10
2292785|NCT02074553|5630501|P5|COMPLETED|Intervention Period 4||12
2292786|NCT02074553|5630502|P4|COMPLETED|Intervention Period 4||11
2292787|NCT02074553|5630503|P3|COMPLETED|Intervention Period 4||11
2292788|NCT02074553|5630504|P2|COMPLETED|Intervention Period 4||12
2292789|NCT02074553|5630505|P1|COMPLETED|Intervention Period 4||11
2292790|NCT02074553|5630498|P8|STARTED|Intervention Period 4||11
2292791|NCT02074553|5630499|P7|STARTED|Intervention Period 4||11
2292792|NCT02074553|5630500|P6|STARTED|Intervention Period 4||10
2292793|NCT02074553|5630501|P5|STARTED|Intervention Period 4||12
2292794|NCT02074553|5630502|P4|STARTED|Intervention Period 4||11
2292795|NCT02074553|5630503|P3|STARTED|Intervention Period 4||11
2292796|NCT02074553|5630504|P2|STARTED|Intervention Period 4||12
2292797|NCT02074553|5630505|P1|STARTED|Intervention Period 4||11
2292798|NCT02074553|5630498|P8|NOT COMPLETED|Washout Period 3||1
2292799|NCT02074553|5630499|P7|NOT COMPLETED|Washout Period 3||0
2292800|NCT02074553|5630500|P6|NOT COMPLETED|Washout Period 3||0
2292801|NCT02074553|5630501|P5|NOT COMPLETED|Washout Period 3||0
2292802|NCT02074553|5630502|P4|NOT COMPLETED|Washout Period 3||0
2292803|NCT02074553|5630503|P3|NOT COMPLETED|Washout Period 3||0
2292804|NCT02074553|5630504|P2|NOT COMPLETED|Washout Period 3||0
2292805|NCT02074553|5630505|P1|NOT COMPLETED|Washout Period 3||0
2292806|NCT02074553|5630498|P8|COMPLETED|Washout Period 3||11
2292807|NCT02074553|5630499|P7|COMPLETED|Washout Period 3||11
2292808|NCT02074553|5630500|P6|COMPLETED|Washout Period 3||10
2292809|NCT02074553|5630501|P5|COMPLETED|Washout Period 3||12
2292810|NCT02074553|5630502|P4|COMPLETED|Washout Period 3||11
2292811|NCT02074553|5630503|P3|COMPLETED|Washout Period 3||11
2292812|NCT02074553|5630504|P2|COMPLETED|Washout Period 3||12
2292813|NCT02074553|5630505|P1|COMPLETED|Washout Period 3||11
2292814|NCT02074553|5630498|P8|STARTED|Washout Period 3||12
2292815|NCT02074553|5630499|P7|STARTED|Washout Period 3||11
2292816|NCT02074553|5630500|P6|STARTED|Washout Period 3||10
2292817|NCT02074553|5630501|P5|STARTED|Washout Period 3||12
2292818|NCT02074553|5630502|P4|STARTED|Washout Period 3||11
2292819|NCT02074553|5630503|P3|STARTED|Washout Period 3||11
2292820|NCT02074553|5630504|P2|STARTED|Washout Period 3||12
2292821|NCT02074553|5630505|P1|STARTED|Washout Period 3||11
2292822|NCT02074553|5630498|P8|NOT COMPLETED|Intervention Period 3||0
2292823|NCT02074553|5630499|P7|NOT COMPLETED|Intervention Period 3||0
2292824|NCT02074553|5630500|P6|NOT COMPLETED|Intervention Period 3||0
2292825|NCT02074553|5630501|P5|NOT COMPLETED|Intervention Period 3||0
2292826|NCT02074553|5630502|P4|NOT COMPLETED|Intervention Period 3||0
2292827|NCT02074553|5630503|P3|NOT COMPLETED|Intervention Period 3||0
2292828|NCT02074553|5630504|P2|NOT COMPLETED|Intervention Period 3||0
2292829|NCT02074553|5630505|P1|NOT COMPLETED|Intervention Period 3||0
2292830|NCT02074553|5630498|P8|COMPLETED|Intervention Period 3||12
2292831|NCT02074553|5630499|P7|COMPLETED|Intervention Period 3||11
2292832|NCT02074553|5630500|P6|COMPLETED|Intervention Period 3||10
2292833|NCT02074553|5630501|P5|COMPLETED|Intervention Period 3||12
2292834|NCT02074553|5630502|P4|COMPLETED|Intervention Period 3||11
2292835|NCT02074553|5630503|P3|COMPLETED|Intervention Period 3||11
2292836|NCT02074553|5630504|P2|COMPLETED|Intervention Period 3||12
2292837|NCT02074553|5630505|P1|COMPLETED|Intervention Period 3||11
2292838|NCT02074553|5630498|P8|STARTED|Intervention Period 3||12
2292839|NCT02074553|5630499|P7|STARTED|Intervention Period 3||11
2292840|NCT02074553|5630500|P6|STARTED|Intervention Period 3||10
2292841|NCT02074553|5630501|P5|STARTED|Intervention Period 3||12
2292842|NCT02074553|5630502|P4|STARTED|Intervention Period 3||11
2292843|NCT02074553|5630503|P3|STARTED|Intervention Period 3||11
2292844|NCT02074553|5630504|P2|STARTED|Intervention Period 3||12
2292845|NCT02074553|5630505|P1|STARTED|Intervention Period 3||11
2292846|NCT02074553|5630498|P8|NOT COMPLETED|Washout Period 2||0
2292847|NCT02074553|5630499|P7|NOT COMPLETED|Washout Period 2||1
2292848|NCT02074553|5630500|P6|NOT COMPLETED|Washout Period 2||1
2292849|NCT02074553|5630501|P5|NOT COMPLETED|Washout Period 2||0
2292850|NCT02074553|5630502|P4|NOT COMPLETED|Washout Period 2||0
2292851|NCT02074553|5630503|P3|NOT COMPLETED|Washout Period 2||1
2292852|NCT02074553|5630504|P2|NOT COMPLETED|Washout Period 2||0
2292853|NCT02074553|5630505|P1|NOT COMPLETED|Washout Period 2||0
2292854|NCT02074553|5630498|P8|COMPLETED|Washout Period 2||12
2292855|NCT02074553|5630499|P7|COMPLETED|Washout Period 2||11
2292856|NCT02074553|5630500|P6|COMPLETED|Washout Period 2||10
2292857|NCT02074553|5630501|P5|COMPLETED|Washout Period 2||12
2292858|NCT02074553|5630502|P4|COMPLETED|Washout Period 2||11
2292859|NCT02074553|5630503|P3|COMPLETED|Washout Period 2||11
2292860|NCT02074553|5630504|P2|COMPLETED|Washout Period 2||12
2292861|NCT02074553|5630505|P1|COMPLETED|Washout Period 2||11
2292862|NCT02074553|5630498|P8|STARTED|Washout Period 2||12
2292863|NCT02074553|5630499|P7|STARTED|Washout Period 2||12
2292864|NCT02074553|5630500|P6|STARTED|Washout Period 2||11
2292865|NCT02074553|5630501|P5|STARTED|Washout Period 2||12
2292866|NCT02074553|5630502|P4|STARTED|Washout Period 2||11
2292867|NCT02074553|5630503|P3|STARTED|Washout Period 2||12
2292868|NCT02074553|5630504|P2|STARTED|Washout Period 2||12
2292869|NCT02074553|5630505|P1|STARTED|Washout Period 2||11
2292870|NCT02074553|5630498|P8|NOT COMPLETED|Intervention Period 2||0
2292871|NCT02074553|5630499|P7|NOT COMPLETED|Intervention Period 2||0
2292872|NCT02074553|5630500|P6|NOT COMPLETED|Intervention Period 2||0
2292873|NCT02074553|5630501|P5|NOT COMPLETED|Intervention Period 2||0
2292874|NCT02074553|5630502|P4|NOT COMPLETED|Intervention Period 2||0
2292875|NCT02074553|5630503|P3|NOT COMPLETED|Intervention Period 2||0
2292876|NCT02074553|5630504|P2|NOT COMPLETED|Intervention Period 2||0
2292877|NCT02074553|5630505|P1|NOT COMPLETED|Intervention Period 2||0
2292878|NCT02074553|5630498|P8|COMPLETED|Intervention Period 2||12
2292879|NCT02074553|5630499|P7|COMPLETED|Intervention Period 2||12
2292880|NCT02074553|5630500|P6|COMPLETED|Intervention Period 2||11
2292881|NCT02074553|5630501|P5|COMPLETED|Intervention Period 2||12
2292882|NCT02074553|5630502|P4|COMPLETED|Intervention Period 2||11
2292883|NCT02074553|5630503|P3|COMPLETED|Intervention Period 2||12
2292884|NCT02074553|5630504|P2|COMPLETED|Intervention Period 2||12
2292885|NCT02074553|5630505|P1|COMPLETED|Intervention Period 2||11
2292886|NCT02074553|5630498|P8|STARTED|Intervention Period 2||12
2292887|NCT02074553|5630499|P7|STARTED|Intervention Period 2||12
2292888|NCT02074553|5630500|P6|STARTED|Intervention Period 2||11
2292889|NCT02074553|5630501|P5|STARTED|Intervention Period 2||12
2292890|NCT02074553|5630502|P4|STARTED|Intervention Period 2||11
2292891|NCT02074553|5630503|P3|STARTED|Intervention Period 2||12
2292892|NCT02074553|5630504|P2|STARTED|Intervention Period 2||12
2292893|NCT02074553|5630505|P1|STARTED|Intervention Period 2||11
2292894|NCT02074553|5630498|P8|NOT COMPLETED|Washout Period 1||0
2292895|NCT02074553|5630499|P7|NOT COMPLETED|Washout Period 1||0
2292896|NCT02074553|5630500|P6|NOT COMPLETED|Washout Period 1||1
2292897|NCT02074553|5630501|P5|NOT COMPLETED|Washout Period 1||0
2292898|NCT02074553|5630502|P4|NOT COMPLETED|Washout Period 1||1
2292899|NCT02074553|5630503|P3|NOT COMPLETED|Washout Period 1||0
2292900|NCT02074553|5630504|P2|NOT COMPLETED|Washout Period 1||0
2292901|NCT02074553|5630505|P1|NOT COMPLETED|Washout Period 1||1
2292902|NCT02074553|5630498|P8|COMPLETED|Washout Period 1||12
2292903|NCT02074553|5630499|P7|COMPLETED|Washout Period 1||12
2292904|NCT02074553|5630500|P6|COMPLETED|Washout Period 1||11
2292905|NCT02074553|5630501|P5|COMPLETED|Washout Period 1||12
2292906|NCT02074553|5630502|P4|COMPLETED|Washout Period 1||11
2292907|NCT02074553|5630503|P3|COMPLETED|Washout Period 1||12
2292908|NCT02074553|5630504|P2|COMPLETED|Washout Period 1||12
2292909|NCT02074553|5630505|P1|COMPLETED|Washout Period 1||11
2292910|NCT02074553|5630498|P8|STARTED|Washout Period 1||12
2292911|NCT02074553|5630499|P7|STARTED|Washout Period 1||12
2292912|NCT02074553|5630500|P6|STARTED|Washout Period 1||12
2292913|NCT02074553|5630501|P5|STARTED|Washout Period 1||12
2292914|NCT02074553|5630502|P4|STARTED|Washout Period 1||12
2292915|NCT02074553|5630503|P3|STARTED|Washout Period 1||12
2292916|NCT02074553|5630504|P2|STARTED|Washout Period 1||12
2292917|NCT02074553|5630505|P1|STARTED|Washout Period 1||12
2292918|NCT02074553|5630498|P8|NOT COMPLETED|Intervention Period 1||0
2292919|NCT02074553|5630499|P7|NOT COMPLETED|Intervention Period 1||0
2292920|NCT02074553|5630500|P6|NOT COMPLETED|Intervention Period 1||0
2292921|NCT02074553|5630501|P5|NOT COMPLETED|Intervention Period 1||0
2292922|NCT02074553|5630502|P4|NOT COMPLETED|Intervention Period 1||1
2292923|NCT02074553|5630503|P3|NOT COMPLETED|Intervention Period 1||0
2292924|NCT02074553|5630504|P2|NOT COMPLETED|Intervention Period 1||0
2292925|NCT02074553|5630505|P1|NOT COMPLETED|Intervention Period 1||0
2292926|NCT02074553|5630498|P8|COMPLETED|Intervention Period 1||12
2292927|NCT02074553|5630499|P7|COMPLETED|Intervention Period 1||12
2292928|NCT02074553|5630500|P6|COMPLETED|Intervention Period 1||12
2292929|NCT02074553|5630501|P5|COMPLETED|Intervention Period 1||12
2292930|NCT02074553|5630502|P4|COMPLETED|Intervention Period 1||12
2292931|NCT02074553|5630503|P3|COMPLETED|Intervention Period 1||12
2292932|NCT02074553|5630504|P2|COMPLETED|Intervention Period 1||12
2292933|NCT02074553|5630505|P1|COMPLETED|Intervention Period 1||12
2292934|NCT02074553|5630498|P8|STARTED|Intervention Period 1||12
2292935|NCT02074553|5630499|P7|STARTED|Intervention Period 1||12
2292936|NCT02074553|5630500|P6|STARTED|Intervention Period 1||12
2292937|NCT02074553|5630501|P5|STARTED|Intervention Period 1||12
2292938|NCT02074553|5630502|P4|STARTED|Intervention Period 1||13
2292939|NCT02074553|5630503|P3|STARTED|Intervention Period 1||12
2292940|NCT02074553|5630504|P2|STARTED|Intervention Period 1||12
2292941|NCT02074553|5630505|P1|STARTED|Intervention Period 1||12
2292942|NCT02074514|5630687|P2|NOT COMPLETED|Overall Study||4
2292943|NCT02074514|5630688|P1|NOT COMPLETED|Overall Study||3
2292944|NCT02074514|5630687|P2|COMPLETED|Overall Study||54
2292945|NCT02074514|5630688|P1|COMPLETED|Overall Study||56
2292946|NCT02074514|5630687|P2|STARTED|Overall Study||58
2292947|NCT02074514|5630688|P1|STARTED|Overall Study||59
2292948|NCT02074384|5630709|P3|NOT COMPLETED|Overall Study||0
2292949|NCT02074384|5630710|P2|NOT COMPLETED|Overall Study||0
2292950|NCT02074384|5630711|P1|NOT COMPLETED|Overall Study||0
2292951|NCT02074384|5630709|P3|COMPLETED|Overall Study||17
2292952|NCT02074384|5630710|P2|COMPLETED|Overall Study||70
2292953|NCT02074384|5630711|P1|COMPLETED|Overall Study||74
2292954|NCT02074384|5630709|P3|STARTED|Overall Study||17
2292955|NCT02074384|5630710|P2|STARTED|Overall Study||70
2292956|NCT02074384|5630711|P1|STARTED|Overall Study||74
2292957|NCT02074358|5630719|P6|NOT COMPLETED|Overall Study||0
2292958|NCT02074358|5630720|P5|NOT COMPLETED|Overall Study||0
2292959|NCT02074358|5630721|P4|NOT COMPLETED|Overall Study||0
2292960|NCT02074358|5630722|P3|NOT COMPLETED|Overall Study||0
2292961|NCT02074358|5630723|P2|NOT COMPLETED|Overall Study||0
2292962|NCT02074358|5630724|P1|NOT COMPLETED|Overall Study||0
2292963|NCT02074358|5630719|P6|COMPLETED|Overall Study||2
2292964|NCT02074358|5630720|P5|COMPLETED|Overall Study||3
2292965|NCT02074358|5630721|P4|COMPLETED|Overall Study||2
2292966|NCT02074358|5630722|P3|COMPLETED|Overall Study||2
2292967|NCT02074358|5630723|P2|COMPLETED|Overall Study||3
2292968|NCT02074358|5630724|P1|COMPLETED|Overall Study||3
2292969|NCT02074358|5630719|P6|STARTED|Overall Study||2
2292970|NCT02074358|5630720|P5|STARTED|Overall Study||3
2292971|NCT02074358|5630721|P4|STARTED|Overall Study||2
2292972|NCT02074358|5630722|P3|STARTED|Overall Study||2
2292973|NCT02074358|5630723|P2|STARTED|Overall Study||3
2292974|NCT02074358|5630724|P1|STARTED|Overall Study||3
2292975|NCT02074345|5630813|P1|NOT COMPLETED|Overall Study||0
2292976|NCT02074345|5630813|P1|COMPLETED|Overall Study||31
2292977|NCT02074345|5630813|P1|STARTED|Overall Study||31
2292978|NCT02074059|5630829|P6|NOT COMPLETED|Overall Study||1
2292979|NCT02074059|5630830|P5|NOT COMPLETED|Overall Study||1
2292980|NCT02074059|5630831|P4|NOT COMPLETED|Overall Study||0
2292981|NCT02074059|5630832|P3|NOT COMPLETED|Overall Study||0
2292982|NCT02074059|5630833|P2|NOT COMPLETED|Overall Study||0
2292983|NCT02074059|5630834|P1|NOT COMPLETED|Overall Study||0
2292984|NCT02074059|5630829|P6|COMPLETED|Overall Study||39
2292985|NCT02074059|5630830|P5|COMPLETED|Overall Study||7
2292986|NCT02074059|5630831|P4|COMPLETED|Overall Study||8
2292987|NCT02074059|5630832|P3|COMPLETED|Overall Study||8
2292988|NCT02074059|5630833|P2|COMPLETED|Overall Study||8
2292989|NCT02074059|5630834|P1|COMPLETED|Overall Study||8
2292990|NCT02074059|5630829|P6|STARTED|Overall Study||40
2292991|NCT02074059|5630830|P5|STARTED|Overall Study||8
2292992|NCT02074059|5630831|P4|STARTED|Overall Study||8
2292993|NCT02074059|5630832|P3|STARTED|Overall Study||8
2292994|NCT02074059|5630833|P2|STARTED|Overall Study||8
2292995|NCT02074059|5630834|P1|STARTED|Overall Study||8
2292996|NCT02073968|5630872|P1|NOT COMPLETED|Overall Study||0
2292997|NCT02073968|5630872|P1|COMPLETED|Overall Study||35
2292998|NCT02073968|5630872|P1|STARTED|Overall Study||35
2292999|NCT02073929|5630878|P2|NOT COMPLETED|Overall Study||3
2293000|NCT02073929|5630879|P1|NOT COMPLETED|Overall Study||4
2293001|NCT02073929|5630878|P2|COMPLETED|Overall Study||21
2293002|NCT02073929|5630879|P1|COMPLETED|Overall Study||44
2293003|NCT02073929|5630878|P2|STARTED|Overall Study||24
2293004|NCT02073929|5630879|P1|STARTED|Overall Study||48
2293005|NCT02073747|5630907|P2|NOT COMPLETED|Overall Study||1
2293006|NCT02073747|5630908|P1|NOT COMPLETED|Overall Study||1
2293007|NCT02073747|5630907|P2|COMPLETED|Overall Study||14
2293008|NCT02073747|5630908|P1|COMPLETED|Overall Study||14
2293009|NCT02073747|5630907|P2|STARTED|Overall Study||15
2293010|NCT02073747|5630908|P1|STARTED|Overall Study||15
2293011|NCT02073682|5630916|P2|NOT COMPLETED|Overall Study||370
2293012|NCT02073682|5630917|P1|NOT COMPLETED|Overall Study||322
2293013|NCT02073682|5630916|P2|COMPLETED|Overall Study||154
2293014|NCT02073682|5630917|P1|COMPLETED|Overall Study||200
2293015|NCT02073682|5630916|P2|STARTED|Overall Study||524
2293016|NCT02073682|5630917|P1|STARTED|Overall Study||522
2293017|NCT02073656|5630935|P1|NOT COMPLETED|Retreatment Substudy||0
2293018|NCT02073656|5630935|P1|COMPLETED|Retreatment Substudy||9
2293019|NCT02073656|5630935|P1|STARTED|Retreatment Substudy|Only participants experiencing virologic relapse in the Primary Study were eligible for retreatment.|9
2293020|NCT02073656|5630935|P1|NOT COMPLETED|Primary Study||8
2293021|NCT02073656|5630935|P1|COMPLETED|Primary Study||327
2293022|NCT02073656|5630935|P1|STARTED|Primary Study||335
2293023|NCT02073643|5630951|P1|NOT COMPLETED|Overall Study||24
2293024|NCT02073643|5630951|P1|COMPLETED|Overall Study||180
2293025|NCT02073643|5630951|P1|STARTED|Overall Study||204
2293026|NCT02073565|5630962|P2|NOT COMPLETED|Cohort C||4
2293027|NCT02073565|5630963|P1|NOT COMPLETED|Cohort C||0
2293028|NCT02073565|5630962|P2|COMPLETED|Cohort C||211
2293029|NCT02073565|5630963|P1|COMPLETED|Cohort C||217
2293030|NCT02073565|5630962|P2|STARTED|Cohort C||215
2293031|NCT02073565|5630963|P1|STARTED|Cohort C||217
2293032|NCT02073565|5630962|P2|NOT COMPLETED|Cohort B||2
2293033|NCT02073565|5630963|P1|NOT COMPLETED|Cohort B||1
2293034|NCT02073565|5630962|P2|COMPLETED|Cohort B||54
2293035|NCT02073565|5630963|P1|COMPLETED|Cohort B||53
2293036|NCT02073565|5630962|P2|STARTED|Cohort B||56
2293037|NCT02073565|5630963|P1|STARTED|Cohort B||54
2293038|NCT02073565|5630962|P2|NOT COMPLETED|Cohort A||0
2293039|NCT02073565|5630963|P1|NOT COMPLETED|Cohort A||1
2293040|NCT02073565|5630962|P2|COMPLETED|Cohort A||14
2293041|NCT02073565|5630963|P1|COMPLETED|Cohort A||15
2293042|NCT02073565|5630962|P2|STARTED|Cohort A||14
2293043|NCT02073565|5630963|P1|STARTED|Cohort A||16
2293044|NCT02073565|5630962|P2|NOT COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||6
2293045|NCT02073565|5630963|P1|NOT COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||2
2293046|NCT02073565|5630962|P2|COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||279
2293047|NCT02073565|5630963|P1|COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||285
2293048|NCT02073565|5630962|P2|STARTED|Intention-To-Treat Subjects-Cohorts AB&C||285
2293049|NCT02073565|5630963|P1|STARTED|Intention-To-Treat Subjects-Cohorts AB&C||287
2293050|NCT02073461|5630978|P3|NOT COMPLETED|Overall Study||1
2293051|NCT02073461|5630979|P2|NOT COMPLETED|Overall Study||1
2293052|NCT02073461|5630980|P1|NOT COMPLETED|Overall Study||4
2293053|NCT02073461|5630978|P3|COMPLETED|Overall Study||78
2293054|NCT02073461|5630979|P2|COMPLETED|Overall Study||77
2293055|NCT02073461|5630980|P1|COMPLETED|Overall Study||75
2293056|NCT02073461|5630978|P3|STARTED|Overall Study||79
2293057|NCT02073461|5630979|P2|STARTED|Overall Study||78
2293058|NCT02073461|5630980|P1|STARTED|Overall Study||79
2293059|NCT02073448|5631009|P3|NOT COMPLETED|Overall Study||5
2293060|NCT02073448|5631010|P2|NOT COMPLETED|Overall Study||12
2293061|NCT02073448|5631011|P1|NOT COMPLETED|Overall Study||2
2293062|NCT02073448|5631009|P3|COMPLETED|Overall Study||99
2293063|NCT02073448|5631010|P2|COMPLETED|Overall Study||200
2293064|NCT02073448|5631011|P1|COMPLETED|Overall Study||99
2293065|NCT02073448|5631009|P3|STARTED|Overall Study||104
2293066|NCT02073448|5631010|P2|STARTED|Overall Study||212
2293067|NCT02073448|5631011|P1|STARTED|Overall Study||101
2293068|NCT02073435|5631039|P2|NOT COMPLETED|Overall Study||0
2293069|NCT02073435|5631040|P1|NOT COMPLETED|Overall Study||0
2293070|NCT02073435|5631039|P2|COMPLETED|Overall Study||96
2293071|NCT02073435|5631040|P1|COMPLETED|Overall Study||81
2293072|NCT02073435|5631039|P2|STARTED|Overall Study||96
2293073|NCT02073435|5631040|P1|STARTED|Overall Study||81
2293074|NCT02073331|5631048|P1|NOT COMPLETED|Overall Study||0
2293075|NCT02073331|5631048|P1|COMPLETED|Overall Study||1420
2293076|NCT02073331|5631048|P1|STARTED|Overall Study||1420
2293077|NCT02073162|5631054|P2|NOT COMPLETED|Overall Study||11
2293078|NCT02073162|5631055|P1|NOT COMPLETED|Overall Study||6
2293079|NCT02073162|5631054|P2|COMPLETED|Overall Study||1490
2293080|NCT02073162|5631055|P1|COMPLETED|Overall Study||1493
2293081|NCT02073162|5631054|P2|STARTED|Overall Study||1501
2293082|NCT02073162|5631055|P1|STARTED|Overall Study||1499
2293083|NCT02072980|5631083|P2|NOT COMPLETED|Period 2, Second Wear||1
2293084|NCT02072980|5631084|P1|NOT COMPLETED|Period 2, Second Wear||0
2293085|NCT02072980|5631083|P2|COMPLETED|Period 2, Second Wear||7
2293086|NCT02072980|5631084|P1|COMPLETED|Period 2, Second Wear||7
2293087|NCT02072980|5631083|P2|STARTED|Period 2, Second Wear||8
2293088|NCT02072980|5631084|P1|STARTED|Period 2, Second Wear||7
2293089|NCT02072980|5631083|P2|NOT COMPLETED|Period 1, First Wear||0
2293090|NCT02072980|5631084|P1|NOT COMPLETED|Period 1, First Wear||0
2293091|NCT02072980|5631083|P2|COMPLETED|Period 1, First Wear||8
2293092|NCT02072980|5631084|P1|COMPLETED|Period 1, First Wear||7
2293093|NCT02072980|5631083|P2|STARTED|Period 1, First Wear||8
2293094|NCT02072980|5631084|P1|STARTED|Period 1, First Wear||7
2293095|NCT02072941|5631092|P2|NOT COMPLETED|Overall Study||29
2293096|NCT02072941|5631093|P1|NOT COMPLETED|Overall Study||38
2293097|NCT02072941|5631092|P2|COMPLETED|Overall Study||197
2293098|NCT02072941|5631093|P1|COMPLETED|Overall Study||181
2293099|NCT02072941|5631092|P2|STARTED|Overall Study||226
2293100|NCT02072941|5631093|P1|STARTED|Overall Study||219
2293101|NCT02072928|5631101|P1|NOT COMPLETED|Overall Study||0
2293102|NCT02072928|5631101|P1|COMPLETED|Overall Study||55
2293103|NCT02072928|5631101|P1|STARTED|Overall Study||55
2293104|NCT02072824|5631108|P3|NOT COMPLETED|Overall Study||3
2293105|NCT02072824|5631109|P2|NOT COMPLETED|Overall Study||1
2293106|NCT02072824|5631110|P1|NOT COMPLETED|Overall Study||2
2293107|NCT02072824|5631108|P3|COMPLETED|Overall Study||67
2293108|NCT02072824|5631109|P2|COMPLETED|Overall Study||33
2293109|NCT02072824|5631110|P1|COMPLETED|Overall Study||69
2293110|NCT02072824|5631108|P3|STARTED|Overall Study||70
2293111|NCT02072824|5631109|P2|STARTED|Overall Study||34
2293112|NCT02072824|5631110|P1|STARTED|Overall Study||71
2293113|NCT02072434|5631147|P2|NOT COMPLETED|Overall Study||90
2293114|NCT02072434|5631148|P1|NOT COMPLETED|Overall Study||54
2293115|NCT02072434|5631147|P2|COMPLETED|Overall Study||1014
2293116|NCT02072434|5631148|P1|COMPLETED|Overall Study||1041
2293117|NCT02072434|5631147|P2|Safety Analysis Set|Overall Study||1082
2293118|NCT02072434|5631148|P1|Safety Analysis Set|Overall Study||1067
2293119|NCT02072434|5631147|P2|Received Study Drug|Overall Study||1082
2293120|NCT02072434|5631148|P1|Received Study Drug|Overall Study||1067
2293121|NCT02072434|5631147|P2|Intent to Treat Analysis Set|Overall Study||1104
2293122|NCT02072434|5631148|P1|Intent to Treat Analysis Set|Overall Study||1095
2293123|NCT02072434|5631147|P2|STARTED|Overall Study||1104
2293124|NCT02072434|5631148|P1|STARTED|Overall Study||1095
2293125|NCT02072421|5631158|P1|NOT COMPLETED|Overall Study||390
2293126|NCT02072421|5631158|P1|COMPLETED|Overall Study||2489
2293127|NCT02072421|5631158|P1|STARTED|Overall Study||2879
2293128|NCT02072226|5631168|P2|NOT COMPLETED|Overall Study||10
2293129|NCT02072226|5631169|P1|NOT COMPLETED|Overall Study||15
2293130|NCT02072226|5631168|P2|COMPLETED|Overall Study||147
2293131|NCT02072226|5631169|P1|COMPLETED|Overall Study||141
2293132|NCT02072226|5631168|P2|STARTED|Overall Study||157
2293133|NCT02072226|5631169|P1|STARTED|Overall Study||156
2293134|NCT02072200|5631191|P1|NOT COMPLETED|Overall Study||2
2293135|NCT02072200|5631191|P1|COMPLETED|Overall Study||145
2293136|NCT02072200|5631191|P1|STARTED|Overall Study||147
2293137|NCT02072174|5631199|P2|NOT COMPLETED|Overall Study||39
2293138|NCT02072174|5631200|P1|NOT COMPLETED|Overall Study||32
2293139|NCT02072174|5631199|P2|COMPLETED|Overall Study||240
2293140|NCT02072174|5631200|P1|COMPLETED|Overall Study||258
2293141|NCT02072174|5631199|P2|STARTED|Overall Study||279
2293142|NCT02072174|5631200|P1|STARTED|Overall Study||290
2293143|NCT02072096|5631224|P2|NOT COMPLETED|Overall Study||78
2293144|NCT02072096|5631225|P1|NOT COMPLETED|Overall Study||85
2293145|NCT02072096|5631224|P2|COMPLETED|Overall Study||15
2293146|NCT02072096|5631225|P1|COMPLETED|Overall Study||14
2293147|NCT02072096|5631224|P2|Received at Least One Dose of Study Drug|Overall Study||93
2293148|NCT02072096|5631225|P1|Received at Least One Dose of Study Drug|Overall Study||98
2293149|NCT02072096|5631224|P2|STARTED|Overall Study||93
2293150|NCT02072096|5631225|P1|STARTED|Overall Study||99
2293151|NCT02071849|5631247|P1|NOT COMPLETED|2-year Extended Follow-up||1
2293152|NCT02071849|5631247|P1|COMPLETED|2-year Extended Follow-up||14
2293153|NCT02071849|5631247|P1|STARTED|2-year Extended Follow-up||15
2293154|NCT02071849|5631247|P1|NOT COMPLETED|6-month Primary Endpoint||5
2293155|NCT02071849|5631247|P1|COMPLETED|6-month Primary Endpoint||15
2293156|NCT02071849|5631247|P1|STARTED|6-month Primary Endpoint||20
2293157|NCT02071823|5631281|P2|NOT COMPLETED|Overall Study||0
2293158|NCT02071823|5631282|P1|NOT COMPLETED|Overall Study||1
2293159|NCT02071823|5631281|P2|COMPLETED|Overall Study||6
2293160|NCT02071823|5631282|P1|COMPLETED|Overall Study||5
2293161|NCT02071823|5631281|P2|STARTED|Overall Study||6
2293162|NCT02071823|5631282|P1|STARTED|Overall Study||6
2293163|NCT02071810|5631297|P5|NOT COMPLETED|Overall Study||1
2293164|NCT02071810|5631298|P4|NOT COMPLETED|Overall Study||1
2293165|NCT02071810|5631299|P3|NOT COMPLETED|Overall Study||0
2293166|NCT02071810|5631300|P2|NOT COMPLETED|Overall Study||0
2293167|NCT02071810|5631301|P1|NOT COMPLETED|Overall Study||0
2293168|NCT02071810|5631297|P5|COMPLETED|Overall Study||8
2293169|NCT02071810|5631298|P4|COMPLETED|Overall Study||6
2293170|NCT02071810|5631299|P3|COMPLETED|Overall Study||6
2293171|NCT02071810|5631300|P2|COMPLETED|Overall Study||6
2293172|NCT02071810|5631301|P1|COMPLETED|Overall Study||6
2293173|NCT02071810|5631297|P5|STARTED|Overall Study||9
2293174|NCT02071810|5631298|P4|STARTED|Overall Study||7
2293175|NCT02071810|5631299|P3|STARTED|Overall Study||6
2293176|NCT02071810|5631300|P2|STARTED|Overall Study||6
2293177|NCT02071810|5631301|P1|STARTED|Overall Study||6
2293178|NCT02071771|5631313|P2|NOT COMPLETED|Period 2: Second 10 Days||0
2293179|NCT02071771|5631314|P1|NOT COMPLETED|Period 2: Second 10 Days||0
2293180|NCT02071771|5631313|P2|COMPLETED|Period 2: Second 10 Days||38
2293181|NCT02071771|5631314|P1|COMPLETED|Period 2: Second 10 Days||39
2293182|NCT02071771|5631313|P2|STARTED|Period 2: Second 10 Days|One participant completed Period 1 but did not start Period 2 due to unacceptable fit with DACP T.|38
2293183|NCT02071771|5631314|P1|STARTED|Period 2: Second 10 Days||39
2293184|NCT02071771|5631313|P2|NOT COMPLETED|Period 1: First 10 Days||0
2293185|NCT02071771|5631314|P1|NOT COMPLETED|Period 1: First 10 Days||2
2293186|NCT02071771|5631313|P2|COMPLETED|Period 1: First 10 Days||39
2293187|NCT02071771|5631314|P1|COMPLETED|Period 1: First 10 Days||39
2293188|NCT02071771|5631313|P2|Dispensed|Period 1: First 10 Days||39
2293189|NCT02071771|5631314|P1|Dispensed|Period 1: First 10 Days||39
2293190|NCT02071771|5631313|P2|STARTED|Period 1: First 10 Days||39
2293191|NCT02071771|5631314|P1|STARTED|Period 1: First 10 Days||41
2293192|NCT02071706|5631322|P1|NOT COMPLETED|Overall Study||3
2293193|NCT02071706|5631322|P1|COMPLETED|Overall Study||59
2293194|NCT02071706|5631322|P1|STARTED|Overall Study||62
2293195|NCT02071420|5631329|P2|NOT COMPLETED|Overall Study||3
2293196|NCT02071420|5631330|P1|NOT COMPLETED|Overall Study||3
2293197|NCT02071420|5631329|P2|COMPLETED|Overall Study||27
2293198|NCT02071420|5631330|P1|COMPLETED|Overall Study||27
2293199|NCT02071420|5631329|P2|STARTED|Overall Study||30
2293200|NCT02071420|5631330|P1|STARTED|Overall Study||30
2293201|NCT02071290|5631338|P2|NOT COMPLETED|Overall Study||7
2293202|NCT02071290|5631339|P1|NOT COMPLETED|Overall Study||4
2293203|NCT02071290|5631338|P2|COMPLETED|Overall Study||18
2293204|NCT02071290|5631339|P1|COMPLETED|Overall Study||21
2293205|NCT02071290|5631338|P2|STARTED|Overall Study||25
2293206|NCT02071290|5631339|P1|STARTED|Overall Study||25
2293207|NCT02071225|5631393|P1|NOT COMPLETED|Overall Study||30
2293208|NCT02071225|5631393|P1|COMPLETED|Overall Study||42
2293209|NCT02071225|5631393|P1|STARTED|Overall Study||72
2293210|NCT02071108|5631411|P1|NOT COMPLETED|Overall Study||0
2293211|NCT02071108|5631411|P1|COMPLETED|Overall Study||35
2293212|NCT02071108|5631411|P1|STARTED|Overall Study||35
2293213|NCT02071095|5631432|P2|NOT COMPLETED|Overall Study||0
2293214|NCT02071095|5631433|P1|NOT COMPLETED|Overall Study||0
2293215|NCT02071095|5631432|P2|COMPLETED|Overall Study||3
2293216|NCT02071095|5631433|P1|COMPLETED|Overall Study||12
2293217|NCT02071095|5631432|P2|STARTED|Overall Study||3
2293218|NCT02071095|5631433|P1|STARTED|Overall Study||12
2293219|NCT02071082|5631449|P2|NOT COMPLETED|Overall Study||7
2293220|NCT02071082|5631450|P1|NOT COMPLETED|Overall Study||2
2293221|NCT02071082|5631449|P2|COMPLETED|Overall Study||68
2293222|NCT02071082|5631450|P1|COMPLETED|Overall Study||2
2293223|NCT02071082|5631449|P2|STARTED|Overall Study||75
2293224|NCT02071082|5631450|P1|STARTED|Overall Study||4
2293225|NCT02070991|5631480|P2|NOT COMPLETED|Overall Study||0
2293226|NCT02070991|5631481|P1|NOT COMPLETED|Overall Study||3
2293227|NCT02070991|5631480|P2|COMPLETED|Overall Study||32
2293228|NCT02070991|5631481|P1|COMPLETED|Overall Study||28
2293229|NCT02070991|5631480|P2|STARTED|Overall Study||32
2293230|NCT02070991|5631481|P1|STARTED|Overall Study||31
2293231|NCT02070978|5631504|P3|NOT COMPLETED|Overall Study||53
2293232|NCT02070978|5631505|P2|NOT COMPLETED|Overall Study||53
2293233|NCT02070978|5631506|P1|NOT COMPLETED|Overall Study||47
2293234|NCT02070978|5631504|P3|COMPLETED|Overall Study||35
2293235|NCT02070978|5631505|P2|COMPLETED|Overall Study||29
2293236|NCT02070978|5631506|P1|COMPLETED|Overall Study||36
2293237|NCT02070978|5631504|P3|STARTED|Overall Study||88
2293238|NCT02070978|5631505|P2|STARTED|Overall Study||82
2293239|NCT02070978|5631506|P1|STARTED|Overall Study||83
2293240|NCT02070965|5631568|P3|NOT COMPLETED|Overall Study||1
2293241|NCT02070965|5631569|P2|NOT COMPLETED|Overall Study||2
2293242|NCT02070965|5631570|P1|NOT COMPLETED|Overall Study||2
2293243|NCT02070965|5631568|P3|COMPLETED|Overall Study||24
2293244|NCT02070965|5631569|P2|COMPLETED|Overall Study||21
2293245|NCT02070965|5631570|P1|COMPLETED|Overall Study||25
2293246|NCT02070965|5631568|P3|STARTED|Overall Study||25
2293247|NCT02070965|5631569|P2|STARTED|Overall Study||23
2293248|NCT02070965|5631570|P1|STARTED|Overall Study||27
2293249|NCT02070757|5631580|P2|NOT COMPLETED|Overall Study||114
2293250|NCT02070757|5631581|P1|NOT COMPLETED|Overall Study||117
2293251|NCT02070757|5631580|P2|COMPLETED|Overall Study||250
2293252|NCT02070757|5631581|P1|COMPLETED|Overall Study||245
2293253|NCT02070757|5631580|P2|Treated Participants|Overall Study||359
2293254|NCT02070757|5631581|P1|Treated Participants|Overall Study||361
2293255|NCT02070757|5631580|P2|STARTED|Overall Study||364
2293256|NCT02070757|5631581|P1|STARTED|Overall Study||362
2293257|NCT02070744|5631615|P5|NOT COMPLETED|OLE Phase (48 Weeks)||3
2293258|NCT02070744|5631616|P4|NOT COMPLETED|OLE Phase (48 Weeks)||0
2293259|NCT02070744|5631617|P3|NOT COMPLETED|OLE Phase (48 Weeks)||0
2293260|NCT02070744|5631618|P2|NOT COMPLETED|OLE Phase (48 Weeks)||0
2293261|NCT02070744|5631619|P1|NOT COMPLETED|OLE Phase (48 Weeks)||0
2293262|NCT02070744|5631615|P5|COMPLETED|OLE Phase (48 Weeks)||24
2293263|NCT02070744|5631616|P4|COMPLETED|OLE Phase (48 Weeks)||0
2293264|NCT02070744|5631617|P3|COMPLETED|OLE Phase (48 Weeks)||0
2293265|NCT02070744|5631618|P2|COMPLETED|OLE Phase (48 Weeks)||0
2293266|NCT02070744|5631619|P1|COMPLETED|OLE Phase (48 Weeks)||0
2293267|NCT02070744|5631615|P5|STARTED|OLE Phase (48 Weeks)|12 participants completed PC phase, but did not enter OLE phase.|27
2293268|NCT02070744|5631616|P4|STARTED|OLE Phase (48 Weeks)||0
2293269|NCT02070744|5631617|P3|STARTED|OLE Phase (48 Weeks)||0
2293270|NCT02070744|5631618|P2|STARTED|OLE Phase (48 Weeks)||0
2293271|NCT02070744|5631619|P1|STARTED|OLE Phase (48 Weeks)||0
2293272|NCT02070744|5631615|P5|NOT COMPLETED|PC Phase (12 Weeks)||0
2293273|NCT02070744|5631616|P4|NOT COMPLETED|PC Phase (12 Weeks)||1
2293274|NCT02070744|5631617|P3|NOT COMPLETED|PC Phase (12 Weeks)||0
2293275|NCT02070744|5631618|P2|NOT COMPLETED|PC Phase (12 Weeks)||0
2293276|NCT02070744|5631619|P1|NOT COMPLETED|PC Phase (12 Weeks)||0
2293277|NCT02070744|5631615|P5|COMPLETED|PC Phase (12 Weeks)||0
2293278|NCT02070744|5631616|P4|COMPLETED|PC Phase (12 Weeks)||13
2293279|NCT02070744|5631617|P3|COMPLETED|PC Phase (12 Weeks)||15
2293280|NCT02070744|5631618|P2|COMPLETED|PC Phase (12 Weeks)||5
2293281|NCT02070744|5631619|P1|COMPLETED|PC Phase (12 Weeks)||6
2293282|NCT02070744|5631615|P5|Treated|PC Phase (12 Weeks)||0
2293283|NCT02070744|5631616|P4|Treated|PC Phase (12 Weeks)||13
2293284|NCT02070744|5631617|P3|Treated|PC Phase (12 Weeks)||15
2293285|NCT02070744|5631618|P2|Treated|PC Phase (12 Weeks)||5
2293286|NCT02070744|5631619|P1|Treated|PC Phase (12 Weeks)||6
2293287|NCT02070744|5631615|P5|STARTED|PC Phase (12 Weeks)||0
2293288|NCT02070744|5631616|P4|STARTED|PC Phase (12 Weeks)||14
2293289|NCT02070744|5631617|P3|STARTED|PC Phase (12 Weeks)||15
2293290|NCT02070744|5631618|P2|STARTED|PC Phase (12 Weeks)||5
2293291|NCT02070744|5631619|P1|STARTED|PC Phase (12 Weeks)||6
2293292|NCT02070692|5631671|P2|NOT COMPLETED|Overall Study||12
2293293|NCT02070692|5631672|P1|NOT COMPLETED|Overall Study||10
2293294|NCT02070692|5631671|P2|COMPLETED|Overall Study||16
2293295|NCT02070692|5631672|P1|COMPLETED|Overall Study||18
2293296|NCT02070692|5631671|P2|STARTED|Overall Study||28
2293297|NCT02070692|5631672|P1|STARTED|Overall Study||28
2293298|NCT02070640|5631688|P2|NOT COMPLETED|Overall Study||0
2293299|NCT02070640|5631689|P1|NOT COMPLETED|Overall Study||11
2293300|NCT02070640|5631688|P2|COMPLETED|Overall Study||6
2293301|NCT02070640|5631689|P1|COMPLETED|Overall Study||82
2293302|NCT02070640|5631688|P2|STARTED|Overall Study||6
2293303|NCT02070640|5631689|P1|STARTED|Overall Study||93
2293304|NCT02070588|5631702|P3|NOT COMPLETED|Overall Study||0
2293305|NCT02070588|5631703|P2|NOT COMPLETED|Overall Study||1
2293306|NCT02070588|5631704|P1|NOT COMPLETED|Overall Study||39
2293307|NCT02070588|5631702|P3|COMPLETED|Overall Study||0
2293308|NCT02070588|5631703|P2|COMPLETED|Overall Study||25
2293309|NCT02070588|5631704|P1|COMPLETED|Overall Study||47
2293310|NCT02070588|5631702|P3|STARTED|Overall Study||0
2293311|NCT02070588|5631703|P2|STARTED|Overall Study||26
2293312|NCT02070588|5631704|P1|STARTED|Overall Study||86
2293313|NCT02070484|5631720|P2|NOT COMPLETED|Overall Study||0
2293314|NCT02070484|5631721|P1|NOT COMPLETED|Overall Study||1
2293315|NCT02070484|5631720|P2|COMPLETED|Overall Study||3
2293316|NCT02070484|5631721|P1|COMPLETED|Overall Study||2
2293317|NCT02070484|5631720|P2|STARTED|Overall Study||3
2293318|NCT02070484|5631721|P1|STARTED|Overall Study||3
2293319|NCT02070380|5631743|P4|NOT COMPLETED|Second Injection||5
2293320|NCT02070380|5631744|P3|NOT COMPLETED|Second Injection||1
2293321|NCT02070380|5631745|P2|NOT COMPLETED|Second Injection||2
2293322|NCT02070380|5631746|P1|NOT COMPLETED|Second Injection||0
2293323|NCT02070380|5631743|P4|COMPLETED|Second Injection||46
2293324|NCT02070380|5631744|P3|COMPLETED|Second Injection||50
2293325|NCT02070380|5631745|P2|COMPLETED|Second Injection||32
2293326|NCT02070380|5631746|P1|COMPLETED|Second Injection||31
2293327|NCT02070380|5631743|P4|STARTED|Second Injection||51
2293328|NCT02070380|5631744|P3|STARTED|Second Injection||51
2293329|NCT02070380|5631745|P2|STARTED|Second Injection||34
2293330|NCT02070380|5631746|P1|STARTED|Second Injection||31
2293331|NCT02070380|5631743|P4|NOT COMPLETED|Washout (no Second Injection/MRI)||3
2293332|NCT02070380|5631744|P3|NOT COMPLETED|Washout (no Second Injection/MRI)||2
2293333|NCT02070380|5631745|P2|NOT COMPLETED|Washout (no Second Injection/MRI)||5
2293334|NCT02070380|5631746|P1|NOT COMPLETED|Washout (no Second Injection/MRI)||0
2293335|NCT02070380|5631743|P4|COMPLETED|Washout (no Second Injection/MRI)||51
2293336|NCT02070380|5631744|P3|COMPLETED|Washout (no Second Injection/MRI)||51
2293337|NCT02070380|5631745|P2|COMPLETED|Washout (no Second Injection/MRI)||34
2293338|NCT02070380|5631746|P1|COMPLETED|Washout (no Second Injection/MRI)||31
2293339|NCT02070380|5631743|P4|STARTED|Washout (no Second Injection/MRI)||54
2293340|NCT02070380|5631744|P3|STARTED|Washout (no Second Injection/MRI)||53
2293341|NCT02070380|5631745|P2|STARTED|Washout (no Second Injection/MRI)||39
2293342|NCT02070380|5631746|P1|STARTED|Washout (no Second Injection/MRI)||31
2293343|NCT02070380|5631743|P4|NOT COMPLETED|First Injection||0
2293344|NCT02070380|5631744|P3|NOT COMPLETED|First Injection||0
2293345|NCT02070380|5631745|P2|NOT COMPLETED|First Injection||0
2293346|NCT02070380|5631746|P1|NOT COMPLETED|First Injection||0
2293347|NCT02070380|5631743|P4|COMPLETED|First Injection||54
2293348|NCT02070380|5631744|P3|COMPLETED|First Injection||53
2293349|NCT02070380|5631745|P2|COMPLETED|First Injection||39
2293350|NCT02070380|5631746|P1|COMPLETED|First Injection||31
2293351|NCT02070380|5631743|P4|STARTED|First Injection||54
2293352|NCT02070380|5631744|P3|STARTED|First Injection||53
2293353|NCT02070380|5631745|P2|STARTED|First Injection||39
2293354|NCT02070380|5631746|P1|STARTED|First Injection||31
2293355|NCT02070302|5631796|P2|NOT COMPLETED|Overall Study||0
2293356|NCT02070302|5631797|P1|NOT COMPLETED|Overall Study||0
2293357|NCT02070302|5631796|P2|COMPLETED|Overall Study||5
2293358|NCT02070302|5631797|P1|COMPLETED|Overall Study||5
2293359|NCT02070302|5631796|P2|STARTED|Overall Study||5
2293360|NCT02070302|5631797|P1|STARTED|Overall Study||5
2293361|NCT02070276|5631816|P3|NOT COMPLETED|Overall Study||0
2293362|NCT02070276|5631817|P2|NOT COMPLETED|Overall Study||0
2293363|NCT02070276|5631818|P1|NOT COMPLETED|Overall Study||0
2293364|NCT02070276|5631816|P3|COMPLETED|Overall Study||148
2293365|NCT02070276|5631817|P2|COMPLETED|Overall Study||132
2293366|NCT02070276|5631818|P1|COMPLETED|Overall Study||149
2293367|NCT02070276|5631816|P3|STARTED|Overall Study||148
2293368|NCT02070276|5631817|P2|STARTED|Overall Study||132
2293369|NCT02070276|5631818|P1|STARTED|Overall Study||149
2293370|NCT02070237|5631834|P2|NOT COMPLETED|Overall Study||3
2293371|NCT02070237|5631835|P1|NOT COMPLETED|Overall Study||3
2293372|NCT02070237|5631834|P2|COMPLETED|Overall Study||42
2293373|NCT02070237|5631835|P1|COMPLETED|Overall Study||42
2293374|NCT02070237|5631834|P2|STARTED|Overall Study||45
2293375|NCT02070237|5631835|P1|STARTED|Overall Study||45
2293376|NCT02069704|5631845|P2|NOT COMPLETED|Overall Study||0
2293377|NCT02069704|5631846|P1|NOT COMPLETED|Overall Study||0
2293378|NCT02069704|5631845|P2|COMPLETED|Overall Study||71
2293379|NCT02069704|5631846|P1|COMPLETED|Overall Study||69
2293380|NCT02069704|5631845|P2|STARTED|Overall Study||71
2293381|NCT02069704|5631846|P1|STARTED|Overall Study|Two patients were randomized but they did not received study treatment|69
2293382|NCT02069392|5631878|P2|NOT COMPLETED|Overall Study||2
2293383|NCT02069392|5631879|P1|NOT COMPLETED|Overall Study||4
2293384|NCT02069392|5631878|P2|COMPLETED|Overall Study||15
2293385|NCT02069392|5631879|P1|COMPLETED|Overall Study||10
2293386|NCT02069392|5631878|P2|STARTED|Overall Study||17
2293387|NCT02069392|5631879|P1|STARTED|Overall Study||14
2293388|NCT02069379|5631903|P4|NOT COMPLETED|Second Treatment Arm||0
2293389|NCT02069379|5631904|P3|NOT COMPLETED|Second Treatment Arm||1
2293390|NCT02069379|5631905|P2|NOT COMPLETED|Second Treatment Arm||0
2293391|NCT02069379|5631906|P1|NOT COMPLETED|Second Treatment Arm||0
2293392|NCT02069379|5631903|P4|COMPLETED|Second Treatment Arm||0
2293393|NCT02069379|5631904|P3|COMPLETED|Second Treatment Arm||0
2293394|NCT02069379|5631905|P2|COMPLETED|Second Treatment Arm||1
2293395|NCT02069379|5631906|P1|COMPLETED|Second Treatment Arm||0
2293396|NCT02069379|5631903|P4|STARTED|Second Treatment Arm|Insulin resistant women who are not randomized are not involved after initial baseline collection|0
2293397|NCT02069379|5631904|P3|STARTED|Second Treatment Arm||1
2293398|NCT02069379|5631905|P2|STARTED|Second Treatment Arm||1
2293399|NCT02069379|5631906|P1|STARTED|Second Treatment Arm|Controls are not involved after initial baseline collection|0
2293400|NCT02069379|5631903|P4|NOT COMPLETED|Washout Period (4 Weeks)||0
2293401|NCT02069379|5631904|P3|NOT COMPLETED|Washout Period (4 Weeks)||0
2293402|NCT02069379|5631905|P2|NOT COMPLETED|Washout Period (4 Weeks)||2
2293403|NCT02069379|5631906|P1|NOT COMPLETED|Washout Period (4 Weeks)||0
2293404|NCT02069379|5631903|P4|COMPLETED|Washout Period (4 Weeks)||0
2293405|NCT02069379|5631904|P3|COMPLETED|Washout Period (4 Weeks)||1
2293406|NCT02069379|5631905|P2|COMPLETED|Washout Period (4 Weeks)||1
2293407|NCT02069379|5631906|P1|COMPLETED|Washout Period (4 Weeks)||0
2293408|NCT02069379|5631903|P4|STARTED|Washout Period (4 Weeks)|Insulin resistant woman who were not randomized are not involved after initial baseline collection|0
2293409|NCT02069379|5631904|P3|STARTED|Washout Period (4 Weeks)||1
2293410|NCT02069379|5631905|P2|STARTED|Washout Period (4 Weeks)||3
2293411|NCT02069379|5631906|P1|STARTED|Washout Period (4 Weeks)|Controls are not involved after initial baseline collection|0
2293412|NCT02069379|5631903|P4|NOT COMPLETED|First Treatment Arm||0
2293413|NCT02069379|5631904|P3|NOT COMPLETED|First Treatment Arm||1
2293414|NCT02069379|5631905|P2|NOT COMPLETED|First Treatment Arm||1
2293415|NCT02069379|5631906|P1|NOT COMPLETED|First Treatment Arm||0
2293416|NCT02069379|5631903|P4|COMPLETED|First Treatment Arm||0
2293417|NCT02069379|5631904|P3|COMPLETED|First Treatment Arm||1
2293418|NCT02069379|5631905|P2|COMPLETED|First Treatment Arm||3
2293419|NCT02069379|5631906|P1|COMPLETED|First Treatment Arm||0
2293420|NCT02069379|5631903|P4|STARTED|First Treatment Arm|Insulin resistant woman not randomized are not involved after initial baseline collection|0
2293421|NCT02069379|5631904|P3|STARTED|First Treatment Arm||2
2293422|NCT02069379|5631905|P2|STARTED|First Treatment Arm||4
2293423|NCT02069379|5631906|P1|STARTED|First Treatment Arm|Controls are not involved after initial baseline collection|0
2293424|NCT02069379|5631903|P4|NOT COMPLETED|Baseline Measurements||2
2293425|NCT02069379|5631904|P3|NOT COMPLETED|Baseline Measurements||0
2293426|NCT02069379|5631905|P2|NOT COMPLETED|Baseline Measurements||0
2293427|NCT02069379|5631906|P1|NOT COMPLETED|Baseline Measurements||3
2293428|NCT02069379|5631903|P4|COMPLETED|Baseline Measurements||4
2293429|NCT02069379|5631904|P3|COMPLETED|Baseline Measurements||2
2293430|NCT02069379|5631905|P2|COMPLETED|Baseline Measurements||4
2293431|NCT02069379|5631906|P1|COMPLETED|Baseline Measurements||27
2293432|NCT02069379|5631903|P4|Baseline Measurements Taken|Baseline Measurements||6
2293433|NCT02069379|5631904|P3|Baseline Measurements Taken|Baseline Measurements||2
2293434|NCT02069379|5631905|P2|Baseline Measurements Taken|Baseline Measurements||4
2293435|NCT02069379|5631906|P1|Baseline Measurements Taken|Baseline Measurements||30
2293436|NCT02069379|5631903|P4|STARTED|Baseline Measurements||6
2293437|NCT02069379|5631904|P3|STARTED|Baseline Measurements||2
2293438|NCT02069379|5631905|P2|STARTED|Baseline Measurements||4
2293439|NCT02069379|5631906|P1|STARTED|Baseline Measurements||30
2293440|NCT02069353|5631932|P1|NOT COMPLETED|Overall Study||0
2293441|NCT02069353|5631932|P1|COMPLETED|Overall Study||4
2293442|NCT02069353|5631932|P1|STARTED|Overall Study||4
2293443|NCT02069184|5631943|P2|NOT COMPLETED|Overall Study||2
2293444|NCT02069184|5631944|P1|NOT COMPLETED|Overall Study||6
2293445|NCT02069184|5631943|P2|COMPLETED|Overall Study||31
2293446|NCT02069184|5631944|P1|COMPLETED|Overall Study||27
2293447|NCT02069184|5631943|P2|STARTED|Overall Study||33
2293448|NCT02069184|5631944|P1|STARTED|Overall Study||33
2293449|NCT02069119|5631966|P4|NOT COMPLETED|Overall Study||0
2293450|NCT02069119|5631967|P3|NOT COMPLETED|Overall Study||0
2293451|NCT02069119|5631968|P2|NOT COMPLETED|Overall Study||0
2293452|NCT02069119|5631969|P1|NOT COMPLETED|Overall Study||0
2293453|NCT02069119|5631966|P4|COMPLETED|Overall Study||4
2293454|NCT02069119|5631967|P3|COMPLETED|Overall Study||20
2293455|NCT02069119|5631968|P2|COMPLETED|Overall Study||4
2293456|NCT02069119|5631969|P1|COMPLETED|Overall Study||20
2293457|NCT02069119|5631966|P4|STARTED|Overall Study||4
2293458|NCT02069119|5631967|P3|STARTED|Overall Study||20
2293459|NCT02069119|5631968|P2|STARTED|Overall Study||4
2293460|NCT02069119|5631969|P1|STARTED|Overall Study||20
2293461|NCT02069093|5631993|P1|NOT COMPLETED|Overall Study||30
2293462|NCT02069093|5631993|P1|COMPLETED|Overall Study||56
2293463|NCT02069093|5631993|P1|Pharmacokinetic Analysis Set|Overall Study||50
2293464|NCT02069093|5631993|P1|STARTED|Overall Study||86
2293465|NCT02069041|5632002|P1|NOT COMPLETED|Overall Study||0
2293466|NCT02069041|5632002|P1|COMPLETED|Overall Study||8
2293467|NCT02069041|5632002|P1|Received at Least One Dose of Study Drug|Overall Study||8
2293468|NCT02069041|5632002|P1|STARTED|Overall Study||8
2293469|NCT02068846|5632012|P2|NOT COMPLETED|Overall Study||1
2293470|NCT02068846|5632013|P1|NOT COMPLETED|Overall Study||1
2293471|NCT02068846|5632012|P2|COMPLETED|Overall Study||7
2293472|NCT02068846|5632013|P1|COMPLETED|Overall Study||8
2293473|NCT02068846|5632012|P2|STARTED|Overall Study||8
2293474|NCT02068846|5632013|P1|STARTED|Overall Study||9
2293475|NCT02068820|5632031|P2|NOT COMPLETED|Overall Study||0
2293476|NCT02068820|5632032|P1|NOT COMPLETED|Overall Study||0
2293477|NCT02068820|5632031|P2|COMPLETED|Overall Study||180
2293478|NCT02068820|5632032|P1|COMPLETED|Overall Study||20
2293479|NCT02068820|5632031|P2|STARTED|Overall Study||180
2293480|NCT02068820|5632032|P1|STARTED|Overall Study||20
2293481|NCT02068768|5632043|P1|NOT COMPLETED|Overall Study||7
2293482|NCT02068768|5632043|P1|COMPLETED|Overall Study||6
2293483|NCT02068768|5632043|P1|STARTED|Overall Study||13
2293484|NCT02068599|5632052|P3|NOT COMPLETED|Overall Study||13
2293485|NCT02068599|5632053|P2|NOT COMPLETED|Overall Study||10
2293486|NCT02068599|5632054|P1|NOT COMPLETED|Overall Study||11
2293487|NCT02068599|5632052|P3|COMPLETED|Overall Study||117
2293488|NCT02068599|5632053|P2|COMPLETED|Overall Study||119
2293489|NCT02068599|5632054|P1|COMPLETED|Overall Study||119
2293490|NCT02068599|5632052|P3|Full Analysis Set|Overall Study||130
2293491|NCT02068599|5632053|P2|Full Analysis Set|Overall Study||128
2293492|NCT02068599|5632054|P1|Full Analysis Set|Overall Study||129
2293493|NCT02068599|5632052|P3|Safety Analysis Set|Overall Study||130
2293494|NCT02068599|5632053|P2|Safety Analysis Set|Overall Study|One participant withdrew before taking any study drug.|128
2293495|NCT02068599|5632054|P1|Safety Analysis Set|Overall Study|One participant withdrew before taking any study drug.|129
2293496|NCT02068599|5632052|P3|STARTED|Overall Study||130
2293497|NCT02068599|5632053|P2|STARTED|Overall Study||129
2293498|NCT02068599|5632054|P1|STARTED|Overall Study||130
2293499|NCT02068547|5632094|P2|NOT COMPLETED|Overall Study||3
2293500|NCT02068547|5632095|P1|NOT COMPLETED|Overall Study||4
2293501|NCT02068547|5632094|P2|COMPLETED|Overall Study||1
2293502|NCT02068547|5632095|P1|COMPLETED|Overall Study||0
2293503|NCT02068547|5632094|P2|STARTED|Overall Study||4
2293504|NCT02068547|5632095|P1|STARTED|Overall Study||4
2293505|NCT02068508|5632105|P1|NOT COMPLETED|Overall Study||32
2293506|NCT02068508|5632105|P1|COMPLETED|Overall Study||1035
2293507|NCT02068508|5632105|P1|STARTED|Overall Study||1067
2293508|NCT02068495|5632115|P1|NOT COMPLETED|Overall Study||109
2293509|NCT02068495|5632115|P1|COMPLETED|Overall Study||3300
2293510|NCT02068495|5632115|P1|STARTED|Overall Study||3409
2293511|NCT02068443|5632127|P3|NOT COMPLETED|Overall Study||3
2293512|NCT02068443|5632128|P2|NOT COMPLETED|Overall Study||6
2293513|NCT02068443|5632129|P1|NOT COMPLETED|Overall Study||7
2293514|NCT02068443|5632127|P3|COMPLETED|Overall Study||148
2293515|NCT02068443|5632128|P2|COMPLETED|Overall Study||146
2293516|NCT02068443|5632129|P1|COMPLETED|Overall Study||64
2293517|NCT02068443|5632127|P3|STARTED|Overall Study||151
2293518|NCT02068443|5632128|P2|STARTED|Overall Study||152
2293519|NCT02068443|5632129|P1|STARTED|Overall Study||71
2293520|NCT02068222|5632164|P1|NOT COMPLETED|Overall Study||1
2293521|NCT02068222|5632164|P1|COMPLETED|Overall Study||9
2293522|NCT02068222|5632164|P1|STARTED|Overall Study||10
2293523|NCT02068157|5632171|P1|NOT COMPLETED|Overall Study||0
2293524|NCT02068157|5632171|P1|COMPLETED|Overall Study||3
2293525|NCT02068157|5632171|P1|STARTED|Overall Study||3
2293526|NCT02068027|5632178|P2|NOT COMPLETED|Overall Study||16
2293527|NCT02068027|5632179|P1|NOT COMPLETED|Overall Study||13
2293528|NCT02068027|5632178|P2|COMPLETED|Overall Study||114
2293529|NCT02068027|5632179|P1|COMPLETED|Overall Study||117
2293530|NCT02068027|5632178|P2|STARTED|Overall Study||130
2293531|NCT02068027|5632179|P1|STARTED|Overall Study||130
2293532|NCT02067858|5632187|P1|NOT COMPLETED|Overall Study||0
2293533|NCT02067858|5632187|P1|COMPLETED|Overall Study||6
2293534|NCT02067858|5632187|P1|STARTED|Overall Study||6
2293535|NCT02067728|5632195|P2|NOT COMPLETED|6 Month Measurements||97
2293536|NCT02067728|5632196|P1|NOT COMPLETED|6 Month Measurements||114
2293537|NCT02067728|5632195|P2|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|113
2293538|NCT02067728|5632196|P1|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|106
2293539|NCT02067728|5632195|P2|STARTED|6 Month Measurements||210
2293540|NCT02067728|5632196|P1|STARTED|6 Month Measurements||220
2293541|NCT02067728|5632195|P2|NOT COMPLETED|6 Month Follow up Survey||60
2293542|NCT02067728|5632196|P1|NOT COMPLETED|6 Month Follow up Survey||48
2293543|NCT02067728|5632195|P2|COMPLETED|6 Month Follow up Survey|150 parent/guardians completed surveys at this time point, along with 69 teens.|150
2293632|NCT02066896|5632447|P1|NOT COMPLETED|Overall Study||0
2293544|NCT02067728|5632196|P1|COMPLETED|6 Month Follow up Survey|172 parent/guardians completed surveys at this time point, along with 71 teens.|172
2293545|NCT02067728|5632195|P2|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|210
2293546|NCT02067728|5632196|P1|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|220
2293547|NCT02067728|5632195|P2|NOT COMPLETED|Baseline - 1 Month Follow up Survey||28
2293548|NCT02067728|5632196|P1|NOT COMPLETED|Baseline - 1 Month Follow up Survey||7
2293549|NCT02067728|5632195|P2|COMPLETED|Baseline - 1 Month Follow up Survey|182 parent/guardians completed the surveys, along with 75 teens.|182
2293550|NCT02067728|5632196|P1|COMPLETED|Baseline - 1 Month Follow up Survey|213 parents/guardians completed the surveys, along with 82 teens.|213
2293551|NCT02067728|5632195|P2|STARTED|Baseline - 1 Month Follow up Survey||210
2293552|NCT02067728|5632196|P1|STARTED|Baseline - 1 Month Follow up Survey||220
2293553|NCT02067676|5632230|P6|NOT COMPLETED|Overall Study||0
2293554|NCT02067676|5632231|P5|NOT COMPLETED|Overall Study||0
2293555|NCT02067676|5632232|P4|NOT COMPLETED|Overall Study||0
2293556|NCT02067676|5632233|P3|NOT COMPLETED|Overall Study||0
2293557|NCT02067676|5632234|P2|NOT COMPLETED|Overall Study||0
2293558|NCT02067676|5632235|P1|NOT COMPLETED|Overall Study||1
2293559|NCT02067676|5632230|P6|COMPLETED|Overall Study||8
2293560|NCT02067676|5632231|P5|COMPLETED|Overall Study||8
2293561|NCT02067676|5632232|P4|COMPLETED|Overall Study||8
2293562|NCT02067676|5632233|P3|COMPLETED|Overall Study||8
2293563|NCT02067676|5632234|P2|COMPLETED|Overall Study||8
2293564|NCT02067676|5632235|P1|COMPLETED|Overall Study||7
2293565|NCT02067676|5632230|P6|STARTED|Overall Study||8
2293566|NCT02067676|5632231|P5|STARTED|Overall Study||8
2293567|NCT02067676|5632232|P4|STARTED|Overall Study||8
2293568|NCT02067676|5632233|P3|STARTED|Overall Study||8
2293569|NCT02067676|5632234|P2|STARTED|Overall Study||8
2293570|NCT02067676|5632235|P1|STARTED|Overall Study||8
2293571|NCT02067663|5632275|P2|NOT COMPLETED|Overall Study||14
2293572|NCT02067663|5632276|P1|NOT COMPLETED|Overall Study||13
2293573|NCT02067663|5632275|P2|COMPLETED|Overall Study||41
2293574|NCT02067663|5632276|P1|COMPLETED|Overall Study||55
2293575|NCT02067663|5632275|P2|STARTED|Overall Study||55
2293576|NCT02067663|5632276|P1|STARTED|Overall Study||68
2293577|NCT02067611|5632296|P3|NOT COMPLETED|Overall Study||4
2293578|NCT02067611|5632297|P2|NOT COMPLETED|Overall Study||6
2293579|NCT02067611|5632298|P1|NOT COMPLETED|Overall Study||6
2293580|NCT02067611|5632296|P3|COMPLETED|Overall Study||68
2293581|NCT02067611|5632297|P2|COMPLETED|Overall Study||66
2293582|NCT02067611|5632298|P1|COMPLETED|Overall Study||66
2293583|NCT02067611|5632296|P3|STARTED|Overall Study||72
2293584|NCT02067611|5632297|P2|STARTED|Overall Study||72
2293585|NCT02067611|5632298|P1|STARTED|Overall Study||72
2293586|NCT02067585|5632336|P3|NOT COMPLETED|Overall Study||0
2293587|NCT02067585|5632337|P2|NOT COMPLETED|Overall Study||0
2293588|NCT02067585|5632338|P1|NOT COMPLETED|Overall Study||0
2293589|NCT02067585|5632336|P3|COMPLETED|Overall Study||16
2293590|NCT02067585|5632337|P2|COMPLETED|Overall Study||16
2293591|NCT02067585|5632338|P1|COMPLETED|Overall Study||16
2293592|NCT02067585|5632336|P3|STARTED|Overall Study||16
2293593|NCT02067585|5632337|P2|STARTED|Overall Study||16
2293594|NCT02067585|5632338|P1|STARTED|Overall Study||16
2293595|NCT02067533|5632375|P2|NOT COMPLETED|Overall Study||2
2293596|NCT02067533|5632376|P1|NOT COMPLETED|Overall Study||4
2293597|NCT02067533|5632375|P2|COMPLETED|Overall Study||44
2293598|NCT02067533|5632376|P1|COMPLETED|Overall Study||41
2293599|NCT02067533|5632375|P2|STARTED|Overall Study||46
2293600|NCT02067533|5632376|P1|STARTED|Overall Study||45
2293601|NCT02067468|5632385|P3|NOT COMPLETED|Overall Study||0
2293602|NCT02067468|5632386|P2|NOT COMPLETED|Overall Study||0
2293603|NCT02067468|5632387|P1|NOT COMPLETED|Overall Study||0
2293604|NCT02067468|5632385|P3|COMPLETED|Overall Study||889
2293605|NCT02067468|5632386|P2|COMPLETED|Overall Study||890
2293606|NCT02067468|5632387|P1|COMPLETED|Overall Study||882
2293607|NCT02067468|5632385|P3|Had at Least One Routine Colposcopy|Overall Study||462
2293608|NCT02067468|5632386|P2|Had at Least One Routine Colposcopy|Overall Study||372
2293609|NCT02067468|5632387|P1|Had at Least One Routine Colposcopy|Overall Study||772
2293610|NCT02067468|5632385|P3|Followed-up Through Medical Records|Overall Study||889
2293611|NCT02067468|5632386|P2|Followed-up Through Medical Records|Overall Study||890
2293612|NCT02067468|5632387|P1|Followed-up Through Medical Records|Overall Study||882
2293613|NCT02067468|5632385|P3|STARTED|Overall Study||889
2293614|NCT02067468|5632386|P2|STARTED|Overall Study||890
2293615|NCT02067468|5632387|P1|STARTED|Overall Study||882
2293616|NCT02067273|5632418|P2|NOT COMPLETED|Overall Study||3
2293617|NCT02067273|5632419|P1|NOT COMPLETED|Overall Study||0
2293618|NCT02067273|5632418|P2|COMPLETED|Overall Study||12
2293619|NCT02067273|5632419|P1|COMPLETED|Overall Study||5
2293620|NCT02067273|5632418|P2|STARTED|Overall Study||15
2293621|NCT02067273|5632419|P1|STARTED|Overall Study||5
2293622|NCT02067104|5632427|P2|NOT COMPLETED|Overall Study||5
2293623|NCT02067104|5632428|P1|NOT COMPLETED|Overall Study||4
2293624|NCT02067104|5632427|P2|COMPLETED|Overall Study||0
2293625|NCT02067104|5632428|P1|COMPLETED|Overall Study||0
2293626|NCT02067104|5632427|P2|STARTED|Overall Study||5
2293627|NCT02067104|5632428|P1|STARTED|Overall Study||4
2293628|NCT02066922|5632436|P1|NOT COMPLETED|Overall Study||1
2293629|NCT02066922|5632436|P1|COMPLETED|Overall Study||14
2293630|NCT02066922|5632436|P1|STARTED|Overall Study||15
2293631|NCT02066896|5632446|P2|NOT COMPLETED|Overall Study||0
2293633|NCT02066896|5632446|P2|COMPLETED|Overall Study||33
2293634|NCT02066896|5632447|P1|COMPLETED|Overall Study||33
2293635|NCT02066896|5632446|P2|STARTED|Overall Study||33
2293636|NCT02066896|5632447|P1|STARTED|Overall Study||33
2293637|NCT02066857|5632459|P2|NOT COMPLETED|Overall Study||1
2293638|NCT02066857|5632460|P1|NOT COMPLETED|Overall Study||1
2293639|NCT02066857|5632459|P2|COMPLETED|Overall Study||3
2293640|NCT02066857|5632460|P1|COMPLETED|Overall Study||0
2293641|NCT02066857|5632459|P2|STARTED|Overall Study||4
2293642|NCT02066857|5632460|P1|STARTED|Overall Study||1
2293643|NCT02066740|5632474|P1|NOT COMPLETED|Overall Study||2
2293644|NCT02066740|5632474|P1|COMPLETED|Overall Study||32
2293645|NCT02066740|5632474|P1|STARTED|Overall Study||34
2293646|NCT02066727|5632481|P2|NOT COMPLETED|Overall Study||0
2293647|NCT02066727|5632482|P1|NOT COMPLETED|Overall Study||0
2293648|NCT02066727|5632481|P2|COMPLETED|Overall Study||30
2293649|NCT02066727|5632482|P1|COMPLETED|Overall Study||30
2293650|NCT02066727|5632481|P2|STARTED|Overall Study||30
2293651|NCT02066727|5632482|P1|STARTED|Overall Study||30
2293652|NCT02066467|5632488|P1|NOT COMPLETED|Overall Study||215
2293653|NCT02066467|5632488|P1|COMPLETED|Overall Study||648
2293654|NCT02066467|5632488|P1|STARTED|Overall Study||863
2293655|NCT02066415|5632497|P3|NOT COMPLETED|Overall Study||8
2293656|NCT02066415|5632498|P2|NOT COMPLETED|Overall Study||7
2293657|NCT02066415|5632499|P1|NOT COMPLETED|Overall Study||21
2293658|NCT02066415|5632497|P3|COMPLETED|Overall Study||182
2293659|NCT02066415|5632498|P2|COMPLETED|Overall Study||184
2293660|NCT02066415|5632499|P1|COMPLETED|Overall Study||265
2293661|NCT02066415|5632497|P3|Received Study Drug|Overall Study||188
2293662|NCT02066415|5632498|P2|Received Study Drug|Overall Study||190
2293663|NCT02066415|5632499|P1|Received Study Drug|Overall Study||282
2293664|NCT02066415|5632497|P3|STARTED|Overall Study||190
2293665|NCT02066415|5632498|P2|STARTED|Overall Study||191
2293666|NCT02066415|5632499|P1|STARTED|Overall Study||286
2293667|NCT02066402|5632524|P2|NOT COMPLETED|Overall Study||23
2293668|NCT02066402|5632525|P1|NOT COMPLETED|Overall Study||26
2293669|NCT02066402|5632524|P2|COMPLETED|Overall Study||275
2293670|NCT02066402|5632525|P1|COMPLETED|Overall Study||274
2293671|NCT02066402|5632524|P2|Completed Study Treatment Period|Overall Study||256
2293672|NCT02066402|5632525|P1|Completed Study Treatment Period|Overall Study||261
2293673|NCT02066402|5632524|P2|Participants Received Treatment|Overall Study||297
2293674|NCT02066402|5632525|P1|Participants Received Treatment|Overall Study||292
2293675|NCT02066402|5632524|P2|STARTED|Overall Study||298
2293676|NCT02066402|5632525|P1|STARTED|Overall Study||300
2293677|NCT02066389|5632557|P6|NOT COMPLETED|Overall Study||5
2293678|NCT02066389|5632558|P5|NOT COMPLETED|Overall Study||7
2293679|NCT02066389|5632559|P4|NOT COMPLETED|Overall Study||3
2293680|NCT02066389|5632560|P3|NOT COMPLETED|Overall Study||6
2293681|NCT02066389|5632561|P2|NOT COMPLETED|Overall Study||1
2293682|NCT02066389|5632562|P1|NOT COMPLETED|Overall Study||5
2293683|NCT02066389|5632557|P6|COMPLETED|Overall Study||45
2293684|NCT02066389|5632558|P5|COMPLETED|Overall Study||43
2293685|NCT02066389|5632559|P4|COMPLETED|Overall Study||47
2293686|NCT02066389|5632560|P3|COMPLETED|Overall Study||44
2293687|NCT02066389|5632561|P2|COMPLETED|Overall Study||49
2293688|NCT02066389|5632562|P1|COMPLETED|Overall Study||45
2293689|NCT02066389|5632557|P6|Received Study Drug|Overall Study||49
2293690|NCT02066389|5632558|P5|Received Study Drug|Overall Study||50
2293691|NCT02066389|5632559|P4|Received Study Drug|Overall Study||50
2293692|NCT02066389|5632560|P3|Received Study Drug|Overall Study||50
2293693|NCT02066389|5632561|P2|Received Study Drug|Overall Study||50
2293694|NCT02066389|5632562|P1|Received Study Drug|Overall Study||50
2293695|NCT02066389|5632557|P6|STARTED|Overall Study||50
2293696|NCT02066389|5632558|P5|STARTED|Overall Study||50
2293697|NCT02066389|5632559|P4|STARTED|Overall Study||50
2293698|NCT02066389|5632560|P3|STARTED|Overall Study||50
2293699|NCT02066389|5632561|P2|STARTED|Overall Study||50
2293700|NCT02066389|5632562|P1|STARTED|Overall Study||50
2293704|NCT02066298|5632622|P6|NOT COMPLETED|Overall Study||12
2293705|NCT02066298|5632623|P5|NOT COMPLETED|Overall Study||9
2293706|NCT02066298|5632624|P4|NOT COMPLETED|Overall Study||6
2293707|NCT02066298|5632625|P3|NOT COMPLETED|Overall Study||10
2293708|NCT02066298|5632626|P2|NOT COMPLETED|Overall Study||8
2293709|NCT02066298|5632627|P1|NOT COMPLETED|Overall Study||9
2293710|NCT02066298|5632622|P6|COMPLETED|Overall Study||38
2293711|NCT02066298|5632623|P5|COMPLETED|Overall Study||38
2293712|NCT02066298|5632624|P4|COMPLETED|Overall Study||45
2293713|NCT02066298|5632625|P3|COMPLETED|Overall Study||40
2293714|NCT02066298|5632626|P2|COMPLETED|Overall Study||40
2293715|NCT02066298|5632627|P1|COMPLETED|Overall Study||40
2293716|NCT02066298|5632622|P6|Completed 3rd Period|Overall Study||38
2293717|NCT02066298|5632623|P5|Completed 3rd Period|Overall Study||38
2293718|NCT02066298|5632624|P4|Completed 3rd Period|Overall Study||45
2293719|NCT02066298|5632625|P3|Completed 3rd Period|Overall Study||40
2293720|NCT02066298|5632626|P2|Completed 3rd Period|Overall Study||40
2293721|NCT02066298|5632627|P1|Completed 3rd Period|Overall Study||40
2293722|NCT02066298|5632622|P6|Completed 2nd Period|Overall Study||41
2293723|NCT02066298|5632623|P5|Completed 2nd Period|Overall Study||42
2293724|NCT02066298|5632624|P4|Completed 2nd Period|Overall Study||46
2293725|NCT02066298|5632625|P3|Completed 2nd Period|Overall Study||41
2293726|NCT02066298|5632626|P2|Completed 2nd Period|Overall Study||41
2293727|NCT02066298|5632627|P1|Completed 2nd Period|Overall Study||41
2293728|NCT02066298|5632622|P6|Completed 1st Period|Overall Study||45
2293729|NCT02066298|5632623|P5|Completed 1st Period|Overall Study||46
2293730|NCT02066298|5632624|P4|Completed 1st Period|Overall Study||48
2293731|NCT02066298|5632625|P3|Completed 1st Period|Overall Study||45
2293732|NCT02066298|5632626|P2|Completed 1st Period|Overall Study||47
2293733|NCT02066298|5632627|P1|Completed 1st Period|Overall Study||44
2293734|NCT02066298|5632622|P6|STARTED|Overall Study||50
2293735|NCT02066298|5632623|P5|STARTED|Overall Study||47
2293736|NCT02066298|5632624|P4|STARTED|Overall Study||51
2293737|NCT02066298|5632625|P3|STARTED|Overall Study||50
2293738|NCT02066298|5632626|P2|STARTED|Overall Study||48
2293739|NCT02066298|5632627|P1|STARTED|Overall Study||49
2293740|NCT02066233|5632651|P2|NOT COMPLETED|Standard Endoscopy (Day 2)||0
2293741|NCT02066233|5632652|P1|NOT COMPLETED|Standard Endoscopy (Day 2)||0
2293742|NCT02066233|5632651|P2|COMPLETED|Standard Endoscopy (Day 2)||44
2293743|NCT02066233|5632652|P1|COMPLETED|Standard Endoscopy (Day 2)||44
2293744|NCT02066233|5632651|P2|STARTED|Standard Endoscopy (Day 2)||44
2293745|NCT02066233|5632652|P1|STARTED|Standard Endoscopy (Day 2)||44
2293746|NCT02066233|5632651|P2|NOT COMPLETED|EG Scan II (Day 1)||6
2293747|NCT02066233|5632652|P1|NOT COMPLETED|EG Scan II (Day 1)||6
2293748|NCT02066233|5632651|P2|COMPLETED|EG Scan II (Day 1)||44
2293749|NCT02066233|5632652|P1|COMPLETED|EG Scan II (Day 1)||44
2293750|NCT02066233|5632651|P2|STARTED|EG Scan II (Day 1)||50
2293751|NCT02066233|5632652|P1|STARTED|EG Scan II (Day 1)||50
2293752|NCT02066181|5632662|P2|NOT COMPLETED|Overall Study||1
2293753|NCT02066181|5632663|P1|NOT COMPLETED|Overall Study||1
2293754|NCT02066181|5632662|P2|COMPLETED|Overall Study||36
2293755|NCT02066181|5632663|P1|COMPLETED|Overall Study||49
2293756|NCT02066181|5632662|P2|Crossed Over|Overall Study||28
2293757|NCT02066181|5632663|P1|Crossed Over|Overall Study||0
2293758|NCT02066181|5632662|P2|STARTED|Overall Study||37
2293759|NCT02066181|5632663|P1|STARTED|Overall Study||50
2293760|NCT02066129|5632685|P2|NOT COMPLETED|Overall Study||33
2293761|NCT02066129|5632686|P1|NOT COMPLETED|Overall Study||29
2293762|NCT02066129|5632685|P2|COMPLETED|Overall Study||94
2293763|NCT02066129|5632686|P1|COMPLETED|Overall Study||98
2293764|NCT02066129|5632685|P2|STARTED|Overall Study||127
2293765|NCT02066129|5632686|P1|STARTED|Overall Study||127
2293766|NCT02066051|5632700|P1|NOT COMPLETED|Overall Study||1
2293767|NCT02066051|5632700|P1|COMPLETED|Overall Study||7
2293768|NCT02066051|5632700|P1|STARTED|Overall Study||8
2293769|NCT02065895|5632705|P6|NOT COMPLETED|Overall Study||0
2293770|NCT02065895|5632706|P5|NOT COMPLETED|Overall Study||0
2293771|NCT02065895|5632707|P4|NOT COMPLETED|Overall Study||1
2293772|NCT02065895|5632708|P3|NOT COMPLETED|Overall Study||0
2293773|NCT02065895|5632709|P2|NOT COMPLETED|Overall Study||1
2293774|NCT02065895|5632710|P1|NOT COMPLETED|Overall Study||1
2293775|NCT02065895|5632705|P6|COMPLETED|Overall Study||1
2293776|NCT02065895|5632706|P5|COMPLETED|Overall Study||1
2293777|NCT02065895|5632707|P4|COMPLETED|Overall Study||0
2293778|NCT02065895|5632708|P3|COMPLETED|Overall Study||1
2293779|NCT02065895|5632709|P2|COMPLETED|Overall Study||2
2293780|NCT02065895|5632710|P1|COMPLETED|Overall Study||0
2293781|NCT02065895|5632705|P6|STARTED|Overall Study||1
2293782|NCT02065895|5632706|P5|STARTED|Overall Study||1
2293783|NCT02065895|5632707|P4|STARTED|Overall Study||1
2293784|NCT02065895|5632708|P3|STARTED|Overall Study||1
2293785|NCT02065895|5632709|P2|STARTED|Overall Study||3
2293786|NCT02065895|5632710|P1|STARTED|Overall Study||1
2293787|NCT02065791|5632729|P2|NOT COMPLETED|Overall Study||15
2293788|NCT02065791|5632730|P1|NOT COMPLETED|Overall Study||25
2293789|NCT02065791|5632729|P2|COMPLETED|Overall Study||2187
2293790|NCT02065791|5632730|P1|COMPLETED|Overall Study||2174
2293791|NCT02065791|5632729|P2|Treated|Overall Study||2200
2293792|NCT02065791|5632730|P1|Treated|Overall Study||2197
2293793|NCT02065791|5632729|P2|STARTED|Overall Study||2202
2293794|NCT02065791|5632730|P1|STARTED|Overall Study||2199
2293795|NCT02065518|5632754|P4|NOT COMPLETED|Overall Study||5
2293796|NCT02065518|5632755|P3|NOT COMPLETED|Overall Study||9
2293797|NCT02065518|5632756|P2|NOT COMPLETED|Overall Study||8
2293798|NCT02065518|5632757|P1|NOT COMPLETED|Overall Study||6
2293799|NCT02065518|5632754|P4|COMPLETED|Overall Study||15
2293800|NCT02065518|5632755|P3|COMPLETED|Overall Study||11
2293801|NCT02065518|5632756|P2|COMPLETED|Overall Study||11
2293802|NCT02065518|5632757|P1|COMPLETED|Overall Study||13
2293803|NCT02065518|5632754|P4|STARTED|Overall Study||20
2293804|NCT02065518|5632755|P3|STARTED|Overall Study||20
2293805|NCT02065518|5632756|P2|STARTED|Overall Study||19
2293806|NCT02065518|5632757|P1|STARTED|Overall Study||19
2293807|NCT02065453|5632809|P2|NOT COMPLETED|Overall Study||4
2293808|NCT02065453|5632810|P1|NOT COMPLETED|Overall Study||3
2293809|NCT02065453|5632809|P2|COMPLETED|Overall Study||21
2293810|NCT02065453|5632810|P1|COMPLETED|Overall Study||24
2293811|NCT02065453|5632809|P2|STARTED|Overall Study||25
2293812|NCT02065453|5632810|P1|STARTED|Overall Study||27
2293813|NCT02065336|5632823|P10|NOT COMPLETED|Extension Phase||8
2293814|NCT02065336|5632824|P9|NOT COMPLETED|Extension Phase||2
2293815|NCT02065336|5632825|P8|NOT COMPLETED|Extension Phase||0
2293816|NCT02065336|5632826|P7|NOT COMPLETED|Extension Phase||0
2293817|NCT02065336|5632827|P6|NOT COMPLETED|Extension Phase||0
2293818|NCT02065336|5632828|P5|NOT COMPLETED|Extension Phase||0
2293819|NCT02065336|5632829|P4|NOT COMPLETED|Extension Phase||0
2293820|NCT02065336|5632830|P3|NOT COMPLETED|Extension Phase||0
2293821|NCT02065336|5632831|P2|NOT COMPLETED|Extension Phase||0
2293822|NCT02065336|5632832|P1|NOT COMPLETED|Extension Phase||0
2293823|NCT02065336|5632823|P10|COMPLETED|Extension Phase||0
2293824|NCT02065336|5632824|P9|COMPLETED|Extension Phase||0
2293825|NCT02065336|5632825|P8|COMPLETED|Extension Phase||0
2293826|NCT02065336|5632826|P7|COMPLETED|Extension Phase||0
2293827|NCT02065336|5632827|P6|COMPLETED|Extension Phase||0
2293828|NCT02065336|5632828|P5|COMPLETED|Extension Phase||0
2293829|NCT02065336|5632829|P4|COMPLETED|Extension Phase||0
2293830|NCT02065336|5632830|P3|COMPLETED|Extension Phase||0
2293831|NCT02065336|5632831|P2|COMPLETED|Extension Phase||0
2293832|NCT02065336|5632832|P1|COMPLETED|Extension Phase||0
2293833|NCT02065336|5632823|P10|STARTED|Extension Phase||8
2293834|NCT02065336|5632824|P9|STARTED|Extension Phase||2
2293835|NCT02065336|5632825|P8|STARTED|Extension Phase||0
2293836|NCT02065336|5632826|P7|STARTED|Extension Phase||0
2293837|NCT02065336|5632827|P6|STARTED|Extension Phase||0
2293838|NCT02065336|5632828|P5|STARTED|Extension Phase||0
2293839|NCT02065336|5632829|P4|STARTED|Extension Phase||0
2293840|NCT02065336|5632830|P3|STARTED|Extension Phase||0
2293841|NCT02065336|5632831|P2|STARTED|Extension Phase||0
2293842|NCT02065336|5632832|P1|STARTED|Extension Phase||0
2293843|NCT02065336|5632823|P10|NOT COMPLETED|Main Study||0
2293844|NCT02065336|5632824|P9|NOT COMPLETED|Main Study||0
2293845|NCT02065336|5632825|P8|NOT COMPLETED|Main Study||0
2293846|NCT02065336|5632826|P7|NOT COMPLETED|Main Study||0
2293847|NCT02065336|5632827|P6|NOT COMPLETED|Main Study||0
2293848|NCT02065336|5632828|P5|NOT COMPLETED|Main Study||0
2293849|NCT02065336|5632829|P4|NOT COMPLETED|Main Study||0
2293850|NCT02065336|5632830|P3|NOT COMPLETED|Main Study||0
2293851|NCT02065336|5632831|P2|NOT COMPLETED|Main Study||0
2293852|NCT02065336|5632832|P1|NOT COMPLETED|Main Study||0
2293853|NCT02065336|5632823|P10|COMPLETED|Main Study||0
2293854|NCT02065336|5632824|P9|COMPLETED|Main Study||0
2293855|NCT02065336|5632825|P8|COMPLETED|Main Study||10
2293856|NCT02065336|5632826|P7|COMPLETED|Main Study||12
2293857|NCT02065336|5632827|P6|COMPLETED|Main Study||6
2293858|NCT02065336|5632828|P5|COMPLETED|Main Study||6
2293859|NCT02065336|5632829|P4|COMPLETED|Main Study||6
2293860|NCT02065336|5632830|P3|COMPLETED|Main Study||6
2293861|NCT02065336|5632831|P2|COMPLETED|Main Study||6
2293862|NCT02065336|5632832|P1|COMPLETED|Main Study||6
2293863|NCT02065336|5632823|P10|STARTED|Main Study||0
2293864|NCT02065336|5632824|P9|STARTED|Main Study||0
2293865|NCT02065336|5632825|P8|STARTED|Main Study||10
2293866|NCT02065336|5632826|P7|STARTED|Main Study||12
2293867|NCT02065336|5632827|P6|STARTED|Main Study||6
2293868|NCT02065336|5632828|P5|STARTED|Main Study||6
2293869|NCT02065336|5632829|P4|STARTED|Main Study||6
2293870|NCT02065336|5632830|P3|STARTED|Main Study||6
2293871|NCT02065336|5632831|P2|STARTED|Main Study||6
2293872|NCT02065336|5632832|P1|STARTED|Main Study||6
2293873|NCT02064985|5632927|P3|NOT COMPLETED|Overall Study||0
2293874|NCT02064985|5632928|P2|NOT COMPLETED|Overall Study||0
2293875|NCT02064985|5632929|P1|NOT COMPLETED|Overall Study||0
2293876|NCT02064985|5632927|P3|COMPLETED|Overall Study||12
2293877|NCT02064985|5632928|P2|COMPLETED|Overall Study||12
2293878|NCT02064985|5632929|P1|COMPLETED|Overall Study||12
2293879|NCT02064985|5632927|P3|STARTED|Overall Study||12
2293880|NCT02064985|5632928|P2|STARTED|Overall Study||12
2293881|NCT02064985|5632929|P1|STARTED|Overall Study||12
2293882|NCT02064920|5633092|P2|NOT COMPLETED|Overall Study||9
2293883|NCT02064920|5633093|P1|NOT COMPLETED|Overall Study||1
2293884|NCT02064920|5633092|P2|COMPLETED|Overall Study||21
2293885|NCT02064920|5633093|P1|COMPLETED|Overall Study||5
2293886|NCT02064920|5633092|P2|Treated|Overall Study|Two participants discontinued from study prior to treatment|28
2293887|NCT02064920|5633093|P1|Treated|Overall Study||6
2293888|NCT02064920|5633092|P2|STARTED|Overall Study||30
2293889|NCT02064920|5633093|P1|STARTED|Overall Study||6
2293890|NCT02064907|5633103|P2|NOT COMPLETED|Period 2||0
2293891|NCT02064907|5633104|P1|NOT COMPLETED|Period 2||0
2293892|NCT02064907|5633103|P2|COMPLETED|Period 2||26
2293893|NCT02064907|5633104|P1|COMPLETED|Period 2||26
2293894|NCT02064907|5633103|P2|STARTED|Period 2||26
2293895|NCT02064907|5633104|P1|STARTED|Period 2||26
2293896|NCT02064907|5633103|P2|NOT COMPLETED|Period 1||0
2293897|NCT02064907|5633104|P1|NOT COMPLETED|Period 1||0
2293898|NCT02064907|5633103|P2|COMPLETED|Period 1||26
2293899|NCT02064907|5633104|P1|COMPLETED|Period 1||26
2293900|NCT02064907|5633103|P2|STARTED|Period 1||26
2293901|NCT02064907|5633104|P1|STARTED|Period 1||26
2293902|NCT02064894|5633123|P3|NOT COMPLETED|Overall Study||115
2293903|NCT02064894|5633124|P2|NOT COMPLETED|Overall Study||102
2293904|NCT02064894|5633125|P1|NOT COMPLETED|Overall Study||43
2293905|NCT02064894|5633123|P3|COMPLETED|Overall Study||86
2293906|NCT02064894|5633124|P2|COMPLETED|Overall Study||99
2293907|NCT02064894|5633125|P1|COMPLETED|Overall Study||56
2293908|NCT02064894|5633123|P3|Avalaible at T-90|Overall Study||129
2293909|NCT02064894|5633124|P2|Avalaible at T-90|Overall Study||134
2293910|NCT02064894|5633125|P1|Avalaible at T-90|Overall Study||74
2293911|NCT02064894|5633123|P3|Available at T-60|Overall Study||177
2293912|NCT02064894|5633124|P2|Available at T-60|Overall Study||188
2293913|NCT02064894|5633125|P1|Available at T-60|Overall Study||91
2293914|NCT02064894|5633123|P3|STARTED|Overall Study|"Received allocated intervention (n=199)~Did not receive allocated intervention (n=2)"|201
2294071|NCT02063867|5633633|P2|NOT COMPLETED|Overall Study||2965
2293915|NCT02064894|5633124|P2|STARTED|Overall Study|"Received allocated intervention (n=198)~Did not receive allocated intervention (n=3)"|201
2293916|NCT02064894|5633125|P1|STARTED|Overall Study|"Received allocated intervention (n=98)~Did not receive intervention (n=1)"|99
2293917|NCT02064868|5633138|P2|NOT COMPLETED|Overall Study||13
2293918|NCT02064868|5633139|P1|NOT COMPLETED|Overall Study||34
2293919|NCT02064868|5633138|P2|COMPLETED|Overall Study||881
2293920|NCT02064868|5633139|P1|COMPLETED|Overall Study||1722
2293921|NCT02064868|5633138|P2|Per Protocol Set|Overall Study||627
2293922|NCT02064868|5633139|P1|Per Protocol Set|Overall Study||1155
2293923|NCT02064868|5633138|P2|Safety Set|Overall Study||894
2293924|NCT02064868|5633139|P1|Safety Set|Overall Study|The Safety Set includes one patient not randomized but treated with serelaxin|1729
2293925|NCT02064868|5633138|P2|Full Analysis Set|Overall Study||894
2293926|NCT02064868|5633139|P1|Full Analysis Set|Overall Study||1756
2293927|NCT02064868|5633138|P2|STARTED|Overall Study||894
2293928|NCT02064868|5633139|P1|STARTED|Overall Study||1756
2293929|NCT02064816|5633159|P2|NOT COMPLETED|Overall Study||8
2293930|NCT02064816|5633160|P1|NOT COMPLETED|Overall Study||8
2293931|NCT02064816|5633159|P2|COMPLETED|Overall Study||88
2293932|NCT02064816|5633160|P1|COMPLETED|Overall Study||96
2293933|NCT02064816|5633159|P2|STARTED|Overall Study||96
2293934|NCT02064816|5633160|P1|STARTED|Overall Study||104
2293935|NCT02064439|5633201|P3|NOT COMPLETED|Overall Study||182
2293936|NCT02064439|5633202|P2|NOT COMPLETED|Overall Study||138
2293937|NCT02064439|5633203|P1|NOT COMPLETED|Overall Study||143
2293938|NCT02064439|5633201|P3|COMPLETED|Overall Study||949
2293939|NCT02064439|5633202|P2|COMPLETED|Overall Study||969
2293940|NCT02064439|5633203|P1|COMPLETED|Overall Study||984
2293941|NCT02064439|5633201|P3|STARTED|Overall Study|FAS, randomized and received study medication|1131
2293942|NCT02064439|5633202|P2|STARTED|Overall Study|FAS, randomized and received study medication|1107
2293943|NCT02064439|5633203|P1|STARTED|Overall Study|Full Analysis Set (FAS), randomized and received study medication|1127
2293944|NCT02064387|5633231|P11|NOT COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||13
2293945|NCT02064387|5633232|P10|NOT COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
2293946|NCT02064387|5633233|P9|NOT COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
2293947|NCT02064387|5633234|P8|NOT COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
2293948|NCT02064387|5633235|P7|NOT COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
2293949|NCT02064387|5633236|P6|NOT COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
2293950|NCT02064387|5633237|P5|NOT COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
2293951|NCT02064387|5633238|P4|NOT COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
2293952|NCT02064387|5633239|P3|NOT COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
2293953|NCT02064387|5633240|P2|NOT COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
2293954|NCT02064387|5633241|P1|NOT COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
2293955|NCT02064387|5633231|P11|COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||22
2293956|NCT02064387|5633232|P10|COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
2293957|NCT02064387|5633233|P9|COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
2293958|NCT02064387|5633234|P8|COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
2293959|NCT02064387|5633235|P7|COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
2293960|NCT02064387|5633236|P6|COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
2293961|NCT02064387|5633237|P5|COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
2293962|NCT02064387|5633238|P4|COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
2293963|NCT02064387|5633239|P3|COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
2293964|NCT02064387|5633240|P2|COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
2293965|NCT02064387|5633241|P1|COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
2293966|NCT02064387|5633231|P11|STARTED|Part 2 Max 24.2 Mnths Follow-up Duration||35
2293967|NCT02064387|5633232|P10|STARTED|Part 2 Max 24.2 Mnths Follow-up Duration||0
2293968|NCT02064387|5633233|P9|STARTED|Part 2 Max 24.2 Mnths Follow-up Duration||0
2293969|NCT02064387|5633234|P8|STARTED|Part 2 Max 24.2 Mnths Follow-up Duration||0
2293970|NCT02064387|5633235|P7|STARTED|Part 2 Max 24.2 Mnths Follow-up Duration||0
2293971|NCT02064387|5633236|P6|STARTED|Part 2 Max 24.2 Mnths Follow-up Duration||0
2293972|NCT02064387|5633237|P5|STARTED|Part 2 Max 24.2 Mnths Follow-up Duration||0
2293973|NCT02064387|5633238|P4|STARTED|Part 2 Max 24.2 Mnths Follow-up Duration||0
2293974|NCT02064387|5633239|P3|STARTED|Part 2 Max 24.2 Mnths Follow-up Duration||0
2293975|NCT02064387|5633240|P2|STARTED|Part 2 Max 24.2 Mnths Follow-up Duration||0
2293976|NCT02064387|5633241|P1|STARTED|Part 2 Max 24.2 Mnths Follow-up Duration||0
2293977|NCT02064387|5633231|P11|NOT COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||0
2293978|NCT02064387|5633232|P10|NOT COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||1
2293979|NCT02064387|5633233|P9|NOT COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||1
2293980|NCT02064387|5633234|P8|NOT COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||3
2293981|NCT02064387|5633235|P7|NOT COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||0
2293982|NCT02064387|5633236|P6|NOT COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||0
2293983|NCT02064387|5633237|P5|NOT COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||0
2293984|NCT02064387|5633238|P4|NOT COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||0
2293985|NCT02064387|5633239|P3|NOT COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||0
2293986|NCT02064387|5633240|P2|NOT COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||0
2293987|NCT02064387|5633241|P1|NOT COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||0
2293988|NCT02064387|5633231|P11|COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||0
2293989|NCT02064387|5633232|P10|COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||5
2293990|NCT02064387|5633233|P9|COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||2
2293991|NCT02064387|5633234|P8|COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||5
2293992|NCT02064387|5633235|P7|COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||4
2293993|NCT02064387|5633236|P6|COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||3
2293994|NCT02064387|5633237|P5|COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||4
2293995|NCT02064387|5633238|P4|COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||4
2293996|NCT02064387|5633239|P3|COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||4
2293997|NCT02064387|5633240|P2|COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||1
2293998|NCT02064387|5633241|P1|COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||1
2293999|NCT02064387|5633231|P11|STARTED|Part 1 Max 21.6 Mnths Follow-up Duration||0
2294000|NCT02064387|5633232|P10|STARTED|Part 1 Max 21.6 Mnths Follow-up Duration||6
2294001|NCT02064387|5633233|P9|STARTED|Part 1 Max 21.6 Mnths Follow-up Duration||3
2294002|NCT02064387|5633234|P8|STARTED|Part 1 Max 21.6 Mnths Follow-up Duration||8
2294003|NCT02064387|5633235|P7|STARTED|Part 1 Max 21.6 Mnths Follow-up Duration||4
2294004|NCT02064387|5633236|P6|STARTED|Part 1 Max 21.6 Mnths Follow-up Duration||3
2294005|NCT02064387|5633237|P5|STARTED|Part 1 Max 21.6 Mnths Follow-up Duration||4
2294006|NCT02064387|5633238|P4|STARTED|Part 1 Max 21.6 Mnths Follow-up Duration||4
2294007|NCT02064387|5633239|P3|STARTED|Part 1 Max 21.6 Mnths Follow-up Duration||4
2294008|NCT02064387|5633240|P2|STARTED|Part 1 Max 21.6 Mnths Follow-up Duration||1
2294009|NCT02064387|5633241|P1|STARTED|Part 1 Max 21.6 Mnths Follow-up Duration||1
2294010|NCT02064270|5633540|P2|NOT COMPLETED|Overall Study||32
2294011|NCT02064270|5633541|P1|NOT COMPLETED|Overall Study||62
2294012|NCT02064270|5633540|P2|COMPLETED|Overall Study||231
2294013|NCT02064270|5633541|P1|COMPLETED|Overall Study||201
2294014|NCT02064270|5633540|P2|STARTED|Overall Study||263
2294015|NCT02064270|5633541|P1|STARTED|Overall Study||263
2294016|NCT02064231|5633556|P4|NOT COMPLETED|Third Test Period (Own Product)||0
2294017|NCT02064231|5633557|P3|NOT COMPLETED|Third Test Period (Own Product)||0
2294018|NCT02064231|5633558|P2|NOT COMPLETED|Third Test Period (Own Product)||0
2294019|NCT02064231|5633559|P1|NOT COMPLETED|Third Test Period (Own Product)||0
2294020|NCT02064231|5633556|P4|COMPLETED|Third Test Period (Own Product)||1
2294021|NCT02064231|5633557|P3|COMPLETED|Third Test Period (Own Product)||0
2294022|NCT02064231|5633558|P2|COMPLETED|Third Test Period (Own Product)||8
2294023|NCT02064231|5633559|P1|COMPLETED|Third Test Period (Own Product)||8
2294024|NCT02064231|5633556|P4|STARTED|Third Test Period (Own Product)||1
2294025|NCT02064231|5633557|P3|STARTED|Third Test Period (Own Product)||0
2294026|NCT02064231|5633558|P2|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test C proceeded to test Own product afterwards|8
2294027|NCT02064231|5633559|P1|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test A proceeded to test Own product afterwards.|8
2294028|NCT02064231|5633556|P4|NOT COMPLETED|Second Test Period (Test B or Test D)||0
2294029|NCT02064231|5633557|P3|NOT COMPLETED|Second Test Period (Test B or Test D)||0
2294030|NCT02064231|5633558|P2|NOT COMPLETED|Second Test Period (Test B or Test D)||1
2294031|NCT02064231|5633559|P1|NOT COMPLETED|Second Test Period (Test B or Test D)||1
2294032|NCT02064231|5633556|P4|COMPLETED|Second Test Period (Test B or Test D)||1
2294033|NCT02064231|5633557|P3|COMPLETED|Second Test Period (Test B or Test D)||0
2294034|NCT02064231|5633558|P2|COMPLETED|Second Test Period (Test B or Test D)||7
2294035|NCT02064231|5633559|P1|COMPLETED|Second Test Period (Test B or Test D)||6
2294036|NCT02064231|5633556|P4|STARTED|Second Test Period (Test B or Test D)||1
2294037|NCT02064231|5633557|P3|STARTED|Second Test Period (Test B or Test D)||0
2294038|NCT02064231|5633558|P2|STARTED|Second Test Period (Test B or Test D)||8
2294039|NCT02064231|5633559|P1|STARTED|Second Test Period (Test B or Test D)||7
2294040|NCT02064231|5633556|P4|NOT COMPLETED|First Test Period (Test A or Test C)||0
2294041|NCT02064231|5633557|P3|NOT COMPLETED|First Test Period (Test A or Test C)||1
2294042|NCT02064231|5633558|P2|NOT COMPLETED|First Test Period (Test A or Test C)||4
2294043|NCT02064231|5633559|P1|NOT COMPLETED|First Test Period (Test A or Test C)||7
2294044|NCT02064231|5633556|P4|COMPLETED|First Test Period (Test A or Test C)||1
2294045|NCT02064231|5633557|P3|COMPLETED|First Test Period (Test A or Test C)||0
2294046|NCT02064231|5633558|P2|COMPLETED|First Test Period (Test A or Test C)||8
2294047|NCT02064231|5633559|P1|COMPLETED|First Test Period (Test A or Test C)||7
2294048|NCT02064231|5633556|P4|STARTED|First Test Period (Test A or Test C)||1
2294049|NCT02064231|5633557|P3|STARTED|First Test Period (Test A or Test C)||1
2294050|NCT02064231|5633558|P2|STARTED|First Test Period (Test A or Test C)||12
2294051|NCT02064231|5633559|P1|STARTED|First Test Period (Test A or Test C)||14
2294052|NCT02064205|5633571|P1|NOT COMPLETED|Overall Study||1
2294053|NCT02064205|5633571|P1|COMPLETED|Overall Study||31
2294054|NCT02064205|5633571|P1|Condition D|Overall Study||32
2294055|NCT02064205|5633571|P1|Condition C|Overall Study||31
2294056|NCT02064205|5633571|P1|Condition B|Overall Study||32
2294057|NCT02064205|5633571|P1|Condition A|Overall Study||32
2294058|NCT02064205|5633571|P1|STARTED|Overall Study||32
2294059|NCT02064166|5633589|P2|NOT COMPLETED|Overall Study||0
2294060|NCT02064166|5633590|P1|NOT COMPLETED|Overall Study||1
2294061|NCT02064166|5633589|P2|COMPLETED|Overall Study||6
2294062|NCT02064166|5633590|P1|COMPLETED|Overall Study||8
2294063|NCT02064166|5633589|P2|STARTED|Overall Study||6
2294064|NCT02064166|5633590|P1|STARTED|Overall Study||9
2294065|NCT02063880|5633620|P2|NOT COMPLETED|Overall Study||27
2294066|NCT02063880|5633621|P1|NOT COMPLETED|Overall Study||28
2294067|NCT02063880|5633620|P2|COMPLETED|Overall Study||66
2294068|NCT02063880|5633621|P1|COMPLETED|Overall Study||62
2294069|NCT02063880|5633620|P2|STARTED|Overall Study||93
2294070|NCT02063880|5633621|P1|STARTED|Overall Study||90
2294072|NCT02063867|5633634|P1|NOT COMPLETED|Overall Study||4291
2294073|NCT02063867|5633633|P2|COMPLETED|Overall Study||180048
2294074|NCT02063867|5633634|P1|COMPLETED|Overall Study||152598
2294075|NCT02063867|5633633|P2|STARTED|Overall Study||183013
2294076|NCT02063867|5633634|P1|STARTED|Overall Study||156889
2294077|NCT02063854|5633659|P7|NOT COMPLETED|Overall Study||6
2294078|NCT02063854|5633660|P6|NOT COMPLETED|Overall Study||31
2294079|NCT02063854|5633661|P5|NOT COMPLETED|Overall Study||11
2294080|NCT02063854|5633662|P4|NOT COMPLETED|Overall Study||10
2294081|NCT02063854|5633663|P3|NOT COMPLETED|Overall Study||30
2294082|NCT02063854|5633664|P2|NOT COMPLETED|Overall Study||12
2294083|NCT02063854|5633665|P1|NOT COMPLETED|Overall Study||21
2294084|NCT02063854|5633659|P7|COMPLETED|Overall Study||60
2294085|NCT02063854|5633660|P6|COMPLETED|Overall Study||170
2294086|NCT02063854|5633661|P5|COMPLETED|Overall Study||54
2294087|NCT02063854|5633662|P4|COMPLETED|Overall Study||58
2294088|NCT02063854|5633663|P3|COMPLETED|Overall Study||176
2294089|NCT02063854|5633664|P2|COMPLETED|Overall Study||54
2294090|NCT02063854|5633665|P1|COMPLETED|Overall Study||178
2294091|NCT02063854|5633659|P7|Full Analysis Set: Received Study Drug|Overall Study||66
2294092|NCT02063854|5633660|P6|Full Analysis Set: Received Study Drug|Overall Study||200
2294093|NCT02063854|5633661|P5|Full Analysis Set: Received Study Drug|Overall Study||65
2294094|NCT02063854|5633662|P4|Full Analysis Set: Received Study Drug|Overall Study||68
2294095|NCT02063854|5633663|P3|Full Analysis Set: Received Study Drug|Overall Study||206
2294096|NCT02063854|5633664|P2|Full Analysis Set: Received Study Drug|Overall Study||66
2294097|NCT02063854|5633665|P1|Full Analysis Set: Received Study Drug|Overall Study||199
2294098|NCT02063854|5633659|P7|STARTED|Overall Study||66
2294099|NCT02063854|5633660|P6|STARTED|Overall Study||201
2294100|NCT02063854|5633661|P5|STARTED|Overall Study||65
2294101|NCT02063854|5633662|P4|STARTED|Overall Study||68
2294102|NCT02063854|5633663|P3|STARTED|Overall Study||206
2294103|NCT02063854|5633664|P2|STARTED|Overall Study||66
2294104|NCT02063854|5633665|P1|STARTED|Overall Study||199
2294105|NCT02063737|5633749|P2|NOT COMPLETED|Overall Study||4
2294106|NCT02063737|5633750|P1|NOT COMPLETED|Overall Study||11
2294107|NCT02063737|5633749|P2|COMPLETED|Overall Study||44
2294108|NCT02063737|5633750|P1|COMPLETED|Overall Study||41
2294109|NCT02063737|5633749|P2|STARTED|Overall Study||48
2294110|NCT02063737|5633750|P1|STARTED|Overall Study||52
2294111|NCT02063724|5633782|P1|NOT COMPLETED|Overall Study||1
2294112|NCT02063724|5633782|P1|COMPLETED|Overall Study||14
2294113|NCT02063724|5633782|P1|STARTED|Overall Study||15
2294114|NCT02063698|5633790|P2|NOT COMPLETED|Overall Study||2
2294115|NCT02063698|5633791|P1|NOT COMPLETED|Overall Study||1
2294116|NCT02063698|5633790|P2|COMPLETED|Overall Study||13
2294117|NCT02063698|5633791|P1|COMPLETED|Overall Study||14
2294118|NCT02063698|5633790|P2|STARTED|Overall Study||15
2294119|NCT02063698|5633791|P1|STARTED|Overall Study||15
2294120|NCT02063672|5633815|P2|NOT COMPLETED|Overall Study||22
2294121|NCT02063672|5633816|P1|NOT COMPLETED|Overall Study||35
2294122|NCT02063672|5633815|P2|COMPLETED|Overall Study||7
2294123|NCT02063672|5633816|P1|COMPLETED|Overall Study||18
2294124|NCT02063672|5633815|P2|STARTED|Overall Study||29
2294125|NCT02063672|5633816|P1|STARTED|Overall Study||53
2294126|NCT02063659|5633863|P4|NOT COMPLETED|Open-Label Extension Period (OLE)||20
2294127|NCT02063659|5633864|P3|NOT COMPLETED|Open-Label Extension Period (OLE)||0
2294128|NCT02063659|5633865|P2|NOT COMPLETED|Open-Label Extension Period (OLE)||0
2294129|NCT02063659|5633866|P1|NOT COMPLETED|Open-Label Extension Period (OLE)||0
2294130|NCT02063659|5633863|P4|COMPLETED|Open-Label Extension Period (OLE)||47
2294131|NCT02063659|5633864|P3|COMPLETED|Open-Label Extension Period (OLE)||0
2294132|NCT02063659|5633865|P2|COMPLETED|Open-Label Extension Period (OLE)||0
2294133|NCT02063659|5633866|P1|COMPLETED|Open-Label Extension Period (OLE)||0
2294134|NCT02063659|5633863|P4|STARTED|Open-Label Extension Period (OLE)||67
2294135|NCT02063659|5633864|P3|STARTED|Open-Label Extension Period (OLE)||0
2294136|NCT02063659|5633865|P2|STARTED|Open-Label Extension Period (OLE)||0
2294137|NCT02063659|5633866|P1|STARTED|Open-Label Extension Period (OLE)||0
2294138|NCT02063659|5633863|P4|NOT COMPLETED|Double-Blind Treatment Period||0
2294139|NCT02063659|5633864|P3|NOT COMPLETED|Double-Blind Treatment Period||3
2294140|NCT02063659|5633865|P2|NOT COMPLETED|Double-Blind Treatment Period||3
2294141|NCT02063659|5633866|P1|NOT COMPLETED|Double-Blind Treatment Period||2
2294142|NCT02063659|5633863|P4|COMPLETED|Double-Blind Treatment Period||0
2294143|NCT02063659|5633864|P3|COMPLETED|Double-Blind Treatment Period||22
2294144|NCT02063659|5633865|P2|COMPLETED|Double-Blind Treatment Period||22
2294145|NCT02063659|5633866|P1|COMPLETED|Double-Blind Treatment Period||24
2294146|NCT02063659|5633863|P4|STARTED|Double-Blind Treatment Period||0
2294147|NCT02063659|5633864|P3|STARTED|Double-Blind Treatment Period||25
2294148|NCT02063659|5633865|P2|STARTED|Double-Blind Treatment Period||25
2294149|NCT02063659|5633866|P1|STARTED|Double-Blind Treatment Period||26
2294150|NCT02063516|5633898|P2|NOT COMPLETED|Overall Study||0
2294151|NCT02063516|5633899|P1|NOT COMPLETED|Overall Study||0
2294152|NCT02063516|5633898|P2|COMPLETED|Overall Study||40
2294153|NCT02063516|5633899|P1|COMPLETED|Overall Study||40
2294154|NCT02063516|5633898|P2|STARTED|Overall Study||40
2294155|NCT02063516|5633899|P1|STARTED|Overall Study||40
2294156|NCT02063230|5633913|P4|NOT COMPLETED|Overall Study||0
2294157|NCT02063230|5633914|P3|NOT COMPLETED|Overall Study||0
2294158|NCT02063230|5633915|P2|NOT COMPLETED|Overall Study||0
2294159|NCT02063230|5633916|P1|NOT COMPLETED|Overall Study||0
2294160|NCT02063230|5633913|P4|COMPLETED|Overall Study||8
2294161|NCT02063230|5633914|P3|COMPLETED|Overall Study||8
2294162|NCT02063230|5633915|P2|COMPLETED|Overall Study||8
2294163|NCT02063230|5633916|P1|COMPLETED|Overall Study||8
2294164|NCT02063230|5633913|P4|Received Treatment|Overall Study||8
2294165|NCT02063230|5633914|P3|Received Treatment|Overall Study||8
2294166|NCT02063230|5633915|P2|Received Treatment|Overall Study||8
2294167|NCT02063230|5633916|P1|Received Treatment|Overall Study||8
2294168|NCT02063230|5633913|P4|STARTED|Overall Study||8
2294169|NCT02063230|5633914|P3|STARTED|Overall Study||8
2294170|NCT02063230|5633915|P2|STARTED|Overall Study||8
2294171|NCT02063230|5633916|P1|STARTED|Overall Study||8
2294172|NCT02063217|5633949|P3|NOT COMPLETED|Overall Study||0
2294173|NCT02063217|5633950|P2|NOT COMPLETED|Overall Study||0
2294174|NCT02063217|5633951|P1|NOT COMPLETED|Overall Study||1
2294175|NCT02063217|5633949|P3|COMPLETED|Overall Study||12
2294176|NCT02063217|5633950|P2|COMPLETED|Overall Study||12
2294177|NCT02063217|5633951|P1|COMPLETED|Overall Study||11
2294178|NCT02063217|5633949|P3|STARTED|Overall Study||12
2294179|NCT02063217|5633950|P2|STARTED|Overall Study||12
2294180|NCT02063217|5633951|P1|STARTED|Overall Study||12
2294181|NCT02063178|5633961|P2|NOT COMPLETED|Overall Study||47
2294182|NCT02063178|5633962|P1|NOT COMPLETED|Overall Study||29
2294183|NCT02063178|5633961|P2|COMPLETED|Overall Study||77
2294184|NCT02063178|5633962|P1|COMPLETED|Overall Study||95
2294185|NCT02063178|5633961|P2|STARTED|Overall Study||124
2294186|NCT02063178|5633962|P1|STARTED|Overall Study||124
2294187|NCT02063087|5633976|P2|NOT COMPLETED|7 Day Follow-up||0
2294188|NCT02063087|5633977|P1|NOT COMPLETED|7 Day Follow-up||0
2294189|NCT02063087|5633976|P2|COMPLETED|7 Day Follow-up||478
2294190|NCT02063087|5633977|P1|COMPLETED|7 Day Follow-up||493
2294191|NCT02063087|5633976|P2|STARTED|7 Day Follow-up||478
2294192|NCT02063087|5633977|P1|STARTED|7 Day Follow-up||493
2294193|NCT02063087|5633976|P2|NOT COMPLETED|Emergency Department Intervention||0
2294194|NCT02063087|5633977|P1|NOT COMPLETED|Emergency Department Intervention||0
2294195|NCT02063087|5633976|P2|COMPLETED|Emergency Department Intervention||478
2294196|NCT02063087|5633977|P1|COMPLETED|Emergency Department Intervention||493
2294197|NCT02063087|5633976|P2|STARTED|Emergency Department Intervention||478
2294198|NCT02063087|5633977|P1|STARTED|Emergency Department Intervention||493
2294199|NCT02063035|5634001|P2|NOT COMPLETED|Overall Study||0
2294200|NCT02063035|5634002|P1|NOT COMPLETED|Overall Study||0
2294201|NCT02063035|5634001|P2|COMPLETED|Overall Study||17
2294202|NCT02063035|5634002|P1|COMPLETED|Overall Study||12
2294203|NCT02063035|5634001|P2|STARTED|Overall Study||17
2294204|NCT02063035|5634002|P1|STARTED|Overall Study||12
2294205|NCT02062905|5634016|P2|NOT COMPLETED|Overall Study||2
2294206|NCT02062905|5634017|P1|NOT COMPLETED|Overall Study||7
2294207|NCT02062905|5634016|P2|COMPLETED|Overall Study||31
2294208|NCT02062905|5634017|P1|COMPLETED|Overall Study||28
2294209|NCT02062905|5634016|P2|STARTED|Overall Study||33
2294210|NCT02062905|5634017|P1|STARTED|Overall Study||35
2294211|NCT02062879|5634027|P2|NOT COMPLETED|Overall Study||1
2294212|NCT02062879|5634028|P1|NOT COMPLETED|Overall Study||4
2294213|NCT02062879|5634027|P2|COMPLETED|Overall Study||9
2294214|NCT02062879|5634028|P1|COMPLETED|Overall Study||6
2294215|NCT02062879|5634027|P2|STARTED|Overall Study||10
2294216|NCT02062879|5634028|P1|STARTED|Overall Study||10
2294217|NCT02062801|5634040|P2|NOT COMPLETED|Overall Study||4
2294218|NCT02062801|5634041|P1|NOT COMPLETED|Overall Study||2
2294219|NCT02062801|5634040|P2|COMPLETED|Overall Study||297
2294220|NCT02062801|5634041|P1|COMPLETED|Overall Study||299
2294221|NCT02062801|5634040|P2|STARTED|Overall Study||301
2294222|NCT02062801|5634041|P1|STARTED|Overall Study||301
2294223|NCT02062710|5634051|P6|NOT COMPLETED|Overall Study||0
2294224|NCT02062710|5634052|P5|NOT COMPLETED|Overall Study||0
2294225|NCT02062710|5634053|P4|NOT COMPLETED|Overall Study||0
2294226|NCT02062710|5634054|P3|NOT COMPLETED|Overall Study||0
2294227|NCT02062710|5634055|P2|NOT COMPLETED|Overall Study||0
2294228|NCT02062710|5634056|P1|NOT COMPLETED|Overall Study||0
2294229|NCT02062710|5634051|P6|COMPLETED|Overall Study||4
2294230|NCT02062710|5634052|P5|COMPLETED|Overall Study||3
2294231|NCT02062710|5634053|P4|COMPLETED|Overall Study||3
2294232|NCT02062710|5634054|P3|COMPLETED|Overall Study||5
2294233|NCT02062710|5634055|P2|COMPLETED|Overall Study||4
2294234|NCT02062710|5634056|P1|COMPLETED|Overall Study||3
2294235|NCT02062710|5634051|P6|STARTED|Overall Study|4 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
2294236|NCT02062710|5634052|P5|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this aprticular sequence|3
2294237|NCT02062710|5634053|P4|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
2294238|NCT02062710|5634054|P3|STARTED|Overall Study|5 of total of 22 subjects randomized to receive the 3 study drugs in this particular sequence|5
2294239|NCT02062710|5634055|P2|STARTED|Overall Study|4 of the total 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
2294240|NCT02062710|5634056|P1|STARTED|Overall Study|3 of total 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
2294241|NCT02062658|5634064|P1|NOT COMPLETED|Overall Study||2
2294242|NCT02062658|5634064|P1|COMPLETED|Overall Study||8
2294243|NCT02062658|5634064|P1|STARTED|Overall Study||10
2294244|NCT02062645|5634068|P1|NOT COMPLETED|Overall Study||15
2294245|NCT02062645|5634068|P1|COMPLETED|Overall Study||100
2294246|NCT02062645|5634068|P1|STARTED|Overall Study||115
2294247|NCT02062632|5634076|P1|NOT COMPLETED|Overall Study||1
2294248|NCT02062632|5634076|P1|COMPLETED|Overall Study||2
2294249|NCT02062632|5634076|P1|STARTED|Overall Study||3
2294250|NCT02062580|5634085|P2|NOT COMPLETED|Overall Study||13
2294251|NCT02062580|5634086|P1|NOT COMPLETED|Overall Study||12
2294252|NCT02062580|5634085|P2|COMPLETED|Overall Study||65
2294253|NCT02062580|5634086|P1|COMPLETED|Overall Study||59
2294254|NCT02062580|5634085|P2|STARTED|Overall Study||78
2294255|NCT02062580|5634086|P1|STARTED|Overall Study||71
2294256|NCT02062502|5634096|P2|NOT COMPLETED|Overall Study||35
2294257|NCT02062502|5634097|P1|NOT COMPLETED|Overall Study||43
2294258|NCT02062502|5634096|P2|COMPLETED|Overall Study||270
2294259|NCT02062502|5634097|P1|COMPLETED|Overall Study||263
2294260|NCT02062502|5634096|P2|Vaccinated Dose 1|Overall Study||305
2294261|NCT02062502|5634097|P1|Vaccinated Dose 1|Overall Study||306
2294262|NCT02062502|5634096|P2|STARTED|Overall Study||305
2294263|NCT02062502|5634097|P1|STARTED|Overall Study||306
2294264|NCT02062450|5634117|P1|NOT COMPLETED|Overall Study||124
2294265|NCT02062450|5634117|P1|COMPLETED|Overall Study||255
2294266|NCT02062450|5634117|P1|Per Protocol Cohort|Overall Study|255 patients attended their 2-year follow-up visit.|255
2294267|NCT02062450|5634117|P1|STARTED|Overall Study|379 patients were successfully reached by phone and convoked for the 2-year follow-up visit.|379
2294268|NCT02062437|5634131|P1|NOT COMPLETED|Overall Study||52
2294269|NCT02062437|5634131|P1|COMPLETED|Overall Study|80 patients were effectively enrolled, when coming back for their 2-year follow-up visit.|80
2294270|NCT02062437|5634131|P1|STARTED|Overall Study|132 patients who undergone THR (July-Oct 2010), complying with in/exclusion criteria were identified|132
2294271|NCT02062398|5634140|P1|NOT COMPLETED|Overall Study||1
2294272|NCT02062398|5634140|P1|COMPLETED|Overall Study||12
2294273|NCT02062398|5634140|P1|STARTED|Overall Study||13
2294274|NCT02062385|5634152|P4|NOT COMPLETED|Overall Study||9
2294275|NCT02062385|5634153|P3|NOT COMPLETED|Overall Study||12
2294276|NCT02062385|5634154|P2|NOT COMPLETED|Overall Study||65
2294277|NCT02062385|5634155|P1|NOT COMPLETED|Overall Study||78
2294278|NCT02062385|5634152|P4|COMPLETED|Overall Study||391
2294279|NCT02062385|5634153|P3|COMPLETED|Overall Study||388
2294280|NCT02062385|5634154|P2|COMPLETED|Overall Study||1555
2294281|NCT02062385|5634155|P1|COMPLETED|Overall Study||1542
2294282|NCT02062385|5634152|P4|Received Vaccination 3|Overall Study||392
2294283|NCT02062385|5634153|P3|Received Vaccination 3|Overall Study||389
2294284|NCT02062385|5634154|P2|Received Vaccination 3|Overall Study||1554
2294285|NCT02062385|5634155|P1|Received Vaccination 3|Overall Study||1543
2294286|NCT02062385|5634152|P4|Received Vaccination 2|Overall Study||393
2294287|NCT02062385|5634153|P3|Received Vaccination 2|Overall Study||392
2294288|NCT02062385|5634154|P2|Received Vaccination 2|Overall Study||1566
2294289|NCT02062385|5634155|P1|Received Vaccination 2|Overall Study||1554
2294290|NCT02062385|5634152|P4|Received Vaccination 1|Overall Study||400
2294291|NCT02062385|5634153|P3|Received Vaccination 1|Overall Study||400
2294292|NCT02062385|5634154|P2|Received Vaccination 1|Overall Study||1619
2294293|NCT02062385|5634155|P1|Received Vaccination 1|Overall Study||1618
2294294|NCT02062385|5634152|P4|STARTED|Overall Study||400
2294295|NCT02062385|5634153|P3|STARTED|Overall Study||400
2294296|NCT02062385|5634154|P2|STARTED|Overall Study||1620
2294297|NCT02062385|5634155|P1|STARTED|Overall Study||1620
2294298|NCT02062359|5634175|P1|NOT COMPLETED|Overall Study||0
2294299|NCT02062359|5634175|P1|COMPLETED|Overall Study||2
2294300|NCT02062359|5634175|P1|STARTED|Overall Study||2
2294301|NCT02062294|5634181|P1|NOT COMPLETED|Overall Study||0
2294302|NCT02062294|5634181|P1|COMPLETED|Overall Study||14
2294303|NCT02062294|5634181|P1|STARTED|Overall Study||14
2294304|NCT02062177|5634188|P2|NOT COMPLETED|Overall Study||0
2294305|NCT02062177|5634189|P1|NOT COMPLETED|Overall Study||0
2294306|NCT02062177|5634188|P2|COMPLETED|Overall Study||70
2294307|NCT02062177|5634189|P1|COMPLETED|Overall Study||70
2294308|NCT02062177|5634188|P2|STARTED|Overall Study||70
2294309|NCT02062177|5634189|P1|STARTED|Overall Study||70
2294310|NCT02062151|5634199|P1|NOT COMPLETED|Overall Study||1
2294311|NCT02062151|5634199|P1|COMPLETED|Overall Study||20
2294312|NCT02062151|5634199|P1|STARTED|Overall Study||21
2294313|NCT02061969|5634206|P2|NOT COMPLETED|Overall Study||0
2294314|NCT02061969|5634207|P1|NOT COMPLETED|Overall Study||0
2294315|NCT02061969|5634206|P2|COMPLETED|Overall Study||67
2294316|NCT02061969|5634207|P1|COMPLETED|Overall Study||73
2294317|NCT02061969|5634206|P2|STARTED|Overall Study||67
2294318|NCT02061969|5634207|P1|STARTED|Overall Study||73
2294319|NCT02061748|5634237|P2|NOT COMPLETED|Overall Study||0
2294320|NCT02061748|5634238|P1|NOT COMPLETED|Overall Study||0
2294321|NCT02061748|5634237|P2|COMPLETED|Overall Study||30853
2294322|NCT02061748|5634238|P1|COMPLETED|Overall Study||7646
2294323|NCT02061748|5634237|P2|STARTED|Overall Study||30853
2294324|NCT02061748|5634238|P1|STARTED|Overall Study||7646
2294325|NCT02061696|5634312|P2|NOT COMPLETED|Overall Study||0
2294326|NCT02061696|5634313|P1|NOT COMPLETED|Overall Study||0
2294327|NCT02061696|5634312|P2|COMPLETED|Overall Study||22
2294328|NCT02061696|5634313|P1|COMPLETED|Overall Study||17
2294329|NCT02061696|5634312|P2|STARTED|Overall Study||22
2294330|NCT02061696|5634313|P1|STARTED|Overall Study||17
2294331|NCT02061683|5634337|P1|NOT COMPLETED|Overall Study||60
2294332|NCT02061683|5634337|P1|COMPLETED|Overall Study||203
2294333|NCT02061683|5634337|P1|STARTED|Overall Study||263
2294334|NCT02061592|5634344|P2|NOT COMPLETED|Period 2||1
2294335|NCT02061592|5634345|P1|NOT COMPLETED|Period 2||0
2294336|NCT02061592|5634344|P2|COMPLETED|Period 2||61
2294337|NCT02061592|5634345|P1|COMPLETED|Period 2||64
2294338|NCT02061592|5634344|P2|STARTED|Period 2||62
2294339|NCT02061592|5634345|P1|STARTED|Period 2||64
2294340|NCT02061592|5634344|P2|NOT COMPLETED|Period 1||0
2294341|NCT02061592|5634345|P1|NOT COMPLETED|Period 1||2
2294342|NCT02061592|5634344|P2|COMPLETED|Period 1||62
2294343|NCT02061592|5634345|P1|COMPLETED|Period 1||64
2294344|NCT02061592|5634344|P2|STARTED|Period 1||62
2294345|NCT02061592|5634345|P1|STARTED|Period 1||66
2294346|NCT02061540|5634357|P1|NOT COMPLETED|Overall Study||4
2294347|NCT02061540|5634357|P1|COMPLETED|Overall Study||23
2294348|NCT02061540|5634357|P1|Down-Titrated on LUM001 During the Study|Overall Study||5
2294349|NCT02061540|5634357|P1|STARTED|Overall Study||27
2294350|NCT02061358|5634379|P9|NOT COMPLETED|Overall Study||0
2294351|NCT02061358|5634380|P8|NOT COMPLETED|Overall Study||0
2294352|NCT02061358|5634381|P7|NOT COMPLETED|Overall Study||0
2294353|NCT02061358|5634382|P6|NOT COMPLETED|Overall Study||0
2294354|NCT02061358|5634383|P5|NOT COMPLETED|Overall Study||0
2294355|NCT02061358|5634384|P4|NOT COMPLETED|Overall Study||0
2294356|NCT02061358|5634385|P3|NOT COMPLETED|Overall Study||0
2294357|NCT02061358|5634386|P2|NOT COMPLETED|Overall Study||0
2294358|NCT02061358|5634387|P1|NOT COMPLETED|Overall Study||0
2294359|NCT02061358|5634379|P9|COMPLETED|Overall Study||16
2294360|NCT02061358|5634380|P8|COMPLETED|Overall Study||6
2294361|NCT02061358|5634381|P7|COMPLETED|Overall Study||6
2294362|NCT02061358|5634382|P6|COMPLETED|Overall Study||6
2294363|NCT02061358|5634383|P5|COMPLETED|Overall Study||6
2294364|NCT02061358|5634384|P4|COMPLETED|Overall Study||6
2294365|NCT02061358|5634385|P3|COMPLETED|Overall Study||6
2294366|NCT02061358|5634386|P2|COMPLETED|Overall Study||6
2294367|NCT02061358|5634387|P1|COMPLETED|Overall Study||6
2294368|NCT02061358|5634379|P9|STARTED|Overall Study||16
2294369|NCT02061358|5634380|P8|STARTED|Overall Study||6
2294370|NCT02061358|5634381|P7|STARTED|Overall Study||6
2294371|NCT02061358|5634382|P6|STARTED|Overall Study||6
2294372|NCT02061358|5634383|P5|STARTED|Overall Study||6
2294373|NCT02061358|5634384|P4|STARTED|Overall Study||6
2294374|NCT02061358|5634385|P3|STARTED|Overall Study||6
2294375|NCT02061358|5634386|P2|STARTED|Overall Study||6
2294376|NCT02061358|5634387|P1|STARTED|Overall Study||6
2294377|NCT02061280|5634525|P2|NOT COMPLETED|Overall Study||12
2294378|NCT02061280|5634526|P1|NOT COMPLETED|Overall Study||18
2294379|NCT02061280|5634525|P2|COMPLETED|Overall Study||25
2294380|NCT02061280|5634526|P1|COMPLETED|Overall Study||53
2294381|NCT02061280|5634525|P2|Randomized to Treatment|Overall Study||25
2294382|NCT02061280|5634526|P1|Randomized to Treatment|Overall Study||54
2294383|NCT02061280|5634525|P2|STARTED|Overall Study||37
2294384|NCT02061280|5634526|P1|STARTED|Overall Study||71
2294385|NCT02061202|5634558|P2|NOT COMPLETED|Overall Study||1
2294386|NCT02061202|5634559|P1|NOT COMPLETED|Overall Study||1
2294387|NCT02061202|5634558|P2|COMPLETED|Overall Study||17
2294388|NCT02061202|5634559|P1|COMPLETED|Overall Study||35
2294389|NCT02061202|5634558|P2|STARTED|Overall Study||18
2294390|NCT02061202|5634559|P1|STARTED|Overall Study||36
2294391|NCT02060890|5634583|P1|NOT COMPLETED|Overall Study||4
2294392|NCT02060890|5634583|P1|COMPLETED|Overall Study||16
2294393|NCT02060890|5634583|P1|STARTED|Overall Study||20
2294394|NCT02060838|5634592|P2|NOT COMPLETED|Overall Study||0
2294395|NCT02060838|5634593|P1|NOT COMPLETED|Overall Study||0
2294396|NCT02060838|5634592|P2|COMPLETED|Overall Study||22
2294397|NCT02060838|5634593|P1|COMPLETED|Overall Study||28
2294398|NCT02060838|5634592|P2|STARTED|Overall Study||22
2294399|NCT02060838|5634593|P1|STARTED|Overall Study||28
2294400|NCT02060539|5634601|P1|NOT COMPLETED|Overall Study||0
2294401|NCT02060539|5634601|P1|COMPLETED|Overall Study||19
2294402|NCT02060539|5634601|P1|STARTED|Overall Study||19
2294403|NCT02060526|5634649|P3|NOT COMPLETED|Overall Study||0
2294404|NCT02060526|5634650|P2|NOT COMPLETED|Overall Study||0
2294405|NCT02060526|5634651|P1|NOT COMPLETED|Overall Study||0
2294406|NCT02060526|5634649|P3|COMPLETED|Overall Study||7
2294407|NCT02060526|5634650|P2|COMPLETED|Overall Study||7
2294408|NCT02060526|5634651|P1|COMPLETED|Overall Study||7
2294409|NCT02060526|5634649|P3|STARTED|Overall Study||7
2294410|NCT02060526|5634650|P2|STARTED|Overall Study||7
2294411|NCT02060526|5634651|P1|STARTED|Overall Study||7
2294412|NCT02060461|5634687|P1|NOT COMPLETED|Overall Study||0
2294413|NCT02060461|5634687|P1|COMPLETED|Overall Study||33
2294414|NCT02060461|5634687|P1|STARTED|Overall Study||33
2294415|NCT02060383|5634698|P5|NOT COMPLETED|Extension Phase||7
2294416|NCT02060383|5634699|P4|NOT COMPLETED|Extension Phase||2
2294417|NCT02060383|5634700|P3|NOT COMPLETED|Extension Phase||3
2294418|NCT02060383|5634701|P2|NOT COMPLETED|Extension Phase||3
2294419|NCT02060383|5634702|P1|NOT COMPLETED|Extension Phase||3
2294420|NCT02060383|5634698|P5|COMPLETED|Extension Phase||46
2294421|NCT02060383|5634699|P4|COMPLETED|Extension Phase||19
2294422|NCT02060383|5634700|P3|COMPLETED|Extension Phase||7
2294423|NCT02060383|5634701|P2|COMPLETED|Extension Phase||14
2294424|NCT02060383|5634702|P1|COMPLETED|Extension Phase||14
2294425|NCT02060383|5634698|P5|STARTED|Extension Phase||53
2294426|NCT02060383|5634699|P4|STARTED|Extension Phase||21
2294427|NCT02060383|5634700|P3|STARTED|Extension Phase||10
2294428|NCT02060383|5634701|P2|STARTED|Extension Phase||17
2294429|NCT02060383|5634702|P1|STARTED|Extension Phase||17
2294430|NCT02060383|5634698|P5|NOT COMPLETED|Core Phase||8
2294431|NCT02060383|5634699|P4|NOT COMPLETED|Core Phase||7
2294432|NCT02060383|5634700|P3|NOT COMPLETED|Core Phase||0
2294433|NCT02060383|5634701|P2|NOT COMPLETED|Core Phase||6
2294434|NCT02060383|5634702|P1|NOT COMPLETED|Core Phase||3
2294435|NCT02060383|5634698|P5|COMPLETED|Core Phase||95
2294436|NCT02060383|5634699|P4|COMPLETED|Core Phase||39
2294437|NCT02060383|5634700|P3|COMPLETED|Core Phase||19
2294438|NCT02060383|5634701|P2|COMPLETED|Core Phase||37
2294439|NCT02060383|5634702|P1|COMPLETED|Core Phase||35
2294440|NCT02060383|5634698|P5|Completed Core/Did Not Enter Extension|Core Phase||42
2294441|NCT02060383|5634699|P4|Completed Core/Did Not Enter Extension|Core Phase||18
2294442|NCT02060383|5634700|P3|Completed Core/Did Not Enter Extension|Core Phase||9
2294443|NCT02060383|5634701|P2|Completed Core/Did Not Enter Extension|Core Phase||20
2294444|NCT02060383|5634702|P1|Completed Core/Did Not Enter Extension|Core Phase||18
2294445|NCT02060383|5634698|P5|Completed Core/Entered Extension|Core Phase||53
2294446|NCT02060383|5634699|P4|Completed Core/Entered Extension|Core Phase||21
2294447|NCT02060383|5634700|P3|Completed Core/Entered Extension|Core Phase||10
2294448|NCT02060383|5634701|P2|Completed Core/Entered Extension|Core Phase||17
2294449|NCT02060383|5634702|P1|Completed Core/Entered Extension|Core Phase||17
2294450|NCT02060383|5634698|P5|STARTED|Core Phase||103
2294451|NCT02060383|5634699|P4|STARTED|Core Phase||46
2294452|NCT02060383|5634700|P3|STARTED|Core Phase||19
2294453|NCT02060383|5634701|P2|STARTED|Core Phase||43
2294454|NCT02060383|5634702|P1|STARTED|Core Phase||38
2294455|NCT02060058|5634731|P3|NOT COMPLETED|Overall Study||0
2294456|NCT02060058|5634732|P2|NOT COMPLETED|Overall Study||0
2294457|NCT02060058|5634733|P1|NOT COMPLETED|Overall Study||0
2294458|NCT02060058|5634731|P3|COMPLETED|Overall Study||8
2294459|NCT02060058|5634732|P2|COMPLETED|Overall Study||0
2294460|NCT02060058|5634733|P1|COMPLETED|Overall Study||4
2294461|NCT02060058|5634731|P3|STARTED|Overall Study||8
2294462|NCT02060058|5634732|P2|STARTED|Overall Study||0
2294463|NCT02060058|5634733|P1|STARTED|Overall Study||4
2294464|NCT02059993|5634749|P2|NOT COMPLETED|Overall Study||4
2294465|NCT02059993|5634750|P1|NOT COMPLETED|Overall Study||2
2294466|NCT02059993|5634749|P2|COMPLETED|Overall Study||37
2294467|NCT02059993|5634750|P1|COMPLETED|Overall Study||40
2294468|NCT02059993|5634749|P2|STARTED|Overall Study||41
2294469|NCT02059993|5634750|P1|STARTED|Overall Study||42
2294470|NCT02059980|5634758|P2|NOT COMPLETED|Overall Study||1
2294471|NCT02059980|5634759|P1|NOT COMPLETED|Overall Study||2
2294472|NCT02059980|5634758|P2|COMPLETED|Overall Study||14
2294473|NCT02059980|5634759|P1|COMPLETED|Overall Study||16
2294474|NCT02059980|5634758|P2|STARTED|Overall Study||15
2294475|NCT02059980|5634759|P1|STARTED|Overall Study||18
2294476|NCT02059928|5634771|P1|NOT COMPLETED|Overall Study||0
2294477|NCT02059928|5634771|P1|COMPLETED|Overall Study||20
2294478|NCT02059928|5634771|P1|STARTED|Overall Study||20
2294479|NCT02059902|5634777|P2|NOT COMPLETED|Overall Study||4
2294480|NCT02059902|5634778|P1|NOT COMPLETED|Overall Study||4
2294481|NCT02059902|5634777|P2|COMPLETED|Overall Study||14
2294482|NCT02059902|5634778|P1|COMPLETED|Overall Study||14
2294483|NCT02059902|5634777|P2|STARTED|Overall Study||18
2294484|NCT02059902|5634778|P1|STARTED|Overall Study||18
2294485|NCT02059642|5634786|P2|NOT COMPLETED|Overall Study||24
2294486|NCT02059642|5634787|P1|NOT COMPLETED|Overall Study||27
2294487|NCT02059642|5634786|P2|COMPLETED|Overall Study||128
2294488|NCT02059642|5634787|P1|COMPLETED|Overall Study||121
2294489|NCT02059642|5634786|P2|STARTED|Overall Study||152
2294490|NCT02059642|5634787|P1|STARTED|Overall Study||148
2294491|NCT02059434|5634804|P9|NOT COMPLETED|Period 8||0
2294492|NCT02059434|5634805|P8|NOT COMPLETED|Period 8||0
2294493|NCT02059434|5634806|P7|NOT COMPLETED|Period 8||0
2294494|NCT02059434|5634807|P6|NOT COMPLETED|Period 8||0
2294495|NCT02059434|5634808|P5|NOT COMPLETED|Period 8||0
2294496|NCT02059434|5634809|P4|NOT COMPLETED|Period 8||0
2294497|NCT02059434|5634810|P3|NOT COMPLETED|Period 8||0
2294498|NCT02059434|5634811|P2|NOT COMPLETED|Period 8||0
2294499|NCT02059434|5634812|P1|NOT COMPLETED|Period 8||0
2294500|NCT02059434|5634804|P9|COMPLETED|Period 8||34
2294501|NCT02059434|5634805|P8|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
2294502|NCT02059434|5634806|P7|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
2294503|NCT02059434|5634807|P6|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
2294504|NCT02059434|5634808|P5|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
2294505|NCT02059434|5634809|P4|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
2294506|NCT02059434|5634810|P3|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
2294507|NCT02059434|5634811|P2|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
2294508|NCT02059434|5634812|P1|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
2294509|NCT02059434|5634804|P9|STARTED|Period 8||34
2294510|NCT02059434|5634805|P8|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
2294511|NCT02059434|5634806|P7|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
2294512|NCT02059434|5634807|P6|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
2294513|NCT02059434|5634808|P5|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
2294514|NCT02059434|5634809|P4|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
2294515|NCT02059434|5634810|P3|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
2294516|NCT02059434|5634811|P2|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
2294517|NCT02059434|5634812|P1|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
2294518|NCT02059434|5634804|P9|NOT COMPLETED|Washout Between Periods 7 and 8||2
2294519|NCT02059434|5634805|P8|NOT COMPLETED|Washout Between Periods 7 and 8||0
2294520|NCT02059434|5634806|P7|NOT COMPLETED|Washout Between Periods 7 and 8||0
2294521|NCT02059434|5634807|P6|NOT COMPLETED|Washout Between Periods 7 and 8||0
2294522|NCT02059434|5634808|P5|NOT COMPLETED|Washout Between Periods 7 and 8||0
2294523|NCT02059434|5634809|P4|NOT COMPLETED|Washout Between Periods 7 and 8||0
2294524|NCT02059434|5634810|P3|NOT COMPLETED|Washout Between Periods 7 and 8||0
2294525|NCT02059434|5634811|P2|NOT COMPLETED|Washout Between Periods 7 and 8||0
2294526|NCT02059434|5634812|P1|NOT COMPLETED|Washout Between Periods 7 and 8||0
2294527|NCT02059434|5634804|P9|COMPLETED|Washout Between Periods 7 and 8||34
2294528|NCT02059434|5634805|P8|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
2294529|NCT02059434|5634806|P7|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
2294530|NCT02059434|5634807|P6|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
2294531|NCT02059434|5634808|P5|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
2294532|NCT02059434|5634809|P4|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
2294533|NCT02059434|5634810|P3|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
2294534|NCT02059434|5634811|P2|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
2294535|NCT02059434|5634812|P1|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
2294536|NCT02059434|5634804|P9|STARTED|Washout Between Periods 7 and 8||36
2294537|NCT02059434|5634805|P8|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
2294538|NCT02059434|5634806|P7|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
2294539|NCT02059434|5634807|P6|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
2294540|NCT02059434|5634808|P5|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
2294541|NCT02059434|5634809|P4|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
2294542|NCT02059434|5634810|P3|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
2294543|NCT02059434|5634811|P2|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
2294544|NCT02059434|5634812|P1|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
2294545|NCT02059434|5634804|P9|NOT COMPLETED|Period 7||0
2294546|NCT02059434|5634805|P8|NOT COMPLETED|Period 7||0
2294547|NCT02059434|5634806|P7|NOT COMPLETED|Period 7||0
2294548|NCT02059434|5634807|P6|NOT COMPLETED|Period 7||0
2294549|NCT02059434|5634808|P5|NOT COMPLETED|Period 7||0
2294550|NCT02059434|5634809|P4|NOT COMPLETED|Period 7||0
2294551|NCT02059434|5634810|P3|NOT COMPLETED|Period 7||0
2294552|NCT02059434|5634811|P2|NOT COMPLETED|Period 7||0
2294553|NCT02059434|5634812|P1|NOT COMPLETED|Period 7||0
2294554|NCT02059434|5634804|P9|COMPLETED|Period 7||36
2294555|NCT02059434|5634805|P8|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
2294556|NCT02059434|5634806|P7|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
2294557|NCT02059434|5634807|P6|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
2294558|NCT02059434|5634808|P5|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
2294559|NCT02059434|5634809|P4|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
2294560|NCT02059434|5634810|P3|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
2294561|NCT02059434|5634811|P2|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
2294562|NCT02059434|5634812|P1|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
2294563|NCT02059434|5634804|P9|STARTED|Period 7||36
2294564|NCT02059434|5634805|P8|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
2294565|NCT02059434|5634806|P7|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
2294566|NCT02059434|5634807|P6|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
2294567|NCT02059434|5634808|P5|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
2294568|NCT02059434|5634809|P4|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
2294569|NCT02059434|5634810|P3|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
2294570|NCT02059434|5634811|P2|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
2294571|NCT02059434|5634812|P1|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
2294572|NCT02059434|5634804|P9|NOT COMPLETED|Washout Between Periods 6 and 7||1
2294573|NCT02059434|5634805|P8|NOT COMPLETED|Washout Between Periods 6 and 7||0
2294574|NCT02059434|5634806|P7|NOT COMPLETED|Washout Between Periods 6 and 7||0
2294575|NCT02059434|5634807|P6|NOT COMPLETED|Washout Between Periods 6 and 7||0
2294576|NCT02059434|5634808|P5|NOT COMPLETED|Washout Between Periods 6 and 7||0
2294577|NCT02059434|5634809|P4|NOT COMPLETED|Washout Between Periods 6 and 7||0
2294578|NCT02059434|5634810|P3|NOT COMPLETED|Washout Between Periods 6 and 7||0
2294579|NCT02059434|5634811|P2|NOT COMPLETED|Washout Between Periods 6 and 7||0
2294580|NCT02059434|5634812|P1|NOT COMPLETED|Washout Between Periods 6 and 7||0
2294581|NCT02059434|5634804|P9|COMPLETED|Washout Between Periods 6 and 7||36
2294582|NCT02059434|5634805|P8|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
2294583|NCT02059434|5634806|P7|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
2294584|NCT02059434|5634807|P6|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
2294585|NCT02059434|5634808|P5|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
2294586|NCT02059434|5634809|P4|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
2294587|NCT02059434|5634810|P3|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
2294588|NCT02059434|5634811|P2|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
2294589|NCT02059434|5634812|P1|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
2294590|NCT02059434|5634804|P9|STARTED|Washout Between Periods 6 and 7||37
2294591|NCT02059434|5634805|P8|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
2294592|NCT02059434|5634806|P7|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
2294593|NCT02059434|5634807|P6|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
2294594|NCT02059434|5634808|P5|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
2294595|NCT02059434|5634809|P4|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
2294596|NCT02059434|5634810|P3|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
2294597|NCT02059434|5634811|P2|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
2294598|NCT02059434|5634812|P1|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
2294599|NCT02059434|5634804|P9|NOT COMPLETED|Period 6||0
2294600|NCT02059434|5634805|P8|NOT COMPLETED|Period 6||0
2294601|NCT02059434|5634806|P7|NOT COMPLETED|Period 6||0
2294602|NCT02059434|5634807|P6|NOT COMPLETED|Period 6||0
2294603|NCT02059434|5634808|P5|NOT COMPLETED|Period 6||0
2294604|NCT02059434|5634809|P4|NOT COMPLETED|Period 6||0
2294605|NCT02059434|5634810|P3|NOT COMPLETED|Period 6||0
2294606|NCT02059434|5634811|P2|NOT COMPLETED|Period 6||0
2294607|NCT02059434|5634812|P1|NOT COMPLETED|Period 6||0
2294608|NCT02059434|5634804|P9|COMPLETED|Period 6||37
2294609|NCT02059434|5634805|P8|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
2294610|NCT02059434|5634806|P7|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
2294611|NCT02059434|5634807|P6|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
2294612|NCT02059434|5634808|P5|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
2294613|NCT02059434|5634809|P4|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
2294614|NCT02059434|5634810|P3|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
2294615|NCT02059434|5634811|P2|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
2294616|NCT02059434|5634812|P1|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
2294617|NCT02059434|5634804|P9|STARTED|Period 6||37
2294618|NCT02059434|5634805|P8|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
2294619|NCT02059434|5634806|P7|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
2294620|NCT02059434|5634807|P6|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
2294621|NCT02059434|5634808|P5|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
2294622|NCT02059434|5634809|P4|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
2294623|NCT02059434|5634810|P3|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
2294624|NCT02059434|5634811|P2|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
2294625|NCT02059434|5634812|P1|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
2294626|NCT02059434|5634804|P9|NOT COMPLETED|Washout Between Periods 5 and 6||0
2294627|NCT02059434|5634805|P8|NOT COMPLETED|Washout Between Periods 5 and 6||0
2294628|NCT02059434|5634806|P7|NOT COMPLETED|Washout Between Periods 5 and 6||0
2294629|NCT02059434|5634807|P6|NOT COMPLETED|Washout Between Periods 5 and 6||0
2294630|NCT02059434|5634808|P5|NOT COMPLETED|Washout Between Periods 5 and 6||0
2294631|NCT02059434|5634809|P4|NOT COMPLETED|Washout Between Periods 5 and 6||0
2294632|NCT02059434|5634810|P3|NOT COMPLETED|Washout Between Periods 5 and 6||0
2294633|NCT02059434|5634811|P2|NOT COMPLETED|Washout Between Periods 5 and 6||0
2294634|NCT02059434|5634812|P1|NOT COMPLETED|Washout Between Periods 5 and 6||0
2294635|NCT02059434|5634804|P9|COMPLETED|Washout Between Periods 5 and 6||37
2294636|NCT02059434|5634805|P8|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
2294637|NCT02059434|5634806|P7|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
2294638|NCT02059434|5634807|P6|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
2294639|NCT02059434|5634808|P5|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
2294640|NCT02059434|5634809|P4|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
2294641|NCT02059434|5634810|P3|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
2294642|NCT02059434|5634811|P2|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
2294643|NCT02059434|5634812|P1|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
2294644|NCT02059434|5634804|P9|STARTED|Washout Between Periods 5 and 6||37
2294645|NCT02059434|5634805|P8|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
2294646|NCT02059434|5634806|P7|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
2294647|NCT02059434|5634807|P6|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
2294648|NCT02059434|5634808|P5|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
2294649|NCT02059434|5634809|P4|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
2294650|NCT02059434|5634810|P3|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
2294651|NCT02059434|5634811|P2|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
2294652|NCT02059434|5634812|P1|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
2294653|NCT02059434|5634804|P9|NOT COMPLETED|Period 5||0
2294654|NCT02059434|5634805|P8|NOT COMPLETED|Period 5||0
2294655|NCT02059434|5634806|P7|NOT COMPLETED|Period 5||0
2294656|NCT02059434|5634807|P6|NOT COMPLETED|Period 5||0
2294657|NCT02059434|5634808|P5|NOT COMPLETED|Period 5||0
2294658|NCT02059434|5634809|P4|NOT COMPLETED|Period 5||0
2294659|NCT02059434|5634810|P3|NOT COMPLETED|Period 5||0
2294660|NCT02059434|5634811|P2|NOT COMPLETED|Period 5||0
2294661|NCT02059434|5634812|P1|NOT COMPLETED|Period 5||0
2294662|NCT02059434|5634804|P9|COMPLETED|Period 5||37
2294663|NCT02059434|5634805|P8|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
2294664|NCT02059434|5634806|P7|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
2294665|NCT02059434|5634807|P6|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
2294666|NCT02059434|5634808|P5|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
2294667|NCT02059434|5634809|P4|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
2294668|NCT02059434|5634810|P3|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
2294669|NCT02059434|5634811|P2|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
2294670|NCT02059434|5634812|P1|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
2294671|NCT02059434|5634804|P9|STARTED|Period 5||37
2294672|NCT02059434|5634805|P8|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
2294673|NCT02059434|5634806|P7|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
2294674|NCT02059434|5634807|P6|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
2294675|NCT02059434|5634808|P5|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
2294676|NCT02059434|5634809|P4|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
2294677|NCT02059434|5634810|P3|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
2294678|NCT02059434|5634811|P2|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
2294679|NCT02059434|5634812|P1|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
2294680|NCT02059434|5634804|P9|NOT COMPLETED|Washout Between Periods 4 and 5||1
2294681|NCT02059434|5634805|P8|NOT COMPLETED|Washout Between Periods 4 and 5||0
2294682|NCT02059434|5634806|P7|NOT COMPLETED|Washout Between Periods 4 and 5||0
2294683|NCT02059434|5634807|P6|NOT COMPLETED|Washout Between Periods 4 and 5||0
2294684|NCT02059434|5634808|P5|NOT COMPLETED|Washout Between Periods 4 and 5||0
2294685|NCT02059434|5634809|P4|NOT COMPLETED|Washout Between Periods 4 and 5||0
2294686|NCT02059434|5634810|P3|NOT COMPLETED|Washout Between Periods 4 and 5||0
2294687|NCT02059434|5634811|P2|NOT COMPLETED|Washout Between Periods 4 and 5||0
2294688|NCT02059434|5634812|P1|NOT COMPLETED|Washout Between Periods 4 and 5||0
2294689|NCT02059434|5634804|P9|COMPLETED|Washout Between Periods 4 and 5||37
2294690|NCT02059434|5634805|P8|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
2294691|NCT02059434|5634806|P7|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
2294692|NCT02059434|5634807|P6|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
2294693|NCT02059434|5634808|P5|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
2294694|NCT02059434|5634809|P4|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
2294695|NCT02059434|5634810|P3|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
2294696|NCT02059434|5634811|P2|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
2294697|NCT02059434|5634812|P1|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
2294698|NCT02059434|5634804|P9|STARTED|Washout Between Periods 4 and 5||38
2294699|NCT02059434|5634805|P8|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
2294700|NCT02059434|5634806|P7|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
2294701|NCT02059434|5634807|P6|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
2294702|NCT02059434|5634808|P5|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
2294703|NCT02059434|5634809|P4|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
2294704|NCT02059434|5634810|P3|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
2294705|NCT02059434|5634811|P2|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
2294706|NCT02059434|5634812|P1|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
2294707|NCT02059434|5634804|P9|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
2294708|NCT02059434|5634805|P8|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
2294709|NCT02059434|5634806|P7|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
2294710|NCT02059434|5634807|P6|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
2294711|NCT02059434|5634808|P5|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
2294712|NCT02059434|5634809|P4|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
2294713|NCT02059434|5634810|P3|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
2294714|NCT02059434|5634811|P2|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
2294715|NCT02059434|5634812|P1|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
2294716|NCT02059434|5634804|P9|COMPLETED|Period 4 (After Screening/run-in Period)||38
2294717|NCT02059434|5634805|P8|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
2294718|NCT02059434|5634806|P7|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
2294719|NCT02059434|5634807|P6|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
2294720|NCT02059434|5634808|P5|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
2294721|NCT02059434|5634809|P4|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
2294722|NCT02059434|5634810|P3|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
2294723|NCT02059434|5634811|P2|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
2294724|NCT02059434|5634812|P1|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
2294725|NCT02059434|5634804|P9|STARTED|Period 4 (After Screening/run-in Period)||38
2294726|NCT02059434|5634805|P8|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
2294727|NCT02059434|5634806|P7|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
2294728|NCT02059434|5634807|P6|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
2294729|NCT02059434|5634808|P5|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
2294730|NCT02059434|5634809|P4|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
2294731|NCT02059434|5634810|P3|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
2294732|NCT02059434|5634811|P2|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
2294733|NCT02059434|5634812|P1|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
2294734|NCT02059434|5634804|P9|NOT COMPLETED|Period 3||0
2294735|NCT02059434|5634805|P8|NOT COMPLETED|Period 3||0
2294736|NCT02059434|5634806|P7|NOT COMPLETED|Period 3||0
2294737|NCT02059434|5634807|P6|NOT COMPLETED|Period 3||0
2294738|NCT02059434|5634808|P5|NOT COMPLETED|Period 3||0
2294739|NCT02059434|5634809|P4|NOT COMPLETED|Period 3||0
2294740|NCT02059434|5634810|P3|NOT COMPLETED|Period 3||0
2294741|NCT02059434|5634811|P2|NOT COMPLETED|Period 3||0
2294742|NCT02059434|5634812|P1|NOT COMPLETED|Period 3||0
2294743|NCT02059434|5634804|P9|COMPLETED|Period 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
2294744|NCT02059434|5634805|P8|COMPLETED|Period 3||2
2294745|NCT02059434|5634806|P7|COMPLETED|Period 3||2
2294746|NCT02059434|5634807|P6|COMPLETED|Period 3||2
2294747|NCT02059434|5634808|P5|COMPLETED|Period 3||2
2294748|NCT02059434|5634809|P4|COMPLETED|Period 3||2
2294749|NCT02059434|5634810|P3|COMPLETED|Period 3||2
2294750|NCT02059434|5634811|P2|COMPLETED|Period 3||2
2294751|NCT02059434|5634812|P1|COMPLETED|Period 3||2
2294752|NCT02059434|5634804|P9|STARTED|Period 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
2294753|NCT02059434|5634805|P8|STARTED|Period 3||2
2294754|NCT02059434|5634806|P7|STARTED|Period 3||2
2294755|NCT02059434|5634807|P6|STARTED|Period 3||2
2294756|NCT02059434|5634808|P5|STARTED|Period 3||2
2294757|NCT02059434|5634809|P4|STARTED|Period 3||2
2294758|NCT02059434|5634810|P3|STARTED|Period 3||2
2294759|NCT02059434|5634811|P2|STARTED|Period 3||2
2294760|NCT02059434|5634812|P1|STARTED|Period 3||2
2294761|NCT02059434|5634804|P9|NOT COMPLETED|Washout Between Periods 2 and 3||0
2294762|NCT02059434|5634805|P8|NOT COMPLETED|Washout Between Periods 2 and 3||0
2294763|NCT02059434|5634806|P7|NOT COMPLETED|Washout Between Periods 2 and 3||0
2294764|NCT02059434|5634807|P6|NOT COMPLETED|Washout Between Periods 2 and 3||0
2294765|NCT02059434|5634808|P5|NOT COMPLETED|Washout Between Periods 2 and 3||0
2294766|NCT02059434|5634809|P4|NOT COMPLETED|Washout Between Periods 2 and 3||0
2294767|NCT02059434|5634810|P3|NOT COMPLETED|Washout Between Periods 2 and 3||0
2294768|NCT02059434|5634811|P2|NOT COMPLETED|Washout Between Periods 2 and 3||0
2294769|NCT02059434|5634812|P1|NOT COMPLETED|Washout Between Periods 2 and 3||0
2294770|NCT02059434|5634804|P9|COMPLETED|Washout Between Periods 2 and 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
2294771|NCT02059434|5634805|P8|COMPLETED|Washout Between Periods 2 and 3||2
2294772|NCT02059434|5634806|P7|COMPLETED|Washout Between Periods 2 and 3||2
2294773|NCT02059434|5634807|P6|COMPLETED|Washout Between Periods 2 and 3||2
2294774|NCT02059434|5634808|P5|COMPLETED|Washout Between Periods 2 and 3||2
2294775|NCT02059434|5634809|P4|COMPLETED|Washout Between Periods 2 and 3||2
2294776|NCT02059434|5634810|P3|COMPLETED|Washout Between Periods 2 and 3||2
2294777|NCT02059434|5634811|P2|COMPLETED|Washout Between Periods 2 and 3||2
2294778|NCT02059434|5634812|P1|COMPLETED|Washout Between Periods 2 and 3||2
2294779|NCT02059434|5634804|P9|STARTED|Washout Between Periods 2 and 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
2294780|NCT02059434|5634805|P8|STARTED|Washout Between Periods 2 and 3||2
2294781|NCT02059434|5634806|P7|STARTED|Washout Between Periods 2 and 3||2
2294782|NCT02059434|5634807|P6|STARTED|Washout Between Periods 2 and 3||2
2294783|NCT02059434|5634808|P5|STARTED|Washout Between Periods 2 and 3||2
2294784|NCT02059434|5634809|P4|STARTED|Washout Between Periods 2 and 3||2
2294785|NCT02059434|5634810|P3|STARTED|Washout Between Periods 2 and 3||2
2294786|NCT02059434|5634811|P2|STARTED|Washout Between Periods 2 and 3||2
2294787|NCT02059434|5634812|P1|STARTED|Washout Between Periods 2 and 3||2
2294788|NCT02059434|5634804|P9|NOT COMPLETED|Period 2||0
2294789|NCT02059434|5634805|P8|NOT COMPLETED|Period 2||0
2294790|NCT02059434|5634806|P7|NOT COMPLETED|Period 2||0
2294791|NCT02059434|5634807|P6|NOT COMPLETED|Period 2||0
2294792|NCT02059434|5634808|P5|NOT COMPLETED|Period 2||0
2294793|NCT02059434|5634809|P4|NOT COMPLETED|Period 2||0
2294794|NCT02059434|5634810|P3|NOT COMPLETED|Period 2||0
2294795|NCT02059434|5634811|P2|NOT COMPLETED|Period 2||0
2294796|NCT02059434|5634812|P1|NOT COMPLETED|Period 2||0
2294797|NCT02059434|5634804|P9|COMPLETED|Period 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
2294798|NCT02059434|5634805|P8|COMPLETED|Period 2||2
2294799|NCT02059434|5634806|P7|COMPLETED|Period 2||2
2294800|NCT02059434|5634807|P6|COMPLETED|Period 2||2
2294801|NCT02059434|5634808|P5|COMPLETED|Period 2||2
2294802|NCT02059434|5634809|P4|COMPLETED|Period 2||2
2294803|NCT02059434|5634810|P3|COMPLETED|Period 2||2
2294804|NCT02059434|5634811|P2|COMPLETED|Period 2||2
2294805|NCT02059434|5634812|P1|COMPLETED|Period 2||2
2294806|NCT02059434|5634804|P9|STARTED|Period 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
2294807|NCT02059434|5634805|P8|STARTED|Period 2||2
2294808|NCT02059434|5634806|P7|STARTED|Period 2||2
2294809|NCT02059434|5634807|P6|STARTED|Period 2||2
2294810|NCT02059434|5634808|P5|STARTED|Period 2||2
2294811|NCT02059434|5634809|P4|STARTED|Period 2||2
2294812|NCT02059434|5634810|P3|STARTED|Period 2||2
2294813|NCT02059434|5634811|P2|STARTED|Period 2||2
2294814|NCT02059434|5634812|P1|STARTED|Period 2||2
2294815|NCT02059434|5634804|P9|NOT COMPLETED|Washout Between Periods 1 and 2||0
2294816|NCT02059434|5634805|P8|NOT COMPLETED|Washout Between Periods 1 and 2||1
2294817|NCT02059434|5634806|P7|NOT COMPLETED|Washout Between Periods 1 and 2||0
2294818|NCT02059434|5634807|P6|NOT COMPLETED|Washout Between Periods 1 and 2||0
2294819|NCT02059434|5634808|P5|NOT COMPLETED|Washout Between Periods 1 and 2||0
2294820|NCT02059434|5634809|P4|NOT COMPLETED|Washout Between Periods 1 and 2||0
2294821|NCT02059434|5634810|P3|NOT COMPLETED|Washout Between Periods 1 and 2||0
2294822|NCT02059434|5634811|P2|NOT COMPLETED|Washout Between Periods 1 and 2||0
2294823|NCT02059434|5634812|P1|NOT COMPLETED|Washout Between Periods 1 and 2||0
2294824|NCT02059434|5634804|P9|COMPLETED|Washout Between Periods 1 and 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
2294825|NCT02059434|5634805|P8|COMPLETED|Washout Between Periods 1 and 2||2
2294826|NCT02059434|5634806|P7|COMPLETED|Washout Between Periods 1 and 2||2
2294827|NCT02059434|5634807|P6|COMPLETED|Washout Between Periods 1 and 2||2
2294828|NCT02059434|5634808|P5|COMPLETED|Washout Between Periods 1 and 2||2
2294829|NCT02059434|5634809|P4|COMPLETED|Washout Between Periods 1 and 2||2
2294830|NCT02059434|5634810|P3|COMPLETED|Washout Between Periods 1 and 2||2
2294831|NCT02059434|5634811|P2|COMPLETED|Washout Between Periods 1 and 2||2
2294832|NCT02059434|5634812|P1|COMPLETED|Washout Between Periods 1 and 2||2
2294833|NCT02059434|5634804|P9|STARTED|Washout Between Periods 1 and 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
2294834|NCT02059434|5634805|P8|STARTED|Washout Between Periods 1 and 2||3
2294835|NCT02059434|5634806|P7|STARTED|Washout Between Periods 1 and 2||2
2294836|NCT02059434|5634807|P6|STARTED|Washout Between Periods 1 and 2||2
2294837|NCT02059434|5634808|P5|STARTED|Washout Between Periods 1 and 2||2
2294838|NCT02059434|5634809|P4|STARTED|Washout Between Periods 1 and 2||2
2294839|NCT02059434|5634810|P3|STARTED|Washout Between Periods 1 and 2||2
2294840|NCT02059434|5634811|P2|STARTED|Washout Between Periods 1 and 2||2
2294841|NCT02059434|5634812|P1|STARTED|Washout Between Periods 1 and 2||2
2294842|NCT02059434|5634804|P9|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
2294843|NCT02059434|5634805|P8|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
2294844|NCT02059434|5634806|P7|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
2294845|NCT02059434|5634807|P6|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
2294846|NCT02059434|5634808|P5|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
2294847|NCT02059434|5634809|P4|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
2294848|NCT02059434|5634810|P3|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
2294849|NCT02059434|5634811|P2|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
2294850|NCT02059434|5634812|P1|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
2294851|NCT02059434|5634804|P9|COMPLETED|Period 1 (After Screening/run-in Period)|Part 2 followed Part 1, and comprised 5 treatment periods|0
2294852|NCT02059434|5634805|P8|COMPLETED|Period 1 (After Screening/run-in Period)||3
2294853|NCT02059434|5634806|P7|COMPLETED|Period 1 (After Screening/run-in Period)||2
2294854|NCT02059434|5634807|P6|COMPLETED|Period 1 (After Screening/run-in Period)||2
2294855|NCT02059434|5634808|P5|COMPLETED|Period 1 (After Screening/run-in Period)||2
2294856|NCT02059434|5634809|P4|COMPLETED|Period 1 (After Screening/run-in Period)||2
2294857|NCT02059434|5634810|P3|COMPLETED|Period 1 (After Screening/run-in Period)||2
2294858|NCT02059434|5634811|P2|COMPLETED|Period 1 (After Screening/run-in Period)||2
2294859|NCT02059434|5634812|P1|COMPLETED|Period 1 (After Screening/run-in Period)||2
2294860|NCT02059434|5634804|P9|STARTED|Period 1 (After Screening/run-in Period)|Part 2 followed Part 1, and comprised 5 treatment periods|0
2294861|NCT02059434|5634805|P8|STARTED|Period 1 (After Screening/run-in Period)||3
2294862|NCT02059434|5634806|P7|STARTED|Period 1 (After Screening/run-in Period)||2
2294863|NCT02059434|5634807|P6|STARTED|Period 1 (After Screening/run-in Period)||2
2294864|NCT02059434|5634808|P5|STARTED|Period 1 (After Screening/run-in Period)||2
2294865|NCT02059434|5634809|P4|STARTED|Period 1 (After Screening/run-in Period)||2
2294866|NCT02059434|5634810|P3|STARTED|Period 1 (After Screening/run-in Period)||2
2294867|NCT02059434|5634811|P2|STARTED|Period 1 (After Screening/run-in Period)||2
2294868|NCT02059434|5634812|P1|STARTED|Period 1 (After Screening/run-in Period)||2
2294869|NCT02059408|5634877|P3|NOT COMPLETED|Overall Study||358
2294870|NCT02059408|5634878|P2|NOT COMPLETED|Overall Study||330
2294871|NCT02059408|5634879|P1|NOT COMPLETED|Overall Study||0
2294872|NCT02059408|5634877|P3|COMPLETED|Overall Study||258
2294873|NCT02059408|5634878|P2|COMPLETED|Overall Study||269
2294874|NCT02059408|5634879|P1|COMPLETED|Overall Study||604
2294875|NCT02059408|5634877|P3|STARTED|Overall Study||616
2294876|NCT02059408|5634878|P2|STARTED|Overall Study||599
2294877|NCT02059408|5634879|P1|STARTED|Overall Study||604
2294878|NCT02059395|5634898|P2|NOT COMPLETED|Overall Study||4
2294879|NCT02059395|5634899|P1|NOT COMPLETED|Overall Study||2
2294880|NCT02059395|5634898|P2|COMPLETED|Overall Study||23
2294881|NCT02059395|5634899|P1|COMPLETED|Overall Study||20
2294882|NCT02059395|5634898|P2|STARTED|Overall Study||27
2294883|NCT02059395|5634899|P1|STARTED|Overall Study||22
2294884|NCT02059291|5634914|P25|NOT COMPLETED|Epoch 4||0
2294885|NCT02059291|5634915|P24|NOT COMPLETED|Epoch 4||1
2294886|NCT02059291|5634916|P23|NOT COMPLETED|Epoch 4||1
2294887|NCT02059291|5634917|P22|NOT COMPLETED|Epoch 4||0
2294888|NCT02059291|5634918|P21|NOT COMPLETED|Epoch 4||1
2294889|NCT02059291|5634919|P20|NOT COMPLETED|Epoch 4||0
2294890|NCT02059291|5634920|P19|NOT COMPLETED|Epoch 4||0
2294891|NCT02059291|5634921|P18|NOT COMPLETED|Epoch 4||0
2294892|NCT02059291|5634922|P17|NOT COMPLETED|Epoch 4||2
2294893|NCT02059291|5634923|P16|NOT COMPLETED|Epoch 4||0
2294894|NCT02059291|5634924|P15|NOT COMPLETED|Epoch 4||0
2294895|NCT02059291|5634925|P14|NOT COMPLETED|Epoch 4||0
2294896|NCT02059291|5634926|P13|NOT COMPLETED|Epoch 4||0
2294897|NCT02059291|5634927|P12|NOT COMPLETED|Epoch 4||0
2294898|NCT02059291|5634928|P11|NOT COMPLETED|Epoch 4||0
2294899|NCT02059291|5634929|P10|NOT COMPLETED|Epoch 4||0
2294900|NCT02059291|5634930|P9|NOT COMPLETED|Epoch 4||0
2294901|NCT02059291|5634931|P8|NOT COMPLETED|Epoch 4||0
2294902|NCT02059291|5634932|P7|NOT COMPLETED|Epoch 4||0
2294903|NCT02059291|5634933|P6|NOT COMPLETED|Epoch 4||0
2294904|NCT02059291|5634934|P5|NOT COMPLETED|Epoch 4||0
2294905|NCT02059291|5634935|P4|NOT COMPLETED|Epoch 4||0
2294906|NCT02059291|5634936|P3|NOT COMPLETED|Epoch 4||0
2294907|NCT02059291|5634937|P2|NOT COMPLETED|Epoch 4||0
2294908|NCT02059291|5634938|P1|NOT COMPLETED|Epoch 4||0
2294909|NCT02059291|5634914|P25|COMPLETED|Epoch 4||0
2294910|NCT02059291|5634915|P24|COMPLETED|Epoch 4||21
2294911|NCT02059291|5634916|P23|COMPLETED|Epoch 4||30
2294912|NCT02059291|5634917|P22|COMPLETED|Epoch 4||14
2294913|NCT02059291|5634918|P21|COMPLETED|Epoch 4||33
2294914|NCT02059291|5634919|P20|COMPLETED|Epoch 4||18
2294915|NCT02059291|5634920|P19|COMPLETED|Epoch 4||2
2294916|NCT02059291|5634921|P18|COMPLETED|Epoch 4||14
2294917|NCT02059291|5634922|P17|COMPLETED|Epoch 4||41
2294918|NCT02059291|5634923|P16|COMPLETED|Epoch 4||0
2294919|NCT02059291|5634924|P15|COMPLETED|Epoch 4||0
2294920|NCT02059291|5634925|P14|COMPLETED|Epoch 4||0
2294921|NCT02059291|5634926|P13|COMPLETED|Epoch 4||0
2294922|NCT02059291|5634927|P12|COMPLETED|Epoch 4||0
2294923|NCT02059291|5634928|P11|COMPLETED|Epoch 4||0
2294924|NCT02059291|5634929|P10|COMPLETED|Epoch 4||0
2294925|NCT02059291|5634930|P9|COMPLETED|Epoch 4||0
2294926|NCT02059291|5634931|P8|COMPLETED|Epoch 4||0
2294927|NCT02059291|5634932|P7|COMPLETED|Epoch 4||0
2294928|NCT02059291|5634933|P6|COMPLETED|Epoch 4||0
2294929|NCT02059291|5634934|P5|COMPLETED|Epoch 4||0
2294930|NCT02059291|5634935|P4|COMPLETED|Epoch 4||0
2294931|NCT02059291|5634936|P3|COMPLETED|Epoch 4||0
2294932|NCT02059291|5634937|P2|COMPLETED|Epoch 4||0
2294933|NCT02059291|5634938|P1|COMPLETED|Epoch 4||0
2294934|NCT02059291|5634914|P25|STARTED|Epoch 4||0
2294935|NCT02059291|5634915|P24|STARTED|Epoch 4||22
2294936|NCT02059291|5634916|P23|STARTED|Epoch 4||31
2294937|NCT02059291|5634917|P22|STARTED|Epoch 4||14
2294938|NCT02059291|5634918|P21|STARTED|Epoch 4||34
2294939|NCT02059291|5634919|P20|STARTED|Epoch 4||18
2294940|NCT02059291|5634920|P19|STARTED|Epoch 4||2
2294941|NCT02059291|5634921|P18|STARTED|Epoch 4||14
2294942|NCT02059291|5634922|P17|STARTED|Epoch 4||43
2294943|NCT02059291|5634923|P16|STARTED|Epoch 4||0
2294944|NCT02059291|5634924|P15|STARTED|Epoch 4||0
2294945|NCT02059291|5634925|P14|STARTED|Epoch 4||0
2294946|NCT02059291|5634926|P13|STARTED|Epoch 4||0
2294947|NCT02059291|5634927|P12|STARTED|Epoch 4||0
2294948|NCT02059291|5634928|P11|STARTED|Epoch 4||0
2294949|NCT02059291|5634929|P10|STARTED|Epoch 4||0
2294950|NCT02059291|5634930|P9|STARTED|Epoch 4||0
2294951|NCT02059291|5634931|P8|STARTED|Epoch 4||0
2294952|NCT02059291|5634932|P7|STARTED|Epoch 4||0
2294953|NCT02059291|5634933|P6|STARTED|Epoch 4||0
2294954|NCT02059291|5634934|P5|STARTED|Epoch 4||0
2294955|NCT02059291|5634935|P4|STARTED|Epoch 4||0
2294956|NCT02059291|5634936|P3|STARTED|Epoch 4||0
2294957|NCT02059291|5634937|P2|STARTED|Epoch 4||0
2294958|NCT02059291|5634938|P1|STARTED|Epoch 4||0
2294959|NCT02059291|5634914|P25|NOT COMPLETED|Epoch 3||0
2294960|NCT02059291|5634915|P24|NOT COMPLETED|Epoch 3||0
2294961|NCT02059291|5634916|P23|NOT COMPLETED|Epoch 3||0
2294962|NCT02059291|5634917|P22|NOT COMPLETED|Epoch 3||0
2294963|NCT02059291|5634918|P21|NOT COMPLETED|Epoch 3||0
2294964|NCT02059291|5634919|P20|NOT COMPLETED|Epoch 3||0
2294965|NCT02059291|5634920|P19|NOT COMPLETED|Epoch 3||0
2294966|NCT02059291|5634921|P18|NOT COMPLETED|Epoch 3||0
2294967|NCT02059291|5634922|P17|NOT COMPLETED|Epoch 3||0
2294968|NCT02059291|5634923|P16|NOT COMPLETED|Epoch 3||6
2294969|NCT02059291|5634924|P15|NOT COMPLETED|Epoch 3||0
2294970|NCT02059291|5634925|P14|NOT COMPLETED|Epoch 3||1
2294971|NCT02059291|5634926|P13|NOT COMPLETED|Epoch 3||0
2294972|NCT02059291|5634927|P12|NOT COMPLETED|Epoch 3||0
2294973|NCT02059291|5634928|P11|NOT COMPLETED|Epoch 3||0
2294974|NCT02059291|5634929|P10|NOT COMPLETED|Epoch 3||0
2294975|NCT02059291|5634930|P9|NOT COMPLETED|Epoch 3||0
2294976|NCT02059291|5634931|P8|NOT COMPLETED|Epoch 3||0
2294977|NCT02059291|5634932|P7|NOT COMPLETED|Epoch 3||0
2294978|NCT02059291|5634933|P6|NOT COMPLETED|Epoch 3||0
2294979|NCT02059291|5634934|P5|NOT COMPLETED|Epoch 3||0
2294980|NCT02059291|5634935|P4|NOT COMPLETED|Epoch 3||0
2294981|NCT02059291|5634936|P3|NOT COMPLETED|Epoch 3||0
2294982|NCT02059291|5634937|P2|NOT COMPLETED|Epoch 3||0
2294983|NCT02059291|5634938|P1|NOT COMPLETED|Epoch 3||0
2294984|NCT02059291|5634914|P25|COMPLETED|Epoch 3||0
2294985|NCT02059291|5634915|P24|COMPLETED|Epoch 3||0
2294986|NCT02059291|5634916|P23|COMPLETED|Epoch 3||0
2294987|NCT02059291|5634917|P22|COMPLETED|Epoch 3||0
2294988|NCT02059291|5634918|P21|COMPLETED|Epoch 3||0
2294989|NCT02059291|5634919|P20|COMPLETED|Epoch 3||0
2294990|NCT02059291|5634920|P19|COMPLETED|Epoch 3||0
2294991|NCT02059291|5634921|P18|COMPLETED|Epoch 3||0
2294992|NCT02059291|5634922|P17|COMPLETED|Epoch 3||0
2294993|NCT02059291|5634923|P16|COMPLETED|Epoch 3||120
2294994|NCT02059291|5634924|P15|COMPLETED|Epoch 3||5
2294995|NCT02059291|5634925|P14|COMPLETED|Epoch 3||3
2294996|NCT02059291|5634926|P13|COMPLETED|Epoch 3||7
2294997|NCT02059291|5634927|P12|COMPLETED|Epoch 3||6
2294998|NCT02059291|5634928|P11|COMPLETED|Epoch 3||10
2294999|NCT02059291|5634929|P10|COMPLETED|Epoch 3||9
2295000|NCT02059291|5634930|P9|COMPLETED|Epoch 3||0
2295001|NCT02059291|5634931|P8|COMPLETED|Epoch 3||1
2295002|NCT02059291|5634932|P7|COMPLETED|Epoch 3||2
2295003|NCT02059291|5634933|P6|COMPLETED|Epoch 3||0
2295004|NCT02059291|5634934|P5|COMPLETED|Epoch 3||0
2295005|NCT02059291|5634935|P4|COMPLETED|Epoch 3||0
2295006|NCT02059291|5634936|P3|COMPLETED|Epoch 3||0
2295007|NCT02059291|5634937|P2|COMPLETED|Epoch 3||0
2295008|NCT02059291|5634938|P1|COMPLETED|Epoch 3||0
2295009|NCT02059291|5634914|P25|STARTED|Epoch 3||0
2295010|NCT02059291|5634915|P24|STARTED|Epoch 3||0
2295011|NCT02059291|5634916|P23|STARTED|Epoch 3||0
2295012|NCT02059291|5634917|P22|STARTED|Epoch 3||0
2295013|NCT02059291|5634918|P21|STARTED|Epoch 3||0
2295014|NCT02059291|5634919|P20|STARTED|Epoch 3||0
2295015|NCT02059291|5634920|P19|STARTED|Epoch 3||0
2295016|NCT02059291|5634921|P18|STARTED|Epoch 3||0
2295017|NCT02059291|5634922|P17|STARTED|Epoch 3||0
2295018|NCT02059291|5634923|P16|STARTED|Epoch 3||126
2295019|NCT02059291|5634924|P15|STARTED|Epoch 3||5
2295020|NCT02059291|5634925|P14|STARTED|Epoch 3||4
2295021|NCT02059291|5634926|P13|STARTED|Epoch 3||7
2295022|NCT02059291|5634927|P12|STARTED|Epoch 3||6
2295023|NCT02059291|5634928|P11|STARTED|Epoch 3||10
2295024|NCT02059291|5634929|P10|STARTED|Epoch 3||9
2295025|NCT02059291|5634930|P9|STARTED|Epoch 3|Presented in Epoch 2.|0
2295026|NCT02059291|5634931|P8|STARTED|Epoch 3||1
2295027|NCT02059291|5634932|P7|STARTED|Epoch 3||2
2295028|NCT02059291|5634933|P6|STARTED|Epoch 3||0
2295029|NCT02059291|5634934|P5|STARTED|Epoch 3||0
2295030|NCT02059291|5634935|P4|STARTED|Epoch 3||0
2295031|NCT02059291|5634936|P3|STARTED|Epoch 3||0
2295032|NCT02059291|5634937|P2|STARTED|Epoch 3||0
2295033|NCT02059291|5634938|P1|STARTED|Epoch 3||0
2295034|NCT02059291|5634914|P25|NOT COMPLETED|Epoch 2||0
2295035|NCT02059291|5634915|P24|NOT COMPLETED|Epoch 2||0
2295036|NCT02059291|5634916|P23|NOT COMPLETED|Epoch 2||0
2295037|NCT02059291|5634917|P22|NOT COMPLETED|Epoch 2||0
2295038|NCT02059291|5634918|P21|NOT COMPLETED|Epoch 2||0
2295039|NCT02059291|5634919|P20|NOT COMPLETED|Epoch 2||0
2295040|NCT02059291|5634920|P19|NOT COMPLETED|Epoch 2||0
2295041|NCT02059291|5634921|P18|NOT COMPLETED|Epoch 2||0
2295042|NCT02059291|5634922|P17|NOT COMPLETED|Epoch 2||0
2295043|NCT02059291|5634923|P16|NOT COMPLETED|Epoch 2||0
2295044|NCT02059291|5634924|P15|NOT COMPLETED|Epoch 2||0
2295045|NCT02059291|5634925|P14|NOT COMPLETED|Epoch 2||0
2295046|NCT02059291|5634926|P13|NOT COMPLETED|Epoch 2||0
2295047|NCT02059291|5634927|P12|NOT COMPLETED|Epoch 2||0
2295048|NCT02059291|5634928|P11|NOT COMPLETED|Epoch 2||0
2295049|NCT02059291|5634929|P10|NOT COMPLETED|Epoch 2||0
2295050|NCT02059291|5634930|P9|NOT COMPLETED|Epoch 2||2
2295051|NCT02059291|5634931|P8|NOT COMPLETED|Epoch 2||1
2295052|NCT02059291|5634932|P7|NOT COMPLETED|Epoch 2||0
2295053|NCT02059291|5634933|P6|NOT COMPLETED|Epoch 2||2
2295054|NCT02059291|5634934|P5|NOT COMPLETED|Epoch 2||0
2295055|NCT02059291|5634935|P4|NOT COMPLETED|Epoch 2||2
2295056|NCT02059291|5634936|P3|NOT COMPLETED|Epoch 2||1
2295057|NCT02059291|5634937|P2|NOT COMPLETED|Epoch 2||1
2295058|NCT02059291|5634938|P1|NOT COMPLETED|Epoch 2||0
2295059|NCT02059291|5634914|P25|COMPLETED|Epoch 2||0
2295060|NCT02059291|5634915|P24|COMPLETED|Epoch 2||0
2295061|NCT02059291|5634916|P23|COMPLETED|Epoch 2||0
2295062|NCT02059291|5634917|P22|COMPLETED|Epoch 2||0
2295063|NCT02059291|5634918|P21|COMPLETED|Epoch 2||0
2295064|NCT02059291|5634919|P20|COMPLETED|Epoch 2||0
2295065|NCT02059291|5634920|P19|COMPLETED|Epoch 2||0
2295066|NCT02059291|5634921|P18|COMPLETED|Epoch 2||0
2295067|NCT02059291|5634922|P17|COMPLETED|Epoch 2||0
2295068|NCT02059291|5634923|P16|COMPLETED|Epoch 2||0
2295069|NCT02059291|5634924|P15|COMPLETED|Epoch 2||0
2295070|NCT02059291|5634925|P14|COMPLETED|Epoch 2||0
2295071|NCT02059291|5634926|P13|COMPLETED|Epoch 2||0
2295072|NCT02059291|5634927|P12|COMPLETED|Epoch 2||0
2295073|NCT02059291|5634928|P11|COMPLETED|Epoch 2||0
2295074|NCT02059291|5634929|P10|COMPLETED|Epoch 2||0
2295075|NCT02059291|5634930|P9|COMPLETED|Epoch 2||16
2295076|NCT02059291|5634931|P8|COMPLETED|Epoch 2||1
2295077|NCT02059291|5634932|P7|COMPLETED|Epoch 2||2
2295078|NCT02059291|5634933|P6|COMPLETED|Epoch 2||22
2295079|NCT02059291|5634934|P5|COMPLETED|Epoch 2||22
2295080|NCT02059291|5634935|P4|COMPLETED|Epoch 2||33
2295081|NCT02059291|5634936|P3|COMPLETED|Epoch 2||36
2295082|NCT02059291|5634937|P2|COMPLETED|Epoch 2||31
2295083|NCT02059291|5634938|P1|COMPLETED|Epoch 2||31
2295084|NCT02059291|5634914|P25|STARTED|Epoch 2||0
2295085|NCT02059291|5634915|P24|STARTED|Epoch 2||0
2295086|NCT02059291|5634916|P23|STARTED|Epoch 2||0
2295087|NCT02059291|5634917|P22|STARTED|Epoch 2||0
2295088|NCT02059291|5634918|P21|STARTED|Epoch 2||0
2295089|NCT02059291|5634919|P20|STARTED|Epoch 2||0
2295090|NCT02059291|5634920|P19|STARTED|Epoch 2||0
2295091|NCT02059291|5634921|P18|STARTED|Epoch 2||0
2295092|NCT02059291|5634922|P17|STARTED|Epoch 2||0
2295093|NCT02059291|5634923|P16|STARTED|Epoch 2||0
2295094|NCT02059291|5634924|P15|STARTED|Epoch 2||0
2295095|NCT02059291|5634925|P14|STARTED|Epoch 2||0
2295096|NCT02059291|5634926|P13|STARTED|Epoch 2||0
2295097|NCT02059291|5634927|P12|STARTED|Epoch 2||0
2295098|NCT02059291|5634928|P11|STARTED|Epoch 2||0
2295099|NCT02059291|5634929|P10|STARTED|Epoch 2||0
2295100|NCT02059291|5634930|P9|STARTED|Epoch 2|This Epoch 3 group is shown in Epoch 2 to account for the 203 patients enrolled in the study.|18
2295101|NCT02059291|5634931|P8|STARTED|Epoch 2||2
2295102|NCT02059291|5634932|P7|STARTED|Epoch 2||2
2295103|NCT02059291|5634933|P6|STARTED|Epoch 2||24
2295104|NCT02059291|5634934|P5|STARTED|Epoch 2||22
2295105|NCT02059291|5634935|P4|STARTED|Epoch 2||35
2295106|NCT02059291|5634936|P3|STARTED|Epoch 2||37
2295107|NCT02059291|5634937|P2|STARTED|Epoch 2||32
2295108|NCT02059291|5634938|P1|STARTED|Epoch 2||31
2295109|NCT02059278|5634992|P2|NOT COMPLETED|Overall Study||4
2295110|NCT02059278|5634993|P1|NOT COMPLETED|Overall Study||3
2295111|NCT02059278|5634992|P2|COMPLETED|Overall Study||166
2295112|NCT02059278|5634993|P1|COMPLETED|Overall Study||162
2295113|NCT02059278|5634992|P2|STARTED|Overall Study||170
2295114|NCT02059278|5634993|P1|STARTED|Overall Study||165
2295115|NCT02059265|5635007|P1|NOT COMPLETED|Overall Study||4
2295116|NCT02059265|5635007|P1|COMPLETED|Overall Study||28
2295117|NCT02059265|5635007|P1|STARTED|Overall Study||32
2295118|NCT02059213|5635017|P2|NOT COMPLETED|Overall Study||2
2295119|NCT02059213|5635018|P1|NOT COMPLETED|Overall Study||0
2295120|NCT02059213|5635017|P2|COMPLETED|Overall Study||40
2295121|NCT02059213|5635018|P1|COMPLETED|Overall Study||20
2295122|NCT02059213|5635017|P2|Initiated Treatment|Overall Study||40
2295123|NCT02059213|5635018|P1|Initiated Treatment|Overall Study||20
2295124|NCT02059213|5635017|P2|STARTED|Overall Study||42
2295125|NCT02059213|5635018|P1|STARTED|Overall Study||20
2295126|NCT02059187|5635026|P2|NOT COMPLETED|Overall Study||22
2295127|NCT02059187|5635027|P1|NOT COMPLETED|Overall Study||25
2295128|NCT02059187|5635026|P2|COMPLETED|Overall Study||244
2295129|NCT02059187|5635027|P1|COMPLETED|Overall Study||240
2295130|NCT02059187|5635026|P2|STARTED|Overall Study||266
2295131|NCT02059187|5635027|P1|STARTED|Overall Study||265
2295132|NCT02059174|5635053|P2|NOT COMPLETED|Period 4||0
2295133|NCT02059174|5635054|P1|NOT COMPLETED|Period 4||0
2295134|NCT02059174|5635053|P2|COMPLETED|Period 4||35
2295135|NCT02059174|5635054|P1|COMPLETED|Period 4||35
2295136|NCT02059174|5635053|P2|STARTED|Period 4||35
2295137|NCT02059174|5635054|P1|STARTED|Period 4||35
2295138|NCT02059174|5635053|P2|NOT COMPLETED|Period 3||0
2295139|NCT02059174|5635054|P1|NOT COMPLETED|Period 3||1
2295140|NCT02059174|5635053|P2|COMPLETED|Period 3||35
2295141|NCT02059174|5635054|P1|COMPLETED|Period 3||35
2295142|NCT02059174|5635053|P2|STARTED|Period 3||35
2295143|NCT02059174|5635054|P1|STARTED|Period 3||36
2295144|NCT02059174|5635053|P2|NOT COMPLETED|Period 2||2
2295145|NCT02059174|5635054|P1|NOT COMPLETED|Period 2||1
2295146|NCT02059174|5635053|P2|COMPLETED|Period 2||35
2295147|NCT02059174|5635054|P1|COMPLETED|Period 2||36
2295148|NCT02059174|5635053|P2|STARTED|Period 2||37
2295149|NCT02059174|5635054|P1|STARTED|Period 2||37
2295150|NCT02059174|5635053|P2|NOT COMPLETED|Period 1||2
2295151|NCT02059174|5635054|P1|NOT COMPLETED|Period 1||0
2295152|NCT02059174|5635053|P2|COMPLETED|Period 1||37
2295153|NCT02059174|5635054|P1|COMPLETED|Period 1||37
2295154|NCT02059174|5635053|P2|STARTED|Period 1||39
2295155|NCT02059174|5635054|P1|STARTED|Period 1||37
2295156|NCT02059161|5635078|P2|NOT COMPLETED|Overall Study||41
2295157|NCT02059161|5635079|P1|NOT COMPLETED|Overall Study||49
2295158|NCT02059161|5635078|P2|COMPLETED|Overall Study||222
2295159|NCT02059161|5635079|P1|COMPLETED|Overall Study||196
2295160|NCT02059161|5635078|P2|Treated|Overall Study||258
2295161|NCT02059161|5635079|P1|Treated|Overall Study||241
2295162|NCT02059161|5635078|P2|STARTED|Overall Study||263
2295163|NCT02059161|5635079|P1|STARTED|Overall Study||245
2295164|NCT02059148|5635139|P6|NOT COMPLETED|Treatment 3||0
2295165|NCT02059148|5635140|P5|NOT COMPLETED|Treatment 3||0
2295166|NCT02059148|5635141|P4|NOT COMPLETED|Treatment 3||0
2295167|NCT02059148|5635142|P3|NOT COMPLETED|Treatment 3||0
2295168|NCT02059148|5635143|P2|NOT COMPLETED|Treatment 3||0
2295169|NCT02059148|5635144|P1|NOT COMPLETED|Treatment 3||0
2295170|NCT02059148|5635139|P6|COMPLETED|Treatment 3||3
2295171|NCT02059148|5635140|P5|COMPLETED|Treatment 3||4
2295172|NCT02059148|5635141|P4|COMPLETED|Treatment 3||4
2295173|NCT02059148|5635142|P3|COMPLETED|Treatment 3||4
2295174|NCT02059148|5635143|P2|COMPLETED|Treatment 3||4
2295175|NCT02059148|5635144|P1|COMPLETED|Treatment 3||4
2295176|NCT02059148|5635139|P6|STARTED|Treatment 3||3
2295177|NCT02059148|5635140|P5|STARTED|Treatment 3||4
2295178|NCT02059148|5635141|P4|STARTED|Treatment 3||4
2295179|NCT02059148|5635142|P3|STARTED|Treatment 3||4
2295180|NCT02059148|5635143|P2|STARTED|Treatment 3||4
2295181|NCT02059148|5635144|P1|STARTED|Treatment 3||4
2295182|NCT02059148|5635139|P6|NOT COMPLETED|Treatment 2||0
2295183|NCT02059148|5635140|P5|NOT COMPLETED|Treatment 2||0
2295184|NCT02059148|5635141|P4|NOT COMPLETED|Treatment 2||0
2295185|NCT02059148|5635142|P3|NOT COMPLETED|Treatment 2||0
2295186|NCT02059148|5635143|P2|NOT COMPLETED|Treatment 2||0
2295187|NCT02059148|5635144|P1|NOT COMPLETED|Treatment 2||0
2295188|NCT02059148|5635139|P6|COMPLETED|Treatment 2||3
2295189|NCT02059148|5635140|P5|COMPLETED|Treatment 2||4
2295190|NCT02059148|5635141|P4|COMPLETED|Treatment 2||4
2295191|NCT02059148|5635142|P3|COMPLETED|Treatment 2||4
2295192|NCT02059148|5635143|P2|COMPLETED|Treatment 2||4
2295193|NCT02059148|5635144|P1|COMPLETED|Treatment 2||4
2295194|NCT02059148|5635139|P6|STARTED|Treatment 2||3
2295195|NCT02059148|5635140|P5|STARTED|Treatment 2||4
2295196|NCT02059148|5635141|P4|STARTED|Treatment 2||4
2295197|NCT02059148|5635142|P3|STARTED|Treatment 2||4
2295198|NCT02059148|5635143|P2|STARTED|Treatment 2||4
2295199|NCT02059148|5635144|P1|STARTED|Treatment 2||4
2295200|NCT02059148|5635139|P6|NOT COMPLETED|Treatment 1||1
2295201|NCT02059148|5635140|P5|NOT COMPLETED|Treatment 1||0
2295202|NCT02059148|5635141|P4|NOT COMPLETED|Treatment 1||0
2295203|NCT02059148|5635142|P3|NOT COMPLETED|Treatment 1||0
2295204|NCT02059148|5635143|P2|NOT COMPLETED|Treatment 1||0
2295205|NCT02059148|5635144|P1|NOT COMPLETED|Treatment 1||0
2295206|NCT02059148|5635139|P6|COMPLETED|Treatment 1||3
2295207|NCT02059148|5635140|P5|COMPLETED|Treatment 1||4
2295208|NCT02059148|5635141|P4|COMPLETED|Treatment 1||4
2295209|NCT02059148|5635142|P3|COMPLETED|Treatment 1||4
2295210|NCT02059148|5635143|P2|COMPLETED|Treatment 1||4
2295211|NCT02059148|5635144|P1|COMPLETED|Treatment 1||4
2295212|NCT02059148|5635139|P6|STARTED|Treatment 1||4
2295213|NCT02059148|5635140|P5|STARTED|Treatment 1||4
2295214|NCT02059148|5635141|P4|STARTED|Treatment 1||4
2295215|NCT02059148|5635142|P3|STARTED|Treatment 1||4
2295216|NCT02059148|5635143|P2|STARTED|Treatment 1||4
2295217|NCT02059148|5635144|P1|STARTED|Treatment 1||4
2295218|NCT02059135|5635163|P2|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
2295219|NCT02059135|5635164|P1|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
2295220|NCT02059135|5635163|P2|COMPLETED|Neonatal Follow-up (Safety Population)||50
2295221|NCT02059135|5635164|P1|COMPLETED|Neonatal Follow-up (Safety Population)||56
2295222|NCT02059135|5635163|P2|STARTED|Neonatal Follow-up (Safety Population)||54
2295223|NCT02059135|5635164|P1|STARTED|Neonatal Follow-up (Safety Population)||60
2295224|NCT02059135|5635163|P2|NOT COMPLETED|Maternal Follow-up (ITT Population)||7
2295225|NCT02059135|5635164|P1|NOT COMPLETED|Maternal Follow-up (ITT Population)||3
2295226|NCT02059135|5635163|P2|COMPLETED|Maternal Follow-up (ITT Population)||51
2295227|NCT02059135|5635164|P1|COMPLETED|Maternal Follow-up (ITT Population)||59
2295228|NCT02059135|5635163|P2|STARTED|Maternal Follow-up (ITT Population)||58
2295229|NCT02059135|5635164|P1|STARTED|Maternal Follow-up (ITT Population)||62
2295230|NCT02059070|5635178|P2|NOT COMPLETED|Overall Study||4
2295231|NCT02059070|5635179|P1|NOT COMPLETED|Overall Study||5
2295232|NCT02059070|5635178|P2|COMPLETED|Overall Study||16
2295233|NCT02059070|5635179|P1|COMPLETED|Overall Study||14
2295234|NCT02059070|5635178|P2|STARTED|Overall Study||20
2295235|NCT02059070|5635179|P1|STARTED|Overall Study||19
2295236|NCT02059057|5635191|P1|NOT COMPLETED|Overall Study||15
2295237|NCT02059057|5635191|P1|COMPLETED|Overall Study||87
2295238|NCT02059057|5635191|P1|STARTED|Overall Study||102
2295239|NCT02059005|5635200|P2|NOT COMPLETED|Overall Study||24
2295240|NCT02059005|5635201|P1|NOT COMPLETED|Overall Study||20
2295241|NCT02059005|5635200|P2|COMPLETED|Overall Study||24
2295242|NCT02059005|5635201|P1|COMPLETED|Overall Study||29
2295243|NCT02059005|5635200|P2|6 Month Assessment|Overall Study||24
2295244|NCT02059005|5635201|P1|6 Month Assessment|Overall Study||29
2295245|NCT02059005|5635200|P2|3 Month Assessment|Overall Study||33
2295246|NCT02059005|5635201|P1|3 Month Assessment|Overall Study||37
2295247|NCT02059005|5635200|P2|STARTED|Overall Study||48
2295248|NCT02059005|5635201|P1|STARTED|Overall Study||49
2295249|NCT02058992|5635211|P1|NOT COMPLETED|Overall Study||116
2295250|NCT02058992|5635211|P1|COMPLETED|Overall Study||3223
2295251|NCT02058992|5635211|P1|STARTED|Overall Study||3339
2295252|NCT02058966|5635220|P1|NOT COMPLETED|Fourth Intervention||0
2295253|NCT02058966|5635220|P1|COMPLETED|Fourth Intervention||12
2295254|NCT02058966|5635220|P1|Received Entacapone-Meth|Fourth Intervention||2
2295255|NCT02058966|5635220|P1|Received Entacapone-Placebo|Fourth Intervention||3
2295256|NCT02058966|5635220|P1|Received Placebo-Meth|Fourth Intervention||3
2295257|NCT02058966|5635220|P1|Received Placebo-Placebo|Fourth Intervention||4
2295258|NCT02058966|5635220|P1|STARTED|Fourth Intervention||12
2295259|NCT02058966|5635220|P1|NOT COMPLETED|Third Intervention||0
2295260|NCT02058966|5635220|P1|COMPLETED|Third Intervention||12
2295261|NCT02058966|5635220|P1|Received Entacapone-Meth|Third Intervention||3
2295262|NCT02058966|5635220|P1|Received Entacapone-Placebo|Third Intervention||1
2295263|NCT02058966|5635220|P1|Received Placebo-Meth|Third Intervention||4
2295264|NCT02058966|5635220|P1|Received Placebo-Placebo|Third Intervention||4
2295265|NCT02058966|5635220|P1|STARTED|Third Intervention||12
2295266|NCT02058966|5635220|P1|NOT COMPLETED|Second Intervention||0
2295267|NCT02058966|5635220|P1|COMPLETED|Second Intervention||13
2295268|NCT02058966|5635220|P1|Received Entacapone-Meth|Second Intervention||3
2295269|NCT02058966|5635220|P1|Received Entacapone-Placebo|Second Intervention||6
2295270|NCT02058966|5635220|P1|Received Placebo-Meth|Second Intervention||2
2295271|NCT02058966|5635220|P1|Received Placebo-Placebo|Second Intervention||2
2295272|NCT02058966|5635220|P1|STARTED|Second Intervention||13
2295273|NCT02058966|5635220|P1|NOT COMPLETED|First Intervention||1
2295274|NCT02058966|5635220|P1|COMPLETED|First Intervention||14
2295275|NCT02058966|5635220|P1|Received Entacapone-Meth|First Intervention||5
2295276|NCT02058966|5635220|P1|Received Entacapone-Placebo|First Intervention||2
2295277|NCT02058966|5635220|P1|Received Placebo-Meth|First Intervention||4
2295278|NCT02058966|5635220|P1|Received Placebo-Placebo|First Intervention||3
2295279|NCT02058966|5635220|P1|STARTED|First Intervention||15
2295280|NCT02058966|5635220|P1|NOT COMPLETED|Open-Label Methamphetamine||1
2295281|NCT02058966|5635220|P1|COMPLETED|Open-Label Methamphetamine||18
2295282|NCT02058966|5635220|P1|Received Methamphetamine|Open-Label Methamphetamine||18
2295283|NCT02058966|5635220|P1|STARTED|Open-Label Methamphetamine||19
2295284|NCT02058940|5635247|P1|NOT COMPLETED|Overall Study||1
2295285|NCT02058940|5635247|P1|COMPLETED|Overall Study||7
2295286|NCT02058940|5635247|P1|STARTED|Overall Study||8
2295287|NCT02058849|5635271|P2|NOT COMPLETED|Overall Study||1
2295288|NCT02058849|5635272|P1|NOT COMPLETED|Overall Study||7
2295289|NCT02058849|5635271|P2|COMPLETED|Overall Study||1
2295290|NCT02058849|5635272|P1|COMPLETED|Overall Study||4
2295291|NCT02058849|5635271|P2|STARTED|Overall Study||2
2295292|NCT02058849|5635272|P1|STARTED|Overall Study||11
2295293|NCT02058836|5635300|P2|NOT COMPLETED|Overall Study||1
2295294|NCT02058836|5635301|P1|NOT COMPLETED|Overall Study||1
2295295|NCT02058836|5635300|P2|COMPLETED|Overall Study||3
2295296|NCT02058836|5635301|P1|COMPLETED|Overall Study||3
2295297|NCT02058836|5635300|P2|STARTED|Overall Study||4
2295298|NCT02058836|5635301|P1|STARTED|Overall Study||4
2295299|NCT02058628|5635331|P2|NOT COMPLETED|Overall Study||8
2295300|NCT02058628|5635332|P1|NOT COMPLETED|Overall Study||7
2295301|NCT02058628|5635331|P2|COMPLETED|Overall Study||102
2295302|NCT02058628|5635332|P1|COMPLETED|Overall Study||104
2295303|NCT02058628|5635331|P2|STARTED|Overall Study||110
2295304|NCT02058628|5635332|P1|STARTED|Overall Study||111
2295305|NCT02058589|5635364|P2|NOT COMPLETED|Overall Study||2
2295306|NCT02058589|5635365|P1|NOT COMPLETED|Overall Study||2
2295307|NCT02058589|5635364|P2|COMPLETED|Overall Study||130
2295308|NCT02058589|5635365|P1|COMPLETED|Overall Study||130
2295309|NCT02058589|5635364|P2|STARTED|Overall Study||132
2295310|NCT02058589|5635365|P1|STARTED|Overall Study||132
2295311|NCT02058563|5635407|P2|NOT COMPLETED|Overall Study||24
2295312|NCT02058563|5635408|P1|NOT COMPLETED|Overall Study||28
2295313|NCT02058563|5635407|P2|COMPLETED|Overall Study||433
2295314|NCT02058563|5635408|P1|COMPLETED|Overall Study||426
2295315|NCT02058563|5635407|P2|STARTED|Overall Study||457
2295316|NCT02058563|5635408|P1|STARTED|Overall Study||454
2295317|NCT02058537|5635444|P1|NOT COMPLETED|Overall Study||1
2295318|NCT02058537|5635444|P1|COMPLETED|Overall Study||2
2295319|NCT02058537|5635444|P1|STARTED|Overall Study||3
2295320|NCT02058511|5635450|P1|NOT COMPLETED|Overall Study||0
2295321|NCT02058511|5635450|P1|COMPLETED|Overall Study||24
2295322|NCT02058511|5635450|P1|STARTED|Overall Study||24
2295323|NCT02058498|5635455|P1|NOT COMPLETED|Overall Study||4
2295324|NCT02058498|5635455|P1|COMPLETED|Overall Study||8
2295325|NCT02058498|5635455|P1|6 Weeks|Overall Study||8
2295326|NCT02058498|5635455|P1|STARTED|Overall Study||12
2295327|NCT02058368|5635463|P2|NOT COMPLETED|Overall Study||54
2295328|NCT02058368|5635464|P1|NOT COMPLETED|Overall Study||41
2295329|NCT02058368|5635463|P2|COMPLETED|Overall Study||251
2295330|NCT02058368|5635464|P1|COMPLETED|Overall Study||261
2295331|NCT02058368|5635463|P2|STARTED|Overall Study||305
2295332|NCT02058368|5635464|P1|STARTED|Overall Study||302
2295333|NCT02058290|5635516|P2|NOT COMPLETED|Overall Study||9
2295334|NCT02058290|5635517|P1|NOT COMPLETED|Overall Study||11
2295335|NCT02058290|5635516|P2|COMPLETED|Overall Study||36
2295336|NCT02058290|5635517|P1|COMPLETED|Overall Study||66
2295337|NCT02058290|5635516|P2|STARTED|Overall Study||45
2295338|NCT02058290|5635517|P1|STARTED|Overall Study||77
2295339|NCT02058251|5635533|P2|NOT COMPLETED|Overall Study||0
2295340|NCT02058251|5635534|P1|NOT COMPLETED|Overall Study||0
2295341|NCT02058251|5635533|P2|COMPLETED|Overall Study||38
2295342|NCT02058251|5635534|P1|COMPLETED|Overall Study||35
2295343|NCT02058251|5635533|P2|STARTED|Overall Study||38
2295344|NCT02058251|5635534|P1|STARTED|Overall Study||35
2295345|NCT02058160|5635544|P2|NOT COMPLETED|Overall Study||14
2295346|NCT02058160|5635545|P1|NOT COMPLETED|Overall Study||31
2295347|NCT02058160|5635544|P2|COMPLETED|Overall Study||355
2295348|NCT02058160|5635545|P1|COMPLETED|Overall Study||336
2295349|NCT02058160|5635544|P2|Treated|Overall Study||365
2295350|NCT02058160|5635545|P1|Treated|Overall Study||365
2295351|NCT02058160|5635544|P2|STARTED|Overall Study||369
2295352|NCT02058160|5635545|P1|STARTED|Overall Study||367
2295353|NCT02058147|5635582|P3|NOT COMPLETED|Overall Study||29
2295354|NCT02058147|5635583|P2|NOT COMPLETED|Overall Study||27
2295355|NCT02058147|5635584|P1|NOT COMPLETED|Overall Study||29
2295356|NCT02058147|5635582|P3|COMPLETED|Overall Study||205
2295357|NCT02058147|5635583|P2|COMPLETED|Overall Study||440
2295358|NCT02058147|5635584|P1|COMPLETED|Overall Study||440
2295359|NCT02058147|5635582|P3|Treated|Overall Study||233
2295360|NCT02058147|5635583|P2|Treated|Overall Study||467
2295361|NCT02058147|5635584|P1|Treated|Overall Study||469
2295362|NCT02058147|5635582|P3|STARTED|Overall Study||234
2295363|NCT02058147|5635583|P2|STARTED|Overall Study||467
2295364|NCT02058147|5635584|P1|STARTED|Overall Study||469
2295365|NCT02058108|5635635|P2|NOT COMPLETED|Overall Study||10
2295366|NCT02058108|5635636|P1|NOT COMPLETED|Overall Study||41
2295367|NCT02058108|5635635|P2|COMPLETED|Overall Study||0
2295368|NCT02058108|5635636|P1|COMPLETED|Overall Study||2
2295369|NCT02058108|5635635|P2|Switched to Telbivudine After Week 24|Overall Study||5
2295370|NCT02058108|5635636|P1|Switched to Telbivudine After Week 24|Overall Study||0
2295371|NCT02058108|5635635|P2|STARTED|Overall Study||10
2295372|NCT02058108|5635636|P1|STARTED|Overall Study||43
2295373|NCT02058069|5635660|P1|NOT COMPLETED|Overall Study||11
2295374|NCT02058069|5635660|P1|COMPLETED|Overall Study||89
2295375|NCT02058069|5635660|P1|STARTED|Overall Study||100
2295376|NCT02057952|5635672|P3|NOT COMPLETED|Overall Study||22
2295377|NCT02057952|5635673|P2|NOT COMPLETED|Overall Study||10
2295378|NCT02057952|5635674|P1|NOT COMPLETED|Overall Study||8
2295379|NCT02057952|5635672|P3|COMPLETED|Overall Study||28
2295380|NCT02057952|5635673|P2|COMPLETED|Overall Study||39
2295381|NCT02057952|5635674|P1|COMPLETED|Overall Study||43
2295382|NCT02057952|5635672|P3|STARTED|Overall Study||50
2295383|NCT02057952|5635673|P2|STARTED|Overall Study||49
2295384|NCT02057952|5635674|P1|STARTED|Overall Study||51
2295385|NCT02057939|5635709|P1|NOT COMPLETED|Overall Study||1
2295386|NCT02057939|5635709|P1|COMPLETED|Overall Study||37
2295387|NCT02057939|5635709|P1|STARTED|Overall Study||38
2295388|NCT02057874|5635719|P1|NOT COMPLETED|Overall Study||1
2295389|NCT02057874|5635719|P1|COMPLETED|Overall Study||1
2295390|NCT02057874|5635719|P1|STARTED|Overall Study||2
2295391|NCT02057835|5635737|P10|NOT COMPLETED|Overall Study||0
2295392|NCT02057835|5635738|P9|NOT COMPLETED|Overall Study||0
2295393|NCT02057835|5635739|P8|NOT COMPLETED|Overall Study||0
2295394|NCT02057835|5635740|P7|NOT COMPLETED|Overall Study||0
2295395|NCT02057835|5635741|P6|NOT COMPLETED|Overall Study||0
2295396|NCT02057835|5635742|P5|NOT COMPLETED|Overall Study||0
2295397|NCT02057835|5635743|P4|NOT COMPLETED|Overall Study||0
2295398|NCT02057835|5635744|P3|NOT COMPLETED|Overall Study||0
2295399|NCT02057835|5635745|P2|NOT COMPLETED|Overall Study||2
2295400|NCT02057835|5635746|P1|NOT COMPLETED|Overall Study||0
2295401|NCT02057835|5635737|P10|COMPLETED|Overall Study||6
2295402|NCT02057835|5635738|P9|COMPLETED|Overall Study||6
2295403|NCT02057835|5635739|P8|COMPLETED|Overall Study||6
2295404|NCT02057835|5635740|P7|COMPLETED|Overall Study||6
2295405|NCT02057835|5635741|P6|COMPLETED|Overall Study||8
2295406|NCT02057835|5635742|P5|COMPLETED|Overall Study||6
2295407|NCT02057835|5635743|P4|COMPLETED|Overall Study||6
2295408|NCT02057835|5635744|P3|COMPLETED|Overall Study||6
2295409|NCT02057835|5635745|P2|COMPLETED|Overall Study||4
2295410|NCT02057835|5635746|P1|COMPLETED|Overall Study||8
2295411|NCT02057835|5635737|P10|STARTED|Overall Study||6
2295412|NCT02057835|5635738|P9|STARTED|Overall Study||6
2295413|NCT02057835|5635739|P8|STARTED|Overall Study||6
2295414|NCT02057835|5635740|P7|STARTED|Overall Study||6
2295415|NCT02057835|5635741|P6|STARTED|Overall Study||8
2295416|NCT02057835|5635742|P5|STARTED|Overall Study||6
2295417|NCT02057835|5635743|P4|STARTED|Overall Study||6
2295418|NCT02057835|5635744|P3|STARTED|Overall Study||6
2295419|NCT02057835|5635745|P2|STARTED|Overall Study||6
2295420|NCT02057835|5635746|P1|STARTED|Overall Study||8
2295421|NCT02057757|5635825|P2|NOT COMPLETED|Overall Study||8
2295422|NCT02057757|5635826|P1|NOT COMPLETED|Overall Study||14
2295423|NCT02057757|5635825|P2|COMPLETED|Overall Study||121
2295424|NCT02057757|5635826|P1|COMPLETED|Overall Study||117
2295425|NCT02057757|5635825|P2|Intent to Treat|Overall Study||127
2295426|NCT02057757|5635826|P1|Intent to Treat|Overall Study||130
2295427|NCT02057757|5635825|P2|STARTED|Overall Study||129
2295428|NCT02057757|5635826|P1|STARTED|Overall Study||131
2295429|NCT02057692|5635880|P4|NOT COMPLETED|Overall Study||1
2295430|NCT02057692|5635881|P3|NOT COMPLETED|Overall Study||0
2295431|NCT02057692|5635882|P2|NOT COMPLETED|Overall Study||0
2295432|NCT02057692|5635883|P1|NOT COMPLETED|Overall Study||1
2295433|NCT02057692|5635880|P4|COMPLETED|Overall Study||11
2295434|NCT02057692|5635881|P3|COMPLETED|Overall Study||6
2295435|NCT02057692|5635882|P2|COMPLETED|Overall Study||11
2295436|NCT02057692|5635883|P1|COMPLETED|Overall Study||7
2295437|NCT02057692|5635880|P4|STARTED|Overall Study||12
2295438|NCT02057692|5635881|P3|STARTED|Overall Study||6
2295439|NCT02057692|5635882|P2|STARTED|Overall Study||11
2295440|NCT02057692|5635883|P1|STARTED|Overall Study||8
2295441|NCT02057640|5635913|P2|NOT COMPLETED|Phase II Portion of Study at DL2||0
2295442|NCT02057640|5635914|P1|NOT COMPLETED|Phase II Portion of Study at DL2||0
2295443|NCT02057640|5635913|P2|COMPLETED|Phase II Portion of Study at DL2||9
2295444|NCT02057640|5635914|P1|COMPLETED|Phase II Portion of Study at DL2||0
2295445|NCT02057640|5635913|P2|STARTED|Phase II Portion of Study at DL2||9
2295446|NCT02057640|5635914|P1|STARTED|Phase II Portion of Study at DL2||0
2295447|NCT02057640|5635913|P2|NOT COMPLETED|Weeks 1-4||0
2295448|NCT02057640|5635914|P1|NOT COMPLETED|Weeks 1-4||0
2295449|NCT02057640|5635913|P2|COMPLETED|Weeks 1-4||3
2295450|NCT02057640|5635914|P1|COMPLETED|Weeks 1-4||4
2295451|NCT02057640|5635913|P2|STARTED|Weeks 1-4||3
2295452|NCT02057640|5635914|P1|STARTED|Weeks 1-4|1 extra participant accidentally treated at DL1 (in addition to initial 3).|4
2295453|NCT02057575|5635929|P4|NOT COMPLETED|Overall Study||1
2295454|NCT02057575|5635930|P3|NOT COMPLETED|Overall Study||0
2295455|NCT02057575|5635931|P2|NOT COMPLETED|Overall Study||4
2295456|NCT02057575|5635932|P1|NOT COMPLETED|Overall Study||1
2295457|NCT02057575|5635929|P4|COMPLETED|Overall Study||72
2295458|NCT02057575|5635930|P3|COMPLETED|Overall Study||78
2295459|NCT02057575|5635931|P2|COMPLETED|Overall Study||69
2295460|NCT02057575|5635932|P1|COMPLETED|Overall Study||73
2295461|NCT02057575|5635929|P4|STARTED|Overall Study||73
2295462|NCT02057575|5635930|P3|STARTED|Overall Study||78
2295463|NCT02057575|5635931|P2|STARTED|Overall Study||73
2295464|NCT02057575|5635932|P1|STARTED|Overall Study||74
2295465|NCT02057549|5635944|P2|NOT COMPLETED|Overall Study||0
2295466|NCT02057549|5635945|P1|NOT COMPLETED|Overall Study||3
2295467|NCT02057549|5635944|P2|COMPLETED|Overall Study||18
2295468|NCT02057549|5635945|P1|COMPLETED|Overall Study||15
2295469|NCT02057549|5635944|P2|STARTED|Overall Study||18
2295470|NCT02057549|5635945|P1|STARTED|Overall Study||18
2295471|NCT02057406|5635968|P3|NOT COMPLETED|Overall Study||4
2295472|NCT02057406|5635969|P2|NOT COMPLETED|Overall Study||3
2295473|NCT02057406|5635970|P1|NOT COMPLETED|Overall Study||1
2295474|NCT02057406|5635968|P3|COMPLETED|Overall Study||32
2295475|NCT02057406|5635969|P2|COMPLETED|Overall Study||33
2295476|NCT02057406|5635970|P1|COMPLETED|Overall Study||35
2295477|NCT02057406|5635968|P3|STARTED|Overall Study||36
2295478|NCT02057406|5635969|P2|STARTED|Overall Study||36
2295479|NCT02057406|5635970|P1|STARTED|Overall Study||36
2295480|NCT02057393|5635981|P1|NOT COMPLETED|Overall Study||2
2295481|NCT02057393|5635981|P1|COMPLETED|Overall Study||87
2295482|NCT02057393|5635981|P1|STARTED|Overall Study||89
2295483|NCT02057276|5635987|P2|NOT COMPLETED|Overall Study||0
2295484|NCT02057276|5635988|P1|NOT COMPLETED|Overall Study||0
2295485|NCT02057276|5635987|P2|COMPLETED|Overall Study||0
2295486|NCT02057276|5635988|P1|COMPLETED|Overall Study||0
2295487|NCT02057276|5635987|P2|STARTED|Overall Study||0
2295488|NCT02057276|5635988|P1|STARTED|Overall Study||0
2295489|NCT02057250|5636002|P5|NOT COMPLETED|Extension Phase||36
2295490|NCT02057250|5636003|P4|NOT COMPLETED|Extension Phase||0
2295491|NCT02057250|5636004|P3|NOT COMPLETED|Extension Phase||0
2295492|NCT02057250|5636005|P2|NOT COMPLETED|Extension Phase||0
2295493|NCT02057250|5636006|P1|NOT COMPLETED|Extension Phase||0
2295494|NCT02057250|5636002|P5|COMPLETED|Extension Phase||156
2295495|NCT02057250|5636003|P4|COMPLETED|Extension Phase||0
2295496|NCT02057250|5636004|P3|COMPLETED|Extension Phase||0
2295497|NCT02057250|5636005|P2|COMPLETED|Extension Phase||0
2295498|NCT02057250|5636006|P1|COMPLETED|Extension Phase||0
2295499|NCT02057250|5636002|P5|Treated|Extension Phase||188
2295500|NCT02057250|5636003|P4|Treated|Extension Phase||0
2295501|NCT02057250|5636004|P3|Treated|Extension Phase||0
2295502|NCT02057250|5636005|P2|Treated|Extension Phase||0
2295503|NCT02057250|5636006|P1|Treated|Extension Phase||0
2295504|NCT02057250|5636002|P5|STARTED|Extension Phase|9 participants who completed AID Assessment phase did not enter extension phase.|192
2295505|NCT02057250|5636003|P4|STARTED|Extension Phase||0
2295506|NCT02057250|5636004|P3|STARTED|Extension Phase||0
2295507|NCT02057250|5636005|P2|STARTED|Extension Phase||0
2295508|NCT02057250|5636006|P1|STARTED|Extension Phase||0
2295509|NCT02057250|5636002|P5|NOT COMPLETED|AID Assessment Phase||0
2295510|NCT02057250|5636003|P4|NOT COMPLETED|AID Assessment Phase||2
2295511|NCT02057250|5636004|P3|NOT COMPLETED|AID Assessment Phase||7
2295512|NCT02057250|5636005|P2|NOT COMPLETED|AID Assessment Phase||3
2295513|NCT02057250|5636006|P1|NOT COMPLETED|AID Assessment Phase||4
2295514|NCT02057250|5636002|P5|COMPLETED|AID Assessment Phase||0
2295515|NCT02057250|5636003|P4|COMPLETED|AID Assessment Phase||54
2295516|NCT02057250|5636004|P3|COMPLETED|AID Assessment Phase||45
2295517|NCT02057250|5636005|P2|COMPLETED|AID Assessment Phase||50
2295518|NCT02057250|5636006|P1|COMPLETED|AID Assessment Phase||52
2295519|NCT02057250|5636002|P5|STARTED|AID Assessment Phase||0
2295520|NCT02057250|5636003|P4|STARTED|AID Assessment Phase||56
2295521|NCT02057250|5636004|P3|STARTED|AID Assessment Phase||52
2295522|NCT02057250|5636005|P2|STARTED|AID Assessment Phase||53
2295523|NCT02057250|5636006|P1|STARTED|AID Assessment Phase||56
2295524|NCT02057237|5636019|P1|NOT COMPLETED|Overall Study||0
2295525|NCT02057237|5636019|P1|COMPLETED|Overall Study||1
2295526|NCT02057237|5636019|P1|STARTED|Overall Study||1
2295527|NCT02057198|5636027|P3|NOT COMPLETED|Overall Study||1
2295528|NCT02057198|5636028|P2|NOT COMPLETED|Overall Study||1
2295529|NCT02057198|5636029|P1|NOT COMPLETED|Overall Study||0
2295530|NCT02057198|5636027|P3|COMPLETED|Overall Study||10
2295531|NCT02057198|5636028|P2|COMPLETED|Overall Study||10
2295532|NCT02057198|5636029|P1|COMPLETED|Overall Study||11
2295533|NCT02057198|5636027|P3|STARTED|Overall Study||11
2295534|NCT02057198|5636028|P2|STARTED|Overall Study||11
2295535|NCT02057198|5636029|P1|STARTED|Overall Study||11
2295536|NCT02057068|5636054|P2|NOT COMPLETED|Overall Study||8
2295537|NCT02057068|5636055|P1|NOT COMPLETED|Overall Study||8
2295538|NCT02057068|5636054|P2|COMPLETED|Overall Study||28
2295539|NCT02057068|5636055|P1|COMPLETED|Overall Study||52
2295540|NCT02057068|5636054|P2|STARTED|Overall Study||36
2295541|NCT02057068|5636055|P1|STARTED|Overall Study||60
2295542|NCT02057042|5636067|P2|NOT COMPLETED|Overall Study||66
2295543|NCT02057042|5636068|P1|NOT COMPLETED|Overall Study||45
2295544|NCT02057042|5636067|P2|COMPLETED|Overall Study||101
2295545|NCT02057042|5636068|P1|COMPLETED|Overall Study||118
2295546|NCT02057042|5636067|P2|STARTED|Overall Study||167
2295547|NCT02057042|5636068|P1|STARTED|Overall Study||163
2295548|NCT02056834|5636084|P1|NOT COMPLETED|Overall Study||7
2295549|NCT02056834|5636084|P1|COMPLETED|Overall Study||29
2295550|NCT02056834|5636084|P1|6 Months|Overall Study||31
2295551|NCT02056834|5636084|P1|6 Weeks|Overall Study||34
2295552|NCT02056834|5636084|P1|STARTED|Overall Study||36
2295553|NCT02056652|5636105|P2|NOT COMPLETED|Overall Study||3
2295554|NCT02056652|5636106|P1|NOT COMPLETED|Overall Study||1
2295555|NCT02056652|5636105|P2|COMPLETED|Overall Study||58
2295556|NCT02056652|5636106|P1|COMPLETED|Overall Study||60
2295557|NCT02056652|5636105|P2|STARTED|Overall Study||61
2295558|NCT02056652|5636106|P1|STARTED|Overall Study||61
2295559|NCT02056639|5636124|P2|NOT COMPLETED|Overall Study||0
2295560|NCT02056639|5636125|P1|NOT COMPLETED|Overall Study||0
2295561|NCT02056639|5636124|P2|COMPLETED|Overall Study||23
2295562|NCT02056639|5636125|P1|COMPLETED|Overall Study||23
2295563|NCT02056639|5636124|P2|STARTED|Overall Study||23
2295564|NCT02056639|5636125|P1|STARTED|Overall Study||23
2295565|NCT02056626|5636143|P4|NOT COMPLETED|Overall Study||0
2295566|NCT02056626|5636144|P3|NOT COMPLETED|Overall Study||0
2295567|NCT02056626|5636145|P2|NOT COMPLETED|Overall Study||1
2295568|NCT02056626|5636146|P1|NOT COMPLETED|Overall Study||3
2295569|NCT02056626|5636143|P4|COMPLETED|Overall Study||14
2295570|NCT02056626|5636144|P3|COMPLETED|Overall Study||4
2295571|NCT02056626|5636145|P2|COMPLETED|Overall Study||12
2295572|NCT02056626|5636146|P1|COMPLETED|Overall Study||10
2295573|NCT02056626|5636143|P4|STARTED|Overall Study||14
2295574|NCT02056626|5636144|P3|STARTED|Overall Study||4
2295575|NCT02056626|5636145|P2|STARTED|Overall Study||13
2295576|NCT02056626|5636146|P1|STARTED|Overall Study||13
2295577|NCT02056431|5636166|P2|NOT COMPLETED|Overall Study||47
2295578|NCT02056431|5636167|P1|NOT COMPLETED|Overall Study||44
2295579|NCT02056431|5636166|P2|COMPLETED|Overall Study||619
2295580|NCT02056431|5636167|P1|COMPLETED|Overall Study||560
2295581|NCT02056431|5636166|P2|STARTED|Overall Study||666
2295582|NCT02056431|5636167|P1|STARTED|Overall Study||604
2295583|NCT02056392|5636181|P6|NOT COMPLETED|Overall Study||0
2295584|NCT02056392|5636182|P5|NOT COMPLETED|Overall Study||1
2295585|NCT02056392|5636183|P4|NOT COMPLETED|Overall Study||0
2295586|NCT02056392|5636184|P3|NOT COMPLETED|Overall Study||3
2295587|NCT02056392|5636185|P2|NOT COMPLETED|Overall Study||1
2295588|NCT02056392|5636186|P1|NOT COMPLETED|Overall Study||2
2295589|NCT02056392|5636181|P6|COMPLETED|Overall Study||9
2295590|NCT02056392|5636182|P5|COMPLETED|Overall Study||7
2295591|NCT02056392|5636183|P4|COMPLETED|Overall Study||9
2295592|NCT02056392|5636184|P3|COMPLETED|Overall Study||6
2295593|NCT02056392|5636185|P2|COMPLETED|Overall Study||8
2295594|NCT02056392|5636186|P1|COMPLETED|Overall Study||8
2295595|NCT02056392|5636181|P6|STARTED|Overall Study||9
2295596|NCT02056392|5636182|P5|STARTED|Overall Study||8
2295597|NCT02056392|5636183|P4|STARTED|Overall Study||9
2295598|NCT02056392|5636184|P3|STARTED|Overall Study||9
2295599|NCT02056392|5636185|P2|STARTED|Overall Study||9
2295600|NCT02056392|5636186|P1|STARTED|Overall Study||10
2295601|NCT02056340|5636223|P2|NOT COMPLETED|Overall Study||11
2295602|NCT02056340|5636224|P1|NOT COMPLETED|Overall Study||7
2295603|NCT02056340|5636223|P2|COMPLETED|Overall Study||46
2295604|NCT02056340|5636224|P1|COMPLETED|Overall Study||52
2295605|NCT02056340|5636223|P2|STARTED|Overall Study||57
2295606|NCT02056340|5636224|P1|STARTED|Overall Study||59
2295607|NCT02056171|5636234|P2|NOT COMPLETED|Overall Study||0
2295608|NCT02056171|5636235|P1|NOT COMPLETED|Overall Study||0
2295609|NCT02056171|5636234|P2|COMPLETED|Overall Study||3
2295610|NCT02056171|5636235|P1|COMPLETED|Overall Study||3
2295611|NCT02056171|5636234|P2|STARTED|Overall Study||3
2295612|NCT02056171|5636235|P1|STARTED|Overall Study||3
2295613|NCT02055976|5636254|P9|NOT COMPLETED|Overall Study||0
2295614|NCT02055976|5636255|P8|NOT COMPLETED|Overall Study||0
2295615|NCT02055976|5636256|P7|NOT COMPLETED|Overall Study||2
2295616|NCT02055976|5636257|P6|NOT COMPLETED|Overall Study||1
2295617|NCT02055976|5636258|P5|NOT COMPLETED|Overall Study||0
2295618|NCT02055976|5636259|P4|NOT COMPLETED|Overall Study||1
2295619|NCT02055976|5636260|P3|NOT COMPLETED|Overall Study||1
2295620|NCT02055976|5636261|P2|NOT COMPLETED|Overall Study||0
2295621|NCT02055976|5636262|P1|NOT COMPLETED|Overall Study||0
2295622|NCT02055976|5636254|P9|COMPLETED|Overall Study||23
2295623|NCT02055976|5636255|P8|COMPLETED|Overall Study||24
2295624|NCT02055976|5636256|P7|COMPLETED|Overall Study||23
2295625|NCT02055976|5636257|P6|COMPLETED|Overall Study||24
2295626|NCT02055976|5636258|P5|COMPLETED|Overall Study||22
2295627|NCT02055976|5636259|P4|COMPLETED|Overall Study||25
2295628|NCT02055976|5636260|P3|COMPLETED|Overall Study||23
2295629|NCT02055976|5636261|P2|COMPLETED|Overall Study||24
2295630|NCT02055976|5636262|P1|COMPLETED|Overall Study||25
2295631|NCT02055976|5636254|P9|STARTED|Overall Study||23
2295632|NCT02055976|5636255|P8|STARTED|Overall Study||24
2295633|NCT02055976|5636256|P7|STARTED|Overall Study||25
2295634|NCT02055976|5636257|P6|STARTED|Overall Study||25
2295635|NCT02055976|5636258|P5|STARTED|Overall Study||22
2295636|NCT02055976|5636259|P4|STARTED|Overall Study||26
2295637|NCT02055976|5636260|P3|STARTED|Overall Study||24
2295638|NCT02055976|5636261|P2|STARTED|Overall Study||24
2295639|NCT02055976|5636262|P1|STARTED|Overall Study||25
2295640|NCT02055820|5636691|P10|NOT COMPLETED|Phase II: Expansion||0
2295641|NCT02055820|5636692|P9|NOT COMPLETED|Phase II: Expansion||0
2295642|NCT02055820|5636693|P8|NOT COMPLETED|Phase II: Expansion||0
2295643|NCT02055820|5636694|P7|NOT COMPLETED|Phase II: Expansion||0
2295644|NCT02055820|5636695|P6|NOT COMPLETED|Phase II: Expansion||0
2295645|NCT02055820|5636696|P5|NOT COMPLETED|Phase II: Expansion||208
2295646|NCT02055820|5636697|P4|NOT COMPLETED|Phase II: Expansion||0
2295647|NCT02055820|5636698|P3|NOT COMPLETED|Phase II: Expansion||0
2295648|NCT02055820|5636699|P2|NOT COMPLETED|Phase II: Expansion||0
2295649|NCT02055820|5636700|P1|NOT COMPLETED|Phase II: Expansion||0
2295650|NCT02055820|5636691|P10|COMPLETED|Phase II: Expansion||0
2295651|NCT02055820|5636692|P9|COMPLETED|Phase II: Expansion||0
2295652|NCT02055820|5636693|P8|COMPLETED|Phase II: Expansion||0
2295653|NCT02055820|5636694|P7|COMPLETED|Phase II: Expansion||0
2295654|NCT02055820|5636695|P6|COMPLETED|Phase II: Expansion||0
2295655|NCT02055820|5636696|P5|COMPLETED|Phase II: Expansion|Study is still on-going|0
2295656|NCT02055820|5636697|P4|COMPLETED|Phase II: Expansion||0
2295657|NCT02055820|5636698|P3|COMPLETED|Phase II: Expansion||0
2295658|NCT02055820|5636699|P2|COMPLETED|Phase II: Expansion||0
2295659|NCT02055820|5636700|P1|COMPLETED|Phase II: Expansion||0
2295660|NCT02055820|5636691|P10|STARTED|Phase II: Expansion||0
2295661|NCT02055820|5636692|P9|STARTED|Phase II: Expansion||0
2295662|NCT02055820|5636693|P8|STARTED|Phase II: Expansion||0
2295663|NCT02055820|5636694|P7|STARTED|Phase II: Expansion||0
2295664|NCT02055820|5636695|P6|STARTED|Phase II: Expansion||0
2295665|NCT02055820|5636696|P5|STARTED|Phase II: Expansion||208
2295666|NCT02055820|5636697|P4|STARTED|Phase II: Expansion||0
2295667|NCT02055820|5636698|P3|STARTED|Phase II: Expansion||0
2295668|NCT02055820|5636699|P2|STARTED|Phase II: Expansion||0
2295669|NCT02055820|5636700|P1|STARTED|Phase II: Expansion||0
2295670|NCT02055820|5636691|P10|NOT COMPLETED|Phase I: Dose-Finding||6
2295671|NCT02055820|5636692|P9|NOT COMPLETED|Phase I: Dose-Finding||6
2295672|NCT02055820|5636693|P8|NOT COMPLETED|Phase I: Dose-Finding||6
2295673|NCT02055820|5636694|P7|NOT COMPLETED|Phase I: Dose-Finding||7
2295674|NCT02055820|5636695|P6|NOT COMPLETED|Phase I: Dose-Finding||7
2295675|NCT02055820|5636696|P5|NOT COMPLETED|Phase I: Dose-Finding||0
2295676|NCT02055820|5636697|P4|NOT COMPLETED|Phase I: Dose-Finding||6
2295677|NCT02055820|5636698|P3|NOT COMPLETED|Phase I: Dose-Finding||8
2295678|NCT02055820|5636699|P2|NOT COMPLETED|Phase I: Dose-Finding||3
2295679|NCT02055820|5636700|P1|NOT COMPLETED|Phase I: Dose-Finding||7
2295680|NCT02055820|5636691|P10|COMPLETED|Phase I: Dose-Finding|Study is still ongoing|0
2295681|NCT02055820|5636692|P9|COMPLETED|Phase I: Dose-Finding|Study is still ongoing|0
2295682|NCT02055820|5636693|P8|COMPLETED|Phase I: Dose-Finding|Study is still ongoing|0
2295683|NCT02055820|5636694|P7|COMPLETED|Phase I: Dose-Finding|Study is still ongoing|0
2295684|NCT02055820|5636695|P6|COMPLETED|Phase I: Dose-Finding|Study is still ongoing|0
2295685|NCT02055820|5636696|P5|COMPLETED|Phase I: Dose-Finding||0
2295686|NCT02055820|5636697|P4|COMPLETED|Phase I: Dose-Finding|Study is still ongoing|0
2295687|NCT02055820|5636698|P3|COMPLETED|Phase I: Dose-Finding|Study is still ongoing|0
2295688|NCT02055820|5636699|P2|COMPLETED|Phase I: Dose-Finding|Study is still ongoing|0
2295689|NCT02055820|5636700|P1|COMPLETED|Phase I: Dose-Finding|Study is still ongoing|0
2295690|NCT02055820|5636691|P10|STARTED|Phase I: Dose-Finding||6
2295691|NCT02055820|5636692|P9|STARTED|Phase I: Dose-Finding||6
2295692|NCT02055820|5636693|P8|STARTED|Phase I: Dose-Finding||6
2295693|NCT02055820|5636694|P7|STARTED|Phase I: Dose-Finding||7
2295694|NCT02055820|5636695|P6|STARTED|Phase I: Dose-Finding||7
2295695|NCT02055820|5636696|P5|STARTED|Phase I: Dose-Finding||0
2295696|NCT02055820|5636697|P4|STARTED|Phase I: Dose-Finding||6
2295697|NCT02055820|5636698|P3|STARTED|Phase I: Dose-Finding||8
2295698|NCT02055820|5636699|P2|STARTED|Phase I: Dose-Finding||3
2295699|NCT02055820|5636700|P1|STARTED|Phase I: Dose-Finding||7
2295700|NCT02055638|5636804|P2|NOT COMPLETED|Overall Study||8
2295701|NCT02055638|5636805|P1|NOT COMPLETED|Overall Study||10
2295702|NCT02055638|5636804|P2|COMPLETED|Overall Study||40
2295703|NCT02055638|5636805|P1|COMPLETED|Overall Study||39
2295704|NCT02055638|5636804|P2|STARTED|Overall Study||48
2295705|NCT02055638|5636805|P1|STARTED|Overall Study||49
2295706|NCT02055430|5636813|P2|NOT COMPLETED|Overall Study||0
2295707|NCT02055430|5636814|P1|NOT COMPLETED|Overall Study||0
2295708|NCT02055430|5636813|P2|COMPLETED|Overall Study||45
2295709|NCT02055430|5636814|P1|COMPLETED|Overall Study||45
2295710|NCT02055430|5636813|P2|STARTED|Overall Study||45
2295711|NCT02055430|5636814|P1|STARTED|Overall Study||45
2295712|NCT02055404|5636820|P1|NOT COMPLETED|Overall Study||0
2295713|NCT02055404|5636820|P1|COMPLETED|Overall Study||3
2295714|NCT02055404|5636820|P1|STARTED|Overall Study||3
2295715|NCT02055365|5636833|P1|NOT COMPLETED|Overall Study||1
2295716|NCT02055365|5636833|P1|COMPLETED|Overall Study||9
2295717|NCT02055365|5636833|P1|STARTED|Overall Study||10
2295718|NCT02055352|5636846|P2|NOT COMPLETED|Overall Study||17
2295719|NCT02055352|5636847|P1|NOT COMPLETED|Overall Study||6
2295720|NCT02055352|5636846|P2|COMPLETED|Overall Study||96
2295721|NCT02055352|5636847|P1|COMPLETED|Overall Study||103
2295722|NCT02055352|5636846|P2|Per-Protocol Set (PPS)|Overall Study||111
2295723|NCT02055352|5636847|P1|Per-Protocol Set (PPS)|Overall Study||108
2295724|NCT02055352|5636846|P2|STARTED|Overall Study||113
2295725|NCT02055352|5636847|P1|STARTED|Overall Study||109
2295726|NCT02055118|5636864|P3|NOT COMPLETED|Overall Study||0
2295727|NCT02055118|5636865|P2|NOT COMPLETED|Overall Study||2
2295728|NCT02055118|5636866|P1|NOT COMPLETED|Overall Study||0
2295729|NCT02055118|5636864|P3|COMPLETED|Overall Study||9
2295730|NCT02055118|5636865|P2|COMPLETED|Overall Study||32
2295731|NCT02055118|5636866|P1|COMPLETED|Overall Study||15
2295732|NCT02055118|5636864|P3|STARTED|Overall Study||9
2295733|NCT02055118|5636865|P2|STARTED|Overall Study||34
2295734|NCT02055118|5636866|P1|STARTED|Overall Study||15
2295735|NCT02054910|5636925|P2|NOT COMPLETED|Overall Study||1
2295736|NCT02054910|5636926|P1|NOT COMPLETED|Overall Study||4
2295737|NCT02054910|5636925|P2|COMPLETED|Overall Study||0
2295738|NCT02054910|5636926|P1|COMPLETED|Overall Study||0
2295739|NCT02054910|5636925|P2|STARTED|Overall Study||1
2295740|NCT02054910|5636926|P1|STARTED|Overall Study||4
2295741|NCT02054897|5636945|P3|NOT COMPLETED|Overall Study||12
2295742|NCT02054897|5636946|P2|NOT COMPLETED|Overall Study||7
2295743|NCT02054897|5636947|P1|NOT COMPLETED|Overall Study||10
2295744|NCT02054897|5636945|P3|COMPLETED|Overall Study||117
2295745|NCT02054897|5636946|P2|COMPLETED|Overall Study||123
2295746|NCT02054897|5636947|P1|COMPLETED|Overall Study||119
2295747|NCT02054897|5636945|P3|Exposed|Overall Study||129
2295748|NCT02054897|5636946|P2|Exposed|Overall Study||130
2295749|NCT02054897|5636947|P1|Exposed|Overall Study||128
2295750|NCT02054897|5636945|P3|STARTED|Overall Study||129
2295751|NCT02054897|5636946|P2|STARTED|Overall Study||130
2295752|NCT02054897|5636947|P1|STARTED|Overall Study||129
2295753|NCT02054754|5636972|P6|NOT COMPLETED|Overall Study||0
2295754|NCT02054754|5636973|P5|NOT COMPLETED|Overall Study||0
2295755|NCT02054754|5636974|P4|NOT COMPLETED|Overall Study||0
2295756|NCT02054754|5636975|P3|NOT COMPLETED|Overall Study||0
2295757|NCT02054754|5636976|P2|NOT COMPLETED|Overall Study||0
2295758|NCT02054754|5636977|P1|NOT COMPLETED|Overall Study||0
2295759|NCT02054754|5636972|P6|COMPLETED|Overall Study||10
2295760|NCT02054754|5636973|P5|COMPLETED|Overall Study||6
2295761|NCT02054754|5636974|P4|COMPLETED|Overall Study||6
2295762|NCT02054754|5636975|P3|COMPLETED|Overall Study||6
2295763|NCT02054754|5636976|P2|COMPLETED|Overall Study||6
2295764|NCT02054754|5636977|P1|COMPLETED|Overall Study||6
2295765|NCT02054754|5636972|P6|STARTED|Overall Study||10
2295766|NCT02054754|5636973|P5|STARTED|Overall Study||6
2295767|NCT02054754|5636974|P4|STARTED|Overall Study||6
2295768|NCT02054754|5636975|P3|STARTED|Overall Study||6
2295769|NCT02054754|5636976|P2|STARTED|Overall Study||6
2295770|NCT02054754|5636977|P1|STARTED|Overall Study||6
2295771|NCT02054715|5636994|P2|NOT COMPLETED|Follow-up 2||19
2295772|NCT02054715|5636995|P1|NOT COMPLETED|Follow-up 2||19
2295773|NCT02054715|5636994|P2|COMPLETED|Follow-up 2||173
2295774|NCT02054715|5636995|P1|COMPLETED|Follow-up 2||192
2295775|NCT02054715|5636994|P2|STARTED|Follow-up 2||192
2295776|NCT02054715|5636995|P1|STARTED|Follow-up 2||211
2295777|NCT02054715|5636994|P2|NOT COMPLETED|Baseline/Follow-up 1||7
2295778|NCT02054715|5636995|P1|NOT COMPLETED|Baseline/Follow-up 1||8
2295779|NCT02054715|5636994|P2|COMPLETED|Baseline/Follow-up 1||192
2295780|NCT02054715|5636995|P1|COMPLETED|Baseline/Follow-up 1||211
2295781|NCT02054715|5636994|P2|STARTED|Baseline/Follow-up 1||199
2295782|NCT02054715|5636995|P1|STARTED|Baseline/Follow-up 1||219
2295783|NCT02054702|5637009|P2|NOT COMPLETED|Overall Study||12
2295784|NCT02054702|5637010|P1|NOT COMPLETED|Overall Study||24
2295785|NCT02054702|5637009|P2|COMPLETED|Overall Study||21
2295786|NCT02054702|5637010|P1|COMPLETED|Overall Study||40
2295787|NCT02054702|5637009|P2|STARTED|Overall Study||33
2295788|NCT02054702|5637010|P1|STARTED|Overall Study||64
2295789|NCT02054572|5637038|P1|NOT COMPLETED|Overall Study||0
2295790|NCT02054572|5637038|P1|COMPLETED|Overall Study||6
2295791|NCT02054572|5637038|P1|STARTED|Overall Study||6
2295792|NCT02054481|5637065|P4|NOT COMPLETED|Overall Study||1
2295793|NCT02054481|5637066|P3|NOT COMPLETED|Overall Study||2
2295794|NCT02054481|5637067|P2|NOT COMPLETED|Overall Study||2
2295795|NCT02054481|5637068|P1|NOT COMPLETED|Overall Study||4
2295796|NCT02054481|5637065|P4|COMPLETED|Overall Study||39
2295797|NCT02054481|5637066|P3|COMPLETED|Overall Study||40
2295798|NCT02054481|5637067|P2|COMPLETED|Overall Study||39
2295799|NCT02054481|5637068|P1|COMPLETED|Overall Study||39
2295800|NCT02054481|5637065|P4|STARTED|Overall Study||40
2295801|NCT02054481|5637066|P3|STARTED|Overall Study||42
2295802|NCT02054481|5637067|P2|STARTED|Overall Study||41
2295803|NCT02054481|5637068|P1|STARTED|Overall Study||43
2295804|NCT02054338|5637116|P2|NOT COMPLETED|Overall Study||501
2295805|NCT02054338|5637117|P1|NOT COMPLETED|Overall Study||503
2295806|NCT02054338|5637116|P2|COMPLETED|Overall Study||0
2295807|NCT02054338|5637117|P1|COMPLETED|Overall Study||0
2295808|NCT02054338|5637116|P2|STARTED|Overall Study||501
2295809|NCT02054338|5637117|P1|STARTED|Overall Study||503
2295810|NCT02054325|5637129|P2|NOT COMPLETED|Overall Study||5
2295811|NCT02054325|5637130|P1|NOT COMPLETED|Overall Study||8
2295812|NCT02054325|5637129|P2|COMPLETED|Overall Study||50
2295813|NCT02054325|5637130|P1|COMPLETED|Overall Study||43
2295814|NCT02054325|5637129|P2|STARTED|Overall Study||55
2295815|NCT02054325|5637130|P1|STARTED|Overall Study||51
2295816|NCT02054156|5637140|P2|NOT COMPLETED|Overall Study||81
2295817|NCT02054156|5637141|P1|NOT COMPLETED|Overall Study||75
2295818|NCT02054156|5637140|P2|COMPLETED|Overall Study||30
2295819|NCT02054156|5637141|P1|COMPLETED|Overall Study||35
2295820|NCT02054156|5637140|P2|STARTED|Overall Study||111
2295821|NCT02054156|5637141|P1|STARTED|Overall Study||110
2295822|NCT02054130|5637157|P4|NOT COMPLETED|Overall Study||22
2295823|NCT02054130|5637158|P3|NOT COMPLETED|Overall Study||15
2295824|NCT02054130|5637159|P2|NOT COMPLETED|Overall Study||11
2295825|NCT02054130|5637160|P1|NOT COMPLETED|Overall Study||8
2295826|NCT02054130|5637157|P4|COMPLETED|Overall Study||115
2295827|NCT02054130|5637158|P3|COMPLETED|Overall Study||122
2295828|NCT02054130|5637159|P2|COMPLETED|Overall Study||127
2295829|NCT02054130|5637160|P1|COMPLETED|Overall Study||130
2295830|NCT02054130|5637157|P4|STARTED|Overall Study||137
2295831|NCT02054130|5637158|P3|STARTED|Overall Study||137
2295832|NCT02054130|5637159|P2|STARTED|Overall Study||138
2295833|NCT02054130|5637160|P1|STARTED|Overall Study||138
2295834|NCT02053753|5637254|P2|NOT COMPLETED|Overall Study||8
2295835|NCT02053753|5637255|P1|NOT COMPLETED|Overall Study||7
2295836|NCT02053753|5637254|P2|COMPLETED|Overall Study||66
2295837|NCT02053753|5637255|P1|COMPLETED|Overall Study||65
2295838|NCT02053753|5637254|P2|Received Treatment|Overall Study||71
2295839|NCT02053753|5637255|P1|Received Treatment|Overall Study||71
2295840|NCT02053753|5637254|P2|STARTED|Overall Study||74
2295841|NCT02053753|5637255|P1|STARTED|Overall Study||72
2295842|NCT02053610|5637279|P2|NOT COMPLETED|Overall Study||67
2295843|NCT02053610|5637280|P1|NOT COMPLETED|Overall Study||42
2295844|NCT02053610|5637279|P2|COMPLETED|Overall Study|Completed=Completed Treatment|266
2295845|NCT02053610|5637280|P1|COMPLETED|Overall Study|Completed=Completed Treatment|288
2295846|NCT02053610|5637279|P2|Received Study Drug|Overall Study||331
2295847|NCT02053610|5637280|P1|Received Study Drug|Overall Study||326
2295848|NCT02053610|5637279|P2|STARTED|Overall Study||333
2295849|NCT02053610|5637280|P1|STARTED|Overall Study||330
2295850|NCT02053493|5637312|P2|NOT COMPLETED|Overall Study||1
2295851|NCT02053493|5637313|P1|NOT COMPLETED|Overall Study||1
2295852|NCT02053493|5637312|P2|COMPLETED|Overall Study||58
2295853|NCT02053493|5637313|P1|COMPLETED|Overall Study||50
2295854|NCT02053493|5637312|P2|STARTED|Overall Study||59
2295855|NCT02053493|5637313|P1|STARTED|Overall Study||51
2295856|NCT02053376|5637351|P1|NOT COMPLETED|Overall Study||0
2295857|NCT02053376|5637351|P1|COMPLETED|Overall Study||43
2295858|NCT02053376|5637351|P1|STARTED|Overall Study||43
2295859|NCT02053168|5637362|P1|NOT COMPLETED|Overall Study||3
2295860|NCT02053168|5637362|P1|COMPLETED|Overall Study||22
2295861|NCT02053168|5637362|P1|STARTED|Overall Study||25
2295862|NCT02052895|5637379|P3|NOT COMPLETED|Overall Study||0
2295863|NCT02052895|5637380|P2|NOT COMPLETED|Overall Study||0
2295864|NCT02052895|5637381|P1|NOT COMPLETED|Overall Study||0
2295865|NCT02052895|5637379|P3|COMPLETED|Overall Study||15
2295866|NCT02052895|5637380|P2|COMPLETED|Overall Study||15
2295867|NCT02052895|5637381|P1|COMPLETED|Overall Study||196
2295868|NCT02052895|5637379|P3|STARTED|Overall Study||15
2295869|NCT02052895|5637380|P2|STARTED|Overall Study||15
2295870|NCT02052895|5637381|P1|STARTED|Overall Study||196
2295871|NCT02052752|5637391|P3|NOT COMPLETED|Overall Study||0
2295872|NCT02052752|5637392|P2|NOT COMPLETED|Overall Study||0
2295873|NCT02052752|5637393|P1|NOT COMPLETED|Overall Study||0
2295874|NCT02052752|5637391|P3|COMPLETED|Overall Study||30
2295875|NCT02052752|5637392|P2|COMPLETED|Overall Study||30
2295876|NCT02052752|5637393|P1|COMPLETED|Overall Study||30
2295877|NCT02052752|5637391|P3|STARTED|Overall Study||30
2295878|NCT02052752|5637392|P2|STARTED|Overall Study||30
2295879|NCT02052752|5637393|P1|STARTED|Overall Study||30
2295880|NCT02052661|5637416|P1|NOT COMPLETED|Overall Study||0
2295881|NCT02052661|5637416|P1|COMPLETED|Overall Study||300
2295882|NCT02052661|5637416|P1|STARTED|Overall Study||300
2295883|NCT02052635|5637430|P2|NOT COMPLETED|Overall Study||0
2295884|NCT02052635|5637431|P1|NOT COMPLETED|Overall Study||0
2295885|NCT02052635|5637430|P2|COMPLETED|Overall Study||6
2295886|NCT02052635|5637431|P1|COMPLETED|Overall Study||7
2295887|NCT02052635|5637430|P2|STARTED|Overall Study||6
2295888|NCT02052635|5637431|P1|STARTED|Overall Study||7
2295889|NCT02052596|5637441|P2|NOT COMPLETED|Safety Phase||35
2295890|NCT02052596|5637442|P1|NOT COMPLETED|Safety Phase||27
2295891|NCT02052596|5637441|P2|COMPLETED|Safety Phase||383
2295892|NCT02052596|5637442|P1|COMPLETED|Safety Phase||385
2295893|NCT02052596|5637441|P2|STARTED|Safety Phase||418
2295894|NCT02052596|5637442|P1|STARTED|Safety Phase||412
2295895|NCT02052596|5637441|P2|NOT COMPLETED|Active Phase||20
2295896|NCT02052596|5637442|P1|NOT COMPLETED|Active Phase||16
2295897|NCT02052596|5637441|P2|COMPLETED|Active Phase||398
2295898|NCT02052596|5637442|P1|COMPLETED|Active Phase||396
2295899|NCT02052596|5637441|P2|STARTED|Active Phase||418
2295900|NCT02052596|5637442|P1|STARTED|Active Phase||412
2295901|NCT02052544|5637467|P1|NOT COMPLETED|Overall Study||0
2295902|NCT02052544|5637467|P1|COMPLETED|Overall Study|Last Subject Out|123
2295903|NCT02052544|5637467|P1|STARTED|Overall Study|First Subject In|123
2295904|NCT02052466|5637472|P1|NOT COMPLETED|Overall Study||2
2295905|NCT02052466|5637472|P1|COMPLETED|Overall Study||30
2295906|NCT02052466|5637472|P1|STARTED|Overall Study||32
2295907|NCT02052440|5637489|P2|NOT COMPLETED|Overall Study||1
2295908|NCT02052440|5637490|P1|NOT COMPLETED|Overall Study||0
2295909|NCT02052440|5637489|P2|COMPLETED|Overall Study||51
2295910|NCT02052440|5637490|P1|COMPLETED|Overall Study||50
2295911|NCT02052440|5637489|P2|STARTED|Overall Study||52
2295912|NCT02052440|5637490|P1|STARTED|Overall Study||50
2295913|NCT02052414|5637502|P1|NOT COMPLETED|Overall Study||17
2295914|NCT02052414|5637502|P1|COMPLETED|Overall Study||17
2295915|NCT02052414|5637502|P1|STARTED|Overall Study||34
2295916|NCT02052141|5637512|P2|NOT COMPLETED|Intervention Period 2||0
2295917|NCT02052141|5637513|P1|NOT COMPLETED|Intervention Period 2||0
2295918|NCT02052141|5637512|P2|COMPLETED|Intervention Period 2||7
2295919|NCT02052141|5637513|P1|COMPLETED|Intervention Period 2||5
2295920|NCT02052141|5637512|P2|STARTED|Intervention Period 2||7
2295921|NCT02052141|5637513|P1|STARTED|Intervention Period 2||5
2295922|NCT02052141|5637512|P2|NOT COMPLETED|Intervention Period 1||0
2295923|NCT02052141|5637513|P1|NOT COMPLETED|Intervention Period 1||0
2295924|NCT02052141|5637512|P2|COMPLETED|Intervention Period 1||7
2295925|NCT02052141|5637513|P1|COMPLETED|Intervention Period 1||5
2295926|NCT02052141|5637512|P2|STARTED|Intervention Period 1||7
2295927|NCT02052141|5637513|P1|STARTED|Intervention Period 1||5
2295928|NCT02052011|5637537|P2|NOT COMPLETED|Overall Study||2
2295929|NCT02052011|5637538|P1|NOT COMPLETED|Overall Study||4
2295930|NCT02052011|5637537|P2|COMPLETED|Overall Study||8
2295931|NCT02052011|5637538|P1|COMPLETED|Overall Study||17
2295932|NCT02052011|5637537|P2|STARTED|Overall Study||10
2295933|NCT02052011|5637538|P1|STARTED|Overall Study||21
2295934|NCT02051816|5637548|P4|NOT COMPLETED|Overall Study||0
2295935|NCT02051816|5637549|P3|NOT COMPLETED|Overall Study||0
2295936|NCT02051816|5637550|P2|NOT COMPLETED|Overall Study||0
2295937|NCT02051816|5637551|P1|NOT COMPLETED|Overall Study||0
2295938|NCT02051816|5637548|P4|COMPLETED|Overall Study||36
2295939|NCT02051816|5637549|P3|COMPLETED|Overall Study||37
2295940|NCT02051816|5637550|P2|COMPLETED|Overall Study||40
2295941|NCT02051816|5637551|P1|COMPLETED|Overall Study||37
2295942|NCT02051816|5637548|P4|STARTED|Overall Study||36
2295943|NCT02051816|5637549|P3|STARTED|Overall Study||37
2295944|NCT02051816|5637550|P2|STARTED|Overall Study||40
2295945|NCT02051816|5637551|P1|STARTED|Overall Study||37
2295946|NCT02051790|5637589|P1|NOT COMPLETED|Overall Study||0
2295947|NCT02051790|5637589|P1|COMPLETED|Overall Study||241
2295948|NCT02051790|5637589|P1|STARTED|Overall Study||241
2295949|NCT02051686|5637595|P2|NOT COMPLETED|Overall Study||0
2295950|NCT02051686|5637596|P1|NOT COMPLETED|Overall Study||0
2295951|NCT02051686|5637595|P2|COMPLETED|Overall Study||46
2295952|NCT02051686|5637596|P1|COMPLETED|Overall Study||42
2295953|NCT02051686|5637595|P2|STARTED|Overall Study||46
2295954|NCT02051686|5637596|P1|STARTED|Overall Study||42
2295955|NCT02051595|5637604|P1|NOT COMPLETED|Overall Study||0
2295956|NCT02051595|5637604|P1|COMPLETED|Overall Study||25
2295957|NCT02051595|5637604|P1|STARTED|Overall Study||25
2295958|NCT02051452|5637610|P2|NOT COMPLETED|Overall Study||0
2295959|NCT02051452|5637611|P1|NOT COMPLETED|Overall Study||0
2295960|NCT02051452|5637610|P2|COMPLETED|Overall Study||16
2295961|NCT02051452|5637611|P1|COMPLETED|Overall Study||16
2295962|NCT02051452|5637610|P2|STARTED|Overall Study||16
2295963|NCT02051452|5637611|P1|STARTED|Overall Study||16
2295964|NCT02051426|5637623|P2|NOT COMPLETED|Second Intervention||0
2295965|NCT02051426|5637624|P1|NOT COMPLETED|Second Intervention||0
2295966|NCT02051426|5637623|P2|COMPLETED|Second Intervention||19
2295967|NCT02051426|5637624|P1|COMPLETED|Second Intervention||16
2295968|NCT02051426|5637623|P2|STARTED|Second Intervention||19
2295969|NCT02051426|5637624|P1|STARTED|Second Intervention||16
2295970|NCT02051426|5637623|P2|NOT COMPLETED|Washout Period of 1 Month||0
2295971|NCT02051426|5637624|P1|NOT COMPLETED|Washout Period of 1 Month||0
2295972|NCT02051426|5637623|P2|COMPLETED|Washout Period of 1 Month||19
2295973|NCT02051426|5637624|P1|COMPLETED|Washout Period of 1 Month||16
2295974|NCT02051426|5637623|P2|STARTED|Washout Period of 1 Month||19
2295975|NCT02051426|5637624|P1|STARTED|Washout Period of 1 Month||16
2295976|NCT02051426|5637623|P2|NOT COMPLETED|First Intervention||0
2295977|NCT02051426|5637624|P1|NOT COMPLETED|First Intervention||0
2295978|NCT02051426|5637623|P2|COMPLETED|First Intervention||19
2295979|NCT02051426|5637624|P1|COMPLETED|First Intervention||16
2295980|NCT02051426|5637623|P2|STARTED|First Intervention||19
2295981|NCT02051426|5637624|P1|STARTED|First Intervention||16
2295982|NCT02051335|5637638|P4|NOT COMPLETED|Period 4||0
2295983|NCT02051335|5637639|P3|NOT COMPLETED|Period 4||0
2295984|NCT02051335|5637640|P2|NOT COMPLETED|Period 4||0
2295985|NCT02051335|5637641|P1|NOT COMPLETED|Period 4||0
2295986|NCT02051335|5637638|P4|COMPLETED|Period 4||4
2295987|NCT02051335|5637639|P3|COMPLETED|Period 4||5
2295988|NCT02051335|5637640|P2|COMPLETED|Period 4||7
2295989|NCT02051335|5637641|P1|COMPLETED|Period 4||7
2295990|NCT02051335|5637638|P4|STARTED|Period 4||4
2295991|NCT02051335|5637639|P3|STARTED|Period 4||5
2295992|NCT02051335|5637640|P2|STARTED|Period 4||7
2295993|NCT02051335|5637641|P1|STARTED|Period 4||7
2295994|NCT02051335|5637638|P4|NOT COMPLETED|Period 3||0
2295995|NCT02051335|5637639|P3|NOT COMPLETED|Period 3||0
2295996|NCT02051335|5637640|P2|NOT COMPLETED|Period 3||0
2295997|NCT02051335|5637641|P1|NOT COMPLETED|Period 3||0
2295998|NCT02051335|5637638|P4|COMPLETED|Period 3||4
2295999|NCT02051335|5637639|P3|COMPLETED|Period 3||5
2296000|NCT02051335|5637640|P2|COMPLETED|Period 3||7
2296001|NCT02051335|5637641|P1|COMPLETED|Period 3||7
2296002|NCT02051335|5637638|P4|STARTED|Period 3||4
2296003|NCT02051335|5637639|P3|STARTED|Period 3|2 Participants received treatment in Period 2 but discontinued prior to Period 3.|5
2296004|NCT02051335|5637640|P2|STARTED|Period 3||7
2296005|NCT02051335|5637641|P1|STARTED|Period 3||7
2296006|NCT02051335|5637638|P4|NOT COMPLETED|Period 2||0
2296007|NCT02051335|5637639|P3|NOT COMPLETED|Period 2||0
2296008|NCT02051335|5637640|P2|NOT COMPLETED|Period 2||0
2296009|NCT02051335|5637641|P1|NOT COMPLETED|Period 2||0
2296010|NCT02051335|5637638|P4|COMPLETED|Period 2||4
2296011|NCT02051335|5637639|P3|COMPLETED|Period 2||7
2296012|NCT02051335|5637640|P2|COMPLETED|Period 2||7
2296013|NCT02051335|5637641|P1|COMPLETED|Period 2||7
2296014|NCT02051335|5637638|P4|STARTED|Period 2|2 Participants received treatment in Period 1 but discontinued prior to Period 2.|4
2296015|NCT02051335|5637639|P3|STARTED|Period 2||7
2296016|NCT02051335|5637640|P2|STARTED|Period 2||7
2296017|NCT02051335|5637641|P1|STARTED|Period 2||7
2296018|NCT02051335|5637638|P4|NOT COMPLETED|Period 1||0
2296019|NCT02051335|5637639|P3|NOT COMPLETED|Period 1||0
2296020|NCT02051335|5637640|P2|NOT COMPLETED|Period 1||0
2296021|NCT02051335|5637641|P1|NOT COMPLETED|Period 1||0
2296022|NCT02051335|5637638|P4|COMPLETED|Period 1||6
2296023|NCT02051335|5637639|P3|COMPLETED|Period 1||7
2296024|NCT02051335|5637640|P2|COMPLETED|Period 1||7
2296025|NCT02051335|5637641|P1|COMPLETED|Period 1||7
2296026|NCT02051335|5637638|P4|STARTED|Period 1||6
2296027|NCT02051335|5637639|P3|STARTED|Period 1||7
2296028|NCT02051335|5637640|P2|STARTED|Period 1||7
2296029|NCT02051335|5637641|P1|STARTED|Period 1||7
2296030|NCT02051296|5637693|P2|NOT COMPLETED|Overall Study||9
2296031|NCT02051296|5637694|P1|NOT COMPLETED|Overall Study||8
2296032|NCT02051296|5637693|P2|COMPLETED|Overall Study||56
2296033|NCT02051296|5637694|P1|COMPLETED|Overall Study||58
2296034|NCT02051296|5637693|P2|Received Allocated Intervention|Overall Study||58
2296035|NCT02051296|5637694|P1|Received Allocated Intervention|Overall Study||59
2296036|NCT02051296|5637693|P2|STARTED|Overall Study||65
2296037|NCT02051296|5637694|P1|STARTED|Overall Study||66
2296038|NCT02050841|5637700|P1|NOT COMPLETED|Overall Study||0
2296039|NCT02050841|5637700|P1|COMPLETED|Overall Study||50
2296040|NCT02050841|5637700|P1|STARTED|Overall Study||50
2296041|NCT02050334|5637741|P2|NOT COMPLETED|Overall Study||0
2296042|NCT02050334|5637742|P1|NOT COMPLETED|Overall Study||0
2296043|NCT02050334|5637741|P2|COMPLETED|Overall Study||9
2296044|NCT02050334|5637742|P1|COMPLETED|Overall Study||9
2296045|NCT02050334|5637741|P2|STARTED|Overall Study||9
2296046|NCT02050334|5637742|P1|STARTED|Overall Study||9
2296047|NCT02050321|5637750|P1|NOT COMPLETED|Overall Study||2
2296048|NCT02050321|5637750|P1|COMPLETED|Overall Study||0
2296049|NCT02050321|5637750|P1|STARTED|Overall Study||2
2296050|NCT02050308|5637757|P2|NOT COMPLETED|Overall Study||102
2296051|NCT02050308|5637758|P1|NOT COMPLETED|Overall Study||99
2296052|NCT02050308|5637757|P2|COMPLETED|Overall Study||22
2296053|NCT02050308|5637758|P1|COMPLETED|Overall Study||28
2296054|NCT02050308|5637757|P2|STARTED|Overall Study||124
2296055|NCT02050308|5637758|P1|STARTED|Overall Study||127
2296056|NCT02050048|5637766|P2|NOT COMPLETED|Overall Study||2
2296057|NCT02050048|5637767|P1|NOT COMPLETED|Overall Study||5
2296058|NCT02050048|5637766|P2|COMPLETED|Overall Study||10
2296059|NCT02050048|5637767|P1|COMPLETED|Overall Study||9
2296060|NCT02050048|5637766|P2|STARTED|Overall Study||12
2296061|NCT02050048|5637767|P1|STARTED|Overall Study||14
2296062|NCT02049957|5637782|P9|NOT COMPLETED|Overall Study||8
2296063|NCT02049957|5637783|P8|NOT COMPLETED|Overall Study||35
2296064|NCT02049957|5637784|P7|NOT COMPLETED|Overall Study||8
2296065|NCT02049957|5637785|P6|NOT COMPLETED|Overall Study||43
2296066|NCT02049957|5637786|P5|NOT COMPLETED|Overall Study||6
2296067|NCT02049957|5637787|P4|NOT COMPLETED|Overall Study||3
2296068|NCT02049957|5637788|P3|NOT COMPLETED|Overall Study||3
2296069|NCT02049957|5637789|P2|NOT COMPLETED|Overall Study||6
2296070|NCT02049957|5637790|P1|NOT COMPLETED|Overall Study||6
2296071|NCT02049957|5637782|P9|COMPLETED|Overall Study||0
2296072|NCT02049957|5637783|P8|COMPLETED|Overall Study||0
2296073|NCT02049957|5637784|P7|COMPLETED|Overall Study||0
2296074|NCT02049957|5637785|P6|COMPLETED|Overall Study||0
2296075|NCT02049957|5637786|P5|COMPLETED|Overall Study||0
2296076|NCT02049957|5637787|P4|COMPLETED|Overall Study||0
2296077|NCT02049957|5637788|P3|COMPLETED|Overall Study||0
2296078|NCT02049957|5637789|P2|COMPLETED|Overall Study||0
2296079|NCT02049957|5637790|P1|COMPLETED|Overall Study||0
2296080|NCT02049957|5637782|P9|STARTED|Overall Study||8
2296081|NCT02049957|5637783|P8|STARTED|Overall Study||35
2296082|NCT02049957|5637784|P7|STARTED|Overall Study||8
2296083|NCT02049957|5637785|P6|STARTED|Overall Study||43
2296084|NCT02049957|5637786|P5|STARTED|Overall Study||6
2296085|NCT02049957|5637787|P4|STARTED|Overall Study||3
2296086|NCT02049957|5637788|P3|STARTED|Overall Study||3
2296087|NCT02049957|5637789|P2|STARTED|Overall Study||6
2296088|NCT02049957|5637790|P1|STARTED|Overall Study||6
2296089|NCT02049931|5637858|P3|NOT COMPLETED|Overall Study||3
2296090|NCT02049931|5637859|P2|NOT COMPLETED|Overall Study||5
2296091|NCT02049931|5637860|P1|NOT COMPLETED|Overall Study||3
2296092|NCT02049931|5637858|P3|COMPLETED|Overall Study||17
2296093|NCT02049931|5637859|P2|COMPLETED|Overall Study||15
2296094|NCT02049931|5637860|P1|COMPLETED|Overall Study||17
2296095|NCT02049931|5637858|P3|STARTED|Overall Study||20
2296096|NCT02049931|5637859|P2|STARTED|Overall Study||20
2296097|NCT02049931|5637860|P1|STARTED|Overall Study||20
2296098|NCT02049814|5637882|P2|NOT COMPLETED|Overall Study||27
2296099|NCT02049814|5637883|P1|NOT COMPLETED|Overall Study||29
2296100|NCT02049814|5637882|P2|COMPLETED|Overall Study||219
2296101|NCT02049814|5637883|P1|COMPLETED|Overall Study||219
2296102|NCT02049814|5637882|P2|Safety Set|Overall Study||245
2296103|NCT02049814|5637883|P1|Safety Set|Overall Study||248
2296104|NCT02049814|5637882|P2|STARTED|Overall Study||246
2296105|NCT02049814|5637883|P1|STARTED|Overall Study||248
2296106|NCT02049749|5637911|P2|NOT COMPLETED|Overall Study||0
2296107|NCT02049749|5637912|P1|NOT COMPLETED|Overall Study||0
2296108|NCT02049749|5637911|P2|COMPLETED|Overall Study|80 children plus 80 caregivers|160
2296109|NCT02049749|5637912|P1|COMPLETED|Overall Study||80
2296110|NCT02049749|5637911|P2|STARTED|Overall Study|80 children plus 80 caregivers|160
2296111|NCT02049749|5637912|P1|STARTED|Overall Study|40 children plus 40 caregivers|80
2296112|NCT02049502|5637920|P1|NOT COMPLETED|Overall Study||0
2296113|NCT02049502|5637920|P1|COMPLETED|Overall Study||8
2296114|NCT02049502|5637920|P1|STARTED|Overall Study||8
2296115|NCT02049476|5637925|P1|NOT COMPLETED|Overall Study||0
2296116|NCT02049476|5637925|P1|COMPLETED|Overall Study|20th patient completed the study|20
2296117|NCT02049476|5637925|P1|STARTED|Overall Study|First patient enrolled on 1/31/2014|20
2296118|NCT02049450|5637932|P1|NOT COMPLETED|Overall Study||4
2296119|NCT02049450|5637932|P1|COMPLETED|Overall Study|Completed = Completed Core phase of study|26
2296120|NCT02049450|5637932|P1|Entered Extension Phase|Overall Study|Of 26 who completed Core phase 18 moved into Ext. phase; All 18 eventually discontinued Ext. phase|18
2296121|NCT02049450|5637932|P1|Discontinued Treatment Prior to Week 30|Overall Study||4
2296122|NCT02049450|5637932|P1|STARTED|Overall Study||30
2296123|NCT02049385|5637946|P2|NOT COMPLETED|Second Intervention||2
2296124|NCT02049385|5637947|P1|NOT COMPLETED|Second Intervention||0
2296125|NCT02049385|5637946|P2|COMPLETED|Second Intervention||0
2296126|NCT02049385|5637947|P1|COMPLETED|Second Intervention||1
2296127|NCT02049385|5637946|P2|STARTED|Second Intervention||2
2296128|NCT02049385|5637947|P1|STARTED|Second Intervention||1
2296129|NCT02049385|5637946|P2|NOT COMPLETED|First Intervention||0
2296130|NCT02049385|5637947|P1|NOT COMPLETED|First Intervention||3
2296131|NCT02049385|5637946|P2|COMPLETED|First Intervention||2
2296132|NCT02049385|5637947|P1|COMPLETED|First Intervention||1
2296133|NCT02049385|5637946|P2|STARTED|First Intervention||2
2296134|NCT02049385|5637947|P1|STARTED|First Intervention||4
2296135|NCT02049307|5637955|P2|NOT COMPLETED|Overall Study||1
2296136|NCT02049307|5637956|P1|NOT COMPLETED|Overall Study||2
2296137|NCT02049307|5637955|P2|COMPLETED|Overall Study||55
2296138|NCT02049307|5637956|P1|COMPLETED|Overall Study||50
2296139|NCT02049307|5637955|P2|STARTED|Overall Study||56
2296140|NCT02049307|5637956|P1|STARTED|Overall Study||52
2296141|NCT02049151|5637966|P2|NOT COMPLETED|Overall Study||0
2296142|NCT02049151|5637967|P1|NOT COMPLETED|Overall Study||0
2296143|NCT02049151|5637966|P2|COMPLETED|Overall Study||17
2296144|NCT02049151|5637967|P1|COMPLETED|Overall Study||15
2296145|NCT02049151|5637966|P2|STARTED|Overall Study|1 subject did not receive treatment|17
2296146|NCT02049151|5637967|P1|STARTED|Overall Study|2 subjects did not receive treatment|15
2296147|NCT02048904|5637981|P1|NOT COMPLETED|Overall Study||77
2296148|NCT02048904|5637981|P1|COMPLETED|Overall Study||65
2296149|NCT02048904|5637981|P1|STARTED|Overall Study||142
2296150|NCT02048891|5637987|P2|NOT COMPLETED|Overall Study||0
2296151|NCT02048891|5637988|P1|NOT COMPLETED|Overall Study||0
2296152|NCT02048891|5637987|P2|COMPLETED|Overall Study||1
2296153|NCT02048891|5637988|P1|COMPLETED|Overall Study||2
2296154|NCT02048891|5637987|P2|STARTED|Overall Study||1
2296155|NCT02048891|5637988|P1|STARTED|Overall Study||2
2296156|NCT02048878|5637996|P2|NOT COMPLETED|Overall Study||3
2296157|NCT02048878|5637997|P1|NOT COMPLETED|Overall Study||1
2296158|NCT02048878|5637996|P2|COMPLETED|Overall Study||12
2296159|NCT02048878|5637997|P1|COMPLETED|Overall Study||12
2296160|NCT02048878|5637996|P2|STARTED|Overall Study||15
2296161|NCT02048878|5637997|P1|STARTED|Overall Study||13
2296162|NCT02048670|5638015|P2|NOT COMPLETED|Overall Study||0
2296163|NCT02048670|5638016|P1|NOT COMPLETED|Overall Study||0
2296164|NCT02048670|5638015|P2|COMPLETED|Overall Study||6
2296165|NCT02048670|5638016|P1|COMPLETED|Overall Study||6
2296166|NCT02048670|5638015|P2|STARTED|Overall Study||6
2296167|NCT02048670|5638016|P1|STARTED|Overall Study||6
2296168|NCT02048241|5638026|P2|NOT COMPLETED|Overall Study||1
2296169|NCT02048241|5638027|P1|NOT COMPLETED|Overall Study||0
2296170|NCT02048241|5638026|P2|COMPLETED|Overall Study||5
2296171|NCT02048241|5638027|P1|COMPLETED|Overall Study||5
2296172|NCT02048241|5638026|P2|STARTED|Overall Study||6
2296173|NCT02048241|5638027|P1|STARTED|Overall Study||5
2296174|NCT02048072|5638033|P1|NOT COMPLETED|Overall Study||4
2296175|NCT02048072|5638033|P1|COMPLETED|Overall Study||29
2296176|NCT02048072|5638033|P1|STARTED|Overall Study||33
2296177|NCT02047981|5638039|P2|NOT COMPLETED|MORDOR Stage II Year 3||2363
2296178|NCT02047981|5638040|P1|NOT COMPLETED|MORDOR Stage II Year 3||2886
2296179|NCT02047981|5638039|P2|COMPLETED|MORDOR Stage II Year 3||30931
2296180|NCT02047981|5638040|P1|COMPLETED|MORDOR Stage II Year 3||34611
2296181|NCT02047981|5638039|P2|STARTED|MORDOR Stage II Year 3||33294
2296182|NCT02047981|5638040|P1|STARTED|MORDOR Stage II Year 3||37497
2296183|NCT02047981|5638039|P2|NOT COMPLETED|MORDOR Stage I Year 1-2||8717
2296184|NCT02047981|5638040|P1|NOT COMPLETED|MORDOR Stage I Year 1-2||9397
2296185|NCT02047981|5638039|P2|COMPLETED|MORDOR Stage I Year 1-2||84474
2296186|NCT02047981|5638040|P1|COMPLETED|MORDOR Stage I Year 1-2||87650
2296187|NCT02047981|5638039|P2|STARTED|MORDOR Stage I Year 1-2||93191
2296188|NCT02047981|5638040|P1|STARTED|MORDOR Stage I Year 1-2||97047
2296189|NCT02047929|5638057|P3|NOT COMPLETED|Overall Study||0
2296190|NCT02047929|5638058|P2|NOT COMPLETED|Overall Study||0
2296191|NCT02047929|5638059|P1|NOT COMPLETED|Overall Study||0
2296192|NCT02047929|5638057|P3|COMPLETED|Overall Study||2248
2296193|NCT02047929|5638058|P2|COMPLETED|Overall Study||2523
2296194|NCT02047929|5638059|P1|COMPLETED|Overall Study||1503
2296195|NCT02047929|5638057|P3|Surveys Collected|Overall Study|Per protocol, practice did not receive any interaction from practice facilitator|0
2296196|NCT02047929|5638058|P2|Surveys Collected|Overall Study||2523
2296197|NCT02047929|5638059|P1|Surveys Collected|Overall Study||1503
2296198|NCT02047929|5638057|P3|Practice Refresher|Overall Study|Per protocol, practices did not receive any interaction from practice facilitator|0
2296199|NCT02047929|5638058|P2|Practice Refresher|Overall Study||2523
2296200|NCT02047929|5638059|P1|Practice Refresher|Overall Study||1503
2296201|NCT02047929|5638057|P3|Practice Rollout|Overall Study|Per protocol, practice did not receive any intervention from practice facilitator|0
2296202|NCT02047929|5638058|P2|Practice Rollout|Overall Study||2523
2296203|NCT02047929|5638059|P1|Practice Rollout|Overall Study||1503
2296204|NCT02047929|5638057|P3|STARTED|Overall Study||2248
2296205|NCT02047929|5638058|P2|STARTED|Overall Study||2523
2296206|NCT02047929|5638059|P1|STARTED|Overall Study||1503
2296207|NCT02047903|5638072|P1|NOT COMPLETED|Overall Study||59
2296208|NCT02047903|5638072|P1|COMPLETED|Overall Study||102
2296209|NCT02047903|5638072|P1|Treated|Overall Study||152
2296210|NCT02047903|5638072|P1|STARTED|Overall Study||161
2296211|NCT02047747|5638084|P1|NOT COMPLETED|Overall Study||3
2296212|NCT02047747|5638084|P1|COMPLETED|Overall Study||1
2296213|NCT02047747|5638084|P1|STARTED|Overall Study||4
2296214|NCT02047643|5638089|P2|NOT COMPLETED|Overall Study||0
2296215|NCT02047643|5638090|P1|NOT COMPLETED|Overall Study||0
2296216|NCT02047643|5638089|P2|COMPLETED|Overall Study||9
2296217|NCT02047643|5638090|P1|COMPLETED|Overall Study||9
2296218|NCT02047643|5638089|P2|STARTED|Overall Study||9
2296219|NCT02047643|5638090|P1|STARTED|Overall Study||9
2296220|NCT02047500|5638098|P1|NOT COMPLETED|Overall Study||19
2296221|NCT02047500|5638098|P1|COMPLETED|Overall Study||0
2296222|NCT02047500|5638098|P1|STARTED|Overall Study||19
2296223|NCT02047344|5638104|P2|NOT COMPLETED|Overall Study||0
2296224|NCT02047344|5638105|P1|NOT COMPLETED|Overall Study||0
2296225|NCT02047344|5638104|P2|COMPLETED|Overall Study||15
2296226|NCT02047344|5638105|P1|COMPLETED|Overall Study||16
2296227|NCT02047344|5638104|P2|STARTED|Overall Study||15
2296228|NCT02047344|5638105|P1|STARTED|Overall Study|one patient is not evaluable in process. however, evaluable to safety report.|16
2296229|NCT02047253|5638123|P1|NOT COMPLETED|Overall Study||8
2296230|NCT02047253|5638123|P1|COMPLETED|Overall Study||20
2296231|NCT02047253|5638123|P1|STARTED|Overall Study||28
2296232|NCT02047227|5638133|P2|NOT COMPLETED|Overall Study||130
2296233|NCT02047227|5638134|P1|NOT COMPLETED|Overall Study||144
2296234|NCT02047227|5638133|P2|COMPLETED|Overall Study||347
2296235|NCT02047227|5638134|P1|COMPLETED|Overall Study||318
2296236|NCT02047227|5638133|P2|Completed Ovarian Stimulation Phase|Overall Study||440
2296237|NCT02047227|5638134|P1|Completed Ovarian Stimulation Phase|Overall Study||424
2296238|NCT02047227|5638133|P2|STARTED|Overall Study||477
2296239|NCT02047227|5638134|P1|STARTED|Overall Study||462
2296240|NCT02047110|5638154|P4|NOT COMPLETED|OLE Treatment Period||0
2296241|NCT02047110|5638155|P3|NOT COMPLETED|OLE Treatment Period||1
2296242|NCT02047110|5638156|P2|NOT COMPLETED|OLE Treatment Period||0
2296243|NCT02047110|5638157|P1|NOT COMPLETED|OLE Treatment Period||0
2296244|NCT02047110|5638154|P4|COMPLETED|OLE Treatment Period||9
2296245|NCT02047110|5638155|P3|COMPLETED|OLE Treatment Period||4
2296246|NCT02047110|5638156|P2|COMPLETED|OLE Treatment Period||8
2296247|NCT02047110|5638157|P1|COMPLETED|OLE Treatment Period||4
2296248|NCT02047110|5638154|P4|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|9
2296249|NCT02047110|5638155|P3|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|5
2296250|NCT02047110|5638156|P2|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|8
2296251|NCT02047110|5638157|P1|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|4
2296252|NCT02047110|5638154|P4|NOT COMPLETED|Escape Treatment Period||2
2296253|NCT02047110|5638155|P3|NOT COMPLETED|Escape Treatment Period||3
2296254|NCT02047110|5638156|P2|NOT COMPLETED|Escape Treatment Period||6
2296255|NCT02047110|5638157|P1|NOT COMPLETED|Escape Treatment Period||3
2296256|NCT02047110|5638154|P4|COMPLETED|Escape Treatment Period||24
2296257|NCT02047110|5638155|P3|COMPLETED|Escape Treatment Period||20
2296258|NCT02047110|5638156|P2|COMPLETED|Escape Treatment Period||15
2296259|NCT02047110|5638157|P1|COMPLETED|Escape Treatment Period||23
2296260|NCT02047110|5638154|P4|STARTED|Escape Treatment Period|ASAS 20 nonresponders|26
2296261|NCT02047110|5638155|P3|STARTED|Escape Treatment Period|ASAS 20 nonresponders|23
2296262|NCT02047110|5638156|P2|STARTED|Escape Treatment Period|ASAS 20 nonresponders|21
2296263|NCT02047110|5638157|P1|STARTED|Escape Treatment Period|Assessment in SpondyloArthritis international Society (ASAS) 20 nonresponders|26
2296264|NCT02047110|5638154|P4|NOT COMPLETED|DB (Week 12 up to Week 24)||0
2296265|NCT02047110|5638155|P3|NOT COMPLETED|DB (Week 12 up to Week 24)||1
2296266|NCT02047110|5638156|P2|NOT COMPLETED|DB (Week 12 up to Week 24)||2
2296267|NCT02047110|5638157|P1|NOT COMPLETED|DB (Week 12 up to Week 24)||0
2296268|NCT02047110|5638154|P4|COMPLETED|DB (Week 12 up to Week 24)||12
2296269|NCT02047110|5638155|P3|COMPLETED|DB (Week 12 up to Week 24)||12
2296270|NCT02047110|5638156|P2|COMPLETED|DB (Week 12 up to Week 24)||15
2296271|NCT02047110|5638157|P1|COMPLETED|DB (Week 12 up to Week 24)||9
2296272|NCT02047110|5638154|P4|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|12
2296273|NCT02047110|5638155|P3|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|13
2296274|NCT02047110|5638156|P2|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|17
2296275|NCT02047110|5638157|P1|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|9
2296276|NCT02047110|5638154|P4|NOT COMPLETED|DB Treatment Period up to Week 24||2
2296277|NCT02047110|5638155|P3|NOT COMPLETED|DB Treatment Period up to Week 24||3
2296278|NCT02047110|5638156|P2|NOT COMPLETED|DB Treatment Period up to Week 24||2
2296279|NCT02047110|5638157|P1|NOT COMPLETED|DB Treatment Period up to Week 24||5
2296280|NCT02047110|5638154|P4|COMPLETED|DB Treatment Period up to Week 24||38
2296281|NCT02047110|5638155|P3|COMPLETED|DB Treatment Period up to Week 24||36
2296282|NCT02047110|5638156|P2|COMPLETED|DB Treatment Period up to Week 24||38
2296283|NCT02047110|5638157|P1|COMPLETED|DB Treatment Period up to Week 24||35
2296284|NCT02047110|5638154|P4|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
2296285|NCT02047110|5638155|P3|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|39
2296286|NCT02047110|5638156|P2|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
2296287|NCT02047110|5638157|P1|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
2296288|NCT02047045|5638200|P2|NOT COMPLETED|Follow-up Period (24 Weeks)||0
2296289|NCT02047045|5638201|P1|NOT COMPLETED|Follow-up Period (24 Weeks)||0
2296290|NCT02047045|5638200|P2|COMPLETED|Follow-up Period (24 Weeks)||262
2296291|NCT02047045|5638201|P1|COMPLETED|Follow-up Period (24 Weeks)||265
2296292|NCT02047045|5638200|P2|STARTED|Follow-up Period (24 Weeks)||262
2296293|NCT02047045|5638201|P1|STARTED|Follow-up Period (24 Weeks)||265
2296294|NCT02047045|5638200|P2|NOT COMPLETED|Treatment Period (8 Weeks )||3
2296295|NCT02047045|5638201|P1|NOT COMPLETED|Treatment Period (8 Weeks )||7
2296296|NCT02047045|5638200|P2|COMPLETED|Treatment Period (8 Weeks )||262
2296297|NCT02047045|5638201|P1|COMPLETED|Treatment Period (8 Weeks )||265
2296298|NCT02047045|5638200|P2|STARTED|Treatment Period (8 Weeks )||265
2296299|NCT02047045|5638201|P1|STARTED|Treatment Period (8 Weeks )||272
2296300|NCT02047045|5638200|P2|NOT COMPLETED|Baseline||15
2296301|NCT02047045|5638201|P1|NOT COMPLETED|Baseline||8
2296302|NCT02047045|5638200|P2|COMPLETED|Baseline||265
2296303|NCT02047045|5638201|P1|COMPLETED|Baseline||272
2296304|NCT02047045|5638200|P2|STARTED|Baseline||280
2296305|NCT02047045|5638201|P1|STARTED|Baseline||280
2296306|NCT02047032|5638235|P2|NOT COMPLETED|Overall Study||15
2296307|NCT02047032|5638236|P1|NOT COMPLETED|Overall Study||5
2296308|NCT02047032|5638235|P2|COMPLETED|Overall Study||235
2296309|NCT02047032|5638236|P1|COMPLETED|Overall Study||245
2296310|NCT02047032|5638235|P2|STARTED|Overall Study||250
2296311|NCT02047032|5638236|P1|STARTED|Overall Study||250
2296312|NCT02046993|5638265|P2|NOT COMPLETED|Overall Study||11
2296313|NCT02046993|5638266|P1|NOT COMPLETED|Overall Study||3
2296314|NCT02046993|5638265|P2|COMPLETED|Overall Study||94
2296315|NCT02046993|5638266|P1|COMPLETED|Overall Study||102
2296316|NCT02046993|5638265|P2|6th Month|Overall Study||94
2296317|NCT02046993|5638266|P1|6th Month|Overall Study||102
2296318|NCT02046993|5638265|P2|3rd Month|Overall Study||97
2296319|NCT02046993|5638266|P1|3rd Month|Overall Study||104
2296320|NCT02046993|5638265|P2|STARTED|Overall Study||105
2296321|NCT02046993|5638266|P1|STARTED|Overall Study||105
2296322|NCT02046980|5638285|P3|NOT COMPLETED|Overall Study||1
2296323|NCT02046980|5638286|P2|NOT COMPLETED|Overall Study||5
2296324|NCT02046980|5638287|P1|NOT COMPLETED|Overall Study||2
2296325|NCT02046980|5638285|P3|COMPLETED|Overall Study||72
2296326|NCT02046980|5638286|P2|COMPLETED|Overall Study||67
2296327|NCT02046980|5638287|P1|COMPLETED|Overall Study||70
2296328|NCT02046980|5638285|P3|STARTED|Overall Study||73
2296329|NCT02046980|5638286|P2|STARTED|Overall Study||72
2296330|NCT02046980|5638287|P1|STARTED|Overall Study||72
2296331|NCT02046941|5638295|P1|NOT COMPLETED|Overall Study||7
2296332|NCT02046941|5638295|P1|COMPLETED|Overall Study||10
2296333|NCT02046941|5638295|P1|STARTED|Overall Study||17
2296334|NCT02046902|5638304|P3|NOT COMPLETED|Overall Study||0
2296335|NCT02046902|5638305|P2|NOT COMPLETED|Overall Study||0
2296336|NCT02046902|5638306|P1|NOT COMPLETED|Overall Study||0
2296337|NCT02046902|5638304|P3|COMPLETED|Overall Study||137
2296338|NCT02046902|5638305|P2|COMPLETED|Overall Study||113
2296339|NCT02046902|5638306|P1|COMPLETED|Overall Study||336
2296340|NCT02046902|5638304|P3|STARTED|Overall Study||137
2296341|NCT02046902|5638305|P2|STARTED|Overall Study||113
2296342|NCT02046902|5638306|P1|STARTED|Overall Study||336
2296343|NCT02046863|5638317|P1|NOT COMPLETED|Overall Study||0
2296344|NCT02046863|5638317|P1|COMPLETED|Overall Study||7
2296345|NCT02046863|5638317|P1|STARTED|Overall Study||7
2296346|NCT02046772|5638323|P2|NOT COMPLETED|Overall Study||0
2296347|NCT02046772|5638324|P1|NOT COMPLETED|Overall Study||0
2296348|NCT02046772|5638323|P2|COMPLETED|Overall Study||33
2296349|NCT02046772|5638324|P1|COMPLETED|Overall Study||30
2296350|NCT02046772|5638323|P2|STARTED|Overall Study||33
2296351|NCT02046772|5638324|P1|STARTED|Overall Study||30
2296352|NCT02046616|5638338|P1|NOT COMPLETED|8-Week FU Period||1
2296353|NCT02046616|5638338|P1|COMPLETED|8-Week FU Period||113
2296354|NCT02046616|5638338|P1|STARTED|8-Week FU Period||114
2296355|NCT02046616|5638338|P1|NOT COMPLETED|24-Week Treatment Period||19
2296356|NCT02046616|5638338|P1|COMPLETED|24-Week Treatment Period||114
2296357|NCT02046616|5638338|P1|STARTED|24-Week Treatment Period||133
2296358|NCT02046603|5638360|P2|NOT COMPLETED|Overall Study||75
2296359|NCT02046603|5638361|P1|NOT COMPLETED|Overall Study||15
2296360|NCT02046603|5638360|P2|COMPLETED|Overall Study||65
2296361|NCT02046603|5638361|P1|COMPLETED|Overall Study||7
2296362|NCT02046603|5638360|P2|Received at Least 1 Dose of Tocilizumab|Overall Study||140
2296363|NCT02046603|5638361|P1|Received at Least 1 Dose of Tocilizumab|Overall Study||21
2296364|NCT02046603|5638360|P2|STARTED|Overall Study||140
2296365|NCT02046603|5638361|P1|STARTED|Overall Study||22
2296366|NCT02046564|5638440|P2|NOT COMPLETED|Overall Study||20
2296367|NCT02046564|5638441|P1|NOT COMPLETED|Overall Study||15
2296368|NCT02046564|5638440|P2|COMPLETED|Overall Study||183
2296369|NCT02046564|5638441|P1|COMPLETED|Overall Study||194
2296370|NCT02046564|5638440|P2|STARTED|Overall Study||203
2296371|NCT02046564|5638441|P1|STARTED|Overall Study||209
2296372|NCT02046525|5638465|P2|NOT COMPLETED|Overall Study||0
2296373|NCT02046525|5638466|P1|NOT COMPLETED|Overall Study||0
2296374|NCT02046525|5638465|P2|COMPLETED|Overall Study||5
2296375|NCT02046525|5638466|P1|COMPLETED|Overall Study||5
2296376|NCT02046525|5638465|P2|STARTED|Overall Study||5
2296377|NCT02046525|5638466|P1|STARTED|Overall Study||5
2296378|NCT02046382|5638474|P2|NOT COMPLETED|Overall Study||20
2296379|NCT02046382|5638475|P1|NOT COMPLETED|Overall Study||8
2296380|NCT02046382|5638474|P2|COMPLETED|Overall Study||47
2296381|NCT02046382|5638475|P1|COMPLETED|Overall Study||57
2296382|NCT02046382|5638474|P2|STARTED|Overall Study||67
2296383|NCT02046382|5638475|P1|STARTED|Overall Study||65
2296384|NCT02046369|5638489|P2|NOT COMPLETED|Overall Study||18
2296385|NCT02046369|5638490|P1|NOT COMPLETED|Overall Study||14
2296386|NCT02046369|5638489|P2|COMPLETED|Overall Study||156
2296387|NCT02046369|5638490|P1|COMPLETED|Overall Study||162
2296388|NCT02046369|5638489|P2|STARTED|Overall Study||174
2296389|NCT02046369|5638490|P1|STARTED|Overall Study||176
2296390|NCT02046317|5638508|P2|NOT COMPLETED|Overall Study||0
2296391|NCT02046317|5638509|P1|NOT COMPLETED|Overall Study||0
2296392|NCT02046317|5638508|P2|COMPLETED|Overall Study||8
2296393|NCT02046317|5638509|P1|COMPLETED|Overall Study||4
2296394|NCT02046317|5638508|P2|STARTED|Overall Study||8
2296395|NCT02046317|5638509|P1|STARTED|Overall Study||4
2296396|NCT02046265|5638521|P4|NOT COMPLETED|Overall Study||2
2296397|NCT02046265|5638522|P3|NOT COMPLETED|Overall Study||2
2296398|NCT02046265|5638523|P2|NOT COMPLETED|Overall Study||2
2296399|NCT02046265|5638524|P1|NOT COMPLETED|Overall Study||1
2296400|NCT02046265|5638521|P4|COMPLETED|Overall Study||12
2296401|NCT02046265|5638522|P3|COMPLETED|Overall Study||10
2296402|NCT02046265|5638523|P2|COMPLETED|Overall Study||15
2296403|NCT02046265|5638524|P1|COMPLETED|Overall Study||16
2296404|NCT02046265|5638521|P4|STARTED|Overall Study||14
2296405|NCT02046265|5638522|P3|STARTED|Overall Study||12
2296406|NCT02046265|5638523|P2|STARTED|Overall Study||17
2296407|NCT02046265|5638524|P1|STARTED|Overall Study||17
2296408|NCT02046226|5638534|P1|NOT COMPLETED|Overall Study||7
2296409|NCT02046226|5638534|P1|COMPLETED|Overall Study||0
2296410|NCT02046226|5638534|P1|STARTED|Overall Study||7
2296411|NCT02046200|5638541|P2|NOT COMPLETED|Second Intervention (1 Day)||0
2296412|NCT02046200|5638542|P1|NOT COMPLETED|Second Intervention (1 Day)||0
2296413|NCT02046200|5638541|P2|COMPLETED|Second Intervention (1 Day)||6
2296414|NCT02046200|5638542|P1|COMPLETED|Second Intervention (1 Day)||5
2296415|NCT02046200|5638541|P2|STARTED|Second Intervention (1 Day)||6
2296416|NCT02046200|5638542|P1|STARTED|Second Intervention (1 Day)||5
2296417|NCT02046200|5638541|P2|NOT COMPLETED|First Intervention (1 Day)||0
2296418|NCT02046200|5638542|P1|NOT COMPLETED|First Intervention (1 Day)||0
2296419|NCT02046200|5638541|P2|COMPLETED|First Intervention (1 Day)||6
2296420|NCT02046200|5638542|P1|COMPLETED|First Intervention (1 Day)||5
2296421|NCT02046200|5638541|P2|STARTED|First Intervention (1 Day)||6
2296422|NCT02046200|5638542|P1|STARTED|First Intervention (1 Day)||5
2296423|NCT02046148|5638582|P2|NOT COMPLETED|Overall Study||3
2296424|NCT02046148|5638583|P1|NOT COMPLETED|Overall Study||1
2296425|NCT02046148|5638582|P2|COMPLETED|Overall Study||23
2296426|NCT02046148|5638583|P1|COMPLETED|Overall Study||48
2296427|NCT02046148|5638582|P2|STARTED|Overall Study||26
2296428|NCT02046148|5638583|P1|STARTED|Overall Study||49
2296429|NCT02046122|5638643|P1|NOT COMPLETED|Overall Study||9
2296430|NCT02046122|5638643|P1|COMPLETED|Overall Study||8
2296431|NCT02046122|5638643|P1|STARTED|Overall Study||17
2296432|NCT02046070|5638653|P3|NOT COMPLETED|Overall Study||70
2296433|NCT02046070|5638654|P2|NOT COMPLETED|Overall Study||28
2296434|NCT02046070|5638655|P1|NOT COMPLETED|Overall Study||32
2296435|NCT02046070|5638653|P3|COMPLETED|Overall Study||8
2296436|NCT02046070|5638654|P2|COMPLETED|Overall Study||6
2296437|NCT02046070|5638655|P1|COMPLETED|Overall Study||4
2296438|NCT02046070|5638653|P3|STARTED|Overall Study||78
2296439|NCT02046070|5638654|P2|STARTED|Overall Study||34
2296440|NCT02046070|5638655|P1|STARTED|Overall Study||36
2296441|NCT02046005|5638702|P3|NOT COMPLETED|Overall Study||10
2296442|NCT02046005|5638703|P2|NOT COMPLETED|Overall Study||7
2296443|NCT02046005|5638704|P1|NOT COMPLETED|Overall Study||8
2296444|NCT02046005|5638702|P3|COMPLETED|Overall Study||70
2296445|NCT02046005|5638703|P2|COMPLETED|Overall Study||71
2296446|NCT02046005|5638704|P1|COMPLETED|Overall Study||72
2296447|NCT02046005|5638702|P3|STARTED|Overall Study||80
2296448|NCT02046005|5638703|P2|STARTED|Overall Study||78
2296449|NCT02046005|5638704|P1|STARTED|Overall Study||80
2296450|NCT02045979|5638715|P3|NOT COMPLETED|Overall Study||1
2296451|NCT02045979|5638716|P2|NOT COMPLETED|Overall Study||1
2296452|NCT02045979|5638717|P1|NOT COMPLETED|Overall Study||2
2296453|NCT02045979|5638715|P3|COMPLETED|Overall Study||107
2296454|NCT02045979|5638716|P2|COMPLETED|Overall Study||107
2296455|NCT02045979|5638717|P1|COMPLETED|Overall Study||106
2296456|NCT02045979|5638715|P3|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication.|108
2296457|NCT02045979|5638716|P2|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication..|108
2296458|NCT02045979|5638717|P1|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication.|108
2296459|NCT02045875|5638754|P2|NOT COMPLETED|Overall Study||3
2296460|NCT02045875|5638755|P1|NOT COMPLETED|Overall Study||7
2296461|NCT02045875|5638754|P2|COMPLETED|Overall Study||20
2296462|NCT02045875|5638755|P1|COMPLETED|Overall Study||20
2296463|NCT02045875|5638754|P2|STARTED|Overall Study||23
2296464|NCT02045875|5638755|P1|STARTED|Overall Study||27
2296465|NCT02045862|5638766|P3|NOT COMPLETED|Overall Study||126
2296466|NCT02045862|5638767|P2|NOT COMPLETED|Overall Study||40
2296467|NCT02045862|5638768|P1|NOT COMPLETED|Overall Study||39
2296468|NCT02045862|5638766|P3|COMPLETED|Overall Study||1092
2296469|NCT02045862|5638767|P2|COMPLETED|Overall Study||265
2296470|NCT02045862|5638768|P1|COMPLETED|Overall Study||267
2296471|NCT02045862|5638766|P3|Treated|Overall Study||1210
2296472|NCT02045862|5638767|P2|Treated|Overall Study||303
2296473|NCT02045862|5638768|P1|Treated|Overall Study||306
2296474|NCT02045862|5638766|P3|STARTED|Overall Study||1218
2296475|NCT02045862|5638767|P2|STARTED|Overall Study||305
2296476|NCT02045862|5638768|P1|STARTED|Overall Study||306
2296477|NCT02045836|5638949|P2|NOT COMPLETED|Overall Study||14
2296478|NCT02045836|5638950|P1|NOT COMPLETED|Overall Study||9
2296479|NCT02045836|5638949|P2|COMPLETED|Overall Study||419
2296480|NCT02045836|5638950|P1|COMPLETED|Overall Study||423
2296481|NCT02045836|5638949|P2|STARTED|Overall Study||433
2296482|NCT02045836|5638950|P1|STARTED|Overall Study||432
2296483|NCT02045797|5638982|P3|NOT COMPLETED|Overall Study||1
2296484|NCT02045797|5638983|P2|NOT COMPLETED|Overall Study||7
2296485|NCT02045797|5638984|P1|NOT COMPLETED|Overall Study||7
2296486|NCT02045797|5638982|P3|COMPLETED|Overall Study||24
2296487|NCT02045797|5638983|P2|COMPLETED|Overall Study||32
2296488|NCT02045797|5638984|P1|COMPLETED|Overall Study||51
2296489|NCT02045797|5638982|P3|STARTED|Overall Study||25
2296490|NCT02045797|5638983|P2|STARTED|Overall Study||39
2296491|NCT02045797|5638984|P1|STARTED|Overall Study||58
2296492|NCT02045732|5639129|P2|NOT COMPLETED|Overall Study||1
2296493|NCT02045732|5639130|P1|NOT COMPLETED|Overall Study||1
2296494|NCT02045732|5639129|P2|COMPLETED|Overall Study||2
2296495|NCT02045732|5639130|P1|COMPLETED|Overall Study||0
2296496|NCT02045732|5639129|P2|STARTED|Overall Study||3
2296497|NCT02045732|5639130|P1|STARTED|Overall Study||1
2296498|NCT02045511|5639150|P2|NOT COMPLETED|Overall Study||0
2296499|NCT02045511|5639151|P1|NOT COMPLETED|Overall Study||0
2296500|NCT02045511|5639150|P2|COMPLETED|Overall Study||7
2296501|NCT02045511|5639151|P1|COMPLETED|Overall Study||8
2296502|NCT02045511|5639150|P2|STARTED|Overall Study||7
2296503|NCT02045511|5639151|P1|STARTED|Overall Study||8
2296504|NCT02045433|5639167|P1|NOT COMPLETED|Overall Study||1
2296505|NCT02045433|5639167|P1|COMPLETED|Overall Study|Study was Prematurely ended due to toxicity|15
2296506|NCT02045433|5639167|P1|STARTED|Overall Study||16
2296507|NCT02045264|5639171|P1|NOT COMPLETED|Overall Study||0
2296508|NCT02045264|5639171|P1|COMPLETED|Overall Study||12
2296509|NCT02045264|5639171|P1|STARTED|Overall Study||12
2296510|NCT02045238|5639188|P2|NOT COMPLETED|Overall Study||1
2296511|NCT02045238|5639189|P1|NOT COMPLETED|Overall Study||7
2296512|NCT02045238|5639188|P2|COMPLETED|Overall Study||14
2296513|NCT02045238|5639189|P1|COMPLETED|Overall Study||9
2296514|NCT02045238|5639188|P2|STARTED|Overall Study||15
2296515|NCT02045238|5639189|P1|STARTED|Overall Study||16
2296516|NCT02045212|5639199|P2|NOT COMPLETED|Overall Study||1
2296517|NCT02045212|5639200|P1|NOT COMPLETED|Overall Study||2
2296518|NCT02045212|5639199|P2|COMPLETED|Overall Study||8
2296519|NCT02045212|5639200|P1|COMPLETED|Overall Study||11
2296520|NCT02045212|5639199|P2|STARTED|Overall Study||9
2296521|NCT02045212|5639200|P1|STARTED|Overall Study||13
2296522|NCT02045108|5639216|P4|NOT COMPLETED|Overall Study||1
2296523|NCT02045108|5639217|P3|NOT COMPLETED|Overall Study||2
2296524|NCT02045108|5639218|P2|NOT COMPLETED|Overall Study||3
2296525|NCT02045108|5639219|P1|NOT COMPLETED|Overall Study||1
2296526|NCT02045108|5639216|P4|COMPLETED|Overall Study||19
2296527|NCT02045108|5639217|P3|COMPLETED|Overall Study||18
2296528|NCT02045108|5639218|P2|COMPLETED|Overall Study||12
2296529|NCT02045108|5639219|P1|COMPLETED|Overall Study||21
2296530|NCT02045108|5639216|P4|STARTED|Overall Study||20
2296531|NCT02045108|5639217|P3|STARTED|Overall Study||20
2296532|NCT02045108|5639218|P2|STARTED|Overall Study||15
2296533|NCT02045108|5639219|P1|STARTED|Overall Study||22
2296534|NCT02045095|5639265|P7|NOT COMPLETED|Overall Study||1
2296535|NCT02045095|5639266|P6|NOT COMPLETED|Overall Study||8
2296536|NCT02045095|5639267|P5|NOT COMPLETED|Overall Study||5
2296537|NCT02045095|5639268|P4|NOT COMPLETED|Overall Study||4
2296538|NCT02045095|5639269|P3|NOT COMPLETED|Overall Study||4
2296539|NCT02045095|5639270|P2|NOT COMPLETED|Overall Study||4
2296540|NCT02045095|5639271|P1|NOT COMPLETED|Overall Study||3
2296541|NCT02045095|5639265|P7|COMPLETED|Overall Study||0
2296542|NCT02045095|5639266|P6|COMPLETED|Overall Study||0
2296543|NCT02045095|5639267|P5|COMPLETED|Overall Study||0
2296544|NCT02045095|5639268|P4|COMPLETED|Overall Study||0
2296545|NCT02045095|5639269|P3|COMPLETED|Overall Study||0
2296546|NCT02045095|5639270|P2|COMPLETED|Overall Study||0
2296547|NCT02045095|5639271|P1|COMPLETED|Overall Study||0
2296548|NCT02045095|5639265|P7|STARTED|Overall Study||1
2296549|NCT02045095|5639266|P6|STARTED|Overall Study||8
2296550|NCT02045095|5639267|P5|STARTED|Overall Study||5
2296551|NCT02045095|5639268|P4|STARTED|Overall Study||4
2296552|NCT02045095|5639269|P3|STARTED|Overall Study||4
2296553|NCT02045095|5639270|P2|STARTED|Overall Study||4
2296554|NCT02045095|5639271|P1|STARTED|Overall Study||3
2296555|NCT02044991|5639415|P2|NOT COMPLETED|Overall Study||0
2296556|NCT02044991|5639416|P1|NOT COMPLETED|Overall Study||0
2296557|NCT02044991|5639415|P2|COMPLETED|Overall Study||0
2296558|NCT02044991|5639416|P1|COMPLETED|Overall Study||2
2296559|NCT02044991|5639415|P2|STARTED|Overall Study||0
2296560|NCT02044991|5639416|P1|STARTED|Overall Study||2
2296561|NCT02044874|5639429|P3|NOT COMPLETED|Overall Study||60
2296562|NCT02044874|5639430|P2|NOT COMPLETED|Overall Study||55
2296563|NCT02044874|5639431|P1|NOT COMPLETED|Overall Study||30
2296564|NCT02044874|5639429|P3|COMPLETED|Overall Study||140
2296565|NCT02044874|5639430|P2|COMPLETED|Overall Study||147
2296566|NCT02044874|5639431|P1|COMPLETED|Overall Study||171
2296567|NCT02044874|5639429|P3|STARTED|Overall Study||200
2296568|NCT02044874|5639430|P2|STARTED|Overall Study||202
2296569|NCT02044874|5639431|P1|STARTED|Overall Study||201
2296570|NCT02044848|5639453|P2|NOT COMPLETED|Overall Study||3
2296571|NCT02044848|5639454|P1|NOT COMPLETED|Overall Study||2
2296572|NCT02044848|5639453|P2|COMPLETED|Overall Study||0
2296573|NCT02044848|5639454|P1|COMPLETED|Overall Study||0
2296574|NCT02044848|5639453|P2|STARTED|Overall Study||3
2296575|NCT02044848|5639454|P1|STARTED|Overall Study||2
2296576|NCT02044822|5639460|P1|NOT COMPLETED|Overall Study||93
2296577|NCT02044822|5639460|P1|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|9
2296578|NCT02044822|5639460|P1|STARTED|Overall Study||102
2296579|NCT02044796|5639472|P10|NOT COMPLETED|Overall Study||0
2296580|NCT02044796|5639473|P9|NOT COMPLETED|Overall Study||0
2296581|NCT02044796|5639474|P8|NOT COMPLETED|Overall Study||0
2296582|NCT02044796|5639475|P7|NOT COMPLETED|Overall Study||0
2296583|NCT02044796|5639476|P6|NOT COMPLETED|Overall Study||0
2296584|NCT02044796|5639477|P5|NOT COMPLETED|Overall Study||0
2296585|NCT02044796|5639478|P4|NOT COMPLETED|Overall Study||0
2296586|NCT02044796|5639479|P3|NOT COMPLETED|Overall Study||0
2296587|NCT02044796|5639480|P2|NOT COMPLETED|Overall Study||0
2296588|NCT02044796|5639481|P1|NOT COMPLETED|Overall Study||0
2296589|NCT02044796|5639472|P10|COMPLETED|Overall Study||34
2296590|NCT02044796|5639473|P9|COMPLETED|Overall Study||106
2296591|NCT02044796|5639474|P8|COMPLETED|Overall Study||4
2296592|NCT02044796|5639475|P7|COMPLETED|Overall Study||6
2296593|NCT02044796|5639476|P6|COMPLETED|Overall Study||6
2296594|NCT02044796|5639477|P5|COMPLETED|Overall Study||10
2296595|NCT02044796|5639478|P4|COMPLETED|Overall Study||6
2296596|NCT02044796|5639479|P3|COMPLETED|Overall Study||9
2296597|NCT02044796|5639480|P2|COMPLETED|Overall Study||9
2296598|NCT02044796|5639481|P1|COMPLETED|Overall Study||9
2296599|NCT02044796|5639472|P10|STARTED|Overall Study||34
2296600|NCT02044796|5639473|P9|STARTED|Overall Study||106
2296601|NCT02044796|5639474|P8|STARTED|Overall Study||4
2296602|NCT02044796|5639475|P7|STARTED|Overall Study||6
2296603|NCT02044796|5639476|P6|STARTED|Overall Study||6
2296604|NCT02044796|5639477|P5|STARTED|Overall Study||10
2296605|NCT02044796|5639478|P4|STARTED|Overall Study||6
2296606|NCT02044796|5639479|P3|STARTED|Overall Study||9
2296607|NCT02044796|5639480|P2|STARTED|Overall Study||9
2296608|NCT02044796|5639481|P1|STARTED|Overall Study||9
2296609|NCT02044510|5639502|P2|NOT COMPLETED|Overall Study||2
2296610|NCT02044510|5639503|P1|NOT COMPLETED|Overall Study||1
2296611|NCT02044510|5639502|P2|COMPLETED|Overall Study||14
2296612|NCT02044510|5639503|P1|COMPLETED|Overall Study||15
2296613|NCT02044510|5639502|P2|STARTED|Overall Study||16
2296614|NCT02044510|5639503|P1|STARTED|Overall Study||16
2296615|NCT02044458|5639511|P2|NOT COMPLETED|Overall Study||8
2296616|NCT02044458|5639512|P1|NOT COMPLETED|Overall Study||3
2296617|NCT02044458|5639511|P2|COMPLETED|Overall Study||61
2296618|NCT02044458|5639512|P1|COMPLETED|Overall Study||62
2296619|NCT02044458|5639511|P2|STARTED|Overall Study||69
2296620|NCT02044458|5639512|P1|STARTED|Overall Study||65
2296621|NCT02044419|5639525|P3|NOT COMPLETED|Third Intervention||0
2296622|NCT02044419|5639526|P2|NOT COMPLETED|Third Intervention||0
2296623|NCT02044419|5639527|P1|NOT COMPLETED|Third Intervention||0
2296624|NCT02044419|5639525|P3|COMPLETED|Third Intervention||10
2296625|NCT02044419|5639526|P2|COMPLETED|Third Intervention||9
2296626|NCT02044419|5639527|P1|COMPLETED|Third Intervention||11
2296627|NCT02044419|5639525|P3|STARTED|Third Intervention||10
2296628|NCT02044419|5639526|P2|STARTED|Third Intervention||9
2296629|NCT02044419|5639527|P1|STARTED|Third Intervention||11
2296630|NCT02044419|5639525|P3|NOT COMPLETED|Second Intervention||0
2296631|NCT02044419|5639526|P2|NOT COMPLETED|Second Intervention||0
2296632|NCT02044419|5639527|P1|NOT COMPLETED|Second Intervention||0
2296633|NCT02044419|5639525|P3|COMPLETED|Second Intervention||10
2296634|NCT02044419|5639526|P2|COMPLETED|Second Intervention||9
2296635|NCT02044419|5639527|P1|COMPLETED|Second Intervention||11
2296636|NCT02044419|5639525|P3|STARTED|Second Intervention||10
2296637|NCT02044419|5639526|P2|STARTED|Second Intervention||9
2296638|NCT02044419|5639527|P1|STARTED|Second Intervention||11
2296639|NCT02044419|5639525|P3|NOT COMPLETED|First Intervention||1
2296640|NCT02044419|5639526|P2|NOT COMPLETED|First Intervention||1
2296641|NCT02044419|5639527|P1|NOT COMPLETED|First Intervention||0
2296642|NCT02044419|5639525|P3|COMPLETED|First Intervention||10
2296643|NCT02044419|5639526|P2|COMPLETED|First Intervention||9
2296644|NCT02044419|5639527|P1|COMPLETED|First Intervention||11
2296645|NCT02044419|5639525|P3|STARTED|First Intervention||11
2296646|NCT02044419|5639526|P2|STARTED|First Intervention||10
2296647|NCT02044419|5639527|P1|STARTED|First Intervention||11
2296648|NCT02044393|5639552|P2|NOT COMPLETED|Period 2||0
2296649|NCT02044393|5639553|P1|NOT COMPLETED|Period 2||0
2296650|NCT02044393|5639552|P2|COMPLETED|Period 2||10
2296651|NCT02044393|5639553|P1|COMPLETED|Period 2||10
2296652|NCT02044393|5639552|P2|STARTED|Period 2||10
2296653|NCT02044393|5639553|P1|STARTED|Period 2||10
2296654|NCT02044393|5639552|P2|NOT COMPLETED|Period 1||0
2296655|NCT02044393|5639553|P1|NOT COMPLETED|Period 1||0
2296656|NCT02044393|5639552|P2|COMPLETED|Period 1||10
2296657|NCT02044393|5639553|P1|COMPLETED|Period 1||10
2296658|NCT02044393|5639552|P2|STARTED|Period 1||10
2296659|NCT02044393|5639553|P1|STARTED|Period 1||10
2296660|NCT02044380|5639566|P1|NOT COMPLETED|Overall Study||0
2296661|NCT02044380|5639566|P1|COMPLETED|Overall Study||14
2296662|NCT02044380|5639566|P1|STARTED|Overall Study|Started are the treated patients|14
2296663|NCT02044367|5639570|P6|NOT COMPLETED|Overall Study||0
2296664|NCT02044367|5639571|P5|NOT COMPLETED|Overall Study||0
2296665|NCT02044367|5639572|P4|NOT COMPLETED|Overall Study||0
2296666|NCT02044367|5639573|P3|NOT COMPLETED|Overall Study||0
2296667|NCT02044367|5639574|P2|NOT COMPLETED|Overall Study||0
2296668|NCT02044367|5639575|P1|NOT COMPLETED|Overall Study||0
2296669|NCT02044367|5639570|P6|COMPLETED|Overall Study||9
2296670|NCT02044367|5639571|P5|COMPLETED|Overall Study||9
2296671|NCT02044367|5639572|P4|COMPLETED|Overall Study||9
2296672|NCT02044367|5639573|P3|COMPLETED|Overall Study||9
2296673|NCT02044367|5639574|P2|COMPLETED|Overall Study||9
2296674|NCT02044367|5639575|P1|COMPLETED|Overall Study||9
2296675|NCT02044367|5639570|P6|STARTED|Overall Study||9
2296676|NCT02044367|5639571|P5|STARTED|Overall Study||9
2296677|NCT02044367|5639572|P4|STARTED|Overall Study||9
2296678|NCT02044367|5639573|P3|STARTED|Overall Study||9
2296679|NCT02044367|5639574|P2|STARTED|Overall Study||9
2296680|NCT02044367|5639575|P1|STARTED|Overall Study||9
2296681|NCT02044302|5639598|P2|NOT COMPLETED|Overall Study||0
2296682|NCT02044302|5639599|P1|NOT COMPLETED|Overall Study||2
2296683|NCT02044302|5639598|P2|COMPLETED|Overall Study||0
2296684|NCT02044302|5639599|P1|COMPLETED|Overall Study||0
2296685|NCT02044302|5639598|P2|STARTED|Overall Study||0
2296686|NCT02044302|5639599|P1|STARTED|Overall Study||2
2296687|NCT02044159|5639607|P2|NOT COMPLETED|Overall Study||4
2296688|NCT02044159|5639608|P1|NOT COMPLETED|Overall Study||4
2296689|NCT02044159|5639607|P2|COMPLETED|Overall Study||26
2296690|NCT02044159|5639608|P1|COMPLETED|Overall Study||23
2296691|NCT02044159|5639607|P2|STARTED|Overall Study||30
2296692|NCT02044159|5639608|P1|STARTED|Overall Study||27
2296693|NCT02044094|5639621|P1|NOT COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||13
2296694|NCT02044094|5639621|P1|COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||17
2296695|NCT02044094|5639621|P1|STARTED|RBP-6000 Injection 2 (Day 29 to Week 12)||30
2296696|NCT02044094|5639621|P1|NOT COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||9
2296697|NCT02044094|5639621|P1|COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||30
2296698|NCT02044094|5639621|P1|Completers Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects that reached Day 28 + completed all challenges at Week 4 were considered study completers.|30
2296699|NCT02044094|5639621|P1|Intent to Treat Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects who receive >=1 dose of RBP-6000 and have >=1 complete sequence of hydromorphone challenges|38
2296700|NCT02044094|5639621|P1|STARTED|RBP-6000 Injection 1 (Day 1 to Day 28)||39
2296701|NCT02043938|5639678|P1|NOT COMPLETED|Overall Study||10
2296702|NCT02043938|5639678|P1|COMPLETED|Overall Study||36
2296703|NCT02043938|5639678|P1|STARTED|Overall Study||46
2296704|NCT02043860|5639688|P1|NOT COMPLETED|Overall Study||0
2296705|NCT02043860|5639688|P1|COMPLETED|Overall Study||2
2296706|NCT02043860|5639688|P1|STARTED|Overall Study||2
2296707|NCT02043808|5639694|P2|NOT COMPLETED|Overall Study||0
2296708|NCT02043808|5639695|P1|NOT COMPLETED|Overall Study||0
2296709|NCT02043808|5639694|P2|COMPLETED|Overall Study||12793
2296710|NCT02043808|5639695|P1|COMPLETED|Overall Study||12793
2296711|NCT02043808|5639694|P2|STARTED|Overall Study||12793
2296712|NCT02043808|5639695|P1|STARTED|Overall Study||12793
2296713|NCT02043782|5639733|P6|NOT COMPLETED|Period 3||0
2296714|NCT02043782|5639734|P5|NOT COMPLETED|Period 3||0
2296715|NCT02043782|5639735|P4|NOT COMPLETED|Period 3||0
2296716|NCT02043782|5639736|P3|NOT COMPLETED|Period 3||0
2296717|NCT02043782|5639737|P2|NOT COMPLETED|Period 3||0
2296718|NCT02043782|5639738|P1|NOT COMPLETED|Period 3||0
2296719|NCT02043782|5639733|P6|COMPLETED|Period 3||6
2296720|NCT02043782|5639734|P5|COMPLETED|Period 3||6
2296721|NCT02043782|5639735|P4|COMPLETED|Period 3||6
2296722|NCT02043782|5639736|P3|COMPLETED|Period 3||6
2296723|NCT02043782|5639737|P2|COMPLETED|Period 3||6
2296724|NCT02043782|5639738|P1|COMPLETED|Period 3||7
2296725|NCT02043782|5639733|P6|STARTED|Period 3||6
2296726|NCT02043782|5639734|P5|STARTED|Period 3||6
2296727|NCT02043782|5639735|P4|STARTED|Period 3||6
2296728|NCT02043782|5639736|P3|STARTED|Period 3||6
2296729|NCT02043782|5639737|P2|STARTED|Period 3||6
2296730|NCT02043782|5639738|P1|STARTED|Period 3||7
2296731|NCT02043782|5639733|P6|NOT COMPLETED|Period 2||0
2296732|NCT02043782|5639734|P5|NOT COMPLETED|Period 2||0
2296733|NCT02043782|5639735|P4|NOT COMPLETED|Period 2||0
2296734|NCT02043782|5639736|P3|NOT COMPLETED|Period 2||0
2296735|NCT02043782|5639737|P2|NOT COMPLETED|Period 2||0
2296736|NCT02043782|5639738|P1|NOT COMPLETED|Period 2||0
2296737|NCT02043782|5639733|P6|COMPLETED|Period 2||6
2296738|NCT02043782|5639734|P5|COMPLETED|Period 2||6
2296739|NCT02043782|5639735|P4|COMPLETED|Period 2||6
2296740|NCT02043782|5639736|P3|COMPLETED|Period 2||6
2296741|NCT02043782|5639737|P2|COMPLETED|Period 2||6
2296742|NCT02043782|5639738|P1|COMPLETED|Period 2||7
2296743|NCT02043782|5639733|P6|STARTED|Period 2||6
2296744|NCT02043782|5639734|P5|STARTED|Period 2||6
2296745|NCT02043782|5639735|P4|STARTED|Period 2||6
2296746|NCT02043782|5639736|P3|STARTED|Period 2||6
2296747|NCT02043782|5639737|P2|STARTED|Period 2||6
2296748|NCT02043782|5639738|P1|STARTED|Period 2||7
2296749|NCT02043782|5639733|P6|NOT COMPLETED|Period 1||0
2296750|NCT02043782|5639734|P5|NOT COMPLETED|Period 1||0
2296751|NCT02043782|5639735|P4|NOT COMPLETED|Period 1||0
2296752|NCT02043782|5639736|P3|NOT COMPLETED|Period 1||1
2296753|NCT02043782|5639737|P2|NOT COMPLETED|Period 1||0
2296754|NCT02043782|5639738|P1|NOT COMPLETED|Period 1||0
2296755|NCT02043782|5639733|P6|COMPLETED|Period 1||6
2296756|NCT02043782|5639734|P5|COMPLETED|Period 1||6
2296757|NCT02043782|5639735|P4|COMPLETED|Period 1||6
2296758|NCT02043782|5639736|P3|COMPLETED|Period 1|One subject discontinued due to an adverse event while testing own product|6
2296759|NCT02043782|5639737|P2|COMPLETED|Period 1||6
2296760|NCT02043782|5639738|P1|COMPLETED|Period 1||7
2296761|NCT02043782|5639733|P6|STARTED|Period 1||6
2296762|NCT02043782|5639734|P5|STARTED|Period 1||6
2296763|NCT02043782|5639735|P4|STARTED|Period 1||6
2296764|NCT02043782|5639736|P3|STARTED|Period 1||7
2296765|NCT02043782|5639737|P2|STARTED|Period 1||6
2296766|NCT02043782|5639738|P1|STARTED|Period 1||7
2296767|NCT02043704|5639748|P2|NOT COMPLETED|Overall Study||7
2296768|NCT02043704|5639749|P1|NOT COMPLETED|Overall Study||3
2296769|NCT02043704|5639748|P2|COMPLETED|Overall Study||43
2296770|NCT02043704|5639749|P1|COMPLETED|Overall Study||47
2296771|NCT02043704|5639748|P2|STARTED|Overall Study||50
2296772|NCT02043704|5639749|P1|STARTED|Overall Study||50
2296773|NCT02043678|5639781|P2|NOT COMPLETED|Overall Study||405
2296774|NCT02043678|5639782|P1|NOT COMPLETED|Overall Study||401
2296775|NCT02043678|5639781|P2|COMPLETED|Overall Study||0
2296776|NCT02043678|5639782|P1|COMPLETED|Overall Study||0
2296777|NCT02043678|5639781|P2|Treated|Overall Study||396
2296778|NCT02043678|5639782|P1|Treated|Overall Study||390
2296779|NCT02043678|5639781|P2|STARTED|Overall Study||405
2296780|NCT02043678|5639782|P1|STARTED|Overall Study||401
2296781|NCT02043652|5639798|P1|NOT COMPLETED|Overall Study||26
2296782|NCT02043652|5639798|P1|COMPLETED|Overall Study||93
2296783|NCT02043652|5639798|P1|STARTED|Overall Study||119
2296784|NCT02043574|5639805|P2|NOT COMPLETED|Overall Study||6
2296785|NCT02043574|5639806|P1|NOT COMPLETED|Overall Study||6
2296786|NCT02043574|5639805|P2|COMPLETED|Overall Study||20
2296787|NCT02043574|5639806|P1|COMPLETED|Overall Study||19
2296788|NCT02043574|5639805|P2|STARTED|Overall Study||26
2296789|NCT02043574|5639806|P1|STARTED|Overall Study||25
2296790|NCT02043509|5639818|P2|NOT COMPLETED|Baseline to 2nd Follow-up||72
2296791|NCT02043509|5639819|P1|NOT COMPLETED|Baseline to 2nd Follow-up||74
2296792|NCT02043509|5639818|P2|COMPLETED|Baseline to 2nd Follow-up||132
2296793|NCT02043509|5639819|P1|COMPLETED|Baseline to 2nd Follow-up||129
2296794|NCT02043509|5639818|P2|STARTED|Baseline to 2nd Follow-up||204
2296795|NCT02043509|5639819|P1|STARTED|Baseline to 2nd Follow-up||203
2296796|NCT02043509|5639818|P2|NOT COMPLETED|Baseline to 1st Follow-up||47
2296797|NCT02043509|5639819|P1|NOT COMPLETED|Baseline to 1st Follow-up||65
2296798|NCT02043509|5639818|P2|COMPLETED|Baseline to 1st Follow-up||157
2296799|NCT02043509|5639819|P1|COMPLETED|Baseline to 1st Follow-up||138
2296800|NCT02043509|5639818|P2|STARTED|Baseline to 1st Follow-up||204
2296801|NCT02043509|5639819|P1|STARTED|Baseline to 1st Follow-up||203
2296802|NCT02043379|5639844|P2|NOT COMPLETED|Overall Study||0
2296803|NCT02043379|5639845|P1|NOT COMPLETED|Overall Study||0
2296804|NCT02043379|5639844|P2|COMPLETED|Overall Study||20
2296805|NCT02043379|5639845|P1|COMPLETED|Overall Study||30
2296806|NCT02043379|5639844|P2|STARTED|Overall Study||20
2296807|NCT02043379|5639845|P1|STARTED|Overall Study||30
2296808|NCT02043366|5639907|P6|NOT COMPLETED|Overall Study||2
2296809|NCT02043366|5639908|P5|NOT COMPLETED|Overall Study||2
2296810|NCT02043366|5639909|P4|NOT COMPLETED|Overall Study||2
2296811|NCT02043366|5639910|P3|NOT COMPLETED|Overall Study||2
2296812|NCT02043366|5639911|P2|NOT COMPLETED|Overall Study||2
2296813|NCT02043366|5639912|P1|NOT COMPLETED|Overall Study||2
2296814|NCT02043366|5639907|P6|COMPLETED|Overall Study||28
2296815|NCT02043366|5639908|P5|COMPLETED|Overall Study||28
2296816|NCT02043366|5639909|P4|COMPLETED|Overall Study||28
2296817|NCT02043366|5639910|P3|COMPLETED|Overall Study||28
2296818|NCT02043366|5639911|P2|COMPLETED|Overall Study||28
2296819|NCT02043366|5639912|P1|COMPLETED|Overall Study||28
2296820|NCT02043366|5639907|P6|STARTED|Overall Study||30
2296821|NCT02043366|5639908|P5|STARTED|Overall Study||30
2296822|NCT02043366|5639909|P4|STARTED|Overall Study||30
2296823|NCT02043366|5639910|P3|STARTED|Overall Study||30
2296824|NCT02043366|5639911|P2|STARTED|Overall Study||30
2296825|NCT02043366|5639912|P1|STARTED|Overall Study||30
2296826|NCT02043301|5639935|P3|NOT COMPLETED|Overall Study||0
2296827|NCT02043301|5639936|P2|NOT COMPLETED|Overall Study||1
2296828|NCT02043301|5639937|P1|NOT COMPLETED|Overall Study||0
2296829|NCT02043301|5639935|P3|COMPLETED|Overall Study||25
2296830|NCT02043301|5639936|P2|COMPLETED|Overall Study||24
2296831|NCT02043301|5639937|P1|COMPLETED|Overall Study||25
2296832|NCT02043301|5639935|P3|STARTED|Overall Study||25
2296833|NCT02043301|5639936|P2|STARTED|Overall Study||25
2296834|NCT02043301|5639937|P1|STARTED|Overall Study||25
2296835|NCT02043197|5639995|P1|NOT COMPLETED|Overall Study||8
2296836|NCT02043197|5639995|P1|COMPLETED|Overall Study||292
2296837|NCT02043197|5639995|P1|STARTED|Overall Study||300
2296838|NCT02043145|5640019|P3|NOT COMPLETED|Overall Study||0
2296839|NCT02043145|5640020|P2|NOT COMPLETED|Overall Study||0
2296840|NCT02043145|5640021|P1|NOT COMPLETED|Overall Study||0
2296841|NCT02043145|5640019|P3|COMPLETED|Overall Study||425
2296842|NCT02043145|5640020|P2|COMPLETED|Overall Study||247
2296843|NCT02043145|5640021|P1|COMPLETED|Overall Study||55
2296844|NCT02043145|5640019|P3|STARTED|Overall Study||425
2296845|NCT02043145|5640020|P2|STARTED|Overall Study||247
2296846|NCT02043145|5640021|P1|STARTED|Overall Study||55
2296847|NCT02043132|5640034|P2|NOT COMPLETED|Overall Study||9
2296848|NCT02043132|5640035|P1|NOT COMPLETED|Overall Study||5
2296849|NCT02043132|5640034|P2|COMPLETED|Overall Study||49
2296850|NCT02043132|5640035|P1|COMPLETED|Overall Study||53
2296851|NCT02043132|5640034|P2|STARTED|Overall Study||58
2296852|NCT02043132|5640035|P1|STARTED|Overall Study||58
2296853|NCT02043015|5640055|P1|NOT COMPLETED|Overall Study||28
2296854|NCT02043015|5640055|P1|COMPLETED|Overall Study||87
2296855|NCT02043015|5640055|P1|STARTED|Overall Study||115
2296856|NCT02042950|5640068|P1|NOT COMPLETED|Overall Study||4
2296857|NCT02042950|5640068|P1|COMPLETED|Overall Study||0
2296858|NCT02042950|5640068|P1|STARTED|Overall Study||4
2296859|NCT02042924|5640074|P1|NOT COMPLETED|Overall Study||1
2296860|NCT02042924|5640074|P1|COMPLETED|Overall Study||1
2296861|NCT02042924|5640074|P1|STARTED|Overall Study||2
2296862|NCT02042911|5640080|P1|NOT COMPLETED|Overall Study||1
2296863|NCT02042911|5640080|P1|COMPLETED|Overall Study||9
2296864|NCT02042911|5640080|P1|STARTED|Overall Study||10
2296865|NCT02042872|5640094|P2|NOT COMPLETED|Overall Study||5
2296866|NCT02042872|5640095|P1|NOT COMPLETED|Overall Study||0
2296867|NCT02042872|5640094|P2|COMPLETED|Overall Study||8
2296868|NCT02042872|5640095|P1|COMPLETED|Overall Study||8
2296869|NCT02042872|5640094|P2|STARTED|Overall Study||13
2296870|NCT02042872|5640095|P1|STARTED|Overall Study||8
2296871|NCT02042534|5640105|P2|NOT COMPLETED|Overall Study||0
2296872|NCT02042534|5640106|P1|NOT COMPLETED|Overall Study||0
2296873|NCT02042534|5640105|P2|COMPLETED|Overall Study||94
2296874|NCT02042534|5640106|P1|COMPLETED|Overall Study||101
2296875|NCT02042534|5640105|P2|STARTED|Overall Study||94
2296876|NCT02042534|5640106|P1|STARTED|Overall Study||101
2296877|NCT02042443|5640122|P2|NOT COMPLETED|Overall Study||26
2296878|NCT02042443|5640123|P1|NOT COMPLETED|Overall Study||27
2296879|NCT02042443|5640122|P2|COMPLETED|Overall Study||0
2296880|NCT02042443|5640123|P1|COMPLETED|Overall Study||0
2296881|NCT02042443|5640122|P2|Eligible and Analyzable|Overall Study||20
2296882|NCT02042443|5640123|P1|Eligible and Analyzable|Overall Study||24
2296883|NCT02042443|5640122|P2|STARTED|Overall Study||26
2296884|NCT02042443|5640123|P1|STARTED|Overall Study||27
2296885|NCT02042404|5640135|P2|NOT COMPLETED|Overall Study||0
2296886|NCT02042404|5640136|P1|NOT COMPLETED|Overall Study||5
2296887|NCT02042404|5640135|P2|COMPLETED|Overall Study||5
2296888|NCT02042404|5640136|P1|COMPLETED|Overall Study|39 subjects completed 30 days evaluation. 38 subjects completed 120 days evaluation.|38
2296889|NCT02042404|5640135|P2|STARTED|Overall Study||5
2296890|NCT02042404|5640136|P1|STARTED|Overall Study|Enrollment was stopped after 43 were enrolled, had approval to enroll 45 primary cohort subjects|43
2296891|NCT02042274|5640147|P1|NOT COMPLETED|Overall Study||0
2296892|NCT02042274|5640147|P1|COMPLETED|Overall Study||12
2296893|NCT02042274|5640147|P1|STARTED|Overall Study||12
2296894|NCT02042131|5640155|P3|NOT COMPLETED|Overall Study||0
2296895|NCT02042131|5640156|P2|NOT COMPLETED|Overall Study||0
2296896|NCT02042131|5640157|P1|NOT COMPLETED|Overall Study||0
2296897|NCT02042131|5640155|P3|COMPLETED|Overall Study||33
2296898|NCT02042131|5640156|P2|COMPLETED|Overall Study||32
2296899|NCT02042131|5640157|P1|COMPLETED|Overall Study||32
2296900|NCT02042131|5640155|P3|STARTED|Overall Study||33
2296901|NCT02042131|5640156|P2|STARTED|Overall Study||32
2296902|NCT02042131|5640157|P1|STARTED|Overall Study||32
2296903|NCT02042014|5640174|P1|NOT COMPLETED|Overall Study||8
2296904|NCT02042014|5640174|P1|COMPLETED|Overall Study||0
2296905|NCT02042014|5640174|P1|STARTED|Overall Study||8
2296906|NCT02041962|5640180|P2|NOT COMPLETED|Overall Study||84
2296907|NCT02041962|5640181|P1|NOT COMPLETED|Overall Study||81
2296908|NCT02041962|5640180|P2|COMPLETED|Overall Study||31
2296909|NCT02041962|5640181|P1|COMPLETED|Overall Study||42
2296910|NCT02041962|5640180|P2|Participants Completing 12 mo. f/up|Overall Study||31
2296911|NCT02041962|5640181|P1|Participants Completing 12 mo. f/up|Overall Study||42
2296912|NCT02041962|5640180|P2|Participants Completing 6 mo. f/up|Overall Study||44
2296913|NCT02041962|5640181|P1|Participants Completing 6 mo. f/up|Overall Study||69
2296914|NCT02041962|5640180|P2|STARTED|Overall Study||115
2296915|NCT02041962|5640181|P1|STARTED|Overall Study||123
2296916|NCT02041702|5640191|P2|NOT COMPLETED|Overall Study||9
2296917|NCT02041702|5640192|P1|NOT COMPLETED|Overall Study||11
2296918|NCT02041702|5640191|P2|COMPLETED|Overall Study||134
2296919|NCT02041702|5640192|P1|COMPLETED|Overall Study||129
2296920|NCT02041702|5640191|P2|Post MRI Scan/ Post Waiting|Overall Study||140
2296921|NCT02041702|5640192|P1|Post MRI Scan/ Post Waiting|Overall Study||129
2296922|NCT02041702|5640191|P2|Pre MRI Scan/ Pre Waitng|Overall Study||140
2296923|NCT02041702|5640192|P1|Pre MRI Scan/ Pre Waitng|Overall Study||129
2296924|NCT02041702|5640191|P2|STARTED|Overall Study||143
2296925|NCT02041702|5640192|P1|STARTED|Overall Study||140
2296926|NCT02041533|5640207|P2|NOT COMPLETED|Overall Study||258
2296927|NCT02041533|5640208|P1|NOT COMPLETED|Overall Study||228
2296928|NCT02041533|5640207|P2|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|12
2296929|NCT02041533|5640208|P1|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|43
2296930|NCT02041533|5640207|P2|Began Treatment|Overall Study||263
2296931|NCT02041533|5640208|P1|Began Treatment|Overall Study||267
2296932|NCT02041533|5640207|P2|STARTED|Overall Study||270
2296933|NCT02041533|5640208|P1|STARTED|Overall Study||271
2296934|NCT02041520|5640230|P2|NOT COMPLETED|Overall Study||7
2296935|NCT02041520|5640231|P1|NOT COMPLETED|Overall Study||6
2296936|NCT02041520|5640230|P2|COMPLETED|Overall Study||28
2296937|NCT02041520|5640231|P1|COMPLETED|Overall Study||29
2296938|NCT02041520|5640230|P2|STARTED|Overall Study|35 patients randomly assigned to placebo|35
2296939|NCT02041520|5640231|P1|STARTED|Overall Study|35 patients randomly assigned to omega 3 fatty acids|35
2296940|NCT02041377|5640251|P1|NOT COMPLETED|Overall Study||0
2296941|NCT02041377|5640251|P1|COMPLETED|Overall Study||134
2296942|NCT02041377|5640251|P1|STARTED|Overall Study||134
2296943|NCT02041325|5640261|P2|NOT COMPLETED|Overall Study||3
2296944|NCT02041325|5640262|P1|NOT COMPLETED|Overall Study||3
2296945|NCT02041325|5640261|P2|COMPLETED|Overall Study||13
2296946|NCT02041325|5640262|P1|COMPLETED|Overall Study||19
2296947|NCT02041325|5640261|P2|STARTED|Overall Study||16
2296948|NCT02041325|5640262|P1|STARTED|Overall Study||22
2296949|NCT02041286|5640274|P1|NOT COMPLETED|Overall Study||1
2296950|NCT02041286|5640274|P1|COMPLETED|Overall Study|One subject discontinued from testing after low BG fingerstick result (hypoglycemia AE).|135
2296951|NCT02041286|5640274|P1|STARTED|Overall Study||136
2296952|NCT02041221|5640288|P6|NOT COMPLETED|Part 2||0
2296953|NCT02041221|5640289|P5|NOT COMPLETED|Part 2||0
2296954|NCT02041221|5640290|P4|NOT COMPLETED|Part 2||0
2296955|NCT02041221|5640291|P3|NOT COMPLETED|Part 2||1
2296956|NCT02041221|5640292|P2|NOT COMPLETED|Part 2||0
2296957|NCT02041221|5640293|P1|NOT COMPLETED|Part 2||0
2296958|NCT02041221|5640288|P6|COMPLETED|Part 2||6
2296959|NCT02041221|5640289|P5|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
2296960|NCT02041221|5640290|P4|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
2296961|NCT02041221|5640291|P3|COMPLETED|Part 2||5
2296962|NCT02041221|5640292|P2|COMPLETED|Part 2||6
2296963|NCT02041221|5640293|P1|COMPLETED|Part 2||6
2296964|NCT02041221|5640288|P6|STARTED|Part 2||6
2296965|NCT02041221|5640289|P5|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
2296966|NCT02041221|5640290|P4|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually.|0
2296967|NCT02041221|5640291|P3|STARTED|Part 2||6
2296968|NCT02041221|5640292|P2|STARTED|Part 2||6
2296969|NCT02041221|5640293|P1|STARTED|Part 2||6
2296970|NCT02041221|5640288|P6|NOT COMPLETED|Part 1||0
2296971|NCT02041221|5640289|P5|NOT COMPLETED|Part 1||0
2296972|NCT02041221|5640290|P4|NOT COMPLETED|Part 1||0
2296973|NCT02041221|5640291|P3|NOT COMPLETED|Part 1||0
2296974|NCT02041221|5640292|P2|NOT COMPLETED|Part 1||0
2296975|NCT02041221|5640293|P1|NOT COMPLETED|Part 1||0
2296976|NCT02041221|5640288|P6|COMPLETED|Part 1||10
2296977|NCT02041221|5640289|P5|COMPLETED|Part 1||6
2296978|NCT02041221|5640290|P4|COMPLETED|Part 1||6
2296979|NCT02041221|5640291|P3|COMPLETED|Part 1||6
2296980|NCT02041221|5640292|P2|COMPLETED|Part 1||6
2296981|NCT02041221|5640293|P1|COMPLETED|Part 1||6
2296982|NCT02041221|5640288|P6|STARTED|Part 1||10
2296983|NCT02041221|5640289|P5|STARTED|Part 1||6
2296984|NCT02041221|5640290|P4|STARTED|Part 1||6
2296985|NCT02041221|5640291|P3|STARTED|Part 1||6
2296986|NCT02041221|5640292|P2|STARTED|Part 1||6
2296987|NCT02041221|5640293|P1|STARTED|Part 1||6
2296988|NCT02041104|5640309|P2|NOT COMPLETED|Overall Study||7
2296989|NCT02041104|5640310|P1|NOT COMPLETED|Overall Study||1
2296990|NCT02041104|5640309|P2|COMPLETED|Overall Study||16
2296991|NCT02041104|5640310|P1|COMPLETED|Overall Study||27
2296992|NCT02041104|5640309|P2|STARTED|Overall Study||23
2296993|NCT02041104|5640310|P1|STARTED|Overall Study||28
2296994|NCT02041091|5640350|P2|NOT COMPLETED|Optional Safety Extension Period||82
2296995|NCT02041091|5640351|P1|NOT COMPLETED|Optional Safety Extension Period||85
2296996|NCT02041091|5640350|P2|COMPLETED|Optional Safety Extension Period||0
2296997|NCT02041091|5640351|P1|COMPLETED|Optional Safety Extension Period||0
2296998|NCT02041091|5640350|P2|STARTED|Optional Safety Extension Period|Participation was optional for the Safety Extension Period.|82
2296999|NCT02041091|5640351|P1|STARTED|Optional Safety Extension Period|Participation was optional for the Safety Extension Period.|85
2297000|NCT02041091|5640350|P2|NOT COMPLETED|Treatment||23
2297001|NCT02041091|5640351|P1|NOT COMPLETED|Treatment||22
2297002|NCT02041091|5640350|P2|COMPLETED|Treatment||91
2297003|NCT02041091|5640351|P1|COMPLETED|Treatment||90
2297004|NCT02041091|5640350|P2|Participated in Follow Up|Treatment||96
2297005|NCT02041091|5640351|P1|Participated in Follow Up|Treatment||106
2297006|NCT02041091|5640350|P2|Received At Least One Dose of Study Drug|Treatment||114
2297007|NCT02041091|5640351|P1|Received At Least One Dose of Study Drug|Treatment||112
2297008|NCT02041091|5640350|P2|STARTED|Treatment||114
2297009|NCT02041091|5640351|P1|STARTED|Treatment||112
2297010|NCT02040870|5640373|P1|NOT COMPLETED|Overall Study||103
2297011|NCT02040870|5640373|P1|COMPLETED|Overall Study||0
2297012|NCT02040870|5640373|P1|Discontinue From Study|Overall Study||26
2297013|NCT02040870|5640373|P1|Entered Survival Follow-up|Overall Study||75
2297014|NCT02040870|5640373|P1|Entered Post-treatment Follow-up|Overall Study||2
2297015|NCT02040870|5640373|P1|STARTED|Overall Study||103
2297016|NCT02040844|5640397|P3|NOT COMPLETED|Overall Study||47
2297017|NCT02040844|5640398|P2|NOT COMPLETED|Overall Study||39
2297018|NCT02040844|5640399|P1|NOT COMPLETED|Overall Study||50
2297019|NCT02040844|5640397|P3|COMPLETED|Overall Study||97
2297020|NCT02040844|5640398|P2|COMPLETED|Overall Study||109
2297021|NCT02040844|5640399|P1|COMPLETED|Overall Study||88
2297022|NCT02040844|5640397|P3|STARTED|Overall Study||144
2297023|NCT02040844|5640398|P2|STARTED|Overall Study||148
2297024|NCT02040844|5640399|P1|STARTED|Overall Study||138
2297025|NCT02040805|5640424|P2|NOT COMPLETED|Overall Study||50
2297026|NCT02040805|5640425|P1|NOT COMPLETED|Overall Study||42
2297027|NCT02040805|5640424|P2|COMPLETED|Overall Study||113
2297028|NCT02040805|5640425|P1|COMPLETED|Overall Study||118
2297029|NCT02040805|5640424|P2|STARTED|Overall Study||163
2297030|NCT02040805|5640425|P1|STARTED|Overall Study||160
2297031|NCT02040792|5640442|P5|NOT COMPLETED|Overall Study||7
2297032|NCT02040792|5640443|P4|NOT COMPLETED|Overall Study||7
2297033|NCT02040792|5640444|P3|NOT COMPLETED|Overall Study||3
2297034|NCT02040792|5640445|P2|NOT COMPLETED|Overall Study||3
2297035|NCT02040792|5640446|P1|NOT COMPLETED|Overall Study||6
2297036|NCT02040792|5640442|P5|COMPLETED|Overall Study||67
2297037|NCT02040792|5640443|P4|COMPLETED|Overall Study||64
2297038|NCT02040792|5640444|P3|COMPLETED|Overall Study||68
2297039|NCT02040792|5640445|P2|COMPLETED|Overall Study||65
2297040|NCT02040792|5640446|P1|COMPLETED|Overall Study||64
2297041|NCT02040792|5640442|P5|STARTED|Overall Study||74
2297042|NCT02040792|5640443|P4|STARTED|Overall Study||71
2297043|NCT02040792|5640444|P3|STARTED|Overall Study||71
2297044|NCT02040792|5640445|P2|STARTED|Overall Study||68
2297045|NCT02040792|5640446|P1|STARTED|Overall Study||70
2297046|NCT02040779|5640461|P3|NOT COMPLETED|Overall Study||4
2297047|NCT02040779|5640462|P2|NOT COMPLETED|Overall Study||7
2297048|NCT02040779|5640463|P1|NOT COMPLETED|Overall Study||12
2297049|NCT02040779|5640461|P3|COMPLETED|Overall Study||88
2297050|NCT02040779|5640462|P2|COMPLETED|Overall Study||83
2297051|NCT02040779|5640463|P1|COMPLETED|Overall Study||79
2297052|NCT02040779|5640461|P3|Full Analysis Set (FAS)|Overall Study||92
2297053|NCT02040779|5640462|P2|Full Analysis Set (FAS)|Overall Study||88
2297054|NCT02040779|5640463|P1|Full Analysis Set (FAS)|Overall Study||90
2297055|NCT02040779|5640461|P3|STARTED|Overall Study||92
2297056|NCT02040779|5640462|P2|STARTED|Overall Study||90
2297057|NCT02040779|5640463|P1|STARTED|Overall Study||91
2297058|NCT02040766|5640503|P5|NOT COMPLETED|Overall Study||13
2297059|NCT02040766|5640504|P4|NOT COMPLETED|Overall Study||13
2297060|NCT02040766|5640505|P3|NOT COMPLETED|Overall Study||12
2297061|NCT02040766|5640506|P2|NOT COMPLETED|Overall Study||10
2297062|NCT02040766|5640507|P1|NOT COMPLETED|Overall Study||18
2297063|NCT02040766|5640503|P5|COMPLETED|Overall Study||112
2297064|NCT02040766|5640504|P4|COMPLETED|Overall Study||112
2297065|NCT02040766|5640505|P3|COMPLETED|Overall Study||113
2297066|NCT02040766|5640506|P2|COMPLETED|Overall Study||116
2297067|NCT02040766|5640507|P1|COMPLETED|Overall Study||109
2297068|NCT02040766|5640503|P5|STARTED|Overall Study||125
2297069|NCT02040766|5640504|P4|STARTED|Overall Study||125
2297070|NCT02040766|5640505|P3|STARTED|Overall Study||125
2297071|NCT02040766|5640506|P2|STARTED|Overall Study||126
2297072|NCT02040766|5640507|P1|STARTED|Overall Study||127
2297073|NCT02040623|5640548|P3|NOT COMPLETED|Overall Study||2
2297074|NCT02040623|5640549|P2|NOT COMPLETED|Overall Study||6
2297075|NCT02040623|5640550|P1|NOT COMPLETED|Overall Study||4
2297076|NCT02040623|5640548|P3|COMPLETED|Overall Study||10
2297077|NCT02040623|5640549|P2|COMPLETED|Overall Study||6
2297078|NCT02040623|5640550|P1|COMPLETED|Overall Study||7
2297079|NCT02040623|5640548|P3|STARTED|Overall Study||12
2297080|NCT02040623|5640549|P2|STARTED|Overall Study||12
2297081|NCT02040623|5640550|P1|STARTED|Overall Study||11
2297082|NCT02040584|5640560|P2|NOT COMPLETED|Overall Study||32
2297083|NCT02040584|5640561|P1|NOT COMPLETED|Overall Study||35
2297084|NCT02040584|5640560|P2|COMPLETED|Overall Study||74
2297085|NCT02040584|5640561|P1|COMPLETED|Overall Study||70
2297086|NCT02040584|5640560|P2|STARTED|Overall Study||106
2297087|NCT02040584|5640561|P1|STARTED|Overall Study||105
2297088|NCT02040532|5640594|P1|NOT COMPLETED|Overall Study||12
2297089|NCT02040532|5640594|P1|COMPLETED|Overall Study||20
2297090|NCT02040532|5640594|P1|Received at Least One Dose of Medication|Overall Study||26
2297091|NCT02040532|5640594|P1|STARTED|Overall Study||32
2297092|NCT02040428|5640607|P2|NOT COMPLETED|Overall Study||4
2297093|NCT02040428|5640608|P1|NOT COMPLETED|Overall Study||5
2297094|NCT02040428|5640607|P2|COMPLETED|Overall Study||77
2297095|NCT02040428|5640608|P1|COMPLETED|Overall Study||70
2297096|NCT02040428|5640607|P2|Intent to Treat (Randomized Subjects)|Overall Study||80
2297097|NCT02040428|5640608|P1|Intent to Treat (Randomized Subjects)|Overall Study||76
2297098|NCT02040428|5640607|P2|STARTED|Overall Study||81
2297099|NCT02040428|5640608|P1|STARTED|Overall Study||75
2297100|NCT02040116|5640620|P1|NOT COMPLETED|Overall Study||0
2297101|NCT02040116|5640620|P1|COMPLETED|Overall Study||19
2297102|NCT02040116|5640620|P1|STARTED|Overall Study||19
2297103|NCT02040077|5640631|P3|NOT COMPLETED|Overall Study||0
2297104|NCT02040077|5640632|P2|NOT COMPLETED|Overall Study||0
2297105|NCT02040077|5640633|P1|NOT COMPLETED|Overall Study||0
2297106|NCT02040077|5640631|P3|COMPLETED|Overall Study||25
2297107|NCT02040077|5640632|P2|COMPLETED|Overall Study||24
2297108|NCT02040077|5640633|P1|COMPLETED|Overall Study||27
2297109|NCT02040077|5640631|P3|STARTED|Overall Study||25
2297110|NCT02040077|5640632|P2|STARTED|Overall Study||24
2297111|NCT02040077|5640633|P1|STARTED|Overall Study||27
2297112|NCT02039947|5640648|P4|NOT COMPLETED|Overall Study||0
2297113|NCT02039947|5640649|P3|NOT COMPLETED|Overall Study||0
2297114|NCT02039947|5640650|P2|NOT COMPLETED|Overall Study||0
2297115|NCT02039947|5640651|P1|NOT COMPLETED|Overall Study||0
2297116|NCT02039947|5640648|P4|COMPLETED|Overall Study||17
2297117|NCT02039947|5640649|P3|COMPLETED|Overall Study||16
2297118|NCT02039947|5640650|P2|COMPLETED|Overall Study||16
2297119|NCT02039947|5640651|P1|COMPLETED|Overall Study||76
2297120|NCT02039947|5640648|P4|STARTED|Overall Study||17
2297121|NCT02039947|5640649|P3|STARTED|Overall Study||16
2297122|NCT02039947|5640650|P2|STARTED|Overall Study||16
2297123|NCT02039947|5640651|P1|STARTED|Overall Study||76
2297124|NCT02039908|5640686|P4|NOT COMPLETED|Phase 2-School Year||8
2297125|NCT02039908|5640687|P3|NOT COMPLETED|Phase 2-School Year||12
2297126|NCT02039908|5640688|P2|NOT COMPLETED|Phase 2-School Year||0
2297127|NCT02039908|5640689|P1|NOT COMPLETED|Phase 2-School Year||0
2297128|NCT02039908|5640686|P4|COMPLETED|Phase 2-School Year||116
2297129|NCT02039908|5640687|P3|COMPLETED|Phase 2-School Year||109
2297130|NCT02039908|5640688|P2|COMPLETED|Phase 2-School Year||0
2297131|NCT02039908|5640689|P1|COMPLETED|Phase 2-School Year||0
2297132|NCT02039908|5640686|P4|STARTED|Phase 2-School Year||124
2297133|NCT02039908|5640687|P3|STARTED|Phase 2-School Year||121
2297134|NCT02039908|5640688|P2|STARTED|Phase 2-School Year||0
2297135|NCT02039908|5640689|P1|STARTED|Phase 2-School Year||0
2297136|NCT02039908|5640686|P4|NOT COMPLETED|Phase 1-Summer||0
2297137|NCT02039908|5640687|P3|NOT COMPLETED|Phase 1-Summer||0
2297138|NCT02039908|5640688|P2|NOT COMPLETED|Phase 1-Summer||6
2297139|NCT02039908|5640689|P1|NOT COMPLETED|Phase 1-Summer||13
2297140|NCT02039908|5640686|P4|COMPLETED|Phase 1-Summer||0
2297141|NCT02039908|5640687|P3|COMPLETED|Phase 1-Summer||0
2297142|NCT02039908|5640688|P2|COMPLETED|Phase 1-Summer||132
2297143|NCT02039908|5640689|P1|COMPLETED|Phase 1-Summer||116
2297144|NCT02039908|5640686|P4|STARTED|Phase 1-Summer||0
2297145|NCT02039908|5640687|P3|STARTED|Phase 1-Summer||0
2297146|NCT02039908|5640688|P2|STARTED|Phase 1-Summer||138
2297147|NCT02039908|5640689|P1|STARTED|Phase 1-Summer||129
2297148|NCT02039856|5640703|P2|NOT COMPLETED|Overall Study||853
2297149|NCT02039856|5640704|P1|NOT COMPLETED|Overall Study||2027
2297150|NCT02039856|5640703|P2|COMPLETED|Overall Study||327
2297151|NCT02039856|5640704|P1|COMPLETED|Overall Study||693
2297152|NCT02039856|5640703|P2|Total 24-month Completed|Overall Study||327
2297153|NCT02039856|5640704|P1|Total 24-month Completed|Overall Study||693
2297154|NCT02039856|5640703|P2|24-month Completed Providers/Staff|Overall Study||105
2297155|NCT02039856|5640704|P1|24-month Completed Providers/Staff|Overall Study||174
2297156|NCT02039856|5640703|P2|24-month Started Providers/Staff|Overall Study||304
2297157|NCT02039856|5640704|P1|24-month Started Providers/Staff|Overall Study||565
2297158|NCT02039856|5640703|P2|24-month Completed - Patients|Overall Study||222
2297159|NCT02039856|5640704|P1|24-month Completed - Patients|Overall Study||519
2297160|NCT02039856|5640703|P2|24-month Started - Patients|Overall Study||442
2297161|NCT02039856|5640704|P1|24-month Started - Patients|Overall Study||953
2297162|NCT02039856|5640703|P2|24-month Started|Overall Study||746
2297163|NCT02039856|5640704|P1|24-month Started|Overall Study||1518
2297164|NCT02039856|5640703|P2|12-month Providers/Staff|Overall Study||0
2297165|NCT02039856|5640704|P1|12-month Providers/Staff|Overall Study||0
2297166|NCT02039856|5640703|P2|12-month Completed- Patients|Overall Study||241
2297167|NCT02039856|5640704|P1|12-month Completed- Patients|Overall Study||580
2297168|NCT02039856|5640703|P2|12-month Started-patients|Overall Study||442
2297169|NCT02039856|5640704|P1|12-month Started-patients|Overall Study||953
2297170|NCT02039856|5640703|P2|Total Baseline Completed|Overall Study||536
2297171|NCT02039856|5640704|P1|Total Baseline Completed|Overall Study||1147
2297172|NCT02039856|5640703|P2|Baseline Completed -Providers/Staff|Overall Study||94
2297173|NCT02039856|5640704|P1|Baseline Completed -Providers/Staff|Overall Study||194
2297174|NCT02039856|5640703|P2|Baseline Started - Providers/Staff|Overall Study||261
2297175|NCT02039856|5640704|P1|Baseline Started - Providers/Staff|Overall Study||537
2297176|NCT02039856|5640703|P2|Baseline Completed - Patients|Overall Study||442
2297177|NCT02039856|5640704|P1|Baseline Completed - Patients|Overall Study||953
2297178|NCT02039856|5640703|P2|Baseline Started - Patients|Overall Study||919
2297179|NCT02039856|5640704|P1|Baseline Started - Patients|Overall Study||2183
2297180|NCT02039856|5640703|P2|STARTED|Overall Study||1180
2297181|NCT02039856|5640704|P1|STARTED|Overall Study||2720
2297182|NCT02039817|5640726|P2|NOT COMPLETED|Overall Study||0
2297183|NCT02039817|5640727|P1|NOT COMPLETED|Overall Study||0
2297184|NCT02039817|5640726|P2|COMPLETED|Overall Study||8
2297185|NCT02039817|5640727|P1|COMPLETED|Overall Study||8
2297186|NCT02039817|5640726|P2|STARTED|Overall Study||8
2297187|NCT02039817|5640727|P1|STARTED|Overall Study||8
2297188|NCT02039778|5640736|P1|NOT COMPLETED|Overall Study||4
2297189|NCT02039778|5640736|P1|COMPLETED|Overall Study||0
2297190|NCT02039778|5640736|P1|STARTED|Overall Study||4
2297191|NCT02039726|5640746|P2|NOT COMPLETED|Overall Study||16
2297192|NCT02039726|5640747|P1|NOT COMPLETED|Overall Study||45
2297193|NCT02039726|5640746|P2|COMPLETED|Overall Study||106
2297194|NCT02039726|5640747|P1|COMPLETED|Overall Study||200
2297195|NCT02039726|5640746|P2|Did Not Receive Treatment|Overall Study||28
2297196|NCT02039726|5640747|P1|Did Not Receive Treatment|Overall Study||4
2297197|NCT02039726|5640746|P2|Ongoing (as of Data Cutoff)|Overall Study||16
2297198|NCT02039726|5640747|P1|Ongoing (as of Data Cutoff)|Overall Study||45
2297199|NCT02039726|5640746|P2|STARTED|Overall Study||122
2297200|NCT02039726|5640747|P1|STARTED|Overall Study||245
2297201|NCT02039687|5640759|P4|NOT COMPLETED|Overall Study||0
2297202|NCT02039687|5640760|P3|NOT COMPLETED|Overall Study||3
2297203|NCT02039687|5640761|P2|NOT COMPLETED|Overall Study||1
2297204|NCT02039687|5640762|P1|NOT COMPLETED|Overall Study||0
2297205|NCT02039687|5640759|P4|COMPLETED|Overall Study||16
2297206|NCT02039687|5640760|P3|COMPLETED|Overall Study||13
2297207|NCT02039687|5640761|P2|COMPLETED|Overall Study||15
2297208|NCT02039687|5640762|P1|COMPLETED|Overall Study||16
2297209|NCT02039687|5640759|P4|STARTED|Overall Study||16
2297210|NCT02039687|5640760|P3|STARTED|Overall Study||16
2297211|NCT02039687|5640761|P2|STARTED|Overall Study||16
2297212|NCT02039687|5640762|P1|STARTED|Overall Study||16
2297213|NCT02039674|5640802|P14|NOT COMPLETED|Overall Study||33
2297214|NCT02039674|5640803|P13|NOT COMPLETED|Overall Study||63
2297215|NCT02039674|5640804|P12|NOT COMPLETED|Overall Study||60
2297216|NCT02039674|5640805|P11|NOT COMPLETED|Overall Study||7
2297217|NCT02039674|5640806|P10|NOT COMPLETED|Overall Study||12
2297218|NCT02039674|5640807|P9|NOT COMPLETED|Overall Study||12
2297219|NCT02039674|5640808|P8|NOT COMPLETED|Overall Study||3
2297220|NCT02039674|5640809|P7|NOT COMPLETED|Overall Study||3
2297221|NCT02039674|5640810|P6|NOT COMPLETED|Overall Study||12
2297222|NCT02039674|5640811|P5|NOT COMPLETED|Overall Study||12
2297223|NCT02039674|5640812|P4|NOT COMPLETED|Overall Study||13
2297224|NCT02039674|5640813|P3|NOT COMPLETED|Overall Study||12
2297225|NCT02039674|5640814|P2|NOT COMPLETED|Overall Study||12
2297226|NCT02039674|5640815|P1|NOT COMPLETED|Overall Study||12
2297227|NCT02039674|5640802|P14|COMPLETED|Overall Study||0
2297228|NCT02039674|5640803|P13|COMPLETED|Overall Study||0
2297229|NCT02039674|5640804|P12|COMPLETED|Overall Study||0
2297230|NCT02039674|5640805|P11|COMPLETED|Overall Study||0
2297231|NCT02039674|5640806|P10|COMPLETED|Overall Study||0
2297232|NCT02039674|5640807|P9|COMPLETED|Overall Study||0
2297233|NCT02039674|5640808|P8|COMPLETED|Overall Study||0
2297234|NCT02039674|5640809|P7|COMPLETED|Overall Study||0
2297235|NCT02039674|5640810|P6|COMPLETED|Overall Study||0
2297236|NCT02039674|5640811|P5|COMPLETED|Overall Study||0
2297237|NCT02039674|5640812|P4|COMPLETED|Overall Study||0
2297238|NCT02039674|5640813|P3|COMPLETED|Overall Study||0
2297239|NCT02039674|5640814|P2|COMPLETED|Overall Study||0
2297240|NCT02039674|5640815|P1|COMPLETED|Overall Study||1
2297241|NCT02039674|5640802|P14|Treated|Overall Study||33
2297242|NCT02039674|5640803|P13|Treated|Overall Study||62
2297243|NCT02039674|5640804|P12|Treated|Overall Study||59
2297244|NCT02039674|5640805|P11|Treated|Overall Study||7
2297245|NCT02039674|5640806|P10|Treated|Overall Study||12
2297246|NCT02039674|5640807|P9|Treated|Overall Study||12
2297247|NCT02039674|5640808|P8|Treated|Overall Study||3
2297248|NCT02039674|5640809|P7|Treated|Overall Study||3
2297249|NCT02039674|5640810|P6|Treated|Overall Study||12
2297250|NCT02039674|5640811|P5|Treated|Overall Study||12
2297251|NCT02039674|5640812|P4|Treated|Overall Study||13
2297252|NCT02039674|5640813|P3|Treated|Overall Study||11
2297253|NCT02039674|5640814|P2|Treated|Overall Study||12
2297254|NCT02039674|5640815|P1|Treated|Overall Study||13
2297255|NCT02039674|5640802|P14|STARTED|Overall Study||33
2297256|NCT02039674|5640803|P13|STARTED|Overall Study||63
2297257|NCT02039674|5640804|P12|STARTED|Overall Study||60
2297258|NCT02039674|5640805|P11|STARTED|Overall Study||7
2297259|NCT02039674|5640806|P10|STARTED|Overall Study||12
2297260|NCT02039674|5640807|P9|STARTED|Overall Study||12
2297261|NCT02039674|5640808|P8|STARTED|Overall Study||3
2297262|NCT02039674|5640809|P7|STARTED|Overall Study||3
2297263|NCT02039674|5640810|P6|STARTED|Overall Study||12
2297264|NCT02039674|5640811|P5|STARTED|Overall Study||12
2297265|NCT02039674|5640812|P4|STARTED|Overall Study||13
2297266|NCT02039674|5640813|P3|STARTED|Overall Study||12
2297267|NCT02039674|5640814|P2|STARTED|Overall Study||12
2297268|NCT02039674|5640815|P1|STARTED|Overall Study||13
2297269|NCT02039505|5640857|P7|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||71
2297270|NCT02039505|5640858|P6|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
2297271|NCT02039505|5640859|P5|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
2297272|NCT02039505|5640860|P4|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
2297273|NCT02039505|5640861|P3|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
2297274|NCT02039505|5640862|P2|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
2297275|NCT02039505|5640863|P1|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
2297276|NCT02039505|5640857|P7|COMPLETED|Open-Label (Week 10 up to Week 154)||188
2297277|NCT02039505|5640858|P6|COMPLETED|Open-Label (Week 10 up to Week 154)||0
2297278|NCT02039505|5640859|P5|COMPLETED|Open-Label (Week 10 up to Week 154)||0
2297279|NCT02039505|5640860|P4|COMPLETED|Open-Label (Week 10 up to Week 154)||0
2297280|NCT02039505|5640861|P3|COMPLETED|Open-Label (Week 10 up to Week 154)||0
2297281|NCT02039505|5640862|P2|COMPLETED|Open-Label (Week 10 up to Week 154)||0
2297282|NCT02039505|5640863|P1|COMPLETED|Open-Label (Week 10 up to Week 154)||0
2297283|NCT02039505|5640857|P7|STARTED|Open-Label (Week 10 up to Week 154)||259
2297284|NCT02039505|5640858|P6|STARTED|Open-Label (Week 10 up to Week 154)||0
2297285|NCT02039505|5640859|P5|STARTED|Open-Label (Week 10 up to Week 154)||0
2297286|NCT02039505|5640860|P4|STARTED|Open-Label (Week 10 up to Week 154)||0
2297287|NCT02039505|5640861|P3|STARTED|Open-Label (Week 10 up to Week 154)||0
2297288|NCT02039505|5640862|P2|STARTED|Open-Label (Week 10 up to Week 154)||0
2297289|NCT02039505|5640863|P1|STARTED|Open-Label (Week 10 up to Week 154)||0
2297290|NCT02039505|5640857|P7|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
2297291|NCT02039505|5640858|P6|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||14
2297292|NCT02039505|5640859|P5|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||11
2297293|NCT02039505|5640860|P4|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||24
2297294|NCT02039505|5640861|P3|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
2297295|NCT02039505|5640862|P2|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
2297296|NCT02039505|5640863|P1|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
2297297|NCT02039505|5640857|P7|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
2297298|NCT02039505|5640858|P6|COMPLETED|Maintenance Phase (Week 14 to Week 60)||12
2297299|NCT02039505|5640859|P5|COMPLETED|Maintenance Phase (Week 14 to Week 60)||30
2297300|NCT02039505|5640860|P4|COMPLETED|Maintenance Phase (Week 14 to Week 60)||18
2297301|NCT02039505|5640861|P3|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
2297302|NCT02039505|5640862|P2|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
2297303|NCT02039505|5640863|P1|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
2297304|NCT02039505|5640857|P7|STARTED|Maintenance Phase (Week 14 to Week 60)||0
2297305|NCT02039505|5640858|P6|STARTED|Maintenance Phase (Week 14 to Week 60)||26
2297306|NCT02039505|5640859|P5|STARTED|Maintenance Phase (Week 14 to Week 60)||41
2297307|NCT02039505|5640860|P4|STARTED|Maintenance Phase (Week 14 to Week 60)||42
2297308|NCT02039505|5640861|P3|STARTED|Maintenance Phase (Week 14 to Week 60)||0
2297309|NCT02039505|5640862|P2|STARTED|Maintenance Phase (Week 14 to Week 60)||0
2297310|NCT02039505|5640863|P1|STARTED|Maintenance Phase (Week 14 to Week 60)||0
2297311|NCT02039505|5640857|P7|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
2297312|NCT02039505|5640858|P6|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
2297313|NCT02039505|5640859|P5|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
2297314|NCT02039505|5640860|P4|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
2297315|NCT02039505|5640861|P3|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||10
2297316|NCT02039505|5640862|P2|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||9
2297317|NCT02039505|5640863|P1|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||4
2297318|NCT02039505|5640857|P7|COMPLETED|Induction Phase (Week 0 to Week 14)||0
2297319|NCT02039505|5640858|P6|COMPLETED|Induction Phase (Week 0 to Week 14)||0
2297320|NCT02039505|5640859|P5|COMPLETED|Induction Phase (Week 0 to Week 14)||0
2297321|NCT02039505|5640860|P4|COMPLETED|Induction Phase (Week 0 to Week 14)||0
2297322|NCT02039505|5640861|P3|COMPLETED|Induction Phase (Week 0 to Week 14)||36
2297323|NCT02039505|5640862|P2|COMPLETED|Induction Phase (Week 0 to Week 14)||155
2297324|NCT02039505|5640863|P1|COMPLETED|Induction Phase (Week 0 to Week 14)||78
2297325|NCT02039505|5640857|P7|STARTED|Induction Phase (Week 0 to Week 14)||0
2297326|NCT02039505|5640858|P6|STARTED|Induction Phase (Week 0 to Week 14)||0
2297327|NCT02039505|5640859|P5|STARTED|Induction Phase (Week 0 to Week 14)||0
2297328|NCT02039505|5640860|P4|STARTED|Induction Phase (Week 0 to Week 14)||0
2297329|NCT02039505|5640861|P3|STARTED|Induction Phase (Week 0 to Week 14)||46
2297330|NCT02039505|5640862|P2|STARTED|Induction Phase (Week 0 to Week 14)||164
2297331|NCT02039505|5640863|P1|STARTED|Induction Phase (Week 0 to Week 14)||82
2297332|NCT02039427|5640939|P4|NOT COMPLETED|Overall Study||5
2297333|NCT02039427|5640940|P3|NOT COMPLETED|Overall Study||3
2297334|NCT02039427|5640941|P2|NOT COMPLETED|Overall Study||1
2297335|NCT02039427|5640942|P1|NOT COMPLETED|Overall Study||3
2297336|NCT02039427|5640939|P4|COMPLETED|Overall Study||43
2297337|NCT02039427|5640940|P3|COMPLETED|Overall Study||45
2297338|NCT02039427|5640941|P2|COMPLETED|Overall Study||47
2297339|NCT02039427|5640942|P1|COMPLETED|Overall Study||45
2297340|NCT02039427|5640939|P4|STARTED|Overall Study||48
2297341|NCT02039427|5640940|P3|STARTED|Overall Study||48
2297342|NCT02039427|5640941|P2|STARTED|Overall Study||48
2297343|NCT02039427|5640942|P1|STARTED|Overall Study||48
2297344|NCT02039414|5640962|P2|NOT COMPLETED|Overall Study||2
2297345|NCT02039414|5640963|P1|NOT COMPLETED|Overall Study||6
2297346|NCT02039414|5640962|P2|COMPLETED|Overall Study||16
2297347|NCT02039414|5640963|P1|COMPLETED|Overall Study||16
2297348|NCT02039414|5640962|P2|STARTED|Overall Study||18
2297349|NCT02039414|5640963|P1|STARTED|Overall Study||22
2297350|NCT02039219|5640977|P2|NOT COMPLETED|Follow up||1
2297351|NCT02039219|5640978|P1|NOT COMPLETED|Follow up||0
2297352|NCT02039219|5640977|P2|COMPLETED|Follow up||5
2297353|NCT02039219|5640978|P1|COMPLETED|Follow up||7
2297354|NCT02039219|5640977|P2|STARTED|Follow up||6
2297355|NCT02039219|5640978|P1|STARTED|Follow up||7
2297356|NCT02039219|5640977|P2|NOT COMPLETED|Treatment||2
2297357|NCT02039219|5640978|P1|NOT COMPLETED|Treatment||4
2297358|NCT02039219|5640977|P2|COMPLETED|Treatment||6
2297359|NCT02039219|5640978|P1|COMPLETED|Treatment||7
2297360|NCT02039219|5640977|P2|STARTED|Treatment||8
2297361|NCT02039219|5640978|P1|STARTED|Treatment||11
2297362|NCT02039115|5641018|P2|NOT COMPLETED|Overall Study||0
2297363|NCT02039115|5641019|P1|NOT COMPLETED|Overall Study||0
2297364|NCT02039115|5641018|P2|COMPLETED|Overall Study||0
2297365|NCT02039115|5641019|P1|COMPLETED|Overall Study||1
2297366|NCT02039115|5641018|P2|STARTED|Overall Study||0
2297367|NCT02039115|5641019|P1|STARTED|Overall Study||1
2297368|NCT02038959|5641027|P2|NOT COMPLETED|Overall Study||8
2297369|NCT02038959|5641028|P1|NOT COMPLETED|Overall Study||6
2297370|NCT02038959|5641027|P2|COMPLETED|Overall Study||89
2297371|NCT02038959|5641028|P1|COMPLETED|Overall Study||92
2297372|NCT02038959|5641027|P2|STARTED|Overall Study||97
2297373|NCT02038959|5641028|P1|STARTED|Overall Study||98
2297374|NCT02038946|5641054|P1|NOT COMPLETED|Overall Study||11
2297375|NCT02038946|5641054|P1|COMPLETED|Overall Study||81
2297376|NCT02038946|5641054|P1|STARTED|Overall Study||92
2297377|NCT02038933|5641065|P1|NOT COMPLETED|Follow-up||19
2297378|NCT02038933|5641065|P1|COMPLETED|Follow-up|Includes subjects still on-treatment and subjects off-treatment continuing in the Follow-up period.|102
2297379|NCT02038933|5641065|P1|STARTED|Follow-up||121
2297380|NCT02038933|5641065|P1|NOT COMPLETED|Treatment||114
2297381|NCT02038933|5641065|P1|COMPLETED|Treatment|Subjects continuing in the treatment period|7
2297382|NCT02038933|5641065|P1|STARTED|Treatment||121
2297383|NCT02038920|5641086|P6|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||77
2297384|NCT02038920|5641087|P5|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
2297385|NCT02038920|5641088|P4|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
2297386|NCT02038920|5641089|P3|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
2297387|NCT02038920|5641090|P2|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
2297388|NCT02038920|5641091|P1|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
2297389|NCT02038920|5641086|P6|COMPLETED|Open Label Cohort (Week 10 to 154)||57
2297390|NCT02038920|5641087|P5|COMPLETED|Open Label Cohort (Week 10 to 154)||0
2297391|NCT02038920|5641088|P4|COMPLETED|Open Label Cohort (Week 10 to 154)||0
2297392|NCT02038920|5641089|P3|COMPLETED|Open Label Cohort (Week 10 to 154)||0
2297393|NCT02038920|5641090|P2|COMPLETED|Open Label Cohort (Week 10 to 154)||0
2297394|NCT02038920|5641091|P1|COMPLETED|Open Label Cohort (Week 10 to 154)||0
2297395|NCT02038920|5641086|P6|STARTED|Open Label Cohort (Week 10 to 154)||134
2297396|NCT02038920|5641087|P5|STARTED|Open Label Cohort (Week 10 to 154)||0
2297397|NCT02038920|5641088|P4|STARTED|Open Label Cohort (Week 10 to 154)||0
2297398|NCT02038920|5641089|P3|STARTED|Open Label Cohort (Week 10 to 154)||0
2297399|NCT02038920|5641090|P2|STARTED|Open Label Cohort (Week 10 to 154)||0
2297400|NCT02038920|5641091|P1|STARTED|Open Label Cohort (Week 10 to 154)||0
2297401|NCT02038920|5641086|P6|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
2297402|NCT02038920|5641087|P5|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||12
2297403|NCT02038920|5641088|P4|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||8
2297404|NCT02038920|5641089|P3|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||5
2297405|NCT02038920|5641090|P2|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
2297406|NCT02038920|5641091|P1|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
2297407|NCT02038920|5641086|P6|COMPLETED|Maintenance Phase (Week 14 to 60)||0
2297408|NCT02038920|5641087|P5|COMPLETED|Maintenance Phase (Week 14 to 60)||5
2297409|NCT02038920|5641088|P4|COMPLETED|Maintenance Phase (Week 14 to 60)||4
2297410|NCT02038920|5641089|P3|COMPLETED|Maintenance Phase (Week 14 to 60)||7
2297411|NCT02038920|5641090|P2|COMPLETED|Maintenance Phase (Week 14 to 60)||0
2297412|NCT02038920|5641091|P1|COMPLETED|Maintenance Phase (Week 14 to 60)||0
2297413|NCT02038920|5641086|P6|STARTED|Maintenance Phase (Week 14 to 60)||0
2297414|NCT02038920|5641087|P5|STARTED|Maintenance Phase (Week 14 to 60)||17
2297415|NCT02038920|5641088|P4|STARTED|Maintenance Phase (Week 14 to 60)||12
2297416|NCT02038920|5641089|P3|STARTED|Maintenance Phase (Week 14 to 60)||12
2297417|NCT02038920|5641090|P2|STARTED|Maintenance Phase (Week 14 to 60)||0
2297418|NCT02038920|5641091|P1|STARTED|Maintenance Phase (Week 14 to 60)||0
2297419|NCT02038920|5641086|P6|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
2297420|NCT02038920|5641087|P5|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
2297421|NCT02038920|5641088|P4|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
2297422|NCT02038920|5641089|P3|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
2297423|NCT02038920|5641090|P2|NOT COMPLETED|Induction Phase (Week 0 to 14)||12
2297424|NCT02038920|5641091|P1|NOT COMPLETED|Induction Phase (Week 0 to 14)||6
2297425|NCT02038920|5641086|P6|COMPLETED|Induction Phase (Week 0 to 14)||0
2297426|NCT02038920|5641087|P5|COMPLETED|Induction Phase (Week 0 to 14)||0
2297427|NCT02038920|5641088|P4|COMPLETED|Induction Phase (Week 0 to 14)||0
2297428|NCT02038920|5641089|P3|COMPLETED|Induction Phase (Week 0 to 14)||0
2297429|NCT02038920|5641090|P2|COMPLETED|Induction Phase (Week 0 to 14)||66
2297430|NCT02038920|5641091|P1|COMPLETED|Induction Phase (Week 0 to 14)||73
2297431|NCT02038920|5641086|P6|STARTED|Induction Phase (Week 0 to 14)||0
2297432|NCT02038920|5641087|P5|STARTED|Induction Phase (Week 0 to 14)||0
2297433|NCT02038920|5641088|P4|STARTED|Induction Phase (Week 0 to 14)||0
2297434|NCT02038920|5641089|P3|STARTED|Induction Phase (Week 0 to 14)||0
2297435|NCT02038920|5641090|P2|STARTED|Induction Phase (Week 0 to 14)||78
2297436|NCT02038920|5641091|P1|STARTED|Induction Phase (Week 0 to 14)||79
2297437|NCT02038907|5641168|P14|NOT COMPLETED|Overall Study||0
2297438|NCT02038907|5641169|P13|NOT COMPLETED|Overall Study||0
2297439|NCT02038907|5641170|P12|NOT COMPLETED|Overall Study||0
2297440|NCT02038907|5641171|P11|NOT COMPLETED|Overall Study||2
2297441|NCT02038907|5641172|P10|NOT COMPLETED|Overall Study||0
2297442|NCT02038907|5641173|P9|NOT COMPLETED|Overall Study||0
2297443|NCT02038907|5641174|P8|NOT COMPLETED|Overall Study||0
2297444|NCT02038907|5641175|P7|NOT COMPLETED|Overall Study||0
2297445|NCT02038907|5641176|P6|NOT COMPLETED|Overall Study||0
2297446|NCT02038907|5641177|P5|NOT COMPLETED|Overall Study||0
2297447|NCT02038907|5641178|P4|NOT COMPLETED|Overall Study||0
2297448|NCT02038907|5641179|P3|NOT COMPLETED|Overall Study||0
2297449|NCT02038907|5641180|P2|NOT COMPLETED|Overall Study||0
2297450|NCT02038907|5641181|P1|NOT COMPLETED|Overall Study||0
2297451|NCT02038907|5641168|P14|COMPLETED|Overall Study||31
2297452|NCT02038907|5641169|P13|COMPLETED|Overall Study||29
2297453|NCT02038907|5641170|P12|COMPLETED|Overall Study||28
2297454|NCT02038907|5641171|P11|COMPLETED|Overall Study||27
2297455|NCT02038907|5641172|P10|COMPLETED|Overall Study||30
2297456|NCT02038907|5641173|P9|COMPLETED|Overall Study||29
2297457|NCT02038907|5641174|P8|COMPLETED|Overall Study||32
2297458|NCT02038907|5641175|P7|COMPLETED|Overall Study||30
2297459|NCT02038907|5641176|P6|COMPLETED|Overall Study||31
2297460|NCT02038907|5641177|P5|COMPLETED|Overall Study||30
2297461|NCT02038907|5641178|P4|COMPLETED|Overall Study||31
2297462|NCT02038907|5641179|P3|COMPLETED|Overall Study||30
2297463|NCT02038907|5641180|P2|COMPLETED|Overall Study||30
2297464|NCT02038907|5641181|P1|COMPLETED|Overall Study||30
2297465|NCT02038907|5641168|P14|STARTED|Overall Study||31
2297466|NCT02038907|5641169|P13|STARTED|Overall Study||29
2297467|NCT02038907|5641170|P12|STARTED|Overall Study||28
2297468|NCT02038907|5641171|P11|STARTED|Overall Study||29
2297469|NCT02038907|5641172|P10|STARTED|Overall Study||30
2297470|NCT02038907|5641173|P9|STARTED|Overall Study||29
2297471|NCT02038907|5641174|P8|STARTED|Overall Study||32
2297472|NCT02038907|5641175|P7|STARTED|Overall Study||30
2297473|NCT02038907|5641176|P6|STARTED|Overall Study||31
2297474|NCT02038907|5641177|P5|STARTED|Overall Study||30
2297475|NCT02038907|5641178|P4|STARTED|Overall Study||31
2297476|NCT02038907|5641179|P3|STARTED|Overall Study||30
2297477|NCT02038907|5641180|P2|STARTED|Overall Study||30
2297478|NCT02038907|5641181|P1|STARTED|Overall Study||30
2297479|NCT02038829|5641709|P12|NOT COMPLETED|Treatment Period 6||0
2297480|NCT02038829|5641710|P11|NOT COMPLETED|Treatment Period 6||0
2297481|NCT02038829|5641711|P10|NOT COMPLETED|Treatment Period 6||0
2297482|NCT02038829|5641712|P9|NOT COMPLETED|Treatment Period 6||0
2297483|NCT02038829|5641713|P8|NOT COMPLETED|Treatment Period 6||0
2297484|NCT02038829|5641714|P7|NOT COMPLETED|Treatment Period 6||0
2297485|NCT02038829|5641715|P6|NOT COMPLETED|Treatment Period 6||0
2297486|NCT02038829|5641716|P5|NOT COMPLETED|Treatment Period 6||0
2297487|NCT02038829|5641717|P4|NOT COMPLETED|Treatment Period 6||0
2297488|NCT02038829|5641718|P3|NOT COMPLETED|Treatment Period 6||1
2297489|NCT02038829|5641719|P2|NOT COMPLETED|Treatment Period 6||0
2297490|NCT02038829|5641720|P1|NOT COMPLETED|Treatment Period 6||0
2297491|NCT02038829|5641709|P12|COMPLETED|Treatment Period 6||8
2297492|NCT02038829|5641710|P11|COMPLETED|Treatment Period 6||7
2297493|NCT02038829|5641711|P10|COMPLETED|Treatment Period 6||8
2297494|NCT02038829|5641712|P9|COMPLETED|Treatment Period 6||7
2297495|NCT02038829|5641713|P8|COMPLETED|Treatment Period 6||8
2297496|NCT02038829|5641714|P7|COMPLETED|Treatment Period 6||7
2297497|NCT02038829|5641715|P6|COMPLETED|Treatment Period 6||7
2297498|NCT02038829|5641716|P5|COMPLETED|Treatment Period 6||7
2297499|NCT02038829|5641717|P4|COMPLETED|Treatment Period 6||8
2297500|NCT02038829|5641718|P3|COMPLETED|Treatment Period 6||7
2297501|NCT02038829|5641719|P2|COMPLETED|Treatment Period 6||7
2297502|NCT02038829|5641720|P1|COMPLETED|Treatment Period 6||7
2297503|NCT02038829|5641709|P12|STARTED|Treatment Period 6||8
2297504|NCT02038829|5641710|P11|STARTED|Treatment Period 6||7
2297505|NCT02038829|5641711|P10|STARTED|Treatment Period 6||8
2297506|NCT02038829|5641712|P9|STARTED|Treatment Period 6||7
2297507|NCT02038829|5641713|P8|STARTED|Treatment Period 6||8
2297508|NCT02038829|5641714|P7|STARTED|Treatment Period 6||7
2297509|NCT02038829|5641715|P6|STARTED|Treatment Period 6||7
2297510|NCT02038829|5641716|P5|STARTED|Treatment Period 6||7
2297511|NCT02038829|5641717|P4|STARTED|Treatment Period 6||8
2297512|NCT02038829|5641718|P3|STARTED|Treatment Period 6||8
2297513|NCT02038829|5641719|P2|STARTED|Treatment Period 6||7
2297514|NCT02038829|5641720|P1|STARTED|Treatment Period 6||7
2297515|NCT02038829|5641709|P12|NOT COMPLETED|Washout Period 5||0
2297516|NCT02038829|5641710|P11|NOT COMPLETED|Washout Period 5||0
2297517|NCT02038829|5641711|P10|NOT COMPLETED|Washout Period 5||0
2297518|NCT02038829|5641712|P9|NOT COMPLETED|Washout Period 5||0
2297519|NCT02038829|5641713|P8|NOT COMPLETED|Washout Period 5||0
2297520|NCT02038829|5641714|P7|NOT COMPLETED|Washout Period 5||0
2297521|NCT02038829|5641715|P6|NOT COMPLETED|Washout Period 5||0
2297522|NCT02038829|5641716|P5|NOT COMPLETED|Washout Period 5||0
2297523|NCT02038829|5641717|P4|NOT COMPLETED|Washout Period 5||0
2297524|NCT02038829|5641718|P3|NOT COMPLETED|Washout Period 5||0
2297525|NCT02038829|5641719|P2|NOT COMPLETED|Washout Period 5||0
2297526|NCT02038829|5641720|P1|NOT COMPLETED|Washout Period 5||0
2297527|NCT02038829|5641709|P12|COMPLETED|Washout Period 5||8
2297528|NCT02038829|5641710|P11|COMPLETED|Washout Period 5||7
2297529|NCT02038829|5641711|P10|COMPLETED|Washout Period 5||8
2297530|NCT02038829|5641712|P9|COMPLETED|Washout Period 5||7
2297531|NCT02038829|5641713|P8|COMPLETED|Washout Period 5||8
2297532|NCT02038829|5641714|P7|COMPLETED|Washout Period 5||7
2297533|NCT02038829|5641715|P6|COMPLETED|Washout Period 5||7
2297534|NCT02038829|5641716|P5|COMPLETED|Washout Period 5||7
2297535|NCT02038829|5641717|P4|COMPLETED|Washout Period 5||8
2297536|NCT02038829|5641718|P3|COMPLETED|Washout Period 5||8
2297537|NCT02038829|5641719|P2|COMPLETED|Washout Period 5||7
2297538|NCT02038829|5641720|P1|COMPLETED|Washout Period 5||7
2297539|NCT02038829|5641709|P12|STARTED|Washout Period 5||8
2297540|NCT02038829|5641710|P11|STARTED|Washout Period 5||7
2297541|NCT02038829|5641711|P10|STARTED|Washout Period 5||8
2297542|NCT02038829|5641712|P9|STARTED|Washout Period 5||7
2297543|NCT02038829|5641713|P8|STARTED|Washout Period 5||8
2297544|NCT02038829|5641714|P7|STARTED|Washout Period 5||7
2297545|NCT02038829|5641715|P6|STARTED|Washout Period 5||7
2297546|NCT02038829|5641716|P5|STARTED|Washout Period 5||7
2297547|NCT02038829|5641717|P4|STARTED|Washout Period 5||8
2297548|NCT02038829|5641718|P3|STARTED|Washout Period 5||8
2297549|NCT02038829|5641719|P2|STARTED|Washout Period 5||7
2297550|NCT02038829|5641720|P1|STARTED|Washout Period 5||7
2297551|NCT02038829|5641709|P12|NOT COMPLETED|Treatment Period 5||0
2297552|NCT02038829|5641710|P11|NOT COMPLETED|Treatment Period 5||0
2297553|NCT02038829|5641711|P10|NOT COMPLETED|Treatment Period 5||0
2297554|NCT02038829|5641712|P9|NOT COMPLETED|Treatment Period 5||0
2297555|NCT02038829|5641713|P8|NOT COMPLETED|Treatment Period 5||0
2297556|NCT02038829|5641714|P7|NOT COMPLETED|Treatment Period 5||0
2297557|NCT02038829|5641715|P6|NOT COMPLETED|Treatment Period 5||0
2297558|NCT02038829|5641716|P5|NOT COMPLETED|Treatment Period 5||0
2297559|NCT02038829|5641717|P4|NOT COMPLETED|Treatment Period 5||0
2297560|NCT02038829|5641718|P3|NOT COMPLETED|Treatment Period 5||0
2297561|NCT02038829|5641719|P2|NOT COMPLETED|Treatment Period 5||0
2297562|NCT02038829|5641720|P1|NOT COMPLETED|Treatment Period 5||0
2297563|NCT02038829|5641709|P12|COMPLETED|Treatment Period 5||8
2297564|NCT02038829|5641710|P11|COMPLETED|Treatment Period 5||7
2297565|NCT02038829|5641711|P10|COMPLETED|Treatment Period 5||8
2297566|NCT02038829|5641712|P9|COMPLETED|Treatment Period 5||7
2297567|NCT02038829|5641713|P8|COMPLETED|Treatment Period 5||8
2297568|NCT02038829|5641714|P7|COMPLETED|Treatment Period 5||7
2297569|NCT02038829|5641715|P6|COMPLETED|Treatment Period 5||7
2297570|NCT02038829|5641716|P5|COMPLETED|Treatment Period 5||7
2297571|NCT02038829|5641717|P4|COMPLETED|Treatment Period 5||8
2297572|NCT02038829|5641718|P3|COMPLETED|Treatment Period 5||8
2297573|NCT02038829|5641719|P2|COMPLETED|Treatment Period 5||7
2297574|NCT02038829|5641720|P1|COMPLETED|Treatment Period 5||7
2297575|NCT02038829|5641709|P12|STARTED|Treatment Period 5||8
2297576|NCT02038829|5641710|P11|STARTED|Treatment Period 5||7
2297577|NCT02038829|5641711|P10|STARTED|Treatment Period 5||8
2297578|NCT02038829|5641712|P9|STARTED|Treatment Period 5||7
2297579|NCT02038829|5641713|P8|STARTED|Treatment Period 5||8
2297580|NCT02038829|5641714|P7|STARTED|Treatment Period 5||7
2297581|NCT02038829|5641715|P6|STARTED|Treatment Period 5||7
2297582|NCT02038829|5641716|P5|STARTED|Treatment Period 5||7
2297583|NCT02038829|5641717|P4|STARTED|Treatment Period 5||8
2297584|NCT02038829|5641718|P3|STARTED|Treatment Period 5||8
2297585|NCT02038829|5641719|P2|STARTED|Treatment Period 5||7
2297586|NCT02038829|5641720|P1|STARTED|Treatment Period 5||7
2297587|NCT02038829|5641709|P12|NOT COMPLETED|Washout Period 4||0
2297588|NCT02038829|5641710|P11|NOT COMPLETED|Washout Period 4||0
2297589|NCT02038829|5641711|P10|NOT COMPLETED|Washout Period 4||0
2297590|NCT02038829|5641712|P9|NOT COMPLETED|Washout Period 4||0
2297591|NCT02038829|5641713|P8|NOT COMPLETED|Washout Period 4||0
2297592|NCT02038829|5641714|P7|NOT COMPLETED|Washout Period 4||1
2297593|NCT02038829|5641715|P6|NOT COMPLETED|Washout Period 4||0
2297594|NCT02038829|5641716|P5|NOT COMPLETED|Washout Period 4||0
2297595|NCT02038829|5641717|P4|NOT COMPLETED|Washout Period 4||0
2297596|NCT02038829|5641718|P3|NOT COMPLETED|Washout Period 4||0
2297597|NCT02038829|5641719|P2|NOT COMPLETED|Washout Period 4||0
2297598|NCT02038829|5641720|P1|NOT COMPLETED|Washout Period 4||0
2297599|NCT02038829|5641709|P12|COMPLETED|Washout Period 4||8
2297600|NCT02038829|5641710|P11|COMPLETED|Washout Period 4||7
2297601|NCT02038829|5641711|P10|COMPLETED|Washout Period 4||8
2297602|NCT02038829|5641712|P9|COMPLETED|Washout Period 4||7
2297603|NCT02038829|5641713|P8|COMPLETED|Washout Period 4||8
2297604|NCT02038829|5641714|P7|COMPLETED|Washout Period 4||7
2297605|NCT02038829|5641715|P6|COMPLETED|Washout Period 4||7
2297606|NCT02038829|5641716|P5|COMPLETED|Washout Period 4||7
2297607|NCT02038829|5641717|P4|COMPLETED|Washout Period 4||8
2297608|NCT02038829|5641718|P3|COMPLETED|Washout Period 4||8
2297609|NCT02038829|5641719|P2|COMPLETED|Washout Period 4||7
2297610|NCT02038829|5641720|P1|COMPLETED|Washout Period 4||7
2297611|NCT02038829|5641709|P12|STARTED|Washout Period 4||8
2297612|NCT02038829|5641710|P11|STARTED|Washout Period 4||7
2297613|NCT02038829|5641711|P10|STARTED|Washout Period 4||8
2297614|NCT02038829|5641712|P9|STARTED|Washout Period 4||7
2297615|NCT02038829|5641713|P8|STARTED|Washout Period 4||8
2297616|NCT02038829|5641714|P7|STARTED|Washout Period 4||8
2297617|NCT02038829|5641715|P6|STARTED|Washout Period 4||7
2297618|NCT02038829|5641716|P5|STARTED|Washout Period 4||7
2297619|NCT02038829|5641717|P4|STARTED|Washout Period 4||8
2297620|NCT02038829|5641718|P3|STARTED|Washout Period 4||8
2297621|NCT02038829|5641719|P2|STARTED|Washout Period 4||7
2297622|NCT02038829|5641720|P1|STARTED|Washout Period 4||7
2297623|NCT02038829|5641709|P12|NOT COMPLETED|Treatment Period 4||0
2297624|NCT02038829|5641710|P11|NOT COMPLETED|Treatment Period 4||0
2297625|NCT02038829|5641711|P10|NOT COMPLETED|Treatment Period 4||0
2297626|NCT02038829|5641712|P9|NOT COMPLETED|Treatment Period 4||0
2297627|NCT02038829|5641713|P8|NOT COMPLETED|Treatment Period 4||0
2297628|NCT02038829|5641714|P7|NOT COMPLETED|Treatment Period 4||0
2297629|NCT02038829|5641715|P6|NOT COMPLETED|Treatment Period 4||0
2297630|NCT02038829|5641716|P5|NOT COMPLETED|Treatment Period 4||0
2297631|NCT02038829|5641717|P4|NOT COMPLETED|Treatment Period 4||0
2297632|NCT02038829|5641718|P3|NOT COMPLETED|Treatment Period 4||0
2297633|NCT02038829|5641719|P2|NOT COMPLETED|Treatment Period 4||1
2297634|NCT02038829|5641720|P1|NOT COMPLETED|Treatment Period 4||0
2297635|NCT02038829|5641709|P12|COMPLETED|Treatment Period 4||8
2297636|NCT02038829|5641710|P11|COMPLETED|Treatment Period 4||7
2297637|NCT02038829|5641711|P10|COMPLETED|Treatment Period 4||8
2297638|NCT02038829|5641712|P9|COMPLETED|Treatment Period 4||7
2297639|NCT02038829|5641713|P8|COMPLETED|Treatment Period 4||8
2297640|NCT02038829|5641714|P7|COMPLETED|Treatment Period 4||8
2297641|NCT02038829|5641715|P6|COMPLETED|Treatment Period 4||7
2297642|NCT02038829|5641716|P5|COMPLETED|Treatment Period 4||7
2297643|NCT02038829|5641717|P4|COMPLETED|Treatment Period 4||8
2297644|NCT02038829|5641718|P3|COMPLETED|Treatment Period 4||8
2297645|NCT02038829|5641719|P2|COMPLETED|Treatment Period 4||7
2297646|NCT02038829|5641720|P1|COMPLETED|Treatment Period 4||7
2297647|NCT02038829|5641709|P12|STARTED|Treatment Period 4||8
2297648|NCT02038829|5641710|P11|STARTED|Treatment Period 4||7
2297649|NCT02038829|5641711|P10|STARTED|Treatment Period 4||8
2297650|NCT02038829|5641712|P9|STARTED|Treatment Period 4||7
2297651|NCT02038829|5641713|P8|STARTED|Treatment Period 4||8
2297652|NCT02038829|5641714|P7|STARTED|Treatment Period 4||8
2297653|NCT02038829|5641715|P6|STARTED|Treatment Period 4||7
2297654|NCT02038829|5641716|P5|STARTED|Treatment Period 4||7
2297655|NCT02038829|5641717|P4|STARTED|Treatment Period 4||8
2297656|NCT02038829|5641718|P3|STARTED|Treatment Period 4||8
2297657|NCT02038829|5641719|P2|STARTED|Treatment Period 4||8
2297658|NCT02038829|5641720|P1|STARTED|Treatment Period 4||7
2297659|NCT02038829|5641709|P12|NOT COMPLETED|Washout Period 3||0
2297660|NCT02038829|5641710|P11|NOT COMPLETED|Washout Period 3||0
2297661|NCT02038829|5641711|P10|NOT COMPLETED|Washout Period 3||0
2297662|NCT02038829|5641712|P9|NOT COMPLETED|Washout Period 3||0
2297663|NCT02038829|5641713|P8|NOT COMPLETED|Washout Period 3||0
2297664|NCT02038829|5641714|P7|NOT COMPLETED|Washout Period 3||0
2297665|NCT02038829|5641715|P6|NOT COMPLETED|Washout Period 3||0
2297666|NCT02038829|5641716|P5|NOT COMPLETED|Washout Period 3||0
2297667|NCT02038829|5641717|P4|NOT COMPLETED|Washout Period 3||0
2297668|NCT02038829|5641718|P3|NOT COMPLETED|Washout Period 3||0
2297669|NCT02038829|5641719|P2|NOT COMPLETED|Washout Period 3||0
2297670|NCT02038829|5641720|P1|NOT COMPLETED|Washout Period 3||0
2297671|NCT02038829|5641709|P12|COMPLETED|Washout Period 3||8
2297672|NCT02038829|5641710|P11|COMPLETED|Washout Period 3||7
2297673|NCT02038829|5641711|P10|COMPLETED|Washout Period 3||8
2297674|NCT02038829|5641712|P9|COMPLETED|Washout Period 3||7
2297675|NCT02038829|5641713|P8|COMPLETED|Washout Period 3||8
2297676|NCT02038829|5641714|P7|COMPLETED|Washout Period 3||8
2297677|NCT02038829|5641715|P6|COMPLETED|Washout Period 3||7
2297678|NCT02038829|5641716|P5|COMPLETED|Washout Period 3||7
2297679|NCT02038829|5641717|P4|COMPLETED|Washout Period 3||8
2297680|NCT02038829|5641718|P3|COMPLETED|Washout Period 3||8
2297681|NCT02038829|5641719|P2|COMPLETED|Washout Period 3||8
2297682|NCT02038829|5641720|P1|COMPLETED|Washout Period 3||7
2297683|NCT02038829|5641709|P12|STARTED|Washout Period 3||8
2297684|NCT02038829|5641710|P11|STARTED|Washout Period 3||7
2297685|NCT02038829|5641711|P10|STARTED|Washout Period 3||8
2297686|NCT02038829|5641712|P9|STARTED|Washout Period 3||7
2297687|NCT02038829|5641713|P8|STARTED|Washout Period 3||8
2297688|NCT02038829|5641714|P7|STARTED|Washout Period 3||8
2297689|NCT02038829|5641715|P6|STARTED|Washout Period 3||7
2297690|NCT02038829|5641716|P5|STARTED|Washout Period 3||7
2297691|NCT02038829|5641717|P4|STARTED|Washout Period 3||8
2297692|NCT02038829|5641718|P3|STARTED|Washout Period 3||8
2297693|NCT02038829|5641719|P2|STARTED|Washout Period 3||8
2297694|NCT02038829|5641720|P1|STARTED|Washout Period 3||7
2297695|NCT02038829|5641709|P12|NOT COMPLETED|Treatment Period 3||0
2297696|NCT02038829|5641710|P11|NOT COMPLETED|Treatment Period 3||0
2297697|NCT02038829|5641711|P10|NOT COMPLETED|Treatment Period 3||0
2297698|NCT02038829|5641712|P9|NOT COMPLETED|Treatment Period 3||0
2297699|NCT02038829|5641713|P8|NOT COMPLETED|Treatment Period 3||0
2297700|NCT02038829|5641714|P7|NOT COMPLETED|Treatment Period 3||0
2297701|NCT02038829|5641715|P6|NOT COMPLETED|Treatment Period 3||0
2297702|NCT02038829|5641716|P5|NOT COMPLETED|Treatment Period 3||0
2297703|NCT02038829|5641717|P4|NOT COMPLETED|Treatment Period 3||0
2297704|NCT02038829|5641718|P3|NOT COMPLETED|Treatment Period 3||0
2297705|NCT02038829|5641719|P2|NOT COMPLETED|Treatment Period 3||0
2297706|NCT02038829|5641720|P1|NOT COMPLETED|Treatment Period 3||0
2297707|NCT02038829|5641709|P12|COMPLETED|Treatment Period 3||8
2297708|NCT02038829|5641710|P11|COMPLETED|Treatment Period 3||7
2297709|NCT02038829|5641711|P10|COMPLETED|Treatment Period 3||8
2297710|NCT02038829|5641712|P9|COMPLETED|Treatment Period 3||7
2297711|NCT02038829|5641713|P8|COMPLETED|Treatment Period 3||8
2297712|NCT02038829|5641714|P7|COMPLETED|Treatment Period 3||8
2297713|NCT02038829|5641715|P6|COMPLETED|Treatment Period 3||7
2297714|NCT02038829|5641716|P5|COMPLETED|Treatment Period 3||7
2297715|NCT02038829|5641717|P4|COMPLETED|Treatment Period 3||8
2297716|NCT02038829|5641718|P3|COMPLETED|Treatment Period 3||8
2297717|NCT02038829|5641719|P2|COMPLETED|Treatment Period 3||8
2297718|NCT02038829|5641720|P1|COMPLETED|Treatment Period 3||7
2297719|NCT02038829|5641709|P12|STARTED|Treatment Period 3||8
2297720|NCT02038829|5641710|P11|STARTED|Treatment Period 3||7
2297721|NCT02038829|5641711|P10|STARTED|Treatment Period 3||8
2297722|NCT02038829|5641712|P9|STARTED|Treatment Period 3||7
2297723|NCT02038829|5641713|P8|STARTED|Treatment Period 3||8
2297724|NCT02038829|5641714|P7|STARTED|Treatment Period 3||8
2297725|NCT02038829|5641715|P6|STARTED|Treatment Period 3||7
2297726|NCT02038829|5641716|P5|STARTED|Treatment Period 3||7
2297727|NCT02038829|5641717|P4|STARTED|Treatment Period 3||8
2297728|NCT02038829|5641718|P3|STARTED|Treatment Period 3||8
2297729|NCT02038829|5641719|P2|STARTED|Treatment Period 3||8
2297730|NCT02038829|5641720|P1|STARTED|Treatment Period 3||7
2297731|NCT02038829|5641709|P12|NOT COMPLETED|Washout Period 2||0
2297732|NCT02038829|5641710|P11|NOT COMPLETED|Washout Period 2||0
2297733|NCT02038829|5641711|P10|NOT COMPLETED|Washout Period 2||0
2297734|NCT02038829|5641712|P9|NOT COMPLETED|Washout Period 2||1
2297735|NCT02038829|5641713|P8|NOT COMPLETED|Washout Period 2||0
2297736|NCT02038829|5641714|P7|NOT COMPLETED|Washout Period 2||0
2297737|NCT02038829|5641715|P6|NOT COMPLETED|Washout Period 2||1
2297738|NCT02038829|5641716|P5|NOT COMPLETED|Washout Period 2||0
2297739|NCT02038829|5641717|P4|NOT COMPLETED|Washout Period 2||0
2297740|NCT02038829|5641718|P3|NOT COMPLETED|Washout Period 2||0
2297741|NCT02038829|5641719|P2|NOT COMPLETED|Washout Period 2||0
2297742|NCT02038829|5641720|P1|NOT COMPLETED|Washout Period 2||0
2297743|NCT02038829|5641709|P12|COMPLETED|Washout Period 2||8
2297744|NCT02038829|5641710|P11|COMPLETED|Washout Period 2||7
2297745|NCT02038829|5641711|P10|COMPLETED|Washout Period 2||8
2297746|NCT02038829|5641712|P9|COMPLETED|Washout Period 2||7
2297747|NCT02038829|5641713|P8|COMPLETED|Washout Period 2||8
2297748|NCT02038829|5641714|P7|COMPLETED|Washout Period 2||8
2297749|NCT02038829|5641715|P6|COMPLETED|Washout Period 2||7
2297750|NCT02038829|5641716|P5|COMPLETED|Washout Period 2||7
2297751|NCT02038829|5641717|P4|COMPLETED|Washout Period 2||8
2297752|NCT02038829|5641718|P3|COMPLETED|Washout Period 2||8
2297753|NCT02038829|5641719|P2|COMPLETED|Washout Period 2||8
2297754|NCT02038829|5641720|P1|COMPLETED|Washout Period 2||7
2297755|NCT02038829|5641709|P12|STARTED|Washout Period 2||8
2297756|NCT02038829|5641710|P11|STARTED|Washout Period 2||7
2297757|NCT02038829|5641711|P10|STARTED|Washout Period 2||8
2297758|NCT02038829|5641712|P9|STARTED|Washout Period 2||8
2297759|NCT02038829|5641713|P8|STARTED|Washout Period 2||8
2297760|NCT02038829|5641714|P7|STARTED|Washout Period 2||8
2297761|NCT02038829|5641715|P6|STARTED|Washout Period 2||8
2297762|NCT02038829|5641716|P5|STARTED|Washout Period 2||7
2297763|NCT02038829|5641717|P4|STARTED|Washout Period 2||8
2297764|NCT02038829|5641718|P3|STARTED|Washout Period 2||8
2297765|NCT02038829|5641719|P2|STARTED|Washout Period 2||8
2297766|NCT02038829|5641720|P1|STARTED|Washout Period 2||7
2297767|NCT02038829|5641709|P12|NOT COMPLETED|Treatment Period 2||0
2297768|NCT02038829|5641710|P11|NOT COMPLETED|Treatment Period 2||1
2297769|NCT02038829|5641711|P10|NOT COMPLETED|Treatment Period 2||0
2297770|NCT02038829|5641712|P9|NOT COMPLETED|Treatment Period 2||0
2297771|NCT02038829|5641713|P8|NOT COMPLETED|Treatment Period 2||0
2297772|NCT02038829|5641714|P7|NOT COMPLETED|Treatment Period 2||0
2297773|NCT02038829|5641715|P6|NOT COMPLETED|Treatment Period 2||0
2297774|NCT02038829|5641716|P5|NOT COMPLETED|Treatment Period 2||0
2297775|NCT02038829|5641717|P4|NOT COMPLETED|Treatment Period 2||0
2297776|NCT02038829|5641718|P3|NOT COMPLETED|Treatment Period 2||0
2297777|NCT02038829|5641719|P2|NOT COMPLETED|Treatment Period 2||0
2297778|NCT02038829|5641720|P1|NOT COMPLETED|Treatment Period 2||1
2297779|NCT02038829|5641709|P12|COMPLETED|Treatment Period 2||8
2297780|NCT02038829|5641710|P11|COMPLETED|Treatment Period 2||7
2297781|NCT02038829|5641711|P10|COMPLETED|Treatment Period 2||8
2297782|NCT02038829|5641712|P9|COMPLETED|Treatment Period 2||8
2297783|NCT02038829|5641713|P8|COMPLETED|Treatment Period 2||8
2297784|NCT02038829|5641714|P7|COMPLETED|Treatment Period 2||8
2297785|NCT02038829|5641715|P6|COMPLETED|Treatment Period 2||8
2297786|NCT02038829|5641716|P5|COMPLETED|Treatment Period 2||7
2297787|NCT02038829|5641717|P4|COMPLETED|Treatment Period 2||8
2297788|NCT02038829|5641718|P3|COMPLETED|Treatment Period 2||8
2297789|NCT02038829|5641719|P2|COMPLETED|Treatment Period 2||8
2297790|NCT02038829|5641720|P1|COMPLETED|Treatment Period 2||7
2297791|NCT02038829|5641709|P12|STARTED|Treatment Period 2||8
2297792|NCT02038829|5641710|P11|STARTED|Treatment Period 2||8
2297793|NCT02038829|5641711|P10|STARTED|Treatment Period 2||8
2297794|NCT02038829|5641712|P9|STARTED|Treatment Period 2||8
2297795|NCT02038829|5641713|P8|STARTED|Treatment Period 2||8
2297796|NCT02038829|5641714|P7|STARTED|Treatment Period 2||8
2297797|NCT02038829|5641715|P6|STARTED|Treatment Period 2||8
2297798|NCT02038829|5641716|P5|STARTED|Treatment Period 2||7
2297799|NCT02038829|5641717|P4|STARTED|Treatment Period 2||8
2297800|NCT02038829|5641718|P3|STARTED|Treatment Period 2||8
2297801|NCT02038829|5641719|P2|STARTED|Treatment Period 2||8
2297802|NCT02038829|5641720|P1|STARTED|Treatment Period 2||8
2297803|NCT02038829|5641709|P12|NOT COMPLETED|Washout Period 1||0
2297804|NCT02038829|5641710|P11|NOT COMPLETED|Washout Period 1||0
2297805|NCT02038829|5641711|P10|NOT COMPLETED|Washout Period 1||0
2297806|NCT02038829|5641712|P9|NOT COMPLETED|Washout Period 1||0
2297807|NCT02038829|5641713|P8|NOT COMPLETED|Washout Period 1||0
2297808|NCT02038829|5641714|P7|NOT COMPLETED|Washout Period 1||0
2297809|NCT02038829|5641715|P6|NOT COMPLETED|Washout Period 1||0
2297810|NCT02038829|5641716|P5|NOT COMPLETED|Washout Period 1||1
2297811|NCT02038829|5641717|P4|NOT COMPLETED|Washout Period 1||0
2297812|NCT02038829|5641718|P3|NOT COMPLETED|Washout Period 1||0
2297813|NCT02038829|5641719|P2|NOT COMPLETED|Washout Period 1||0
2297814|NCT02038829|5641720|P1|NOT COMPLETED|Washout Period 1||0
2297815|NCT02038829|5641709|P12|COMPLETED|Washout Period 1||8
2297816|NCT02038829|5641710|P11|COMPLETED|Washout Period 1||8
2297817|NCT02038829|5641711|P10|COMPLETED|Washout Period 1||8
2297818|NCT02038829|5641712|P9|COMPLETED|Washout Period 1||8
2297819|NCT02038829|5641713|P8|COMPLETED|Washout Period 1||8
2297820|NCT02038829|5641714|P7|COMPLETED|Washout Period 1||8
2297821|NCT02038829|5641715|P6|COMPLETED|Washout Period 1||8
2297822|NCT02038829|5641716|P5|COMPLETED|Washout Period 1||7
2297823|NCT02038829|5641717|P4|COMPLETED|Washout Period 1||8
2297824|NCT02038829|5641718|P3|COMPLETED|Washout Period 1||8
2297825|NCT02038829|5641719|P2|COMPLETED|Washout Period 1||8
2297826|NCT02038829|5641720|P1|COMPLETED|Washout Period 1||8
2297827|NCT02038829|5641709|P12|STARTED|Washout Period 1||8
2297828|NCT02038829|5641710|P11|STARTED|Washout Period 1||8
2297829|NCT02038829|5641711|P10|STARTED|Washout Period 1||8
2297830|NCT02038829|5641712|P9|STARTED|Washout Period 1||8
2297831|NCT02038829|5641713|P8|STARTED|Washout Period 1||8
2297832|NCT02038829|5641714|P7|STARTED|Washout Period 1||8
2297833|NCT02038829|5641715|P6|STARTED|Washout Period 1||8
2297834|NCT02038829|5641716|P5|STARTED|Washout Period 1||8
2297835|NCT02038829|5641717|P4|STARTED|Washout Period 1||8
2297836|NCT02038829|5641718|P3|STARTED|Washout Period 1||8
2297837|NCT02038829|5641719|P2|STARTED|Washout Period 1||8
2297838|NCT02038829|5641720|P1|STARTED|Washout Period 1||8
2297839|NCT02038829|5641709|P12|NOT COMPLETED|Treatment Period 1||0
2297840|NCT02038829|5641710|P11|NOT COMPLETED|Treatment Period 1||0
2297841|NCT02038829|5641711|P10|NOT COMPLETED|Treatment Period 1||0
2297842|NCT02038829|5641712|P9|NOT COMPLETED|Treatment Period 1||0
2297843|NCT02038829|5641713|P8|NOT COMPLETED|Treatment Period 1||0
2297844|NCT02038829|5641714|P7|NOT COMPLETED|Treatment Period 1||0
2297845|NCT02038829|5641715|P6|NOT COMPLETED|Treatment Period 1||0
2297846|NCT02038829|5641716|P5|NOT COMPLETED|Treatment Period 1||0
2297847|NCT02038829|5641717|P4|NOT COMPLETED|Treatment Period 1||0
2297848|NCT02038829|5641718|P3|NOT COMPLETED|Treatment Period 1||0
2297849|NCT02038829|5641719|P2|NOT COMPLETED|Treatment Period 1||0
2297850|NCT02038829|5641720|P1|NOT COMPLETED|Treatment Period 1||0
2297851|NCT02038829|5641709|P12|COMPLETED|Treatment Period 1||8
2297852|NCT02038829|5641710|P11|COMPLETED|Treatment Period 1||8
2297853|NCT02038829|5641711|P10|COMPLETED|Treatment Period 1||8
2297854|NCT02038829|5641712|P9|COMPLETED|Treatment Period 1||8
2297855|NCT02038829|5641713|P8|COMPLETED|Treatment Period 1||8
2297856|NCT02038829|5641714|P7|COMPLETED|Treatment Period 1||8
2297857|NCT02038829|5641715|P6|COMPLETED|Treatment Period 1||8
2297858|NCT02038829|5641716|P5|COMPLETED|Treatment Period 1||8
2297859|NCT02038829|5641717|P4|COMPLETED|Treatment Period 1||8
2297860|NCT02038829|5641718|P3|COMPLETED|Treatment Period 1||8
2297861|NCT02038829|5641719|P2|COMPLETED|Treatment Period 1||8
2297862|NCT02038829|5641720|P1|COMPLETED|Treatment Period 1||8
2297863|NCT02038829|5641709|P12|STARTED|Treatment Period 1||8
2297864|NCT02038829|5641710|P11|STARTED|Treatment Period 1||8
2297865|NCT02038829|5641711|P10|STARTED|Treatment Period 1||8
2297866|NCT02038829|5641712|P9|STARTED|Treatment Period 1||8
2297867|NCT02038829|5641713|P8|STARTED|Treatment Period 1||8
2297868|NCT02038829|5641714|P7|STARTED|Treatment Period 1||8
2297869|NCT02038829|5641715|P6|STARTED|Treatment Period 1||8
2297870|NCT02038829|5641716|P5|STARTED|Treatment Period 1||8
2297871|NCT02038829|5641717|P4|STARTED|Treatment Period 1||8
2297872|NCT02038829|5641718|P3|STARTED|Treatment Period 1||8
2297873|NCT02038829|5641719|P2|STARTED|Treatment Period 1||8
2297874|NCT02038829|5641720|P1|STARTED|Treatment Period 1||8
2297875|NCT02038790|5641754|P2|NOT COMPLETED|Day 1 - Second Treatment||0
2297876|NCT02038790|5641755|P1|NOT COMPLETED|Day 1 - Second Treatment||0
2297877|NCT02038790|5641754|P2|COMPLETED|Day 1 - Second Treatment||16
2297878|NCT02038790|5641755|P1|COMPLETED|Day 1 - Second Treatment||15
2297879|NCT02038790|5641754|P2|STARTED|Day 1 - Second Treatment||16
2297880|NCT02038790|5641755|P1|STARTED|Day 1 - Second Treatment||15
2297881|NCT02038790|5641754|P2|NOT COMPLETED|Day 0 - First Treatment||1
2297882|NCT02038790|5641755|P1|NOT COMPLETED|Day 0 - First Treatment||1
2297883|NCT02038790|5641754|P2|COMPLETED|Day 0 - First Treatment||16
2297884|NCT02038790|5641755|P1|COMPLETED|Day 0 - First Treatment||15
2297885|NCT02038790|5641754|P2|STARTED|Day 0 - First Treatment||17
2297886|NCT02038790|5641755|P1|STARTED|Day 0 - First Treatment||16
2297887|NCT02038764|5641791|P5|NOT COMPLETED|Overall Study||1
2297888|NCT02038764|5641792|P4|NOT COMPLETED|Overall Study||0
2297889|NCT02038764|5641793|P3|NOT COMPLETED|Overall Study||2
2297890|NCT02038764|5641794|P2|NOT COMPLETED|Overall Study||1
2297891|NCT02038764|5641795|P1|NOT COMPLETED|Overall Study||1
2297892|NCT02038764|5641791|P5|COMPLETED|Overall Study||7
2297893|NCT02038764|5641792|P4|COMPLETED|Overall Study||5
2297894|NCT02038764|5641793|P3|COMPLETED|Overall Study||7
2297895|NCT02038764|5641794|P2|COMPLETED|Overall Study||7
2297896|NCT02038764|5641795|P1|COMPLETED|Overall Study||6
2297897|NCT02038764|5641791|P5|STARTED|Overall Study||8
2297898|NCT02038764|5641792|P4|STARTED|Overall Study||5
2297899|NCT02038764|5641793|P3|STARTED|Overall Study||9
2297900|NCT02038764|5641794|P2|STARTED|Overall Study||8
2297901|NCT02038764|5641795|P1|STARTED|Overall Study||7
2297902|NCT02038647|5641897|P2|NOT COMPLETED|Overall Study||89
2297903|NCT02038647|5641898|P1|NOT COMPLETED|Overall Study||89
2297904|NCT02038647|5641897|P2|COMPLETED|Overall Study||0
2297905|NCT02038647|5641898|P1|COMPLETED|Overall Study||0
2297906|NCT02038647|5641897|P2|STARTED|Overall Study||89
2297907|NCT02038647|5641898|P1|STARTED|Overall Study||89
2297908|NCT02038569|5641930|P1|NOT COMPLETED|Overall Study||5
2297909|NCT02038569|5641930|P1|COMPLETED|Overall Study||102
2297910|NCT02038569|5641930|P1|STARTED|Overall Study||107
2297911|NCT02038543|5641961|P4|NOT COMPLETED|Overall Study||2
2297912|NCT02038543|5641962|P3|NOT COMPLETED|Overall Study||0
2297913|NCT02038543|5641963|P2|NOT COMPLETED|Overall Study||0
2297914|NCT02038543|5641964|P1|NOT COMPLETED|Overall Study||0
2297915|NCT02038543|5641961|P4|COMPLETED|Overall Study||1
2297916|NCT02038543|5641962|P3|COMPLETED|Overall Study||8
2297917|NCT02038543|5641963|P2|COMPLETED|Overall Study||4
2297918|NCT02038543|5641964|P1|COMPLETED|Overall Study||7
2297919|NCT02038543|5641961|P4|STARTED|Overall Study||3
2297920|NCT02038543|5641962|P3|STARTED|Overall Study||8
2297921|NCT02038543|5641963|P2|STARTED|Overall Study||4
2297922|NCT02038543|5641964|P1|STARTED|Overall Study||7
2297923|NCT02038075|5641980|P2|NOT COMPLETED|Overall Study||0
2297924|NCT02038075|5641981|P1|NOT COMPLETED|Overall Study||3
2297925|NCT02038075|5641980|P2|COMPLETED|Overall Study||76
2297926|NCT02038075|5641981|P1|COMPLETED|Overall Study||73
2297927|NCT02038075|5641980|P2|STARTED|Overall Study||76
2297928|NCT02038075|5641981|P1|STARTED|Overall Study||76
2297929|NCT02038049|5641989|P2|NOT COMPLETED|Overall Study||0
2297930|NCT02038049|5641990|P1|NOT COMPLETED|Overall Study||1
2297931|NCT02038049|5641989|P2|COMPLETED|Overall Study||4
2297932|NCT02038049|5641990|P1|COMPLETED|Overall Study||3
2297933|NCT02038049|5641989|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||4
2297934|NCT02038049|5641990|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||4
2297935|NCT02038049|5641989|P2|STARTED|Overall Study||4
2297936|NCT02038049|5641990|P1|STARTED|Overall Study||4
2297937|NCT02038023|5642012|P1|NOT COMPLETED|Overall Study||1
2297938|NCT02038023|5642012|P1|COMPLETED|Overall Study||73
2297939|NCT02038023|5642012|P1|STARTED|Overall Study||74
2297940|NCT02037984|5642027|P8|NOT COMPLETED|Overall Study||12
2297941|NCT02037984|5642028|P7|NOT COMPLETED|Overall Study||17
2297942|NCT02037984|5642029|P6|NOT COMPLETED|Overall Study||12
2297943|NCT02037984|5642030|P5|NOT COMPLETED|Overall Study||12
2297944|NCT02037984|5642031|P4|NOT COMPLETED|Overall Study||21
2297945|NCT02037984|5642032|P3|NOT COMPLETED|Overall Study||12
2297946|NCT02037984|5642033|P2|NOT COMPLETED|Overall Study||0
2297947|NCT02037984|5642034|P1|NOT COMPLETED|Overall Study||1
2297948|NCT02037984|5642027|P8|COMPLETED|Overall Study||39
2297949|NCT02037984|5642028|P7|COMPLETED|Overall Study||33
2297950|NCT02037984|5642029|P6|COMPLETED|Overall Study||37
2297951|NCT02037984|5642030|P5|COMPLETED|Overall Study||38
2297952|NCT02037984|5642031|P4|COMPLETED|Overall Study||30
2297953|NCT02037984|5642032|P3|COMPLETED|Overall Study||38
2297954|NCT02037984|5642033|P2|COMPLETED|Overall Study||20
2297955|NCT02037984|5642034|P1|COMPLETED|Overall Study||19
2297956|NCT02037984|5642027|P8|STARTED|Overall Study||51
2297957|NCT02037984|5642028|P7|STARTED|Overall Study||50
2297958|NCT02037984|5642029|P6|STARTED|Overall Study||49
2297959|NCT02037984|5642030|P5|STARTED|Overall Study||50
2297960|NCT02037984|5642031|P4|STARTED|Overall Study||51
2297961|NCT02037984|5642032|P3|STARTED|Overall Study||50
2297962|NCT02037984|5642033|P2|STARTED|Overall Study||20
2297963|NCT02037984|5642034|P1|STARTED|Overall Study||20
2297964|NCT02037893|5642101|P4|NOT COMPLETED|Overall Study||0
2297965|NCT02037893|5642102|P3|NOT COMPLETED|Overall Study||1
2297966|NCT02037893|5642103|P2|NOT COMPLETED|Overall Study||0
2297967|NCT02037893|5642104|P1|NOT COMPLETED|Overall Study||0
2297968|NCT02037893|5642101|P4|COMPLETED|Overall Study||28
2297969|NCT02037893|5642102|P3|COMPLETED|Overall Study||26
2297970|NCT02037893|5642103|P2|COMPLETED|Overall Study||25
2297971|NCT02037893|5642104|P1|COMPLETED|Overall Study||32
2297972|NCT02037893|5642101|P4|STARTED|Overall Study||28
2297973|NCT02037893|5642102|P3|STARTED|Overall Study||27
2297974|NCT02037893|5642103|P2|STARTED|Overall Study||25
2297975|NCT02037893|5642104|P1|STARTED|Overall Study||32
2297976|NCT02037776|5642156|P2|NOT COMPLETED|Overall Study||4
2297977|NCT02037776|5642157|P1|NOT COMPLETED|Overall Study||5
2297978|NCT02037776|5642156|P2|COMPLETED|Overall Study||60
2297979|NCT02037776|5642157|P1|COMPLETED|Overall Study||56
2297980|NCT02037776|5642156|P2|STARTED|Overall Study||64
2297981|NCT02037776|5642157|P1|STARTED|Overall Study||61
2297982|NCT02037607|5642173|P1|NOT COMPLETED|Overall Study||9
2297983|NCT02037607|5642173|P1|COMPLETED|Overall Study||91
2297984|NCT02037607|5642173|P1|STARTED|Overall Study||100
2297985|NCT02037568|5642179|P2|NOT COMPLETED|Overall Study||39
2297986|NCT02037568|5642180|P1|NOT COMPLETED|Overall Study||36
2297987|NCT02037568|5642179|P2|COMPLETED|Overall Study||37
2297988|NCT02037568|5642180|P1|COMPLETED|Overall Study||47
2297989|NCT02037568|5642179|P2|Month 6 (Post Transplantation)|Overall Study||52
2297990|NCT02037568|5642180|P1|Month 6 (Post Transplantation)|Overall Study||63
2297991|NCT02037568|5642179|P2|Month 3 (Post Transplantation)|Overall Study||62
2297992|NCT02037568|5642180|P1|Month 3 (Post Transplantation)|Overall Study||66
2297993|NCT02037568|5642179|P2|Month 1.5 (Post Transplantation)|Overall Study||76
2297994|NCT02037568|5642180|P1|Month 1.5 (Post Transplantation)|Overall Study||79
2297995|NCT02037568|5642179|P2|STARTED|Overall Study||76
2297996|NCT02037568|5642180|P1|STARTED|Overall Study||83
2297997|NCT02037555|5642204|P2|NOT COMPLETED|Overall Study||21
2297998|NCT02037555|5642205|P1|NOT COMPLETED|Overall Study||23
2297999|NCT02037555|5642204|P2|COMPLETED|Overall Study||191
2298000|NCT02037555|5642205|P1|COMPLETED|Overall Study||190
2298001|NCT02037555|5642204|P2|Dosed and Operated On|Overall Study||196
2298002|NCT02037555|5642205|P1|Dosed and Operated On|Overall Study||200
2298003|NCT02037555|5642204|P2|Dosed|Overall Study||198
2298004|NCT02037555|5642205|P1|Dosed|Overall Study||201
2298005|NCT02037555|5642204|P2|STARTED|Overall Study||212
2298006|NCT02037555|5642205|P1|STARTED|Overall Study||213
2298007|NCT02037477|5642215|P4|NOT COMPLETED|Treatment Period 2||0
2298008|NCT02037477|5642216|P3|NOT COMPLETED|Treatment Period 2||0
2298009|NCT02037477|5642217|P2|NOT COMPLETED|Treatment Period 2||0
2298010|NCT02037477|5642218|P1|NOT COMPLETED|Treatment Period 2||0
2298011|NCT02037477|5642215|P4|COMPLETED|Treatment Period 2||5
2298012|NCT02037477|5642216|P3|COMPLETED|Treatment Period 2||4
2298013|NCT02037477|5642217|P2|COMPLETED|Treatment Period 2||5
2298014|NCT02037477|5642218|P1|COMPLETED|Treatment Period 2||5
2298015|NCT02037477|5642215|P4|STARTED|Treatment Period 2||5
2298016|NCT02037477|5642216|P3|STARTED|Treatment Period 2||4
2298017|NCT02037477|5642217|P2|STARTED|Treatment Period 2||5
2298018|NCT02037477|5642218|P1|STARTED|Treatment Period 2||5
2298019|NCT02037477|5642215|P4|NOT COMPLETED|Treatment Period 1||0
2298020|NCT02037477|5642216|P3|NOT COMPLETED|Treatment Period 1||1
2298021|NCT02037477|5642217|P2|NOT COMPLETED|Treatment Period 1||0
2298022|NCT02037477|5642218|P1|NOT COMPLETED|Treatment Period 1||0
2298023|NCT02037477|5642215|P4|COMPLETED|Treatment Period 1||5
2298024|NCT02037477|5642216|P3|COMPLETED|Treatment Period 1||4
2298025|NCT02037477|5642217|P2|COMPLETED|Treatment Period 1||5
2298026|NCT02037477|5642218|P1|COMPLETED|Treatment Period 1||5
2298027|NCT02037477|5642215|P4|STARTED|Treatment Period 1||5
2298028|NCT02037477|5642216|P3|STARTED|Treatment Period 1||5
2298029|NCT02037477|5642217|P2|STARTED|Treatment Period 1||5
2298030|NCT02037477|5642218|P1|STARTED|Treatment Period 1||5
2298031|NCT02037438|5642246|P2|NOT COMPLETED|Overall Study||355
2298032|NCT02037438|5642247|P1|NOT COMPLETED|Overall Study||346
2298033|NCT02037438|5642246|P2|COMPLETED|Overall Study||561
2298034|NCT02037438|5642247|P1|COMPLETED|Overall Study||574
2298035|NCT02037438|5642246|P2|STARTED|Overall Study||916
2298036|NCT02037438|5642247|P1|STARTED|Overall Study||920
2298037|NCT02037425|5642261|P1|NOT COMPLETED|Overall Study||26
2298038|NCT02037425|5642261|P1|COMPLETED|Overall Study||18
2298039|NCT02037425|5642261|P1|Randomized to Treatment|Overall Study||32
2298040|NCT02037425|5642261|P1|STARTED|Overall Study||44
2298041|NCT02037347|5642303|P1|NOT COMPLETED|Overall Study||0
2298042|NCT02037347|5642303|P1|COMPLETED|Overall Study||1
2298043|NCT02037347|5642303|P1|STARTED|Overall Study||1
2298060|NCT02037204|5642335|P1|NOT COMPLETED|Overall Study||0
2298061|NCT02037204|5642335|P1|COMPLETED|Overall Study||35
2298062|NCT02037204|5642335|P1|STARTED|Overall Study||35
2298063|NCT02037165|5642345|P5|NOT COMPLETED|Period 5 (2 Days)||0
2298064|NCT02037165|5642346|P4|NOT COMPLETED|Period 5 (2 Days)||0
2298065|NCT02037165|5642347|P3|NOT COMPLETED|Period 5 (2 Days)||0
2298066|NCT02037165|5642348|P2|NOT COMPLETED|Period 5 (2 Days)||0
2298067|NCT02037165|5642349|P1|NOT COMPLETED|Period 5 (2 Days)||0
2298068|NCT02037165|5642345|P5|COMPLETED|Period 5 (2 Days)||4
2298069|NCT02037165|5642346|P4|COMPLETED|Period 5 (2 Days)||5
2298070|NCT02037165|5642347|P3|COMPLETED|Period 5 (2 Days)||5
2298071|NCT02037165|5642348|P2|COMPLETED|Period 5 (2 Days)||5
2298072|NCT02037165|5642349|P1|COMPLETED|Period 5 (2 Days)||5
2298073|NCT02037165|5642345|P5|STARTED|Period 5 (2 Days)||4
2298074|NCT02037165|5642346|P4|STARTED|Period 5 (2 Days)||5
2298075|NCT02037165|5642347|P3|STARTED|Period 5 (2 Days)||5
2298076|NCT02037165|5642348|P2|STARTED|Period 5 (2 Days)||5
2298077|NCT02037165|5642349|P1|STARTED|Period 5 (2 Days)||5
2298078|NCT02037165|5642345|P5|NOT COMPLETED|Washout Period 4 (6 Days)||1
2298079|NCT02037165|5642346|P4|NOT COMPLETED|Washout Period 4 (6 Days)||0
2298080|NCT02037165|5642347|P3|NOT COMPLETED|Washout Period 4 (6 Days)||0
2298081|NCT02037165|5642348|P2|NOT COMPLETED|Washout Period 4 (6 Days)||0
2298082|NCT02037165|5642349|P1|NOT COMPLETED|Washout Period 4 (6 Days)||0
2298083|NCT02037165|5642345|P5|COMPLETED|Washout Period 4 (6 Days)||4
2298084|NCT02037165|5642346|P4|COMPLETED|Washout Period 4 (6 Days)||5
2298085|NCT02037165|5642347|P3|COMPLETED|Washout Period 4 (6 Days)||5
2298086|NCT02037165|5642348|P2|COMPLETED|Washout Period 4 (6 Days)||5
2298087|NCT02037165|5642349|P1|COMPLETED|Washout Period 4 (6 Days)||5
2298088|NCT02037165|5642345|P5|STARTED|Washout Period 4 (6 Days)||5
2298089|NCT02037165|5642346|P4|STARTED|Washout Period 4 (6 Days)||5
2298090|NCT02037165|5642347|P3|STARTED|Washout Period 4 (6 Days)||5
2298091|NCT02037165|5642348|P2|STARTED|Washout Period 4 (6 Days)||5
2298092|NCT02037165|5642349|P1|STARTED|Washout Period 4 (6 Days)||5
2298093|NCT02037165|5642345|P5|NOT COMPLETED|Period 4 (2 Days)||0
2298094|NCT02037165|5642346|P4|NOT COMPLETED|Period 4 (2 Days)||0
2298095|NCT02037165|5642347|P3|NOT COMPLETED|Period 4 (2 Days)||0
2298096|NCT02037165|5642348|P2|NOT COMPLETED|Period 4 (2 Days)||0
2298097|NCT02037165|5642349|P1|NOT COMPLETED|Period 4 (2 Days)||0
2298098|NCT02037165|5642345|P5|COMPLETED|Period 4 (2 Days)||5
2298099|NCT02037165|5642346|P4|COMPLETED|Period 4 (2 Days)||5
2298100|NCT02037165|5642347|P3|COMPLETED|Period 4 (2 Days)||5
2298101|NCT02037165|5642348|P2|COMPLETED|Period 4 (2 Days)||5
2298102|NCT02037165|5642349|P1|COMPLETED|Period 4 (2 Days)||5
2298103|NCT02037165|5642345|P5|STARTED|Period 4 (2 Days)||5
2298104|NCT02037165|5642346|P4|STARTED|Period 4 (2 Days)||5
2298105|NCT02037165|5642347|P3|STARTED|Period 4 (2 Days)||5
2298106|NCT02037165|5642348|P2|STARTED|Period 4 (2 Days)||5
2298107|NCT02037165|5642349|P1|STARTED|Period 4 (2 Days)||5
2298108|NCT02037165|5642345|P5|NOT COMPLETED|Washout Period 3 (6 Days)||0
2298109|NCT02037165|5642346|P4|NOT COMPLETED|Washout Period 3 (6 Days)||0
2298110|NCT02037165|5642347|P3|NOT COMPLETED|Washout Period 3 (6 Days)||0
2298111|NCT02037165|5642348|P2|NOT COMPLETED|Washout Period 3 (6 Days)||0
2298112|NCT02037165|5642349|P1|NOT COMPLETED|Washout Period 3 (6 Days)||0
2298113|NCT02037165|5642345|P5|COMPLETED|Washout Period 3 (6 Days)||5
2298114|NCT02037165|5642346|P4|COMPLETED|Washout Period 3 (6 Days)||5
2298115|NCT02037165|5642347|P3|COMPLETED|Washout Period 3 (6 Days)||5
2298116|NCT02037165|5642348|P2|COMPLETED|Washout Period 3 (6 Days)||5
2298117|NCT02037165|5642349|P1|COMPLETED|Washout Period 3 (6 Days)||5
2298118|NCT02037165|5642345|P5|STARTED|Washout Period 3 (6 Days)||5
2298119|NCT02037165|5642346|P4|STARTED|Washout Period 3 (6 Days)||5
2298120|NCT02037165|5642347|P3|STARTED|Washout Period 3 (6 Days)||5
2298121|NCT02037165|5642348|P2|STARTED|Washout Period 3 (6 Days)||5
2298122|NCT02037165|5642349|P1|STARTED|Washout Period 3 (6 Days)||5
2298123|NCT02037165|5642345|P5|NOT COMPLETED|Period 3 (2 Days)||0
2298124|NCT02037165|5642346|P4|NOT COMPLETED|Period 3 (2 Days)||0
2298125|NCT02037165|5642347|P3|NOT COMPLETED|Period 3 (2 Days)||0
2298126|NCT02037165|5642348|P2|NOT COMPLETED|Period 3 (2 Days)||0
2298127|NCT02037165|5642349|P1|NOT COMPLETED|Period 3 (2 Days)||0
2298128|NCT02037165|5642345|P5|COMPLETED|Period 3 (2 Days)||5
2298129|NCT02037165|5642346|P4|COMPLETED|Period 3 (2 Days)||5
2298130|NCT02037165|5642347|P3|COMPLETED|Period 3 (2 Days)||5
2298131|NCT02037165|5642348|P2|COMPLETED|Period 3 (2 Days)||5
2298132|NCT02037165|5642349|P1|COMPLETED|Period 3 (2 Days)||5
2298133|NCT02037165|5642345|P5|STARTED|Period 3 (2 Days)||5
2298134|NCT02037165|5642346|P4|STARTED|Period 3 (2 Days)||5
2298135|NCT02037165|5642347|P3|STARTED|Period 3 (2 Days)||5
2298136|NCT02037165|5642348|P2|STARTED|Period 3 (2 Days)||5
2298137|NCT02037165|5642349|P1|STARTED|Period 3 (2 Days)||5
2298138|NCT02037165|5642345|P5|NOT COMPLETED|Washout Period 2 (6 Days)||0
2298139|NCT02037165|5642346|P4|NOT COMPLETED|Washout Period 2 (6 Days)||0
2298140|NCT02037165|5642347|P3|NOT COMPLETED|Washout Period 2 (6 Days)||0
2298141|NCT02037165|5642348|P2|NOT COMPLETED|Washout Period 2 (6 Days)||0
2298142|NCT02037165|5642349|P1|NOT COMPLETED|Washout Period 2 (6 Days)||0
2298143|NCT02037165|5642345|P5|COMPLETED|Washout Period 2 (6 Days)||5
2298144|NCT02037165|5642346|P4|COMPLETED|Washout Period 2 (6 Days)||5
2298145|NCT02037165|5642347|P3|COMPLETED|Washout Period 2 (6 Days)||5
2298146|NCT02037165|5642348|P2|COMPLETED|Washout Period 2 (6 Days)||5
2298147|NCT02037165|5642349|P1|COMPLETED|Washout Period 2 (6 Days)||5
2298148|NCT02037165|5642345|P5|STARTED|Washout Period 2 (6 Days)||5
2298149|NCT02037165|5642346|P4|STARTED|Washout Period 2 (6 Days)||5
2298150|NCT02037165|5642347|P3|STARTED|Washout Period 2 (6 Days)||5
2298151|NCT02037165|5642348|P2|STARTED|Washout Period 2 (6 Days)||5
2298152|NCT02037165|5642349|P1|STARTED|Washout Period 2 (6 Days)||5
2298153|NCT02037165|5642345|P5|NOT COMPLETED|Period 2 (2 Days)||0
2298154|NCT02037165|5642346|P4|NOT COMPLETED|Period 2 (2 Days)||0
2298155|NCT02037165|5642347|P3|NOT COMPLETED|Period 2 (2 Days)||0
2298156|NCT02037165|5642348|P2|NOT COMPLETED|Period 2 (2 Days)||0
2298157|NCT02037165|5642349|P1|NOT COMPLETED|Period 2 (2 Days)||0
2298158|NCT02037165|5642345|P5|COMPLETED|Period 2 (2 Days)||5
2298159|NCT02037165|5642346|P4|COMPLETED|Period 2 (2 Days)||5
2298160|NCT02037165|5642347|P3|COMPLETED|Period 2 (2 Days)||5
2298161|NCT02037165|5642348|P2|COMPLETED|Period 2 (2 Days)||5
2298162|NCT02037165|5642349|P1|COMPLETED|Period 2 (2 Days)||5
2298163|NCT02037165|5642345|P5|STARTED|Period 2 (2 Days)||5
2298164|NCT02037165|5642346|P4|STARTED|Period 2 (2 Days)||5
2298165|NCT02037165|5642347|P3|STARTED|Period 2 (2 Days)||5
2298166|NCT02037165|5642348|P2|STARTED|Period 2 (2 Days)||5
2298167|NCT02037165|5642349|P1|STARTED|Period 2 (2 Days)||5
2298168|NCT02037165|5642345|P5|NOT COMPLETED|Washout Period 1 (6 Days)||0
2298169|NCT02037165|5642346|P4|NOT COMPLETED|Washout Period 1 (6 Days)||0
2298170|NCT02037165|5642347|P3|NOT COMPLETED|Washout Period 1 (6 Days)||0
2298171|NCT02037165|5642348|P2|NOT COMPLETED|Washout Period 1 (6 Days)||0
2298172|NCT02037165|5642349|P1|NOT COMPLETED|Washout Period 1 (6 Days)||0
2298173|NCT02037165|5642345|P5|COMPLETED|Washout Period 1 (6 Days)||5
2298174|NCT02037165|5642346|P4|COMPLETED|Washout Period 1 (6 Days)||5
2298175|NCT02037165|5642347|P3|COMPLETED|Washout Period 1 (6 Days)||5
2298176|NCT02037165|5642348|P2|COMPLETED|Washout Period 1 (6 Days)||5
2298177|NCT02037165|5642349|P1|COMPLETED|Washout Period 1 (6 Days)||5
2298178|NCT02037165|5642345|P5|STARTED|Washout Period 1 (6 Days)||5
2298179|NCT02037165|5642346|P4|STARTED|Washout Period 1 (6 Days)||5
2298180|NCT02037165|5642347|P3|STARTED|Washout Period 1 (6 Days)||5
2298181|NCT02037165|5642348|P2|STARTED|Washout Period 1 (6 Days)||5
2298182|NCT02037165|5642349|P1|STARTED|Washout Period 1 (6 Days)||5
2298183|NCT02037165|5642345|P5|NOT COMPLETED|Period 1 (2 Days)||0
2298184|NCT02037165|5642346|P4|NOT COMPLETED|Period 1 (2 Days)||0
2298185|NCT02037165|5642347|P3|NOT COMPLETED|Period 1 (2 Days)||0
2298186|NCT02037165|5642348|P2|NOT COMPLETED|Period 1 (2 Days)||0
2298187|NCT02037165|5642349|P1|NOT COMPLETED|Period 1 (2 Days)||0
2298188|NCT02037165|5642345|P5|COMPLETED|Period 1 (2 Days)||5
2298189|NCT02037165|5642346|P4|COMPLETED|Period 1 (2 Days)||5
2298190|NCT02037165|5642347|P3|COMPLETED|Period 1 (2 Days)||5
2298191|NCT02037165|5642348|P2|COMPLETED|Period 1 (2 Days)||5
2298192|NCT02037165|5642349|P1|COMPLETED|Period 1 (2 Days)||5
2298193|NCT02037165|5642345|P5|STARTED|Period 1 (2 Days)|randomized subjects|5
2298194|NCT02037165|5642346|P4|STARTED|Period 1 (2 Days)|randomized subjects|5
2298195|NCT02037165|5642347|P3|STARTED|Period 1 (2 Days)|randomized subjects|5
2298196|NCT02037165|5642348|P2|STARTED|Period 1 (2 Days)|randomized subjects|5
2298197|NCT02037165|5642349|P1|STARTED|Period 1 (2 Days)|randomized subjects|5
2298198|NCT02037061|5642394|P2|NOT COMPLETED|Overall Study||0
2298199|NCT02037061|5642395|P1|NOT COMPLETED|Overall Study||0
2298200|NCT02037061|5642394|P2|COMPLETED|Overall Study||24
2298201|NCT02037061|5642395|P1|COMPLETED|Overall Study||22
2298202|NCT02037061|5642394|P2|STARTED|Overall Study||24
2298203|NCT02037061|5642395|P1|STARTED|Overall Study||22
2298204|NCT02036840|5642405|P1|NOT COMPLETED|Overall Study||0
2298205|NCT02036840|5642405|P1|COMPLETED|Overall Study||513
2298206|NCT02036840|5642405|P1|STARTED|Overall Study||513
2298207|NCT02036775|5642409|P6|NOT COMPLETED|Treatment Period 3 (6 Days)||0
2298208|NCT02036775|5642410|P5|NOT COMPLETED|Treatment Period 3 (6 Days)||0
2298209|NCT02036775|5642411|P4|NOT COMPLETED|Treatment Period 3 (6 Days)||0
2298210|NCT02036775|5642412|P3|NOT COMPLETED|Treatment Period 3 (6 Days)||0
2298211|NCT02036775|5642413|P2|NOT COMPLETED|Treatment Period 3 (6 Days)||0
2298212|NCT02036775|5642414|P1|NOT COMPLETED|Treatment Period 3 (6 Days)||0
2298213|NCT02036775|5642409|P6|COMPLETED|Treatment Period 3 (6 Days)||3
2298214|NCT02036775|5642410|P5|COMPLETED|Treatment Period 3 (6 Days)||4
2298215|NCT02036775|5642411|P4|COMPLETED|Treatment Period 3 (6 Days)||4
2298216|NCT02036775|5642412|P3|COMPLETED|Treatment Period 3 (6 Days)||4
2298217|NCT02036775|5642413|P2|COMPLETED|Treatment Period 3 (6 Days)||4
2298218|NCT02036775|5642414|P1|COMPLETED|Treatment Period 3 (6 Days)||4
2298219|NCT02036775|5642409|P6|STARTED|Treatment Period 3 (6 Days)||3
2298220|NCT02036775|5642410|P5|STARTED|Treatment Period 3 (6 Days)||4
2298221|NCT02036775|5642411|P4|STARTED|Treatment Period 3 (6 Days)||4
2298222|NCT02036775|5642412|P3|STARTED|Treatment Period 3 (6 Days)||4
2298223|NCT02036775|5642413|P2|STARTED|Treatment Period 3 (6 Days)||4
2298224|NCT02036775|5642414|P1|STARTED|Treatment Period 3 (6 Days)||4
2298225|NCT02036775|5642409|P6|NOT COMPLETED|Treatment Period 2 (6 Days)||1
2298226|NCT02036775|5642410|P5|NOT COMPLETED|Treatment Period 2 (6 Days)||0
2298227|NCT02036775|5642411|P4|NOT COMPLETED|Treatment Period 2 (6 Days)||0
2298228|NCT02036775|5642412|P3|NOT COMPLETED|Treatment Period 2 (6 Days)||0
2298229|NCT02036775|5642413|P2|NOT COMPLETED|Treatment Period 2 (6 Days)||0
2298230|NCT02036775|5642414|P1|NOT COMPLETED|Treatment Period 2 (6 Days)||0
2298231|NCT02036775|5642409|P6|COMPLETED|Treatment Period 2 (6 Days)||3
2298232|NCT02036775|5642410|P5|COMPLETED|Treatment Period 2 (6 Days)||4
2298233|NCT02036775|5642411|P4|COMPLETED|Treatment Period 2 (6 Days)||4
2298234|NCT02036775|5642412|P3|COMPLETED|Treatment Period 2 (6 Days)||4
2298235|NCT02036775|5642413|P2|COMPLETED|Treatment Period 2 (6 Days)||4
2298236|NCT02036775|5642414|P1|COMPLETED|Treatment Period 2 (6 Days)||4
2298237|NCT02036775|5642409|P6|STARTED|Treatment Period 2 (6 Days)||4
2298238|NCT02036775|5642410|P5|STARTED|Treatment Period 2 (6 Days)||4
2298239|NCT02036775|5642411|P4|STARTED|Treatment Period 2 (6 Days)||4
2298240|NCT02036775|5642412|P3|STARTED|Treatment Period 2 (6 Days)||4
2298241|NCT02036775|5642413|P2|STARTED|Treatment Period 2 (6 Days)||4
2298242|NCT02036775|5642414|P1|STARTED|Treatment Period 2 (6 Days)||4
2298243|NCT02036775|5642409|P6|NOT COMPLETED|Treatment Period 1 (6 Days)||0
2298244|NCT02036775|5642410|P5|NOT COMPLETED|Treatment Period 1 (6 Days)||0
2298245|NCT02036775|5642411|P4|NOT COMPLETED|Treatment Period 1 (6 Days)||0
2298246|NCT02036775|5642412|P3|NOT COMPLETED|Treatment Period 1 (6 Days)||0
2298247|NCT02036775|5642413|P2|NOT COMPLETED|Treatment Period 1 (6 Days)||0
2298248|NCT02036775|5642414|P1|NOT COMPLETED|Treatment Period 1 (6 Days)||0
2298249|NCT02036775|5642409|P6|COMPLETED|Treatment Period 1 (6 Days)||4
2298250|NCT02036775|5642410|P5|COMPLETED|Treatment Period 1 (6 Days)||4
2298251|NCT02036775|5642411|P4|COMPLETED|Treatment Period 1 (6 Days)||4
2298252|NCT02036775|5642412|P3|COMPLETED|Treatment Period 1 (6 Days)||4
2298253|NCT02036775|5642413|P2|COMPLETED|Treatment Period 1 (6 Days)||4
2298254|NCT02036775|5642414|P1|COMPLETED|Treatment Period 1 (6 Days)||4
2298255|NCT02036775|5642409|P6|STARTED|Treatment Period 1 (6 Days)||4
2298256|NCT02036775|5642410|P5|STARTED|Treatment Period 1 (6 Days)||4
2298257|NCT02036775|5642411|P4|STARTED|Treatment Period 1 (6 Days)||4
2298258|NCT02036775|5642412|P3|STARTED|Treatment Period 1 (6 Days)||4
2298259|NCT02036775|5642413|P2|STARTED|Treatment Period 1 (6 Days)||4
2298260|NCT02036775|5642414|P1|STARTED|Treatment Period 1 (6 Days)||4
2298261|NCT02036645|5642464|P12|NOT COMPLETED|MAD Cohorts: Study Part 2||0
2298262|NCT02036645|5642465|P11|NOT COMPLETED|MAD Cohorts: Study Part 2||0
2298263|NCT02036645|5642466|P10|NOT COMPLETED|MAD Cohorts: Study Part 2||0
2298264|NCT02036645|5642467|P9|NOT COMPLETED|MAD Cohorts: Study Part 2||0
2298265|NCT02036645|5642468|P8|NOT COMPLETED|MAD Cohorts: Study Part 2||0
2298266|NCT02036645|5642469|P7|NOT COMPLETED|MAD Cohorts: Study Part 2||0
2298267|NCT02036645|5642470|P6|NOT COMPLETED|MAD Cohorts: Study Part 2||0
2298268|NCT02036645|5642471|P5|NOT COMPLETED|MAD Cohorts: Study Part 2||0
2298269|NCT02036645|5642472|P4|NOT COMPLETED|MAD Cohorts: Study Part 2||0
2298270|NCT02036645|5642473|P3|NOT COMPLETED|MAD Cohorts: Study Part 2||0
2298271|NCT02036645|5642474|P2|NOT COMPLETED|MAD Cohorts: Study Part 2||0
2298272|NCT02036645|5642475|P1|NOT COMPLETED|MAD Cohorts: Study Part 2||0
2298273|NCT02036645|5642464|P12|COMPLETED|MAD Cohorts: Study Part 2||6
2298274|NCT02036645|5642465|P11|COMPLETED|MAD Cohorts: Study Part 2||6
2298275|NCT02036645|5642466|P10|COMPLETED|MAD Cohorts: Study Part 2||6
2298276|NCT02036645|5642467|P9|COMPLETED|MAD Cohorts: Study Part 2||6
2298277|NCT02036645|5642468|P8|COMPLETED|MAD Cohorts: Study Part 2||8
2298278|NCT02036645|5642469|P7|COMPLETED|MAD Cohorts: Study Part 2||0
2298279|NCT02036645|5642470|P6|COMPLETED|MAD Cohorts: Study Part 2||0
2298280|NCT02036645|5642471|P5|COMPLETED|MAD Cohorts: Study Part 2||0
2298281|NCT02036645|5642472|P4|COMPLETED|MAD Cohorts: Study Part 2||0
2298282|NCT02036645|5642473|P3|COMPLETED|MAD Cohorts: Study Part 2||0
2298283|NCT02036645|5642474|P2|COMPLETED|MAD Cohorts: Study Part 2||0
2298284|NCT02036645|5642475|P1|COMPLETED|MAD Cohorts: Study Part 2||0
2298285|NCT02036645|5642464|P12|STARTED|MAD Cohorts: Study Part 2||6
2298286|NCT02036645|5642465|P11|STARTED|MAD Cohorts: Study Part 2||6
2298287|NCT02036645|5642466|P10|STARTED|MAD Cohorts: Study Part 2||6
2298288|NCT02036645|5642467|P9|STARTED|MAD Cohorts: Study Part 2||6
2298289|NCT02036645|5642468|P8|STARTED|MAD Cohorts: Study Part 2||8
2298290|NCT02036645|5642469|P7|STARTED|MAD Cohorts: Study Part 2||0
2298291|NCT02036645|5642470|P6|STARTED|MAD Cohorts: Study Part 2||0
2298292|NCT02036645|5642471|P5|STARTED|MAD Cohorts: Study Part 2||0
2298293|NCT02036645|5642472|P4|STARTED|MAD Cohorts: Study Part 2||0
2298294|NCT02036645|5642473|P3|STARTED|MAD Cohorts: Study Part 2||0
2298295|NCT02036645|5642474|P2|STARTED|MAD Cohorts: Study Part 2||0
2298296|NCT02036645|5642475|P1|STARTED|MAD Cohorts: Study Part 2|Pooled across Cohorts 7 to 9 (2 per cohort)|0
2298297|NCT02036645|5642464|P12|NOT COMPLETED|SAD Cohorts : Study Part 1||0
2298298|NCT02036645|5642465|P11|NOT COMPLETED|SAD Cohorts : Study Part 1||0
2298299|NCT02036645|5642466|P10|NOT COMPLETED|SAD Cohorts : Study Part 1||0
2298300|NCT02036645|5642467|P9|NOT COMPLETED|SAD Cohorts : Study Part 1||0
2298301|NCT02036645|5642468|P8|NOT COMPLETED|SAD Cohorts : Study Part 1||0
2298302|NCT02036645|5642469|P7|NOT COMPLETED|SAD Cohorts : Study Part 1||1
2298303|NCT02036645|5642470|P6|NOT COMPLETED|SAD Cohorts : Study Part 1||0
2298304|NCT02036645|5642471|P5|NOT COMPLETED|SAD Cohorts : Study Part 1||0
2298305|NCT02036645|5642472|P4|NOT COMPLETED|SAD Cohorts : Study Part 1||1
2298306|NCT02036645|5642473|P3|NOT COMPLETED|SAD Cohorts : Study Part 1||0
2298307|NCT02036645|5642474|P2|NOT COMPLETED|SAD Cohorts : Study Part 1||0
2298308|NCT02036645|5642475|P1|NOT COMPLETED|SAD Cohorts : Study Part 1||0
2298309|NCT02036645|5642464|P12|COMPLETED|SAD Cohorts : Study Part 1||0
2298310|NCT02036645|5642465|P11|COMPLETED|SAD Cohorts : Study Part 1||0
2298311|NCT02036645|5642466|P10|COMPLETED|SAD Cohorts : Study Part 1||0
2298312|NCT02036645|5642467|P9|COMPLETED|SAD Cohorts : Study Part 1||0
2298313|NCT02036645|5642468|P8|COMPLETED|SAD Cohorts : Study Part 1||0
2298314|NCT02036645|5642469|P7|COMPLETED|SAD Cohorts : Study Part 1||5
2298315|NCT02036645|5642470|P6|COMPLETED|SAD Cohorts : Study Part 1||6
2298316|NCT02036645|5642471|P5|COMPLETED|SAD Cohorts : Study Part 1||6
2298317|NCT02036645|5642472|P4|COMPLETED|SAD Cohorts : Study Part 1||5
2298318|NCT02036645|5642473|P3|COMPLETED|SAD Cohorts : Study Part 1||6
2298319|NCT02036645|5642474|P2|COMPLETED|SAD Cohorts : Study Part 1||3
2298320|NCT02036645|5642475|P1|COMPLETED|SAD Cohorts : Study Part 1||12
2298321|NCT02036645|5642464|P12|STARTED|SAD Cohorts : Study Part 1||0
2298322|NCT02036645|5642465|P11|STARTED|SAD Cohorts : Study Part 1||0
2298323|NCT02036645|5642466|P10|STARTED|SAD Cohorts : Study Part 1||0
2298324|NCT02036645|5642467|P9|STARTED|SAD Cohorts : Study Part 1||0
2298325|NCT02036645|5642468|P8|STARTED|SAD Cohorts : Study Part 1||0
2298326|NCT02036645|5642469|P7|STARTED|SAD Cohorts : Study Part 1||6
2298327|NCT02036645|5642470|P6|STARTED|SAD Cohorts : Study Part 1||6
2298328|NCT02036645|5642471|P5|STARTED|SAD Cohorts : Study Part 1||6
2298329|NCT02036645|5642472|P4|STARTED|SAD Cohorts : Study Part 1||6
2298330|NCT02036645|5642473|P3|STARTED|SAD Cohorts : Study Part 1||6
2298331|NCT02036645|5642474|P2|STARTED|SAD Cohorts : Study Part 1||3
2298332|NCT02036645|5642475|P1|STARTED|SAD Cohorts : Study Part 1|Pooled across cohorts 1-5 (2 per cohort)|12
2298333|NCT02036580|5642580|P3|NOT COMPLETED|Overall Study||0
2298334|NCT02036580|5642581|P2|NOT COMPLETED|Overall Study||1
2298335|NCT02036580|5642582|P1|NOT COMPLETED|Overall Study||1
2298336|NCT02036580|5642580|P3|COMPLETED|Overall Study||4
2298337|NCT02036580|5642581|P2|COMPLETED|Overall Study||7
2298338|NCT02036580|5642582|P1|COMPLETED|Overall Study||7
2298339|NCT02036580|5642580|P3|STARTED|Overall Study||4
2298340|NCT02036580|5642581|P2|STARTED|Overall Study||8
2298341|NCT02036580|5642582|P1|STARTED|Overall Study||8
2298342|NCT02036541|5642595|P1|NOT COMPLETED|Overall Study||16
2298343|NCT02036541|5642595|P1|COMPLETED|Overall Study||49
2298344|NCT02036541|5642595|P1|Completed Endpoint Visit|Overall Study||54
2298345|NCT02036541|5642595|P1|STARTED|Overall Study||65
2298346|NCT02036515|5642603|P3|NOT COMPLETED|Overall Study||14
2298347|NCT02036515|5642604|P2|NOT COMPLETED|Overall Study||12
2298348|NCT02036515|5642605|P1|NOT COMPLETED|Overall Study||5
2298349|NCT02036515|5642603|P3|COMPLETED|Overall Study||139
2298350|NCT02036515|5642604|P2|COMPLETED|Overall Study||143
2298351|NCT02036515|5642605|P1|COMPLETED|Overall Study||151
2298352|NCT02036515|5642603|P3|Treated|Overall Study||153
2298353|NCT02036515|5642604|P2|Treated|Overall Study||153
2298354|NCT02036515|5642605|P1|Treated|Overall Study||156
2298355|NCT02036515|5642603|P3|STARTED|Overall Study||153
2298356|NCT02036515|5642604|P2|STARTED|Overall Study||155
2298357|NCT02036515|5642605|P1|STARTED|Overall Study||156
2298358|NCT02036424|5642684|P2|NOT COMPLETED|Overall Study||0
2298359|NCT02036424|5642685|P1|NOT COMPLETED|Overall Study||0
2298360|NCT02036424|5642684|P2|COMPLETED|Overall Study|27 study eyes, not number of subjects|27
2298361|NCT02036424|5642685|P1|COMPLETED|Overall Study|23 study eyes, not number of subjects|23
2298362|NCT02036424|5642684|P2|STARTED|Overall Study|27 study eyes, not number of subjects|27
2298363|NCT02036424|5642685|P1|STARTED|Overall Study|23 study eyes, not number of subjects|23
2298364|NCT02036320|5642693|P2|NOT COMPLETED|Period 2||0
2298365|NCT02036320|5642694|P1|NOT COMPLETED|Period 2||0
2298366|NCT02036320|5642693|P2|COMPLETED|Period 2||95
2298367|NCT02036320|5642694|P1|COMPLETED|Period 2||95
2298368|NCT02036320|5642693|P2|STARTED|Period 2||95
2298369|NCT02036320|5642694|P1|STARTED|Period 2||95
2298370|NCT02036320|5642693|P2|NOT COMPLETED|Period 1||0
2298371|NCT02036320|5642694|P1|NOT COMPLETED|Period 1||0
2298372|NCT02036320|5642693|P2|COMPLETED|Period 1||95
2298373|NCT02036320|5642694|P1|COMPLETED|Period 1||95
2298374|NCT02036320|5642693|P2|STARTED|Period 1||95
2298375|NCT02036320|5642694|P1|STARTED|Period 1||95
2298376|NCT02036294|5642706|P2|NOT COMPLETED|Overall Study||11
2298377|NCT02036294|5642707|P1|NOT COMPLETED|Overall Study||9
2298378|NCT02036294|5642706|P2|COMPLETED|Overall Study||109
2298379|NCT02036294|5642707|P1|COMPLETED|Overall Study||111
2298380|NCT02036294|5642706|P2|STARTED|Overall Study||120
2298381|NCT02036294|5642707|P1|STARTED|Overall Study||120
2298382|NCT02035748|5642723|P1|NOT COMPLETED|Overall Study||20
2298383|NCT02035748|5642723|P1|COMPLETED|Overall Study||448
2298384|NCT02035748|5642723|P1|STARTED|Overall Study||468
2298385|NCT02035696|5642737|P4|NOT COMPLETED|Overall Study||3
2298386|NCT02035696|5642738|P3|NOT COMPLETED|Overall Study||3
2298387|NCT02035696|5642739|P2|NOT COMPLETED|Overall Study||3
2298388|NCT02035696|5642740|P1|NOT COMPLETED|Overall Study||3
2298389|NCT02035696|5642737|P4|COMPLETED|Overall Study||161
2298390|NCT02035696|5642738|P3|COMPLETED|Overall Study||164
2298391|NCT02035696|5642739|P2|COMPLETED|Overall Study||163
2298392|NCT02035696|5642740|P1|COMPLETED|Overall Study||171
2298393|NCT02035696|5642737|P4|STARTED|Overall Study||164
2298394|NCT02035696|5642738|P3|STARTED|Overall Study||167
2298395|NCT02035696|5642739|P2|STARTED|Overall Study||166
2298396|NCT02035696|5642740|P1|STARTED|Overall Study||174
2298397|NCT02035553|5642796|P2|NOT COMPLETED|Overall Study||23
2298398|NCT02035553|5642797|P1|NOT COMPLETED|Overall Study||18
2298399|NCT02035553|5642796|P2|COMPLETED|Overall Study||67
2298400|NCT02035553|5642797|P1|COMPLETED|Overall Study||73
2298401|NCT02035553|5642796|P2|STARTED|Overall Study||90
2298402|NCT02035553|5642797|P1|STARTED|Overall Study||91
2298403|NCT02035475|5642803|P1|NOT COMPLETED|Overall Study||6
2298404|NCT02035475|5642803|P1|COMPLETED|Overall Study|Six subjects did not complete the study due to withdrawal of consent.|114
2298405|NCT02035475|5642803|P1|STARTED|Overall Study|120 subjects were consented for participation in the study.|120
2298406|NCT02035345|5642809|P1|NOT COMPLETED|Overall Study||0
2298407|NCT02035345|5642809|P1|COMPLETED|Overall Study||15
2298408|NCT02035345|5642809|P1|STARTED|Overall Study||15
2298409|NCT02035332|5642814|P1|NOT COMPLETED|Overall Study||1
2298410|NCT02035332|5642814|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|20
2298411|NCT02035332|5642814|P1|Treated|Overall Study|Treatment Completed|20
2298412|NCT02035332|5642814|P1|STARTED|Overall Study|Treatment Attempted|21
2298425|NCT02035202|5642858|P3|NOT COMPLETED|Overall Study||2
2298426|NCT02035202|5642859|P2|NOT COMPLETED|Overall Study||16
2298427|NCT02035202|5642860|P1|NOT COMPLETED|Overall Study||8
2298428|NCT02035202|5642858|P3|COMPLETED|Overall Study||83
2298429|NCT02035202|5642859|P2|COMPLETED|Overall Study||69
2298430|NCT02035202|5642860|P1|COMPLETED|Overall Study||77
2298431|NCT02035202|5642858|P3|STARTED|Overall Study||85
2298432|NCT02035202|5642859|P2|STARTED|Overall Study||85
2298433|NCT02035202|5642860|P1|STARTED|Overall Study||85
2298434|NCT02034916|5642876|P2|NOT COMPLETED|Overall Study||35
2298435|NCT02034916|5642877|P1|NOT COMPLETED|Overall Study||49
2298436|NCT02034916|5642876|P2|COMPLETED|Overall Study||0
2298437|NCT02034916|5642877|P1|COMPLETED|Overall Study||0
2298438|NCT02034916|5642876|P2|Treated|Overall Study||35
2298439|NCT02034916|5642877|P1|Treated|Overall Study||48
2298440|NCT02034916|5642876|P2|STARTED|Overall Study||35
2298441|NCT02034916|5642877|P1|STARTED|Overall Study||49
2298442|NCT02034877|5642914|P2|NOT COMPLETED|Overall Study||6
2298443|NCT02034877|5642915|P1|NOT COMPLETED|Overall Study||0
2298444|NCT02034877|5642914|P2|COMPLETED|Overall Study||993
2298445|NCT02034877|5642915|P1|COMPLETED|Overall Study||200
2298446|NCT02034877|5642914|P2|STARTED|Overall Study||999
2298447|NCT02034877|5642915|P1|STARTED|Overall Study||200
2298448|NCT02034799|5642933|P2|NOT COMPLETED|Overall Study||4
2298449|NCT02034799|5642934|P1|NOT COMPLETED|Overall Study||2
2298450|NCT02034799|5642933|P2|COMPLETED|Overall Study||123
2298451|NCT02034799|5642934|P1|COMPLETED|Overall Study||127
2298452|NCT02034799|5642933|P2|STARTED|Overall Study||127
2298453|NCT02034799|5642934|P1|STARTED|Overall Study||129
2298454|NCT02034708|5642948|P2|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
2298455|NCT02034708|5642949|P1|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
2298456|NCT02034708|5642948|P2|COMPLETED|Second Contrast Agent Injection (1 Day)||120
2298457|NCT02034708|5642949|P1|COMPLETED|Second Contrast Agent Injection (1 Day)||129
2298458|NCT02034708|5642948|P2|STARTED|Second Contrast Agent Injection (1 Day)||120
2298459|NCT02034708|5642949|P1|STARTED|Second Contrast Agent Injection (1 Day)||129
2298460|NCT02034708|5642948|P2|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||10
2298461|NCT02034708|5642949|P1|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||9
2298462|NCT02034708|5642948|P2|COMPLETED|Wash-out (From 2 Days up to 14 Days)||120
2298463|NCT02034708|5642949|P1|COMPLETED|Wash-out (From 2 Days up to 14 Days)||129
2298464|NCT02034708|5642948|P2|STARTED|Wash-out (From 2 Days up to 14 Days)||130
2298465|NCT02034708|5642949|P1|STARTED|Wash-out (From 2 Days up to 14 Days)||138
2298466|NCT02034708|5642948|P2|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
2298467|NCT02034708|5642949|P1|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
2298468|NCT02034708|5642948|P2|COMPLETED|First Contrast Agent Injection (1 Day)||130
2298469|NCT02034708|5642949|P1|COMPLETED|First Contrast Agent Injection (1 Day)||138
2298470|NCT02034708|5642948|P2|STARTED|First Contrast Agent Injection (1 Day)||130
2298471|NCT02034708|5642949|P1|STARTED|First Contrast Agent Injection (1 Day)||138
2298472|NCT02034591|5642960|P6|NOT COMPLETED|Overall Study||0
2298473|NCT02034591|5642961|P5|NOT COMPLETED|Overall Study||1
2298474|NCT02034591|5642962|P4|NOT COMPLETED|Overall Study||0
2298475|NCT02034591|5642963|P3|NOT COMPLETED|Overall Study||0
2298476|NCT02034591|5642964|P2|NOT COMPLETED|Overall Study||0
2298477|NCT02034591|5642965|P1|NOT COMPLETED|Overall Study||0
2298478|NCT02034591|5642960|P6|COMPLETED|Overall Study||3
2298479|NCT02034591|5642961|P5|COMPLETED|Overall Study||3
2298480|NCT02034591|5642962|P4|COMPLETED|Overall Study||3
2298481|NCT02034591|5642963|P3|COMPLETED|Overall Study||4
2298482|NCT02034591|5642964|P2|COMPLETED|Overall Study||3
2298483|NCT02034591|5642965|P1|COMPLETED|Overall Study||4
2298484|NCT02034591|5642960|P6|STARTED|Overall Study||3
2298485|NCT02034591|5642961|P5|STARTED|Overall Study||4
2298486|NCT02034591|5642962|P4|STARTED|Overall Study||3
2298487|NCT02034591|5642963|P3|STARTED|Overall Study||4
2298488|NCT02034591|5642964|P2|STARTED|Overall Study||3
2298489|NCT02034591|5642965|P1|STARTED|Overall Study||4
2298490|NCT02034578|5642988|P6|NOT COMPLETED|Overall Study||0
2298491|NCT02034578|5642989|P5|NOT COMPLETED|Overall Study||0
2298492|NCT02034578|5642990|P4|NOT COMPLETED|Overall Study||0
2298493|NCT02034578|5642991|P3|NOT COMPLETED|Overall Study||0
2298494|NCT02034578|5642992|P2|NOT COMPLETED|Overall Study||0
2298495|NCT02034578|5642993|P1|NOT COMPLETED|Overall Study||0
2298496|NCT02034578|5642988|P6|COMPLETED|Overall Study||3
2298497|NCT02034578|5642989|P5|COMPLETED|Overall Study||4
2298498|NCT02034578|5642990|P4|COMPLETED|Overall Study||3
2298499|NCT02034578|5642991|P3|COMPLETED|Overall Study||4
2298500|NCT02034578|5642992|P2|COMPLETED|Overall Study||3
2298501|NCT02034578|5642993|P1|COMPLETED|Overall Study||4
2298502|NCT02034578|5642988|P6|STARTED|Overall Study||3
2298503|NCT02034578|5642989|P5|STARTED|Overall Study||4
2298504|NCT02034578|5642990|P4|STARTED|Overall Study||3
2298505|NCT02034578|5642991|P3|STARTED|Overall Study||4
2298506|NCT02034578|5642992|P2|STARTED|Overall Study||3
2298507|NCT02034578|5642993|P1|STARTED|Overall Study||4
2298508|NCT02034565|5643020|P2|NOT COMPLETED|Overall Study||0
2298509|NCT02034565|5643021|P1|NOT COMPLETED|Overall Study||1
2298510|NCT02034565|5643020|P2|COMPLETED|Overall Study||7
2298511|NCT02034565|5643021|P1|COMPLETED|Overall Study||6
2298512|NCT02034565|5643020|P2|STARTED|Overall Study||7
2298513|NCT02034565|5643021|P1|STARTED|Overall Study||7
2298514|NCT02034552|5643038|P3|NOT COMPLETED|Overall Study||17
2298515|NCT02034552|5643039|P2|NOT COMPLETED|Overall Study||20
2298516|NCT02034552|5643040|P1|NOT COMPLETED|Overall Study||14
2298517|NCT02034552|5643038|P3|COMPLETED|Overall Study||5
2298518|NCT02034552|5643039|P2|COMPLETED|Overall Study||4
2298519|NCT02034552|5643040|P1|COMPLETED|Overall Study||8
2298520|NCT02034552|5643038|P3|Received Treatment|Overall Study||22
2298521|NCT02034552|5643039|P2|Received Treatment|Overall Study||22
2298522|NCT02034552|5643040|P1|Received Treatment|Overall Study||19
2298523|NCT02034552|5643038|P3|STARTED|Overall Study||22
2298524|NCT02034552|5643039|P2|STARTED|Overall Study||24
2298525|NCT02034552|5643040|P1|STARTED|Overall Study||22
2298526|NCT02034513|5643071|P2|NOT COMPLETED|Overall Study||57
2298527|NCT02034513|5643072|P1|NOT COMPLETED|Overall Study||49
2298528|NCT02034513|5643071|P2|COMPLETED|Overall Study||195
2298529|NCT02034513|5643072|P1|COMPLETED|Overall Study||200
2298530|NCT02034513|5643071|P2|Exposed|Overall Study||251
2298531|NCT02034513|5643072|P1|Exposed|Overall Study||249
2298532|NCT02034513|5643071|P2|STARTED|Overall Study||252
2298533|NCT02034513|5643072|P1|STARTED|Overall Study||249
2298534|NCT02034474|5643090|P2|NOT COMPLETED|Overall Study||4
2298535|NCT02034474|5643091|P1|NOT COMPLETED|Overall Study||4
2298536|NCT02034474|5643090|P2|COMPLETED|Overall Study||13
2298537|NCT02034474|5643091|P1|COMPLETED|Overall Study||15
2298538|NCT02034474|5643090|P2|3 Doses|Overall Study||13
2298539|NCT02034474|5643091|P1|3 Doses|Overall Study||15
2298540|NCT02034474|5643090|P2|2 Doses|Overall Study||0
2298541|NCT02034474|5643091|P1|2 Doses|Overall Study||2
2298542|NCT02034474|5643090|P2|1 Dose|Overall Study||4
2298543|NCT02034474|5643091|P1|1 Dose|Overall Study||2
2298544|NCT02034474|5643090|P2|STARTED|Overall Study||17
2298545|NCT02034474|5643091|P1|STARTED|Overall Study||19
2298546|NCT02034175|5643101|P1|NOT COMPLETED|Overall Study||0
2298547|NCT02034175|5643101|P1|COMPLETED|Overall Study||190
2298548|NCT02034175|5643101|P1|STARTED|Overall Study||190
2298549|NCT02034162|5643107|P3|NOT COMPLETED|Open-label||0
2298550|NCT02034162|5643108|P2|NOT COMPLETED|Open-label||0
2298551|NCT02034162|5643109|P1|NOT COMPLETED|Open-label||0
2298552|NCT02034162|5643107|P3|COMPLETED|Open-label||278
2298553|NCT02034162|5643108|P2|COMPLETED|Open-label||0
2298554|NCT02034162|5643109|P1|COMPLETED|Open-label||0
2298555|NCT02034162|5643107|P3|STARTED|Open-label||278
2298556|NCT02034162|5643108|P2|STARTED|Open-label||0
2298557|NCT02034162|5643109|P1|STARTED|Open-label||0
2298558|NCT02034162|5643107|P3|NOT COMPLETED|Double-blind||0
2298559|NCT02034162|5643108|P2|NOT COMPLETED|Double-blind||8
2298560|NCT02034162|5643109|P1|NOT COMPLETED|Double-blind||9
2298561|NCT02034162|5643107|P3|COMPLETED|Double-blind||0
2298562|NCT02034162|5643108|P2|COMPLETED|Double-blind||141
2298563|NCT02034162|5643109|P1|COMPLETED|Double-blind||137
2298564|NCT02034162|5643107|P3|STARTED|Double-blind||0
2298565|NCT02034162|5643108|P2|STARTED|Double-blind||149
2298566|NCT02034162|5643109|P1|STARTED|Double-blind||146
2298567|NCT02034123|5643155|P18|NOT COMPLETED|Part2(Up to 2 Years)||0
2298568|NCT02034123|5643156|P17|NOT COMPLETED|Part2(Up to 2 Years)||0
2298569|NCT02034123|5643157|P16|NOT COMPLETED|Part2(Up to 2 Years)||0
2298570|NCT02034123|5643158|P15|NOT COMPLETED|Part2(Up to 2 Years)||0
2298571|NCT02034123|5643159|P14|NOT COMPLETED|Part2(Up to 2 Years)||0
2298572|NCT02034123|5643160|P13|NOT COMPLETED|Part2(Up to 2 Years)||0
2298573|NCT02034123|5643161|P12|NOT COMPLETED|Part2(Up to 2 Years)||0
2298574|NCT02034123|5643162|P11|NOT COMPLETED|Part2(Up to 2 Years)||0
2298575|NCT02034123|5643163|P10|NOT COMPLETED|Part2(Up to 2 Years)||0
2298576|NCT02034123|5643164|P9|NOT COMPLETED|Part2(Up to 2 Years)||0
2298577|NCT02034123|5643165|P8|NOT COMPLETED|Part2(Up to 2 Years)||0
2298578|NCT02034123|5643166|P7|NOT COMPLETED|Part2(Up to 2 Years)||0
2298579|NCT02034123|5643167|P6|NOT COMPLETED|Part2(Up to 2 Years)||0
2298580|NCT02034123|5643168|P5|NOT COMPLETED|Part2(Up to 2 Years)||0
2298581|NCT02034123|5643169|P4|NOT COMPLETED|Part2(Up to 2 Years)||0
2298582|NCT02034123|5643170|P3|NOT COMPLETED|Part2(Up to 2 Years)||0
2298583|NCT02034123|5643171|P2|NOT COMPLETED|Part2(Up to 2 Years)||0
2298584|NCT02034123|5643172|P1|NOT COMPLETED|Part2(Up to 2 Years)||0
2298585|NCT02034123|5643155|P18|COMPLETED|Part2(Up to 2 Years)||0
2298586|NCT02034123|5643156|P17|COMPLETED|Part2(Up to 2 Years)||0
2298587|NCT02034123|5643157|P16|COMPLETED|Part2(Up to 2 Years)||0
2298588|NCT02034123|5643158|P15|COMPLETED|Part2(Up to 2 Years)||0
2298589|NCT02034123|5643159|P14|COMPLETED|Part2(Up to 2 Years)||0
2298590|NCT02034123|5643160|P13|COMPLETED|Part2(Up to 2 Years)||0
2298591|NCT02034123|5643161|P12|COMPLETED|Part2(Up to 2 Years)||0
2298592|NCT02034123|5643162|P11|COMPLETED|Part2(Up to 2 Years)||0
2298593|NCT02034123|5643163|P10|COMPLETED|Part2(Up to 2 Years)||0
2298594|NCT02034123|5643164|P9|COMPLETED|Part2(Up to 2 Years)||0
2298595|NCT02034123|5643165|P8|COMPLETED|Part2(Up to 2 Years)||0
2298596|NCT02034123|5643166|P7|COMPLETED|Part2(Up to 2 Years)||0
2298597|NCT02034123|5643167|P6|COMPLETED|Part2(Up to 2 Years)||0
2298598|NCT02034123|5643168|P5|COMPLETED|Part2(Up to 2 Years)||0
2298599|NCT02034123|5643169|P4|COMPLETED|Part2(Up to 2 Years)||0
2298600|NCT02034123|5643170|P3|COMPLETED|Part2(Up to 2 Years)||0
2298601|NCT02034123|5643171|P2|COMPLETED|Part2(Up to 2 Years)||0
2298602|NCT02034123|5643172|P1|COMPLETED|Part2(Up to 2 Years)||0
2298603|NCT02034123|5643155|P18|STARTED|Part2(Up to 2 Years)||0
2298604|NCT02034123|5643156|P17|STARTED|Part2(Up to 2 Years)||0
2298605|NCT02034123|5643157|P16|STARTED|Part2(Up to 2 Years)||0
2298606|NCT02034123|5643158|P15|STARTED|Part2(Up to 2 Years)||0
2298607|NCT02034123|5643159|P14|STARTED|Part2(Up to 2 Years)||0
2298608|NCT02034123|5643160|P13|STARTED|Part2(Up to 2 Years)||0
2298609|NCT02034123|5643161|P12|STARTED|Part2(Up to 2 Years)||0
2298610|NCT02034123|5643162|P11|STARTED|Part2(Up to 2 Years)||0
2298611|NCT02034123|5643163|P10|STARTED|Part2(Up to 2 Years)||0
2298612|NCT02034123|5643164|P9|STARTED|Part2(Up to 2 Years)||0
2298613|NCT02034123|5643165|P8|STARTED|Part2(Up to 2 Years)||0
2298614|NCT02034123|5643166|P7|STARTED|Part2(Up to 2 Years)||0
2298615|NCT02034123|5643167|P6|STARTED|Part2(Up to 2 Years)||0
2298616|NCT02034123|5643168|P5|STARTED|Part2(Up to 2 Years)||0
2298617|NCT02034123|5643169|P4|STARTED|Part2(Up to 2 Years)||0
2298618|NCT02034123|5643170|P3|STARTED|Part2(Up to 2 Years)||0
2298619|NCT02034123|5643171|P2|STARTED|Part2(Up to 2 Years)||0
2298620|NCT02034123|5643172|P1|STARTED|Part2(Up to 2 Years)||0
2298621|NCT02034123|5643155|P18|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
2298622|NCT02034123|5643156|P17|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
2298623|NCT02034123|5643157|P16|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
2298624|NCT02034123|5643158|P15|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
2298625|NCT02034123|5643159|P14|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
2298626|NCT02034123|5643160|P13|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
2298627|NCT02034123|5643161|P12|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
2298628|NCT02034123|5643162|P11|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
2298629|NCT02034123|5643163|P10|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
2298630|NCT02034123|5643164|P9|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
2298631|NCT02034123|5643165|P8|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
2298632|NCT02034123|5643166|P7|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
2298633|NCT02034123|5643167|P6|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
2298634|NCT02034123|5643168|P5|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
2298635|NCT02034123|5643169|P4|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
2298636|NCT02034123|5643170|P3|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
2298637|NCT02034123|5643171|P2|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
2298638|NCT02034123|5643172|P1|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
2298639|NCT02034123|5643155|P18|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
2298640|NCT02034123|5643156|P17|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
2298641|NCT02034123|5643157|P16|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
2298642|NCT02034123|5643158|P15|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
2298643|NCT02034123|5643159|P14|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
2298644|NCT02034123|5643160|P13|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
2298645|NCT02034123|5643161|P12|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
2298646|NCT02034123|5643162|P11|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
2298647|NCT02034123|5643163|P10|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
2298648|NCT02034123|5643164|P9|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
2298649|NCT02034123|5643165|P8|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||4
2298650|NCT02034123|5643166|P7|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
2298651|NCT02034123|5643167|P6|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||3
2298652|NCT02034123|5643168|P5|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||5
2298653|NCT02034123|5643169|P4|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
2298654|NCT02034123|5643170|P3|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||5
2298655|NCT02034123|5643171|P2|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
2298656|NCT02034123|5643172|P1|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
2298657|NCT02034123|5643155|P18|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
2298658|NCT02034123|5643156|P17|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
2298659|NCT02034123|5643157|P16|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
2298660|NCT02034123|5643158|P15|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
2298661|NCT02034123|5643159|P14|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
2298662|NCT02034123|5643160|P13|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
2298663|NCT02034123|5643161|P12|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
2298664|NCT02034123|5643162|P11|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
2298665|NCT02034123|5643163|P10|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
2298666|NCT02034123|5643164|P9|STARTED|Part1(Median of 7.286 Weeks of Exposure)||2
2298667|NCT02034123|5643165|P8|STARTED|Part1(Median of 7.286 Weeks of Exposure)||5
2298668|NCT02034123|5643166|P7|STARTED|Part1(Median of 7.286 Weeks of Exposure)||2
2298669|NCT02034123|5643167|P6|STARTED|Part1(Median of 7.286 Weeks of Exposure)||3
2298670|NCT02034123|5643168|P5|STARTED|Part1(Median of 7.286 Weeks of Exposure)||7
2298671|NCT02034123|5643169|P4|STARTED|Part1(Median of 7.286 Weeks of Exposure)||3
2298672|NCT02034123|5643170|P3|STARTED|Part1(Median of 7.286 Weeks of Exposure)||5
2298673|NCT02034123|5643171|P2|STARTED|Part1(Median of 7.286 Weeks of Exposure)||1
2298674|NCT02034123|5643172|P1|STARTED|Part1(Median of 7.286 Weeks of Exposure)||1
2298675|NCT02034058|5643491|P1|NOT COMPLETED|Overall Study||3
2298676|NCT02034058|5643491|P1|COMPLETED|Overall Study||149
2298677|NCT02034058|5643491|P1|STARTED|Overall Study|Study stopped early per pre-defined criteria for interim analysis.|152
2298678|NCT02034019|5643501|P2|NOT COMPLETED|Overall Study||2
2298679|NCT02034019|5643502|P1|NOT COMPLETED|Overall Study||1
2298680|NCT02034019|5643501|P2|COMPLETED|Overall Study||81
2298681|NCT02034019|5643502|P1|COMPLETED|Overall Study||163
2298682|NCT02034019|5643501|P2|STARTED|Overall Study||83
2298683|NCT02034019|5643502|P1|STARTED|Overall Study||164
2298684|NCT02034006|5643512|P1|NOT COMPLETED|Overall Study||14
2298685|NCT02034006|5643512|P1|COMPLETED|Overall Study||186
2298686|NCT02034006|5643512|P1|Re-treated Patients|Overall Study||130
2298687|NCT02034006|5643512|P1|Once Treated Patients|Overall Study||70
2298688|NCT02034006|5643512|P1|STARTED|Overall Study||200
2298689|NCT02033993|5643545|P2|NOT COMPLETED|Overall Study||9
2298690|NCT02033993|5643546|P1|NOT COMPLETED|Overall Study||3
2298691|NCT02033993|5643545|P2|COMPLETED|Overall Study||91
2298692|NCT02033993|5643546|P1|COMPLETED|Overall Study||96
2298693|NCT02033993|5643545|P2|STARTED|Overall Study||100
2298694|NCT02033993|5643546|P1|STARTED|Overall Study||99
2298695|NCT02033889|5643563|P3|NOT COMPLETED|Overall Study||25
2298696|NCT02033889|5643564|P2|NOT COMPLETED|Overall Study||20
2298697|NCT02033889|5643565|P1|NOT COMPLETED|Overall Study||34
2298698|NCT02033889|5643563|P3|COMPLETED|Overall Study||180
2298699|NCT02033889|5643564|P2|COMPLETED|Overall Study||187
2298700|NCT02033889|5643565|P1|COMPLETED|Overall Study||175
2298701|NCT02033889|5643563|P3|STARTED|Overall Study||205
2298702|NCT02033889|5643564|P2|STARTED|Overall Study||207
2298703|NCT02033889|5643565|P1|STARTED|Overall Study||209
2298704|NCT02033876|5643719|P2|NOT COMPLETED|Overall Study||0
2298705|NCT02033876|5643720|P1|NOT COMPLETED|Overall Study||0
2298706|NCT02033876|5643719|P2|COMPLETED|Overall Study||12
2298707|NCT02033876|5643720|P1|COMPLETED|Overall Study||12
2298708|NCT02033876|5643719|P2|STARTED|Overall Study||12
2298709|NCT02033876|5643720|P1|STARTED|Overall Study||12
2298710|NCT02033850|5643742|P2|NOT COMPLETED|Overall Study||1
2298711|NCT02033850|5643743|P1|NOT COMPLETED|Overall Study||2
2298712|NCT02033850|5643742|P2|COMPLETED|Overall Study||22
2298713|NCT02033850|5643743|P1|COMPLETED|Overall Study||21
2298714|NCT02033850|5643742|P2|STARTED|Overall Study||23
2298715|NCT02033850|5643743|P1|STARTED|Overall Study||23
2298716|NCT02033499|5643768|P3|NOT COMPLETED|Overall Study||9
2298717|NCT02033499|5643769|P2|NOT COMPLETED|Overall Study||8
2298718|NCT02033499|5643770|P1|NOT COMPLETED|Overall Study||5
2298719|NCT02033499|5643768|P3|COMPLETED|Overall Study||139
2298720|NCT02033499|5643769|P2|COMPLETED|Overall Study||142
2298721|NCT02033499|5643770|P1|COMPLETED|Overall Study||147
2298722|NCT02033499|5643768|P3|STARTED|Overall Study||148
2298723|NCT02033499|5643769|P2|STARTED|Overall Study||150
2298724|NCT02033499|5643770|P1|STARTED|Overall Study||152
2298725|NCT02033369|5643810|P2|NOT COMPLETED|Overall Study||5
2298726|NCT02033369|5643811|P1|NOT COMPLETED|Overall Study||5
2298727|NCT02033369|5643810|P2|COMPLETED|Overall Study||21
2298728|NCT02033369|5643811|P1|COMPLETED|Overall Study||21
2298729|NCT02033369|5643810|P2|STARTED|Overall Study||26
2298730|NCT02033369|5643811|P1|STARTED|Overall Study||26
2298731|NCT02033317|5643821|P1|NOT COMPLETED|Overall Study||0
2298732|NCT02033317|5643821|P1|COMPLETED|Overall Study||6
2298733|NCT02033317|5643821|P1|STARTED|Overall Study||6
2298734|NCT02033213|5643828|P2|NOT COMPLETED|Overall Study||0
2298735|NCT02033213|5643829|P1|NOT COMPLETED|Overall Study||0
2298736|NCT02033213|5643828|P2|COMPLETED|Overall Study||8
2298737|NCT02033213|5643829|P1|COMPLETED|Overall Study||8
2298738|NCT02033213|5643828|P2|STARTED|Overall Study||8
2298739|NCT02033213|5643829|P1|STARTED|Overall Study||8
2298740|NCT02033200|5643847|P2|NOT COMPLETED|Overall Study||0
2298741|NCT02033200|5643848|P1|NOT COMPLETED|Overall Study||0
2298742|NCT02033200|5643847|P2|COMPLETED|Overall Study||40
2298743|NCT02033200|5643848|P1|COMPLETED|Overall Study||40
2298744|NCT02033200|5643847|P2|STARTED|Overall Study||40
2298745|NCT02033200|5643848|P1|STARTED|Overall Study||40
2298746|NCT02033174|5643868|P2|NOT COMPLETED|Second Intervention||0
2298747|NCT02033174|5643869|P1|NOT COMPLETED|Second Intervention||0
2298748|NCT02033174|5643868|P2|COMPLETED|Second Intervention||8
2298749|NCT02033174|5643869|P1|COMPLETED|Second Intervention||8
2298750|NCT02033174|5643868|P2|STARTED|Second Intervention||8
2298751|NCT02033174|5643869|P1|STARTED|Second Intervention||8
2298752|NCT02033174|5643868|P2|NOT COMPLETED|Washout (1 Week)||0
2298753|NCT02033174|5643869|P1|NOT COMPLETED|Washout (1 Week)||0
2298754|NCT02033174|5643868|P2|COMPLETED|Washout (1 Week)||8
2298755|NCT02033174|5643869|P1|COMPLETED|Washout (1 Week)||8
2298756|NCT02033174|5643868|P2|STARTED|Washout (1 Week)||8
2298757|NCT02033174|5643869|P1|STARTED|Washout (1 Week)||8
2298758|NCT02033174|5643868|P2|NOT COMPLETED|First Intervention||0
2298759|NCT02033174|5643869|P1|NOT COMPLETED|First Intervention||0
2298760|NCT02033174|5643868|P2|COMPLETED|First Intervention||8
2298761|NCT02033174|5643869|P1|COMPLETED|First Intervention||8
2298762|NCT02033174|5643868|P2|STARTED|First Intervention||8
2298763|NCT02033174|5643869|P1|STARTED|First Intervention||8
2298764|NCT02033083|5643877|P2|NOT COMPLETED|Overall Study||1
2298765|NCT02033083|5643878|P1|NOT COMPLETED|Overall Study||1
2298766|NCT02033083|5643877|P2|COMPLETED|Overall Study||88
2298767|NCT02033083|5643878|P1|COMPLETED|Overall Study||88
2298768|NCT02033083|5643877|P2|STARTED|Overall Study||89
2298769|NCT02033083|5643878|P1|STARTED|Overall Study||89
2298770|NCT02033005|5643887|P3|NOT COMPLETED|Overall Study||10
2298771|NCT02033005|5643888|P2|NOT COMPLETED|Overall Study||0
2298772|NCT02033005|5643889|P1|NOT COMPLETED|Overall Study||44
2298773|NCT02033005|5643887|P3|COMPLETED|Overall Study||25
2298774|NCT02033005|5643888|P2|COMPLETED|Overall Study||9
2298775|NCT02033005|5643889|P1|COMPLETED|Overall Study||36
2298776|NCT02033005|5643887|P3|STARTED|Overall Study||35
2298777|NCT02033005|5643888|P2|STARTED|Overall Study||9
2298778|NCT02033005|5643889|P1|STARTED|Overall Study||80
2298779|NCT02032901|5643905|P2|NOT COMPLETED|Follow-Up Period (24 Weeks)||1
2298780|NCT02032901|5643906|P1|NOT COMPLETED|Follow-Up Period (24 Weeks)||0
2298781|NCT02032901|5643905|P2|COMPLETED|Follow-Up Period (24 Weeks)||50
2298782|NCT02032901|5643906|P1|COMPLETED|Follow-Up Period (24 Weeks)||101
2298783|NCT02032901|5643905|P2|STARTED|Follow-Up Period (24 Weeks)||51
2298784|NCT02032901|5643906|P1|STARTED|Follow-Up Period (24 Weeks)|Participant could enter follow up period even if the treatment period was not completed.|101
2298785|NCT02032901|5643905|P2|NOT COMPLETED|Treatment Period (12 Weeks)||0
2298786|NCT02032901|5643906|P1|NOT COMPLETED|Treatment Period (12 Weeks)||1
2298787|NCT02032901|5643905|P2|COMPLETED|Treatment Period (12 Weeks)||51
2298788|NCT02032901|5643906|P1|COMPLETED|Treatment Period (12 Weeks)||100
2298789|NCT02032901|5643905|P2|STARTED|Treatment Period (12 Weeks)||51
2298790|NCT02032901|5643906|P1|STARTED|Treatment Period (12 Weeks)||101
2298791|NCT02032888|5643930|P3|NOT COMPLETED|Follow-up Period||0
2298792|NCT02032888|5643931|P2|NOT COMPLETED|Follow-up Period||2
2298793|NCT02032888|5643932|P1|NOT COMPLETED|Follow-up Period||3
2298794|NCT02032888|5643930|P3|COMPLETED|Follow-up Period||52
2298795|NCT02032888|5643931|P2|COMPLETED|Follow-up Period||47
2298796|NCT02032888|5643932|P1|COMPLETED|Follow-up Period||97
2298797|NCT02032888|5643930|P3|STARTED|Follow-up Period||52
2298798|NCT02032888|5643931|P2|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|49
2298799|NCT02032888|5643932|P1|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|100
2298800|NCT02032888|5643930|P3|NOT COMPLETED|Treatment Period||0
2298801|NCT02032888|5643931|P2|NOT COMPLETED|Treatment Period||2
2298802|NCT02032888|5643932|P1|NOT COMPLETED|Treatment Period||2
2298803|NCT02032888|5643930|P3|COMPLETED|Treatment Period||52
2298804|NCT02032888|5643931|P2|COMPLETED|Treatment Period||48
2298805|NCT02032888|5643932|P1|COMPLETED|Treatment Period||99
2298806|NCT02032888|5643930|P3|STARTED|Treatment Period||52
2298807|NCT02032888|5643931|P2|STARTED|Treatment Period||50
2298808|NCT02032888|5643932|P1|STARTED|Treatment Period||101
2298809|NCT02032875|5643963|P2|NOT COMPLETED|Follow-up Period||11
2298810|NCT02032875|5643964|P1|NOT COMPLETED|Follow-up Period||3
2298811|NCT02032875|5643963|P2|COMPLETED|Follow-up Period||46
2298812|NCT02032875|5643964|P1|COMPLETED|Follow-up Period||50
2298813|NCT02032875|5643963|P2|STARTED|Follow-up Period|Of 60 participants in treatment period, 57 continued in follow-up, 3 entered treatment extension.|57
2298814|NCT02032875|5643964|P1|STARTED|Follow-up Period|Out of 53 participants who entered the treatment period, all 53 continued in the follow-up period.|53
2298815|NCT02032875|5643963|P2|NOT COMPLETED|Treatment Period||4
2298816|NCT02032875|5643964|P1|NOT COMPLETED|Treatment Period||1
2298817|NCT02032875|5643963|P2|COMPLETED|Treatment Period||56
2298818|NCT02032875|5643964|P1|COMPLETED|Treatment Period||52
2298819|NCT02032875|5643963|P2|STARTED|Treatment Period||60
2298820|NCT02032875|5643964|P1|STARTED|Treatment Period||53
2298821|NCT02032810|5643984|P2|NOT COMPLETED|Overall Study||0
2298822|NCT02032810|5643985|P1|NOT COMPLETED|Overall Study||0
2298823|NCT02032810|5643984|P2|COMPLETED|Overall Study||11
2298824|NCT02032810|5643985|P1|COMPLETED|Overall Study||6
2298825|NCT02032810|5643984|P2|STARTED|Overall Study||11
2298826|NCT02032810|5643985|P1|STARTED|Overall Study||6
2298827|NCT02032758|5643998|P2|NOT COMPLETED|Overall Study||0
2298828|NCT02032758|5643999|P1|NOT COMPLETED|Overall Study||0
2298829|NCT02032758|5643998|P2|COMPLETED|Overall Study||11
2298830|NCT02032758|5643999|P1|COMPLETED|Overall Study||27
2298831|NCT02032758|5643998|P2|STARTED|Overall Study||11
2298832|NCT02032758|5643999|P1|STARTED|Overall Study||27
2298833|NCT02032706|5644007|P1|NOT COMPLETED|Overall Study||6
2298834|NCT02032706|5644007|P1|COMPLETED|Overall Study||30
2298835|NCT02032706|5644007|P1|STARTED|Overall Study||36
2298836|NCT02032641|5644020|P1|NOT COMPLETED|Overall Study||1
2298837|NCT02032641|5644020|P1|COMPLETED|Overall Study|16 brows completed study (half underwent treatment, half were control)|8
2298838|NCT02032641|5644020|P1|STARTED|Overall Study|18 Brows enrolled for evaluation|9
2298839|NCT02032433|5644032|P2|NOT COMPLETED|Overall Study||62
2298840|NCT02032433|5644033|P1|NOT COMPLETED|Overall Study||78
2298841|NCT02032433|5644032|P2|COMPLETED|Overall Study||225
2298842|NCT02032433|5644033|P1|COMPLETED|Overall Study||205
2298843|NCT02032433|5644032|P2|STARTED|Overall Study||287
2298844|NCT02032433|5644033|P1|STARTED|Overall Study||283
2298845|NCT02032420|5644051|P2|NOT COMPLETED|Overall Study||0
2298846|NCT02032420|5644052|P1|NOT COMPLETED|Overall Study||0
2298847|NCT02032420|5644051|P2|COMPLETED|Overall Study||17
2298848|NCT02032420|5644052|P1|COMPLETED|Overall Study||18
2298849|NCT02032420|5644051|P2|STARTED|Overall Study||17
2298850|NCT02032420|5644052|P1|STARTED|Overall Study||18
2298851|NCT02032407|5644064|P1|NOT COMPLETED|Overall Study||5
2298852|NCT02032407|5644064|P1|COMPLETED|Overall Study||63
2298853|NCT02032407|5644064|P1|STARTED|Overall Study||68
2298854|NCT02032238|5644077|P2|NOT COMPLETED|Overall Study||0
2298855|NCT02032238|5644078|P1|NOT COMPLETED|Overall Study||2
2298856|NCT02032238|5644077|P2|COMPLETED|Overall Study||0
2298857|NCT02032238|5644078|P1|COMPLETED|Overall Study||10
2298858|NCT02032238|5644077|P2|STARTED|Overall Study|Study Terminated due to slow enrollment, no subjects enrolled in this study arm|0
2298859|NCT02032238|5644078|P1|STARTED|Overall Study||12
2298860|NCT02032212|5644088|P4|NOT COMPLETED|Overall Study||0
2298861|NCT02032212|5644089|P3|NOT COMPLETED|Overall Study||0
2298862|NCT02032212|5644090|P2|NOT COMPLETED|Overall Study||0
2298863|NCT02032212|5644091|P1|NOT COMPLETED|Overall Study||0
2298864|NCT02032212|5644088|P4|COMPLETED|Overall Study||3
2298865|NCT02032212|5644089|P3|COMPLETED|Overall Study||3
2298866|NCT02032212|5644090|P2|COMPLETED|Overall Study||3
2298867|NCT02032212|5644091|P1|COMPLETED|Overall Study||3
2298868|NCT02032212|5644088|P4|STARTED|Overall Study||3
2298869|NCT02032212|5644089|P3|STARTED|Overall Study||3
2298870|NCT02032212|5644090|P2|STARTED|Overall Study||3
2298871|NCT02032212|5644091|P1|STARTED|Overall Study||3
2298872|NCT02031679|5644119|P2|NOT COMPLETED|Overall Study||2
2298873|NCT02031679|5644120|P1|NOT COMPLETED|Overall Study||0
2298874|NCT02031679|5644119|P2|COMPLETED|Overall Study||12
2298875|NCT02031679|5644120|P1|COMPLETED|Overall Study||14
2298876|NCT02031679|5644119|P2|STARTED|Overall Study||14
2298877|NCT02031679|5644120|P1|STARTED|Overall Study||14
2298878|NCT02031640|5644135|P6|NOT COMPLETED|Double-blind Treatment Period||3
2298879|NCT02031640|5644136|P5|NOT COMPLETED|Double-blind Treatment Period||11
2298880|NCT02031640|5644137|P4|NOT COMPLETED|Double-blind Treatment Period||7
2298881|NCT02031640|5644138|P3|NOT COMPLETED|Double-blind Treatment Period||6
2298882|NCT02031640|5644139|P2|NOT COMPLETED|Double-blind Treatment Period||22
2298883|NCT02031640|5644140|P1|NOT COMPLETED|Double-blind Treatment Period||0
2298884|NCT02031640|5644135|P6|COMPLETED|Double-blind Treatment Period||104
2298885|NCT02031640|5644136|P5|COMPLETED|Double-blind Treatment Period||96
2298886|NCT02031640|5644137|P4|COMPLETED|Double-blind Treatment Period||99
2298887|NCT02031640|5644138|P3|COMPLETED|Double-blind Treatment Period||100
2298888|NCT02031640|5644139|P2|COMPLETED|Double-blind Treatment Period||84
2298889|NCT02031640|5644140|P1|COMPLETED|Double-blind Treatment Period||0
2298890|NCT02031640|5644135|P6|Full Analysis Set|Double-blind Treatment Period||107
2298891|NCT02031640|5644136|P5|Full Analysis Set|Double-blind Treatment Period||106
2298892|NCT02031640|5644137|P4|Full Analysis Set|Double-blind Treatment Period||106
2298893|NCT02031640|5644138|P3|Full Analysis Set|Double-blind Treatment Period||104
2298894|NCT02031640|5644139|P2|Full Analysis Set|Double-blind Treatment Period||106
2298895|NCT02031640|5644140|P1|Full Analysis Set|Double-blind Treatment Period||0
2298896|NCT02031640|5644135|P6|STARTED|Double-blind Treatment Period||107
2298897|NCT02031640|5644136|P5|STARTED|Double-blind Treatment Period||107
2298898|NCT02031640|5644137|P4|STARTED|Double-blind Treatment Period||106
2298899|NCT02031640|5644138|P3|STARTED|Double-blind Treatment Period||106
2298900|NCT02031640|5644139|P2|STARTED|Double-blind Treatment Period||106
2298901|NCT02031640|5644140|P1|STARTED|Double-blind Treatment Period||0
2298902|NCT02031640|5644135|P6|NOT COMPLETED|Run-In Period||0
2298903|NCT02031640|5644136|P5|NOT COMPLETED|Run-In Period||0
2298904|NCT02031640|5644137|P4|NOT COMPLETED|Run-In Period||0
2298905|NCT02031640|5644138|P3|NOT COMPLETED|Run-In Period||0
2298906|NCT02031640|5644139|P2|NOT COMPLETED|Run-In Period||0
2298907|NCT02031640|5644140|P1|NOT COMPLETED|Run-In Period||169
2298908|NCT02031640|5644135|P6|COMPLETED|Run-In Period||0
2298909|NCT02031640|5644136|P5|COMPLETED|Run-In Period||0
2298910|NCT02031640|5644137|P4|COMPLETED|Run-In Period||0
2298911|NCT02031640|5644138|P3|COMPLETED|Run-In Period||0
2298912|NCT02031640|5644139|P2|COMPLETED|Run-In Period||0
2298913|NCT02031640|5644140|P1|COMPLETED|Run-In Period||532
2298914|NCT02031640|5644135|P6|STARTED|Run-In Period||0
2298915|NCT02031640|5644136|P5|STARTED|Run-In Period||0
2298916|NCT02031640|5644137|P4|STARTED|Run-In Period||0
2298917|NCT02031640|5644138|P3|STARTED|Run-In Period||0
2298918|NCT02031640|5644139|P2|STARTED|Run-In Period||0
2298919|NCT02031640|5644140|P1|STARTED|Run-In Period||701
2298920|NCT02031640|5644135|P6|NOT COMPLETED|Screening Period||0
2298921|NCT02031640|5644136|P5|NOT COMPLETED|Screening Period||0
2298922|NCT02031640|5644137|P4|NOT COMPLETED|Screening Period||0
2298923|NCT02031640|5644138|P3|NOT COMPLETED|Screening Period||0
2298924|NCT02031640|5644139|P2|NOT COMPLETED|Screening Period||0
2298925|NCT02031640|5644140|P1|NOT COMPLETED|Screening Period||412
2298926|NCT02031640|5644135|P6|COMPLETED|Screening Period||0
2298927|NCT02031640|5644136|P5|COMPLETED|Screening Period||0
2298928|NCT02031640|5644137|P4|COMPLETED|Screening Period||0
2298929|NCT02031640|5644138|P3|COMPLETED|Screening Period||0
2298930|NCT02031640|5644139|P2|COMPLETED|Screening Period||0
2298931|NCT02031640|5644140|P1|COMPLETED|Screening Period||701
2298932|NCT02031640|5644135|P6|STARTED|Screening Period||0
2298933|NCT02031640|5644136|P5|STARTED|Screening Period||0
2298934|NCT02031640|5644137|P4|STARTED|Screening Period||0
2298935|NCT02031640|5644138|P3|STARTED|Screening Period||0
2298936|NCT02031640|5644139|P2|STARTED|Screening Period||0
2298937|NCT02031640|5644140|P1|STARTED|Screening Period|Consented|1113
2298938|NCT02031471|5644183|P1|NOT COMPLETED|Long Term Extension (LTE) Period||2
2298939|NCT02031471|5644183|P1|COMPLETED|Long Term Extension (LTE) Period||37
2298940|NCT02031471|5644183|P1|STARTED|Long Term Extension (LTE) Period|Only participants who achieved at least a moderate EULAR response at Week 24 entered the LTE Period.|39
2298941|NCT02031471|5644183|P1|NOT COMPLETED|24 Week Treatment Period||11
2298942|NCT02031471|5644183|P1|COMPLETED|24 Week Treatment Period||46
2298943|NCT02031471|5644183|P1|STARTED|24 Week Treatment Period||57
2298944|NCT02031458|5644216|P3|NOT COMPLETED|Baseline to May 8, 2015||253
2298945|NCT02031458|5644217|P2|NOT COMPLETED|Baseline to May 8, 2015||267
2298946|NCT02031458|5644218|P1|NOT COMPLETED|Baseline to May 8, 2015||139
2298947|NCT02031458|5644216|P3|COMPLETED|Baseline to May 8, 2015||0
2298948|NCT02031458|5644217|P2|COMPLETED|Baseline to May 8, 2015||0
2298949|NCT02031458|5644218|P1|COMPLETED|Baseline to May 8, 2015||0
2298950|NCT02031458|5644216|P3|STARTED|Baseline to May 8, 2015||253
2298951|NCT02031458|5644217|P2|STARTED|Baseline to May 8, 2015||267
2298952|NCT02031458|5644218|P1|STARTED|Baseline to May 8, 2015||139
2298953|NCT02031458|5644216|P3|NOT COMPLETED|May 8, 2015 to January 11, 2019||252
2298954|NCT02031458|5644217|P2|NOT COMPLETED|May 8, 2015 to January 11, 2019||269
2298955|NCT02031458|5644218|P1|NOT COMPLETED|May 8, 2015 to January 11, 2019||138
2298956|NCT02031458|5644216|P3|COMPLETED|May 8, 2015 to January 11, 2019||0
2298957|NCT02031458|5644217|P2|COMPLETED|May 8, 2015 to January 11, 2019||0
2298958|NCT02031458|5644218|P1|COMPLETED|May 8, 2015 to January 11, 2019||0
2298959|NCT02031458|5644216|P3|STARTED|May 8, 2015 to January 11, 2019||252
2298960|NCT02031458|5644217|P2|STARTED|May 8, 2015 to January 11, 2019||269
2298961|NCT02031458|5644218|P1|STARTED|May 8, 2015 to January 11, 2019||138
2298962|NCT02031432|5644312|P1|NOT COMPLETED|Overall Study||38
2298963|NCT02031432|5644312|P1|COMPLETED|Overall Study||38
2298964|NCT02031432|5644312|P1|Completing the Treatment|Overall Study||39
2298965|NCT02031432|5644312|P1|Completing the Titration Phase|Overall Study||67
2298966|NCT02031432|5644312|P1|STARTED|Overall Study||76
2298967|NCT02031302|5644339|P2|NOT COMPLETED|Overall Study||0
2298968|NCT02031302|5644340|P1|NOT COMPLETED|Overall Study||164
2298969|NCT02031302|5644339|P2|COMPLETED|Overall Study||50
2298970|NCT02031302|5644340|P1|COMPLETED|Overall Study||850
2298971|NCT02031302|5644339|P2|STARTED|Overall Study||50
2298972|NCT02031302|5644340|P1|STARTED|Overall Study||1014
2298973|NCT02031276|5644361|P3|NOT COMPLETED|Period 3 Open-label Risankizumab SC||2
2298974|NCT02031276|5644362|P2|NOT COMPLETED|Period 3 Open-label Risankizumab SC||3
2298975|NCT02031276|5644363|P1|NOT COMPLETED|Period 3 Open-label Risankizumab SC||3
2298976|NCT02031276|5644361|P3|COMPLETED|Period 3 Open-label Risankizumab SC||19
2298977|NCT02031276|5644362|P2|COMPLETED|Period 3 Open-label Risankizumab SC||19
2298978|NCT02031276|5644363|P1|COMPLETED|Period 3 Open-label Risankizumab SC||16
2298979|NCT02031276|5644361|P3|STARTED|Period 3 Open-label Risankizumab SC|17 participants did not enter period 3 (not in clinical remission)|21
2298980|NCT02031276|5644362|P2|STARTED|Period 3 Open-label Risankizumab SC|11 participants did not enter period 3 (not in clinical remission)|22
2298981|NCT02031276|5644363|P1|STARTED|Period 3 Open-label Risankizumab SC|10 participants did not enter period 3 (not in clinical remission)|19
2298982|NCT02031276|5644361|P3|NOT COMPLETED|Period 2 Open-label Risankizumab IV||1
2298983|NCT02031276|5644362|P2|NOT COMPLETED|Period 2 Open-label Risankizumab IV||2
2298984|NCT02031276|5644363|P1|NOT COMPLETED|Period 2 Open-label Risankizumab IV||4
2298985|NCT02031276|5644361|P3|COMPLETED|Period 2 Open-label Risankizumab IV||38
2298986|NCT02031276|5644362|P2|COMPLETED|Period 2 Open-label Risankizumab IV||33
2298987|NCT02031276|5644363|P1|COMPLETED|Period 2 Open-label Risankizumab IV||29
2298988|NCT02031276|5644361|P3|STARTED|Period 2 Open-label Risankizumab IV|1 participant did not enter Period 2 (declined open-label treatment in Period 2)|39
2298989|NCT02031276|5644362|P2|STARTED|Period 2 Open-label Risankizumab IV||35
2298990|NCT02031276|5644363|P1|STARTED|Period 2 Open-label Risankizumab IV||33
2298991|NCT02031276|5644361|P3|NOT COMPLETED|Period 1 Double-blind IV||1
2298992|NCT02031276|5644362|P2|NOT COMPLETED|Period 1 Double-blind IV||6
2298993|NCT02031276|5644363|P1|NOT COMPLETED|Period 1 Double-blind IV||6
2298994|NCT02031276|5644361|P3|COMPLETED|Period 1 Double-blind IV||40
2298995|NCT02031276|5644362|P2|COMPLETED|Period 1 Double-blind IV||35
2298996|NCT02031276|5644363|P1|COMPLETED|Period 1 Double-blind IV||33
2298997|NCT02031276|5644361|P3|STARTED|Period 1 Double-blind IV||41
2298998|NCT02031276|5644362|P2|STARTED|Period 1 Double-blind IV||41
2298999|NCT02031276|5644363|P1|STARTED|Period 1 Double-blind IV||39
2299000|NCT02031237|5644397|P3|NOT COMPLETED|Overall Study||3
2299001|NCT02031237|5644398|P2|NOT COMPLETED|Overall Study||14
2299002|NCT02031237|5644399|P1|NOT COMPLETED|Overall Study||5
2299003|NCT02031237|5644397|P3|COMPLETED|Overall Study||0
2299004|NCT02031237|5644398|P2|COMPLETED|Overall Study||21
2299005|NCT02031237|5644399|P1|COMPLETED|Overall Study||9
2299006|NCT02031237|5644397|P3|STARTED|Overall Study||3
2299007|NCT02031237|5644398|P2|STARTED|Overall Study||35
2299008|NCT02031237|5644399|P1|STARTED|Overall Study||14
2299009|NCT02030847|5644406|P1|NOT COMPLETED|Overall Study||37
2299010|NCT02030847|5644406|P1|COMPLETED|Overall Study||5
2299011|NCT02030847|5644406|P1|STARTED|Overall Study||42
2299012|NCT02030821|5644415|P4|NOT COMPLETED|Overall Study||2
2299013|NCT02030821|5644416|P3|NOT COMPLETED|Overall Study||5
2299014|NCT02030821|5644417|P2|NOT COMPLETED|Overall Study||2
2299015|NCT02030821|5644418|P1|NOT COMPLETED|Overall Study||2
2299016|NCT02030821|5644415|P4|COMPLETED|Overall Study||72
2299017|NCT02030821|5644416|P3|COMPLETED|Overall Study||73
2299018|NCT02030821|5644417|P2|COMPLETED|Overall Study||44
2299019|NCT02030821|5644418|P1|COMPLETED|Overall Study||46
2299020|NCT02030821|5644415|P4|STARTED|Overall Study||74
2299021|NCT02030821|5644416|P3|STARTED|Overall Study||78
2299022|NCT02030821|5644417|P2|STARTED|Overall Study||46
2299023|NCT02030821|5644418|P1|STARTED|Overall Study||48
2299024|NCT02030600|5644446|P2|NOT COMPLETED|Treatment Period 2||18
2299025|NCT02030600|5644447|P1|NOT COMPLETED|Treatment Period 2||25
2299026|NCT02030600|5644446|P2|COMPLETED|Treatment Period 2||297
2299027|NCT02030600|5644447|P1|COMPLETED|Treatment Period 2||283
2299028|NCT02030600|5644446|P2|STARTED|Treatment Period 2||315
2299029|NCT02030600|5644447|P1|STARTED|Treatment Period 2||308
2299030|NCT02030600|5644446|P2|NOT COMPLETED|Treatment Period 1||45
2299031|NCT02030600|5644447|P1|NOT COMPLETED|Treatment Period 1||53
2299032|NCT02030600|5644446|P2|COMPLETED|Treatment Period 1||315
2299033|NCT02030600|5644447|P1|COMPLETED|Treatment Period 1||308
2299034|NCT02030600|5644446|P2|Exposed|Treatment Period 1||357
2299035|NCT02030600|5644447|P1|Exposed|Treatment Period 1||356
2299036|NCT02030600|5644446|P2|STARTED|Treatment Period 1||360
2299037|NCT02030600|5644447|P1|STARTED|Treatment Period 1||361
2299038|NCT02030574|5644463|P1|NOT COMPLETED|Overall Study||0
2299039|NCT02030574|5644463|P1|COMPLETED|Overall Study||2
2299040|NCT02030574|5644463|P1|STARTED|Overall Study||2
2299041|NCT02030535|5644468|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
2299042|NCT02030535|5644468|P1|COMPLETED|Treatment Period 3 (1 Day)||52
2299043|NCT02030535|5644468|P1|STARTED|Treatment Period 3 (1 Day)||52
2299044|NCT02030535|5644468|P1|NOT COMPLETED|Washout Period 2 (21 Days)||0
2299045|NCT02030535|5644468|P1|COMPLETED|Washout Period 2 (21 Days)||52
2299046|NCT02030535|5644468|P1|STARTED|Washout Period 2 (21 Days)||52
2299047|NCT02030535|5644468|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
2299048|NCT02030535|5644468|P1|COMPLETED|Treatment Period 2 (1 Day)||52
2299049|NCT02030535|5644468|P1|STARTED|Treatment Period 2 (1 Day)||52
2299050|NCT02030535|5644468|P1|NOT COMPLETED|Washout Period 1 (21 Days)||1
2299051|NCT02030535|5644468|P1|COMPLETED|Washout Period 1 (21 Days)||52
2299052|NCT02030535|5644468|P1|STARTED|Washout Period 1 (21 Days)||53
2299053|NCT02030535|5644468|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
2299054|NCT02030535|5644468|P1|COMPLETED|Treatment Period 1 (1 Day)||53
2299055|NCT02030535|5644468|P1|STARTED|Treatment Period 1 (1 Day)||53
2299056|NCT02030405|5644536|P1|NOT COMPLETED|Overall Study||2
2299057|NCT02030405|5644536|P1|COMPLETED|Overall Study||2
2299058|NCT02030405|5644536|P1|STARTED|Overall Study||4
2299059|NCT02030119|5644547|P4|NOT COMPLETED|Overall Study||3
2299060|NCT02030119|5644548|P3|NOT COMPLETED|Overall Study||6
2299061|NCT02030119|5644549|P2|NOT COMPLETED|Overall Study||2
2299062|NCT02030119|5644550|P1|NOT COMPLETED|Overall Study||3
2299063|NCT02030119|5644547|P4|COMPLETED|Overall Study||67
2299064|NCT02030119|5644548|P3|COMPLETED|Overall Study||65
2299065|NCT02030119|5644549|P2|COMPLETED|Overall Study||68
2299066|NCT02030119|5644550|P1|COMPLETED|Overall Study||67
2299067|NCT02030119|5644547|P4|STARTED|Overall Study||70
2299068|NCT02030119|5644548|P3|STARTED|Overall Study||71
2299069|NCT02030119|5644549|P2|STARTED|Overall Study||70
2299070|NCT02030119|5644550|P1|STARTED|Overall Study||70
2299071|NCT02030080|5644568|P4|NOT COMPLETED|Overall Study||2
2299072|NCT02030080|5644569|P3|NOT COMPLETED|Overall Study||0
2299073|NCT02030080|5644570|P2|NOT COMPLETED|Overall Study||0
2299074|NCT02030080|5644571|P1|NOT COMPLETED|Overall Study||0
2299075|NCT02030080|5644568|P4|COMPLETED|Overall Study||42
2299076|NCT02030080|5644569|P3|COMPLETED|Overall Study||80
2299077|NCT02030080|5644570|P2|COMPLETED|Overall Study||64
2299078|NCT02030080|5644571|P1|COMPLETED|Overall Study||100
2299079|NCT02030080|5644568|P4|STARTED|Overall Study|11 teams|44
2299080|NCT02030080|5644569|P3|STARTED|Overall Study|20 teams|80
2299081|NCT02030080|5644570|P2|STARTED|Overall Study|16 teams|64
2299082|NCT02030080|5644571|P1|STARTED|Overall Study|25 teams|100
2299083|NCT02030041|5644588|P3|NOT COMPLETED|Overall Study||1
2299084|NCT02030041|5644589|P2|NOT COMPLETED|Overall Study||2
2299085|NCT02030041|5644590|P1|NOT COMPLETED|Overall Study||2
2299086|NCT02030041|5644588|P3|COMPLETED|Overall Study||10
2299087|NCT02030041|5644589|P2|COMPLETED|Overall Study||9
2299088|NCT02030041|5644590|P1|COMPLETED|Overall Study||9
2299089|NCT02030041|5644588|P3|STARTED|Overall Study||11
2299090|NCT02030041|5644589|P2|STARTED|Overall Study||11
2299091|NCT02030041|5644590|P1|STARTED|Overall Study||11
2299092|NCT02029989|5644603|P2|NOT COMPLETED|Overall Study||11
2299093|NCT02029989|5644604|P1|NOT COMPLETED|Overall Study||16
2299094|NCT02029989|5644603|P2|COMPLETED|Overall Study||49
2299095|NCT02029989|5644604|P1|COMPLETED|Overall Study||45
2299096|NCT02029989|5644603|P2|STARTED|Overall Study||60
2299097|NCT02029989|5644604|P1|STARTED|Overall Study|A subject was given the same ID# as withdrawn subject (ID # counted twice) causing N=61 discrepancy.|61
2299098|NCT02029911|5644610|P1|NOT COMPLETED|Overall Study||0
2299099|NCT02029911|5644610|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|60
2299100|NCT02029911|5644610|P1|Treated|Overall Study|Treatment Completed|60
2299101|NCT02029911|5644610|P1|STARTED|Overall Study|Treatment Attempted|60
2299102|NCT02029872|5644618|P2|NOT COMPLETED|Overall Study||3
2299103|NCT02029872|5644619|P1|NOT COMPLETED|Overall Study||2
2299104|NCT02029872|5644618|P2|COMPLETED|Overall Study||6
2299105|NCT02029872|5644619|P1|COMPLETED|Overall Study||7
2299106|NCT02029872|5644618|P2|STARTED|Overall Study||9
2299107|NCT02029872|5644619|P1|STARTED|Overall Study||9
2299108|NCT02029846|5644627|P2|NOT COMPLETED|Overall Study||1
2299109|NCT02029846|5644628|P1|NOT COMPLETED|Overall Study||1
2299110|NCT02029846|5644627|P2|COMPLETED|Overall Study||0
2299111|NCT02029846|5644628|P1|COMPLETED|Overall Study||0
2299112|NCT02029846|5644627|P2|STARTED|Overall Study||1
2299113|NCT02029846|5644628|P1|STARTED|Overall Study||1
2299114|NCT02029755|5644641|P3|NOT COMPLETED|Overall Study||0
2299115|NCT02029755|5644642|P2|NOT COMPLETED|Overall Study||0
2299116|NCT02029755|5644643|P1|NOT COMPLETED|Overall Study||0
2299117|NCT02029755|5644641|P3|COMPLETED|Overall Study||36
2299118|NCT02029755|5644642|P2|COMPLETED|Overall Study||36
2299119|NCT02029755|5644643|P1|COMPLETED|Overall Study||36
2299120|NCT02029755|5644641|P3|STARTED|Overall Study||36
2299121|NCT02029755|5644642|P2|STARTED|Overall Study||36
2299122|NCT02029755|5644643|P1|STARTED|Overall Study||36
2299123|NCT02029703|5644656|P2|NOT COMPLETED|Overall Study||0
2299124|NCT02029703|5644657|P1|NOT COMPLETED|Overall Study||0
2299125|NCT02029703|5644656|P2|COMPLETED|Overall Study||22
2299126|NCT02029703|5644657|P1|COMPLETED|Overall Study||20
2299127|NCT02029703|5644656|P2|STARTED|Overall Study||22
2299128|NCT02029703|5644657|P1|STARTED|Overall Study||20
2299129|NCT02029638|5644666|P3|NOT COMPLETED|Overall Study||1
2299130|NCT02029638|5644667|P2|NOT COMPLETED|Overall Study||0
2299131|NCT02029638|5644668|P1|NOT COMPLETED|Overall Study||2
2299132|NCT02029638|5644666|P3|COMPLETED|Overall Study||0
2299133|NCT02029638|5644667|P2|COMPLETED|Overall Study||1
2299134|NCT02029638|5644668|P1|COMPLETED|Overall Study||0
2299135|NCT02029638|5644666|P3|STARTED|Overall Study||1
2299136|NCT02029638|5644667|P2|STARTED|Overall Study||1
2299137|NCT02029638|5644668|P1|STARTED|Overall Study||2
2299138|NCT02029521|5644697|P2|NOT COMPLETED|Overall Study||1
2299139|NCT02029521|5644698|P1|NOT COMPLETED|Overall Study||2
2299140|NCT02029521|5644697|P2|COMPLETED|Overall Study||22
2299141|NCT02029521|5644698|P1|COMPLETED|Overall Study||22
2299142|NCT02029521|5644697|P2|STARTED|Overall Study||23
2299143|NCT02029521|5644698|P1|STARTED|Overall Study||24
2299144|NCT02029495|5644783|P3|NOT COMPLETED|Overall Study||2
2299145|NCT02029495|5644784|P2|NOT COMPLETED|Overall Study||0
2299146|NCT02029495|5644785|P1|NOT COMPLETED|Overall Study||1
2299147|NCT02029495|5644783|P3|COMPLETED|Overall Study||159
2299148|NCT02029495|5644784|P2|COMPLETED|Overall Study||158
2299149|NCT02029495|5644785|P1|COMPLETED|Overall Study||158
2299150|NCT02029495|5644783|P3|STARTED|Overall Study||161
2299151|NCT02029495|5644784|P2|STARTED|Overall Study||158
2299152|NCT02029495|5644785|P1|STARTED|Overall Study||159
2299153|NCT02029417|5644796|P1|NOT COMPLETED|Overall Study||2
2299154|NCT02029417|5644796|P1|COMPLETED|Overall Study||0
2299155|NCT02029417|5644796|P1|STARTED|Overall Study||2
2299156|NCT02029274|5644805|P4|NOT COMPLETED|Overall Study||2
2299157|NCT02029274|5644806|P3|NOT COMPLETED|Overall Study||2
2299158|NCT02029274|5644807|P2|NOT COMPLETED|Overall Study||0
2299159|NCT02029274|5644808|P1|NOT COMPLETED|Overall Study||1
2299160|NCT02029274|5644805|P4|COMPLETED|Overall Study||2
2299161|NCT02029274|5644806|P3|COMPLETED|Overall Study||2
2299162|NCT02029274|5644807|P2|COMPLETED|Overall Study||4
2299163|NCT02029274|5644808|P1|COMPLETED|Overall Study||4
2299164|NCT02029274|5644805|P4|Fixed Dose Period 2|Overall Study||4
2299165|NCT02029274|5644806|P3|Fixed Dose Period 2|Overall Study||4
2299166|NCT02029274|5644807|P2|Fixed Dose Period 2|Overall Study||4
2299167|NCT02029274|5644808|P1|Fixed Dose Period 2|Overall Study||5
2299168|NCT02029274|5644805|P4|STARTED|Overall Study||4
2299169|NCT02029274|5644806|P3|STARTED|Overall Study||4
2299170|NCT02029274|5644807|P2|STARTED|Overall Study||4
2299171|NCT02029274|5644808|P1|STARTED|Overall Study||5
2299172|NCT02029235|5644840|P2|NOT COMPLETED|Overall Study||1
2299173|NCT02029235|5644841|P1|NOT COMPLETED|Overall Study||4
2299174|NCT02029235|5644840|P2|COMPLETED|Overall Study||30
2299175|NCT02029235|5644841|P1|COMPLETED|Overall Study||30
2299176|NCT02029235|5644840|P2|STARTED|Overall Study||31
2299177|NCT02029235|5644841|P1|STARTED|Overall Study||34
2299178|NCT02029196|5644851|P2|NOT COMPLETED|Overall Study||1
2299179|NCT02029196|5644852|P1|NOT COMPLETED|Overall Study||20
2299180|NCT02029196|5644851|P2|COMPLETED|Overall Study||101
2299181|NCT02029196|5644852|P1|COMPLETED|Overall Study||286
2299182|NCT02029196|5644851|P2|STARTED|Overall Study||102
2299183|NCT02029196|5644852|P1|STARTED|Overall Study||306
2299184|NCT02029040|5644862|P2|NOT COMPLETED|Overall Study||0
2299185|NCT02029040|5644863|P1|NOT COMPLETED|Overall Study||0
2299186|NCT02029040|5644862|P2|COMPLETED|Overall Study||25
2299187|NCT02029040|5644863|P1|COMPLETED|Overall Study||27
2299188|NCT02029040|5644862|P2|STARTED|Overall Study||25
2299189|NCT02029040|5644863|P1|STARTED|Overall Study||27
2299190|NCT02028871|5644873|P2|NOT COMPLETED|Overall Study||3
2299191|NCT02028871|5644874|P1|NOT COMPLETED|Overall Study||4
2299192|NCT02028871|5644873|P2|COMPLETED|Overall Study||9
2299193|NCT02028871|5644874|P1|COMPLETED|Overall Study||10
2299194|NCT02028871|5644873|P2|STARTED|Overall Study||12
2299195|NCT02028871|5644874|P1|STARTED|Overall Study||14
2299196|NCT02028780|5644895|P12|NOT COMPLETED|Follow up Phase||0
2299197|NCT02028780|5644896|P11|NOT COMPLETED|Follow up Phase||0
2299198|NCT02028780|5644897|P10|NOT COMPLETED|Follow up Phase||0
2299199|NCT02028780|5644898|P9|NOT COMPLETED|Follow up Phase||0
2299200|NCT02028780|5644899|P8|NOT COMPLETED|Follow up Phase||0
2299201|NCT02028780|5644900|P7|NOT COMPLETED|Follow up Phase||0
2299202|NCT02028780|5644901|P6|NOT COMPLETED|Follow up Phase||0
2299203|NCT02028780|5644902|P5|NOT COMPLETED|Follow up Phase||0
2299204|NCT02028780|5644903|P4|NOT COMPLETED|Follow up Phase||0
2299205|NCT02028780|5644904|P3|NOT COMPLETED|Follow up Phase||0
2299206|NCT02028780|5644905|P2|NOT COMPLETED|Follow up Phase||0
2299207|NCT02028780|5644906|P1|NOT COMPLETED|Follow up Phase||0
2299208|NCT02028780|5644895|P12|COMPLETED|Follow up Phase||9
2299209|NCT02028780|5644896|P11|COMPLETED|Follow up Phase||9
2299210|NCT02028780|5644897|P10|COMPLETED|Follow up Phase||9
2299211|NCT02028780|5644898|P9|COMPLETED|Follow up Phase||9
2299212|NCT02028780|5644899|P8|COMPLETED|Follow up Phase||3
2299213|NCT02028780|5644900|P7|COMPLETED|Follow up Phase||9
2299214|NCT02028780|5644901|P6|COMPLETED|Follow up Phase||6
2299215|NCT02028780|5644902|P5|COMPLETED|Follow up Phase||6
2299216|NCT02028780|5644903|P4|COMPLETED|Follow up Phase||6
2299217|NCT02028780|5644904|P3|COMPLETED|Follow up Phase||6
2299218|NCT02028780|5644905|P2|COMPLETED|Follow up Phase||2
2299219|NCT02028780|5644906|P1|COMPLETED|Follow up Phase||6
2299220|NCT02028780|5644895|P12|STARTED|Follow up Phase||9
2299221|NCT02028780|5644896|P11|STARTED|Follow up Phase||9
2299222|NCT02028780|5644897|P10|STARTED|Follow up Phase||9
2299223|NCT02028780|5644898|P9|STARTED|Follow up Phase||9
2299224|NCT02028780|5644899|P8|STARTED|Follow up Phase||3
2299225|NCT02028780|5644900|P7|STARTED|Follow up Phase||9
2299226|NCT02028780|5644901|P6|STARTED|Follow up Phase||6
2299227|NCT02028780|5644902|P5|STARTED|Follow up Phase||6
2299228|NCT02028780|5644903|P4|STARTED|Follow up Phase||6
2299229|NCT02028780|5644904|P3|STARTED|Follow up Phase||6
2299230|NCT02028780|5644905|P2|STARTED|Follow up Phase||2
2299231|NCT02028780|5644906|P1|STARTED|Follow up Phase||6
2299232|NCT02028780|5644895|P12|NOT COMPLETED|Observation Phase||0
2299233|NCT02028780|5644896|P11|NOT COMPLETED|Observation Phase||0
2299234|NCT02028780|5644897|P10|NOT COMPLETED|Observation Phase||0
2299235|NCT02028780|5644898|P9|NOT COMPLETED|Observation Phase||0
2299236|NCT02028780|5644899|P8|NOT COMPLETED|Observation Phase||0
2299237|NCT02028780|5644900|P7|NOT COMPLETED|Observation Phase||0
2299238|NCT02028780|5644901|P6|NOT COMPLETED|Observation Phase||0
2299239|NCT02028780|5644902|P5|NOT COMPLETED|Observation Phase||0
2299240|NCT02028780|5644903|P4|NOT COMPLETED|Observation Phase||0
2299241|NCT02028780|5644904|P3|NOT COMPLETED|Observation Phase||0
2299242|NCT02028780|5644905|P2|NOT COMPLETED|Observation Phase||0
2299243|NCT02028780|5644906|P1|NOT COMPLETED|Observation Phase||0
2299244|NCT02028780|5644895|P12|COMPLETED|Observation Phase||9
2299245|NCT02028780|5644896|P11|COMPLETED|Observation Phase||9
2299246|NCT02028780|5644897|P10|COMPLETED|Observation Phase||9
2299247|NCT02028780|5644898|P9|COMPLETED|Observation Phase||9
2299248|NCT02028780|5644899|P8|COMPLETED|Observation Phase||3
2299249|NCT02028780|5644900|P7|COMPLETED|Observation Phase||9
2299250|NCT02028780|5644901|P6|COMPLETED|Observation Phase||6
2299251|NCT02028780|5644902|P5|COMPLETED|Observation Phase||6
2299252|NCT02028780|5644903|P4|COMPLETED|Observation Phase||6
2299253|NCT02028780|5644904|P3|COMPLETED|Observation Phase||6
2299254|NCT02028780|5644905|P2|COMPLETED|Observation Phase||2
2299255|NCT02028780|5644906|P1|COMPLETED|Observation Phase||6
2299256|NCT02028780|5644895|P12|STARTED|Observation Phase||9
2299257|NCT02028780|5644896|P11|STARTED|Observation Phase||9
2299258|NCT02028780|5644897|P10|STARTED|Observation Phase||9
2299259|NCT02028780|5644898|P9|STARTED|Observation Phase||9
2299260|NCT02028780|5644899|P8|STARTED|Observation Phase||3
2299261|NCT02028780|5644900|P7|STARTED|Observation Phase||9
2299262|NCT02028780|5644901|P6|STARTED|Observation Phase||6
2299263|NCT02028780|5644902|P5|STARTED|Observation Phase||6
2299264|NCT02028780|5644903|P4|STARTED|Observation Phase||6
2299265|NCT02028780|5644904|P3|STARTED|Observation Phase||6
2299266|NCT02028780|5644905|P2|STARTED|Observation Phase||2
2299267|NCT02028780|5644906|P1|STARTED|Observation Phase||6
2299268|NCT02028767|5644971|P2|NOT COMPLETED|Treatment Period 2||0
2299269|NCT02028767|5644972|P1|NOT COMPLETED|Treatment Period 2||2
2299270|NCT02028767|5644971|P2|COMPLETED|Treatment Period 2||16
2299271|NCT02028767|5644972|P1|COMPLETED|Treatment Period 2||14
2299272|NCT02028767|5644971|P2|STARTED|Treatment Period 2||16
2299273|NCT02028767|5644972|P1|STARTED|Treatment Period 2||16
2299274|NCT02028767|5644971|P2|NOT COMPLETED|Treatment Period 1||0
2299275|NCT02028767|5644972|P1|NOT COMPLETED|Treatment Period 1||0
2299276|NCT02028767|5644971|P2|COMPLETED|Treatment Period 1||16
2299277|NCT02028767|5644972|P1|COMPLETED|Treatment Period 1||16
2299278|NCT02028767|5644971|P2|STARTED|Treatment Period 1||16
2299279|NCT02028767|5644972|P1|STARTED|Treatment Period 1||16
2299280|NCT02028754|5644984|P2|NOT COMPLETED|Overall Study||8
2299281|NCT02028754|5644985|P1|NOT COMPLETED|Overall Study||7
2299282|NCT02028754|5644984|P2|COMPLETED|Overall Study||82
2299283|NCT02028754|5644985|P1|COMPLETED|Overall Study||83
2299284|NCT02028754|5644984|P2|STARTED|Overall Study||90
2299285|NCT02028754|5644985|P1|STARTED|Overall Study||90
2299286|NCT02028715|5645005|P2|NOT COMPLETED|Overall Study||4
2299287|NCT02028715|5645006|P1|NOT COMPLETED|Overall Study||5
2299288|NCT02028715|5645005|P2|COMPLETED|Overall Study||30
2299289|NCT02028715|5645006|P1|COMPLETED|Overall Study||29
2299290|NCT02028715|5645005|P2|STARTED|Overall Study||34
2299291|NCT02028715|5645006|P1|STARTED|Overall Study||34
2299292|NCT02028676|5645033|P9|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
2299293|NCT02028676|5645034|P8|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
2299294|NCT02028676|5645035|P7|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
2299295|NCT02028676|5645036|P6|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
2299296|NCT02028676|5645037|P5|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
2299297|NCT02028676|5645038|P4|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
2299298|NCT02028676|5645039|P3|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
2299299|NCT02028676|5645040|P2|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
2299300|NCT02028676|5645041|P1|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
2299301|NCT02028676|5645033|P9|COMPLETED|Subsequent Cotrimoxazole Randomization||382
2299302|NCT02028676|5645034|P8|COMPLETED|Subsequent Cotrimoxazole Randomization||376
2299303|NCT02028676|5645035|P7|COMPLETED|Subsequent Cotrimoxazole Randomization||0
2299304|NCT02028676|5645036|P6|COMPLETED|Subsequent Cotrimoxazole Randomization||0
2299305|NCT02028676|5645037|P5|COMPLETED|Subsequent Cotrimoxazole Randomization||0
2299306|NCT02028676|5645038|P4|COMPLETED|Subsequent Cotrimoxazole Randomization||0
2299307|NCT02028676|5645039|P3|COMPLETED|Subsequent Cotrimoxazole Randomization||0
2299308|NCT02028676|5645040|P2|COMPLETED|Subsequent Cotrimoxazole Randomization||0
2299309|NCT02028676|5645041|P1|COMPLETED|Subsequent Cotrimoxazole Randomization||0
2299310|NCT02028676|5645033|P9|STARTED|Subsequent Cotrimoxazole Randomization||382
2299311|NCT02028676|5645034|P8|STARTED|Subsequent Cotrimoxazole Randomization||376
2299312|NCT02028676|5645035|P7|STARTED|Subsequent Cotrimoxazole Randomization||0
2299313|NCT02028676|5645036|P6|STARTED|Subsequent Cotrimoxazole Randomization||0
2299314|NCT02028676|5645037|P5|STARTED|Subsequent Cotrimoxazole Randomization||0
2299315|NCT02028676|5645038|P4|STARTED|Subsequent Cotrimoxazole Randomization||0
2299316|NCT02028676|5645039|P3|STARTED|Subsequent Cotrimoxazole Randomization||0
2299317|NCT02028676|5645040|P2|STARTED|Subsequent Cotrimoxazole Randomization||0
2299318|NCT02028676|5645041|P1|STARTED|Subsequent Cotrimoxazole Randomization||0
2299319|NCT02028676|5645033|P9|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
2299320|NCT02028676|5645034|P8|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
2299321|NCT02028676|5645035|P7|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
2299322|NCT02028676|5645036|P6|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
2299323|NCT02028676|5645037|P5|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
2299324|NCT02028676|5645038|P4|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
2299325|NCT02028676|5645039|P3|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
2299326|NCT02028676|5645040|P2|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
2299327|NCT02028676|5645041|P1|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
2299328|NCT02028676|5645033|P9|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
2299329|NCT02028676|5645034|P8|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
2299330|NCT02028676|5645035|P7|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||333
2299331|NCT02028676|5645036|P6|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||336
2299332|NCT02028676|5645037|P5|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
2299333|NCT02028676|5645038|P4|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
2299334|NCT02028676|5645039|P3|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
2299335|NCT02028676|5645040|P2|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
2299336|NCT02028676|5645041|P1|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
2299337|NCT02028676|5645033|P9|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
2299338|NCT02028676|5645034|P8|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
2299339|NCT02028676|5645035|P7|STARTED|Subsequent Once vs Twice Daily ABC+3TC||333
2299340|NCT02028676|5645036|P6|STARTED|Subsequent Once vs Twice Daily ABC+3TC||336
2299341|NCT02028676|5645037|P5|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
2299342|NCT02028676|5645038|P4|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
2299343|NCT02028676|5645039|P3|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
2299344|NCT02028676|5645040|P2|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
2299345|NCT02028676|5645041|P1|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
2299346|NCT02028676|5645033|P9|NOT COMPLETED|Initial Enrolment: Induction ART||0
2299347|NCT02028676|5645034|P8|NOT COMPLETED|Initial Enrolment: Induction ART||0
2299348|NCT02028676|5645035|P7|NOT COMPLETED|Initial Enrolment: Induction ART||0
2299349|NCT02028676|5645036|P6|NOT COMPLETED|Initial Enrolment: Induction ART||0
2299350|NCT02028676|5645037|P5|NOT COMPLETED|Initial Enrolment: Induction ART||0
2299351|NCT02028676|5645038|P4|NOT COMPLETED|Initial Enrolment: Induction ART||0
2299352|NCT02028676|5645039|P3|NOT COMPLETED|Initial Enrolment: Induction ART||0
2299353|NCT02028676|5645040|P2|NOT COMPLETED|Initial Enrolment: Induction ART||0
2299354|NCT02028676|5645041|P1|NOT COMPLETED|Initial Enrolment: Induction ART||0
2299355|NCT02028676|5645033|P9|COMPLETED|Initial Enrolment: Induction ART||0
2299356|NCT02028676|5645034|P8|COMPLETED|Initial Enrolment: Induction ART||0
2299357|NCT02028676|5645035|P7|COMPLETED|Initial Enrolment: Induction ART||0
2299358|NCT02028676|5645036|P6|COMPLETED|Initial Enrolment: Induction ART||0
2299359|NCT02028676|5645037|P5|COMPLETED|Initial Enrolment: Induction ART||405
2299360|NCT02028676|5645038|P4|COMPLETED|Initial Enrolment: Induction ART||404
2299361|NCT02028676|5645039|P3|COMPLETED|Initial Enrolment: Induction ART||397
2299362|NCT02028676|5645040|P2|COMPLETED|Initial Enrolment: Induction ART||0
2299363|NCT02028676|5645041|P1|COMPLETED|Initial Enrolment: Induction ART||0
2299364|NCT02028676|5645033|P9|STARTED|Initial Enrolment: Induction ART||0
2299365|NCT02028676|5645034|P8|STARTED|Initial Enrolment: Induction ART||0
2299366|NCT02028676|5645035|P7|STARTED|Initial Enrolment: Induction ART||0
2299367|NCT02028676|5645036|P6|STARTED|Initial Enrolment: Induction ART||0
2299368|NCT02028676|5645037|P5|STARTED|Initial Enrolment: Induction ART||405
2299369|NCT02028676|5645038|P4|STARTED|Initial Enrolment: Induction ART||404
2299370|NCT02028676|5645039|P3|STARTED|Initial Enrolment: Induction ART||397
2299371|NCT02028676|5645040|P2|STARTED|Initial Enrolment: Induction ART||0
2299372|NCT02028676|5645041|P1|STARTED|Initial Enrolment: Induction ART||0
2299373|NCT02028676|5645033|P9|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
2299374|NCT02028676|5645034|P8|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
2299375|NCT02028676|5645035|P7|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
2299376|NCT02028676|5645036|P6|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
2299377|NCT02028676|5645037|P5|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
2299378|NCT02028676|5645038|P4|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
2299379|NCT02028676|5645039|P3|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
2299380|NCT02028676|5645040|P2|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
2299381|NCT02028676|5645041|P1|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
2299382|NCT02028676|5645033|P9|COMPLETED|Initial Enrolment: CDM vs LCM||0
2299383|NCT02028676|5645034|P8|COMPLETED|Initial Enrolment: CDM vs LCM||0
2299384|NCT02028676|5645035|P7|COMPLETED|Initial Enrolment: CDM vs LCM||0
2299385|NCT02028676|5645036|P6|COMPLETED|Initial Enrolment: CDM vs LCM||0
2299386|NCT02028676|5645037|P5|COMPLETED|Initial Enrolment: CDM vs LCM||0
2299387|NCT02028676|5645038|P4|COMPLETED|Initial Enrolment: CDM vs LCM||0
2299388|NCT02028676|5645039|P3|COMPLETED|Initial Enrolment: CDM vs LCM||0
2299389|NCT02028676|5645040|P2|COMPLETED|Initial Enrolment: CDM vs LCM||600
2299390|NCT02028676|5645041|P1|COMPLETED|Initial Enrolment: CDM vs LCM||606
2299391|NCT02028676|5645033|P9|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
2299392|NCT02028676|5645034|P8|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
2299393|NCT02028676|5645035|P7|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
2299394|NCT02028676|5645036|P6|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
2299395|NCT02028676|5645037|P5|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
2299396|NCT02028676|5645038|P4|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
2299397|NCT02028676|5645039|P3|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
2299398|NCT02028676|5645040|P2|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|600
2299399|NCT02028676|5645041|P1|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|606
2299400|NCT02028325|5645214|P1|NOT COMPLETED|Overall Study||10
2299401|NCT02028325|5645214|P1|COMPLETED|Overall Study||126
2299402|NCT02028325|5645214|P1|STARTED|Overall Study||136
2299403|NCT02028169|5645218|P1|NOT COMPLETED|Overall Study||28
2299404|NCT02028169|5645218|P1|COMPLETED|Overall Study||92
2299405|NCT02028169|5645218|P1|STARTED|Overall Study||120
2299406|NCT02028065|5645244|P3|NOT COMPLETED|Treatment Through Study Completion||14
2299407|NCT02028065|5645245|P2|NOT COMPLETED|Treatment Through Study Completion||15
2299408|NCT02028065|5645246|P1|NOT COMPLETED|Treatment Through Study Completion||12
2299409|NCT02028065|5645244|P3|COMPLETED|Treatment Through Study Completion||134
2299410|NCT02028065|5645245|P2|COMPLETED|Treatment Through Study Completion||136
2299411|NCT02028065|5645246|P1|COMPLETED|Treatment Through Study Completion||64
2299412|NCT02028065|5645244|P3|Received Third Dose|Treatment Through Study Completion||134
2299413|NCT02028065|5645245|P2|Received Third Dose|Treatment Through Study Completion||136
2299414|NCT02028065|5645246|P1|Received Third Dose|Treatment Through Study Completion||64
2299415|NCT02028065|5645244|P3|Received Second Dose|Treatment Through Study Completion||138
2299416|NCT02028065|5645245|P2|Received Second Dose|Treatment Through Study Completion||140
2299417|NCT02028065|5645246|P1|Received Second Dose|Treatment Through Study Completion||69
2299418|NCT02028065|5645244|P3|Received First Dose|Treatment Through Study Completion||148
2299419|NCT02028065|5645245|P2|Received First Dose|Treatment Through Study Completion||151
2299420|NCT02028065|5645246|P1|Received First Dose|Treatment Through Study Completion||76
2299421|NCT02028065|5645244|P3|STARTED|Treatment Through Study Completion|Does not include the 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|148
2299422|NCT02028065|5645245|P2|STARTED|Treatment Through Study Completion||151
2299423|NCT02028065|5645246|P1|STARTED|Treatment Through Study Completion|Includes 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|76
2299424|NCT02028065|5645244|P3|NOT COMPLETED|Randomization Through Start Treatment||3
2299425|NCT02028065|5645245|P2|NOT COMPLETED|Randomization Through Start Treatment||3
2299426|NCT02028065|5645246|P1|NOT COMPLETED|Randomization Through Start Treatment||1
2299427|NCT02028065|5645244|P3|COMPLETED|Randomization Through Start Treatment||149
2299428|NCT02028065|5645245|P2|COMPLETED|Randomization Through Start Treatment||151
2299429|NCT02028065|5645246|P1|COMPLETED|Randomization Through Start Treatment||75
2299430|NCT02028065|5645244|P3|STARTED|Randomization Through Start Treatment|Randomized|152
2299431|NCT02028065|5645245|P2|STARTED|Randomization Through Start Treatment|Randomized|154
2299432|NCT02028065|5645246|P1|STARTED|Randomization Through Start Treatment|Randomized|76
2299433|NCT02027883|5645259|P2|NOT COMPLETED|Overall Study||0
2299434|NCT02027883|5645260|P1|NOT COMPLETED|Overall Study||0
2299435|NCT02027883|5645259|P2|COMPLETED|Overall Study||50
2299436|NCT02027883|5645260|P1|COMPLETED|Overall Study||50
2299437|NCT02027883|5645259|P2|STARTED|Overall Study||50
2299438|NCT02027883|5645260|P1|STARTED|Overall Study||50
2299439|NCT02027844|5645273|P3|NOT COMPLETED|Overall Study||2
2299440|NCT02027844|5645274|P2|NOT COMPLETED|Overall Study||6
2299441|NCT02027844|5645275|P1|NOT COMPLETED|Overall Study||5
2299442|NCT02027844|5645273|P3|COMPLETED|Overall Study||37
2299443|NCT02027844|5645274|P2|COMPLETED|Overall Study||33
2299444|NCT02027844|5645275|P1|COMPLETED|Overall Study||34
2299445|NCT02027844|5645273|P3|STARTED|Overall Study||39
2299446|NCT02027844|5645274|P2|STARTED|Overall Study||39
2299447|NCT02027844|5645275|P1|STARTED|Overall Study||39
2299448|NCT02027701|5645292|P1|NOT COMPLETED|Overall Study||16
2299449|NCT02027701|5645292|P1|COMPLETED|Overall Study||66
2299450|NCT02027701|5645292|P1|STARTED|Overall Study||82
2299451|NCT02027623|5645310|P2|NOT COMPLETED|Overall Study||12
2299452|NCT02027623|5645311|P1|NOT COMPLETED|Overall Study||9
2299453|NCT02027623|5645310|P2|COMPLETED|Overall Study||65
2299454|NCT02027623|5645311|P1|COMPLETED|Overall Study||68
2299455|NCT02027623|5645310|P2|STARTED|Overall Study||77
2299456|NCT02027623|5645311|P1|STARTED|Overall Study||77
2299457|NCT02027558|5645403|P2|NOT COMPLETED|Overall Study||2
2299458|NCT02027558|5645404|P1|NOT COMPLETED|Overall Study||9
2299459|NCT02027558|5645403|P2|COMPLETED|Overall Study||61
2299460|NCT02027558|5645404|P1|COMPLETED|Overall Study||53
2299461|NCT02027558|5645403|P2|6-month Follow-up|Overall Study||61
2299462|NCT02027558|5645404|P1|6-month Follow-up|Overall Study||53
2299463|NCT02027558|5645403|P2|3-month Follow-up|Overall Study||58
2299464|NCT02027558|5645404|P1|3-month Follow-up|Overall Study||53
2299465|NCT02027558|5645403|P2|Post-treatment|Overall Study||60
2299466|NCT02027558|5645404|P1|Post-treatment|Overall Study||49
2299467|NCT02027558|5645403|P2|STARTED|Overall Study||63
2299468|NCT02027558|5645404|P1|STARTED|Overall Study||62
2299469|NCT02027545|5645422|P2|NOT COMPLETED|Overall Study||2
2299470|NCT02027545|5645423|P1|NOT COMPLETED|Overall Study||2
2299471|NCT02027545|5645422|P2|COMPLETED|Overall Study||173
2299472|NCT02027545|5645423|P1|COMPLETED|Overall Study||259
2299473|NCT02027545|5645422|P2|STARTED|Overall Study||175
2299474|NCT02027545|5645423|P1|STARTED|Overall Study||261
2299475|NCT02027428|5645435|P3|NOT COMPLETED|Survival Follow-up||30
2299476|NCT02027428|5645436|P2|NOT COMPLETED|Survival Follow-up||48
2299477|NCT02027428|5645437|P1|NOT COMPLETED|Survival Follow-up||0
2299478|NCT02027428|5645435|P3|COMPLETED|Survival Follow-up||19
2299479|NCT02027428|5645436|P2|COMPLETED|Survival Follow-up||43
2299480|NCT02027428|5645437|P1|COMPLETED|Survival Follow-up||0
2299481|NCT02027428|5645435|P3|STARTED|Survival Follow-up|Participants are not taking study intervention but are on appropriate standard of care.|49
2299482|NCT02027428|5645436|P2|STARTED|Survival Follow-up|Participants are not taking study intervention but are on appropriate standard of care.|91
2299483|NCT02027428|5645437|P1|STARTED|Survival Follow-up||0
2299484|NCT02027428|5645435|P3|NOT COMPLETED|Maintenance||60
2299485|NCT02027428|5645436|P2|NOT COMPLETED|Maintenance||124
2299486|NCT02027428|5645437|P1|NOT COMPLETED|Maintenance||0
2299487|NCT02027428|5645435|P3|COMPLETED|Maintenance||6
2299488|NCT02027428|5645436|P2|COMPLETED|Maintenance||12
2299489|NCT02027428|5645437|P1|COMPLETED|Maintenance||0
2299490|NCT02027428|5645435|P3|STARTED|Maintenance||66
2299491|NCT02027428|5645436|P2|STARTED|Maintenance||136
2299492|NCT02027428|5645437|P1|STARTED|Maintenance||0
2299493|NCT02027428|5645435|P3|NOT COMPLETED|Induction||0
2299494|NCT02027428|5645436|P2|NOT COMPLETED|Induction||0
2299495|NCT02027428|5645437|P1|NOT COMPLETED|Induction||225
2299496|NCT02027428|5645435|P3|COMPLETED|Induction||0
2299497|NCT02027428|5645436|P2|COMPLETED|Induction||0
2299498|NCT02027428|5645437|P1|COMPLETED|Induction|If radiologically CR, PR or SD after 4 cycles of treatment, participants continue on to Maintenance.|202
2299499|NCT02027428|5645435|P3|STARTED|Induction||0
2299500|NCT02027428|5645436|P2|STARTED|Induction||0
2299501|NCT02027428|5645437|P1|STARTED|Induction||427
2299502|NCT02027402|5645475|P2|NOT COMPLETED|Overall Study||1
2299503|NCT02027402|5645476|P1|NOT COMPLETED|Overall Study||4
2299504|NCT02027402|5645475|P2|COMPLETED|Overall Study||99
2299505|NCT02027402|5645476|P1|COMPLETED|Overall Study||94
2299506|NCT02027402|5645475|P2|STARTED|Overall Study||100
2299507|NCT02027402|5645476|P1|STARTED|Overall Study||98
2299508|NCT02027376|5645488|P3|NOT COMPLETED|Overall Study||0
2299509|NCT02027376|5645489|P2|NOT COMPLETED|Overall Study||0
2299510|NCT02027376|5645490|P1|NOT COMPLETED|Overall Study||1
2299511|NCT02027376|5645488|P3|COMPLETED|Overall Study||3
2299512|NCT02027376|5645489|P2|COMPLETED|Overall Study||4
2299513|NCT02027376|5645490|P1|COMPLETED|Overall Study||4
2299514|NCT02027376|5645488|P3|STARTED|Overall Study||3
2299515|NCT02027376|5645489|P2|STARTED|Overall Study||4
2299516|NCT02027376|5645490|P1|STARTED|Overall Study||5
2299517|NCT02027311|5645516|P2|NOT COMPLETED|Overall Study||2
2299518|NCT02027311|5645517|P1|NOT COMPLETED|Overall Study||3
2299519|NCT02027311|5645516|P2|COMPLETED|Overall Study|1 cases was dropped due to tachycardia and 1 were desaturation.|33
2299520|NCT02027311|5645517|P1|COMPLETED|Overall Study|1 case was dropped due to hypotension and 2 were desaturation.|30
2299521|NCT02027311|5645516|P2|STARTED|Overall Study||35
2299522|NCT02027311|5645517|P1|STARTED|Overall Study||33
2299523|NCT02027272|5645527|P2|NOT COMPLETED|Overall Study||1
2299524|NCT02027272|5645528|P1|NOT COMPLETED|Overall Study||0
2299525|NCT02027272|5645527|P2|COMPLETED|Overall Study||0
2299526|NCT02027272|5645528|P1|COMPLETED|Overall Study||0
2299527|NCT02027272|5645527|P2|STARTED|Overall Study||1
2299528|NCT02027272|5645528|P1|STARTED|Overall Study||0
2299529|NCT02027025|5645537|P3|NOT COMPLETED|Overall Study||1
2299530|NCT02027025|5645538|P2|NOT COMPLETED|Overall Study||5
2299531|NCT02027025|5645539|P1|NOT COMPLETED|Overall Study||1
2299532|NCT02027025|5645537|P3|COMPLETED|Overall Study||46
2299533|NCT02027025|5645538|P2|COMPLETED|Overall Study||42
2299534|NCT02027025|5645539|P1|COMPLETED|Overall Study||47
2299535|NCT02027025|5645537|P3|STARTED|Overall Study||47
2299536|NCT02027025|5645538|P2|STARTED|Overall Study||47
2299537|NCT02027025|5645539|P1|STARTED|Overall Study||48
2299538|NCT02026687|5645560|P2|NOT COMPLETED|Overall Study||2
2299539|NCT02026687|5645561|P1|NOT COMPLETED|Overall Study||1
2299540|NCT02026687|5645560|P2|COMPLETED|Overall Study||38
2299541|NCT02026687|5645561|P1|COMPLETED|Overall Study||39
2299542|NCT02026687|5645560|P2|STARTED|Overall Study||40
2299543|NCT02026687|5645561|P1|STARTED|Overall Study||40
2299544|NCT02026453|5645574|P3|NOT COMPLETED|Overall Study||13
2299545|NCT02026453|5645575|P2|NOT COMPLETED|Overall Study||9
2299546|NCT02026453|5645576|P1|NOT COMPLETED|Overall Study||6
2299547|NCT02026453|5645574|P3|COMPLETED|Overall Study||89
2299548|NCT02026453|5645575|P2|COMPLETED|Overall Study||94
2299549|NCT02026453|5645576|P1|COMPLETED|Overall Study||95
2299550|NCT02026453|5645574|P3|STARTED|Overall Study||102
2299551|NCT02026453|5645575|P2|STARTED|Overall Study||103
2299552|NCT02026453|5645576|P1|STARTED|Overall Study||101
2299553|NCT02026258|5645589|P2|NOT COMPLETED|Recieved Allocated Intervention||2
2299554|NCT02026258|5645590|P1|NOT COMPLETED|Recieved Allocated Intervention||1
2299555|NCT02026258|5645589|P2|COMPLETED|Recieved Allocated Intervention||17
2299556|NCT02026258|5645590|P1|COMPLETED|Recieved Allocated Intervention||15
2299557|NCT02026258|5645589|P2|STARTED|Recieved Allocated Intervention||19
2299558|NCT02026258|5645590|P1|STARTED|Recieved Allocated Intervention||16
2299559|NCT02026258|5645589|P2|NOT COMPLETED|Randomized||2
2299560|NCT02026258|5645590|P1|NOT COMPLETED|Randomized||4
2299561|NCT02026258|5645589|P2|COMPLETED|Randomized||19
2299562|NCT02026258|5645590|P1|COMPLETED|Randomized||16
2299563|NCT02026258|5645589|P2|STARTED|Randomized||21
2299564|NCT02026258|5645590|P1|STARTED|Randomized||20
2299565|NCT02026206|5645604|P2|NOT COMPLETED|Overall Study||8
2299566|NCT02026206|5645605|P1|NOT COMPLETED|Overall Study||4
2299567|NCT02026206|5645604|P2|COMPLETED|Overall Study||36
2299568|NCT02026206|5645605|P1|COMPLETED|Overall Study||40
2299569|NCT02026206|5645604|P2|STARTED|Overall Study||44
2299570|NCT02026206|5645605|P1|STARTED|Overall Study||44
2299571|NCT02026193|5645615|P2|NOT COMPLETED|Overall Study||0
2299572|NCT02026193|5645616|P1|NOT COMPLETED|Overall Study||0
2299573|NCT02026193|5645615|P2|COMPLETED|Overall Study||8
2299574|NCT02026193|5645616|P1|COMPLETED|Overall Study||3
2299575|NCT02026193|5645615|P2|STARTED|Overall Study||8
2299576|NCT02026193|5645616|P1|STARTED|Overall Study||3
2299577|NCT02026141|5645624|P2|NOT COMPLETED|Overall Study||1
2299578|NCT02026141|5645625|P1|NOT COMPLETED|Overall Study||0
2299579|NCT02026141|5645624|P2|COMPLETED|Overall Study||19
2299580|NCT02026141|5645625|P1|COMPLETED|Overall Study||20
2299581|NCT02026141|5645624|P2|STARTED|Overall Study||20
2299582|NCT02026141|5645625|P1|STARTED|Overall Study||20
2299583|NCT02026063|5645633|P2|NOT COMPLETED|Overall Study||49
2299584|NCT02026063|5645634|P1|NOT COMPLETED|Overall Study||9
2299585|NCT02026063|5645633|P2|COMPLETED|Overall Study||53
2299586|NCT02026063|5645634|P1|COMPLETED|Overall Study||13
2299587|NCT02026063|5645633|P2|STARTED|Overall Study||102
2299588|NCT02026063|5645634|P1|STARTED|Overall Study||22
2299589|NCT02026011|5645646|P2|NOT COMPLETED|Allocation 2 (Second Set of Medication)||2
2299590|NCT02026011|5645647|P1|NOT COMPLETED|Allocation 2 (Second Set of Medication)||1
2299591|NCT02026011|5645646|P2|COMPLETED|Allocation 2 (Second Set of Medication)||35
2299592|NCT02026011|5645647|P1|COMPLETED|Allocation 2 (Second Set of Medication)||37
2299593|NCT02026011|5645646|P2|STARTED|Allocation 2 (Second Set of Medication)||37
2299594|NCT02026011|5645647|P1|STARTED|Allocation 2 (Second Set of Medication)||38
2299595|NCT02026011|5645646|P2|NOT COMPLETED|Allocation 1 (First Set of Medication)||2
2299596|NCT02026011|5645647|P1|NOT COMPLETED|Allocation 1 (First Set of Medication)||8
2299597|NCT02026011|5645646|P2|COMPLETED|Allocation 1 (First Set of Medication)||39
2299598|NCT02026011|5645647|P1|COMPLETED|Allocation 1 (First Set of Medication)||38
2299599|NCT02026011|5645646|P2|STARTED|Allocation 1 (First Set of Medication)||41
2299600|NCT02026011|5645647|P1|STARTED|Allocation 1 (First Set of Medication)||46
2299601|NCT02025907|5645673|P2|NOT COMPLETED|Overall Study||12
2299602|NCT02025907|5645674|P1|NOT COMPLETED|Overall Study||27
2299603|NCT02025907|5645673|P2|COMPLETED|Overall Study||96
2299604|NCT02025907|5645674|P1|COMPLETED|Overall Study||81
2299605|NCT02025907|5645673|P2|STARTED|Overall Study|Participant flow is presented for safety population.|108
2299606|NCT02025907|5645674|P1|STARTED|Overall Study|Participant flow is presented for safety population.|108
2299607|NCT02025829|5645690|P2|NOT COMPLETED|Overall Study||0
2299608|NCT02025829|5645691|P1|NOT COMPLETED|Overall Study||0
2299609|NCT02025829|5645690|P2|COMPLETED|Overall Study||11
2299610|NCT02025829|5645691|P1|COMPLETED|Overall Study||3
2299611|NCT02025829|5645690|P2|STARTED|Overall Study||11
2299612|NCT02025829|5645691|P1|STARTED|Overall Study||3
2299613|NCT02025725|5645702|P2|NOT COMPLETED|Overall Study||4
2299614|NCT02025725|5645703|P1|NOT COMPLETED|Overall Study||11
2299615|NCT02025725|5645702|P2|COMPLETED|Overall Study||99
2299616|NCT02025725|5645703|P1|COMPLETED|Overall Study||91
2299617|NCT02025725|5645702|P2|STARTED|Overall Study||103
2299618|NCT02025725|5645703|P1|STARTED|Overall Study||102
2299619|NCT02025647|5645709|P1|NOT COMPLETED|Overall Study||0
2299620|NCT02025647|5645709|P1|COMPLETED|Overall Study||139
2299621|NCT02025647|5645709|P1|Session 3 (Rating Module: 30-45 Days)|Overall Study|"27 did not generate IRS~36 lost to follow up"|76
2299622|NCT02025647|5645709|P1|Session 2 (Narrative Module: 24-48 Hrs)|Overall Study|"19 lost to follow up or technology issues~3 administered wrong session"|117
2299623|NCT02025647|5645709|P1|Immediate Retest (Rating Module: 5 Min)|Overall Study|"27 did not generate IRS~15 technology issues or administered wrong session"|97
2299624|NCT02025647|5645709|P1|Session 1 (Narrative Module)|Overall Study||139
2299625|NCT02025647|5645709|P1|STARTED|Overall Study||139
2299626|NCT02025621|5645740|P2|NOT COMPLETED|Overall Study||19
2299627|NCT02025621|5645741|P1|NOT COMPLETED|Overall Study||14
2299628|NCT02025621|5645740|P2|COMPLETED|Overall Study||421
2299629|NCT02025621|5645741|P1|COMPLETED|Overall Study||428
2299630|NCT02025621|5645740|P2|STARTED|Overall Study||440
2299631|NCT02025621|5645741|P1|STARTED|Overall Study||442
2299632|NCT02025530|5645761|P2|NOT COMPLETED|Overall Study||1
2299633|NCT02025530|5645762|P1|NOT COMPLETED|Overall Study||5
2299634|NCT02025530|5645761|P2|COMPLETED|Overall Study||733
2299635|NCT02025530|5645762|P1|COMPLETED|Overall Study||291
2299636|NCT02025530|5645761|P2|STARTED|Overall Study||734
2299637|NCT02025530|5645762|P1|STARTED|Overall Study||296
2299638|NCT02025205|5645774|P2|NOT COMPLETED|Overall Study||3
2299639|NCT02025205|5645775|P1|NOT COMPLETED|Overall Study||3
2299640|NCT02025205|5645774|P2|COMPLETED|Overall Study||47
2299641|NCT02025205|5645775|P1|COMPLETED|Overall Study||40
2299642|NCT02025205|5645774|P2|STARTED|Overall Study||50
2299643|NCT02025205|5645775|P1|STARTED|Overall Study||43
2299644|NCT02025179|5645819|P3|NOT COMPLETED|Overall Study||1
2299645|NCT02025179|5645820|P2|NOT COMPLETED|Overall Study||0
2299646|NCT02025179|5645821|P1|NOT COMPLETED|Overall Study||0
2299647|NCT02025179|5645819|P3|COMPLETED|Overall Study||7
2299648|NCT02025179|5645820|P2|COMPLETED|Overall Study||9
2299649|NCT02025179|5645821|P1|COMPLETED|Overall Study||8
2299650|NCT02025179|5645819|P3|STARTED|Overall Study||8
2299651|NCT02025179|5645820|P2|STARTED|Overall Study||9
2299652|NCT02025179|5645821|P1|STARTED|Overall Study||8
2299653|NCT02025075|5645846|P2|NOT COMPLETED|Overall Study||2
2299654|NCT02025075|5645847|P1|NOT COMPLETED|Overall Study||0
2299655|NCT02025075|5645846|P2|COMPLETED|Overall Study||19
2299656|NCT02025075|5645847|P1|COMPLETED|Overall Study||16
2299657|NCT02025075|5645846|P2|STARTED|Overall Study||21
2299658|NCT02025075|5645847|P1|STARTED|Overall Study||16
2299659|NCT02024971|5645871|P1|NOT COMPLETED|Overall Study||36
2299660|NCT02024971|5645871|P1|COMPLETED|Overall Study|Including 162 patients with missing efficacy data at two or more time points.|1067
2299661|NCT02024971|5645871|P1|Safety Analysis Set|Overall Study|All participants with available data who were enrolled prior to Day 15 of the start of treatment.|1067
2299662|NCT02024971|5645871|P1|STARTED|Overall Study||1103
2299663|NCT02024932|5645884|P6|NOT COMPLETED|Overall Study||0
2299664|NCT02024932|5645885|P5|NOT COMPLETED|Overall Study||2
2299665|NCT02024932|5645886|P4|NOT COMPLETED|Overall Study||2
2299666|NCT02024932|5645887|P3|NOT COMPLETED|Overall Study||0
2299667|NCT02024932|5645888|P2|NOT COMPLETED|Overall Study||3
2299668|NCT02024932|5645889|P1|NOT COMPLETED|Overall Study||2
2299669|NCT02024932|5645884|P6|COMPLETED|Overall Study||9
2299670|NCT02024932|5645885|P5|COMPLETED|Overall Study||16
2299671|NCT02024932|5645886|P4|COMPLETED|Overall Study||0
2299672|NCT02024932|5645887|P3|COMPLETED|Overall Study||2
2299673|NCT02024932|5645888|P2|COMPLETED|Overall Study||1
2299674|NCT02024932|5645889|P1|COMPLETED|Overall Study||0
2299675|NCT02024932|5645884|P6|Pharmacodynamic (PD) Analysis Set|Overall Study||9
2299676|NCT02024932|5645885|P5|Pharmacodynamic (PD) Analysis Set|Overall Study||18
2299677|NCT02024932|5645886|P4|Pharmacodynamic (PD) Analysis Set|Overall Study||2
2299678|NCT02024932|5645887|P3|Pharmacodynamic (PD) Analysis Set|Overall Study||2
2299679|NCT02024932|5645888|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||4
2299680|NCT02024932|5645889|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||2
2299681|NCT02024932|5645884|P6|Pharmacokinetic (PK) Analysis Set|Overall Study||0
2299682|NCT02024932|5645885|P5|Pharmacokinetic (PK) Analysis Set|Overall Study||18
2299683|NCT02024932|5645886|P4|Pharmacokinetic (PK) Analysis Set|Overall Study||2
2299684|NCT02024932|5645887|P3|Pharmacokinetic (PK) Analysis Set|Overall Study||0
2299685|NCT02024932|5645888|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||4
2299686|NCT02024932|5645889|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||2
2299687|NCT02024932|5645884|P6|Safety Analysis Set|Overall Study||9
2299688|NCT02024932|5645885|P5|Safety Analysis Set|Overall Study||18
2299689|NCT02024932|5645886|P4|Safety Analysis Set|Overall Study||2
2299690|NCT02024932|5645887|P3|Safety Analysis Set|Overall Study||2
2299691|NCT02024932|5645888|P2|Safety Analysis Set|Overall Study||4
2299692|NCT02024932|5645889|P1|Safety Analysis Set|Overall Study||2
2299693|NCT02024932|5645884|P6|STARTED|Overall Study||9
2299694|NCT02024932|5645885|P5|STARTED|Overall Study||18
2299695|NCT02024932|5645886|P4|STARTED|Overall Study||2
2299696|NCT02024932|5645887|P3|STARTED|Overall Study||2
2299697|NCT02024932|5645888|P2|STARTED|Overall Study||4
2299698|NCT02024932|5645889|P1|STARTED|Overall Study||2
2299699|NCT02024867|5645948|P2|NOT COMPLETED|Overall Study||7
2299700|NCT02024867|5645949|P1|NOT COMPLETED|Overall Study||9
2299701|NCT02024867|5645948|P2|COMPLETED|Overall Study||124
2299702|NCT02024867|5645949|P1|COMPLETED|Overall Study||125
2299703|NCT02024867|5645948|P2|STARTED|Overall Study||131
2299704|NCT02024867|5645949|P1|STARTED|Overall Study||134
2299705|NCT02024750|5645967|P2|NOT COMPLETED|Overall Study||1
2299706|NCT02024750|5645968|P1|NOT COMPLETED|Overall Study||2
2299707|NCT02024750|5645967|P2|COMPLETED|Overall Study||107
2299708|NCT02024750|5645968|P1|COMPLETED|Overall Study||104
2299709|NCT02024750|5645967|P2|STARTED|Overall Study||108
2299710|NCT02024750|5645968|P1|STARTED|Overall Study||106
2299711|NCT02024724|5645982|P2|NOT COMPLETED|Overall Study||0
2299712|NCT02024724|5645983|P1|NOT COMPLETED|Overall Study||1
2299713|NCT02024724|5645982|P2|COMPLETED|Overall Study||30
2299714|NCT02024724|5645983|P1|COMPLETED|Overall Study||29
2299715|NCT02024724|5645982|P2|STARTED|Overall Study||30
2299716|NCT02024724|5645983|P1|STARTED|Overall Study||30
2299717|NCT02024698|5645989|P2|NOT COMPLETED|Second Intervention (7 Days)||0
2299718|NCT02024698|5645990|P1|NOT COMPLETED|Second Intervention (7 Days)||0
2299719|NCT02024698|5645989|P2|COMPLETED|Second Intervention (7 Days)||26
2299720|NCT02024698|5645990|P1|COMPLETED|Second Intervention (7 Days)||16
2299721|NCT02024698|5645989|P2|Received Etafilcon A Twice|Second Intervention (7 Days)||0
2299722|NCT02024698|5645990|P1|Received Etafilcon A Twice|Second Intervention (7 Days)||1
2299723|NCT02024698|5645989|P2|STARTED|Second Intervention (7 Days)||26
2299724|NCT02024698|5645990|P1|STARTED|Second Intervention (7 Days)||16
2299725|NCT02024698|5645989|P2|NOT COMPLETED|First Intervention (7 Days)||1
2299726|NCT02024698|5645990|P1|NOT COMPLETED|First Intervention (7 Days)||0
2299727|NCT02024698|5645989|P2|COMPLETED|First Intervention (7 Days)||26
2299728|NCT02024698|5645990|P1|COMPLETED|First Intervention (7 Days)||16
2299729|NCT02024698|5645989|P2|STARTED|First Intervention (7 Days)||27
2299730|NCT02024698|5645990|P1|STARTED|First Intervention (7 Days)||16
2299731|NCT02024477|5646018|P2|NOT COMPLETED|Overall Study||0
2299732|NCT02024477|5646019|P1|NOT COMPLETED|Overall Study||0
2299733|NCT02024477|5646018|P2|COMPLETED|Overall Study||21
2299734|NCT02024477|5646019|P1|COMPLETED|Overall Study||21
2299735|NCT02024477|5646018|P2|STARTED|Overall Study||21
2299736|NCT02024477|5646019|P1|STARTED|Overall Study||21
2299737|NCT02024386|5646040|P3|NOT COMPLETED|Overall Study||0
2299738|NCT02024386|5646041|P2|NOT COMPLETED|Overall Study||0
2299739|NCT02024386|5646042|P1|NOT COMPLETED|Overall Study||0
2299740|NCT02024386|5646040|P3|COMPLETED|Overall Study||5
2299741|NCT02024386|5646041|P2|COMPLETED|Overall Study||11
2299742|NCT02024386|5646042|P1|COMPLETED|Overall Study||6
2299743|NCT02024386|5646040|P3|STARTED|Overall Study||5
2299744|NCT02024386|5646041|P2|STARTED|Overall Study||11
2299745|NCT02024386|5646042|P1|STARTED|Overall Study||6
2299746|NCT02024165|5646065|P1|NOT COMPLETED|Overall Study||0
2299747|NCT02024165|5646065|P1|COMPLETED|Overall Study||71
2299748|NCT02024165|5646065|P1|STARTED|Overall Study||71
2299749|NCT02023983|5646072|P2|NOT COMPLETED|Overall Study||0
2299750|NCT02023983|5646073|P1|NOT COMPLETED|Overall Study||0
2299751|NCT02023983|5646072|P2|COMPLETED|Overall Study||75
2299752|NCT02023983|5646073|P1|COMPLETED|Overall Study||76
2299753|NCT02023983|5646072|P2|STARTED|Overall Study||75
2299754|NCT02023983|5646073|P1|STARTED|Overall Study||76
2299755|NCT02023944|5646083|P2|NOT COMPLETED|Overall Study||1
2299756|NCT02023944|5646084|P1|NOT COMPLETED|Overall Study||0
2299757|NCT02023944|5646083|P2|COMPLETED|Overall Study||24
2299758|NCT02023944|5646084|P1|COMPLETED|Overall Study||25
2299759|NCT02023944|5646083|P2|STARTED|Overall Study||25
2299760|NCT02023944|5646084|P1|STARTED|Overall Study||25
2299761|NCT02023918|5646092|P1|NOT COMPLETED|Overall Study||0
2299762|NCT02023918|5646092|P1|COMPLETED|Overall Study||6
2299763|NCT02023918|5646092|P1|STARTED|Overall Study||6
2299764|NCT02023879|5646100|P3|NOT COMPLETED|Extension Open Label Treatment||5
2299765|NCT02023879|5646101|P2|NOT COMPLETED|Extension Open Label Treatment||17
2299766|NCT02023879|5646102|P1|NOT COMPLETED|Extension Open Label Treatment||5
2299767|NCT02023879|5646100|P3|COMPLETED|Extension Open Label Treatment||43
2299768|NCT02023879|5646101|P2|COMPLETED|Extension Open Label Treatment||89
2299769|NCT02023879|5646102|P1|COMPLETED|Extension Open Label Treatment||46
2299770|NCT02023879|5646100|P3|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|48
2299771|NCT02023879|5646101|P2|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|106
2299772|NCT02023879|5646102|P1|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|51
2299773|NCT02023879|5646100|P3|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||9
2299774|NCT02023879|5646101|P2|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||9
2299775|NCT02023879|5646102|P1|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||4
2299776|NCT02023879|5646100|P3|COMPLETED|Period 1: 24-Week Double-blind Treatment||50
2299777|NCT02023879|5646101|P2|COMPLETED|Period 1: 24-Week Double-blind Treatment||107
2299778|NCT02023879|5646102|P1|COMPLETED|Period 1: 24-Week Double-blind Treatment||54
2299779|NCT02023879|5646100|P3|Treated|Period 1: 24-Week Double-blind Treatment||58
2299780|NCT02023879|5646101|P2|Treated|Period 1: 24-Week Double-blind Treatment||115
2299781|NCT02023879|5646102|P1|Treated|Period 1: 24-Week Double-blind Treatment||58
2299782|NCT02023879|5646100|P3|STARTED|Period 1: 24-Week Double-blind Treatment||59
2299783|NCT02023879|5646101|P2|STARTED|Period 1: 24-Week Double-blind Treatment||116
2299784|NCT02023879|5646102|P1|STARTED|Period 1: 24-Week Double-blind Treatment||58
2299785|NCT02023866|5646191|P1|NOT COMPLETED|Overall Study||6
2299786|NCT02023866|5646191|P1|COMPLETED|Overall Study||30
2299787|NCT02023866|5646191|P1|STARTED|Overall Study||36
2299788|NCT02023801|5646204|P1|NOT COMPLETED|Overall Study||0
2299789|NCT02023801|5646204|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|24
2299790|NCT02023801|5646204|P1|Treated|Overall Study|Treatment Completed|24
2299791|NCT02023801|5646204|P1|STARTED|Overall Study|Treatment Attempted|24
2299792|NCT02023697|5646213|P3|NOT COMPLETED|Long-term Follow-up Period||17
2299793|NCT02023697|5646214|P2|NOT COMPLETED|Long-term Follow-up Period||21
2299794|NCT02023697|5646215|P1|NOT COMPLETED|Long-term Follow-up Period||28
2299795|NCT02023697|5646213|P3|COMPLETED|Long-term Follow-up Period||0
2299796|NCT02023697|5646214|P2|COMPLETED|Long-term Follow-up Period||0
2299797|NCT02023697|5646215|P1|COMPLETED|Long-term Follow-up Period||0
2299798|NCT02023697|5646213|P3|STARTED|Long-term Follow-up Period||17
2299799|NCT02023697|5646214|P2|STARTED|Long-term Follow-up Period||21
2299800|NCT02023697|5646215|P1|STARTED|Long-term Follow-up Period||28
2299801|NCT02023697|5646213|P3|NOT COMPLETED|Active Follow-up Period||99
2299802|NCT02023697|5646214|P2|NOT COMPLETED|Active Follow-up Period||99
2299803|NCT02023697|5646215|P1|NOT COMPLETED|Active Follow-up Period||92
2299804|NCT02023697|5646213|P3|COMPLETED|Active Follow-up Period||17
2299805|NCT02023697|5646214|P2|COMPLETED|Active Follow-up Period||21
2299806|NCT02023697|5646215|P1|COMPLETED|Active Follow-up Period||28
2299807|NCT02023697|5646213|P3|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|116
2299808|NCT02023697|5646214|P2|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|120
2299809|NCT02023697|5646215|P1|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|120
2299810|NCT02023697|5646213|P3|NOT COMPLETED|Treatment Period||102
2299811|NCT02023697|5646214|P2|NOT COMPLETED|Treatment Period||63
2299812|NCT02023697|5646215|P1|NOT COMPLETED|Treatment Period||46
2299813|NCT02023697|5646213|P3|COMPLETED|Treatment Period||29
2299814|NCT02023697|5646214|P2|COMPLETED|Treatment Period||67
2299815|NCT02023697|5646215|P1|COMPLETED|Treatment Period||84
2299816|NCT02023697|5646213|P3|Received Treatment|Treatment Period||121
2299817|NCT02023697|5646214|P2|Received Treatment|Treatment Period||124
2299818|NCT02023697|5646215|P1|Received Treatment|Treatment Period||125
2299819|NCT02023697|5646213|P3|STARTED|Treatment Period||131
2299820|NCT02023697|5646214|P2|STARTED|Treatment Period||130
2299821|NCT02023697|5646215|P1|STARTED|Treatment Period||130
2299822|NCT02023515|5646317|P2|NOT COMPLETED|Overall Study||3
2299823|NCT02023515|5646318|P1|NOT COMPLETED|Overall Study||1
2299824|NCT02023515|5646317|P2|COMPLETED|Overall Study||22
2299825|NCT02023515|5646318|P1|COMPLETED|Overall Study||23
2299826|NCT02023515|5646317|P2|STARTED|Overall Study||25
2299827|NCT02023515|5646318|P1|STARTED|Overall Study||24
2299828|NCT02023268|5646328|P2|NOT COMPLETED|Overall Study||4
2299829|NCT02023268|5646329|P1|NOT COMPLETED|Overall Study||0
2299830|NCT02023268|5646328|P2|COMPLETED|Overall Study||49
2299831|NCT02023268|5646329|P1|COMPLETED|Overall Study||52
2299832|NCT02023268|5646328|P2|STARTED|Overall Study||53
2299833|NCT02023268|5646329|P1|STARTED|Overall Study||52
2299834|NCT02023242|5646337|P2|NOT COMPLETED|Overall Study||2
2299835|NCT02023242|5646338|P1|NOT COMPLETED|Overall Study||3
2299836|NCT02023242|5646337|P2|COMPLETED|Overall Study||75
2299837|NCT02023242|5646338|P1|COMPLETED|Overall Study||72
2299838|NCT02023242|5646337|P2|STARTED|Overall Study||77
2299839|NCT02023242|5646338|P1|STARTED|Overall Study||75
2299840|NCT02023151|5646352|P1|NOT COMPLETED|Overall Study||4
2299841|NCT02023151|5646352|P1|COMPLETED|Overall Study||13
2299842|NCT02023151|5646352|P1|STARTED|Overall Study||17
2299843|NCT02023125|5646359|P3|NOT COMPLETED|Period 2||0
2299844|NCT02023125|5646360|P2|NOT COMPLETED|Period 2||0
2299845|NCT02023125|5646361|P1|NOT COMPLETED|Period 2||0
2299846|NCT02023125|5646359|P3|COMPLETED|Period 2||24
2299847|NCT02023125|5646360|P2|COMPLETED|Period 2||9
2299848|NCT02023125|5646361|P1|COMPLETED|Period 2||9
2299849|NCT02023125|5646359|P3|STARTED|Period 2||24
2299850|NCT02023125|5646360|P2|STARTED|Period 2||9
2299851|NCT02023125|5646361|P1|STARTED|Period 2||9
2299852|NCT02023125|5646359|P3|NOT COMPLETED|Washout Period||0
2299853|NCT02023125|5646360|P2|NOT COMPLETED|Washout Period||0
2299854|NCT02023125|5646361|P1|NOT COMPLETED|Washout Period||0
2299855|NCT02023125|5646359|P3|COMPLETED|Washout Period||24
2299856|NCT02023125|5646360|P2|COMPLETED|Washout Period||9
2299857|NCT02023125|5646361|P1|COMPLETED|Washout Period||9
2299858|NCT02023125|5646359|P3|STARTED|Washout Period||24
2299859|NCT02023125|5646360|P2|STARTED|Washout Period||9
2299860|NCT02023125|5646361|P1|STARTED|Washout Period||9
2299861|NCT02023125|5646359|P3|NOT COMPLETED|Period 1||0
2299862|NCT02023125|5646360|P2|NOT COMPLETED|Period 1||0
2299863|NCT02023125|5646361|P1|NOT COMPLETED|Period 1||0
2299864|NCT02023125|5646359|P3|COMPLETED|Period 1||24
2299865|NCT02023125|5646360|P2|COMPLETED|Period 1||9
2299866|NCT02023125|5646361|P1|COMPLETED|Period 1||9
2299867|NCT02023125|5646359|P3|STARTED|Period 1||24
2299868|NCT02023125|5646360|P2|STARTED|Period 1||9
2299869|NCT02023125|5646361|P1|STARTED|Period 1||9
2299870|NCT02023112|5646422|P2|NOT COMPLETED|Overall Study||1
2299871|NCT02023112|5646423|P1|NOT COMPLETED|Overall Study||2
2299872|NCT02023112|5646422|P2|COMPLETED|Overall Study||85
2299873|NCT02023112|5646423|P1|COMPLETED|Overall Study||83
2299874|NCT02023112|5646422|P2|STARTED|Overall Study||86
2299875|NCT02023112|5646423|P1|STARTED|Overall Study||85
2299876|NCT02023099|5646444|P3|NOT COMPLETED|Overall Study||3
2299877|NCT02023099|5646445|P2|NOT COMPLETED|Overall Study||0
2299878|NCT02023099|5646446|P1|NOT COMPLETED|Overall Study||3
2299879|NCT02023099|5646444|P3|COMPLETED|Overall Study||39
2299880|NCT02023099|5646445|P2|COMPLETED|Overall Study||106
2299881|NCT02023099|5646446|P1|COMPLETED|Overall Study||212
2299882|NCT02023099|5646444|P3|STARTED|Overall Study||42
2299883|NCT02023099|5646445|P2|STARTED|Overall Study||106
2299884|NCT02023099|5646446|P1|STARTED|Overall Study||215
2299885|NCT02022826|5646462|P1|NOT COMPLETED|Overall Study||28
2299886|NCT02022826|5646462|P1|COMPLETED|Overall Study||139
2299887|NCT02022826|5646462|P1|STARTED|Overall Study||167
2299888|NCT02022748|5646469|P3|NOT COMPLETED|Overall Study||0
2299889|NCT02022748|5646470|P2|NOT COMPLETED|Overall Study||2
2299890|NCT02022748|5646471|P1|NOT COMPLETED|Overall Study||1
2299891|NCT02022748|5646469|P3|COMPLETED|Overall Study||13
2299892|NCT02022748|5646470|P2|COMPLETED|Overall Study||4
2299893|NCT02022748|5646471|P1|COMPLETED|Overall Study||7
2299894|NCT02022748|5646469|P3|Subjects Who Completed Treatment|Overall Study||13
2299895|NCT02022748|5646470|P2|Subjects Who Completed Treatment|Overall Study||4
2299896|NCT02022748|5646471|P1|Subjects Who Completed Treatment|Overall Study||7
2299897|NCT02022748|5646469|P3|Subject Who Started Treatment|Overall Study||13
2299898|NCT02022748|5646470|P2|Subject Who Started Treatment|Overall Study||6
2299899|NCT02022748|5646471|P1|Subject Who Started Treatment|Overall Study||8
2299900|NCT02022748|5646469|P3|STARTED|Overall Study||13
2299901|NCT02022748|5646470|P2|STARTED|Overall Study||6
2299902|NCT02022748|5646471|P1|STARTED|Overall Study||8
2299903|NCT02022670|5646497|P3|NOT COMPLETED|Overall Study||1
2299904|NCT02022670|5646498|P2|NOT COMPLETED|Overall Study||0
2299905|NCT02022670|5646499|P1|NOT COMPLETED|Overall Study||1
2299906|NCT02022670|5646497|P3|COMPLETED|Overall Study||11
2299907|NCT02022670|5646498|P2|COMPLETED|Overall Study||10
2299908|NCT02022670|5646499|P1|COMPLETED|Overall Study||10
2299909|NCT02022670|5646497|P3|STARTED|Overall Study||12
2299910|NCT02022670|5646498|P2|STARTED|Overall Study||10
2299911|NCT02022670|5646499|P1|STARTED|Overall Study||11
2299912|NCT02022657|5646513|P6|NOT COMPLETED|Overall Study||1
2299913|NCT02022657|5646514|P5|NOT COMPLETED|Overall Study||0
2299914|NCT02022657|5646515|P4|NOT COMPLETED|Overall Study||0
2299915|NCT02022657|5646516|P3|NOT COMPLETED|Overall Study||1
2299916|NCT02022657|5646517|P2|NOT COMPLETED|Overall Study||0
2299917|NCT02022657|5646518|P1|NOT COMPLETED|Overall Study||2
2299918|NCT02022657|5646513|P6|COMPLETED|Overall Study||8
2299919|NCT02022657|5646514|P5|COMPLETED|Overall Study||8
2299920|NCT02022657|5646515|P4|COMPLETED|Overall Study||8
2299921|NCT02022657|5646516|P3|COMPLETED|Overall Study||8
2299922|NCT02022657|5646517|P2|COMPLETED|Overall Study||8
2299923|NCT02022657|5646518|P1|COMPLETED|Overall Study||8
2299924|NCT02022657|5646513|P6|STARTED|Overall Study||9
2299925|NCT02022657|5646514|P5|STARTED|Overall Study||8
2299926|NCT02022657|5646515|P4|STARTED|Overall Study||8
2299927|NCT02022657|5646516|P3|STARTED|Overall Study||9
2299928|NCT02022657|5646517|P2|STARTED|Overall Study||8
2299929|NCT02022657|5646518|P1|STARTED|Overall Study||10
2299930|NCT02022085|5646524|P1|NOT COMPLETED|Overall Study||1
2299931|NCT02022085|5646524|P1|COMPLETED|Overall Study||53
2299932|NCT02022085|5646524|P1|STARTED|Overall Study||54
2299933|NCT02022020|5646550|P1|NOT COMPLETED|Overall Study||0
2299934|NCT02022020|5646550|P1|COMPLETED|Overall Study||220
2299935|NCT02022020|5646550|P1|STARTED|Overall Study||220
2299936|NCT02022007|5646559|P3|NOT COMPLETED|Overall Study||2
2299937|NCT02022007|5646560|P2|NOT COMPLETED|Overall Study||1
2299938|NCT02022007|5646561|P1|NOT COMPLETED|Overall Study||1
2299939|NCT02022007|5646559|P3|COMPLETED|Overall Study||11
2299940|NCT02022007|5646560|P2|COMPLETED|Overall Study||11
2299941|NCT02022007|5646561|P1|COMPLETED|Overall Study||12
2299942|NCT02022007|5646559|P3|STARTED|Overall Study||13
2299943|NCT02022007|5646560|P2|STARTED|Overall Study||12
2299944|NCT02022007|5646561|P1|STARTED|Overall Study||13
2299945|NCT02021942|5646602|P1|NOT COMPLETED|Overall Study||0
2299946|NCT02021942|5646602|P1|COMPLETED|Overall Study||16
2299947|NCT02021942|5646602|P1|STARTED|Overall Study||16
2299948|NCT02021929|5646614|P2|NOT COMPLETED|Overall Study||1
2299949|NCT02021929|5646615|P1|NOT COMPLETED|Overall Study||2
2299950|NCT02021929|5646614|P2|COMPLETED|Overall Study||11
2299951|NCT02021929|5646615|P1|COMPLETED|Overall Study||14
2299952|NCT02021929|5646614|P2|STARTED|Overall Study||12
2299953|NCT02021929|5646615|P1|STARTED|Overall Study||16
2299954|NCT02021812|5646625|P1|NOT COMPLETED|Overall Study||24
2299955|NCT02021812|5646625|P1|COMPLETED|Overall Study||7
2299956|NCT02021812|5646625|P1|STARTED|Overall Study||31
2299957|NCT02021669|5646635|P2|NOT COMPLETED|Overall Study||3
2299958|NCT02021669|5646636|P1|NOT COMPLETED|Overall Study||7
2299959|NCT02021669|5646635|P2|COMPLETED|Overall Study||70
2299960|NCT02021669|5646636|P1|COMPLETED|Overall Study||64
2299961|NCT02021669|5646635|P2|STARTED|Overall Study||73
2299962|NCT02021669|5646636|P1|STARTED|Overall Study||71
2299963|NCT02021656|5646644|P1|NOT COMPLETED|Overall Study||6
2299964|NCT02021656|5646644|P1|COMPLETED|Overall Study||378
2299965|NCT02021656|5646644|P1|STARTED|Overall Study||384
2299966|NCT02021643|5646664|P4|NOT COMPLETED|Overall Study||12
2299967|NCT02021643|5646665|P3|NOT COMPLETED|Overall Study||0
2299968|NCT02021643|5646666|P2|NOT COMPLETED|Overall Study||10
2299969|NCT02021643|5646667|P1|NOT COMPLETED|Overall Study||9
2299970|NCT02021643|5646664|P4|COMPLETED|Overall Study||218
2299971|NCT02021643|5646665|P3|COMPLETED|Overall Study||11
2299972|NCT02021643|5646666|P2|COMPLETED|Overall Study||280
2299973|NCT02021643|5646667|P1|COMPLETED|Overall Study||147
2299974|NCT02021643|5646664|P4|STARTED|Overall Study||230
2299975|NCT02021643|5646665|P3|STARTED|Overall Study||11
2299976|NCT02021643|5646666|P2|STARTED|Overall Study||290
2299977|NCT02021643|5646667|P1|STARTED|Overall Study||156
2299978|NCT02021565|5646709|P2|NOT COMPLETED|3-month Follow-up||2
2299979|NCT02021565|5646710|P1|NOT COMPLETED|3-month Follow-up||10
2299980|NCT02021565|5646709|P2|COMPLETED|3-month Follow-up||34
2299981|NCT02021565|5646710|P1|COMPLETED|3-month Follow-up||50
2299982|NCT02021565|5646709|P2|Care Recipients|3-month Follow-up||18
2299983|NCT02021565|5646710|P1|Care Recipients|3-month Follow-up||30
2299984|NCT02021565|5646709|P2|Caregivers|3-month Follow-up||18
2299985|NCT02021565|5646710|P1|Caregivers|3-month Follow-up||30
2299986|NCT02021565|5646709|P2|STARTED|3-month Follow-up||36
2299987|NCT02021565|5646710|P1|STARTED|3-month Follow-up||60
2299988|NCT02021565|5646709|P2|NOT COMPLETED|Baseline Through Intervention||18
2299989|NCT02021565|5646710|P1|NOT COMPLETED|Baseline Through Intervention||12
2299990|NCT02021565|5646709|P2|COMPLETED|Baseline Through Intervention||36
2299991|NCT02021565|5646710|P1|COMPLETED|Baseline Through Intervention||60
2299992|NCT02021565|5646709|P2|Care Recipients|Baseline Through Intervention||27
2299993|NCT02021565|5646710|P1|Care Recipients|Baseline Through Intervention||36
2299994|NCT02021565|5646709|P2|Caregivers|Baseline Through Intervention||27
2299995|NCT02021565|5646710|P1|Caregivers|Baseline Through Intervention||36
2299996|NCT02021565|5646709|P2|STARTED|Baseline Through Intervention||54
2299997|NCT02021565|5646710|P1|STARTED|Baseline Through Intervention||72
2299998|NCT02021461|5646722|P1|NOT COMPLETED|Overall Study||0
2299999|NCT02021461|5646722|P1|COMPLETED|Overall Study||38
2300000|NCT02021461|5646722|P1|STARTED|Overall Study||38
2300001|NCT02021331|5646730|P2|NOT COMPLETED|Overall Study||2
2300002|NCT02021331|5646731|P1|NOT COMPLETED|Overall Study||0
2300003|NCT02021331|5646730|P2|COMPLETED|Overall Study||1
2300004|NCT02021331|5646731|P1|COMPLETED|Overall Study||2
2300005|NCT02021331|5646730|P2|STARTED|Overall Study||3
2300006|NCT02021331|5646731|P1|STARTED|Overall Study||2
2300007|NCT02021292|5646743|P2|NOT COMPLETED|Overall Study||3
2300008|NCT02021292|5646744|P1|NOT COMPLETED|Overall Study||0
2300009|NCT02021292|5646743|P2|COMPLETED|Overall Study||37
2300010|NCT02021292|5646744|P1|COMPLETED|Overall Study||40
2300011|NCT02021292|5646743|P2|STARTED|Overall Study||40
2300012|NCT02021292|5646744|P1|STARTED|Overall Study||40
2300013|NCT02021071|5646762|P2|NOT COMPLETED|Overall Study||0
2300014|NCT02021071|5646763|P1|NOT COMPLETED|Overall Study||0
2300015|NCT02021071|5646762|P2|COMPLETED|Overall Study||12
2300016|NCT02021071|5646763|P1|COMPLETED|Overall Study||12
2300017|NCT02021071|5646762|P2|STARTED|Overall Study||12
2300018|NCT02021071|5646763|P1|STARTED|Overall Study||12
2300019|NCT02020941|5646770|P1|NOT COMPLETED|Overall Study||8
2300020|NCT02020941|5646770|P1|COMPLETED|Overall Study||2
2300021|NCT02020941|5646770|P1|STARTED|Overall Study||10
2300022|NCT02020889|5646781|P2|NOT COMPLETED|Overall Study||3
2300023|NCT02020889|5646782|P1|NOT COMPLETED|Overall Study||7
2300024|NCT02020889|5646781|P2|COMPLETED|Overall Study||65
2300025|NCT02020889|5646782|P1|COMPLETED|Overall Study||61
2300026|NCT02020889|5646781|P2|STARTED|Overall Study||68
2300027|NCT02020889|5646782|P1|STARTED|Overall Study||68
2300028|NCT02020863|5646836|P1|NOT COMPLETED|Overall Study||5
2300029|NCT02020863|5646836|P1|COMPLETED|Overall Study||35
2300030|NCT02020863|5646836|P1|STARTED|Overall Study||40
2300031|NCT02020837|5646840|P1|NOT COMPLETED|Overall Study||0
2300032|NCT02020837|5646840|P1|COMPLETED|Overall Study||2
2300033|NCT02020837|5646840|P1|STARTED|Overall Study||2
2300034|NCT02020785|5646846|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
2300035|NCT02020785|5646847|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
2300036|NCT02020785|5646846|P2|COMPLETED|Second Intervention (3 Weeks)||16
2300037|NCT02020785|5646847|P1|COMPLETED|Second Intervention (3 Weeks)||15
2300038|NCT02020785|5646846|P2|STARTED|Second Intervention (3 Weeks)||16
2300039|NCT02020785|5646847|P1|STARTED|Second Intervention (3 Weeks)||15
2300040|NCT02020785|5646846|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
2300041|NCT02020785|5646847|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
2300042|NCT02020785|5646846|P2|COMPLETED|First Intervention (3 Weeks)||16
2300043|NCT02020785|5646847|P1|COMPLETED|First Intervention (3 Weeks)||15
2300044|NCT02020785|5646846|P2|STARTED|First Intervention (3 Weeks)||16
2300045|NCT02020785|5646847|P1|STARTED|First Intervention (3 Weeks)||15
2300046|NCT02020616|5646866|P7|NOT COMPLETED|Overall Study||4
2300047|NCT02020616|5646867|P6|NOT COMPLETED|Overall Study||5
2300048|NCT02020616|5646868|P5|NOT COMPLETED|Overall Study||2
2300049|NCT02020616|5646869|P4|NOT COMPLETED|Overall Study||2
2300050|NCT02020616|5646870|P3|NOT COMPLETED|Overall Study||2
2300051|NCT02020616|5646871|P2|NOT COMPLETED|Overall Study||1
2300052|NCT02020616|5646872|P1|NOT COMPLETED|Overall Study||0
2300053|NCT02020616|5646866|P7|COMPLETED|Overall Study||6
2300054|NCT02020616|5646867|P6|COMPLETED|Overall Study||3
2300055|NCT02020616|5646868|P5|COMPLETED|Overall Study||6
2300056|NCT02020616|5646869|P4|COMPLETED|Overall Study||6
2300057|NCT02020616|5646870|P3|COMPLETED|Overall Study||6
2300058|NCT02020616|5646871|P2|COMPLETED|Overall Study||7
2300059|NCT02020616|5646872|P1|COMPLETED|Overall Study||10
2300060|NCT02020616|5646866|P7|Received at Least One Dose of Study Drug|Overall Study||10
2300061|NCT02020616|5646867|P6|Received at Least One Dose of Study Drug|Overall Study||8
2300062|NCT02020616|5646868|P5|Received at Least One Dose of Study Drug|Overall Study||8
2300063|NCT02020616|5646869|P4|Received at Least One Dose of Study Drug|Overall Study||7
2300064|NCT02020616|5646870|P3|Received at Least One Dose of Study Drug|Overall Study||8
2300065|NCT02020616|5646871|P2|Received at Least One Dose of Study Drug|Overall Study||8
2300066|NCT02020616|5646872|P1|Received at Least One Dose of Study Drug|Overall Study||10
2300067|NCT02020616|5646866|P7|STARTED|Overall Study||10
2300068|NCT02020616|5646867|P6|STARTED|Overall Study||8
2300069|NCT02020616|5646868|P5|STARTED|Overall Study||8
2300070|NCT02020616|5646869|P4|STARTED|Overall Study||8
2300071|NCT02020616|5646870|P3|STARTED|Overall Study||8
2300072|NCT02020616|5646871|P2|STARTED|Overall Study||8
2300073|NCT02020616|5646872|P1|STARTED|Overall Study||10
2300074|NCT02020577|5646965|P2|NOT COMPLETED|Overall Study||55
2300075|NCT02020577|5646966|P1|NOT COMPLETED|Overall Study||3
2300076|NCT02020577|5646965|P2|COMPLETED|Overall Study||0
2300077|NCT02020577|5646966|P1|COMPLETED|Overall Study||0
2300078|NCT02020577|5646965|P2|STARTED|Overall Study||55
2300079|NCT02020577|5646966|P1|STARTED|Overall Study||3
2300080|NCT02020512|5646993|P1|NOT COMPLETED|Overall Study||8
2300081|NCT02020512|5646993|P1|COMPLETED|Overall Study||79
2300082|NCT02020512|5646993|P1|STARTED|Overall Study||87
2300083|NCT02020369|5646999|P2|NOT COMPLETED|Overall Study||2
2300084|NCT02020369|5647000|P1|NOT COMPLETED|Overall Study||3
2300085|NCT02020369|5646999|P2|COMPLETED|Overall Study||11
2300086|NCT02020369|5647000|P1|COMPLETED|Overall Study||11
2300087|NCT02020369|5646999|P2|STARTED|Overall Study||13
2300088|NCT02020369|5647000|P1|STARTED|Overall Study||14
2300089|NCT02020304|5647016|P2|NOT COMPLETED|Overall Study||2
2300090|NCT02020304|5647017|P1|NOT COMPLETED|Overall Study||3
2300091|NCT02020304|5647016|P2|COMPLETED|Overall Study||26
2300092|NCT02020304|5647017|P1|COMPLETED|Overall Study||27
2300093|NCT02020304|5647016|P2|STARTED|Overall Study||28
2300094|NCT02020304|5647017|P1|STARTED|Overall Study||30
2300095|NCT02020135|5647033|P1|NOT COMPLETED|Overall Study||9
2300096|NCT02020135|5647033|P1|COMPLETED|Overall Study||0
2300097|NCT02020135|5647033|P1|STARTED|Overall Study||9
2300098|NCT02020031|5647045|P2|NOT COMPLETED|Overall Study||1
2300099|NCT02020031|5647046|P1|NOT COMPLETED|Overall Study||1
2300100|NCT02020031|5647045|P2|COMPLETED|Overall Study||10
2300101|NCT02020031|5647046|P1|COMPLETED|Overall Study||10
2300102|NCT02020031|5647045|P2|STARTED|Overall Study||11
2300103|NCT02020031|5647046|P1|STARTED|Overall Study||11
2300104|NCT02020018|5647056|P2|NOT COMPLETED|Overall Study||0
2300105|NCT02020018|5647057|P1|NOT COMPLETED|Overall Study||0
2300106|NCT02020018|5647056|P2|COMPLETED|Overall Study||1597
2300107|NCT02020018|5647057|P1|COMPLETED|Overall Study||272
2300108|NCT02020018|5647056|P2|STARTED|Overall Study||1597
2300109|NCT02020018|5647057|P1|STARTED|Overall Study||272
2300110|NCT02019979|5647067|P1|NOT COMPLETED|Overall Study||14
2300111|NCT02019979|5647067|P1|COMPLETED|Overall Study||0
2300112|NCT02019979|5647067|P1|STARTED|Overall Study||14
2300113|NCT02019927|5647079|P6|NOT COMPLETED|Overall Study||1
2300114|NCT02019927|5647080|P5|NOT COMPLETED|Overall Study||3
2300115|NCT02019927|5647081|P4|NOT COMPLETED|Overall Study||2
2300116|NCT02019927|5647082|P3|NOT COMPLETED|Overall Study||1
2300117|NCT02019927|5647083|P2|NOT COMPLETED|Overall Study||4
2300118|NCT02019927|5647084|P1|NOT COMPLETED|Overall Study||2
2300119|NCT02019927|5647079|P6|COMPLETED|Overall Study||3
2300120|NCT02019927|5647080|P5|COMPLETED|Overall Study||7
2300121|NCT02019927|5647081|P4|COMPLETED|Overall Study||3
2300122|NCT02019927|5647082|P3|COMPLETED|Overall Study||8
2300123|NCT02019927|5647083|P2|COMPLETED|Overall Study||19
2300124|NCT02019927|5647084|P1|COMPLETED|Overall Study||44
2300125|NCT02019927|5647079|P6|STARTED|Overall Study||4
2300126|NCT02019927|5647080|P5|STARTED|Overall Study||10
2300127|NCT02019927|5647081|P4|STARTED|Overall Study||5
2300128|NCT02019927|5647082|P3|STARTED|Overall Study||9
2300129|NCT02019927|5647083|P2|STARTED|Overall Study||23
2300130|NCT02019927|5647084|P1|STARTED|Overall Study||46
2300131|NCT02019758|5647154|P2|NOT COMPLETED|Overall Study||9
2300132|NCT02019758|5647155|P1|NOT COMPLETED|Overall Study||9
2300133|NCT02019758|5647154|P2|COMPLETED|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|55
2300134|NCT02019758|5647155|P1|COMPLETED|Overall Study||56
2300135|NCT02019758|5647154|P2|Lost to Follow-up|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|8
2300136|NCT02019758|5647155|P1|Lost to Follow-up|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|8
2300137|NCT02019758|5647154|P2|Did Not Receive Intervention|Overall Study||1
2300138|NCT02019758|5647155|P1|Did Not Receive Intervention|Overall Study||1
2300139|NCT02019758|5647154|P2|Received Intervention|Overall Study||63
2300140|NCT02019758|5647155|P1|Received Intervention|Overall Study||64
2300141|NCT02019758|5647154|P2|STARTED|Overall Study|63 received intervention; 1 did not receive intervention|64
2300142|NCT02019758|5647155|P1|STARTED|Overall Study|64 received intervention; 1 did not receive intervention|65
2300143|NCT02019719|5647176|P5|NOT COMPLETED|Overall Study||2
2300144|NCT02019719|5647177|P4|NOT COMPLETED|Overall Study||2
2300145|NCT02019719|5647178|P3|NOT COMPLETED|Overall Study||0
2300146|NCT02019719|5647179|P2|NOT COMPLETED|Overall Study||1
2300147|NCT02019719|5647180|P1|NOT COMPLETED|Overall Study||6
2300148|NCT02019719|5647176|P5|COMPLETED|Overall Study||18
2300149|NCT02019719|5647177|P4|COMPLETED|Overall Study||17
2300150|NCT02019719|5647178|P3|COMPLETED|Overall Study||20
2300151|NCT02019719|5647179|P2|COMPLETED|Overall Study||18
2300152|NCT02019719|5647180|P1|COMPLETED|Overall Study||13
2300153|NCT02019719|5647176|P5|STARTED|Overall Study||20
2300154|NCT02019719|5647177|P4|STARTED|Overall Study||19
2300155|NCT02019719|5647178|P3|STARTED|Overall Study||20
2300156|NCT02019719|5647179|P2|STARTED|Overall Study||19
2300157|NCT02019719|5647180|P1|STARTED|Overall Study||19
2300182|NCT02019602|5647298|P2|NOT COMPLETED|Sampling Period||0
2300183|NCT02019602|5647299|P1|NOT COMPLETED|Sampling Period||0
2300184|NCT02019602|5647298|P2|COMPLETED|Sampling Period||16
2300185|NCT02019602|5647299|P1|COMPLETED|Sampling Period||16
2300186|NCT02019602|5647298|P2|STARTED|Sampling Period||16
2300187|NCT02019602|5647299|P1|STARTED|Sampling Period||16
2300188|NCT02019602|5647298|P2|NOT COMPLETED|Screening Period||0
2300189|NCT02019602|5647299|P1|NOT COMPLETED|Screening Period||5
2300190|NCT02019602|5647298|P2|COMPLETED|Screening Period||16
2300191|NCT02019602|5647299|P1|COMPLETED|Screening Period||16
2300192|NCT02019602|5647298|P2|STARTED|Screening Period||16
2300193|NCT02019602|5647299|P1|STARTED|Screening Period||21
2300194|NCT02019563|5647311|P2|NOT COMPLETED|Overall Study||0
2300195|NCT02019563|5647312|P1|NOT COMPLETED|Overall Study||0
2300196|NCT02019563|5647311|P2|COMPLETED|Overall Study|72 incisors were treated in the RCT group|30
2300197|NCT02019563|5647312|P1|COMPLETED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
2300198|NCT02019563|5647311|P2|STARTED|Overall Study|72 incisors were treated in the RCT group|30
2300199|NCT02019563|5647312|P1|STARTED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
2300200|NCT02019550|5647328|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
2300201|NCT02019550|5647329|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
2300202|NCT02019550|5647328|P2|COMPLETED|Treatment Period 2 (4 Weeks)||50
2300203|NCT02019550|5647329|P1|COMPLETED|Treatment Period 2 (4 Weeks)||46
2300204|NCT02019550|5647328|P2|STARTED|Treatment Period 2 (4 Weeks)||50
2300205|NCT02019550|5647329|P1|STARTED|Treatment Period 2 (4 Weeks)||46
2300206|NCT02019550|5647328|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
2300207|NCT02019550|5647329|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
2300208|NCT02019550|5647328|P2|COMPLETED|Treatment Period 1 (4 Weeks)||50
2300209|NCT02019550|5647329|P1|COMPLETED|Treatment Period 1 (4 Weeks)||46
2300210|NCT02019550|5647328|P2|STARTED|Treatment Period 1 (4 Weeks)||51
2300211|NCT02019550|5647329|P1|STARTED|Treatment Period 1 (4 Weeks)||46
2300212|NCT02019472|5647370|P3|NOT COMPLETED|Overall Study||42
2300213|NCT02019472|5647371|P2|NOT COMPLETED|Overall Study||52
2300214|NCT02019472|5647372|P1|NOT COMPLETED|Overall Study||37
2300215|NCT02019472|5647370|P3|COMPLETED|Overall Study||145
2300216|NCT02019472|5647371|P2|COMPLETED|Overall Study||134
2300217|NCT02019472|5647372|P1|COMPLETED|Overall Study||149
2300218|NCT02019472|5647370|P3|STARTED|Overall Study||187
2300219|NCT02019472|5647371|P2|STARTED|Overall Study||186
2300220|NCT02019472|5647372|P1|STARTED|Overall Study||186
2300221|NCT02019420|5647395|P2|NOT COMPLETED|Overall Study||106
2300222|NCT02019420|5647396|P1|NOT COMPLETED|Overall Study||108
2300223|NCT02019420|5647395|P2|COMPLETED|Overall Study||254
2300224|NCT02019420|5647396|P1|COMPLETED|Overall Study||258
2300225|NCT02019420|5647395|P2|Treated|Overall Study||357
2300226|NCT02019420|5647396|P1|Treated|Overall Study||361
2300227|NCT02019420|5647395|P2|STARTED|Overall Study||360
2300228|NCT02019420|5647396|P1|STARTED|Overall Study||366
2300229|NCT02019277|5647424|P1|NOT COMPLETED|Overall Study||12
2300230|NCT02019277|5647424|P1|COMPLETED|Overall Study||38
2300231|NCT02019277|5647424|P1|STARTED|Overall Study||50
2300232|NCT02019264|5647443|P2|NOT COMPLETED|Overall Study||207
2300233|NCT02019264|5647444|P1|NOT COMPLETED|Overall Study||248
2300234|NCT02019264|5647443|P2|COMPLETED|Overall Study||5793
2300235|NCT02019264|5647444|P1|COMPLETED|Overall Study||5752
2300236|NCT02019264|5647443|P2|Safety Analysis Set|Overall Study||5995
2300237|NCT02019264|5647444|P1|Safety Analysis Set|Overall Study||5992
2300238|NCT02019264|5647443|P2|STARTED|Overall Study||6000
2300239|NCT02019264|5647444|P1|STARTED|Overall Study||6000
2300240|NCT02019108|5647480|P2|NOT COMPLETED|Overall Study||7
2300241|NCT02019108|5647481|P1|NOT COMPLETED|Overall Study||5
2300242|NCT02019108|5647480|P2|COMPLETED|Overall Study||32
2300243|NCT02019108|5647481|P1|COMPLETED|Overall Study||35
2300244|NCT02019108|5647480|P2|Retention (Week 21)|Overall Study||32
2300245|NCT02019108|5647481|P1|Retention (Week 21)|Overall Study||35
2300246|NCT02019108|5647480|P2|Follow-up (Week 17)|Overall Study||36
2300247|NCT02019108|5647481|P1|Follow-up (Week 17)|Overall Study||38
2300248|NCT02019108|5647480|P2|Baseline (Week 0)|Overall Study||39
2300249|NCT02019108|5647481|P1|Baseline (Week 0)|Overall Study||40
2300250|NCT02019108|5647480|P2|STARTED|Overall Study||39
2300251|NCT02019108|5647481|P1|STARTED|Overall Study||40
2300252|NCT02019069|5647503|P1|NOT COMPLETED|Overall Study||0
2300253|NCT02019069|5647503|P1|COMPLETED|Overall Study||11
2300254|NCT02019069|5647503|P1|STARTED|Overall Study||11
2300255|NCT02018887|5647523|P11|NOT COMPLETED|Part C: Cohort 8 Overall||1
2300256|NCT02018887|5647524|P10|NOT COMPLETED|Part C: Cohort 8 Overall||3
2300257|NCT02018887|5647525|P9|NOT COMPLETED|Part C: Cohort 8 Overall||3
2300258|NCT02018887|5647526|P8|NOT COMPLETED|Part C: Cohort 8 Overall||0
2300259|NCT02018887|5647527|P7|NOT COMPLETED|Part C: Cohort 8 Overall||0
2300260|NCT02018887|5647528|P6|NOT COMPLETED|Part C: Cohort 8 Overall||0
2300261|NCT02018887|5647529|P5|NOT COMPLETED|Part C: Cohort 8 Overall||0
2300262|NCT02018887|5647530|P4|NOT COMPLETED|Part C: Cohort 8 Overall||0
2300263|NCT02018887|5647531|P3|NOT COMPLETED|Part C: Cohort 8 Overall||0
2300264|NCT02018887|5647532|P2|NOT COMPLETED|Part C: Cohort 8 Overall||0
2300265|NCT02018887|5647533|P1|NOT COMPLETED|Part C: Cohort 8 Overall||0
2300266|NCT02018887|5647523|P11|COMPLETED|Part C: Cohort 8 Overall||6
2300267|NCT02018887|5647524|P10|COMPLETED|Part C: Cohort 8 Overall||1
2300268|NCT02018887|5647525|P9|COMPLETED|Part C: Cohort 8 Overall||7
2300269|NCT02018887|5647526|P8|COMPLETED|Part C: Cohort 8 Overall||0
2300270|NCT02018887|5647527|P7|COMPLETED|Part C: Cohort 8 Overall||0
2300271|NCT02018887|5647528|P6|COMPLETED|Part C: Cohort 8 Overall||0
2300272|NCT02018887|5647529|P5|COMPLETED|Part C: Cohort 8 Overall||0
2300273|NCT02018887|5647530|P4|COMPLETED|Part C: Cohort 8 Overall||0
2300274|NCT02018887|5647531|P3|COMPLETED|Part C: Cohort 8 Overall||0
2300275|NCT02018887|5647532|P2|COMPLETED|Part C: Cohort 8 Overall||0
2300276|NCT02018887|5647533|P1|COMPLETED|Part C: Cohort 8 Overall||0
2300277|NCT02018887|5647523|P11|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||7
2300278|NCT02018887|5647524|P10|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||4
2300279|NCT02018887|5647525|P9|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||10
2300280|NCT02018887|5647526|P8|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
2300281|NCT02018887|5647527|P7|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
2300282|NCT02018887|5647528|P6|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
2300283|NCT02018887|5647529|P5|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
2300284|NCT02018887|5647530|P4|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
2300285|NCT02018887|5647531|P3|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
2300286|NCT02018887|5647532|P2|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
2300287|NCT02018887|5647533|P1|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
2300288|NCT02018887|5647523|P11|STARTED|Part C: Cohort 8 Overall||7
2300289|NCT02018887|5647524|P10|STARTED|Part C: Cohort 8 Overall||4
2300290|NCT02018887|5647525|P9|STARTED|Part C: Cohort 8 Overall||10
2300291|NCT02018887|5647526|P8|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
2300292|NCT02018887|5647527|P7|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
2300293|NCT02018887|5647528|P6|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
2300294|NCT02018887|5647529|P5|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
2300295|NCT02018887|5647530|P4|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
2300296|NCT02018887|5647531|P3|STARTED|Part C: Cohort 8 Overall|Placebo was not administered in this period.|0
2300297|NCT02018887|5647532|P2|STARTED|Part C: Cohort 8 Overall||0
2300298|NCT02018887|5647533|P1|STARTED|Part C: Cohort 8 Overall||0
2300299|NCT02018887|5647523|P11|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
2300300|NCT02018887|5647524|P10|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
2300301|NCT02018887|5647525|P9|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
2300302|NCT02018887|5647526|P8|NOT COMPLETED|Part B: Cohorts 3-7 Overall||4
2300303|NCT02018887|5647527|P7|NOT COMPLETED|Part B: Cohorts 3-7 Overall||1
2300304|NCT02018887|5647528|P6|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
2300305|NCT02018887|5647529|P5|NOT COMPLETED|Part B: Cohorts 3-7 Overall||1
2300306|NCT02018887|5647530|P4|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
2300307|NCT02018887|5647531|P3|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
2300308|NCT02018887|5647532|P2|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
2300309|NCT02018887|5647533|P1|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
2300310|NCT02018887|5647523|P11|COMPLETED|Part B: Cohorts 3-7 Overall||0
2300311|NCT02018887|5647524|P10|COMPLETED|Part B: Cohorts 3-7 Overall||0
2300312|NCT02018887|5647525|P9|COMPLETED|Part B: Cohorts 3-7 Overall||0
2300313|NCT02018887|5647526|P8|COMPLETED|Part B: Cohorts 3-7 Overall||5
2300314|NCT02018887|5647527|P7|COMPLETED|Part B: Cohorts 3-7 Overall||8
2300315|NCT02018887|5647528|P6|COMPLETED|Part B: Cohorts 3-7 Overall||9
2300316|NCT02018887|5647529|P5|COMPLETED|Part B: Cohorts 3-7 Overall||8
2300317|NCT02018887|5647530|P4|COMPLETED|Part B: Cohorts 3-7 Overall||9
2300318|NCT02018887|5647531|P3|COMPLETED|Part B: Cohorts 3-7 Overall||15
2300319|NCT02018887|5647532|P2|COMPLETED|Part B: Cohorts 3-7 Overall||0
2300320|NCT02018887|5647533|P1|COMPLETED|Part B: Cohorts 3-7 Overall||0
2300321|NCT02018887|5647523|P11|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
2300322|NCT02018887|5647524|P10|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
2300323|NCT02018887|5647525|P9|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
2300324|NCT02018887|5647526|P8|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
2300325|NCT02018887|5647527|P7|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
2300326|NCT02018887|5647528|P6|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
2300327|NCT02018887|5647529|P5|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
2300400|NCT02018887|5647525|P9|COMPLETED|Part A: Cohorts 1-2: Period 2||0
2300328|NCT02018887|5647530|P4|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
2300329|NCT02018887|5647531|P3|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||15
2300330|NCT02018887|5647532|P2|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
2300331|NCT02018887|5647533|P1|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
2300332|NCT02018887|5647523|P11|STARTED|Part B: Cohorts 3-7 Overall|This dose was not administered in this period.|0
2300333|NCT02018887|5647524|P10|STARTED|Part B: Cohorts 3-7 Overall|This dose was not administered in this period.|0
2300334|NCT02018887|5647525|P9|STARTED|Part B: Cohorts 3-7 Overall|Placebo was not administered in this period.|0
2300335|NCT02018887|5647526|P8|STARTED|Part B: Cohorts 3-7 Overall||9
2300336|NCT02018887|5647527|P7|STARTED|Part B: Cohorts 3-7 Overall||9
2300337|NCT02018887|5647528|P6|STARTED|Part B: Cohorts 3-7 Overall||9
2300338|NCT02018887|5647529|P5|STARTED|Part B: Cohorts 3-7 Overall||9
2300339|NCT02018887|5647530|P4|STARTED|Part B: Cohorts 3-7 Overall||9
2300340|NCT02018887|5647531|P3|STARTED|Part B: Cohorts 3-7 Overall||15
2300341|NCT02018887|5647532|P2|STARTED|Part B: Cohorts 3-7 Overall|Column for Part A data only.|0
2300342|NCT02018887|5647533|P1|STARTED|Part B: Cohorts 3-7 Overall|Column for Part A data only.|0
2300343|NCT02018887|5647523|P11|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
2300344|NCT02018887|5647524|P10|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
2300345|NCT02018887|5647525|P9|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
2300346|NCT02018887|5647526|P8|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
2300347|NCT02018887|5647527|P7|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
2300348|NCT02018887|5647528|P6|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
2300349|NCT02018887|5647529|P5|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
2300350|NCT02018887|5647530|P4|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
2300351|NCT02018887|5647531|P3|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
2300352|NCT02018887|5647532|P2|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
2300353|NCT02018887|5647533|P1|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||1
2300354|NCT02018887|5647523|P11|COMPLETED|Part A: Cohorts 1-2: Period 3||0
2300355|NCT02018887|5647524|P10|COMPLETED|Part A: Cohorts 1-2: Period 3||0
2300356|NCT02018887|5647525|P9|COMPLETED|Part A: Cohorts 1-2: Period 3||0
2300357|NCT02018887|5647526|P8|COMPLETED|Part A: Cohorts 1-2: Period 3||0
2300358|NCT02018887|5647527|P7|COMPLETED|Part A: Cohorts 1-2: Period 3||0
2300359|NCT02018887|5647528|P6|COMPLETED|Part A: Cohorts 1-2: Period 3||0
2300360|NCT02018887|5647529|P5|COMPLETED|Part A: Cohorts 1-2: Period 3||0
2300361|NCT02018887|5647530|P4|COMPLETED|Part A: Cohorts 1-2: Period 3||0
2300362|NCT02018887|5647531|P3|COMPLETED|Part A: Cohorts 1-2: Period 3||0
2300363|NCT02018887|5647532|P2|COMPLETED|Part A: Cohorts 1-2: Period 3||9
2300364|NCT02018887|5647533|P1|COMPLETED|Part A: Cohorts 1-2: Period 3||8
2300365|NCT02018887|5647523|P11|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
2300366|NCT02018887|5647524|P10|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
2300367|NCT02018887|5647525|P9|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
2300368|NCT02018887|5647526|P8|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
2300369|NCT02018887|5647527|P7|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
2300370|NCT02018887|5647528|P6|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
2300371|NCT02018887|5647529|P5|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
2300372|NCT02018887|5647530|P4|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
2300373|NCT02018887|5647531|P3|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
2300374|NCT02018887|5647532|P2|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||9
2300375|NCT02018887|5647533|P1|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||8
2300376|NCT02018887|5647523|P11|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
2300377|NCT02018887|5647524|P10|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
2300378|NCT02018887|5647525|P9|STARTED|Part A: Cohorts 1-2: Period 3|Placebo was not administered in this period.|0
2300379|NCT02018887|5647526|P8|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
2300380|NCT02018887|5647527|P7|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
2300381|NCT02018887|5647528|P6|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
2300382|NCT02018887|5647529|P5|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
2300383|NCT02018887|5647530|P4|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
2300384|NCT02018887|5647531|P3|STARTED|Part A: Cohorts 1-2: Period 3|Placebo was not administered in this period.|0
2300385|NCT02018887|5647532|P2|STARTED|Part A: Cohorts 1-2: Period 3||9
2300386|NCT02018887|5647533|P1|STARTED|Part A: Cohorts 1-2: Period 3||9
2300387|NCT02018887|5647523|P11|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
2300388|NCT02018887|5647524|P10|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
2300389|NCT02018887|5647525|P9|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
2300390|NCT02018887|5647526|P8|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
2300391|NCT02018887|5647527|P7|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
2300392|NCT02018887|5647528|P6|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
2300393|NCT02018887|5647529|P5|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
2300394|NCT02018887|5647530|P4|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
2300395|NCT02018887|5647531|P3|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
2300396|NCT02018887|5647532|P2|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
2300397|NCT02018887|5647533|P1|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
2300398|NCT02018887|5647523|P11|COMPLETED|Part A: Cohorts 1-2: Period 2||0
2300399|NCT02018887|5647524|P10|COMPLETED|Part A: Cohorts 1-2: Period 2||0
2300401|NCT02018887|5647526|P8|COMPLETED|Part A: Cohorts 1-2: Period 2||0
2300402|NCT02018887|5647527|P7|COMPLETED|Part A: Cohorts 1-2: Period 2||0
2300403|NCT02018887|5647528|P6|COMPLETED|Part A: Cohorts 1-2: Period 2||0
2300404|NCT02018887|5647529|P5|COMPLETED|Part A: Cohorts 1-2: Period 2||0
2300405|NCT02018887|5647530|P4|COMPLETED|Part A: Cohorts 1-2: Period 2||0
2300406|NCT02018887|5647531|P3|COMPLETED|Part A: Cohorts 1-2: Period 2||0
2300407|NCT02018887|5647532|P2|COMPLETED|Part A: Cohorts 1-2: Period 2||9
2300408|NCT02018887|5647533|P1|COMPLETED|Part A: Cohorts 1-2: Period 2||9
2300409|NCT02018887|5647523|P11|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
2300410|NCT02018887|5647524|P10|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
2300411|NCT02018887|5647525|P9|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
2300412|NCT02018887|5647526|P8|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
2300413|NCT02018887|5647527|P7|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
2300414|NCT02018887|5647528|P6|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
2300415|NCT02018887|5647529|P5|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
2300416|NCT02018887|5647530|P4|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
2300417|NCT02018887|5647531|P3|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
2300418|NCT02018887|5647532|P2|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||9
2300419|NCT02018887|5647533|P1|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||9
2300420|NCT02018887|5647523|P11|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
2300421|NCT02018887|5647524|P10|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
2300422|NCT02018887|5647525|P9|STARTED|Part A: Cohorts 1-2: Period 2|Placebo was not administered in this period.|0
2300423|NCT02018887|5647526|P8|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
2300424|NCT02018887|5647527|P7|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
2300425|NCT02018887|5647528|P6|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
2300426|NCT02018887|5647529|P5|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
2300427|NCT02018887|5647530|P4|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
2300428|NCT02018887|5647531|P3|STARTED|Part A: Cohorts 1-2: Period 2|Placebo was not administered in this period.|0
2300429|NCT02018887|5647532|P2|STARTED|Part A: Cohorts 1-2: Period 2||9
2300430|NCT02018887|5647533|P1|STARTED|Part A: Cohorts 1-2: Period 2||9
2300431|NCT02018887|5647523|P11|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
2300432|NCT02018887|5647524|P10|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
2300433|NCT02018887|5647525|P9|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
2300434|NCT02018887|5647526|P8|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
2300435|NCT02018887|5647527|P7|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
2300436|NCT02018887|5647528|P6|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
2300437|NCT02018887|5647529|P5|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
2300438|NCT02018887|5647530|P4|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
2300439|NCT02018887|5647531|P3|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
2300440|NCT02018887|5647532|P2|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
2300441|NCT02018887|5647533|P1|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
2300442|NCT02018887|5647523|P11|COMPLETED|Part A: Cohorts 1-2: Period 1||0
2300443|NCT02018887|5647524|P10|COMPLETED|Part A: Cohorts 1-2: Period 1||0
2300444|NCT02018887|5647525|P9|COMPLETED|Part A: Cohorts 1-2: Period 1||0
2300445|NCT02018887|5647526|P8|COMPLETED|Part A: Cohorts 1-2: Period 1||0
2300446|NCT02018887|5647527|P7|COMPLETED|Part A: Cohorts 1-2: Period 1||0
2300447|NCT02018887|5647528|P6|COMPLETED|Part A: Cohorts 1-2: Period 1||0
2300448|NCT02018887|5647529|P5|COMPLETED|Part A: Cohorts 1-2: Period 1||0
2300449|NCT02018887|5647530|P4|COMPLETED|Part A: Cohorts 1-2: Period 1||0
2300450|NCT02018887|5647531|P3|COMPLETED|Part A: Cohorts 1-2: Period 1||0
2300451|NCT02018887|5647532|P2|COMPLETED|Part A: Cohorts 1-2: Period 1||9
2300452|NCT02018887|5647533|P1|COMPLETED|Part A: Cohorts 1-2: Period 1||9
2300453|NCT02018887|5647523|P11|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
2300454|NCT02018887|5647524|P10|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
2300455|NCT02018887|5647525|P9|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
2300456|NCT02018887|5647526|P8|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
2300457|NCT02018887|5647527|P7|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
2300458|NCT02018887|5647528|P6|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
2300459|NCT02018887|5647529|P5|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
2300460|NCT02018887|5647530|P4|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
2300461|NCT02018887|5647531|P3|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
2300462|NCT02018887|5647532|P2|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||9
2300463|NCT02018887|5647533|P1|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||9
2300464|NCT02018887|5647523|P11|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
2300465|NCT02018887|5647524|P10|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
2300466|NCT02018887|5647525|P9|STARTED|Part A: Cohorts 1-2: Period 1|Placebo was not administered in this period.|0
2300467|NCT02018887|5647526|P8|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
2300468|NCT02018887|5647527|P7|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
2300469|NCT02018887|5647528|P6|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
2300470|NCT02018887|5647529|P5|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
2300471|NCT02018887|5647530|P4|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
2300472|NCT02018887|5647531|P3|STARTED|Part A: Cohorts 1-2: Period 1|Placebo was not administered in this period.|0
2300473|NCT02018887|5647532|P2|STARTED|Part A: Cohorts 1-2: Period 1||9
2300474|NCT02018887|5647533|P1|STARTED|Part A: Cohorts 1-2: Period 1||9
2300475|NCT02018822|5647622|P3|NOT COMPLETED|Overall Study||6
2300476|NCT02018822|5647623|P2|NOT COMPLETED|Overall Study||8
2300477|NCT02018822|5647624|P1|NOT COMPLETED|Overall Study||6
2300478|NCT02018822|5647622|P3|COMPLETED|Overall Study||29
2300479|NCT02018822|5647623|P2|COMPLETED|Overall Study||42
2300480|NCT02018822|5647624|P1|COMPLETED|Overall Study||44
2300481|NCT02018822|5647622|P3|STARTED|Overall Study||35
2300482|NCT02018822|5647623|P2|STARTED|Overall Study||50
2300483|NCT02018822|5647624|P1|STARTED|Overall Study||50
2300484|NCT02018809|5647651|P4|NOT COMPLETED|Overall Study||0
2300485|NCT02018809|5647652|P3|NOT COMPLETED|Overall Study||0
2300486|NCT02018809|5647653|P2|NOT COMPLETED|Overall Study||0
2300487|NCT02018809|5647654|P1|NOT COMPLETED|Overall Study||0
2300488|NCT02018809|5647651|P4|COMPLETED|Overall Study||50
2300489|NCT02018809|5647652|P3|COMPLETED|Overall Study||50
2300490|NCT02018809|5647653|P2|COMPLETED|Overall Study||50
2300491|NCT02018809|5647654|P1|COMPLETED|Overall Study||50
2300492|NCT02018809|5647651|P4|STARTED|Overall Study||50
2300493|NCT02018809|5647652|P3|STARTED|Overall Study||50
2300494|NCT02018809|5647653|P2|STARTED|Overall Study||50
2300495|NCT02018809|5647654|P1|STARTED|Overall Study||50
2300496|NCT02018653|5647670|P2|NOT COMPLETED|Overall Study||1
2300497|NCT02018653|5647671|P1|NOT COMPLETED|Overall Study||0
2300498|NCT02018653|5647670|P2|COMPLETED|Overall Study||0
2300499|NCT02018653|5647671|P1|COMPLETED|Overall Study||1
2300500|NCT02018653|5647670|P2|STARTED|Overall Study||1
2300501|NCT02018653|5647671|P1|STARTED|Overall Study||1
2300502|NCT02018627|5647679|P2|NOT COMPLETED|Overall Study||0
2300503|NCT02018627|5647680|P1|NOT COMPLETED|Overall Study||0
2300504|NCT02018627|5647679|P2|COMPLETED|Overall Study||6
2300505|NCT02018627|5647680|P1|COMPLETED|Overall Study||7
2300506|NCT02018627|5647679|P2|STARTED|Overall Study||6
2300507|NCT02018627|5647680|P1|STARTED|Overall Study||7
2300508|NCT02018562|5647704|P2|NOT COMPLETED|Overall Study||0
2300509|NCT02018562|5647705|P1|NOT COMPLETED|Overall Study||3
2300510|NCT02018562|5647704|P2|COMPLETED|Overall Study||25
2300511|NCT02018562|5647705|P1|COMPLETED|Overall Study||22
2300512|NCT02018562|5647704|P2|STARTED|Overall Study||25
2300513|NCT02018562|5647705|P1|STARTED|Overall Study||25
2300517|NCT02018315|5647734|P1|NOT COMPLETED|Overall Study||0
2300518|NCT02018315|5647734|P1|COMPLETED|Overall Study||14
2300519|NCT02018315|5647734|P1|STARTED|Overall Study||14
2300520|NCT02018042|5647739|P1|NOT COMPLETED|Overall Study||1
2300521|NCT02018042|5647739|P1|COMPLETED|Overall Study||14
2300522|NCT02018042|5647739|P1|STARTED|Overall Study||15
2300523|NCT02017964|5647745|P1|NOT COMPLETED|Overall Study||1
2300524|NCT02017964|5647745|P1|COMPLETED|Overall Study||25
2300525|NCT02017964|5647745|P1|STARTED|Overall Study||26
2300526|NCT02017899|5647759|P6|NOT COMPLETED|Overall Study||0
2300527|NCT02017899|5647760|P5|NOT COMPLETED|Overall Study||1
2300528|NCT02017899|5647761|P4|NOT COMPLETED|Overall Study||1
2300529|NCT02017899|5647762|P3|NOT COMPLETED|Overall Study||0
2300530|NCT02017899|5647763|P2|NOT COMPLETED|Overall Study||0
2300531|NCT02017899|5647764|P1|NOT COMPLETED|Overall Study||0
2300532|NCT02017899|5647759|P6|COMPLETED|Overall Study||8
2300533|NCT02017899|5647760|P5|COMPLETED|Overall Study||8
2300534|NCT02017899|5647761|P4|COMPLETED|Overall Study||7
2300535|NCT02017899|5647762|P3|COMPLETED|Overall Study||8
2300536|NCT02017899|5647763|P2|COMPLETED|Overall Study||9
2300537|NCT02017899|5647764|P1|COMPLETED|Overall Study||8
2300538|NCT02017899|5647759|P6|STARTED|Overall Study||8
2300539|NCT02017899|5647760|P5|STARTED|Overall Study||9
2300540|NCT02017899|5647761|P4|STARTED|Overall Study||8
2300541|NCT02017899|5647762|P3|STARTED|Overall Study||8
2300542|NCT02017899|5647763|P2|STARTED|Overall Study||9
2300543|NCT02017899|5647764|P1|STARTED|Overall Study||8
2300544|NCT02017574|5647840|P2|NOT COMPLETED|Overall Study||0
2300545|NCT02017574|5647841|P1|NOT COMPLETED|Overall Study||0
2300546|NCT02017574|5647840|P2|COMPLETED|Overall Study||12
2300547|NCT02017574|5647841|P1|COMPLETED|Overall Study||12
2300548|NCT02017574|5647840|P2|STARTED|Overall Study||12
2300549|NCT02017574|5647841|P1|STARTED|Overall Study||12
2300550|NCT02017522|5647849|P1|NOT COMPLETED|Overall Study||1
2300551|NCT02017522|5647849|P1|COMPLETED|Overall Study||2
2300552|NCT02017522|5647849|P1|Scan|Overall Study||2
2300553|NCT02017522|5647849|P1|STARTED|Overall Study||3
2300554|NCT02017223|5647854|P1|NOT COMPLETED|Overall Study||2
2300555|NCT02017223|5647854|P1|COMPLETED|Overall Study||10
2300556|NCT02017223|5647854|P1|STARTED|Overall Study||12
2300566|NCT02017093|5647900|P2|NOT COMPLETED|Overall Study||0
2300567|NCT02017093|5647901|P1|NOT COMPLETED|Overall Study||0
2300568|NCT02017093|5647900|P2|COMPLETED|Overall Study||3
2300569|NCT02017093|5647901|P1|COMPLETED|Overall Study||4
2300570|NCT02017093|5647900|P2|STARTED|Overall Study||3
2300571|NCT02017093|5647901|P1|STARTED|Overall Study||4
2300572|NCT02017015|5647909|P1|NOT COMPLETED|Overall Study||69
2300573|NCT02017015|5647909|P1|COMPLETED|Overall Study|Completed = Participants remaining on treatment at the time of the data cut-off of 01 Jun 2015|14
2300574|NCT02017015|5647909|P1|Safety Population|Overall Study||83
2300575|NCT02017015|5647909|P1|STARTED|Overall Study||83
2300576|NCT02016963|5647916|P1|NOT COMPLETED|Overall Study||0
2300577|NCT02016963|5647916|P1|COMPLETED|Overall Study||20
2300578|NCT02016963|5647916|P1|STARTED|Overall Study||20
2300579|NCT02016898|5647934|P2|NOT COMPLETED|Overall Study||5
2300580|NCT02016898|5647935|P1|NOT COMPLETED|Overall Study||5
2300581|NCT02016898|5647934|P2|COMPLETED|Overall Study||40
2300582|NCT02016898|5647935|P1|COMPLETED|Overall Study||45
2300583|NCT02016898|5647934|P2|STARTED|Overall Study||45
2300584|NCT02016898|5647935|P1|STARTED|Overall Study||50
2300585|NCT02016885|5647948|P5|NOT COMPLETED|Overall Study||1
2300586|NCT02016885|5647949|P4|NOT COMPLETED|Overall Study||10
2300587|NCT02016885|5647950|P3|NOT COMPLETED|Overall Study||1
2300588|NCT02016885|5647951|P2|NOT COMPLETED|Overall Study||4
2300589|NCT02016885|5647952|P1|NOT COMPLETED|Overall Study||4
2300590|NCT02016885|5647948|P5|COMPLETED|Overall Study||39
2300591|NCT02016885|5647949|P4|COMPLETED|Overall Study||30
2300592|NCT02016885|5647950|P3|COMPLETED|Overall Study||39
2300593|NCT02016885|5647951|P2|COMPLETED|Overall Study||36
2300594|NCT02016885|5647952|P1|COMPLETED|Overall Study||34
2300595|NCT02016885|5647948|P5|STARTED|Overall Study||40
2300596|NCT02016885|5647949|P4|STARTED|Overall Study||40
2300597|NCT02016885|5647950|P3|STARTED|Overall Study||40
2300598|NCT02016885|5647951|P2|STARTED|Overall Study||40
2300599|NCT02016885|5647952|P1|STARTED|Overall Study||38
2300600|NCT02016716|5647992|P3|NOT COMPLETED|Overall Study||6
2300601|NCT02016716|5647993|P2|NOT COMPLETED|Overall Study||8
2300602|NCT02016716|5647994|P1|NOT COMPLETED|Overall Study||6
2300603|NCT02016716|5647992|P3|COMPLETED|Overall Study||117
2300604|NCT02016716|5647993|P2|COMPLETED|Overall Study||110
2300605|NCT02016716|5647994|P1|COMPLETED|Overall Study||47
2300606|NCT02016716|5647992|P3|Received Study Treatment|Overall Study||123
2300607|NCT02016716|5647993|P2|Received Study Treatment|Overall Study||118
2300608|NCT02016716|5647994|P1|Received Study Treatment|Overall Study||53
2300609|NCT02016716|5647992|P3|STARTED|Overall Study||123
2300610|NCT02016716|5647993|P2|STARTED|Overall Study||118
2300611|NCT02016716|5647994|P1|STARTED|Overall Study||53
2300612|NCT02016690|5648015|P1|NOT COMPLETED|Overall Study||24
2300613|NCT02016690|5648015|P1|COMPLETED|Overall Study|(Effectiveness analysis set)|288
2300614|NCT02016690|5648015|P1|Safety Analysis Set (SAS)|Overall Study||304
2300615|NCT02016690|5648015|P1|Treated|Overall Study||312
2300616|NCT02016690|5648015|P1|STARTED|Overall Study||312
2300617|NCT02016625|5648028|P2|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||0
2300618|NCT02016625|5648029|P1|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||3
2300619|NCT02016625|5648028|P2|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
2300620|NCT02016625|5648029|P1|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||13
2300621|NCT02016625|5648028|P2|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
2300622|NCT02016625|5648029|P1|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||16
2300623|NCT02016625|5648028|P2|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||1
2300624|NCT02016625|5648029|P1|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||0
2300625|NCT02016625|5648028|P2|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||15
2300626|NCT02016625|5648029|P1|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||16
2300627|NCT02016625|5648028|P2|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
2300628|NCT02016625|5648029|P1|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
2300629|NCT02016612|5648065|P4|NOT COMPLETED|Overall Study||0
2300630|NCT02016612|5648066|P3|NOT COMPLETED|Overall Study||0
2300631|NCT02016612|5648067|P2|NOT COMPLETED|Overall Study||0
2300632|NCT02016612|5648068|P1|NOT COMPLETED|Overall Study||0
2300633|NCT02016612|5648065|P4|COMPLETED|Overall Study||61
2300634|NCT02016612|5648066|P3|COMPLETED|Overall Study||26
2300635|NCT02016612|5648067|P2|COMPLETED|Overall Study||25
2300636|NCT02016612|5648068|P1|COMPLETED|Overall Study||25
2300637|NCT02016612|5648065|P4|STARTED|Overall Study||61
2300638|NCT02016612|5648066|P3|STARTED|Overall Study||26
2300639|NCT02016612|5648067|P2|STARTED|Overall Study||25
2300640|NCT02016612|5648068|P1|STARTED|Overall Study||25
2300641|NCT02016482|5648084|P2|NOT COMPLETED|Period B||7
2300642|NCT02016482|5648085|P1|NOT COMPLETED|Period B||13
2300643|NCT02016482|5648084|P2|COMPLETED|Period B||87
2300644|NCT02016482|5648085|P1|COMPLETED|Period B||81
2300645|NCT02016482|5648084|P2|STARTED|Period B||94
2300646|NCT02016482|5648085|P1|STARTED|Period B||94
2300647|NCT02016482|5648084|P2|NOT COMPLETED|Period A||15
2300648|NCT02016482|5648085|P1|NOT COMPLETED|Period A||14
2300649|NCT02016482|5648084|P2|COMPLETED|Period A|8 participants early escaped to the end of Period A and 86 continued to the end of Period A.|94
2300650|NCT02016482|5648085|P1|COMPLETED|Period A|56 participants early escaped to the end of Period A and 38 continued to the end of Period A.|94
2300651|NCT02016482|5648084|P2|STARTED|Period A||109
2300652|NCT02016482|5648085|P1|STARTED|Period A||108
2300653|NCT02016300|5648175|P2|NOT COMPLETED|Overall Study||3
2300654|NCT02016300|5648176|P1|NOT COMPLETED|Overall Study||0
2300655|NCT02016300|5648175|P2|COMPLETED|Overall Study||9
2300656|NCT02016300|5648176|P1|COMPLETED|Overall Study||12
2300657|NCT02016300|5648175|P2|STARTED|Overall Study||12
2300658|NCT02016300|5648176|P1|STARTED|Overall Study||12
2300659|NCT02016183|5648194|P1|NOT COMPLETED|Overall Study||65
2300660|NCT02016183|5648194|P1|COMPLETED|Overall Study||3157
2300661|NCT02016183|5648194|P1|STARTED|Overall Study||3222
2300662|NCT02016170|5648204|P3|NOT COMPLETED|Overall Study||0
2300663|NCT02016170|5648205|P2|NOT COMPLETED|Overall Study||1
2300664|NCT02016170|5648206|P1|NOT COMPLETED|Overall Study||2
2300665|NCT02016170|5648204|P3|COMPLETED|Overall Study||27
2300666|NCT02016170|5648205|P2|COMPLETED|Overall Study||27
2300667|NCT02016170|5648206|P1|COMPLETED|Overall Study||25
2300668|NCT02016170|5648204|P3|STARTED|Overall Study||27
2300669|NCT02016170|5648205|P2|STARTED|Overall Study||28
2300670|NCT02016170|5648206|P1|STARTED|Overall Study||27
2300671|NCT02016105|5648217|P6|NOT COMPLETED|EXTENSION PERIOD||6
2300672|NCT02016105|5648218|P5|NOT COMPLETED|EXTENSION PERIOD||6
2300673|NCT02016105|5648219|P4|NOT COMPLETED|EXTENSION PERIOD||5
2300674|NCT02016105|5648220|P3|NOT COMPLETED|EXTENSION PERIOD||5
2300675|NCT02016105|5648221|P2|NOT COMPLETED|EXTENSION PERIOD||0
2300676|NCT02016105|5648222|P1|NOT COMPLETED|EXTENSION PERIOD||0
2300677|NCT02016105|5648217|P6|COMPLETED|EXTENSION PERIOD||100
2300678|NCT02016105|5648218|P5|COMPLETED|EXTENSION PERIOD||50
2300679|NCT02016105|5648219|P4|COMPLETED|EXTENSION PERIOD||104
2300680|NCT02016105|5648220|P3|COMPLETED|EXTENSION PERIOD||47
2300681|NCT02016105|5648221|P2|COMPLETED|EXTENSION PERIOD||0
2300682|NCT02016105|5648222|P1|COMPLETED|EXTENSION PERIOD||0
2300683|NCT02016105|5648217|P6|STARTED|EXTENSION PERIOD|6 patients did not proceed from Treatment Period 2 into Extension Period|106
2300684|NCT02016105|5648218|P5|STARTED|EXTENSION PERIOD|3 patients did not proceed from Treatment Period 2 into Extension Period|56
2300685|NCT02016105|5648219|P4|STARTED|EXTENSION PERIOD|7 patients did not proceed from Treatment Period 2 into Extension Period|109
2300686|NCT02016105|5648220|P3|STARTED|EXTENSION PERIOD|5 patients did not proceed from Treatment Period 2 into Extension Period|52
2300687|NCT02016105|5648221|P2|STARTED|EXTENSION PERIOD||0
2300688|NCT02016105|5648222|P1|STARTED|EXTENSION PERIOD||0
2300689|NCT02016105|5648217|P6|NOT COMPLETED|TREATMENT PERIOD 2||14
2300690|NCT02016105|5648218|P5|NOT COMPLETED|TREATMENT PERIOD 2||4
2300691|NCT02016105|5648219|P4|NOT COMPLETED|TREATMENT PERIOD 2||11
2300692|NCT02016105|5648220|P3|NOT COMPLETED|TREATMENT PERIOD 2||6
2300693|NCT02016105|5648221|P2|NOT COMPLETED|TREATMENT PERIOD 2||0
2300694|NCT02016105|5648222|P1|NOT COMPLETED|TREATMENT PERIOD 2||0
2300695|NCT02016105|5648217|P6|COMPLETED|TREATMENT PERIOD 2||112
2300696|NCT02016105|5648218|P5|COMPLETED|TREATMENT PERIOD 2||59
2300697|NCT02016105|5648219|P4|COMPLETED|TREATMENT PERIOD 2||116
2300698|NCT02016105|5648220|P3|COMPLETED|TREATMENT PERIOD 2||57
2300699|NCT02016105|5648221|P2|COMPLETED|TREATMENT PERIOD 2||0
2300700|NCT02016105|5648222|P1|COMPLETED|TREATMENT PERIOD 2||0
2300701|NCT02016105|5648217|P6|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|126
2300702|NCT02016105|5648218|P5|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|63
2300703|NCT02016105|5648219|P4|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|127
2300704|NCT02016105|5648220|P3|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|63
2300705|NCT02016105|5648221|P2|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
2300706|NCT02016105|5648222|P1|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
2300707|NCT02016105|5648217|P6|NOT COMPLETED|TREATMENT PERIOD 1||0
2300708|NCT02016105|5648218|P5|NOT COMPLETED|TREATMENT PERIOD 1||0
2300709|NCT02016105|5648219|P4|NOT COMPLETED|TREATMENT PERIOD 1||0
2300710|NCT02016105|5648220|P3|NOT COMPLETED|TREATMENT PERIOD 1||0
2300711|NCT02016105|5648221|P2|NOT COMPLETED|TREATMENT PERIOD 1||33
2300712|NCT02016105|5648222|P1|NOT COMPLETED|TREATMENT PERIOD 1||30
2300713|NCT02016105|5648217|P6|COMPLETED|TREATMENT PERIOD 1||0
2300714|NCT02016105|5648218|P5|COMPLETED|TREATMENT PERIOD 1||0
2300715|NCT02016105|5648219|P4|COMPLETED|TREATMENT PERIOD 1||0
2300716|NCT02016105|5648220|P3|COMPLETED|TREATMENT PERIOD 1||0
2300717|NCT02016105|5648221|P2|COMPLETED|TREATMENT PERIOD 1|11 patients did not proceed into Treatment Period 2|201
2300718|NCT02016105|5648222|P1|COMPLETED|TREATMENT PERIOD 1|12 patients did not proceed into Treatment Period 2|201
2300719|NCT02016105|5648217|P6|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
2300720|NCT02016105|5648218|P5|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
2300721|NCT02016105|5648219|P4|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
2300722|NCT02016105|5648220|P3|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
2300723|NCT02016105|5648221|P2|STARTED|TREATMENT PERIOD 1||234
2300724|NCT02016105|5648222|P1|STARTED|TREATMENT PERIOD 1||231
2300725|NCT02015910|5648272|P2|NOT COMPLETED|Overall Study||0
2300726|NCT02015910|5648273|P1|NOT COMPLETED|Overall Study||0
2300727|NCT02015910|5648272|P2|COMPLETED|Overall Study||1
2300728|NCT02015910|5648273|P1|COMPLETED|Overall Study||0
2300729|NCT02015910|5648272|P2|STARTED|Overall Study||1
2300730|NCT02015910|5648273|P1|STARTED|Overall Study||0
2300731|NCT02015793|5648281|P2|NOT COMPLETED|Overall Study||4
2300732|NCT02015793|5648282|P1|NOT COMPLETED|Overall Study||4
2300733|NCT02015793|5648281|P2|COMPLETED|Overall Study||11
2300734|NCT02015793|5648282|P1|COMPLETED|Overall Study||11
2300735|NCT02015793|5648281|P2|Entered Open-label Extension Period|Overall Study||14
2300736|NCT02015793|5648282|P1|Entered Open-label Extension Period|Overall Study||13
2300737|NCT02015793|5648281|P2|Completed Double-Blind Period|Overall Study||14
2300738|NCT02015793|5648282|P1|Completed Double-Blind Period|Overall Study||14
2300739|NCT02015793|5648281|P2|STARTED|Overall Study||15
2300740|NCT02015793|5648282|P1|STARTED|Overall Study||15
2300741|NCT02015754|5648312|P1|NOT COMPLETED|Overall Study||11
2300742|NCT02015754|5648312|P1|COMPLETED|Overall Study||3
2300743|NCT02015754|5648312|P1|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to follow-up|13
2300744|NCT02015754|5648312|P1|Completed First TACE|Overall Study||14
2300745|NCT02015754|5648312|P1|STARTED|Overall Study|17 participants were consented, but 3 participants were screened out prior to treatment|14
2300746|NCT02015676|5648332|P3|NOT COMPLETED|Overall Study||3
2300747|NCT02015676|5648333|P2|NOT COMPLETED|Overall Study||34
2300748|NCT02015676|5648334|P1|NOT COMPLETED|Overall Study||9
2300749|NCT02015676|5648332|P3|COMPLETED|Overall Study||3
2300750|NCT02015676|5648333|P2|COMPLETED|Overall Study||14
2300751|NCT02015676|5648334|P1|COMPLETED|Overall Study||6
2300752|NCT02015676|5648332|P3|STARTED|Overall Study||6
2300753|NCT02015676|5648333|P2|STARTED|Overall Study||48
2300754|NCT02015676|5648334|P1|STARTED|Overall Study||15
2300755|NCT02015663|5648350|P2|NOT COMPLETED|Overall Study||12
2300756|NCT02015663|5648351|P1|NOT COMPLETED|Overall Study||15
2300757|NCT02015663|5648350|P2|COMPLETED|Overall Study||4
2300758|NCT02015663|5648351|P1|COMPLETED|Overall Study||1
2300759|NCT02015663|5648350|P2|STARTED|Overall Study||16
2300760|NCT02015663|5648351|P1|STARTED|Overall Study||16
2300761|NCT02015637|5648382|P2|NOT COMPLETED|Overall Study||5
2300762|NCT02015637|5648383|P1|NOT COMPLETED|Overall Study||8
2300763|NCT02015637|5648382|P2|COMPLETED|Overall Study||149
2300764|NCT02015637|5648383|P1|COMPLETED|Overall Study||298
2300765|NCT02015637|5648382|P2|STARTED|Overall Study||154
2300766|NCT02015637|5648383|P1|STARTED|Overall Study||306
2300767|NCT02015546|5648394|P3|NOT COMPLETED|Overall Study||4
2300768|NCT02015546|5648395|P2|NOT COMPLETED|Overall Study||2
2300769|NCT02015546|5648396|P1|NOT COMPLETED|Overall Study||3
2300770|NCT02015546|5648394|P3|COMPLETED|Overall Study||22
2300771|NCT02015546|5648395|P2|COMPLETED|Overall Study||19
2300772|NCT02015546|5648396|P1|COMPLETED|Overall Study||20
2300773|NCT02015546|5648394|P3|STARTED|Overall Study||26
2300774|NCT02015546|5648395|P2|STARTED|Overall Study||21
2300775|NCT02015546|5648396|P1|STARTED|Overall Study||23
2300776|NCT02015481|5648428|P1|NOT COMPLETED|Overall Study||1
2300777|NCT02015481|5648428|P1|COMPLETED|Overall Study||24
2300778|NCT02015481|5648428|P1|STARTED|Overall Study||25
2300779|NCT02015442|5648435|P2|NOT COMPLETED|Second Intervention (7 Days)||0
2300780|NCT02015442|5648436|P1|NOT COMPLETED|Second Intervention (7 Days)||0
2300781|NCT02015442|5648435|P2|COMPLETED|Second Intervention (7 Days)||4
2300782|NCT02015442|5648436|P1|COMPLETED|Second Intervention (7 Days)||5
2300783|NCT02015442|5648435|P2|STARTED|Second Intervention (7 Days)||4
2300784|NCT02015442|5648436|P1|STARTED|Second Intervention (7 Days)||5
2300785|NCT02015442|5648435|P2|NOT COMPLETED|Wash-out (4 Weeks)||0
2300786|NCT02015442|5648436|P1|NOT COMPLETED|Wash-out (4 Weeks)||0
2300787|NCT02015442|5648435|P2|COMPLETED|Wash-out (4 Weeks)||4
2300788|NCT02015442|5648436|P1|COMPLETED|Wash-out (4 Weeks)||5
2300789|NCT02015442|5648435|P2|STARTED|Wash-out (4 Weeks)||4
2300790|NCT02015442|5648436|P1|STARTED|Wash-out (4 Weeks)||5
2300791|NCT02015442|5648435|P2|NOT COMPLETED|First Intervention (7 Days)||0
2300792|NCT02015442|5648436|P1|NOT COMPLETED|First Intervention (7 Days)||0
2300793|NCT02015442|5648435|P2|COMPLETED|First Intervention (7 Days)||4
2300794|NCT02015442|5648436|P1|COMPLETED|First Intervention (7 Days)||5
2300795|NCT02015442|5648435|P2|STARTED|First Intervention (7 Days)||4
2300796|NCT02015442|5648436|P1|STARTED|First Intervention (7 Days)||5
2300797|NCT02015234|5648446|P2|NOT COMPLETED|Overall Study||25
2300798|NCT02015234|5648447|P1|NOT COMPLETED|Overall Study||36
2300799|NCT02015234|5648446|P2|COMPLETED|Overall Study||54
2300800|NCT02015234|5648447|P1|COMPLETED|Overall Study||43
2300801|NCT02015234|5648446|P2|STARTED|Overall Study||79
2300802|NCT02015234|5648447|P1|STARTED|Overall Study||79
2300803|NCT02015221|5648461|P2|NOT COMPLETED|Overall Study||6
2300804|NCT02015221|5648462|P1|NOT COMPLETED|Overall Study||9
2300805|NCT02015221|5648461|P2|COMPLETED|Overall Study||34
2300806|NCT02015221|5648462|P1|COMPLETED|Overall Study||32
2300807|NCT02015221|5648461|P2|STARTED|Overall Study||40
2300808|NCT02015221|5648462|P1|STARTED|Overall Study||41
2300809|NCT02015195|5648475|P7|NOT COMPLETED|Overall Study||0
2300810|NCT02015195|5648476|P6|NOT COMPLETED|Overall Study||0
2300811|NCT02015195|5648477|P5|NOT COMPLETED|Overall Study||0
2300812|NCT02015195|5648478|P4|NOT COMPLETED|Overall Study||1
2300813|NCT02015195|5648479|P3|NOT COMPLETED|Overall Study||0
2300814|NCT02015195|5648480|P2|NOT COMPLETED|Overall Study||0
2300815|NCT02015195|5648481|P1|NOT COMPLETED|Overall Study||0
2300816|NCT02015195|5648475|P7|COMPLETED|Overall Study||16
2300817|NCT02015195|5648476|P6|COMPLETED|Overall Study||16
2300818|NCT02015195|5648477|P5|COMPLETED|Overall Study||16
2300819|NCT02015195|5648478|P4|COMPLETED|Overall Study||0
2300820|NCT02015195|5648479|P3|COMPLETED|Overall Study||16
2300821|NCT02015195|5648480|P2|COMPLETED|Overall Study||16
2300822|NCT02015195|5648481|P1|COMPLETED|Overall Study||16
2300823|NCT02015195|5648475|P7|STARTED|Overall Study||16
2300824|NCT02015195|5648476|P6|STARTED|Overall Study||16
2300825|NCT02015195|5648477|P5|STARTED|Overall Study||16
2300826|NCT02015195|5648478|P4|STARTED|Overall Study||1
2300827|NCT02015195|5648479|P3|STARTED|Overall Study||16
2300828|NCT02015195|5648480|P2|STARTED|Overall Study||16
2300829|NCT02015195|5648481|P1|STARTED|Overall Study||16
2300830|NCT02015104|5648504|P2|NOT COMPLETED|Overall Study||1
2300831|NCT02015104|5648505|P1|NOT COMPLETED|Overall Study||1
2300832|NCT02015104|5648504|P2|COMPLETED|Overall Study||15
2300833|NCT02015104|5648505|P1|COMPLETED|Overall Study||15
2300834|NCT02015104|5648504|P2|STARTED|Overall Study||16
2300835|NCT02015104|5648505|P1|STARTED|Overall Study||16
2300836|NCT02015065|5648522|P3|NOT COMPLETED|Overall Study||1
2300837|NCT02015065|5648523|P2|NOT COMPLETED|Overall Study||2
2300838|NCT02015065|5648524|P1|NOT COMPLETED|Overall Study||1
2300839|NCT02015065|5648522|P3|COMPLETED|Overall Study||1
2300840|NCT02015065|5648523|P2|COMPLETED|Overall Study||3
2300841|NCT02015065|5648524|P1|COMPLETED|Overall Study||1
2300842|NCT02015065|5648522|P3|STARTED|Overall Study||2
2300843|NCT02015065|5648523|P2|STARTED|Overall Study||5
2300844|NCT02015065|5648524|P1|STARTED|Overall Study||2
2300845|NCT02015039|5648543|P2|NOT COMPLETED|Overall Study||1
2300846|NCT02015039|5648544|P1|NOT COMPLETED|Overall Study||0
2300847|NCT02015039|5648543|P2|COMPLETED|Overall Study||6
2300848|NCT02015039|5648544|P1|COMPLETED|Overall Study||6
2300849|NCT02015039|5648543|P2|STARTED|Overall Study||7
2300850|NCT02015039|5648544|P1|STARTED|Overall Study||6
2300851|NCT02014740|5648564|P2|NOT COMPLETED|Overall Study||5
2300852|NCT02014740|5648565|P1|NOT COMPLETED|Overall Study||6
2300853|NCT02014740|5648564|P2|COMPLETED|Overall Study||40
2300854|NCT02014740|5648565|P1|COMPLETED|Overall Study||49
2300855|NCT02014740|5648564|P2|STARTED|Overall Study||45
2300856|NCT02014740|5648565|P1|STARTED|Overall Study||55
2300857|NCT02014584|5648573|P6|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
2300858|NCT02014584|5648574|P5|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||1
2300859|NCT02014584|5648575|P4|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
2300860|NCT02014584|5648576|P3|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
2300861|NCT02014584|5648577|P2|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
2300862|NCT02014584|5648578|P1|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
2300863|NCT02014584|5648573|P6|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
2300864|NCT02014584|5648574|P5|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
2300865|NCT02014584|5648575|P4|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
2300866|NCT02014584|5648576|P3|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
2300867|NCT02014584|5648577|P2|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
2300868|NCT02014584|5648578|P1|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
2300869|NCT02014584|5648573|P6|STARTED|Target Follow-up (F/U) Period (24 Weeks)||2
2300870|NCT02014584|5648574|P5|STARTED|Target Follow-up (F/U) Period (24 Weeks)||3
2300871|NCT02014584|5648575|P4|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
2300872|NCT02014584|5648576|P3|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
2300873|NCT02014584|5648577|P2|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
2300874|NCT02014584|5648578|P1|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
2300875|NCT02014584|5648573|P6|NOT COMPLETED|Open-Label Period (24 Weeks)||0
2300876|NCT02014584|5648574|P5|NOT COMPLETED|Open-Label Period (24 Weeks)||0
2300877|NCT02014584|5648575|P4|NOT COMPLETED|Open-Label Period (24 Weeks)||1
2300878|NCT02014584|5648576|P3|NOT COMPLETED|Open-Label Period (24 Weeks)||5
2300879|NCT02014584|5648577|P2|NOT COMPLETED|Open-Label Period (24 Weeks)||0
2300880|NCT02014584|5648578|P1|NOT COMPLETED|Open-Label Period (24 Weeks)||0
2300881|NCT02014584|5648573|P6|COMPLETED|Open-Label Period (24 Weeks)||0
2300882|NCT02014584|5648574|P5|COMPLETED|Open-Label Period (24 Weeks)||0
2300883|NCT02014584|5648575|P4|COMPLETED|Open-Label Period (24 Weeks)||47
2300884|NCT02014584|5648576|P3|COMPLETED|Open-Label Period (24 Weeks)||44
2300885|NCT02014584|5648577|P2|COMPLETED|Open-Label Period (24 Weeks)||0
2300886|NCT02014584|5648578|P1|COMPLETED|Open-Label Period (24 Weeks)||0
2300887|NCT02014584|5648573|P6|STARTED|Open-Label Period (24 Weeks)||0
2300888|NCT02014584|5648574|P5|STARTED|Open-Label Period (24 Weeks)||0
2300889|NCT02014584|5648575|P4|STARTED|Open-Label Period (24 Weeks)||48
2300890|NCT02014584|5648576|P3|STARTED|Open-Label Period (24 Weeks)||49
2300891|NCT02014584|5648577|P2|STARTED|Open-Label Period (24 Weeks)||0
2300892|NCT02014584|5648578|P1|STARTED|Open-Label Period (24 Weeks)||0
2300893|NCT02014584|5648573|P6|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
2300894|NCT02014584|5648574|P5|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
2300895|NCT02014584|5648575|P4|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
2300896|NCT02014584|5648576|P3|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
2300897|NCT02014584|5648577|P2|NOT COMPLETED|Double-Blind Period (24 Weeks)||6
2300898|NCT02014584|5648578|P1|NOT COMPLETED|Double-Blind Period (24 Weeks)||2
2300899|NCT02014584|5648573|P6|COMPLETED|Double-Blind Period (24 Weeks)||0
2300900|NCT02014584|5648574|P5|COMPLETED|Double-Blind Period (24 Weeks)||0
2300901|NCT02014584|5648575|P4|COMPLETED|Double-Blind Period (24 Weeks)||0
2300902|NCT02014584|5648576|P3|COMPLETED|Double-Blind Period (24 Weeks)||0
2300903|NCT02014584|5648577|P2|COMPLETED|Double-Blind Period (24 Weeks)||52
2300904|NCT02014584|5648578|P1|COMPLETED|Double-Blind Period (24 Weeks)||57
2300905|NCT02014584|5648573|P6|STARTED|Double-Blind Period (24 Weeks)||0
2300906|NCT02014584|5648574|P5|STARTED|Double-Blind Period (24 Weeks)||0
2300907|NCT02014584|5648575|P4|STARTED|Double-Blind Period (24 Weeks)||0
2300908|NCT02014584|5648576|P3|STARTED|Double-Blind Period (24 Weeks)||0
2300909|NCT02014584|5648577|P2|STARTED|Double-Blind Period (24 Weeks)||58
2300910|NCT02014584|5648578|P1|STARTED|Double-Blind Period (24 Weeks)||59
2300911|NCT02014558|5648708|P13|NOT COMPLETED|Overall Study||17
2300912|NCT02014558|5648709|P12|NOT COMPLETED|Overall Study||102
2300913|NCT02014558|5648710|P11|NOT COMPLETED|Overall Study||69
2300914|NCT02014558|5648711|P10|NOT COMPLETED|Overall Study||21
2300915|NCT02014558|5648712|P9|NOT COMPLETED|Overall Study||15
2300916|NCT02014558|5648713|P8|NOT COMPLETED|Overall Study||11
2300917|NCT02014558|5648714|P7|NOT COMPLETED|Overall Study||4
2300918|NCT02014558|5648715|P6|NOT COMPLETED|Overall Study||3
2300919|NCT02014558|5648716|P5|NOT COMPLETED|Overall Study||4
2300920|NCT02014558|5648717|P4|NOT COMPLETED|Overall Study||3
2300921|NCT02014558|5648718|P3|NOT COMPLETED|Overall Study||3
2300922|NCT02014558|5648719|P2|NOT COMPLETED|Overall Study||3
2300923|NCT02014558|5648720|P1|NOT COMPLETED|Overall Study||5
2300924|NCT02014558|5648708|P13|COMPLETED|Overall Study||0
2300925|NCT02014558|5648709|P12|COMPLETED|Overall Study||0
2300926|NCT02014558|5648710|P11|COMPLETED|Overall Study||0
2300927|NCT02014558|5648711|P10|COMPLETED|Overall Study||0
2300928|NCT02014558|5648712|P9|COMPLETED|Overall Study||0
2300929|NCT02014558|5648713|P8|COMPLETED|Overall Study||0
2300930|NCT02014558|5648714|P7|COMPLETED|Overall Study||0
2300931|NCT02014558|5648715|P6|COMPLETED|Overall Study||0
2300932|NCT02014558|5648716|P5|COMPLETED|Overall Study||0
2300933|NCT02014558|5648717|P4|COMPLETED|Overall Study||0
2300934|NCT02014558|5648718|P3|COMPLETED|Overall Study||0
2300935|NCT02014558|5648719|P2|COMPLETED|Overall Study||0
2300936|NCT02014558|5648720|P1|COMPLETED|Overall Study||0
2300937|NCT02014558|5648708|P13|Treated|Overall Study||17
2300938|NCT02014558|5648709|P12|Treated|Overall Study||100
2300939|NCT02014558|5648710|P11|Treated|Overall Study|A participant randomized to the 120 mg was treated with an initial dose of 20 mg by mistake.|66
2300940|NCT02014558|5648711|P10|Treated|Overall Study||21
2300941|NCT02014558|5648712|P9|Treated|Overall Study||13
2300942|NCT02014558|5648713|P8|Treated|Overall Study|A participant randomized to the 120 mg was treated with an initial dose of 20 mg by mistake.|12
2300943|NCT02014558|5648714|P7|Treated|Overall Study||3
2300944|NCT02014558|5648715|P6|Treated|Overall Study||3
2300945|NCT02014558|5648716|P5|Treated|Overall Study||3
2300946|NCT02014558|5648717|P4|Treated|Overall Study||3
2300947|NCT02014558|5648718|P3|Treated|Overall Study||3
2300948|NCT02014558|5648719|P2|Treated|Overall Study||3
2300949|NCT02014558|5648720|P1|Treated|Overall Study||5
2300950|NCT02014558|5648708|P13|STARTED|Overall Study||17
2300951|NCT02014558|5648709|P12|STARTED|Overall Study||102
2300952|NCT02014558|5648710|P11|STARTED|Overall Study||69
2300953|NCT02014558|5648711|P10|STARTED|Overall Study||21
2300954|NCT02014558|5648712|P9|STARTED|Overall Study||15
2300955|NCT02014558|5648713|P8|STARTED|Overall Study||11
2300956|NCT02014558|5648714|P7|STARTED|Overall Study||4
2300957|NCT02014558|5648715|P6|STARTED|Overall Study||3
2300958|NCT02014558|5648716|P5|STARTED|Overall Study||4
2300959|NCT02014558|5648717|P4|STARTED|Overall Study||3
2300960|NCT02014558|5648718|P3|STARTED|Overall Study||3
2300961|NCT02014558|5648719|P2|STARTED|Overall Study||3
2300962|NCT02014558|5648720|P1|STARTED|Overall Study||5
2300963|NCT02014519|5649028|P1|NOT COMPLETED|Overall Study||0
2300964|NCT02014519|5649028|P1|COMPLETED|Overall Study||2000
2300965|NCT02014519|5649028|P1|STARTED|Overall Study||2000
2300966|NCT02014480|5649085|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||2
2300967|NCT02014480|5649086|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
2300968|NCT02014480|5649087|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
2300969|NCT02014480|5649088|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
2300970|NCT02014480|5649089|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||1
2300971|NCT02014480|5649090|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
2300972|NCT02014480|5649085|P6|COMPLETED|Treatment Period 3 (14 Days)||32
2300973|NCT02014480|5649086|P5|COMPLETED|Treatment Period 3 (14 Days)||34
2300974|NCT02014480|5649087|P4|COMPLETED|Treatment Period 3 (14 Days)||31
2300975|NCT02014480|5649088|P3|COMPLETED|Treatment Period 3 (14 Days)||29
2300976|NCT02014480|5649089|P2|COMPLETED|Treatment Period 3 (14 Days)||32
2300977|NCT02014480|5649090|P1|COMPLETED|Treatment Period 3 (14 Days)||34
2300978|NCT02014480|5649085|P6|STARTED|Treatment Period 3 (14 Days)||34
2300979|NCT02014480|5649086|P5|STARTED|Treatment Period 3 (14 Days)||34
2300980|NCT02014480|5649087|P4|STARTED|Treatment Period 3 (14 Days)||31
2300981|NCT02014480|5649088|P3|STARTED|Treatment Period 3 (14 Days)||30
2300982|NCT02014480|5649089|P2|STARTED|Treatment Period 3 (14 Days)||33
2300983|NCT02014480|5649090|P1|STARTED|Treatment Period 3 (14 Days)||34
2300984|NCT02014480|5649085|P6|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
2300985|NCT02014480|5649086|P5|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
2300986|NCT02014480|5649087|P4|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
2300987|NCT02014480|5649088|P3|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
2300988|NCT02014480|5649089|P2|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
2300989|NCT02014480|5649090|P1|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
2300990|NCT02014480|5649085|P6|COMPLETED|Washout Period 2 (10 to 14 Days)||34
2300991|NCT02014480|5649086|P5|COMPLETED|Washout Period 2 (10 to 14 Days)||34
2300992|NCT02014480|5649087|P4|COMPLETED|Washout Period 2 (10 to 14 Days)||31
2300993|NCT02014480|5649088|P3|COMPLETED|Washout Period 2 (10 to 14 Days)||30
2300994|NCT02014480|5649089|P2|COMPLETED|Washout Period 2 (10 to 14 Days)||33
2300995|NCT02014480|5649090|P1|COMPLETED|Washout Period 2 (10 to 14 Days)||34
2300996|NCT02014480|5649085|P6|STARTED|Washout Period 2 (10 to 14 Days)||34
2300997|NCT02014480|5649086|P5|STARTED|Washout Period 2 (10 to 14 Days)||34
2300998|NCT02014480|5649087|P4|STARTED|Washout Period 2 (10 to 14 Days)||31
2300999|NCT02014480|5649088|P3|STARTED|Washout Period 2 (10 to 14 Days)||30
2301000|NCT02014480|5649089|P2|STARTED|Washout Period 2 (10 to 14 Days)||33
2301001|NCT02014480|5649090|P1|STARTED|Washout Period 2 (10 to 14 Days)||34
2301002|NCT02014480|5649085|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
2301003|NCT02014480|5649086|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
2301004|NCT02014480|5649087|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
2301005|NCT02014480|5649088|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||2
2301006|NCT02014480|5649089|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
2301007|NCT02014480|5649090|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||1
2301008|NCT02014480|5649085|P6|COMPLETED|Treatment Period 2 (14 Days)||34
2301009|NCT02014480|5649086|P5|COMPLETED|Treatment Period 2 (14 Days)||34
2301010|NCT02014480|5649087|P4|COMPLETED|Treatment Period 2 (14 Days)||31
2301011|NCT02014480|5649088|P3|COMPLETED|Treatment Period 2 (14 Days)||30
2301012|NCT02014480|5649089|P2|COMPLETED|Treatment Period 2 (14 Days)||33
2301013|NCT02014480|5649090|P1|COMPLETED|Treatment Period 2 (14 Days)||34
2301014|NCT02014480|5649085|P6|STARTED|Treatment Period 2 (14 Days)||34
2301015|NCT02014480|5649086|P5|STARTED|Treatment Period 2 (14 Days)||34
2301016|NCT02014480|5649087|P4|STARTED|Treatment Period 2 (14 Days)||32
2301017|NCT02014480|5649088|P3|STARTED|Treatment Period 2 (14 Days)||32
2301018|NCT02014480|5649089|P2|STARTED|Treatment Period 2 (14 Days)||34
2301019|NCT02014480|5649090|P1|STARTED|Treatment Period 2 (14 Days)||35
2301020|NCT02014480|5649085|P6|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
2301021|NCT02014480|5649086|P5|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
2301022|NCT02014480|5649087|P4|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
2301023|NCT02014480|5649088|P3|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
2301024|NCT02014480|5649089|P2|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
2301025|NCT02014480|5649090|P1|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
2301026|NCT02014480|5649085|P6|COMPLETED|Washout Period 1 (10 to 14 Days)||34
2301027|NCT02014480|5649086|P5|COMPLETED|Washout Period 1 (10 to 14 Days)||34
2301028|NCT02014480|5649087|P4|COMPLETED|Washout Period 1 (10 to 14 Days)||32
2301029|NCT02014480|5649088|P3|COMPLETED|Washout Period 1 (10 to 14 Days)||32
2301030|NCT02014480|5649089|P2|COMPLETED|Washout Period 1 (10 to 14 Days)||34
2301031|NCT02014480|5649090|P1|COMPLETED|Washout Period 1 (10 to 14 Days)||35
2301032|NCT02014480|5649085|P6|STARTED|Washout Period 1 (10 to 14 Days)||34
2301033|NCT02014480|5649086|P5|STARTED|Washout Period 1 (10 to 14 Days)||34
2301034|NCT02014480|5649087|P4|STARTED|Washout Period 1 (10 to 14 Days)||32
2301035|NCT02014480|5649088|P3|STARTED|Washout Period 1 (10 to 14 Days)||33
2301036|NCT02014480|5649089|P2|STARTED|Washout Period 1 (10 to 14 Days)||34
2301037|NCT02014480|5649090|P1|STARTED|Washout Period 1 (10 to 14 Days)||35
2301038|NCT02014480|5649085|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||0
2301039|NCT02014480|5649086|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||1
2301040|NCT02014480|5649087|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||2
2301041|NCT02014480|5649088|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||1
2301042|NCT02014480|5649089|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
2301043|NCT02014480|5649090|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||0
2301044|NCT02014480|5649085|P6|COMPLETED|Treatment Period 1 (14 Days)||34
2301045|NCT02014480|5649086|P5|COMPLETED|Treatment Period 1 (14 Days)||34
2301046|NCT02014480|5649087|P4|COMPLETED|Treatment Period 1 (14 Days)||32
2301047|NCT02014480|5649088|P3|COMPLETED|Treatment Period 1 (14 Days)||33
2301048|NCT02014480|5649089|P2|COMPLETED|Treatment Period 1 (14 Days)||34
2301049|NCT02014480|5649090|P1|COMPLETED|Treatment Period 1 (14 Days)||35
2301050|NCT02014480|5649085|P6|STARTED|Treatment Period 1 (14 Days)|One participant randomized to Sequence 6 actually received UMEC in Treatment Periods 2 and 3.|34
2301051|NCT02014480|5649086|P5|STARTED|Treatment Period 1 (14 Days)||35
2301052|NCT02014480|5649087|P4|STARTED|Treatment Period 1 (14 Days)||34
2301053|NCT02014480|5649088|P3|STARTED|Treatment Period 1 (14 Days)||34
2301054|NCT02014480|5649089|P2|STARTED|Treatment Period 1 (14 Days)||35
2301055|NCT02014480|5649090|P1|STARTED|Treatment Period 1 (14 Days)||35
2301056|NCT02014467|5649109|P2|NOT COMPLETED|Overall Study||7
2301057|NCT02014467|5649110|P1|NOT COMPLETED|Overall Study||25
2301058|NCT02014467|5649109|P2|COMPLETED|Overall Study||112
2301059|NCT02014467|5649110|P1|COMPLETED|Overall Study||340
2301060|NCT02014467|5649109|P2|STARTED|Overall Study||119
2301061|NCT02014467|5649110|P1|STARTED|Overall Study||365
2301062|NCT02014441|5649170|P1|NOT COMPLETED|Overall Study||12
2301063|NCT02014441|5649170|P1|COMPLETED|Overall Study||49
2301064|NCT02014441|5649170|P1|Received Treatment|Overall Study||60
2301065|NCT02014441|5649170|P1|STARTED|Overall Study||61
2301066|NCT02014402|5649266|P4|NOT COMPLETED|Overall Study||3
2301067|NCT02014402|5649267|P3|NOT COMPLETED|Overall Study||3
2301068|NCT02014402|5649268|P2|NOT COMPLETED|Overall Study||3
2301069|NCT02014402|5649269|P1|NOT COMPLETED|Overall Study||2
2301070|NCT02014402|5649266|P4|COMPLETED|Overall Study||82
2301071|NCT02014402|5649267|P3|COMPLETED|Overall Study||32
2301072|NCT02014402|5649268|P2|COMPLETED|Overall Study||27
2301073|NCT02014402|5649269|P1|COMPLETED|Overall Study||29
2301074|NCT02014402|5649266|P4|Bovine Thrombin|Overall Study||28
2301075|NCT02014402|5649267|P3|Bovine Thrombin|Overall Study||12
2301076|NCT02014402|5649268|P2|Bovine Thrombin|Overall Study||10
2301077|NCT02014402|5649269|P1|Bovine Thrombin|Overall Study||11
2301078|NCT02014402|5649266|P4|Human Thrombin|Overall Study||57
2301079|NCT02014402|5649267|P3|Human Thrombin|Overall Study||23
2301080|NCT02014402|5649268|P2|Human Thrombin|Overall Study||20
2301081|NCT02014402|5649269|P1|Human Thrombin|Overall Study||20
2301082|NCT02014402|5649266|P4|STARTED|Overall Study||85
2301083|NCT02014402|5649267|P3|STARTED|Overall Study||35
2301084|NCT02014402|5649268|P2|STARTED|Overall Study||30
2301085|NCT02014402|5649269|P1|STARTED|Overall Study||31
2301086|NCT02014376|5649299|P3|NOT COMPLETED|Overall Study||0
2301087|NCT02014376|5649300|P2|NOT COMPLETED|Overall Study||1
2301088|NCT02014376|5649301|P1|NOT COMPLETED|Overall Study||3
2301089|NCT02014376|5649299|P3|COMPLETED|Overall Study||17
2301090|NCT02014376|5649300|P2|COMPLETED|Overall Study||15
2301091|NCT02014376|5649301|P1|COMPLETED|Overall Study||12
2301092|NCT02014376|5649299|P3|Received at Least 1 Dose of Study Drug|Overall Study||17
2301093|NCT02014376|5649300|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
2301094|NCT02014376|5649301|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
2301095|NCT02014376|5649299|P3|STARTED|Overall Study||17
2301096|NCT02014376|5649300|P2|STARTED|Overall Study||16
2301097|NCT02014376|5649301|P1|STARTED|Overall Study||15
2301098|NCT02014363|5649327|P3|NOT COMPLETED|Overall Study||24
2301099|NCT02014363|5649328|P2|NOT COMPLETED|Overall Study||19
2301100|NCT02014363|5649329|P1|NOT COMPLETED|Overall Study||17
2301101|NCT02014363|5649327|P3|COMPLETED|Overall Study||31
2301102|NCT02014363|5649328|P2|COMPLETED|Overall Study||35
2301103|NCT02014363|5649329|P1|COMPLETED|Overall Study||38
2301104|NCT02014363|5649327|P3|STARTED|Overall Study||55
2301105|NCT02014363|5649328|P2|STARTED|Overall Study||54
2301106|NCT02014363|5649329|P1|STARTED|Overall Study||55
2301107|NCT02014272|5649337|P2|NOT COMPLETED|Intervention Period 2||0
2301108|NCT02014272|5649338|P1|NOT COMPLETED|Intervention Period 2||0
2301109|NCT02014272|5649337|P2|COMPLETED|Intervention Period 2||13
2301110|NCT02014272|5649338|P1|COMPLETED|Intervention Period 2||13
2301111|NCT02014272|5649337|P2|STARTED|Intervention Period 2||13
2301112|NCT02014272|5649338|P1|STARTED|Intervention Period 2||13
2301113|NCT02014272|5649337|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
2301114|NCT02014272|5649338|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
2301115|NCT02014272|5649337|P2|COMPLETED|Washout Period 1 (7 Days)||13
2301116|NCT02014272|5649338|P1|COMPLETED|Washout Period 1 (7 Days)||13
2301117|NCT02014272|5649337|P2|STARTED|Washout Period 1 (7 Days)||13
2301118|NCT02014272|5649338|P1|STARTED|Washout Period 1 (7 Days)||13
2301119|NCT02014272|5649337|P2|NOT COMPLETED|Intervention Period 1||1
2301120|NCT02014272|5649338|P1|NOT COMPLETED|Intervention Period 1||1
2301121|NCT02014272|5649337|P2|COMPLETED|Intervention Period 1||13
2301122|NCT02014272|5649338|P1|COMPLETED|Intervention Period 1||13
2301123|NCT02014272|5649337|P2|STARTED|Intervention Period 1||14
2301124|NCT02014272|5649338|P1|STARTED|Intervention Period 1||14
2301125|NCT02014116|5649365|P9|NOT COMPLETED|Overall Study||10
2301126|NCT02014116|5649366|P8|NOT COMPLETED|Overall Study||5
2301127|NCT02014116|5649367|P7|NOT COMPLETED|Overall Study||1
2301128|NCT02014116|5649368|P6|NOT COMPLETED|Overall Study||16
2301129|NCT02014116|5649369|P5|NOT COMPLETED|Overall Study||2
2301130|NCT02014116|5649370|P4|NOT COMPLETED|Overall Study||7
2301131|NCT02014116|5649371|P3|NOT COMPLETED|Overall Study||3
2301132|NCT02014116|5649372|P2|NOT COMPLETED|Overall Study||4
2301133|NCT02014116|5649373|P1|NOT COMPLETED|Overall Study||3
2301134|NCT02014116|5649365|P9|COMPLETED|Overall Study||0
2301135|NCT02014116|5649366|P8|COMPLETED|Overall Study||0
2301136|NCT02014116|5649367|P7|COMPLETED|Overall Study||0
2301137|NCT02014116|5649368|P6|COMPLETED|Overall Study||0
2301138|NCT02014116|5649369|P5|COMPLETED|Overall Study||0
2301139|NCT02014116|5649370|P4|COMPLETED|Overall Study||0
2301140|NCT02014116|5649371|P3|COMPLETED|Overall Study||0
2301141|NCT02014116|5649372|P2|COMPLETED|Overall Study||0
2301142|NCT02014116|5649373|P1|COMPLETED|Overall Study||0
2301143|NCT02014116|5649365|P9|Received at Least One Dose of Study Drug|Overall Study||10
2301144|NCT02014116|5649366|P8|Received at Least One Dose of Study Drug|Overall Study||5
2301145|NCT02014116|5649367|P7|Received at Least One Dose of Study Drug|Overall Study||1
2301146|NCT02014116|5649368|P6|Received at Least One Dose of Study Drug|Overall Study||16
2301147|NCT02014116|5649369|P5|Received at Least One Dose of Study Drug|Overall Study||2
2301148|NCT02014116|5649370|P4|Received at Least One Dose of Study Drug|Overall Study||7
2301149|NCT02014116|5649371|P3|Received at Least One Dose of Study Drug|Overall Study||3
2301150|NCT02014116|5649372|P2|Received at Least One Dose of Study Drug|Overall Study||4
2301151|NCT02014116|5649373|P1|Received at Least One Dose of Study Drug|Overall Study||3
2301152|NCT02014116|5649365|P9|STARTED|Overall Study||10
2301153|NCT02014116|5649366|P8|STARTED|Overall Study||5
2301154|NCT02014116|5649367|P7|STARTED|Overall Study||1
2301155|NCT02014116|5649368|P6|STARTED|Overall Study||16
2301156|NCT02014116|5649369|P5|STARTED|Overall Study||2
2301157|NCT02014116|5649370|P4|STARTED|Overall Study||7
2301158|NCT02014116|5649371|P3|STARTED|Overall Study||3
2301159|NCT02014116|5649372|P2|STARTED|Overall Study||4
2301160|NCT02014116|5649373|P1|STARTED|Overall Study||3
2301161|NCT02014051|5649424|P2|NOT COMPLETED|Overall Study||1
2301162|NCT02014051|5649425|P1|NOT COMPLETED|Overall Study||1
2301163|NCT02014051|5649424|P2|COMPLETED|Overall Study||5
2301164|NCT02014051|5649425|P1|COMPLETED|Overall Study||2
2301165|NCT02014051|5649424|P2|STARTED|Overall Study||6
2301166|NCT02014051|5649425|P1|STARTED|Overall Study||3
2301167|NCT02013830|5649438|P1|NOT COMPLETED|Overall Study||30
2301168|NCT02013830|5649438|P1|COMPLETED|Overall Study||15
2301169|NCT02013830|5649438|P1|STARTED|Overall Study||45
2301170|NCT02013817|5649449|P1|NOT COMPLETED|Overall Study||27
2301171|NCT02013817|5649449|P1|COMPLETED|Overall Study||16
2301172|NCT02013817|5649449|P1|STARTED|Overall Study||43
2301173|NCT02013791|5649467|P9|NOT COMPLETED|Period 2||0
2301174|NCT02013791|5649468|P8|NOT COMPLETED|Period 2||0
2301175|NCT02013791|5649469|P7|NOT COMPLETED|Period 2||0
2301176|NCT02013791|5649470|P6|NOT COMPLETED|Period 2||0
2301177|NCT02013791|5649471|P5|NOT COMPLETED|Period 2||0
2301178|NCT02013791|5649472|P4|NOT COMPLETED|Period 2||0
2301179|NCT02013791|5649473|P3|NOT COMPLETED|Period 2||0
2301180|NCT02013791|5649474|P2|NOT COMPLETED|Period 2||0
2301181|NCT02013791|5649475|P1|NOT COMPLETED|Period 2||0
2301182|NCT02013791|5649467|P9|COMPLETED|Period 2||0
2301183|NCT02013791|5649468|P8|COMPLETED|Period 2||0
2301184|NCT02013791|5649469|P7|COMPLETED|Period 2||3
2301185|NCT02013791|5649470|P6|COMPLETED|Period 2||0
2301186|NCT02013791|5649471|P5|COMPLETED|Period 2||0
2301187|NCT02013791|5649472|P4|COMPLETED|Period 2||0
2301188|NCT02013791|5649473|P3|COMPLETED|Period 2||2
2301189|NCT02013791|5649474|P2|COMPLETED|Period 2||0
2301190|NCT02013791|5649475|P1|COMPLETED|Period 2||0
2301191|NCT02013791|5649467|P9|STARTED|Period 2||0
2301192|NCT02013791|5649468|P8|STARTED|Period 2||0
2301193|NCT02013791|5649469|P7|STARTED|Period 2||3
2301194|NCT02013791|5649470|P6|STARTED|Period 2||0
2301195|NCT02013791|5649471|P5|STARTED|Period 2||0
2301196|NCT02013791|5649472|P4|STARTED|Period 2||0
2301197|NCT02013791|5649473|P3|STARTED|Period 2||2
2301198|NCT02013791|5649474|P2|STARTED|Period 2||0
2301199|NCT02013791|5649475|P1|STARTED|Period 2||0
2301200|NCT02013791|5649467|P9|NOT COMPLETED|Period 1||0
2301201|NCT02013791|5649468|P8|NOT COMPLETED|Period 1||1
2301202|NCT02013791|5649469|P7|NOT COMPLETED|Period 1||1
2301203|NCT02013791|5649470|P6|NOT COMPLETED|Period 1||0
2301204|NCT02013791|5649471|P5|NOT COMPLETED|Period 1||0
2301205|NCT02013791|5649472|P4|NOT COMPLETED|Period 1||1
2301206|NCT02013791|5649473|P3|NOT COMPLETED|Period 1||0
2301207|NCT02013791|5649474|P2|NOT COMPLETED|Period 1||2
2301208|NCT02013791|5649475|P1|NOT COMPLETED|Period 1||0
2301209|NCT02013791|5649467|P9|COMPLETED|Period 1||3
2301210|NCT02013791|5649468|P8|COMPLETED|Period 1||7
2301211|NCT02013791|5649469|P7|COMPLETED|Period 1||3
2301212|NCT02013791|5649470|P6|COMPLETED|Period 1||8
2301213|NCT02013791|5649471|P5|COMPLETED|Period 1||4
2301214|NCT02013791|5649472|P4|COMPLETED|Period 1||7
2301215|NCT02013791|5649473|P3|COMPLETED|Period 1||4
2301216|NCT02013791|5649474|P2|COMPLETED|Period 1||6
2301217|NCT02013791|5649475|P1|COMPLETED|Period 1||8
2301218|NCT02013791|5649467|P9|STARTED|Period 1||3
2301219|NCT02013791|5649468|P8|STARTED|Period 1||8
2301220|NCT02013791|5649469|P7|STARTED|Period 1||4
2301221|NCT02013791|5649470|P6|STARTED|Period 1||8
2301222|NCT02013791|5649471|P5|STARTED|Period 1||4
2301223|NCT02013791|5649472|P4|STARTED|Period 1||8
2301224|NCT02013791|5649473|P3|STARTED|Period 1||4
2301225|NCT02013791|5649474|P2|STARTED|Period 1||8
2301226|NCT02013791|5649475|P1|STARTED|Period 1||8
2301227|NCT02013765|5649496|P1|NOT COMPLETED|Overall Study||1
2301228|NCT02013765|5649496|P1|COMPLETED|Overall Study||4
2301229|NCT02013765|5649496|P1|STARTED|Overall Study||5
2301230|NCT02013687|5649510|P4|NOT COMPLETED|Overall Study||2
2301231|NCT02013687|5649511|P3|NOT COMPLETED|Overall Study||2
2301232|NCT02013687|5649512|P2|NOT COMPLETED|Overall Study||0
2301233|NCT02013687|5649513|P1|NOT COMPLETED|Overall Study||0
2301234|NCT02013687|5649510|P4|COMPLETED|Overall Study||14
2301235|NCT02013687|5649511|P3|COMPLETED|Overall Study||14
2301236|NCT02013687|5649512|P2|COMPLETED|Overall Study||6
2301237|NCT02013687|5649513|P1|COMPLETED|Overall Study||6
2301238|NCT02013687|5649510|P4|STARTED|Overall Study||16
2301239|NCT02013687|5649511|P3|STARTED|Overall Study||16
2301240|NCT02013687|5649512|P2|STARTED|Overall Study||6
2301241|NCT02013687|5649513|P1|STARTED|Overall Study||6
2301242|NCT02013674|5649545|P2|NOT COMPLETED|Overall Study||1
2301243|NCT02013674|5649546|P1|NOT COMPLETED|Overall Study||1
2301244|NCT02013674|5649545|P2|COMPLETED|Overall Study||14
2301245|NCT02013674|5649546|P1|COMPLETED|Overall Study||14
2301246|NCT02013674|5649545|P2|STARTED|Overall Study||15
2301247|NCT02013674|5649546|P1|STARTED|Overall Study||15
2301248|NCT02013622|5649596|P1|NOT COMPLETED|Overall Study||24
2301249|NCT02013622|5649596|P1|COMPLETED|Overall Study||25
2301250|NCT02013622|5649596|P1|STARTED|Overall Study||49
2301251|NCT02013609|5649616|P1|NOT COMPLETED|Overall Study||18
2301252|NCT02013609|5649616|P1|COMPLETED|Overall Study||29
2301253|NCT02013609|5649616|P1|STARTED|Overall Study|One participant out of 48 participants enrolled had discontinued before receiving study medication.|47
2301254|NCT02013544|5649641|P2|NOT COMPLETED|Overall Study||20
2301255|NCT02013544|5649642|P1|NOT COMPLETED|Overall Study||11
2301256|NCT02013544|5649641|P2|COMPLETED|Overall Study||356
2301257|NCT02013544|5649642|P1|COMPLETED|Overall Study||171
2301258|NCT02013544|5649641|P2|ITT Population|Overall Study||325
2301259|NCT02013544|5649642|P1|ITT Population|Overall Study||157
2301260|NCT02013544|5649641|P2|Safety Population|Overall Study||374
2301261|NCT02013544|5649642|P1|Safety Population|Overall Study||180
2301262|NCT02013544|5649641|P2|STARTED|Overall Study||376
2301263|NCT02013544|5649642|P1|STARTED|Overall Study||182
2301264|NCT02013531|5649664|P1|NOT COMPLETED|Overall Study||5
2301265|NCT02013531|5649664|P1|COMPLETED|Overall Study||32
2301266|NCT02013531|5649664|P1|STARTED|Overall Study||37
2301267|NCT02013414|5649686|P1|NOT COMPLETED|Overall Study||0
2301268|NCT02013414|5649686|P1|COMPLETED|Overall Study||9
2301269|NCT02013414|5649686|P1|STARTED|Overall Study||9
2301270|NCT02013388|5649700|P8|NOT COMPLETED|Overall Study||0
2301271|NCT02013388|5649701|P7|NOT COMPLETED|Overall Study||0
2301272|NCT02013388|5649702|P6|NOT COMPLETED|Overall Study||0
2301273|NCT02013388|5649703|P5|NOT COMPLETED|Overall Study||1
2301274|NCT02013388|5649704|P4|NOT COMPLETED|Overall Study||0
2301275|NCT02013388|5649705|P3|NOT COMPLETED|Overall Study||0
2301276|NCT02013388|5649706|P2|NOT COMPLETED|Overall Study||0
2301277|NCT02013388|5649707|P1|NOT COMPLETED|Overall Study||1
2301278|NCT02013388|5649700|P8|COMPLETED|Overall Study||4
2301279|NCT02013388|5649701|P7|COMPLETED|Overall Study||6
2301280|NCT02013388|5649702|P6|COMPLETED|Overall Study||6
2301281|NCT02013388|5649703|P5|COMPLETED|Overall Study||5
2301282|NCT02013388|5649704|P4|COMPLETED|Overall Study||6
2301283|NCT02013388|5649705|P3|COMPLETED|Overall Study||6
2301284|NCT02013388|5649706|P2|COMPLETED|Overall Study||6
2301285|NCT02013388|5649707|P1|COMPLETED|Overall Study||8
2301286|NCT02013388|5649700|P8|STARTED|Overall Study||4
2301287|NCT02013388|5649701|P7|STARTED|Overall Study||6
2301288|NCT02013388|5649702|P6|STARTED|Overall Study||6
2301289|NCT02013388|5649703|P5|STARTED|Overall Study||6
2301290|NCT02013388|5649704|P4|STARTED|Overall Study||6
2301291|NCT02013388|5649705|P3|STARTED|Overall Study||6
2301292|NCT02013388|5649706|P2|STARTED|Overall Study||6
2301293|NCT02013388|5649707|P1|STARTED|Overall Study||9
2301294|NCT02013375|5649741|P1|NOT COMPLETED|Overall Study||2
2301295|NCT02013375|5649741|P1|COMPLETED|Overall Study||0
2301296|NCT02013375|5649741|P1|STARTED|Overall Study||2
2301297|NCT02013245|5649752|P4|NOT COMPLETED|Overall Study||0
2301298|NCT02013245|5649753|P3|NOT COMPLETED|Overall Study||0
2301299|NCT02013245|5649754|P2|NOT COMPLETED|Overall Study||1
2301300|NCT02013245|5649755|P1|NOT COMPLETED|Overall Study||0
2301301|NCT02013245|5649752|P4|COMPLETED|Overall Study||9
2301302|NCT02013245|5649753|P3|COMPLETED|Overall Study||9
2301303|NCT02013245|5649754|P2|COMPLETED|Overall Study||8
2301304|NCT02013245|5649755|P1|COMPLETED|Overall Study||9
2301305|NCT02013245|5649752|P4|STARTED|Overall Study||9
2301306|NCT02013245|5649753|P3|STARTED|Overall Study||9
2301307|NCT02013245|5649754|P2|STARTED|Overall Study||9
2301308|NCT02013245|5649755|P1|STARTED|Overall Study||9
2301309|NCT02013206|5649771|P2|NOT COMPLETED|Overall Study||22
2301310|NCT02013206|5649772|P1|NOT COMPLETED|Overall Study||27
2301311|NCT02013206|5649771|P2|COMPLETED|Overall Study||1
2301312|NCT02013206|5649772|P1|COMPLETED|Overall Study|3 Patients were on-going at clinical cut-off. Not Completed=patients who discontinued treatment.|2
2301313|NCT02013206|5649771|P2|Received Study Drug|Overall Study||23
2301314|NCT02013206|5649772|P1|Received Study Drug|Overall Study||26
2301315|NCT02013206|5649771|P2|STARTED|Overall Study||23
2301316|NCT02013206|5649772|P1|STARTED|Overall Study||29
2301317|NCT02013180|5649794|P2|NOT COMPLETED|Overall Study||0
2301318|NCT02013180|5649795|P1|NOT COMPLETED|Overall Study||0
2301319|NCT02013180|5649794|P2|COMPLETED|Overall Study||361
2301320|NCT02013180|5649795|P1|COMPLETED|Overall Study||119
2301321|NCT02013180|5649794|P2|STARTED|Overall Study||361
2301322|NCT02013180|5649795|P1|STARTED|Overall Study||119
2301323|NCT02013167|5649803|P2|NOT COMPLETED|Overall Study||178
2301324|NCT02013167|5649804|P1|NOT COMPLETED|Overall Study||101
2301325|NCT02013167|5649803|P2|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off; 22 were receiving treatment|93
2301326|NCT02013167|5649804|P1|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off|33
2301327|NCT02013167|5649803|P2|Received Treatment|Overall Study||267
2301328|NCT02013167|5649804|P1|Received Treatment|Overall Study||109
2301329|NCT02013167|5649803|P2|STARTED|Overall Study||271
2301330|NCT02013167|5649804|P1|STARTED|Overall Study||134
2301331|NCT02013050|5649835|P4|NOT COMPLETED|Overall Study||4
2301332|NCT02013050|5649836|P3|NOT COMPLETED|Overall Study||0
2301333|NCT02013050|5649837|P2|NOT COMPLETED|Overall Study||5
2301334|NCT02013050|5649838|P1|NOT COMPLETED|Overall Study||4
2301335|NCT02013050|5649835|P4|COMPLETED|Overall Study||19
2301336|NCT02013050|5649836|P3|COMPLETED|Overall Study||3
2301337|NCT02013050|5649837|P2|COMPLETED|Overall Study||36
2301338|NCT02013050|5649838|P1|COMPLETED|Overall Study||38
2301339|NCT02013050|5649835|P4|STARTED|Overall Study||23
2301340|NCT02013050|5649836|P3|STARTED|Overall Study||3
2301341|NCT02013050|5649837|P2|STARTED|Overall Study||41
2301342|NCT02013050|5649838|P1|STARTED|Overall Study||42
2301343|NCT02012959|5649880|P5|NOT COMPLETED|Treatment Phase B||0
2301344|NCT02012959|5649881|P4|NOT COMPLETED|Treatment Phase B||0
2301345|NCT02012959|5649882|P3|NOT COMPLETED|Treatment Phase B||0
2301346|NCT02012959|5649883|P2|NOT COMPLETED|Treatment Phase B||0
2301347|NCT02012959|5649884|P1|NOT COMPLETED|Treatment Phase B||0
2301348|NCT02012959|5649880|P5|COMPLETED|Treatment Phase B||1
2301349|NCT02012959|5649881|P4|COMPLETED|Treatment Phase B||1
2301350|NCT02012959|5649882|P3|COMPLETED|Treatment Phase B||3
2301351|NCT02012959|5649883|P2|COMPLETED|Treatment Phase B||2
2301352|NCT02012959|5649884|P1|COMPLETED|Treatment Phase B||0
2301353|NCT02012959|5649880|P5|Received At Least 1 Dose of Study Drug|Treatment Phase B||1
2301354|NCT02012959|5649881|P4|Received At Least 1 Dose of Study Drug|Treatment Phase B||1
2301355|NCT02012959|5649882|P3|Received At Least 1 Dose of Study Drug|Treatment Phase B||3
2301356|NCT02012959|5649883|P2|Received At Least 1 Dose of Study Drug|Treatment Phase B||2
2301357|NCT02012959|5649884|P1|Received At Least 1 Dose of Study Drug|Treatment Phase B||0
2301358|NCT02012959|5649880|P5|STARTED|Treatment Phase B|Participants in this group could receive the investigator's preferred standard of care|1
2301359|NCT02012959|5649881|P4|STARTED|Treatment Phase B|Participants in this group could continue study drug treatment, per the investigator’s discretion|1
2301360|NCT02012959|5649882|P3|STARTED|Treatment Phase B|Participants in this group did not receive additional study drug after Phase A|3
2301361|NCT02012959|5649883|P2|STARTED|Treatment Phase B|Participants in this group continued treatment with the study drug|2
2301362|NCT02012959|5649884|P1|STARTED|Treatment Phase B|Zero participants noted because participants had completed Phase A|0
2301363|NCT02012959|5649880|P5|NOT COMPLETED|Treatment Phase A||0
2301364|NCT02012959|5649881|P4|NOT COMPLETED|Treatment Phase A||0
2301365|NCT02012959|5649882|P3|NOT COMPLETED|Treatment Phase A||0
2301366|NCT02012959|5649883|P2|NOT COMPLETED|Treatment Phase A||0
2301367|NCT02012959|5649884|P1|NOT COMPLETED|Treatment Phase A||2
2301368|NCT02012959|5649880|P5|COMPLETED|Treatment Phase A||0
2301369|NCT02012959|5649881|P4|COMPLETED|Treatment Phase A||0
2301370|NCT02012959|5649882|P3|COMPLETED|Treatment Phase A||0
2301371|NCT02012959|5649883|P2|COMPLETED|Treatment Phase A||0
2301372|NCT02012959|5649884|P1|COMPLETED|Treatment Phase A||7
2301373|NCT02012959|5649880|P5|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
2301374|NCT02012959|5649881|P4|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
2301375|NCT02012959|5649882|P3|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
2301376|NCT02012959|5649883|P2|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
2301377|NCT02012959|5649884|P1|Received At Least 1 Dose of Study Drug|Treatment Phase A||9
2301378|NCT02012959|5649880|P5|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
2301379|NCT02012959|5649881|P4|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
2301380|NCT02012959|5649882|P3|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
2301381|NCT02012959|5649883|P2|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
2301382|NCT02012959|5649884|P1|STARTED|Treatment Phase A||9
2301383|NCT02012686|5649897|P2|NOT COMPLETED|Overall Study||2
2301384|NCT02012686|5649898|P1|NOT COMPLETED|Overall Study||0
2301385|NCT02012686|5649897|P2|COMPLETED|Overall Study||48
2301386|NCT02012686|5649898|P1|COMPLETED|Overall Study||50
2301387|NCT02012686|5649897|P2|STARTED|Overall Study||50
2301388|NCT02012686|5649898|P1|STARTED|Overall Study||50
2301389|NCT02012621|5649910|P1|NOT COMPLETED|Overall Study||0
2301390|NCT02012621|5649910|P1|COMPLETED|Overall Study||807
2301391|NCT02012621|5649910|P1|Visit 3 Completed|Overall Study||444
2301392|NCT02012621|5649910|P1|Visit 2 Completed|Overall Study||688
2301393|NCT02012621|5649910|P1|Visit 1 Completed|Overall Study||807
2301394|NCT02012621|5649910|P1|STARTED|Overall Study||807
2301395|NCT02012608|5649918|P2|NOT COMPLETED|Overall Study||0
2301396|NCT02012608|5649919|P1|NOT COMPLETED|Overall Study||3
2301397|NCT02012608|5649918|P2|COMPLETED|Overall Study||7
2301398|NCT02012608|5649919|P1|COMPLETED|Overall Study||4
2301399|NCT02012608|5649918|P2|STARTED|Overall Study||7
2301400|NCT02012608|5649919|P1|STARTED|Overall Study||7
2301401|NCT02012582|5649929|P4|NOT COMPLETED|Overall Study||1
2301402|NCT02012582|5649930|P3|NOT COMPLETED|Overall Study||0
2301403|NCT02012582|5649931|P2|NOT COMPLETED|Overall Study||0
2301404|NCT02012582|5649932|P1|NOT COMPLETED|Overall Study||0
2301405|NCT02012582|5649929|P4|COMPLETED|Overall Study||7
2301406|NCT02012582|5649930|P3|COMPLETED|Overall Study||8
2301407|NCT02012582|5649931|P2|COMPLETED|Overall Study||8
2301408|NCT02012582|5649932|P1|COMPLETED|Overall Study||8
2301409|NCT02012582|5649929|P4|STARTED|Overall Study||8
2301410|NCT02012582|5649930|P3|STARTED|Overall Study||8
2301411|NCT02012582|5649931|P2|STARTED|Overall Study||8
2301412|NCT02012582|5649932|P1|STARTED|Overall Study||8
2301413|NCT02012491|5649960|P2|NOT COMPLETED|Overall Study||1
2301414|NCT02012491|5649961|P1|NOT COMPLETED|Overall Study||2
2301415|NCT02012491|5649960|P2|COMPLETED|Overall Study||148
2301416|NCT02012491|5649961|P1|COMPLETED|Overall Study||149
2301417|NCT02012491|5649960|P2|STARTED|Overall Study||149
2301418|NCT02012491|5649961|P1|STARTED|Overall Study||151
2301419|NCT02012452|5649979|P2|NOT COMPLETED|Overall Study||1
2301420|NCT02012452|5649980|P1|NOT COMPLETED|Overall Study||6
2301421|NCT02012452|5649979|P2|COMPLETED|Overall Study||1
2301422|NCT02012452|5649980|P1|COMPLETED|Overall Study||1
2301423|NCT02012452|5649979|P2|STARTED|Overall Study||2
2301424|NCT02012452|5649980|P1|STARTED|Overall Study||7
2301425|NCT02012348|5649991|P3|NOT COMPLETED|Overall Study||0
2301426|NCT02012348|5649992|P2|NOT COMPLETED|Overall Study||0
2301427|NCT02012348|5649993|P1|NOT COMPLETED|Overall Study||0
2301428|NCT02012348|5649991|P3|COMPLETED|Overall Study||10
2301429|NCT02012348|5649992|P2|COMPLETED|Overall Study||10
2301430|NCT02012348|5649993|P1|COMPLETED|Overall Study||10
2301431|NCT02012348|5649991|P3|STARTED|Overall Study||10
2301432|NCT02012348|5649992|P2|STARTED|Overall Study||10
2301433|NCT02012348|5649993|P1|STARTED|Overall Study||10
2301434|NCT02012283|5650006|P2|NOT COMPLETED|Third Intervention||0
2301435|NCT02012283|5650007|P1|NOT COMPLETED|Third Intervention||0
2301436|NCT02012283|5650006|P2|COMPLETED|Third Intervention||10
2301437|NCT02012283|5650007|P1|COMPLETED|Third Intervention||10
2301438|NCT02012283|5650006|P2|STARTED|Third Intervention||10
2301439|NCT02012283|5650007|P1|STARTED|Third Intervention||10
2301440|NCT02012283|5650006|P2|NOT COMPLETED|Second Intervention||0
2301441|NCT02012283|5650007|P1|NOT COMPLETED|Second Intervention||0
2301442|NCT02012283|5650006|P2|COMPLETED|Second Intervention||10
2301443|NCT02012283|5650007|P1|COMPLETED|Second Intervention||10
2301444|NCT02012283|5650006|P2|STARTED|Second Intervention||10
2301445|NCT02012283|5650007|P1|STARTED|Second Intervention||10
2301446|NCT02012283|5650006|P2|NOT COMPLETED|First Intervention||0
2301447|NCT02012283|5650007|P1|NOT COMPLETED|First Intervention||0
2301448|NCT02012283|5650006|P2|COMPLETED|First Intervention||10
2301449|NCT02012283|5650007|P1|COMPLETED|First Intervention||10
2301450|NCT02012283|5650006|P2|STARTED|First Intervention||10
2301451|NCT02012283|5650007|P1|STARTED|First Intervention||10
2301452|NCT02012218|5650023|P5|NOT COMPLETED|Overall Study||1
2301453|NCT02012218|5650024|P4|NOT COMPLETED|Overall Study||2
2301454|NCT02012218|5650025|P3|NOT COMPLETED|Overall Study||2
2301455|NCT02012218|5650026|P2|NOT COMPLETED|Overall Study||1
2301456|NCT02012218|5650027|P1|NOT COMPLETED|Overall Study||4
2301457|NCT02012218|5650023|P5|COMPLETED|Overall Study||5
2301458|NCT02012218|5650024|P4|COMPLETED|Overall Study||17
2301459|NCT02012218|5650025|P3|COMPLETED|Overall Study||11
2301460|NCT02012218|5650026|P2|COMPLETED|Overall Study||10
2301461|NCT02012218|5650027|P1|COMPLETED|Overall Study||8
2301462|NCT02012218|5650023|P5|STARTED|Overall Study||6
2301463|NCT02012218|5650024|P4|STARTED|Overall Study||19
2301464|NCT02012218|5650025|P3|STARTED|Overall Study||13
2301465|NCT02012218|5650026|P2|STARTED|Overall Study||11
2301466|NCT02012218|5650027|P1|STARTED|Overall Study||12
2301467|NCT02012192|5650041|P2|NOT COMPLETED|Overall Study||0
2301468|NCT02012192|5650042|P1|NOT COMPLETED|Overall Study||27
2301469|NCT02012192|5650041|P2|COMPLETED|Overall Study||43
2301470|NCT02012192|5650042|P1|COMPLETED|Overall Study||63
2301471|NCT02012192|5650041|P2|STARTED|Overall Study||43
2301472|NCT02012192|5650042|P1|STARTED|Overall Study||90
2301482|NCT02011893|5650130|P3|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||1
2301483|NCT02011893|5650131|P2|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
2301484|NCT02011893|5650132|P1|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
2301485|NCT02011893|5650130|P3|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||51
2301486|NCT02011893|5650131|P2|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||45
2301487|NCT02011893|5650132|P1|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
2301488|NCT02011893|5650130|P3|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
2301489|NCT02011893|5650131|P2|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||45
2301490|NCT02011893|5650132|P1|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
2301491|NCT02011893|5650130|P3|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
2301492|NCT02011893|5650131|P2|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||44
2301493|NCT02011893|5650132|P1|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
2301494|NCT02011893|5650130|P3|STARTED|Period 2 (12 Weeks to 24 Weeks)||52
2301495|NCT02011893|5650131|P2|STARTED|Period 2 (12 Weeks to 24 Weeks)||45
2301496|NCT02011893|5650132|P1|STARTED|Period 2 (12 Weeks to 24 Weeks)||0
2301497|NCT02011893|5650130|P3|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||3
2301498|NCT02011893|5650131|P2|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
2301499|NCT02011893|5650132|P1|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
2301500|NCT02011893|5650130|P3|COMPLETED|Period 1 (Randomization to 12 Weeks)||52
2301501|NCT02011893|5650131|P2|COMPLETED|Period 1 (Randomization to 12 Weeks)||45
2301502|NCT02011893|5650132|P1|COMPLETED|Period 1 (Randomization to 12 Weeks)||0
2301503|NCT02011893|5650130|P3|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
2301504|NCT02011893|5650131|P2|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
2301505|NCT02011893|5650132|P1|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
2301506|NCT02011893|5650130|P3|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
2301507|NCT02011893|5650131|P2|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
2301508|NCT02011893|5650132|P1|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
2301509|NCT02011893|5650130|P3|STARTED|Period 1 (Randomization to 12 Weeks)||55
2301510|NCT02011893|5650131|P2|STARTED|Period 1 (Randomization to 12 Weeks)||45
2301511|NCT02011893|5650132|P1|STARTED|Period 1 (Randomization to 12 Weeks)||0
2301512|NCT02011893|5650130|P3|NOT COMPLETED|Enrollment to Randomization||0
2301513|NCT02011893|5650131|P2|NOT COMPLETED|Enrollment to Randomization||0
2301514|NCT02011893|5650132|P1|NOT COMPLETED|Enrollment to Randomization||73
2301515|NCT02011893|5650130|P3|COMPLETED|Enrollment to Randomization||0
2301516|NCT02011893|5650131|P2|COMPLETED|Enrollment to Randomization||0
2301517|NCT02011893|5650132|P1|COMPLETED|Enrollment to Randomization||100
2301518|NCT02011893|5650130|P3|Randomization|Enrollment to Randomization||0
2301519|NCT02011893|5650131|P2|Randomization|Enrollment to Randomization||0
2301520|NCT02011893|5650132|P1|Randomization|Enrollment to Randomization||100
2301521|NCT02011893|5650130|P3|Permanent Stimulation Implant|Enrollment to Randomization||0
2301522|NCT02011893|5650131|P2|Permanent Stimulation Implant|Enrollment to Randomization||0
2301523|NCT02011893|5650132|P1|Permanent Stimulation Implant|Enrollment to Randomization||101
2301524|NCT02011893|5650130|P3|Trial Stimulation Implant|Enrollment to Randomization||0
2301525|NCT02011893|5650131|P2|Trial Stimulation Implant|Enrollment to Randomization||0
2301526|NCT02011893|5650132|P1|Trial Stimulation Implant|Enrollment to Randomization||121
2301527|NCT02011893|5650130|P3|Baseline|Enrollment to Randomization||0
2301528|NCT02011893|5650131|P2|Baseline|Enrollment to Randomization||0
2301529|NCT02011893|5650132|P1|Baseline|Enrollment to Randomization||141
2301530|NCT02011893|5650130|P3|STARTED|Enrollment to Randomization||0
2301531|NCT02011893|5650131|P2|STARTED|Enrollment to Randomization||0
2301532|NCT02011893|5650132|P1|STARTED|Enrollment to Randomization||173
2301533|NCT02011542|5650143|P1|NOT COMPLETED|Overall Study||1
2301534|NCT02011542|5650143|P1|COMPLETED|Overall Study||29
2301535|NCT02011542|5650143|P1|STARTED|Overall Study||30
2301536|NCT02011516|5650150|P2|NOT COMPLETED|Overall Study||2
2301537|NCT02011516|5650151|P1|NOT COMPLETED|Overall Study||4
2301538|NCT02011516|5650150|P2|COMPLETED|Overall Study||6
2301539|NCT02011516|5650151|P1|COMPLETED|Overall Study||4
2301540|NCT02011516|5650150|P2|STARTED|Overall Study||8
2301541|NCT02011516|5650151|P1|STARTED|Overall Study||8
2301542|NCT02011490|5650160|P6|NOT COMPLETED|Part 2||0
2301543|NCT02011490|5650161|P5|NOT COMPLETED|Part 2||0
2301544|NCT02011490|5650162|P4|NOT COMPLETED|Part 2||0
2301545|NCT02011490|5650163|P3|NOT COMPLETED|Part 2||0
2301546|NCT02011490|5650164|P2|NOT COMPLETED|Part 2||0
2301547|NCT02011490|5650165|P1|NOT COMPLETED|Part 2||0
2301548|NCT02011490|5650160|P6|COMPLETED|Part 2||6
2301549|NCT02011490|5650161|P5|COMPLETED|Part 2||6
2301550|NCT02011490|5650162|P4|COMPLETED|Part 2||6
2301551|NCT02011490|5650163|P3|COMPLETED|Part 2||0
2301552|NCT02011490|5650164|P2|COMPLETED|Part 2||0
2301553|NCT02011490|5650165|P1|COMPLETED|Part 2||0
2301554|NCT02011490|5650160|P6|STARTED|Part 2|2 had also participated in Part 1 (both in healthy group)|6
2301555|NCT02011490|5650161|P5|STARTED|Part 2|3 had also participated in Part 1 (2 in moderate, 1 in severe groups)|6
2301556|NCT02011490|5650162|P4|STARTED|Part 2|4 had also participated in Part 1 (all in severe group)|6
2301557|NCT02011490|5650163|P3|STARTED|Part 2||0
2301558|NCT02011490|5650164|P2|STARTED|Part 2||0
2301559|NCT02011490|5650165|P1|STARTED|Part 2||0
2301560|NCT02011490|5650160|P6|NOT COMPLETED|Part 1||0
2301561|NCT02011490|5650161|P5|NOT COMPLETED|Part 1||0
2301562|NCT02011490|5650162|P4|NOT COMPLETED|Part 1||0
2301563|NCT02011490|5650163|P3|NOT COMPLETED|Part 1||0
2301564|NCT02011490|5650164|P2|NOT COMPLETED|Part 1||0
2301565|NCT02011490|5650165|P1|NOT COMPLETED|Part 1||0
2301566|NCT02011490|5650160|P6|COMPLETED|Part 1||0
2301567|NCT02011490|5650161|P5|COMPLETED|Part 1||0
2301568|NCT02011490|5650162|P4|COMPLETED|Part 1||0
2301569|NCT02011490|5650163|P3|COMPLETED|Part 1||8
2301570|NCT02011490|5650164|P2|COMPLETED|Part 1||8
2301571|NCT02011490|5650165|P1|COMPLETED|Part 1||8
2301572|NCT02011490|5650160|P6|STARTED|Part 1||0
2301573|NCT02011490|5650161|P5|STARTED|Part 1||0
2301574|NCT02011490|5650162|P4|STARTED|Part 1||0
2301575|NCT02011490|5650163|P3|STARTED|Part 1||8
2301576|NCT02011490|5650164|P2|STARTED|Part 1||8
2301577|NCT02011490|5650165|P1|STARTED|Part 1||8
2301578|NCT02011464|5650253|P2|NOT COMPLETED|Overall Study||0
2301579|NCT02011464|5650254|P1|NOT COMPLETED|Overall Study||0
2301580|NCT02011464|5650253|P2|COMPLETED|Overall Study||10
2301581|NCT02011464|5650254|P1|COMPLETED|Overall Study||10
2301582|NCT02011464|5650253|P2|STARTED|Overall Study||10
2301583|NCT02011464|5650254|P1|STARTED|Overall Study||10
2301584|NCT02011113|5650274|P1|NOT COMPLETED|Overall Study||36
2301585|NCT02011113|5650274|P1|COMPLETED|Overall Study|Completed = participants with progressive disease were considered as completed.|0
2301586|NCT02011113|5650274|P1|STARTED|Overall Study||36
2301587|NCT02010996|5650290|P2|NOT COMPLETED|Overall Study||0
2301588|NCT02010996|5650291|P1|NOT COMPLETED|Overall Study||0
2301589|NCT02010996|5650290|P2|COMPLETED|Overall Study||36
2301590|NCT02010996|5650291|P1|COMPLETED|Overall Study||36
2301591|NCT02010996|5650290|P2|STARTED|Overall Study||36
2301592|NCT02010996|5650291|P1|STARTED|Overall Study||36
2301593|NCT02010775|5650306|P5|NOT COMPLETED|Overall Study||6
2301594|NCT02010775|5650307|P4|NOT COMPLETED|Overall Study||3
2301595|NCT02010775|5650308|P3|NOT COMPLETED|Overall Study||3
2301596|NCT02010775|5650309|P2|NOT COMPLETED|Overall Study||3
2301597|NCT02010775|5650310|P1|NOT COMPLETED|Overall Study||5
2301598|NCT02010775|5650306|P5|COMPLETED|Overall Study||31
2301599|NCT02010775|5650307|P4|COMPLETED|Overall Study||34
2301600|NCT02010775|5650308|P3|COMPLETED|Overall Study||34
2301601|NCT02010775|5650309|P2|COMPLETED|Overall Study||35
2301602|NCT02010775|5650310|P1|COMPLETED|Overall Study||33
2301603|NCT02010775|5650306|P5|STARTED|Overall Study||37
2301604|NCT02010775|5650307|P4|STARTED|Overall Study||37
2301605|NCT02010775|5650308|P3|STARTED|Overall Study||37
2301606|NCT02010775|5650309|P2|STARTED|Overall Study||38
2301607|NCT02010775|5650310|P1|STARTED|Overall Study||38
2301608|NCT02010697|5650330|P3|NOT COMPLETED|Overall Study||0
2301609|NCT02010697|5650331|P2|NOT COMPLETED|Overall Study||0
2301610|NCT02010697|5650332|P1|NOT COMPLETED|Overall Study||0
2301611|NCT02010697|5650330|P3|COMPLETED|Overall Study||1043
2301612|NCT02010697|5650331|P2|COMPLETED|Overall Study||1038
2301613|NCT02010697|5650332|P1|COMPLETED|Overall Study||1044
2301614|NCT02010697|5650330|P3|STARTED|Overall Study||1043
2301615|NCT02010697|5650331|P2|STARTED|Overall Study||1038
2301616|NCT02010697|5650332|P1|STARTED|Overall Study||1044
2301617|NCT02010684|5650351|P2|NOT COMPLETED|Overall Study||23
2301618|NCT02010684|5650352|P1|NOT COMPLETED|Overall Study||12
2301619|NCT02010684|5650351|P2|COMPLETED|Overall Study||59
2301620|NCT02010684|5650352|P1|COMPLETED|Overall Study||27
2301621|NCT02010684|5650351|P2|STARTED|Overall Study||82
2301622|NCT02010684|5650352|P1|STARTED|Overall Study||39
2301623|NCT02010645|5650370|P1|NOT COMPLETED|Overall Study||0
2301624|NCT02010645|5650370|P1|COMPLETED|Overall Study||6
2301625|NCT02010645|5650370|P1|STARTED|Overall Study||6
2301626|NCT02010632|5650374|P2|NOT COMPLETED|Second Intervention (7 Days)||0
2301627|NCT02010632|5650375|P1|NOT COMPLETED|Second Intervention (7 Days)||1
2301628|NCT02010632|5650374|P2|COMPLETED|Second Intervention (7 Days)||16
2301629|NCT02010632|5650375|P1|COMPLETED|Second Intervention (7 Days)||15
2301630|NCT02010632|5650374|P2|STARTED|Second Intervention (7 Days)||16
2301631|NCT02010632|5650375|P1|STARTED|Second Intervention (7 Days)||16
2301632|NCT02010632|5650374|P2|NOT COMPLETED|Wash Out Period (14 Days)||0
2301633|NCT02010632|5650375|P1|NOT COMPLETED|Wash Out Period (14 Days)||0
2301634|NCT02010632|5650374|P2|COMPLETED|Wash Out Period (14 Days)||16
2301635|NCT02010632|5650375|P1|COMPLETED|Wash Out Period (14 Days)||16
2301636|NCT02010632|5650374|P2|STARTED|Wash Out Period (14 Days)||16
2301637|NCT02010632|5650375|P1|STARTED|Wash Out Period (14 Days)||16
2301638|NCT02010632|5650374|P2|NOT COMPLETED|First Intervention (7 Days)||0
2301639|NCT02010632|5650375|P1|NOT COMPLETED|First Intervention (7 Days)||0
2301640|NCT02010632|5650374|P2|COMPLETED|First Intervention (7 Days)||16
2301641|NCT02010632|5650375|P1|COMPLETED|First Intervention (7 Days)||16
2301642|NCT02010632|5650374|P2|STARTED|First Intervention (7 Days)||16
2301643|NCT02010632|5650375|P1|STARTED|First Intervention (7 Days)||16
2301644|NCT02010567|5650386|P5|NOT COMPLETED|Overall Study||1
2301645|NCT02010567|5650387|P4|NOT COMPLETED|Overall Study||0
2301646|NCT02010567|5650388|P3|NOT COMPLETED|Overall Study||1
2301647|NCT02010567|5650389|P2|NOT COMPLETED|Overall Study||0
2301648|NCT02010567|5650390|P1|NOT COMPLETED|Overall Study||0
2301649|NCT02010567|5650386|P5|COMPLETED|Overall Study||5
2301650|NCT02010567|5650387|P4|COMPLETED|Overall Study||3
2301651|NCT02010567|5650388|P3|COMPLETED|Overall Study||13
2301652|NCT02010567|5650389|P2|COMPLETED|Overall Study||6
2301653|NCT02010567|5650390|P1|COMPLETED|Overall Study||3
2301654|NCT02010567|5650386|P5|STARTED|Overall Study||6
2301655|NCT02010567|5650387|P4|STARTED|Overall Study||3
2301656|NCT02010567|5650388|P3|STARTED|Overall Study||14
2301657|NCT02010567|5650389|P2|STARTED|Overall Study||6
2301658|NCT02010567|5650390|P1|STARTED|Overall Study||3
2301659|NCT02010359|5650403|P2|NOT COMPLETED|Overall Study||2
2301660|NCT02010359|5650404|P1|NOT COMPLETED|Overall Study||2
2301661|NCT02010359|5650403|P2|COMPLETED|Overall Study||12
2301662|NCT02010359|5650404|P1|COMPLETED|Overall Study||13
2301663|NCT02010359|5650403|P2|STARTED|Overall Study||14
2301664|NCT02010359|5650404|P1|STARTED|Overall Study||15
2301665|NCT02010255|5650442|P14|NOT COMPLETED|Overall Study||1
2301666|NCT02010255|5650443|P13|NOT COMPLETED|Overall Study||0
2301667|NCT02010255|5650444|P12|NOT COMPLETED|Overall Study||1
2301668|NCT02010255|5650445|P11|NOT COMPLETED|Overall Study||2
2301669|NCT02010255|5650446|P10|NOT COMPLETED|Overall Study||0
2301670|NCT02010255|5650447|P9|NOT COMPLETED|Overall Study||1
2301671|NCT02010255|5650448|P8|NOT COMPLETED|Overall Study||1
2301672|NCT02010255|5650449|P7|NOT COMPLETED|Overall Study||1
2301673|NCT02010255|5650450|P6|NOT COMPLETED|Overall Study||0
2301674|NCT02010255|5650451|P5|NOT COMPLETED|Overall Study||4
2301675|NCT02010255|5650452|P4|NOT COMPLETED|Overall Study||6
2301676|NCT02010255|5650453|P3|NOT COMPLETED|Overall Study||7
2301677|NCT02010255|5650454|P2|NOT COMPLETED|Overall Study||2
2301678|NCT02010255|5650455|P1|NOT COMPLETED|Overall Study||6
2301679|NCT02010255|5650442|P14|COMPLETED|Overall Study||2
2301680|NCT02010255|5650443|P13|COMPLETED|Overall Study||3
2301681|NCT02010255|5650444|P12|COMPLETED|Overall Study||4
2301682|NCT02010255|5650445|P11|COMPLETED|Overall Study||1
2301683|NCT02010255|5650446|P10|COMPLETED|Overall Study||23
2301684|NCT02010255|5650447|P9|COMPLETED|Overall Study||21
2301685|NCT02010255|5650448|P8|COMPLETED|Overall Study||32
2301686|NCT02010255|5650449|P7|COMPLETED|Overall Study||33
2301687|NCT02010255|5650450|P6|COMPLETED|Overall Study||49
2301688|NCT02010255|5650451|P5|COMPLETED|Overall Study||48
2301689|NCT02010255|5650452|P4|COMPLETED|Overall Study||20
2301690|NCT02010255|5650453|P3|COMPLETED|Overall Study||18
2301691|NCT02010255|5650454|P2|COMPLETED|Overall Study||26
2301692|NCT02010255|5650455|P1|COMPLETED|Overall Study||22
2301693|NCT02010255|5650442|P14|STARTED|Overall Study||3
2301694|NCT02010255|5650443|P13|STARTED|Overall Study||3
2301695|NCT02010255|5650444|P12|STARTED|Overall Study||5
2301696|NCT02010255|5650445|P11|STARTED|Overall Study||3
2301697|NCT02010255|5650446|P10|STARTED|Overall Study||23
2301698|NCT02010255|5650447|P9|STARTED|Overall Study||22
2301699|NCT02010255|5650448|P8|STARTED|Overall Study||33
2301700|NCT02010255|5650449|P7|STARTED|Overall Study||34
2301701|NCT02010255|5650450|P6|STARTED|Overall Study||49
2301702|NCT02010255|5650451|P5|STARTED|Overall Study||52
2301703|NCT02010255|5650452|P4|STARTED|Overall Study||26
2301704|NCT02010255|5650453|P3|STARTED|Overall Study||25
2301705|NCT02010255|5650454|P2|STARTED|Overall Study||28
2301706|NCT02010255|5650455|P1|STARTED|Overall Study||28
2301707|NCT02010216|5650779|P1|NOT COMPLETED|Overall Study||0
2301708|NCT02010216|5650779|P1|COMPLETED|Overall Study||23
2301709|NCT02010216|5650779|P1|STARTED|Overall Study||23
2301725|NCT02010021|5650867|P2|NOT COMPLETED|Overall Study||0
2301726|NCT02010021|5650868|P1|NOT COMPLETED|Overall Study||0
2301727|NCT02010021|5650867|P2|COMPLETED|Overall Study||7
2301728|NCT02010021|5650868|P1|COMPLETED|Overall Study||10
2301729|NCT02010021|5650867|P2|STARTED|Overall Study||7
2301730|NCT02010021|5650868|P1|STARTED|Overall Study||10
2301731|NCT02009982|5650878|P2|NOT COMPLETED|Overall Study||0
2301732|NCT02009982|5650879|P1|NOT COMPLETED|Overall Study||0
2301733|NCT02009982|5650878|P2|COMPLETED|Overall Study||2
2301734|NCT02009982|5650879|P1|COMPLETED|Overall Study||1
2301735|NCT02009982|5650878|P2|STARTED|Overall Study||2
2301736|NCT02009982|5650879|P1|STARTED|Overall Study||1
2301737|NCT02009878|5650890|P3|NOT COMPLETED|Overall Study||0
2301738|NCT02009878|5650891|P2|NOT COMPLETED|Overall Study||1
2301739|NCT02009878|5650892|P1|NOT COMPLETED|Overall Study||0
2301740|NCT02009878|5650890|P3|COMPLETED|Overall Study||9
2301741|NCT02009878|5650891|P2|COMPLETED|Overall Study||10
2301742|NCT02009878|5650892|P1|COMPLETED|Overall Study||10
2301743|NCT02009878|5650890|P3|STARTED|Overall Study||9
2301744|NCT02009878|5650891|P2|STARTED|Overall Study||11
2301745|NCT02009878|5650892|P1|STARTED|Overall Study||10
2301746|NCT02009865|5650926|P2|NOT COMPLETED|Overall Study||5
2301747|NCT02009865|5650927|P1|NOT COMPLETED|Overall Study||1
2301748|NCT02009865|5650926|P2|COMPLETED|Overall Study||76
2301749|NCT02009865|5650927|P1|COMPLETED|Overall Study||80
2301750|NCT02009865|5650926|P2|STARTED|Overall Study||81
2301751|NCT02009865|5650927|P1|STARTED|Overall Study||81
2301752|NCT02009722|5650943|P2|NOT COMPLETED|Overall Study||3
2301753|NCT02009722|5650944|P1|NOT COMPLETED|Overall Study||1
2301754|NCT02009722|5650943|P2|COMPLETED|Overall Study||40
2301755|NCT02009722|5650944|P1|COMPLETED|Overall Study||40
2301756|NCT02009722|5650943|P2|Received Intervention|Overall Study||42
2301757|NCT02009722|5650944|P1|Received Intervention|Overall Study||41
2301758|NCT02009722|5650943|P2|STARTED|Overall Study||43
2301759|NCT02009722|5650944|P1|STARTED|Overall Study||41
2301760|NCT02009696|5650968|P1|NOT COMPLETED|Overall Study||2
2301761|NCT02009696|5650968|P1|COMPLETED|Overall Study||219
2301762|NCT02009696|5650968|P1|STARTED|Overall Study||221
2301763|NCT02009501|5650978|P2|NOT COMPLETED|Overall Study||0
2301764|NCT02009501|5650979|P1|NOT COMPLETED|Overall Study||0
2301765|NCT02009501|5650978|P2|COMPLETED|Overall Study||11
2301766|NCT02009501|5650979|P1|COMPLETED|Overall Study||9
2301767|NCT02009501|5650978|P2|STARTED|Overall Study||11
2301768|NCT02009501|5650979|P1|STARTED|Overall Study||9
2301769|NCT02009163|5650985|P3|NOT COMPLETED|Randomized-withdrawal Period||35
2301770|NCT02009163|5650986|P2|NOT COMPLETED|Randomized-withdrawal Period||88
2301771|NCT02009163|5650987|P1|NOT COMPLETED|Randomized-withdrawal Period||0
2301772|NCT02009163|5650985|P3|COMPLETED|Randomized-withdrawal Period||102
2301773|NCT02009163|5650986|P2|COMPLETED|Randomized-withdrawal Period||50
2301774|NCT02009163|5650987|P1|COMPLETED|Randomized-withdrawal Period||0
2301775|NCT02009163|5650985|P3|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|137
2301776|NCT02009163|5650986|P2|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|138
2301777|NCT02009163|5650987|P1|STARTED|Randomized-withdrawal Period|The open-label treatment group is not an arm of the randomized-withdrawal period.|0
2301778|NCT02009163|5650985|P3|NOT COMPLETED|Open-label Period (Non-randomized)||0
2301779|NCT02009163|5650986|P2|NOT COMPLETED|Open-label Period (Non-randomized)||0
2301780|NCT02009163|5650987|P1|NOT COMPLETED|Open-label Period (Non-randomized)||143
2301781|NCT02009163|5650985|P3|COMPLETED|Open-label Period (Non-randomized)||0
2301782|NCT02009163|5650986|P2|COMPLETED|Open-label Period (Non-randomized)||0
2301783|NCT02009163|5650987|P1|COMPLETED|Open-label Period (Non-randomized)||275
2301784|NCT02009163|5650985|P3|STARTED|Open-label Period (Non-randomized)||0
2301785|NCT02009163|5650986|P2|STARTED|Open-label Period (Non-randomized)||0
2301786|NCT02009163|5650987|P1|STARTED|Open-label Period (Non-randomized)||418
2301787|NCT02009046|5651022|P2|NOT COMPLETED|Overall Study||206
2301788|NCT02009046|5651023|P1|NOT COMPLETED|Overall Study||256
2301789|NCT02009046|5651022|P2|COMPLETED|Overall Study||678
2301790|NCT02009046|5651023|P1|COMPLETED|Overall Study||769
2301791|NCT02009046|5651022|P2|Ctrl Curriculm +1 SchoolWide Component|Overall Study||428
2301792|NCT02009046|5651023|P1|Ctrl Curriculm +1 SchoolWide Component|Overall Study||0
2301793|NCT02009046|5651022|P2|Ctrl Curriculum Only|Overall Study||456
2301794|NCT02009046|5651023|P1|Ctrl Curriculum Only|Overall Study||0
2301795|NCT02009046|5651022|P2|SEI Curriculum + 3 SchoolWide Components|Overall Study||0
2301796|NCT02009046|5651023|P1|SEI Curriculum + 3 SchoolWide Components|Overall Study||544
2301797|NCT02009046|5651022|P2|SEI Curriculum Only|Overall Study||0
2301798|NCT02009046|5651023|P1|SEI Curriculum Only|Overall Study||461
2301799|NCT02009046|5651022|P2|STARTED|Overall Study||884
2301800|NCT02009046|5651023|P1|STARTED|Overall Study||1025
2301801|NCT02008942|5651073|P2|NOT COMPLETED|Second Intervention||0
2301802|NCT02008942|5651074|P1|NOT COMPLETED|Second Intervention||1
2301803|NCT02008942|5651073|P2|COMPLETED|Second Intervention||30
2301804|NCT02008942|5651074|P1|COMPLETED|Second Intervention||25
2301805|NCT02008942|5651073|P2|STARTED|Second Intervention||30
2301806|NCT02008942|5651074|P1|STARTED|Second Intervention||26
2301807|NCT02008942|5651073|P2|NOT COMPLETED|First Intervention||0
2301808|NCT02008942|5651074|P1|NOT COMPLETED|First Intervention||0
2301809|NCT02008942|5651073|P2|COMPLETED|First Intervention||30
2301810|NCT02008942|5651074|P1|COMPLETED|First Intervention||27
2301811|NCT02008942|5651073|P2|STARTED|First Intervention||30
2301812|NCT02008942|5651074|P1|STARTED|First Intervention||27
2301813|NCT02008916|5651083|P3|NOT COMPLETED|Week 16 - 156||10
2301814|NCT02008916|5651084|P2|NOT COMPLETED|Week 16 - 156||13
2301815|NCT02008916|5651085|P1|NOT COMPLETED|Week 16 - 156||19
2301816|NCT02008916|5651083|P3|COMPLETED|Week 16 - 156||63
2301817|NCT02008916|5651084|P2|COMPLETED|Week 16 - 156||62
2301818|NCT02008916|5651085|P1|COMPLETED|Week 16 - 156||55
2301819|NCT02008916|5651083|P3|STARTED|Week 16 - 156||73
2301820|NCT02008916|5651084|P2|STARTED|Week 16 - 156||75
2301821|NCT02008916|5651085|P1|STARTED|Week 16 - 156||74
2301822|NCT02008916|5651083|P3|NOT COMPLETED|Primary Assessment (up to Week 16)||3
2301823|NCT02008916|5651084|P2|NOT COMPLETED|Primary Assessment (up to Week 16)||1
2301824|NCT02008916|5651085|P1|NOT COMPLETED|Primary Assessment (up to Week 16)||0
2301825|NCT02008916|5651083|P3|COMPLETED|Primary Assessment (up to Week 16)||73
2301826|NCT02008916|5651084|P2|COMPLETED|Primary Assessment (up to Week 16)||75
2301827|NCT02008916|5651085|P1|COMPLETED|Primary Assessment (up to Week 16)||74
2301828|NCT02008916|5651083|P3|Safety Set|Primary Assessment (up to Week 16)||75
2301829|NCT02008916|5651084|P2|Safety Set|Primary Assessment (up to Week 16)||76
2301830|NCT02008916|5651085|P1|Safety Set|Primary Assessment (up to Week 16)||74
2301831|NCT02008916|5651083|P3|FAS|Primary Assessment (up to Week 16)||76
2301832|NCT02008916|5651084|P2|FAS|Primary Assessment (up to Week 16)||76
2301833|NCT02008916|5651085|P1|FAS|Primary Assessment (up to Week 16)||74
2301834|NCT02008916|5651083|P3|STARTED|Primary Assessment (up to Week 16)||76
2301835|NCT02008916|5651084|P2|STARTED|Primary Assessment (up to Week 16)||76
2301836|NCT02008916|5651085|P1|STARTED|Primary Assessment (up to Week 16)||74
2301837|NCT02008890|5651121|P5|NOT COMPLETED|Extension Period||4
2301838|NCT02008890|5651122|P4|NOT COMPLETED|Extension Period||4
2301839|NCT02008890|5651123|P3|NOT COMPLETED|Extension Period||0
2301840|NCT02008890|5651124|P2|NOT COMPLETED|Extension Period||5
2301841|NCT02008890|5651125|P1|NOT COMPLETED|Extension Period||5
2301842|NCT02008890|5651121|P5|COMPLETED|Extension Period||13
2301843|NCT02008890|5651122|P4|COMPLETED|Extension Period||6
2301844|NCT02008890|5651123|P3|COMPLETED|Extension Period||0
2301845|NCT02008890|5651124|P2|COMPLETED|Extension Period||31
2301846|NCT02008890|5651125|P1|COMPLETED|Extension Period||26
2301847|NCT02008890|5651121|P5|STARTED|Extension Period||17
2301848|NCT02008890|5651122|P4|STARTED|Extension Period||10
2301849|NCT02008890|5651123|P3|STARTED|Extension Period||0
2301850|NCT02008890|5651124|P2|STARTED|Extension Period||36
2301851|NCT02008890|5651125|P1|STARTED|Extension Period||31
2301852|NCT02008890|5651121|P5|NOT COMPLETED|Period 2||8
2301853|NCT02008890|5651122|P4|NOT COMPLETED|Period 2||14
2301854|NCT02008890|5651123|P3|NOT COMPLETED|Period 2||1
2301855|NCT02008890|5651124|P2|NOT COMPLETED|Period 2||15
2301856|NCT02008890|5651125|P1|NOT COMPLETED|Period 2||27
2301857|NCT02008890|5651121|P5|COMPLETED|Period 2||20
2301858|NCT02008890|5651122|P4|COMPLETED|Period 2||13
2301859|NCT02008890|5651123|P3|COMPLETED|Period 2||9
2301860|NCT02008890|5651124|P2|COMPLETED|Period 2||49
2301861|NCT02008890|5651125|P1|COMPLETED|Period 2||38
2301862|NCT02008890|5651121|P5|STARTED|Period 2||28
2301863|NCT02008890|5651122|P4|STARTED|Period 2||27
2301864|NCT02008890|5651123|P3|STARTED|Period 2||10
2301865|NCT02008890|5651124|P2|STARTED|Period 2||64
2301866|NCT02008890|5651125|P1|STARTED|Period 2||65
2301867|NCT02008890|5651121|P5|NOT COMPLETED|Period 1||0
2301868|NCT02008890|5651122|P4|NOT COMPLETED|Period 1||0
2301869|NCT02008890|5651123|P3|NOT COMPLETED|Period 1||12
2301870|NCT02008890|5651124|P2|NOT COMPLETED|Period 1||15
2301871|NCT02008890|5651125|P1|NOT COMPLETED|Period 1||15
2301872|NCT02008890|5651121|P5|COMPLETED|Period 1||0
2301873|NCT02008890|5651122|P4|COMPLETED|Period 1||0
2301874|NCT02008890|5651123|P3|COMPLETED|Period 1||66
2301875|NCT02008890|5651124|P2|COMPLETED|Period 1||64
2301876|NCT02008890|5651125|P1|COMPLETED|Period 1||65
2301877|NCT02008890|5651121|P5|STARTED|Period 1||0
2301878|NCT02008890|5651122|P4|STARTED|Period 1||0
2301879|NCT02008890|5651123|P3|STARTED|Period 1||78
2301880|NCT02008890|5651124|P2|STARTED|Period 1||79
2301881|NCT02008890|5651125|P1|STARTED|Period 1||80
2301882|NCT02008877|5651161|P3|NOT COMPLETED|Overall Study||0
2301883|NCT02008877|5651162|P2|NOT COMPLETED|Overall Study||1
2301884|NCT02008877|5651163|P1|NOT COMPLETED|Overall Study||0
2301885|NCT02008877|5651161|P3|COMPLETED|Overall Study||10
2301886|NCT02008877|5651162|P2|COMPLETED|Overall Study||6
2301887|NCT02008877|5651163|P1|COMPLETED|Overall Study||3
2301888|NCT02008877|5651161|P3|STARTED|Overall Study||10
2301889|NCT02008877|5651162|P2|STARTED|Overall Study||7
2301890|NCT02008877|5651163|P1|STARTED|Overall Study||3
2301891|NCT02008773|5651182|P4|NOT COMPLETED|Overall Study||12
2301892|NCT02008773|5651183|P3|NOT COMPLETED|Overall Study||14
2301893|NCT02008773|5651184|P2|NOT COMPLETED|Overall Study||9
2301894|NCT02008773|5651185|P1|NOT COMPLETED|Overall Study||13
2301895|NCT02008773|5651182|P4|COMPLETED|Overall Study||38
2301896|NCT02008773|5651183|P3|COMPLETED|Overall Study||32
2301897|NCT02008773|5651184|P2|COMPLETED|Overall Study||25
2301898|NCT02008773|5651185|P1|COMPLETED|Overall Study||27
2301899|NCT02008773|5651182|P4|STARTED|Overall Study||50
2301900|NCT02008773|5651183|P3|STARTED|Overall Study||46
2301901|NCT02008773|5651184|P2|STARTED|Overall Study||34
2301902|NCT02008773|5651185|P1|STARTED|Overall Study||40
2301903|NCT02008682|5651215|P2|NOT COMPLETED|Overall Study||14
2301904|NCT02008682|5651216|P1|NOT COMPLETED|Overall Study||27
2301905|NCT02008682|5651215|P2|COMPLETED|Overall Study|Completed without discontinuation of trial product|170
2301906|NCT02008682|5651216|P1|COMPLETED|Overall Study|Completed without discontinuation of trial product|157
2301907|NCT02008682|5651215|P2|Exposed|Overall Study||184
2301908|NCT02008682|5651216|P1|Exposed|Overall Study|1 subject withdrawn before exposure to trial product|183
2301909|NCT02008682|5651215|P2|STARTED|Overall Study||184
2301910|NCT02008682|5651216|P1|STARTED|Overall Study||184
2301911|NCT02008617|5651234|P2|NOT COMPLETED|Overall Study||0
2301912|NCT02008617|5651235|P1|NOT COMPLETED|Overall Study||0
2301913|NCT02008617|5651234|P2|COMPLETED|Overall Study||10
2301914|NCT02008617|5651235|P1|COMPLETED|Overall Study||8
2301915|NCT02008617|5651234|P2|STARTED|Overall Study||10
2301916|NCT02008617|5651235|P1|STARTED|Overall Study||8
2301917|NCT02008565|5651251|P4|NOT COMPLETED|Overall Study||0
2301918|NCT02008565|5651252|P3|NOT COMPLETED|Overall Study||2
2301919|NCT02008565|5651253|P2|NOT COMPLETED|Overall Study||1
2301920|NCT02008565|5651254|P1|NOT COMPLETED|Overall Study||1
2301921|NCT02008565|5651251|P4|COMPLETED|Overall Study||42
2301922|NCT02008565|5651252|P3|COMPLETED|Overall Study||86
2301923|NCT02008565|5651253|P2|COMPLETED|Overall Study||83
2301924|NCT02008565|5651254|P1|COMPLETED|Overall Study||85
2301925|NCT02008565|5651251|P4|STARTED|Overall Study||42
2301926|NCT02008565|5651252|P3|STARTED|Overall Study||88
2301927|NCT02008565|5651253|P2|STARTED|Overall Study||84
2301928|NCT02008565|5651254|P1|STARTED|Overall Study||86
2301929|NCT02008526|5651315|P3|NOT COMPLETED|Overall Study||9
2301930|NCT02008526|5651316|P2|NOT COMPLETED|Overall Study||14
2301931|NCT02008526|5651317|P1|NOT COMPLETED|Overall Study||8
2301932|NCT02008526|5651315|P3|COMPLETED|Overall Study||84
2301933|NCT02008526|5651316|P2|COMPLETED|Overall Study||85
2301934|NCT02008526|5651317|P1|COMPLETED|Overall Study||86
2301935|NCT02008526|5651315|P3|STARTED|Overall Study||93
2301936|NCT02008526|5651316|P2|STARTED|Overall Study||99
2301937|NCT02008526|5651317|P1|STARTED|Overall Study||94
2301938|NCT02008370|5651328|P1|NOT COMPLETED|Overall Study||7
2301939|NCT02008370|5651328|P1|COMPLETED|Overall Study||0
2301940|NCT02008370|5651328|P1|STARTED|Overall Study||7
2301941|NCT02008318|5651336|P2|NOT COMPLETED|Overall Study||1
2301942|NCT02008318|5651337|P1|NOT COMPLETED|Overall Study||12
2301943|NCT02008318|5651336|P2|COMPLETED|Overall Study||1
2301944|NCT02008318|5651337|P1|COMPLETED|Overall Study||29
2301945|NCT02008318|5651336|P2|Received At Least 1 Dose of Study Drug|Overall Study||2
2301946|NCT02008318|5651337|P1|Received At Least 1 Dose of Study Drug|Overall Study||41
2301947|NCT02008318|5651336|P2|STARTED|Overall Study||2
2301948|NCT02008318|5651337|P1|STARTED|Overall Study||41
2301949|NCT02008227|5651358|P2|NOT COMPLETED|Overall Study||613
2301950|NCT02008227|5651359|P1|NOT COMPLETED|Overall Study||612
2301951|NCT02008227|5651358|P2|COMPLETED|Overall Study||0
2301952|NCT02008227|5651359|P1|COMPLETED|Overall Study||0
2301953|NCT02008227|5651358|P2|Treated|Overall Study||608
2301954|NCT02008227|5651359|P1|Treated|Overall Study||579
2301955|NCT02008227|5651358|P2|STARTED|Overall Study||613
2301956|NCT02008227|5651359|P1|STARTED|Overall Study||612
2301957|NCT02008149|5651437|P3|NOT COMPLETED|Overall Study||0
2301958|NCT02008149|5651438|P2|NOT COMPLETED|Overall Study||1
2301959|NCT02008149|5651439|P1|NOT COMPLETED|Overall Study||3
2301960|NCT02008149|5651437|P3|COMPLETED|Overall Study||1
2301961|NCT02008149|5651438|P2|COMPLETED|Overall Study||0
2301962|NCT02008149|5651439|P1|COMPLETED|Overall Study||4
2301963|NCT02008149|5651437|P3|STARTED|Overall Study||1
2301964|NCT02008149|5651438|P2|STARTED|Overall Study||1
2301965|NCT02008149|5651439|P1|STARTED|Overall Study||7
2301966|NCT02007954|5651447|P1|NOT COMPLETED|Overall Study||7
2301967|NCT02007954|5651447|P1|COMPLETED|Overall Study||17
2301968|NCT02007954|5651447|P1|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to first imaging follow-up due to unrelated serious adverse event and death|23
2301969|NCT02007954|5651447|P1|Completed First TACE|Overall Study||24
2301970|NCT02007954|5651447|P1|STARTED|Overall Study|A total of 32 participants were consented, with 8 patients screened out prior to treatment.|24
2301971|NCT02007863|5651460|P1|NOT COMPLETED|Overall Study||0
2301972|NCT02007863|5651460|P1|COMPLETED|Overall Study||2
2301973|NCT02007863|5651460|P1|STARTED|Overall Study||2
2301974|NCT02007720|5651466|P2|NOT COMPLETED|Overall Study||72
2301975|NCT02007720|5651467|P1|NOT COMPLETED|Overall Study||82
2301976|NCT02007720|5651466|P2|COMPLETED|Overall Study||368
2301977|NCT02007720|5651467|P1|COMPLETED|Overall Study||354
2301978|NCT02007720|5651466|P2|Safety Set|Overall Study||432
2301979|NCT02007720|5651467|P1|Safety Set|Overall Study||426
2301980|NCT02007720|5651466|P2|Full Analysis Set|Overall Study||437
2301981|NCT02007720|5651467|P1|Full Analysis Set|Overall Study||433
2301982|NCT02007720|5651466|P2|STARTED|Overall Study||440
2301983|NCT02007720|5651467|P1|STARTED|Overall Study||436
2301984|NCT02007577|5651502|P2|NOT COMPLETED|Overall Study||1
2301985|NCT02007577|5651503|P1|NOT COMPLETED|Overall Study||1
2301986|NCT02007577|5651502|P2|COMPLETED|Overall Study||13
2301987|NCT02007577|5651503|P1|COMPLETED|Overall Study||26
2301988|NCT02007577|5651502|P2|STARTED|Overall Study||14
2301989|NCT02007577|5651503|P1|STARTED|Overall Study||27
2301990|NCT02007512|5651515|P4|NOT COMPLETED|Open Label Treatment Period||12
2301991|NCT02007512|5651516|P3|NOT COMPLETED|Open Label Treatment Period||0
2301992|NCT02007512|5651517|P2|NOT COMPLETED|Open Label Treatment Period||21
2301993|NCT02007512|5651518|P1|NOT COMPLETED|Open Label Treatment Period||0
2301994|NCT02007512|5651515|P4|COMPLETED|Open Label Treatment Period||0
2301995|NCT02007512|5651516|P3|COMPLETED|Open Label Treatment Period||0
2301996|NCT02007512|5651517|P2|COMPLETED|Open Label Treatment Period||0
2301997|NCT02007512|5651518|P1|COMPLETED|Open Label Treatment Period||0
2301998|NCT02007512|5651515|P4|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 12 entered open label period.|12
2301999|NCT02007512|5651516|P3|STARTED|Open Label Treatment Period||0
2302000|NCT02007512|5651517|P2|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 21 entered open label period.|21
2302001|NCT02007512|5651518|P1|STARTED|Open Label Treatment Period||0
2302002|NCT02007512|5651515|P4|NOT COMPLETED|Double Blind Treatment Period||60
2302003|NCT02007512|5651516|P3|NOT COMPLETED|Double Blind Treatment Period||60
2302004|NCT02007512|5651517|P2|NOT COMPLETED|Double Blind Treatment Period||64
2302005|NCT02007512|5651518|P1|NOT COMPLETED|Double Blind Treatment Period||63
2302006|NCT02007512|5651515|P4|COMPLETED|Double Blind Treatment Period||0
2302007|NCT02007512|5651516|P3|COMPLETED|Double Blind Treatment Period||0
2302008|NCT02007512|5651517|P2|COMPLETED|Double Blind Treatment Period||0
2302009|NCT02007512|5651518|P1|COMPLETED|Double Blind Treatment Period||0
2302010|NCT02007512|5651515|P4|Treated|Double Blind Treatment Period||60
2302011|NCT02007512|5651516|P3|Treated|Double Blind Treatment Period||60
2302012|NCT02007512|5651517|P2|Treated|Double Blind Treatment Period||63
2302013|NCT02007512|5651518|P1|Treated|Double Blind Treatment Period||62
2302014|NCT02007512|5651515|P4|STARTED|Double Blind Treatment Period||60
2302015|NCT02007512|5651516|P3|STARTED|Double Blind Treatment Period||60
2302016|NCT02007512|5651517|P2|STARTED|Double Blind Treatment Period||64
2302017|NCT02007512|5651518|P1|STARTED|Double Blind Treatment Period||63
2302018|NCT02007434|5651596|P8|NOT COMPLETED|Overall Study||0
2302019|NCT02007434|5651597|P7|NOT COMPLETED|Overall Study||0
2302020|NCT02007434|5651598|P6|NOT COMPLETED|Overall Study||0
2302021|NCT02007434|5651599|P5|NOT COMPLETED|Overall Study||0
2302022|NCT02007434|5651600|P4|NOT COMPLETED|Overall Study||0
2302023|NCT02007434|5651601|P3|NOT COMPLETED|Overall Study||1
2302024|NCT02007434|5651602|P2|NOT COMPLETED|Overall Study||1
2302025|NCT02007434|5651603|P1|NOT COMPLETED|Overall Study||1
2302026|NCT02007434|5651596|P8|COMPLETED|Overall Study||4
2302027|NCT02007434|5651597|P7|COMPLETED|Overall Study||18
2302028|NCT02007434|5651598|P6|COMPLETED|Overall Study||4
2302029|NCT02007434|5651599|P5|COMPLETED|Overall Study||16
2302030|NCT02007434|5651600|P4|COMPLETED|Overall Study||4
2302031|NCT02007434|5651601|P3|COMPLETED|Overall Study||16
2302032|NCT02007434|5651602|P2|COMPLETED|Overall Study||3
2302033|NCT02007434|5651603|P1|COMPLETED|Overall Study||16
2302034|NCT02007434|5651596|P8|Received Treatment|Overall Study||4
2302035|NCT02007434|5651597|P7|Received Treatment|Overall Study||18
2302036|NCT02007434|5651598|P6|Received Treatment|Overall Study||4
2302037|NCT02007434|5651599|P5|Received Treatment|Overall Study||16
2302038|NCT02007434|5651600|P4|Received Treatment|Overall Study||4
2302039|NCT02007434|5651601|P3|Received Treatment|Overall Study||17
2302040|NCT02007434|5651602|P2|Received Treatment|Overall Study||3
2302041|NCT02007434|5651603|P1|Received Treatment|Overall Study||17
2302042|NCT02007434|5651596|P8|STARTED|Overall Study||4
2302043|NCT02007434|5651597|P7|STARTED|Overall Study||18
2302044|NCT02007434|5651598|P6|STARTED|Overall Study||4
2302045|NCT02007434|5651599|P5|STARTED|Overall Study||16
2302046|NCT02007434|5651600|P4|STARTED|Overall Study||4
2302047|NCT02007434|5651601|P3|STARTED|Overall Study||17
2302048|NCT02007434|5651602|P2|STARTED|Overall Study||4
2302049|NCT02007434|5651603|P1|STARTED|Overall Study||17
2302050|NCT02007369|5651704|P3|NOT COMPLETED|Overall Study||0
2302051|NCT02007369|5651705|P2|NOT COMPLETED|Overall Study||0
2302052|NCT02007369|5651706|P1|NOT COMPLETED|Overall Study||0
2302053|NCT02007369|5651704|P3|COMPLETED|Overall Study||54
2302054|NCT02007369|5651705|P2|COMPLETED|Overall Study||40
2302055|NCT02007369|5651706|P1|COMPLETED|Overall Study||42
2302056|NCT02007369|5651704|P3|STARTED|Overall Study||54
2302057|NCT02007369|5651705|P2|STARTED|Overall Study||40
2302058|NCT02007369|5651706|P1|STARTED|Overall Study||42
2302059|NCT02007291|5651723|P2|NOT COMPLETED|Overall Study||0
2302060|NCT02007291|5651724|P1|NOT COMPLETED|Overall Study||0
2302061|NCT02007291|5651723|P2|COMPLETED|Overall Study||23
2302062|NCT02007291|5651724|P1|COMPLETED|Overall Study||48
2302063|NCT02007291|5651723|P2|STARTED|Overall Study||23
2302064|NCT02007291|5651724|P1|STARTED|Overall Study||48
2302065|NCT02007278|5651734|P2|NOT COMPLETED|Overall Study||3
2302066|NCT02007278|5651735|P1|NOT COMPLETED|Overall Study||2
2302067|NCT02007278|5651734|P2|COMPLETED|Overall Study||17
2302068|NCT02007278|5651735|P1|COMPLETED|Overall Study||18
2302069|NCT02007278|5651734|P2|STARTED|Overall Study||20
2302070|NCT02007278|5651735|P1|STARTED|Overall Study||20
2302071|NCT02007252|5651757|P2|NOT COMPLETED|Overall Study||11
2302072|NCT02007252|5651758|P1|NOT COMPLETED|Overall Study||11
2302073|NCT02007252|5651757|P2|COMPLETED|Overall Study||22
2302074|NCT02007252|5651758|P1|COMPLETED|Overall Study||20
2302075|NCT02007252|5651757|P2|Pharmacodynamic Analysis Set|Overall Study||33
2302076|NCT02007252|5651758|P1|Pharmacodynamic Analysis Set|Overall Study||31
2302077|NCT02007252|5651757|P2|Safety Analysis Set|Overall Study||33
2302078|NCT02007252|5651758|P1|Safety Analysis Set|Overall Study||31
2302079|NCT02007252|5651757|P2|STARTED|Overall Study||33
2302080|NCT02007252|5651758|P1|STARTED|Overall Study||31
2302081|NCT02007200|5651764|P1|NOT COMPLETED|Overall Study||0
2302082|NCT02007200|5651764|P1|COMPLETED|Overall Study||55
2302083|NCT02007200|5651764|P1|STARTED|Overall Study||55
2302084|NCT02007096|5651773|P2|NOT COMPLETED|Overall Study||16
2302085|NCT02007096|5651774|P1|NOT COMPLETED|Overall Study||11
2302086|NCT02007096|5651773|P2|COMPLETED|Overall Study||48
2302087|NCT02007096|5651774|P1|COMPLETED|Overall Study||52
2302088|NCT02007096|5651773|P2|STARTED|Overall Study||64
2302089|NCT02007096|5651774|P1|STARTED|Overall Study||63
2302090|NCT02007070|5651786|P1|NOT COMPLETED|Overall Study||33
2302091|NCT02007070|5651786|P1|COMPLETED|Overall Study|Completed 2 years of treatment.|5
2302092|NCT02007070|5651786|P1|STARTED|Overall Study||38
2302093|NCT02006979|5651807|P2|NOT COMPLETED|Overall Study||2
2302094|NCT02006979|5651808|P1|NOT COMPLETED|Overall Study||1
2302095|NCT02006979|5651807|P2|COMPLETED|Overall Study||11
2302096|NCT02006979|5651808|P1|COMPLETED|Overall Study||13
2302097|NCT02006979|5651807|P2|STARTED|Overall Study||13
2302098|NCT02006979|5651808|P1|STARTED|Overall Study||14
2302099|NCT02006888|5651823|P3|NOT COMPLETED|Overall Study||22
2302100|NCT02006888|5651824|P2|NOT COMPLETED|Overall Study||34
2302101|NCT02006888|5651825|P1|NOT COMPLETED|Overall Study||36
2302102|NCT02006888|5651823|P3|COMPLETED|Overall Study||58
2302103|NCT02006888|5651824|P2|COMPLETED|Overall Study||122
2302104|NCT02006888|5651825|P1|COMPLETED|Overall Study||122
2302105|NCT02006888|5651823|P3|STARTED|Overall Study||80
2302106|NCT02006888|5651824|P2|STARTED|Overall Study||156
2302107|NCT02006888|5651825|P1|STARTED|Overall Study||158
2302108|NCT02006836|5651836|P3|NOT COMPLETED|Self-control Period: Month 7-month 12||0
2302109|NCT02006836|5651837|P2|NOT COMPLETED|Self-control Period: Month 7-month 12||0
2302110|NCT02006836|5651838|P1|NOT COMPLETED|Self-control Period: Month 7-month 12||0
2302111|NCT02006836|5651836|P3|COMPLETED|Self-control Period: Month 7-month 12||19
2302112|NCT02006836|5651837|P2|COMPLETED|Self-control Period: Month 7-month 12||0
2302113|NCT02006836|5651838|P1|COMPLETED|Self-control Period: Month 7-month 12||0
2302114|NCT02006836|5651836|P3|STARTED|Self-control Period: Month 7-month 12||19
2302115|NCT02006836|5651837|P2|STARTED|Self-control Period: Month 7-month 12||0
2302116|NCT02006836|5651838|P1|STARTED|Self-control Period: Month 7-month 12||0
2302117|NCT02006836|5651836|P3|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
2302118|NCT02006836|5651837|P2|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
2302119|NCT02006836|5651838|P1|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
2302120|NCT02006836|5651836|P3|COMPLETED|Case-control Period: Month 1- Month 6||0
2302121|NCT02006836|5651837|P2|COMPLETED|Case-control Period: Month 1- Month 6||20
2302122|NCT02006836|5651838|P1|COMPLETED|Case-control Period: Month 1- Month 6||20
2302123|NCT02006836|5651836|P3|STARTED|Case-control Period: Month 1- Month 6||0
2302124|NCT02006836|5651837|P2|STARTED|Case-control Period: Month 1- Month 6||20
2302125|NCT02006836|5651838|P1|STARTED|Case-control Period: Month 1- Month 6||20
2302126|NCT02006758|5651854|P1|NOT COMPLETED|Overall Study||13
2302127|NCT02006758|5651854|P1|COMPLETED|Overall Study||55
2302128|NCT02006758|5651854|P1|12-month Follow up|Overall Study|12-month follow up completed|55
2302129|NCT02006758|5651854|P1|6-month Follow up|Overall Study|6-month follow up completed|60
2302130|NCT02006758|5651854|P1|1-month Follow up|Overall Study|1-month follow up completed|66
2302131|NCT02006758|5651854|P1|Underwent Renal Denervation|Overall Study|Underwent renal denervation|67
2302132|NCT02006758|5651854|P1|STARTED|Overall Study|Total number of enrolled participants|68
2302133|NCT02006732|5651885|P4|NOT COMPLETED|Overall Study||4
2302134|NCT02006732|5651886|P3|NOT COMPLETED|Overall Study||9
2302135|NCT02006732|5651887|P2|NOT COMPLETED|Overall Study||12
2302136|NCT02006732|5651888|P1|NOT COMPLETED|Overall Study||20
2302137|NCT02006732|5651885|P4|COMPLETED|Overall Study||198
2302138|NCT02006732|5651886|P3|COMPLETED|Overall Study||193
2302139|NCT02006732|5651887|P2|COMPLETED|Overall Study||191
2302140|NCT02006732|5651888|P1|COMPLETED|Overall Study||182
2302141|NCT02006732|5651885|P4|STARTED|Overall Study||202
2302142|NCT02006732|5651886|P3|STARTED|Overall Study||202
2302143|NCT02006732|5651887|P2|STARTED|Overall Study||203
2302144|NCT02006732|5651888|P1|STARTED|Overall Study||202
2302145|NCT02006719|5651928|P2|NOT COMPLETED|Overall Study||5
2302146|NCT02006719|5651929|P1|NOT COMPLETED|Overall Study||18
2302147|NCT02006719|5651928|P2|COMPLETED|Overall Study||80
2302148|NCT02006719|5651929|P1|COMPLETED|Overall Study||219
2302149|NCT02006719|5651928|P2|STARTED|Overall Study||85
2302150|NCT02006719|5651929|P1|STARTED|Overall Study||237
2302151|NCT02006706|5651959|P1|NOT COMPLETED|Overall Study||1
2302152|NCT02006706|5651959|P1|COMPLETED|Overall Study||14
2302153|NCT02006706|5651959|P1|STARTED|Overall Study||15
2302154|NCT02006693|5651966|P2|NOT COMPLETED|Overall Study||13
2302155|NCT02006693|5651967|P1|NOT COMPLETED|Overall Study||28
2302156|NCT02006693|5651966|P2|COMPLETED|Overall Study||74
2302157|NCT02006693|5651967|P1|COMPLETED|Overall Study||84
2302158|NCT02006693|5651966|P2|STARTED|Overall Study||87
2302159|NCT02006693|5651967|P1|STARTED|Overall Study||112
2302160|NCT02006667|5651979|P1|NOT COMPLETED|Overall Study||6
2302161|NCT02006667|5651979|P1|COMPLETED|Overall Study||7
2302162|NCT02006667|5651979|P1|STARTED|Overall Study||13
2302163|NCT02006654|5651991|P2|NOT COMPLETED|Overall Study||44
2302164|NCT02006654|5651992|P1|NOT COMPLETED|Overall Study||45
2302165|NCT02006654|5651991|P2|COMPLETED|Overall Study||321
2302166|NCT02006654|5651992|P1|COMPLETED|Overall Study||324
2302167|NCT02006654|5651991|P2|Treated|Overall Study||363
2302168|NCT02006654|5651992|P1|Treated|Overall Study||365
2302169|NCT02006654|5651991|P2|STARTED|Overall Study||365
2302170|NCT02006654|5651992|P1|STARTED|Overall Study||369
2302171|NCT02006641|5652021|P3|NOT COMPLETED|Overall Study||36
2302172|NCT02006641|5652022|P2|NOT COMPLETED|Overall Study||33
2302173|NCT02006641|5652023|P1|NOT COMPLETED|Overall Study||26
2302174|NCT02006641|5652021|P3|COMPLETED|Overall Study||248
2302175|NCT02006641|5652022|P2|COMPLETED|Overall Study||257
2302176|NCT02006641|5652023|P1|COMPLETED|Overall Study||258
2302177|NCT02006641|5652021|P3|Treated|Overall Study||281
2302178|NCT02006641|5652022|P2|Treated|Overall Study||285
2302179|NCT02006641|5652023|P1|Treated|Overall Study||282
2302180|NCT02006641|5652021|P3|STARTED|Overall Study||284
2302181|NCT02006641|5652022|P2|STARTED|Overall Study||290
2302182|NCT02006641|5652023|P1|STARTED|Overall Study||284
2302183|NCT02006628|5652063|P2|NOT COMPLETED|Overall Study||2
2302184|NCT02006628|5652064|P1|NOT COMPLETED|Overall Study||3
2302185|NCT02006628|5652063|P2|COMPLETED|Overall Study||43
2302186|NCT02006628|5652064|P1|COMPLETED|Overall Study||40
2302187|NCT02006628|5652063|P2|Intention to Treat (ITT) Analysis Set|Overall Study||44
2302188|NCT02006628|5652064|P1|Intention to Treat (ITT) Analysis Set|Overall Study||42
2302189|NCT02006628|5652063|P2|Received at Least 1 Dose of Study Drug|Overall Study||45
2302190|NCT02006628|5652064|P1|Received at Least 1 Dose of Study Drug|Overall Study||43
2302191|NCT02006628|5652063|P2|STARTED|Overall Study||45
2302192|NCT02006628|5652064|P1|STARTED|Overall Study||43
2302193|NCT02006576|5652089|P3|NOT COMPLETED|Overall Study||17
2302194|NCT02006576|5652090|P2|NOT COMPLETED|Overall Study||7
2302195|NCT02006576|5652091|P1|NOT COMPLETED|Overall Study||18
2302196|NCT02006576|5652089|P3|COMPLETED|Overall Study||15
2302197|NCT02006576|5652090|P2|COMPLETED|Overall Study||44
2302198|NCT02006576|5652091|P1|COMPLETED|Overall Study||17
2302199|NCT02006576|5652089|P3|STARTED|Overall Study||32
2302200|NCT02006576|5652090|P2|STARTED|Overall Study||51
2302201|NCT02006576|5652091|P1|STARTED|Overall Study||35
2302202|NCT02006420|5652104|P2|NOT COMPLETED|Overall Study||0
2302203|NCT02006420|5652105|P1|NOT COMPLETED|Overall Study||0
2302204|NCT02006420|5652104|P2|COMPLETED|Overall Study||21
2302205|NCT02006420|5652105|P1|COMPLETED|Overall Study||24
2302206|NCT02006420|5652104|P2|STARTED|Overall Study||21
2302207|NCT02006420|5652105|P1|STARTED|Overall Study||24
2302208|NCT02006407|5652119|P1|NOT COMPLETED|Overall Study||0
2302209|NCT02006407|5652119|P1|COMPLETED|Overall Study||5
2302210|NCT02006407|5652119|P1|STARTED|Overall Study||5
2302211|NCT02006342|5652127|P2|NOT COMPLETED|Overall Study||0
2302212|NCT02006342|5652128|P1|NOT COMPLETED|Overall Study||1
2302213|NCT02006342|5652127|P2|COMPLETED|Overall Study||20
2302214|NCT02006342|5652128|P1|COMPLETED|Overall Study||19
2302215|NCT02006342|5652127|P2|STARTED|Overall Study||20
2302216|NCT02006342|5652128|P1|STARTED|Overall Study||20
2302217|NCT02006264|5652144|P2|NOT COMPLETED|Overall Study||0
2302218|NCT02006264|5652145|P1|NOT COMPLETED|Overall Study||1
2302219|NCT02006264|5652144|P2|COMPLETED|Overall Study||15
2302220|NCT02006264|5652145|P1|COMPLETED|Overall Study||14
2302221|NCT02006264|5652144|P2|STARTED|Overall Study||15
2302222|NCT02006264|5652145|P1|STARTED|Overall Study||15
2302223|NCT02006160|5652165|P2|NOT COMPLETED|Overall Study||0
2302224|NCT02006160|5652166|P1|NOT COMPLETED|Overall Study||4
2302225|NCT02006160|5652165|P2|COMPLETED|Overall Study||16
2302226|NCT02006160|5652166|P1|COMPLETED|Overall Study||41
2302227|NCT02006160|5652165|P2|STARTED|Overall Study||16
2302228|NCT02006160|5652166|P1|STARTED|Overall Study||45
2302229|NCT02006121|5652174|P2|NOT COMPLETED|Open Label Phase||0
2302230|NCT02006121|5652175|P1|NOT COMPLETED|Open Label Phase||25
2302231|NCT02006121|5652174|P2|COMPLETED|Open Label Phase||0
2302232|NCT02006121|5652175|P1|COMPLETED|Open Label Phase|30 who continued on apomorphine from blinded phase, 29 who switched to apomorphine from placebo|59
2302233|NCT02006121|5652174|P2|STARTED|Open Label Phase|No patients received placebo in the open label phase|0
2302234|NCT02006121|5652175|P1|STARTED|Open Label Phase|From Apo: 38 completers and 2 early switched; From Placebo: 28 completers and 16 early switched|84
2302235|NCT02006121|5652174|P2|NOT COMPLETED|Double Blind Phase||24
2302236|NCT02006121|5652175|P1|NOT COMPLETED|Double Blind Phase||12
2302237|NCT02006121|5652174|P2|COMPLETED|Double Blind Phase|16 placebo-treated patients early switched to open label phase due to lack of efficacy|29
2302238|NCT02006121|5652175|P1|COMPLETED|Double Blind Phase|Early switching to open label: 1 for lack of efficacy, 1 could not tolerate 3 mg/hour minimum rate|42
2302239|NCT02006121|5652174|P2|STARTED|Double Blind Phase||53
2302240|NCT02006121|5652175|P1|STARTED|Double Blind Phase||54
2302241|NCT02006108|5652189|P1|NOT COMPLETED|Overall Study||2
2302242|NCT02006108|5652189|P1|COMPLETED|Overall Study||19
2302243|NCT02006108|5652189|P1|MR Imaging|Overall Study||19
2302244|NCT02006108|5652189|P1|STARTED|Overall Study||21
2302245|NCT02006056|5652196|P2|NOT COMPLETED|Overall Study||0
2302246|NCT02006056|5652197|P1|NOT COMPLETED|Overall Study||0
2302247|NCT02006056|5652196|P2|COMPLETED|Overall Study||4
2302248|NCT02006056|5652197|P1|COMPLETED|Overall Study||26
2302249|NCT02006056|5652196|P2|STARTED|Overall Study||4
2302250|NCT02006056|5652197|P1|STARTED|Overall Study||26
2302251|NCT02005887|5652208|P2|NOT COMPLETED|Overall Study||2
2302252|NCT02005887|5652209|P1|NOT COMPLETED|Overall Study||0
2302253|NCT02005887|5652208|P2|COMPLETED|Overall Study||23
2302254|NCT02005887|5652209|P1|COMPLETED|Overall Study||26
2302255|NCT02005887|5652208|P2|STARTED|Overall Study||25
2302256|NCT02005887|5652209|P1|STARTED|Overall Study||26
2302257|NCT02005692|5652227|P1|NOT COMPLETED|Overall Study||7
2302258|NCT02005692|5652227|P1|COMPLETED|Overall Study||63
2302259|NCT02005692|5652227|P1|STARTED|Overall Study||70
2302260|NCT02005627|5652234|P2|NOT COMPLETED|Overall Study||4
2302261|NCT02005627|5652235|P1|NOT COMPLETED|Overall Study||2
2302262|NCT02005627|5652234|P2|COMPLETED|Overall Study||19
2302263|NCT02005627|5652235|P1|COMPLETED|Overall Study||21
2302264|NCT02005627|5652234|P2|STARTED|Overall Study||23
2302265|NCT02005627|5652235|P1|STARTED|Overall Study||23
2302266|NCT02005601|5652251|P2|NOT COMPLETED|Overall Study||0
2302267|NCT02005601|5652252|P1|NOT COMPLETED|Overall Study||0
2302268|NCT02005601|5652251|P2|COMPLETED|Overall Study||53
2302269|NCT02005601|5652252|P1|COMPLETED|Overall Study||53
2302270|NCT02005601|5652251|P2|STARTED|Overall Study||53
2302271|NCT02005601|5652252|P1|STARTED|Overall Study||53
2302272|NCT02005562|5652264|P2|NOT COMPLETED|Overall Study||15
2302273|NCT02005562|5652265|P1|NOT COMPLETED|Overall Study||12
2302274|NCT02005562|5652264|P2|COMPLETED|Overall Study||110
2302275|NCT02005562|5652265|P1|COMPLETED|Overall Study||115
2302276|NCT02005562|5652264|P2|Transplanted|Overall Study||121
2302277|NCT02005562|5652265|P1|Transplanted|Overall Study||126
2302278|NCT02005562|5652264|P2|STARTED|Overall Study||125
2302279|NCT02005562|5652265|P1|STARTED|Overall Study||127
2302280|NCT02005549|5652293|P1|NOT COMPLETED|Overall Study||0
2302281|NCT02005549|5652293|P1|COMPLETED|Overall Study||18
2302282|NCT02005549|5652293|P1|STARTED|Overall Study||18
2302283|NCT02005536|5652299|P1|NOT COMPLETED|Overall Study||0
2302284|NCT02005536|5652299|P1|COMPLETED|Overall Study||60
2302285|NCT02005536|5652299|P1|STARTED|Overall Study||60
2302286|NCT02005484|5652307|P1|NOT COMPLETED|Overall Study||4
2302287|NCT02005484|5652307|P1|COMPLETED|Overall Study||2
2302288|NCT02005484|5652307|P1|STARTED|Overall Study||6
2302297|NCT02005445|5652375|P2|NOT COMPLETED|Overall Study||1
2302298|NCT02005445|5652376|P1|NOT COMPLETED|Overall Study||0
2302299|NCT02005445|5652375|P2|COMPLETED|Overall Study||1
2302300|NCT02005445|5652376|P1|COMPLETED|Overall Study||2
2302301|NCT02005445|5652375|P2|STARTED|Overall Study||2
2302302|NCT02005445|5652376|P1|STARTED|Overall Study||2
2302303|NCT02005393|5652382|P1|NOT COMPLETED|Overall Study||0
2302304|NCT02005393|5652382|P1|COMPLETED|Overall Study||20
2302305|NCT02005393|5652382|P1|STARTED|Overall Study||20
2302306|NCT02005354|5652388|P2|NOT COMPLETED|Overall Study||0
2302307|NCT02005354|5652389|P1|NOT COMPLETED|Overall Study||0
2302308|NCT02005354|5652388|P2|COMPLETED|Overall Study||35
2302309|NCT02005354|5652389|P1|COMPLETED|Overall Study||35
2302310|NCT02005354|5652388|P2|STARTED|Overall Study||35
2302311|NCT02005354|5652389|P1|STARTED|Overall Study||35
2302312|NCT02005276|5652399|P4|NOT COMPLETED|Overall Study||3
2302313|NCT02005276|5652400|P3|NOT COMPLETED|Overall Study||3
2302314|NCT02005276|5652401|P2|NOT COMPLETED|Overall Study||2
2302315|NCT02005276|5652402|P1|NOT COMPLETED|Overall Study||5
2302316|NCT02005276|5652399|P4|COMPLETED|Overall Study||41
2302317|NCT02005276|5652400|P3|COMPLETED|Overall Study||56
2302318|NCT02005276|5652401|P2|COMPLETED|Overall Study||39
2302319|NCT02005276|5652402|P1|COMPLETED|Overall Study||60
2302320|NCT02005276|5652399|P4|Completed Intervention|Overall Study||42
2302321|NCT02005276|5652400|P3|Completed Intervention|Overall Study||56
2302322|NCT02005276|5652401|P2|Completed Intervention|Overall Study||39
2302323|NCT02005276|5652402|P1|Completed Intervention|Overall Study||61
2302324|NCT02005276|5652399|P4|STARTED|Overall Study||44
2302325|NCT02005276|5652400|P3|STARTED|Overall Study||59
2302326|NCT02005276|5652401|P2|STARTED|Overall Study||41
2302327|NCT02005276|5652402|P1|STARTED|Overall Study||65
2302328|NCT02005211|5652423|P7|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
2302329|NCT02005211|5652424|P6|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
2302330|NCT02005211|5652425|P5|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||1
2302331|NCT02005211|5652426|P4|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
2302332|NCT02005211|5652427|P3|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
2302333|NCT02005211|5652428|P2|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
2302334|NCT02005211|5652429|P1|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
2302335|NCT02005211|5652423|P7|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
2302336|NCT02005211|5652424|P6|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
2302337|NCT02005211|5652425|P5|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||5
2302338|NCT02005211|5652426|P4|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
2302339|NCT02005211|5652427|P3|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
2302340|NCT02005211|5652428|P2|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
2302341|NCT02005211|5652429|P1|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
2302342|NCT02005211|5652423|P7|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
2302343|NCT02005211|5652424|P6|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
2302344|NCT02005211|5652425|P5|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
2302345|NCT02005211|5652426|P4|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
2302346|NCT02005211|5652427|P3|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
2302347|NCT02005211|5652428|P2|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
2302348|NCT02005211|5652429|P1|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
2302349|NCT02005211|5652423|P7|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
2302350|NCT02005211|5652424|P6|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
2302351|NCT02005211|5652425|P5|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
2302352|NCT02005211|5652426|P4|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
2302353|NCT02005211|5652427|P3|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
2302354|NCT02005211|5652428|P2|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
2302355|NCT02005211|5652429|P1|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
2302356|NCT02005211|5652423|P7|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
2302357|NCT02005211|5652424|P6|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
2302358|NCT02005211|5652425|P5|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
2302359|NCT02005211|5652426|P4|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
2302360|NCT02005211|5652427|P3|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
2302361|NCT02005211|5652428|P2|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
2302362|NCT02005211|5652429|P1|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
2302363|NCT02005211|5652423|P7|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
2302364|NCT02005211|5652424|P6|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
2302365|NCT02005211|5652425|P5|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
2302366|NCT02005211|5652426|P4|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
2302367|NCT02005211|5652427|P3|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
2302368|NCT02005211|5652428|P2|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
2302369|NCT02005211|5652429|P1|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
2302370|NCT02005029|5652464|P2|NOT COMPLETED|Second Intervention (1 Day)||0
2302371|NCT02005029|5652465|P1|NOT COMPLETED|Second Intervention (1 Day)||0
2302372|NCT02005029|5652464|P2|COMPLETED|Second Intervention (1 Day)||5
2302373|NCT02005029|5652465|P1|COMPLETED|Second Intervention (1 Day)||4
2302374|NCT02005029|5652464|P2|STARTED|Second Intervention (1 Day)||5
2302375|NCT02005029|5652465|P1|STARTED|Second Intervention (1 Day)||4
2302376|NCT02005029|5652464|P2|NOT COMPLETED|Washout (2 Weeks)||0
2302377|NCT02005029|5652465|P1|NOT COMPLETED|Washout (2 Weeks)||0
2302378|NCT02005029|5652464|P2|COMPLETED|Washout (2 Weeks)||5
2302379|NCT02005029|5652465|P1|COMPLETED|Washout (2 Weeks)||4
2302380|NCT02005029|5652464|P2|STARTED|Washout (2 Weeks)||5
2302381|NCT02005029|5652465|P1|STARTED|Washout (2 Weeks)||4
2302382|NCT02005029|5652464|P2|NOT COMPLETED|First Intervention (1 Day)||0
2302383|NCT02005029|5652465|P1|NOT COMPLETED|First Intervention (1 Day)||1
2302384|NCT02005029|5652464|P2|COMPLETED|First Intervention (1 Day)||5
2302385|NCT02005029|5652465|P1|COMPLETED|First Intervention (1 Day)||4
2302386|NCT02005029|5652464|P2|STARTED|First Intervention (1 Day)||5
2302387|NCT02005029|5652465|P1|STARTED|First Intervention (1 Day)||5
2302388|NCT02005016|5652491|P1|NOT COMPLETED|Overall Study||2
2302389|NCT02005016|5652491|P1|COMPLETED|Overall Study||44
2302390|NCT02005016|5652491|P1|STARTED|Overall Study||46
2302391|NCT02004990|5652496|P1|NOT COMPLETED|Overall Study||0
2302392|NCT02004990|5652496|P1|COMPLETED|Overall Study||12
2302393|NCT02004990|5652496|P1|STARTED|Overall Study||12
2302394|NCT02004977|5652503|P2|NOT COMPLETED|Overall Study||5
2302395|NCT02004977|5652504|P1|NOT COMPLETED|Overall Study||54
2302396|NCT02004977|5652503|P2|COMPLETED|Overall Study||436
2302397|NCT02004977|5652504|P1|COMPLETED|Overall Study||409
2302398|NCT02004977|5652503|P2|STARTED|Overall Study||441
2302399|NCT02004977|5652504|P1|STARTED|Overall Study||463
2302400|NCT02004886|5652522|P4|NOT COMPLETED|Overall Study||0
2302401|NCT02004886|5652523|P3|NOT COMPLETED|Overall Study||0
2302402|NCT02004886|5652524|P2|NOT COMPLETED|Overall Study||1
2302403|NCT02004886|5652525|P1|NOT COMPLETED|Overall Study||1
2302404|NCT02004886|5652522|P4|COMPLETED|Overall Study||19
2302405|NCT02004886|5652523|P3|COMPLETED|Overall Study||18
2302406|NCT02004886|5652524|P2|COMPLETED|Overall Study||17
2302407|NCT02004886|5652525|P1|COMPLETED|Overall Study||18
2302408|NCT02004886|5652522|P4|STARTED|Overall Study||19
2302409|NCT02004886|5652523|P3|STARTED|Overall Study||18
2302410|NCT02004886|5652524|P2|STARTED|Overall Study||18
2302411|NCT02004886|5652525|P1|STARTED|Overall Study||19
2302412|NCT02004873|5652575|P1|NOT COMPLETED|Overall Study||424
2302413|NCT02004873|5652575|P1|COMPLETED|Overall Study|6-Month Follow-up|301
2302414|NCT02004873|5652575|P1|Micra Implant Success|Overall Study||719
2302415|NCT02004873|5652575|P1|STARTED|Overall Study|Micra Implant Attempt|725
2302416|NCT02004847|5652584|P2|NOT COMPLETED|Overall Study||1
2302417|NCT02004847|5652585|P1|NOT COMPLETED|Overall Study||1
2302418|NCT02004847|5652584|P2|COMPLETED|Overall Study||22
2302419|NCT02004847|5652585|P1|COMPLETED|Overall Study||23
2302420|NCT02004847|5652584|P2|STARTED|Overall Study||23
2302421|NCT02004847|5652585|P1|STARTED|Overall Study||24
2302422|NCT02004522|5652631|P2|NOT COMPLETED|Overall Study||159
2302423|NCT02004522|5652632|P1|NOT COMPLETED|Overall Study||126
2302424|NCT02004522|5652631|P2|COMPLETED|Overall Study|Completed defined here as still on treatment.|0
2302425|NCT02004522|5652632|P1|COMPLETED|Overall Study|Completed defined here as still on treatment.|34
2302426|NCT02004522|5652631|P2|Number of Subjects Treated|Overall Study||155
2302427|NCT02004522|5652632|P1|Number of Subjects Treated|Overall Study||158
2302428|NCT02004522|5652631|P2|STARTED|Overall Study||159
2302429|NCT02004522|5652632|P1|STARTED|Overall Study||160
2302430|NCT02004366|5652656|P5|NOT COMPLETED|On Discharge||0
2302431|NCT02004366|5652657|P4|NOT COMPLETED|On Discharge||0
2302432|NCT02004366|5652658|P3|NOT COMPLETED|On Discharge||0
2302433|NCT02004366|5652659|P2|NOT COMPLETED|On Discharge||0
2302434|NCT02004366|5652660|P1|NOT COMPLETED|On Discharge||0
2302435|NCT02004366|5652656|P5|COMPLETED|On Discharge||39
2302436|NCT02004366|5652657|P4|COMPLETED|On Discharge||93
2302437|NCT02004366|5652658|P3|COMPLETED|On Discharge||92
2302438|NCT02004366|5652659|P2|COMPLETED|On Discharge||0
2302439|NCT02004366|5652660|P1|COMPLETED|On Discharge||0
2302440|NCT02004366|5652656|P5|STARTED|On Discharge||39
2302441|NCT02004366|5652657|P4|STARTED|On Discharge||93
2302442|NCT02004366|5652658|P3|STARTED|On Discharge||92
2302443|NCT02004366|5652659|P2|STARTED|On Discharge||0
2302444|NCT02004366|5652660|P1|STARTED|On Discharge||0
2302445|NCT02004366|5652656|P5|NOT COMPLETED|In-hospital||0
2302446|NCT02004366|5652657|P4|NOT COMPLETED|In-hospital||0
2302447|NCT02004366|5652658|P3|NOT COMPLETED|In-hospital||0
2302448|NCT02004366|5652659|P2|NOT COMPLETED|In-hospital||0
2302449|NCT02004366|5652660|P1|NOT COMPLETED|In-hospital||0
2302450|NCT02004366|5652656|P5|COMPLETED|In-hospital||0
2302451|NCT02004366|5652657|P4|COMPLETED|In-hospital||0
2302452|NCT02004366|5652658|P3|COMPLETED|In-hospital||0
2302453|NCT02004366|5652659|P2|COMPLETED|In-hospital||122
2302454|NCT02004366|5652660|P1|COMPLETED|In-hospital||128
2302455|NCT02004366|5652656|P5|STARTED|In-hospital||0
2302456|NCT02004366|5652657|P4|STARTED|In-hospital||0
2302457|NCT02004366|5652658|P3|STARTED|In-hospital||0
2302458|NCT02004366|5652659|P2|STARTED|In-hospital||122
2302459|NCT02004366|5652660|P1|STARTED|In-hospital||128
2302460|NCT02004262|5652753|P6|NOT COMPLETED|Overall Study||30
2302461|NCT02004262|5652754|P5|NOT COMPLETED|Overall Study||31
2302462|NCT02004262|5652755|P4|NOT COMPLETED|Overall Study||29
2302463|NCT02004262|5652756|P3|NOT COMPLETED|Overall Study||72
2302464|NCT02004262|5652757|P2|NOT COMPLETED|Overall Study||68
2302465|NCT02004262|5652758|P1|NOT COMPLETED|Overall Study||73
2302466|NCT02004262|5652753|P6|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
2302467|NCT02004262|5652754|P5|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
2302468|NCT02004262|5652755|P4|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
2302469|NCT02004262|5652756|P3|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
2302470|NCT02004262|5652757|P2|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
2302471|NCT02004262|5652758|P1|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
2302472|NCT02004262|5652753|P6|Treated|Overall Study||11
2302473|NCT02004262|5652754|P5|Treated|Overall Study||29
2302474|NCT02004262|5652755|P4|Treated|Overall Study||26
2302475|NCT02004262|5652756|P3|Treated|Overall Study||43
2302476|NCT02004262|5652757|P2|Treated|Overall Study||58
2302477|NCT02004262|5652758|P1|Treated|Overall Study||68
2302478|NCT02004262|5652753|P6|STARTED|Overall Study||30
2302479|NCT02004262|5652754|P5|STARTED|Overall Study||31
2302480|NCT02004262|5652755|P4|STARTED|Overall Study||29
2302481|NCT02004262|5652756|P3|STARTED|Overall Study||72
2302482|NCT02004262|5652757|P2|STARTED|Overall Study||68
2302483|NCT02004262|5652758|P1|STARTED|Overall Study||73
2302484|NCT02004236|5652778|P3|NOT COMPLETED|Overall Study||16
2302485|NCT02004236|5652779|P2|NOT COMPLETED|Overall Study||0
2302486|NCT02004236|5652780|P1|NOT COMPLETED|Overall Study||0
2302487|NCT02004236|5652778|P3|COMPLETED|Overall Study|Leave the group because the parents does't find any clinical improvement.|59
2302488|NCT02004236|5652779|P2|COMPLETED|Overall Study||75
2302489|NCT02004236|5652780|P1|COMPLETED|Overall Study||75
2302490|NCT02004236|5652778|P3|STARTED|Overall Study||75
2302491|NCT02004236|5652779|P2|STARTED|Overall Study||75
2302492|NCT02004236|5652780|P1|STARTED|Overall Study||75
2302493|NCT02004158|5652824|P1|NOT COMPLETED|Overall Study||3
2302494|NCT02004158|5652824|P1|COMPLETED|Overall Study||20
2302495|NCT02004158|5652824|P1|STARTED|Overall Study||23
2302496|NCT02004132|5652832|P1|NOT COMPLETED|Overall Study||0
2302497|NCT02004132|5652832|P1|COMPLETED|Overall Study||12
2302498|NCT02004132|5652832|P1|Received Study Drug|Overall Study||12
2302499|NCT02004132|5652832|P1|STARTED|Overall Study||12
2302500|NCT02004093|5652840|P2|NOT COMPLETED|Overall Study||73
2302501|NCT02004093|5652841|P1|NOT COMPLETED|Overall Study||74
2302502|NCT02004093|5652840|P2|COMPLETED|Overall Study||1
2302503|NCT02004093|5652841|P1|COMPLETED|Overall Study||1
2302504|NCT02004093|5652840|P2|STARTED|Overall Study||74
2302505|NCT02004093|5652841|P1|STARTED|Overall Study|Includes 1 participant who was randomized to chemotherapy group but received pertuzumab+chemotherapy|75
2302506|NCT02003963|5652873|P2|NOT COMPLETED|Overall Study||1
2302507|NCT02003963|5652874|P1|NOT COMPLETED|Overall Study||2
2302508|NCT02003963|5652873|P2|COMPLETED|Overall Study|1 participant was removed from analysis for completing final visit outside of visit window.|18
2302509|NCT02003963|5652874|P1|COMPLETED|Overall Study|2 participants dropped out: 1 due to lack of interest and 1 due to a mental health hospitalization.|20
2302510|NCT02003963|5652873|P2|STARTED|Overall Study||19
2302511|NCT02003963|5652874|P1|STARTED|Overall Study||22
2302512|NCT02003924|5652896|P2|NOT COMPLETED|Overall Study||468
2302513|NCT02003924|5652897|P1|NOT COMPLETED|Overall Study||933
2302514|NCT02003924|5652896|P2|COMPLETED|Overall Study||0
2302515|NCT02003924|5652897|P1|COMPLETED|Overall Study||0
2302516|NCT02003924|5652896|P2|Treated|Overall Study||465
2302517|NCT02003924|5652897|P1|Treated|Overall Study||930
2302518|NCT02003924|5652896|P2|STARTED|Overall Study||468
2302519|NCT02003924|5652897|P1|STARTED|Overall Study||933
2302520|NCT02003898|5652995|P1|NOT COMPLETED|Overall Study||67
2302521|NCT02003898|5652995|P1|COMPLETED|Overall Study||305
2302522|NCT02003898|5652995|P1|STARTED|Overall Study||372
2302523|NCT02003638|5653004|P2|NOT COMPLETED|Overall Study||0
2302524|NCT02003638|5653005|P1|NOT COMPLETED|Overall Study||1
2302525|NCT02003638|5653004|P2|COMPLETED|Overall Study||3
2302526|NCT02003638|5653005|P1|COMPLETED|Overall Study|1 withdrew after developing bacterial pharyngitis. Not considered treatment-emergent.|5
2302527|NCT02003638|5653004|P2|STARTED|Overall Study||3
2302528|NCT02003638|5653005|P1|STARTED|Overall Study||6
2302529|NCT02003573|5653014|P3|NOT COMPLETED|Overall Study||6
2302530|NCT02003573|5653015|P2|NOT COMPLETED|Overall Study||4
2302531|NCT02003573|5653016|P1|NOT COMPLETED|Overall Study||3
2302532|NCT02003573|5653014|P3|COMPLETED|Overall Study||0
2302533|NCT02003573|5653015|P2|COMPLETED|Overall Study||0
2302534|NCT02003573|5653016|P1|COMPLETED|Overall Study||0
2302535|NCT02003573|5653014|P3|STARTED|Overall Study|Started are treated patients|6
2302536|NCT02003573|5653015|P2|STARTED|Overall Study|Started are treated patients|4
2302537|NCT02003573|5653016|P1|STARTED|Overall Study|Started are treated patients|3
2302538|NCT02003534|5653026|P1|NOT COMPLETED|Overall Study||47
2302539|NCT02003534|5653026|P1|COMPLETED|Overall Study||329
2302540|NCT02003534|5653026|P1|STARTED|Overall Study||376
2302541|NCT02003404|5653030|P1|NOT COMPLETED|Overall Study||0
2302542|NCT02003404|5653030|P1|COMPLETED|Overall Study||17
2302543|NCT02003404|5653030|P1|STARTED|Overall Study||17
2302544|NCT02003391|5653038|P2|NOT COMPLETED|Overall Study||2
2302545|NCT02003391|5653039|P1|NOT COMPLETED|Overall Study||3
2302546|NCT02003391|5653038|P2|COMPLETED|Overall Study||73
2302547|NCT02003391|5653039|P1|COMPLETED|Overall Study||78
2302548|NCT02003391|5653038|P2|Intent to Treat Population|Overall Study||73
2302549|NCT02003391|5653039|P1|Intent to Treat Population|Overall Study||78
2302550|NCT02003391|5653038|P2|Safety Population|Overall Study||75
2302551|NCT02003391|5653039|P1|Safety Population|Overall Study||81
2302552|NCT02003391|5653038|P2|STARTED|Overall Study||75
2302553|NCT02003391|5653039|P1|STARTED|Overall Study||81
2302554|NCT02003365|5653052|P3|NOT COMPLETED|Overall Study||1
2302555|NCT02003365|5653053|P2|NOT COMPLETED|Overall Study||0
2302556|NCT02003365|5653054|P1|NOT COMPLETED|Overall Study||0
2302557|NCT02003365|5653052|P3|COMPLETED|Overall Study||9
2302558|NCT02003365|5653053|P2|COMPLETED|Overall Study||30
2302559|NCT02003365|5653054|P1|COMPLETED|Overall Study||10
2302560|NCT02003365|5653052|P3|STARTED|Overall Study||10
2302561|NCT02003365|5653053|P2|STARTED|Overall Study||30
2302562|NCT02003365|5653054|P1|STARTED|Overall Study||10
2302563|NCT02003352|5653065|P1|NOT COMPLETED|Overall Study||0
2302564|NCT02003352|5653065|P1|COMPLETED|Overall Study||98
2302565|NCT02003352|5653065|P1|STARTED|Overall Study||98
2302566|NCT02003183|5653071|P2|NOT COMPLETED|Overall Study||2
2302567|NCT02003183|5653072|P1|NOT COMPLETED|Overall Study||0
2302568|NCT02003183|5653071|P2|COMPLETED|Overall Study||15
2302569|NCT02003183|5653072|P1|COMPLETED|Overall Study||7
2302570|NCT02003183|5653071|P2|STARTED|Overall Study||17
2302571|NCT02003183|5653072|P1|STARTED|Overall Study||7
2302572|NCT02003053|5653080|P2|NOT COMPLETED|Overall Study||0
2302573|NCT02003053|5653081|P1|NOT COMPLETED|Overall Study||0
2302574|NCT02003053|5653080|P2|COMPLETED|Overall Study||3
2302575|NCT02003053|5653081|P1|COMPLETED|Overall Study||4
2302576|NCT02003053|5653080|P2|STARTED|Overall Study||3
2302577|NCT02003053|5653081|P1|STARTED|Overall Study||4
2302578|NCT02003014|5653087|P1|NOT COMPLETED|Overall Study||19
2302579|NCT02003014|5653087|P1|COMPLETED|Overall Study||880
2302580|NCT02003014|5653087|P1|STARTED|Overall Study||899
2302581|NCT02002975|5653097|P1|NOT COMPLETED|Overall Study||572
2302582|NCT02002975|5653097|P1|COMPLETED|Overall Study||17651
2302583|NCT02002975|5653097|P1|STARTED|Overall Study||18223
2302584|NCT02002936|5653113|P1|NOT COMPLETED|Overall Study||0
2302585|NCT02002936|5653113|P1|COMPLETED|Overall Study||1
2302586|NCT02002936|5653113|P1|STARTED|Overall Study||1
2302587|NCT02002871|5653122|P1|NOT COMPLETED|Overall Study||1
2302588|NCT02002871|5653122|P1|COMPLETED|Overall Study||20
2302589|NCT02002871|5653122|P1|STARTED|Overall Study||21
2302590|NCT02002832|5653150|P2|NOT COMPLETED|Overall Study||26
2302591|NCT02002832|5653151|P1|NOT COMPLETED|Overall Study||28
2302592|NCT02002832|5653150|P2|COMPLETED|Overall Study||168
2302593|NCT02002832|5653151|P1|COMPLETED|Overall Study||166
2302594|NCT02002832|5653150|P2|STARTED|Overall Study||194
2302595|NCT02002832|5653151|P1|STARTED|Overall Study||194
2302596|NCT02002702|5653162|P3|NOT COMPLETED|Overall Study||0
2302597|NCT02002702|5653163|P2|NOT COMPLETED|Overall Study||0
2302598|NCT02002702|5653164|P1|NOT COMPLETED|Overall Study||0
2302599|NCT02002702|5653162|P3|COMPLETED|Overall Study||15
2302600|NCT02002702|5653163|P2|COMPLETED|Overall Study||15
2302601|NCT02002702|5653164|P1|COMPLETED|Overall Study||16
2302602|NCT02002702|5653162|P3|STARTED|Overall Study||15
2302603|NCT02002702|5653163|P2|STARTED|Overall Study||15
2302604|NCT02002702|5653164|P1|STARTED|Overall Study||16
2302605|NCT02002689|5653196|P1|NOT COMPLETED|Overall Study||10
2302606|NCT02002689|5653196|P1|COMPLETED|Overall Study||0
2302607|NCT02002689|5653196|P1|STARTED|Overall Study||10
2302608|NCT02002650|5653204|P2|NOT COMPLETED|Overall Study||0
2302609|NCT02002650|5653205|P1|NOT COMPLETED|Overall Study||0
2302610|NCT02002650|5653204|P2|COMPLETED|Overall Study||1303
2302611|NCT02002650|5653205|P1|COMPLETED|Overall Study||1297
2302612|NCT02002650|5653204|P2|STARTED|Overall Study||1303
2302613|NCT02002650|5653205|P1|STARTED|Overall Study||1297
2302614|NCT02002533|5653215|P2|NOT COMPLETED|Overall Study||18
2302615|NCT02002533|5653216|P1|NOT COMPLETED|Overall Study||6
2302616|NCT02002533|5653215|P2|COMPLETED|Overall Study||19
2302617|NCT02002533|5653216|P1|COMPLETED|Overall Study||28
2302618|NCT02002533|5653215|P2|STARTED|Overall Study||37
2302619|NCT02002533|5653216|P1|STARTED|Overall Study||34
2302620|NCT02002221|5653241|P2|NOT COMPLETED|Overall Study||3
2302621|NCT02002221|5653242|P1|NOT COMPLETED|Overall Study||2
2302622|NCT02002221|5653241|P2|COMPLETED|Overall Study||75
2302623|NCT02002221|5653242|P1|COMPLETED|Overall Study||76
2302624|NCT02002221|5653241|P2|STARTED|Overall Study||78
2302625|NCT02002221|5653242|P1|STARTED|Overall Study||78
2302626|NCT02002208|5653258|P2|NOT COMPLETED|Overall Study||40
2302627|NCT02002208|5653259|P1|NOT COMPLETED|Overall Study||37
2302628|NCT02002208|5653258|P2|COMPLETED|Overall Study||30
2302629|NCT02002208|5653259|P1|COMPLETED|Overall Study||32
2302630|NCT02002208|5653258|P2|STARTED|Overall Study||70
2302631|NCT02002208|5653259|P1|STARTED|Overall Study||69
2302632|NCT02002091|5653269|P2|NOT COMPLETED|One Year Follow up||0
2302633|NCT02002091|5653270|P1|NOT COMPLETED|One Year Follow up||0
2302634|NCT02002091|5653269|P2|COMPLETED|One Year Follow up||191
2302635|NCT02002091|5653270|P1|COMPLETED|One Year Follow up||109
2302636|NCT02002091|5653269|P2|STARTED|One Year Follow up||191
2302637|NCT02002091|5653270|P1|STARTED|One Year Follow up||109
2302638|NCT02002091|5653269|P2|NOT COMPLETED|Screening||14
2302639|NCT02002091|5653270|P1|NOT COMPLETED|Screening||13
2302640|NCT02002091|5653269|P2|COMPLETED|Screening||191
2302641|NCT02002091|5653270|P1|COMPLETED|Screening||109
2302642|NCT02002091|5653269|P2|STARTED|Screening||205
2302643|NCT02002091|5653270|P1|STARTED|Screening||122
2302644|NCT02001987|5653305|P1|NOT COMPLETED|LTE Period (52 Weeks)||9
2302645|NCT02001987|5653305|P1|COMPLETED|LTE Period (52 Weeks)||107
2302646|NCT02001987|5653305|P1|STARTED|LTE Period (52 Weeks)||116
2302647|NCT02001987|5653305|P1|NOT COMPLETED|Core Study Period (24 Weeks)||23
2302648|NCT02001987|5653305|P1|COMPLETED|Core Study Period (24 Weeks)||116
2302649|NCT02001987|5653305|P1|STARTED|Core Study Period (24 Weeks)||139
2302650|NCT02001714|5653381|P2|NOT COMPLETED|Overall Study||12
2302651|NCT02001714|5653382|P1|NOT COMPLETED|Overall Study||22
2302652|NCT02001714|5653381|P2|COMPLETED|Overall Study||219
2302653|NCT02001714|5653382|P1|COMPLETED|Overall Study||210
2302654|NCT02001714|5653381|P2|STARTED|Overall Study||231
2302655|NCT02001714|5653382|P1|STARTED|Overall Study||232
2302656|NCT02001688|5653391|P3|NOT COMPLETED|Overall Study||1
2302657|NCT02001688|5653392|P2|NOT COMPLETED|Overall Study||1
2302658|NCT02001688|5653393|P1|NOT COMPLETED|Overall Study||0
2302659|NCT02001688|5653391|P3|COMPLETED|Overall Study||11
2302660|NCT02001688|5653392|P2|COMPLETED|Overall Study||11
2302661|NCT02001688|5653393|P1|COMPLETED|Overall Study||12
2302662|NCT02001688|5653391|P3|STARTED|Overall Study||12
2302663|NCT02001688|5653392|P2|STARTED|Overall Study||12
2302664|NCT02001688|5653393|P1|STARTED|Overall Study||12
2302665|NCT02001558|5653412|P2|NOT COMPLETED|Overall Study||14
2302666|NCT02001558|5653413|P1|NOT COMPLETED|Overall Study||8
2302667|NCT02001558|5653412|P2|COMPLETED|Overall Study||19
2302668|NCT02001558|5653413|P1|COMPLETED|Overall Study||24
2302669|NCT02001558|5653412|P2|STARTED|Overall Study||33
2302670|NCT02001558|5653413|P1|STARTED|Overall Study||32
2302671|NCT02001194|5653449|P4|NOT COMPLETED|Follow-Up Period (13 Weeks)||0
2302672|NCT02001194|5653450|P3|NOT COMPLETED|Follow-Up Period (13 Weeks)||1
2302673|NCT02001194|5653451|P2|NOT COMPLETED|Follow-Up Period (13 Weeks)||2
2302674|NCT02001194|5653452|P1|NOT COMPLETED|Follow-Up Period (13 Weeks)||3
2302675|NCT02001194|5653449|P4|COMPLETED|Follow-Up Period (13 Weeks)||78
2302676|NCT02001194|5653450|P3|COMPLETED|Follow-Up Period (13 Weeks)||73
2302677|NCT02001194|5653451|P2|COMPLETED|Follow-Up Period (13 Weeks)||78
2302678|NCT02001194|5653452|P1|COMPLETED|Follow-Up Period (13 Weeks)||64
2302679|NCT02001194|5653449|P4|STARTED|Follow-Up Period (13 Weeks)||78
2302680|NCT02001194|5653450|P3|STARTED|Follow-Up Period (13 Weeks)||74
2302681|NCT02001194|5653451|P2|STARTED|Follow-Up Period (13 Weeks)||80
2302682|NCT02001194|5653452|P1|STARTED|Follow-Up Period (13 Weeks)||67
2302683|NCT02001194|5653449|P4|NOT COMPLETED|Intervention Period (13 Weeks)||2
2302684|NCT02001194|5653450|P3|NOT COMPLETED|Intervention Period (13 Weeks)||2
2302685|NCT02001194|5653451|P2|NOT COMPLETED|Intervention Period (13 Weeks)||0
2302686|NCT02001194|5653452|P1|NOT COMPLETED|Intervention Period (13 Weeks)||1
2302687|NCT02001194|5653449|P4|COMPLETED|Intervention Period (13 Weeks)|20 teams|78
2302688|NCT02001194|5653450|P3|COMPLETED|Intervention Period (13 Weeks)|19 teams|74
2302689|NCT02001194|5653451|P2|COMPLETED|Intervention Period (13 Weeks)|20 teams|80
2302690|NCT02001194|5653452|P1|COMPLETED|Intervention Period (13 Weeks)|16 teams|67
2302691|NCT02001194|5653449|P4|STARTED|Intervention Period (13 Weeks)|20 teams|80
2302692|NCT02001194|5653450|P3|STARTED|Intervention Period (13 Weeks)|19 teams|76
2302693|NCT02001194|5653451|P2|STARTED|Intervention Period (13 Weeks)|20 teams|80
2302694|NCT02001194|5653452|P1|STARTED|Intervention Period (13 Weeks)|17 teams|68
2302695|NCT02001181|5653468|P2|NOT COMPLETED|Overall Study||3
2302696|NCT02001181|5653469|P1|NOT COMPLETED|Overall Study||1
2302697|NCT02001181|5653468|P2|COMPLETED|Overall Study||31
2302698|NCT02001181|5653469|P1|COMPLETED|Overall Study||34
2302699|NCT02001181|5653468|P2|STARTED|Overall Study||34
2302700|NCT02001181|5653469|P1|STARTED|Overall Study||35
2302701|NCT02001051|5653485|P2|NOT COMPLETED|Overall Study||1
2302702|NCT02001051|5653486|P1|NOT COMPLETED|Overall Study||0
2302703|NCT02001051|5653485|P2|COMPLETED|Overall Study||1
2302704|NCT02001051|5653486|P1|COMPLETED|Overall Study||2
2302705|NCT02001051|5653485|P2|STARTED|Overall Study||2
2302706|NCT02001051|5653486|P1|STARTED|Overall Study||2
2302707|NCT02000973|5653510|P4|NOT COMPLETED|Overall Study||0
2302708|NCT02000973|5653511|P3|NOT COMPLETED|Overall Study||0
2302709|NCT02000973|5653512|P2|NOT COMPLETED|Overall Study||0
2302710|NCT02000973|5653513|P1|NOT COMPLETED|Overall Study||0
2302711|NCT02000973|5653510|P4|COMPLETED|Overall Study||20
2302712|NCT02000973|5653511|P3|COMPLETED|Overall Study||20
2302713|NCT02000973|5653512|P2|COMPLETED|Overall Study||20
2302714|NCT02000973|5653513|P1|COMPLETED|Overall Study||20
2302715|NCT02000973|5653510|P4|STARTED|Overall Study||20
2302716|NCT02000973|5653511|P3|STARTED|Overall Study||20
2302717|NCT02000973|5653512|P2|STARTED|Overall Study||20
2302718|NCT02000973|5653513|P1|STARTED|Overall Study||20
2302719|NCT02000921|5653538|P3|NOT COMPLETED|Overall Study||10
2302720|NCT02000921|5653539|P2|NOT COMPLETED|Overall Study||16
2302721|NCT02000921|5653540|P1|NOT COMPLETED|Overall Study||5
2302722|NCT02000921|5653538|P3|COMPLETED|Overall Study||46
2302723|NCT02000921|5653539|P2|COMPLETED|Overall Study||37
2302724|NCT02000921|5653540|P1|COMPLETED|Overall Study||22
2302725|NCT02000921|5653538|P3|STARTED|Overall Study||56
2302726|NCT02000921|5653539|P2|STARTED|Overall Study||53
2302727|NCT02000921|5653540|P1|STARTED|Overall Study||27
2302728|NCT02000908|5653559|P2|NOT COMPLETED|Overall Study||4
2302729|NCT02000908|5653560|P1|NOT COMPLETED|Overall Study||2
2302730|NCT02000908|5653559|P2|COMPLETED|Overall Study||36
2302731|NCT02000908|5653560|P1|COMPLETED|Overall Study||28
2302732|NCT02000908|5653559|P2|STARTED|Overall Study||40
2302733|NCT02000908|5653560|P1|STARTED|Overall Study||30
2302734|NCT02000817|5653570|P4|NOT COMPLETED|Overall Study||0
2302735|NCT02000817|5653571|P3|NOT COMPLETED|Overall Study||1
2302736|NCT02000817|5653572|P2|NOT COMPLETED|Overall Study||1
2302737|NCT02000817|5653573|P1|NOT COMPLETED|Overall Study||2
2302738|NCT02000817|5653570|P4|COMPLETED|Overall Study||7
2302739|NCT02000817|5653571|P3|COMPLETED|Overall Study||7
2302740|NCT02000817|5653572|P2|COMPLETED|Overall Study||8
2302741|NCT02000817|5653573|P1|COMPLETED|Overall Study||4
2302742|NCT02000817|5653570|P4|STARTED|Overall Study||7
2302743|NCT02000817|5653571|P3|STARTED|Overall Study||8
2302744|NCT02000817|5653572|P2|STARTED|Overall Study||9
2302745|NCT02000817|5653573|P1|STARTED|Overall Study||6
2302746|NCT02000752|5653668|P2|NOT COMPLETED|Overall Study||13
2302747|NCT02000752|5653669|P1|NOT COMPLETED|Overall Study||31
2302748|NCT02000752|5653668|P2|COMPLETED|Overall Study||47
2302749|NCT02000752|5653669|P1|COMPLETED|Overall Study||29
2302750|NCT02000752|5653668|P2|STARTED|Overall Study||60
2302751|NCT02000752|5653669|P1|STARTED|Overall Study||60
2302758|NCT02000531|5653706|P2|NOT COMPLETED|Overall Study||8
2302759|NCT02000531|5653707|P1|NOT COMPLETED|Overall Study||4
2302760|NCT02000531|5653706|P2|COMPLETED|Overall Study||16
2302761|NCT02000531|5653707|P1|COMPLETED|Overall Study||17
2302762|NCT02000531|5653706|P2|Safety Population|Overall Study||24
2302763|NCT02000531|5653707|P1|Safety Population|Overall Study||21
2302764|NCT02000531|5653706|P2|STARTED|Overall Study||24
2302765|NCT02000531|5653707|P1|STARTED|Overall Study||21
2302766|NCT02000440|5653715|P1|NOT COMPLETED|Overall Study||4
2302767|NCT02000440|5653715|P1|COMPLETED|Overall Study||13
2302768|NCT02000440|5653715|P1|STARTED|Overall Study||17
2302769|NCT02000427|5653735|P1|NOT COMPLETED|Overall Study||22
2302770|NCT02000427|5653735|P1|COMPLETED|Overall Study|Indicates participants ongoing in study as of the data cut-off date of 20 May 2015.|23
2302771|NCT02000427|5653735|P1|STARTED|Overall Study||45
2302772|NCT02000180|5653752|P2|NOT COMPLETED|Overall Study||0
2302773|NCT02000180|5653753|P1|NOT COMPLETED|Overall Study||0
2302774|NCT02000180|5653752|P2|COMPLETED|Overall Study||19
2302775|NCT02000180|5653753|P1|COMPLETED|Overall Study||18
2302776|NCT02000180|5653752|P2|STARTED|Overall Study||19
2302777|NCT02000180|5653753|P1|STARTED|Overall Study||18
2302778|NCT02000154|5653765|P1|NOT COMPLETED|Overall Study||0
2302779|NCT02000154|5653765|P1|COMPLETED|Overall Study||1
2302780|NCT02000154|5653765|P1|STARTED|Overall Study||1
2302781|NCT01999985|5653773|P3|NOT COMPLETED|Overall Study||0
2302782|NCT01999985|5653774|P2|NOT COMPLETED|Overall Study||0
2302783|NCT01999985|5653775|P1|NOT COMPLETED|Overall Study||0
2302784|NCT01999985|5653773|P3|COMPLETED|Overall Study||14
2302785|NCT01999985|5653774|P2|COMPLETED|Overall Study||3
2302786|NCT01999985|5653775|P1|COMPLETED|Overall Study||8
2302787|NCT01999985|5653773|P3|STARTED|Overall Study||14
2302788|NCT01999985|5653774|P2|STARTED|Overall Study||3
2302789|NCT01999985|5653775|P1|STARTED|Overall Study||8
2302790|NCT01999972|5653789|P6|NOT COMPLETED|Dose Expansion Part||7
2302791|NCT01999972|5653790|P5|NOT COMPLETED|Dose Expansion Part||21
2302792|NCT01999972|5653791|P4|NOT COMPLETED|Dose Expansion Part||0
2302793|NCT01999972|5653792|P3|NOT COMPLETED|Dose Expansion Part||0
2302794|NCT01999972|5653793|P2|NOT COMPLETED|Dose Expansion Part||0
2302795|NCT01999972|5653794|P1|NOT COMPLETED|Dose Expansion Part||0
2302796|NCT01999972|5653789|P6|COMPLETED|Dose Expansion Part||0
2302797|NCT01999972|5653790|P5|COMPLETED|Dose Expansion Part||0
2302798|NCT01999972|5653791|P4|COMPLETED|Dose Expansion Part||0
2302799|NCT01999972|5653792|P3|COMPLETED|Dose Expansion Part||0
2302800|NCT01999972|5653793|P2|COMPLETED|Dose Expansion Part||0
2302801|NCT01999972|5653794|P1|COMPLETED|Dose Expansion Part||0
2302802|NCT01999972|5653789|P6|Treated|Dose Expansion Part||7
2302803|NCT01999972|5653790|P5|Treated|Dose Expansion Part||21
2302804|NCT01999972|5653791|P4|Treated|Dose Expansion Part||0
2302805|NCT01999972|5653792|P3|Treated|Dose Expansion Part||0
2302806|NCT01999972|5653793|P2|Treated|Dose Expansion Part||0
2302807|NCT01999972|5653794|P1|Treated|Dose Expansion Part||0
2302808|NCT01999972|5653789|P6|STARTED|Dose Expansion Part||7
2302809|NCT01999972|5653790|P5|STARTED|Dose Expansion Part||21
2302810|NCT01999972|5653791|P4|STARTED|Dose Expansion Part||0
2302811|NCT01999972|5653792|P3|STARTED|Dose Expansion Part||0
2302812|NCT01999972|5653793|P2|STARTED|Dose Expansion Part||0
2302813|NCT01999972|5653794|P1|STARTED|Dose Expansion Part||0
2302814|NCT01999972|5653789|P6|NOT COMPLETED|Dose Escalation Part||0
2302815|NCT01999972|5653790|P5|NOT COMPLETED|Dose Escalation Part||0
2302816|NCT01999972|5653791|P4|NOT COMPLETED|Dose Escalation Part||11
2302817|NCT01999972|5653792|P3|NOT COMPLETED|Dose Escalation Part||5
2302818|NCT01999972|5653793|P2|NOT COMPLETED|Dose Escalation Part||3
2302819|NCT01999972|5653794|P1|NOT COMPLETED|Dose Escalation Part||5
2302820|NCT01999972|5653789|P6|COMPLETED|Dose Escalation Part||0
2302821|NCT01999972|5653790|P5|COMPLETED|Dose Escalation Part||0
2302822|NCT01999972|5653791|P4|COMPLETED|Dose Escalation Part||0
2302823|NCT01999972|5653792|P3|COMPLETED|Dose Escalation Part||0
2302824|NCT01999972|5653793|P2|COMPLETED|Dose Escalation Part||0
2302825|NCT01999972|5653794|P1|COMPLETED|Dose Escalation Part||0
2302826|NCT01999972|5653789|P6|Treated|Dose Escalation Part||0
2302827|NCT01999972|5653790|P5|Treated|Dose Escalation Part||0
2302828|NCT01999972|5653791|P4|Treated|Dose Escalation Part||10
2302829|NCT01999972|5653792|P3|Treated|Dose Escalation Part||4
2302830|NCT01999972|5653793|P2|Treated|Dose Escalation Part||3
2302831|NCT01999972|5653794|P1|Treated|Dose Escalation Part||5
2302832|NCT01999972|5653789|P6|STARTED|Dose Escalation Part||0
2302833|NCT01999972|5653790|P5|STARTED|Dose Escalation Part||0
2302834|NCT01999972|5653791|P4|STARTED|Dose Escalation Part||11
2302835|NCT01999972|5653792|P3|STARTED|Dose Escalation Part||5
2302836|NCT01999972|5653793|P2|STARTED|Dose Escalation Part||3
2302837|NCT01999972|5653794|P1|STARTED|Dose Escalation Part||5
2302838|NCT01999920|5653908|P2|NOT COMPLETED|Overall Study||2
2302839|NCT01999920|5653909|P1|NOT COMPLETED|Overall Study||6
2302840|NCT01999920|5653908|P2|COMPLETED|Overall Study||9
2302841|NCT01999920|5653909|P1|COMPLETED|Overall Study||7
2302842|NCT01999920|5653908|P2|STARTED|Overall Study||11
2302843|NCT01999920|5653909|P1|STARTED|Overall Study||13
2302844|NCT01999894|5653925|P1|NOT COMPLETED|Overall Study||36
2302845|NCT01999894|5653925|P1|COMPLETED|Overall Study||66
2302846|NCT01999894|5653925|P1|STARTED|Overall Study||102
2302847|NCT01999868|5653933|P3|NOT COMPLETED|Blinded Observation Phase (Week 40 – 88)||0
2302848|NCT01999868|5653934|P2|NOT COMPLETED|Blinded Observation Phase (Week 40 – 88)||29
2302849|NCT01999868|5653935|P1|NOT COMPLETED|Blinded Observation Phase (Week 40 – 88)||23
2302850|NCT01999868|5653933|P3|COMPLETED|Blinded Observation Phase (Week 40 – 88)||0
2302851|NCT01999868|5653934|P2|COMPLETED|Blinded Observation Phase (Week 40 – 88)||6
2302852|NCT01999868|5653935|P1|COMPLETED|Blinded Observation Phase (Week 40 – 88)||4
2302853|NCT01999868|5653933|P3|STARTED|Blinded Observation Phase (Week 40 – 88)||0
2302854|NCT01999868|5653934|P2|STARTED|Blinded Observation Phase (Week 40 – 88)||35
2302855|NCT01999868|5653935|P1|STARTED|Blinded Observation Phase (Week 40 – 88)||27
2302856|NCT01999868|5653933|P3|NOT COMPLETED|Blinded Treatment Phase (Week 12 – 40)||0
2302857|NCT01999868|5653934|P2|NOT COMPLETED|Blinded Treatment Phase (Week 12 – 40)||11
2302858|NCT01999868|5653935|P1|NOT COMPLETED|Blinded Treatment Phase (Week 12 – 40)||18
2302859|NCT01999868|5653933|P3|COMPLETED|Blinded Treatment Phase (Week 12 – 40)||0
2302860|NCT01999868|5653934|P2|COMPLETED|Blinded Treatment Phase (Week 12 – 40)||35
2302861|NCT01999868|5653935|P1|COMPLETED|Blinded Treatment Phase (Week 12 – 40)||27
2302862|NCT01999868|5653933|P3|STARTED|Blinded Treatment Phase (Week 12 – 40)|Participants didn't meet eligibility requirements for randomization or withdrew prior to Week 12.|0
2302863|NCT01999868|5653934|P2|STARTED|Blinded Treatment Phase (Week 12 – 40)||46
2302864|NCT01999868|5653935|P1|STARTED|Blinded Treatment Phase (Week 12 – 40)||45
2302865|NCT01999868|5653933|P3|NOT COMPLETED|Lead-in Phase (Week 0 – 12)||5
2302866|NCT01999868|5653934|P2|NOT COMPLETED|Lead-in Phase (Week 0 – 12)||0
2302867|NCT01999868|5653935|P1|NOT COMPLETED|Lead-in Phase (Week 0 – 12)||0
2302868|NCT01999868|5653933|P3|COMPLETED|Lead-in Phase (Week 0 – 12)||12
2302869|NCT01999868|5653934|P2|COMPLETED|Lead-in Phase (Week 0 – 12)||46
2302870|NCT01999868|5653935|P1|COMPLETED|Lead-in Phase (Week 0 – 12)||45
2302871|NCT01999868|5653933|P3|STARTED|Lead-in Phase (Week 0 – 12)||17
2302872|NCT01999868|5653934|P2|STARTED|Lead-in Phase (Week 0 – 12)||46
2302873|NCT01999868|5653935|P1|STARTED|Lead-in Phase (Week 0 – 12)||45
2302874|NCT01999777|5653962|P2|NOT COMPLETED|Overall Study||0
2302875|NCT01999777|5653963|P1|NOT COMPLETED|Overall Study||0
2302876|NCT01999777|5653962|P2|COMPLETED|Overall Study||31
2302877|NCT01999777|5653963|P1|COMPLETED|Overall Study||31
2302878|NCT01999777|5653962|P2|STARTED|Overall Study||31
2302879|NCT01999777|5653963|P1|STARTED|Overall Study||31
2302880|NCT01999530|5653971|P1|NOT COMPLETED|Overall Study||13
2302881|NCT01999530|5653971|P1|COMPLETED|Overall Study||7
2302882|NCT01999530|5653971|P1|STARTED|Overall Study||20
2302883|NCT01999517|5653977|P2|NOT COMPLETED|Overall Study||0
2302884|NCT01999517|5653978|P1|NOT COMPLETED|Overall Study||0
2302885|NCT01999517|5653977|P2|COMPLETED|Overall Study||54
2302886|NCT01999517|5653978|P1|COMPLETED|Overall Study||68
2302887|NCT01999517|5653977|P2|STARTED|Overall Study||54
2302888|NCT01999517|5653978|P1|STARTED|Overall Study||68
2302889|NCT01999465|5653986|P2|NOT COMPLETED|Overall Study||3
2302890|NCT01999465|5653987|P1|NOT COMPLETED|Overall Study||0
2302891|NCT01999465|5653986|P2|COMPLETED|Overall Study||7
2302892|NCT01999465|5653987|P1|COMPLETED|Overall Study||10
2302893|NCT01999465|5653986|P2|STARTED|Overall Study||10
2302894|NCT01999465|5653987|P1|STARTED|Overall Study||10
2302895|NCT01999400|5653995|P6|NOT COMPLETED|Fourth Intervention (1 Day)||0
2302896|NCT01999400|5653996|P5|NOT COMPLETED|Fourth Intervention (1 Day)||0
2302897|NCT01999400|5653997|P4|NOT COMPLETED|Fourth Intervention (1 Day)||0
2302898|NCT01999400|5653998|P3|NOT COMPLETED|Fourth Intervention (1 Day)||0
2302899|NCT01999400|5653999|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
2302900|NCT01999400|5654000|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
2302901|NCT01999400|5653995|P6|COMPLETED|Fourth Intervention (1 Day)||0
2302902|NCT01999400|5653996|P5|COMPLETED|Fourth Intervention (1 Day)||0
2302903|NCT01999400|5653997|P4|COMPLETED|Fourth Intervention (1 Day)||0
2302904|NCT01999400|5653998|P3|COMPLETED|Fourth Intervention (1 Day)||1
2302905|NCT01999400|5653999|P2|COMPLETED|Fourth Intervention (1 Day)||0
2302906|NCT01999400|5654000|P1|COMPLETED|Fourth Intervention (1 Day)||1
2302907|NCT01999400|5653995|P6|STARTED|Fourth Intervention (1 Day)||0
2302908|NCT01999400|5653996|P5|STARTED|Fourth Intervention (1 Day)||0
2302909|NCT01999400|5653997|P4|STARTED|Fourth Intervention (1 Day)||0
2302910|NCT01999400|5653998|P3|STARTED|Fourth Intervention (1 Day)||1
2302911|NCT01999400|5653999|P2|STARTED|Fourth Intervention (1 Day)||0
2302912|NCT01999400|5654000|P1|STARTED|Fourth Intervention (1 Day)||1
2302913|NCT01999400|5653995|P6|NOT COMPLETED|Washout (10 Days)||0
2302914|NCT01999400|5653996|P5|NOT COMPLETED|Washout (10 Days)||0
2302915|NCT01999400|5653997|P4|NOT COMPLETED|Washout (10 Days)||0
2302916|NCT01999400|5653998|P3|NOT COMPLETED|Washout (10 Days)||0
2302917|NCT01999400|5653999|P2|NOT COMPLETED|Washout (10 Days)||0
2302918|NCT01999400|5654000|P1|NOT COMPLETED|Washout (10 Days)||0
2302919|NCT01999400|5653995|P6|COMPLETED|Washout (10 Days)||0
2302920|NCT01999400|5653996|P5|COMPLETED|Washout (10 Days)||0
2302921|NCT01999400|5653997|P4|COMPLETED|Washout (10 Days)||0
2302922|NCT01999400|5653998|P3|COMPLETED|Washout (10 Days)||1
2302923|NCT01999400|5653999|P2|COMPLETED|Washout (10 Days)||0
2302924|NCT01999400|5654000|P1|COMPLETED|Washout (10 Days)||1
2302925|NCT01999400|5653995|P6|STARTED|Washout (10 Days)||0
2302926|NCT01999400|5653996|P5|STARTED|Washout (10 Days)||0
2302927|NCT01999400|5653997|P4|STARTED|Washout (10 Days)||0
2302928|NCT01999400|5653998|P3|STARTED|Washout (10 Days)||1
2302929|NCT01999400|5653999|P2|STARTED|Washout (10 Days)||0
2302930|NCT01999400|5654000|P1|STARTED|Washout (10 Days)||1
2302931|NCT01999400|5653995|P6|NOT COMPLETED|Third Intervention (1 Day)||1
2302932|NCT01999400|5653996|P5|NOT COMPLETED|Third Intervention (1 Day)||0
2302933|NCT01999400|5653997|P4|NOT COMPLETED|Third Intervention (1 Day)||0
2302934|NCT01999400|5653998|P3|NOT COMPLETED|Third Intervention (1 Day)||0
2302935|NCT01999400|5653999|P2|NOT COMPLETED|Third Intervention (1 Day)||0
2302936|NCT01999400|5654000|P1|NOT COMPLETED|Third Intervention (1 Day)||0
2302937|NCT01999400|5653995|P6|COMPLETED|Third Intervention (1 Day)||0
2302938|NCT01999400|5653996|P5|COMPLETED|Third Intervention (1 Day)||1
2302939|NCT01999400|5653997|P4|COMPLETED|Third Intervention (1 Day)||1
2302940|NCT01999400|5653998|P3|COMPLETED|Third Intervention (1 Day)||1
2302941|NCT01999400|5653999|P2|COMPLETED|Third Intervention (1 Day)||0
2302942|NCT01999400|5654000|P1|COMPLETED|Third Intervention (1 Day)||2
2302943|NCT01999400|5653995|P6|STARTED|Third Intervention (1 Day)||1
2302944|NCT01999400|5653996|P5|STARTED|Third Intervention (1 Day)||1
2302945|NCT01999400|5653997|P4|STARTED|Third Intervention (1 Day)||1
2302946|NCT01999400|5653998|P3|STARTED|Third Intervention (1 Day)||1
2302947|NCT01999400|5653999|P2|STARTED|Third Intervention (1 Day)||0
2302948|NCT01999400|5654000|P1|STARTED|Third Intervention (1 Day)||2
2302949|NCT01999400|5653995|P6|NOT COMPLETED|Washout (10 Days)||0
2302950|NCT01999400|5653996|P5|NOT COMPLETED|Washout (10 Days)||0
2302951|NCT01999400|5653997|P4|NOT COMPLETED|Washout (10 Days)||0
2302952|NCT01999400|5653998|P3|NOT COMPLETED|Washout (10 Days)||0
2302953|NCT01999400|5653999|P2|NOT COMPLETED|Washout (10 Days)||0
2302954|NCT01999400|5654000|P1|NOT COMPLETED|Washout (10 Days)||0
2302955|NCT01999400|5653995|P6|COMPLETED|Washout (10 Days)||1
2302956|NCT01999400|5653996|P5|COMPLETED|Washout (10 Days)||1
2302957|NCT01999400|5653997|P4|COMPLETED|Washout (10 Days)||1
2302958|NCT01999400|5653998|P3|COMPLETED|Washout (10 Days)||1
2302959|NCT01999400|5653999|P2|COMPLETED|Washout (10 Days)||0
2302960|NCT01999400|5654000|P1|COMPLETED|Washout (10 Days)||2
2302961|NCT01999400|5653995|P6|STARTED|Washout (10 Days)||1
2302962|NCT01999400|5653996|P5|STARTED|Washout (10 Days)||1
2302963|NCT01999400|5653997|P4|STARTED|Washout (10 Days)||1
2302964|NCT01999400|5653998|P3|STARTED|Washout (10 Days)||1
2302965|NCT01999400|5653999|P2|STARTED|Washout (10 Days)||0
2302966|NCT01999400|5654000|P1|STARTED|Washout (10 Days)||2
2302967|NCT01999400|5653995|P6|NOT COMPLETED|Second Intervention (1 Day)||0
2302968|NCT01999400|5653996|P5|NOT COMPLETED|Second Intervention (1 Day)||0
2302969|NCT01999400|5653997|P4|NOT COMPLETED|Second Intervention (1 Day)||0
2302970|NCT01999400|5653998|P3|NOT COMPLETED|Second Intervention (1 Day)||0
2302971|NCT01999400|5653999|P2|NOT COMPLETED|Second Intervention (1 Day)||0
2302972|NCT01999400|5654000|P1|NOT COMPLETED|Second Intervention (1 Day)||0
2302973|NCT01999400|5653995|P6|COMPLETED|Second Intervention (1 Day)||3
2302974|NCT01999400|5653996|P5|COMPLETED|Second Intervention (1 Day)||3
2302975|NCT01999400|5653997|P4|COMPLETED|Second Intervention (1 Day)||2
2302976|NCT01999400|5653998|P3|COMPLETED|Second Intervention (1 Day)||3
2302977|NCT01999400|5653999|P2|COMPLETED|Second Intervention (1 Day)||4
2302978|NCT01999400|5654000|P1|COMPLETED|Second Intervention (1 Day)||5
2302979|NCT01999400|5653995|P6|STARTED|Second Intervention (1 Day)||3
2302980|NCT01999400|5653996|P5|STARTED|Second Intervention (1 Day)||3
2302981|NCT01999400|5653997|P4|STARTED|Second Intervention (1 Day)||2
2302982|NCT01999400|5653998|P3|STARTED|Second Intervention (1 Day)||3
2302983|NCT01999400|5653999|P2|STARTED|Second Intervention (1 Day)||4
2302984|NCT01999400|5654000|P1|STARTED|Second Intervention (1 Day)||5
2302985|NCT01999400|5653995|P6|NOT COMPLETED|Washout (10 Days)||0
2302986|NCT01999400|5653996|P5|NOT COMPLETED|Washout (10 Days)||0
2302987|NCT01999400|5653997|P4|NOT COMPLETED|Washout (10 Days)||0
2302988|NCT01999400|5653998|P3|NOT COMPLETED|Washout (10 Days)||0
2302989|NCT01999400|5653999|P2|NOT COMPLETED|Washout (10 Days)||0
2302990|NCT01999400|5654000|P1|NOT COMPLETED|Washout (10 Days)||0
2302991|NCT01999400|5653995|P6|COMPLETED|Washout (10 Days)||3
2302992|NCT01999400|5653996|P5|COMPLETED|Washout (10 Days)||3
2302993|NCT01999400|5653997|P4|COMPLETED|Washout (10 Days)||2
2302994|NCT01999400|5653998|P3|COMPLETED|Washout (10 Days)||3
2302995|NCT01999400|5653999|P2|COMPLETED|Washout (10 Days)||4
2302996|NCT01999400|5654000|P1|COMPLETED|Washout (10 Days)||5
2302997|NCT01999400|5653995|P6|STARTED|Washout (10 Days)||3
2302998|NCT01999400|5653996|P5|STARTED|Washout (10 Days)||3
2302999|NCT01999400|5653997|P4|STARTED|Washout (10 Days)||2
2303000|NCT01999400|5653998|P3|STARTED|Washout (10 Days)||3
2303001|NCT01999400|5653999|P2|STARTED|Washout (10 Days)||4
2303002|NCT01999400|5654000|P1|STARTED|Washout (10 Days)||5
2303003|NCT01999400|5653995|P6|NOT COMPLETED|First Intervention (1 Day)||1
2303004|NCT01999400|5653996|P5|NOT COMPLETED|First Intervention (1 Day)||0
2303005|NCT01999400|5653997|P4|NOT COMPLETED|First Intervention (1 Day)||3
2303006|NCT01999400|5653998|P3|NOT COMPLETED|First Intervention (1 Day)||2
2303007|NCT01999400|5653999|P2|NOT COMPLETED|First Intervention (1 Day)||2
2303008|NCT01999400|5654000|P1|NOT COMPLETED|First Intervention (1 Day)||2
2303009|NCT01999400|5653995|P6|COMPLETED|First Intervention (1 Day)||3
2303010|NCT01999400|5653996|P5|COMPLETED|First Intervention (1 Day)||4
2303011|NCT01999400|5653997|P4|COMPLETED|First Intervention (1 Day)||2
2303012|NCT01999400|5653998|P3|COMPLETED|First Intervention (1 Day)||3
2303013|NCT01999400|5653999|P2|COMPLETED|First Intervention (1 Day)||4
2303014|NCT01999400|5654000|P1|COMPLETED|First Intervention (1 Day)||4
2303015|NCT01999400|5653995|P6|STARTED|First Intervention (1 Day)||4
2303016|NCT01999400|5653996|P5|STARTED|First Intervention (1 Day)||4
2303017|NCT01999400|5653997|P4|STARTED|First Intervention (1 Day)||5
2303018|NCT01999400|5653998|P3|STARTED|First Intervention (1 Day)||5
2303019|NCT01999400|5653999|P2|STARTED|First Intervention (1 Day)||6
2303020|NCT01999400|5654000|P1|STARTED|First Intervention (1 Day)||6
2303021|NCT01999348|5654020|P1|NOT COMPLETED|Overall Study||120
2303022|NCT01999348|5654020|P1|COMPLETED|Overall Study||1433
2303023|NCT01999348|5654020|P1|STARTED|Overall Study||1553
2303024|NCT01999322|5654032|P2|NOT COMPLETED|Overall Study||0
2303025|NCT01999322|5654033|P1|NOT COMPLETED|Overall Study||1
2303026|NCT01999322|5654032|P2|COMPLETED|Overall Study||12
2303027|NCT01999322|5654033|P1|COMPLETED|Overall Study||24
2303028|NCT01999322|5654032|P2|STARTED|Overall Study||12
2303029|NCT01999322|5654033|P1|STARTED|Overall Study||25
2303030|NCT01999231|5654049|P4|NOT COMPLETED|Overall Study||0
2303031|NCT01999231|5654050|P3|NOT COMPLETED|Overall Study||0
2303032|NCT01999231|5654051|P2|NOT COMPLETED|Overall Study||0
2303033|NCT01999231|5654052|P1|NOT COMPLETED|Overall Study||0
2303034|NCT01999231|5654049|P4|COMPLETED|Overall Study||6
2303035|NCT01999231|5654050|P3|COMPLETED|Overall Study||6
2303036|NCT01999231|5654051|P2|COMPLETED|Overall Study||6
2303037|NCT01999231|5654052|P1|COMPLETED|Overall Study||6
2303038|NCT01999231|5654049|P4|STARTED|Overall Study||6
2303039|NCT01999231|5654050|P3|STARTED|Overall Study||6
2303040|NCT01999231|5654051|P2|STARTED|Overall Study||6
2303041|NCT01999231|5654052|P1|STARTED|Overall Study||6
2303042|NCT01999218|5654085|P3|NOT COMPLETED|Overall Study||110
2303043|NCT01999218|5654086|P2|NOT COMPLETED|Overall Study||101
2303044|NCT01999218|5654087|P1|NOT COMPLETED|Overall Study||109
2303045|NCT01999218|5654085|P3|COMPLETED|Overall Study||327
2303046|NCT01999218|5654086|P2|COMPLETED|Overall Study||340
2303047|NCT01999218|5654087|P1|COMPLETED|Overall Study||339
2303048|NCT01999218|5654085|P3|Site Issue|Overall Study||435
2303049|NCT01999218|5654086|P2|Site Issue|Overall Study||435
2303050|NCT01999218|5654087|P1|Site Issue|Overall Study||445
2303051|NCT01999218|5654085|P3|Treated|Overall Study||437
2303052|NCT01999218|5654086|P2|Treated|Overall Study||440
2303053|NCT01999218|5654087|P1|Treated|Overall Study||448
2303054|NCT01999218|5654085|P3|STARTED|Overall Study||437
2303055|NCT01999218|5654086|P2|STARTED|Overall Study||441
2303056|NCT01999218|5654087|P1|STARTED|Overall Study||448
2303057|NCT01999192|5654114|P4|NOT COMPLETED|Extension Phase||0
2303058|NCT01999192|5654115|P3|NOT COMPLETED|Extension Phase||24
2303059|NCT01999192|5654116|P2|NOT COMPLETED|Extension Phase||18
2303060|NCT01999192|5654117|P1|NOT COMPLETED|Extension Phase||13
2303061|NCT01999192|5654114|P4|COMPLETED|Extension Phase||0
2303062|NCT01999192|5654115|P3|COMPLETED|Extension Phase||44
2303063|NCT01999192|5654116|P2|COMPLETED|Extension Phase||38
2303064|NCT01999192|5654117|P1|COMPLETED|Extension Phase||41
2303065|NCT01999192|5654114|P4|STARTED|Extension Phase|No Placebo arm for Extension Phase, all patients terminated or were switched to tregalizumab Groups.|0
2303066|NCT01999192|5654115|P3|STARTED|Extension Phase|Some patients terminated after Main Phase 2.|68
2303067|NCT01999192|5654116|P2|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|56
2303068|NCT01999192|5654117|P1|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|54
2303069|NCT01999192|5654114|P4|NOT COMPLETED|Main Phase II||1
2303070|NCT01999192|5654115|P3|NOT COMPLETED|Main Phase II||22
2303071|NCT01999192|5654116|P2|NOT COMPLETED|Main Phase II||9
2303072|NCT01999192|5654117|P1|NOT COMPLETED|Main Phase II||9
2303073|NCT01999192|5654114|P4|COMPLETED|Main Phase II||43
2303074|NCT01999192|5654115|P3|COMPLETED|Main Phase II||76
2303075|NCT01999192|5654116|P2|COMPLETED|Main Phase II||66
2303076|NCT01999192|5654117|P1|COMPLETED|Main Phase II||55
2303077|NCT01999192|5654114|P4|STARTED|Main Phase II|non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched|44
2303078|NCT01999192|5654115|P3|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|98
2303079|NCT01999192|5654116|P2|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|75
2303080|NCT01999192|5654117|P1|STARTED|Main Phase II|Non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched.|64
2303081|NCT01999192|5654114|P4|NOT COMPLETED|Main Phase I||8
2303082|NCT01999192|5654115|P3|NOT COMPLETED|Main Phase I||8
2303083|NCT01999192|5654116|P2|NOT COMPLETED|Main Phase I||10
2303084|NCT01999192|5654117|P1|NOT COMPLETED|Main Phase I||11
2303085|NCT01999192|5654114|P4|COMPLETED|Main Phase I||72
2303086|NCT01999192|5654115|P3|COMPLETED|Main Phase I||70
2303087|NCT01999192|5654116|P2|COMPLETED|Main Phase I||70
2303088|NCT01999192|5654117|P1|COMPLETED|Main Phase I||72
2303089|NCT01999192|5654114|P4|STARTED|Main Phase I||80
2303090|NCT01999192|5654115|P3|STARTED|Main Phase I||78
2303091|NCT01999192|5654116|P2|STARTED|Main Phase I||80
2303092|NCT01999192|5654117|P1|STARTED|Main Phase I||83
2303093|NCT01999114|5654132|P5|NOT COMPLETED|Overall Study||4
2303094|NCT01999114|5654133|P4|NOT COMPLETED|Overall Study||3
2303095|NCT01999114|5654134|P3|NOT COMPLETED|Overall Study||5
2303096|NCT01999114|5654135|P2|NOT COMPLETED|Overall Study||7
2303097|NCT01999114|5654136|P1|NOT COMPLETED|Overall Study||8
2303098|NCT01999114|5654132|P5|COMPLETED|Overall Study||61
2303099|NCT01999114|5654133|P4|COMPLETED|Overall Study||62
2303100|NCT01999114|5654134|P3|COMPLETED|Overall Study||61
2303101|NCT01999114|5654135|P2|COMPLETED|Overall Study||59
2303102|NCT01999114|5654136|P1|COMPLETED|Overall Study||58
2303103|NCT01999114|5654132|P5|STARTED|Overall Study||65
2303104|NCT01999114|5654133|P4|STARTED|Overall Study||65
2303105|NCT01999114|5654134|P3|STARTED|Overall Study||66
2303106|NCT01999114|5654135|P2|STARTED|Overall Study||66
2303107|NCT01999114|5654136|P1|STARTED|Overall Study||66
2303108|NCT01998984|5654204|P4|NOT COMPLETED|Overall Study||3
2303109|NCT01998984|5654205|P3|NOT COMPLETED|Overall Study||1
2303110|NCT01998984|5654206|P2|NOT COMPLETED|Overall Study||1
2303111|NCT01998984|5654207|P1|NOT COMPLETED|Overall Study||0
2303112|NCT01998984|5654204|P4|COMPLETED|Overall Study||58
2303113|NCT01998984|5654205|P3|COMPLETED|Overall Study||48
2303114|NCT01998984|5654206|P2|COMPLETED|Overall Study||58
2303115|NCT01998984|5654207|P1|COMPLETED|Overall Study||55
2303116|NCT01998984|5654204|P4|STARTED|Overall Study||61
2303117|NCT01998984|5654205|P3|STARTED|Overall Study||49
2303118|NCT01998984|5654206|P2|STARTED|Overall Study||59
2303119|NCT01998984|5654207|P1|STARTED|Overall Study||55
2303120|NCT01998958|5654232|P32|NOT COMPLETED|Follow-up Phase||0
2303121|NCT01998958|5654233|P31|NOT COMPLETED|Follow-up Phase||0
2303122|NCT01998958|5654234|P30|NOT COMPLETED|Follow-up Phase||0
2303123|NCT01998958|5654235|P29|NOT COMPLETED|Follow-up Phase||0
2303124|NCT01998958|5654236|P28|NOT COMPLETED|Follow-up Phase||0
2303125|NCT01998958|5654237|P27|NOT COMPLETED|Follow-up Phase||0
2303126|NCT01998958|5654238|P26|NOT COMPLETED|Follow-up Phase||0
2303127|NCT01998958|5654239|P25|NOT COMPLETED|Follow-up Phase||0
2303128|NCT01998958|5654240|P24|NOT COMPLETED|Follow-up Phase||0
2303129|NCT01998958|5654241|P23|NOT COMPLETED|Follow-up Phase||0
2303130|NCT01998958|5654242|P22|NOT COMPLETED|Follow-up Phase||0
2303131|NCT01998958|5654243|P21|NOT COMPLETED|Follow-up Phase||0
2303132|NCT01998958|5654244|P20|NOT COMPLETED|Follow-up Phase||0
2303133|NCT01998958|5654245|P19|NOT COMPLETED|Follow-up Phase||0
2303134|NCT01998958|5654246|P18|NOT COMPLETED|Follow-up Phase||0
2303135|NCT01998958|5654247|P17|NOT COMPLETED|Follow-up Phase||0
2303136|NCT01998958|5654248|P16|NOT COMPLETED|Follow-up Phase||0
2303137|NCT01998958|5654249|P15|NOT COMPLETED|Follow-up Phase||0
2303138|NCT01998958|5654250|P14|NOT COMPLETED|Follow-up Phase||0
2303139|NCT01998958|5654251|P13|NOT COMPLETED|Follow-up Phase||0
2303140|NCT01998958|5654252|P12|NOT COMPLETED|Follow-up Phase||0
2303141|NCT01998958|5654253|P11|NOT COMPLETED|Follow-up Phase||0
2303142|NCT01998958|5654254|P10|NOT COMPLETED|Follow-up Phase||0
2303143|NCT01998958|5654255|P9|NOT COMPLETED|Follow-up Phase||0
2303144|NCT01998958|5654256|P8|NOT COMPLETED|Follow-up Phase||0
2303145|NCT01998958|5654257|P7|NOT COMPLETED|Follow-up Phase||0
2303146|NCT01998958|5654258|P6|NOT COMPLETED|Follow-up Phase||0
2303147|NCT01998958|5654259|P5|NOT COMPLETED|Follow-up Phase||0
2303148|NCT01998958|5654260|P4|NOT COMPLETED|Follow-up Phase||0
2303149|NCT01998958|5654261|P3|NOT COMPLETED|Follow-up Phase||0
2303150|NCT01998958|5654262|P2|NOT COMPLETED|Follow-up Phase||0
2303151|NCT01998958|5654263|P1|NOT COMPLETED|Follow-up Phase||0
2303152|NCT01998958|5654232|P32|COMPLETED|Follow-up Phase||42
2303153|NCT01998958|5654233|P31|COMPLETED|Follow-up Phase||39
2303154|NCT01998958|5654234|P30|COMPLETED|Follow-up Phase||12
2303155|NCT01998958|5654235|P29|COMPLETED|Follow-up Phase||4
2303156|NCT01998958|5654236|P28|COMPLETED|Follow-up Phase||1
2303157|NCT01998958|5654237|P27|COMPLETED|Follow-up Phase||0
2303158|NCT01998958|5654238|P26|COMPLETED|Follow-up Phase||0
2303159|NCT01998958|5654239|P25|COMPLETED|Follow-up Phase||0
2303160|NCT01998958|5654240|P24|COMPLETED|Follow-up Phase||0
2303161|NCT01998958|5654241|P23|COMPLETED|Follow-up Phase||0
2303162|NCT01998958|5654242|P22|COMPLETED|Follow-up Phase||0
2303163|NCT01998958|5654243|P21|COMPLETED|Follow-up Phase||0
2303164|NCT01998958|5654244|P20|COMPLETED|Follow-up Phase||0
2303165|NCT01998958|5654245|P19|COMPLETED|Follow-up Phase||0
2303166|NCT01998958|5654246|P18|COMPLETED|Follow-up Phase||0
2303167|NCT01998958|5654247|P17|COMPLETED|Follow-up Phase||0
2303168|NCT01998958|5654248|P16|COMPLETED|Follow-up Phase||0
2303169|NCT01998958|5654249|P15|COMPLETED|Follow-up Phase||0
2303170|NCT01998958|5654250|P14|COMPLETED|Follow-up Phase||0
2303171|NCT01998958|5654251|P13|COMPLETED|Follow-up Phase||0
2303172|NCT01998958|5654252|P12|COMPLETED|Follow-up Phase||0
2303173|NCT01998958|5654253|P11|COMPLETED|Follow-up Phase||0
2303174|NCT01998958|5654254|P10|COMPLETED|Follow-up Phase||0
2303175|NCT01998958|5654255|P9|COMPLETED|Follow-up Phase||0
2303176|NCT01998958|5654256|P8|COMPLETED|Follow-up Phase||0
2303177|NCT01998958|5654257|P7|COMPLETED|Follow-up Phase||0
2303178|NCT01998958|5654258|P6|COMPLETED|Follow-up Phase||0
2303179|NCT01998958|5654259|P5|COMPLETED|Follow-up Phase||0
2303180|NCT01998958|5654260|P4|COMPLETED|Follow-up Phase||0
2303181|NCT01998958|5654261|P3|COMPLETED|Follow-up Phase||0
2303182|NCT01998958|5654262|P2|COMPLETED|Follow-up Phase||0
2303183|NCT01998958|5654263|P1|COMPLETED|Follow-up Phase||0
2303184|NCT01998958|5654232|P32|STARTED|Follow-up Phase||42
2303185|NCT01998958|5654233|P31|STARTED|Follow-up Phase||39
2303186|NCT01998958|5654234|P30|STARTED|Follow-up Phase||12
2303187|NCT01998958|5654235|P29|STARTED|Follow-up Phase||4
2303188|NCT01998958|5654236|P28|STARTED|Follow-up Phase||1
2303189|NCT01998958|5654237|P27|STARTED|Follow-up Phase||0
2303190|NCT01998958|5654238|P26|STARTED|Follow-up Phase||0
2303191|NCT01998958|5654239|P25|STARTED|Follow-up Phase||0
2303192|NCT01998958|5654240|P24|STARTED|Follow-up Phase||0
2303193|NCT01998958|5654241|P23|STARTED|Follow-up Phase||0
2303194|NCT01998958|5654242|P22|STARTED|Follow-up Phase||0
2303195|NCT01998958|5654243|P21|STARTED|Follow-up Phase||0
2303196|NCT01998958|5654244|P20|STARTED|Follow-up Phase||0
2303197|NCT01998958|5654245|P19|STARTED|Follow-up Phase||0
2303198|NCT01998958|5654246|P18|STARTED|Follow-up Phase||0
2303199|NCT01998958|5654247|P17|STARTED|Follow-up Phase||0
2303200|NCT01998958|5654248|P16|STARTED|Follow-up Phase||0
2303201|NCT01998958|5654249|P15|STARTED|Follow-up Phase||0
2303202|NCT01998958|5654250|P14|STARTED|Follow-up Phase||0
2303203|NCT01998958|5654251|P13|STARTED|Follow-up Phase||0
2303204|NCT01998958|5654252|P12|STARTED|Follow-up Phase||0
2303205|NCT01998958|5654253|P11|STARTED|Follow-up Phase||0
2303206|NCT01998958|5654254|P10|STARTED|Follow-up Phase||0
2303207|NCT01998958|5654255|P9|STARTED|Follow-up Phase||0
2303208|NCT01998958|5654256|P8|STARTED|Follow-up Phase||0
2303209|NCT01998958|5654257|P7|STARTED|Follow-up Phase||0
2303210|NCT01998958|5654258|P6|STARTED|Follow-up Phase||0
2303211|NCT01998958|5654259|P5|STARTED|Follow-up Phase||0
2303212|NCT01998958|5654260|P4|STARTED|Follow-up Phase||0
2303213|NCT01998958|5654261|P3|STARTED|Follow-up Phase||0
2303214|NCT01998958|5654262|P2|STARTED|Follow-up Phase||0
2303215|NCT01998958|5654263|P1|STARTED|Follow-up Phase||0
2303216|NCT01998958|5654232|P32|NOT COMPLETED|Open Label Phase (Optional)||0
2303217|NCT01998958|5654233|P31|NOT COMPLETED|Open Label Phase (Optional)||0
2303218|NCT01998958|5654234|P30|NOT COMPLETED|Open Label Phase (Optional)||0
2303219|NCT01998958|5654235|P29|NOT COMPLETED|Open Label Phase (Optional)||0
2303220|NCT01998958|5654236|P28|NOT COMPLETED|Open Label Phase (Optional)||0
2303221|NCT01998958|5654237|P27|NOT COMPLETED|Open Label Phase (Optional)||0
2303222|NCT01998958|5654238|P26|NOT COMPLETED|Open Label Phase (Optional)||0
2303223|NCT01998958|5654239|P25|NOT COMPLETED|Open Label Phase (Optional)||0
2303224|NCT01998958|5654240|P24|NOT COMPLETED|Open Label Phase (Optional)||4
2303225|NCT01998958|5654241|P23|NOT COMPLETED|Open Label Phase (Optional)||9
2303226|NCT01998958|5654242|P22|NOT COMPLETED|Open Label Phase (Optional)||3
2303227|NCT01998958|5654243|P21|NOT COMPLETED|Open Label Phase (Optional)||0
2303228|NCT01998958|5654244|P20|NOT COMPLETED|Open Label Phase (Optional)||0
2303229|NCT01998958|5654245|P19|NOT COMPLETED|Open Label Phase (Optional)||0
2303230|NCT01998958|5654246|P18|NOT COMPLETED|Open Label Phase (Optional)||0
2303231|NCT01998958|5654247|P17|NOT COMPLETED|Open Label Phase (Optional)||0
2303232|NCT01998958|5654248|P16|NOT COMPLETED|Open Label Phase (Optional)||0
2303233|NCT01998958|5654249|P15|NOT COMPLETED|Open Label Phase (Optional)||0
2303234|NCT01998958|5654250|P14|NOT COMPLETED|Open Label Phase (Optional)||0
2303235|NCT01998958|5654251|P13|NOT COMPLETED|Open Label Phase (Optional)||0
2303236|NCT01998958|5654252|P12|NOT COMPLETED|Open Label Phase (Optional)||0
2303237|NCT01998958|5654253|P11|NOT COMPLETED|Open Label Phase (Optional)||0
2303238|NCT01998958|5654254|P10|NOT COMPLETED|Open Label Phase (Optional)||0
2303239|NCT01998958|5654255|P9|NOT COMPLETED|Open Label Phase (Optional)||0
2303240|NCT01998958|5654256|P8|NOT COMPLETED|Open Label Phase (Optional)||0
2303241|NCT01998958|5654257|P7|NOT COMPLETED|Open Label Phase (Optional)||0
2303242|NCT01998958|5654258|P6|NOT COMPLETED|Open Label Phase (Optional)||0
2303243|NCT01998958|5654259|P5|NOT COMPLETED|Open Label Phase (Optional)||0
2303244|NCT01998958|5654260|P4|NOT COMPLETED|Open Label Phase (Optional)||0
2303245|NCT01998958|5654261|P3|NOT COMPLETED|Open Label Phase (Optional)||0
2303246|NCT01998958|5654262|P2|NOT COMPLETED|Open Label Phase (Optional)||0
2303247|NCT01998958|5654263|P1|NOT COMPLETED|Open Label Phase (Optional)||0
2303248|NCT01998958|5654232|P32|COMPLETED|Open Label Phase (Optional)||0
2303249|NCT01998958|5654233|P31|COMPLETED|Open Label Phase (Optional)||0
2303250|NCT01998958|5654234|P30|COMPLETED|Open Label Phase (Optional)||0
2303251|NCT01998958|5654235|P29|COMPLETED|Open Label Phase (Optional)||0
2303252|NCT01998958|5654236|P28|COMPLETED|Open Label Phase (Optional)||0
2303253|NCT01998958|5654237|P27|COMPLETED|Open Label Phase (Optional)||19
2303254|NCT01998958|5654238|P26|COMPLETED|Open Label Phase (Optional)||7
2303255|NCT01998958|5654239|P25|COMPLETED|Open Label Phase (Optional)||13
2303256|NCT01998958|5654240|P24|COMPLETED|Open Label Phase (Optional)||23
2303257|NCT01998958|5654241|P23|COMPLETED|Open Label Phase (Optional)||11
2303258|NCT01998958|5654242|P22|COMPLETED|Open Label Phase (Optional)||7
2303259|NCT01998958|5654243|P21|COMPLETED|Open Label Phase (Optional)||0
2303260|NCT01998958|5654244|P20|COMPLETED|Open Label Phase (Optional)||0
2303261|NCT01998958|5654245|P19|COMPLETED|Open Label Phase (Optional)||0
2303262|NCT01998958|5654246|P18|COMPLETED|Open Label Phase (Optional)||0
2303263|NCT01998958|5654247|P17|COMPLETED|Open Label Phase (Optional)||0
2303264|NCT01998958|5654248|P16|COMPLETED|Open Label Phase (Optional)||0
2303265|NCT01998958|5654249|P15|COMPLETED|Open Label Phase (Optional)||0
2303266|NCT01998958|5654250|P14|COMPLETED|Open Label Phase (Optional)||0
2303267|NCT01998958|5654251|P13|COMPLETED|Open Label Phase (Optional)||0
2303268|NCT01998958|5654252|P12|COMPLETED|Open Label Phase (Optional)||0
2303269|NCT01998958|5654253|P11|COMPLETED|Open Label Phase (Optional)||0
2303270|NCT01998958|5654254|P10|COMPLETED|Open Label Phase (Optional)||0
2303271|NCT01998958|5654255|P9|COMPLETED|Open Label Phase (Optional)||0
2303272|NCT01998958|5654256|P8|COMPLETED|Open Label Phase (Optional)||0
2303273|NCT01998958|5654257|P7|COMPLETED|Open Label Phase (Optional)||0
2303274|NCT01998958|5654258|P6|COMPLETED|Open Label Phase (Optional)||0
2303275|NCT01998958|5654259|P5|COMPLETED|Open Label Phase (Optional)||0
2303276|NCT01998958|5654260|P4|COMPLETED|Open Label Phase (Optional)||0
2303277|NCT01998958|5654261|P3|COMPLETED|Open Label Phase (Optional)||0
2303278|NCT01998958|5654262|P2|COMPLETED|Open Label Phase (Optional)||0
2303279|NCT01998958|5654263|P1|COMPLETED|Open Label Phase (Optional)||0
2303280|NCT01998958|5654232|P32|STARTED|Open Label Phase (Optional)||0
2303281|NCT01998958|5654233|P31|STARTED|Open Label Phase (Optional)||0
2303282|NCT01998958|5654234|P30|STARTED|Open Label Phase (Optional)||0
2303283|NCT01998958|5654235|P29|STARTED|Open Label Phase (Optional)||0
2303284|NCT01998958|5654236|P28|STARTED|Open Label Phase (Optional)||0
2303285|NCT01998958|5654237|P27|STARTED|Open Label Phase (Optional)||19
2303286|NCT01998958|5654238|P26|STARTED|Open Label Phase (Optional)||7
2303287|NCT01998958|5654239|P25|STARTED|Open Label Phase (Optional)||13
2303288|NCT01998958|5654240|P24|STARTED|Open Label Phase (Optional)||27
2303289|NCT01998958|5654241|P23|STARTED|Open Label Phase (Optional)||20
2303290|NCT01998958|5654242|P22|STARTED|Open Label Phase (Optional)||10
2303291|NCT01998958|5654243|P21|STARTED|Open Label Phase (Optional)||0
2303292|NCT01998958|5654244|P20|STARTED|Open Label Phase (Optional)||0
2303293|NCT01998958|5654245|P19|STARTED|Open Label Phase (Optional)||0
2303294|NCT01998958|5654246|P18|STARTED|Open Label Phase (Optional)||0
2303295|NCT01998958|5654247|P17|STARTED|Open Label Phase (Optional)||0
2303296|NCT01998958|5654248|P16|STARTED|Open Label Phase (Optional)||0
2303297|NCT01998958|5654249|P15|STARTED|Open Label Phase (Optional)||0
2303298|NCT01998958|5654250|P14|STARTED|Open Label Phase (Optional)||0
2303299|NCT01998958|5654251|P13|STARTED|Open Label Phase (Optional)||0
2303300|NCT01998958|5654252|P12|STARTED|Open Label Phase (Optional)||0
2303301|NCT01998958|5654253|P11|STARTED|Open Label Phase (Optional)||0
2303302|NCT01998958|5654254|P10|STARTED|Open Label Phase (Optional)||0
2303303|NCT01998958|5654255|P9|STARTED|Open Label Phase (Optional)||0
2303304|NCT01998958|5654256|P8|STARTED|Open Label Phase (Optional)||0
2303305|NCT01998958|5654257|P7|STARTED|Open Label Phase (Optional)||0
2303306|NCT01998958|5654258|P6|STARTED|Open Label Phase (Optional)||0
2303307|NCT01998958|5654259|P5|STARTED|Open Label Phase (Optional)||0
2303308|NCT01998958|5654260|P4|STARTED|Open Label Phase (Optional)||0
2303309|NCT01998958|5654261|P3|STARTED|Open Label Phase (Optional)||0
2303310|NCT01998958|5654262|P2|STARTED|Open Label Phase (Optional)||0
2303311|NCT01998958|5654263|P1|STARTED|Open Label Phase (Optional)||0
2303312|NCT01998958|5654232|P32|NOT COMPLETED|Period 2 (Panel A and B)||0
2303313|NCT01998958|5654233|P31|NOT COMPLETED|Period 2 (Panel A and B)||0
2303314|NCT01998958|5654234|P30|NOT COMPLETED|Period 2 (Panel A and B)||0
2303315|NCT01998958|5654235|P29|NOT COMPLETED|Period 2 (Panel A and B)||0
2303316|NCT01998958|5654236|P28|NOT COMPLETED|Period 2 (Panel A and B)||0
2303317|NCT01998958|5654237|P27|NOT COMPLETED|Period 2 (Panel A and B)||0
2303318|NCT01998958|5654238|P26|NOT COMPLETED|Period 2 (Panel A and B)||0
2303319|NCT01998958|5654239|P25|NOT COMPLETED|Period 2 (Panel A and B)||0
2303320|NCT01998958|5654240|P24|NOT COMPLETED|Period 2 (Panel A and B)||0
2303321|NCT01998958|5654241|P23|NOT COMPLETED|Period 2 (Panel A and B)||0
2303322|NCT01998958|5654242|P22|NOT COMPLETED|Period 2 (Panel A and B)||0
2303323|NCT01998958|5654243|P21|NOT COMPLETED|Period 2 (Panel A and B)||0
2303324|NCT01998958|5654244|P20|NOT COMPLETED|Period 2 (Panel A and B)||0
2303325|NCT01998958|5654245|P19|NOT COMPLETED|Period 2 (Panel A and B)||1
2303326|NCT01998958|5654246|P18|NOT COMPLETED|Period 2 (Panel A and B)||0
2303327|NCT01998958|5654247|P17|NOT COMPLETED|Period 2 (Panel A and B)||0
2303328|NCT01998958|5654248|P16|NOT COMPLETED|Period 2 (Panel A and B)||0
2303329|NCT01998958|5654249|P15|NOT COMPLETED|Period 2 (Panel A and B)||2
2303330|NCT01998958|5654250|P14|NOT COMPLETED|Period 2 (Panel A and B)||0
2303331|NCT01998958|5654251|P13|NOT COMPLETED|Period 2 (Panel A and B)||0
2303332|NCT01998958|5654252|P12|NOT COMPLETED|Period 2 (Panel A and B)||0
2303333|NCT01998958|5654253|P11|NOT COMPLETED|Period 2 (Panel A and B)||1
2303334|NCT01998958|5654254|P10|NOT COMPLETED|Period 2 (Panel A and B)||0
2303335|NCT01998958|5654255|P9|NOT COMPLETED|Period 2 (Panel A and B)||0
2303336|NCT01998958|5654256|P8|NOT COMPLETED|Period 2 (Panel A and B)||0
2303337|NCT01998958|5654257|P7|NOT COMPLETED|Period 2 (Panel A and B)||0
2303338|NCT01998958|5654258|P6|NOT COMPLETED|Period 2 (Panel A and B)||0
2303339|NCT01998958|5654259|P5|NOT COMPLETED|Period 2 (Panel A and B)||0
2303340|NCT01998958|5654260|P4|NOT COMPLETED|Period 2 (Panel A and B)||0
2303341|NCT01998958|5654261|P3|NOT COMPLETED|Period 2 (Panel A and B)||0
2303342|NCT01998958|5654262|P2|NOT COMPLETED|Period 2 (Panel A and B)||0
2303343|NCT01998958|5654263|P1|NOT COMPLETED|Period 2 (Panel A and B)||0
2303344|NCT01998958|5654232|P32|COMPLETED|Period 2 (Panel A and B)||0
2303345|NCT01998958|5654233|P31|COMPLETED|Period 2 (Panel A and B)||0
2303346|NCT01998958|5654234|P30|COMPLETED|Period 2 (Panel A and B)||0
2303347|NCT01998958|5654235|P29|COMPLETED|Period 2 (Panel A and B)||0
2303348|NCT01998958|5654236|P28|COMPLETED|Period 2 (Panel A and B)||0
2303349|NCT01998958|5654237|P27|COMPLETED|Period 2 (Panel A and B)||0
2303350|NCT01998958|5654238|P26|COMPLETED|Period 2 (Panel A and B)||0
2303351|NCT01998958|5654239|P25|COMPLETED|Period 2 (Panel A and B)||0
2303352|NCT01998958|5654240|P24|COMPLETED|Period 2 (Panel A and B)||0
2303353|NCT01998958|5654241|P23|COMPLETED|Period 2 (Panel A and B)||0
2303354|NCT01998958|5654242|P22|COMPLETED|Period 2 (Panel A and B)||0
2303355|NCT01998958|5654243|P21|COMPLETED|Period 2 (Panel A and B)||9
2303356|NCT01998958|5654244|P20|COMPLETED|Period 2 (Panel A and B)||11
2303357|NCT01998958|5654245|P19|COMPLETED|Period 2 (Panel A and B)||2
2303358|NCT01998958|5654246|P18|COMPLETED|Period 2 (Panel A and B)||5
2303359|NCT01998958|5654247|P17|COMPLETED|Period 2 (Panel A and B)||8
2303360|NCT01998958|5654248|P16|COMPLETED|Period 2 (Panel A and B)||5
2303361|NCT01998958|5654249|P15|COMPLETED|Period 2 (Panel A and B)||10
2303362|NCT01998958|5654250|P14|COMPLETED|Period 2 (Panel A and B)||11
2303363|NCT01998958|5654251|P13|COMPLETED|Period 2 (Panel A and B)||8
2303364|NCT01998958|5654252|P12|COMPLETED|Period 2 (Panel A and B)||5
2303365|NCT01998958|5654253|P11|COMPLETED|Period 2 (Panel A and B)||8
2303366|NCT01998958|5654254|P10|COMPLETED|Period 2 (Panel A and B)||8
2303367|NCT01998958|5654255|P9|COMPLETED|Period 2 (Panel A and B)||4
2303368|NCT01998958|5654256|P8|COMPLETED|Period 2 (Panel A and B)||6
2303369|NCT01998958|5654257|P7|COMPLETED|Period 2 (Panel A and B)||0
2303370|NCT01998958|5654258|P6|COMPLETED|Period 2 (Panel A and B)||0
2303371|NCT01998958|5654259|P5|COMPLETED|Period 2 (Panel A and B)||0
2303372|NCT01998958|5654260|P4|COMPLETED|Period 2 (Panel A and B)||0
2303373|NCT01998958|5654261|P3|COMPLETED|Period 2 (Panel A and B)||0
2303374|NCT01998958|5654262|P2|COMPLETED|Period 2 (Panel A and B)||0
2303375|NCT01998958|5654263|P1|COMPLETED|Period 2 (Panel A and B)||0
2303376|NCT01998958|5654232|P32|STARTED|Period 2 (Panel A and B)||0
2303377|NCT01998958|5654233|P31|STARTED|Period 2 (Panel A and B)||0
2303378|NCT01998958|5654234|P30|STARTED|Period 2 (Panel A and B)||0
2303379|NCT01998958|5654235|P29|STARTED|Period 2 (Panel A and B)||0
2303380|NCT01998958|5654236|P28|STARTED|Period 2 (Panel A and B)||0
2303381|NCT01998958|5654237|P27|STARTED|Period 2 (Panel A and B)||0
2303382|NCT01998958|5654238|P26|STARTED|Period 2 (Panel A and B)||0
2303383|NCT01998958|5654239|P25|STARTED|Period 2 (Panel A and B)||0
2303384|NCT01998958|5654240|P24|STARTED|Period 2 (Panel A and B)||0
2303385|NCT01998958|5654241|P23|STARTED|Period 2 (Panel A and B)||0
2303386|NCT01998958|5654242|P22|STARTED|Period 2 (Panel A and B)||0
2303387|NCT01998958|5654243|P21|STARTED|Period 2 (Panel A and B)||9
2303388|NCT01998958|5654244|P20|STARTED|Period 2 (Panel A and B)||11
2303389|NCT01998958|5654245|P19|STARTED|Period 2 (Panel A and B)||3
2303390|NCT01998958|5654246|P18|STARTED|Period 2 (Panel A and B)||5
2303391|NCT01998958|5654247|P17|STARTED|Period 2 (Panel A and B)||8
2303392|NCT01998958|5654248|P16|STARTED|Period 2 (Panel A and B)||5
2303393|NCT01998958|5654249|P15|STARTED|Period 2 (Panel A and B)||12
2303394|NCT01998958|5654250|P14|STARTED|Period 2 (Panel A and B)||11
2303395|NCT01998958|5654251|P13|STARTED|Period 2 (Panel A and B)||8
2303396|NCT01998958|5654252|P12|STARTED|Period 2 (Panel A and B)||5
2303397|NCT01998958|5654253|P11|STARTED|Period 2 (Panel A and B)||9
2303398|NCT01998958|5654254|P10|STARTED|Period 2 (Panel A and B)||8
2303399|NCT01998958|5654255|P9|STARTED|Period 2 (Panel A and B)||4
2303400|NCT01998958|5654256|P8|STARTED|Period 2 (Panel A and B)||6
2303401|NCT01998958|5654257|P7|STARTED|Period 2 (Panel A and B)||0
2303402|NCT01998958|5654258|P6|STARTED|Period 2 (Panel A and B)||0
2303403|NCT01998958|5654259|P5|STARTED|Period 2 (Panel A and B)||0
2303404|NCT01998958|5654260|P4|STARTED|Period 2 (Panel A and B)||0
2303405|NCT01998958|5654261|P3|STARTED|Period 2 (Panel A and B)||0
2303406|NCT01998958|5654262|P2|STARTED|Period 2 (Panel A and B)||0
2303407|NCT01998958|5654263|P1|STARTED|Period 2 (Panel A and B)||0
2303408|NCT01998958|5654232|P32|NOT COMPLETED|Period 1 (Panel A and B)||0
2303409|NCT01998958|5654233|P31|NOT COMPLETED|Period 1 (Panel A and B)||0
2303410|NCT01998958|5654234|P30|NOT COMPLETED|Period 1 (Panel A and B)||0
2303411|NCT01998958|5654235|P29|NOT COMPLETED|Period 1 (Panel A and B)||0
2303412|NCT01998958|5654236|P28|NOT COMPLETED|Period 1 (Panel A and B)||0
2303413|NCT01998958|5654237|P27|NOT COMPLETED|Period 1 (Panel A and B)||0
2303414|NCT01998958|5654238|P26|NOT COMPLETED|Period 1 (Panel A and B)||0
2303415|NCT01998958|5654239|P25|NOT COMPLETED|Period 1 (Panel A and B)||0
2303416|NCT01998958|5654240|P24|NOT COMPLETED|Period 1 (Panel A and B)||0
2303417|NCT01998958|5654241|P23|NOT COMPLETED|Period 1 (Panel A and B)||0
2303418|NCT01998958|5654242|P22|NOT COMPLETED|Period 1 (Panel A and B)||0
2303419|NCT01998958|5654243|P21|NOT COMPLETED|Period 1 (Panel A and B)||0
2303420|NCT01998958|5654244|P20|NOT COMPLETED|Period 1 (Panel A and B)||0
2303421|NCT01998958|5654245|P19|NOT COMPLETED|Period 1 (Panel A and B)||0
2303422|NCT01998958|5654246|P18|NOT COMPLETED|Period 1 (Panel A and B)||0
2303423|NCT01998958|5654247|P17|NOT COMPLETED|Period 1 (Panel A and B)||0
2303424|NCT01998958|5654248|P16|NOT COMPLETED|Period 1 (Panel A and B)||0
2303425|NCT01998958|5654249|P15|NOT COMPLETED|Period 1 (Panel A and B)||0
2303426|NCT01998958|5654250|P14|NOT COMPLETED|Period 1 (Panel A and B)||0
2303427|NCT01998958|5654251|P13|NOT COMPLETED|Period 1 (Panel A and B)||0
2303428|NCT01998958|5654252|P12|NOT COMPLETED|Period 1 (Panel A and B)||0
2303429|NCT01998958|5654253|P11|NOT COMPLETED|Period 1 (Panel A and B)||0
2303430|NCT01998958|5654254|P10|NOT COMPLETED|Period 1 (Panel A and B)||0
2303431|NCT01998958|5654255|P9|NOT COMPLETED|Period 1 (Panel A and B)||0
2303432|NCT01998958|5654256|P8|NOT COMPLETED|Period 1 (Panel A and B)||0
2303433|NCT01998958|5654257|P7|NOT COMPLETED|Period 1 (Panel A and B)||0
2303434|NCT01998958|5654258|P6|NOT COMPLETED|Period 1 (Panel A and B)||0
2303435|NCT01998958|5654259|P5|NOT COMPLETED|Period 1 (Panel A and B)||0
2303436|NCT01998958|5654260|P4|NOT COMPLETED|Period 1 (Panel A and B)||0
2303437|NCT01998958|5654261|P3|NOT COMPLETED|Period 1 (Panel A and B)||0
2303438|NCT01998958|5654262|P2|NOT COMPLETED|Period 1 (Panel A and B)||3
2303439|NCT01998958|5654263|P1|NOT COMPLETED|Period 1 (Panel A and B)||1
2303440|NCT01998958|5654232|P32|COMPLETED|Period 1 (Panel A and B)||0
2303441|NCT01998958|5654233|P31|COMPLETED|Period 1 (Panel A and B)||0
2303442|NCT01998958|5654234|P30|COMPLETED|Period 1 (Panel A and B)||0
2303443|NCT01998958|5654235|P29|COMPLETED|Period 1 (Panel A and B)||0
2303444|NCT01998958|5654236|P28|COMPLETED|Period 1 (Panel A and B)||0
2303445|NCT01998958|5654237|P27|COMPLETED|Period 1 (Panel A and B)||0
2303446|NCT01998958|5654238|P26|COMPLETED|Period 1 (Panel A and B)||0
2303447|NCT01998958|5654239|P25|COMPLETED|Period 1 (Panel A and B)||0
2303448|NCT01998958|5654240|P24|COMPLETED|Period 1 (Panel A and B)||0
2303449|NCT01998958|5654241|P23|COMPLETED|Period 1 (Panel A and B)||0
2303450|NCT01998958|5654242|P22|COMPLETED|Period 1 (Panel A and B)||0
2303451|NCT01998958|5654243|P21|COMPLETED|Period 1 (Panel A and B)||0
2303452|NCT01998958|5654244|P20|COMPLETED|Period 1 (Panel A and B)||0
2303453|NCT01998958|5654245|P19|COMPLETED|Period 1 (Panel A and B)||0
2303454|NCT01998958|5654246|P18|COMPLETED|Period 1 (Panel A and B)||0
2303455|NCT01998958|5654247|P17|COMPLETED|Period 1 (Panel A and B)||0
2303456|NCT01998958|5654248|P16|COMPLETED|Period 1 (Panel A and B)||0
2303457|NCT01998958|5654249|P15|COMPLETED|Period 1 (Panel A and B)||0
2303458|NCT01998958|5654250|P14|COMPLETED|Period 1 (Panel A and B)||0
2303459|NCT01998958|5654251|P13|COMPLETED|Period 1 (Panel A and B)||0
2303460|NCT01998958|5654252|P12|COMPLETED|Period 1 (Panel A and B)||0
2303461|NCT01998958|5654253|P11|COMPLETED|Period 1 (Panel A and B)||0
2303462|NCT01998958|5654254|P10|COMPLETED|Period 1 (Panel A and B)||0
2303463|NCT01998958|5654255|P9|COMPLETED|Period 1 (Panel A and B)||0
2303464|NCT01998958|5654256|P8|COMPLETED|Period 1 (Panel A and B)||0
2303465|NCT01998958|5654257|P7|COMPLETED|Period 1 (Panel A and B)||9
2303466|NCT01998958|5654258|P6|COMPLETED|Period 1 (Panel A and B)||11
2303467|NCT01998958|5654259|P5|COMPLETED|Period 1 (Panel A and B)||21
2303468|NCT01998958|5654260|P4|COMPLETED|Period 1 (Panel A and B)||12
2303469|NCT01998958|5654261|P3|COMPLETED|Period 1 (Panel A and B)||11
2303470|NCT01998958|5654262|P2|COMPLETED|Period 1 (Panel A and B)||8
2303471|NCT01998958|5654263|P1|COMPLETED|Period 1 (Panel A and B)||32
2303472|NCT01998958|5654232|P32|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
2303473|NCT01998958|5654233|P31|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
2303474|NCT01998958|5654234|P30|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
2303475|NCT01998958|5654235|P29|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
2303476|NCT01998958|5654236|P28|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
2303477|NCT01998958|5654237|P27|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
2303478|NCT01998958|5654238|P26|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
2303479|NCT01998958|5654239|P25|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
2303480|NCT01998958|5654240|P24|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
2303481|NCT01998958|5654241|P23|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
2303482|NCT01998958|5654242|P22|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
2303483|NCT01998958|5654243|P21|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
2303484|NCT01998958|5654244|P20|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
2303485|NCT01998958|5654245|P19|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
2303486|NCT01998958|5654246|P18|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
2303642|NCT01998581|5654546|P2|COMPLETED|Overall Study||44
2303487|NCT01998958|5654247|P17|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
2303488|NCT01998958|5654248|P16|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
2303489|NCT01998958|5654249|P15|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
2303490|NCT01998958|5654250|P14|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
2303491|NCT01998958|5654251|P13|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
2303492|NCT01998958|5654252|P12|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
2303493|NCT01998958|5654253|P11|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
2303494|NCT01998958|5654254|P10|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
2303495|NCT01998958|5654255|P9|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
2303496|NCT01998958|5654256|P8|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
2303497|NCT01998958|5654257|P7|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
2303498|NCT01998958|5654258|P6|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
2303499|NCT01998958|5654259|P5|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
2303500|NCT01998958|5654260|P4|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
2303501|NCT01998958|5654261|P3|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
2303502|NCT01998958|5654262|P2|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
2303503|NCT01998958|5654263|P1|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||5
2303504|NCT01998958|5654232|P32|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
2303505|NCT01998958|5654233|P31|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
2303506|NCT01998958|5654234|P30|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
2303507|NCT01998958|5654235|P29|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
2303508|NCT01998958|5654236|P28|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
2303509|NCT01998958|5654237|P27|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
2303510|NCT01998958|5654238|P26|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
2303511|NCT01998958|5654239|P25|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
2303512|NCT01998958|5654240|P24|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
2303513|NCT01998958|5654241|P23|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
2303514|NCT01998958|5654242|P22|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
2303515|NCT01998958|5654243|P21|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
2303516|NCT01998958|5654244|P20|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
2303517|NCT01998958|5654245|P19|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
2303518|NCT01998958|5654246|P18|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
2303519|NCT01998958|5654247|P17|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
2303520|NCT01998958|5654248|P16|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
2303521|NCT01998958|5654249|P15|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
2303522|NCT01998958|5654250|P14|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
2303523|NCT01998958|5654251|P13|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
2303524|NCT01998958|5654252|P12|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
2303525|NCT01998958|5654253|P11|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
2303526|NCT01998958|5654254|P10|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
2303527|NCT01998958|5654255|P9|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
2303528|NCT01998958|5654256|P8|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
2303529|NCT01998958|5654257|P7|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
2303530|NCT01998958|5654258|P6|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
2303531|NCT01998958|5654259|P5|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
2303532|NCT01998958|5654260|P4|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
2303533|NCT01998958|5654261|P3|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
2303534|NCT01998958|5654262|P2|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
2303535|NCT01998958|5654263|P1|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||8
2303536|NCT01998958|5654232|P32|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
2303537|NCT01998958|5654233|P31|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
2303538|NCT01998958|5654234|P30|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
2303539|NCT01998958|5654235|P29|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
2303540|NCT01998958|5654236|P28|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
2303541|NCT01998958|5654237|P27|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
2303542|NCT01998958|5654238|P26|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
2303543|NCT01998958|5654239|P25|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
2303544|NCT01998958|5654240|P24|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
2303545|NCT01998958|5654241|P23|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
2303546|NCT01998958|5654242|P22|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
2303547|NCT01998958|5654243|P21|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
2303548|NCT01998958|5654244|P20|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
2303549|NCT01998958|5654245|P19|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
2303550|NCT01998958|5654246|P18|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
2303551|NCT01998958|5654247|P17|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
2303552|NCT01998958|5654248|P16|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
2303553|NCT01998958|5654249|P15|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
2303554|NCT01998958|5654250|P14|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
2303555|NCT01998958|5654251|P13|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
2303556|NCT01998958|5654252|P12|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
2303557|NCT01998958|5654253|P11|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
2303558|NCT01998958|5654254|P10|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
2303559|NCT01998958|5654255|P9|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
2303560|NCT01998958|5654256|P8|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
2303561|NCT01998958|5654257|P7|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
2303562|NCT01998958|5654258|P6|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
2303563|NCT01998958|5654259|P5|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
2303564|NCT01998958|5654260|P4|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
2303565|NCT01998958|5654261|P3|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
2303566|NCT01998958|5654262|P2|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
2303567|NCT01998958|5654263|P1|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||9
2303568|NCT01998958|5654232|P32|STARTED|Period 1 (Panel A and B)||0
2303569|NCT01998958|5654233|P31|STARTED|Period 1 (Panel A and B)||0
2303570|NCT01998958|5654234|P30|STARTED|Period 1 (Panel A and B)||0
2303571|NCT01998958|5654235|P29|STARTED|Period 1 (Panel A and B)||0
2303572|NCT01998958|5654236|P28|STARTED|Period 1 (Panel A and B)||0
2303573|NCT01998958|5654237|P27|STARTED|Period 1 (Panel A and B)||0
2303574|NCT01998958|5654238|P26|STARTED|Period 1 (Panel A and B)||0
2303575|NCT01998958|5654239|P25|STARTED|Period 1 (Panel A and B)||0
2303576|NCT01998958|5654240|P24|STARTED|Period 1 (Panel A and B)||0
2303577|NCT01998958|5654241|P23|STARTED|Period 1 (Panel A and B)||0
2303578|NCT01998958|5654242|P22|STARTED|Period 1 (Panel A and B)||0
2303579|NCT01998958|5654243|P21|STARTED|Period 1 (Panel A and B)||0
2303580|NCT01998958|5654244|P20|STARTED|Period 1 (Panel A and B)||0
2303581|NCT01998958|5654245|P19|STARTED|Period 1 (Panel A and B)||0
2303582|NCT01998958|5654246|P18|STARTED|Period 1 (Panel A and B)||0
2303583|NCT01998958|5654247|P17|STARTED|Period 1 (Panel A and B)||0
2303584|NCT01998958|5654248|P16|STARTED|Period 1 (Panel A and B)||0
2303585|NCT01998958|5654249|P15|STARTED|Period 1 (Panel A and B)||0
2303586|NCT01998958|5654250|P14|STARTED|Period 1 (Panel A and B)||0
2303587|NCT01998958|5654251|P13|STARTED|Period 1 (Panel A and B)||0
2303588|NCT01998958|5654252|P12|STARTED|Period 1 (Panel A and B)||0
2303589|NCT01998958|5654253|P11|STARTED|Period 1 (Panel A and B)||0
2303590|NCT01998958|5654254|P10|STARTED|Period 1 (Panel A and B)||0
2303591|NCT01998958|5654255|P9|STARTED|Period 1 (Panel A and B)||0
2303592|NCT01998958|5654256|P8|STARTED|Period 1 (Panel A and B)||0
2303593|NCT01998958|5654257|P7|STARTED|Period 1 (Panel A and B)||9
2303594|NCT01998958|5654258|P6|STARTED|Period 1 (Panel A and B)||11
2303595|NCT01998958|5654259|P5|STARTED|Period 1 (Panel A and B)||21
2303596|NCT01998958|5654260|P4|STARTED|Period 1 (Panel A and B)||12
2303597|NCT01998958|5654261|P3|STARTED|Period 1 (Panel A and B)||11
2303598|NCT01998958|5654262|P2|STARTED|Period 1 (Panel A and B)||11
2303599|NCT01998958|5654263|P1|STARTED|Period 1 (Panel A and B)||33
2303600|NCT01998919|5654402|P2|NOT COMPLETED|Overall Study||35
2303601|NCT01998919|5654403|P1|NOT COMPLETED|Overall Study||42
2303602|NCT01998919|5654402|P2|COMPLETED|Overall Study||39
2303603|NCT01998919|5654403|P1|COMPLETED|Overall Study||37
2303604|NCT01998919|5654402|P2|Randomized|Overall Study|One participant withdrew consent prior to 1st dose and was excluded from safety analysis population.|76
2303605|NCT01998919|5654403|P1|Randomized|Overall Study|1 participant randomized to erlotinib didn't receive study drug; analyzed in placebo for safety|78
2303606|NCT01998919|5654402|P2|STARTED|Overall Study||74
2303607|NCT01998919|5654403|P1|STARTED|Overall Study||79
2303608|NCT01998906|5654424|P3|NOT COMPLETED|Overall Study||98
2303609|NCT01998906|5654425|P2|NOT COMPLETED|Overall Study||114
2303610|NCT01998906|5654426|P1|NOT COMPLETED|Overall Study||114
2303611|NCT01998906|5654424|P3|COMPLETED|Overall Study||1
2303612|NCT01998906|5654425|P2|COMPLETED|Overall Study||2
2303613|NCT01998906|5654426|P1|COMPLETED|Overall Study||1
2303614|NCT01998906|5654424|P3|STARTED|Overall Study||99
2303615|NCT01998906|5654425|P2|STARTED|Overall Study||116
2303616|NCT01998906|5654426|P1|STARTED|Overall Study||115
2303617|NCT01998893|5654470|P1|NOT COMPLETED|Overall Study||17
2303618|NCT01998893|5654470|P1|COMPLETED|Overall Study||21
2303619|NCT01998893|5654470|P1|2nd Treatment Cycle Completed Until PD|Overall Study||3
2303620|NCT01998893|5654470|P1|2nd Treatment Cycle Started|Overall Study||5
2303621|NCT01998893|5654470|P1|1st Treatment Cycle Completed Until PD|Overall Study|Progressive disease (PD)|30
2303622|NCT01998893|5654470|P1|STARTED|Overall Study||38
2303623|NCT01998880|5654482|P2|NOT COMPLETED|Overall Study||40
2303624|NCT01998880|5654483|P1|NOT COMPLETED|Overall Study||28
2303625|NCT01998880|5654482|P2|COMPLETED|Overall Study||78
2303626|NCT01998880|5654483|P1|COMPLETED|Overall Study|Completed=Completed treatment.|205
2303627|NCT01998880|5654482|P2|Received Study Drug|Overall Study||116
2303628|NCT01998880|5654483|P1|Received Study Drug|Overall Study||230
2303629|NCT01998880|5654482|P2|STARTED|Overall Study||118
2303630|NCT01998880|5654483|P1|STARTED|Overall Study||233
2303631|NCT01998737|5654515|P2|NOT COMPLETED|Overall Study||0
2303632|NCT01998737|5654516|P1|NOT COMPLETED|Overall Study||23
2303633|NCT01998737|5654515|P2|COMPLETED|Overall Study||100
2303634|NCT01998737|5654516|P1|COMPLETED|Overall Study||888
2303635|NCT01998737|5654515|P2|STARTED|Overall Study||100
2303636|NCT01998737|5654516|P1|STARTED|Overall Study||911
2303637|NCT01998633|5654528|P1|NOT COMPLETED|Overall Study||1
2303638|NCT01998633|5654528|P1|COMPLETED|Overall Study||46
2303639|NCT01998633|5654528|P1|STARTED|Overall Study||47
2303640|NCT01998581|5654546|P2|NOT COMPLETED|Overall Study||12
2303641|NCT01998581|5654547|P1|NOT COMPLETED|Overall Study||46
2303643|NCT01998581|5654547|P1|COMPLETED|Overall Study||123
2303644|NCT01998581|5654546|P2|STARTED|Overall Study||56
2303645|NCT01998581|5654547|P1|STARTED|Overall Study||169
2303646|NCT01998477|5654560|P2|NOT COMPLETED|Overall Study||5
2303647|NCT01998477|5654561|P1|NOT COMPLETED|Overall Study||10
2303648|NCT01998477|5654560|P2|COMPLETED|Overall Study||143
2303649|NCT01998477|5654561|P1|COMPLETED|Overall Study||272
2303650|NCT01998477|5654560|P2|STARTED|Overall Study||148
2303651|NCT01998477|5654561|P1|STARTED|Overall Study||282
2303652|NCT01998438|5654595|P3|NOT COMPLETED|Overall Study||0
2303653|NCT01998438|5654596|P2|NOT COMPLETED|Overall Study||0
2303654|NCT01998438|5654597|P1|NOT COMPLETED|Overall Study||0
2303655|NCT01998438|5654595|P3|COMPLETED|Overall Study||318
2303656|NCT01998438|5654596|P2|COMPLETED|Overall Study||318
2303657|NCT01998438|5654597|P1|COMPLETED|Overall Study||319
2303658|NCT01998438|5654595|P3|STARTED|Overall Study||318
2303659|NCT01998438|5654596|P2|STARTED|Overall Study||318
2303660|NCT01998438|5654597|P1|STARTED|Overall Study||319
2303661|NCT01998399|5654607|P2|NOT COMPLETED|Overall Study||9
2303662|NCT01998399|5654608|P1|NOT COMPLETED|Overall Study||8
2303663|NCT01998399|5654607|P2|COMPLETED|Overall Study||4
2303664|NCT01998399|5654608|P1|COMPLETED|Overall Study||4
2303665|NCT01998399|5654607|P2|STARTED|Overall Study||13
2303666|NCT01998399|5654608|P1|STARTED|Overall Study||12
2303667|NCT01998360|5654642|P2|NOT COMPLETED|Overall Study||0
2303668|NCT01998360|5654643|P1|NOT COMPLETED|Overall Study||0
2303669|NCT01998360|5654642|P2|COMPLETED|Overall Study||50
2303670|NCT01998360|5654643|P1|COMPLETED|Overall Study||50
2303671|NCT01998360|5654642|P2|STARTED|Overall Study||50
2303672|NCT01998360|5654643|P1|STARTED|Overall Study||50
2303673|NCT01998269|5654657|P1|NOT COMPLETED|Overall Study||0
2303674|NCT01998269|5654657|P1|COMPLETED|Overall Study||193
2303675|NCT01998269|5654657|P1|STARTED|Overall Study||193
2303676|NCT01998243|5654663|P2|NOT COMPLETED|Overall Study||7
2303677|NCT01998243|5654664|P1|NOT COMPLETED|Overall Study||8
2303678|NCT01998243|5654663|P2|COMPLETED|Overall Study||32
2303679|NCT01998243|5654664|P1|COMPLETED|Overall Study||34
2303680|NCT01998243|5654663|P2|STARTED|Overall Study||39
2303681|NCT01998243|5654664|P1|STARTED|Overall Study||42
2303682|NCT01997905|5654678|P1|NOT COMPLETED|Overall Study||3
2303683|NCT01997905|5654678|P1|COMPLETED|Overall Study||10
2303684|NCT01997905|5654678|P1|Baseline Completed|Overall Study||11
2303685|NCT01997905|5654678|P1|STARTED|Overall Study||13
2303686|NCT01997892|5654687|P1|NOT COMPLETED|Overall Study||68
2303687|NCT01997892|5654687|P1|COMPLETED|Overall Study||959
2303688|NCT01997892|5654687|P1|Received Darbepoetin Alfa|Overall Study||987
2303689|NCT01997892|5654687|P1|STARTED|Overall Study||1027
2303690|NCT01997723|5654699|P1|NOT COMPLETED|Overall Study||0
2303691|NCT01997723|5654699|P1|COMPLETED|Overall Study||75
2303692|NCT01997723|5654699|P1|STARTED|Overall Study||75
2303693|NCT01997567|5654707|P2|NOT COMPLETED|Overall Study||0
2303694|NCT01997567|5654708|P1|NOT COMPLETED|Overall Study||0
2303695|NCT01997567|5654707|P2|COMPLETED|Overall Study||0
2303696|NCT01997567|5654708|P1|COMPLETED|Overall Study||0
2303697|NCT01997567|5654707|P2|STARTED|Overall Study||0
2303698|NCT01997567|5654708|P1|STARTED|Overall Study||0
2303699|NCT01997515|5654728|P2|NOT COMPLETED|Overall Study||5
2303700|NCT01997515|5654729|P1|NOT COMPLETED|Overall Study||4
2303701|NCT01997515|5654728|P2|COMPLETED|Overall Study||35
2303702|NCT01997515|5654729|P1|COMPLETED|Overall Study||36
2303703|NCT01997515|5654728|P2|STARTED|Overall Study||40
2303704|NCT01997515|5654729|P1|STARTED|Overall Study||40
2303705|NCT01997437|5654741|P1|NOT COMPLETED|Overall Study||0
2303706|NCT01997437|5654741|P1|COMPLETED|Overall Study||6
2303707|NCT01997437|5654741|P1|STARTED|Overall Study||6
2303708|NCT01997411|5654753|P8|NOT COMPLETED|Overall Study||0
2303709|NCT01997411|5654754|P7|NOT COMPLETED|Overall Study||0
2303710|NCT01997411|5654755|P6|NOT COMPLETED|Overall Study||1
2303711|NCT01997411|5654756|P5|NOT COMPLETED|Overall Study||0
2303712|NCT01997411|5654757|P4|NOT COMPLETED|Overall Study||0
2303713|NCT01997411|5654758|P3|NOT COMPLETED|Overall Study||0
2303714|NCT01997411|5654759|P2|NOT COMPLETED|Overall Study||0
2303715|NCT01997411|5654760|P1|NOT COMPLETED|Overall Study||0
2303716|NCT01997411|5654753|P8|COMPLETED|Overall Study||6
2303717|NCT01997411|5654754|P7|COMPLETED|Overall Study||6
2303718|NCT01997411|5654755|P6|COMPLETED|Overall Study||5
2303719|NCT01997411|5654756|P5|COMPLETED|Overall Study||6
2303720|NCT01997411|5654757|P4|COMPLETED|Overall Study||6
2303721|NCT01997411|5654758|P3|COMPLETED|Overall Study||6
2303722|NCT01997411|5654759|P2|COMPLETED|Overall Study||6
2303723|NCT01997411|5654760|P1|COMPLETED|Overall Study||6
2303724|NCT01997411|5654753|P8|STARTED|Overall Study||6
2303725|NCT01997411|5654754|P7|STARTED|Overall Study||6
2303726|NCT01997411|5654755|P6|STARTED|Overall Study||6
2303727|NCT01997411|5654756|P5|STARTED|Overall Study||6
2303728|NCT01997411|5654757|P4|STARTED|Overall Study||6
2303729|NCT01997411|5654758|P3|STARTED|Overall Study||6
2303730|NCT01997411|5654759|P2|STARTED|Overall Study||6
2303731|NCT01997411|5654760|P1|STARTED|Overall Study||6
2303732|NCT01997398|5654850|P1|NOT COMPLETED|Overall Study||1
2303733|NCT01997398|5654850|P1|COMPLETED|Overall Study|One patient took PD meds 3 hours prior to 6 mo. UPDRS testing and was excluded from the analysis.|34
2303734|NCT01997398|5654850|P1|STARTED|Overall Study||35
2303735|NCT01997333|5654861|P2|NOT COMPLETED|Survival Follow up||14
2303736|NCT01997333|5654862|P1|NOT COMPLETED|Survival Follow up||16
2303737|NCT01997333|5654861|P2|COMPLETED|Survival Follow up||199
2303738|NCT01997333|5654862|P1|COMPLETED|Survival Follow up||76
2303739|NCT01997333|5654861|P2|STARTED|Survival Follow up||213
2303740|NCT01997333|5654862|P1|STARTED|Survival Follow up||92
2303741|NCT01997333|5654861|P2|NOT COMPLETED|Randomization and Treatment||203
2303742|NCT01997333|5654862|P1|NOT COMPLETED|Randomization and Treatment||103
2303743|NCT01997333|5654861|P2|COMPLETED|Randomization and Treatment||15
2303744|NCT01997333|5654862|P1|COMPLETED|Randomization and Treatment||6
2303745|NCT01997333|5654861|P2|STARTED|Randomization and Treatment||218
2303746|NCT01997333|5654862|P1|STARTED|Randomization and Treatment||109
2303747|NCT01997229|5654879|P2|NOT COMPLETED|Overall Study||2
2303748|NCT01997229|5654880|P1|NOT COMPLETED|Overall Study||5
2303749|NCT01997229|5654879|P2|COMPLETED|Overall Study||61
2303750|NCT01997229|5654880|P1|COMPLETED|Overall Study||57
2303751|NCT01997229|5654879|P2|STARTED|Overall Study||63
2303752|NCT01997229|5654880|P1|STARTED|Overall Study||62
2303753|NCT01997216|5654886|P2|NOT COMPLETED|Second 9 Hours||0
2303754|NCT01997216|5654887|P1|NOT COMPLETED|Second 9 Hours||0
2303755|NCT01997216|5654886|P2|COMPLETED|Second 9 Hours||21
2303756|NCT01997216|5654887|P1|COMPLETED|Second 9 Hours||19
2303757|NCT01997216|5654886|P2|STARTED|Second 9 Hours||21
2303758|NCT01997216|5654887|P1|STARTED|Second 9 Hours|One participant was not exposed to Pair 1 due to product unavailability, but was exposed to Pair 2.|19
2303759|NCT01997216|5654886|P2|NOT COMPLETED|First 9 Hours||0
2303760|NCT01997216|5654887|P1|NOT COMPLETED|First 9 Hours||0
2303761|NCT01997216|5654886|P2|COMPLETED|First 9 Hours||21
2303762|NCT01997216|5654887|P1|COMPLETED|First 9 Hours||18
2303763|NCT01997216|5654886|P2|STARTED|First 9 Hours||21
2303764|NCT01997216|5654887|P1|STARTED|First 9 Hours||18
2303765|NCT01996982|5654897|P1|NOT COMPLETED|Overall Study||7
2303766|NCT01996982|5654897|P1|COMPLETED|Overall Study||0
2303767|NCT01996982|5654897|P1|STARTED|Overall Study||7
2303768|NCT01996917|5654902|P1|NOT COMPLETED|Overall Study||0
2303769|NCT01996917|5654902|P1|COMPLETED|Overall Study||21
2303770|NCT01996917|5654902|P1|STARTED|Overall Study||21
2303771|NCT01996904|5654913|P2|NOT COMPLETED|Overall Study||27
2303772|NCT01996904|5654914|P1|NOT COMPLETED|Overall Study||38
2303773|NCT01996904|5654913|P2|COMPLETED|Overall Study||90
2303774|NCT01996904|5654914|P1|COMPLETED|Overall Study||101
2303775|NCT01996904|5654913|P2|STARTED|Overall Study||117
2303776|NCT01996904|5654914|P1|STARTED|Overall Study||139
2303777|NCT01996852|5654923|P3|NOT COMPLETED|Overall Study||0
2303778|NCT01996852|5654924|P2|NOT COMPLETED|Overall Study||0
2303779|NCT01996852|5654925|P1|NOT COMPLETED|Overall Study||0
2303780|NCT01996852|5654923|P3|COMPLETED|Overall Study||0
2303781|NCT01996852|5654924|P2|COMPLETED|Overall Study||0
2303782|NCT01996852|5654925|P1|COMPLETED|Overall Study||0
2303783|NCT01996852|5654923|P3|STARTED|Overall Study||0
2303784|NCT01996852|5654924|P2|STARTED|Overall Study||0
2303785|NCT01996852|5654925|P1|STARTED|Overall Study||0
2303786|NCT01996813|5654971|P2|NOT COMPLETED|Overall Study||0
2303787|NCT01996813|5654972|P1|NOT COMPLETED|Overall Study||0
2303788|NCT01996813|5654971|P2|COMPLETED|Overall Study||24
2303789|NCT01996813|5654972|P1|COMPLETED|Overall Study||23
2303790|NCT01996813|5654971|P2|STARTED|Overall Study||24
2303791|NCT01996813|5654972|P1|STARTED|Overall Study||23
2303792|NCT01996748|5654982|P2|NOT COMPLETED|Overall Study||6
2303793|NCT01996748|5654983|P1|NOT COMPLETED|Overall Study||8
2303794|NCT01996748|5654982|P2|COMPLETED|Overall Study||63
2303795|NCT01996748|5654983|P1|COMPLETED|Overall Study||58
2303796|NCT01996748|5654982|P2|STARTED|Overall Study||69
2303797|NCT01996748|5654983|P1|STARTED|Overall Study||66
2303798|NCT01996709|5654997|P2|NOT COMPLETED|Overall Study||1
2303799|NCT01996709|5654998|P1|NOT COMPLETED|Overall Study||5
2303800|NCT01996709|5654997|P2|COMPLETED|Overall Study||67
2303801|NCT01996709|5654998|P1|COMPLETED|Overall Study||61
2303802|NCT01996709|5654997|P2|STARTED|Overall Study||68
2303803|NCT01996709|5654998|P1|STARTED|Overall Study||66
2303804|NCT01996657|5655015|P3|NOT COMPLETED|Overall Study||14
2303805|NCT01996657|5655016|P2|NOT COMPLETED|Overall Study||11
2303806|NCT01996657|5655017|P1|NOT COMPLETED|Overall Study||13
2303807|NCT01996657|5655015|P3|COMPLETED|Overall Study||234
2303808|NCT01996657|5655016|P2|COMPLETED|Overall Study||239
2303809|NCT01996657|5655017|P1|COMPLETED|Overall Study||237
2303810|NCT01996657|5655015|P3|STARTED|Overall Study||248
2303811|NCT01996657|5655016|P2|STARTED|Overall Study||250
2303812|NCT01996657|5655017|P1|STARTED|Overall Study||250
2303813|NCT01996644|5655033|P2|NOT COMPLETED|Overall Study||0
2303814|NCT01996644|5655034|P1|NOT COMPLETED|Overall Study||0
2303815|NCT01996644|5655033|P2|COMPLETED|Overall Study||16
2303816|NCT01996644|5655034|P1|COMPLETED|Overall Study||20
2303817|NCT01996644|5655033|P2|STARTED|Overall Study||16
2303818|NCT01996644|5655034|P1|STARTED|Overall Study||20
2303819|NCT01996592|5655045|P1|NOT COMPLETED|Overall Study||45
2303820|NCT01996592|5655045|P1|COMPLETED|Overall Study||530
2303821|NCT01996592|5655045|P1|STARTED|Overall Study||575
2303822|NCT01996410|5655062|P8|NOT COMPLETED|Overall Study||0
2303823|NCT01996410|5655063|P7|NOT COMPLETED|Overall Study||0
2303824|NCT01996410|5655064|P6|NOT COMPLETED|Overall Study||0
2303825|NCT01996410|5655065|P5|NOT COMPLETED|Overall Study||0
2303826|NCT01996410|5655066|P4|NOT COMPLETED|Overall Study||0
2303827|NCT01996410|5655067|P3|NOT COMPLETED|Overall Study||0
2303828|NCT01996410|5655068|P2|NOT COMPLETED|Overall Study||0
2303829|NCT01996410|5655069|P1|NOT COMPLETED|Overall Study||0
2303830|NCT01996410|5655062|P8|COMPLETED|Overall Study||0
2303831|NCT01996410|5655063|P7|COMPLETED|Overall Study||0
2303832|NCT01996410|5655064|P6|COMPLETED|Overall Study||2
2303833|NCT01996410|5655065|P5|COMPLETED|Overall Study||2
2303834|NCT01996410|5655066|P4|COMPLETED|Overall Study||0
2303835|NCT01996410|5655067|P3|COMPLETED|Overall Study||0
2303836|NCT01996410|5655068|P2|COMPLETED|Overall Study||3
2303837|NCT01996410|5655069|P1|COMPLETED|Overall Study||3
2303838|NCT01996410|5655062|P8|STARTED|Overall Study||0
2303839|NCT01996410|5655063|P7|STARTED|Overall Study||0
2303840|NCT01996410|5655064|P6|STARTED|Overall Study||2
2303841|NCT01996410|5655065|P5|STARTED|Overall Study||2
2303842|NCT01996410|5655066|P4|STARTED|Overall Study||0
2303843|NCT01996410|5655067|P3|STARTED|Overall Study||0
2303844|NCT01996410|5655068|P2|STARTED|Overall Study||3
2303845|NCT01996410|5655069|P1|STARTED|Overall Study||3
2303846|NCT01996332|5655081|P1|NOT COMPLETED|Overall Study||1805
2303847|NCT01996332|5655081|P1|COMPLETED|Overall Study||0
2303848|NCT01996332|5655081|P1|STARTED|Overall Study||1805
2303849|NCT01996319|5655089|P2|NOT COMPLETED|Overall Study||3
2303850|NCT01996319|5655090|P1|NOT COMPLETED|Overall Study||8
2303851|NCT01996319|5655089|P2|COMPLETED|Overall Study||95
2303852|NCT01996319|5655090|P1|COMPLETED|Overall Study||88
2303853|NCT01996319|5655089|P2|STARTED|Overall Study||98
2303854|NCT01996319|5655090|P1|STARTED|Overall Study||96
2303855|NCT01996241|5655112|P2|NOT COMPLETED|Overall Study||235
2303856|NCT01996241|5655113|P1|NOT COMPLETED|Overall Study||252
2303857|NCT01996241|5655112|P2|COMPLETED|Overall Study||876
2303858|NCT01996241|5655113|P1|COMPLETED|Overall Study||912
2303859|NCT01996241|5655112|P2|STARTED|Overall Study||1111
2303860|NCT01996241|5655113|P1|STARTED|Overall Study||1164
2303861|NCT01996033|5655129|P1|NOT COMPLETED|Overall Study||9
2303862|NCT01996033|5655129|P1|COMPLETED|Overall Study||16
2303863|NCT01996033|5655129|P1|STARTED|Overall Study||25
2303864|NCT01995838|5655149|P7|NOT COMPLETED|Overall Study||5
2303865|NCT01995838|5655150|P6|NOT COMPLETED|Overall Study||2
2303866|NCT01995838|5655151|P5|NOT COMPLETED|Overall Study||2
2303867|NCT01995838|5655152|P4|NOT COMPLETED|Overall Study||2
2303868|NCT01995838|5655153|P3|NOT COMPLETED|Overall Study||0
2303869|NCT01995838|5655154|P2|NOT COMPLETED|Overall Study||2
2303870|NCT01995838|5655155|P1|NOT COMPLETED|Overall Study||5
2303871|NCT01995838|5655149|P7|COMPLETED|Overall Study||45
2303872|NCT01995838|5655150|P6|COMPLETED|Overall Study||54
2303873|NCT01995838|5655151|P5|COMPLETED|Overall Study||30
2303874|NCT01995838|5655152|P4|COMPLETED|Overall Study||36
2303875|NCT01995838|5655153|P3|COMPLETED|Overall Study||27
2303876|NCT01995838|5655154|P2|COMPLETED|Overall Study||30
2303877|NCT01995838|5655155|P1|COMPLETED|Overall Study||51
2303878|NCT01995838|5655149|P7|STARTED|Overall Study||50
2303879|NCT01995838|5655150|P6|STARTED|Overall Study||56
2303880|NCT01995838|5655151|P5|STARTED|Overall Study||32
2303881|NCT01995838|5655152|P4|STARTED|Overall Study||38
2303882|NCT01995838|5655153|P3|STARTED|Overall Study||27
2303883|NCT01995838|5655154|P2|STARTED|Overall Study||32
2303884|NCT01995838|5655155|P1|STARTED|Overall Study||56
2303885|NCT01995552|5655254|P1|NOT COMPLETED|Overall Study||17
2303886|NCT01995552|5655254|P1|COMPLETED|Overall Study|There were 233 patients who were eligible for primary objective analysis|233
2303887|NCT01995552|5655254|P1|STARTED|Overall Study|There were 249 patients were included for Baseline cohort and 233 in analysis cohort|250
2303888|NCT01995539|5655260|P1|NOT COMPLETED|Overall Study||33
2303889|NCT01995539|5655260|P1|COMPLETED|Overall Study||148
2303890|NCT01995539|5655260|P1|STARTED|Overall Study||181
2303891|NCT01995526|5655265|P1|NOT COMPLETED|Overall Study||1
2303892|NCT01995526|5655265|P1|COMPLETED|Overall Study||10
2303893|NCT01995526|5655265|P1|Received One Dose of Study Drug|Overall Study||11
2303894|NCT01995526|5655265|P1|STARTED|Overall Study||11
2303895|NCT01995513|5655273|P3|NOT COMPLETED|Double Blind Treatment Period||125
2303896|NCT01995513|5655274|P2|NOT COMPLETED|Double Blind Treatment Period||126
2303897|NCT01995513|5655275|P1|NOT COMPLETED|Double Blind Treatment Period||0
2303898|NCT01995513|5655273|P3|COMPLETED|Double Blind Treatment Period||0
2303899|NCT01995513|5655274|P2|COMPLETED|Double Blind Treatment Period||0
2303900|NCT01995513|5655275|P1|COMPLETED|Double Blind Treatment Period||0
2303901|NCT01995513|5655273|P3|Treated|Double Blind Treatment Period||124
2303902|NCT01995513|5655274|P2|Treated|Double Blind Treatment Period||125
2303903|NCT01995513|5655275|P1|Treated|Double Blind Treatment Period||0
2303904|NCT01995513|5655273|P3|STARTED|Double Blind Treatment Period||125
2303905|NCT01995513|5655274|P2|STARTED|Double Blind Treatment Period||126
2303906|NCT01995513|5655275|P1|STARTED|Double Blind Treatment Period||0
2303907|NCT01995513|5655273|P3|NOT COMPLETED|Open Label Treatment Period||0
2303908|NCT01995513|5655274|P2|NOT COMPLETED|Open Label Treatment Period||0
2303909|NCT01995513|5655275|P1|NOT COMPLETED|Open Label Treatment Period||258
2303910|NCT01995513|5655273|P3|COMPLETED|Open Label Treatment Period||0
2303911|NCT01995513|5655274|P2|COMPLETED|Open Label Treatment Period||0
2303912|NCT01995513|5655275|P1|COMPLETED|Open Label Treatment Period||251
2303913|NCT01995513|5655273|P3|STARTED|Open Label Treatment Period||0
2303914|NCT01995513|5655274|P2|STARTED|Open Label Treatment Period||0
2303915|NCT01995513|5655275|P1|STARTED|Open Label Treatment Period||509
2303916|NCT01995461|5655318|P1|NOT COMPLETED|Overall Study||5
2303917|NCT01995461|5655318|P1|COMPLETED|Overall Study||21
2303918|NCT01995461|5655318|P1|STARTED|Overall Study||26
2303919|NCT01995357|5655324|P6|NOT COMPLETED|Period 5||0
2303920|NCT01995357|5655325|P5|NOT COMPLETED|Period 5||0
2303921|NCT01995357|5655326|P4|NOT COMPLETED|Period 5||0
2303922|NCT01995357|5655327|P3|NOT COMPLETED|Period 5||1
2303923|NCT01995357|5655328|P2|NOT COMPLETED|Period 5||0
2303924|NCT01995357|5655329|P1|NOT COMPLETED|Period 5||2
2303925|NCT01995357|5655324|P6|COMPLETED|Period 5||4
2303926|NCT01995357|5655325|P5|COMPLETED|Period 5||4
2303927|NCT01995357|5655326|P4|COMPLETED|Period 5||3
2303928|NCT01995357|5655327|P3|COMPLETED|Period 5||3
2303929|NCT01995357|5655328|P2|COMPLETED|Period 5||3
2303930|NCT01995357|5655329|P1|COMPLETED|Period 5||2
2303931|NCT01995357|5655324|P6|STARTED|Period 5||4
2303932|NCT01995357|5655325|P5|STARTED|Period 5|1 subject terminated due to an adverse event. Subject counted as completed as some B products tested|4
2303933|NCT01995357|5655326|P4|STARTED|Period 5||3
2303934|NCT01995357|5655327|P3|STARTED|Period 5||4
2303935|NCT01995357|5655328|P2|STARTED|Period 5||3
2303936|NCT01995357|5655329|P1|STARTED|Period 5|The two discontinued subjects tested zero planned B products in period 5.|4
2303937|NCT01995357|5655324|P6|NOT COMPLETED|Period 4||0
2303938|NCT01995357|5655325|P5|NOT COMPLETED|Period 4||0
2303939|NCT01995357|5655326|P4|NOT COMPLETED|Period 4||0
2303940|NCT01995357|5655327|P3|NOT COMPLETED|Period 4||0
2303941|NCT01995357|5655328|P2|NOT COMPLETED|Period 4||0
2303942|NCT01995357|5655329|P1|NOT COMPLETED|Period 4||0
2303943|NCT01995357|5655324|P6|COMPLETED|Period 4||4
2303944|NCT01995357|5655325|P5|COMPLETED|Period 4||4
2303945|NCT01995357|5655326|P4|COMPLETED|Period 4||3
2303946|NCT01995357|5655327|P3|COMPLETED|Period 4||4
2303947|NCT01995357|5655328|P2|COMPLETED|Period 4||3
2303948|NCT01995357|5655329|P1|COMPLETED|Period 4||4
2303949|NCT01995357|5655324|P6|STARTED|Period 4||4
2303950|NCT01995357|5655325|P5|STARTED|Period 4||4
2303951|NCT01995357|5655326|P4|STARTED|Period 4||3
2303952|NCT01995357|5655327|P3|STARTED|Period 4|The subject who did not complete period 5, erroneously used product A when B should have been used.|4
2303953|NCT01995357|5655328|P2|STARTED|Period 4||3
2303954|NCT01995357|5655329|P1|STARTED|Period 4||4
2303955|NCT01995357|5655324|P6|NOT COMPLETED|Period 3||0
2303956|NCT01995357|5655325|P5|NOT COMPLETED|Period 3||0
2303957|NCT01995357|5655326|P4|NOT COMPLETED|Period 3||0
2303958|NCT01995357|5655327|P3|NOT COMPLETED|Period 3||0
2303959|NCT01995357|5655328|P2|NOT COMPLETED|Period 3||0
2303960|NCT01995357|5655329|P1|NOT COMPLETED|Period 3||0
2303961|NCT01995357|5655324|P6|COMPLETED|Period 3||4
2303962|NCT01995357|5655325|P5|COMPLETED|Period 3||4
2303963|NCT01995357|5655326|P4|COMPLETED|Period 3||3
2303964|NCT01995357|5655327|P3|COMPLETED|Period 3||4
2303965|NCT01995357|5655328|P2|COMPLETED|Period 3||3
2303966|NCT01995357|5655329|P1|COMPLETED|Period 3||4
2303967|NCT01995357|5655324|P6|STARTED|Period 3||4
2303968|NCT01995357|5655325|P5|STARTED|Period 3||4
2303969|NCT01995357|5655326|P4|STARTED|Period 3||3
2303970|NCT01995357|5655327|P3|STARTED|Period 3||4
2303971|NCT01995357|5655328|P2|STARTED|Period 3||3
2303972|NCT01995357|5655329|P1|STARTED|Period 3||4
2303973|NCT01995357|5655324|P6|NOT COMPLETED|Period 2||0
2303974|NCT01995357|5655325|P5|NOT COMPLETED|Period 2||0
2303975|NCT01995357|5655326|P4|NOT COMPLETED|Period 2||0
2303976|NCT01995357|5655327|P3|NOT COMPLETED|Period 2||0
2303977|NCT01995357|5655328|P2|NOT COMPLETED|Period 2||0
2303978|NCT01995357|5655329|P1|NOT COMPLETED|Period 2||0
2303979|NCT01995357|5655324|P6|COMPLETED|Period 2||4
2303980|NCT01995357|5655325|P5|COMPLETED|Period 2||4
2303981|NCT01995357|5655326|P4|COMPLETED|Period 2||3
2303982|NCT01995357|5655327|P3|COMPLETED|Period 2||4
2303983|NCT01995357|5655328|P2|COMPLETED|Period 2||3
2303984|NCT01995357|5655329|P1|COMPLETED|Period 2||4
2303985|NCT01995357|5655324|P6|STARTED|Period 2||4
2303986|NCT01995357|5655325|P5|STARTED|Period 2||4
2303987|NCT01995357|5655326|P4|STARTED|Period 2||3
2303988|NCT01995357|5655327|P3|STARTED|Period 2||4
2303989|NCT01995357|5655328|P2|STARTED|Period 2||3
2303990|NCT01995357|5655329|P1|STARTED|Period 2||4
2303991|NCT01995357|5655324|P6|NOT COMPLETED|Period 1||0
2303992|NCT01995357|5655325|P5|NOT COMPLETED|Period 1||0
2303993|NCT01995357|5655326|P4|NOT COMPLETED|Period 1||0
2303994|NCT01995357|5655327|P3|NOT COMPLETED|Period 1||0
2303995|NCT01995357|5655328|P2|NOT COMPLETED|Period 1||0
2303996|NCT01995357|5655329|P1|NOT COMPLETED|Period 1||0
2303997|NCT01995357|5655324|P6|COMPLETED|Period 1||4
2303998|NCT01995357|5655325|P5|COMPLETED|Period 1||4
2303999|NCT01995357|5655326|P4|COMPLETED|Period 1||3
2304000|NCT01995357|5655327|P3|COMPLETED|Period 1||4
2304001|NCT01995357|5655328|P2|COMPLETED|Period 1||3
2304002|NCT01995357|5655329|P1|COMPLETED|Period 1||4
2304003|NCT01995357|5655324|P6|STARTED|Period 1||4
2304004|NCT01995357|5655325|P5|STARTED|Period 1||4
2304005|NCT01995357|5655326|P4|STARTED|Period 1||3
2304006|NCT01995357|5655327|P3|STARTED|Period 1||4
2304007|NCT01995357|5655328|P2|STARTED|Period 1||3
2304008|NCT01995357|5655329|P1|STARTED|Period 1||4
2304009|NCT01995266|5655345|P1|NOT COMPLETED|Overall Study||9
2304010|NCT01995266|5655345|P1|COMPLETED|Overall Study||150
2304011|NCT01995266|5655345|P1|STARTED|Overall Study||159
2304012|NCT01995201|5655360|P7|NOT COMPLETED|From Week 24 Until Week 48||2
2304013|NCT01995201|5655361|P6|NOT COMPLETED|From Week 24 Until Week 48||8
2304014|NCT01995201|5655362|P5|NOT COMPLETED|From Week 24 Until Week 48||6
2304015|NCT01995201|5655363|P4|NOT COMPLETED|From Week 24 Until Week 48||1
2304016|NCT01995201|5655364|P3|NOT COMPLETED|From Week 24 Until Week 48||5
2304017|NCT01995201|5655365|P2|NOT COMPLETED|From Week 24 Until Week 48||0
2304018|NCT01995201|5655366|P1|NOT COMPLETED|From Week 24 Until Week 48||0
2304019|NCT01995201|5655360|P7|COMPLETED|From Week 24 Until Week 48||0
2304020|NCT01995201|5655361|P6|COMPLETED|From Week 24 Until Week 48||59
2304021|NCT01995201|5655362|P5|COMPLETED|From Week 24 Until Week 48||89
2304022|NCT01995201|5655363|P4|COMPLETED|From Week 24 Until Week 48||89
2304023|NCT01995201|5655364|P3|COMPLETED|From Week 24 Until Week 48||84
2304024|NCT01995201|5655365|P2|COMPLETED|From Week 24 Until Week 48||0
2304025|NCT01995201|5655366|P1|COMPLETED|From Week 24 Until Week 48||0
2304026|NCT01995201|5655360|P7|STARTED|From Week 24 Until Week 48||2
2304027|NCT01995201|5655361|P6|STARTED|From Week 24 Until Week 48||67
2304028|NCT01995201|5655362|P5|STARTED|From Week 24 Until Week 48||95
2304029|NCT01995201|5655363|P4|STARTED|From Week 24 Until Week 48||90
2304030|NCT01995201|5655364|P3|STARTED|From Week 24 Until Week 48||89
2304031|NCT01995201|5655365|P2|STARTED|From Week 24 Until Week 48||0
2304032|NCT01995201|5655366|P1|STARTED|From Week 24 Until Week 48||0
2304033|NCT01995201|5655360|P7|NOT COMPLETED|From Baseline Until Week 24||0
2304034|NCT01995201|5655361|P6|NOT COMPLETED|From Baseline Until Week 24||0
2304035|NCT01995201|5655362|P5|NOT COMPLETED|From Baseline Until Week 24||0
2304036|NCT01995201|5655363|P4|NOT COMPLETED|From Baseline Until Week 24||0
2304037|NCT01995201|5655364|P3|NOT COMPLETED|From Baseline Until Week 24||0
2304038|NCT01995201|5655365|P2|NOT COMPLETED|From Baseline Until Week 24||46
2304039|NCT01995201|5655366|P1|NOT COMPLETED|From Baseline Until Week 24||10
2304040|NCT01995201|5655360|P7|COMPLETED|From Baseline Until Week 24||0
2304041|NCT01995201|5655361|P6|COMPLETED|From Baseline Until Week 24||0
2304042|NCT01995201|5655362|P5|COMPLETED|From Baseline Until Week 24||0
2304043|NCT01995201|5655363|P4|COMPLETED|From Baseline Until Week 24||0
2304044|NCT01995201|5655364|P3|COMPLETED|From Baseline Until Week 24||0
2304045|NCT01995201|5655365|P2|COMPLETED|From Baseline Until Week 24||281
2304046|NCT01995201|5655366|P1|COMPLETED|From Baseline Until Week 24||64
2304047|NCT01995201|5655360|P7|STARTED|From Baseline Until Week 24||0
2304048|NCT01995201|5655361|P6|STARTED|From Baseline Until Week 24||0
2304049|NCT01995201|5655362|P5|STARTED|From Baseline Until Week 24||0
2304050|NCT01995201|5655363|P4|STARTED|From Baseline Until Week 24||0
2304051|NCT01995201|5655364|P3|STARTED|From Baseline Until Week 24||0
2304052|NCT01995201|5655365|P2|STARTED|From Baseline Until Week 24||327
2304053|NCT01995201|5655366|P1|STARTED|From Baseline Until Week 24||74
2304054|NCT01995175|5655475|P1|NOT COMPLETED|Overall Study||253
2304055|NCT01995175|5655475|P1|COMPLETED|Overall Study||2148
2304056|NCT01995175|5655475|P1|STARTED|Overall Study||2401
2304057|NCT01995136|5655485|P1|NOT COMPLETED|Overall Study||1
2304058|NCT01995136|5655485|P1|COMPLETED|Overall Study||31
2304059|NCT01995136|5655485|P1|STARTED|Overall Study||32
2304060|NCT01995071|5655501|P12|NOT COMPLETED|Overall Study||0
2304061|NCT01995071|5655502|P11|NOT COMPLETED|Overall Study||1
2304062|NCT01995071|5655503|P10|NOT COMPLETED|Overall Study||0
2304063|NCT01995071|5655504|P9|NOT COMPLETED|Overall Study||1
2304064|NCT01995071|5655505|P8|NOT COMPLETED|Overall Study||2
2304065|NCT01995071|5655506|P7|NOT COMPLETED|Overall Study||1
2304066|NCT01995071|5655507|P6|NOT COMPLETED|Overall Study||0
2304067|NCT01995071|5655508|P5|NOT COMPLETED|Overall Study||1
2304068|NCT01995071|5655509|P4|NOT COMPLETED|Overall Study||0
2304069|NCT01995071|5655510|P3|NOT COMPLETED|Overall Study||1
2304070|NCT01995071|5655511|P2|NOT COMPLETED|Overall Study||0
2304071|NCT01995071|5655512|P1|NOT COMPLETED|Overall Study||1
2304072|NCT01995071|5655501|P12|COMPLETED|Overall Study||0
2304073|NCT01995071|5655502|P11|COMPLETED|Overall Study||7
2304074|NCT01995071|5655503|P10|COMPLETED|Overall Study||8
2304075|NCT01995071|5655504|P9|COMPLETED|Overall Study||7
2304076|NCT01995071|5655505|P8|COMPLETED|Overall Study||6
2304077|NCT01995071|5655506|P7|COMPLETED|Overall Study||7
2304078|NCT01995071|5655507|P6|COMPLETED|Overall Study||8
2304079|NCT01995071|5655508|P5|COMPLETED|Overall Study||7
2304080|NCT01995071|5655509|P4|COMPLETED|Overall Study||8
2304081|NCT01995071|5655510|P3|COMPLETED|Overall Study||8
2304082|NCT01995071|5655511|P2|COMPLETED|Overall Study||8
2304083|NCT01995071|5655512|P1|COMPLETED|Overall Study||7
2304084|NCT01995071|5655501|P12|STARTED|Overall Study||0
2304085|NCT01995071|5655502|P11|STARTED|Overall Study||8
2304086|NCT01995071|5655503|P10|STARTED|Overall Study||8
2304087|NCT01995071|5655504|P9|STARTED|Overall Study||8
2304088|NCT01995071|5655505|P8|STARTED|Overall Study||8
2304089|NCT01995071|5655506|P7|STARTED|Overall Study||8
2304090|NCT01995071|5655507|P6|STARTED|Overall Study||8
2304091|NCT01995071|5655508|P5|STARTED|Overall Study||8
2304092|NCT01995071|5655509|P4|STARTED|Overall Study||8
2304093|NCT01995071|5655510|P3|STARTED|Overall Study||9
2304094|NCT01995071|5655511|P2|STARTED|Overall Study||8
2304095|NCT01995071|5655512|P1|STARTED|Overall Study||8
2304096|NCT01995045|5655573|P2|NOT COMPLETED|Overall Study||0
2304097|NCT01995045|5655574|P1|NOT COMPLETED|Overall Study||0
2304098|NCT01995045|5655573|P2|COMPLETED|Overall Study||28
2304099|NCT01995045|5655574|P1|COMPLETED|Overall Study||29
2304100|NCT01995045|5655573|P2|STARTED|Overall Study||28
2304101|NCT01995045|5655574|P1|STARTED|Overall Study||29
2304102|NCT01994993|5655591|P5|NOT COMPLETED|Overall Study||2
2304103|NCT01994993|5655592|P4|NOT COMPLETED|Overall Study||46
2304104|NCT01994993|5655593|P3|NOT COMPLETED|Overall Study||47
2304105|NCT01994993|5655594|P2|NOT COMPLETED|Overall Study||35
2304106|NCT01994993|5655595|P1|NOT COMPLETED|Overall Study||35
2304107|NCT01994993|5655591|P5|COMPLETED|Overall Study||22
2304108|NCT01994993|5655592|P4|COMPLETED|Overall Study||9
2304109|NCT01994993|5655593|P3|COMPLETED|Overall Study||23
2304110|NCT01994993|5655594|P2|COMPLETED|Overall Study||12
2304111|NCT01994993|5655595|P1|COMPLETED|Overall Study||28
2304112|NCT01994993|5655591|P5|STARTED|Overall Study||24
2304113|NCT01994993|5655592|P4|STARTED|Overall Study||55
2304114|NCT01994993|5655593|P3|STARTED|Overall Study||70
2304115|NCT01994993|5655594|P2|STARTED|Overall Study||47
2304116|NCT01994993|5655595|P1|STARTED|Overall Study||63
2304117|NCT01994954|5655649|P2|NOT COMPLETED|Overall Study||30
2304118|NCT01994954|5655650|P1|NOT COMPLETED|Overall Study||25
2304119|NCT01994954|5655649|P2|COMPLETED|Overall Study||67
2304120|NCT01994954|5655650|P1|COMPLETED|Overall Study||74
2304121|NCT01994954|5655649|P2|STARTED|Overall Study||97
2304122|NCT01994954|5655650|P1|STARTED|Overall Study||99
2304123|NCT01994902|5655668|P2|NOT COMPLETED|Test Period 2||6
2304124|NCT01994902|5655669|P1|NOT COMPLETED|Test Period 2||0
2304125|NCT01994902|5655668|P2|COMPLETED|Test Period 2||55
2304126|NCT01994902|5655669|P1|COMPLETED|Test Period 2||57
2304127|NCT01994902|5655668|P2|STARTED|Test Period 2||61
2304128|NCT01994902|5655669|P1|STARTED|Test Period 2||57
2304129|NCT01994902|5655668|P2|NOT COMPLETED|Test Period 1||3
2304130|NCT01994902|5655669|P1|NOT COMPLETED|Test Period 1||6
2304131|NCT01994902|5655668|P2|COMPLETED|Test Period 1|The subject testing Coloplast test product discontinued due to device deficiency with adverse event|61
2304132|NCT01994902|5655669|P1|COMPLETED|Test Period 1||57
2304133|NCT01994902|5655668|P2|STARTED|Test Period 1|Randomisation mistake:a subject randomised to SenSura Convex Light but tested Coloplast test product|64
2304134|NCT01994902|5655669|P1|STARTED|Test Period 1||63
2304135|NCT01994889|5655678|P3|NOT COMPLETED|Overall Study||92
2304136|NCT01994889|5655679|P2|NOT COMPLETED|Overall Study||63
2304137|NCT01994889|5655680|P1|NOT COMPLETED|Overall Study||28
2304138|NCT01994889|5655678|P3|COMPLETED|Overall Study||85
2304139|NCT01994889|5655679|P2|COMPLETED|Overall Study||113
2304140|NCT01994889|5655680|P1|COMPLETED|Overall Study||60
2304141|NCT01994889|5655678|P3|STARTED|Overall Study||177
2304142|NCT01994889|5655679|P2|STARTED|Overall Study||176
2304143|NCT01994889|5655680|P1|STARTED|Overall Study||88
2304144|NCT01994876|5655699|P2|NOT COMPLETED|Test Period 2||1
2304145|NCT01994876|5655700|P1|NOT COMPLETED|Test Period 2||1
2304146|NCT01994876|5655699|P2|COMPLETED|Test Period 2||6
2304147|NCT01994876|5655700|P1|COMPLETED|Test Period 2||8
2304148|NCT01994876|5655699|P2|STARTED|Test Period 2||7
2304149|NCT01994876|5655700|P1|STARTED|Test Period 2||9
2304150|NCT01994876|5655699|P2|NOT COMPLETED|Test Period 1||2
2304151|NCT01994876|5655700|P1|NOT COMPLETED|Test Period 1||0
2304152|NCT01994876|5655699|P2|COMPLETED|Test Period 1||7
2304153|NCT01994876|5655700|P1|COMPLETED|Test Period 1||9
2304154|NCT01994876|5655699|P2|STARTED|Test Period 1||9
2304155|NCT01994876|5655700|P1|STARTED|Test Period 1||9
2304156|NCT01994876|5655699|P2|NOT COMPLETED|Baseline - Own Product||0
2304157|NCT01994876|5655700|P1|NOT COMPLETED|Baseline - Own Product||0
2304158|NCT01994876|5655699|P2|COMPLETED|Baseline - Own Product||9
2304159|NCT01994876|5655700|P1|COMPLETED|Baseline - Own Product||9
2304160|NCT01994876|5655699|P2|STARTED|Baseline - Own Product||9
2304161|NCT01994876|5655700|P1|STARTED|Baseline - Own Product||9
2304162|NCT01994863|5655708|P2|NOT COMPLETED|Period 2||4
2304163|NCT01994863|5655709|P1|NOT COMPLETED|Period 2||1
2304164|NCT01994863|5655708|P2|COMPLETED|Period 2||5
2304165|NCT01994863|5655709|P1|COMPLETED|Period 2||7
2304166|NCT01994863|5655708|P2|STARTED|Period 2||9
2304167|NCT01994863|5655709|P1|STARTED|Period 2||8
2304168|NCT01994863|5655708|P2|NOT COMPLETED|Period 1||3
2304169|NCT01994863|5655709|P1|NOT COMPLETED|Period 1||7
2304170|NCT01994863|5655708|P2|COMPLETED|Period 1||9
2304171|NCT01994863|5655709|P1|COMPLETED|Period 1||4
2304172|NCT01994863|5655708|P2|STARTED|Period 1||12
2304173|NCT01994863|5655709|P1|STARTED|Period 1||11
2304174|NCT01994850|5655715|P1|NOT COMPLETED|Overall Study||2
2304175|NCT01994850|5655715|P1|COMPLETED|Overall Study||30
2304176|NCT01994850|5655715|P1|STARTED|Overall Study||32
2304177|NCT01994837|5655720|P1|NOT COMPLETED|Overall Study||32
2304178|NCT01994837|5655720|P1|COMPLETED|Overall Study||0
2304179|NCT01994837|5655720|P1|Treated|Overall Study||32
2304180|NCT01994837|5655720|P1|STARTED|Overall Study||32
2304181|NCT01994785|5655737|P4|NOT COMPLETED|Overall Study||3
2304182|NCT01994785|5655738|P3|NOT COMPLETED|Overall Study||0
2304183|NCT01994785|5655739|P2|NOT COMPLETED|Overall Study||1
2304184|NCT01994785|5655740|P1|NOT COMPLETED|Overall Study||8
2304185|NCT01994785|5655737|P4|COMPLETED|Overall Study||114
2304186|NCT01994785|5655738|P3|COMPLETED|Overall Study||117
2304187|NCT01994785|5655739|P2|COMPLETED|Overall Study||108
2304188|NCT01994785|5655740|P1|COMPLETED|Overall Study||101
2304189|NCT01994785|5655737|P4|STARTED|Overall Study||117
2304190|NCT01994785|5655738|P3|STARTED|Overall Study||117
2304191|NCT01994785|5655739|P2|STARTED|Overall Study||109
2304192|NCT01994785|5655740|P1|STARTED|Overall Study||109
2304193|NCT01994746|5655750|P2|NOT COMPLETED|Second Visit||0
2304194|NCT01994746|5655751|P1|NOT COMPLETED|Second Visit||0
2304195|NCT01994746|5655750|P2|COMPLETED|Second Visit||38
2304196|NCT01994746|5655751|P1|COMPLETED|Second Visit||38
2304197|NCT01994746|5655750|P2|Completed Both Dosing Visits|Second Visit||38
2304198|NCT01994746|5655751|P1|Completed Both Dosing Visits|Second Visit||38
2304199|NCT01994746|5655750|P2|STARTED|Second Visit||38
2304200|NCT01994746|5655751|P1|STARTED|Second Visit|One participant requested to withdraw after completing the first dosing visit.|38
2304201|NCT01994746|5655750|P2|NOT COMPLETED|First Visit||0
2304202|NCT01994746|5655751|P1|NOT COMPLETED|First Visit||0
2304203|NCT01994746|5655750|P2|COMPLETED|First Visit||38
2304204|NCT01994746|5655751|P1|COMPLETED|First Visit||39
2304205|NCT01994746|5655750|P2|Received At Least 1 Dose|First Visit||38
2304206|NCT01994746|5655751|P1|Received At Least 1 Dose|First Visit||39
2304207|NCT01994746|5655750|P2|STARTED|First Visit||38
2304208|NCT01994746|5655751|P1|STARTED|First Visit||39
2304209|NCT01994720|5655777|P2|NOT COMPLETED|Overall Study||56
2304210|NCT01994720|5655778|P1|NOT COMPLETED|Overall Study||46
2304211|NCT01994720|5655777|P2|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6554
2304212|NCT01994720|5655778|P1|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6543
2304213|NCT01994720|5655777|P2|STARTED|Overall Study||6610
2304214|NCT01994720|5655778|P1|STARTED|Overall Study||6589
2304215|NCT01994629|5655820|P2|NOT COMPLETED|Overall Study||3
2304216|NCT01994629|5655821|P1|NOT COMPLETED|Overall Study||1
2304217|NCT01994629|5655820|P2|COMPLETED|Overall Study||99
2304218|NCT01994629|5655821|P1|COMPLETED|Overall Study||99
2304219|NCT01994629|5655820|P2|STARTED|Overall Study||102
2304220|NCT01994629|5655821|P1|STARTED|Overall Study||100
2304221|NCT01994590|5655845|P1|NOT COMPLETED|Overall Study||2
2304222|NCT01994590|5655845|P1|COMPLETED|Overall Study||2
2304223|NCT01994590|5655845|P1|STARTED|Overall Study||4
2304224|NCT01994486|5655849|P1|NOT COMPLETED|Overall Study||0
2304225|NCT01994486|5655849|P1|COMPLETED|Overall Study||20
2304226|NCT01994486|5655849|P1|STARTED|Overall Study||20
2304227|NCT01994395|5655860|P2|NOT COMPLETED|Overall Study||2
2304228|NCT01994395|5655861|P1|NOT COMPLETED|Overall Study||1
2304229|NCT01994395|5655860|P2|COMPLETED|Overall Study||25
2304230|NCT01994395|5655861|P1|COMPLETED|Overall Study||25
2304231|NCT01994395|5655860|P2|STARTED|Overall Study||27
2304232|NCT01994395|5655861|P1|STARTED|Overall Study||26
2304233|NCT01994291|5655886|P3|NOT COMPLETED|Overall Study||9
2304234|NCT01994291|5655887|P2|NOT COMPLETED|Overall Study||7
2304235|NCT01994291|5655888|P1|NOT COMPLETED|Overall Study||15
2304236|NCT01994291|5655886|P3|COMPLETED|Overall Study||47
2304237|NCT01994291|5655887|P2|COMPLETED|Overall Study||36
2304238|NCT01994291|5655888|P1|COMPLETED|Overall Study||84
2304239|NCT01994291|5655886|P3|Received Treatment|Overall Study||56
2304240|NCT01994291|5655887|P2|Received Treatment|Overall Study||43
2304241|NCT01994291|5655888|P1|Received Treatment|Overall Study||99
2304242|NCT01994291|5655886|P3|STARTED|Overall Study||56
2304243|NCT01994291|5655887|P2|STARTED|Overall Study||43
2304244|NCT01994291|5655888|P1|STARTED|Overall Study||99
2304245|NCT01994226|5655944|P2|NOT COMPLETED|Overall Study||21
2304246|NCT01994226|5655945|P1|NOT COMPLETED|Overall Study||19
2304247|NCT01994226|5655944|P2|COMPLETED|Overall Study||179
2304248|NCT01994226|5655945|P1|COMPLETED|Overall Study||180
2304249|NCT01994226|5655944|P2|STARTED|Overall Study||200
2304250|NCT01994226|5655945|P1|STARTED|Overall Study||199
2304251|NCT01994109|5655954|P4|NOT COMPLETED|Open-label Phase (Part B)||42
2304252|NCT01994109|5655955|P3|NOT COMPLETED|Open-label Phase (Part B)||0
2304253|NCT01994109|5655956|P2|NOT COMPLETED|Open-label Phase (Part B)||0
2304254|NCT01994109|5655957|P1|NOT COMPLETED|Open-label Phase (Part B)||0
2304255|NCT01994109|5655954|P4|COMPLETED|Open-label Phase (Part B)||128
2304256|NCT01994109|5655955|P3|COMPLETED|Open-label Phase (Part B)|No placebo group in Part B.|0
2304257|NCT01994109|5655956|P2|COMPLETED|Open-label Phase (Part B)||0
2304258|NCT01994109|5655957|P1|COMPLETED|Open-label Phase (Part B)||0
2304259|NCT01994109|5655954|P4|STARTED|Open-label Phase (Part B)|61 from 2500 U group, 57 from 3500 U group, 52 from Placebo group continued to Part B|170
2304260|NCT01994109|5655955|P3|STARTED|Open-label Phase (Part B)|No placebo group in Part B.|0
2304261|NCT01994109|5655956|P2|STARTED|Open-label Phase (Part B)||0
2304262|NCT01994109|5655957|P1|STARTED|Open-label Phase (Part B)||0
2304263|NCT01994109|5655954|P4|NOT COMPLETED|Double-blind Phase (Part A)||0
2304264|NCT01994109|5655955|P3|NOT COMPLETED|Double-blind Phase (Part A)||7
2304265|NCT01994109|5655956|P2|NOT COMPLETED|Double-blind Phase (Part A)||3
2304266|NCT01994109|5655957|P1|NOT COMPLETED|Double-blind Phase (Part A)||1
2304267|NCT01994109|5655954|P4|COMPLETED|Double-blind Phase (Part A)||0
2304268|NCT01994109|5655955|P3|COMPLETED|Double-blind Phase (Part A)||53
2304269|NCT01994109|5655956|P2|COMPLETED|Double-blind Phase (Part A)||61
2304270|NCT01994109|5655957|P1|COMPLETED|Double-blind Phase (Part A)||62
2304271|NCT01994109|5655954|P4|STARTED|Double-blind Phase (Part A)||0
2304272|NCT01994109|5655955|P3|STARTED|Double-blind Phase (Part A)||60
2304273|NCT01994109|5655956|P2|STARTED|Double-blind Phase (Part A)||64
2304274|NCT01994109|5655957|P1|STARTED|Double-blind Phase (Part A)||63
2304275|NCT01993940|5655971|P2|NOT COMPLETED|Overall Study||44
2304276|NCT01993940|5655972|P1|NOT COMPLETED|Overall Study||40
2304277|NCT01993940|5655971|P2|COMPLETED|Overall Study||232
2304278|NCT01993940|5655972|P1|COMPLETED|Overall Study||237
2304279|NCT01993940|5655971|P2|Received Treatment|Overall Study||276
2304280|NCT01993940|5655972|P1|Received Treatment|Overall Study||272
2304281|NCT01993940|5655971|P2|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|276
2304282|NCT01993940|5655972|P1|STARTED|Overall Study|Includes one participant who enrolled at two different sites|277
2304283|NCT01993927|5655986|P1|NOT COMPLETED|Overall Study||29
2304284|NCT01993927|5655986|P1|COMPLETED|Overall Study||713
2304285|NCT01993927|5655986|P1|STARTED|Overall Study||742
2304286|NCT01993888|5655994|P2|NOT COMPLETED|Overall Study||3
2304287|NCT01993888|5655995|P1|NOT COMPLETED|Overall Study||2
2304288|NCT01993888|5655994|P2|COMPLETED|Overall Study||49
2304289|NCT01993888|5655995|P1|COMPLETED|Overall Study||48
2304290|NCT01993888|5655994|P2|STARTED|Overall Study||52
2304291|NCT01993888|5655995|P1|STARTED|Overall Study||50
2304292|NCT01993875|5656013|P2|NOT COMPLETED|Overall Study||6
2304293|NCT01993875|5656014|P1|NOT COMPLETED|Overall Study||7
2304294|NCT01993875|5656013|P2|COMPLETED|Overall Study||76
2304295|NCT01993875|5656014|P1|COMPLETED|Overall Study||75
2304296|NCT01993875|5656013|P2|STARTED|Overall Study||82
2304297|NCT01993875|5656014|P1|STARTED|Overall Study||82
2304298|NCT01993849|5656032|P2|NOT COMPLETED|Overall Study||2
2304299|NCT01993849|5656033|P1|NOT COMPLETED|Overall Study||3
2304300|NCT01993849|5656032|P2|COMPLETED|Overall Study||9
2304301|NCT01993849|5656033|P1|COMPLETED|Overall Study||9
2304302|NCT01993849|5656032|P2|STARTED|Overall Study||11
2304303|NCT01993849|5656033|P1|STARTED|Overall Study||12
2304304|NCT01993823|5656043|P2|NOT COMPLETED|Overall Study||16
2304305|NCT01993823|5656044|P1|NOT COMPLETED|Overall Study||7
2304306|NCT01993823|5656043|P2|COMPLETED|Overall Study||79
2304307|NCT01993823|5656044|P1|COMPLETED|Overall Study||88
2304308|NCT01993823|5656043|P2|STARTED|Overall Study||95
2304309|NCT01993823|5656044|P1|STARTED|Overall Study||95
2304310|NCT01993667|5656054|P2|NOT COMPLETED|Overall Study||19
2304311|NCT01993667|5656055|P1|NOT COMPLETED|Overall Study||21
2304312|NCT01993667|5656054|P2|COMPLETED|Overall Study||47
2304313|NCT01993667|5656055|P1|COMPLETED|Overall Study||43
2304314|NCT01993667|5656054|P2|STARTED|Overall Study||66
2304315|NCT01993667|5656055|P1|STARTED|Overall Study||64
2304316|NCT01993238|5656063|P1|NOT COMPLETED|Overall Study||0
2304317|NCT01993238|5656063|P1|COMPLETED|Overall Study||11
2304318|NCT01993238|5656063|P1|STARTED|Overall Study||11
2304319|NCT01993108|5656070|P2|NOT COMPLETED|Overall Study||0
2304320|NCT01993108|5656071|P1|NOT COMPLETED|Overall Study||0
2304321|NCT01993108|5656070|P2|COMPLETED|Overall Study||12
2304322|NCT01993108|5656071|P1|COMPLETED|Overall Study||11
2304323|NCT01993108|5656070|P2|STARTED|Overall Study||12
2304324|NCT01993108|5656071|P1|STARTED|Overall Study||11
2304325|NCT01993030|5656102|P2|NOT COMPLETED|Overall Study||4
2304326|NCT01993030|5656103|P1|NOT COMPLETED|Overall Study||0
2304327|NCT01993030|5656102|P2|COMPLETED|Overall Study||31
2304328|NCT01993030|5656103|P1|COMPLETED|Overall Study||36
2304329|NCT01993030|5656102|P2|STARTED|Overall Study||35
2304330|NCT01993030|5656103|P1|STARTED|Overall Study||36
2304331|NCT01993017|5656120|P3|NOT COMPLETED|Overall Study||79
2304332|NCT01993017|5656121|P2|NOT COMPLETED|Overall Study||90
2304333|NCT01993017|5656122|P1|NOT COMPLETED|Overall Study||106
2304334|NCT01993017|5656120|P3|COMPLETED|Overall Study||421
2304335|NCT01993017|5656121|P2|COMPLETED|Overall Study||411
2304336|NCT01993017|5656122|P1|COMPLETED|Overall Study||393
2304337|NCT01993017|5656120|P3|STARTED|Overall Study||500
2304338|NCT01993017|5656121|P2|STARTED|Overall Study||501
2304339|NCT01993017|5656122|P1|STARTED|Overall Study||499
2304340|NCT01992874|5656133|P3|NOT COMPLETED|Part B||0
2304341|NCT01992874|5656134|P2|NOT COMPLETED|Part B||0
2304342|NCT01992874|5656135|P1|NOT COMPLETED|Part B||0
2304343|NCT01992874|5656133|P3|COMPLETED|Part B||38
2304344|NCT01992874|5656134|P2|COMPLETED|Part B||0
2304345|NCT01992874|5656135|P1|COMPLETED|Part B||0
2304346|NCT01992874|5656133|P3|STARTED|Part B||38
2304347|NCT01992874|5656134|P2|STARTED|Part B||0
2304348|NCT01992874|5656135|P1|STARTED|Part B||0
2304349|NCT01992874|5656133|P3|NOT COMPLETED|Part A||0
2304350|NCT01992874|5656134|P2|NOT COMPLETED|Part A||0
2304351|NCT01992874|5656135|P1|NOT COMPLETED|Part A||0
2304352|NCT01992874|5656133|P3|COMPLETED|Part A||0
2304353|NCT01992874|5656134|P2|COMPLETED|Part A||17
2304354|NCT01992874|5656135|P1|COMPLETED|Part A||21
2304355|NCT01992874|5656133|P3|STARTED|Part A||0
2304356|NCT01992874|5656134|P2|STARTED|Part A||17
2304357|NCT01992874|5656135|P1|STARTED|Part A||21
2304358|NCT01992757|5656163|P1|NOT COMPLETED|Overall Study||2
2304359|NCT01992757|5656163|P1|COMPLETED|Overall Study||49
2304360|NCT01992757|5656163|P1|STARTED|Overall Study||51
2304361|NCT01992549|5656168|P1|NOT COMPLETED|Overall Study||4
2304362|NCT01992549|5656168|P1|COMPLETED|Overall Study||44
2304363|NCT01992549|5656168|P1|SURG Population|Overall Study||3
2304364|NCT01992549|5656168|P1|BLEED Population|Overall Study||29
2304365|NCT01992549|5656168|P1|PROPH Population|Overall Study||47
2304366|NCT01992549|5656168|P1|ITT Population|Overall Study||47
2304367|NCT01992549|5656168|P1|SAF Population|Overall Study||48
2304368|NCT01992549|5656168|P1|STARTED|Overall Study||48
2304369|NCT01992536|5656188|P10|NOT COMPLETED|Overall Study||1
2304370|NCT01992536|5656189|P9|NOT COMPLETED|Overall Study||1
2304371|NCT01992536|5656190|P8|NOT COMPLETED|Overall Study||0
2304372|NCT01992536|5656191|P7|NOT COMPLETED|Overall Study||7
2304373|NCT01992536|5656192|P6|NOT COMPLETED|Overall Study||1
2304374|NCT01992536|5656193|P5|NOT COMPLETED|Overall Study||0
2304375|NCT01992536|5656194|P4|NOT COMPLETED|Overall Study||2
2304376|NCT01992536|5656195|P3|NOT COMPLETED|Overall Study||1
2304377|NCT01992536|5656196|P2|NOT COMPLETED|Overall Study||3
2304378|NCT01992536|5656197|P1|NOT COMPLETED|Overall Study||4
2304379|NCT01992536|5656188|P10|COMPLETED|Overall Study||18
2304380|NCT01992536|5656189|P9|COMPLETED|Overall Study||18
2304381|NCT01992536|5656190|P8|COMPLETED|Overall Study||21
2304382|NCT01992536|5656191|P7|COMPLETED|Overall Study||0
2304383|NCT01992536|5656192|P6|COMPLETED|Overall Study||20
2304384|NCT01992536|5656193|P5|COMPLETED|Overall Study||11
2304385|NCT01992536|5656194|P4|COMPLETED|Overall Study||22
2304386|NCT01992536|5656195|P3|COMPLETED|Overall Study||16
2304387|NCT01992536|5656196|P2|COMPLETED|Overall Study||22
2304388|NCT01992536|5656197|P1|COMPLETED|Overall Study||22
2304389|NCT01992536|5656188|P10|STARTED|Overall Study||19
2304390|NCT01992536|5656189|P9|STARTED|Overall Study||19
2304391|NCT01992536|5656190|P8|STARTED|Overall Study||21
2304392|NCT01992536|5656191|P7|STARTED|Overall Study||7
2304393|NCT01992536|5656192|P6|STARTED|Overall Study||21
2304394|NCT01992536|5656193|P5|STARTED|Overall Study||11
2304395|NCT01992536|5656194|P4|STARTED|Overall Study||24
2304396|NCT01992536|5656195|P3|STARTED|Overall Study||17
2304397|NCT01992536|5656196|P2|STARTED|Overall Study||25
2304398|NCT01992536|5656197|P1|STARTED|Overall Study||26
2304399|NCT01992523|5656414|P2|NOT COMPLETED|Overall Study||0
2304400|NCT01992523|5656415|P1|NOT COMPLETED|Overall Study||0
2304401|NCT01992523|5656414|P2|COMPLETED|Overall Study||41
2304402|NCT01992523|5656415|P1|COMPLETED|Overall Study||41
2304403|NCT01992523|5656414|P2|STARTED|Overall Study||41
2304404|NCT01992523|5656415|P1|STARTED|Overall Study||41
2304405|NCT01992354|5656427|P1|NOT COMPLETED|Overall Study||0
2304406|NCT01992354|5656427|P1|COMPLETED|Overall Study||4
2304407|NCT01992354|5656427|P1|STARTED|Overall Study||4
2304408|NCT01992185|5656434|P2|NOT COMPLETED|Overall Study||0
2304409|NCT01992185|5656435|P1|NOT COMPLETED|Overall Study||0
2304410|NCT01992185|5656434|P2|COMPLETED|Overall Study||8
2304411|NCT01992185|5656435|P1|COMPLETED|Overall Study||7
2304412|NCT01992185|5656434|P2|STARTED|Overall Study||8
2304413|NCT01992185|5656435|P1|STARTED|Overall Study||7
2304414|NCT01992172|5656443|P2|NOT COMPLETED|Overall Study||0
2304415|NCT01992172|5656444|P1|NOT COMPLETED|Overall Study||0
2304416|NCT01992172|5656443|P2|COMPLETED|Overall Study||0
2304417|NCT01992172|5656444|P1|COMPLETED|Overall Study||7
2304418|NCT01992172|5656443|P2|STARTED|Overall Study||0
2304419|NCT01992172|5656444|P1|STARTED|Overall Study||7
2304420|NCT01992159|5656454|P4|NOT COMPLETED|Overall Study||4
2304421|NCT01992159|5656455|P3|NOT COMPLETED|Overall Study||1
2304422|NCT01992159|5656456|P2|NOT COMPLETED|Overall Study||8
2304423|NCT01992159|5656457|P1|NOT COMPLETED|Overall Study||4
2304424|NCT01992159|5656454|P4|COMPLETED|Overall Study||59
2304425|NCT01992159|5656455|P3|COMPLETED|Overall Study||62
2304426|NCT01992159|5656456|P2|COMPLETED|Overall Study||55
2304427|NCT01992159|5656457|P1|COMPLETED|Overall Study||59
2304428|NCT01992159|5656454|P4|Completed First 12 Months of Study|Overall Study||59
2304429|NCT01992159|5656455|P3|Completed First 12 Months of Study|Overall Study||63
2304430|NCT01992159|5656456|P2|Completed First 12 Months of Study|Overall Study||56
2304431|NCT01992159|5656457|P1|Completed First 12 Months of Study|Overall Study||59
2304432|NCT01992159|5656454|P4|Received Treatment|Overall Study||63
2304433|NCT01992159|5656455|P3|Received Treatment|Overall Study||63
2304434|NCT01992159|5656456|P2|Received Treatment|Overall Study||63
2304435|NCT01992159|5656457|P1|Received Treatment|Overall Study||63
2304436|NCT01992159|5656454|P4|STARTED|Overall Study||63
2304437|NCT01992159|5656455|P3|STARTED|Overall Study||63
2304438|NCT01992159|5656456|P2|STARTED|Overall Study||63
2304439|NCT01992159|5656457|P1|STARTED|Overall Study||63
2304440|NCT01992107|5656510|P3|NOT COMPLETED|Overall Study||36
2304441|NCT01992107|5656511|P2|NOT COMPLETED|Overall Study||33
2304442|NCT01992107|5656512|P1|NOT COMPLETED|Overall Study||68
2304443|NCT01992107|5656510|P3|COMPLETED|Overall Study||545
2304444|NCT01992107|5656511|P2|COMPLETED|Overall Study||560
2304445|NCT01992107|5656512|P1|COMPLETED|Overall Study||1091
2304446|NCT01992107|5656510|P3|STARTED|Overall Study||581
2304447|NCT01992107|5656511|P2|STARTED|Overall Study||593
2304448|NCT01992107|5656512|P1|STARTED|Overall Study||1159
2304449|NCT01992094|5656568|P3|NOT COMPLETED|Overall Study||21
2304450|NCT01992094|5656569|P2|NOT COMPLETED|Overall Study||24
2304451|NCT01992094|5656570|P1|NOT COMPLETED|Overall Study||50
2304452|NCT01992094|5656568|P3|COMPLETED|Overall Study||648
2304453|NCT01992094|5656569|P2|COMPLETED|Overall Study||652
2304454|NCT01992094|5656570|P1|COMPLETED|Overall Study||1285
2304455|NCT01992094|5656568|P3|STARTED|Overall Study||669
2304456|NCT01992094|5656569|P2|STARTED|Overall Study||676
2304457|NCT01992094|5656570|P1|STARTED|Overall Study||1335
2304458|NCT01992016|5656628|P2|NOT COMPLETED|Overall Study||0
2304459|NCT01992016|5656629|P1|NOT COMPLETED|Overall Study||0
2304460|NCT01992016|5656628|P2|COMPLETED|Overall Study||7
2304461|NCT01992016|5656629|P1|COMPLETED|Overall Study||4
2304462|NCT01992016|5656628|P2|STARTED|Overall Study||7
2304463|NCT01992016|5656629|P1|STARTED|Overall Study||4
2304464|NCT01991990|5656637|P2|NOT COMPLETED|Overall Study||0
2304465|NCT01991990|5656638|P1|NOT COMPLETED|Overall Study||0
2304466|NCT01991990|5656637|P2|COMPLETED|Overall Study||12
2304467|NCT01991990|5656638|P1|COMPLETED|Overall Study||6
2304468|NCT01991990|5656637|P2|STARTED|Overall Study||12
2304469|NCT01991990|5656638|P1|STARTED|Overall Study||6
2304470|NCT01991860|5656680|P2|NOT COMPLETED|Overall Study||2
2304471|NCT01991860|5656681|P1|NOT COMPLETED|Overall Study||4
2304472|NCT01991860|5656680|P2|COMPLETED|Overall Study||164
2304473|NCT01991860|5656681|P1|COMPLETED|Overall Study||172
2304474|NCT01991860|5656680|P2|STARTED|Overall Study||166
2304475|NCT01991860|5656681|P1|STARTED|Overall Study||176
2304476|NCT01991821|5656701|P2|NOT COMPLETED|Overall Study||167
2304477|NCT01991821|5656702|P1|NOT COMPLETED|Overall Study||163
2304478|NCT01991821|5656701|P2|COMPLETED|Overall Study||11
2304479|NCT01991821|5656702|P1|COMPLETED|Overall Study||6
2304480|NCT01991821|5656701|P2|STARTED|Overall Study||178
2304481|NCT01991821|5656702|P1|STARTED|Overall Study||169
2304482|NCT01991808|5656720|P1|NOT COMPLETED|Overall Study||0
2304483|NCT01991808|5656720|P1|COMPLETED|Overall Study||16
2304484|NCT01991808|5656720|P1|STARTED|Overall Study||16
2304485|NCT01991743|5656728|P4|NOT COMPLETED|Overall Study||0
2304486|NCT01991743|5656729|P3|NOT COMPLETED|Overall Study||1
2304487|NCT01991743|5656730|P2|NOT COMPLETED|Overall Study||0
2304488|NCT01991743|5656731|P1|NOT COMPLETED|Overall Study||0
2304489|NCT01991743|5656728|P4|COMPLETED|Overall Study||60
2304490|NCT01991743|5656729|P3|COMPLETED|Overall Study||59
2304491|NCT01991743|5656730|P2|COMPLETED|Overall Study||60
2304492|NCT01991743|5656731|P1|COMPLETED|Overall Study||60
2304493|NCT01991743|5656728|P4|STARTED|Overall Study||60
2304494|NCT01991743|5656729|P3|STARTED|Overall Study||60
2304495|NCT01991743|5656730|P2|STARTED|Overall Study||60
2304496|NCT01991743|5656731|P1|STARTED|Overall Study||60
2304497|NCT01991548|5656757|P1|NOT COMPLETED|Overall Study||1
2304498|NCT01991548|5656757|P1|COMPLETED|Overall Study||39
2304499|NCT01991548|5656757|P1|STARTED|Overall Study||40
2304500|NCT01991522|5656763|P2|NOT COMPLETED|Overall Study||0
2304501|NCT01991522|5656764|P1|NOT COMPLETED|Overall Study||0
2304502|NCT01991522|5656763|P2|COMPLETED|Overall Study||17
2304503|NCT01991522|5656764|P1|COMPLETED|Overall Study||16
2304504|NCT01991522|5656763|P2|STARTED|Overall Study||17
2304505|NCT01991522|5656764|P1|STARTED|Overall Study||16
2304506|NCT01991483|5656776|P4|NOT COMPLETED|Dose Level 1000 mg||1
2304507|NCT01991483|5656777|P3|NOT COMPLETED|Dose Level 1000 mg||0
2304508|NCT01991483|5656778|P2|NOT COMPLETED|Dose Level 1000 mg||0
2304509|NCT01991483|5656779|P1|NOT COMPLETED|Dose Level 1000 mg||0
2304510|NCT01991483|5656776|P4|COMPLETED|Dose Level 1000 mg||3
2304511|NCT01991483|5656777|P3|COMPLETED|Dose Level 1000 mg||0
2304512|NCT01991483|5656778|P2|COMPLETED|Dose Level 1000 mg||0
2304513|NCT01991483|5656779|P1|COMPLETED|Dose Level 1000 mg||0
2304514|NCT01991483|5656776|P4|Received at Least One Dose of Study Drug|Dose Level 1000 mg||4
2304515|NCT01991483|5656777|P3|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
2304516|NCT01991483|5656778|P2|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
2304517|NCT01991483|5656779|P1|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
2304518|NCT01991483|5656776|P4|STARTED|Dose Level 1000 mg|Multiple periods were added for each dose level to represent dose escalation.|4
2304519|NCT01991483|5656777|P3|STARTED|Dose Level 1000 mg|Multiple periods were added for each dose level to represent dose escalation.|0
2304520|NCT01991483|5656778|P2|STARTED|Dose Level 1000 mg||0
2304521|NCT01991483|5656779|P1|STARTED|Dose Level 1000 mg||0
2304522|NCT01991483|5656776|P4|NOT COMPLETED|Dose Level 600 mg||0
2304523|NCT01991483|5656777|P3|NOT COMPLETED|Dose Level 600 mg||2
2304524|NCT01991483|5656778|P2|NOT COMPLETED|Dose Level 600 mg||0
2304525|NCT01991483|5656779|P1|NOT COMPLETED|Dose Level 600 mg||0
2304526|NCT01991483|5656776|P4|COMPLETED|Dose Level 600 mg||0
2304527|NCT01991483|5656777|P3|COMPLETED|Dose Level 600 mg||9
2304528|NCT01991483|5656778|P2|COMPLETED|Dose Level 600 mg||0
2304529|NCT01991483|5656779|P1|COMPLETED|Dose Level 600 mg||0
2304530|NCT01991483|5656776|P4|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
2304531|NCT01991483|5656777|P3|Receive at Least One Dose of Study Drug|Dose Level 600 mg||11
2304532|NCT01991483|5656778|P2|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
2304533|NCT01991483|5656779|P1|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
2304534|NCT01991483|5656776|P4|STARTED|Dose Level 600 mg||0
2304535|NCT01991483|5656777|P3|STARTED|Dose Level 600 mg|Multiple periods were added for each dose level to represent dose escalation.|11
2304536|NCT01991483|5656778|P2|STARTED|Dose Level 600 mg|Multiple periods were added for each dose level to represent dose escalation.|0
2304537|NCT01991483|5656779|P1|STARTED|Dose Level 600 mg||0
2304538|NCT01991483|5656776|P4|NOT COMPLETED|Dose Level 300 mg||0
2304539|NCT01991483|5656777|P3|NOT COMPLETED|Dose Level 300 mg||0
2304540|NCT01991483|5656778|P2|NOT COMPLETED|Dose Level 300 mg||0
2304541|NCT01991483|5656779|P1|NOT COMPLETED|Dose Level 300 mg||0
2304542|NCT01991483|5656776|P4|COMPLETED|Dose Level 300 mg||0
2304543|NCT01991483|5656777|P3|COMPLETED|Dose Level 300 mg||0
2304544|NCT01991483|5656778|P2|COMPLETED|Dose Level 300 mg||6
2304545|NCT01991483|5656779|P1|COMPLETED|Dose Level 300 mg||0
2304546|NCT01991483|5656776|P4|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
2304547|NCT01991483|5656777|P3|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
2304548|NCT01991483|5656778|P2|Received at Least One Dose of Study Drug|Dose Level 300 mg||6
2304549|NCT01991483|5656779|P1|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
2304550|NCT01991483|5656776|P4|STARTED|Dose Level 300 mg||0
2304551|NCT01991483|5656777|P3|STARTED|Dose Level 300 mg||0
2304552|NCT01991483|5656778|P2|STARTED|Dose Level 300 mg|Multiple periods were added for each dose level to represent dose escalation.|6
2304553|NCT01991483|5656779|P1|STARTED|Dose Level 300 mg|Multiple periods were added for each dose level to represent dose escalation.|0
2304554|NCT01991483|5656776|P4|NOT COMPLETED|Dose Level: Placebo||0
2304555|NCT01991483|5656777|P3|NOT COMPLETED|Dose Level: Placebo||0
2304556|NCT01991483|5656778|P2|NOT COMPLETED|Dose Level: Placebo||0
2304557|NCT01991483|5656779|P1|NOT COMPLETED|Dose Level: Placebo||0
2304558|NCT01991483|5656776|P4|COMPLETED|Dose Level: Placebo||0
2304559|NCT01991483|5656777|P3|COMPLETED|Dose Level: Placebo||0
2304560|NCT01991483|5656778|P2|COMPLETED|Dose Level: Placebo||0
2304561|NCT01991483|5656779|P1|COMPLETED|Dose Level: Placebo||7
2304562|NCT01991483|5656776|P4|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
2304563|NCT01991483|5656777|P3|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
2304564|NCT01991483|5656778|P2|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
2304565|NCT01991483|5656779|P1|Received at Least One Dose of Study Drug|Dose Level: Placebo||7
2304566|NCT01991483|5656776|P4|STARTED|Dose Level: Placebo||0
2304567|NCT01991483|5656777|P3|STARTED|Dose Level: Placebo||0
2304568|NCT01991483|5656778|P2|STARTED|Dose Level: Placebo||0
2304569|NCT01991483|5656779|P1|STARTED|Dose Level: Placebo||7
2304570|NCT01991470|5656845|P1|NOT COMPLETED|Enlite 3 Period||12
2304571|NCT01991470|5656845|P1|COMPLETED|Enlite 3 Period||146
2304572|NCT01991470|5656845|P1|STARTED|Enlite 3 Period|Additional 25 subjects who participated only Enlite 3 phase|158
2304573|NCT01991470|5656845|P1|NOT COMPLETED|Enlite 1 Period||20
2304574|NCT01991470|5656845|P1|COMPLETED|Enlite 1 Period||141
2304575|NCT01991470|5656845|P1|STARTED|Enlite 1 Period||161
2304576|NCT01991314|5656859|P2|NOT COMPLETED|Overall Study||11
2304577|NCT01991314|5656860|P1|NOT COMPLETED|Overall Study||11
2304578|NCT01991314|5656859|P2|COMPLETED|Overall Study||32
2304579|NCT01991314|5656860|P1|COMPLETED|Overall Study||34
2304580|NCT01991314|5656859|P2|STARTED|Overall Study||43
2304581|NCT01991314|5656860|P1|STARTED|Overall Study||45
2304582|NCT01990898|5656878|P1|NOT COMPLETED|Overall Study||4
2304583|NCT01990898|5656878|P1|COMPLETED|Overall Study||22
2304584|NCT01990898|5656878|P1|3 Months|Overall Study||22
2304585|NCT01990898|5656878|P1|STARTED|Overall Study||26
2304586|NCT01990859|5656882|P1|NOT COMPLETED|90 Day Follow Up for All Participants||0
2304587|NCT01990859|5656882|P1|COMPLETED|90 Day Follow Up for All Participants||20
2304588|NCT01990859|5656882|P1|STARTED|90 Day Follow Up for All Participants|All entered into 90 day follow-up whether treatment and/or post dose follow up was completed or not.|20
2304589|NCT01990859|5656882|P1|NOT COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||17
2304590|NCT01990859|5656882|P1|COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||3
2304591|NCT01990859|5656882|P1|STARTED|Week 12 to Week 24 Post Dosing Follow Up|All were entered into follow-up whether dosing was completed or not.|20
2304592|NCT01990859|5656882|P1|NOT COMPLETED|Treatment (4 Doses Over 12 Weeks)||5
2304593|NCT01990859|5656882|P1|COMPLETED|Treatment (4 Doses Over 12 Weeks)||15
2304594|NCT01990859|5656882|P1|STARTED|Treatment (4 Doses Over 12 Weeks)||20
2304601|NCT01990794|5656902|P1|NOT COMPLETED|Overall Study||3
2304602|NCT01990794|5656902|P1|COMPLETED|Overall Study||10
2304603|NCT01990794|5656902|P1|One Month Into Study|Overall Study||10
2304604|NCT01990794|5656902|P1|STARTED|Overall Study||13
2304605|NCT01990768|5657017|P3|NOT COMPLETED|6-Month Follow-up||58
2304606|NCT01990768|5657018|P2|NOT COMPLETED|6-Month Follow-up||51
2304607|NCT01990768|5657019|P1|NOT COMPLETED|6-Month Follow-up||39
2304608|NCT01990768|5657017|P3|COMPLETED|6-Month Follow-up||288
2304609|NCT01990768|5657018|P2|COMPLETED|6-Month Follow-up||261
2304610|NCT01990768|5657019|P1|COMPLETED|6-Month Follow-up||270
2304611|NCT01990768|5657017|P3|STARTED|6-Month Follow-up||346
2304612|NCT01990768|5657018|P2|STARTED|6-Month Follow-up||312
2304613|NCT01990768|5657019|P1|STARTED|6-Month Follow-up||309
2304614|NCT01990768|5657017|P3|NOT COMPLETED|In-Hospital Study Drug Infusion||80
2304615|NCT01990768|5657018|P2|NOT COMPLETED|In-Hospital Study Drug Infusion||83
2304616|NCT01990768|5657019|P1|NOT COMPLETED|In-Hospital Study Drug Infusion||95
2304617|NCT01990768|5657017|P3|COMPLETED|In-Hospital Study Drug Infusion||266
2304618|NCT01990768|5657018|P2|COMPLETED|In-Hospital Study Drug Infusion||229
2304619|NCT01990768|5657019|P1|COMPLETED|In-Hospital Study Drug Infusion||214
2304620|NCT01990768|5657017|P3|STARTED|In-Hospital Study Drug Infusion||346
2304621|NCT01990768|5657018|P2|STARTED|In-Hospital Study Drug Infusion||312
2304622|NCT01990768|5657019|P1|STARTED|In-Hospital Study Drug Infusion||309
2304623|NCT01990768|5657017|P3|NOT COMPLETED|Prehospital Study Drug Infusion||19
2304624|NCT01990768|5657018|P2|NOT COMPLETED|Prehospital Study Drug Infusion||27
2304625|NCT01990768|5657019|P1|NOT COMPLETED|Prehospital Study Drug Infusion||19
2304626|NCT01990768|5657017|P3|COMPLETED|Prehospital Study Drug Infusion||327
2304627|NCT01990768|5657018|P2|COMPLETED|Prehospital Study Drug Infusion||285
2304628|NCT01990768|5657019|P1|COMPLETED|Prehospital Study Drug Infusion||290
2304629|NCT01990768|5657017|P3|STARTED|Prehospital Study Drug Infusion||346
2304630|NCT01990768|5657018|P2|STARTED|Prehospital Study Drug Infusion||312
2304631|NCT01990768|5657019|P1|STARTED|Prehospital Study Drug Infusion||309
2304632|NCT01990768|5657017|P3|NOT COMPLETED|Intervention Started||27
2304633|NCT01990768|5657018|P2|NOT COMPLETED|Intervention Started||33
2304634|NCT01990768|5657019|P1|NOT COMPLETED|Intervention Started||36
2304635|NCT01990768|5657017|P3|COMPLETED|Intervention Started||346
2304636|NCT01990768|5657018|P2|COMPLETED|Intervention Started||312
2304637|NCT01990768|5657019|P1|COMPLETED|Intervention Started||309
2304638|NCT01990768|5657017|P3|STARTED|Intervention Started||373
2304639|NCT01990768|5657018|P2|STARTED|Intervention Started||345
2304640|NCT01990768|5657019|P1|STARTED|Intervention Started||345
2304641|NCT01990742|5657084|P2|NOT COMPLETED|Overall Study||1353
2304642|NCT01990742|5657085|P1|NOT COMPLETED|Overall Study||407
2304643|NCT01990742|5657084|P2|COMPLETED|Overall Study|Eleven nursing homes completed the control group /usual care allocation.|2978
2304644|NCT01990742|5657085|P1|COMPLETED|Overall Study|Fourteen facilities completed the intervention.|2852
2304645|NCT01990742|5657084|P2|STARTED|Overall Study|This is a facility-level control , access to individual participants occurred only via MDS records.|4331
2304646|NCT01990742|5657085|P1|STARTED|Overall Study|This is a facility-level intervention, access to individual level records occurred via MDS data only|3259
2304647|NCT01990703|5657097|P2|NOT COMPLETED|Overall Study||45
2304648|NCT01990703|5657098|P1|NOT COMPLETED|Overall Study||39
2304649|NCT01990703|5657097|P2|COMPLETED|Overall Study||93
2304650|NCT01990703|5657098|P1|COMPLETED|Overall Study||108
2304651|NCT01990703|5657097|P2|STARTED|Overall Study||138
2304652|NCT01990703|5657098|P1|STARTED|Overall Study||147
2304653|NCT01990677|5657108|P2|NOT COMPLETED|Overall Study||1
2304654|NCT01990677|5657109|P1|NOT COMPLETED|Overall Study||2
2304655|NCT01990677|5657108|P2|COMPLETED|Overall Study||5
2304656|NCT01990677|5657109|P1|COMPLETED|Overall Study||10
2304657|NCT01990677|5657108|P2|STARTED|Overall Study||6
2304658|NCT01990677|5657109|P1|STARTED|Overall Study||12
2304659|NCT01990664|5657121|P2|NOT COMPLETED|Overall Study||11
2304660|NCT01990664|5657122|P1|NOT COMPLETED|Overall Study||7
2304661|NCT01990664|5657121|P2|COMPLETED|Overall Study||79
2304662|NCT01990664|5657122|P1|COMPLETED|Overall Study||95
2304663|NCT01990664|5657121|P2|STARTED|Overall Study||90
2304664|NCT01990664|5657122|P1|STARTED|Overall Study||102
2304665|NCT01990612|5657130|P2|NOT COMPLETED|Overall Study||3
2304666|NCT01990612|5657131|P1|NOT COMPLETED|Overall Study||7
2304667|NCT01990612|5657130|P2|COMPLETED|Overall Study||3059
2304668|NCT01990612|5657131|P1|COMPLETED|Overall Study||3037
2304669|NCT01990612|5657130|P2|STARTED|Overall Study||3062
2304670|NCT01990612|5657131|P1|STARTED|Overall Study||3044
2304671|NCT01990573|5657212|P3|NOT COMPLETED|Overall Study||1
2304672|NCT01990573|5657213|P2|NOT COMPLETED|Overall Study||0
2304673|NCT01990573|5657214|P1|NOT COMPLETED|Overall Study||0
2304674|NCT01990573|5657212|P3|COMPLETED|Overall Study||16
2304675|NCT01990573|5657213|P2|COMPLETED|Overall Study||14
2304676|NCT01990573|5657214|P1|COMPLETED|Overall Study||20
2304677|NCT01990573|5657212|P3|STARTED|Overall Study||17
2304678|NCT01990573|5657213|P2|STARTED|Overall Study||14
2304679|NCT01990573|5657214|P1|STARTED|Overall Study||20
2304680|NCT01990560|5657227|P1|NOT COMPLETED|Overall Study||1
2304681|NCT01990560|5657227|P1|COMPLETED|Overall Study||7
2304682|NCT01990560|5657227|P1|STARTED|Overall Study||8
2304683|NCT01990534|5657241|P1|NOT COMPLETED|Overall Study||60
2304684|NCT01990534|5657241|P1|COMPLETED|Overall Study||0
2304685|NCT01990534|5657241|P1|Ongoing|Overall Study||36
2304686|NCT01990534|5657241|P1|STARTED|Overall Study||60
2304687|NCT01990339|5657257|P1|NOT COMPLETED|Overall Study||2312
2304688|NCT01990339|5657257|P1|COMPLETED|Overall Study||12653
2304689|NCT01990339|5657257|P1|STARTED|Overall Study||14965
2304690|NCT01990313|5657262|P1|NOT COMPLETED|Overall Study||1
2304691|NCT01990313|5657262|P1|COMPLETED|Overall Study||14
2304692|NCT01990313|5657262|P1|STARTED|Overall Study||15
2304693|NCT01990300|5657267|P1|NOT COMPLETED|Overall Study||142
2304694|NCT01990300|5657267|P1|COMPLETED|Overall Study||3139
2304695|NCT01990300|5657267|P1|STARTED|Overall Study||3281
2304696|NCT01990261|5657273|P1|NOT COMPLETED|Overall Study||25
2304697|NCT01990261|5657273|P1|COMPLETED|Overall Study||8
2304698|NCT01990261|5657273|P1|Treated|Overall Study||29
2304699|NCT01990261|5657273|P1|STARTED|Overall Study||33
2304700|NCT01989975|5657283|P1|NOT COMPLETED|Overall Study||0
2304701|NCT01989975|5657283|P1|COMPLETED|Overall Study||40
2304702|NCT01989975|5657283|P1|STARTED|Overall Study||40
2304703|NCT01989910|5657292|P2|NOT COMPLETED|Overall Study||0
2304704|NCT01989910|5657293|P1|NOT COMPLETED|Overall Study||2
2304705|NCT01989910|5657292|P2|COMPLETED|Overall Study||54
2304706|NCT01989910|5657293|P1|COMPLETED|Overall Study||51
2304707|NCT01989910|5657292|P2|STARTED|Overall Study||54
2304708|NCT01989910|5657293|P1|STARTED|Overall Study||53
2304709|NCT01989793|5657305|P2|NOT COMPLETED|Overall Study||4
2304710|NCT01989793|5657306|P1|NOT COMPLETED|Overall Study||8
2304711|NCT01989793|5657305|P2|COMPLETED|Overall Study||15
2304712|NCT01989793|5657306|P1|COMPLETED|Overall Study||10
2304713|NCT01989793|5657305|P2|STARTED|Overall Study||19
2304714|NCT01989793|5657306|P1|STARTED|Overall Study||18
2304715|NCT01989754|5657330|P2|NOT COMPLETED|Overall Study||35
2304716|NCT01989754|5657331|P1|NOT COMPLETED|Overall Study||39
2304717|NCT01989754|5657330|P2|COMPLETED|Overall Study|Participants who died are included in this category.|2872
2304718|NCT01989754|5657331|P1|COMPLETED|Overall Study|Participants who died are included in this category.|2866
2304719|NCT01989754|5657330|P2|Treated|Overall Study||2904
2304720|NCT01989754|5657331|P1|Treated|Overall Study||2903
2304721|NCT01989754|5657330|P2|STARTED|Overall Study||2907
2304722|NCT01989754|5657331|P1|STARTED|Overall Study||2905
2304723|NCT01989689|5657343|P2|NOT COMPLETED|Treatment Period ( 3 Months)||0
2304724|NCT01989689|5657344|P1|NOT COMPLETED|Treatment Period ( 3 Months)||0
2304725|NCT01989689|5657343|P2|COMPLETED|Treatment Period ( 3 Months)||10
2304726|NCT01989689|5657344|P1|COMPLETED|Treatment Period ( 3 Months)||11
2304727|NCT01989689|5657343|P2|STARTED|Treatment Period ( 3 Months)||10
2304728|NCT01989689|5657344|P1|STARTED|Treatment Period ( 3 Months)||11
2304729|NCT01989689|5657343|P2|NOT COMPLETED|Treatment Period 1 ( 3 Months)||3
2304730|NCT01989689|5657344|P1|NOT COMPLETED|Treatment Period 1 ( 3 Months)||0
2304731|NCT01989689|5657343|P2|COMPLETED|Treatment Period 1 ( 3 Months)||10
2304732|NCT01989689|5657344|P1|COMPLETED|Treatment Period 1 ( 3 Months)||11
2304733|NCT01989689|5657343|P2|STARTED|Treatment Period 1 ( 3 Months)||13
2304734|NCT01989689|5657344|P1|STARTED|Treatment Period 1 ( 3 Months)||11
2304735|NCT01989689|5657343|P2|NOT COMPLETED|Baseline||0
2304736|NCT01989689|5657344|P1|NOT COMPLETED|Baseline||0
2304737|NCT01989689|5657343|P2|COMPLETED|Baseline||13
2304738|NCT01989689|5657344|P1|COMPLETED|Baseline||11
2304739|NCT01989689|5657343|P2|STARTED|Baseline||13
2304740|NCT01989689|5657344|P1|STARTED|Baseline||11
2304741|NCT01989676|5657356|P2|NOT COMPLETED|Overall Study||347
2304742|NCT01989676|5657357|P1|NOT COMPLETED|Overall Study||338
2304743|NCT01989676|5657356|P2|COMPLETED|Overall Study||6
2304744|NCT01989676|5657357|P1|COMPLETED|Overall Study||11
2304745|NCT01989676|5657356|P2|STARTED|Overall Study|Treated (355 randomized)|353
2304746|NCT01989676|5657357|P1|STARTED|Overall Study|Treated (352 randomized)|349
2304747|NCT01989572|5657383|P6|NOT COMPLETED|Overall Study||110
2304748|NCT01989572|5657384|P5|NOT COMPLETED|Overall Study||98
2304749|NCT01989572|5657385|P4|NOT COMPLETED|Overall Study||51
2304750|NCT01989572|5657386|P3|NOT COMPLETED|Overall Study||62
2304751|NCT01989572|5657387|P2|NOT COMPLETED|Overall Study||58
2304752|NCT01989572|5657388|P1|NOT COMPLETED|Overall Study||55
2304753|NCT01989572|5657383|P6|COMPLETED|Overall Study||79
2304754|NCT01989572|5657384|P5|COMPLETED|Overall Study||92
2304755|NCT01989572|5657385|P4|COMPLETED|Overall Study||56
2304756|NCT01989572|5657386|P3|COMPLETED|Overall Study||47
2304757|NCT01989572|5657387|P2|COMPLETED|Overall Study||53
2304758|NCT01989572|5657388|P1|COMPLETED|Overall Study||54
2304759|NCT01989572|5657383|P6|Treated|Overall Study||171
2304760|NCT01989572|5657384|P5|Treated|Overall Study||186
2304761|NCT01989572|5657385|P4|Treated|Overall Study||104
2304762|NCT01989572|5657386|P3|Treated|Overall Study||107
2304763|NCT01989572|5657387|P2|Treated|Overall Study||110
2304764|NCT01989572|5657388|P1|Treated|Overall Study||104
2304765|NCT01989572|5657383|P6|STARTED|Overall Study||189
2304766|NCT01989572|5657384|P5|STARTED|Overall Study||190
2304767|NCT01989572|5657385|P4|STARTED|Overall Study||107
2304768|NCT01989572|5657386|P3|STARTED|Overall Study||109
2304769|NCT01989572|5657387|P2|STARTED|Overall Study||111
2304770|NCT01989572|5657388|P1|STARTED|Overall Study||109
2304771|NCT01989468|5657419|P5|NOT COMPLETED|Overall Study||8
2304772|NCT01989468|5657420|P4|NOT COMPLETED|Overall Study||16
2304773|NCT01989468|5657421|P3|NOT COMPLETED|Overall Study||19
2304774|NCT01989468|5657422|P2|NOT COMPLETED|Overall Study||37
2304775|NCT01989468|5657423|P1|NOT COMPLETED|Overall Study||47
2304776|NCT01989468|5657419|P5|COMPLETED|Overall Study||0
2304777|NCT01989468|5657420|P4|COMPLETED|Overall Study||49
2304778|NCT01989468|5657421|P3|COMPLETED|Overall Study||45
2304779|NCT01989468|5657422|P2|COMPLETED|Overall Study||102
2304780|NCT01989468|5657423|P1|COMPLETED|Overall Study||91
2304781|NCT01989468|5657419|P5|STARTED|Overall Study||8
2304782|NCT01989468|5657420|P4|STARTED|Overall Study||65
2304783|NCT01989468|5657421|P3|STARTED|Overall Study||64
2304784|NCT01989468|5657422|P2|STARTED|Overall Study||139
2304785|NCT01989468|5657423|P1|STARTED|Overall Study||138
2304786|NCT01989455|5657465|P5|NOT COMPLETED|Overall Study||1
2304787|NCT01989455|5657466|P4|NOT COMPLETED|Overall Study||0
2304788|NCT01989455|5657467|P3|NOT COMPLETED|Overall Study||1
2304789|NCT01989455|5657468|P2|NOT COMPLETED|Overall Study||2
2304790|NCT01989455|5657469|P1|NOT COMPLETED|Overall Study||0
2304791|NCT01989455|5657465|P5|COMPLETED|Overall Study||7
2304792|NCT01989455|5657466|P4|COMPLETED|Overall Study||14
2304793|NCT01989455|5657467|P3|COMPLETED|Overall Study||13
2304794|NCT01989455|5657468|P2|COMPLETED|Overall Study||12
2304795|NCT01989455|5657469|P1|COMPLETED|Overall Study||14
2304796|NCT01989455|5657465|P5|STARTED|Overall Study||8
2304797|NCT01989455|5657466|P4|STARTED|Overall Study||14
2304798|NCT01989455|5657467|P3|STARTED|Overall Study||14
2304799|NCT01989455|5657468|P2|STARTED|Overall Study||14
2304800|NCT01989455|5657469|P1|STARTED|Overall Study||14
2304801|NCT01989195|5657503|P1|NOT COMPLETED|Overall Study||0
2304802|NCT01989195|5657503|P1|COMPLETED|Overall Study||6
2304803|NCT01989195|5657503|P1|STARTED|Overall Study||6
2304804|NCT01989169|5657513|P2|NOT COMPLETED|Period 2||1
2304805|NCT01989169|5657514|P1|NOT COMPLETED|Period 2||0
2304806|NCT01989169|5657513|P2|COMPLETED|Period 2||14
2304807|NCT01989169|5657514|P1|COMPLETED|Period 2||15
2304808|NCT01989169|5657513|P2|STARTED|Period 2||15
2304809|NCT01989169|5657514|P1|STARTED|Period 2||15
2304810|NCT01989169|5657513|P2|NOT COMPLETED|Period 1||0
2304811|NCT01989169|5657514|P1|NOT COMPLETED|Period 1||0
2304812|NCT01989169|5657513|P2|COMPLETED|Period 1||15
2304813|NCT01989169|5657514|P1|COMPLETED|Period 1||15
2304814|NCT01989169|5657513|P2|STARTED|Period 1||15
2304815|NCT01989169|5657514|P1|STARTED|Period 1||15
2304816|NCT01989156|5657527|P3|NOT COMPLETED|End of Study (Population at Day 90)||3
2304817|NCT01989156|5657528|P2|NOT COMPLETED|End of Study (Population at Day 90)||5
2304818|NCT01989156|5657529|P1|NOT COMPLETED|End of Study (Population at Day 90)||7
2304819|NCT01989156|5657527|P3|COMPLETED|End of Study (Population at Day 90)||31
2304820|NCT01989156|5657528|P2|COMPLETED|End of Study (Population at Day 90)||35
2304821|NCT01989156|5657529|P1|COMPLETED|End of Study (Population at Day 90)||73
2304822|NCT01989156|5657527|P3|STARTED|End of Study (Population at Day 90)||34
2304823|NCT01989156|5657528|P2|STARTED|End of Study (Population at Day 90)||40
2304824|NCT01989156|5657529|P1|STARTED|End of Study (Population at Day 90)||80
2304825|NCT01989156|5657527|P3|NOT COMPLETED|Confinement Period (Population at Day 5)||5
2304826|NCT01989156|5657528|P2|NOT COMPLETED|Confinement Period (Population at Day 5)||1
2304827|NCT01989156|5657529|P1|NOT COMPLETED|Confinement Period (Population at Day 5)||0
2304828|NCT01989156|5657527|P3|COMPLETED|Confinement Period (Population at Day 5)||34
2304829|NCT01989156|5657528|P2|COMPLETED|Confinement Period (Population at Day 5)||40
2304830|NCT01989156|5657529|P1|COMPLETED|Confinement Period (Population at Day 5)||80
2304831|NCT01989156|5657527|P3|STARTED|Confinement Period (Population at Day 5)||39
2304832|NCT01989156|5657528|P2|STARTED|Confinement Period (Population at Day 5)||41
2304833|NCT01989156|5657529|P1|STARTED|Confinement Period (Population at Day 5)||80
2304834|NCT01989130|5657551|P2|NOT COMPLETED|Overall Study||0
2304835|NCT01989130|5657552|P1|NOT COMPLETED|Overall Study||0
2304836|NCT01989130|5657551|P2|COMPLETED|Overall Study||27
2304837|NCT01989130|5657552|P1|COMPLETED|Overall Study||43
2304838|NCT01989130|5657551|P2|STARTED|Overall Study||27
2304839|NCT01989130|5657552|P1|STARTED|Overall Study||43
2304840|NCT01988922|5657567|P3|NOT COMPLETED|Overall Study||0
2304841|NCT01988922|5657568|P2|NOT COMPLETED|Overall Study||0
2304842|NCT01988922|5657569|P1|NOT COMPLETED|Overall Study||0
2304843|NCT01988922|5657567|P3|COMPLETED|Overall Study||10
2304844|NCT01988922|5657568|P2|COMPLETED|Overall Study||10
2304845|NCT01988922|5657569|P1|COMPLETED|Overall Study||10
2304846|NCT01988922|5657567|P3|STARTED|Overall Study||10
2304847|NCT01988922|5657568|P2|STARTED|Overall Study||10
2304848|NCT01988922|5657569|P1|STARTED|Overall Study||10
2304849|NCT01988857|5657580|P1|NOT COMPLETED|Overall Study||0
2304850|NCT01988857|5657580|P1|COMPLETED|Overall Study||300
2304851|NCT01988857|5657580|P1|STARTED|Overall Study||300
2304852|NCT01988779|5657589|P2|NOT COMPLETED|Overall Study||2
2304853|NCT01988779|5657590|P1|NOT COMPLETED|Overall Study||3
2304854|NCT01988779|5657589|P2|COMPLETED|Overall Study||11
2304855|NCT01988779|5657590|P1|COMPLETED|Overall Study||9
2304856|NCT01988779|5657589|P2|STARTED|Overall Study||13
2304857|NCT01988779|5657590|P1|STARTED|Overall Study||12
2304858|NCT01988662|5657598|P2|NOT COMPLETED|Overall Study||2
2304859|NCT01988662|5657599|P1|NOT COMPLETED|Overall Study||4
2304860|NCT01988662|5657598|P2|COMPLETED|Overall Study||99
2304861|NCT01988662|5657599|P1|COMPLETED|Overall Study||100
2304862|NCT01988662|5657598|P2|STARTED|Overall Study||101
2304863|NCT01988662|5657599|P1|STARTED|Overall Study||104
2304864|NCT01988493|5657621|P5|NOT COMPLETED|Overall Study||1
2304865|NCT01988493|5657622|P4|NOT COMPLETED|Overall Study||2
2304866|NCT01988493|5657623|P3|NOT COMPLETED|Overall Study||0
2304867|NCT01988493|5657624|P2|NOT COMPLETED|Overall Study||0
2304868|NCT01988493|5657625|P1|NOT COMPLETED|Overall Study||0
2304869|NCT01988493|5657621|P5|COMPLETED|Overall Study||44
2304870|NCT01988493|5657622|P4|COMPLETED|Overall Study||43
2304871|NCT01988493|5657623|P3|COMPLETED|Overall Study||6
2304872|NCT01988493|5657624|P2|COMPLETED|Overall Study||14
2304873|NCT01988493|5657625|P1|COMPLETED|Overall Study||7
2304874|NCT01988493|5657621|P5|Safety Population|Overall Study||44
2304875|NCT01988493|5657622|P4|Safety Population|Overall Study||45
2304876|NCT01988493|5657623|P3|Safety Population|Overall Study||6
2304877|NCT01988493|5657624|P2|Safety Population|Overall Study||14
2304878|NCT01988493|5657625|P1|Safety Population|Overall Study||7
2304879|NCT01988493|5657621|P5|Treated|Overall Study||44
2304880|NCT01988493|5657622|P4|Treated|Overall Study||45
2304881|NCT01988493|5657623|P3|Treated|Overall Study||6
2304882|NCT01988493|5657624|P2|Treated|Overall Study||14
2304883|NCT01988493|5657625|P1|Treated|Overall Study||7
2304884|NCT01988493|5657621|P5|STARTED|Overall Study||45
2304885|NCT01988493|5657622|P4|STARTED|Overall Study||45
2304886|NCT01988493|5657623|P3|STARTED|Overall Study||6
2304887|NCT01988493|5657624|P2|STARTED|Overall Study||14
2304888|NCT01988493|5657625|P1|STARTED|Overall Study||7
2304889|NCT01988415|5657694|P1|NOT COMPLETED|Overall Study||0
2304890|NCT01988415|5657694|P1|COMPLETED|Overall Study||26
2304891|NCT01988415|5657694|P1|STARTED|Overall Study|52 eyes of 26 subjects (paired-eyes: commercial and investigational software)|26
2304892|NCT01988402|5657704|P2|NOT COMPLETED|Overall Study||2
2304893|NCT01988402|5657705|P1|NOT COMPLETED|Overall Study||2
2304894|NCT01988402|5657704|P2|COMPLETED|Overall Study||17
2304895|NCT01988402|5657705|P1|COMPLETED|Overall Study||14
2304896|NCT01988402|5657704|P2|STARTED|Overall Study||19
2304897|NCT01988402|5657705|P1|STARTED|Overall Study||16
2304898|NCT01988376|5657719|P2|NOT COMPLETED|Overall Study||0
2304899|NCT01988376|5657720|P1|NOT COMPLETED|Overall Study||0
2304900|NCT01988376|5657719|P2|COMPLETED|Overall Study||129
2304901|NCT01988376|5657720|P1|COMPLETED|Overall Study||129
2304902|NCT01988376|5657719|P2|STARTED|Overall Study||129
2304903|NCT01988376|5657720|P1|STARTED|Overall Study||129
2304904|NCT01988129|5657728|P2|NOT COMPLETED|Overall Study||0
2304905|NCT01988129|5657729|P1|NOT COMPLETED|Overall Study||0
2304906|NCT01988129|5657728|P2|COMPLETED|Overall Study||588
2304907|NCT01988129|5657729|P1|COMPLETED|Overall Study||601
2304908|NCT01988129|5657728|P2|Completed 1-year Follow-up Survey|Overall Study||4
2304909|NCT01988129|5657729|P1|Completed 1-year Follow-up Survey|Overall Study||100
2304910|NCT01988129|5657728|P2|Screened for Sleep Disorders|Overall Study||15
2304911|NCT01988129|5657729|P1|Screened for Sleep Disorders|Overall Study||416
2304912|NCT01988129|5657728|P2|Attended Education Session|Overall Study||18
2304913|NCT01988129|5657729|P1|Attended Education Session|Overall Study||542
2304914|NCT01988129|5657728|P2|STARTED|Overall Study|Control participant data obtained from department. Individuals were not enrolled.|588
2304915|NCT01988129|5657729|P1|STARTED|Overall Study|Intervention participant data obtained from department. Individuals not enrolled for primary aim.|601
2304916|NCT01988090|5657758|P2|NOT COMPLETED|Complete Study After Start||1
2304917|NCT01988090|5657759|P1|NOT COMPLETED|Complete Study After Start||3
2304918|NCT01988090|5657758|P2|COMPLETED|Complete Study After Start||42
2304919|NCT01988090|5657759|P1|COMPLETED|Complete Study After Start||41
2304920|NCT01988090|5657758|P2|STARTED|Complete Study After Start||43
2304921|NCT01988090|5657759|P1|STARTED|Complete Study After Start||44
2304922|NCT01988090|5657758|P2|NOT COMPLETED|Start Treament After Randomization||4
2304923|NCT01988090|5657759|P1|NOT COMPLETED|Start Treament After Randomization||2
2304924|NCT01988090|5657758|P2|COMPLETED|Start Treament After Randomization||43
2304925|NCT01988090|5657759|P1|COMPLETED|Start Treament After Randomization||44
2304926|NCT01988090|5657758|P2|STARTED|Start Treament After Randomization||47
2304927|NCT01988090|5657759|P1|STARTED|Start Treament After Randomization||46
2304928|NCT01988012|5657769|P1|NOT COMPLETED|Overall Study||15
2304929|NCT01988012|5657769|P1|COMPLETED|Overall Study||85
2304930|NCT01988012|5657769|P1|STARTED|Overall Study||100
2304931|NCT01987986|5657795|P4|NOT COMPLETED|Overall Study||0
2304932|NCT01987986|5657796|P3|NOT COMPLETED|Overall Study||2
2304933|NCT01987986|5657797|P2|NOT COMPLETED|Overall Study||0
2304934|NCT01987986|5657798|P1|NOT COMPLETED|Overall Study||2
2304935|NCT01987986|5657795|P4|COMPLETED|Overall Study||24
2304936|NCT01987986|5657796|P3|COMPLETED|Overall Study||38
2304937|NCT01987986|5657797|P2|COMPLETED|Overall Study||43
2304938|NCT01987986|5657798|P1|COMPLETED|Overall Study||41
2304939|NCT01987986|5657795|P4|STARTED|Overall Study||24
2304940|NCT01987986|5657796|P3|STARTED|Overall Study||40
2304941|NCT01987986|5657797|P2|STARTED|Overall Study||43
2304942|NCT01987986|5657798|P1|STARTED|Overall Study||43
2304943|NCT01987960|5657838|P4|NOT COMPLETED|Period 3||71
2304944|NCT01987960|5657839|P3|NOT COMPLETED|Period 3||0
2304945|NCT01987960|5657840|P2|NOT COMPLETED|Period 3||0
2304946|NCT01987960|5657841|P1|NOT COMPLETED|Period 3||0
2304947|NCT01987960|5657838|P4|COMPLETED|Period 3||119
2304948|NCT01987960|5657839|P3|COMPLETED|Period 3||0
2304949|NCT01987960|5657840|P2|COMPLETED|Period 3||0
2304950|NCT01987960|5657841|P1|COMPLETED|Period 3||0
2304951|NCT01987960|5657838|P4|STARTED|Period 3||190
2304952|NCT01987960|5657839|P3|STARTED|Period 3||0
2304953|NCT01987960|5657840|P2|STARTED|Period 3||0
2304954|NCT01987960|5657841|P1|STARTED|Period 3||0
2304955|NCT01987960|5657838|P4|NOT COMPLETED|Period 2||0
2304956|NCT01987960|5657839|P3|NOT COMPLETED|Period 2||9
2304957|NCT01987960|5657840|P2|NOT COMPLETED|Period 2||5
2304958|NCT01987960|5657841|P1|NOT COMPLETED|Period 2||0
2304959|NCT01987960|5657838|P4|COMPLETED|Period 2||0
2304960|NCT01987960|5657839|P3|COMPLETED|Period 2||14
2304961|NCT01987960|5657840|P2|COMPLETED|Period 2||12
2304962|NCT01987960|5657841|P1|COMPLETED|Period 2||0
2304963|NCT01987960|5657838|P4|STARTED|Period 2||0
2304964|NCT01987960|5657839|P3|STARTED|Period 2||23
2304965|NCT01987960|5657840|P2|STARTED|Period 2||17
2304966|NCT01987960|5657841|P1|STARTED|Period 2||0
2304967|NCT01987960|5657838|P4|NOT COMPLETED|Period 1||0
2304968|NCT01987960|5657839|P3|NOT COMPLETED|Period 1||0
2304969|NCT01987960|5657840|P2|NOT COMPLETED|Period 1||0
2304970|NCT01987960|5657841|P1|NOT COMPLETED|Period 1||186
2304971|NCT01987960|5657838|P4|COMPLETED|Period 1||0
2304972|NCT01987960|5657839|P3|COMPLETED|Period 1||0
2304973|NCT01987960|5657840|P2|COMPLETED|Period 1||0
2304974|NCT01987960|5657841|P1|COMPLETED|Period 1||231
2304975|NCT01987960|5657838|P4|STARTED|Period 1||0
2304976|NCT01987960|5657839|P3|STARTED|Period 1||0
2304977|NCT01987960|5657840|P2|STARTED|Period 1||0
2304978|NCT01987960|5657841|P1|STARTED|Period 1||417
2304979|NCT01987908|5657853|P3|NOT COMPLETED|Post-Treatment Observation Period||0
2304980|NCT01987908|5657854|P2|NOT COMPLETED|Post-Treatment Observation Period||3
2304981|NCT01987908|5657855|P1|NOT COMPLETED|Post-Treatment Observation Period||0
2304982|NCT01987908|5657853|P3|COMPLETED|Post-Treatment Observation Period||2
2304983|NCT01987908|5657854|P2|COMPLETED|Post-Treatment Observation Period||7
2304984|NCT01987908|5657855|P1|COMPLETED|Post-Treatment Observation Period||0
2304985|NCT01987908|5657853|P3|STARTED|Post-Treatment Observation Period||2
2304986|NCT01987908|5657854|P2|STARTED|Post-Treatment Observation Period||10
2304987|NCT01987908|5657855|P1|STARTED|Post-Treatment Observation Period||0
2304988|NCT01987908|5657853|P3|NOT COMPLETED|Treatment Period||1
2304989|NCT01987908|5657854|P2|NOT COMPLETED|Treatment Period||1
2304990|NCT01987908|5657855|P1|NOT COMPLETED|Treatment Period||0
2304991|NCT01987908|5657853|P3|COMPLETED|Treatment Period||2
2304992|NCT01987908|5657854|P2|COMPLETED|Treatment Period||10
2304993|NCT01987908|5657855|P1|COMPLETED|Treatment Period||0
2304994|NCT01987908|5657853|P3|STARTED|Treatment Period||3
2304995|NCT01987908|5657854|P2|STARTED|Treatment Period||11
2304996|NCT01987908|5657855|P1|STARTED|Treatment Period||0
2304997|NCT01987908|5657853|P3|NOT COMPLETED|Placebo Lead-in Period||0
2304998|NCT01987908|5657854|P2|NOT COMPLETED|Placebo Lead-in Period||0
2304999|NCT01987908|5657855|P1|NOT COMPLETED|Placebo Lead-in Period||9
2305000|NCT01987908|5657853|P3|COMPLETED|Placebo Lead-in Period||0
2305001|NCT01987908|5657854|P2|COMPLETED|Placebo Lead-in Period||0
2305002|NCT01987908|5657855|P1|COMPLETED|Placebo Lead-in Period||14
2305003|NCT01987908|5657853|P3|STARTED|Placebo Lead-in Period||0
2305004|NCT01987908|5657854|P2|STARTED|Placebo Lead-in Period||0
2305005|NCT01987908|5657855|P1|STARTED|Placebo Lead-in Period||23
2305006|NCT01987895|5657938|P2|NOT COMPLETED|Overall Study||30
2305007|NCT01987895|5657939|P1|NOT COMPLETED|Overall Study||30
2305008|NCT01987895|5657938|P2|COMPLETED|Overall Study||296
2305009|NCT01987895|5657939|P1|COMPLETED|Overall Study||276
2305010|NCT01987895|5657938|P2|STARTED|Overall Study||326
2305011|NCT01987895|5657939|P1|STARTED|Overall Study||306
2305012|NCT01987765|5657963|P1|NOT COMPLETED|Overall Study||102
2305013|NCT01987765|5657963|P1|COMPLETED|Overall Study||745
2305014|NCT01987765|5657963|P1|STARTED|Overall Study||847
2305015|NCT01987752|5657968|P1|NOT COMPLETED|Overall Study||0
2305016|NCT01987752|5657968|P1|COMPLETED|Overall Study||732
2305017|NCT01987752|5657968|P1|STARTED|Overall Study||732
2305018|NCT01987609|5657973|P1|NOT COMPLETED|Overall Study||1
2305019|NCT01987609|5657973|P1|COMPLETED|Overall Study||6
2305020|NCT01987609|5657973|P1|Normal Saline Injected in Arm|Overall Study||6
2305021|NCT01987609|5657973|P1|Hylenex Injected in Arm|Overall Study||6
2305022|NCT01987609|5657973|P1|STARTED|Overall Study|one arm on one patient|7
2305023|NCT01987583|5658006|P2|NOT COMPLETED|Overall Study||2
2305024|NCT01987583|5658007|P1|NOT COMPLETED|Overall Study||3
2305025|NCT01987583|5658006|P2|COMPLETED|Overall Study||38
2305026|NCT01987583|5658007|P1|COMPLETED|Overall Study||37
2305027|NCT01987583|5658006|P2|STARTED|Overall Study||40
2305028|NCT01987583|5658007|P1|STARTED|Overall Study||40
2305029|NCT01987557|5658018|P3|NOT COMPLETED|Overall Study||3
2305030|NCT01987557|5658019|P2|NOT COMPLETED|Overall Study||3
2305031|NCT01987557|5658020|P1|NOT COMPLETED|Overall Study||3
2305032|NCT01987557|5658018|P3|COMPLETED|Overall Study||13
2305033|NCT01987557|5658019|P2|COMPLETED|Overall Study||13
2305034|NCT01987557|5658020|P1|COMPLETED|Overall Study||13
2305035|NCT01987557|5658018|P3|STARTED|Overall Study||16
2305036|NCT01987557|5658019|P2|STARTED|Overall Study||16
2305037|NCT01987557|5658020|P1|STARTED|Overall Study||16
2305038|NCT01987505|5658030|P1|NOT COMPLETED|Overall Study||34
2305039|NCT01987505|5658030|P1|COMPLETED|Overall Study||106
2305040|NCT01987505|5658030|P1|STARTED|Overall Study||140
2305041|NCT01987479|5658060|P1|NOT COMPLETED|Overall Study||17
2305042|NCT01987479|5658060|P1|COMPLETED|Overall Study||133
2305043|NCT01987479|5658060|P1|STARTED|Overall Study||150
2305044|NCT01987453|5658088|P3|NOT COMPLETED|Overall Study||1
2305045|NCT01987453|5658089|P2|NOT COMPLETED|Overall Study||12
2305046|NCT01987453|5658090|P1|NOT COMPLETED|Overall Study||1
2305047|NCT01987453|5658088|P3|COMPLETED|Overall Study||7
2305048|NCT01987453|5658089|P2|COMPLETED|Overall Study||29
2305049|NCT01987453|5658090|P1|COMPLETED|Overall Study||50
2305050|NCT01987453|5658088|P3|STARTED|Overall Study||8
2305051|NCT01987453|5658089|P2|STARTED|Overall Study||41
2305052|NCT01987453|5658090|P1|STARTED|Overall Study||51
2305053|NCT01987427|5658116|P3|NOT COMPLETED|Overall Study||20
2305054|NCT01987427|5658117|P2|NOT COMPLETED|Overall Study||10
2305055|NCT01987427|5658118|P1|NOT COMPLETED|Overall Study||14
2305056|NCT01987427|5658116|P3|COMPLETED|Overall Study||59
2305057|NCT01987427|5658117|P2|COMPLETED|Overall Study||68
2305058|NCT01987427|5658118|P1|COMPLETED|Overall Study||64
2305059|NCT01987427|5658116|P3|STARTED|Overall Study||79
2305060|NCT01987427|5658117|P2|STARTED|Overall Study||78
2305061|NCT01987427|5658118|P1|STARTED|Overall Study||78
2305062|NCT01987414|5658149|P2|NOT COMPLETED|Overall Study||2
2305063|NCT01987414|5658150|P1|NOT COMPLETED|Overall Study||2
2305064|NCT01987414|5658149|P2|COMPLETED|Overall Study||6
2305065|NCT01987414|5658150|P1|COMPLETED|Overall Study||8
2305066|NCT01987414|5658149|P2|STARTED|Overall Study||8
2305067|NCT01987414|5658150|P1|STARTED|Overall Study||10
2305068|NCT01987401|5658199|P3|NOT COMPLETED|Overall Study||44
2305069|NCT01987401|5658200|P2|NOT COMPLETED|Overall Study||470
2305070|NCT01987401|5658201|P1|NOT COMPLETED|Overall Study||454
2305071|NCT01987401|5658199|P3|COMPLETED|Overall Study||16
2305072|NCT01987401|5658200|P2|COMPLETED|Overall Study||121
2305073|NCT01987401|5658201|P1|COMPLETED|Overall Study||137
2305074|NCT01987401|5658199|P3|STARTED|Overall Study||60
2305075|NCT01987401|5658200|P2|STARTED|Overall Study||591
2305076|NCT01987401|5658201|P1|STARTED|Overall Study||591
2305077|NCT01987349|5658217|P8|NOT COMPLETED|Overall Study||1
2305078|NCT01987349|5658218|P7|NOT COMPLETED|Overall Study||0
2305079|NCT01987349|5658219|P6|NOT COMPLETED|Overall Study||0
2305080|NCT01987349|5658220|P5|NOT COMPLETED|Overall Study||0
2305081|NCT01987349|5658221|P4|NOT COMPLETED|Overall Study||0
2305082|NCT01987349|5658222|P3|NOT COMPLETED|Overall Study||0
2305083|NCT01987349|5658223|P2|NOT COMPLETED|Overall Study||0
2305084|NCT01987349|5658224|P1|NOT COMPLETED|Overall Study||0
2305085|NCT01987349|5658217|P8|COMPLETED|Overall Study||24
2305086|NCT01987349|5658218|P7|COMPLETED|Overall Study||10
2305087|NCT01987349|5658219|P6|COMPLETED|Overall Study||6
2305088|NCT01987349|5658220|P5|COMPLETED|Overall Study||6
2305089|NCT01987349|5658221|P4|COMPLETED|Overall Study||6
2305090|NCT01987349|5658222|P3|COMPLETED|Overall Study||8
2305091|NCT01987349|5658223|P2|COMPLETED|Overall Study||6
2305092|NCT01987349|5658224|P1|COMPLETED|Overall Study||6
2305093|NCT01987349|5658217|P8|STARTED|Overall Study||25
2305094|NCT01987349|5658218|P7|STARTED|Overall Study||10
2305095|NCT01987349|5658219|P6|STARTED|Overall Study||6
2305096|NCT01987349|5658220|P5|STARTED|Overall Study||6
2305097|NCT01987349|5658221|P4|STARTED|Overall Study||6
2305098|NCT01987349|5658222|P3|STARTED|Overall Study||8
2305099|NCT01987349|5658223|P2|STARTED|Overall Study||6
2305100|NCT01987349|5658224|P1|STARTED|Overall Study||6
2305101|NCT01987232|5658255|P5|NOT COMPLETED|Overall Study||0
2305102|NCT01987232|5658256|P4|NOT COMPLETED|Overall Study||1
2305103|NCT01987232|5658257|P3|NOT COMPLETED|Overall Study||0
2305104|NCT01987232|5658258|P2|NOT COMPLETED|Overall Study||0
2305105|NCT01987232|5658259|P1|NOT COMPLETED|Overall Study||0
2305106|NCT01987232|5658255|P5|COMPLETED|Overall Study||6
2305107|NCT01987232|5658256|P4|COMPLETED|Overall Study||14
2305108|NCT01987232|5658257|P3|COMPLETED|Overall Study||3
2305109|NCT01987232|5658258|P2|COMPLETED|Overall Study||3
2305110|NCT01987232|5658259|P1|COMPLETED|Overall Study||5
2305111|NCT01987232|5658255|P5|STARTED|Overall Study||6
2305112|NCT01987232|5658256|P4|STARTED|Overall Study||15
2305113|NCT01987232|5658257|P3|STARTED|Overall Study||3
2305114|NCT01987232|5658258|P2|STARTED|Overall Study||3
2305115|NCT01987232|5658259|P1|STARTED|Overall Study||5
2305116|NCT01987219|5658324|P6|NOT COMPLETED|Overall Study||0
2305117|NCT01987219|5658325|P5|NOT COMPLETED|Overall Study||0
2305118|NCT01987219|5658326|P4|NOT COMPLETED|Overall Study||0
2305119|NCT01987219|5658327|P3|NOT COMPLETED|Overall Study||1
2305120|NCT01987219|5658328|P2|NOT COMPLETED|Overall Study||0
2305121|NCT01987219|5658329|P1|NOT COMPLETED|Overall Study||0
2305122|NCT01987219|5658324|P6|COMPLETED|Overall Study||1
2305123|NCT01987219|5658325|P5|COMPLETED|Overall Study||1
2305124|NCT01987219|5658326|P4|COMPLETED|Overall Study||2
2305125|NCT01987219|5658327|P3|COMPLETED|Overall Study||6
2305126|NCT01987219|5658328|P2|COMPLETED|Overall Study||2
2305127|NCT01987219|5658329|P1|COMPLETED|Overall Study||2
2305128|NCT01987219|5658324|P6|STARTED|Overall Study||1
2305129|NCT01987219|5658325|P5|STARTED|Overall Study||1
2305130|NCT01987219|5658326|P4|STARTED|Overall Study||2
2305131|NCT01987219|5658327|P3|STARTED|Overall Study||7
2305132|NCT01987219|5658328|P2|STARTED|Overall Study||2
2305133|NCT01987219|5658329|P1|STARTED|Overall Study||2
2305134|NCT01987102|5658348|P2|NOT COMPLETED|2 Courses of HDMTX With MOD Rescue||1
2305135|NCT01987102|5658349|P1|NOT COMPLETED|2 Courses of HDMTX With MOD Rescue||0
2305136|NCT01987102|5658348|P2|COMPLETED|2 Courses of HDMTX With MOD Rescue||3
2305137|NCT01987102|5658349|P1|COMPLETED|2 Courses of HDMTX With MOD Rescue||4
2305138|NCT01987102|5658348|P2|STARTED|2 Courses of HDMTX With MOD Rescue||4
2305139|NCT01987102|5658349|P1|STARTED|2 Courses of HDMTX With MOD Rescue||4
2305140|NCT01987102|5658348|P2|NOT COMPLETED|2 Courses of HDMTX With SOC Rescue||6
2305141|NCT01987102|5658349|P1|NOT COMPLETED|2 Courses of HDMTX With SOC Rescue||4
2305142|NCT01987102|5658348|P2|COMPLETED|2 Courses of HDMTX With SOC Rescue||4
2305143|NCT01987102|5658349|P1|COMPLETED|2 Courses of HDMTX With SOC Rescue||4
2305144|NCT01987102|5658348|P2|STARTED|2 Courses of HDMTX With SOC Rescue||10
2305145|NCT01987102|5658349|P1|STARTED|2 Courses of HDMTX With SOC Rescue||8
2305146|NCT01986985|5658381|P1|NOT COMPLETED|Overall Study||7
2305147|NCT01986985|5658381|P1|COMPLETED|Overall Study||51
2305148|NCT01986985|5658381|P1|STARTED|Overall Study||58
2305149|NCT01986946|5658387|P2|NOT COMPLETED|Overall Study||0
2305150|NCT01986946|5658388|P1|NOT COMPLETED|Overall Study||0
2305151|NCT01986946|5658387|P2|COMPLETED|Overall Study||9
2305152|NCT01986946|5658388|P1|COMPLETED|Overall Study||5
2305153|NCT01986946|5658387|P2|STARTED|Overall Study||9
2305154|NCT01986946|5658388|P1|STARTED|Overall Study||5
2305155|NCT01986920|5658418|P4|NOT COMPLETED|Placebo||1
2305156|NCT01986920|5658419|P3|NOT COMPLETED|Placebo||0
2305157|NCT01986920|5658420|P2|NOT COMPLETED|Placebo||0
2305158|NCT01986920|5658421|P1|NOT COMPLETED|Placebo||0
2305159|NCT01986920|5658418|P4|COMPLETED|Placebo||34
2305160|NCT01986920|5658419|P3|COMPLETED|Placebo||0
2305161|NCT01986920|5658420|P2|COMPLETED|Placebo||0
2305162|NCT01986920|5658421|P1|COMPLETED|Placebo||0
2305163|NCT01986920|5658418|P4|STARTED|Placebo||35
2305164|NCT01986920|5658419|P3|STARTED|Placebo||0
2305165|NCT01986920|5658420|P2|STARTED|Placebo||0
2305166|NCT01986920|5658421|P1|STARTED|Placebo||0
2305167|NCT01986920|5658418|P4|NOT COMPLETED|A-101 40%||0
2305168|NCT01986920|5658419|P3|NOT COMPLETED|A-101 40%||1
2305169|NCT01986920|5658420|P2|NOT COMPLETED|A-101 40%||0
2305170|NCT01986920|5658421|P1|NOT COMPLETED|A-101 40%||0
2305171|NCT01986920|5658418|P4|COMPLETED|A-101 40%||0
2305172|NCT01986920|5658419|P3|COMPLETED|A-101 40%||34
2305173|NCT01986920|5658420|P2|COMPLETED|A-101 40%||0
2305174|NCT01986920|5658421|P1|COMPLETED|A-101 40%||0
2305175|NCT01986920|5658418|P4|STARTED|A-101 40%||0
2305176|NCT01986920|5658419|P3|STARTED|A-101 40%||35
2305177|NCT01986920|5658420|P2|STARTED|A-101 40%||0
2305178|NCT01986920|5658421|P1|STARTED|A-101 40%||0
2305179|NCT01986920|5658418|P4|NOT COMPLETED|A-101 32.5%||0
2305180|NCT01986920|5658419|P3|NOT COMPLETED|A-101 32.5%||0
2305181|NCT01986920|5658420|P2|NOT COMPLETED|A-101 32.5%||1
2305182|NCT01986920|5658421|P1|NOT COMPLETED|A-101 32.5%||0
2305183|NCT01986920|5658418|P4|COMPLETED|A-101 32.5%||0
2305184|NCT01986920|5658419|P3|COMPLETED|A-101 32.5%||0
2305185|NCT01986920|5658420|P2|COMPLETED|A-101 32.5%||34
2305186|NCT01986920|5658421|P1|COMPLETED|A-101 32.5%||0
2305187|NCT01986920|5658418|P4|STARTED|A-101 32.5%||0
2305188|NCT01986920|5658419|P3|STARTED|A-101 32.5%||0
2305189|NCT01986920|5658420|P2|STARTED|A-101 32.5%||35
2305190|NCT01986920|5658421|P1|STARTED|A-101 32.5%||0
2305191|NCT01986920|5658418|P4|NOT COMPLETED|A- 101 25%||0
2305192|NCT01986920|5658419|P3|NOT COMPLETED|A- 101 25%||0
2305193|NCT01986920|5658420|P2|NOT COMPLETED|A- 101 25%||0
2305194|NCT01986920|5658421|P1|NOT COMPLETED|A- 101 25%||1
2305195|NCT01986920|5658418|P4|COMPLETED|A- 101 25%||0
2305196|NCT01986920|5658419|P3|COMPLETED|A- 101 25%||0
2305197|NCT01986920|5658420|P2|COMPLETED|A- 101 25%||0
2305198|NCT01986920|5658421|P1|COMPLETED|A- 101 25%||34
2305199|NCT01986920|5658418|P4|STARTED|A- 101 25%||0
2305200|NCT01986920|5658419|P3|STARTED|A- 101 25%||0
2305201|NCT01986920|5658420|P2|STARTED|A- 101 25%||0
2305202|NCT01986920|5658421|P1|STARTED|A- 101 25%||35
2305203|NCT01986907|5658435|P1|NOT COMPLETED|Overall Study||162
2305204|NCT01986907|5658435|P1|COMPLETED|Overall Study||774
2305205|NCT01986907|5658435|P1|STARTED|Overall Study||936
2305206|NCT01986855|5658448|P3|NOT COMPLETED|Overall Study||11
2305207|NCT01986855|5658449|P2|NOT COMPLETED|Overall Study||14
2305208|NCT01986855|5658450|P1|NOT COMPLETED|Overall Study||13
2305209|NCT01986855|5658448|P3|COMPLETED|Overall Study||143
2305210|NCT01986855|5658449|P2|COMPLETED|Overall Study||142
2305211|NCT01986855|5658450|P1|COMPLETED|Overall Study||145
2305212|NCT01986855|5658448|P3|Treated|Overall Study||154
2305213|NCT01986855|5658449|P2|Treated|Overall Study||155
2305214|NCT01986855|5658450|P1|Treated|Overall Study||158
2305215|NCT01986855|5658448|P3|STARTED|Overall Study||154
2305216|NCT01986855|5658449|P2|STARTED|Overall Study||156
2305217|NCT01986855|5658450|P1|STARTED|Overall Study||158
2305218|NCT01986829|5658479|P1|NOT COMPLETED|Overall Study||1
2305219|NCT01986829|5658479|P1|COMPLETED|Overall Study||8
2305220|NCT01986829|5658479|P1|STARTED|Overall Study||9
2305221|NCT01986790|5658509|P3|NOT COMPLETED|Overall Study||0
2305222|NCT01986790|5658510|P2|NOT COMPLETED|Overall Study||0
2305223|NCT01986790|5658511|P1|NOT COMPLETED|Overall Study||0
2305224|NCT01986790|5658509|P3|COMPLETED|Overall Study||98
2305225|NCT01986790|5658510|P2|COMPLETED|Overall Study||154
2305226|NCT01986790|5658511|P1|COMPLETED|Overall Study||91
2305227|NCT01986790|5658509|P3|STARTED|Overall Study||98
2305228|NCT01986790|5658510|P2|STARTED|Overall Study||154
2305229|NCT01986790|5658511|P1|STARTED|Overall Study||91
2305230|NCT01986751|5658527|P2|NOT COMPLETED|Overall Study||2
2305231|NCT01986751|5658528|P1|NOT COMPLETED|Overall Study||10
2305232|NCT01986751|5658527|P2|COMPLETED|Overall Study||2
2305233|NCT01986751|5658528|P1|COMPLETED|Overall Study||0
2305234|NCT01986751|5658527|P2|STARTED|Overall Study||4
2305235|NCT01986751|5658528|P1|STARTED|Overall Study||10
2305236|NCT01986686|5658550|P2|NOT COMPLETED|Overall Study||0
2305237|NCT01986686|5658551|P1|NOT COMPLETED|Overall Study||0
2305238|NCT01986686|5658550|P2|COMPLETED|Overall Study||26
2305239|NCT01986686|5658551|P1|COMPLETED|Overall Study||81
2305240|NCT01986686|5658550|P2|STARTED|Overall Study||26
2305241|NCT01986686|5658551|P1|STARTED|Overall Study||81
2305242|NCT01986647|5658561|P4|NOT COMPLETED|Overall Study||11
2305243|NCT01986647|5658562|P3|NOT COMPLETED|Overall Study||12
2305244|NCT01986647|5658563|P2|NOT COMPLETED|Overall Study||7
2305245|NCT01986647|5658564|P1|NOT COMPLETED|Overall Study||10
2305246|NCT01986647|5658561|P4|COMPLETED|Overall Study||66
2305247|NCT01986647|5658562|P3|COMPLETED|Overall Study||37
2305248|NCT01986647|5658563|P2|COMPLETED|Overall Study||139
2305249|NCT01986647|5658564|P1|COMPLETED|Overall Study||142
2305250|NCT01986647|5658561|P4|STARTED|Overall Study||77
2305251|NCT01986647|5658562|P3|STARTED|Overall Study||49
2305252|NCT01986647|5658563|P2|STARTED|Overall Study||146
2305253|NCT01986647|5658564|P1|STARTED|Overall Study||152
2305254|NCT01986361|5658636|P2|NOT COMPLETED|Overall Study||0
2305255|NCT01986361|5658637|P1|NOT COMPLETED|Overall Study||0
2305256|NCT01986361|5658636|P2|COMPLETED|Overall Study||21
2305257|NCT01986361|5658637|P1|COMPLETED|Overall Study||101
2305258|NCT01986361|5658636|P2|STARTED|Overall Study||21
2305259|NCT01986361|5658637|P1|STARTED|Overall Study||101
2305260|NCT01986231|5658659|P1|NOT COMPLETED|Overall Study||1
2305261|NCT01986231|5658659|P1|COMPLETED|Overall Study||11
2305262|NCT01986231|5658659|P1|STARTED|Overall Study||12
2305263|NCT01986140|5658666|P2|NOT COMPLETED|Overall Study||28
2305264|NCT01986140|5658667|P1|NOT COMPLETED|Overall Study||35
2305265|NCT01986140|5658666|P2|COMPLETED|Overall Study||51
2305266|NCT01986140|5658667|P1|COMPLETED|Overall Study||122
2305267|NCT01986140|5658666|P2|STARTED|Overall Study||79
2305268|NCT01986140|5658667|P1|STARTED|Overall Study||157
2305269|NCT01986114|5658673|P1|NOT COMPLETED|Overall Study||156
2305270|NCT01986114|5658673|P1|COMPLETED|Overall Study||339
2305271|NCT01986114|5658673|P1|STARTED|Overall Study||495
2305272|NCT01986101|5658688|P3|NOT COMPLETED|Overall Study||32
2305273|NCT01986101|5658689|P2|NOT COMPLETED|Overall Study||27
2305274|NCT01986101|5658690|P1|NOT COMPLETED|Overall Study||33
2305275|NCT01986101|5658688|P3|COMPLETED|Overall Study||137
2305276|NCT01986101|5658689|P2|COMPLETED|Overall Study||157
2305277|NCT01986101|5658690|P1|COMPLETED|Overall Study||139
2305278|NCT01986101|5658688|P3|Safety Population|Overall Study||169
2305279|NCT01986101|5658689|P2|Safety Population|Overall Study||184
2305280|NCT01986101|5658690|P1|Safety Population|Overall Study||172
2305281|NCT01986101|5658688|P3|Intent-to-Treat Population|Overall Study||169
2305282|NCT01986101|5658689|P2|Intent-to-Treat Population|Overall Study||182
2305283|NCT01986101|5658690|P1|Intent-to-Treat Population|Overall Study||171
2305284|NCT01986101|5658688|P3|STARTED|Overall Study||169
2305285|NCT01986101|5658689|P2|STARTED|Overall Study||184
2305286|NCT01986101|5658690|P1|STARTED|Overall Study||172
2305287|NCT01986062|5658712|P2|NOT COMPLETED|Overall Study||1
2305288|NCT01986062|5658713|P1|NOT COMPLETED|Overall Study||1
2305289|NCT01986062|5658712|P2|COMPLETED|Overall Study||49
2305290|NCT01986062|5658713|P1|COMPLETED|Overall Study||46
2305291|NCT01986062|5658712|P2|STARTED|Overall Study||50
2305292|NCT01986062|5658713|P1|STARTED|Overall Study||47
2305293|NCT01985971|5658729|P1|NOT COMPLETED|Overall Study||1
2305294|NCT01985971|5658729|P1|COMPLETED|Overall Study||1
2305295|NCT01985971|5658729|P1|STARTED|Overall Study||2
2305296|NCT01985958|5658733|P1|NOT COMPLETED|Overall Study||1
2305297|NCT01985958|5658733|P1|COMPLETED|Overall Study||3
2305298|NCT01985958|5658733|P1|STARTED|Overall Study||4
2305299|NCT01985932|5658737|P1|NOT COMPLETED|Overall Study||0
2305300|NCT01985932|5658737|P1|COMPLETED|Overall Study||15
2305301|NCT01985932|5658737|P1|STARTED|Overall Study||15
2305302|NCT01985763|5658741|P1|NOT COMPLETED|Overall Study||0
2305303|NCT01985763|5658741|P1|COMPLETED|Overall Study||13
2305304|NCT01985763|5658741|P1|STARTED|Overall Study||13
2305305|NCT01985685|5658756|P2|NOT COMPLETED|Overall Study||0
2305306|NCT01985685|5658757|P1|NOT COMPLETED|Overall Study||0
2305307|NCT01985685|5658756|P2|COMPLETED|Overall Study||29
2305308|NCT01985685|5658757|P1|COMPLETED|Overall Study||27
2305309|NCT01985685|5658756|P2|STARTED|Overall Study||29
2305310|NCT01985685|5658757|P1|STARTED|Overall Study||27
2305311|NCT01985581|5658769|P2|NOT COMPLETED|Second Intervention||4
2305312|NCT01985581|5658770|P1|NOT COMPLETED|Second Intervention||2
2305313|NCT01985581|5658769|P2|COMPLETED|Second Intervention||19
2305314|NCT01985581|5658770|P1|COMPLETED|Second Intervention||20
2305315|NCT01985581|5658769|P2|STARTED|Second Intervention||23
2305316|NCT01985581|5658770|P1|STARTED|Second Intervention||22
2305317|NCT01985581|5658769|P2|NOT COMPLETED|First Intervention||2
2305318|NCT01985581|5658770|P1|NOT COMPLETED|First Intervention||3
2305319|NCT01985581|5658769|P2|COMPLETED|First Intervention||23
2305320|NCT01985581|5658770|P1|COMPLETED|First Intervention||22
2305321|NCT01985581|5658769|P2|STARTED|First Intervention||25
2305322|NCT01985581|5658770|P1|STARTED|First Intervention||25
2305323|NCT01985425|5658790|P2|NOT COMPLETED|Overall Study||0
2305324|NCT01985425|5658791|P1|NOT COMPLETED|Overall Study||0
2305325|NCT01985425|5658790|P2|COMPLETED|Overall Study||51
2305326|NCT01985425|5658791|P1|COMPLETED|Overall Study||49
2305327|NCT01985425|5658790|P2|STARTED|Overall Study||51
2305328|NCT01985425|5658791|P1|STARTED|Overall Study||49
2305329|NCT01985334|5658817|P8|NOT COMPLETED|Overall Study||121
2305330|NCT01985334|5658818|P7|NOT COMPLETED|Overall Study||37
2305331|NCT01985334|5658819|P6|NOT COMPLETED|Overall Study||156
2305332|NCT01985334|5658820|P5|NOT COMPLETED|Overall Study||40
2305333|NCT01985334|5658821|P4|NOT COMPLETED|Overall Study||229
2305334|NCT01985334|5658822|P3|NOT COMPLETED|Overall Study||53
2305335|NCT01985334|5658823|P2|NOT COMPLETED|Overall Study||84
2305336|NCT01985334|5658824|P1|NOT COMPLETED|Overall Study||23
2305337|NCT01985334|5658817|P8|COMPLETED|Overall Study||699
2305338|NCT01985334|5658818|P7|COMPLETED|Overall Study||237
2305339|NCT01985334|5658819|P6|COMPLETED|Overall Study||666
2305340|NCT01985334|5658820|P5|COMPLETED|Overall Study||234
2305341|NCT01985334|5658821|P4|COMPLETED|Overall Study||1033
2305342|NCT01985334|5658822|P3|COMPLETED|Overall Study||367
2305343|NCT01985334|5658823|P2|COMPLETED|Overall Study||303
2305344|NCT01985334|5658824|P1|COMPLETED|Overall Study||107
2305345|NCT01985334|5658817|P8|The Intention-to-treat (ITT) Population|Overall Study||811
2305346|NCT01985334|5658818|P7|The Intention-to-treat (ITT) Population|Overall Study||268
2305347|NCT01985334|5658819|P6|The Intention-to-treat (ITT) Population|Overall Study||811
2305348|NCT01985334|5658820|P5|The Intention-to-treat (ITT) Population|Overall Study||269
2305349|NCT01985334|5658821|P4|The Intention-to-treat (ITT) Population|Overall Study||1254
2305350|NCT01985334|5658822|P3|The Intention-to-treat (ITT) Population|Overall Study||420
2305351|NCT01985334|5658823|P2|The Intention-to-treat (ITT) Population|Overall Study||369
2305352|NCT01985334|5658824|P1|The Intention-to-treat (ITT) Population|Overall Study||122
2305353|NCT01985334|5658817|P8|STARTED|Overall Study||820
2305354|NCT01985334|5658818|P7|STARTED|Overall Study||274
2305355|NCT01985334|5658819|P6|STARTED|Overall Study||822
2305356|NCT01985334|5658820|P5|STARTED|Overall Study||274
2305357|NCT01985334|5658821|P4|STARTED|Overall Study||1262
2305358|NCT01985334|5658822|P3|STARTED|Overall Study||420
2305359|NCT01985334|5658823|P2|STARTED|Overall Study||387
2305360|NCT01985334|5658824|P1|STARTED|Overall Study||130
2305361|NCT01985321|5658892|P2|NOT COMPLETED|Overall Study||5
2305362|NCT01985321|5658893|P1|NOT COMPLETED|Overall Study||11
2305363|NCT01985321|5658892|P2|COMPLETED|Overall Study||78
2305364|NCT01985321|5658893|P1|COMPLETED|Overall Study||79
2305365|NCT01985321|5658892|P2|STARTED|Overall Study|This is treatment eligible subjects only|83
2305366|NCT01985321|5658893|P1|STARTED|Overall Study|This is Treatment Eligible Subjects only|90
2305367|NCT01985126|5658903|P2|NOT COMPLETED|Overall Study||106
2305368|NCT01985126|5658904|P1|NOT COMPLETED|Overall Study||18
2305369|NCT01985126|5658903|P2|COMPLETED|Overall Study||0
2305370|NCT01985126|5658904|P1|COMPLETED|Overall Study||0
2305371|NCT01985126|5658903|P2|STARTED|Overall Study||106
2305372|NCT01985126|5658904|P1|STARTED|Overall Study||18
2305373|NCT01984892|5658922|P1|NOT COMPLETED|Overall Study||7
2305374|NCT01984892|5658922|P1|COMPLETED|Overall Study|1 completed all study visits up until the termination of the study, last study visit not done.|1
2305375|NCT01984892|5658922|P1|STARTED|Overall Study||8
2305376|NCT01984697|5658933|P5|NOT COMPLETED|Overall Study||35
2305377|NCT01984697|5658934|P4|NOT COMPLETED|Overall Study||21
2305378|NCT01984697|5658935|P3|NOT COMPLETED|Overall Study||29
2305379|NCT01984697|5658936|P2|NOT COMPLETED|Overall Study||31
2305380|NCT01984697|5658937|P1|NOT COMPLETED|Overall Study||43
2305381|NCT01984697|5658933|P5|COMPLETED|Overall Study||279
2305382|NCT01984697|5658934|P4|COMPLETED|Overall Study||280
2305383|NCT01984697|5658935|P3|COMPLETED|Overall Study||272
2305384|NCT01984697|5658936|P2|COMPLETED|Overall Study||270
2305385|NCT01984697|5658937|P1|COMPLETED|Overall Study||258
2305386|NCT01984697|5658933|P5|Month 36 Vaccination|Overall Study||31
2305387|NCT01984697|5658934|P4|Month 36 Vaccination|Overall Study||9
2305388|NCT01984697|5658935|P3|Month 36 Vaccination|Overall Study||280
2305389|NCT01984697|5658936|P2|Month 36 Vaccination|Overall Study||281
2305390|NCT01984697|5658937|P1|Month 36 Vaccination|Overall Study||270
2305391|NCT01984697|5658933|P5|Vaccination 3|Overall Study||311
2305392|NCT01984697|5658934|P4|Vaccination 3|Overall Study||293
2305393|NCT01984697|5658935|P3|Vaccination 3|Overall Study||0
2305394|NCT01984697|5658936|P2|Vaccination 3|Overall Study||0
2305395|NCT01984697|5658937|P1|Vaccination 3|Overall Study||0
2305396|NCT01984697|5658933|P5|Vaccination 2|Overall Study||313
2305397|NCT01984697|5658934|P4|Vaccination 2|Overall Study||298
2305398|NCT01984697|5658935|P3|Vaccination 2|Overall Study||291
2305399|NCT01984697|5658936|P2|Vaccination 2|Overall Study||296
2305400|NCT01984697|5658937|P1|Vaccination 2|Overall Study||293
2305401|NCT01984697|5658933|P5|Vaccination 1|Overall Study||314
2305402|NCT01984697|5658934|P4|Vaccination 1|Overall Study||300
2305403|NCT01984697|5658935|P3|Vaccination 1|Overall Study||300
2305404|NCT01984697|5658936|P2|Vaccination 1|Overall Study||301
2305405|NCT01984697|5658937|P1|Vaccination 1|Overall Study||301
2305406|NCT01984697|5658933|P5|STARTED|Overall Study||314
2305407|NCT01984697|5658934|P4|STARTED|Overall Study||301
2305408|NCT01984697|5658935|P3|STARTED|Overall Study||301
2305409|NCT01984697|5658936|P2|STARTED|Overall Study||301
2305410|NCT01984697|5658937|P1|STARTED|Overall Study||301
2305411|NCT01984684|5659056|P2|NOT COMPLETED|Overall Study||59
2305412|NCT01984684|5659057|P1|NOT COMPLETED|Overall Study||57
2305413|NCT01984684|5659056|P2|COMPLETED|Overall Study||368
2305414|NCT01984684|5659057|P1|COMPLETED|Overall Study||366
2305415|NCT01984684|5659056|P2|STARTED|Overall Study||427
2305416|NCT01984684|5659057|P1|STARTED|Overall Study||423
2305417|NCT01984515|5659067|P1|NOT COMPLETED|Overall Study||19
2305418|NCT01984515|5659067|P1|COMPLETED|Overall Study||40
2305419|NCT01984515|5659067|P1|Received CBT Session|Overall Study||40
2305420|NCT01984515|5659067|P1|STARTED|Overall Study||59
2305421|NCT01984424|5659075|P2|NOT COMPLETED|Overall Study||7
2305422|NCT01984424|5659076|P1|NOT COMPLETED|Overall Study||3
2305423|NCT01984424|5659075|P2|COMPLETED|Overall Study||138
2305424|NCT01984424|5659076|P1|COMPLETED|Overall Study||70
2305425|NCT01984424|5659075|P2|STARTED|Overall Study||145
2305426|NCT01984424|5659076|P1|STARTED|Overall Study||73
2305427|NCT01984398|5659130|P4|NOT COMPLETED|Treatment Period 2||0
2305428|NCT01984398|5659131|P3|NOT COMPLETED|Treatment Period 2||0
2305429|NCT01984398|5659132|P2|NOT COMPLETED|Treatment Period 2||0
2305430|NCT01984398|5659133|P1|NOT COMPLETED|Treatment Period 2||0
2305431|NCT01984398|5659130|P4|COMPLETED|Treatment Period 2||4
2305432|NCT01984398|5659131|P3|COMPLETED|Treatment Period 2||4
2305433|NCT01984398|5659132|P2|COMPLETED|Treatment Period 2||4
2305434|NCT01984398|5659133|P1|COMPLETED|Treatment Period 2||4
2305435|NCT01984398|5659130|P4|STARTED|Treatment Period 2||4
2305436|NCT01984398|5659131|P3|STARTED|Treatment Period 2||4
2305437|NCT01984398|5659132|P2|STARTED|Treatment Period 2||4
2305438|NCT01984398|5659133|P1|STARTED|Treatment Period 2||4
2305439|NCT01984398|5659130|P4|NOT COMPLETED|Washout Period of 5 to 7 Days||0
2305440|NCT01984398|5659131|P3|NOT COMPLETED|Washout Period of 5 to 7 Days||0
2305441|NCT01984398|5659132|P2|NOT COMPLETED|Washout Period of 5 to 7 Days||0
2305442|NCT01984398|5659133|P1|NOT COMPLETED|Washout Period of 5 to 7 Days||0
2305443|NCT01984398|5659130|P4|COMPLETED|Washout Period of 5 to 7 Days||4
2305444|NCT01984398|5659131|P3|COMPLETED|Washout Period of 5 to 7 Days||4
2305445|NCT01984398|5659132|P2|COMPLETED|Washout Period of 5 to 7 Days||4
2305446|NCT01984398|5659133|P1|COMPLETED|Washout Period of 5 to 7 Days||4
2305447|NCT01984398|5659130|P4|STARTED|Washout Period of 5 to 7 Days||4
2305448|NCT01984398|5659131|P3|STARTED|Washout Period of 5 to 7 Days||4
2305449|NCT01984398|5659132|P2|STARTED|Washout Period of 5 to 7 Days||4
2305450|NCT01984398|5659133|P1|STARTED|Washout Period of 5 to 7 Days||4
2305451|NCT01984398|5659130|P4|NOT COMPLETED|Treatment Period 1||0
2305452|NCT01984398|5659131|P3|NOT COMPLETED|Treatment Period 1||0
2305453|NCT01984398|5659132|P2|NOT COMPLETED|Treatment Period 1||0
2305454|NCT01984398|5659133|P1|NOT COMPLETED|Treatment Period 1||0
2305455|NCT01984398|5659130|P4|COMPLETED|Treatment Period 1||4
2305456|NCT01984398|5659131|P3|COMPLETED|Treatment Period 1||4
2305457|NCT01984398|5659132|P2|COMPLETED|Treatment Period 1||4
2305458|NCT01984398|5659133|P1|COMPLETED|Treatment Period 1||4
2305459|NCT01984398|5659130|P4|STARTED|Treatment Period 1||4
2305460|NCT01984398|5659131|P3|STARTED|Treatment Period 1||4
2305461|NCT01984398|5659132|P2|STARTED|Treatment Period 1||4
2305462|NCT01984398|5659133|P1|STARTED|Treatment Period 1||4
2305463|NCT01984294|5659146|P3|NOT COMPLETED|Overall Study||7
2305464|NCT01984294|5659147|P2|NOT COMPLETED|Overall Study||3
2305465|NCT01984294|5659148|P1|NOT COMPLETED|Overall Study||4
2305466|NCT01984294|5659146|P3|COMPLETED|Overall Study||27
2305467|NCT01984294|5659147|P2|COMPLETED|Overall Study||29
2305468|NCT01984294|5659148|P1|COMPLETED|Overall Study||31
2305469|NCT01984294|5659146|P3|STARTED|Overall Study||34
2305470|NCT01984294|5659147|P2|STARTED|Overall Study||32
2305471|NCT01984294|5659148|P1|STARTED|Overall Study||35
2305472|NCT01984242|5659171|P3|NOT COMPLETED|Overall Study||101
2305473|NCT01984242|5659172|P2|NOT COMPLETED|Overall Study||103
2305474|NCT01984242|5659173|P1|NOT COMPLETED|Overall Study||101
2305475|NCT01984242|5659171|P3|COMPLETED|Overall Study||0
2305476|NCT01984242|5659172|P2|COMPLETED|Overall Study||0
2305477|NCT01984242|5659173|P1|COMPLETED|Overall Study||0
2305478|NCT01984242|5659171|P3|Treated|Overall Study||100
2305479|NCT01984242|5659172|P2|Treated|Overall Study||103
2305480|NCT01984242|5659173|P1|Treated|Overall Study||101
2305481|NCT01984242|5659171|P3|STARTED|Overall Study||101
2305482|NCT01984242|5659172|P2|STARTED|Overall Study||103
2305483|NCT01984242|5659173|P1|STARTED|Overall Study||101
2305484|NCT01984229|5659323|P2|NOT COMPLETED|Safety Follow-up Period||1
2305485|NCT01984229|5659324|P1|NOT COMPLETED|Safety Follow-up Period||2
2305486|NCT01984229|5659323|P2|COMPLETED|Safety Follow-up Period||16
2305487|NCT01984229|5659324|P1|COMPLETED|Safety Follow-up Period||4
2305488|NCT01984229|5659323|P2|STARTED|Safety Follow-up Period||17
2305489|NCT01984229|5659324|P1|STARTED|Safety Follow-up Period||6
2305490|NCT01984229|5659323|P2|NOT COMPLETED|Period 3||0
2305491|NCT01984229|5659324|P1|NOT COMPLETED|Period 3||0
2305492|NCT01984229|5659323|P2|COMPLETED|Period 3||17
2305493|NCT01984229|5659324|P1|COMPLETED|Period 3||6
2305494|NCT01984229|5659323|P2|STARTED|Period 3||17
2305495|NCT01984229|5659324|P1|STARTED|Period 3||6
2305496|NCT01984229|5659323|P2|NOT COMPLETED|Period 2||0
2305497|NCT01984229|5659324|P1|NOT COMPLETED|Period 2||0
2305498|NCT01984229|5659323|P2|COMPLETED|Period 2||17
2305499|NCT01984229|5659324|P1|COMPLETED|Period 2||6
2305500|NCT01984229|5659323|P2|STARTED|Period 2||17
2305501|NCT01984229|5659324|P1|STARTED|Period 2||6
2305502|NCT01984229|5659323|P2|NOT COMPLETED|Period 1||0
2305503|NCT01984229|5659324|P1|NOT COMPLETED|Period 1||0
2305504|NCT01984229|5659323|P2|COMPLETED|Period 1||17
2305505|NCT01984229|5659324|P1|COMPLETED|Period 1||6
2305506|NCT01984229|5659323|P2|STARTED|Period 1||17
2305507|NCT01984229|5659324|P1|STARTED|Period 1||6
2305508|NCT01983969|5659377|P3|NOT COMPLETED|Overall Study||0
2305509|NCT01983969|5659378|P2|NOT COMPLETED|Overall Study||1
2305510|NCT01983969|5659379|P1|NOT COMPLETED|Overall Study||0
2305511|NCT01983969|5659377|P3|COMPLETED|Overall Study||5
2305512|NCT01983969|5659378|P2|COMPLETED|Overall Study||18
2305513|NCT01983969|5659379|P1|COMPLETED|Overall Study||37
2305514|NCT01983969|5659377|P3|STARTED|Overall Study||5
2305515|NCT01983969|5659378|P2|STARTED|Overall Study||19
2305516|NCT01983969|5659379|P1|STARTED|Overall Study||37
2305517|NCT01983930|5659393|P2|NOT COMPLETED|Overall Study||9
2305518|NCT01983930|5659394|P1|NOT COMPLETED|Overall Study||9
2305519|NCT01983930|5659393|P2|COMPLETED|Overall Study||29
2305520|NCT01983930|5659394|P1|COMPLETED|Overall Study||32
2305521|NCT01983930|5659393|P2|STARTED|Overall Study||38
2305522|NCT01983930|5659394|P1|STARTED|Overall Study||41
2305523|NCT01983878|5659406|P1|NOT COMPLETED|Overall Study||0
2305524|NCT01983878|5659406|P1|COMPLETED|Overall Study||36
2305525|NCT01983878|5659406|P1|Received At Least One Dose of Study Drug|Overall Study||36
2305526|NCT01983878|5659406|P1|STARTED|Overall Study||36
2305527|NCT01983839|5659417|P1|NOT COMPLETED|Overall Study||0
2305528|NCT01983839|5659417|P1|COMPLETED|Overall Study||18
2305529|NCT01983839|5659417|P1|STARTED|Overall Study||18
2305530|NCT01983826|5659424|P2|NOT COMPLETED|Overall Study||0
2305531|NCT01983826|5659425|P1|NOT COMPLETED|Overall Study||0
2305532|NCT01983826|5659424|P2|COMPLETED|Overall Study||8
2305533|NCT01983826|5659425|P1|COMPLETED|Overall Study||13
2305534|NCT01983826|5659424|P2|STARTED|Overall Study||8
2305535|NCT01983826|5659425|P1|STARTED|Overall Study||13
2305536|NCT01983787|5659443|P1|NOT COMPLETED|Overall Study||0
2305537|NCT01983787|5659443|P1|COMPLETED|Overall Study||10
2305538|NCT01983787|5659443|P1|STARTED|Overall Study||10
2305539|NCT01983683|5659468|P2|NOT COMPLETED|Overall Study||51
2305540|NCT01983683|5659469|P1|NOT COMPLETED|Overall Study||38
2305541|NCT01983683|5659468|P2|COMPLETED|Overall Study||260
2305542|NCT01983683|5659469|P1|COMPLETED|Overall Study||260
2305543|NCT01983683|5659468|P2|STARTED|Overall Study||311
2305544|NCT01983683|5659469|P1|STARTED|Overall Study||298
2305545|NCT01983566|5659497|P4|NOT COMPLETED|Test Period 4||0
2305546|NCT01983566|5659498|P3|NOT COMPLETED|Test Period 4||0
2305547|NCT01983566|5659499|P2|NOT COMPLETED|Test Period 4||0
2305548|NCT01983566|5659500|P1|NOT COMPLETED|Test Period 4||0
2305549|NCT01983566|5659497|P4|COMPLETED|Test Period 4||0
2305550|NCT01983566|5659498|P3|COMPLETED|Test Period 4||0
2305551|NCT01983566|5659499|P2|COMPLETED|Test Period 4||0
2305552|NCT01983566|5659500|P1|COMPLETED|Test Period 4||0
2305553|NCT01983566|5659497|P4|STARTED|Test Period 4||0
2305554|NCT01983566|5659498|P3|STARTED|Test Period 4||0
2305555|NCT01983566|5659499|P2|STARTED|Test Period 4||0
2305556|NCT01983566|5659500|P1|STARTED|Test Period 4||0
2305557|NCT01983566|5659497|P4|NOT COMPLETED|Wash-Out 3||0
2305558|NCT01983566|5659498|P3|NOT COMPLETED|Wash-Out 3||0
2305559|NCT01983566|5659499|P2|NOT COMPLETED|Wash-Out 3||0
2305560|NCT01983566|5659500|P1|NOT COMPLETED|Wash-Out 3||0
2305561|NCT01983566|5659497|P4|COMPLETED|Wash-Out 3||0
2305562|NCT01983566|5659498|P3|COMPLETED|Wash-Out 3||0
2305563|NCT01983566|5659499|P2|COMPLETED|Wash-Out 3||0
2305564|NCT01983566|5659500|P1|COMPLETED|Wash-Out 3||0
2305565|NCT01983566|5659497|P4|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
2305566|NCT01983566|5659498|P3|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
2305567|NCT01983566|5659499|P2|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
2305568|NCT01983566|5659500|P1|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
2305569|NCT01983566|5659497|P4|NOT COMPLETED|Test Period 3||0
2305570|NCT01983566|5659498|P3|NOT COMPLETED|Test Period 3||0
2305571|NCT01983566|5659499|P2|NOT COMPLETED|Test Period 3||0
2305572|NCT01983566|5659500|P1|NOT COMPLETED|Test Period 3||0
2305573|NCT01983566|5659497|P4|COMPLETED|Test Period 3||4
2305574|NCT01983566|5659498|P3|COMPLETED|Test Period 3||2
2305575|NCT01983566|5659499|P2|COMPLETED|Test Period 3||3
2305576|NCT01983566|5659500|P1|COMPLETED|Test Period 3||2
2305577|NCT01983566|5659497|P4|STARTED|Test Period 3||4
2305578|NCT01983566|5659498|P3|STARTED|Test Period 3||2
2305579|NCT01983566|5659499|P2|STARTED|Test Period 3||3
2305580|NCT01983566|5659500|P1|STARTED|Test Period 3||2
2305581|NCT01983566|5659497|P4|NOT COMPLETED|Wash-Out 2||0
2305582|NCT01983566|5659498|P3|NOT COMPLETED|Wash-Out 2||0
2305583|NCT01983566|5659499|P2|NOT COMPLETED|Wash-Out 2||0
2305584|NCT01983566|5659500|P1|NOT COMPLETED|Wash-Out 2||0
2305585|NCT01983566|5659497|P4|COMPLETED|Wash-Out 2||4
2305586|NCT01983566|5659498|P3|COMPLETED|Wash-Out 2||2
2305587|NCT01983566|5659499|P2|COMPLETED|Wash-Out 2||3
2305588|NCT01983566|5659500|P1|COMPLETED|Wash-Out 2||2
2305589|NCT01983566|5659497|P4|STARTED|Wash-Out 2||4
2305590|NCT01983566|5659498|P3|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
2305591|NCT01983566|5659499|P2|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|3
2305592|NCT01983566|5659500|P1|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
2305593|NCT01983566|5659497|P4|NOT COMPLETED|Test Period 2||0
2305594|NCT01983566|5659498|P3|NOT COMPLETED|Test Period 2||0
2305595|NCT01983566|5659499|P2|NOT COMPLETED|Test Period 2||0
2305596|NCT01983566|5659500|P1|NOT COMPLETED|Test Period 2||0
2305597|NCT01983566|5659497|P4|COMPLETED|Test Period 2||4
2305598|NCT01983566|5659498|P3|COMPLETED|Test Period 2||4
2305599|NCT01983566|5659499|P2|COMPLETED|Test Period 2||4
2305600|NCT01983566|5659500|P1|COMPLETED|Test Period 2||4
2305601|NCT01983566|5659497|P4|STARTED|Test Period 2||4
2305602|NCT01983566|5659498|P3|STARTED|Test Period 2||4
2305603|NCT01983566|5659499|P2|STARTED|Test Period 2||4
2305604|NCT01983566|5659500|P1|STARTED|Test Period 2||4
2305605|NCT01983566|5659497|P4|NOT COMPLETED|Wash-Out 1||0
2305606|NCT01983566|5659498|P3|NOT COMPLETED|Wash-Out 1||0
2305607|NCT01983566|5659499|P2|NOT COMPLETED|Wash-Out 1||0
2305608|NCT01983566|5659500|P1|NOT COMPLETED|Wash-Out 1||0
2305609|NCT01983566|5659497|P4|COMPLETED|Wash-Out 1||4
2305610|NCT01983566|5659498|P3|COMPLETED|Wash-Out 1||4
2305611|NCT01983566|5659499|P2|COMPLETED|Wash-Out 1||4
2305612|NCT01983566|5659500|P1|COMPLETED|Wash-Out 1||4
2305613|NCT01983566|5659497|P4|STARTED|Wash-Out 1||4
2305614|NCT01983566|5659498|P3|STARTED|Wash-Out 1||4
2305615|NCT01983566|5659499|P2|STARTED|Wash-Out 1||4
2305616|NCT01983566|5659500|P1|STARTED|Wash-Out 1||4
2305617|NCT01983566|5659497|P4|NOT COMPLETED|Test Period 1||0
2305618|NCT01983566|5659498|P3|NOT COMPLETED|Test Period 1||0
2305619|NCT01983566|5659499|P2|NOT COMPLETED|Test Period 1||0
2305620|NCT01983566|5659500|P1|NOT COMPLETED|Test Period 1||0
2305621|NCT01983566|5659497|P4|COMPLETED|Test Period 1||4
2305622|NCT01983566|5659498|P3|COMPLETED|Test Period 1||4
2305623|NCT01983566|5659499|P2|COMPLETED|Test Period 1||4
2305624|NCT01983566|5659500|P1|COMPLETED|Test Period 1||4
2305625|NCT01983566|5659497|P4|STARTED|Test Period 1||4
2305626|NCT01983566|5659498|P3|STARTED|Test Period 1||4
2305627|NCT01983566|5659499|P2|STARTED|Test Period 1||4
2305628|NCT01983566|5659500|P1|STARTED|Test Period 1||4
2305629|NCT01983553|5659521|P2|NOT COMPLETED|Overall Study||0
2305630|NCT01983553|5659522|P1|NOT COMPLETED|Overall Study||0
2305631|NCT01983553|5659521|P2|COMPLETED|Overall Study||1072
2305632|NCT01983553|5659522|P1|COMPLETED|Overall Study||2131
2305633|NCT01983553|5659521|P2|STARTED|Overall Study||1072
2305634|NCT01983553|5659522|P1|STARTED|Overall Study||2131
2305635|NCT01983293|5659556|P2|NOT COMPLETED|Overall Study||19
2305636|NCT01983293|5659557|P1|NOT COMPLETED|Overall Study||33
2305637|NCT01983293|5659556|P2|COMPLETED|Overall Study||62
2305638|NCT01983293|5659557|P1|COMPLETED|Overall Study||128
2305639|NCT01983293|5659556|P2|STARTED|Overall Study||81
2305640|NCT01983293|5659557|P1|STARTED|Overall Study||161
2305641|NCT01983254|5659565|P2|NOT COMPLETED|Overall Study||30
2305642|NCT01983254|5659566|P1|NOT COMPLETED|Overall Study||34
2305643|NCT01983254|5659565|P2|COMPLETED|Overall Study|69 patients, 37 caregivers|106
2305644|NCT01983254|5659566|P1|COMPLETED|Overall Study|62 patients, 29 caregivers|91
2305645|NCT01983254|5659565|P2|Interview 3|Overall Study|69 patients, 37 caregivers|106
2305646|NCT01983254|5659566|P1|Interview 3|Overall Study|62 patients, 29 caregivers|91
2305647|NCT01983254|5659565|P2|Interview 2|Overall Study|71 patients, 39 caregivers|110
2305648|NCT01983254|5659566|P1|Interview 2|Overall Study|65 patients, 30 caregivers|95
2305649|NCT01983254|5659565|P2|Interview 1|Overall Study|89 patients, 47 caregivers|136
2305650|NCT01983254|5659566|P1|Interview 1|Overall Study|86 patients, 39 caregivers|125
2305651|NCT01983254|5659565|P2|STARTED|Overall Study|89 patients, 47 caregivers|136
2305652|NCT01983254|5659566|P1|STARTED|Overall Study|86 patients, 39 caregivers|125
2305653|NCT01983111|5659578|P2|NOT COMPLETED|Overall Study||7
2305654|NCT01983111|5659579|P1|NOT COMPLETED|Overall Study||12
2305655|NCT01983111|5659578|P2|COMPLETED|Overall Study||59
2305656|NCT01983111|5659579|P1|COMPLETED|Overall Study||58
2305657|NCT01983111|5659578|P2|STARTED|Overall Study||66
2305658|NCT01983111|5659579|P1|STARTED|Overall Study||70
2305659|NCT01983020|5659599|P4|NOT COMPLETED|Overall Study||0
2305660|NCT01983020|5659600|P3|NOT COMPLETED|Overall Study||0
2305661|NCT01983020|5659601|P2|NOT COMPLETED|Overall Study||0
2305662|NCT01983020|5659602|P1|NOT COMPLETED|Overall Study||0
2305663|NCT01983020|5659599|P4|COMPLETED|Overall Study||11
2305664|NCT01983020|5659600|P3|COMPLETED|Overall Study||12
2305665|NCT01983020|5659601|P2|COMPLETED|Overall Study||11
2305666|NCT01983020|5659602|P1|COMPLETED|Overall Study||12
2305667|NCT01983020|5659599|P4|STARTED|Overall Study||11
2305668|NCT01983020|5659600|P3|STARTED|Overall Study||12
2305669|NCT01983020|5659601|P2|STARTED|Overall Study||11
2305670|NCT01983020|5659602|P1|STARTED|Overall Study||12
2305671|NCT01982812|5659614|P2|NOT COMPLETED|Overall Study||10
2305672|NCT01982812|5659615|P1|NOT COMPLETED|Overall Study||1
2305673|NCT01982812|5659614|P2|COMPLETED|Overall Study||11
2305674|NCT01982812|5659615|P1|COMPLETED|Overall Study||22
2305675|NCT01982812|5659614|P2|STARTED|Overall Study||21
2305676|NCT01982812|5659615|P1|STARTED|Overall Study||23
2305677|NCT01982773|5659629|P2|NOT COMPLETED|Overall Study||4
2305678|NCT01982773|5659630|P1|NOT COMPLETED|Overall Study||8
2305679|NCT01982773|5659629|P2|COMPLETED|Overall Study||56
2305680|NCT01982773|5659630|P1|COMPLETED|Overall Study||50
2305681|NCT01982773|5659629|P2|STARTED|Overall Study||60
2305682|NCT01982773|5659630|P1|STARTED|Overall Study||58
2305683|NCT01982695|5659644|P2|NOT COMPLETED|Overall Study||1
2305684|NCT01982695|5659645|P1|NOT COMPLETED|Overall Study||0
2305685|NCT01982695|5659644|P2|COMPLETED|Overall Study||10
2305686|NCT01982695|5659645|P1|COMPLETED|Overall Study||12
2305687|NCT01982695|5659644|P2|STARTED|Overall Study||11
2305688|NCT01982695|5659645|P1|STARTED|Overall Study||12
2305689|NCT01982682|5659651|P1|NOT COMPLETED|Overall Study||1
2305690|NCT01982682|5659651|P1|COMPLETED|Overall Study||40
2305691|NCT01982682|5659651|P1|STARTED|Overall Study||41
2305692|NCT01982539|5659659|P1|NOT COMPLETED|Overall Study||0
2305693|NCT01982539|5659659|P1|COMPLETED|Overall Study||25
2305694|NCT01982539|5659659|P1|STARTED|Overall Study||25
2305695|NCT01982435|5659665|P2|NOT COMPLETED|Overall Study||0
2305696|NCT01982435|5659666|P1|NOT COMPLETED|Overall Study||1
2305697|NCT01982435|5659665|P2|COMPLETED|Overall Study||12
2305698|NCT01982435|5659666|P1|COMPLETED|Overall Study||14
2305699|NCT01982435|5659665|P2|STARTED|Overall Study||12
2305700|NCT01982435|5659666|P1|STARTED|Overall Study||15
2305701|NCT01982383|5659696|P2|NOT COMPLETED|Overall Study||0
2305702|NCT01982383|5659697|P1|NOT COMPLETED|Overall Study||0
2305703|NCT01982383|5659696|P2|COMPLETED|Overall Study||0
2305704|NCT01982383|5659697|P1|COMPLETED|Overall Study||2
2305705|NCT01982383|5659696|P2|STARTED|Overall Study||0
2305706|NCT01982383|5659697|P1|STARTED|Overall Study||2
2305707|NCT01982331|5659705|P2|NOT COMPLETED|Completed Study (Day 112)||0
2305708|NCT01982331|5659706|P1|NOT COMPLETED|Completed Study (Day 112)||2
2305709|NCT01982331|5659705|P2|COMPLETED|Completed Study (Day 112)||7
2305710|NCT01982331|5659706|P1|COMPLETED|Completed Study (Day 112)||25
2305711|NCT01982331|5659705|P2|STARTED|Completed Study (Day 112)||7
2305712|NCT01982331|5659706|P1|STARTED|Completed Study (Day 112)||27
2305713|NCT01982331|5659705|P2|NOT COMPLETED|Received Vaccination 2||3
2305714|NCT01982331|5659706|P1|NOT COMPLETED|Received Vaccination 2||1
2305715|NCT01982331|5659705|P2|COMPLETED|Received Vaccination 2||7
2305716|NCT01982331|5659706|P1|COMPLETED|Received Vaccination 2||27
2305717|NCT01982331|5659705|P2|STARTED|Received Vaccination 2||10
2305718|NCT01982331|5659706|P1|STARTED|Received Vaccination 2||28
2305719|NCT01982331|5659705|P2|NOT COMPLETED|Received Vaccination 1||0
2305720|NCT01982331|5659706|P1|NOT COMPLETED|Received Vaccination 1||0
2305721|NCT01982331|5659705|P2|COMPLETED|Received Vaccination 1||10
2305722|NCT01982331|5659706|P1|COMPLETED|Received Vaccination 1||28
2305723|NCT01982331|5659705|P2|STARTED|Received Vaccination 1||10
2305724|NCT01982331|5659706|P1|STARTED|Received Vaccination 1||28
2305725|NCT01982292|5659742|P2|NOT COMPLETED|Overall Study||1
2305726|NCT01982292|5659743|P1|NOT COMPLETED|Overall Study||12
2305727|NCT01982292|5659742|P2|COMPLETED|Overall Study||107
2305728|NCT01982292|5659743|P1|COMPLETED|Overall Study||203
2305729|NCT01982292|5659742|P2|Safety Set|Overall Study||108
2305730|NCT01982292|5659743|P1|Safety Set|Overall Study||212
2305731|NCT01982292|5659742|P2|Full Analaysis Set (FAS)|Overall Study||108
2305732|NCT01982292|5659743|P1|Full Analaysis Set (FAS)|Overall Study|FAS excludes mis-randomized patients|213
2305733|NCT01982292|5659742|P2|STARTED|Overall Study||108
2305734|NCT01982292|5659743|P1|STARTED|Overall Study|"Started indicates Randomized set"|215
2305735|NCT01982253|5659764|P3|NOT COMPLETED|Overall Study||4
2305736|NCT01982253|5659765|P2|NOT COMPLETED|Overall Study||4
2305737|NCT01982253|5659766|P1|NOT COMPLETED|Overall Study||2
2305738|NCT01982253|5659764|P3|COMPLETED|Overall Study||0
2305739|NCT01982253|5659765|P2|COMPLETED|Overall Study||0
2305740|NCT01982253|5659766|P1|COMPLETED|Overall Study||0
2305741|NCT01982253|5659764|P3|STARTED|Overall Study||4
2305742|NCT01982253|5659765|P2|STARTED|Overall Study||4
2305743|NCT01982253|5659766|P1|STARTED|Overall Study||2
2305744|NCT01982240|5659780|P3|NOT COMPLETED|Overall Study||70
2305745|NCT01982240|5659781|P2|NOT COMPLETED|Overall Study||69
2305746|NCT01982240|5659782|P1|NOT COMPLETED|Overall Study||67
2305747|NCT01982240|5659780|P3|COMPLETED|Overall Study||371
2305748|NCT01982240|5659781|P2|COMPLETED|Overall Study||384
2305749|NCT01982240|5659782|P1|COMPLETED|Overall Study||385
2305750|NCT01982240|5659780|P3|STARTED|Overall Study||441
2305751|NCT01982240|5659781|P2|STARTED|Overall Study||453
2305752|NCT01982240|5659782|P1|STARTED|Overall Study||452
2305753|NCT01982123|5659802|P1|NOT COMPLETED|Overall Study||0
2305754|NCT01982123|5659802|P1|COMPLETED|Overall Study||12
2305755|NCT01982123|5659802|P1|STARTED|Overall Study||12
2305756|NCT01981967|5659809|P2|NOT COMPLETED|Overall Study||0
2305757|NCT01981967|5659810|P1|NOT COMPLETED|Overall Study||0
2305758|NCT01981967|5659809|P2|COMPLETED|Overall Study||3149
2305759|NCT01981967|5659810|P1|COMPLETED|Overall Study||6851
2305760|NCT01981967|5659809|P2|STARTED|Overall Study||3149
2305761|NCT01981967|5659810|P1|STARTED|Overall Study||6851
2305762|NCT01981954|5659820|P1|NOT COMPLETED|Fixed-Dose Assessment Period||1
2305763|NCT01981954|5659820|P1|COMPLETED|Fixed-Dose Assessment Period||21
2305764|NCT01981954|5659820|P1|Treated|Fixed-Dose Assessment Period||22
2305765|NCT01981954|5659820|P1|STARTED|Fixed-Dose Assessment Period||22
2305766|NCT01981954|5659820|P1|NOT COMPLETED|Titration Period||1
2305767|NCT01981954|5659820|P1|COMPLETED|Titration Period||22
2305768|NCT01981954|5659820|P1|Treated|Titration Period||23
2305769|NCT01981954|5659820|P1|STARTED|Titration Period||23
2305770|NCT01981863|5659867|P2|NOT COMPLETED|Overall Study||0
2305771|NCT01981863|5659868|P1|NOT COMPLETED|Overall Study||0
2305772|NCT01981863|5659867|P2|COMPLETED|Overall Study||20
2305773|NCT01981863|5659868|P1|COMPLETED|Overall Study||20
2305774|NCT01981863|5659867|P2|STARTED|Overall Study||20
2305775|NCT01981863|5659868|P1|STARTED|Overall Study||20
2305776|NCT01981759|5659880|P2|NOT COMPLETED|Overall Study||11
2305777|NCT01981759|5659881|P1|NOT COMPLETED|Overall Study||7
2305778|NCT01981759|5659880|P2|COMPLETED|Overall Study||19
2305779|NCT01981759|5659881|P1|COMPLETED|Overall Study||21
2305780|NCT01981759|5659880|P2|Completed Week 12|Overall Study||22
2305781|NCT01981759|5659881|P1|Completed Week 12|Overall Study||22
2305782|NCT01981759|5659880|P2|Randomization (Week 3)|Overall Study||30
2305783|NCT01981759|5659881|P1|Randomization (Week 3)|Overall Study||28
2305784|NCT01981759|5659880|P2|Baseline (Week 1)|Overall Study||30
2305785|NCT01981759|5659881|P1|Baseline (Week 1)|Overall Study||28
2305786|NCT01981759|5659880|P2|STARTED|Overall Study||30
2305787|NCT01981759|5659881|P1|STARTED|Overall Study||28
2305788|NCT01981616|5659893|P2|NOT COMPLETED|Overall Study||1
2305789|NCT01981616|5659894|P1|NOT COMPLETED|Overall Study||1
2305790|NCT01981616|5659893|P2|COMPLETED|Overall Study||62
2305791|NCT01981616|5659894|P1|COMPLETED|Overall Study||63
2305792|NCT01981616|5659893|P2|STARTED|Overall Study||63
2305793|NCT01981616|5659894|P1|STARTED|Overall Study||64
2305794|NCT01981564|5659908|P2|NOT COMPLETED|Overall Study||9
2305795|NCT01981564|5659909|P1|NOT COMPLETED|Overall Study||9
2305796|NCT01981564|5659908|P2|COMPLETED|Overall Study||106
2305797|NCT01981564|5659909|P1|COMPLETED|Overall Study||98
2305798|NCT01981564|5659908|P2|STARTED|Overall Study||115
2305799|NCT01981564|5659909|P1|STARTED|Overall Study||107
2305800|NCT01981551|5659917|P1|NOT COMPLETED|Overall Study||9
2305801|NCT01981551|5659917|P1|COMPLETED|Overall Study||8
2305802|NCT01981551|5659917|P1|STARTED|Overall Study||17
2305803|NCT01981473|5659927|P3|NOT COMPLETED|Overall Study||8
2305804|NCT01981473|5659928|P2|NOT COMPLETED|Overall Study||0
2305805|NCT01981473|5659929|P1|NOT COMPLETED|Overall Study||2
2305806|NCT01981473|5659927|P3|COMPLETED|Overall Study||196
2305807|NCT01981473|5659928|P2|COMPLETED|Overall Study||199
2305808|NCT01981473|5659929|P1|COMPLETED|Overall Study||200
2305809|NCT01981473|5659927|P3|STARTED|Overall Study||204
2305810|NCT01981473|5659928|P2|STARTED|Overall Study||199
2305811|NCT01981473|5659929|P1|STARTED|Overall Study||202
2305812|NCT01981356|5659970|P2|NOT COMPLETED|Overall Study||2
2305813|NCT01981356|5659971|P1|NOT COMPLETED|Overall Study||7
2305814|NCT01981356|5659970|P2|COMPLETED|Overall Study||4
2305815|NCT01981356|5659971|P1|COMPLETED|Overall Study||5
2305816|NCT01981356|5659970|P2|STARTED|Overall Study||6
2305817|NCT01981356|5659971|P1|STARTED|Overall Study||12
2305818|NCT01981122|5659998|P2|NOT COMPLETED|Overall Study||20
2305819|NCT01981122|5659999|P1|NOT COMPLETED|Overall Study||14
2305820|NCT01981122|5659998|P2|COMPLETED|Overall Study||7
2305821|NCT01981122|5659999|P1|COMPLETED|Overall Study||11
2305822|NCT01981122|5659998|P2|STARTED|Overall Study||27
2305823|NCT01981122|5659999|P1|STARTED|Overall Study||25
2305824|NCT01981109|5660005|P1|NOT COMPLETED|Overall Study||224
2305825|NCT01981109|5660005|P1|COMPLETED|Overall Study||1
2305826|NCT01981109|5660005|P1|STARTED|Overall Study||225
2305827|NCT01981096|5660012|P2|NOT COMPLETED|Overall Study||1
2305828|NCT01981096|5660013|P1|NOT COMPLETED|Overall Study||3
2305829|NCT01981096|5660012|P2|COMPLETED|Overall Study||19
2305830|NCT01981096|5660013|P1|COMPLETED|Overall Study||17
2305831|NCT01981096|5660012|P2|Post-treatment|Overall Study||19
2305832|NCT01981096|5660013|P1|Post-treatment|Overall Study||17
2305833|NCT01981096|5660012|P2|STARTED|Overall Study||20
2305834|NCT01981096|5660013|P1|STARTED|Overall Study||20
2305835|NCT01981057|5660025|P2|NOT COMPLETED|Overall Study||0
2305836|NCT01981057|5660026|P1|NOT COMPLETED|Overall Study||0
2305837|NCT01981057|5660025|P2|COMPLETED|Overall Study||50
2305838|NCT01981057|5660026|P1|COMPLETED|Overall Study||50
2305839|NCT01981057|5660025|P2|STARTED|Overall Study||50
2305840|NCT01981057|5660026|P1|STARTED|Overall Study||50
2305841|NCT01980992|5660034|P2|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||1
2305842|NCT01980992|5660035|P1|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||3
2305843|NCT01980992|5660034|P2|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
2305844|NCT01980992|5660035|P1|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
2305845|NCT01980992|5660034|P2|STARTED|52 Weeks Open Label Active Wheat OIT||19
2305846|NCT01980992|5660035|P1|STARTED|52 Weeks Open Label Active Wheat OIT||21
2305847|NCT01980992|5660034|P2|NOT COMPLETED|52 Weeks Blinded Study Treatment||4
2305848|NCT01980992|5660035|P1|NOT COMPLETED|52 Weeks Blinded Study Treatment||2
2305849|NCT01980992|5660034|P2|COMPLETED|52 Weeks Blinded Study Treatment||19
2305850|NCT01980992|5660035|P1|COMPLETED|52 Weeks Blinded Study Treatment||21
2305851|NCT01980992|5660034|P2|STARTED|52 Weeks Blinded Study Treatment||23
2305852|NCT01980992|5660035|P1|STARTED|52 Weeks Blinded Study Treatment||23
2305853|NCT01980940|5660060|P8|NOT COMPLETED|Overall Study||0
2305854|NCT01980940|5660061|P7|NOT COMPLETED|Overall Study||0
2305855|NCT01980940|5660062|P6|NOT COMPLETED|Overall Study||2
2305856|NCT01980940|5660063|P5|NOT COMPLETED|Overall Study||0
2305857|NCT01980940|5660064|P4|NOT COMPLETED|Overall Study||0
2305858|NCT01980940|5660065|P3|NOT COMPLETED|Overall Study||0
2305859|NCT01980940|5660066|P2|NOT COMPLETED|Overall Study||0
2305860|NCT01980940|5660067|P1|NOT COMPLETED|Overall Study||0
2305861|NCT01980940|5660060|P8|COMPLETED|Overall Study||24
2305862|NCT01980940|5660061|P7|COMPLETED|Overall Study||24
2305863|NCT01980940|5660062|P6|COMPLETED|Overall Study||0
2305864|NCT01980940|5660063|P5|COMPLETED|Overall Study||2
2305865|NCT01980940|5660064|P4|COMPLETED|Overall Study||3
2305866|NCT01980940|5660065|P3|COMPLETED|Overall Study||5
2305867|NCT01980940|5660066|P2|COMPLETED|Overall Study||5
2305868|NCT01980940|5660067|P1|COMPLETED|Overall Study||5
2305869|NCT01980940|5660060|P8|Treated|Overall Study||24
2305870|NCT01980940|5660061|P7|Treated|Overall Study||24
2305871|NCT01980940|5660062|P6|Treated|Overall Study||2
2305872|NCT01980940|5660063|P5|Treated|Overall Study||2
2305873|NCT01980940|5660064|P4|Treated|Overall Study||3
2305874|NCT01980940|5660065|P3|Treated|Overall Study||5
2305875|NCT01980940|5660066|P2|Treated|Overall Study||5
2305876|NCT01980940|5660067|P1|Treated|Overall Study||5
2305877|NCT01980940|5660060|P8|STARTED|Overall Study||24
2305878|NCT01980940|5660061|P7|STARTED|Overall Study||24
2305879|NCT01980940|5660062|P6|STARTED|Overall Study||2
2305880|NCT01980940|5660063|P5|STARTED|Overall Study||2
2305881|NCT01980940|5660064|P4|STARTED|Overall Study||3
2305882|NCT01980940|5660065|P3|STARTED|Overall Study||5
2305883|NCT01980940|5660066|P2|STARTED|Overall Study||5
2305884|NCT01980940|5660067|P1|STARTED|Overall Study||5
2305885|NCT01980888|5660121|P2|NOT COMPLETED|Overall Study||133
2305886|NCT01980888|5660122|P1|NOT COMPLETED|Overall Study||144
2305887|NCT01980888|5660121|P2|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|21
2305888|NCT01980888|5660122|P1|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|13
2305889|NCT01980888|5660121|P2|STARTED|Overall Study||154
2305890|NCT01980888|5660122|P1|STARTED|Overall Study||157
2305891|NCT01980875|5660141|P3|NOT COMPLETED|Overall Study||24
2305892|NCT01980875|5660142|P2|NOT COMPLETED|Overall Study||25
2305893|NCT01980875|5660143|P1|NOT COMPLETED|Overall Study||8
2305894|NCT01980875|5660141|P3|COMPLETED|Overall Study||0
2305895|NCT01980875|5660142|P2|COMPLETED|Overall Study||0
2305896|NCT01980875|5660143|P1|COMPLETED|Overall Study||0
2305897|NCT01980875|5660141|P3|STARTED|Overall Study||24
2305898|NCT01980875|5660142|P2|STARTED|Overall Study||25
2305899|NCT01980875|5660143|P1|STARTED|Overall Study||8
2305900|NCT01980771|5660168|P2|NOT COMPLETED|Overall Study||119
2305901|NCT01980771|5660169|P1|NOT COMPLETED|Overall Study||84
2305902|NCT01980771|5660168|P2|COMPLETED|Overall Study||305
2305903|NCT01980771|5660169|P1|COMPLETED|Overall Study||352
2305904|NCT01980771|5660168|P2|STARTED|Overall Study||424
2305905|NCT01980771|5660169|P1|STARTED|Overall Study||436
2305906|NCT01980706|5660178|P3|NOT COMPLETED|Overall Study||13
2305907|NCT01980706|5660179|P2|NOT COMPLETED|Overall Study||17
2305908|NCT01980706|5660180|P1|NOT COMPLETED|Overall Study||17
2305909|NCT01980706|5660178|P3|COMPLETED|Overall Study||24
2305910|NCT01980706|5660179|P2|COMPLETED|Overall Study||26
2305911|NCT01980706|5660180|P1|COMPLETED|Overall Study||23
2305912|NCT01980706|5660178|P3|STARTED|Overall Study||37
2305913|NCT01980706|5660179|P2|STARTED|Overall Study||43
2305914|NCT01980706|5660180|P1|STARTED|Overall Study||40
2305915|NCT01980654|5660205|P2|NOT COMPLETED|Overall Study||0
2305916|NCT01980654|5660206|P1|NOT COMPLETED|Overall Study||0
2305917|NCT01980654|5660205|P2|COMPLETED|Overall Study||20
2305918|NCT01980654|5660206|P1|COMPLETED|Overall Study||60
2305919|NCT01980654|5660205|P2|STARTED|Overall Study||20
2305920|NCT01980654|5660206|P1|STARTED|Overall Study||60
2305921|NCT01980628|5660220|P1|NOT COMPLETED|Overall Study||63
2305922|NCT01980628|5660220|P1|COMPLETED|Overall Study|Participants who remain on treatment at Final Analysis.|0
2305923|NCT01980628|5660220|P1|STARTED|Overall Study|Total number of patients enrolled to the study and received study treatment|63
2305924|NCT01980589|5660228|P3|NOT COMPLETED|Overall Study||0
2305925|NCT01980589|5660229|P2|NOT COMPLETED|Overall Study||0
2305926|NCT01980589|5660230|P1|NOT COMPLETED|Overall Study||0
2305927|NCT01980589|5660228|P3|COMPLETED|Overall Study||16
2305928|NCT01980589|5660229|P2|COMPLETED|Overall Study||3
2305929|NCT01980589|5660230|P1|COMPLETED|Overall Study||3
2305930|NCT01980589|5660228|P3|STARTED|Overall Study||16
2305931|NCT01980589|5660229|P2|STARTED|Overall Study||3
2305932|NCT01980589|5660230|P1|STARTED|Overall Study||3
2305933|NCT01980524|5660247|P2|NOT COMPLETED|Study Day 2||0
2305934|NCT01980524|5660248|P1|NOT COMPLETED|Study Day 2||0
2305935|NCT01980524|5660247|P2|COMPLETED|Study Day 2||4
2305936|NCT01980524|5660248|P1|COMPLETED|Study Day 2||4
2305937|NCT01980524|5660247|P2|STARTED|Study Day 2||4
2305938|NCT01980524|5660248|P1|STARTED|Study Day 2||4
2305939|NCT01980524|5660247|P2|NOT COMPLETED|Washout (at Least 2 Weeks)||0
2305940|NCT01980524|5660248|P1|NOT COMPLETED|Washout (at Least 2 Weeks)||0
2305941|NCT01980524|5660247|P2|COMPLETED|Washout (at Least 2 Weeks)||4
2305942|NCT01980524|5660248|P1|COMPLETED|Washout (at Least 2 Weeks)||4
2305943|NCT01980524|5660247|P2|STARTED|Washout (at Least 2 Weeks)||4
2305944|NCT01980524|5660248|P1|STARTED|Washout (at Least 2 Weeks)||4
2305945|NCT01980524|5660247|P2|NOT COMPLETED|Study Day 1||0
2305946|NCT01980524|5660248|P1|NOT COMPLETED|Study Day 1||0
2305947|NCT01980524|5660247|P2|COMPLETED|Study Day 1||4
2305948|NCT01980524|5660248|P1|COMPLETED|Study Day 1||4
2305949|NCT01980524|5660247|P2|STARTED|Study Day 1||4
2305950|NCT01980524|5660248|P1|STARTED|Study Day 1||4
2305951|NCT01980485|5660260|P2|NOT COMPLETED|Overall Study||25
2305952|NCT01980485|5660261|P1|NOT COMPLETED|Overall Study||36
2305953|NCT01980485|5660260|P2|COMPLETED|Overall Study||80
2305954|NCT01980485|5660261|P1|COMPLETED|Overall Study||84
2305955|NCT01980485|5660260|P2|STARTED|Overall Study||105
2305956|NCT01980485|5660261|P1|STARTED|Overall Study||120
2305957|NCT01980342|5660269|P1|NOT COMPLETED|Overall Study||1
2305958|NCT01980342|5660269|P1|COMPLETED|Overall Study||0
2305959|NCT01980342|5660269|P1|STARTED|Overall Study||1
2305960|NCT01980095|5660279|P2|NOT COMPLETED|Overall Study||11
2305961|NCT01980095|5660280|P1|NOT COMPLETED|Overall Study||15
2305962|NCT01980095|5660279|P2|COMPLETED|Overall Study||30
2305963|NCT01980095|5660280|P1|COMPLETED|Overall Study||63
2305964|NCT01980095|5660279|P2|Treated|Overall Study||41
2305965|NCT01980095|5660280|P1|Treated|Overall Study|Of 78 patients randomized, 1 patient erroneously randomized and not treated|77
2305966|NCT01980095|5660279|P2|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|41
2305967|NCT01980095|5660280|P1|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|78
2305968|NCT01980056|5660291|P3|NOT COMPLETED|Overall Study||0
2305969|NCT01980056|5660292|P2|NOT COMPLETED|Overall Study||1
2305970|NCT01980056|5660293|P1|NOT COMPLETED|Overall Study||1
2305971|NCT01980056|5660291|P3|COMPLETED|Overall Study||2
2305972|NCT01980056|5660292|P2|COMPLETED|Overall Study||3
2305973|NCT01980056|5660293|P1|COMPLETED|Overall Study||3
2305974|NCT01980056|5660291|P3|STARTED|Overall Study||2
2305975|NCT01980056|5660292|P2|STARTED|Overall Study||4
2305976|NCT01980056|5660293|P1|STARTED|Overall Study||4
2305977|NCT01979952|5660307|P2|NOT COMPLETED|Overall Study||6
2305978|NCT01979952|5660308|P1|NOT COMPLETED|Overall Study||8
2305979|NCT01979952|5660307|P2|COMPLETED|Overall Study||51
2305980|NCT01979952|5660308|P1|COMPLETED|Overall Study||48
2305981|NCT01979952|5660307|P2|STARTED|Overall Study||57
2305982|NCT01979952|5660308|P1|STARTED|Overall Study||56
2305983|NCT01979614|5660338|P2|NOT COMPLETED|Overall Study||1
2305984|NCT01979614|5660339|P1|NOT COMPLETED|Overall Study||1
2305985|NCT01979614|5660338|P2|COMPLETED|Overall Study||27
2305986|NCT01979614|5660339|P1|COMPLETED|Overall Study||29
2305987|NCT01979614|5660338|P2|PD Analysis Set|Overall Study||26
2305988|NCT01979614|5660339|P1|PD Analysis Set|Overall Study||25
2305989|NCT01979614|5660338|P2|PK Analysis Set|Overall Study||0
2305990|NCT01979614|5660339|P1|PK Analysis Set|Overall Study||30
2305991|NCT01979614|5660338|P2|Safety Analysis Set|Overall Study||28
2305992|NCT01979614|5660339|P1|Safety Analysis Set|Overall Study||30
2305993|NCT01979614|5660338|P2|STARTED|Overall Study||28
2305994|NCT01979614|5660339|P1|STARTED|Overall Study||30
2306021|NCT01979276|5660414|P1|NOT COMPLETED|Overall Study||0
2306022|NCT01979276|5660414|P1|COMPLETED|Overall Study||2
2306023|NCT01979276|5660414|P1|STARTED|Overall Study||2
2306024|NCT01979185|5660422|P2|NOT COMPLETED|Period 2||1
2306025|NCT01979185|5660423|P1|NOT COMPLETED|Period 2||0
2306026|NCT01979185|5660422|P2|COMPLETED|Period 2|1 subject discontinued due to a positive drug test prior to receiving Simvastatin alone in Period 2.|14
2306027|NCT01979185|5660423|P1|COMPLETED|Period 2||15
2306028|NCT01979185|5660422|P2|STARTED|Period 2||15
2306029|NCT01979185|5660423|P1|STARTED|Period 2||15
2306030|NCT01979185|5660422|P2|NOT COMPLETED|Period 1||0
2306031|NCT01979185|5660423|P1|NOT COMPLETED|Period 1||0
2306032|NCT01979185|5660422|P2|COMPLETED|Period 1||15
2306033|NCT01979185|5660423|P1|COMPLETED|Period 1||15
2306034|NCT01979185|5660422|P2|STARTED|Period 1||15
2306035|NCT01979185|5660423|P1|STARTED|Period 1||15
2306036|NCT01979159|5660433|P1|NOT COMPLETED|Overall Study||0
2306037|NCT01979159|5660433|P1|COMPLETED|Overall Study||4
2306038|NCT01979159|5660433|P1|STARTED|Overall Study||4
2306039|NCT01979133|5660439|P1|NOT COMPLETED|Overall Study||3
2306040|NCT01979133|5660439|P1|COMPLETED|Overall Study||7
2306041|NCT01979133|5660439|P1|STARTED|Overall Study||10
2306042|NCT01979029|5660458|P2|NOT COMPLETED|Overall Study||0
2306043|NCT01979029|5660459|P1|NOT COMPLETED|Overall Study||0
2306044|NCT01979029|5660458|P2|COMPLETED|Overall Study||28
2306045|NCT01979029|5660459|P1|COMPLETED|Overall Study||29
2306046|NCT01979029|5660458|P2|STARTED|Overall Study||28
2306047|NCT01979029|5660459|P1|STARTED|Overall Study||29
2306048|NCT01978938|5660471|P2|NOT COMPLETED|Overall Study||14
2306049|NCT01978938|5660472|P1|NOT COMPLETED|Overall Study||23
2306050|NCT01978938|5660471|P2|COMPLETED|Overall Study||439
2306051|NCT01978938|5660472|P1|COMPLETED|Overall Study||432
2306052|NCT01978938|5660471|P2|Received at Least 1 Dose of Study Drug|Overall Study||451
2306053|NCT01978938|5660472|P1|Received at Least 1 Dose of Study Drug|Overall Study||454
2306054|NCT01978938|5660471|P2|STARTED|Overall Study||453
2306055|NCT01978938|5660472|P1|STARTED|Overall Study||455
2306056|NCT01978912|5660486|P4|NOT COMPLETED|Overall Study||3
2306057|NCT01978912|5660487|P3|NOT COMPLETED|Overall Study||3
2306058|NCT01978912|5660488|P2|NOT COMPLETED|Overall Study||3
2306059|NCT01978912|5660489|P1|NOT COMPLETED|Overall Study||3
2306060|NCT01978912|5660486|P4|COMPLETED|Overall Study||3
2306061|NCT01978912|5660487|P3|COMPLETED|Overall Study||3
2306062|NCT01978912|5660488|P2|COMPLETED|Overall Study||3
2306063|NCT01978912|5660489|P1|COMPLETED|Overall Study||3
2306064|NCT01978912|5660486|P4|STARTED|Overall Study||6
2306065|NCT01978912|5660487|P3|STARTED|Overall Study||6
2306066|NCT01978912|5660488|P2|STARTED|Overall Study||6
2306067|NCT01978912|5660489|P1|STARTED|Overall Study||6
2306068|NCT01978743|5660535|P1|NOT COMPLETED|Overall Study||0
2306069|NCT01978743|5660535|P1|COMPLETED|Overall Study||10
2306070|NCT01978743|5660535|P1|STARTED|Overall Study||10
2306071|NCT01978600|5660549|P2|NOT COMPLETED|Overall Study||0
2306072|NCT01978600|5660550|P1|NOT COMPLETED|Overall Study||0
2306073|NCT01978600|5660549|P2|COMPLETED|Overall Study||42
2306074|NCT01978600|5660550|P1|COMPLETED|Overall Study||44
2306075|NCT01978600|5660549|P2|STARTED|Overall Study||42
2306076|NCT01978600|5660550|P1|STARTED|Overall Study||44
2306077|NCT01978535|5660562|P2|NOT COMPLETED|Overall Study||0
2306078|NCT01978535|5660563|P1|NOT COMPLETED|Overall Study||0
2306079|NCT01978535|5660562|P2|COMPLETED|Overall Study||2
2306080|NCT01978535|5660563|P1|COMPLETED|Overall Study||1
2306081|NCT01978535|5660562|P2|STARTED|Overall Study||2
2306082|NCT01978535|5660563|P1|STARTED|Overall Study||1
2306083|NCT01978314|5660574|P5|NOT COMPLETED|Overall Study||0
2306084|NCT01978314|5660575|P4|NOT COMPLETED|Overall Study||0
2306085|NCT01978314|5660576|P3|NOT COMPLETED|Overall Study||0
2306086|NCT01978314|5660577|P2|NOT COMPLETED|Overall Study||0
2306087|NCT01978314|5660578|P1|NOT COMPLETED|Overall Study||0
2306088|NCT01978314|5660574|P5|COMPLETED|Overall Study||8
2306089|NCT01978314|5660575|P4|COMPLETED|Overall Study||1
2306090|NCT01978314|5660576|P3|COMPLETED|Overall Study||8
2306091|NCT01978314|5660577|P2|COMPLETED|Overall Study||8
2306092|NCT01978314|5660578|P1|COMPLETED|Overall Study||8
2306093|NCT01978314|5660574|P5|STARTED|Overall Study||8
2306094|NCT01978314|5660575|P4|STARTED|Overall Study||1
2306095|NCT01978314|5660576|P3|STARTED|Overall Study||8
2306096|NCT01978314|5660577|P2|STARTED|Overall Study||8
2306097|NCT01978314|5660578|P1|STARTED|Overall Study||8
2306098|NCT01978262|5660660|P1|NOT COMPLETED|Overall Study||11
2306099|NCT01978262|5660660|P1|COMPLETED|Overall Study||92
2306100|NCT01978262|5660660|P1|STARTED|Overall Study||103
2306101|NCT01978236|5660665|P1|NOT COMPLETED|Overall Study||2
2306102|NCT01978236|5660665|P1|COMPLETED|Overall Study||4
2306103|NCT01978236|5660665|P1|STARTED|Overall Study||6
2306104|NCT01978184|5660686|P2|NOT COMPLETED|Overall Study||20
2306105|NCT01978184|5660687|P1|NOT COMPLETED|Overall Study||13
2306106|NCT01978184|5660686|P2|COMPLETED|Overall Study||41
2306107|NCT01978184|5660687|P1|COMPLETED|Overall Study||30
2306108|NCT01978184|5660686|P2|STARTED|Overall Study||61
2306109|NCT01978184|5660687|P1|STARTED|Overall Study||43
2306110|NCT01978145|5660713|P2|NOT COMPLETED|Treatment Period 2||14
2306111|NCT01978145|5660714|P1|NOT COMPLETED|Treatment Period 2||19
2306112|NCT01978145|5660713|P2|COMPLETED|Treatment Period 2||179
2306113|NCT01978145|5660714|P1|COMPLETED|Treatment Period 2||185
2306114|NCT01978145|5660713|P2|STARTED|Treatment Period 2||193
2306115|NCT01978145|5660714|P1|STARTED|Treatment Period 2||204
2306116|NCT01978145|5660713|P2|NOT COMPLETED|Washout Period 1||3
2306117|NCT01978145|5660714|P1|NOT COMPLETED|Washout Period 1||1
2306118|NCT01978145|5660713|P2|COMPLETED|Washout Period 1||193
2306119|NCT01978145|5660714|P1|COMPLETED|Washout Period 1||204
2306120|NCT01978145|5660713|P2|STARTED|Washout Period 1||196
2306121|NCT01978145|5660714|P1|STARTED|Washout Period 1||205
2306122|NCT01978145|5660713|P2|NOT COMPLETED|Treatment Period 1||16
2306123|NCT01978145|5660714|P1|NOT COMPLETED|Treatment Period 1||9
2306124|NCT01978145|5660713|P2|COMPLETED|Treatment Period 1||196
2306125|NCT01978145|5660714|P1|COMPLETED|Treatment Period 1||205
2306126|NCT01978145|5660713|P2|STARTED|Treatment Period 1||212
2306127|NCT01978145|5660714|P1|STARTED|Treatment Period 1||214
2306128|NCT01978119|5660730|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||2
2306129|NCT01978119|5660731|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||0
2306130|NCT01978119|5660730|P2|COMPLETED|Treatment Period 2 (12 Weeks)||40
2306131|NCT01978119|5660731|P1|COMPLETED|Treatment Period 2 (12 Weeks)||38
2306132|NCT01978119|5660730|P2|STARTED|Treatment Period 2 (12 Weeks)||42
2306133|NCT01978119|5660731|P1|STARTED|Treatment Period 2 (12 Weeks)||38
2306134|NCT01978119|5660730|P2|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
2306135|NCT01978119|5660731|P1|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
2306136|NCT01978119|5660730|P2|COMPLETED|Washout Period 1 (3 Weeks)||42
2306137|NCT01978119|5660731|P1|COMPLETED|Washout Period 1 (3 Weeks)||38
2306138|NCT01978119|5660730|P2|STARTED|Washout Period 1 (3 Weeks)||42
2306139|NCT01978119|5660731|P1|STARTED|Washout Period 1 (3 Weeks)||38
2306140|NCT01978119|5660730|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||0
2306141|NCT01978119|5660731|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
2306142|NCT01978119|5660730|P2|COMPLETED|Treatment Period 1 (12 Weeks)||42
2306143|NCT01978119|5660731|P1|COMPLETED|Treatment Period 1 (12 Weeks)||38
2306144|NCT01978119|5660730|P2|STARTED|Treatment Period 1 (12 Weeks)||42
2306145|NCT01978119|5660731|P1|STARTED|Treatment Period 1 (12 Weeks)||40
2306146|NCT01978093|5660757|P2|NOT COMPLETED|Overall Study||73
2306147|NCT01978093|5660758|P1|NOT COMPLETED|Overall Study||65
2306148|NCT01978093|5660757|P2|COMPLETED|Overall Study||230
2306149|NCT01978093|5660758|P1|COMPLETED|Overall Study||232
2306150|NCT01978093|5660757|P2|STARTED|Overall Study||303
2306151|NCT01978093|5660758|P1|STARTED|Overall Study||297
2306152|NCT01977937|5660802|P2|NOT COMPLETED|Overall Study||2
2306153|NCT01977937|5660803|P1|NOT COMPLETED|Overall Study||3
2306154|NCT01977937|5660802|P2|COMPLETED|Overall Study||26
2306155|NCT01977937|5660803|P1|COMPLETED|Overall Study||24
2306156|NCT01977937|5660802|P2|STARTED|Overall Study||28
2306157|NCT01977937|5660803|P1|STARTED|Overall Study||27
2306158|NCT01977846|5660813|P2|NOT COMPLETED|Total Study - Prospective||29
2306159|NCT01977846|5660814|P1|NOT COMPLETED|Total Study - Prospective||0
2306160|NCT01977846|5660813|P2|COMPLETED|Total Study - Prospective||230
2306161|NCT01977846|5660814|P1|COMPLETED|Total Study - Prospective||0
2306162|NCT01977846|5660813|P2|STARTED|Total Study - Prospective||259
2306163|NCT01977846|5660814|P1|STARTED|Total Study - Prospective||0
2306164|NCT01977846|5660813|P2|NOT COMPLETED|Total Study - Retrospective||0
2306165|NCT01977846|5660814|P1|NOT COMPLETED|Total Study - Retrospective||0
2306166|NCT01977846|5660813|P2|COMPLETED|Total Study - Retrospective||0
2306167|NCT01977846|5660814|P1|COMPLETED|Total Study - Retrospective||251
2306168|NCT01977846|5660813|P2|STARTED|Total Study - Retrospective||0
2306169|NCT01977846|5660814|P1|STARTED|Total Study - Retrospective||251
2306170|NCT01977820|5660832|P2|NOT COMPLETED|Overall Study||1
2306171|NCT01977820|5660833|P1|NOT COMPLETED|Overall Study||1
2306172|NCT01977820|5660832|P2|COMPLETED|Overall Study||0
2306173|NCT01977820|5660833|P1|COMPLETED|Overall Study||0
2306174|NCT01977820|5660832|P2|STARTED|Overall Study||1
2306175|NCT01977820|5660833|P1|STARTED|Overall Study||1
2306176|NCT01977794|5660841|P2|NOT COMPLETED|Overall Study||6
2306177|NCT01977794|5660842|P1|NOT COMPLETED|Overall Study||8
2306178|NCT01977794|5660841|P2|COMPLETED|Overall Study||94
2306179|NCT01977794|5660842|P1|COMPLETED|Overall Study||92
2306180|NCT01977794|5660841|P2|STARTED|Overall Study||100
2306181|NCT01977794|5660842|P1|STARTED|Overall Study||100
2306182|NCT01977781|5660858|P2|NOT COMPLETED|Overall Study||1
2306183|NCT01977781|5660859|P1|NOT COMPLETED|Overall Study||6
2306184|NCT01977781|5660858|P2|COMPLETED|Overall Study||15
2306185|NCT01977781|5660859|P1|COMPLETED|Overall Study||18
2306186|NCT01977781|5660858|P2|STARTED|Overall Study||16
2306187|NCT01977781|5660859|P1|STARTED|Overall Study||24
2306188|NCT01977729|5660877|P1|NOT COMPLETED|Overall Study||1
2306189|NCT01977729|5660877|P1|COMPLETED|Overall Study||0
2306190|NCT01977729|5660877|P1|STARTED|Overall Study||1
2306191|NCT01977690|5660889|P2|NOT COMPLETED|Overall Study||4
2306192|NCT01977690|5660890|P1|NOT COMPLETED|Overall Study||0
2306193|NCT01977690|5660889|P2|COMPLETED|Overall Study||11
2306194|NCT01977690|5660890|P1|COMPLETED|Overall Study||15
2306195|NCT01977690|5660889|P2|STARTED|Overall Study||15
2306196|NCT01977690|5660890|P1|STARTED|Overall Study||15
2306197|NCT01977677|5660899|P3|NOT COMPLETED|Overall Study||1
2306198|NCT01977677|5660900|P2|NOT COMPLETED|Overall Study||0
2306199|NCT01977677|5660901|P1|NOT COMPLETED|Overall Study||0
2306200|NCT01977677|5660899|P3|COMPLETED|Overall Study||20
2306201|NCT01977677|5660900|P2|COMPLETED|Overall Study||6
2306202|NCT01977677|5660901|P1|COMPLETED|Overall Study||3
2306203|NCT01977677|5660899|P3|STARTED|Overall Study||21
2306204|NCT01977677|5660900|P2|STARTED|Overall Study||6
2306205|NCT01977677|5660901|P1|STARTED|Overall Study||3
2306206|NCT01977625|5660912|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
2306207|NCT01977625|5660913|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
2306208|NCT01977625|5660912|P2|COMPLETED|Second Intervention (4 Weeks)||7
2306209|NCT01977625|5660913|P1|COMPLETED|Second Intervention (4 Weeks)||7
2306210|NCT01977625|5660912|P2|STARTED|Second Intervention (4 Weeks)||7
2306211|NCT01977625|5660913|P1|STARTED|Second Intervention (4 Weeks)||8
2306212|NCT01977625|5660912|P2|NOT COMPLETED|Washout (2 Weeks)||0
2306213|NCT01977625|5660913|P1|NOT COMPLETED|Washout (2 Weeks)||0
2306214|NCT01977625|5660912|P2|COMPLETED|Washout (2 Weeks)||7
2306215|NCT01977625|5660913|P1|COMPLETED|Washout (2 Weeks)||8
2306216|NCT01977625|5660912|P2|STARTED|Washout (2 Weeks)||7
2306217|NCT01977625|5660913|P1|STARTED|Washout (2 Weeks)||8
2306218|NCT01977625|5660912|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
2306219|NCT01977625|5660913|P1|NOT COMPLETED|First Intervention (4 Weeks)||3
2306220|NCT01977625|5660912|P2|COMPLETED|First Intervention (4 Weeks)||7
2306221|NCT01977625|5660913|P1|COMPLETED|First Intervention (4 Weeks)||8
2306222|NCT01977625|5660912|P2|STARTED|First Intervention (4 Weeks)||7
2306223|NCT01977625|5660913|P1|STARTED|First Intervention (4 Weeks)||11
2306224|NCT01977612|5660923|P2|NOT COMPLETED|Overall Study||1
2306225|NCT01977612|5660924|P1|NOT COMPLETED|Overall Study||1
2306226|NCT01977612|5660923|P2|COMPLETED|Overall Study||79
2306227|NCT01977612|5660924|P1|COMPLETED|Overall Study||84
2306228|NCT01977612|5660923|P2|STARTED|Overall Study||80
2306229|NCT01977612|5660924|P1|STARTED|Overall Study||85
2306230|NCT01977573|5660946|P4|NOT COMPLETED|Overall Study||3
2306231|NCT01977573|5660947|P3|NOT COMPLETED|Overall Study||4
2306232|NCT01977573|5660948|P2|NOT COMPLETED|Overall Study||3
2306233|NCT01977573|5660949|P1|NOT COMPLETED|Overall Study||20
2306234|NCT01977573|5660946|P4|COMPLETED|Overall Study||33
2306235|NCT01977573|5660947|P3|COMPLETED|Overall Study||32
2306236|NCT01977573|5660948|P2|COMPLETED|Overall Study||41
2306237|NCT01977573|5660949|P1|COMPLETED|Overall Study||116
2306238|NCT01977573|5660946|P4|STARTED|Overall Study||36
2306239|NCT01977573|5660947|P3|STARTED|Overall Study||36
2306240|NCT01977573|5660948|P2|STARTED|Overall Study||44
2306241|NCT01977573|5660949|P1|STARTED|Overall Study||136
2306242|NCT01977482|5661063|P6|NOT COMPLETED|Overall Study||5
2306243|NCT01977482|5661064|P5|NOT COMPLETED|Overall Study||3
2306244|NCT01977482|5661065|P4|NOT COMPLETED|Overall Study||4
2306245|NCT01977482|5661066|P3|NOT COMPLETED|Overall Study||5
2306246|NCT01977482|5661067|P2|NOT COMPLETED|Overall Study||9
2306247|NCT01977482|5661068|P1|NOT COMPLETED|Overall Study||3
2306248|NCT01977482|5661063|P6|COMPLETED|Overall Study||14
2306249|NCT01977482|5661064|P5|COMPLETED|Overall Study||37
2306250|NCT01977482|5661065|P4|COMPLETED|Overall Study||35
2306251|NCT01977482|5661066|P3|COMPLETED|Overall Study||35
2306252|NCT01977482|5661067|P2|COMPLETED|Overall Study||30
2306253|NCT01977482|5661068|P1|COMPLETED|Overall Study||36
2306254|NCT01977482|5661063|P6|STARTED|Overall Study||19
2306255|NCT01977482|5661064|P5|STARTED|Overall Study||40
2306256|NCT01977482|5661065|P4|STARTED|Overall Study||39
2306257|NCT01977482|5661066|P3|STARTED|Overall Study||40
2306258|NCT01977482|5661067|P2|STARTED|Overall Study||39
2306259|NCT01977482|5661068|P1|STARTED|Overall Study||39
2306260|NCT01977456|5661183|P1|NOT COMPLETED|Overall Study||5
2306261|NCT01977456|5661183|P1|COMPLETED|Overall Study||22
2306262|NCT01977456|5661183|P1|STARTED|Overall Study||27
2306263|NCT01977352|5661192|P2|NOT COMPLETED|Overall Study||2
2306264|NCT01977352|5661193|P1|NOT COMPLETED|Overall Study||1
2306265|NCT01977352|5661192|P2|COMPLETED|Overall Study||19
2306266|NCT01977352|5661193|P1|COMPLETED|Overall Study||20
2306267|NCT01977352|5661192|P2|STARTED|Overall Study||21
2306268|NCT01977352|5661193|P1|STARTED|Overall Study||21
2306269|NCT01977222|5661211|P1|NOT COMPLETED|Overall Study||1
2306270|NCT01977222|5661211|P1|COMPLETED|Overall Study||11
2306271|NCT01977222|5661211|P1|STARTED|Overall Study||12
2306272|NCT01977092|5661224|P2|NOT COMPLETED|Overall Study||30
2306273|NCT01977092|5661225|P1|NOT COMPLETED|Overall Study||31
2306274|NCT01977092|5661224|P2|COMPLETED|Overall Study||151
2306275|NCT01977092|5661225|P1|COMPLETED|Overall Study||118
2306276|NCT01977092|5661224|P2|STARTED|Overall Study||181
2306277|NCT01977092|5661225|P1|STARTED|Overall Study||149
2306278|NCT01977040|5661235|P1|NOT COMPLETED|Overall Study||2
2306279|NCT01977040|5661235|P1|COMPLETED|Overall Study||66
2306280|NCT01977040|5661235|P1|STARTED|Overall Study||68
2306281|NCT01976988|5661247|P2|NOT COMPLETED|Overall Study||18
2306282|NCT01976988|5661248|P1|NOT COMPLETED|Overall Study||16
2306283|NCT01976988|5661247|P2|COMPLETED|Overall Study||184
2306284|NCT01976988|5661248|P1|COMPLETED|Overall Study||192
2306285|NCT01976988|5661247|P2|STARTED|Overall Study||202
2306286|NCT01976988|5661248|P1|STARTED|Overall Study||208
2306287|NCT01976975|5661266|P2|NOT COMPLETED|Overall Study||12
2306288|NCT01976975|5661267|P1|NOT COMPLETED|Overall Study||147
2306289|NCT01976975|5661266|P2|COMPLETED|Overall Study||32
2306290|NCT01976975|5661267|P1|COMPLETED|Overall Study||79
2306291|NCT01976975|5661266|P2|STARTED|Overall Study||44
2306292|NCT01976975|5661267|P1|STARTED|Overall Study||226
2306293|NCT01976871|5661277|P1|NOT COMPLETED|Overall Study||1
2306294|NCT01976871|5661277|P1|COMPLETED|Overall Study||20
2306295|NCT01976871|5661277|P1|STARTED|Overall Study||21
2306296|NCT01976845|5661289|P3|NOT COMPLETED|Overall Study||3
2306297|NCT01976845|5661290|P2|NOT COMPLETED|Overall Study||8
2306298|NCT01976845|5661291|P1|NOT COMPLETED|Overall Study||8
2306299|NCT01976845|5661289|P3|COMPLETED|Overall Study||40
2306300|NCT01976845|5661290|P2|COMPLETED|Overall Study||40
2306301|NCT01976845|5661291|P1|COMPLETED|Overall Study||40
2306302|NCT01976845|5661289|P3|STARTED|Overall Study||43
2306303|NCT01976845|5661290|P2|STARTED|Overall Study||48
2306304|NCT01976845|5661291|P1|STARTED|Overall Study||48
2306305|NCT01976819|5661305|P1|NOT COMPLETED|Overall Study||5
2306306|NCT01976819|5661305|P1|COMPLETED|Overall Study||11
2306307|NCT01976819|5661305|P1|STARTED|Overall Study||16
2306308|NCT01976806|5661316|P2|NOT COMPLETED|Overall Study||6
2306309|NCT01976806|5661317|P1|NOT COMPLETED|Overall Study||3
2306310|NCT01976806|5661316|P2|COMPLETED|Overall Study||22
2306311|NCT01976806|5661317|P1|COMPLETED|Overall Study||24
2306312|NCT01976806|5661316|P2|STARTED|Overall Study||28
2306313|NCT01976806|5661317|P1|STARTED|Overall Study||27
2306314|NCT01976663|5661345|P1|NOT COMPLETED|Overall Study||42
2306315|NCT01976663|5661345|P1|COMPLETED|Overall Study||84
2306316|NCT01976663|5661345|P1|Received Repeat Treatment|Overall Study||85
2306317|NCT01976663|5661345|P1|Received Asymmetry Correction|Overall Study||45
2306318|NCT01976663|5661345|P1|Received Touch-up Treatment|Overall Study||63
2306319|NCT01976663|5661345|P1|STARTED|Overall Study||126
2306320|NCT01976650|5661359|P1|NOT COMPLETED|Overall Study||6
2306321|NCT01976650|5661359|P1|COMPLETED|Overall Study||718
2306322|NCT01976650|5661359|P1|STARTED|Overall Study||724
2306323|NCT01976624|5661364|P1|NOT COMPLETED|Overall Study||14
2306324|NCT01976624|5661364|P1|COMPLETED|Overall Study||742
2306325|NCT01976624|5661364|P1|STARTED|Overall Study||756
2306326|NCT01976572|5661369|P3|NOT COMPLETED|Overall Study||0
2306327|NCT01976572|5661370|P2|NOT COMPLETED|Overall Study||0
2306328|NCT01976572|5661371|P1|NOT COMPLETED|Overall Study||0
2306329|NCT01976572|5661369|P3|COMPLETED|Overall Study||6
2306330|NCT01976572|5661370|P2|COMPLETED|Overall Study||6
2306331|NCT01976572|5661371|P1|COMPLETED|Overall Study||6
2306332|NCT01976572|5661369|P3|STARTED|Overall Study||6
2306333|NCT01976572|5661370|P2|STARTED|Overall Study||6
2306334|NCT01976572|5661371|P1|STARTED|Overall Study||6
2306335|NCT01976507|5661392|P1|NOT COMPLETED|Overall Study||7
2306336|NCT01976507|5661392|P1|COMPLETED|Overall Study||94
2306337|NCT01976507|5661392|P1|Received Initial Dose of Dabigatran|Overall Study||100
2306338|NCT01976507|5661392|P1|STARTED|Overall Study||101
2306339|NCT01976442|5661401|P2|NOT COMPLETED|Overall Study||0
2306340|NCT01976442|5661402|P1|NOT COMPLETED|Overall Study||0
2306341|NCT01976442|5661401|P2|COMPLETED|Overall Study||31
2306342|NCT01976442|5661402|P1|COMPLETED|Overall Study||69
2306343|NCT01976442|5661401|P2|STARTED|Overall Study||31
2306344|NCT01976442|5661402|P1|STARTED|Overall Study||69
2306345|NCT01976416|5661416|P2|NOT COMPLETED|Overall Study||2
2306346|NCT01976416|5661417|P1|NOT COMPLETED|Overall Study||2
2306347|NCT01976416|5661416|P2|COMPLETED|Overall Study||102
2306348|NCT01976416|5661417|P1|COMPLETED|Overall Study||102
2306349|NCT01976416|5661416|P2|STARTED|Overall Study||104
2306350|NCT01976416|5661417|P1|STARTED|Overall Study||104
2306351|NCT01976338|5661425|P2|NOT COMPLETED|Overall Study||4
2306352|NCT01976338|5661426|P1|NOT COMPLETED|Overall Study||13
2306353|NCT01976338|5661425|P2|COMPLETED|Overall Study|12 months|89
2306354|NCT01976338|5661426|P1|COMPLETED|Overall Study|12 months|177
2306355|NCT01976338|5661425|P2|Discontinued Study Prior to 6 Months|Overall Study||2
2306356|NCT01976338|5661426|P1|Discontinued Study Prior to 6 Months|Overall Study||5
2306357|NCT01976338|5661425|P2|Completed 6 Months|Overall Study||91
2306358|NCT01976338|5661426|P1|Completed 6 Months|Overall Study||185
2306359|NCT01976338|5661425|P2|STARTED|Overall Study||93
2306360|NCT01976338|5661426|P1|STARTED|Overall Study||190
2306361|NCT01976312|5661453|P2|NOT COMPLETED|Overall Study||9
2306362|NCT01976312|5661454|P1|NOT COMPLETED|Overall Study||17
2306363|NCT01976312|5661453|P2|COMPLETED|Overall Study|Completed study at 12 months|53
2306364|NCT01976312|5661454|P1|COMPLETED|Overall Study|Completed study at 12 months|173
2306365|NCT01976312|5661453|P2|Discontinued Study Prior to 3 Months|Overall Study||2
2306366|NCT01976312|5661454|P1|Discontinued Study Prior to 3 Months|Overall Study||4
2306367|NCT01976312|5661453|P2|Completed 3 Months|Overall Study||60
2306368|NCT01976312|5661454|P1|Completed 3 Months|Overall Study||186
2306369|NCT01976312|5661453|P2|STARTED|Overall Study||62
2306370|NCT01976312|5661454|P1|STARTED|Overall Study||190
2306371|NCT01976299|5661475|P2|NOT COMPLETED|Overall Study||6
2306372|NCT01976299|5661476|P1|NOT COMPLETED|Overall Study||23
2306373|NCT01976299|5661475|P2|COMPLETED|Overall Study|2 subjects did not proceed onto procedure in this arm.|280
2306374|NCT01976299|5661476|P1|COMPLETED|Overall Study|9 subjects did not proceed onto procedure in this arm.|269
2306375|NCT01976299|5661475|P2|Completed Procedure|Overall Study||284
2306376|NCT01976299|5661476|P1|Completed Procedure|Overall Study||283
2306377|NCT01976299|5661475|P2|STARTED|Overall Study||286
2306378|NCT01976299|5661476|P1|STARTED|Overall Study||292
2306379|NCT01976273|5661492|P2|NOT COMPLETED|Overall Study||1
2306380|NCT01976273|5661493|P1|NOT COMPLETED|Overall Study||1
2306381|NCT01976273|5661492|P2|COMPLETED|Overall Study||9
2306382|NCT01976273|5661493|P1|COMPLETED|Overall Study||9
2306383|NCT01976273|5661492|P2|STARTED|Overall Study||10
2306384|NCT01976273|5661493|P1|STARTED|Overall Study||10
2306385|NCT01976104|5661503|P4|NOT COMPLETED|Overall Study||3
2306386|NCT01976104|5661504|P3|NOT COMPLETED|Overall Study||2
2306387|NCT01976104|5661505|P2|NOT COMPLETED|Overall Study||2
2306388|NCT01976104|5661506|P1|NOT COMPLETED|Overall Study||6
2306389|NCT01976104|5661503|P4|COMPLETED|Overall Study||55
2306390|NCT01976104|5661504|P3|COMPLETED|Overall Study||31
2306391|NCT01976104|5661505|P2|COMPLETED|Overall Study||68
2306392|NCT01976104|5661506|P1|COMPLETED|Overall Study||37
2306393|NCT01976104|5661503|P4|STARTED|Overall Study||58
2306394|NCT01976104|5661504|P3|STARTED|Overall Study||33
2306395|NCT01976104|5661505|P2|STARTED|Overall Study||70
2306396|NCT01976104|5661506|P1|STARTED|Overall Study||43
2306397|NCT01975974|5661532|P1|NOT COMPLETED|Overall Study||0
2306398|NCT01975974|5661532|P1|COMPLETED|Overall Study||100
2306399|NCT01975974|5661532|P1|STARTED|Overall Study||100
2306400|NCT01975948|5661540|P4|NOT COMPLETED|Overall Study||6
2306401|NCT01975948|5661541|P3|NOT COMPLETED|Overall Study||7
2306402|NCT01975948|5661542|P2|NOT COMPLETED|Overall Study||21
2306403|NCT01975948|5661543|P1|NOT COMPLETED|Overall Study||17
2306404|NCT01975948|5661540|P4|COMPLETED|Overall Study||51
2306405|NCT01975948|5661541|P3|COMPLETED|Overall Study||65
2306406|NCT01975948|5661542|P2|COMPLETED|Overall Study||34
2306407|NCT01975948|5661543|P1|COMPLETED|Overall Study||39
2306408|NCT01975948|5661540|P4|STARTED|Overall Study||57
2306409|NCT01975948|5661541|P3|STARTED|Overall Study||72
2306410|NCT01975948|5661542|P2|STARTED|Overall Study||55
2306411|NCT01975948|5661543|P1|STARTED|Overall Study||56
2306412|NCT01975935|5661569|P2|NOT COMPLETED|Overall Study||1
2306413|NCT01975935|5661570|P1|NOT COMPLETED|Overall Study||3
2306414|NCT01975935|5661569|P2|COMPLETED|Overall Study||20
2306415|NCT01975935|5661570|P1|COMPLETED|Overall Study||18
2306416|NCT01975935|5661569|P2|STARTED|Overall Study||21
2306417|NCT01975935|5661570|P1|STARTED|Overall Study||21
2306418|NCT01975922|5661582|P2|NOT COMPLETED|Overall Study||9
2306419|NCT01975922|5661583|P1|NOT COMPLETED|Overall Study||0
2306420|NCT01975922|5661582|P2|COMPLETED|Overall Study||43
2306421|NCT01975922|5661583|P1|COMPLETED|Overall Study||45
2306422|NCT01975922|5661582|P2|STARTED|Overall Study||52
2306423|NCT01975922|5661583|P1|STARTED|Overall Study||45
2306424|NCT01975909|5661593|P2|NOT COMPLETED|Overall Study||0
2306425|NCT01975909|5661594|P1|NOT COMPLETED|Overall Study||0
2306426|NCT01975909|5661593|P2|COMPLETED|Overall Study||10
2306427|NCT01975909|5661594|P1|COMPLETED|Overall Study||10
2306428|NCT01975909|5661593|P2|STARTED|Overall Study||10
2306429|NCT01975909|5661594|P1|STARTED|Overall Study||10
2306430|NCT01975701|5661610|P1|NOT COMPLETED|Overall Study||25
2306431|NCT01975701|5661610|P1|COMPLETED|Overall Study||1
2306432|NCT01975701|5661610|P1|STARTED|Overall Study||26
2306433|NCT01975675|5661621|P4|NOT COMPLETED|Overall Study||0
2306434|NCT01975675|5661622|P3|NOT COMPLETED|Overall Study||0
2306435|NCT01975675|5661623|P2|NOT COMPLETED|Overall Study||1
2306436|NCT01975675|5661624|P1|NOT COMPLETED|Overall Study||0
2306437|NCT01975675|5661621|P4|COMPLETED|Overall Study||87
2306438|NCT01975675|5661622|P3|COMPLETED|Overall Study||88
2306439|NCT01975675|5661623|P2|COMPLETED|Overall Study||82
2306440|NCT01975675|5661624|P1|COMPLETED|Overall Study||83
2306441|NCT01975675|5661621|P4|STARTED|Overall Study||87
2306442|NCT01975675|5661622|P3|STARTED|Overall Study||88
2306443|NCT01975675|5661623|P2|STARTED|Overall Study||83
2306444|NCT01975675|5661624|P1|STARTED|Overall Study||83
2306445|NCT01975467|5661646|P2|NOT COMPLETED|Overall Study||0
2306446|NCT01975467|5661647|P1|NOT COMPLETED|Overall Study||0
2306447|NCT01975467|5661646|P2|COMPLETED|Overall Study||0
2306448|NCT01975467|5661647|P1|COMPLETED|Overall Study||0
2306449|NCT01975467|5661646|P2|STARTED|Overall Study|Study terminated before enrollment|0
2306450|NCT01975467|5661647|P1|STARTED|Overall Study|Study terminated before enrollment|0
2306451|NCT01975389|5661657|P2|NOT COMPLETED|Overall Study||236
2306452|NCT01975389|5661658|P1|NOT COMPLETED|Overall Study||252
2306453|NCT01975389|5661657|P2|COMPLETED|Overall Study||5045
2306454|NCT01975389|5661658|P1|COMPLETED|Overall Study||5031
2306455|NCT01975389|5661657|P2|Treated|Overall Study||5276
2306456|NCT01975389|5661658|P1|Treated|Overall Study||5279
2306457|NCT01975389|5661657|P2|STARTED|Overall Study||5281
2306458|NCT01975389|5661658|P1|STARTED|Overall Study||5283
2306459|NCT01975376|5661718|P2|NOT COMPLETED|Overall Study||217
2306460|NCT01975376|5661719|P1|NOT COMPLETED|Overall Study||226
2306461|NCT01975376|5661718|P2|COMPLETED|Overall Study||8177
2306462|NCT01975376|5661719|P1|COMPLETED|Overall Study||8164
2306463|NCT01975376|5661718|P2|Treated|Overall Study||8386
2306464|NCT01975376|5661719|P1|Treated|Overall Study||8374
2306465|NCT01975376|5661718|P2|STARTED|Overall Study||8394
2306466|NCT01975376|5661719|P1|STARTED|Overall Study||8390
2306467|NCT01975285|5661779|P2|NOT COMPLETED|Overall Study||2
2306468|NCT01975285|5661780|P1|NOT COMPLETED|Overall Study||2
2306469|NCT01975285|5661779|P2|COMPLETED|Overall Study||28
2306470|NCT01975285|5661780|P1|COMPLETED|Overall Study||28
2306471|NCT01975285|5661779|P2|STARTED|Overall Study||30
2306472|NCT01975285|5661780|P1|STARTED|Overall Study||30
2306473|NCT01975246|5661796|P2|NOT COMPLETED|Overall Study||2
2306474|NCT01975246|5661797|P1|NOT COMPLETED|Overall Study||4
2306475|NCT01975246|5661796|P2|COMPLETED|Overall Study||158
2306476|NCT01975246|5661797|P1|COMPLETED|Overall Study||145
2306477|NCT01975246|5661796|P2|STARTED|Overall Study||160
2306478|NCT01975246|5661797|P1|STARTED|Overall Study||149
2306479|NCT01975220|5661810|P6|NOT COMPLETED|Test Period 2||0
2306480|NCT01975220|5661811|P5|NOT COMPLETED|Test Period 2||0
2306481|NCT01975220|5661812|P4|NOT COMPLETED|Test Period 2||0
2306482|NCT01975220|5661813|P3|NOT COMPLETED|Test Period 2||0
2306483|NCT01975220|5661814|P2|NOT COMPLETED|Test Period 2||0
2306484|NCT01975220|5661815|P1|NOT COMPLETED|Test Period 2||0
2306485|NCT01975220|5661810|P6|COMPLETED|Test Period 2||12
2306486|NCT01975220|5661811|P5|COMPLETED|Test Period 2||12
2306487|NCT01975220|5661812|P4|COMPLETED|Test Period 2||12
2306488|NCT01975220|5661813|P3|COMPLETED|Test Period 2||12
2306489|NCT01975220|5661814|P2|COMPLETED|Test Period 2||11
2306490|NCT01975220|5661815|P1|COMPLETED|Test Period 2||12
2306491|NCT01975220|5661810|P6|STARTED|Test Period 2||12
2306492|NCT01975220|5661811|P5|STARTED|Test Period 2||12
2306493|NCT01975220|5661812|P4|STARTED|Test Period 2||12
2306494|NCT01975220|5661813|P3|STARTED|Test Period 2||12
2306495|NCT01975220|5661814|P2|STARTED|Test Period 2||11
2306496|NCT01975220|5661815|P1|STARTED|Test Period 2||12
2306497|NCT01975220|5661810|P6|NOT COMPLETED|Test Period 1||0
2306498|NCT01975220|5661811|P5|NOT COMPLETED|Test Period 1||0
2306499|NCT01975220|5661812|P4|NOT COMPLETED|Test Period 1||0
2306500|NCT01975220|5661813|P3|NOT COMPLETED|Test Period 1||0
2306501|NCT01975220|5661814|P2|NOT COMPLETED|Test Period 1||1
2306502|NCT01975220|5661815|P1|NOT COMPLETED|Test Period 1||0
2306503|NCT01975220|5661810|P6|COMPLETED|Test Period 1||12
2306504|NCT01975220|5661811|P5|COMPLETED|Test Period 1||12
2306505|NCT01975220|5661812|P4|COMPLETED|Test Period 1||12
2306506|NCT01975220|5661813|P3|COMPLETED|Test Period 1||12
2306507|NCT01975220|5661814|P2|COMPLETED|Test Period 1||11
2306508|NCT01975220|5661815|P1|COMPLETED|Test Period 1||12
2306509|NCT01975220|5661810|P6|STARTED|Test Period 1||12
2306510|NCT01975220|5661811|P5|STARTED|Test Period 1||12
2306511|NCT01975220|5661812|P4|STARTED|Test Period 1||12
2306512|NCT01975220|5661813|P3|STARTED|Test Period 1||12
2306513|NCT01975220|5661814|P2|STARTED|Test Period 1||12
2306514|NCT01975220|5661815|P1|STARTED|Test Period 1||12
2306515|NCT01975090|5661859|P1|NOT COMPLETED|Overall Study||12
2306516|NCT01975090|5661859|P1|COMPLETED|Overall Study||117
2306517|NCT01975090|5661859|P1|6-month Follow-up|Overall Study||117
2306518|NCT01975090|5661859|P1|STARTED|Overall Study||129
2306519|NCT01974895|5661871|P2|NOT COMPLETED|Overall Study||15
2306520|NCT01974895|5661872|P1|NOT COMPLETED|Overall Study||15
2306521|NCT01974895|5661871|P2|COMPLETED|Overall Study||141
2306522|NCT01974895|5661872|P1|COMPLETED|Overall Study||143
2306523|NCT01974895|5661871|P2|STARTED|Overall Study||156
2306524|NCT01974895|5661872|P1|STARTED|Overall Study||158
2306525|NCT01974817|5661902|P1|NOT COMPLETED|Overall Study||8
2306526|NCT01974817|5661902|P1|COMPLETED|Overall Study||17
2306527|NCT01974817|5661902|P1|STARTED|Overall Study||25
2306528|NCT01974752|5661908|P2|NOT COMPLETED|Overall Study||15
2306529|NCT01974752|5661909|P1|NOT COMPLETED|Overall Study||37
2306530|NCT01974752|5661908|P2|COMPLETED|Overall Study||17
2306531|NCT01974752|5661909|P1|COMPLETED|Overall Study||60
2306532|NCT01974752|5661908|P2|STARTED|Overall Study||32
2306533|NCT01974752|5661909|P1|STARTED|Overall Study||97
2306534|NCT01974700|5661923|P2|NOT COMPLETED|Overall Study||0
2306535|NCT01974700|5661924|P1|NOT COMPLETED|Overall Study||0
2306536|NCT01974700|5661923|P2|COMPLETED|Overall Study||3
2306537|NCT01974700|5661924|P1|COMPLETED|Overall Study||5
2306538|NCT01974700|5661923|P2|STARTED|Overall Study||3
2306539|NCT01974700|5661924|P1|STARTED|Overall Study||5
2306540|NCT01974687|5661959|P25|NOT COMPLETED|Overall Study||0
2306541|NCT01974687|5661960|P24|NOT COMPLETED|Overall Study||0
2306542|NCT01974687|5661961|P23|NOT COMPLETED|Overall Study||0
2306543|NCT01974687|5661962|P22|NOT COMPLETED|Overall Study||0
2306544|NCT01974687|5661963|P21|NOT COMPLETED|Overall Study||0
2306545|NCT01974687|5661964|P20|NOT COMPLETED|Overall Study||0
2306546|NCT01974687|5661965|P19|NOT COMPLETED|Overall Study||0
2306547|NCT01974687|5661966|P18|NOT COMPLETED|Overall Study||3
2306548|NCT01974687|5661967|P17|NOT COMPLETED|Overall Study||1
2306549|NCT01974687|5661968|P16|NOT COMPLETED|Overall Study||1
2306550|NCT01974687|5661969|P15|NOT COMPLETED|Overall Study||1
2306551|NCT01974687|5661970|P14|NOT COMPLETED|Overall Study||2
2306552|NCT01974687|5661971|P13|NOT COMPLETED|Overall Study||3
2306553|NCT01974687|5661972|P12|NOT COMPLETED|Overall Study||2
2306554|NCT01974687|5661973|P11|NOT COMPLETED|Overall Study||0
2306555|NCT01974687|5661974|P10|NOT COMPLETED|Overall Study||0
2306556|NCT01974687|5661975|P9|NOT COMPLETED|Overall Study||0
2306557|NCT01974687|5661976|P8|NOT COMPLETED|Overall Study||0
2306558|NCT01974687|5661977|P7|NOT COMPLETED|Overall Study||0
2306559|NCT01974687|5661978|P6|NOT COMPLETED|Overall Study||0
2306560|NCT01974687|5661979|P5|NOT COMPLETED|Overall Study||0
2306561|NCT01974687|5661980|P4|NOT COMPLETED|Overall Study||0
2306562|NCT01974687|5661981|P3|NOT COMPLETED|Overall Study||0
2306563|NCT01974687|5661982|P2|NOT COMPLETED|Overall Study||0
2306564|NCT01974687|5661983|P1|NOT COMPLETED|Overall Study||0
2306565|NCT01974687|5661959|P25|COMPLETED|Overall Study||10
2306566|NCT01974687|5661960|P24|COMPLETED|Overall Study||6
2306567|NCT01974687|5661961|P23|COMPLETED|Overall Study||8
2306568|NCT01974687|5661962|P22|COMPLETED|Overall Study||8
2306569|NCT01974687|5661963|P21|COMPLETED|Overall Study||3
2306570|NCT01974687|5661964|P20|COMPLETED|Overall Study||3
2306571|NCT01974687|5661965|P19|COMPLETED|Overall Study||9
2306572|NCT01974687|5661966|P18|COMPLETED|Overall Study||8
2306573|NCT01974687|5661967|P17|COMPLETED|Overall Study||8
2306574|NCT01974687|5661968|P16|COMPLETED|Overall Study||8
2306575|NCT01974687|5661969|P15|COMPLETED|Overall Study||18
2306576|NCT01974687|5661970|P14|COMPLETED|Overall Study||8
2306577|NCT01974687|5661971|P13|COMPLETED|Overall Study||10
2306578|NCT01974687|5661972|P12|COMPLETED|Overall Study||11
2306579|NCT01974687|5661973|P11|COMPLETED|Overall Study||3
2306580|NCT01974687|5661974|P10|COMPLETED|Overall Study||3
2306581|NCT01974687|5661975|P9|COMPLETED|Overall Study||3
2306582|NCT01974687|5661976|P8|COMPLETED|Overall Study||3
2306583|NCT01974687|5661977|P7|COMPLETED|Overall Study||3
2306584|NCT01974687|5661978|P6|COMPLETED|Overall Study||6
2306585|NCT01974687|5661979|P5|COMPLETED|Overall Study||2
2306586|NCT01974687|5661980|P4|COMPLETED|Overall Study||6
2306587|NCT01974687|5661981|P3|COMPLETED|Overall Study||6
2306588|NCT01974687|5661982|P2|COMPLETED|Overall Study||6
2306589|NCT01974687|5661983|P1|COMPLETED|Overall Study||6
2306590|NCT01974687|5661959|P25|Treated|Overall Study||10
2306591|NCT01974687|5661960|P24|Treated|Overall Study||6
2306592|NCT01974687|5661961|P23|Treated|Overall Study||8
2306593|NCT01974687|5661962|P22|Treated|Overall Study||8
2306594|NCT01974687|5661963|P21|Treated|Overall Study||3
2306595|NCT01974687|5661964|P20|Treated|Overall Study||3
2306596|NCT01974687|5661965|P19|Treated|Overall Study||9
2306597|NCT01974687|5661966|P18|Treated|Overall Study|3 participants discontinued prior to receiving study drug|8
2306598|NCT01974687|5661967|P17|Treated|Overall Study|1 participant discontinued prior to receiving study drug|8
2306599|NCT01974687|5661968|P16|Treated|Overall Study|1 participant discontinued prior to receiving study drug|8
2306600|NCT01974687|5661969|P15|Treated|Overall Study|1 participant discontinued prior to receiving study drug|18
2306601|NCT01974687|5661970|P14|Treated|Overall Study|2 participants discontinued prior to receiving study drug|8
2306602|NCT01974687|5661971|P13|Treated|Overall Study|3 participants discontinued prior to receiving study drug|10
2306699|NCT01973595|5662473|P4|COMPLETED|Intervention Phase 2||14
2306603|NCT01974687|5661972|P12|Treated|Overall Study|2 participants discontinued prior to receiving study drug|11
2306604|NCT01974687|5661973|P11|Treated|Overall Study||3
2306605|NCT01974687|5661974|P10|Treated|Overall Study||3
2306606|NCT01974687|5661975|P9|Treated|Overall Study||3
2306607|NCT01974687|5661976|P8|Treated|Overall Study||3
2306608|NCT01974687|5661977|P7|Treated|Overall Study||3
2306609|NCT01974687|5661978|P6|Treated|Overall Study||6
2306610|NCT01974687|5661979|P5|Treated|Overall Study||2
2306611|NCT01974687|5661980|P4|Treated|Overall Study||6
2306612|NCT01974687|5661981|P3|Treated|Overall Study||6
2306613|NCT01974687|5661982|P2|Treated|Overall Study||6
2306614|NCT01974687|5661983|P1|Treated|Overall Study||6
2306615|NCT01974687|5661959|P25|STARTED|Overall Study||10
2306616|NCT01974687|5661960|P24|STARTED|Overall Study||6
2306617|NCT01974687|5661961|P23|STARTED|Overall Study||8
2306618|NCT01974687|5661962|P22|STARTED|Overall Study||8
2306619|NCT01974687|5661963|P21|STARTED|Overall Study||3
2306620|NCT01974687|5661964|P20|STARTED|Overall Study||3
2306621|NCT01974687|5661965|P19|STARTED|Overall Study||9
2306622|NCT01974687|5661966|P18|STARTED|Overall Study||11
2306623|NCT01974687|5661967|P17|STARTED|Overall Study||9
2306624|NCT01974687|5661968|P16|STARTED|Overall Study||9
2306625|NCT01974687|5661969|P15|STARTED|Overall Study||19
2306626|NCT01974687|5661970|P14|STARTED|Overall Study||10
2306627|NCT01974687|5661971|P13|STARTED|Overall Study||13
2306628|NCT01974687|5661972|P12|STARTED|Overall Study||13
2306629|NCT01974687|5661973|P11|STARTED|Overall Study||3
2306630|NCT01974687|5661974|P10|STARTED|Overall Study||3
2306631|NCT01974687|5661975|P9|STARTED|Overall Study||3
2306632|NCT01974687|5661976|P8|STARTED|Overall Study||3
2306633|NCT01974687|5661977|P7|STARTED|Overall Study||3
2306634|NCT01974687|5661978|P6|STARTED|Overall Study||6
2306635|NCT01974687|5661979|P5|STARTED|Overall Study||2
2306636|NCT01974687|5661980|P4|STARTED|Overall Study||6
2306637|NCT01974687|5661981|P3|STARTED|Overall Study||6
2306638|NCT01974687|5661982|P2|STARTED|Overall Study||6
2306639|NCT01974687|5661983|P1|STARTED|Overall Study||6
2306640|NCT01974635|5662330|P1|NOT COMPLETED|Overall Study||0
2306641|NCT01974635|5662330|P1|COMPLETED|Overall Study||2
2306642|NCT01974635|5662330|P1|STARTED|Overall Study||2
2306643|NCT01974323|5662337|P2|NOT COMPLETED|Overall Study||93
2306644|NCT01974323|5662338|P1|NOT COMPLETED|Overall Study||92
2306645|NCT01974323|5662337|P2|COMPLETED|Overall Study||1027
2306646|NCT01974323|5662338|P1|COMPLETED|Overall Study||1026
2306647|NCT01974323|5662337|P2|STARTED|Overall Study||1120
2306648|NCT01974323|5662338|P1|STARTED|Overall Study||1118
2306649|NCT01974284|5662360|P1|NOT COMPLETED|Overall Study||7
2306650|NCT01974284|5662360|P1|COMPLETED|Overall Study||0
2306651|NCT01974284|5662360|P1|STARTED|Overall Study||7
2306652|NCT01974245|5662369|P2|NOT COMPLETED|Overall Study||8
2306653|NCT01974245|5662370|P1|NOT COMPLETED|Overall Study||9
2306654|NCT01974245|5662369|P2|COMPLETED|Overall Study||20
2306655|NCT01974245|5662370|P1|COMPLETED|Overall Study||18
2306656|NCT01974245|5662369|P2|STARTED|Overall Study||28
2306657|NCT01974245|5662370|P1|STARTED|Overall Study||27
2306658|NCT01974141|5662378|P2|NOT COMPLETED|Overall Study||82
2306659|NCT01974141|5662379|P1|NOT COMPLETED|Overall Study||96
2306660|NCT01974141|5662378|P2|COMPLETED|Overall Study||976
2306661|NCT01974141|5662379|P1|COMPLETED|Overall Study||948
2306662|NCT01974141|5662378|P2|STARTED|Overall Study||1058
2306663|NCT01974141|5662379|P1|STARTED|Overall Study||1044
2306664|NCT01974089|5662403|P2|NOT COMPLETED|Overall Study||0
2306665|NCT01974089|5662404|P1|NOT COMPLETED|Overall Study||0
2306666|NCT01974089|5662403|P2|COMPLETED|Overall Study||101
2306667|NCT01974089|5662404|P1|COMPLETED|Overall Study||53
2306668|NCT01974089|5662403|P2|STARTED|Overall Study||101
2306669|NCT01974089|5662404|P1|STARTED|Overall Study||53
2306670|NCT01974050|5662414|P1|NOT COMPLETED|Overall Study||25
2306671|NCT01974050|5662414|P1|COMPLETED|Overall Study||141
2306672|NCT01974050|5662414|P1|STARTED|Overall Study||166
2306673|NCT01973972|5662423|P2|NOT COMPLETED|Overall Study||19
2306674|NCT01973972|5662424|P1|NOT COMPLETED|Overall Study||18
2306675|NCT01973972|5662423|P2|COMPLETED|Overall Study||117
2306676|NCT01973972|5662424|P1|COMPLETED|Overall Study||109
2306677|NCT01973972|5662423|P2|STARTED|Overall Study||136
2306678|NCT01973972|5662424|P1|STARTED|Overall Study||127
2306679|NCT01973777|5662438|P1|NOT COMPLETED|Overall Study||7
2306680|NCT01973777|5662438|P1|COMPLETED|Overall Study||44
2306681|NCT01973777|5662438|P1|One Year Follow-up|Overall Study||44
2306682|NCT01973777|5662438|P1|STARTED|Overall Study|January 2014|51
2306683|NCT01973608|5662448|P4|NOT COMPLETED|Overall Study||0
2306684|NCT01973608|5662449|P3|NOT COMPLETED|Overall Study||0
2306685|NCT01973608|5662450|P2|NOT COMPLETED|Overall Study||0
2306686|NCT01973608|5662451|P1|NOT COMPLETED|Overall Study||0
2306687|NCT01973608|5662448|P4|COMPLETED|Overall Study||2
2306688|NCT01973608|5662449|P3|COMPLETED|Overall Study||6
2306689|NCT01973608|5662450|P2|COMPLETED|Overall Study||2
2306690|NCT01973608|5662451|P1|COMPLETED|Overall Study||2
2306691|NCT01973608|5662448|P4|STARTED|Overall Study||2
2306692|NCT01973608|5662449|P3|STARTED|Overall Study||6
2306693|NCT01973608|5662450|P2|STARTED|Overall Study||2
2306694|NCT01973608|5662451|P1|STARTED|Overall Study||2
2306695|NCT01973595|5662473|P4|NOT COMPLETED|Intervention Phase 2||0
2306696|NCT01973595|5662474|P3|NOT COMPLETED|Intervention Phase 2||0
2306697|NCT01973595|5662475|P2|NOT COMPLETED|Intervention Phase 2||0
2306698|NCT01973595|5662476|P1|NOT COMPLETED|Intervention Phase 2||0
2306700|NCT01973595|5662474|P3|COMPLETED|Intervention Phase 2||14
2306701|NCT01973595|5662475|P2|COMPLETED|Intervention Phase 2||14
2306702|NCT01973595|5662476|P1|COMPLETED|Intervention Phase 2||14
2306703|NCT01973595|5662473|P4|STARTED|Intervention Phase 2||14
2306704|NCT01973595|5662474|P3|STARTED|Intervention Phase 2||14
2306705|NCT01973595|5662475|P2|STARTED|Intervention Phase 2||14
2306706|NCT01973595|5662476|P1|STARTED|Intervention Phase 2||14
2306707|NCT01973595|5662473|P4|NOT COMPLETED|Washout||0
2306708|NCT01973595|5662474|P3|NOT COMPLETED|Washout||1
2306709|NCT01973595|5662475|P2|NOT COMPLETED|Washout||0
2306710|NCT01973595|5662476|P1|NOT COMPLETED|Washout||1
2306711|NCT01973595|5662473|P4|COMPLETED|Washout||14
2306712|NCT01973595|5662474|P3|COMPLETED|Washout||14
2306713|NCT01973595|5662475|P2|COMPLETED|Washout||14
2306714|NCT01973595|5662476|P1|COMPLETED|Washout||14
2306715|NCT01973595|5662473|P4|STARTED|Washout||14
2306716|NCT01973595|5662474|P3|STARTED|Washout||15
2306717|NCT01973595|5662475|P2|STARTED|Washout||14
2306718|NCT01973595|5662476|P1|STARTED|Washout||15
2306719|NCT01973595|5662473|P4|NOT COMPLETED|Intervention Phase 1||0
2306720|NCT01973595|5662474|P3|NOT COMPLETED|Intervention Phase 1||0
2306721|NCT01973595|5662475|P2|NOT COMPLETED|Intervention Phase 1||0
2306722|NCT01973595|5662476|P1|NOT COMPLETED|Intervention Phase 1||0
2306723|NCT01973595|5662473|P4|COMPLETED|Intervention Phase 1||14
2306724|NCT01973595|5662474|P3|COMPLETED|Intervention Phase 1||15
2306725|NCT01973595|5662475|P2|COMPLETED|Intervention Phase 1||14
2306726|NCT01973595|5662476|P1|COMPLETED|Intervention Phase 1||15
2306727|NCT01973595|5662473|P4|STARTED|Intervention Phase 1||14
2306728|NCT01973595|5662474|P3|STARTED|Intervention Phase 1||15
2306729|NCT01973595|5662475|P2|STARTED|Intervention Phase 1||14
2306730|NCT01973595|5662476|P1|STARTED|Intervention Phase 1||15
2306731|NCT01973569|5662493|P3|NOT COMPLETED|Overall Study||18
2306732|NCT01973569|5662494|P2|NOT COMPLETED|Overall Study||25
2306733|NCT01973569|5662495|P1|NOT COMPLETED|Overall Study||29
2306734|NCT01973569|5662493|P3|COMPLETED|Overall Study||208
2306735|NCT01973569|5662494|P2|COMPLETED|Overall Study||200
2306736|NCT01973569|5662495|P1|COMPLETED|Overall Study||199
2306737|NCT01973569|5662493|P3|Discontinued Study|Overall Study||15
2306738|NCT01973569|5662494|P2|Discontinued Study|Overall Study||22
2306739|NCT01973569|5662495|P1|Discontinued Study|Overall Study||23
2306740|NCT01973569|5662493|P3|Discontinued Study Treatment|Overall Study||15
2306741|NCT01973569|5662494|P2|Discontinued Study Treatment|Overall Study||22
2306742|NCT01973569|5662495|P1|Discontinued Study Treatment|Overall Study||23
2306743|NCT01973569|5662493|P3|Did Not Receive Study Drug|Overall Study||3
2306744|NCT01973569|5662494|P2|Did Not Receive Study Drug|Overall Study||3
2306745|NCT01973569|5662495|P1|Did Not Receive Study Drug|Overall Study||6
2306746|NCT01973569|5662493|P3|Received Study Drug|Overall Study||223
2306747|NCT01973569|5662494|P2|Received Study Drug|Overall Study||222
2306748|NCT01973569|5662495|P1|Received Study Drug|Overall Study||222
2306749|NCT01973569|5662493|P3|STARTED|Overall Study||226
2306750|NCT01973569|5662494|P2|STARTED|Overall Study||225
2306751|NCT01973569|5662495|P1|STARTED|Overall Study||228
2306752|NCT01973491|5662521|P1|NOT COMPLETED|Treatment Period (16 Weeks)||1
2306753|NCT01973491|5662521|P1|COMPLETED|Treatment Period (16 Weeks)||18
2306754|NCT01973491|5662521|P1|STARTED|Treatment Period (16 Weeks)||19
2306755|NCT01973491|5662521|P1|NOT COMPLETED|Titration Period(4 Weeks)||0
2306756|NCT01973491|5662521|P1|COMPLETED|Titration Period(4 Weeks)||19
2306757|NCT01973491|5662521|P1|STARTED|Titration Period(4 Weeks)||19
2306758|NCT01973491|5662521|P1|NOT COMPLETED|Baseline Control Period (8 Weeks)||18
2306759|NCT01973491|5662521|P1|COMPLETED|Baseline Control Period (8 Weeks)||19
2306760|NCT01973491|5662521|P1|STARTED|Baseline Control Period (8 Weeks)||37
2306761|NCT01973439|5662537|P1|NOT COMPLETED|Overall Study||5
2306762|NCT01973439|5662537|P1|COMPLETED|Overall Study||18
2306763|NCT01973439|5662537|P1|One Evaluable PK Day Only|Overall Study|5 children had only one evaluable PK day.|5
2306764|NCT01973439|5662537|P1|Two Evaluable PK Days|Overall Study|18 Children had two evaluable PK days|18
2306765|NCT01973439|5662537|P1|STARTED|Overall Study||23
2306766|NCT01973413|5662546|P2|NOT COMPLETED|Overall Study||0
2306767|NCT01973413|5662547|P1|NOT COMPLETED|Overall Study||1
2306768|NCT01973413|5662546|P2|COMPLETED|Overall Study||20
2306769|NCT01973413|5662547|P1|COMPLETED|Overall Study||11
2306770|NCT01973413|5662546|P2|STARTED|Overall Study||20
2306771|NCT01973413|5662547|P1|STARTED|Overall Study||12
2306772|NCT01973387|5662559|P2|NOT COMPLETED|Overall Study||18
2306773|NCT01973387|5662560|P1|NOT COMPLETED|Overall Study||106
2306774|NCT01973387|5662559|P2|COMPLETED|Overall Study||36
2306775|NCT01973387|5662560|P1|COMPLETED|Overall Study||0
2306776|NCT01973387|5662559|P2|Treated|Overall Study||52
2306777|NCT01973387|5662560|P1|Treated|Overall Study||104
2306778|NCT01973387|5662559|P2|STARTED|Overall Study||54
2306779|NCT01973387|5662560|P1|STARTED|Overall Study||106
2306780|NCT01973348|5662578|P4|NOT COMPLETED|Overall Study||0
2306781|NCT01973348|5662579|P3|NOT COMPLETED|Overall Study||0
2306782|NCT01973348|5662580|P2|NOT COMPLETED|Overall Study||3
2306783|NCT01973348|5662581|P1|NOT COMPLETED|Overall Study||8
2306784|NCT01973348|5662578|P4|COMPLETED|Overall Study||0
2306785|NCT01973348|5662579|P3|COMPLETED|Overall Study||0
2306786|NCT01973348|5662580|P2|COMPLETED|Overall Study||15
2306787|NCT01973348|5662581|P1|COMPLETED|Overall Study||19
2306788|NCT01973348|5662578|P4|STARTED|Overall Study||0
2306789|NCT01973348|5662579|P3|STARTED|Overall Study||0
2306790|NCT01973348|5662580|P2|STARTED|Overall Study||18
2306791|NCT01973348|5662581|P1|STARTED|Overall Study||27
2306792|NCT01973335|5662603|P4|NOT COMPLETED|Overall Study||0
2306793|NCT01973335|5662604|P3|NOT COMPLETED|Overall Study||0
2306794|NCT01973335|5662605|P2|NOT COMPLETED|Overall Study||0
2306795|NCT01973335|5662606|P1|NOT COMPLETED|Overall Study||0
2306796|NCT01973335|5662603|P4|COMPLETED|Overall Study||9
2306797|NCT01973335|5662604|P3|COMPLETED|Overall Study||9
2306798|NCT01973335|5662605|P2|COMPLETED|Overall Study||7
2306799|NCT01973335|5662606|P1|COMPLETED|Overall Study||9
2306800|NCT01973335|5662603|P4|STARTED|Overall Study||9
2306801|NCT01973335|5662604|P3|STARTED|Overall Study||9
2306802|NCT01973335|5662605|P2|STARTED|Overall Study||7
2306803|NCT01973335|5662606|P1|STARTED|Overall Study||9
2306804|NCT01973231|5662642|P2|NOT COMPLETED|Overall Study||12
2306805|NCT01973231|5662643|P1|NOT COMPLETED|Overall Study||11
2306806|NCT01973231|5662642|P2|COMPLETED|Overall Study||190
2306807|NCT01973231|5662643|P1|COMPLETED|Overall Study||191
2306808|NCT01973231|5662642|P2|STARTED|Overall Study||202
2306809|NCT01973231|5662643|P1|STARTED|Overall Study||202
2306810|NCT01973218|5662663|P2|NOT COMPLETED|Overall Study||0
2306811|NCT01973218|5662664|P1|NOT COMPLETED|Overall Study||2
2306812|NCT01973218|5662663|P2|COMPLETED|Overall Study||88
2306813|NCT01973218|5662664|P1|COMPLETED|Overall Study||174
2306814|NCT01973218|5662663|P2|STARTED|Overall Study||88
2306815|NCT01973218|5662664|P1|STARTED|Overall Study||176
2306816|NCT01973205|5662687|P2|NOT COMPLETED|Overall Study||22
2306817|NCT01973205|5662688|P1|NOT COMPLETED|Overall Study||30
2306818|NCT01973205|5662687|P2|COMPLETED|Overall Study||425
2306819|NCT01973205|5662688|P1|COMPLETED|Overall Study||423
2306820|NCT01973205|5662687|P2|STARTED|Overall Study||447
2306821|NCT01973205|5662688|P1|STARTED|Overall Study||453
2306822|NCT01973062|5662700|P1|NOT COMPLETED|Overall Study||0
2306823|NCT01973062|5662700|P1|COMPLETED|Overall Study||1
2306824|NCT01973062|5662700|P1|STARTED|Overall Study||1
2306825|NCT01973036|5662710|P2|NOT COMPLETED|Overall Study||0
2306826|NCT01973036|5662711|P1|NOT COMPLETED|Overall Study||0
2306827|NCT01973036|5662710|P2|COMPLETED|Overall Study||93
2306828|NCT01973036|5662711|P1|COMPLETED|Overall Study||108
2306829|NCT01973036|5662710|P2|Received Assigned Intervention|Overall Study||88
2306830|NCT01973036|5662711|P1|Received Assigned Intervention|Overall Study||113
2306831|NCT01973036|5662710|P2|STARTED|Overall Study||93
2306832|NCT01973036|5662711|P1|STARTED|Overall Study||108
2306833|NCT01972841|5662757|P6|NOT COMPLETED|Overall Study||85
2306834|NCT01972841|5662758|P5|NOT COMPLETED|Overall Study||83
2306835|NCT01972841|5662759|P4|NOT COMPLETED|Overall Study||37
2306836|NCT01972841|5662760|P3|NOT COMPLETED|Overall Study||50
2306837|NCT01972841|5662761|P2|NOT COMPLETED|Overall Study||44
2306838|NCT01972841|5662762|P1|NOT COMPLETED|Overall Study||43
2306839|NCT01972841|5662757|P6|COMPLETED|Overall Study||798
2306840|NCT01972841|5662758|P5|COMPLETED|Overall Study||802
2306841|NCT01972841|5662759|P4|COMPLETED|Overall Study||397
2306842|NCT01972841|5662760|P3|COMPLETED|Overall Study||387
2306843|NCT01972841|5662761|P2|COMPLETED|Overall Study||397
2306844|NCT01972841|5662762|P1|COMPLETED|Overall Study||404
2306845|NCT01972841|5662757|P6|STARTED|Overall Study||883
2306846|NCT01972841|5662758|P5|STARTED|Overall Study||885
2306847|NCT01972841|5662759|P4|STARTED|Overall Study||434
2306848|NCT01972841|5662760|P3|STARTED|Overall Study||437
2306849|NCT01972841|5662761|P2|STARTED|Overall Study||441
2306850|NCT01972841|5662762|P1|STARTED|Overall Study||447
2306851|NCT01972789|5663192|P2|NOT COMPLETED|Overall Study||30
2306852|NCT01972789|5663193|P1|NOT COMPLETED|Overall Study||40
2306853|NCT01972789|5663192|P2|COMPLETED|Overall Study||145
2306854|NCT01972789|5663193|P1|COMPLETED|Overall Study||134
2306855|NCT01972789|5663192|P2|STARTED|Overall Study||175
2306856|NCT01972789|5663193|P1|STARTED|Overall Study||174
2306857|NCT01972776|5663227|P6|NOT COMPLETED|Part 2||7
2306858|NCT01972776|5663228|P5|NOT COMPLETED|Part 2||13
2306859|NCT01972776|5663229|P4|NOT COMPLETED|Part 2||0
2306860|NCT01972776|5663230|P3|NOT COMPLETED|Part 2||0
2306861|NCT01972776|5663231|P2|NOT COMPLETED|Part 2||0
2306862|NCT01972776|5663232|P1|NOT COMPLETED|Part 2||0
2306863|NCT01972776|5663227|P6|COMPLETED|Part 2||0
2306864|NCT01972776|5663228|P5|COMPLETED|Part 2||1
2306865|NCT01972776|5663229|P4|COMPLETED|Part 2||0
2306866|NCT01972776|5663230|P3|COMPLETED|Part 2||0
2306867|NCT01972776|5663231|P2|COMPLETED|Part 2||0
2306868|NCT01972776|5663232|P1|COMPLETED|Part 2||0
2306869|NCT01972776|5663227|P6|STARTED|Part 2||7
2306870|NCT01972776|5663228|P5|STARTED|Part 2||14
2306871|NCT01972776|5663229|P4|STARTED|Part 2||0
2306872|NCT01972776|5663230|P3|STARTED|Part 2||0
2306873|NCT01972776|5663231|P2|STARTED|Part 2||0
2306874|NCT01972776|5663232|P1|STARTED|Part 2||0
2306875|NCT01972776|5663227|P6|NOT COMPLETED|Part 1||0
2306876|NCT01972776|5663228|P5|NOT COMPLETED|Part 1||0
2306877|NCT01972776|5663229|P4|NOT COMPLETED|Part 1||1
2306878|NCT01972776|5663230|P3|NOT COMPLETED|Part 1||2
2306879|NCT01972776|5663231|P2|NOT COMPLETED|Part 1||0
2306880|NCT01972776|5663232|P1|NOT COMPLETED|Part 1||0
2306881|NCT01972776|5663227|P6|COMPLETED|Part 1||0
2306882|NCT01972776|5663228|P5|COMPLETED|Part 1||0
2306883|NCT01972776|5663229|P4|COMPLETED|Part 1||6
2306884|NCT01972776|5663230|P3|COMPLETED|Part 1||6
2306885|NCT01972776|5663231|P2|COMPLETED|Part 1||6
2306886|NCT01972776|5663232|P1|COMPLETED|Part 1||6
2306887|NCT01972776|5663227|P6|STARTED|Part 1||0
2306888|NCT01972776|5663228|P5|STARTED|Part 1||0
2306889|NCT01972776|5663229|P4|STARTED|Part 1||7
2306890|NCT01972776|5663230|P3|STARTED|Part 1||8
2306891|NCT01972776|5663231|P2|STARTED|Part 1||6
2306892|NCT01972776|5663232|P1|STARTED|Part 1||6
2306893|NCT01972724|5663303|P3|NOT COMPLETED|Open-Label||5
2306894|NCT01972724|5663304|P2|NOT COMPLETED|Open-Label||0
2306895|NCT01972724|5663305|P1|NOT COMPLETED|Open-Label||0
2306896|NCT01972724|5663303|P3|COMPLETED|Open-Label||72
2306897|NCT01972724|5663304|P2|COMPLETED|Open-Label||0
2306898|NCT01972724|5663305|P1|COMPLETED|Open-Label||0
2306899|NCT01972724|5663303|P3|STARTED|Open-Label||77
2306900|NCT01972724|5663304|P2|STARTED|Open-Label||0
2306901|NCT01972724|5663305|P1|STARTED|Open-Label||0
2306902|NCT01972724|5663303|P3|NOT COMPLETED|Double-Blind||0
2306903|NCT01972724|5663304|P2|NOT COMPLETED|Double-Blind||9
2306904|NCT01972724|5663305|P1|NOT COMPLETED|Double-Blind||9
2306905|NCT01972724|5663303|P3|COMPLETED|Double-Blind||0
2306906|NCT01972724|5663304|P2|COMPLETED|Double-Blind||9
2306907|NCT01972724|5663305|P1|COMPLETED|Double-Blind||10
2306908|NCT01972724|5663303|P3|Intent-to-treat:Received Study Drug|Double-Blind||0
2306909|NCT01972724|5663304|P2|Intent-to-treat:Received Study Drug|Double-Blind||17
2306910|NCT01972724|5663305|P1|Intent-to-treat:Received Study Drug|Double-Blind||17
2306911|NCT01972724|5663303|P3|STARTED|Double-Blind||0
2306912|NCT01972724|5663304|P2|STARTED|Double-Blind||18
2306913|NCT01972724|5663305|P1|STARTED|Double-Blind||19
2306914|NCT01972659|5663318|P2|NOT COMPLETED|Overall Study||3
2306915|NCT01972659|5663319|P1|NOT COMPLETED|Overall Study||4
2306916|NCT01972659|5663318|P2|COMPLETED|Overall Study||37
2306917|NCT01972659|5663319|P1|COMPLETED|Overall Study||36
2306918|NCT01972659|5663318|P2|STARTED|Overall Study||40
2306919|NCT01972659|5663319|P1|STARTED|Overall Study||40
2306920|NCT01972568|5663328|P3|NOT COMPLETED|Overall Study||16
2306921|NCT01972568|5663329|P2|NOT COMPLETED|Overall Study||12
2306922|NCT01972568|5663330|P1|NOT COMPLETED|Overall Study||16
2306923|NCT01972568|5663328|P3|COMPLETED|Overall Study||84
2306924|NCT01972568|5663329|P2|COMPLETED|Overall Study||92
2306925|NCT01972568|5663330|P1|COMPLETED|Overall Study||86
2306926|NCT01972568|5663328|P3|STARTED|Overall Study||100
2306927|NCT01972568|5663329|P2|STARTED|Overall Study||104
2306928|NCT01972568|5663330|P1|STARTED|Overall Study||102
2306929|NCT01972529|5663369|P4|NOT COMPLETED|Overall Study||4
2306930|NCT01972529|5663370|P3|NOT COMPLETED|Overall Study||2
2306931|NCT01972529|5663371|P2|NOT COMPLETED|Overall Study||5
2306932|NCT01972529|5663372|P1|NOT COMPLETED|Overall Study||2
2306933|NCT01972529|5663369|P4|COMPLETED|Overall Study||55
2306934|NCT01972529|5663370|P3|COMPLETED|Overall Study||32
2306935|NCT01972529|5663371|P2|COMPLETED|Overall Study||85
2306936|NCT01972529|5663372|P1|COMPLETED|Overall Study||46
2306937|NCT01972529|5663369|P4|STARTED|Overall Study||59
2306938|NCT01972529|5663370|P3|STARTED|Overall Study||34
2306939|NCT01972529|5663371|P2|STARTED|Overall Study||90
2306940|NCT01972529|5663372|P1|STARTED|Overall Study||48
2306941|NCT01972516|5663400|P2|NOT COMPLETED|Overall Study||0
2306942|NCT01972516|5663401|P1|NOT COMPLETED|Overall Study||0
2306943|NCT01972516|5663400|P2|COMPLETED|Overall Study||1
2306944|NCT01972516|5663401|P1|COMPLETED|Overall Study||3
2306945|NCT01972516|5663400|P2|STARTED|Overall Study||1
2306946|NCT01972516|5663401|P1|STARTED|Overall Study||3
2306947|NCT01972464|5663417|P2|NOT COMPLETED|3-Month Follow-Up (Week 20)||1
2306948|NCT01972464|5663418|P1|NOT COMPLETED|3-Month Follow-Up (Week 20)||1
2306949|NCT01972464|5663417|P2|COMPLETED|3-Month Follow-Up (Week 20)||17
2306950|NCT01972464|5663418|P1|COMPLETED|3-Month Follow-Up (Week 20)||15
2306951|NCT01972464|5663417|P2|STARTED|3-Month Follow-Up (Week 20)||18
2306952|NCT01972464|5663418|P1|STARTED|3-Month Follow-Up (Week 20)||16
2306953|NCT01972464|5663417|P2|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||4
2306954|NCT01972464|5663418|P1|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||3
2306955|NCT01972464|5663417|P2|COMPLETED|Treatment Period (Week 1 Through Week 8)||18
2306956|NCT01972464|5663418|P1|COMPLETED|Treatment Period (Week 1 Through Week 8)||16
2306957|NCT01972464|5663417|P2|STARTED|Treatment Period (Week 1 Through Week 8)||22
2306958|NCT01972464|5663418|P1|STARTED|Treatment Period (Week 1 Through Week 8)||19
2306959|NCT01972438|5663434|P2|NOT COMPLETED|Post Month 12 Study Period||4
2306960|NCT01972438|5663435|P1|NOT COMPLETED|Post Month 12 Study Period||3
2306961|NCT01972438|5663434|P2|COMPLETED|Post Month 12 Study Period||0
2306962|NCT01972438|5663435|P1|COMPLETED|Post Month 12 Study Period||0
2306963|NCT01972438|5663434|P2|STARTED|Post Month 12 Study Period||4
2306964|NCT01972438|5663435|P1|STARTED|Post Month 12 Study Period||3
2306965|NCT01972438|5663434|P2|NOT COMPLETED|Months 6-12 Study Period||2
2306966|NCT01972438|5663435|P1|NOT COMPLETED|Months 6-12 Study Period||3
2306967|NCT01972438|5663434|P2|COMPLETED|Months 6-12 Study Period||4
2306968|NCT01972438|5663435|P1|COMPLETED|Months 6-12 Study Period||3
2306969|NCT01972438|5663434|P2|STARTED|Months 6-12 Study Period||6
2306970|NCT01972438|5663435|P1|STARTED|Months 6-12 Study Period||6
2306971|NCT01972438|5663434|P2|NOT COMPLETED|Months 3-6 Crossover Period||1
2306972|NCT01972438|5663435|P1|NOT COMPLETED|Months 3-6 Crossover Period||0
2306973|NCT01972438|5663434|P2|COMPLETED|Months 3-6 Crossover Period||6
2306974|NCT01972438|5663435|P1|COMPLETED|Months 3-6 Crossover Period||6
2306975|NCT01972438|5663434|P2|STARTED|Months 3-6 Crossover Period|Two participants who missed Month 3 visit completed this pd but one who completed Month 3 didn't|7
2306976|NCT01972438|5663435|P1|STARTED|Months 3-6 Crossover Period||6
2306977|NCT01972438|5663434|P2|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
2306978|NCT01972438|5663435|P1|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
2306979|NCT01972438|5663434|P2|COMPLETED|Baseline-Month 3 Crossover Period||6
2306980|NCT01972438|5663435|P1|COMPLETED|Baseline-Month 3 Crossover Period||6
2306981|NCT01972438|5663434|P2|STARTED|Baseline-Month 3 Crossover Period|One participant never started IP, as unable to donate blood for preparation of ASEDs|9
2306982|NCT01972438|5663435|P1|STARTED|Baseline-Month 3 Crossover Period|Two participants never started IP: one died and one did not meet the inclusion criteria|9
2306983|NCT01972308|5663489|P2|NOT COMPLETED|Overall Study||8
2306984|NCT01972308|5663490|P1|NOT COMPLETED|Overall Study||8
2306985|NCT01972308|5663489|P2|COMPLETED|Overall Study||148
2306986|NCT01972308|5663490|P1|COMPLETED|Overall Study||148
2306987|NCT01972308|5663489|P2|STARTED|Overall Study||156
2306988|NCT01972308|5663490|P1|STARTED|Overall Study||156
2306989|NCT01972282|5663506|P1|NOT COMPLETED|Overall Study||15
2306990|NCT01972282|5663506|P1|COMPLETED|Overall Study||1005
2306991|NCT01972282|5663506|P1|STARTED|Overall Study||1020
2306992|NCT01972217|5663516|P4|NOT COMPLETED|Part B Double-blind, Randomised Period||47
2306993|NCT01972217|5663517|P3|NOT COMPLETED|Part B Double-blind, Randomised Period||46
2306994|NCT01972217|5663518|P2|NOT COMPLETED|Part B Double-blind, Randomised Period||0
2306995|NCT01972217|5663519|P1|NOT COMPLETED|Part B Double-blind, Randomised Period||0
2306996|NCT01972217|5663516|P4|COMPLETED|Part B Double-blind, Randomised Period||24
2306997|NCT01972217|5663517|P3|COMPLETED|Part B Double-blind, Randomised Period||25
2306998|NCT01972217|5663518|P2|COMPLETED|Part B Double-blind, Randomised Period||0
2306999|NCT01972217|5663519|P1|COMPLETED|Part B Double-blind, Randomised Period||0
2307000|NCT01972217|5663516|P4|Received Abiraterone|Part B Double-blind, Randomised Period||71
2307001|NCT01972217|5663517|P3|Received Abiraterone|Part B Double-blind, Randomised Period||71
2307002|NCT01972217|5663518|P2|Received Abiraterone|Part B Double-blind, Randomised Period||0
2307003|NCT01972217|5663519|P1|Received Abiraterone|Part B Double-blind, Randomised Period||0
2307004|NCT01972217|5663516|P4|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||71
2307005|NCT01972217|5663517|P3|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||71
2307006|NCT01972217|5663518|P2|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||0
2307007|NCT01972217|5663519|P1|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||0
2307008|NCT01972217|5663516|P4|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part B did not participate in Part A.|71
2307009|NCT01972217|5663517|P3|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part B did not participate in Part A.|71
2307010|NCT01972217|5663518|P2|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part A did not participate in Part B.|0
2307011|NCT01972217|5663519|P1|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part A did not participate in Part B.|0
2307012|NCT01972217|5663516|P4|NOT COMPLETED|Part A: Open-label Safety Run-in Period||0
2307013|NCT01972217|5663517|P3|NOT COMPLETED|Part A: Open-label Safety Run-in Period||0
2307014|NCT01972217|5663518|P2|NOT COMPLETED|Part A: Open-label Safety Run-in Period||12
2307015|NCT01972217|5663519|P1|NOT COMPLETED|Part A: Open-label Safety Run-in Period||1
2307016|NCT01972217|5663516|P4|COMPLETED|Part A: Open-label Safety Run-in Period||0
2307017|NCT01972217|5663517|P3|COMPLETED|Part A: Open-label Safety Run-in Period||0
2307018|NCT01972217|5663518|P2|COMPLETED|Part A: Open-label Safety Run-in Period||1
2307019|NCT01972217|5663519|P1|COMPLETED|Part A: Open-label Safety Run-in Period||2
2307020|NCT01972217|5663516|P4|STARTED|Part A: Open-label Safety Run-in Period||0
2307021|NCT01972217|5663517|P3|STARTED|Part A: Open-label Safety Run-in Period||0
2307022|NCT01972217|5663518|P2|STARTED|Part A: Open-label Safety Run-in Period||13
2307023|NCT01972217|5663519|P1|STARTED|Part A: Open-label Safety Run-in Period||3
2307024|NCT01972204|5663567|P2|NOT COMPLETED|Overall Study||4
2307025|NCT01972204|5663568|P1|NOT COMPLETED|Overall Study||4
2307026|NCT01972204|5663567|P2|COMPLETED|Overall Study||59
2307027|NCT01972204|5663568|P1|COMPLETED|Overall Study||58
2307028|NCT01972204|5663567|P2|STARTED|Overall Study||63
2307029|NCT01972204|5663568|P1|STARTED|Overall Study||62
2307030|NCT01972152|5663580|P6|NOT COMPLETED|Third Treatment Visit||0
2307031|NCT01972152|5663581|P5|NOT COMPLETED|Third Treatment Visit||0
2307032|NCT01972152|5663582|P4|NOT COMPLETED|Third Treatment Visit||0
2307033|NCT01972152|5663583|P3|NOT COMPLETED|Third Treatment Visit||0
2307034|NCT01972152|5663584|P2|NOT COMPLETED|Third Treatment Visit||0
2307035|NCT01972152|5663585|P1|NOT COMPLETED|Third Treatment Visit||0
2307036|NCT01972152|5663580|P6|COMPLETED|Third Treatment Visit||5
2307037|NCT01972152|5663581|P5|COMPLETED|Third Treatment Visit||5
2307038|NCT01972152|5663582|P4|COMPLETED|Third Treatment Visit||5
2307039|NCT01972152|5663583|P3|COMPLETED|Third Treatment Visit||5
2307040|NCT01972152|5663584|P2|COMPLETED|Third Treatment Visit||3
2307041|NCT01972152|5663585|P1|COMPLETED|Third Treatment Visit||5
2307042|NCT01972152|5663580|P6|STARTED|Third Treatment Visit||5
2307043|NCT01972152|5663581|P5|STARTED|Third Treatment Visit||5
2307044|NCT01972152|5663582|P4|STARTED|Third Treatment Visit||5
2307045|NCT01972152|5663583|P3|STARTED|Third Treatment Visit||5
2307046|NCT01972152|5663584|P2|STARTED|Third Treatment Visit||3
2307047|NCT01972152|5663585|P1|STARTED|Third Treatment Visit||5
2307048|NCT01972152|5663580|P6|NOT COMPLETED|Second Treatment Visit||0
2307049|NCT01972152|5663581|P5|NOT COMPLETED|Second Treatment Visit||0
2307050|NCT01972152|5663582|P4|NOT COMPLETED|Second Treatment Visit||0
2307051|NCT01972152|5663583|P3|NOT COMPLETED|Second Treatment Visit||0
2307052|NCT01972152|5663584|P2|NOT COMPLETED|Second Treatment Visit||1
2307053|NCT01972152|5663585|P1|NOT COMPLETED|Second Treatment Visit||0
2307054|NCT01972152|5663580|P6|COMPLETED|Second Treatment Visit||5
2307055|NCT01972152|5663581|P5|COMPLETED|Second Treatment Visit||5
2307056|NCT01972152|5663582|P4|COMPLETED|Second Treatment Visit||5
2307057|NCT01972152|5663583|P3|COMPLETED|Second Treatment Visit||5
2307058|NCT01972152|5663584|P2|COMPLETED|Second Treatment Visit||3
2307059|NCT01972152|5663585|P1|COMPLETED|Second Treatment Visit||5
2307060|NCT01972152|5663580|P6|STARTED|Second Treatment Visit||5
2307061|NCT01972152|5663581|P5|STARTED|Second Treatment Visit||5
2307062|NCT01972152|5663582|P4|STARTED|Second Treatment Visit||5
2307063|NCT01972152|5663583|P3|STARTED|Second Treatment Visit||5
2307064|NCT01972152|5663584|P2|STARTED|Second Treatment Visit||4
2307065|NCT01972152|5663585|P1|STARTED|Second Treatment Visit||5
2307066|NCT01972152|5663580|P6|NOT COMPLETED|First Treatment Visit||0
2307067|NCT01972152|5663581|P5|NOT COMPLETED|First Treatment Visit||0
2307068|NCT01972152|5663582|P4|NOT COMPLETED|First Treatment Visit||0
2307069|NCT01972152|5663583|P3|NOT COMPLETED|First Treatment Visit||0
2307070|NCT01972152|5663584|P2|NOT COMPLETED|First Treatment Visit||1
2307071|NCT01972152|5663585|P1|NOT COMPLETED|First Treatment Visit||0
2307072|NCT01972152|5663580|P6|COMPLETED|First Treatment Visit||5
2307073|NCT01972152|5663581|P5|COMPLETED|First Treatment Visit||5
2307074|NCT01972152|5663582|P4|COMPLETED|First Treatment Visit||5
2307075|NCT01972152|5663583|P3|COMPLETED|First Treatment Visit||5
2307076|NCT01972152|5663584|P2|COMPLETED|First Treatment Visit||4
2307077|NCT01972152|5663585|P1|COMPLETED|First Treatment Visit||5
2307078|NCT01972152|5663580|P6|STARTED|First Treatment Visit||5
2307079|NCT01972152|5663581|P5|STARTED|First Treatment Visit||5
2307080|NCT01972152|5663582|P4|STARTED|First Treatment Visit||5
2307081|NCT01972152|5663583|P3|STARTED|First Treatment Visit||5
2307082|NCT01972152|5663584|P2|STARTED|First Treatment Visit||5
2307083|NCT01972152|5663585|P1|STARTED|First Treatment Visit||5
2307084|NCT01972074|5663623|P3|NOT COMPLETED|Overall Study||3
2307085|NCT01972074|5663624|P2|NOT COMPLETED|Overall Study||4
2307086|NCT01972074|5663625|P1|NOT COMPLETED|Overall Study||6
2307087|NCT01972074|5663623|P3|COMPLETED|Overall Study||15
2307088|NCT01972074|5663624|P2|COMPLETED|Overall Study||17
2307089|NCT01972074|5663625|P1|COMPLETED|Overall Study||16
2307090|NCT01972074|5663623|P3|STARTED|Overall Study||18
2307091|NCT01972074|5663624|P2|STARTED|Overall Study||21
2307092|NCT01972074|5663625|P1|STARTED|Overall Study||22
2307093|NCT01971723|5663634|P2|NOT COMPLETED|Overall Study||3
2307094|NCT01971723|5663635|P1|NOT COMPLETED|Overall Study||2
2307095|NCT01971723|5663634|P2|COMPLETED|Overall Study||13
2307096|NCT01971723|5663635|P1|COMPLETED|Overall Study||14
2307097|NCT01971723|5663634|P2|STARTED|Overall Study||16
2307098|NCT01971723|5663635|P1|STARTED|Overall Study||16
2307099|NCT01971645|5663668|P3|NOT COMPLETED|Overall Study||2
2307100|NCT01971645|5663669|P2|NOT COMPLETED|Overall Study||0
2307101|NCT01971645|5663670|P1|NOT COMPLETED|Overall Study||2
2307102|NCT01971645|5663668|P3|COMPLETED|Overall Study||23
2307103|NCT01971645|5663669|P2|COMPLETED|Overall Study||27
2307104|NCT01971645|5663670|P1|COMPLETED|Overall Study||23
2307105|NCT01971645|5663668|P3|STARTED|Overall Study||25
2307106|NCT01971645|5663669|P2|STARTED|Overall Study||27
2307107|NCT01971645|5663670|P1|STARTED|Overall Study||25
2307108|NCT01971593|5663681|P2|NOT COMPLETED|Overall Study||4
2307109|NCT01971593|5663682|P1|NOT COMPLETED|Overall Study||5
2307110|NCT01971593|5663681|P2|COMPLETED|Overall Study||8
2307111|NCT01971593|5663682|P1|COMPLETED|Overall Study||9
2307112|NCT01971593|5663681|P2|STARTED|Overall Study||12
2307113|NCT01971593|5663682|P1|STARTED|Overall Study||14
2307114|NCT01971580|5663693|P2|NOT COMPLETED|Overall Study||5
2307115|NCT01971580|5663694|P1|NOT COMPLETED|Overall Study||4
2307116|NCT01971580|5663693|P2|COMPLETED|Overall Study||9
2307117|NCT01971580|5663694|P1|COMPLETED|Overall Study||10
2307118|NCT01971580|5663693|P2|STARTED|Overall Study||14
2307119|NCT01971580|5663694|P1|STARTED|Overall Study||14
2307120|NCT01971567|5663704|P2|NOT COMPLETED|Overall Study||2
2307121|NCT01971567|5663705|P1|NOT COMPLETED|Overall Study||4
2307122|NCT01971567|5663704|P2|COMPLETED|Overall Study||49
2307123|NCT01971567|5663705|P1|COMPLETED|Overall Study||52
2307124|NCT01971567|5663704|P2|STARTED|Overall Study||51
2307125|NCT01971567|5663705|P1|STARTED|Overall Study||56
2307126|NCT01971554|5663731|P4|NOT COMPLETED|Overall Study||0
2307127|NCT01971554|5663732|P3|NOT COMPLETED|Overall Study||0
2307128|NCT01971554|5663733|P2|NOT COMPLETED|Overall Study||0
2307129|NCT01971554|5663734|P1|NOT COMPLETED|Overall Study||1
2307130|NCT01971554|5663731|P4|COMPLETED|Overall Study||18
2307131|NCT01971554|5663732|P3|COMPLETED|Overall Study||18
2307132|NCT01971554|5663733|P2|COMPLETED|Overall Study||18
2307133|NCT01971554|5663734|P1|COMPLETED|Overall Study||8
2307134|NCT01971554|5663731|P4|STARTED|Overall Study||18
2307135|NCT01971554|5663732|P3|STARTED|Overall Study||18
2307136|NCT01971554|5663733|P2|STARTED|Overall Study||18
2307137|NCT01971554|5663734|P1|STARTED|Overall Study||9
2307138|NCT01971476|5663771|P3|NOT COMPLETED|Cohort 2: 12 to <18 Years||0
2307139|NCT01971476|5663772|P2|NOT COMPLETED|Cohort 2: 12 to <18 Years||4
2307140|NCT01971476|5663773|P1|NOT COMPLETED|Cohort 2: 12 to <18 Years||6
2307141|NCT01971476|5663771|P3|COMPLETED|Cohort 2: 12 to <18 Years||0
2307142|NCT01971476|5663772|P2|COMPLETED|Cohort 2: 12 to <18 Years||0
2307143|NCT01971476|5663773|P1|COMPLETED|Cohort 2: 12 to <18 Years||0
2307144|NCT01971476|5663771|P3|STARTED|Cohort 2: 12 to <18 Years||0
2307145|NCT01971476|5663772|P2|STARTED|Cohort 2: 12 to <18 Years||4
2307146|NCT01971476|5663773|P1|STARTED|Cohort 2: 12 to <18 Years||6
2307147|NCT01971476|5663771|P3|NOT COMPLETED|Cohort 1: 2 to <12 Years||6
2307148|NCT01971476|5663772|P2|NOT COMPLETED|Cohort 1: 2 to <12 Years||3
2307149|NCT01971476|5663773|P1|NOT COMPLETED|Cohort 1: 2 to <12 Years||3
2307150|NCT01971476|5663771|P3|COMPLETED|Cohort 1: 2 to <12 Years||0
2307151|NCT01971476|5663772|P2|COMPLETED|Cohort 1: 2 to <12 Years||0
2307152|NCT01971476|5663773|P1|COMPLETED|Cohort 1: 2 to <12 Years||0
2307153|NCT01971476|5663771|P3|STARTED|Cohort 1: 2 to <12 Years||6
2307154|NCT01971476|5663772|P2|STARTED|Cohort 1: 2 to <12 Years||3
2307155|NCT01971476|5663773|P1|STARTED|Cohort 1: 2 to <12 Years||3
2307156|NCT01971463|5663850|P1|NOT COMPLETED|Overall Study||0
2307157|NCT01971463|5663850|P1|COMPLETED|Overall Study||81
2307158|NCT01971463|5663850|P1|STARTED|Overall Study||81
2307159|NCT01971385|5663858|P3|NOT COMPLETED|Overall Study||4
2307160|NCT01971385|5663859|P2|NOT COMPLETED|Overall Study||5
2307161|NCT01971385|5663860|P1|NOT COMPLETED|Overall Study||3
2307162|NCT01971385|5663858|P3|COMPLETED|Overall Study||15
2307163|NCT01971385|5663859|P2|COMPLETED|Overall Study||13
2307164|NCT01971385|5663860|P1|COMPLETED|Overall Study||14
2307165|NCT01971385|5663858|P3|STARTED|Overall Study||19
2307166|NCT01971385|5663859|P2|STARTED|Overall Study||18
2307167|NCT01971385|5663860|P1|STARTED|Overall Study||17
2307168|NCT01971346|5663867|P1|NOT COMPLETED|Overall Study||8
2307169|NCT01971346|5663867|P1|COMPLETED|Overall Study||42
2307170|NCT01971346|5663867|P1|STARTED|Overall Study|Four subjects signed the informed consent and terminated the study before beginning.|50
2307171|NCT01971255|5663881|P2|NOT COMPLETED|Overall Study||2
2307172|NCT01971255|5663882|P1|NOT COMPLETED|Overall Study||1
2307173|NCT01971255|5663881|P2|COMPLETED|Overall Study||40
2307174|NCT01971255|5663882|P1|COMPLETED|Overall Study||31
2307175|NCT01971255|5663881|P2|STARTED|Overall Study||42
2307176|NCT01971255|5663882|P1|STARTED|Overall Study||32
2307177|NCT01971203|5663900|P2|NOT COMPLETED|Overall Study||8
2307178|NCT01971203|5663901|P1|NOT COMPLETED|Overall Study||9
2307179|NCT01971203|5663900|P2|COMPLETED|Overall Study||21
2307180|NCT01971203|5663901|P1|COMPLETED|Overall Study||17
2307181|NCT01971203|5663900|P2|STARTED|Overall Study||29
2307182|NCT01971203|5663901|P1|STARTED|Overall Study||26
2307183|NCT01971086|5663913|P1|NOT COMPLETED|Overall Study||0
2307184|NCT01971086|5663913|P1|COMPLETED|Overall Study||300
2307185|NCT01971086|5663913|P1|STARTED|Overall Study||300
2307186|NCT01970995|5663928|P3|NOT COMPLETED|End of Study (Population at Day 90)||1
2307187|NCT01970995|5663929|P2|NOT COMPLETED|End of Study (Population at Day 90)||0
2307188|NCT01970995|5663930|P1|NOT COMPLETED|End of Study (Population at Day 90)||1
2307189|NCT01970995|5663928|P3|COMPLETED|End of Study (Population at Day 90)||38
2307190|NCT01970995|5663929|P2|COMPLETED|End of Study (Population at Day 90)||41
2307191|NCT01970995|5663930|P1|COMPLETED|End of Study (Population at Day 90)||76
2307192|NCT01970995|5663928|P3|STARTED|End of Study (Population at Day 90)||39
2307193|NCT01970995|5663929|P2|STARTED|End of Study (Population at Day 90)||41
2307194|NCT01970995|5663930|P1|STARTED|End of Study (Population at Day 90)||77
2307195|NCT01970995|5663928|P3|NOT COMPLETED|Confinement Period (Population at Day 5)||1
2307196|NCT01970995|5663929|P2|NOT COMPLETED|Confinement Period (Population at Day 5)||1
2307197|NCT01970995|5663930|P1|NOT COMPLETED|Confinement Period (Population at Day 5)||1
2307198|NCT01970995|5663928|P3|COMPLETED|Confinement Period (Population at Day 5)||39
2307199|NCT01970995|5663929|P2|COMPLETED|Confinement Period (Population at Day 5)||41
2307200|NCT01970995|5663930|P1|COMPLETED|Confinement Period (Population at Day 5)||77
2307201|NCT01970995|5663928|P3|STARTED|Confinement Period (Population at Day 5)||40
2307202|NCT01970995|5663929|P2|STARTED|Confinement Period (Population at Day 5)||42
2307203|NCT01970995|5663930|P1|STARTED|Confinement Period (Population at Day 5)||78
2307204|NCT01970982|5663953|P3|NOT COMPLETED|Overall Study||2
2307205|NCT01970982|5663954|P2|NOT COMPLETED|Overall Study||0
2307206|NCT01970982|5663955|P1|NOT COMPLETED|Overall Study||0
2307207|NCT01970982|5663953|P3|COMPLETED|Overall Study||38
2307208|NCT01970982|5663954|P2|COMPLETED|Overall Study||40
2307209|NCT01970982|5663955|P1|COMPLETED|Overall Study||80
2307210|NCT01970982|5663953|P3|STARTED|Overall Study||40
2307211|NCT01970982|5663954|P2|STARTED|Overall Study||40
2307212|NCT01970982|5663955|P1|STARTED|Overall Study||80
2307213|NCT01970943|5663973|P2|NOT COMPLETED|Overall Study||1
2307214|NCT01970943|5663974|P1|NOT COMPLETED|Overall Study||3
2307215|NCT01970943|5663973|P2|COMPLETED|Overall Study||11
2307216|NCT01970943|5663974|P1|COMPLETED|Overall Study||8
2307217|NCT01970943|5663973|P2|STARTED|Overall Study||12
2307218|NCT01970943|5663974|P1|STARTED|Overall Study||11
2307219|NCT01970878|5663990|P4|NOT COMPLETED|Overall Study||24
2307220|NCT01970878|5663991|P3|NOT COMPLETED|Overall Study||26
2307221|NCT01970878|5663992|P2|NOT COMPLETED|Overall Study||27
2307222|NCT01970878|5663993|P1|NOT COMPLETED|Overall Study||37
2307223|NCT01970878|5663990|P4|COMPLETED|Overall Study||147
2307224|NCT01970878|5663991|P3|COMPLETED|Overall Study||187
2307225|NCT01970878|5663992|P2|COMPLETED|Overall Study||191
2307226|NCT01970878|5663993|P1|COMPLETED|Overall Study||253
2307227|NCT01970878|5663990|P4|STARTED|Overall Study||171
2307228|NCT01970878|5663991|P3|STARTED|Overall Study||213
2307229|NCT01970878|5663992|P2|STARTED|Overall Study|218 subjects were reported in the CSR, 1 had no completion status|218
2307230|NCT01970878|5663993|P1|STARTED|Overall Study||290
2307231|NCT01970865|5664036|P17|NOT COMPLETED|Overall Study||3
2307232|NCT01970865|5664037|P16|NOT COMPLETED|Overall Study||47
2307233|NCT01970865|5664038|P15|NOT COMPLETED|Overall Study||46
2307234|NCT01970865|5664039|P14|NOT COMPLETED|Overall Study||66
2307235|NCT01970865|5664040|P13|NOT COMPLETED|Overall Study||60
2307236|NCT01970865|5664041|P12|NOT COMPLETED|Overall Study||27
2307237|NCT01970865|5664042|P11|NOT COMPLETED|Overall Study||30
2307238|NCT01970865|5664043|P10|NOT COMPLETED|Overall Study||4
2307239|NCT01970865|5664044|P9|NOT COMPLETED|Overall Study||3
2307240|NCT01970865|5664045|P8|NOT COMPLETED|Overall Study||3
2307241|NCT01970865|5664046|P7|NOT COMPLETED|Overall Study||3
2307242|NCT01970865|5664047|P6|NOT COMPLETED|Overall Study||3
2307243|NCT01970865|5664048|P5|NOT COMPLETED|Overall Study||17
2307244|NCT01970865|5664049|P4|NOT COMPLETED|Overall Study||13
2307245|NCT01970865|5664050|P3|NOT COMPLETED|Overall Study||3
2307246|NCT01970865|5664051|P2|NOT COMPLETED|Overall Study||3
2307247|NCT01970865|5664052|P1|NOT COMPLETED|Overall Study||3
2307248|NCT01970865|5664036|P17|COMPLETED|Overall Study||0
2307249|NCT01970865|5664037|P16|COMPLETED|Overall Study||0
2307250|NCT01970865|5664038|P15|COMPLETED|Overall Study||0
2307251|NCT01970865|5664039|P14|COMPLETED|Overall Study||0
2307252|NCT01970865|5664040|P13|COMPLETED|Overall Study||0
2307253|NCT01970865|5664041|P12|COMPLETED|Overall Study||0
2307254|NCT01970865|5664042|P11|COMPLETED|Overall Study||0
2307255|NCT01970865|5664043|P10|COMPLETED|Overall Study||0
2307256|NCT01970865|5664044|P9|COMPLETED|Overall Study||0
2307257|NCT01970865|5664045|P8|COMPLETED|Overall Study||0
2307258|NCT01970865|5664046|P7|COMPLETED|Overall Study||0
2307259|NCT01970865|5664047|P6|COMPLETED|Overall Study||0
2307260|NCT01970865|5664048|P5|COMPLETED|Overall Study||0
2307261|NCT01970865|5664049|P4|COMPLETED|Overall Study||0
2307262|NCT01970865|5664050|P3|COMPLETED|Overall Study||0
2307263|NCT01970865|5664051|P2|COMPLETED|Overall Study||0
2307264|NCT01970865|5664052|P1|COMPLETED|Overall Study||0
2307265|NCT01970865|5664036|P17|Received Treatment|Overall Study||3
2307266|NCT01970865|5664037|P16|Received Treatment|Overall Study||47
2307267|NCT01970865|5664038|P15|Received Treatment|Overall Study||46
2307268|NCT01970865|5664039|P14|Received Treatment|Overall Study||65
2307269|NCT01970865|5664040|P13|Received Treatment|Overall Study||60
2307270|NCT01970865|5664041|P12|Received Treatment|Overall Study||27
2307271|NCT01970865|5664042|P11|Received Treatment|Overall Study||30
2307272|NCT01970865|5664043|P10|Received Treatment|Overall Study||4
2307273|NCT01970865|5664044|P9|Received Treatment|Overall Study||3
2307274|NCT01970865|5664045|P8|Received Treatment|Overall Study||3
2307275|NCT01970865|5664046|P7|Received Treatment|Overall Study||3
2307276|NCT01970865|5664047|P6|Received Treatment|Overall Study||3
2307277|NCT01970865|5664048|P5|Received Treatment|Overall Study||17
2307278|NCT01970865|5664049|P4|Received Treatment|Overall Study||12
2307279|NCT01970865|5664050|P3|Received Treatment|Overall Study||3
2307280|NCT01970865|5664051|P2|Received Treatment|Overall Study||3
2307281|NCT01970865|5664052|P1|Received Treatment|Overall Study||3
2307282|NCT01970865|5664036|P17|STARTED|Overall Study||3
2307283|NCT01970865|5664037|P16|STARTED|Overall Study||47
2307284|NCT01970865|5664038|P15|STARTED|Overall Study||46
2307285|NCT01970865|5664039|P14|STARTED|Overall Study||66
2307286|NCT01970865|5664040|P13|STARTED|Overall Study||60
2307287|NCT01970865|5664041|P12|STARTED|Overall Study||27
2307288|NCT01970865|5664042|P11|STARTED|Overall Study||30
2307289|NCT01970865|5664043|P10|STARTED|Overall Study||4
2307290|NCT01970865|5664044|P9|STARTED|Overall Study||3
2307291|NCT01970865|5664045|P8|STARTED|Overall Study||3
2307292|NCT01970865|5664046|P7|STARTED|Overall Study||3
2307293|NCT01970865|5664047|P6|STARTED|Overall Study||3
2307294|NCT01970865|5664048|P5|STARTED|Overall Study||17
2307295|NCT01970865|5664049|P4|STARTED|Overall Study||13
2307296|NCT01970865|5664050|P3|STARTED|Overall Study||3
2307297|NCT01970865|5664051|P2|STARTED|Overall Study||3
2307298|NCT01970865|5664052|P1|STARTED|Overall Study||3
2307299|NCT01970787|5664476|P1|NOT COMPLETED|Overall Study||1
2307300|NCT01970787|5664476|P1|COMPLETED|Overall Study||21
2307301|NCT01970787|5664476|P1|STARTED|Overall Study||22
2307302|NCT01970527|5664486|P2|NOT COMPLETED|Follow-up Clinic Visit||3
2307303|NCT01970527|5664487|P1|NOT COMPLETED|Follow-up Clinic Visit||1
2307304|NCT01970527|5664486|P2|COMPLETED|Follow-up Clinic Visit||8
2307305|NCT01970527|5664487|P1|COMPLETED|Follow-up Clinic Visit||7
2307306|NCT01970527|5664486|P2|STARTED|Follow-up Clinic Visit||11
2307307|NCT01970527|5664487|P1|STARTED|Follow-up Clinic Visit||8
2307308|NCT01970527|5664486|P2|NOT COMPLETED|Treatment||3
2307309|NCT01970527|5664487|P1|NOT COMPLETED|Treatment||0
2307310|NCT01970527|5664486|P2|COMPLETED|Treatment||11
2307311|NCT01970527|5664487|P1|COMPLETED|Treatment||8
2307312|NCT01970527|5664486|P2|STARTED|Treatment||14
2307313|NCT01970527|5664487|P1|STARTED|Treatment||8
2307314|NCT01970527|5664486|P2|NOT COMPLETED|Pre-treatment/Baseline||0
2307315|NCT01970527|5664487|P1|NOT COMPLETED|Pre-treatment/Baseline||1
2307316|NCT01970527|5664486|P2|COMPLETED|Pre-treatment/Baseline||14
2307317|NCT01970527|5664487|P1|COMPLETED|Pre-treatment/Baseline||8
2307318|NCT01970527|5664486|P2|STARTED|Pre-treatment/Baseline||14
2307319|NCT01970527|5664487|P1|STARTED|Pre-treatment/Baseline||9
2307320|NCT01970488|5664500|P5|NOT COMPLETED|Part 2: Post Week 16||8
2307321|NCT01970488|5664501|P4|NOT COMPLETED|Part 2: Post Week 16||8
2307322|NCT01970488|5664502|P3|NOT COMPLETED|Part 2: Post Week 16||17
2307323|NCT01970488|5664503|P2|NOT COMPLETED|Part 2: Post Week 16||0
2307324|NCT01970488|5664504|P1|NOT COMPLETED|Part 2: Post Week 16||0
2307325|NCT01970488|5664500|P5|COMPLETED|Part 2: Post Week 16||69
2307326|NCT01970488|5664501|P4|COMPLETED|Part 2: Post Week 16||71
2307327|NCT01970488|5664502|P3|COMPLETED|Part 2: Post Week 16||135
2307328|NCT01970488|5664503|P2|COMPLETED|Part 2: Post Week 16||0
2307329|NCT01970488|5664504|P1|COMPLETED|Part 2: Post Week 16||0
2307330|NCT01970488|5664500|P5|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|77
2307331|NCT01970488|5664501|P4|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|79
2307332|NCT01970488|5664502|P3|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|152
2307333|NCT01970488|5664503|P2|STARTED|Part 2: Post Week 16||0
2307334|NCT01970488|5664504|P1|STARTED|Part 2: Post Week 16||0
2307335|NCT01970488|5664500|P5|NOT COMPLETED|Part 1: Through Week 16||0
2307336|NCT01970488|5664501|P4|NOT COMPLETED|Part 1: Through Week 16||0
2307337|NCT01970488|5664502|P3|NOT COMPLETED|Part 1: Through Week 16||0
2307338|NCT01970488|5664503|P2|NOT COMPLETED|Part 1: Through Week 16||13
2307339|NCT01970488|5664504|P1|NOT COMPLETED|Part 1: Through Week 16||11
2307340|NCT01970488|5664500|P5|COMPLETED|Part 1: Through Week 16||0
2307341|NCT01970488|5664501|P4|COMPLETED|Part 1: Through Week 16||0
2307342|NCT01970488|5664502|P3|COMPLETED|Part 1: Through Week 16||0
2307343|NCT01970488|5664503|P2|COMPLETED|Part 1: Through Week 16||162
2307344|NCT01970488|5664504|P1|COMPLETED|Part 1: Through Week 16||164
2307345|NCT01970488|5664500|P5|Received Treatment|Part 1: Through Week 16||0
2307346|NCT01970488|5664501|P4|Received Treatment|Part 1: Through Week 16||0
2307347|NCT01970488|5664502|P3|Received Treatment|Part 1: Through Week 16||0
2307348|NCT01970488|5664503|P2|Received Treatment|Part 1: Through Week 16||173
2307349|NCT01970488|5664504|P1|Received Treatment|Part 1: Through Week 16||174
2307350|NCT01970488|5664500|P5|STARTED|Part 1: Through Week 16||0
2307351|NCT01970488|5664501|P4|STARTED|Part 1: Through Week 16||0
2307352|NCT01970488|5664502|P3|STARTED|Part 1: Through Week 16||0
2307353|NCT01970488|5664503|P2|STARTED|Part 1: Through Week 16||175
2307354|NCT01970488|5664504|P1|STARTED|Part 1: Through Week 16||175
2307355|NCT01970475|5664571|P2|NOT COMPLETED|Overall Study||11
2307356|NCT01970475|5664572|P1|NOT COMPLETED|Overall Study||21
2307357|NCT01970475|5664571|P2|COMPLETED|Overall Study||251
2307358|NCT01970475|5664572|P1|COMPLETED|Overall Study||243
2307359|NCT01970475|5664571|P2|STARTED|Overall Study||262
2307360|NCT01970475|5664572|P1|STARTED|Overall Study||264
2307361|NCT01970462|5664592|P2|NOT COMPLETED|Overall Study||2
2307362|NCT01970462|5664593|P1|NOT COMPLETED|Overall Study||0
2307363|NCT01970462|5664592|P2|COMPLETED|Overall Study||2
2307364|NCT01970462|5664593|P1|COMPLETED|Overall Study||1
2307365|NCT01970462|5664592|P2|STARTED|Overall Study||4
2307366|NCT01970462|5664593|P1|STARTED|Overall Study||1
2307367|NCT01970397|5664607|P2|NOT COMPLETED|Overall Study||5
2307368|NCT01970397|5664608|P1|NOT COMPLETED|Overall Study||2
2307369|NCT01970397|5664607|P2|COMPLETED|Overall Study||64
2307370|NCT01970397|5664608|P1|COMPLETED|Overall Study||67
2307371|NCT01970397|5664607|P2|STARTED|Overall Study||69
2307372|NCT01970397|5664608|P1|STARTED|Overall Study||69
2307373|NCT01970371|5664621|P3|NOT COMPLETED|Overall Study||13
2307374|NCT01970371|5664622|P2|NOT COMPLETED|Overall Study||13
2307375|NCT01970371|5664623|P1|NOT COMPLETED|Overall Study||8
2307376|NCT01970371|5664621|P3|COMPLETED|Overall Study||17
2307377|NCT01970371|5664622|P2|COMPLETED|Overall Study||8
2307378|NCT01970371|5664623|P1|COMPLETED|Overall Study||10
2307379|NCT01970371|5664621|P3|STARTED|Overall Study||30
2307380|NCT01970371|5664622|P2|STARTED|Overall Study||21
2307381|NCT01970371|5664623|P1|STARTED|Overall Study||18
2307382|NCT01970241|5664648|P2|NOT COMPLETED|Overall Study||8
2307383|NCT01970241|5664649|P1|NOT COMPLETED|Overall Study||17
2307384|NCT01970241|5664648|P2|COMPLETED|Overall Study||31
2307385|NCT01970241|5664649|P1|COMPLETED|Overall Study||29
2307386|NCT01970241|5664648|P2|STARTED|Overall Study||39
2307387|NCT01970241|5664649|P1|STARTED|Overall Study||46
2307388|NCT01969916|5664689|P1|NOT COMPLETED|Overall Study||45
2307389|NCT01969916|5664689|P1|COMPLETED|Overall Study||105
2307390|NCT01969916|5664689|P1|STARTED|Overall Study||150
2307391|NCT01969851|5664696|P3|NOT COMPLETED|Overall Study||7
2307392|NCT01969851|5664697|P2|NOT COMPLETED|Overall Study||3
2307393|NCT01969851|5664698|P1|NOT COMPLETED|Overall Study||1
2307394|NCT01969851|5664696|P3|COMPLETED|Overall Study||14
2307395|NCT01969851|5664697|P2|COMPLETED|Overall Study||21
2307396|NCT01969851|5664698|P1|COMPLETED|Overall Study||9
2307397|NCT01969851|5664696|P3|STARTED|Overall Study||21
2307398|NCT01969851|5664697|P2|STARTED|Overall Study||24
2307399|NCT01969851|5664698|P1|STARTED|Overall Study||10
2307400|NCT01969799|5664720|P2|NOT COMPLETED|Overall Study||14
2307401|NCT01969799|5664721|P1|NOT COMPLETED|Overall Study||17
2307402|NCT01969799|5664720|P2|COMPLETED|Overall Study||58
2307403|NCT01969799|5664721|P1|COMPLETED|Overall Study||54
2307404|NCT01969799|5664720|P2|STARTED|Overall Study||72
2307405|NCT01969799|5664721|P1|STARTED|Overall Study||71
2307406|NCT01969747|5664745|P4|NOT COMPLETED|Overall Study||0
2307407|NCT01969747|5664746|P3|NOT COMPLETED|Overall Study||0
2307408|NCT01969747|5664747|P2|NOT COMPLETED|Overall Study||0
2307409|NCT01969747|5664748|P1|NOT COMPLETED|Overall Study||0
2307410|NCT01969747|5664745|P4|COMPLETED|Overall Study||18
2307411|NCT01969747|5664746|P3|COMPLETED|Overall Study||19
2307412|NCT01969747|5664747|P2|COMPLETED|Overall Study||19
2307413|NCT01969747|5664748|P1|COMPLETED|Overall Study||19
2307414|NCT01969747|5664745|P4|STARTED|Overall Study||18
2307415|NCT01969747|5664746|P3|STARTED|Overall Study||19
2307416|NCT01969747|5664747|P2|STARTED|Overall Study||19
2307417|NCT01969747|5664748|P1|STARTED|Overall Study||19
2307418|NCT01969721|5664758|P4|NOT COMPLETED|Overall Study||6
2307419|NCT01969721|5664759|P3|NOT COMPLETED|Overall Study||5
2307420|NCT01969721|5664760|P2|NOT COMPLETED|Overall Study||12
2307421|NCT01969721|5664761|P1|NOT COMPLETED|Overall Study||4
2307422|NCT01969721|5664758|P4|COMPLETED|Overall Study||46
2307423|NCT01969721|5664759|P3|COMPLETED|Overall Study||45
2307424|NCT01969721|5664760|P2|COMPLETED|Overall Study||57
2307425|NCT01969721|5664761|P1|COMPLETED|Overall Study||54
2307426|NCT01969721|5664758|P4|STARTED|Overall Study||52
2307427|NCT01969721|5664759|P3|STARTED|Overall Study||50
2307428|NCT01969721|5664760|P2|STARTED|Overall Study||69
2307429|NCT01969721|5664761|P1|STARTED|Overall Study||58
2307430|NCT01969708|5664789|P2|NOT COMPLETED|Overall Study||9
2307431|NCT01969708|5664790|P1|NOT COMPLETED|Overall Study||5
2307432|NCT01969708|5664789|P2|COMPLETED|Overall Study||173
2307433|NCT01969708|5664790|P1|COMPLETED|Overall Study||175
2307434|NCT01969708|5664789|P2|STARTED|Overall Study||182
2307435|NCT01969708|5664790|P1|STARTED|Overall Study||180
2307436|NCT01969565|5664806|P1|NOT COMPLETED|Overall Study||1
2307437|NCT01969565|5664806|P1|COMPLETED|Overall Study||0
2307438|NCT01969565|5664806|P1|STARTED|Overall Study||1
2307439|NCT01969539|5664812|P1|NOT COMPLETED|Overall Study||0
2307440|NCT01969539|5664812|P1|COMPLETED|Overall Study||11
2307441|NCT01969539|5664812|P1|STARTED|Overall Study||11
2307442|NCT01969500|5664820|P2|NOT COMPLETED|Overall Study||2
2307443|NCT01969500|5664821|P1|NOT COMPLETED|Overall Study||1
2307444|NCT01969500|5664820|P2|COMPLETED|Overall Study||24
2307445|NCT01969500|5664821|P1|COMPLETED|Overall Study||24
2307446|NCT01969500|5664820|P2|STARTED|Overall Study||26
2307447|NCT01969500|5664821|P1|STARTED|Overall Study||25
2307448|NCT01969448|5664836|P3|NOT COMPLETED|Overall Study||0
2307449|NCT01969448|5664837|P2|NOT COMPLETED|Overall Study||0
2307450|NCT01969448|5664838|P1|NOT COMPLETED|Overall Study||0
2307451|NCT01969448|5664836|P3|COMPLETED|Overall Study||0
2307452|NCT01969448|5664837|P2|COMPLETED|Overall Study||24
2307453|NCT01969448|5664838|P1|COMPLETED|Overall Study||55
2307454|NCT01969448|5664836|P3|STARTED|Overall Study||0
2307455|NCT01969448|5664837|P2|STARTED|Overall Study||24
2307456|NCT01969448|5664838|P1|STARTED|Overall Study||55
2307457|NCT01969435|5664861|P1|NOT COMPLETED|Overall Study||0
2307458|NCT01969435|5664861|P1|COMPLETED|Overall Study||50
2307459|NCT01969435|5664861|P1|STARTED|Overall Study||50
2307460|NCT01969240|5664877|P2|NOT COMPLETED|Overall Study||0
2307461|NCT01969240|5664878|P1|NOT COMPLETED|Overall Study||0
2307462|NCT01969240|5664877|P2|COMPLETED|Overall Study||447
2307463|NCT01969240|5664878|P1|COMPLETED|Overall Study||451
2307464|NCT01969240|5664877|P2|STARTED|Overall Study||447
2307465|NCT01969240|5664878|P1|STARTED|Overall Study||451
2307466|NCT01969201|5664898|P2|NOT COMPLETED|Overall Study||45
2307467|NCT01969201|5664899|P1|NOT COMPLETED|Overall Study||45
2307468|NCT01969201|5664898|P2|COMPLETED|Overall Study||313
2307469|NCT01969201|5664899|P1|COMPLETED|Overall Study||307
2307470|NCT01969201|5664898|P2|STARTED|Overall Study||358
2307471|NCT01969201|5664899|P1|STARTED|Overall Study||352
2307472|NCT01969162|5664919|P1|NOT COMPLETED|Overall Study||0
2307473|NCT01969162|5664919|P1|COMPLETED|Overall Study||35
2307474|NCT01969162|5664919|P1|STARTED|Overall Study||35
2307475|NCT01969084|5664925|P2|NOT COMPLETED|Overall Study||1
2307476|NCT01969084|5664926|P1|NOT COMPLETED|Overall Study||0
2307477|NCT01969084|5664925|P2|COMPLETED|Overall Study|One subject withdrew due to unrelated serious adverse event|21
2307478|NCT01969084|5664926|P1|COMPLETED|Overall Study||19
2307479|NCT01969084|5664925|P2|STARTED|Overall Study||22
2307480|NCT01969084|5664926|P1|STARTED|Overall Study||19
2307481|NCT01969058|5664942|P2|NOT COMPLETED|Overall Study||0
2307482|NCT01969058|5664943|P1|NOT COMPLETED|Overall Study||3
2307483|NCT01969058|5664942|P2|COMPLETED|Overall Study||26
2307484|NCT01969058|5664943|P1|COMPLETED|Overall Study||47
2307485|NCT01969058|5664942|P2|STARTED|Overall Study||26
2307486|NCT01969058|5664943|P1|STARTED|Overall Study||50
2307487|NCT01968980|5664987|P2|NOT COMPLETED|Overall Study||14
2307488|NCT01968980|5664988|P1|NOT COMPLETED|Overall Study||16
2307489|NCT01968980|5664987|P2|COMPLETED|Overall Study||171
2307490|NCT01968980|5664988|P1|COMPLETED|Overall Study||169
2307491|NCT01968980|5664987|P2|STARTED|Overall Study||185
2307492|NCT01968980|5664988|P1|STARTED|Overall Study||185
2307493|NCT01968967|5665050|P5|NOT COMPLETED|Extension Period||5
2307494|NCT01968967|5665051|P4|NOT COMPLETED|Extension Period||0
2307495|NCT01968967|5665052|P3|NOT COMPLETED|Extension Period||2
2307496|NCT01968967|5665053|P2|NOT COMPLETED|Extension Period||0
2307497|NCT01968967|5665054|P1|NOT COMPLETED|Extension Period||0
2307498|NCT01968967|5665050|P5|COMPLETED|Extension Period||34
2307499|NCT01968967|5665051|P4|COMPLETED|Extension Period||19
2307500|NCT01968967|5665052|P3|COMPLETED|Extension Period||45
2307501|NCT01968967|5665053|P2|COMPLETED|Extension Period||0
2307502|NCT01968967|5665054|P1|COMPLETED|Extension Period||0
2307503|NCT01968967|5665050|P5|STARTED|Extension Period||39
2307504|NCT01968967|5665051|P4|STARTED|Extension Period||19
2307505|NCT01968967|5665052|P3|STARTED|Extension Period||47
2307506|NCT01968967|5665053|P2|STARTED|Extension Period||0
2307507|NCT01968967|5665054|P1|STARTED|Extension Period||0
2307508|NCT01968967|5665050|P5|NOT COMPLETED|Treatment Period||0
2307509|NCT01968967|5665051|P4|NOT COMPLETED|Treatment Period||0
2307510|NCT01968967|5665052|P3|NOT COMPLETED|Treatment Period||0
2307511|NCT01968967|5665053|P2|NOT COMPLETED|Treatment Period||134
2307512|NCT01968967|5665054|P1|NOT COMPLETED|Treatment Period||146
2307513|NCT01968967|5665050|P5|COMPLETED|Treatment Period||0
2307514|NCT01968967|5665051|P4|COMPLETED|Treatment Period||0
2307515|NCT01968967|5665052|P3|COMPLETED|Treatment Period||0
2307516|NCT01968967|5665053|P2|COMPLETED|Treatment Period||934
2307517|NCT01968967|5665054|P1|COMPLETED|Treatment Period||925
2307518|NCT01968967|5665050|P5|Treated|Treatment Period||0
2307519|NCT01968967|5665051|P4|Treated|Treatment Period||0
2307520|NCT01968967|5665052|P3|Treated|Treatment Period||0
2307521|NCT01968967|5665053|P2|Treated|Treatment Period||1063
2307522|NCT01968967|5665054|P1|Treated|Treatment Period||1065
2307523|NCT01968967|5665050|P5|STARTED|Treatment Period||0
2307524|NCT01968967|5665051|P4|STARTED|Treatment Period||0
2307525|NCT01968967|5665052|P3|STARTED|Treatment Period||0
2307526|NCT01968967|5665053|P2|STARTED|Treatment Period||1068
2307527|NCT01968967|5665054|P1|STARTED|Treatment Period||1071
2307528|NCT01968954|5665123|P2|NOT COMPLETED|Overall Study||43
2307529|NCT01968954|5665124|P1|NOT COMPLETED|Overall Study||40
2307530|NCT01968954|5665123|P2|COMPLETED|Overall Study||314
2307531|NCT01968954|5665124|P1|COMPLETED|Overall Study||314
2307532|NCT01968954|5665123|P2|Treated|Overall Study||356
2307533|NCT01968954|5665124|P1|Treated|Overall Study||353
2307534|NCT01968954|5665123|P2|STARTED|Overall Study||357
2307535|NCT01968954|5665124|P1|STARTED|Overall Study||354
2307536|NCT01968811|5665188|P1|NOT COMPLETED|Overall Study||5
2307537|NCT01968811|5665188|P1|COMPLETED|Overall Study||5
2307538|NCT01968811|5665188|P1|STARTED|Overall Study||10
2307539|NCT01968694|5665195|P2|NOT COMPLETED|Visit 2 (1 Day)||0
2307540|NCT01968694|5665196|P1|NOT COMPLETED|Visit 2 (1 Day)||0
2307541|NCT01968694|5665195|P2|COMPLETED|Visit 2 (1 Day)||8
2307542|NCT01968694|5665196|P1|COMPLETED|Visit 2 (1 Day)||10
2307543|NCT01968694|5665195|P2|STARTED|Visit 2 (1 Day)||8
2307544|NCT01968694|5665196|P1|STARTED|Visit 2 (1 Day)||10
2307545|NCT01968694|5665195|P2|NOT COMPLETED|Washout (1 Month)||1
2307546|NCT01968694|5665196|P1|NOT COMPLETED|Washout (1 Month)||0
2307547|NCT01968694|5665195|P2|COMPLETED|Washout (1 Month)||8
2307548|NCT01968694|5665196|P1|COMPLETED|Washout (1 Month)||10
2307549|NCT01968694|5665195|P2|STARTED|Washout (1 Month)||9
2307550|NCT01968694|5665196|P1|STARTED|Washout (1 Month)||10
2307551|NCT01968694|5665195|P2|NOT COMPLETED|Visit 1 (1 Day)||0
2307552|NCT01968694|5665196|P1|NOT COMPLETED|Visit 1 (1 Day)||0
2307553|NCT01968694|5665195|P2|COMPLETED|Visit 1 (1 Day)||9
2307554|NCT01968694|5665196|P1|COMPLETED|Visit 1 (1 Day)||10
2307555|NCT01968694|5665195|P2|STARTED|Visit 1 (1 Day)||9
2307556|NCT01968694|5665196|P1|STARTED|Visit 1 (1 Day)||10
2307557|NCT01968551|5665213|P3|NOT COMPLETED|Extension Phase||4
2307558|NCT01968551|5665214|P2|NOT COMPLETED|Extension Phase||1
2307559|NCT01968551|5665215|P1|NOT COMPLETED|Extension Phase||1
2307560|NCT01968551|5665213|P3|COMPLETED|Extension Phase||30
2307561|NCT01968551|5665214|P2|COMPLETED|Extension Phase||86
2307562|NCT01968551|5665215|P1|COMPLETED|Extension Phase||19
2307563|NCT01968551|5665213|P3|STARTED|Extension Phase|7 participant completed the Open-Label Phase, but did not enter in the Extension Phase|34
2307564|NCT01968551|5665214|P2|STARTED|Extension Phase||87
2307565|NCT01968551|5665215|P1|STARTED|Extension Phase||20
2307566|NCT01968551|5665213|P3|NOT COMPLETED|Open Label Phase (48 Weeks)||5
2307567|NCT01968551|5665214|P2|NOT COMPLETED|Open Label Phase (48 Weeks)||3
2307568|NCT01968551|5665215|P1|NOT COMPLETED|Open Label Phase (48 Weeks)||2
2307569|NCT01968551|5665213|P3|COMPLETED|Open Label Phase (48 Weeks)||41
2307570|NCT01968551|5665214|P2|COMPLETED|Open Label Phase (48 Weeks)||87
2307571|NCT01968551|5665215|P1|COMPLETED|Open Label Phase (48 Weeks)||20
2307572|NCT01968551|5665213|P3|STARTED|Open Label Phase (48 Weeks)||46
2307573|NCT01968551|5665214|P2|STARTED|Open Label Phase (48 Weeks)||90
2307574|NCT01968551|5665215|P1|STARTED|Open Label Phase (48 Weeks)||22
2307575|NCT01968434|5665231|P2|NOT COMPLETED|Overall Study||6
2307576|NCT01968434|5665232|P1|NOT COMPLETED|Overall Study||3
2307577|NCT01968434|5665231|P2|COMPLETED|Overall Study||66
2307578|NCT01968434|5665232|P1|COMPLETED|Overall Study||75
2307579|NCT01968434|5665231|P2|STARTED|Overall Study||72
2307580|NCT01968434|5665232|P1|STARTED|Overall Study||78
2307581|NCT01968382|5665245|P3|NOT COMPLETED|Overall Study||0
2307582|NCT01968382|5665246|P2|NOT COMPLETED|Overall Study||0
2307583|NCT01968382|5665247|P1|NOT COMPLETED|Overall Study||0
2307584|NCT01968382|5665245|P3|COMPLETED|Overall Study||20
2307585|NCT01968382|5665246|P2|COMPLETED|Overall Study||19
2307586|NCT01968382|5665247|P1|COMPLETED|Overall Study||18
2307587|NCT01968382|5665245|P3|STARTED|Overall Study||20
2307588|NCT01968382|5665246|P2|STARTED|Overall Study||19
2307589|NCT01968382|5665247|P1|STARTED|Overall Study||18
2307590|NCT01968226|5665291|P1|NOT COMPLETED|Overall Study||2
2307591|NCT01968226|5665291|P1|COMPLETED|Overall Study||1
2307592|NCT01968226|5665291|P1|STARTED|Overall Study||3
2307599|NCT01968135|5665309|P2|NOT COMPLETED|Overall Study||0
2307600|NCT01968135|5665310|P1|NOT COMPLETED|Overall Study||0
2307601|NCT01968135|5665309|P2|COMPLETED|Overall Study||16
2307602|NCT01968135|5665310|P1|COMPLETED|Overall Study||16
2307603|NCT01968135|5665309|P2|STARTED|Overall Study||16
2307604|NCT01968135|5665310|P1|STARTED|Overall Study||16
2307605|NCT01968070|5665340|P18|NOT COMPLETED|Period 3||0
2307606|NCT01968070|5665341|P17|NOT COMPLETED|Period 3||0
2307607|NCT01968070|5665342|P16|NOT COMPLETED|Period 3||0
2307608|NCT01968070|5665343|P15|NOT COMPLETED|Period 3||0
2307609|NCT01968070|5665344|P14|NOT COMPLETED|Period 3||0
2307610|NCT01968070|5665345|P13|NOT COMPLETED|Period 3||0
2307611|NCT01968070|5665346|P12|NOT COMPLETED|Period 3||0
2307612|NCT01968070|5665347|P11|NOT COMPLETED|Period 3||0
2307613|NCT01968070|5665348|P10|NOT COMPLETED|Period 3||0
2307614|NCT01968070|5665349|P9|NOT COMPLETED|Period 3||0
2307615|NCT01968070|5665350|P8|NOT COMPLETED|Period 3||0
2307616|NCT01968070|5665351|P7|NOT COMPLETED|Period 3||0
2307617|NCT01968070|5665352|P6|NOT COMPLETED|Period 3||0
2307618|NCT01968070|5665353|P5|NOT COMPLETED|Period 3||0
2307619|NCT01968070|5665354|P4|NOT COMPLETED|Period 3||0
2307620|NCT01968070|5665355|P3|NOT COMPLETED|Period 3||0
2307621|NCT01968070|5665356|P2|NOT COMPLETED|Period 3||0
2307622|NCT01968070|5665357|P1|NOT COMPLETED|Period 3||0
2307623|NCT01968070|5665340|P18|COMPLETED|Period 3||0
2307624|NCT01968070|5665341|P17|COMPLETED|Period 3||0
2307625|NCT01968070|5665342|P16|COMPLETED|Period 3||0
2307626|NCT01968070|5665343|P15|COMPLETED|Period 3||0
2307627|NCT01968070|5665344|P14|COMPLETED|Period 3||0
2307628|NCT01968070|5665345|P13|COMPLETED|Period 3||0
2307629|NCT01968070|5665346|P12|COMPLETED|Period 3||0
2307630|NCT01968070|5665347|P11|COMPLETED|Period 3||0
2307631|NCT01968070|5665348|P10|COMPLETED|Period 3||0
2307632|NCT01968070|5665349|P9|COMPLETED|Period 3||0
2307633|NCT01968070|5665350|P8|COMPLETED|Period 3||0
2307634|NCT01968070|5665351|P7|COMPLETED|Period 3||0
2307635|NCT01968070|5665352|P6|COMPLETED|Period 3||4
2307636|NCT01968070|5665353|P5|COMPLETED|Period 3||3
2307637|NCT01968070|5665354|P4|COMPLETED|Period 3||4
2307638|NCT01968070|5665355|P3|COMPLETED|Period 3||4
2307639|NCT01968070|5665356|P2|COMPLETED|Period 3||4
2307640|NCT01968070|5665357|P1|COMPLETED|Period 3||4
2307641|NCT01968070|5665340|P18|STARTED|Period 3||0
2307642|NCT01968070|5665341|P17|STARTED|Period 3||0
2307643|NCT01968070|5665342|P16|STARTED|Period 3||0
2307644|NCT01968070|5665343|P15|STARTED|Period 3||0
2307645|NCT01968070|5665344|P14|STARTED|Period 3||0
2307646|NCT01968070|5665345|P13|STARTED|Period 3||0
2307647|NCT01968070|5665346|P12|STARTED|Period 3||0
2307648|NCT01968070|5665347|P11|STARTED|Period 3||0
2307649|NCT01968070|5665348|P10|STARTED|Period 3||0
2307650|NCT01968070|5665349|P9|STARTED|Period 3||0
2307651|NCT01968070|5665350|P8|STARTED|Period 3||0
2307652|NCT01968070|5665351|P7|STARTED|Period 3||0
2307653|NCT01968070|5665352|P6|STARTED|Period 3||4
2307654|NCT01968070|5665353|P5|STARTED|Period 3||3
2307655|NCT01968070|5665354|P4|STARTED|Period 3||4
2307656|NCT01968070|5665355|P3|STARTED|Period 3||4
2307657|NCT01968070|5665356|P2|STARTED|Period 3||4
2307658|NCT01968070|5665357|P1|STARTED|Period 3||4
2307659|NCT01968070|5665340|P18|NOT COMPLETED|Period 2||0
2307660|NCT01968070|5665341|P17|NOT COMPLETED|Period 2||0
2307661|NCT01968070|5665342|P16|NOT COMPLETED|Period 2||0
2307662|NCT01968070|5665343|P15|NOT COMPLETED|Period 2||0
2307663|NCT01968070|5665344|P14|NOT COMPLETED|Period 2||0
2307664|NCT01968070|5665345|P13|NOT COMPLETED|Period 2||0
2307665|NCT01968070|5665346|P12|NOT COMPLETED|Period 2||0
2307666|NCT01968070|5665347|P11|NOT COMPLETED|Period 2||0
2307667|NCT01968070|5665348|P10|NOT COMPLETED|Period 2||0
2307668|NCT01968070|5665349|P9|NOT COMPLETED|Period 2||0
2307669|NCT01968070|5665350|P8|NOT COMPLETED|Period 2||0
2307670|NCT01968070|5665351|P7|NOT COMPLETED|Period 2||0
2307671|NCT01968070|5665352|P6|NOT COMPLETED|Period 2||0
2307672|NCT01968070|5665353|P5|NOT COMPLETED|Period 2||1
2307673|NCT01968070|5665354|P4|NOT COMPLETED|Period 2||0
2307674|NCT01968070|5665355|P3|NOT COMPLETED|Period 2||0
2307675|NCT01968070|5665356|P2|NOT COMPLETED|Period 2||0
2307676|NCT01968070|5665357|P1|NOT COMPLETED|Period 2||0
2307677|NCT01968070|5665340|P18|COMPLETED|Period 2||0
2307678|NCT01968070|5665341|P17|COMPLETED|Period 2||0
2307679|NCT01968070|5665342|P16|COMPLETED|Period 2||0
2307680|NCT01968070|5665343|P15|COMPLETED|Period 2||0
2307681|NCT01968070|5665344|P14|COMPLETED|Period 2||0
2307682|NCT01968070|5665345|P13|COMPLETED|Period 2||0
2307683|NCT01968070|5665346|P12|COMPLETED|Period 2||0
2307684|NCT01968070|5665347|P11|COMPLETED|Period 2||0
2307685|NCT01968070|5665348|P10|COMPLETED|Period 2||0
2307686|NCT01968070|5665349|P9|COMPLETED|Period 2||0
2307687|NCT01968070|5665350|P8|COMPLETED|Period 2||0
2307688|NCT01968070|5665351|P7|COMPLETED|Period 2||0
2307689|NCT01968070|5665352|P6|COMPLETED|Period 2||4
2307690|NCT01968070|5665353|P5|COMPLETED|Period 2||2
2307691|NCT01968070|5665354|P4|COMPLETED|Period 2||4
2307692|NCT01968070|5665355|P3|COMPLETED|Period 2||4
2307693|NCT01968070|5665356|P2|COMPLETED|Period 2||4
2307694|NCT01968070|5665357|P1|COMPLETED|Period 2||4
2307695|NCT01968070|5665340|P18|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
2307696|NCT01968070|5665341|P17|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
2307697|NCT01968070|5665342|P16|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
2307698|NCT01968070|5665343|P15|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
2307699|NCT01968070|5665344|P14|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
2307700|NCT01968070|5665345|P13|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
2307701|NCT01968070|5665346|P12|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
2307702|NCT01968070|5665347|P11|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
2307703|NCT01968070|5665348|P10|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
2307704|NCT01968070|5665349|P9|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
2307705|NCT01968070|5665350|P8|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
2307706|NCT01968070|5665351|P7|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
2307707|NCT01968070|5665352|P6|STARTED|Period 2||4
2307708|NCT01968070|5665353|P5|STARTED|Period 2||3
2307709|NCT01968070|5665354|P4|STARTED|Period 2|2 participants were added to replace the 2 participants who discontinued the period 1.|4
2307710|NCT01968070|5665355|P3|STARTED|Period 2||4
2307711|NCT01968070|5665356|P2|STARTED|Period 2|1 participant was added to replace the participant who discontinued the period 1.|4
2307712|NCT01968070|5665357|P1|STARTED|Period 2||4
2307713|NCT01968070|5665340|P18|NOT COMPLETED|Period 1||0
2307714|NCT01968070|5665341|P17|NOT COMPLETED|Period 1||0
2307715|NCT01968070|5665342|P16|NOT COMPLETED|Period 1||1
2307716|NCT01968070|5665343|P15|NOT COMPLETED|Period 1||0
2307717|NCT01968070|5665344|P14|NOT COMPLETED|Period 1||0
2307718|NCT01968070|5665345|P13|NOT COMPLETED|Period 1||0
2307719|NCT01968070|5665346|P12|NOT COMPLETED|Period 1||1
2307720|NCT01968070|5665347|P11|NOT COMPLETED|Period 1||0
2307721|NCT01968070|5665348|P10|NOT COMPLETED|Period 1||0
2307722|NCT01968070|5665349|P9|NOT COMPLETED|Period 1||0
2307723|NCT01968070|5665350|P8|NOT COMPLETED|Period 1||0
2307724|NCT01968070|5665351|P7|NOT COMPLETED|Period 1||2
2307725|NCT01968070|5665352|P6|NOT COMPLETED|Period 1||0
2307726|NCT01968070|5665353|P5|NOT COMPLETED|Period 1||1
2307727|NCT01968070|5665354|P4|NOT COMPLETED|Period 1||2
2307728|NCT01968070|5665355|P3|NOT COMPLETED|Period 1||0
2307729|NCT01968070|5665356|P2|NOT COMPLETED|Period 1||1
2307730|NCT01968070|5665357|P1|NOT COMPLETED|Period 1||0
2307731|NCT01968070|5665340|P18|COMPLETED|Period 1||2
2307732|NCT01968070|5665341|P17|COMPLETED|Period 1||2
2307733|NCT01968070|5665342|P16|COMPLETED|Period 1||8
2307734|NCT01968070|5665343|P15|COMPLETED|Period 1||2
2307735|NCT01968070|5665344|P14|COMPLETED|Period 1||2
2307736|NCT01968070|5665345|P13|COMPLETED|Period 1||9
2307737|NCT01968070|5665346|P12|COMPLETED|Period 1||1
2307738|NCT01968070|5665347|P11|COMPLETED|Period 1||2
2307739|NCT01968070|5665348|P10|COMPLETED|Period 1||9
2307740|NCT01968070|5665349|P9|COMPLETED|Period 1||2
2307741|NCT01968070|5665350|P8|COMPLETED|Period 1||2
2307742|NCT01968070|5665351|P7|COMPLETED|Period 1||8
2307743|NCT01968070|5665352|P6|COMPLETED|Period 1||4
2307744|NCT01968070|5665353|P5|COMPLETED|Period 1||3
2307745|NCT01968070|5665354|P4|COMPLETED|Period 1||2
2307746|NCT01968070|5665355|P3|COMPLETED|Period 1||4
2307747|NCT01968070|5665356|P2|COMPLETED|Period 1||3
2307748|NCT01968070|5665357|P1|COMPLETED|Period 1||4
2307749|NCT01968070|5665340|P18|STARTED|Period 1||2
2307750|NCT01968070|5665341|P17|STARTED|Period 1||2
2307751|NCT01968070|5665342|P16|STARTED|Period 1||9
2307752|NCT01968070|5665343|P15|STARTED|Period 1||2
2307753|NCT01968070|5665344|P14|STARTED|Period 1||2
2307754|NCT01968070|5665345|P13|STARTED|Period 1||9
2307755|NCT01968070|5665346|P12|STARTED|Period 1||2
2307756|NCT01968070|5665347|P11|STARTED|Period 1||2
2307757|NCT01968070|5665348|P10|STARTED|Period 1||9
2307758|NCT01968070|5665349|P9|STARTED|Period 1||2
2307759|NCT01968070|5665350|P8|STARTED|Period 1||2
2307760|NCT01968070|5665351|P7|STARTED|Period 1||10
2307761|NCT01968070|5665352|P6|STARTED|Period 1||4
2307762|NCT01968070|5665353|P5|STARTED|Period 1||4
2307763|NCT01968070|5665354|P4|STARTED|Period 1||4
2307764|NCT01968070|5665355|P3|STARTED|Period 1||4
2307765|NCT01968070|5665356|P2|STARTED|Period 1||4
2307766|NCT01968070|5665357|P1|STARTED|Period 1||4
2307767|NCT01968057|5665415|P1|NOT COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||0
2307768|NCT01968057|5665415|P1|COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||18
2307769|NCT01968057|5665415|P1|Received Baricitinib + Ciclosporin|Period 2 (At Dosing Day 4 to Day 7)||18
2307770|NCT01968057|5665415|P1|STARTED|Period 2 (At Dosing Day 4 to Day 7)||18
2307771|NCT01968057|5665415|P1|NOT COMPLETED|Period 1 (Day 1 to Predosing Day 4)||0
2307772|NCT01968057|5665415|P1|COMPLETED|Period 1 (Day 1 to Predosing Day 4)||18
2307773|NCT01968057|5665415|P1|Received Baricitinib|Period 1 (Day 1 to Predosing Day 4)||18
2307774|NCT01968057|5665415|P1|STARTED|Period 1 (Day 1 to Predosing Day 4)||18
2307775|NCT01967940|5665428|P4|NOT COMPLETED|Part 2||3
2307776|NCT01967940|5665429|P3|NOT COMPLETED|Part 2||0
2307777|NCT01967940|5665430|P2|NOT COMPLETED|Part 2||0
2307778|NCT01967940|5665431|P1|NOT COMPLETED|Part 2||0
2307779|NCT01967940|5665428|P4|COMPLETED|Part 2||35
2307780|NCT01967940|5665429|P3|COMPLETED|Part 2||0
2307781|NCT01967940|5665430|P2|COMPLETED|Part 2||0
2307782|NCT01967940|5665431|P1|COMPLETED|Part 2||0
2307783|NCT01967940|5665428|P4|STARTED|Part 2|38 participants from the Part 1 groups moved to this Part 2 E/C/F/TAF + ATV group|38
2307784|NCT01967940|5665429|P3|STARTED|Part 2|1 participant completed Part 1 and did not enter Part 2; 14 participants moved to the Part 2 group|0
2307785|NCT01967940|5665430|P2|STARTED|Part 2|12 participants completed Part 1 and did not enter Part 2; 16 participants moved to the Part 2 group|0
2307786|NCT01967940|5665431|P1|STARTED|Part 2|4 participants completed Part 1 and did not enter Part 2; 8 participants moved to the Part 2 group|0
2307787|NCT01967940|5665428|P4|NOT COMPLETED|Part 1||0
2307788|NCT01967940|5665429|P3|NOT COMPLETED|Part 1||0
2307789|NCT01967940|5665430|P2|NOT COMPLETED|Part 1||0
2307790|NCT01967940|5665431|P1|NOT COMPLETED|Part 1||0
2307791|NCT01967940|5665428|P4|COMPLETED|Part 1||0
2307792|NCT01967940|5665429|P3|COMPLETED|Part 1||15
2307793|NCT01967940|5665430|P2|COMPLETED|Part 1||28
2307794|NCT01967940|5665431|P1|COMPLETED|Part 1||12
2307795|NCT01967940|5665428|P4|STARTED|Part 1||0
2307796|NCT01967940|5665429|P3|STARTED|Part 1||15
2307797|NCT01967940|5665430|P2|STARTED|Part 1||28
2307798|NCT01967940|5665431|P1|STARTED|Part 1||12
2307799|NCT01967888|5665459|P2|NOT COMPLETED|Overall Study||7
2307800|NCT01967888|5665460|P1|NOT COMPLETED|Overall Study||10
2307801|NCT01967888|5665459|P2|COMPLETED|Overall Study||45
2307802|NCT01967888|5665460|P1|COMPLETED|Overall Study||42
2307803|NCT01967888|5665459|P2|STARTED|Overall Study||52
2307804|NCT01967888|5665460|P1|STARTED|Overall Study||52
2307805|NCT01967836|5665528|P1|NOT COMPLETED|Overall Study||9
2307806|NCT01967836|5665528|P1|COMPLETED|Overall Study||11
2307807|NCT01967836|5665528|P1|STARTED|Overall Study||20
2307808|NCT01967784|5665534|P1|NOT COMPLETED|Overall Study||0
2307809|NCT01967784|5665534|P1|COMPLETED|Overall Study||100
2307810|NCT01967784|5665534|P1|STARTED|Overall Study||100
2307811|NCT01967732|5665544|P4|NOT COMPLETED|Second Intervention (Day 3)||0
2307812|NCT01967732|5665545|P3|NOT COMPLETED|Second Intervention (Day 3)||0
2307813|NCT01967732|5665546|P2|NOT COMPLETED|Second Intervention (Day 3)||0
2307814|NCT01967732|5665547|P1|NOT COMPLETED|Second Intervention (Day 3)||0
2307815|NCT01967732|5665544|P4|COMPLETED|Second Intervention (Day 3)||9
2307816|NCT01967732|5665545|P3|COMPLETED|Second Intervention (Day 3)||9
2307817|NCT01967732|5665546|P2|COMPLETED|Second Intervention (Day 3)||20
2307818|NCT01967732|5665547|P1|COMPLETED|Second Intervention (Day 3)||22
2307819|NCT01967732|5665544|P4|STARTED|Second Intervention (Day 3)||9
2307820|NCT01967732|5665545|P3|STARTED|Second Intervention (Day 3)||9
2307821|NCT01967732|5665546|P2|STARTED|Second Intervention (Day 3)||20
2307822|NCT01967732|5665547|P1|STARTED|Second Intervention (Day 3)||22
2307823|NCT01967732|5665544|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
2307824|NCT01967732|5665545|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
2307825|NCT01967732|5665546|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
2307826|NCT01967732|5665547|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
2307827|NCT01967732|5665544|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
2307828|NCT01967732|5665545|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
2307829|NCT01967732|5665546|P2|COMPLETED|Washout Period of 1 Day (Day 2)||20
2307830|NCT01967732|5665547|P1|COMPLETED|Washout Period of 1 Day (Day 2)||22
2307831|NCT01967732|5665544|P4|STARTED|Washout Period of 1 Day (Day 2)||9
2307832|NCT01967732|5665545|P3|STARTED|Washout Period of 1 Day (Day 2)||9
2307833|NCT01967732|5665546|P2|STARTED|Washout Period of 1 Day (Day 2)||20
2307834|NCT01967732|5665547|P1|STARTED|Washout Period of 1 Day (Day 2)||22
2307835|NCT01967732|5665544|P4|NOT COMPLETED|First Intervention (Day 1)||0
2307836|NCT01967732|5665545|P3|NOT COMPLETED|First Intervention (Day 1)||0
2307837|NCT01967732|5665546|P2|NOT COMPLETED|First Intervention (Day 1)||1
2307838|NCT01967732|5665547|P1|NOT COMPLETED|First Intervention (Day 1)||0
2307839|NCT01967732|5665544|P4|COMPLETED|First Intervention (Day 1)||9
2307840|NCT01967732|5665545|P3|COMPLETED|First Intervention (Day 1)||9
2307841|NCT01967732|5665546|P2|COMPLETED|First Intervention (Day 1)|Subject discontinued from the study prior to product use|20
2307842|NCT01967732|5665547|P1|COMPLETED|First Intervention (Day 1)||22
2307843|NCT01967732|5665544|P4|STARTED|First Intervention (Day 1)||9
2307844|NCT01967732|5665545|P3|STARTED|First Intervention (Day 1)||9
2307845|NCT01967732|5665546|P2|STARTED|First Intervention (Day 1)||21
2307846|NCT01967732|5665547|P1|STARTED|First Intervention (Day 1)||22
2307847|NCT01967732|5665544|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
2307848|NCT01967732|5665545|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
2307849|NCT01967732|5665546|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||1
2307850|NCT01967732|5665547|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
2307851|NCT01967732|5665544|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
2307852|NCT01967732|5665545|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
2307853|NCT01967732|5665546|P2|COMPLETED|Washout Period of 1 Day (Day 0)||21
2307854|NCT01967732|5665547|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
2307855|NCT01967732|5665544|P4|STARTED|Washout Period of 1 Day (Day 0)||9
2307856|NCT01967732|5665545|P3|STARTED|Washout Period of 1 Day (Day 0)||9
2307857|NCT01967732|5665546|P2|STARTED|Washout Period of 1 Day (Day 0)||22
2307858|NCT01967732|5665547|P1|STARTED|Washout Period of 1 Day (Day 0)||22
2307859|NCT01967719|5665561|P4|NOT COMPLETED|Second Intervention (Day 3)||0
2307860|NCT01967719|5665562|P3|NOT COMPLETED|Second Intervention (Day 3)||0
2307861|NCT01967719|5665563|P2|NOT COMPLETED|Second Intervention (Day 3)||1
2307862|NCT01967719|5665564|P1|NOT COMPLETED|Second Intervention (Day 3)||0
2307863|NCT01967719|5665561|P4|COMPLETED|Second Intervention (Day 3)||8
2307864|NCT01967719|5665562|P3|COMPLETED|Second Intervention (Day 3)||9
2307865|NCT01967719|5665563|P2|COMPLETED|Second Intervention (Day 3)||20
2307866|NCT01967719|5665564|P1|COMPLETED|Second Intervention (Day 3)||22
2307867|NCT01967719|5665561|P4|STARTED|Second Intervention (Day 3)||8
2307868|NCT01967719|5665562|P3|STARTED|Second Intervention (Day 3)||9
2307869|NCT01967719|5665563|P2|STARTED|Second Intervention (Day 3)||21
2307870|NCT01967719|5665564|P1|STARTED|Second Intervention (Day 3)||22
2307871|NCT01967719|5665561|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
2307872|NCT01967719|5665562|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
2307873|NCT01967719|5665563|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
2307874|NCT01967719|5665564|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
2307875|NCT01967719|5665561|P4|COMPLETED|Washout Period of 1 Day (Day 2)||8
2307876|NCT01967719|5665562|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
2307877|NCT01967719|5665563|P2|COMPLETED|Washout Period of 1 Day (Day 2)||21
2307878|NCT01967719|5665564|P1|COMPLETED|Washout Period of 1 Day (Day 2)||22
2307879|NCT01967719|5665561|P4|STARTED|Washout Period of 1 Day (Day 2)||8
2307880|NCT01967719|5665562|P3|STARTED|Washout Period of 1 Day (Day 2)||9
2307881|NCT01967719|5665563|P2|STARTED|Washout Period of 1 Day (Day 2)||21
2307882|NCT01967719|5665564|P1|STARTED|Washout Period of 1 Day (Day 2)||22
2307883|NCT01967719|5665561|P4|NOT COMPLETED|First Intervention (Day 1)||1
2307884|NCT01967719|5665562|P3|NOT COMPLETED|First Intervention (Day 1)||0
2307885|NCT01967719|5665563|P2|NOT COMPLETED|First Intervention (Day 1)||1
2307886|NCT01967719|5665564|P1|NOT COMPLETED|First Intervention (Day 1)||0
2307887|NCT01967719|5665561|P4|COMPLETED|First Intervention (Day 1)||8
2307888|NCT01967719|5665562|P3|COMPLETED|First Intervention (Day 1)||9
2307889|NCT01967719|5665563|P2|COMPLETED|First Intervention (Day 1)||21
2307890|NCT01967719|5665564|P1|COMPLETED|First Intervention (Day 1)||22
2307891|NCT01967719|5665561|P4|STARTED|First Intervention (Day 1)||9
2307892|NCT01967719|5665562|P3|STARTED|First Intervention (Day 1)||9
2307893|NCT01967719|5665563|P2|STARTED|First Intervention (Day 1)||22
2307894|NCT01967719|5665564|P1|STARTED|First Intervention (Day 1)||22
2307895|NCT01967719|5665561|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
2307896|NCT01967719|5665562|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
2307897|NCT01967719|5665563|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
2307898|NCT01967719|5665564|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
2307899|NCT01967719|5665561|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
2307900|NCT01967719|5665562|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
2307901|NCT01967719|5665563|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
2307902|NCT01967719|5665564|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
2307903|NCT01967719|5665561|P4|STARTED|Washout Period of 1 Day (Day 0)||9
2307904|NCT01967719|5665562|P3|STARTED|Washout Period of 1 Day (Day 0)||9
2307905|NCT01967719|5665563|P2|STARTED|Washout Period of 1 Day (Day 0)||22
2307906|NCT01967719|5665564|P1|STARTED|Washout Period of 1 Day (Day 0)||22
2307907|NCT01967706|5665579|P4|NOT COMPLETED|Second Intervention (Day 3)||0
2307908|NCT01967706|5665580|P3|NOT COMPLETED|Second Intervention (Day 3)||0
2307909|NCT01967706|5665581|P2|NOT COMPLETED|Second Intervention (Day 3)||0
2307910|NCT01967706|5665582|P1|NOT COMPLETED|Second Intervention (Day 3)||0
2307911|NCT01967706|5665579|P4|COMPLETED|Second Intervention (Day 3)||9
2307912|NCT01967706|5665580|P3|COMPLETED|Second Intervention (Day 3)||9
2307913|NCT01967706|5665581|P2|COMPLETED|Second Intervention (Day 3)||22
2307914|NCT01967706|5665582|P1|COMPLETED|Second Intervention (Day 3)||21
2307915|NCT01967706|5665579|P4|STARTED|Second Intervention (Day 3)||9
2307916|NCT01967706|5665580|P3|STARTED|Second Intervention (Day 3)||9
2307917|NCT01967706|5665581|P2|STARTED|Second Intervention (Day 3)||22
2307918|NCT01967706|5665582|P1|STARTED|Second Intervention (Day 3)||21
2307919|NCT01967706|5665579|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
2307920|NCT01967706|5665580|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
2307921|NCT01967706|5665581|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
2307922|NCT01967706|5665582|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
2307923|NCT01967706|5665579|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
2307924|NCT01967706|5665580|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
2307925|NCT01967706|5665581|P2|COMPLETED|Washout Period of 1 Day (Day 2)||22
2307926|NCT01967706|5665582|P1|COMPLETED|Washout Period of 1 Day (Day 2)||21
2307927|NCT01967706|5665579|P4|STARTED|Washout Period of 1 Day (Day 2)||9
2307928|NCT01967706|5665580|P3|STARTED|Washout Period of 1 Day (Day 2)||9
2307929|NCT01967706|5665581|P2|STARTED|Washout Period of 1 Day (Day 2)||22
2307930|NCT01967706|5665582|P1|STARTED|Washout Period of 1 Day (Day 2)||21
2307931|NCT01967706|5665579|P4|NOT COMPLETED|First Intervention (Day 1)||0
2307932|NCT01967706|5665580|P3|NOT COMPLETED|First Intervention (Day 1)||0
2307933|NCT01967706|5665581|P2|NOT COMPLETED|First Intervention (Day 1)||0
2307934|NCT01967706|5665582|P1|NOT COMPLETED|First Intervention (Day 1)||1
2307935|NCT01967706|5665579|P4|COMPLETED|First Intervention (Day 1)||9
2307936|NCT01967706|5665580|P3|COMPLETED|First Intervention (Day 1)||9
2307937|NCT01967706|5665581|P2|COMPLETED|First Intervention (Day 1)||22
2307938|NCT01967706|5665582|P1|COMPLETED|First Intervention (Day 1)||21
2307939|NCT01967706|5665579|P4|STARTED|First Intervention (Day 1)||9
2307940|NCT01967706|5665580|P3|STARTED|First Intervention (Day 1)||9
2307941|NCT01967706|5665581|P2|STARTED|First Intervention (Day 1)||22
2307942|NCT01967706|5665582|P1|STARTED|First Intervention (Day 1)||22
2307943|NCT01967706|5665579|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
2307944|NCT01967706|5665580|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
2307945|NCT01967706|5665581|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
2307946|NCT01967706|5665582|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
2307947|NCT01967706|5665579|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
2307948|NCT01967706|5665580|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
2307949|NCT01967706|5665581|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
2307950|NCT01967706|5665582|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
2307951|NCT01967706|5665579|P4|STARTED|Washout Period of 1 Day (Day 0)||9
2307952|NCT01967706|5665580|P3|STARTED|Washout Period of 1 Day (Day 0)||9
2307953|NCT01967706|5665581|P2|STARTED|Washout Period of 1 Day (Day 0)||22
2307954|NCT01967706|5665582|P1|STARTED|Washout Period of 1 Day (Day 0)||22
2307955|NCT01967641|5665595|P1|NOT COMPLETED|12-week Outpatient Phase||13
2307956|NCT01967641|5665595|P1|COMPLETED|12-week Outpatient Phase|Completed week 12 of outpatient phase|18
2307957|NCT01967641|5665595|P1|STARTED|12-week Outpatient Phase||31
2307958|NCT01967641|5665595|P1|NOT COMPLETED|Admission to Inpatient Phase||12
2307959|NCT01967641|5665595|P1|COMPLETED|Admission to Inpatient Phase|Completed 7 week inpatient phase|31
2307960|NCT01967641|5665595|P1|STARTED|Admission to Inpatient Phase||43
2307961|NCT01967641|5665595|P1|NOT COMPLETED|Randomized||8
2307962|NCT01967641|5665595|P1|COMPLETED|Randomized|Completed week 12|43
2307963|NCT01967641|5665595|P1|STARTED|Randomized||51
2307964|NCT01967628|5665603|P2|NOT COMPLETED|Overall Study||31
2307965|NCT01967628|5665604|P1|NOT COMPLETED|Overall Study||27
2307966|NCT01967628|5665603|P2|COMPLETED|Overall Study||19
2307967|NCT01967628|5665604|P1|COMPLETED|Overall Study||21
2307968|NCT01967628|5665603|P2|STARTED|Overall Study||50
2307969|NCT01967628|5665604|P1|STARTED|Overall Study||48
2307970|NCT01967550|5665612|P2|NOT COMPLETED|Overall Study||2
2307971|NCT01967550|5665613|P1|NOT COMPLETED|Overall Study||5
2307972|NCT01967550|5665612|P2|COMPLETED|Overall Study||149
2307973|NCT01967550|5665613|P1|COMPLETED|Overall Study||148
2307974|NCT01967550|5665612|P2|STARTED|Overall Study||151
2307975|NCT01967550|5665613|P1|STARTED|Overall Study||153
2307976|NCT01967537|5665619|P1|NOT COMPLETED|Overall Study||60
2307977|NCT01967537|5665619|P1|COMPLETED|Overall Study||281
2307978|NCT01967537|5665619|P1|STARTED|Overall Study||341
2307979|NCT01967342|5665631|P3|NOT COMPLETED|Overall Study||29
2307980|NCT01967342|5665632|P2|NOT COMPLETED|Overall Study||25
2307981|NCT01967342|5665633|P1|NOT COMPLETED|Overall Study||27
2307982|NCT01967342|5665631|P3|COMPLETED|Overall Study||68
2307983|NCT01967342|5665632|P2|COMPLETED|Overall Study||70
2307984|NCT01967342|5665633|P1|COMPLETED|Overall Study||71
2307985|NCT01967342|5665631|P3|10-week Follow-up|Overall Study||80
2307986|NCT01967342|5665632|P2|10-week Follow-up|Overall Study||83
2307987|NCT01967342|5665633|P1|10-week Follow-up|Overall Study||78
2307988|NCT01967342|5665631|P3|5-week Follow-up|Overall Study||76
2307989|NCT01967342|5665632|P2|5-week Follow-up|Overall Study||78
2307990|NCT01967342|5665633|P1|5-week Follow-up|Overall Study||83
2307991|NCT01967342|5665631|P3|STARTED|Overall Study||97
2307992|NCT01967342|5665632|P2|STARTED|Overall Study||95
2307993|NCT01967342|5665633|P1|STARTED|Overall Study||98
2307994|NCT01967277|5665652|P2|NOT COMPLETED|Overall Study||3
2307995|NCT01967277|5665653|P1|NOT COMPLETED|Overall Study||1
2307996|NCT01967277|5665652|P2|COMPLETED|Overall Study||19
2307997|NCT01967277|5665653|P1|COMPLETED|Overall Study||21
2307998|NCT01967277|5665652|P2|STARTED|Overall Study||22
2307999|NCT01967277|5665653|P1|STARTED|Overall Study||22
2308000|NCT01967225|5665665|P2|NOT COMPLETED|Overall Study||3
2308001|NCT01967225|5665666|P1|NOT COMPLETED|Overall Study||12
2308002|NCT01967225|5665665|P2|COMPLETED|Overall Study||38
2308003|NCT01967225|5665666|P1|COMPLETED|Overall Study||72
2308004|NCT01967225|5665665|P2|Participants Received Treatment|Overall Study||41
2308005|NCT01967225|5665666|P1|Participants Received Treatment|Overall Study||83
2308006|NCT01967225|5665665|P2|STARTED|Overall Study||41
2308007|NCT01967225|5665666|P1|STARTED|Overall Study||84
2308008|NCT01967173|5665698|P8|NOT COMPLETED|Overall Study||24
2308009|NCT01967173|5665699|P7|NOT COMPLETED|Overall Study||18
2308010|NCT01967173|5665700|P6|NOT COMPLETED|Overall Study||23
2308011|NCT01967173|5665701|P5|NOT COMPLETED|Overall Study||17
2308012|NCT01967173|5665702|P4|NOT COMPLETED|Overall Study||14
2308013|NCT01967173|5665703|P3|NOT COMPLETED|Overall Study||16
2308014|NCT01967173|5665704|P2|NOT COMPLETED|Overall Study||17
2308015|NCT01967173|5665705|P1|NOT COMPLETED|Overall Study||24
2308016|NCT01967173|5665698|P8|COMPLETED|Overall Study||50
2308017|NCT01967173|5665699|P7|COMPLETED|Overall Study||57
2308018|NCT01967173|5665700|P6|COMPLETED|Overall Study||49
2308019|NCT01967173|5665701|P5|COMPLETED|Overall Study||56
2308020|NCT01967173|5665702|P4|COMPLETED|Overall Study||57
2308021|NCT01967173|5665703|P3|COMPLETED|Overall Study||55
2308022|NCT01967173|5665704|P2|COMPLETED|Overall Study||52
2308023|NCT01967173|5665705|P1|COMPLETED|Overall Study||45
2308024|NCT01967173|5665698|P8|Completed 4th Period|Overall Study||50
2308025|NCT01967173|5665699|P7|Completed 4th Period|Overall Study||57
2308026|NCT01967173|5665700|P6|Completed 4th Period|Overall Study||49
2308027|NCT01967173|5665701|P5|Completed 4th Period|Overall Study||56
2308028|NCT01967173|5665702|P4|Completed 4th Period|Overall Study||57
2308029|NCT01967173|5665703|P3|Completed 4th Period|Overall Study||55
2308030|NCT01967173|5665704|P2|Completed 4th Period|Overall Study||52
2308031|NCT01967173|5665705|P1|Completed 4th Period|Overall Study||45
2308032|NCT01967173|5665698|P8|Completed 3rd Period|Overall Study||56
2308033|NCT01967173|5665699|P7|Completed 3rd Period|Overall Study||59
2308034|NCT01967173|5665700|P6|Completed 3rd Period|Overall Study||56
2308035|NCT01967173|5665701|P5|Completed 3rd Period|Overall Study||59
2308036|NCT01967173|5665702|P4|Completed 3rd Period|Overall Study||61
2308037|NCT01967173|5665703|P3|Completed 3rd Period|Overall Study||60
2308038|NCT01967173|5665704|P2|Completed 3rd Period|Overall Study||54
2308039|NCT01967173|5665705|P1|Completed 3rd Period|Overall Study||48
2308040|NCT01967173|5665698|P8|Completed 2nd Period|Overall Study||61
2308041|NCT01967173|5665699|P7|Completed 2nd Period|Overall Study||63
2308042|NCT01967173|5665700|P6|Completed 2nd Period|Overall Study||57
2308043|NCT01967173|5665701|P5|Completed 2nd Period|Overall Study||63
2308044|NCT01967173|5665702|P4|Completed 2nd Period|Overall Study||62
2308045|NCT01967173|5665703|P3|Completed 2nd Period|Overall Study||63
2308046|NCT01967173|5665704|P2|Completed 2nd Period|Overall Study||58
2308047|NCT01967173|5665705|P1|Completed 2nd Period|Overall Study||52
2308048|NCT01967173|5665698|P8|Completed 1st Period|Overall Study||69
2308049|NCT01967173|5665699|P7|Completed 1st Period|Overall Study||67
2308050|NCT01967173|5665700|P6|Completed 1st Period|Overall Study||62
2308051|NCT01967173|5665701|P5|Completed 1st Period|Overall Study||64
2308052|NCT01967173|5665702|P4|Completed 1st Period|Overall Study||65
2308053|NCT01967173|5665703|P3|Completed 1st Period|Overall Study||67
2308054|NCT01967173|5665704|P2|Completed 1st Period|Overall Study||60
2308055|NCT01967173|5665705|P1|Completed 1st Period|Overall Study||58
2308056|NCT01967173|5665698|P8|STARTED|Overall Study||74
2308057|NCT01967173|5665699|P7|STARTED|Overall Study||75
2308058|NCT01967173|5665700|P6|STARTED|Overall Study||72
2308059|NCT01967173|5665701|P5|STARTED|Overall Study||73
2308060|NCT01967173|5665702|P4|STARTED|Overall Study||71
2308061|NCT01967173|5665703|P3|STARTED|Overall Study||71
2308062|NCT01967173|5665704|P2|STARTED|Overall Study||69
2308063|NCT01967173|5665705|P1|STARTED|Overall Study||69
2308064|NCT01967147|5665719|P2|NOT COMPLETED|Overall Study||20
2308065|NCT01967147|5665720|P1|NOT COMPLETED|Overall Study||13
2308066|NCT01967147|5665719|P2|COMPLETED|Overall Study||82
2308067|NCT01967147|5665720|P1|COMPLETED|Overall Study||99
2308068|NCT01967147|5665719|P2|STARTED|Overall Study||102
2308069|NCT01967147|5665720|P1|STARTED|Overall Study||112
2308070|NCT01967134|5665738|P3|NOT COMPLETED|Overall Study||0
2308071|NCT01967134|5665739|P2|NOT COMPLETED|Overall Study||1
2308072|NCT01967134|5665740|P1|NOT COMPLETED|Overall Study||0
2308073|NCT01967134|5665738|P3|COMPLETED|Overall Study||9
2308074|NCT01967134|5665739|P2|COMPLETED|Overall Study||7
2308075|NCT01967134|5665740|P1|COMPLETED|Overall Study||8
2308076|NCT01967134|5665738|P3|STARTED|Overall Study||9
2308077|NCT01967134|5665739|P2|STARTED|Overall Study||8
2308078|NCT01967134|5665740|P1|STARTED|Overall Study||8
2308079|NCT01967121|5665763|P3|NOT COMPLETED|Overall Study||0
2308080|NCT01967121|5665764|P2|NOT COMPLETED|Overall Study||0
2308081|NCT01967121|5665765|P1|NOT COMPLETED|Overall Study||0
2308082|NCT01967121|5665763|P3|COMPLETED|Overall Study||25
2308083|NCT01967121|5665764|P2|COMPLETED|Overall Study||25
2308084|NCT01967121|5665765|P1|COMPLETED|Overall Study||25
2308085|NCT01967121|5665763|P3|STARTED|Overall Study||25
2308086|NCT01967121|5665764|P2|STARTED|Overall Study||25
2308087|NCT01967121|5665765|P1|STARTED|Overall Study||25
2308088|NCT01967069|5665775|P2|NOT COMPLETED|Overall Study||8
2308089|NCT01967069|5665776|P1|NOT COMPLETED|Overall Study||8
2308090|NCT01967069|5665775|P2|COMPLETED|Overall Study||87
2308091|NCT01967069|5665776|P1|COMPLETED|Overall Study||174
2308092|NCT01967069|5665775|P2|STARTED|Overall Study||95
2308093|NCT01967069|5665776|P1|STARTED|Overall Study||182
2308094|NCT01966978|5665784|P2|NOT COMPLETED|Overall Study||13
2308095|NCT01966978|5665785|P1|NOT COMPLETED|Overall Study||17
2308096|NCT01966978|5665784|P2|COMPLETED|Overall Study||46
2308097|NCT01966978|5665785|P1|COMPLETED|Overall Study||44
2308098|NCT01966978|5665784|P2|STARTED|Overall Study||59
2308099|NCT01966978|5665785|P1|STARTED|Overall Study||61
2308100|NCT01966926|5665807|P2|NOT COMPLETED|Overall Study||0
2308101|NCT01966926|5665808|P1|NOT COMPLETED|Overall Study||0
2308102|NCT01966926|5665807|P2|COMPLETED|Overall Study||15
2308103|NCT01966926|5665808|P1|COMPLETED|Overall Study||15
2308104|NCT01966926|5665807|P2|STARTED|Overall Study||15
2308105|NCT01966926|5665808|P1|STARTED|Overall Study||15
2308106|NCT01966900|5665826|P2|NOT COMPLETED|Overall Study||0
2308107|NCT01966900|5665827|P1|NOT COMPLETED|Overall Study||2
2308108|NCT01966900|5665826|P2|COMPLETED|Overall Study||6
2308109|NCT01966900|5665827|P1|COMPLETED|Overall Study||6
2308110|NCT01966900|5665826|P2|STARTED|Overall Study||6
2308111|NCT01966900|5665827|P1|STARTED|Overall Study||8
2308112|NCT01966809|5665837|P1|NOT COMPLETED|Overall Study||0
2308113|NCT01966809|5665837|P1|COMPLETED|Overall Study||1
2308114|NCT01966809|5665837|P1|STARTED|Overall Study||1
2308115|NCT01966770|5665844|P1|NOT COMPLETED|Overall Study||0
2308116|NCT01966770|5665844|P1|COMPLETED|Overall Study||20
2308117|NCT01966770|5665844|P1|STARTED|Overall Study||20
2308118|NCT01966718|5665953|P1|NOT COMPLETED|Overall Study||0
2308119|NCT01966718|5665953|P1|COMPLETED|Overall Study||8
2308120|NCT01966718|5665953|P1|STARTED|Overall Study||8
2308121|NCT01966458|5665963|P2|NOT COMPLETED|Overall Study||2
2308122|NCT01966458|5665964|P1|NOT COMPLETED|Overall Study||4
2308123|NCT01966458|5665963|P2|COMPLETED|Overall Study||155
2308124|NCT01966458|5665964|P1|COMPLETED|Overall Study||304
2308125|NCT01966458|5665963|P2|STARTED|Overall Study||157
2308126|NCT01966458|5665964|P1|STARTED|Overall Study||308
2308127|NCT01966445|5665979|P7|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||5
2308128|NCT01966445|5665980|P6|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
2308129|NCT01966445|5665981|P5|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
2308130|NCT01966445|5665982|P4|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
2308131|NCT01966445|5665983|P3|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
2308132|NCT01966445|5665984|P2|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
2308133|NCT01966445|5665985|P1|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
2308134|NCT01966445|5665979|P7|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||4
2308135|NCT01966445|5665980|P6|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
2308136|NCT01966445|5665981|P5|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
2308137|NCT01966445|5665982|P4|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
2308138|NCT01966445|5665983|P3|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
2308139|NCT01966445|5665984|P2|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
2308140|NCT01966445|5665985|P1|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
2308141|NCT01966445|5665979|P7|STARTED|Part2 (Median Exposure of 7.143 Weeks)||9
2308142|NCT01966445|5665980|P6|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
2308143|NCT01966445|5665981|P5|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
2308144|NCT01966445|5665982|P4|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
2308145|NCT01966445|5665983|P3|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
2308146|NCT01966445|5665984|P2|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
2308147|NCT01966445|5665985|P1|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
2308148|NCT01966445|5665979|P7|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
2308149|NCT01966445|5665980|P6|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
2308150|NCT01966445|5665981|P5|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||3
2308151|NCT01966445|5665982|P4|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||3
2308152|NCT01966445|5665983|P3|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
2308153|NCT01966445|5665984|P2|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||2
2308154|NCT01966445|5665985|P1|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
2308155|NCT01966445|5665979|P7|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
2308156|NCT01966445|5665980|P6|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||4
2308157|NCT01966445|5665981|P5|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
2308158|NCT01966445|5665982|P4|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||2
2308159|NCT01966445|5665983|P3|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
2308160|NCT01966445|5665984|P2|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
2308161|NCT01966445|5665985|P1|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
2308162|NCT01966445|5665979|P7|STARTED|Part1 (Median Exposure of 6.143 Weeks)||0
2308163|NCT01966445|5665980|P6|STARTED|Part1 (Median Exposure of 6.143 Weeks)||5
2308164|NCT01966445|5665981|P5|STARTED|Part1 (Median Exposure of 6.143 Weeks)||4
2308165|NCT01966445|5665982|P4|STARTED|Part1 (Median Exposure of 6.143 Weeks)||5
2308166|NCT01966445|5665983|P3|STARTED|Part1 (Median Exposure of 6.143 Weeks)||2
2308167|NCT01966445|5665984|P2|STARTED|Part1 (Median Exposure of 6.143 Weeks)||3
2308168|NCT01966445|5665985|P1|STARTED|Part1 (Median Exposure of 6.143 Weeks)||1
2308169|NCT01966432|5666095|P3|NOT COMPLETED|Overall Study||26
2308170|NCT01966432|5666096|P2|NOT COMPLETED|Overall Study||13
2308171|NCT01966432|5666097|P1|NOT COMPLETED|Overall Study||5
2308172|NCT01966432|5666095|P3|COMPLETED|Overall Study||28
2308173|NCT01966432|5666096|P2|COMPLETED|Overall Study||21
2308174|NCT01966432|5666097|P1|COMPLETED|Overall Study||5
2308175|NCT01966432|5666095|P3|STARTED|Overall Study||54
2308176|NCT01966432|5666096|P2|STARTED|Overall Study||34
2308177|NCT01966432|5666097|P1|STARTED|Overall Study||10
2308178|NCT01966380|5666117|P2|NOT COMPLETED|Overall Study||1
2308179|NCT01966380|5666118|P1|NOT COMPLETED|Overall Study||0
2308180|NCT01966380|5666117|P2|COMPLETED|Overall Study||2
2308181|NCT01966380|5666118|P1|COMPLETED|Overall Study||3
2308182|NCT01966380|5666117|P2|STARTED|Overall Study||3
2308183|NCT01966380|5666118|P1|STARTED|Overall Study||3
2308184|NCT01966354|5666127|P3|NOT COMPLETED|Overall Study||0
2308185|NCT01966354|5666128|P2|NOT COMPLETED|Overall Study||0
2308186|NCT01966354|5666129|P1|NOT COMPLETED|Overall Study||0
2308187|NCT01966354|5666127|P3|COMPLETED|Overall Study||72
2308188|NCT01966354|5666128|P2|COMPLETED|Overall Study||73
2308189|NCT01966354|5666129|P1|COMPLETED|Overall Study||75
2308190|NCT01966354|5666127|P3|STARTED|Overall Study||72
2308191|NCT01966354|5666128|P2|STARTED|Overall Study||73
2308192|NCT01966354|5666129|P1|STARTED|Overall Study||75
2308193|NCT01966159|5666154|P2|NOT COMPLETED|Overall Study||0
2308194|NCT01966159|5666155|P1|NOT COMPLETED|Overall Study||0
2308195|NCT01966159|5666154|P2|COMPLETED|Overall Study||207
2308196|NCT01966159|5666155|P1|COMPLETED|Overall Study||205
2308197|NCT01966159|5666154|P2|STARTED|Overall Study||207
2308198|NCT01966159|5666155|P1|STARTED|Overall Study||205
2308199|NCT01966120|5666167|P2|NOT COMPLETED|Overall Study||6
2308200|NCT01966120|5666168|P1|NOT COMPLETED|Overall Study||1
2308201|NCT01966120|5666167|P2|COMPLETED|Overall Study||26
2308202|NCT01966120|5666168|P1|COMPLETED|Overall Study||54
2308203|NCT01966120|5666167|P2|STARTED|Overall Study||32
2308204|NCT01966120|5666168|P1|STARTED|Overall Study||55
2308205|NCT01966107|5666192|P2|NOT COMPLETED|Overall Study||881
2308206|NCT01966107|5666193|P1|NOT COMPLETED|Overall Study||802
2308207|NCT01966107|5666192|P2|COMPLETED|Overall Study||937
2308208|NCT01966107|5666193|P1|COMPLETED|Overall Study||1010
2308209|NCT01966107|5666192|P2|Full Analysis Set|Overall Study||1798
2308210|NCT01966107|5666193|P1|Full Analysis Set|Overall Study||1791
2308211|NCT01966107|5666192|P2|STARTED|Overall Study||1818
2308212|NCT01966107|5666193|P1|STARTED|Overall Study||1812
2308213|NCT01966068|5666207|P1|NOT COMPLETED|Overall Study||138
2308214|NCT01966068|5666207|P1|COMPLETED|Overall Study||156
2308215|NCT01966068|5666207|P1|Use the MyAsthma Portal More Than Once|Overall Study||156
2308216|NCT01966068|5666207|P1|Used the MyAsthma Portal at Least Once|Overall Study||237
2308217|NCT01966068|5666207|P1|STARTED|Overall Study||294
2308218|NCT01966042|5666212|P1|NOT COMPLETED|Overall Study||2
2308219|NCT01966042|5666212|P1|COMPLETED|Overall Study||11
2308220|NCT01966042|5666212|P1|STARTED|Overall Study||13
2308221|NCT01966003|5666221|P2|NOT COMPLETED|Overall Study||270
2308222|NCT01966003|5666222|P1|NOT COMPLETED|Overall Study||270
2308223|NCT01966003|5666221|P2|COMPLETED|Overall Study||44
2308224|NCT01966003|5666222|P1|COMPLETED|Overall Study||58
2308225|NCT01966003|5666221|P2|Received Study Drug|Overall Study||309
2308226|NCT01966003|5666222|P1|Received Study Drug|Overall Study||324
2308227|NCT01966003|5666221|P2|STARTED|Overall Study||314
2308228|NCT01966003|5666222|P1|STARTED|Overall Study||328
2308229|NCT01965938|5666240|P2|NOT COMPLETED|Overall Study||0
2308230|NCT01965938|5666241|P1|NOT COMPLETED|Overall Study||1
2308231|NCT01965938|5666240|P2|COMPLETED|Overall Study||20
2308232|NCT01965938|5666241|P1|COMPLETED|Overall Study||20
2308233|NCT01965938|5666240|P2|STARTED|Overall Study||20
2308234|NCT01965938|5666241|P1|STARTED|Overall Study||21
2308235|NCT01965899|5666261|P1|NOT COMPLETED|Overall Study||6
2308236|NCT01965899|5666261|P1|COMPLETED|Overall Study||145
2308237|NCT01965899|5666261|P1|STARTED|Overall Study||151
2308238|NCT01965834|5666272|P1|NOT COMPLETED|Overall Study||4
2308239|NCT01965834|5666272|P1|COMPLETED|Overall Study||2
2308240|NCT01965834|5666272|P1|STARTED|Overall Study||6
2308241|NCT01965782|5666278|P1|NOT COMPLETED|Overall Study||0
2308242|NCT01965782|5666278|P1|COMPLETED|Overall Study||0
2308243|NCT01965782|5666278|P1|STARTED|Overall Study||0
2308244|NCT01965756|5666290|P2|NOT COMPLETED|Overall Study||0
2308245|NCT01965756|5666291|P1|NOT COMPLETED|Overall Study||0
2308246|NCT01965756|5666290|P2|COMPLETED|Overall Study||10
2308247|NCT01965756|5666291|P1|COMPLETED|Overall Study||10
2308248|NCT01965756|5666290|P2|STARTED|Overall Study||10
2308249|NCT01965756|5666291|P1|STARTED|Overall Study||10
2308250|NCT01965665|5666305|P1|NOT COMPLETED|Overall Study||1
2308251|NCT01965665|5666305|P1|COMPLETED|Overall Study||19
2308252|NCT01965665|5666305|P1|STARTED|Overall Study||20
2308253|NCT01965652|5666313|P2|NOT COMPLETED|Overall Study||210
2308254|NCT01965652|5666314|P1|NOT COMPLETED|Overall Study||210
2308255|NCT01965652|5666313|P2|COMPLETED|Overall Study||413
2308256|NCT01965652|5666314|P1|COMPLETED|Overall Study||413
2308257|NCT01965652|5666313|P2|Received Treatment|Overall Study||623
2308258|NCT01965652|5666314|P1|Received Treatment|Overall Study||622
2308259|NCT01965652|5666313|P2|STARTED|Overall Study|Includes three participants who each enrolled at two different sites|623
2308260|NCT01965652|5666314|P1|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|623
2308261|NCT01965600|5666344|P4|NOT COMPLETED|Second Intervention||2
2308262|NCT01965600|5666345|P3|NOT COMPLETED|Second Intervention||2
2308263|NCT01965600|5666346|P2|NOT COMPLETED|Second Intervention||0
2308264|NCT01965600|5666347|P1|NOT COMPLETED|Second Intervention||0
2308265|NCT01965600|5666344|P4|COMPLETED|Second Intervention||0
2308266|NCT01965600|5666345|P3|COMPLETED|Second Intervention||1
2308267|NCT01965600|5666346|P2|COMPLETED|Second Intervention||4
2308268|NCT01965600|5666347|P1|COMPLETED|Second Intervention||4
2308269|NCT01965600|5666344|P4|STARTED|Second Intervention||2
2308270|NCT01965600|5666345|P3|STARTED|Second Intervention||3
2308271|NCT01965600|5666346|P2|STARTED|Second Intervention||4
2308272|NCT01965600|5666347|P1|STARTED|Second Intervention||4
2308273|NCT01965600|5666344|P4|NOT COMPLETED|Washout Period of Approximately 15 Days||2
2308274|NCT01965600|5666345|P3|NOT COMPLETED|Washout Period of Approximately 15 Days||2
2308275|NCT01965600|5666346|P2|NOT COMPLETED|Washout Period of Approximately 15 Days||4
2308276|NCT01965600|5666347|P1|NOT COMPLETED|Washout Period of Approximately 15 Days||2
2308277|NCT01965600|5666344|P4|COMPLETED|Washout Period of Approximately 15 Days||2
2308278|NCT01965600|5666345|P3|COMPLETED|Washout Period of Approximately 15 Days||3
2308279|NCT01965600|5666346|P2|COMPLETED|Washout Period of Approximately 15 Days||4
2308280|NCT01965600|5666347|P1|COMPLETED|Washout Period of Approximately 15 Days||4
2308281|NCT01965600|5666344|P4|STARTED|Washout Period of Approximately 15 Days||4
2308282|NCT01965600|5666345|P3|STARTED|Washout Period of Approximately 15 Days||5
2308283|NCT01965600|5666346|P2|STARTED|Washout Period of Approximately 15 Days||8
2308284|NCT01965600|5666347|P1|STARTED|Washout Period of Approximately 15 Days||6
2308285|NCT01965600|5666344|P4|NOT COMPLETED|First Intervention||0
2308286|NCT01965600|5666345|P3|NOT COMPLETED|First Intervention||0
2308287|NCT01965600|5666346|P2|NOT COMPLETED|First Intervention||0
2308288|NCT01965600|5666347|P1|NOT COMPLETED|First Intervention||0
2308289|NCT01965600|5666344|P4|COMPLETED|First Intervention||4
2308290|NCT01965600|5666345|P3|COMPLETED|First Intervention||5
2308291|NCT01965600|5666346|P2|COMPLETED|First Intervention||8
2308292|NCT01965600|5666347|P1|COMPLETED|First Intervention||6
2308293|NCT01965600|5666344|P4|Received at Least One Dose of Drug|First Intervention||4
2308294|NCT01965600|5666345|P3|Received at Least One Dose of Drug|First Intervention||5
2308295|NCT01965600|5666346|P2|Received at Least One Dose of Drug|First Intervention||8
2308296|NCT01965600|5666347|P1|Received at Least One Dose of Drug|First Intervention||6
2308297|NCT01965600|5666344|P4|STARTED|First Intervention||4
2308298|NCT01965600|5666345|P3|STARTED|First Intervention||5
2308299|NCT01965600|5666346|P2|STARTED|First Intervention||8
2308300|NCT01965600|5666347|P1|STARTED|First Intervention||6
2308301|NCT01965561|5666391|P1|NOT COMPLETED|Overall Study||0
2308302|NCT01965561|5666391|P1|COMPLETED|Overall Study||10
2308303|NCT01965561|5666391|P1|STARTED|Overall Study||10
2308304|NCT01965535|5666404|P2|NOT COMPLETED|Overall Study||1
2308305|NCT01965535|5666405|P1|NOT COMPLETED|Overall Study||2
2308306|NCT01965535|5666404|P2|COMPLETED|Overall Study||76
2308307|NCT01965535|5666405|P1|COMPLETED|Overall Study||76
2308308|NCT01965535|5666404|P2|STARTED|Overall Study||77
2308309|NCT01965535|5666405|P1|STARTED|Overall Study||78
2308310|NCT01965431|5666419|P6|NOT COMPLETED|Overall Study||6
2308311|NCT01965431|5666420|P5|NOT COMPLETED|Overall Study||6
2308312|NCT01965431|5666421|P4|NOT COMPLETED|Overall Study||6
2308313|NCT01965431|5666422|P3|NOT COMPLETED|Overall Study||6
2308314|NCT01965431|5666423|P2|NOT COMPLETED|Overall Study||6
2308315|NCT01965431|5666424|P1|NOT COMPLETED|Overall Study||6
2308316|NCT01965431|5666419|P6|COMPLETED|Overall Study||2
2308317|NCT01965431|5666420|P5|COMPLETED|Overall Study||2
2308318|NCT01965431|5666421|P4|COMPLETED|Overall Study||2
2308319|NCT01965431|5666422|P3|COMPLETED|Overall Study||2
2308320|NCT01965431|5666423|P2|COMPLETED|Overall Study||2
2308321|NCT01965431|5666424|P1|COMPLETED|Overall Study||2
2308322|NCT01965431|5666419|P6|STARTED|Overall Study||8
2308323|NCT01965431|5666420|P5|STARTED|Overall Study||8
2308324|NCT01965431|5666421|P4|STARTED|Overall Study||8
2308325|NCT01965431|5666422|P3|STARTED|Overall Study||8
2308326|NCT01965431|5666423|P2|STARTED|Overall Study||8
2308327|NCT01965431|5666424|P1|STARTED|Overall Study|Started are actually Treated subjects|8
2308328|NCT01965366|5666439|P2|NOT COMPLETED|Overall Study||5
2308329|NCT01965366|5666440|P1|NOT COMPLETED|Overall Study||10
2308330|NCT01965366|5666439|P2|COMPLETED|Overall Study||9
2308331|NCT01965366|5666440|P1|COMPLETED|Overall Study||3
2308332|NCT01965366|5666439|P2|STARTED|Overall Study||14
2308333|NCT01965366|5666440|P1|STARTED|Overall Study||13
2308334|NCT01965327|5666448|P1|NOT COMPLETED|Overall Study||2
2308335|NCT01965327|5666448|P1|COMPLETED|Overall Study|Prior to completion, 2 subjects were withdrawn by the PI for failure to adhere to study protocol.|10
2308336|NCT01965327|5666448|P1|STARTED|Overall Study||12
2308337|NCT01965288|5666455|P2|NOT COMPLETED|Overall Study||0
2308338|NCT01965288|5666456|P1|NOT COMPLETED|Overall Study||0
2308339|NCT01965288|5666455|P2|COMPLETED|Overall Study||30
2308340|NCT01965288|5666456|P1|COMPLETED|Overall Study||30
2308341|NCT01965288|5666455|P2|STARTED|Overall Study||30
2308342|NCT01965288|5666456|P1|STARTED|Overall Study||30
2308343|NCT01965262|5666662|P2|NOT COMPLETED|Second Intervention (7 Days)||10
2308344|NCT01965262|5666663|P1|NOT COMPLETED|Second Intervention (7 Days)||1
2308345|NCT01965262|5666662|P2|COMPLETED|Second Intervention (7 Days)||5
2308346|NCT01965262|5666663|P1|COMPLETED|Second Intervention (7 Days)||14
2308347|NCT01965262|5666662|P2|STARTED|Second Intervention (7 Days)||15
2308348|NCT01965262|5666663|P1|STARTED|Second Intervention (7 Days)||15
2308349|NCT01965262|5666662|P2|NOT COMPLETED|First Intervention (7 Days)||0
2308350|NCT01965262|5666663|P1|NOT COMPLETED|First Intervention (7 Days)||0
2308351|NCT01965262|5666662|P2|COMPLETED|First Intervention (7 Days)||15
2308352|NCT01965262|5666663|P1|COMPLETED|First Intervention (7 Days)||15
2308353|NCT01965262|5666662|P2|STARTED|First Intervention (7 Days)||15
2308354|NCT01965262|5666663|P1|STARTED|First Intervention (7 Days)||15
2308355|NCT01965158|5666727|P2|NOT COMPLETED|Overall Study||35
2308356|NCT01965158|5666728|P1|NOT COMPLETED|Overall Study||41
2308357|NCT01965158|5666727|P2|COMPLETED|Overall Study||238
2308358|NCT01965158|5666728|P1|COMPLETED|Overall Study||233
2308359|NCT01965158|5666727|P2|Received Treatment|Overall Study||273
2308360|NCT01965158|5666728|P1|Received Treatment|Overall Study||272
2308361|NCT01965158|5666727|P2|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|273
2308362|NCT01965158|5666728|P1|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|274
2308363|NCT01965067|5666744|P2|NOT COMPLETED|Overall Study||0
2308364|NCT01965067|5666745|P1|NOT COMPLETED|Overall Study||0
2308365|NCT01965067|5666744|P2|COMPLETED|Overall Study||30
2308366|NCT01965067|5666745|P1|COMPLETED|Overall Study||30
2308367|NCT01965067|5666744|P2|STARTED|Overall Study||30
2308368|NCT01965067|5666745|P1|STARTED|Overall Study||30
2308369|NCT01965002|5666761|P1|NOT COMPLETED|Overall Study||0
2308370|NCT01965002|5666761|P1|COMPLETED|Overall Study||5
2308371|NCT01965002|5666761|P1|STARTED|Overall Study||5
2308372|NCT01964976|5666769|P1|NOT COMPLETED|Overall Study||31
2308373|NCT01964976|5666769|P1|COMPLETED|Overall Study||1065
2308374|NCT01964976|5666769|P1|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1096
2308375|NCT01964963|5666781|P1|NOT COMPLETED|Overall Study||943
2308376|NCT01964963|5666781|P1|COMPLETED|Overall Study||18249
2308377|NCT01964963|5666781|P1|STARTED|Overall Study||19192
2308378|NCT01964950|5666789|P1|NOT COMPLETED|Overall Study||25
2308379|NCT01964950|5666789|P1|COMPLETED|Overall Study||1076
2308380|NCT01964950|5666789|P1|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1101
2308381|NCT01964924|5666801|P2|NOT COMPLETED|Trametinib + GSK2141||0
2308382|NCT01964924|5666802|P1|NOT COMPLETED|Trametinib + GSK2141||0
2308383|NCT01964924|5666801|P2|COMPLETED|Trametinib + GSK2141||19
2308384|NCT01964924|5666802|P1|COMPLETED|Trametinib + GSK2141||0
2308385|NCT01964924|5666801|P2|STARTED|Trametinib + GSK2141|Progressed in Part 1 and therefore initiated combination treatment in Part 2|19
2308386|NCT01964924|5666802|P1|STARTED|Trametinib + GSK2141||0
2308387|NCT01964924|5666801|P2|NOT COMPLETED|Trametinib Monotherapy||0
2308388|NCT01964924|5666802|P1|NOT COMPLETED|Trametinib Monotherapy||19
2308389|NCT01964924|5666801|P2|COMPLETED|Trametinib Monotherapy||0
2308390|NCT01964924|5666802|P1|COMPLETED|Trametinib Monotherapy||18
2308391|NCT01964924|5666801|P2|STARTED|Trametinib Monotherapy||0
2308392|NCT01964924|5666802|P1|STARTED|Trametinib Monotherapy||37
2308393|NCT01964898|5666826|P2|NOT COMPLETED|Overall Study||7
2308394|NCT01964898|5666827|P1|NOT COMPLETED|Overall Study||7
2308395|NCT01964898|5666826|P2|COMPLETED|Overall Study||26
2308396|NCT01964898|5666827|P1|COMPLETED|Overall Study||24
2308397|NCT01964898|5666826|P2|12 Week Assessment|Overall Study||30
2308398|NCT01964898|5666827|P1|12 Week Assessment|Overall Study||25
2308399|NCT01964898|5666826|P2|STARTED|Overall Study||33
2308400|NCT01964898|5666827|P1|STARTED|Overall Study||31
2308401|NCT01964755|5666847|P1|NOT COMPLETED|Overall Study||2
2308402|NCT01964755|5666847|P1|COMPLETED|Overall Study||4
2308403|NCT01964755|5666847|P1|Cycle 5|Overall Study||4
2308404|NCT01964755|5666847|P1|Cycle 4|Overall Study||4
2308405|NCT01964755|5666847|P1|Cycle 3|Overall Study||4
2308406|NCT01964755|5666847|P1|Cycle 2|Overall Study||5
2308407|NCT01964755|5666847|P1|STARTED|Overall Study||6
2308408|NCT01964716|5666862|P2|NOT COMPLETED|Overall Study||6
2308409|NCT01964716|5666863|P1|NOT COMPLETED|Overall Study||5
2308410|NCT01964716|5666862|P2|COMPLETED|Overall Study||244
2308411|NCT01964716|5666863|P1|COMPLETED|Overall Study||245
2308412|NCT01964716|5666862|P2|Vaccinated Dose 3|Overall Study||244
2308413|NCT01964716|5666863|P1|Vaccinated Dose 3|Overall Study||247
2308414|NCT01964716|5666862|P2|Vaccinated Dose 2|Overall Study||248
2308415|NCT01964716|5666863|P1|Vaccinated Dose 2|Overall Study||249
2308416|NCT01964716|5666862|P2|Vaccinated Dose 1|Overall Study||250
2308417|NCT01964716|5666863|P1|Vaccinated Dose 1|Overall Study||250
2308418|NCT01964716|5666862|P2|STARTED|Overall Study||250
2308419|NCT01964716|5666863|P1|STARTED|Overall Study||250
2308420|NCT01964547|5666901|P2|NOT COMPLETED|Overall Study||11
2308421|NCT01964547|5666902|P1|NOT COMPLETED|Overall Study||12
2308422|NCT01964547|5666901|P2|COMPLETED|Overall Study||48
2308423|NCT01964547|5666902|P1|COMPLETED|Overall Study||50
2308424|NCT01964547|5666901|P2|STARTED|Overall Study||59
2308425|NCT01964547|5666902|P1|STARTED|Overall Study||62
2308426|NCT01964521|5666926|P1|NOT COMPLETED|Overall Study||4
2308427|NCT01964521|5666926|P1|COMPLETED|Overall Study||20
2308428|NCT01964521|5666926|P1|STARTED|Overall Study||24
2308429|NCT01964430|5666933|P2|NOT COMPLETED|Overall Study||124
2308430|NCT01964430|5666934|P1|NOT COMPLETED|Overall Study||145
2308431|NCT01964430|5666933|P2|COMPLETED|Overall Study||310
2308432|NCT01964430|5666934|P1|COMPLETED|Overall Study||287
2308433|NCT01964430|5666933|P2|Treated Population|Overall Study||423
2308434|NCT01964430|5666934|P1|Treated Population|Overall Study||429
2308435|NCT01964430|5666933|P2|STARTED|Overall Study||434
2308436|NCT01964430|5666934|P1|STARTED|Overall Study||432
2308445|NCT01964352|5666983|P4|NOT COMPLETED|Overall Study||8
2308446|NCT01964352|5666984|P3|NOT COMPLETED|Overall Study||6
2308447|NCT01964352|5666985|P2|NOT COMPLETED|Overall Study||11
2308448|NCT01964352|5666986|P1|NOT COMPLETED|Overall Study||26
2308449|NCT01964352|5666983|P4|COMPLETED|Overall Study||195
2308450|NCT01964352|5666984|P3|COMPLETED|Overall Study||196
2308451|NCT01964352|5666985|P2|COMPLETED|Overall Study||192
2308452|NCT01964352|5666986|P1|COMPLETED|Overall Study||178
2308453|NCT01964352|5666983|P4|STARTED|Overall Study||203
2308454|NCT01964352|5666984|P3|STARTED|Overall Study||202
2308455|NCT01964352|5666985|P2|STARTED|Overall Study||203
2308456|NCT01964352|5666986|P1|STARTED|Overall Study||204
2308457|NCT01964326|5667016|P1|NOT COMPLETED|Overall Study||297
2308458|NCT01964326|5667016|P1|COMPLETED|Overall Study||1014
2308459|NCT01964326|5667016|P1|STARTED|Overall Study||1311
2308466|NCT01964222|5667040|P2|NOT COMPLETED|Overall Study||11
2308467|NCT01964222|5667041|P1|NOT COMPLETED|Overall Study||15
2308468|NCT01964222|5667040|P2|COMPLETED|Overall Study||89
2308469|NCT01964222|5667041|P1|COMPLETED|Overall Study||86
2308470|NCT01964222|5667040|P2|STARTED|Overall Study||100
2308471|NCT01964222|5667041|P1|STARTED|Overall Study||101
2308472|NCT01964105|5667058|P3|NOT COMPLETED|Overall Study||0
2308473|NCT01964105|5667059|P2|NOT COMPLETED|Overall Study||13
2308474|NCT01964105|5667060|P1|NOT COMPLETED|Overall Study||2
2308475|NCT01964105|5667058|P3|COMPLETED|Overall Study||10
2308476|NCT01964105|5667059|P2|COMPLETED|Overall Study||62
2308477|NCT01964105|5667060|P1|COMPLETED|Overall Study||13
2308478|NCT01964105|5667058|P3|STARTED|Overall Study||10
2308479|NCT01964105|5667059|P2|STARTED|Overall Study||75
2308480|NCT01964105|5667060|P1|STARTED|Overall Study||15
2308481|NCT01963845|5667070|P2|NOT COMPLETED|Overall Study||0
2308482|NCT01963845|5667071|P1|NOT COMPLETED|Overall Study||0
2308483|NCT01963845|5667070|P2|COMPLETED|Overall Study||25
2308484|NCT01963845|5667071|P1|COMPLETED|Overall Study||25
2308485|NCT01963845|5667070|P2|STARTED|Overall Study||25
2308486|NCT01963845|5667071|P1|STARTED|Overall Study||25
2308487|NCT01963767|5667087|P2|NOT COMPLETED|Overall Study||2
2308488|NCT01963767|5667088|P1|NOT COMPLETED|Overall Study||6
2308489|NCT01963767|5667087|P2|COMPLETED|Overall Study||53
2308490|NCT01963767|5667088|P1|COMPLETED|Overall Study||52
2308491|NCT01963767|5667087|P2|STARTED|Overall Study||55
2308492|NCT01963767|5667088|P1|STARTED|Overall Study||58
2308493|NCT01963676|5667098|P2|NOT COMPLETED|Overall Study||0
2308494|NCT01963676|5667099|P1|NOT COMPLETED|Overall Study||1
2308495|NCT01963676|5667098|P2|COMPLETED|Overall Study||13
2308496|NCT01963676|5667099|P1|COMPLETED|Overall Study||13
2308497|NCT01963676|5667098|P2|STARTED|Overall Study||13
2308498|NCT01963676|5667099|P1|STARTED|Overall Study||14
2308499|NCT01963611|5667112|P5|NOT COMPLETED|Overall Study||51
2308500|NCT01963611|5667113|P4|NOT COMPLETED|Overall Study||52
2308501|NCT01963611|5667114|P3|NOT COMPLETED|Overall Study||52
2308502|NCT01963611|5667115|P2|NOT COMPLETED|Overall Study||49
2308503|NCT01963611|5667116|P1|NOT COMPLETED|Overall Study||51
2308504|NCT01963611|5667112|P5|COMPLETED|Overall Study||0
2308505|NCT01963611|5667113|P4|COMPLETED|Overall Study||0
2308506|NCT01963611|5667114|P3|COMPLETED|Overall Study||0
2308507|NCT01963611|5667115|P2|COMPLETED|Overall Study||0
2308508|NCT01963611|5667116|P1|COMPLETED|Overall Study||0
2308509|NCT01963611|5667112|P5|Safety Analysis Set|Overall Study||50
2308510|NCT01963611|5667113|P4|Safety Analysis Set|Overall Study||52
2308511|NCT01963611|5667114|P3|Safety Analysis Set|Overall Study||52
2308512|NCT01963611|5667115|P2|Safety Analysis Set|Overall Study||49
2308513|NCT01963611|5667116|P1|Safety Analysis Set|Overall Study||51
2308514|NCT01963611|5667112|P5|STARTED|Overall Study||51
2308515|NCT01963611|5667113|P4|STARTED|Overall Study||52
2308516|NCT01963611|5667114|P3|STARTED|Overall Study||52
2308517|NCT01963611|5667115|P2|STARTED|Overall Study||49
2308518|NCT01963611|5667116|P1|STARTED|Overall Study||51
2308519|NCT01963403|5667175|P2|NOT COMPLETED|Overall Study||4
2308520|NCT01963403|5667176|P1|NOT COMPLETED|Overall Study||2
2308521|NCT01963403|5667175|P2|COMPLETED|Overall Study|Follow-up over three months|9
2308522|NCT01963403|5667176|P1|COMPLETED|Overall Study|Follow-up over three months|11
2308523|NCT01963403|5667175|P2|STARTED|Overall Study||13
2308524|NCT01963403|5667176|P1|STARTED|Overall Study||13
2308525|NCT01963260|5667198|P10|NOT COMPLETED|Overall Study||0
2308526|NCT01963260|5667199|P9|NOT COMPLETED|Overall Study||0
2308527|NCT01963260|5667200|P8|NOT COMPLETED|Overall Study||0
2308528|NCT01963260|5667201|P7|NOT COMPLETED|Overall Study||0
2308529|NCT01963260|5667202|P6|NOT COMPLETED|Overall Study||0
2308530|NCT01963260|5667203|P5|NOT COMPLETED|Overall Study||2
2308531|NCT01963260|5667204|P4|NOT COMPLETED|Overall Study||1
2308532|NCT01963260|5667205|P3|NOT COMPLETED|Overall Study||0
2308533|NCT01963260|5667206|P2|NOT COMPLETED|Overall Study||0
2308534|NCT01963260|5667207|P1|NOT COMPLETED|Overall Study||2
2308535|NCT01963260|5667198|P10|COMPLETED|Overall Study||4
2308536|NCT01963260|5667199|P9|COMPLETED|Overall Study||1
2308537|NCT01963260|5667200|P8|COMPLETED|Overall Study||2
2308538|NCT01963260|5667201|P7|COMPLETED|Overall Study||3
2308539|NCT01963260|5667202|P6|COMPLETED|Overall Study||10
2308540|NCT01963260|5667203|P5|COMPLETED|Overall Study||4
2308541|NCT01963260|5667204|P4|COMPLETED|Overall Study||5
2308542|NCT01963260|5667205|P3|COMPLETED|Overall Study||6
2308543|NCT01963260|5667206|P2|COMPLETED|Overall Study||6
2308544|NCT01963260|5667207|P1|COMPLETED|Overall Study||4
2308545|NCT01963260|5667198|P10|Treated|Overall Study||4
2308546|NCT01963260|5667199|P9|Treated|Overall Study||1
2308547|NCT01963260|5667200|P8|Treated|Overall Study||2
2308548|NCT01963260|5667201|P7|Treated|Overall Study||3
2308549|NCT01963260|5667202|P6|Treated|Overall Study||10
2308550|NCT01963260|5667203|P5|Treated|Overall Study||6
2308551|NCT01963260|5667204|P4|Treated|Overall Study||6
2308552|NCT01963260|5667205|P3|Treated|Overall Study||6
2308553|NCT01963260|5667206|P2|Treated|Overall Study||6
2308554|NCT01963260|5667207|P1|Treated|Overall Study||6
2308555|NCT01963260|5667198|P10|STARTED|Overall Study||4
2308556|NCT01963260|5667199|P9|STARTED|Overall Study||1
2308557|NCT01963260|5667200|P8|STARTED|Overall Study||2
2308558|NCT01963260|5667201|P7|STARTED|Overall Study||3
2308559|NCT01963260|5667202|P6|STARTED|Overall Study||10
2308560|NCT01963260|5667203|P5|STARTED|Overall Study||6
2308561|NCT01963260|5667204|P4|STARTED|Overall Study||6
2308562|NCT01963260|5667205|P3|STARTED|Overall Study||6
2308563|NCT01963260|5667206|P2|STARTED|Overall Study||6
2308564|NCT01963260|5667207|P1|STARTED|Overall Study||6
2308565|NCT01963234|5667262|P2|NOT COMPLETED|Overall Study||0
2308566|NCT01963234|5667263|P1|NOT COMPLETED|Overall Study||61
2308567|NCT01963234|5667262|P2|COMPLETED|Overall Study||171
2308568|NCT01963234|5667263|P1|COMPLETED|Overall Study||207
2308569|NCT01963234|5667262|P2|STARTED|Overall Study||171
2308570|NCT01963234|5667263|P1|STARTED|Overall Study||268
2308571|NCT01963169|5667290|P3|NOT COMPLETED|Overall Study||26
2308572|NCT01963169|5667291|P2|NOT COMPLETED|Overall Study||82
2308573|NCT01963169|5667292|P1|NOT COMPLETED|Overall Study||59
2308574|NCT01963169|5667290|P3|COMPLETED|Overall Study||237
2308575|NCT01963169|5667291|P2|COMPLETED|Overall Study||220
2308576|NCT01963169|5667292|P1|COMPLETED|Overall Study||242
2308577|NCT01963169|5667290|P3|STARTED|Overall Study||263
2308578|NCT01963169|5667291|P2|STARTED|Overall Study||302
2308579|NCT01963169|5667292|P1|STARTED|Overall Study||301
2308580|NCT01963143|5667309|P3|NOT COMPLETED|Overall Study||1
2308581|NCT01963143|5667310|P2|NOT COMPLETED|Overall Study||1
2308582|NCT01963143|5667311|P1|NOT COMPLETED|Overall Study||0
2308583|NCT01963143|5667309|P3|COMPLETED|Overall Study||14
2308584|NCT01963143|5667310|P2|COMPLETED|Overall Study||18
2308585|NCT01963143|5667311|P1|COMPLETED|Overall Study||14
2308586|NCT01963143|5667309|P3|STARTED|Overall Study||15
2308587|NCT01963143|5667310|P2|STARTED|Overall Study||19
2308588|NCT01963143|5667311|P1|STARTED|Overall Study||14
2308589|NCT01963091|5667323|P2|NOT COMPLETED|Overall Study||0
2308590|NCT01963091|5667324|P1|NOT COMPLETED|Overall Study||0
2308591|NCT01963091|5667323|P2|COMPLETED|Overall Study||16
2308592|NCT01963091|5667324|P1|COMPLETED|Overall Study||17
2308593|NCT01963091|5667323|P2|STARTED|Overall Study||16
2308594|NCT01963091|5667324|P1|STARTED|Overall Study||17
2308595|NCT01963078|5667338|P4|NOT COMPLETED|Overall Study||2
2308596|NCT01963078|5667339|P3|NOT COMPLETED|Overall Study||1
2308597|NCT01963078|5667340|P2|NOT COMPLETED|Overall Study||1
2308598|NCT01963078|5667341|P1|NOT COMPLETED|Overall Study||1
2308599|NCT01963078|5667338|P4|COMPLETED|Overall Study||7
2308600|NCT01963078|5667339|P3|COMPLETED|Overall Study||9
2308601|NCT01963078|5667340|P2|COMPLETED|Overall Study||9
2308602|NCT01963078|5667341|P1|COMPLETED|Overall Study||8
2308603|NCT01963078|5667338|P4|STARTED|Overall Study||9
2308604|NCT01963078|5667339|P3|STARTED|Overall Study||10
2308605|NCT01963078|5667340|P2|STARTED|Overall Study||10
2308606|NCT01963078|5667341|P1|STARTED|Overall Study||9
2308607|NCT01962974|5667351|P1|NOT COMPLETED|Overall Study||7
2308608|NCT01962974|5667351|P1|COMPLETED|Overall Study||0
2308609|NCT01962974|5667351|P1|STARTED|Overall Study||7
2308610|NCT01962961|5667360|P3|NOT COMPLETED|Overall Study||1
2308611|NCT01962961|5667361|P2|NOT COMPLETED|Overall Study||1
2308612|NCT01962961|5667362|P1|NOT COMPLETED|Overall Study||0
2308613|NCT01962961|5667360|P3|COMPLETED|Overall Study||6
2308614|NCT01962961|5667361|P2|COMPLETED|Overall Study||7
2308615|NCT01962961|5667362|P1|COMPLETED|Overall Study||9
2308616|NCT01962961|5667360|P3|STARTED|Overall Study||7
2308617|NCT01962961|5667361|P2|STARTED|Overall Study||8
2308618|NCT01962961|5667362|P1|STARTED|Overall Study||9
2308619|NCT01962922|5667378|P2|NOT COMPLETED|Extendion Portion (up to Month 6)||3
2308620|NCT01962922|5667379|P1|NOT COMPLETED|Extendion Portion (up to Month 6)||5
2308621|NCT01962922|5667378|P2|COMPLETED|Extendion Portion (up to Month 6)||20
2308622|NCT01962922|5667379|P1|COMPLETED|Extendion Portion (up to Month 6)||18
2308623|NCT01962922|5667378|P2|STARTED|Extendion Portion (up to Month 6)||23
2308624|NCT01962922|5667379|P1|STARTED|Extendion Portion (up to Month 6)||23
2308625|NCT01962922|5667378|P2|NOT COMPLETED|PK Portion Day 21||0
2308626|NCT01962922|5667379|P1|NOT COMPLETED|PK Portion Day 21||0
2308627|NCT01962922|5667378|P2|COMPLETED|PK Portion Day 21||23
2308628|NCT01962922|5667379|P1|COMPLETED|PK Portion Day 21||23
2308629|NCT01962922|5667378|P2|STARTED|PK Portion Day 21||23
2308630|NCT01962922|5667379|P1|STARTED|PK Portion Day 21||23
2308631|NCT01962922|5667378|P2|NOT COMPLETED|PK Portion Day 14||0
2308632|NCT01962922|5667379|P1|NOT COMPLETED|PK Portion Day 14||0
2308633|NCT01962922|5667378|P2|COMPLETED|PK Portion Day 14||23
2308634|NCT01962922|5667379|P1|COMPLETED|PK Portion Day 14||23
2308635|NCT01962922|5667378|P2|STARTED|PK Portion Day 14||23
2308636|NCT01962922|5667379|P1|STARTED|PK Portion Day 14||23
2308637|NCT01962922|5667378|P2|NOT COMPLETED|PK Portion Day 7||0
2308638|NCT01962922|5667379|P1|NOT COMPLETED|PK Portion Day 7||4
2308639|NCT01962922|5667378|P2|COMPLETED|PK Portion Day 7||23
2308640|NCT01962922|5667379|P1|COMPLETED|PK Portion Day 7||23
2308641|NCT01962922|5667378|P2|STARTED|PK Portion Day 7||23
2308642|NCT01962922|5667379|P1|STARTED|PK Portion Day 7||27
2308643|NCT01962896|5667401|P1|NOT COMPLETED|Overall Study||4
2308644|NCT01962896|5667401|P1|COMPLETED|Overall Study||0
2308645|NCT01962896|5667401|P1|STARTED|Overall Study||4
2308646|NCT01962870|5667410|P2|NOT COMPLETED|Overall Study||0
2308647|NCT01962870|5667411|P1|NOT COMPLETED|Overall Study||0
2308648|NCT01962870|5667410|P2|COMPLETED|Overall Study||17
2308649|NCT01962870|5667411|P1|COMPLETED|Overall Study||13
2308650|NCT01962870|5667410|P2|STARTED|Overall Study||17
2308651|NCT01962870|5667411|P1|STARTED|Overall Study||13
2308652|NCT01962688|5667459|P2|NOT COMPLETED|Overall Study||0
2308653|NCT01962688|5667460|P1|NOT COMPLETED|Overall Study||0
2308654|NCT01962688|5667459|P2|COMPLETED|Overall Study||18
2308655|NCT01962688|5667460|P1|COMPLETED|Overall Study||19
2308656|NCT01962688|5667459|P2|STARTED|Overall Study||18
2308657|NCT01962688|5667460|P1|STARTED|Overall Study||19
2308658|NCT01962675|5667478|P2|NOT COMPLETED|Overall Study||0
2308659|NCT01962675|5667479|P1|NOT COMPLETED|Overall Study||0
2308660|NCT01962675|5667478|P2|COMPLETED|Overall Study||7
2308661|NCT01962675|5667479|P1|COMPLETED|Overall Study||7
2308662|NCT01962675|5667478|P2|STARTED|Overall Study||7
2308663|NCT01962675|5667479|P1|STARTED|Overall Study||7
2308664|NCT01962558|5667493|P2|NOT COMPLETED|Overall Study||0
2308665|NCT01962558|5667494|P1|NOT COMPLETED|Overall Study||0
2308666|NCT01962558|5667493|P2|COMPLETED|Overall Study||14
2308667|NCT01962558|5667494|P1|COMPLETED|Overall Study||16
2308668|NCT01962558|5667493|P2|12-Weeks|Overall Study||14
2308669|NCT01962558|5667494|P1|12-Weeks|Overall Study||16
2308670|NCT01962558|5667493|P2|Acute Study|Overall Study||14
2308671|NCT01962558|5667494|P1|Acute Study|Overall Study||16
2308672|NCT01962558|5667493|P2|STARTED|Overall Study||14
2308673|NCT01962558|5667494|P1|STARTED|Overall Study||16
2308674|NCT01962493|5667512|P2|NOT COMPLETED|Overall Study||5
2308675|NCT01962493|5667513|P1|NOT COMPLETED|Overall Study||5
2308676|NCT01962493|5667512|P2|COMPLETED|Overall Study||77
2308677|NCT01962493|5667513|P1|COMPLETED|Overall Study||73
2308678|NCT01962493|5667512|P2|STARTED|Overall Study||82
2308679|NCT01962493|5667513|P1|STARTED|Overall Study||78
2308680|NCT01962441|5667536|P3|NOT COMPLETED|Retreatment Substudy||0
2308681|NCT01962441|5667537|P2|NOT COMPLETED|Retreatment Substudy||0
2308682|NCT01962441|5667538|P1|NOT COMPLETED|Retreatment Substudy||2
2308683|NCT01962441|5667536|P3|COMPLETED|Retreatment Substudy||0
2308684|NCT01962441|5667537|P2|COMPLETED|Retreatment Substudy||10
2308685|NCT01962441|5667538|P1|COMPLETED|Retreatment Substudy||18
2308686|NCT01962441|5667536|P3|STARTED|Retreatment Substudy|Participants in the SOF+RBV+Peg-IFN group were not eligible to enroll in the Retreatment Substudy.|0
2308687|NCT01962441|5667537|P2|STARTED|Retreatment Substudy|10 participants who experienced virologic failure enrolled into the Retreatment Substudy.|10
2308774|NCT01962103|5667729|P1|STARTED|Phase 2||0
2308688|NCT01962441|5667538|P1|STARTED|Retreatment Substudy|20 participants who experienced virologic failure enrolled into the Retreatment Substudy.|20
2308689|NCT01962441|5667536|P3|NOT COMPLETED|Randomized Period||11
2308690|NCT01962441|5667537|P2|NOT COMPLETED|Randomized Period||11
2308691|NCT01962441|5667538|P1|NOT COMPLETED|Randomized Period||10
2308692|NCT01962441|5667536|P3|COMPLETED|Randomized Period||189
2308693|NCT01962441|5667537|P2|COMPLETED|Randomized Period||190
2308694|NCT01962441|5667538|P1|COMPLETED|Randomized Period||190
2308695|NCT01962441|5667536|P3|STARTED|Randomized Period||200
2308696|NCT01962441|5667537|P2|STARTED|Randomized Period||201
2308697|NCT01962441|5667538|P1|STARTED|Randomized Period||200
2308698|NCT01962428|5667570|P2|NOT COMPLETED|Overall Study||6
2308699|NCT01962428|5667571|P1|NOT COMPLETED|Overall Study||10
2308700|NCT01962428|5667570|P2|COMPLETED|Overall Study||133
2308701|NCT01962428|5667571|P1|COMPLETED|Overall Study||129
2308702|NCT01962428|5667570|P2|STARTED|Overall Study||139
2308703|NCT01962428|5667571|P1|STARTED|Overall Study||139
2308704|NCT01962298|5667582|P5|NOT COMPLETED|Overall Study||6
2308705|NCT01962298|5667583|P4|NOT COMPLETED|Overall Study||2
2308706|NCT01962298|5667584|P3|NOT COMPLETED|Overall Study||5
2308707|NCT01962298|5667585|P2|NOT COMPLETED|Overall Study||4
2308708|NCT01962298|5667586|P1|NOT COMPLETED|Overall Study||3
2308709|NCT01962298|5667582|P5|COMPLETED|Overall Study||9
2308710|NCT01962298|5667583|P4|COMPLETED|Overall Study||13
2308711|NCT01962298|5667584|P3|COMPLETED|Overall Study||10
2308712|NCT01962298|5667585|P2|COMPLETED|Overall Study||11
2308713|NCT01962298|5667586|P1|COMPLETED|Overall Study||12
2308714|NCT01962298|5667582|P5|Received Intervention|Overall Study||15
2308715|NCT01962298|5667583|P4|Received Intervention|Overall Study||15
2308716|NCT01962298|5667584|P3|Received Intervention|Overall Study||15
2308717|NCT01962298|5667585|P2|Received Intervention|Overall Study||15
2308718|NCT01962298|5667586|P1|Received Intervention|Overall Study|1 subject did not receive the planned intervention and received a different one for clinical reasons|14
2308719|NCT01962298|5667582|P5|STARTED|Overall Study||15
2308720|NCT01962298|5667583|P4|STARTED|Overall Study||15
2308721|NCT01962298|5667584|P3|STARTED|Overall Study||15
2308722|NCT01962298|5667585|P2|STARTED|Overall Study||15
2308723|NCT01962298|5667586|P1|STARTED|Overall Study||15
2308724|NCT01962207|5667607|P4|NOT COMPLETED|Booster Phase (6 Months)||0
2308725|NCT01962207|5667608|P3|NOT COMPLETED|Booster Phase (6 Months)||0
2308726|NCT01962207|5667609|P2|NOT COMPLETED|Booster Phase (6 Months)||0
2308727|NCT01962207|5667610|P1|NOT COMPLETED|Booster Phase (6 Months)||0
2308728|NCT01962207|5667607|P4|COMPLETED|Booster Phase (6 Months)||21
2308729|NCT01962207|5667608|P3|COMPLETED|Booster Phase (6 Months)||77
2308730|NCT01962207|5667609|P2|COMPLETED|Booster Phase (6 Months)||16
2308731|NCT01962207|5667610|P1|COMPLETED|Booster Phase (6 Months)||67
2308732|NCT01962207|5667607|P4|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|21
2308733|NCT01962207|5667608|P3|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|77
2308734|NCT01962207|5667609|P2|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|16
2308735|NCT01962207|5667610|P1|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|67
2308736|NCT01962207|5667607|P4|NOT COMPLETED|Persistence Phase (5 Years)||12
2308737|NCT01962207|5667608|P3|NOT COMPLETED|Persistence Phase (5 Years)||44
2308738|NCT01962207|5667609|P2|NOT COMPLETED|Persistence Phase (5 Years)||13
2308739|NCT01962207|5667610|P1|NOT COMPLETED|Persistence Phase (5 Years)||29
2308740|NCT01962207|5667607|P4|COMPLETED|Persistence Phase (5 Years)||17
2308741|NCT01962207|5667608|P3|COMPLETED|Persistence Phase (5 Years)||71
2308742|NCT01962207|5667609|P2|COMPLETED|Persistence Phase (5 Years)||10
2308743|NCT01962207|5667610|P1|COMPLETED|Persistence Phase (5 Years)||47
2308744|NCT01962207|5667607|P4|STARTED|Persistence Phase (5 Years)||29
2308745|NCT01962207|5667608|P3|STARTED|Persistence Phase (5 Years)||115
2308746|NCT01962207|5667609|P2|STARTED|Persistence Phase (5 Years)||23
2308747|NCT01962207|5667610|P1|STARTED|Persistence Phase (5 Years)||76
2308748|NCT01962103|5667721|P9|NOT COMPLETED|Phase 2||14
2308749|NCT01962103|5667722|P8|NOT COMPLETED|Phase 2||14
2308750|NCT01962103|5667723|P7|NOT COMPLETED|Phase 2||14
2308751|NCT01962103|5667724|P6|NOT COMPLETED|Phase 2||0
2308752|NCT01962103|5667725|P5|NOT COMPLETED|Phase 2||0
2308753|NCT01962103|5667726|P4|NOT COMPLETED|Phase 2||0
2308754|NCT01962103|5667727|P3|NOT COMPLETED|Phase 2||0
2308755|NCT01962103|5667728|P2|NOT COMPLETED|Phase 2||0
2308756|NCT01962103|5667729|P1|NOT COMPLETED|Phase 2||0
2308757|NCT01962103|5667721|P9|COMPLETED|Phase 2|completed treatment|0
2308758|NCT01962103|5667722|P8|COMPLETED|Phase 2|completed treatment|0
2308759|NCT01962103|5667723|P7|COMPLETED|Phase 2|completed treatment|0
2308760|NCT01962103|5667724|P6|COMPLETED|Phase 2||0
2308761|NCT01962103|5667725|P5|COMPLETED|Phase 2||0
2308762|NCT01962103|5667726|P4|COMPLETED|Phase 2||0
2308763|NCT01962103|5667727|P3|COMPLETED|Phase 2||0
2308764|NCT01962103|5667728|P2|COMPLETED|Phase 2||0
2308765|NCT01962103|5667729|P1|COMPLETED|Phase 2||0
2308766|NCT01962103|5667721|P9|STARTED|Phase 2||14
2308767|NCT01962103|5667722|P8|STARTED|Phase 2||14
2308768|NCT01962103|5667723|P7|STARTED|Phase 2||14
2308769|NCT01962103|5667724|P6|STARTED|Phase 2||0
2308770|NCT01962103|5667725|P5|STARTED|Phase 2||0
2308771|NCT01962103|5667726|P4|STARTED|Phase 2||0
2308772|NCT01962103|5667727|P3|STARTED|Phase 2||0
2308773|NCT01962103|5667728|P2|STARTED|Phase 2||0
2308775|NCT01962103|5667721|P9|NOT COMPLETED|Phase 1||0
2308776|NCT01962103|5667722|P8|NOT COMPLETED|Phase 1||0
2308777|NCT01962103|5667723|P7|NOT COMPLETED|Phase 1||0
2308778|NCT01962103|5667724|P6|NOT COMPLETED|Phase 1||7
2308779|NCT01962103|5667725|P5|NOT COMPLETED|Phase 1||8
2308780|NCT01962103|5667726|P4|NOT COMPLETED|Phase 1||11
2308781|NCT01962103|5667727|P3|NOT COMPLETED|Phase 1||14
2308782|NCT01962103|5667728|P2|NOT COMPLETED|Phase 1||8
2308783|NCT01962103|5667729|P1|NOT COMPLETED|Phase 1||16
2308784|NCT01962103|5667721|P9|COMPLETED|Phase 1||0
2308785|NCT01962103|5667722|P8|COMPLETED|Phase 1||0
2308786|NCT01962103|5667723|P7|COMPLETED|Phase 1||0
2308787|NCT01962103|5667724|P6|COMPLETED|Phase 1||0
2308788|NCT01962103|5667725|P5|COMPLETED|Phase 1||0
2308789|NCT01962103|5667726|P4|COMPLETED|Phase 1||0
2308790|NCT01962103|5667727|P3|COMPLETED|Phase 1||0
2308791|NCT01962103|5667728|P2|COMPLETED|Phase 1||0
2308792|NCT01962103|5667729|P1|COMPLETED|Phase 1||0
2308793|NCT01962103|5667721|P9|STARTED|Phase 1||0
2308794|NCT01962103|5667722|P8|STARTED|Phase 1||0
2308795|NCT01962103|5667723|P7|STARTED|Phase 1||0
2308796|NCT01962103|5667724|P6|STARTED|Phase 1||7
2308797|NCT01962103|5667725|P5|STARTED|Phase 1||8
2308798|NCT01962103|5667726|P4|STARTED|Phase 1||11
2308799|NCT01962103|5667727|P3|STARTED|Phase 1||14
2308800|NCT01962103|5667728|P2|STARTED|Phase 1||8
2308801|NCT01962103|5667729|P1|STARTED|Phase 1||16
2308802|NCT01961921|5667829|P1|NOT COMPLETED|Overall Study||2
2308803|NCT01961921|5667829|P1|COMPLETED|Overall Study||25
2308804|NCT01961921|5667829|P1|STARTED|Overall Study||27
2308805|NCT01961609|5667841|P4|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||7
2308806|NCT01961609|5667842|P3|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||4
2308807|NCT01961609|5667843|P2|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||6
2308808|NCT01961609|5667844|P1|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||12
2308809|NCT01961609|5667841|P4|COMPLETED|Maintanence 2 (Weeks 49 - 72)||17
2308810|NCT01961609|5667842|P3|COMPLETED|Maintanence 2 (Weeks 49 - 72)||12
2308811|NCT01961609|5667843|P2|COMPLETED|Maintanence 2 (Weeks 49 - 72)||25
2308812|NCT01961609|5667844|P1|COMPLETED|Maintanence 2 (Weeks 49 - 72)||71
2308813|NCT01961609|5667841|P4|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||24
2308814|NCT01961609|5667842|P3|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||16
2308815|NCT01961609|5667843|P2|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||31
2308816|NCT01961609|5667844|P1|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||83
2308817|NCT01961609|5667841|P4|Safety Set|Maintanence 2 (Weeks 49 - 72)||24
2308818|NCT01961609|5667842|P3|Safety Set|Maintanence 2 (Weeks 49 - 72)||16
2308819|NCT01961609|5667843|P2|Safety Set|Maintanence 2 (Weeks 49 - 72)||31
2308820|NCT01961609|5667844|P1|Safety Set|Maintanence 2 (Weeks 49 - 72)||83
2308821|NCT01961609|5667841|P4|STARTED|Maintanence 2 (Weeks 49 - 72)||24
2308822|NCT01961609|5667842|P3|STARTED|Maintanence 2 (Weeks 49 - 72)||16
2308823|NCT01961609|5667843|P2|STARTED|Maintanence 2 (Weeks 49 - 72)||31
2308824|NCT01961609|5667844|P1|STARTED|Maintanence 2 (Weeks 49 - 72)||83
2308825|NCT01961609|5667841|P4|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||0
2308826|NCT01961609|5667842|P3|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||19
2308827|NCT01961609|5667843|P2|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||11
2308828|NCT01961609|5667844|P1|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||23
2308829|NCT01961609|5667841|P4|COMPLETED|Maintenance 1 (Weeks 17 - 48)||0
2308830|NCT01961609|5667842|P3|COMPLETED|Maintenance 1 (Weeks 17 - 48)||18
2308831|NCT01961609|5667843|P2|COMPLETED|Maintenance 1 (Weeks 17 - 48)||55
2308832|NCT01961609|5667844|P1|COMPLETED|Maintenance 1 (Weeks 17 - 48)||84
2308833|NCT01961609|5667841|P4|Safety Set|Maintenance 1 (Weeks 17 - 48)||0
2308834|NCT01961609|5667842|P3|Safety Set|Maintenance 1 (Weeks 17 - 48)||37
2308835|NCT01961609|5667843|P2|Safety Set|Maintenance 1 (Weeks 17 - 48)||66
2308836|NCT01961609|5667844|P1|Safety Set|Maintenance 1 (Weeks 17 - 48)||107
2308837|NCT01961609|5667841|P4|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||0
2308838|NCT01961609|5667842|P3|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||37
2308839|NCT01961609|5667843|P2|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||66
2308840|NCT01961609|5667844|P1|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||107
2308841|NCT01961609|5667841|P4|STARTED|Maintenance 1 (Weeks 17 - 48)||0
2308842|NCT01961609|5667842|P3|STARTED|Maintenance 1 (Weeks 17 - 48)||37
2308843|NCT01961609|5667843|P2|STARTED|Maintenance 1 (Weeks 17 - 48)||66
2308844|NCT01961609|5667844|P1|STARTED|Maintenance 1 (Weeks 17 - 48)||107
2308845|NCT01961609|5667841|P4|NOT COMPLETED|Initiation||0
2308846|NCT01961609|5667842|P3|NOT COMPLETED|Initiation||0
2308847|NCT01961609|5667843|P2|NOT COMPLETED|Initiation||13
2308848|NCT01961609|5667844|P1|NOT COMPLETED|Initiation||12
2308849|NCT01961609|5667841|P4|COMPLETED|Initiation||0
2308850|NCT01961609|5667842|P3|COMPLETED|Initiation||0
2308851|NCT01961609|5667843|P2|COMPLETED|Initiation||103
2308852|NCT01961609|5667844|P1|COMPLETED|Initiation||107
2308853|NCT01961609|5667841|P4|Full Analysis Set|Initiation||0
2308854|NCT01961609|5667842|P3|Full Analysis Set|Initiation||0
2308855|NCT01961609|5667843|P2|Full Analysis Set|Initiation||115
2308856|NCT01961609|5667844|P1|Full Analysis Set|Initiation||118
2308857|NCT01961609|5667841|P4|Safety Set|Initiation||0
2308858|NCT01961609|5667842|P3|Safety Set|Initiation||0
2308859|NCT01961609|5667843|P2|Safety Set|Initiation||115
2308860|NCT01961609|5667844|P1|Safety Set|Initiation||118
2308861|NCT01961609|5667841|P4|STARTED|Initiation||0
2308862|NCT01961609|5667842|P3|STARTED|Initiation||0
2308863|NCT01961609|5667843|P2|STARTED|Initiation||116
2308864|NCT01961609|5667844|P1|STARTED|Initiation||119
2308865|NCT01961544|5667896|P1|NOT COMPLETED|Overall Study||13
2308866|NCT01961544|5667896|P1|COMPLETED|Overall Study||88
2308867|NCT01961544|5667896|P1|STARTED|Overall Study||101
2308871|NCT01961349|5667910|P3|NOT COMPLETED|Overall Study||2
2308872|NCT01961349|5667911|P2|NOT COMPLETED|Overall Study||6
2308873|NCT01961349|5667912|P1|NOT COMPLETED|Overall Study||3
2308874|NCT01961349|5667910|P3|COMPLETED|Overall Study||109
2308875|NCT01961349|5667911|P2|COMPLETED|Overall Study||101
2308876|NCT01961349|5667912|P1|COMPLETED|Overall Study||51
2308877|NCT01961349|5667910|P3|STARTED|Overall Study||111
2308878|NCT01961349|5667911|P2|STARTED|Overall Study||107
2308879|NCT01961349|5667912|P1|STARTED|Overall Study||54
2308880|NCT01961323|5667923|P1|NOT COMPLETED|Overall Study||49
2308881|NCT01961323|5667923|P1|COMPLETED|Overall Study||21
2308882|NCT01961323|5667923|P1|STARTED|Overall Study||70
2308883|NCT01961297|5667931|P2|NOT COMPLETED|Overall Study||1
2308884|NCT01961297|5667932|P1|NOT COMPLETED|Overall Study||2
2308885|NCT01961297|5667931|P2|COMPLETED|Overall Study||22
2308886|NCT01961297|5667932|P1|COMPLETED|Overall Study||28
2308887|NCT01961297|5667931|P2|STARTED|Overall Study||23
2308888|NCT01961297|5667932|P1|STARTED|Overall Study||30
2308889|NCT01961271|5667946|P1|NOT COMPLETED|Overall Study||50
2308890|NCT01961271|5667946|P1|COMPLETED|Overall Study||64
2308891|NCT01961271|5667946|P1|STARTED|Overall Study||114
2308892|NCT01961167|5667955|P1|NOT COMPLETED|Overall Study||0
2308893|NCT01961167|5667955|P1|COMPLETED|Overall Study||27
2308894|NCT01961167|5667955|P1|STARTED|Overall Study||27
2308895|NCT01961115|5667996|P3|NOT COMPLETED|Overall Study||4
2308896|NCT01961115|5667997|P2|NOT COMPLETED|Overall Study||0
2308897|NCT01961115|5667998|P1|NOT COMPLETED|Overall Study||2
2308898|NCT01961115|5667996|P3|COMPLETED|Overall Study||5
2308899|NCT01961115|5667997|P2|COMPLETED|Overall Study||0
2308900|NCT01961115|5667998|P1|COMPLETED|Overall Study||0
2308901|NCT01961115|5667996|P3|STARTED|Overall Study||9
2308902|NCT01961115|5667997|P2|STARTED|Overall Study||0
2308903|NCT01961115|5667998|P1|STARTED|Overall Study||2
2308904|NCT01961089|5668033|P1|NOT COMPLETED|Overall Study||0
2308905|NCT01961089|5668033|P1|COMPLETED|Overall Study||40
2308906|NCT01961089|5668033|P1|STARTED|Overall Study||40
2308907|NCT01960907|5668041|P2|NOT COMPLETED|Overall Study||45
2308908|NCT01960907|5668042|P1|NOT COMPLETED|Overall Study||36
2308909|NCT01960907|5668041|P2|COMPLETED|Overall Study||109
2308910|NCT01960907|5668042|P1|COMPLETED|Overall Study||122
2308911|NCT01960907|5668041|P2|STARTED|Overall Study||154
2308912|NCT01960907|5668042|P1|STARTED|Overall Study||158
2308913|NCT01960855|5668057|P5|NOT COMPLETED|Overall Study||5
2308914|NCT01960855|5668058|P4|NOT COMPLETED|Overall Study||4
2308915|NCT01960855|5668059|P3|NOT COMPLETED|Overall Study||9
2308916|NCT01960855|5668060|P2|NOT COMPLETED|Overall Study||4
2308917|NCT01960855|5668061|P1|NOT COMPLETED|Overall Study||11
2308918|NCT01960855|5668057|P5|COMPLETED|Overall Study||50
2308919|NCT01960855|5668058|P4|COMPLETED|Overall Study||51
2308920|NCT01960855|5668059|P3|COMPLETED|Overall Study||46
2308921|NCT01960855|5668060|P2|COMPLETED|Overall Study||51
2308922|NCT01960855|5668061|P1|COMPLETED|Overall Study||45
2308923|NCT01960855|5668057|P5|STARTED|Overall Study||55
2308924|NCT01960855|5668058|P4|STARTED|Overall Study||55
2308925|NCT01960855|5668059|P3|STARTED|Overall Study||55
2308926|NCT01960855|5668060|P2|STARTED|Overall Study||55
2308927|NCT01960855|5668061|P1|STARTED|Overall Study||56
2308928|NCT01960842|5668093|P1|NOT COMPLETED|Overall Study||3
2308929|NCT01960842|5668093|P1|COMPLETED|Overall Study||28
2308930|NCT01960842|5668093|P1|STARTED|Overall Study||31
2308931|NCT01960816|5668116|P1|NOT COMPLETED|Overall Study||1
2308932|NCT01960816|5668116|P1|COMPLETED|Overall Study||32
2308933|NCT01960816|5668116|P1|STARTED|Overall Study||33
2308934|NCT01960790|5668122|P1|NOT COMPLETED|Overall Study||11
2308935|NCT01960790|5668122|P1|COMPLETED|Overall Study||462
2308936|NCT01960790|5668122|P1|STARTED|Overall Study||473
2308937|NCT01960725|5668134|P2|NOT COMPLETED|Overall Study||5
2308938|NCT01960725|5668135|P1|NOT COMPLETED|Overall Study||6
2308939|NCT01960725|5668134|P2|COMPLETED|Overall Study||28
2308940|NCT01960725|5668135|P1|COMPLETED|Overall Study||27
2308941|NCT01960725|5668134|P2|Received Third Vaccine|Overall Study||32
2308942|NCT01960725|5668135|P1|Received Third Vaccine|Overall Study||32
2308943|NCT01960725|5668134|P2|Recieved Second Vaccine|Overall Study||33
2308944|NCT01960725|5668135|P1|Recieved Second Vaccine|Overall Study||33
2308945|NCT01960725|5668134|P2|Received First Vaccine|Overall Study||33
2308946|NCT01960725|5668135|P1|Received First Vaccine|Overall Study||33
2308947|NCT01960725|5668134|P2|STARTED|Overall Study||33
2308948|NCT01960725|5668135|P1|STARTED|Overall Study||33
2308949|NCT01960530|5668157|P1|NOT COMPLETED|Overall Study||0
2308950|NCT01960530|5668157|P1|COMPLETED|Overall Study||14
2308951|NCT01960530|5668157|P1|STARTED|Overall Study||14
2308952|NCT01960413|5668192|P2|NOT COMPLETED|Overall Study||1
2308953|NCT01960413|5668193|P1|NOT COMPLETED|Overall Study||4
2308954|NCT01960413|5668192|P2|COMPLETED|Overall Study||21
2308955|NCT01960413|5668193|P1|COMPLETED|Overall Study||20
2308956|NCT01960413|5668192|P2|STARTED|Overall Study||22
2308957|NCT01960413|5668193|P1|STARTED|Overall Study||24
2308958|NCT01960400|5668201|P2|NOT COMPLETED|Overall Study||0
2308959|NCT01960400|5668202|P1|NOT COMPLETED|Overall Study||0
2308960|NCT01960400|5668201|P2|COMPLETED|Overall Study||11
2308961|NCT01960400|5668202|P1|COMPLETED|Overall Study||11
2308962|NCT01960400|5668201|P2|STARTED|Overall Study||11
2308963|NCT01960400|5668202|P1|STARTED|Overall Study||11
2308964|NCT01960387|5668214|P1|NOT COMPLETED|Overall Study||0
2308965|NCT01960387|5668214|P1|COMPLETED|Overall Study||2
2308966|NCT01960387|5668214|P1|STARTED|Overall Study||2
2308967|NCT01960348|5668223|P2|NOT COMPLETED|Overall Study||22
2308968|NCT01960348|5668224|P1|NOT COMPLETED|Overall Study||10
2308969|NCT01960348|5668223|P2|COMPLETED|Overall Study||55
2308970|NCT01960348|5668224|P1|COMPLETED|Overall Study||138
2308971|NCT01960348|5668223|P2|STARTED|Overall Study||77
2308972|NCT01960348|5668224|P1|STARTED|Overall Study||148
2308973|NCT01960296|5668244|P2|NOT COMPLETED|Overall Study||3
2308974|NCT01960296|5668245|P1|NOT COMPLETED|Overall Study||2
2308975|NCT01960296|5668244|P2|COMPLETED|Overall Study||22
2308976|NCT01960296|5668245|P1|COMPLETED|Overall Study||21
2308977|NCT01960296|5668244|P2|STARTED|Overall Study||25
2308978|NCT01960296|5668245|P1|STARTED|Overall Study||23
2308979|NCT01960140|5668265|P1|NOT COMPLETED|Period 2 (Days 3-18)||2
2308980|NCT01960140|5668265|P1|COMPLETED|Period 2 (Days 3-18)||38
2308981|NCT01960140|5668265|P1|Received Simvastatin|Period 2 (Days 3-18)||38
2308982|NCT01960140|5668265|P1|Received At Least 1 Dose of Baricitinib|Period 2 (Days 3-18)||40
2308983|NCT01960140|5668265|P1|STARTED|Period 2 (Days 3-18)||40
2308984|NCT01960140|5668265|P1|NOT COMPLETED|Period 1 (Days 1-2)||0
2308985|NCT01960140|5668265|P1|COMPLETED|Period 1 (Days 1-2)||40
2308986|NCT01960140|5668265|P1|Received Simvastatin|Period 1 (Days 1-2)||40
2308987|NCT01960140|5668265|P1|STARTED|Period 1 (Days 1-2)||40
2308988|NCT01960114|5668276|P2|NOT COMPLETED|Overall Study||1
2308989|NCT01960114|5668277|P1|NOT COMPLETED|Overall Study||1
2308990|NCT01960114|5668276|P2|COMPLETED|Overall Study||268
2308991|NCT01960114|5668277|P1|COMPLETED|Overall Study||133
2308992|NCT01960114|5668276|P2|STARTED|Overall Study||269
2308993|NCT01960114|5668277|P1|STARTED|Overall Study||134
2308994|NCT01959945|5668295|P4|NOT COMPLETED|Overall Study||16
2308995|NCT01959945|5668296|P3|NOT COMPLETED|Overall Study||19
2308996|NCT01959945|5668297|P2|NOT COMPLETED|Overall Study||3
2308997|NCT01959945|5668298|P1|NOT COMPLETED|Overall Study||4
2308998|NCT01959945|5668295|P4|COMPLETED|Overall Study||15
2308999|NCT01959945|5668296|P3|COMPLETED|Overall Study||9
2309000|NCT01959945|5668297|P2|COMPLETED|Overall Study||75
2309001|NCT01959945|5668298|P1|COMPLETED|Overall Study||76
2309002|NCT01959945|5668295|P4|STARTED|Overall Study||31
2309003|NCT01959945|5668296|P3|STARTED|Overall Study||28
2309004|NCT01959945|5668297|P2|STARTED|Overall Study||78
2309005|NCT01959945|5668298|P1|STARTED|Overall Study||80
2309006|NCT01959932|5668323|P3|NOT COMPLETED|Overall Study||0
2309007|NCT01959932|5668324|P2|NOT COMPLETED|Overall Study||0
2309008|NCT01959932|5668325|P1|NOT COMPLETED|Overall Study||1
2309009|NCT01959932|5668323|P3|COMPLETED|Overall Study||39
2309010|NCT01959932|5668324|P2|COMPLETED|Overall Study||41
2309011|NCT01959932|5668325|P1|COMPLETED|Overall Study||79
2309012|NCT01959932|5668323|P3|STARTED|Overall Study||39
2309013|NCT01959932|5668324|P2|STARTED|Overall Study||41
2309014|NCT01959932|5668325|P1|STARTED|Overall Study||80
2309015|NCT01959919|5668343|P1|NOT COMPLETED|Overall Study||2
2309016|NCT01959919|5668343|P1|COMPLETED|Overall Study||84
2309017|NCT01959919|5668343|P1|STARTED|Overall Study||86
2309018|NCT01959880|5668357|P4|NOT COMPLETED|Overall Study||181
2309019|NCT01959880|5668358|P3|NOT COMPLETED|Overall Study||208
2309020|NCT01959880|5668359|P2|NOT COMPLETED|Overall Study||369
2309021|NCT01959880|5668360|P1|NOT COMPLETED|Overall Study||1132
2309022|NCT01959880|5668357|P4|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
2309023|NCT01959880|5668358|P3|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|1
2309024|NCT01959880|5668359|P2|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
2309025|NCT01959880|5668360|P1|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
2309026|NCT01959880|5668357|P4|STARTED|Overall Study||181
2309027|NCT01959880|5668358|P3|STARTED|Overall Study||209
2309028|NCT01959880|5668359|P2|STARTED|Overall Study||369
2309029|NCT01959880|5668360|P1|STARTED|Overall Study||1132
2309030|NCT01959841|5668385|P3|NOT COMPLETED|Overall Study||43
2309031|NCT01959841|5668386|P2|NOT COMPLETED|Overall Study||57
2309032|NCT01959841|5668387|P1|NOT COMPLETED|Overall Study||43
2309033|NCT01959841|5668385|P3|COMPLETED|Overall Study||206
2309034|NCT01959841|5668386|P2|COMPLETED|Overall Study||193
2309035|NCT01959841|5668387|P1|COMPLETED|Overall Study||209
2309036|NCT01959841|5668385|P3|Reason FAS Excluding 3|Overall Study||0
2309037|NCT01959841|5668386|P2|Reason FAS Excluding 3|Overall Study||1
2309038|NCT01959841|5668387|P1|Reason FAS Excluding 3|Overall Study||0
2309039|NCT01959841|5668385|P3|Reason FAS Excluding 2|Overall Study||0
2309040|NCT01959841|5668386|P2|Reason FAS Excluding 2|Overall Study||1
2309041|NCT01959841|5668387|P1|Reason FAS Excluding 2|Overall Study||0
2309042|NCT01959841|5668385|P3|Reason FAS Excluding 1|Overall Study||4
2309043|NCT01959841|5668386|P2|Reason FAS Excluding 1|Overall Study||5
2309044|NCT01959841|5668387|P1|Reason FAS Excluding 1|Overall Study||5
2309045|NCT01959841|5668385|P3|Full Analysis Set Excluded|Overall Study||4
2309046|NCT01959841|5668386|P2|Full Analysis Set Excluded|Overall Study||7
2309047|NCT01959841|5668387|P1|Full Analysis Set Excluded|Overall Study||5
2309048|NCT01959841|5668385|P3|Full Analysis Set Included|Overall Study||245
2309049|NCT01959841|5668386|P2|Full Analysis Set Included|Overall Study||243
2309050|NCT01959841|5668387|P1|Full Analysis Set Included|Overall Study||247
2309051|NCT01959841|5668385|P3|STARTED|Overall Study||249
2309052|NCT01959841|5668386|P2|STARTED|Overall Study||250
2309053|NCT01959841|5668387|P1|STARTED|Overall Study||252
2309054|NCT01959685|5668410|P1|NOT COMPLETED|Overall Study||0
2309055|NCT01959685|5668410|P1|COMPLETED|Overall Study||9
2309056|NCT01959685|5668410|P1|STARTED|Overall Study||9
2309057|NCT01959672|5668415|P1|NOT COMPLETED|Overall Study||1
2309058|NCT01959672|5668415|P1|COMPLETED|Overall Study||10
2309059|NCT01959672|5668415|P1|STARTED|Overall Study||11
2309060|NCT01959607|5668421|P4|NOT COMPLETED|Second Intervention (Day 3)||0
2309061|NCT01959607|5668422|P3|NOT COMPLETED|Second Intervention (Day 3)||0
2309062|NCT01959607|5668423|P2|NOT COMPLETED|Second Intervention (Day 3)||0
2309063|NCT01959607|5668424|P1|NOT COMPLETED|Second Intervention (Day 3)||0
2309064|NCT01959607|5668421|P4|COMPLETED|Second Intervention (Day 3)||9
2309065|NCT01959607|5668422|P3|COMPLETED|Second Intervention (Day 3)||9
2309066|NCT01959607|5668423|P2|COMPLETED|Second Intervention (Day 3)||21
2309067|NCT01959607|5668424|P1|COMPLETED|Second Intervention (Day 3)||21
2309068|NCT01959607|5668421|P4|STARTED|Second Intervention (Day 3)||9
2309069|NCT01959607|5668422|P3|STARTED|Second Intervention (Day 3)||9
2309070|NCT01959607|5668423|P2|STARTED|Second Intervention (Day 3)||21
2309071|NCT01959607|5668424|P1|STARTED|Second Intervention (Day 3)||21
2309072|NCT01959607|5668421|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
2309073|NCT01959607|5668422|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
2309074|NCT01959607|5668423|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
2309075|NCT01959607|5668424|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
2309076|NCT01959607|5668421|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
2309077|NCT01959607|5668422|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
2309078|NCT01959607|5668423|P2|COMPLETED|Washout Period of 1 Day (Day 2)||21
2309079|NCT01959607|5668424|P1|COMPLETED|Washout Period of 1 Day (Day 2)||21
2309080|NCT01959607|5668421|P4|STARTED|Washout Period of 1 Day (Day 2)||9
2309081|NCT01959607|5668422|P3|STARTED|Washout Period of 1 Day (Day 2)||9
2309082|NCT01959607|5668423|P2|STARTED|Washout Period of 1 Day (Day 2)||21
2309083|NCT01959607|5668424|P1|STARTED|Washout Period of 1 Day (Day 2)||21
2309084|NCT01959607|5668421|P4|NOT COMPLETED|First Intervention (Day 1)||0
2309085|NCT01959607|5668422|P3|NOT COMPLETED|First Intervention (Day 1)||0
2309086|NCT01959607|5668423|P2|NOT COMPLETED|First Intervention (Day 1)||1
2309087|NCT01959607|5668424|P1|NOT COMPLETED|First Intervention (Day 1)||1
2309088|NCT01959607|5668421|P4|COMPLETED|First Intervention (Day 1)||9
2309089|NCT01959607|5668422|P3|COMPLETED|First Intervention (Day 1)||9
2309090|NCT01959607|5668423|P2|COMPLETED|First Intervention (Day 1)||21
2309091|NCT01959607|5668424|P1|COMPLETED|First Intervention (Day 1)||21
2309092|NCT01959607|5668421|P4|STARTED|First Intervention (Day 1)||9
2309093|NCT01959607|5668422|P3|STARTED|First Intervention (Day 1)||9
2309094|NCT01959607|5668423|P2|STARTED|First Intervention (Day 1)||22
2309095|NCT01959607|5668424|P1|STARTED|First Intervention (Day 1)||22
2309096|NCT01959607|5668421|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
2309097|NCT01959607|5668422|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
2309098|NCT01959607|5668423|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
2309099|NCT01959607|5668424|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
2309100|NCT01959607|5668421|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
2309101|NCT01959607|5668422|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
2309102|NCT01959607|5668423|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
2309103|NCT01959607|5668424|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
2309104|NCT01959607|5668421|P4|STARTED|Washout Period of 1 Day (Day 0)||9
2309105|NCT01959607|5668422|P3|STARTED|Washout Period of 1 Day (Day 0)||9
2309106|NCT01959607|5668423|P2|STARTED|Washout Period of 1 Day (Day 0)||22
2309107|NCT01959607|5668424|P1|STARTED|Washout Period of 1 Day (Day 0)||22
2309108|NCT01959581|5668437|P1|NOT COMPLETED|Overall Study||5
2309109|NCT01959581|5668437|P1|COMPLETED|Overall Study||25
2309110|NCT01959581|5668437|P1|STARTED|Overall Study||30
2309111|NCT01959529|5668443|P2|NOT COMPLETED|Overall Study||72
2309112|NCT01959529|5668444|P1|NOT COMPLETED|Overall Study||76
2309113|NCT01959529|5668443|P2|COMPLETED|Overall Study||3747
2309114|NCT01959529|5668444|P1|COMPLETED|Overall Study||3742
2309115|NCT01959529|5668443|P2|Exposed|Overall Study||3806
2309116|NCT01959529|5668444|P1|Exposed|Overall Study||3809
2309117|NCT01959529|5668443|P2|STARTED|Overall Study||3819
2309118|NCT01959529|5668444|P1|STARTED|Overall Study||3818
2309119|NCT01959516|5668456|P2|NOT COMPLETED|Epoch 2||1
2309120|NCT01959516|5668457|P1|NOT COMPLETED|Epoch 2||2
2309121|NCT01959516|5668456|P2|COMPLETED|Epoch 2||62
2309122|NCT01959516|5668457|P1|COMPLETED|Epoch 2||61
2309123|NCT01959516|5668456|P2|STARTED|Epoch 2||63
2309124|NCT01959516|5668457|P1|STARTED|Epoch 2||63
2309125|NCT01959516|5668456|P2|NOT COMPLETED|Epoch 1||5
2309126|NCT01959516|5668457|P1|NOT COMPLETED|Epoch 1||10
2309127|NCT01959516|5668456|P2|COMPLETED|Epoch 1||58
2309128|NCT01959516|5668457|P1|COMPLETED|Epoch 1||53
2309129|NCT01959516|5668456|P2|ITT Population|Epoch 1||62
2309130|NCT01959516|5668457|P1|ITT Population|Epoch 1||62
2309131|NCT01959516|5668456|P2|Safety Population|Epoch 1||62
2309132|NCT01959516|5668457|P1|Safety Population|Epoch 1||62
2309133|NCT01959516|5668456|P2|STARTED|Epoch 1||63
2309134|NCT01959516|5668457|P1|STARTED|Epoch 1||63
2309135|NCT01959503|5668467|P2|NOT COMPLETED|Overall Study||2
2309136|NCT01959503|5668468|P1|NOT COMPLETED|Overall Study||3
2309137|NCT01959503|5668467|P2|COMPLETED|Overall Study||49
2309138|NCT01959503|5668468|P1|COMPLETED|Overall Study||104
2309139|NCT01959503|5668467|P2|STARTED|Overall Study||51
2309140|NCT01959503|5668468|P1|STARTED|Overall Study||107
2309141|NCT01959490|5668491|P3|NOT COMPLETED|Overall Study||0
2309142|NCT01959490|5668492|P2|NOT COMPLETED|Overall Study||0
2309143|NCT01959490|5668493|P1|NOT COMPLETED|Overall Study||0
2309144|NCT01959490|5668491|P3|COMPLETED|Overall Study||5
2309145|NCT01959490|5668492|P2|COMPLETED|Overall Study||6
2309146|NCT01959490|5668493|P1|COMPLETED|Overall Study||5
2309147|NCT01959490|5668491|P3|STARTED|Overall Study||5
2309148|NCT01959490|5668492|P2|STARTED|Overall Study||6
2309149|NCT01959490|5668493|P1|STARTED|Overall Study||5
2309150|NCT01959412|5668519|P6|NOT COMPLETED|Overall Study||0
2309151|NCT01959412|5668520|P5|NOT COMPLETED|Overall Study||3
2309152|NCT01959412|5668521|P4|NOT COMPLETED|Overall Study||2
2309153|NCT01959412|5668522|P3|NOT COMPLETED|Overall Study||0
2309154|NCT01959412|5668523|P2|NOT COMPLETED|Overall Study||1
2309155|NCT01959412|5668524|P1|NOT COMPLETED|Overall Study||1
2309156|NCT01959412|5668519|P6|COMPLETED|Overall Study||15
2309157|NCT01959412|5668520|P5|COMPLETED|Overall Study||13
2309158|NCT01959412|5668521|P4|COMPLETED|Overall Study||13
2309159|NCT01959412|5668522|P3|COMPLETED|Overall Study||15
2309160|NCT01959412|5668523|P2|COMPLETED|Overall Study||14
2309161|NCT01959412|5668524|P1|COMPLETED|Overall Study||14
2309162|NCT01959412|5668519|P6|STARTED|Overall Study||15
2309163|NCT01959412|5668520|P5|STARTED|Overall Study||16
2309164|NCT01959412|5668521|P4|STARTED|Overall Study||15
2309165|NCT01959412|5668522|P3|STARTED|Overall Study||15
2309166|NCT01959412|5668523|P2|STARTED|Overall Study||15
2309167|NCT01959412|5668524|P1|STARTED|Overall Study||15
2309168|NCT01959334|5668564|P2|NOT COMPLETED|Third Dose||1
2309169|NCT01959334|5668565|P1|NOT COMPLETED|Third Dose||0
2309170|NCT01959334|5668564|P2|COMPLETED|Third Dose||48
2309171|NCT01959334|5668565|P1|COMPLETED|Third Dose||25
2309172|NCT01959334|5668564|P2|STARTED|Third Dose||49
2309173|NCT01959334|5668565|P1|STARTED|Third Dose||25
2309174|NCT01959334|5668564|P2|NOT COMPLETED|Second Dose||0
2309175|NCT01959334|5668565|P1|NOT COMPLETED|Second Dose||1
2309176|NCT01959334|5668564|P2|COMPLETED|Second Dose||49
2309177|NCT01959334|5668565|P1|COMPLETED|Second Dose||25
2309178|NCT01959334|5668564|P2|STARTED|Second Dose||49
2309179|NCT01959334|5668565|P1|STARTED|Second Dose||26
2309180|NCT01959334|5668564|P2|NOT COMPLETED|First Dose||0
2309181|NCT01959334|5668565|P1|NOT COMPLETED|First Dose||0
2309182|NCT01959334|5668564|P2|COMPLETED|First Dose|Each Dosing Period is separated by at least 7 calendar days.|49
2309183|NCT01959334|5668565|P1|COMPLETED|First Dose|Each Dosing Period separated by at least 7 calendar days.|26
2309184|NCT01959334|5668564|P2|STARTED|First Dose||49
2309185|NCT01959334|5668565|P1|STARTED|First Dose||26
2309186|NCT01959243|5668577|P2|NOT COMPLETED|Overall Study||4
2309187|NCT01959243|5668578|P1|NOT COMPLETED|Overall Study||13
2309188|NCT01959243|5668577|P2|COMPLETED|Overall Study||166
2309189|NCT01959243|5668578|P1|COMPLETED|Overall Study||324
2309190|NCT01959243|5668577|P2|Received at Least 1 Dose of Study Drug|Overall Study||170
2309191|NCT01959243|5668578|P1|Received at Least 1 Dose of Study Drug|Overall Study||337
2309192|NCT01959243|5668577|P2|STARTED|Overall Study||170
2309193|NCT01959243|5668578|P1|STARTED|Overall Study||337
2309194|NCT01959230|5668590|P2|NOT COMPLETED|Overall Study||1
2309195|NCT01959230|5668591|P1|NOT COMPLETED|Overall Study||4
2309196|NCT01959230|5668590|P2|COMPLETED|Overall Study||19
2309197|NCT01959230|5668591|P1|COMPLETED|Overall Study||36
2309198|NCT01959230|5668590|P2|Received at Least 1 Dose of Study Drug|Overall Study||20
2309199|NCT01959230|5668591|P1|Received at Least 1 Dose of Study Drug|Overall Study||40
2309200|NCT01959230|5668590|P2|STARTED|Overall Study||20
2309201|NCT01959230|5668591|P1|STARTED|Overall Study||40
2309202|NCT01959165|5668605|P4|NOT COMPLETED|Overall Study||2
2309203|NCT01959165|5668606|P3|NOT COMPLETED|Overall Study||0
2309204|NCT01959165|5668607|P2|NOT COMPLETED|Overall Study||1
2309205|NCT01959165|5668608|P1|NOT COMPLETED|Overall Study||1
2309206|NCT01959165|5668605|P4|COMPLETED|Overall Study||7
2309207|NCT01959165|5668606|P3|COMPLETED|Overall Study||12
2309208|NCT01959165|5668607|P2|COMPLETED|Overall Study||10
2309209|NCT01959165|5668608|P1|COMPLETED|Overall Study||12
2309210|NCT01959165|5668605|P4|STARTED|Overall Study||9
2309211|NCT01959165|5668606|P3|STARTED|Overall Study||12
2309212|NCT01959165|5668607|P2|STARTED|Overall Study|1 patient discontinued the study without any treatment out of 11 patients.|11
2309213|NCT01959165|5668608|P1|STARTED|Overall Study||13
2309214|NCT01959139|5668634|P4|NOT COMPLETED|Phase II||55
2309215|NCT01959139|5668635|P3|NOT COMPLETED|Phase II||56
2309216|NCT01959139|5668636|P2|NOT COMPLETED|Phase II||0
2309217|NCT01959139|5668637|P1|NOT COMPLETED|Phase II||0
2309218|NCT01959139|5668634|P4|COMPLETED|Phase II||0
2309219|NCT01959139|5668635|P3|COMPLETED|Phase II||0
2309220|NCT01959139|5668636|P2|COMPLETED|Phase II||0
2309221|NCT01959139|5668637|P1|COMPLETED|Phase II||0
2309222|NCT01959139|5668634|P4|Assessed for AEs|Phase II||51
2309223|NCT01959139|5668635|P3|Assessed for AEs|Phase II||54
2309224|NCT01959139|5668636|P2|Assessed for AEs|Phase II||0
2309225|NCT01959139|5668637|P1|Assessed for AEs|Phase II||0
2309226|NCT01959139|5668634|P4|STARTED|Phase II||55
2309227|NCT01959139|5668635|P3|STARTED|Phase II||56
2309228|NCT01959139|5668636|P2|STARTED|Phase II||0
2309229|NCT01959139|5668637|P1|STARTED|Phase II||0
2309230|NCT01959139|5668634|P4|NOT COMPLETED|Phase I: Cohort 2||0
2309231|NCT01959139|5668635|P3|NOT COMPLETED|Phase I: Cohort 2||0
2309232|NCT01959139|5668636|P2|NOT COMPLETED|Phase I: Cohort 2||0
2309233|NCT01959139|5668637|P1|NOT COMPLETED|Phase I: Cohort 2||0
2309234|NCT01959139|5668634|P4|COMPLETED|Phase I: Cohort 2||0
2309235|NCT01959139|5668635|P3|COMPLETED|Phase I: Cohort 2||0
2309236|NCT01959139|5668636|P2|COMPLETED|Phase I: Cohort 2||6
2309237|NCT01959139|5668637|P1|COMPLETED|Phase I: Cohort 2||0
2309238|NCT01959139|5668634|P4|STARTED|Phase I: Cohort 2||0
2309239|NCT01959139|5668635|P3|STARTED|Phase I: Cohort 2||0
2309240|NCT01959139|5668636|P2|STARTED|Phase I: Cohort 2||6
2309241|NCT01959139|5668637|P1|STARTED|Phase I: Cohort 2||0
2309242|NCT01959139|5668634|P4|NOT COMPLETED|Phase I: Cohort 1||0
2309243|NCT01959139|5668635|P3|NOT COMPLETED|Phase I: Cohort 1||0
2309244|NCT01959139|5668636|P2|NOT COMPLETED|Phase I: Cohort 1||0
2309245|NCT01959139|5668637|P1|NOT COMPLETED|Phase I: Cohort 1||0
2309246|NCT01959139|5668634|P4|COMPLETED|Phase I: Cohort 1||0
2309247|NCT01959139|5668635|P3|COMPLETED|Phase I: Cohort 1||0
2309248|NCT01959139|5668636|P2|COMPLETED|Phase I: Cohort 1||0
2309249|NCT01959139|5668637|P1|COMPLETED|Phase I: Cohort 1||5
2309250|NCT01959139|5668634|P4|STARTED|Phase I: Cohort 1||0
2309251|NCT01959139|5668635|P3|STARTED|Phase I: Cohort 1||0
2309252|NCT01959139|5668636|P2|STARTED|Phase I: Cohort 1||0
2309253|NCT01959139|5668637|P1|STARTED|Phase I: Cohort 1||5
2309254|NCT01959048|5668656|P1|NOT COMPLETED|Overall Study||0
2309255|NCT01959048|5668656|P1|COMPLETED|Overall Study||3
2309256|NCT01959048|5668656|P1|STARTED|Overall Study||3
2309257|NCT01959035|5668664|P1|NOT COMPLETED|Overall Study||11
2309258|NCT01959035|5668664|P1|COMPLETED|Overall Study||77
2309259|NCT01959035|5668664|P1|STARTED|Overall Study||88
2309260|NCT01958918|5668692|P2|NOT COMPLETED|Overall Study||42
2309261|NCT01958918|5668693|P1|NOT COMPLETED|Overall Study||43
2309262|NCT01958918|5668692|P2|COMPLETED|Overall Study||314
2309263|NCT01958918|5668693|P1|COMPLETED|Overall Study||313
2309264|NCT01958918|5668692|P2|Full Analysis Set|Overall Study||354
2309265|NCT01958918|5668693|P1|Full Analysis Set|Overall Study||353
2309266|NCT01958918|5668692|P2|STARTED|Overall Study||356
2309267|NCT01958918|5668693|P1|STARTED|Overall Study||356
2309268|NCT01958827|5668707|P1|NOT COMPLETED|Overall Study||10
2309269|NCT01958827|5668707|P1|COMPLETED|Overall Study||18
2309270|NCT01958827|5668707|P1|STARTED|Overall Study||28
2309271|NCT01958788|5668725|P1|NOT COMPLETED|Overall Study||0
2309272|NCT01958788|5668725|P1|COMPLETED|Overall Study||7
2309273|NCT01958788|5668725|P1|STARTED|Overall Study||7
2309274|NCT01958671|5668738|P3|NOT COMPLETED|Overall Study||32
2309275|NCT01958671|5668739|P2|NOT COMPLETED|Overall Study||24
2309276|NCT01958671|5668740|P1|NOT COMPLETED|Overall Study||19
2309277|NCT01958671|5668738|P3|COMPLETED|Overall Study||121
2309278|NCT01958671|5668739|P2|COMPLETED|Overall Study||128
2309279|NCT01958671|5668740|P1|COMPLETED|Overall Study||137
2309280|NCT01958671|5668738|P3|STARTED|Overall Study||153
2309281|NCT01958671|5668739|P2|STARTED|Overall Study||152
2309282|NCT01958671|5668740|P1|STARTED|Overall Study||156
2309283|NCT01958645|5668784|P3|NOT COMPLETED|Overall Study||0
2309284|NCT01958645|5668785|P2|NOT COMPLETED|Overall Study||0
2309285|NCT01958645|5668786|P1|NOT COMPLETED|Overall Study||0
2309286|NCT01958645|5668784|P3|COMPLETED|Overall Study||4
2309287|NCT01958645|5668785|P2|COMPLETED|Overall Study||4
2309288|NCT01958645|5668786|P1|COMPLETED|Overall Study||4
2309289|NCT01958645|5668784|P3|STARTED|Overall Study||4
2309290|NCT01958645|5668785|P2|STARTED|Overall Study||4
2309291|NCT01958645|5668786|P1|STARTED|Overall Study||4
2309292|NCT01958619|5668814|P4|NOT COMPLETED|Overall Study||0
2309293|NCT01958619|5668815|P3|NOT COMPLETED|Overall Study||1
2309294|NCT01958619|5668816|P2|NOT COMPLETED|Overall Study||0
2309295|NCT01958619|5668817|P1|NOT COMPLETED|Overall Study||2
2309296|NCT01958619|5668814|P4|COMPLETED|Overall Study||12
2309297|NCT01958619|5668815|P3|COMPLETED|Overall Study||13
2309298|NCT01958619|5668816|P2|COMPLETED|Overall Study||14
2309299|NCT01958619|5668817|P1|COMPLETED|Overall Study||13
2309300|NCT01958619|5668814|P4|STARTED|Overall Study||12
2309301|NCT01958619|5668815|P3|STARTED|Overall Study||14
2309302|NCT01958619|5668816|P2|STARTED|Overall Study||14
2309303|NCT01958619|5668817|P1|STARTED|Overall Study||15
2309304|NCT01958606|5668839|P2|NOT COMPLETED|Overall Study||0
2309305|NCT01958606|5668840|P1|NOT COMPLETED|Overall Study||2
2309306|NCT01958606|5668839|P2|COMPLETED|Overall Study||5
2309307|NCT01958606|5668840|P1|COMPLETED|Overall Study||11
2309308|NCT01958606|5668839|P2|STARTED|Overall Study||5
2309309|NCT01958606|5668840|P1|STARTED|Overall Study||13
2309310|NCT01958489|5668878|P2|NOT COMPLETED|Period 2||1
2309311|NCT01958489|5668879|P1|NOT COMPLETED|Period 2||0
2309312|NCT01958489|5668878|P2|COMPLETED|Period 2||23
2309313|NCT01958489|5668879|P1|COMPLETED|Period 2||0
2309314|NCT01958489|5668878|P2|Received at Least 1 Dose of Study Drug|Period 2||24
2309315|NCT01958489|5668879|P1|Received at Least 1 Dose of Study Drug|Period 2||0
2309316|NCT01958489|5668878|P2|STARTED|Period 2|Participants who started Period 2 treatment crossed over from Period 1 treatment|24
2309317|NCT01958489|5668879|P1|STARTED|Period 2|Participants who completed Period 1 treatment crossed over to Period 2 treatment|0
2309318|NCT01958489|5668878|P2|NOT COMPLETED|Period 1||0
2309319|NCT01958489|5668879|P1|NOT COMPLETED|Period 1||0
2309320|NCT01958489|5668878|P2|COMPLETED|Period 1||0
2309321|NCT01958489|5668879|P1|COMPLETED|Period 1||24
2309322|NCT01958489|5668878|P2|Received at Least 1 Dose of Study Drug|Period 1||0
2309323|NCT01958489|5668879|P1|Received at Least 1 Dose of Study Drug|Period 1||24
2309324|NCT01958489|5668878|P2|STARTED|Period 1||0
2309325|NCT01958489|5668879|P1|STARTED|Period 1||24
2309326|NCT01958476|5668895|P2|NOT COMPLETED|Overall Study||0
2309327|NCT01958476|5668896|P1|NOT COMPLETED|Overall Study||1
2309328|NCT01958476|5668895|P2|COMPLETED|Overall Study||58
2309329|NCT01958476|5668896|P1|COMPLETED|Overall Study||58
2309330|NCT01958476|5668895|P2|STARTED|Overall Study||58
2309331|NCT01958476|5668896|P1|STARTED|Overall Study||59
2309332|NCT01958437|5668926|P4|NOT COMPLETED|Overall Study||1
2309333|NCT01958437|5668927|P3|NOT COMPLETED|Overall Study||1
2309334|NCT01958437|5668928|P2|NOT COMPLETED|Overall Study||0
2309335|NCT01958437|5668929|P1|NOT COMPLETED|Overall Study||0
2309336|NCT01958437|5668926|P4|COMPLETED|Overall Study||10
2309337|NCT01958437|5668927|P3|COMPLETED|Overall Study||10
2309338|NCT01958437|5668928|P2|COMPLETED|Overall Study||11
2309339|NCT01958437|5668929|P1|COMPLETED|Overall Study||11
2309340|NCT01958437|5668926|P4|STARTED|Overall Study||11
2309341|NCT01958437|5668927|P3|STARTED|Overall Study||11
2309342|NCT01958437|5668928|P2|STARTED|Overall Study||11
2309343|NCT01958437|5668929|P1|STARTED|Overall Study||11
2309344|NCT01958346|5668953|P2|NOT COMPLETED|Overall Study||0
2309345|NCT01958346|5668954|P1|NOT COMPLETED|Overall Study||0
2309346|NCT01958346|5668953|P2|COMPLETED|Overall Study||39
2309347|NCT01958346|5668954|P1|COMPLETED|Overall Study||39
2309348|NCT01958346|5668953|P2|STARTED|Overall Study||39
2309349|NCT01958346|5668954|P1|STARTED|Overall Study||39
2309350|NCT01958320|5668964|P2|NOT COMPLETED|Overall Study||0
2309351|NCT01958320|5668965|P1|NOT COMPLETED|Overall Study||0
2309352|NCT01958320|5668964|P2|COMPLETED|Overall Study||98
2309353|NCT01958320|5668965|P1|COMPLETED|Overall Study||104
2309354|NCT01958320|5668964|P2|STARTED|Overall Study||98
2309355|NCT01958320|5668965|P1|STARTED|Overall Study||104
2309356|NCT01958294|5668993|P1|NOT COMPLETED|Overall Study||2
2309357|NCT01958294|5668993|P1|COMPLETED|Overall Study||10
2309358|NCT01958294|5668993|P1|STARTED|Overall Study||12
2309359|NCT01958281|5669002|P3|NOT COMPLETED|Overall Study||0
2309360|NCT01958281|5669003|P2|NOT COMPLETED|Overall Study||4
2309361|NCT01958281|5669004|P1|NOT COMPLETED|Overall Study||6
2309362|NCT01958281|5669002|P3|COMPLETED|Overall Study||18
2309363|NCT01958281|5669003|P2|COMPLETED|Overall Study||6
2309364|NCT01958281|5669004|P1|COMPLETED|Overall Study||4
2309365|NCT01958281|5669002|P3|STARTED|Overall Study||18
2309366|NCT01958281|5669003|P2|STARTED|Overall Study||10
2309367|NCT01958281|5669004|P1|STARTED|Overall Study||10
2309368|NCT01958164|5669080|P2|NOT COMPLETED|Overall Study||5
2309369|NCT01958164|5669081|P1|NOT COMPLETED|Overall Study||2
2309370|NCT01958164|5669080|P2|COMPLETED|Overall Study||5
2309371|NCT01958164|5669081|P1|COMPLETED|Overall Study||4
2309372|NCT01958164|5669080|P2|STARTED|Overall Study|Randomised and treated|10
2309373|NCT01958164|5669081|P1|STARTED|Overall Study|Randomised and treated|6
2309374|NCT01958125|5669096|P2|NOT COMPLETED|Overall Study||8
2309375|NCT01958125|5669097|P1|NOT COMPLETED|Overall Study||2
2309376|NCT01958125|5669096|P2|COMPLETED|Overall Study||44
2309377|NCT01958125|5669097|P1|COMPLETED|Overall Study||48
2309378|NCT01958125|5669096|P2|STARTED|Overall Study||52
2309379|NCT01958125|5669097|P1|STARTED|Overall Study||50
2309380|NCT01958112|5669111|P1|NOT COMPLETED|Overall Study||0
2309381|NCT01958112|5669111|P1|COMPLETED|Overall Study||14
2309382|NCT01958112|5669111|P1|STARTED|Overall Study||14
2309383|NCT01958060|5669125|P6|NOT COMPLETED|Overall Study||0
2309384|NCT01958060|5669126|P5|NOT COMPLETED|Overall Study||1
2309385|NCT01958060|5669127|P4|NOT COMPLETED|Overall Study||0
2309386|NCT01958060|5669128|P3|NOT COMPLETED|Overall Study||0
2309387|NCT01958060|5669129|P2|NOT COMPLETED|Overall Study||0
2309388|NCT01958060|5669130|P1|NOT COMPLETED|Overall Study||2
2309389|NCT01958060|5669125|P6|COMPLETED|Overall Study|One subject in the 100 mg iv dose group did not receive complete dose of trial medication.|1
2309390|NCT01958060|5669126|P5|COMPLETED|Overall Study|One subject in the 50 mg iv dose group did not receive complete dose of trial medication.|6
2309391|NCT01958060|5669127|P4|COMPLETED|Overall Study||5
2309392|NCT01958060|5669128|P3|COMPLETED|Overall Study||6
2309393|NCT01958060|5669129|P2|COMPLETED|Overall Study||6
2309394|NCT01958060|5669130|P1|COMPLETED|Overall Study||8
2309395|NCT01958060|5669125|P6|STARTED|Overall Study||1
2309396|NCT01958060|5669126|P5|STARTED|Overall Study||7
2309397|NCT01958060|5669127|P4|STARTED|Overall Study||5
2309398|NCT01958060|5669128|P3|STARTED|Overall Study||6
2309399|NCT01958060|5669129|P2|STARTED|Overall Study||6
2309400|NCT01958060|5669130|P1|STARTED|Overall Study||10
2309401|NCT01958021|5669155|P2|NOT COMPLETED|Overall Study||180
2309402|NCT01958021|5669156|P1|NOT COMPLETED|Overall Study||139
2309403|NCT01958021|5669155|P2|COMPLETED|Overall Study|Completed = Treatment ongoing|154
2309404|NCT01958021|5669156|P1|COMPLETED|Overall Study|Completed = Treatment ongoing|195
2309405|NCT01958021|5669155|P2|Patients Treated|Overall Study||330
2309406|NCT01958021|5669156|P1|Patients Treated|Overall Study||334
2309407|NCT01958021|5669155|P2|Patients Untreated|Overall Study||4
2309408|NCT01958021|5669156|P1|Patients Untreated|Overall Study||0
2309409|NCT01958021|5669155|P2|STARTED|Overall Study||334
2309410|NCT01958021|5669156|P1|STARTED|Overall Study||334
2309411|NCT01958008|5669168|P4|NOT COMPLETED|Overall Study||0
2309412|NCT01958008|5669169|P3|NOT COMPLETED|Overall Study||1
2309413|NCT01958008|5669170|P2|NOT COMPLETED|Overall Study||0
2309414|NCT01958008|5669171|P1|NOT COMPLETED|Overall Study||1
2309415|NCT01958008|5669168|P4|COMPLETED|Overall Study||21
2309416|NCT01958008|5669169|P3|COMPLETED|Overall Study||20
2309417|NCT01958008|5669170|P2|COMPLETED|Overall Study||21
2309418|NCT01958008|5669171|P1|COMPLETED|Overall Study||20
2309419|NCT01958008|5669168|P4|STARTED|Overall Study||21
2309420|NCT01958008|5669169|P3|STARTED|Overall Study||21
2309421|NCT01958008|5669170|P2|STARTED|Overall Study||21
2309422|NCT01958008|5669171|P1|STARTED|Overall Study||21
2309423|NCT01957930|5669201|P2|NOT COMPLETED|Overall Study||0
2309424|NCT01957930|5669202|P1|NOT COMPLETED|Overall Study||0
2309425|NCT01957930|5669201|P2|COMPLETED|Overall Study||37
2309426|NCT01957930|5669202|P1|COMPLETED|Overall Study||35
2309427|NCT01957930|5669201|P2|STARTED|Overall Study||37
2309428|NCT01957930|5669202|P1|STARTED|Overall Study||35
2309429|NCT01957865|5669211|P3|NOT COMPLETED|Overall Study||3
2309430|NCT01957865|5669212|P2|NOT COMPLETED|Overall Study||2
2309431|NCT01957865|5669213|P1|NOT COMPLETED|Overall Study||0
2309432|NCT01957865|5669211|P3|COMPLETED|Overall Study||19
2309433|NCT01957865|5669212|P2|COMPLETED|Overall Study||18
2309434|NCT01957865|5669213|P1|COMPLETED|Overall Study||21
2309435|NCT01957865|5669211|P3|STARTED|Overall Study||22
2309436|NCT01957865|5669212|P2|STARTED|Overall Study||20
2309437|NCT01957865|5669213|P1|STARTED|Overall Study||21
2309438|NCT01957787|5669224|P1|NOT COMPLETED|Overall Study||36
2309439|NCT01957787|5669224|P1|COMPLETED|Overall Study||95
2309440|NCT01957787|5669224|P1|Modified ITT (mITT) Population|Overall Study||128
2309441|NCT01957787|5669224|P1|Intent-to-Treat (ITT) Population|Overall Study||130
2309442|NCT01957787|5669224|P1|STARTED|Overall Study|Participant who was withdrawn prior to study treatment was not included in Number of Index Tumors.|131
2309443|NCT01957761|5669239|P1|NOT COMPLETED|Overall Study||0
2309444|NCT01957761|5669239|P1|COMPLETED|Overall Study||189
2309445|NCT01957761|5669239|P1|STARTED|Overall Study||189
2309446|NCT01957709|5669243|P1|NOT COMPLETED|Overall Study||1
2309447|NCT01957709|5669243|P1|COMPLETED|Overall Study||7
2309448|NCT01957709|5669243|P1|STARTED|Overall Study||8
2309449|NCT01957657|5669249|P1|NOT COMPLETED|Overall Study||0
2309450|NCT01957657|5669249|P1|COMPLETED|Overall Study||4
2309451|NCT01957657|5669249|P1|STARTED|Overall Study||4
2309452|NCT01957644|5669268|P5|NOT COMPLETED|Overall Study||1
2309453|NCT01957644|5669269|P4|NOT COMPLETED|Overall Study||2
2309454|NCT01957644|5669270|P3|NOT COMPLETED|Overall Study||1
2309455|NCT01957644|5669271|P2|NOT COMPLETED|Overall Study||6
2309456|NCT01957644|5669272|P1|NOT COMPLETED|Overall Study||6
2309457|NCT01957644|5669268|P5|COMPLETED|Overall Study||0
2309458|NCT01957644|5669269|P4|COMPLETED|Overall Study||0
2309459|NCT01957644|5669270|P3|COMPLETED|Overall Study||0
2309460|NCT01957644|5669271|P2|COMPLETED|Overall Study||0
2309461|NCT01957644|5669272|P1|COMPLETED|Overall Study||0
2309462|NCT01957644|5669268|P5|STARTED|Overall Study||1
2309463|NCT01957644|5669269|P4|STARTED|Overall Study||2
2309464|NCT01957644|5669270|P3|STARTED|Overall Study||1
2309465|NCT01957644|5669271|P2|STARTED|Overall Study||6
2309466|NCT01957644|5669272|P1|STARTED|Overall Study||6
2309467|NCT01957579|5669296|P4|NOT COMPLETED|Overall Study||0
2309468|NCT01957579|5669297|P3|NOT COMPLETED|Overall Study||2
2309469|NCT01957579|5669298|P2|NOT COMPLETED|Overall Study||1
2309470|NCT01957579|5669299|P1|NOT COMPLETED|Overall Study||0
2309471|NCT01957579|5669296|P4|COMPLETED|Overall Study||6
2309472|NCT01957579|5669297|P3|COMPLETED|Overall Study||2
2309473|NCT01957579|5669298|P2|COMPLETED|Overall Study||6
2309474|NCT01957579|5669299|P1|COMPLETED|Overall Study||3
2309475|NCT01957579|5669296|P4|STARTED|Overall Study||6
2309476|NCT01957579|5669297|P3|STARTED|Overall Study||4
2309477|NCT01957579|5669298|P2|STARTED|Overall Study||7
2309478|NCT01957579|5669299|P1|STARTED|Overall Study||3
2309479|NCT01957553|5669366|P2|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||7
2309480|NCT01957553|5669367|P1|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||3
2309481|NCT01957553|5669366|P2|COMPLETED|Test Period 2 (21 +- 1 Days)||56
2309482|NCT01957553|5669367|P1|COMPLETED|Test Period 2 (21 +- 1 Days)||51
2309483|NCT01957553|5669366|P2|STARTED|Test Period 2 (21 +- 1 Days)||63
2309484|NCT01957553|5669367|P1|STARTED|Test Period 2 (21 +- 1 Days)||54
2309485|NCT01957553|5669366|P2|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||3
2309486|NCT01957553|5669367|P1|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||7
2309487|NCT01957553|5669366|P2|COMPLETED|Test Period 1 (21 +- 1 Days)||63
2309488|NCT01957553|5669367|P1|COMPLETED|Test Period 1 (21 +- 1 Days)||54
2309489|NCT01957553|5669366|P2|STARTED|Test Period 1 (21 +- 1 Days)||66
2309490|NCT01957553|5669367|P1|STARTED|Test Period 1 (21 +- 1 Days)||61
2309491|NCT01957488|5669373|P6|NOT COMPLETED|Test Period 3||0
2309492|NCT01957488|5669374|P5|NOT COMPLETED|Test Period 3||0
2309493|NCT01957488|5669375|P4|NOT COMPLETED|Test Period 3||0
2309494|NCT01957488|5669376|P3|NOT COMPLETED|Test Period 3||0
2309495|NCT01957488|5669377|P2|NOT COMPLETED|Test Period 3||1
2309496|NCT01957488|5669378|P1|NOT COMPLETED|Test Period 3||1
2309497|NCT01957488|5669373|P6|COMPLETED|Test Period 3||23
2309498|NCT01957488|5669374|P5|COMPLETED|Test Period 3||25
2309499|NCT01957488|5669375|P4|COMPLETED|Test Period 3||28
2309500|NCT01957488|5669376|P3|COMPLETED|Test Period 3||25
2309501|NCT01957488|5669377|P2|COMPLETED|Test Period 3||26
2309502|NCT01957488|5669378|P1|COMPLETED|Test Period 3||23
2309503|NCT01957488|5669373|P6|STARTED|Test Period 3||23
2309504|NCT01957488|5669374|P5|STARTED|Test Period 3||25
2309505|NCT01957488|5669375|P4|STARTED|Test Period 3||28
2309506|NCT01957488|5669376|P3|STARTED|Test Period 3||25
2309507|NCT01957488|5669377|P2|STARTED|Test Period 3||27
2309508|NCT01957488|5669378|P1|STARTED|Test Period 3||24
2309509|NCT01957488|5669373|P6|NOT COMPLETED|Test Period 2||1
2309510|NCT01957488|5669374|P5|NOT COMPLETED|Test Period 2||2
2309511|NCT01957488|5669375|P4|NOT COMPLETED|Test Period 2||1
2309512|NCT01957488|5669376|P3|NOT COMPLETED|Test Period 2||1
2309513|NCT01957488|5669377|P2|NOT COMPLETED|Test Period 2||1
2309514|NCT01957488|5669378|P1|NOT COMPLETED|Test Period 2||3
2309515|NCT01957488|5669373|P6|COMPLETED|Test Period 2||23
2309516|NCT01957488|5669374|P5|COMPLETED|Test Period 2||25
2309517|NCT01957488|5669375|P4|COMPLETED|Test Period 2||28
2309518|NCT01957488|5669376|P3|COMPLETED|Test Period 2||25
2309519|NCT01957488|5669377|P2|COMPLETED|Test Period 2||27
2309520|NCT01957488|5669378|P1|COMPLETED|Test Period 2||24
2309521|NCT01957488|5669373|P6|STARTED|Test Period 2||24
2309522|NCT01957488|5669374|P5|STARTED|Test Period 2||27
2309523|NCT01957488|5669375|P4|STARTED|Test Period 2||29
2309524|NCT01957488|5669376|P3|STARTED|Test Period 2||26
2309525|NCT01957488|5669377|P2|STARTED|Test Period 2||28
2309526|NCT01957488|5669378|P1|STARTED|Test Period 2||27
2309527|NCT01957488|5669373|P6|NOT COMPLETED|Test Period 1||6
2309528|NCT01957488|5669374|P5|NOT COMPLETED|Test Period 1||3
2309529|NCT01957488|5669375|P4|NOT COMPLETED|Test Period 1||3
2309530|NCT01957488|5669376|P3|NOT COMPLETED|Test Period 1||4
2309531|NCT01957488|5669377|P2|NOT COMPLETED|Test Period 1||3
2309532|NCT01957488|5669378|P1|NOT COMPLETED|Test Period 1||3
2309533|NCT01957488|5669373|P6|COMPLETED|Test Period 1||24
2309534|NCT01957488|5669374|P5|COMPLETED|Test Period 1||27
2309535|NCT01957488|5669375|P4|COMPLETED|Test Period 1||29
2309536|NCT01957488|5669376|P3|COMPLETED|Test Period 1||26
2309537|NCT01957488|5669377|P2|COMPLETED|Test Period 1||28
2309538|NCT01957488|5669378|P1|COMPLETED|Test Period 1||27
2309539|NCT01957488|5669373|P6|STARTED|Test Period 1||30
2309540|NCT01957488|5669374|P5|STARTED|Test Period 1||30
2309541|NCT01957488|5669375|P4|STARTED|Test Period 1||32
2309542|NCT01957488|5669376|P3|STARTED|Test Period 1||30
2309543|NCT01957488|5669377|P2|STARTED|Test Period 1||31
2309544|NCT01957488|5669378|P1|STARTED|Test Period 1||30
2309545|NCT01957475|5669386|P2|NOT COMPLETED|Test Period 2||0
2309546|NCT01957475|5669387|P1|NOT COMPLETED|Test Period 2||1
2309547|NCT01957475|5669386|P2|COMPLETED|Test Period 2||8
2309548|NCT01957475|5669387|P1|COMPLETED|Test Period 2||8
2309549|NCT01957475|5669386|P2|STARTED|Test Period 2||8
2309550|NCT01957475|5669387|P1|STARTED|Test Period 2||9
2309551|NCT01957475|5669386|P2|NOT COMPLETED|Test Period 1||1
2309552|NCT01957475|5669387|P1|NOT COMPLETED|Test Period 1||2
2309553|NCT01957475|5669386|P2|COMPLETED|Test Period 1||9
2309554|NCT01957475|5669387|P1|COMPLETED|Test Period 1||8
2309555|NCT01957475|5669386|P2|STARTED|Test Period 1||10
2309556|NCT01957475|5669387|P1|STARTED|Test Period 1||10
2309557|NCT01957462|5669393|P2|NOT COMPLETED|Test Period 2||0
2309558|NCT01957462|5669394|P1|NOT COMPLETED|Test Period 2||0
2309559|NCT01957462|5669393|P2|COMPLETED|Test Period 2||15
2309560|NCT01957462|5669394|P1|COMPLETED|Test Period 2||14
2309561|NCT01957462|5669393|P2|STARTED|Test Period 2||15
2309562|NCT01957462|5669394|P1|STARTED|Test Period 2||14
2309563|NCT01957462|5669393|P2|NOT COMPLETED|Test Period 1||0
2309564|NCT01957462|5669394|P1|NOT COMPLETED|Test Period 1||2
2309565|NCT01957462|5669393|P2|COMPLETED|Test Period 1||15
2309566|NCT01957462|5669394|P1|COMPLETED|Test Period 1||14
2309567|NCT01957462|5669393|P2|STARTED|Test Period 1||15
2309568|NCT01957462|5669394|P1|STARTED|Test Period 1||16
2309569|NCT01957410|5669400|P1|NOT COMPLETED|Optional Open Label||0
2309570|NCT01957410|5669400|P1|COMPLETED|Optional Open Label||13
2309571|NCT01957410|5669400|P1|STARTED|Optional Open Label||13
2309572|NCT01957410|5669400|P1|NOT COMPLETED|Open Label||0
2309573|NCT01957410|5669400|P1|COMPLETED|Open Label||13
2309574|NCT01957410|5669400|P1|STARTED|Open Label||13
2309575|NCT01957397|5669405|P2|NOT COMPLETED|Test Period 3||2
2309576|NCT01957397|5669406|P1|NOT COMPLETED|Test Period 3||2
2309577|NCT01957397|5669405|P2|COMPLETED|Test Period 3||9
2309578|NCT01957397|5669406|P1|COMPLETED|Test Period 3||9
2309579|NCT01957397|5669405|P2|STARTED|Test Period 3||11
2309580|NCT01957397|5669406|P1|STARTED|Test Period 3||11
2309581|NCT01957397|5669405|P2|NOT COMPLETED|Test Period 2||1
2309582|NCT01957397|5669406|P1|NOT COMPLETED|Test Period 2||0
2309583|NCT01957397|5669405|P2|COMPLETED|Test Period 2||11
2309584|NCT01957397|5669406|P1|COMPLETED|Test Period 2||11
2309585|NCT01957397|5669405|P2|STARTED|Test Period 2||12
2309586|NCT01957397|5669406|P1|STARTED|Test Period 2||11
2309587|NCT01957397|5669405|P2|NOT COMPLETED|Test Period 1||1
2309588|NCT01957397|5669406|P1|NOT COMPLETED|Test Period 1||2
2309589|NCT01957397|5669405|P2|COMPLETED|Test Period 1||12
2309590|NCT01957397|5669406|P1|COMPLETED|Test Period 1||11
2309591|NCT01957397|5669405|P2|STARTED|Test Period 1||13
2309592|NCT01957397|5669406|P1|STARTED|Test Period 1||13
2309593|NCT01957397|5669405|P2|NOT COMPLETED|Baseline Own Product||0
2309594|NCT01957397|5669406|P1|NOT COMPLETED|Baseline Own Product||0
2309595|NCT01957397|5669405|P2|COMPLETED|Baseline Own Product||13
2309596|NCT01957397|5669406|P1|COMPLETED|Baseline Own Product||13
2309597|NCT01957397|5669405|P2|STARTED|Baseline Own Product||13
2309598|NCT01957397|5669406|P1|STARTED|Baseline Own Product||13
2309599|NCT01957384|5669416|P6|NOT COMPLETED|Test Period 3 (14 Days)||0
2309600|NCT01957384|5669417|P5|NOT COMPLETED|Test Period 3 (14 Days)||0
2309601|NCT01957384|5669418|P4|NOT COMPLETED|Test Period 3 (14 Days)||0
2309602|NCT01957384|5669419|P3|NOT COMPLETED|Test Period 3 (14 Days)||0
2309603|NCT01957384|5669420|P2|NOT COMPLETED|Test Period 3 (14 Days)||0
2309604|NCT01957384|5669421|P1|NOT COMPLETED|Test Period 3 (14 Days)||0
2309605|NCT01957384|5669416|P6|COMPLETED|Test Period 3 (14 Days)||3
2309606|NCT01957384|5669417|P5|COMPLETED|Test Period 3 (14 Days)||3
2309607|NCT01957384|5669418|P4|COMPLETED|Test Period 3 (14 Days)||4
2309608|NCT01957384|5669419|P3|COMPLETED|Test Period 3 (14 Days)||4
2309609|NCT01957384|5669420|P2|COMPLETED|Test Period 3 (14 Days)||4
2309610|NCT01957384|5669421|P1|COMPLETED|Test Period 3 (14 Days)||4
2309611|NCT01957384|5669416|P6|STARTED|Test Period 3 (14 Days)||3
2309612|NCT01957384|5669417|P5|STARTED|Test Period 3 (14 Days)||3
2309613|NCT01957384|5669418|P4|STARTED|Test Period 3 (14 Days)||4
2309614|NCT01957384|5669419|P3|STARTED|Test Period 3 (14 Days)||4
2309615|NCT01957384|5669420|P2|STARTED|Test Period 3 (14 Days)||4
2309616|NCT01957384|5669421|P1|STARTED|Test Period 3 (14 Days)||4
2309617|NCT01957384|5669416|P6|NOT COMPLETED|Test Period 2 (14 Days)||0
2309618|NCT01957384|5669417|P5|NOT COMPLETED|Test Period 2 (14 Days)||0
2309619|NCT01957384|5669418|P4|NOT COMPLETED|Test Period 2 (14 Days)||0
2309620|NCT01957384|5669419|P3|NOT COMPLETED|Test Period 2 (14 Days)||0
2309621|NCT01957384|5669420|P2|NOT COMPLETED|Test Period 2 (14 Days)||0
2309622|NCT01957384|5669421|P1|NOT COMPLETED|Test Period 2 (14 Days)||0
2309623|NCT01957384|5669416|P6|COMPLETED|Test Period 2 (14 Days)||3
2309624|NCT01957384|5669417|P5|COMPLETED|Test Period 2 (14 Days)||3
2309625|NCT01957384|5669418|P4|COMPLETED|Test Period 2 (14 Days)||4
2309626|NCT01957384|5669419|P3|COMPLETED|Test Period 2 (14 Days)||4
2309627|NCT01957384|5669420|P2|COMPLETED|Test Period 2 (14 Days)||4
2309628|NCT01957384|5669421|P1|COMPLETED|Test Period 2 (14 Days)||4
2309629|NCT01957384|5669416|P6|STARTED|Test Period 2 (14 Days)||3
2309630|NCT01957384|5669417|P5|STARTED|Test Period 2 (14 Days)||3
2309631|NCT01957384|5669418|P4|STARTED|Test Period 2 (14 Days)||4
2309632|NCT01957384|5669419|P3|STARTED|Test Period 2 (14 Days)||4
2309633|NCT01957384|5669420|P2|STARTED|Test Period 2 (14 Days)||4
2309634|NCT01957384|5669421|P1|STARTED|Test Period 2 (14 Days)||4
2309635|NCT01957384|5669416|P6|NOT COMPLETED|Test Period 1 (14 Days)||0
2309636|NCT01957384|5669417|P5|NOT COMPLETED|Test Period 1 (14 Days)||0
2309637|NCT01957384|5669418|P4|NOT COMPLETED|Test Period 1 (14 Days)||0
2309638|NCT01957384|5669419|P3|NOT COMPLETED|Test Period 1 (14 Days)||0
2309639|NCT01957384|5669420|P2|NOT COMPLETED|Test Period 1 (14 Days)||0
2309640|NCT01957384|5669421|P1|NOT COMPLETED|Test Period 1 (14 Days)||0
2309641|NCT01957384|5669416|P6|COMPLETED|Test Period 1 (14 Days)||3
2309642|NCT01957384|5669417|P5|COMPLETED|Test Period 1 (14 Days)||3
2309643|NCT01957384|5669418|P4|COMPLETED|Test Period 1 (14 Days)||4
2309644|NCT01957384|5669419|P3|COMPLETED|Test Period 1 (14 Days)||4
2309645|NCT01957384|5669420|P2|COMPLETED|Test Period 1 (14 Days)||4
2309646|NCT01957384|5669421|P1|COMPLETED|Test Period 1 (14 Days)||4
2309647|NCT01957384|5669416|P6|STARTED|Test Period 1 (14 Days)||3
2309648|NCT01957384|5669417|P5|STARTED|Test Period 1 (14 Days)||3
2309649|NCT01957384|5669418|P4|STARTED|Test Period 1 (14 Days)||4
2309650|NCT01957384|5669419|P3|STARTED|Test Period 1 (14 Days)||4
2309651|NCT01957384|5669420|P2|STARTED|Test Period 1 (14 Days)||4
2309652|NCT01957384|5669421|P1|STARTED|Test Period 1 (14 Days)||4
2309653|NCT01957215|5669431|P2|NOT COMPLETED|Overall Study||12
2309654|NCT01957215|5669432|P1|NOT COMPLETED|Overall Study||13
2309655|NCT01957215|5669431|P2|COMPLETED|Overall Study||123
2309656|NCT01957215|5669432|P1|COMPLETED|Overall Study||122
2309657|NCT01957215|5669431|P2|STARTED|Overall Study||135
2309658|NCT01957215|5669432|P1|STARTED|Overall Study||135
2309659|NCT01957202|5669460|P18|NOT COMPLETED|Treatment Period 3 (8 Days)||0
2309660|NCT01957202|5669461|P17|NOT COMPLETED|Treatment Period 3 (8 Days)||1
2309661|NCT01957202|5669462|P16|NOT COMPLETED|Treatment Period 3 (8 Days)||0
2309662|NCT01957202|5669463|P15|NOT COMPLETED|Treatment Period 3 (8 Days)||0
2309663|NCT01957202|5669464|P14|NOT COMPLETED|Treatment Period 3 (8 Days)||0
2309664|NCT01957202|5669465|P13|NOT COMPLETED|Treatment Period 3 (8 Days)||0
2309665|NCT01957202|5669466|P12|NOT COMPLETED|Treatment Period 3 (8 Days)||0
2309666|NCT01957202|5669467|P11|NOT COMPLETED|Treatment Period 3 (8 Days)||0
2309667|NCT01957202|5669468|P10|NOT COMPLETED|Treatment Period 3 (8 Days)||0
2309668|NCT01957202|5669469|P9|NOT COMPLETED|Treatment Period 3 (8 Days)||0
2309669|NCT01957202|5669470|P8|NOT COMPLETED|Treatment Period 3 (8 Days)||0
2309670|NCT01957202|5669471|P7|NOT COMPLETED|Treatment Period 3 (8 Days)||0
2309671|NCT01957202|5669472|P6|NOT COMPLETED|Treatment Period 3 (8 Days)||0
2309672|NCT01957202|5669473|P5|NOT COMPLETED|Treatment Period 3 (8 Days)||0
2309673|NCT01957202|5669474|P4|NOT COMPLETED|Treatment Period 3 (8 Days)||0
2309674|NCT01957202|5669475|P3|NOT COMPLETED|Treatment Period 3 (8 Days)||0
2309675|NCT01957202|5669476|P2|NOT COMPLETED|Treatment Period 3 (8 Days)||0
2309676|NCT01957202|5669477|P1|NOT COMPLETED|Treatment Period 3 (8 Days)||0
2309677|NCT01957202|5669460|P18|COMPLETED|Treatment Period 3 (8 Days)||3
2309678|NCT01957202|5669461|P17|COMPLETED|Treatment Period 3 (8 Days)||4
2309679|NCT01957202|5669462|P16|COMPLETED|Treatment Period 3 (8 Days)||3
2309680|NCT01957202|5669463|P15|COMPLETED|Treatment Period 3 (8 Days)||6
2309681|NCT01957202|5669464|P14|COMPLETED|Treatment Period 3 (8 Days)||3
2309682|NCT01957202|5669465|P13|COMPLETED|Treatment Period 3 (8 Days)||3
2309683|NCT01957202|5669466|P12|COMPLETED|Treatment Period 3 (8 Days)||6
2309684|NCT01957202|5669467|P11|COMPLETED|Treatment Period 3 (8 Days)||3
2309685|NCT01957202|5669468|P10|COMPLETED|Treatment Period 3 (8 Days)||6
2309686|NCT01957202|5669469|P9|COMPLETED|Treatment Period 3 (8 Days)||3
2309687|NCT01957202|5669470|P8|COMPLETED|Treatment Period 3 (8 Days)||3
2309688|NCT01957202|5669471|P7|COMPLETED|Treatment Period 3 (8 Days)||3
2309689|NCT01957202|5669472|P6|COMPLETED|Treatment Period 3 (8 Days)||2
2309690|NCT01957202|5669473|P5|COMPLETED|Treatment Period 3 (8 Days)||3
2309691|NCT01957202|5669474|P4|COMPLETED|Treatment Period 3 (8 Days)||3
2309692|NCT01957202|5669475|P3|COMPLETED|Treatment Period 3 (8 Days)||6
2309693|NCT01957202|5669476|P2|COMPLETED|Treatment Period 3 (8 Days)||5
2309694|NCT01957202|5669477|P1|COMPLETED|Treatment Period 3 (8 Days)||3
2309695|NCT01957202|5669460|P18|STARTED|Treatment Period 3 (8 Days)||3
2309696|NCT01957202|5669461|P17|STARTED|Treatment Period 3 (8 Days)||5
2309697|NCT01957202|5669462|P16|STARTED|Treatment Period 3 (8 Days)||3
2309698|NCT01957202|5669463|P15|STARTED|Treatment Period 3 (8 Days)||6
2309699|NCT01957202|5669464|P14|STARTED|Treatment Period 3 (8 Days)||3
2309700|NCT01957202|5669465|P13|STARTED|Treatment Period 3 (8 Days)||3
2309701|NCT01957202|5669466|P12|STARTED|Treatment Period 3 (8 Days)||6
2309702|NCT01957202|5669467|P11|STARTED|Treatment Period 3 (8 Days)||3
2309703|NCT01957202|5669468|P10|STARTED|Treatment Period 3 (8 Days)||6
2309704|NCT01957202|5669469|P9|STARTED|Treatment Period 3 (8 Days)||3
2309705|NCT01957202|5669470|P8|STARTED|Treatment Period 3 (8 Days)||3
2309706|NCT01957202|5669471|P7|STARTED|Treatment Period 3 (8 Days)||3
2309707|NCT01957202|5669472|P6|STARTED|Treatment Period 3 (8 Days)||2
2309708|NCT01957202|5669473|P5|STARTED|Treatment Period 3 (8 Days)||3
2309709|NCT01957202|5669474|P4|STARTED|Treatment Period 3 (8 Days)||3
2309710|NCT01957202|5669475|P3|STARTED|Treatment Period 3 (8 Days)||6
2309711|NCT01957202|5669476|P2|STARTED|Treatment Period 3 (8 Days)||5
2309712|NCT01957202|5669477|P1|STARTED|Treatment Period 3 (8 Days)||3
2309713|NCT01957202|5669460|P18|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
2309714|NCT01957202|5669461|P17|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
2309715|NCT01957202|5669462|P16|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
2309716|NCT01957202|5669463|P15|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
2309717|NCT01957202|5669464|P14|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
2309718|NCT01957202|5669465|P13|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
2309719|NCT01957202|5669466|P12|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
2309720|NCT01957202|5669467|P11|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
2309721|NCT01957202|5669468|P10|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
2309722|NCT01957202|5669469|P9|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
2309723|NCT01957202|5669470|P8|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
2309724|NCT01957202|5669471|P7|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
2309725|NCT01957202|5669472|P6|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
2309726|NCT01957202|5669473|P5|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
2309727|NCT01957202|5669474|P4|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
2309728|NCT01957202|5669475|P3|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
2309729|NCT01957202|5669476|P2|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
2309730|NCT01957202|5669477|P1|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
2309731|NCT01957202|5669460|P18|COMPLETED|Washout Period 2 (14 to 28 Days)||3
2309732|NCT01957202|5669461|P17|COMPLETED|Washout Period 2 (14 to 28 Days)||5
2309733|NCT01957202|5669462|P16|COMPLETED|Washout Period 2 (14 to 28 Days)||3
2309734|NCT01957202|5669463|P15|COMPLETED|Washout Period 2 (14 to 28 Days)||6
2309735|NCT01957202|5669464|P14|COMPLETED|Washout Period 2 (14 to 28 Days)||3
2309736|NCT01957202|5669465|P13|COMPLETED|Washout Period 2 (14 to 28 Days)||3
2309737|NCT01957202|5669466|P12|COMPLETED|Washout Period 2 (14 to 28 Days)||6
2309738|NCT01957202|5669467|P11|COMPLETED|Washout Period 2 (14 to 28 Days)||3
2309739|NCT01957202|5669468|P10|COMPLETED|Washout Period 2 (14 to 28 Days)||6
2309740|NCT01957202|5669469|P9|COMPLETED|Washout Period 2 (14 to 28 Days)||3
2309741|NCT01957202|5669470|P8|COMPLETED|Washout Period 2 (14 to 28 Days)||3
2309742|NCT01957202|5669471|P7|COMPLETED|Washout Period 2 (14 to 28 Days)||3
2309743|NCT01957202|5669472|P6|COMPLETED|Washout Period 2 (14 to 28 Days)||2
2309744|NCT01957202|5669473|P5|COMPLETED|Washout Period 2 (14 to 28 Days)||3
2309745|NCT01957202|5669474|P4|COMPLETED|Washout Period 2 (14 to 28 Days)||3
2309746|NCT01957202|5669475|P3|COMPLETED|Washout Period 2 (14 to 28 Days)||6
2309747|NCT01957202|5669476|P2|COMPLETED|Washout Period 2 (14 to 28 Days)||5
2309748|NCT01957202|5669477|P1|COMPLETED|Washout Period 2 (14 to 28 Days)||3
2309749|NCT01957202|5669460|P18|STARTED|Washout Period 2 (14 to 28 Days)||3
2309750|NCT01957202|5669461|P17|STARTED|Washout Period 2 (14 to 28 Days)||5
2309751|NCT01957202|5669462|P16|STARTED|Washout Period 2 (14 to 28 Days)||3
2309752|NCT01957202|5669463|P15|STARTED|Washout Period 2 (14 to 28 Days)||6
2309753|NCT01957202|5669464|P14|STARTED|Washout Period 2 (14 to 28 Days)||3
2309754|NCT01957202|5669465|P13|STARTED|Washout Period 2 (14 to 28 Days)||3
2309755|NCT01957202|5669466|P12|STARTED|Washout Period 2 (14 to 28 Days)||6
2309756|NCT01957202|5669467|P11|STARTED|Washout Period 2 (14 to 28 Days)||3
2309757|NCT01957202|5669468|P10|STARTED|Washout Period 2 (14 to 28 Days)||6
2309758|NCT01957202|5669469|P9|STARTED|Washout Period 2 (14 to 28 Days)||3
2309759|NCT01957202|5669470|P8|STARTED|Washout Period 2 (14 to 28 Days)||3
2309760|NCT01957202|5669471|P7|STARTED|Washout Period 2 (14 to 28 Days)||3
2309761|NCT01957202|5669472|P6|STARTED|Washout Period 2 (14 to 28 Days)||2
2309762|NCT01957202|5669473|P5|STARTED|Washout Period 2 (14 to 28 Days)||3
2309763|NCT01957202|5669474|P4|STARTED|Washout Period 2 (14 to 28 Days)||3
2309764|NCT01957202|5669475|P3|STARTED|Washout Period 2 (14 to 28 Days)||6
2309765|NCT01957202|5669476|P2|STARTED|Washout Period 2 (14 to 28 Days)||5
2309766|NCT01957202|5669477|P1|STARTED|Washout Period 2 (14 to 28 Days)||3
2309767|NCT01957202|5669460|P18|NOT COMPLETED|Treatment Period 2 (8 Days)||0
2309768|NCT01957202|5669461|P17|NOT COMPLETED|Treatment Period 2 (8 Days)||1
2309769|NCT01957202|5669462|P16|NOT COMPLETED|Treatment Period 2 (8 Days)||0
2309770|NCT01957202|5669463|P15|NOT COMPLETED|Treatment Period 2 (8 Days)||0
2309771|NCT01957202|5669464|P14|NOT COMPLETED|Treatment Period 2 (8 Days)||0
2309772|NCT01957202|5669465|P13|NOT COMPLETED|Treatment Period 2 (8 Days)||0
2309773|NCT01957202|5669466|P12|NOT COMPLETED|Treatment Period 2 (8 Days)||0
2309774|NCT01957202|5669467|P11|NOT COMPLETED|Treatment Period 2 (8 Days)||0
2309775|NCT01957202|5669468|P10|NOT COMPLETED|Treatment Period 2 (8 Days)||0
2309776|NCT01957202|5669469|P9|NOT COMPLETED|Treatment Period 2 (8 Days)||0
2309777|NCT01957202|5669470|P8|NOT COMPLETED|Treatment Period 2 (8 Days)||0
2309778|NCT01957202|5669471|P7|NOT COMPLETED|Treatment Period 2 (8 Days)||0
2309779|NCT01957202|5669472|P6|NOT COMPLETED|Treatment Period 2 (8 Days)||0
2309780|NCT01957202|5669473|P5|NOT COMPLETED|Treatment Period 2 (8 Days)||0
2309781|NCT01957202|5669474|P4|NOT COMPLETED|Treatment Period 2 (8 Days)||0
2309782|NCT01957202|5669475|P3|NOT COMPLETED|Treatment Period 2 (8 Days)||0
2309783|NCT01957202|5669476|P2|NOT COMPLETED|Treatment Period 2 (8 Days)||1
2309784|NCT01957202|5669477|P1|NOT COMPLETED|Treatment Period 2 (8 Days)||0
2309785|NCT01957202|5669460|P18|COMPLETED|Treatment Period 2 (8 Days)||3
2309786|NCT01957202|5669461|P17|COMPLETED|Treatment Period 2 (8 Days)||5
2309787|NCT01957202|5669462|P16|COMPLETED|Treatment Period 2 (8 Days)||3
2309788|NCT01957202|5669463|P15|COMPLETED|Treatment Period 2 (8 Days)||6
2309789|NCT01957202|5669464|P14|COMPLETED|Treatment Period 2 (8 Days)||3
2309790|NCT01957202|5669465|P13|COMPLETED|Treatment Period 2 (8 Days)||3
2309791|NCT01957202|5669466|P12|COMPLETED|Treatment Period 2 (8 Days)||6
2309792|NCT01957202|5669467|P11|COMPLETED|Treatment Period 2 (8 Days)||3
2309793|NCT01957202|5669468|P10|COMPLETED|Treatment Period 2 (8 Days)||6
2309794|NCT01957202|5669469|P9|COMPLETED|Treatment Period 2 (8 Days)||3
2309795|NCT01957202|5669470|P8|COMPLETED|Treatment Period 2 (8 Days)||3
2309796|NCT01957202|5669471|P7|COMPLETED|Treatment Period 2 (8 Days)||3
2309797|NCT01957202|5669472|P6|COMPLETED|Treatment Period 2 (8 Days)||2
2309798|NCT01957202|5669473|P5|COMPLETED|Treatment Period 2 (8 Days)||3
2309799|NCT01957202|5669474|P4|COMPLETED|Treatment Period 2 (8 Days)||3
2309800|NCT01957202|5669475|P3|COMPLETED|Treatment Period 2 (8 Days)||6
2309801|NCT01957202|5669476|P2|COMPLETED|Treatment Period 2 (8 Days)||5
2309802|NCT01957202|5669477|P1|COMPLETED|Treatment Period 2 (8 Days)||3
2309803|NCT01957202|5669460|P18|STARTED|Treatment Period 2 (8 Days)||3
2309804|NCT01957202|5669461|P17|STARTED|Treatment Period 2 (8 Days)||6
2309805|NCT01957202|5669462|P16|STARTED|Treatment Period 2 (8 Days)||3
2309806|NCT01957202|5669463|P15|STARTED|Treatment Period 2 (8 Days)||6
2309807|NCT01957202|5669464|P14|STARTED|Treatment Period 2 (8 Days)||3
2309808|NCT01957202|5669465|P13|STARTED|Treatment Period 2 (8 Days)||3
2309809|NCT01957202|5669466|P12|STARTED|Treatment Period 2 (8 Days)||6
2309810|NCT01957202|5669467|P11|STARTED|Treatment Period 2 (8 Days)||3
2309811|NCT01957202|5669468|P10|STARTED|Treatment Period 2 (8 Days)||6
2309812|NCT01957202|5669469|P9|STARTED|Treatment Period 2 (8 Days)||3
2309813|NCT01957202|5669470|P8|STARTED|Treatment Period 2 (8 Days)||3
2309814|NCT01957202|5669471|P7|STARTED|Treatment Period 2 (8 Days)||3
2309815|NCT01957202|5669472|P6|STARTED|Treatment Period 2 (8 Days)||2
2309816|NCT01957202|5669473|P5|STARTED|Treatment Period 2 (8 Days)||3
2309817|NCT01957202|5669474|P4|STARTED|Treatment Period 2 (8 Days)||3
2309818|NCT01957202|5669475|P3|STARTED|Treatment Period 2 (8 Days)||6
2309819|NCT01957202|5669476|P2|STARTED|Treatment Period 2 (8 Days)||6
2309820|NCT01957202|5669477|P1|STARTED|Treatment Period 2 (8 Days)||3
2309821|NCT01957202|5669460|P18|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
2309822|NCT01957202|5669461|P17|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
2309823|NCT01957202|5669462|P16|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
2309824|NCT01957202|5669463|P15|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
2309825|NCT01957202|5669464|P14|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
2309826|NCT01957202|5669465|P13|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
2309827|NCT01957202|5669466|P12|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
2309828|NCT01957202|5669467|P11|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
2309829|NCT01957202|5669468|P10|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
2309830|NCT01957202|5669469|P9|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
2309831|NCT01957202|5669470|P8|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
2309832|NCT01957202|5669471|P7|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
2309833|NCT01957202|5669472|P6|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
2309834|NCT01957202|5669473|P5|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
2309835|NCT01957202|5669474|P4|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
2309836|NCT01957202|5669475|P3|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
2309837|NCT01957202|5669476|P2|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
2309838|NCT01957202|5669477|P1|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
2309839|NCT01957202|5669460|P18|COMPLETED|Washout Period 1 (14 to 28 Days)||3
2309840|NCT01957202|5669461|P17|COMPLETED|Washout Period 1 (14 to 28 Days)||6
2309841|NCT01957202|5669462|P16|COMPLETED|Washout Period 1 (14 to 28 Days)||3
2309842|NCT01957202|5669463|P15|COMPLETED|Washout Period 1 (14 to 28 Days)||6
2309843|NCT01957202|5669464|P14|COMPLETED|Washout Period 1 (14 to 28 Days)||3
2309844|NCT01957202|5669465|P13|COMPLETED|Washout Period 1 (14 to 28 Days)||3
2309845|NCT01957202|5669466|P12|COMPLETED|Washout Period 1 (14 to 28 Days)||6
2309846|NCT01957202|5669467|P11|COMPLETED|Washout Period 1 (14 to 28 Days)||3
2309847|NCT01957202|5669468|P10|COMPLETED|Washout Period 1 (14 to 28 Days)||6
2309848|NCT01957202|5669469|P9|COMPLETED|Washout Period 1 (14 to 28 Days)||3
2309849|NCT01957202|5669470|P8|COMPLETED|Washout Period 1 (14 to 28 Days)||3
2309850|NCT01957202|5669471|P7|COMPLETED|Washout Period 1 (14 to 28 Days)||3
2309851|NCT01957202|5669472|P6|COMPLETED|Washout Period 1 (14 to 28 Days)||2
2309852|NCT01957202|5669473|P5|COMPLETED|Washout Period 1 (14 to 28 Days)||3
2309853|NCT01957202|5669474|P4|COMPLETED|Washout Period 1 (14 to 28 Days)||3
2309854|NCT01957202|5669475|P3|COMPLETED|Washout Period 1 (14 to 28 Days)||6
2309855|NCT01957202|5669476|P2|COMPLETED|Washout Period 1 (14 to 28 Days)||6
2309856|NCT01957202|5669477|P1|COMPLETED|Washout Period 1 (14 to 28 Days)||3
2309857|NCT01957202|5669460|P18|STARTED|Washout Period 1 (14 to 28 Days)||3
2309858|NCT01957202|5669461|P17|STARTED|Washout Period 1 (14 to 28 Days)||6
2309859|NCT01957202|5669462|P16|STARTED|Washout Period 1 (14 to 28 Days)||3
2309860|NCT01957202|5669463|P15|STARTED|Washout Period 1 (14 to 28 Days)||6
2309861|NCT01957202|5669464|P14|STARTED|Washout Period 1 (14 to 28 Days)||3
2309862|NCT01957202|5669465|P13|STARTED|Washout Period 1 (14 to 28 Days)||3
2309863|NCT01957202|5669466|P12|STARTED|Washout Period 1 (14 to 28 Days)||6
2309864|NCT01957202|5669467|P11|STARTED|Washout Period 1 (14 to 28 Days)||3
2309865|NCT01957202|5669468|P10|STARTED|Washout Period 1 (14 to 28 Days)||6
2309866|NCT01957202|5669469|P9|STARTED|Washout Period 1 (14 to 28 Days)||3
2309867|NCT01957202|5669470|P8|STARTED|Washout Period 1 (14 to 28 Days)||3
2309868|NCT01957202|5669471|P7|STARTED|Washout Period 1 (14 to 28 Days)||3
2309869|NCT01957202|5669472|P6|STARTED|Washout Period 1 (14 to 28 Days)||2
2309870|NCT01957202|5669473|P5|STARTED|Washout Period 1 (14 to 28 Days)||3
2309871|NCT01957202|5669474|P4|STARTED|Washout Period 1 (14 to 28 Days)||3
2309872|NCT01957202|5669475|P3|STARTED|Washout Period 1 (14 to 28 Days)||6
2309873|NCT01957202|5669476|P2|STARTED|Washout Period 1 (14 to 28 Days)||6
2309874|NCT01957202|5669477|P1|STARTED|Washout Period 1 (14 to 28 Days)||3
2309875|NCT01957202|5669460|P18|NOT COMPLETED|Treatment Period 1 (8 Days)||0
2309876|NCT01957202|5669461|P17|NOT COMPLETED|Treatment Period 1 (8 Days)||0
2309877|NCT01957202|5669462|P16|NOT COMPLETED|Treatment Period 1 (8 Days)||0
2309878|NCT01957202|5669463|P15|NOT COMPLETED|Treatment Period 1 (8 Days)||0
2309879|NCT01957202|5669464|P14|NOT COMPLETED|Treatment Period 1 (8 Days)||0
2309880|NCT01957202|5669465|P13|NOT COMPLETED|Treatment Period 1 (8 Days)||0
2309881|NCT01957202|5669466|P12|NOT COMPLETED|Treatment Period 1 (8 Days)||0
2309882|NCT01957202|5669467|P11|NOT COMPLETED|Treatment Period 1 (8 Days)||0
2309883|NCT01957202|5669468|P10|NOT COMPLETED|Treatment Period 1 (8 Days)||0
2309884|NCT01957202|5669469|P9|NOT COMPLETED|Treatment Period 1 (8 Days)||0
2309885|NCT01957202|5669470|P8|NOT COMPLETED|Treatment Period 1 (8 Days)||0
2309886|NCT01957202|5669471|P7|NOT COMPLETED|Treatment Period 1 (8 Days)||0
2309887|NCT01957202|5669472|P6|NOT COMPLETED|Treatment Period 1 (8 Days)||0
2309888|NCT01957202|5669473|P5|NOT COMPLETED|Treatment Period 1 (8 Days)||0
2309889|NCT01957202|5669474|P4|NOT COMPLETED|Treatment Period 1 (8 Days)||0
2309890|NCT01957202|5669475|P3|NOT COMPLETED|Treatment Period 1 (8 Days)||0
2309891|NCT01957202|5669476|P2|NOT COMPLETED|Treatment Period 1 (8 Days)||0
2309892|NCT01957202|5669477|P1|NOT COMPLETED|Treatment Period 1 (8 Days)||0
2309893|NCT01957202|5669460|P18|COMPLETED|Treatment Period 1 (8 Days)||3
2309894|NCT01957202|5669461|P17|COMPLETED|Treatment Period 1 (8 Days)||6
2309895|NCT01957202|5669462|P16|COMPLETED|Treatment Period 1 (8 Days)||3
2309896|NCT01957202|5669463|P15|COMPLETED|Treatment Period 1 (8 Days)||6
2309897|NCT01957202|5669464|P14|COMPLETED|Treatment Period 1 (8 Days)||3
2309898|NCT01957202|5669465|P13|COMPLETED|Treatment Period 1 (8 Days)||3
2309899|NCT01957202|5669466|P12|COMPLETED|Treatment Period 1 (8 Days)||6
2309900|NCT01957202|5669467|P11|COMPLETED|Treatment Period 1 (8 Days)||3
2309901|NCT01957202|5669468|P10|COMPLETED|Treatment Period 1 (8 Days)||6
2309902|NCT01957202|5669469|P9|COMPLETED|Treatment Period 1 (8 Days)||3
2309903|NCT01957202|5669470|P8|COMPLETED|Treatment Period 1 (8 Days)||3
2309904|NCT01957202|5669471|P7|COMPLETED|Treatment Period 1 (8 Days)||3
2309905|NCT01957202|5669472|P6|COMPLETED|Treatment Period 1 (8 Days)||2
2309906|NCT01957202|5669473|P5|COMPLETED|Treatment Period 1 (8 Days)||3
2309907|NCT01957202|5669474|P4|COMPLETED|Treatment Period 1 (8 Days)||3
2309908|NCT01957202|5669475|P3|COMPLETED|Treatment Period 1 (8 Days)||6
2309909|NCT01957202|5669476|P2|COMPLETED|Treatment Period 1 (8 Days)||6
2309910|NCT01957202|5669477|P1|COMPLETED|Treatment Period 1 (8 Days)||3
2309911|NCT01957202|5669460|P18|STARTED|Treatment Period 1 (8 Days)||3
2309912|NCT01957202|5669461|P17|STARTED|Treatment Period 1 (8 Days)||6
2309913|NCT01957202|5669462|P16|STARTED|Treatment Period 1 (8 Days)||3
2309914|NCT01957202|5669463|P15|STARTED|Treatment Period 1 (8 Days)||6
2309915|NCT01957202|5669464|P14|STARTED|Treatment Period 1 (8 Days)||3
2309916|NCT01957202|5669465|P13|STARTED|Treatment Period 1 (8 Days)||3
2309917|NCT01957202|5669466|P12|STARTED|Treatment Period 1 (8 Days)||6
2309918|NCT01957202|5669467|P11|STARTED|Treatment Period 1 (8 Days)||3
2309919|NCT01957202|5669468|P10|STARTED|Treatment Period 1 (8 Days)||6
2309920|NCT01957202|5669469|P9|STARTED|Treatment Period 1 (8 Days)||3
2309921|NCT01957202|5669470|P8|STARTED|Treatment Period 1 (8 Days)||3
2309922|NCT01957202|5669471|P7|STARTED|Treatment Period 1 (8 Days)||3
2309923|NCT01957202|5669472|P6|STARTED|Treatment Period 1 (8 Days)||2
2309924|NCT01957202|5669473|P5|STARTED|Treatment Period 1 (8 Days)||3
2309925|NCT01957202|5669474|P4|STARTED|Treatment Period 1 (8 Days)||3
2309926|NCT01957202|5669475|P3|STARTED|Treatment Period 1 (8 Days)||6
2309927|NCT01957202|5669476|P2|STARTED|Treatment Period 1 (8 Days)||6
2309928|NCT01957202|5669477|P1|STARTED|Treatment Period 1 (8 Days)||3
2309929|NCT01957163|5669502|P3|NOT COMPLETED|Overall Study||18
2309930|NCT01957163|5669503|P2|NOT COMPLETED|Overall Study||11
2309931|NCT01957163|5669504|P1|NOT COMPLETED|Overall Study||15
2309932|NCT01957163|5669502|P3|COMPLETED|Overall Study||189
2309933|NCT01957163|5669503|P2|COMPLETED|Overall Study||195
2309934|NCT01957163|5669504|P1|COMPLETED|Overall Study||191
2309935|NCT01957163|5669502|P3|STARTED|Overall Study||207
2309936|NCT01957163|5669503|P2|STARTED|Overall Study||206
2309937|NCT01957163|5669504|P1|STARTED|Overall Study||206
2309938|NCT01957150|5669517|P2|NOT COMPLETED|Overall Study||58
2309939|NCT01957150|5669518|P1|NOT COMPLETED|Overall Study||55
2309940|NCT01957150|5669517|P2|COMPLETED|Overall Study||83
2309941|NCT01957150|5669518|P1|COMPLETED|Overall Study||87
2309942|NCT01957150|5669517|P2|STARTED|Overall Study||141
2309943|NCT01957150|5669518|P1|STARTED|Overall Study||142
2309944|NCT01957137|5669534|P1|NOT COMPLETED|No Stimulation||0
2309945|NCT01957137|5669534|P1|COMPLETED|No Stimulation||28
2309946|NCT01957137|5669534|P1|STARTED|No Stimulation|Following randomized portion, all subjects went through no stimulation for approximately 4 weeks.|28
2309947|NCT01957137|5669534|P1|NOT COMPLETED|Randomized Portion||2
2309948|NCT01957137|5669534|P1|COMPLETED|Randomized Portion||28
2309949|NCT01957137|5669534|P1|Cycling Parameter #3|Randomized Portion|Subjects received Cycling Parameter #3 for approximately 4 weeks.|28
2309950|NCT01957137|5669534|P1|Cycling Parameter #2|Randomized Portion|Subjects received Cycling Parameter #2 for approximately 4 weeks.|28
2309951|NCT01957137|5669534|P1|Cycling Parameter #1|Randomized Portion|Subjects received Cycling Parameter #1 for approximately 4 weeks.|30
2309952|NCT01957137|5669534|P1|Continuous Stimulation|Randomized Portion|Subjects received continuous stimulation for approximately 4 weeks.|29
2309953|NCT01957137|5669534|P1|STARTED|Randomized Portion||30
2309954|NCT01957111|5669564|P2|NOT COMPLETED|Overall Study||1
2309955|NCT01957111|5669565|P1|NOT COMPLETED|Overall Study||1
2309956|NCT01957111|5669564|P2|COMPLETED|Overall Study||15
2309957|NCT01957111|5669565|P1|COMPLETED|Overall Study||15
2309958|NCT01957111|5669564|P2|STARTED|Overall Study||16
2309959|NCT01957111|5669565|P1|STARTED|Overall Study||16
2309960|NCT01956773|5669575|P2|NOT COMPLETED|Overall Study||1
2309961|NCT01956773|5669576|P1|NOT COMPLETED|Overall Study||628
2309962|NCT01956773|5669575|P2|COMPLETED|Overall Study||99
2309963|NCT01956773|5669576|P1|COMPLETED|Overall Study||1892
2309964|NCT01956773|5669575|P2|STARTED|Overall Study||100
2309965|NCT01956773|5669576|P1|STARTED|Overall Study||2520
2309966|NCT01956435|5669587|P2|NOT COMPLETED|Overall Study||0
2309967|NCT01956435|5669588|P1|NOT COMPLETED|Overall Study||0
2309968|NCT01956435|5669587|P2|COMPLETED|Overall Study||3
2309969|NCT01956435|5669588|P1|COMPLETED|Overall Study||3
2309970|NCT01956435|5669587|P2|STARTED|Overall Study||3
2309971|NCT01956435|5669588|P1|STARTED|Overall Study||3
2309972|NCT01956240|5669597|P2|NOT COMPLETED|Overall Study||24
2309973|NCT01956240|5669598|P1|NOT COMPLETED|Overall Study||23
2309974|NCT01956240|5669597|P2|COMPLETED|Overall Study||25
2309975|NCT01956240|5669598|P1|COMPLETED|Overall Study||25
2309976|NCT01956240|5669597|P2|STARTED|Overall Study||49
2309977|NCT01956240|5669598|P1|STARTED|Overall Study||48
2309978|NCT01956123|5669608|P4|NOT COMPLETED|COS Cycle 3||2
2309979|NCT01956123|5669609|P3|NOT COMPLETED|COS Cycle 3||6
2309980|NCT01956123|5669610|P2|NOT COMPLETED|COS Cycle 3||0
2309981|NCT01956123|5669611|P1|NOT COMPLETED|COS Cycle 3||0
2309982|NCT01956123|5669608|P4|COMPLETED|COS Cycle 3||91
2309983|NCT01956123|5669609|P3|COMPLETED|COS Cycle 3||89
2309984|NCT01956123|5669610|P2|COMPLETED|COS Cycle 3||0
2309985|NCT01956123|5669611|P1|COMPLETED|COS Cycle 3||0
2309986|NCT01956123|5669608|P4|STARTED|COS Cycle 3|Subjects in COS cycle 2 who failed to achieve an ongoing pregnancy could undergo COS cycle 3|93
2309987|NCT01956123|5669609|P3|STARTED|COS Cycle 3|Subjects in COS cycle 2 who failed to achieve an ongoing pregnancy could undergo COS cycle 3|95
2309988|NCT01956123|5669610|P2|STARTED|COS Cycle 3||0
2309989|NCT01956123|5669611|P1|STARTED|COS Cycle 3||0
2309990|NCT01956123|5669608|P4|NOT COMPLETED|COS Cycle 2||0
2309991|NCT01956123|5669609|P3|NOT COMPLETED|COS Cycle 2||0
2309992|NCT01956123|5669610|P2|NOT COMPLETED|COS Cycle 2||7
2309993|NCT01956123|5669611|P1|NOT COMPLETED|COS Cycle 2||14
2309994|NCT01956123|5669608|P4|COMPLETED|COS Cycle 2||0
2309995|NCT01956123|5669609|P3|COMPLETED|COS Cycle 2||0
2309996|NCT01956123|5669610|P2|COMPLETED|COS Cycle 2||254
2309997|NCT01956123|5669611|P1|COMPLETED|COS Cycle 2||238
2309998|NCT01956123|5669608|P4|STARTED|COS Cycle 2||0
2309999|NCT01956123|5669609|P3|STARTED|COS Cycle 2||0
2310000|NCT01956123|5669610|P2|STARTED|COS Cycle 2||261
2310001|NCT01956123|5669611|P1|STARTED|COS Cycle 2||252
2310002|NCT01956110|5669663|P2|NOT COMPLETED|Overall Study||22
2310003|NCT01956110|5669664|P1|NOT COMPLETED|Overall Study||35
2310004|NCT01956110|5669663|P2|COMPLETED|Overall Study||639
2310005|NCT01956110|5669664|P1|COMPLETED|Overall Study||630
2310006|NCT01956110|5669663|P2|STARTED|Overall Study||661
2310007|NCT01956110|5669664|P1|STARTED|Overall Study||665
2310008|NCT01956097|5669717|P3|NOT COMPLETED|Overall Study||0
2310009|NCT01956097|5669718|P2|NOT COMPLETED|Overall Study||2
2310010|NCT01956097|5669719|P1|NOT COMPLETED|Overall Study||6
2310011|NCT01956097|5669717|P3|COMPLETED|Overall Study||15
2310012|NCT01956097|5669718|P2|COMPLETED|Overall Study||28
2310013|NCT01956097|5669719|P1|COMPLETED|Overall Study||24
2310014|NCT01956097|5669717|P3|STARTED|Overall Study||15
2310015|NCT01956097|5669718|P2|STARTED|Overall Study||30
2310016|NCT01956097|5669719|P1|STARTED|Overall Study||30
2310017|NCT01956071|5669736|P1|NOT COMPLETED|Overall Study||0
2310018|NCT01956071|5669736|P1|COMPLETED|Overall Study||44
2310019|NCT01956071|5669736|P1|STARTED|Overall Study||44
2310020|NCT01956032|5669740|P1|NOT COMPLETED|Overall Study||0
2310021|NCT01956032|5669740|P1|COMPLETED|Overall Study||15
2310022|NCT01956032|5669740|P1|STARTED|Overall Study||15
2310023|NCT01955954|5669787|P1|NOT COMPLETED|Overall Study||36
2310024|NCT01955954|5669787|P1|COMPLETED|Overall Study|12-months|33
2310025|NCT01955954|5669787|P1|Completed 6-month Assessement|Overall Study||42
2310026|NCT01955954|5669787|P1|Completed 2-month Assessment|Overall Study|Primary endpoint|46
2310027|NCT01955954|5669787|P1|Completed Post-treatment Assessement|Overall Study||48
2310028|NCT01955954|5669787|P1|Completed Treatment|Overall Study||53
2310029|NCT01955954|5669787|P1|Received Treatment|Overall Study||66
2310030|NCT01955954|5669787|P1|STARTED|Overall Study||69
2310031|NCT01955733|5669799|P3|NOT COMPLETED|Period 2||21
2310032|NCT01955733|5669800|P2|NOT COMPLETED|Period 2||19
2310033|NCT01955733|5669801|P1|NOT COMPLETED|Period 2||12
2310034|NCT01955733|5669799|P3|COMPLETED|Period 2||8
2310035|NCT01955733|5669800|P2|COMPLETED|Period 2||10
2310036|NCT01955733|5669801|P1|COMPLETED|Period 2||20
2310037|NCT01955733|5669799|P3|STARTED|Period 2||29
2310038|NCT01955733|5669800|P2|STARTED|Period 2||29
2310039|NCT01955733|5669801|P1|STARTED|Period 2||32
2310040|NCT01955733|5669799|P3|NOT COMPLETED|Period 1||0
2310041|NCT01955733|5669800|P2|NOT COMPLETED|Period 1||0
2310042|NCT01955733|5669801|P1|NOT COMPLETED|Period 1||1
2310043|NCT01955733|5669799|P3|COMPLETED|Period 1||29
2310044|NCT01955733|5669800|P2|COMPLETED|Period 1||29
2310045|NCT01955733|5669801|P1|COMPLETED|Period 1||32
2310046|NCT01955733|5669799|P3|STARTED|Period 1||29
2310047|NCT01955733|5669800|P2|STARTED|Period 1||29
2310048|NCT01955733|5669801|P1|STARTED|Period 1||33
2310049|NCT01955720|5669821|P6|NOT COMPLETED|Overall Study||0
2310050|NCT01955720|5669822|P5|NOT COMPLETED|Overall Study||0
2310051|NCT01955720|5669823|P4|NOT COMPLETED|Overall Study||0
2310052|NCT01955720|5669824|P3|NOT COMPLETED|Overall Study||0
2310053|NCT01955720|5669825|P2|NOT COMPLETED|Overall Study||0
2310054|NCT01955720|5669826|P1|NOT COMPLETED|Overall Study||0
2310055|NCT01955720|5669821|P6|COMPLETED|Overall Study||7
2310056|NCT01955720|5669822|P5|COMPLETED|Overall Study||7
2310057|NCT01955720|5669823|P4|COMPLETED|Overall Study||3
2310058|NCT01955720|5669824|P3|COMPLETED|Overall Study||3
2310059|NCT01955720|5669825|P2|COMPLETED|Overall Study||13
2310060|NCT01955720|5669826|P1|COMPLETED|Overall Study||13
2310061|NCT01955720|5669821|P6|Subjects With Moderate Renal Impairment|Overall Study||0
2310062|NCT01955720|5669822|P5|Subjects With Moderate Renal Impairment|Overall Study||0
2310063|NCT01955720|5669823|P4|Subjects With Moderate Renal Impairment|Overall Study||0
2310064|NCT01955720|5669824|P3|Subjects With Moderate Renal Impairment|Overall Study||0
2310065|NCT01955720|5669825|P2|Subjects With Moderate Renal Impairment|Overall Study||3
2310066|NCT01955720|5669826|P1|Subjects With Moderate Renal Impairment|Overall Study||3
2310067|NCT01955720|5669821|P6|Subjects With Mild Renal Impairment|Overall Study||3
2310068|NCT01955720|5669822|P5|Subjects With Mild Renal Impairment|Overall Study||3
2310069|NCT01955720|5669823|P4|Subjects With Mild Renal Impairment|Overall Study||0
2310070|NCT01955720|5669824|P3|Subjects With Mild Renal Impairment|Overall Study||0
2310071|NCT01955720|5669825|P2|Subjects With Mild Renal Impairment|Overall Study||3
2310072|NCT01955720|5669826|P1|Subjects With Mild Renal Impairment|Overall Study||3
2310073|NCT01955720|5669821|P6|Healthy Subjects Aged 65-80|Overall Study||4
2310074|NCT01955720|5669822|P5|Healthy Subjects Aged 65-80|Overall Study||4
2310075|NCT01955720|5669823|P4|Healthy Subjects Aged 65-80|Overall Study||0
2310076|NCT01955720|5669824|P3|Healthy Subjects Aged 65-80|Overall Study||0
2310077|NCT01955720|5669825|P2|Healthy Subjects Aged 65-80|Overall Study||4
2310078|NCT01955720|5669826|P1|Healthy Subjects Aged 65-80|Overall Study||4
2310079|NCT01955720|5669821|P6|Healthy Subjects Aged 45-64|Overall Study||0
2310080|NCT01955720|5669822|P5|Healthy Subjects Aged 45-64|Overall Study||0
2310081|NCT01955720|5669823|P4|Healthy Subjects Aged 45-64|Overall Study||3
2310082|NCT01955720|5669824|P3|Healthy Subjects Aged 45-64|Overall Study||3
2310083|NCT01955720|5669825|P2|Healthy Subjects Aged 45-64|Overall Study||3
2310084|NCT01955720|5669826|P1|Healthy Subjects Aged 45-64|Overall Study||3
2310085|NCT01955720|5669821|P6|STARTED|Overall Study||7
2310086|NCT01955720|5669822|P5|STARTED|Overall Study||7
2310087|NCT01955720|5669823|P4|STARTED|Overall Study||3
2310088|NCT01955720|5669824|P3|STARTED|Overall Study||3
2310089|NCT01955720|5669825|P2|STARTED|Overall Study||13
2310090|NCT01955720|5669826|P1|STARTED|Overall Study||13
2310091|NCT01955707|5669894|P2|NOT COMPLETED|Overall Study||22
2310092|NCT01955707|5669895|P1|NOT COMPLETED|Overall Study||20
2310093|NCT01955707|5669894|P2|COMPLETED|Overall Study||57
2310094|NCT01955707|5669895|P1|COMPLETED|Overall Study||62
2310095|NCT01955707|5669894|P2|Received Total Volume of Study Drug|Overall Study||77
2310096|NCT01955707|5669895|P1|Received Total Volume of Study Drug|Overall Study||82
2310097|NCT01955707|5669894|P2|Dosed|Overall Study||78
2310098|NCT01955707|5669895|P1|Dosed|Overall Study||82
2310099|NCT01955707|5669894|P2|Withdrew Prior to Dosing|Overall Study||1
2310100|NCT01955707|5669895|P1|Withdrew Prior to Dosing|Overall Study||0
2310101|NCT01955707|5669894|P2|STARTED|Overall Study||79
2310102|NCT01955707|5669895|P1|STARTED|Overall Study||82
2310103|NCT01955629|5669919|P1|NOT COMPLETED|Overall Study||0
2310104|NCT01955629|5669919|P1|COMPLETED|Overall Study|1 participant with DP and 3 with unacceptable toxicity were considered completed as per protocol.|4
2310105|NCT01955629|5669919|P1|STARTED|Overall Study||4
2310106|NCT01955564|5669938|P7|NOT COMPLETED|Overall Study||0
2310107|NCT01955564|5669939|P6|NOT COMPLETED|Overall Study||0
2310108|NCT01955564|5669940|P5|NOT COMPLETED|Overall Study||0
2310109|NCT01955564|5669941|P4|NOT COMPLETED|Overall Study||0
2310110|NCT01955564|5669942|P3|NOT COMPLETED|Overall Study||0
2310111|NCT01955564|5669943|P2|NOT COMPLETED|Overall Study||0
2310112|NCT01955564|5669944|P1|NOT COMPLETED|Overall Study||0
2310113|NCT01955564|5669938|P7|COMPLETED|Overall Study||6
2310114|NCT01955564|5669939|P6|COMPLETED|Overall Study||6
2310115|NCT01955564|5669940|P5|COMPLETED|Overall Study||6
2310116|NCT01955564|5669941|P4|COMPLETED|Overall Study||6
2310117|NCT01955564|5669942|P3|COMPLETED|Overall Study||6
2310118|NCT01955564|5669943|P2|COMPLETED|Overall Study||6
2310119|NCT01955564|5669944|P1|COMPLETED|Overall Study||18
2310120|NCT01955564|5669938|P7|STARTED|Overall Study||6
2310121|NCT01955564|5669939|P6|STARTED|Overall Study||6
2310122|NCT01955564|5669940|P5|STARTED|Overall Study||6
2310123|NCT01955564|5669941|P4|STARTED|Overall Study||6
2310124|NCT01955564|5669942|P3|STARTED|Overall Study||6
2310125|NCT01955564|5669943|P2|STARTED|Overall Study||6
2310126|NCT01955564|5669944|P1|STARTED|Overall Study||18
2310127|NCT01955473|5669977|P5|NOT COMPLETED|Overall Study||0
2310128|NCT01955473|5669978|P4|NOT COMPLETED|Overall Study||0
2310129|NCT01955473|5669979|P3|NOT COMPLETED|Overall Study||0
2310130|NCT01955473|5669980|P2|NOT COMPLETED|Overall Study||0
2310131|NCT01955473|5669981|P1|NOT COMPLETED|Overall Study||0
2310132|NCT01955473|5669977|P5|COMPLETED|Overall Study||30
2310133|NCT01955473|5669978|P4|COMPLETED|Overall Study||6
2310134|NCT01955473|5669979|P3|COMPLETED|Overall Study||6
2310135|NCT01955473|5669980|P2|COMPLETED|Overall Study||6
2310136|NCT01955473|5669981|P1|COMPLETED|Overall Study||3
2310137|NCT01955473|5669977|P5|STARTED|Overall Study||30
2310138|NCT01955473|5669978|P4|STARTED|Overall Study||6
2310139|NCT01955473|5669979|P3|STARTED|Overall Study||6
2310140|NCT01955473|5669980|P2|STARTED|Overall Study||6
2310141|NCT01955473|5669981|P1|STARTED|Overall Study||3
2310142|NCT01955434|5670135|P1|NOT COMPLETED|Overall Study||0
2310143|NCT01955434|5670135|P1|COMPLETED|Overall Study||25
2310144|NCT01955434|5670135|P1|STARTED|Overall Study||25
2310145|NCT01955382|5670145|P2|NOT COMPLETED|Overall Study||0
2310146|NCT01955382|5670146|P1|NOT COMPLETED|Overall Study||0
2310147|NCT01955382|5670145|P2|COMPLETED|Overall Study||35
2310148|NCT01955382|5670146|P1|COMPLETED|Overall Study||35
2310149|NCT01955382|5670145|P2|STARTED|Overall Study||35
2310150|NCT01955382|5670146|P1|STARTED|Overall Study||35
2310151|NCT01955369|5670154|P1|NOT COMPLETED|Overall Study||0
2310152|NCT01955369|5670154|P1|COMPLETED|Overall Study||200
2310153|NCT01955369|5670154|P1|STARTED|Overall Study||200
2310154|NCT01955161|5670163|P3|NOT COMPLETED|Overall Study||35
2310155|NCT01955161|5670164|P2|NOT COMPLETED|Overall Study||25
2310156|NCT01955161|5670165|P1|NOT COMPLETED|Overall Study||27
2310157|NCT01955161|5670163|P3|COMPLETED|Overall Study||275
2310158|NCT01955161|5670164|P2|COMPLETED|Overall Study||288
2310159|NCT01955161|5670165|P1|COMPLETED|Overall Study||283
2310160|NCT01955161|5670163|P3|Treated|Overall Study||309
2310161|NCT01955161|5670164|P2|Treated|Overall Study||313
2310162|NCT01955161|5670165|P1|Treated|Overall Study||308
2310163|NCT01955161|5670163|P3|STARTED|Overall Study||310
2310164|NCT01955161|5670164|P2|STARTED|Overall Study||313
2310165|NCT01955161|5670165|P1|STARTED|Overall Study||310
2310166|NCT01955122|5670205|P2|NOT COMPLETED|Overall Study||5
2310167|NCT01955122|5670206|P1|NOT COMPLETED|Overall Study||5
2310168|NCT01955122|5670205|P2|COMPLETED|Overall Study||57
2310169|NCT01955122|5670206|P1|COMPLETED|Overall Study||59
2310170|NCT01955122|5670205|P2|No. Patients Completed Double Procedure|Overall Study||57
2310171|NCT01955122|5670206|P1|No. Patients Completed Double Procedure|Overall Study||59
2310172|NCT01955122|5670205|P2|No.Patients Enrolled|Overall Study||62
2310173|NCT01955122|5670206|P1|No.Patients Enrolled|Overall Study||64
2310174|NCT01955122|5670205|P2|STARTED|Overall Study|"Excluded (n = 5)~Included in analysis (n = 57)"|62
2310175|NCT01955122|5670206|P1|STARTED|Overall Study|"Excluded (n = 5)~Included in analysis (n = 59)"|64
2310176|NCT01955083|5670226|P2|NOT COMPLETED|Overall Study||1
2310177|NCT01955083|5670227|P1|NOT COMPLETED|Overall Study||1
2310178|NCT01955083|5670226|P2|COMPLETED|Overall Study||14
2310179|NCT01955083|5670227|P1|COMPLETED|Overall Study||14
2310180|NCT01955083|5670226|P2|STARTED|Overall Study||15
2310181|NCT01955083|5670227|P1|STARTED|Overall Study||15
2310182|NCT01955044|5670260|P3|NOT COMPLETED|Overall Study||0
2310183|NCT01955044|5670261|P2|NOT COMPLETED|Overall Study||1
2310184|NCT01955044|5670262|P1|NOT COMPLETED|Overall Study||1
2310185|NCT01955044|5670260|P3|COMPLETED|Overall Study||10
2310186|NCT01955044|5670261|P2|COMPLETED|Overall Study||9
2310187|NCT01955044|5670262|P1|COMPLETED|Overall Study||9
2310188|NCT01955044|5670260|P3|STARTED|Overall Study||10
2310189|NCT01955044|5670261|P2|STARTED|Overall Study||10
2310190|NCT01955044|5670262|P1|STARTED|Overall Study||10
2310191|NCT01955005|5670275|P2|NOT COMPLETED|Overall Study||5
2310192|NCT01955005|5670276|P1|NOT COMPLETED|Overall Study||3
2310193|NCT01955005|5670275|P2|COMPLETED|Overall Study||25
2310194|NCT01955005|5670276|P1|COMPLETED|Overall Study||27
2310195|NCT01955005|5670275|P2|STARTED|Overall Study||30
2310196|NCT01955005|5670276|P1|STARTED|Overall Study||30
2310197|NCT01954927|5670288|P2|NOT COMPLETED|Overall Study||1
2310198|NCT01954927|5670289|P1|NOT COMPLETED|Overall Study||3
2310199|NCT01954927|5670288|P2|COMPLETED|Overall Study||44
2310200|NCT01954927|5670289|P1|COMPLETED|Overall Study||42
2310201|NCT01954927|5670288|P2|STARTED|Overall Study||45
2310202|NCT01954927|5670289|P1|STARTED|Overall Study||45
2310203|NCT01954771|5670310|P3|NOT COMPLETED|Overall Study||3
2310204|NCT01954771|5670311|P2|NOT COMPLETED|Overall Study||3
2310205|NCT01954771|5670312|P1|NOT COMPLETED|Overall Study||7
2310206|NCT01954771|5670310|P3|COMPLETED|Overall Study||25
2310207|NCT01954771|5670311|P2|COMPLETED|Overall Study||29
2310208|NCT01954771|5670312|P1|COMPLETED|Overall Study||22
2310209|NCT01954771|5670310|P3|STARTED|Overall Study||28
2310210|NCT01954771|5670311|P2|STARTED|Overall Study||32
2310211|NCT01954771|5670312|P1|STARTED|Overall Study||29
2310212|NCT01954745|5670329|P1|NOT COMPLETED|Overall Study||19
2310213|NCT01954745|5670329|P1|COMPLETED|Overall Study||0
2310214|NCT01954745|5670329|P1|STARTED|Overall Study||19
2310215|NCT01954628|5670338|P2|NOT COMPLETED|Overall Study||27
2310216|NCT01954628|5670339|P1|NOT COMPLETED|Overall Study||31
2310217|NCT01954628|5670338|P2|COMPLETED|Overall Study||173
2310218|NCT01954628|5670339|P1|COMPLETED|Overall Study||169
2310219|NCT01954628|5670338|P2|US 6 Month Ophthalmology Safety Visit|Overall Study||32
2310220|NCT01954628|5670339|P1|US 6 Month Ophthalmology Safety Visit|Overall Study||37
2310221|NCT01954628|5670338|P2|Pharmacokinetic Population|Overall Study||0
2310222|NCT01954628|5670339|P1|Pharmacokinetic Population|Overall Study||181
2310223|NCT01954628|5670338|P2|Safety Set|Overall Study||200
2310224|NCT01954628|5670339|P1|Safety Set|Overall Study||200
2310225|NCT01954628|5670338|P2|Full Analysis Set (FAS)|Overall Study||198
2310226|NCT01954628|5670339|P1|Full Analysis Set (FAS)|Overall Study||200
2310227|NCT01954628|5670338|P2|STARTED|Overall Study||200
2310228|NCT01954628|5670339|P1|STARTED|Overall Study||200
2310229|NCT01954394|5670360|P2|NOT COMPLETED|Overall Study||57
2310230|NCT01954394|5670361|P1|NOT COMPLETED|Overall Study||30
2310231|NCT01954394|5670360|P2|COMPLETED|Overall Study||598
2310232|NCT01954394|5670361|P1|COMPLETED|Overall Study||301
2310233|NCT01954394|5670360|P2|Treated|Overall Study|Safety population|655
2310234|NCT01954394|5670361|P1|Treated|Overall Study|Safety population|330
2310235|NCT01954394|5670360|P2|STARTED|Overall Study|Enrolled|655
2310236|NCT01954394|5670361|P1|STARTED|Overall Study|Enrolled|331
2310237|NCT01954264|5670411|P1|NOT COMPLETED|Overall Study||0
2310238|NCT01954264|5670411|P1|COMPLETED|Overall Study||2421
2310239|NCT01954264|5670411|P1|STARTED|Overall Study||2421
2310240|NCT01954251|5670463|P2|NOT COMPLETED|Overall Study||19
2310241|NCT01954251|5670464|P1|NOT COMPLETED|Overall Study||13
2310242|NCT01954251|5670463|P2|COMPLETED|Overall Study||396
2310243|NCT01954251|5670464|P1|COMPLETED|Overall Study||400
2310244|NCT01954251|5670463|P2|STARTED|Overall Study||415
2310245|NCT01954251|5670464|P1|STARTED|Overall Study||413
2310246|NCT01954160|5670500|P2|NOT COMPLETED|Overall Study||0
2310247|NCT01954160|5670501|P1|NOT COMPLETED|Overall Study||5
2310248|NCT01954160|5670500|P2|COMPLETED|Overall Study||0
2310249|NCT01954160|5670501|P1|COMPLETED|Overall Study|Only 4 subjects completed the first early denervation. No subjects completed the late denervation.|0
2310250|NCT01954160|5670500|P2|STARTED|Overall Study|Not started|0
2310251|NCT01954160|5670501|P1|STARTED|Overall Study||5
2310252|NCT01954121|5670561|P2|NOT COMPLETED|Overall Study||91
2310253|NCT01954121|5670562|P1|NOT COMPLETED|Overall Study||127
2310254|NCT01954121|5670561|P2|COMPLETED|Overall Study||125
2310255|NCT01954121|5670562|P1|COMPLETED|Overall Study||93
2310256|NCT01954121|5670561|P2|STARTED|Overall Study||216
2310257|NCT01954121|5670562|P1|STARTED|Overall Study||220
2310258|NCT01954082|5670578|P2|NOT COMPLETED|Overall Study||57
2310259|NCT01954082|5670579|P1|NOT COMPLETED|Overall Study||68
2310260|NCT01954082|5670578|P2|COMPLETED|Overall Study|There were 27 infants that received more doses than intended per protocol.|264
2310261|NCT01954082|5670579|P1|COMPLETED|Overall Study|There were 22 infants that received more doses than intended per protocol.|249
2310262|NCT01954082|5670578|P2|Treated|Overall Study|The 2 participants who were not treated died before treatment start.|319
2310263|NCT01954082|5670579|P1|Treated|Overall Study|The 4 participants who were not treated either died (3) or withdrew before treatment start (1).|313
2310264|NCT01954082|5670578|P2|STARTED|Overall Study||321
2310265|NCT01954082|5670579|P1|STARTED|Overall Study||317
2310266|NCT01954056|5670599|P2|NOT COMPLETED|Birth to 22-26 Mos. Corrected GA||0
2310267|NCT01954056|5670600|P1|NOT COMPLETED|Birth to 22-26 Mos. Corrected GA||1
2310268|NCT01954056|5670599|P2|COMPLETED|Birth to 22-26 Mos. Corrected GA||6
2310269|NCT01954056|5670600|P1|COMPLETED|Birth to 22-26 Mos. Corrected GA||5
2310270|NCT01954056|5670599|P2|STARTED|Birth to 22-26 Mos. Corrected GA||6
2310271|NCT01954056|5670600|P1|STARTED|Birth to 22-26 Mos. Corrected GA||6
2310272|NCT01954056|5670599|P2|NOT COMPLETED|Birth to 60 Days of Life||0
2310273|NCT01954056|5670600|P1|NOT COMPLETED|Birth to 60 Days of Life||0
2310274|NCT01954056|5670599|P2|COMPLETED|Birth to 60 Days of Life||6
2310275|NCT01954056|5670600|P1|COMPLETED|Birth to 60 Days of Life||6
2310276|NCT01954056|5670599|P2|STARTED|Birth to 60 Days of Life||6
2310277|NCT01954056|5670600|P1|STARTED|Birth to 60 Days of Life||6
2310278|NCT01953913|5670642|P1|NOT COMPLETED|Overall Study||542
2310279|NCT01953913|5670642|P1|COMPLETED|Overall Study||0
2310280|NCT01953913|5670642|P1|Treated|Overall Study||541
2310281|NCT01953913|5670642|P1|STARTED|Overall Study||542
2310282|NCT01953874|5670650|P2|NOT COMPLETED|Overall Study||0
2310283|NCT01953874|5670651|P1|NOT COMPLETED|Overall Study||0
2310284|NCT01953874|5670650|P2|COMPLETED|Overall Study||61
2310285|NCT01953874|5670651|P1|COMPLETED|Overall Study||65
2310286|NCT01953874|5670650|P2|STARTED|Overall Study||61
2310287|NCT01953874|5670651|P1|STARTED|Overall Study||65
2310288|NCT01953601|5670697|P3|NOT COMPLETED|Part 2 (Extension Study)||204
2310289|NCT01953601|5670698|P2|NOT COMPLETED|Part 2 (Extension Study)||191
2310290|NCT01953601|5670699|P1|NOT COMPLETED|Part 2 (Extension Study)||198
2310291|NCT01953601|5670697|P3|COMPLETED|Part 2 (Extension Study)||0
2310292|NCT01953601|5670698|P2|COMPLETED|Part 2 (Extension Study)||0
2310293|NCT01953601|5670699|P1|COMPLETED|Part 2 (Extension Study)||0
2310294|NCT01953601|5670697|P3|Treated|Part 2 (Extension Study)||204
2310295|NCT01953601|5670698|P2|Treated|Part 2 (Extension Study)||191
2310296|NCT01953601|5670699|P1|Treated|Part 2 (Extension Study)||197
2310297|NCT01953601|5670697|P3|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|204
2310298|NCT01953601|5670698|P2|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|191
2310299|NCT01953601|5670699|P1|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|198
2310300|NCT01953601|5670697|P3|NOT COMPLETED|Part 1 (Base Study)||246
2310301|NCT01953601|5670698|P2|NOT COMPLETED|Part 1 (Base Study)||253
2310302|NCT01953601|5670699|P1|NOT COMPLETED|Part 1 (Base Study)||251
2310303|NCT01953601|5670697|P3|COMPLETED|Part 1 (Base Study)||239
2310304|NCT01953601|5670698|P2|COMPLETED|Part 1 (Base Study)||231
2310305|NCT01953601|5670699|P1|COMPLETED|Part 1 (Base Study)||234
2310306|NCT01953601|5670697|P3|Treated|Part 1 (Base Study)||484
2310307|NCT01953601|5670698|P2|Treated|Part 1 (Base Study)||484
2310308|NCT01953601|5670699|P1|Treated|Part 1 (Base Study)||483
2310309|NCT01953601|5670697|P3|STARTED|Part 1 (Base Study)||485
2310310|NCT01953601|5670698|P2|STARTED|Part 1 (Base Study)||484
2310311|NCT01953601|5670699|P1|STARTED|Part 1 (Base Study)||485
2310318|NCT01953354|5670757|P2|NOT COMPLETED|Overall Study||2
2310319|NCT01953354|5670758|P1|NOT COMPLETED|Overall Study||1
2310320|NCT01953354|5670757|P2|COMPLETED|Overall Study||5
2310321|NCT01953354|5670758|P1|COMPLETED|Overall Study||8
2310322|NCT01953354|5670757|P2|STARTED|Overall Study||7
2310323|NCT01953354|5670758|P1|STARTED|Overall Study||9
2310324|NCT01953328|5670786|P8|NOT COMPLETED|Overall Study||0
2310325|NCT01953328|5670787|P7|NOT COMPLETED|Overall Study||0
2310326|NCT01953328|5670788|P6|NOT COMPLETED|Overall Study||0
2310327|NCT01953328|5670789|P5|NOT COMPLETED|Overall Study||2
2310328|NCT01953328|5670790|P4|NOT COMPLETED|Overall Study||0
2310329|NCT01953328|5670791|P3|NOT COMPLETED|Overall Study||0
2310330|NCT01953328|5670792|P2|NOT COMPLETED|Overall Study||0
2310331|NCT01953328|5670793|P1|NOT COMPLETED|Overall Study||0
2310332|NCT01953328|5670786|P8|COMPLETED|Overall Study||51
2310333|NCT01953328|5670787|P7|COMPLETED|Overall Study||51
2310334|NCT01953328|5670788|P6|COMPLETED|Overall Study||51
2310335|NCT01953328|5670789|P5|COMPLETED|Overall Study||50
2310336|NCT01953328|5670790|P4|COMPLETED|Overall Study||50
2310337|NCT01953328|5670791|P3|COMPLETED|Overall Study||50
2310338|NCT01953328|5670792|P2|COMPLETED|Overall Study||50
2310339|NCT01953328|5670793|P1|COMPLETED|Overall Study||49
2310340|NCT01953328|5670786|P8|Received Treatment|Overall Study||51
2310341|NCT01953328|5670787|P7|Received Treatment|Overall Study||51
2310342|NCT01953328|5670788|P6|Received Treatment|Overall Study||51
2310343|NCT01953328|5670789|P5|Received Treatment|Overall Study||52
2310344|NCT01953328|5670790|P4|Received Treatment|Overall Study||50
2310345|NCT01953328|5670791|P3|Received Treatment|Overall Study||50
2310346|NCT01953328|5670792|P2|Received Treatment|Overall Study||50
2310347|NCT01953328|5670793|P1|Received Treatment|Overall Study||49
2310348|NCT01953328|5670786|P8|STARTED|Overall Study||51
2310349|NCT01953328|5670787|P7|STARTED|Overall Study||51
2310350|NCT01953328|5670788|P6|STARTED|Overall Study||51
2310351|NCT01953328|5670789|P5|STARTED|Overall Study||52
2310352|NCT01953328|5670790|P4|STARTED|Overall Study||50
2310353|NCT01953328|5670791|P3|STARTED|Overall Study||50
2310354|NCT01953328|5670792|P2|STARTED|Overall Study||50
2310355|NCT01953328|5670793|P1|STARTED|Overall Study||49
2310356|NCT01953237|5670997|P2|NOT COMPLETED|Overall Study||0
2310357|NCT01953237|5670998|P1|NOT COMPLETED|Overall Study||0
2310358|NCT01953237|5670997|P2|COMPLETED|Overall Study||21
2310359|NCT01953237|5670998|P1|COMPLETED|Overall Study||10
2310360|NCT01953237|5670997|P2|STARTED|Overall Study||21
2310361|NCT01953237|5670998|P1|STARTED|Overall Study||10
2310362|NCT01953224|5671006|P2|NOT COMPLETED|Overall Study||3
2310363|NCT01953224|5671007|P1|NOT COMPLETED|Overall Study||2
2310364|NCT01953224|5671006|P2|COMPLETED|Overall Study||17
2310365|NCT01953224|5671007|P1|COMPLETED|Overall Study||18
2310366|NCT01953224|5671006|P2|STARTED|Overall Study||20
2310367|NCT01953224|5671007|P1|STARTED|Overall Study||20
2310368|NCT01953211|5671023|P1|NOT COMPLETED|Overall Study||0
2310369|NCT01953211|5671023|P1|COMPLETED|Overall Study|completed prior to clinical trials submission|64
2310370|NCT01953211|5671023|P1|STARTED|Overall Study|completed prior to clinical trials submission|64
2310377|NCT01953003|5671056|P2|NOT COMPLETED|Overall Study||55
2310378|NCT01953003|5671057|P1|NOT COMPLETED|Overall Study||56
2310379|NCT01953003|5671056|P2|COMPLETED|Overall Study||1
2310380|NCT01953003|5671057|P1|COMPLETED|Overall Study||0
2310381|NCT01953003|5671056|P2|STARTED|Overall Study||56
2310382|NCT01953003|5671057|P1|STARTED|Overall Study||56
2310383|NCT01952834|5671063|P1|NOT COMPLETED|Overall Study||1
2310384|NCT01952834|5671063|P1|COMPLETED|Overall Study||20
2310385|NCT01952834|5671063|P1|STARTED|Overall Study||21
2310386|NCT01952691|5671070|P1|NOT COMPLETED|Overall Study||2
2310387|NCT01952691|5671070|P1|COMPLETED|Overall Study||20
2310388|NCT01952691|5671070|P1|STARTED|Overall Study||22
2310389|NCT01952678|5671078|P2|NOT COMPLETED|Overall Study||0
2310390|NCT01952678|5671079|P1|NOT COMPLETED|Overall Study||0
2310391|NCT01952678|5671078|P2|COMPLETED|Overall Study||102
2310392|NCT01952678|5671079|P1|COMPLETED|Overall Study||102
2310393|NCT01952678|5671078|P2|STARTED|Overall Study||102
2310394|NCT01952678|5671079|P1|STARTED|Overall Study||102
2310395|NCT01952665|5671097|P2|NOT COMPLETED|Overall Study||6
2310396|NCT01952665|5671098|P1|NOT COMPLETED|Overall Study||6
2310397|NCT01952665|5671097|P2|COMPLETED|Overall Study||20
2310398|NCT01952665|5671098|P1|COMPLETED|Overall Study||31
2310399|NCT01952665|5671097|P2|STARTED|Overall Study||26
2310400|NCT01952665|5671098|P1|STARTED|Overall Study||37
2310401|NCT01952600|5671239|P3|NOT COMPLETED|Overall Study||7
2310402|NCT01952600|5671240|P2|NOT COMPLETED|Overall Study||13
2310403|NCT01952600|5671241|P1|NOT COMPLETED|Overall Study||15
2310404|NCT01952600|5671239|P3|COMPLETED|Overall Study||38
2310405|NCT01952600|5671240|P2|COMPLETED|Overall Study||77
2310406|NCT01952600|5671241|P1|COMPLETED|Overall Study||65
2310407|NCT01952600|5671239|P3|STARTED|Overall Study||45
2310408|NCT01952600|5671240|P2|STARTED|Overall Study||90
2310409|NCT01952600|5671241|P1|STARTED|Overall Study||80
2310410|NCT01952574|5671253|P4|NOT COMPLETED|Overall Study||6
2310411|NCT01952574|5671254|P3|NOT COMPLETED|Overall Study||9
2310412|NCT01952574|5671255|P2|NOT COMPLETED|Overall Study||3
2310413|NCT01952574|5671256|P1|NOT COMPLETED|Overall Study||17
2310414|NCT01952574|5671253|P4|COMPLETED|Overall Study||101
2310415|NCT01952574|5671254|P3|COMPLETED|Overall Study||99
2310416|NCT01952574|5671255|P2|COMPLETED|Overall Study||105
2310417|NCT01952574|5671256|P1|COMPLETED|Overall Study||143
2310418|NCT01952574|5671253|P4|Received Study Drug|Overall Study||106
2310419|NCT01952574|5671254|P3|Received Study Drug|Overall Study||105
2310420|NCT01952574|5671255|P2|Received Study Drug|Overall Study||108
2310421|NCT01952574|5671256|P1|Received Study Drug|Overall Study||153
2310422|NCT01952574|5671253|P4|STARTED|Overall Study||107
2310423|NCT01952574|5671254|P3|STARTED|Overall Study||108
2310424|NCT01952574|5671255|P2|STARTED|Overall Study||108
2310425|NCT01952574|5671256|P1|STARTED|Overall Study||160
2310426|NCT01952470|5671276|P2|NOT COMPLETED|Overall Study||3
2310427|NCT01952470|5671277|P1|NOT COMPLETED|Overall Study||3
2310428|NCT01952470|5671276|P2|COMPLETED|Overall Study||13
2310429|NCT01952470|5671277|P1|COMPLETED|Overall Study||13
2310430|NCT01952470|5671276|P2|Missing 3 Month LCI 2% Data.|Overall Study||0
2310431|NCT01952470|5671277|P1|Missing 3 Month LCI 2% Data.|Overall Study||1
2310432|NCT01952470|5671276|P2|Missing 1+3 Month LCI 2% Data.|Overall Study||1
2310433|NCT01952470|5671277|P1|Missing 1+3 Month LCI 2% Data.|Overall Study||2
2310434|NCT01952470|5671276|P2|Missing Baseline LCI 2% Data.|Overall Study||2
2310435|NCT01952470|5671277|P1|Missing Baseline LCI 2% Data.|Overall Study||0
2310436|NCT01952470|5671276|P2|Death|Overall Study||1
2310437|NCT01952470|5671277|P1|Death|Overall Study||1
2310438|NCT01952470|5671276|P2|Discontinued Intervention|Overall Study||1
2310439|NCT01952470|5671277|P1|Discontinued Intervention|Overall Study||2
2310440|NCT01952470|5671276|P2|ITT Analysis|Overall Study||16
2310441|NCT01952470|5671277|P1|ITT Analysis|Overall Study||16
2310442|NCT01952470|5671276|P2|STARTED|Overall Study||16
2310443|NCT01952470|5671277|P1|STARTED|Overall Study||16
2310444|NCT01952444|5671315|P2|NOT COMPLETED|Overall Study||1
2310445|NCT01952444|5671316|P1|NOT COMPLETED|Overall Study||0
2310446|NCT01952444|5671315|P2|COMPLETED|Overall Study||19
2310447|NCT01952444|5671316|P1|COMPLETED|Overall Study||20
2310448|NCT01952444|5671315|P2|STARTED|Overall Study||20
2310449|NCT01952444|5671316|P1|STARTED|Overall Study||20
2310450|NCT01952418|5671342|P2|NOT COMPLETED|Overall Study||0
2310451|NCT01952418|5671343|P1|NOT COMPLETED|Overall Study||0
2310452|NCT01952418|5671342|P2|COMPLETED|Overall Study||895
2310453|NCT01952418|5671343|P1|COMPLETED|Overall Study||910
2310454|NCT01952418|5671342|P2|STARTED|Overall Study||895
2310455|NCT01952418|5671343|P1|STARTED|Overall Study||910
2310456|NCT01952366|5671355|P1|NOT COMPLETED|Overall Study||31
2310457|NCT01952366|5671355|P1|COMPLETED|Overall Study||138
2310458|NCT01952366|5671355|P1|STARTED|Overall Study||169
2310459|NCT01952301|5671362|P1|NOT COMPLETED|Overall Study||0
2310460|NCT01952301|5671362|P1|COMPLETED|Overall Study||30
2310461|NCT01952301|5671362|P1|STARTED|Overall Study|We designed and implemented a single-blind, randomized, controlled, split-mouth study of 30 subjects|30
2310462|NCT01952145|5671370|P2|NOT COMPLETED|Overall Study||14
2310463|NCT01952145|5671371|P1|NOT COMPLETED|Overall Study||28
2310464|NCT01952145|5671370|P2|COMPLETED|Overall Study||265
2310465|NCT01952145|5671371|P1|COMPLETED|Overall Study||250
2310466|NCT01952145|5671370|P2|STARTED|Overall Study||279
2310467|NCT01952145|5671371|P1|STARTED|Overall Study||278
2310468|NCT01952080|5671385|P4|NOT COMPLETED|Overall Study||1
2310469|NCT01952080|5671386|P3|NOT COMPLETED|Overall Study||0
2310470|NCT01952080|5671387|P2|NOT COMPLETED|Overall Study||1
2310471|NCT01952080|5671388|P1|NOT COMPLETED|Overall Study||0
2310472|NCT01952080|5671385|P4|COMPLETED|Overall Study||14
2310473|NCT01952080|5671386|P3|COMPLETED|Overall Study||14
2310474|NCT01952080|5671387|P2|COMPLETED|Overall Study||7
2310475|NCT01952080|5671388|P1|COMPLETED|Overall Study||5
2310476|NCT01952080|5671385|P4|Treated|Overall Study||15
2310477|NCT01952080|5671386|P3|Treated|Overall Study||14
2310478|NCT01952080|5671387|P2|Treated|Overall Study||8
2310479|NCT01952080|5671388|P1|Treated|Overall Study||5
2310480|NCT01952080|5671385|P4|STARTED|Overall Study||15
2310481|NCT01952080|5671386|P3|STARTED|Overall Study||14
2310482|NCT01952080|5671387|P2|STARTED|Overall Study||8
2310483|NCT01952080|5671388|P1|STARTED|Overall Study||5
2310484|NCT01952054|5671434|P1|NOT COMPLETED|Overall Study||1
2310485|NCT01952054|5671434|P1|COMPLETED|Overall Study||5
2310486|NCT01952054|5671434|P1|STARTED|Overall Study||6
2310487|NCT01952041|5671442|P2|NOT COMPLETED|Overall Study||21
2310488|NCT01952041|5671443|P1|NOT COMPLETED|Overall Study||17
2310489|NCT01952041|5671442|P2|COMPLETED|Overall Study||43
2310490|NCT01952041|5671443|P1|COMPLETED|Overall Study||45
2310491|NCT01952041|5671442|P2|STARTED|Overall Study||64
2310492|NCT01952041|5671443|P1|STARTED|Overall Study||62
2310493|NCT01952015|5671457|P1|NOT COMPLETED|Treatment Period 3||9
2310494|NCT01952015|5671457|P1|COMPLETED|Treatment Period 3||0
2310495|NCT01952015|5671457|P1|STARTED|Treatment Period 3||9
2310496|NCT01952015|5671457|P1|NOT COMPLETED|Maintenance||2
2310497|NCT01952015|5671457|P1|COMPLETED|Maintenance||9
2310498|NCT01952015|5671457|P1|STARTED|Maintenance||11
2310499|NCT01952015|5671457|P1|NOT COMPLETED|Induction||1
2310500|NCT01952015|5671457|P1|COMPLETED|Induction||11
2310501|NCT01952015|5671457|P1|STARTED|Induction||12
2310502|NCT01951963|5671480|P2|NOT COMPLETED|Overall Study||0
2310503|NCT01951963|5671481|P1|NOT COMPLETED|Overall Study||0
2310504|NCT01951963|5671480|P2|COMPLETED|Overall Study||32
2310505|NCT01951963|5671481|P1|COMPLETED|Overall Study||31
2310506|NCT01951963|5671480|P2|STARTED|Overall Study||32
2310507|NCT01951963|5671481|P1|STARTED|Overall Study||31
2310508|NCT01951950|5671493|P2|NOT COMPLETED|Overall Study||6
2310509|NCT01951950|5671494|P1|NOT COMPLETED|Overall Study||6
2310510|NCT01951950|5671493|P2|COMPLETED|Overall Study||20
2310511|NCT01951950|5671494|P1|COMPLETED|Overall Study||20
2310512|NCT01951950|5671493|P2|STARTED|Overall Study||26
2310513|NCT01951950|5671494|P1|STARTED|Overall Study||26
2310514|NCT01951820|5671502|P2|NOT COMPLETED|Overall Study||0
2310515|NCT01951820|5671503|P1|NOT COMPLETED|Overall Study||0
2310516|NCT01951820|5671502|P2|COMPLETED|Overall Study||30
2310517|NCT01951820|5671503|P1|COMPLETED|Overall Study||34
2310518|NCT01951820|5671502|P2|STARTED|Overall Study||30
2310519|NCT01951820|5671503|P1|STARTED|Overall Study||34
2310520|NCT01951768|5671511|P2|NOT COMPLETED|Overall Study||0
2310521|NCT01951768|5671512|P1|NOT COMPLETED|Overall Study||0
2310522|NCT01951768|5671511|P2|COMPLETED|Overall Study|45 patients|45
2310523|NCT01951768|5671512|P1|COMPLETED|Overall Study|43 patients|43
2310524|NCT01951768|5671511|P2|STARTED|Overall Study||45
2310525|NCT01951768|5671512|P1|STARTED|Overall Study||43
2310526|NCT01951703|5671524|P2|NOT COMPLETED|Second Intervention||2
2310527|NCT01951703|5671525|P1|NOT COMPLETED|Second Intervention||0
2310528|NCT01951703|5671524|P2|COMPLETED|Second Intervention||60
2310529|NCT01951703|5671525|P1|COMPLETED|Second Intervention||61
2310530|NCT01951703|5671524|P2|STARTED|Second Intervention||62
2310531|NCT01951703|5671525|P1|STARTED|Second Intervention||61
2310532|NCT01951703|5671524|P2|NOT COMPLETED|First Intervention||1
2310533|NCT01951703|5671525|P1|NOT COMPLETED|First Intervention||3
2310534|NCT01951703|5671524|P2|COMPLETED|First Intervention||62
2310535|NCT01951703|5671525|P1|COMPLETED|First Intervention||61
2310536|NCT01951703|5671524|P2|STARTED|First Intervention||63
2310537|NCT01951703|5671525|P1|STARTED|First Intervention||64
2310538|NCT01951651|5671535|P2|NOT COMPLETED|Overall Study||2
2310539|NCT01951651|5671536|P1|NOT COMPLETED|Overall Study||4
2310540|NCT01951651|5671535|P2|COMPLETED|Overall Study||10
2310541|NCT01951651|5671536|P1|COMPLETED|Overall Study||8
2310542|NCT01951651|5671535|P2|STARTED|Overall Study||12
2310543|NCT01951651|5671536|P1|STARTED|Overall Study||12
2310544|NCT01951586|5671550|P2|NOT COMPLETED|Overall Study||148
2310545|NCT01951586|5671551|P1|NOT COMPLETED|Overall Study||78
2310546|NCT01951586|5671550|P2|COMPLETED|Overall Study||0
2310547|NCT01951586|5671551|P1|COMPLETED|Overall Study||0
2310548|NCT01951586|5671550|P2|Received Study Drug|Overall Study||145
2310549|NCT01951586|5671551|P1|Received Study Drug|Overall Study||76
2310550|NCT01951586|5671550|P2|STARTED|Overall Study||148
2310551|NCT01951586|5671551|P1|STARTED|Overall Study||78
2310552|NCT01951573|5671575|P2|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
2310553|NCT01951573|5671576|P1|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
2310554|NCT01951573|5671575|P2|COMPLETED|Period 2, Second 9 Hours of Wear||16
2310555|NCT01951573|5671576|P1|COMPLETED|Period 2, Second 9 Hours of Wear||17
2310556|NCT01951573|5671575|P2|STARTED|Period 2, Second 9 Hours of Wear||16
2310557|NCT01951573|5671576|P1|STARTED|Period 2, Second 9 Hours of Wear||17
2310558|NCT01951573|5671575|P2|NOT COMPLETED|Washout Period||1
2310559|NCT01951573|5671576|P1|NOT COMPLETED|Washout Period||0
2310560|NCT01951573|5671575|P2|COMPLETED|Washout Period||16
2310561|NCT01951573|5671576|P1|COMPLETED|Washout Period||17
2310562|NCT01951573|5671575|P2|STARTED|Washout Period||17
2310563|NCT01951573|5671576|P1|STARTED|Washout Period||17
2310564|NCT01951573|5671575|P2|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
2310565|NCT01951573|5671576|P1|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
2310566|NCT01951573|5671575|P2|COMPLETED|Period 1, First 9 Hours of Wear||17
2310567|NCT01951573|5671576|P1|COMPLETED|Period 1, First 9 Hours of Wear||17
2310568|NCT01951573|5671575|P2|STARTED|Period 1, First 9 Hours of Wear||17
2310569|NCT01951573|5671576|P1|STARTED|Period 1, First 9 Hours of Wear||17
2310570|NCT01951417|5671586|P1|NOT COMPLETED|Overall Study||9
2310571|NCT01951417|5671586|P1|COMPLETED|Overall Study||72
2310572|NCT01951417|5671586|P1|STARTED|Overall Study||81
2310573|NCT01951391|5671611|P2|NOT COMPLETED|Overall Study||0
2310574|NCT01951391|5671612|P1|NOT COMPLETED|Overall Study||0
2310575|NCT01951391|5671611|P2|COMPLETED|Overall Study||5
2310576|NCT01951391|5671612|P1|COMPLETED|Overall Study||5
2310577|NCT01951391|5671611|P2|STARTED|Overall Study||5
2310578|NCT01951391|5671612|P1|STARTED|Overall Study||5
2310579|NCT01951352|5671620|P1|NOT COMPLETED|Overall Study||0
2310580|NCT01951352|5671620|P1|COMPLETED|Overall Study||10
2310581|NCT01951352|5671620|P1|STARTED|Overall Study||10
2310582|NCT01951339|5671629|P2|NOT COMPLETED|Overall Study||1
2310583|NCT01951339|5671630|P1|NOT COMPLETED|Overall Study||2
2310584|NCT01951339|5671629|P2|COMPLETED|Overall Study||14
2310585|NCT01951339|5671630|P1|COMPLETED|Overall Study||13
2310586|NCT01951339|5671629|P2|STARTED|Overall Study||15
2310587|NCT01951339|5671630|P1|STARTED|Overall Study||15
2310588|NCT01951170|5671652|P1|NOT COMPLETED|Overall Study||1
2310589|NCT01951170|5671652|P1|COMPLETED|Overall Study||51
2310590|NCT01951170|5671652|P1|STARTED|Overall Study||52
2310591|NCT01951157|5671678|P3|NOT COMPLETED|Overall Study||25
2310592|NCT01951157|5671679|P2|NOT COMPLETED|Overall Study||22
2310593|NCT01951157|5671680|P1|NOT COMPLETED|Overall Study||22
2310594|NCT01951157|5671678|P3|COMPLETED|Overall Study||0
2310595|NCT01951157|5671679|P2|COMPLETED|Overall Study||0
2310596|NCT01951157|5671680|P1|COMPLETED|Overall Study||0
2310597|NCT01951157|5671678|P3|STARTED|Overall Study||25
2310598|NCT01951157|5671679|P2|STARTED|Overall Study||22
2310599|NCT01951157|5671680|P1|STARTED|Overall Study||22
2310600|NCT01951105|5671712|P3|NOT COMPLETED|Overall Study||2
2310601|NCT01951105|5671713|P2|NOT COMPLETED|Overall Study||10
2310602|NCT01951105|5671714|P1|NOT COMPLETED|Overall Study||1
2310603|NCT01951105|5671712|P3|COMPLETED|Overall Study||28
2310604|NCT01951105|5671713|P2|COMPLETED|Overall Study||21
2310605|NCT01951105|5671714|P1|COMPLETED|Overall Study||10
2310606|NCT01951105|5671712|P3|Completed 12 Weeks Treatment|Overall Study||28
2310607|NCT01951105|5671713|P2|Completed 12 Weeks Treatment|Overall Study||24
2310608|NCT01951105|5671714|P1|Completed 12 Weeks Treatment|Overall Study||10
2310609|NCT01951105|5671712|P3|STARTED|Overall Study||30
2310610|NCT01951105|5671713|P2|STARTED|Overall Study||31
2310611|NCT01951105|5671714|P1|STARTED|Overall Study||11
2310612|NCT01951092|5671728|P1|NOT COMPLETED|Overall Study||12
2310613|NCT01951092|5671728|P1|COMPLETED|Overall Study||20
2310614|NCT01951092|5671728|P1|STARTED|Overall Study||32
2310615|NCT01951066|5671733|P2|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
2310616|NCT01951066|5671734|P1|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
2310617|NCT01951066|5671733|P2|COMPLETED|Second Intervention (Week 16 to Week 32)||10
2310618|NCT01951066|5671734|P1|COMPLETED|Second Intervention (Week 16 to Week 32)||10
2310619|NCT01951066|5671733|P2|STARTED|Second Intervention (Week 16 to Week 32)||10
2310620|NCT01951066|5671734|P1|STARTED|Second Intervention (Week 16 to Week 32)||10
2310621|NCT01951066|5671733|P2|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
2310622|NCT01951066|5671734|P1|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
2310623|NCT01951066|5671733|P2|COMPLETED|First Intervention (Baseline to Week 16)||10
2310624|NCT01951066|5671734|P1|COMPLETED|First Intervention (Baseline to Week 16)||10
2310625|NCT01951066|5671733|P2|STARTED|First Intervention (Baseline to Week 16)||10
2310626|NCT01951066|5671734|P1|STARTED|First Intervention (Baseline to Week 16)||10
2310627|NCT01950819|5671741|P2|NOT COMPLETED|Overall Study||134
2310628|NCT01950819|5671742|P1|NOT COMPLETED|Overall Study||129
2310629|NCT01950819|5671741|P2|COMPLETED|Overall Study||881
2310630|NCT01950819|5671742|P1|COMPLETED|Overall Study||893
2310631|NCT01950819|5671741|P2|STARTED|Overall Study||1015
2310632|NCT01950819|5671742|P1|STARTED|Overall Study||1022
2310633|NCT01950780|5671790|P1|NOT COMPLETED|Overall Study||0
2310634|NCT01950780|5671790|P1|COMPLETED|Overall Study||12
2310635|NCT01950780|5671790|P1|STARTED|Overall Study||12
2310636|NCT01950741|5671795|P1|NOT COMPLETED|Overall Study||3
2310637|NCT01950741|5671795|P1|COMPLETED|Overall Study||45
2310638|NCT01950741|5671795|P1|STARTED|Overall Study||48
2310639|NCT01950663|5671804|P1|NOT COMPLETED|Overall Study||1
2310640|NCT01950663|5671804|P1|COMPLETED|Overall Study||467
2310641|NCT01950663|5671804|P1|STARTED|Overall Study||468
2310642|NCT01950364|5671810|P2|NOT COMPLETED|Overall Study||10
2310643|NCT01950364|5671811|P1|NOT COMPLETED|Overall Study||10
2310644|NCT01950364|5671810|P2|COMPLETED|Overall Study||0
2310645|NCT01950364|5671811|P1|COMPLETED|Overall Study||0
2310646|NCT01950364|5671810|P2|STARTED|Overall Study||10
2310647|NCT01950364|5671811|P1|STARTED|Overall Study||10
2310648|NCT01950299|5671912|P3|NOT COMPLETED|Overall Study||7
2310649|NCT01950299|5671913|P2|NOT COMPLETED|Overall Study||4
2310650|NCT01950299|5671914|P1|NOT COMPLETED|Overall Study||11
2310651|NCT01950299|5671912|P3|COMPLETED|Overall Study||28
2310652|NCT01950299|5671913|P2|COMPLETED|Overall Study||27
2310653|NCT01950299|5671914|P1|COMPLETED|Overall Study||22
2310654|NCT01950299|5671912|P3|STARTED|Overall Study||35
2310655|NCT01950299|5671913|P2|STARTED|Overall Study||31
2310656|NCT01950299|5671914|P1|STARTED|Overall Study||33
2310657|NCT01950273|5671933|P2|NOT COMPLETED|Overall Study||0
2310658|NCT01950273|5671934|P1|NOT COMPLETED|Overall Study||4
2310659|NCT01950273|5671933|P2|COMPLETED|Overall Study||46
2310660|NCT01950273|5671934|P1|COMPLETED|Overall Study||45
2310661|NCT01950273|5671933|P2|STARTED|Overall Study||46
2310662|NCT01950273|5671934|P1|STARTED|Overall Study||49
2310663|NCT01950260|5671956|P2|NOT COMPLETED|Overall Study||0
2310664|NCT01950260|5671957|P1|NOT COMPLETED|Overall Study||0
2310665|NCT01950260|5671956|P2|COMPLETED|Overall Study||31
2310666|NCT01950260|5671957|P1|COMPLETED|Overall Study||30
2310667|NCT01950260|5671956|P2|STARTED|Overall Study||31
2310668|NCT01950260|5671957|P1|STARTED|Overall Study||30
2310669|NCT01950078|5671969|P2|NOT COMPLETED|Overall Study||12
2310670|NCT01950078|5671970|P1|NOT COMPLETED|Overall Study||20
2310671|NCT01950078|5671969|P2|COMPLETED|Overall Study||496
2310672|NCT01950078|5671970|P1|COMPLETED|Overall Study||1005
2310673|NCT01950078|5671969|P2|STARTED|Overall Study||508
2310674|NCT01950078|5671970|P1|STARTED|Overall Study||1025
2310675|NCT01950013|5671981|P3|NOT COMPLETED|Overall Study||0
2310676|NCT01950013|5671982|P2|NOT COMPLETED|Overall Study||2
2310677|NCT01950013|5671983|P1|NOT COMPLETED|Overall Study||0
2310678|NCT01950013|5671981|P3|COMPLETED|Overall Study||15
2310679|NCT01950013|5671982|P2|COMPLETED|Overall Study||13
2310680|NCT01950013|5671983|P1|COMPLETED|Overall Study||15
2310681|NCT01950013|5671981|P3|STARTED|Overall Study||15
2310682|NCT01950013|5671982|P2|STARTED|Overall Study||15
2310683|NCT01950013|5671983|P1|STARTED|Overall Study||15
2310684|NCT01949870|5671994|P1|NOT COMPLETED|Overall Study||6
2310685|NCT01949870|5671994|P1|COMPLETED|Overall Study||0
2310686|NCT01949870|5671994|P1|Received Treatment|Overall Study||4
2310687|NCT01949870|5671994|P1|STARTED|Overall Study||6
2310688|NCT01949844|5671998|P1|NOT COMPLETED|Overall Study||0
2310689|NCT01949844|5671998|P1|COMPLETED|Overall Study||44
2310690|NCT01949844|5671998|P1|STARTED|Overall Study||44
2310691|NCT01949779|5672002|P1|NOT COMPLETED|Overall Study||2
2310692|NCT01949779|5672002|P1|COMPLETED|Overall Study||79
2310693|NCT01949779|5672002|P1|STARTED|Overall Study||81
2310694|NCT01949545|5672012|P4|NOT COMPLETED|Overall Study||0
2310695|NCT01949545|5672013|P3|NOT COMPLETED|Overall Study||0
2310696|NCT01949545|5672014|P2|NOT COMPLETED|Overall Study||0
2310697|NCT01949545|5672015|P1|NOT COMPLETED|Overall Study||0
2310698|NCT01949545|5672012|P4|COMPLETED|Overall Study||4
2310699|NCT01949545|5672013|P3|COMPLETED|Overall Study||14
2310700|NCT01949545|5672014|P2|COMPLETED|Overall Study||17
2310701|NCT01949545|5672015|P1|COMPLETED|Overall Study||11
2310702|NCT01949545|5672012|P4|STARTED|Overall Study||4
2310703|NCT01949545|5672013|P3|STARTED|Overall Study||14
2310704|NCT01949545|5672014|P2|STARTED|Overall Study||17
2310705|NCT01949545|5672015|P1|STARTED|Overall Study||11
2310706|NCT01949532|5672163|P2|NOT COMPLETED|Overall Study||3
2310707|NCT01949532|5672164|P1|NOT COMPLETED|Overall Study||3
2310708|NCT01949532|5672163|P2|COMPLETED|Overall Study||8
2310709|NCT01949532|5672164|P1|COMPLETED|Overall Study||12
2310710|NCT01949532|5672163|P2|STARTED|Overall Study||11
2310711|NCT01949532|5672164|P1|STARTED|Overall Study||15
2310712|NCT01949480|5672234|P2|NOT COMPLETED|Overall Study||8
2310713|NCT01949480|5672235|P1|NOT COMPLETED|Overall Study||5
2310714|NCT01949480|5672234|P2|COMPLETED|Overall Study||14
2310715|NCT01949480|5672235|P1|COMPLETED|Overall Study||15
2310716|NCT01949480|5672234|P2|STARTED|Overall Study||22
2310717|NCT01949480|5672235|P1|STARTED|Overall Study||20
2310718|NCT01949389|5672263|P1|NOT COMPLETED|Overall Study||0
2310719|NCT01949389|5672263|P1|COMPLETED|Overall Study||51
2310720|NCT01949389|5672263|P1|STARTED|Overall Study||51
2310721|NCT01949155|5672270|P2|NOT COMPLETED|Overall Study||0
2310722|NCT01949155|5672271|P1|NOT COMPLETED|Overall Study||2
2310723|NCT01949155|5672270|P2|COMPLETED|Overall Study||88
2310724|NCT01949155|5672271|P1|COMPLETED|Overall Study||176
2310725|NCT01949155|5672270|P2|STARTED|Overall Study||88
2310726|NCT01949155|5672271|P1|STARTED|Overall Study||178
2310727|NCT01949142|5672283|P2|NOT COMPLETED|Overall Study||1
2310728|NCT01949142|5672284|P1|NOT COMPLETED|Overall Study||3
2310729|NCT01949142|5672283|P2|COMPLETED|Overall Study||86
2310730|NCT01949142|5672284|P1|COMPLETED|Overall Study||176
2310731|NCT01949142|5672283|P2|STARTED|Overall Study||87
2310732|NCT01949142|5672284|P1|STARTED|Overall Study||179
2310733|NCT01949116|5672296|P2|NOT COMPLETED|Overall Study||6
2310734|NCT01949116|5672297|P1|NOT COMPLETED|Overall Study||8
2310735|NCT01949116|5672296|P2|COMPLETED|Overall Study||84
2310736|NCT01949116|5672297|P1|COMPLETED|Overall Study||78
2310737|NCT01949116|5672296|P2|STARTED|Overall Study||90
2310738|NCT01949116|5672297|P1|STARTED|Overall Study||86
2310739|NCT01949090|5672334|P5|NOT COMPLETED|Overall Study||4
2310740|NCT01949090|5672335|P4|NOT COMPLETED|Overall Study||1
2310741|NCT01949090|5672336|P3|NOT COMPLETED|Overall Study||2
2310742|NCT01949090|5672337|P2|NOT COMPLETED|Overall Study||2
2310743|NCT01949090|5672338|P1|NOT COMPLETED|Overall Study||4
2310744|NCT01949090|5672334|P5|COMPLETED|Overall Study||116
2310745|NCT01949090|5672335|P4|COMPLETED|Overall Study||59
2310746|NCT01949090|5672336|P3|COMPLETED|Overall Study||58
2310747|NCT01949090|5672337|P2|COMPLETED|Overall Study||58
2310748|NCT01949090|5672338|P1|COMPLETED|Overall Study||56
2310749|NCT01949090|5672334|P5|STARTED|Overall Study||120
2310750|NCT01949090|5672335|P4|STARTED|Overall Study||60
2310751|NCT01949090|5672336|P3|STARTED|Overall Study||60
2310752|NCT01949090|5672337|P2|STARTED|Overall Study||60
2310753|NCT01949090|5672338|P1|STARTED|Overall Study||60
2310754|NCT01949051|5672515|P6|NOT COMPLETED|Treatment Period 3 (7 Days)||0
2310755|NCT01949051|5672516|P5|NOT COMPLETED|Treatment Period 3 (7 Days)||0
2310756|NCT01949051|5672517|P4|NOT COMPLETED|Treatment Period 3 (7 Days)||0
2310757|NCT01949051|5672518|P3|NOT COMPLETED|Treatment Period 3 (7 Days)||0
2310758|NCT01949051|5672519|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||0
2310759|NCT01949051|5672520|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
2310760|NCT01949051|5672515|P6|COMPLETED|Treatment Period 3 (7 Days)||12
2310761|NCT01949051|5672516|P5|COMPLETED|Treatment Period 3 (7 Days)||13
2310762|NCT01949051|5672517|P4|COMPLETED|Treatment Period 3 (7 Days)||12
2310763|NCT01949051|5672518|P3|COMPLETED|Treatment Period 3 (7 Days)||12
2310764|NCT01949051|5672519|P2|COMPLETED|Treatment Period 3 (7 Days)||12
2310765|NCT01949051|5672520|P1|COMPLETED|Treatment Period 3 (7 Days)||11
2310766|NCT01949051|5672515|P6|STARTED|Treatment Period 3 (7 Days)||12
2310767|NCT01949051|5672516|P5|STARTED|Treatment Period 3 (7 Days)||13
2310768|NCT01949051|5672517|P4|STARTED|Treatment Period 3 (7 Days)||12
2310769|NCT01949051|5672518|P3|STARTED|Treatment Period 3 (7 Days)||12
2310770|NCT01949051|5672519|P2|STARTED|Treatment Period 3 (7 Days)||12
2310771|NCT01949051|5672520|P1|STARTED|Treatment Period 3 (7 Days)||11
2310772|NCT01949051|5672515|P6|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
2310773|NCT01949051|5672516|P5|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
2310774|NCT01949051|5672517|P4|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
2310775|NCT01949051|5672518|P3|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
2310776|NCT01949051|5672519|P2|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
2310777|NCT01949051|5672520|P1|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
2310778|NCT01949051|5672515|P6|COMPLETED|Washout Period 2 (14 to 20 Days)||12
2310779|NCT01949051|5672516|P5|COMPLETED|Washout Period 2 (14 to 20 Days)||13
2310780|NCT01949051|5672517|P4|COMPLETED|Washout Period 2 (14 to 20 Days)||12
2310781|NCT01949051|5672518|P3|COMPLETED|Washout Period 2 (14 to 20 Days)||12
2310782|NCT01949051|5672519|P2|COMPLETED|Washout Period 2 (14 to 20 Days)||12
2310783|NCT01949051|5672520|P1|COMPLETED|Washout Period 2 (14 to 20 Days)||11
2310784|NCT01949051|5672515|P6|STARTED|Washout Period 2 (14 to 20 Days)||12
2310785|NCT01949051|5672516|P5|STARTED|Washout Period 2 (14 to 20 Days)||13
2310786|NCT01949051|5672517|P4|STARTED|Washout Period 2 (14 to 20 Days)||12
2310787|NCT01949051|5672518|P3|STARTED|Washout Period 2 (14 to 20 Days)||12
2310788|NCT01949051|5672519|P2|STARTED|Washout Period 2 (14 to 20 Days)||12
2310789|NCT01949051|5672520|P1|STARTED|Washout Period 2 (14 to 20 Days)||11
2310790|NCT01949051|5672515|P6|NOT COMPLETED|Treatment Period 2 (7 Days)||1
2310791|NCT01949051|5672516|P5|NOT COMPLETED|Treatment Period 2 (7 Days)||0
2310792|NCT01949051|5672517|P4|NOT COMPLETED|Treatment Period 2 (7 Days)||0
2310793|NCT01949051|5672518|P3|NOT COMPLETED|Treatment Period 2 (7 Days)||1
2310794|NCT01949051|5672519|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||1
2310795|NCT01949051|5672520|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
2310796|NCT01949051|5672515|P6|COMPLETED|Treatment Period 2 (7 Days)||12
2310797|NCT01949051|5672516|P5|COMPLETED|Treatment Period 2 (7 Days)||13
2310798|NCT01949051|5672517|P4|COMPLETED|Treatment Period 2 (7 Days)||12
2310799|NCT01949051|5672518|P3|COMPLETED|Treatment Period 2 (7 Days)||12
2310800|NCT01949051|5672519|P2|COMPLETED|Treatment Period 2 (7 Days)||12
2310801|NCT01949051|5672520|P1|COMPLETED|Treatment Period 2 (7 Days)||11
2310802|NCT01949051|5672515|P6|STARTED|Treatment Period 2 (7 Days)||13
2310803|NCT01949051|5672516|P5|STARTED|Treatment Period 2 (7 Days)||13
2310804|NCT01949051|5672517|P4|STARTED|Treatment Period 2 (7 Days)||12
2310805|NCT01949051|5672518|P3|STARTED|Treatment Period 2 (7 Days)||13
2310806|NCT01949051|5672519|P2|STARTED|Treatment Period 2 (7 Days)||13
2310807|NCT01949051|5672520|P1|STARTED|Treatment Period 2 (7 Days)||11
2310808|NCT01949051|5672515|P6|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
2310809|NCT01949051|5672516|P5|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
2310810|NCT01949051|5672517|P4|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
2310811|NCT01949051|5672518|P3|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
2310812|NCT01949051|5672519|P2|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
2310813|NCT01949051|5672520|P1|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
2310814|NCT01949051|5672515|P6|COMPLETED|Washout Period 1 (14 to 20 Days)||13
2310815|NCT01949051|5672516|P5|COMPLETED|Washout Period 1 (14 to 20 Days)||13
2310816|NCT01949051|5672517|P4|COMPLETED|Washout Period 1 (14 to 20 Days)||12
2310817|NCT01949051|5672518|P3|COMPLETED|Washout Period 1 (14 to 20 Days)||13
2310818|NCT01949051|5672519|P2|COMPLETED|Washout Period 1 (14 to 20 Days)||13
2310819|NCT01949051|5672520|P1|COMPLETED|Washout Period 1 (14 to 20 Days)||11
2310820|NCT01949051|5672515|P6|STARTED|Washout Period 1 (14 to 20 Days)||13
2310821|NCT01949051|5672516|P5|STARTED|Washout Period 1 (14 to 20 Days)||13
2310822|NCT01949051|5672517|P4|STARTED|Washout Period 1 (14 to 20 Days)||12
2310823|NCT01949051|5672518|P3|STARTED|Washout Period 1 (14 to 20 Days)||13
2310824|NCT01949051|5672519|P2|STARTED|Washout Period 1 (14 to 20 Days)||13
2310825|NCT01949051|5672520|P1|STARTED|Washout Period 1 (14 to 20 Days)||11
2310826|NCT01949051|5672515|P6|NOT COMPLETED|Treatment Period 1 (7 Days)||0
2310827|NCT01949051|5672516|P5|NOT COMPLETED|Treatment Period 1 (7 Days)||0
2310828|NCT01949051|5672517|P4|NOT COMPLETED|Treatment Period 1 (7 Days)||1
2310829|NCT01949051|5672518|P3|NOT COMPLETED|Treatment Period 1 (7 Days)||0
2310830|NCT01949051|5672519|P2|NOT COMPLETED|Treatment Period 1 (7 Days)||0
2310831|NCT01949051|5672520|P1|NOT COMPLETED|Treatment Period 1 (7 Days)||2
2310832|NCT01949051|5672515|P6|COMPLETED|Treatment Period 1 (7 Days)||13
2310833|NCT01949051|5672516|P5|COMPLETED|Treatment Period 1 (7 Days)||13
2310834|NCT01949051|5672517|P4|COMPLETED|Treatment Period 1 (7 Days)||12
2310835|NCT01949051|5672518|P3|COMPLETED|Treatment Period 1 (7 Days)||13
2310836|NCT01949051|5672519|P2|COMPLETED|Treatment Period 1 (7 Days)||13
2310837|NCT01949051|5672520|P1|COMPLETED|Treatment Period 1 (7 Days)||11
2310838|NCT01949051|5672515|P6|STARTED|Treatment Period 1 (7 Days)||13
2310839|NCT01949051|5672516|P5|STARTED|Treatment Period 1 (7 Days)||13
2310840|NCT01949051|5672517|P4|STARTED|Treatment Period 1 (7 Days)||13
2310841|NCT01949051|5672518|P3|STARTED|Treatment Period 1 (7 Days)||13
2310842|NCT01949051|5672519|P2|STARTED|Treatment Period 1 (7 Days)||13
2310843|NCT01949051|5672520|P1|STARTED|Treatment Period 1 (7 Days)||13
2310844|NCT01948986|5672536|P5|NOT COMPLETED|Overall Study||0
2310845|NCT01948986|5672537|P4|NOT COMPLETED|Overall Study||0
2310846|NCT01948986|5672538|P3|NOT COMPLETED|Overall Study||0
2310847|NCT01948986|5672539|P2|NOT COMPLETED|Overall Study||0
2310848|NCT01948986|5672540|P1|NOT COMPLETED|Overall Study||0
2310849|NCT01948986|5672536|P5|COMPLETED|Overall Study||8
2310850|NCT01948986|5672537|P4|COMPLETED|Overall Study||6
2310851|NCT01948986|5672538|P3|COMPLETED|Overall Study||8
2310852|NCT01948986|5672539|P2|COMPLETED|Overall Study||8
2310853|NCT01948986|5672540|P1|COMPLETED|Overall Study||6
2310854|NCT01948986|5672536|P5|STARTED|Overall Study||8
2310855|NCT01948986|5672537|P4|STARTED|Overall Study||6
2310856|NCT01948986|5672538|P3|STARTED|Overall Study||8
2310857|NCT01948986|5672539|P2|STARTED|Overall Study||8
2310858|NCT01948986|5672540|P1|STARTED|Overall Study||6
2310859|NCT01948947|5672699|P2|NOT COMPLETED|Overall Study||0
2310860|NCT01948947|5672700|P1|NOT COMPLETED|Overall Study||0
2310861|NCT01948947|5672699|P2|COMPLETED|Overall Study||15
2310862|NCT01948947|5672700|P1|COMPLETED|Overall Study||14
2310863|NCT01948947|5672699|P2|STARTED|Overall Study||15
2310864|NCT01948947|5672700|P1|STARTED|Overall Study||14
2310865|NCT01948908|5672715|P3|NOT COMPLETED|Overall Study||2
2310866|NCT01948908|5672716|P2|NOT COMPLETED|Overall Study||0
2310867|NCT01948908|5672717|P1|NOT COMPLETED|Overall Study||1
2310868|NCT01948908|5672715|P3|COMPLETED|Overall Study||31
2310869|NCT01948908|5672716|P2|COMPLETED|Overall Study||33
2310870|NCT01948908|5672717|P1|COMPLETED|Overall Study||32
2310871|NCT01948908|5672715|P3|STARTED|Overall Study||33
2310872|NCT01948908|5672716|P2|STARTED|Overall Study||33
2310873|NCT01948908|5672717|P1|STARTED|Overall Study||33
2310874|NCT01948830|5672733|P2|NOT COMPLETED|Overall Study||32
2310875|NCT01948830|5672734|P1|NOT COMPLETED|Overall Study||33
2310876|NCT01948830|5672733|P2|COMPLETED|Overall Study||295
2310877|NCT01948830|5672734|P1|COMPLETED|Overall Study||290
2310878|NCT01948830|5672733|P2|Safety Set|Overall Study||326
2310879|NCT01948830|5672734|P1|Safety Set|Overall Study||323
2310880|NCT01948830|5672733|P2|STARTED|Overall Study||327
2310881|NCT01948830|5672734|P1|STARTED|Overall Study||323
2310882|NCT01948791|5672766|P1|NOT COMPLETED|Overall Study||71
2310883|NCT01948791|5672766|P1|COMPLETED|Overall Study||151
2310884|NCT01948791|5672766|P1|STARTED|Overall Study||222
2310885|NCT01948518|5672774|P1|NOT COMPLETED|Overall Study||0
2310886|NCT01948518|5672774|P1|COMPLETED|Overall Study||15
2310887|NCT01948518|5672774|P1|STARTED|Overall Study||15
2310888|NCT01948388|5672781|P2|NOT COMPLETED|Overall Study||1
2310889|NCT01948388|5672782|P1|NOT COMPLETED|Overall Study||2
2310890|NCT01948388|5672781|P2|COMPLETED|Overall Study||9
2310891|NCT01948388|5672782|P1|COMPLETED|Overall Study||8
2310892|NCT01948388|5672781|P2|STARTED|Overall Study||10
2310893|NCT01948388|5672782|P1|STARTED|Overall Study||10
2310894|NCT01948375|5672798|P2|NOT COMPLETED|Overall Study||0
2310895|NCT01948375|5672799|P1|NOT COMPLETED|Overall Study||0
2310896|NCT01948375|5672798|P2|COMPLETED|Overall Study||30
2310897|NCT01948375|5672799|P1|COMPLETED|Overall Study||30
2310898|NCT01948375|5672798|P2|STARTED|Overall Study||30
2310899|NCT01948375|5672799|P1|STARTED|Overall Study||30
2310900|NCT01948310|5672815|P2|NOT COMPLETED|Overall Study||5
2310901|NCT01948310|5672816|P1|NOT COMPLETED|Overall Study||3
2310902|NCT01948310|5672815|P2|COMPLETED|Overall Study||13
2310903|NCT01948310|5672816|P1|COMPLETED|Overall Study||16
2310904|NCT01948310|5672815|P2|STARTED|Overall Study||18
2310905|NCT01948310|5672816|P1|STARTED|Overall Study||19
2310906|NCT01948258|5672826|P1|NOT COMPLETED|Overall Study||162
2310907|NCT01948258|5672826|P1|COMPLETED|Overall Study||233
2310908|NCT01948258|5672826|P1|STARTED|Overall Study||395
2310909|NCT01948193|5672832|P1|NOT COMPLETED|Overall Study||9
2310910|NCT01948193|5672832|P1|COMPLETED|Overall Study||168
2310911|NCT01948193|5672832|P1|STARTED|Overall Study||177
2310912|NCT01948141|5672841|P1|NOT COMPLETED|Overall Study||0
2310913|NCT01948141|5672841|P1|COMPLETED|Overall Study||6
2310914|NCT01948141|5672841|P1|STARTED|Overall Study||6
2310915|NCT01948076|5672854|P2|NOT COMPLETED|Overall Study||1
2310916|NCT01948076|5672855|P1|NOT COMPLETED|Overall Study||0
2310917|NCT01948076|5672854|P2|COMPLETED|Overall Study||19
2310918|NCT01948076|5672855|P1|COMPLETED|Overall Study||20
2310919|NCT01948076|5672854|P2|STARTED|Overall Study||20
2310920|NCT01948076|5672855|P1|STARTED|Overall Study||20
2310921|NCT01948063|5672865|P2|NOT COMPLETED|Overall Study||2
2310922|NCT01948063|5672866|P1|NOT COMPLETED|Overall Study||1
2310923|NCT01948063|5672865|P2|COMPLETED|Overall Study||19
2310924|NCT01948063|5672866|P1|COMPLETED|Overall Study||19
2310925|NCT01948063|5672865|P2|STARTED|Overall Study||21
2310926|NCT01948063|5672866|P1|STARTED|Overall Study||20
2310927|NCT01948050|5672874|P2|NOT COMPLETED|Overall Study||1
2310928|NCT01948050|5672875|P1|NOT COMPLETED|Overall Study||0
2310929|NCT01948050|5672874|P2|COMPLETED|Overall Study||7
2310930|NCT01948050|5672875|P1|COMPLETED|Overall Study||16
2310931|NCT01948050|5672874|P2|STARTED|Overall Study||8
2310932|NCT01948050|5672875|P1|STARTED|Overall Study||16
2310933|NCT01947946|5672884|P3|NOT COMPLETED|Overall Study||5
2310934|NCT01947946|5672885|P2|NOT COMPLETED|Overall Study||5
2310935|NCT01947946|5672886|P1|NOT COMPLETED|Overall Study||3
2310936|NCT01947946|5672884|P3|COMPLETED|Overall Study||0
2310937|NCT01947946|5672885|P2|COMPLETED|Overall Study||0
2310938|NCT01947946|5672886|P1|COMPLETED|Overall Study|Study Stopped|0
2310939|NCT01947946|5672884|P3|STARTED|Overall Study||5
2310940|NCT01947946|5672885|P2|STARTED|Overall Study||5
2310941|NCT01947946|5672886|P1|STARTED|Overall Study||3
2310942|NCT01947907|5672898|P4|NOT COMPLETED|Overall Study||0
2310943|NCT01947907|5672899|P3|NOT COMPLETED|Overall Study||0
2310944|NCT01947907|5672900|P2|NOT COMPLETED|Overall Study||0
2310945|NCT01947907|5672901|P1|NOT COMPLETED|Overall Study||0
2310946|NCT01947907|5672898|P4|COMPLETED|Overall Study||13
2310947|NCT01947907|5672899|P3|COMPLETED|Overall Study||14
2310948|NCT01947907|5672900|P2|COMPLETED|Overall Study||14
2310949|NCT01947907|5672901|P1|COMPLETED|Overall Study||12
2310950|NCT01947907|5672898|P4|STARTED|Overall Study||13
2310951|NCT01947907|5672899|P3|STARTED|Overall Study||14
2310952|NCT01947907|5672900|P2|STARTED|Overall Study||14
2310953|NCT01947907|5672901|P1|STARTED|Overall Study||12
2310954|NCT01947894|5672943|P3|NOT COMPLETED|Overall Study||27
2310955|NCT01947894|5672944|P2|NOT COMPLETED|Overall Study||18
2310956|NCT01947894|5672945|P1|NOT COMPLETED|Overall Study||87
2310957|NCT01947894|5672943|P3|COMPLETED|Overall Study||61
2310958|NCT01947894|5672944|P2|COMPLETED|Overall Study||24
2310959|NCT01947894|5672945|P1|COMPLETED|Overall Study||160
2310960|NCT01947894|5672943|P3|Treated|Overall Study||87
2310961|NCT01947894|5672944|P2|Treated|Overall Study||41
2310962|NCT01947894|5672945|P1|Treated|Overall Study||246
2310963|NCT01947894|5672943|P3|STARTED|Overall Study||88
2310964|NCT01947894|5672944|P2|STARTED|Overall Study||42
2310965|NCT01947894|5672945|P1|STARTED|Overall Study||247
2310966|NCT01947855|5673010|P3|NOT COMPLETED|Overall Study||0
2310967|NCT01947855|5673011|P2|NOT COMPLETED|Overall Study||0
2310968|NCT01947855|5673012|P1|NOT COMPLETED|Overall Study||1
2310969|NCT01947855|5673010|P3|COMPLETED|Overall Study||19
2310970|NCT01947855|5673011|P2|COMPLETED|Overall Study||20
2310971|NCT01947855|5673012|P1|COMPLETED|Overall Study||20
2310972|NCT01947855|5673010|P3|STARTED|Overall Study||19
2310973|NCT01947855|5673011|P2|STARTED|Overall Study||20
2310974|NCT01947855|5673012|P1|STARTED|Overall Study||21
2310975|NCT01947816|5673020|P1|NOT COMPLETED|Overall Study||70
2310976|NCT01947816|5673020|P1|COMPLETED|Overall Study||1523
2310977|NCT01947816|5673020|P1|STARTED|Overall Study||1593
2310978|NCT01947647|5673030|P2|NOT COMPLETED|6-month Followup Phase||8
2310979|NCT01947647|5673031|P1|NOT COMPLETED|6-month Followup Phase||9
2310980|NCT01947647|5673030|P2|COMPLETED|6-month Followup Phase||13
2310981|NCT01947647|5673031|P1|COMPLETED|6-month Followup Phase||20
2310982|NCT01947647|5673030|P2|STARTED|6-month Followup Phase||21
2310983|NCT01947647|5673031|P1|STARTED|6-month Followup Phase||29
2310984|NCT01947647|5673030|P2|NOT COMPLETED|Treatment Phase||26
2310985|NCT01947647|5673031|P1|NOT COMPLETED|Treatment Phase||17
2310986|NCT01947647|5673030|P2|COMPLETED|Treatment Phase||21
2310987|NCT01947647|5673031|P1|COMPLETED|Treatment Phase||29
2310988|NCT01947647|5673030|P2|STARTED|Treatment Phase||47
2310989|NCT01947647|5673031|P1|STARTED|Treatment Phase||46
2310990|NCT01947582|5673047|P1|NOT COMPLETED|Overall Study||1
2310991|NCT01947582|5673047|P1|COMPLETED|Overall Study||1
2310992|NCT01947582|5673047|P1|STARTED|Overall Study||2
2310993|NCT01947517|5673056|P2|NOT COMPLETED|Overall Study||1
2310994|NCT01947517|5673057|P1|NOT COMPLETED|Overall Study||1
2310995|NCT01947517|5673056|P2|COMPLETED|Overall Study||25
2310996|NCT01947517|5673057|P1|COMPLETED|Overall Study||25
2310997|NCT01947517|5673056|P2|STARTED|Overall Study||26
2310998|NCT01947517|5673057|P1|STARTED|Overall Study||26
2310999|NCT01947491|5673075|P4|NOT COMPLETED|Overall Study||5
2311000|NCT01947491|5673076|P3|NOT COMPLETED|Overall Study||2
2311001|NCT01947491|5673077|P2|NOT COMPLETED|Overall Study||6
2311002|NCT01947491|5673078|P1|NOT COMPLETED|Overall Study||8
2311003|NCT01947491|5673075|P4|COMPLETED|Overall Study||38
2311004|NCT01947491|5673076|P3|COMPLETED|Overall Study||88
2311005|NCT01947491|5673077|P2|COMPLETED|Overall Study||81
2311006|NCT01947491|5673078|P1|COMPLETED|Overall Study||166
2311007|NCT01947491|5673075|P4|STARTED|Overall Study||43
2311008|NCT01947491|5673076|P3|STARTED|Overall Study||90
2311009|NCT01947491|5673077|P2|STARTED|Overall Study||87
2311010|NCT01947491|5673078|P1|STARTED|Overall Study||174
2311011|NCT01947335|5673090|P2|NOT COMPLETED|Overall Study||0
2311012|NCT01947335|5673091|P1|NOT COMPLETED|Overall Study||0
2311013|NCT01947335|5673090|P2|COMPLETED|Overall Study||41
2311014|NCT01947335|5673091|P1|COMPLETED|Overall Study||42
2311015|NCT01947335|5673090|P2|STARTED|Overall Study||41
2311016|NCT01947335|5673091|P1|STARTED|Overall Study||42
2311017|NCT01947283|5673108|P7|NOT COMPLETED|Overall Study||8
2311018|NCT01947283|5673109|P6|NOT COMPLETED|Overall Study||7
2311019|NCT01947283|5673110|P5|NOT COMPLETED|Overall Study||0
2311020|NCT01947283|5673111|P4|NOT COMPLETED|Overall Study||17
2311021|NCT01947283|5673112|P3|NOT COMPLETED|Overall Study||21
2311022|NCT01947283|5673113|P2|NOT COMPLETED|Overall Study||23
2311023|NCT01947283|5673114|P1|NOT COMPLETED|Overall Study||29
2311024|NCT01947283|5673108|P7|COMPLETED|Overall Study||32
2311025|NCT01947283|5673109|P6|COMPLETED|Overall Study||27
2311026|NCT01947283|5673110|P5|COMPLETED|Overall Study||95
2311027|NCT01947283|5673111|P4|COMPLETED|Overall Study||55
2311028|NCT01947283|5673112|P3|COMPLETED|Overall Study||62
2311029|NCT01947283|5673113|P2|COMPLETED|Overall Study||45
2311030|NCT01947283|5673114|P1|COMPLETED|Overall Study||60
2311031|NCT01947283|5673108|P7|Completed NRCT Baseline Assessment|Overall Study||0
2311032|NCT01947283|5673109|P6|Completed NRCT Baseline Assessment|Overall Study||0
2311033|NCT01947283|5673110|P5|Completed NRCT Baseline Assessment|Overall Study||95
2311034|NCT01947283|5673111|P4|Completed NRCT Baseline Assessment|Overall Study||0
2311035|NCT01947283|5673112|P3|Completed NRCT Baseline Assessment|Overall Study||0
2311036|NCT01947283|5673113|P2|Completed NRCT Baseline Assessment|Overall Study||0
2311037|NCT01947283|5673114|P1|Completed NRCT Baseline Assessment|Overall Study||0
2311038|NCT01947283|5673108|P7|In Analysis|Overall Study||38
2311039|NCT01947283|5673109|P6|In Analysis|Overall Study||30
2311040|NCT01947283|5673110|P5|In Analysis|Overall Study||95
2311041|NCT01947283|5673111|P4|In Analysis|Overall Study||72
2311042|NCT01947283|5673112|P3|In Analysis|Overall Study||83
2311043|NCT01947283|5673113|P2|In Analysis|Overall Study||68
2311044|NCT01947283|5673114|P1|In Analysis|Overall Study||89
2311045|NCT01947283|5673108|P7|End-of-Intervention Assessment|Overall Study||33
2311046|NCT01947283|5673109|P6|End-of-Intervention Assessment|Overall Study||32
2311047|NCT01947283|5673110|P5|End-of-Intervention Assessment|Overall Study||0
2311048|NCT01947283|5673111|P4|End-of-Intervention Assessment|Overall Study||66
2311049|NCT01947283|5673112|P3|End-of-Intervention Assessment|Overall Study||73
2311050|NCT01947283|5673113|P2|End-of-Intervention Assessment|Overall Study||53
2311051|NCT01947283|5673114|P1|End-of-Intervention Assessment|Overall Study||74
2311052|NCT01947283|5673108|P7|Clinical Recording|Overall Study||0
2311053|NCT01947283|5673109|P6|Clinical Recording|Overall Study||0
2311054|NCT01947283|5673110|P5|Clinical Recording|Overall Study||0
2311055|NCT01947283|5673111|P4|Clinical Recording|Overall Study||57
2311056|NCT01947283|5673112|P3|Clinical Recording|Overall Study||68
2311057|NCT01947283|5673113|P2|Clinical Recording|Overall Study||54
2311058|NCT01947283|5673114|P1|Clinical Recording|Overall Study||65
2311059|NCT01947283|5673108|P7|Follow-up Assessment|Overall Study||36
2311060|NCT01947283|5673109|P6|Follow-up Assessment|Overall Study||27
2311061|NCT01947283|5673110|P5|Follow-up Assessment|Overall Study||0
2311062|NCT01947283|5673111|P4|Follow-up Assessment|Overall Study||59
2311063|NCT01947283|5673112|P3|Follow-up Assessment|Overall Study||65
2311064|NCT01947283|5673113|P2|Follow-up Assessment|Overall Study||51
2311065|NCT01947283|5673114|P1|Follow-up Assessment|Overall Study||64
2311066|NCT01947283|5673108|P7|Baseline Assessment|Overall Study||40
2311067|NCT01947283|5673109|P6|Baseline Assessment|Overall Study||34
2311068|NCT01947283|5673110|P5|Baseline Assessment|Overall Study||0
2311069|NCT01947283|5673111|P4|Baseline Assessment|Overall Study||72
2311070|NCT01947283|5673112|P3|Baseline Assessment|Overall Study||83
2311071|NCT01947283|5673113|P2|Baseline Assessment|Overall Study||68
2311072|NCT01947283|5673114|P1|Baseline Assessment|Overall Study||89
2311073|NCT01947283|5673108|P7|STARTED|Overall Study||40
2311074|NCT01947283|5673109|P6|STARTED|Overall Study||34
2311075|NCT01947283|5673110|P5|STARTED|Overall Study||95
2311076|NCT01947283|5673111|P4|STARTED|Overall Study||72
2311077|NCT01947283|5673112|P3|STARTED|Overall Study||83
2311078|NCT01947283|5673113|P2|STARTED|Overall Study||68
2311079|NCT01947283|5673114|P1|STARTED|Overall Study||89
2311080|NCT01947153|5673165|P2|NOT COMPLETED|Test Period 2||0
2311081|NCT01947153|5673166|P1|NOT COMPLETED|Test Period 2||0
2311082|NCT01947153|5673165|P2|COMPLETED|Test Period 2||18
2311083|NCT01947153|5673166|P1|COMPLETED|Test Period 2||18
2311084|NCT01947153|5673165|P2|STARTED|Test Period 2||18
2311085|NCT01947153|5673166|P1|STARTED|Test Period 2||18
2311086|NCT01947153|5673165|P2|NOT COMPLETED|Test Period 1||0
2311087|NCT01947153|5673166|P1|NOT COMPLETED|Test Period 1||0
2311088|NCT01947153|5673165|P2|COMPLETED|Test Period 1||18
2311089|NCT01947153|5673166|P1|COMPLETED|Test Period 1||18
2311090|NCT01947153|5673165|P2|STARTED|Test Period 1||18
2311091|NCT01947153|5673166|P1|STARTED|Test Period 1||18
2311092|NCT01947127|5673186|P2|NOT COMPLETED|Overall Study||43
2311093|NCT01947127|5673187|P1|NOT COMPLETED|Overall Study||23
2311094|NCT01947127|5673186|P2|COMPLETED|Overall Study||249
2311095|NCT01947127|5673187|P1|COMPLETED|Overall Study||143
2311096|NCT01947127|5673186|P2|STARTED|Overall Study||292
2311097|NCT01947127|5673187|P1|STARTED|Overall Study||166
2311098|NCT01946542|5673199|P2|NOT COMPLETED|Testing Visit 2||0
2311099|NCT01946542|5673200|P1|NOT COMPLETED|Testing Visit 2||0
2311100|NCT01946542|5673199|P2|COMPLETED|Testing Visit 2||1
2311101|NCT01946542|5673200|P1|COMPLETED|Testing Visit 2||1
2311102|NCT01946542|5673199|P2|STARTED|Testing Visit 2||1
2311103|NCT01946542|5673200|P1|STARTED|Testing Visit 2||1
2311104|NCT01946542|5673199|P2|NOT COMPLETED|Testing Visit 1||0
2311105|NCT01946542|5673200|P1|NOT COMPLETED|Testing Visit 1||0
2311106|NCT01946542|5673199|P2|COMPLETED|Testing Visit 1||1
2311107|NCT01946542|5673200|P1|COMPLETED|Testing Visit 1||1
2311108|NCT01946542|5673199|P2|STARTED|Testing Visit 1||1
2311109|NCT01946542|5673200|P1|STARTED|Testing Visit 1||1
2311110|NCT01946529|5673211|P3|NOT COMPLETED|Completion of All Therapy||6
2311111|NCT01946529|5673212|P2|NOT COMPLETED|Completion of All Therapy||16
2311112|NCT01946529|5673213|P1|NOT COMPLETED|Completion of All Therapy||1
2311113|NCT01946529|5673211|P3|COMPLETED|Completion of All Therapy||0
2311114|NCT01946529|5673212|P2|COMPLETED|Completion of All Therapy||0
2311115|NCT01946529|5673213|P1|COMPLETED|Completion of All Therapy||0
2311116|NCT01946529|5673211|P3|STARTED|Completion of All Therapy||6
2311117|NCT01946529|5673212|P2|STARTED|Completion of All Therapy||16
2311118|NCT01946529|5673213|P1|STARTED|Completion of All Therapy||1
2311119|NCT01946529|5673211|P3|NOT COMPLETED|End of Window Therapy (2 Courses)||0
2311120|NCT01946529|5673212|P2|NOT COMPLETED|End of Window Therapy (2 Courses)||1
2311121|NCT01946529|5673213|P1|NOT COMPLETED|End of Window Therapy (2 Courses)||0
2311122|NCT01946529|5673211|P3|COMPLETED|End of Window Therapy (2 Courses)||6
2311123|NCT01946529|5673212|P2|COMPLETED|End of Window Therapy (2 Courses)||16
2311124|NCT01946529|5673213|P1|COMPLETED|End of Window Therapy (2 Courses)||1
2311125|NCT01946529|5673211|P3|STARTED|End of Window Therapy (2 Courses)||6
2311126|NCT01946529|5673212|P2|STARTED|End of Window Therapy (2 Courses)||17
2311127|NCT01946529|5673213|P1|STARTED|End of Window Therapy (2 Courses)||1
2311128|NCT01946438|5673224|P4|NOT COMPLETED|Overall Study||1
2311129|NCT01946438|5673225|P3|NOT COMPLETED|Overall Study||1
2311130|NCT01946438|5673226|P2|NOT COMPLETED|Overall Study||0
2311131|NCT01946438|5673227|P1|NOT COMPLETED|Overall Study||2
2311132|NCT01946438|5673224|P4|COMPLETED|Overall Study||51
2311133|NCT01946438|5673225|P3|COMPLETED|Overall Study||51
2311134|NCT01946438|5673226|P2|COMPLETED|Overall Study||52
2311135|NCT01946438|5673227|P1|COMPLETED|Overall Study||50
2311136|NCT01946438|5673224|P4|STARTED|Overall Study||52
2311137|NCT01946438|5673225|P3|STARTED|Overall Study||52
2311138|NCT01946438|5673226|P2|STARTED|Overall Study||52
2311139|NCT01946438|5673227|P1|STARTED|Overall Study||52
2311140|NCT01946425|5673255|P2|NOT COMPLETED|Overall Study||0
2311141|NCT01946425|5673256|P1|NOT COMPLETED|Overall Study||2
2311142|NCT01946425|5673255|P2|COMPLETED|Overall Study||30
2311143|NCT01946425|5673256|P1|COMPLETED|Overall Study||28
2311144|NCT01946425|5673255|P2|STARTED|Overall Study||30
2311145|NCT01946425|5673256|P1|STARTED|Overall Study||30
2311146|NCT01946412|5673270|P1|NOT COMPLETED|Overall Study||5
2311147|NCT01946412|5673270|P1|COMPLETED|Overall Study||28
2311148|NCT01946412|5673270|P1|STARTED|Overall Study||33
2311149|NCT01946243|5673292|P1|NOT COMPLETED|Overall Study||0
2311150|NCT01946243|5673292|P1|COMPLETED|Overall Study||96
2311151|NCT01946243|5673292|P1|STARTED|Overall Study||96
2311152|NCT01946204|5673315|P2|NOT COMPLETED|Overall Study||806
2311153|NCT01946204|5673316|P1|NOT COMPLETED|Overall Study||401
2311154|NCT01946204|5673315|P2|COMPLETED|Overall Study||0
2311155|NCT01946204|5673316|P1|COMPLETED|Overall Study||0
2311156|NCT01946204|5673315|P2|Treated|Overall Study||803
2311157|NCT01946204|5673316|P1|Treated|Overall Study||398
2311158|NCT01946204|5673315|P2|STARTED|Overall Study||806
2311159|NCT01946204|5673316|P1|STARTED|Overall Study||401
2311160|NCT01946178|5673332|P1|NOT COMPLETED|Overall Study||2
2311161|NCT01946178|5673332|P1|COMPLETED|Overall Study||71
2311162|NCT01946178|5673332|P1|STARTED|Overall Study||73
2311163|NCT01946165|5673342|P2|NOT COMPLETED|Overall Study||2
2311164|NCT01946165|5673343|P1|NOT COMPLETED|Overall Study||2
2311165|NCT01946165|5673342|P2|COMPLETED|Overall Study||21
2311166|NCT01946165|5673343|P1|COMPLETED|Overall Study||43
2311167|NCT01946165|5673342|P2|STARTED|Overall Study||23
2311168|NCT01946165|5673343|P1|STARTED|Overall Study||45
2311169|NCT01946126|5673353|P2|NOT COMPLETED|Overall Study||0
2311170|NCT01946126|5673354|P1|NOT COMPLETED|Overall Study||0
2311171|NCT01946126|5673353|P2|COMPLETED|Overall Study||275
2311172|NCT01946126|5673354|P1|COMPLETED|Overall Study||184
2311173|NCT01946126|5673353|P2|STARTED|Overall Study||275
2311174|NCT01946126|5673354|P1|STARTED|Overall Study||184
2311175|NCT01945996|5673370|P2|NOT COMPLETED|Overall Study||5
2311176|NCT01945996|5673371|P1|NOT COMPLETED|Overall Study||3
2311177|NCT01945996|5673370|P2|COMPLETED|Overall Study||17
2311178|NCT01945996|5673371|P1|COMPLETED|Overall Study||19
2311179|NCT01945996|5673370|P2|STARTED|Overall Study||22
2311180|NCT01945996|5673371|P1|STARTED|Overall Study||22
2311181|NCT01945970|5673403|P6|NOT COMPLETED|Overall Study||0
2311182|NCT01945970|5673404|P5|NOT COMPLETED|Overall Study||0
2311183|NCT01945970|5673405|P4|NOT COMPLETED|Overall Study||0
2311184|NCT01945970|5673406|P3|NOT COMPLETED|Overall Study||0
2311185|NCT01945970|5673407|P2|NOT COMPLETED|Overall Study||0
2311186|NCT01945970|5673408|P1|NOT COMPLETED|Overall Study||0
2311187|NCT01945970|5673403|P6|COMPLETED|Overall Study||5
2311188|NCT01945970|5673404|P5|COMPLETED|Overall Study||5
2311189|NCT01945970|5673405|P4|COMPLETED|Overall Study||5
2311190|NCT01945970|5673406|P3|COMPLETED|Overall Study||5
2311191|NCT01945970|5673407|P2|COMPLETED|Overall Study||5
2311192|NCT01945970|5673408|P1|COMPLETED|Overall Study||5
2311193|NCT01945970|5673403|P6|STARTED|Overall Study||5
2311194|NCT01945970|5673404|P5|STARTED|Overall Study||5
2311195|NCT01945970|5673405|P4|STARTED|Overall Study||5
2311196|NCT01945970|5673406|P3|STARTED|Overall Study||5
2311197|NCT01945970|5673407|P2|STARTED|Overall Study||5
2311198|NCT01945970|5673408|P1|STARTED|Overall Study||5
2311199|NCT01945944|5673447|P2|NOT COMPLETED|Overall Study||3
2311200|NCT01945944|5673448|P1|NOT COMPLETED|Overall Study||1
2311201|NCT01945944|5673447|P2|COMPLETED|Overall Study||6
2311202|NCT01945944|5673448|P1|COMPLETED|Overall Study||8
2311203|NCT01945944|5673447|P2|STARTED|Overall Study||9
2311204|NCT01945944|5673448|P1|STARTED|Overall Study||9
2311205|NCT01945866|5673472|P2|NOT COMPLETED|Overall Study||0
2311206|NCT01945866|5673473|P1|NOT COMPLETED|Overall Study||2
2311207|NCT01945866|5673472|P2|COMPLETED|Overall Study||64
2311208|NCT01945866|5673473|P1|COMPLETED|Overall Study||63
2311209|NCT01945866|5673472|P2|STARTED|Overall Study||64
2311210|NCT01945866|5673473|P1|STARTED|Overall Study||65
2311211|NCT01945775|5673494|P2|NOT COMPLETED|Overall Study||144
2311212|NCT01945775|5673495|P1|NOT COMPLETED|Overall Study||287
2311213|NCT01945775|5673494|P2|COMPLETED|Overall Study||0
2311214|NCT01945775|5673495|P1|COMPLETED|Overall Study||0
2311215|NCT01945775|5673494|P2|Treated|Overall Study||126
2311216|NCT01945775|5673495|P1|Treated|Overall Study||286
2311217|NCT01945775|5673494|P2|STARTED|Overall Study||144
2311218|NCT01945775|5673495|P1|STARTED|Overall Study||287
2311219|NCT01945710|5673531|P7|NOT COMPLETED|Overall Study||23
2311220|NCT01945710|5673532|P6|NOT COMPLETED|Overall Study||3
2311221|NCT01945710|5673533|P5|NOT COMPLETED|Overall Study||9
2311222|NCT01945710|5673534|P4|NOT COMPLETED|Overall Study||3
2311223|NCT01945710|5673535|P3|NOT COMPLETED|Overall Study||7
2311224|NCT01945710|5673536|P2|NOT COMPLETED|Overall Study||6
2311225|NCT01945710|5673537|P1|NOT COMPLETED|Overall Study||7
2311226|NCT01945710|5673531|P7|COMPLETED|Overall Study||0
2311227|NCT01945710|5673532|P6|COMPLETED|Overall Study||0
2311228|NCT01945710|5673533|P5|COMPLETED|Overall Study||0
2311229|NCT01945710|5673534|P4|COMPLETED|Overall Study||0
2311230|NCT01945710|5673535|P3|COMPLETED|Overall Study||0
2311231|NCT01945710|5673536|P2|COMPLETED|Overall Study||0
2311232|NCT01945710|5673537|P1|COMPLETED|Overall Study||0
2311233|NCT01945710|5673531|P7|STARTED|Overall Study||23
2311234|NCT01945710|5673532|P6|STARTED|Overall Study||3
2311235|NCT01945710|5673533|P5|STARTED|Overall Study||9
2311236|NCT01945710|5673534|P4|STARTED|Overall Study||3
2311237|NCT01945710|5673535|P3|STARTED|Overall Study||7
2311238|NCT01945710|5673536|P2|STARTED|Overall Study||6
2311239|NCT01945710|5673537|P1|STARTED|Overall Study||7
2311240|NCT01945593|5673656|P4|NOT COMPLETED|Overall Study||20
2311241|NCT01945593|5673657|P3|NOT COMPLETED|Overall Study||3
2311242|NCT01945593|5673658|P2|NOT COMPLETED|Overall Study||8
2311243|NCT01945593|5673659|P1|NOT COMPLETED|Overall Study||0
2311244|NCT01945593|5673656|P4|COMPLETED|Overall Study||105
2311245|NCT01945593|5673657|P3|COMPLETED|Overall Study||23
2311246|NCT01945593|5673658|P2|COMPLETED|Overall Study||56
2311247|NCT01945593|5673659|P1|COMPLETED|Overall Study||3
2311248|NCT01945593|5673656|P4|STARTED|Overall Study||125
2311249|NCT01945593|5673657|P3|STARTED|Overall Study||26
2311250|NCT01945593|5673658|P2|STARTED|Overall Study||64
2311251|NCT01945593|5673659|P1|STARTED|Overall Study||3
2311252|NCT01945489|5673741|P2|NOT COMPLETED|Cycle 2||1
2311253|NCT01945489|5673742|P1|NOT COMPLETED|Cycle 2||1
2311254|NCT01945489|5673741|P2|COMPLETED|Cycle 2||106
2311255|NCT01945489|5673742|P1|COMPLETED|Cycle 2||87
2311256|NCT01945489|5673741|P2|STARTED|Cycle 2||107
2311257|NCT01945489|5673742|P1|STARTED|Cycle 2|Not all participants participated in Cycle 2.|88
2311258|NCT01945489|5673741|P2|NOT COMPLETED|Cycle 1||4
2311259|NCT01945489|5673742|P1|NOT COMPLETED|Cycle 1||13
2311260|NCT01945489|5673741|P2|COMPLETED|Cycle 1||121
2311261|NCT01945489|5673742|P1|COMPLETED|Cycle 1||116
2311262|NCT01945489|5673741|P2|STARTED|Cycle 1||125
2311263|NCT01945489|5673742|P1|STARTED|Cycle 1||129
2311264|NCT01945294|5673762|P4|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||6
2311265|NCT01945294|5673763|P3|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||8
2311266|NCT01945294|5673764|P2|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||5
2311267|NCT01945294|5673765|P1|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
2311268|NCT01945294|5673762|P4|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||23
2311269|NCT01945294|5673763|P3|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
2311270|NCT01945294|5673764|P2|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
2311271|NCT01945294|5673765|P1|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
2311272|NCT01945294|5673762|P4|STARTED|Period 2: BOC+ PR Treatment & Follow-up||29
2311273|NCT01945294|5673763|P3|STARTED|Period 2: BOC+ PR Treatment & Follow-up||105
2311274|NCT01945294|5673764|P2|STARTED|Period 2: BOC+ PR Treatment & Follow-up||102
2311275|NCT01945294|5673765|P1|STARTED|Period 2: BOC+ PR Treatment & Follow-up|Participants were assigned to 1 of the 3 arms after upon the 12-week BOC + PR lead-in.|0
2311276|NCT01945294|5673762|P4|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
2311277|NCT01945294|5673763|P3|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
2311278|NCT01945294|5673764|P2|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
2311279|NCT01945294|5673765|P1|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||21
2311280|NCT01945294|5673762|P4|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
2311281|NCT01945294|5673763|P3|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
2311282|NCT01945294|5673764|P2|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
2311283|NCT01945294|5673765|P1|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||236
2311284|NCT01945294|5673762|P4|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
2311285|NCT01945294|5673763|P3|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
2311286|NCT01945294|5673764|P2|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
2311287|NCT01945294|5673765|P1|STARTED|Period 1: 12-Week PR + BOC Lead-In||257
2311288|NCT01945281|5673796|P2|NOT COMPLETED|Overall Study||4
2311289|NCT01945281|5673797|P1|NOT COMPLETED|Overall Study||6
2311290|NCT01945281|5673796|P2|COMPLETED|Overall Study||13
2311291|NCT01945281|5673797|P1|COMPLETED|Overall Study||28
2311292|NCT01945281|5673796|P2|Treated|Overall Study||16
2311293|NCT01945281|5673797|P1|Treated|Overall Study||33
2311294|NCT01945281|5673796|P2|STARTED|Overall Study||17
2311295|NCT01945281|5673797|P1|STARTED|Overall Study||34
2311296|NCT01945242|5673809|P2|NOT COMPLETED|Overall Study||3
2311297|NCT01945242|5673810|P1|NOT COMPLETED|Overall Study||3
2311298|NCT01945242|5673809|P2|COMPLETED|Overall Study||120
2311299|NCT01945242|5673810|P1|COMPLETED|Overall Study||1248
2311300|NCT01945242|5673809|P2|STARTED|Overall Study||123
2311301|NCT01945242|5673810|P1|STARTED|Overall Study||1251
2311302|NCT01945216|5673825|P1|NOT COMPLETED|Overall Study||99
2311303|NCT01945216|5673825|P1|COMPLETED|Overall Study||3218
2311304|NCT01945216|5673825|P1|STARTED|Overall Study||3317
2311305|NCT01945138|5673839|P2|NOT COMPLETED|Overall Study||0
2311306|NCT01945138|5673840|P1|NOT COMPLETED|Overall Study||0
2311307|NCT01945138|5673839|P2|COMPLETED|Overall Study||7
2311308|NCT01945138|5673840|P1|COMPLETED|Overall Study||7
2311309|NCT01945138|5673839|P2|STARTED|Overall Study||7
2311310|NCT01945138|5673840|P1|STARTED|Overall Study||7
2311311|NCT01945112|5673874|P2|NOT COMPLETED|Overall Study||0
2311312|NCT01945112|5673875|P1|NOT COMPLETED|Overall Study||0
2311313|NCT01945112|5673874|P2|COMPLETED|Overall Study||51
2311314|NCT01945112|5673875|P1|COMPLETED|Overall Study||77
2311315|NCT01945112|5673874|P2|STARTED|Overall Study|total number of sites where tape was applied|51
2311316|NCT01945112|5673875|P1|STARTED|Overall Study|total number of sites where tape was applied|77
2311317|NCT01945086|5673883|P3|NOT COMPLETED|Overall Study||2
2311318|NCT01945086|5673884|P2|NOT COMPLETED|Overall Study||0
2311319|NCT01945086|5673885|P1|NOT COMPLETED|Overall Study||1
2311320|NCT01945086|5673883|P3|COMPLETED|Overall Study||26
2311321|NCT01945086|5673884|P2|COMPLETED|Overall Study||24
2311322|NCT01945086|5673885|P1|COMPLETED|Overall Study||26
2311323|NCT01945086|5673883|P3|STARTED|Overall Study||28
2311324|NCT01945086|5673884|P2|STARTED|Overall Study||24
2311325|NCT01945086|5673885|P1|STARTED|Overall Study||27
2311326|NCT01945034|5673929|P3|NOT COMPLETED|Overall Study||7
2311327|NCT01945034|5673930|P2|NOT COMPLETED|Overall Study||5
2311328|NCT01945034|5673931|P1|NOT COMPLETED|Overall Study||1
2311329|NCT01945034|5673929|P3|COMPLETED|Overall Study||145
2311330|NCT01945034|5673930|P2|COMPLETED|Overall Study||80
2311331|NCT01945034|5673931|P1|COMPLETED|Overall Study||66
2311332|NCT01945034|5673929|P3|STARTED|Overall Study||152
2311333|NCT01945034|5673930|P2|STARTED|Overall Study||85
2311334|NCT01945034|5673931|P1|STARTED|Overall Study||67
2311335|NCT01945021|5673981|P1|NOT COMPLETED|Overall Study||47
2311336|NCT01945021|5673981|P1|COMPLETED|Overall Study|Completed is defined as patients who continued crizotinib at the time of final analysis (ongoing)|80
2311337|NCT01945021|5673981|P1|Patient Reported Outcome -Evaluable|Overall Study|All patients from the safety population who completed a baseline and >/= 1 post-baseline assessment.|123
2311338|NCT01945021|5673981|P1|Response Evaluable Population|Overall Study|All patients in the safety population who had an adequate baseline tumor assessment|127
2311339|NCT01945021|5673981|P1|Safety Population|Overall Study|All enrolled patients who received at least 1 dose of study medication.|127
2311340|NCT01945021|5673981|P1|STARTED|Overall Study|127 pts with ROS1+ & ALK negative tumors were consented and started study (2 more were screen fails)|127
2311341|NCT01944969|5673995|P1|NOT COMPLETED|Overall Study||26
2311342|NCT01944969|5673995|P1|COMPLETED|Overall Study||0
2311343|NCT01944969|5673995|P1|STARTED|Overall Study||26
2311344|NCT01944878|5674008|P2|NOT COMPLETED|Overall Study||0
2311345|NCT01944878|5674009|P1|NOT COMPLETED|Overall Study||0
2311346|NCT01944878|5674008|P2|COMPLETED|Overall Study||328
2311347|NCT01944878|5674009|P1|COMPLETED|Overall Study||127
2311348|NCT01944878|5674008|P2|STARTED|Overall Study||328
2311349|NCT01944878|5674009|P1|STARTED|Overall Study||127
2311350|NCT01944839|5674019|P2|NOT COMPLETED|Overall Study||28
2311351|NCT01944839|5674020|P1|NOT COMPLETED|Overall Study||22
2311352|NCT01944839|5674019|P2|COMPLETED|Overall Study||282
2311353|NCT01944839|5674020|P1|COMPLETED|Overall Study||287
2311354|NCT01944839|5674019|P2|STARTED|Overall Study||310
2311355|NCT01944839|5674020|P1|STARTED|Overall Study||309
2311356|NCT01944774|5674029|P3|NOT COMPLETED|Overall Study||8
2311357|NCT01944774|5674030|P2|NOT COMPLETED|Overall Study||8
2311358|NCT01944774|5674031|P1|NOT COMPLETED|Overall Study||6
2311359|NCT01944774|5674029|P3|COMPLETED|Overall Study||62
2311360|NCT01944774|5674030|P2|COMPLETED|Overall Study||60
2311361|NCT01944774|5674031|P1|COMPLETED|Overall Study||63
2311362|NCT01944774|5674029|P3|Received Treatment|Overall Study||70
2311363|NCT01944774|5674030|P2|Received Treatment|Overall Study||67
2311364|NCT01944774|5674031|P1|Received Treatment|Overall Study||68
2311365|NCT01944774|5674029|P3|STARTED|Overall Study||70
2311366|NCT01944774|5674030|P2|STARTED|Overall Study||68
2311367|NCT01944774|5674031|P1|STARTED|Overall Study||69
2311368|NCT01944722|5674074|P1|NOT COMPLETED|Overall Study||9515
2311369|NCT01944722|5674074|P1|COMPLETED|Overall Study||24343
2311370|NCT01944722|5674074|P1|STARTED|Overall Study||33858
2311371|NCT01944670|5674108|P1|NOT COMPLETED|Overall Study||2
2311372|NCT01944670|5674108|P1|COMPLETED|Overall Study||24
2311373|NCT01944670|5674108|P1|STARTED|Overall Study||26
2311374|NCT01944644|5674115|P2|NOT COMPLETED|Overall Study||0
2311375|NCT01944644|5674116|P1|NOT COMPLETED|Overall Study||0
2311376|NCT01944644|5674115|P2|COMPLETED|Overall Study||32
2311377|NCT01944644|5674116|P1|COMPLETED|Overall Study||34
2311378|NCT01944644|5674115|P2|STARTED|Overall Study||32
2311379|NCT01944644|5674116|P1|STARTED|Overall Study||34
2311380|NCT01944631|5674130|P2|NOT COMPLETED|Overall Study||2
2311381|NCT01944631|5674131|P1|NOT COMPLETED|Overall Study||4
2311382|NCT01944631|5674130|P2|COMPLETED|Overall Study||98
2311383|NCT01944631|5674131|P1|COMPLETED|Overall Study||96
2311384|NCT01944631|5674130|P2|STARTED|Overall Study||100
2311385|NCT01944631|5674131|P1|STARTED|Overall Study||100
2311386|NCT01944462|5674147|P1|NOT COMPLETED|Optional Vaccination||0
2311387|NCT01944462|5674147|P1|COMPLETED|Optional Vaccination||20
2311388|NCT01944462|5674147|P1|STARTED|Optional Vaccination||20
2311389|NCT01944462|5674147|P1|NOT COMPLETED|PPPP Educational Program||60
2311390|NCT01944462|5674147|P1|COMPLETED|PPPP Educational Program||143
2311391|NCT01944462|5674147|P1|3 Month Follow-Up|PPPP Educational Program||143
2311392|NCT01944462|5674147|P1|Post-Test|PPPP Educational Program||187
2311393|NCT01944462|5674147|P1|Baseline|PPPP Educational Program||203
2311394|NCT01944462|5674147|P1|STARTED|PPPP Educational Program||203
2311395|NCT01944345|5674156|P1|NOT COMPLETED|Overall Study||0
2311396|NCT01944345|5674156|P1|COMPLETED|Overall Study||69
2311397|NCT01944345|5674156|P1|STARTED|Overall Study||69
2311398|NCT01944319|5674164|P2|NOT COMPLETED|Overall Study||0
2311399|NCT01944319|5674165|P1|NOT COMPLETED|Overall Study||0
2311400|NCT01944319|5674164|P2|COMPLETED|Overall Study||39
2311401|NCT01944319|5674165|P1|COMPLETED|Overall Study||40
2311402|NCT01944319|5674164|P2|STARTED|Overall Study||39
2311403|NCT01944319|5674165|P1|STARTED|Overall Study||40
2311404|NCT01944293|5674177|P2|NOT COMPLETED|Overall Study||0
2311405|NCT01944293|5674178|P1|NOT COMPLETED|Overall Study||0
2311406|NCT01944293|5674177|P2|COMPLETED|Overall Study||9
2311407|NCT01944293|5674178|P1|COMPLETED|Overall Study||7
2311408|NCT01944293|5674177|P2|STARTED|Overall Study||9
2311409|NCT01944293|5674178|P1|STARTED|Overall Study||7
2311410|NCT01944098|5674188|P2|NOT COMPLETED|Overall Study||0
2311411|NCT01944098|5674189|P1|NOT COMPLETED|Overall Study||1
2311412|NCT01944098|5674188|P2|COMPLETED|Overall Study||10
2311413|NCT01944098|5674189|P1|COMPLETED|Overall Study||9
2311414|NCT01944098|5674188|P2|STARTED|Overall Study||10
2311415|NCT01944098|5674189|P1|STARTED|Overall Study||10
2311416|NCT01944059|5674201|P1|NOT COMPLETED|Overall Study||7
2311417|NCT01944059|5674201|P1|COMPLETED|Overall Study||24
2311418|NCT01944059|5674201|P1|STARTED|Overall Study||31
2311419|NCT01943864|5674210|P1|NOT COMPLETED|Overall Study||0
2311420|NCT01943864|5674210|P1|COMPLETED|Overall Study|Death or 1 year from randomization after progression was considered completion; 20 participants died|20
2311421|NCT01943864|5674210|P1|STARTED|Overall Study||20
2311422|NCT01943825|5674242|P4|NOT COMPLETED|Overall Study||11
2311423|NCT01943825|5674243|P3|NOT COMPLETED|Overall Study||15
2311424|NCT01943825|5674244|P2|NOT COMPLETED|Overall Study||4
2311425|NCT01943825|5674245|P1|NOT COMPLETED|Overall Study||10
2311426|NCT01943825|5674242|P4|COMPLETED|Overall Study||14
2311427|NCT01943825|5674243|P3|COMPLETED|Overall Study||10
2311428|NCT01943825|5674244|P2|COMPLETED|Overall Study||11
2311429|NCT01943825|5674245|P1|COMPLETED|Overall Study||15
2311430|NCT01943825|5674242|P4|STARTED|Overall Study||25
2311431|NCT01943825|5674243|P3|STARTED|Overall Study||25
2311432|NCT01943825|5674244|P2|STARTED|Overall Study||15
2311433|NCT01943825|5674245|P1|STARTED|Overall Study||25
2311434|NCT01943799|5674287|P4|NOT COMPLETED|Overall Study||0
2311435|NCT01943799|5674288|P3|NOT COMPLETED|Overall Study||2
2311436|NCT01943799|5674289|P2|NOT COMPLETED|Overall Study||3
2311437|NCT01943799|5674290|P1|NOT COMPLETED|Overall Study||5
2311438|NCT01943799|5674287|P4|COMPLETED|Overall Study||50
2311439|NCT01943799|5674288|P3|COMPLETED|Overall Study||49
2311440|NCT01943799|5674289|P2|COMPLETED|Overall Study||47
2311441|NCT01943799|5674290|P1|COMPLETED|Overall Study||22
2311442|NCT01943799|5674287|P4|STARTED|Overall Study||50
2311443|NCT01943799|5674288|P3|STARTED|Overall Study|1 participant was randomized to OAV + GS-4774 2 YU but received OAV + GS-4774 10 YU.|51
2311444|NCT01943799|5674289|P2|STARTED|Overall Study||50
2311445|NCT01943799|5674290|P1|STARTED|Overall Study||27
2311446|NCT01943591|5674330|P2|NOT COMPLETED|Overall Study||11
2311447|NCT01943591|5674331|P1|NOT COMPLETED|Overall Study||5
2311448|NCT01943591|5674330|P2|COMPLETED|Overall Study||95
2311449|NCT01943591|5674331|P1|COMPLETED|Overall Study||99
2311450|NCT01943591|5674330|P2|STARTED|Overall Study||106
2311451|NCT01943591|5674331|P1|STARTED|Overall Study||104
2311452|NCT01943565|5674356|P3|NOT COMPLETED|Overall Study||0
2311453|NCT01943565|5674357|P2|NOT COMPLETED|Overall Study||0
2311454|NCT01943565|5674358|P1|NOT COMPLETED|Overall Study||0
2311455|NCT01943565|5674356|P3|COMPLETED|Overall Study||9
2311456|NCT01943565|5674357|P2|COMPLETED|Overall Study||9
2311457|NCT01943565|5674358|P1|COMPLETED|Overall Study||11
2311458|NCT01943565|5674356|P3|STARTED|Overall Study||9
2311459|NCT01943565|5674357|P2|STARTED|Overall Study||9
2311460|NCT01943565|5674358|P1|STARTED|Overall Study||11
2311461|NCT01943552|5674389|P2|NOT COMPLETED|Overall Study||25
2311462|NCT01943552|5674390|P1|NOT COMPLETED|Overall Study||25
2311463|NCT01943552|5674389|P2|COMPLETED|Overall Study||69
2311464|NCT01943552|5674390|P1|COMPLETED|Overall Study||71
2311465|NCT01943552|5674389|P2|STARTED|Overall Study||94
2311466|NCT01943552|5674390|P1|STARTED|Overall Study|One patient was randomised to the placebo group, but received nebulized ipratropium bromide.|96
2311467|NCT01943539|5674406|P2|NOT COMPLETED|Overall Study||0
2311468|NCT01943539|5674407|P1|NOT COMPLETED|Overall Study||4
2311469|NCT01943539|5674406|P2|COMPLETED|Overall Study||40
2311470|NCT01943539|5674407|P1|COMPLETED|Overall Study||40
2311471|NCT01943539|5674406|P2|STARTED|Overall Study||40
2311472|NCT01943539|5674407|P1|STARTED|Overall Study||44
2311473|NCT01943474|5674418|P2|NOT COMPLETED|Overall Study||0
2311474|NCT01943474|5674419|P1|NOT COMPLETED|Overall Study||0
2311475|NCT01943474|5674418|P2|COMPLETED|Overall Study||125
2311476|NCT01943474|5674419|P1|COMPLETED|Overall Study||123
2311477|NCT01943474|5674418|P2|STARTED|Overall Study||125
2311478|NCT01943474|5674419|P1|STARTED|Overall Study||123
2311479|NCT01943435|5674443|P3|NOT COMPLETED|6 Month Follow up||15
2311480|NCT01943435|5674444|P2|NOT COMPLETED|6 Month Follow up||7
2311481|NCT01943435|5674445|P1|NOT COMPLETED|6 Month Follow up||12
2311482|NCT01943435|5674443|P3|COMPLETED|6 Month Follow up||65
2311483|NCT01943435|5674444|P2|COMPLETED|6 Month Follow up||59
2311484|NCT01943435|5674445|P1|COMPLETED|6 Month Follow up||67
2311485|NCT01943435|5674443|P3|STARTED|6 Month Follow up||80
2311486|NCT01943435|5674444|P2|STARTED|6 Month Follow up||66
2311487|NCT01943435|5674445|P1|STARTED|6 Month Follow up||79
2311488|NCT01943435|5674443|P3|NOT COMPLETED|2 Month Follow up||0
2311489|NCT01943435|5674444|P2|NOT COMPLETED|2 Month Follow up||3
2311490|NCT01943435|5674445|P1|NOT COMPLETED|2 Month Follow up||2
2311491|NCT01943435|5674443|P3|COMPLETED|2 Month Follow up||80
2311492|NCT01943435|5674444|P2|COMPLETED|2 Month Follow up||66
2311493|NCT01943435|5674445|P1|COMPLETED|2 Month Follow up||79
2311494|NCT01943435|5674443|P3|STARTED|2 Month Follow up||80
2311495|NCT01943435|5674444|P2|STARTED|2 Month Follow up||69
2311496|NCT01943435|5674445|P1|STARTED|2 Month Follow up||81
2311497|NCT01943435|5674443|P3|NOT COMPLETED|Intervention Period||4
2311498|NCT01943435|5674444|P2|NOT COMPLETED|Intervention Period||3
2311499|NCT01943435|5674445|P1|NOT COMPLETED|Intervention Period||3
2311500|NCT01943435|5674443|P3|COMPLETED|Intervention Period||80
2311501|NCT01943435|5674444|P2|COMPLETED|Intervention Period||69
2311502|NCT01943435|5674445|P1|COMPLETED|Intervention Period||81
2311503|NCT01943435|5674443|P3|STARTED|Intervention Period||84
2311504|NCT01943435|5674444|P2|STARTED|Intervention Period||72
2311505|NCT01943435|5674445|P1|STARTED|Intervention Period||84
2311506|NCT01943435|5674443|P3|NOT COMPLETED|Baseline Eligibility and Randomization||3
2311507|NCT01943435|5674444|P2|NOT COMPLETED|Baseline Eligibility and Randomization||12
2311508|NCT01943435|5674445|P1|NOT COMPLETED|Baseline Eligibility and Randomization||4
2311509|NCT01943435|5674443|P3|COMPLETED|Baseline Eligibility and Randomization||84
2311510|NCT01943435|5674444|P2|COMPLETED|Baseline Eligibility and Randomization||72
2311511|NCT01943435|5674445|P1|COMPLETED|Baseline Eligibility and Randomization||84
2311512|NCT01943435|5674443|P3|STARTED|Baseline Eligibility and Randomization||87
2311513|NCT01943435|5674444|P2|STARTED|Baseline Eligibility and Randomization||84
2311514|NCT01943435|5674445|P1|STARTED|Baseline Eligibility and Randomization||88
2311515|NCT01943344|5674459|P1|NOT COMPLETED|Overall Study||3
2311516|NCT01943344|5674459|P1|COMPLETED|Overall Study||9
2311517|NCT01943344|5674459|P1|STARTED|Overall Study||12
2311518|NCT01943292|5674468|P3|NOT COMPLETED|Overall Study||0
2311519|NCT01943292|5674469|P2|NOT COMPLETED|Overall Study||0
2311520|NCT01943292|5674470|P1|NOT COMPLETED|Overall Study||1
2311521|NCT01943292|5674468|P3|COMPLETED|Overall Study||3
2311522|NCT01943292|5674469|P2|COMPLETED|Overall Study||3
2311523|NCT01943292|5674470|P1|COMPLETED|Overall Study||2
2311524|NCT01943292|5674468|P3|Completed Follow-Up|Overall Study||3
2311525|NCT01943292|5674469|P2|Completed Follow-Up|Overall Study||3
2311526|NCT01943292|5674470|P1|Completed Follow-Up|Overall Study||2
2311527|NCT01943292|5674468|P3|Completed Treatment|Overall Study||3
2311528|NCT01943292|5674469|P2|Completed Treatment|Overall Study||3
2311529|NCT01943292|5674470|P1|Completed Treatment|Overall Study||3
2311530|NCT01943292|5674468|P3|Completed Cycle 1|Overall Study||3
2311531|NCT01943292|5674469|P2|Completed Cycle 1|Overall Study||3
2311532|NCT01943292|5674470|P1|Completed Cycle 1|Overall Study||3
2311533|NCT01943292|5674468|P3|STARTED|Overall Study||3
2311534|NCT01943292|5674469|P2|STARTED|Overall Study||3
2311535|NCT01943292|5674470|P1|STARTED|Overall Study||3
2311536|NCT01943227|5674483|P2|NOT COMPLETED|Overall Study||0
2311537|NCT01943227|5674484|P1|NOT COMPLETED|Overall Study||0
2311538|NCT01943227|5674483|P2|COMPLETED|Overall Study||10
2311539|NCT01943227|5674484|P1|COMPLETED|Overall Study||10
2311540|NCT01943227|5674483|P2|STARTED|Overall Study||10
2311541|NCT01943227|5674484|P1|STARTED|Overall Study||10
2311542|NCT01943110|5674490|P1|NOT COMPLETED|Overall Study||0
2311543|NCT01943110|5674490|P1|COMPLETED|Overall Study||30
2311544|NCT01943110|5674490|P1|STARTED|Overall Study||30
2311545|NCT01942785|5674506|P1|NOT COMPLETED|Overall Study||4
2311546|NCT01942785|5674506|P1|COMPLETED|Overall Study||50
2311547|NCT01942785|5674506|P1|STARTED|Overall Study||54
2311548|NCT01942733|5674535|P1|NOT COMPLETED|Overall Study||3
2311549|NCT01942733|5674535|P1|COMPLETED|Overall Study||41
2311550|NCT01942733|5674535|P1|STARTED|Overall Study||44
2311551|NCT01942720|5674564|P1|NOT COMPLETED|Overall Study||21
2311552|NCT01942720|5674564|P1|COMPLETED|Overall Study||53
2311553|NCT01942720|5674564|P1|STARTED|Overall Study||74
2311554|NCT01942707|5674574|P2|NOT COMPLETED|Overall Study||0
2311555|NCT01942707|5674575|P1|NOT COMPLETED|Overall Study||0
2311556|NCT01942707|5674574|P2|COMPLETED|Overall Study||23
2311557|NCT01942707|5674575|P1|COMPLETED|Overall Study||23
2311558|NCT01942707|5674574|P2|STARTED|Overall Study||23
2311559|NCT01942707|5674575|P1|STARTED|Overall Study||23
2311560|NCT01942668|5674590|P5|NOT COMPLETED|Overall Study||59
2311561|NCT01942668|5674591|P4|NOT COMPLETED|Overall Study||146
2311562|NCT01942668|5674592|P3|NOT COMPLETED|Overall Study||110
2311563|NCT01942668|5674593|P2|NOT COMPLETED|Overall Study||121
2311564|NCT01942668|5674594|P1|NOT COMPLETED|Overall Study||134
2311565|NCT01942668|5674590|P5|COMPLETED|Overall Study||93
2311566|NCT01942668|5674591|P4|COMPLETED|Overall Study||281
2311567|NCT01942668|5674592|P3|COMPLETED|Overall Study||312
2311568|NCT01942668|5674593|P2|COMPLETED|Overall Study||305
2311569|NCT01942668|5674594|P1|COMPLETED|Overall Study||284
2311570|NCT01942668|5674590|P5|STARTED|Overall Study||152
2311571|NCT01942668|5674591|P4|STARTED|Overall Study||427
2311572|NCT01942668|5674592|P3|STARTED|Overall Study||422
2311573|NCT01942668|5674593|P2|STARTED|Overall Study||426
2311574|NCT01942668|5674594|P1|STARTED|Overall Study||418
2311575|NCT01942590|5675653|P2|NOT COMPLETED|Overall Study||1
2311576|NCT01942590|5675654|P1|NOT COMPLETED|Overall Study||1
2311577|NCT01942590|5675653|P2|COMPLETED|Overall Study||4
2311578|NCT01942590|5675654|P1|COMPLETED|Overall Study||7
2311579|NCT01942590|5675653|P2|STARTED|Overall Study||5
2311580|NCT01942590|5675654|P1|STARTED|Overall Study||8
2311581|NCT01942161|5675687|P3|NOT COMPLETED|Overall Study||6
2311582|NCT01942161|5675688|P2|NOT COMPLETED|Overall Study||6
2311583|NCT01942161|5675689|P1|NOT COMPLETED|Overall Study||8
2311584|NCT01942161|5675687|P3|COMPLETED|Overall Study||35
2311585|NCT01942161|5675688|P2|COMPLETED|Overall Study||24
2311586|NCT01942161|5675689|P1|COMPLETED|Overall Study||27
2311587|NCT01942161|5675687|P3|STARTED|Overall Study||41
2311588|NCT01942161|5675688|P2|STARTED|Overall Study||30
2311589|NCT01942161|5675689|P1|STARTED|Overall Study||35
2311590|NCT01942148|5675709|P1|NOT COMPLETED|Overall Study||27
2311591|NCT01942148|5675709|P1|COMPLETED|Overall Study||41
2311592|NCT01942148|5675709|P1|STARTED|Overall Study||68
2311593|NCT01942135|5675717|P2|NOT COMPLETED|Overall Study||174
2311594|NCT01942135|5675718|P1|NOT COMPLETED|Overall Study||347
2311595|NCT01942135|5675717|P2|COMPLETED|Overall Study||0
2311596|NCT01942135|5675718|P1|COMPLETED|Overall Study||0
2311597|NCT01942135|5675717|P2|STARTED|Overall Study||174
2311598|NCT01942135|5675718|P1|STARTED|Overall Study||347
2311599|NCT01941940|5675755|P1|NOT COMPLETED|Overall Study||33
2311600|NCT01941940|5675755|P1|COMPLETED|Overall Study||194
2311601|NCT01941940|5675755|P1|STARTED|Overall Study||227
2311602|NCT01941927|5675797|P2|NOT COMPLETED|Overall Study||0
2311603|NCT01941927|5675798|P1|NOT COMPLETED|Overall Study||0
2311604|NCT01941927|5675797|P2|COMPLETED|Overall Study||10
2311605|NCT01941927|5675798|P1|COMPLETED|Overall Study||10
2311606|NCT01941927|5675797|P2|STARTED|Overall Study||10
2311607|NCT01941927|5675798|P1|STARTED|Overall Study||10
2311608|NCT01941745|5675814|P4|NOT COMPLETED|Overall Study||0
2311609|NCT01941745|5675815|P3|NOT COMPLETED|Overall Study||0
2311610|NCT01941745|5675816|P2|NOT COMPLETED|Overall Study||0
2311611|NCT01941745|5675817|P1|NOT COMPLETED|Overall Study||0
2311612|NCT01941745|5675814|P4|COMPLETED|Overall Study||23
2311613|NCT01941745|5675815|P3|COMPLETED|Overall Study||21
2311614|NCT01941745|5675816|P2|COMPLETED|Overall Study||22
2311615|NCT01941745|5675817|P1|COMPLETED|Overall Study||22
2311616|NCT01941745|5675814|P4|STARTED|Overall Study||23
2311617|NCT01941745|5675815|P3|STARTED|Overall Study||21
2311618|NCT01941745|5675816|P2|STARTED|Overall Study||22
2311619|NCT01941745|5675817|P1|STARTED|Overall Study||22
2311620|NCT01941628|5675841|P2|NOT COMPLETED|Overall Study||0
2311621|NCT01941628|5675842|P1|NOT COMPLETED|Overall Study||1
2311622|NCT01941628|5675841|P2|COMPLETED|Overall Study||45
2311623|NCT01941628|5675842|P1|COMPLETED|Overall Study||45
2311624|NCT01941628|5675841|P2|STARTED|Overall Study||45
2311625|NCT01941628|5675842|P1|STARTED|Overall Study||46
2311626|NCT01941615|5675852|P1|NOT COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
2311627|NCT01941615|5675852|P1|COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
2311628|NCT01941615|5675852|P1|STARTED|Microgynon® Plus Deleobuvir+Faldaprevir||0
2311629|NCT01941615|5675852|P1|NOT COMPLETED|Reference Treatment: Microgynon®||0
2311630|NCT01941615|5675852|P1|COMPLETED|Reference Treatment: Microgynon®||0
2311631|NCT01941615|5675852|P1|STARTED|Reference Treatment: Microgynon®||0
2311632|NCT01941615|5675852|P1|NOT COMPLETED|Run in Treatment: Microgynon®||0
2311633|NCT01941615|5675852|P1|COMPLETED|Run in Treatment: Microgynon®||16
2311634|NCT01941615|5675852|P1|STARTED|Run in Treatment: Microgynon®||16
2311635|NCT01941537|5675863|P2|NOT COMPLETED|Overall Study||3
2311636|NCT01941537|5675864|P1|NOT COMPLETED|Overall Study||4
2311637|NCT01941537|5675863|P2|COMPLETED|Overall Study||17
2311638|NCT01941537|5675864|P1|COMPLETED|Overall Study||36
2311639|NCT01941537|5675863|P2|STARTED|Overall Study||20
2311640|NCT01941537|5675864|P1|STARTED|Overall Study||40
2311641|NCT01941498|5675876|P1|NOT COMPLETED|Overall Study||1
2311642|NCT01941498|5675876|P1|COMPLETED|Overall Study||96
2311643|NCT01941498|5675876|P1|STARTED|Overall Study||97
2311644|NCT01941485|5675922|P1|NOT COMPLETED|Overall Study||0
2311645|NCT01941485|5675922|P1|COMPLETED|Overall Study||59
2311646|NCT01941485|5675922|P1|STARTED|Overall Study||59
2311647|NCT01941472|5675988|P1|NOT COMPLETED|Overall Study||0
2311648|NCT01941472|5675988|P1|COMPLETED|Overall Study||40
2311649|NCT01941472|5675988|P1|STARTED|Overall Study||40
2311650|NCT01941186|5675994|P2|NOT COMPLETED|Follow-up||0
2311651|NCT01941186|5675995|P1|NOT COMPLETED|Follow-up||1
2311652|NCT01941186|5675994|P2|COMPLETED|Follow-up||33
2311653|NCT01941186|5675995|P1|COMPLETED|Follow-up||30
2311654|NCT01941186|5675994|P2|STARTED|Follow-up||33
2311655|NCT01941186|5675995|P1|STARTED|Follow-up||31
2311656|NCT01941186|5675994|P2|NOT COMPLETED|Randomization/Allocation to Study Group||0
2311657|NCT01941186|5675995|P1|NOT COMPLETED|Randomization/Allocation to Study Group||0
2311658|NCT01941186|5675994|P2|COMPLETED|Randomization/Allocation to Study Group||33
2311659|NCT01941186|5675995|P1|COMPLETED|Randomization/Allocation to Study Group||31
2311660|NCT01941186|5675994|P2|STARTED|Randomization/Allocation to Study Group||33
2311661|NCT01941186|5675995|P1|STARTED|Randomization/Allocation to Study Group||31
2311662|NCT01941095|5676021|P1|NOT COMPLETED|Overall Study||56
2311663|NCT01941095|5676021|P1|COMPLETED|Overall Study||41
2311664|NCT01941095|5676021|P1|STARTED|Overall Study||97
2311665|NCT01941030|5676046|P2|NOT COMPLETED|Overall Study||13
2311666|NCT01941030|5676047|P1|NOT COMPLETED|Overall Study||13
2311667|NCT01941030|5676046|P2|COMPLETED|Overall Study||13
2311668|NCT01941030|5676047|P1|COMPLETED|Overall Study||12
2311669|NCT01941030|5676046|P2|STARTED|Overall Study||26
2311670|NCT01941030|5676047|P1|STARTED|Overall Study||25
2311671|NCT01940939|5676069|P2|NOT COMPLETED|Overall Study||8
2311672|NCT01940939|5676070|P1|NOT COMPLETED|Overall Study||2
2311673|NCT01940939|5676069|P2|COMPLETED|Overall Study||27
2311674|NCT01940939|5676070|P1|COMPLETED|Overall Study||33
2311675|NCT01940939|5676069|P2|STARTED|Overall Study||35
2311676|NCT01940939|5676070|P1|STARTED|Overall Study||35
2311677|NCT01940900|5676082|P2|NOT COMPLETED|Overall Study||31
2311678|NCT01940900|5676083|P1|NOT COMPLETED|Overall Study||29
2311679|NCT01940900|5676082|P2|COMPLETED|Overall Study||284
2311680|NCT01940900|5676083|P1|COMPLETED|Overall Study||282
2311681|NCT01940900|5676082|P2|STARTED|Overall Study||315
2311682|NCT01940900|5676083|P1|STARTED|Overall Study||311
2311683|NCT01940705|5676093|P4|NOT COMPLETED|Overall Study||4
2311684|NCT01940705|5676094|P3|NOT COMPLETED|Overall Study||8
2311685|NCT01940705|5676095|P2|NOT COMPLETED|Overall Study||8
2311686|NCT01940705|5676096|P1|NOT COMPLETED|Overall Study||4
2311687|NCT01940705|5676093|P4|COMPLETED|Overall Study||63
2311688|NCT01940705|5676094|P3|COMPLETED|Overall Study||61
2311689|NCT01940705|5676095|P2|COMPLETED|Overall Study||59
2311690|NCT01940705|5676096|P1|COMPLETED|Overall Study||62
2311691|NCT01940705|5676093|P4|STARTED|Overall Study||67
2311692|NCT01940705|5676094|P3|STARTED|Overall Study||69
2311693|NCT01940705|5676095|P2|STARTED|Overall Study||67
2311694|NCT01940705|5676096|P1|STARTED|Overall Study||66
2311695|NCT01940523|5676116|P2|NOT COMPLETED|Overall Study||0
2311696|NCT01940523|5676117|P1|NOT COMPLETED|Overall Study||0
2311697|NCT01940523|5676116|P2|COMPLETED|Overall Study||320
2311698|NCT01940523|5676117|P1|COMPLETED|Overall Study||320
2311699|NCT01940523|5676116|P2|STARTED|Overall Study||320
2311700|NCT01940523|5676117|P1|STARTED|Overall Study||320
2311701|NCT01940510|5676127|P1|NOT COMPLETED|Overall Study||0
2311702|NCT01940510|5676127|P1|COMPLETED|Overall Study||24
2311703|NCT01940510|5676127|P1|STARTED|Overall Study||24
2311704|NCT01940497|5676160|P2|NOT COMPLETED|Overall Study||118
2311705|NCT01940497|5676161|P1|NOT COMPLETED|Overall Study||120
2311706|NCT01940497|5676160|P2|COMPLETED|Overall Study||1
2311707|NCT01940497|5676161|P1|COMPLETED|Overall Study||1
2311708|NCT01940497|5676160|P2|Treated: Neoadjuvant|Overall Study||21
2311709|NCT01940497|5676161|P1|Treated: Neoadjuvant|Overall Study||20
2311710|NCT01940497|5676160|P2|Treated: Adjuvant|Overall Study||92
2311711|NCT01940497|5676161|P1|Treated: Adjuvant|Overall Study||95
2311712|NCT01940497|5676160|P2|Treated|Overall Study||113
2311713|NCT01940497|5676161|P1|Treated|Overall Study||115
2311714|NCT01940497|5676160|P2|STARTED|Overall Study||119
2311715|NCT01940497|5676161|P1|STARTED|Overall Study||121
2311716|NCT01940484|5676200|P1|NOT COMPLETED|Overall Study||10
2311717|NCT01940484|5676200|P1|COMPLETED|Overall Study||88
2311718|NCT01940484|5676200|P1|STARTED|Overall Study||98
2311719|NCT01940471|5676220|P2|NOT COMPLETED|Open-Label Extension||8
2311720|NCT01940471|5676221|P1|NOT COMPLETED|Open-Label Extension||14
2311721|NCT01940471|5676220|P2|COMPLETED|Open-Label Extension||0
2311722|NCT01940471|5676221|P1|COMPLETED|Open-Label Extension||0
2311723|NCT01940471|5676220|P2|STARTED|Open-Label Extension||8
2311724|NCT01940471|5676221|P1|STARTED|Open-Label Extension||14
2311725|NCT01940471|5676220|P2|NOT COMPLETED|Double-Blind Phase||285
2311726|NCT01940471|5676221|P1|NOT COMPLETED|Double-Blind Phase||568
2311727|NCT01940471|5676220|P2|COMPLETED|Double-Blind Phase||8
2311728|NCT01940471|5676221|P1|COMPLETED|Double-Blind Phase||14
2311729|NCT01940471|5676220|P2|STARTED|Double-Blind Phase||293
2311730|NCT01940471|5676221|P1|STARTED|Double-Blind Phase||582
2311731|NCT01940354|5676239|P2|NOT COMPLETED|Overall Study||2
2311732|NCT01940354|5676240|P1|NOT COMPLETED|Overall Study||4
2311733|NCT01940354|5676239|P2|COMPLETED|Overall Study||108
2311734|NCT01940354|5676240|P1|COMPLETED|Overall Study||106
2311735|NCT01940354|5676239|P2|STARTED|Overall Study||110
2311736|NCT01940354|5676240|P1|STARTED|Overall Study||110
2311737|NCT01940341|5676252|P2|NOT COMPLETED|Open-label Extension Phase||1
2311738|NCT01940341|5676253|P1|NOT COMPLETED|Open-label Extension Phase||4
2311739|NCT01940341|5676252|P2|COMPLETED|Open-label Extension Phase||0
2311740|NCT01940341|5676253|P1|COMPLETED|Open-label Extension Phase||0
2311741|NCT01940341|5676252|P2|STARTED|Open-label Extension Phase||1
2311742|NCT01940341|5676253|P1|STARTED|Open-label Extension Phase||4
2311743|NCT01940341|5676252|P2|NOT COMPLETED|Double-Blind Phase||140
2311744|NCT01940341|5676253|P1|NOT COMPLETED|Double-Blind Phase||281
2311745|NCT01940341|5676252|P2|COMPLETED|Double-Blind Phase||1
2311746|NCT01940341|5676253|P1|COMPLETED|Double-Blind Phase||4
2311747|NCT01940341|5676252|P2|STARTED|Double-Blind Phase||141
2311748|NCT01940341|5676253|P1|STARTED|Double-Blind Phase||285
2311749|NCT01940146|5676271|P4|NOT COMPLETED|Overall Study||2
2311750|NCT01940146|5676272|P3|NOT COMPLETED|Overall Study||1
2311751|NCT01940146|5676273|P2|NOT COMPLETED|Overall Study||0
2311752|NCT01940146|5676274|P1|NOT COMPLETED|Overall Study||1
2311753|NCT01940146|5676271|P4|COMPLETED|Overall Study||53
2311754|NCT01940146|5676272|P3|COMPLETED|Overall Study||55
2311755|NCT01940146|5676273|P2|COMPLETED|Overall Study||55
2311756|NCT01940146|5676274|P1|COMPLETED|Overall Study||55
2311757|NCT01940146|5676271|P4|STARTED|Overall Study||55
2311758|NCT01940146|5676272|P3|STARTED|Overall Study||56
2311759|NCT01940146|5676273|P2|STARTED|Overall Study||55
2311760|NCT01940146|5676274|P1|STARTED|Overall Study||56
2311761|NCT01940120|5676284|P1|NOT COMPLETED|Overall Study||48
2311762|NCT01940120|5676284|P1|COMPLETED|Overall Study||30
2311763|NCT01940120|5676284|P1|STARTED|Overall Study||78
2311764|NCT01939977|5676440|P2|NOT COMPLETED|Overall Study||7
2311765|NCT01939977|5676441|P1|NOT COMPLETED|Overall Study||9
2311766|NCT01939977|5676440|P2|COMPLETED|Overall Study||41
2311767|NCT01939977|5676441|P1|COMPLETED|Overall Study||37
2311768|NCT01939977|5676440|P2|STARTED|Overall Study|48 patients randomized but 1 did not meet inclusion criteria. 47 patients analyzed.|48
2311769|NCT01939977|5676441|P1|STARTED|Overall Study||46
2311770|NCT01939938|5676477|P1|NOT COMPLETED|Overall Study||0
2311771|NCT01939938|5676477|P1|COMPLETED|Overall Study||10
2311772|NCT01939938|5676477|P1|STARTED|Overall Study||10
2311773|NCT01939899|5676488|P5|NOT COMPLETED|Phase 2||1
2311774|NCT01939899|5676489|P4|NOT COMPLETED|Phase 2||11
2311775|NCT01939899|5676490|P3|NOT COMPLETED|Phase 2||0
2311776|NCT01939899|5676491|P2|NOT COMPLETED|Phase 2||0
2311777|NCT01939899|5676492|P1|NOT COMPLETED|Phase 2||0
2311778|NCT01939899|5676488|P5|COMPLETED|Phase 2||0
2311779|NCT01939899|5676489|P4|COMPLETED|Phase 2||1
2311780|NCT01939899|5676490|P3|COMPLETED|Phase 2||0
2311781|NCT01939899|5676491|P2|COMPLETED|Phase 2||0
2311782|NCT01939899|5676492|P1|COMPLETED|Phase 2||0
2311783|NCT01939899|5676488|P5|STARTED|Phase 2||1
2311784|NCT01939899|5676489|P4|STARTED|Phase 2||12
2311785|NCT01939899|5676490|P3|STARTED|Phase 2||0
2311786|NCT01939899|5676491|P2|STARTED|Phase 2||0
2311787|NCT01939899|5676492|P1|STARTED|Phase 2||0
2311788|NCT01939899|5676488|P5|NOT COMPLETED|Lead-in Dose Finding Phase||0
2311789|NCT01939899|5676489|P4|NOT COMPLETED|Lead-in Dose Finding Phase||0
2311790|NCT01939899|5676490|P3|NOT COMPLETED|Lead-in Dose Finding Phase||5
2311791|NCT01939899|5676491|P2|NOT COMPLETED|Lead-in Dose Finding Phase||7
2311792|NCT01939899|5676492|P1|NOT COMPLETED|Lead-in Dose Finding Phase||2
2311793|NCT01939899|5676488|P5|COMPLETED|Lead-in Dose Finding Phase||0
2311794|NCT01939899|5676489|P4|COMPLETED|Lead-in Dose Finding Phase||0
2311795|NCT01939899|5676490|P3|COMPLETED|Lead-in Dose Finding Phase||1
2311796|NCT01939899|5676491|P2|COMPLETED|Lead-in Dose Finding Phase||0
2311797|NCT01939899|5676492|P1|COMPLETED|Lead-in Dose Finding Phase||1
2311798|NCT01939899|5676488|P5|STARTED|Lead-in Dose Finding Phase||0
2311799|NCT01939899|5676489|P4|STARTED|Lead-in Dose Finding Phase||0
2311800|NCT01939899|5676490|P3|STARTED|Lead-in Dose Finding Phase||6
2311801|NCT01939899|5676491|P2|STARTED|Lead-in Dose Finding Phase||7
2311802|NCT01939899|5676492|P1|STARTED|Lead-in Dose Finding Phase||3
2311803|NCT01939548|5676539|P3|NOT COMPLETED|Overall Study||30
2311804|NCT01939548|5676540|P2|NOT COMPLETED|Overall Study||49
2311805|NCT01939548|5676541|P1|NOT COMPLETED|Overall Study||37
2311806|NCT01939548|5676539|P3|COMPLETED|Overall Study||50
2311807|NCT01939548|5676540|P2|COMPLETED|Overall Study||33
2311808|NCT01939548|5676541|P1|COMPLETED|Overall Study||41
2311809|NCT01939548|5676539|P3|STARTED|Overall Study||80
2311810|NCT01939548|5676540|P2|STARTED|Overall Study||82
2311811|NCT01939548|5676541|P1|STARTED|Overall Study||78
2311812|NCT01939496|5676615|P3|NOT COMPLETED|Overall Study||2
2311813|NCT01939496|5676616|P2|NOT COMPLETED|Overall Study||3
2311814|NCT01939496|5676617|P1|NOT COMPLETED|Overall Study||9
2311815|NCT01939496|5676615|P3|COMPLETED|Overall Study||54
2311816|NCT01939496|5676616|P2|COMPLETED|Overall Study||54
2311817|NCT01939496|5676617|P1|COMPLETED|Overall Study||47
2311818|NCT01939496|5676615|P3|STARTED|Overall Study||56
2311819|NCT01939496|5676616|P2|STARTED|Overall Study||57
2311820|NCT01939496|5676617|P1|STARTED|Overall Study||56
2311821|NCT01939405|5676669|P2|NOT COMPLETED|Overall Study||2
2311822|NCT01939405|5676670|P1|NOT COMPLETED|Overall Study||3
2311823|NCT01939405|5676669|P2|COMPLETED|Overall Study||28
2311824|NCT01939405|5676670|P1|COMPLETED|Overall Study||27
2311825|NCT01939405|5676669|P2|STARTED|Overall Study||30
2311826|NCT01939405|5676670|P1|STARTED|Overall Study||30
2311827|NCT01939366|5676687|P5|NOT COMPLETED|Overall Study||18
2311828|NCT01939366|5676688|P4|NOT COMPLETED|Overall Study||17
2311829|NCT01939366|5676689|P3|NOT COMPLETED|Overall Study||38
2311830|NCT01939366|5676690|P2|NOT COMPLETED|Overall Study||23
2311831|NCT01939366|5676691|P1|NOT COMPLETED|Overall Study||14
2311832|NCT01939366|5676687|P5|COMPLETED|Overall Study||48
2311833|NCT01939366|5676688|P4|COMPLETED|Overall Study||51
2311834|NCT01939366|5676689|P3|COMPLETED|Overall Study||27
2311835|NCT01939366|5676690|P2|COMPLETED|Overall Study||41
2311836|NCT01939366|5676691|P1|COMPLETED|Overall Study||52
2311837|NCT01939366|5676687|P5|Per Protocol Set|Overall Study||49
2311838|NCT01939366|5676688|P4|Per Protocol Set|Overall Study||51
2311839|NCT01939366|5676689|P3|Per Protocol Set|Overall Study||50
2311840|NCT01939366|5676690|P2|Per Protocol Set|Overall Study||55
2311841|NCT01939366|5676691|P1|Per Protocol Set|Overall Study||58
2311842|NCT01939366|5676687|P5|Full Analysis Set|Overall Study||62
2311843|NCT01939366|5676688|P4|Full Analysis Set|Overall Study||65
2311844|NCT01939366|5676689|P3|Full Analysis Set|Overall Study||61
2311845|NCT01939366|5676690|P2|Full Analysis Set|Overall Study||60
2311846|NCT01939366|5676691|P1|Full Analysis Set|Overall Study||64
2311847|NCT01939366|5676687|P5|Safety Set|Overall Study||62
2311848|NCT01939366|5676688|P4|Safety Set|Overall Study||65
2311849|NCT01939366|5676689|P3|Safety Set|Overall Study||62
2311850|NCT01939366|5676690|P2|Safety Set|Overall Study||61
2311851|NCT01939366|5676691|P1|Safety Set|Overall Study||64
2311852|NCT01939366|5676687|P5|Allocated Set Excl. Non-compliant Sites|Overall Study||63
2311853|NCT01939366|5676688|P4|Allocated Set Excl. Non-compliant Sites|Overall Study||65
2311854|NCT01939366|5676689|P3|Allocated Set Excl. Non-compliant Sites|Overall Study||63
2311855|NCT01939366|5676690|P2|Allocated Set Excl. Non-compliant Sites|Overall Study||61
2311856|NCT01939366|5676691|P1|Allocated Set Excl. Non-compliant Sites|Overall Study||64
2311857|NCT01939366|5676687|P5|STARTED|Overall Study||66
2311858|NCT01939366|5676688|P4|STARTED|Overall Study||68
2311859|NCT01939366|5676689|P3|STARTED|Overall Study||65
2311860|NCT01939366|5676690|P2|STARTED|Overall Study||64
2311861|NCT01939366|5676691|P1|STARTED|Overall Study||66
2311862|NCT01939314|5676705|P2|NOT COMPLETED|Overall Study||8
2311863|NCT01939314|5676706|P1|NOT COMPLETED|Overall Study||9
2311864|NCT01939314|5676705|P2|COMPLETED|Overall Study||40
2311865|NCT01939314|5676706|P1|COMPLETED|Overall Study||36
2311866|NCT01939314|5676705|P2|24 Hour Endpoint|Overall Study||40
2311867|NCT01939314|5676706|P1|24 Hour Endpoint|Overall Study||36
2311868|NCT01939314|5676705|P2|15 Minute Endpoint|Overall Study||46
2311869|NCT01939314|5676706|P1|15 Minute Endpoint|Overall Study||41
2311870|NCT01939314|5676705|P2|STARTED|Overall Study||48
2311871|NCT01939314|5676706|P1|STARTED|Overall Study||45
2311872|NCT01939301|5676718|P2|NOT COMPLETED|Overall Study||1
2311873|NCT01939301|5676719|P1|NOT COMPLETED|Overall Study||1
2311874|NCT01939301|5676718|P2|COMPLETED|Overall Study||38
2311875|NCT01939301|5676719|P1|COMPLETED|Overall Study||38
2311876|NCT01939301|5676718|P2|STARTED|Overall Study||39
2311877|NCT01939301|5676719|P1|STARTED|Overall Study||39
2311878|NCT01939288|5676727|P2|NOT COMPLETED|Overall Study||0
2311879|NCT01939288|5676728|P1|NOT COMPLETED|Overall Study||0
2311880|NCT01939288|5676727|P2|COMPLETED|Overall Study||5
2311881|NCT01939288|5676728|P1|COMPLETED|Overall Study||5
2311882|NCT01939288|5676727|P2|STARTED|Overall Study||5
2311883|NCT01939288|5676728|P1|STARTED|Overall Study||5
2311884|NCT01939275|5676734|P1|NOT COMPLETED|Overall Study||0
2311885|NCT01939275|5676734|P1|COMPLETED|Overall Study||8
2311886|NCT01939275|5676734|P1|STARTED|Overall Study||8
2311887|NCT01939223|5676740|P2|NOT COMPLETED|Overall Study||11
2311888|NCT01939223|5676741|P1|NOT COMPLETED|Overall Study||13
2311889|NCT01939223|5676740|P2|COMPLETED|Overall Study||0
2311890|NCT01939223|5676741|P1|COMPLETED|Overall Study||1
2311891|NCT01939223|5676740|P2|Participants Received Treatment|Overall Study||11
2311892|NCT01939223|5676741|P1|Participants Received Treatment|Overall Study||14
2311893|NCT01939223|5676740|P2|STARTED|Overall Study||11
2311894|NCT01939223|5676741|P1|STARTED|Overall Study||14
2311895|NCT01939197|5676756|P7|NOT COMPLETED|Overall Study||2
2311896|NCT01939197|5676757|P6|NOT COMPLETED|Overall Study||1
2311897|NCT01939197|5676758|P5|NOT COMPLETED|Overall Study||4
2311898|NCT01939197|5676759|P4|NOT COMPLETED|Overall Study||1
2311899|NCT01939197|5676760|P3|NOT COMPLETED|Overall Study||0
2311900|NCT01939197|5676761|P2|NOT COMPLETED|Overall Study||1
2311901|NCT01939197|5676762|P1|NOT COMPLETED|Overall Study||1
2311902|NCT01939197|5676756|P7|COMPLETED|Overall Study||26
2311903|NCT01939197|5676757|P6|COMPLETED|Overall Study||4
2311904|NCT01939197|5676758|P5|COMPLETED|Overall Study||196
2311905|NCT01939197|5676759|P4|COMPLETED|Overall Study||11
2311906|NCT01939197|5676760|P3|COMPLETED|Overall Study||10
2311907|NCT01939197|5676761|P2|COMPLETED|Overall Study||31
2311908|NCT01939197|5676762|P1|COMPLETED|Overall Study||30
2311909|NCT01939197|5676756|P7|STARTED|Overall Study||28
2311910|NCT01939197|5676757|P6|STARTED|Overall Study||5
2311911|NCT01939197|5676758|P5|STARTED|Overall Study||200
2311912|NCT01939197|5676759|P4|STARTED|Overall Study||12
2311913|NCT01939197|5676760|P3|STARTED|Overall Study||10
2311914|NCT01939197|5676761|P2|STARTED|Overall Study||32
2311915|NCT01939197|5676762|P1|STARTED|Overall Study||31
2311916|NCT01939145|5676822|P2|NOT COMPLETED|Overall Study||7
2311917|NCT01939145|5676823|P1|NOT COMPLETED|Overall Study||2
2311918|NCT01939145|5676822|P2|COMPLETED|Overall Study||44
2311919|NCT01939145|5676823|P1|COMPLETED|Overall Study||47
2311920|NCT01939145|5676822|P2|STARTED|Overall Study||51
2311921|NCT01939145|5676823|P1|STARTED|Overall Study||49
2311922|NCT01939002|5676833|P2|NOT COMPLETED|Overall Study||18
2311923|NCT01939002|5676834|P1|NOT COMPLETED|Overall Study||19
2311924|NCT01939002|5676833|P2|COMPLETED|Overall Study||80
2311925|NCT01939002|5676834|P1|COMPLETED|Overall Study||84
2311926|NCT01939002|5676833|P2|STARTED|Overall Study||98
2311927|NCT01939002|5676834|P1|STARTED|Overall Study||103
2311928|NCT01938989|5676900|P2|NOT COMPLETED|Overall Study||0
2311929|NCT01938989|5676901|P1|NOT COMPLETED|Overall Study||0
2311930|NCT01938989|5676900|P2|COMPLETED|Overall Study||77
2311931|NCT01938989|5676901|P1|COMPLETED|Overall Study||77
2311932|NCT01938989|5676900|P2|STARTED|Overall Study||77
2311933|NCT01938989|5676901|P1|STARTED|Overall Study||77
2311934|NCT01938846|5676910|P3|NOT COMPLETED|Overall Study||24
2311935|NCT01938846|5676911|P2|NOT COMPLETED|Overall Study||25
2311936|NCT01938846|5676912|P1|NOT COMPLETED|Overall Study||41
2311937|NCT01938846|5676910|P3|COMPLETED|Overall Study||0
2311938|NCT01938846|5676911|P2|COMPLETED|Overall Study||0
2311939|NCT01938846|5676912|P1|COMPLETED|Overall Study||0
2311940|NCT01938846|5676910|P3|STARTED|Overall Study||24
2311941|NCT01938846|5676911|P2|STARTED|Overall Study||25
2311942|NCT01938846|5676912|P1|STARTED|Overall Study||41
2311943|NCT01938833|5677104|P1|NOT COMPLETED|Overall Study||0
2311944|NCT01938833|5677104|P1|COMPLETED|Overall Study||9
2311945|NCT01938833|5677104|P1|STARTED|Overall Study||9
2311946|NCT01938664|5677114|P2|NOT COMPLETED|Overall Study||10
2311947|NCT01938664|5677115|P1|NOT COMPLETED|Overall Study||15
2311948|NCT01938664|5677114|P2|COMPLETED|Overall Study||0
2311949|NCT01938664|5677115|P1|COMPLETED|Overall Study||5
2311950|NCT01938664|5677114|P2|STARTED|Overall Study||10
2311951|NCT01938664|5677115|P1|STARTED|Overall Study||20
2311952|NCT01938625|5677127|P2|NOT COMPLETED|Overall Study||2
2311953|NCT01938625|5677128|P1|NOT COMPLETED|Overall Study||0
2311954|NCT01938625|5677127|P2|COMPLETED|Overall Study||23
2311955|NCT01938625|5677128|P1|COMPLETED|Overall Study||10
2311956|NCT01938625|5677127|P2|STARTED|Overall Study||25
2311957|NCT01938625|5677128|P1|STARTED|Overall Study||10
2311958|NCT01938573|5677148|P2|NOT COMPLETED|Overall Study||0
2311959|NCT01938573|5677149|P1|NOT COMPLETED|Overall Study||2
2311960|NCT01938573|5677148|P2|COMPLETED|Overall Study||6
2311961|NCT01938573|5677149|P1|COMPLETED|Overall Study||13
2311962|NCT01938573|5677148|P2|STARTED|Overall Study||6
2311963|NCT01938573|5677149|P1|STARTED|Overall Study||15
2311964|NCT01938430|5677169|P14|NOT COMPLETED|Overall Study||1
2311965|NCT01938430|5677170|P13|NOT COMPLETED|Overall Study||0
2311966|NCT01938430|5677171|P12|NOT COMPLETED|Overall Study||1
2311967|NCT01938430|5677172|P11|NOT COMPLETED|Overall Study||3
2311968|NCT01938430|5677173|P10|NOT COMPLETED|Overall Study||3
2311969|NCT01938430|5677174|P9|NOT COMPLETED|Overall Study||4
2311970|NCT01938430|5677175|P8|NOT COMPLETED|Overall Study||1
2311971|NCT01938430|5677176|P7|NOT COMPLETED|Overall Study||2
2311972|NCT01938430|5677177|P6|NOT COMPLETED|Overall Study||1
2311973|NCT01938430|5677178|P5|NOT COMPLETED|Overall Study||0
2311974|NCT01938430|5677179|P4|NOT COMPLETED|Overall Study||2
2311975|NCT01938430|5677180|P3|NOT COMPLETED|Overall Study||5
2311976|NCT01938430|5677181|P2|NOT COMPLETED|Overall Study||3
2311977|NCT01938430|5677182|P1|NOT COMPLETED|Overall Study||4
2311978|NCT01938430|5677169|P14|COMPLETED|Overall Study||2
2311979|NCT01938430|5677170|P13|COMPLETED|Overall Study||4
2311980|NCT01938430|5677171|P12|COMPLETED|Overall Study||3
2311981|NCT01938430|5677172|P11|COMPLETED|Overall Study||3
2311982|NCT01938430|5677173|P10|COMPLETED|Overall Study||23
2311983|NCT01938430|5677174|P9|COMPLETED|Overall Study||22
2311984|NCT01938430|5677175|P8|COMPLETED|Overall Study||24
2311985|NCT01938430|5677176|P7|COMPLETED|Overall Study||24
2311986|NCT01938430|5677177|P6|COMPLETED|Overall Study||55
2311987|NCT01938430|5677178|P5|COMPLETED|Overall Study||55
2311988|NCT01938430|5677179|P4|COMPLETED|Overall Study||24
2311989|NCT01938430|5677180|P3|COMPLETED|Overall Study||18
2311990|NCT01938430|5677181|P2|COMPLETED|Overall Study||26
2311991|NCT01938430|5677182|P1|COMPLETED|Overall Study||26
2311992|NCT01938430|5677169|P14|STARTED|Overall Study||3
2311993|NCT01938430|5677170|P13|STARTED|Overall Study||4
2311994|NCT01938430|5677171|P12|STARTED|Overall Study||4
2311995|NCT01938430|5677172|P11|STARTED|Overall Study||6
2311996|NCT01938430|5677173|P10|STARTED|Overall Study||26
2311997|NCT01938430|5677174|P9|STARTED|Overall Study||26
2311998|NCT01938430|5677175|P8|STARTED|Overall Study||25
2311999|NCT01938430|5677176|P7|STARTED|Overall Study||26
2312000|NCT01938430|5677177|P6|STARTED|Overall Study||56
2312001|NCT01938430|5677178|P5|STARTED|Overall Study||55
2312002|NCT01938430|5677179|P4|STARTED|Overall Study||26
2312003|NCT01938430|5677180|P3|STARTED|Overall Study||23
2312004|NCT01938430|5677181|P2|STARTED|Overall Study||29
2312005|NCT01938430|5677182|P1|STARTED|Overall Study||30
2312006|NCT01938391|5677507|P1|NOT COMPLETED|12 Month Follow up||2
2312007|NCT01938391|5677507|P1|COMPLETED|12 Month Follow up||22
2312008|NCT01938391|5677507|P1|STARTED|12 Month Follow up||24
2312009|NCT01938391|5677507|P1|NOT COMPLETED|6 Month Follow up||1
2312010|NCT01938391|5677507|P1|COMPLETED|6 Month Follow up||24
2312011|NCT01938391|5677507|P1|STARTED|6 Month Follow up||25
2312012|NCT01938391|5677507|P1|NOT COMPLETED|2 Week Follow up||0
2312013|NCT01938391|5677507|P1|COMPLETED|2 Week Follow up||25
2312014|NCT01938391|5677507|P1|STARTED|2 Week Follow up||25
2312015|NCT01938391|5677507|P1|NOT COMPLETED|Baseline||0
2312016|NCT01938391|5677507|P1|COMPLETED|Baseline||25
2312017|NCT01938391|5677507|P1|STARTED|Baseline||25
2312018|NCT01938170|5677517|P1|NOT COMPLETED|Overall Study||0
2312019|NCT01938170|5677517|P1|COMPLETED|Overall Study||41
2312020|NCT01938170|5677517|P1|STARTED|Overall Study||41
2312021|NCT01938079|5677524|P2|NOT COMPLETED|Overall Study||0
2312022|NCT01938079|5677525|P1|NOT COMPLETED|Overall Study||0
2312023|NCT01938079|5677524|P2|COMPLETED|Overall Study||10
2312024|NCT01938079|5677525|P1|COMPLETED|Overall Study||10
2312025|NCT01938079|5677524|P2|STARTED|Overall Study||10
2312026|NCT01938079|5677525|P1|STARTED|Overall Study||10
2312027|NCT01938066|5677533|P2|NOT COMPLETED|Overall Study||2
2312028|NCT01938066|5677534|P1|NOT COMPLETED|Overall Study||1
2312029|NCT01938066|5677533|P2|COMPLETED|Overall Study||13
2312030|NCT01938066|5677534|P1|COMPLETED|Overall Study||14
2312031|NCT01938066|5677533|P2|STARTED|Overall Study||15
2312032|NCT01938066|5677534|P1|STARTED|Overall Study||15
2312033|NCT01938040|5677544|P2|NOT COMPLETED|Overall Study||0
2312034|NCT01938040|5677545|P1|NOT COMPLETED|Overall Study||0
2312035|NCT01938040|5677544|P2|COMPLETED|Overall Study||27
2312036|NCT01938040|5677545|P1|COMPLETED|Overall Study||28
2312037|NCT01938040|5677544|P2|Behavior Metrics|Overall Study||27
2312038|NCT01938040|5677545|P1|Behavior Metrics|Overall Study||28
2312039|NCT01938040|5677544|P2|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|25
2312040|NCT01938040|5677545|P1|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|24
2312041|NCT01938040|5677544|P2|STARTED|Overall Study||27
2312042|NCT01938040|5677545|P1|STARTED|Overall Study||28
2312043|NCT01938001|5677573|P2|NOT COMPLETED|Overall Study||47
2312044|NCT01938001|5677574|P1|NOT COMPLETED|Overall Study||43
2312045|NCT01938001|5677573|P2|COMPLETED|Overall Study||133
2312046|NCT01938001|5677574|P1|COMPLETED|Overall Study||135
2312047|NCT01938001|5677573|P2|Completed Treatment|Overall Study||110
2312048|NCT01938001|5677574|P1|Completed Treatment|Overall Study||124
2312049|NCT01938001|5677573|P2|Participants Received Treatment|Overall Study||180
2312050|NCT01938001|5677574|P1|Participants Received Treatment|Overall Study||176
2312051|NCT01938001|5677573|P2|STARTED|Overall Study||180
2312052|NCT01938001|5677574|P1|STARTED|Overall Study||178
2312053|NCT01937975|5677601|P3|NOT COMPLETED|Overall Study||0
2312054|NCT01937975|5677602|P2|NOT COMPLETED|Overall Study||0
2312055|NCT01937975|5677603|P1|NOT COMPLETED|Overall Study||0
2312056|NCT01937975|5677601|P3|COMPLETED|Overall Study||8
2312057|NCT01937975|5677602|P2|COMPLETED|Overall Study||8
2312058|NCT01937975|5677603|P1|COMPLETED|Overall Study||8
2312059|NCT01937975|5677601|P3|STARTED|Overall Study||8
2312060|NCT01937975|5677602|P2|STARTED|Overall Study||8
2312061|NCT01937975|5677603|P1|STARTED|Overall Study||8
2312062|NCT01937871|5677653|P3|NOT COMPLETED|Overall Study||11
2312063|NCT01937871|5677654|P2|NOT COMPLETED|Overall Study||17
2312064|NCT01937871|5677655|P1|NOT COMPLETED|Overall Study||24
2312065|NCT01937871|5677653|P3|COMPLETED|Overall Study||174
2312066|NCT01937871|5677654|P2|COMPLETED|Overall Study||346
2312067|NCT01937871|5677655|P1|COMPLETED|Overall Study||337
2312068|NCT01937871|5677653|P3|Received at Least One Dose of Study Drug|Overall Study||185
2312069|NCT01937871|5677654|P2|Received at Least One Dose of Study Drug|Overall Study||362
2312070|NCT01937871|5677655|P1|Received at Least One Dose of Study Drug|Overall Study||361
2312071|NCT01937871|5677653|P3|STARTED|Overall Study||185
2312072|NCT01937871|5677654|P2|STARTED|Overall Study||363
2312073|NCT01937871|5677655|P1|STARTED|Overall Study||361
2312074|NCT01937715|5677731|P5|NOT COMPLETED|Overall Study||2
2312075|NCT01937715|5677732|P4|NOT COMPLETED|Overall Study||4
2312076|NCT01937715|5677733|P3|NOT COMPLETED|Overall Study||0
2312077|NCT01937715|5677734|P2|NOT COMPLETED|Overall Study||1
2312078|NCT01937715|5677735|P1|NOT COMPLETED|Overall Study||0
2312079|NCT01937715|5677731|P5|COMPLETED|Overall Study||1
2312080|NCT01937715|5677732|P4|COMPLETED|Overall Study||1
2312081|NCT01937715|5677733|P3|COMPLETED|Overall Study||3
2312082|NCT01937715|5677734|P2|COMPLETED|Overall Study||3
2312083|NCT01937715|5677735|P1|COMPLETED|Overall Study||3
2312084|NCT01937715|5677731|P5|STARTED|Overall Study||3
2312085|NCT01937715|5677732|P4|STARTED|Overall Study||5
2312086|NCT01937715|5677733|P3|STARTED|Overall Study||3
2312087|NCT01937715|5677734|P2|STARTED|Overall Study||4
2312088|NCT01937715|5677735|P1|STARTED|Overall Study||3
2312089|NCT01937624|5677857|P1|NOT COMPLETED|Overall Study||0
2312090|NCT01937624|5677857|P1|COMPLETED|Overall Study||51
2312091|NCT01937624|5677857|P1|STARTED|Overall Study||51
2312092|NCT01937598|5677861|P2|NOT COMPLETED|Overall Study||0
2312093|NCT01937598|5677862|P1|NOT COMPLETED|Overall Study||0
2312094|NCT01937598|5677861|P2|COMPLETED|Overall Study||8
2312095|NCT01937598|5677862|P1|COMPLETED|Overall Study||8
2312096|NCT01937598|5677861|P2|STARTED|Overall Study||8
2312097|NCT01937598|5677862|P1|STARTED|Overall Study||8
2312098|NCT01937520|5677886|P2|NOT COMPLETED|Overall Study||0
2312099|NCT01937520|5677887|P1|NOT COMPLETED|Overall Study||0
2312100|NCT01937520|5677886|P2|COMPLETED|Overall Study||9
2312101|NCT01937520|5677887|P1|COMPLETED|Overall Study||11
2312102|NCT01937520|5677886|P2|STARTED|Overall Study||9
2312103|NCT01937520|5677887|P1|STARTED|Overall Study||11
2312104|NCT01937507|5677923|P1|NOT COMPLETED|Overall Study||2
2312105|NCT01937507|5677923|P1|COMPLETED|Overall Study||0
2312106|NCT01937507|5677923|P1|STARTED|Overall Study||2
2312107|NCT01937390|5677930|P1|NOT COMPLETED|Overall Study||35
2312108|NCT01937390|5677930|P1|COMPLETED|Overall Study||550
2312109|NCT01937390|5677930|P1|STARTED|Overall Study||585
2312110|NCT01937364|5677940|P2|NOT COMPLETED|Overall Study||1
2312111|NCT01937364|5677941|P1|NOT COMPLETED|Overall Study||2
2312112|NCT01937364|5677940|P2|COMPLETED|Overall Study||7
2312113|NCT01937364|5677941|P1|COMPLETED|Overall Study||7
2312114|NCT01937364|5677940|P2|STARTED|Overall Study||8
2312115|NCT01937364|5677941|P1|STARTED|Overall Study||9
2312116|NCT01937351|5677953|P2|NOT COMPLETED|Overall Study||2
2312117|NCT01937351|5677954|P1|NOT COMPLETED|Overall Study||9
2312118|NCT01937351|5677953|P2|COMPLETED|Overall Study||26
2312119|NCT01937351|5677954|P1|COMPLETED|Overall Study||125
2312120|NCT01937351|5677953|P2|6-Month Follow-up|Overall Study||26
2312121|NCT01937351|5677954|P1|6-Month Follow-up|Overall Study||125
2312122|NCT01937351|5677953|P2|30-Day Follow-up|Overall Study||27
2312123|NCT01937351|5677954|P1|30-Day Follow-up|Overall Study||128
2312124|NCT01937351|5677953|P2|Treated w Study Device|Overall Study||28
2312125|NCT01937351|5677954|P1|Treated w Study Device|Overall Study||130
2312126|NCT01937351|5677953|P2|STARTED|Overall Study||28
2312127|NCT01937351|5677954|P1|STARTED|Overall Study||134
2312128|NCT01937312|5677962|P2|NOT COMPLETED|Overall Study||3
2312129|NCT01937312|5677963|P1|NOT COMPLETED|Overall Study||11
2312130|NCT01937312|5677962|P2|COMPLETED|Overall Study||92
2312131|NCT01937312|5677963|P1|COMPLETED|Overall Study||83
2312132|NCT01937312|5677962|P2|Treated|Overall Study||95
2312133|NCT01937312|5677963|P1|Treated|Overall Study||93
2312134|NCT01937312|5677962|P2|STARTED|Overall Study||95
2312135|NCT01937312|5677963|P1|STARTED|Overall Study||94
2312136|NCT01937299|5677978|P2|NOT COMPLETED|Overall Study||4
2312137|NCT01937299|5677979|P1|NOT COMPLETED|Overall Study||14
2312138|NCT01937299|5677978|P2|COMPLETED|Overall Study||112
2312139|NCT01937299|5677979|P1|COMPLETED|Overall Study||103
2312140|NCT01937299|5677978|P2|STARTED|Overall Study||116
2312141|NCT01937299|5677979|P1|STARTED|Overall Study||117
2312142|NCT01937260|5677992|P2|NOT COMPLETED|Overall Study||0
2312143|NCT01937260|5677993|P1|NOT COMPLETED|Overall Study||1
2312144|NCT01937260|5677992|P2|COMPLETED|Overall Study||10
2312145|NCT01937260|5677993|P1|COMPLETED|Overall Study||20
2312146|NCT01937260|5677992|P2|STARTED|Overall Study||10
2312147|NCT01937260|5677993|P1|STARTED|Overall Study||21
2312148|NCT01937195|5678000|P1|NOT COMPLETED|Overall Study||0
2312149|NCT01937195|5678000|P1|COMPLETED|Overall Study||95
2312150|NCT01937195|5678000|P1|STARTED|Overall Study||95
2312151|NCT01937130|5678014|P4|NOT COMPLETED|Overall Study||2
2312152|NCT01937130|5678015|P3|NOT COMPLETED|Overall Study||3
2312153|NCT01937130|5678016|P2|NOT COMPLETED|Overall Study||4
2312154|NCT01937130|5678017|P1|NOT COMPLETED|Overall Study||5
2312155|NCT01937130|5678014|P4|COMPLETED|Overall Study||2
2312156|NCT01937130|5678015|P3|COMPLETED|Overall Study||2
2312157|NCT01937130|5678016|P2|COMPLETED|Overall Study||3
2312158|NCT01937130|5678017|P1|COMPLETED|Overall Study||0
2312159|NCT01937130|5678014|P4|STARTED|Overall Study||4
2312160|NCT01937130|5678015|P3|STARTED|Overall Study||5
2312161|NCT01937130|5678016|P2|STARTED|Overall Study||7
2312162|NCT01937130|5678017|P1|STARTED|Overall Study||5
2312163|NCT01937117|5678044|P1|NOT COMPLETED|Overall Study||13
2312164|NCT01937117|5678044|P1|COMPLETED|Overall Study||75
2312165|NCT01937117|5678044|P1|STARTED|Overall Study||88
2312166|NCT01937026|5678048|P1|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||0
2312167|NCT01937026|5678048|P1|COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||18
2312168|NCT01937026|5678048|P1|Received Probenecid on Days 3 Through 7|Period 2 (At Dosing Day 3 Through Day 8)||18
2312169|NCT01937026|5678048|P1|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day 8)||18
2312170|NCT01937026|5678048|P1|STARTED|Period 2 (At Dosing Day 3 Through Day 8)||18
2312171|NCT01937026|5678048|P1|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
2312172|NCT01937026|5678048|P1|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||18
2312173|NCT01937026|5678048|P1|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||18
2312174|NCT01937026|5678048|P1|STARTED|Period 1 (Day 1 Through Predose Day 3)||18
2312175|NCT01936974|5678059|P2|NOT COMPLETED|Overall Study||5
2312176|NCT01936974|5678060|P1|NOT COMPLETED|Overall Study||2
2312177|NCT01936974|5678059|P2|COMPLETED|Overall Study||0
2312178|NCT01936974|5678060|P1|COMPLETED|Overall Study||0
2312179|NCT01936974|5678059|P2|STARTED|Overall Study||5
2312180|NCT01936974|5678060|P1|STARTED|Overall Study||2
2312181|NCT01936909|5678069|P3|NOT COMPLETED|Overall Study||6
2312182|NCT01936909|5678070|P2|NOT COMPLETED|Overall Study||8
2312183|NCT01936909|5678071|P1|NOT COMPLETED|Overall Study||10
2312184|NCT01936909|5678069|P3|COMPLETED|Overall Study||14
2312185|NCT01936909|5678070|P2|COMPLETED|Overall Study||12
2312186|NCT01936909|5678071|P1|COMPLETED|Overall Study||10
2312187|NCT01936909|5678069|P3|STARTED|Overall Study||20
2312188|NCT01936909|5678070|P2|STARTED|Overall Study||20
2312189|NCT01936909|5678071|P1|STARTED|Overall Study||20
2312190|NCT01936896|5678085|P1|NOT COMPLETED|Overall Study||0
2312191|NCT01936896|5678085|P1|COMPLETED|Overall Study||10
2312192|NCT01936896|5678085|P1|STARTED|Overall Study||10
2312193|NCT01936870|5678090|P1|NOT COMPLETED|Overall Study||189
2312194|NCT01936870|5678090|P1|COMPLETED|Overall Study||2303
2312195|NCT01936870|5678090|P1|STARTED|Overall Study||2492
2312196|NCT01936844|5678105|P2|NOT COMPLETED|Overall Study||7
2312197|NCT01936844|5678106|P1|NOT COMPLETED|Overall Study||6
2312198|NCT01936844|5678105|P2|COMPLETED|Overall Study||8
2312199|NCT01936844|5678106|P1|COMPLETED|Overall Study||9
2312200|NCT01936844|5678105|P2|STARTED|Overall Study||15
2312201|NCT01936844|5678106|P1|STARTED|Overall Study||15
2312202|NCT01936662|5678118|P2|NOT COMPLETED|Overall Study||0
2312203|NCT01936662|5678119|P1|NOT COMPLETED|Overall Study||0
2312204|NCT01936662|5678118|P2|COMPLETED|Overall Study||42
2312205|NCT01936662|5678119|P1|COMPLETED|Overall Study||42
2312206|NCT01936662|5678118|P2|STARTED|Overall Study||42
2312207|NCT01936662|5678119|P1|STARTED|Overall Study||42
2312208|NCT01936649|5678127|P1|NOT COMPLETED|Overall Study||13
2312209|NCT01936649|5678127|P1|COMPLETED|Overall Study||50
2312210|NCT01936649|5678127|P1|Treated|Overall Study||51
2312211|NCT01936649|5678127|P1|STARTED|Overall Study||63
2312212|NCT01936623|5678134|P2|NOT COMPLETED|Overall Study||5
2312213|NCT01936623|5678135|P1|NOT COMPLETED|Overall Study||0
2312214|NCT01936623|5678134|P2|COMPLETED|Overall Study||35
2312215|NCT01936623|5678135|P1|COMPLETED|Overall Study||40
2312216|NCT01936623|5678134|P2|STARTED|Overall Study||40
2312217|NCT01936623|5678135|P1|STARTED|Overall Study||40
2312218|NCT01936467|5678149|P2|NOT COMPLETED|Overall Study||0
2312219|NCT01936467|5678150|P1|NOT COMPLETED|Overall Study||0
2312220|NCT01936467|5678149|P2|COMPLETED|Overall Study||61
2312221|NCT01936467|5678150|P1|COMPLETED|Overall Study||60
2312222|NCT01936467|5678149|P2|STARTED|Overall Study||61
2312223|NCT01936467|5678150|P1|STARTED|Overall Study||60
2312224|NCT01936389|5678170|P2|NOT COMPLETED|Overall Study||0
2312225|NCT01936389|5678171|P1|NOT COMPLETED|Overall Study||1
2312226|NCT01936389|5678170|P2|COMPLETED|Overall Study||5
2312227|NCT01936389|5678171|P1|COMPLETED|Overall Study||4
2312228|NCT01936389|5678170|P2|STARTED|Overall Study||5
2312229|NCT01936389|5678171|P1|STARTED|Overall Study||5
2312230|NCT01936363|5678179|P2|NOT COMPLETED|Overall Study||0
2312231|NCT01936363|5678180|P1|NOT COMPLETED|Overall Study||0
2312232|NCT01936363|5678179|P2|COMPLETED|Overall Study||33
2312233|NCT01936363|5678180|P1|COMPLETED|Overall Study||32
2312234|NCT01936363|5678179|P2|STARTED|Overall Study||33
2312235|NCT01936363|5678180|P1|STARTED|Overall Study||32
2312236|NCT01936324|5678207|P3|NOT COMPLETED|Overall Study||5
2312237|NCT01936324|5678208|P2|NOT COMPLETED|Overall Study||6
2312238|NCT01936324|5678209|P1|NOT COMPLETED|Overall Study||0
2312239|NCT01936324|5678207|P3|COMPLETED|Overall Study||50
2312240|NCT01936324|5678208|P2|COMPLETED|Overall Study||47
2312241|NCT01936324|5678209|P1|COMPLETED|Overall Study||6
2312242|NCT01936324|5678207|P3|STARTED|Overall Study||55
2312243|NCT01936324|5678208|P2|STARTED|Overall Study||53
2312244|NCT01936324|5678209|P1|STARTED|Overall Study||6
2312245|NCT01936259|5678222|P2|NOT COMPLETED|Overall Study||20
2312246|NCT01936259|5678223|P1|NOT COMPLETED|Overall Study||12
2312247|NCT01936259|5678222|P2|COMPLETED|Overall Study||111
2312248|NCT01936259|5678223|P1|COMPLETED|Overall Study||118
2312249|NCT01936259|5678222|P2|STARTED|Overall Study||131
2312250|NCT01936259|5678223|P1|STARTED|Overall Study||130
2312251|NCT01936181|5678243|P4|NOT COMPLETED|Transition-extension||5
2312252|NCT01936181|5678244|P3|NOT COMPLETED|Transition-extension||6
2312253|NCT01936181|5678245|P2|NOT COMPLETED|Transition-extension||0
2312254|NCT01936181|5678246|P1|NOT COMPLETED|Transition-extension||15
2312255|NCT01936181|5678243|P4|COMPLETED|Transition-extension||96
2312256|NCT01936181|5678244|P3|COMPLETED|Transition-extension||88
2312257|NCT01936181|5678245|P2|COMPLETED|Transition-extension||0
2312258|NCT01936181|5678246|P1|COMPLETED|Transition-extension||186
2312259|NCT01936181|5678243|P4|STARTED|Transition-extension||101
2312260|NCT01936181|5678244|P3|STARTED|Transition-extension||94
2312261|NCT01936181|5678245|P2|STARTED|Transition-extension||0
2312262|NCT01936181|5678246|P1|STARTED|Transition-extension||201
2312263|NCT01936181|5678243|P4|NOT COMPLETED|Randomised, Double-blind||0
2312264|NCT01936181|5678244|P3|NOT COMPLETED|Randomised, Double-blind||0
2312265|NCT01936181|5678245|P2|NOT COMPLETED|Randomised, Double-blind||68
2312266|NCT01936181|5678246|P1|NOT COMPLETED|Randomised, Double-blind||64
2312267|NCT01936181|5678243|P4|COMPLETED|Randomised, Double-blind||0
2312268|NCT01936181|5678244|P3|COMPLETED|Randomised, Double-blind||0
2312269|NCT01936181|5678245|P2|COMPLETED|Randomised, Double-blind||225
2312270|NCT01936181|5678246|P1|COMPLETED|Randomised, Double-blind||227
2312271|NCT01936181|5678243|P4|STARTED|Randomised, Double-blind||0
2312272|NCT01936181|5678244|P3|STARTED|Randomised, Double-blind||0
2312273|NCT01936181|5678245|P2|STARTED|Randomised, Double-blind||293
2312274|NCT01936181|5678246|P1|STARTED|Randomised, Double-blind||291
2312275|NCT01935947|5678260|P3|NOT COMPLETED|Overall Study||2
2312276|NCT01935947|5678261|P2|NOT COMPLETED|Overall Study||4
2312277|NCT01935947|5678262|P1|NOT COMPLETED|Overall Study||3
2312278|NCT01935947|5678260|P3|COMPLETED|Overall Study||0
2312279|NCT01935947|5678261|P2|COMPLETED|Overall Study||0
2312280|NCT01935947|5678262|P1|COMPLETED|Overall Study||1
2312281|NCT01935947|5678260|P3|Cytotoxic Therapy|Overall Study||2
2312282|NCT01935947|5678261|P2|Cytotoxic Therapy|Overall Study||3
2312283|NCT01935947|5678262|P1|Cytotoxic Therapy|Overall Study||3
2312284|NCT01935947|5678260|P3|Epigenetic Therapy|Overall Study||0
2312285|NCT01935947|5678261|P2|Epigenetic Therapy|Overall Study||4
2312286|NCT01935947|5678262|P1|Epigenetic Therapy|Overall Study||4
2312287|NCT01935947|5678260|P3|STARTED|Overall Study||2
2312288|NCT01935947|5678261|P2|STARTED|Overall Study||4
2312289|NCT01935947|5678262|P1|STARTED|Overall Study||4
2312290|NCT01935622|5678288|P3|NOT COMPLETED|Overall Study||0
2312291|NCT01935622|5678289|P2|NOT COMPLETED|Overall Study||2
2312292|NCT01935622|5678290|P1|NOT COMPLETED|Overall Study||2
2312293|NCT01935622|5678288|P3|COMPLETED|Overall Study||4
2312294|NCT01935622|5678289|P2|COMPLETED|Overall Study||1
2312295|NCT01935622|5678290|P1|COMPLETED|Overall Study||1
2312296|NCT01935622|5678288|P3|STARTED|Overall Study||4
2312297|NCT01935622|5678289|P2|STARTED|Overall Study||3
2312298|NCT01935622|5678290|P1|STARTED|Overall Study||3
2312299|NCT01935180|5678300|P2|NOT COMPLETED|Overall Study||14
2312300|NCT01935180|5678301|P1|NOT COMPLETED|Overall Study||21
2312301|NCT01935180|5678300|P2|COMPLETED|Overall Study||561
2312302|NCT01935180|5678301|P1|COMPLETED|Overall Study||552
2312303|NCT01935180|5678300|P2|STARTED|Overall Study||575
2312304|NCT01935180|5678301|P1|STARTED|Overall Study||573
2312305|NCT01934894|5678321|P2|NOT COMPLETED|Overall Study||5
2312306|NCT01934894|5678322|P1|NOT COMPLETED|Overall Study||6
2312307|NCT01934894|5678321|P2|COMPLETED|Overall Study||0
2312308|NCT01934894|5678322|P1|COMPLETED|Overall Study||0
2312309|NCT01934894|5678321|P2|STARTED|Overall Study||5
2312310|NCT01934894|5678322|P1|STARTED|Overall Study||6
2312311|NCT01934790|5678337|P1|NOT COMPLETED|Long Term Follow up||0
2312312|NCT01934790|5678337|P1|COMPLETED|Long Term Follow up||12
2312313|NCT01934790|5678337|P1|STARTED|Long Term Follow up||12
2312314|NCT01934790|5678337|P1|NOT COMPLETED|Active Follow up||24
2312315|NCT01934790|5678337|P1|COMPLETED|Active Follow up||10
2312316|NCT01934790|5678337|P1|STARTED|Active Follow up||34
2312317|NCT01934790|5678337|P1|NOT COMPLETED|Treatment||16
2312318|NCT01934790|5678337|P1|COMPLETED|Treatment||29
2312319|NCT01934790|5678337|P1|Participants Received Study Treatment|Treatment||44
2312320|NCT01934790|5678337|P1|STARTED|Treatment|Eligible for treatment|45
2312321|NCT01934647|5678368|P3|NOT COMPLETED|Overall Study||0
2312322|NCT01934647|5678369|P2|NOT COMPLETED|Overall Study||0
2312323|NCT01934647|5678370|P1|NOT COMPLETED|Overall Study||0
2312324|NCT01934647|5678368|P3|COMPLETED|Overall Study||3
2312325|NCT01934647|5678369|P2|COMPLETED|Overall Study||2
2312326|NCT01934647|5678370|P1|COMPLETED|Overall Study||2
2312327|NCT01934647|5678368|P3|STARTED|Overall Study||3
2312328|NCT01934647|5678369|P2|STARTED|Overall Study||2
2312329|NCT01934647|5678370|P1|STARTED|Overall Study||2
2312330|NCT01934582|5678378|P1|NOT COMPLETED|Overall Study||0
2312331|NCT01934582|5678378|P1|COMPLETED|Overall Study||13
2312332|NCT01934582|5678378|P1|STARTED|Overall Study||13
2312333|NCT01934517|5678392|P1|NOT COMPLETED|Overall Study||0
2312334|NCT01934517|5678392|P1|COMPLETED|Overall Study||25
2312335|NCT01934517|5678392|P1|STARTED|Overall Study||25
2312336|NCT01934504|5678404|P4|NOT COMPLETED|Overall Study||7
2312337|NCT01934504|5678405|P3|NOT COMPLETED|Overall Study||5
2312338|NCT01934504|5678406|P2|NOT COMPLETED|Overall Study||0
2312339|NCT01934504|5678407|P1|NOT COMPLETED|Overall Study||1
2312340|NCT01934504|5678404|P4|COMPLETED|Overall Study||1
2312341|NCT01934504|5678405|P3|COMPLETED|Overall Study||11
2312342|NCT01934504|5678406|P2|COMPLETED|Overall Study||3
2312343|NCT01934504|5678407|P1|COMPLETED|Overall Study||5
2312344|NCT01934504|5678404|P4|STARTED|Overall Study||8
2312345|NCT01934504|5678405|P3|STARTED|Overall Study||16
2312346|NCT01934504|5678406|P2|STARTED|Overall Study||3
2312347|NCT01934504|5678407|P1|STARTED|Overall Study||6
2312348|NCT01934231|5678429|P1|NOT COMPLETED|Overall Study||0
2312349|NCT01934231|5678429|P1|COMPLETED|Overall Study||27
2312350|NCT01934231|5678429|P1|STARTED|Overall Study||27
2312351|NCT01934218|5678440|P2|NOT COMPLETED|Open-Label Phase||24
2312352|NCT01934218|5678441|P1|NOT COMPLETED|Open-Label Phase||26
2312353|NCT01934218|5678440|P2|COMPLETED|Open-Label Phase||304
2312354|NCT01934218|5678441|P1|COMPLETED|Open-Label Phase||290
2312355|NCT01934218|5678440|P2|STARTED|Open-Label Phase||328
2312356|NCT01934218|5678441|P1|STARTED|Open-Label Phase||316
2312357|NCT01934218|5678440|P2|NOT COMPLETED|Double-blind Phase||54
2312358|NCT01934218|5678441|P1|NOT COMPLETED|Double-blind Phase||48
2312359|NCT01934218|5678440|P2|COMPLETED|Double-blind Phase||356
2312360|NCT01934218|5678441|P1|COMPLETED|Double-blind Phase||356
2312361|NCT01934218|5678440|P2|Analyzed Participants|Double-blind Phase||407
2312362|NCT01934218|5678441|P1|Analyzed Participants|Double-blind Phase||402
2312363|NCT01934218|5678440|P2|STARTED|Double-blind Phase||410
2312364|NCT01934218|5678441|P1|STARTED|Double-blind Phase||404
2312365|NCT01934192|5678452|P4|NOT COMPLETED|Overall Study||1
2312366|NCT01934192|5678453|P3|NOT COMPLETED|Overall Study||1
2312367|NCT01934192|5678454|P2|NOT COMPLETED|Overall Study||7
2312368|NCT01934192|5678455|P1|NOT COMPLETED|Overall Study||9
2312369|NCT01934192|5678452|P4|COMPLETED|Overall Study||3
2312370|NCT01934192|5678453|P3|COMPLETED|Overall Study||3
2312371|NCT01934192|5678454|P2|COMPLETED|Overall Study||37
2312372|NCT01934192|5678455|P1|COMPLETED|Overall Study||31
2312373|NCT01934192|5678452|P4|STARTED|Overall Study||4
2312374|NCT01934192|5678453|P3|STARTED|Overall Study||4
2312375|NCT01934192|5678454|P2|STARTED|Overall Study||44
2312376|NCT01934192|5678455|P1|STARTED|Overall Study||40
2312377|NCT01934140|5678591|P2|NOT COMPLETED|Booster Phase (6 Months)||3
2312378|NCT01934140|5678592|P1|NOT COMPLETED|Booster Phase (6 Months)||5
2312379|NCT01934140|5678591|P2|COMPLETED|Booster Phase (6 Months)||53
2312380|NCT01934140|5678592|P1|COMPLETED|Booster Phase (6 Months)||159
2312381|NCT01934140|5678591|P2|Vaccinated|Booster Phase (6 Months)||56
2312382|NCT01934140|5678592|P1|Vaccinated|Booster Phase (6 Months)||164
2312383|NCT01934140|5678591|P2|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent, were enrolled in booster phase.|56
2312384|NCT01934140|5678592|P1|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent, were enrolled in booster phase.|164
2312385|NCT01934140|5678591|P2|NOT COMPLETED|Persistence Phase (Year 6-10)||25
2312386|NCT01934140|5678592|P1|NOT COMPLETED|Persistence Phase (Year 6-10)||83
2312387|NCT01934140|5678591|P2|COMPLETED|Persistence Phase (Year 6-10)|Participants completed all persistence phase visits|51
2312388|NCT01934140|5678592|P1|COMPLETED|Persistence Phase (Year 6-10)|Participants completed all persistence phase visits|152
2312389|NCT01934140|5678591|P2|STARTED|Persistence Phase (Year 6-10)||76
2312390|NCT01934140|5678592|P1|STARTED|Persistence Phase (Year 6-10)||235
2312391|NCT01934010|5678643|P3|NOT COMPLETED|Overall Study||2
2312392|NCT01934010|5678644|P2|NOT COMPLETED|Overall Study||11
2312393|NCT01934010|5678645|P1|NOT COMPLETED|Overall Study||23
2312394|NCT01934010|5678643|P3|COMPLETED|Overall Study||74
2312395|NCT01934010|5678644|P2|COMPLETED|Overall Study||56
2312396|NCT01934010|5678645|P1|COMPLETED|Overall Study||91
2312397|NCT01934010|5678643|P3|STARTED|Overall Study||76
2312398|NCT01934010|5678644|P2|STARTED|Overall Study||67
2312399|NCT01934010|5678645|P1|STARTED|Overall Study||114
2312406|NCT01933932|5678687|P2|NOT COMPLETED|Overall Study||178
2312407|NCT01933932|5678688|P1|NOT COMPLETED|Overall Study||184
2312408|NCT01933932|5678687|P2|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|78
2312409|NCT01933932|5678688|P1|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|70
2312410|NCT01933932|5678687|P2|STARTED|Overall Study||256
2312411|NCT01933932|5678688|P1|STARTED|Overall Study||254
2312412|NCT01933919|5678706|P2|NOT COMPLETED|Open-label Long-term Phase||6
2312413|NCT01933919|5678707|P1|NOT COMPLETED|Open-label Long-term Phase||7
2312414|NCT01933919|5678706|P2|COMPLETED|Open-label Long-term Phase||9
2312415|NCT01933919|5678707|P1|COMPLETED|Open-label Long-term Phase||12
2312416|NCT01933919|5678706|P2|STARTED|Open-label Long-term Phase||15
2312417|NCT01933919|5678707|P1|STARTED|Open-label Long-term Phase||19
2312418|NCT01933919|5678706|P2|NOT COMPLETED|Double-blind Placebo-controlled Phase||4
2312419|NCT01933919|5678707|P1|NOT COMPLETED|Double-blind Placebo-controlled Phase||0
2312420|NCT01933919|5678706|P2|COMPLETED|Double-blind Placebo-controlled Phase||15
2312421|NCT01933919|5678707|P1|COMPLETED|Double-blind Placebo-controlled Phase||19
2312422|NCT01933919|5678706|P2|Received Study Drug|Double-blind Placebo-controlled Phase||19
2312423|NCT01933919|5678707|P1|Received Study Drug|Double-blind Placebo-controlled Phase||19
2312424|NCT01933919|5678706|P2|STARTED|Double-blind Placebo-controlled Phase||19
2312425|NCT01933919|5678707|P1|STARTED|Double-blind Placebo-controlled Phase||19
2312426|NCT01933880|5678743|P2|NOT COMPLETED|Overall Study||1
2312427|NCT01933880|5678744|P1|NOT COMPLETED|Overall Study||30
2312428|NCT01933880|5678743|P2|COMPLETED|Overall Study||40
2312429|NCT01933880|5678744|P1|COMPLETED|Overall Study||123
2312430|NCT01933880|5678743|P2|STARTED|Overall Study||41
2312431|NCT01933880|5678744|P1|STARTED|Overall Study||153
2312432|NCT01933789|5678818|P9|NOT COMPLETED|Overall Study||0
2312433|NCT01933789|5678819|P8|NOT COMPLETED|Overall Study||14
2312434|NCT01933789|5678820|P7|NOT COMPLETED|Overall Study||15
2312435|NCT01933789|5678821|P6|NOT COMPLETED|Overall Study||67
2312436|NCT01933789|5678822|P5|NOT COMPLETED|Overall Study||59
2312437|NCT01933789|5678823|P4|NOT COMPLETED|Overall Study||1
2312438|NCT01933789|5678824|P3|NOT COMPLETED|Overall Study||0
2312439|NCT01933789|5678825|P2|NOT COMPLETED|Overall Study||1
2312440|NCT01933789|5678826|P1|NOT COMPLETED|Overall Study||6
2312441|NCT01933789|5678818|P9|COMPLETED|Overall Study||25
2312442|NCT01933789|5678819|P8|COMPLETED|Overall Study||47
2312443|NCT01933789|5678820|P7|COMPLETED|Overall Study||43
2312444|NCT01933789|5678821|P6|COMPLETED|Overall Study||221
2312445|NCT01933789|5678822|P5|COMPLETED|Overall Study||190
2312446|NCT01933789|5678823|P4|COMPLETED|Overall Study||1
2312447|NCT01933789|5678824|P3|COMPLETED|Overall Study||2
2312448|NCT01933789|5678825|P2|COMPLETED|Overall Study||66
2312449|NCT01933789|5678826|P1|COMPLETED|Overall Study||59
2312450|NCT01933789|5678818|P9|Qualitative Interviews|Overall Study||25
2312451|NCT01933789|5678819|P8|Qualitative Interviews|Overall Study||0
2312452|NCT01933789|5678820|P7|Qualitative Interviews|Overall Study||0
2312453|NCT01933789|5678821|P6|Qualitative Interviews|Overall Study||0
2312454|NCT01933789|5678822|P5|Qualitative Interviews|Overall Study||0
2312455|NCT01933789|5678823|P4|Qualitative Interviews|Overall Study||0
2312456|NCT01933789|5678824|P3|Qualitative Interviews|Overall Study||0
2312457|NCT01933789|5678825|P2|Qualitative Interviews|Overall Study||0
2312458|NCT01933789|5678826|P1|Qualitative Interviews|Overall Study||0
2312459|NCT01933789|5678818|P9|Completed 6-Month Survey|Overall Study||0
2312460|NCT01933789|5678819|P8|Completed 6-Month Survey|Overall Study||40
2312461|NCT01933789|5678820|P7|Completed 6-Month Survey|Overall Study||35
2312462|NCT01933789|5678821|P6|Completed 6-Month Survey|Overall Study||188
2312463|NCT01933789|5678822|P5|Completed 6-Month Survey|Overall Study||160
2312464|NCT01933789|5678823|P4|Completed 6-Month Survey|Overall Study||0
2312465|NCT01933789|5678824|P3|Completed 6-Month Survey|Overall Study||0
2312466|NCT01933789|5678825|P2|Completed 6-Month Survey|Overall Study||0
2312467|NCT01933789|5678826|P1|Completed 6-Month Survey|Overall Study||0
2312468|NCT01933789|5678818|P9|Completed 3-Month Survey|Overall Study||0
2312469|NCT01933789|5678819|P8|Completed 3-Month Survey|Overall Study||43
2312470|NCT01933789|5678820|P7|Completed 3-Month Survey|Overall Study||37
2312471|NCT01933789|5678821|P6|Completed 3-Month Survey|Overall Study||211
2312472|NCT01933789|5678822|P5|Completed 3-Month Survey|Overall Study||176
2312473|NCT01933789|5678823|P4|Completed 3-Month Survey|Overall Study||0
2312474|NCT01933789|5678824|P3|Completed 3-Month Survey|Overall Study||0
2312475|NCT01933789|5678825|P2|Completed 3-Month Survey|Overall Study||0
2312476|NCT01933789|5678826|P1|Completed 3-Month Survey|Overall Study||0
2312477|NCT01933789|5678818|P9|Completed 2-Week Survey|Overall Study||0
2312478|NCT01933789|5678819|P8|Completed 2-Week Survey|Overall Study||0
2312479|NCT01933789|5678820|P7|Completed 2-Week Survey|Overall Study||0
2312480|NCT01933789|5678821|P6|Completed 2-Week Survey|Overall Study||215
2312481|NCT01933789|5678822|P5|Completed 2-Week Survey|Overall Study||184
2312482|NCT01933789|5678823|P4|Completed 2-Week Survey|Overall Study||0
2312483|NCT01933789|5678824|P3|Completed 2-Week Survey|Overall Study||0
2312484|NCT01933789|5678825|P2|Completed 2-Week Survey|Overall Study||0
2312485|NCT01933789|5678826|P1|Completed 2-Week Survey|Overall Study||0
2312486|NCT01933789|5678818|P9|Completed After-visit Survey|Overall Study||0
2312487|NCT01933789|5678819|P8|Completed After-visit Survey|Overall Study||0
2312488|NCT01933789|5678820|P7|Completed After-visit Survey|Overall Study||0
2312489|NCT01933789|5678821|P6|Completed After-visit Survey|Overall Study||0
2312490|NCT01933789|5678822|P5|Completed After-visit Survey|Overall Study||0
2312491|NCT01933789|5678823|P4|Completed After-visit Survey|Overall Study|Number reflects individual IP Team members who returned surveys for up to 6 enrolled patients|1
2312492|NCT01933789|5678824|P3|Completed After-visit Survey|Overall Study|Number reflects individual IP Team members who returned surveys for up to 6 enrolled patients|2
2312493|NCT01933789|5678825|P2|Completed After-visit Survey|Overall Study|Number reflects individual clinicians who returned surveys for up to 6 enrolled patients|64
2312494|NCT01933789|5678826|P1|Completed After-visit Survey|Overall Study|Number reflects individual clinicians who returned surveys for up to 6 enrolled patients|57
2312495|NCT01933789|5678818|P9|Had Target Visit|Overall Study||0
2312496|NCT01933789|5678819|P8|Had Target Visit|Overall Study||0
2312497|NCT01933789|5678820|P7|Had Target Visit|Overall Study||0
2312498|NCT01933789|5678821|P6|Had Target Visit|Overall Study||266
2312499|NCT01933789|5678822|P5|Had Target Visit|Overall Study||228
2312500|NCT01933789|5678823|P4|Had Target Visit|Overall Study||2
2312501|NCT01933789|5678824|P3|Had Target Visit|Overall Study||2
2312502|NCT01933789|5678825|P2|Had Target Visit|Overall Study|Had target visit(s) completed before clinician or patient withdrawal|65
2312503|NCT01933789|5678826|P1|Had Target Visit|Overall Study|Had target visit(s) completed before clinician or patient withdrawal|61
2312504|NCT01933789|5678818|P9|STARTED|Overall Study||25
2312505|NCT01933789|5678819|P8|STARTED|Overall Study||61
2312506|NCT01933789|5678820|P7|STARTED|Overall Study||58
2312507|NCT01933789|5678821|P6|STARTED|Overall Study||288
2312508|NCT01933789|5678822|P5|STARTED|Overall Study||249
2312509|NCT01933789|5678823|P4|STARTED|Overall Study||2
2312510|NCT01933789|5678824|P3|STARTED|Overall Study||2
2312511|NCT01933789|5678825|P2|STARTED|Overall Study||67
2312512|NCT01933789|5678826|P1|STARTED|Overall Study||65
2312513|NCT01933776|5679127|P2|NOT COMPLETED|Overall Study||0
2312514|NCT01933776|5679128|P1|NOT COMPLETED|Overall Study||0
2312515|NCT01933776|5679127|P2|COMPLETED|Overall Study||20
2312516|NCT01933776|5679128|P1|COMPLETED|Overall Study||20
2312517|NCT01933776|5679127|P2|STARTED|Overall Study||20
2312518|NCT01933776|5679128|P1|STARTED|Overall Study||20
2312519|NCT01933672|5679136|P7|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
2312520|NCT01933672|5679137|P6|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
2312521|NCT01933672|5679138|P5|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
2312522|NCT01933672|5679139|P4|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
2312523|NCT01933672|5679140|P3|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
2312524|NCT01933672|5679141|P2|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
2312525|NCT01933672|5679142|P1|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
2312526|NCT01933672|5679136|P7|COMPLETED|Third Intervention Period (12-16 Days)||6
2312527|NCT01933672|5679137|P6|COMPLETED|Third Intervention Period (12-16 Days)||4
2312528|NCT01933672|5679138|P5|COMPLETED|Third Intervention Period (12-16 Days)||6
2312529|NCT01933672|5679139|P4|COMPLETED|Third Intervention Period (12-16 Days)||4
2312530|NCT01933672|5679140|P3|COMPLETED|Third Intervention Period (12-16 Days)||1
2312531|NCT01933672|5679141|P2|COMPLETED|Third Intervention Period (12-16 Days)||5
2312532|NCT01933672|5679142|P1|COMPLETED|Third Intervention Period (12-16 Days)||0
2312533|NCT01933672|5679136|P7|STARTED|Third Intervention Period (12-16 Days)||6
2312534|NCT01933672|5679137|P6|STARTED|Third Intervention Period (12-16 Days)||4
2312535|NCT01933672|5679138|P5|STARTED|Third Intervention Period (12-16 Days)||6
2312536|NCT01933672|5679139|P4|STARTED|Third Intervention Period (12-16 Days)||5
2312537|NCT01933672|5679140|P3|STARTED|Third Intervention Period (12-16 Days)||1
2312538|NCT01933672|5679141|P2|STARTED|Third Intervention Period (12-16 Days)||6
2312539|NCT01933672|5679142|P1|STARTED|Third Intervention Period (12-16 Days)||0
2312540|NCT01933672|5679136|P7|NOT COMPLETED|Second Washout Period (7-14 Days)||0
2312541|NCT01933672|5679137|P6|NOT COMPLETED|Second Washout Period (7-14 Days)||0
2312542|NCT01933672|5679138|P5|NOT COMPLETED|Second Washout Period (7-14 Days)||0
2312543|NCT01933672|5679139|P4|NOT COMPLETED|Second Washout Period (7-14 Days)||0
2312544|NCT01933672|5679140|P3|NOT COMPLETED|Second Washout Period (7-14 Days)||0
2312545|NCT01933672|5679141|P2|NOT COMPLETED|Second Washout Period (7-14 Days)||0
2312546|NCT01933672|5679142|P1|NOT COMPLETED|Second Washout Period (7-14 Days)||0
2312547|NCT01933672|5679136|P7|COMPLETED|Second Washout Period (7-14 Days)||6
2312548|NCT01933672|5679137|P6|COMPLETED|Second Washout Period (7-14 Days)||4
2312549|NCT01933672|5679138|P5|COMPLETED|Second Washout Period (7-14 Days)||6
2312550|NCT01933672|5679139|P4|COMPLETED|Second Washout Period (7-14 Days)||5
2312551|NCT01933672|5679140|P3|COMPLETED|Second Washout Period (7-14 Days)||1
2312552|NCT01933672|5679141|P2|COMPLETED|Second Washout Period (7-14 Days)||6
2312553|NCT01933672|5679142|P1|COMPLETED|Second Washout Period (7-14 Days)||0
2312554|NCT01933672|5679136|P7|STARTED|Second Washout Period (7-14 Days)||6
2312555|NCT01933672|5679137|P6|STARTED|Second Washout Period (7-14 Days)||4
2312556|NCT01933672|5679138|P5|STARTED|Second Washout Period (7-14 Days)||6
2312557|NCT01933672|5679139|P4|STARTED|Second Washout Period (7-14 Days)||5
2312558|NCT01933672|5679140|P3|STARTED|Second Washout Period (7-14 Days)||1
2312559|NCT01933672|5679141|P2|STARTED|Second Washout Period (7-14 Days)||6
2312560|NCT01933672|5679142|P1|STARTED|Second Washout Period (7-14 Days)||0
2312561|NCT01933672|5679136|P7|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
2312562|NCT01933672|5679137|P6|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
2312563|NCT01933672|5679138|P5|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
2312564|NCT01933672|5679139|P4|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
2312565|NCT01933672|5679140|P3|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
2312566|NCT01933672|5679141|P2|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
2312567|NCT01933672|5679142|P1|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
2312568|NCT01933672|5679136|P7|COMPLETED|Second Intervention Period (12-16 Days)||6
2312569|NCT01933672|5679137|P6|COMPLETED|Second Intervention Period (12-16 Days)||4
2312570|NCT01933672|5679138|P5|COMPLETED|Second Intervention Period (12-16 Days)||6
2312571|NCT01933672|5679139|P4|COMPLETED|Second Intervention Period (12-16 Days)||5
2312572|NCT01933672|5679140|P3|COMPLETED|Second Intervention Period (12-16 Days)||1
2312573|NCT01933672|5679141|P2|COMPLETED|Second Intervention Period (12-16 Days)||6
2312574|NCT01933672|5679142|P1|COMPLETED|Second Intervention Period (12-16 Days)||0
2312575|NCT01933672|5679136|P7|STARTED|Second Intervention Period (12-16 Days)||6
2312576|NCT01933672|5679137|P6|STARTED|Second Intervention Period (12-16 Days)||4
2312577|NCT01933672|5679138|P5|STARTED|Second Intervention Period (12-16 Days)||6
2312578|NCT01933672|5679139|P4|STARTED|Second Intervention Period (12-16 Days)||5
2312579|NCT01933672|5679140|P3|STARTED|Second Intervention Period (12-16 Days)||2
2312580|NCT01933672|5679141|P2|STARTED|Second Intervention Period (12-16 Days)||7
2312581|NCT01933672|5679142|P1|STARTED|Second Intervention Period (12-16 Days)||0
2312582|NCT01933672|5679136|P7|NOT COMPLETED|First Washout Period (7-14 Days)||0
2312583|NCT01933672|5679137|P6|NOT COMPLETED|First Washout Period (7-14 Days)||0
2312584|NCT01933672|5679138|P5|NOT COMPLETED|First Washout Period (7-14 Days)||0
2312585|NCT01933672|5679139|P4|NOT COMPLETED|First Washout Period (7-14 Days)||0
2312586|NCT01933672|5679140|P3|NOT COMPLETED|First Washout Period (7-14 Days)||0
2312587|NCT01933672|5679141|P2|NOT COMPLETED|First Washout Period (7-14 Days)||0
2312588|NCT01933672|5679142|P1|NOT COMPLETED|First Washout Period (7-14 Days)||0
2312589|NCT01933672|5679136|P7|COMPLETED|First Washout Period (7-14 Days)||6
2312590|NCT01933672|5679137|P6|COMPLETED|First Washout Period (7-14 Days)||4
2312591|NCT01933672|5679138|P5|COMPLETED|First Washout Period (7-14 Days)||6
2312592|NCT01933672|5679139|P4|COMPLETED|First Washout Period (7-14 Days)||5
2312593|NCT01933672|5679140|P3|COMPLETED|First Washout Period (7-14 Days)||2
2312594|NCT01933672|5679141|P2|COMPLETED|First Washout Period (7-14 Days)||7
2312595|NCT01933672|5679142|P1|COMPLETED|First Washout Period (7-14 Days)||0
2312596|NCT01933672|5679136|P7|STARTED|First Washout Period (7-14 Days)||6
2312597|NCT01933672|5679137|P6|STARTED|First Washout Period (7-14 Days)||4
2312598|NCT01933672|5679138|P5|STARTED|First Washout Period (7-14 Days)||6
2312599|NCT01933672|5679139|P4|STARTED|First Washout Period (7-14 Days)||5
2312600|NCT01933672|5679140|P3|STARTED|First Washout Period (7-14 Days)||2
2312601|NCT01933672|5679141|P2|STARTED|First Washout Period (7-14 Days)||7
2312602|NCT01933672|5679142|P1|STARTED|First Washout Period (7-14 Days)||0
2312603|NCT01933672|5679136|P7|NOT COMPLETED|First Intervention Period (12-16 Days)||0
2312604|NCT01933672|5679137|P6|NOT COMPLETED|First Intervention Period (12-16 Days)||1
2312605|NCT01933672|5679138|P5|NOT COMPLETED|First Intervention Period (12-16 Days)||1
2312606|NCT01933672|5679139|P4|NOT COMPLETED|First Intervention Period (12-16 Days)||0
2312607|NCT01933672|5679140|P3|NOT COMPLETED|First Intervention Period (12-16 Days)||1
2312608|NCT01933672|5679141|P2|NOT COMPLETED|First Intervention Period (12-16 Days)||0
2312609|NCT01933672|5679142|P1|NOT COMPLETED|First Intervention Period (12-16 Days)||0
2312610|NCT01933672|5679136|P7|COMPLETED|First Intervention Period (12-16 Days)||6
2312611|NCT01933672|5679137|P6|COMPLETED|First Intervention Period (12-16 Days)||4
2312612|NCT01933672|5679138|P5|COMPLETED|First Intervention Period (12-16 Days)||6
2312613|NCT01933672|5679139|P4|COMPLETED|First Intervention Period (12-16 Days)||5
2312614|NCT01933672|5679140|P3|COMPLETED|First Intervention Period (12-16 Days)||2
2312615|NCT01933672|5679141|P2|COMPLETED|First Intervention Period (12-16 Days)||7
2312616|NCT01933672|5679142|P1|COMPLETED|First Intervention Period (12-16 Days)||0
2312617|NCT01933672|5679136|P7|STARTED|First Intervention Period (12-16 Days)||6
2312618|NCT01933672|5679137|P6|STARTED|First Intervention Period (12-16 Days)||5
2312619|NCT01933672|5679138|P5|STARTED|First Intervention Period (12-16 Days)||7
2312620|NCT01933672|5679139|P4|STARTED|First Intervention Period (12-16 Days)||5
2312621|NCT01933672|5679140|P3|STARTED|First Intervention Period (12-16 Days)||3
2312622|NCT01933672|5679141|P2|STARTED|First Intervention Period (12-16 Days)||7
2312623|NCT01933672|5679142|P1|STARTED|First Intervention Period (12-16 Days)||0
2312624|NCT01933672|5679136|P7|NOT COMPLETED|Metformin Run-in Period||0
2312625|NCT01933672|5679137|P6|NOT COMPLETED|Metformin Run-in Period||0
2312626|NCT01933672|5679138|P5|NOT COMPLETED|Metformin Run-in Period||0
2312627|NCT01933672|5679139|P4|NOT COMPLETED|Metformin Run-in Period||0
2312628|NCT01933672|5679140|P3|NOT COMPLETED|Metformin Run-in Period||0
2312629|NCT01933672|5679141|P2|NOT COMPLETED|Metformin Run-in Period||0
2312630|NCT01933672|5679142|P1|NOT COMPLETED|Metformin Run-in Period||10
2312631|NCT01933672|5679136|P7|COMPLETED|Metformin Run-in Period||0
2312632|NCT01933672|5679137|P6|COMPLETED|Metformin Run-in Period||0
2312633|NCT01933672|5679138|P5|COMPLETED|Metformin Run-in Period||0
2312634|NCT01933672|5679139|P4|COMPLETED|Metformin Run-in Period||0
2312635|NCT01933672|5679140|P3|COMPLETED|Metformin Run-in Period||0
2312636|NCT01933672|5679141|P2|COMPLETED|Metformin Run-in Period||0
2312637|NCT01933672|5679142|P1|COMPLETED|Metformin Run-in Period||33
2312638|NCT01933672|5679136|P7|Received Treatment|Metformin Run-in Period||0
2312639|NCT01933672|5679137|P6|Received Treatment|Metformin Run-in Period||0
2312640|NCT01933672|5679138|P5|Received Treatment|Metformin Run-in Period||0
2312641|NCT01933672|5679139|P4|Received Treatment|Metformin Run-in Period||0
2312642|NCT01933672|5679140|P3|Received Treatment|Metformin Run-in Period||0
2312643|NCT01933672|5679141|P2|Received Treatment|Metformin Run-in Period||0
2312644|NCT01933672|5679142|P1|Received Treatment|Metformin Run-in Period||43
2312645|NCT01933672|5679136|P7|STARTED|Metformin Run-in Period||0
2312646|NCT01933672|5679137|P6|STARTED|Metformin Run-in Period||0
2312647|NCT01933672|5679138|P5|STARTED|Metformin Run-in Period||0
2312648|NCT01933672|5679139|P4|STARTED|Metformin Run-in Period||0
2312649|NCT01933672|5679140|P3|STARTED|Metformin Run-in Period||0
2312650|NCT01933672|5679141|P2|STARTED|Metformin Run-in Period||0
2312651|NCT01933672|5679142|P1|STARTED|Metformin Run-in Period||43
2312652|NCT01933594|5679194|P6|NOT COMPLETED|Overall Study||0
2312653|NCT01933594|5679195|P5|NOT COMPLETED|Overall Study||2
2312654|NCT01933594|5679196|P4|NOT COMPLETED|Overall Study||0
2312655|NCT01933594|5679197|P3|NOT COMPLETED|Overall Study||0
2312656|NCT01933594|5679198|P2|NOT COMPLETED|Overall Study||0
2312657|NCT01933594|5679199|P1|NOT COMPLETED|Overall Study||1
2312658|NCT01933594|5679194|P6|COMPLETED|Overall Study||3
2312659|NCT01933594|5679195|P5|COMPLETED|Overall Study||11
2312660|NCT01933594|5679196|P4|COMPLETED|Overall Study||7
2312661|NCT01933594|5679197|P3|COMPLETED|Overall Study||12
2312662|NCT01933594|5679198|P2|COMPLETED|Overall Study||12
2312663|NCT01933594|5679199|P1|COMPLETED|Overall Study||11
2312664|NCT01933594|5679194|P6|STARTED|Overall Study||3
2312665|NCT01933594|5679195|P5|STARTED|Overall Study||13
2312666|NCT01933594|5679196|P4|STARTED|Overall Study||7
2312667|NCT01933594|5679197|P3|STARTED|Overall Study||12
2312668|NCT01933594|5679198|P2|STARTED|Overall Study||12
2312669|NCT01933594|5679199|P1|STARTED|Overall Study||12
2312670|NCT01933464|5679291|P2|NOT COMPLETED|Overall Study||0
2312671|NCT01933464|5679292|P1|NOT COMPLETED|Overall Study||0
2312672|NCT01933464|5679291|P2|COMPLETED|Overall Study||5
2312673|NCT01933464|5679292|P1|COMPLETED|Overall Study||5
2312674|NCT01933464|5679291|P2|STARTED|Overall Study||5
2312675|NCT01933464|5679292|P1|STARTED|Overall Study||5
2312676|NCT01933425|5679304|P2|NOT COMPLETED|Overall Study||0
2312677|NCT01933425|5679305|P1|NOT COMPLETED|Overall Study||0
2312678|NCT01933425|5679304|P2|COMPLETED|Overall Study||7
2312679|NCT01933425|5679305|P1|COMPLETED|Overall Study||7
2312680|NCT01933425|5679304|P2|STARTED|Overall Study||7
2312681|NCT01933425|5679305|P1|STARTED|Overall Study||7
2312682|NCT01933399|5679318|P3|NOT COMPLETED|Overall Study||0
2312683|NCT01933399|5679319|P2|NOT COMPLETED|Overall Study||0
2312684|NCT01933399|5679320|P1|NOT COMPLETED|Overall Study||0
2312685|NCT01933399|5679318|P3|COMPLETED|Overall Study||37
2312686|NCT01933399|5679319|P2|COMPLETED|Overall Study||32
2312687|NCT01933399|5679320|P1|COMPLETED|Overall Study||29
2312688|NCT01933399|5679318|P3|STARTED|Overall Study||37
2312689|NCT01933399|5679319|P2|STARTED|Overall Study||32
2312690|NCT01933399|5679320|P1|STARTED|Overall Study||29
2312691|NCT01933334|5679333|P2|NOT COMPLETED|Overall Study||2
2312692|NCT01933334|5679334|P1|NOT COMPLETED|Overall Study||5
2312693|NCT01933334|5679333|P2|COMPLETED|Overall Study||29
2312694|NCT01933334|5679334|P1|COMPLETED|Overall Study||27
2312695|NCT01933334|5679333|P2|STARTED|Overall Study||31
2312696|NCT01933334|5679334|P1|STARTED|Overall Study||32
2312697|NCT01933243|5679346|P2|NOT COMPLETED|Overall Study||4
2312698|NCT01933243|5679347|P1|NOT COMPLETED|Overall Study||2
2312699|NCT01933243|5679346|P2|COMPLETED|Overall Study||8
2312700|NCT01933243|5679347|P1|COMPLETED|Overall Study||10
2312701|NCT01933243|5679346|P2|STARTED|Overall Study||12
2312702|NCT01933243|5679347|P1|STARTED|Overall Study||12
2312703|NCT01933230|5679357|P1|NOT COMPLETED|Overall Study||0
2312704|NCT01933230|5679357|P1|COMPLETED|Overall Study||2
2312705|NCT01933230|5679357|P1|STARTED|Overall Study||2
2312706|NCT01933113|5679361|P1|NOT COMPLETED|Overall Study||1
2312707|NCT01933113|5679361|P1|COMPLETED|Overall Study||2
2312708|NCT01933113|5679361|P1|STARTED|Overall Study||3
2312709|NCT01933048|5679367|P2|NOT COMPLETED|Overall Study||28
2312710|NCT01933048|5679368|P1|NOT COMPLETED|Overall Study||25
2312711|NCT01933048|5679367|P2|COMPLETED|Overall Study||501
2312712|NCT01933048|5679368|P1|COMPLETED|Overall Study||523
2312713|NCT01933048|5679367|P2|STARTED|Overall Study||529
2312714|NCT01933048|5679368|P1|STARTED|Overall Study||548
2312715|NCT01932970|5679381|P1|NOT COMPLETED|Overall Study||18
2312716|NCT01932970|5679381|P1|COMPLETED|Overall Study||140
2312717|NCT01932970|5679381|P1|Received Treatment|Overall Study|Includes participants who completed the washout period and received etelcalcetide|148
2312718|NCT01932970|5679381|P1|STARTED|Overall Study|Includes all participants who enrolled into the washout period.|158
2312719|NCT01932788|5679391|P2|NOT COMPLETED|Overall Study||51
2312720|NCT01932788|5679392|P1|NOT COMPLETED|Overall Study||38
2312721|NCT01932788|5679391|P2|COMPLETED|Overall Study||118
2312722|NCT01932788|5679392|P1|COMPLETED|Overall Study||135
2312723|NCT01932788|5679391|P2|STARTED|Overall Study||169
2312724|NCT01932788|5679392|P1|STARTED|Overall Study||173
2312725|NCT01932762|5679402|P4|NOT COMPLETED|Overall Study||1
2312726|NCT01932762|5679403|P3|NOT COMPLETED|Overall Study||0
2312727|NCT01932762|5679404|P2|NOT COMPLETED|Overall Study||2
2312728|NCT01932762|5679405|P1|NOT COMPLETED|Overall Study||6
2312729|NCT01932762|5679402|P4|COMPLETED|Overall Study||18
2312730|NCT01932762|5679403|P3|COMPLETED|Overall Study||19
2312731|NCT01932762|5679404|P2|COMPLETED|Overall Study||28
2312732|NCT01932762|5679405|P1|COMPLETED|Overall Study||24
2312733|NCT01932762|5679402|P4|STARTED|Overall Study||19
2312734|NCT01932762|5679403|P3|STARTED|Overall Study||19
2312735|NCT01932762|5679404|P2|STARTED|Overall Study||30
2312736|NCT01932762|5679405|P1|STARTED|Overall Study||30
2312737|NCT01932697|5679441|P2|NOT COMPLETED|Overall Study||0
2312738|NCT01932697|5679442|P1|NOT COMPLETED|Overall Study||2
2312739|NCT01932697|5679441|P2|COMPLETED|Overall Study||43
2312740|NCT01932697|5679442|P1|COMPLETED|Overall Study||36
2312741|NCT01932697|5679441|P2|STARTED|Overall Study||43
2312742|NCT01932697|5679442|P1|STARTED|Overall Study||38
2312743|NCT01932606|5679456|P2|NOT COMPLETED|Overall Study||0
2312744|NCT01932606|5679457|P1|NOT COMPLETED|Overall Study||0
2312745|NCT01932606|5679456|P2|COMPLETED|Overall Study||14
2312746|NCT01932606|5679457|P1|COMPLETED|Overall Study||14
2312747|NCT01932606|5679456|P2|STARTED|Overall Study||14
2312748|NCT01932606|5679457|P1|STARTED|Overall Study||14
2312749|NCT01932437|5679509|P6|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||1
2312750|NCT01932437|5679510|P5|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
2312751|NCT01932437|5679511|P4|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
2312752|NCT01932437|5679512|P3|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
2312753|NCT01932437|5679513|P2|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
2312754|NCT01932437|5679514|P1|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
2312755|NCT01932437|5679509|P6|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||5
2312756|NCT01932437|5679510|P5|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
2312757|NCT01932437|5679511|P4|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
2312758|NCT01932437|5679512|P3|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
2312759|NCT01932437|5679513|P2|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
2312760|NCT01932437|5679514|P1|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||2
2312761|NCT01932437|5679509|P6|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||6
2312762|NCT01932437|5679510|P5|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
2312763|NCT01932437|5679511|P4|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
2312764|NCT01932437|5679512|P3|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
2312765|NCT01932437|5679513|P2|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
2312766|NCT01932437|5679514|P1|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||2
2312767|NCT01932437|5679509|P6|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
2312768|NCT01932437|5679510|P5|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
2312769|NCT01932437|5679511|P4|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
2312770|NCT01932437|5679512|P3|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
2312771|NCT01932437|5679513|P2|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
2312772|NCT01932437|5679514|P1|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
2312773|NCT01932437|5679509|P6|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
2312774|NCT01932437|5679510|P5|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||6
2312775|NCT01932437|5679511|P4|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
2312776|NCT01932437|5679512|P3|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
2312777|NCT01932437|5679513|P2|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
2312778|NCT01932437|5679514|P1|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||2
2312779|NCT01932437|5679509|P6|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
2312780|NCT01932437|5679510|P5|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||6
2312781|NCT01932437|5679511|P4|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
2312782|NCT01932437|5679512|P3|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
2312783|NCT01932437|5679513|P2|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
2312784|NCT01932437|5679514|P1|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||2
2312785|NCT01932437|5679509|P6|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
2312786|NCT01932437|5679510|P5|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
2312787|NCT01932437|5679511|P4|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
2312788|NCT01932437|5679512|P3|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
2312789|NCT01932437|5679513|P2|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
2312790|NCT01932437|5679514|P1|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
2312791|NCT01932437|5679509|P6|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
2312792|NCT01932437|5679510|P5|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
2312793|NCT01932437|5679511|P4|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||6
2312794|NCT01932437|5679512|P3|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
2312795|NCT01932437|5679513|P2|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
2312796|NCT01932437|5679514|P1|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||2
2312797|NCT01932437|5679509|P6|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
2312798|NCT01932437|5679510|P5|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
2312799|NCT01932437|5679511|P4|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||6
2312800|NCT01932437|5679512|P3|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
2312801|NCT01932437|5679513|P2|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
2312802|NCT01932437|5679514|P1|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||2
2312803|NCT01932437|5679509|P6|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
2312804|NCT01932437|5679510|P5|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
2312805|NCT01932437|5679511|P4|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
2312806|NCT01932437|5679512|P3|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
2312807|NCT01932437|5679513|P2|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
2312808|NCT01932437|5679514|P1|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
2312809|NCT01932437|5679509|P6|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
2312810|NCT01932437|5679510|P5|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
2312811|NCT01932437|5679511|P4|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
2312812|NCT01932437|5679512|P3|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||6
2312813|NCT01932437|5679513|P2|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
2312814|NCT01932437|5679514|P1|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||2
2312815|NCT01932437|5679509|P6|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
2312816|NCT01932437|5679510|P5|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
2312817|NCT01932437|5679511|P4|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
2312818|NCT01932437|5679512|P3|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||6
2312819|NCT01932437|5679513|P2|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
2312820|NCT01932437|5679514|P1|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||2
2312821|NCT01932437|5679509|P6|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
2312822|NCT01932437|5679510|P5|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
2312823|NCT01932437|5679511|P4|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
2312824|NCT01932437|5679512|P3|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
2312825|NCT01932437|5679513|P2|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
2312826|NCT01932437|5679514|P1|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
2312827|NCT01932437|5679509|P6|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
2312828|NCT01932437|5679510|P5|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
2312829|NCT01932437|5679511|P4|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
2312830|NCT01932437|5679512|P3|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
2312831|NCT01932437|5679513|P2|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||3
2312832|NCT01932437|5679514|P1|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||1
2312833|NCT01932437|5679509|P6|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
2312834|NCT01932437|5679510|P5|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
2312835|NCT01932437|5679511|P4|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
2312836|NCT01932437|5679512|P3|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
2312837|NCT01932437|5679513|P2|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||3
2312838|NCT01932437|5679514|P1|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||1
2312839|NCT01932294|5679564|P1|NOT COMPLETED|Overall Study||99
2312840|NCT01932294|5679564|P1|COMPLETED|Overall Study||72
2312841|NCT01932294|5679564|P1|STARTED|Overall Study||171
2312842|NCT01932242|5679572|P2|NOT COMPLETED|Overall Study||5
2312843|NCT01932242|5679573|P1|NOT COMPLETED|Overall Study||5
2312844|NCT01932242|5679572|P2|COMPLETED|Overall Study||30
2312845|NCT01932242|5679573|P1|COMPLETED|Overall Study||30
2312846|NCT01932242|5679572|P2|STARTED|Overall Study||35
2312847|NCT01932242|5679573|P1|STARTED|Overall Study||35
2312848|NCT01932164|5679617|P1|NOT COMPLETED|Overall Study||0
2312849|NCT01932164|5679617|P1|COMPLETED|Overall Study|In all 5 patients we observed bone formation closing the alveolar cleft after 6 months|5
2312850|NCT01932164|5679617|P1|Cleft Lip and Palate|Overall Study|The surgeries were performed between december 2013 and june 2014.|5
2312851|NCT01932164|5679617|P1|Cleft Lip and Palate|Overall Study|Alveolar bone graft surgeries were did using their dental pulp stem cells with biomaterial|5
2312852|NCT01932164|5679617|P1|Cleft Lip and Palate|Overall Study|Mesenchymal stem cell obtained from dental pulp of 5patients was obtained, caractherized and frozen|5
2312853|NCT01932164|5679617|P1|Cleft Lip and Palate|Overall Study|Dental pulp was obtained from teeth of 5 different patients (09/2013)|5
2312854|NCT01932164|5679617|P1|Cleft Lip and Palate|Overall Study|It was performed de extraction of deciduous teeth of 5 cleft lip/palate patients (09/2013)|5
2312855|NCT01932164|5679617|P1|STARTED|Overall Study|It was performed the selection of 5 patients to participate of these study (08/2013)|5
2312856|NCT01932112|5679622|P1|NOT COMPLETED|Overall Study||0
2312857|NCT01932112|5679622|P1|COMPLETED|Overall Study||378
2312858|NCT01932112|5679622|P1|STARTED|Overall Study||378
2312859|NCT01932060|5679628|P2|NOT COMPLETED|Overall Study||0
2312860|NCT01932060|5679629|P1|NOT COMPLETED|Overall Study||0
2312861|NCT01932060|5679628|P2|COMPLETED|Overall Study||24
2312862|NCT01932060|5679629|P1|COMPLETED|Overall Study||27
2312863|NCT01932060|5679628|P2|STARTED|Overall Study||24
2312864|NCT01932060|5679629|P1|STARTED|Overall Study||27
2312865|NCT01931956|5679641|P4|NOT COMPLETED|Overall Study||133
2312866|NCT01931956|5679642|P3|NOT COMPLETED|Overall Study||487
2312867|NCT01931956|5679643|P2|NOT COMPLETED|Overall Study||7
2312868|NCT01931956|5679644|P1|NOT COMPLETED|Overall Study||51
2312869|NCT01931956|5679641|P4|COMPLETED|Overall Study||138
2312870|NCT01931956|5679642|P3|COMPLETED|Overall Study||141
2312871|NCT01931956|5679643|P2|COMPLETED|Overall Study||0
2312872|NCT01931956|5679644|P1|COMPLETED|Overall Study||8
2312873|NCT01931956|5679641|P4|STARTED|Overall Study||271
2312874|NCT01931956|5679642|P3|STARTED|Overall Study||628
2312875|NCT01931956|5679643|P2|STARTED|Overall Study||7
2312876|NCT01931956|5679644|P1|STARTED|Overall Study||59
2312877|NCT01931878|5680000|P2|NOT COMPLETED|Second Intervention (After 3 Months)||2
2312878|NCT01931878|5680001|P1|NOT COMPLETED|Second Intervention (After 3 Months)||0
2312879|NCT01931878|5680000|P2|COMPLETED|Second Intervention (After 3 Months)||12
2312880|NCT01931878|5680001|P1|COMPLETED|Second Intervention (After 3 Months)||9
2312881|NCT01931878|5680000|P2|STARTED|Second Intervention (After 3 Months)||14
2312882|NCT01931878|5680001|P1|STARTED|Second Intervention (After 3 Months)||9
2312883|NCT01931878|5680000|P2|NOT COMPLETED|First Intervention||0
2312884|NCT01931878|5680001|P1|NOT COMPLETED|First Intervention||1
2312885|NCT01931878|5680000|P2|COMPLETED|First Intervention||14
2312886|NCT01931878|5680001|P1|COMPLETED|First Intervention||9
2312887|NCT01931878|5680000|P2|STARTED|First Intervention||14
2312888|NCT01931878|5680001|P1|STARTED|First Intervention||10
2312889|NCT01931865|5680011|P1|NOT COMPLETED|Overall Study||4
2312890|NCT01931865|5680011|P1|COMPLETED|Overall Study||8
2312891|NCT01931865|5680011|P1|STARTED|Overall Study||12
2312892|NCT01931839|5680024|P7|NOT COMPLETED|Overall Study||4
2312893|NCT01931839|5680025|P6|NOT COMPLETED|Overall Study||5
2312894|NCT01931839|5680026|P5|NOT COMPLETED|Overall Study||1
2312895|NCT01931839|5680027|P4|NOT COMPLETED|Overall Study||14
2312896|NCT01931839|5680028|P3|NOT COMPLETED|Overall Study||39
2312897|NCT01931839|5680029|P2|NOT COMPLETED|Overall Study||26
2312898|NCT01931839|5680030|P1|NOT COMPLETED|Overall Study||41
2312899|NCT01931839|5680024|P7|COMPLETED|Overall Study||56
2312900|NCT01931839|5680025|P6|COMPLETED|Overall Study||50
2312901|NCT01931839|5680026|P5|COMPLETED|Overall Study||18
2312902|NCT01931839|5680027|P4|COMPLETED|Overall Study||162
2312903|NCT01931839|5680028|P3|COMPLETED|Overall Study||301
2312904|NCT01931839|5680029|P2|COMPLETED|Overall Study||152
2312905|NCT01931839|5680030|P1|COMPLETED|Overall Study||294
2312988|NCT01931566|5680256|P2|STARTED|Overall Study||1516
2312906|NCT01931839|5680024|P7|Safety Analysis Set (As Dosed)|Overall Study||60
2312907|NCT01931839|5680025|P6|Safety Analysis Set (As Dosed)|Overall Study||55
2312908|NCT01931839|5680026|P5|Safety Analysis Set (As Dosed)|Overall Study||19
2312909|NCT01931839|5680027|P4|Safety Analysis Set (As Dosed)|Overall Study||176
2312910|NCT01931839|5680028|P3|Safety Analysis Set (As Dosed)|Overall Study||340
2312911|NCT01931839|5680029|P2|Safety Analysis Set (As Dosed)|Overall Study||178
2312912|NCT01931839|5680030|P1|Safety Analysis Set (As Dosed)|Overall Study||335
2312913|NCT01931839|5680024|P7|Full Analysis Set (As Randomized)|Overall Study||60
2312914|NCT01931839|5680025|P6|Full Analysis Set (As Randomized)|Overall Study||55
2312915|NCT01931839|5680026|P5|Full Analysis Set (As Randomized)|Overall Study||19
2312916|NCT01931839|5680027|P4|Full Analysis Set (As Randomized)|Overall Study||176
2312917|NCT01931839|5680028|P3|Full Analysis Set (As Randomized)|Overall Study||340
2312918|NCT01931839|5680029|P2|Full Analysis Set (As Randomized)|Overall Study||179
2312919|NCT01931839|5680030|P1|Full Analysis Set (As Randomized)|Overall Study||334
2312920|NCT01931839|5680024|P7|STARTED|Overall Study||60
2312921|NCT01931839|5680025|P6|STARTED|Overall Study||55
2312922|NCT01931839|5680026|P5|STARTED|Overall Study||19
2312923|NCT01931839|5680027|P4|STARTED|Overall Study||176
2312924|NCT01931839|5680028|P3|STARTED|Overall Study||340
2312925|NCT01931839|5680029|P2|STARTED|Overall Study||178
2312926|NCT01931839|5680030|P1|STARTED|Overall Study||335
2312927|NCT01931735|5680102|P4|NOT COMPLETED|Observational Non-Randomized Phase||2
2312928|NCT01931735|5680103|P3|NOT COMPLETED|Observational Non-Randomized Phase||0
2312929|NCT01931735|5680104|P2|NOT COMPLETED|Observational Non-Randomized Phase||0
2312930|NCT01931735|5680105|P1|NOT COMPLETED|Observational Non-Randomized Phase||0
2312931|NCT01931735|5680102|P4|COMPLETED|Observational Non-Randomized Phase||9
2312932|NCT01931735|5680103|P3|COMPLETED|Observational Non-Randomized Phase||0
2312933|NCT01931735|5680104|P2|COMPLETED|Observational Non-Randomized Phase||1
2312934|NCT01931735|5680105|P1|COMPLETED|Observational Non-Randomized Phase||2
2312935|NCT01931735|5680102|P4|STARTED|Observational Non-Randomized Phase|Participants recruited post-amendment|11
2312936|NCT01931735|5680103|P3|STARTED|Observational Non-Randomized Phase||0
2312937|NCT01931735|5680104|P2|STARTED|Observational Non-Randomized Phase|Participants continued from the randomized phase|1
2312938|NCT01931735|5680105|P1|STARTED|Observational Non-Randomized Phase|Participants continued from the randomized phase|2
2312939|NCT01931735|5680102|P4|NOT COMPLETED|Randomized Phase||0
2312940|NCT01931735|5680103|P3|NOT COMPLETED|Randomized Phase||5
2312941|NCT01931735|5680104|P2|NOT COMPLETED|Randomized Phase||2
2312942|NCT01931735|5680105|P1|NOT COMPLETED|Randomized Phase||2
2312943|NCT01931735|5680102|P4|COMPLETED|Randomized Phase||0
2312944|NCT01931735|5680103|P3|COMPLETED|Randomized Phase||4
2312945|NCT01931735|5680104|P2|COMPLETED|Randomized Phase||1
2312946|NCT01931735|5680105|P1|COMPLETED|Randomized Phase||2
2312947|NCT01931735|5680102|P4|STARTED|Randomized Phase||0
2312948|NCT01931735|5680103|P3|STARTED|Randomized Phase||9
2312949|NCT01931735|5680104|P2|STARTED|Randomized Phase||3
2312950|NCT01931735|5680105|P1|STARTED|Randomized Phase||4
2312951|NCT01931709|5680139|P1|NOT COMPLETED|Overall Study||0
2312952|NCT01931709|5680139|P1|COMPLETED|Overall Study||35
2312953|NCT01931709|5680139|P1|STARTED|Overall Study||35
2312954|NCT01931670|5680152|P3|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||21
2312955|NCT01931670|5680153|P2|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||12
2312956|NCT01931670|5680154|P1|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||19
2312957|NCT01931670|5680152|P3|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||33
2312958|NCT01931670|5680153|P2|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||28
2312959|NCT01931670|5680154|P1|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||42
2312960|NCT01931670|5680152|P3|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||15
2312961|NCT01931670|5680153|P2|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||4
2312962|NCT01931670|5680154|P1|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||0
2312963|NCT01931670|5680152|P3|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||18
2312964|NCT01931670|5680153|P2|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||24
2312965|NCT01931670|5680154|P1|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||42
2312966|NCT01931670|5680152|P3|STARTED|Post-Treatment Follow-Up (PTFU) Period||54
2312967|NCT01931670|5680153|P2|STARTED|Post-Treatment Follow-Up (PTFU) Period||40
2312968|NCT01931670|5680154|P1|STARTED|Post-Treatment Follow-Up (PTFU) Period||61
2312969|NCT01931670|5680152|P3|NOT COMPLETED|Treatment Period||45
2312970|NCT01931670|5680153|P2|NOT COMPLETED|Treatment Period||48
2312971|NCT01931670|5680154|P1|NOT COMPLETED|Treatment Period||90
2312972|NCT01931670|5680152|P3|COMPLETED|Treatment Period||184
2312973|NCT01931670|5680153|P2|COMPLETED|Treatment Period||178
2312974|NCT01931670|5680154|P1|COMPLETED|Treatment Period||270
2312975|NCT01931670|5680152|P3|STARTED|Treatment Period||229
2312976|NCT01931670|5680153|P2|STARTED|Treatment Period||226
2312977|NCT01931670|5680154|P1|STARTED|Treatment Period||360
2312978|NCT01931566|5680255|P3|NOT COMPLETED|Overall Study||1506
2312979|NCT01931566|5680256|P2|NOT COMPLETED|Overall Study||1476
2312980|NCT01931566|5680257|P1|NOT COMPLETED|Overall Study||429
2312981|NCT01931566|5680255|P3|COMPLETED|Overall Study||39
2312982|NCT01931566|5680256|P2|COMPLETED|Overall Study||40
2312983|NCT01931566|5680257|P1|COMPLETED|Overall Study||4
2312984|NCT01931566|5680255|P3|Treated|Overall Study||1531
2312985|NCT01931566|5680256|P2|Treated|Overall Study||1507
2312986|NCT01931566|5680257|P1|Treated|Overall Study||427
2312987|NCT01931566|5680255|P3|STARTED|Overall Study||1545
2312989|NCT01931566|5680257|P1|STARTED|Overall Study||433
2312990|NCT01931527|5680272|P2|NOT COMPLETED|Overall Study||0
2312991|NCT01931527|5680273|P1|NOT COMPLETED|Overall Study||0
2312992|NCT01931527|5680272|P2|COMPLETED|Overall Study||15
2312993|NCT01931527|5680273|P1|COMPLETED|Overall Study||16
2312994|NCT01931527|5680272|P2|STARTED|Overall Study||15
2312995|NCT01931527|5680273|P1|STARTED|Overall Study||16
2312996|NCT01931475|5680295|P2|NOT COMPLETED|Period 2: Extension Treatment Phase||19
2312997|NCT01931475|5680296|P1|NOT COMPLETED|Period 2: Extension Treatment Phase||4
2312998|NCT01931475|5680295|P2|COMPLETED|Period 2: Extension Treatment Phase||157
2312999|NCT01931475|5680296|P1|COMPLETED|Period 2: Extension Treatment Phase||162
2313000|NCT01931475|5680295|P2|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||175
2313001|NCT01931475|5680296|P1|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||166
2313002|NCT01931475|5680295|P2|STARTED|Period 2: Extension Treatment Phase||176
2313003|NCT01931475|5680296|P1|STARTED|Period 2: Extension Treatment Phase||166
2313004|NCT01931475|5680295|P2|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||26
2313005|NCT01931475|5680296|P1|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||39
2313006|NCT01931475|5680295|P2|COMPLETED|Period 1: Double-Blind Treatment Phase||176
2313007|NCT01931475|5680296|P1|COMPLETED|Period 1: Double-Blind Treatment Phase||166
2313008|NCT01931475|5680295|P2|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||198
2313009|NCT01931475|5680296|P1|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||199
2313010|NCT01931475|5680295|P2|STARTED|Period 1: Double-Blind Treatment Phase||202
2313011|NCT01931475|5680296|P1|STARTED|Period 1: Double-Blind Treatment Phase||205
2313012|NCT01931462|5680323|P1|NOT COMPLETED|Overall Study||1
2313013|NCT01931462|5680323|P1|COMPLETED|Overall Study||1
2313014|NCT01931462|5680323|P1|STARTED|Overall Study||2
2313015|NCT01931397|5680334|P1|NOT COMPLETED|Overall Study||11
2313016|NCT01931397|5680334|P1|COMPLETED|Overall Study||19
2313017|NCT01931397|5680334|P1|STARTED|Overall Study||30
2313018|NCT01931150|5680345|P2|NOT COMPLETED|Overall Study||2
2313019|NCT01931150|5680346|P1|NOT COMPLETED|Overall Study||1
2313020|NCT01931150|5680345|P2|COMPLETED|Overall Study||4
2313021|NCT01931150|5680346|P1|COMPLETED|Overall Study||4
2313022|NCT01931150|5680345|P2|STARTED|Overall Study||6
2313023|NCT01931150|5680346|P1|STARTED|Overall Study||5
2313024|NCT01931059|5680354|P2|NOT COMPLETED|Day3||0
2313025|NCT01931059|5680355|P1|NOT COMPLETED|Day3||1
2313026|NCT01931059|5680354|P2|COMPLETED|Day3||4
2313027|NCT01931059|5680355|P1|COMPLETED|Day3||5
2313028|NCT01931059|5680354|P2|STARTED|Day3||4
2313029|NCT01931059|5680355|P1|STARTED|Day3||6
2313030|NCT01931059|5680354|P2|NOT COMPLETED|Day2||0
2313031|NCT01931059|5680355|P1|NOT COMPLETED|Day2||0
2313032|NCT01931059|5680354|P2|COMPLETED|Day2||4
2313033|NCT01931059|5680355|P1|COMPLETED|Day2||6
2313034|NCT01931059|5680354|P2|STARTED|Day2||4
2313035|NCT01931059|5680355|P1|STARTED|Day2||6
2313036|NCT01931059|5680354|P2|NOT COMPLETED|Day 1||1
2313037|NCT01931059|5680355|P1|NOT COMPLETED|Day 1||0
2313038|NCT01931059|5680354|P2|COMPLETED|Day 1||4
2313039|NCT01931059|5680355|P1|COMPLETED|Day 1||6
2313040|NCT01931059|5680354|P2|STARTED|Day 1||5
2313041|NCT01931059|5680355|P1|STARTED|Day 1||6
2313042|NCT01930890|5680371|P4|NOT COMPLETED|Overall Study||27
2313043|NCT01930890|5680372|P3|NOT COMPLETED|Overall Study||13
2313044|NCT01930890|5680373|P2|NOT COMPLETED|Overall Study||33
2313045|NCT01930890|5680374|P1|NOT COMPLETED|Overall Study||14
2313046|NCT01930890|5680371|P4|COMPLETED|Overall Study||0
2313047|NCT01930890|5680372|P3|COMPLETED|Overall Study||0
2313048|NCT01930890|5680373|P2|COMPLETED|Overall Study||0
2313049|NCT01930890|5680374|P1|COMPLETED|Overall Study||0
2313050|NCT01930890|5680371|P4|STARTED|Overall Study||27
2313051|NCT01930890|5680372|P3|STARTED|Overall Study||13
2313052|NCT01930890|5680373|P2|STARTED|Overall Study||33
2313053|NCT01930890|5680374|P1|STARTED|Overall Study||14
2313054|NCT01930799|5680388|P1|NOT COMPLETED|Overall Study||8
2313055|NCT01930799|5680388|P1|COMPLETED|Overall Study||112
2313056|NCT01930799|5680388|P1|STARTED|Overall Study||120
2313057|NCT01930747|5680396|P3|NOT COMPLETED|Overall Study||0
2313058|NCT01930747|5680397|P2|NOT COMPLETED|Overall Study||0
2313059|NCT01930747|5680398|P1|NOT COMPLETED|Overall Study||0
2313060|NCT01930747|5680396|P3|COMPLETED|Overall Study||12
2313061|NCT01930747|5680397|P2|COMPLETED|Overall Study||14
2313062|NCT01930747|5680398|P1|COMPLETED|Overall Study||16
2313063|NCT01930747|5680396|P3|STARTED|Overall Study||12
2313064|NCT01930747|5680397|P2|STARTED|Overall Study||14
2313065|NCT01930747|5680398|P1|STARTED|Overall Study||16
2313066|NCT01930643|5680414|P2|NOT COMPLETED|Overall Study||0
2313067|NCT01930643|5680415|P1|NOT COMPLETED|Overall Study||0
2313068|NCT01930643|5680414|P2|COMPLETED|Overall Study||6
2313069|NCT01930643|5680415|P1|COMPLETED|Overall Study||7
2313070|NCT01930643|5680414|P2|STARTED|Overall Study||6
2313071|NCT01930643|5680415|P1|STARTED|Overall Study||7
2313072|NCT01930487|5680421|P2|NOT COMPLETED|Second Intervention (30 Days)||0
2313073|NCT01930487|5680422|P1|NOT COMPLETED|Second Intervention (30 Days)||0
2313074|NCT01930487|5680421|P2|COMPLETED|Second Intervention (30 Days)||23
2313075|NCT01930487|5680422|P1|COMPLETED|Second Intervention (30 Days)||19
2313076|NCT01930487|5680421|P2|STARTED|Second Intervention (30 Days)||23
2313077|NCT01930487|5680422|P1|STARTED|Second Intervention (30 Days)||19
2313078|NCT01930487|5680421|P2|NOT COMPLETED|Washout Period (3 Weeks)||0
2313079|NCT01930487|5680422|P1|NOT COMPLETED|Washout Period (3 Weeks)||0
2313080|NCT01930487|5680421|P2|COMPLETED|Washout Period (3 Weeks)||23
2313081|NCT01930487|5680422|P1|COMPLETED|Washout Period (3 Weeks)||19
2313082|NCT01930487|5680421|P2|STARTED|Washout Period (3 Weeks)||23
2313083|NCT01930487|5680422|P1|STARTED|Washout Period (3 Weeks)||19
2313084|NCT01930487|5680421|P2|NOT COMPLETED|First Intervention (30 Days)||2
2313085|NCT01930487|5680422|P1|NOT COMPLETED|First Intervention (30 Days)||2
2313086|NCT01930487|5680421|P2|COMPLETED|First Intervention (30 Days)||23
2313087|NCT01930487|5680422|P1|COMPLETED|First Intervention (30 Days)||19
2313088|NCT01930487|5680421|P2|STARTED|First Intervention (30 Days)||25
2313089|NCT01930487|5680422|P1|STARTED|First Intervention (30 Days)||21
2313090|NCT01930435|5680516|P1|NOT COMPLETED|Overall Study||0
2313091|NCT01930435|5680516|P1|COMPLETED|Overall Study||20
2313092|NCT01930435|5680516|P1|STARTED|Overall Study||20
2313093|NCT01930214|5680527|P3|NOT COMPLETED|Overall Study||25
2313094|NCT01930214|5680528|P2|NOT COMPLETED|Overall Study||21
2313095|NCT01930214|5680529|P1|NOT COMPLETED|Overall Study||20
2313096|NCT01930214|5680527|P3|COMPLETED|Overall Study||108
2313097|NCT01930214|5680528|P2|COMPLETED|Overall Study||96
2313098|NCT01930214|5680529|P1|COMPLETED|Overall Study||80
2313099|NCT01930214|5680527|P3|STARTED|Overall Study||133
2313100|NCT01930214|5680528|P2|STARTED|Overall Study||117
2313101|NCT01930214|5680529|P1|STARTED|Overall Study||100
2313102|NCT01930188|5680549|P3|NOT COMPLETED|Overall Study||19
2313103|NCT01930188|5680550|P2|NOT COMPLETED|Overall Study||21
2313104|NCT01930188|5680551|P1|NOT COMPLETED|Overall Study||22
2313105|NCT01930188|5680549|P3|COMPLETED|Overall Study||388
2313106|NCT01930188|5680550|P2|COMPLETED|Overall Study||388
2313107|NCT01930188|5680551|P1|COMPLETED|Overall Study||387
2313108|NCT01930188|5680549|P3|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|32
2313109|NCT01930188|5680550|P2|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|61
2313110|NCT01930188|5680551|P1|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|53
2313111|NCT01930188|5680549|P3|STARTED|Overall Study||407
2313112|NCT01930188|5680550|P2|STARTED|Overall Study||409
2313113|NCT01930188|5680551|P1|STARTED|Overall Study||409
2313114|NCT01930162|5680575|P1|NOT COMPLETED|Overall Study||5
2313115|NCT01930162|5680575|P1|COMPLETED|Overall Study||4
2313116|NCT01930162|5680575|P1|STARTED|Overall Study||9
2313117|NCT01930058|5680587|P3|NOT COMPLETED|Overall Study||0
2313118|NCT01930058|5680588|P2|NOT COMPLETED|Overall Study||0
2313119|NCT01930058|5680589|P1|NOT COMPLETED|Overall Study||0
2313120|NCT01930058|5680587|P3|COMPLETED|Overall Study||3
2313121|NCT01930058|5680588|P2|COMPLETED|Overall Study||3
2313122|NCT01930058|5680589|P1|COMPLETED|Overall Study||3
2313123|NCT01930058|5680587|P3|STARTED|Overall Study||3
2313124|NCT01930058|5680588|P2|STARTED|Overall Study||3
2313125|NCT01930058|5680589|P1|STARTED|Overall Study||3
2313126|NCT01930045|5680611|P6|NOT COMPLETED|Part 2 - Period 5||0
2313127|NCT01930045|5680612|P5|NOT COMPLETED|Part 2 - Period 5||0
2313128|NCT01930045|5680613|P4|NOT COMPLETED|Part 2 - Period 5||0
2313129|NCT01930045|5680614|P3|NOT COMPLETED|Part 2 - Period 5||0
2313130|NCT01930045|5680615|P2|NOT COMPLETED|Part 2 - Period 5||0
2313131|NCT01930045|5680616|P1|NOT COMPLETED|Part 2 - Period 5||0
2313132|NCT01930045|5680611|P6|COMPLETED|Part 2 - Period 5||1
2313133|NCT01930045|5680612|P5|COMPLETED|Part 2 - Period 5||3
2313134|NCT01930045|5680613|P4|COMPLETED|Part 2 - Period 5||3
2313135|NCT01930045|5680614|P3|COMPLETED|Part 2 - Period 5||3
2313136|NCT01930045|5680615|P2|COMPLETED|Part 2 - Period 5||3
2313137|NCT01930045|5680616|P1|COMPLETED|Part 2 - Period 5||3
2313138|NCT01930045|5680611|P6|STARTED|Part 2 - Period 5||1
2313139|NCT01930045|5680612|P5|STARTED|Part 2 - Period 5||3
2313140|NCT01930045|5680613|P4|STARTED|Part 2 - Period 5||3
2313141|NCT01930045|5680614|P3|STARTED|Part 2 - Period 5||3
2313142|NCT01930045|5680615|P2|STARTED|Part 2 - Period 5||3
2313143|NCT01930045|5680616|P1|STARTED|Part 2 - Period 5||3
2313144|NCT01930045|5680611|P6|NOT COMPLETED|Part 2 - Period 4||0
2313145|NCT01930045|5680612|P5|NOT COMPLETED|Part 2 - Period 4||0
2313146|NCT01930045|5680613|P4|NOT COMPLETED|Part 2 - Period 4||0
2313147|NCT01930045|5680614|P3|NOT COMPLETED|Part 2 - Period 4||0
2313148|NCT01930045|5680615|P2|NOT COMPLETED|Part 2 - Period 4||0
2313149|NCT01930045|5680616|P1|NOT COMPLETED|Part 2 - Period 4||0
2313150|NCT01930045|5680611|P6|COMPLETED|Part 2 - Period 4||1
2313151|NCT01930045|5680612|P5|COMPLETED|Part 2 - Period 4||3
2313152|NCT01930045|5680613|P4|COMPLETED|Part 2 - Period 4||3
2313153|NCT01930045|5680614|P3|COMPLETED|Part 2 - Period 4||3
2313154|NCT01930045|5680615|P2|COMPLETED|Part 2 - Period 4||3
2313155|NCT01930045|5680616|P1|COMPLETED|Part 2 - Period 4||3
2313156|NCT01930045|5680611|P6|STARTED|Part 2 - Period 4||1
2313157|NCT01930045|5680612|P5|STARTED|Part 2 - Period 4||3
2313158|NCT01930045|5680613|P4|STARTED|Part 2 - Period 4||3
2313159|NCT01930045|5680614|P3|STARTED|Part 2 - Period 4||3
2313160|NCT01930045|5680615|P2|STARTED|Part 2 - Period 4||3
2313161|NCT01930045|5680616|P1|STARTED|Part 2 - Period 4||3
2313162|NCT01930045|5680611|P6|NOT COMPLETED|Pause (up to 37 Days)||2
2313163|NCT01930045|5680612|P5|NOT COMPLETED|Pause (up to 37 Days)||0
2313164|NCT01930045|5680613|P4|NOT COMPLETED|Pause (up to 37 Days)||0
2313165|NCT01930045|5680614|P3|NOT COMPLETED|Pause (up to 37 Days)||0
2313166|NCT01930045|5680615|P2|NOT COMPLETED|Pause (up to 37 Days)||0
2313167|NCT01930045|5680616|P1|NOT COMPLETED|Pause (up to 37 Days)||0
2313168|NCT01930045|5680611|P6|COMPLETED|Pause (up to 37 Days)||1
2313169|NCT01930045|5680612|P5|COMPLETED|Pause (up to 37 Days)||3
2313170|NCT01930045|5680613|P4|COMPLETED|Pause (up to 37 Days)||3
2313171|NCT01930045|5680614|P3|COMPLETED|Pause (up to 37 Days)||3
2313172|NCT01930045|5680615|P2|COMPLETED|Pause (up to 37 Days)||3
2313173|NCT01930045|5680616|P1|COMPLETED|Pause (up to 37 Days)||3
2313174|NCT01930045|5680611|P6|STARTED|Pause (up to 37 Days)||3
2313175|NCT01930045|5680612|P5|STARTED|Pause (up to 37 Days)||3
2313176|NCT01930045|5680613|P4|STARTED|Pause (up to 37 Days)||3
2313177|NCT01930045|5680614|P3|STARTED|Pause (up to 37 Days)|The participant who missed treatment in Period 3, resumed the study|3
2313178|NCT01930045|5680615|P2|STARTED|Pause (up to 37 Days)||3
2313179|NCT01930045|5680616|P1|STARTED|Pause (up to 37 Days)||3
2313180|NCT01930045|5680611|P6|NOT COMPLETED|Part 1 - Period 3||0
2313181|NCT01930045|5680612|P5|NOT COMPLETED|Part 1 - Period 3||0
2313182|NCT01930045|5680613|P4|NOT COMPLETED|Part 1 - Period 3||0
2313183|NCT01930045|5680614|P3|NOT COMPLETED|Part 1 - Period 3||0
2313184|NCT01930045|5680615|P2|NOT COMPLETED|Part 1 - Period 3||0
2313185|NCT01930045|5680616|P1|NOT COMPLETED|Part 1 - Period 3||0
2313186|NCT01930045|5680611|P6|COMPLETED|Part 1 - Period 3||3
2313187|NCT01930045|5680612|P5|COMPLETED|Part 1 - Period 3||3
2313188|NCT01930045|5680613|P4|COMPLETED|Part 1 - Period 3||3
2313189|NCT01930045|5680614|P3|COMPLETED|Part 1 - Period 3||2
2313190|NCT01930045|5680615|P2|COMPLETED|Part 1 - Period 3||3
2313191|NCT01930045|5680616|P1|COMPLETED|Part 1 - Period 3||3
2313192|NCT01930045|5680611|P6|STARTED|Part 1 - Period 3||3
2313193|NCT01930045|5680612|P5|STARTED|Part 1 - Period 3||3
2313194|NCT01930045|5680613|P4|STARTED|Part 1 - Period 3||3
2313195|NCT01930045|5680614|P3|STARTED|Part 1 - Period 3|One participant missed treatment during Period 3 only.|2
2313196|NCT01930045|5680615|P2|STARTED|Part 1 - Period 3||3
2313197|NCT01930045|5680616|P1|STARTED|Part 1 - Period 3||3
2313198|NCT01930045|5680611|P6|NOT COMPLETED|Part 1 - Period 2||0
2313199|NCT01930045|5680612|P5|NOT COMPLETED|Part 1 - Period 2||0
2313200|NCT01930045|5680613|P4|NOT COMPLETED|Part 1 - Period 2||0
2313201|NCT01930045|5680614|P3|NOT COMPLETED|Part 1 - Period 2||0
2313202|NCT01930045|5680615|P2|NOT COMPLETED|Part 1 - Period 2||0
2313203|NCT01930045|5680616|P1|NOT COMPLETED|Part 1 - Period 2||0
2313204|NCT01930045|5680611|P6|COMPLETED|Part 1 - Period 2||3
2313205|NCT01930045|5680612|P5|COMPLETED|Part 1 - Period 2||3
2313206|NCT01930045|5680613|P4|COMPLETED|Part 1 - Period 2||3
2313207|NCT01930045|5680614|P3|COMPLETED|Part 1 - Period 2||3
2313208|NCT01930045|5680615|P2|COMPLETED|Part 1 - Period 2||3
2313209|NCT01930045|5680616|P1|COMPLETED|Part 1 - Period 2||3
2313210|NCT01930045|5680611|P6|STARTED|Part 1 - Period 2||3
2313211|NCT01930045|5680612|P5|STARTED|Part 1 - Period 2||3
2313212|NCT01930045|5680613|P4|STARTED|Part 1 - Period 2||3
2313213|NCT01930045|5680614|P3|STARTED|Part 1 - Period 2||3
2313214|NCT01930045|5680615|P2|STARTED|Part 1 - Period 2||3
2313215|NCT01930045|5680616|P1|STARTED|Part 1 - Period 2||3
2313216|NCT01930045|5680611|P6|NOT COMPLETED|Part 1 - Period 1||0
2313217|NCT01930045|5680612|P5|NOT COMPLETED|Part 1 - Period 1||0
2313218|NCT01930045|5680613|P4|NOT COMPLETED|Part 1 - Period 1||0
2313219|NCT01930045|5680614|P3|NOT COMPLETED|Part 1 - Period 1||0
2313220|NCT01930045|5680615|P2|NOT COMPLETED|Part 1 - Period 1||0
2313221|NCT01930045|5680616|P1|NOT COMPLETED|Part 1 - Period 1||0
2313222|NCT01930045|5680611|P6|COMPLETED|Part 1 - Period 1||3
2313223|NCT01930045|5680612|P5|COMPLETED|Part 1 - Period 1||3
2313224|NCT01930045|5680613|P4|COMPLETED|Part 1 - Period 1||3
2313225|NCT01930045|5680614|P3|COMPLETED|Part 1 - Period 1||3
2313226|NCT01930045|5680615|P2|COMPLETED|Part 1 - Period 1||3
2313227|NCT01930045|5680616|P1|COMPLETED|Part 1 - Period 1||3
2313228|NCT01930045|5680611|P6|STARTED|Part 1 - Period 1||3
2313229|NCT01930045|5680612|P5|STARTED|Part 1 - Period 1||3
2313230|NCT01930045|5680613|P4|STARTED|Part 1 - Period 1||3
2313231|NCT01930045|5680614|P3|STARTED|Part 1 - Period 1||3
2313232|NCT01930045|5680615|P2|STARTED|Part 1 - Period 1||3
2313233|NCT01930045|5680616|P1|STARTED|Part 1 - Period 1||3
2313234|NCT01929993|5680643|P2|NOT COMPLETED|Overall Study||28
2313235|NCT01929993|5680644|P1|NOT COMPLETED|Overall Study||30
2313236|NCT01929993|5680643|P2|COMPLETED|Overall Study||54
2313237|NCT01929993|5680644|P1|COMPLETED|Overall Study||52
2313238|NCT01929993|5680643|P2|STARTED|Overall Study||82
2313239|NCT01929993|5680644|P1|STARTED|Overall Study||82
2313240|NCT01929980|5680650|P1|NOT COMPLETED|Overall Study||1
2313241|NCT01929980|5680650|P1|COMPLETED|Overall Study||3
2313242|NCT01929980|5680650|P1|STARTED|Overall Study||4
2313243|NCT01929889|5680654|P1|NOT COMPLETED|Overall Study||5
2313244|NCT01929889|5680654|P1|COMPLETED|Overall Study|3 subjects completed the study.|3
2313245|NCT01929889|5680654|P1|STARTED|Overall Study|Target enrollment goal was 20 completed subjects.|8
2313246|NCT01929876|5680658|P1|NOT COMPLETED|Period 2||1
2313247|NCT01929876|5680658|P1|COMPLETED|Period 2||15
2313248|NCT01929876|5680658|P1|STARTED|Period 2||16
2313249|NCT01929876|5680658|P1|NOT COMPLETED|Period 1||0
2313250|NCT01929876|5680658|P1|COMPLETED|Period 1||16
2313251|NCT01929876|5680658|P1|STARTED|Period 1||16
2313252|NCT01929863|5680671|P2|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
2313253|NCT01929863|5680672|P1|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
2313254|NCT01929863|5680671|P2|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
2313255|NCT01929863|5680672|P1|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
2313256|NCT01929863|5680671|P2|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
2313257|NCT01929863|5680672|P1|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
2313258|NCT01929863|5680671|P2|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||1
2313259|NCT01929863|5680672|P1|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||0
2313260|NCT01929863|5680671|P2|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
2313261|NCT01929863|5680672|P1|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
2313262|NCT01929863|5680671|P2|STARTED|Period 3:Intervention Period 2 (7 Days)||7
2313263|NCT01929863|5680672|P1|STARTED|Period 3:Intervention Period 2 (7 Days)||6
2313264|NCT01929863|5680671|P2|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
2313265|NCT01929863|5680672|P1|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
2313266|NCT01929863|5680671|P2|COMPLETED|Period 2:Washout Period (13-15 Days)||7
2313267|NCT01929863|5680672|P1|COMPLETED|Period 2:Washout Period (13-15 Days)||6
2313268|NCT01929863|5680671|P2|STARTED|Period 2:Washout Period (13-15 Days)||7
2313269|NCT01929863|5680672|P1|STARTED|Period 2:Washout Period (13-15 Days)||6
2313270|NCT01929863|5680671|P2|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
2313271|NCT01929863|5680672|P1|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
2313272|NCT01929863|5680671|P2|COMPLETED|Period 1:Intervention Period 1 (7 Days)||7
2313273|NCT01929863|5680672|P1|COMPLETED|Period 1:Intervention Period 1 (7 Days)||6
2313274|NCT01929863|5680671|P2|STARTED|Period 1:Intervention Period 1 (7 Days)||8
2313275|NCT01929863|5680672|P1|STARTED|Period 1:Intervention Period 1 (7 Days)||7
2313276|NCT01929759|5680715|P1|NOT COMPLETED|Overall Study||0
2313277|NCT01929759|5680715|P1|COMPLETED|Overall Study||10
2313278|NCT01929759|5680715|P1|STARTED|Overall Study||10
2313279|NCT01929707|5680727|P8|NOT COMPLETED|Intervention Period 2||0
2313280|NCT01929707|5680728|P7|NOT COMPLETED|Intervention Period 2||0
2313281|NCT01929707|5680729|P6|NOT COMPLETED|Intervention Period 2||2
2313282|NCT01929707|5680730|P5|NOT COMPLETED|Intervention Period 2||0
2313283|NCT01929707|5680731|P4|NOT COMPLETED|Intervention Period 2||0
2313284|NCT01929707|5680732|P3|NOT COMPLETED|Intervention Period 2||0
2313285|NCT01929707|5680733|P2|NOT COMPLETED|Intervention Period 2||0
2313286|NCT01929707|5680734|P1|NOT COMPLETED|Intervention Period 2||0
2313287|NCT01929707|5680727|P8|COMPLETED|Intervention Period 2||4
2313288|NCT01929707|5680728|P7|COMPLETED|Intervention Period 2||12
2313289|NCT01929707|5680729|P6|COMPLETED|Intervention Period 2||6
2313290|NCT01929707|5680730|P5|COMPLETED|Intervention Period 2||6
2313291|NCT01929707|5680731|P4|COMPLETED|Intervention Period 2||5
2313292|NCT01929707|5680732|P3|COMPLETED|Intervention Period 2||0
2313293|NCT01929707|5680733|P2|COMPLETED|Intervention Period 2||0
2313294|NCT01929707|5680734|P1|COMPLETED|Intervention Period 2||0
2313295|NCT01929707|5680727|P8|STARTED|Intervention Period 2|Incomplete-crossover design|4
2313296|NCT01929707|5680728|P7|STARTED|Intervention Period 2|Incomplete-crossover design|12
2313297|NCT01929707|5680729|P6|STARTED|Intervention Period 2|Incomplete-crossover design|8
2313298|NCT01929707|5680730|P5|STARTED|Intervention Period 2|Incomplete-crossover design|6
2313299|NCT01929707|5680731|P4|STARTED|Intervention Period 2|Incomplete-crossover design|5
2313300|NCT01929707|5680732|P3|STARTED|Intervention Period 2|Incomplete-crossover design|0
2313301|NCT01929707|5680733|P2|STARTED|Intervention Period 2|Incomplete-crossover design|0
2313302|NCT01929707|5680734|P1|STARTED|Intervention Period 2|Incomplete-crossover design|0
2313303|NCT01929707|5680727|P8|NOT COMPLETED|Washout Period ≥7 Days||0
2313304|NCT01929707|5680728|P7|NOT COMPLETED|Washout Period ≥7 Days||0
2313305|NCT01929707|5680729|P6|NOT COMPLETED|Washout Period ≥7 Days||0
2313306|NCT01929707|5680730|P5|NOT COMPLETED|Washout Period ≥7 Days||0
2313307|NCT01929707|5680731|P4|NOT COMPLETED|Washout Period ≥7 Days||0
2313308|NCT01929707|5680732|P3|NOT COMPLETED|Washout Period ≥7 Days||0
2313309|NCT01929707|5680733|P2|NOT COMPLETED|Washout Period ≥7 Days||0
2313310|NCT01929707|5680734|P1|NOT COMPLETED|Washout Period ≥7 Days||0
2313311|NCT01929707|5680727|P8|COMPLETED|Washout Period ≥7 Days||0
2313312|NCT01929707|5680728|P7|COMPLETED|Washout Period ≥7 Days||0
2313313|NCT01929707|5680729|P6|COMPLETED|Washout Period ≥7 Days||0
2313314|NCT01929707|5680730|P5|COMPLETED|Washout Period ≥7 Days||0
2313315|NCT01929707|5680731|P4|COMPLETED|Washout Period ≥7 Days||7
2313316|NCT01929707|5680732|P3|COMPLETED|Washout Period ≥7 Days||12
2313317|NCT01929707|5680733|P2|COMPLETED|Washout Period ≥7 Days||8
2313318|NCT01929707|5680734|P1|COMPLETED|Washout Period ≥7 Days||6
2313319|NCT01929707|5680727|P8|STARTED|Washout Period ≥7 Days||0
2313320|NCT01929707|5680728|P7|STARTED|Washout Period ≥7 Days||0
2313321|NCT01929707|5680729|P6|STARTED|Washout Period ≥7 Days||0
2313322|NCT01929707|5680730|P5|STARTED|Washout Period ≥7 Days||0
2313323|NCT01929707|5680731|P4|STARTED|Washout Period ≥7 Days||7
2313324|NCT01929707|5680732|P3|STARTED|Washout Period ≥7 Days||12
2313325|NCT01929707|5680733|P2|STARTED|Washout Period ≥7 Days||8
2313326|NCT01929707|5680734|P1|STARTED|Washout Period ≥7 Days||6
2313327|NCT01929707|5680727|P8|NOT COMPLETED|Intervention Period 1||0
2313328|NCT01929707|5680728|P7|NOT COMPLETED|Intervention Period 1||0
2313329|NCT01929707|5680729|P6|NOT COMPLETED|Intervention Period 1||0
2313330|NCT01929707|5680730|P5|NOT COMPLETED|Intervention Period 1||0
2313331|NCT01929707|5680731|P4|NOT COMPLETED|Intervention Period 1||3
2313332|NCT01929707|5680732|P3|NOT COMPLETED|Intervention Period 1||0
2313333|NCT01929707|5680733|P2|NOT COMPLETED|Intervention Period 1||0
2313334|NCT01929707|5680734|P1|NOT COMPLETED|Intervention Period 1||0
2313335|NCT01929707|5680727|P8|COMPLETED|Intervention Period 1||0
2313336|NCT01929707|5680728|P7|COMPLETED|Intervention Period 1||0
2313337|NCT01929707|5680729|P6|COMPLETED|Intervention Period 1||0
2313338|NCT01929707|5680730|P5|COMPLETED|Intervention Period 1||0
2313339|NCT01929707|5680731|P4|COMPLETED|Intervention Period 1|Two discontinued participants were replaced in Period 2|7
2313340|NCT01929707|5680732|P3|COMPLETED|Intervention Period 1||12
2313341|NCT01929707|5680733|P2|COMPLETED|Intervention Period 1||8
2313342|NCT01929707|5680734|P1|COMPLETED|Intervention Period 1||6
2313343|NCT01929707|5680727|P8|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
2313344|NCT01929707|5680728|P7|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
2313345|NCT01929707|5680729|P6|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
2313346|NCT01929707|5680730|P5|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
2313347|NCT01929707|5680731|P4|Received at Least 1 Dose of Study Drug|Intervention Period 1||10
2313348|NCT01929707|5680732|P3|Received at Least 1 Dose of Study Drug|Intervention Period 1||12
2313349|NCT01929707|5680733|P2|Received at Least 1 Dose of Study Drug|Intervention Period 1||8
2313350|NCT01929707|5680734|P1|Received at Least 1 Dose of Study Drug|Intervention Period 1||6
2313351|NCT01929707|5680727|P8|STARTED|Intervention Period 1||0
2313352|NCT01929707|5680728|P7|STARTED|Intervention Period 1||0
2313353|NCT01929707|5680729|P6|STARTED|Intervention Period 1||0
2313354|NCT01929707|5680730|P5|STARTED|Intervention Period 1||0
2313355|NCT01929707|5680731|P4|STARTED|Intervention Period 1||10
2313356|NCT01929707|5680732|P3|STARTED|Intervention Period 1||12
2313357|NCT01929707|5680733|P2|STARTED|Intervention Period 1||8
2313358|NCT01929707|5680734|P1|STARTED|Intervention Period 1||6
2313359|NCT01929681|5680766|P2|NOT COMPLETED|Overall Study||1
2313360|NCT01929681|5680767|P1|NOT COMPLETED|Overall Study||2
2313361|NCT01929681|5680766|P2|COMPLETED|Overall Study||24
2313362|NCT01929681|5680767|P1|COMPLETED|Overall Study||26
2313363|NCT01929681|5680766|P2|STARTED|Overall Study||25
2313364|NCT01929681|5680767|P1|STARTED|Overall Study||28
2313365|NCT01929473|5680781|P1|NOT COMPLETED|Overall Study||587
2313366|NCT01929473|5680781|P1|COMPLETED|Overall Study||3243
2313367|NCT01929473|5680781|P1|365 Day|Overall Study||3589
2313368|NCT01929473|5680781|P1|STARTED|Overall Study|0 day|3830
2313369|NCT01929460|5680787|P2|NOT COMPLETED|Overall Study||0
2313370|NCT01929460|5680788|P1|NOT COMPLETED|Overall Study||0
2313371|NCT01929460|5680787|P2|COMPLETED|Overall Study||13
2313372|NCT01929460|5680788|P1|COMPLETED|Overall Study||13
2313373|NCT01929460|5680787|P2|STARTED|Overall Study||13
2313374|NCT01929460|5680788|P1|STARTED|Overall Study||13
2313375|NCT01929408|5680810|P1|NOT COMPLETED|Overall Study||8
2313376|NCT01929408|5680810|P1|COMPLETED|Overall Study||695
2313377|NCT01929408|5680810|P1|STARTED|Overall Study||703
2313378|NCT01929395|5680818|P3|NOT COMPLETED|Overall Study||1
2313379|NCT01929395|5680819|P2|NOT COMPLETED|Overall Study||1
2313380|NCT01929395|5680820|P1|NOT COMPLETED|Overall Study||1
2313381|NCT01929395|5680818|P3|COMPLETED|Overall Study||69
2313382|NCT01929395|5680819|P2|COMPLETED|Overall Study||69
2313383|NCT01929395|5680820|P1|COMPLETED|Overall Study||18
2313384|NCT01929395|5680818|P3|STARTED|Overall Study||70
2313385|NCT01929395|5680819|P2|STARTED|Overall Study||70
2313386|NCT01929395|5680820|P1|STARTED|Overall Study||19
2313387|NCT01929317|5680832|P2|NOT COMPLETED|Long-term Phase||4
2313388|NCT01929317|5680833|P1|NOT COMPLETED|Long-term Phase||19
2313389|NCT01929317|5680832|P2|COMPLETED|Long-term Phase||14
2313390|NCT01929317|5680833|P1|COMPLETED|Long-term Phase||25
2313391|NCT01929317|5680832|P2|STARTED|Long-term Phase||18
2313392|NCT01929317|5680833|P1|STARTED|Long-term Phase||44
2313393|NCT01929317|5680832|P2|NOT COMPLETED|Dose Increase Effect Verification Phase||1
2313394|NCT01929317|5680833|P1|NOT COMPLETED|Dose Increase Effect Verification Phase||9
2313395|NCT01929317|5680832|P2|COMPLETED|Dose Increase Effect Verification Phase||19
2313396|NCT01929317|5680833|P1|COMPLETED|Dose Increase Effect Verification Phase||52
2313397|NCT01929317|5680832|P2|STARTED|Dose Increase Effect Verification Phase||20
2313398|NCT01929317|5680833|P1|STARTED|Dose Increase Effect Verification Phase||61
2313399|NCT01929291|5680900|P1|NOT COMPLETED|Overall Study||0
2313400|NCT01929291|5680900|P1|COMPLETED|Overall Study||672
2313401|NCT01929291|5680900|P1|STARTED|Overall Study||672
2313402|NCT01929226|5680908|P2|NOT COMPLETED|Overall Study||1
2313403|NCT01929226|5680909|P1|NOT COMPLETED|Overall Study||5
2313404|NCT01929226|5680908|P2|COMPLETED|Overall Study||69
2313405|NCT01929226|5680909|P1|COMPLETED|Overall Study||205
2313406|NCT01929226|5680908|P2|STARTED|Overall Study||70
2313407|NCT01929226|5680909|P1|STARTED|Overall Study||210
2313408|NCT01929135|5680935|P2|NOT COMPLETED|Overall Study||1
2313409|NCT01929135|5680936|P1|NOT COMPLETED|Overall Study||1
2313410|NCT01929135|5680935|P2|COMPLETED|Overall Study||18
2313411|NCT01929135|5680936|P1|COMPLETED|Overall Study||18
2313412|NCT01929135|5680935|P2|STARTED|Overall Study||19
2313413|NCT01929135|5680936|P1|STARTED|Overall Study||19
2313414|NCT01929109|5680955|P5|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
2313415|NCT01929109|5680956|P4|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
2313416|NCT01929109|5680957|P3|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
2313417|NCT01929109|5680958|P2|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
2313418|NCT01929109|5680959|P1|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
2313419|NCT01929109|5680955|P5|COMPLETED|Period 2 (End Stage Renal Disease Only)||8
2313420|NCT01929109|5680956|P4|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
2313421|NCT01929109|5680957|P3|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
2313422|NCT01929109|5680958|P2|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
2313423|NCT01929109|5680959|P1|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
2313424|NCT01929109|5680955|P5|STARTED|Period 2 (End Stage Renal Disease Only)||8
2313425|NCT01929109|5680956|P4|STARTED|Period 2 (End Stage Renal Disease Only)||0
2313426|NCT01929109|5680957|P3|STARTED|Period 2 (End Stage Renal Disease Only)||0
2313427|NCT01929109|5680958|P2|STARTED|Period 2 (End Stage Renal Disease Only)||0
2313428|NCT01929109|5680959|P1|STARTED|Period 2 (End Stage Renal Disease Only)||0
2313429|NCT01929109|5680955|P5|NOT COMPLETED|Period 1 (All Groups)||0
2313430|NCT01929109|5680956|P4|NOT COMPLETED|Period 1 (All Groups)||0
2313431|NCT01929109|5680957|P3|NOT COMPLETED|Period 1 (All Groups)||1
2313432|NCT01929109|5680958|P2|NOT COMPLETED|Period 1 (All Groups)||0
2313433|NCT01929109|5680959|P1|NOT COMPLETED|Period 1 (All Groups)||0
2313434|NCT01929109|5680955|P5|COMPLETED|Period 1 (All Groups)||8
2313435|NCT01929109|5680956|P4|COMPLETED|Period 1 (All Groups)||8
2313436|NCT01929109|5680957|P3|COMPLETED|Period 1 (All Groups)||8
2313437|NCT01929109|5680958|P2|COMPLETED|Period 1 (All Groups)||8
2313438|NCT01929109|5680959|P1|COMPLETED|Period 1 (All Groups)||14
2313439|NCT01929109|5680955|P5|STARTED|Period 1 (All Groups)||8
2313440|NCT01929109|5680956|P4|STARTED|Period 1 (All Groups)||8
2313441|NCT01929109|5680957|P3|STARTED|Period 1 (All Groups)||9
2313442|NCT01929109|5680958|P2|STARTED|Period 1 (All Groups)||8
2313443|NCT01929109|5680959|P1|STARTED|Period 1 (All Groups)||14
2313444|NCT01929083|5680978|P2|NOT COMPLETED|Intervention 2||1
2313445|NCT01929083|5680979|P1|NOT COMPLETED|Intervention 2||0
2313446|NCT01929083|5680978|P2|COMPLETED|Intervention 2||8
2313447|NCT01929083|5680979|P1|COMPLETED|Intervention 2||7
2313448|NCT01929083|5680978|P2|Returned for 2nd Ibutilide Administratio|Intervention 2||8
2313449|NCT01929083|5680979|P1|Returned for 2nd Ibutilide Administratio|Intervention 2||7
2313450|NCT01929083|5680978|P2|STARTED|Intervention 2||9
2313451|NCT01929083|5680979|P1|STARTED|Intervention 2||7
2313452|NCT01929083|5680978|P2|NOT COMPLETED|Intervention 1||0
2313453|NCT01929083|5680979|P1|NOT COMPLETED|Intervention 1||3
2313454|NCT01929083|5680978|P2|COMPLETED|Intervention 1||9
2313455|NCT01929083|5680979|P1|COMPLETED|Intervention 1||7
2313456|NCT01929083|5680978|P2|Returned for 1st Ibutilide Administratio|Intervention 1||9
2313457|NCT01929083|5680979|P1|Returned for 1st Ibutilide Administratio|Intervention 1||7
2313458|NCT01929083|5680978|P2|STARTED|Intervention 1||9
2313459|NCT01929083|5680979|P1|STARTED|Intervention 1|Number of patients randomized to receive progesterone first|10
2313460|NCT01929057|5681005|P2|NOT COMPLETED|Overall Study||0
2313461|NCT01929057|5681006|P1|NOT COMPLETED|Overall Study||0
2313462|NCT01929057|5681005|P2|COMPLETED|Overall Study||3
2313463|NCT01929057|5681006|P1|COMPLETED|Overall Study||31
2313464|NCT01929057|5681005|P2|STARTED|Overall Study||3
2313465|NCT01929057|5681006|P1|STARTED|Overall Study||31
2313466|NCT01929044|5681016|P2|NOT COMPLETED|Overall Study||17
2313467|NCT01929044|5681017|P1|NOT COMPLETED|Overall Study||11
2313468|NCT01929044|5681016|P2|COMPLETED|Overall Study||129
2313469|NCT01929044|5681017|P1|COMPLETED|Overall Study||142
2313470|NCT01929044|5681016|P2|STARTED|Overall Study||146
2313471|NCT01929044|5681017|P1|STARTED|Overall Study||153
2313472|NCT01929031|5681039|P6|NOT COMPLETED|Overall Study||1
2313473|NCT01929031|5681040|P5|NOT COMPLETED|Overall Study||1
2313474|NCT01929031|5681041|P4|NOT COMPLETED|Overall Study||0
2313475|NCT01929031|5681042|P3|NOT COMPLETED|Overall Study||1
2313476|NCT01929031|5681043|P2|NOT COMPLETED|Overall Study||2
2313477|NCT01929031|5681044|P1|NOT COMPLETED|Overall Study||4
2313478|NCT01929031|5681039|P6|COMPLETED|Overall Study||35
2313479|NCT01929031|5681040|P5|COMPLETED|Overall Study||33
2313480|NCT01929031|5681041|P4|COMPLETED|Overall Study||35
2313481|NCT01929031|5681042|P3|COMPLETED|Overall Study||34
2313482|NCT01929031|5681043|P2|COMPLETED|Overall Study||207
2313483|NCT01929031|5681044|P1|COMPLETED|Overall Study||209
2313484|NCT01929031|5681039|P6|STARTED|Overall Study||36
2313485|NCT01929031|5681040|P5|STARTED|Overall Study||34
2313486|NCT01929031|5681041|P4|STARTED|Overall Study||35
2313487|NCT01929031|5681042|P3|STARTED|Overall Study||35
2313488|NCT01929031|5681043|P2|STARTED|Overall Study||209
2313489|NCT01929031|5681044|P1|STARTED|Overall Study||213
2313490|NCT01929018|5681068|P2|NOT COMPLETED|Overall Study||1
2313491|NCT01929018|5681069|P1|NOT COMPLETED|Overall Study||1
2313492|NCT01929018|5681068|P2|COMPLETED|Overall Study||18
2313493|NCT01929018|5681069|P1|COMPLETED|Overall Study||18
2313494|NCT01929018|5681068|P2|STARTED|Overall Study||19
2313495|NCT01929018|5681069|P1|STARTED|Overall Study||19
2313496|NCT01928940|5681093|P2|NOT COMPLETED|Overall Study||1
2313497|NCT01928940|5681094|P1|NOT COMPLETED|Overall Study||0
2313498|NCT01928940|5681093|P2|COMPLETED|Overall Study||5
2313499|NCT01928940|5681094|P1|COMPLETED|Overall Study||6
2313500|NCT01928940|5681093|P2|STARTED|Overall Study||6
2313501|NCT01928940|5681094|P1|STARTED|Overall Study||6
2313502|NCT01928927|5681137|P2|NOT COMPLETED|Overall Study||1
2313503|NCT01928927|5681138|P1|NOT COMPLETED|Overall Study||2
2313504|NCT01928927|5681137|P2|COMPLETED|Overall Study||14
2313505|NCT01928927|5681138|P1|COMPLETED|Overall Study||27
2313506|NCT01928927|5681137|P2|STARTED|Overall Study||15
2313507|NCT01928927|5681138|P1|STARTED|Overall Study||29
2313508|NCT01928862|5681265|P5|NOT COMPLETED|Overall Study||1
2313509|NCT01928862|5681266|P4|NOT COMPLETED|Overall Study||0
2313510|NCT01928862|5681267|P3|NOT COMPLETED|Overall Study||0
2313511|NCT01928862|5681268|P2|NOT COMPLETED|Overall Study||0
2313512|NCT01928862|5681269|P1|NOT COMPLETED|Overall Study||1
2313513|NCT01928862|5681265|P5|COMPLETED|Overall Study||13
2313514|NCT01928862|5681266|P4|COMPLETED|Overall Study||16
2313515|NCT01928862|5681267|P3|COMPLETED|Overall Study||16
2313516|NCT01928862|5681268|P2|COMPLETED|Overall Study||16
2313517|NCT01928862|5681269|P1|COMPLETED|Overall Study||15
2313518|NCT01928862|5681265|P5|STARTED|Overall Study||14
2313519|NCT01928862|5681266|P4|STARTED|Overall Study||16
2313520|NCT01928862|5681267|P3|STARTED|Overall Study||16
2313521|NCT01928862|5681268|P2|STARTED|Overall Study||16
2313522|NCT01928862|5681269|P1|STARTED|Overall Study||16
2313523|NCT01928849|5681308|P2|NOT COMPLETED|Overall Study||7
2313524|NCT01928849|5681309|P1|NOT COMPLETED|Overall Study||14
2313525|NCT01928849|5681308|P2|COMPLETED|Overall Study||55
2313526|NCT01928849|5681309|P1|COMPLETED|Overall Study||52
2313527|NCT01928849|5681308|P2|STARTED|Overall Study||62
2313528|NCT01928849|5681309|P1|STARTED|Overall Study||66
2313529|NCT01928797|5681329|P2|NOT COMPLETED|Overall Study||0
2313530|NCT01928797|5681330|P1|NOT COMPLETED|Overall Study||0
2313531|NCT01928797|5681329|P2|COMPLETED|Overall Study||30
2313532|NCT01928797|5681330|P1|COMPLETED|Overall Study||30
2313533|NCT01928797|5681329|P2|STARTED|Overall Study||30
2313534|NCT01928797|5681330|P1|STARTED|Overall Study||30
2313535|NCT01928771|5681343|P3|NOT COMPLETED|Overall Study||40
2313536|NCT01928771|5681344|P2|NOT COMPLETED|Overall Study||40
2313537|NCT01928771|5681345|P1|NOT COMPLETED|Overall Study||46
2313538|NCT01928771|5681343|P3|COMPLETED|Overall Study||367
2313539|NCT01928771|5681344|P2|COMPLETED|Overall Study||358
2313540|NCT01928771|5681345|P1|COMPLETED|Overall Study||354
2313541|NCT01928771|5681343|P3|Received Treatment|Overall Study||407
2313542|NCT01928771|5681344|P2|Received Treatment|Overall Study||398
2313543|NCT01928771|5681345|P1|Received Treatment|Overall Study||399
2313544|NCT01928771|5681343|P3|STARTED|Overall Study||407
2313545|NCT01928771|5681344|P2|STARTED|Overall Study||398
2313546|NCT01928771|5681345|P1|STARTED|Overall Study||400
2313547|NCT01928758|5681424|P2|NOT COMPLETED|Overall Study||20
2313548|NCT01928758|5681425|P1|NOT COMPLETED|Overall Study||25
2313549|NCT01928758|5681424|P2|COMPLETED|Overall Study||74
2313550|NCT01928758|5681425|P1|COMPLETED|Overall Study||69
2313551|NCT01928758|5681424|P2|STARTED|Overall Study||94
2313552|NCT01928758|5681425|P1|STARTED|Overall Study||94
2313553|NCT01928719|5681443|P2|NOT COMPLETED|Overall Study||19
2313554|NCT01928719|5681444|P1|NOT COMPLETED|Overall Study||52
2313555|NCT01928719|5681443|P2|COMPLETED|Overall Study||104
2313556|NCT01928719|5681444|P1|COMPLETED|Overall Study||70
2313557|NCT01928719|5681443|P2|STARTED|Overall Study||123
2313558|NCT01928719|5681444|P1|STARTED|Overall Study||122
2313559|NCT01928693|5681464|P3|NOT COMPLETED|Overall Study||0
2313560|NCT01928693|5681465|P2|NOT COMPLETED|Overall Study||0
2313561|NCT01928693|5681466|P1|NOT COMPLETED|Overall Study||0
2313562|NCT01928693|5681464|P3|COMPLETED|Overall Study||1
2313563|NCT01928693|5681465|P2|COMPLETED|Overall Study||1
2313564|NCT01928693|5681466|P1|COMPLETED|Overall Study||0
2313565|NCT01928693|5681464|P3|STARTED|Overall Study||1
2313566|NCT01928693|5681465|P2|STARTED|Overall Study||1
2313567|NCT01928693|5681466|P1|STARTED|Overall Study||0
2313568|NCT01928680|5681492|P1|NOT COMPLETED|Overall Study||0
2313569|NCT01928680|5681492|P1|COMPLETED|Overall Study||33
2313570|NCT01928680|5681492|P1|STARTED|Overall Study||33
2313571|NCT01928615|5681496|P1|NOT COMPLETED|Overall Study||2
2313572|NCT01928615|5681496|P1|COMPLETED|Overall Study||0
2313573|NCT01928615|5681496|P1|STARTED|Overall Study||2
2313574|NCT01928472|5681515|P4|NOT COMPLETED|Overall Study||2
2313575|NCT01928472|5681516|P3|NOT COMPLETED|Overall Study||7
2313576|NCT01928472|5681517|P2|NOT COMPLETED|Overall Study||8
2313577|NCT01928472|5681518|P1|NOT COMPLETED|Overall Study||8
2313578|NCT01928472|5681515|P4|COMPLETED|Overall Study||100
2313579|NCT01928472|5681516|P3|COMPLETED|Overall Study||91
2313580|NCT01928472|5681517|P2|COMPLETED|Overall Study||96
2313581|NCT01928472|5681518|P1|COMPLETED|Overall Study||90
2313582|NCT01928472|5681515|P4|STARTED|Overall Study||102
2313583|NCT01928472|5681516|P3|STARTED|Overall Study||98
2313584|NCT01928472|5681517|P2|STARTED|Overall Study||104
2313585|NCT01928472|5681518|P1|STARTED|Overall Study||98
2313586|NCT01928433|5681588|P3|NOT COMPLETED|Overall Study||28
2313587|NCT01928433|5681589|P2|NOT COMPLETED|Overall Study||21
2313588|NCT01928433|5681590|P1|NOT COMPLETED|Overall Study||20
2313589|NCT01928433|5681588|P3|COMPLETED|Overall Study||46
2313590|NCT01928433|5681589|P2|COMPLETED|Overall Study||54
2313591|NCT01928433|5681590|P1|COMPLETED|Overall Study||56
2313592|NCT01928433|5681588|P3|STARTED|Overall Study||74
2313593|NCT01928433|5681589|P2|STARTED|Overall Study||75
2313594|NCT01928433|5681590|P1|STARTED|Overall Study||76
2313595|NCT01928381|5681613|P7|NOT COMPLETED|Part 2 - Post Third Intervention||0
2313596|NCT01928381|5681614|P6|NOT COMPLETED|Part 2 - Post Third Intervention||0
2313597|NCT01928381|5681615|P5|NOT COMPLETED|Part 2 - Post Third Intervention||0
2313598|NCT01928381|5681616|P4|NOT COMPLETED|Part 2 - Post Third Intervention||0
2313599|NCT01928381|5681617|P3|NOT COMPLETED|Part 2 - Post Third Intervention||1
2313600|NCT01928381|5681618|P2|NOT COMPLETED|Part 2 - Post Third Intervention||0
2313601|NCT01928381|5681619|P1|NOT COMPLETED|Part 2 - Post Third Intervention||0
2313602|NCT01928381|5681613|P7|COMPLETED|Part 2 - Post Third Intervention||5
2313603|NCT01928381|5681614|P6|COMPLETED|Part 2 - Post Third Intervention||5
2313604|NCT01928381|5681615|P5|COMPLETED|Part 2 - Post Third Intervention||3
2313605|NCT01928381|5681616|P4|COMPLETED|Part 2 - Post Third Intervention||4
2313606|NCT01928381|5681617|P3|COMPLETED|Part 2 - Post Third Intervention||3
2313607|NCT01928381|5681618|P2|COMPLETED|Part 2 - Post Third Intervention||5
2313608|NCT01928381|5681619|P1|COMPLETED|Part 2 - Post Third Intervention||0
2313609|NCT01928381|5681613|P7|STARTED|Part 2 - Post Third Intervention||5
2313610|NCT01928381|5681614|P6|STARTED|Part 2 - Post Third Intervention||5
2313611|NCT01928381|5681615|P5|STARTED|Part 2 - Post Third Intervention||3
2313612|NCT01928381|5681616|P4|STARTED|Part 2 - Post Third Intervention||4
2313613|NCT01928381|5681617|P3|STARTED|Part 2 - Post Third Intervention||4
2313614|NCT01928381|5681618|P2|STARTED|Part 2 - Post Third Intervention||5
2313615|NCT01928381|5681619|P1|STARTED|Part 2 - Post Third Intervention||0
2313616|NCT01928381|5681613|P7|NOT COMPLETED|Part 2 - Third Intervention||0
2313617|NCT01928381|5681614|P6|NOT COMPLETED|Part 2 - Third Intervention||0
2313618|NCT01928381|5681615|P5|NOT COMPLETED|Part 2 - Third Intervention||0
2313619|NCT01928381|5681616|P4|NOT COMPLETED|Part 2 - Third Intervention||0
2313620|NCT01928381|5681617|P3|NOT COMPLETED|Part 2 - Third Intervention||0
2313621|NCT01928381|5681618|P2|NOT COMPLETED|Part 2 - Third Intervention||0
2313622|NCT01928381|5681619|P1|NOT COMPLETED|Part 2 - Third Intervention||0
2313623|NCT01928381|5681613|P7|COMPLETED|Part 2 - Third Intervention||5
2313624|NCT01928381|5681614|P6|COMPLETED|Part 2 - Third Intervention||5
2313625|NCT01928381|5681615|P5|COMPLETED|Part 2 - Third Intervention||3
2313626|NCT01928381|5681616|P4|COMPLETED|Part 2 - Third Intervention||4
2313627|NCT01928381|5681617|P3|COMPLETED|Part 2 - Third Intervention||4
2313628|NCT01928381|5681618|P2|COMPLETED|Part 2 - Third Intervention||5
2313629|NCT01928381|5681619|P1|COMPLETED|Part 2 - Third Intervention||0
2313630|NCT01928381|5681613|P7|STARTED|Part 2 - Third Intervention||5
2313631|NCT01928381|5681614|P6|STARTED|Part 2 - Third Intervention||5
2313632|NCT01928381|5681615|P5|STARTED|Part 2 - Third Intervention||3
2313633|NCT01928381|5681616|P4|STARTED|Part 2 - Third Intervention||4
2313634|NCT01928381|5681617|P3|STARTED|Part 2 - Third Intervention||4
2313635|NCT01928381|5681618|P2|STARTED|Part 2 - Third Intervention||5
2313636|NCT01928381|5681619|P1|STARTED|Part 2 - Third Intervention||0
2313637|NCT01928381|5681613|P7|NOT COMPLETED|Washout Second Intervention||0
2313638|NCT01928381|5681614|P6|NOT COMPLETED|Washout Second Intervention||0
2313639|NCT01928381|5681615|P5|NOT COMPLETED|Washout Second Intervention||0
2313640|NCT01928381|5681616|P4|NOT COMPLETED|Washout Second Intervention||0
2313641|NCT01928381|5681617|P3|NOT COMPLETED|Washout Second Intervention||0
2313642|NCT01928381|5681618|P2|NOT COMPLETED|Washout Second Intervention||0
2313643|NCT01928381|5681619|P1|NOT COMPLETED|Washout Second Intervention||0
2313644|NCT01928381|5681613|P7|COMPLETED|Washout Second Intervention||5
2313645|NCT01928381|5681614|P6|COMPLETED|Washout Second Intervention||5
2313646|NCT01928381|5681615|P5|COMPLETED|Washout Second Intervention||3
2313647|NCT01928381|5681616|P4|COMPLETED|Washout Second Intervention||4
2313648|NCT01928381|5681617|P3|COMPLETED|Washout Second Intervention||4
2313649|NCT01928381|5681618|P2|COMPLETED|Washout Second Intervention||5
2313650|NCT01928381|5681619|P1|COMPLETED|Washout Second Intervention||0
2313651|NCT01928381|5681613|P7|STARTED|Washout Second Intervention||5
2313652|NCT01928381|5681614|P6|STARTED|Washout Second Intervention||5
2313653|NCT01928381|5681615|P5|STARTED|Washout Second Intervention||3
2313654|NCT01928381|5681616|P4|STARTED|Washout Second Intervention||4
2313655|NCT01928381|5681617|P3|STARTED|Washout Second Intervention||4
2313656|NCT01928381|5681618|P2|STARTED|Washout Second Intervention||5
2313657|NCT01928381|5681619|P1|STARTED|Washout Second Intervention||0
2313658|NCT01928381|5681613|P7|NOT COMPLETED|Part 2 - Second Intervention||0
2313659|NCT01928381|5681614|P6|NOT COMPLETED|Part 2 - Second Intervention||0
2313660|NCT01928381|5681615|P5|NOT COMPLETED|Part 2 - Second Intervention||0
2313661|NCT01928381|5681616|P4|NOT COMPLETED|Part 2 - Second Intervention||1
2313662|NCT01928381|5681617|P3|NOT COMPLETED|Part 2 - Second Intervention||0
2313663|NCT01928381|5681618|P2|NOT COMPLETED|Part 2 - Second Intervention||1
2313664|NCT01928381|5681619|P1|NOT COMPLETED|Part 2 - Second Intervention||0
2313665|NCT01928381|5681613|P7|COMPLETED|Part 2 - Second Intervention||5
2313666|NCT01928381|5681614|P6|COMPLETED|Part 2 - Second Intervention||5
2313667|NCT01928381|5681615|P5|COMPLETED|Part 2 - Second Intervention||3
2313668|NCT01928381|5681616|P4|COMPLETED|Part 2 - Second Intervention||4
2313669|NCT01928381|5681617|P3|COMPLETED|Part 2 - Second Intervention||4
2313670|NCT01928381|5681618|P2|COMPLETED|Part 2 - Second Intervention||5
2313671|NCT01928381|5681619|P1|COMPLETED|Part 2 - Second Intervention||0
2313672|NCT01928381|5681613|P7|STARTED|Part 2 - Second Intervention||5
2313673|NCT01928381|5681614|P6|STARTED|Part 2 - Second Intervention||5
2313674|NCT01928381|5681615|P5|STARTED|Part 2 - Second Intervention||3
2313675|NCT01928381|5681616|P4|STARTED|Part 2 - Second Intervention||5
2313676|NCT01928381|5681617|P3|STARTED|Part 2 - Second Intervention||4
2313677|NCT01928381|5681618|P2|STARTED|Part 2 - Second Intervention||6
2313678|NCT01928381|5681619|P1|STARTED|Part 2 - Second Intervention||0
2313679|NCT01928381|5681613|P7|NOT COMPLETED|Washout First Intervention||0
2313680|NCT01928381|5681614|P6|NOT COMPLETED|Washout First Intervention||0
2313681|NCT01928381|5681615|P5|NOT COMPLETED|Washout First Intervention||1
2313682|NCT01928381|5681616|P4|NOT COMPLETED|Washout First Intervention||0
2313683|NCT01928381|5681617|P3|NOT COMPLETED|Washout First Intervention||0
2313684|NCT01928381|5681618|P2|NOT COMPLETED|Washout First Intervention||0
2313685|NCT01928381|5681619|P1|NOT COMPLETED|Washout First Intervention||0
2313686|NCT01928381|5681613|P7|COMPLETED|Washout First Intervention||5
2313687|NCT01928381|5681614|P6|COMPLETED|Washout First Intervention||5
2313688|NCT01928381|5681615|P5|COMPLETED|Washout First Intervention||3
2313689|NCT01928381|5681616|P4|COMPLETED|Washout First Intervention||5
2313690|NCT01928381|5681617|P3|COMPLETED|Washout First Intervention||4
2313691|NCT01928381|5681618|P2|COMPLETED|Washout First Intervention||6
2313692|NCT01928381|5681619|P1|COMPLETED|Washout First Intervention||0
2313693|NCT01928381|5681613|P7|STARTED|Washout First Intervention||5
2313694|NCT01928381|5681614|P6|STARTED|Washout First Intervention||5
2313695|NCT01928381|5681615|P5|STARTED|Washout First Intervention||4
2313696|NCT01928381|5681616|P4|STARTED|Washout First Intervention||5
2313697|NCT01928381|5681617|P3|STARTED|Washout First Intervention||4
2313698|NCT01928381|5681618|P2|STARTED|Washout First Intervention||6
2313699|NCT01928381|5681619|P1|STARTED|Washout First Intervention||0
2313700|NCT01928381|5681613|P7|NOT COMPLETED|Part 2 - First Intervention||1
2313701|NCT01928381|5681614|P6|NOT COMPLETED|Part 2 - First Intervention||1
2313702|NCT01928381|5681615|P5|NOT COMPLETED|Part 2 - First Intervention||0
2313703|NCT01928381|5681616|P4|NOT COMPLETED|Part 2 - First Intervention||1
2313704|NCT01928381|5681617|P3|NOT COMPLETED|Part 2 - First Intervention||2
2313705|NCT01928381|5681618|P2|NOT COMPLETED|Part 2 - First Intervention||0
2313706|NCT01928381|5681619|P1|NOT COMPLETED|Part 2 - First Intervention||0
2313707|NCT01928381|5681613|P7|COMPLETED|Part 2 - First Intervention||5
2313708|NCT01928381|5681614|P6|COMPLETED|Part 2 - First Intervention||5
2313709|NCT01928381|5681615|P5|COMPLETED|Part 2 - First Intervention||4
2313710|NCT01928381|5681616|P4|COMPLETED|Part 2 - First Intervention||5
2313711|NCT01928381|5681617|P3|COMPLETED|Part 2 - First Intervention||4
2313712|NCT01928381|5681618|P2|COMPLETED|Part 2 - First Intervention||6
2313713|NCT01928381|5681619|P1|COMPLETED|Part 2 - First Intervention||0
2313714|NCT01928381|5681613|P7|STARTED|Part 2 - First Intervention||6
2313715|NCT01928381|5681614|P6|STARTED|Part 2 - First Intervention||6
2313716|NCT01928381|5681615|P5|STARTED|Part 2 - First Intervention||4
2313717|NCT01928381|5681616|P4|STARTED|Part 2 - First Intervention||6
2313718|NCT01928381|5681617|P3|STARTED|Part 2 - First Intervention||6
2313719|NCT01928381|5681618|P2|STARTED|Part 2 - First Intervention||6
2313720|NCT01928381|5681619|P1|STARTED|Part 2 - First Intervention||0
2313721|NCT01928381|5681613|P7|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
2313722|NCT01928381|5681614|P6|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
2313723|NCT01928381|5681615|P5|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
2313724|NCT01928381|5681616|P4|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
2313725|NCT01928381|5681617|P3|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
2313726|NCT01928381|5681618|P2|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
2313727|NCT01928381|5681619|P1|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||14
2313728|NCT01928381|5681613|P7|COMPLETED|Placebo run-in & Part 2 Eligibility||0
2313729|NCT01928381|5681614|P6|COMPLETED|Placebo run-in & Part 2 Eligibility||0
2313730|NCT01928381|5681615|P5|COMPLETED|Placebo run-in & Part 2 Eligibility||0
2313731|NCT01928381|5681616|P4|COMPLETED|Placebo run-in & Part 2 Eligibility||0
2313732|NCT01928381|5681617|P3|COMPLETED|Placebo run-in & Part 2 Eligibility||0
2313733|NCT01928381|5681618|P2|COMPLETED|Placebo run-in & Part 2 Eligibility||0
2313734|NCT01928381|5681619|P1|COMPLETED|Placebo run-in & Part 2 Eligibility||34
2313735|NCT01928381|5681613|P7|STARTED|Placebo run-in & Part 2 Eligibility||0
2313736|NCT01928381|5681614|P6|STARTED|Placebo run-in & Part 2 Eligibility||0
2313737|NCT01928381|5681615|P5|STARTED|Placebo run-in & Part 2 Eligibility||0
2313738|NCT01928381|5681616|P4|STARTED|Placebo run-in & Part 2 Eligibility||0
2313739|NCT01928381|5681617|P3|STARTED|Placebo run-in & Part 2 Eligibility||0
2313740|NCT01928381|5681618|P2|STARTED|Placebo run-in & Part 2 Eligibility||0
2313741|NCT01928381|5681619|P1|STARTED|Placebo run-in & Part 2 Eligibility||48
2313742|NCT01928381|5681613|P7|NOT COMPLETED|Part 1 - Pain Training||0
2313743|NCT01928381|5681614|P6|NOT COMPLETED|Part 1 - Pain Training||0
2313744|NCT01928381|5681615|P5|NOT COMPLETED|Part 1 - Pain Training||0
2313745|NCT01928381|5681616|P4|NOT COMPLETED|Part 1 - Pain Training||0
2313746|NCT01928381|5681617|P3|NOT COMPLETED|Part 1 - Pain Training||0
2313747|NCT01928381|5681618|P2|NOT COMPLETED|Part 1 - Pain Training||0
2313748|NCT01928381|5681619|P1|NOT COMPLETED|Part 1 - Pain Training||35
2313749|NCT01928381|5681613|P7|COMPLETED|Part 1 - Pain Training||0
2313750|NCT01928381|5681614|P6|COMPLETED|Part 1 - Pain Training||0
2313751|NCT01928381|5681615|P5|COMPLETED|Part 1 - Pain Training||0
2313752|NCT01928381|5681616|P4|COMPLETED|Part 1 - Pain Training||0
2313753|NCT01928381|5681617|P3|COMPLETED|Part 1 - Pain Training||0
2313754|NCT01928381|5681618|P2|COMPLETED|Part 1 - Pain Training||0
2313755|NCT01928381|5681619|P1|COMPLETED|Part 1 - Pain Training||48
2313756|NCT01928381|5681613|P7|STARTED|Part 1 - Pain Training||0
2313757|NCT01928381|5681614|P6|STARTED|Part 1 - Pain Training||0
2313758|NCT01928381|5681615|P5|STARTED|Part 1 - Pain Training||0
2313759|NCT01928381|5681616|P4|STARTED|Part 1 - Pain Training||0
2313760|NCT01928381|5681617|P3|STARTED|Part 1 - Pain Training||0
2313761|NCT01928381|5681618|P2|STARTED|Part 1 - Pain Training||0
2313762|NCT01928381|5681619|P1|STARTED|Part 1 - Pain Training||83
2313763|NCT01928381|5681613|P7|NOT COMPLETED|Screening for Pain Training||0
2313764|NCT01928381|5681614|P6|NOT COMPLETED|Screening for Pain Training||0
2313765|NCT01928381|5681615|P5|NOT COMPLETED|Screening for Pain Training||0
2313766|NCT01928381|5681616|P4|NOT COMPLETED|Screening for Pain Training||0
2313767|NCT01928381|5681617|P3|NOT COMPLETED|Screening for Pain Training||0
2313768|NCT01928381|5681618|P2|NOT COMPLETED|Screening for Pain Training||0
2313769|NCT01928381|5681619|P1|NOT COMPLETED|Screening for Pain Training||60
2313770|NCT01928381|5681613|P7|COMPLETED|Screening for Pain Training||0
2313771|NCT01928381|5681614|P6|COMPLETED|Screening for Pain Training||0
2313772|NCT01928381|5681615|P5|COMPLETED|Screening for Pain Training||0
2313773|NCT01928381|5681616|P4|COMPLETED|Screening for Pain Training||0
2313774|NCT01928381|5681617|P3|COMPLETED|Screening for Pain Training||0
2313775|NCT01928381|5681618|P2|COMPLETED|Screening for Pain Training||0
2313776|NCT01928381|5681619|P1|COMPLETED|Screening for Pain Training||83
2313777|NCT01928381|5681613|P7|STARTED|Screening for Pain Training||0
2313778|NCT01928381|5681614|P6|STARTED|Screening for Pain Training||0
2313779|NCT01928381|5681615|P5|STARTED|Screening for Pain Training||0
2313780|NCT01928381|5681616|P4|STARTED|Screening for Pain Training||0
2313781|NCT01928381|5681617|P3|STARTED|Screening for Pain Training||0
2313782|NCT01928381|5681618|P2|STARTED|Screening for Pain Training||0
2313783|NCT01928381|5681619|P1|STARTED|Screening for Pain Training||143
2313784|NCT01928329|5681634|P2|NOT COMPLETED|Overall Study||14
2313785|NCT01928329|5681635|P1|NOT COMPLETED|Overall Study||12
2313786|NCT01928329|5681634|P2|COMPLETED|Overall Study||25
2313787|NCT01928329|5681635|P1|COMPLETED|Overall Study||28
2313788|NCT01928329|5681634|P2|STARTED|Overall Study||39
2313789|NCT01928329|5681635|P1|STARTED|Overall Study||40
2313790|NCT01928290|5681649|P2|NOT COMPLETED|Overall Study||0
2313791|NCT01928290|5681650|P1|NOT COMPLETED|Overall Study||0
2313792|NCT01928290|5681649|P2|COMPLETED|Overall Study||26
2313793|NCT01928290|5681650|P1|COMPLETED|Overall Study||41
2313794|NCT01928290|5681649|P2|STARTED|Overall Study||26
2313795|NCT01928290|5681650|P1|STARTED|Overall Study||41
2313796|NCT01928186|5681660|P1|NOT COMPLETED|Overall Study||0
2313797|NCT01928186|5681660|P1|COMPLETED|Overall Study||28
2313798|NCT01928186|5681660|P1|STARTED|Overall Study||28
2313799|NCT01928082|5681674|P1|NOT COMPLETED|Overall Study||1
2313800|NCT01928082|5681674|P1|COMPLETED|Overall Study||0
2313801|NCT01928082|5681674|P1|STARTED|Overall Study||1
2313802|NCT01928030|5681692|P3|NOT COMPLETED|Overall Study||0
2313803|NCT01928030|5681693|P2|NOT COMPLETED|Overall Study||0
2313804|NCT01928030|5681694|P1|NOT COMPLETED|Overall Study||0
2313805|NCT01928030|5681692|P3|COMPLETED|Overall Study||0
2313806|NCT01928030|5681693|P2|COMPLETED|Overall Study||0
2313807|NCT01928030|5681694|P1|COMPLETED|Overall Study||3
2313808|NCT01928030|5681692|P3|STARTED|Overall Study||0
2313809|NCT01928030|5681693|P2|STARTED|Overall Study||0
2313810|NCT01928030|5681694|P1|STARTED|Overall Study||3
2313811|NCT01927887|5681701|P1|NOT COMPLETED|Overall Study||0
2313812|NCT01927887|5681701|P1|COMPLETED|Overall Study||12
2313813|NCT01927887|5681701|P1|STARTED|Overall Study||12
2313814|NCT01927861|5681708|P2|NOT COMPLETED|Extended Treatment Phase (26 Weeks)||0
2313815|NCT01927861|5681709|P1|NOT COMPLETED|Extended Treatment Phase (26 Weeks)||0
2313816|NCT01927861|5681708|P2|COMPLETED|Extended Treatment Phase (26 Weeks)||14
2313817|NCT01927861|5681709|P1|COMPLETED|Extended Treatment Phase (26 Weeks)||15
2313818|NCT01927861|5681708|P2|STARTED|Extended Treatment Phase (26 Weeks)|14 participants agreed to continue the treatment for 26 weeks in the extended treatment phase.|14
2313819|NCT01927861|5681709|P1|STARTED|Extended Treatment Phase (26 Weeks)|15 participants agreed to continue the treatment for 26 weeks in the extended treatment phase.|15
2313820|NCT01927861|5681708|P2|NOT COMPLETED|Extension Phase (104 Weeks)||3
2313821|NCT01927861|5681709|P1|NOT COMPLETED|Extension Phase (104 Weeks)||0
2313822|NCT01927861|5681708|P2|COMPLETED|Extension Phase (104 Weeks)||23
2313823|NCT01927861|5681709|P1|COMPLETED|Extension Phase (104 Weeks)||25
2313824|NCT01927861|5681708|P2|STARTED|Extension Phase (104 Weeks)||26
2313825|NCT01927861|5681709|P1|STARTED|Extension Phase (104 Weeks)||25
2313826|NCT01927861|5681708|P2|NOT COMPLETED|Pivotal Phase (104 Weeks)||0
2313827|NCT01927861|5681709|P1|NOT COMPLETED|Pivotal Phase (104 Weeks)||0
2313828|NCT01927861|5681708|P2|COMPLETED|Pivotal Phase (104 Weeks)||26
2313829|NCT01927861|5681709|P1|COMPLETED|Pivotal Phase (104 Weeks)||25
2313830|NCT01927861|5681708|P2|STARTED|Pivotal Phase (104 Weeks)||26
2313831|NCT01927861|5681709|P1|STARTED|Pivotal Phase (104 Weeks)||25
2313832|NCT01927757|5681847|P1|NOT COMPLETED|Overall Study||23
2313833|NCT01927757|5681847|P1|COMPLETED|Overall Study||67
2313834|NCT01927757|5681847|P1|Received Etanercept|Overall Study||88
2313835|NCT01927757|5681847|P1|STARTED|Overall Study||90
2313836|NCT01927718|5681865|P1|NOT COMPLETED|Overall Study||0
2313837|NCT01927718|5681865|P1|COMPLETED|Overall Study||10
2313838|NCT01927718|5681865|P1|STARTED|Overall Study||10
2313839|NCT01927627|5681869|P1|NOT COMPLETED|Overall Study||5
2313840|NCT01927627|5681869|P1|COMPLETED|Overall Study||37
2313841|NCT01927627|5681869|P1|STARTED|Overall Study||42
2313842|NCT01927575|5681874|P1|NOT COMPLETED|Overall Study||0
2313843|NCT01927575|5681874|P1|COMPLETED|Overall Study||1
2313844|NCT01927575|5681874|P1|STARTED|Overall Study||1
2313845|NCT01927419|5681884|P2|NOT COMPLETED|Overall Study||28
2313846|NCT01927419|5681885|P1|NOT COMPLETED|Overall Study||70
2313847|NCT01927419|5681884|P2|COMPLETED|Overall Study|All participants who did not discontinue study drug during treatment period (Parts 1 and 2)|19
2313848|NCT01927419|5681885|P1|COMPLETED|Overall Study|All participants who did not discontinue study drug during treatment period (Parts 1 and 2)|25
2313849|NCT01927419|5681884|P2|Received Treatment|Overall Study||46
2313850|NCT01927419|5681885|P1|Received Treatment|Overall Study||94
2313851|NCT01927419|5681884|P2|STARTED|Overall Study||47
2313852|NCT01927419|5681885|P1|STARTED|Overall Study||95
2313853|NCT01927120|5681901|P1|NOT COMPLETED|Overall Study||10
2313854|NCT01927120|5681901|P1|COMPLETED|Overall Study||10
2313855|NCT01927120|5681901|P1|STARTED|Overall Study||20
2313856|NCT01927055|5681919|P3|NOT COMPLETED|Double-Blind||13
2313857|NCT01927055|5681920|P2|NOT COMPLETED|Double-Blind||11
2313858|NCT01927055|5681921|P1|NOT COMPLETED|Double-Blind||0
2313859|NCT01927055|5681919|P3|COMPLETED|Double-Blind||10
2313860|NCT01927055|5681920|P2|COMPLETED|Double-Blind||11
2313861|NCT01927055|5681921|P1|COMPLETED|Double-Blind||0
2313862|NCT01927055|5681919|P3|STARTED|Double-Blind||23
2313863|NCT01927055|5681920|P2|STARTED|Double-Blind||22
2313864|NCT01927055|5681921|P1|STARTED|Double-Blind||0
2313865|NCT01927055|5681919|P3|NOT COMPLETED|Open-label||0
2313866|NCT01927055|5681920|P2|NOT COMPLETED|Open-label||0
2313867|NCT01927055|5681921|P1|NOT COMPLETED|Open-label||16
2313868|NCT01927055|5681919|P3|COMPLETED|Open-label||0
2313869|NCT01927055|5681920|P2|COMPLETED|Open-label||0
2313870|NCT01927055|5681921|P1|COMPLETED|Open-label||45
2313871|NCT01927055|5681919|P3|STARTED|Open-label||0
2313872|NCT01927055|5681920|P2|STARTED|Open-label||0
2313873|NCT01927055|5681921|P1|STARTED|Open-label||61
2313874|NCT01926977|5681930|P2|NOT COMPLETED|Overall Study||0
2313875|NCT01926977|5681931|P1|NOT COMPLETED|Overall Study||0
2313876|NCT01926977|5681930|P2|COMPLETED|Overall Study||53
2313877|NCT01926977|5681931|P1|COMPLETED|Overall Study||47
2313878|NCT01926977|5681930|P2|STARTED|Overall Study||53
2313879|NCT01926977|5681931|P1|STARTED|Overall Study||47
2313880|NCT01926886|5681939|P2|NOT COMPLETED|Overall Study||0
2313881|NCT01926886|5681940|P1|NOT COMPLETED|Overall Study||32
2313882|NCT01926886|5681939|P2|COMPLETED|Overall Study|Partcipants were HCPs included for polling purposes. HCPs were not enrolled in the study.|21
2313883|NCT01926886|5681940|P1|COMPLETED|Overall Study||70
2313884|NCT01926886|5681939|P2|Received at Least 1 Dose of Study Drug|Overall Study|Partcipants were HCPs included for polling purposes. HCPs were not enrolled in the study.|0
2313885|NCT01926886|5681940|P1|Received at Least 1 Dose of Study Drug|Overall Study||101
2313886|NCT01926886|5681939|P2|STARTED|Overall Study|HCPs were not enrolled in the study. No baseline data were collected for these participants.|21
2313887|NCT01926886|5681940|P1|STARTED|Overall Study||102
2313888|NCT01926782|5681959|P6|NOT COMPLETED|Overall Study||41
2313889|NCT01926782|5681960|P5|NOT COMPLETED|Overall Study||8
2313890|NCT01926782|5681961|P4|NOT COMPLETED|Overall Study||20
2313891|NCT01926782|5681962|P3|NOT COMPLETED|Overall Study||40
2313892|NCT01926782|5681963|P2|NOT COMPLETED|Overall Study||13
2313893|NCT01926782|5681964|P1|NOT COMPLETED|Overall Study||28
2313894|NCT01926782|5681959|P6|COMPLETED|Overall Study||105
2313895|NCT01926782|5681960|P5|COMPLETED|Overall Study||29
2313896|NCT01926782|5681961|P4|COMPLETED|Overall Study||53
2313897|NCT01926782|5681962|P3|COMPLETED|Overall Study||272
2313898|NCT01926782|5681963|P2|COMPLETED|Overall Study||65
2313899|NCT01926782|5681964|P1|COMPLETED|Overall Study||129
2313900|NCT01926782|5681959|P6|Completed 24 Weeks Treatment Period|Overall Study||120
2313901|NCT01926782|5681960|P5|Completed 24 Weeks Treatment Period|Overall Study||31
2313902|NCT01926782|5681961|P4|Completed 24 Weeks Treatment Period|Overall Study||58
2313903|NCT01926782|5681962|P3|Completed 24 Weeks Treatment Period|Overall Study||285
2313904|NCT01926782|5681963|P2|Completed 24 Weeks Treatment Period|Overall Study||68
2313905|NCT01926782|5681964|P1|Completed 24 Weeks Treatment Period|Overall Study||137
2313906|NCT01926782|5681959|P6|Treated|Overall Study||146
2313907|NCT01926782|5681960|P5|Treated|Overall Study||37
2313908|NCT01926782|5681961|P4|Treated|Overall Study||72
2313909|NCT01926782|5681962|P3|Treated|Overall Study||312
2313910|NCT01926782|5681963|P2|Treated|Overall Study||78
2313911|NCT01926782|5681964|P1|Treated|Overall Study||157
2313912|NCT01926782|5681959|P6|STARTED|Overall Study||146
2313913|NCT01926782|5681960|P5|STARTED|Overall Study||37
2313914|NCT01926782|5681961|P4|STARTED|Overall Study||73
2313915|NCT01926782|5681962|P3|STARTED|Overall Study||312
2313916|NCT01926782|5681963|P2|STARTED|Overall Study||78
2313917|NCT01926782|5681964|P1|STARTED|Overall Study||157
2313918|NCT01926626|5682113|P1|NOT COMPLETED|Overall Study||22
2313919|NCT01926626|5682113|P1|COMPLETED|Overall Study||16
2313920|NCT01926626|5682113|P1|Received Moclobemide|Overall Study||37
2313921|NCT01926626|5682113|P1|STARTED|Overall Study||38
2313922|NCT01926509|5682127|P4|NOT COMPLETED|Overall Study||0
2313923|NCT01926509|5682128|P3|NOT COMPLETED|Overall Study||0
2313924|NCT01926509|5682129|P2|NOT COMPLETED|Overall Study||0
2313925|NCT01926509|5682130|P1|NOT COMPLETED|Overall Study||1
2313926|NCT01926509|5682127|P4|COMPLETED|Overall Study||6
2313927|NCT01926509|5682128|P3|COMPLETED|Overall Study||5
2313928|NCT01926509|5682129|P2|COMPLETED|Overall Study||6
2313929|NCT01926509|5682130|P1|COMPLETED|Overall Study||5
2313930|NCT01926509|5682127|P4|STARTED|Overall Study||6
2313931|NCT01926509|5682128|P3|STARTED|Overall Study||5
2313932|NCT01926509|5682129|P2|STARTED|Overall Study||6
2313933|NCT01926509|5682130|P1|STARTED|Overall Study||6
2313934|NCT01926444|5682151|P4|NOT COMPLETED|Overall Study||2
2313935|NCT01926444|5682152|P3|NOT COMPLETED|Overall Study||4
2313936|NCT01926444|5682153|P2|NOT COMPLETED|Overall Study||0
2313937|NCT01926444|5682154|P1|NOT COMPLETED|Overall Study||0
2313938|NCT01926444|5682151|P4|COMPLETED|Overall Study||101
2313939|NCT01926444|5682152|P3|COMPLETED|Overall Study||53
2313940|NCT01926444|5682153|P2|COMPLETED|Overall Study||52
2313941|NCT01926444|5682154|P1|COMPLETED|Overall Study||56
2313942|NCT01926444|5682151|P4|STARTED|Overall Study||103
2313943|NCT01926444|5682152|P3|STARTED|Overall Study||57
2313944|NCT01926444|5682153|P2|STARTED|Overall Study||52
2313945|NCT01926444|5682154|P1|STARTED|Overall Study||56
2313946|NCT01926119|5682196|P1|NOT COMPLETED|Overall Study||1
2313947|NCT01926119|5682196|P1|COMPLETED|Overall Study||3
2313948|NCT01926119|5682196|P1|STARTED|Overall Study||4
2313949|NCT01926028|5682209|P3|NOT COMPLETED|Overall Study||2
2313950|NCT01926028|5682210|P2|NOT COMPLETED|Overall Study||22
2313951|NCT01926028|5682211|P1|NOT COMPLETED|Overall Study||21
2313952|NCT01926028|5682209|P3|COMPLETED|Overall Study||12
2313953|NCT01926028|5682210|P2|COMPLETED|Overall Study||67
2313954|NCT01926028|5682211|P1|COMPLETED|Overall Study||64
2313955|NCT01926028|5682209|P3|STARTED|Overall Study||14
2313956|NCT01926028|5682210|P2|STARTED|Overall Study||89
2313957|NCT01926028|5682211|P1|STARTED|Overall Study||85
2313958|NCT01926015|5682247|P2|NOT COMPLETED|Overall Study||1
2313959|NCT01926015|5682248|P1|NOT COMPLETED|Overall Study||2
2313960|NCT01926015|5682247|P2|COMPLETED|Overall Study||95
2313961|NCT01926015|5682248|P1|COMPLETED|Overall Study||94
2313962|NCT01926015|5682247|P2|Received >=1 Vaccination|Overall Study||96
2313963|NCT01926015|5682248|P1|Received >=1 Vaccination|Overall Study||94
2313964|NCT01926015|5682247|P2|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
2313965|NCT01926015|5682248|P1|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
2313966|NCT01925989|5682280|P3|NOT COMPLETED|Period 2||0
2313967|NCT01925989|5682281|P2|NOT COMPLETED|Period 2||0
2313968|NCT01925989|5682282|P1|NOT COMPLETED|Period 2||0
2313969|NCT01925989|5682280|P3|COMPLETED|Period 2||12
2313970|NCT01925989|5682281|P2|COMPLETED|Period 2||6
2313971|NCT01925989|5682282|P1|COMPLETED|Period 2||6
2313972|NCT01925989|5682280|P3|STARTED|Period 2||12
2313973|NCT01925989|5682281|P2|STARTED|Period 2||6
2313974|NCT01925989|5682282|P1|STARTED|Period 2||6
2313975|NCT01925989|5682280|P3|NOT COMPLETED|Period 1||0
2313976|NCT01925989|5682281|P2|NOT COMPLETED|Period 1||2
2313977|NCT01925989|5682282|P1|NOT COMPLETED|Period 1||1
2313978|NCT01925989|5682280|P3|COMPLETED|Period 1||12
2313979|NCT01925989|5682281|P2|COMPLETED|Period 1||6
2313980|NCT01925989|5682282|P1|COMPLETED|Period 1||6
2313981|NCT01925989|5682280|P3|Received at Least 1 Dose of Study Drug|Period 1||0
2313982|NCT01925989|5682281|P2|Received at Least 1 Dose of Study Drug|Period 1||8
2313983|NCT01925989|5682282|P1|Received at Least 1 Dose of Study Drug|Period 1||7
2313984|NCT01925989|5682280|P3|STARTED|Period 1||12
2313985|NCT01925989|5682281|P2|STARTED|Period 1||8
2313986|NCT01925989|5682282|P1|STARTED|Period 1||7
2313987|NCT01925950|5682302|P2|NOT COMPLETED|Part 2||0
2313988|NCT01925950|5682303|P1|NOT COMPLETED|Part 2||1
2313989|NCT01925950|5682302|P2|COMPLETED|Part 2||0
2313990|NCT01925950|5682303|P1|COMPLETED|Part 2||0
2313991|NCT01925950|5682302|P2|STARTED|Part 2|The 1 orBec subject completed Part 1 but did not meet the criteria of a CR to continue to Part 2|0
2313992|NCT01925950|5682303|P1|STARTED|Part 2||1
2313993|NCT01925950|5682302|P2|NOT COMPLETED|Part 1||0
2313994|NCT01925950|5682303|P1|NOT COMPLETED|Part 1||0
2313995|NCT01925950|5682302|P2|COMPLETED|Part 1||1
2313996|NCT01925950|5682303|P1|COMPLETED|Part 1||1
2313997|NCT01925950|5682302|P2|STARTED|Part 1||1
2313998|NCT01925950|5682303|P1|STARTED|Part 1||1
2313999|NCT01925781|5682311|P2|NOT COMPLETED|Overall Study||4
2314000|NCT01925781|5682312|P1|NOT COMPLETED|Overall Study||2
2314001|NCT01925781|5682311|P2|COMPLETED|Overall Study||1
2314002|NCT01925781|5682312|P1|COMPLETED|Overall Study||3
2314003|NCT01925781|5682311|P2|STARTED|Overall Study||5
2314004|NCT01925781|5682312|P1|STARTED|Overall Study||5
2314005|NCT01925768|5682322|P2|NOT COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||18
2314006|NCT01925768|5682323|P1|NOT COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||20
2314007|NCT01925768|5682322|P2|COMPLETED|ActiveTreatment/Extension (Weeks 24-104)|Completed Apremilast treatment at Week 104|67
2314008|NCT01925768|5682323|P1|COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||75
2314009|NCT01925768|5682322|P2|STARTED|ActiveTreatment/Extension (Weeks 24-104)||85
2314010|NCT01925768|5682323|P1|STARTED|ActiveTreatment/Extension (Weeks 24-104)||95
2314011|NCT01925768|5682322|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23
2314012|NCT01925768|5682323|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||11
2314013|NCT01925768|5682322|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|2 participants who completed Week 24 did not enter the active treatment phase|87
2314014|NCT01925768|5682323|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|3 participants who completed Week 24 did not enter the active treatment phase|98
2314015|NCT01925768|5682322|P2|Escaped Early (EE)|Placebo-controlled Phase (Week 0 - 24)||13
2314016|NCT01925768|5682323|P1|Escaped Early (EE)|Placebo-controlled Phase (Week 0 - 24)||35
2314017|NCT01925768|5682322|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||91
2314018|NCT01925768|5682323|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||101
2314019|NCT01925768|5682322|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||109
2314020|NCT01925768|5682323|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||109
2314021|NCT01925768|5682322|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||110
2314022|NCT01925768|5682323|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||109
2314023|NCT01925703|5682371|P1|NOT COMPLETED|Overall Study||4
2314024|NCT01925703|5682371|P1|COMPLETED|Overall Study||9
2314025|NCT01925703|5682371|P1|Follow-up Completed|Overall Study||9
2314026|NCT01925703|5682371|P1|Full Iron Repletion Achieved|Overall Study||11
2314027|NCT01925703|5682371|P1|Dosing Regimen Completed|Overall Study||12
2314028|NCT01925703|5682371|P1|STARTED|Overall Study||13
2314029|NCT01925677|5682377|P1|NOT COMPLETED|Overall Study||0
2314030|NCT01925677|5682377|P1|COMPLETED|Overall Study||3
2314031|NCT01925677|5682377|P1|STARTED|Overall Study||3
2314032|NCT01925612|5682389|P5|NOT COMPLETED|Overall Study||2
2314033|NCT01925612|5682390|P4|NOT COMPLETED|Overall Study||1
2314034|NCT01925612|5682391|P3|NOT COMPLETED|Overall Study||1
2314035|NCT01925612|5682392|P2|NOT COMPLETED|Overall Study||4
2314036|NCT01925612|5682393|P1|NOT COMPLETED|Overall Study||4
2314037|NCT01925612|5682389|P5|COMPLETED|Overall Study||10
2314038|NCT01925612|5682390|P4|COMPLETED|Overall Study||10
2314039|NCT01925612|5682391|P3|COMPLETED|Overall Study||10
2314040|NCT01925612|5682392|P2|COMPLETED|Overall Study||18
2314041|NCT01925612|5682393|P1|COMPLETED|Overall Study||25
2314042|NCT01925612|5682389|P5|STARTED|Overall Study||12
2314043|NCT01925612|5682390|P4|STARTED|Overall Study||11
2314044|NCT01925612|5682391|P3|STARTED|Overall Study||11
2314045|NCT01925612|5682392|P2|STARTED|Overall Study||22
2314046|NCT01925612|5682393|P1|STARTED|Overall Study||29
2314047|NCT01925469|5682432|P2|NOT COMPLETED|Overall Study||0
2314048|NCT01925469|5682433|P1|NOT COMPLETED|Overall Study||1
2314049|NCT01925469|5682432|P2|COMPLETED|Overall Study||15
2314050|NCT01925469|5682433|P1|COMPLETED|Overall Study||14
2314051|NCT01925469|5682432|P2|STARTED|Overall Study||15
2314052|NCT01925469|5682433|P1|STARTED|Overall Study||15
2314053|NCT01925417|5682443|P1|NOT COMPLETED|Overall Study||3
2314054|NCT01925417|5682443|P1|COMPLETED|Overall Study||31
2314055|NCT01925417|5682443|P1|STARTED|Overall Study||34
2314056|NCT01925404|5682455|P4|NOT COMPLETED|Overall Study||0
2314057|NCT01925404|5682456|P3|NOT COMPLETED|Overall Study||0
2314058|NCT01925404|5682457|P2|NOT COMPLETED|Overall Study||0
2314059|NCT01925404|5682458|P1|NOT COMPLETED|Overall Study||0
2314060|NCT01925404|5682455|P4|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
2314061|NCT01925404|5682456|P3|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
2314062|NCT01925404|5682457|P2|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
2314063|NCT01925404|5682458|P1|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
2314064|NCT01925404|5682455|P4|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|0
2314065|NCT01925404|5682456|P3|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|0
2314066|NCT01925404|5682457|P2|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|0
2314067|NCT01925404|5682458|P1|STARTED|Overall Study|"The primary outcome of this study is at the level of a park.~The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users"|0
2314068|NCT01925339|5682474|P2|NOT COMPLETED|Overall Study||0
2314069|NCT01925339|5682475|P1|NOT COMPLETED|Overall Study||2
2314070|NCT01925339|5682474|P2|COMPLETED|Overall Study||20
2314071|NCT01925339|5682475|P1|COMPLETED|Overall Study||18
2314072|NCT01925339|5682474|P2|STARTED|Overall Study||20
2314073|NCT01925339|5682475|P1|STARTED|Overall Study||20
2314074|NCT01925274|5682486|P3|NOT COMPLETED|Overall Study||6
2314075|NCT01925274|5682487|P2|NOT COMPLETED|Overall Study||6
2314076|NCT01925274|5682488|P1|NOT COMPLETED|Overall Study||7
2314077|NCT01925274|5682486|P3|COMPLETED|Overall Study||0
2314078|NCT01925274|5682487|P2|COMPLETED|Overall Study||0
2314079|NCT01925274|5682488|P1|COMPLETED|Overall Study||0
2314080|NCT01925274|5682486|P3|STARTED|Overall Study||6
2314081|NCT01925274|5682487|P2|STARTED|Overall Study||6
2314082|NCT01925274|5682488|P1|STARTED|Overall Study||7
2314083|NCT01925209|5682569|P4|NOT COMPLETED|Follow-up||4
2314084|NCT01925209|5682570|P3|NOT COMPLETED|Follow-up||1
2314085|NCT01925209|5682571|P2|NOT COMPLETED|Follow-up||6
2314086|NCT01925209|5682572|P1|NOT COMPLETED|Follow-up||1
2314087|NCT01925209|5682569|P4|COMPLETED|Follow-up||54
2314088|NCT01925209|5682570|P3|COMPLETED|Follow-up||55
2314089|NCT01925209|5682571|P2|COMPLETED|Follow-up||55
2314090|NCT01925209|5682572|P1|COMPLETED|Follow-up||56
2314091|NCT01925209|5682569|P4|STARTED|Follow-up||58
2314092|NCT01925209|5682570|P3|STARTED|Follow-up||56
2314093|NCT01925209|5682571|P2|STARTED|Follow-up||61
2314094|NCT01925209|5682572|P1|STARTED|Follow-up||57
2314095|NCT01925209|5682569|P4|NOT COMPLETED|Maintenance Treatment Epoch||2
2314096|NCT01925209|5682570|P3|NOT COMPLETED|Maintenance Treatment Epoch||2
2314097|NCT01925209|5682571|P2|NOT COMPLETED|Maintenance Treatment Epoch||1
2314098|NCT01925209|5682572|P1|NOT COMPLETED|Maintenance Treatment Epoch||0
2314099|NCT01925209|5682569|P4|COMPLETED|Maintenance Treatment Epoch||48
2314100|NCT01925209|5682570|P3|COMPLETED|Maintenance Treatment Epoch||50
2314101|NCT01925209|5682571|P2|COMPLETED|Maintenance Treatment Epoch||45
2314102|NCT01925209|5682572|P1|COMPLETED|Maintenance Treatment Epoch||49
2314103|NCT01925209|5682569|P4|STARTED|Maintenance Treatment Epoch||50
2314104|NCT01925209|5682570|P3|STARTED|Maintenance Treatment Epoch||52
2314105|NCT01925209|5682571|P2|STARTED|Maintenance Treatment Epoch||46
2314106|NCT01925209|5682572|P1|STARTED|Maintenance Treatment Epoch||49
2314107|NCT01925209|5682569|P4|NOT COMPLETED|Treatment Epoch||5
2314108|NCT01925209|5682570|P3|NOT COMPLETED|Treatment Epoch||7
2314109|NCT01925209|5682571|P2|NOT COMPLETED|Treatment Epoch||8
2314110|NCT01925209|5682572|P1|NOT COMPLETED|Treatment Epoch||9
2314111|NCT01925209|5682569|P4|COMPLETED|Treatment Epoch||57
2314112|NCT01925209|5682570|P3|COMPLETED|Treatment Epoch||56
2314113|NCT01925209|5682571|P2|COMPLETED|Treatment Epoch||55
2314114|NCT01925209|5682572|P1|COMPLETED|Treatment Epoch||54
2314115|NCT01925209|5682569|P4|Full Analysis Set|Treatment Epoch||62
2314116|NCT01925209|5682570|P3|Full Analysis Set|Treatment Epoch||63
2314117|NCT01925209|5682571|P2|Full Analysis Set|Treatment Epoch||63
2314118|NCT01925209|5682572|P1|Full Analysis Set|Treatment Epoch||63
2314119|NCT01925209|5682569|P4|STARTED|Treatment Epoch||62
2314120|NCT01925209|5682570|P3|STARTED|Treatment Epoch||63
2314121|NCT01925209|5682571|P2|STARTED|Treatment Epoch||63
2314122|NCT01925209|5682572|P1|STARTED|Treatment Epoch||63
2314123|NCT01925183|5682604|P2|NOT COMPLETED|Overall Study||0
2314124|NCT01925183|5682605|P1|NOT COMPLETED|Overall Study||1
2314125|NCT01925183|5682604|P2|COMPLETED|Overall Study||3
2314126|NCT01925183|5682605|P1|COMPLETED|Overall Study||2
2314127|NCT01925183|5682604|P2|STARTED|Overall Study||3
2314128|NCT01925183|5682605|P1|STARTED|Overall Study||3
2314129|NCT01925170|5682613|P1|NOT COMPLETED|Overall Study||53
2314130|NCT01925170|5682613|P1|COMPLETED|Overall Study||1585
2314131|NCT01925170|5682613|P1|STARTED|Overall Study||1638
2314132|NCT01925144|5682631|P1|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||0
2314133|NCT01925144|5682631|P1|COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||30
2314134|NCT01925144|5682631|P1|Received 8 Doses of Omeprazole|Period 2 (At Dosing Day 3 Through Day12)||30
2314135|NCT01925144|5682631|P1|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day12)||30
2314136|NCT01925144|5682631|P1|STARTED|Period 2 (At Dosing Day 3 Through Day12)||30
2314137|NCT01925144|5682631|P1|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
2314138|NCT01925144|5682631|P1|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||30
2314139|NCT01925144|5682631|P1|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||30
2314140|NCT01925144|5682631|P1|STARTED|Period 1 (Day 1 Through Predose Day 3)||30
2314141|NCT01925014|5682644|P2|NOT COMPLETED|Overall Study||19
2314142|NCT01925014|5682645|P1|NOT COMPLETED|Overall Study||9
2314143|NCT01925014|5682644|P2|COMPLETED|Overall Study||1520
2314144|NCT01925014|5682645|P1|COMPLETED|Overall Study||1526
2314145|NCT01925014|5682644|P2|STARTED|Overall Study||1539
2314146|NCT01925014|5682645|P1|STARTED|Overall Study||1535
2314147|NCT01924988|5682679|P1|NOT COMPLETED|Overall Study||0
2314148|NCT01924988|5682679|P1|COMPLETED|Overall Study||15
2314149|NCT01924988|5682679|P1|STARTED|Overall Study||15
2314150|NCT01924975|5682691|P2|NOT COMPLETED|Overall Study||0
2314151|NCT01924975|5682692|P1|NOT COMPLETED|Overall Study||0
2314152|NCT01924975|5682691|P2|COMPLETED|Overall Study||51
2314153|NCT01924975|5682692|P1|COMPLETED|Overall Study||51
2314154|NCT01924975|5682691|P2|STARTED|Overall Study||51
2314155|NCT01924975|5682692|P1|STARTED|Overall Study||51
2314156|NCT01924949|5682702|P1|NOT COMPLETED|Overall Study||0
2314157|NCT01924949|5682702|P1|COMPLETED|Overall Study||5
2314158|NCT01924949|5682702|P1|STARTED|Overall Study||5
2314159|NCT01924871|5682713|P2|NOT COMPLETED|Overall Study||2
2314160|NCT01924871|5682714|P1|NOT COMPLETED|Overall Study||6
2314161|NCT01924871|5682713|P2|COMPLETED|Overall Study||29
2314162|NCT01924871|5682714|P1|COMPLETED|Overall Study||25
2314163|NCT01924871|5682713|P2|STARTED|Overall Study||31
2314164|NCT01924871|5682714|P1|STARTED|Overall Study||31
2314165|NCT01924845|5682720|P1|NOT COMPLETED|Overall Study||6
2314166|NCT01924845|5682720|P1|COMPLETED|Overall Study||18
2314167|NCT01924845|5682720|P1|STARTED|Overall Study||24
2314168|NCT01924767|5682733|P5|NOT COMPLETED|Overall Study||0
2314169|NCT01924767|5682734|P4|NOT COMPLETED|Overall Study||0
2314170|NCT01924767|5682735|P3|NOT COMPLETED|Overall Study||1
2314171|NCT01924767|5682736|P2|NOT COMPLETED|Overall Study||0
2314172|NCT01924767|5682737|P1|NOT COMPLETED|Overall Study||1
2314173|NCT01924767|5682733|P5|COMPLETED|Overall Study||9
2314174|NCT01924767|5682734|P4|COMPLETED|Overall Study||9
2314175|NCT01924767|5682735|P3|COMPLETED|Overall Study||8
2314176|NCT01924767|5682736|P2|COMPLETED|Overall Study||9
2314177|NCT01924767|5682737|P1|COMPLETED|Overall Study||11
2314178|NCT01924767|5682733|P5|STARTED|Overall Study||9
2314179|NCT01924767|5682734|P4|STARTED|Overall Study||9
2314180|NCT01924767|5682735|P3|STARTED|Overall Study||9
2314181|NCT01924767|5682736|P2|STARTED|Overall Study||9
2314182|NCT01924767|5682737|P1|STARTED|Overall Study||12
2314183|NCT01924689|5682843|P6|NOT COMPLETED|Overall Study||2
2314184|NCT01924689|5682844|P5|NOT COMPLETED|Overall Study||6
2314185|NCT01924689|5682845|P4|NOT COMPLETED|Overall Study||6
2314186|NCT01924689|5682846|P3|NOT COMPLETED|Overall Study||4
2314187|NCT01924689|5682847|P2|NOT COMPLETED|Overall Study||3
2314188|NCT01924689|5682848|P1|NOT COMPLETED|Overall Study||3
2314189|NCT01924689|5682843|P6|COMPLETED|Overall Study||0
2314190|NCT01924689|5682844|P5|COMPLETED|Overall Study||0
2314191|NCT01924689|5682845|P4|COMPLETED|Overall Study||0
2314192|NCT01924689|5682846|P3|COMPLETED|Overall Study||0
2314193|NCT01924689|5682847|P2|COMPLETED|Overall Study||0
2314194|NCT01924689|5682848|P1|COMPLETED|Overall Study||0
2314195|NCT01924689|5682843|P6|STARTED|Overall Study||2
2314196|NCT01924689|5682844|P5|STARTED|Overall Study||6
2314197|NCT01924689|5682845|P4|STARTED|Overall Study||6
2314198|NCT01924689|5682846|P3|STARTED|Overall Study||4
2314199|NCT01924689|5682847|P2|STARTED|Overall Study||3
2314200|NCT01924689|5682848|P1|STARTED|Overall Study||3
2314201|NCT01924559|5682906|P1|NOT COMPLETED|Overall Study||0
2314202|NCT01924559|5682906|P1|COMPLETED|Overall Study|The order in which subjects started scenarios (in biohazard gear vs street clothing) was randomized|37
2314203|NCT01924559|5682906|P1|STARTED|Overall Study|All 37 participants were scored under the same six scenarios, resulting in 222 observations.|37
2314204|NCT01924533|5682922|P2|NOT COMPLETED|Overall Study||205
2314205|NCT01924533|5682923|P1|NOT COMPLETED|Overall Study||189
2314206|NCT01924533|5682922|P2|COMPLETED|Overall Study||57
2314207|NCT01924533|5682923|P1|COMPLETED|Overall Study||74
2314208|NCT01924533|5682922|P2|STARTED|Overall Study||262
2314209|NCT01924533|5682923|P1|STARTED|Overall Study||263
2314210|NCT01924442|5682953|P2|NOT COMPLETED|Overall Study||137
2314211|NCT01924442|5682954|P1|NOT COMPLETED|Overall Study||40
2314212|NCT01924442|5682953|P2|COMPLETED|Overall Study||967
2314213|NCT01924442|5682954|P1|COMPLETED|Overall Study||1059
2314214|NCT01924442|5682953|P2|STARTED|Overall Study||1104
2314215|NCT01924442|5682954|P1|STARTED|Overall Study||1099
2314216|NCT01924429|5682964|P2|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0
2314217|NCT01924429|5682965|P1|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0
2314218|NCT01924429|5682964|P2|COMPLETED|Period 2 - Second Intervention (4 Weeks)||11
2314219|NCT01924429|5682965|P1|COMPLETED|Period 2 - Second Intervention (4 Weeks)||14
2314220|NCT01924429|5682964|P2|STARTED|Period 2 - Second Intervention (4 Weeks)||11
2314221|NCT01924429|5682965|P1|STARTED|Period 2 - Second Intervention (4 Weeks)||14
2314222|NCT01924429|5682964|P2|NOT COMPLETED|Washout Period (2 Weeks)||2
2314223|NCT01924429|5682965|P1|NOT COMPLETED|Washout Period (2 Weeks)||3
2314224|NCT01924429|5682964|P2|COMPLETED|Washout Period (2 Weeks)||11
2314225|NCT01924429|5682965|P1|COMPLETED|Washout Period (2 Weeks)||14
2314226|NCT01924429|5682964|P2|STARTED|Washout Period (2 Weeks)||13
2314227|NCT01924429|5682965|P1|STARTED|Washout Period (2 Weeks)||17
2314228|NCT01924429|5682964|P2|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0
2314229|NCT01924429|5682965|P1|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0
2314230|NCT01924429|5682964|P2|COMPLETED|Period 1 - First Intervention (4 Weeks)||13
2314231|NCT01924429|5682965|P1|COMPLETED|Period 1 - First Intervention (4 Weeks)||17
2314232|NCT01924429|5682964|P2|STARTED|Period 1 - First Intervention (4 Weeks)||13
2314233|NCT01924429|5682965|P1|STARTED|Period 1 - First Intervention (4 Weeks)||17
2314234|NCT01924390|5682997|P2|NOT COMPLETED|Overall Study||1
2314235|NCT01924390|5682998|P1|NOT COMPLETED|Overall Study||1
2314236|NCT01924390|5682997|P2|COMPLETED|Overall Study||21
2314237|NCT01924390|5682998|P1|COMPLETED|Overall Study||21
2314238|NCT01924390|5682997|P2|STARTED|Overall Study||22
2314239|NCT01924390|5682998|P1|STARTED|Overall Study||22
2314240|NCT01924364|5683008|P1|NOT COMPLETED|Overall Study||3
2314241|NCT01924364|5683008|P1|COMPLETED|Overall Study||4
2314242|NCT01924364|5683008|P1|STARTED|Overall Study||7
2314243|NCT01924299|5683025|P2|NOT COMPLETED|Period 2||1
2314244|NCT01924299|5683026|P1|NOT COMPLETED|Period 2||1
2314245|NCT01924299|5683025|P2|COMPLETED|Period 2||17
2314246|NCT01924299|5683026|P1|COMPLETED|Period 2||17
2314247|NCT01924299|5683025|P2|Received Baricitinib|Period 2||17
2314248|NCT01924299|5683026|P1|Received Baricitinib|Period 2||17
2314249|NCT01924299|5683025|P2|Received at Least 1 Dose of Study Drug|Period 2||18
2314250|NCT01924299|5683026|P1|Received at Least 1 Dose of Study Drug|Period 2||18
2314251|NCT01924299|5683025|P2|STARTED|Period 2||18
2314252|NCT01924299|5683026|P1|STARTED|Period 2||18
2314253|NCT01924299|5683025|P2|NOT COMPLETED|Period 1||0
2314254|NCT01924299|5683026|P1|NOT COMPLETED|Period 1||0
2314255|NCT01924299|5683025|P2|COMPLETED|Period 1||18
2314256|NCT01924299|5683026|P1|COMPLETED|Period 1||18
2314257|NCT01924299|5683025|P2|Received Baricitinib|Period 1||18
2314258|NCT01924299|5683026|P1|Received Baricitinib|Period 1||18
2314259|NCT01924299|5683025|P2|STARTED|Period 1||18
2314260|NCT01924299|5683026|P1|STARTED|Period 1||18
2314261|NCT01924182|5683048|P2|NOT COMPLETED|Overall Study||0
2314262|NCT01924182|5683049|P1|NOT COMPLETED|Overall Study||1
2314263|NCT01924182|5683048|P2|COMPLETED|Overall Study||0
2314264|NCT01924182|5683049|P1|COMPLETED|Overall Study||2
2314265|NCT01924182|5683048|P2|STARTED|Overall Study||0
2314266|NCT01924182|5683049|P1|STARTED|Overall Study||3
2314267|NCT01924169|5683061|P1|NOT COMPLETED|Overall Study||0
2314268|NCT01924169|5683061|P1|COMPLETED|Overall Study||3
2314269|NCT01924169|5683061|P1|STARTED|Overall Study||3
2314270|NCT01923961|5683069|P3|NOT COMPLETED|Third Intervention||0
2314271|NCT01923961|5683070|P2|NOT COMPLETED|Third Intervention||0
2314272|NCT01923961|5683071|P1|NOT COMPLETED|Third Intervention||0
2314273|NCT01923961|5683069|P3|COMPLETED|Third Intervention||2
2314274|NCT01923961|5683070|P2|COMPLETED|Third Intervention||3
2314275|NCT01923961|5683071|P1|COMPLETED|Third Intervention||3
2314276|NCT01923961|5683069|P3|STARTED|Third Intervention||2
2314277|NCT01923961|5683070|P2|STARTED|Third Intervention||3
2314278|NCT01923961|5683071|P1|STARTED|Third Intervention||3
2314279|NCT01923961|5683069|P3|NOT COMPLETED|Washout (1 Week)||0
2314280|NCT01923961|5683070|P2|NOT COMPLETED|Washout (1 Week)||0
2314281|NCT01923961|5683071|P1|NOT COMPLETED|Washout (1 Week)||0
2314282|NCT01923961|5683069|P3|COMPLETED|Washout (1 Week)||2
2314283|NCT01923961|5683070|P2|COMPLETED|Washout (1 Week)||3
2314284|NCT01923961|5683071|P1|COMPLETED|Washout (1 Week)||3
2314285|NCT01923961|5683069|P3|STARTED|Washout (1 Week)||2
2314286|NCT01923961|5683070|P2|STARTED|Washout (1 Week)||3
2314287|NCT01923961|5683071|P1|STARTED|Washout (1 Week)||3
2314288|NCT01923961|5683069|P3|NOT COMPLETED|Second Intervention||0
2314289|NCT01923961|5683070|P2|NOT COMPLETED|Second Intervention||0
2314290|NCT01923961|5683071|P1|NOT COMPLETED|Second Intervention||0
2314291|NCT01923961|5683069|P3|COMPLETED|Second Intervention||2
2314292|NCT01923961|5683070|P2|COMPLETED|Second Intervention||3
2314293|NCT01923961|5683071|P1|COMPLETED|Second Intervention||3
2314294|NCT01923961|5683069|P3|STARTED|Second Intervention||2
2314295|NCT01923961|5683070|P2|STARTED|Second Intervention||3
2314296|NCT01923961|5683071|P1|STARTED|Second Intervention||3
2314297|NCT01923961|5683069|P3|NOT COMPLETED|Washout (1 Week)||0
2314298|NCT01923961|5683070|P2|NOT COMPLETED|Washout (1 Week)||0
2314299|NCT01923961|5683071|P1|NOT COMPLETED|Washout (1 Week)||0
2314300|NCT01923961|5683069|P3|COMPLETED|Washout (1 Week)||2
2314301|NCT01923961|5683070|P2|COMPLETED|Washout (1 Week)||3
2314302|NCT01923961|5683071|P1|COMPLETED|Washout (1 Week)||3
2314303|NCT01923961|5683069|P3|STARTED|Washout (1 Week)||2
2314304|NCT01923961|5683070|P2|STARTED|Washout (1 Week)||3
2314305|NCT01923961|5683071|P1|STARTED|Washout (1 Week)||3
2314306|NCT01923961|5683069|P3|NOT COMPLETED|First Intervention||0
2314307|NCT01923961|5683070|P2|NOT COMPLETED|First Intervention||0
2314308|NCT01923961|5683071|P1|NOT COMPLETED|First Intervention||0
2314309|NCT01923961|5683069|P3|COMPLETED|First Intervention||2
2314310|NCT01923961|5683070|P2|COMPLETED|First Intervention||3
2314311|NCT01923961|5683071|P1|COMPLETED|First Intervention||3
2314312|NCT01923961|5683069|P3|STARTED|First Intervention||2
2314313|NCT01923961|5683070|P2|STARTED|First Intervention||3
2314314|NCT01923961|5683071|P1|STARTED|First Intervention||3
2314315|NCT01923896|5683090|P2|NOT COMPLETED|Overall Study||0
2314316|NCT01923896|5683091|P1|NOT COMPLETED|Overall Study||1
2314317|NCT01923896|5683090|P2|COMPLETED|Overall Study||8
2314318|NCT01923896|5683091|P1|COMPLETED|Overall Study||7
2314319|NCT01923896|5683090|P2|STARTED|Overall Study||8
2314320|NCT01923896|5683091|P1|STARTED|Overall Study||8
2314321|NCT01923805|5683105|P2|NOT COMPLETED|Overall Study||5
2314322|NCT01923805|5683106|P1|NOT COMPLETED|Overall Study||3
2314323|NCT01923805|5683105|P2|COMPLETED|Overall Study||0
2314324|NCT01923805|5683106|P1|COMPLETED|Overall Study||0
2314325|NCT01923805|5683105|P2|STARTED|Overall Study|early termination|5
2314326|NCT01923805|5683106|P1|STARTED|Overall Study|early termination|3
2314327|NCT01923740|5683114|P2|NOT COMPLETED|Overall Study||9
2314328|NCT01923740|5683115|P1|NOT COMPLETED|Overall Study||6
2314329|NCT01923740|5683114|P2|COMPLETED|Overall Study||223
2314330|NCT01923740|5683115|P1|COMPLETED|Overall Study||221
2314331|NCT01923740|5683114|P2|STARTED|Overall Study||232
2314332|NCT01923740|5683115|P1|STARTED|Overall Study||227
2314333|NCT01923480|5683380|P6|NOT COMPLETED|Period 2 (Hours 1-7)||0
2314334|NCT01923480|5683381|P5|NOT COMPLETED|Period 2 (Hours 1-7)||0
2314335|NCT01923480|5683382|P4|NOT COMPLETED|Period 2 (Hours 1-7)||0
2314336|NCT01923480|5683383|P3|NOT COMPLETED|Period 2 (Hours 1-7)||0
2314337|NCT01923480|5683384|P2|NOT COMPLETED|Period 2 (Hours 1-7)||0
2314338|NCT01923480|5683385|P1|NOT COMPLETED|Period 2 (Hours 1-7)||0
2314339|NCT01923480|5683380|P6|COMPLETED|Period 2 (Hours 1-7)||2
2314340|NCT01923480|5683381|P5|COMPLETED|Period 2 (Hours 1-7)||2
2314341|NCT01923480|5683382|P4|COMPLETED|Period 2 (Hours 1-7)||2
2314342|NCT01923480|5683383|P3|COMPLETED|Period 2 (Hours 1-7)||2
2314343|NCT01923480|5683384|P2|COMPLETED|Period 2 (Hours 1-7)||1
2314344|NCT01923480|5683385|P1|COMPLETED|Period 2 (Hours 1-7)||1
2314345|NCT01923480|5683380|P6|STARTED|Period 2 (Hours 1-7)||2
2314346|NCT01923480|5683381|P5|STARTED|Period 2 (Hours 1-7)||2
2314347|NCT01923480|5683382|P4|STARTED|Period 2 (Hours 1-7)||2
2314348|NCT01923480|5683383|P3|STARTED|Period 2 (Hours 1-7)||2
2314349|NCT01923480|5683384|P2|STARTED|Period 2 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|1
2314350|NCT01923480|5683385|P1|STARTED|Period 2 (Hours 1-7)||1
2314351|NCT01923480|5683380|P6|NOT COMPLETED|Period 1 (Hours 1-7)||0
2314352|NCT01923480|5683381|P5|NOT COMPLETED|Period 1 (Hours 1-7)||0
2314353|NCT01923480|5683382|P4|NOT COMPLETED|Period 1 (Hours 1-7)||0
2314354|NCT01923480|5683383|P3|NOT COMPLETED|Period 1 (Hours 1-7)||0
2314355|NCT01923480|5683384|P2|NOT COMPLETED|Period 1 (Hours 1-7)||0
2314356|NCT01923480|5683385|P1|NOT COMPLETED|Period 1 (Hours 1-7)||0
2314357|NCT01923480|5683380|P6|COMPLETED|Period 1 (Hours 1-7)||2
2314358|NCT01923480|5683381|P5|COMPLETED|Period 1 (Hours 1-7)||2
2314359|NCT01923480|5683382|P4|COMPLETED|Period 1 (Hours 1-7)||2
2314360|NCT01923480|5683383|P3|COMPLETED|Period 1 (Hours 1-7)||2
2314361|NCT01923480|5683384|P2|COMPLETED|Period 1 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|2
2314362|NCT01923480|5683385|P1|COMPLETED|Period 1 (Hours 1-7)||1
2314363|NCT01923480|5683380|P6|STARTED|Period 1 (Hours 1-7)||2
2314364|NCT01923480|5683381|P5|STARTED|Period 1 (Hours 1-7)||2
2314365|NCT01923480|5683382|P4|STARTED|Period 1 (Hours 1-7)||2
2314366|NCT01923480|5683383|P3|STARTED|Period 1 (Hours 1-7)||2
2314367|NCT01923480|5683384|P2|STARTED|Period 1 (Hours 1-7)||2
2314368|NCT01923480|5683385|P1|STARTED|Period 1 (Hours 1-7)||1
2314369|NCT01923467|5683540|P1|NOT COMPLETED|Overall Study||541
2314370|NCT01923467|5683540|P1|COMPLETED|Overall Study|Completed 3-month follow up survey|226
2314371|NCT01923467|5683540|P1|Baseline Completed, Enrolled|Overall Study||288
2314372|NCT01923467|5683540|P1|STARTED|Overall Study|Offered stop smoking program|767
2314373|NCT01923428|5683548|P4|NOT COMPLETED|Overall Study||10
2314374|NCT01923428|5683549|P3|NOT COMPLETED|Overall Study||11
2314375|NCT01923428|5683550|P2|NOT COMPLETED|Overall Study||12
2314376|NCT01923428|5683551|P1|NOT COMPLETED|Overall Study||19
2314377|NCT01923428|5683548|P4|COMPLETED|Overall Study||80
2314378|NCT01923428|5683549|P3|COMPLETED|Overall Study||78
2314379|NCT01923428|5683550|P2|COMPLETED|Overall Study||77
2314380|NCT01923428|5683551|P1|COMPLETED|Overall Study||69
2314381|NCT01923428|5683548|P4|STARTED|Overall Study||90
2314382|NCT01923428|5683549|P3|STARTED|Overall Study||89
2314383|NCT01923428|5683550|P2|STARTED|Overall Study||89
2314384|NCT01923428|5683551|P1|STARTED|Overall Study||88
2314385|NCT01923389|5683563|P2|NOT COMPLETED|Overall Study||0
2314386|NCT01923389|5683564|P1|NOT COMPLETED|Overall Study||1
2314387|NCT01923389|5683563|P2|COMPLETED|Overall Study||2
2314388|NCT01923389|5683564|P1|COMPLETED|Overall Study||1
2314389|NCT01923389|5683563|P2|STARTED|Overall Study||2
2314390|NCT01923389|5683564|P1|STARTED|Overall Study||2
2314391|NCT01923363|5683586|P1|NOT COMPLETED|Overall Study||1
2314392|NCT01923363|5683586|P1|COMPLETED|Overall Study||28
2314393|NCT01923363|5683586|P1|STARTED|Overall Study||29
2314394|NCT01923311|5683595|P2|NOT COMPLETED|Overall Study||1
2314395|NCT01923311|5683596|P1|NOT COMPLETED|Overall Study||17
2314396|NCT01923311|5683595|P2|COMPLETED|Overall Study||13
2314397|NCT01923311|5683596|P1|COMPLETED|Overall Study||0
2314398|NCT01923311|5683595|P2|STARTED|Overall Study||14
2314399|NCT01923311|5683596|P1|STARTED|Overall Study||17
2314445|NCT01923168|5683734|P3|NOT COMPLETED|Overall Study||17
2314446|NCT01923168|5683735|P2|NOT COMPLETED|Overall Study||39
2314447|NCT01923168|5683736|P1|NOT COMPLETED|Overall Study||37
2314448|NCT01923168|5683734|P3|COMPLETED|Overall Study||109
2314449|NCT01923168|5683735|P2|COMPLETED|Overall Study||44
2314450|NCT01923168|5683736|P1|COMPLETED|Overall Study||94
2314451|NCT01923168|5683734|P3|STARTED|Overall Study||126
2314452|NCT01923168|5683735|P2|STARTED|Overall Study||83
2314453|NCT01923168|5683736|P1|STARTED|Overall Study||131
2314454|NCT01923129|5683795|P2|NOT COMPLETED|Overall Study||0
2314455|NCT01923129|5683796|P1|NOT COMPLETED|Overall Study||0
2314456|NCT01923129|5683795|P2|COMPLETED|Overall Study||71
2314457|NCT01923129|5683796|P1|COMPLETED|Overall Study||71
2314458|NCT01923129|5683795|P2|STARTED|Overall Study||71
2314459|NCT01923129|5683796|P1|STARTED|Overall Study||71
2314460|NCT01922986|5683806|P2|NOT COMPLETED|Overall Study||0
2314461|NCT01922986|5683807|P1|NOT COMPLETED|Overall Study||0
2314462|NCT01922986|5683806|P2|COMPLETED|Overall Study||2
2314463|NCT01922986|5683807|P1|COMPLETED|Overall Study||2
2314464|NCT01922986|5683806|P2|STARTED|Overall Study||2
2314465|NCT01922986|5683807|P1|STARTED|Overall Study||2
2314466|NCT01922934|5683819|P2|NOT COMPLETED|Visit 12 / Final Visits||290
2314467|NCT01922934|5683820|P1|NOT COMPLETED|Visit 12 / Final Visits||6
2314468|NCT01922934|5683819|P2|COMPLETED|Visit 12 / Final Visits|290 patients did not have a second weight recorded at one year (+/- 6months) of first weight|2640
2314469|NCT01922934|5683820|P1|COMPLETED|Visit 12 / Final Visits|6 patients did not return for final visit and weight measure|113
2314470|NCT01922934|5683819|P2|STARTED|Visit 12 / Final Visits||2930
2314471|NCT01922934|5683820|P1|STARTED|Visit 12 / Final Visits||119
2314472|NCT01922934|5683819|P2|NOT COMPLETED|Visit 1- Weight Measured||1284
2314473|NCT01922934|5683820|P1|NOT COMPLETED|Visit 1- Weight Measured||21
2314474|NCT01922934|5683819|P2|COMPLETED|Visit 1- Weight Measured|1284 patients did not have any weights recorded in EMR during study timeframe|2930
2314475|NCT01922934|5683820|P1|COMPLETED|Visit 1- Weight Measured|Patients first received tool and were weighed at Visit 1|119
2314476|NCT01922934|5683819|P2|STARTED|Visit 1- Weight Measured||4214
2314559|NCT01922102|5684037|P2|NOT COMPLETED|Overall Study||9
2314477|NCT01922934|5683820|P1|STARTED|Visit 1- Weight Measured|21 patients did not return for Visit 1 to receive tool or have weight measured.|140
2314478|NCT01922934|5683819|P2|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||0
2314479|NCT01922934|5683820|P1|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||235
2314480|NCT01922934|5683819|P2|COMPLETED|Visit 0 - Patient Contacted & Consented||4214
2314481|NCT01922934|5683820|P1|COMPLETED|Visit 0 - Patient Contacted & Consented|reflects number of patients that were contacted and agreed to attend Visit 0|140
2314482|NCT01922934|5683819|P2|STARTED|Visit 0 - Patient Contacted & Consented|Control group patients were not contacted or offered intervention|4214
2314483|NCT01922934|5683820|P1|STARTED|Visit 0 - Patient Contacted & Consented||375
2314484|NCT01922934|5683819|P2|NOT COMPLETED|Eligible Patients||88
2314485|NCT01922934|5683820|P1|NOT COMPLETED|Eligible Patients||53
2314486|NCT01922934|5683819|P2|COMPLETED|Eligible Patients|81 patients did not meet inclusion criteria as they were 80 years or older. 7 patients had died.|4214
2314487|NCT01922934|5683820|P1|COMPLETED|Eligible Patients|375 patients determined eligible after original random selection from DHHA data warehouse.|375
2314488|NCT01922934|5683819|P2|STARTED|Eligible Patients||4302
2314489|NCT01922934|5683820|P1|STARTED|Eligible Patients||428
2314490|NCT01922739|5683832|P1|NOT COMPLETED|Open-label Treatment Period||34
2314491|NCT01922739|5683832|P1|COMPLETED|Open-label Treatment Period||136
2314492|NCT01922739|5683832|P1|Treatment SAS and FAS|Open-label Treatment Period|SAS = safety analysis set FAS = full analysis set|170
2314493|NCT01922739|5683832|P1|STARTED|Open-label Treatment Period||170
2314494|NCT01922739|5683832|P1|NOT COMPLETED|Titration/Adjustment Period||12
2314495|NCT01922739|5683832|P1|COMPLETED|Titration/Adjustment Period||170
2314496|NCT01922739|5683832|P1|Safety Analysis Set|Titration/Adjustment Period||182
2314497|NCT01922739|5683832|P1|STARTED|Titration/Adjustment Period||182
2314498|NCT01922349|5683861|P4|NOT COMPLETED|Multiple Rising Dose (MRD) Period||1
2314499|NCT01922349|5683862|P3|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
2314500|NCT01922349|5683863|P2|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
2314501|NCT01922349|5683864|P1|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
2314502|NCT01922349|5683861|P4|COMPLETED|Multiple Rising Dose (MRD) Period||26
2314503|NCT01922349|5683862|P3|COMPLETED|Multiple Rising Dose (MRD) Period||18
2314504|NCT01922349|5683863|P2|COMPLETED|Multiple Rising Dose (MRD) Period||27
2314505|NCT01922349|5683864|P1|COMPLETED|Multiple Rising Dose (MRD) Period||24
2314506|NCT01922349|5683861|P4|STARTED|Multiple Rising Dose (MRD) Period||27
2314507|NCT01922349|5683862|P3|STARTED|Multiple Rising Dose (MRD) Period||18
2314508|NCT01922349|5683863|P2|STARTED|Multiple Rising Dose (MRD) Period||27
2314509|NCT01922349|5683864|P1|STARTED|Multiple Rising Dose (MRD) Period|One subject discontinued the trial after the SRD period due to non-compliance with the protocol.|24
2314510|NCT01922349|5683861|P4|NOT COMPLETED|Single Rising Dose (SRD) Period||0
2314511|NCT01922349|5683862|P3|NOT COMPLETED|Single Rising Dose (SRD) Period||0
2314512|NCT01922349|5683863|P2|NOT COMPLETED|Single Rising Dose (SRD) Period||0
2314513|NCT01922349|5683864|P1|NOT COMPLETED|Single Rising Dose (SRD) Period||0
2314514|NCT01922349|5683861|P4|COMPLETED|Single Rising Dose (SRD) Period||27
2314515|NCT01922349|5683862|P3|COMPLETED|Single Rising Dose (SRD) Period||18
2314516|NCT01922349|5683863|P2|COMPLETED|Single Rising Dose (SRD) Period||27
2314517|NCT01922349|5683864|P1|COMPLETED|Single Rising Dose (SRD) Period||25
2314518|NCT01922349|5683861|P4|STARTED|Single Rising Dose (SRD) Period||27
2314519|NCT01922349|5683862|P3|STARTED|Single Rising Dose (SRD) Period||18
2314520|NCT01922349|5683863|P2|STARTED|Single Rising Dose (SRD) Period||27
2314521|NCT01922349|5683864|P1|STARTED|Single Rising Dose (SRD) Period||25
2314522|NCT01922336|5683972|P3|NOT COMPLETED|Overall Study||0
2314523|NCT01922336|5683973|P2|NOT COMPLETED|Overall Study||0
2314524|NCT01922336|5683974|P1|NOT COMPLETED|Overall Study||0
2314525|NCT01922336|5683972|P3|COMPLETED|Overall Study||53
2314526|NCT01922336|5683973|P2|COMPLETED|Overall Study||53
2314527|NCT01922336|5683974|P1|COMPLETED|Overall Study||53
2314528|NCT01922336|5683972|P3|STARTED|Overall Study||53
2314529|NCT01922336|5683973|P2|STARTED|Overall Study||53
2314530|NCT01922336|5683974|P1|STARTED|Overall Study||53
2314531|NCT01922271|5683993|P2|NOT COMPLETED|PERIOD 2||0
2314532|NCT01922271|5683994|P1|NOT COMPLETED|PERIOD 2||0
2314533|NCT01922271|5683993|P2|COMPLETED|PERIOD 2||76
2314534|NCT01922271|5683994|P1|COMPLETED|PERIOD 2||75
2314535|NCT01922271|5683993|P2|STARTED|PERIOD 2||76
2314536|NCT01922271|5683994|P1|STARTED|PERIOD 2||75
2314537|NCT01922271|5683993|P2|NOT COMPLETED|WASHOUT Period||0
2314538|NCT01922271|5683994|P1|NOT COMPLETED|WASHOUT Period||1
2314539|NCT01922271|5683993|P2|COMPLETED|WASHOUT Period||76
2314540|NCT01922271|5683994|P1|COMPLETED|WASHOUT Period||75
2314541|NCT01922271|5683993|P2|STARTED|WASHOUT Period||76
2314542|NCT01922271|5683994|P1|STARTED|WASHOUT Period||76
2314543|NCT01922271|5683993|P2|NOT COMPLETED|PERIOD 1||0
2314544|NCT01922271|5683994|P1|NOT COMPLETED|PERIOD 1||0
2314545|NCT01922271|5683993|P2|COMPLETED|PERIOD 1||76
2314546|NCT01922271|5683994|P1|COMPLETED|PERIOD 1||76
2314547|NCT01922271|5683993|P2|STARTED|PERIOD 1||76
2314548|NCT01922271|5683994|P1|STARTED|PERIOD 1||76
2314549|NCT01922219|5684012|P1|NOT COMPLETED|Overall Study||9
2314550|NCT01922219|5684012|P1|COMPLETED|Overall Study||28
2314551|NCT01922219|5684012|P1|STARTED|Overall Study||37
2314552|NCT01922115|5684020|P2|NOT COMPLETED|Overall Study||7
2314553|NCT01922115|5684021|P1|NOT COMPLETED|Overall Study||7
2314554|NCT01922115|5684020|P2|COMPLETED|Overall Study||24
2314555|NCT01922115|5684021|P1|COMPLETED|Overall Study||21
2314556|NCT01922115|5684020|P2|STARTED|Overall Study||31
2314557|NCT01922115|5684021|P1|STARTED|Overall Study||28
2314558|NCT01922102|5684036|P3|NOT COMPLETED|Overall Study||8
2314560|NCT01922102|5684038|P1|NOT COMPLETED|Overall Study||9
2314561|NCT01922102|5684036|P3|COMPLETED|Overall Study||83
2314562|NCT01922102|5684037|P2|COMPLETED|Overall Study||175
2314563|NCT01922102|5684038|P1|COMPLETED|Overall Study||173
2314564|NCT01922102|5684036|P3|STARTED|Overall Study||91
2314565|NCT01922102|5684037|P2|STARTED|Overall Study||184
2314566|NCT01922102|5684038|P1|STARTED|Overall Study||182
2314567|NCT01922089|5684074|P2|NOT COMPLETED|Overall Study||30
2314568|NCT01922089|5684075|P1|NOT COMPLETED|Overall Study||39
2314569|NCT01922089|5684074|P2|COMPLETED|Overall Study||221
2314570|NCT01922089|5684075|P1|COMPLETED|Overall Study||208
2314571|NCT01922089|5684074|P2|Safety Set|Overall Study||251
2314572|NCT01922089|5684075|P1|Safety Set|Overall Study||246
2314573|NCT01922089|5684074|P2|STARTED|Overall Study||251
2314574|NCT01922089|5684075|P1|STARTED|Overall Study||247
2314575|NCT01922050|5684099|P14|NOT COMPLETED|Part 2 Double-blind Phase||3
2314576|NCT01922050|5684100|P13|NOT COMPLETED|Part 2 Double-blind Phase||0
2314577|NCT01922050|5684101|P12|NOT COMPLETED|Part 2 Double-blind Phase||2
2314578|NCT01922050|5684102|P11|NOT COMPLETED|Part 2 Double-blind Phase||1
2314579|NCT01922050|5684103|P10|NOT COMPLETED|Part 2 Double-blind Phase||0
2314580|NCT01922050|5684104|P9|NOT COMPLETED|Part 2 Double-blind Phase||0
2314581|NCT01922050|5684105|P8|NOT COMPLETED|Part 2 Double-blind Phase||0
2314582|NCT01922050|5684106|P7|NOT COMPLETED|Part 2 Double-blind Phase||0
2314583|NCT01922050|5684107|P6|NOT COMPLETED|Part 2 Double-blind Phase||0
2314584|NCT01922050|5684108|P5|NOT COMPLETED|Part 2 Double-blind Phase||0
2314585|NCT01922050|5684109|P4|NOT COMPLETED|Part 2 Double-blind Phase||0
2314586|NCT01922050|5684110|P3|NOT COMPLETED|Part 2 Double-blind Phase||0
2314587|NCT01922050|5684111|P2|NOT COMPLETED|Part 2 Double-blind Phase||0
2314588|NCT01922050|5684112|P1|NOT COMPLETED|Part 2 Double-blind Phase||0
2314589|NCT01922050|5684099|P14|COMPLETED|Part 2 Double-blind Phase||56
2314590|NCT01922050|5684100|P13|COMPLETED|Part 2 Double-blind Phase||62
2314591|NCT01922050|5684101|P12|COMPLETED|Part 2 Double-blind Phase||58
2314592|NCT01922050|5684102|P11|COMPLETED|Part 2 Double-blind Phase||61
2314593|NCT01922050|5684103|P10|COMPLETED|Part 2 Double-blind Phase||0
2314594|NCT01922050|5684104|P9|COMPLETED|Part 2 Double-blind Phase||0
2314595|NCT01922050|5684105|P8|COMPLETED|Part 2 Double-blind Phase||0
2314596|NCT01922050|5684106|P7|COMPLETED|Part 2 Double-blind Phase||0
2314597|NCT01922050|5684107|P6|COMPLETED|Part 2 Double-blind Phase||0
2314598|NCT01922050|5684108|P5|COMPLETED|Part 2 Double-blind Phase||0
2314599|NCT01922050|5684109|P4|COMPLETED|Part 2 Double-blind Phase||0
2314600|NCT01922050|5684110|P3|COMPLETED|Part 2 Double-blind Phase||0
2314601|NCT01922050|5684111|P2|COMPLETED|Part 2 Double-blind Phase||0
2314602|NCT01922050|5684112|P1|COMPLETED|Part 2 Double-blind Phase||0
2314603|NCT01922050|5684099|P14|STARTED|Part 2 Double-blind Phase||59
2314604|NCT01922050|5684100|P13|STARTED|Part 2 Double-blind Phase||62
2314605|NCT01922050|5684101|P12|STARTED|Part 2 Double-blind Phase||60
2314606|NCT01922050|5684102|P11|STARTED|Part 2 Double-blind Phase||62
2314607|NCT01922050|5684103|P10|STARTED|Part 2 Double-blind Phase||0
2314608|NCT01922050|5684104|P9|STARTED|Part 2 Double-blind Phase||0
2314609|NCT01922050|5684105|P8|STARTED|Part 2 Double-blind Phase||0
2314610|NCT01922050|5684106|P7|STARTED|Part 2 Double-blind Phase||0
2314611|NCT01922050|5684107|P6|STARTED|Part 2 Double-blind Phase||0
2314612|NCT01922050|5684108|P5|STARTED|Part 2 Double-blind Phase||0
2314613|NCT01922050|5684109|P4|STARTED|Part 2 Double-blind Phase||0
2314614|NCT01922050|5684110|P3|STARTED|Part 2 Double-blind Phase||0
2314615|NCT01922050|5684111|P2|STARTED|Part 2 Double-blind Phase||0
2314616|NCT01922050|5684112|P1|STARTED|Part 2 Double-blind Phase||0
2314617|NCT01922050|5684099|P14|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
2314618|NCT01922050|5684100|P13|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
2314619|NCT01922050|5684101|P12|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
2314620|NCT01922050|5684102|P11|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
2314621|NCT01922050|5684103|P10|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
2314622|NCT01922050|5684104|P9|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
2314623|NCT01922050|5684105|P8|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
2314624|NCT01922050|5684106|P7|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
2314625|NCT01922050|5684107|P6|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
2314626|NCT01922050|5684108|P5|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
2314627|NCT01922050|5684109|P4|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
2314628|NCT01922050|5684110|P3|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
2314629|NCT01922050|5684111|P2|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
2314630|NCT01922050|5684112|P1|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
2314631|NCT01922050|5684099|P14|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
2314632|NCT01922050|5684100|P13|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
2314633|NCT01922050|5684101|P12|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
2314634|NCT01922050|5684102|P11|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
2314635|NCT01922050|5684103|P10|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
2314636|NCT01922050|5684104|P9|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
2314637|NCT01922050|5684105|P8|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
2314638|NCT01922050|5684106|P7|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
2314639|NCT01922050|5684107|P6|COMPLETED|Part 1 Open-label, Dose-escalation Phase||18
2314640|NCT01922050|5684108|P5|COMPLETED|Part 1 Open-label, Dose-escalation Phase||17
2314641|NCT01922050|5684109|P4|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
2314642|NCT01922050|5684110|P3|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
2314643|NCT01922050|5684111|P2|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
2314644|NCT01922050|5684112|P1|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
2314645|NCT01922050|5684099|P14|STARTED|Part 1 Open-label, Dose-escalation Phase||0
2314646|NCT01922050|5684100|P13|STARTED|Part 1 Open-label, Dose-escalation Phase||0
2314647|NCT01922050|5684101|P12|STARTED|Part 1 Open-label, Dose-escalation Phase||0
2314648|NCT01922050|5684102|P11|STARTED|Part 1 Open-label, Dose-escalation Phase||0
2314649|NCT01922050|5684103|P10|STARTED|Part 1 Open-label, Dose-escalation Phase||12
2314650|NCT01922050|5684104|P9|STARTED|Part 1 Open-label, Dose-escalation Phase||6
2314651|NCT01922050|5684105|P8|STARTED|Part 1 Open-label, Dose-escalation Phase||3
2314652|NCT01922050|5684106|P7|STARTED|Part 1 Open-label, Dose-escalation Phase||3
2314653|NCT01922050|5684107|P6|STARTED|Part 1 Open-label, Dose-escalation Phase||18
2314654|NCT01922050|5684108|P5|STARTED|Part 1 Open-label, Dose-escalation Phase||17
2314655|NCT01922050|5684109|P4|STARTED|Part 1 Open-label, Dose-escalation Phase||6
2314656|NCT01922050|5684110|P3|STARTED|Part 1 Open-label, Dose-escalation Phase||6
2314657|NCT01922050|5684111|P2|STARTED|Part 1 Open-label, Dose-escalation Phase||3
2314658|NCT01922050|5684112|P1|STARTED|Part 1 Open-label, Dose-escalation Phase||3
2314659|NCT01922037|5684152|P2|NOT COMPLETED|Overall Study||174
2314660|NCT01922037|5684153|P1|NOT COMPLETED|Overall Study||10
2314661|NCT01922037|5684152|P2|COMPLETED|Overall Study||563
2314662|NCT01922037|5684153|P1|COMPLETED|Overall Study||59
2314663|NCT01922037|5684152|P2|Treated|Overall Study||732
2314664|NCT01922037|5684153|P1|Treated|Overall Study||69
2314665|NCT01922037|5684152|P2|STARTED|Overall Study||737
2314666|NCT01922037|5684153|P1|STARTED|Overall Study||69
2314667|NCT01922024|5684247|P2|NOT COMPLETED|Overall Study||0
2314668|NCT01922024|5684248|P1|NOT COMPLETED|Overall Study||0
2314669|NCT01922024|5684247|P2|COMPLETED|Overall Study||471
2314670|NCT01922024|5684248|P1|COMPLETED|Overall Study||1653
2314671|NCT01922024|5684247|P2|STARTED|Overall Study||471
2314672|NCT01922024|5684248|P1|STARTED|Overall Study||1653
2314673|NCT01922011|5684256|P2|NOT COMPLETED|Overall Study||5
2314674|NCT01922011|5684257|P1|NOT COMPLETED|Overall Study||6
2314675|NCT01922011|5684256|P2|COMPLETED|Overall Study||69
2314676|NCT01922011|5684257|P1|COMPLETED|Overall Study||69
2314677|NCT01922011|5684256|P2|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|72
2314678|NCT01922011|5684257|P1|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|74
2314679|NCT01922011|5684256|P2|Treated|Overall Study|Treated Participants|73
2314680|NCT01922011|5684257|P1|Treated|Overall Study|Treated Participants|73
2314681|NCT01922011|5684256|P2|STARTED|Overall Study|Randomized participants|74
2314682|NCT01922011|5684257|P1|STARTED|Overall Study|Randomized participants|75
2314683|NCT01921894|5684300|P3|NOT COMPLETED|Overall Study||0
2314684|NCT01921894|5684301|P2|NOT COMPLETED|Overall Study||0
2314685|NCT01921894|5684302|P1|NOT COMPLETED|Overall Study||0
2314686|NCT01921894|5684300|P3|COMPLETED|Overall Study||8
2314687|NCT01921894|5684301|P2|COMPLETED|Overall Study||8
2314688|NCT01921894|5684302|P1|COMPLETED|Overall Study||8
2314689|NCT01921894|5684300|P3|STARTED|Overall Study||8
2314690|NCT01921894|5684301|P2|STARTED|Overall Study||8
2314691|NCT01921894|5684302|P1|STARTED|Overall Study||8
2314692|NCT01921829|5684324|P2|NOT COMPLETED|Overall Study||1
2314693|NCT01921829|5684325|P1|NOT COMPLETED|Overall Study||0
2314694|NCT01921829|5684324|P2|COMPLETED|Overall Study||8
2314695|NCT01921829|5684325|P1|COMPLETED|Overall Study||10
2314696|NCT01921829|5684324|P2|STARTED|Overall Study||9
2314697|NCT01921829|5684325|P1|STARTED|Overall Study||10
2314698|NCT01921751|5684374|P3|NOT COMPLETED|Overall Study||0
2314699|NCT01921751|5684375|P2|NOT COMPLETED|Overall Study||0
2314700|NCT01921751|5684376|P1|NOT COMPLETED|Overall Study||0
2314701|NCT01921751|5684374|P3|COMPLETED|Overall Study|All randomized patients are reported here.|5
2314702|NCT01921751|5684375|P2|COMPLETED|Overall Study|All randomized patients are reported here.|4
2314703|NCT01921751|5684376|P1|COMPLETED|Overall Study|All randomized patients are reported here.|4
2314704|NCT01921751|5684374|P3|STARTED|Overall Study||5
2314705|NCT01921751|5684375|P2|STARTED|Overall Study||4
2314706|NCT01921751|5684376|P1|STARTED|Overall Study||4
2314707|NCT01921517|5684396|P2|NOT COMPLETED|Overall Study||9
2314708|NCT01921517|5684397|P1|NOT COMPLETED|Overall Study||15
2314709|NCT01921517|5684396|P2|COMPLETED|Overall Study||29
2314710|NCT01921517|5684397|P1|COMPLETED|Overall Study||27
2314711|NCT01921517|5684396|P2|STARTED|Overall Study||38
2314712|NCT01921517|5684397|P1|STARTED|Overall Study||42
2314713|NCT01921452|5684403|P1|NOT COMPLETED|Overall Study||0
2314714|NCT01921452|5684403|P1|COMPLETED|Overall Study||283
2314715|NCT01921452|5684403|P1|STARTED|Overall Study||283
2314716|NCT01921387|5684408|P1|NOT COMPLETED|Overall Study||1
2314717|NCT01921387|5684408|P1|COMPLETED|Overall Study||19
2314718|NCT01921387|5684408|P1|STARTED|Overall Study||20
2314719|NCT01921348|5684417|P2|NOT COMPLETED|Overall Study||2
2314720|NCT01921348|5684418|P1|NOT COMPLETED|Overall Study||1
2314721|NCT01921348|5684417|P2|COMPLETED|Overall Study||7
2314722|NCT01921348|5684418|P1|COMPLETED|Overall Study||8
2314723|NCT01921348|5684417|P2|STARTED|Overall Study||9
2314724|NCT01921348|5684418|P1|STARTED|Overall Study||9
2314725|NCT01921322|5684430|P2|NOT COMPLETED|Overall Study||17
2314726|NCT01921322|5684431|P1|NOT COMPLETED|Overall Study||15
2314727|NCT01921322|5684430|P2|COMPLETED|Overall Study||44
2314728|NCT01921322|5684431|P1|COMPLETED|Overall Study||42
2314729|NCT01921322|5684430|P2|STARTED|Overall Study||61
2314730|NCT01921322|5684431|P1|STARTED|Overall Study||57
2314731|NCT01921296|5684439|P1|NOT COMPLETED|Overall Study||0
2314732|NCT01921296|5684439|P1|COMPLETED|Overall Study||2
2314733|NCT01921296|5684439|P1|STARTED|Overall Study||2
2314734|NCT01921270|5684447|P1|NOT COMPLETED|Overall Study||1
2314735|NCT01921270|5684447|P1|COMPLETED|Overall Study||17
2314736|NCT01921270|5684447|P1|STARTED|Overall Study||18
2314737|NCT01921257|5684463|P1|NOT COMPLETED|Overall Study||3
2314738|NCT01921257|5684463|P1|COMPLETED|Overall Study||13
2314739|NCT01921257|5684463|P1|Active Treatment|Overall Study||13
2314740|NCT01921257|5684463|P1|Placebo run-in|Overall Study||16
2314741|NCT01921257|5684463|P1|STARTED|Overall Study||16
2314742|NCT01921205|5684470|P2|NOT COMPLETED|Overall Study||20
2314743|NCT01921205|5684471|P1|NOT COMPLETED|Overall Study||21
2314744|NCT01921205|5684470|P2|COMPLETED|Overall Study||151
2314745|NCT01921205|5684471|P1|COMPLETED|Overall Study||151
2314746|NCT01921205|5684470|P2|STARTED|Overall Study||171
2314747|NCT01921205|5684471|P1|STARTED|Overall Study||172
2314760|NCT01921166|5684517|P2|NOT COMPLETED|Overall Study||0
2314761|NCT01921166|5684518|P1|NOT COMPLETED|Overall Study||0
2314762|NCT01921166|5684517|P2|COMPLETED|Overall Study||15
2314763|NCT01921166|5684518|P1|COMPLETED|Overall Study||8
2314764|NCT01921166|5684517|P2|STARTED|Overall Study||15
2314765|NCT01921166|5684518|P1|STARTED|Overall Study||8
2314766|NCT01921114|5684528|P2|NOT COMPLETED|Overall Study||0
2314767|NCT01921114|5684529|P1|NOT COMPLETED|Overall Study||0
2314768|NCT01921114|5684528|P2|COMPLETED|Overall Study||0
2314769|NCT01921114|5684529|P1|COMPLETED|Overall Study||0
2314770|NCT01921114|5684528|P2|STARTED|Overall Study||0
2314771|NCT01921114|5684529|P1|STARTED|Overall Study||0
2314772|NCT01921101|5684539|P2|NOT COMPLETED|Overall Study||6
2314773|NCT01921101|5684540|P1|NOT COMPLETED|Overall Study||16
2314774|NCT01921101|5684539|P2|COMPLETED|Overall Study||32
2314775|NCT01921101|5684540|P1|COMPLETED|Overall Study||24
2314776|NCT01921101|5684539|P2|STARTED|Overall Study||38
2314777|NCT01921101|5684540|P1|STARTED|Overall Study||40
2314778|NCT01920958|5684548|P1|NOT COMPLETED|Overall Study||5
2314779|NCT01920958|5684548|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|228
2314780|NCT01920958|5684548|P1|STARTED|Overall Study||233
2314781|NCT01920893|5684566|P2|NOT COMPLETED|Overall Study||2
2314782|NCT01920893|5684567|P1|NOT COMPLETED|Overall Study||7
2314783|NCT01920893|5684566|P2|COMPLETED|Overall Study||28
2314784|NCT01920893|5684567|P1|COMPLETED|Overall Study||23
2314785|NCT01920893|5684566|P2|Treated (Safety Population)|Overall Study||30
2314786|NCT01920893|5684567|P1|Treated (Safety Population)|Overall Study||30
2314787|NCT01920893|5684566|P2|STARTED|Overall Study||30
2314788|NCT01920893|5684567|P1|STARTED|Overall Study||30
2314789|NCT01920854|5684600|P7|NOT COMPLETED|Overall Study||1
2314790|NCT01920854|5684601|P6|NOT COMPLETED|Overall Study||0
2314791|NCT01920854|5684602|P5|NOT COMPLETED|Overall Study||1
2314792|NCT01920854|5684603|P4|NOT COMPLETED|Overall Study||0
2314793|NCT01920854|5684604|P3|NOT COMPLETED|Overall Study||0
2314794|NCT01920854|5684605|P2|NOT COMPLETED|Overall Study||0
2314795|NCT01920854|5684606|P1|NOT COMPLETED|Overall Study||1
2314796|NCT01920854|5684600|P7|COMPLETED|Overall Study||5
2314797|NCT01920854|5684601|P6|COMPLETED|Overall Study||6
2314798|NCT01920854|5684602|P5|COMPLETED|Overall Study||5
2314799|NCT01920854|5684603|P4|COMPLETED|Overall Study||6
2314800|NCT01920854|5684604|P3|COMPLETED|Overall Study||6
2314801|NCT01920854|5684605|P2|COMPLETED|Overall Study||6
2314802|NCT01920854|5684606|P1|COMPLETED|Overall Study||11
2314803|NCT01920854|5684600|P7|STARTED|Overall Study||6
2314804|NCT01920854|5684601|P6|STARTED|Overall Study||6
2314805|NCT01920854|5684602|P5|STARTED|Overall Study||6
2314806|NCT01920854|5684603|P4|STARTED|Overall Study||6
2314807|NCT01920854|5684604|P3|STARTED|Overall Study||6
2314808|NCT01920854|5684605|P2|STARTED|Overall Study||6
2314809|NCT01920854|5684606|P1|STARTED|Overall Study||12
2314810|NCT01920802|5684733|P3|NOT COMPLETED|Overall Study||1
2314811|NCT01920802|5684734|P2|NOT COMPLETED|Overall Study||2
2314812|NCT01920802|5684735|P1|NOT COMPLETED|Overall Study||4
2314813|NCT01920802|5684733|P3|COMPLETED|Overall Study||10
2314814|NCT01920802|5684734|P2|COMPLETED|Overall Study||7
2314815|NCT01920802|5684735|P1|COMPLETED|Overall Study||7
2314816|NCT01920802|5684733|P3|STARTED|Overall Study||11
2314817|NCT01920802|5684734|P2|STARTED|Overall Study||9
2314818|NCT01920802|5684735|P1|STARTED|Overall Study||11
2314819|NCT01920594|5684766|P2|NOT COMPLETED|Overall Study||3
2314820|NCT01920594|5684767|P1|NOT COMPLETED|Overall Study||7
2314821|NCT01920594|5684766|P2|COMPLETED|Overall Study||25
2314822|NCT01920594|5684767|P1|COMPLETED|Overall Study||20
2314823|NCT01920594|5684766|P2|STARTED|Overall Study||28
2314824|NCT01920594|5684767|P1|STARTED|Overall Study||27
2314825|NCT01920568|5684817|P2|NOT COMPLETED|Overall Study||84
2314826|NCT01920568|5684818|P1|NOT COMPLETED|Overall Study||151
2314827|NCT01920568|5684817|P2|COMPLETED|Overall Study||75
2314828|NCT01920568|5684818|P1|COMPLETED|Overall Study||175
2314829|NCT01920568|5684817|P2|STARTED|Overall Study||159
2314830|NCT01920568|5684818|P1|STARTED|Overall Study||326
2314831|NCT01920555|5684844|P5|NOT COMPLETED|Overall Study||1
2314832|NCT01920555|5684845|P4|NOT COMPLETED|Overall Study||3
2314833|NCT01920555|5684846|P3|NOT COMPLETED|Overall Study||1
2314834|NCT01920555|5684847|P2|NOT COMPLETED|Overall Study||4
2314835|NCT01920555|5684848|P1|NOT COMPLETED|Overall Study||4
2314836|NCT01920555|5684844|P5|COMPLETED|Overall Study||18
2314837|NCT01920555|5684845|P4|COMPLETED|Overall Study||17
2314838|NCT01920555|5684846|P3|COMPLETED|Overall Study||21
2314839|NCT01920555|5684847|P2|COMPLETED|Overall Study||16
2314840|NCT01920555|5684848|P1|COMPLETED|Overall Study||14
2314841|NCT01920555|5684844|P5|STARTED|Overall Study||19
2314842|NCT01920555|5684845|P4|STARTED|Overall Study||20
2314843|NCT01920555|5684846|P3|STARTED|Overall Study||22
2314844|NCT01920555|5684847|P2|STARTED|Overall Study||20
2314845|NCT01920555|5684848|P1|STARTED|Overall Study||18
2314846|NCT01920477|5684907|P2|NOT COMPLETED|Overall Study||17
2314847|NCT01920477|5684908|P1|NOT COMPLETED|Overall Study||15
2314848|NCT01920477|5684907|P2|COMPLETED|Overall Study||1
2314849|NCT01920477|5684908|P1|COMPLETED|Overall Study||2
2314850|NCT01920477|5684907|P2|Requiried Individualized Follow-up|Overall Study||0
2314851|NCT01920477|5684908|P1|Requiried Individualized Follow-up|Overall Study||1
2314852|NCT01920477|5684907|P2|STARTED|Overall Study||18
2314853|NCT01920477|5684908|P1|STARTED|Overall Study||17
2314854|NCT01920282|5684942|P3|NOT COMPLETED|Overall Study||0
2314855|NCT01920282|5684943|P2|NOT COMPLETED|Overall Study||0
2314856|NCT01920282|5684944|P1|NOT COMPLETED|Overall Study||0
2314857|NCT01920282|5684942|P3|COMPLETED|Overall Study||15
2314858|NCT01920282|5684943|P2|COMPLETED|Overall Study||15
2314859|NCT01920282|5684944|P1|COMPLETED|Overall Study||15
2314860|NCT01920282|5684942|P3|STARTED|Overall Study||15
2314861|NCT01920282|5684943|P2|STARTED|Overall Study||15
2314862|NCT01920282|5684944|P1|STARTED|Overall Study||15
2314863|NCT01920178|5684957|P2|NOT COMPLETED|Overall Study||1
2314864|NCT01920178|5684958|P1|NOT COMPLETED|Overall Study||2
2314865|NCT01920178|5684957|P2|COMPLETED|Overall Study||1
2314866|NCT01920178|5684958|P1|COMPLETED|Overall Study||3
2314867|NCT01920178|5684957|P2|STARTED|Overall Study||2
2314868|NCT01920178|5684958|P1|STARTED|Overall Study||5
2314869|NCT01919996|5684968|P1|NOT COMPLETED|Overall Study||0
2314870|NCT01919996|5684968|P1|COMPLETED|Overall Study||8
2314871|NCT01919996|5684968|P1|STARTED|Overall Study||8
2314872|NCT01919970|5684976|P2|NOT COMPLETED|Overall Study||0
2314873|NCT01919970|5684977|P1|NOT COMPLETED|Overall Study||3
2314874|NCT01919970|5684976|P2|COMPLETED|Overall Study||18
2314875|NCT01919970|5684977|P1|COMPLETED|Overall Study||11
2314876|NCT01919970|5684976|P2|STARTED|Overall Study||18
2314877|NCT01919970|5684977|P1|STARTED|Overall Study||14
2314878|NCT01919814|5684985|P2|NOT COMPLETED|Overall Study||0
2314879|NCT01919814|5684986|P1|NOT COMPLETED|Overall Study||3
2314880|NCT01919814|5684985|P2|COMPLETED|Overall Study||30
2314881|NCT01919814|5684986|P1|COMPLETED|Overall Study||27
2314882|NCT01919814|5684985|P2|STARTED|Overall Study||30
2314883|NCT01919814|5684986|P1|STARTED|Overall Study||30
2314884|NCT01919801|5684998|P2|NOT COMPLETED|Overall Study||3
2314885|NCT01919801|5684999|P1|NOT COMPLETED|Overall Study||1
2314886|NCT01919801|5684998|P2|COMPLETED|Overall Study||57
2314887|NCT01919801|5684999|P1|COMPLETED|Overall Study||60
2314888|NCT01919801|5684998|P2|STARTED|Overall Study||60
2314889|NCT01919801|5684999|P1|STARTED|Overall Study||61
2314890|NCT01919723|5685024|P2|NOT COMPLETED|Overall Study||2
2314891|NCT01919723|5685025|P1|NOT COMPLETED|Overall Study||2
2314892|NCT01919723|5685024|P2|COMPLETED|Overall Study||33
2314893|NCT01919723|5685025|P1|COMPLETED|Overall Study||33
2314894|NCT01919723|5685024|P2|STARTED|Overall Study||35
2314895|NCT01919723|5685025|P1|STARTED|Overall Study||35
2314896|NCT01919697|5685039|P2|NOT COMPLETED|Overall Study||385
2314897|NCT01919697|5685040|P1|NOT COMPLETED|Overall Study||53
2314898|NCT01919697|5685039|P2|COMPLETED|Overall Study||1761
2314899|NCT01919697|5685040|P1|COMPLETED|Overall Study||171
2314900|NCT01919697|5685039|P2|STARTED|Overall Study||2146
2314901|NCT01919697|5685040|P1|STARTED|Overall Study||224
2314902|NCT01919606|5685070|P2|NOT COMPLETED|Overall Study||0
2314903|NCT01919606|5685071|P1|NOT COMPLETED|Overall Study||0
2314904|NCT01919606|5685070|P2|COMPLETED|Overall Study||0
2314905|NCT01919606|5685071|P1|COMPLETED|Overall Study||1
2314906|NCT01919606|5685070|P2|STARTED|Overall Study||0
2314907|NCT01919606|5685071|P1|STARTED|Overall Study||1
2314908|NCT01919450|5685083|P4|NOT COMPLETED|Overall Study||1
2314909|NCT01919450|5685084|P3|NOT COMPLETED|Overall Study||0
2314910|NCT01919450|5685085|P2|NOT COMPLETED|Overall Study||0
2314911|NCT01919450|5685086|P1|NOT COMPLETED|Overall Study||0
2314912|NCT01919450|5685083|P4|COMPLETED|Overall Study||19
2314913|NCT01919450|5685084|P3|COMPLETED|Overall Study||20
2314914|NCT01919450|5685085|P2|COMPLETED|Overall Study||20
2314915|NCT01919450|5685086|P1|COMPLETED|Overall Study||20
2314916|NCT01919450|5685083|P4|STARTED|Overall Study||20
2314917|NCT01919450|5685084|P3|STARTED|Overall Study||20
2314918|NCT01919450|5685085|P2|STARTED|Overall Study||20
2314919|NCT01919450|5685086|P1|STARTED|Overall Study||20
2314926|NCT01919398|5685118|P3|NOT COMPLETED|Overall Study||4
2314927|NCT01919398|5685119|P2|NOT COMPLETED|Overall Study||0
2314928|NCT01919398|5685120|P1|NOT COMPLETED|Overall Study||0
2314929|NCT01919398|5685118|P3|COMPLETED|Overall Study||9
2314930|NCT01919398|5685119|P2|COMPLETED|Overall Study||3
2314931|NCT01919398|5685120|P1|COMPLETED|Overall Study||3
2314932|NCT01919398|5685118|P3|Received at Least One Dose of Study Drug|Overall Study||13
2314933|NCT01919398|5685119|P2|Received at Least One Dose of Study Drug|Overall Study||3
2314934|NCT01919398|5685120|P1|Received at Least One Dose of Study Drug|Overall Study||3
2314935|NCT01919398|5685118|P3|STARTED|Overall Study||13
2314936|NCT01919398|5685119|P2|STARTED|Overall Study||3
2314937|NCT01919398|5685120|P1|STARTED|Overall Study||3
2314938|NCT01919307|5685140|P1|NOT COMPLETED|Overall Study||9
2314939|NCT01919307|5685140|P1|COMPLETED|Overall Study||20
2314940|NCT01919307|5685140|P1|STARTED|Overall Study||29
2314941|NCT01919229|5685150|P3|NOT COMPLETED|Overall Study||1
2314942|NCT01919229|5685151|P2|NOT COMPLETED|Overall Study||0
2314943|NCT01919229|5685152|P1|NOT COMPLETED|Overall Study||0
2314944|NCT01919229|5685150|P3|COMPLETED|Overall Study||3
2314945|NCT01919229|5685151|P2|COMPLETED|Overall Study||6
2314946|NCT01919229|5685152|P1|COMPLETED|Overall Study||4
2314947|NCT01919229|5685150|P3|STARTED|Overall Study||4
2314948|NCT01919229|5685151|P2|STARTED|Overall Study||6
2314949|NCT01919229|5685152|P1|STARTED|Overall Study||4
2314950|NCT01919216|5685184|P3|NOT COMPLETED|Overall Study||1
2314951|NCT01919216|5685185|P2|NOT COMPLETED|Overall Study||1
2314952|NCT01919216|5685186|P1|NOT COMPLETED|Overall Study||2
2314953|NCT01919216|5685184|P3|COMPLETED|Overall Study||4
2314954|NCT01919216|5685185|P2|COMPLETED|Overall Study||20
2314955|NCT01919216|5685186|P1|COMPLETED|Overall Study||26
2314956|NCT01919216|5685184|P3|STARTED|Overall Study||5
2314957|NCT01919216|5685185|P2|STARTED|Overall Study||21
2314958|NCT01919216|5685186|P1|STARTED|Overall Study||28
2314959|NCT01918800|5685196|P2|NOT COMPLETED|Overall Study||5
2314960|NCT01918800|5685197|P1|NOT COMPLETED|Overall Study||9
2314961|NCT01918800|5685196|P2|COMPLETED|Overall Study||104
2314962|NCT01918800|5685197|P1|COMPLETED|Overall Study||100
2314963|NCT01918800|5685196|P2|STARTED|Overall Study||109
2314964|NCT01918800|5685197|P1|STARTED|Overall Study||109
2314965|NCT01918774|5685215|P1|NOT COMPLETED|Overall Study||5
2314966|NCT01918774|5685215|P1|COMPLETED|Overall Study||52
2314967|NCT01918774|5685215|P1|STARTED|Overall Study||57
2314968|NCT01918761|5685230|P1|NOT COMPLETED|Overall Study||0
2314969|NCT01918761|5685230|P1|COMPLETED|Overall Study||5
2314970|NCT01918761|5685230|P1|STARTED|Overall Study||5
2314971|NCT01918371|5685239|P2|NOT COMPLETED|Overall Study||1
2314972|NCT01918371|5685240|P1|NOT COMPLETED|Overall Study||1
2314973|NCT01918371|5685239|P2|COMPLETED|Overall Study||156
2314974|NCT01918371|5685240|P1|COMPLETED|Overall Study||165
2314975|NCT01918371|5685239|P2|Participants With Complete Data|Overall Study||156
2314976|NCT01918371|5685240|P1|Participants With Complete Data|Overall Study||165
2314977|NCT01918371|5685239|P2|STARTED|Overall Study||157
2314978|NCT01918371|5685240|P1|STARTED|Overall Study||166
2314979|NCT01918332|5685318|P4|NOT COMPLETED|Overall Study||7
2314980|NCT01918332|5685319|P3|NOT COMPLETED|Overall Study||9
2314981|NCT01918332|5685320|P2|NOT COMPLETED|Overall Study||5
2314982|NCT01918332|5685321|P1|NOT COMPLETED|Overall Study||8
2314983|NCT01918332|5685318|P4|COMPLETED|Overall Study||38
2314984|NCT01918332|5685319|P3|COMPLETED|Overall Study||30
2314985|NCT01918332|5685320|P2|COMPLETED|Overall Study||36
2314986|NCT01918332|5685321|P1|COMPLETED|Overall Study||35
2314987|NCT01918332|5685318|P4|STARTED|Overall Study||45
2314988|NCT01918332|5685319|P3|STARTED|Overall Study||39
2314989|NCT01918332|5685320|P2|STARTED|Overall Study||41
2314990|NCT01918332|5685321|P1|STARTED|Overall Study||43
2314991|NCT01918306|5685333|P4|NOT COMPLETED|Overall Study||3
2314992|NCT01918306|5685334|P3|NOT COMPLETED|Overall Study||2
2314993|NCT01918306|5685335|P2|NOT COMPLETED|Overall Study||0
2314994|NCT01918306|5685336|P1|NOT COMPLETED|Overall Study||6
2314995|NCT01918306|5685333|P4|COMPLETED|Overall Study||0
2314996|NCT01918306|5685334|P3|COMPLETED|Overall Study||0
2314997|NCT01918306|5685335|P2|COMPLETED|Overall Study||0
2314998|NCT01918306|5685336|P1|COMPLETED|Overall Study||0
2314999|NCT01918306|5685333|P4|STARTED|Overall Study||3
2315000|NCT01918306|5685334|P3|STARTED|Overall Study|1 participant Crossed-over to ARM 2|2
2315001|NCT01918306|5685335|P2|STARTED|Overall Study|No patients enrolled|0
2315002|NCT01918306|5685336|P1|STARTED|Overall Study||6
2315003|NCT01918189|5685356|P1|NOT COMPLETED|Overall Study||18
2315004|NCT01918189|5685356|P1|COMPLETED|Overall Study||41
2315005|NCT01918189|5685356|P1|Completed Follow-up Assessment|Overall Study||41
2315006|NCT01918189|5685356|P1|Completed Baseline Assessment|Overall Study||58
2315007|NCT01918189|5685356|P1|STARTED|Overall Study||59
2315008|NCT01918085|5685367|P2|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
2315259|NCT01916980|5685619|P2|STARTED|Overall Study||29
2315009|NCT01918085|5685368|P1|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
2315010|NCT01918085|5685367|P2|COMPLETED|Test Period 2: Hydrocolloid Strip||11
2315011|NCT01918085|5685368|P1|COMPLETED|Test Period 2: Hydrocolloid Strip||10
2315012|NCT01918085|5685367|P2|STARTED|Test Period 2: Hydrocolloid Strip||11
2315013|NCT01918085|5685368|P1|STARTED|Test Period 2: Hydrocolloid Strip||10
2315014|NCT01918085|5685367|P2|NOT COMPLETED|Test Period 2: Strata Strip||0
2315015|NCT01918085|5685368|P1|NOT COMPLETED|Test Period 2: Strata Strip||0
2315016|NCT01918085|5685367|P2|COMPLETED|Test Period 2: Strata Strip||11
2315017|NCT01918085|5685368|P1|COMPLETED|Test Period 2: Strata Strip||10
2315018|NCT01918085|5685367|P2|STARTED|Test Period 2: Strata Strip||11
2315019|NCT01918085|5685368|P1|STARTED|Test Period 2: Strata Strip||10
2315020|NCT01918085|5685367|P2|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
2315021|NCT01918085|5685368|P1|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
2315022|NCT01918085|5685367|P2|COMPLETED|Test Period 1: Hydrocolloid Strip||11
2315023|NCT01918085|5685368|P1|COMPLETED|Test Period 1: Hydrocolloid Strip||10
2315024|NCT01918085|5685367|P2|STARTED|Test Period 1: Hydrocolloid Strip||11
2315025|NCT01918085|5685368|P1|STARTED|Test Period 1: Hydrocolloid Strip||10
2315026|NCT01918085|5685367|P2|NOT COMPLETED|Test Period 1: Strata Strip||1
2315027|NCT01918085|5685368|P1|NOT COMPLETED|Test Period 1: Strata Strip||0
2315028|NCT01918085|5685367|P2|COMPLETED|Test Period 1: Strata Strip||11
2315029|NCT01918085|5685368|P1|COMPLETED|Test Period 1: Strata Strip||10
2315030|NCT01918085|5685367|P2|STARTED|Test Period 1: Strata Strip||12
2315031|NCT01918085|5685368|P1|STARTED|Test Period 1: Strata Strip||10
2315032|NCT01918072|5685376|P3|NOT COMPLETED|Quality Assessment Period||0
2315033|NCT01918072|5685377|P2|NOT COMPLETED|Quality Assessment Period||0
2315034|NCT01918072|5685378|P1|NOT COMPLETED|Quality Assessment Period||0
2315035|NCT01918072|5685376|P3|COMPLETED|Quality Assessment Period||202
2315036|NCT01918072|5685377|P2|COMPLETED|Quality Assessment Period||0
2315037|NCT01918072|5685378|P1|COMPLETED|Quality Assessment Period||0
2315038|NCT01918072|5685376|P3|STARTED|Quality Assessment Period||202
2315039|NCT01918072|5685377|P2|STARTED|Quality Assessment Period||0
2315040|NCT01918072|5685378|P1|STARTED|Quality Assessment Period||0
2315041|NCT01918072|5685376|P3|NOT COMPLETED|E-consult Assessment Period||0
2315042|NCT01918072|5685377|P2|NOT COMPLETED|E-consult Assessment Period||0
2315043|NCT01918072|5685378|P1|NOT COMPLETED|E-consult Assessment Period||0
2315044|NCT01918072|5685376|P3|COMPLETED|E-consult Assessment Period||0
2315045|NCT01918072|5685377|P2|COMPLETED|E-consult Assessment Period||42
2315046|NCT01918072|5685378|P1|COMPLETED|E-consult Assessment Period||0
2315047|NCT01918072|5685376|P3|STARTED|E-consult Assessment Period||0
2315048|NCT01918072|5685377|P2|STARTED|E-consult Assessment Period||42
2315049|NCT01918072|5685378|P1|STARTED|E-consult Assessment Period||0
2315050|NCT01918072|5685376|P3|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
2315051|NCT01918072|5685377|P2|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
2315052|NCT01918072|5685378|P1|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
2315053|NCT01918072|5685376|P3|COMPLETED|Controlled Trial Step Five - Four Months||0
2315054|NCT01918072|5685377|P2|COMPLETED|Controlled Trial Step Five - Four Months||0
2315055|NCT01918072|5685378|P1|COMPLETED|Controlled Trial Step Five - Four Months||11
2315056|NCT01918072|5685376|P3|Control|Controlled Trial Step Five - Four Months||0
2315057|NCT01918072|5685377|P2|Control|Controlled Trial Step Five - Four Months||0
2315058|NCT01918072|5685378|P1|Control|Controlled Trial Step Five - Four Months||0
2315059|NCT01918072|5685376|P3|Intervention|Controlled Trial Step Five - Four Months||0
2315060|NCT01918072|5685377|P2|Intervention|Controlled Trial Step Five - Four Months||0
2315061|NCT01918072|5685378|P1|Intervention|Controlled Trial Step Five - Four Months||11
2315062|NCT01918072|5685376|P3|STARTED|Controlled Trial Step Five - Four Months||0
2315063|NCT01918072|5685377|P2|STARTED|Controlled Trial Step Five - Four Months||0
2315064|NCT01918072|5685378|P1|STARTED|Controlled Trial Step Five - Four Months||11
2315065|NCT01918072|5685376|P3|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
2315066|NCT01918072|5685377|P2|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
2315067|NCT01918072|5685378|P1|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
2315068|NCT01918072|5685376|P3|COMPLETED|Controlled Trial Step Four - Six Months||0
2315069|NCT01918072|5685377|P2|COMPLETED|Controlled Trial Step Four - Six Months||0
2315070|NCT01918072|5685378|P1|COMPLETED|Controlled Trial Step Four - Six Months||11
2315071|NCT01918072|5685376|P3|Control|Controlled Trial Step Four - Six Months||0
2315072|NCT01918072|5685377|P2|Control|Controlled Trial Step Four - Six Months||0
2315073|NCT01918072|5685378|P1|Control|Controlled Trial Step Four - Six Months||0
2315074|NCT01918072|5685376|P3|Intervention|Controlled Trial Step Four - Six Months||0
2315075|NCT01918072|5685377|P2|Intervention|Controlled Trial Step Four - Six Months||0
2315076|NCT01918072|5685378|P1|Intervention|Controlled Trial Step Four - Six Months||11
2315077|NCT01918072|5685376|P3|STARTED|Controlled Trial Step Four - Six Months||0
2315078|NCT01918072|5685377|P2|STARTED|Controlled Trial Step Four - Six Months||0
2315079|NCT01918072|5685378|P1|STARTED|Controlled Trial Step Four - Six Months||11
2315080|NCT01918072|5685376|P3|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
2315081|NCT01918072|5685377|P2|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
2315082|NCT01918072|5685378|P1|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
2315083|NCT01918072|5685376|P3|COMPLETED|Controlled Trial Step Three - Six Months||0
2315084|NCT01918072|5685377|P2|COMPLETED|Controlled Trial Step Three - Six Months||0
2315085|NCT01918072|5685378|P1|COMPLETED|Controlled Trial Step Three - Six Months||11
2315086|NCT01918072|5685376|P3|Control|Controlled Trial Step Three - Six Months||0
2315087|NCT01918072|5685377|P2|Control|Controlled Trial Step Three - Six Months||0
2315088|NCT01918072|5685378|P1|Control|Controlled Trial Step Three - Six Months||2
2315089|NCT01918072|5685376|P3|Intervention|Controlled Trial Step Three - Six Months||0
2315090|NCT01918072|5685377|P2|Intervention|Controlled Trial Step Three - Six Months||0
2315091|NCT01918072|5685378|P1|Intervention|Controlled Trial Step Three - Six Months||9
2315092|NCT01918072|5685376|P3|STARTED|Controlled Trial Step Three - Six Months||0
2315093|NCT01918072|5685377|P2|STARTED|Controlled Trial Step Three - Six Months||0
2315094|NCT01918072|5685378|P1|STARTED|Controlled Trial Step Three - Six Months||11
2315095|NCT01918072|5685376|P3|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
2315096|NCT01918072|5685377|P2|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
2315097|NCT01918072|5685378|P1|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
2315098|NCT01918072|5685376|P3|COMPLETED|Controlled Trial Step Two - Six Months||0
2315099|NCT01918072|5685377|P2|COMPLETED|Controlled Trial Step Two - Six Months||0
2315100|NCT01918072|5685378|P1|COMPLETED|Controlled Trial Step Two - Six Months||11
2315101|NCT01918072|5685376|P3|Control|Controlled Trial Step Two - Six Months||0
2315102|NCT01918072|5685377|P2|Control|Controlled Trial Step Two - Six Months||0
2315103|NCT01918072|5685378|P1|Control|Controlled Trial Step Two - Six Months||4
2315104|NCT01918072|5685376|P3|Intervention|Controlled Trial Step Two - Six Months||0
2315105|NCT01918072|5685377|P2|Intervention|Controlled Trial Step Two - Six Months||0
2315106|NCT01918072|5685378|P1|Intervention|Controlled Trial Step Two - Six Months||7
2315107|NCT01918072|5685376|P3|STARTED|Controlled Trial Step Two - Six Months||0
2315108|NCT01918072|5685377|P2|STARTED|Controlled Trial Step Two - Six Months||0
2315109|NCT01918072|5685378|P1|STARTED|Controlled Trial Step Two - Six Months||11
2315110|NCT01918072|5685376|P3|NOT COMPLETED|Controlled Trial Step One - Six Months||0
2315111|NCT01918072|5685377|P2|NOT COMPLETED|Controlled Trial Step One - Six Months||0
2315112|NCT01918072|5685378|P1|NOT COMPLETED|Controlled Trial Step One - Six Months||0
2315113|NCT01918072|5685376|P3|COMPLETED|Controlled Trial Step One - Six Months||0
2315114|NCT01918072|5685377|P2|COMPLETED|Controlled Trial Step One - Six Months||0
2315115|NCT01918072|5685378|P1|COMPLETED|Controlled Trial Step One - Six Months||11
2315116|NCT01918072|5685376|P3|Control|Controlled Trial Step One - Six Months||0
2315117|NCT01918072|5685377|P2|Control|Controlled Trial Step One - Six Months||0
2315118|NCT01918072|5685378|P1|Control|Controlled Trial Step One - Six Months||10
2315119|NCT01918072|5685376|P3|Intervention|Controlled Trial Step One - Six Months||0
2315120|NCT01918072|5685377|P2|Intervention|Controlled Trial Step One - Six Months||0
2315121|NCT01918072|5685378|P1|Intervention|Controlled Trial Step One - Six Months||1
2315122|NCT01918072|5685376|P3|STARTED|Controlled Trial Step One - Six Months||0
2315123|NCT01918072|5685377|P2|STARTED|Controlled Trial Step One - Six Months||0
2315124|NCT01918072|5685378|P1|STARTED|Controlled Trial Step One - Six Months||11
2315125|NCT01918033|5685392|P3|NOT COMPLETED|Overall Study||3
2315126|NCT01918033|5685393|P2|NOT COMPLETED|Overall Study||2
2315127|NCT01918033|5685394|P1|NOT COMPLETED|Overall Study||5
2315128|NCT01918033|5685392|P3|COMPLETED|Overall Study||199
2315129|NCT01918033|5685393|P2|COMPLETED|Overall Study||201
2315130|NCT01918033|5685394|P1|COMPLETED|Overall Study||198
2315131|NCT01918033|5685392|P3|Treated|Overall Study|One randomized participant did not receive study drug.|201
2315132|NCT01918033|5685393|P2|Treated|Overall Study||203
2315133|NCT01918033|5685394|P1|Treated|Overall Study|One randomized participant did not receive study drug.|202
2315134|NCT01918033|5685392|P3|STARTED|Overall Study||202
2315135|NCT01918033|5685393|P2|STARTED|Overall Study||203
2315136|NCT01918033|5685394|P1|STARTED|Overall Study||203
2315137|NCT01917812|5685435|P3|NOT COMPLETED|Overall Study||0
2315138|NCT01917812|5685436|P2|NOT COMPLETED|Overall Study||0
2315139|NCT01917812|5685437|P1|NOT COMPLETED|Overall Study||1
2315140|NCT01917812|5685435|P3|COMPLETED|Overall Study||16
2315141|NCT01917812|5685436|P2|COMPLETED|Overall Study||16
2315142|NCT01917812|5685437|P1|COMPLETED|Overall Study||15
2315143|NCT01917812|5685435|P3|STARTED|Overall Study||16
2315144|NCT01917812|5685436|P2|STARTED|Overall Study||16
2315145|NCT01917812|5685437|P1|STARTED|Overall Study||16
2315146|NCT01917773|5685457|P1|NOT COMPLETED|Overall Study||0
2315147|NCT01917773|5685457|P1|COMPLETED|Overall Study||13
2315148|NCT01917773|5685457|P1|STARTED|Overall Study||13
2315149|NCT01917747|5685465|P2|NOT COMPLETED|Overall Study||0
2315150|NCT01917747|5685466|P1|NOT COMPLETED|Overall Study||1
2315151|NCT01917747|5685465|P2|COMPLETED|Overall Study||47
2315152|NCT01917747|5685466|P1|COMPLETED|Overall Study||58
2315153|NCT01917747|5685465|P2|STARTED|Overall Study||47
2315154|NCT01917747|5685466|P1|STARTED|Overall Study||59
2315155|NCT01917656|5685474|P2|NOT COMPLETED|Overall Study||24
2315156|NCT01917656|5685475|P1|NOT COMPLETED|Overall Study||26
2315157|NCT01917656|5685474|P2|COMPLETED|Overall Study||147
2315158|NCT01917656|5685475|P1|COMPLETED|Overall Study||146
2315159|NCT01917656|5685474|P2|Exposed During Ramadan (Fasting)|Overall Study||163
2315160|NCT01917656|5685475|P1|Exposed During Ramadan (Fasting)|Overall Study||152
2315161|NCT01917656|5685474|P2|Exposed|Overall Study|1 subject was withdrawn prior to exposure to first SU dose after randomisation|170
2315162|NCT01917656|5685475|P1|Exposed|Overall Study|1 subject was withdrawn prior to exposure to trial products|171
2315163|NCT01917656|5685474|P2|STARTED|Overall Study||171
2315164|NCT01917656|5685475|P1|STARTED|Overall Study||172
2315165|NCT01917526|5685501|P2|NOT COMPLETED|Overall Study||1
2315166|NCT01917526|5685502|P1|NOT COMPLETED|Overall Study||1
2315167|NCT01917526|5685501|P2|COMPLETED|Overall Study|1 patient in oxygen cannula group receive oxygen mask|249
2315168|NCT01917526|5685502|P1|COMPLETED|Overall Study|One patient in oxygen mask received oxygen cannula|249
2315169|NCT01917526|5685501|P2|STARTED|Overall Study||250
2315170|NCT01917526|5685502|P1|STARTED|Overall Study||250
2315171|NCT01917513|5685512|P2|NOT COMPLETED|Overall Study||102
2315172|NCT01917513|5685513|P1|NOT COMPLETED|Overall Study||95
2315173|NCT01917513|5685512|P2|COMPLETED|Overall Study||396
2315174|NCT01917513|5685513|P1|COMPLETED|Overall Study||407
2315175|NCT01917513|5685512|P2|STARTED|Overall Study||498
2315176|NCT01917513|5685513|P1|STARTED|Overall Study||502
2315177|NCT01917344|5685519|P1|NOT COMPLETED|Overall Study||1
2315178|NCT01917344|5685519|P1|COMPLETED|Overall Study||9
2315179|NCT01917344|5685519|P1|STARTED|Overall Study||10
2315180|NCT01917318|5685525|P2|NOT COMPLETED|Second Treatment||0
2315181|NCT01917318|5685526|P1|NOT COMPLETED|Second Treatment||0
2315182|NCT01917318|5685525|P2|COMPLETED|Second Treatment||0
2315183|NCT01917318|5685526|P1|COMPLETED|Second Treatment||0
2315184|NCT01917318|5685525|P2|STARTED|Second Treatment||0
2315185|NCT01917318|5685526|P1|STARTED|Second Treatment||0
2315186|NCT01917318|5685525|P2|NOT COMPLETED|First Treatment||1
2315187|NCT01917318|5685526|P1|NOT COMPLETED|First Treatment||0
2315188|NCT01917318|5685525|P2|COMPLETED|First Treatment||0
2315189|NCT01917318|5685526|P1|COMPLETED|First Treatment||0
2315190|NCT01917318|5685525|P2|STARTED|First Treatment||1
2315191|NCT01917318|5685526|P1|STARTED|First Treatment||0
2315192|NCT01917214|5685546|P1|NOT COMPLETED|Overall Study||0
2315193|NCT01917214|5685546|P1|COMPLETED|Overall Study||212
2315194|NCT01917214|5685546|P1|STARTED|Overall Study||212
2315195|NCT01917188|5685558|P3|NOT COMPLETED|Overall Study||9
2315196|NCT01917188|5685559|P2|NOT COMPLETED|Overall Study||6
2315197|NCT01917188|5685560|P1|NOT COMPLETED|Overall Study||12
2315198|NCT01917188|5685558|P3|COMPLETED|Overall Study||11
2315199|NCT01917188|5685559|P2|COMPLETED|Overall Study||17
2315200|NCT01917188|5685560|P1|COMPLETED|Overall Study||17
2315201|NCT01917188|5685558|P3|STARTED|Overall Study||20
2315202|NCT01917188|5685559|P2|STARTED|Overall Study||23
2315203|NCT01917188|5685560|P1|STARTED|Overall Study||29
2315204|NCT01917136|5685568|P1|NOT COMPLETED|Overall Study||0
2315205|NCT01917136|5685568|P1|COMPLETED|Overall Study||21
2315206|NCT01917136|5685568|P1|STARTED|Overall Study||21
2315207|NCT01917006|5685579|P8|NOT COMPLETED|Open-label Period||2
2315208|NCT01917006|5685580|P7|NOT COMPLETED|Open-label Period||0
2315209|NCT01917006|5685581|P6|NOT COMPLETED|Open-label Period||0
2315210|NCT01917006|5685582|P5|NOT COMPLETED|Open-label Period||0
2315211|NCT01917006|5685583|P4|NOT COMPLETED|Open-label Period||0
2315212|NCT01917006|5685584|P3|NOT COMPLETED|Open-label Period||0
2315213|NCT01917006|5685585|P2|NOT COMPLETED|Open-label Period||0
2315214|NCT01917006|5685586|P1|NOT COMPLETED|Open-label Period||0
2315215|NCT01917006|5685579|P8|COMPLETED|Open-label Period||6
2315216|NCT01917006|5685580|P7|COMPLETED|Open-label Period||0
2315217|NCT01917006|5685581|P6|COMPLETED|Open-label Period||0
2315218|NCT01917006|5685582|P5|COMPLETED|Open-label Period||0
2315219|NCT01917006|5685583|P4|COMPLETED|Open-label Period||0
2315220|NCT01917006|5685584|P3|COMPLETED|Open-label Period||0
2315221|NCT01917006|5685585|P2|COMPLETED|Open-label Period||0
2315222|NCT01917006|5685586|P1|COMPLETED|Open-label Period||0
2315223|NCT01917006|5685579|P8|STARTED|Open-label Period||8
2315224|NCT01917006|5685580|P7|STARTED|Open-label Period||0
2315225|NCT01917006|5685581|P6|STARTED|Open-label Period||0
2315226|NCT01917006|5685582|P5|STARTED|Open-label Period||0
2315227|NCT01917006|5685583|P4|STARTED|Open-label Period||0
2315228|NCT01917006|5685584|P3|STARTED|Open-label Period||0
2315229|NCT01917006|5685585|P2|STARTED|Open-label Period||0
2315230|NCT01917006|5685586|P1|STARTED|Open-label Period||0
2315231|NCT01917006|5685579|P8|NOT COMPLETED|Randomized-treatment Period||0
2315232|NCT01917006|5685580|P7|NOT COMPLETED|Randomized-treatment Period||1
2315233|NCT01917006|5685581|P6|NOT COMPLETED|Randomized-treatment Period||1
2315234|NCT01917006|5685582|P5|NOT COMPLETED|Randomized-treatment Period||0
2315235|NCT01917006|5685583|P4|NOT COMPLETED|Randomized-treatment Period||1
2315236|NCT01917006|5685584|P3|NOT COMPLETED|Randomized-treatment Period||0
2315237|NCT01917006|5685585|P2|NOT COMPLETED|Randomized-treatment Period||0
2315238|NCT01917006|5685586|P1|NOT COMPLETED|Randomized-treatment Period||2
2315239|NCT01917006|5685579|P8|COMPLETED|Randomized-treatment Period||0
2315240|NCT01917006|5685580|P7|COMPLETED|Randomized-treatment Period||14
2315241|NCT01917006|5685581|P6|COMPLETED|Randomized-treatment Period||7
2315242|NCT01917006|5685582|P5|COMPLETED|Randomized-treatment Period||8
2315243|NCT01917006|5685583|P4|COMPLETED|Randomized-treatment Period||7
2315244|NCT01917006|5685584|P3|COMPLETED|Randomized-treatment Period||8
2315245|NCT01917006|5685585|P2|COMPLETED|Randomized-treatment Period||7
2315246|NCT01917006|5685586|P1|COMPLETED|Randomized-treatment Period||3
2315247|NCT01917006|5685579|P8|STARTED|Randomized-treatment Period||0
2315248|NCT01917006|5685580|P7|STARTED|Randomized-treatment Period||15
2315249|NCT01917006|5685581|P6|STARTED|Randomized-treatment Period||8
2315250|NCT01917006|5685582|P5|STARTED|Randomized-treatment Period||8
2315251|NCT01917006|5685583|P4|STARTED|Randomized-treatment Period||8
2315252|NCT01917006|5685584|P3|STARTED|Randomized-treatment Period||8
2315253|NCT01917006|5685585|P2|STARTED|Randomized-treatment Period||7
2315254|NCT01917006|5685586|P1|STARTED|Randomized-treatment Period||5
2315255|NCT01916980|5685619|P2|NOT COMPLETED|Overall Study||4
2315256|NCT01916980|5685620|P1|NOT COMPLETED|Overall Study||7
2315257|NCT01916980|5685619|P2|COMPLETED|Overall Study||25
2315258|NCT01916980|5685620|P1|COMPLETED|Overall Study||58
2315260|NCT01916980|5685620|P1|STARTED|Overall Study||65
2315261|NCT01916967|5685639|P3|NOT COMPLETED|Overall Study||9
2315262|NCT01916967|5685640|P2|NOT COMPLETED|Overall Study||1
2315263|NCT01916967|5685641|P1|NOT COMPLETED|Overall Study||0
2315264|NCT01916967|5685639|P3|COMPLETED|Overall Study||71
2315265|NCT01916967|5685640|P2|COMPLETED|Overall Study||78
2315266|NCT01916967|5685641|P1|COMPLETED|Overall Study||80
2315267|NCT01916967|5685639|P3|STARTED|Overall Study||80
2315268|NCT01916967|5685640|P2|STARTED|Overall Study||79
2315269|NCT01916967|5685641|P1|STARTED|Overall Study||80
2315270|NCT01916941|5685684|P2|NOT COMPLETED|Overall Study||4
2315271|NCT01916941|5685685|P1|NOT COMPLETED|Overall Study||5
2315272|NCT01916941|5685684|P2|COMPLETED|Overall Study||14
2315273|NCT01916941|5685685|P1|COMPLETED|Overall Study||13
2315274|NCT01916941|5685684|P2|STARTED|Overall Study||18
2315275|NCT01916941|5685685|P1|STARTED|Overall Study||18
2315276|NCT01916928|5685691|P1|NOT COMPLETED|Overall Study||0
2315277|NCT01916928|5685691|P1|COMPLETED|Overall Study||50
2315278|NCT01916928|5685691|P1|STARTED|Overall Study||50
2315279|NCT01916824|5685697|P2|NOT COMPLETED|Overall Study||9
2315280|NCT01916824|5685698|P1|NOT COMPLETED|Overall Study||7
2315281|NCT01916824|5685697|P2|COMPLETED|Overall Study||20
2315282|NCT01916824|5685698|P1|COMPLETED|Overall Study||17
2315283|NCT01916824|5685697|P2|STARTED|Overall Study||29
2315284|NCT01916824|5685698|P1|STARTED|Overall Study||24
2315285|NCT01916681|5685708|P4|NOT COMPLETED|Overall Study||0
2315286|NCT01916681|5685709|P3|NOT COMPLETED|Overall Study||0
2315287|NCT01916681|5685710|P2|NOT COMPLETED|Overall Study||0
2315288|NCT01916681|5685711|P1|NOT COMPLETED|Overall Study||0
2315289|NCT01916681|5685708|P4|COMPLETED|Overall Study||125
2315290|NCT01916681|5685709|P3|COMPLETED|Overall Study||123
2315291|NCT01916681|5685710|P2|COMPLETED|Overall Study||120
2315292|NCT01916681|5685711|P1|COMPLETED|Overall Study||123
2315293|NCT01916681|5685708|P4|STARTED|Overall Study||125
2315294|NCT01916681|5685709|P3|STARTED|Overall Study||123
2315295|NCT01916681|5685710|P2|STARTED|Overall Study||120
2315296|NCT01916681|5685711|P1|STARTED|Overall Study||123
2315297|NCT01916655|5685752|P3|NOT COMPLETED|Overall Study||29
2315298|NCT01916655|5685753|P2|NOT COMPLETED|Overall Study||20
2315299|NCT01916655|5685754|P1|NOT COMPLETED|Overall Study||15
2315300|NCT01916655|5685752|P3|COMPLETED|Overall Study||91
2315301|NCT01916655|5685753|P2|COMPLETED|Overall Study||89
2315302|NCT01916655|5685754|P1|COMPLETED|Overall Study||116
2315303|NCT01916655|5685752|P3|STARTED|Overall Study||120
2315304|NCT01916655|5685753|P2|STARTED|Overall Study||109
2315305|NCT01916655|5685754|P1|STARTED|Overall Study||131
2315306|NCT01916629|5685764|P2|NOT COMPLETED|Overall Study||0
2315307|NCT01916629|5685765|P1|NOT COMPLETED|Overall Study||0
2315308|NCT01916629|5685764|P2|COMPLETED|Overall Study||5
2315309|NCT01916629|5685765|P1|COMPLETED|Overall Study||7
2315310|NCT01916629|5685764|P2|STARTED|Overall Study||5
2315311|NCT01916629|5685765|P1|STARTED|Overall Study||7
2315312|NCT01916590|5685773|P2|NOT COMPLETED|Overall Study||0
2315313|NCT01916590|5685774|P1|NOT COMPLETED|Overall Study||0
2315314|NCT01916590|5685773|P2|COMPLETED|Overall Study||3
2315315|NCT01916590|5685774|P1|COMPLETED|Overall Study||4
2315316|NCT01916590|5685773|P2|STARTED|Overall Study||3
2315317|NCT01916590|5685774|P1|STARTED|Overall Study||4
2315318|NCT01916304|5685780|P1|NOT COMPLETED|Overall Study||17
2315319|NCT01916304|5685780|P1|COMPLETED|Overall Study||84
2315320|NCT01916304|5685780|P1|Intent-to-Treat Set|Overall Study||84
2315321|NCT01916304|5685780|P1|Safety Set|Overall Study||101
2315322|NCT01916304|5685780|P1|STARTED|Overall Study||101
2315323|NCT01916226|5685792|P4|NOT COMPLETED|Overall Study||4
2315324|NCT01916226|5685793|P3|NOT COMPLETED|Overall Study||3
2315325|NCT01916226|5685794|P2|NOT COMPLETED|Overall Study||1
2315326|NCT01916226|5685795|P1|NOT COMPLETED|Overall Study||1
2315327|NCT01916226|5685792|P4|COMPLETED|Overall Study||167
2315328|NCT01916226|5685793|P3|COMPLETED|Overall Study||168
2315329|NCT01916226|5685794|P2|COMPLETED|Overall Study||169
2315330|NCT01916226|5685795|P1|COMPLETED|Overall Study||169
2315331|NCT01916226|5685792|P4|STARTED|Overall Study||171
2315332|NCT01916226|5685793|P3|STARTED|Overall Study||171
2315333|NCT01916226|5685794|P2|STARTED|Overall Study||170
2315334|NCT01916226|5685795|P1|STARTED|Overall Study||170
2315335|NCT01916109|5685829|P1|NOT COMPLETED|Overall Study||1
2315336|NCT01916109|5685829|P1|COMPLETED|Overall Study||3
2315337|NCT01916109|5685829|P1|STARTED|Overall Study||4
2315338|NCT01915940|5685835|P3|NOT COMPLETED|Treatment Period||4
2315339|NCT01915940|5685836|P2|NOT COMPLETED|Treatment Period||11
2315340|NCT01915940|5685837|P1|NOT COMPLETED|Treatment Period||0
2315341|NCT01915940|5685835|P3|COMPLETED|Treatment Period||62
2315342|NCT01915940|5685836|P2|COMPLETED|Treatment Period||53
2315343|NCT01915940|5685837|P1|COMPLETED|Treatment Period||0
2315344|NCT01915940|5685835|P3|STARTED|Treatment Period||66
2315345|NCT01915940|5685836|P2|STARTED|Treatment Period||64
2315346|NCT01915940|5685837|P1|STARTED|Treatment Period||0
2315347|NCT01915940|5685835|P3|NOT COMPLETED|Pre-randomization Washout Period||0
2315348|NCT01915940|5685836|P2|NOT COMPLETED|Pre-randomization Washout Period||0
2315349|NCT01915940|5685837|P1|NOT COMPLETED|Pre-randomization Washout Period||39
2315350|NCT01915940|5685835|P3|COMPLETED|Pre-randomization Washout Period||0
2315351|NCT01915940|5685836|P2|COMPLETED|Pre-randomization Washout Period||0
2315352|NCT01915940|5685837|P1|COMPLETED|Pre-randomization Washout Period||130
2315353|NCT01915940|5685835|P3|STARTED|Pre-randomization Washout Period||0
2315354|NCT01915940|5685836|P2|STARTED|Pre-randomization Washout Period||0
2315355|NCT01915940|5685837|P1|STARTED|Pre-randomization Washout Period||169
2315356|NCT01915914|5685853|P4|NOT COMPLETED|Follow-up Phase||2
2315357|NCT01915914|5685854|P3|NOT COMPLETED|Follow-up Phase||0
2315358|NCT01915914|5685855|P2|NOT COMPLETED|Follow-up Phase||0
2315359|NCT01915914|5685856|P1|NOT COMPLETED|Follow-up Phase||0
2315360|NCT01915914|5685853|P4|COMPLETED|Follow-up Phase||64
2315361|NCT01915914|5685854|P3|COMPLETED|Follow-up Phase||0
2315362|NCT01915914|5685855|P2|COMPLETED|Follow-up Phase||0
2315363|NCT01915914|5685856|P1|COMPLETED|Follow-up Phase||0
2315364|NCT01915914|5685853|P4|STARTED|Follow-up Phase||66
2315365|NCT01915914|5685854|P3|STARTED|Follow-up Phase||0
2315366|NCT01915914|5685855|P2|STARTED|Follow-up Phase||0
2315367|NCT01915914|5685856|P1|STARTED|Follow-up Phase||0
2315368|NCT01915914|5685853|P4|NOT COMPLETED|Maintenance Phase||0
2315369|NCT01915914|5685854|P3|NOT COMPLETED|Maintenance Phase||2
2315370|NCT01915914|5685855|P2|NOT COMPLETED|Maintenance Phase||6
2315371|NCT01915914|5685856|P1|NOT COMPLETED|Maintenance Phase||0
2315372|NCT01915914|5685853|P4|COMPLETED|Maintenance Phase||0
2315373|NCT01915914|5685854|P3|COMPLETED|Maintenance Phase||51
2315374|NCT01915914|5685855|P2|COMPLETED|Maintenance Phase||48
2315375|NCT01915914|5685856|P1|COMPLETED|Maintenance Phase||0
2315376|NCT01915914|5685853|P4|STARTED|Maintenance Phase||0
2315377|NCT01915914|5685854|P3|STARTED|Maintenance Phase||53
2315378|NCT01915914|5685855|P2|STARTED|Maintenance Phase||54
2315379|NCT01915914|5685856|P1|STARTED|Maintenance Phase||0
2315380|NCT01915914|5685853|P4|NOT COMPLETED|Acute Phase||0
2315381|NCT01915914|5685854|P3|NOT COMPLETED|Acute Phase||0
2315382|NCT01915914|5685855|P2|NOT COMPLETED|Acute Phase||0
2315383|NCT01915914|5685856|P1|NOT COMPLETED|Acute Phase||12
2315384|NCT01915914|5685853|P4|COMPLETED|Acute Phase||0
2315385|NCT01915914|5685854|P3|COMPLETED|Acute Phase||0
2315386|NCT01915914|5685855|P2|COMPLETED|Acute Phase||0
2315387|NCT01915914|5685856|P1|COMPLETED|Acute Phase||111
2315388|NCT01915914|5685853|P4|Completed–Not Entered Maintenance Phase|Acute Phase||0
2315389|NCT01915914|5685854|P3|Completed–Not Entered Maintenance Phase|Acute Phase||0
2315390|NCT01915914|5685855|P2|Completed–Not Entered Maintenance Phase|Acute Phase||0
2315391|NCT01915914|5685856|P1|Completed–Not Entered Maintenance Phase|Acute Phase||4
2315392|NCT01915914|5685853|P4|STARTED|Acute Phase||0
2315393|NCT01915914|5685854|P3|STARTED|Acute Phase||0
2315394|NCT01915914|5685855|P2|STARTED|Acute Phase||0
2315395|NCT01915914|5685856|P1|STARTED|Acute Phase||123
2315396|NCT01915849|5685888|P4|NOT COMPLETED|Treatment Period 4 (4 Days)||0
2315397|NCT01915849|5685889|P3|NOT COMPLETED|Treatment Period 4 (4 Days)||0
2315398|NCT01915849|5685890|P2|NOT COMPLETED|Treatment Period 4 (4 Days)||0
2315399|NCT01915849|5685891|P1|NOT COMPLETED|Treatment Period 4 (4 Days)||0
2315400|NCT01915849|5685888|P4|COMPLETED|Treatment Period 4 (4 Days)||3
2315401|NCT01915849|5685889|P3|COMPLETED|Treatment Period 4 (4 Days)||3
2315402|NCT01915849|5685890|P2|COMPLETED|Treatment Period 4 (4 Days)||3
2315403|NCT01915849|5685891|P1|COMPLETED|Treatment Period 4 (4 Days)||3
2315404|NCT01915849|5685888|P4|STARTED|Treatment Period 4 (4 Days)||3
2315405|NCT01915849|5685889|P3|STARTED|Treatment Period 4 (4 Days)||3
2315406|NCT01915849|5685890|P2|STARTED|Treatment Period 4 (4 Days)||3
2315407|NCT01915849|5685891|P1|STARTED|Treatment Period 4 (4 Days)||3
2315408|NCT01915849|5685888|P4|NOT COMPLETED|Treatment Period 3 (4 Days)||0
2315409|NCT01915849|5685889|P3|NOT COMPLETED|Treatment Period 3 (4 Days)||0
2315410|NCT01915849|5685890|P2|NOT COMPLETED|Treatment Period 3 (4 Days)||0
2315411|NCT01915849|5685891|P1|NOT COMPLETED|Treatment Period 3 (4 Days)||0
2315412|NCT01915849|5685888|P4|COMPLETED|Treatment Period 3 (4 Days)||3
2315413|NCT01915849|5685889|P3|COMPLETED|Treatment Period 3 (4 Days)||3
2315414|NCT01915849|5685890|P2|COMPLETED|Treatment Period 3 (4 Days)||3
2315415|NCT01915849|5685891|P1|COMPLETED|Treatment Period 3 (4 Days)||3
2315416|NCT01915849|5685888|P4|STARTED|Treatment Period 3 (4 Days)||3
2315417|NCT01915849|5685889|P3|STARTED|Treatment Period 3 (4 Days)||3
2315418|NCT01915849|5685890|P2|STARTED|Treatment Period 3 (4 Days)||3
2315419|NCT01915849|5685891|P1|STARTED|Treatment Period 3 (4 Days)||3
2315420|NCT01915849|5685888|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
2315421|NCT01915849|5685889|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
2315422|NCT01915849|5685890|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
2315423|NCT01915849|5685891|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
2315424|NCT01915849|5685888|P4|COMPLETED|Treatment Period 2 (4 Days)||3
2315425|NCT01915849|5685889|P3|COMPLETED|Treatment Period 2 (4 Days)||3
2315426|NCT01915849|5685890|P2|COMPLETED|Treatment Period 2 (4 Days)||3
2315427|NCT01915849|5685891|P1|COMPLETED|Treatment Period 2 (4 Days)||3
2315428|NCT01915849|5685888|P4|STARTED|Treatment Period 2 (4 Days)||3
2315429|NCT01915849|5685889|P3|STARTED|Treatment Period 2 (4 Days)||3
2315430|NCT01915849|5685890|P2|STARTED|Treatment Period 2 (4 Days)||3
2315431|NCT01915849|5685891|P1|STARTED|Treatment Period 2 (4 Days)||3
2315432|NCT01915849|5685888|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
2315433|NCT01915849|5685889|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
2315434|NCT01915849|5685890|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
2315435|NCT01915849|5685891|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||2
2315436|NCT01915849|5685888|P4|COMPLETED|Treatment Period 1 (4 Days)||3
2315437|NCT01915849|5685889|P3|COMPLETED|Treatment Period 1 (4 Days)||3
2315438|NCT01915849|5685890|P2|COMPLETED|Treatment Period 1 (4 Days)||3
2315439|NCT01915849|5685891|P1|COMPLETED|Treatment Period 1 (4 Days)||3
2315440|NCT01915849|5685888|P4|STARTED|Treatment Period 1 (4 Days)||3
2315441|NCT01915849|5685889|P3|STARTED|Treatment Period 1 (4 Days)||3
2315442|NCT01915849|5685890|P2|STARTED|Treatment Period 1 (4 Days)||3
2315443|NCT01915849|5685891|P1|STARTED|Treatment Period 1 (4 Days)||5
2315444|NCT01915823|5685903|P2|NOT COMPLETED|Overall Study||2
2315445|NCT01915823|5685904|P1|NOT COMPLETED|Overall Study||2
2315446|NCT01915823|5685903|P2|COMPLETED|Overall Study||173
2315447|NCT01915823|5685904|P1|COMPLETED|Overall Study||171
2315448|NCT01915823|5685903|P2|STARTED|Overall Study||175
2315449|NCT01915823|5685904|P1|STARTED|Overall Study||173
2315450|NCT01915732|5685916|P2|NOT COMPLETED|Overall Study||71
2315451|NCT01915732|5685917|P1|NOT COMPLETED|Overall Study||70
2315452|NCT01915732|5685916|P2|COMPLETED|Overall Study||445
2315453|NCT01915732|5685917|P1|COMPLETED|Overall Study||430
2315454|NCT01915732|5685916|P2|STARTED|Overall Study||516
2315455|NCT01915732|5685917|P1|STARTED|Overall Study||500
2315456|NCT01915563|5685943|P2|NOT COMPLETED|Overall Study||0
2315457|NCT01915563|5685944|P1|NOT COMPLETED|Overall Study||0
2315458|NCT01915563|5685943|P2|COMPLETED|Overall Study||227
2315459|NCT01915563|5685944|P1|COMPLETED|Overall Study||243
2315460|NCT01915563|5685943|P2|STARTED|Overall Study||227
2315461|NCT01915563|5685944|P1|STARTED|Overall Study||243
2315462|NCT01915173|5685956|P4|NOT COMPLETED|Overall Study||0
2315463|NCT01915173|5685957|P3|NOT COMPLETED|Overall Study||0
2315464|NCT01915173|5685958|P2|NOT COMPLETED|Overall Study||0
2315465|NCT01915173|5685959|P1|NOT COMPLETED|Overall Study||0
2315466|NCT01915173|5685956|P4|COMPLETED|Overall Study||6
2315467|NCT01915173|5685957|P3|COMPLETED|Overall Study||6
2315468|NCT01915173|5685958|P2|COMPLETED|Overall Study||6
2315469|NCT01915173|5685959|P1|COMPLETED|Overall Study||6
2315470|NCT01915173|5685956|P4|STARTED|Overall Study||6
2315471|NCT01915173|5685957|P3|STARTED|Overall Study||6
2315472|NCT01915173|5685958|P2|STARTED|Overall Study||6
2315473|NCT01915173|5685959|P1|STARTED|Overall Study||6
2315474|NCT01915108|5685981|P4|NOT COMPLETED|Overall Study||2
2315475|NCT01915108|5685982|P3|NOT COMPLETED|Overall Study||1
2315476|NCT01915108|5685983|P2|NOT COMPLETED|Overall Study||3
2315477|NCT01915108|5685984|P1|NOT COMPLETED|Overall Study||2
2315478|NCT01915108|5685981|P4|COMPLETED|Overall Study|two patients were excluded from the study|30
2315479|NCT01915108|5685982|P3|COMPLETED|Overall Study|one patients were excluded from the study|31
2315480|NCT01915108|5685983|P2|COMPLETED|Overall Study|three patients were excluded from the study|29
2315481|NCT01915108|5685984|P1|COMPLETED|Overall Study|two patients were excluded from the study|30
2315482|NCT01915108|5685981|P4|STARTED|Overall Study||32
2315483|NCT01915108|5685982|P3|STARTED|Overall Study||32
2315484|NCT01915108|5685983|P2|STARTED|Overall Study||32
2315485|NCT01915108|5685984|P1|STARTED|Overall Study||32
2315486|NCT01914926|5685996|P2|NOT COMPLETED|Overall Study||1
2315487|NCT01914926|5685997|P1|NOT COMPLETED|Overall Study||1
2315488|NCT01914926|5685996|P2|COMPLETED|Overall Study||24
2315489|NCT01914926|5685997|P1|COMPLETED|Overall Study||28
2315490|NCT01914926|5685996|P2|STARTED|Overall Study||25
2315491|NCT01914926|5685997|P1|STARTED|Overall Study||29
2315492|NCT01914757|5686006|P3|NOT COMPLETED|Overall Study||38
2315493|NCT01914757|5686007|P2|NOT COMPLETED|Overall Study||51
2315494|NCT01914757|5686008|P1|NOT COMPLETED|Overall Study||36
2315495|NCT01914757|5686006|P3|COMPLETED|Overall Study||402
2315496|NCT01914757|5686007|P2|COMPLETED|Overall Study||390
2315497|NCT01914757|5686008|P1|COMPLETED|Overall Study||389
2315498|NCT01914757|5686006|P3|STARTED|Overall Study||440
2315499|NCT01914757|5686007|P2|STARTED|Overall Study||441
2315500|NCT01914757|5686008|P1|STARTED|Overall Study||425
2315501|NCT01914679|5686082|P1|NOT COMPLETED|Overall Study||5
2315502|NCT01914679|5686082|P1|COMPLETED|Overall Study||12
2315503|NCT01914679|5686082|P1|Began 12 Week Actual RINCE Treatment|Overall Study||17
2315504|NCT01914679|5686082|P1|STARTED|Overall Study||17
2315505|NCT01914666|5686089|P3|NOT COMPLETED|Tapering Period||0
2315506|NCT01914666|5686090|P2|NOT COMPLETED|Tapering Period||0
2315507|NCT01914666|5686091|P1|NOT COMPLETED|Tapering Period||0
2315508|NCT01914666|5686089|P3|COMPLETED|Tapering Period||40
2315509|NCT01914666|5686090|P2|COMPLETED|Tapering Period||39
2315510|NCT01914666|5686091|P1|COMPLETED|Tapering Period||59
2315511|NCT01914666|5686089|P3|STARTED|Tapering Period|7 Pts who discontinued, and 33 Pts who completed Treatment Period entered Tapering Period.|40
2315512|NCT01914666|5686090|P2|STARTED|Tapering Period|3 Pts who discontinued, and 36 Pts who completed Treatment Period entered Tapering Period.|39
2315513|NCT01914666|5686091|P1|STARTED|Tapering Period|4 Pts who discontinued, and 55 Pts who completed Treatment Period entered Tapering Period.|59
2315514|NCT01914666|5686089|P3|NOT COMPLETED|Treatment Period||8
2315515|NCT01914666|5686090|P2|NOT COMPLETED|Treatment Period||6
2315516|NCT01914666|5686091|P1|NOT COMPLETED|Treatment Period||13
2315517|NCT01914666|5686089|P3|COMPLETED|Treatment Period||33
2315518|NCT01914666|5686090|P2|COMPLETED|Treatment Period||36
2315519|NCT01914666|5686091|P1|COMPLETED|Treatment Period||55
2315520|NCT01914666|5686089|P3|Received at Least 1 Dose of Study Drug|Treatment Period||41
2315521|NCT01914666|5686090|P2|Received at Least 1 Dose of Study Drug|Treatment Period||42
2315522|NCT01914666|5686091|P1|Received at Least 1 Dose of Study Drug|Treatment Period||68
2315523|NCT01914666|5686089|P3|STARTED|Treatment Period||41
2315524|NCT01914666|5686090|P2|STARTED|Treatment Period||42
2315525|NCT01914666|5686091|P1|STARTED|Treatment Period||68
2315526|NCT01914510|5686124|P1|NOT COMPLETED|Overall Study||2
2315527|NCT01914510|5686124|P1|COMPLETED|Overall Study||38
2315528|NCT01914510|5686124|P1|STARTED|Overall Study||40
2315529|NCT01914393|5686134|P3|NOT COMPLETED|Overall Study||138
2315530|NCT01914393|5686135|P2|NOT COMPLETED|Overall Study||71
2315531|NCT01914393|5686136|P1|NOT COMPLETED|Overall Study||115
2315532|NCT01914393|5686134|P3|COMPLETED|Overall Study||168
2315533|NCT01914393|5686135|P2|COMPLETED|Overall Study||54
2315534|NCT01914393|5686136|P1|COMPLETED|Overall Study||156
2315535|NCT01914393|5686134|P3|STARTED|Overall Study||306
2315536|NCT01914393|5686135|P2|STARTED|Overall Study||125
2315537|NCT01914393|5686136|P1|STARTED|Overall Study||271
2315538|NCT01914159|5686168|P1|NOT COMPLETED|Overall Study||3
2315539|NCT01914159|5686168|P1|COMPLETED|Overall Study||21
2315540|NCT01914159|5686168|P1|STARTED|Overall Study||24
2315541|NCT01914003|5686176|P2|NOT COMPLETED|Overall Study||12
2315542|NCT01914003|5686177|P1|NOT COMPLETED|Overall Study||8
2315543|NCT01914003|5686176|P2|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|14
2315544|NCT01914003|5686177|P1|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|19
2315545|NCT01914003|5686176|P2|STARTED|Overall Study||26
2315546|NCT01914003|5686177|P1|STARTED|Overall Study||27
2315547|NCT01913795|5686187|P4|NOT COMPLETED|Overall Study||1
2315548|NCT01913795|5686188|P3|NOT COMPLETED|Overall Study||0
2315549|NCT01913795|5686189|P2|NOT COMPLETED|Overall Study||3
2315550|NCT01913795|5686190|P1|NOT COMPLETED|Overall Study||0
2315551|NCT01913795|5686187|P4|COMPLETED|Overall Study||5
2315552|NCT01913795|5686188|P3|COMPLETED|Overall Study||9
2315553|NCT01913795|5686189|P2|COMPLETED|Overall Study||7
2315554|NCT01913795|5686190|P1|COMPLETED|Overall Study||4
2315555|NCT01913795|5686187|P4|STARTED|Overall Study||6
2315556|NCT01913795|5686188|P3|STARTED|Overall Study||9
2315557|NCT01913795|5686189|P2|STARTED|Overall Study||10
2315558|NCT01913795|5686190|P1|STARTED|Overall Study||4
2315559|NCT01913600|5686204|P1|NOT COMPLETED|Overall Study||1
2315560|NCT01913600|5686204|P1|COMPLETED|Overall Study||55
2315561|NCT01913600|5686204|P1|STARTED|Overall Study||56
2315562|NCT01913535|5686226|P5|NOT COMPLETED|Phase 2 (Days 3-5)||0
2315563|NCT01913535|5686227|P4|NOT COMPLETED|Phase 2 (Days 3-5)||0
2315564|NCT01913535|5686228|P3|NOT COMPLETED|Phase 2 (Days 3-5)||0
2315565|NCT01913535|5686229|P2|NOT COMPLETED|Phase 2 (Days 3-5)||0
2315566|NCT01913535|5686230|P1|NOT COMPLETED|Phase 2 (Days 3-5)||0
2315567|NCT01913535|5686226|P5|COMPLETED|Phase 2 (Days 3-5)||1
2315568|NCT01913535|5686227|P4|COMPLETED|Phase 2 (Days 3-5)||2
2315569|NCT01913535|5686228|P3|COMPLETED|Phase 2 (Days 3-5)||1
2315570|NCT01913535|5686229|P2|COMPLETED|Phase 2 (Days 3-5)||2
2315571|NCT01913535|5686230|P1|COMPLETED|Phase 2 (Days 3-5)||2
2315572|NCT01913535|5686226|P5|STARTED|Phase 2 (Days 3-5)||1
2315573|NCT01913535|5686227|P4|STARTED|Phase 2 (Days 3-5)||2
2315574|NCT01913535|5686228|P3|STARTED|Phase 2 (Days 3-5)||1
2315575|NCT01913535|5686229|P2|STARTED|Phase 2 (Days 3-5)||2
2315576|NCT01913535|5686230|P1|STARTED|Phase 2 (Days 3-5)||2
2315577|NCT01913535|5686226|P5|NOT COMPLETED|Phase 1 (Days 0-2)||0
2315578|NCT01913535|5686227|P4|NOT COMPLETED|Phase 1 (Days 0-2)||0
2315579|NCT01913535|5686228|P3|NOT COMPLETED|Phase 1 (Days 0-2)||0
2315580|NCT01913535|5686229|P2|NOT COMPLETED|Phase 1 (Days 0-2)||0
2315581|NCT01913535|5686230|P1|NOT COMPLETED|Phase 1 (Days 0-2)||0
2315582|NCT01913535|5686226|P5|COMPLETED|Phase 1 (Days 0-2)||1
2315583|NCT01913535|5686227|P4|COMPLETED|Phase 1 (Days 0-2)||2
2315584|NCT01913535|5686228|P3|COMPLETED|Phase 1 (Days 0-2)||1
2315585|NCT01913535|5686229|P2|COMPLETED|Phase 1 (Days 0-2)||2
2315586|NCT01913535|5686230|P1|COMPLETED|Phase 1 (Days 0-2)||2
2315587|NCT01913535|5686226|P5|STARTED|Phase 1 (Days 0-2)||1
2315588|NCT01913535|5686227|P4|STARTED|Phase 1 (Days 0-2)||2
2315589|NCT01913535|5686228|P3|STARTED|Phase 1 (Days 0-2)||1
2315590|NCT01913535|5686229|P2|STARTED|Phase 1 (Days 0-2)||2
2315591|NCT01913535|5686230|P1|STARTED|Phase 1 (Days 0-2)||2
2315592|NCT01913483|5686263|P2|NOT COMPLETED|Overall Study||22
2315593|NCT01913483|5686264|P1|NOT COMPLETED|Overall Study||21
2315594|NCT01913483|5686263|P2|COMPLETED|Overall Study||343
2315595|NCT01913483|5686264|P1|COMPLETED|Overall Study||346
2315596|NCT01913483|5686263|P2|Received at Least 1 Dose of Study Drug|Overall Study||321
2315597|NCT01913483|5686264|P1|Received at Least 1 Dose of Study Drug|Overall Study||335
2315598|NCT01913483|5686263|P2|STARTED|Overall Study||365
2315599|NCT01913483|5686264|P1|STARTED|Overall Study||367
2315600|NCT01913470|5686276|P2|NOT COMPLETED|Overall Study||3
2315601|NCT01913470|5686277|P1|NOT COMPLETED|Overall Study||0
2315602|NCT01913470|5686276|P2|COMPLETED|Overall Study||4
2315603|NCT01913470|5686277|P1|COMPLETED|Overall Study||5
2315604|NCT01913470|5686276|P2|STARTED|Overall Study||7
2315605|NCT01913470|5686277|P1|STARTED|Overall Study||5
2315606|NCT01913405|5686295|P1|NOT COMPLETED|Overall Study||2
2315607|NCT01913405|5686295|P1|COMPLETED|Overall Study||20
2315608|NCT01913405|5686295|P1|STARTED|Overall Study||22
2315609|NCT01913353|5686351|P2|NOT COMPLETED|Overall Study||15
2315610|NCT01913353|5686352|P1|NOT COMPLETED|Overall Study||32
2315611|NCT01913353|5686351|P2|COMPLETED|Overall Study||204
2315612|NCT01913353|5686352|P1|COMPLETED|Overall Study||189
2315613|NCT01913353|5686351|P2|STARTED|Overall Study||219
2315614|NCT01913353|5686352|P1|STARTED|Overall Study||221
2315615|NCT01913314|5686420|P1|NOT COMPLETED|Overall Study||0
2315616|NCT01913314|5686420|P1|COMPLETED|Overall Study||6
2315617|NCT01913314|5686420|P1|Received Study Drug|Overall Study||6
2315618|NCT01913314|5686420|P1|STARTED|Overall Study||6
2315619|NCT01913041|5686433|P1|NOT COMPLETED|Overall Study||39
2315620|NCT01913041|5686433|P1|COMPLETED|Overall Study||830
2315621|NCT01913041|5686433|P1|STARTED|Overall Study||869
2315622|NCT01912963|5686440|P3|NOT COMPLETED|Overall Study||7
2315623|NCT01912963|5686441|P2|NOT COMPLETED|Overall Study||19
2315624|NCT01912963|5686442|P1|NOT COMPLETED|Overall Study||6
2315625|NCT01912963|5686440|P3|COMPLETED|Overall Study||0
2315626|NCT01912963|5686441|P2|COMPLETED|Overall Study||0
2315627|NCT01912963|5686442|P1|COMPLETED|Overall Study||0
2315628|NCT01912963|5686440|P3|STARTED|Overall Study||7
2315629|NCT01912963|5686441|P2|STARTED|Overall Study||19
2315630|NCT01912963|5686442|P1|STARTED|Overall Study||6
2315631|NCT01912872|5686465|P4|NOT COMPLETED|Overall Study||12
2315632|NCT01912872|5686466|P3|NOT COMPLETED|Overall Study||10
2315633|NCT01912872|5686467|P2|NOT COMPLETED|Overall Study||4
2315634|NCT01912872|5686468|P1|NOT COMPLETED|Overall Study||5
2315635|NCT01912872|5686465|P4|COMPLETED|Overall Study||27
2315636|NCT01912872|5686466|P3|COMPLETED|Overall Study||30
2315637|NCT01912872|5686467|P2|COMPLETED|Overall Study||13
2315638|NCT01912872|5686468|P1|COMPLETED|Overall Study||11
2315639|NCT01912872|5686465|P4|Discontinued Treatment Prior to Month 12|Overall Study||11
2315640|NCT01912872|5686466|P3|Discontinued Treatment Prior to Month 12|Overall Study||10
2315641|NCT01912872|5686467|P2|Discontinued Treatment Prior to Month 12|Overall Study||4
2315642|NCT01912872|5686468|P1|Discontinued Treatment Prior to Month 12|Overall Study||5
2315643|NCT01912872|5686465|P4|Completed Study Treatment at Month 12|Overall Study||27
2315644|NCT01912872|5686466|P3|Completed Study Treatment at Month 12|Overall Study||30
2315645|NCT01912872|5686467|P2|Completed Study Treatment at Month 12|Overall Study||13
2315646|NCT01912872|5686468|P1|Completed Study Treatment at Month 12|Overall Study||11
2315647|NCT01912872|5686465|P4|STARTED|Overall Study||39
2315648|NCT01912872|5686466|P3|STARTED|Overall Study||40
2315649|NCT01912872|5686467|P2|STARTED|Overall Study||17
2315650|NCT01912872|5686468|P1|STARTED|Overall Study||16
2315651|NCT01912781|5686512|P2|NOT COMPLETED|Overall Study||0
2315652|NCT01912781|5686513|P1|NOT COMPLETED|Overall Study||2
2315653|NCT01912781|5686512|P2|COMPLETED|Overall Study||35
2315654|NCT01912781|5686513|P1|COMPLETED|Overall Study||69
2315655|NCT01912781|5686512|P2|STARTED|Overall Study||35
2315656|NCT01912781|5686513|P1|STARTED|Overall Study||71
2315657|NCT01912768|5686544|P2|NOT COMPLETED|Overall Study||4
2315658|NCT01912768|5686545|P1|NOT COMPLETED|Overall Study||10
2315659|NCT01912768|5686544|P2|COMPLETED|Overall Study||109
2315660|NCT01912768|5686545|P1|COMPLETED|Overall Study||229
2315661|NCT01912768|5686544|P2|STARTED|Overall Study||113
2315662|NCT01912768|5686545|P1|STARTED|Overall Study||239
2315663|NCT01912729|5686576|P2|NOT COMPLETED|Overall Study||1
2315664|NCT01912729|5686577|P1|NOT COMPLETED|Overall Study||0
2315665|NCT01912729|5686576|P2|COMPLETED|Overall Study||19
2315666|NCT01912729|5686577|P1|COMPLETED|Overall Study||20
2315667|NCT01912729|5686576|P2|STARTED|Overall Study||20
2315668|NCT01912729|5686577|P1|STARTED|Overall Study||20
2315669|NCT01912716|5686589|P2|NOT COMPLETED|Overall Study||0
2315670|NCT01912716|5686590|P1|NOT COMPLETED|Overall Study||0
2315671|NCT01912716|5686589|P2|COMPLETED|Overall Study||515
2315672|NCT01912716|5686590|P1|COMPLETED|Overall Study||522
2315673|NCT01912716|5686589|P2|3-day Follow-up|Overall Study||513
2315674|NCT01912716|5686590|P1|3-day Follow-up|Overall Study||521
2315675|NCT01912716|5686589|P2|5-day Follow-up|Overall Study||515
2315676|NCT01912716|5686590|P1|5-day Follow-up|Overall Study||522
2315677|NCT01912716|5686589|P2|Receipt of 2nd Dose|Overall Study||503
2315678|NCT01912716|5686590|P1|Receipt of 2nd Dose|Overall Study||511
2315679|NCT01912716|5686589|P2|STARTED|Overall Study||515
2315680|NCT01912716|5686590|P1|STARTED|Overall Study|receipt of 1st dose of indomethacin|522
2315681|NCT01912599|5686600|P2|NOT COMPLETED|Overall Study||1
2315682|NCT01912599|5686601|P1|NOT COMPLETED|Overall Study||0
2315683|NCT01912599|5686600|P2|COMPLETED|Overall Study||15
2315684|NCT01912599|5686601|P1|COMPLETED|Overall Study||20
2315685|NCT01912599|5686600|P2|STARTED|Overall Study||16
2315686|NCT01912599|5686601|P1|STARTED|Overall Study||20
2315687|NCT01912495|5686615|P1|NOT COMPLETED|Overall Study||0
2315688|NCT01912495|5686615|P1|COMPLETED|Overall Study||57
2315689|NCT01912495|5686615|P1|STARTED|Overall Study|8 patients had only screening visit, total enrollment: 65|57
2315690|NCT01912404|5686626|P2|NOT COMPLETED|Overall Study||0
2315691|NCT01912404|5686627|P1|NOT COMPLETED|Overall Study||1
2315692|NCT01912404|5686626|P2|COMPLETED|Overall Study||2
2315693|NCT01912404|5686627|P1|COMPLETED|Overall Study||2
2315694|NCT01912404|5686626|P2|STARTED|Overall Study||2
2315695|NCT01912404|5686627|P1|STARTED|Overall Study||3
2315696|NCT01912352|5686633|P1|NOT COMPLETED|Overall Study||5
2315697|NCT01912352|5686633|P1|COMPLETED|Overall Study||78
2315698|NCT01912352|5686633|P1|STARTED|Overall Study||83
2315726|NCT01912222|5686659|P3|NOT COMPLETED|Part B: Treatment Period||20
2315727|NCT01912222|5686660|P2|NOT COMPLETED|Part B: Treatment Period||15
2315728|NCT01912222|5686661|P1|NOT COMPLETED|Part B: Treatment Period||13
2315729|NCT01912222|5686659|P3|COMPLETED|Part B: Treatment Period||0
2315730|NCT01912222|5686660|P2|COMPLETED|Part B: Treatment Period||0
2315731|NCT01912222|5686661|P1|COMPLETED|Part B: Treatment Period||0
2315732|NCT01912222|5686659|P3|STARTED|Part B: Treatment Period||20
2315733|NCT01912222|5686660|P2|STARTED|Part B: Treatment Period||15
2315734|NCT01912222|5686661|P1|STARTED|Part B: Treatment Period||13
2315735|NCT01912222|5686659|P3|NOT COMPLETED|Part A: Pharmacokinetic Period||2
2315736|NCT01912222|5686660|P2|NOT COMPLETED|Part A: Pharmacokinetic Period||2
2315737|NCT01912222|5686661|P1|NOT COMPLETED|Part A: Pharmacokinetic Period||1
2315738|NCT01912222|5686659|P3|COMPLETED|Part A: Pharmacokinetic Period||18
2315739|NCT01912222|5686660|P2|COMPLETED|Part A: Pharmacokinetic Period||13
2315740|NCT01912222|5686661|P1|COMPLETED|Part A: Pharmacokinetic Period||12
2315741|NCT01912222|5686659|P3|STARTED|Part A: Pharmacokinetic Period||20
2315742|NCT01912222|5686660|P2|STARTED|Part A: Pharmacokinetic Period||15
2315743|NCT01912222|5686661|P1|STARTED|Part A: Pharmacokinetic Period||13
2315744|NCT01911845|5686684|P1|NOT COMPLETED|Overall Study||6
2315745|NCT01911845|5686684|P1|COMPLETED|Overall Study||32
2315746|NCT01911845|5686684|P1|Completed Study Drug|Overall Study||37
2315747|NCT01911845|5686684|P1|STARTED|Overall Study||38
2315748|NCT01911819|5686701|P3|NOT COMPLETED|Overall Study||0
2315749|NCT01911819|5686702|P2|NOT COMPLETED|Overall Study||2
2315750|NCT01911819|5686703|P1|NOT COMPLETED|Overall Study||1
2315751|NCT01911819|5686701|P3|COMPLETED|Overall Study||10
2315752|NCT01911819|5686702|P2|COMPLETED|Overall Study||9
2315753|NCT01911819|5686703|P1|COMPLETED|Overall Study||9
2315754|NCT01911819|5686701|P3|STARTED|Overall Study||10
2315755|NCT01911819|5686702|P2|STARTED|Overall Study|One of 10 sinuses was replaced to another sinus due to infection.|11
2315756|NCT01911819|5686703|P1|STARTED|Overall Study||10
2315757|NCT01911793|5686716|P2|NOT COMPLETED|Overall Study||5
2315758|NCT01911793|5686717|P1|NOT COMPLETED|Overall Study||1
2315759|NCT01911793|5686716|P2|COMPLETED|Overall Study||0
2315760|NCT01911793|5686717|P1|COMPLETED|Overall Study||0
2315761|NCT01911793|5686716|P2|STARTED|Overall Study||5
2315762|NCT01911793|5686717|P1|STARTED|Overall Study||1
2315763|NCT01911780|5686741|P2|NOT COMPLETED|Extension Period (52 Weeks)||3
2315764|NCT01911780|5686742|P1|NOT COMPLETED|Extension Period (52 Weeks)||4
2315765|NCT01911780|5686741|P2|COMPLETED|Extension Period (52 Weeks)||58
2315766|NCT01911780|5686742|P1|COMPLETED|Extension Period (52 Weeks)||61
2315767|NCT01911780|5686741|P2|STARTED|Extension Period (52 Weeks)||61
2315768|NCT01911780|5686742|P1|STARTED|Extension Period (52 Weeks)||65
2315769|NCT01911780|5686741|P2|NOT COMPLETED|Double-blind Period (8 Weeks)||3
2315770|NCT01911780|5686742|P1|NOT COMPLETED|Double-blind Period (8 Weeks)||3
2315771|NCT01911780|5686741|P2|COMPLETED|Double-blind Period (8 Weeks)||61
2315772|NCT01911780|5686742|P1|COMPLETED|Double-blind Period (8 Weeks)||65
2315773|NCT01911780|5686741|P2|STARTED|Double-blind Period (8 Weeks)||64
2315774|NCT01911780|5686742|P1|STARTED|Double-blind Period (8 Weeks)||68
2315775|NCT01911689|5686762|P2|NOT COMPLETED|Overall Study||0
2315776|NCT01911689|5686763|P1|NOT COMPLETED|Overall Study||0
2315777|NCT01911689|5686762|P2|COMPLETED|Overall Study||51
2315778|NCT01911689|5686763|P1|COMPLETED|Overall Study||117
2315779|NCT01911689|5686762|P2|STARTED|Overall Study||51
2315780|NCT01911689|5686763|P1|STARTED|Overall Study||117
2315781|NCT01911546|5686776|P1|NOT COMPLETED|Overall Study||6
2315782|NCT01911546|5686776|P1|COMPLETED|Overall Study||14
2315783|NCT01911546|5686776|P1|STARTED|Overall Study||20
2315784|NCT01911442|5686786|P3|NOT COMPLETED|Overall Study||12
2315785|NCT01911442|5686787|P2|NOT COMPLETED|Overall Study||4
2315786|NCT01911442|5686788|P1|NOT COMPLETED|Overall Study||6
2315787|NCT01911442|5686786|P3|COMPLETED|Overall Study||38
2315788|NCT01911442|5686787|P2|COMPLETED|Overall Study||47
2315789|NCT01911442|5686788|P1|COMPLETED|Overall Study||43
2315790|NCT01911442|5686786|P3|STARTED|Overall Study||50
2315791|NCT01911442|5686787|P2|STARTED|Overall Study||51
2315792|NCT01911442|5686788|P1|STARTED|Overall Study||49
2315793|NCT01911429|5686817|P3|NOT COMPLETED|Overall Study||20
2315794|NCT01911429|5686818|P2|NOT COMPLETED|Overall Study||10
2315795|NCT01911429|5686819|P1|NOT COMPLETED|Overall Study||12
2315796|NCT01911429|5686817|P3|COMPLETED|Overall Study||93
2315797|NCT01911429|5686818|P2|COMPLETED|Overall Study||96
2315798|NCT01911429|5686819|P1|COMPLETED|Overall Study||96
2315799|NCT01911429|5686817|P3|STARTED|Overall Study|one subject randomized to Placebo group was never dosed for study medication, making the total 112|113
2315800|NCT01911429|5686818|P2|STARTED|Overall Study|Subjects received lurasidone 40/mg day from Days 1-3, and 80mg/day from days 4 to Week 6 visit|106
2315801|NCT01911429|5686819|P1|STARTED|Overall Study||108
2315802|NCT01911403|5686853|P2|NOT COMPLETED|Overall Study||3
2315803|NCT01911403|5686854|P1|NOT COMPLETED|Overall Study||9
2315804|NCT01911403|5686853|P2|COMPLETED|Overall Study||59
2315805|NCT01911403|5686854|P1|COMPLETED|Overall Study||52
2315806|NCT01911403|5686853|P2|STARTED|Overall Study||62
2315807|NCT01911403|5686854|P1|STARTED|Overall Study||61
2315808|NCT01911390|5686875|P4|NOT COMPLETED|Overall Study||1
2315809|NCT01911390|5686876|P3|NOT COMPLETED|Overall Study||1
2315810|NCT01911390|5686877|P2|NOT COMPLETED|Overall Study||0
2315811|NCT01911390|5686878|P1|NOT COMPLETED|Overall Study||1
2315812|NCT01911390|5686875|P4|COMPLETED|Overall Study||10
2315813|NCT01911390|5686876|P3|COMPLETED|Overall Study||9
2315814|NCT01911390|5686877|P2|COMPLETED|Overall Study||10
2315815|NCT01911390|5686878|P1|COMPLETED|Overall Study||9
2315816|NCT01911390|5686875|P4|STARTED|Overall Study||11
2315817|NCT01911390|5686876|P3|STARTED|Overall Study||10
2315818|NCT01911390|5686877|P2|STARTED|Overall Study||10
2315819|NCT01911390|5686878|P1|STARTED|Overall Study||10
2315820|NCT01911351|5686894|P2|NOT COMPLETED|Overall Study||0
2315821|NCT01911351|5686895|P1|NOT COMPLETED|Overall Study||0
2315822|NCT01911351|5686894|P2|COMPLETED|Overall Study||43
2315823|NCT01911351|5686895|P1|COMPLETED|Overall Study||39
2315824|NCT01911351|5686894|P2|STARTED|Overall Study||43
2315825|NCT01911351|5686895|P1|STARTED|Overall Study||39
2315826|NCT01911273|5686911|P2|NOT COMPLETED|Overall Study||2
2315827|NCT01911273|5686912|P1|NOT COMPLETED|Overall Study||1
2315828|NCT01911273|5686911|P2|COMPLETED|Overall Study||0
2315829|NCT01911273|5686912|P1|COMPLETED|Overall Study||0
2315830|NCT01911273|5686911|P2|STARTED|Overall Study||2
2315831|NCT01911273|5686912|P1|STARTED|Overall Study||1
2315832|NCT01911260|5686946|P4|NOT COMPLETED|Follow-up Period||12
2315833|NCT01911260|5686947|P3|NOT COMPLETED|Follow-up Period||15
2315834|NCT01911260|5686948|P2|NOT COMPLETED|Follow-up Period||20
2315835|NCT01911260|5686949|P1|NOT COMPLETED|Follow-up Period||13
2315836|NCT01911260|5686946|P4|COMPLETED|Follow-up Period||30
2315837|NCT01911260|5686947|P3|COMPLETED|Follow-up Period||24
2315838|NCT01911260|5686948|P2|COMPLETED|Follow-up Period||18
2315839|NCT01911260|5686949|P1|COMPLETED|Follow-up Period||27
2315840|NCT01911260|5686946|P4|STARTED|Follow-up Period||42
2315841|NCT01911260|5686947|P3|STARTED|Follow-up Period||39
2315842|NCT01911260|5686948|P2|STARTED|Follow-up Period||38
2315843|NCT01911260|5686949|P1|STARTED|Follow-up Period||40
2315844|NCT01911260|5686946|P4|NOT COMPLETED|Supplementation Period||8
2315845|NCT01911260|5686947|P3|NOT COMPLETED|Supplementation Period||10
2315846|NCT01911260|5686948|P2|NOT COMPLETED|Supplementation Period||12
2315847|NCT01911260|5686949|P1|NOT COMPLETED|Supplementation Period||10
2315848|NCT01911260|5686946|P4|COMPLETED|Supplementation Period||42
2315849|NCT01911260|5686947|P3|COMPLETED|Supplementation Period||39
2315850|NCT01911260|5686948|P2|COMPLETED|Supplementation Period||38
2315851|NCT01911260|5686949|P1|COMPLETED|Supplementation Period||40
2315852|NCT01911260|5686946|P4|STARTED|Supplementation Period||50
2315853|NCT01911260|5686947|P3|STARTED|Supplementation Period||49
2315854|NCT01911260|5686948|P2|STARTED|Supplementation Period||50
2315855|NCT01911260|5686949|P1|STARTED|Supplementation Period||50
2315856|NCT01911221|5686959|P1|NOT COMPLETED|Overall Study||0
2315857|NCT01911221|5686959|P1|COMPLETED|Overall Study||13
2315858|NCT01911221|5686959|P1|STARTED|Overall Study||13
2315859|NCT01911169|5686975|P2|NOT COMPLETED|Overall Study||0
2315860|NCT01911169|5686976|P1|NOT COMPLETED|Overall Study||0
2315861|NCT01911169|5686975|P2|COMPLETED|Overall Study||3
2315862|NCT01911169|5686976|P1|COMPLETED|Overall Study||6
2315863|NCT01911169|5686975|P2|STARTED|Overall Study||3
2315864|NCT01911169|5686976|P1|STARTED|Overall Study||6
2315865|NCT01911065|5686986|P2|NOT COMPLETED|Overall Study||0
2315866|NCT01911065|5686987|P1|NOT COMPLETED|Overall Study||0
2315867|NCT01911065|5686986|P2|COMPLETED|Overall Study||9
2315868|NCT01911065|5686987|P1|COMPLETED|Overall Study||45
2315869|NCT01911065|5686986|P2|STARTED|Overall Study||9
2315870|NCT01911065|5686987|P1|STARTED|Overall Study||45
2315871|NCT01910831|5686995|P1|NOT COMPLETED|Overall Study||1
2315872|NCT01910831|5686995|P1|COMPLETED|Overall Study||19
2315873|NCT01910831|5686995|P1|STARTED|Overall Study||20
2315874|NCT01910792|5687004|P2|NOT COMPLETED|Overall Study||0
2315875|NCT01910792|5687005|P1|NOT COMPLETED|Overall Study||0
2315876|NCT01910792|5687004|P2|COMPLETED|Overall Study||10
2315877|NCT01910792|5687005|P1|COMPLETED|Overall Study||9
2315878|NCT01910792|5687004|P2|STARTED|Overall Study||10
2315879|NCT01910792|5687005|P1|STARTED|Overall Study||9
2315880|NCT01910688|5687011|P1|NOT COMPLETED|Overall Study||5
2315881|NCT01910688|5687011|P1|COMPLETED|Overall Study||20
2315882|NCT01910688|5687011|P1|12months|Overall Study||22
2315883|NCT01910688|5687011|P1|3rd RFA Treatment|Overall Study||18
2315884|NCT01910688|5687011|P1|7.5months|Overall Study||24
2315885|NCT01910688|5687011|P1|2nd RFA Treatment|Overall Study||22
2315886|NCT01910688|5687011|P1|3.5month|Overall Study||25
2315887|NCT01910688|5687011|P1|STARTED|Overall Study||25
2315888|NCT01910636|5687020|P2|NOT COMPLETED|Overall Study||0
2315889|NCT01910636|5687021|P1|NOT COMPLETED|Overall Study||0
2315890|NCT01910636|5687020|P2|COMPLETED|Overall Study||63
2315891|NCT01910636|5687021|P1|COMPLETED|Overall Study||90
2315892|NCT01910636|5687020|P2|STARTED|Overall Study||63
2315893|NCT01910636|5687021|P1|STARTED|Overall Study||90
2315894|NCT01910519|5687035|P2|NOT COMPLETED|Overall Study||0
2315895|NCT01910519|5687036|P1|NOT COMPLETED|Overall Study||4
2315896|NCT01910519|5687035|P2|COMPLETED|Overall Study||15
2315897|NCT01910519|5687036|P1|COMPLETED|Overall Study||31
2315898|NCT01910519|5687035|P2|STARTED|Overall Study||15
2315899|NCT01910519|5687036|P1|STARTED|Overall Study||35
2315900|NCT01910441|5687062|P2|NOT COMPLETED|Overall Study||10
2315901|NCT01910441|5687063|P1|NOT COMPLETED|Overall Study||7
2315902|NCT01910441|5687062|P2|COMPLETED|Overall Study||37
2315903|NCT01910441|5687063|P1|COMPLETED|Overall Study||41
2315904|NCT01910441|5687062|P2|STARTED|Overall Study||47
2315905|NCT01910441|5687063|P1|STARTED|Overall Study||48
2315906|NCT01910402|5687071|P2|NOT COMPLETED|Continuation Phase||0
2315907|NCT01910402|5687072|P1|NOT COMPLETED|Continuation Phase||90
2315908|NCT01910402|5687071|P2|COMPLETED|Continuation Phase||0
2315909|NCT01910402|5687072|P1|COMPLETED|Continuation Phase||30
2315910|NCT01910402|5687071|P2|STARTED|Continuation Phase||0
2315911|NCT01910402|5687072|P1|STARTED|Continuation Phase||120
2315912|NCT01910402|5687071|P2|NOT COMPLETED|Randomized Phase||55
2315913|NCT01910402|5687072|P1|NOT COMPLETED|Randomized Phase||42
2315914|NCT01910402|5687071|P2|COMPLETED|Randomized Phase||192
2315915|NCT01910402|5687072|P1|COMPLETED|Randomized Phase||206
2315916|NCT01910402|5687071|P2|STARTED|Randomized Phase||247
2315917|NCT01910402|5687072|P1|STARTED|Randomized Phase||248
2315918|NCT01910389|5687142|P2|NOT COMPLETED|Overall Study||8
2315919|NCT01910389|5687143|P1|NOT COMPLETED|Overall Study||15
2315920|NCT01910389|5687142|P2|COMPLETED|Overall Study||0
2315921|NCT01910389|5687143|P1|COMPLETED|Overall Study||0
2315922|NCT01910389|5687142|P2|STARTED|Overall Study||8
2315923|NCT01910389|5687143|P1|STARTED|Overall Study||15
2315924|NCT01910311|5687173|P1|NOT COMPLETED|Period 2 (Days 3-32)||0
2315925|NCT01910311|5687173|P1|COMPLETED|Period 2 (Days 3-32)||18
2315926|NCT01910311|5687173|P1|Received At Least 1 Dose of Rifampicin|Period 2 (Days 3-32)||18
2315927|NCT01910311|5687173|P1|Received Baricitinib|Period 2 (Days 3-32)||18
2315928|NCT01910311|5687173|P1|STARTED|Period 2 (Days 3-32)||18
2315929|NCT01910311|5687173|P1|NOT COMPLETED|Period 1 (Days 1-2)||0
2315930|NCT01910311|5687173|P1|COMPLETED|Period 1 (Days 1-2)||18
2315931|NCT01910311|5687173|P1|Received Baricitinib|Period 1 (Days 1-2)||18
2315932|NCT01910311|5687173|P1|STARTED|Period 1 (Days 1-2)||18
2315933|NCT01910298|5687186|P2|NOT COMPLETED|Overall Study||32
2315934|NCT01910298|5687187|P1|NOT COMPLETED|Overall Study||5
2315935|NCT01910298|5687186|P2|COMPLETED|Overall Study||23
2315936|NCT01910298|5687187|P1|COMPLETED|Overall Study||71
2315937|NCT01910298|5687186|P2|Safety Set|Overall Study|4 participants did not have first surgery date and were not included in Safety Set.|51
2315938|NCT01910298|5687187|P1|Safety Set|Overall Study||76
2315939|NCT01910298|5687186|P2|STARTED|Overall Study||55
2315940|NCT01910298|5687187|P1|STARTED|Overall Study||76
2315941|NCT01910181|5687205|P1|NOT COMPLETED|Overall Study||46
2315942|NCT01910181|5687205|P1|COMPLETED|Overall Study||0
2315943|NCT01910181|5687205|P1|Expansion Cohort|Overall Study||26
2315944|NCT01910181|5687205|P1|PK Cohort|Overall Study||20
2315945|NCT01910181|5687205|P1|STARTED|Overall Study||46
2315946|NCT01910129|5687232|P3|NOT COMPLETED|Randomized Phase 3||0
2315947|NCT01910129|5687233|P2|NOT COMPLETED|Randomized Phase 3||1
2315948|NCT01910129|5687234|P1|NOT COMPLETED|Randomized Phase 3||0
2315949|NCT01910129|5687232|P3|COMPLETED|Randomized Phase 3||0
2315950|NCT01910129|5687233|P2|COMPLETED|Randomized Phase 3||4
2315951|NCT01910129|5687234|P1|COMPLETED|Randomized Phase 3||5
2315952|NCT01910129|5687232|P3|STARTED|Randomized Phase 3||0
2315953|NCT01910129|5687233|P2|STARTED|Randomized Phase 3||5
2315954|NCT01910129|5687234|P1|STARTED|Randomized Phase 3||5
2315955|NCT01910129|5687232|P3|NOT COMPLETED|Randomized Phase 2||0
2315956|NCT01910129|5687233|P2|NOT COMPLETED|Randomized Phase 2||1
2315957|NCT01910129|5687234|P1|NOT COMPLETED|Randomized Phase 2||2
2315958|NCT01910129|5687232|P3|COMPLETED|Randomized Phase 2||0
2315959|NCT01910129|5687233|P2|COMPLETED|Randomized Phase 2||5
2315960|NCT01910129|5687234|P1|COMPLETED|Randomized Phase 2||5
2315961|NCT01910129|5687232|P3|STARTED|Randomized Phase 2||0
2315962|NCT01910129|5687233|P2|STARTED|Randomized Phase 2||6
2315963|NCT01910129|5687234|P1|STARTED|Randomized Phase 2||7
2315964|NCT01910129|5687232|P3|NOT COMPLETED|Run-in Period Phase 1||0
2315965|NCT01910129|5687233|P2|NOT COMPLETED|Run-in Period Phase 1||0
2315966|NCT01910129|5687234|P1|NOT COMPLETED|Run-in Period Phase 1||0
2315967|NCT01910129|5687232|P3|COMPLETED|Run-in Period Phase 1||13
2315968|NCT01910129|5687233|P2|COMPLETED|Run-in Period Phase 1||0
2315969|NCT01910129|5687234|P1|COMPLETED|Run-in Period Phase 1||0
2315970|NCT01910129|5687232|P3|STARTED|Run-in Period Phase 1||13
2315971|NCT01910129|5687233|P2|STARTED|Run-in Period Phase 1||0
2315972|NCT01910129|5687234|P1|STARTED|Run-in Period Phase 1||0
2315973|NCT01910116|5687258|P2|NOT COMPLETED|Overall Study||16
2315974|NCT01910116|5687259|P1|NOT COMPLETED|Overall Study||14
2315975|NCT01910116|5687258|P2|COMPLETED|Overall Study||94
2315976|NCT01910116|5687259|P1|COMPLETED|Overall Study||96
2315977|NCT01910116|5687258|P2|Week 16|Overall Study||94
2315978|NCT01910116|5687259|P1|Week 16|Overall Study||96
2315979|NCT01910116|5687258|P2|Week 12|Overall Study||96
2315980|NCT01910116|5687259|P1|Week 12|Overall Study||97
2315981|NCT01910116|5687258|P2|Week 8|Overall Study||99
2315982|NCT01910116|5687259|P1|Week 8|Overall Study||98
2315983|NCT01910116|5687258|P2|Week 4|Overall Study||102
2315984|NCT01910116|5687259|P1|Week 4|Overall Study||106
2315985|NCT01910116|5687258|P2|STARTED|Overall Study||110
2315986|NCT01910116|5687259|P1|STARTED|Overall Study||110
2315987|NCT01910064|5687335|P1|NOT COMPLETED|Overall Study||45
2315988|NCT01910064|5687335|P1|COMPLETED|Overall Study||391
2315989|NCT01910064|5687335|P1|STARTED|Overall Study||436
2315990|NCT01909973|5687346|P2|NOT COMPLETED|Overall Study||0
2315991|NCT01909973|5687347|P1|NOT COMPLETED|Overall Study||1
2315992|NCT01909973|5687346|P2|COMPLETED|Overall Study||7
2315993|NCT01909973|5687347|P1|COMPLETED|Overall Study||7
2315994|NCT01909973|5687346|P2|STARTED|Overall Study||7
2315995|NCT01909973|5687347|P1|STARTED|Overall Study||8
2315996|NCT01909804|5687367|P12|NOT COMPLETED|Overall Study||3
2315997|NCT01909804|5687368|P11|NOT COMPLETED|Overall Study||1
2315998|NCT01909804|5687369|P10|NOT COMPLETED|Overall Study||1
2315999|NCT01909804|5687370|P9|NOT COMPLETED|Overall Study||0
2316000|NCT01909804|5687371|P8|NOT COMPLETED|Overall Study||1
2316001|NCT01909804|5687372|P7|NOT COMPLETED|Overall Study||2
2316002|NCT01909804|5687373|P6|NOT COMPLETED|Overall Study||4
2316003|NCT01909804|5687374|P5|NOT COMPLETED|Overall Study||8
2316004|NCT01909804|5687375|P4|NOT COMPLETED|Overall Study||0
2316005|NCT01909804|5687376|P3|NOT COMPLETED|Overall Study||0
2316006|NCT01909804|5687377|P2|NOT COMPLETED|Overall Study||1
2316007|NCT01909804|5687378|P1|NOT COMPLETED|Overall Study||4
2316008|NCT01909804|5687367|P12|COMPLETED|Overall Study||26
2316009|NCT01909804|5687368|P11|COMPLETED|Overall Study||26
2316010|NCT01909804|5687369|P10|COMPLETED|Overall Study||28
2316011|NCT01909804|5687370|P9|COMPLETED|Overall Study||27
2316012|NCT01909804|5687371|P8|COMPLETED|Overall Study||25
2316013|NCT01909804|5687372|P7|COMPLETED|Overall Study||25
2316014|NCT01909804|5687373|P6|COMPLETED|Overall Study||21
2316015|NCT01909804|5687374|P5|COMPLETED|Overall Study||18
2316016|NCT01909804|5687375|P4|COMPLETED|Overall Study||26
2316017|NCT01909804|5687376|P3|COMPLETED|Overall Study||27
2316018|NCT01909804|5687377|P2|COMPLETED|Overall Study||27
2316019|NCT01909804|5687378|P1|COMPLETED|Overall Study||22
2316020|NCT01909804|5687367|P12|STARTED|Overall Study||29
2316021|NCT01909804|5687368|P11|STARTED|Overall Study||27
2316022|NCT01909804|5687369|P10|STARTED|Overall Study||29
2316023|NCT01909804|5687370|P9|STARTED|Overall Study||27
2316024|NCT01909804|5687371|P8|STARTED|Overall Study||26
2316025|NCT01909804|5687372|P7|STARTED|Overall Study||27
2316026|NCT01909804|5687373|P6|STARTED|Overall Study||25
2316027|NCT01909804|5687374|P5|STARTED|Overall Study||26
2316028|NCT01909804|5687375|P4|STARTED|Overall Study||26
2316029|NCT01909804|5687376|P3|STARTED|Overall Study||27
2316030|NCT01909804|5687377|P2|STARTED|Overall Study||28
2316031|NCT01909804|5687378|P1|STARTED|Overall Study||26
2316032|NCT01909791|5687427|P3|NOT COMPLETED|Overall Study||28
2316033|NCT01909791|5687428|P2|NOT COMPLETED|Overall Study||28
2316034|NCT01909791|5687429|P1|NOT COMPLETED|Overall Study||21
2316035|NCT01909791|5687427|P3|COMPLETED|Overall Study||208
2316036|NCT01909791|5687428|P2|COMPLETED|Overall Study||212
2316037|NCT01909791|5687429|P1|COMPLETED|Overall Study||205
2316038|NCT01909791|5687427|P3|STARTED|Overall Study||236
2316039|NCT01909791|5687428|P2|STARTED|Overall Study||240
2316040|NCT01909791|5687429|P1|STARTED|Overall Study||226
2316041|NCT01909778|5687487|P1|NOT COMPLETED|Overall Study||1
2316042|NCT01909778|5687487|P1|COMPLETED|Overall Study||1
2316043|NCT01909778|5687487|P1|STARTED|Overall Study||2
2316044|NCT01909713|5687511|P1|NOT COMPLETED|Overall Study||0
2316045|NCT01909713|5687511|P1|COMPLETED|Overall Study||35
2316046|NCT01909713|5687511|P1|STARTED|Overall Study||35
2316047|NCT01909674|5687566|P2|NOT COMPLETED|Overall Study||2
2316048|NCT01909674|5687567|P1|NOT COMPLETED|Overall Study||5
2316049|NCT01909674|5687566|P2|COMPLETED|Overall Study||7
2316050|NCT01909674|5687567|P1|COMPLETED|Overall Study||7
2316051|NCT01909674|5687566|P2|STARTED|Overall Study||9
2316052|NCT01909674|5687567|P1|STARTED|Overall Study||12
2316053|NCT01909570|5687575|P2|NOT COMPLETED|Overall Study||27
2316054|NCT01909570|5687576|P1|NOT COMPLETED|Overall Study||27
2316055|NCT01909570|5687575|P2|COMPLETED|Overall Study||64
2316056|NCT01909570|5687576|P1|COMPLETED|Overall Study||57
2316057|NCT01909570|5687575|P2|STARTED|Overall Study||91
2316058|NCT01909570|5687576|P1|STARTED|Overall Study||84
2316059|NCT01909466|5687586|P2|NOT COMPLETED|Overall Study||23
2316060|NCT01909466|5687587|P1|NOT COMPLETED|Overall Study||22
2316061|NCT01909466|5687586|P2|COMPLETED|Overall Study||50
2316062|NCT01909466|5687587|P1|COMPLETED|Overall Study||46
2316063|NCT01909466|5687586|P2|STARTED|Overall Study||73
2316064|NCT01909466|5687587|P1|STARTED|Overall Study||68
2316065|NCT01909336|5687610|P3|NOT COMPLETED|Overall Study||3
2316066|NCT01909336|5687611|P2|NOT COMPLETED|Overall Study||3
2316067|NCT01909336|5687612|P1|NOT COMPLETED|Overall Study||4
2316068|NCT01909336|5687610|P3|COMPLETED|Overall Study||52
2316069|NCT01909336|5687611|P2|COMPLETED|Overall Study||50
2316070|NCT01909336|5687612|P1|COMPLETED|Overall Study||49
2316071|NCT01909336|5687610|P3|STARTED|Overall Study||55
2316072|NCT01909336|5687611|P2|STARTED|Overall Study||53
2316073|NCT01909336|5687612|P1|STARTED|Overall Study||53
2316074|NCT01909180|5687626|P1|NOT COMPLETED|Overall Study||0
2316075|NCT01909180|5687626|P1|COMPLETED|Overall Study||49
2316076|NCT01909180|5687626|P1|STARTED|Overall Study||49
2316077|NCT01909154|5687632|P1|NOT COMPLETED|Overall Study||0
2316078|NCT01909154|5687632|P1|COMPLETED|Overall Study||12
2316079|NCT01909154|5687632|P1|STARTED|Overall Study||12
2316080|NCT01909141|5687643|P2|NOT COMPLETED|Overall Study||0
2316081|NCT01909141|5687644|P1|NOT COMPLETED|Overall Study||0
2316082|NCT01909141|5687643|P2|COMPLETED|Overall Study||50
2316083|NCT01909141|5687644|P1|COMPLETED|Overall Study||50
2316084|NCT01909141|5687643|P2|STARTED|Overall Study||50
2316085|NCT01909141|5687644|P1|STARTED|Overall Study||50
2316086|NCT01909011|5687660|P2|NOT COMPLETED|Overall Study||0
2316087|NCT01909011|5687661|P1|NOT COMPLETED|Overall Study||0
2316088|NCT01909011|5687660|P2|COMPLETED|Overall Study||9
2316089|NCT01909011|5687661|P1|COMPLETED|Overall Study||7
2316090|NCT01909011|5687660|P2|STARTED|Overall Study||9
2316091|NCT01909011|5687661|P1|STARTED|Overall Study||7
2316092|NCT01908972|5687673|P2|NOT COMPLETED|Overall Study||0
2316093|NCT01908972|5687674|P1|NOT COMPLETED|Overall Study||2
2316094|NCT01908972|5687673|P2|COMPLETED|Overall Study||17
2316095|NCT01908972|5687674|P1|COMPLETED|Overall Study||15
2316096|NCT01908972|5687673|P2|STARTED|Overall Study||17
2316097|NCT01908972|5687674|P1|STARTED|Overall Study||17
2316098|NCT01908907|5687710|P2|NOT COMPLETED|Overall Study||0
2316099|NCT01908907|5687711|P1|NOT COMPLETED|Overall Study||2
2316100|NCT01908907|5687710|P2|COMPLETED|Overall Study||29
2316101|NCT01908907|5687711|P1|COMPLETED|Overall Study||29
2316102|NCT01908907|5687710|P2|STARTED|Overall Study||29
2316103|NCT01908907|5687711|P1|STARTED|Overall Study||31
2316104|NCT01908842|5687733|P2|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||17
2316105|NCT01908842|5687734|P1|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||25
2316106|NCT01908842|5687733|P2|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
2316107|NCT01908842|5687734|P1|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
2316108|NCT01908842|5687733|P2|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||279
2316109|NCT01908842|5687734|P1|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||287
2316110|NCT01908842|5687733|P2|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||65
2316111|NCT01908842|5687734|P1|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||70
2316112|NCT01908842|5687733|P2|COMPLETED|Switch to Other BNX Formulation (Day 15)||279
2316113|NCT01908842|5687734|P1|COMPLETED|Switch to Other BNX Formulation (Day 15)||287
2316114|NCT01908842|5687733|P2|STARTED|Switch to Other BNX Formulation (Day 15)||344
2316115|NCT01908842|5687734|P1|STARTED|Switch to Other BNX Formulation (Day 15)||357
2316116|NCT01908842|5687733|P2|NOT COMPLETED|Induction||31
2316117|NCT01908842|5687734|P1|NOT COMPLETED|Induction||26
2316118|NCT01908842|5687733|P2|COMPLETED|Induction||344
2316119|NCT01908842|5687734|P1|COMPLETED|Induction||357
2316120|NCT01908842|5687733|P2|STARTED|Induction||375
2316121|NCT01908842|5687734|P1|STARTED|Induction||383
2316122|NCT01908829|5687755|P3|NOT COMPLETED|Overall Study||39
2316123|NCT01908829|5687756|P2|NOT COMPLETED|Overall Study||49
2316124|NCT01908829|5687757|P1|NOT COMPLETED|Overall Study||49
2316125|NCT01908829|5687755|P3|COMPLETED|Overall Study||680
2316126|NCT01908829|5687756|P2|COMPLETED|Overall Study||679
2316127|NCT01908829|5687757|P1|COMPLETED|Overall Study||678
2316128|NCT01908829|5687755|P3|Treated With Double-blind Drug|Overall Study||719
2316129|NCT01908829|5687756|P2|Treated With Double-blind Drug|Overall Study||728
2316130|NCT01908829|5687757|P1|Treated With Double-blind Drug|Overall Study||725
2316131|NCT01908829|5687755|P3|STARTED|Overall Study||719
2316132|NCT01908829|5687756|P2|STARTED|Overall Study||728
2316133|NCT01908829|5687757|P1|STARTED|Overall Study||727
2316134|NCT01908816|5687874|P4|NOT COMPLETED|Overall Study||35
2316135|NCT01908816|5687875|P3|NOT COMPLETED|Overall Study||58
2316136|NCT01908816|5687876|P2|NOT COMPLETED|Overall Study||84
2316137|NCT01908816|5687877|P1|NOT COMPLETED|Overall Study||93
2316138|NCT01908816|5687874|P4|COMPLETED|Overall Study||0
2316139|NCT01908816|5687875|P3|COMPLETED|Overall Study||0
2316140|NCT01908816|5687876|P2|COMPLETED|Overall Study||0
2316141|NCT01908816|5687877|P1|COMPLETED|Overall Study||0
2316142|NCT01908816|5687874|P4|STARTED|Overall Study||35
2316143|NCT01908816|5687875|P3|STARTED|Overall Study||58
2316144|NCT01908816|5687876|P2|STARTED|Overall Study||84
2316145|NCT01908816|5687877|P1|STARTED|Overall Study||93
2316146|NCT01908803|5687902|P2|NOT COMPLETED|Overall Study||1
2316147|NCT01908803|5687903|P1|NOT COMPLETED|Overall Study||4
2316148|NCT01908803|5687902|P2|COMPLETED|Overall Study||23
2316149|NCT01908803|5687903|P1|COMPLETED|Overall Study||42
2316150|NCT01908803|5687902|P2|Treated|Overall Study||24
2316151|NCT01908803|5687903|P1|Treated|Overall Study|Two randomized subjects discontinued prior to receiving investigational product.|44
2316152|NCT01908803|5687902|P2|STARTED|Overall Study||24
2316153|NCT01908803|5687903|P1|STARTED|Overall Study||46
2316154|NCT01908582|5687914|P1|NOT COMPLETED|Period 2||2
2316155|NCT01908582|5687914|P1|COMPLETED|Period 2||24
2316156|NCT01908582|5687914|P1|STARTED|Period 2||26
2316157|NCT01908582|5687914|P1|NOT COMPLETED|Period 1||0
2316158|NCT01908582|5687914|P1|COMPLETED|Period 1||26
2316159|NCT01908582|5687914|P1|Received at Least One Dose of Study Drug|Period 1||26
2316160|NCT01908582|5687914|P1|STARTED|Period 1||26
2316161|NCT01908530|5687928|P3|NOT COMPLETED|Overall Study||0
2316162|NCT01908530|5687929|P2|NOT COMPLETED|Overall Study||0
2316163|NCT01908530|5687930|P1|NOT COMPLETED|Overall Study||0
2316164|NCT01908530|5687928|P3|COMPLETED|Overall Study||10
2316165|NCT01908530|5687929|P2|COMPLETED|Overall Study||8
2316166|NCT01908530|5687930|P1|COMPLETED|Overall Study||8
2316167|NCT01908530|5687928|P3|STARTED|Overall Study||10
2316168|NCT01908530|5687929|P2|STARTED|Overall Study||8
2316169|NCT01908530|5687930|P1|STARTED|Overall Study||8
2316170|NCT01908426|5687958|P2|NOT COMPLETED|Overall Study||211
2316171|NCT01908426|5687959|P1|NOT COMPLETED|Overall Study||397
2316172|NCT01908426|5687958|P2|COMPLETED|Overall Study||26
2316173|NCT01908426|5687959|P1|COMPLETED|Overall Study||73
2316174|NCT01908426|5687958|P2|STARTED|Overall Study||237
2316175|NCT01908426|5687959|P1|STARTED|Overall Study||470
2316176|NCT01908140|5687971|P2|NOT COMPLETED|Overall Study||79
2316177|NCT01908140|5687972|P1|NOT COMPLETED|Overall Study||66
2316178|NCT01908140|5687971|P2|COMPLETED|Overall Study||386
2316179|NCT01908140|5687972|P1|COMPLETED|Overall Study||402
2316180|NCT01908140|5687971|P2|STARTED|Overall Study||465
2316181|NCT01908140|5687972|P1|STARTED|Overall Study||468
2316182|NCT01908127|5687982|P2|NOT COMPLETED|Overall Study||0
2316183|NCT01908127|5687983|P1|NOT COMPLETED|Overall Study||1
2316184|NCT01908127|5687982|P2|COMPLETED|Overall Study||23
2316185|NCT01908127|5687983|P1|COMPLETED|Overall Study||22
2316186|NCT01908127|5687982|P2|STARTED|Overall Study||23
2316187|NCT01908127|5687983|P1|STARTED|Overall Study||23
2316188|NCT01908062|5687993|P2|NOT COMPLETED|Overall Study||3
2316189|NCT01908062|5687994|P1|NOT COMPLETED|Overall Study||2
2316190|NCT01908062|5687993|P2|COMPLETED|Overall Study||22
2316191|NCT01908062|5687994|P1|COMPLETED|Overall Study||24
2316192|NCT01908062|5687993|P2|STARTED|Overall Study||25
2316193|NCT01908062|5687994|P1|STARTED|Overall Study||26
2316194|NCT01907906|5688021|P2|NOT COMPLETED|Overall Study||1
2316195|NCT01907906|5688022|P1|NOT COMPLETED|Overall Study||4
2316196|NCT01907906|5688021|P2|COMPLETED|Overall Study||12
2316197|NCT01907906|5688022|P1|COMPLETED|Overall Study||12
2316198|NCT01907906|5688021|P2|STARTED|Overall Study||13
2316199|NCT01907906|5688022|P1|STARTED|Overall Study||16
2316200|NCT01907854|5688102|P2|NOT COMPLETED|Overall Study||13
2316201|NCT01907854|5688103|P1|NOT COMPLETED|Overall Study||16
2316202|NCT01907854|5688102|P2|COMPLETED|Overall Study||191
2316203|NCT01907854|5688103|P1|COMPLETED|Overall Study||187
2316204|NCT01907854|5688102|P2|Exposed|Overall Study||204
2316205|NCT01907854|5688103|P1|Exposed|Overall Study|One subject in lira arm was not exposed (Reason: withdrawal by subject)|202
2316206|NCT01907854|5688102|P2|STARTED|Overall Study||204
2316207|NCT01907854|5688103|P1|STARTED|Overall Study||203
2316208|NCT01907815|5688123|P2|NOT COMPLETED|Overall Study||0
2316209|NCT01907815|5688124|P1|NOT COMPLETED|Overall Study||1
2316210|NCT01907815|5688123|P2|COMPLETED|Overall Study||7
2316211|NCT01907815|5688124|P1|COMPLETED|Overall Study||16
2316212|NCT01907815|5688123|P2|STARTED|Overall Study||7
2316213|NCT01907815|5688124|P1|STARTED|Overall Study||17
2316214|NCT01907737|5688138|P1|NOT COMPLETED|Overall Study||1
2316215|NCT01907737|5688138|P1|COMPLETED|Overall Study||21
2316216|NCT01907737|5688138|P1|STARTED|Overall Study||22
2316217|NCT01907516|5688150|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
2316218|NCT01907516|5688151|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
2316219|NCT01907516|5688150|P2|COMPLETED|Second Intervention (3 Weeks)||34
2316220|NCT01907516|5688151|P1|COMPLETED|Second Intervention (3 Weeks)||40
2316221|NCT01907516|5688150|P2|STARTED|Second Intervention (3 Weeks)||34
2316222|NCT01907516|5688151|P1|STARTED|Second Intervention (3 Weeks)||40
2316223|NCT01907516|5688150|P2|NOT COMPLETED|First Intervention (3 Weeks)||16
2316224|NCT01907516|5688151|P1|NOT COMPLETED|First Intervention (3 Weeks)||10
2316225|NCT01907516|5688150|P2|COMPLETED|First Intervention (3 Weeks)||34
2316226|NCT01907516|5688151|P1|COMPLETED|First Intervention (3 Weeks)||40
2316227|NCT01907516|5688150|P2|STARTED|First Intervention (3 Weeks)||50
2316228|NCT01907516|5688151|P1|STARTED|First Intervention (3 Weeks)||50
2316229|NCT01907490|5688158|P1|NOT COMPLETED|Overall Study||0
2316230|NCT01907490|5688158|P1|COMPLETED|Overall Study||38
2316231|NCT01907490|5688158|P1|STARTED|Overall Study||38
2316232|NCT01907334|5688162|P2|NOT COMPLETED|Overall Study||0
2316233|NCT01907334|5688163|P1|NOT COMPLETED|Overall Study||0
2316234|NCT01907334|5688162|P2|COMPLETED|Overall Study||4
2316235|NCT01907334|5688163|P1|COMPLETED|Overall Study||6
2316236|NCT01907334|5688162|P2|STARTED|Overall Study||4
2316237|NCT01907334|5688163|P1|STARTED|Overall Study||6
2316238|NCT01907321|5688168|P1|NOT COMPLETED|Overall Study||2
2316239|NCT01907321|5688168|P1|COMPLETED|Overall Study||12
2316240|NCT01907321|5688168|P1|STARTED|Overall Study||14
2316241|NCT01907269|5688175|P2|NOT COMPLETED|18 Month Outcome Measures Post-intervent||280
2316242|NCT01907269|5688176|P1|NOT COMPLETED|18 Month Outcome Measures Post-intervent||319
2316243|NCT01907269|5688175|P2|COMPLETED|18 Month Outcome Measures Post-intervent||970
2316244|NCT01907269|5688176|P1|COMPLETED|18 Month Outcome Measures Post-intervent||859
2316245|NCT01907269|5688175|P2|STARTED|18 Month Outcome Measures Post-intervent||1250
2316246|NCT01907269|5688176|P1|STARTED|18 Month Outcome Measures Post-intervent||1178
2316247|NCT01907269|5688175|P2|NOT COMPLETED|6 Month Outcome Measures Post-interventi||289
2316248|NCT01907269|5688176|P1|NOT COMPLETED|6 Month Outcome Measures Post-interventi||389
2316249|NCT01907269|5688175|P2|COMPLETED|6 Month Outcome Measures Post-interventi||1053
2316250|NCT01907269|5688176|P1|COMPLETED|6 Month Outcome Measures Post-interventi||953
2316251|NCT01907269|5688175|P2|STARTED|6 Month Outcome Measures Post-interventi||1342
2316252|NCT01907269|5688176|P1|STARTED|6 Month Outcome Measures Post-interventi||1342
2316253|NCT01907217|5688192|P2|NOT COMPLETED|Overall Study||2
2316254|NCT01907217|5688193|P1|NOT COMPLETED|Overall Study||0
2316255|NCT01907217|5688192|P2|COMPLETED|Overall Study||67
2316256|NCT01907217|5688193|P1|COMPLETED|Overall Study||69
2316257|NCT01907217|5688192|P2|STARTED|Overall Study||69
2316258|NCT01907217|5688193|P1|STARTED|Overall Study||69
2316259|NCT01907113|5688210|P5|NOT COMPLETED|Overall Study||0
2316260|NCT01907113|5688211|P4|NOT COMPLETED|Overall Study||0
2316261|NCT01907113|5688212|P3|NOT COMPLETED|Overall Study||0
2316262|NCT01907113|5688213|P2|NOT COMPLETED|Overall Study||0
2316263|NCT01907113|5688214|P1|NOT COMPLETED|Overall Study||0
2316264|NCT01907113|5688210|P5|COMPLETED|Overall Study||8
2316265|NCT01907113|5688211|P4|COMPLETED|Overall Study||8
2316266|NCT01907113|5688212|P3|COMPLETED|Overall Study||7
2316267|NCT01907113|5688213|P2|COMPLETED|Overall Study||9
2316268|NCT01907113|5688214|P1|COMPLETED|Overall Study||8
2316269|NCT01907113|5688210|P5|STARTED|Overall Study||8
2316270|NCT01907113|5688211|P4|STARTED|Overall Study||8
2316271|NCT01907113|5688212|P3|STARTED|Overall Study||7
2316272|NCT01907113|5688213|P2|STARTED|Overall Study||9
2316273|NCT01907113|5688214|P1|STARTED|Overall Study||8
2316274|NCT01907100|5688305|P4|NOT COMPLETED|Overall Study||146
2316275|NCT01907100|5688306|P3|NOT COMPLETED|Overall Study||147
2316276|NCT01907100|5688307|P2|NOT COMPLETED|Overall Study||40
2316277|NCT01907100|5688308|P1|NOT COMPLETED|Overall Study||42
2316278|NCT01907100|5688305|P4|COMPLETED|Overall Study||83
2316279|NCT01907100|5688306|P3|COMPLETED|Overall Study||82
2316280|NCT01907100|5688307|P2|COMPLETED|Overall Study||4
2316281|NCT01907100|5688308|P1|COMPLETED|Overall Study||1
2316282|NCT01907100|5688305|P4|Treated Patients|Overall Study||227
2316283|NCT01907100|5688306|P3|Treated Patients|Overall Study||228
2316284|NCT01907100|5688307|P2|Treated Patients|Overall Study||44
2316285|NCT01907100|5688308|P1|Treated Patients|Overall Study||41
2316286|NCT01907100|5688305|P4|STARTED|Overall Study||229
2316287|NCT01907100|5688306|P3|STARTED|Overall Study||229
2316288|NCT01907100|5688307|P2|STARTED|Overall Study||44
2316289|NCT01907100|5688308|P1|STARTED|Overall Study||43
2316290|NCT01907087|5688322|P1|NOT COMPLETED|Overall Study||1
2316291|NCT01907087|5688322|P1|COMPLETED|Overall Study||23
2316292|NCT01907087|5688322|P1|STARTED|Overall Study||24
2316293|NCT01906866|5688333|P2|NOT COMPLETED|Overall Study||21
2316294|NCT01906866|5688334|P1|NOT COMPLETED|Overall Study||9
2316295|NCT01906866|5688333|P2|COMPLETED|Overall Study||44
2316296|NCT01906866|5688334|P1|COMPLETED|Overall Study||51
2316297|NCT01906866|5688333|P2|STARTED|Overall Study||65
2316298|NCT01906866|5688334|P1|STARTED|Overall Study||60
2316299|NCT01906658|5688347|P4|NOT COMPLETED|Overall Study||0
2316300|NCT01906658|5688348|P3|NOT COMPLETED|Overall Study||3
2316301|NCT01906658|5688349|P2|NOT COMPLETED|Overall Study||1
2316302|NCT01906658|5688350|P1|NOT COMPLETED|Overall Study||2
2316303|NCT01906658|5688347|P4|COMPLETED|Overall Study||11
2316304|NCT01906658|5688348|P3|COMPLETED|Overall Study||7
2316305|NCT01906658|5688349|P2|COMPLETED|Overall Study||10
2316306|NCT01906658|5688350|P1|COMPLETED|Overall Study||9
2316307|NCT01906658|5688347|P4|STARTED|Overall Study||11
2316308|NCT01906658|5688348|P3|STARTED|Overall Study||10
2316309|NCT01906658|5688349|P2|STARTED|Overall Study||11
2316310|NCT01906658|5688350|P1|STARTED|Overall Study||11
2316311|NCT01906515|5688374|P2|NOT COMPLETED|Overall Study||0
2316312|NCT01906515|5688375|P1|NOT COMPLETED|Overall Study||0
2316313|NCT01906515|5688374|P2|COMPLETED|Overall Study||61
2316314|NCT01906515|5688375|P1|COMPLETED|Overall Study||45
2316315|NCT01906515|5688374|P2|STARTED|Overall Study||61
2316316|NCT01906515|5688375|P1|STARTED|Overall Study||45
2316317|NCT01906372|5688383|P1|NOT COMPLETED|Overall Study||2
2316318|NCT01906372|5688383|P1|COMPLETED|Overall Study||10
2316319|NCT01906372|5688383|P1|Visit 10: Follow up Phase Completed|Overall Study||8
2316320|NCT01906372|5688383|P1|Visit 7: Treatment Phase Completed|Overall Study||10
2316321|NCT01906372|5688383|P1|STARTED|Overall Study||12
2316322|NCT01906346|5688388|P1|NOT COMPLETED|Overall Study||1
2316323|NCT01906346|5688388|P1|COMPLETED|Overall Study||8
2316324|NCT01906346|5688388|P1|STARTED|Overall Study||9
2316325|NCT01905956|5688396|P2|NOT COMPLETED|Overall Study||11
2316326|NCT01905956|5688397|P1|NOT COMPLETED|Overall Study||6
2316327|NCT01905956|5688396|P2|COMPLETED|Overall Study|Per-protocol population|48
2316328|NCT01905956|5688397|P1|COMPLETED|Overall Study|Per-protocol population|54
2316329|NCT01905956|5688396|P2|Intention-to-treat Population|Overall Study|Intention-to-treat population|54
2316330|NCT01905956|5688397|P1|Intention-to-treat Population|Overall Study|Intention-to-treat population|57
2316331|NCT01905956|5688396|P2|STARTED|Overall Study|Randomized|59
2316332|NCT01905956|5688397|P1|STARTED|Overall Study|Randomized|60
2316333|NCT01905943|5688419|P1|NOT COMPLETED|Overall Study||314
2316334|NCT01905943|5688419|P1|COMPLETED|Overall Study|All patients provide reason at final analysis|658
2316335|NCT01905943|5688419|P1|STARTED|Overall Study||972
2316336|NCT01905683|5688536|P1|NOT COMPLETED|Overall Study||51
2316337|NCT01905683|5688536|P1|COMPLETED|Overall Study||319
2316338|NCT01905683|5688536|P1|STARTED|Overall Study||370
2316339|NCT01905657|5688552|P3|NOT COMPLETED|Overall Study||328
2316340|NCT01905657|5688553|P2|NOT COMPLETED|Overall Study||346
2316341|NCT01905657|5688554|P1|NOT COMPLETED|Overall Study||345
2316342|NCT01905657|5688552|P3|COMPLETED|Overall Study||15
2316343|NCT01905657|5688553|P2|COMPLETED|Overall Study||0
2316344|NCT01905657|5688554|P1|COMPLETED|Overall Study||0
2316345|NCT01905657|5688552|P3|Treated|Overall Study||309
2316346|NCT01905657|5688553|P2|Treated|Overall Study||343
2316347|NCT01905657|5688554|P1|Treated|Overall Study||339
2316348|NCT01905657|5688552|P3|STARTED|Overall Study||343
2316349|NCT01905657|5688553|P2|STARTED|Overall Study||346
2316350|NCT01905657|5688554|P1|STARTED|Overall Study||345
2316351|NCT01905553|5688579|P2|NOT COMPLETED|Period 2||0
2316352|NCT01905553|5688580|P1|NOT COMPLETED|Period 2||1
2316353|NCT01905553|5688579|P2|COMPLETED|Period 2||4
2316354|NCT01905553|5688580|P1|COMPLETED|Period 2||4
2316355|NCT01905553|5688579|P2|STARTED|Period 2||4
2316356|NCT01905553|5688580|P1|STARTED|Period 2||5
2316357|NCT01905553|5688579|P2|NOT COMPLETED|Period 1||0
2316358|NCT01905553|5688580|P1|NOT COMPLETED|Period 1||0
2316359|NCT01905553|5688579|P2|COMPLETED|Period 1||4
2316360|NCT01905553|5688580|P1|COMPLETED|Period 1||5
2316361|NCT01905553|5688579|P2|STARTED|Period 1||4
2316362|NCT01905553|5688580|P1|STARTED|Period 1||5
2316363|NCT01905540|5688594|P4|NOT COMPLETED|Period 3||1
2316364|NCT01905540|5688595|P3|NOT COMPLETED|Period 3||1
2316365|NCT01905540|5688596|P2|NOT COMPLETED|Period 3||0
2316366|NCT01905540|5688597|P1|NOT COMPLETED|Period 3||1
2316367|NCT01905540|5688594|P4|COMPLETED|Period 3||6
2316368|NCT01905540|5688595|P3|COMPLETED|Period 3||6
2316369|NCT01905540|5688596|P2|COMPLETED|Period 3||7
2316370|NCT01905540|5688597|P1|COMPLETED|Period 3||6
2316371|NCT01905540|5688594|P4|STARTED|Period 3||7
2316372|NCT01905540|5688595|P3|STARTED|Period 3||7
2316373|NCT01905540|5688596|P2|STARTED|Period 3||7
2316374|NCT01905540|5688597|P1|STARTED|Period 3||7
2316375|NCT01905540|5688594|P4|NOT COMPLETED|Period 2||0
2316376|NCT01905540|5688595|P3|NOT COMPLETED|Period 2||0
2316377|NCT01905540|5688596|P2|NOT COMPLETED|Period 2||0
2316378|NCT01905540|5688597|P1|NOT COMPLETED|Period 2||0
2316379|NCT01905540|5688594|P4|COMPLETED|Period 2||7
2316380|NCT01905540|5688595|P3|COMPLETED|Period 2||7
2316381|NCT01905540|5688596|P2|COMPLETED|Period 2||7
2316382|NCT01905540|5688597|P1|COMPLETED|Period 2||7
2316383|NCT01905540|5688594|P4|STARTED|Period 2||7
2316384|NCT01905540|5688595|P3|STARTED|Period 2||7
2316385|NCT01905540|5688596|P2|STARTED|Period 2||7
2316386|NCT01905540|5688597|P1|STARTED|Period 2||7
2316387|NCT01905540|5688594|P4|NOT COMPLETED|Period 1||0
2316388|NCT01905540|5688595|P3|NOT COMPLETED|Period 1||0
2316389|NCT01905540|5688596|P2|NOT COMPLETED|Period 1||0
2316390|NCT01905540|5688597|P1|NOT COMPLETED|Period 1||0
2316391|NCT01905540|5688594|P4|COMPLETED|Period 1||7
2316392|NCT01905540|5688595|P3|COMPLETED|Period 1||7
2316393|NCT01905540|5688596|P2|COMPLETED|Period 1||7
2316394|NCT01905540|5688597|P1|COMPLETED|Period 1||7
2316395|NCT01905540|5688594|P4|STARTED|Period 1||7
2316396|NCT01905540|5688595|P3|STARTED|Period 1||7
2316397|NCT01905540|5688596|P2|STARTED|Period 1||7
2316398|NCT01905540|5688597|P1|STARTED|Period 1||7
2316399|NCT01905423|5688619|P4|NOT COMPLETED|Overall Study||0
2316400|NCT01905423|5688620|P3|NOT COMPLETED|Overall Study||0
2316401|NCT01905423|5688621|P2|NOT COMPLETED|Overall Study||0
2316402|NCT01905423|5688622|P1|NOT COMPLETED|Overall Study||0
2316403|NCT01905423|5688619|P4|COMPLETED|Overall Study||3324
2316404|NCT01905423|5688620|P3|COMPLETED|Overall Study||4119
2316405|NCT01905423|5688621|P2|COMPLETED|Overall Study||4111
2316406|NCT01905423|5688622|P1|COMPLETED|Overall Study||7753
2316407|NCT01905423|5688619|P4|Year 3 Follow-up|Overall Study||0
2316408|NCT01905423|5688620|P3|Year 3 Follow-up|Overall Study||0
2316409|NCT01905423|5688621|P2|Year 3 Follow-up|Overall Study||1028
2316410|NCT01905423|5688622|P1|Year 3 Follow-up|Overall Study||1776
2316411|NCT01905423|5688619|P4|Year 2 Follow-up|Overall Study||0
2316412|NCT01905423|5688620|P3|Year 2 Follow-up|Overall Study||0
2316413|NCT01905423|5688621|P2|Year 2 Follow-up|Overall Study||1043
2316414|NCT01905423|5688622|P1|Year 2 Follow-up|Overall Study||1972
2316415|NCT01905423|5688619|P4|Year 1 Follow-up|Overall Study||1690
2316416|NCT01905423|5688620|P3|Year 1 Follow-up|Overall Study||2037
2316417|NCT01905423|5688621|P2|Year 1 Follow-up|Overall Study||1007
2316418|NCT01905423|5688622|P1|Year 1 Follow-up|Overall Study||1840
2316419|NCT01905423|5688619|P4|Baseline|Overall Study||1634
2316420|NCT01905423|5688620|P3|Baseline|Overall Study||2082
2316421|NCT01905423|5688621|P2|Baseline|Overall Study||1033
2316422|NCT01905423|5688622|P1|Baseline|Overall Study||2165
2316423|NCT01905423|5688619|P4|STARTED|Overall Study||3324
2316424|NCT01905423|5688620|P3|STARTED|Overall Study||4119
2316425|NCT01905423|5688621|P2|STARTED|Overall Study||4111
2316426|NCT01905423|5688622|P1|STARTED|Overall Study||7753
2316427|NCT01905267|5688632|P2|NOT COMPLETED|Overall Study||2
2316428|NCT01905267|5688633|P1|NOT COMPLETED|Overall Study||2
2316429|NCT01905267|5688632|P2|COMPLETED|Overall Study||14
2316430|NCT01905267|5688633|P1|COMPLETED|Overall Study||15
2316431|NCT01905267|5688632|P2|STARTED|Overall Study||16
2316432|NCT01905267|5688633|P1|STARTED|Overall Study||17
2316433|NCT01905254|5688641|P1|NOT COMPLETED|Overall Study||0
2316434|NCT01905254|5688641|P1|COMPLETED|Overall Study||34
2316435|NCT01905254|5688641|P1|STARTED|Overall Study||34
2316436|NCT01904864|5688647|P2|NOT COMPLETED|Overall Study||12
2316437|NCT01904864|5688648|P1|NOT COMPLETED|Overall Study||9
2316438|NCT01904864|5688647|P2|COMPLETED|Overall Study||28
2316439|NCT01904864|5688648|P1|COMPLETED|Overall Study||31
2316440|NCT01904864|5688647|P2|STARTED|Overall Study||40
2316441|NCT01904864|5688648|P1|STARTED|Overall Study||40
2316442|NCT01904773|5688654|P9|NOT COMPLETED|Sixth Intervention||0
2316443|NCT01904773|5688655|P8|NOT COMPLETED|Sixth Intervention||0
2316444|NCT01904773|5688656|P7|NOT COMPLETED|Sixth Intervention||0
2316445|NCT01904773|5688657|P6|NOT COMPLETED|Sixth Intervention||0
2316446|NCT01904773|5688658|P5|NOT COMPLETED|Sixth Intervention||0
2316447|NCT01904773|5688659|P4|NOT COMPLETED|Sixth Intervention||0
2316448|NCT01904773|5688660|P3|NOT COMPLETED|Sixth Intervention||0
2316449|NCT01904773|5688661|P2|NOT COMPLETED|Sixth Intervention||0
2316450|NCT01904773|5688662|P1|NOT COMPLETED|Sixth Intervention||0
2316451|NCT01904773|5688654|P9|COMPLETED|Sixth Intervention||4
2316452|NCT01904773|5688655|P8|COMPLETED|Sixth Intervention||2
2316453|NCT01904773|5688656|P7|COMPLETED|Sixth Intervention||3
2316454|NCT01904773|5688657|P6|COMPLETED|Sixth Intervention||4
2316455|NCT01904773|5688658|P5|COMPLETED|Sixth Intervention||3
2316456|NCT01904773|5688659|P4|COMPLETED|Sixth Intervention||2
2316457|NCT01904773|5688660|P3|COMPLETED|Sixth Intervention||1
2316458|NCT01904773|5688661|P2|COMPLETED|Sixth Intervention||0
2316459|NCT01904773|5688662|P1|COMPLETED|Sixth Intervention||0
2316460|NCT01904773|5688654|P9|STARTED|Sixth Intervention||4
2316461|NCT01904773|5688655|P8|STARTED|Sixth Intervention||2
2316462|NCT01904773|5688656|P7|STARTED|Sixth Intervention||3
2316463|NCT01904773|5688657|P6|STARTED|Sixth Intervention||4
2316464|NCT01904773|5688658|P5|STARTED|Sixth Intervention||3
2316465|NCT01904773|5688659|P4|STARTED|Sixth Intervention||2
2316466|NCT01904773|5688660|P3|STARTED|Sixth Intervention||1
2316467|NCT01904773|5688661|P2|STARTED|Sixth Intervention||0
2316468|NCT01904773|5688662|P1|STARTED|Sixth Intervention||0
2316469|NCT01904773|5688654|P9|NOT COMPLETED|Placebo Washout Fifth Intervention||0
2316470|NCT01904773|5688655|P8|NOT COMPLETED|Placebo Washout Fifth Intervention||0
2316471|NCT01904773|5688656|P7|NOT COMPLETED|Placebo Washout Fifth Intervention||0
2316472|NCT01904773|5688657|P6|NOT COMPLETED|Placebo Washout Fifth Intervention||0
2316473|NCT01904773|5688658|P5|NOT COMPLETED|Placebo Washout Fifth Intervention||0
2316474|NCT01904773|5688659|P4|NOT COMPLETED|Placebo Washout Fifth Intervention||0
2316475|NCT01904773|5688660|P3|NOT COMPLETED|Placebo Washout Fifth Intervention||0
2316476|NCT01904773|5688661|P2|NOT COMPLETED|Placebo Washout Fifth Intervention||1
2316477|NCT01904773|5688662|P1|NOT COMPLETED|Placebo Washout Fifth Intervention||0
2316478|NCT01904773|5688654|P9|COMPLETED|Placebo Washout Fifth Intervention||4
2316479|NCT01904773|5688655|P8|COMPLETED|Placebo Washout Fifth Intervention||2
2316480|NCT01904773|5688656|P7|COMPLETED|Placebo Washout Fifth Intervention||3
2316481|NCT01904773|5688657|P6|COMPLETED|Placebo Washout Fifth Intervention||4
2316482|NCT01904773|5688658|P5|COMPLETED|Placebo Washout Fifth Intervention||3
2316483|NCT01904773|5688659|P4|COMPLETED|Placebo Washout Fifth Intervention||2
2316484|NCT01904773|5688660|P3|COMPLETED|Placebo Washout Fifth Intervention||1
2316485|NCT01904773|5688661|P2|COMPLETED|Placebo Washout Fifth Intervention||0
2316486|NCT01904773|5688662|P1|COMPLETED|Placebo Washout Fifth Intervention||0
2316487|NCT01904773|5688654|P9|STARTED|Placebo Washout Fifth Intervention||4
2316488|NCT01904773|5688655|P8|STARTED|Placebo Washout Fifth Intervention||2
2316489|NCT01904773|5688656|P7|STARTED|Placebo Washout Fifth Intervention||3
2316490|NCT01904773|5688657|P6|STARTED|Placebo Washout Fifth Intervention||4
2316491|NCT01904773|5688658|P5|STARTED|Placebo Washout Fifth Intervention||3
2316492|NCT01904773|5688659|P4|STARTED|Placebo Washout Fifth Intervention||2
2316493|NCT01904773|5688660|P3|STARTED|Placebo Washout Fifth Intervention||1
2316494|NCT01904773|5688661|P2|STARTED|Placebo Washout Fifth Intervention||1
2316495|NCT01904773|5688662|P1|STARTED|Placebo Washout Fifth Intervention||0
2316496|NCT01904773|5688654|P9|NOT COMPLETED|Fifth Intervention||0
2316497|NCT01904773|5688655|P8|NOT COMPLETED|Fifth Intervention||1
2316498|NCT01904773|5688656|P7|NOT COMPLETED|Fifth Intervention||0
2316499|NCT01904773|5688657|P6|NOT COMPLETED|Fifth Intervention||0
2316500|NCT01904773|5688658|P5|NOT COMPLETED|Fifth Intervention||0
2316501|NCT01904773|5688659|P4|NOT COMPLETED|Fifth Intervention||0
2316502|NCT01904773|5688660|P3|NOT COMPLETED|Fifth Intervention||0
2316503|NCT01904773|5688661|P2|NOT COMPLETED|Fifth Intervention||0
2316504|NCT01904773|5688662|P1|NOT COMPLETED|Fifth Intervention||0
2316505|NCT01904773|5688654|P9|COMPLETED|Fifth Intervention||4
2316506|NCT01904773|5688655|P8|COMPLETED|Fifth Intervention||2
2316507|NCT01904773|5688656|P7|COMPLETED|Fifth Intervention||3
2316508|NCT01904773|5688657|P6|COMPLETED|Fifth Intervention||4
2316509|NCT01904773|5688658|P5|COMPLETED|Fifth Intervention||3
2316510|NCT01904773|5688659|P4|COMPLETED|Fifth Intervention||2
2316511|NCT01904773|5688660|P3|COMPLETED|Fifth Intervention||1
2316512|NCT01904773|5688661|P2|COMPLETED|Fifth Intervention||1
2316513|NCT01904773|5688662|P1|COMPLETED|Fifth Intervention||0
2316514|NCT01904773|5688654|P9|STARTED|Fifth Intervention||4
2316515|NCT01904773|5688655|P8|STARTED|Fifth Intervention||3
2316516|NCT01904773|5688656|P7|STARTED|Fifth Intervention||3
2316517|NCT01904773|5688657|P6|STARTED|Fifth Intervention||4
2316518|NCT01904773|5688658|P5|STARTED|Fifth Intervention||3
2316519|NCT01904773|5688659|P4|STARTED|Fifth Intervention||2
2316520|NCT01904773|5688660|P3|STARTED|Fifth Intervention||1
2316521|NCT01904773|5688661|P2|STARTED|Fifth Intervention||1
2316522|NCT01904773|5688662|P1|STARTED|Fifth Intervention||0
2316523|NCT01904773|5688654|P9|NOT COMPLETED|Placebo Washout Fourth Intervention||0
2316524|NCT01904773|5688655|P8|NOT COMPLETED|Placebo Washout Fourth Intervention||0
2316525|NCT01904773|5688656|P7|NOT COMPLETED|Placebo Washout Fourth Intervention||0
2316526|NCT01904773|5688657|P6|NOT COMPLETED|Placebo Washout Fourth Intervention||0
2316527|NCT01904773|5688658|P5|NOT COMPLETED|Placebo Washout Fourth Intervention||0
2316528|NCT01904773|5688659|P4|NOT COMPLETED|Placebo Washout Fourth Intervention||0
2316529|NCT01904773|5688660|P3|NOT COMPLETED|Placebo Washout Fourth Intervention||0
2316530|NCT01904773|5688661|P2|NOT COMPLETED|Placebo Washout Fourth Intervention||0
2316531|NCT01904773|5688662|P1|NOT COMPLETED|Placebo Washout Fourth Intervention||0
2316532|NCT01904773|5688654|P9|COMPLETED|Placebo Washout Fourth Intervention||4
2316533|NCT01904773|5688655|P8|COMPLETED|Placebo Washout Fourth Intervention||3
2316534|NCT01904773|5688656|P7|COMPLETED|Placebo Washout Fourth Intervention||3
2316535|NCT01904773|5688657|P6|COMPLETED|Placebo Washout Fourth Intervention||4
2316536|NCT01904773|5688658|P5|COMPLETED|Placebo Washout Fourth Intervention||3
2316537|NCT01904773|5688659|P4|COMPLETED|Placebo Washout Fourth Intervention||2
2316538|NCT01904773|5688660|P3|COMPLETED|Placebo Washout Fourth Intervention||1
2316539|NCT01904773|5688661|P2|COMPLETED|Placebo Washout Fourth Intervention||1
2316540|NCT01904773|5688662|P1|COMPLETED|Placebo Washout Fourth Intervention||0
2316541|NCT01904773|5688654|P9|STARTED|Placebo Washout Fourth Intervention||4
2316542|NCT01904773|5688655|P8|STARTED|Placebo Washout Fourth Intervention||3
2316543|NCT01904773|5688656|P7|STARTED|Placebo Washout Fourth Intervention||3
2316544|NCT01904773|5688657|P6|STARTED|Placebo Washout Fourth Intervention||4
2316545|NCT01904773|5688658|P5|STARTED|Placebo Washout Fourth Intervention||3
2316546|NCT01904773|5688659|P4|STARTED|Placebo Washout Fourth Intervention||2
2316547|NCT01904773|5688660|P3|STARTED|Placebo Washout Fourth Intervention||1
2316548|NCT01904773|5688661|P2|STARTED|Placebo Washout Fourth Intervention||1
2316549|NCT01904773|5688662|P1|STARTED|Placebo Washout Fourth Intervention||0
2316550|NCT01904773|5688654|P9|NOT COMPLETED|Fourth Intervention||0
2316551|NCT01904773|5688655|P8|NOT COMPLETED|Fourth Intervention||0
2316552|NCT01904773|5688656|P7|NOT COMPLETED|Fourth Intervention||0
2316553|NCT01904773|5688657|P6|NOT COMPLETED|Fourth Intervention||0
2316554|NCT01904773|5688658|P5|NOT COMPLETED|Fourth Intervention||0
2316555|NCT01904773|5688659|P4|NOT COMPLETED|Fourth Intervention||0
2316556|NCT01904773|5688660|P3|NOT COMPLETED|Fourth Intervention||0
2316557|NCT01904773|5688661|P2|NOT COMPLETED|Fourth Intervention||0
2316558|NCT01904773|5688662|P1|NOT COMPLETED|Fourth Intervention||0
2316559|NCT01904773|5688654|P9|COMPLETED|Fourth Intervention||4
2316560|NCT01904773|5688655|P8|COMPLETED|Fourth Intervention||3
2316561|NCT01904773|5688656|P7|COMPLETED|Fourth Intervention||3
2316562|NCT01904773|5688657|P6|COMPLETED|Fourth Intervention||4
2316563|NCT01904773|5688658|P5|COMPLETED|Fourth Intervention||3
2316564|NCT01904773|5688659|P4|COMPLETED|Fourth Intervention||2
2316565|NCT01904773|5688660|P3|COMPLETED|Fourth Intervention||1
2316566|NCT01904773|5688661|P2|COMPLETED|Fourth Intervention||1
2316567|NCT01904773|5688662|P1|COMPLETED|Fourth Intervention||0
2316568|NCT01904773|5688654|P9|STARTED|Fourth Intervention||4
2316569|NCT01904773|5688655|P8|STARTED|Fourth Intervention||3
2316570|NCT01904773|5688656|P7|STARTED|Fourth Intervention||3
2316571|NCT01904773|5688657|P6|STARTED|Fourth Intervention||4
2316572|NCT01904773|5688658|P5|STARTED|Fourth Intervention||3
2316573|NCT01904773|5688659|P4|STARTED|Fourth Intervention||2
2316574|NCT01904773|5688660|P3|STARTED|Fourth Intervention||1
2316575|NCT01904773|5688661|P2|STARTED|Fourth Intervention||1
2316576|NCT01904773|5688662|P1|STARTED|Fourth Intervention||0
2316577|NCT01904773|5688654|P9|NOT COMPLETED|Placebo Washout Third Intervention||0
2316578|NCT01904773|5688655|P8|NOT COMPLETED|Placebo Washout Third Intervention||0
2316579|NCT01904773|5688656|P7|NOT COMPLETED|Placebo Washout Third Intervention||0
2316580|NCT01904773|5688657|P6|NOT COMPLETED|Placebo Washout Third Intervention||0
2316581|NCT01904773|5688658|P5|NOT COMPLETED|Placebo Washout Third Intervention||0
2316582|NCT01904773|5688659|P4|NOT COMPLETED|Placebo Washout Third Intervention||0
2316583|NCT01904773|5688660|P3|NOT COMPLETED|Placebo Washout Third Intervention||0
2316584|NCT01904773|5688661|P2|NOT COMPLETED|Placebo Washout Third Intervention||0
2316585|NCT01904773|5688662|P1|NOT COMPLETED|Placebo Washout Third Intervention||0
2316586|NCT01904773|5688654|P9|COMPLETED|Placebo Washout Third Intervention||4
2316587|NCT01904773|5688655|P8|COMPLETED|Placebo Washout Third Intervention||3
2316588|NCT01904773|5688656|P7|COMPLETED|Placebo Washout Third Intervention||3
2316589|NCT01904773|5688657|P6|COMPLETED|Placebo Washout Third Intervention||4
2316590|NCT01904773|5688658|P5|COMPLETED|Placebo Washout Third Intervention||3
2316591|NCT01904773|5688659|P4|COMPLETED|Placebo Washout Third Intervention||2
2316592|NCT01904773|5688660|P3|COMPLETED|Placebo Washout Third Intervention||1
2316593|NCT01904773|5688661|P2|COMPLETED|Placebo Washout Third Intervention||1
2316594|NCT01904773|5688662|P1|COMPLETED|Placebo Washout Third Intervention||0
2316595|NCT01904773|5688654|P9|STARTED|Placebo Washout Third Intervention||4
2316596|NCT01904773|5688655|P8|STARTED|Placebo Washout Third Intervention||3
2316597|NCT01904773|5688656|P7|STARTED|Placebo Washout Third Intervention||3
2316598|NCT01904773|5688657|P6|STARTED|Placebo Washout Third Intervention||4
2316599|NCT01904773|5688658|P5|STARTED|Placebo Washout Third Intervention||3
2316600|NCT01904773|5688659|P4|STARTED|Placebo Washout Third Intervention||2
2316601|NCT01904773|5688660|P3|STARTED|Placebo Washout Third Intervention||1
2316602|NCT01904773|5688661|P2|STARTED|Placebo Washout Third Intervention||1
2316603|NCT01904773|5688662|P1|STARTED|Placebo Washout Third Intervention||0
2316604|NCT01904773|5688654|P9|NOT COMPLETED|Third Intervention||0
2316605|NCT01904773|5688655|P8|NOT COMPLETED|Third Intervention||0
2316606|NCT01904773|5688656|P7|NOT COMPLETED|Third Intervention||0
2316607|NCT01904773|5688657|P6|NOT COMPLETED|Third Intervention||0
2316608|NCT01904773|5688658|P5|NOT COMPLETED|Third Intervention||0
2316609|NCT01904773|5688659|P4|NOT COMPLETED|Third Intervention||0
2316610|NCT01904773|5688660|P3|NOT COMPLETED|Third Intervention||0
2316611|NCT01904773|5688661|P2|NOT COMPLETED|Third Intervention||0
2316612|NCT01904773|5688662|P1|NOT COMPLETED|Third Intervention||0
2316613|NCT01904773|5688654|P9|COMPLETED|Third Intervention||4
2316614|NCT01904773|5688655|P8|COMPLETED|Third Intervention||3
2316615|NCT01904773|5688656|P7|COMPLETED|Third Intervention||3
2316616|NCT01904773|5688657|P6|COMPLETED|Third Intervention||4
2316617|NCT01904773|5688658|P5|COMPLETED|Third Intervention||3
2316618|NCT01904773|5688659|P4|COMPLETED|Third Intervention||2
2316619|NCT01904773|5688660|P3|COMPLETED|Third Intervention||1
2316620|NCT01904773|5688661|P2|COMPLETED|Third Intervention||1
2316621|NCT01904773|5688662|P1|COMPLETED|Third Intervention||0
2316622|NCT01904773|5688654|P9|STARTED|Third Intervention||4
2316623|NCT01904773|5688655|P8|STARTED|Third Intervention||3
2316624|NCT01904773|5688656|P7|STARTED|Third Intervention||3
2316625|NCT01904773|5688657|P6|STARTED|Third Intervention||4
2316626|NCT01904773|5688658|P5|STARTED|Third Intervention||3
2316627|NCT01904773|5688659|P4|STARTED|Third Intervention||2
2316628|NCT01904773|5688660|P3|STARTED|Third Intervention||1
2316629|NCT01904773|5688661|P2|STARTED|Third Intervention||1
2316630|NCT01904773|5688662|P1|STARTED|Third Intervention||0
2316631|NCT01904773|5688654|P9|NOT COMPLETED|Placebo Washout Second Intervention||0
2316632|NCT01904773|5688655|P8|NOT COMPLETED|Placebo Washout Second Intervention||0
2316633|NCT01904773|5688656|P7|NOT COMPLETED|Placebo Washout Second Intervention||0
2316634|NCT01904773|5688657|P6|NOT COMPLETED|Placebo Washout Second Intervention||0
2316635|NCT01904773|5688658|P5|NOT COMPLETED|Placebo Washout Second Intervention||0
2316636|NCT01904773|5688659|P4|NOT COMPLETED|Placebo Washout Second Intervention||0
2316637|NCT01904773|5688660|P3|NOT COMPLETED|Placebo Washout Second Intervention||0
2316638|NCT01904773|5688661|P2|NOT COMPLETED|Placebo Washout Second Intervention||0
2316639|NCT01904773|5688662|P1|NOT COMPLETED|Placebo Washout Second Intervention||0
2316640|NCT01904773|5688654|P9|COMPLETED|Placebo Washout Second Intervention||4
2316641|NCT01904773|5688655|P8|COMPLETED|Placebo Washout Second Intervention||3
2316642|NCT01904773|5688656|P7|COMPLETED|Placebo Washout Second Intervention||3
2316643|NCT01904773|5688657|P6|COMPLETED|Placebo Washout Second Intervention||4
2316644|NCT01904773|5688658|P5|COMPLETED|Placebo Washout Second Intervention||3
2316645|NCT01904773|5688659|P4|COMPLETED|Placebo Washout Second Intervention||2
2316646|NCT01904773|5688660|P3|COMPLETED|Placebo Washout Second Intervention||1
2316647|NCT01904773|5688661|P2|COMPLETED|Placebo Washout Second Intervention||1
2316648|NCT01904773|5688662|P1|COMPLETED|Placebo Washout Second Intervention||0
2316649|NCT01904773|5688654|P9|STARTED|Placebo Washout Second Intervention||4
2316650|NCT01904773|5688655|P8|STARTED|Placebo Washout Second Intervention||3
2316651|NCT01904773|5688656|P7|STARTED|Placebo Washout Second Intervention||3
2316652|NCT01904773|5688657|P6|STARTED|Placebo Washout Second Intervention||4
2316653|NCT01904773|5688658|P5|STARTED|Placebo Washout Second Intervention||3
2316654|NCT01904773|5688659|P4|STARTED|Placebo Washout Second Intervention||2
2316655|NCT01904773|5688660|P3|STARTED|Placebo Washout Second Intervention||1
2316656|NCT01904773|5688661|P2|STARTED|Placebo Washout Second Intervention||1
2316657|NCT01904773|5688662|P1|STARTED|Placebo Washout Second Intervention||0
2316658|NCT01904773|5688654|P9|NOT COMPLETED|Second Intervention||0
2316659|NCT01904773|5688655|P8|NOT COMPLETED|Second Intervention||0
2316660|NCT01904773|5688656|P7|NOT COMPLETED|Second Intervention||0
2316661|NCT01904773|5688657|P6|NOT COMPLETED|Second Intervention||0
2316662|NCT01904773|5688658|P5|NOT COMPLETED|Second Intervention||0
2316663|NCT01904773|5688659|P4|NOT COMPLETED|Second Intervention||0
2316664|NCT01904773|5688660|P3|NOT COMPLETED|Second Intervention||0
2316665|NCT01904773|5688661|P2|NOT COMPLETED|Second Intervention||0
2316666|NCT01904773|5688662|P1|NOT COMPLETED|Second Intervention||0
2316667|NCT01904773|5688654|P9|COMPLETED|Second Intervention||4
2316668|NCT01904773|5688655|P8|COMPLETED|Second Intervention||3
2316669|NCT01904773|5688656|P7|COMPLETED|Second Intervention||3
2316670|NCT01904773|5688657|P6|COMPLETED|Second Intervention||4
2316671|NCT01904773|5688658|P5|COMPLETED|Second Intervention||3
2316672|NCT01904773|5688659|P4|COMPLETED|Second Intervention||2
2316673|NCT01904773|5688660|P3|COMPLETED|Second Intervention||1
2316674|NCT01904773|5688661|P2|COMPLETED|Second Intervention||1
2316675|NCT01904773|5688662|P1|COMPLETED|Second Intervention||0
2316676|NCT01904773|5688654|P9|STARTED|Second Intervention||4
2316677|NCT01904773|5688655|P8|STARTED|Second Intervention||3
2316678|NCT01904773|5688656|P7|STARTED|Second Intervention||3
2316679|NCT01904773|5688657|P6|STARTED|Second Intervention||4
2316680|NCT01904773|5688658|P5|STARTED|Second Intervention||3
2316681|NCT01904773|5688659|P4|STARTED|Second Intervention||2
2316682|NCT01904773|5688660|P3|STARTED|Second Intervention||1
2316683|NCT01904773|5688661|P2|STARTED|Second Intervention||1
2316684|NCT01904773|5688662|P1|STARTED|Second Intervention||0
2316685|NCT01904773|5688654|P9|NOT COMPLETED|Placebo Washout First Intervention||0
2316686|NCT01904773|5688655|P8|NOT COMPLETED|Placebo Washout First Intervention||0
2316687|NCT01904773|5688656|P7|NOT COMPLETED|Placebo Washout First Intervention||0
2316688|NCT01904773|5688657|P6|NOT COMPLETED|Placebo Washout First Intervention||0
2316689|NCT01904773|5688658|P5|NOT COMPLETED|Placebo Washout First Intervention||0
2316690|NCT01904773|5688659|P4|NOT COMPLETED|Placebo Washout First Intervention||0
2316691|NCT01904773|5688660|P3|NOT COMPLETED|Placebo Washout First Intervention||0
2316692|NCT01904773|5688661|P2|NOT COMPLETED|Placebo Washout First Intervention||1
2316693|NCT01904773|5688662|P1|NOT COMPLETED|Placebo Washout First Intervention||0
2316694|NCT01904773|5688654|P9|COMPLETED|Placebo Washout First Intervention||4
2316695|NCT01904773|5688655|P8|COMPLETED|Placebo Washout First Intervention||3
2316696|NCT01904773|5688656|P7|COMPLETED|Placebo Washout First Intervention||3
2316697|NCT01904773|5688657|P6|COMPLETED|Placebo Washout First Intervention||4
2316698|NCT01904773|5688658|P5|COMPLETED|Placebo Washout First Intervention||3
2316699|NCT01904773|5688659|P4|COMPLETED|Placebo Washout First Intervention||2
2316700|NCT01904773|5688660|P3|COMPLETED|Placebo Washout First Intervention||1
2316701|NCT01904773|5688661|P2|COMPLETED|Placebo Washout First Intervention||1
2316702|NCT01904773|5688662|P1|COMPLETED|Placebo Washout First Intervention||0
2316703|NCT01904773|5688654|P9|STARTED|Placebo Washout First Intervention||4
2316704|NCT01904773|5688655|P8|STARTED|Placebo Washout First Intervention||3
2316705|NCT01904773|5688656|P7|STARTED|Placebo Washout First Intervention||3
2316706|NCT01904773|5688657|P6|STARTED|Placebo Washout First Intervention||4
2316707|NCT01904773|5688658|P5|STARTED|Placebo Washout First Intervention||3
2316708|NCT01904773|5688659|P4|STARTED|Placebo Washout First Intervention||2
2316709|NCT01904773|5688660|P3|STARTED|Placebo Washout First Intervention||1
2316710|NCT01904773|5688661|P2|STARTED|Placebo Washout First Intervention||2
2316711|NCT01904773|5688662|P1|STARTED|Placebo Washout First Intervention||0
2316712|NCT01904773|5688654|P9|NOT COMPLETED|First Intervention||0
2316713|NCT01904773|5688655|P8|NOT COMPLETED|First Intervention||0
2316714|NCT01904773|5688656|P7|NOT COMPLETED|First Intervention||1
2316715|NCT01904773|5688657|P6|NOT COMPLETED|First Intervention||0
2316716|NCT01904773|5688658|P5|NOT COMPLETED|First Intervention||0
2316717|NCT01904773|5688659|P4|NOT COMPLETED|First Intervention||0
2316718|NCT01904773|5688660|P3|NOT COMPLETED|First Intervention||0
2316719|NCT01904773|5688661|P2|NOT COMPLETED|First Intervention||0
2316720|NCT01904773|5688662|P1|NOT COMPLETED|First Intervention||0
2316721|NCT01904773|5688654|P9|COMPLETED|First Intervention||4
2316722|NCT01904773|5688655|P8|COMPLETED|First Intervention||3
2316723|NCT01904773|5688656|P7|COMPLETED|First Intervention||3
2316724|NCT01904773|5688657|P6|COMPLETED|First Intervention||4
2316725|NCT01904773|5688658|P5|COMPLETED|First Intervention||3
2316726|NCT01904773|5688659|P4|COMPLETED|First Intervention||2
2316727|NCT01904773|5688660|P3|COMPLETED|First Intervention||1
2316728|NCT01904773|5688661|P2|COMPLETED|First Intervention||2
2316729|NCT01904773|5688662|P1|COMPLETED|First Intervention||0
2316730|NCT01904773|5688654|P9|STARTED|First Intervention||4
2316731|NCT01904773|5688655|P8|STARTED|First Intervention||3
2316732|NCT01904773|5688656|P7|STARTED|First Intervention||4
2316733|NCT01904773|5688657|P6|STARTED|First Intervention||4
2316734|NCT01904773|5688658|P5|STARTED|First Intervention||3
2316735|NCT01904773|5688659|P4|STARTED|First Intervention||2
2316736|NCT01904773|5688660|P3|STARTED|First Intervention||1
2316737|NCT01904773|5688661|P2|STARTED|First Intervention||2
2316738|NCT01904773|5688662|P1|STARTED|First Intervention||0
2316739|NCT01904773|5688654|P9|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316740|NCT01904773|5688655|P8|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316741|NCT01904773|5688656|P7|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316742|NCT01904773|5688657|P6|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316743|NCT01904773|5688658|P5|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316744|NCT01904773|5688659|P4|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316745|NCT01904773|5688660|P3|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316746|NCT01904773|5688661|P2|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316747|NCT01904773|5688662|P1|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||1
2316748|NCT01904773|5688654|P9|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316749|NCT01904773|5688655|P8|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316750|NCT01904773|5688656|P7|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316751|NCT01904773|5688657|P6|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316752|NCT01904773|5688658|P5|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316753|NCT01904773|5688659|P4|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316754|NCT01904773|5688660|P3|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316755|NCT01904773|5688661|P2|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316756|NCT01904773|5688662|P1|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||23
2316757|NCT01904773|5688654|P9|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316758|NCT01904773|5688655|P8|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316759|NCT01904773|5688656|P7|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316760|NCT01904773|5688657|P6|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316761|NCT01904773|5688658|P5|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316762|NCT01904773|5688659|P4|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316763|NCT01904773|5688660|P3|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316764|NCT01904773|5688661|P2|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316765|NCT01904773|5688662|P1|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||4
2316766|NCT01904773|5688654|P9|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316767|NCT01904773|5688655|P8|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316768|NCT01904773|5688656|P7|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316769|NCT01904773|5688657|P6|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316770|NCT01904773|5688658|P5|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316771|NCT01904773|5688659|P4|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316772|NCT01904773|5688660|P3|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316773|NCT01904773|5688661|P2|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316774|NCT01904773|5688662|P1|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||20
2316775|NCT01904773|5688654|P9|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316776|NCT01904773|5688655|P8|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316777|NCT01904773|5688656|P7|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316778|NCT01904773|5688657|P6|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316779|NCT01904773|5688658|P5|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316780|NCT01904773|5688659|P4|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316781|NCT01904773|5688660|P3|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316782|NCT01904773|5688661|P2|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
2316783|NCT01904773|5688662|P1|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||24
2316784|NCT01904773|5688654|P9|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
2316785|NCT01904773|5688655|P8|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
2316786|NCT01904773|5688656|P7|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
2316787|NCT01904773|5688657|P6|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
2316788|NCT01904773|5688658|P5|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
2316789|NCT01904773|5688659|P4|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
2316790|NCT01904773|5688660|P3|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
2316791|NCT01904773|5688661|P2|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
2316792|NCT01904773|5688662|P1|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
2316793|NCT01904773|5688654|P9|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
2316794|NCT01904773|5688655|P8|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
2316795|NCT01904773|5688656|P7|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
2316796|NCT01904773|5688657|P6|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
2316797|NCT01904773|5688658|P5|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
2316798|NCT01904773|5688659|P4|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
2316799|NCT01904773|5688660|P3|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
2316800|NCT01904773|5688661|P2|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
2316801|NCT01904773|5688662|P1|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||24
2316802|NCT01904773|5688654|P9|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
2316803|NCT01904773|5688655|P8|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
2316804|NCT01904773|5688656|P7|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
2316805|NCT01904773|5688657|P6|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
2316806|NCT01904773|5688658|P5|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
2316807|NCT01904773|5688659|P4|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
2316808|NCT01904773|5688660|P3|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
2316809|NCT01904773|5688661|P2|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
2316810|NCT01904773|5688662|P1|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||24
2316811|NCT01904773|5688654|P9|NOT COMPLETED|Screen||0
2316812|NCT01904773|5688655|P8|NOT COMPLETED|Screen||0
2316813|NCT01904773|5688656|P7|NOT COMPLETED|Screen||0
2316814|NCT01904773|5688657|P6|NOT COMPLETED|Screen||0
2316815|NCT01904773|5688658|P5|NOT COMPLETED|Screen||0
2316816|NCT01904773|5688659|P4|NOT COMPLETED|Screen||0
2316817|NCT01904773|5688660|P3|NOT COMPLETED|Screen||0
2316818|NCT01904773|5688661|P2|NOT COMPLETED|Screen||0
2316819|NCT01904773|5688662|P1|NOT COMPLETED|Screen||4
2316820|NCT01904773|5688654|P9|COMPLETED|Screen||0
2316821|NCT01904773|5688655|P8|COMPLETED|Screen||0
2316822|NCT01904773|5688656|P7|COMPLETED|Screen||0
2316823|NCT01904773|5688657|P6|COMPLETED|Screen||0
2316824|NCT01904773|5688658|P5|COMPLETED|Screen||0
2316825|NCT01904773|5688659|P4|COMPLETED|Screen||0
2316826|NCT01904773|5688660|P3|COMPLETED|Screen||0
2316827|NCT01904773|5688661|P2|COMPLETED|Screen||0
2316828|NCT01904773|5688662|P1|COMPLETED|Screen||24
2316829|NCT01904773|5688654|P9|STARTED|Screen||0
2316830|NCT01904773|5688655|P8|STARTED|Screen||0
2316831|NCT01904773|5688656|P7|STARTED|Screen||0
2316832|NCT01904773|5688657|P6|STARTED|Screen||0
2316833|NCT01904773|5688658|P5|STARTED|Screen||0
2316834|NCT01904773|5688659|P4|STARTED|Screen||0
2316835|NCT01904773|5688660|P3|STARTED|Screen||0
2316836|NCT01904773|5688661|P2|STARTED|Screen||0
2316837|NCT01904773|5688662|P1|STARTED|Screen||28
2316838|NCT01904760|5688679|P2|NOT COMPLETED|Overall Study||0
2316839|NCT01904760|5688680|P1|NOT COMPLETED|Overall Study||1
2316840|NCT01904760|5688679|P2|COMPLETED|Overall Study||40
2316841|NCT01904760|5688680|P1|COMPLETED|Overall Study||39
2316842|NCT01904760|5688679|P2|STARTED|Overall Study||40
2316843|NCT01904760|5688680|P1|STARTED|Overall Study||40
2316844|NCT01904721|5688695|P7|NOT COMPLETED|Overall Study||7
2316845|NCT01904721|5688696|P6|NOT COMPLETED|Overall Study||9
2316846|NCT01904721|5688697|P5|NOT COMPLETED|Overall Study||8
2316847|NCT01904721|5688698|P4|NOT COMPLETED|Overall Study||1
2316848|NCT01904721|5688699|P3|NOT COMPLETED|Overall Study||1
2316849|NCT01904721|5688700|P2|NOT COMPLETED|Overall Study||0
2316850|NCT01904721|5688701|P1|NOT COMPLETED|Overall Study||0
2316851|NCT01904721|5688695|P7|COMPLETED|Overall Study||57
2316852|NCT01904721|5688696|P6|COMPLETED|Overall Study||56
2316853|NCT01904721|5688697|P5|COMPLETED|Overall Study||57
2316854|NCT01904721|5688698|P4|COMPLETED|Overall Study||11
2316855|NCT01904721|5688699|P3|COMPLETED|Overall Study||11
2316856|NCT01904721|5688700|P2|COMPLETED|Overall Study||13
2316857|NCT01904721|5688701|P1|COMPLETED|Overall Study||13
2316858|NCT01904721|5688695|P7|STARTED|Overall Study||64
2316859|NCT01904721|5688696|P6|STARTED|Overall Study||65
2316860|NCT01904721|5688697|P5|STARTED|Overall Study||65
2316861|NCT01904721|5688698|P4|STARTED|Overall Study||12
2316862|NCT01904721|5688699|P3|STARTED|Overall Study||12
2316863|NCT01904721|5688700|P2|STARTED|Overall Study||13
2316864|NCT01904721|5688701|P1|STARTED|Overall Study||13
2316865|NCT01904604|5688731|P3|NOT COMPLETED|Overall Study||2
2316866|NCT01904604|5688732|P2|NOT COMPLETED|Overall Study||7
2316867|NCT01904604|5688733|P1|NOT COMPLETED|Overall Study||7
2316868|NCT01904604|5688731|P3|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|23
2316869|NCT01904604|5688732|P2|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|18
2316870|NCT01904604|5688733|P1|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|18
2316871|NCT01904604|5688731|P3|Completed Week 130 OFC|Overall Study||23
2316872|NCT01904604|5688732|P2|Completed Week 130 OFC|Overall Study||18
2316873|NCT01904604|5688733|P1|Completed Week 130 OFC|Overall Study||18
2316874|NCT01904604|5688731|P3|Began Crossover Treatment|Overall Study|Per protocol, this treatment group did not crossover.|0
2316875|NCT01904604|5688732|P2|Began Crossover Treatment|Overall Study||21
2316876|NCT01904604|5688733|P1|Began Crossover Treatment|Overall Study|2 participants who completed the Week 52 OFC did not crossover; 1 passed the OFC and 1 relocated.|20
2316877|NCT01904604|5688731|P3|Completed Week 52 OFC|Overall Study||25
2316878|NCT01904604|5688732|P2|Completed Week 52 OFC|Overall Study||21
2316879|NCT01904604|5688733|P1|Completed Week 52 OFC|Overall Study||22
2316880|NCT01904604|5688731|P3|STARTED|Overall Study||25
2316881|NCT01904604|5688732|P2|STARTED|Overall Study||25
2316882|NCT01904604|5688733|P1|STARTED|Overall Study||25
2316883|NCT01904526|5688762|P1|NOT COMPLETED|Overall Study||0
2316884|NCT01904526|5688762|P1|COMPLETED|Overall Study||5
2316885|NCT01904526|5688762|P1|STARTED|Overall Study||5
2316886|NCT01904448|5688776|P1|NOT COMPLETED|Overall Study||0
2316887|NCT01904448|5688776|P1|COMPLETED|Overall Study||5
2316888|NCT01904448|5688776|P1|STARTED|Overall Study||5
2316889|NCT01904383|5688798|P1|NOT COMPLETED|Overall Study||1774
2316890|NCT01904383|5688798|P1|COMPLETED|Overall Study||2283
2316891|NCT01904383|5688798|P1|Treated|Overall Study||3940
2316892|NCT01904383|5688798|P1|STARTED|Overall Study||4057
2316893|NCT01904279|5688805|P2|NOT COMPLETED|Overall Study||3
2316894|NCT01904279|5688806|P1|NOT COMPLETED|Overall Study||3
2316895|NCT01904279|5688805|P2|COMPLETED|Overall Study||22
2316896|NCT01904279|5688806|P1|COMPLETED|Overall Study||24
2316897|NCT01904279|5688805|P2|STARTED|Overall Study||25
2316898|NCT01904279|5688806|P1|STARTED|Overall Study||27
2316899|NCT01904149|5688832|P6|NOT COMPLETED|Overall Study||3
2316900|NCT01904149|5688833|P5|NOT COMPLETED|Overall Study||5
2316901|NCT01904149|5688834|P4|NOT COMPLETED|Overall Study||4
2316902|NCT01904149|5688835|P3|NOT COMPLETED|Overall Study||2
2316903|NCT01904149|5688836|P2|NOT COMPLETED|Overall Study||11
2316904|NCT01904149|5688837|P1|NOT COMPLETED|Overall Study||5
2316905|NCT01904149|5688832|P6|COMPLETED|Overall Study||48
2316906|NCT01904149|5688833|P5|COMPLETED|Overall Study||46
2316907|NCT01904149|5688834|P4|COMPLETED|Overall Study||47
2316908|NCT01904149|5688835|P3|COMPLETED|Overall Study||148
2316909|NCT01904149|5688836|P2|COMPLETED|Overall Study||140
2316910|NCT01904149|5688837|P1|COMPLETED|Overall Study||147
2316911|NCT01904149|5688832|P6|Multiple-dose Phase|Overall Study||49
2316912|NCT01904149|5688833|P5|Multiple-dose Phase|Overall Study||48
2316913|NCT01904149|5688834|P4|Multiple-dose Phase|Overall Study||48
2316914|NCT01904149|5688835|P3|Multiple-dose Phase|Overall Study||149
2316915|NCT01904149|5688836|P2|Multiple-dose Phase|Overall Study||146
2316916|NCT01904149|5688837|P1|Multiple-dose Phase|Overall Study||150
2316917|NCT01904149|5688832|P6|Single-dose Phase|Overall Study||51
2316918|NCT01904149|5688833|P5|Single-dose Phase|Overall Study||51
2316919|NCT01904149|5688834|P4|Single-dose Phase|Overall Study||51
2316920|NCT01904149|5688835|P3|Single-dose Phase|Overall Study||150
2316921|NCT01904149|5688836|P2|Single-dose Phase|Overall Study||151
2316922|NCT01904149|5688837|P1|Single-dose Phase|Overall Study||152
2316923|NCT01904149|5688832|P6|STARTED|Overall Study||51
2316924|NCT01904149|5688833|P5|STARTED|Overall Study||51
2316925|NCT01904149|5688834|P4|STARTED|Overall Study||51
2316926|NCT01904149|5688835|P3|STARTED|Overall Study||150
2316927|NCT01904149|5688836|P2|STARTED|Overall Study||151
2316928|NCT01904149|5688837|P1|STARTED|Overall Study||152
2316929|NCT01904071|5688862|P3|NOT COMPLETED|Overall Study||0
2316930|NCT01904071|5688863|P2|NOT COMPLETED|Overall Study||0
2316931|NCT01904071|5688864|P1|NOT COMPLETED|Overall Study||0
2316932|NCT01904071|5688862|P3|COMPLETED|Overall Study||20
2316933|NCT01904071|5688863|P2|COMPLETED|Overall Study||20
2316934|NCT01904071|5688864|P1|COMPLETED|Overall Study||24
2316935|NCT01904071|5688862|P3|STARTED|Overall Study||20
2316936|NCT01904071|5688863|P2|STARTED|Overall Study||20
2316937|NCT01904071|5688864|P1|STARTED|Overall Study||24
2316938|NCT01904058|5688888|P4|NOT COMPLETED|Overall Study||1
2316939|NCT01904058|5688889|P3|NOT COMPLETED|Overall Study||1
2316940|NCT01904058|5688890|P2|NOT COMPLETED|Overall Study||0
2316941|NCT01904058|5688891|P1|NOT COMPLETED|Overall Study||3
2316942|NCT01904058|5688888|P4|COMPLETED|Overall Study||12
2316943|NCT01904058|5688889|P3|COMPLETED|Overall Study||10
2316944|NCT01904058|5688890|P2|COMPLETED|Overall Study||21
2316945|NCT01904058|5688891|P1|COMPLETED|Overall Study||18
2316946|NCT01904058|5688888|P4|STARTED|Overall Study||13
2316947|NCT01904058|5688889|P3|STARTED|Overall Study||11
2316948|NCT01904058|5688890|P2|STARTED|Overall Study||21
2316949|NCT01904058|5688891|P1|STARTED|Overall Study||21
2316950|NCT01903993|5688931|P2|NOT COMPLETED|Overall Study||144
2316951|NCT01903993|5688932|P1|NOT COMPLETED|Overall Study||143
2316952|NCT01903993|5688931|P2|COMPLETED|Overall Study||0
2316953|NCT01903993|5688932|P1|COMPLETED|Overall Study||0
2316954|NCT01903993|5688931|P2|Received Treatment|Overall Study||142
2316955|NCT01903993|5688932|P1|Received Treatment|Overall Study||135
2316956|NCT01903993|5688931|P2|STARTED|Overall Study||144
2316957|NCT01903993|5688932|P1|STARTED|Overall Study||143
2316958|NCT01903876|5688949|P2|NOT COMPLETED|Six-Month Follow-up Period||145
2316959|NCT01903876|5688950|P1|NOT COMPLETED|Six-Month Follow-up Period||91
2316960|NCT01903876|5688949|P2|COMPLETED|Six-Month Follow-up Period||123
2316961|NCT01903876|5688950|P1|COMPLETED|Six-Month Follow-up Period||92
2316962|NCT01903876|5688949|P2|STARTED|Six-Month Follow-up Period||268
2316963|NCT01903876|5688950|P1|STARTED|Six-Month Follow-up Period||183
2316964|NCT01903876|5688949|P2|NOT COMPLETED|Baseline to Post-Intervention Period||108
2316965|NCT01903876|5688950|P1|NOT COMPLETED|Baseline to Post-Intervention Period||184
2316966|NCT01903876|5688949|P2|COMPLETED|Baseline to Post-Intervention Period||268
2316967|NCT01903876|5688950|P1|COMPLETED|Baseline to Post-Intervention Period||183
2316968|NCT01903876|5688949|P2|STARTED|Baseline to Post-Intervention Period||376
2316969|NCT01903876|5688950|P1|STARTED|Baseline to Post-Intervention Period||367
2316970|NCT01903863|5688960|P2|NOT COMPLETED|Overall Study||0
2316971|NCT01903863|5688961|P1|NOT COMPLETED|Overall Study||2
2316972|NCT01903863|5688960|P2|COMPLETED|Overall Study||16
2316973|NCT01903863|5688961|P1|COMPLETED|Overall Study||13
2316974|NCT01903863|5688960|P2|STARTED|Overall Study||16
2316975|NCT01903863|5688961|P1|STARTED|Overall Study||15
2316976|NCT01903811|5688983|P2|NOT COMPLETED|Overall Study||14
2316977|NCT01903811|5688984|P1|NOT COMPLETED|Overall Study||8
2316978|NCT01903811|5688983|P2|COMPLETED|Overall Study||57
2316979|NCT01903811|5688984|P1|COMPLETED|Overall Study||64
2316980|NCT01903811|5688983|P2|Crossover to Arm II|Overall Study||0
2316981|NCT01903811|5688984|P1|Crossover to Arm II|Overall Study|Following disease progression on Arm I. Note: these patients are also counted in 'Completed'.|16
2316982|NCT01903811|5688983|P2|STARTED|Overall Study||71
2316983|NCT01903811|5688984|P1|STARTED|Overall Study||72
2316984|NCT01903798|5689001|P4|NOT COMPLETED|Overall Study||0
2316985|NCT01903798|5689002|P3|NOT COMPLETED|Overall Study||0
2316986|NCT01903798|5689003|P2|NOT COMPLETED|Overall Study||0
2316987|NCT01903798|5689004|P1|NOT COMPLETED|Overall Study||0
2316988|NCT01903798|5689001|P4|COMPLETED|Overall Study||1
2316989|NCT01903798|5689002|P3|COMPLETED|Overall Study||1
2316990|NCT01903798|5689003|P2|COMPLETED|Overall Study||0
2316991|NCT01903798|5689004|P1|COMPLETED|Overall Study||2
2316992|NCT01903798|5689001|P4|STARTED|Overall Study||1
2316993|NCT01903798|5689002|P3|STARTED|Overall Study||1
2316994|NCT01903798|5689003|P2|STARTED|Overall Study||0
2316995|NCT01903798|5689004|P1|STARTED|Overall Study||2
2316996|NCT01903720|5689018|P1|NOT COMPLETED|Overall Study||12
2316997|NCT01903720|5689018|P1|COMPLETED|Overall Study||59
2316998|NCT01903720|5689018|P1|STARTED|Overall Study||71
2316999|NCT01903564|5689035|P2|NOT COMPLETED|Overall Study||0
2317000|NCT01903564|5689036|P1|NOT COMPLETED|Overall Study||0
2317001|NCT01903564|5689035|P2|COMPLETED|Overall Study||29
2317002|NCT01903564|5689036|P1|COMPLETED|Overall Study||10
2317003|NCT01903564|5689035|P2|STARTED|Overall Study||29
2317004|NCT01903564|5689036|P1|STARTED|Overall Study||10
2317005|NCT01903460|5689056|P4|NOT COMPLETED|Overall Study||1
2317006|NCT01903460|5689057|P3|NOT COMPLETED|Overall Study||0
2317007|NCT01903460|5689058|P2|NOT COMPLETED|Overall Study||0
2317008|NCT01903460|5689059|P1|NOT COMPLETED|Overall Study||0
2317009|NCT01903460|5689056|P4|COMPLETED|Overall Study||2
2317010|NCT01903460|5689057|P3|COMPLETED|Overall Study||3
2317011|NCT01903460|5689058|P2|COMPLETED|Overall Study||8
2317012|NCT01903460|5689059|P1|COMPLETED|Overall Study||6
2317013|NCT01903460|5689056|P4|STARTED|Overall Study||3
2317014|NCT01903460|5689057|P3|STARTED|Overall Study||3
2317015|NCT01903460|5689058|P2|STARTED|Overall Study||8
2317016|NCT01903460|5689059|P1|STARTED|Overall Study||6
2317017|NCT01903434|5689076|P2|NOT COMPLETED|Treatment Period 3||0
2317018|NCT01903434|5689077|P1|NOT COMPLETED|Treatment Period 3||0
2317019|NCT01903434|5689076|P2|COMPLETED|Treatment Period 3||28
2317020|NCT01903434|5689077|P1|COMPLETED|Treatment Period 3||29
2317021|NCT01903434|5689076|P2|Received at Least 1 Dose of Study Drug|Treatment Period 3||28
2317022|NCT01903434|5689077|P1|Received at Least 1 Dose of Study Drug|Treatment Period 3||29
2317023|NCT01903434|5689076|P2|STARTED|Treatment Period 3||28
2317024|NCT01903434|5689077|P1|STARTED|Treatment Period 3||29
2317025|NCT01903434|5689076|P2|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
2317026|NCT01903434|5689077|P1|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
2317027|NCT01903434|5689076|P2|COMPLETED|Washout Period 1 (at Least 14 Days)||28
2317028|NCT01903434|5689077|P1|COMPLETED|Washout Period 1 (at Least 14 Days)||29
2317029|NCT01903434|5689076|P2|STARTED|Washout Period 1 (at Least 14 Days)||28
2317030|NCT01903434|5689077|P1|STARTED|Washout Period 1 (at Least 14 Days)||29
2317031|NCT01903434|5689076|P2|NOT COMPLETED|Treatment Period 2||0
2317032|NCT01903434|5689077|P1|NOT COMPLETED|Treatment Period 2||0
2317033|NCT01903434|5689076|P2|COMPLETED|Treatment Period 2||28
2317034|NCT01903434|5689077|P1|COMPLETED|Treatment Period 2||29
2317035|NCT01903434|5689076|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||28
2317036|NCT01903434|5689077|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||29
2317037|NCT01903434|5689076|P2|STARTED|Treatment Period 2||28
2317038|NCT01903434|5689077|P1|STARTED|Treatment Period 2||29
2317039|NCT01903434|5689076|P2|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||2
2317040|NCT01903434|5689077|P1|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||1
2317041|NCT01903434|5689076|P2|COMPLETED|Washout Period 1 (at Least 14 Days)||28
2317042|NCT01903434|5689077|P1|COMPLETED|Washout Period 1 (at Least 14 Days)||29
2317043|NCT01903434|5689076|P2|STARTED|Washout Period 1 (at Least 14 Days)||30
2317044|NCT01903434|5689077|P1|STARTED|Washout Period 1 (at Least 14 Days)||30
2317045|NCT01903434|5689076|P2|NOT COMPLETED|Treatment Period 1||0
2317046|NCT01903434|5689077|P1|NOT COMPLETED|Treatment Period 1||0
2317047|NCT01903434|5689076|P2|COMPLETED|Treatment Period 1||30
2317048|NCT01903434|5689077|P1|COMPLETED|Treatment Period 1||30
2317049|NCT01903434|5689076|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||30
2317050|NCT01903434|5689077|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||30
2317051|NCT01903434|5689076|P2|STARTED|Treatment Period 1||30
2317052|NCT01903434|5689077|P1|STARTED|Treatment Period 1||30
2317053|NCT01903356|5689085|P1|NOT COMPLETED|Overall Study||15
2317054|NCT01903356|5689085|P1|COMPLETED|Overall Study||709
2317055|NCT01903356|5689085|P1|STARTED|Overall Study||724
2317056|NCT01903265|5689095|P2|NOT COMPLETED|Overall Study||17
2317057|NCT01903265|5689096|P1|NOT COMPLETED|Overall Study||14
2317058|NCT01903265|5689095|P2|COMPLETED|Overall Study||85
2317059|NCT01903265|5689096|P1|COMPLETED|Overall Study||89
2317060|NCT01903265|5689095|P2|STARTED|Overall Study||102
2317061|NCT01903265|5689096|P1|STARTED|Overall Study||103
2317062|NCT01903252|5689112|P6|NOT COMPLETED|Maintenance, Open-Label||18
2317063|NCT01903252|5689113|P5|NOT COMPLETED|Maintenance, Open-Label||21
2317064|NCT01903252|5689114|P4|NOT COMPLETED|Maintenance, Open-Label||6
2317065|NCT01903252|5689115|P3|NOT COMPLETED|Maintenance, Open-Label||0
2317066|NCT01903252|5689116|P2|NOT COMPLETED|Maintenance, Open-Label||0
2317067|NCT01903252|5689117|P1|NOT COMPLETED|Maintenance, Open-Label||0
2317068|NCT01903252|5689112|P6|COMPLETED|Maintenance, Open-Label||181
2317069|NCT01903252|5689113|P5|COMPLETED|Maintenance, Open-Label||253
2317070|NCT01903252|5689114|P4|COMPLETED|Maintenance, Open-Label||196
2317071|NCT01903252|5689115|P3|COMPLETED|Maintenance, Open-Label||0
2317072|NCT01903252|5689116|P2|COMPLETED|Maintenance, Open-Label||0
2317073|NCT01903252|5689117|P1|COMPLETED|Maintenance, Open-Label||0
2317074|NCT01903252|5689112|P6|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|199
2317075|NCT01903252|5689113|P5|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|274
2317076|NCT01903252|5689114|P4|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|202
2317077|NCT01903252|5689115|P3|STARTED|Maintenance, Open-Label|Period 2 (extended induction) is completed, subjects are newly allocated to Period 3, maintenance.|0
2317078|NCT01903252|5689116|P2|STARTED|Maintenance, Open-Label||0
2317079|NCT01903252|5689117|P1|STARTED|Maintenance, Open-Label||0
2317080|NCT01903252|5689112|P6|NOT COMPLETED|Extended Induction, Open-Label||0
2317081|NCT01903252|5689113|P5|NOT COMPLETED|Extended Induction, Open-Label||0
2317082|NCT01903252|5689114|P4|NOT COMPLETED|Extended Induction, Open-Label||0
2317083|NCT01903252|5689115|P3|NOT COMPLETED|Extended Induction, Open-Label||23
2317084|NCT01903252|5689116|P2|NOT COMPLETED|Extended Induction, Open-Label||0
2317085|NCT01903252|5689117|P1|NOT COMPLETED|Extended Induction, Open-Label||0
2317086|NCT01903252|5689112|P6|COMPLETED|Extended Induction, Open-Label||0
2317087|NCT01903252|5689113|P5|COMPLETED|Extended Induction, Open-Label||0
2317088|NCT01903252|5689114|P4|COMPLETED|Extended Induction, Open-Label||0
2317089|NCT01903252|5689115|P3|COMPLETED|Extended Induction, Open-Label||220
2317090|NCT01903252|5689116|P2|COMPLETED|Extended Induction, Open-Label||0
2317091|NCT01903252|5689117|P1|COMPLETED|Extended Induction, Open-Label||0
2317092|NCT01903252|5689112|P6|STARTED|Extended Induction, Open-Label||0
2317093|NCT01903252|5689113|P5|STARTED|Extended Induction, Open-Label||0
2317094|NCT01903252|5689114|P4|STARTED|Extended Induction, Open-Label||0
2317095|NCT01903252|5689115|P3|STARTED|Extended Induction, Open-Label|The subjects in this phase were non-responders at week 8 and discontinued the double-blind phase.|243
2317096|NCT01903252|5689116|P2|STARTED|Extended Induction, Open-Label|This treatment arm was only used in Period 1, double-blind induction phase.|0
2317097|NCT01903252|5689117|P1|STARTED|Extended Induction, Open-Label||0
2317098|NCT01903252|5689112|P6|NOT COMPLETED|Double-Blind Induction||0
2317099|NCT01903252|5689113|P5|NOT COMPLETED|Double-Blind Induction||0
2317100|NCT01903252|5689114|P4|NOT COMPLETED|Double-Blind Induction||0
2317101|NCT01903252|5689115|P3|NOT COMPLETED|Double-Blind Induction||0
2317102|NCT01903252|5689116|P2|NOT COMPLETED|Double-Blind Induction||41
2317103|NCT01903252|5689117|P1|NOT COMPLETED|Double-Blind Induction||39
2317104|NCT01903252|5689112|P6|COMPLETED|Double-Blind Induction||0
2317105|NCT01903252|5689113|P5|COMPLETED|Double-Blind Induction||0
2317106|NCT01903252|5689114|P4|COMPLETED|Double-Blind Induction||0
2317107|NCT01903252|5689115|P3|COMPLETED|Double-Blind Induction||0
2317108|NCT01903252|5689116|P2|COMPLETED|Double-Blind Induction||367
2317109|NCT01903252|5689117|P1|COMPLETED|Double-Blind Induction||370
2317110|NCT01903252|5689112|P6|STARTED|Double-Blind Induction||0
2317111|NCT01903252|5689113|P5|STARTED|Double-Blind Induction||0
2317112|NCT01903252|5689114|P4|STARTED|Double-Blind Induction||0
2317113|NCT01903252|5689115|P3|STARTED|Double-Blind Induction||0
2317114|NCT01903252|5689116|P2|STARTED|Double-Blind Induction||408
2317115|NCT01903252|5689117|P1|STARTED|Double-Blind Induction||409
2317116|NCT01903187|5689196|P2|NOT COMPLETED|12 Month||0
2317117|NCT01903187|5689197|P1|NOT COMPLETED|12 Month||0
2317118|NCT01903187|5689196|P2|COMPLETED|12 Month||0
2317119|NCT01903187|5689197|P1|COMPLETED|12 Month||2
2317120|NCT01903187|5689196|P2|STARTED|12 Month||0
2317121|NCT01903187|5689197|P1|STARTED|12 Month||2
2317122|NCT01903187|5689196|P2|NOT COMPLETED|6 Month||0
2317123|NCT01903187|5689197|P1|NOT COMPLETED|6 Month||0
2317124|NCT01903187|5689196|P2|COMPLETED|6 Month||0
2317125|NCT01903187|5689197|P1|COMPLETED|6 Month||2
2317126|NCT01903187|5689196|P2|STARTED|6 Month||0
2317127|NCT01903187|5689197|P1|STARTED|6 Month||2
2317128|NCT01903187|5689196|P2|NOT COMPLETED|3 Month||0
2317129|NCT01903187|5689197|P1|NOT COMPLETED|3 Month||0
2317130|NCT01903187|5689196|P2|COMPLETED|3 Month||0
2317131|NCT01903187|5689197|P1|COMPLETED|3 Month||2
2317132|NCT01903187|5689196|P2|STARTED|3 Month||0
2317133|NCT01903187|5689197|P1|STARTED|3 Month||2
2317134|NCT01903187|5689196|P2|NOT COMPLETED|1 Month||0
2317135|NCT01903187|5689197|P1|NOT COMPLETED|1 Month||0
2317136|NCT01903187|5689196|P2|COMPLETED|1 Month||2
2317137|NCT01903187|5689197|P1|COMPLETED|1 Month||2
2317138|NCT01903187|5689196|P2|STARTED|1 Month||2
2317139|NCT01903187|5689197|P1|STARTED|1 Month||2
2317140|NCT01903187|5689196|P2|NOT COMPLETED|Procedure||0
2317141|NCT01903187|5689197|P1|NOT COMPLETED|Procedure||0
2317142|NCT01903187|5689196|P2|COMPLETED|Procedure||2
2317143|NCT01903187|5689197|P1|COMPLETED|Procedure||2
2317144|NCT01903187|5689196|P2|STARTED|Procedure||2
2317145|NCT01903187|5689197|P1|STARTED|Procedure||2
2317146|NCT01903148|5689211|P1|NOT COMPLETED|Overall Study||0
2317147|NCT01903148|5689211|P1|COMPLETED|Overall Study||441
2317148|NCT01903148|5689211|P1|STARTED|Overall Study||441
2317149|NCT01903031|5689230|P3|NOT COMPLETED|Overall Study||5
2317150|NCT01903031|5689231|P2|NOT COMPLETED|Overall Study||3
2317151|NCT01903031|5689232|P1|NOT COMPLETED|Overall Study||2
2317152|NCT01903031|5689230|P3|COMPLETED|Overall Study||24
2317153|NCT01903031|5689231|P2|COMPLETED|Overall Study||25
2317154|NCT01903031|5689232|P1|COMPLETED|Overall Study||25
2317155|NCT01903031|5689230|P3|STARTED|Overall Study||29
2317156|NCT01903031|5689231|P2|STARTED|Overall Study||28
2317157|NCT01903031|5689232|P1|STARTED|Overall Study||27
2317158|NCT01903005|5689274|P1|NOT COMPLETED|Overall Study||373
2317159|NCT01903005|5689274|P1|COMPLETED|Overall Study|Primary study OX219-006 (n=194); Primary study OX219-007 (n=98)|292
2317160|NCT01903005|5689274|P1|STARTED|Overall Study|Primary study OX219-006 (n=475); Primary study OX219-007 (n=190)|665
2317161|NCT01902901|5689290|P2|NOT COMPLETED|Overall Study||2
2317162|NCT01902901|5689291|P1|NOT COMPLETED|Overall Study||0
2317163|NCT01902901|5689290|P2|COMPLETED|Overall Study||201
2317164|NCT01902901|5689291|P1|COMPLETED|Overall Study||180
2317165|NCT01902901|5689290|P2|STARTED|Overall Study||203
2317166|NCT01902901|5689291|P1|STARTED|Overall Study||180
2317167|NCT01902888|5689301|P1|NOT COMPLETED|Overall Study||3
2317168|NCT01902888|5689301|P1|COMPLETED|Overall Study||0
2317169|NCT01902888|5689301|P1|STARTED|Overall Study||3
2317170|NCT01902758|5689308|P2|NOT COMPLETED|Overall Study||0
2317171|NCT01902758|5689309|P1|NOT COMPLETED|Overall Study||0
2317172|NCT01902758|5689308|P2|COMPLETED|Overall Study||14
2317173|NCT01902758|5689309|P1|COMPLETED|Overall Study||14
2317174|NCT01902758|5689308|P2|STARTED|Overall Study||14
2317175|NCT01902758|5689309|P1|STARTED|Overall Study||14
2317176|NCT01902628|5689315|P1|NOT COMPLETED|Overall Study||83
2317177|NCT01902628|5689315|P1|COMPLETED|Overall Study||354
2317178|NCT01902628|5689315|P1|STARTED|Overall Study||437
2317179|NCT01902459|5689324|P2|NOT COMPLETED|Overall Study||0
2317180|NCT01902459|5689325|P1|NOT COMPLETED|Overall Study||0
2317181|NCT01902459|5689324|P2|COMPLETED|Overall Study||75
2317182|NCT01902459|5689325|P1|COMPLETED|Overall Study||75
2317183|NCT01902459|5689324|P2|STARTED|Overall Study||75
2317184|NCT01902459|5689325|P1|STARTED|Overall Study||75
2317185|NCT01902303|5689343|P2|NOT COMPLETED|Overall Study||24
2317186|NCT01902303|5689344|P1|NOT COMPLETED|Overall Study||23
2317187|NCT01902303|5689343|P2|COMPLETED|Overall Study|19 not treated /did not use medication as they did not develop a cold sore|57
2317188|NCT01902303|5689344|P1|COMPLETED|Overall Study|21 not treated - did not use placebo medication as they did not develop cold sore|54
2317189|NCT01902303|5689343|P2|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|62
2317190|NCT01902303|5689344|P1|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|56
2317191|NCT01902303|5689343|P2|STARTED|Overall Study|Allocated to active treatment|81
2317192|NCT01902303|5689344|P1|STARTED|Overall Study|Allocated to placebo|77
2317193|NCT01902134|5689358|P6|NOT COMPLETED|Overall Study||9
2317194|NCT01902134|5689359|P5|NOT COMPLETED|Overall Study||7
2317195|NCT01902134|5689360|P4|NOT COMPLETED|Overall Study||2
2317196|NCT01902134|5689361|P3|NOT COMPLETED|Overall Study||15
2317197|NCT01902134|5689362|P2|NOT COMPLETED|Overall Study||11
2317198|NCT01902134|5689363|P1|NOT COMPLETED|Overall Study||8
2317199|NCT01902134|5689358|P6|COMPLETED|Overall Study||45
2317200|NCT01902134|5689359|P5|COMPLETED|Overall Study||46
2317201|NCT01902134|5689360|P4|COMPLETED|Overall Study||52
2317202|NCT01902134|5689361|P3|COMPLETED|Overall Study||145
2317203|NCT01902134|5689362|P2|COMPLETED|Overall Study||150
2317204|NCT01902134|5689363|P1|COMPLETED|Overall Study||151
2317205|NCT01902134|5689358|P6|Multiple-dose Phase|Overall Study||52
2317206|NCT01902134|5689359|P5|Multiple-dose Phase|Overall Study||53
2317207|NCT01902134|5689360|P4|Multiple-dose Phase|Overall Study||54
2317208|NCT01902134|5689361|P3|Multiple-dose Phase|Overall Study||160
2317209|NCT01902134|5689362|P2|Multiple-dose Phase|Overall Study||160
2317210|NCT01902134|5689363|P1|Multiple-dose Phase|Overall Study||159
2317211|NCT01902134|5689358|P6|Single-dose Phase|Overall Study||54
2317212|NCT01902134|5689359|P5|Single-dose Phase|Overall Study||53
2317213|NCT01902134|5689360|P4|Single-dose Phase|Overall Study||54
2317214|NCT01902134|5689361|P3|Single-dose Phase|Overall Study||160
2317215|NCT01902134|5689362|P2|Single-dose Phase|Overall Study||161
2317216|NCT01902134|5689363|P1|Single-dose Phase|Overall Study||159
2317217|NCT01902134|5689358|P6|STARTED|Overall Study||54
2317218|NCT01902134|5689359|P5|STARTED|Overall Study||53
2317219|NCT01902134|5689360|P4|STARTED|Overall Study||54
2317220|NCT01902134|5689361|P3|STARTED|Overall Study||160
2317221|NCT01902134|5689362|P2|STARTED|Overall Study||161
2317222|NCT01902134|5689363|P1|STARTED|Overall Study||159
2317223|NCT01902004|5689387|P2|NOT COMPLETED|Overall Study||18
2317224|NCT01902004|5689388|P1|NOT COMPLETED|Overall Study||15
2317225|NCT01902004|5689387|P2|COMPLETED|Overall Study||29
2317226|NCT01902004|5689388|P1|COMPLETED|Overall Study||33
2317227|NCT01902004|5689387|P2|STARTED|Overall Study||47
2317228|NCT01902004|5689388|P1|STARTED|Overall Study||48
2317229|NCT01901874|5689400|P1|NOT COMPLETED|1-Year (365-Day) MAE Evaluation||20
2317230|NCT01901874|5689400|P1|COMPLETED|1-Year (365-Day) MAE Evaluation||244
2317231|NCT01901874|5689400|P1|STARTED|1-Year (365-Day) MAE Evaluation||264
2317232|NCT01901874|5689400|P1|NOT COMPLETED|30-Day MAE Evaluation||1
2317233|NCT01901874|5689400|P1|COMPLETED|30-Day MAE Evaluation||264
2317234|NCT01901874|5689400|P1|STARTED|30-Day MAE Evaluation||265
2317235|NCT01901874|5689400|P1|NOT COMPLETED|Screening Committee Retrospective Review||47
2317236|NCT01901874|5689400|P1|COMPLETED|Screening Committee Retrospective Review||265
2317237|NCT01901874|5689400|P1|STARTED|Screening Committee Retrospective Review||312
2317238|NCT01901874|5689400|P1|NOT COMPLETED|Procedure||0
2317239|NCT01901874|5689400|P1|COMPLETED|Procedure||312
2317240|NCT01901874|5689400|P1|STARTED|Procedure||312
2317241|NCT01901848|5689415|P2|NOT COMPLETED|Removed From Analyses||0
2317242|NCT01901848|5689416|P1|NOT COMPLETED|Removed From Analyses||10
2317243|NCT01901848|5689415|P2|COMPLETED|Removed From Analyses||19
2317244|NCT01901848|5689416|P1|COMPLETED|Removed From Analyses||12
2317245|NCT01901848|5689415|P2|STARTED|Removed From Analyses||19
2317246|NCT01901848|5689416|P1|STARTED|Removed From Analyses||22
2317247|NCT01901848|5689415|P2|NOT COMPLETED|Randomized and Treated||6
2317248|NCT01901848|5689416|P1|NOT COMPLETED|Randomized and Treated||3
2317249|NCT01901848|5689415|P2|COMPLETED|Randomized and Treated||19
2317250|NCT01901848|5689416|P1|COMPLETED|Randomized and Treated|Ten cases were practice cases used to establish fidelity to CPT, and were removed from analyses.|22
2317251|NCT01901848|5689415|P2|STARTED|Randomized and Treated||25
2317252|NCT01901848|5689416|P1|STARTED|Randomized and Treated||25
2317253|NCT01901809|5689428|P4|NOT COMPLETED|Overall Study||2
2317254|NCT01901809|5689429|P3|NOT COMPLETED|Overall Study||3
2317255|NCT01901809|5689430|P2|NOT COMPLETED|Overall Study||0
2317256|NCT01901809|5689431|P1|NOT COMPLETED|Overall Study||0
2317257|NCT01901809|5689428|P4|COMPLETED|Overall Study||22
2317258|NCT01901809|5689429|P3|COMPLETED|Overall Study||21
2317259|NCT01901809|5689430|P2|COMPLETED|Overall Study||23
2317260|NCT01901809|5689431|P1|COMPLETED|Overall Study||19
2317261|NCT01901809|5689428|P4|STARTED|Overall Study||24
2317262|NCT01901809|5689429|P3|STARTED|Overall Study||24
2317263|NCT01901809|5689430|P2|STARTED|Overall Study||23
2317264|NCT01901809|5689431|P1|STARTED|Overall Study||19
2317265|NCT01901653|5689458|P13|NOT COMPLETED|Overall Study||5
2317266|NCT01901653|5689459|P12|NOT COMPLETED|Overall Study||16
2317267|NCT01901653|5689460|P11|NOT COMPLETED|Overall Study||2
2317268|NCT01901653|5689461|P10|NOT COMPLETED|Overall Study||18
2317269|NCT01901653|5689462|P9|NOT COMPLETED|Overall Study||1
2317270|NCT01901653|5689463|P8|NOT COMPLETED|Overall Study||10
2317271|NCT01901653|5689464|P7|NOT COMPLETED|Overall Study||7
2317272|NCT01901653|5689465|P6|NOT COMPLETED|Overall Study||3
2317273|NCT01901653|5689466|P5|NOT COMPLETED|Overall Study||2
2317274|NCT01901653|5689467|P4|NOT COMPLETED|Overall Study||3
2317275|NCT01901653|5689468|P3|NOT COMPLETED|Overall Study||11
2317276|NCT01901653|5689469|P2|NOT COMPLETED|Overall Study||1
2317277|NCT01901653|5689470|P1|NOT COMPLETED|Overall Study||3
2317278|NCT01901653|5689458|P13|COMPLETED|Overall Study||0
2317279|NCT01901653|5689459|P12|COMPLETED|Overall Study||0
2317280|NCT01901653|5689460|P11|COMPLETED|Overall Study||0
2317281|NCT01901653|5689461|P10|COMPLETED|Overall Study||0
2317282|NCT01901653|5689462|P9|COMPLETED|Overall Study||0
2317283|NCT01901653|5689463|P8|COMPLETED|Overall Study||0
2317284|NCT01901653|5689464|P7|COMPLETED|Overall Study||0
2317285|NCT01901653|5689465|P6|COMPLETED|Overall Study||0
2317286|NCT01901653|5689466|P5|COMPLETED|Overall Study||0
2317287|NCT01901653|5689467|P4|COMPLETED|Overall Study||0
2317288|NCT01901653|5689468|P3|COMPLETED|Overall Study||0
2317289|NCT01901653|5689469|P2|COMPLETED|Overall Study||0
2317290|NCT01901653|5689470|P1|COMPLETED|Overall Study||0
2317291|NCT01901653|5689458|P13|STARTED|Overall Study||5
2317292|NCT01901653|5689459|P12|STARTED|Overall Study||16
2317293|NCT01901653|5689460|P11|STARTED|Overall Study||2
2317294|NCT01901653|5689461|P10|STARTED|Overall Study||18
2317295|NCT01901653|5689462|P9|STARTED|Overall Study||1
2317296|NCT01901653|5689463|P8|STARTED|Overall Study||10
2317297|NCT01901653|5689464|P7|STARTED|Overall Study||7
2317298|NCT01901653|5689465|P6|STARTED|Overall Study||3
2317299|NCT01901653|5689466|P5|STARTED|Overall Study||2
2317300|NCT01901653|5689467|P4|STARTED|Overall Study||3
2317301|NCT01901653|5689468|P3|STARTED|Overall Study||11
2317302|NCT01901653|5689469|P2|STARTED|Overall Study||1
2317303|NCT01901653|5689470|P1|STARTED|Overall Study||3
2317304|NCT01901614|5689514|P2|NOT COMPLETED|Overall Study||1
2317305|NCT01901614|5689515|P1|NOT COMPLETED|Overall Study||2
2317306|NCT01901614|5689514|P2|COMPLETED|Overall Study||1
2317307|NCT01901614|5689515|P1|COMPLETED|Overall Study||1
2317308|NCT01901614|5689514|P2|STARTED|Overall Study||2
2317309|NCT01901614|5689515|P1|STARTED|Overall Study||3
2317310|NCT01901588|5689523|P2|NOT COMPLETED|Overall Study||0
2317311|NCT01901588|5689524|P1|NOT COMPLETED|Overall Study||0
2317312|NCT01901588|5689523|P2|COMPLETED|Overall Study||31
2317313|NCT01901588|5689524|P1|COMPLETED|Overall Study||32
2317314|NCT01901588|5689523|P2|STARTED|Overall Study||31
2317315|NCT01901588|5689524|P1|STARTED|Overall Study||32
2317316|NCT01901575|5689540|P1|NOT COMPLETED|Overall Study||0
2317317|NCT01901575|5689540|P1|COMPLETED|Overall Study||16
2317318|NCT01901575|5689540|P1|STARTED|Overall Study|enrolled patients with PVC's present prior to sedation with remifentanil IVPCA|16
2317319|NCT01901432|5689550|P5|NOT COMPLETED|Overall Study||9
2317320|NCT01901432|5689551|P4|NOT COMPLETED|Overall Study||0
2317321|NCT01901432|5689552|P3|NOT COMPLETED|Overall Study||2
2317322|NCT01901432|5689553|P2|NOT COMPLETED|Overall Study||1
2317323|NCT01901432|5689554|P1|NOT COMPLETED|Overall Study||0
2317324|NCT01901432|5689550|P5|COMPLETED|Overall Study||27
2317325|NCT01901432|5689551|P4|COMPLETED|Overall Study||3
2317326|NCT01901432|5689552|P3|COMPLETED|Overall Study||1
2317327|NCT01901432|5689553|P2|COMPLETED|Overall Study||2
2317328|NCT01901432|5689554|P1|COMPLETED|Overall Study||3
2317329|NCT01901432|5689550|P5|Received Study Drug|Overall Study||35
2317330|NCT01901432|5689551|P4|Received Study Drug|Overall Study||3
2317331|NCT01901432|5689552|P3|Received Study Drug|Overall Study||3
2317332|NCT01901432|5689553|P2|Received Study Drug|Overall Study||3
2317333|NCT01901432|5689554|P1|Received Study Drug|Overall Study||3
2317334|NCT01901432|5689550|P5|STARTED|Overall Study||36
2317335|NCT01901432|5689551|P4|STARTED|Overall Study||3
2317336|NCT01901432|5689552|P3|STARTED|Overall Study||3
2317337|NCT01901432|5689553|P2|STARTED|Overall Study||3
2317338|NCT01901432|5689554|P1|STARTED|Overall Study||3
2317339|NCT01901393|5689606|P2|NOT COMPLETED|Overall Study||0
2317340|NCT01901393|5689607|P1|NOT COMPLETED|Overall Study||1
2317341|NCT01901393|5689606|P2|COMPLETED|Overall Study||49
2317342|NCT01901393|5689607|P1|COMPLETED|Overall Study||50
2317343|NCT01901393|5689606|P2|STARTED|Overall Study||49
2317344|NCT01901393|5689607|P1|STARTED|Overall Study||51
2317345|NCT01901341|5689625|P2|NOT COMPLETED|Overall Study||21
2317346|NCT01901341|5689626|P1|NOT COMPLETED|Overall Study||20
2317347|NCT01901341|5689625|P2|COMPLETED|Overall Study||1
2317348|NCT01901341|5689626|P1|COMPLETED|Overall Study||2
2317349|NCT01901341|5689625|P2|Received at Least 1 Dose of Study Drug|Overall Study||22
2317350|NCT01901341|5689626|P1|Received at Least 1 Dose of Study Drug|Overall Study||22
2317351|NCT01901341|5689625|P2|STARTED|Overall Study||22
2317352|NCT01901341|5689626|P1|STARTED|Overall Study||22
2317353|NCT01901328|5689640|P2|NOT COMPLETED|Overall Study||21
2317354|NCT01901328|5689641|P1|NOT COMPLETED|Overall Study||22
2317355|NCT01901328|5689640|P2|COMPLETED|Overall Study||2
2317356|NCT01901328|5689641|P1|COMPLETED|Overall Study||4
2317357|NCT01901328|5689640|P2|Received at Least 1 Dose of Study Drug|Overall Study||23
2317358|NCT01901328|5689641|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
2317359|NCT01901328|5689640|P2|STARTED|Overall Study||23
2317360|NCT01901328|5689641|P1|STARTED|Overall Study||26
2317361|NCT01901302|5689655|P2|NOT COMPLETED|Overall Study||23
2317362|NCT01901302|5689656|P1|NOT COMPLETED|Overall Study||27
2317363|NCT01901302|5689655|P2|COMPLETED|Overall Study||7
2317364|NCT01901302|5689656|P1|COMPLETED|Overall Study||4
2317365|NCT01901302|5689655|P2|Received at Least 1 Dose of Study Drug|Overall Study||30
2317366|NCT01901302|5689656|P1|Received at Least 1 Dose of Study Drug|Overall Study||31
2317367|NCT01901302|5689655|P2|STARTED|Overall Study||30
2317368|NCT01901302|5689656|P1|STARTED|Overall Study||31
2317369|NCT01901289|5689668|P1|NOT COMPLETED|Overall Study||200
2317370|NCT01901289|5689668|P1|COMPLETED|Overall Study||0
2317371|NCT01901289|5689668|P1|12-Month Follow-up|Overall Study||175
2317372|NCT01901289|5689668|P1|STARTED|Overall Study||200
2317373|NCT01901250|5689674|P2|NOT COMPLETED|Overall Study||126
2317374|NCT01901250|5689675|P1|NOT COMPLETED|Overall Study||138
2317375|NCT01901250|5689674|P2|COMPLETED|Overall Study||139
2317376|NCT01901250|5689675|P1|COMPLETED|Overall Study||122
2317377|NCT01901250|5689674|P2|End of 1st Grade|Overall Study||151
2317378|NCT01901250|5689675|P1|End of 1st Grade|Overall Study||143
2317379|NCT01901250|5689674|P2|Start of 1st Grade|Overall Study||176
2317380|NCT01901250|5689675|P1|Start of 1st Grade|Overall Study||173
2317381|NCT01901250|5689674|P2|End of Kidergarten|Overall Study||212
2317382|NCT01901250|5689675|P1|End of Kidergarten|Overall Study||215
2317383|NCT01901250|5689674|P2|STARTED|Overall Study||265
2317384|NCT01901250|5689675|P1|STARTED|Overall Study||260
2317385|NCT01901224|5689681|P1|NOT COMPLETED|Overall Study||2
2317386|NCT01901224|5689681|P1|COMPLETED|Overall Study||0
2317387|NCT01901224|5689681|P1|STARTED|Overall Study||2
2317388|NCT01901211|5689692|P2|NOT COMPLETED|Second Ten-week Period||0
2317389|NCT01901211|5689693|P1|NOT COMPLETED|Second Ten-week Period||0
2317390|NCT01901211|5689692|P2|COMPLETED|Second Ten-week Period||5
2317391|NCT01901211|5689693|P1|COMPLETED|Second Ten-week Period||6
2317392|NCT01901211|5689692|P2|STARTED|Second Ten-week Period||5
2317393|NCT01901211|5689693|P1|STARTED|Second Ten-week Period||6
2317394|NCT01901211|5689692|P2|NOT COMPLETED|Washout (6 Weeks)||0
2317395|NCT01901211|5689693|P1|NOT COMPLETED|Washout (6 Weeks)||0
2317396|NCT01901211|5689692|P2|COMPLETED|Washout (6 Weeks)||5
2317397|NCT01901211|5689693|P1|COMPLETED|Washout (6 Weeks)||6
2317398|NCT01901211|5689692|P2|STARTED|Washout (6 Weeks)||5
2317399|NCT01901211|5689693|P1|STARTED|Washout (6 Weeks)||6
2317400|NCT01901211|5689692|P2|NOT COMPLETED|First Ten-week Period||0
2317401|NCT01901211|5689693|P1|NOT COMPLETED|First Ten-week Period||0
2317402|NCT01901211|5689692|P2|COMPLETED|First Ten-week Period||5
2317403|NCT01901211|5689693|P1|COMPLETED|First Ten-week Period||6
2317404|NCT01901211|5689692|P2|STARTED|First Ten-week Period||5
2317405|NCT01901211|5689693|P1|STARTED|First Ten-week Period||6
2317406|NCT01901185|5689716|P1|NOT COMPLETED|Overall Study||2
2317407|NCT01901185|5689716|P1|COMPLETED|Overall Study||75
2317408|NCT01901185|5689716|P1|Received Etanercept With Autoinjector A|Overall Study||75
2317409|NCT01901185|5689716|P1|STARTED|Overall Study||77
2317410|NCT01901146|5689725|P5|NOT COMPLETED|Adjuvant Phase||14
2317411|NCT01901146|5689726|P4|NOT COMPLETED|Adjuvant Phase||7
2317412|NCT01901146|5689727|P3|NOT COMPLETED|Adjuvant Phase||26
2317413|NCT01901146|5689728|P2|NOT COMPLETED|Adjuvant Phase||0
2317414|NCT01901146|5689729|P1|NOT COMPLETED|Adjuvant Phase||0
2317415|NCT01901146|5689725|P5|COMPLETED|Adjuvant Phase||157
2317416|NCT01901146|5689726|P4|COMPLETED|Adjuvant Phase||164
2317417|NCT01901146|5689727|P3|COMPLETED|Adjuvant Phase||323
2317418|NCT01901146|5689728|P2|COMPLETED|Adjuvant Phase||0
2317419|NCT01901146|5689729|P1|COMPLETED|Adjuvant Phase||0
2317420|NCT01901146|5689725|P5|STARTED|Adjuvant Phase|Three participants discontinued the study after surgery but before entering adjuvant phase.|171
2317421|NCT01901146|5689726|P4|STARTED|Adjuvant Phase|Two participants discontinued the study after surgery but before entering adjuvant phase.|171
2317422|NCT01901146|5689727|P3|STARTED|Adjuvant Phase|Nine participants discontinued the study after surgery but before entering adjuvant phase.|349
2317423|NCT01901146|5689728|P2|STARTED|Adjuvant Phase||0
2317424|NCT01901146|5689729|P1|STARTED|Adjuvant Phase||0
2317425|NCT01901146|5689725|P5|NOT COMPLETED|Neoadjuvant Phase||0
2317426|NCT01901146|5689726|P4|NOT COMPLETED|Neoadjuvant Phase||0
2317427|NCT01901146|5689727|P3|NOT COMPLETED|Neoadjuvant Phase||0
2317428|NCT01901146|5689728|P2|NOT COMPLETED|Neoadjuvant Phase||14
2317429|NCT01901146|5689729|P1|NOT COMPLETED|Neoadjuvant Phase||6
2317430|NCT01901146|5689725|P5|COMPLETED|Neoadjuvant Phase||0
2317431|NCT01901146|5689726|P4|COMPLETED|Neoadjuvant Phase||0
2317432|NCT01901146|5689727|P3|COMPLETED|Neoadjuvant Phase||0
2317433|NCT01901146|5689728|P2|COMPLETED|Neoadjuvant Phase|Indicates participants who completed surgery|347
2317434|NCT01901146|5689729|P1|COMPLETED|Neoadjuvant Phase|Indicates participants who completed surgery|358
2317435|NCT01901146|5689725|P5|STARTED|Neoadjuvant Phase||0
2317436|NCT01901146|5689726|P4|STARTED|Neoadjuvant Phase||0
2317437|NCT01901146|5689727|P3|STARTED|Neoadjuvant Phase||0
2317438|NCT01901146|5689728|P2|STARTED|Neoadjuvant Phase||361
2317439|NCT01901146|5689729|P1|STARTED|Neoadjuvant Phase||364
2317440|NCT01900899|5689744|P2|NOT COMPLETED|Overall Study||1
2317441|NCT01900899|5689745|P1|NOT COMPLETED|Overall Study||9
2317442|NCT01900899|5689744|P2|COMPLETED|Overall Study||24
2317443|NCT01900899|5689745|P1|COMPLETED|Overall Study||150
2317444|NCT01900899|5689744|P2|STARTED|Overall Study||25
2317445|NCT01900899|5689745|P1|STARTED|Overall Study||159
2317452|NCT01900665|5689780|P2|NOT COMPLETED|Open Label Period||859
2317453|NCT01900665|5689781|P1|NOT COMPLETED|Open Label Period||881
2317454|NCT01900665|5689780|P2|COMPLETED|Open Label Period||0
2317455|NCT01900665|5689781|P1|COMPLETED|Open Label Period||0
2317456|NCT01900665|5689780|P2|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|859
2317457|NCT01900665|5689781|P1|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|881
2317458|NCT01900665|5689780|P2|NOT COMPLETED|Placebo Controlled Period||164
2317459|NCT01900665|5689781|P1|NOT COMPLETED|Placebo Controlled Period||143
2317460|NCT01900665|5689780|P2|COMPLETED|Placebo Controlled Period||908
2317461|NCT01900665|5689781|P1|COMPLETED|Placebo Controlled Period||914
2317462|NCT01900665|5689780|P2|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1067
2317463|NCT01900665|5689781|P1|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1054
2317464|NCT01900665|5689780|P2|STARTED|Placebo Controlled Period||1072
2317465|NCT01900665|5689781|P1|STARTED|Placebo Controlled Period||1057
2317466|NCT01900652|5689824|P2|NOT COMPLETED|Overall Study||3
2317467|NCT01900652|5689825|P1|NOT COMPLETED|Overall Study||8
2317468|NCT01900652|5689824|P2|COMPLETED|Overall Study||25
2317469|NCT01900652|5689825|P1|COMPLETED|Overall Study||75
2317470|NCT01900652|5689824|P2|Post-Erlotinib Progression Tumor Sample|Overall Study||23
2317471|NCT01900652|5689825|P1|Post-Erlotinib Progression Tumor Sample|Overall Study||66
2317472|NCT01900652|5689824|P2|STARTED|Overall Study||28
2317473|NCT01900652|5689825|P1|STARTED|Overall Study||83
2317474|NCT01900626|5689861|P2|NOT COMPLETED|Overall Study||1
2317475|NCT01900626|5689862|P1|NOT COMPLETED|Overall Study||1
2317476|NCT01900626|5689861|P2|COMPLETED|Overall Study||0
2317477|NCT01900626|5689862|P1|COMPLETED|Overall Study||0
2317478|NCT01900626|5689861|P2|STARTED|Overall Study||1
2317479|NCT01900626|5689862|P1|STARTED|Overall Study||1
2317480|NCT01900561|5689880|P2|NOT COMPLETED|Overall Study||9
2317481|NCT01900561|5689881|P1|NOT COMPLETED|Overall Study||17
2317482|NCT01900561|5689880|P2|COMPLETED|Overall Study||269
2317483|NCT01900561|5689881|P1|COMPLETED|Overall Study||261
2317484|NCT01900561|5689880|P2|STARTED|Overall Study||278
2317485|NCT01900561|5689881|P1|STARTED|Overall Study||278
2317486|NCT01900444|5689941|P1|NOT COMPLETED|Overall Study||3
2317487|NCT01900444|5689941|P1|COMPLETED|Overall Study||116
2317488|NCT01900444|5689941|P1|STARTED|Overall Study||119
2317489|NCT01900431|5689954|P3|NOT COMPLETED|Open-Label Treatment Period (Part C)||8
2317490|NCT01900431|5689955|P2|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
2317491|NCT01900431|5689956|P1|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
2317492|NCT01900431|5689954|P3|COMPLETED|Open-Label Treatment Period (Part C)||13
2317493|NCT01900431|5689955|P2|COMPLETED|Open-Label Treatment Period (Part C)||0
2317494|NCT01900431|5689956|P1|COMPLETED|Open-Label Treatment Period (Part C)||0
2317495|NCT01900431|5689954|P3|STARTED|Open-Label Treatment Period (Part C)|10 non-responders (5 Placebo, 5 Sarilumab) & 11 non-completers (6 Placebo, 5 Sarilumab) from Part A.|21
2317496|NCT01900431|5689955|P2|STARTED|Open-Label Treatment Period (Part C)||0
2317497|NCT01900431|5689956|P1|STARTED|Open-Label Treatment Period (Part C)||0
2317498|NCT01900431|5689954|P3|NOT COMPLETED|Extended Treatment Period (Part B)||0
2317499|NCT01900431|5689955|P2|NOT COMPLETED|Extended Treatment Period (Part B)||10
2317500|NCT01900431|5689956|P1|NOT COMPLETED|Extended Treatment Period (Part B)||1
2317501|NCT01900431|5689954|P3|COMPLETED|Extended Treatment Period (Part B)||0
2317502|NCT01900431|5689955|P2|COMPLETED|Extended Treatment Period (Part B)||12
2317503|NCT01900431|5689956|P1|COMPLETED|Extended Treatment Period (Part B)||7
2317504|NCT01900431|5689954|P3|STARTED|Extended Treatment Period (Part B)||0
2317505|NCT01900431|5689955|P2|STARTED|Extended Treatment Period (Part B)||22
2317506|NCT01900431|5689956|P1|STARTED|Extended Treatment Period (Part B)||8
2317507|NCT01900431|5689954|P3|NOT COMPLETED|Principal Treatment Period (Part A)||0
2317508|NCT01900431|5689955|P2|NOT COMPLETED|Principal Treatment Period (Part A)||10
2317509|NCT01900431|5689956|P1|NOT COMPLETED|Principal Treatment Period (Part A)||7
2317510|NCT01900431|5689954|P3|COMPLETED|Principal Treatment Period (Part A)||0
2317511|NCT01900431|5689955|P2|COMPLETED|Principal Treatment Period (Part A)|22 responders entered Part B, 5 non-responders entered Part C, 1 discontinued the study.|28
2317512|NCT01900431|5689956|P1|COMPLETED|Principal Treatment Period (Part A)|8 responders entered Part B and 5 non-responders entered Part C.|13
2317513|NCT01900431|5689954|P3|STARTED|Principal Treatment Period (Part A)||0
2317514|NCT01900431|5689955|P2|STARTED|Principal Treatment Period (Part A)||38
2317515|NCT01900431|5689956|P1|STARTED|Principal Treatment Period (Part A)||20
2317516|NCT01900392|5689983|P3|NOT COMPLETED|Overall Study||0
2317517|NCT01900392|5689984|P2|NOT COMPLETED|Overall Study||1
2317518|NCT01900392|5689985|P1|NOT COMPLETED|Overall Study||1
2317519|NCT01900392|5689983|P3|COMPLETED|Overall Study||77
2317520|NCT01900392|5689984|P2|COMPLETED|Overall Study||74
2317521|NCT01900392|5689985|P1|COMPLETED|Overall Study||38
2317522|NCT01900392|5689983|P3|STARTED|Overall Study||77
2317523|NCT01900392|5689984|P2|STARTED|Overall Study||75
2317524|NCT01900392|5689985|P1|STARTED|Overall Study||39
2317525|NCT01900314|5689998|P2|NOT COMPLETED|Overall Study||4
2317526|NCT01900314|5689999|P1|NOT COMPLETED|Overall Study||4
2317527|NCT01900314|5689998|P2|COMPLETED|Overall Study|1 patient had 4 TMS Tx, but missed too many for protocol requirements,|16
2317528|NCT01900314|5689999|P1|COMPLETED|Overall Study|1 patient had MRI, then moved away after 5 TMS treatments|16
2317529|NCT01900314|5689998|P2|Completed MRI#1|Overall Study|2 withdrew consent, 1 patient was unable to tolerate MRI|17
2317530|NCT01900314|5689999|P1|Completed MRI#1|Overall Study|2 withdrew consent prior to MRI, 1 had MRI technical failure|17
2317531|NCT01900314|5689998|P2|STARTED|Overall Study||20
2317532|NCT01900314|5689999|P1|STARTED|Overall Study||20
2317533|NCT01900249|5690010|P3|NOT COMPLETED|Overall Study||4
2317534|NCT01900249|5690011|P2|NOT COMPLETED|Overall Study||5
2317535|NCT01900249|5690012|P1|NOT COMPLETED|Overall Study||3
2317536|NCT01900249|5690010|P3|COMPLETED|Overall Study||65
2317537|NCT01900249|5690011|P2|COMPLETED|Overall Study||63
2317538|NCT01900249|5690012|P1|COMPLETED|Overall Study||64
2317539|NCT01900249|5690010|P3|STARTED|Overall Study||69
2317540|NCT01900249|5690011|P2|STARTED|Overall Study||68
2317541|NCT01900249|5690012|P1|STARTED|Overall Study||67
2317542|NCT01900067|5690022|P2|NOT COMPLETED|Overall Study||13
2317543|NCT01900067|5690023|P1|NOT COMPLETED|Overall Study||12
2317544|NCT01900067|5690022|P2|COMPLETED|Overall Study||124
2317545|NCT01900067|5690023|P1|COMPLETED|Overall Study||122
2317546|NCT01900067|5690022|P2|STARTED|Overall Study||137
2317547|NCT01900067|5690023|P1|STARTED|Overall Study||134
2317548|NCT01900054|5690029|P1|NOT COMPLETED|Overall Study||2
2317549|NCT01900054|5690029|P1|COMPLETED|Overall Study||56
2317550|NCT01900054|5690029|P1|STARTED|Overall Study||58
2317551|NCT01899911|5690034|P1|NOT COMPLETED|Overall Study||0
2317552|NCT01899911|5690034|P1|COMPLETED|Overall Study||12
2317553|NCT01899911|5690034|P1|STARTED|Overall Study||12
2317554|NCT01899768|5690038|P1|NOT COMPLETED|Part C||0
2317555|NCT01899768|5690038|P1|COMPLETED|Part C||11
2317556|NCT01899768|5690038|P1|STARTED|Part C||11
2317557|NCT01899768|5690038|P1|NOT COMPLETED|Part B||2
2317558|NCT01899768|5690038|P1|COMPLETED|Part B||11
2317559|NCT01899768|5690038|P1|STARTED|Part B||13
2317560|NCT01899768|5690038|P1|NOT COMPLETED|Part A||3
2317561|NCT01899768|5690038|P1|COMPLETED|Part A||13
2317562|NCT01899768|5690038|P1|STARTED|Part A||16
2317563|NCT01899742|5690112|P2|NOT COMPLETED|Overall Study||16
2317564|NCT01899742|5690113|P1|NOT COMPLETED|Overall Study||17
2317565|NCT01899742|5690112|P2|COMPLETED|Overall Study||231
2317566|NCT01899742|5690113|P1|COMPLETED|Overall Study||230
2317567|NCT01899742|5690112|P2|STARTED|Overall Study||247
2317568|NCT01899742|5690113|P1|STARTED|Overall Study||247
2317569|NCT01899729|5690126|P5|NOT COMPLETED|Overall Study||2
2317570|NCT01899729|5690127|P4|NOT COMPLETED|Overall Study||0
2317571|NCT01899729|5690128|P3|NOT COMPLETED|Overall Study||2
2317572|NCT01899729|5690129|P2|NOT COMPLETED|Overall Study||2
2317573|NCT01899729|5690130|P1|NOT COMPLETED|Overall Study||2
2317574|NCT01899729|5690126|P5|COMPLETED|Overall Study||9
2317575|NCT01899729|5690127|P4|COMPLETED|Overall Study||9
2317576|NCT01899729|5690128|P3|COMPLETED|Overall Study||6
2317577|NCT01899729|5690129|P2|COMPLETED|Overall Study||7
2317578|NCT01899729|5690130|P1|COMPLETED|Overall Study||7
2317579|NCT01899729|5690126|P5|STARTED|Overall Study||11
2317580|NCT01899729|5690127|P4|STARTED|Overall Study||9
2317581|NCT01899729|5690128|P3|STARTED|Overall Study||8
2317582|NCT01899729|5690129|P2|STARTED|Overall Study||9
2317583|NCT01899729|5690130|P1|STARTED|Overall Study||9
2317584|NCT01899677|5690144|P2|NOT COMPLETED|Overall Study||7
2317585|NCT01899677|5690145|P1|NOT COMPLETED|Overall Study||10
2317586|NCT01899677|5690144|P2|COMPLETED|Overall Study||28
2317587|NCT01899677|5690145|P1|COMPLETED|Overall Study||25
2317588|NCT01899677|5690144|P2|STARTED|Overall Study||35
2317589|NCT01899677|5690145|P1|STARTED|Overall Study||35
2317590|NCT01899261|5690173|P1|NOT COMPLETED|Overall Study||0
2317591|NCT01899261|5690173|P1|COMPLETED|Overall Study||20
2317592|NCT01899261|5690173|P1|STARTED|Overall Study||20
2317593|NCT01899144|5690177|P1|NOT COMPLETED|Treatment Period 5||1
2317594|NCT01899144|5690177|P1|COMPLETED|Treatment Period 5|Last treatment taken by the patient who discontinued was ABS Spiromax 180 mcg.|57
2317595|NCT01899144|5690177|P1|STARTED|Treatment Period 5||58
2317596|NCT01899144|5690177|P1|NOT COMPLETED|Treatment Period 4||0
2317597|NCT01899144|5690177|P1|COMPLETED|Treatment Period 4||58
2317598|NCT01899144|5690177|P1|STARTED|Treatment Period 4||58
2317599|NCT01899144|5690177|P1|NOT COMPLETED|Treatment Period 3||2
2317600|NCT01899144|5690177|P1|COMPLETED|Treatment Period 3|Last treatment taken by patients who discontinued were ABS Spiromax 180 mcg and ABS Spiromax 90 mcg.|58
2317601|NCT01899144|5690177|P1|STARTED|Treatment Period 3||60
2317602|NCT01899144|5690177|P1|NOT COMPLETED|Treatment Period 2||1
2317603|NCT01899144|5690177|P1|COMPLETED|Treatment Period 2|Last treatment taken by the patient who discontinued was placebo.|60
2317604|NCT01899144|5690177|P1|STARTED|Treatment Period 2||61
2317605|NCT01899144|5690177|P1|NOT COMPLETED|Treatment Period 1||0
2317606|NCT01899144|5690177|P1|COMPLETED|Treatment Period 1||61
2317607|NCT01899144|5690177|P1|STARTED|Treatment Period 1||61
2317608|NCT01899053|5690213|P14|NOT COMPLETED|Overall Study||20
2317609|NCT01899053|5690214|P13|NOT COMPLETED|Overall Study||14
2317610|NCT01899053|5690215|P12|NOT COMPLETED|Overall Study||7
2317611|NCT01899053|5690216|P11|NOT COMPLETED|Overall Study||16
2317612|NCT01899053|5690217|P10|NOT COMPLETED|Overall Study||3
2317613|NCT01899053|5690218|P9|NOT COMPLETED|Overall Study||6
2317614|NCT01899053|5690219|P8|NOT COMPLETED|Overall Study||3
2317615|NCT01899053|5690220|P7|NOT COMPLETED|Overall Study||3
2317616|NCT01899053|5690221|P6|NOT COMPLETED|Overall Study||3
2317617|NCT01899053|5690222|P5|NOT COMPLETED|Overall Study||6
2317618|NCT01899053|5690223|P4|NOT COMPLETED|Overall Study||3
2317619|NCT01899053|5690224|P3|NOT COMPLETED|Overall Study||7
2317620|NCT01899053|5690225|P2|NOT COMPLETED|Overall Study||3
2317621|NCT01899053|5690226|P1|NOT COMPLETED|Overall Study||7
2317622|NCT01899053|5690213|P14|COMPLETED|Overall Study||0
2317623|NCT01899053|5690214|P13|COMPLETED|Overall Study||0
2317624|NCT01899053|5690215|P12|COMPLETED|Overall Study||0
2317625|NCT01899053|5690216|P11|COMPLETED|Overall Study||0
2317626|NCT01899053|5690217|P10|COMPLETED|Overall Study||0
2317627|NCT01899053|5690218|P9|COMPLETED|Overall Study||0
2317628|NCT01899053|5690219|P8|COMPLETED|Overall Study||0
2317629|NCT01899053|5690220|P7|COMPLETED|Overall Study||0
2317630|NCT01899053|5690221|P6|COMPLETED|Overall Study||0
2317631|NCT01899053|5690222|P5|COMPLETED|Overall Study||0
2317632|NCT01899053|5690223|P4|COMPLETED|Overall Study||0
2317633|NCT01899053|5690224|P3|COMPLETED|Overall Study||0
2317634|NCT01899053|5690225|P2|COMPLETED|Overall Study||0
2317635|NCT01899053|5690226|P1|COMPLETED|Overall Study||0
2317636|NCT01899053|5690213|P14|STARTED|Overall Study||20
2317637|NCT01899053|5690214|P13|STARTED|Overall Study||14
2317638|NCT01899053|5690215|P12|STARTED|Overall Study||7
2317639|NCT01899053|5690216|P11|STARTED|Overall Study||16
2317640|NCT01899053|5690217|P10|STARTED|Overall Study||3
2317641|NCT01899053|5690218|P9|STARTED|Overall Study||6
2317642|NCT01899053|5690219|P8|STARTED|Overall Study||3
2317643|NCT01899053|5690220|P7|STARTED|Overall Study||3
2317644|NCT01899053|5690221|P6|STARTED|Overall Study||3
2317645|NCT01899053|5690222|P5|STARTED|Overall Study||6
2317646|NCT01899053|5690223|P4|STARTED|Overall Study||3
2317647|NCT01899053|5690224|P3|STARTED|Overall Study||7
2317648|NCT01899053|5690225|P2|STARTED|Overall Study||3
2317649|NCT01899053|5690226|P1|STARTED|Overall Study||7
2317650|NCT01898884|5690483|P9|NOT COMPLETED|Multiple Dose Period||1
2317651|NCT01898884|5690484|P8|NOT COMPLETED|Multiple Dose Period||0
2317652|NCT01898884|5690485|P7|NOT COMPLETED|Multiple Dose Period||1
2317653|NCT01898884|5690486|P6|NOT COMPLETED|Multiple Dose Period||0
2317654|NCT01898884|5690487|P5|NOT COMPLETED|Multiple Dose Period||0
2317655|NCT01898884|5690488|P4|NOT COMPLETED|Multiple Dose Period||0
2317656|NCT01898884|5690489|P3|NOT COMPLETED|Multiple Dose Period||0
2317657|NCT01898884|5690490|P2|NOT COMPLETED|Multiple Dose Period||0
2317658|NCT01898884|5690491|P1|NOT COMPLETED|Multiple Dose Period||0
2317659|NCT01898884|5690483|P9|COMPLETED|Multiple Dose Period||5
2317660|NCT01898884|5690484|P8|COMPLETED|Multiple Dose Period||6
2317661|NCT01898884|5690485|P7|COMPLETED|Multiple Dose Period||5
2317662|NCT01898884|5690486|P6|COMPLETED|Multiple Dose Period||6
2317663|NCT01898884|5690487|P5|COMPLETED|Multiple Dose Period||0
2317664|NCT01898884|5690488|P4|COMPLETED|Multiple Dose Period||0
2317665|NCT01898884|5690489|P3|COMPLETED|Multiple Dose Period||0
2317666|NCT01898884|5690490|P2|COMPLETED|Multiple Dose Period||0
2317667|NCT01898884|5690491|P1|COMPLETED|Multiple Dose Period||0
2317668|NCT01898884|5690483|P9|Treated|Multiple Dose Period||5
2317669|NCT01898884|5690484|P8|Treated|Multiple Dose Period||6
2317670|NCT01898884|5690485|P7|Treated|Multiple Dose Period||6
2317671|NCT01898884|5690486|P6|Treated|Multiple Dose Period||6
2317672|NCT01898884|5690487|P5|Treated|Multiple Dose Period||0
2317673|NCT01898884|5690488|P4|Treated|Multiple Dose Period||0
2317674|NCT01898884|5690489|P3|Treated|Multiple Dose Period||0
2317675|NCT01898884|5690490|P2|Treated|Multiple Dose Period||0
2317676|NCT01898884|5690491|P1|Treated|Multiple Dose Period||0
2317677|NCT01898884|5690483|P9|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
2317678|NCT01898884|5690484|P8|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
2317679|NCT01898884|5690485|P7|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
2317680|NCT01898884|5690486|P6|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
2317681|NCT01898884|5690487|P5|STARTED|Multiple Dose Period||0
2317682|NCT01898884|5690488|P4|STARTED|Multiple Dose Period||0
2317683|NCT01898884|5690489|P3|STARTED|Multiple Dose Period||0
2317684|NCT01898884|5690490|P2|STARTED|Multiple Dose Period||0
2317685|NCT01898884|5690491|P1|STARTED|Multiple Dose Period||0
2317686|NCT01898884|5690483|P9|NOT COMPLETED|Single Dose Period||0
2317687|NCT01898884|5690484|P8|NOT COMPLETED|Single Dose Period||0
2317688|NCT01898884|5690485|P7|NOT COMPLETED|Single Dose Period||0
2317689|NCT01898884|5690486|P6|NOT COMPLETED|Single Dose Period||0
2317690|NCT01898884|5690487|P5|NOT COMPLETED|Single Dose Period||0
2317691|NCT01898884|5690488|P4|NOT COMPLETED|Single Dose Period||0
2317692|NCT01898884|5690489|P3|NOT COMPLETED|Single Dose Period||0
2317693|NCT01898884|5690490|P2|NOT COMPLETED|Single Dose Period||0
2317694|NCT01898884|5690491|P1|NOT COMPLETED|Single Dose Period||0
2317695|NCT01898884|5690483|P9|COMPLETED|Single Dose Period||0
2317696|NCT01898884|5690484|P8|COMPLETED|Single Dose Period||0
2317697|NCT01898884|5690485|P7|COMPLETED|Single Dose Period||0
2317698|NCT01898884|5690486|P6|COMPLETED|Single Dose Period||0
2317699|NCT01898884|5690487|P5|COMPLETED|Single Dose Period||6
2317700|NCT01898884|5690488|P4|COMPLETED|Single Dose Period||6
2317701|NCT01898884|5690489|P3|COMPLETED|Single Dose Period||6
2317702|NCT01898884|5690490|P2|COMPLETED|Single Dose Period||6
2317703|NCT01898884|5690491|P1|COMPLETED|Single Dose Period||8
2317704|NCT01898884|5690483|P9|STARTED|Single Dose Period||0
2317705|NCT01898884|5690484|P8|STARTED|Single Dose Period||0
2317706|NCT01898884|5690485|P7|STARTED|Single Dose Period||0
2317707|NCT01898884|5690486|P6|STARTED|Single Dose Period||0
2317708|NCT01898884|5690487|P5|STARTED|Single Dose Period||6
2317709|NCT01898884|5690488|P4|STARTED|Single Dose Period||6
2317710|NCT01898884|5690489|P3|STARTED|Single Dose Period||6
2317711|NCT01898884|5690490|P2|STARTED|Single Dose Period||6
2317712|NCT01898884|5690491|P1|STARTED|Single Dose Period||8
2317713|NCT01898806|5690641|P1|NOT COMPLETED|Overall Study||3
2317714|NCT01898806|5690641|P1|COMPLETED|Overall Study||8
2317715|NCT01898806|5690641|P1|STARTED|Overall Study||11
2317716|NCT01898611|5690648|P2|NOT COMPLETED|Overall Study||1
2317717|NCT01898611|5690649|P1|NOT COMPLETED|Overall Study||0
2317718|NCT01898611|5690648|P2|COMPLETED|Overall Study||10
2317719|NCT01898611|5690649|P1|COMPLETED|Overall Study||5
2317720|NCT01898611|5690648|P2|STARTED|Overall Study||11
2317721|NCT01898611|5690649|P1|STARTED|Overall Study||5
2317722|NCT01898598|5690671|P2|NOT COMPLETED|Overall Study||2
2317723|NCT01898598|5690672|P1|NOT COMPLETED|Overall Study||4
2317724|NCT01898598|5690671|P2|COMPLETED|Overall Study||4
2317725|NCT01898598|5690672|P1|COMPLETED|Overall Study||8
2317726|NCT01898598|5690671|P2|Treated|Overall Study||5
2317727|NCT01898598|5690672|P1|Treated|Overall Study||11
2317728|NCT01898598|5690671|P2|STARTED|Overall Study||6
2317729|NCT01898598|5690672|P1|STARTED|Overall Study||12
2317730|NCT01898442|5690691|P3|NOT COMPLETED|Overall Study||3
2317731|NCT01898442|5690692|P2|NOT COMPLETED|Overall Study||2
2317732|NCT01898442|5690693|P1|NOT COMPLETED|Overall Study||1
2317733|NCT01898442|5690691|P3|COMPLETED|Overall Study||15
2317734|NCT01898442|5690692|P2|COMPLETED|Overall Study||15
2317735|NCT01898442|5690693|P1|COMPLETED|Overall Study||16
2317736|NCT01898442|5690691|P3|STARTED|Overall Study||18
2317737|NCT01898442|5690692|P2|STARTED|Overall Study||17
2317738|NCT01898442|5690693|P1|STARTED|Overall Study||17
2317739|NCT01898429|5690716|P3|NOT COMPLETED|Phase 3||0
2317740|NCT01898429|5690717|P2|NOT COMPLETED|Phase 3||0
2317741|NCT01898429|5690718|P1|NOT COMPLETED|Phase 3||0
2317742|NCT01898429|5690716|P3|COMPLETED|Phase 3||5
2317743|NCT01898429|5690717|P2|COMPLETED|Phase 3||0
2317744|NCT01898429|5690718|P1|COMPLETED|Phase 3||0
2317745|NCT01898429|5690716|P3|STARTED|Phase 3||5
2317746|NCT01898429|5690717|P2|STARTED|Phase 3||0
2317747|NCT01898429|5690718|P1|STARTED|Phase 3||0
2317748|NCT01898429|5690716|P3|NOT COMPLETED|Phase 2||0
2317749|NCT01898429|5690717|P2|NOT COMPLETED|Phase 2||0
2317750|NCT01898429|5690718|P1|NOT COMPLETED|Phase 2||0
2317751|NCT01898429|5690716|P3|COMPLETED|Phase 2||0
2317752|NCT01898429|5690717|P2|COMPLETED|Phase 2||5
2317753|NCT01898429|5690718|P1|COMPLETED|Phase 2||0
2317754|NCT01898429|5690716|P3|STARTED|Phase 2||0
2317755|NCT01898429|5690717|P2|STARTED|Phase 2||5
2317756|NCT01898429|5690718|P1|STARTED|Phase 2||0
2317757|NCT01898429|5690716|P3|NOT COMPLETED|Phase 1||0
2317758|NCT01898429|5690717|P2|NOT COMPLETED|Phase 1||0
2317759|NCT01898429|5690718|P1|NOT COMPLETED|Phase 1||0
2317760|NCT01898429|5690716|P3|COMPLETED|Phase 1||0
2317761|NCT01898429|5690717|P2|COMPLETED|Phase 1||0
2317762|NCT01898429|5690718|P1|COMPLETED|Phase 1||5
2317763|NCT01898429|5690716|P3|STARTED|Phase 1||0
2317764|NCT01898429|5690717|P2|STARTED|Phase 1||0
2317765|NCT01898429|5690718|P1|STARTED|Phase 1||5
2317766|NCT01898403|5690722|P1|NOT COMPLETED|Overall Study||0
2317767|NCT01898403|5690722|P1|COMPLETED|Overall Study||50
2317768|NCT01898403|5690722|P1|STARTED|Overall Study||50
2317769|NCT01898286|5690728|P1|NOT COMPLETED|Overall Study||3
2317770|NCT01898286|5690728|P1|COMPLETED|Overall Study|"For this study completed is defined as completing the Early Termination visit"|35
2317771|NCT01898286|5690728|P1|STARTED|Overall Study||38
2317772|NCT01898208|5690738|P3|NOT COMPLETED|Overall Study||37
2317773|NCT01898208|5690739|P2|NOT COMPLETED|Overall Study||49
2317774|NCT01898208|5690740|P1|NOT COMPLETED|Overall Study||40
2317775|NCT01898208|5690738|P3|COMPLETED|Overall Study||212
2317776|NCT01898208|5690739|P2|COMPLETED|Overall Study||198
2317777|NCT01898208|5690740|P1|COMPLETED|Overall Study||207
2317778|NCT01898208|5690738|P3|STARTED|Overall Study||249
2317779|NCT01898208|5690739|P2|STARTED|Overall Study||247
2317780|NCT01898208|5690740|P1|STARTED|Overall Study||247
2317781|NCT01898195|5690787|P3|NOT COMPLETED|Smoking Abstinence||36
2317782|NCT01898195|5690788|P2|NOT COMPLETED|Smoking Abstinence||38
2317783|NCT01898195|5690789|P1|NOT COMPLETED|Smoking Abstinence||35
2317784|NCT01898195|5690787|P3|COMPLETED|Smoking Abstinence||15
2317785|NCT01898195|5690788|P2|COMPLETED|Smoking Abstinence||16
2317786|NCT01898195|5690789|P1|COMPLETED|Smoking Abstinence||18
2317787|NCT01898195|5690787|P3|STARTED|Smoking Abstinence||51
2317788|NCT01898195|5690788|P2|STARTED|Smoking Abstinence||54
2317789|NCT01898195|5690789|P1|STARTED|Smoking Abstinence||53
2317790|NCT01898195|5690787|P3|NOT COMPLETED|Varenicline Adherence||36
2317791|NCT01898195|5690788|P2|NOT COMPLETED|Varenicline Adherence||38
2317792|NCT01898195|5690789|P1|NOT COMPLETED|Varenicline Adherence||35
2317793|NCT01898195|5690787|P3|COMPLETED|Varenicline Adherence||15
2317794|NCT01898195|5690788|P2|COMPLETED|Varenicline Adherence||16
2317795|NCT01898195|5690789|P1|COMPLETED|Varenicline Adherence||18
2317796|NCT01898195|5690787|P3|STARTED|Varenicline Adherence||51
2317797|NCT01898195|5690788|P2|STARTED|Varenicline Adherence||54
2317798|NCT01898195|5690789|P1|STARTED|Varenicline Adherence||53
2317799|NCT01898130|5690800|P1|NOT COMPLETED|Follow up Until PD or Death||1
2317800|NCT01898130|5690800|P1|COMPLETED|Follow up Until PD or Death||26
2317801|NCT01898130|5690800|P1|STARTED|Follow up Until PD or Death|All patients treated on study go into follow up period for survival data.|27
2317802|NCT01898130|5690800|P1|NOT COMPLETED|Treatment||6
2317803|NCT01898130|5690800|P1|COMPLETED|Treatment||21
2317804|NCT01898130|5690800|P1|Went on to Start Cycle 3|Treatment||21
2317805|NCT01898130|5690800|P1|Reached 1st Response/2 Cycles|Treatment||24
2317806|NCT01898130|5690800|P1|STARTED|Treatment||27
2317807|NCT01898091|5690815|P2|NOT COMPLETED|Overall Study||6
2317808|NCT01898091|5690816|P1|NOT COMPLETED|Overall Study||2
2317809|NCT01898091|5690815|P2|COMPLETED|Overall Study||19
2317810|NCT01898091|5690816|P1|COMPLETED|Overall Study||23
2317811|NCT01898091|5690815|P2|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
2317812|NCT01898091|5690816|P1|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
2317813|NCT01898078|5690824|P2|NOT COMPLETED|Overall Study||8
2317814|NCT01898078|5690825|P1|NOT COMPLETED|Overall Study||6
2317815|NCT01898078|5690824|P2|COMPLETED|Overall Study|Completed treatment|5
2317816|NCT01898078|5690825|P1|COMPLETED|Overall Study|Completed treatment|7
2317817|NCT01898078|5690824|P2|STARTED|Overall Study||13
2317818|NCT01898078|5690825|P1|STARTED|Overall Study||13
2317819|NCT01898013|5690843|P2|NOT COMPLETED|Visit 6||5
2317820|NCT01898013|5690844|P1|NOT COMPLETED|Visit 6||3
2317821|NCT01898013|5690843|P2|COMPLETED|Visit 6||42
2317822|NCT01898013|5690844|P1|COMPLETED|Visit 6||41
2317823|NCT01898013|5690843|P2|STARTED|Visit 6||47
2317824|NCT01898013|5690844|P1|STARTED|Visit 6||44
2317825|NCT01898013|5690843|P2|NOT COMPLETED|Visit 5||1
2317826|NCT01898013|5690844|P1|NOT COMPLETED|Visit 5||1
2317827|NCT01898013|5690843|P2|COMPLETED|Visit 5||47
2317828|NCT01898013|5690844|P1|COMPLETED|Visit 5||44
2317829|NCT01898013|5690843|P2|STARTED|Visit 5||48
2317830|NCT01898013|5690844|P1|STARTED|Visit 5||45
2317831|NCT01898013|5690843|P2|NOT COMPLETED|Visit 4||1
2317832|NCT01898013|5690844|P1|NOT COMPLETED|Visit 4||0
2317833|NCT01898013|5690843|P2|COMPLETED|Visit 4||48
2317834|NCT01898013|5690844|P1|COMPLETED|Visit 4||45
2317835|NCT01898013|5690843|P2|STARTED|Visit 4||49
2317836|NCT01898013|5690844|P1|STARTED|Visit 4||45
2317837|NCT01898013|5690843|P2|NOT COMPLETED|Visit 3 (Randomization Visit)||0
2317838|NCT01898013|5690844|P1|NOT COMPLETED|Visit 3 (Randomization Visit)||0
2317839|NCT01898013|5690843|P2|COMPLETED|Visit 3 (Randomization Visit)||49
2317840|NCT01898013|5690844|P1|COMPLETED|Visit 3 (Randomization Visit)||45
2317841|NCT01898013|5690843|P2|STARTED|Visit 3 (Randomization Visit)||49
2317842|NCT01898013|5690844|P1|STARTED|Visit 3 (Randomization Visit)||45
2317843|NCT01897896|5690862|P2|NOT COMPLETED|Overall Study||12
2317844|NCT01897896|5690863|P1|NOT COMPLETED|Overall Study||26
2317845|NCT01897896|5690862|P2|COMPLETED|Overall Study||25
2317846|NCT01897896|5690863|P1|COMPLETED|Overall Study||56
2317847|NCT01897896|5690862|P2|STARTED|Overall Study||37
2317848|NCT01897896|5690863|P1|STARTED|Overall Study||82
2317849|NCT01897792|5690945|P2|NOT COMPLETED|Overall Study||0
2317850|NCT01897792|5690946|P1|NOT COMPLETED|Overall Study||0
2317851|NCT01897792|5690945|P2|COMPLETED|Overall Study||5
2317852|NCT01897792|5690946|P1|COMPLETED|Overall Study||6
2317853|NCT01897792|5690945|P2|STARTED|Overall Study||5
2317854|NCT01897792|5690946|P1|STARTED|Overall Study||6
2317855|NCT01897766|5690970|P1|NOT COMPLETED|Overall Study||0
2317856|NCT01897766|5690970|P1|COMPLETED|Overall Study||482
2317857|NCT01897766|5690970|P1|STARTED|Overall Study||482
2317858|NCT01897727|5690995|P2|NOT COMPLETED|Overall Study||1
2317859|NCT01897727|5690996|P1|NOT COMPLETED|Overall Study||0
2317860|NCT01897727|5690995|P2|COMPLETED|Overall Study||8
2317861|NCT01897727|5690996|P1|COMPLETED|Overall Study||8
2317862|NCT01897727|5690995|P2|STARTED|Overall Study||9
2317863|NCT01897727|5690996|P1|STARTED|Overall Study||8
2317864|NCT01897532|5691004|P2|NOT COMPLETED|Discontinuation From Trial||41
2317865|NCT01897532|5691005|P1|NOT COMPLETED|Discontinuation From Trial||62
2317866|NCT01897532|5691004|P2|COMPLETED|Discontinuation From Trial||3458
2317867|NCT01897532|5691005|P1|COMPLETED|Discontinuation From Trial||3430
2317868|NCT01897532|5691004|P2|Treated|Discontinuation From Trial||3494
2317869|NCT01897532|5691005|P1|Treated|Discontinuation From Trial||3485
2317870|NCT01897532|5691004|P2|STARTED|Discontinuation From Trial||3499
2317871|NCT01897532|5691005|P1|STARTED|Discontinuation From Trial||3492
2317872|NCT01897532|5691004|P2|NOT COMPLETED|Discontinuation From Treatment||839
2317873|NCT01897532|5691005|P1|NOT COMPLETED|Discontinuation From Treatment||962
2317874|NCT01897532|5691004|P2|COMPLETED|Discontinuation From Treatment||2660
2317875|NCT01897532|5691005|P1|COMPLETED|Discontinuation From Treatment||2530
2317876|NCT01897532|5691004|P2|Treated|Discontinuation From Treatment||3494
2317877|NCT01897532|5691005|P1|Treated|Discontinuation From Treatment||3485
2317878|NCT01897532|5691004|P2|STARTED|Discontinuation From Treatment||3499
2317879|NCT01897532|5691005|P1|STARTED|Discontinuation From Treatment||3492
2317880|NCT01897493|5691013|P1|NOT COMPLETED|Period 2 (Day 6 Postdose Through Day 20)||0
2317881|NCT01897493|5691013|P1|COMPLETED|Period 2 (Day 6 Postdose Through Day 20)||15
2317882|NCT01897493|5691013|P1|Received at Least 1 Dose of Study Drug|Period 2 (Day 6 Postdose Through Day 20)||15
2317883|NCT01897493|5691013|P1|STARTED|Period 2 (Day 6 Postdose Through Day 20)||15
2317884|NCT01897493|5691013|P1|NOT COMPLETED|Period 1 (Day 1 Through Day 6 Predose)||1
2317885|NCT01897493|5691013|P1|COMPLETED|Period 1 (Day 1 Through Day 6 Predose)||15
2317886|NCT01897493|5691013|P1|Received at Least 1 Dose of Study Drug|Period 1 (Day 1 Through Day 6 Predose)||16
2317887|NCT01897493|5691013|P1|STARTED|Period 1 (Day 1 Through Day 6 Predose)||16
2317888|NCT01897402|5691028|P2|NOT COMPLETED|Overall Study||16
2317889|NCT01897402|5691029|P1|NOT COMPLETED|Overall Study||19
2317890|NCT01897402|5691028|P2|COMPLETED|Overall Study||244
2317891|NCT01897402|5691029|P1|COMPLETED|Overall Study||246
2317892|NCT01897402|5691028|P2|STARTED|Overall Study||260
2317893|NCT01897402|5691029|P1|STARTED|Overall Study||265
2317894|NCT01897285|5691041|P1|NOT COMPLETED|Overall Study||0
2317895|NCT01897285|5691041|P1|COMPLETED|Overall Study||20
2317896|NCT01897285|5691041|P1|STARTED|Overall Study|All 20 participants received original AND test adhesive dressings on upper arms and lower back.|20
2317897|NCT01897233|5691049|P1|NOT COMPLETED|Part B (24 Weeks)||4
2317898|NCT01897233|5691049|P1|COMPLETED|Part B (24 Weeks)||54
2317899|NCT01897233|5691049|P1|STARTED|Part B (24 Weeks)|6 participants from Part A also participated in Part B of the study.|58
2317900|NCT01897233|5691049|P1|NOT COMPLETED|Part A (14 Days)||0
2317901|NCT01897233|5691049|P1|COMPLETED|Part A (14 Days)||10
2317902|NCT01897233|5691049|P1|Part A Cohort 2 (9 to 11 Years)|Part A (14 Days)||5
2317903|NCT01897233|5691049|P1|Part A Cohort 1 (6 to 8 Years)|Part A (14 Days)||5
2317904|NCT01897233|5691049|P1|STARTED|Part A (14 Days)||10
2317905|NCT01897077|5691073|P2|NOT COMPLETED|Overall Study||0
2317906|NCT01897077|5691074|P1|NOT COMPLETED|Overall Study||0
2317907|NCT01897077|5691073|P2|COMPLETED|Overall Study||5
2317908|NCT01897077|5691074|P1|COMPLETED|Overall Study||0
2317909|NCT01897077|5691073|P2|STARTED|Overall Study||5
2317910|NCT01897077|5691074|P1|STARTED|Overall Study||0
2317911|NCT01897025|5691092|P2|NOT COMPLETED|Overall Study||0
2317912|NCT01897025|5691093|P1|NOT COMPLETED|Overall Study||0
2317913|NCT01897025|5691092|P2|COMPLETED|Overall Study||9
2317914|NCT01897025|5691093|P1|COMPLETED|Overall Study||10
2317915|NCT01897025|5691092|P2|STARTED|Overall Study||9
2317916|NCT01897025|5691093|P1|STARTED|Overall Study||10
2317917|NCT01896986|5691101|P2|NOT COMPLETED|Overall Study||23
2317918|NCT01896986|5691102|P1|NOT COMPLETED|Overall Study||14
2317919|NCT01896986|5691101|P2|COMPLETED|Overall Study||0
2317920|NCT01896986|5691102|P1|COMPLETED|Overall Study||0
2317921|NCT01896986|5691101|P2|STARTED|Overall Study||23
2317922|NCT01896986|5691102|P1|STARTED|Overall Study||14
2317923|NCT01896934|5691108|P1|NOT COMPLETED|Overall Study||2
2317924|NCT01896934|5691108|P1|COMPLETED|Overall Study||19
2317925|NCT01896934|5691108|P1|STARTED|Overall Study||21
2317926|NCT01896921|5691114|P1|NOT COMPLETED|Overall Study||2
2317927|NCT01896921|5691114|P1|COMPLETED|Overall Study||5
2317928|NCT01896921|5691114|P1|STARTED|Overall Study||7
2317929|NCT01896895|5691121|P4|NOT COMPLETED|OLEX Period||0
2317930|NCT01896895|5691122|P3|NOT COMPLETED|OLEX Period||0
2317931|NCT01896895|5691123|P2|NOT COMPLETED|OLEX Period||0
2317932|NCT01896895|5691124|P1|NOT COMPLETED|OLEX Period||0
2317933|NCT01896895|5691121|P4|COMPLETED|OLEX Period||39
2317934|NCT01896895|5691122|P3|COMPLETED|OLEX Period||0
2317935|NCT01896895|5691123|P2|COMPLETED|OLEX Period||0
2317936|NCT01896895|5691124|P1|COMPLETED|OLEX Period||0
2317937|NCT01896895|5691121|P4|STARTED|OLEX Period|Not all participants who completed double-blind MP fulfilled the inclusion criteria for OLEX period.|39
2317938|NCT01896895|5691122|P3|STARTED|OLEX Period||0
2317939|NCT01896895|5691123|P2|STARTED|OLEX Period||0
2317940|NCT01896895|5691124|P1|STARTED|OLEX Period||0
2317941|NCT01896895|5691121|P4|NOT COMPLETED|Double-blind MP||0
2317942|NCT01896895|5691122|P3|NOT COMPLETED|Double-blind MP||3
2317943|NCT01896895|5691123|P2|NOT COMPLETED|Double-blind MP||2
2317944|NCT01896895|5691124|P1|NOT COMPLETED|Double-blind MP||1
2317945|NCT01896895|5691121|P4|COMPLETED|Double-blind MP||0
2317946|NCT01896895|5691122|P3|COMPLETED|Double-blind MP||16
2317947|NCT01896895|5691123|P2|COMPLETED|Double-blind MP||20
2317948|NCT01896895|5691124|P1|COMPLETED|Double-blind MP||19
2317949|NCT01896895|5691121|P4|STARTED|Double-blind MP||0
2317950|NCT01896895|5691122|P3|STARTED|Double-blind MP||19
2317951|NCT01896895|5691123|P2|STARTED|Double-blind MP||22
2317952|NCT01896895|5691124|P1|STARTED|Double-blind MP||20
2317953|NCT01896726|5691139|P1|NOT COMPLETED|Treatment Period 2 (Days 23-31)||2
2317954|NCT01896726|5691139|P1|COMPLETED|Treatment Period 2 (Days 23-31)||18
2317955|NCT01896726|5691139|P1|Received Microgynon|Treatment Period 2 (Days 23-31)||18
2317956|NCT01896726|5691139|P1|Received at Least 1 Dose of Baricitinib|Treatment Period 2 (Days 23-31)||20
2317957|NCT01896726|5691139|P1|STARTED|Treatment Period 2 (Days 23-31)||20
2317958|NCT01896726|5691139|P1|NOT COMPLETED|Treatment Period 1 (Days 1-22)||0
2317959|NCT01896726|5691139|P1|COMPLETED|Treatment Period 1 (Days 1-22)||20
2317960|NCT01896726|5691139|P1|Received Microgynon|Treatment Period 1 (Days 1-22)||20
2317961|NCT01896726|5691139|P1|STARTED|Treatment Period 1 (Days 1-22)||20
2317962|NCT01896700|5691154|P2|NOT COMPLETED|Overall Study||6
2317963|NCT01896700|5691155|P1|NOT COMPLETED|Overall Study||4
2317964|NCT01896700|5691154|P2|COMPLETED|Overall Study||6
2317965|NCT01896700|5691155|P1|COMPLETED|Overall Study||8
2317966|NCT01896700|5691154|P2|STARTED|Overall Study||12
2317967|NCT01896700|5691155|P1|STARTED|Overall Study||12
2317968|NCT01896687|5691177|P2|NOT COMPLETED|Overall Study||0
2317969|NCT01896687|5691178|P1|NOT COMPLETED|Overall Study||0
2317970|NCT01896687|5691177|P2|COMPLETED|Overall Study||15
2317971|NCT01896687|5691178|P1|COMPLETED|Overall Study||15
2317972|NCT01896687|5691177|P2|STARTED|Overall Study||15
2317973|NCT01896687|5691178|P1|STARTED|Overall Study||15
2317974|NCT01896557|5691186|P2|NOT COMPLETED|Clopidogrel + GI Protector||4
2317975|NCT01896557|5691187|P1|NOT COMPLETED|Clopidogrel + GI Protector||2
2317976|NCT01896557|5691186|P2|COMPLETED|Clopidogrel + GI Protector||44
2317977|NCT01896557|5691187|P1|COMPLETED|Clopidogrel + GI Protector||41
2317978|NCT01896557|5691186|P2|STARTED|Clopidogrel + GI Protector||48
2317979|NCT01896557|5691187|P1|STARTED|Clopidogrel + GI Protector||43
2317980|NCT01896557|5691186|P2|NOT COMPLETED|Clopidogrel Alone||0
2317981|NCT01896557|5691187|P1|NOT COMPLETED|Clopidogrel Alone||1
2317982|NCT01896557|5691186|P2|COMPLETED|Clopidogrel Alone||48
2317983|NCT01896557|5691187|P1|COMPLETED|Clopidogrel Alone||43
2317984|NCT01896557|5691186|P2|STARTED|Clopidogrel Alone||48
2317985|NCT01896557|5691187|P1|STARTED|Clopidogrel Alone||44
2317986|NCT01896544|5691202|P3|NOT COMPLETED|Overall Study||0
2317987|NCT01896544|5691203|P2|NOT COMPLETED|Overall Study||0
2317988|NCT01896544|5691204|P1|NOT COMPLETED|Overall Study||0
2317989|NCT01896544|5691202|P3|COMPLETED|Overall Study||10
2317990|NCT01896544|5691203|P2|COMPLETED|Overall Study||10
2317991|NCT01896544|5691204|P1|COMPLETED|Overall Study||10
2317992|NCT01896544|5691202|P3|STARTED|Overall Study||10
2317993|NCT01896544|5691203|P2|STARTED|Overall Study||10
2317994|NCT01896544|5691204|P1|STARTED|Overall Study||10
2317995|NCT01896297|5691224|P1|NOT COMPLETED|Overall Study||1
2317996|NCT01896297|5691224|P1|COMPLETED|Overall Study||59
2317997|NCT01896297|5691224|P1|STARTED|Overall Study||60
2317998|NCT01896232|5691231|P2|NOT COMPLETED|Overall Study||53
2317999|NCT01896232|5691232|P1|NOT COMPLETED|Overall Study||49
2318000|NCT01896232|5691231|P2|COMPLETED|Overall Study||287
2318001|NCT01896232|5691232|P1|COMPLETED|Overall Study||294
2318002|NCT01896232|5691231|P2|Received Treatment|Overall Study||338
2318003|NCT01896232|5691232|P1|Received Treatment|Overall Study||341
2318004|NCT01896232|5691231|P2|STARTED|Overall Study||340
2318005|NCT01896232|5691232|P1|STARTED|Overall Study||343
2318006|NCT01896206|5691252|P1|NOT COMPLETED|Overall Study||0
2318007|NCT01896206|5691252|P1|COMPLETED|Overall Study||21
2318008|NCT01896206|5691252|P1|STARTED|Overall Study||21
2318009|NCT01896193|5691260|P2|NOT COMPLETED|Overall Study||12
2318010|NCT01896193|5691261|P1|NOT COMPLETED|Overall Study||21
2318011|NCT01896193|5691260|P2|COMPLETED|Overall Study||53
2318012|NCT01896193|5691261|P1|COMPLETED|Overall Study||41
2318013|NCT01896193|5691260|P2|STARTED|Overall Study||65
2318014|NCT01896193|5691261|P1|STARTED|Overall Study||62
2318015|NCT01896128|5691287|P2|NOT COMPLETED|Overall Study||3
2318016|NCT01896128|5691288|P1|NOT COMPLETED|Overall Study||3
2318017|NCT01896128|5691287|P2|COMPLETED|Overall Study||8
2318018|NCT01896128|5691288|P1|COMPLETED|Overall Study||5
2318019|NCT01896128|5691287|P2|STARTED|Overall Study||11
2318020|NCT01896128|5691288|P1|STARTED|Overall Study||8
2318021|NCT01896115|5691304|P2|NOT COMPLETED|Overall Study||0
2318022|NCT01896115|5691305|P1|NOT COMPLETED|Overall Study||1
2318023|NCT01896115|5691304|P2|COMPLETED|Overall Study||24
2318024|NCT01896115|5691305|P1|COMPLETED|Overall Study||15
2318025|NCT01896115|5691304|P2|Phase 2 Steering|Overall Study||24
2318026|NCT01896115|5691305|P1|Phase 2 Steering|Overall Study||0
2318027|NCT01896115|5691304|P2|Phase 2 Single Contact|Overall Study||24
2318028|NCT01896115|5691305|P1|Phase 2 Single Contact|Overall Study||0
2318029|NCT01896115|5691304|P2|Phase 1 Ventral Steering|Overall Study||0
2318030|NCT01896115|5691305|P1|Phase 1 Ventral Steering|Overall Study||15
2318031|NCT01896115|5691304|P2|Phase 1 Dorsal Steering|Overall Study||0
2318032|NCT01896115|5691305|P1|Phase 1 Dorsal Steering|Overall Study||15
2318033|NCT01896115|5691304|P2|Phase 1 Conventional PW|Overall Study||0
2318034|NCT01896115|5691305|P1|Phase 1 Conventional PW|Overall Study||15
2318035|NCT01896115|5691304|P2|Phase 1 Short PW|Overall Study||0
2318036|NCT01896115|5691305|P1|Phase 1 Short PW|Overall Study||15
2318037|NCT01896115|5691304|P2|STARTED|Overall Study||24
2318038|NCT01896115|5691305|P1|STARTED|Overall Study||16
2318039|NCT01896050|5691330|P2|NOT COMPLETED|Overall Study||2
2318040|NCT01896050|5691331|P1|NOT COMPLETED|Overall Study||38
2318041|NCT01896050|5691330|P2|COMPLETED|Overall Study||20
2318042|NCT01896050|5691331|P1|COMPLETED|Overall Study|This includes only patients who remained on the same aromatase inhibitor medication for 12 months|55
2318043|NCT01896050|5691330|P2|STARTED|Overall Study||22
2318044|NCT01896050|5691331|P1|STARTED|Overall Study||93
2318045|NCT01895972|5691341|P1|NOT COMPLETED|Overall Study||9
2318046|NCT01895972|5691341|P1|COMPLETED|Overall Study||121
2318047|NCT01895972|5691341|P1|STARTED|Overall Study||130
2318048|NCT01895946|5691348|P2|NOT COMPLETED|Overall Study||0
2318049|NCT01895946|5691349|P1|NOT COMPLETED|Overall Study||0
2318050|NCT01895946|5691348|P2|COMPLETED|Overall Study||12
2318051|NCT01895946|5691349|P1|COMPLETED|Overall Study||18
2318052|NCT01895946|5691348|P2|STARTED|Overall Study||12
2318053|NCT01895946|5691349|P1|STARTED|Overall Study||18
2318054|NCT01895647|5691370|P3|NOT COMPLETED|Overall Study||0
2318055|NCT01895647|5691371|P2|NOT COMPLETED|Overall Study||0
2318056|NCT01895647|5691372|P1|NOT COMPLETED|Overall Study||0
2318057|NCT01895647|5691370|P3|COMPLETED|Overall Study||7
2318058|NCT01895647|5691371|P2|COMPLETED|Overall Study||10
2318059|NCT01895647|5691372|P1|COMPLETED|Overall Study||8
2318060|NCT01895647|5691370|P3|STARTED|Overall Study||7
2318061|NCT01895647|5691371|P2|STARTED|Overall Study||10
2318062|NCT01895647|5691372|P1|STARTED|Overall Study||8
2318063|NCT01895634|5691386|P1|NOT COMPLETED|Overall Study||3
2318064|NCT01895634|5691386|P1|COMPLETED|Overall Study||46
2318065|NCT01895634|5691386|P1|STARTED|Overall Study||49
2318066|NCT01895608|5691398|P4|NOT COMPLETED|Overall Study||0
2318067|NCT01895608|5691399|P3|NOT COMPLETED|Overall Study||3
2318068|NCT01895608|5691400|P2|NOT COMPLETED|Overall Study||1
2318069|NCT01895608|5691401|P1|NOT COMPLETED|Overall Study||0
2318070|NCT01895608|5691398|P4|COMPLETED|Overall Study||6
2318071|NCT01895608|5691399|P3|COMPLETED|Overall Study||8
2318072|NCT01895608|5691400|P2|COMPLETED|Overall Study||6
2318073|NCT01895608|5691401|P1|COMPLETED|Overall Study||10
2318074|NCT01895608|5691398|P4|STARTED|Overall Study||6
2318075|NCT01895608|5691399|P3|STARTED|Overall Study||11
2318076|NCT01895608|5691400|P2|STARTED|Overall Study||7
2318077|NCT01895608|5691401|P1|STARTED|Overall Study||10
2318078|NCT01895543|5691431|P1|NOT COMPLETED|Overall Study||129
2318079|NCT01895543|5691431|P1|COMPLETED|Overall Study||282
2318080|NCT01895543|5691431|P1|Per Protocol Analysis Set|Overall Study|Set included all enrolled patients who had no major protocol deviations.|380
2318081|NCT01895543|5691431|P1|Safety Analysis Set|Overall Study|Set included all enrolled patients who took at least one dose of Investigational Medicinal Product.|409
2318082|NCT01895543|5691431|P1|STARTED|Overall Study||411
2318083|NCT01895452|5691447|P2|NOT COMPLETED|Overall Study||28
2318084|NCT01895452|5691448|P1|NOT COMPLETED|Overall Study||4
2318085|NCT01895452|5691447|P2|COMPLETED|Overall Study||198
2318086|NCT01895452|5691448|P1|COMPLETED|Overall Study||61
2318087|NCT01895452|5691447|P2|STARTED|Overall Study||226
2318088|NCT01895452|5691448|P1|STARTED|Overall Study||65
2318089|NCT01895361|5691461|P3|NOT COMPLETED|Overall Study||24
2318090|NCT01895361|5691462|P2|NOT COMPLETED|Overall Study||21
2318091|NCT01895361|5691463|P1|NOT COMPLETED|Overall Study||24
2318092|NCT01895361|5691461|P3|COMPLETED|Overall Study||41
2318093|NCT01895361|5691462|P2|COMPLETED|Overall Study||45
2318094|NCT01895361|5691463|P1|COMPLETED|Overall Study||43
2318095|NCT01895361|5691461|P3|STARTED|Overall Study||65
2318096|NCT01895361|5691462|P2|STARTED|Overall Study||66
2318097|NCT01895361|5691463|P1|STARTED|Overall Study||67
2318098|NCT01895335|5691492|P1|NOT COMPLETED|Overall Study||215
2318099|NCT01895335|5691492|P1|COMPLETED|Overall Study||786
2318100|NCT01895335|5691492|P1|Treated|Overall Study||1000
2318101|NCT01895335|5691492|P1|STARTED|Overall Study||1001
2318102|NCT01895322|5691509|P1|NOT COMPLETED|Overall Study||13
2318103|NCT01895322|5691509|P1|COMPLETED|Overall Study||7
2318104|NCT01895322|5691509|P1|STARTED|Overall Study||20
2318105|NCT01895309|5691518|P2|NOT COMPLETED|Overall Study||51
2318106|NCT01895309|5691519|P1|NOT COMPLETED|Overall Study||40
2318107|NCT01895309|5691518|P2|COMPLETED|Overall Study||246
2318108|NCT01895309|5691519|P1|COMPLETED|Overall Study||259
2318109|NCT01895309|5691518|P2|STARTED|Overall Study||297
2318110|NCT01895309|5691519|P1|STARTED|Overall Study||299
2318111|NCT01895270|5691533|P2|NOT COMPLETED|Isradipine Taper (W7-8)||2
2318112|NCT01895270|5691534|P1|NOT COMPLETED|Isradipine Taper (W7-8)||0
2318113|NCT01895270|5691533|P2|COMPLETED|Isradipine Taper (W7-8)||0
2318114|NCT01895270|5691534|P1|COMPLETED|Isradipine Taper (W7-8)||2
2318115|NCT01895270|5691533|P2|STARTED|Isradipine Taper (W7-8)||2
2318116|NCT01895270|5691534|P1|STARTED|Isradipine Taper (W7-8)||2
2318117|NCT01895270|5691533|P2|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||5
2318118|NCT01895270|5691534|P1|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||3
2318119|NCT01895270|5691533|P2|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
2318120|NCT01895270|5691534|P1|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
2318121|NCT01895270|5691533|P2|STARTED|Buprenorphine Taper (W5 to W6D3)|1 subject missed meds prior to bup taper so did not start this phase|7
2318122|NCT01895270|5691534|P1|STARTED|Buprenorphine Taper (W5 to W6D3)||5
2318123|NCT01895270|5691533|P2|NOT COMPLETED|Study Medications Induction (W1-4)||6
2318124|NCT01895270|5691534|P1|NOT COMPLETED|Study Medications Induction (W1-4)||6
2318125|NCT01895270|5691533|P2|COMPLETED|Study Medications Induction (W1-4)||8
2318126|NCT01895270|5691534|P1|COMPLETED|Study Medications Induction (W1-4)||5
2318127|NCT01895270|5691533|P2|STARTED|Study Medications Induction (W1-4)||14
2318128|NCT01895270|5691534|P1|STARTED|Study Medications Induction (W1-4)||11
2318129|NCT01895127|5691542|P2|NOT COMPLETED|Long Term Follow-up (Month 3-12)||3
2318130|NCT01895127|5691543|P1|NOT COMPLETED|Long Term Follow-up (Month 3-12)||2
2318131|NCT01895127|5691542|P2|COMPLETED|Long Term Follow-up (Month 3-12)||4
2318132|NCT01895127|5691543|P1|COMPLETED|Long Term Follow-up (Month 3-12)||1
2318133|NCT01895127|5691542|P2|STARTED|Long Term Follow-up (Month 3-12)||7
2318134|NCT01895127|5691543|P1|STARTED|Long Term Follow-up (Month 3-12)||3
2318135|NCT01895127|5691542|P2|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
2318136|NCT01895127|5691543|P1|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
2318137|NCT01895127|5691542|P2|COMPLETED|Month 3 Follow-up & Biopsy||7
2318138|NCT01895127|5691543|P1|COMPLETED|Month 3 Follow-up & Biopsy||3
2318139|NCT01895127|5691542|P2|STARTED|Month 3 Follow-up & Biopsy||7
2318140|NCT01895127|5691543|P1|STARTED|Month 3 Follow-up & Biopsy||3
2318141|NCT01895127|5691542|P2|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
2318142|NCT01895127|5691543|P1|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
2318143|NCT01895127|5691542|P2|COMPLETED|Treatment Period (Week 0-Month 3)||7
2318144|NCT01895127|5691543|P1|COMPLETED|Treatment Period (Week 0-Month 3)||3
2318145|NCT01895127|5691542|P2|STARTED|Treatment Period (Week 0-Month 3)||7
2318146|NCT01895127|5691543|P1|STARTED|Treatment Period (Week 0-Month 3)||3
2318147|NCT01895127|5691542|P2|NOT COMPLETED|Screening||0
2318148|NCT01895127|5691543|P1|NOT COMPLETED|Screening||0
2318149|NCT01895127|5691542|P2|COMPLETED|Screening||7
2318150|NCT01895127|5691543|P1|COMPLETED|Screening|One subject was found to be pregnant at screening so was withdrawn from the study prior to treatment|4
2318151|NCT01895127|5691542|P2|STARTED|Screening||7
2318152|NCT01895127|5691543|P1|STARTED|Screening||4
2318153|NCT01895101|5691553|P3|NOT COMPLETED|Overall Study||5
2318154|NCT01895101|5691554|P2|NOT COMPLETED|Overall Study||5
2318155|NCT01895101|5691555|P1|NOT COMPLETED|Overall Study||1
2318156|NCT01895101|5691553|P3|COMPLETED|Overall Study||245
2318157|NCT01895101|5691554|P2|COMPLETED|Overall Study||245
2318158|NCT01895101|5691555|P1|COMPLETED|Overall Study||249
2318159|NCT01895101|5691553|P3|STARTED|Overall Study||250
2318160|NCT01895101|5691554|P2|STARTED|Overall Study||250
2318161|NCT01895101|5691555|P1|STARTED|Overall Study||250
2318162|NCT01895088|5691569|P1|NOT COMPLETED|Overall Study||18
2318163|NCT01895088|5691569|P1|COMPLETED|Overall Study||253
2318164|NCT01895088|5691569|P1|STARTED|Overall Study|1 subject consented for monitoring after device removal (not included in cohort), per FDA request.|271
2318165|NCT01895062|5691575|P2|NOT COMPLETED|Overall Study||0
2318166|NCT01895062|5691576|P1|NOT COMPLETED|Overall Study||0
2318167|NCT01895062|5691575|P2|COMPLETED|Overall Study||24
2318168|NCT01895062|5691576|P1|COMPLETED|Overall Study||30
2318169|NCT01895062|5691575|P2|STARTED|Overall Study||24
2318170|NCT01895062|5691576|P1|STARTED|Overall Study||30
2318171|NCT01895036|5691584|P1|NOT COMPLETED|Overall Study||0
2318172|NCT01895036|5691584|P1|COMPLETED|Overall Study||6
2318173|NCT01895036|5691584|P1|STARTED|Overall Study||6
2318174|NCT01894984|5691590|P2|NOT COMPLETED|Overall Study||175
2318175|NCT01894984|5691591|P1|NOT COMPLETED|Overall Study||314
2318176|NCT01894984|5691590|P2|COMPLETED|Overall Study||69
2318177|NCT01894984|5691591|P1|COMPLETED|Overall Study||82
2318178|NCT01894984|5691590|P2|STARTED|Overall Study||244
2318179|NCT01894984|5691591|P1|STARTED|Overall Study||396
2318180|NCT01894919|5691620|P13|NOT COMPLETED|Overall Study||0
2318181|NCT01894919|5691621|P12|NOT COMPLETED|Overall Study||0
2318182|NCT01894919|5691622|P11|NOT COMPLETED|Overall Study||2
2318183|NCT01894919|5691623|P10|NOT COMPLETED|Overall Study||1
2318184|NCT01894919|5691624|P9|NOT COMPLETED|Overall Study||0
2318185|NCT01894919|5691625|P8|NOT COMPLETED|Overall Study||0
2318186|NCT01894919|5691626|P7|NOT COMPLETED|Overall Study||0
2318187|NCT01894919|5691627|P6|NOT COMPLETED|Overall Study||0
2318188|NCT01894919|5691628|P5|NOT COMPLETED|Overall Study||3
2318189|NCT01894919|5691629|P4|NOT COMPLETED|Overall Study||0
2318190|NCT01894919|5691630|P3|NOT COMPLETED|Overall Study||0
2318191|NCT01894919|5691631|P2|NOT COMPLETED|Overall Study||0
2318192|NCT01894919|5691632|P1|NOT COMPLETED|Overall Study||2
2318193|NCT01894919|5691620|P13|COMPLETED|Overall Study||50
2318194|NCT01894919|5691621|P12|COMPLETED|Overall Study||55
2318195|NCT01894919|5691622|P11|COMPLETED|Overall Study||98
2318196|NCT01894919|5691623|P10|COMPLETED|Overall Study||89
2318197|NCT01894919|5691624|P9|COMPLETED|Overall Study||91
2318198|NCT01894919|5691625|P8|COMPLETED|Overall Study||36
2318199|NCT01894919|5691626|P7|COMPLETED|Overall Study||32
2318200|NCT01894919|5691627|P6|COMPLETED|Overall Study||39
2318201|NCT01894919|5691628|P5|COMPLETED|Overall Study||78
2318202|NCT01894919|5691629|P4|COMPLETED|Overall Study||43
2318203|NCT01894919|5691630|P3|COMPLETED|Overall Study||89
2318204|NCT01894919|5691631|P2|COMPLETED|Overall Study||47
2318205|NCT01894919|5691632|P1|COMPLETED|Overall Study||96
2318206|NCT01894919|5691620|P13|STARTED|Overall Study||50
2318207|NCT01894919|5691621|P12|STARTED|Overall Study||55
2318208|NCT01894919|5691622|P11|STARTED|Overall Study||100
2318209|NCT01894919|5691623|P10|STARTED|Overall Study||90
2318210|NCT01894919|5691624|P9|STARTED|Overall Study||91
2318211|NCT01894919|5691625|P8|STARTED|Overall Study||36
2318212|NCT01894919|5691626|P7|STARTED|Overall Study||32
2318213|NCT01894919|5691627|P6|STARTED|Overall Study||39
2318214|NCT01894919|5691628|P5|STARTED|Overall Study||81
2318215|NCT01894919|5691629|P4|STARTED|Overall Study||43
2318216|NCT01894919|5691630|P3|STARTED|Overall Study||89
2318217|NCT01894919|5691631|P2|STARTED|Overall Study||47
2318218|NCT01894919|5691632|P1|STARTED|Overall Study||98
2318219|NCT01894906|5691754|P2|NOT COMPLETED|Overall Study||0
2318220|NCT01894906|5691755|P1|NOT COMPLETED|Overall Study||0
2318221|NCT01894906|5691754|P2|COMPLETED|Overall Study||6
2318222|NCT01894906|5691755|P1|COMPLETED|Overall Study||6
2318223|NCT01894906|5691754|P2|Treatment F|Overall Study||6
2318224|NCT01894906|5691755|P1|Treatment F|Overall Study||6
2318225|NCT01894906|5691754|P2|Treatment E|Overall Study||6
2318226|NCT01894906|5691755|P1|Treatment E|Overall Study||6
2318227|NCT01894906|5691754|P2|Treatment D|Overall Study||6
2318228|NCT01894906|5691755|P1|Treatment D|Overall Study||6
2318229|NCT01894906|5691754|P2|Treatment C|Overall Study||6
2318230|NCT01894906|5691755|P1|Treatment C|Overall Study||6
2318231|NCT01894906|5691754|P2|Treatment B|Overall Study||6
2318232|NCT01894906|5691755|P1|Treatment B|Overall Study||6
2318233|NCT01894906|5691754|P2|Treatment A|Overall Study||6
2318234|NCT01894906|5691755|P1|Treatment A|Overall Study||6
2318235|NCT01894906|5691754|P2|STARTED|Overall Study||6
2318236|NCT01894906|5691755|P1|STARTED|Overall Study||6
2318237|NCT01894841|5691787|P2|NOT COMPLETED|Overall Study||9
2318238|NCT01894841|5691788|P1|NOT COMPLETED|Overall Study||18
2318239|NCT01894841|5691787|P2|COMPLETED|Overall Study||44
2318240|NCT01894841|5691788|P1|COMPLETED|Overall Study||34
2318241|NCT01894841|5691787|P2|STARTED|Overall Study||53
2318242|NCT01894841|5691788|P1|STARTED|Overall Study||52
2318243|NCT01894672|5691804|P1|NOT COMPLETED|Overall Study||0
2318244|NCT01894672|5691804|P1|COMPLETED|Overall Study||7
2318245|NCT01894672|5691804|P1|STARTED|Overall Study||7
2318246|NCT01894620|5691812|P2|NOT COMPLETED|Overall Study||1
2318247|NCT01894620|5691813|P1|NOT COMPLETED|Overall Study||0
2318248|NCT01894620|5691812|P2|COMPLETED|Overall Study||4
2318249|NCT01894620|5691813|P1|COMPLETED|Overall Study||6
2318250|NCT01894620|5691812|P2|STARTED|Overall Study||5
2318251|NCT01894620|5691813|P1|STARTED|Overall Study||6
2318252|NCT01894607|5691821|P1|NOT COMPLETED|Overall Study||1
2318253|NCT01894607|5691821|P1|COMPLETED|Overall Study||10
2318254|NCT01894607|5691821|P1|STARTED|Overall Study||11
2318255|NCT01894581|5691828|P2|NOT COMPLETED|Overall Study||7
2318256|NCT01894581|5691829|P1|NOT COMPLETED|Overall Study||5
2318257|NCT01894581|5691828|P2|COMPLETED|Overall Study||12
2318258|NCT01894581|5691829|P1|COMPLETED|Overall Study||15
2318259|NCT01894581|5691828|P2|STARTED|Overall Study||19
2318260|NCT01894581|5691829|P1|STARTED|Overall Study||20
2318261|NCT01894568|5691837|P2|NOT COMPLETED|Overall Study||10
2318262|NCT01894568|5691838|P1|NOT COMPLETED|Overall Study||10
2318263|NCT01894568|5691837|P2|COMPLETED|Overall Study||186
2318264|NCT01894568|5691838|P1|COMPLETED|Overall Study||182
2318265|NCT01894568|5691837|P2|Received at Least 1 Dose of Study Drug|Overall Study||196
2318266|NCT01894568|5691838|P1|Received at Least 1 Dose of Study Drug|Overall Study||192
2318267|NCT01894568|5691837|P2|STARTED|Overall Study||196
2318268|NCT01894568|5691838|P1|STARTED|Overall Study||192
2318269|NCT01894555|5691878|P1|NOT COMPLETED|Overall Study||0
2318270|NCT01894555|5691878|P1|COMPLETED|Overall Study||33
2318271|NCT01894555|5691878|P1|STARTED|Overall Study||33
2318272|NCT01894503|5691882|P1|NOT COMPLETED|Overall Study||0
2318273|NCT01894503|5691882|P1|COMPLETED|Overall Study||5
2318274|NCT01894503|5691882|P1|STARTED|Overall Study||5
2318275|NCT01894477|5691889|P2|NOT COMPLETED|Overall Study||2
2318276|NCT01894477|5691890|P1|NOT COMPLETED|Overall Study||0
2318277|NCT01894477|5691889|P2|COMPLETED|Overall Study||65
2318278|NCT01894477|5691890|P1|COMPLETED|Overall Study||35
2318279|NCT01894477|5691889|P2|STARTED|Overall Study||67
2318280|NCT01894477|5691890|P1|STARTED|Overall Study||35
2318281|NCT01894256|5691901|P3|NOT COMPLETED|Part B||14
2318282|NCT01894256|5691902|P2|NOT COMPLETED|Part B||14
2318283|NCT01894256|5691903|P1|NOT COMPLETED|Part B||15
2318284|NCT01894256|5691901|P3|COMPLETED|Part B||0
2318285|NCT01894256|5691902|P2|COMPLETED|Part B||0
2318286|NCT01894256|5691903|P1|COMPLETED|Part B||0
2318287|NCT01894256|5691901|P3|STARTED|Part B||14
2318288|NCT01894256|5691902|P2|STARTED|Part B||14
2318289|NCT01894256|5691903|P1|STARTED|Part B||15
2318290|NCT01894256|5691901|P3|NOT COMPLETED|Part A||0
2318291|NCT01894256|5691902|P2|NOT COMPLETED|Part A||1
2318292|NCT01894256|5691903|P1|NOT COMPLETED|Part A||0
2318293|NCT01894256|5691901|P3|COMPLETED|Part A||14
2318294|NCT01894256|5691902|P2|COMPLETED|Part A||14
2318295|NCT01894256|5691903|P1|COMPLETED|Part A||15
2318296|NCT01894256|5691901|P3|STARTED|Part A||14
2318297|NCT01894256|5691902|P2|STARTED|Part A||15
2318298|NCT01894256|5691903|P1|STARTED|Part A||15
2318299|NCT01894243|5691950|P3|NOT COMPLETED|Overall Study||8
2318300|NCT01894243|5691951|P2|NOT COMPLETED|Overall Study||10
2318301|NCT01894243|5691952|P1|NOT COMPLETED|Overall Study||13
2318302|NCT01894243|5691950|P3|COMPLETED|Overall Study||0
2318303|NCT01894243|5691951|P2|COMPLETED|Overall Study||0
2318304|NCT01894243|5691952|P1|COMPLETED|Overall Study||0
2318305|NCT01894243|5691950|P3|Ongoing Into Part B|Overall Study||8
2318306|NCT01894243|5691951|P2|Ongoing Into Part B|Overall Study||10
2318307|NCT01894243|5691952|P1|Ongoing Into Part B|Overall Study||13
2318308|NCT01894243|5691950|P3|Completed Treatment in Part A|Overall Study||8
2318309|NCT01894243|5691951|P2|Completed Treatment in Part A|Overall Study||10
2318310|NCT01894243|5691952|P1|Completed Treatment in Part A|Overall Study||13
2318311|NCT01894243|5691950|P3|STARTED|Overall Study||8
2318312|NCT01894243|5691951|P2|STARTED|Overall Study||10
2318313|NCT01894243|5691952|P1|STARTED|Overall Study||13
2318314|NCT01894230|5691991|P2|NOT COMPLETED|Overall Study||7
2318315|NCT01894230|5691992|P1|NOT COMPLETED|Overall Study||7
2318316|NCT01894230|5691991|P2|COMPLETED|Overall Study||69
2318317|NCT01894230|5691992|P1|COMPLETED|Overall Study||76
2318318|NCT01894230|5691991|P2|STARTED|Overall Study||76
2318319|NCT01894230|5691992|P1|STARTED|Overall Study||83
2318320|NCT01894178|5692018|P2|NOT COMPLETED|Overall Study||0
2318321|NCT01894178|5692019|P1|NOT COMPLETED|Overall Study||0
2318322|NCT01894178|5692018|P2|COMPLETED|Overall Study||30
2318323|NCT01894178|5692019|P1|COMPLETED|Overall Study||30
2318324|NCT01894178|5692018|P2|STARTED|Overall Study||30
2318325|NCT01894178|5692019|P1|STARTED|Overall Study||30
2318326|NCT01894152|5692027|P1|NOT COMPLETED|Overall Study||143
2318327|NCT01894152|5692027|P1|COMPLETED|Overall Study||1859
2318328|NCT01894152|5692027|P1|STARTED|Overall Study||2002
2318329|NCT01894100|5692076|P2|NOT COMPLETED|Overall Study||1
2318330|NCT01894100|5692077|P1|NOT COMPLETED|Overall Study||3
2318331|NCT01894100|5692076|P2|COMPLETED|Overall Study||14
2318332|NCT01894100|5692077|P1|COMPLETED|Overall Study||12
2318333|NCT01894100|5692076|P2|STARTED|Overall Study||15
2318334|NCT01894100|5692077|P1|STARTED|Overall Study||15
2318335|NCT01894087|5692087|P2|NOT COMPLETED|Overall Study||0
2318336|NCT01894087|5692088|P1|NOT COMPLETED|Overall Study||6
2318337|NCT01894087|5692087|P2|COMPLETED|Overall Study||102
2318338|NCT01894087|5692088|P1|COMPLETED|Overall Study||96
2318339|NCT01894087|5692087|P2|STARTED|Overall Study||102
2318340|NCT01894087|5692088|P1|STARTED|Overall Study||102
2318341|NCT01894022|5692102|P2|NOT COMPLETED|Overall Study||10
2318342|NCT01894022|5692103|P1|NOT COMPLETED|Overall Study||9
2318343|NCT01894022|5692102|P2|COMPLETED|Overall Study||0
2318344|NCT01894022|5692103|P1|COMPLETED|Overall Study||0
2318345|NCT01894022|5692102|P2|STARTED|Overall Study||10
2318346|NCT01894022|5692103|P1|STARTED|Overall Study||9
2318347|NCT01893983|5692157|P2|NOT COMPLETED|Overall Study||6
2318348|NCT01893983|5692158|P1|NOT COMPLETED|Overall Study||10
2318349|NCT01893983|5692157|P2|COMPLETED|Overall Study||134
2318350|NCT01893983|5692158|P1|COMPLETED|Overall Study||130
2318351|NCT01893983|5692157|P2|STARTED|Overall Study||140
2318352|NCT01893983|5692158|P1|STARTED|Overall Study||140
2318353|NCT01893905|5692172|P2|NOT COMPLETED|Overall Study||14
2318354|NCT01893905|5692173|P1|NOT COMPLETED|Overall Study||25
2318355|NCT01893905|5692172|P2|COMPLETED|Overall Study||64
2318356|NCT01893905|5692173|P1|COMPLETED|Overall Study||55
2318357|NCT01893905|5692172|P2|STARTED|Overall Study||78
2318358|NCT01893905|5692173|P1|STARTED|Overall Study||80
2318359|NCT01893879|5692181|P2|NOT COMPLETED|Overall Study||3
2318360|NCT01893879|5692182|P1|NOT COMPLETED|Overall Study||2
2318361|NCT01893879|5692181|P2|COMPLETED|Overall Study||4
2318362|NCT01893879|5692182|P1|COMPLETED|Overall Study||5
2318363|NCT01893879|5692181|P2|STARTED|Overall Study||7
2318364|NCT01893879|5692182|P1|STARTED|Overall Study||7
2318365|NCT01893801|5692188|P1|NOT COMPLETED|Overall Study||0
2318366|NCT01893801|5692188|P1|COMPLETED|Overall Study||25
2318367|NCT01893801|5692188|P1|STARTED|Overall Study||25
2318368|NCT01893632|5692198|P2|NOT COMPLETED|Overall Study||0
2318369|NCT01893632|5692199|P1|NOT COMPLETED|Overall Study||0
2318370|NCT01893632|5692198|P2|COMPLETED|Overall Study||1
2318371|NCT01893632|5692199|P1|COMPLETED|Overall Study||1
2318372|NCT01893632|5692198|P2|STARTED|Overall Study||1
2318373|NCT01893632|5692199|P1|STARTED|Overall Study||1
2318374|NCT01893567|5692205|P1|NOT COMPLETED|Overall Study||0
2318375|NCT01893567|5692205|P1|COMPLETED|Overall Study||28
2318376|NCT01893567|5692205|P1|STARTED|Overall Study||28
2318377|NCT01893411|5692212|P3|NOT COMPLETED|Overall Study||9
2318378|NCT01893411|5692213|P2|NOT COMPLETED|Overall Study||7
2318379|NCT01893411|5692214|P1|NOT COMPLETED|Overall Study||17
2318380|NCT01893411|5692212|P3|COMPLETED|Overall Study||69
2318381|NCT01893411|5692213|P2|COMPLETED|Overall Study||70
2318382|NCT01893411|5692214|P1|COMPLETED|Overall Study||139
2318383|NCT01893411|5692212|P3|STARTED|Overall Study||78
2318384|NCT01893411|5692213|P2|STARTED|Overall Study||77
2318385|NCT01893411|5692214|P1|STARTED|Overall Study||156
2318392|NCT01893359|5692294|P3|NOT COMPLETED|Overall Study||0
2318393|NCT01893359|5692295|P2|NOT COMPLETED|Overall Study||0
2318394|NCT01893359|5692296|P1|NOT COMPLETED|Overall Study||0
2318395|NCT01893359|5692294|P3|COMPLETED|Overall Study||0
2318396|NCT01893359|5692295|P2|COMPLETED|Overall Study||2
2318397|NCT01893359|5692296|P1|COMPLETED|Overall Study||0
2318398|NCT01893359|5692294|P3|STARTED|Overall Study||0
2318399|NCT01893359|5692295|P2|STARTED|Overall Study||2
2318400|NCT01893359|5692296|P1|STARTED|Overall Study||0
2318401|NCT01893346|5692311|P4|NOT COMPLETED|Overall Study||0
2318402|NCT01893346|5692312|P3|NOT COMPLETED|Overall Study||0
2318403|NCT01893346|5692313|P2|NOT COMPLETED|Overall Study||1
2318404|NCT01893346|5692314|P1|NOT COMPLETED|Overall Study||3
2318405|NCT01893346|5692311|P4|COMPLETED|Overall Study||8
2318406|NCT01893346|5692312|P3|COMPLETED|Overall Study||8
2318407|NCT01893346|5692313|P2|COMPLETED|Overall Study||7
2318408|NCT01893346|5692314|P1|COMPLETED|Overall Study||8
2318409|NCT01893346|5692311|P4|Patients Who Received Full Infusion|Overall Study||8
2318410|NCT01893346|5692312|P3|Patients Who Received Full Infusion|Overall Study||8
2318411|NCT01893346|5692313|P2|Patients Who Received Full Infusion|Overall Study||8
2318412|NCT01893346|5692314|P1|Patients Who Received Full Infusion|Overall Study||8
2318413|NCT01893346|5692311|P4|STARTED|Overall Study||8
2318414|NCT01893346|5692312|P3|STARTED|Overall Study||8
2318415|NCT01893346|5692313|P2|STARTED|Overall Study||8
2318416|NCT01893346|5692314|P1|STARTED|Overall Study||11
2318417|NCT01893281|5692328|P1|NOT COMPLETED|Overall Study||3
2318418|NCT01893281|5692328|P1|COMPLETED|Overall Study||75
2318419|NCT01893281|5692328|P1|Received at Least 1 Dose of Study Drug|Overall Study||78
2318420|NCT01893281|5692328|P1|STARTED|Overall Study||78
2318421|NCT01893203|5692335|P1|NOT COMPLETED|Overall Study||1
2318422|NCT01893203|5692335|P1|COMPLETED|Overall Study||13
2318423|NCT01893203|5692335|P1|STARTED|Overall Study||14
2318424|NCT01892865|5692344|P2|NOT COMPLETED|Overall Study||0
2318425|NCT01892865|5692345|P1|NOT COMPLETED|Overall Study||0
2318426|NCT01892865|5692344|P2|COMPLETED|Overall Study||379
2318427|NCT01892865|5692345|P1|COMPLETED|Overall Study||356
2318428|NCT01892865|5692344|P2|STARTED|Overall Study|100 operative days scheduled with the Predictive Modeling System method were included|379
2318429|NCT01892865|5692345|P1|STARTED|Overall Study|107 operative days scheduled with the Historical Means method were included|356
2318430|NCT01892722|5692359|P2|NOT COMPLETED|Overall Study||20
2318431|NCT01892722|5692360|P1|NOT COMPLETED|Overall Study||7
2318432|NCT01892722|5692359|P2|COMPLETED|Overall Study||88
2318433|NCT01892722|5692360|P1|COMPLETED|Overall Study||100
2318434|NCT01892722|5692359|P2|Full Analysis Set|Overall Study||107
2318435|NCT01892722|5692360|P1|Full Analysis Set|Overall Study||107
2318436|NCT01892722|5692359|P2|STARTED|Overall Study||108
2318437|NCT01892722|5692360|P1|STARTED|Overall Study||107
2318438|NCT01892709|5692366|P1|NOT COMPLETED|Overall Study||0
2318439|NCT01892709|5692366|P1|COMPLETED|Overall Study||215
2318440|NCT01892709|5692366|P1|STARTED|Overall Study||215
2318441|NCT01892657|5692376|P1|NOT COMPLETED|Overall Study||18
2318442|NCT01892657|5692376|P1|COMPLETED|Overall Study||110
2318443|NCT01892657|5692376|P1|STARTED|Overall Study||128
2318453|NCT01892436|5692418|P4|NOT COMPLETED|Overall Study||14
2318454|NCT01892436|5692419|P3|NOT COMPLETED|Overall Study||11
2318455|NCT01892436|5692420|P2|NOT COMPLETED|Overall Study||29
2318456|NCT01892436|5692421|P1|NOT COMPLETED|Overall Study||23
2318457|NCT01892436|5692418|P4|COMPLETED|Overall Study||61
2318458|NCT01892436|5692419|P3|COMPLETED|Overall Study||63
2318459|NCT01892436|5692420|P2|COMPLETED|Overall Study||132
2318460|NCT01892436|5692421|P1|COMPLETED|Overall Study||124
2318461|NCT01892436|5692418|P4|STARTED|Overall Study||75
2318462|NCT01892436|5692419|P3|STARTED|Overall Study||74
2318463|NCT01892436|5692420|P2|STARTED|Overall Study||161
2318464|NCT01892436|5692421|P1|STARTED|Overall Study||147
2318465|NCT01892345|5692461|P2|NOT COMPLETED|Overall Study||3
2318466|NCT01892345|5692462|P1|NOT COMPLETED|Overall Study||16
2318467|NCT01892345|5692461|P2|COMPLETED|Overall Study||44
2318468|NCT01892345|5692462|P1|COMPLETED|Overall Study||80
2318469|NCT01892345|5692461|P2|Received At Least 1 Dose Of Study Drug|Overall Study||47
2318470|NCT01892345|5692462|P1|Received At Least 1 Dose Of Study Drug|Overall Study||96
2318471|NCT01892345|5692461|P2|STARTED|Overall Study||47
2318472|NCT01892345|5692462|P1|STARTED|Overall Study||96
2318473|NCT01892306|5692482|P2|NOT COMPLETED|Overall Study||6
2318474|NCT01892306|5692483|P1|NOT COMPLETED|Overall Study||5
2318475|NCT01892306|5692482|P2|COMPLETED|Overall Study||10
2318476|NCT01892306|5692483|P1|COMPLETED|Overall Study||8
2318477|NCT01892306|5692482|P2|STARTED|Overall Study||16
2318478|NCT01892306|5692483|P1|STARTED|Overall Study||13
2318479|NCT01892293|5692503|P1|NOT COMPLETED|Overall Study||4
2318480|NCT01892293|5692503|P1|COMPLETED|Overall Study||2
2318481|NCT01892293|5692503|P1|Received T-cell|Overall Study||2
2318482|NCT01892293|5692503|P1|STARTED|Overall Study||6
2318483|NCT01892267|5692511|P2|NOT COMPLETED|Overall Study||0
2318484|NCT01892267|5692512|P1|NOT COMPLETED|Overall Study||0
2318485|NCT01892267|5692511|P2|COMPLETED|Overall Study||10
2318486|NCT01892267|5692512|P1|COMPLETED|Overall Study||9
2318487|NCT01892267|5692511|P2|STARTED|Overall Study||10
2318488|NCT01892267|5692512|P1|STARTED|Overall Study||9
2318489|NCT01892189|5692547|P9|NOT COMPLETED|Third Intervention Period (1 Day)||0
2318490|NCT01892189|5692548|P8|NOT COMPLETED|Third Intervention Period (1 Day)||0
2318491|NCT01892189|5692549|P7|NOT COMPLETED|Third Intervention Period (1 Day)||0
2318492|NCT01892189|5692550|P6|NOT COMPLETED|Third Intervention Period (1 Day)||0
2318493|NCT01892189|5692551|P5|NOT COMPLETED|Third Intervention Period (1 Day)||0
2318494|NCT01892189|5692552|P4|NOT COMPLETED|Third Intervention Period (1 Day)||0
2318495|NCT01892189|5692553|P3|NOT COMPLETED|Third Intervention Period (1 Day)||0
2318496|NCT01892189|5692554|P2|NOT COMPLETED|Third Intervention Period (1 Day)||0
2318497|NCT01892189|5692555|P1|NOT COMPLETED|Third Intervention Period (1 Day)||0
2318498|NCT01892189|5692547|P9|COMPLETED|Third Intervention Period (1 Day)||1
2318499|NCT01892189|5692548|P8|COMPLETED|Third Intervention Period (1 Day)||3
2318500|NCT01892189|5692549|P7|COMPLETED|Third Intervention Period (1 Day)||2
2318501|NCT01892189|5692550|P6|COMPLETED|Third Intervention Period (1 Day)||2
2318502|NCT01892189|5692551|P5|COMPLETED|Third Intervention Period (1 Day)||3
2318503|NCT01892189|5692552|P4|COMPLETED|Third Intervention Period (1 Day)||2
2318504|NCT01892189|5692553|P3|COMPLETED|Third Intervention Period (1 Day)||1
2318505|NCT01892189|5692554|P2|COMPLETED|Third Intervention Period (1 Day)||3
2318506|NCT01892189|5692555|P1|COMPLETED|Third Intervention Period (1 Day)||3
2318507|NCT01892189|5692547|P9|STARTED|Third Intervention Period (1 Day)||1
2318508|NCT01892189|5692548|P8|STARTED|Third Intervention Period (1 Day)||3
2318509|NCT01892189|5692549|P7|STARTED|Third Intervention Period (1 Day)||2
2318510|NCT01892189|5692550|P6|STARTED|Third Intervention Period (1 Day)||2
2318511|NCT01892189|5692551|P5|STARTED|Third Intervention Period (1 Day)||3
2318512|NCT01892189|5692552|P4|STARTED|Third Intervention Period (1 Day)||2
2318513|NCT01892189|5692553|P3|STARTED|Third Intervention Period (1 Day)||1
2318514|NCT01892189|5692554|P2|STARTED|Third Intervention Period (1 Day)||3
2318515|NCT01892189|5692555|P1|STARTED|Third Intervention Period (1 Day)||3
2318516|NCT01892189|5692547|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
2318517|NCT01892189|5692548|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
2318518|NCT01892189|5692549|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
2318519|NCT01892189|5692550|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
2318520|NCT01892189|5692551|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
2318521|NCT01892189|5692552|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
2318522|NCT01892189|5692553|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
2318523|NCT01892189|5692554|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
2318524|NCT01892189|5692555|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
2318525|NCT01892189|5692547|P9|COMPLETED|Washout Period 2 (7 Days)||1
2318526|NCT01892189|5692548|P8|COMPLETED|Washout Period 2 (7 Days)||3
2318527|NCT01892189|5692549|P7|COMPLETED|Washout Period 2 (7 Days)||2
2318528|NCT01892189|5692550|P6|COMPLETED|Washout Period 2 (7 Days)||2
2318529|NCT01892189|5692551|P5|COMPLETED|Washout Period 2 (7 Days)||3
2318530|NCT01892189|5692552|P4|COMPLETED|Washout Period 2 (7 Days)||2
2318531|NCT01892189|5692553|P3|COMPLETED|Washout Period 2 (7 Days)||1
2318532|NCT01892189|5692554|P2|COMPLETED|Washout Period 2 (7 Days)||3
2318533|NCT01892189|5692555|P1|COMPLETED|Washout Period 2 (7 Days)||3
2318534|NCT01892189|5692547|P9|STARTED|Washout Period 2 (7 Days)||1
2318535|NCT01892189|5692548|P8|STARTED|Washout Period 2 (7 Days)||3
2318536|NCT01892189|5692549|P7|STARTED|Washout Period 2 (7 Days)||2
2318537|NCT01892189|5692550|P6|STARTED|Washout Period 2 (7 Days)||2
2318538|NCT01892189|5692551|P5|STARTED|Washout Period 2 (7 Days)||3
2318539|NCT01892189|5692552|P4|STARTED|Washout Period 2 (7 Days)||2
2318540|NCT01892189|5692553|P3|STARTED|Washout Period 2 (7 Days)||1
2318541|NCT01892189|5692554|P2|STARTED|Washout Period 2 (7 Days)||3
2318542|NCT01892189|5692555|P1|STARTED|Washout Period 2 (7 Days)||3
2318543|NCT01892189|5692547|P9|NOT COMPLETED|Second Intervention Period (1 Day)||0
2318544|NCT01892189|5692548|P8|NOT COMPLETED|Second Intervention Period (1 Day)||0
2318545|NCT01892189|5692549|P7|NOT COMPLETED|Second Intervention Period (1 Day)||0
2318546|NCT01892189|5692550|P6|NOT COMPLETED|Second Intervention Period (1 Day)||0
2318547|NCT01892189|5692551|P5|NOT COMPLETED|Second Intervention Period (1 Day)||0
2318548|NCT01892189|5692552|P4|NOT COMPLETED|Second Intervention Period (1 Day)||0
2318549|NCT01892189|5692553|P3|NOT COMPLETED|Second Intervention Period (1 Day)||0
2318550|NCT01892189|5692554|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
2318551|NCT01892189|5692555|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
2318552|NCT01892189|5692547|P9|COMPLETED|Second Intervention Period (1 Day)||1
2318553|NCT01892189|5692548|P8|COMPLETED|Second Intervention Period (1 Day)||3
2318554|NCT01892189|5692549|P7|COMPLETED|Second Intervention Period (1 Day)||2
2318555|NCT01892189|5692550|P6|COMPLETED|Second Intervention Period (1 Day)||2
2318556|NCT01892189|5692551|P5|COMPLETED|Second Intervention Period (1 Day)||3
2318557|NCT01892189|5692552|P4|COMPLETED|Second Intervention Period (1 Day)||2
2318558|NCT01892189|5692553|P3|COMPLETED|Second Intervention Period (1 Day)||1
2318559|NCT01892189|5692554|P2|COMPLETED|Second Intervention Period (1 Day)||3
2318560|NCT01892189|5692555|P1|COMPLETED|Second Intervention Period (1 Day)||3
2318561|NCT01892189|5692547|P9|STARTED|Second Intervention Period (1 Day)||1
2318562|NCT01892189|5692548|P8|STARTED|Second Intervention Period (1 Day)||3
2318563|NCT01892189|5692549|P7|STARTED|Second Intervention Period (1 Day)||2
2318564|NCT01892189|5692550|P6|STARTED|Second Intervention Period (1 Day)||2
2318565|NCT01892189|5692551|P5|STARTED|Second Intervention Period (1 Day)||3
2318566|NCT01892189|5692552|P4|STARTED|Second Intervention Period (1 Day)||2
2318567|NCT01892189|5692553|P3|STARTED|Second Intervention Period (1 Day)||1
2318568|NCT01892189|5692554|P2|STARTED|Second Intervention Period (1 Day)||3
2318569|NCT01892189|5692555|P1|STARTED|Second Intervention Period (1 Day)||3
2318570|NCT01892189|5692547|P9|NOT COMPLETED|Washout Period 1 (7 Days)||2
2318571|NCT01892189|5692548|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
2318572|NCT01892189|5692549|P7|NOT COMPLETED|Washout Period 1 (7 Days)||1
2318573|NCT01892189|5692550|P6|NOT COMPLETED|Washout Period 1 (7 Days)||1
2318574|NCT01892189|5692551|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
2318575|NCT01892189|5692552|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
2318576|NCT01892189|5692553|P3|NOT COMPLETED|Washout Period 1 (7 Days)||2
2318577|NCT01892189|5692554|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
2318578|NCT01892189|5692555|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
2318579|NCT01892189|5692547|P9|COMPLETED|Washout Period 1 (7 Days)||1
2318580|NCT01892189|5692548|P8|COMPLETED|Washout Period 1 (7 Days)||3
2318581|NCT01892189|5692549|P7|COMPLETED|Washout Period 1 (7 Days)||2
2318582|NCT01892189|5692550|P6|COMPLETED|Washout Period 1 (7 Days)||2
2318583|NCT01892189|5692551|P5|COMPLETED|Washout Period 1 (7 Days)||3
2318584|NCT01892189|5692552|P4|COMPLETED|Washout Period 1 (7 Days)||2
2318585|NCT01892189|5692553|P3|COMPLETED|Washout Period 1 (7 Days)||1
2318586|NCT01892189|5692554|P2|COMPLETED|Washout Period 1 (7 Days)||3
2318587|NCT01892189|5692555|P1|COMPLETED|Washout Period 1 (7 Days)||3
2318588|NCT01892189|5692547|P9|STARTED|Washout Period 1 (7 Days)||3
2318589|NCT01892189|5692548|P8|STARTED|Washout Period 1 (7 Days)||3
2318590|NCT01892189|5692549|P7|STARTED|Washout Period 1 (7 Days)||3
2318591|NCT01892189|5692550|P6|STARTED|Washout Period 1 (7 Days)||3
2318592|NCT01892189|5692551|P5|STARTED|Washout Period 1 (7 Days)||3
2318593|NCT01892189|5692552|P4|STARTED|Washout Period 1 (7 Days)||3
2318594|NCT01892189|5692553|P3|STARTED|Washout Period 1 (7 Days)||3
2318595|NCT01892189|5692554|P2|STARTED|Washout Period 1 (7 Days)||3
2318596|NCT01892189|5692555|P1|STARTED|Washout Period 1 (7 Days)||3
2318597|NCT01892189|5692547|P9|NOT COMPLETED|First Intervention Period (1 Day)||0
2318598|NCT01892189|5692548|P8|NOT COMPLETED|First Intervention Period (1 Day)||0
2318599|NCT01892189|5692549|P7|NOT COMPLETED|First Intervention Period (1 Day)||0
2318600|NCT01892189|5692550|P6|NOT COMPLETED|First Intervention Period (1 Day)||0
2318601|NCT01892189|5692551|P5|NOT COMPLETED|First Intervention Period (1 Day)||0
2318602|NCT01892189|5692552|P4|NOT COMPLETED|First Intervention Period (1 Day)||0
2318603|NCT01892189|5692553|P3|NOT COMPLETED|First Intervention Period (1 Day)||0
2318604|NCT01892189|5692554|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
2318605|NCT01892189|5692555|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
2318606|NCT01892189|5692547|P9|COMPLETED|First Intervention Period (1 Day)||3
2318607|NCT01892189|5692548|P8|COMPLETED|First Intervention Period (1 Day)||3
2318608|NCT01892189|5692549|P7|COMPLETED|First Intervention Period (1 Day)||3
2318609|NCT01892189|5692550|P6|COMPLETED|First Intervention Period (1 Day)||3
2318610|NCT01892189|5692551|P5|COMPLETED|First Intervention Period (1 Day)||3
2318611|NCT01892189|5692552|P4|COMPLETED|First Intervention Period (1 Day)||3
2318612|NCT01892189|5692553|P3|COMPLETED|First Intervention Period (1 Day)||3
2318613|NCT01892189|5692554|P2|COMPLETED|First Intervention Period (1 Day)||3
2318614|NCT01892189|5692555|P1|COMPLETED|First Intervention Period (1 Day)||3
2318615|NCT01892189|5692547|P9|STARTED|First Intervention Period (1 Day)||3
2318616|NCT01892189|5692548|P8|STARTED|First Intervention Period (1 Day)||3
2318617|NCT01892189|5692549|P7|STARTED|First Intervention Period (1 Day)||3
2318618|NCT01892189|5692550|P6|STARTED|First Intervention Period (1 Day)||3
2318619|NCT01892189|5692551|P5|STARTED|First Intervention Period (1 Day)||3
2318620|NCT01892189|5692552|P4|STARTED|First Intervention Period (1 Day)||3
2318621|NCT01892189|5692553|P3|STARTED|First Intervention Period (1 Day)||3
2318622|NCT01892189|5692554|P2|STARTED|First Intervention Period (1 Day)||3
2318623|NCT01892189|5692555|P1|STARTED|First Intervention Period (1 Day)||3
2318624|NCT01892163|5692597|P2|NOT COMPLETED|Overall Study||1
2318625|NCT01892163|5692598|P1|NOT COMPLETED|Overall Study||2
2318626|NCT01892163|5692597|P2|COMPLETED|Overall Study||49
2318627|NCT01892163|5692598|P1|COMPLETED|Overall Study||48
2318628|NCT01892163|5692597|P2|STARTED|Overall Study||50
2318629|NCT01892163|5692598|P1|STARTED|Overall Study||50
2318630|NCT01892020|5692610|P2|NOT COMPLETED|Period 2||0
2318631|NCT01892020|5692611|P1|NOT COMPLETED|Period 2||1
2318632|NCT01892020|5692610|P2|COMPLETED|Period 2||74
2318633|NCT01892020|5692611|P1|COMPLETED|Period 2||77
2318634|NCT01892020|5692610|P2|STARTED|Period 2||74
2318635|NCT01892020|5692611|P1|STARTED|Period 2||78
2318636|NCT01892020|5692610|P2|NOT COMPLETED|Period 1||6
2318637|NCT01892020|5692611|P1|NOT COMPLETED|Period 1||3
2318638|NCT01892020|5692610|P2|COMPLETED|Period 1||74
2318639|NCT01892020|5692611|P1|COMPLETED|Period 1||78
2318640|NCT01892020|5692610|P2|STARTED|Period 1||80
2318641|NCT01892020|5692611|P1|STARTED|Period 1||81
2318642|NCT01891994|5692629|P1|NOT COMPLETED|Overall Study||0
2318643|NCT01891994|5692629|P1|COMPLETED|Overall Study||40
2318644|NCT01891994|5692629|P1|STARTED|Overall Study||40
2318645|NCT01891968|5692633|P1|NOT COMPLETED|Overall Study||0
2318646|NCT01891968|5692633|P1|COMPLETED|Overall Study||15
2318647|NCT01891968|5692633|P1|STARTED|Overall Study||15
2318648|NCT01891890|5692640|P3|NOT COMPLETED|Overall Study||7
2318649|NCT01891890|5692641|P2|NOT COMPLETED|Overall Study||3
2318650|NCT01891890|5692642|P1|NOT COMPLETED|Overall Study||7
2318651|NCT01891890|5692640|P3|COMPLETED|Overall Study||14
2318652|NCT01891890|5692641|P2|COMPLETED|Overall Study||24
2318653|NCT01891890|5692642|P1|COMPLETED|Overall Study||17
2318654|NCT01891890|5692640|P3|STARTED|Overall Study||21
2318655|NCT01891890|5692641|P2|STARTED|Overall Study||27
2318656|NCT01891890|5692642|P1|STARTED|Overall Study||24
2318657|NCT01891864|5692685|P6|NOT COMPLETED|Extension Period||0
2318658|NCT01891864|5692686|P5|NOT COMPLETED|Extension Period||7
2318659|NCT01891864|5692687|P4|NOT COMPLETED|Extension Period||5
2318660|NCT01891864|5692688|P3|NOT COMPLETED|Extension Period||8
2318661|NCT01891864|5692689|P2|NOT COMPLETED|Extension Period||0
2318662|NCT01891864|5692690|P1|NOT COMPLETED|Extension Period||0
2318663|NCT01891864|5692685|P6|COMPLETED|Extension Period||90
2318664|NCT01891864|5692686|P5|COMPLETED|Extension Period||88
2318665|NCT01891864|5692687|P4|COMPLETED|Extension Period||137
2318666|NCT01891864|5692688|P3|COMPLETED|Extension Period||132
2318667|NCT01891864|5692689|P2|COMPLETED|Extension Period||0
2318668|NCT01891864|5692690|P1|COMPLETED|Extension Period||0
2318669|NCT01891864|5692685|P6|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to an adverse event|90
2318670|NCT01891864|5692686|P5|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to lack of efficacy|95
2318671|NCT01891864|5692687|P4|STARTED|Extension Period||142
2318672|NCT01891864|5692688|P3|STARTED|Extension Period|2 patients withdrew consent 1 patient lost to FU between Treatment Period 2 and the Extension period|140
2318673|NCT01891864|5692689|P2|STARTED|Extension Period||0
2318674|NCT01891864|5692690|P1|STARTED|Extension Period||0
2318675|NCT01891864|5692685|P6|NOT COMPLETED|Treatment Period 2||5
2318676|NCT01891864|5692686|P5|NOT COMPLETED|Treatment Period 2||4
2318677|NCT01891864|5692687|P4|NOT COMPLETED|Treatment Period 2||9
2318678|NCT01891864|5692688|P3|NOT COMPLETED|Treatment Period 2||7
2318679|NCT01891864|5692689|P2|NOT COMPLETED|Treatment Period 2||0
2318680|NCT01891864|5692690|P1|NOT COMPLETED|Treatment Period 2||0
2318681|NCT01891864|5692685|P6|COMPLETED|Treatment Period 2||91
2318682|NCT01891864|5692686|P5|COMPLETED|Treatment Period 2||96
2318683|NCT01891864|5692687|P4|COMPLETED|Treatment Period 2||142
2318684|NCT01891864|5692688|P3|COMPLETED|Treatment Period 2||143
2318685|NCT01891864|5692689|P2|COMPLETED|Treatment Period 2||0
2318686|NCT01891864|5692690|P1|COMPLETED|Treatment Period 2||0
2318687|NCT01891864|5692685|P6|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|96
2318688|NCT01891864|5692686|P5|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|100
2318689|NCT01891864|5692687|P4|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|151
2318690|NCT01891864|5692688|P3|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|150
2318691|NCT01891864|5692689|P2|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
2318692|NCT01891864|5692690|P1|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
2318693|NCT01891864|5692685|P6|NOT COMPLETED|Treatment Period 1||0
2318694|NCT01891864|5692686|P5|NOT COMPLETED|Treatment Period 1||0
2318695|NCT01891864|5692687|P4|NOT COMPLETED|Treatment Period 1||0
2318696|NCT01891864|5692688|P3|NOT COMPLETED|Treatment Period 1||0
2318697|NCT01891864|5692689|P2|NOT COMPLETED|Treatment Period 1||12
2318698|NCT01891864|5692690|P1|NOT COMPLETED|Treatment Period 1||8
2318699|NCT01891864|5692685|P6|COMPLETED|Treatment Period 1||0
2318700|NCT01891864|5692686|P5|COMPLETED|Treatment Period 1||0
2318701|NCT01891864|5692687|P4|COMPLETED|Treatment Period 1||0
2318702|NCT01891864|5692688|P3|COMPLETED|Treatment Period 1||0
2318703|NCT01891864|5692689|P2|COMPLETED|Treatment Period 1|8 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|255
2318704|NCT01891864|5692690|P1|COMPLETED|Treatment Period 1|6 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|256
2318705|NCT01891864|5692685|P6|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
2318706|NCT01891864|5692686|P5|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
2318707|NCT01891864|5692687|P4|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
2318708|NCT01891864|5692688|P3|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
2318709|NCT01891864|5692689|P2|STARTED|Treatment Period 1||267
2318710|NCT01891864|5692690|P1|STARTED|Treatment Period 1||264
2318711|NCT01891734|5692712|P2|NOT COMPLETED|Overall Study||3
2318712|NCT01891734|5692713|P1|NOT COMPLETED|Overall Study||3
2318713|NCT01891734|5692712|P2|COMPLETED|Overall Study||13
2318714|NCT01891734|5692713|P1|COMPLETED|Overall Study||14
2318715|NCT01891734|5692712|P2|STARTED|Overall Study||16
2318716|NCT01891734|5692713|P1|STARTED|Overall Study||17
2318717|NCT01891721|5692726|P3|NOT COMPLETED|Overall Study||1
2318718|NCT01891721|5692727|P2|NOT COMPLETED|Overall Study||5
2318719|NCT01891721|5692728|P1|NOT COMPLETED|Overall Study||10
2318720|NCT01891721|5692726|P3|COMPLETED|Overall Study||19
2318721|NCT01891721|5692727|P2|COMPLETED|Overall Study||35
2318722|NCT01891721|5692728|P1|COMPLETED|Overall Study||29
2318723|NCT01891721|5692726|P3|STARTED|Overall Study||20
2318724|NCT01891721|5692727|P2|STARTED|Overall Study||40
2318725|NCT01891721|5692728|P1|STARTED|Overall Study||39
2318726|NCT01891669|5692752|P10|NOT COMPLETED|Overall Study||2
2318727|NCT01891669|5692753|P9|NOT COMPLETED|Overall Study||1
2318728|NCT01891669|5692754|P8|NOT COMPLETED|Overall Study||4
2318729|NCT01891669|5692755|P7|NOT COMPLETED|Overall Study||1
2318730|NCT01891669|5692756|P6|NOT COMPLETED|Overall Study||0
2318731|NCT01891669|5692757|P5|NOT COMPLETED|Overall Study||0
2318732|NCT01891669|5692758|P4|NOT COMPLETED|Overall Study||0
2318733|NCT01891669|5692759|P3|NOT COMPLETED|Overall Study||0
2318734|NCT01891669|5692760|P2|NOT COMPLETED|Overall Study||1
2318735|NCT01891669|5692761|P1|NOT COMPLETED|Overall Study||2
2318736|NCT01891669|5692752|P10|COMPLETED|Overall Study||1
2318737|NCT01891669|5692753|P9|COMPLETED|Overall Study||2
2318738|NCT01891669|5692754|P8|COMPLETED|Overall Study||2
2318739|NCT01891669|5692755|P7|COMPLETED|Overall Study||1
2318740|NCT01891669|5692756|P6|COMPLETED|Overall Study||2
2318741|NCT01891669|5692757|P5|COMPLETED|Overall Study||2
2318742|NCT01891669|5692758|P4|COMPLETED|Overall Study||2
2318743|NCT01891669|5692759|P3|COMPLETED|Overall Study||2
2318744|NCT01891669|5692760|P2|COMPLETED|Overall Study||1
2318745|NCT01891669|5692761|P1|COMPLETED|Overall Study||0
2318746|NCT01891669|5692752|P10|STARTED|Overall Study||3
2318747|NCT01891669|5692753|P9|STARTED|Overall Study||3
2318748|NCT01891669|5692754|P8|STARTED|Overall Study||6
2318749|NCT01891669|5692755|P7|STARTED|Overall Study||2
2318750|NCT01891669|5692756|P6|STARTED|Overall Study||2
2318751|NCT01891669|5692757|P5|STARTED|Overall Study||2
2318752|NCT01891669|5692758|P4|STARTED|Overall Study||2
2318753|NCT01891669|5692759|P3|STARTED|Overall Study||2
2318754|NCT01891669|5692760|P2|STARTED|Overall Study||2
2318755|NCT01891669|5692761|P1|STARTED|Overall Study||2
2318756|NCT01891357|5692912|P1|NOT COMPLETED|Overall Study||3
2318757|NCT01891357|5692912|P1|COMPLETED|Overall Study||61
2318758|NCT01891357|5692912|P1|STARTED|Overall Study||64
2318759|NCT01891331|5692923|P4|NOT COMPLETED|Overall Study||2
2318760|NCT01891331|5692924|P3|NOT COMPLETED|Overall Study||1
2318761|NCT01891331|5692925|P2|NOT COMPLETED|Overall Study||2
2318762|NCT01891331|5692926|P1|NOT COMPLETED|Overall Study||2
2318763|NCT01891331|5692923|P4|COMPLETED|Overall Study||13
2318764|NCT01891331|5692924|P3|COMPLETED|Overall Study||13
2318765|NCT01891331|5692925|P2|COMPLETED|Overall Study||10
2318766|NCT01891331|5692926|P1|COMPLETED|Overall Study||12
2318767|NCT01891331|5692923|P4|STARTED|Overall Study||15
2318768|NCT01891331|5692924|P3|STARTED|Overall Study||14
2318769|NCT01891331|5692925|P2|STARTED|Overall Study||12
2318770|NCT01891331|5692926|P1|STARTED|Overall Study||14
2318771|NCT01891305|5692940|P4|NOT COMPLETED|Overall Study||0
2318772|NCT01891305|5692941|P3|NOT COMPLETED|Overall Study||3
2318773|NCT01891305|5692942|P2|NOT COMPLETED|Overall Study||1
2318774|NCT01891305|5692943|P1|NOT COMPLETED|Overall Study||3
2318775|NCT01891305|5692940|P4|COMPLETED|Overall Study||12
2318776|NCT01891305|5692941|P3|COMPLETED|Overall Study||11
2318777|NCT01891305|5692942|P2|COMPLETED|Overall Study||11
2318778|NCT01891305|5692943|P1|COMPLETED|Overall Study||9
2318779|NCT01891305|5692940|P4|STARTED|Overall Study||12
2318780|NCT01891305|5692941|P3|STARTED|Overall Study||14
2318781|NCT01891305|5692942|P2|STARTED|Overall Study||12
2318782|NCT01891305|5692943|P1|STARTED|Overall Study||12
2318783|NCT01890967|5692959|P6|NOT COMPLETED|Overall Study||13
2318784|NCT01890967|5692960|P5|NOT COMPLETED|Overall Study||10
2318785|NCT01890967|5692961|P4|NOT COMPLETED|Overall Study||11
2318786|NCT01890967|5692962|P3|NOT COMPLETED|Overall Study||10
2318787|NCT01890967|5692963|P2|NOT COMPLETED|Overall Study||11
2318788|NCT01890967|5692964|P1|NOT COMPLETED|Overall Study||10
2318789|NCT01890967|5692959|P6|COMPLETED|Overall Study||75
2318790|NCT01890967|5692960|P5|COMPLETED|Overall Study||77
2318791|NCT01890967|5692961|P4|COMPLETED|Overall Study||77
2318792|NCT01890967|5692962|P3|COMPLETED|Overall Study||78
2318793|NCT01890967|5692963|P2|COMPLETED|Overall Study||77
2318794|NCT01890967|5692964|P1|COMPLETED|Overall Study||78
2318795|NCT01890967|5692959|P6|Received at Least One Dose of Study Drug|Overall Study||87
2318796|NCT01890967|5692960|P5|Received at Least One Dose of Study Drug|Overall Study||86
2318797|NCT01890967|5692961|P4|Received at Least One Dose of Study Drug|Overall Study||86
2318798|NCT01890967|5692962|P3|Received at Least One Dose of Study Drug|Overall Study||86
2318799|NCT01890967|5692963|P2|Received at Least One Dose of Study Drug|Overall Study||87
2318800|NCT01890967|5692964|P1|Received at Least One Dose of Study Drug|Overall Study||87
2318801|NCT01890967|5692959|P6|STARTED|Overall Study||88
2318802|NCT01890967|5692960|P5|STARTED|Overall Study||87
2318803|NCT01890967|5692961|P4|STARTED|Overall Study||88
2318804|NCT01890967|5692962|P3|STARTED|Overall Study||88
2318805|NCT01890967|5692963|P2|STARTED|Overall Study||88
2318806|NCT01890967|5692964|P1|STARTED|Overall Study||88
2318807|NCT01890954|5693033|P2|NOT COMPLETED|Overall Study||0
2318808|NCT01890954|5693034|P1|NOT COMPLETED|Overall Study||1
2318809|NCT01890954|5693033|P2|COMPLETED|Overall Study||8
2318810|NCT01890954|5693034|P1|COMPLETED|Overall Study||8
2318811|NCT01890954|5693033|P2|STARTED|Overall Study||8
2318812|NCT01890954|5693034|P1|STARTED|Overall Study||9
2318813|NCT01890915|5693042|P2|NOT COMPLETED|Overall Study||1
2318814|NCT01890915|5693043|P1|NOT COMPLETED|Overall Study||3
2318815|NCT01890915|5693042|P2|COMPLETED|Overall Study||9
2318816|NCT01890915|5693043|P1|COMPLETED|Overall Study||8
2318817|NCT01890915|5693042|P2|STARTED|Overall Study||10
2318818|NCT01890915|5693043|P1|STARTED|Overall Study||11
2318819|NCT01890785|5693059|P6|NOT COMPLETED|Third Intervention||0
2318820|NCT01890785|5693060|P5|NOT COMPLETED|Third Intervention||0
2318821|NCT01890785|5693061|P4|NOT COMPLETED|Third Intervention||0
2318822|NCT01890785|5693062|P3|NOT COMPLETED|Third Intervention||0
2318823|NCT01890785|5693063|P2|NOT COMPLETED|Third Intervention||1
2318824|NCT01890785|5693064|P1|NOT COMPLETED|Third Intervention||0
2318825|NCT01890785|5693059|P6|COMPLETED|Third Intervention||5
2318826|NCT01890785|5693060|P5|COMPLETED|Third Intervention||5
2318827|NCT01890785|5693061|P4|COMPLETED|Third Intervention||5
2318828|NCT01890785|5693062|P3|COMPLETED|Third Intervention||5
2318829|NCT01890785|5693063|P2|COMPLETED|Third Intervention||4
2318830|NCT01890785|5693064|P1|COMPLETED|Third Intervention||5
2318831|NCT01890785|5693059|P6|STARTED|Third Intervention||5
2318832|NCT01890785|5693060|P5|STARTED|Third Intervention||5
2318833|NCT01890785|5693061|P4|STARTED|Third Intervention||5
2318834|NCT01890785|5693062|P3|STARTED|Third Intervention||5
2318835|NCT01890785|5693063|P2|STARTED|Third Intervention||5
2318836|NCT01890785|5693064|P1|STARTED|Third Intervention||5
2318837|NCT01890785|5693059|P6|NOT COMPLETED|Second Intervention||0
2318838|NCT01890785|5693060|P5|NOT COMPLETED|Second Intervention||0
2318839|NCT01890785|5693061|P4|NOT COMPLETED|Second Intervention||0
2318840|NCT01890785|5693062|P3|NOT COMPLETED|Second Intervention||0
2318841|NCT01890785|5693063|P2|NOT COMPLETED|Second Intervention||0
2318842|NCT01890785|5693064|P1|NOT COMPLETED|Second Intervention||0
2318843|NCT01890785|5693059|P6|COMPLETED|Second Intervention||5
2318844|NCT01890785|5693060|P5|COMPLETED|Second Intervention||5
2318845|NCT01890785|5693061|P4|COMPLETED|Second Intervention||5
2318846|NCT01890785|5693062|P3|COMPLETED|Second Intervention||5
2318847|NCT01890785|5693063|P2|COMPLETED|Second Intervention||5
2318848|NCT01890785|5693064|P1|COMPLETED|Second Intervention||5
2318849|NCT01890785|5693059|P6|STARTED|Second Intervention||5
2318850|NCT01890785|5693060|P5|STARTED|Second Intervention||5
2318851|NCT01890785|5693061|P4|STARTED|Second Intervention||5
2318852|NCT01890785|5693062|P3|STARTED|Second Intervention||5
2318853|NCT01890785|5693063|P2|STARTED|Second Intervention||5
2318854|NCT01890785|5693064|P1|STARTED|Second Intervention||5
2318855|NCT01890785|5693059|P6|NOT COMPLETED|First Intervention||0
2318856|NCT01890785|5693060|P5|NOT COMPLETED|First Intervention||0
2318857|NCT01890785|5693061|P4|NOT COMPLETED|First Intervention||0
2318858|NCT01890785|5693062|P3|NOT COMPLETED|First Intervention||0
2318859|NCT01890785|5693063|P2|NOT COMPLETED|First Intervention||0
2318860|NCT01890785|5693064|P1|NOT COMPLETED|First Intervention||0
2318861|NCT01890785|5693059|P6|COMPLETED|First Intervention||5
2318862|NCT01890785|5693060|P5|COMPLETED|First Intervention||5
2318863|NCT01890785|5693061|P4|COMPLETED|First Intervention||5
2318864|NCT01890785|5693062|P3|COMPLETED|First Intervention||5
2318865|NCT01890785|5693063|P2|COMPLETED|First Intervention||5
2318866|NCT01890785|5693064|P1|COMPLETED|First Intervention||5
2318867|NCT01890785|5693059|P6|STARTED|First Intervention||5
2318868|NCT01890785|5693060|P5|STARTED|First Intervention||5
2318869|NCT01890785|5693061|P4|STARTED|First Intervention||5
2318870|NCT01890785|5693062|P3|STARTED|First Intervention||5
2318871|NCT01890785|5693063|P2|STARTED|First Intervention||5
2318872|NCT01890785|5693064|P1|STARTED|First Intervention||5
2318873|NCT01890759|5693083|P2|NOT COMPLETED|Overall Study||12
2318874|NCT01890759|5693084|P1|NOT COMPLETED|Overall Study||2
2318875|NCT01890759|5693083|P2|COMPLETED|Overall Study||188
2318876|NCT01890759|5693084|P1|COMPLETED|Overall Study||98
2318877|NCT01890759|5693083|P2|STARTED|Overall Study||200
2318878|NCT01890759|5693084|P1|STARTED|Overall Study||100
2318879|NCT01890746|5693118|P2|NOT COMPLETED|Overall Study||41
2318880|NCT01890746|5693119|P1|NOT COMPLETED|Overall Study||52
2318881|NCT01890746|5693118|P2|COMPLETED|Overall Study||33
2318882|NCT01890746|5693119|P1|COMPLETED|Overall Study||22
2318883|NCT01890746|5693118|P2|STARTED|Overall Study||74
2318884|NCT01890746|5693119|P1|STARTED|Overall Study||74
2318885|NCT01890707|5693205|P2|NOT COMPLETED|Overall Study||1
2318886|NCT01890707|5693206|P1|NOT COMPLETED|Overall Study||1
2318887|NCT01890707|5693205|P2|COMPLETED|Overall Study||7
2318888|NCT01890707|5693206|P1|COMPLETED|Overall Study||10
2318889|NCT01890707|5693205|P2|STARTED|Overall Study||8
2318890|NCT01890707|5693206|P1|STARTED|Overall Study||11
2318891|NCT01890694|5693214|P2|NOT COMPLETED|Overall Study||1
2318892|NCT01890694|5693215|P1|NOT COMPLETED|Overall Study||1
2318893|NCT01890694|5693214|P2|COMPLETED|Overall Study||0
2318894|NCT01890694|5693215|P1|COMPLETED|Overall Study||0
2318895|NCT01890694|5693214|P2|STARTED|Overall Study||1
2318896|NCT01890694|5693215|P1|STARTED|Overall Study||1
2318897|NCT01890642|5693250|P3|NOT COMPLETED|Overall Study||0
2318898|NCT01890642|5693251|P2|NOT COMPLETED|Overall Study||0
2318899|NCT01890642|5693252|P1|NOT COMPLETED|Overall Study||0
2318900|NCT01890642|5693250|P3|COMPLETED|Overall Study||96
2318901|NCT01890642|5693251|P2|COMPLETED|Overall Study||53
2318902|NCT01890642|5693252|P1|COMPLETED|Overall Study||56
2318903|NCT01890642|5693250|P3|STARTED|Overall Study||96
2318904|NCT01890642|5693251|P2|STARTED|Overall Study||53
2318905|NCT01890642|5693252|P1|STARTED|Overall Study||56
2318906|NCT01890577|5693272|P1|NOT COMPLETED|Overall Study||28
2318907|NCT01890577|5693272|P1|COMPLETED|Overall Study||0
2318908|NCT01890577|5693272|P1|STARTED|Overall Study||28
2318909|NCT01890512|5693285|P1|NOT COMPLETED|Overall Study||3
2318910|NCT01890512|5693285|P1|COMPLETED|Overall Study||17
2318911|NCT01890512|5693285|P1|STARTED|Overall Study||20
2318912|NCT01890473|5693291|P2|NOT COMPLETED|Overall Study||0
2318913|NCT01890473|5693292|P1|NOT COMPLETED|Overall Study||2
2318914|NCT01890473|5693291|P2|COMPLETED|Overall Study||113
2318915|NCT01890473|5693292|P1|COMPLETED|Overall Study||109
2318916|NCT01890473|5693291|P2|STARTED|Overall Study||113
2318917|NCT01890473|5693292|P1|STARTED|Overall Study||111
2318918|NCT01890434|5693318|P1|NOT COMPLETED|Overall Study||20
2318919|NCT01890434|5693318|P1|COMPLETED|Overall Study||458
2318920|NCT01890434|5693318|P1|Evaluated for Efficacy|Overall Study||389
2318921|NCT01890434|5693318|P1|STARTED|Overall Study||478
2318922|NCT01890421|5693348|P1|NOT COMPLETED|Overall Study||11
2318923|NCT01890421|5693348|P1|COMPLETED|Overall Study||415
2318924|NCT01890421|5693348|P1|STARTED|Overall Study||426
2318925|NCT01890343|5693374|P3|NOT COMPLETED|Overall Study||0
2318926|NCT01890343|5693375|P2|NOT COMPLETED|Overall Study||0
2318927|NCT01890343|5693376|P1|NOT COMPLETED|Overall Study||0
2318928|NCT01890343|5693374|P3|COMPLETED|Overall Study||10
2318929|NCT01890343|5693375|P2|COMPLETED|Overall Study||10
2318930|NCT01890343|5693376|P1|COMPLETED|Overall Study||8
2318931|NCT01890343|5693374|P3|STARTED|Overall Study||10
2318932|NCT01890343|5693375|P2|STARTED|Overall Study||10
2318933|NCT01890343|5693376|P1|STARTED|Overall Study||8
2318940|NCT01890148|5693402|P1|NOT COMPLETED|Overall Study||1
2318941|NCT01890148|5693402|P1|COMPLETED|Overall Study||4
2318942|NCT01890148|5693402|P1|STARTED|Overall Study||5
2318943|NCT01890122|5693422|P4|NOT COMPLETED|Overall Study||59
2318944|NCT01890122|5693423|P3|NOT COMPLETED|Overall Study||13
2318945|NCT01890122|5693424|P2|NOT COMPLETED|Overall Study||37
2318946|NCT01890122|5693425|P1|NOT COMPLETED|Overall Study||27
2318947|NCT01890122|5693422|P4|COMPLETED|Overall Study||104
2318948|NCT01890122|5693423|P3|COMPLETED|Overall Study||146
2318949|NCT01890122|5693424|P2|COMPLETED|Overall Study||126
2318950|NCT01890122|5693425|P1|COMPLETED|Overall Study||135
2318951|NCT01890122|5693422|P4|Treated|Overall Study||163
2318952|NCT01890122|5693423|P3|Treated|Overall Study||159
2318953|NCT01890122|5693424|P2|Treated|Overall Study||162
2318954|NCT01890122|5693425|P1|Treated|Overall Study|Treated = Randomized participants who received at least one dose of study drug.|161
2318955|NCT01890122|5693422|P4|STARTED|Overall Study||163
2318956|NCT01890122|5693423|P3|STARTED|Overall Study||159
2318957|NCT01890122|5693424|P2|STARTED|Overall Study||163
2318958|NCT01890122|5693425|P1|STARTED|Overall Study|Started = Enrolled set which included all participants who signed informed consent.|162
2318959|NCT01890109|5693489|P2|NOT COMPLETED|Overall Study||5
2318960|NCT01890109|5693490|P1|NOT COMPLETED|Overall Study||1
2318961|NCT01890109|5693489|P2|COMPLETED|Overall Study||46
2318962|NCT01890109|5693490|P1|COMPLETED|Overall Study||51
2318963|NCT01890109|5693489|P2|Received Study Treatment|Overall Study||50
2318964|NCT01890109|5693490|P1|Received Study Treatment|Overall Study||52
2318965|NCT01890109|5693489|P2|STARTED|Overall Study||51
2318966|NCT01890109|5693490|P1|STARTED|Overall Study||52
2318967|NCT01890031|5693514|P5|NOT COMPLETED|Overall Study||0
2318968|NCT01890031|5693515|P4|NOT COMPLETED|Overall Study||0
2318969|NCT01890031|5693516|P3|NOT COMPLETED|Overall Study||0
2318970|NCT01890031|5693517|P2|NOT COMPLETED|Overall Study||0
2318971|NCT01890031|5693518|P1|NOT COMPLETED|Overall Study||0
2318972|NCT01890031|5693514|P5|COMPLETED|Overall Study||8
2318973|NCT01890031|5693515|P4|COMPLETED|Overall Study||11
2318974|NCT01890031|5693516|P3|COMPLETED|Overall Study||12
2318975|NCT01890031|5693517|P2|COMPLETED|Overall Study||50
2318976|NCT01890031|5693518|P1|COMPLETED|Overall Study||50
2318977|NCT01890031|5693514|P5|STARTED|Overall Study||8
2318978|NCT01890031|5693515|P4|STARTED|Overall Study||11
2318979|NCT01890031|5693516|P3|STARTED|Overall Study||12
2318980|NCT01890031|5693517|P2|STARTED|Overall Study||50
2318981|NCT01890031|5693518|P1|STARTED|Overall Study||50
2318982|NCT01889862|5693539|P4|NOT COMPLETED|Overall Study||0
2318983|NCT01889862|5693540|P3|NOT COMPLETED|Overall Study||1
2318984|NCT01889862|5693541|P2|NOT COMPLETED|Overall Study||0
2318985|NCT01889862|5693542|P1|NOT COMPLETED|Overall Study||0
2318986|NCT01889862|5693539|P4|COMPLETED|Overall Study||14
2318987|NCT01889862|5693540|P3|COMPLETED|Overall Study||31
2318988|NCT01889862|5693541|P2|COMPLETED|Overall Study||15
2318989|NCT01889862|5693542|P1|COMPLETED|Overall Study||34
2318990|NCT01889862|5693539|P4|STARTED|Overall Study||14
2318991|NCT01889862|5693540|P3|STARTED|Overall Study||32
2318992|NCT01889862|5693541|P2|STARTED|Overall Study||15
2318993|NCT01889862|5693542|P1|STARTED|Overall Study||34
2318994|NCT01889797|5693554|P2|NOT COMPLETED|Overall Study||0
2318995|NCT01889797|5693555|P1|NOT COMPLETED|Overall Study||0
2318996|NCT01889797|5693554|P2|COMPLETED|Overall Study||16
2318997|NCT01889797|5693555|P1|COMPLETED|Overall Study||16
2318998|NCT01889797|5693554|P2|STARTED|Overall Study||16
2318999|NCT01889797|5693555|P1|STARTED|Overall Study||16
2319000|NCT01889667|5693570|P3|NOT COMPLETED|Overall Study||0
2319001|NCT01889667|5693571|P2|NOT COMPLETED|Overall Study||0
2319002|NCT01889667|5693572|P1|NOT COMPLETED|Overall Study||0
2319003|NCT01889667|5693570|P3|COMPLETED|Overall Study||10
2319004|NCT01889667|5693571|P2|COMPLETED|Overall Study||10
2319005|NCT01889667|5693572|P1|COMPLETED|Overall Study||10
2319006|NCT01889667|5693570|P3|STARTED|Overall Study||10
2319007|NCT01889667|5693571|P2|STARTED|Overall Study||10
2319008|NCT01889667|5693572|P1|STARTED|Overall Study||10
2319009|NCT01889602|5693595|P3|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
2319010|NCT01889602|5693596|P2|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
2319011|NCT01889602|5693597|P1|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
2319012|NCT01889602|5693595|P3|COMPLETED|Third Washout Period of at Least 2 Weeks||16
2319013|NCT01889602|5693596|P2|COMPLETED|Third Washout Period of at Least 2 Weeks||15
2319014|NCT01889602|5693597|P1|COMPLETED|Third Washout Period of at Least 2 Weeks||15
2319015|NCT01889602|5693595|P3|STARTED|Third Washout Period of at Least 2 Weeks||16
2319016|NCT01889602|5693596|P2|STARTED|Third Washout Period of at Least 2 Weeks||15
2319017|NCT01889602|5693597|P1|STARTED|Third Washout Period of at Least 2 Weeks||15
2319018|NCT01889602|5693595|P3|NOT COMPLETED|Third Intervention||0
2319019|NCT01889602|5693596|P2|NOT COMPLETED|Third Intervention||2
2319020|NCT01889602|5693597|P1|NOT COMPLETED|Third Intervention||3
2319021|NCT01889602|5693595|P3|COMPLETED|Third Intervention||16
2319022|NCT01889602|5693596|P2|COMPLETED|Third Intervention||15
2319023|NCT01889602|5693597|P1|COMPLETED|Third Intervention||15
2319024|NCT01889602|5693595|P3|STARTED|Third Intervention||16
2319025|NCT01889602|5693596|P2|STARTED|Third Intervention||17
2319026|NCT01889602|5693597|P1|STARTED|Third Intervention||18
2319027|NCT01889602|5693595|P3|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
2319028|NCT01889602|5693596|P2|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
2319029|NCT01889602|5693597|P1|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
2319030|NCT01889602|5693595|P3|COMPLETED|Second Washout Period of at Least 2 Week||16
2319031|NCT01889602|5693596|P2|COMPLETED|Second Washout Period of at Least 2 Week||17
2319032|NCT01889602|5693597|P1|COMPLETED|Second Washout Period of at Least 2 Week||18
2319033|NCT01889602|5693595|P3|STARTED|Second Washout Period of at Least 2 Week||16
2319034|NCT01889602|5693596|P2|STARTED|Second Washout Period of at Least 2 Week||17
2319035|NCT01889602|5693597|P1|STARTED|Second Washout Period of at Least 2 Week||18
2319036|NCT01889602|5693595|P3|NOT COMPLETED|Second Intervention||2
2319037|NCT01889602|5693596|P2|NOT COMPLETED|Second Intervention||0
2319038|NCT01889602|5693597|P1|NOT COMPLETED|Second Intervention||1
2319039|NCT01889602|5693595|P3|COMPLETED|Second Intervention||16
2319040|NCT01889602|5693596|P2|COMPLETED|Second Intervention||17
2319041|NCT01889602|5693597|P1|COMPLETED|Second Intervention||18
2319042|NCT01889602|5693595|P3|STARTED|Second Intervention||18
2319043|NCT01889602|5693596|P2|STARTED|Second Intervention||17
2319044|NCT01889602|5693597|P1|STARTED|Second Intervention||19
2319045|NCT01889602|5693595|P3|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
2319046|NCT01889602|5693596|P2|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
2319047|NCT01889602|5693597|P1|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
2319048|NCT01889602|5693595|P3|COMPLETED|First Washout Period of at Least 2 Weeks||18
2319049|NCT01889602|5693596|P2|COMPLETED|First Washout Period of at Least 2 Weeks||17
2319050|NCT01889602|5693597|P1|COMPLETED|First Washout Period of at Least 2 Weeks||19
2319051|NCT01889602|5693595|P3|STARTED|First Washout Period of at Least 2 Weeks||18
2319052|NCT01889602|5693596|P2|STARTED|First Washout Period of at Least 2 Weeks||17
2319053|NCT01889602|5693597|P1|STARTED|First Washout Period of at Least 2 Weeks||19
2319054|NCT01889602|5693595|P3|NOT COMPLETED|First Intervention||2
2319055|NCT01889602|5693596|P2|NOT COMPLETED|First Intervention||3
2319056|NCT01889602|5693597|P1|NOT COMPLETED|First Intervention||1
2319057|NCT01889602|5693595|P3|COMPLETED|First Intervention||18
2319058|NCT01889602|5693596|P2|COMPLETED|First Intervention||17
2319059|NCT01889602|5693597|P1|COMPLETED|First Intervention||19
2319060|NCT01889602|5693595|P3|STARTED|First Intervention||20
2319061|NCT01889602|5693596|P2|STARTED|First Intervention||20
2319062|NCT01889602|5693597|P1|STARTED|First Intervention||20
2319063|NCT01889563|5693624|P2|NOT COMPLETED|Overall Study||5
2319064|NCT01889563|5693625|P1|NOT COMPLETED|Overall Study||7
2319065|NCT01889563|5693624|P2|COMPLETED|Overall Study||10
2319066|NCT01889563|5693625|P1|COMPLETED|Overall Study||10
2319067|NCT01889563|5693624|P2|STARTED|Overall Study||15
2319068|NCT01889563|5693625|P1|STARTED|Overall Study||17
2319069|NCT01889420|5693633|P1|NOT COMPLETED|Overall Study||0
2319070|NCT01889420|5693633|P1|COMPLETED|Overall Study||1
2319071|NCT01889420|5693633|P1|STARTED|Overall Study||1
2319072|NCT01889355|5693639|P1|NOT COMPLETED|Overall Study||2
2319073|NCT01889355|5693639|P1|COMPLETED|Overall Study||113
2319074|NCT01889355|5693639|P1|STARTED|Overall Study||115
2319075|NCT01889251|5693645|P2|NOT COMPLETED|Overall Study||0
2319076|NCT01889251|5693646|P1|NOT COMPLETED|Overall Study||1
2319077|NCT01889251|5693645|P2|COMPLETED|Overall Study||57
2319078|NCT01889251|5693646|P1|COMPLETED|Overall Study||114
2319079|NCT01889251|5693645|P2|STARTED|Overall Study||57
2319080|NCT01889251|5693646|P1|STARTED|Overall Study||115
2319081|NCT01889238|5693652|P1|NOT COMPLETED|Overall Study||9
2319082|NCT01889238|5693652|P1|COMPLETED|Overall Study|DP, AE, death, treatment withdrawal were considered completed (defined in protocol).|109
2319083|NCT01889238|5693652|P1|STARTED|Overall Study||118
2319084|NCT01888965|5693669|P1|NOT COMPLETED|Overall Study||9
2319085|NCT01888965|5693669|P1|COMPLETED|Overall Study||0
2319086|NCT01888965|5693669|P1|STARTED|Overall Study||9
2319087|NCT01888952|5693675|P1|NOT COMPLETED|Overall Study||0
2319088|NCT01888952|5693675|P1|COMPLETED|Overall Study||10
2319089|NCT01888952|5693675|P1|STARTED|Overall Study||10
2319090|NCT01888900|5693681|P2|NOT COMPLETED|Overall Study||2
2319091|NCT01888900|5693682|P1|NOT COMPLETED|Overall Study||0
2319092|NCT01888900|5693681|P2|COMPLETED|Overall Study||11
2319093|NCT01888900|5693682|P1|COMPLETED|Overall Study||22
2319094|NCT01888900|5693681|P2|STARTED|Overall Study||13
2319095|NCT01888900|5693682|P1|STARTED|Overall Study||22
2319096|NCT01888640|5693705|P3|NOT COMPLETED|Overall Study||5
2319097|NCT01888640|5693706|P2|NOT COMPLETED|Overall Study||31
2319098|NCT01888640|5693707|P1|NOT COMPLETED|Overall Study||27
2319099|NCT01888640|5693705|P3|COMPLETED|Overall Study||94
2319100|NCT01888640|5693706|P2|COMPLETED|Overall Study||68
2319101|NCT01888640|5693707|P1|COMPLETED|Overall Study||76
2319102|NCT01888640|5693705|P3|STARTED|Overall Study||99
2319103|NCT01888640|5693706|P2|STARTED|Overall Study||99
2319104|NCT01888640|5693707|P1|STARTED|Overall Study||103
2319105|NCT01888432|5693763|P2|NOT COMPLETED|36-month Analysis (Extension)||0
2319106|NCT01888432|5693764|P1|NOT COMPLETED|36-month Analysis (Extension)||1
2319107|NCT01888432|5693763|P2|COMPLETED|36-month Analysis (Extension)||5
2319108|NCT01888432|5693764|P1|COMPLETED|36-month Analysis (Extension)||12
2319109|NCT01888432|5693763|P2|STARTED|36-month Analysis (Extension)||5
2319110|NCT01888432|5693764|P1|STARTED|36-month Analysis (Extension)||13
2319111|NCT01888432|5693763|P2|NOT COMPLETED|24-month Analysis (FAS)||17
2319112|NCT01888432|5693764|P1|NOT COMPLETED|24-month Analysis (FAS)||17
2319113|NCT01888432|5693763|P2|COMPLETED|24-month Analysis (FAS)||125
2319114|NCT01888432|5693764|P1|COMPLETED|24-month Analysis (FAS)||125
2319115|NCT01888432|5693763|P2|STARTED|24-month Analysis (FAS)||142
2319116|NCT01888432|5693764|P1|STARTED|24-month Analysis (FAS)||142
2319117|NCT01888432|5693763|P2|NOT COMPLETED|12-month Analysis (FAS)||9
2319118|NCT01888432|5693764|P1|NOT COMPLETED|12-month Analysis (FAS)||11
2319119|NCT01888432|5693763|P2|COMPLETED|12-month Analysis (FAS)||133
2319120|NCT01888432|5693764|P1|COMPLETED|12-month Analysis (FAS)||131
2319121|NCT01888432|5693763|P2|STARTED|12-month Analysis (FAS)||142
2319122|NCT01888432|5693764|P1|STARTED|12-month Analysis (FAS)||142
2319123|NCT01888367|5693805|P3|NOT COMPLETED|Overall Study||5
2319124|NCT01888367|5693806|P2|NOT COMPLETED|Overall Study||5
2319125|NCT01888367|5693807|P1|NOT COMPLETED|Overall Study||8
2319126|NCT01888367|5693805|P3|COMPLETED|Overall Study||73
2319127|NCT01888367|5693806|P2|COMPLETED|Overall Study||66
2319128|NCT01888367|5693807|P1|COMPLETED|Overall Study||288
2319129|NCT01888367|5693805|P3|STARTED|Overall Study||78
2319130|NCT01888367|5693806|P2|STARTED|Overall Study||71
2319131|NCT01888367|5693807|P1|STARTED|Overall Study||296
2319132|NCT01888003|5693827|P3|NOT COMPLETED|Overall Study||40
2319133|NCT01888003|5693828|P2|NOT COMPLETED|Overall Study||6
2319134|NCT01888003|5693829|P1|NOT COMPLETED|Overall Study||5
2319135|NCT01888003|5693827|P3|COMPLETED|Overall Study||0
2319136|NCT01888003|5693828|P2|COMPLETED|Overall Study||0
2319137|NCT01888003|5693829|P1|COMPLETED|Overall Study||0
2319138|NCT01888003|5693827|P3|STARTED|Overall Study||40
2319139|NCT01888003|5693828|P2|STARTED|Overall Study||6
2319140|NCT01888003|5693829|P1|STARTED|Overall Study||5
2319141|NCT01887990|5693850|P4|NOT COMPLETED|Overall Study||0
2319142|NCT01887990|5693851|P3|NOT COMPLETED|Overall Study||0
2319143|NCT01887990|5693852|P2|NOT COMPLETED|Overall Study||0
2319144|NCT01887990|5693853|P1|NOT COMPLETED|Overall Study||0
2319145|NCT01887990|5693850|P4|COMPLETED|Overall Study||2
2319146|NCT01887990|5693851|P3|COMPLETED|Overall Study||2
2319147|NCT01887990|5693852|P2|COMPLETED|Overall Study||7
2319148|NCT01887990|5693853|P1|COMPLETED|Overall Study||7
2319149|NCT01887990|5693850|P4|STARTED|Overall Study||2
2319150|NCT01887990|5693851|P3|STARTED|Overall Study||2
2319151|NCT01887990|5693852|P2|STARTED|Overall Study||7
2319152|NCT01887990|5693853|P1|STARTED|Overall Study||7
2319153|NCT01887912|5693869|P2|NOT COMPLETED|Overall Study||731
2319154|NCT01887912|5693870|P1|NOT COMPLETED|Overall Study||1392
2319155|NCT01887912|5693869|P2|COMPLETED|Overall Study||2370
2319156|NCT01887912|5693870|P1|COMPLETED|Overall Study||4809
2319157|NCT01887912|5693869|P2|Safety Population|Overall Study||3057
2319158|NCT01887912|5693870|P1|Safety Population|Overall Study||6113
2319159|NCT01887912|5693869|P2|STARTED|Overall Study||3101
2319160|NCT01887912|5693870|P1|STARTED|Overall Study||6201
2319161|NCT01887717|5693898|P2|NOT COMPLETED|Overall Study||11
2319162|NCT01887717|5693899|P1|NOT COMPLETED|Overall Study||6
2319163|NCT01887717|5693898|P2|COMPLETED|Overall Study||8
2319164|NCT01887717|5693899|P1|COMPLETED|Overall Study||11
2319165|NCT01887717|5693898|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
2319166|NCT01887717|5693899|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
2319167|NCT01887717|5693898|P2|STARTED|Overall Study||19
2319168|NCT01887717|5693899|P1|STARTED|Overall Study||17
2319169|NCT01887678|5693921|P2|NOT COMPLETED|Overall Study||28
2319170|NCT01887678|5693922|P1|NOT COMPLETED|Overall Study||17
2319171|NCT01887678|5693921|P2|COMPLETED|Overall Study||85
2319172|NCT01887678|5693922|P1|COMPLETED|Overall Study||102
2319173|NCT01887678|5693921|P2|STARTED|Overall Study||113
2319174|NCT01887678|5693922|P1|STARTED|Overall Study||119
2319175|NCT01887587|5693964|P1|NOT COMPLETED|Overall Study||0
2319176|NCT01887587|5693964|P1|COMPLETED|Overall Study||5
2319177|NCT01887587|5693964|P1|STARTED|Overall Study||5
2319178|NCT01887470|5693973|P4|NOT COMPLETED|Overall Study||0
2319179|NCT01887470|5693974|P3|NOT COMPLETED|Overall Study||0
2319180|NCT01887470|5693975|P2|NOT COMPLETED|Overall Study||0
2319181|NCT01887470|5693976|P1|NOT COMPLETED|Overall Study||0
2319182|NCT01887470|5693973|P4|COMPLETED|Overall Study||10
2319183|NCT01887470|5693974|P3|COMPLETED|Overall Study||10
2319184|NCT01887470|5693975|P2|COMPLETED|Overall Study||10
2319185|NCT01887470|5693976|P1|COMPLETED|Overall Study||10
2319186|NCT01887470|5693973|P4|STARTED|Overall Study||10
2319187|NCT01887470|5693974|P3|STARTED|Overall Study||10
2319188|NCT01887470|5693975|P2|STARTED|Overall Study||10
2319189|NCT01887470|5693976|P1|STARTED|Overall Study||10
2319190|NCT01887418|5693995|P3|NOT COMPLETED|Overall Study||1
2319191|NCT01887418|5693996|P2|NOT COMPLETED|Overall Study||0
2319192|NCT01887418|5693997|P1|NOT COMPLETED|Overall Study||0
2319193|NCT01887418|5693995|P3|COMPLETED|Overall Study||9
2319194|NCT01887418|5693996|P2|COMPLETED|Overall Study||14
2319195|NCT01887418|5693997|P1|COMPLETED|Overall Study||15
2319196|NCT01887418|5693995|P3|STARTED|Overall Study||10
2319197|NCT01887418|5693996|P2|STARTED|Overall Study||14
2319198|NCT01887418|5693997|P1|STARTED|Overall Study||15
2319199|NCT01887353|5694016|P2|NOT COMPLETED|Overall Study||3
2319200|NCT01887353|5694017|P1|NOT COMPLETED|Overall Study||4
2319201|NCT01887353|5694016|P2|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|1
2319202|NCT01887353|5694017|P1|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|0
2319203|NCT01887353|5694016|P2|STARTED|Overall Study||4
2319204|NCT01887353|5694017|P1|STARTED|Overall Study||4
2319205|NCT01887327|5694026|P3|NOT COMPLETED|Overall Study||3
2319206|NCT01887327|5694027|P2|NOT COMPLETED|Overall Study||4
2319207|NCT01887327|5694028|P1|NOT COMPLETED|Overall Study||1
2319208|NCT01887327|5694026|P3|COMPLETED|Overall Study||27
2319209|NCT01887327|5694027|P2|COMPLETED|Overall Study||27
2319210|NCT01887327|5694028|P1|COMPLETED|Overall Study||29
2319211|NCT01887327|5694026|P3|STARTED|Overall Study||30
2319212|NCT01887327|5694027|P2|STARTED|Overall Study||31
2319213|NCT01887327|5694028|P1|STARTED|Overall Study||30
2319214|NCT01887288|5694045|P1|NOT COMPLETED|Overall Study||16
2319215|NCT01887288|5694045|P1|COMPLETED|Overall Study||0
2319216|NCT01887288|5694045|P1|STARTED|Overall Study||16
2319217|NCT01887210|5694052|P2|NOT COMPLETED|Overall Study||4
2319218|NCT01887210|5694053|P1|NOT COMPLETED|Overall Study||1
2319219|NCT01887210|5694052|P2|COMPLETED|Overall Study||29
2319220|NCT01887210|5694053|P1|COMPLETED|Overall Study||32
2319221|NCT01887210|5694052|P2|STARTED|Overall Study||33
2319222|NCT01887210|5694053|P1|STARTED|Overall Study||33
2319223|NCT01887171|5694067|P2|NOT COMPLETED|Overall Study||0
2319224|NCT01887171|5694068|P1|NOT COMPLETED|Overall Study||0
2319225|NCT01887171|5694067|P2|COMPLETED|Overall Study||43
2319226|NCT01887171|5694068|P1|COMPLETED|Overall Study||43
2319227|NCT01887171|5694067|P2|STARTED|Overall Study||43
2319228|NCT01887171|5694068|P1|STARTED|Overall Study||43
2319229|NCT01887132|5694074|P1|NOT COMPLETED|Overall Study||0
2319230|NCT01887132|5694074|P1|COMPLETED|Overall Study||4
2319231|NCT01887132|5694074|P1|STARTED|Overall Study||4
2319232|NCT01886963|5694081|P2|NOT COMPLETED|Overall Study||4
2319233|NCT01886963|5694082|P1|NOT COMPLETED|Overall Study||5
2319234|NCT01886963|5694081|P2|COMPLETED|Overall Study||49
2319235|NCT01886963|5694082|P1|COMPLETED|Overall Study||46
2319236|NCT01886963|5694081|P2|12 Week Follow Up|Overall Study||22
2319237|NCT01886963|5694082|P1|12 Week Follow Up|Overall Study||24
2319238|NCT01886963|5694081|P2|4 Week Follow Up|Overall Study||26
2319239|NCT01886963|5694082|P1|4 Week Follow Up|Overall Study||24
2319240|NCT01886963|5694081|P2|2 Week Follow Up|Overall Study||35
2319241|NCT01886963|5694082|P1|2 Week Follow Up|Overall Study||38
2319242|NCT01886963|5694081|P2|STARTED|Overall Study||53
2319243|NCT01886963|5694082|P1|STARTED|Overall Study||51
2319244|NCT01886937|5694090|P2|NOT COMPLETED|Overall Study||0
2319245|NCT01886937|5694091|P1|NOT COMPLETED|Overall Study||0
2319246|NCT01886937|5694090|P2|COMPLETED|Overall Study||6
2319247|NCT01886937|5694091|P1|COMPLETED|Overall Study||7
2319248|NCT01886937|5694090|P2|STARTED|Overall Study||6
2319249|NCT01886937|5694091|P1|STARTED|Overall Study||7
2319268|NCT01886833|5694135|P1|NOT COMPLETED|Overall Study||204
2319269|NCT01886833|5694135|P1|COMPLETED|Overall Study||216
2319270|NCT01886833|5694135|P1|STARTED|Overall Study||420
2319271|NCT01886807|5694146|P3|NOT COMPLETED|Overall Study||10
2319272|NCT01886807|5694147|P2|NOT COMPLETED|Overall Study||10
2319273|NCT01886807|5694148|P1|NOT COMPLETED|Overall Study||5
2319274|NCT01886807|5694146|P3|COMPLETED|Overall Study||153
2319275|NCT01886807|5694147|P2|COMPLETED|Overall Study||145
2319276|NCT01886807|5694148|P1|COMPLETED|Overall Study||159
2319277|NCT01886807|5694146|P3|STARTED|Overall Study||163
2319278|NCT01886807|5694147|P2|STARTED|Overall Study||155
2319279|NCT01886807|5694148|P1|STARTED|Overall Study||164
2319280|NCT01886781|5694167|P2|NOT COMPLETED|Overall Study||2
2319281|NCT01886781|5694168|P1|NOT COMPLETED|Overall Study||14
2319282|NCT01886781|5694167|P2|COMPLETED|Overall Study||25
2319283|NCT01886781|5694168|P1|COMPLETED|Overall Study||40
2319284|NCT01886781|5694167|P2|STARTED|Overall Study||27
2319285|NCT01886781|5694168|P1|STARTED|Overall Study||54
2319286|NCT01886716|5694178|P4|NOT COMPLETED|1-Month Post Follow-Up||0
2319287|NCT01886716|5694179|P3|NOT COMPLETED|1-Month Post Follow-Up||0
2319288|NCT01886716|5694180|P2|NOT COMPLETED|1-Month Post Follow-Up||0
2319289|NCT01886716|5694181|P1|NOT COMPLETED|1-Month Post Follow-Up||0
2319290|NCT01886716|5694178|P4|COMPLETED|1-Month Post Follow-Up||14
2319291|NCT01886716|5694179|P3|COMPLETED|1-Month Post Follow-Up||19
2319292|NCT01886716|5694180|P2|COMPLETED|1-Month Post Follow-Up||17
2319293|NCT01886716|5694181|P1|COMPLETED|1-Month Post Follow-Up||20
2319294|NCT01886716|5694178|P4|STARTED|1-Month Post Follow-Up||14
2319295|NCT01886716|5694179|P3|STARTED|1-Month Post Follow-Up||19
2319296|NCT01886716|5694180|P2|STARTED|1-Month Post Follow-Up||17
2319297|NCT01886716|5694181|P1|STARTED|1-Month Post Follow-Up||20
2319298|NCT01886716|5694178|P4|NOT COMPLETED|1-Week Post Follow-Up||0
2319299|NCT01886716|5694179|P3|NOT COMPLETED|1-Week Post Follow-Up||0
2319300|NCT01886716|5694180|P2|NOT COMPLETED|1-Week Post Follow-Up||0
2319301|NCT01886716|5694181|P1|NOT COMPLETED|1-Week Post Follow-Up||0
2319302|NCT01886716|5694178|P4|COMPLETED|1-Week Post Follow-Up||14
2319303|NCT01886716|5694179|P3|COMPLETED|1-Week Post Follow-Up||19
2319304|NCT01886716|5694180|P2|COMPLETED|1-Week Post Follow-Up||17
2319305|NCT01886716|5694181|P1|COMPLETED|1-Week Post Follow-Up||20
2319306|NCT01886716|5694178|P4|STARTED|1-Week Post Follow-Up||14
2319307|NCT01886716|5694179|P3|STARTED|1-Week Post Follow-Up||19
2319308|NCT01886716|5694180|P2|STARTED|1-Week Post Follow-Up||17
2319309|NCT01886716|5694181|P1|STARTED|1-Week Post Follow-Up||20
2319310|NCT01886716|5694178|P4|NOT COMPLETED|Week 4||0
2319311|NCT01886716|5694179|P3|NOT COMPLETED|Week 4||0
2319312|NCT01886716|5694180|P2|NOT COMPLETED|Week 4||0
2319313|NCT01886716|5694181|P1|NOT COMPLETED|Week 4||0
2319314|NCT01886716|5694178|P4|COMPLETED|Week 4||14
2319315|NCT01886716|5694179|P3|COMPLETED|Week 4||19
2319316|NCT01886716|5694180|P2|COMPLETED|Week 4||17
2319317|NCT01886716|5694181|P1|COMPLETED|Week 4||20
2319318|NCT01886716|5694178|P4|STARTED|Week 4||14
2319319|NCT01886716|5694179|P3|STARTED|Week 4||19
2319320|NCT01886716|5694180|P2|STARTED|Week 4||17
2319321|NCT01886716|5694181|P1|STARTED|Week 4||20
2319322|NCT01886716|5694178|P4|NOT COMPLETED|Week 3||1
2319323|NCT01886716|5694179|P3|NOT COMPLETED|Week 3||0
2319324|NCT01886716|5694180|P2|NOT COMPLETED|Week 3||1
2319325|NCT01886716|5694181|P1|NOT COMPLETED|Week 3||1
2319326|NCT01886716|5694178|P4|COMPLETED|Week 3||14
2319327|NCT01886716|5694179|P3|COMPLETED|Week 3||19
2319328|NCT01886716|5694180|P2|COMPLETED|Week 3||17
2319329|NCT01886716|5694181|P1|COMPLETED|Week 3||20
2319330|NCT01886716|5694178|P4|STARTED|Week 3||15
2319331|NCT01886716|5694179|P3|STARTED|Week 3||19
2319332|NCT01886716|5694180|P2|STARTED|Week 3||18
2319333|NCT01886716|5694181|P1|STARTED|Week 3||21
2319334|NCT01886716|5694178|P4|NOT COMPLETED|Week 2||3
2319335|NCT01886716|5694179|P3|NOT COMPLETED|Week 2||1
2319336|NCT01886716|5694180|P2|NOT COMPLETED|Week 2||2
2319337|NCT01886716|5694181|P1|NOT COMPLETED|Week 2||3
2319338|NCT01886716|5694178|P4|COMPLETED|Week 2||15
2319339|NCT01886716|5694179|P3|COMPLETED|Week 2||19
2319340|NCT01886716|5694180|P2|COMPLETED|Week 2||18
2319341|NCT01886716|5694181|P1|COMPLETED|Week 2||21
2319342|NCT01886716|5694178|P4|STARTED|Week 2||18
2319343|NCT01886716|5694179|P3|STARTED|Week 2||20
2319344|NCT01886716|5694180|P2|STARTED|Week 2||20
2319345|NCT01886716|5694181|P1|STARTED|Week 2||24
2319346|NCT01886716|5694178|P4|NOT COMPLETED|Week 1||2
2319347|NCT01886716|5694179|P3|NOT COMPLETED|Week 1||2
2319348|NCT01886716|5694180|P2|NOT COMPLETED|Week 1||0
2319349|NCT01886716|5694181|P1|NOT COMPLETED|Week 1||0
2319350|NCT01886716|5694178|P4|COMPLETED|Week 1||18
2319351|NCT01886716|5694179|P3|COMPLETED|Week 1||20
2319352|NCT01886716|5694180|P2|COMPLETED|Week 1||20
2319353|NCT01886716|5694181|P1|COMPLETED|Week 1||24
2319354|NCT01886716|5694178|P4|STARTED|Week 1||20
2319355|NCT01886716|5694179|P3|STARTED|Week 1||22
2319356|NCT01886716|5694180|P2|STARTED|Week 1||20
2319357|NCT01886716|5694181|P1|STARTED|Week 1||24
2319358|NCT01886690|5694197|P2|NOT COMPLETED|Overall Study||2
2319359|NCT01886690|5694198|P1|NOT COMPLETED|Overall Study||0
2319360|NCT01886690|5694197|P2|COMPLETED|Overall Study||71
2319361|NCT01886690|5694198|P1|COMPLETED|Overall Study||75
2319362|NCT01886690|5694197|P2|STARTED|Overall Study||73
2319363|NCT01886690|5694198|P1|STARTED|Overall Study||75
2319364|NCT01886313|5694214|P2|NOT COMPLETED|Overall Study||1
2319365|NCT01886313|5694215|P1|NOT COMPLETED|Overall Study||1
2319366|NCT01886313|5694214|P2|COMPLETED|Overall Study||4
2319367|NCT01886313|5694215|P1|COMPLETED|Overall Study||5
2319368|NCT01886313|5694214|P2|STARTED|Overall Study||5
2319369|NCT01886313|5694215|P1|STARTED|Overall Study||6
2319370|NCT01886300|5694221|P1|NOT COMPLETED|Overall Study||16
2319371|NCT01886300|5694221|P1|COMPLETED|Overall Study||0
2319372|NCT01886300|5694221|P1|STARTED|Overall Study||16
2319373|NCT01886287|5694232|P1|NOT COMPLETED|Overall Study||2
2319374|NCT01886287|5694232|P1|COMPLETED|Overall Study||0
2319375|NCT01886287|5694232|P1|STARTED|Overall Study||2
2319376|NCT01886235|5694237|P1|NOT COMPLETED|Overall Study||0
2319377|NCT01886235|5694237|P1|COMPLETED|Overall Study||10
2319378|NCT01886235|5694237|P1|STARTED|Overall Study||10
2319379|NCT01886105|5694248|P1|NOT COMPLETED|Overall Study||3
2319380|NCT01886105|5694248|P1|COMPLETED|Overall Study||1
2319381|NCT01886105|5694248|P1|STARTED|Overall Study||4
2319382|NCT01885936|5694255|P2|NOT COMPLETED|Overall Study||0
2319383|NCT01885936|5694256|P1|NOT COMPLETED|Overall Study||1
2319384|NCT01885936|5694255|P2|COMPLETED|Overall Study||5
2319385|NCT01885936|5694256|P1|COMPLETED|Overall Study||7
2319386|NCT01885936|5694255|P2|STARTED|Overall Study||5
2319387|NCT01885936|5694256|P1|STARTED|Overall Study||8
2319388|NCT01885910|5694266|P1|NOT COMPLETED|Overall Study||8
2319389|NCT01885910|5694266|P1|COMPLETED|Overall Study||24
2319390|NCT01885910|5694266|P1|STARTED|Overall Study||32
2319391|NCT01885871|5694280|P1|NOT COMPLETED|Overall Study||0
2319392|NCT01885871|5694280|P1|COMPLETED|Overall Study||20
2319393|NCT01885871|5694280|P1|STARTED|Overall Study||20
2319394|NCT01885559|5694290|P2|NOT COMPLETED|Overall Study||36
2319395|NCT01885559|5694291|P1|NOT COMPLETED|Overall Study||24
2319396|NCT01885559|5694290|P2|COMPLETED|Overall Study||208
2319397|NCT01885559|5694291|P1|COMPLETED|Overall Study||218
2319398|NCT01885559|5694290|P2|STARTED|Overall Study||244
2319399|NCT01885559|5694291|P1|STARTED|Overall Study||242
2319400|NCT01885208|5694313|P2|NOT COMPLETED|Overall Study||38
2319401|NCT01885208|5694314|P1|NOT COMPLETED|Overall Study||32
2319402|NCT01885208|5694313|P2|COMPLETED|Overall Study||369
2319403|NCT01885208|5694314|P1|COMPLETED|Overall Study||374
2319404|NCT01885208|5694313|P2|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|85
2319405|NCT01885208|5694314|P1|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|82
2319406|NCT01885208|5694313|P2|Exposed|Overall Study||405
2319407|NCT01885208|5694314|P1|Exposed|Overall Study||404
2319408|NCT01885208|5694313|P2|STARTED|Overall Study||407
2319409|NCT01885208|5694314|P1|STARTED|Overall Study||406
2319410|NCT01885182|5694332|P2|NOT COMPLETED|Overall Study||22
2319411|NCT01885182|5694333|P1|NOT COMPLETED|Overall Study||34
2319412|NCT01885182|5694332|P2|COMPLETED|Overall Study||93
2319413|NCT01885182|5694333|P1|COMPLETED|Overall Study||83
2319414|NCT01885182|5694332|P2|FAP Population|Overall Study||106
2319415|NCT01885182|5694333|P1|FAP Population|Overall Study||107
2319416|NCT01885182|5694332|P2|Safety Population|Overall Study||111
2319417|NCT01885182|5694333|P1|Safety Population|Overall Study||114
2319418|NCT01885182|5694332|P2|STARTED|Overall Study||115
2319419|NCT01885182|5694333|P1|STARTED|Overall Study||117
2319420|NCT01885117|5694357|P2|NOT COMPLETED|Overall Study||0
2319421|NCT01885117|5694358|P1|NOT COMPLETED|Overall Study||0
2319422|NCT01885117|5694357|P2|COMPLETED|Overall Study||64
2319423|NCT01885117|5694358|P1|COMPLETED|Overall Study||61
2319424|NCT01885117|5694357|P2|STARTED|Overall Study||64
2319425|NCT01885117|5694358|P1|STARTED|Overall Study||61
2319426|NCT01885104|5694380|P2|NOT COMPLETED|Overall Study||1
2319427|NCT01885104|5694381|P1|NOT COMPLETED|Overall Study||2
2319428|NCT01885104|5694380|P2|COMPLETED|Overall Study||33
2319429|NCT01885104|5694381|P1|COMPLETED|Overall Study||29
2319430|NCT01885104|5694380|P2|STARTED|Overall Study||34
2319431|NCT01885104|5694381|P1|STARTED|Overall Study||31
2319432|NCT01885000|5694391|P2|NOT COMPLETED|Overall Study||2
2319433|NCT01885000|5694392|P1|NOT COMPLETED|Overall Study||2
2319434|NCT01885000|5694391|P2|COMPLETED|Overall Study||42
2319435|NCT01885000|5694392|P1|COMPLETED|Overall Study||46
2319436|NCT01885000|5694391|P2|STARTED|Overall Study||44
2319437|NCT01885000|5694392|P1|STARTED|Overall Study||48
2319438|NCT01884844|5694406|P2|NOT COMPLETED|Overall Study||5
2319439|NCT01884844|5694407|P1|NOT COMPLETED|Overall Study||3
2319440|NCT01884844|5694406|P2|COMPLETED|Overall Study||12
2319441|NCT01884844|5694407|P1|COMPLETED|Overall Study||13
2319442|NCT01884844|5694406|P2|STARTED|Overall Study||17
2319443|NCT01884844|5694407|P1|STARTED|Overall Study||16
2319444|NCT01884688|5694413|P1|NOT COMPLETED|Overall Study||2
2319445|NCT01884688|5694413|P1|COMPLETED|Overall Study||1
2319446|NCT01884688|5694413|P1|STARTED|Overall Study||3
2319447|NCT01884675|5694419|P2|NOT COMPLETED|Overall Study||2
2319448|NCT01884675|5694420|P1|NOT COMPLETED|Overall Study||3
2319449|NCT01884675|5694419|P2|COMPLETED|Overall Study||15
2319450|NCT01884675|5694420|P1|COMPLETED|Overall Study||13
2319451|NCT01884675|5694419|P2|STARTED|Overall Study||17
2319452|NCT01884675|5694420|P1|STARTED|Overall Study||16
2319453|NCT01884597|5694463|P3|NOT COMPLETED|Overall Study||1
2319454|NCT01884597|5694464|P2|NOT COMPLETED|Overall Study||1
2319455|NCT01884597|5694465|P1|NOT COMPLETED|Overall Study||1
2319456|NCT01884597|5694463|P3|COMPLETED|Overall Study||15
2319457|NCT01884597|5694464|P2|COMPLETED|Overall Study||2
2319458|NCT01884597|5694465|P1|COMPLETED|Overall Study||4
2319459|NCT01884597|5694463|P3|STARTED|Overall Study||16
2319460|NCT01884597|5694464|P2|STARTED|Overall Study||3
2319461|NCT01884597|5694465|P1|STARTED|Overall Study||5
2319462|NCT01884571|5694494|P1|NOT COMPLETED|Overall Study||8
2319463|NCT01884571|5694494|P1|COMPLETED|Overall Study||23
2319464|NCT01884571|5694494|P1|STARTED|Overall Study||31
2319465|NCT01884545|5694509|P4|NOT COMPLETED|Overall Study||9
2319466|NCT01884545|5694510|P3|NOT COMPLETED|Overall Study||14
2319467|NCT01884545|5694511|P2|NOT COMPLETED|Overall Study||18
2319468|NCT01884545|5694512|P1|NOT COMPLETED|Overall Study||13
2319469|NCT01884545|5694509|P4|COMPLETED|Overall Study||43
2319470|NCT01884545|5694510|P3|COMPLETED|Overall Study||35
2319471|NCT01884545|5694511|P2|COMPLETED|Overall Study||31
2319472|NCT01884545|5694512|P1|COMPLETED|Overall Study||37
2319473|NCT01884545|5694509|P4|STARTED|Overall Study||52
2319474|NCT01884545|5694510|P3|STARTED|Overall Study||49
2319475|NCT01884545|5694511|P2|STARTED|Overall Study||49
2319476|NCT01884545|5694512|P1|STARTED|Overall Study||50
2319477|NCT01884519|5694620|P2|NOT COMPLETED|Overall Study||0
2319478|NCT01884519|5694621|P1|NOT COMPLETED|Overall Study||0
2319479|NCT01884519|5694620|P2|COMPLETED|Overall Study||60
2319480|NCT01884519|5694621|P1|COMPLETED|Overall Study||60
2319481|NCT01884519|5694620|P2|STARTED|Overall Study||60
2319482|NCT01884519|5694621|P1|STARTED|Overall Study||60
2319483|NCT01884350|5694665|P3|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||11
2319484|NCT01884350|5694666|P2|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||13
2319485|NCT01884350|5694667|P1|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||80
2319486|NCT01884350|5694665|P3|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||250
2319487|NCT01884350|5694666|P2|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||250
2319488|NCT01884350|5694667|P1|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||503
2319489|NCT01884350|5694665|P3|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||223
2319490|NCT01884350|5694666|P2|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||308
2319491|NCT01884350|5694667|P1|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||604
2319492|NCT01884350|5694665|P3|STARTED|Primary Efficacy Analysis Set (48 Weeks)|After 24 weeks participants were randomized to continue AEP or stop AEP and revert to SOC.|261
2319493|NCT01884350|5694666|P2|STARTED|Primary Efficacy Analysis Set (48 Weeks)|After 24 weeks participants were randomized to continue AEP or stop AEP and revert to SOC.|263
2319494|NCT01884350|5694667|P1|STARTED|Primary Efficacy Analysis Set (48 Weeks)||583
2319495|NCT01884350|5694665|P3|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||0
2319496|NCT01884350|5694666|P2|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||54
2319497|NCT01884350|5694667|P1|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||54
2319498|NCT01884350|5694665|P3|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||0
2319499|NCT01884350|5694666|P2|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||525
2319500|NCT01884350|5694667|P1|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||529
2319501|NCT01884350|5694665|P3|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||0
2319502|NCT01884350|5694666|P2|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||558
2319503|NCT01884350|5694667|P1|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||604
2319504|NCT01884350|5694665|P3|STARTED|Primary Efficacy Analysis Set (24 Weeks)|Participants were not randomized to this arm until after initial 24-week period|0
2319505|NCT01884350|5694666|P2|STARTED|Primary Efficacy Analysis Set (24 Weeks)||579
2319506|NCT01884350|5694667|P1|STARTED|Primary Efficacy Analysis Set (24 Weeks)||583
2319507|NCT01884337|5694690|P2|NOT COMPLETED|Follow-up Period||1
2319508|NCT01884337|5694691|P1|NOT COMPLETED|Follow-up Period||1
2319509|NCT01884337|5694690|P2|COMPLETED|Follow-up Period||170
2319510|NCT01884337|5694691|P1|COMPLETED|Follow-up Period||323
2319511|NCT01884337|5694690|P2|STARTED|Follow-up Period||171
2319512|NCT01884337|5694691|P1|STARTED|Follow-up Period||324
2319513|NCT01884337|5694690|P2|NOT COMPLETED|Treatment||2
2319514|NCT01884337|5694691|P1|NOT COMPLETED|Treatment||4
2319515|NCT01884337|5694690|P2|COMPLETED|Treatment||170
2319516|NCT01884337|5694691|P1|COMPLETED|Treatment||322
2319517|NCT01884337|5694690|P2|Continuing Into Follow-up Period|Treatment||171
2319518|NCT01884337|5694691|P1|Continuing Into Follow-up Period|Treatment||324
2319519|NCT01884337|5694690|P2|STARTED|Treatment||172
2319520|NCT01884337|5694691|P1|STARTED|Treatment||326
2319521|NCT01884311|5694699|P1|NOT COMPLETED|Overall Study||5
2319522|NCT01884311|5694699|P1|COMPLETED|Overall Study||33
2319523|NCT01884311|5694699|P1|STARTED|Overall Study||38
2319524|NCT01884077|5694709|P2|NOT COMPLETED|Overall Study||10
2319525|NCT01884077|5694710|P1|NOT COMPLETED|Overall Study||8
2319526|NCT01884077|5694709|P2|COMPLETED|Overall Study||1
2319527|NCT01884077|5694710|P1|COMPLETED|Overall Study||0
2319528|NCT01884077|5694709|P2|STARTED|Overall Study||11
2319529|NCT01884077|5694710|P1|STARTED|Overall Study||8
2319530|NCT01884064|5694722|P2|NOT COMPLETED|Overall Study||0
2319531|NCT01884064|5694723|P1|NOT COMPLETED|Overall Study||0
2319532|NCT01884064|5694722|P2|COMPLETED|Overall Study||5
2319533|NCT01884064|5694723|P1|COMPLETED|Overall Study||12
2319534|NCT01884064|5694722|P2|STARTED|Overall Study||5
2319535|NCT01884064|5694723|P1|STARTED|Overall Study||12
2319536|NCT01884025|5694731|P2|NOT COMPLETED|Overall Study||4
2319537|NCT01884025|5694732|P1|NOT COMPLETED|Overall Study||3
2319538|NCT01884025|5694731|P2|COMPLETED|Overall Study||10
2319539|NCT01884025|5694732|P1|COMPLETED|Overall Study||10
2319540|NCT01884025|5694731|P2|STARTED|Overall Study||14
2319541|NCT01884025|5694732|P1|STARTED|Overall Study||13
2319542|NCT01883999|5694760|P1|NOT COMPLETED|Overall Study||3
2319543|NCT01883999|5694760|P1|COMPLETED|Overall Study||61
2319544|NCT01883999|5694760|P1|STARTED|Overall Study||64
2319545|NCT01883986|5694768|P2|NOT COMPLETED|Overall Study||1
2319546|NCT01883986|5694769|P1|NOT COMPLETED|Overall Study||3
2319547|NCT01883986|5694768|P2|COMPLETED|Overall Study|Completed study|19
2319548|NCT01883986|5694769|P1|COMPLETED|Overall Study|Received allocated intervention|17
2319549|NCT01883986|5694768|P2|Did Not Complete Study|Overall Study|Did not completed study|1
2319550|NCT01883986|5694769|P1|Did Not Complete Study|Overall Study||3
2319551|NCT01883986|5694768|P2|STARTED|Overall Study|Allocated to usual care arm|20
2319552|NCT01883986|5694769|P1|STARTED|Overall Study|Allocated to intervention arm|20
2319553|NCT01883908|5694783|P2|NOT COMPLETED|Overall Study||0
2319554|NCT01883908|5694784|P1|NOT COMPLETED|Overall Study||0
2319555|NCT01883908|5694783|P2|COMPLETED|Overall Study||1
2319556|NCT01883908|5694784|P1|COMPLETED|Overall Study||3
2319557|NCT01883908|5694783|P2|STARTED|Overall Study||1
2319558|NCT01883908|5694784|P1|STARTED|Overall Study||3
2319559|NCT01883895|5694792|P1|NOT COMPLETED|Overall Study||2
2319560|NCT01883895|5694792|P1|COMPLETED|Overall Study||32
2319561|NCT01883895|5694792|P1|STARTED|Overall Study||34
2319562|NCT01883804|5694797|P1|NOT COMPLETED|Overall Study||5
2319563|NCT01883804|5694797|P1|COMPLETED|Overall Study||20
2319564|NCT01883804|5694797|P1|STARTED|Overall Study||25
2319565|NCT01883635|5694806|P2|NOT COMPLETED|Overall Study||0
2319566|NCT01883635|5694807|P1|NOT COMPLETED|Overall Study||4
2319567|NCT01883635|5694806|P2|COMPLETED|Overall Study||20
2319568|NCT01883635|5694807|P1|COMPLETED|Overall Study||20
2319569|NCT01883635|5694806|P2|STARTED|Overall Study||20
2319570|NCT01883635|5694807|P1|STARTED|Overall Study||24
2319577|NCT01883453|5694854|P2|NOT COMPLETED|Overall Study||23
2319578|NCT01883453|5694855|P1|NOT COMPLETED|Overall Study||25
2319579|NCT01883453|5694854|P2|COMPLETED|Overall Study||50
2319580|NCT01883453|5694855|P1|COMPLETED|Overall Study||48
2319581|NCT01883453|5694854|P2|STARTED|Overall Study||73
2319582|NCT01883453|5694855|P1|STARTED|Overall Study||73
2319583|NCT01883440|5694863|P2|NOT COMPLETED|Overall Study||0
2319584|NCT01883440|5694864|P1|NOT COMPLETED|Overall Study||3
2319585|NCT01883440|5694863|P2|COMPLETED|Overall Study||45
2319586|NCT01883440|5694864|P1|COMPLETED|Overall Study||42
2319587|NCT01883440|5694863|P2|STARTED|Overall Study||45
2319588|NCT01883440|5694864|P1|STARTED|Overall Study||45
2319589|NCT01883427|5694874|P2|NOT COMPLETED|Overall Study||0
2319590|NCT01883427|5694875|P1|NOT COMPLETED|Overall Study||0
2319591|NCT01883427|5694874|P2|COMPLETED|Overall Study||20
2319592|NCT01883427|5694875|P1|COMPLETED|Overall Study||20
2319593|NCT01883427|5694874|P2|STARTED|Overall Study||20
2319594|NCT01883427|5694875|P1|STARTED|Overall Study||20
2319595|NCT01883141|5694881|P1|NOT COMPLETED|Overall Study||0
2319596|NCT01883141|5694881|P1|COMPLETED|Overall Study|Exit form with exit reason available|31
2319597|NCT01883141|5694881|P1|Multivein|Overall Study||23
2319598|NCT01883141|5694881|P1|Biv Pacing-Posterior|Overall Study||22
2319599|NCT01883141|5694881|P1|BiV Pacing-Anterior|Overall Study||23
2319600|NCT01883141|5694881|P1|Multispot-pacing|Overall Study||24
2319601|NCT01883141|5694881|P1|BiV Pacing-Standard Therapy|Overall Study||26
2319602|NCT01883141|5694881|P1|BiV Pacing-Mid|Overall Study||25
2319603|NCT01883141|5694881|P1|BiV Pacing-Distal|Overall Study||24
2319604|NCT01883141|5694881|P1|Usable EP Data|Overall Study||26
2319605|NCT01883141|5694881|P1|EP Study Performed|Overall Study||30
2319606|NCT01883141|5694881|P1|Passing Eligibility|Overall Study||30
2319607|NCT01883141|5694881|P1|STARTED|Overall Study||31
2319608|NCT01882985|5694890|P1|NOT COMPLETED|Overall Study||2
2319609|NCT01882985|5694890|P1|COMPLETED|Overall Study||12
2319610|NCT01882985|5694890|P1|STARTED|Overall Study||14
2319611|NCT01882907|5694899|P2|NOT COMPLETED|Overall Study||28
2319612|NCT01882907|5694900|P1|NOT COMPLETED|Overall Study||14
2319613|NCT01882907|5694899|P2|COMPLETED|Overall Study||83
2319614|NCT01882907|5694900|P1|COMPLETED|Overall Study||103
2319615|NCT01882907|5694899|P2|STARTED|Overall Study||111
2319616|NCT01882907|5694900|P1|STARTED|Overall Study||117
2319617|NCT01882868|5694916|P1|NOT COMPLETED|Overall Study||0
2319618|NCT01882868|5694916|P1|COMPLETED|Overall Study||62
2319619|NCT01882868|5694916|P1|STARTED|Overall Study||62
2319620|NCT01882829|5694946|P1|NOT COMPLETED|Overall Study||6
2319621|NCT01882829|5694946|P1|COMPLETED|Overall Study||14
2319622|NCT01882829|5694946|P1|STARTED|Overall Study||20
2319623|NCT01882803|5694960|P1|NOT COMPLETED|Overall Study||94
2319624|NCT01882803|5694960|P1|COMPLETED|Overall Study|Subject received treatment in 28-day cycles until disease progression or unacceptable toxicity.|35
2319625|NCT01882803|5694960|P1|STARTED|Overall Study||129
2319626|NCT01882764|5694973|P2|NOT COMPLETED|Overall Study||18
2319627|NCT01882764|5694974|P1|NOT COMPLETED|Overall Study||47
2319628|NCT01882764|5694973|P2|COMPLETED|Overall Study||1
2319629|NCT01882764|5694974|P1|COMPLETED|Overall Study||0
2319630|NCT01882764|5694973|P2|STARTED|Overall Study||19
2319631|NCT01882764|5694974|P1|STARTED|Overall Study||47
2319632|NCT01882725|5694980|P1|NOT COMPLETED|Overall Study||0
2319633|NCT01882725|5694980|P1|COMPLETED|Overall Study||14
2319634|NCT01882725|5694980|P1|STARTED|Overall Study||14
2319635|NCT01882647|5694987|P2|NOT COMPLETED|Overall Study||6
2319636|NCT01882647|5694988|P1|NOT COMPLETED|Overall Study||2
2319637|NCT01882647|5694987|P2|COMPLETED|Overall Study||106
2319638|NCT01882647|5694988|P1|COMPLETED|Overall Study||108
2319639|NCT01882647|5694987|P2|STARTED|Overall Study||112
2319640|NCT01882647|5694988|P1|STARTED|Overall Study||110
2319641|NCT01882543|5695006|P2|NOT COMPLETED|Overall Study||3
2319642|NCT01882543|5695007|P1|NOT COMPLETED|Overall Study||4
2319643|NCT01882543|5695006|P2|COMPLETED|Overall Study||29
2319644|NCT01882543|5695007|P1|COMPLETED|Overall Study||33
2319645|NCT01882543|5695006|P2|STARTED|Overall Study||32
2319646|NCT01882543|5695007|P1|STARTED|Overall Study||37
2319647|NCT01882465|5695028|P7|NOT COMPLETED|Period 3||0
2319648|NCT01882465|5695029|P6|NOT COMPLETED|Period 3||0
2319649|NCT01882465|5695030|P5|NOT COMPLETED|Period 3||0
2319650|NCT01882465|5695031|P4|NOT COMPLETED|Period 3||0
2319651|NCT01882465|5695032|P3|NOT COMPLETED|Period 3||0
2319652|NCT01882465|5695033|P2|NOT COMPLETED|Period 3||0
2319653|NCT01882465|5695034|P1|NOT COMPLETED|Period 3||0
2319654|NCT01882465|5695028|P7|COMPLETED|Period 3||0
2319655|NCT01882465|5695029|P6|COMPLETED|Period 3||5
2319656|NCT01882465|5695030|P5|COMPLETED|Period 3||4
2319657|NCT01882465|5695031|P4|COMPLETED|Period 3||5
2319658|NCT01882465|5695032|P3|COMPLETED|Period 3||5
2319659|NCT01882465|5695033|P2|COMPLETED|Period 3||6
2319660|NCT01882465|5695034|P1|COMPLETED|Period 3||6
2319661|NCT01882465|5695028|P7|STARTED|Period 3||0
2319662|NCT01882465|5695029|P6|STARTED|Period 3||5
2319663|NCT01882465|5695030|P5|STARTED|Period 3||4
2319664|NCT01882465|5695031|P4|STARTED|Period 3||5
2319665|NCT01882465|5695032|P3|STARTED|Period 3||5
2319666|NCT01882465|5695033|P2|STARTED|Period 3||6
2319667|NCT01882465|5695034|P1|STARTED|Period 3||6
2319668|NCT01882465|5695028|P7|NOT COMPLETED|Period 2||0
2319669|NCT01882465|5695029|P6|NOT COMPLETED|Period 2||0
2319670|NCT01882465|5695030|P5|NOT COMPLETED|Period 2||1
2319671|NCT01882465|5695031|P4|NOT COMPLETED|Period 2||0
2319672|NCT01882465|5695032|P3|NOT COMPLETED|Period 2||0
2319673|NCT01882465|5695033|P2|NOT COMPLETED|Period 2||0
2319674|NCT01882465|5695034|P1|NOT COMPLETED|Period 2||0
2319675|NCT01882465|5695028|P7|COMPLETED|Period 2||0
2319676|NCT01882465|5695029|P6|COMPLETED|Period 2||5
2319677|NCT01882465|5695030|P5|COMPLETED|Period 2||4
2319678|NCT01882465|5695031|P4|COMPLETED|Period 2||5
2319679|NCT01882465|5695032|P3|COMPLETED|Period 2||5
2319680|NCT01882465|5695033|P2|COMPLETED|Period 2||6
2319681|NCT01882465|5695034|P1|COMPLETED|Period 2||6
2319682|NCT01882465|5695028|P7|STARTED|Period 2||0
2319683|NCT01882465|5695029|P6|STARTED|Period 2||5
2319684|NCT01882465|5695030|P5|STARTED|Period 2||5
2319685|NCT01882465|5695031|P4|STARTED|Period 2||5
2319686|NCT01882465|5695032|P3|STARTED|Period 2||5
2319687|NCT01882465|5695033|P2|STARTED|Period 2||6
2319688|NCT01882465|5695034|P1|STARTED|Period 2||6
2319689|NCT01882465|5695028|P7|NOT COMPLETED|Period 1||1
2319690|NCT01882465|5695029|P6|NOT COMPLETED|Period 1||0
2319691|NCT01882465|5695030|P5|NOT COMPLETED|Period 1||0
2319692|NCT01882465|5695031|P4|NOT COMPLETED|Period 1||1
2319693|NCT01882465|5695032|P3|NOT COMPLETED|Period 1||0
2319694|NCT01882465|5695033|P2|NOT COMPLETED|Period 1||0
2319695|NCT01882465|5695034|P1|NOT COMPLETED|Period 1||0
2319696|NCT01882465|5695028|P7|COMPLETED|Period 1||0
2319697|NCT01882465|5695029|P6|COMPLETED|Period 1||5
2319698|NCT01882465|5695030|P5|COMPLETED|Period 1||5
2319699|NCT01882465|5695031|P4|COMPLETED|Period 1||5
2319700|NCT01882465|5695032|P3|COMPLETED|Period 1||5
2319701|NCT01882465|5695033|P2|COMPLETED|Period 1||6
2319702|NCT01882465|5695034|P1|COMPLETED|Period 1||6
2319703|NCT01882465|5695028|P7|STARTED|Period 1||1
2319704|NCT01882465|5695029|P6|STARTED|Period 1||5
2319705|NCT01882465|5695030|P5|STARTED|Period 1||5
2319706|NCT01882465|5695031|P4|STARTED|Period 1||6
2319707|NCT01882465|5695032|P3|STARTED|Period 1||5
2319708|NCT01882465|5695033|P2|STARTED|Period 1||6
2319709|NCT01882465|5695034|P1|STARTED|Period 1||6
2319710|NCT01882439|5695046|P4|NOT COMPLETED|Overall Study||9
2319711|NCT01882439|5695047|P3|NOT COMPLETED|Overall Study||10
2319712|NCT01882439|5695048|P2|NOT COMPLETED|Overall Study||21
2319713|NCT01882439|5695049|P1|NOT COMPLETED|Overall Study||9
2319714|NCT01882439|5695046|P4|COMPLETED|Overall Study||56
2319715|NCT01882439|5695047|P3|COMPLETED|Overall Study||56
2319716|NCT01882439|5695048|P2|COMPLETED|Overall Study||111
2319717|NCT01882439|5695049|P1|COMPLETED|Overall Study||122
2319718|NCT01882439|5695046|P4|STARTED|Overall Study|Received treatment|65
2319719|NCT01882439|5695047|P3|STARTED|Overall Study|Received treatment|66
2319720|NCT01882439|5695048|P2|STARTED|Overall Study|Received treatment|132
2319721|NCT01882439|5695049|P1|STARTED|Overall Study|Received treatment|131
2319722|NCT01882413|5695229|P1|NOT COMPLETED|Overall Study||0
2319723|NCT01882413|5695229|P1|COMPLETED|Overall Study||204
2319724|NCT01882413|5695229|P1|STARTED|Overall Study||204
2319725|NCT01882257|5695246|P3|NOT COMPLETED|Therapy Portion of Study (12 Months)||4
2319726|NCT01882257|5695247|P2|NOT COMPLETED|Therapy Portion of Study (12 Months)||11
2319727|NCT01882257|5695248|P1|NOT COMPLETED|Therapy Portion of Study (12 Months)||0
2319728|NCT01882257|5695246|P3|COMPLETED|Therapy Portion of Study (12 Months)||18
2319729|NCT01882257|5695247|P2|COMPLETED|Therapy Portion of Study (12 Months)||27
2319730|NCT01882257|5695248|P1|COMPLETED|Therapy Portion of Study (12 Months)||11
2319731|NCT01882257|5695246|P3|STARTED|Therapy Portion of Study (12 Months)||22
2319732|NCT01882257|5695247|P2|STARTED|Therapy Portion of Study (12 Months)||38
2319733|NCT01882257|5695248|P1|STARTED|Therapy Portion of Study (12 Months)||11
2319734|NCT01882257|5695246|P3|NOT COMPLETED|Study Origination to Beginning Therapy||1
2319735|NCT01882257|5695247|P2|NOT COMPLETED|Study Origination to Beginning Therapy||2
2319736|NCT01882257|5695248|P1|NOT COMPLETED|Study Origination to Beginning Therapy||0
2319737|NCT01882257|5695246|P3|COMPLETED|Study Origination to Beginning Therapy||22
2319738|NCT01882257|5695247|P2|COMPLETED|Study Origination to Beginning Therapy||38
2319739|NCT01882257|5695248|P1|COMPLETED|Study Origination to Beginning Therapy||11
2319740|NCT01882257|5695246|P3|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 23 who were given the device, 1 chose not to begin the actual therapy|22
2319741|NCT01882257|5695247|P2|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 40 who were given the device, 2 chose not to begin the actual therapy|38
2319742|NCT01882257|5695248|P1|Started Therapy Using Device|Study Origination to Beginning Therapy||11
2319743|NCT01882257|5695246|P3|STARTED|Study Origination to Beginning Therapy||23
2319744|NCT01882257|5695247|P2|STARTED|Study Origination to Beginning Therapy||40
2319745|NCT01882257|5695248|P1|STARTED|Study Origination to Beginning Therapy||11
2319746|NCT01882088|5695255|P1|NOT COMPLETED|Overall Study||5
2319747|NCT01882088|5695255|P1|COMPLETED|Overall Study||30
2319748|NCT01882088|5695255|P1|STARTED|Overall Study|35 patients were provided with psyllium in 5.0 sachets, 3 sachets per day for 10 days|35
2319749|NCT01882062|5695268|P1|NOT COMPLETED|Overall Study||0
2319750|NCT01882062|5695268|P1|COMPLETED|Overall Study|18th of july 2013|10
2319751|NCT01882062|5695268|P1|STARTED|Overall Study|16th of may 2013|10
2319752|NCT01881984|5695272|P1|NOT COMPLETED|Overall Study||0
2319753|NCT01881984|5695272|P1|COMPLETED|Overall Study||4
2319754|NCT01881984|5695272|P1|STARTED|Overall Study||4
2319755|NCT01881932|5695280|P3|NOT COMPLETED|Overall Study||0
2319756|NCT01881932|5695281|P2|NOT COMPLETED|Overall Study||0
2319757|NCT01881932|5695282|P1|NOT COMPLETED|Overall Study||0
2319758|NCT01881932|5695280|P3|COMPLETED|Overall Study||13
2319759|NCT01881932|5695281|P2|COMPLETED|Overall Study||4
2319760|NCT01881932|5695282|P1|COMPLETED|Overall Study||2
2319761|NCT01881932|5695280|P3|STARTED|Overall Study||13
2319762|NCT01881932|5695281|P2|STARTED|Overall Study||4
2319763|NCT01881932|5695282|P1|STARTED|Overall Study||2
2319764|NCT01881867|5695292|P2|NOT COMPLETED|Overall Study||13
2319765|NCT01881867|5695293|P1|NOT COMPLETED|Overall Study||12
2319766|NCT01881867|5695292|P2|COMPLETED|Overall Study||15
2319767|NCT01881867|5695293|P1|COMPLETED|Overall Study||14
2319768|NCT01881867|5695292|P2|STARTED|Overall Study||28
2319769|NCT01881867|5695293|P1|STARTED|Overall Study||26
2319770|NCT01881828|5695313|P2|NOT COMPLETED|Overall Study||0
2319771|NCT01881828|5695314|P1|NOT COMPLETED|Overall Study||0
2319772|NCT01881828|5695313|P2|COMPLETED|Overall Study||69
2319773|NCT01881828|5695314|P1|COMPLETED|Overall Study||71
2319774|NCT01881828|5695313|P2|STARTED|Overall Study|23 excluded from randomization from enrollment|69
2319775|NCT01881828|5695314|P1|STARTED|Overall Study|23 excluded at randomization from enrollment|71
2319776|NCT01881776|5695337|P3|NOT COMPLETED|Overall Study||2
2319777|NCT01881776|5695338|P2|NOT COMPLETED|Overall Study||4
2319778|NCT01881776|5695339|P1|NOT COMPLETED|Overall Study||1
2319779|NCT01881776|5695337|P3|COMPLETED|Overall Study||20
2319780|NCT01881776|5695338|P2|COMPLETED|Overall Study||20
2319781|NCT01881776|5695339|P1|COMPLETED|Overall Study||23
2319782|NCT01881776|5695337|P3|STARTED|Overall Study||22
2319783|NCT01881776|5695338|P2|STARTED|Overall Study||24
2319784|NCT01881776|5695339|P1|STARTED|Overall Study||24
2319785|NCT01881750|5695367|P2|NOT COMPLETED|Overall Study||4
2319786|NCT01881750|5695368|P1|NOT COMPLETED|Overall Study||2
2319787|NCT01881750|5695367|P2|COMPLETED|Overall Study||22
2319788|NCT01881750|5695368|P1|COMPLETED|Overall Study||25
2319789|NCT01881750|5695367|P2|STARTED|Overall Study||26
2319790|NCT01881750|5695368|P1|STARTED|Overall Study||27
2319791|NCT01881737|5695386|P1|NOT COMPLETED|Overall Study||5
2319792|NCT01881737|5695386|P1|COMPLETED|Overall Study||10
2319793|NCT01881737|5695386|P1|Number Screened|Overall Study||15
2319794|NCT01881737|5695386|P1|STARTED|Overall Study|This is a pilot study|15
2319795|NCT01881620|5695395|P1|NOT COMPLETED|Overall Study||4
2319796|NCT01881620|5695395|P1|COMPLETED|Overall Study|Eligible patients with PET-CT scanner performed AND interpretation of 2 pairs of observors available|105
2319797|NCT01881620|5695395|P1|STARTED|Overall Study||109
2319798|NCT01881230|5695407|P3|NOT COMPLETED|Overall Study||66
2319799|NCT01881230|5695408|P2|NOT COMPLETED|Overall Study||64
2319800|NCT01881230|5695409|P1|NOT COMPLETED|Overall Study||61
2319801|NCT01881230|5695407|P3|COMPLETED|Overall Study|Not applicable according to the study design|0
2319802|NCT01881230|5695408|P2|COMPLETED|Overall Study|Not applicable according to the study design|0
2319803|NCT01881230|5695409|P1|COMPLETED|Overall Study|Not applicable according to the study design|0
2319804|NCT01881230|5695407|P3|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64
2319805|NCT01881230|5695408|P2|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64
2319806|NCT01881230|5695409|P1|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|60
2319807|NCT01881230|5695407|P3|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64
2319808|NCT01881230|5695408|P2|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64
2319809|NCT01881230|5695409|P1|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of Investigational Product (IP)|60
2319810|NCT01881230|5695407|P3|STARTED|Overall Study||66
2319811|NCT01881230|5695408|P2|STARTED|Overall Study||64
2319812|NCT01881230|5695409|P1|STARTED|Overall Study||61
2319813|NCT01881126|5695437|P2|NOT COMPLETED|Overall Study||2
2319814|NCT01881126|5695438|P1|NOT COMPLETED|Overall Study||1
2319815|NCT01881126|5695437|P2|COMPLETED|Overall Study||44
2319816|NCT01881126|5695438|P1|COMPLETED|Overall Study||46
2319817|NCT01881126|5695437|P2|STARTED|Overall Study||46
2319818|NCT01881126|5695438|P1|STARTED|Overall Study||47
2319819|NCT01881113|5695446|P2|NOT COMPLETED|Overall Study||6
2319820|NCT01881113|5695447|P1|NOT COMPLETED|Overall Study||8
2319821|NCT01881113|5695446|P2|COMPLETED|Overall Study||44
2319822|NCT01881113|5695447|P1|COMPLETED|Overall Study||43
2319823|NCT01881113|5695446|P2|STARTED|Overall Study||50
2319824|NCT01881113|5695447|P1|STARTED|Overall Study||51
2319825|NCT01881087|5695504|P3|NOT COMPLETED|Overall Study||2
2319826|NCT01881087|5695505|P2|NOT COMPLETED|Overall Study||0
2319827|NCT01881087|5695506|P1|NOT COMPLETED|Overall Study||1
2319828|NCT01881087|5695504|P3|COMPLETED|Overall Study||60
2319829|NCT01881087|5695505|P2|COMPLETED|Overall Study||61
2319830|NCT01881087|5695506|P1|COMPLETED|Overall Study||59
2319831|NCT01881087|5695504|P3|STARTED|Overall Study||62
2319832|NCT01881087|5695505|P2|STARTED|Overall Study||61
2319833|NCT01881087|5695506|P1|STARTED|Overall Study||60
2319834|NCT01881009|5695519|P2|NOT COMPLETED|Summer Camp Session (6 Days)||1
2319835|NCT01881009|5695520|P1|NOT COMPLETED|Summer Camp Session (6 Days)||0
2319836|NCT01881009|5695519|P2|COMPLETED|Summer Camp Session (6 Days)||21
2319837|NCT01881009|5695520|P1|COMPLETED|Summer Camp Session (6 Days)||0
2319838|NCT01881009|5695519|P2|STARTED|Summer Camp Session (6 Days)||22
2319839|NCT01881009|5695520|P1|STARTED|Summer Camp Session (6 Days)||0
2319840|NCT01881009|5695519|P2|NOT COMPLETED|Inpatient Safety Testing (22 Hours)||0
2319841|NCT01881009|5695520|P1|NOT COMPLETED|Inpatient Safety Testing (22 Hours)||0
2319842|NCT01881009|5695519|P2|COMPLETED|Inpatient Safety Testing (22 Hours)||0
2319843|NCT01881009|5695520|P1|COMPLETED|Inpatient Safety Testing (22 Hours)||16
2319844|NCT01881009|5695519|P2|STARTED|Inpatient Safety Testing (22 Hours)||0
2319845|NCT01881009|5695520|P1|STARTED|Inpatient Safety Testing (22 Hours)||16
2319846|NCT01880840|5695531|P2|NOT COMPLETED|Overall Study||5
2319847|NCT01880840|5695532|P1|NOT COMPLETED|Overall Study||8
2319848|NCT01880840|5695531|P2|COMPLETED|Overall Study||91
2319849|NCT01880840|5695532|P1|COMPLETED|Overall Study||87
2319850|NCT01880840|5695531|P2|STARTED|Overall Study||96
2319851|NCT01880840|5695532|P1|STARTED|Overall Study||95
2319852|NCT01880736|5695542|P4|NOT COMPLETED|Overall Study||6
2319853|NCT01880736|5695543|P3|NOT COMPLETED|Overall Study||1
2319854|NCT01880736|5695544|P2|NOT COMPLETED|Overall Study||2
2319855|NCT01880736|5695545|P1|NOT COMPLETED|Overall Study||1
2319856|NCT01880736|5695542|P4|COMPLETED|Overall Study||108
2319857|NCT01880736|5695543|P3|COMPLETED|Overall Study||114
2319858|NCT01880736|5695544|P2|COMPLETED|Overall Study||113
2319859|NCT01880736|5695545|P1|COMPLETED|Overall Study||113
2319860|NCT01880736|5695542|P4|STARTED|Overall Study||114
2319861|NCT01880736|5695543|P3|STARTED|Overall Study||115
2319862|NCT01880736|5695544|P2|STARTED|Overall Study||115
2319863|NCT01880736|5695545|P1|STARTED|Overall Study||114
2319864|NCT01880723|5695589|P2|NOT COMPLETED|Overall Study||0
2319865|NCT01880723|5695590|P1|NOT COMPLETED|Overall Study||0
2319866|NCT01880723|5695589|P2|COMPLETED|Overall Study||16
2319867|NCT01880723|5695590|P1|COMPLETED|Overall Study||16
2319868|NCT01880723|5695589|P2|STARTED|Overall Study||16
2319869|NCT01880723|5695590|P1|STARTED|Overall Study||16
2319870|NCT01880697|5695606|P2|NOT COMPLETED|Overall Study||1
2319871|NCT01880697|5695607|P1|NOT COMPLETED|Overall Study||0
2319872|NCT01880697|5695606|P2|COMPLETED|Overall Study||62
2319873|NCT01880697|5695607|P1|COMPLETED|Overall Study||63
2319874|NCT01880697|5695606|P2|STARTED|Overall Study||63
2319875|NCT01880697|5695607|P1|STARTED|Overall Study||63
2319876|NCT01880593|5695629|P2|NOT COMPLETED|Overall Study||6
2319877|NCT01880593|5695630|P1|NOT COMPLETED|Overall Study||8
2319878|NCT01880593|5695629|P2|COMPLETED|Overall Study||10
2319879|NCT01880593|5695630|P1|COMPLETED|Overall Study||10
2319880|NCT01880593|5695629|P2|STARTED|Overall Study||16
2319881|NCT01880593|5695630|P1|STARTED|Overall Study||18
2319882|NCT01880528|5695650|P2|NOT COMPLETED|Overall Study||1
2319883|NCT01880528|5695651|P1|NOT COMPLETED|Overall Study||1
2319884|NCT01880528|5695650|P2|COMPLETED|Overall Study||10
2319885|NCT01880528|5695651|P1|COMPLETED|Overall Study||11
2319886|NCT01880528|5695650|P2|STARTED|Overall Study||11
2319887|NCT01880528|5695651|P1|STARTED|Overall Study||12
2319888|NCT01880515|5695667|P2|NOT COMPLETED|Overall Study||9
2319889|NCT01880515|5695668|P1|NOT COMPLETED|Overall Study||8
2319890|NCT01880515|5695667|P2|COMPLETED|Overall Study||45
2319891|NCT01880515|5695668|P1|COMPLETED|Overall Study||45
2319892|NCT01880515|5695667|P2|STARTED|Overall Study||54
2319893|NCT01880515|5695668|P1|STARTED|Overall Study||53
2319894|NCT01880437|5695679|P3|NOT COMPLETED|Overall Study||19
2319895|NCT01880437|5695680|P2|NOT COMPLETED|Overall Study||4
2319896|NCT01880437|5695681|P1|NOT COMPLETED|Overall Study||15
2319897|NCT01880437|5695679|P3|COMPLETED|Overall Study||0
2319898|NCT01880437|5695680|P2|COMPLETED|Overall Study||0
2319899|NCT01880437|5695681|P1|COMPLETED|Overall Study||0
2319900|NCT01880437|5695679|P3|STARTED|Overall Study||19
2319901|NCT01880437|5695680|P2|STARTED|Overall Study||4
2319902|NCT01880437|5695681|P1|STARTED|Overall Study||15
2319903|NCT01880424|5695707|P2|NOT COMPLETED|Overall Study||55
2319904|NCT01880424|5695708|P1|NOT COMPLETED|Overall Study||33
2319905|NCT01880424|5695707|P2|COMPLETED|Overall Study||367
2319906|NCT01880424|5695708|P1|COMPLETED|Overall Study||384
2319907|NCT01880424|5695707|P2|STARTED|Overall Study||422
2319908|NCT01880424|5695708|P1|STARTED|Overall Study||417
2319909|NCT01880320|5695733|P3|NOT COMPLETED|Overall Study||8
2319910|NCT01880320|5695734|P2|NOT COMPLETED|Overall Study||25
2319911|NCT01880320|5695735|P1|NOT COMPLETED|Overall Study||20
2319912|NCT01880320|5695733|P3|COMPLETED|Overall Study||61
2319913|NCT01880320|5695734|P2|COMPLETED|Overall Study||192
2319914|NCT01880320|5695735|P1|COMPLETED|Overall Study||197
2319915|NCT01880320|5695733|P3|STARTED|Overall Study||69
2319916|NCT01880320|5695734|P2|STARTED|Overall Study||217
2319917|NCT01880320|5695735|P1|STARTED|Overall Study||217
2319918|NCT01880099|5695752|P3|NOT COMPLETED|Overall Study||7
2319919|NCT01880099|5695753|P2|NOT COMPLETED|Overall Study||10
2319920|NCT01880099|5695754|P1|NOT COMPLETED|Overall Study||8
2319921|NCT01880099|5695752|P3|COMPLETED|Overall Study||15
2319922|NCT01880099|5695753|P2|COMPLETED|Overall Study||11
2319923|NCT01880099|5695754|P1|COMPLETED|Overall Study||9
2319924|NCT01880099|5695752|P3|STARTED|Overall Study||22
2319925|NCT01880099|5695753|P2|STARTED|Overall Study||21
2319926|NCT01880099|5695754|P1|STARTED|Overall Study||17
2319927|NCT01880086|5695764|P2|NOT COMPLETED|Overall Study||1
2319928|NCT01880086|5695765|P1|NOT COMPLETED|Overall Study||1
2319929|NCT01880086|5695764|P2|COMPLETED|Overall Study||6
2319930|NCT01880086|5695765|P1|COMPLETED|Overall Study||5
2319931|NCT01880086|5695764|P2|STARTED|Overall Study||7
2319932|NCT01880086|5695765|P1|STARTED|Overall Study||6
2319933|NCT01880047|5695787|P4|NOT COMPLETED|Extension Phase - 18 Months||2
2319934|NCT01880047|5695788|P3|NOT COMPLETED|Extension Phase - 18 Months||1
2319935|NCT01880047|5695789|P2|NOT COMPLETED|Extension Phase - 18 Months||3
2319936|NCT01880047|5695790|P1|NOT COMPLETED|Extension Phase - 18 Months||9
2319937|NCT01880047|5695787|P4|COMPLETED|Extension Phase - 18 Months||0
2319938|NCT01880047|5695788|P3|COMPLETED|Extension Phase - 18 Months||3
2319939|NCT01880047|5695789|P2|COMPLETED|Extension Phase - 18 Months||3
2319940|NCT01880047|5695790|P1|COMPLETED|Extension Phase - 18 Months||6
2319941|NCT01880047|5695787|P4|STARTED|Extension Phase - 18 Months|2 subjects went into extension phase, were followed for variable periods of time|2
2319942|NCT01880047|5695788|P3|STARTED|Extension Phase - 18 Months|4 subjects went into extension phase, were followed for variable periods of time|4
2319943|NCT01880047|5695789|P2|STARTED|Extension Phase - 18 Months|6 subjects went into extension phase, were followed for variable periods of time|6
2319944|NCT01880047|5695790|P1|STARTED|Extension Phase - 18 Months|15 subjects went into extension phase, were followed for variable periods of time|15
2319945|NCT01880047|5695787|P4|NOT COMPLETED|Weeks 5-8||0
2319946|NCT01880047|5695788|P3|NOT COMPLETED|Weeks 5-8||0
2319947|NCT01880047|5695789|P2|NOT COMPLETED|Weeks 5-8||1
2319948|NCT01880047|5695790|P1|NOT COMPLETED|Weeks 5-8||2
2319949|NCT01880047|5695787|P4|COMPLETED|Weeks 5-8||2
2319950|NCT01880047|5695788|P3|COMPLETED|Weeks 5-8||4
2319951|NCT01880047|5695789|P2|COMPLETED|Weeks 5-8||6
2319952|NCT01880047|5695790|P1|COMPLETED|Weeks 5-8||15
2319953|NCT01880047|5695787|P4|STARTED|Weeks 5-8||2
2319954|NCT01880047|5695788|P3|STARTED|Weeks 5-8||4
2319955|NCT01880047|5695789|P2|STARTED|Weeks 5-8||7
2319956|NCT01880047|5695790|P1|STARTED|Weeks 5-8||17
2319957|NCT01880047|5695787|P4|NOT COMPLETED|Weeks 3-4||0
2319958|NCT01880047|5695788|P3|NOT COMPLETED|Weeks 3-4||0
2319959|NCT01880047|5695789|P2|NOT COMPLETED|Weeks 3-4||1
2319960|NCT01880047|5695790|P1|NOT COMPLETED|Weeks 3-4||0
2319961|NCT01880047|5695787|P4|COMPLETED|Weeks 3-4||2
2319962|NCT01880047|5695788|P3|COMPLETED|Weeks 3-4||4
2319963|NCT01880047|5695789|P2|COMPLETED|Weeks 3-4||7
2319964|NCT01880047|5695790|P1|COMPLETED|Weeks 3-4||17
2319965|NCT01880047|5695787|P4|STARTED|Weeks 3-4||2
2319966|NCT01880047|5695788|P3|STARTED|Weeks 3-4||4
2319967|NCT01880047|5695789|P2|STARTED|Weeks 3-4||8
2319968|NCT01880047|5695790|P1|STARTED|Weeks 3-4||17
2319969|NCT01880047|5695787|P4|NOT COMPLETED|Weeks 0-2||1
2319970|NCT01880047|5695788|P3|NOT COMPLETED|Weeks 0-2||1
2319971|NCT01880047|5695789|P2|NOT COMPLETED|Weeks 0-2||1
2319972|NCT01880047|5695790|P1|NOT COMPLETED|Weeks 0-2||0
2319973|NCT01880047|5695787|P4|COMPLETED|Weeks 0-2||2
2319974|NCT01880047|5695788|P3|COMPLETED|Weeks 0-2||4
2319975|NCT01880047|5695789|P2|COMPLETED|Weeks 0-2||8
2319976|NCT01880047|5695790|P1|COMPLETED|Weeks 0-2||17
2319977|NCT01880047|5695787|P4|STARTED|Weeks 0-2||3
2319978|NCT01880047|5695788|P3|STARTED|Weeks 0-2||5
2319979|NCT01880047|5695789|P2|STARTED|Weeks 0-2||9
2319980|NCT01880047|5695790|P1|STARTED|Weeks 0-2||17
2319981|NCT01879852|5695813|P2|NOT COMPLETED|Overall Study||0
2319982|NCT01879852|5695814|P1|NOT COMPLETED|Overall Study||2
2319983|NCT01879852|5695813|P2|COMPLETED|Overall Study||13
2319984|NCT01879852|5695814|P1|COMPLETED|Overall Study||12
2319985|NCT01879852|5695813|P2|STARTED|Overall Study||13
2319986|NCT01879852|5695814|P1|STARTED|Overall Study||14
2319987|NCT01879826|5695828|P2|NOT COMPLETED|Overall Study||0
2319988|NCT01879826|5695829|P1|NOT COMPLETED|Overall Study||0
2319989|NCT01879826|5695828|P2|COMPLETED|Overall Study||40
2319990|NCT01879826|5695829|P1|COMPLETED|Overall Study||41
2319991|NCT01879826|5695828|P2|STARTED|Overall Study||40
2319992|NCT01879826|5695829|P1|STARTED|Overall Study||41
2319993|NCT01879800|5695839|P2|NOT COMPLETED|Overall Study||4
2319994|NCT01879800|5695840|P1|NOT COMPLETED|Overall Study||0
2319995|NCT01879800|5695839|P2|COMPLETED|Overall Study||26
2319996|NCT01879800|5695840|P1|COMPLETED|Overall Study||14
2319997|NCT01879800|5695839|P2|STARTED|Overall Study||30
2319998|NCT01879800|5695840|P1|STARTED|Overall Study||14
2319999|NCT01879735|5695852|P2|NOT COMPLETED|Overall Study||0
2320000|NCT01879735|5695853|P1|NOT COMPLETED|Overall Study||0
2320001|NCT01879735|5695852|P2|COMPLETED|Overall Study||16
2320002|NCT01879735|5695853|P1|COMPLETED|Overall Study||6
2320003|NCT01879735|5695852|P2|STARTED|Overall Study||16
2320004|NCT01879735|5695853|P1|STARTED|Overall Study||6
2320005|NCT01879722|5695869|P10|NOT COMPLETED|Overall Study||0
2320006|NCT01879722|5695870|P9|NOT COMPLETED|Overall Study||2
2320007|NCT01879722|5695871|P8|NOT COMPLETED|Overall Study||1
2320008|NCT01879722|5695872|P7|NOT COMPLETED|Overall Study||0
2320009|NCT01879722|5695873|P6|NOT COMPLETED|Overall Study||0
2320010|NCT01879722|5695874|P5|NOT COMPLETED|Overall Study||1
2320011|NCT01879722|5695875|P4|NOT COMPLETED|Overall Study||1
2320012|NCT01879722|5695876|P3|NOT COMPLETED|Overall Study||0
2320013|NCT01879722|5695877|P2|NOT COMPLETED|Overall Study||1
2320014|NCT01879722|5695878|P1|NOT COMPLETED|Overall Study||0
2320015|NCT01879722|5695869|P10|COMPLETED|Overall Study||6
2320016|NCT01879722|5695870|P9|COMPLETED|Overall Study||6
2320017|NCT01879722|5695871|P8|COMPLETED|Overall Study||7
2320018|NCT01879722|5695872|P7|COMPLETED|Overall Study||8
2320019|NCT01879722|5695873|P6|COMPLETED|Overall Study||9
2320020|NCT01879722|5695874|P5|COMPLETED|Overall Study||7
2320021|NCT01879722|5695875|P4|COMPLETED|Overall Study||7
2320022|NCT01879722|5695876|P3|COMPLETED|Overall Study||7
2320023|NCT01879722|5695877|P2|COMPLETED|Overall Study||7
2320024|NCT01879722|5695878|P1|COMPLETED|Overall Study||7
2320025|NCT01879722|5695869|P10|STARTED|Overall Study||6
2320026|NCT01879722|5695870|P9|STARTED|Overall Study||8
2320027|NCT01879722|5695871|P8|STARTED|Overall Study||8
2320028|NCT01879722|5695872|P7|STARTED|Overall Study||8
2320029|NCT01879722|5695873|P6|STARTED|Overall Study||9
2320030|NCT01879722|5695874|P5|STARTED|Overall Study||8
2320031|NCT01879722|5695875|P4|STARTED|Overall Study||8
2320032|NCT01879722|5695876|P3|STARTED|Overall Study||7
2320033|NCT01879722|5695877|P2|STARTED|Overall Study||8
2320034|NCT01879722|5695878|P1|STARTED|Overall Study||7
2320035|NCT01879683|5696026|P1|NOT COMPLETED|Overall Study||1
2320036|NCT01879683|5696026|P1|COMPLETED|Overall Study||9
2320037|NCT01879683|5696026|P1|STARTED|Overall Study||10
2320038|NCT01879618|5696033|P1|NOT COMPLETED|Overall Study||21
2320039|NCT01879618|5696033|P1|COMPLETED|Overall Study||131
2320040|NCT01879618|5696033|P1|STARTED|Overall Study||152
2320041|NCT01879579|5696040|P2|NOT COMPLETED|Overall Study||2
2320042|NCT01879579|5696041|P1|NOT COMPLETED|Overall Study||5
2320043|NCT01879579|5696040|P2|COMPLETED|Overall Study||26
2320044|NCT01879579|5696041|P1|COMPLETED|Overall Study||28
2320045|NCT01879579|5696040|P2|STARTED|Overall Study||28
2320046|NCT01879579|5696041|P1|STARTED|Overall Study||33
2320047|NCT01879553|5696071|P2|NOT COMPLETED|Overall Study||0
2320048|NCT01879553|5696072|P1|NOT COMPLETED|Overall Study||1
2320049|NCT01879553|5696071|P2|COMPLETED|Overall Study||63
2320050|NCT01879553|5696072|P1|COMPLETED|Overall Study||62
2320051|NCT01879553|5696071|P2|STARTED|Overall Study||63
2320052|NCT01879553|5696072|P1|STARTED|Overall Study||63
2320053|NCT01879540|5696093|P1|NOT COMPLETED|Overall Study||0
2320054|NCT01879540|5696093|P1|COMPLETED|Overall Study||63
2320055|NCT01879540|5696093|P1|STARTED|Overall Study||63
2320056|NCT01879410|5696106|P2|NOT COMPLETED|Overall Study||38
2320057|NCT01879410|5696107|P1|NOT COMPLETED|Overall Study||24
2320058|NCT01879410|5696106|P2|COMPLETED|Overall Study||312
2320059|NCT01879410|5696107|P1|COMPLETED|Overall Study||326
2320060|NCT01879410|5696106|P2|Intent-to-Treat Population|Overall Study||348
2320061|NCT01879410|5696107|P1|Intent-to-Treat Population|Overall Study||349
2320062|NCT01879410|5696106|P2|STARTED|Overall Study||350
2320063|NCT01879410|5696107|P1|STARTED|Overall Study||350
2320064|NCT01879371|5696121|P6|NOT COMPLETED|Overall Study||0
2320065|NCT01879371|5696122|P5|NOT COMPLETED|Overall Study||0
2320066|NCT01879371|5696123|P4|NOT COMPLETED|Overall Study||0
2320067|NCT01879371|5696124|P3|NOT COMPLETED|Overall Study||0
2320068|NCT01879371|5696125|P2|NOT COMPLETED|Overall Study||0
2320069|NCT01879371|5696126|P1|NOT COMPLETED|Overall Study||0
2320070|NCT01879371|5696121|P6|COMPLETED|Overall Study||6
2320071|NCT01879371|5696122|P5|COMPLETED|Overall Study||6
2320072|NCT01879371|5696123|P4|COMPLETED|Overall Study||6
2320073|NCT01879371|5696124|P3|COMPLETED|Overall Study||6
2320074|NCT01879371|5696125|P2|COMPLETED|Overall Study||6
2320075|NCT01879371|5696126|P1|COMPLETED|Overall Study||6
2320076|NCT01879371|5696121|P6|STARTED|Overall Study||6
2320077|NCT01879371|5696122|P5|STARTED|Overall Study||6
2320078|NCT01879371|5696123|P4|STARTED|Overall Study||6
2320079|NCT01879371|5696124|P3|STARTED|Overall Study||6
2320080|NCT01879371|5696125|P2|STARTED|Overall Study||6
2320081|NCT01879371|5696126|P1|STARTED|Overall Study||6
2320082|NCT01879345|5696143|P3|NOT COMPLETED|7-day Multiple-dose Period||0
2320083|NCT01879345|5696144|P2|NOT COMPLETED|7-day Multiple-dose Period||0
2320084|NCT01879345|5696145|P1|NOT COMPLETED|7-day Multiple-dose Period||0
2320085|NCT01879345|5696143|P3|COMPLETED|7-day Multiple-dose Period||6
2320086|NCT01879345|5696144|P2|COMPLETED|7-day Multiple-dose Period||6
2320087|NCT01879345|5696145|P1|COMPLETED|7-day Multiple-dose Period||6
2320088|NCT01879345|5696143|P3|STARTED|7-day Multiple-dose Period||6
2320089|NCT01879345|5696144|P2|STARTED|7-day Multiple-dose Period||6
2320090|NCT01879345|5696145|P1|STARTED|7-day Multiple-dose Period||6
2320091|NCT01879345|5696143|P3|NOT COMPLETED|Single-dose Period||0
2320092|NCT01879345|5696144|P2|NOT COMPLETED|Single-dose Period||0
2320093|NCT01879345|5696145|P1|NOT COMPLETED|Single-dose Period||0
2320094|NCT01879345|5696143|P3|COMPLETED|Single-dose Period||6
2320095|NCT01879345|5696144|P2|COMPLETED|Single-dose Period||6
2320096|NCT01879345|5696145|P1|COMPLETED|Single-dose Period||6
2320097|NCT01879345|5696143|P3|STARTED|Single-dose Period||6
2320098|NCT01879345|5696144|P2|STARTED|Single-dose Period||6
2320099|NCT01879345|5696145|P1|STARTED|Single-dose Period||6
2320100|NCT01879332|5696162|P3|NOT COMPLETED|Overall Study||4
2320101|NCT01879332|5696163|P2|NOT COMPLETED|Overall Study||6
2320102|NCT01879332|5696164|P1|NOT COMPLETED|Overall Study||6
2320103|NCT01879332|5696162|P3|COMPLETED|Overall Study||0
2320104|NCT01879332|5696163|P2|COMPLETED|Overall Study||0
2320105|NCT01879332|5696164|P1|COMPLETED|Overall Study||0
2320106|NCT01879332|5696162|P3|STARTED|Overall Study||4
2320107|NCT01879332|5696163|P2|STARTED|Overall Study||6
2320108|NCT01879332|5696164|P1|STARTED|Overall Study||6
2320109|NCT01879319|5696174|P2|NOT COMPLETED|Overall Study||5
2320110|NCT01879319|5696175|P1|NOT COMPLETED|Overall Study||2
2320111|NCT01879319|5696174|P2|COMPLETED|Overall Study||77
2320112|NCT01879319|5696175|P1|COMPLETED|Overall Study||80
2320113|NCT01879319|5696174|P2|Received Treatment|Overall Study||82
2320114|NCT01879319|5696175|P1|Received Treatment|Overall Study||82
2320115|NCT01879319|5696174|P2|STARTED|Overall Study||82
2320116|NCT01879319|5696175|P1|STARTED|Overall Study||82
2320117|NCT01879176|5696185|P2|NOT COMPLETED|Overall Study||6
2320118|NCT01879176|5696186|P1|NOT COMPLETED|Overall Study||8
2320119|NCT01879176|5696185|P2|COMPLETED|Overall Study||16
2320120|NCT01879176|5696186|P1|COMPLETED|Overall Study||16
2320121|NCT01879176|5696185|P2|STARTED|Overall Study||22
2320122|NCT01879176|5696186|P1|STARTED|Overall Study||24
2320123|NCT01879072|5696192|P1|NOT COMPLETED|Overall Study||151
2320124|NCT01879072|5696192|P1|COMPLETED|Overall Study||1709
2320125|NCT01879072|5696192|P1|STARTED|Overall Study||1860
2320126|NCT01879059|5696196|P1|NOT COMPLETED|Overall Study||0
2320127|NCT01879059|5696196|P1|COMPLETED|Overall Study||13
2320128|NCT01879059|5696196|P1|STARTED|Overall Study||13
2320129|NCT01878825|5696202|P2|NOT COMPLETED|Overall Study||0
2320130|NCT01878825|5696203|P1|NOT COMPLETED|Overall Study||0
2320131|NCT01878825|5696202|P2|COMPLETED|Overall Study||60
2320132|NCT01878825|5696203|P1|COMPLETED|Overall Study||60
2320133|NCT01878825|5696202|P2|STARTED|Overall Study||60
2320134|NCT01878825|5696203|P1|STARTED|Overall Study||60
2320135|NCT01878812|5696241|P2|NOT COMPLETED|Overall Study||0
2320136|NCT01878812|5696242|P1|NOT COMPLETED|Overall Study||0
2320137|NCT01878812|5696241|P2|COMPLETED|Overall Study||57
2320138|NCT01878812|5696242|P1|COMPLETED|Overall Study||60
2320139|NCT01878812|5696241|P2|STARTED|Overall Study||57
2320140|NCT01878812|5696242|P1|STARTED|Overall Study||60
2320141|NCT01878799|5696278|P2|NOT COMPLETED|Overall Study||0
2320142|NCT01878799|5696279|P1|NOT COMPLETED|Overall Study||1
2320143|NCT01878799|5696278|P2|COMPLETED|Overall Study||13
2320144|NCT01878799|5696279|P1|COMPLETED|Overall Study||36
2320145|NCT01878799|5696278|P2|STARTED|Overall Study||13
2320146|NCT01878799|5696279|P1|STARTED|Overall Study||37
2320147|NCT01878786|5696288|P3|NOT COMPLETED|Overall Study||7
2320148|NCT01878786|5696289|P2|NOT COMPLETED|Overall Study||9
2320149|NCT01878786|5696290|P1|NOT COMPLETED|Overall Study||9
2320150|NCT01878786|5696288|P3|COMPLETED|Overall Study|Study closed prematurely; 1 patient was a screen fail|0
2320151|NCT01878786|5696289|P2|COMPLETED|Overall Study|Study closed prematurely|0
2320152|NCT01878786|5696290|P1|COMPLETED|Overall Study|Study closed prematurely|0
2320153|NCT01878786|5696288|P3|STARTED|Overall Study||7
2320154|NCT01878786|5696289|P2|STARTED|Overall Study||9
2320155|NCT01878786|5696290|P1|STARTED|Overall Study||9
2320156|NCT01878656|5696306|P2|NOT COMPLETED|Overall Study||0
2320157|NCT01878656|5696307|P1|NOT COMPLETED|Overall Study||0
2320158|NCT01878656|5696306|P2|COMPLETED|Overall Study||72
2320159|NCT01878656|5696307|P1|COMPLETED|Overall Study||72
2320160|NCT01878656|5696306|P2|STARTED|Overall Study||72
2320161|NCT01878656|5696307|P1|STARTED|Overall Study||72
2320162|NCT01878604|5696313|P1|NOT COMPLETED|Overall Study||0
2320163|NCT01878604|5696313|P1|COMPLETED|Overall Study||5
2320164|NCT01878604|5696313|P1|STARTED|Overall Study||5
2320165|NCT01878526|5696320|P2|NOT COMPLETED|Overall Study||2
2320166|NCT01878526|5696321|P1|NOT COMPLETED|Overall Study||3
2320167|NCT01878526|5696320|P2|COMPLETED|Overall Study||38
2320168|NCT01878526|5696321|P1|COMPLETED|Overall Study||37
2320169|NCT01878526|5696320|P2|STARTED|Overall Study||40
2320170|NCT01878526|5696321|P1|STARTED|Overall Study||40
2320171|NCT01878292|5696337|P3|NOT COMPLETED|Double-blind Down-Taper Period||4
2320172|NCT01878292|5696338|P2|NOT COMPLETED|Double-blind Down-Taper Period||8
2320173|NCT01878292|5696339|P1|NOT COMPLETED|Double-blind Down-Taper Period||5
2320174|NCT01878292|5696337|P3|COMPLETED|Double-blind Down-Taper Period||142
2320175|NCT01878292|5696338|P2|COMPLETED|Double-blind Down-Taper Period||132
2320176|NCT01878292|5696339|P1|COMPLETED|Double-blind Down-Taper Period||122
2320177|NCT01878292|5696337|P3|STARTED|Double-blind Down-Taper Period||146
2320178|NCT01878292|5696338|P2|STARTED|Double-blind Down-Taper Period||140
2320179|NCT01878292|5696339|P1|STARTED|Double-blind Down-Taper Period||127
2320180|NCT01878292|5696337|P3|NOT COMPLETED|Double-blind Treatment Period||19
2320181|NCT01878292|5696338|P2|NOT COMPLETED|Double-blind Treatment Period||26
2320182|NCT01878292|5696339|P1|NOT COMPLETED|Double-blind Treatment Period||29
2320183|NCT01878292|5696337|P3|COMPLETED|Double-blind Treatment Period||161
2320184|NCT01878292|5696338|P2|COMPLETED|Double-blind Treatment Period||149
2320185|NCT01878292|5696339|P1|COMPLETED|Double-blind Treatment Period||142
2320186|NCT01878292|5696337|P3|STARTED|Double-blind Treatment Period||180
2320187|NCT01878292|5696338|P2|STARTED|Double-blind Treatment Period||175
2320188|NCT01878292|5696339|P1|STARTED|Double-blind Treatment Period||171
2320189|NCT01878292|5696337|P3|NOT COMPLETED|Randomized||0
2320190|NCT01878292|5696338|P2|NOT COMPLETED|Randomized||0
2320191|NCT01878292|5696339|P1|NOT COMPLETED|Randomized||3
2320192|NCT01878292|5696337|P3|COMPLETED|Randomized||180
2320193|NCT01878292|5696338|P2|COMPLETED|Randomized||175
2320194|NCT01878292|5696339|P1|COMPLETED|Randomized||171
2320195|NCT01878292|5696337|P3|STARTED|Randomized||180
2320196|NCT01878292|5696338|P2|STARTED|Randomized||175
2320197|NCT01878292|5696339|P1|STARTED|Randomized||174
2320198|NCT01878253|5696350|P1|NOT COMPLETED|Overall Study||9
2320199|NCT01878253|5696350|P1|COMPLETED|Overall Study||86
2320200|NCT01878253|5696350|P1|2 Year|Overall Study||86
2320201|NCT01878253|5696350|P1|1 Year|Overall Study||88
2320202|NCT01878253|5696350|P1|6 Months|Overall Study||90
2320203|NCT01878253|5696350|P1|6 Weeks|Overall Study||95
2320204|NCT01878253|5696350|P1|Pre-Operative|Overall Study||95
2320205|NCT01878253|5696350|P1|STARTED|Overall Study||95
2320206|NCT01878214|5696361|P2|NOT COMPLETED|Overall Study||44
2320207|NCT01878214|5696362|P1|NOT COMPLETED|Overall Study||53
2320208|NCT01878214|5696361|P2|COMPLETED|Overall Study||175
2320209|NCT01878214|5696362|P1|COMPLETED|Overall Study||170
2320210|NCT01878214|5696361|P2|STARTED|Overall Study||219
2320211|NCT01878214|5696362|P1|STARTED|Overall Study||223
2320212|NCT01878175|5696376|P1|NOT COMPLETED|Overall Study||2
2320213|NCT01878175|5696376|P1|COMPLETED|Overall Study||13
2320214|NCT01878175|5696376|P1|STARTED|Overall Study||15
2320215|NCT01878149|5696395|P2|NOT COMPLETED|Overall Study||2
2320216|NCT01878149|5696396|P1|NOT COMPLETED|Overall Study||2
2320217|NCT01878149|5696395|P2|COMPLETED|Overall Study||15
2320218|NCT01878149|5696396|P1|COMPLETED|Overall Study||19
2320219|NCT01878149|5696395|P2|STARTED|Overall Study||17
2320220|NCT01878149|5696396|P1|STARTED|Overall Study||21
2320221|NCT01878097|5696404|P2|NOT COMPLETED|Implementation Year 4||3007
2320222|NCT01878097|5696405|P1|NOT COMPLETED|Implementation Year 4||3604
2320223|NCT01878097|5696404|P2|COMPLETED|Implementation Year 4||6607
2320224|NCT01878097|5696405|P1|COMPLETED|Implementation Year 4||6981
2320225|NCT01878097|5696404|P2|STARTED|Implementation Year 4||9614
2320226|NCT01878097|5696405|P1|STARTED|Implementation Year 4||10585
2320227|NCT01878097|5696404|P2|NOT COMPLETED|Implementation Year 3||2980
2320228|NCT01878097|5696405|P1|NOT COMPLETED|Implementation Year 3||3494
2320229|NCT01878097|5696404|P2|COMPLETED|Implementation Year 3||6770
2320230|NCT01878097|5696405|P1|COMPLETED|Implementation Year 3||7046
2320231|NCT01878097|5696404|P2|STARTED|Implementation Year 3||9750
2320232|NCT01878097|5696405|P1|STARTED|Implementation Year 3||10540
2320233|NCT01878097|5696404|P2|NOT COMPLETED|Implementation Year 2||2841
2320234|NCT01878097|5696405|P1|NOT COMPLETED|Implementation Year 2||3281
2320235|NCT01878097|5696404|P2|COMPLETED|Implementation Year 2||6770
2320236|NCT01878097|5696405|P1|COMPLETED|Implementation Year 2||8286
2320237|NCT01878097|5696404|P2|STARTED|Implementation Year 2||9611
2320238|NCT01878097|5696405|P1|STARTED|Implementation Year 2||11567
2320239|NCT01878097|5696404|P2|NOT COMPLETED|Implementation Year 1||2549
2320240|NCT01878097|5696405|P1|NOT COMPLETED|Implementation Year 1||3202
2320241|NCT01878097|5696404|P2|COMPLETED|Implementation Year 1||7317
2320242|NCT01878097|5696405|P1|COMPLETED|Implementation Year 1||8540
2320243|NCT01878097|5696404|P2|STARTED|Implementation Year 1||9866
2320244|NCT01878097|5696405|P1|STARTED|Implementation Year 1||11742
2320245|NCT01878097|5696404|P2|NOT COMPLETED|Baseline||1800
2320246|NCT01878097|5696405|P1|NOT COMPLETED|Baseline||2497
2320247|NCT01878097|5696404|P2|COMPLETED|Baseline|Anonymous surveys; sum of all completed surveys.|8281
2320248|NCT01878097|5696405|P1|COMPLETED|Baseline|Anonymous surveys so only last year data provided as annual completed.|8228
2320249|NCT01878097|5696404|P2|STARTED|Baseline|number of students in 13 control schools completing anonymous surveys with non missing data|10081
2320250|NCT01878097|5696405|P1|STARTED|Baseline|number of students in 13 intervention schools completing anonymous surveys with non missing data|10725
2320256|NCT01878006|5696418|P2|NOT COMPLETED|Study Session 2||0
2320257|NCT01878006|5696419|P1|NOT COMPLETED|Study Session 2||0
2320258|NCT01878006|5696418|P2|COMPLETED|Study Session 2||5
2320259|NCT01878006|5696419|P1|COMPLETED|Study Session 2||5
2320260|NCT01878006|5696418|P2|STARTED|Study Session 2||5
2320261|NCT01878006|5696419|P1|STARTED|Study Session 2||5
2320262|NCT01878006|5696418|P2|NOT COMPLETED|Study Session 1||0
2320263|NCT01878006|5696419|P1|NOT COMPLETED|Study Session 1||0
2320264|NCT01878006|5696418|P2|COMPLETED|Study Session 1||5
2320265|NCT01878006|5696419|P1|COMPLETED|Study Session 1||5
2320266|NCT01878006|5696418|P2|STARTED|Study Session 1||5
2320267|NCT01878006|5696419|P1|STARTED|Study Session 1||5
2320268|NCT01877941|5696439|P1|NOT COMPLETED|Overall Study||0
2320269|NCT01877941|5696439|P1|COMPLETED|Overall Study||39
2320270|NCT01877941|5696439|P1|STARTED|Overall Study||39
2320271|NCT01877915|5696447|P2|NOT COMPLETED|Overall Study||68
2320272|NCT01877915|5696448|P1|NOT COMPLETED|Overall Study||54
2320273|NCT01877915|5696447|P2|COMPLETED|Overall Study||2447
2320274|NCT01877915|5696448|P1|COMPLETED|Overall Study||2453
2320275|NCT01877915|5696447|P2|STARTED|Overall Study||2515
2320276|NCT01877915|5696448|P1|STARTED|Overall Study||2507
2320277|NCT01877720|5696470|P2|NOT COMPLETED|Overall Study||0
2320278|NCT01877720|5696471|P1|NOT COMPLETED|Overall Study||1
2320279|NCT01877720|5696470|P2|COMPLETED|Overall Study||8
2320280|NCT01877720|5696471|P1|COMPLETED|Overall Study||7
2320281|NCT01877720|5696470|P2|2nd Intervention|Overall Study||8
2320282|NCT01877720|5696471|P1|2nd Intervention|Overall Study||7
2320283|NCT01877720|5696470|P2|1st Intervention|Overall Study||8
2320284|NCT01877720|5696471|P1|1st Intervention|Overall Study||7
2320285|NCT01877720|5696470|P2|STARTED|Overall Study||8
2320286|NCT01877720|5696471|P1|STARTED|Overall Study||8
2320287|NCT01877668|5696500|P5|NOT COMPLETED|Overall Study||10
2320288|NCT01877668|5696501|P4|NOT COMPLETED|Overall Study||8
2320289|NCT01877668|5696502|P3|NOT COMPLETED|Overall Study||12
2320290|NCT01877668|5696503|P2|NOT COMPLETED|Overall Study||8
2320291|NCT01877668|5696504|P1|NOT COMPLETED|Overall Study||11
2320292|NCT01877668|5696500|P5|COMPLETED|Overall Study||43
2320293|NCT01877668|5696501|P4|COMPLETED|Overall Study||44
2320294|NCT01877668|5696502|P3|COMPLETED|Overall Study||94
2320295|NCT01877668|5696503|P2|COMPLETED|Overall Study||96
2320296|NCT01877668|5696504|P1|COMPLETED|Overall Study||96
2320297|NCT01877668|5696500|P5|STARTED|Overall Study|Received treatment|53
2320298|NCT01877668|5696501|P4|STARTED|Overall Study|Received treatment|52
2320299|NCT01877668|5696502|P3|STARTED|Overall Study|Received treatment|106
2320300|NCT01877668|5696503|P2|STARTED|Overall Study|Received treatment|104
2320301|NCT01877668|5696504|P1|STARTED|Overall Study|Received treatment|107
2320302|NCT01877655|5696735|P2|NOT COMPLETED|Overall Study||97
2320303|NCT01877655|5696736|P1|NOT COMPLETED|Overall Study||98
2320304|NCT01877655|5696735|P2|COMPLETED|Overall Study||154
2320305|NCT01877655|5696736|P1|COMPLETED|Overall Study||165
2320306|NCT01877655|5696735|P2|Received Treatment|Overall Study||246
2320307|NCT01877655|5696736|P1|Received Treatment|Overall Study||255
2320308|NCT01877655|5696735|P2|STARTED|Overall Study||251
2320309|NCT01877655|5696736|P1|STARTED|Overall Study||263
2320310|NCT01877642|5696754|P7|NOT COMPLETED|Overall Study||0
2320311|NCT01877642|5696755|P6|NOT COMPLETED|Overall Study||0
2320312|NCT01877642|5696756|P5|NOT COMPLETED|Overall Study||0
2320313|NCT01877642|5696757|P4|NOT COMPLETED|Overall Study||0
2320314|NCT01877642|5696758|P3|NOT COMPLETED|Overall Study||0
2320315|NCT01877642|5696759|P2|NOT COMPLETED|Overall Study||0
2320316|NCT01877642|5696760|P1|NOT COMPLETED|Overall Study||0
2320317|NCT01877642|5696754|P7|COMPLETED|Overall Study||3
2320318|NCT01877642|5696755|P6|COMPLETED|Overall Study||3
2320319|NCT01877642|5696756|P5|COMPLETED|Overall Study||3
2320320|NCT01877642|5696757|P4|COMPLETED|Overall Study||3
2320321|NCT01877642|5696758|P3|COMPLETED|Overall Study||3
2320322|NCT01877642|5696759|P2|COMPLETED|Overall Study||3
2320323|NCT01877642|5696760|P1|COMPLETED|Overall Study||4
2320324|NCT01877642|5696754|P7|STARTED|Overall Study||3
2320325|NCT01877642|5696755|P6|STARTED|Overall Study||3
2320326|NCT01877642|5696756|P5|STARTED|Overall Study||3
2320327|NCT01877642|5696757|P4|STARTED|Overall Study||3
2320328|NCT01877642|5696758|P3|STARTED|Overall Study||3
2320329|NCT01877642|5696759|P2|STARTED|Overall Study||3
2320330|NCT01877642|5696760|P1|STARTED|Overall Study||4
2320331|NCT01877564|5696783|P2|NOT COMPLETED|Overall Study||0
2320332|NCT01877564|5696784|P1|NOT COMPLETED|Overall Study||0
2320333|NCT01877564|5696783|P2|COMPLETED|Overall Study||4
2320334|NCT01877564|5696784|P1|COMPLETED|Overall Study||6
2320335|NCT01877564|5696783|P2|STARTED|Overall Study||4
2320336|NCT01877564|5696784|P1|STARTED|Overall Study||6
2320337|NCT01877551|5696792|P2|NOT COMPLETED|Overall Study||1
2320338|NCT01877551|5696793|P1|NOT COMPLETED|Overall Study||0
2320339|NCT01877551|5696792|P2|COMPLETED|Overall Study||13
2320340|NCT01877551|5696793|P1|COMPLETED|Overall Study||13
2320341|NCT01877551|5696792|P2|STARTED|Overall Study||14
2320342|NCT01877551|5696793|P1|STARTED|Overall Study||13
2320343|NCT01877538|5696805|P1|NOT COMPLETED|Overall Study||0
2320344|NCT01877538|5696805|P1|COMPLETED|Overall Study||7
2320345|NCT01877538|5696805|P1|STARTED|Overall Study||7
2320346|NCT01877421|5696842|P18|NOT COMPLETED|Phase 2||0
2320347|NCT01877421|5696843|P17|NOT COMPLETED|Phase 2||0
2320348|NCT01877421|5696844|P16|NOT COMPLETED|Phase 2||1
2320349|NCT01877421|5696845|P15|NOT COMPLETED|Phase 2||0
2320350|NCT01877421|5696846|P14|NOT COMPLETED|Phase 2||0
2320351|NCT01877421|5696847|P13|NOT COMPLETED|Phase 2||1
2320352|NCT01877421|5696848|P12|NOT COMPLETED|Phase 2||0
2320353|NCT01877421|5696849|P11|NOT COMPLETED|Phase 2||2
2320354|NCT01877421|5696850|P10|NOT COMPLETED|Phase 2||0
2320355|NCT01877421|5696851|P9|NOT COMPLETED|Phase 2||1
2320356|NCT01877421|5696852|P8|NOT COMPLETED|Phase 2||0
2320357|NCT01877421|5696853|P7|NOT COMPLETED|Phase 2||1
2320358|NCT01877421|5696854|P6|NOT COMPLETED|Phase 2||0
2320359|NCT01877421|5696855|P5|NOT COMPLETED|Phase 2||0
2320360|NCT01877421|5696856|P4|NOT COMPLETED|Phase 2||0
2320361|NCT01877421|5696857|P3|NOT COMPLETED|Phase 2||0
2320362|NCT01877421|5696858|P2|NOT COMPLETED|Phase 2||0
2320363|NCT01877421|5696859|P1|NOT COMPLETED|Phase 2||0
2320364|NCT01877421|5696842|P18|COMPLETED|Phase 2||0
2320365|NCT01877421|5696843|P17|COMPLETED|Phase 2||0
2320366|NCT01877421|5696844|P16|COMPLETED|Phase 2||2
2320367|NCT01877421|5696845|P15|COMPLETED|Phase 2||7
2320368|NCT01877421|5696846|P14|COMPLETED|Phase 2||3
2320369|NCT01877421|5696847|P13|COMPLETED|Phase 2||6
2320370|NCT01877421|5696848|P12|COMPLETED|Phase 2||3
2320371|NCT01877421|5696849|P11|COMPLETED|Phase 2||5
2320372|NCT01877421|5696850|P10|COMPLETED|Phase 2||3
2320373|NCT01877421|5696851|P9|COMPLETED|Phase 2||5
2320374|NCT01877421|5696852|P8|COMPLETED|Phase 2||2
2320375|NCT01877421|5696853|P7|COMPLETED|Phase 2||6
2320376|NCT01877421|5696854|P6|COMPLETED|Phase 2||3
2320377|NCT01877421|5696855|P5|COMPLETED|Phase 2||7
2320378|NCT01877421|5696856|P4|COMPLETED|Phase 2||2
2320379|NCT01877421|5696857|P3|COMPLETED|Phase 2||4
2320380|NCT01877421|5696858|P2|COMPLETED|Phase 2||0
2320381|NCT01877421|5696859|P1|COMPLETED|Phase 2||0
2320382|NCT01877421|5696842|P18|STARTED|Phase 2||0
2320383|NCT01877421|5696843|P17|STARTED|Phase 2||0
2320384|NCT01877421|5696844|P16|STARTED|Phase 2||3
2320385|NCT01877421|5696845|P15|STARTED|Phase 2||7
2320386|NCT01877421|5696846|P14|STARTED|Phase 2||3
2320387|NCT01877421|5696847|P13|STARTED|Phase 2||7
2320388|NCT01877421|5696848|P12|STARTED|Phase 2||3
2320389|NCT01877421|5696849|P11|STARTED|Phase 2||7
2320390|NCT01877421|5696850|P10|STARTED|Phase 2||3
2320391|NCT01877421|5696851|P9|STARTED|Phase 2||6
2320392|NCT01877421|5696852|P8|STARTED|Phase 2||2
2320393|NCT01877421|5696853|P7|STARTED|Phase 2||7
2320394|NCT01877421|5696854|P6|STARTED|Phase 2||3
2320395|NCT01877421|5696855|P5|STARTED|Phase 2||7
2320396|NCT01877421|5696856|P4|STARTED|Phase 2||2
2320397|NCT01877421|5696857|P3|STARTED|Phase 2||4
2320398|NCT01877421|5696858|P2|STARTED|Phase 2||0
2320399|NCT01877421|5696859|P1|STARTED|Phase 2||0
2320400|NCT01877421|5696842|P18|NOT COMPLETED|Phase 1||0
2320401|NCT01877421|5696843|P17|NOT COMPLETED|Phase 1||0
2320402|NCT01877421|5696844|P16|NOT COMPLETED|Phase 1||0
2320403|NCT01877421|5696845|P15|NOT COMPLETED|Phase 1||0
2320404|NCT01877421|5696846|P14|NOT COMPLETED|Phase 1||0
2320405|NCT01877421|5696847|P13|NOT COMPLETED|Phase 1||0
2320406|NCT01877421|5696848|P12|NOT COMPLETED|Phase 1||0
2320407|NCT01877421|5696849|P11|NOT COMPLETED|Phase 1||0
2320408|NCT01877421|5696850|P10|NOT COMPLETED|Phase 1||0
2320409|NCT01877421|5696851|P9|NOT COMPLETED|Phase 1||0
2320410|NCT01877421|5696852|P8|NOT COMPLETED|Phase 1||0
2320411|NCT01877421|5696853|P7|NOT COMPLETED|Phase 1||0
2320412|NCT01877421|5696854|P6|NOT COMPLETED|Phase 1||0
2320413|NCT01877421|5696855|P5|NOT COMPLETED|Phase 1||0
2320414|NCT01877421|5696856|P4|NOT COMPLETED|Phase 1||0
2320415|NCT01877421|5696857|P3|NOT COMPLETED|Phase 1||0
2320416|NCT01877421|5696858|P2|NOT COMPLETED|Phase 1||0
2320417|NCT01877421|5696859|P1|NOT COMPLETED|Phase 1||0
2320418|NCT01877421|5696842|P18|COMPLETED|Phase 1||3
2320419|NCT01877421|5696843|P17|COMPLETED|Phase 1||7
2320420|NCT01877421|5696844|P16|COMPLETED|Phase 1||3
2320421|NCT01877421|5696845|P15|COMPLETED|Phase 1||7
2320422|NCT01877421|5696846|P14|COMPLETED|Phase 1||3
2320423|NCT01877421|5696847|P13|COMPLETED|Phase 1||7
2320424|NCT01877421|5696848|P12|COMPLETED|Phase 1||3
2320425|NCT01877421|5696849|P11|COMPLETED|Phase 1||7
2320426|NCT01877421|5696850|P10|COMPLETED|Phase 1||3
2320427|NCT01877421|5696851|P9|COMPLETED|Phase 1||7
2320428|NCT01877421|5696852|P8|COMPLETED|Phase 1||2
2320429|NCT01877421|5696853|P7|COMPLETED|Phase 1||4
2320430|NCT01877421|5696854|P6|COMPLETED|Phase 1||2
2320431|NCT01877421|5696855|P5|COMPLETED|Phase 1||4
2320432|NCT01877421|5696856|P4|COMPLETED|Phase 1||2
2320433|NCT01877421|5696857|P3|COMPLETED|Phase 1||4
2320434|NCT01877421|5696858|P2|COMPLETED|Phase 1||1
2320435|NCT01877421|5696859|P1|COMPLETED|Phase 1||2
2320436|NCT01877421|5696842|P18|STARTED|Phase 1||3
2320437|NCT01877421|5696843|P17|STARTED|Phase 1||7
2320438|NCT01877421|5696844|P16|STARTED|Phase 1||3
2320439|NCT01877421|5696845|P15|STARTED|Phase 1||7
2320440|NCT01877421|5696846|P14|STARTED|Phase 1||3
2320441|NCT01877421|5696847|P13|STARTED|Phase 1||7
2320442|NCT01877421|5696848|P12|STARTED|Phase 1||3
2320443|NCT01877421|5696849|P11|STARTED|Phase 1||7
2320444|NCT01877421|5696850|P10|STARTED|Phase 1||3
2320445|NCT01877421|5696851|P9|STARTED|Phase 1||7
2320446|NCT01877421|5696852|P8|STARTED|Phase 1||2
2320447|NCT01877421|5696853|P7|STARTED|Phase 1||4
2320448|NCT01877421|5696854|P6|STARTED|Phase 1||2
2320449|NCT01877421|5696855|P5|STARTED|Phase 1||4
2320450|NCT01877421|5696856|P4|STARTED|Phase 1||2
2320451|NCT01877421|5696857|P3|STARTED|Phase 1||4
2320452|NCT01877421|5696858|P2|STARTED|Phase 1||1
2320453|NCT01877421|5696859|P1|STARTED|Phase 1||2
2320454|NCT01877408|5696969|P2|NOT COMPLETED|Overall Study||2
2320455|NCT01877408|5696970|P1|NOT COMPLETED|Overall Study||0
2320456|NCT01877408|5696969|P2|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|98
2320457|NCT01877408|5696970|P1|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|50
2320458|NCT01877408|5696969|P2|STARTED|Overall Study||100
2320459|NCT01877408|5696970|P1|STARTED|Overall Study||50
2320460|NCT01877343|5696990|P7|NOT COMPLETED|Overall Study||0
2320461|NCT01877343|5696991|P6|NOT COMPLETED|Overall Study||0
2320462|NCT01877343|5696992|P5|NOT COMPLETED|Overall Study||0
2320463|NCT01877343|5696993|P4|NOT COMPLETED|Overall Study||0
2320464|NCT01877343|5696994|P3|NOT COMPLETED|Overall Study||0
2320465|NCT01877343|5696995|P2|NOT COMPLETED|Overall Study||0
2320466|NCT01877343|5696996|P1|NOT COMPLETED|Overall Study||0
2320467|NCT01877343|5696990|P7|COMPLETED|Overall Study||0
2320468|NCT01877343|5696991|P6|COMPLETED|Overall Study||5
2320469|NCT01877343|5696992|P5|COMPLETED|Overall Study||0
2320470|NCT01877343|5696993|P4|COMPLETED|Overall Study||0
2320471|NCT01877343|5696994|P3|COMPLETED|Overall Study||0
2320472|NCT01877343|5696995|P2|COMPLETED|Overall Study||3
2320473|NCT01877343|5696996|P1|COMPLETED|Overall Study||2
2320474|NCT01877343|5696990|P7|STARTED|Overall Study||0
2320475|NCT01877343|5696991|P6|STARTED|Overall Study||5
2320476|NCT01877343|5696992|P5|STARTED|Overall Study||0
2320477|NCT01877343|5696993|P4|STARTED|Overall Study||0
2320478|NCT01877343|5696994|P3|STARTED|Overall Study||0
2320479|NCT01877343|5696995|P2|STARTED|Overall Study||3
2320480|NCT01877343|5696996|P1|STARTED|Overall Study||2
2320481|NCT01877278|5697003|P2|NOT COMPLETED|Overall Study||3
2320482|NCT01877278|5697004|P1|NOT COMPLETED|Overall Study||3
2320483|NCT01877278|5697003|P2|COMPLETED|Overall Study||30
2320484|NCT01877278|5697004|P1|COMPLETED|Overall Study||30
2320485|NCT01877278|5697003|P2|STARTED|Overall Study||33
2320486|NCT01877278|5697004|P1|STARTED|Overall Study||33
2320487|NCT01877265|5697012|P6|NOT COMPLETED|Treatment Period 3||0
2320488|NCT01877265|5697013|P5|NOT COMPLETED|Treatment Period 3||0
2320489|NCT01877265|5697014|P4|NOT COMPLETED|Treatment Period 3||0
2320490|NCT01877265|5697015|P3|NOT COMPLETED|Treatment Period 3||0
2320491|NCT01877265|5697016|P2|NOT COMPLETED|Treatment Period 3||0
2320492|NCT01877265|5697017|P1|NOT COMPLETED|Treatment Period 3||1
2320493|NCT01877265|5697012|P6|COMPLETED|Treatment Period 3||2
2320494|NCT01877265|5697013|P5|COMPLETED|Treatment Period 3||3
2320495|NCT01877265|5697014|P4|COMPLETED|Treatment Period 3||3
2320496|NCT01877265|5697015|P3|COMPLETED|Treatment Period 3||2
2320497|NCT01877265|5697016|P2|COMPLETED|Treatment Period 3||3
2320498|NCT01877265|5697017|P1|COMPLETED|Treatment Period 3||2
2320499|NCT01877265|5697012|P6|Received at Least One Dose of Study Drug|Treatment Period 3||2
2320500|NCT01877265|5697013|P5|Received at Least One Dose of Study Drug|Treatment Period 3||3
2320501|NCT01877265|5697014|P4|Received at Least One Dose of Study Drug|Treatment Period 3||3
2320502|NCT01877265|5697015|P3|Received at Least One Dose of Study Drug|Treatment Period 3||2
2320503|NCT01877265|5697016|P2|Received at Least One Dose of Study Drug|Treatment Period 3||3
2320504|NCT01877265|5697017|P1|Received at Least One Dose of Study Drug|Treatment Period 3||3
2320505|NCT01877265|5697012|P6|STARTED|Treatment Period 3||2
2320506|NCT01877265|5697013|P5|STARTED|Treatment Period 3||3
2320507|NCT01877265|5697014|P4|STARTED|Treatment Period 3||3
2320508|NCT01877265|5697015|P3|STARTED|Treatment Period 3||2
2320509|NCT01877265|5697016|P2|STARTED|Treatment Period 3||3
2320510|NCT01877265|5697017|P1|STARTED|Treatment Period 3||3
2320511|NCT01877265|5697012|P6|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||1
2320512|NCT01877265|5697013|P5|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
2320513|NCT01877265|5697014|P4|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
2320514|NCT01877265|5697015|P3|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
2320515|NCT01877265|5697016|P2|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
2320516|NCT01877265|5697017|P1|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
2320517|NCT01877265|5697012|P6|COMPLETED|Washout Period 2 (at Least 14 Days)||2
2320518|NCT01877265|5697013|P5|COMPLETED|Washout Period 2 (at Least 14 Days)||3
2320519|NCT01877265|5697014|P4|COMPLETED|Washout Period 2 (at Least 14 Days)||3
2320520|NCT01877265|5697015|P3|COMPLETED|Washout Period 2 (at Least 14 Days)||2
2320521|NCT01877265|5697016|P2|COMPLETED|Washout Period 2 (at Least 14 Days)||3
2320522|NCT01877265|5697017|P1|COMPLETED|Washout Period 2 (at Least 14 Days)||3
2320523|NCT01877265|5697012|P6|STARTED|Washout Period 2 (at Least 14 Days)||3
2320524|NCT01877265|5697013|P5|STARTED|Washout Period 2 (at Least 14 Days)||3
2320525|NCT01877265|5697014|P4|STARTED|Washout Period 2 (at Least 14 Days)||3
2320526|NCT01877265|5697015|P3|STARTED|Washout Period 2 (at Least 14 Days)||2
2320527|NCT01877265|5697016|P2|STARTED|Washout Period 2 (at Least 14 Days)||3
2320528|NCT01877265|5697017|P1|STARTED|Washout Period 2 (at Least 14 Days)||3
2320529|NCT01877265|5697012|P6|NOT COMPLETED|Treatment Period 2||0
2320530|NCT01877265|5697013|P5|NOT COMPLETED|Treatment Period 2||0
2320531|NCT01877265|5697014|P4|NOT COMPLETED|Treatment Period 2||0
2320532|NCT01877265|5697015|P3|NOT COMPLETED|Treatment Period 2||0
2320533|NCT01877265|5697016|P2|NOT COMPLETED|Treatment Period 2||0
2320534|NCT01877265|5697017|P1|NOT COMPLETED|Treatment Period 2||0
2320535|NCT01877265|5697012|P6|COMPLETED|Treatment Period 2||3
2320536|NCT01877265|5697013|P5|COMPLETED|Treatment Period 2||3
2320537|NCT01877265|5697014|P4|COMPLETED|Treatment Period 2||3
2320538|NCT01877265|5697015|P3|COMPLETED|Treatment Period 2||2
2320539|NCT01877265|5697016|P2|COMPLETED|Treatment Period 2||3
2320540|NCT01877265|5697017|P1|COMPLETED|Treatment Period 2||3
2320541|NCT01877265|5697012|P6|Received at Least One Dose of Study Drug|Treatment Period 2||3
2320542|NCT01877265|5697013|P5|Received at Least One Dose of Study Drug|Treatment Period 2||3
2320543|NCT01877265|5697014|P4|Received at Least One Dose of Study Drug|Treatment Period 2||3
2320544|NCT01877265|5697015|P3|Received at Least One Dose of Study Drug|Treatment Period 2||2
2320545|NCT01877265|5697016|P2|Received at Least One Dose of Study Drug|Treatment Period 2||3
2320546|NCT01877265|5697017|P1|Received at Least One Dose of Study Drug|Treatment Period 2||3
2320547|NCT01877265|5697012|P6|STARTED|Treatment Period 2||3
2320548|NCT01877265|5697013|P5|STARTED|Treatment Period 2||3
2320549|NCT01877265|5697014|P4|STARTED|Treatment Period 2||3
2320550|NCT01877265|5697015|P3|STARTED|Treatment Period 2||2
2320551|NCT01877265|5697016|P2|STARTED|Treatment Period 2||3
2320552|NCT01877265|5697017|P1|STARTED|Treatment Period 2||3
2320553|NCT01877265|5697012|P6|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
2320554|NCT01877265|5697013|P5|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
2320555|NCT01877265|5697014|P4|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
2320556|NCT01877265|5697015|P3|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
2320557|NCT01877265|5697016|P2|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
2320558|NCT01877265|5697017|P1|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
2320559|NCT01877265|5697012|P6|COMPLETED|Washout Period 1 (at Least 14 Days)||3
2320560|NCT01877265|5697013|P5|COMPLETED|Washout Period 1 (at Least 14 Days)||3
2320561|NCT01877265|5697014|P4|COMPLETED|Washout Period 1 (at Least 14 Days)||3
2320562|NCT01877265|5697015|P3|COMPLETED|Washout Period 1 (at Least 14 Days)||2
2320563|NCT01877265|5697016|P2|COMPLETED|Washout Period 1 (at Least 14 Days)||3
2320564|NCT01877265|5697017|P1|COMPLETED|Washout Period 1 (at Least 14 Days)||3
2320565|NCT01877265|5697012|P6|STARTED|Washout Period 1 (at Least 14 Days)||3
2320566|NCT01877265|5697013|P5|STARTED|Washout Period 1 (at Least 14 Days)||3
2320567|NCT01877265|5697014|P4|STARTED|Washout Period 1 (at Least 14 Days)||3
2320568|NCT01877265|5697015|P3|STARTED|Washout Period 1 (at Least 14 Days)||2
2320569|NCT01877265|5697016|P2|STARTED|Washout Period 1 (at Least 14 Days)||3
2320570|NCT01877265|5697017|P1|STARTED|Washout Period 1 (at Least 14 Days)||3
2320571|NCT01877265|5697012|P6|NOT COMPLETED|Treatment Period 1||0
2320572|NCT01877265|5697013|P5|NOT COMPLETED|Treatment Period 1||0
2320573|NCT01877265|5697014|P4|NOT COMPLETED|Treatment Period 1||0
2320574|NCT01877265|5697015|P3|NOT COMPLETED|Treatment Period 1||1
2320575|NCT01877265|5697016|P2|NOT COMPLETED|Treatment Period 1||0
2320576|NCT01877265|5697017|P1|NOT COMPLETED|Treatment Period 1||0
2320577|NCT01877265|5697012|P6|COMPLETED|Treatment Period 1||3
2320578|NCT01877265|5697013|P5|COMPLETED|Treatment Period 1||3
2320579|NCT01877265|5697014|P4|COMPLETED|Treatment Period 1||3
2320580|NCT01877265|5697015|P3|COMPLETED|Treatment Period 1||2
2320581|NCT01877265|5697016|P2|COMPLETED|Treatment Period 1||3
2320582|NCT01877265|5697017|P1|COMPLETED|Treatment Period 1||3
2320583|NCT01877265|5697012|P6|Received at Least One Dose of Study Drug|Treatment Period 1||3
2320584|NCT01877265|5697013|P5|Received at Least One Dose of Study Drug|Treatment Period 1||3
2320585|NCT01877265|5697014|P4|Received at Least One Dose of Study Drug|Treatment Period 1||3
2320586|NCT01877265|5697015|P3|Received at Least One Dose of Study Drug|Treatment Period 1||3
2320587|NCT01877265|5697016|P2|Received at Least One Dose of Study Drug|Treatment Period 1||3
2320588|NCT01877265|5697017|P1|Received at Least One Dose of Study Drug|Treatment Period 1||3
2320589|NCT01877265|5697012|P6|STARTED|Treatment Period 1||3
2320590|NCT01877265|5697013|P5|STARTED|Treatment Period 1||3
2320591|NCT01877265|5697014|P4|STARTED|Treatment Period 1||3
2320592|NCT01877265|5697015|P3|STARTED|Treatment Period 1||3
2320593|NCT01877265|5697016|P2|STARTED|Treatment Period 1||3
2320594|NCT01877265|5697017|P1|STARTED|Treatment Period 1||3
2320595|NCT01877239|5697034|P1|NOT COMPLETED|Overall Study||50
2320596|NCT01877239|5697034|P1|COMPLETED|Overall Study||61
2320597|NCT01877239|5697034|P1|Treated|Overall Study||76
2320598|NCT01877239|5697034|P1|STARTED|Overall Study||111
2320599|NCT01877161|5697040|P1|NOT COMPLETED|Third Session of Stimulation||0
2320600|NCT01877161|5697040|P1|COMPLETED|Third Session of Stimulation||12
2320601|NCT01877161|5697040|P1|STARTED|Third Session of Stimulation||12
2320602|NCT01877161|5697040|P1|NOT COMPLETED|Washout (at Least 3 Days)||0
2320603|NCT01877161|5697040|P1|COMPLETED|Washout (at Least 3 Days)||12
2320604|NCT01877161|5697040|P1|STARTED|Washout (at Least 3 Days)||12
2320605|NCT01877161|5697040|P1|NOT COMPLETED|Second Session of Stimulation||0
2320606|NCT01877161|5697040|P1|COMPLETED|Second Session of Stimulation||12
2320607|NCT01877161|5697040|P1|STARTED|Second Session of Stimulation||12
2320608|NCT01877161|5697040|P1|NOT COMPLETED|Washout (at Least 3 Days)||0
2320609|NCT01877161|5697040|P1|COMPLETED|Washout (at Least 3 Days)||12
2320610|NCT01877161|5697040|P1|STARTED|Washout (at Least 3 Days)||12
2320611|NCT01877161|5697040|P1|NOT COMPLETED|First Session of Stimulation||0
2320612|NCT01877161|5697040|P1|COMPLETED|First Session of Stimulation||12
2320613|NCT01877161|5697040|P1|STARTED|First Session of Stimulation||12
2320614|NCT01877148|5697050|P2|NOT COMPLETED|Overall Study||1
2320615|NCT01877148|5697051|P1|NOT COMPLETED|Overall Study||1
2320616|NCT01877148|5697050|P2|COMPLETED|Overall Study||5
2320617|NCT01877148|5697051|P1|COMPLETED|Overall Study||5
2320618|NCT01877148|5697050|P2|STARTED|Overall Study||6
2320619|NCT01877148|5697051|P1|STARTED|Overall Study||6
2320620|NCT01877083|5697063|P1|NOT COMPLETED|Extension Phase||5
2320621|NCT01877083|5697063|P1|COMPLETED|Extension Phase||0
2320622|NCT01877083|5697063|P1|STARTED|Extension Phase||5
2320623|NCT01877083|5697063|P1|NOT COMPLETED|Treatment Phase||20
2320624|NCT01877083|5697063|P1|COMPLETED|Treatment Phase||5
2320625|NCT01877083|5697063|P1|STARTED|Treatment Phase||25
2320626|NCT01876992|5697072|P2|NOT COMPLETED|Overall Study||0
2320627|NCT01876992|5697073|P1|NOT COMPLETED|Overall Study||0
2320628|NCT01876992|5697072|P2|COMPLETED|Overall Study||5
2320629|NCT01876992|5697073|P1|COMPLETED|Overall Study||5
2320630|NCT01876992|5697072|P2|STARTED|Overall Study||5
2320631|NCT01876992|5697073|P1|STARTED|Overall Study||5
2320632|NCT01876979|5697087|P2|NOT COMPLETED|Overall Study||3
2320633|NCT01876979|5697088|P1|NOT COMPLETED|Overall Study||2
2320634|NCT01876979|5697087|P2|COMPLETED|Overall Study||0
2320635|NCT01876979|5697088|P1|COMPLETED|Overall Study||0
2320636|NCT01876979|5697087|P2|STARTED|Overall Study||3
2320637|NCT01876979|5697088|P1|STARTED|Overall Study||2
2320638|NCT01876823|5697094|P1|NOT COMPLETED|Overall Study||9
2320639|NCT01876823|5697094|P1|COMPLETED|Overall Study||26
2320640|NCT01876823|5697094|P1|STARTED|Overall Study||35
2320641|NCT01876810|5697107|P2|NOT COMPLETED|Overall Study||1
2320642|NCT01876810|5697108|P1|NOT COMPLETED|Overall Study||0
2320643|NCT01876810|5697107|P2|COMPLETED|Overall Study||13
2320644|NCT01876810|5697108|P1|COMPLETED|Overall Study||14
2320645|NCT01876810|5697107|P2|STARTED|Overall Study||14
2320646|NCT01876810|5697108|P1|STARTED|Overall Study||14
2320647|NCT01876784|5697120|P2|NOT COMPLETED|Overall Study||119
2320648|NCT01876784|5697121|P1|NOT COMPLETED|Overall Study||119
2320649|NCT01876784|5697120|P2|COMPLETED|Overall Study||0
2320650|NCT01876784|5697121|P1|COMPLETED|Overall Study||0
2320651|NCT01876784|5697120|P2|Treated|Overall Study||118
2320652|NCT01876784|5697121|P1|Treated|Overall Study||117
2320653|NCT01876784|5697120|P2|STARTED|Overall Study||119
2320654|NCT01876784|5697121|P1|STARTED|Overall Study||119
2320655|NCT01876732|5697127|P1|NOT COMPLETED|Overall Study||75
2320656|NCT01876732|5697127|P1|COMPLETED|Overall Study||57
2320657|NCT01876732|5697127|P1|STARTED|Overall Study||132
2320658|NCT01876706|5697132|P1|NOT COMPLETED|Overall Study||25
2320659|NCT01876706|5697132|P1|COMPLETED|Overall Study||26
2320660|NCT01876706|5697132|P1|60 Months|Overall Study||26
2320661|NCT01876706|5697132|P1|48 Months|Overall Study||31
2320662|NCT01876706|5697132|P1|36 Months|Overall Study||32
2320663|NCT01876706|5697132|P1|24 Months|Overall Study||35
2320664|NCT01876706|5697132|P1|12 Months|Overall Study||42
2320665|NCT01876706|5697132|P1|6 Months|Overall Study||46
2320666|NCT01876706|5697132|P1|3 Months|Overall Study||51
2320667|NCT01876706|5697132|P1|1 Month|Overall Study||51
2320668|NCT01876706|5697132|P1|STARTED|Overall Study||51
2320669|NCT01876511|5697152|P3|NOT COMPLETED|Overall Study||31
2320670|NCT01876511|5697153|P2|NOT COMPLETED|Overall Study||25
2320671|NCT01876511|5697154|P1|NOT COMPLETED|Overall Study||23
2320672|NCT01876511|5697152|P3|COMPLETED|Overall Study||16
2320673|NCT01876511|5697153|P2|COMPLETED|Overall Study||0
2320674|NCT01876511|5697154|P1|COMPLETED|Overall Study||18
2320675|NCT01876511|5697152|P3|Stages 1 and 2|Overall Study||21
2320676|NCT01876511|5697153|P2|Stages 1 and 2|Overall Study||25
2320677|NCT01876511|5697154|P1|Stages 1 and 2|Overall Study||24
2320678|NCT01876511|5697152|P3|STARTED|Overall Study||47
2320679|NCT01876511|5697153|P2|STARTED|Overall Study||25
2320680|NCT01876511|5697154|P1|STARTED|Overall Study||41
2320681|NCT01876485|5697191|P2|NOT COMPLETED|Overall Study||26
2320682|NCT01876485|5697192|P1|NOT COMPLETED|Overall Study||24
2320683|NCT01876485|5697191|P2|COMPLETED|Overall Study||114
2320684|NCT01876485|5697192|P1|COMPLETED|Overall Study||116
2320685|NCT01876485|5697191|P2|Maintenance|Overall Study||114
2320686|NCT01876485|5697192|P1|Maintenance|Overall Study||116
2320687|NCT01876485|5697191|P2|Post-Intervention|Overall Study||129
2320688|NCT01876485|5697192|P1|Post-Intervention|Overall Study||125
2320689|NCT01876485|5697191|P2|STARTED|Overall Study||140
2320690|NCT01876485|5697192|P1|STARTED|Overall Study||140
2320691|NCT01876446|5697202|P2|NOT COMPLETED|Overall Study||6
2320692|NCT01876446|5697203|P1|NOT COMPLETED|Overall Study||2
2320693|NCT01876446|5697202|P2|COMPLETED|Overall Study||12
2320694|NCT01876446|5697203|P1|COMPLETED|Overall Study||18
2320695|NCT01876446|5697202|P2|STARTED|Overall Study||18
2320696|NCT01876446|5697203|P1|STARTED|Overall Study||20
2320697|NCT01876420|5697219|P1|NOT COMPLETED|Overall Study||1
2320698|NCT01876420|5697219|P1|COMPLETED|Overall Study||59
2320699|NCT01876420|5697219|P1|STARTED|Overall Study||60
2320700|NCT01876381|5697231|P1|NOT COMPLETED|Overall Study||7
2320701|NCT01876381|5697231|P1|COMPLETED|Overall Study||16
2320702|NCT01876381|5697231|P1|STARTED|Overall Study||23
2320703|NCT01876368|5697238|P2|NOT COMPLETED|Overall Study||13
2320704|NCT01876368|5697239|P1|NOT COMPLETED|Overall Study||9
2320705|NCT01876368|5697238|P2|COMPLETED|Overall Study||175
2320706|NCT01876368|5697239|P1|COMPLETED|Overall Study||179
2320707|NCT01876368|5697238|P2|Safety Set (SAF)|Overall Study||187
2320708|NCT01876368|5697239|P1|Safety Set (SAF)|Overall Study||188
2320709|NCT01876368|5697238|P2|Full Analysis Set (FAS)|Overall Study|One patient was not included in the SAF and FAS due to mis-randomization.|187
2320710|NCT01876368|5697239|P1|Full Analysis Set (FAS)|Overall Study||188
2320711|NCT01876368|5697238|P2|STARTED|Overall Study||188
2320712|NCT01876368|5697239|P1|STARTED|Overall Study||188
2320713|NCT01876329|5697268|P3|NOT COMPLETED|Overall Study||0
2320714|NCT01876329|5697269|P2|NOT COMPLETED|Overall Study||0
2320715|NCT01876329|5697270|P1|NOT COMPLETED|Overall Study||0
2320716|NCT01876329|5697268|P3|COMPLETED|Overall Study||44
2320717|NCT01876329|5697269|P2|COMPLETED|Overall Study||36
2320718|NCT01876329|5697270|P1|COMPLETED|Overall Study||45
2320719|NCT01876329|5697268|P3|STARTED|Overall Study||44
2320720|NCT01876329|5697269|P2|STARTED|Overall Study||36
2320721|NCT01876329|5697270|P1|STARTED|Overall Study||45
2320722|NCT01876251|5697284|P3|NOT COMPLETED|Overall Study||11
2320723|NCT01876251|5697285|P2|NOT COMPLETED|Overall Study||3
2320724|NCT01876251|5697286|P1|NOT COMPLETED|Overall Study||15
2320725|NCT01876251|5697284|P3|COMPLETED|Overall Study||0
2320726|NCT01876251|5697285|P2|COMPLETED|Overall Study||0
2320727|NCT01876251|5697286|P1|COMPLETED|Overall Study||0
2320728|NCT01876251|5697284|P3|STARTED|Overall Study||11
2320729|NCT01876251|5697285|P2|STARTED|Overall Study||3
2320730|NCT01876251|5697286|P1|STARTED|Overall Study||15
2320731|NCT01876212|5697345|P2|NOT COMPLETED|Overall Study||0
2320732|NCT01876212|5697346|P1|NOT COMPLETED|Overall Study||0
2320733|NCT01876212|5697345|P2|COMPLETED|Overall Study||6
2320734|NCT01876212|5697346|P1|COMPLETED|Overall Study||9
2320735|NCT01876212|5697345|P2|STARTED|Overall Study||6
2320736|NCT01876212|5697346|P1|STARTED|Overall Study||9
2320737|NCT01876043|5697390|P1|NOT COMPLETED|Overall Study||2
2320738|NCT01876043|5697390|P1|COMPLETED|Overall Study||22
2320739|NCT01876043|5697390|P1|Interim Analysis Population|Overall Study||17
2320740|NCT01876043|5697390|P1|STARTED|Overall Study||24
2320741|NCT01875991|5697402|P2|NOT COMPLETED|Overall Study||6
2320742|NCT01875991|5697403|P1|NOT COMPLETED|Overall Study||7
2320743|NCT01875991|5697402|P2|COMPLETED|Overall Study||103
2320744|NCT01875991|5697403|P1|COMPLETED|Overall Study||101
2320745|NCT01875991|5697402|P2|Received Etanercept in Period 2|Overall Study||103
2320746|NCT01875991|5697403|P1|Received Etanercept in Period 2|Overall Study||102
2320747|NCT01875991|5697402|P2|Received Etanercept in Period 1|Overall Study||108
2320748|NCT01875991|5697403|P1|Received Etanercept in Period 1|Overall Study||108
2320749|NCT01875991|5697402|P2|STARTED|Overall Study||109
2320750|NCT01875991|5697403|P1|STARTED|Overall Study||108
2320751|NCT01875978|5697426|P2|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
2320752|NCT01875978|5697427|P1|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
2320753|NCT01875978|5697426|P2|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
2320754|NCT01875978|5697427|P1|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
2320755|NCT01875978|5697426|P2|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
2320756|NCT01875978|5697427|P1|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
2320757|NCT01875978|5697426|P2|NOT COMPLETED|Study 4weeks||0
2320758|NCT01875978|5697427|P1|NOT COMPLETED|Study 4weeks||0
2320759|NCT01875978|5697426|P2|COMPLETED|Study 4weeks||20
2320760|NCT01875978|5697427|P1|COMPLETED|Study 4weeks||20
2320761|NCT01875978|5697426|P2|STARTED|Study 4weeks||20
2320762|NCT01875978|5697427|P1|STARTED|Study 4weeks||20
2320763|NCT01875874|5697439|P1|NOT COMPLETED|Overall Study||3
2320764|NCT01875874|5697439|P1|COMPLETED|Overall Study||5
2320765|NCT01875874|5697439|P1|STARTED|Overall Study||8
2320766|NCT01875861|5697446|P2|NOT COMPLETED|Sustainability||0
2320767|NCT01875861|5697447|P1|NOT COMPLETED|Sustainability||0
2320768|NCT01875861|5697446|P2|COMPLETED|Sustainability||3444
2320769|NCT01875861|5697447|P1|COMPLETED|Sustainability||4306
2320770|NCT01875861|5697446|P2|STARTED|Sustainability||3444
2320771|NCT01875861|5697447|P1|STARTED|Sustainability||4306
2320772|NCT01875861|5697446|P2|NOT COMPLETED|Implementation||0
2320773|NCT01875861|5697447|P1|NOT COMPLETED|Implementation||0
2320774|NCT01875861|5697446|P2|COMPLETED|Implementation||3444
2320775|NCT01875861|5697447|P1|COMPLETED|Implementation||4546
2320776|NCT01875861|5697446|P2|STARTED|Implementation||3444
2320777|NCT01875861|5697447|P1|STARTED|Implementation||4546
2320778|NCT01875861|5697446|P2|NOT COMPLETED|Pre-implementation||0
2320779|NCT01875861|5697447|P1|NOT COMPLETED|Pre-implementation||0
2320780|NCT01875861|5697446|P2|COMPLETED|Pre-implementation||3714
2320781|NCT01875861|5697447|P1|COMPLETED|Pre-implementation||4779
2320782|NCT01875861|5697446|P2|STARTED|Pre-implementation||3714
2320783|NCT01875861|5697447|P1|STARTED|Pre-implementation||4779
2320784|NCT01875848|5697459|P2|NOT COMPLETED|Overall Study||0
2320785|NCT01875848|5697460|P1|NOT COMPLETED|Overall Study||2
2320786|NCT01875848|5697459|P2|COMPLETED|Overall Study|4 patients completed the opioid dose escalation arm of the study|4
2320787|NCT01875848|5697460|P1|COMPLETED|Overall Study|1 patient completed the Buprenorphine arm of the study. 2 patients withdrew|1
2320788|NCT01875848|5697459|P2|STARTED|Overall Study|4 patients were enrolled in the opioid dose escalation arm of the study|4
2320789|NCT01875848|5697460|P1|STARTED|Overall Study|3 patients were enrolled in the Buprenorphine arm of the study|3
2320790|NCT01875783|5697468|P1|NOT COMPLETED|Overall Study||0
2320791|NCT01875783|5697468|P1|COMPLETED|Overall Study||385
2320792|NCT01875783|5697468|P1|STARTED|Overall Study||385
2320793|NCT01875731|5697477|P2|NOT COMPLETED|Overall Study||0
2320794|NCT01875731|5697478|P1|NOT COMPLETED|Overall Study||1
2320795|NCT01875731|5697477|P2|COMPLETED|Overall Study||32
2320796|NCT01875731|5697478|P1|COMPLETED|Overall Study||33
2320797|NCT01875731|5697477|P2|STARTED|Overall Study||32
2320798|NCT01875731|5697478|P1|STARTED|Overall Study||34
2320799|NCT01875510|5697488|P2|NOT COMPLETED|Overall Study||0
2320800|NCT01875510|5697489|P1|NOT COMPLETED|Overall Study||0
2320801|NCT01875510|5697488|P2|COMPLETED|Overall Study||40
2320802|NCT01875510|5697489|P1|COMPLETED|Overall Study||40
2320803|NCT01875510|5697488|P2|STARTED|Overall Study||40
2320804|NCT01875510|5697489|P1|STARTED|Overall Study||40
2320805|NCT01875471|5697497|P2|NOT COMPLETED|Overall Study||1
2320806|NCT01875471|5697498|P1|NOT COMPLETED|Overall Study||1
2320807|NCT01875471|5697497|P2|COMPLETED|Overall Study||137
2320808|NCT01875471|5697498|P1|COMPLETED|Overall Study||136
2320809|NCT01875471|5697497|P2|Completed Per Protocol|Overall Study||123
2320810|NCT01875471|5697498|P1|Completed Per Protocol|Overall Study||127
2320811|NCT01875471|5697497|P2|STARTED|Overall Study||138
2320812|NCT01875471|5697498|P1|STARTED|Overall Study||137
2320813|NCT01875445|5697506|P2|NOT COMPLETED|Overall Study||0
2320814|NCT01875445|5697507|P1|NOT COMPLETED|Overall Study||7
2320815|NCT01875445|5697506|P2|COMPLETED|Overall Study||19
2320816|NCT01875445|5697507|P1|COMPLETED|Overall Study||12
2320817|NCT01875445|5697506|P2|STARTED|Overall Study||19
2320818|NCT01875445|5697507|P1|STARTED|Overall Study||19
2320819|NCT01875237|5697517|P2|NOT COMPLETED|Overall Study||0
2320820|NCT01875237|5697518|P1|NOT COMPLETED|Overall Study||2
2320821|NCT01875237|5697517|P2|COMPLETED|Overall Study||1
2320822|NCT01875237|5697518|P1|COMPLETED|Overall Study||0
2320823|NCT01875237|5697517|P2|STARTED|Overall Study||1
2320824|NCT01875237|5697518|P1|STARTED|Overall Study||2
2320825|NCT01875185|5697544|P2|NOT COMPLETED|Overall Study||48
2320826|NCT01875185|5697545|P1|NOT COMPLETED|Overall Study||52
2320827|NCT01875185|5697544|P2|COMPLETED|Overall Study||0
2320828|NCT01875185|5697545|P1|COMPLETED|Overall Study||0
2320829|NCT01875185|5697544|P2|STARTED|Overall Study||48
2320830|NCT01875185|5697545|P1|STARTED|Overall Study||52
2320831|NCT01875159|5697559|P2|NOT COMPLETED|Overall Study||0
2320832|NCT01875159|5697560|P1|NOT COMPLETED|Overall Study||3
2320833|NCT01875159|5697559|P2|COMPLETED|Overall Study||53
2320834|NCT01875159|5697560|P1|COMPLETED|Overall Study||42
2320835|NCT01875159|5697559|P2|STARTED|Overall Study||53
2320836|NCT01875159|5697560|P1|STARTED|Overall Study||45
2320837|NCT01874951|5697570|P2|NOT COMPLETED|Overall Study||0
2320838|NCT01874951|5697571|P1|NOT COMPLETED|Overall Study||0
2320839|NCT01874951|5697570|P2|COMPLETED|Overall Study||6
2320840|NCT01874951|5697571|P1|COMPLETED|Overall Study||6
2320841|NCT01874951|5697570|P2|STARTED|Overall Study||6
2320842|NCT01874951|5697571|P1|STARTED|Overall Study||6
2320843|NCT01874756|5697595|P4|NOT COMPLETED|Overall Study||6
2320844|NCT01874756|5697596|P3|NOT COMPLETED|Overall Study||2
2320845|NCT01874756|5697597|P2|NOT COMPLETED|Overall Study||0
2320846|NCT01874756|5697598|P1|NOT COMPLETED|Overall Study||1
2320847|NCT01874756|5697595|P4|COMPLETED|Overall Study||21
2320848|NCT01874756|5697596|P3|COMPLETED|Overall Study||27
2320849|NCT01874756|5697597|P2|COMPLETED|Overall Study||10
2320850|NCT01874756|5697598|P1|COMPLETED|Overall Study||28
2320851|NCT01874756|5697595|P4|STARTED|Overall Study||27
2320852|NCT01874756|5697596|P3|STARTED|Overall Study||29
2320853|NCT01874756|5697597|P2|STARTED|Overall Study||10
2320854|NCT01874756|5697598|P1|STARTED|Overall Study||29
2320855|NCT01874665|5697630|P2|NOT COMPLETED|Overall Study||15
2320856|NCT01874665|5697631|P1|NOT COMPLETED|Overall Study||30
2320857|NCT01874665|5697630|P2|COMPLETED|Overall Study||0
2320858|NCT01874665|5697631|P1|COMPLETED|Overall Study||0
2320859|NCT01874665|5697630|P2|STARTED|Overall Study||15
2320860|NCT01874665|5697631|P1|STARTED|Overall Study||30
2320861|NCT01874535|5697659|P2|NOT COMPLETED|Overall Study||44
2320862|NCT01874535|5697660|P1|NOT COMPLETED|Overall Study||55
2320863|NCT01874535|5697659|P2|COMPLETED|Overall Study||157
2320864|NCT01874535|5697660|P1|COMPLETED|Overall Study||152
2320865|NCT01874535|5697659|P2|STARTED|Overall Study||201
2320866|NCT01874535|5697660|P1|STARTED|Overall Study||207
2320867|NCT01874353|5697668|P2|NOT COMPLETED|Overall Study||37
2320868|NCT01874353|5697669|P1|NOT COMPLETED|Overall Study||55
2320869|NCT01874353|5697668|P2|COMPLETED|Overall Study||62
2320870|NCT01874353|5697669|P1|COMPLETED|Overall Study||141
2320871|NCT01874353|5697668|P2|STARTED|Overall Study||99
2320872|NCT01874353|5697669|P1|STARTED|Overall Study||196
2320873|NCT01874340|5697696|P4|NOT COMPLETED|Overall Study||5
2320874|NCT01874340|5697697|P3|NOT COMPLETED|Overall Study||8
2320875|NCT01874340|5697698|P2|NOT COMPLETED|Overall Study||8
2320876|NCT01874340|5697699|P1|NOT COMPLETED|Overall Study||6
2320877|NCT01874340|5697696|P4|COMPLETED|Overall Study||1
2320878|NCT01874340|5697697|P3|COMPLETED|Overall Study||0
2320879|NCT01874340|5697698|P2|COMPLETED|Overall Study||0
2320880|NCT01874340|5697699|P1|COMPLETED|Overall Study||0
2320881|NCT01874340|5697696|P4|STARTED|Overall Study||6
2320882|NCT01874340|5697697|P3|STARTED|Overall Study||8
2320883|NCT01874340|5697698|P2|STARTED|Overall Study||8
2320884|NCT01874340|5697699|P1|STARTED|Overall Study||6
2320885|NCT01874275|5697727|P2|NOT COMPLETED|Overall Study||0
2320886|NCT01874275|5697728|P1|NOT COMPLETED|Overall Study||1
2320887|NCT01874275|5697727|P2|COMPLETED|Overall Study||2
2320888|NCT01874275|5697728|P1|COMPLETED|Overall Study||3
2320889|NCT01874275|5697727|P2|STARTED|Overall Study||2
2320890|NCT01874275|5697728|P1|STARTED|Overall Study||4
2320891|NCT01874262|5697742|P2|NOT COMPLETED|Overall Study||3
2320892|NCT01874262|5697743|P1|NOT COMPLETED|Overall Study||5
2320893|NCT01874262|5697742|P2|COMPLETED|Overall Study||80
2320894|NCT01874262|5697743|P1|COMPLETED|Overall Study||86
2320895|NCT01874262|5697742|P2|Not Included Due to Tehnical Issues|Overall Study||3
2320896|NCT01874262|5697743|P1|Not Included Due to Tehnical Issues|Overall Study||3
2320897|NCT01874262|5697742|P2|Not Correctly Randomised|Overall Study||0
2320898|NCT01874262|5697743|P1|Not Correctly Randomised|Overall Study||2
2320899|NCT01874262|5697742|P2|STARTED|Overall Study||83
2320900|NCT01874262|5697743|P1|STARTED|Overall Study||91
2320901|NCT01874145|5697751|P2|NOT COMPLETED|Extension Period||4
2320902|NCT01874145|5697752|P1|NOT COMPLETED|Extension Period||6
2320903|NCT01874145|5697751|P2|COMPLETED|Extension Period||97
2320904|NCT01874145|5697752|P1|COMPLETED|Extension Period||91
2320905|NCT01874145|5697751|P2|Full Analysis Set|Extension Period||101
2320906|NCT01874145|5697752|P1|Full Analysis Set|Extension Period||95
2320907|NCT01874145|5697751|P2|STARTED|Extension Period|Non-Switchers|101
2320908|NCT01874145|5697752|P1|STARTED|Extension Period|Switchers|97
2320909|NCT01874145|5697751|P2|NOT COMPLETED|Core Period||7
2320910|NCT01874145|5697752|P1|NOT COMPLETED|Core Period||3
2320911|NCT01874145|5697751|P2|COMPLETED|Core Period||101
2320912|NCT01874145|5697752|P1|COMPLETED|Core Period||98
2320913|NCT01874145|5697751|P2|Full Analysis Set|Core Period||108
2320914|NCT01874145|5697752|P1|Full Analysis Set|Core Period||100
2320915|NCT01874145|5697751|P2|STARTED|Core Period||108
2320916|NCT01874145|5697752|P1|STARTED|Core Period||101
2320917|NCT01874132|5697791|P3|NOT COMPLETED|Overall Study||3
2320918|NCT01874132|5697792|P2|NOT COMPLETED|Overall Study||4
2320919|NCT01874132|5697793|P1|NOT COMPLETED|Overall Study||4
2320920|NCT01874132|5697791|P3|COMPLETED|Overall Study||19
2320921|NCT01874132|5697792|P2|COMPLETED|Overall Study||18
2320922|NCT01874132|5697793|P1|COMPLETED|Overall Study||18
2320923|NCT01874132|5697791|P3|STARTED|Overall Study||22
2320924|NCT01874132|5697792|P2|STARTED|Overall Study||22
2320925|NCT01874132|5697793|P1|STARTED|Overall Study||22
2320926|NCT01874119|5697804|P2|NOT COMPLETED|Second Intervention (6 Days)||0
2320927|NCT01874119|5697805|P1|NOT COMPLETED|Second Intervention (6 Days)||0
2320928|NCT01874119|5697804|P2|COMPLETED|Second Intervention (6 Days)||3
2320929|NCT01874119|5697805|P1|COMPLETED|Second Intervention (6 Days)||4
2320930|NCT01874119|5697804|P2|STARTED|Second Intervention (6 Days)||3
2320931|NCT01874119|5697805|P1|STARTED|Second Intervention (6 Days)||4
2320932|NCT01874119|5697804|P2|NOT COMPLETED|Washout (7 Days)||2
2320933|NCT01874119|5697805|P1|NOT COMPLETED|Washout (7 Days)||3
2320934|NCT01874119|5697804|P2|COMPLETED|Washout (7 Days)||3
2320935|NCT01874119|5697805|P1|COMPLETED|Washout (7 Days)||4
2320936|NCT01874119|5697804|P2|STARTED|Washout (7 Days)||5
2320937|NCT01874119|5697805|P1|STARTED|Washout (7 Days)||7
2320938|NCT01874119|5697804|P2|NOT COMPLETED|First Intervention (6 Days)||0
2320939|NCT01874119|5697805|P1|NOT COMPLETED|First Intervention (6 Days)||1
2320940|NCT01874119|5697804|P2|COMPLETED|First Intervention (6 Days)||5
2320941|NCT01874119|5697805|P1|COMPLETED|First Intervention (6 Days)||7
2320942|NCT01874119|5697804|P2|STARTED|First Intervention (6 Days)||5
2320943|NCT01874119|5697805|P1|STARTED|First Intervention (6 Days)||8
2320944|NCT01874054|5697811|P1|NOT COMPLETED|Overall Study||55
2320945|NCT01874054|5697811|P1|COMPLETED|Overall Study||0
2320946|NCT01874054|5697811|P1|Completed 16 Cycles of BV Treatment|Overall Study||17
2320947|NCT01874054|5697811|P1|Completed ≥2 Cycles of Combo Treatment|Overall Study||53
2320948|NCT01874054|5697811|P1|STARTED|Overall Study||55
2320949|NCT01873989|5697822|P2|NOT COMPLETED|Overall Study||1
2320950|NCT01873989|5697823|P1|NOT COMPLETED|Overall Study||1
2320951|NCT01873989|5697822|P2|COMPLETED|Overall Study||6
2320952|NCT01873989|5697823|P1|COMPLETED|Overall Study||7
2320953|NCT01873989|5697822|P2|STARTED|Overall Study||7
2320954|NCT01873989|5697823|P1|STARTED|Overall Study||8
2320955|NCT01873950|5697833|P5|NOT COMPLETED|Period 5||0
2320956|NCT01873950|5697834|P4|NOT COMPLETED|Period 5||1
2320957|NCT01873950|5697835|P3|NOT COMPLETED|Period 5||0
2320958|NCT01873950|5697836|P2|NOT COMPLETED|Period 5||0
2320959|NCT01873950|5697837|P1|NOT COMPLETED|Period 5||0
2320960|NCT01873950|5697833|P5|COMPLETED|Period 5||4
2320961|NCT01873950|5697834|P4|COMPLETED|Period 5||3
2320962|NCT01873950|5697835|P3|COMPLETED|Period 5||4
2320963|NCT01873950|5697836|P2|COMPLETED|Period 5||5
2320964|NCT01873950|5697837|P1|COMPLETED|Period 5||4
2320965|NCT01873950|5697833|P5|STARTED|Period 5||4
2320966|NCT01873950|5697834|P4|STARTED|Period 5||4
2320967|NCT01873950|5697835|P3|STARTED|Period 5||4
2320968|NCT01873950|5697836|P2|STARTED|Period 5||5
2320969|NCT01873950|5697837|P1|STARTED|Period 5||4
2320970|NCT01873950|5697833|P5|NOT COMPLETED|Period 4||0
2320971|NCT01873950|5697834|P4|NOT COMPLETED|Period 4||0
2320972|NCT01873950|5697835|P3|NOT COMPLETED|Period 4||0
2320973|NCT01873950|5697836|P2|NOT COMPLETED|Period 4||0
2320974|NCT01873950|5697837|P1|NOT COMPLETED|Period 4||0
2320975|NCT01873950|5697833|P5|COMPLETED|Period 4||5
2320976|NCT01873950|5697834|P4|COMPLETED|Period 4||4
2320977|NCT01873950|5697835|P3|COMPLETED|Period 4||4
2320978|NCT01873950|5697836|P2|COMPLETED|Period 4||5
2320979|NCT01873950|5697837|P1|COMPLETED|Period 4||4
2320980|NCT01873950|5697833|P5|STARTED|Period 4||5
2320981|NCT01873950|5697834|P4|STARTED|Period 4||4
2320982|NCT01873950|5697835|P3|STARTED|Period 4||4
2320983|NCT01873950|5697836|P2|STARTED|Period 4||5
2320984|NCT01873950|5697837|P1|STARTED|Period 4||4
2320985|NCT01873950|5697833|P5|NOT COMPLETED|Period 3||0
2320986|NCT01873950|5697834|P4|NOT COMPLETED|Period 3||0
2320987|NCT01873950|5697835|P3|NOT COMPLETED|Period 3||0
2320988|NCT01873950|5697836|P2|NOT COMPLETED|Period 3||0
2320989|NCT01873950|5697837|P1|NOT COMPLETED|Period 3||0
2320990|NCT01873950|5697833|P5|COMPLETED|Period 3||4
2320991|NCT01873950|5697834|P4|COMPLETED|Period 3||5
2320992|NCT01873950|5697835|P3|COMPLETED|Period 3||5
2320993|NCT01873950|5697836|P2|COMPLETED|Period 3||4
2320994|NCT01873950|5697837|P1|COMPLETED|Period 3||4
2320995|NCT01873950|5697833|P5|STARTED|Period 3||4
2320996|NCT01873950|5697834|P4|STARTED|Period 3||5
2320997|NCT01873950|5697835|P3|STARTED|Period 3||5
2320998|NCT01873950|5697836|P2|STARTED|Period 3||4
2320999|NCT01873950|5697837|P1|STARTED|Period 3||4
2321000|NCT01873950|5697833|P5|NOT COMPLETED|Period 2||0
2321001|NCT01873950|5697834|P4|NOT COMPLETED|Period 2||0
2321002|NCT01873950|5697835|P3|NOT COMPLETED|Period 2||0
2321003|NCT01873950|5697836|P2|NOT COMPLETED|Period 2||0
2321004|NCT01873950|5697837|P1|NOT COMPLETED|Period 2||0
2321005|NCT01873950|5697833|P5|COMPLETED|Period 2||5
2321006|NCT01873950|5697834|P4|COMPLETED|Period 2||4
2321007|NCT01873950|5697835|P3|COMPLETED|Period 2||4
2321008|NCT01873950|5697836|P2|COMPLETED|Period 2||4
2321009|NCT01873950|5697837|P1|COMPLETED|Period 2||5
2321010|NCT01873950|5697833|P5|STARTED|Period 2||5
2321011|NCT01873950|5697834|P4|STARTED|Period 2||4
2321012|NCT01873950|5697835|P3|STARTED|Period 2||4
2321013|NCT01873950|5697836|P2|STARTED|Period 2||4
2321014|NCT01873950|5697837|P1|STARTED|Period 2||5
2321015|NCT01873950|5697833|P5|NOT COMPLETED|Period 1||0
2321016|NCT01873950|5697834|P4|NOT COMPLETED|Period 1||0
2321017|NCT01873950|5697835|P3|NOT COMPLETED|Period 1||0
2321018|NCT01873950|5697836|P2|NOT COMPLETED|Period 1||0
2321019|NCT01873950|5697837|P1|NOT COMPLETED|Period 1||0
2321020|NCT01873950|5697833|P5|COMPLETED|Period 1||4
2321021|NCT01873950|5697834|P4|COMPLETED|Period 1||4
2321022|NCT01873950|5697835|P3|COMPLETED|Period 1||5
2321023|NCT01873950|5697836|P2|COMPLETED|Period 1||4
2321024|NCT01873950|5697837|P1|COMPLETED|Period 1||5
2321025|NCT01873950|5697833|P5|STARTED|Period 1||4
2321026|NCT01873950|5697834|P4|STARTED|Period 1||4
2321027|NCT01873950|5697835|P3|STARTED|Period 1||5
2321028|NCT01873950|5697836|P2|STARTED|Period 1||4
2321029|NCT01873950|5697837|P1|STARTED|Period 1||5
2321030|NCT01873859|5697874|P2|NOT COMPLETED|Overall Study||4
2321031|NCT01873859|5697875|P1|NOT COMPLETED|Overall Study||0
2321032|NCT01873859|5697874|P2|COMPLETED|Overall Study||79
2321033|NCT01873859|5697875|P1|COMPLETED|Overall Study||83
2321034|NCT01873859|5697874|P2|STARTED|Overall Study||83
2321035|NCT01873859|5697875|P1|STARTED|Overall Study||83
2321036|NCT01873846|5697883|P1|NOT COMPLETED|Overall Study||12
2321037|NCT01873846|5697883|P1|COMPLETED|Overall Study||388
2321038|NCT01873846|5697883|P1|Eligble Participants Dispensed Lenses|Overall Study||396
2321039|NCT01873846|5697883|P1|STARTED|Overall Study||400
2321040|NCT01873729|5697891|P1|NOT COMPLETED|Overall Study||1
2321041|NCT01873729|5697891|P1|COMPLETED|Overall Study||2
2321042|NCT01873729|5697891|P1|STARTED|Overall Study||3
2321043|NCT01873586|5697896|P1|NOT COMPLETED|Overall Study||3
2321044|NCT01873586|5697896|P1|COMPLETED|Overall Study||26
2321045|NCT01873586|5697896|P1|STARTED|Overall Study||29
2321046|NCT01873495|5697909|P1|NOT COMPLETED|Overall Study||7
2321047|NCT01873495|5697909|P1|COMPLETED|Overall Study||0
2321048|NCT01873495|5697909|P1|STARTED|Overall Study||7
2321049|NCT01873417|5697917|P1|NOT COMPLETED|Overall Study||35
2321050|NCT01873417|5697917|P1|COMPLETED|Overall Study||202
2321051|NCT01873417|5697917|P1|Safety Population|Overall Study|Participants who received at least 1 dose of dimethyl fumarate (DMF), recorded in diary data.|233
2321052|NCT01873417|5697917|P1|STARTED|Overall Study||237
2321053|NCT01873287|5697930|P2|NOT COMPLETED|Overall Study||174
2321054|NCT01873287|5697931|P1|NOT COMPLETED|Overall Study||305
2321055|NCT01873287|5697930|P2|COMPLETED|Overall Study||883
2321056|NCT01873287|5697931|P1|COMPLETED|Overall Study||1701
2321057|NCT01873287|5697930|P2|STARTED|Overall Study||1057
2321058|NCT01873287|5697931|P1|STARTED|Overall Study||2006
2321059|NCT01872910|5697945|P6|NOT COMPLETED|Overall Study||0
2321060|NCT01872910|5697946|P5|NOT COMPLETED|Overall Study||0
2321061|NCT01872910|5697947|P4|NOT COMPLETED|Overall Study||0
2321062|NCT01872910|5697948|P3|NOT COMPLETED|Overall Study||2
2321063|NCT01872910|5697949|P2|NOT COMPLETED|Overall Study||0
2321064|NCT01872910|5697950|P1|NOT COMPLETED|Overall Study||2
2321065|NCT01872910|5697945|P6|COMPLETED|Overall Study||3
2321066|NCT01872910|5697946|P5|COMPLETED|Overall Study||15
2321067|NCT01872910|5697947|P4|COMPLETED|Overall Study||15
2321068|NCT01872910|5697948|P3|COMPLETED|Overall Study||28
2321069|NCT01872910|5697949|P2|COMPLETED|Overall Study||31
2321070|NCT01872910|5697950|P1|COMPLETED|Overall Study||28
2321071|NCT01872910|5697945|P6|Received Any Study Drug|Overall Study||3
2321072|NCT01872910|5697946|P5|Received Any Study Drug|Overall Study||15
2321073|NCT01872910|5697947|P4|Received Any Study Drug|Overall Study||15
2321074|NCT01872910|5697948|P3|Received Any Study Drug|Overall Study||30
2321075|NCT01872910|5697949|P2|Received Any Study Drug|Overall Study||31
2321076|NCT01872910|5697950|P1|Received Any Study Drug|Overall Study||30
2321077|NCT01872910|5697945|P6|STARTED|Overall Study||3
2321078|NCT01872910|5697946|P5|STARTED|Overall Study||15
2321079|NCT01872910|5697947|P4|STARTED|Overall Study||15
2321080|NCT01872910|5697948|P3|STARTED|Overall Study||30
2321081|NCT01872910|5697949|P2|STARTED|Overall Study||31
2321082|NCT01872910|5697950|P1|STARTED|Overall Study||30
2321083|NCT01872819|5697990|P1|NOT COMPLETED|Overall Study||0
2321084|NCT01872819|5697990|P1|COMPLETED|Overall Study||14
2321085|NCT01872819|5697990|P1|STARTED|Overall Study||14
2321086|NCT01872715|5697995|P1|NOT COMPLETED|Overall Study||4
2321087|NCT01872715|5697995|P1|COMPLETED|Overall Study||20
2321088|NCT01872715|5697995|P1|STARTED|Overall Study||24
2321089|NCT01872689|5698014|P4|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||0
2321090|NCT01872689|5698015|P3|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||0
2321091|NCT01872689|5698016|P2|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||23
2321092|NCT01872689|5698017|P1|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||21
2321093|NCT01872689|5698014|P4|COMPLETED|Open-Label Period (Only For Monotherapy)||0
2321094|NCT01872689|5698015|P3|COMPLETED|Open-Label Period (Only For Monotherapy)||0
2321095|NCT01872689|5698016|P2|COMPLETED|Open-Label Period (Only For Monotherapy)||33
2321096|NCT01872689|5698017|P1|COMPLETED|Open-Label Period (Only For Monotherapy)||31
2321097|NCT01872689|5698014|P4|STARTED|Open-Label Period (Only For Monotherapy)|As per study design, Period 2 was not intended for this arm.|0
2321098|NCT01872689|5698015|P3|STARTED|Open-Label Period (Only For Monotherapy)|As per study design, Period 2 was not intended for this arm.|0
2321099|NCT01872689|5698016|P2|STARTED|Open-Label Period (Only For Monotherapy)|Of the 58 participants who completed Period 1, only 56 started Period 2.|56
2321100|NCT01872689|5698017|P1|STARTED|Open-Label Period (Only For Monotherapy)|Of the 56 participants who completed Period 1, only 52 started Period 2.|52
2321101|NCT01872689|5698014|P4|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||38
2321102|NCT01872689|5698015|P3|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||48
2321103|NCT01872689|5698016|P2|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||20
2321104|NCT01872689|5698017|P1|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||20
2321105|NCT01872689|5698014|P4|COMPLETED|Double-Blind/Placebo-Controlled Period||136
2321106|NCT01872689|5698015|P3|COMPLETED|Double-Blind/Placebo-Controlled Period||129
2321107|NCT01872689|5698016|P2|COMPLETED|Double-Blind/Placebo-Controlled Period||58
2321108|NCT01872689|5698017|P1|COMPLETED|Double-Blind/Placebo-Controlled Period||56
2321109|NCT01872689|5698014|P4|STARTED|Double-Blind/Placebo-Controlled Period||174
2321110|NCT01872689|5698015|P3|STARTED|Double-Blind/Placebo-Controlled Period||177
2321111|NCT01872689|5698016|P2|STARTED|Double-Blind/Placebo-Controlled Period||78
2321112|NCT01872689|5698017|P1|STARTED|Double-Blind/Placebo-Controlled Period||76
2321113|NCT01872611|5698093|P2|NOT COMPLETED|Overall Study||12
2321114|NCT01872611|5698094|P1|NOT COMPLETED|Overall Study||24
2321115|NCT01872611|5698093|P2|COMPLETED|Overall Study||292
2321116|NCT01872611|5698094|P1|COMPLETED|Overall Study||277
2321117|NCT01872611|5698093|P2|Full Analysis Set|Overall Study||293
2321118|NCT01872611|5698094|P1|Full Analysis Set|Overall Study||289
2321119|NCT01872611|5698093|P2|Treated (Safety Analysis Set)|Overall Study||295
2321120|NCT01872611|5698094|P1|Treated (Safety Analysis Set)|Overall Study||293
2321121|NCT01872611|5698093|P2|Randomized|Overall Study||304
2321122|NCT01872611|5698094|P1|Randomized|Overall Study||301
2321123|NCT01872611|5698093|P2|STARTED|Overall Study||304
2321124|NCT01872611|5698094|P1|STARTED|Overall Study||301
2321125|NCT01872078|5698116|P4|NOT COMPLETED|Overall Study||2
2321126|NCT01872078|5698117|P3|NOT COMPLETED|Overall Study||3
2321127|NCT01872078|5698118|P2|NOT COMPLETED|Overall Study||0
2321128|NCT01872078|5698119|P1|NOT COMPLETED|Overall Study||0
2321129|NCT01872078|5698116|P4|COMPLETED|Overall Study||15
2321130|NCT01872078|5698117|P3|COMPLETED|Overall Study||14
2321131|NCT01872078|5698118|P2|COMPLETED|Overall Study||15
2321132|NCT01872078|5698119|P1|COMPLETED|Overall Study||16
2321133|NCT01872078|5698116|P4|STARTED|Overall Study||17
2321134|NCT01872078|5698117|P3|STARTED|Overall Study||17
2321135|NCT01872078|5698118|P2|STARTED|Overall Study||15
2321136|NCT01872078|5698119|P1|STARTED|Overall Study||16
2321137|NCT01871870|5698129|P1|NOT COMPLETED|Overall Study||9
2321138|NCT01871870|5698129|P1|COMPLETED|Overall Study||11
2321139|NCT01871870|5698129|P1|STARTED|Overall Study||20
2321140|NCT01871805|5698140|P6|NOT COMPLETED|Phase II||87
2321141|NCT01871805|5698141|P5|NOT COMPLETED|Phase II||0
2321142|NCT01871805|5698142|P4|NOT COMPLETED|Phase II||0
2321143|NCT01871805|5698143|P3|NOT COMPLETED|Phase II||0
2321144|NCT01871805|5698144|P2|NOT COMPLETED|Phase II||0
2321145|NCT01871805|5698145|P1|NOT COMPLETED|Phase II||0
2321146|NCT01871805|5698140|P6|COMPLETED|Phase II||0
2321147|NCT01871805|5698141|P5|COMPLETED|Phase II||0
2321148|NCT01871805|5698142|P4|COMPLETED|Phase II||0
2321149|NCT01871805|5698143|P3|COMPLETED|Phase II||0
2321150|NCT01871805|5698144|P2|COMPLETED|Phase II||0
2321151|NCT01871805|5698145|P1|COMPLETED|Phase II||0
2321152|NCT01871805|5698140|P6|STARTED|Phase II||87
2321153|NCT01871805|5698141|P5|STARTED|Phase II||0
2321154|NCT01871805|5698142|P4|STARTED|Phase II||0
2321155|NCT01871805|5698143|P3|STARTED|Phase II||0
2321156|NCT01871805|5698144|P2|STARTED|Phase II||0
2321157|NCT01871805|5698145|P1|STARTED|Phase II||0
2321158|NCT01871805|5698140|P6|NOT COMPLETED|Phase I||0
2321159|NCT01871805|5698141|P5|NOT COMPLETED|Phase I||13
2321160|NCT01871805|5698142|P4|NOT COMPLETED|Phase I||7
2321161|NCT01871805|5698143|P3|NOT COMPLETED|Phase I||13
2321162|NCT01871805|5698144|P2|NOT COMPLETED|Phase I||7
2321163|NCT01871805|5698145|P1|NOT COMPLETED|Phase I||7
2321164|NCT01871805|5698140|P6|COMPLETED|Phase I||0
2321165|NCT01871805|5698141|P5|COMPLETED|Phase I||0
2321166|NCT01871805|5698142|P4|COMPLETED|Phase I||0
2321167|NCT01871805|5698143|P3|COMPLETED|Phase I||0
2321168|NCT01871805|5698144|P2|COMPLETED|Phase I||0
2321169|NCT01871805|5698145|P1|COMPLETED|Phase I||0
2321170|NCT01871805|5698140|P6|STARTED|Phase I||0
2321171|NCT01871805|5698141|P5|STARTED|Phase I||13
2321172|NCT01871805|5698142|P4|STARTED|Phase I||7
2321173|NCT01871805|5698143|P3|STARTED|Phase I||13
2321174|NCT01871805|5698144|P2|STARTED|Phase I||7
2321175|NCT01871805|5698145|P1|STARTED|Phase I||7
2321176|NCT01871558|5698217|P2|NOT COMPLETED|Overall Study||2
2321177|NCT01871558|5698218|P1|NOT COMPLETED|Overall Study||3
2321178|NCT01871558|5698217|P2|COMPLETED|Overall Study||19
2321179|NCT01871558|5698218|P1|COMPLETED|Overall Study||18
2321180|NCT01871558|5698217|P2|STARTED|Overall Study||21
2321181|NCT01871558|5698218|P1|STARTED|Overall Study||21
2321182|NCT01871532|5698238|P2|NOT COMPLETED|Overall Study||2
2321183|NCT01871532|5698239|P1|NOT COMPLETED|Overall Study||1
2321184|NCT01871532|5698238|P2|COMPLETED|Overall Study||10
2321185|NCT01871532|5698239|P1|COMPLETED|Overall Study||11
2321186|NCT01871532|5698238|P2|Subjects Received hCG Treatment|Overall Study||9
2321187|NCT01871532|5698239|P1|Subjects Received hCG Treatment|Overall Study||11
2321188|NCT01871532|5698238|P2|STARTED|Overall Study||12
2321189|NCT01871532|5698239|P1|STARTED|Overall Study||12
2321190|NCT01871519|5698273|P1|NOT COMPLETED|Overall Study||90
2321191|NCT01871519|5698273|P1|COMPLETED|Overall Study||260
2321192|NCT01871519|5698273|P1|STARTED|Overall Study||350
2321193|NCT01871506|5698296|P2|NOT COMPLETED|Overall Study||0
2321194|NCT01871506|5698297|P1|NOT COMPLETED|Overall Study||0
2321195|NCT01871506|5698296|P2|COMPLETED|Overall Study||153
2321196|NCT01871506|5698297|P1|COMPLETED|Overall Study||150
2321197|NCT01871506|5698296|P2|STARTED|Overall Study||153
2321198|NCT01871506|5698297|P1|STARTED|Overall Study||150
2321199|NCT01871441|5698321|P1|NOT COMPLETED|Overall Study||0
2321200|NCT01871441|5698321|P1|COMPLETED|Overall Study||4
2321201|NCT01871441|5698321|P1|STARTED|Overall Study||4
2321202|NCT01871402|5698330|P2|NOT COMPLETED|Overall Study||3
2321203|NCT01871402|5698331|P1|NOT COMPLETED|Overall Study||1
2321204|NCT01871402|5698330|P2|COMPLETED|Overall Study||108
2321205|NCT01871402|5698331|P1|COMPLETED|Overall Study||109
2321206|NCT01871402|5698330|P2|STARTED|Overall Study||111
2321207|NCT01871402|5698331|P1|STARTED|Overall Study||110
2321208|NCT01871285|5698349|P4|NOT COMPLETED|Second Intervention (1 Day)||0
2321209|NCT01871285|5698350|P3|NOT COMPLETED|Second Intervention (1 Day)||0
2321210|NCT01871285|5698351|P2|NOT COMPLETED|Second Intervention (1 Day)||0
2321211|NCT01871285|5698352|P1|NOT COMPLETED|Second Intervention (1 Day)||0
2321212|NCT01871285|5698349|P4|COMPLETED|Second Intervention (1 Day)||2
2321213|NCT01871285|5698350|P3|COMPLETED|Second Intervention (1 Day)||3
2321214|NCT01871285|5698351|P2|COMPLETED|Second Intervention (1 Day)||14
2321215|NCT01871285|5698352|P1|COMPLETED|Second Intervention (1 Day)||17
2321216|NCT01871285|5698349|P4|STARTED|Second Intervention (1 Day)||2
2321217|NCT01871285|5698350|P3|STARTED|Second Intervention (1 Day)||3
2321218|NCT01871285|5698351|P2|STARTED|Second Intervention (1 Day)||14
2321219|NCT01871285|5698352|P1|STARTED|Second Intervention (1 Day)||17
2321220|NCT01871285|5698349|P4|NOT COMPLETED|First Intervention (1 Day)||0
2321221|NCT01871285|5698350|P3|NOT COMPLETED|First Intervention (1 Day)||1
2321222|NCT01871285|5698351|P2|NOT COMPLETED|First Intervention (1 Day)||1
2321223|NCT01871285|5698352|P1|NOT COMPLETED|First Intervention (1 Day)||1
2321224|NCT01871285|5698349|P4|COMPLETED|First Intervention (1 Day)||2
2321225|NCT01871285|5698350|P3|COMPLETED|First Intervention (1 Day)||3
2321226|NCT01871285|5698351|P2|COMPLETED|First Intervention (1 Day)||14
2321227|NCT01871285|5698352|P1|COMPLETED|First Intervention (1 Day)||17
2321228|NCT01871285|5698349|P4|STARTED|First Intervention (1 Day)||2
2321229|NCT01871285|5698350|P3|STARTED|First Intervention (1 Day)||4
2321230|NCT01871285|5698351|P2|STARTED|First Intervention (1 Day)||15
2321231|NCT01871285|5698352|P1|STARTED|First Intervention (1 Day)||18
2321232|NCT01871142|5698378|P1|NOT COMPLETED|Overall Study||1
2321233|NCT01871142|5698378|P1|COMPLETED|Overall Study||11
2321234|NCT01871142|5698378|P1|Received 3000mg Aes-103 + Hypoxia|Overall Study||12
2321235|NCT01871142|5698378|P1|Received 1000mg Aes 103+ Hypoxia|Overall Study||11
2321236|NCT01871142|5698378|P1|Received Placebo + Hypoxia|Overall Study||12
2321237|NCT01871142|5698378|P1|Received Placebo + Normoixa|Overall Study||11
2321238|NCT01871142|5698378|P1|STARTED|Overall Study||12
2321239|NCT01871090|5698394|P2|NOT COMPLETED|Overall Study||23
2321240|NCT01871090|5698395|P1|NOT COMPLETED|Overall Study||2
2321241|NCT01871090|5698394|P2|COMPLETED|Overall Study||25
2321242|NCT01871090|5698395|P1|COMPLETED|Overall Study||33
2321243|NCT01871090|5698394|P2|STARTED|Overall Study||48
2321244|NCT01871090|5698395|P1|STARTED|Overall Study||35
2321245|NCT01871077|5698405|P1|NOT COMPLETED|Overall Study||0
2321246|NCT01871077|5698405|P1|COMPLETED|Overall Study||30
2321247|NCT01871077|5698405|P1|STARTED|Overall Study||30
2321248|NCT01870999|5698415|P3|NOT COMPLETED|Overall Study||7
2321249|NCT01870999|5698416|P2|NOT COMPLETED|Overall Study||8
2321250|NCT01870999|5698417|P1|NOT COMPLETED|Overall Study||4
2321251|NCT01870999|5698415|P3|COMPLETED|Overall Study||4
2321252|NCT01870999|5698416|P2|COMPLETED|Overall Study||8
2321253|NCT01870999|5698417|P1|COMPLETED|Overall Study||10
2321254|NCT01870999|5698415|P3|Safety Population; Received Study Drug|Overall Study||10
2321255|NCT01870999|5698416|P2|Safety Population; Received Study Drug|Overall Study||15
2321256|NCT01870999|5698417|P1|Safety Population; Received Study Drug|Overall Study||14
2321257|NCT01870999|5698415|P3|STARTED|Overall Study||11
2321258|NCT01870999|5698416|P2|STARTED|Overall Study||16
2321259|NCT01870999|5698417|P1|STARTED|Overall Study||14
2321260|NCT01870973|5698475|P2|NOT COMPLETED|Overall Study||3
2321261|NCT01870973|5698476|P1|NOT COMPLETED|Overall Study||10
2321262|NCT01870973|5698475|P2|COMPLETED|Overall Study||49
2321263|NCT01870973|5698476|P1|COMPLETED|Overall Study||46
2321264|NCT01870973|5698475|P2|STARTED|Overall Study||52
2321265|NCT01870973|5698476|P1|STARTED|Overall Study||56
2321266|NCT01870921|5698482|P1|NOT COMPLETED|Overall Study||90
2321267|NCT01870921|5698482|P1|COMPLETED|Overall Study||1914
2321268|NCT01870921|5698482|P1|STARTED|Overall Study||2004
2321269|NCT01870856|5698490|P2|NOT COMPLETED|Overall Study||0
2321270|NCT01870856|5698491|P1|NOT COMPLETED|Overall Study||0
2321271|NCT01870856|5698490|P2|COMPLETED|Overall Study||27
2321272|NCT01870856|5698491|P1|COMPLETED|Overall Study||25
2321273|NCT01870856|5698490|P2|STARTED|Overall Study||27
2321274|NCT01870856|5698491|P1|STARTED|Overall Study||25
2321275|NCT01870843|5698501|P1|NOT COMPLETED|Overall Study||53
2321276|NCT01870843|5698501|P1|COMPLETED|Overall Study||208
2321277|NCT01870843|5698501|P1|STARTED|Overall Study||261
2321278|NCT01870778|5698516|P2|NOT COMPLETED|Overall Study||9
2321279|NCT01870778|5698517|P1|NOT COMPLETED|Overall Study||8
2321280|NCT01870778|5698516|P2|COMPLETED|Overall Study||3262
2321281|NCT01870778|5698517|P1|COMPLETED|Overall Study||3266
2321282|NCT01870778|5698516|P2|Biomarker Analysis Set|Overall Study||510
2321283|NCT01870778|5698517|P1|Biomarker Analysis Set|Overall Study||521
2321284|NCT01870778|5698516|P2|Full Analysis Set|Overall Study||3271
2321285|NCT01870778|5698517|P1|Full Analysis Set|Overall Study||3274
2321286|NCT01870778|5698516|P2|Safety Set|Overall Study||3248
2321287|NCT01870778|5698517|P1|Safety Set|Overall Study||3257
2321288|NCT01870778|5698516|P2|STARTED|Overall Study||3271
2321289|NCT01870778|5698517|P1|STARTED|Overall Study||3274
2321290|NCT01870739|5698543|P2|NOT COMPLETED|Add-on Period (40 Weeks)||2
2321291|NCT01870739|5698544|P1|NOT COMPLETED|Add-on Period (40 Weeks)||3
2321292|NCT01870739|5698543|P2|COMPLETED|Add-on Period (40 Weeks)||51
2321293|NCT01870739|5698544|P1|COMPLETED|Add-on Period (40 Weeks)||51
2321294|NCT01870739|5698543|P2|STARTED|Add-on Period (40 Weeks)||53
2321295|NCT01870739|5698544|P1|STARTED|Add-on Period (40 Weeks)||54
2321296|NCT01870739|5698543|P2|NOT COMPLETED|Single Drug Treatment (12 Weeks)||4
2321297|NCT01870739|5698544|P1|NOT COMPLETED|Single Drug Treatment (12 Weeks)||3
2321298|NCT01870739|5698543|P2|COMPLETED|Single Drug Treatment (12 Weeks)||53
2321299|NCT01870739|5698544|P1|COMPLETED|Single Drug Treatment (12 Weeks)|"Completed indicates maintenance dose complete"|54
2321300|NCT01870739|5698543|P2|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||56
2321301|NCT01870739|5698544|P1|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||57
2321302|NCT01870739|5698543|P2|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||56
2321303|NCT01870739|5698544|P1|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||57
2321304|NCT01870739|5698543|P2|STARTED|Single Drug Treatment (12 Weeks)||57
2321305|NCT01870739|5698544|P1|STARTED|Single Drug Treatment (12 Weeks)|"Start = Safety/Pharmacokinetic/Pharmacodynamic analysis set"|57
2321306|NCT01870726|5698583|P7|NOT COMPLETED|Overall Study||10
2321307|NCT01870726|5698584|P6|NOT COMPLETED|Overall Study||5
2321308|NCT01870726|5698585|P5|NOT COMPLETED|Overall Study||7
2321309|NCT01870726|5698586|P4|NOT COMPLETED|Overall Study||6
2321310|NCT01870726|5698587|P3|NOT COMPLETED|Overall Study||4
2321311|NCT01870726|5698588|P2|NOT COMPLETED|Overall Study||6
2321312|NCT01870726|5698589|P1|NOT COMPLETED|Overall Study||5
2321313|NCT01870726|5698583|P7|COMPLETED|Overall Study||0
2321314|NCT01870726|5698584|P6|COMPLETED|Overall Study||0
2321315|NCT01870726|5698585|P5|COMPLETED|Overall Study||0
2321316|NCT01870726|5698586|P4|COMPLETED|Overall Study||0
2321317|NCT01870726|5698587|P3|COMPLETED|Overall Study||0
2321318|NCT01870726|5698588|P2|COMPLETED|Overall Study||0
2321319|NCT01870726|5698589|P1|COMPLETED|Overall Study||0
2321320|NCT01870726|5698583|P7|STARTED|Overall Study||10
2321321|NCT01870726|5698584|P6|STARTED|Overall Study||5
2321322|NCT01870726|5698585|P5|STARTED|Overall Study||7
2321323|NCT01870726|5698586|P4|STARTED|Overall Study||6
2321324|NCT01870726|5698587|P3|STARTED|Overall Study||4
2321325|NCT01870726|5698588|P2|STARTED|Overall Study||6
2321326|NCT01870726|5698589|P1|STARTED|Overall Study||5
2321327|NCT01870596|5698674|P2|NOT COMPLETED|Overall Study||0
2321328|NCT01870596|5698675|P1|NOT COMPLETED|Overall Study||0
2321329|NCT01870596|5698674|P2|COMPLETED|Overall Study||18
2321330|NCT01870596|5698675|P1|COMPLETED|Overall Study||14
2321331|NCT01870596|5698674|P2|STARTED|Overall Study||18
2321332|NCT01870596|5698675|P1|STARTED|Overall Study||14
2321333|NCT01870583|5698684|P3|NOT COMPLETED|Overall Study||8
2321334|NCT01870583|5698685|P2|NOT COMPLETED|Overall Study||18
2321335|NCT01870583|5698686|P1|NOT COMPLETED|Overall Study||11
2321336|NCT01870583|5698684|P3|COMPLETED|Overall Study||455
2321337|NCT01870583|5698685|P2|COMPLETED|Overall Study||456
2321338|NCT01870583|5698686|P1|COMPLETED|Overall Study||456
2321339|NCT01870583|5698684|P3|STARTED|Overall Study||463
2321340|NCT01870583|5698685|P2|STARTED|Overall Study||474
2321341|NCT01870583|5698686|P1|STARTED|Overall Study||467
2321342|NCT01870388|5698696|P2|NOT COMPLETED|Overall Study||0
2321343|NCT01870388|5698697|P1|NOT COMPLETED|Overall Study||0
2321344|NCT01870388|5698696|P2|COMPLETED|Overall Study||8
2321345|NCT01870388|5698697|P1|COMPLETED|Overall Study||8
2321346|NCT01870388|5698696|P2|Received 1 Dose of Study Drug|Overall Study||8
2321347|NCT01870388|5698697|P1|Received 1 Dose of Study Drug|Overall Study||8
2321348|NCT01870388|5698696|P2|STARTED|Overall Study||8
2321349|NCT01870388|5698697|P1|STARTED|Overall Study||8
2321350|NCT01870297|5698712|P7|NOT COMPLETED|Overall Study||2
2321351|NCT01870297|5698713|P6|NOT COMPLETED|Overall Study||1
2321352|NCT01870297|5698714|P5|NOT COMPLETED|Overall Study||3
2321353|NCT01870297|5698715|P4|NOT COMPLETED|Overall Study||0
2321354|NCT01870297|5698716|P3|NOT COMPLETED|Overall Study||1
2321355|NCT01870297|5698717|P2|NOT COMPLETED|Overall Study||7
2321356|NCT01870297|5698718|P1|NOT COMPLETED|Overall Study||0
2321357|NCT01870297|5698712|P7|COMPLETED|Overall Study||8
2321358|NCT01870297|5698713|P6|COMPLETED|Overall Study||8
2321359|NCT01870297|5698714|P5|COMPLETED|Overall Study||7
2321360|NCT01870297|5698715|P4|COMPLETED|Overall Study||9
2321361|NCT01870297|5698716|P3|COMPLETED|Overall Study||7
2321362|NCT01870297|5698717|P2|COMPLETED|Overall Study||8
2321363|NCT01870297|5698718|P1|COMPLETED|Overall Study||11
2321364|NCT01870297|5698712|P7|STARTED|Overall Study||10
2321365|NCT01870297|5698713|P6|STARTED|Overall Study||9
2321366|NCT01870297|5698714|P5|STARTED|Overall Study||10
2321367|NCT01870297|5698715|P4|STARTED|Overall Study||9
2321368|NCT01870297|5698716|P3|STARTED|Overall Study||8
2321369|NCT01870297|5698717|P2|STARTED|Overall Study||15
2321370|NCT01870297|5698718|P1|STARTED|Overall Study||11
2321371|NCT01870076|5698762|P4|NOT COMPLETED|Overall Study||0
2321372|NCT01870076|5698763|P3|NOT COMPLETED|Overall Study||1
2321373|NCT01870076|5698764|P2|NOT COMPLETED|Overall Study||0
2321374|NCT01870076|5698765|P1|NOT COMPLETED|Overall Study||1
2321375|NCT01870076|5698762|P4|COMPLETED|Overall Study||11
2321376|NCT01870076|5698763|P3|COMPLETED|Overall Study||7
2321377|NCT01870076|5698764|P2|COMPLETED|Overall Study||12
2321378|NCT01870076|5698765|P1|COMPLETED|Overall Study||9
2321379|NCT01870076|5698762|P4|STARTED|Overall Study||11
2321380|NCT01870076|5698763|P3|STARTED|Overall Study||8
2321381|NCT01870076|5698764|P2|STARTED|Overall Study||12
2321382|NCT01870076|5698765|P1|STARTED|Overall Study||10
2321383|NCT01869959|5698783|P5|NOT COMPLETED|Treatment Period||0
2321384|NCT01869959|5698784|P4|NOT COMPLETED|Treatment Period||2
2321385|NCT01869959|5698785|P3|NOT COMPLETED|Treatment Period||3
2321386|NCT01869959|5698786|P2|NOT COMPLETED|Treatment Period||2
2321387|NCT01869959|5698787|P1|NOT COMPLETED|Treatment Period||1
2321388|NCT01869959|5698783|P5|COMPLETED|Treatment Period||0
2321389|NCT01869959|5698784|P4|COMPLETED|Treatment Period||8
2321390|NCT01869959|5698785|P3|COMPLETED|Treatment Period||12
2321391|NCT01869959|5698786|P2|COMPLETED|Treatment Period||8
2321392|NCT01869959|5698787|P1|COMPLETED|Treatment Period||10
2321393|NCT01869959|5698783|P5|Received at Least 1 Dose of Study Drug|Treatment Period||0
2321394|NCT01869959|5698784|P4|Received at Least 1 Dose of Study Drug|Treatment Period||10
2321395|NCT01869959|5698785|P3|Received at Least 1 Dose of Study Drug|Treatment Period||15
2321396|NCT01869959|5698786|P2|Received at Least 1 Dose of Study Drug|Treatment Period||10
2321397|NCT01869959|5698787|P1|Received at Least 1 Dose of Study Drug|Treatment Period||11
2321398|NCT01869959|5698783|P5|STARTED|Treatment Period|Participants were randomized to treatment groups for the Treatment Period.|0
2321399|NCT01869959|5698784|P4|STARTED|Treatment Period||10
2321400|NCT01869959|5698785|P3|STARTED|Treatment Period||15
2321401|NCT01869959|5698786|P2|STARTED|Treatment Period||10
2321402|NCT01869959|5698787|P1|STARTED|Treatment Period||11
2321403|NCT01869959|5698783|P5|NOT COMPLETED|Randomization Period||1
2321404|NCT01869959|5698784|P4|NOT COMPLETED|Randomization Period||0
2321405|NCT01869959|5698785|P3|NOT COMPLETED|Randomization Period||0
2321406|NCT01869959|5698786|P2|NOT COMPLETED|Randomization Period||0
2321407|NCT01869959|5698787|P1|NOT COMPLETED|Randomization Period||0
2321408|NCT01869959|5698783|P5|COMPLETED|Randomization Period|One participant discontinued after randomization but did not receive study drug.|46
2321409|NCT01869959|5698784|P4|COMPLETED|Randomization Period||0
2321410|NCT01869959|5698785|P3|COMPLETED|Randomization Period||0
2321411|NCT01869959|5698786|P2|COMPLETED|Randomization Period||0
2321412|NCT01869959|5698787|P1|COMPLETED|Randomization Period||0
2321413|NCT01869959|5698783|P5|STARTED|Randomization Period||47
2321414|NCT01869959|5698784|P4|STARTED|Randomization Period||0
2321415|NCT01869959|5698785|P3|STARTED|Randomization Period||0
2321416|NCT01869959|5698786|P2|STARTED|Randomization Period||0
2321417|NCT01869959|5698787|P1|STARTED|Randomization Period||0
2321418|NCT01869764|5698857|P2|NOT COMPLETED|Overall Study||2
2321419|NCT01869764|5698858|P1|NOT COMPLETED|Overall Study||0
2321420|NCT01869764|5698857|P2|COMPLETED|Overall Study||27
2321421|NCT01869764|5698858|P1|COMPLETED|Overall Study||28
2321422|NCT01869764|5698857|P2|STARTED|Overall Study||29
2321423|NCT01869764|5698858|P1|STARTED|Overall Study||28
2321424|NCT01869699|5698876|P2|NOT COMPLETED|Overall Study||0
2321425|NCT01869699|5698877|P1|NOT COMPLETED|Overall Study||1
2321426|NCT01869699|5698876|P2|COMPLETED|Overall Study||20
2321427|NCT01869699|5698877|P1|COMPLETED|Overall Study||20
2321428|NCT01869699|5698876|P2|STARTED|Overall Study||20
2321429|NCT01869699|5698877|P1|STARTED|Overall Study||21
2321430|NCT01869686|5698895|P1|NOT COMPLETED|Overall Study||0
2321431|NCT01869686|5698895|P1|COMPLETED|Overall Study||12
2321432|NCT01869686|5698895|P1|STARTED|Overall Study||12
2321433|NCT01869647|5698910|P3|NOT COMPLETED|Overall Study||0
2321434|NCT01869647|5698911|P2|NOT COMPLETED|Overall Study||6
2321435|NCT01869647|5698912|P1|NOT COMPLETED|Overall Study||1
2321436|NCT01869647|5698910|P3|COMPLETED|Overall Study||62
2321437|NCT01869647|5698911|P2|COMPLETED|Overall Study||130
2321438|NCT01869647|5698912|P1|COMPLETED|Overall Study||65
2321439|NCT01869647|5698910|P3|STARTED|Overall Study||62
2321440|NCT01869647|5698911|P2|STARTED|Overall Study||136
2321441|NCT01869647|5698912|P1|STARTED|Overall Study||66
2321442|NCT01869478|5698925|P2|NOT COMPLETED|Overall Study||0
2321443|NCT01869478|5698926|P1|NOT COMPLETED|Overall Study||0
2321444|NCT01869478|5698925|P2|COMPLETED|Overall Study||1
2321445|NCT01869478|5698926|P1|COMPLETED|Overall Study||0
2321446|NCT01869478|5698925|P2|STARTED|Overall Study||1
2321447|NCT01869478|5698926|P1|STARTED|Overall Study||0
2321448|NCT01869439|5698934|P1|NOT COMPLETED|Overall Study||0
2321449|NCT01869439|5698934|P1|COMPLETED|Overall Study||40
2321450|NCT01869439|5698934|P1|STARTED|Overall Study||40
2321451|NCT01869348|5698940|P2|NOT COMPLETED|Overall Study||1
2321452|NCT01869348|5698941|P1|NOT COMPLETED|Overall Study||1
2321453|NCT01869348|5698940|P2|COMPLETED|Overall Study||19
2321454|NCT01869348|5698941|P1|COMPLETED|Overall Study||19
2321455|NCT01869348|5698940|P2|STARTED|Overall Study||20
2321456|NCT01869348|5698941|P1|STARTED|Overall Study||20
2321457|NCT01869192|5698949|P2|NOT COMPLETED|Postoperative Chemotherapy||2
2321458|NCT01869192|5698950|P1|NOT COMPLETED|Postoperative Chemotherapy||0
2321459|NCT01869192|5698949|P2|COMPLETED|Postoperative Chemotherapy||31
2321460|NCT01869192|5698950|P1|COMPLETED|Postoperative Chemotherapy||32
2321461|NCT01869192|5698949|P2|STARTED|Postoperative Chemotherapy||33
2321462|NCT01869192|5698950|P1|STARTED|Postoperative Chemotherapy|3 did not start postop chemotherapy|32
2321463|NCT01869192|5698949|P2|NOT COMPLETED|Preoperative Chemotherapy to Surgery||1
2321464|NCT01869192|5698950|P1|NOT COMPLETED|Preoperative Chemotherapy to Surgery||2
2321465|NCT01869192|5698949|P2|COMPLETED|Preoperative Chemotherapy to Surgery|one never got treatment on study|34
2321466|NCT01869192|5698950|P1|COMPLETED|Preoperative Chemotherapy to Surgery||35
2321467|NCT01869192|5698949|P2|STARTED|Preoperative Chemotherapy to Surgery||35
2321468|NCT01869192|5698950|P1|STARTED|Preoperative Chemotherapy to Surgery||37
2321469|NCT01869075|5698964|P6|NOT COMPLETED|Phase 2||0
2321470|NCT01869075|5698965|P5|NOT COMPLETED|Phase 2||0
2321471|NCT01869075|5698966|P4|NOT COMPLETED|Phase 2||0
2321472|NCT01869075|5698967|P3|NOT COMPLETED|Phase 2||0
2321473|NCT01869075|5698968|P2|NOT COMPLETED|Phase 2||0
2321474|NCT01869075|5698969|P1|NOT COMPLETED|Phase 2||0
2321475|NCT01869075|5698964|P6|COMPLETED|Phase 2||45
2321476|NCT01869075|5698965|P5|COMPLETED|Phase 2||75
2321477|NCT01869075|5698966|P4|COMPLETED|Phase 2||45
2321478|NCT01869075|5698967|P3|COMPLETED|Phase 2||75
2321479|NCT01869075|5698968|P2|COMPLETED|Phase 2||30
2321480|NCT01869075|5698969|P1|COMPLETED|Phase 2||90
2321481|NCT01869075|5698964|P6|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
2321482|NCT01869075|5698965|P5|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
2321483|NCT01869075|5698966|P4|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
2321484|NCT01869075|5698967|P3|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
2321485|NCT01869075|5698968|P2|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|30
2321486|NCT01869075|5698969|P1|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|90
2321487|NCT01869075|5698964|P6|NOT COMPLETED|Phase 1||0
2321488|NCT01869075|5698965|P5|NOT COMPLETED|Phase 1||0
2321489|NCT01869075|5698966|P4|NOT COMPLETED|Phase 1||0
2321490|NCT01869075|5698967|P3|NOT COMPLETED|Phase 1||0
2321491|NCT01869075|5698968|P2|NOT COMPLETED|Phase 1||0
2321492|NCT01869075|5698969|P1|NOT COMPLETED|Phase 1||0
2321493|NCT01869075|5698964|P6|COMPLETED|Phase 1||90
2321494|NCT01869075|5698965|P5|COMPLETED|Phase 1||30
2321495|NCT01869075|5698966|P4|COMPLETED|Phase 1||75
2321496|NCT01869075|5698967|P3|COMPLETED|Phase 1||45
2321497|NCT01869075|5698968|P2|COMPLETED|Phase 1||75
2321498|NCT01869075|5698969|P1|COMPLETED|Phase 1||45
2321499|NCT01869075|5698964|P6|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|90
2321500|NCT01869075|5698965|P5|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|30
2321501|NCT01869075|5698966|P4|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
2321502|NCT01869075|5698967|P3|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
2321503|NCT01869075|5698968|P2|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
2321504|NCT01869075|5698969|P1|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
2321505|NCT01869075|5698964|P6|NOT COMPLETED|Phase 0 (Baseline)||0
2321506|NCT01869075|5698965|P5|NOT COMPLETED|Phase 0 (Baseline)||0
2321507|NCT01869075|5698966|P4|NOT COMPLETED|Phase 0 (Baseline)||0
2321508|NCT01869075|5698967|P3|NOT COMPLETED|Phase 0 (Baseline)||0
2321509|NCT01869075|5698968|P2|NOT COMPLETED|Phase 0 (Baseline)||0
2321510|NCT01869075|5698969|P1|NOT COMPLETED|Phase 0 (Baseline)||0
2321511|NCT01869075|5698964|P6|COMPLETED|Phase 0 (Baseline)||341
2321512|NCT01869075|5698965|P5|COMPLETED|Phase 0 (Baseline)||0
2321513|NCT01869075|5698966|P4|COMPLETED|Phase 0 (Baseline)||416
2321514|NCT01869075|5698967|P3|COMPLETED|Phase 0 (Baseline)||0
2321515|NCT01869075|5698968|P2|COMPLETED|Phase 0 (Baseline)||418
2321516|NCT01869075|5698969|P1|COMPLETED|Phase 0 (Baseline)||0
2321517|NCT01869075|5698964|P6|STARTED|Phase 0 (Baseline)||341
2321518|NCT01869075|5698965|P5|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
2321519|NCT01869075|5698966|P4|STARTED|Phase 0 (Baseline)||416
2321520|NCT01869075|5698967|P3|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
2321521|NCT01869075|5698968|P2|STARTED|Phase 0 (Baseline)||418
2321522|NCT01869075|5698969|P1|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
2321523|NCT01868997|5698985|P2|NOT COMPLETED|Overall Study||6
2321524|NCT01868997|5698986|P1|NOT COMPLETED|Overall Study||7
2321525|NCT01868997|5698985|P2|COMPLETED|Overall Study||36
2321526|NCT01868997|5698986|P1|COMPLETED|Overall Study||38
2321527|NCT01868997|5698985|P2|STARTED|Overall Study|randomized and treated|42
2321528|NCT01868997|5698986|P1|STARTED|Overall Study|randomized and treated|45
2321529|NCT01868893|5699002|P1|NOT COMPLETED|Overall Study||20
2321530|NCT01868893|5699002|P1|COMPLETED|Overall Study||0
2321531|NCT01868893|5699002|P1|STARTED|Overall Study||20
2321532|NCT01868789|5699011|P2|NOT COMPLETED|Overall Study||2
2321533|NCT01868789|5699012|P1|NOT COMPLETED|Overall Study||2
2321534|NCT01868789|5699011|P2|COMPLETED|Overall Study||12
2321535|NCT01868789|5699012|P1|COMPLETED|Overall Study||7
2321536|NCT01868789|5699011|P2|STARTED|Overall Study||14
2321537|NCT01868789|5699012|P1|STARTED|Overall Study||9
2321538|NCT01868776|5699022|P2|NOT COMPLETED|Overall Study||0
2321539|NCT01868776|5699023|P1|NOT COMPLETED|Overall Study||0
2321540|NCT01868776|5699022|P2|COMPLETED|Overall Study||50
2321541|NCT01868776|5699023|P1|COMPLETED|Overall Study||50
2321542|NCT01868776|5699022|P2|STARTED|Overall Study||50
2321543|NCT01868776|5699023|P1|STARTED|Overall Study||50
2321544|NCT01868646|5699031|P2|NOT COMPLETED|Overall Study||5
2321545|NCT01868646|5699032|P1|NOT COMPLETED|Overall Study||3
2321546|NCT01868646|5699031|P2|COMPLETED|Overall Study||67
2321547|NCT01868646|5699032|P1|COMPLETED|Overall Study||73
2321548|NCT01868646|5699031|P2|STARTED|Overall Study||72
2321549|NCT01868646|5699032|P1|STARTED|Overall Study||76
2321550|NCT01868633|5699060|P2|NOT COMPLETED|Overall Study||0
2321551|NCT01868633|5699061|P1|NOT COMPLETED|Overall Study||0
2321552|NCT01868633|5699060|P2|COMPLETED|Overall Study||26
2321553|NCT01868633|5699061|P1|COMPLETED|Overall Study||26
2321554|NCT01868633|5699060|P2|STARTED|Overall Study||26
2321555|NCT01868633|5699061|P1|STARTED|Overall Study||26
2321556|NCT01868594|5699077|P2|NOT COMPLETED|Overall Study||3
2321557|NCT01868594|5699078|P1|NOT COMPLETED|Overall Study||4
2321558|NCT01868594|5699077|P2|COMPLETED|Overall Study||72
2321559|NCT01868594|5699078|P1|COMPLETED|Overall Study||72
2321560|NCT01868594|5699077|P2|STARTED|Overall Study||75
2321561|NCT01868594|5699078|P1|STARTED|Overall Study||76
2321562|NCT01868542|5699098|P2|NOT COMPLETED|Overall Study||2
2321563|NCT01868542|5699099|P1|NOT COMPLETED|Overall Study||0
2321564|NCT01868542|5699098|P2|COMPLETED|Overall Study||21
2321565|NCT01868542|5699099|P1|COMPLETED|Overall Study||23
2321566|NCT01868542|5699098|P2|STARTED|Overall Study||23
2321567|NCT01868542|5699099|P1|STARTED|Overall Study||23
2321568|NCT01868503|5699117|P1|NOT COMPLETED|Overall Study||2
2321569|NCT01868503|5699117|P1|COMPLETED|Overall Study||5
2321570|NCT01868503|5699117|P1|STARTED|Overall Study||7
2321571|NCT01868477|5699127|P2|NOT COMPLETED|Overall Study||5
2321572|NCT01868477|5699128|P1|NOT COMPLETED|Overall Study||4
2321573|NCT01868477|5699127|P2|COMPLETED|Overall Study||6
2321574|NCT01868477|5699128|P1|COMPLETED|Overall Study||8
2321575|NCT01868477|5699127|P2|Not Switched to EPO+DFX|Overall Study||0
2321576|NCT01868477|5699128|P1|Not Switched to EPO+DFX|Overall Study||7
2321577|NCT01868477|5699127|P2|Switched to EPO+DFX|Overall Study||0
2321578|NCT01868477|5699128|P1|Switched to EPO+DFX|Overall Study||5
2321579|NCT01868477|5699127|P2|STARTED|Overall Study||11
2321580|NCT01868477|5699128|P1|STARTED|Overall Study||12
2321581|NCT01868334|5699156|P4|NOT COMPLETED|Year 2 Pre-post Study||0
2321582|NCT01868334|5699157|P3|NOT COMPLETED|Year 2 Pre-post Study||0
2321583|NCT01868334|5699158|P2|NOT COMPLETED|Year 2 Pre-post Study||0
2321584|NCT01868334|5699159|P1|NOT COMPLETED|Year 2 Pre-post Study||0
2321585|NCT01868334|5699156|P4|COMPLETED|Year 2 Pre-post Study||19274
2321586|NCT01868334|5699157|P3|COMPLETED|Year 2 Pre-post Study||20904
2321587|NCT01868334|5699158|P2|COMPLETED|Year 2 Pre-post Study||8047
2321588|NCT01868334|5699159|P1|COMPLETED|Year 2 Pre-post Study||22324
2321589|NCT01868334|5699156|P4|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Intervention sites who chose not to actively engage Year 2|19274
2321590|NCT01868334|5699157|P3|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Control sites who became active in the intervention during Year 2|20904
2321591|NCT01868334|5699158|P2|STARTED|Year 2 Pre-post Study|Reflects: the six Year 1 Intervention sites who chose not to actively engage Year 2|8047
2321592|NCT01868334|5699159|P1|STARTED|Year 2 Pre-post Study|Reflects: control sites from Year 1 (N=8) and Year 1 Intervention sites who continued in Y2 (N=4)|22324
2321593|NCT01868334|5699156|P4|NOT COMPLETED|Year 1 RCCT Study||0
2321594|NCT01868334|5699157|P3|NOT COMPLETED|Year 1 RCCT Study||0
2321595|NCT01868334|5699158|P2|NOT COMPLETED|Year 1 RCCT Study||0
2321596|NCT01868334|5699159|P1|NOT COMPLETED|Year 1 RCCT Study||0
2321597|NCT01868334|5699156|P4|COMPLETED|Year 1 RCCT Study||20904
2321598|NCT01868334|5699157|P3|COMPLETED|Year 1 RCCT Study||19274
2321599|NCT01868334|5699158|P2|COMPLETED|Year 1 RCCT Study||17185
2321600|NCT01868334|5699159|P1|COMPLETED|Year 1 RCCT Study||13186
2321601|NCT01868334|5699156|P4|STARTED|Year 1 RCCT Study||20904
2321602|NCT01868334|5699157|P3|STARTED|Year 1 RCCT Study||19274
2321603|NCT01868334|5699158|P2|STARTED|Year 1 RCCT Study||17185
2321604|NCT01868334|5699159|P1|STARTED|Year 1 RCCT Study||13186
2321605|NCT01868243|5699199|P2|NOT COMPLETED|Overall Study||1
2321606|NCT01868243|5699200|P1|NOT COMPLETED|Overall Study||0
2321607|NCT01868243|5699199|P2|COMPLETED|Overall Study||11
2321608|NCT01868243|5699200|P1|COMPLETED|Overall Study||15
2321609|NCT01868243|5699199|P2|STARTED|Overall Study||12
2321610|NCT01868243|5699200|P1|STARTED|Overall Study||15
2321611|NCT01868165|5699208|P1|NOT COMPLETED|Overall Study||45
2321612|NCT01868165|5699208|P1|COMPLETED|Overall Study||292
2321613|NCT01868165|5699208|P1|STARTED|Overall Study||337
2321617|NCT01868074|5699224|P2|NOT COMPLETED|Overall Study||4
2321618|NCT01868074|5699225|P1|NOT COMPLETED|Overall Study||7
2321619|NCT01868074|5699224|P2|COMPLETED|Overall Study||32
2321620|NCT01868074|5699225|P1|COMPLETED|Overall Study||29
2321621|NCT01868074|5699224|P2|STARTED|Overall Study||36
2321622|NCT01868074|5699225|P1|STARTED|Overall Study||36
2321623|NCT01868035|5699235|P1|NOT COMPLETED|Overall Study||7
2321624|NCT01868035|5699235|P1|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|8
2321625|NCT01868035|5699235|P1|STARTED|Overall Study||15
2321626|NCT01868022|5699260|P9|NOT COMPLETED|Overall Study||2
2321627|NCT01868022|5699261|P8|NOT COMPLETED|Overall Study||9
2321628|NCT01868022|5699262|P7|NOT COMPLETED|Overall Study||0
2321629|NCT01868022|5699263|P6|NOT COMPLETED|Overall Study||1
2321630|NCT01868022|5699264|P5|NOT COMPLETED|Overall Study||2
2321631|NCT01868022|5699265|P4|NOT COMPLETED|Overall Study||1
2321632|NCT01868022|5699266|P3|NOT COMPLETED|Overall Study||1
2321633|NCT01868022|5699267|P2|NOT COMPLETED|Overall Study||0
2321634|NCT01868022|5699268|P1|NOT COMPLETED|Overall Study||0
2321635|NCT01868022|5699260|P9|COMPLETED|Overall Study||6
2321636|NCT01868022|5699261|P8|COMPLETED|Overall Study||16
2321637|NCT01868022|5699262|P7|COMPLETED|Overall Study||3
2321638|NCT01868022|5699263|P6|COMPLETED|Overall Study||2
2321639|NCT01868022|5699264|P5|COMPLETED|Overall Study||1
2321640|NCT01868022|5699265|P4|COMPLETED|Overall Study||2
2321641|NCT01868022|5699266|P3|COMPLETED|Overall Study||13
2321642|NCT01868022|5699267|P2|COMPLETED|Overall Study||3
2321643|NCT01868022|5699268|P1|COMPLETED|Overall Study||3
2321644|NCT01868022|5699260|P9|STARTED|Overall Study||8
2321645|NCT01868022|5699261|P8|STARTED|Overall Study||25
2321646|NCT01868022|5699262|P7|STARTED|Overall Study||3
2321647|NCT01868022|5699263|P6|STARTED|Overall Study||3
2321648|NCT01868022|5699264|P5|STARTED|Overall Study||3
2321649|NCT01868022|5699265|P4|STARTED|Overall Study||3
2321650|NCT01868022|5699266|P3|STARTED|Overall Study||14
2321651|NCT01868022|5699267|P2|STARTED|Overall Study||3
2321652|NCT01868022|5699268|P1|STARTED|Overall Study||3
2321653|NCT01868009|5699474|P2|NOT COMPLETED|Period 2 (5-9 Days)||0
2321654|NCT01868009|5699475|P1|NOT COMPLETED|Period 2 (5-9 Days)||2
2321655|NCT01868009|5699474|P2|COMPLETED|Period 2 (5-9 Days)||142
2321656|NCT01868009|5699475|P1|COMPLETED|Period 2 (5-9 Days)||141
2321657|NCT01868009|5699474|P2|STARTED|Period 2 (5-9 Days)||142
2321658|NCT01868009|5699475|P1|STARTED|Period 2 (5-9 Days)||143
2321659|NCT01868009|5699474|P2|NOT COMPLETED|Period 1 (5-9 Days)||2
2321660|NCT01868009|5699475|P1|NOT COMPLETED|Period 1 (5-9 Days)||0
2321661|NCT01868009|5699474|P2|COMPLETED|Period 1 (5-9 Days)||142
2321662|NCT01868009|5699475|P1|COMPLETED|Period 1 (5-9 Days)||143
2321663|NCT01868009|5699474|P2|STARTED|Period 1 (5-9 Days)||144
2321664|NCT01868009|5699475|P1|STARTED|Period 1 (5-9 Days)||143
2321665|NCT01867710|5699489|P4|NOT COMPLETED|Overall Study||42
2321666|NCT01867710|5699490|P3|NOT COMPLETED|Overall Study||40
2321667|NCT01867710|5699491|P2|NOT COMPLETED|Overall Study||41
2321668|NCT01867710|5699492|P1|NOT COMPLETED|Overall Study||41
2321669|NCT01867710|5699489|P4|COMPLETED|Overall Study||0
2321670|NCT01867710|5699490|P3|COMPLETED|Overall Study||0
2321671|NCT01867710|5699491|P2|COMPLETED|Overall Study||0
2321672|NCT01867710|5699492|P1|COMPLETED|Overall Study||0
2321673|NCT01867710|5699489|P4|Treated|Overall Study||42
2321674|NCT01867710|5699490|P3|Treated|Overall Study||39
2321675|NCT01867710|5699491|P2|Treated|Overall Study||41
2321676|NCT01867710|5699492|P1|Treated|Overall Study||41
2321677|NCT01867710|5699489|P4|STARTED|Overall Study||42
2321678|NCT01867710|5699490|P3|STARTED|Overall Study||40
2321679|NCT01867710|5699491|P2|STARTED|Overall Study||41
2321680|NCT01867710|5699492|P1|STARTED|Overall Study||41
2321681|NCT01867671|5699560|P2|NOT COMPLETED|Overall Study||28
2321682|NCT01867671|5699561|P1|NOT COMPLETED|Overall Study||29
2321683|NCT01867671|5699560|P2|COMPLETED|Overall Study||22
2321684|NCT01867671|5699561|P1|COMPLETED|Overall Study||67
2321685|NCT01867671|5699560|P2|STARTED|Overall Study||50
2321686|NCT01867671|5699561|P1|STARTED|Overall Study||96
2321687|NCT01867658|5699574|P1|NOT COMPLETED|Overall Study||9
2321688|NCT01867658|5699574|P1|COMPLETED|Overall Study||103
2321689|NCT01867658|5699574|P1|STARTED|Overall Study||112
2321690|NCT01867632|5699587|P2|NOT COMPLETED|Overall Study||0
2321691|NCT01867632|5699588|P1|NOT COMPLETED|Overall Study||0
2321692|NCT01867632|5699587|P2|COMPLETED|Overall Study||66
2321693|NCT01867632|5699588|P1|COMPLETED|Overall Study||65
2321694|NCT01867632|5699587|P2|STARTED|Overall Study||66
2321695|NCT01867632|5699588|P1|STARTED|Overall Study||65
2321696|NCT01867580|5699598|P2|NOT COMPLETED|Overall Study||24
2321697|NCT01867580|5699599|P1|NOT COMPLETED|Overall Study||28
2321698|NCT01867580|5699598|P2|COMPLETED|Overall Study||64
2321699|NCT01867580|5699599|P1|COMPLETED|Overall Study||65
2321700|NCT01867580|5699598|P2|STARTED|Overall Study||88
2321701|NCT01867580|5699599|P1|STARTED|Overall Study||93
2321702|NCT01867515|5699612|P3|NOT COMPLETED|Overall Study||11
2321703|NCT01867515|5699613|P2|NOT COMPLETED|Overall Study||1
2321704|NCT01867515|5699614|P1|NOT COMPLETED|Overall Study||0
2321705|NCT01867515|5699612|P3|COMPLETED|Overall Study||14
2321706|NCT01867515|5699613|P2|COMPLETED|Overall Study||11
2321707|NCT01867515|5699614|P1|COMPLETED|Overall Study||13
2321708|NCT01867515|5699612|P3|STARTED|Overall Study||25
2321709|NCT01867515|5699613|P2|STARTED|Overall Study||12
2321710|NCT01867515|5699614|P1|STARTED|Overall Study||13
2321711|NCT01867424|5699624|P2|NOT COMPLETED|Overall Study||1
2321712|NCT01867424|5699625|P1|NOT COMPLETED|Overall Study||2
2321713|NCT01867424|5699624|P2|COMPLETED|Overall Study||11
2321714|NCT01867424|5699625|P1|COMPLETED|Overall Study||10
2321715|NCT01867424|5699624|P2|STARTED|Overall Study||12
2321716|NCT01867424|5699625|P1|STARTED|Overall Study||12
2321717|NCT01867307|5699639|P2|NOT COMPLETED|Overall Study||3
2321718|NCT01867307|5699640|P1|NOT COMPLETED|Overall Study||3
2321719|NCT01867307|5699639|P2|COMPLETED|Overall Study||16
2321720|NCT01867307|5699640|P1|COMPLETED|Overall Study||15
2321721|NCT01867307|5699639|P2|STARTED|Overall Study|Started are the treated patients|19
2321722|NCT01867307|5699640|P1|STARTED|Overall Study|Started are the treated patients|18
2321723|NCT01867294|5699650|P4|NOT COMPLETED|Overall Study||0
2321724|NCT01867294|5699651|P3|NOT COMPLETED|Overall Study||0
2321725|NCT01867294|5699652|P2|NOT COMPLETED|Overall Study||1
2321726|NCT01867294|5699653|P1|NOT COMPLETED|Overall Study||1
2321727|NCT01867294|5699650|P4|COMPLETED|Overall Study||0
2321728|NCT01867294|5699651|P3|COMPLETED|Overall Study||0
2321729|NCT01867294|5699652|P2|COMPLETED|Overall Study||9
2321730|NCT01867294|5699653|P1|COMPLETED|Overall Study||8
2321731|NCT01867294|5699650|P4|STARTED|Overall Study||0
2321732|NCT01867294|5699651|P3|STARTED|Overall Study||0
2321733|NCT01867294|5699652|P2|STARTED|Overall Study||10
2321734|NCT01867294|5699653|P1|STARTED|Overall Study||9
2321735|NCT01867216|5699700|P7|NOT COMPLETED|Overall Study||1
2321736|NCT01867216|5699701|P6|NOT COMPLETED|Overall Study||0
2321737|NCT01867216|5699702|P5|NOT COMPLETED|Overall Study||1
2321738|NCT01867216|5699703|P4|NOT COMPLETED|Overall Study||0
2321739|NCT01867216|5699704|P3|NOT COMPLETED|Overall Study||0
2321740|NCT01867216|5699705|P2|NOT COMPLETED|Overall Study||0
2321741|NCT01867216|5699706|P1|NOT COMPLETED|Overall Study||4
2321742|NCT01867216|5699700|P7|COMPLETED|Overall Study||8
2321743|NCT01867216|5699701|P6|COMPLETED|Overall Study||8
2321744|NCT01867216|5699702|P5|COMPLETED|Overall Study||8
2321745|NCT01867216|5699703|P4|COMPLETED|Overall Study||8
2321746|NCT01867216|5699704|P3|COMPLETED|Overall Study||8
2321747|NCT01867216|5699705|P2|COMPLETED|Overall Study||8
2321748|NCT01867216|5699706|P1|COMPLETED|Overall Study||12
2321749|NCT01867216|5699700|P7|Received Study Drug|Overall Study||9
2321750|NCT01867216|5699701|P6|Received Study Drug|Overall Study||8
2321751|NCT01867216|5699702|P5|Received Study Drug|Overall Study||9
2321752|NCT01867216|5699703|P4|Received Study Drug|Overall Study||8
2321753|NCT01867216|5699704|P3|Received Study Drug|Overall Study||8
2321754|NCT01867216|5699705|P2|Received Study Drug|Overall Study||8
2321755|NCT01867216|5699706|P1|Received Study Drug|Overall Study||14
2321756|NCT01867216|5699700|P7|STARTED|Overall Study||9
2321757|NCT01867216|5699701|P6|STARTED|Overall Study||8
2321758|NCT01867216|5699702|P5|STARTED|Overall Study||9
2321759|NCT01867216|5699703|P4|STARTED|Overall Study||8
2321760|NCT01867216|5699704|P3|STARTED|Overall Study||8
2321761|NCT01867216|5699705|P2|STARTED|Overall Study||8
2321762|NCT01867216|5699706|P1|STARTED|Overall Study||16
2321763|NCT01867164|5699763|P2|NOT COMPLETED|Overall Study||0
2321764|NCT01867164|5699764|P1|NOT COMPLETED|Overall Study||0
2321765|NCT01867164|5699763|P2|COMPLETED|Overall Study||79
2321766|NCT01867164|5699764|P1|COMPLETED|Overall Study||81
2321767|NCT01867164|5699763|P2|STARTED|Overall Study||79
2321768|NCT01867164|5699764|P1|STARTED|Overall Study||81
2321769|NCT01867086|5699778|P1|NOT COMPLETED|Overall Study||1
2321770|NCT01867086|5699778|P1|COMPLETED|Overall Study|"Completed means subject had been given all manufactured doses."|0
2321771|NCT01867086|5699778|P1|STARTED|Overall Study||1
2321772|NCT01867047|5699787|P2|NOT COMPLETED|Overall Study||5
2321773|NCT01867047|5699788|P1|NOT COMPLETED|Overall Study||8
2321774|NCT01867047|5699787|P2|COMPLETED|Overall Study||23
2321775|NCT01867047|5699788|P1|COMPLETED|Overall Study||23
2321776|NCT01867047|5699787|P2|STARTED|Overall Study||28
2321777|NCT01867047|5699788|P1|STARTED|Overall Study||31
2321778|NCT01867021|5699808|P2|NOT COMPLETED|Overall Study||10
2321779|NCT01867021|5699809|P1|NOT COMPLETED|Overall Study||2
2321780|NCT01867021|5699808|P2|COMPLETED|Overall Study||1440
2321781|NCT01867021|5699809|P1|COMPLETED|Overall Study||1450
2321782|NCT01867021|5699808|P2|STARTED|Overall Study||1450
2321783|NCT01867021|5699809|P1|STARTED|Overall Study||1452
2321784|NCT01866943|5699828|P2|NOT COMPLETED|Overall Study||22
2321785|NCT01866943|5699829|P1|NOT COMPLETED|Overall Study||19
2321786|NCT01866943|5699828|P2|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0
2321787|NCT01866943|5699829|P1|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0
2321788|NCT01866943|5699828|P2|STARTED|Overall Study||22
2321789|NCT01866943|5699829|P1|STARTED|Overall Study||19
2321808|NCT01866709|5699855|P2|NOT COMPLETED|Overall Study||0
2321809|NCT01866709|5699856|P1|NOT COMPLETED|Overall Study||1
2321810|NCT01866709|5699855|P2|COMPLETED|Overall Study||17
2321811|NCT01866709|5699856|P1|COMPLETED|Overall Study||14
2321812|NCT01866709|5699855|P2|STARTED|Overall Study||17
2321813|NCT01866709|5699856|P1|STARTED|Overall Study||15
2321814|NCT01866592|5699864|P1|NOT COMPLETED|Overall Study||23
2321815|NCT01866592|5699864|P1|COMPLETED|Overall Study||58
2321816|NCT01866592|5699864|P1|STARTED|Overall Study||81
2321817|NCT01866423|5699897|P1|NOT COMPLETED|Overall Study||4
2321818|NCT01866423|5699897|P1|COMPLETED|Overall Study||0
2321819|NCT01866423|5699897|P1|STARTED|Overall Study||4
2321820|NCT01866410|5699907|P1|NOT COMPLETED|Overall Study||0
2321821|NCT01866410|5699907|P1|COMPLETED|Overall Study||37
2321822|NCT01866410|5699907|P1|STARTED|Overall Study||37
2321823|NCT01866319|5699925|P3|NOT COMPLETED|Overall Study||277
2321824|NCT01866319|5699926|P2|NOT COMPLETED|Overall Study||279
2321825|NCT01866319|5699927|P1|NOT COMPLETED|Overall Study||277
2321826|NCT01866319|5699925|P3|COMPLETED|Overall Study||0
2321827|NCT01866319|5699926|P2|COMPLETED|Overall Study||0
2321828|NCT01866319|5699927|P1|COMPLETED|Overall Study||1
2321829|NCT01866319|5699925|P3|Treated|Overall Study||277
2321830|NCT01866319|5699926|P2|Treated|Overall Study||278
2321831|NCT01866319|5699927|P1|Treated|Overall Study||256
2321832|NCT01866319|5699925|P3|STARTED|Overall Study||277
2321833|NCT01866319|5699926|P2|STARTED|Overall Study||279
2321834|NCT01866319|5699927|P1|STARTED|Overall Study||278
2321835|NCT01866306|5699948|P7|NOT COMPLETED|Overall Study||0
2321836|NCT01866306|5699949|P6|NOT COMPLETED|Overall Study||0
2321837|NCT01866306|5699950|P5|NOT COMPLETED|Overall Study||0
2321838|NCT01866306|5699951|P4|NOT COMPLETED|Overall Study||0
2321839|NCT01866306|5699952|P3|NOT COMPLETED|Overall Study||0
2321840|NCT01866306|5699953|P2|NOT COMPLETED|Overall Study||0
2321841|NCT01866306|5699954|P1|NOT COMPLETED|Overall Study||0
2321842|NCT01866306|5699948|P7|COMPLETED|Overall Study||23
2321843|NCT01866306|5699949|P6|COMPLETED|Overall Study||6
2321844|NCT01866306|5699950|P5|COMPLETED|Overall Study||6
2321845|NCT01866306|5699951|P4|COMPLETED|Overall Study||6
2321846|NCT01866306|5699952|P3|COMPLETED|Overall Study||6
2321847|NCT01866306|5699953|P2|COMPLETED|Overall Study||6
2321848|NCT01866306|5699954|P1|COMPLETED|Overall Study||6
2321849|NCT01866306|5699948|P7|STARTED|Overall Study||23
2321850|NCT01866306|5699949|P6|STARTED|Overall Study||6
2321851|NCT01866306|5699950|P5|STARTED|Overall Study||6
2321852|NCT01866306|5699951|P4|STARTED|Overall Study||6
2321853|NCT01866306|5699952|P3|STARTED|Overall Study||6
2321854|NCT01866306|5699953|P2|STARTED|Overall Study||6
2321855|NCT01866306|5699954|P1|STARTED|Overall Study||6
2321856|NCT01866293|5700026|P1|NOT COMPLETED|Overall Study||2
2321857|NCT01866293|5700026|P1|COMPLETED|Overall Study||9
2321858|NCT01866293|5700026|P1|STARTED|Overall Study||11
2321859|NCT01866163|5700036|P2|NOT COMPLETED|Overall Study||4
2321860|NCT01866163|5700037|P1|NOT COMPLETED|Overall Study||10
2321861|NCT01866163|5700036|P2|COMPLETED|Overall Study||99
2321862|NCT01866163|5700037|P1|COMPLETED|Overall Study||313
2321863|NCT01866163|5700036|P2|STARTED|Overall Study||103
2321864|NCT01866163|5700037|P1|STARTED|Overall Study||323
2321865|NCT01866150|5700047|P1|NOT COMPLETED|Overall Study||0
2321866|NCT01866150|5700047|P1|COMPLETED|Overall Study||450
2321867|NCT01866150|5700047|P1|STARTED|Overall Study||450
2321868|NCT01865812|5700068|P1|NOT COMPLETED|Overall Study||2
2321869|NCT01865812|5700068|P1|COMPLETED|Overall Study||24
2321870|NCT01865812|5700068|P1|STARTED|Overall Study||26
2321871|NCT01865747|5700076|P2|NOT COMPLETED|Primary Intent to Treat (PITT)||152
2321872|NCT01865747|5700077|P1|NOT COMPLETED|Primary Intent to Treat (PITT)||131
2321873|NCT01865747|5700076|P2|COMPLETED|Primary Intent to Treat (PITT)||36
2321874|NCT01865747|5700077|P1|COMPLETED|Primary Intent to Treat (PITT)||56
2321875|NCT01865747|5700076|P2|STARTED|Primary Intent to Treat (PITT)|Three subjects in the everolimus arm were randomized but not treated.|188
2321876|NCT01865747|5700077|P1|STARTED|Primary Intent to Treat (PITT)||187
2321877|NCT01865747|5700076|P2|NOT COMPLETED|Overall Study (ITT)||255
2321878|NCT01865747|5700077|P1|NOT COMPLETED|Overall Study (ITT)||198
2321879|NCT01865747|5700076|P2|COMPLETED|Overall Study (ITT)|Five subjects were randomized but not treated|73
2321880|NCT01865747|5700077|P1|COMPLETED|Overall Study (ITT)|One subject randomized to everolimus arm received cabozantinib discontd due to clin. deterioration|132
2321881|NCT01865747|5700076|P2|STARTED|Overall Study (ITT)||328
2321882|NCT01865747|5700077|P1|STARTED|Overall Study (ITT)||330
2321883|NCT01865708|5700087|P1|NOT COMPLETED|Overall Study||0
2321884|NCT01865708|5700087|P1|COMPLETED|Overall Study||10
2321885|NCT01865708|5700087|P1|STARTED|Overall Study||10
2321886|NCT01865552|5700098|P6|NOT COMPLETED|Period 2||0
2321887|NCT01865552|5700099|P5|NOT COMPLETED|Period 2||0
2321888|NCT01865552|5700100|P4|NOT COMPLETED|Period 2||0
2321889|NCT01865552|5700101|P3|NOT COMPLETED|Period 2||0
2321890|NCT01865552|5700102|P2|NOT COMPLETED|Period 2||0
2321891|NCT01865552|5700103|P1|NOT COMPLETED|Period 2||0
2321892|NCT01865552|5700098|P6|COMPLETED|Period 2||22
2321893|NCT01865552|5700099|P5|COMPLETED|Period 2||20
2321894|NCT01865552|5700100|P4|COMPLETED|Period 2||22
2321895|NCT01865552|5700101|P3|COMPLETED|Period 2||23
2321896|NCT01865552|5700102|P2|COMPLETED|Period 2||23
2321897|NCT01865552|5700103|P1|COMPLETED|Period 2||22
2321898|NCT01865552|5700098|P6|STARTED|Period 2||22
2321899|NCT01865552|5700099|P5|STARTED|Period 2||20
2321900|NCT01865552|5700100|P4|STARTED|Period 2||22
2321901|NCT01865552|5700101|P3|STARTED|Period 2||23
2321902|NCT01865552|5700102|P2|STARTED|Period 2||23
2321903|NCT01865552|5700103|P1|STARTED|Period 2||22
2321904|NCT01865552|5700098|P6|NOT COMPLETED|Period 1||1
2321905|NCT01865552|5700099|P5|NOT COMPLETED|Period 1||3
2321906|NCT01865552|5700100|P4|NOT COMPLETED|Period 1||1
2321907|NCT01865552|5700101|P3|NOT COMPLETED|Period 1||0
2321908|NCT01865552|5700102|P2|NOT COMPLETED|Period 1||0
2321909|NCT01865552|5700103|P1|NOT COMPLETED|Period 1||1
2321910|NCT01865552|5700098|P6|COMPLETED|Period 1||22
2321911|NCT01865552|5700099|P5|COMPLETED|Period 1||20
2321912|NCT01865552|5700100|P4|COMPLETED|Period 1||22
2321913|NCT01865552|5700101|P3|COMPLETED|Period 1||23
2321914|NCT01865552|5700102|P2|COMPLETED|Period 1||23
2321915|NCT01865552|5700103|P1|COMPLETED|Period 1||22
2321916|NCT01865552|5700098|P6|Discontinued From Period 1|Period 1||1
2321917|NCT01865552|5700099|P5|Discontinued From Period 1|Period 1||3
2321918|NCT01865552|5700100|P4|Discontinued From Period 1|Period 1||1
2321919|NCT01865552|5700101|P3|Discontinued From Period 1|Period 1||0
2321920|NCT01865552|5700102|P2|Discontinued From Period 1|Period 1||0
2321921|NCT01865552|5700103|P1|Discontinued From Period 1|Period 1||1
2321922|NCT01865552|5700098|P6|STARTED|Period 1||23
2321923|NCT01865552|5700099|P5|STARTED|Period 1||23
2321924|NCT01865552|5700100|P4|STARTED|Period 1||23
2321925|NCT01865552|5700101|P3|STARTED|Period 1||23
2321926|NCT01865552|5700102|P2|STARTED|Period 1||23
2321927|NCT01865552|5700103|P1|STARTED|Period 1||23
2321928|NCT01865487|5700141|P10|NOT COMPLETED|Overall Study||0
2321929|NCT01865487|5700142|P9|NOT COMPLETED|Overall Study||0
2321930|NCT01865487|5700143|P8|NOT COMPLETED|Overall Study||0
2321931|NCT01865487|5700144|P7|NOT COMPLETED|Overall Study||1
2321932|NCT01865487|5700145|P6|NOT COMPLETED|Overall Study||0
2321933|NCT01865487|5700146|P5|NOT COMPLETED|Overall Study||1
2321934|NCT01865487|5700147|P4|NOT COMPLETED|Overall Study||1
2321935|NCT01865487|5700148|P3|NOT COMPLETED|Overall Study||0
2321936|NCT01865487|5700149|P2|NOT COMPLETED|Overall Study||0
2321937|NCT01865487|5700150|P1|NOT COMPLETED|Overall Study||0
2321938|NCT01865487|5700141|P10|COMPLETED|Overall Study||4
2321939|NCT01865487|5700142|P9|COMPLETED|Overall Study||12
2321940|NCT01865487|5700143|P8|COMPLETED|Overall Study||4
2321941|NCT01865487|5700144|P7|COMPLETED|Overall Study||11
2321942|NCT01865487|5700145|P6|COMPLETED|Overall Study||4
2321943|NCT01865487|5700146|P5|COMPLETED|Overall Study||11
2321944|NCT01865487|5700147|P4|COMPLETED|Overall Study||4
2321945|NCT01865487|5700148|P3|COMPLETED|Overall Study||15
2321946|NCT01865487|5700149|P2|COMPLETED|Overall Study||15
2321947|NCT01865487|5700150|P1|COMPLETED|Overall Study||15
2321948|NCT01865487|5700141|P10|STARTED|Overall Study||4
2321949|NCT01865487|5700142|P9|STARTED|Overall Study||12
2321950|NCT01865487|5700143|P8|STARTED|Overall Study||4
2321951|NCT01865487|5700144|P7|STARTED|Overall Study||12
2321952|NCT01865487|5700145|P6|STARTED|Overall Study||4
2321953|NCT01865487|5700146|P5|STARTED|Overall Study||12
2321954|NCT01865487|5700147|P4|STARTED|Overall Study||5
2321955|NCT01865487|5700148|P3|STARTED|Overall Study||15
2321956|NCT01865487|5700149|P2|STARTED|Overall Study||15
2321957|NCT01865487|5700150|P1|STARTED|Overall Study||15
2321958|NCT01865448|5700189|P2|NOT COMPLETED|Overall Study||3
2321959|NCT01865448|5700190|P1|NOT COMPLETED|Overall Study||2
2321960|NCT01865448|5700189|P2|COMPLETED|Overall Study||14
2321961|NCT01865448|5700190|P1|COMPLETED|Overall Study||15
2321962|NCT01865448|5700189|P2|STARTED|Overall Study||17
2321963|NCT01865448|5700190|P1|STARTED|Overall Study||17
2321964|NCT01865084|5700301|P3|NOT COMPLETED|Open Label Extension (OLE) Period||7
2321965|NCT01865084|5700302|P2|NOT COMPLETED|Open Label Extension (OLE) Period||11
2321966|NCT01865084|5700303|P1|NOT COMPLETED|Open Label Extension (OLE) Period||0
2321967|NCT01865084|5700301|P3|COMPLETED|Open Label Extension (OLE) Period||158
2321968|NCT01865084|5700302|P2|COMPLETED|Open Label Extension (OLE) Period||139
2321969|NCT01865084|5700303|P1|COMPLETED|Open Label Extension (OLE) Period||0
2321970|NCT01865084|5700301|P3|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|165
2321971|NCT01865084|5700302|P2|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|150
2321972|NCT01865084|5700303|P1|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|0
2321973|NCT01865084|5700301|P3|NOT COMPLETED|Double Blind Period (DB)||6
2321974|NCT01865084|5700302|P2|NOT COMPLETED|Double Blind Period (DB)||4
2321975|NCT01865084|5700303|P1|NOT COMPLETED|Double Blind Period (DB)||5
2321976|NCT01865084|5700301|P3|COMPLETED|Double Blind Period (DB)||107
2321977|NCT01865084|5700302|P2|COMPLETED|Double Blind Period (DB)|One participant stopped therapy during the DB period but remained in the study for follow-up.|98
2321978|NCT01865084|5700303|P1|COMPLETED|Double Blind Period (DB)||111
2321979|NCT01865084|5700301|P3|Received at Least One Dose of Study Drug|Double Blind Period (DB)||112
2321980|NCT01865084|5700302|P2|Received at Least One Dose of Study Drug|Double Blind Period (DB)||102
2321981|NCT01865084|5700303|P1|Received at Least One Dose of Study Drug|Double Blind Period (DB)||116
2321982|NCT01865084|5700301|P3|STARTED|Double Blind Period (DB)||113
2321983|NCT01865084|5700302|P2|STARTED|Double Blind Period (DB)||102
2321984|NCT01865084|5700303|P1|STARTED|Double Blind Period (DB)||116
2321985|NCT01864538|5700329|P1|NOT COMPLETED|Overall Study||11
2321986|NCT01864538|5700329|P1|COMPLETED|Overall Study||0
2321987|NCT01864538|5700329|P1|STARTED|Overall Study||11
2321988|NCT01864525|5700335|P2|NOT COMPLETED|Overall Study||0
2321989|NCT01864525|5700336|P1|NOT COMPLETED|Overall Study||1
2321990|NCT01864525|5700335|P2|COMPLETED|Overall Study||7
2321991|NCT01864525|5700336|P1|COMPLETED|Overall Study||9
2321992|NCT01864525|5700335|P2|STARTED|Overall Study||7
2321993|NCT01864525|5700336|P1|STARTED|Overall Study||10
2321994|NCT01864434|5700346|P2|NOT COMPLETED|Overall Study||0
2321995|NCT01864434|5700347|P1|NOT COMPLETED|Overall Study||0
2321996|NCT01864434|5700346|P2|COMPLETED|Overall Study||25
2321997|NCT01864434|5700347|P1|COMPLETED|Overall Study||25
2321998|NCT01864434|5700346|P2|STARTED|Overall Study||25
2321999|NCT01864434|5700347|P1|STARTED|Overall Study||25
2322000|NCT01864200|5700359|P2|NOT COMPLETED|Overall Study||3
2322001|NCT01864200|5700360|P1|NOT COMPLETED|Overall Study||2
2322002|NCT01864200|5700359|P2|COMPLETED|Overall Study||26
2322003|NCT01864200|5700360|P1|COMPLETED|Overall Study||43
2322004|NCT01864200|5700359|P2|STARTED|Overall Study||29
2322005|NCT01864200|5700360|P1|STARTED|Overall Study||45
2322006|NCT01864174|5700368|P2|NOT COMPLETED|Off Treatment Follow-Up||0
2322007|NCT01864174|5700369|P1|NOT COMPLETED|Off Treatment Follow-Up||3
2322008|NCT01864174|5700368|P2|COMPLETED|Off Treatment Follow-Up||1
2322009|NCT01864174|5700369|P1|COMPLETED|Off Treatment Follow-Up||6
2322010|NCT01864174|5700368|P2|STARTED|Off Treatment Follow-Up||1
2322011|NCT01864174|5700369|P1|STARTED|Off Treatment Follow-Up||9
2322012|NCT01864174|5700368|P2|NOT COMPLETED|Double Blind - Compliant Randomized||26
2322013|NCT01864174|5700369|P1|NOT COMPLETED|Double Blind - Compliant Randomized||23
2322014|NCT01864174|5700368|P2|COMPLETED|Double Blind - Compliant Randomized||245
2322015|NCT01864174|5700369|P1|COMPLETED|Double Blind - Compliant Randomized||245
2322016|NCT01864174|5700368|P2|STARTED|Double Blind - Compliant Randomized||271
2322017|NCT01864174|5700369|P1|STARTED|Double Blind - Compliant Randomized||268
2322018|NCT01864174|5700368|P2|NOT COMPLETED|Double Blind Treatment - All Treated||14
2322019|NCT01864174|5700369|P1|NOT COMPLETED|Double Blind Treatment - All Treated||15
2322020|NCT01864174|5700368|P2|COMPLETED|Double Blind Treatment - All Treated||271
2322021|NCT01864174|5700369|P1|COMPLETED|Double Blind Treatment - All Treated||268
2322022|NCT01864174|5700368|P2|STARTED|Double Blind Treatment - All Treated||285
2322023|NCT01864174|5700369|P1|STARTED|Double Blind Treatment - All Treated||283
2322024|NCT01864148|5700388|P5|NOT COMPLETED|Overall Study||23
2322025|NCT01864148|5700389|P4|NOT COMPLETED|Overall Study||26
2322026|NCT01864148|5700390|P3|NOT COMPLETED|Overall Study||11
2322027|NCT01864148|5700391|P2|NOT COMPLETED|Overall Study||5
2322028|NCT01864148|5700392|P1|NOT COMPLETED|Overall Study||20
2322029|NCT01864148|5700388|P5|COMPLETED|Overall Study||69
2322030|NCT01864148|5700389|P4|COMPLETED|Overall Study||68
2322031|NCT01864148|5700390|P3|COMPLETED|Overall Study||84
2322032|NCT01864148|5700391|P2|COMPLETED|Overall Study||40
2322033|NCT01864148|5700392|P1|COMPLETED|Overall Study||73
2322034|NCT01864148|5700388|P5|Randomized and Dosed|Overall Study||92
2322035|NCT01864148|5700389|P4|Randomized and Dosed|Overall Study||93
2322036|NCT01864148|5700390|P3|Randomized and Dosed|Overall Study||95
2322037|NCT01864148|5700391|P2|Randomized and Dosed|Overall Study||45
2322038|NCT01864148|5700392|P1|Randomized and Dosed|Overall Study||93
2322039|NCT01864148|5700388|P5|STARTED|Overall Study||92
2322040|NCT01864148|5700389|P4|STARTED|Overall Study||94
2322041|NCT01864148|5700390|P3|STARTED|Overall Study||95
2322042|NCT01864148|5700391|P2|STARTED|Overall Study||45
2322043|NCT01864148|5700392|P1|STARTED|Overall Study||93
2322044|NCT01864005|5700421|P2|NOT COMPLETED|Overall Study||6
2322045|NCT01864005|5700422|P1|NOT COMPLETED|Overall Study||3
2322046|NCT01864005|5700421|P2|COMPLETED|Overall Study||25
2322047|NCT01864005|5700422|P1|COMPLETED|Overall Study||26
2322048|NCT01864005|5700421|P2|STARTED|Overall Study||31
2322049|NCT01864005|5700422|P1|STARTED|Overall Study||29
2322050|NCT01863953|5700439|P3|NOT COMPLETED|Overall Study||1
2322051|NCT01863953|5700440|P2|NOT COMPLETED|Overall Study||0
2322052|NCT01863953|5700441|P1|NOT COMPLETED|Overall Study||0
2322053|NCT01863953|5700439|P3|COMPLETED|Overall Study||37
2322054|NCT01863953|5700440|P2|COMPLETED|Overall Study||36
2322055|NCT01863953|5700441|P1|COMPLETED|Overall Study||38
2322056|NCT01863953|5700439|P3|STARTED|Overall Study||38
2322057|NCT01863953|5700440|P2|STARTED|Overall Study||36
2322058|NCT01863953|5700441|P1|STARTED|Overall Study||38
2322059|NCT01863771|5700455|P4|NOT COMPLETED|Maintenance Phase||43
2322060|NCT01863771|5700456|P3|NOT COMPLETED|Maintenance Phase||12
2322061|NCT01863771|5700457|P2|NOT COMPLETED|Maintenance Phase||5
2322062|NCT01863771|5700458|P1|NOT COMPLETED|Maintenance Phase||0
2322063|NCT01863771|5700455|P4|COMPLETED|Maintenance Phase||17
2322064|NCT01863771|5700456|P3|COMPLETED|Maintenance Phase||19
2322065|NCT01863771|5700457|P2|COMPLETED|Maintenance Phase||27
2322066|NCT01863771|5700458|P1|COMPLETED|Maintenance Phase||0
2322067|NCT01863771|5700455|P4|STARTED|Maintenance Phase||60
2322068|NCT01863771|5700456|P3|STARTED|Maintenance Phase||31
2322069|NCT01863771|5700457|P2|STARTED|Maintenance Phase||32
2322070|NCT01863771|5700458|P1|STARTED|Maintenance Phase||0
2322071|NCT01863771|5700455|P4|NOT COMPLETED|Induction Phase||0
2322072|NCT01863771|5700456|P3|NOT COMPLETED|Induction Phase||0
2322073|NCT01863771|5700457|P2|NOT COMPLETED|Induction Phase||0
2322074|NCT01863771|5700458|P1|NOT COMPLETED|Induction Phase||21
2322075|NCT01863771|5700455|P4|COMPLETED|Induction Phase||0
2322076|NCT01863771|5700456|P3|COMPLETED|Induction Phase||0
2322077|NCT01863771|5700457|P2|COMPLETED|Induction Phase||0
2322078|NCT01863771|5700458|P1|COMPLETED|Induction Phase|Same participants who completed the induction phase participated in the maintenance phase.|123
2322079|NCT01863771|5700455|P4|STARTED|Induction Phase||0
2322080|NCT01863771|5700456|P3|STARTED|Induction Phase||0
2322081|NCT01863771|5700457|P2|STARTED|Induction Phase||0
2322082|NCT01863771|5700458|P1|STARTED|Induction Phase||144
2322083|NCT01863758|5700470|P1|NOT COMPLETED|Prophylactic Treatment-Phase II||2
2322084|NCT01863758|5700470|P1|COMPLETED|Prophylactic Treatment-Phase II||64
2322085|NCT01863758|5700470|P1|STARTED|Prophylactic Treatment-Phase II||66
2322086|NCT01863758|5700470|P1|NOT COMPLETED|Prophylactic Treatment-Phase I||0
2322087|NCT01863758|5700470|P1|COMPLETED|Prophylactic Treatment-Phase I||66
2322088|NCT01863758|5700470|P1|STARTED|Prophylactic Treatment-Phase I||66
2322089|NCT01863758|5700470|P1|NOT COMPLETED|Pharmacokinetic Assessment||0
2322090|NCT01863758|5700470|P1|COMPLETED|Pharmacokinetic Assessment||66
2322091|NCT01863758|5700470|P1|STARTED|Pharmacokinetic Assessment||66
2322092|NCT01863732|5700482|P4|NOT COMPLETED|Overall Study||8
2322093|NCT01863732|5700483|P3|NOT COMPLETED|Overall Study||11
2322094|NCT01863732|5700484|P2|NOT COMPLETED|Overall Study||12
2322095|NCT01863732|5700485|P1|NOT COMPLETED|Overall Study||13
2322096|NCT01863732|5700482|P4|COMPLETED|Overall Study||33
2322097|NCT01863732|5700483|P3|COMPLETED|Overall Study||35
2322098|NCT01863732|5700484|P2|COMPLETED|Overall Study||75
2322099|NCT01863732|5700485|P1|COMPLETED|Overall Study||87
2322100|NCT01863732|5700482|P4|STARTED|Overall Study||41
2322101|NCT01863732|5700483|P3|STARTED|Overall Study||46
2322102|NCT01863732|5700484|P2|STARTED|Overall Study||87
2322103|NCT01863732|5700485|P1|STARTED|Overall Study||100
2322104|NCT01863680|5700498|P1|NOT COMPLETED|Overall Study||57
2322105|NCT01863680|5700498|P1|COMPLETED|Overall Study||121
2322106|NCT01863680|5700498|P1|Subjects Who Have Undergone IVF/ET|Overall Study||123
2322107|NCT01863680|5700498|P1|Subjects Received Study Drug|Overall Study||149
2322108|NCT01863680|5700498|P1|Subjects Received hCG Injection|Overall Study||162
2322109|NCT01863680|5700498|P1|Subjects Started COS Treatment|Overall Study||169
2322110|NCT01863680|5700498|P1|STARTED|Overall Study||178
2322111|NCT01863667|5700506|P2|NOT COMPLETED|Overall Study||32
2322112|NCT01863667|5700507|P1|NOT COMPLETED|Overall Study||33
2322113|NCT01863667|5700506|P2|COMPLETED|Overall Study||0
2322114|NCT01863667|5700507|P1|COMPLETED|Overall Study||0
2322115|NCT01863667|5700506|P2|STARTED|Overall Study||32
2322116|NCT01863667|5700507|P1|STARTED|Overall Study||33
2322117|NCT01863563|5700527|P1|NOT COMPLETED|Overall Study||0
2322118|NCT01863563|5700527|P1|COMPLETED|Overall Study||100
2322119|NCT01863563|5700527|P1|STARTED|Overall Study||100
2322120|NCT01863433|5700531|P1|NOT COMPLETED|Overall Study||1
2322121|NCT01863433|5700531|P1|COMPLETED|Overall Study|1 subject was withdrawn from the study due to evidence of substance abuse.|119
2322122|NCT01863433|5700531|P1|STARTED|Overall Study||120
2322123|NCT01863368|5700541|P2|NOT COMPLETED|Phase II, Day 35 to Day 90||0
2322124|NCT01863368|5700542|P1|NOT COMPLETED|Phase II, Day 35 to Day 90||2
2322125|NCT01863368|5700541|P2|COMPLETED|Phase II, Day 35 to Day 90||41
2322126|NCT01863368|5700542|P1|COMPLETED|Phase II, Day 35 to Day 90||41
2322127|NCT01863368|5700541|P2|STARTED|Phase II, Day 35 to Day 90||41
2322128|NCT01863368|5700542|P1|STARTED|Phase II, Day 35 to Day 90||43
2322129|NCT01863368|5700541|P2|NOT COMPLETED|Phase I, Day 0 to Day 35||7
2322130|NCT01863368|5700542|P1|NOT COMPLETED|Phase I, Day 0 to Day 35||3
2322131|NCT01863368|5700541|P2|COMPLETED|Phase I, Day 0 to Day 35||41
2322132|NCT01863368|5700542|P1|COMPLETED|Phase I, Day 0 to Day 35||43
2322133|NCT01863368|5700541|P2|Treated|Phase I, Day 0 to Day 35||47
2322134|NCT01863368|5700542|P1|Treated|Phase I, Day 0 to Day 35||46
2322135|NCT01863368|5700541|P2|STARTED|Phase I, Day 0 to Day 35||48
2322136|NCT01863368|5700542|P1|STARTED|Phase I, Day 0 to Day 35||46
2322137|NCT01863134|5700557|P2|NOT COMPLETED|Overall Study||0
2322138|NCT01863134|5700558|P1|NOT COMPLETED|Overall Study||0
2322139|NCT01863134|5700557|P2|COMPLETED|Overall Study||68
2322140|NCT01863134|5700558|P1|COMPLETED|Overall Study||72
2322141|NCT01863134|5700557|P2|STARTED|Overall Study||68
2322142|NCT01863134|5700558|P1|STARTED|Overall Study||72
2322143|NCT01863030|5700564|P1|NOT COMPLETED|Follow up||18
2322144|NCT01863030|5700564|P1|COMPLETED|Follow up||13
2322145|NCT01863030|5700564|P1|24 Months|Follow up||13
2322146|NCT01863030|5700564|P1|12 Months|Follow up||26
2322147|NCT01863030|5700564|P1|6 Months|Follow up||29
2322148|NCT01863030|5700564|P1|3 Months|Follow up||28
2322149|NCT01863030|5700564|P1|2 Weeks|Follow up||31
2322150|NCT01863030|5700564|P1|STARTED|Follow up||31
2322151|NCT01863030|5700564|P1|NOT COMPLETED|Baseline||0
2322152|NCT01863030|5700564|P1|COMPLETED|Baseline||31
2322153|NCT01863030|5700564|P1|STARTED|Baseline||31
2322154|NCT01863017|5700582|P2|NOT COMPLETED|Overall Study||0
2322155|NCT01863017|5700583|P1|NOT COMPLETED|Overall Study||0
2322156|NCT01863017|5700582|P2|COMPLETED|Overall Study||19
2322157|NCT01863017|5700583|P1|COMPLETED|Overall Study||12
2322158|NCT01863017|5700582|P2|Participants With PWS|Overall Study||7
2322159|NCT01863017|5700583|P1|Participants With PWS|Overall Study||3
2322160|NCT01863017|5700582|P2|Obese Participants|Overall Study||7
2322161|NCT01863017|5700583|P1|Obese Participants|Overall Study||4
2322162|NCT01863017|5700582|P2|Normal Weight Participants|Overall Study||5
2322163|NCT01863017|5700583|P1|Normal Weight Participants|Overall Study||5
2322164|NCT01863017|5700582|P2|STARTED|Overall Study||19
2322165|NCT01863017|5700583|P1|STARTED|Overall Study||12
2322166|NCT01862991|5700596|P3|NOT COMPLETED|Overall Study||1
2322167|NCT01862991|5700597|P2|NOT COMPLETED|Overall Study||1
2322168|NCT01862991|5700598|P1|NOT COMPLETED|Overall Study||3
2322169|NCT01862991|5700596|P3|COMPLETED|Overall Study||27
2322170|NCT01862991|5700597|P2|COMPLETED|Overall Study||27
2322171|NCT01862991|5700598|P1|COMPLETED|Overall Study||21
2322172|NCT01862991|5700596|P3|STARTED|Overall Study||28
2322173|NCT01862991|5700597|P2|STARTED|Overall Study||28
2322174|NCT01862991|5700598|P1|STARTED|Overall Study||24
2322175|NCT01862874|5700611|P2|NOT COMPLETED|Overall Study||77
2322176|NCT01862874|5700612|P1|NOT COMPLETED|Overall Study||79
2322177|NCT01862874|5700611|P2|COMPLETED|Overall Study||485
2322178|NCT01862874|5700612|P1|COMPLETED|Overall Study||483
2322179|NCT01862874|5700611|P2|Vaccination 3|Overall Study||532
2322180|NCT01862874|5700612|P1|Vaccination 3|Overall Study||530
2322181|NCT01862874|5700611|P2|Vaccination 2|Overall Study||542
2322182|NCT01862874|5700612|P1|Vaccination 2|Overall Study||539
2322183|NCT01862874|5700611|P2|Vaccination 1|Overall Study||562
2322184|NCT01862874|5700612|P1|Vaccination 1|Overall Study||561
2322185|NCT01862874|5700611|P2|STARTED|Overall Study|Randomized participants|562
2322186|NCT01862874|5700612|P1|STARTED|Overall Study|Randomized participants|562
2322187|NCT01862796|5700631|P3|NOT COMPLETED|Overall Study||1
2322188|NCT01862796|5700632|P2|NOT COMPLETED|Overall Study||0
2322189|NCT01862796|5700633|P1|NOT COMPLETED|Overall Study||0
2322190|NCT01862796|5700631|P3|COMPLETED|Overall Study||23
2322191|NCT01862796|5700632|P2|COMPLETED|Overall Study||18
2322192|NCT01862796|5700633|P1|COMPLETED|Overall Study||19
2322193|NCT01862796|5700631|P3|STARTED|Overall Study||24
2322194|NCT01862796|5700632|P2|STARTED|Overall Study||18
2322195|NCT01862796|5700633|P1|STARTED|Overall Study||19
2322196|NCT01862484|5700646|P2|NOT COMPLETED|Overall Study||8
2322197|NCT01862484|5700647|P1|NOT COMPLETED|Overall Study||2
2322198|NCT01862484|5700646|P2|COMPLETED|Overall Study||6
2322199|NCT01862484|5700647|P1|COMPLETED|Overall Study||13
2322200|NCT01862484|5700646|P2|STARTED|Overall Study||14
2322201|NCT01862484|5700647|P1|STARTED|Overall Study||15
2322202|NCT01862419|5700655|P2|NOT COMPLETED|Overall Study||0
2322203|NCT01862419|5700656|P1|NOT COMPLETED|Overall Study||0
2322204|NCT01862419|5700655|P2|COMPLETED|Overall Study||1192
2322205|NCT01862419|5700656|P1|COMPLETED|Overall Study||1201
2322206|NCT01862419|5700655|P2|STARTED|Overall Study||1192
2322207|NCT01862419|5700656|P1|STARTED|Overall Study||1201
2322208|NCT01862250|5700666|P1|NOT COMPLETED|Overall Study||4
2322209|NCT01862250|5700666|P1|COMPLETED|Overall Study||8
2322210|NCT01862250|5700666|P1|STARTED|Overall Study||12
2322211|NCT01862159|5700673|P1|NOT COMPLETED|Overall Study||0
2322212|NCT01862159|5700673|P1|COMPLETED|Overall Study||25038
2322213|NCT01862159|5700673|P1|STARTED|Overall Study||25038
2322214|NCT01862133|5700680|P2|NOT COMPLETED|Overall Study||0
2322215|NCT01862133|5700681|P1|NOT COMPLETED|Overall Study||0
2322216|NCT01862133|5700680|P2|COMPLETED|Overall Study||31
2322217|NCT01862133|5700681|P1|COMPLETED|Overall Study|All 105 patients recorded preferences; 92 (88%) returned to the study clinic during the 6 mo. study|105
2322218|NCT01862133|5700680|P2|Returned During 6 mo Study|Overall Study||31
2322219|NCT01862133|5700681|P1|Returned During 6 mo Study|Overall Study||92
2322220|NCT01862133|5700680|P2|STARTED|Overall Study||31
2322221|NCT01862133|5700681|P1|STARTED|Overall Study||105
2322222|NCT01862029|5700687|P1|NOT COMPLETED|Overall Study||1
2322223|NCT01862029|5700687|P1|COMPLETED|Overall Study||8
2322224|NCT01862029|5700687|P1|STARTED|Overall Study||9
2322225|NCT01861925|5700695|P3|NOT COMPLETED|Overall Study||0
2322226|NCT01861925|5700696|P2|NOT COMPLETED|Overall Study||0
2322227|NCT01861925|5700697|P1|NOT COMPLETED|Overall Study||0
2322228|NCT01861925|5700695|P3|COMPLETED|Overall Study||8
2322229|NCT01861925|5700696|P2|COMPLETED|Overall Study||8
2322230|NCT01861925|5700697|P1|COMPLETED|Overall Study||34
2322231|NCT01861925|5700695|P3|STARTED|Overall Study||8
2322232|NCT01861925|5700696|P2|STARTED|Overall Study||8
2322233|NCT01861925|5700697|P1|STARTED|Overall Study||34
2322234|NCT01861756|5700720|P2|NOT COMPLETED|Overall Study||18
2322235|NCT01861756|5700721|P1|NOT COMPLETED|Overall Study||13
2322236|NCT01861756|5700720|P2|COMPLETED|Overall Study||85
2322237|NCT01861756|5700721|P1|COMPLETED|Overall Study||88
2322238|NCT01861756|5700720|P2|STARTED|Overall Study||103
2322239|NCT01861756|5700721|P1|STARTED|Overall Study||101
2322240|NCT01861704|5700729|P2|NOT COMPLETED|Overall Study||3
2322241|NCT01861704|5700730|P1|NOT COMPLETED|Overall Study||3
2322242|NCT01861704|5700729|P2|COMPLETED|Overall Study||104
2322243|NCT01861704|5700730|P1|COMPLETED|Overall Study||67
2322244|NCT01861704|5700729|P2|STARTED|Overall Study||107
2322245|NCT01861704|5700730|P1|STARTED|Overall Study||70
2322246|NCT01861665|5700738|P2|NOT COMPLETED|Overall Study||0
2322247|NCT01861665|5700739|P1|NOT COMPLETED|Overall Study||0
2322248|NCT01861665|5700738|P2|COMPLETED|Overall Study||17
2322249|NCT01861665|5700739|P1|COMPLETED|Overall Study||10
2322250|NCT01861665|5700738|P2|STARTED|Overall Study||17
2322251|NCT01861665|5700739|P1|STARTED|Overall Study||10
2322252|NCT01861587|5700747|P2|NOT COMPLETED|Overall Study||0
2322253|NCT01861587|5700748|P1|NOT COMPLETED|Overall Study||0
2322254|NCT01861587|5700747|P2|COMPLETED|Overall Study||13
2322255|NCT01861587|5700748|P1|COMPLETED|Overall Study||14
2322256|NCT01861587|5700747|P2|STARTED|Overall Study||13
2322257|NCT01861587|5700748|P1|STARTED|Overall Study||14
2322258|NCT01861574|5700764|P4|NOT COMPLETED|Overall Study||0
2322259|NCT01861574|5700765|P3|NOT COMPLETED|Overall Study||0
2322260|NCT01861574|5700766|P2|NOT COMPLETED|Overall Study||0
2322261|NCT01861574|5700767|P1|NOT COMPLETED|Overall Study||0
2322262|NCT01861574|5700764|P4|COMPLETED|Overall Study||28
2322263|NCT01861574|5700765|P3|COMPLETED|Overall Study||27
2322264|NCT01861574|5700766|P2|COMPLETED|Overall Study||25
2322265|NCT01861574|5700767|P1|COMPLETED|Overall Study||28
2322266|NCT01861574|5700764|P4|STARTED|Overall Study||28
2322267|NCT01861574|5700765|P3|STARTED|Overall Study||27
2322268|NCT01861574|5700766|P2|STARTED|Overall Study||25
2322269|NCT01861574|5700767|P1|STARTED|Overall Study||28
2322270|NCT01861522|5700790|P2|NOT COMPLETED|Overall Study||0
2322271|NCT01861522|5700791|P1|NOT COMPLETED|Overall Study||3
2322272|NCT01861522|5700790|P2|COMPLETED|Overall Study||232
2322273|NCT01861522|5700791|P1|COMPLETED|Overall Study||237
2322274|NCT01861522|5700790|P2|STARTED|Overall Study|One subject who did not receive any study drug was excluded from the FAS and the Safety Analysis Set|232
2322275|NCT01861522|5700791|P1|STARTED|Overall Study||240
2322276|NCT01861457|5700799|P2|NOT COMPLETED|Overall Study||0
2322277|NCT01861457|5700800|P1|NOT COMPLETED|Overall Study||0
2322278|NCT01861457|5700799|P2|COMPLETED|Overall Study||19
2322279|NCT01861457|5700800|P1|COMPLETED|Overall Study||20
2322280|NCT01861457|5700799|P2|STARTED|Overall Study||19
2322281|NCT01861457|5700800|P1|STARTED|Overall Study||20
2322282|NCT01861301|5700808|P1|NOT COMPLETED|Overall Study||0
2322283|NCT01861301|5700808|P1|COMPLETED|Overall Study||18
2322284|NCT01861301|5700808|P1|STARTED|Overall Study||18
2322285|NCT01860989|5700815|P1|NOT COMPLETED|Overall Study||5
2322286|NCT01860989|5700815|P1|COMPLETED|Overall Study||6
2322287|NCT01860989|5700815|P1|STARTED|Overall Study||11
2322288|NCT01860976|5700821|P2|NOT COMPLETED|Long Term Extension||107
2322289|NCT01860976|5700822|P1|NOT COMPLETED|Long Term Extension||113
2322290|NCT01860976|5700821|P2|COMPLETED|Long Term Extension||8
2322291|NCT01860976|5700822|P1|COMPLETED|Long Term Extension||0
2322292|NCT01860976|5700821|P2|STARTED|Long Term Extension||115
2322293|NCT01860976|5700822|P1|STARTED|Long Term Extension||113
2322294|NCT01860976|5700821|P2|NOT COMPLETED|Open-Label||64
2322295|NCT01860976|5700822|P1|NOT COMPLETED|Open-Label||74
2322296|NCT01860976|5700821|P2|COMPLETED|Open-Label||121
2322297|NCT01860976|5700822|P1|COMPLETED|Open-Label||123
2322298|NCT01860976|5700821|P2|STARTED|Open-Label||185
2322299|NCT01860976|5700822|P1|STARTED|Open-Label||197
2322300|NCT01860976|5700821|P2|NOT COMPLETED|Blinded Treatment||113
2322301|NCT01860976|5700822|P1|NOT COMPLETED|Blinded Treatment||88
2322302|NCT01860976|5700821|P2|COMPLETED|Blinded Treatment||98
2322303|NCT01860976|5700822|P1|COMPLETED|Blinded Treatment||125
2322304|NCT01860976|5700821|P2|STARTED|Blinded Treatment||211
2322305|NCT01860976|5700822|P1|STARTED|Blinded Treatment||213
2322306|NCT01860950|5700850|P6|NOT COMPLETED|Overall Study||0
2322307|NCT01860950|5700851|P5|NOT COMPLETED|Overall Study||0
2322308|NCT01860950|5700852|P4|NOT COMPLETED|Overall Study||0
2322309|NCT01860950|5700853|P3|NOT COMPLETED|Overall Study||0
2322310|NCT01860950|5700854|P2|NOT COMPLETED|Overall Study||0
2322311|NCT01860950|5700855|P1|NOT COMPLETED|Overall Study||0
2322312|NCT01860950|5700850|P6|COMPLETED|Overall Study||13
2322313|NCT01860950|5700851|P5|COMPLETED|Overall Study||14
2322314|NCT01860950|5700852|P4|COMPLETED|Overall Study||13
2322315|NCT01860950|5700853|P3|COMPLETED|Overall Study||10
2322316|NCT01860950|5700854|P2|COMPLETED|Overall Study||15
2322317|NCT01860950|5700855|P1|COMPLETED|Overall Study||14
2322318|NCT01860950|5700850|P6|STARTED|Overall Study||13
2322319|NCT01860950|5700851|P5|STARTED|Overall Study||14
2322320|NCT01860950|5700852|P4|STARTED|Overall Study||13
2322321|NCT01860950|5700853|P3|STARTED|Overall Study||10
2322322|NCT01860950|5700854|P2|STARTED|Overall Study||15
2322323|NCT01860950|5700855|P1|STARTED|Overall Study||14
2322324|NCT01860846|5700876|P1|NOT COMPLETED|Overall Study||33
2322325|NCT01860846|5700876|P1|COMPLETED|Overall Study||73
2322326|NCT01860846|5700876|P1|Month 12|Overall Study||73
2322327|NCT01860846|5700876|P1|Month 6|Overall Study||85
2322328|NCT01860846|5700876|P1|Month 4|Overall Study||82
2322329|NCT01860846|5700876|P1|Month 2|Overall Study||83
2322330|NCT01860846|5700876|P1|Month 1|Overall Study||97
2322331|NCT01860846|5700876|P1|STARTED|Overall Study||106
2322332|NCT01860807|5700889|P2|NOT COMPLETED|Overall Study||29
2322333|NCT01860807|5700890|P1|NOT COMPLETED|Overall Study||30
2322334|NCT01860807|5700889|P2|COMPLETED|Overall Study||32
2322335|NCT01860807|5700890|P1|COMPLETED|Overall Study||34
2322336|NCT01860807|5700889|P2|STARTED|Overall Study||61
2322337|NCT01860807|5700890|P1|STARTED|Overall Study||64
2322338|NCT01860703|5700896|P4|NOT COMPLETED|Overall Study||2
2322339|NCT01860703|5700897|P3|NOT COMPLETED|Overall Study||1
2322340|NCT01860703|5700898|P2|NOT COMPLETED|Overall Study||5
2322341|NCT01860703|5700899|P1|NOT COMPLETED|Overall Study||2
2322342|NCT01860703|5700896|P4|COMPLETED|Overall Study||10
2322343|NCT01860703|5700897|P3|COMPLETED|Overall Study||11
2322344|NCT01860703|5700898|P2|COMPLETED|Overall Study||8
2322345|NCT01860703|5700899|P1|COMPLETED|Overall Study||11
2322346|NCT01860703|5700896|P4|STARTED|Overall Study||12
2322347|NCT01860703|5700897|P3|STARTED|Overall Study||12
2322348|NCT01860703|5700898|P2|STARTED|Overall Study||13
2322349|NCT01860703|5700899|P1|STARTED|Overall Study||13
2322350|NCT01860677|5700931|P2|NOT COMPLETED|Second Intervention (1 Day)||0
2322351|NCT01860677|5700932|P1|NOT COMPLETED|Second Intervention (1 Day)||7
2322352|NCT01860677|5700931|P2|COMPLETED|Second Intervention (1 Day)||0
2322353|NCT01860677|5700932|P1|COMPLETED|Second Intervention (1 Day)||1
2322354|NCT01860677|5700931|P2|STARTED|Second Intervention (1 Day)||0
2322355|NCT01860677|5700932|P1|STARTED|Second Intervention (1 Day)||8
2322356|NCT01860677|5700931|P2|NOT COMPLETED|First Intervention (1 Day)||0
2322357|NCT01860677|5700932|P1|NOT COMPLETED|First Intervention (1 Day)||0
2322358|NCT01860677|5700931|P2|COMPLETED|First Intervention (1 Day)||0
2322359|NCT01860677|5700932|P1|COMPLETED|First Intervention (1 Day)||8
2322360|NCT01860677|5700931|P2|STARTED|First Intervention (1 Day)||0
2322361|NCT01860677|5700932|P1|STARTED|First Intervention (1 Day)||8
2322362|NCT01860651|5700943|P2|NOT COMPLETED|Overall Study||8
2322363|NCT01860651|5700944|P1|NOT COMPLETED|Overall Study||25
2322364|NCT01860651|5700943|P2|COMPLETED|Overall Study||39
2322365|NCT01860651|5700944|P1|COMPLETED|Overall Study||31
2322366|NCT01860651|5700943|P2|STARTED|Overall Study||47
2322367|NCT01860651|5700944|P1|STARTED|Overall Study||56
2322368|NCT01860586|5700960|P1|NOT COMPLETED|Overall Study||0
2322369|NCT01860586|5700960|P1|COMPLETED|Overall Study||20
2322370|NCT01860586|5700960|P1|STARTED|Overall Study||20
2322371|NCT01860573|5700968|P2|NOT COMPLETED|Overall Study||0
2322372|NCT01860573|5700969|P1|NOT COMPLETED|Overall Study||0
2322373|NCT01860573|5700968|P2|COMPLETED|Overall Study||85
2322374|NCT01860573|5700969|P1|COMPLETED|Overall Study||83
2322375|NCT01860573|5700968|P2|STARTED|Overall Study||85
2322376|NCT01860573|5700969|P1|STARTED|Overall Study||83
2322377|NCT01860534|5700989|P2|NOT COMPLETED|ROP #2||0
2322378|NCT01860534|5700990|P1|NOT COMPLETED|ROP #2||1
2322379|NCT01860534|5700989|P2|COMPLETED|ROP #2||13
2322380|NCT01860534|5700990|P1|COMPLETED|ROP #2||13
2322381|NCT01860534|5700989|P2|STARTED|ROP #2||13
2322382|NCT01860534|5700990|P1|STARTED|ROP #2||14
2322383|NCT01860534|5700989|P2|NOT COMPLETED|ROP #1||1
2322384|NCT01860534|5700990|P1|NOT COMPLETED|ROP #1||0
2322385|NCT01860534|5700989|P2|COMPLETED|ROP #1||13
2322386|NCT01860534|5700990|P1|COMPLETED|ROP #1||14
2322387|NCT01860534|5700989|P2|STARTED|ROP #1||14
2322388|NCT01860534|5700990|P1|STARTED|ROP #1||14
2322389|NCT01860521|5701004|P2|NOT COMPLETED|Overall Study||0
2322390|NCT01860521|5701005|P1|NOT COMPLETED|Overall Study||0
2322391|NCT01860521|5701004|P2|COMPLETED|Overall Study|June 2013|52
2322392|NCT01860521|5701005|P1|COMPLETED|Overall Study|June 2013|52
2322393|NCT01860521|5701004|P2|STARTED|Overall Study|September 2011|52
2322394|NCT01860521|5701005|P1|STARTED|Overall Study|September 2011|52
2322395|NCT01860287|5701020|P3|NOT COMPLETED|Overall Study||0
2322396|NCT01860287|5701021|P2|NOT COMPLETED|Overall Study||0
2322397|NCT01860287|5701022|P1|NOT COMPLETED|Overall Study||0
2322398|NCT01860287|5701020|P3|COMPLETED|Overall Study||15
2322399|NCT01860287|5701021|P2|COMPLETED|Overall Study||15
2322400|NCT01860287|5701022|P1|COMPLETED|Overall Study||18
2322401|NCT01860287|5701020|P3|STARTED|Overall Study||15
2322402|NCT01860287|5701021|P2|STARTED|Overall Study||15
2322403|NCT01860287|5701022|P1|STARTED|Overall Study||18
2322404|NCT01860170|5701033|P3|NOT COMPLETED|Overall Study||0
2322405|NCT01860170|5701034|P2|NOT COMPLETED|Overall Study||0
2322406|NCT01860170|5701035|P1|NOT COMPLETED|Overall Study||0
2322407|NCT01860170|5701033|P3|COMPLETED|Overall Study||22
2322408|NCT01860170|5701034|P2|COMPLETED|Overall Study||3
2322409|NCT01860170|5701035|P1|COMPLETED|Overall Study||3
2322410|NCT01860170|5701033|P3|STARTED|Overall Study||22
2322411|NCT01860170|5701034|P2|STARTED|Overall Study||3
2322412|NCT01860170|5701035|P1|STARTED|Overall Study||3
2322413|NCT01860079|5701051|P2|NOT COMPLETED|Overall Study||22
2322414|NCT01860079|5701052|P1|NOT COMPLETED|Overall Study||14
2322415|NCT01860079|5701051|P2|COMPLETED|Overall Study||363
2322416|NCT01860079|5701052|P1|COMPLETED|Overall Study||370
2322417|NCT01860079|5701051|P2|STARTED|Overall Study||385
2322418|NCT01860079|5701052|P1|STARTED|Overall Study||384
2322419|NCT01860040|5701060|P2|NOT COMPLETED|Overall Study||0
2322420|NCT01860040|5701061|P1|NOT COMPLETED|Overall Study||1
2322421|NCT01860040|5701060|P2|COMPLETED|Overall Study|did not meet recruitment goal|0
2322422|NCT01860040|5701061|P1|COMPLETED|Overall Study|did not meet recruitment goal|0
2322423|NCT01860040|5701060|P2|STARTED|Overall Study|did not meet recruitment goal|0
2322424|NCT01860040|5701061|P1|STARTED|Overall Study|did not meet recruitment goal|1
2322425|NCT01859988|5701072|P6|NOT COMPLETED|Overall Study||19
2322426|NCT01859988|5701073|P5|NOT COMPLETED|Overall Study||23
2322427|NCT01859988|5701074|P4|NOT COMPLETED|Overall Study||10
2322428|NCT01859988|5701075|P3|NOT COMPLETED|Overall Study||28
2322429|NCT01859988|5701076|P2|NOT COMPLETED|Overall Study||12
2322430|NCT01859988|5701077|P1|NOT COMPLETED|Overall Study||11
2322431|NCT01859988|5701072|P6|COMPLETED|Overall Study||42
2322432|NCT01859988|5701073|P5|COMPLETED|Overall Study||42
2322433|NCT01859988|5701074|P4|COMPLETED|Overall Study||55
2322434|NCT01859988|5701075|P3|COMPLETED|Overall Study||34
2322435|NCT01859988|5701076|P2|COMPLETED|Overall Study||52
2322436|NCT01859988|5701077|P1|COMPLETED|Overall Study||52
2322437|NCT01859988|5701072|P6|Treated|Overall Study||61
2322438|NCT01859988|5701073|P5|Treated|Overall Study||65
2322439|NCT01859988|5701074|P4|Treated|Overall Study||65
2322440|NCT01859988|5701075|P3|Treated|Overall Study||61
2322441|NCT01859988|5701076|P2|Treated|Overall Study||64
2322442|NCT01859988|5701077|P1|Treated|Overall Study||63
2322443|NCT01859988|5701072|P6|STARTED|Overall Study||61
2322444|NCT01859988|5701073|P5|STARTED|Overall Study||65
2322445|NCT01859988|5701074|P4|STARTED|Overall Study||65
2322446|NCT01859988|5701075|P3|STARTED|Overall Study||62
2322447|NCT01859988|5701076|P2|STARTED|Overall Study||64
2322448|NCT01859988|5701077|P1|STARTED|Overall Study||63
2322449|NCT01859949|5701171|P2|NOT COMPLETED|Overall Study||17
2322450|NCT01859949|5701172|P1|NOT COMPLETED|Overall Study||14
2322451|NCT01859949|5701171|P2|COMPLETED|Overall Study||15
2322452|NCT01859949|5701172|P1|COMPLETED|Overall Study||15
2322453|NCT01859949|5701171|P2|STARTED|Overall Study|Treated participants|32
2322454|NCT01859949|5701172|P1|STARTED|Overall Study|Treated participants|29
2322455|NCT01859793|5701190|P2|NOT COMPLETED|2nd Intervention Period||0
2322456|NCT01859793|5701191|P1|NOT COMPLETED|2nd Intervention Period||0
2322457|NCT01859793|5701190|P2|COMPLETED|2nd Intervention Period||16
2322458|NCT01859793|5701191|P1|COMPLETED|2nd Intervention Period||14
2322459|NCT01859793|5701190|P2|STARTED|2nd Intervention Period||16
2322460|NCT01859793|5701191|P1|STARTED|2nd Intervention Period||14
2322461|NCT01859793|5701190|P2|NOT COMPLETED|Washout Period (4 Weeks)||1
2322462|NCT01859793|5701191|P1|NOT COMPLETED|Washout Period (4 Weeks)||1
2322463|NCT01859793|5701190|P2|COMPLETED|Washout Period (4 Weeks)||16
2322464|NCT01859793|5701191|P1|COMPLETED|Washout Period (4 Weeks)||14
2322465|NCT01859793|5701190|P2|STARTED|Washout Period (4 Weeks)||17
2322466|NCT01859793|5701191|P1|STARTED|Washout Period (4 Weeks)||15
2322467|NCT01859793|5701190|P2|NOT COMPLETED|First Intervention (8 Weeks)||1
2322468|NCT01859793|5701191|P1|NOT COMPLETED|First Intervention (8 Weeks)||5
2322469|NCT01859793|5701190|P2|COMPLETED|First Intervention (8 Weeks)||17
2322470|NCT01859793|5701191|P1|COMPLETED|First Intervention (8 Weeks)||15
2322471|NCT01859793|5701190|P2|STARTED|First Intervention (8 Weeks)||18
2322472|NCT01859793|5701191|P1|STARTED|First Intervention (8 Weeks)||20
2322473|NCT01859741|5701209|P8|NOT COMPLETED|Overall Study||70
2322474|NCT01859741|5701210|P7|NOT COMPLETED|Overall Study||70
2322475|NCT01859741|5701211|P6|NOT COMPLETED|Overall Study||6
2322476|NCT01859741|5701212|P5|NOT COMPLETED|Overall Study||6
2322477|NCT01859741|5701213|P4|NOT COMPLETED|Overall Study||3
2322478|NCT01859741|5701214|P3|NOT COMPLETED|Overall Study||6
2322479|NCT01859741|5701215|P2|NOT COMPLETED|Overall Study||3
2322480|NCT01859741|5701216|P1|NOT COMPLETED|Overall Study||3
2322481|NCT01859741|5701209|P8|COMPLETED|Overall Study||3
2322482|NCT01859741|5701210|P7|COMPLETED|Overall Study||2
2322483|NCT01859741|5701211|P6|COMPLETED|Overall Study||0
2322484|NCT01859741|5701212|P5|COMPLETED|Overall Study||0
2322485|NCT01859741|5701213|P4|COMPLETED|Overall Study||0
2322486|NCT01859741|5701214|P3|COMPLETED|Overall Study||0
2322487|NCT01859741|5701215|P2|COMPLETED|Overall Study||0
2322488|NCT01859741|5701216|P1|COMPLETED|Overall Study||0
2322489|NCT01859741|5701209|P8|STARTED|Overall Study||73
2322490|NCT01859741|5701210|P7|STARTED|Overall Study||72
2322491|NCT01859741|5701211|P6|STARTED|Overall Study||6
2322492|NCT01859741|5701212|P5|STARTED|Overall Study||6
2322493|NCT01859741|5701213|P4|STARTED|Overall Study||3
2322494|NCT01859741|5701214|P3|STARTED|Overall Study||6
2322495|NCT01859741|5701215|P2|STARTED|Overall Study||3
2322496|NCT01859741|5701216|P1|STARTED|Overall Study||3
2322497|NCT01859715|5701245|P3|NOT COMPLETED|Overall Study||23
2322498|NCT01859715|5701246|P2|NOT COMPLETED|Overall Study||8
2322499|NCT01859715|5701247|P1|NOT COMPLETED|Overall Study||16
2322500|NCT01859715|5701245|P3|COMPLETED|Overall Study||93
2322501|NCT01859715|5701246|P2|COMPLETED|Overall Study||83
2322502|NCT01859715|5701247|P1|COMPLETED|Overall Study||125
2322503|NCT01859715|5701245|P3|STARTED|Overall Study||116
2322504|NCT01859715|5701246|P2|STARTED|Overall Study||91
2322505|NCT01859715|5701247|P1|STARTED|Overall Study||141
2322506|NCT01859702|5701258|P1|NOT COMPLETED|Overall Study||5
2322507|NCT01859702|5701258|P1|COMPLETED|Overall Study||31
2322508|NCT01859702|5701258|P1|STARTED|Overall Study||36
2322509|NCT01859637|5701262|P1|NOT COMPLETED|Overall Study||0
2322510|NCT01859637|5701262|P1|COMPLETED|Overall Study||6
2322511|NCT01859637|5701262|P1|STARTED|Overall Study||6
2322512|NCT01859611|5701268|P1|NOT COMPLETED|Overall Study||8
2322513|NCT01859611|5701268|P1|COMPLETED|Overall Study||43
2322514|NCT01859611|5701268|P1|STARTED|Overall Study||51
2322515|NCT01859598|5701272|P1|NOT COMPLETED|Visit 3 at 6 Months||912
2322516|NCT01859598|5701272|P1|COMPLETED|Visit 3 at 6 Months|Loss to follow-up, N=1517; Come back at visit 3, N=605;|16341
2322517|NCT01859598|5701272|P1|STARTED|Visit 3 at 6 Months||17253
2322518|NCT01859598|5701272|P1|NOT COMPLETED|Visit 2 at 3 Months||1742
2322519|NCT01859598|5701272|P1|COMPLETED|Visit 2 at 3 Months||17253
2322520|NCT01859598|5701272|P1|STARTED|Visit 2 at 3 Months|At visit 1, patients remained at baseline, N=18995|18995
2322521|NCT01859507|5701280|P1|NOT COMPLETED|Overall Study||4
2322522|NCT01859507|5701280|P1|COMPLETED|Overall Study||28
2322523|NCT01859507|5701280|P1|STARTED|Overall Study||32
2322524|NCT01859494|5701285|P1|NOT COMPLETED|Overall Study||1
2322525|NCT01859494|5701285|P1|COMPLETED|Overall Study||218
2322526|NCT01859494|5701285|P1|STARTED|Overall Study||219
2322527|NCT01859390|5701296|P2|NOT COMPLETED|Overall Study||7
2322528|NCT01859390|5701297|P1|NOT COMPLETED|Overall Study||1
2322529|NCT01859390|5701296|P2|COMPLETED|Overall Study||30
2322530|NCT01859390|5701297|P1|COMPLETED|Overall Study||35
2322531|NCT01859390|5701296|P2|Withdrawals|Overall Study||2
2322532|NCT01859390|5701297|P1|Withdrawals|Overall Study||2
2322533|NCT01859390|5701296|P2|STARTED|Overall Study||37
2322534|NCT01859390|5701297|P1|STARTED|Overall Study||36
2322535|NCT01859325|5701321|P3|NOT COMPLETED|Overall Study||0
2322536|NCT01859325|5701322|P2|NOT COMPLETED|Overall Study||4
2322537|NCT01859325|5701323|P1|NOT COMPLETED|Overall Study||3
2322538|NCT01859325|5701321|P3|COMPLETED|Overall Study||2
2322539|NCT01859325|5701322|P2|COMPLETED|Overall Study||12
2322540|NCT01859325|5701323|P1|COMPLETED|Overall Study||12
2322541|NCT01859325|5701321|P3|STARTED|Overall Study||2
2322542|NCT01859325|5701322|P2|STARTED|Overall Study||16
2322543|NCT01859325|5701323|P1|STARTED|Overall Study||15
2322544|NCT01859312|5701331|P1|NOT COMPLETED|Overall Study||0
2322545|NCT01859312|5701331|P1|COMPLETED|Overall Study|Based on medication & supply accountability, one participant was found to be partially non-compliant|8
2322546|NCT01859312|5701331|P1|STARTED|Overall Study||8
2322547|NCT01859247|5701386|P8|NOT COMPLETED|Overall Study||0
2322548|NCT01859247|5701387|P7|NOT COMPLETED|Overall Study||0
2322549|NCT01859247|5701388|P6|NOT COMPLETED|Overall Study||0
2322550|NCT01859247|5701389|P5|NOT COMPLETED|Overall Study||0
2322551|NCT01859247|5701390|P4|NOT COMPLETED|Overall Study||0
2322552|NCT01859247|5701391|P3|NOT COMPLETED|Overall Study||0
2322553|NCT01859247|5701392|P2|NOT COMPLETED|Overall Study||0
2322554|NCT01859247|5701393|P1|NOT COMPLETED|Overall Study||0
2322555|NCT01859247|5701386|P8|COMPLETED|Overall Study||1
2322556|NCT01859247|5701387|P7|COMPLETED|Overall Study||1
2322557|NCT01859247|5701388|P6|COMPLETED|Overall Study||1
2322558|NCT01859247|5701389|P5|COMPLETED|Overall Study||1
2322559|NCT01859247|5701390|P4|COMPLETED|Overall Study||1
2322560|NCT01859247|5701391|P3|COMPLETED|Overall Study||1
2322561|NCT01859247|5701392|P2|COMPLETED|Overall Study||1
2322562|NCT01859247|5701393|P1|COMPLETED|Overall Study||1
2322563|NCT01859247|5701386|P8|STARTED|Overall Study||1
2322564|NCT01859247|5701387|P7|STARTED|Overall Study||1
2322565|NCT01859247|5701388|P6|STARTED|Overall Study||1
2322566|NCT01859247|5701389|P5|STARTED|Overall Study||1
2322567|NCT01859247|5701390|P4|STARTED|Overall Study||1
2322568|NCT01859247|5701391|P3|STARTED|Overall Study||1
2322569|NCT01859247|5701392|P2|STARTED|Overall Study||1
2322570|NCT01859247|5701393|P1|STARTED|Overall Study||1
2322571|NCT01859195|5701420|P2|NOT COMPLETED|Overall Study||0
2322572|NCT01859195|5701421|P1|NOT COMPLETED|Overall Study||0
2322573|NCT01859195|5701420|P2|COMPLETED|Overall Study||12
2322574|NCT01859195|5701421|P1|COMPLETED|Overall Study||24
2322575|NCT01859195|5701420|P2|STARTED|Overall Study||12
2322576|NCT01859195|5701421|P1|STARTED|Overall Study||24
2322577|NCT01859143|5701431|P2|NOT COMPLETED|Overall Study||0
2322578|NCT01859143|5701432|P1|NOT COMPLETED|Overall Study||2
2322579|NCT01859143|5701431|P2|COMPLETED|Overall Study||60
2322580|NCT01859143|5701432|P1|COMPLETED|Overall Study||238
2322581|NCT01859143|5701431|P2|STARTED|Overall Study|One participant in this group received trivalent influenza vaccine on Day 1.|60
2322582|NCT01859143|5701432|P1|STARTED|Overall Study||240
2322583|NCT01859078|5701446|P1|NOT COMPLETED|Overall Study||0
2322584|NCT01859078|5701446|P1|COMPLETED|Overall Study||28
2322585|NCT01859078|5701446|P1|STARTED|Overall Study||28
2322586|NCT01859013|5701462|P2|NOT COMPLETED|Overall Study||5
2322587|NCT01859013|5701463|P1|NOT COMPLETED|Overall Study||4
2322588|NCT01859013|5701462|P2|COMPLETED|Overall Study||9
2322589|NCT01859013|5701463|P1|COMPLETED|Overall Study||12
2322590|NCT01859013|5701462|P2|STARTED|Overall Study||14
2322591|NCT01859013|5701463|P1|STARTED|Overall Study||16
2322592|NCT01858766|5701488|P19|NOT COMPLETED|Overall Study||4
2322593|NCT01858766|5701489|P18|NOT COMPLETED|Overall Study||4
2322594|NCT01858766|5701490|P17|NOT COMPLETED|Overall Study||3
2322595|NCT01858766|5701491|P16|NOT COMPLETED|Overall Study||6
2322596|NCT01858766|5701492|P15|NOT COMPLETED|Overall Study||8
2322597|NCT01858766|5701493|P14|NOT COMPLETED|Overall Study||3
2322598|NCT01858766|5701494|P13|NOT COMPLETED|Overall Study||5
2322599|NCT01858766|5701495|P12|NOT COMPLETED|Overall Study||5
2322600|NCT01858766|5701496|P11|NOT COMPLETED|Overall Study||0
2322601|NCT01858766|5701497|P10|NOT COMPLETED|Overall Study||0
2322602|NCT01858766|5701498|P9|NOT COMPLETED|Overall Study||0
2322603|NCT01858766|5701499|P8|NOT COMPLETED|Overall Study||2
2322604|NCT01858766|5701500|P7|NOT COMPLETED|Overall Study||0
2322605|NCT01858766|5701501|P6|NOT COMPLETED|Overall Study||4
2322606|NCT01858766|5701502|P5|NOT COMPLETED|Overall Study||1
2322607|NCT01858766|5701503|P4|NOT COMPLETED|Overall Study||0
2322608|NCT01858766|5701504|P3|NOT COMPLETED|Overall Study||1
2322609|NCT01858766|5701505|P2|NOT COMPLETED|Overall Study||0
2322610|NCT01858766|5701506|P1|NOT COMPLETED|Overall Study||1
2322611|NCT01858766|5701488|P19|COMPLETED|Overall Study||22
2322612|NCT01858766|5701489|P18|COMPLETED|Overall Study||23
2322613|NCT01858766|5701490|P17|COMPLETED|Overall Study||22
2322614|NCT01858766|5701491|P16|COMPLETED|Overall Study||20
2322615|NCT01858766|5701492|P15|COMPLETED|Overall Study||23
2322616|NCT01858766|5701493|P14|COMPLETED|Overall Study||26
2322617|NCT01858766|5701494|P13|COMPLETED|Overall Study||25
2322618|NCT01858766|5701495|P12|COMPLETED|Overall Study||25
2322619|NCT01858766|5701496|P11|COMPLETED|Overall Study||5
2322620|NCT01858766|5701497|P10|COMPLETED|Overall Study||4
2322621|NCT01858766|5701498|P9|COMPLETED|Overall Study||1
2322622|NCT01858766|5701499|P8|COMPLETED|Overall Study||5
2322623|NCT01858766|5701500|P7|COMPLETED|Overall Study||7
2322624|NCT01858766|5701501|P6|COMPLETED|Overall Study||24
2322625|NCT01858766|5701502|P5|COMPLETED|Overall Study||26
2322626|NCT01858766|5701503|P4|COMPLETED|Overall Study||10
2322627|NCT01858766|5701504|P3|COMPLETED|Overall Study||10
2322628|NCT01858766|5701505|P2|COMPLETED|Overall Study||28
2322629|NCT01858766|5701506|P1|COMPLETED|Overall Study||26
2322630|NCT01858766|5701488|P19|STARTED|Overall Study||26
2322631|NCT01858766|5701489|P18|STARTED|Overall Study||27
2322632|NCT01858766|5701490|P17|STARTED|Overall Study||25
2322633|NCT01858766|5701491|P16|STARTED|Overall Study||26
2322634|NCT01858766|5701492|P15|STARTED|Overall Study||31
2322635|NCT01858766|5701493|P14|STARTED|Overall Study||29
2322636|NCT01858766|5701494|P13|STARTED|Overall Study||30
2322637|NCT01858766|5701495|P12|STARTED|Overall Study||30
2322638|NCT01858766|5701496|P11|STARTED|Overall Study||5
2322639|NCT01858766|5701497|P10|STARTED|Overall Study||4
2322640|NCT01858766|5701498|P9|STARTED|Overall Study||1
2322641|NCT01858766|5701499|P8|STARTED|Overall Study||7
2322642|NCT01858766|5701500|P7|STARTED|Overall Study||7
2322643|NCT01858766|5701501|P6|STARTED|Overall Study||28
2322644|NCT01858766|5701502|P5|STARTED|Overall Study||27
2322645|NCT01858766|5701503|P4|STARTED|Overall Study||10
2322646|NCT01858766|5701504|P3|STARTED|Overall Study||11
2322647|NCT01858766|5701505|P2|STARTED|Overall Study||28
2322648|NCT01858766|5701506|P1|STARTED|Overall Study||27
2322649|NCT01858701|5701577|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
2322650|NCT01858701|5701578|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
2322651|NCT01858701|5701577|P2|COMPLETED|Period 2, Second 30 Days of Wear||16
2322652|NCT01858701|5701578|P1|COMPLETED|Period 2, Second 30 Days of Wear||18
2322653|NCT01858701|5701577|P2|STARTED|Period 2, Second 30 Days of Wear||17
2322654|NCT01858701|5701578|P1|STARTED|Period 2, Second 30 Days of Wear||18
2322655|NCT01858701|5701577|P2|NOT COMPLETED|Washout Period, 1-13 Days||2
2322656|NCT01858701|5701578|P1|NOT COMPLETED|Washout Period, 1-13 Days||2
2322657|NCT01858701|5701577|P2|COMPLETED|Washout Period, 1-13 Days||17
2322658|NCT01858701|5701578|P1|COMPLETED|Washout Period, 1-13 Days||18
2322659|NCT01858701|5701577|P2|STARTED|Washout Period, 1-13 Days||19
2322660|NCT01858701|5701578|P1|STARTED|Washout Period, 1-13 Days||20
2322661|NCT01858701|5701577|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||1
2322662|NCT01858701|5701578|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
2322663|NCT01858701|5701577|P2|COMPLETED|Period 1, First 30 Days of Wear||19
2322664|NCT01858701|5701578|P1|COMPLETED|Period 1, First 30 Days of Wear||20
2322665|NCT01858701|5701577|P2|STARTED|Period 1, First 30 Days of Wear||20
2322666|NCT01858701|5701578|P1|STARTED|Period 1, First 30 Days of Wear||20
2322667|NCT01858636|5701584|P1|NOT COMPLETED|Overall Study||28
2322668|NCT01858636|5701584|P1|COMPLETED|Overall Study||207
2322669|NCT01858636|5701584|P1|Device Deployment|Overall Study||211
2322670|NCT01858636|5701584|P1|STARTED|Overall Study|Subjects consented|235
2322671|NCT01858545|5701591|P2|NOT COMPLETED|Overall Study||6
2322672|NCT01858545|5701592|P1|NOT COMPLETED|Overall Study||4
2322673|NCT01858545|5701591|P2|COMPLETED|Overall Study||23
2322674|NCT01858545|5701592|P1|COMPLETED|Overall Study||23
2322675|NCT01858545|5701591|P2|STARTED|Overall Study||29
2322676|NCT01858545|5701592|P1|STARTED|Overall Study||27
2322677|NCT01858532|5701602|P4|NOT COMPLETED|Overall Study||93
2322678|NCT01858532|5701603|P3|NOT COMPLETED|Overall Study||98
2322679|NCT01858532|5701604|P2|NOT COMPLETED|Overall Study||192
2322680|NCT01858532|5701605|P1|NOT COMPLETED|Overall Study||181
2322681|NCT01858532|5701602|P4|COMPLETED|Overall Study||418
2322682|NCT01858532|5701603|P3|COMPLETED|Overall Study||411
2322683|NCT01858532|5701604|P2|COMPLETED|Overall Study||1131
2322684|NCT01858532|5701605|P1|COMPLETED|Overall Study||1144
2322685|NCT01858532|5701602|P4|STARTED|Overall Study||511
2322686|NCT01858532|5701603|P3|STARTED|Overall Study||509
2322687|NCT01858532|5701604|P2|STARTED|Overall Study||1323
2322688|NCT01858532|5701605|P1|STARTED|Overall Study||1325
2322689|NCT01858428|5701622|P2|NOT COMPLETED|Overall Study||10
2322690|NCT01858428|5701623|P1|NOT COMPLETED|Overall Study||1
2322691|NCT01858428|5701622|P2|COMPLETED|Overall Study||190
2322692|NCT01858428|5701623|P1|COMPLETED|Overall Study||99
2322693|NCT01858428|5701622|P2|STARTED|Overall Study||200
2322694|NCT01858428|5701623|P1|STARTED|Overall Study|EverCross™ Balloon Catheter now a product of Medtronic|100
2322695|NCT01858389|5701659|P2|NOT COMPLETED|Overall Study||25
2322696|NCT01858389|5701660|P1|NOT COMPLETED|Overall Study||16
2322697|NCT01858389|5701659|P2|COMPLETED|Overall Study||0
2322698|NCT01858389|5701660|P1|COMPLETED|Overall Study||0
2322699|NCT01858389|5701659|P2|Received Treatment|Overall Study||22
2322700|NCT01858389|5701660|P1|Received Treatment|Overall Study||16
2322701|NCT01858389|5701659|P2|STARTED|Overall Study|Enrolled|25
2322702|NCT01858389|5701660|P1|STARTED|Overall Study|Enrolled|16
2322703|NCT01858376|5701675|P1|NOT COMPLETED|Overall Study||4
2322704|NCT01858376|5701675|P1|COMPLETED|Overall Study||20
2322705|NCT01858376|5701675|P1|STARTED|Overall Study||24
2322706|NCT01857986|5701684|P2|NOT COMPLETED|Overall Study||7
2322707|NCT01857986|5701685|P1|NOT COMPLETED|Overall Study||5
2322708|NCT01857986|5701684|P2|COMPLETED|Overall Study||30
2322709|NCT01857986|5701685|P1|COMPLETED|Overall Study||34
2322710|NCT01857986|5701684|P2|STARTED|Overall Study||37
2322711|NCT01857986|5701685|P1|STARTED|Overall Study||39
2322712|NCT01857973|5701695|P1|NOT COMPLETED|Overall Study||5
2322713|NCT01857973|5701695|P1|COMPLETED|Overall Study||73
2322714|NCT01857973|5701695|P1|Phase 7|Overall Study||4
2322715|NCT01857973|5701695|P1|Phase 6|Overall Study||4
2322716|NCT01857973|5701695|P1|Phase 4|Overall Study||10
2322717|NCT01857973|5701695|P1|Phase 3|Overall Study||10
2322718|NCT01857973|5701695|P1|Phase 2|Overall Study||14
2322719|NCT01857973|5701695|P1|Phase 1|Overall Study||17
2322720|NCT01857973|5701695|P1|Xploratory B Phase|Overall Study||9
2322721|NCT01857973|5701695|P1|Exploratory A Phase|Overall Study||9
2322722|NCT01857973|5701695|P1|STARTED|Overall Study||78
2322723|NCT01857882|5701708|P2|NOT COMPLETED|Overall Study||0
2322724|NCT01857882|5701709|P1|NOT COMPLETED|Overall Study||0
2322725|NCT01857882|5701708|P2|COMPLETED|Overall Study||20
2322726|NCT01857882|5701709|P1|COMPLETED|Overall Study||21
2322727|NCT01857882|5701708|P2|STARTED|Overall Study||20
2322728|NCT01857882|5701709|P1|STARTED|Overall Study||21
2322729|NCT01857869|5701725|P10|NOT COMPLETED|Booster/Rechallenge Phase||0
2322730|NCT01857869|5701726|P9|NOT COMPLETED|Booster/Rechallenge Phase||0
2322731|NCT01857869|5701727|P8|NOT COMPLETED|Booster/Rechallenge Phase||0
2322732|NCT01857869|5701728|P7|NOT COMPLETED|Booster/Rechallenge Phase||0
2322733|NCT01857869|5701729|P6|NOT COMPLETED|Booster/Rechallenge Phase||0
2322734|NCT01857869|5701730|P5|NOT COMPLETED|Booster/Rechallenge Phase||0
2322735|NCT01857869|5701731|P4|NOT COMPLETED|Booster/Rechallenge Phase||2
2322736|NCT01857869|5701732|P3|NOT COMPLETED|Booster/Rechallenge Phase||0
2322737|NCT01857869|5701733|P2|NOT COMPLETED|Booster/Rechallenge Phase||0
2322738|NCT01857869|5701734|P1|NOT COMPLETED|Booster/Rechallenge Phase||0
2322739|NCT01857869|5701725|P10|COMPLETED|Booster/Rechallenge Phase||6
2322740|NCT01857869|5701726|P9|COMPLETED|Booster/Rechallenge Phase||3
2322741|NCT01857869|5701727|P8|COMPLETED|Booster/Rechallenge Phase||4
2322742|NCT01857869|5701728|P7|COMPLETED|Booster/Rechallenge Phase||5
2322743|NCT01857869|5701729|P6|COMPLETED|Booster/Rechallenge Phase||2
2322744|NCT01857869|5701730|P5|COMPLETED|Booster/Rechallenge Phase||10
2322745|NCT01857869|5701731|P4|COMPLETED|Booster/Rechallenge Phase||7
2322746|NCT01857869|5701732|P3|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
2322747|NCT01857869|5701733|P2|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
2322748|NCT01857869|5701734|P1|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
2322749|NCT01857869|5701725|P10|STARTED|Booster/Rechallenge Phase||6
2322750|NCT01857869|5701726|P9|STARTED|Booster/Rechallenge Phase||3
2322751|NCT01857869|5701727|P8|STARTED|Booster/Rechallenge Phase||4
2322752|NCT01857869|5701728|P7|STARTED|Booster/Rechallenge Phase||5
2322753|NCT01857869|5701729|P6|STARTED|Booster/Rechallenge Phase||2
2322754|NCT01857869|5701730|P5|STARTED|Booster/Rechallenge Phase||10
2322755|NCT01857869|5701731|P4|STARTED|Booster/Rechallenge Phase||9
2322756|NCT01857869|5701732|P3|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
2322757|NCT01857869|5701733|P2|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
2322830|NCT01857297|5701880|P2|NOT COMPLETED|Overall Study||0
2322831|NCT01857297|5701881|P1|NOT COMPLETED|Overall Study||0
2322758|NCT01857869|5701734|P1|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
2322759|NCT01857869|5701725|P10|NOT COMPLETED|Primary/Challenge Phase||0
2322760|NCT01857869|5701726|P9|NOT COMPLETED|Primary/Challenge Phase||0
2322761|NCT01857869|5701727|P8|NOT COMPLETED|Primary/Challenge Phase||0
2322762|NCT01857869|5701728|P7|NOT COMPLETED|Primary/Challenge Phase||0
2322763|NCT01857869|5701729|P6|NOT COMPLETED|Primary/Challenge Phase||0
2322764|NCT01857869|5701730|P5|NOT COMPLETED|Primary/Challenge Phase||0
2322765|NCT01857869|5701731|P4|NOT COMPLETED|Primary/Challenge Phase||0
2322766|NCT01857869|5701732|P3|NOT COMPLETED|Primary/Challenge Phase||0
2322767|NCT01857869|5701733|P2|NOT COMPLETED|Primary/Challenge Phase||1
2322768|NCT01857869|5701734|P1|NOT COMPLETED|Primary/Challenge Phase||5
2322769|NCT01857869|5701725|P10|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
2322770|NCT01857869|5701726|P9|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
2322771|NCT01857869|5701727|P8|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
2322772|NCT01857869|5701728|P7|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
2322773|NCT01857869|5701729|P6|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
2322774|NCT01857869|5701730|P5|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
2322775|NCT01857869|5701731|P4|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
2322776|NCT01857869|5701732|P3|COMPLETED|Primary/Challenge Phase||12
2322777|NCT01857869|5701733|P2|COMPLETED|Primary/Challenge Phase||16
2322778|NCT01857869|5701734|P1|COMPLETED|Primary/Challenge Phase||29
2322779|NCT01857869|5701725|P10|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
2322780|NCT01857869|5701726|P9|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
2322781|NCT01857869|5701727|P8|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
2322782|NCT01857869|5701728|P7|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
2322783|NCT01857869|5701729|P6|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
2322784|NCT01857869|5701730|P5|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
2322785|NCT01857869|5701731|P4|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
2322786|NCT01857869|5701732|P3|STARTED|Primary/Challenge Phase||12
2322787|NCT01857869|5701733|P2|STARTED|Primary/Challenge Phase||17
2322788|NCT01857869|5701734|P1|STARTED|Primary/Challenge Phase||34
2322789|NCT01857713|5701814|P1|NOT COMPLETED|Overall Study||6
2322790|NCT01857713|5701814|P1|COMPLETED|Overall Study||89
2322791|NCT01857713|5701814|P1|STARTED|Overall Study||95
2322792|NCT01857622|5701824|P3|NOT COMPLETED|Overall Study||2
2322793|NCT01857622|5701825|P2|NOT COMPLETED|Overall Study||1
2322794|NCT01857622|5701826|P1|NOT COMPLETED|Overall Study||11
2322795|NCT01857622|5701824|P3|COMPLETED|Overall Study||19
2322796|NCT01857622|5701825|P2|COMPLETED|Overall Study||21
2322797|NCT01857622|5701826|P1|COMPLETED|Overall Study||39
2322798|NCT01857622|5701824|P3|STARTED|Overall Study||21
2322799|NCT01857622|5701825|P2|STARTED|Overall Study||22
2322800|NCT01857622|5701826|P1|STARTED|Overall Study||50
2322801|NCT01857583|5701838|P4|NOT COMPLETED|Overall Study||4
2322802|NCT01857583|5701839|P3|NOT COMPLETED|Overall Study||3
2322803|NCT01857583|5701840|P2|NOT COMPLETED|Overall Study||1
2322804|NCT01857583|5701841|P1|NOT COMPLETED|Overall Study||1
2322805|NCT01857583|5701838|P4|COMPLETED|Overall Study||17
2322806|NCT01857583|5701839|P3|COMPLETED|Overall Study||19
2322807|NCT01857583|5701840|P2|COMPLETED|Overall Study||6
2322808|NCT01857583|5701841|P1|COMPLETED|Overall Study||29
2322809|NCT01857583|5701838|P4|Safety Analysis Population|Overall Study||20
2322810|NCT01857583|5701839|P3|Safety Analysis Population|Overall Study||22
2322811|NCT01857583|5701840|P2|Safety Analysis Population|Overall Study||7
2322812|NCT01857583|5701841|P1|Safety Analysis Population|Overall Study||30
2322813|NCT01857583|5701838|P4|STARTED|Overall Study||21
2322814|NCT01857583|5701839|P3|STARTED|Overall Study||22
2322815|NCT01857583|5701840|P2|STARTED|Overall Study||7
2322816|NCT01857583|5701841|P1|STARTED|Overall Study||30
2322817|NCT01857531|5701851|P1|NOT COMPLETED|Overall Study||4
2322818|NCT01857531|5701851|P1|COMPLETED|Overall Study||12
2322819|NCT01857531|5701851|P1|STARTED|Overall Study||16
2322820|NCT01857362|5701860|P2|NOT COMPLETED|Overall Study||0
2322821|NCT01857362|5701861|P1|NOT COMPLETED|Overall Study||0
2322822|NCT01857362|5701860|P2|COMPLETED|Overall Study||6
2322823|NCT01857362|5701861|P1|COMPLETED|Overall Study||6
2322824|NCT01857362|5701860|P2|STARTED|Overall Study||6
2322825|NCT01857362|5701861|P1|STARTED|Overall Study||6
2322826|NCT01857323|5701869|P1|NOT COMPLETED|Overall Study||64
2322827|NCT01857323|5701869|P1|COMPLETED|Overall Study||253
2322828|NCT01857323|5701869|P1|Safety Population|Overall Study|One enrolled participant was lost to follow-up.|316
2322829|NCT01857323|5701869|P1|STARTED|Overall Study|36 day treatment cohort: 45 participants 50 day treatment cohort: 272 participants|317
2322832|NCT01857297|5701880|P2|COMPLETED|Overall Study||60
2322833|NCT01857297|5701881|P1|COMPLETED|Overall Study||60
2322834|NCT01857297|5701880|P2|STARTED|Overall Study||60
2322835|NCT01857297|5701881|P1|STARTED|Overall Study||60
2322836|NCT01857258|5701895|P2|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
2322837|NCT01857258|5701896|P1|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
2322838|NCT01857258|5701895|P2|COMPLETED|Second Intervention (3 h Postprandially)||7
2322839|NCT01857258|5701896|P1|COMPLETED|Second Intervention (3 h Postprandially)||8
2322840|NCT01857258|5701895|P2|STARTED|Second Intervention (3 h Postprandially)||7
2322841|NCT01857258|5701896|P1|STARTED|Second Intervention (3 h Postprandially)||8
2322842|NCT01857258|5701895|P2|NOT COMPLETED|Wash-out Period (7 Days)||0
2322843|NCT01857258|5701896|P1|NOT COMPLETED|Wash-out Period (7 Days)||0
2322844|NCT01857258|5701895|P2|COMPLETED|Wash-out Period (7 Days)||7
2322845|NCT01857258|5701896|P1|COMPLETED|Wash-out Period (7 Days)||8
2322846|NCT01857258|5701895|P2|STARTED|Wash-out Period (7 Days)||7
2322847|NCT01857258|5701896|P1|STARTED|Wash-out Period (7 Days)||8
2322848|NCT01857258|5701895|P2|NOT COMPLETED|First Intervention (3 h Postprandially)||0
2322849|NCT01857258|5701896|P1|NOT COMPLETED|First Intervention (3 h Postprandially)||0
2322850|NCT01857258|5701895|P2|COMPLETED|First Intervention (3 h Postprandially)||7
2322851|NCT01857258|5701896|P1|COMPLETED|First Intervention (3 h Postprandially)||8
2322852|NCT01857258|5701895|P2|STARTED|First Intervention (3 h Postprandially)||7
2322853|NCT01857258|5701896|P1|STARTED|First Intervention (3 h Postprandially)||8
2322854|NCT01857232|5701921|P5|NOT COMPLETED|Overall Study||6
2322855|NCT01857232|5701922|P4|NOT COMPLETED|Overall Study||2
2322856|NCT01857232|5701923|P3|NOT COMPLETED|Overall Study||4
2322857|NCT01857232|5701924|P2|NOT COMPLETED|Overall Study||2
2322858|NCT01857232|5701925|P1|NOT COMPLETED|Overall Study||8
2322859|NCT01857232|5701921|P5|COMPLETED|Overall Study||63
2322860|NCT01857232|5701922|P4|COMPLETED|Overall Study||68
2322861|NCT01857232|5701923|P3|COMPLETED|Overall Study||63
2322862|NCT01857232|5701924|P2|COMPLETED|Overall Study||65
2322863|NCT01857232|5701925|P1|COMPLETED|Overall Study||61
2322864|NCT01857232|5701921|P5|Evaluable ITT|Overall Study||65
2322865|NCT01857232|5701922|P4|Evaluable ITT|Overall Study||68
2322866|NCT01857232|5701923|P3|Evaluable ITT|Overall Study||63
2322867|NCT01857232|5701924|P2|Evaluable ITT|Overall Study||66
2322868|NCT01857232|5701925|P1|Evaluable ITT|Overall Study||66
2322869|NCT01857232|5701921|P5|STARTED|Overall Study||69
2322870|NCT01857232|5701922|P4|STARTED|Overall Study||70
2322871|NCT01857232|5701923|P3|STARTED|Overall Study||67
2322872|NCT01857232|5701924|P2|STARTED|Overall Study||67
2322873|NCT01857232|5701925|P1|STARTED|Overall Study||69
2322874|NCT01857206|5701944|P2|NOT COMPLETED|Overall Study||10
2322875|NCT01857206|5701945|P1|NOT COMPLETED|Overall Study||13
2322876|NCT01857206|5701944|P2|COMPLETED|Overall Study||673
2322877|NCT01857206|5701945|P1|COMPLETED|Overall Study||1359
2322878|NCT01857206|5701944|P2|STARTED|Overall Study||683
2322879|NCT01857206|5701945|P1|STARTED|Overall Study||1372
2322880|NCT01857102|5701963|P2|NOT COMPLETED|Period 2||0
2322881|NCT01857102|5701964|P1|NOT COMPLETED|Period 2||2
2322882|NCT01857102|5701963|P2|COMPLETED|Period 2||51
2322883|NCT01857102|5701964|P1|COMPLETED|Period 2||53
2322884|NCT01857102|5701963|P2|Neophytes|Period 2||4
2322885|NCT01857102|5701964|P1|Neophytes|Period 2||7
2322886|NCT01857102|5701963|P2|Habitual Users|Period 2||47
2322887|NCT01857102|5701964|P1|Habitual Users|Period 2||48
2322888|NCT01857102|5701963|P2|STARTED|Period 2||51
2322889|NCT01857102|5701964|P1|STARTED|Period 2||55
2322890|NCT01857102|5701963|P2|NOT COMPLETED|Period 1||5
2322891|NCT01857102|5701964|P1|NOT COMPLETED|Period 1||3
2322892|NCT01857102|5701963|P2|COMPLETED|Period 1||51
2322893|NCT01857102|5701964|P1|COMPLETED|Period 1||55
2322894|NCT01857102|5701963|P2|Neophtyes|Period 1||4
2322895|NCT01857102|5701964|P1|Neophtyes|Period 1||7
2322896|NCT01857102|5701963|P2|Habitual Users|Period 1||52
2322897|NCT01857102|5701964|P1|Habitual Users|Period 1||51
2322898|NCT01857102|5701963|P2|STARTED|Period 1||56
2322899|NCT01857102|5701964|P1|STARTED|Period 1||58
2322900|NCT01857063|5701974|P2|NOT COMPLETED|Period 2 (7 Days)||2
2322901|NCT01857063|5701975|P1|NOT COMPLETED|Period 2 (7 Days)||4
2322902|NCT01857063|5701974|P2|COMPLETED|Period 2 (7 Days)||104
2322903|NCT01857063|5701975|P1|COMPLETED|Period 2 (7 Days)||104
2322904|NCT01857063|5701974|P2|STARTED|Period 2 (7 Days)||106
2322905|NCT01857063|5701975|P1|STARTED|Period 2 (7 Days)||108
2322906|NCT01857063|5701974|P2|NOT COMPLETED|Period 1 (7 Days)||4
2322907|NCT01857063|5701975|P1|NOT COMPLETED|Period 1 (7 Days)||2
2322908|NCT01857063|5701974|P2|COMPLETED|Period 1 (7 Days)||106
2322909|NCT01857063|5701975|P1|COMPLETED|Period 1 (7 Days)||108
2322910|NCT01857063|5701974|P2|STARTED|Period 1 (7 Days)||110
2322911|NCT01857063|5701975|P1|STARTED|Period 1 (7 Days)||110
2322912|NCT01856933|5702001|P1|NOT COMPLETED|Overall Study||0
2322913|NCT01856933|5702001|P1|COMPLETED|Overall Study||6
2322914|NCT01856933|5702001|P1|STARTED|Overall Study||6
2322915|NCT01856907|5702009|P3|NOT COMPLETED|Overall Study||0
2322916|NCT01856907|5702010|P2|NOT COMPLETED|Overall Study||3
2322917|NCT01856907|5702011|P1|NOT COMPLETED|Overall Study||0
2322918|NCT01856907|5702009|P3|COMPLETED|Overall Study||12
2322919|NCT01856907|5702010|P2|COMPLETED|Overall Study||9
2322920|NCT01856907|5702011|P1|COMPLETED|Overall Study||12
2322921|NCT01856907|5702009|P3|STARTED|Overall Study||12
2322922|NCT01856907|5702010|P2|STARTED|Overall Study||12
2322923|NCT01856907|5702011|P1|STARTED|Overall Study||12
2322924|NCT01856790|5702049|P1|NOT COMPLETED|Closed Loop Control + Liraglutide||2
2322925|NCT01856790|5702049|P1|COMPLETED|Closed Loop Control + Liraglutide||11
2322926|NCT01856790|5702049|P1|STARTED|Closed Loop Control + Liraglutide||13
2322927|NCT01856790|5702049|P1|NOT COMPLETED|Closed Loop Control||2
2322928|NCT01856790|5702049|P1|COMPLETED|Closed Loop Control||13
2322929|NCT01856790|5702049|P1|STARTED|Closed Loop Control||15
2322930|NCT01856764|5702075|P2|NOT COMPLETED|Overall Study||0
2322931|NCT01856764|5702076|P1|NOT COMPLETED|Overall Study||0
2322932|NCT01856764|5702075|P2|COMPLETED|Overall Study||20
2322933|NCT01856764|5702076|P1|COMPLETED|Overall Study||20
2322934|NCT01856764|5702075|P2|STARTED|Overall Study||20
2322935|NCT01856764|5702076|P1|STARTED|Overall Study||20
2322936|NCT01856712|5702088|P2|NOT COMPLETED|Overall Study||3
2322937|NCT01856712|5702089|P1|NOT COMPLETED|Overall Study||7
2322938|NCT01856712|5702088|P2|COMPLETED|Overall Study||19
2322939|NCT01856712|5702089|P1|COMPLETED|Overall Study||16
2322940|NCT01856712|5702088|P2|Lost to 45 Day Follow up|Overall Study||1
2322941|NCT01856712|5702089|P1|Lost to 45 Day Follow up|Overall Study||1
2322942|NCT01856712|5702088|P2|Lost to 14 Day Follow up|Overall Study||2
2322943|NCT01856712|5702089|P1|Lost to 14 Day Follow up|Overall Study||6
2322944|NCT01856712|5702088|P2|STARTED|Overall Study|1 received oral in error thus randomized.|22
2322945|NCT01856712|5702089|P1|STARTED|Overall Study||23
2322946|NCT01856686|5702103|P2|NOT COMPLETED|Overall Study||11
2322947|NCT01856686|5702104|P1|NOT COMPLETED|Overall Study||5
2322948|NCT01856686|5702103|P2|COMPLETED|Overall Study||22
2322949|NCT01856686|5702104|P1|COMPLETED|Overall Study||26
2322950|NCT01856686|5702103|P2|STARTED|Overall Study||33
2322951|NCT01856686|5702104|P1|STARTED|Overall Study||31
2322952|NCT01856673|5702147|P3|NOT COMPLETED|Overall Study||34
2322953|NCT01856673|5702148|P2|NOT COMPLETED|Overall Study||85
2322954|NCT01856673|5702149|P1|NOT COMPLETED|Overall Study||98
2322955|NCT01856673|5702147|P3|COMPLETED|Overall Study||137
2322956|NCT01856673|5702148|P2|COMPLETED|Overall Study|A percentage of 80.9% completed the follow-up (exit survey)|90
2322957|NCT01856673|5702149|P1|COMPLETED|Overall Study|A percentage of 75.1% completed the follow-up (exit survey)|77
2322958|NCT01856673|5702147|P3|Quibdó Participants|Overall Study||83
2322959|NCT01856673|5702148|P2|Quibdó Participants|Overall Study||86
2322960|NCT01856673|5702149|P1|Quibdó Participants|Overall Study||83
2322961|NCT01856673|5702147|P3|Buenaventura Participants|Overall Study||88
2322962|NCT01856673|5702148|P2|Buenaventura Participants|Overall Study||89
2322963|NCT01856673|5702149|P1|Buenaventura Participants|Overall Study||92
2322964|NCT01856673|5702147|P3|STARTED|Overall Study||171
2322965|NCT01856673|5702148|P2|STARTED|Overall Study||175
2322966|NCT01856673|5702149|P1|STARTED|Overall Study||175
2322967|NCT01856595|5702169|P9|NOT COMPLETED|Overall Study||0
2322968|NCT01856595|5702170|P8|NOT COMPLETED|Overall Study||0
2322969|NCT01856595|5702171|P7|NOT COMPLETED|Overall Study||1
2322970|NCT01856595|5702172|P6|NOT COMPLETED|Overall Study||0
2322971|NCT01856595|5702173|P5|NOT COMPLETED|Overall Study||0
2322972|NCT01856595|5702174|P4|NOT COMPLETED|Overall Study||0
2322973|NCT01856595|5702175|P3|NOT COMPLETED|Overall Study||0
2322974|NCT01856595|5702176|P2|NOT COMPLETED|Overall Study||1
2322975|NCT01856595|5702177|P1|NOT COMPLETED|Overall Study||0
2322976|NCT01856595|5702169|P9|COMPLETED|Overall Study||14
2322977|NCT01856595|5702170|P8|COMPLETED|Overall Study||10
2322978|NCT01856595|5702171|P7|COMPLETED|Overall Study||12
2322979|NCT01856595|5702172|P6|COMPLETED|Overall Study||12
2322980|NCT01856595|5702173|P5|COMPLETED|Overall Study||14
2322981|NCT01856595|5702174|P4|COMPLETED|Overall Study||12
2322982|NCT01856595|5702175|P3|COMPLETED|Overall Study||12
2322983|NCT01856595|5702176|P2|COMPLETED|Overall Study||11
2322984|NCT01856595|5702177|P1|COMPLETED|Overall Study||18
2322985|NCT01856595|5702169|P9|STARTED|Overall Study||14
2322986|NCT01856595|5702170|P8|STARTED|Overall Study||10
2322987|NCT01856595|5702171|P7|STARTED|Overall Study||13
2322988|NCT01856595|5702172|P6|STARTED|Overall Study||12
2322989|NCT01856595|5702173|P5|STARTED|Overall Study||14
2322990|NCT01856595|5702174|P4|STARTED|Overall Study||12
2322991|NCT01856595|5702175|P3|STARTED|Overall Study||12
2322992|NCT01856595|5702176|P2|STARTED|Overall Study||12
2322993|NCT01856595|5702177|P1|STARTED|Overall Study||18
2322994|NCT01856582|5702410|P1|NOT COMPLETED|Overall Study||1
2322995|NCT01856582|5702410|P1|COMPLETED|Overall Study||22
2322996|NCT01856582|5702410|P1|STARTED|Overall Study||23
2322997|NCT01856569|5702414|P1|NOT COMPLETED|Overall Study||13
2322998|NCT01856569|5702414|P1|COMPLETED|Overall Study||139
2322999|NCT01856569|5702414|P1|Full Analysis Set|Overall Study||144
2323000|NCT01856569|5702414|P1|STARTED|Overall Study||152
2323001|NCT01856543|5702425|P2|NOT COMPLETED|Overall Study||6
2323002|NCT01856543|5702426|P1|NOT COMPLETED|Overall Study||13
2323003|NCT01856543|5702425|P2|COMPLETED|Overall Study||64
2323004|NCT01856543|5702426|P1|COMPLETED|Overall Study||60
2323005|NCT01856543|5702425|P2|STARTED|Overall Study||70
2323006|NCT01856543|5702426|P1|STARTED|Overall Study||73
2323007|NCT01856530|5702438|P2|NOT COMPLETED|Overall Study||0
2323008|NCT01856530|5702439|P1|NOT COMPLETED|Overall Study||0
2323009|NCT01856530|5702438|P2|COMPLETED|Overall Study||27
2323010|NCT01856530|5702439|P1|COMPLETED|Overall Study||27
2323011|NCT01856530|5702438|P2|STARTED|Overall Study||27
2323012|NCT01856530|5702439|P1|STARTED|Overall Study||27
2323013|NCT01856491|5702455|P1|NOT COMPLETED|Overall Study||15
2323014|NCT01856491|5702455|P1|COMPLETED|Overall Study||152
2323015|NCT01856491|5702455|P1|STARTED|Overall Study||167
2323016|NCT01856361|5702466|P2|NOT COMPLETED|Overall Study||0
2323017|NCT01856361|5702467|P1|NOT COMPLETED|Overall Study||0
2323018|NCT01856361|5702466|P2|COMPLETED|Overall Study||1
2323019|NCT01856361|5702467|P1|COMPLETED|Overall Study||1
2323020|NCT01856361|5702466|P2|STARTED|Overall Study||1
2323021|NCT01856361|5702467|P1|STARTED|Overall Study||1
2323022|NCT01856322|5702484|P3|NOT COMPLETED|Overall Study||3
2323023|NCT01856322|5702485|P2|NOT COMPLETED|Overall Study||0
2323024|NCT01856322|5702486|P1|NOT COMPLETED|Overall Study||0
2323025|NCT01856322|5702484|P3|COMPLETED|Overall Study||0
2323026|NCT01856322|5702485|P2|COMPLETED|Overall Study||0
2323027|NCT01856322|5702486|P1|COMPLETED|Overall Study||0
2323028|NCT01856322|5702484|P3|STARTED|Overall Study||3
2323029|NCT01856322|5702485|P2|STARTED|Overall Study||0
2323030|NCT01856322|5702486|P1|STARTED|Overall Study||0
2323031|NCT01856309|5702497|P4|NOT COMPLETED|Overall Study||609
2323032|NCT01856309|5702498|P3|NOT COMPLETED|Overall Study||595
2323033|NCT01856309|5702499|P2|NOT COMPLETED|Overall Study||288
2323034|NCT01856309|5702500|P1|NOT COMPLETED|Overall Study||299
2323035|NCT01856309|5702497|P4|COMPLETED|Overall Study||9
2323036|NCT01856309|5702498|P3|COMPLETED|Overall Study||11
2323037|NCT01856309|5702499|P2|COMPLETED|Overall Study||3
2323038|NCT01856309|5702500|P1|COMPLETED|Overall Study||6
2323039|NCT01856309|5702497|P4|Treated Partcipants|Overall Study||618
2323040|NCT01856309|5702498|P3|Treated Partcipants|Overall Study||605
2323041|NCT01856309|5702499|P2|Treated Partcipants|Overall Study||290
2323042|NCT01856309|5702500|P1|Treated Partcipants|Overall Study||305
2323043|NCT01856309|5702497|P4|Participants From Study CNTO136ARA3003|Overall Study||206
2323044|NCT01856309|5702498|P3|Participants From Study CNTO136ARA3003|Overall Study||201
2323045|NCT01856309|5702499|P2|Participants From Study CNTO136ARA3003|Overall Study||104
2323046|NCT01856309|5702500|P1|Participants From Study CNTO136ARA3003|Overall Study||108
2323047|NCT01856309|5702497|P4|Participants From Study CNTO136ARA3002|Overall Study||412
2323048|NCT01856309|5702498|P3|Participants From Study CNTO136ARA3002|Overall Study||405
2323049|NCT01856309|5702499|P2|Participants From Study CNTO136ARA3002|Overall Study||187
2323050|NCT01856309|5702500|P1|Participants From Study CNTO136ARA3002|Overall Study||197
2323051|NCT01856309|5702497|P4|STARTED|Overall Study||618
2323052|NCT01856309|5702498|P3|STARTED|Overall Study||606
2323053|NCT01856309|5702499|P2|STARTED|Overall Study||291
2323054|NCT01856309|5702500|P1|STARTED|Overall Study||305
2323055|NCT01856270|5702600|P2|NOT COMPLETED|Overall Study||12
2323056|NCT01856270|5702601|P1|NOT COMPLETED|Overall Study||11
2323057|NCT01856270|5702600|P2|COMPLETED|Overall Study||14
2323058|NCT01856270|5702601|P1|COMPLETED|Overall Study||13
2323059|NCT01856270|5702600|P2|STARTED|Overall Study||26
2323060|NCT01856270|5702601|P1|STARTED|Overall Study||24
2323061|NCT01856257|5702624|P4|NOT COMPLETED|Overall Study||2
2323062|NCT01856257|5702625|P3|NOT COMPLETED|Overall Study||0
2323063|NCT01856257|5702626|P2|NOT COMPLETED|Overall Study||1
2323064|NCT01856257|5702627|P1|NOT COMPLETED|Overall Study||3
2323065|NCT01856257|5702624|P4|COMPLETED|Overall Study||0
2323066|NCT01856257|5702625|P3|COMPLETED|Overall Study||11
2323067|NCT01856257|5702626|P2|COMPLETED|Overall Study||28
2323068|NCT01856257|5702627|P1|COMPLETED|Overall Study||26
2323069|NCT01856257|5702624|P4|STARTED|Overall Study||2
2323070|NCT01856257|5702625|P3|STARTED|Overall Study||11
2323071|NCT01856257|5702626|P2|STARTED|Overall Study||29
2323072|NCT01856257|5702627|P1|STARTED|Overall Study||29
2323073|NCT01856218|5702726|P1|NOT COMPLETED|Long-Term Extension Phase||0
2323074|NCT01856218|5702726|P1|COMPLETED|Long-Term Extension Phase||3
2323075|NCT01856218|5702726|P1|STARTED|Long-Term Extension Phase||3
2323076|NCT01856218|5702726|P1|NOT COMPLETED|First Phase||0
2323077|NCT01856218|5702726|P1|COMPLETED|First Phase||3
2323078|NCT01856218|5702726|P1|STARTED|First Phase||3
2323079|NCT01855997|5702740|P1|NOT COMPLETED|Overall Study||0
2323080|NCT01855997|5702740|P1|COMPLETED|Overall Study||1669
2323081|NCT01855997|5702740|P1|STARTED|Overall Study||1669
2323082|NCT01855958|5702795|P2|NOT COMPLETED|Overall Study||0
2323083|NCT01855958|5702796|P1|NOT COMPLETED|Overall Study||1
2323084|NCT01855958|5702795|P2|COMPLETED|Overall Study||13
2323085|NCT01855958|5702796|P1|COMPLETED|Overall Study||12
2323086|NCT01855958|5702795|P2|STARTED|Overall Study||13
2323087|NCT01855958|5702796|P1|STARTED|Overall Study||13
2323088|NCT01855945|5702826|P12|NOT COMPLETED|Overall Study||3
2323089|NCT01855945|5702827|P11|NOT COMPLETED|Overall Study||5
2323090|NCT01855945|5702828|P10|NOT COMPLETED|Overall Study||2
2323091|NCT01855945|5702829|P9|NOT COMPLETED|Overall Study||2
2323092|NCT01855945|5702830|P8|NOT COMPLETED|Overall Study||8
2323093|NCT01855945|5702831|P7|NOT COMPLETED|Overall Study||10
2323094|NCT01855945|5702832|P6|NOT COMPLETED|Overall Study||3
2323095|NCT01855945|5702833|P5|NOT COMPLETED|Overall Study||1
2323096|NCT01855945|5702834|P4|NOT COMPLETED|Overall Study||4
2323097|NCT01855945|5702835|P3|NOT COMPLETED|Overall Study||12
2323098|NCT01855945|5702836|P2|NOT COMPLETED|Overall Study||11
2323099|NCT01855945|5702837|P1|NOT COMPLETED|Overall Study||16
2323100|NCT01855945|5702826|P12|COMPLETED|Overall Study||49
2323101|NCT01855945|5702827|P11|COMPLETED|Overall Study||46
2323102|NCT01855945|5702828|P10|COMPLETED|Overall Study||49
2323103|NCT01855945|5702829|P9|COMPLETED|Overall Study||46
2323104|NCT01855945|5702830|P8|COMPLETED|Overall Study||47
2323105|NCT01855945|5702831|P7|COMPLETED|Overall Study||43
2323106|NCT01855945|5702832|P6|COMPLETED|Overall Study||50
2323107|NCT01855945|5702833|P5|COMPLETED|Overall Study||50
2323108|NCT01855945|5702834|P4|COMPLETED|Overall Study||49
2323109|NCT01855945|5702835|P3|COMPLETED|Overall Study||39
2323110|NCT01855945|5702836|P2|COMPLETED|Overall Study||44
2323111|NCT01855945|5702837|P1|COMPLETED|Overall Study||38
2323112|NCT01855945|5702826|P12|STARTED|Overall Study||52
2323113|NCT01855945|5702827|P11|STARTED|Overall Study||51
2323114|NCT01855945|5702828|P10|STARTED|Overall Study||51
2323115|NCT01855945|5702829|P9|STARTED|Overall Study||48
2323116|NCT01855945|5702830|P8|STARTED|Overall Study||55
2323117|NCT01855945|5702831|P7|STARTED|Overall Study||53
2323118|NCT01855945|5702832|P6|STARTED|Overall Study||53
2323119|NCT01855945|5702833|P5|STARTED|Overall Study||51
2323120|NCT01855945|5702834|P4|STARTED|Overall Study||53
2323121|NCT01855945|5702835|P3|STARTED|Overall Study||51
2323122|NCT01855945|5702836|P2|STARTED|Overall Study||55
2323123|NCT01855945|5702837|P1|STARTED|Overall Study||54
2323124|NCT01855919|5702973|P2|NOT COMPLETED|Overall Study||26
2323125|NCT01855919|5702974|P1|NOT COMPLETED|Overall Study||23
2323126|NCT01855919|5702973|P2|COMPLETED|Overall Study||200
2323127|NCT01855919|5702974|P1|COMPLETED|Overall Study||209
2323128|NCT01855919|5702973|P2|Received at Least 1 Dose of Study Drug|Overall Study||226
2323129|NCT01855919|5702974|P1|Received at Least 1 Dose of Study Drug|Overall Study||232
2323130|NCT01855919|5702973|P2|STARTED|Overall Study||226
2323131|NCT01855919|5702974|P1|STARTED|Overall Study||232
2323132|NCT01855789|5703006|P4|NOT COMPLETED|2) Week 24 up to End of Study||58
2323133|NCT01855789|5703007|P3|NOT COMPLETED|2) Week 24 up to End of Study||18
2323134|NCT01855789|5703008|P2|NOT COMPLETED|2) Week 24 up to End of Study||15
2323135|NCT01855789|5703009|P1|NOT COMPLETED|2) Week 24 up to End of Study||0
2323136|NCT01855789|5703006|P4|COMPLETED|2) Week 24 up to End of Study||250
2323137|NCT01855789|5703007|P3|COMPLETED|2) Week 24 up to End of Study||129
2323138|NCT01855789|5703008|P2|COMPLETED|2) Week 24 up to End of Study||132
2323139|NCT01855789|5703009|P1|COMPLETED|2) Week 24 up to End of Study||0
2323140|NCT01855789|5703006|P4|STARTED|2) Week 24 up to End of Study||308
2323141|NCT01855789|5703007|P3|STARTED|2) Week 24 up to End of Study||147
2323142|NCT01855789|5703008|P2|STARTED|2) Week 24 up to End of Study||147
2323143|NCT01855789|5703009|P1|STARTED|2) Week 24 up to End of Study||0
2323144|NCT01855789|5703006|P4|NOT COMPLETED|1) Baseline up to Week 24||0
2323145|NCT01855789|5703007|P3|NOT COMPLETED|1) Baseline up to Week 24||0
2323146|NCT01855789|5703008|P2|NOT COMPLETED|1) Baseline up to Week 24||0
2323147|NCT01855789|5703009|P1|NOT COMPLETED|1) Baseline up to Week 24||116
2323148|NCT01855789|5703006|P4|COMPLETED|1) Baseline up to Week 24||0
2323149|NCT01855789|5703007|P3|COMPLETED|1) Baseline up to Week 24||0
2323150|NCT01855789|5703008|P2|COMPLETED|1) Baseline up to Week 24||0
2323151|NCT01855789|5703009|P1|COMPLETED|1) Baseline up to Week 24||602
2323152|NCT01855789|5703006|P4|STARTED|1) Baseline up to Week 24||0
2323153|NCT01855789|5703007|P3|STARTED|1) Baseline up to Week 24||0
2323154|NCT01855789|5703008|P2|STARTED|1) Baseline up to Week 24||0
2323155|NCT01855789|5703009|P1|STARTED|1) Baseline up to Week 24||718
2323156|NCT01855750|5703033|P2|NOT COMPLETED|Overall Study||106
2323157|NCT01855750|5703034|P1|NOT COMPLETED|Overall Study||107
2323158|NCT01855750|5703033|P2|COMPLETED|Overall Study||313
2323159|NCT01855750|5703034|P1|COMPLETED|Overall Study||312
2323160|NCT01855750|5703033|P2|Treated|Overall Study|1 participant not treated: withdrew consent.|418
2323161|NCT01855750|5703034|P1|Treated|Overall Study|3 participants not treated:2 withdrew consent and 1 not treated per Sponsor/investigator's decision.|416
2323162|NCT01855750|5703033|P2|STARTED|Overall Study||419
2323163|NCT01855750|5703034|P1|STARTED|Overall Study||419
2323164|NCT01855425|5703050|P1|NOT COMPLETED|Overall Study||20
2323165|NCT01855425|5703050|P1|COMPLETED|Overall Study||76
2323166|NCT01855425|5703050|P1|STARTED|Overall Study||96
2323167|NCT01855399|5703056|P2|NOT COMPLETED|12 Month||11
2323168|NCT01855399|5703057|P1|NOT COMPLETED|12 Month||7
2323169|NCT01855399|5703056|P2|COMPLETED|12 Month||118
2323170|NCT01855399|5703057|P1|COMPLETED|12 Month||119
2323171|NCT01855399|5703056|P2|STARTED|12 Month||129
2323172|NCT01855399|5703057|P1|STARTED|12 Month||126
2323173|NCT01855399|5703056|P2|NOT COMPLETED|6 Month||15
2323174|NCT01855399|5703057|P1|NOT COMPLETED|6 Month||20
2323175|NCT01855399|5703056|P2|COMPLETED|6 Month||129
2323176|NCT01855399|5703057|P1|COMPLETED|6 Month||126
2323177|NCT01855399|5703056|P2|STARTED|6 Month||144
2323178|NCT01855399|5703057|P1|STARTED|6 Month||146
2323179|NCT01855243|5703066|P3|NOT COMPLETED|Overall Study||0
2323180|NCT01855243|5703067|P2|NOT COMPLETED|Overall Study||0
2323181|NCT01855243|5703068|P1|NOT COMPLETED|Overall Study||1
2323182|NCT01855243|5703066|P3|COMPLETED|Overall Study||22
2323183|NCT01855243|5703067|P2|COMPLETED|Overall Study||21
2323184|NCT01855243|5703068|P1|COMPLETED|Overall Study||19
2323185|NCT01855243|5703066|P3|STARTED|Overall Study||22
2323186|NCT01855243|5703067|P2|STARTED|Overall Study||21
2323187|NCT01855243|5703068|P1|STARTED|Overall Study||20
2323188|NCT01855126|5703090|P2|NOT COMPLETED|Second Intervention (8 Weeks)||2
2323189|NCT01855126|5703091|P1|NOT COMPLETED|Second Intervention (8 Weeks)||2
2323190|NCT01855126|5703090|P2|COMPLETED|Second Intervention (8 Weeks)||14
2323191|NCT01855126|5703091|P1|COMPLETED|Second Intervention (8 Weeks)||18
2323192|NCT01855126|5703090|P2|STARTED|Second Intervention (8 Weeks)||16
2323193|NCT01855126|5703091|P1|STARTED|Second Intervention (8 Weeks)||20
2323194|NCT01855126|5703090|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
2323195|NCT01855126|5703091|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
2323196|NCT01855126|5703090|P2|COMPLETED|Washout Period (2 Weeks)||16
2323197|NCT01855126|5703091|P1|COMPLETED|Washout Period (2 Weeks)||20
2323198|NCT01855126|5703090|P2|STARTED|Washout Period (2 Weeks)||16
2323199|NCT01855126|5703091|P1|STARTED|Washout Period (2 Weeks)||20
2323200|NCT01855126|5703090|P2|NOT COMPLETED|First Intervention (8 Weeks)||6
2323201|NCT01855126|5703091|P1|NOT COMPLETED|First Intervention (8 Weeks)||4
2323202|NCT01855126|5703090|P2|COMPLETED|First Intervention (8 Weeks)||16
2323203|NCT01855126|5703091|P1|COMPLETED|First Intervention (8 Weeks)||20
2323204|NCT01855126|5703090|P2|STARTED|First Intervention (8 Weeks)||22
2323205|NCT01855126|5703091|P1|STARTED|First Intervention (8 Weeks)||24
2323206|NCT01855074|5703103|P1|NOT COMPLETED|Overall Study||14
2323207|NCT01855074|5703103|P1|COMPLETED|Overall Study||66
2323208|NCT01855074|5703103|P1|Treated|Overall Study||79
2323209|NCT01855074|5703103|P1|STARTED|Overall Study||80
2323210|NCT01854944|5703115|P3|NOT COMPLETED|Overall Study||1
2323211|NCT01854944|5703116|P2|NOT COMPLETED|Overall Study||0
2323212|NCT01854944|5703117|P1|NOT COMPLETED|Overall Study||0
2323213|NCT01854944|5703115|P3|COMPLETED|Overall Study||3
2323214|NCT01854944|5703116|P2|COMPLETED|Overall Study||4
2323215|NCT01854944|5703117|P1|COMPLETED|Overall Study||4
2323216|NCT01854944|5703115|P3|STARTED|Overall Study||4
2323217|NCT01854944|5703116|P2|STARTED|Overall Study||4
2323218|NCT01854944|5703117|P1|STARTED|Overall Study||4
2323219|NCT01854918|5703169|P2|NOT COMPLETED|All-IP Period (Years 2 and 3)||195
2323220|NCT01854918|5703170|P1|NOT COMPLETED|All-IP Period (Years 2 and 3)||118
2323221|NCT01854918|5703169|P2|COMPLETED|All-IP Period (Years 2 and 3)||2196
2323222|NCT01854918|5703170|P1|COMPLETED|All-IP Period (Years 2 and 3)||1079
2323223|NCT01854918|5703169|P2|Received Evolocumab|All-IP Period (Years 2 and 3)||2291
2323224|NCT01854918|5703170|P1|Received Evolocumab|All-IP Period (Years 2 and 3)||1152
2323225|NCT01854918|5703169|P2|STARTED|All-IP Period (Years 2 and 3)||2391
2323226|NCT01854918|5703170|P1|STARTED|All-IP Period (Years 2 and 3)||1197
2323227|NCT01854918|5703169|P2|NOT COMPLETED|SOC-controlled Period (Year 1)||63
2323228|NCT01854918|5703170|P1|NOT COMPLETED|SOC-controlled Period (Year 1)||30
2323229|NCT01854918|5703169|P2|COMPLETED|SOC-controlled Period (Year 1)||2391
2323230|NCT01854918|5703170|P1|COMPLETED|SOC-controlled Period (Year 1)||1197
2323231|NCT01854918|5703169|P2|Received Evolocumab|SOC-controlled Period (Year 1)||2452
2323232|NCT01854918|5703170|P1|Received Evolocumab|SOC-controlled Period (Year 1)|5 participants received evolocumab in error|5
2323233|NCT01854918|5703169|P2|STARTED|SOC-controlled Period (Year 1)||2454
2323234|NCT01854918|5703170|P1|STARTED|SOC-controlled Period (Year 1)||1227
2323235|NCT01854905|5703185|P1|NOT COMPLETED|Overall Study||0
2323236|NCT01854905|5703185|P1|COMPLETED|Overall Study||400
2323237|NCT01854905|5703185|P1|STARTED|Overall Study||400
2323238|NCT01854827|5703189|P1|NOT COMPLETED|Overall Study||1
2323239|NCT01854827|5703189|P1|COMPLETED|Overall Study||29
2323240|NCT01854827|5703189|P1|STARTED|Overall Study||30
2323241|NCT01854710|5703201|P6|NOT COMPLETED|Overall Study||2
2323242|NCT01854710|5703202|P5|NOT COMPLETED|Overall Study||2
2323243|NCT01854710|5703203|P4|NOT COMPLETED|Overall Study||2
2323244|NCT01854710|5703204|P3|NOT COMPLETED|Overall Study||2
2323245|NCT01854710|5703205|P2|NOT COMPLETED|Overall Study||3
2323246|NCT01854710|5703206|P1|NOT COMPLETED|Overall Study||4
2323247|NCT01854710|5703201|P6|COMPLETED|Overall Study||8
2323248|NCT01854710|5703202|P5|COMPLETED|Overall Study||8
2323249|NCT01854710|5703203|P4|COMPLETED|Overall Study||8
2323250|NCT01854710|5703204|P3|COMPLETED|Overall Study||8
2323251|NCT01854710|5703205|P2|COMPLETED|Overall Study||7
2323252|NCT01854710|5703206|P1|COMPLETED|Overall Study||6
2323253|NCT01854710|5703201|P6|STARTED|Overall Study||10
2323254|NCT01854710|5703202|P5|STARTED|Overall Study||10
2323255|NCT01854710|5703203|P4|STARTED|Overall Study||10
2323256|NCT01854710|5703204|P3|STARTED|Overall Study||10
2323257|NCT01854710|5703205|P2|STARTED|Overall Study||10
2323258|NCT01854710|5703206|P1|STARTED|Overall Study||10
2323259|NCT01854697|5703227|P5|NOT COMPLETED|Overall Study||2
2323260|NCT01854697|5703228|P4|NOT COMPLETED|Overall Study||3
2323261|NCT01854697|5703229|P3|NOT COMPLETED|Overall Study||2
2323262|NCT01854697|5703230|P2|NOT COMPLETED|Overall Study||3
2323263|NCT01854697|5703231|P1|NOT COMPLETED|Overall Study||6
2323264|NCT01854697|5703227|P5|COMPLETED|Overall Study||39
2323265|NCT01854697|5703228|P4|COMPLETED|Overall Study||80
2323266|NCT01854697|5703229|P3|COMPLETED|Overall Study||82
2323267|NCT01854697|5703230|P2|COMPLETED|Overall Study||31
2323268|NCT01854697|5703231|P1|COMPLETED|Overall Study||63
2323269|NCT01854697|5703227|P5|STARTED|Overall Study||41
2323270|NCT01854697|5703228|P4|STARTED|Overall Study||83
2323271|NCT01854697|5703229|P3|STARTED|Overall Study||84
2323272|NCT01854697|5703230|P2|STARTED|Overall Study||34
2323273|NCT01854697|5703231|P1|STARTED|Overall Study||69
2323274|NCT01854658|5703275|P4|NOT COMPLETED|Overall Study||59
2323275|NCT01854658|5703276|P3|NOT COMPLETED|Overall Study||80
2323276|NCT01854658|5703277|P2|NOT COMPLETED|Overall Study||75
2323277|NCT01854658|5703278|P1|NOT COMPLETED|Overall Study||93
2323278|NCT01854658|5703275|P4|COMPLETED|Overall Study||165
2323279|NCT01854658|5703276|P3|COMPLETED|Overall Study||432
2323280|NCT01854658|5703277|P2|COMPLETED|Overall Study||365
2323281|NCT01854658|5703278|P1|COMPLETED|Overall Study||346
2323282|NCT01854658|5703275|P4|STARTED|Overall Study||224
2323283|NCT01854658|5703276|P3|STARTED|Overall Study||512
2323284|NCT01854658|5703277|P2|STARTED|Overall Study||440
2323285|NCT01854658|5703278|P1|STARTED|Overall Study||439
2323286|NCT01854645|5703313|P5|NOT COMPLETED|Overall Study||60
2323287|NCT01854645|5703314|P4|NOT COMPLETED|Overall Study||62
2323288|NCT01854645|5703315|P3|NOT COMPLETED|Overall Study||82
2323289|NCT01854645|5703316|P2|NOT COMPLETED|Overall Study||106
2323290|NCT01854645|5703317|P1|NOT COMPLETED|Overall Study||98
2323291|NCT01854645|5703313|P5|COMPLETED|Overall Study||160
2323292|NCT01854645|5703314|P4|COMPLETED|Overall Study||391
2323293|NCT01854645|5703315|P3|COMPLETED|Overall Study||370
2323294|NCT01854645|5703316|P2|COMPLETED|Overall Study||345
2323295|NCT01854645|5703317|P1|COMPLETED|Overall Study||429
2323296|NCT01854645|5703313|P5|STARTED|Overall Study||220
2323297|NCT01854645|5703314|P4|STARTED|Overall Study||453
2323298|NCT01854645|5703315|P3|STARTED|Overall Study||452
2323299|NCT01854645|5703316|P2|STARTED|Overall Study||451
2323300|NCT01854645|5703317|P1|STARTED|Overall Study||527
2323301|NCT01854632|5703356|P2|NOT COMPLETED|Overall Study||13
2323302|NCT01854632|5703357|P1|NOT COMPLETED|Overall Study||26
2323303|NCT01854632|5703356|P2|COMPLETED|Overall Study||574
2323304|NCT01854632|5703357|P1|COMPLETED|Overall Study||1148
2323305|NCT01854632|5703356|P2|STARTED|Overall Study||587
2323306|NCT01854632|5703357|P1|STARTED|Overall Study||1174
2323307|NCT01854593|5703365|P2|NOT COMPLETED|Overall Study||1
2323308|NCT01854593|5703366|P1|NOT COMPLETED|Overall Study||2
2323309|NCT01854593|5703365|P2|COMPLETED|Overall Study||34
2323310|NCT01854593|5703366|P1|COMPLETED|Overall Study||32
2323311|NCT01854593|5703365|P2|STARTED|Overall Study||35
2323312|NCT01854593|5703366|P1|STARTED|Overall Study||34
2323313|NCT01854528|5703398|P2|NOT COMPLETED|Overall Study||15
2323314|NCT01854528|5703399|P1|NOT COMPLETED|Overall Study||0
2323315|NCT01854528|5703398|P2|COMPLETED|Overall Study||32
2323316|NCT01854528|5703399|P1|COMPLETED|Overall Study||101
2323317|NCT01854528|5703398|P2|STARTED|Overall Study||47
2323318|NCT01854528|5703399|P1|STARTED|Overall Study||101
2323319|NCT01854281|5703419|P4|NOT COMPLETED|Overall Study||0
2323320|NCT01854281|5703420|P3|NOT COMPLETED|Overall Study||0
2323321|NCT01854281|5703421|P2|NOT COMPLETED|Overall Study||0
2323322|NCT01854281|5703422|P1|NOT COMPLETED|Overall Study||0
2323323|NCT01854281|5703419|P4|COMPLETED|Overall Study||8
2323324|NCT01854281|5703420|P3|COMPLETED|Overall Study||5
2323325|NCT01854281|5703421|P2|COMPLETED|Overall Study||19
2323326|NCT01854281|5703422|P1|COMPLETED|Overall Study||15
2323327|NCT01854281|5703419|P4|STARTED|Overall Study||8
2323328|NCT01854281|5703420|P3|STARTED|Overall Study||5
2323329|NCT01854281|5703421|P2|STARTED|Overall Study||19
2323330|NCT01854281|5703422|P1|STARTED|Overall Study||15
2323331|NCT01854268|5703432|P1|NOT COMPLETED|Overall Study||0
2323332|NCT01854268|5703432|P1|COMPLETED|Overall Study||25
2323333|NCT01854268|5703432|P1|STARTED|Overall Study||25
2323334|NCT01854242|5703438|P1|NOT COMPLETED|Overall Study||0
2323335|NCT01854242|5703438|P1|COMPLETED|Overall Study||50
2323336|NCT01854242|5703438|P1|STARTED|Overall Study||50
2323337|NCT01854177|5703442|P1|NOT COMPLETED|Overall Study||0
2323338|NCT01854177|5703442|P1|COMPLETED|Overall Study||10
2323339|NCT01854177|5703442|P1|STARTED|Overall Study||10
2323340|NCT01854138|5703452|P2|NOT COMPLETED|Overall Study||52
2323341|NCT01854138|5703453|P1|NOT COMPLETED|Overall Study||0
2323342|NCT01854138|5703452|P2|COMPLETED|Overall Study||196
2323343|NCT01854138|5703453|P1|COMPLETED|Overall Study||400
2323344|NCT01854138|5703452|P2|STARTED|Overall Study||248
2323345|NCT01854138|5703453|P1|STARTED|Overall Study|historical control with waiver of authorization; no informed consent signed|400
2323346|NCT01854047|5703470|P5|NOT COMPLETED|Overall Study||19
2323347|NCT01854047|5703471|P4|NOT COMPLETED|Overall Study||15
2323348|NCT01854047|5703472|P3|NOT COMPLETED|Overall Study||13
2323349|NCT01854047|5703473|P2|NOT COMPLETED|Overall Study||8
2323350|NCT01854047|5703474|P1|NOT COMPLETED|Overall Study||12
2323351|NCT01854047|5703470|P5|COMPLETED|Overall Study||135
2323352|NCT01854047|5703471|P4|COMPLETED|Overall Study||142
2323353|NCT01854047|5703472|P3|COMPLETED|Overall Study||137
2323354|NCT01854047|5703473|P2|COMPLETED|Overall Study||149
2323355|NCT01854047|5703474|P1|COMPLETED|Overall Study||146
2323356|NCT01854047|5703470|P5|Completed 12-week Study Treatment|Overall Study||143
2323357|NCT01854047|5703471|P4|Completed 12-week Study Treatment|Overall Study||146
2323358|NCT01854047|5703472|P3|Completed 12-week Study Treatment|Overall Study||141
2323359|NCT01854047|5703473|P2|Completed 12-week Study Treatment|Overall Study||149
2323360|NCT01854047|5703474|P1|Completed 12-week Study Treatment|Overall Study||153
2323361|NCT01854047|5703470|P5|Treated|Overall Study||150
2323362|NCT01854047|5703471|P4|Treated|Overall Study||157
2323363|NCT01854047|5703472|P3|Treated|Overall Study||148
2323364|NCT01854047|5703473|P2|Treated|Overall Study||156
2323365|NCT01854047|5703474|P1|Treated|Overall Study||158
2323366|NCT01854047|5703470|P5|STARTED|Overall Study||154
2323367|NCT01854047|5703471|P4|STARTED|Overall Study||157
2323368|NCT01854047|5703472|P3|STARTED|Overall Study||150
2323369|NCT01854047|5703473|P2|STARTED|Overall Study||157
2323370|NCT01854047|5703474|P1|STARTED|Overall Study||158
2323371|NCT01854034|5703596|P1|NOT COMPLETED|Overall Study||0
2323372|NCT01854034|5703596|P1|COMPLETED|Overall Study||29
2323373|NCT01854034|5703596|P1|STARTED|Overall Study||29
2323374|NCT01853982|5703605|P2|NOT COMPLETED|Overall Study||1
2323375|NCT01853982|5703606|P1|NOT COMPLETED|Overall Study||2
2323376|NCT01853982|5703605|P2|COMPLETED|Overall Study||1
2323377|NCT01853982|5703606|P1|COMPLETED|Overall Study||0
2323378|NCT01853982|5703605|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
2323379|NCT01853982|5703606|P1|Received at Least 1 Dose of Study Drug|Overall Study||2
2323380|NCT01853982|5703605|P2|STARTED|Overall Study||2
2323381|NCT01853982|5703606|P1|STARTED|Overall Study||2
2323382|NCT01853930|5703614|P2|NOT COMPLETED|Overall Study||0
2323383|NCT01853930|5703615|P1|NOT COMPLETED|Overall Study||0
2323384|NCT01853930|5703614|P2|COMPLETED|Overall Study||8
2323385|NCT01853930|5703615|P1|COMPLETED|Overall Study||25
2323386|NCT01853930|5703614|P2|STARTED|Overall Study||8
2323387|NCT01853930|5703615|P1|STARTED|Overall Study||25
2323388|NCT01853878|5703623|P2|NOT COMPLETED|Overall Study||44
2323389|NCT01853878|5703624|P1|NOT COMPLETED|Overall Study||63
2323390|NCT01853878|5703623|P2|COMPLETED|Overall Study||3
2323391|NCT01853878|5703624|P1|COMPLETED|Overall Study||23
2323392|NCT01853878|5703623|P2|STARTED|Overall Study||47
2323393|NCT01853878|5703624|P1|STARTED|Overall Study||86
2323394|NCT01853839|5703648|P1|NOT COMPLETED|Overall Study||429
2323395|NCT01853839|5703648|P1|COMPLETED|Overall Study||1663
2323396|NCT01853839|5703648|P1|STARTED|Overall Study||2092
2323397|NCT01853774|5703670|P2|NOT COMPLETED|Overall Study||28
2323398|NCT01853774|5703671|P1|NOT COMPLETED|Overall Study||46
2323399|NCT01853774|5703670|P2|COMPLETED|Overall Study||134
2323400|NCT01853774|5703671|P1|COMPLETED|Overall Study||211
2323401|NCT01853774|5703670|P2|STARTED|Overall Study||162
2323402|NCT01853774|5703671|P1|STARTED|Overall Study||257
2323403|NCT01853696|5703681|P2|NOT COMPLETED|Overall Study||5
2323404|NCT01853696|5703682|P1|NOT COMPLETED|Overall Study||6
2323405|NCT01853696|5703681|P2|COMPLETED|Overall Study||78
2323406|NCT01853696|5703682|P1|COMPLETED|Overall Study||78
2323407|NCT01853696|5703681|P2|STARTED|Overall Study||83
2323408|NCT01853696|5703682|P1|STARTED|Overall Study||84
2323409|NCT01853618|5703695|P5|NOT COMPLETED|Overall Study||3
2323410|NCT01853618|5703696|P4|NOT COMPLETED|Overall Study||1
2323411|NCT01853618|5703697|P3|NOT COMPLETED|Overall Study||2
2323412|NCT01853618|5703698|P2|NOT COMPLETED|Overall Study||2
2323413|NCT01853618|5703699|P1|NOT COMPLETED|Overall Study||2
2323414|NCT01853618|5703695|P5|COMPLETED|Overall Study||17
2323415|NCT01853618|5703696|P4|COMPLETED|Overall Study||8
2323416|NCT01853618|5703697|P3|COMPLETED|Overall Study||10
2323417|NCT01853618|5703698|P2|COMPLETED|Overall Study||10
2323418|NCT01853618|5703699|P1|COMPLETED|Overall Study||6
2323419|NCT01853618|5703695|P5|STARTED|Overall Study||20
2323420|NCT01853618|5703696|P4|STARTED|Overall Study||9
2323421|NCT01853618|5703697|P3|STARTED|Overall Study||12
2323422|NCT01853618|5703698|P2|STARTED|Overall Study||12
2323423|NCT01853618|5703699|P1|STARTED|Overall Study||8
2323424|NCT01853605|5703730|P4|NOT COMPLETED|Overall Study||0
2323425|NCT01853605|5703731|P3|NOT COMPLETED|Overall Study||0
2323426|NCT01853605|5703732|P2|NOT COMPLETED|Overall Study||0
2323427|NCT01853605|5703733|P1|NOT COMPLETED|Overall Study||0
2323428|NCT01853605|5703730|P4|COMPLETED|Overall Study||428
2323429|NCT01853605|5703731|P3|COMPLETED|Overall Study||751
2323430|NCT01853605|5703732|P2|COMPLETED|Overall Study||693
2323431|NCT01853605|5703733|P1|COMPLETED|Overall Study||1939
2323432|NCT01853605|5703730|P4|STARTED|Overall Study||428
2323433|NCT01853605|5703731|P3|STARTED|Overall Study||751
2323434|NCT01853605|5703732|P2|STARTED|Overall Study||693
2323435|NCT01853605|5703733|P1|STARTED|Overall Study||1939
2323436|NCT01853553|5703753|P2|NOT COMPLETED|Overall Study||0
2323437|NCT01853553|5703754|P1|NOT COMPLETED|Overall Study||1
2323438|NCT01853553|5703753|P2|COMPLETED|Overall Study||32
2323439|NCT01853553|5703754|P1|COMPLETED|Overall Study||28
2323440|NCT01853553|5703753|P2|STARTED|Overall Study||32
2323441|NCT01853553|5703754|P1|STARTED|Overall Study||29
2323442|NCT01853475|5703765|P3|NOT COMPLETED|Overall Study||0
2323443|NCT01853475|5703766|P2|NOT COMPLETED|Overall Study||1
2323444|NCT01853475|5703767|P1|NOT COMPLETED|Overall Study||0
2323445|NCT01853475|5703765|P3|COMPLETED|Overall Study||8
2323446|NCT01853475|5703766|P2|COMPLETED|Overall Study||7
2323447|NCT01853475|5703767|P1|COMPLETED|Overall Study||8
2323448|NCT01853475|5703765|P3|STARTED|Overall Study||8
2323449|NCT01853475|5703766|P2|STARTED|Overall Study||8
2323450|NCT01853475|5703767|P1|STARTED|Overall Study||8
2323451|NCT01853462|5703786|P2|NOT COMPLETED|Overall Study||1
2323452|NCT01853462|5703787|P1|NOT COMPLETED|Overall Study||1
2323453|NCT01853462|5703786|P2|COMPLETED|Overall Study||10
2323454|NCT01853462|5703787|P1|COMPLETED|Overall Study||10
2323455|NCT01853462|5703786|P2|STARTED|Overall Study||11
2323456|NCT01853462|5703787|P1|STARTED|Overall Study||11
2323457|NCT01853397|5703857|P4|NOT COMPLETED|Overall Study||2
2323458|NCT01853397|5703858|P3|NOT COMPLETED|Overall Study||0
2323459|NCT01853397|5703859|P2|NOT COMPLETED|Overall Study||0
2323460|NCT01853397|5703860|P1|NOT COMPLETED|Overall Study||0
2323461|NCT01853397|5703857|P4|COMPLETED|Overall Study||15
2323462|NCT01853397|5703858|P3|COMPLETED|Overall Study||17
2323463|NCT01853397|5703859|P2|COMPLETED|Overall Study||20
2323464|NCT01853397|5703860|P1|COMPLETED|Overall Study||18
2323465|NCT01853397|5703857|P4|STARTED|Overall Study||17
2323466|NCT01853397|5703858|P3|STARTED|Overall Study||17
2323467|NCT01853397|5703859|P2|STARTED|Overall Study||20
2323468|NCT01853397|5703860|P1|STARTED|Overall Study||18
2323469|NCT01853384|5703888|P2|NOT COMPLETED|Completed Follow up Visit 2||3
2323470|NCT01853384|5703889|P1|NOT COMPLETED|Completed Follow up Visit 2||3
2323471|NCT01853384|5703888|P2|COMPLETED|Completed Follow up Visit 2||91
2323472|NCT01853384|5703889|P1|COMPLETED|Completed Follow up Visit 2||93
2323473|NCT01853384|5703888|P2|STARTED|Completed Follow up Visit 2||94
2323474|NCT01853384|5703889|P1|STARTED|Completed Follow up Visit 2||96
2323475|NCT01853384|5703888|P2|NOT COMPLETED|Completed Follow up Visit 1||9
2323476|NCT01853384|5703889|P1|NOT COMPLETED|Completed Follow up Visit 1||14
2323477|NCT01853384|5703888|P2|COMPLETED|Completed Follow up Visit 1||85
2323478|NCT01853384|5703889|P1|COMPLETED|Completed Follow up Visit 1||82
2323479|NCT01853384|5703888|P2|STARTED|Completed Follow up Visit 1||94
2323480|NCT01853384|5703889|P1|STARTED|Completed Follow up Visit 1||96
2323481|NCT01853384|5703888|P2|NOT COMPLETED|Enrolled in Follow up Period||0
2323482|NCT01853384|5703889|P1|NOT COMPLETED|Enrolled in Follow up Period||0
2323483|NCT01853384|5703888|P2|COMPLETED|Enrolled in Follow up Period||94
2323484|NCT01853384|5703889|P1|COMPLETED|Enrolled in Follow up Period||96
2323485|NCT01853384|5703888|P2|Not Enrolled in Follow-up|Enrolled in Follow up Period||27
2323486|NCT01853384|5703889|P1|Not Enrolled in Follow-up|Enrolled in Follow up Period||35
2323487|NCT01853384|5703888|P2|STARTED|Enrolled in Follow up Period||94
2323488|NCT01853384|5703889|P1|STARTED|Enrolled in Follow up Period||96
2323489|NCT01853384|5703888|P2|NOT COMPLETED|Randomized||46
2323490|NCT01853384|5703889|P1|NOT COMPLETED|Randomized||62
2323491|NCT01853384|5703888|P2|COMPLETED|Randomized||75
2323492|NCT01853384|5703889|P1|COMPLETED|Randomized||69
2323493|NCT01853384|5703888|P2|STARTED|Randomized||121
2323494|NCT01853384|5703889|P1|STARTED|Randomized||131
2323495|NCT01853371|5703909|P2|NOT COMPLETED|Overall Study||2
2323496|NCT01853371|5703910|P1|NOT COMPLETED|Overall Study||0
2323497|NCT01853371|5703909|P2|COMPLETED|Overall Study||8
2323498|NCT01853371|5703910|P1|COMPLETED|Overall Study||10
2323499|NCT01853371|5703909|P2|STARTED|Overall Study||10
2323500|NCT01853371|5703910|P1|STARTED|Overall Study||10
2323501|NCT01853332|5703918|P1|NOT COMPLETED|Overall Study||59
2323502|NCT01853332|5703918|P1|COMPLETED|Overall Study||151
2323503|NCT01853332|5703918|P1|STARTED|Overall Study||210
2323504|NCT01853280|5703929|P2|NOT COMPLETED|Overall Study||6
2323505|NCT01853280|5703930|P1|NOT COMPLETED|Overall Study||2
2323506|NCT01853280|5703929|P2|COMPLETED|Overall Study||16
2323507|NCT01853280|5703930|P1|COMPLETED|Overall Study||20
2323508|NCT01853280|5703929|P2|STARTED|Overall Study||22
2323509|NCT01853280|5703930|P1|STARTED|Overall Study||22
2323510|NCT01853254|5703936|P1|NOT COMPLETED|Overall Study||104
2323511|NCT01853254|5703936|P1|COMPLETED|Overall Study||168
2323512|NCT01853254|5703936|P1|STARTED|Overall Study||272
2323513|NCT01853228|5703940|P2|NOT COMPLETED|Phase 2||8
2323514|NCT01853228|5703941|P1|NOT COMPLETED|Phase 2||0
2323515|NCT01853228|5703940|P2|COMPLETED|Phase 2||0
2323516|NCT01853228|5703941|P1|COMPLETED|Phase 2||0
2323517|NCT01853228|5703940|P2|STARTED|Phase 2|1 additional participant was enrolled, making total of 8 participants evaluable in Phase 2.|8
2323518|NCT01853228|5703941|P1|STARTED|Phase 2||0
2323519|NCT01853228|5703940|P2|NOT COMPLETED|Phase 1||0
2323520|NCT01853228|5703941|P1|NOT COMPLETED|Phase 1||9
2323521|NCT01853228|5703940|P2|COMPLETED|Phase 1|Participants who completed Phase 1 moved to Phase 2.|7
2323522|NCT01853228|5703941|P1|COMPLETED|Phase 1||0
2323523|NCT01853228|5703940|P2|STARTED|Phase 1||7
2323524|NCT01853228|5703941|P1|STARTED|Phase 1||9
2323525|NCT01853215|5703958|P1|NOT COMPLETED|Overall Study||0
2323526|NCT01853215|5703958|P1|COMPLETED|Overall Study||24
2323527|NCT01853215|5703958|P1|STARTED|Overall Study||24
2323528|NCT01853176|5703971|P2|NOT COMPLETED|Overall Study||0
2323529|NCT01853176|5703972|P1|NOT COMPLETED|Overall Study||4
2323530|NCT01853176|5703971|P2|COMPLETED|Overall Study||0
2323531|NCT01853176|5703972|P1|COMPLETED|Overall Study||0
2323532|NCT01853176|5703971|P2|STARTED|Overall Study||0
2323533|NCT01853176|5703972|P1|STARTED|Overall Study||4
2323534|NCT01853085|5703978|P1|NOT COMPLETED|Overall Study||235
2323535|NCT01853085|5703978|P1|COMPLETED|Overall Study||1595
2323536|NCT01853085|5703978|P1|STARTED|Overall Study||1830
2323537|NCT01853072|5703991|P2|NOT COMPLETED|Overall Study||21
2323538|NCT01853072|5703992|P1|NOT COMPLETED|Overall Study||12
2323539|NCT01853072|5703991|P2|COMPLETED|Overall Study||286
2323540|NCT01853072|5703992|P1|COMPLETED|Overall Study||296
2323541|NCT01853072|5703991|P2|Full Analysis Set|Overall Study||300
2323542|NCT01853072|5703992|P1|Full Analysis Set|Overall Study||298
2323543|NCT01853072|5703991|P2|Treated (Safety Analysis Set)|Overall Study||302
2323544|NCT01853072|5703992|P1|Treated (Safety Analysis Set)|Overall Study||301
2323545|NCT01853072|5703991|P2|Randomized|Overall Study||307
2323546|NCT01853072|5703992|P1|Randomized|Overall Study||308
2323547|NCT01853072|5703991|P2|STARTED|Overall Study||307
2323548|NCT01853072|5703992|P1|STARTED|Overall Study||308
2323549|NCT01853046|5704012|P2|NOT COMPLETED|Overall Study||6
2323550|NCT01853046|5704013|P1|NOT COMPLETED|Overall Study||18
2323551|NCT01853046|5704012|P2|COMPLETED|Overall Study||0
2323552|NCT01853046|5704013|P1|COMPLETED|Overall Study||0
2323553|NCT01853046|5704012|P2|Received Treatment|Overall Study||6
2323554|NCT01853046|5704013|P1|Received Treatment|Overall Study||18
2323555|NCT01853046|5704012|P2|STARTED|Overall Study||6
2323556|NCT01853046|5704013|P1|STARTED|Overall Study||18
2323557|NCT01852955|5704067|P2|NOT COMPLETED|Overall Study||3
2323558|NCT01852955|5704068|P1|NOT COMPLETED|Overall Study||2
2323559|NCT01852955|5704067|P2|COMPLETED|Overall Study||32
2323560|NCT01852955|5704068|P1|COMPLETED|Overall Study||33
2323561|NCT01852955|5704067|P2|STARTED|Overall Study||35
2323562|NCT01852955|5704068|P1|STARTED|Overall Study||35
2323563|NCT01852825|5704081|P3|NOT COMPLETED|Overall Study||0
2323564|NCT01852825|5704082|P2|NOT COMPLETED|Overall Study||0
2323565|NCT01852825|5704083|P1|NOT COMPLETED|Overall Study||2
2323566|NCT01852825|5704081|P3|COMPLETED|Overall Study||3
2323567|NCT01852825|5704082|P2|COMPLETED|Overall Study||7
2323568|NCT01852825|5704083|P1|COMPLETED|Overall Study||14
2323569|NCT01852825|5704081|P3|STARTED|Overall Study||3
2323570|NCT01852825|5704082|P2|STARTED|Overall Study||7
2323571|NCT01852825|5704083|P1|STARTED|Overall Study||16
2323572|NCT01852812|5704109|P3|NOT COMPLETED|Overall Study||1
2323573|NCT01852812|5704110|P2|NOT COMPLETED|Overall Study||1
2323574|NCT01852812|5704111|P1|NOT COMPLETED|Overall Study||0
2323575|NCT01852812|5704109|P3|COMPLETED|Overall Study||17
2323576|NCT01852812|5704110|P2|COMPLETED|Overall Study||17
2323577|NCT01852812|5704111|P1|COMPLETED|Overall Study||51
2323578|NCT01852812|5704109|P3|STARTED|Overall Study||18
2323579|NCT01852812|5704110|P2|STARTED|Overall Study||18
2323580|NCT01852812|5704111|P1|STARTED|Overall Study||51
2323581|NCT01852799|5704131|P1|NOT COMPLETED|Overall Study||18
2323582|NCT01852799|5704131|P1|COMPLETED|Overall Study||0
2323583|NCT01852799|5704131|P1|STARTED|Overall Study||18
2323584|NCT01852669|5704142|P2|NOT COMPLETED|Overall Study||1
2323585|NCT01852669|5704143|P1|NOT COMPLETED|Overall Study||0
2323586|NCT01852669|5704142|P2|COMPLETED|Overall Study|Randomisation error. Patient has protocol violation which necessitated exclusion from analysis|68
2323587|NCT01852669|5704143|P1|COMPLETED|Overall Study||71
2323588|NCT01852669|5704142|P2|STARTED|Overall Study||69
2323589|NCT01852669|5704143|P1|STARTED|Overall Study||71
2323590|NCT01852591|5704149|P1|NOT COMPLETED|Overall Study||3
2323591|NCT01852591|5704149|P1|COMPLETED|Overall Study||5
2323592|NCT01852591|5704149|P1|STARTED|Overall Study||8
2323593|NCT01852383|5704156|P1|NOT COMPLETED|Overall Study||11
2323594|NCT01852383|5704156|P1|COMPLETED|Overall Study||19
2323595|NCT01852383|5704156|P1|STARTED|Overall Study||30
2323596|NCT01852344|5704167|P4|NOT COMPLETED|Overall Study||0
2323597|NCT01852344|5704168|P3|NOT COMPLETED|Overall Study||0
2323598|NCT01852344|5704169|P2|NOT COMPLETED|Overall Study||0
2323599|NCT01852344|5704170|P1|NOT COMPLETED|Overall Study||0
2323600|NCT01852344|5704167|P4|COMPLETED|Overall Study||27
2323601|NCT01852344|5704168|P3|COMPLETED|Overall Study||27
2323602|NCT01852344|5704169|P2|COMPLETED|Overall Study||27
2323603|NCT01852344|5704170|P1|COMPLETED|Overall Study||27
2323604|NCT01852344|5704167|P4|Actual Participation in First Assignment|Overall Study||27
2323605|NCT01852344|5704168|P3|Actual Participation in First Assignment|Overall Study||27
2323606|NCT01852344|5704169|P2|Actual Participation in First Assignment|Overall Study||27
2323607|NCT01852344|5704170|P1|Actual Participation in First Assignment|Overall Study||27
2323608|NCT01852344|5704167|P4|STARTED|Overall Study||27
2323609|NCT01852344|5704168|P3|STARTED|Overall Study||27
2323610|NCT01852344|5704169|P2|STARTED|Overall Study||27
2323611|NCT01852344|5704170|P1|STARTED|Overall Study||27
2323612|NCT01852292|5704190|P2|NOT COMPLETED|Overall Study||79
2323613|NCT01852292|5704191|P1|NOT COMPLETED|Overall Study||79
2323614|NCT01852292|5704190|P2|COMPLETED|Overall Study|Completed = participants who were ongoing and did not discontinue study treatment per protocol|0
2323615|NCT01852292|5704191|P1|COMPLETED|Overall Study|Completed = participants who were ongoing and did not discontinue study treatment per protocol|0
2323616|NCT01852292|5704190|P2|STARTED|Overall Study||79
2323617|NCT01852292|5704191|P1|STARTED|Overall Study||79
2323618|NCT01852214|5704215|P2|NOT COMPLETED|Period 2||0
2323619|NCT01852214|5704216|P1|NOT COMPLETED|Period 2||0
2323620|NCT01852214|5704215|P2|COMPLETED|Period 2||20
2323621|NCT01852214|5704216|P1|COMPLETED|Period 2||25
2323622|NCT01852214|5704215|P2|STARTED|Period 2||20
2323623|NCT01852214|5704216|P1|STARTED|Period 2||25
2323624|NCT01852214|5704215|P2|NOT COMPLETED|Washout Period||1
2323625|NCT01852214|5704216|P1|NOT COMPLETED|Washout Period||0
2323626|NCT01852214|5704215|P2|COMPLETED|Washout Period||20
2323627|NCT01852214|5704216|P1|COMPLETED|Washout Period||25
2323628|NCT01852214|5704215|P2|STARTED|Washout Period||21
2323629|NCT01852214|5704216|P1|STARTED|Washout Period||25
2323630|NCT01852214|5704215|P2|NOT COMPLETED|Period 1||3
2323631|NCT01852214|5704216|P1|NOT COMPLETED|Period 1||1
2323632|NCT01852214|5704215|P2|COMPLETED|Period 1||21
2323633|NCT01852214|5704216|P1|COMPLETED|Period 1||25
2323634|NCT01852214|5704215|P2|STARTED|Period 1||24
2323635|NCT01852214|5704216|P1|STARTED|Period 1||26
2323636|NCT01852201|5704230|P2|NOT COMPLETED|Overall Study||0
2323637|NCT01852201|5704231|P1|NOT COMPLETED|Overall Study||0
2323638|NCT01852201|5704230|P2|COMPLETED|Overall Study||12
2323639|NCT01852201|5704231|P1|COMPLETED|Overall Study||21
2323640|NCT01852201|5704230|P2|STARTED|Overall Study||12
2323641|NCT01852201|5704231|P1|STARTED|Overall Study||21
2323642|NCT01852175|5704255|P2|NOT COMPLETED|Overall Study||0
2323643|NCT01852175|5704256|P1|NOT COMPLETED|Overall Study||0
2323644|NCT01852175|5704255|P2|COMPLETED|Overall Study||55
2323645|NCT01852175|5704256|P1|COMPLETED|Overall Study||55
2323646|NCT01852175|5704255|P2|STARTED|Overall Study||55
2323647|NCT01852175|5704256|P1|STARTED|Overall Study||55
2323648|NCT01852162|5704268|P2|NOT COMPLETED|Overall Study||1
2323649|NCT01852162|5704269|P1|NOT COMPLETED|Overall Study||4
2323650|NCT01852162|5704268|P2|COMPLETED|Overall Study||16
2323651|NCT01852162|5704269|P1|COMPLETED|Overall Study||14
2323652|NCT01852162|5704268|P2|STARTED|Overall Study||17
2323653|NCT01852162|5704269|P1|STARTED|Overall Study||18
2323654|NCT01852110|5704285|P6|NOT COMPLETED|Overall Study||0
2323655|NCT01852110|5704286|P5|NOT COMPLETED|Overall Study||0
2323656|NCT01852110|5704287|P4|NOT COMPLETED|Overall Study||0
2323657|NCT01852110|5704288|P3|NOT COMPLETED|Overall Study||0
2323658|NCT01852110|5704289|P2|NOT COMPLETED|Overall Study||46
2323659|NCT01852110|5704290|P1|NOT COMPLETED|Overall Study||50
2323660|NCT01852110|5704285|P6|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
2323661|NCT01852110|5704286|P5|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
2323662|NCT01852110|5704287|P4|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
2323663|NCT01852110|5704288|P3|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
2323664|NCT01852110|5704289|P2|COMPLETED|Overall Study||74
2323665|NCT01852110|5704290|P1|COMPLETED|Overall Study||70
2323666|NCT01852110|5704285|P6|Treated|Overall Study||0
2323667|NCT01852110|5704286|P5|Treated|Overall Study||0
2323668|NCT01852110|5704287|P4|Treated|Overall Study||0
2323669|NCT01852110|5704288|P3|Treated|Overall Study||0
2323670|NCT01852110|5704289|P2|Treated|Overall Study||120
2323671|NCT01852110|5704290|P1|Treated|Overall Study||119
2323672|NCT01852110|5704285|P6|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
2323673|NCT01852110|5704286|P5|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
2323674|NCT01852110|5704287|P4|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
2323675|NCT01852110|5704288|P3|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
2323676|NCT01852110|5704289|P2|STARTED|Overall Study||120
2323677|NCT01852110|5704290|P1|STARTED|Overall Study||120
2323678|NCT01852045|5704321|P3|NOT COMPLETED|Overall Study||4
2323679|NCT01852045|5704322|P2|NOT COMPLETED|Overall Study||4
2323680|NCT01852045|5704323|P1|NOT COMPLETED|Overall Study||6
2323681|NCT01852045|5704321|P3|COMPLETED|Overall Study||26
2323682|NCT01852045|5704322|P2|COMPLETED|Overall Study||41
2323683|NCT01852045|5704323|P1|COMPLETED|Overall Study||33
2323684|NCT01852045|5704321|P3|Safety Population|Overall Study||30
2323685|NCT01852045|5704322|P2|Safety Population|Overall Study||45
2323686|NCT01852045|5704323|P1|Safety Population|Overall Study||38
2323687|NCT01852045|5704321|P3|mITT Population|Overall Study||30
2323688|NCT01852045|5704322|P2|mITT Population|Overall Study||45
2323689|NCT01852045|5704323|P1|mITT Population|Overall Study||38
2323690|NCT01852045|5704321|P3|STARTED|Overall Study||30
2323691|NCT01852045|5704322|P2|STARTED|Overall Study||45
2323692|NCT01852045|5704323|P1|STARTED|Overall Study||39
2323693|NCT01852032|5704361|P1|NOT COMPLETED|Overall Study||0
2323694|NCT01852032|5704361|P1|COMPLETED|Overall Study||23
2323695|NCT01852032|5704361|P1|STARTED|Overall Study||23
2323696|NCT01852019|5704371|P5|NOT COMPLETED|Day 8||0
2323697|NCT01852019|5704372|P4|NOT COMPLETED|Day 8||0
2323698|NCT01852019|5704373|P3|NOT COMPLETED|Day 8||0
2323699|NCT01852019|5704374|P2|NOT COMPLETED|Day 8||0
2323700|NCT01852019|5704375|P1|NOT COMPLETED|Day 8||0
2323701|NCT01852019|5704371|P5|COMPLETED|Day 8||6
2323702|NCT01852019|5704372|P4|COMPLETED|Day 8||6
2323703|NCT01852019|5704373|P3|COMPLETED|Day 8||0
2323704|NCT01852019|5704374|P2|COMPLETED|Day 8||0
2323705|NCT01852019|5704375|P1|COMPLETED|Day 8||0
2323706|NCT01852019|5704371|P5|STARTED|Day 8||6
2323707|NCT01852019|5704372|P4|STARTED|Day 8||6
2323708|NCT01852019|5704373|P3|STARTED|Day 8||0
2323709|NCT01852019|5704374|P2|STARTED|Day 8||0
2323710|NCT01852019|5704375|P1|STARTED|Day 8||0
2323711|NCT01852019|5704371|P5|NOT COMPLETED|Day 1||0
2323712|NCT01852019|5704372|P4|NOT COMPLETED|Day 1||0
2323713|NCT01852019|5704373|P3|NOT COMPLETED|Day 1||0
2323714|NCT01852019|5704374|P2|NOT COMPLETED|Day 1||0
2323715|NCT01852019|5704375|P1|NOT COMPLETED|Day 1||0
2323716|NCT01852019|5704371|P5|COMPLETED|Day 1||0
2323717|NCT01852019|5704372|P4|COMPLETED|Day 1||0
2323718|NCT01852019|5704373|P3|COMPLETED|Day 1||6
2323719|NCT01852019|5704374|P2|COMPLETED|Day 1||3
2323720|NCT01852019|5704375|P1|COMPLETED|Day 1||3
2323721|NCT01852019|5704371|P5|STARTED|Day 1||0
2323722|NCT01852019|5704372|P4|STARTED|Day 1||0
2323723|NCT01852019|5704373|P3|STARTED|Day 1||6
2323724|NCT01852019|5704374|P2|STARTED|Day 1||3
2323725|NCT01852019|5704375|P1|STARTED|Day 1||3
2323726|NCT01851876|5704396|P2|NOT COMPLETED|Overall Study||0
2323727|NCT01851876|5704397|P1|NOT COMPLETED|Overall Study||0
2323728|NCT01851876|5704396|P2|COMPLETED|Overall Study||62
2323729|NCT01851876|5704397|P1|COMPLETED|Overall Study||56
2323730|NCT01851876|5704396|P2|STARTED|Overall Study||62
2323731|NCT01851876|5704397|P1|STARTED|Overall Study||56
2323732|NCT01851863|5704407|P4|NOT COMPLETED|Overall Study||3
2323733|NCT01851863|5704408|P3|NOT COMPLETED|Overall Study||5
2323734|NCT01851863|5704409|P2|NOT COMPLETED|Overall Study||9
2323735|NCT01851863|5704410|P1|NOT COMPLETED|Overall Study||5
2323736|NCT01851863|5704407|P4|COMPLETED|Overall Study||63
2323737|NCT01851863|5704408|P3|COMPLETED|Overall Study||60
2323738|NCT01851863|5704409|P2|COMPLETED|Overall Study||57
2323739|NCT01851863|5704410|P1|COMPLETED|Overall Study||60
2323740|NCT01851863|5704407|P4|STARTED|Overall Study||66
2323741|NCT01851863|5704408|P3|STARTED|Overall Study||65
2323742|NCT01851863|5704409|P2|STARTED|Overall Study||66
2323743|NCT01851863|5704410|P1|STARTED|Overall Study||65
2323744|NCT01851772|5704431|P1|NOT COMPLETED|Overall Study||0
2323745|NCT01851772|5704431|P1|COMPLETED|Overall Study||3
2323746|NCT01851772|5704431|P1|STARTED|Overall Study||3
2323747|NCT01851720|5704439|P2|NOT COMPLETED|Overall Study||1
2323748|NCT01851720|5704440|P1|NOT COMPLETED|Overall Study||0
2323749|NCT01851720|5704439|P2|COMPLETED|Overall Study||0
2323750|NCT01851720|5704440|P1|COMPLETED|Overall Study||0
2323751|NCT01851720|5704439|P2|STARTED|Overall Study||1
2323752|NCT01851720|5704440|P1|STARTED|Overall Study||0
2323753|NCT01851655|5704448|P2|NOT COMPLETED|Overall Study||0
2323754|NCT01851655|5704449|P1|NOT COMPLETED|Overall Study||0
2323755|NCT01851655|5704448|P2|COMPLETED|Overall Study||12
2323756|NCT01851655|5704449|P1|COMPLETED|Overall Study||12
2323757|NCT01851655|5704448|P2|STARTED|Overall Study||12
2323758|NCT01851655|5704449|P1|STARTED|Overall Study||12
2323759|NCT01851590|5704470|P3|NOT COMPLETED|Overall Study||3
2323760|NCT01851590|5704471|P2|NOT COMPLETED|Overall Study||1
2323761|NCT01851590|5704472|P1|NOT COMPLETED|Overall Study||0
2323762|NCT01851590|5704470|P3|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|22
2323763|NCT01851590|5704471|P2|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|24
2323764|NCT01851590|5704472|P1|COMPLETED|Overall Study|All patients (23) were included in the ITT population and final outcome analyses.|23
2323765|NCT01851590|5704470|P3|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|22
2323766|NCT01851590|5704471|P2|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|24
2323767|NCT01851590|5704472|P1|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|23
2323768|NCT01851590|5704470|P3|At 9 Month: End of Topical Treatments|Overall Study|Washout period of the Terbinafine treatment arm continues.|22
2323769|NCT01851590|5704471|P2|At 9 Month: End of Topical Treatments|Overall Study|End of topical Amorolfine Lacquer treatment. Washout period of the Amorolfine treatment arm begins.|24
2323770|NCT01851590|5704472|P1|At 9 Month: End of Topical Treatments|Overall Study|End of topical Resin Lacquer treatment. Washout period of the Resin Lacquer treatment arm begins.|23
2323771|NCT01851590|5704470|P3|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|22
2323772|NCT01851590|5704471|P2|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|24
2323773|NCT01851590|5704472|P1|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|23
2323774|NCT01851590|5704470|P3|At 3 Month: End of Terbinafine Treatment|Overall Study|End of oral Terbinafine treatment. Washout period of the Terbinafine treatment arm begins.|22
2323775|NCT01851590|5704471|P2|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Amorolfine Lacquer Treatment continues ->|24
2323776|NCT01851590|5704472|P1|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Resin Lacquer treatment continues ->|23
2323777|NCT01851590|5704470|P3|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
2323778|NCT01851590|5704471|P2|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
2323779|NCT01851590|5704472|P1|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|23
2323780|NCT01851330|5704495|P3|NOT COMPLETED|Overall Study||12
2323781|NCT01851330|5704496|P2|NOT COMPLETED|Overall Study||16
2323782|NCT01851330|5704497|P1|NOT COMPLETED|Overall Study||13
2323783|NCT01851330|5704495|P3|COMPLETED|Overall Study||204
2323784|NCT01851330|5704496|P2|COMPLETED|Overall Study||200
2323785|NCT01851330|5704497|P1|COMPLETED|Overall Study||202
2323786|NCT01851330|5704495|P3|STARTED|Overall Study||216
2323787|NCT01851330|5704496|P2|STARTED|Overall Study||216
2323788|NCT01851330|5704497|P1|STARTED|Overall Study||215
2323789|NCT01851174|5704532|P1|NOT COMPLETED|Overall Study||0
2323790|NCT01851174|5704532|P1|COMPLETED|Overall Study||15
2323791|NCT01851174|5704532|P1|STARTED|Overall Study||15
2323792|NCT01850745|5704540|P3|NOT COMPLETED|Overall Study||0
2323793|NCT01850745|5704541|P2|NOT COMPLETED|Overall Study||0
2323794|NCT01850745|5704542|P1|NOT COMPLETED|Overall Study||0
2323795|NCT01850745|5704540|P3|COMPLETED|Overall Study||131
2323796|NCT01850745|5704541|P2|COMPLETED|Overall Study||169
2323797|NCT01850745|5704542|P1|COMPLETED|Overall Study||147
2323798|NCT01850745|5704540|P3|STARTED|Overall Study||131
2323799|NCT01850745|5704541|P2|STARTED|Overall Study||169
2323800|NCT01850745|5704542|P1|STARTED|Overall Study||147
2323801|NCT01850641|5704550|P1|NOT COMPLETED|Overall Study||5
2323802|NCT01850641|5704550|P1|COMPLETED|Overall Study||30
2323803|NCT01850641|5704550|P1|STARTED|Overall Study||35
2323804|NCT01850615|5704564|P2|NOT COMPLETED|Overall Study||5
2323805|NCT01850615|5704565|P1|NOT COMPLETED|Overall Study||9
2323806|NCT01850615|5704564|P2|COMPLETED|Overall Study||115
2323807|NCT01850615|5704565|P1|COMPLETED|Overall Study||107
2323808|NCT01850615|5704564|P2|Exposed|Overall Study||120
2323809|NCT01850615|5704565|P1|Exposed|Overall Study||115
2323810|NCT01850615|5704564|P2|STARTED|Overall Study||120
2323811|NCT01850615|5704565|P1|STARTED|Overall Study||116
2323812|NCT01850602|5704583|P2|NOT COMPLETED|Overall Study||18
2323813|NCT01850602|5704584|P1|NOT COMPLETED|Overall Study||14
2323814|NCT01850602|5704583|P2|COMPLETED|Overall Study||87
2323815|NCT01850602|5704584|P1|COMPLETED|Overall Study||94
2323816|NCT01850602|5704583|P2|STARTED|Overall Study||105
2323817|NCT01850602|5704584|P1|STARTED|Overall Study||108
2323818|NCT01850589|5704598|P2|NOT COMPLETED|Overall Study||0
2323819|NCT01850589|5704599|P1|NOT COMPLETED|Overall Study||8
2323820|NCT01850589|5704598|P2|COMPLETED|Overall Study||22
2323821|NCT01850589|5704599|P1|COMPLETED|Overall Study||14
2323822|NCT01850589|5704598|P2|STARTED|Overall Study||22
2323823|NCT01850589|5704599|P1|STARTED|Overall Study||22
2323824|NCT01850550|5704607|P2|NOT COMPLETED|Overall Study||3
2323825|NCT01850550|5704608|P1|NOT COMPLETED|Overall Study||0
2323826|NCT01850550|5704607|P2|COMPLETED|Overall Study||37
2323827|NCT01850550|5704608|P1|COMPLETED|Overall Study||40
2323828|NCT01850550|5704607|P2|STARTED|Overall Study||40
2323829|NCT01850550|5704608|P1|STARTED|Overall Study||40
2323830|NCT01850485|5704618|P2|NOT COMPLETED|Overall Study||0
2323831|NCT01850485|5704619|P1|NOT COMPLETED|Overall Study||0
2323832|NCT01850485|5704618|P2|COMPLETED|Overall Study||13
2323833|NCT01850485|5704619|P1|COMPLETED|Overall Study||9
2323834|NCT01850485|5704618|P2|STARTED|Overall Study||13
2323835|NCT01850485|5704619|P1|STARTED|Overall Study||9
2323836|NCT01850394|5704640|P3|NOT COMPLETED|Overall Study||0
2323837|NCT01850394|5704641|P2|NOT COMPLETED|Overall Study||0
2323838|NCT01850394|5704642|P1|NOT COMPLETED|Overall Study||0
2323839|NCT01850394|5704640|P3|COMPLETED|Overall Study||45
2323840|NCT01850394|5704641|P2|COMPLETED|Overall Study||45
2323841|NCT01850394|5704642|P1|COMPLETED|Overall Study||45
2323842|NCT01850394|5704640|P3|STARTED|Overall Study||45
2323843|NCT01850394|5704641|P2|STARTED|Overall Study||45
2323844|NCT01850394|5704642|P1|STARTED|Overall Study||45
2323845|NCT01850030|5704664|P2|NOT COMPLETED|Overall Study||369
2323846|NCT01850030|5704665|P1|NOT COMPLETED|Overall Study||347
2323847|NCT01850030|5704664|P2|COMPLETED|Overall Study||142
2323848|NCT01850030|5704665|P1|COMPLETED|Overall Study||173
2323849|NCT01850030|5704664|P2|STARTED|Overall Study||511
2323850|NCT01850030|5704665|P1|STARTED|Overall Study||520
2323851|NCT01850004|5704677|P1|NOT COMPLETED|Overall Study||8
2323852|NCT01850004|5704677|P1|COMPLETED|Overall Study||76
2323853|NCT01850004|5704677|P1|STARTED|Overall Study||84
2323854|NCT01849848|5704684|P1|NOT COMPLETED|Overall Study||4
2323855|NCT01849848|5704684|P1|COMPLETED|Overall Study||13
2323856|NCT01849848|5704684|P1|STARTED|Overall Study||17
2323857|NCT01849770|5704701|P3|NOT COMPLETED|Overall Study||1
2323858|NCT01849770|5704702|P2|NOT COMPLETED|Overall Study||4
2323859|NCT01849770|5704703|P1|NOT COMPLETED|Overall Study||0
2323860|NCT01849770|5704701|P3|COMPLETED|Overall Study||19
2323861|NCT01849770|5704702|P2|COMPLETED|Overall Study||15
2323862|NCT01849770|5704703|P1|COMPLETED|Overall Study||20
2323863|NCT01849770|5704701|P3|STARTED|Overall Study||20
2323864|NCT01849770|5704702|P2|STARTED|Overall Study||19
2323865|NCT01849770|5704703|P1|STARTED|Overall Study||20
2323866|NCT01849692|5704746|P8|NOT COMPLETED|Overall Study||0
2323867|NCT01849692|5704747|P7|NOT COMPLETED|Overall Study||0
2323868|NCT01849692|5704748|P6|NOT COMPLETED|Overall Study||0
2323869|NCT01849692|5704749|P5|NOT COMPLETED|Overall Study||0
2323870|NCT01849692|5704750|P4|NOT COMPLETED|Overall Study||0
2323871|NCT01849692|5704751|P3|NOT COMPLETED|Overall Study||0
2323872|NCT01849692|5704752|P2|NOT COMPLETED|Overall Study||0
2323873|NCT01849692|5704753|P1|NOT COMPLETED|Overall Study||0
2323874|NCT01849692|5704746|P8|COMPLETED|Overall Study||3
2323875|NCT01849692|5704747|P7|COMPLETED|Overall Study||10
2323876|NCT01849692|5704748|P6|COMPLETED|Overall Study||3
2323877|NCT01849692|5704749|P5|COMPLETED|Overall Study||10
2323878|NCT01849692|5704750|P4|COMPLETED|Overall Study||3
2323879|NCT01849692|5704751|P3|COMPLETED|Overall Study||10
2323880|NCT01849692|5704752|P2|COMPLETED|Overall Study||3
2323881|NCT01849692|5704753|P1|COMPLETED|Overall Study||10
2323882|NCT01849692|5704746|P8|STARTED|Overall Study||3
2323883|NCT01849692|5704747|P7|STARTED|Overall Study||10
2323884|NCT01849692|5704748|P6|STARTED|Overall Study||3
2323885|NCT01849692|5704749|P5|STARTED|Overall Study||10
2323886|NCT01849692|5704750|P4|STARTED|Overall Study||3
2323887|NCT01849692|5704751|P3|STARTED|Overall Study||10
2323888|NCT01849692|5704752|P2|STARTED|Overall Study||3
2323889|NCT01849692|5704753|P1|STARTED|Overall Study||10
2323890|NCT01849588|5704782|P1|NOT COMPLETED|Overall Study||3
2323891|NCT01849588|5704782|P1|COMPLETED|Overall Study||0
2323892|NCT01849588|5704782|P1|STARTED|Overall Study||3
2323893|NCT01849562|5704792|P3|NOT COMPLETED|Overall Study||0
2323894|NCT01849562|5704793|P2|NOT COMPLETED|Overall Study||0
2323895|NCT01849562|5704794|P1|NOT COMPLETED|Overall Study||2
2323896|NCT01849562|5704792|P3|COMPLETED|Overall Study||10
2323897|NCT01849562|5704793|P2|COMPLETED|Overall Study||10
2323898|NCT01849562|5704794|P1|COMPLETED|Overall Study||8
2323899|NCT01849562|5704792|P3|STARTED|Overall Study||10
2323900|NCT01849562|5704793|P2|STARTED|Overall Study||10
2323901|NCT01849562|5704794|P1|STARTED|Overall Study||10
2323902|NCT01849497|5704807|P2|NOT COMPLETED|Overall Study||4
2323903|NCT01849497|5704808|P1|NOT COMPLETED|Overall Study||1
2323904|NCT01849497|5704807|P2|COMPLETED|Overall Study||70
2323905|NCT01849497|5704808|P1|COMPLETED|Overall Study||74
2323906|NCT01849497|5704807|P2|Received Treatment|Overall Study||74
2323907|NCT01849497|5704808|P1|Received Treatment|Overall Study||75
2323908|NCT01849497|5704807|P2|STARTED|Overall Study||74
2323909|NCT01849497|5704808|P1|STARTED|Overall Study||75
2323910|NCT01849458|5704816|P1|NOT COMPLETED|Overall Study||4
2323911|NCT01849458|5704816|P1|COMPLETED|Overall Study||46
2323912|NCT01849458|5704816|P1|6 Months Follow-up|Overall Study||50
2323913|NCT01849458|5704816|P1|STARTED|Overall Study||50
2323914|NCT01849419|5704826|P1|NOT COMPLETED|Overall Study||0
2323915|NCT01849419|5704826|P1|COMPLETED|Overall Study||65
2323916|NCT01849419|5704826|P1|STARTED|Overall Study||65
2323917|NCT01849289|5704855|P2|NOT COMPLETED|Overall Study||24
2323918|NCT01849289|5704856|P1|NOT COMPLETED|Overall Study||32
2323919|NCT01849289|5704855|P2|COMPLETED|Overall Study||254
2323920|NCT01849289|5704856|P1|COMPLETED|Overall Study||523
2323921|NCT01849289|5704855|P2|Exposed|Overall Study||278
2323922|NCT01849289|5704856|P1|Exposed|Overall Study|2 subjects withdrew prior to exposure of trial products|553
2323923|NCT01849289|5704855|P2|STARTED|Overall Study||278
2323924|NCT01849289|5704856|P1|STARTED|Overall Study||555
2323925|NCT01849276|5704872|P1|NOT COMPLETED|Followed for Survival for 5 Years||2
2323926|NCT01849276|5704872|P1|COMPLETED|Followed for Survival for 5 Years||0
2323927|NCT01849276|5704872|P1|STARTED|Followed for Survival for 5 Years||2
2323928|NCT01849276|5704872|P1|NOT COMPLETED|Completed Treatment||0
2323929|NCT01849276|5704872|P1|COMPLETED|Completed Treatment||2
2323930|NCT01849276|5704872|P1|STARTED|Completed Treatment||2
2323931|NCT01849276|5704872|P1|NOT COMPLETED|Registered to the Study||0
2323932|NCT01849276|5704872|P1|COMPLETED|Registered to the Study||2
2323933|NCT01849276|5704872|P1|STARTED|Registered to the Study||2
2323934|NCT01849263|5704884|P1|NOT COMPLETED|Overall Study||0
2323935|NCT01849263|5704884|P1|COMPLETED|Overall Study||40
2323936|NCT01849263|5704884|P1|STARTED|Overall Study||40
2323937|NCT01849172|5704896|P2|NOT COMPLETED|Overall Study||6
2323938|NCT01849172|5704897|P1|NOT COMPLETED|Overall Study||7
2323939|NCT01849172|5704896|P2|COMPLETED|Overall Study||174
2323940|NCT01849172|5704897|P1|COMPLETED|Overall Study||173
2323941|NCT01849172|5704896|P2|STARTED|Overall Study||180
2323942|NCT01849172|5704897|P1|STARTED|Overall Study||180
2323943|NCT01849068|5704935|P2|NOT COMPLETED|Overall Study||0
2323944|NCT01849068|5704936|P1|NOT COMPLETED|Overall Study||0
2323945|NCT01849068|5704935|P2|COMPLETED|Overall Study||10
2323946|NCT01849068|5704936|P1|COMPLETED|Overall Study||10
2323947|NCT01849068|5704935|P2|STARTED|Overall Study||10
2323948|NCT01849068|5704936|P1|STARTED|Overall Study||10
2323949|NCT01849055|5704954|P6|NOT COMPLETED|Overall Study||0
2323950|NCT01849055|5704955|P5|NOT COMPLETED|Overall Study||0
2323951|NCT01849055|5704956|P4|NOT COMPLETED|Overall Study||0
2323952|NCT01849055|5704957|P3|NOT COMPLETED|Overall Study||1
2323953|NCT01849055|5704958|P2|NOT COMPLETED|Overall Study||0
2323954|NCT01849055|5704959|P1|NOT COMPLETED|Overall Study||0
2323955|NCT01849055|5704954|P6|COMPLETED|Overall Study||8
2323956|NCT01849055|5704955|P5|COMPLETED|Overall Study||8
2323957|NCT01849055|5704956|P4|COMPLETED|Overall Study||8
2323958|NCT01849055|5704957|P3|COMPLETED|Overall Study||7
2323959|NCT01849055|5704958|P2|COMPLETED|Overall Study||8
2323960|NCT01849055|5704959|P1|COMPLETED|Overall Study||8
2323961|NCT01849055|5704954|P6|STARTED|Overall Study||8
2323962|NCT01849055|5704955|P5|STARTED|Overall Study||8
2323963|NCT01849055|5704956|P4|STARTED|Overall Study||8
2323964|NCT01849055|5704957|P3|STARTED|Overall Study||8
2323965|NCT01849055|5704958|P2|STARTED|Overall Study||8
2323966|NCT01849055|5704959|P1|STARTED|Overall Study||8
2323967|NCT01848990|5704994|P3|NOT COMPLETED|Overall Study||16
2323968|NCT01848990|5704995|P2|NOT COMPLETED|Overall Study||20
2323969|NCT01848990|5704996|P1|NOT COMPLETED|Overall Study||46
2323970|NCT01848990|5704994|P3|COMPLETED|Overall Study||98
2323971|NCT01848990|5704995|P2|COMPLETED|Overall Study||95
2323972|NCT01848990|5704996|P1|COMPLETED|Overall Study||181
2323973|NCT01848990|5704994|P3|Completed Month 6|Overall Study||103
2323974|NCT01848990|5704995|P2|Completed Month 6|Overall Study||106
2323975|NCT01848990|5704996|P1|Completed Month 6|Overall Study||194
2323976|NCT01848990|5704994|P3|Received at Least 1 Dose of Study Drug|Overall Study||113
2323977|NCT01848990|5704995|P2|Received at Least 1 Dose of Study Drug|Overall Study||115
2323978|NCT01848990|5704996|P1|Received at Least 1 Dose of Study Drug|Overall Study||227
2323979|NCT01848990|5704994|P3|STARTED|Overall Study|One participant was randomized and withdrew consent before start of study treatment.|114
2323980|NCT01848990|5704995|P2|STARTED|Overall Study||115
2323981|NCT01848990|5704996|P1|STARTED|Overall Study||227
2323982|NCT01848977|5705055|P1|NOT COMPLETED|Overall Study||0
2323983|NCT01848977|5705055|P1|COMPLETED|Overall Study||20
2323984|NCT01848977|5705055|P1|STARTED|Overall Study||20
2323985|NCT01848938|5705066|P2|NOT COMPLETED|Overall Study||1
2323986|NCT01848938|5705067|P1|NOT COMPLETED|Overall Study||1
2323987|NCT01848938|5705066|P2|COMPLETED|Overall Study||60
2323988|NCT01848938|5705067|P1|COMPLETED|Overall Study||61
2323989|NCT01848938|5705066|P2|STARTED|Overall Study||61
2323990|NCT01848938|5705067|P1|STARTED|Overall Study||62
2323991|NCT01848899|5705085|P2|NOT COMPLETED|Overall Study||0
2323992|NCT01848899|5705086|P1|NOT COMPLETED|Overall Study||0
2323993|NCT01848899|5705085|P2|COMPLETED|Overall Study||50
2323994|NCT01848899|5705086|P1|COMPLETED|Overall Study||50
2323995|NCT01848899|5705085|P2|STARTED|Overall Study||50
2323996|NCT01848899|5705086|P1|STARTED|Overall Study||50
2323997|NCT01848847|5705102|P2|NOT COMPLETED|Overall Study||3
2323998|NCT01848847|5705103|P1|NOT COMPLETED|Overall Study||2
2323999|NCT01848847|5705102|P2|COMPLETED|Overall Study||48
2324000|NCT01848847|5705103|P1|COMPLETED|Overall Study||49
2324001|NCT01848847|5705102|P2|STARTED|Overall Study||51
2324002|NCT01848847|5705103|P1|STARTED|Overall Study||51
2324003|NCT01848834|5705116|P5|NOT COMPLETED|Overall Study||132
2324004|NCT01848834|5705117|P4|NOT COMPLETED|Overall Study||37
2324005|NCT01848834|5705118|P3|NOT COMPLETED|Overall Study||32
2324006|NCT01848834|5705119|P2|NOT COMPLETED|Overall Study||60
2324007|NCT01848834|5705120|P1|NOT COMPLETED|Overall Study||30
2324008|NCT01848834|5705116|P5|COMPLETED|Overall Study|Completed means two-year treatment completed|0
2324009|NCT01848834|5705117|P4|COMPLETED|Overall Study|Completed means two-year treatment completed|2
2324010|NCT01848834|5705118|P3|COMPLETED|Overall Study|Completed means two-year treatment completed|1
2324011|NCT01848834|5705119|P2|COMPLETED|Overall Study|Completed means two-year treatment completed|1
2324012|NCT01848834|5705120|P1|COMPLETED|Overall Study|Completed means two-year treatment completed|2
2324013|NCT01848834|5705116|P5|Treated|Overall Study||132
2324014|NCT01848834|5705117|P4|Treated|Overall Study||39
2324015|NCT01848834|5705118|P3|Treated|Overall Study||33
2324016|NCT01848834|5705119|P2|Treated|Overall Study||60
2324017|NCT01848834|5705120|P1|Treated|Overall Study||32
2324018|NCT01848834|5705116|P5|STARTED|Overall Study||132
2324019|NCT01848834|5705117|P4|STARTED|Overall Study||39
2324020|NCT01848834|5705118|P3|STARTED|Overall Study||33
2324021|NCT01848834|5705119|P2|STARTED|Overall Study||61
2324022|NCT01848834|5705120|P1|STARTED|Overall Study||32
2324023|NCT01848821|5705157|P2|NOT COMPLETED|Overall Study||0
2324024|NCT01848821|5705158|P1|NOT COMPLETED|Overall Study||0
2324025|NCT01848821|5705157|P2|COMPLETED|Overall Study||7
2324026|NCT01848821|5705158|P1|COMPLETED|Overall Study||7
2324027|NCT01848821|5705157|P2|STARTED|Overall Study||7
2324028|NCT01848821|5705158|P1|STARTED|Overall Study||7
2324029|NCT01848756|5705168|P1|NOT COMPLETED|Overall Study||3
2324030|NCT01848756|5705168|P1|COMPLETED|Overall Study|Cycle 1|12
2324031|NCT01848756|5705168|P1|STARTED|Overall Study||15
2324032|NCT01848483|5705180|P2|NOT COMPLETED|Overall Study||11
2324033|NCT01848483|5705181|P1|NOT COMPLETED|Overall Study||11
2324034|NCT01848483|5705180|P2|COMPLETED|Overall Study||49
2324035|NCT01848483|5705181|P1|COMPLETED|Overall Study||50
2324036|NCT01848483|5705180|P2|STARTED|Overall Study||60
2324037|NCT01848483|5705181|P1|STARTED|Overall Study||61
2324038|NCT01848366|5705195|P1|NOT COMPLETED|Overall Study||0
2324039|NCT01848366|5705195|P1|COMPLETED|Overall Study||8
2324040|NCT01848366|5705195|P1|STARTED|Overall Study||8
2324041|NCT01848353|5705203|P4|NOT COMPLETED|Phase 3||0
2324042|NCT01848353|5705204|P3|NOT COMPLETED|Phase 3||0
2324043|NCT01848353|5705205|P2|NOT COMPLETED|Phase 3||1
2324044|NCT01848353|5705206|P1|NOT COMPLETED|Phase 3||1
2324045|NCT01848353|5705203|P4|COMPLETED|Phase 3||0
2324046|NCT01848353|5705204|P3|COMPLETED|Phase 3||0
2324047|NCT01848353|5705205|P2|COMPLETED|Phase 3||9
2324048|NCT01848353|5705206|P1|COMPLETED|Phase 3||4
2324049|NCT01848353|5705203|P4|STARTED|Phase 3|Normal weight participants only completed baseline testing in Phase 1.|0
2324050|NCT01848353|5705204|P3|STARTED|Phase 3|Normal weight participants only completed baseline testing in Phase 1.|0
2324051|NCT01848353|5705205|P2|STARTED|Phase 3|31 participants from Phase 2 intervention (both groups) withdrew and did not complete Phase 3|10
2324052|NCT01848353|5705206|P1|STARTED|Phase 3|31 participants from Phase 2 intervention (both groups) withdrew and did not complete Phase 3|5
2324053|NCT01848353|5705203|P4|NOT COMPLETED|Phase 2||0
2324054|NCT01848353|5705204|P3|NOT COMPLETED|Phase 2||0
2324055|NCT01848353|5705205|P2|NOT COMPLETED|Phase 2||2
2324056|NCT01848353|5705206|P1|NOT COMPLETED|Phase 2||3
2324057|NCT01848353|5705203|P4|COMPLETED|Phase 2||0
2324058|NCT01848353|5705204|P3|COMPLETED|Phase 2||0
2324059|NCT01848353|5705205|P2|COMPLETED|Phase 2||26
2324060|NCT01848353|5705206|P1|COMPLETED|Phase 2||20
2324061|NCT01848353|5705203|P4|STARTED|Phase 2|Normal weight participants only completed baseline testing in Phase 1.|0
2324062|NCT01848353|5705204|P3|STARTED|Phase 2|Normal weight participants only completed baseline testing in Phase 1.|0
2324063|NCT01848353|5705205|P2|STARTED|Phase 2|26 participants from Phase 1 intervention (both groups) withdrew and did not complete Phase 2|28
2324064|NCT01848353|5705206|P1|STARTED|Phase 2|26 participants from Phase 1 intervention (both groups) withdrew and did not complete Phase 2|23
2324065|NCT01848353|5705203|P4|NOT COMPLETED|Phase 1||0
2324066|NCT01848353|5705204|P3|NOT COMPLETED|Phase 1||0
2324067|NCT01848353|5705205|P2|NOT COMPLETED|Phase 1||1
2324068|NCT01848353|5705206|P1|NOT COMPLETED|Phase 1||3
2324069|NCT01848353|5705203|P4|COMPLETED|Phase 1||19
2324070|NCT01848353|5705204|P3|COMPLETED|Phase 1||20
2324071|NCT01848353|5705205|P2|COMPLETED|Phase 1||42
2324072|NCT01848353|5705206|P1|COMPLETED|Phase 1||35
2324073|NCT01848353|5705203|P4|STARTED|Phase 1||19
2324074|NCT01848353|5705204|P3|STARTED|Phase 1||20
2324075|NCT01848353|5705205|P2|STARTED|Phase 1||43
2324076|NCT01848353|5705206|P1|STARTED|Phase 1||38
2324077|NCT01848288|5705262|P1|NOT COMPLETED|Overall Study||3
2324078|NCT01848288|5705262|P1|COMPLETED|Overall Study|Two subjects were discontinued prior to undergoing surgery.|97
2324079|NCT01848288|5705262|P1|STARTED|Overall Study||100
2324080|NCT01848210|5705273|P2|NOT COMPLETED|Overall Study||78
2324081|NCT01848210|5705274|P1|NOT COMPLETED|Overall Study||88
2324082|NCT01848210|5705273|P2|COMPLETED|Overall Study||340
2324083|NCT01848210|5705274|P1|COMPLETED|Overall Study||323
2324084|NCT01848210|5705273|P2|Per Protocol Population|Overall Study||245
2324085|NCT01848210|5705274|P1|Per Protocol Population|Overall Study||222
2324086|NCT01848210|5705273|P2|Intent-to-Treat (ITT) Population|Overall Study||388
2324087|NCT01848210|5705274|P1|Intent-to-Treat (ITT) Population|Overall Study||383
2324088|NCT01848210|5705273|P2|Safety Population-Received Study Drug|Overall Study||398
2324089|NCT01848210|5705274|P1|Safety Population-Received Study Drug|Overall Study||394
2324090|NCT01848210|5705273|P2|STARTED|Overall Study||418
2324091|NCT01848210|5705274|P1|STARTED|Overall Study||411
2324092|NCT01848184|5705286|P1|NOT COMPLETED|Overall Study||26
2324093|NCT01848184|5705286|P1|COMPLETED|Overall Study||100
2324094|NCT01848184|5705286|P1|STARTED|Overall Study||126
2324095|NCT01848145|5705296|P1|NOT COMPLETED|Subsequent Infusions: Weeks 3-8||10
2324096|NCT01848145|5705296|P1|COMPLETED|Subsequent Infusions: Weeks 3-8||20
2324097|NCT01848145|5705296|P1|STARTED|Subsequent Infusions: Weeks 3-8||30
2324098|NCT01848145|5705296|P1|NOT COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||1
2324099|NCT01848145|5705296|P1|COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||30
2324100|NCT01848145|5705296|P1|Completed Within 15min of Infusion Time|Infusion 3: Week 2, Day 1 - 120 Minutes||26
2324101|NCT01848145|5705296|P1|STARTED|Infusion 3: Week 2, Day 1 - 120 Minutes||31
2324102|NCT01848145|5705296|P1|NOT COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes||2
2324103|NCT01848145|5705296|P1|COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes|Includes participants that completed Infusion 2 and proceeded to the next infusion, Infusion 3.|31
2324104|NCT01848145|5705296|P1|Completed Within 15min of Infusion Time|Infusion 2: Week 1, Day 3 - 167 Minutes||24
2324105|NCT01848145|5705296|P1|STARTED|Infusion 2: Week 1, Day 3 - 167 Minutes||33
2324106|NCT01848145|5705296|P1|NOT COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes||1
2324107|NCT01848145|5705296|P1|COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes|Includes participants that completed Infusion 1 and proceeded to the next infusion, Infusion 2.|33
2324108|NCT01848145|5705296|P1|Completed Within 15min of Infusion Time|Infusion 1: Week 1, Day 1 - 226 Minutes|Number of patients who completed within 15 minutes (min) of infusion time.|1
2324109|NCT01848145|5705296|P1|STARTED|Infusion 1: Week 1, Day 1 - 226 Minutes||34
2324110|NCT01848067|5705305|P1|NOT COMPLETED|Overall Study||0
2324111|NCT01848067|5705305|P1|COMPLETED|Overall Study||9
2324112|NCT01848067|5705305|P1|STARTED|Overall Study||9
2324113|NCT01848054|5705313|P2|NOT COMPLETED|Stabilization/Maintenance||40
2324114|NCT01848054|5705314|P1|NOT COMPLETED|Stabilization/Maintenance||40
2324115|NCT01848054|5705313|P2|COMPLETED|Stabilization/Maintenance||107
2324116|NCT01848054|5705314|P1|COMPLETED|Stabilization/Maintenance||92
2324117|NCT01848054|5705313|P2|STARTED|Stabilization/Maintenance||147
2324118|NCT01848054|5705314|P1|STARTED|Stabilization/Maintenance||132
2324119|NCT01848054|5705313|P2|NOT COMPLETED|Induction Phase||8
2324120|NCT01848054|5705314|P1|NOT COMPLETED|Induction Phase||23
2324121|NCT01848054|5705313|P2|COMPLETED|Induction Phase||147
2324122|NCT01848054|5705314|P1|COMPLETED|Induction Phase||132
2324123|NCT01848054|5705313|P2|STARTED|Induction Phase||155
2324124|NCT01848054|5705314|P1|STARTED|Induction Phase||155
2324125|NCT01847885|5705336|P3|NOT COMPLETED|Randomization||2
2324126|NCT01847885|5705337|P2|NOT COMPLETED|Randomization||4
2324127|NCT01847885|5705338|P1|NOT COMPLETED|Randomization||0
2324128|NCT01847885|5705336|P3|COMPLETED|Randomization||13
2324129|NCT01847885|5705337|P2|COMPLETED|Randomization||27
2324130|NCT01847885|5705338|P1|COMPLETED|Randomization||0
2324131|NCT01847885|5705336|P3|Per Protocol Set|Randomization||13
2324132|NCT01847885|5705337|P2|Per Protocol Set|Randomization||27
2324133|NCT01847885|5705338|P1|Per Protocol Set|Randomization||0
2324134|NCT01847885|5705336|P3|Safety Set|Randomization||13
2324135|NCT01847885|5705337|P2|Safety Set|Randomization||28
2324136|NCT01847885|5705338|P1|Safety Set|Randomization||0
2324137|NCT01847885|5705336|P3|Full Analysis Set|Randomization||15
2324138|NCT01847885|5705337|P2|Full Analysis Set|Randomization||28
2324139|NCT01847885|5705338|P1|Full Analysis Set|Randomization||0
2324140|NCT01847885|5705336|P3|STARTED|Randomization||15
2324141|NCT01847885|5705337|P2|STARTED|Randomization||31
2324142|NCT01847885|5705338|P1|STARTED|Randomization||0
2324143|NCT01847885|5705336|P3|NOT COMPLETED|Initial Enrollment (Consented)||0
2324144|NCT01847885|5705337|P2|NOT COMPLETED|Initial Enrollment (Consented)||0
2324145|NCT01847885|5705338|P1|NOT COMPLETED|Initial Enrollment (Consented)||48
2324146|NCT01847885|5705336|P3|COMPLETED|Initial Enrollment (Consented)||0
2324147|NCT01847885|5705337|P2|COMPLETED|Initial Enrollment (Consented)||0
2324148|NCT01847885|5705338|P1|COMPLETED|Initial Enrollment (Consented)||40
2324149|NCT01847885|5705336|P3|Per Protocol Set|Initial Enrollment (Consented)||0
2324150|NCT01847885|5705337|P2|Per Protocol Set|Initial Enrollment (Consented)||0
2324151|NCT01847885|5705338|P1|Per Protocol Set|Initial Enrollment (Consented)||40
2324152|NCT01847885|5705336|P3|Safety Set|Initial Enrollment (Consented)||0
2324153|NCT01847885|5705337|P2|Safety Set|Initial Enrollment (Consented)||0
2324154|NCT01847885|5705338|P1|Safety Set|Initial Enrollment (Consented)||41
2324155|NCT01847885|5705336|P3|Full Analysis Set|Initial Enrollment (Consented)||0
2324156|NCT01847885|5705337|P2|Full Analysis Set|Initial Enrollment (Consented)||0
2324157|NCT01847885|5705338|P1|Full Analysis Set|Initial Enrollment (Consented)||43
2324158|NCT01847885|5705336|P3|Randomized|Initial Enrollment (Consented)||0
2324159|NCT01847885|5705337|P2|Randomized|Initial Enrollment (Consented)||0
2324160|NCT01847885|5705338|P1|Randomized|Initial Enrollment (Consented)||46
2324161|NCT01847885|5705336|P3|STARTED|Initial Enrollment (Consented)||0
2324162|NCT01847885|5705337|P2|STARTED|Initial Enrollment (Consented)||0
2324163|NCT01847885|5705338|P1|STARTED|Initial Enrollment (Consented)||88
2324164|NCT01847638|5705372|P2|NOT COMPLETED|Overall Study||0
2324165|NCT01847638|5705373|P1|NOT COMPLETED|Overall Study||0
2324166|NCT01847638|5705372|P2|COMPLETED|Overall Study||25
2324167|NCT01847638|5705373|P1|COMPLETED|Overall Study||25
2324168|NCT01847638|5705372|P2|STARTED|Overall Study||25
2324169|NCT01847638|5705373|P1|STARTED|Overall Study||25
2324170|NCT01847560|5705393|P10|NOT COMPLETED|Overall Study||0
2324171|NCT01847560|5705394|P9|NOT COMPLETED|Overall Study||0
2324172|NCT01847560|5705395|P8|NOT COMPLETED|Overall Study||0
2324173|NCT01847560|5705396|P7|NOT COMPLETED|Overall Study||0
2324174|NCT01847560|5705397|P6|NOT COMPLETED|Overall Study||0
2324175|NCT01847560|5705398|P5|NOT COMPLETED|Overall Study||0
2324176|NCT01847560|5705399|P4|NOT COMPLETED|Overall Study||0
2324177|NCT01847560|5705400|P3|NOT COMPLETED|Overall Study||0
2324178|NCT01847560|5705401|P2|NOT COMPLETED|Overall Study||0
2324179|NCT01847560|5705402|P1|NOT COMPLETED|Overall Study||0
2324180|NCT01847560|5705393|P10|COMPLETED|Overall Study||39438
2324181|NCT01847560|5705394|P9|COMPLETED|Overall Study||77547
2324182|NCT01847560|5705395|P8|COMPLETED|Overall Study||19829
2324183|NCT01847560|5705396|P7|COMPLETED|Overall Study||40971
2324184|NCT01847560|5705397|P6|COMPLETED|Overall Study||28343
2324185|NCT01847560|5705398|P5|COMPLETED|Overall Study||27731
2324186|NCT01847560|5705399|P4|COMPLETED|Overall Study||56655
2324187|NCT01847560|5705400|P3|COMPLETED|Overall Study||9731
2324188|NCT01847560|5705401|P2|COMPLETED|Overall Study||19955
2324189|NCT01847560|5705402|P1|COMPLETED|Overall Study||13464
2324190|NCT01847560|5705393|P10|STARTED|Overall Study||39438
2324191|NCT01847560|5705394|P9|STARTED|Overall Study||77547
2324192|NCT01847560|5705395|P8|STARTED|Overall Study||19829
2324193|NCT01847560|5705396|P7|STARTED|Overall Study||40971
2324194|NCT01847560|5705397|P6|STARTED|Overall Study||28343
2324195|NCT01847560|5705398|P5|STARTED|Overall Study||27731
2324196|NCT01847560|5705399|P4|STARTED|Overall Study||56655
2324197|NCT01847560|5705400|P3|STARTED|Overall Study||9731
2324198|NCT01847560|5705401|P2|STARTED|Overall Study||19955
2324199|NCT01847560|5705402|P1|STARTED|Overall Study||13464
2324200|NCT01847547|5705446|P2|NOT COMPLETED|Overall Study||0
2324201|NCT01847547|5705447|P1|NOT COMPLETED|Overall Study||0
2324202|NCT01847547|5705446|P2|COMPLETED|Overall Study||2991
2324203|NCT01847547|5705447|P1|COMPLETED|Overall Study||2991
2324204|NCT01847547|5705446|P2|STARTED|Overall Study||2991
2324205|NCT01847547|5705447|P1|STARTED|Overall Study||2991
2324206|NCT01847443|5705489|P4|NOT COMPLETED|Study Period 4||0
2324207|NCT01847443|5705490|P3|NOT COMPLETED|Study Period 4||0
2324208|NCT01847443|5705491|P2|NOT COMPLETED|Study Period 4||0
2324209|NCT01847443|5705492|P1|NOT COMPLETED|Study Period 4||0
2324210|NCT01847443|5705489|P4|COMPLETED|Study Period 4||21
2324211|NCT01847443|5705490|P3|COMPLETED|Study Period 4||21
2324212|NCT01847443|5705491|P2|COMPLETED|Study Period 4||19
2324213|NCT01847443|5705492|P1|COMPLETED|Study Period 4||16
2324214|NCT01847443|5705489|P4|STARTED|Study Period 4||21
2324215|NCT01847443|5705490|P3|STARTED|Study Period 4||21
2324216|NCT01847443|5705491|P2|STARTED|Study Period 4||19
2324217|NCT01847443|5705492|P1|STARTED|Study Period 4||16
2324218|NCT01847443|5705489|P4|NOT COMPLETED|Washout Period Before Study Period 4||0
2324219|NCT01847443|5705490|P3|NOT COMPLETED|Washout Period Before Study Period 4||0
2324220|NCT01847443|5705491|P2|NOT COMPLETED|Washout Period Before Study Period 4||0
2324221|NCT01847443|5705492|P1|NOT COMPLETED|Washout Period Before Study Period 4||2
2324222|NCT01847443|5705489|P4|COMPLETED|Washout Period Before Study Period 4||21
2324223|NCT01847443|5705490|P3|COMPLETED|Washout Period Before Study Period 4||21
2324224|NCT01847443|5705491|P2|COMPLETED|Washout Period Before Study Period 4||19
2324225|NCT01847443|5705492|P1|COMPLETED|Washout Period Before Study Period 4||16
2324226|NCT01847443|5705489|P4|STARTED|Washout Period Before Study Period 4||21
2324227|NCT01847443|5705490|P3|STARTED|Washout Period Before Study Period 4||21
2324228|NCT01847443|5705491|P2|STARTED|Washout Period Before Study Period 4||19
2324229|NCT01847443|5705492|P1|STARTED|Washout Period Before Study Period 4||18
2324230|NCT01847443|5705489|P4|NOT COMPLETED|Study Period 3||0
2324231|NCT01847443|5705490|P3|NOT COMPLETED|Study Period 3||0
2324232|NCT01847443|5705491|P2|NOT COMPLETED|Study Period 3||0
2324233|NCT01847443|5705492|P1|NOT COMPLETED|Study Period 3||0
2324234|NCT01847443|5705489|P4|COMPLETED|Study Period 3||21
2324235|NCT01847443|5705490|P3|COMPLETED|Study Period 3||21
2324236|NCT01847443|5705491|P2|COMPLETED|Study Period 3||19
2324237|NCT01847443|5705492|P1|COMPLETED|Study Period 3||18
2324238|NCT01847443|5705489|P4|STARTED|Study Period 3||21
2324239|NCT01847443|5705490|P3|STARTED|Study Period 3||21
2324240|NCT01847443|5705491|P2|STARTED|Study Period 3||19
2324241|NCT01847443|5705492|P1|STARTED|Study Period 3||18
2324242|NCT01847443|5705489|P4|NOT COMPLETED|Washout Period Before Study Period 3||0
2324243|NCT01847443|5705490|P3|NOT COMPLETED|Washout Period Before Study Period 3||0
2324244|NCT01847443|5705491|P2|NOT COMPLETED|Washout Period Before Study Period 3||0
2324245|NCT01847443|5705492|P1|NOT COMPLETED|Washout Period Before Study Period 3||1
2324246|NCT01847443|5705489|P4|COMPLETED|Washout Period Before Study Period 3||21
2324247|NCT01847443|5705490|P3|COMPLETED|Washout Period Before Study Period 3||21
2324248|NCT01847443|5705491|P2|COMPLETED|Washout Period Before Study Period 3||19
2324249|NCT01847443|5705492|P1|COMPLETED|Washout Period Before Study Period 3||18
2324250|NCT01847443|5705489|P4|STARTED|Washout Period Before Study Period 3||21
2324251|NCT01847443|5705490|P3|STARTED|Washout Period Before Study Period 3||21
2324252|NCT01847443|5705491|P2|STARTED|Washout Period Before Study Period 3||19
2324253|NCT01847443|5705492|P1|STARTED|Washout Period Before Study Period 3||19
2324254|NCT01847443|5705489|P4|NOT COMPLETED|Study Period 2||0
2324255|NCT01847443|5705490|P3|NOT COMPLETED|Study Period 2||0
2324256|NCT01847443|5705491|P2|NOT COMPLETED|Study Period 2||0
2324257|NCT01847443|5705492|P1|NOT COMPLETED|Study Period 2||0
2324258|NCT01847443|5705489|P4|COMPLETED|Study Period 2||21
2324259|NCT01847443|5705490|P3|COMPLETED|Study Period 2||21
2324260|NCT01847443|5705491|P2|COMPLETED|Study Period 2||19
2324261|NCT01847443|5705492|P1|COMPLETED|Study Period 2||19
2324262|NCT01847443|5705489|P4|STARTED|Study Period 2||21
2324263|NCT01847443|5705490|P3|STARTED|Study Period 2||21
2324264|NCT01847443|5705491|P2|STARTED|Study Period 2||19
2324265|NCT01847443|5705492|P1|STARTED|Study Period 2||19
2324266|NCT01847443|5705489|P4|NOT COMPLETED|Washout Period Before Study Period 2||0
2324267|NCT01847443|5705490|P3|NOT COMPLETED|Washout Period Before Study Period 2||0
2324268|NCT01847443|5705491|P2|NOT COMPLETED|Washout Period Before Study Period 2||1
2324269|NCT01847443|5705492|P1|NOT COMPLETED|Washout Period Before Study Period 2||2
2324270|NCT01847443|5705489|P4|COMPLETED|Washout Period Before Study Period 2||21
2324271|NCT01847443|5705490|P3|COMPLETED|Washout Period Before Study Period 2||21
2324272|NCT01847443|5705491|P2|COMPLETED|Washout Period Before Study Period 2||19
2324273|NCT01847443|5705492|P1|COMPLETED|Washout Period Before Study Period 2||19
2324274|NCT01847443|5705489|P4|STARTED|Washout Period Before Study Period 2||21
2324275|NCT01847443|5705490|P3|STARTED|Washout Period Before Study Period 2||21
2324276|NCT01847443|5705491|P2|STARTED|Washout Period Before Study Period 2||20
2324277|NCT01847443|5705492|P1|STARTED|Washout Period Before Study Period 2||21
2324278|NCT01847443|5705489|P4|NOT COMPLETED|Study Period 1||0
2324279|NCT01847443|5705490|P3|NOT COMPLETED|Study Period 1||0
2324280|NCT01847443|5705491|P2|NOT COMPLETED|Study Period 1||1
2324281|NCT01847443|5705492|P1|NOT COMPLETED|Study Period 1||0
2324282|NCT01847443|5705489|P4|COMPLETED|Study Period 1||21
2324283|NCT01847443|5705490|P3|COMPLETED|Study Period 1||21
2324284|NCT01847443|5705491|P2|COMPLETED|Study Period 1||20
2324285|NCT01847443|5705492|P1|COMPLETED|Study Period 1||21
2324286|NCT01847443|5705489|P4|STARTED|Study Period 1||21
2324287|NCT01847443|5705490|P3|STARTED|Study Period 1||21
2324288|NCT01847443|5705491|P2|STARTED|Study Period 1||21
2324289|NCT01847443|5705492|P1|STARTED|Study Period 1||21
2324290|NCT01847430|5705522|P1|NOT COMPLETED|Overall Study||0
2324291|NCT01847430|5705522|P1|COMPLETED|Overall Study||302
2324292|NCT01847430|5705522|P1|STARTED|Overall Study||302
2324293|NCT01847313|5705535|P2|NOT COMPLETED|Overall Study||2
2324294|NCT01847313|5705536|P1|NOT COMPLETED|Overall Study||0
2324295|NCT01847313|5705535|P2|COMPLETED|Overall Study||8
2324296|NCT01847313|5705536|P1|COMPLETED|Overall Study||10
2324297|NCT01847313|5705535|P2|STARTED|Overall Study||10
2324298|NCT01847313|5705536|P1|STARTED|Overall Study||10
2324299|NCT01847274|5705552|P4|NOT COMPLETED|Overall Study||104
2324300|NCT01847274|5705553|P3|NOT COMPLETED|Overall Study||188
2324301|NCT01847274|5705554|P2|NOT COMPLETED|Overall Study||61
2324302|NCT01847274|5705555|P1|NOT COMPLETED|Overall Study||91
2324303|NCT01847274|5705552|P4|COMPLETED|Overall Study||12
2324304|NCT01847274|5705553|P3|COMPLETED|Overall Study||46
2324305|NCT01847274|5705554|P2|COMPLETED|Overall Study||4
2324306|NCT01847274|5705555|P1|COMPLETED|Overall Study||47
2324307|NCT01847274|5705552|P4|STARTED|Overall Study||116
2324308|NCT01847274|5705553|P3|STARTED|Overall Study||234
2324309|NCT01847274|5705554|P2|STARTED|Overall Study||65
2324310|NCT01847274|5705555|P1|STARTED|Overall Study||138
2324311|NCT01847209|5705609|P1|NOT COMPLETED|Overall Study||2
2324312|NCT01847209|5705609|P1|COMPLETED|Overall Study||23
2324313|NCT01847209|5705609|P1|STARTED|Overall Study||25
2324314|NCT01847196|5705614|P1|NOT COMPLETED|Overall Study||0
2324315|NCT01847196|5705614|P1|COMPLETED|Overall Study||5
2324316|NCT01847196|5705614|P1|STARTED|Overall Study|Includes all subjects in which Angel Catheter placement was attempted.|5
2324317|NCT01847131|5705621|P2|NOT COMPLETED|Overall Study||0
2324318|NCT01847131|5705622|P1|NOT COMPLETED|Overall Study||0
2324319|NCT01847131|5705621|P2|COMPLETED|Overall Study||25
2324320|NCT01847131|5705622|P1|COMPLETED|Overall Study||25
2324321|NCT01847131|5705621|P2|STARTED|Overall Study||25
2324322|NCT01847131|5705622|P1|STARTED|Overall Study||25
2324323|NCT01847027|5705632|P2|NOT COMPLETED|Overall Study||2
2324324|NCT01847027|5705633|P1|NOT COMPLETED|Overall Study||1
2324325|NCT01847027|5705632|P2|COMPLETED|Overall Study||10
2324326|NCT01847027|5705633|P1|COMPLETED|Overall Study||10
2324327|NCT01847027|5705632|P2|STARTED|Overall Study||12
2324328|NCT01847027|5705633|P1|STARTED|Overall Study||11
2324329|NCT01847014|5705643|P1|NOT COMPLETED|Completion of Extension Study||4
2324330|NCT01847014|5705643|P1|COMPLETED|Completion of Extension Study||0
2324331|NCT01847014|5705643|P1|STARTED|Completion of Extension Study||4
2324332|NCT01847014|5705643|P1|NOT COMPLETED|Baseline Extension Visit||0
2324333|NCT01847014|5705643|P1|COMPLETED|Baseline Extension Visit||4
2324334|NCT01847014|5705643|P1|STARTED|Baseline Extension Visit||4
2324335|NCT01847001|5705647|P1|NOT COMPLETED|Overall Study||0
2324336|NCT01847001|5705647|P1|COMPLETED|Overall Study||10
2324337|NCT01847001|5705647|P1|STARTED|Overall Study||10
2324338|NCT01846871|5705651|P1|NOT COMPLETED|Overall Study||0
2324339|NCT01846871|5705651|P1|COMPLETED|Overall Study||10
2324340|NCT01846871|5705651|P1|STARTED|Overall Study||10
2324341|NCT01846741|5705676|P1|NOT COMPLETED|Implantation to 18-Month/End of Study||0
2324342|NCT01846741|5705676|P1|COMPLETED|Implantation to 18-Month/End of Study||20
2324343|NCT01846741|5705676|P1|STARTED|Implantation to 18-Month/End of Study||20
2324344|NCT01846741|5705676|P1|NOT COMPLETED|Baseline Visit||2
2324345|NCT01846741|5705676|P1|COMPLETED|Baseline Visit||20
2324346|NCT01846741|5705676|P1|STARTED|Baseline Visit||22
2324347|NCT01846728|5705732|P1|NOT COMPLETED|Overall Study||0
2324348|NCT01846728|5705732|P1|COMPLETED|Overall Study||6
2324349|NCT01846728|5705732|P1|STARTED|Overall Study||6
2324350|NCT01846702|5705747|P7|NOT COMPLETED|Overall Study||0
2324351|NCT01846702|5705748|P6|NOT COMPLETED|Overall Study||0
2324352|NCT01846702|5705749|P5|NOT COMPLETED|Overall Study||0
2324353|NCT01846702|5705750|P4|NOT COMPLETED|Overall Study||0
2324354|NCT01846702|5705751|P3|NOT COMPLETED|Overall Study||1
2324355|NCT01846702|5705752|P2|NOT COMPLETED|Overall Study||0
2324356|NCT01846702|5705753|P1|NOT COMPLETED|Overall Study||0
2324357|NCT01846702|5705747|P7|COMPLETED|Overall Study||6
2324358|NCT01846702|5705748|P6|COMPLETED|Overall Study||6
2324359|NCT01846702|5705749|P5|COMPLETED|Overall Study||6
2324360|NCT01846702|5705750|P4|COMPLETED|Overall Study||6
2324361|NCT01846702|5705751|P3|COMPLETED|Overall Study||6
2324362|NCT01846702|5705752|P2|COMPLETED|Overall Study||6
2324363|NCT01846702|5705753|P1|COMPLETED|Overall Study||6
2324364|NCT01846702|5705747|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
2324365|NCT01846702|5705748|P6|Received at Least 1 Dose of Study Drug|Overall Study||6
2324366|NCT01846702|5705749|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
2324367|NCT01846702|5705750|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
2324368|NCT01846702|5705751|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
2324369|NCT01846702|5705752|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
2324370|NCT01846702|5705753|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
2324371|NCT01846702|5705747|P7|STARTED|Overall Study||6
2324372|NCT01846702|5705748|P6|STARTED|Overall Study||6
2324373|NCT01846702|5705749|P5|STARTED|Overall Study||6
2324374|NCT01846702|5705750|P4|STARTED|Overall Study||6
2324375|NCT01846702|5705751|P3|STARTED|Overall Study||7
2324376|NCT01846702|5705752|P2|STARTED|Overall Study||6
2324377|NCT01846702|5705753|P1|STARTED|Overall Study||6
2324378|NCT01846624|5705832|P1|NOT COMPLETED|Overall Study||1
2324379|NCT01846624|5705832|P1|COMPLETED|Overall Study||12
2324380|NCT01846624|5705832|P1|STARTED|Overall Study||13
2324381|NCT01846611|5705842|P2|NOT COMPLETED|Overall Study||43
2324382|NCT01846611|5705843|P1|NOT COMPLETED|Overall Study||38
2324383|NCT01846611|5705842|P2|COMPLETED|Overall Study||244
2324384|NCT01846611|5705843|P1|COMPLETED|Overall Study||251
2324385|NCT01846611|5705842|P2|Treated|Overall Study||282
2324386|NCT01846611|5705843|P1|Treated|Overall Study||286
2324387|NCT01846611|5705842|P2|STARTED|Overall Study||287
2324388|NCT01846611|5705843|P1|STARTED|Overall Study||289
2324389|NCT01846507|5705853|P1|NOT COMPLETED|Overall Study||7
2324390|NCT01846507|5705853|P1|COMPLETED|Overall Study||25
2324391|NCT01846507|5705853|P1|STARTED|Overall Study||32
2324392|NCT01846494|5705872|P2|NOT COMPLETED|Overall Study||38
2324393|NCT01846494|5705873|P1|NOT COMPLETED|Overall Study||30
2324394|NCT01846494|5705872|P2|COMPLETED|Overall Study||25
2324395|NCT01846494|5705873|P1|COMPLETED|Overall Study||20
2324396|NCT01846494|5705872|P2|STARTED|Overall Study||63
2324397|NCT01846494|5705873|P1|STARTED|Overall Study||50
2324398|NCT01846455|5705886|P5|NOT COMPLETED|Overall Study||0
2324399|NCT01846455|5705887|P4|NOT COMPLETED|Overall Study||0
2324400|NCT01846455|5705888|P3|NOT COMPLETED|Overall Study||0
2324401|NCT01846455|5705889|P2|NOT COMPLETED|Overall Study||0
2324402|NCT01846455|5705890|P1|NOT COMPLETED|Overall Study||0
2324403|NCT01846455|5705886|P5|COMPLETED|Overall Study||8
2324404|NCT01846455|5705887|P4|COMPLETED|Overall Study||10
2324405|NCT01846455|5705888|P3|COMPLETED|Overall Study||8
2324406|NCT01846455|5705889|P2|COMPLETED|Overall Study||8
2324407|NCT01846455|5705890|P1|COMPLETED|Overall Study||9
2324408|NCT01846455|5705886|P5|PK Population|Overall Study||8
2324409|NCT01846455|5705887|P4|PK Population|Overall Study||6
2324410|NCT01846455|5705888|P3|PK Population|Overall Study||6
2324411|NCT01846455|5705889|P2|PK Population|Overall Study||7
2324412|NCT01846455|5705890|P1|PK Population|Overall Study||6
2324413|NCT01846455|5705886|P5|STARTED|Overall Study||8
2324414|NCT01846455|5705887|P4|STARTED|Overall Study||10
2324415|NCT01846455|5705888|P3|STARTED|Overall Study||8
2324416|NCT01846455|5705889|P2|STARTED|Overall Study||8
2324417|NCT01846455|5705890|P1|STARTED|Overall Study||9
2324418|NCT01846442|5705951|P4|NOT COMPLETED|Overall Study||3
2324419|NCT01846442|5705952|P3|NOT COMPLETED|Overall Study||4
2324420|NCT01846442|5705953|P2|NOT COMPLETED|Overall Study||6
2324421|NCT01846442|5705954|P1|NOT COMPLETED|Overall Study||6
2324422|NCT01846442|5705951|P4|COMPLETED|Overall Study||51
2324423|NCT01846442|5705952|P3|COMPLETED|Overall Study||52
2324424|NCT01846442|5705953|P2|COMPLETED|Overall Study||48
2324425|NCT01846442|5705954|P1|COMPLETED|Overall Study||48
2324426|NCT01846442|5705951|P4|ITT Population|Overall Study||54
2324427|NCT01846442|5705952|P3|ITT Population|Overall Study||56
2324428|NCT01846442|5705953|P2|ITT Population|Overall Study||53
2324429|NCT01846442|5705954|P1|ITT Population|Overall Study||53
2324430|NCT01846442|5705951|P4|Safety Population|Overall Study||54
2324431|NCT01846442|5705952|P3|Safety Population|Overall Study||56
2324432|NCT01846442|5705953|P2|Safety Population|Overall Study||53
2324433|NCT01846442|5705954|P1|Safety Population|Overall Study||54
2324434|NCT01846442|5705951|P4|STARTED|Overall Study||54
2324435|NCT01846442|5705952|P3|STARTED|Overall Study||56
2324436|NCT01846442|5705953|P2|STARTED|Overall Study||54
2324437|NCT01846442|5705954|P1|STARTED|Overall Study||54
2324438|NCT01846416|5705995|P3|NOT COMPLETED|Survival Follow-up||12
2324439|NCT01846416|5705996|P2|NOT COMPLETED|Survival Follow-up||80
2324440|NCT01846416|5705997|P1|NOT COMPLETED|Survival Follow-up||28
2324441|NCT01846416|5705995|P3|COMPLETED|Survival Follow-up||0
2324442|NCT01846416|5705996|P2|COMPLETED|Survival Follow-up||0
2324443|NCT01846416|5705997|P1|COMPLETED|Survival Follow-up||0
2324444|NCT01846416|5705995|P3|STARTED|Survival Follow-up||12
2324445|NCT01846416|5705996|P2|STARTED|Survival Follow-up||80
2324446|NCT01846416|5705997|P1|STARTED|Survival Follow-up||28
2324447|NCT01846416|5705995|P3|NOT COMPLETED|Treatment Phase||13
2324448|NCT01846416|5705996|P2|NOT COMPLETED|Treatment Phase||93
2324449|NCT01846416|5705997|P1|NOT COMPLETED|Treatment Phase||31
2324450|NCT01846416|5705995|P3|COMPLETED|Treatment Phase||0
2324451|NCT01846416|5705996|P2|COMPLETED|Treatment Phase||0
2324452|NCT01846416|5705997|P1|COMPLETED|Treatment Phase||0
2324453|NCT01846416|5705995|P3|STARTED|Treatment Phase||13
2324454|NCT01846416|5705996|P2|STARTED|Treatment Phase||93
2324455|NCT01846416|5705997|P1|STARTED|Treatment Phase||31
2324456|NCT01846299|5706042|P2|NOT COMPLETED|Overall Study||10
2324457|NCT01846299|5706043|P1|NOT COMPLETED|Overall Study||12
2324458|NCT01846299|5706042|P2|COMPLETED|Overall Study||50
2324459|NCT01846299|5706043|P1|COMPLETED|Overall Study||106
2324460|NCT01846299|5706042|P2|Safety Set|Overall Study||58
2324461|NCT01846299|5706043|P1|Safety Set|Overall Study|Two participants randomized to sham received ranibizumab at Month 1.|119
2324462|NCT01846299|5706042|P2|Full Analysis Set|Overall Study||60
2324463|NCT01846299|5706043|P1|Full Analysis Set|Overall Study|One participant did not receive study treatment prior to discontinuation.|117
2324464|NCT01846299|5706042|P2|STARTED|Overall Study||60
2324465|NCT01846299|5706043|P1|STARTED|Overall Study||118
2324466|NCT01846273|5706082|P3|NOT COMPLETED|Overall Study||0
2324467|NCT01846273|5706083|P2|NOT COMPLETED|Overall Study||26
2324468|NCT01846273|5706084|P1|NOT COMPLETED|Overall Study||22
2324469|NCT01846273|5706082|P3|COMPLETED|Overall Study||41
2324470|NCT01846273|5706083|P2|COMPLETED|Overall Study||87
2324471|NCT01846273|5706084|P1|COMPLETED|Overall Study||146
2324472|NCT01846273|5706082|P3|Safety Analysis Set|Overall Study||14
2324473|NCT01846273|5706083|P2|Safety Analysis Set|Overall Study||135
2324474|NCT01846273|5706084|P1|Safety Analysis Set|Overall Study||172
2324475|NCT01846273|5706082|P3|STARTED|Overall Study||41
2324476|NCT01846273|5706083|P2|STARTED|Overall Study||113
2324477|NCT01846273|5706084|P1|STARTED|Overall Study||168
2324478|NCT01846221|5706140|P2|NOT COMPLETED|Overall Study||0
2324479|NCT01846221|5706141|P1|NOT COMPLETED|Overall Study||3
2324480|NCT01846221|5706140|P2|COMPLETED|Overall Study||51
2324481|NCT01846221|5706141|P1|COMPLETED|Overall Study||47
2324482|NCT01846221|5706140|P2|STARTED|Overall Study||51
2324483|NCT01846221|5706141|P1|STARTED|Overall Study||50
2324484|NCT01846208|5706158|P3|NOT COMPLETED|Overall Study||8
2324485|NCT01846208|5706159|P2|NOT COMPLETED|Overall Study||4
2324486|NCT01846208|5706160|P1|NOT COMPLETED|Overall Study||9
2324487|NCT01846208|5706158|P3|COMPLETED|Overall Study||32
2324488|NCT01846208|5706159|P2|COMPLETED|Overall Study||20
2324489|NCT01846208|5706160|P1|COMPLETED|Overall Study||19
2324490|NCT01846208|5706158|P3|Year 2 Sustained Unresponsiveness OFC|Overall Study||21
2324491|NCT01846208|5706159|P2|Year 2 Sustained Unresponsiveness OFC|Overall Study||18
2324492|NCT01846208|5706160|P1|Year 2 Sustained Unresponsiveness OFC|Overall Study||4
2324493|NCT01846208|5706158|P3|Year 2 Desensitization OFC|Overall Study||33
2324494|NCT01846208|5706159|P2|Year 2 Desensitization OFC|Overall Study||20
2324495|NCT01846208|5706160|P1|Year 2 Desensitization OFC|Overall Study||19
2324496|NCT01846208|5706158|P3|Year 1 Desensitization OFC|Overall Study||34
2324497|NCT01846208|5706159|P2|Year 1 Desensitization OFC|Overall Study||20
2324498|NCT01846208|5706160|P1|Year 1 Desensitization OFC|Overall Study||23
2324499|NCT01846208|5706158|P3|Initiatiated Treatment|Overall Study||39
2324500|NCT01846208|5706159|P2|Initiatiated Treatment|Overall Study||23
2324501|NCT01846208|5706160|P1|Initiatiated Treatment|Overall Study||27
2324502|NCT01846208|5706158|P3|STARTED|Overall Study||40
2324503|NCT01846208|5706159|P2|STARTED|Overall Study||24
2324504|NCT01846208|5706160|P1|STARTED|Overall Study||28
2324505|NCT01846104|5706180|P1|NOT COMPLETED|Overall Study||1
2324506|NCT01846104|5706180|P1|COMPLETED|Overall Study||3
2324507|NCT01846104|5706180|P1|STARTED|Overall Study||4
2324508|NCT01846039|5706186|P1|NOT COMPLETED|Overall Study||2
2324509|NCT01846039|5706186|P1|COMPLETED|Overall Study||27
2324510|NCT01846039|5706186|P1|STARTED|Overall Study||29
2324511|NCT01845974|5706198|P2|NOT COMPLETED|Overall Study||0
2324512|NCT01845974|5706199|P1|NOT COMPLETED|Overall Study||1
2324513|NCT01845974|5706198|P2|COMPLETED|Overall Study||9
2324514|NCT01845974|5706199|P1|COMPLETED|Overall Study||3
2324515|NCT01845974|5706198|P2|STARTED|Overall Study||9
2324516|NCT01845974|5706199|P1|STARTED|Overall Study||4
2324517|NCT01845831|5706207|P5|NOT COMPLETED|Outpatient Phase||0
2324518|NCT01845831|5706208|P4|NOT COMPLETED|Outpatient Phase||0
2324519|NCT01845831|5706209|P3|NOT COMPLETED|Outpatient Phase||0
2324520|NCT01845831|5706210|P2|NOT COMPLETED|Outpatient Phase||0
2324521|NCT01845831|5706211|P1|NOT COMPLETED|Outpatient Phase||0
2324522|NCT01845831|5706207|P5|COMPLETED|Outpatient Phase||87
2324523|NCT01845831|5706208|P4|COMPLETED|Outpatient Phase||98
2324524|NCT01845831|5706209|P3|COMPLETED|Outpatient Phase||68
2324525|NCT01845831|5706210|P2|COMPLETED|Outpatient Phase||0
2324526|NCT01845831|5706211|P1|COMPLETED|Outpatient Phase||0
2324527|NCT01845831|5706207|P5|STARTED|Outpatient Phase||87
2324528|NCT01845831|5706208|P4|STARTED|Outpatient Phase||98
2324529|NCT01845831|5706209|P3|STARTED|Outpatient Phase||68
2324530|NCT01845831|5706210|P2|STARTED|Outpatient Phase||0
2324531|NCT01845831|5706211|P1|STARTED|Outpatient Phase||0
2324532|NCT01845831|5706207|P5|NOT COMPLETED|Inpatient Phase||0
2324533|NCT01845831|5706208|P4|NOT COMPLETED|Inpatient Phase||0
2324534|NCT01845831|5706209|P3|NOT COMPLETED|Inpatient Phase||0
2324535|NCT01845831|5706210|P2|NOT COMPLETED|Inpatient Phase||1
2324536|NCT01845831|5706211|P1|NOT COMPLETED|Inpatient Phase||1
2324537|NCT01845831|5706207|P5|COMPLETED|Inpatient Phase||0
2324538|NCT01845831|5706208|P4|COMPLETED|Inpatient Phase||0
2324539|NCT01845831|5706209|P3|COMPLETED|Inpatient Phase||0
2324540|NCT01845831|5706210|P2|COMPLETED|Inpatient Phase||138
2324541|NCT01845831|5706211|P1|COMPLETED|Inpatient Phase||139
2324542|NCT01845831|5706207|P5|STARTED|Inpatient Phase||0
2324543|NCT01845831|5706208|P4|STARTED|Inpatient Phase||0
2324544|NCT01845831|5706209|P3|STARTED|Inpatient Phase||0
2324545|NCT01845831|5706210|P2|STARTED|Inpatient Phase||139
2324546|NCT01845831|5706211|P1|STARTED|Inpatient Phase||140
2324547|NCT01845818|5706240|P2|NOT COMPLETED|Overall Study||17
2324548|NCT01845818|5706241|P1|NOT COMPLETED|Overall Study||45
2324549|NCT01845818|5706240|P2|COMPLETED|Overall Study||40
2324550|NCT01845818|5706241|P1|COMPLETED|Overall Study||81
2324551|NCT01845818|5706240|P2|STARTED|Overall Study||57
2324552|NCT01845818|5706241|P1|STARTED|Overall Study||126
2324553|NCT01845792|5706282|P2|NOT COMPLETED|Overall Study||0
2324554|NCT01845792|5706283|P1|NOT COMPLETED|Overall Study||0
2324555|NCT01845792|5706282|P2|COMPLETED|Overall Study||2
2324556|NCT01845792|5706283|P1|COMPLETED|Overall Study||5
2324557|NCT01845792|5706282|P2|STARTED|Overall Study||2
2324558|NCT01845792|5706283|P1|STARTED|Overall Study||5
2324559|NCT01845636|5706291|P1|NOT COMPLETED|Overall Study||4
2324560|NCT01845636|5706291|P1|COMPLETED|Overall Study||37
2324561|NCT01845636|5706291|P1|STARTED|Overall Study||41
2324562|NCT01845220|5706299|P2|NOT COMPLETED|Overall Study||0
2324563|NCT01845220|5706300|P1|NOT COMPLETED|Overall Study||0
2324564|NCT01845220|5706299|P2|COMPLETED|Overall Study||30
2324565|NCT01845220|5706300|P1|COMPLETED|Overall Study||30
2324566|NCT01845220|5706299|P2|STARTED|Overall Study||30
2324567|NCT01845220|5706300|P1|STARTED|Overall Study||30
2324568|NCT01845155|5706308|P2|NOT COMPLETED|Overall Study||0
2324569|NCT01845155|5706309|P1|NOT COMPLETED|Overall Study||1
2324570|NCT01845155|5706308|P2|COMPLETED|Overall Study||144
2324571|NCT01845155|5706309|P1|COMPLETED|Overall Study||145
2324572|NCT01845155|5706308|P2|STARTED|Overall Study||144
2324573|NCT01845155|5706309|P1|STARTED|Overall Study||146
2324574|NCT01845103|5706317|P1|NOT COMPLETED|Overall Study||0
2324575|NCT01845103|5706317|P1|COMPLETED|Overall Study||1
2324576|NCT01845103|5706317|P1|STARTED|Overall Study||1
2324577|NCT01845077|5706325|P6|NOT COMPLETED|Treatment Period 2||0
2324578|NCT01845077|5706326|P5|NOT COMPLETED|Treatment Period 2||0
2324579|NCT01845077|5706327|P4|NOT COMPLETED|Treatment Period 2||0
2324580|NCT01845077|5706328|P3|NOT COMPLETED|Treatment Period 2||0
2324581|NCT01845077|5706329|P2|NOT COMPLETED|Treatment Period 2||0
2324582|NCT01845077|5706330|P1|NOT COMPLETED|Treatment Period 2||0
2324583|NCT01845077|5706325|P6|COMPLETED|Treatment Period 2||11
2324584|NCT01845077|5706326|P5|COMPLETED|Treatment Period 2||11
2324585|NCT01845077|5706327|P4|COMPLETED|Treatment Period 2||10
2324586|NCT01845077|5706328|P3|COMPLETED|Treatment Period 2||11
2324587|NCT01845077|5706329|P2|COMPLETED|Treatment Period 2||11
2324588|NCT01845077|5706330|P1|COMPLETED|Treatment Period 2||11
2324589|NCT01845077|5706325|P6|STARTED|Treatment Period 2||11
2324590|NCT01845077|5706326|P5|STARTED|Treatment Period 2||11
2324591|NCT01845077|5706327|P4|STARTED|Treatment Period 2||10
2324592|NCT01845077|5706328|P3|STARTED|Treatment Period 2||11
2324593|NCT01845077|5706329|P2|STARTED|Treatment Period 2||11
2324594|NCT01845077|5706330|P1|STARTED|Treatment Period 2||11
2324595|NCT01845077|5706325|P6|NOT COMPLETED|Washout Period||1
2324596|NCT01845077|5706326|P5|NOT COMPLETED|Washout Period||1
2324597|NCT01845077|5706327|P4|NOT COMPLETED|Washout Period||2
2324598|NCT01845077|5706328|P3|NOT COMPLETED|Washout Period||1
2324599|NCT01845077|5706329|P2|NOT COMPLETED|Washout Period||1
2324600|NCT01845077|5706330|P1|NOT COMPLETED|Washout Period||1
2324601|NCT01845077|5706325|P6|COMPLETED|Washout Period||11
2324602|NCT01845077|5706326|P5|COMPLETED|Washout Period||11
2324603|NCT01845077|5706327|P4|COMPLETED|Washout Period||10
2324604|NCT01845077|5706328|P3|COMPLETED|Washout Period||11
2324605|NCT01845077|5706329|P2|COMPLETED|Washout Period||11
2324606|NCT01845077|5706330|P1|COMPLETED|Washout Period||11
2324607|NCT01845077|5706325|P6|STARTED|Washout Period||12
2324608|NCT01845077|5706326|P5|STARTED|Washout Period||12
2324609|NCT01845077|5706327|P4|STARTED|Washout Period||12
2324610|NCT01845077|5706328|P3|STARTED|Washout Period||12
2324611|NCT01845077|5706329|P2|STARTED|Washout Period||12
2324612|NCT01845077|5706330|P1|STARTED|Washout Period||12
2324613|NCT01845077|5706325|P6|NOT COMPLETED|Treatment Period 1||0
2324614|NCT01845077|5706326|P5|NOT COMPLETED|Treatment Period 1||0
2324615|NCT01845077|5706327|P4|NOT COMPLETED|Treatment Period 1||0
2324616|NCT01845077|5706328|P3|NOT COMPLETED|Treatment Period 1||0
2324617|NCT01845077|5706329|P2|NOT COMPLETED|Treatment Period 1||0
2324618|NCT01845077|5706330|P1|NOT COMPLETED|Treatment Period 1||0
2324619|NCT01845077|5706325|P6|COMPLETED|Treatment Period 1||12
2324620|NCT01845077|5706326|P5|COMPLETED|Treatment Period 1||12
2324621|NCT01845077|5706327|P4|COMPLETED|Treatment Period 1||12
2324622|NCT01845077|5706328|P3|COMPLETED|Treatment Period 1||12
2324623|NCT01845077|5706329|P2|COMPLETED|Treatment Period 1||12
2324624|NCT01845077|5706330|P1|COMPLETED|Treatment Period 1||12
2324625|NCT01845077|5706325|P6|STARTED|Treatment Period 1||12
2324626|NCT01845077|5706326|P5|STARTED|Treatment Period 1||12
2324627|NCT01845077|5706327|P4|STARTED|Treatment Period 1||12
2324628|NCT01845077|5706328|P3|STARTED|Treatment Period 1||12
2324629|NCT01845077|5706329|P2|STARTED|Treatment Period 1||12
2324630|NCT01845077|5706330|P1|STARTED|Treatment Period 1||12
2324631|NCT01845025|5706376|P2|NOT COMPLETED|Overall Study||77
2324632|NCT01845025|5706377|P1|NOT COMPLETED|Overall Study||85
2324633|NCT01845025|5706376|P2|COMPLETED|Overall Study||332
2324634|NCT01845025|5706377|P1|COMPLETED|Overall Study||326
2324635|NCT01845025|5706376|P2|STARTED|Overall Study||409
2324636|NCT01845025|5706377|P1|STARTED|Overall Study||411
2324637|NCT01844986|5706401|P2|NOT COMPLETED|Overall Study||40
2324638|NCT01844986|5706402|P1|NOT COMPLETED|Overall Study||77
2324639|NCT01844986|5706401|P2|COMPLETED|Overall Study||91
2324640|NCT01844986|5706402|P1|COMPLETED|Overall Study||183
2324641|NCT01844986|5706401|P2|STARTED|Overall Study||131
2324642|NCT01844986|5706402|P1|STARTED|Overall Study||260
2324643|NCT01844895|5706424|P1|NOT COMPLETED|Day 29 - Day113 - Autoinjector||6
2324644|NCT01844895|5706424|P1|COMPLETED|Day 29 - Day113 - Autoinjector||111
2324645|NCT01844895|5706424|P1|STARTED|Day 29 - Day113 - Autoinjector||117
2324646|NCT01844895|5706424|P1|NOT COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||3
2324647|NCT01844895|5706424|P1|COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||117
2324648|NCT01844895|5706424|P1|STARTED|Day 1 to Day 28 - Pre-filled Syringe||120
2324649|NCT01844856|5706442|P2|NOT COMPLETED|Overall Study||16
2324650|NCT01844856|5706443|P1|NOT COMPLETED|Overall Study||24
2324651|NCT01844856|5706442|P2|COMPLETED|Overall Study||255
2324652|NCT01844856|5706443|P1|COMPLETED|Overall Study||246
2324653|NCT01844856|5706442|P2|Received at Least 1 Dose of Study Drug|Overall Study||268
2324654|NCT01844856|5706443|P1|Received at Least 1 Dose of Study Drug|Overall Study||270
2324655|NCT01844856|5706442|P2|STARTED|Overall Study||271
2324656|NCT01844856|5706443|P1|STARTED|Overall Study||270
2324657|NCT01844830|5706455|P2|NOT COMPLETED|Overall Study||0
2324658|NCT01844830|5706456|P1|NOT COMPLETED|Overall Study||1
2324659|NCT01844830|5706455|P2|COMPLETED|Overall Study||30
2324660|NCT01844830|5706456|P1|COMPLETED|Overall Study||59
2324661|NCT01844830|5706455|P2|400 µL Dose|Overall Study||10
2324662|NCT01844830|5706456|P1|400 µL Dose|Overall Study||20
2324663|NCT01844830|5706455|P2|200 µL Dose|Overall Study||12
2324664|NCT01844830|5706456|P1|200 µL Dose|Overall Study||24
2324665|NCT01844830|5706455|P2|100 µL Dose|Overall Study||8
2324666|NCT01844830|5706456|P1|100 µL Dose|Overall Study||16
2324667|NCT01844830|5706455|P2|STARTED|Overall Study||30
2324668|NCT01844830|5706456|P1|STARTED|Overall Study||60
2324669|NCT01844817|5706486|P2|NOT COMPLETED|Treatment||63
2324670|NCT01844817|5706487|P1|NOT COMPLETED|Treatment||64
2324671|NCT01844817|5706486|P2|COMPLETED|Treatment||0
2324672|NCT01844817|5706487|P1|COMPLETED|Treatment||0
2324673|NCT01844817|5706486|P2|STARTED|Treatment||63
2324674|NCT01844817|5706487|P1|STARTED|Treatment||64
2324675|NCT01844817|5706486|P2|NOT COMPLETED|Enrolled and Randomized||3
2324676|NCT01844817|5706487|P1|NOT COMPLETED|Enrolled and Randomized||2
2324677|NCT01844817|5706486|P2|COMPLETED|Enrolled and Randomized||63
2324678|NCT01844817|5706487|P1|COMPLETED|Enrolled and Randomized||64
2324679|NCT01844817|5706486|P2|STARTED|Enrolled and Randomized||66
2324680|NCT01844817|5706487|P1|STARTED|Enrolled and Randomized||66
2324681|NCT01844778|5706500|P3|NOT COMPLETED|Overall Study||4
2324682|NCT01844778|5706501|P2|NOT COMPLETED|Overall Study||3
2324683|NCT01844778|5706502|P1|NOT COMPLETED|Overall Study||2
2324684|NCT01844778|5706500|P3|COMPLETED|Overall Study||14
2324685|NCT01844778|5706501|P2|COMPLETED|Overall Study||25
2324686|NCT01844778|5706502|P1|COMPLETED|Overall Study||12
2324687|NCT01844778|5706500|P3|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||15
2324688|NCT01844778|5706501|P2|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||25
2324689|NCT01844778|5706502|P1|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||12
2324690|NCT01844778|5706500|P3|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||18
2324691|NCT01844778|5706501|P2|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||28
2324692|NCT01844778|5706502|P1|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||14
2324693|NCT01844778|5706500|P3|STARTED|Overall Study||18
2324694|NCT01844778|5706501|P2|STARTED|Overall Study||28
2324695|NCT01844778|5706502|P1|STARTED|Overall Study||14
2324696|NCT01844765|5706528|P2|NOT COMPLETED|Overall Study||6
2324697|NCT01844765|5706529|P1|NOT COMPLETED|Overall Study||9
2324698|NCT01844765|5706528|P2|COMPLETED|Overall Study|Completed = patients ongoing treatment at time of data cut-off|19
2324699|NCT01844765|5706529|P1|COMPLETED|Overall Study|Completed = patients ongoing treatment at time of data cut-off|25
2324700|NCT01844765|5706528|P2|Untreated|Overall Study||0
2324701|NCT01844765|5706529|P1|Untreated|Overall Study|Did not receive study drug due to adverse event (AE).|1
2324702|NCT01844765|5706528|P2|Treated|Overall Study||25
2324703|NCT01844765|5706529|P1|Treated|Overall Study||33
2324704|NCT01844765|5706528|P2|STARTED|Overall Study||25
2324705|NCT01844765|5706529|P1|STARTED|Overall Study||34
2324706|NCT01844700|5706549|P2|NOT COMPLETED|Overall Study||1
2324707|NCT01844700|5706550|P1|NOT COMPLETED|Overall Study||3
2324708|NCT01844700|5706549|P2|COMPLETED|Overall Study||2
2324709|NCT01844700|5706550|P1|COMPLETED|Overall Study||1
2324710|NCT01844700|5706549|P2|STARTED|Overall Study||3
2324711|NCT01844700|5706550|P1|STARTED|Overall Study||4
2324712|NCT01844687|5706562|P1|NOT COMPLETED|Visit 8||0
2324713|NCT01844687|5706562|P1|COMPLETED|Visit 8||31
2324714|NCT01844687|5706562|P1|STARTED|Visit 8||31
2324715|NCT01844687|5706562|P1|NOT COMPLETED|Visit 7||0
2324716|NCT01844687|5706562|P1|COMPLETED|Visit 7||31
2324717|NCT01844687|5706562|P1|STARTED|Visit 7||31
2324718|NCT01844687|5706562|P1|NOT COMPLETED|Visit 6||0
2324719|NCT01844687|5706562|P1|COMPLETED|Visit 6||31
2324720|NCT01844687|5706562|P1|STARTED|Visit 6||31
2324721|NCT01844687|5706562|P1|NOT COMPLETED|Visit 5||0
2324722|NCT01844687|5706562|P1|COMPLETED|Visit 5||31
2324723|NCT01844687|5706562|P1|STARTED|Visit 5||31
2324724|NCT01844687|5706562|P1|NOT COMPLETED|Visit 4||4
2324725|NCT01844687|5706562|P1|COMPLETED|Visit 4||31
2324726|NCT01844687|5706562|P1|STARTED|Visit 4||35
2324727|NCT01844687|5706562|P1|NOT COMPLETED|Visit 3||5
2324728|NCT01844687|5706562|P1|COMPLETED|Visit 3||35
2324729|NCT01844687|5706562|P1|STARTED|Visit 3||40
2324730|NCT01844687|5706562|P1|NOT COMPLETED|Visit 2||2
2324731|NCT01844687|5706562|P1|COMPLETED|Visit 2||40
2324732|NCT01844687|5706562|P1|STARTED|Visit 2||42
2324733|NCT01844687|5706562|P1|NOT COMPLETED|Visit 1||8
2324734|NCT01844687|5706562|P1|COMPLETED|Visit 1||42
2324735|NCT01844687|5706562|P1|STARTED|Visit 1||50
2324736|NCT01844583|5706623|P2|NOT COMPLETED|Overall Study||10
2324737|NCT01844583|5706624|P1|NOT COMPLETED|Overall Study||8
2324738|NCT01844583|5706623|P2|COMPLETED|Overall Study||19
2324739|NCT01844583|5706624|P1|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK/ECG assessment.|18
2324740|NCT01844583|5706623|P2|STARTED|Overall Study||29
2324741|NCT01844583|5706624|P1|STARTED|Overall Study||26
2324742|NCT01844531|5706656|P4|NOT COMPLETED|Overall Study||0
2324743|NCT01844531|5706657|P3|NOT COMPLETED|Overall Study||0
2324744|NCT01844531|5706658|P2|NOT COMPLETED|Overall Study||1
2324745|NCT01844531|5706659|P1|NOT COMPLETED|Overall Study||0
2324746|NCT01844531|5706656|P4|COMPLETED|Overall Study||6
2324747|NCT01844531|5706657|P3|COMPLETED|Overall Study||6
2324748|NCT01844531|5706658|P2|COMPLETED|Overall Study||5
2324749|NCT01844531|5706659|P1|COMPLETED|Overall Study||6
2324750|NCT01844531|5706656|P4|STARTED|Overall Study||6
2324751|NCT01844531|5706657|P3|STARTED|Overall Study||6
2324752|NCT01844531|5706658|P2|STARTED|Overall Study||6
2324753|NCT01844531|5706659|P1|STARTED|Overall Study||6
2324754|NCT01844518|5706689|P1|NOT COMPLETED|Long-Term Extension||157
2324755|NCT01844518|5706689|P1|COMPLETED|Long-Term Extension|Study is on-going|0
2324756|NCT01844518|5706689|P1|STARTED|Long-Term Extension|7 participants completed ST but did not continue in study.|157
2324757|NCT01844518|5706689|P1|NOT COMPLETED|Short-Term (ST) Period||9
2324758|NCT01844518|5706689|P1|COMPLETED|Short-Term (ST) Period||164
2324759|NCT01844518|5706689|P1|STARTED|Short-Term (ST) Period||173
2324760|NCT01844505|5706706|P3|NOT COMPLETED|Overall Study||295
2324761|NCT01844505|5706707|P2|NOT COMPLETED|Overall Study||269
2324762|NCT01844505|5706708|P1|NOT COMPLETED|Overall Study||249
2324763|NCT01844505|5706706|P3|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|16
2324764|NCT01844505|5706707|P2|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|44
2324765|NCT01844505|5706708|P1|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|64
2324766|NCT01844505|5706706|P3|STARTED|Overall Study||311
2324767|NCT01844505|5706707|P2|STARTED|Overall Study||313
2324768|NCT01844505|5706708|P1|STARTED|Overall Study||313
2324769|NCT01844479|5706758|P2|NOT COMPLETED|Second Intervention up to 30 Minutes||0
2324770|NCT01844479|5706759|P1|NOT COMPLETED|Second Intervention up to 30 Minutes||0
2324771|NCT01844479|5706758|P2|COMPLETED|Second Intervention up to 30 Minutes||13
2324772|NCT01844479|5706759|P1|COMPLETED|Second Intervention up to 30 Minutes||14
2324773|NCT01844479|5706758|P2|STARTED|Second Intervention up to 30 Minutes||13
2324774|NCT01844479|5706759|P1|STARTED|Second Intervention up to 30 Minutes||14
2324775|NCT01844479|5706758|P2|NOT COMPLETED|First Intervention up to 30 Minutes||0
2324776|NCT01844479|5706759|P1|NOT COMPLETED|First Intervention up to 30 Minutes||0
2324777|NCT01844479|5706758|P2|COMPLETED|First Intervention up to 30 Minutes||13
2324778|NCT01844479|5706759|P1|COMPLETED|First Intervention up to 30 Minutes||14
2324779|NCT01844479|5706758|P2|STARTED|First Intervention up to 30 Minutes||13
2324780|NCT01844479|5706759|P1|STARTED|First Intervention up to 30 Minutes||14
2324781|NCT01844388|5706789|P2|NOT COMPLETED|Overall Study||7
2324782|NCT01844388|5706790|P1|NOT COMPLETED|Overall Study||8
2324783|NCT01844388|5706789|P2|COMPLETED|Overall Study||114
2324784|NCT01844388|5706790|P1|COMPLETED|Overall Study||236
2324785|NCT01844388|5706789|P2|STARTED|Overall Study||121
2324786|NCT01844388|5706790|P1|STARTED|Overall Study||244
2324787|NCT01844375|5706802|P2|NOT COMPLETED|Overall Study||1
2324788|NCT01844375|5706803|P1|NOT COMPLETED|Overall Study||1
2324789|NCT01844375|5706802|P2|COMPLETED|Overall Study||34
2324790|NCT01844375|5706803|P1|COMPLETED|Overall Study||34
2324791|NCT01844375|5706802|P2|STARTED|Overall Study||35
2324792|NCT01844375|5706803|P1|STARTED|Overall Study||35
2324793|NCT01844284|5706815|P2|NOT COMPLETED|Overall Study||7
2324794|NCT01844284|5706816|P1|NOT COMPLETED|Overall Study||12
2324795|NCT01844284|5706815|P2|COMPLETED|Overall Study||127
2324796|NCT01844284|5706816|P1|COMPLETED|Overall Study||254
2324797|NCT01844284|5706815|P2|STARTED|Overall Study|Intent-to-treat (ITT) population|134
2324798|NCT01844284|5706816|P1|STARTED|Overall Study|Intent-to-treat (ITT) population|266
2324799|NCT01844206|5707026|P2|NOT COMPLETED|Overall Study||1
2324800|NCT01844206|5707027|P1|NOT COMPLETED|Overall Study||0
2324801|NCT01844206|5707026|P2|COMPLETED|Overall Study|One patient requested that epidural catheter be removed during the first post-operative day.|2
2324802|NCT01844206|5707027|P1|COMPLETED|Overall Study||2
2324803|NCT01844206|5707026|P2|STARTED|Overall Study||3
2324804|NCT01844206|5707027|P1|STARTED|Overall Study||2
2324805|NCT01844115|5707035|P2|NOT COMPLETED|Overall Study||58
2324806|NCT01844115|5707036|P1|NOT COMPLETED|Overall Study||39
2324807|NCT01844115|5707035|P2|COMPLETED|Overall Study||144
2324808|NCT01844115|5707036|P1|COMPLETED|Overall Study||163
2324809|NCT01844115|5707035|P2|STARTED|Overall Study||202
2324810|NCT01844115|5707036|P1|STARTED|Overall Study||202
2324811|NCT01843972|5707054|P10|NOT COMPLETED|Overall Study||0
2324812|NCT01843972|5707055|P9|NOT COMPLETED|Overall Study||0
2324813|NCT01843972|5707056|P8|NOT COMPLETED|Overall Study||0
2324814|NCT01843972|5707057|P7|NOT COMPLETED|Overall Study||0
2324815|NCT01843972|5707058|P6|NOT COMPLETED|Overall Study||0
2324816|NCT01843972|5707059|P5|NOT COMPLETED|Overall Study||1
2324817|NCT01843972|5707060|P4|NOT COMPLETED|Overall Study||0
2324818|NCT01843972|5707061|P3|NOT COMPLETED|Overall Study||0
2324819|NCT01843972|5707062|P2|NOT COMPLETED|Overall Study||0
2324820|NCT01843972|5707063|P1|NOT COMPLETED|Overall Study||0
2324821|NCT01843972|5707054|P10|COMPLETED|Overall Study||12
2324822|NCT01843972|5707055|P9|COMPLETED|Overall Study||17
2324823|NCT01843972|5707056|P8|COMPLETED|Overall Study||5
2324824|NCT01843972|5707057|P7|COMPLETED|Overall Study||5
2324825|NCT01843972|5707058|P6|COMPLETED|Overall Study||6
2324826|NCT01843972|5707059|P5|COMPLETED|Overall Study||5
2324827|NCT01843972|5707060|P4|COMPLETED|Overall Study||6
2324828|NCT01843972|5707061|P3|COMPLETED|Overall Study||5
2324829|NCT01843972|5707062|P2|COMPLETED|Overall Study||6
2324830|NCT01843972|5707063|P1|COMPLETED|Overall Study||13
2324831|NCT01843972|5707054|P10|STARTED|Overall Study||12
2324832|NCT01843972|5707055|P9|STARTED|Overall Study||17
2324833|NCT01843972|5707056|P8|STARTED|Overall Study||5
2324834|NCT01843972|5707057|P7|STARTED|Overall Study||5
2324835|NCT01843972|5707058|P6|STARTED|Overall Study||6
2324836|NCT01843972|5707059|P5|STARTED|Overall Study||6
2324837|NCT01843972|5707060|P4|STARTED|Overall Study||6
2324838|NCT01843972|5707061|P3|STARTED|Overall Study||5
2324839|NCT01843972|5707062|P2|STARTED|Overall Study||6
2324840|NCT01843972|5707063|P1|STARTED|Overall Study||13
2324841|NCT01843933|5707133|P2|NOT COMPLETED|Overall Study||4
2324842|NCT01843933|5707134|P1|NOT COMPLETED|Overall Study||6
2324843|NCT01843933|5707133|P2|COMPLETED|Overall Study||103
2324844|NCT01843933|5707134|P1|COMPLETED|Overall Study||98
2324845|NCT01843933|5707133|P2|STARTED|Overall Study||107
2324846|NCT01843933|5707134|P1|STARTED|Overall Study||104
2324847|NCT01843920|5707142|P2|NOT COMPLETED|Overall Study||0
2324848|NCT01843920|5707143|P1|NOT COMPLETED|Overall Study||0
2324849|NCT01843920|5707142|P2|COMPLETED|Overall Study||9
2324850|NCT01843920|5707143|P1|COMPLETED|Overall Study||12
2324851|NCT01843920|5707142|P2|STARTED|Overall Study||9
2324852|NCT01843920|5707143|P1|STARTED|Overall Study||12
2324853|NCT01843842|5707153|P2|NOT COMPLETED|Overall Study||1
2324854|NCT01843842|5707154|P1|NOT COMPLETED|Overall Study||1
2324855|NCT01843842|5707153|P2|COMPLETED|Overall Study||151
2324856|NCT01843842|5707154|P1|COMPLETED|Overall Study||153
2324857|NCT01843842|5707153|P2|STARTED|Overall Study||152
2324858|NCT01843842|5707154|P1|STARTED|Overall Study||154
2324859|NCT01843803|5707176|P2|NOT COMPLETED|Overall Study||3
2324860|NCT01843803|5707177|P1|NOT COMPLETED|Overall Study||1
2324861|NCT01843803|5707176|P2|COMPLETED|Overall Study||136
2324862|NCT01843803|5707177|P1|COMPLETED|Overall Study||136
2324863|NCT01843803|5707176|P2|STARTED|Overall Study||139
2324864|NCT01843803|5707177|P1|STARTED|Overall Study||137
2324865|NCT01843777|5707191|P2|NOT COMPLETED|Overall Study||0
2324866|NCT01843777|5707192|P1|NOT COMPLETED|Overall Study||1
2324867|NCT01843777|5707191|P2|COMPLETED|Overall Study|Number of subjects who received the treatment that completed collection of outcome measures|10
2324868|NCT01843777|5707192|P1|COMPLETED|Overall Study|Final number of standard-of-care participants.|10
2324869|NCT01843777|5707191|P2|Per Protocol Population|Overall Study|A subject was randomized to treatment but received standard of care and is not in the analyses.|9
2324870|NCT01843777|5707192|P1|Per Protocol Population|Overall Study||11
2324871|NCT01843777|5707191|P2|STARTED|Overall Study|Number of participants randomized to treatment.|10
2324872|NCT01843777|5707192|P1|STARTED|Overall Study|Number of participants randomized to standard-of-care.|11
2324873|NCT01843751|5707202|P2|NOT COMPLETED|Overall Study||7
2324874|NCT01843751|5707203|P1|NOT COMPLETED|Overall Study||11
2324875|NCT01843751|5707202|P2|COMPLETED|Overall Study||3
2324876|NCT01843751|5707203|P1|COMPLETED|Overall Study||0
2324877|NCT01843751|5707202|P2|STARTED|Overall Study||10
2324878|NCT01843751|5707203|P1|STARTED|Overall Study||11
2324879|NCT01843673|5707217|P1|NOT COMPLETED|Overall Study||6
2324880|NCT01843673|5707217|P1|COMPLETED|Overall Study||10
2324881|NCT01843673|5707217|P1|STARTED|Overall Study||16
2324882|NCT01843660|5707229|P1|NOT COMPLETED|Overall Study||30
2324883|NCT01843660|5707229|P1|COMPLETED|Overall Study||1029
2324884|NCT01843660|5707229|P1|STARTED|Overall Study||1059
2324885|NCT01843621|5707247|P1|NOT COMPLETED|Overall Study||0
2324886|NCT01843621|5707247|P1|COMPLETED|Overall Study||7
2324887|NCT01843621|5707247|P1|STARTED|Overall Study||7
2324888|NCT01843465|5707264|P1|NOT COMPLETED|Overall Study||0
2324889|NCT01843465|5707264|P1|COMPLETED|Overall Study||34
2324890|NCT01843465|5707264|P1|STARTED|Overall Study|This study had no follow-up. It focused in the acute setting of cryoballoon ablation.|34
2324891|NCT01843374|5707270|P2|NOT COMPLETED|Overall Study||379
2324892|NCT01843374|5707271|P1|NOT COMPLETED|Overall Study||189
2324893|NCT01843374|5707270|P2|COMPLETED|Overall Study||3
2324894|NCT01843374|5707271|P1|COMPLETED|Overall Study||0
2324895|NCT01843374|5707270|P2|RANDOMIZED|Overall Study||382
2324896|NCT01843374|5707271|P1|RANDOMIZED|Overall Study||189
2324897|NCT01843374|5707270|P2|STARTED|Overall Study||382
2324898|NCT01843374|5707271|P1|STARTED|Overall Study||189
2324899|NCT01843348|5707298|P3|NOT COMPLETED|Overall Study||41
2324900|NCT01843348|5707299|P2|NOT COMPLETED|Overall Study||40
2324901|NCT01843348|5707300|P1|NOT COMPLETED|Overall Study||23
2324902|NCT01843348|5707298|P3|COMPLETED|Overall Study||158
2324903|NCT01843348|5707299|P2|COMPLETED|Overall Study||168
2324904|NCT01843348|5707300|P1|COMPLETED|Overall Study||182
2324905|NCT01843348|5707298|P3|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|80
2324906|NCT01843348|5707299|P2|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|111
2324907|NCT01843348|5707300|P1|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|147
2324908|NCT01843348|5707298|P3|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|199
2324909|NCT01843348|5707299|P2|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|208
2324910|NCT01843348|5707300|P1|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|205
2324998|NCT01842620|5707576|P1|STARTED|Washout Period||12
2324911|NCT01843348|5707298|P3|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|198
2324912|NCT01843348|5707299|P2|Safety Analysis Set (SAS)|Overall Study|Two participants received TAC + Certican in other arms in errorr - analyzed with TAC + Certican arm|210
2324913|NCT01843348|5707300|P1|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|204
2324914|NCT01843348|5707298|P3|STARTED|Overall Study||199
2324915|NCT01843348|5707299|P2|STARTED|Overall Study||208
2324916|NCT01843348|5707300|P1|STARTED|Overall Study||205
2324917|NCT01843205|5707340|P2|NOT COMPLETED|Second Treatment (11 Days)||0
2324918|NCT01843205|5707341|P1|NOT COMPLETED|Second Treatment (11 Days)||0
2324919|NCT01843205|5707340|P2|COMPLETED|Second Treatment (11 Days)||4
2324920|NCT01843205|5707341|P1|COMPLETED|Second Treatment (11 Days)||4
2324921|NCT01843205|5707340|P2|STARTED|Second Treatment (11 Days)||4
2324922|NCT01843205|5707341|P1|STARTED|Second Treatment (11 Days)||4
2324923|NCT01843205|5707340|P2|NOT COMPLETED|First Treatment (11 Days)||0
2324924|NCT01843205|5707341|P1|NOT COMPLETED|First Treatment (11 Days)||1
2324925|NCT01843205|5707340|P2|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to placebo for Condition 2.|4
2324926|NCT01843205|5707341|P1|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to buspirone for Condition 2.|4
2324927|NCT01843205|5707340|P2|STARTED|First Treatment (11 Days)||4
2324928|NCT01843205|5707341|P1|STARTED|First Treatment (11 Days)||5
2324929|NCT01843192|5707402|P3|NOT COMPLETED|Overall Study||2
2324930|NCT01843192|5707403|P2|NOT COMPLETED|Overall Study||6
2324931|NCT01843192|5707404|P1|NOT COMPLETED|Overall Study||2
2324932|NCT01843192|5707402|P3|COMPLETED|Overall Study||9
2324933|NCT01843192|5707403|P2|COMPLETED|Overall Study||28
2324934|NCT01843192|5707404|P1|COMPLETED|Overall Study||24
2324935|NCT01843192|5707402|P3|STARTED|Overall Study||11
2324936|NCT01843192|5707403|P2|STARTED|Overall Study||34
2324937|NCT01843192|5707404|P1|STARTED|Overall Study||26
2324938|NCT01843062|5707435|P2|NOT COMPLETED|Overall Study||9
2324939|NCT01843062|5707436|P1|NOT COMPLETED|Overall Study||22
2324940|NCT01843062|5707435|P2|COMPLETED|Overall Study||69
2324941|NCT01843062|5707436|P1|COMPLETED|Overall Study||133
2324942|NCT01843062|5707435|P2|Ongoing at Primary Analysis Data Cut-off|Overall Study||71
2324943|NCT01843062|5707436|P1|Ongoing at Primary Analysis Data Cut-off|Overall Study||134
2324944|NCT01843062|5707435|P2|BRAF/NRAS Mutation Positive Analysis Set|Overall Study||51
2324945|NCT01843062|5707436|P1|BRAF/NRAS Mutation Positive Analysis Set|Overall Study||91
2324946|NCT01843062|5707435|P2|Safety Analysis Set|Overall Study||77
2324947|NCT01843062|5707436|P1|Safety Analysis Set|Overall Study||154
2324948|NCT01843062|5707435|P2|Intention to Treat (ITT) Analysis Set|Overall Study||78
2324949|NCT01843062|5707436|P1|Intention to Treat (ITT) Analysis Set|Overall Study||155
2324950|NCT01843062|5707435|P2|STARTED|Overall Study||78
2324951|NCT01843062|5707436|P1|STARTED|Overall Study||155
2324952|NCT01842958|5707450|P2|NOT COMPLETED|Overall Study||1
2324953|NCT01842958|5707451|P1|NOT COMPLETED|Overall Study||1
2324954|NCT01842958|5707450|P2|COMPLETED|Overall Study||24
2324955|NCT01842958|5707451|P1|COMPLETED|Overall Study||24
2324956|NCT01842958|5707450|P2|Randomized|Overall Study||25
2324957|NCT01842958|5707451|P1|Randomized|Overall Study|One subject was randomized to 3.3 mm implant, but received the 4.1 mm implant.|25
2324958|NCT01842958|5707450|P2|STARTED|Overall Study||25
2324959|NCT01842958|5707451|P1|STARTED|Overall Study||25
2324960|NCT01842906|5707471|P2|NOT COMPLETED|Overall Study||0
2324961|NCT01842906|5707472|P1|NOT COMPLETED|Overall Study||0
2324962|NCT01842906|5707471|P2|COMPLETED|Overall Study||104
2324963|NCT01842906|5707472|P1|COMPLETED|Overall Study||115
2324964|NCT01842906|5707471|P2|STARTED|Overall Study||104
2324965|NCT01842906|5707472|P1|STARTED|Overall Study||115
2324966|NCT01842841|5707484|P1|NOT COMPLETED|Overall Study||0
2324967|NCT01842841|5707484|P1|COMPLETED|Overall Study||5
2324968|NCT01842841|5707484|P1|STARTED|Overall Study||5
2324969|NCT01842789|5707505|P2|NOT COMPLETED|Overall Study||0
2324970|NCT01842789|5707506|P1|NOT COMPLETED|Overall Study||0
2324971|NCT01842789|5707505|P2|COMPLETED|Overall Study||8
2324972|NCT01842789|5707506|P1|COMPLETED|Overall Study||10
2324973|NCT01842789|5707505|P2|STARTED|Overall Study||8
2324974|NCT01842789|5707506|P1|STARTED|Overall Study||10
2324975|NCT01842646|5707515|P1|NOT COMPLETED|Overall Study||0
2324976|NCT01842646|5707515|P1|COMPLETED|Overall Study||35
2324977|NCT01842646|5707515|P1|STARTED|Overall Study||35
2324978|NCT01842633|5707526|P3|NOT COMPLETED|Overall Study||0
2324979|NCT01842633|5707527|P2|NOT COMPLETED|Overall Study||2
2324980|NCT01842633|5707528|P1|NOT COMPLETED|Overall Study||3
2324981|NCT01842633|5707526|P3|COMPLETED|Overall Study||34
2324982|NCT01842633|5707527|P2|COMPLETED|Overall Study||64
2324983|NCT01842633|5707528|P1|COMPLETED|Overall Study||62
2324984|NCT01842633|5707526|P3|STARTED|Overall Study||34
2324985|NCT01842633|5707527|P2|STARTED|Overall Study||66
2324986|NCT01842633|5707528|P1|STARTED|Overall Study||65
2324987|NCT01842620|5707575|P2|NOT COMPLETED|Period 2||0
2324988|NCT01842620|5707576|P1|NOT COMPLETED|Period 2||0
2324989|NCT01842620|5707575|P2|COMPLETED|Period 2||12
2324990|NCT01842620|5707576|P1|COMPLETED|Period 2||12
2324991|NCT01842620|5707575|P2|STARTED|Period 2||12
2324992|NCT01842620|5707576|P1|STARTED|Period 2||12
2324993|NCT01842620|5707575|P2|NOT COMPLETED|Washout Period||0
2324994|NCT01842620|5707576|P1|NOT COMPLETED|Washout Period||0
2324995|NCT01842620|5707575|P2|COMPLETED|Washout Period||12
2324996|NCT01842620|5707576|P1|COMPLETED|Washout Period||12
2324997|NCT01842620|5707575|P2|STARTED|Washout Period||12
2324999|NCT01842620|5707575|P2|NOT COMPLETED|Period 1||0
2325000|NCT01842620|5707576|P1|NOT COMPLETED|Period 1||1
2325001|NCT01842620|5707575|P2|COMPLETED|Period 1||12
2325002|NCT01842620|5707576|P1|COMPLETED|Period 1||12
2325003|NCT01842620|5707575|P2|STARTED|Period 1||12
2325004|NCT01842620|5707576|P1|STARTED|Period 1||13
2325005|NCT01842607|5707592|P1|NOT COMPLETED|Overall Study||66
2325006|NCT01842607|5707592|P1|COMPLETED|Overall Study||585
2325007|NCT01842607|5707592|P1|STARTED|Overall Study||651
2325008|NCT01842594|5707611|P1|NOT COMPLETED|Overall Study||3
2325009|NCT01842594|5707611|P1|COMPLETED|Overall Study||10
2325010|NCT01842594|5707611|P1|STARTED|Overall Study||13
2325011|NCT01842581|5707618|P2|NOT COMPLETED|Overall Study||30
2325012|NCT01842581|5707619|P1|NOT COMPLETED|Overall Study||44
2325013|NCT01842581|5707618|P2|COMPLETED|Overall Study||79
2325014|NCT01842581|5707619|P1|COMPLETED|Overall Study||69
2325015|NCT01842581|5707618|P2|Received at Least 1 Dose of Study Drug|Overall Study||108
2325016|NCT01842581|5707619|P1|Received at Least 1 Dose of Study Drug|Overall Study||113
2325017|NCT01842581|5707618|P2|STARTED|Overall Study||109
2325018|NCT01842581|5707619|P1|STARTED|Overall Study||113
2325019|NCT01842464|5707635|P1|NOT COMPLETED|Overall Study||0
2325020|NCT01842464|5707635|P1|COMPLETED|Overall Study||44
2325021|NCT01842464|5707635|P1|STARTED|Overall Study||44
2325022|NCT01842438|5707643|P2|NOT COMPLETED|T2: 6month Follow-up||4
2325023|NCT01842438|5707644|P1|NOT COMPLETED|T2: 6month Follow-up||4
2325024|NCT01842438|5707643|P2|COMPLETED|T2: 6month Follow-up||32
2325025|NCT01842438|5707644|P1|COMPLETED|T2: 6month Follow-up||32
2325026|NCT01842438|5707643|P2|STARTED|T2: 6month Follow-up||36
2325027|NCT01842438|5707644|P1|STARTED|T2: 6month Follow-up||36
2325028|NCT01842438|5707643|P2|NOT COMPLETED|T1: Immediately After the Intervention||8
2325029|NCT01842438|5707644|P1|NOT COMPLETED|T1: Immediately After the Intervention||6
2325030|NCT01842438|5707643|P2|COMPLETED|T1: Immediately After the Intervention||36
2325031|NCT01842438|5707644|P1|COMPLETED|T1: Immediately After the Intervention||36
2325032|NCT01842438|5707643|P2|STARTED|T1: Immediately After the Intervention||44
2325033|NCT01842438|5707644|P1|STARTED|T1: Immediately After the Intervention||42
2325034|NCT01842334|5707658|P2|NOT COMPLETED|Overall Study||4
2325035|NCT01842334|5707659|P1|NOT COMPLETED|Overall Study||3
2325036|NCT01842334|5707658|P2|COMPLETED|Overall Study||3
2325037|NCT01842334|5707659|P1|COMPLETED|Overall Study||2
2325038|NCT01842334|5707658|P2|STARTED|Overall Study||7
2325039|NCT01842334|5707659|P1|STARTED|Overall Study||5
2325040|NCT01841970|5707665|P1|NOT COMPLETED|Overall Study||11
2325041|NCT01841970|5707665|P1|COMPLETED|Overall Study||9
2325042|NCT01841970|5707665|P1|STARTED|Overall Study||20
2325043|NCT01841931|5707681|P1|NOT COMPLETED|Overall Study||4
2325044|NCT01841931|5707681|P1|COMPLETED|Overall Study|As the PI left the institution the study was terminated|0
2325045|NCT01841931|5707681|P1|STARTED|Overall Study||4
2325046|NCT01841762|5707689|P1|NOT COMPLETED|Post-Treatment Safety Follow-Up Period||15
2325047|NCT01841762|5707689|P1|COMPLETED|Post-Treatment Safety Follow-Up Period||269
2325048|NCT01841762|5707689|P1|STARTED|Post-Treatment Safety Follow-Up Period||284
2325049|NCT01841762|5707689|P1|NOT COMPLETED|Treatment Period||32
2325050|NCT01841762|5707689|P1|COMPLETED|Treatment Period||252
2325051|NCT01841762|5707689|P1|STARTED|Treatment Period||284
2325052|NCT01841762|5707689|P1|NOT COMPLETED|Screening Period||51
2325053|NCT01841762|5707689|P1|COMPLETED|Screening Period||284
2325054|NCT01841762|5707689|P1|STARTED|Screening Period||335
2325055|NCT01841697|5707699|P2|NOT COMPLETED|Overall Study||18
2325056|NCT01841697|5707700|P1|NOT COMPLETED|Overall Study||20
2325057|NCT01841697|5707699|P2|COMPLETED|Overall Study||302
2325058|NCT01841697|5707700|P1|COMPLETED|Overall Study||302
2325059|NCT01841697|5707699|P2|STARTED|Overall Study||320
2325060|NCT01841697|5707700|P1|STARTED|Overall Study||322
2325061|NCT01841632|5707716|P1|NOT COMPLETED|Overall Study||0
2325062|NCT01841632|5707716|P1|COMPLETED|Overall Study||3
2325063|NCT01841632|5707716|P1|STARTED|Overall Study||3
2325064|NCT01841619|5707721|P1|NOT COMPLETED|Overall Study||0
2325065|NCT01841619|5707721|P1|COMPLETED|Overall Study||16
2325066|NCT01841619|5707721|P1|STARTED|Overall Study||16
2325067|NCT01841606|5707731|P2|NOT COMPLETED|Overall Study||0
2325068|NCT01841606|5707732|P1|NOT COMPLETED|Overall Study||0
2325069|NCT01841606|5707731|P2|COMPLETED|Overall Study||27
2325070|NCT01841606|5707732|P1|COMPLETED|Overall Study||25
2325071|NCT01841606|5707731|P2|STARTED|Overall Study||27
2325072|NCT01841606|5707732|P1|STARTED|Overall Study||25
2325073|NCT01841593|5707740|P2|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
2325074|NCT01841593|5707741|P1|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
2325075|NCT01841593|5707740|P2|COMPLETED|Third Intervention (Days 15 to 21)||6
2325076|NCT01841593|5707741|P1|COMPLETED|Third Intervention (Days 15 to 21)||11
2325077|NCT01841593|5707740|P2|STARTED|Third Intervention (Days 15 to 21)||6
2325078|NCT01841593|5707741|P1|STARTED|Third Intervention (Days 15 to 21)||11
2325079|NCT01841593|5707740|P2|NOT COMPLETED|Second Intervention (Days 8 to 14)||0
2325080|NCT01841593|5707741|P1|NOT COMPLETED|Second Intervention (Days 8 to 14)||1
2325081|NCT01841593|5707740|P2|COMPLETED|Second Intervention (Days 8 to 14)||6
2325082|NCT01841593|5707741|P1|COMPLETED|Second Intervention (Days 8 to 14)||11
2325083|NCT01841593|5707740|P2|STARTED|Second Intervention (Days 8 to 14)||6
2325084|NCT01841593|5707741|P1|STARTED|Second Intervention (Days 8 to 14)||12
2325085|NCT01841593|5707740|P2|NOT COMPLETED|First Intervention (Days 1 to 7)||1
2325086|NCT01841593|5707741|P1|NOT COMPLETED|First Intervention (Days 1 to 7)||0
2325087|NCT01841593|5707740|P2|COMPLETED|First Intervention (Days 1 to 7)||6
2325088|NCT01841593|5707741|P1|COMPLETED|First Intervention (Days 1 to 7)||12
2325089|NCT01841593|5707740|P2|STARTED|First Intervention (Days 1 to 7)||7
2325090|NCT01841593|5707741|P1|STARTED|First Intervention (Days 1 to 7)||12
2325091|NCT01841567|5707757|P1|NOT COMPLETED|Overall Study||3
2325092|NCT01841567|5707757|P1|COMPLETED|Overall Study||57
2325093|NCT01841567|5707757|P1|STARTED|Overall Study||60
2325094|NCT01841216|5707764|P2|NOT COMPLETED|Overall Study||0
2325095|NCT01841216|5707765|P1|NOT COMPLETED|Overall Study||0
2325096|NCT01841216|5707764|P2|COMPLETED|Overall Study||15
2325097|NCT01841216|5707765|P1|COMPLETED|Overall Study||15
2325098|NCT01841216|5707764|P2|STARTED|Overall Study||15
2325099|NCT01841216|5707765|P1|STARTED|Overall Study||15
2325100|NCT01841073|5707775|P2|NOT COMPLETED|Overall Study||3
2325101|NCT01841073|5707776|P1|NOT COMPLETED|Overall Study||2
2325102|NCT01841073|5707775|P2|COMPLETED|Overall Study||19
2325103|NCT01841073|5707776|P1|COMPLETED|Overall Study||20
2325104|NCT01841073|5707775|P2|STARTED|Overall Study||22
2325105|NCT01841073|5707776|P1|STARTED|Overall Study||22
2325106|NCT01841021|5707786|P1|NOT COMPLETED|Overall Study||0
2325107|NCT01841021|5707786|P1|COMPLETED|Overall Study||1
2325108|NCT01841021|5707786|P1|STARTED|Overall Study||1
2325109|NCT01840943|5707798|P2|NOT COMPLETED|Overall Study||12
2325110|NCT01840943|5707799|P1|NOT COMPLETED|Overall Study||13
2325111|NCT01840943|5707798|P2|COMPLETED|Overall Study||0
2325112|NCT01840943|5707799|P1|COMPLETED|Overall Study||1
2325113|NCT01840943|5707798|P2|STARTED|Overall Study||12
2325114|NCT01840943|5707799|P1|STARTED|Overall Study||14
2325115|NCT01840722|5707835|P2|NOT COMPLETED|Overall Study||69
2325116|NCT01840722|5707836|P1|NOT COMPLETED|Overall Study||0
2325117|NCT01840722|5707835|P2|COMPLETED|Overall Study||130
2325118|NCT01840722|5707836|P1|COMPLETED|Overall Study||201
2325119|NCT01840722|5707835|P2|STARTED|Overall Study||199
2325120|NCT01840722|5707836|P1|STARTED|Overall Study||201
2325121|NCT01840605|5707848|P2|NOT COMPLETED|Overall Study||2
2325122|NCT01840605|5707849|P1|NOT COMPLETED|Overall Study||2
2325123|NCT01840605|5707848|P2|COMPLETED|Overall Study||150
2325124|NCT01840605|5707849|P1|COMPLETED|Overall Study||149
2325125|NCT01840605|5707848|P2|STARTED|Overall Study||152
2325126|NCT01840605|5707849|P1|STARTED|Overall Study||151
2325127|NCT01840410|5707863|P2|NOT COMPLETED|Overall Study||4
2325128|NCT01840410|5707864|P1|NOT COMPLETED|Overall Study||7
2325129|NCT01840410|5707863|P2|COMPLETED|Overall Study||55
2325130|NCT01840410|5707864|P1|COMPLETED|Overall Study||112
2325131|NCT01840410|5707863|P2|Full Analysis Set|Overall Study||59
2325132|NCT01840410|5707864|P1|Full Analysis Set|Overall Study||119
2325133|NCT01840410|5707863|P2|Safety Set|Overall Study|52 received ranibizumab at or after Month 2;7 did not receive ranibizumab any time during the study|59
2325134|NCT01840410|5707864|P1|Safety Set|Overall Study||119
2325135|NCT01840410|5707863|P2|STARTED|Overall Study||59
2325136|NCT01840410|5707864|P1|STARTED|Overall Study||119
2325137|NCT01840345|5707900|P1|NOT COMPLETED|Overall Study||1
2325138|NCT01840345|5707900|P1|COMPLETED|Overall Study||10
2325139|NCT01840345|5707900|P1|STARTED|Overall Study||11
2325140|NCT01840319|5707907|P1|NOT COMPLETED|Overall Study||0
2325141|NCT01840319|5707907|P1|COMPLETED|Overall Study||156
2325142|NCT01840319|5707907|P1|STARTED|Overall Study||156
2325143|NCT01840228|5707913|P2|NOT COMPLETED|Overall Study||1
2325144|NCT01840228|5707914|P1|NOT COMPLETED|Overall Study||1
2325145|NCT01840228|5707913|P2|COMPLETED|Overall Study||18
2325146|NCT01840228|5707914|P1|COMPLETED|Overall Study||18
2325147|NCT01840228|5707913|P2|STARTED|Overall Study||19
2325148|NCT01840228|5707914|P1|STARTED|Overall Study||19
2325149|NCT01840163|5707942|P2|NOT COMPLETED|Systemic Follow Up-secondary Outcome||75
2325150|NCT01840163|5707943|P1|NOT COMPLETED|Systemic Follow Up-secondary Outcome||91
2325151|NCT01840163|5707942|P2|COMPLETED|Systemic Follow Up-secondary Outcome||191
2325152|NCT01840163|5707943|P1|COMPLETED|Systemic Follow Up-secondary Outcome||174
2325153|NCT01840163|5707942|P2|STARTED|Systemic Follow Up-secondary Outcome|4 participants became unreachable and lost to follow up before sending 9 mo follow up|266
2325154|NCT01840163|5707943|P1|STARTED|Systemic Follow Up-secondary Outcome|From primary outcome to secondary outcome prd 1 participant withdrew and 1 became deceased|265
2325155|NCT01840163|5707942|P2|NOT COMPLETED|First Follow up -Primary Outcome||16
2325156|NCT01840163|5707943|P1|NOT COMPLETED|First Follow up -Primary Outcome||19
2325157|NCT01840163|5707942|P2|COMPLETED|First Follow up -Primary Outcome||254
2325158|NCT01840163|5707943|P1|COMPLETED|First Follow up -Primary Outcome||248
2325159|NCT01840163|5707942|P2|STARTED|First Follow up -Primary Outcome||270
2325160|NCT01840163|5707943|P1|STARTED|First Follow up -Primary Outcome||267
2325161|NCT01840072|5707965|P2|NOT COMPLETED|Overall Study||47
2325162|NCT01840072|5707966|P1|NOT COMPLETED|Overall Study||7
2325163|NCT01840072|5707965|P2|COMPLETED|Overall Study||1986
2325164|NCT01840072|5707966|P1|COMPLETED|Overall Study||2031
2325165|NCT01840072|5707965|P2|STARTED|Overall Study||2033
2325166|NCT01840072|5707966|P1|STARTED|Overall Study||2038
2325167|NCT01839916|5707988|P1|NOT COMPLETED|Overall Study||41
2325168|NCT01839916|5707988|P1|COMPLETED|Overall Study||36
2325169|NCT01839916|5707988|P1|STARTED|Overall Study||77
2325170|NCT01839708|5707999|P2|NOT COMPLETED|Overall Study||67
2325171|NCT01839708|5708000|P1|NOT COMPLETED|Overall Study||76
2325172|NCT01839708|5707999|P2|COMPLETED|Overall Study||115
2325173|NCT01839708|5708000|P1|COMPLETED|Overall Study||311
2325174|NCT01839708|5707999|P2|STARTED|Overall Study||182
2325175|NCT01839708|5708000|P1|STARTED|Overall Study||387
2325176|NCT01839695|5708032|P1|NOT COMPLETED|Overall Study||0
2325177|NCT01839695|5708032|P1|COMPLETED|Overall Study||9
2325178|NCT01839695|5708032|P1|STARTED|Overall Study||9
2325179|NCT01839656|5708039|P2|NOT COMPLETED|Overall Study||16
2325180|NCT01839656|5708040|P1|NOT COMPLETED|Overall Study||3
2325181|NCT01839656|5708039|P2|COMPLETED|Overall Study||0
2325182|NCT01839656|5708040|P1|COMPLETED|Overall Study||2
2325183|NCT01839656|5708039|P2|Completed Loading Dose Period|Overall Study||15
2325184|NCT01839656|5708040|P1|Completed Loading Dose Period|Overall Study||4
2325185|NCT01839656|5708039|P2|STARTED|Overall Study||16
2325186|NCT01839656|5708040|P1|STARTED|Overall Study||5
2325187|NCT01839604|5708067|P5|NOT COMPLETED|Overall Study||0
2325188|NCT01839604|5708068|P4|NOT COMPLETED|Overall Study||0
2325189|NCT01839604|5708069|P3|NOT COMPLETED|Overall Study||0
2325190|NCT01839604|5708070|P2|NOT COMPLETED|Overall Study||0
2325191|NCT01839604|5708071|P1|NOT COMPLETED|Overall Study||0
2325192|NCT01839604|5708067|P5|COMPLETED|Overall Study||15
2325193|NCT01839604|5708068|P4|COMPLETED|Overall Study||5
2325194|NCT01839604|5708069|P3|COMPLETED|Overall Study||7
2325195|NCT01839604|5708070|P2|COMPLETED|Overall Study||6
2325196|NCT01839604|5708071|P1|COMPLETED|Overall Study||6
2325197|NCT01839604|5708067|P5|STARTED|Overall Study||15
2325198|NCT01839604|5708068|P4|STARTED|Overall Study||5
2325199|NCT01839604|5708069|P3|STARTED|Overall Study||7
2325200|NCT01839604|5708070|P2|STARTED|Overall Study||6
2325201|NCT01839604|5708071|P1|STARTED|Overall Study||6
2325202|NCT01839396|5708100|P2|NOT COMPLETED|Overall Study||0
2325203|NCT01839396|5708101|P1|NOT COMPLETED|Overall Study||0
2325204|NCT01839396|5708100|P2|COMPLETED|Overall Study||39
2325205|NCT01839396|5708101|P1|COMPLETED|Overall Study||121
2325206|NCT01839396|5708100|P2|STARTED|Overall Study||39
2325207|NCT01839396|5708101|P1|STARTED|Overall Study||121
2325208|NCT01839318|5708109|P6|NOT COMPLETED|Period 3, Third Day of Wear||0
2325209|NCT01839318|5708110|P5|NOT COMPLETED|Period 3, Third Day of Wear||0
2325210|NCT01839318|5708111|P4|NOT COMPLETED|Period 3, Third Day of Wear||0
2325211|NCT01839318|5708112|P3|NOT COMPLETED|Period 3, Third Day of Wear||0
2325212|NCT01839318|5708113|P2|NOT COMPLETED|Period 3, Third Day of Wear||0
2325213|NCT01839318|5708114|P1|NOT COMPLETED|Period 3, Third Day of Wear||0
2325214|NCT01839318|5708109|P6|COMPLETED|Period 3, Third Day of Wear||2
2325215|NCT01839318|5708110|P5|COMPLETED|Period 3, Third Day of Wear||7
2325216|NCT01839318|5708111|P4|COMPLETED|Period 3, Third Day of Wear||6
2325217|NCT01839318|5708112|P3|COMPLETED|Period 3, Third Day of Wear||5
2325218|NCT01839318|5708113|P2|COMPLETED|Period 3, Third Day of Wear||4
2325219|NCT01839318|5708114|P1|COMPLETED|Period 3, Third Day of Wear||4
2325220|NCT01839318|5708109|P6|STARTED|Period 3, Third Day of Wear||2
2325221|NCT01839318|5708110|P5|STARTED|Period 3, Third Day of Wear||7
2325222|NCT01839318|5708111|P4|STARTED|Period 3, Third Day of Wear||6
2325223|NCT01839318|5708112|P3|STARTED|Period 3, Third Day of Wear||5
2325224|NCT01839318|5708113|P2|STARTED|Period 3, Third Day of Wear||4
2325225|NCT01839318|5708114|P1|STARTED|Period 3, Third Day of Wear||4
2325226|NCT01839318|5708109|P6|NOT COMPLETED|Period 2, Second Day of Wear||0
2325227|NCT01839318|5708110|P5|NOT COMPLETED|Period 2, Second Day of Wear||0
2325228|NCT01839318|5708111|P4|NOT COMPLETED|Period 2, Second Day of Wear||0
2325229|NCT01839318|5708112|P3|NOT COMPLETED|Period 2, Second Day of Wear||0
2325230|NCT01839318|5708113|P2|NOT COMPLETED|Period 2, Second Day of Wear||0
2325231|NCT01839318|5708114|P1|NOT COMPLETED|Period 2, Second Day of Wear||0
2325232|NCT01839318|5708109|P6|COMPLETED|Period 2, Second Day of Wear||2
2325233|NCT01839318|5708110|P5|COMPLETED|Period 2, Second Day of Wear||7
2325234|NCT01839318|5708111|P4|COMPLETED|Period 2, Second Day of Wear||6
2325235|NCT01839318|5708112|P3|COMPLETED|Period 2, Second Day of Wear||5
2325236|NCT01839318|5708113|P2|COMPLETED|Period 2, Second Day of Wear||4
2325237|NCT01839318|5708114|P1|COMPLETED|Period 2, Second Day of Wear||4
2325238|NCT01839318|5708109|P6|STARTED|Period 2, Second Day of Wear||2
2325239|NCT01839318|5708110|P5|STARTED|Period 2, Second Day of Wear||7
2325240|NCT01839318|5708111|P4|STARTED|Period 2, Second Day of Wear||6
2325241|NCT01839318|5708112|P3|STARTED|Period 2, Second Day of Wear||5
2325242|NCT01839318|5708113|P2|STARTED|Period 2, Second Day of Wear||4
2325243|NCT01839318|5708114|P1|STARTED|Period 2, Second Day of Wear||4
2325244|NCT01839318|5708109|P6|NOT COMPLETED|Period 1, First Day of Wear||0
2325245|NCT01839318|5708110|P5|NOT COMPLETED|Period 1, First Day of Wear||0
2325246|NCT01839318|5708111|P4|NOT COMPLETED|Period 1, First Day of Wear||0
2325247|NCT01839318|5708112|P3|NOT COMPLETED|Period 1, First Day of Wear||0
2325248|NCT01839318|5708113|P2|NOT COMPLETED|Period 1, First Day of Wear||0
2325249|NCT01839318|5708114|P1|NOT COMPLETED|Period 1, First Day of Wear||0
2325250|NCT01839318|5708109|P6|COMPLETED|Period 1, First Day of Wear||2
2325251|NCT01839318|5708110|P5|COMPLETED|Period 1, First Day of Wear||7
2325252|NCT01839318|5708111|P4|COMPLETED|Period 1, First Day of Wear||6
2325253|NCT01839318|5708112|P3|COMPLETED|Period 1, First Day of Wear||5
2325254|NCT01839318|5708113|P2|COMPLETED|Period 1, First Day of Wear||4
2325255|NCT01839318|5708114|P1|COMPLETED|Period 1, First Day of Wear||4
2325256|NCT01839318|5708109|P6|STARTED|Period 1, First Day of Wear||2
2325257|NCT01839318|5708110|P5|STARTED|Period 1, First Day of Wear||7
2325258|NCT01839318|5708111|P4|STARTED|Period 1, First Day of Wear||6
2325259|NCT01839318|5708112|P3|STARTED|Period 1, First Day of Wear||5
2325260|NCT01839318|5708113|P2|STARTED|Period 1, First Day of Wear||4
2325261|NCT01839318|5708114|P1|STARTED|Period 1, First Day of Wear||4
2325262|NCT01839279|5708128|P3|NOT COMPLETED|Overall Study||2
2325263|NCT01839279|5708129|P2|NOT COMPLETED|Overall Study||2
2325264|NCT01839279|5708130|P1|NOT COMPLETED|Overall Study||13
2325265|NCT01839279|5708128|P3|COMPLETED|Overall Study||30
2325266|NCT01839279|5708129|P2|COMPLETED|Overall Study||30
2325267|NCT01839279|5708130|P1|COMPLETED|Overall Study||59
2325268|NCT01839279|5708128|P3|PK/QTc Analysis Set|Overall Study||0
2325269|NCT01839279|5708129|P2|PK/QTc Analysis Set|Overall Study||0
2325270|NCT01839279|5708130|P1|PK/QTc Analysis Set|Overall Study||70
2325271|NCT01839279|5708128|P3|Moxifloxacin/Placebo Analysis Set|Overall Study||30
2325272|NCT01839279|5708129|P2|Moxifloxacin/Placebo Analysis Set|Overall Study||31
2325273|NCT01839279|5708130|P1|Moxifloxacin/Placebo Analysis Set|Overall Study||0
2325274|NCT01839279|5708128|P3|PK Analysis Set|Overall Study||0
2325275|NCT01839279|5708129|P2|PK Analysis Set|Overall Study||0
2325276|NCT01839279|5708130|P1|PK Analysis Set|Overall Study||70
2325277|NCT01839279|5708128|P3|QT/QTc Analysis Set|Overall Study||32
2325278|NCT01839279|5708129|P2|QT/QTc Analysis Set|Overall Study||32
2325279|NCT01839279|5708130|P1|QT/QTc Analysis Set|Overall Study||72
2325280|NCT01839279|5708128|P3|STARTED|Overall Study||32
2325281|NCT01839279|5708129|P2|STARTED|Overall Study||32
2325282|NCT01839279|5708130|P1|STARTED|Overall Study||72
2325283|NCT01839188|5708149|P1|NOT COMPLETED|Overall Study||1
2325284|NCT01839188|5708149|P1|COMPLETED|Overall Study|N=1 treated participant withdrew before receiving V3|384
2325285|NCT01839188|5708149|P1|Treated|Overall Study||385
2325286|NCT01839188|5708149|P1|STARTED|Overall Study||385
2325287|NCT01839110|5708192|P3|NOT COMPLETED|Overall Study||3
2325288|NCT01839110|5708193|P2|NOT COMPLETED|Overall Study||2
2325289|NCT01839110|5708194|P1|NOT COMPLETED|Overall Study||3
2325290|NCT01839110|5708192|P3|COMPLETED|Overall Study||6
2325291|NCT01839110|5708193|P2|COMPLETED|Overall Study||4
2325292|NCT01839110|5708194|P1|COMPLETED|Overall Study||4
2325293|NCT01839110|5708192|P3|STARTED|Overall Study||9
2325294|NCT01839110|5708193|P2|STARTED|Overall Study||6
2325295|NCT01839110|5708194|P1|STARTED|Overall Study||7
2325296|NCT01839058|5708204|P2|NOT COMPLETED|Overall Study||3
2325297|NCT01839058|5708205|P1|NOT COMPLETED|Overall Study||4
2325298|NCT01839058|5708204|P2|COMPLETED|Overall Study||16
2325299|NCT01839058|5708205|P1|COMPLETED|Overall Study||17
2325300|NCT01839058|5708204|P2|STARTED|Overall Study||19
2325301|NCT01839058|5708205|P1|STARTED|Overall Study||21
2325302|NCT01838980|5708217|P1|NOT COMPLETED|Overall Study||0
2325303|NCT01838980|5708217|P1|COMPLETED|Overall Study||15
2325304|NCT01838980|5708217|P1|STARTED|Overall Study||15
2325305|NCT01838941|5708221|P1|NOT COMPLETED|Overall Study||2
2325306|NCT01838941|5708221|P1|COMPLETED|Overall Study||10
2325307|NCT01838941|5708221|P1|STARTED|Overall Study||12
2325308|NCT01838876|5708226|P1|NOT COMPLETED|Overall Study||233
2325309|NCT01838876|5708226|P1|COMPLETED|Overall Study||209
2325310|NCT01838876|5708226|P1|Entered Safety Follow-up Period|Overall Study||287
2325311|NCT01838876|5708226|P1|Safety Population; Received Study Drug|Overall Study||345
2325312|NCT01838876|5708226|P1|STARTED|Overall Study||442
2325313|NCT01838863|5708241|P2|NOT COMPLETED|Overall Study||9
2325314|NCT01838863|5708242|P1|NOT COMPLETED|Overall Study||10
2325315|NCT01838863|5708241|P2|COMPLETED|Overall Study||60
2325316|NCT01838863|5708242|P1|COMPLETED|Overall Study||65
2325317|NCT01838863|5708241|P2|STARTED|Overall Study||69
2325318|NCT01838863|5708242|P1|STARTED|Overall Study||75
2325319|NCT01838785|5708328|P1|NOT COMPLETED|Overall Study||0
2325320|NCT01838785|5708328|P1|COMPLETED|Overall Study||25
2325321|NCT01838785|5708328|P1|STARTED|Overall Study||25
2325322|NCT01838694|5708335|P2|NOT COMPLETED|Overall Study||1
2325323|NCT01838694|5708336|P1|NOT COMPLETED|Overall Study||0
2325324|NCT01838694|5708335|P2|COMPLETED|Overall Study||21
2325325|NCT01838694|5708336|P1|COMPLETED|Overall Study||8
2325326|NCT01838694|5708335|P2|STARTED|Overall Study||22
2325327|NCT01838694|5708336|P1|STARTED|Overall Study||8
2325328|NCT01838681|5708345|P4|NOT COMPLETED|Period B/A+||117
2325329|NCT01838681|5708346|P3|NOT COMPLETED|Period B/A+||95
2325330|NCT01838681|5708347|P2|NOT COMPLETED|Period B/A+||62
2325331|NCT01838681|5708348|P1|NOT COMPLETED|Period B/A+||0
2325332|NCT01838681|5708345|P4|COMPLETED|Period B/A+||653
2325333|NCT01838681|5708346|P3|COMPLETED|Period B/A+||349
2325334|NCT01838681|5708347|P2|COMPLETED|Period B/A+||380
2325335|NCT01838681|5708348|P1|COMPLETED|Period B/A+||0
2325336|NCT01838681|5708345|P4|STARTED|Period B/A+||770
2325337|NCT01838681|5708346|P3|STARTED|Period B/A+||444
2325338|NCT01838681|5708347|P2|STARTED|Period B/A+||442
2325339|NCT01838681|5708348|P1|STARTED|Period B/A+||0
2325340|NCT01838681|5708345|P4|NOT COMPLETED|Period A||0
2325341|NCT01838681|5708346|P3|NOT COMPLETED|Period A||0
2325342|NCT01838681|5708347|P2|NOT COMPLETED|Period A||0
2325343|NCT01838681|5708348|P1|NOT COMPLETED|Period A||325
2325344|NCT01838681|5708345|P4|COMPLETED|Period A||0
2325345|NCT01838681|5708346|P3|COMPLETED|Period A||0
2325346|NCT01838681|5708347|P2|COMPLETED|Period A||0
2325347|NCT01838681|5708348|P1|COMPLETED|Period A||1661
2325348|NCT01838681|5708345|P4|STARTED|Period A||0
2325349|NCT01838681|5708346|P3|STARTED|Period A||0
2325350|NCT01838681|5708347|P2|STARTED|Period A||0
2325351|NCT01838681|5708348|P1|STARTED|Period A||1986
2325352|NCT01838655|5708388|P1|NOT COMPLETED|Overall Study||0
2325353|NCT01838655|5708388|P1|COMPLETED|Overall Study||5
2325354|NCT01838655|5708388|P1|STARTED|Overall Study||5
2325355|NCT01838642|5708456|P1|NOT COMPLETED|Overall Study||1
2325356|NCT01838642|5708456|P1|COMPLETED|Overall Study||2
2325357|NCT01838642|5708456|P1|STARTED|Overall Study||3
2325358|NCT01838616|5708469|P2|NOT COMPLETED|Pick-up Arm||0
2325359|NCT01838616|5708470|P1|NOT COMPLETED|Pick-up Arm||15
2325360|NCT01838616|5708469|P2|COMPLETED|Pick-up Arm||0
2325361|NCT01838616|5708470|P1|COMPLETED|Pick-up Arm|Participants completed the tapentadol pick-up arm after initially on oxycodone/naloxone PR treatment|35
2325362|NCT01838616|5708469|P2|Full Analysis Set|Pick-up Arm||0
2325363|NCT01838616|5708470|P1|Full Analysis Set|Pick-up Arm||49
2325364|NCT01838616|5708469|P2|STARTED|Pick-up Arm||0
2325365|NCT01838616|5708470|P1|STARTED|Pick-up Arm|Switch to Tapentadol (PR) after Oxycodone/Naloxone (PR) treatment discontinuation.|50
2325366|NCT01838616|5708469|P2|NOT COMPLETED|Continuation Period||14
2325367|NCT01838616|5708470|P1|NOT COMPLETED|Continuation Period||14
2325368|NCT01838616|5708469|P2|COMPLETED|Continuation Period||48
2325369|NCT01838616|5708470|P1|COMPLETED|Continuation Period||86
2325370|NCT01838616|5708469|P2|Switched to Pick-up Arm|Continuation Period||7
2325371|NCT01838616|5708470|P1|Switched to Pick-up Arm|Continuation Period||0
2325372|NCT01838616|5708469|P2|STARTED|Continuation Period||62
2325373|NCT01838616|5708470|P1|STARTED|Continuation Period||100
2325374|NCT01838616|5708469|P2|NOT COMPLETED|Titration Period||66
2325375|NCT01838616|5708470|P1|NOT COMPLETED|Titration Period||30
2325376|NCT01838616|5708469|P2|COMPLETED|Titration Period||62
2325377|NCT01838616|5708470|P1|COMPLETED|Titration Period||100
2325378|NCT01838616|5708469|P2|Per Protocol Set|Titration Period||112
2325379|NCT01838616|5708470|P1|Per Protocol Set|Titration Period||117
2325380|NCT01838616|5708469|P2|Full Analysis Set|Titration Period||128
2325381|NCT01838616|5708470|P1|Full Analysis Set|Titration Period||130
2325382|NCT01838616|5708469|P2|Switched to Pick-up Arm|Titration Period||43
2325383|NCT01838616|5708470|P1|Switched to Pick-up Arm|Titration Period||0
2325384|NCT01838616|5708469|P2|Major Protocol Deviations|Titration Period||16
2325385|NCT01838616|5708470|P1|Major Protocol Deviations|Titration Period||13
2325386|NCT01838616|5708469|P2|No Post Baseline Pain Intensity Values|Titration Period||2
2325387|NCT01838616|5708470|P1|No Post Baseline Pain Intensity Values|Titration Period||0
2325388|NCT01838616|5708469|P2|STARTED|Titration Period||128
2325389|NCT01838616|5708470|P1|STARTED|Titration Period||130
2325390|NCT01838590|5708541|P2|NOT COMPLETED|Overall Study||5
2325391|NCT01838590|5708542|P1|NOT COMPLETED|Overall Study||12
2325392|NCT01838590|5708541|P2|COMPLETED|Overall Study||46
2325393|NCT01838590|5708542|P1|COMPLETED|Overall Study||40
2325394|NCT01838590|5708541|P2|STARTED|Overall Study||51
2325395|NCT01838590|5708542|P1|STARTED|Overall Study||52
2325396|NCT01838499|5708566|P2|NOT COMPLETED|Overall Study||17
2325397|NCT01838499|5708567|P1|NOT COMPLETED|Overall Study||24
2325398|NCT01838499|5708566|P2|COMPLETED|Overall Study||37
2325399|NCT01838499|5708567|P1|COMPLETED|Overall Study||31
2325400|NCT01838499|5708566|P2|STARTED|Overall Study||54
2325401|NCT01838499|5708567|P1|STARTED|Overall Study||55
2325402|NCT01838447|5708579|P2|NOT COMPLETED|Overall Study||3
2325403|NCT01838447|5708580|P1|NOT COMPLETED|Overall Study||2
2325404|NCT01838447|5708579|P2|COMPLETED|Overall Study||21
2325405|NCT01838447|5708580|P1|COMPLETED|Overall Study||20
2325406|NCT01838447|5708579|P2|STARTED|Overall Study||24
2325407|NCT01838447|5708580|P1|STARTED|Overall Study||22
2325408|NCT01838304|5708600|P2|NOT COMPLETED|Overall Study||0
2325409|NCT01838304|5708601|P1|NOT COMPLETED|Overall Study||1
2325410|NCT01838304|5708600|P2|COMPLETED|Overall Study||20
2325411|NCT01838304|5708601|P1|COMPLETED|Overall Study||19
2325412|NCT01838304|5708600|P2|STARTED|Overall Study||20
2325413|NCT01838304|5708601|P1|STARTED|Overall Study||20
2325414|NCT01838213|5708615|P2|NOT COMPLETED|Overall Study||191
2325415|NCT01838213|5708616|P1|NOT COMPLETED|Overall Study||166
2325416|NCT01838213|5708615|P2|COMPLETED|Overall Study||262
2325417|NCT01838213|5708616|P1|COMPLETED|Overall Study||81
2325418|NCT01838213|5708615|P2|STARTED|Overall Study||453
2325419|NCT01838213|5708616|P1|STARTED|Overall Study||247
2325420|NCT01838200|5708624|P2|NOT COMPLETED|Overall Study||2
2325421|NCT01838200|5708625|P1|NOT COMPLETED|Overall Study||3
2325422|NCT01838200|5708624|P2|COMPLETED|Overall Study||0
2325423|NCT01838200|5708625|P1|COMPLETED|Overall Study||0
2325424|NCT01838200|5708624|P2|STARTED|Overall Study||2
2325425|NCT01838200|5708625|P1|STARTED|Overall Study||3
2325426|NCT01838044|5708637|P2|NOT COMPLETED|Overall Study||16
2325427|NCT01838044|5708638|P1|NOT COMPLETED|Overall Study||8
2325428|NCT01838044|5708637|P2|COMPLETED|Overall Study||75
2325429|NCT01838044|5708638|P1|COMPLETED|Overall Study||81
2325430|NCT01838044|5708637|P2|STARTED|Overall Study||91
2325431|NCT01838044|5708638|P1|STARTED|Overall Study||89
2325432|NCT01837966|5708671|P2|NOT COMPLETED|Overall Study||1
2325433|NCT01837966|5708672|P1|NOT COMPLETED|Overall Study||2
2325434|NCT01837966|5708671|P2|COMPLETED|Overall Study||45
2325435|NCT01837966|5708672|P1|COMPLETED|Overall Study||45
2325436|NCT01837966|5708671|P2|STARTED|Overall Study||46
2325437|NCT01837966|5708672|P1|STARTED|Overall Study||47
2325438|NCT01837823|5708678|P1|NOT COMPLETED|Overall Study||6
2325439|NCT01837823|5708678|P1|COMPLETED|Overall Study||85
2325440|NCT01837823|5708678|P1|STARTED|Overall Study||91
2325441|NCT01837797|5708709|P5|NOT COMPLETED|Period 3||23
2325442|NCT01837797|5708710|P4|NOT COMPLETED|Period 3||0
2325443|NCT01837797|5708711|P3|NOT COMPLETED|Period 3||0
2325444|NCT01837797|5708712|P2|NOT COMPLETED|Period 3||0
2325445|NCT01837797|5708713|P1|NOT COMPLETED|Period 3||0
2325446|NCT01837797|5708709|P5|COMPLETED|Period 3||24
2325447|NCT01837797|5708710|P4|COMPLETED|Period 3||0
2325448|NCT01837797|5708711|P3|COMPLETED|Period 3||0
2325449|NCT01837797|5708712|P2|COMPLETED|Period 3||0
2325450|NCT01837797|5708713|P1|COMPLETED|Period 3||0
2325451|NCT01837797|5708709|P5|STARTED|Period 3||47
2325452|NCT01837797|5708710|P4|STARTED|Period 3||0
2325453|NCT01837797|5708711|P3|STARTED|Period 3||0
2325454|NCT01837797|5708712|P2|STARTED|Period 3||0
2325455|NCT01837797|5708713|P1|STARTED|Period 3||0
2325456|NCT01837797|5708709|P5|NOT COMPLETED|Period 2||0
2325457|NCT01837797|5708710|P4|NOT COMPLETED|Period 2||5
2325458|NCT01837797|5708711|P3|NOT COMPLETED|Period 2||2
2325459|NCT01837797|5708712|P2|NOT COMPLETED|Period 2||5
2325460|NCT01837797|5708713|P1|NOT COMPLETED|Period 2||0
2325461|NCT01837797|5708709|P5|COMPLETED|Period 2||0
2325462|NCT01837797|5708710|P4|COMPLETED|Period 2||1
2325463|NCT01837797|5708711|P3|COMPLETED|Period 2||1
2325464|NCT01837797|5708712|P2|COMPLETED|Period 2||1
2325465|NCT01837797|5708713|P1|COMPLETED|Period 2||0
2325466|NCT01837797|5708709|P5|STARTED|Period 2||0
2325467|NCT01837797|5708710|P4|STARTED|Period 2||6
2325468|NCT01837797|5708711|P3|STARTED|Period 2||3
2325469|NCT01837797|5708712|P2|STARTED|Period 2||6
2325470|NCT01837797|5708713|P1|STARTED|Period 2||0
2325471|NCT01837797|5708709|P5|NOT COMPLETED|Period 1||0
2325472|NCT01837797|5708710|P4|NOT COMPLETED|Period 1||0
2325473|NCT01837797|5708711|P3|NOT COMPLETED|Period 1||0
2325474|NCT01837797|5708712|P2|NOT COMPLETED|Period 1||0
2325475|NCT01837797|5708713|P1|NOT COMPLETED|Period 1||102
2325476|NCT01837797|5708709|P5|COMPLETED|Period 1||0
2325477|NCT01837797|5708710|P4|COMPLETED|Period 1||0
2325478|NCT01837797|5708711|P3|COMPLETED|Period 1||0
2325479|NCT01837797|5708712|P2|COMPLETED|Period 1||0
2325480|NCT01837797|5708713|P1|COMPLETED|Period 1||27
2325481|NCT01837797|5708709|P5|STARTED|Period 1||0
2325482|NCT01837797|5708710|P4|STARTED|Period 1||0
2325483|NCT01837797|5708711|P3|STARTED|Period 1||0
2325484|NCT01837797|5708712|P2|STARTED|Period 1||0
2325485|NCT01837797|5708713|P1|STARTED|Period 1||129
2325486|NCT01837719|5708748|P1|NOT COMPLETED|Period 5: Days 29-31 (Treatment E)||1
2325487|NCT01837719|5708748|P1|COMPLETED|Period 5: Days 29-31 (Treatment E)||30
2325488|NCT01837719|5708748|P1|STARTED|Period 5: Days 29-31 (Treatment E)|Reflects the 31 patients remaining after 32 were discharged at the end of Period 4, as per protocol|31
2325489|NCT01837719|5708748|P1|NOT COMPLETED|Period 4: Days 22-28 (Treatment D or C)||0
2325490|NCT01837719|5708748|P1|COMPLETED|Period 4: Days 22-28 (Treatment D or C)|Number finishing period; 32 patients were discharged following Period 4, as per protocol|63
2325491|NCT01837719|5708748|P1|STARTED|Period 4: Days 22-28 (Treatment D or C)||63
2325492|NCT01837719|5708748|P1|NOT COMPLETED|Period 3: Days 15-21 (Treatment C or D)||0
2325493|NCT01837719|5708748|P1|COMPLETED|Period 3: Days 15-21 (Treatment C or D)||63
2325494|NCT01837719|5708748|P1|STARTED|Period 3: Days 15-21 (Treatment C or D)||63
2325495|NCT01837719|5708748|P1|NOT COMPLETED|Period 2: Days 8-14 (Treatment B or A)||1
2325496|NCT01837719|5708748|P1|COMPLETED|Period 2: Days 8-14 (Treatment B or A)||63
2325497|NCT01837719|5708748|P1|STARTED|Period 2: Days 8-14 (Treatment B or A)||64
2325498|NCT01837719|5708748|P1|NOT COMPLETED|Period 1: Days 1-7 (Treatment A or B)||0
2325499|NCT01837719|5708748|P1|COMPLETED|Period 1: Days 1-7 (Treatment A or B)||64
2325500|NCT01837719|5708748|P1|STARTED|Period 1: Days 1-7 (Treatment A or B)|Received treatment|64
2325501|NCT01837680|5708817|P2|NOT COMPLETED|Overall Study||8
2325502|NCT01837680|5708818|P1|NOT COMPLETED|Overall Study||10
2325503|NCT01837680|5708817|P2|COMPLETED|Overall Study||45
2325504|NCT01837680|5708818|P1|COMPLETED|Overall Study||42
2325505|NCT01837680|5708817|P2|STARTED|Overall Study||53
2325506|NCT01837680|5708818|P1|STARTED|Overall Study||52
2325507|NCT01837654|5708856|P2|NOT COMPLETED|Overall Study||0
2325508|NCT01837654|5708857|P1|NOT COMPLETED|Overall Study||0
2325509|NCT01837654|5708856|P2|COMPLETED|Overall Study||11
2325510|NCT01837654|5708857|P1|COMPLETED|Overall Study||11
2325511|NCT01837654|5708856|P2|STARTED|Overall Study||11
2325512|NCT01837654|5708857|P1|STARTED|Overall Study||11
2325513|NCT01837550|5708867|P2|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
2325514|NCT01837550|5708868|P1|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
2325515|NCT01837550|5708867|P2|COMPLETED|T0-T2, 6 Months Follow-up||37
2325516|NCT01837550|5708868|P1|COMPLETED|T0-T2, 6 Months Follow-up||37
2325517|NCT01837550|5708867|P2|STARTED|T0-T2, 6 Months Follow-up||37
2325518|NCT01837550|5708868|P1|STARTED|T0-T2, 6 Months Follow-up||37
2325519|NCT01837550|5708867|P2|NOT COMPLETED|T0-T1, 5 Weeks||0
2325520|NCT01837550|5708868|P1|NOT COMPLETED|T0-T1, 5 Weeks||0
2325521|NCT01837550|5708867|P2|COMPLETED|T0-T1, 5 Weeks||37
2325522|NCT01837550|5708868|P1|COMPLETED|T0-T1, 5 Weeks||37
2325523|NCT01837550|5708867|P2|STARTED|T0-T1, 5 Weeks||37
2325524|NCT01837550|5708868|P1|STARTED|T0-T1, 5 Weeks||37
2325525|NCT01837537|5708880|P1|NOT COMPLETED|Overall Study||0
2325526|NCT01837537|5708880|P1|COMPLETED|Overall Study||90
2325527|NCT01837537|5708880|P1|STARTED|Overall Study||90
2325528|NCT01837524|5708887|P2|NOT COMPLETED|Overall Study||2
2325529|NCT01837524|5708888|P1|NOT COMPLETED|Overall Study||3
2325530|NCT01837524|5708887|P2|COMPLETED|Overall Study||25
2325531|NCT01837524|5708888|P1|COMPLETED|Overall Study||25
2325532|NCT01837524|5708887|P2|STARTED|Overall Study||27
2325533|NCT01837524|5708888|P1|STARTED|Overall Study||28
2325534|NCT01836809|5708898|P4|NOT COMPLETED|Overall Study||2
2325535|NCT01836809|5708899|P3|NOT COMPLETED|Overall Study||0
2325536|NCT01836809|5708900|P2|NOT COMPLETED|Overall Study||0
2325537|NCT01836809|5708901|P1|NOT COMPLETED|Overall Study||0
2325538|NCT01836809|5708898|P4|COMPLETED|Overall Study||0
2325539|NCT01836809|5708899|P3|COMPLETED|Overall Study||0
2325540|NCT01836809|5708900|P2|COMPLETED|Overall Study||0
2325541|NCT01836809|5708901|P1|COMPLETED|Overall Study||0
2325542|NCT01836809|5708898|P4|STARTED|Overall Study||2
2325543|NCT01836809|5708899|P3|STARTED|Overall Study||0
2325544|NCT01836809|5708900|P2|STARTED|Overall Study||0
2325545|NCT01836809|5708901|P1|STARTED|Overall Study||0
2325546|NCT01836549|5708937|P7|NOT COMPLETED|Overall Study||1
2325547|NCT01836549|5708938|P6|NOT COMPLETED|Overall Study||0
2325548|NCT01836549|5708939|P5|NOT COMPLETED|Overall Study||0
2325549|NCT01836549|5708940|P4|NOT COMPLETED|Overall Study||1
2325550|NCT01836549|5708941|P3|NOT COMPLETED|Overall Study||1
2325551|NCT01836549|5708942|P2|NOT COMPLETED|Overall Study||0
2325552|NCT01836549|5708943|P1|NOT COMPLETED|Overall Study||0
2325553|NCT01836549|5708937|P7|COMPLETED|Overall Study||8
2325554|NCT01836549|5708938|P6|COMPLETED|Overall Study||4
2325555|NCT01836549|5708939|P5|COMPLETED|Overall Study||18
2325556|NCT01836549|5708940|P4|COMPLETED|Overall Study||8
2325557|NCT01836549|5708941|P3|COMPLETED|Overall Study||0
2325558|NCT01836549|5708942|P2|COMPLETED|Overall Study||1
2325559|NCT01836549|5708943|P1|COMPLETED|Overall Study||1
2325560|NCT01836549|5708937|P7|STARTED|Overall Study||9
2325561|NCT01836549|5708938|P6|STARTED|Overall Study||4
2325562|NCT01836549|5708939|P5|STARTED|Overall Study||18
2325563|NCT01836549|5708940|P4|STARTED|Overall Study||9
2325564|NCT01836549|5708941|P3|STARTED|Overall Study||1
2325565|NCT01836549|5708942|P2|STARTED|Overall Study||1
2325566|NCT01836549|5708943|P1|STARTED|Overall Study||1
2325567|NCT01836523|5708967|P4|NOT COMPLETED|Overall Study||74
2325568|NCT01836523|5708968|P3|NOT COMPLETED|Overall Study||91
2325569|NCT01836523|5708969|P2|NOT COMPLETED|Overall Study||85
2325570|NCT01836523|5708970|P1|NOT COMPLETED|Overall Study||51
2325571|NCT01836523|5708967|P4|COMPLETED|Overall Study||274
2325572|NCT01836523|5708968|P3|COMPLETED|Overall Study||258
2325573|NCT01836523|5708969|P2|COMPLETED|Overall Study||265
2325574|NCT01836523|5708970|P1|COMPLETED|Overall Study||300
2325575|NCT01836523|5708967|P4|Exposed|Overall Study||348
2325576|NCT01836523|5708968|P3|Exposed|Overall Study||347
2325577|NCT01836523|5708969|P2|Exposed|Overall Study||348
2325578|NCT01836523|5708970|P1|Exposed|Overall Study||350
2325579|NCT01836523|5708967|P4|STARTED|Overall Study||348
2325580|NCT01836523|5708968|P3|STARTED|Overall Study||349
2325581|NCT01836523|5708969|P2|STARTED|Overall Study||350
2325582|NCT01836523|5708970|P1|STARTED|Overall Study||351
2325583|NCT01836471|5708997|P5|NOT COMPLETED|Overall Study||5
2325584|NCT01836471|5708998|P4|NOT COMPLETED|Overall Study||2
2325585|NCT01836471|5708999|P3|NOT COMPLETED|Overall Study||2
2325586|NCT01836471|5709000|P2|NOT COMPLETED|Overall Study||9
2325587|NCT01836471|5709001|P1|NOT COMPLETED|Overall Study||11
2325588|NCT01836471|5708997|P5|COMPLETED|Overall Study||49
2325589|NCT01836471|5708998|P4|COMPLETED|Overall Study||40
2325590|NCT01836471|5708999|P3|COMPLETED|Overall Study||49
2325591|NCT01836471|5709000|P2|COMPLETED|Overall Study||85
2325592|NCT01836471|5709001|P1|COMPLETED|Overall Study||82
2325593|NCT01836471|5708997|P5|STARTED|Overall Study||54
2325594|NCT01836471|5708998|P4|STARTED|Overall Study||42
2325595|NCT01836471|5708999|P3|STARTED|Overall Study||51
2325596|NCT01836471|5709000|P2|STARTED|Overall Study||94
2325597|NCT01836471|5709001|P1|STARTED|Overall Study||93
2325598|NCT01836458|5709030|P4|NOT COMPLETED|Overall Study||6
2325599|NCT01836458|5709031|P3|NOT COMPLETED|Overall Study||5
2325600|NCT01836458|5709032|P2|NOT COMPLETED|Overall Study||2
2325601|NCT01836458|5709033|P1|NOT COMPLETED|Overall Study||3
2325602|NCT01836458|5709030|P4|COMPLETED|Overall Study||1
2325603|NCT01836458|5709031|P3|COMPLETED|Overall Study||2
2325604|NCT01836458|5709032|P2|COMPLETED|Overall Study||2
2325605|NCT01836458|5709033|P1|COMPLETED|Overall Study||4
2325606|NCT01836458|5709030|P4|STARTED|Overall Study||7
2325607|NCT01836458|5709031|P3|STARTED|Overall Study||7
2325608|NCT01836458|5709032|P2|STARTED|Overall Study||4
2325609|NCT01836458|5709033|P1|STARTED|Overall Study||7
2325610|NCT01836445|5709057|P2|NOT COMPLETED|12 Month STI Testing||77
2325611|NCT01836445|5709058|P1|NOT COMPLETED|12 Month STI Testing||80
2325612|NCT01836445|5709057|P2|COMPLETED|12 Month STI Testing||378
2325613|NCT01836445|5709058|P1|COMPLETED|12 Month STI Testing||365
2325614|NCT01836445|5709057|P2|STARTED|12 Month STI Testing|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
2325615|NCT01836445|5709058|P1|STARTED|12 Month STI Testing|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
2325616|NCT01836445|5709057|P2|NOT COMPLETED|12 Month Follow-up Assessment||64
2325617|NCT01836445|5709058|P1|NOT COMPLETED|12 Month Follow-up Assessment||75
2325618|NCT01836445|5709057|P2|COMPLETED|12 Month Follow-up Assessment||391
2325619|NCT01836445|5709058|P1|COMPLETED|12 Month Follow-up Assessment||370
2325620|NCT01836445|5709057|P2|STARTED|12 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
2325621|NCT01836445|5709058|P1|STARTED|12 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
2325622|NCT01836445|5709057|P2|NOT COMPLETED|6 Month Follow-up Assessment||75
2325623|NCT01836445|5709058|P1|NOT COMPLETED|6 Month Follow-up Assessment||103
2325624|NCT01836445|5709057|P2|COMPLETED|6 Month Follow-up Assessment||380
2325625|NCT01836445|5709058|P1|COMPLETED|6 Month Follow-up Assessment||342
2325626|NCT01836445|5709057|P2|STARTED|6 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
2325627|NCT01836445|5709058|P1|STARTED|6 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
2325628|NCT01836445|5709057|P2|NOT COMPLETED|3 Month Follow-up Assessment||47
2325629|NCT01836445|5709058|P1|NOT COMPLETED|3 Month Follow-up Assessment||97
2325630|NCT01836445|5709057|P2|COMPLETED|3 Month Follow-up Assessment||409
2325631|NCT01836445|5709058|P1|COMPLETED|3 Month Follow-up Assessment||348
2325632|NCT01836445|5709057|P2|STARTED|3 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|456
2325633|NCT01836445|5709058|P1|STARTED|3 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
2325634|NCT01836445|5709057|P2|NOT COMPLETED|Intervention Modules||22
2325635|NCT01836445|5709058|P1|NOT COMPLETED|Intervention Modules||70
2325636|NCT01836445|5709057|P2|COMPLETED|Intervention Modules||434
2325637|NCT01836445|5709058|P1|COMPLETED|Intervention Modules||375
2325638|NCT01836445|5709057|P2|STARTED|Intervention Modules||456
2325639|NCT01836445|5709058|P1|STARTED|Intervention Modules||445
2325640|NCT01836276|5709118|P2|NOT COMPLETED|Overall Study||51
2325641|NCT01836276|5709119|P1|NOT COMPLETED|Overall Study||28
2325642|NCT01836276|5709118|P2|COMPLETED|Overall Study||174
2325643|NCT01836276|5709119|P1|COMPLETED|Overall Study||196
2325644|NCT01836276|5709118|P2|Week 12|Overall Study||165
2325645|NCT01836276|5709119|P1|Week 12|Overall Study||183
2325646|NCT01836276|5709118|P2|Week 4|Overall Study||186
2325647|NCT01836276|5709119|P1|Week 4|Overall Study||198
2325648|NCT01836276|5709118|P2|STARTED|Overall Study||225
2325649|NCT01836276|5709119|P1|STARTED|Overall Study||224
2325650|NCT01836198|5709127|P3|NOT COMPLETED|Part B||0
2325651|NCT01836198|5709128|P2|NOT COMPLETED|Part B||0
2325652|NCT01836198|5709129|P1|NOT COMPLETED|Part B||0
2325653|NCT01836198|5709127|P3|COMPLETED|Part B||12
2325654|NCT01836198|5709128|P2|COMPLETED|Part B||0
2325655|NCT01836198|5709129|P1|COMPLETED|Part B||0
2325656|NCT01836198|5709127|P3|Received at Least 1 Dose of Study Drug|Part B||12
2325657|NCT01836198|5709128|P2|Received at Least 1 Dose of Study Drug|Part B||0
2325658|NCT01836198|5709129|P1|Received at Least 1 Dose of Study Drug|Part B||0
2325659|NCT01836198|5709127|P3|STARTED|Part B||12
2325660|NCT01836198|5709128|P2|STARTED|Part B||0
2325661|NCT01836198|5709129|P1|STARTED|Part B||0
2325662|NCT01836198|5709127|P3|NOT COMPLETED|Part A, Period 2||0
2325663|NCT01836198|5709128|P2|NOT COMPLETED|Part A, Period 2||1
2325664|NCT01836198|5709129|P1|NOT COMPLETED|Part A, Period 2||0
2325665|NCT01836198|5709127|P3|COMPLETED|Part A, Period 2||0
2325666|NCT01836198|5709128|P2|COMPLETED|Part A, Period 2||14
2325667|NCT01836198|5709129|P1|COMPLETED|Part A, Period 2||15
2325668|NCT01836198|5709127|P3|Completed Part A, Entered Part B|Part A, Period 2||0
2325669|NCT01836198|5709128|P2|Completed Part A, Entered Part B|Part A, Period 2||6
2325670|NCT01836198|5709129|P1|Completed Part A, Entered Part B|Part A, Period 2||6
2325671|NCT01836198|5709127|P3|STARTED|Part A, Period 2||0
2325672|NCT01836198|5709128|P2|STARTED|Part A, Period 2||15
2325673|NCT01836198|5709129|P1|STARTED|Part A, Period 2||15
2325674|NCT01836198|5709127|P3|NOT COMPLETED|Part A, Period 1||0
2325675|NCT01836198|5709128|P2|NOT COMPLETED|Part A, Period 1||0
2325676|NCT01836198|5709129|P1|NOT COMPLETED|Part A, Period 1||0
2325677|NCT01836198|5709127|P3|COMPLETED|Part A, Period 1||0
2325678|NCT01836198|5709128|P2|COMPLETED|Part A, Period 1||15
2325679|NCT01836198|5709129|P1|COMPLETED|Part A, Period 1||15
2325680|NCT01836198|5709127|P3|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
2325681|NCT01836198|5709128|P2|Received at Least 1 Dose of Study Drug|Part A, Period 1||15
2325682|NCT01836198|5709129|P1|Received at Least 1 Dose of Study Drug|Part A, Period 1||15
2325683|NCT01836198|5709127|P3|STARTED|Part A, Period 1||0
2325684|NCT01836198|5709128|P2|STARTED|Part A, Period 1||15
2325685|NCT01836198|5709129|P1|STARTED|Part A, Period 1||15
2325686|NCT01836185|5709155|P4|NOT COMPLETED|Overall Study||0
2325687|NCT01836185|5709156|P3|NOT COMPLETED|Overall Study||0
2325688|NCT01836185|5709157|P2|NOT COMPLETED|Overall Study||0
2325689|NCT01836185|5709158|P1|NOT COMPLETED|Overall Study||0
2325690|NCT01836185|5709155|P4|COMPLETED|Overall Study||6
2325691|NCT01836185|5709156|P3|COMPLETED|Overall Study||8
2325692|NCT01836185|5709157|P2|COMPLETED|Overall Study||8
2325693|NCT01836185|5709158|P1|COMPLETED|Overall Study||10
2325694|NCT01836185|5709155|P4|Received Single Dose of Study Treatment|Overall Study||6
2325695|NCT01836185|5709156|P3|Received Single Dose of Study Treatment|Overall Study||8
2325696|NCT01836185|5709157|P2|Received Single Dose of Study Treatment|Overall Study||8
2325697|NCT01836185|5709158|P1|Received Single Dose of Study Treatment|Overall Study||10
2325698|NCT01836185|5709155|P4|STARTED|Overall Study||6
2325699|NCT01836185|5709156|P3|STARTED|Overall Study||8
2325700|NCT01836185|5709157|P2|STARTED|Overall Study||8
2325701|NCT01836185|5709158|P1|STARTED|Overall Study||10
2325702|NCT01836133|5709176|P1|NOT COMPLETED|Overall Study||0
2325703|NCT01836133|5709176|P1|COMPLETED|Overall Study||70
2325704|NCT01836133|5709176|P1|STARTED|Overall Study||70
2325705|NCT01836042|5709185|P3|NOT COMPLETED|Overall Study||0
2325706|NCT01836042|5709186|P2|NOT COMPLETED|Overall Study||0
2325707|NCT01836042|5709187|P1|NOT COMPLETED|Overall Study||0
2325708|NCT01836042|5709185|P3|COMPLETED|Overall Study||22
2325709|NCT01836042|5709186|P2|COMPLETED|Overall Study||35
2325710|NCT01836042|5709187|P1|COMPLETED|Overall Study||51
2325711|NCT01836042|5709185|P3|STARTED|Overall Study||22
2325712|NCT01836042|5709186|P2|STARTED|Overall Study||35
2325713|NCT01836042|5709187|P1|STARTED|Overall Study||51
2325714|NCT01836029|5709197|P2|NOT COMPLETED|Overall Study||0
2325715|NCT01836029|5709198|P1|NOT COMPLETED|Overall Study||0
2325716|NCT01836029|5709197|P2|COMPLETED|Overall Study||95
2325717|NCT01836029|5709198|P1|COMPLETED|Overall Study||100
2325718|NCT01836029|5709197|P2|STARTED|Overall Study||95
2325719|NCT01836029|5709198|P1|STARTED|Overall Study||100
2325720|NCT01835912|5709210|P1|NOT COMPLETED|Overall Study||0
2325721|NCT01835912|5709210|P1|COMPLETED|Overall Study||10
2325722|NCT01835912|5709210|P1|Chronic Placebo|Overall Study||10
2325723|NCT01835912|5709210|P1|Chronic|Overall Study||10
2325724|NCT01835912|5709210|P1|Acute Placebo|Overall Study||10
2325725|NCT01835912|5709210|P1|Acute|Overall Study||10
2325726|NCT01835912|5709210|P1|STARTED|Overall Study||10
2325727|NCT01835899|5709231|P3|NOT COMPLETED|Overall Study||1
2325728|NCT01835899|5709232|P2|NOT COMPLETED|Overall Study||1
2325729|NCT01835899|5709233|P1|NOT COMPLETED|Overall Study||0
2325730|NCT01835899|5709231|P3|COMPLETED|Overall Study||8
2325731|NCT01835899|5709232|P2|COMPLETED|Overall Study||8
2325732|NCT01835899|5709233|P1|COMPLETED|Overall Study||6
2325733|NCT01835899|5709231|P3|STARTED|Overall Study||9
2325734|NCT01835899|5709232|P2|STARTED|Overall Study||9
2325735|NCT01835899|5709233|P1|STARTED|Overall Study||6
2325736|NCT01835756|5709253|P2|NOT COMPLETED|Overall Study||0
2325737|NCT01835756|5709254|P1|NOT COMPLETED|Overall Study||0
2325738|NCT01835756|5709253|P2|COMPLETED|Overall Study||31
2325739|NCT01835756|5709254|P1|COMPLETED|Overall Study||31
2325740|NCT01835756|5709253|P2|STARTED|Overall Study||31
2325741|NCT01835756|5709254|P1|STARTED|Overall Study||31
2325742|NCT01835743|5709266|P2|NOT COMPLETED|Overall Study||0
2325743|NCT01835743|5709267|P1|NOT COMPLETED|Overall Study||0
2325744|NCT01835743|5709266|P2|COMPLETED|Overall Study||32
2325745|NCT01835743|5709267|P1|COMPLETED|Overall Study||37
2325746|NCT01835743|5709266|P2|STARTED|Overall Study||32
2325747|NCT01835743|5709267|P1|STARTED|Overall Study||37
2325748|NCT01835587|5709279|P4|NOT COMPLETED|Overall Study||9
2325749|NCT01835587|5709280|P3|NOT COMPLETED|Overall Study||2
2325750|NCT01835587|5709281|P2|NOT COMPLETED|Overall Study||4
2325751|NCT01835587|5709282|P1|NOT COMPLETED|Overall Study||2
2325752|NCT01835587|5709279|P4|COMPLETED|Overall Study||10
2325753|NCT01835587|5709280|P3|COMPLETED|Overall Study||2
2325754|NCT01835587|5709281|P2|COMPLETED|Overall Study||0
2325755|NCT01835587|5709282|P1|COMPLETED|Overall Study||1
2325756|NCT01835587|5709279|P4|STARTED|Overall Study||19
2325757|NCT01835587|5709280|P3|STARTED|Overall Study||4
2325758|NCT01835587|5709281|P2|STARTED|Overall Study||4
2325759|NCT01835587|5709282|P1|STARTED|Overall Study||3
2325760|NCT01835548|5709343|P3|NOT COMPLETED|Double-Blind Treatment Period||0
2325761|NCT01835548|5709344|P2|NOT COMPLETED|Double-Blind Treatment Period||2
2325762|NCT01835548|5709345|P1|NOT COMPLETED|Double-Blind Treatment Period||0
2325763|NCT01835548|5709343|P3|COMPLETED|Double-Blind Treatment Period||0
2325764|NCT01835548|5709344|P2|COMPLETED|Double-Blind Treatment Period||39
2325765|NCT01835548|5709345|P1|COMPLETED|Double-Blind Treatment Period||44
2325766|NCT01835548|5709343|P3|STARTED|Double-Blind Treatment Period||0
2325767|NCT01835548|5709344|P2|STARTED|Double-Blind Treatment Period||41
2325768|NCT01835548|5709345|P1|STARTED|Double-Blind Treatment Period||44
2325769|NCT01835548|5709343|P3|NOT COMPLETED|Dose Stabilization Period||0
2325770|NCT01835548|5709344|P2|NOT COMPLETED|Dose Stabilization Period||0
2325771|NCT01835548|5709345|P1|NOT COMPLETED|Dose Stabilization Period||0
2325772|NCT01835548|5709343|P3|COMPLETED|Dose Stabilization Period||85
2325773|NCT01835548|5709344|P2|COMPLETED|Dose Stabilization Period||0
2325774|NCT01835548|5709345|P1|COMPLETED|Dose Stabilization Period||0
2325775|NCT01835548|5709343|P3|STARTED|Dose Stabilization Period||85
2325776|NCT01835548|5709344|P2|STARTED|Dose Stabilization Period||0
2325777|NCT01835548|5709345|P1|STARTED|Dose Stabilization Period||0
2325778|NCT01835548|5709343|P3|NOT COMPLETED|Dose Optimization Period||2
2325779|NCT01835548|5709344|P2|NOT COMPLETED|Dose Optimization Period||0
2325780|NCT01835548|5709345|P1|NOT COMPLETED|Dose Optimization Period||0
2325781|NCT01835548|5709343|P3|COMPLETED|Dose Optimization Period||85
2325782|NCT01835548|5709344|P2|COMPLETED|Dose Optimization Period||0
2325783|NCT01835548|5709345|P1|COMPLETED|Dose Optimization Period||0
2325784|NCT01835548|5709343|P3|STARTED|Dose Optimization Period||87
2325785|NCT01835548|5709344|P2|STARTED|Dose Optimization Period||0
2325786|NCT01835548|5709345|P1|STARTED|Dose Optimization Period||0
2325787|NCT01835548|5709343|P3|NOT COMPLETED|Screening/Washout Period||0
2325788|NCT01835548|5709344|P2|NOT COMPLETED|Screening/Washout Period||0
2325789|NCT01835548|5709345|P1|NOT COMPLETED|Screening/Washout Period||0
2325790|NCT01835548|5709343|P3|COMPLETED|Screening/Washout Period||87
2325791|NCT01835548|5709344|P2|COMPLETED|Screening/Washout Period||0
2325792|NCT01835548|5709345|P1|COMPLETED|Screening/Washout Period||0
2325793|NCT01835548|5709343|P3|STARTED|Screening/Washout Period||87
2325794|NCT01835548|5709344|P2|STARTED|Screening/Washout Period||0
2325795|NCT01835548|5709345|P1|STARTED|Screening/Washout Period||0
2325796|NCT01835496|5709365|P1|NOT COMPLETED|Overall Study||0
2325797|NCT01835496|5709365|P1|COMPLETED|Overall Study||8
2325798|NCT01835496|5709365|P1|STARTED|Overall Study||8
2325799|NCT01835470|5709374|P1|NOT COMPLETED|Long Term Treatment Period||4
2325800|NCT01835470|5709374|P1|COMPLETED|Long Term Treatment Period|Completed LT period|16
2325801|NCT01835470|5709374|P1|STARTED|Long Term Treatment Period||20
2325802|NCT01835470|5709374|P1|NOT COMPLETED|Short Term Treatment Period (to Week 16)||0
2325803|NCT01835470|5709374|P1|COMPLETED|Short Term Treatment Period (to Week 16)||20
2325804|NCT01835470|5709374|P1|STARTED|Short Term Treatment Period (to Week 16)||20
2325805|NCT01835431|5709386|P2|NOT COMPLETED|Overall Study||12
2325806|NCT01835431|5709387|P1|NOT COMPLETED|Overall Study||8
2325807|NCT01835431|5709386|P2|COMPLETED|Overall Study||168
2325808|NCT01835431|5709387|P1|COMPLETED|Overall Study||174
2325809|NCT01835431|5709386|P2|Exposed|Overall Study|One subject was withdrawn before exposure|179
2325810|NCT01835431|5709387|P1|Exposed|Overall Study|One subject was withdrawn before exposure.|181
2325811|NCT01835431|5709386|P2|STARTED|Overall Study||180
2325812|NCT01835431|5709387|P1|STARTED|Overall Study||182
2325813|NCT01835379|5709407|P2|NOT COMPLETED|Overall Study||0
2325814|NCT01835379|5709408|P1|NOT COMPLETED|Overall Study||0
2325815|NCT01835379|5709407|P2|COMPLETED|Overall Study||41
2325816|NCT01835379|5709408|P1|COMPLETED|Overall Study||41
2325817|NCT01835379|5709407|P2|STARTED|Overall Study||41
2325818|NCT01835379|5709408|P1|STARTED|Overall Study||41
2325819|NCT01835262|5709418|P2|NOT COMPLETED|Overall Study||0
2325820|NCT01835262|5709419|P1|NOT COMPLETED|Overall Study||0
2325821|NCT01835262|5709418|P2|COMPLETED|Overall Study||45
2325822|NCT01835262|5709419|P1|COMPLETED|Overall Study||45
2325823|NCT01835262|5709418|P2|STARTED|Overall Study||45
2325824|NCT01835262|5709419|P1|STARTED|Overall Study||45
2325825|NCT01835158|5709427|P2|NOT COMPLETED|Overall Study||6
2325826|NCT01835158|5709428|P1|NOT COMPLETED|Overall Study||1
2325827|NCT01835158|5709427|P2|COMPLETED|Overall Study||72
2325828|NCT01835158|5709428|P1|COMPLETED|Overall Study||78
2325829|NCT01835158|5709427|P2|STARTED|Overall Study||78
2325830|NCT01835158|5709428|P1|STARTED|Overall Study||79
2325831|NCT01835145|5709440|P2|NOT COMPLETED|Overall Study||0
2325832|NCT01835145|5709441|P1|NOT COMPLETED|Overall Study||1
2325833|NCT01835145|5709440|P2|COMPLETED|Overall Study||15
2325834|NCT01835145|5709441|P1|COMPLETED|Overall Study||31
2325835|NCT01835145|5709440|P2|STARTED|Overall Study||15
2325836|NCT01835145|5709441|P1|STARTED|Overall Study||32
2325837|NCT01835132|5709456|P1|NOT COMPLETED|2nd Extension Phase - As Needed (PRN)||0
2325838|NCT01835132|5709456|P1|COMPLETED|2nd Extension Phase - As Needed (PRN)||3
2325839|NCT01835132|5709456|P1|STARTED|2nd Extension Phase - As Needed (PRN)|PRN extension - Participants starting this phase may not equal those who completed the 1st extension|3
2325840|NCT01835132|5709456|P1|NOT COMPLETED|1st Extension Phase||0
2325841|NCT01835132|5709456|P1|COMPLETED|1st Extension Phase|Completed 52 Weeks|6
2325842|NCT01835132|5709456|P1|STARTED|1st Extension Phase||6
2325843|NCT01835132|5709456|P1|NOT COMPLETED|Initial Phase||2
2325844|NCT01835132|5709456|P1|COMPLETED|Initial Phase||6
2325845|NCT01835132|5709456|P1|STARTED|Initial Phase||8
2325846|NCT01835015|5709501|P5|NOT COMPLETED|Overall Study||0
2325847|NCT01835015|5709502|P4|NOT COMPLETED|Overall Study||0
2325848|NCT01835015|5709503|P3|NOT COMPLETED|Overall Study||1
2325849|NCT01835015|5709504|P2|NOT COMPLETED|Overall Study||0
2325850|NCT01835015|5709505|P1|NOT COMPLETED|Overall Study||0
2325851|NCT01835015|5709501|P5|COMPLETED|Overall Study||6
2325852|NCT01835015|5709502|P4|COMPLETED|Overall Study||6
2325853|NCT01835015|5709503|P3|COMPLETED|Overall Study||6
2325854|NCT01835015|5709504|P2|COMPLETED|Overall Study||6
2325855|NCT01835015|5709505|P1|COMPLETED|Overall Study||6
2325856|NCT01835015|5709501|P5|STARTED|Overall Study||6
2325857|NCT01835015|5709502|P4|STARTED|Overall Study||6
2325858|NCT01835015|5709503|P3|STARTED|Overall Study||7
2325859|NCT01835015|5709504|P2|STARTED|Overall Study||6
2325860|NCT01835015|5709505|P1|STARTED|Overall Study||6
2325861|NCT01834729|5709582|P4|NOT COMPLETED|Overall Study||2
2325862|NCT01834729|5709583|P3|NOT COMPLETED|Overall Study||3
2325863|NCT01834729|5709584|P2|NOT COMPLETED|Overall Study||1
2325864|NCT01834729|5709585|P1|NOT COMPLETED|Overall Study||1
2325865|NCT01834729|5709582|P4|COMPLETED|Overall Study||16
2325866|NCT01834729|5709583|P3|COMPLETED|Overall Study||15
2325867|NCT01834729|5709584|P2|COMPLETED|Overall Study||19
2325868|NCT01834729|5709585|P1|COMPLETED|Overall Study||17
2325869|NCT01834729|5709582|P4|STARTED|Overall Study||18
2325870|NCT01834729|5709583|P3|STARTED|Overall Study||18
2325871|NCT01834729|5709584|P2|STARTED|Overall Study||20
2325872|NCT01834729|5709585|P1|STARTED|Overall Study||18
2325873|NCT01834716|5709601|P2|NOT COMPLETED|Overall Study||1
2325874|NCT01834716|5709602|P1|NOT COMPLETED|Overall Study||0
2325875|NCT01834716|5709601|P2|COMPLETED|Overall Study||11
2325876|NCT01834716|5709602|P1|COMPLETED|Overall Study||4
2325877|NCT01834716|5709601|P2|STARTED|Overall Study||12
2325878|NCT01834716|5709602|P1|STARTED|Overall Study||4
2325879|NCT01834651|5709608|P1|NOT COMPLETED|Overall Study||1
2325880|NCT01834651|5709608|P1|COMPLETED|Overall Study|Evaluable for primary outcome assessment at 12 weeks|16
2325881|NCT01834651|5709608|P1|STARTED|Overall Study||17
2325882|NCT01834586|5709618|P1|NOT COMPLETED|Overall Study||1
2325883|NCT01834586|5709618|P1|COMPLETED|Overall Study||29
2325884|NCT01834586|5709618|P1|STARTED|Overall Study||30
2325885|NCT01834404|5709625|P2|NOT COMPLETED|Overall Study||0
2325886|NCT01834404|5709626|P1|NOT COMPLETED|Overall Study||0
2325887|NCT01834404|5709625|P2|COMPLETED|Overall Study||12
2325888|NCT01834404|5709626|P1|COMPLETED|Overall Study||12
2325889|NCT01834404|5709625|P2|STARTED|Overall Study||12
2325890|NCT01834404|5709626|P1|STARTED|Overall Study||12
2325891|NCT01834274|5709658|P2|NOT COMPLETED|Overall Study||41
2325892|NCT01834274|5709659|P1|NOT COMPLETED|Overall Study||47
2325893|NCT01834274|5709658|P2|COMPLETED|Overall Study||5
2325894|NCT01834274|5709659|P1|COMPLETED|Overall Study||3
2325895|NCT01834274|5709658|P2|STARTED|Overall Study||46
2325896|NCT01834274|5709659|P1|STARTED|Overall Study||50
2325897|NCT01834261|5709671|P2|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
2325898|NCT01834261|5709672|P1|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
2325899|NCT01834261|5709671|P2|COMPLETED|MGH Rest + Nueroeconomic Task fMRI||10
2325900|NCT01834261|5709672|P1|COMPLETED|MGH Rest + Nueroeconomic Task fMRI|Enrollment completed in May 2015.|10
2325901|NCT01834261|5709671|P2|STARTED|MGH Rest + Nueroeconomic Task fMRI||10
2325902|NCT01834261|5709672|P1|STARTED|MGH Rest + Nueroeconomic Task fMRI|Subjects who dropped out/were excluded (10), did so before they received either Oxytocin or Placebo.|10
2325903|NCT01834261|5709671|P2|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
2325904|NCT01834261|5709672|P1|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
2325905|NCT01834261|5709671|P2|COMPLETED|MIT fMRI and MEG Resting State Study||9
2325906|NCT01834261|5709672|P1|COMPLETED|MIT fMRI and MEG Resting State Study|Enrollment completed in March 2014.|10
2325907|NCT01834261|5709671|P2|STARTED|MIT fMRI and MEG Resting State Study||10
2325908|NCT01834261|5709672|P1|STARTED|MIT fMRI and MEG Resting State Study||11
2325909|NCT01834222|5709682|P1|NOT COMPLETED|Overall Study||1
2325910|NCT01834222|5709682|P1|COMPLETED|Overall Study||658
2325911|NCT01834222|5709682|P1|Treated|Overall Study||658
2325912|NCT01834222|5709682|P1|STARTED|Overall Study||659
2325913|NCT01834144|5709693|P2|NOT COMPLETED|Overall Study||1
2325914|NCT01834144|5709694|P1|NOT COMPLETED|Overall Study||0
2325915|NCT01834144|5709693|P2|COMPLETED|Overall Study||2
2325916|NCT01834144|5709694|P1|COMPLETED|Overall Study||1
2325917|NCT01834144|5709693|P2|STARTED|Overall Study||3
2325918|NCT01834144|5709694|P1|STARTED|Overall Study||1
2325919|NCT01834027|5709702|P2|NOT COMPLETED|Overall Study||0
2325920|NCT01834027|5709703|P1|NOT COMPLETED|Overall Study||0
2325921|NCT01834027|5709702|P2|COMPLETED|Overall Study||28
2325922|NCT01834027|5709703|P1|COMPLETED|Overall Study||28
2325923|NCT01834027|5709702|P2|STARTED|Overall Study||28
2325924|NCT01834027|5709703|P1|STARTED|Overall Study||28
2325925|NCT01833988|5709713|P2|NOT COMPLETED|Overall Study||0
2325926|NCT01833988|5709714|P1|NOT COMPLETED|Overall Study||0
2325927|NCT01833988|5709713|P2|COMPLETED|Overall Study||16
2325928|NCT01833988|5709714|P1|COMPLETED|Overall Study||16
2325929|NCT01833988|5709713|P2|STARTED|Overall Study||16
2325930|NCT01833988|5709714|P1|STARTED|Overall Study||16
2325931|NCT01833936|5709770|P2|NOT COMPLETED|Overall Study||2
2325932|NCT01833936|5709771|P1|NOT COMPLETED|Overall Study||4
2325933|NCT01833936|5709770|P2|COMPLETED|Overall Study||18
2325934|NCT01833936|5709771|P1|COMPLETED|Overall Study||16
2325935|NCT01833936|5709770|P2|STARTED|Overall Study||20
2325936|NCT01833936|5709771|P1|STARTED|Overall Study||20
2325937|NCT01833897|5709777|P1|NOT COMPLETED|Overall Study||1
2325938|NCT01833897|5709777|P1|COMPLETED|Overall Study||7
2325939|NCT01833897|5709777|P1|STARTED|Overall Study||8
2325940|NCT01833845|5709785|P1|NOT COMPLETED|Overall Study||0
2325941|NCT01833845|5709785|P1|COMPLETED|Overall Study||4
2325942|NCT01833845|5709785|P1|STARTED|Overall Study||4
2325943|NCT01833832|5709789|P1|NOT COMPLETED|Overall Study||1
2325944|NCT01833832|5709789|P1|COMPLETED|Overall Study||10
2325945|NCT01833832|5709789|P1|STARTED|Overall Study||11
2325946|NCT01833754|5709800|P3|NOT COMPLETED|Overall Study||0
2325947|NCT01833754|5709801|P2|NOT COMPLETED|Overall Study||0
2325948|NCT01833754|5709802|P1|NOT COMPLETED|Overall Study||0
2325949|NCT01833754|5709800|P3|COMPLETED|Overall Study||8
2325950|NCT01833754|5709801|P2|COMPLETED|Overall Study||8
2325951|NCT01833754|5709802|P1|COMPLETED|Overall Study||8
2325952|NCT01833754|5709800|P3|STARTED|Overall Study||8
2325953|NCT01833754|5709801|P2|STARTED|Overall Study||8
2325954|NCT01833754|5709802|P1|STARTED|Overall Study||8
2325955|NCT01833741|5709831|P1|NOT COMPLETED|Overall Study||140
2325956|NCT01833741|5709831|P1|COMPLETED|Overall Study||997
2325957|NCT01833741|5709831|P1|STARTED|Overall Study||1137
2325958|NCT01833546|5709848|P4|NOT COMPLETED|Overall Study||0
2325959|NCT01833546|5709849|P3|NOT COMPLETED|Overall Study||0
2325960|NCT01833546|5709850|P2|NOT COMPLETED|Overall Study||0
2325961|NCT01833546|5709851|P1|NOT COMPLETED|Overall Study||0
2325962|NCT01833546|5709848|P4|COMPLETED|Overall Study||6
2325963|NCT01833546|5709849|P3|COMPLETED|Overall Study||8
2325964|NCT01833546|5709850|P2|COMPLETED|Overall Study||3
2325965|NCT01833546|5709851|P1|COMPLETED|Overall Study||3
2325966|NCT01833546|5709848|P4|STARTED|Overall Study||6
2325967|NCT01833546|5709849|P3|STARTED|Overall Study||8
2325968|NCT01833546|5709850|P2|STARTED|Overall Study||3
2325969|NCT01833546|5709851|P1|STARTED|Overall Study||3
2325970|NCT01833533|5709944|P2|NOT COMPLETED|Overall Study||21
2325971|NCT01833533|5709945|P1|NOT COMPLETED|Overall Study||6
2325972|NCT01833533|5709944|P2|COMPLETED|Overall Study||184
2325973|NCT01833533|5709945|P1|COMPLETED|Overall Study||94
2325974|NCT01833533|5709944|P2|STARTED|Overall Study||205
2325975|NCT01833533|5709945|P1|STARTED|Overall Study||100
2325976|NCT01833494|5709959|P1|NOT COMPLETED|Overall Study||45
2325977|NCT01833494|5709959|P1|COMPLETED|Overall Study||116
2325978|NCT01833494|5709959|P1|STARTED|Overall Study||161
2325979|NCT01833481|5709969|P3|NOT COMPLETED|Overall Study||0
2325980|NCT01833481|5709970|P2|NOT COMPLETED|Overall Study||0
2325981|NCT01833481|5709971|P1|NOT COMPLETED|Overall Study||0
2325982|NCT01833481|5709969|P3|COMPLETED|Overall Study||10
2325983|NCT01833481|5709970|P2|COMPLETED|Overall Study||10
2325984|NCT01833481|5709971|P1|COMPLETED|Overall Study||10
2325985|NCT01833481|5709969|P3|STARTED|Overall Study||10
2325986|NCT01833481|5709970|P2|STARTED|Overall Study||10
2325987|NCT01833481|5709971|P1|STARTED|Overall Study||10
2325988|NCT01833455|5709987|P2|NOT COMPLETED|Overall Study||0
2325989|NCT01833455|5709988|P1|NOT COMPLETED|Overall Study||1
2325990|NCT01833455|5709987|P2|COMPLETED|Overall Study||4
2325991|NCT01833455|5709988|P1|COMPLETED|Overall Study||3
2325992|NCT01833455|5709987|P2|Completed 2nd Baseline (Washout)|Overall Study||4
2325993|NCT01833455|5709988|P1|Completed 2nd Baseline (Washout)|Overall Study||3
2325994|NCT01833455|5709987|P2|Completed 1st Intervention|Overall Study||4
2325995|NCT01833455|5709988|P1|Completed 1st Intervention|Overall Study||3
2325996|NCT01833455|5709987|P2|Completed 1st Baseline|Overall Study||4
2325997|NCT01833455|5709988|P1|Completed 1st Baseline|Overall Study||4
2325998|NCT01833455|5709987|P2|STARTED|Overall Study||4
2325999|NCT01833455|5709988|P1|STARTED|Overall Study||4
2326000|NCT01833403|5710006|P1|NOT COMPLETED|Overall Study||0
2326001|NCT01833403|5710006|P1|COMPLETED|Overall Study||4
2326002|NCT01833403|5710006|P1|STARTED|Overall Study||4
2326003|NCT01833247|5710011|P1|NOT COMPLETED|Overall Study||0
2326004|NCT01833247|5710011|P1|COMPLETED|Overall Study||12
2326005|NCT01833247|5710011|P1|STARTED|Overall Study||12
2326006|NCT01833169|5710017|P1|NOT COMPLETED|Overall Study||146
2326007|NCT01833169|5710017|P1|COMPLETED|Overall Study||0
2326008|NCT01833169|5710017|P1|Consented to be Followed for Survival|Overall Study||128
2326009|NCT01833169|5710017|P1|STARTED|Overall Study||146
2326010|NCT01833130|5710030|P2|NOT COMPLETED|Overall Study||19
2326011|NCT01833130|5710031|P1|NOT COMPLETED|Overall Study||10
2326012|NCT01833130|5710030|P2|COMPLETED|Overall Study||8
2326013|NCT01833130|5710031|P1|COMPLETED|Overall Study||15
2326014|NCT01833130|5710030|P2|STARTED|Overall Study||27
2326015|NCT01833130|5710031|P1|STARTED|Overall Study||25
2326016|NCT01833117|5710069|P2|NOT COMPLETED|Overall Study||0
2326017|NCT01833117|5710070|P1|NOT COMPLETED|Overall Study||0
2326018|NCT01833117|5710069|P2|COMPLETED|Overall Study||19
2326019|NCT01833117|5710070|P1|COMPLETED|Overall Study||43
2326020|NCT01833117|5710069|P2|STARTED|Overall Study||19
2326021|NCT01833117|5710070|P1|STARTED|Overall Study||43
2326022|NCT01833078|5710078|P1|NOT COMPLETED|Overall Study||0
2326023|NCT01833078|5710078|P1|COMPLETED|Overall Study||5
2326024|NCT01833078|5710078|P1|STARTED|Overall Study||5
2326025|NCT01833065|5710086|P5|NOT COMPLETED|Overall Study||36
2326026|NCT01833065|5710087|P4|NOT COMPLETED|Overall Study||9
2326027|NCT01833065|5710088|P3|NOT COMPLETED|Overall Study||12
2326028|NCT01833065|5710089|P2|NOT COMPLETED|Overall Study||13
2326029|NCT01833065|5710090|P1|NOT COMPLETED|Overall Study||24
2326030|NCT01833065|5710086|P5|COMPLETED|Overall Study||74
2326031|NCT01833065|5710087|P4|COMPLETED|Overall Study||41
2326032|NCT01833065|5710088|P3|COMPLETED|Overall Study||23
2326033|NCT01833065|5710089|P2|COMPLETED|Overall Study||40
2326034|NCT01833065|5710090|P1|COMPLETED|Overall Study||41
2326035|NCT01833065|5710086|P5|Intention-to-treat Analysis Set|Overall Study|Randomized patients|111
2326036|NCT01833065|5710087|P4|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
2326037|NCT01833065|5710088|P3|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
2326038|NCT01833065|5710089|P2|Intention-to-treat Analysis Set|Overall Study|Randomized patients|53
2326039|NCT01833065|5710090|P1|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
2326040|NCT01833065|5710086|P5|STARTED|Overall Study|Randomized patients - As treated|110
2326041|NCT01833065|5710087|P4|STARTED|Overall Study|Randomized patients - As treated|50
2326042|NCT01833065|5710088|P3|STARTED|Overall Study|Randomized patients - As treated|35
2326043|NCT01833065|5710089|P2|STARTED|Overall Study|Randomized patients - As treated|53
2326044|NCT01833065|5710090|P1|STARTED|Overall Study|Randomized patients - As treated|65
2326045|NCT01833026|5710123|P2|NOT COMPLETED|Overall Study||0
2326046|NCT01833026|5710124|P1|NOT COMPLETED|Overall Study||0
2326047|NCT01833026|5710123|P2|COMPLETED|Overall Study||34
2326048|NCT01833026|5710124|P1|COMPLETED|Overall Study||22
2326049|NCT01833026|5710123|P2|STARTED|Overall Study||34
2326050|NCT01833026|5710124|P1|STARTED|Overall Study||22
2326051|NCT01832818|5710130|P1|NOT COMPLETED|Overall Study||6
2326052|NCT01832818|5710130|P1|COMPLETED|Overall Study||8
2326053|NCT01832818|5710130|P1|STARTED|Overall Study||14
2326054|NCT01832766|5710139|P2|NOT COMPLETED|Second Intervention||0
2326055|NCT01832766|5710140|P1|NOT COMPLETED|Second Intervention||0
2326056|NCT01832766|5710139|P2|COMPLETED|Second Intervention||5
2326057|NCT01832766|5710140|P1|COMPLETED|Second Intervention||7
2326058|NCT01832766|5710139|P2|STARTED|Second Intervention||5
2326059|NCT01832766|5710140|P1|STARTED|Second Intervention||7
2326060|NCT01832766|5710139|P2|NOT COMPLETED|Washout||1
2326061|NCT01832766|5710140|P1|NOT COMPLETED|Washout||0
2326062|NCT01832766|5710139|P2|COMPLETED|Washout||5
2326063|NCT01832766|5710140|P1|COMPLETED|Washout||7
2326064|NCT01832766|5710139|P2|STARTED|Washout||6
2326065|NCT01832766|5710140|P1|STARTED|Washout||7
2326066|NCT01832766|5710139|P2|NOT COMPLETED|First Intervention||0
2326067|NCT01832766|5710140|P1|NOT COMPLETED|First Intervention||0
2326068|NCT01832766|5710139|P2|COMPLETED|First Intervention|one participant did not return for cross over visit|6
2326069|NCT01832766|5710140|P1|COMPLETED|First Intervention||7
2326070|NCT01832766|5710139|P2|STARTED|First Intervention||6
2326071|NCT01832766|5710140|P1|STARTED|First Intervention||7
2326072|NCT01832753|5710153|P3|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
2326073|NCT01832753|5710154|P2|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
2326074|NCT01832753|5710155|P1|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
2326075|NCT01832753|5710153|P3|COMPLETED|Open Label Dose Phase (Months 12-18)||0
2326076|NCT01832753|5710154|P2|COMPLETED|Open Label Dose Phase (Months 12-18)||3
2326077|NCT01832753|5710155|P1|COMPLETED|Open Label Dose Phase (Months 12-18)||3
2326078|NCT01832753|5710153|P3|STARTED|Open Label Dose Phase (Months 12-18)||0
2326079|NCT01832753|5710154|P2|STARTED|Open Label Dose Phase (Months 12-18)||3
2326080|NCT01832753|5710155|P1|STARTED|Open Label Dose Phase (Months 12-18)||3
2326081|NCT01832753|5710153|P3|NOT COMPLETED|Randomization Phase (Months 6-12)||0
2326082|NCT01832753|5710154|P2|NOT COMPLETED|Randomization Phase (Months 6-12)||1
2326083|NCT01832753|5710155|P1|NOT COMPLETED|Randomization Phase (Months 6-12)||1
2326084|NCT01832753|5710153|P3|COMPLETED|Randomization Phase (Months 6-12)||0
2326085|NCT01832753|5710154|P2|COMPLETED|Randomization Phase (Months 6-12)||3
2326086|NCT01832753|5710155|P1|COMPLETED|Randomization Phase (Months 6-12)||4
2326087|NCT01832753|5710153|P3|STARTED|Randomization Phase (Months 6-12)|1 subject was not randomized as they did not meet inclusion criteria at the end of observation phase|0
2326088|NCT01832753|5710154|P2|STARTED|Randomization Phase (Months 6-12)||4
2326089|NCT01832753|5710155|P1|STARTED|Randomization Phase (Months 6-12)||5
2326090|NCT01832753|5710153|P3|NOT COMPLETED|Observation Phase (Months 0-6)||2
2326091|NCT01832753|5710154|P2|NOT COMPLETED|Observation Phase (Months 0-6)||0
2326092|NCT01832753|5710155|P1|NOT COMPLETED|Observation Phase (Months 0-6)||0
2326093|NCT01832753|5710153|P3|COMPLETED|Observation Phase (Months 0-6)||1
2326094|NCT01832753|5710154|P2|COMPLETED|Observation Phase (Months 0-6)||4
2326095|NCT01832753|5710155|P1|COMPLETED|Observation Phase (Months 0-6)||5
2326096|NCT01832753|5710153|P3|STARTED|Observation Phase (Months 0-6)||3
2326097|NCT01832753|5710154|P2|STARTED|Observation Phase (Months 0-6)||4
2326098|NCT01832753|5710155|P1|STARTED|Observation Phase (Months 0-6)||5
2326099|NCT01832610|5710167|P1|NOT COMPLETED|Overall Study||4
2326100|NCT01832610|5710167|P1|COMPLETED|Overall Study||97
2326101|NCT01832610|5710167|P1|STARTED|Overall Study||101
2326102|NCT01832506|5710181|P3|NOT COMPLETED|Overall Study||0
2326103|NCT01832506|5710182|P2|NOT COMPLETED|Overall Study||0
2326104|NCT01832506|5710183|P1|NOT COMPLETED|Overall Study||0
2326105|NCT01832506|5710181|P3|COMPLETED|Overall Study||6
2326106|NCT01832506|5710182|P2|COMPLETED|Overall Study||3
2326107|NCT01832506|5710183|P1|COMPLETED|Overall Study||3
2326108|NCT01832506|5710181|P3|STARTED|Overall Study||6
2326109|NCT01832506|5710182|P2|STARTED|Overall Study||3
2326110|NCT01832506|5710183|P1|STARTED|Overall Study||3
2326111|NCT01832493|5710234|P1|NOT COMPLETED|Overall Study||8
2326112|NCT01832493|5710234|P1|COMPLETED|Overall Study||42
2326113|NCT01832493|5710234|P1|STARTED|Overall Study||50
2326114|NCT01832480|5710243|P2|NOT COMPLETED|Overall Study||42
2326115|NCT01832480|5710244|P1|NOT COMPLETED|Overall Study||41
2326116|NCT01832480|5710243|P2|COMPLETED|Overall Study||270
2326117|NCT01832480|5710244|P1|COMPLETED|Overall Study||270
2326118|NCT01832480|5710243|P2|STARTED|Overall Study||312
2326119|NCT01832480|5710244|P1|STARTED|Overall Study||311
2326120|NCT01832259|5710252|P2|NOT COMPLETED|Overall Study||0
2326121|NCT01832259|5710253|P1|NOT COMPLETED|Overall Study||0
2326122|NCT01832259|5710252|P2|COMPLETED|Overall Study||15
2326123|NCT01832259|5710253|P1|COMPLETED|Overall Study||15
2326124|NCT01832259|5710252|P2|STARTED|Overall Study||15
2326125|NCT01832259|5710253|P1|STARTED|Overall Study||15
2326126|NCT01832155|5710265|P2|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
2326127|NCT01832155|5710266|P1|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
2326128|NCT01832155|5710265|P2|COMPLETED|End of Study: 4 - 8 Weeks||18
2326129|NCT01832155|5710266|P1|COMPLETED|End of Study: 4 - 8 Weeks||16
2326130|NCT01832155|5710265|P2|STARTED|End of Study: 4 - 8 Weeks||18
2326131|NCT01832155|5710266|P1|STARTED|End of Study: 4 - 8 Weeks||16
2326132|NCT01832155|5710265|P2|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||0
2326133|NCT01832155|5710266|P1|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||1
2326134|NCT01832155|5710265|P2|COMPLETED|Mid-point of Study: 0 - 4 Weeks||18
2326135|NCT01832155|5710266|P1|COMPLETED|Mid-point of Study: 0 - 4 Weeks||16
2326136|NCT01832155|5710265|P2|STARTED|Mid-point of Study: 0 - 4 Weeks||18
2326137|NCT01832155|5710266|P1|STARTED|Mid-point of Study: 0 - 4 Weeks||17
2326138|NCT01832155|5710265|P2|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||0
2326139|NCT01832155|5710266|P1|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||1
2326140|NCT01832155|5710265|P2|COMPLETED|Beginning of Study: Baseline at 0 Week||18
2326141|NCT01832155|5710266|P1|COMPLETED|Beginning of Study: Baseline at 0 Week||17
2326142|NCT01832155|5710265|P2|STARTED|Beginning of Study: Baseline at 0 Week||18
2326143|NCT01832155|5710266|P1|STARTED|Beginning of Study: Baseline at 0 Week||18
2326144|NCT01832090|5710289|P2|NOT COMPLETED|Overall Study||1
2326145|NCT01832090|5710290|P1|NOT COMPLETED|Overall Study||6
2326146|NCT01832090|5710289|P2|COMPLETED|Overall Study||28
2326147|NCT01832090|5710290|P1|COMPLETED|Overall Study||83
2326148|NCT01832090|5710289|P2|STARTED|Overall Study||29
2326149|NCT01832090|5710290|P1|STARTED|Overall Study||89
2326150|NCT01831934|5710335|P2|NOT COMPLETED|Overall Study||0
2326151|NCT01831934|5710336|P1|NOT COMPLETED|Overall Study||1
2326152|NCT01831934|5710335|P2|COMPLETED|Overall Study||10
2326153|NCT01831934|5710336|P1|COMPLETED|Overall Study|Volunteer consented but not enrolled after reporting a prior bad reaction to influenza vaccine.|11
2326154|NCT01831934|5710335|P2|STARTED|Overall Study||10
2326155|NCT01831934|5710336|P1|STARTED|Overall Study||12
2326156|NCT01831921|5710344|P2|NOT COMPLETED|Overall Study||39
2326157|NCT01831921|5710345|P1|NOT COMPLETED|Overall Study||84
2326158|NCT01831921|5710344|P2|COMPLETED|Overall Study|Of 42 eligible for this visit.|36
2326159|NCT01831921|5710345|P1|COMPLETED|Overall Study|Of 85 eligible for this visit.|66
2326160|NCT01831921|5710344|P2|18 Months|Overall Study|Of 59 eligible for this visit.|49
2326161|NCT01831921|5710345|P1|18 Months|Overall Study|Of 118 eligible for this visit.|90
2326162|NCT01831921|5710344|P2|12 Months|Overall Study||62
2326257|NCT01831466|5710620|P1|COMPLETED|Overall Study||55
2326163|NCT01831921|5710345|P1|12 Months|Overall Study|All participants were followed for 12 months to 24 months, depending on date of randomization.|120
2326164|NCT01831921|5710344|P2|6 Months|Overall Study||63
2326165|NCT01831921|5710345|P1|6 Months|Overall Study||122
2326166|NCT01831921|5710344|P2|STARTED|Overall Study||75
2326167|NCT01831921|5710345|P1|STARTED|Overall Study||150
2326168|NCT01831856|5710369|P2|NOT COMPLETED|Overall Study||37
2326169|NCT01831856|5710370|P1|NOT COMPLETED|Overall Study||34
2326170|NCT01831856|5710369|P2|COMPLETED|Overall Study||30
2326171|NCT01831856|5710370|P1|COMPLETED|Overall Study||33
2326172|NCT01831856|5710369|P2|STARTED|Overall Study||67
2326173|NCT01831856|5710370|P1|STARTED|Overall Study||67
2326174|NCT01831817|5710380|P4|NOT COMPLETED|Overall Study||0
2326175|NCT01831817|5710381|P3|NOT COMPLETED|Overall Study||0
2326176|NCT01831817|5710382|P2|NOT COMPLETED|Overall Study||0
2326177|NCT01831817|5710383|P1|NOT COMPLETED|Overall Study||4
2326178|NCT01831817|5710380|P4|COMPLETED|Overall Study||36
2326179|NCT01831817|5710381|P3|COMPLETED|Overall Study||35
2326180|NCT01831817|5710382|P2|COMPLETED|Overall Study||34
2326181|NCT01831817|5710383|P1|COMPLETED|Overall Study||31
2326182|NCT01831817|5710380|P4|STARTED|Overall Study||36
2326183|NCT01831817|5710381|P3|STARTED|Overall Study||35
2326184|NCT01831817|5710382|P2|STARTED|Overall Study||34
2326185|NCT01831817|5710383|P1|STARTED|Overall Study||35
2326186|NCT01831804|5710430|P9|NOT COMPLETED|Overall Study||2
2326187|NCT01831804|5710431|P8|NOT COMPLETED|Overall Study||3
2326188|NCT01831804|5710432|P7|NOT COMPLETED|Overall Study||1
2326189|NCT01831804|5710433|P6|NOT COMPLETED|Overall Study||0
2326190|NCT01831804|5710434|P5|NOT COMPLETED|Overall Study||2
2326191|NCT01831804|5710435|P4|NOT COMPLETED|Overall Study||0
2326192|NCT01831804|5710436|P3|NOT COMPLETED|Overall Study||6
2326193|NCT01831804|5710437|P2|NOT COMPLETED|Overall Study||2
2326194|NCT01831804|5710438|P1|NOT COMPLETED|Overall Study||1
2326195|NCT01831804|5710430|P9|COMPLETED|Overall Study||2
2326196|NCT01831804|5710431|P8|COMPLETED|Overall Study||23
2326197|NCT01831804|5710432|P7|COMPLETED|Overall Study||3
2326198|NCT01831804|5710433|P6|COMPLETED|Overall Study||3
2326199|NCT01831804|5710434|P5|COMPLETED|Overall Study||3
2326200|NCT01831804|5710435|P4|COMPLETED|Overall Study||5
2326201|NCT01831804|5710436|P3|COMPLETED|Overall Study||3
2326202|NCT01831804|5710437|P2|COMPLETED|Overall Study||1
2326203|NCT01831804|5710438|P1|COMPLETED|Overall Study||3
2326204|NCT01831804|5710430|P9|STARTED|Overall Study||4
2326205|NCT01831804|5710431|P8|STARTED|Overall Study||26
2326206|NCT01831804|5710432|P7|STARTED|Overall Study||4
2326207|NCT01831804|5710433|P6|STARTED|Overall Study||3
2326208|NCT01831804|5710434|P5|STARTED|Overall Study||5
2326209|NCT01831804|5710435|P4|STARTED|Overall Study||5
2326210|NCT01831804|5710436|P3|STARTED|Overall Study||9
2326211|NCT01831804|5710437|P2|STARTED|Overall Study||3
2326212|NCT01831804|5710438|P1|STARTED|Overall Study||4
2326213|NCT01831791|5710533|P1|NOT COMPLETED|Overall Study||10
2326214|NCT01831791|5710533|P1|COMPLETED|Overall Study||110
2326215|NCT01831791|5710533|P1|STARTED|Overall Study||120
2326216|NCT01831765|5710562|P3|NOT COMPLETED|Overall Study||42
2326217|NCT01831765|5710563|P2|NOT COMPLETED|Overall Study||27
2326218|NCT01831765|5710564|P1|NOT COMPLETED|Overall Study||44
2326219|NCT01831765|5710562|P3|COMPLETED|Overall Study||338
2326220|NCT01831765|5710563|P2|COMPLETED|Overall Study||355
2326221|NCT01831765|5710564|P1|COMPLETED|Overall Study||337
2326222|NCT01831765|5710562|P3|Completed 52 Weeks|Overall Study||338
2326223|NCT01831765|5710563|P2|Completed 52 Weeks|Overall Study|This arm did not continue in the trial after 26 weeks ( 26 to 52 weeks).|0
2326224|NCT01831765|5710564|P1|Completed 52 Weeks|Overall Study||337
2326225|NCT01831765|5710562|P3|Completed 26 Weeks|Overall Study||356
2326226|NCT01831765|5710563|P2|Completed 26 Weeks|Overall Study||355
2326227|NCT01831765|5710564|P1|Completed 26 Weeks|Overall Study||351
2326228|NCT01831765|5710562|P3|STARTED|Overall Study||380
2326229|NCT01831765|5710563|P2|STARTED|Overall Study||382
2326230|NCT01831765|5710564|P1|STARTED|Overall Study||381
2326231|NCT01831726|5710590|P1|NOT COMPLETED|Overall Study||80
2326232|NCT01831726|5710590|P1|COMPLETED|Overall Study||0
2326233|NCT01831726|5710590|P1|STARTED|Overall Study||80
2326234|NCT01831466|5710609|P12|NOT COMPLETED|Overall Study||4
2326235|NCT01831466|5710610|P11|NOT COMPLETED|Overall Study||2
2326236|NCT01831466|5710611|P10|NOT COMPLETED|Overall Study||5
2326237|NCT01831466|5710612|P9|NOT COMPLETED|Overall Study||3
2326238|NCT01831466|5710613|P8|NOT COMPLETED|Overall Study||2
2326239|NCT01831466|5710614|P7|NOT COMPLETED|Overall Study||1
2326240|NCT01831466|5710615|P6|NOT COMPLETED|Overall Study||26
2326241|NCT01831466|5710616|P5|NOT COMPLETED|Overall Study||17
2326242|NCT01831466|5710617|P4|NOT COMPLETED|Overall Study||19
2326243|NCT01831466|5710618|P3|NOT COMPLETED|Overall Study||23
2326244|NCT01831466|5710619|P2|NOT COMPLETED|Overall Study||18
2326245|NCT01831466|5710620|P1|NOT COMPLETED|Overall Study||16
2326246|NCT01831466|5710609|P12|COMPLETED|Overall Study||3
2326247|NCT01831466|5710610|P11|COMPLETED|Overall Study||4
2326248|NCT01831466|5710611|P10|COMPLETED|Overall Study||2
2326249|NCT01831466|5710612|P9|COMPLETED|Overall Study||4
2326250|NCT01831466|5710613|P8|COMPLETED|Overall Study||5
2326251|NCT01831466|5710614|P7|COMPLETED|Overall Study||6
2326252|NCT01831466|5710615|P6|COMPLETED|Overall Study||48
2326253|NCT01831466|5710616|P5|COMPLETED|Overall Study||57
2326254|NCT01831466|5710617|P4|COMPLETED|Overall Study||51
2326255|NCT01831466|5710618|P3|COMPLETED|Overall Study||48
2326256|NCT01831466|5710619|P2|COMPLETED|Overall Study||52
2326258|NCT01831466|5710609|P12|STARTED|Overall Study|Treated|7
2326259|NCT01831466|5710610|P11|STARTED|Overall Study|Treated|6
2326260|NCT01831466|5710611|P10|STARTED|Overall Study|Treated|7
2326261|NCT01831466|5710612|P9|STARTED|Overall Study|Treated|7
2326262|NCT01831466|5710613|P8|STARTED|Overall Study|Treated|7
2326263|NCT01831466|5710614|P7|STARTED|Overall Study|Treated|7
2326264|NCT01831466|5710615|P6|STARTED|Overall Study|Treated|74
2326265|NCT01831466|5710616|P5|STARTED|Overall Study|Treated|74
2326266|NCT01831466|5710617|P4|STARTED|Overall Study|Treated|70
2326267|NCT01831466|5710618|P3|STARTED|Overall Study|Treated|71
2326268|NCT01831466|5710619|P2|STARTED|Overall Study|Treated|70
2326269|NCT01831466|5710620|P1|STARTED|Overall Study|Treated|71
2326270|NCT01831258|5710742|P2|NOT COMPLETED|Overall Study||3
2326271|NCT01831258|5710743|P1|NOT COMPLETED|Overall Study||5
2326272|NCT01831258|5710742|P2|COMPLETED|Overall Study||32
2326273|NCT01831258|5710743|P1|COMPLETED|Overall Study||30
2326274|NCT01831258|5710742|P2|STARTED|Overall Study||35
2326275|NCT01831258|5710743|P1|STARTED|Overall Study||35
2326276|NCT01831232|5710769|P1|NOT COMPLETED|Overall Study||0
2326277|NCT01831232|5710769|P1|COMPLETED|Overall Study||24
2326278|NCT01831232|5710769|P1|STARTED|Overall Study||24
2326279|NCT01831219|5710780|P2|NOT COMPLETED|Overall Study||24
2326280|NCT01831219|5710781|P1|NOT COMPLETED|Overall Study||33
2326281|NCT01831219|5710780|P2|COMPLETED|Overall Study||21
2326282|NCT01831219|5710781|P1|COMPLETED|Overall Study||40
2326283|NCT01831219|5710780|P2|STARTED|Overall Study||45
2326284|NCT01831219|5710781|P1|STARTED|Overall Study||73
2326285|NCT01831154|5710802|P3|NOT COMPLETED|Overall Study||0
2326286|NCT01831154|5710803|P2|NOT COMPLETED|Overall Study||0
2326287|NCT01831154|5710804|P1|NOT COMPLETED|Overall Study||0
2326288|NCT01831154|5710802|P3|COMPLETED|Overall Study||11
2326289|NCT01831154|5710803|P2|COMPLETED|Overall Study||11
2326290|NCT01831154|5710804|P1|COMPLETED|Overall Study||15
2326291|NCT01831154|5710802|P3|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
2326292|NCT01831154|5710803|P2|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
2326293|NCT01831154|5710804|P1|STARTED|Overall Study|Study Institutional Review Board (IRB) approval 11-11-2009, first subjects enrolled 6-7-2010|15
2326294|NCT01831076|5710829|P2|NOT COMPLETED|Overall Study||1
2326295|NCT01831076|5710830|P1|NOT COMPLETED|Overall Study||1
2326296|NCT01831076|5710829|P2|COMPLETED|Overall Study||4
2326297|NCT01831076|5710830|P1|COMPLETED|Overall Study||30
2326298|NCT01831076|5710829|P2|STARTED|Overall Study||5
2326299|NCT01831076|5710830|P1|STARTED|Overall Study||31
2326300|NCT01830972|5710838|P2|NOT COMPLETED|Part IV||1
2326301|NCT01830972|5710839|P1|NOT COMPLETED|Part IV||3
2326302|NCT01830972|5710838|P2|COMPLETED|Part IV||10
2326303|NCT01830972|5710839|P1|COMPLETED|Part IV||39
2326304|NCT01830972|5710838|P2|STARTED|Part IV||11
2326305|NCT01830972|5710839|P1|STARTED|Part IV||42
2326306|NCT01830972|5710838|P2|NOT COMPLETED|Part III||0
2326307|NCT01830972|5710839|P1|NOT COMPLETED|Part III||2
2326308|NCT01830972|5710838|P2|COMPLETED|Part III||11
2326309|NCT01830972|5710839|P1|COMPLETED|Part III||42
2326310|NCT01830972|5710838|P2|STARTED|Part III||11
2326311|NCT01830972|5710839|P1|STARTED|Part III|2 participants withdrew consent and did not enter Part 3|44
2326312|NCT01830972|5710838|P2|NOT COMPLETED|Part II||2
2326313|NCT01830972|5710839|P1|NOT COMPLETED|Part II||2
2326314|NCT01830972|5710838|P2|COMPLETED|Part II||11
2326315|NCT01830972|5710839|P1|COMPLETED|Part II||44
2326316|NCT01830972|5710838|P2|STARTED|Part II|Entered study at Part 2|13
2326317|NCT01830972|5710839|P1|STARTED|Part II||46
2326318|NCT01830972|5710838|P2|NOT COMPLETED|Part I||0
2326319|NCT01830972|5710839|P1|NOT COMPLETED|Part I||0
2326320|NCT01830972|5710838|P2|COMPLETED|Part I|Not applicable; participants in this arm entered during Part 2.|0
2326321|NCT01830972|5710839|P1|COMPLETED|Part I||46
2326322|NCT01830972|5710838|P2|STARTED|Part I|Not applicable; participants in this arm entered during Part 2.|0
2326323|NCT01830972|5710839|P1|STARTED|Part I||46
2326324|NCT01830933|5710865|P2|NOT COMPLETED|Overall Study||232
2326325|NCT01830933|5710866|P1|NOT COMPLETED|Overall Study||168
2326326|NCT01830933|5710865|P2|COMPLETED|Overall Study||580
2326327|NCT01830933|5710866|P1|COMPLETED|Overall Study||655
2326328|NCT01830933|5710865|P2|Completed Meet-up|Overall Study||603
2326329|NCT01830933|5710866|P1|Completed Meet-up|Overall Study||675
2326330|NCT01830933|5710865|P2|STARTED|Overall Study||812
2326331|NCT01830933|5710866|P1|STARTED|Overall Study||823
2326332|NCT01830920|5710883|P5|NOT COMPLETED|Overall Study||8
2326333|NCT01830920|5710884|P4|NOT COMPLETED|Overall Study||16
2326334|NCT01830920|5710885|P3|NOT COMPLETED|Overall Study||8
2326335|NCT01830920|5710886|P2|NOT COMPLETED|Overall Study||6
2326336|NCT01830920|5710887|P1|NOT COMPLETED|Overall Study||21
2326337|NCT01830920|5710883|P5|COMPLETED|Overall Study||99
2326338|NCT01830920|5710884|P4|COMPLETED|Overall Study||109
2326339|NCT01830920|5710885|P3|COMPLETED|Overall Study||40
2326340|NCT01830920|5710886|P2|COMPLETED|Overall Study||40
2326341|NCT01830920|5710887|P1|COMPLETED|Overall Study||105
2326342|NCT01830920|5710883|P5|Received Allocated Drug|Overall Study||105
2326343|NCT01830920|5710884|P4|Received Allocated Drug|Overall Study||119
2326344|NCT01830920|5710885|P3|Received Allocated Drug|Overall Study||47
2326345|NCT01830920|5710886|P2|Received Allocated Drug|Overall Study||45
2326346|NCT01830920|5710887|P1|Received Allocated Drug|Overall Study||115
2326347|NCT01830920|5710883|P5|STARTED|Overall Study||107
2326348|NCT01830920|5710884|P4|STARTED|Overall Study||125
2326349|NCT01830920|5710885|P3|STARTED|Overall Study||48
2326350|NCT01830920|5710886|P2|STARTED|Overall Study||46
2326351|NCT01830920|5710887|P1|STARTED|Overall Study||126
2326352|NCT01830881|5710926|P2|NOT COMPLETED|Overall Study||1
2326353|NCT01830881|5710927|P1|NOT COMPLETED|Overall Study||0
2326354|NCT01830881|5710926|P2|COMPLETED|Overall Study||61
2326355|NCT01830881|5710927|P1|COMPLETED|Overall Study||62
2326356|NCT01830881|5710926|P2|STARTED|Overall Study||62
2326357|NCT01830881|5710927|P1|STARTED|Overall Study||62
2326358|NCT01830855|5710975|P4|NOT COMPLETED|Overall Study||82
2326359|NCT01830855|5710976|P3|NOT COMPLETED|Overall Study||66
2326360|NCT01830855|5710977|P2|NOT COMPLETED|Overall Study||61
2326361|NCT01830855|5710978|P1|NOT COMPLETED|Overall Study||155
2326362|NCT01830855|5710975|P4|COMPLETED|Overall Study||815
2326363|NCT01830855|5710976|P3|COMPLETED|Overall Study||521
2326364|NCT01830855|5710977|P2|COMPLETED|Overall Study||537
2326365|NCT01830855|5710978|P1|COMPLETED|Overall Study||1353
2326366|NCT01830855|5710975|P4|STARTED|Overall Study||897
2326367|NCT01830855|5710976|P3|STARTED|Overall Study||587
2326368|NCT01830855|5710977|P2|STARTED|Overall Study||598
2326369|NCT01830855|5710978|P1|STARTED|Overall Study||1508
2326370|NCT01830842|5711084|P2|NOT COMPLETED|Overall Study||2
2326371|NCT01830842|5711085|P1|NOT COMPLETED|Overall Study||5
2326372|NCT01830842|5711084|P2|COMPLETED|Overall Study||22
2326373|NCT01830842|5711085|P1|COMPLETED|Overall Study||25
2326374|NCT01830842|5711084|P2|STARTED|Overall Study||24
2326375|NCT01830842|5711085|P1|STARTED|Overall Study||30
2326376|NCT01830816|5711094|P3|NOT COMPLETED|Overall Study||7
2326377|NCT01830816|5711095|P2|NOT COMPLETED|Overall Study||14
2326378|NCT01830816|5711096|P1|NOT COMPLETED|Overall Study||20
2326379|NCT01830816|5711094|P3|COMPLETED|Overall Study||0
2326380|NCT01830816|5711095|P2|COMPLETED|Overall Study||0
2326381|NCT01830816|5711096|P1|COMPLETED|Overall Study||0
2326382|NCT01830816|5711094|P3|Pharmacokinetic-Evaluable Population|Overall Study||6
2326383|NCT01830816|5711095|P2|Pharmacokinetic-Evaluable Population|Overall Study||14
2326384|NCT01830816|5711096|P1|Pharmacokinetic-Evaluable Population|Overall Study|Participants are considered to have completed study treatment if they are PK evaluable.|18
2326385|NCT01830816|5711094|P3|STARTED|Overall Study||7
2326386|NCT01830816|5711095|P2|STARTED|Overall Study||14
2326387|NCT01830816|5711096|P1|STARTED|Overall Study||20
2326388|NCT01830790|5711121|P2|NOT COMPLETED|Overall Study||0
2326389|NCT01830790|5711122|P1|NOT COMPLETED|Overall Study||0
2326390|NCT01830790|5711121|P2|COMPLETED|Overall Study||10
2326391|NCT01830790|5711122|P1|COMPLETED|Overall Study||0
2326392|NCT01830790|5711121|P2|STARTED|Overall Study||10
2326393|NCT01830790|5711122|P1|STARTED|Overall Study||0
2326394|NCT01830699|5711132|P2|NOT COMPLETED|Overall Study||0
2326395|NCT01830699|5711133|P1|NOT COMPLETED|Overall Study||0
2326396|NCT01830699|5711132|P2|COMPLETED|Overall Study||20
2326397|NCT01830699|5711133|P1|COMPLETED|Overall Study||13
2326398|NCT01830699|5711132|P2|STARTED|Overall Study||20
2326399|NCT01830699|5711133|P1|STARTED|Overall Study||13
2326400|NCT01830621|5711145|P2|NOT COMPLETED|Overall Study||0
2326401|NCT01830621|5711146|P1|NOT COMPLETED|Overall Study||0
2326402|NCT01830621|5711145|P2|COMPLETED|Overall Study||144
2326403|NCT01830621|5711146|P1|COMPLETED|Overall Study||138
2326404|NCT01830621|5711145|P2|STARTED|Overall Study||144
2326405|NCT01830621|5711146|P1|STARTED|Overall Study||138
2326406|NCT01830595|5711160|P2|NOT COMPLETED|Second Period||0
2326407|NCT01830595|5711161|P1|NOT COMPLETED|Second Period||0
2326408|NCT01830595|5711160|P2|COMPLETED|Second Period||23
2326409|NCT01830595|5711161|P1|COMPLETED|Second Period||23
2326410|NCT01830595|5711160|P2|STARTED|Second Period||23
2326411|NCT01830595|5711161|P1|STARTED|Second Period||23
2326412|NCT01830595|5711160|P2|NOT COMPLETED|Washout||2
2326413|NCT01830595|5711161|P1|NOT COMPLETED|Washout||2
2326414|NCT01830595|5711160|P2|COMPLETED|Washout||23
2326415|NCT01830595|5711161|P1|COMPLETED|Washout||23
2326416|NCT01830595|5711160|P2|STARTED|Washout||25
2326417|NCT01830595|5711161|P1|STARTED|Washout||25
2326418|NCT01830595|5711160|P2|NOT COMPLETED|First Period||3
2326419|NCT01830595|5711161|P1|NOT COMPLETED|First Period||1
2326420|NCT01830595|5711160|P2|COMPLETED|First Period||25
2326421|NCT01830595|5711161|P1|COMPLETED|First Period||25
2326422|NCT01830595|5711160|P2|Received at Least One Dose|First Period||28
2326423|NCT01830595|5711161|P1|Received at Least One Dose|First Period||26
2326424|NCT01830595|5711160|P2|STARTED|First Period||28
2326425|NCT01830595|5711161|P1|STARTED|First Period||26
2326426|NCT01830543|5711178|P3|NOT COMPLETED|Overall Study||214
2326427|NCT01830543|5711179|P2|NOT COMPLETED|Overall Study||152
2326428|NCT01830543|5711180|P1|NOT COMPLETED|Overall Study||159
2326429|NCT01830543|5711178|P3|COMPLETED|Overall Study||492
2326430|NCT01830543|5711179|P2|COMPLETED|Overall Study||557
2326431|NCT01830543|5711180|P1|COMPLETED|Overall Study||550
2326432|NCT01830543|5711178|P3|Treated|Overall Study||697
2326433|NCT01830543|5711179|P2|Treated|Overall Study||706
2326434|NCT01830543|5711180|P1|Treated|Overall Study||696
2326435|NCT01830543|5711178|P3|STARTED|Overall Study||706
2326436|NCT01830543|5711179|P2|STARTED|Overall Study||709
2326437|NCT01830543|5711180|P1|STARTED|Overall Study||709
2326438|NCT01830205|5711216|P4|NOT COMPLETED|Overall Study||0
2326439|NCT01830205|5711217|P3|NOT COMPLETED|Overall Study||0
2326440|NCT01830205|5711218|P2|NOT COMPLETED|Overall Study||0
2326441|NCT01830205|5711219|P1|NOT COMPLETED|Overall Study||0
2326442|NCT01830205|5711216|P4|COMPLETED|Overall Study||12
2326443|NCT01830205|5711217|P3|COMPLETED|Overall Study||6
2326444|NCT01830205|5711218|P2|COMPLETED|Overall Study||6
2326445|NCT01830205|5711219|P1|COMPLETED|Overall Study||12
2326446|NCT01830205|5711216|P4|STARTED|Overall Study||12
2326447|NCT01830205|5711217|P3|STARTED|Overall Study||6
2326448|NCT01830205|5711218|P2|STARTED|Overall Study||6
2326449|NCT01830205|5711219|P1|STARTED|Overall Study||12
2326450|NCT01830140|5711303|P2|NOT COMPLETED|Overall Study||4
2326451|NCT01830140|5711304|P1|NOT COMPLETED|Overall Study||7
2326452|NCT01830140|5711303|P2|COMPLETED|Overall Study||229
2326453|NCT01830140|5711304|P1|COMPLETED|Overall Study||226
2326454|NCT01830140|5711303|P2|STARTED|Overall Study||233
2326455|NCT01830140|5711304|P1|STARTED|Overall Study||233
2326456|NCT01830127|5711312|P2|NOT COMPLETED|Overall Study||9
2326457|NCT01830127|5711313|P1|NOT COMPLETED|Overall Study||5
2326458|NCT01830127|5711312|P2|COMPLETED|Overall Study||8
2326459|NCT01830127|5711313|P1|COMPLETED|Overall Study||13
2326460|NCT01830127|5711312|P2|STARTED|Overall Study||17
2326461|NCT01830127|5711313|P1|STARTED|Overall Study||18
2326462|NCT01829997|5711321|P1|NOT COMPLETED|Overall Study||6
2326463|NCT01829997|5711321|P1|COMPLETED|Overall Study||16
2326464|NCT01829997|5711321|P1|STARTED|Overall Study||22
2326465|NCT01829919|5711330|P1|NOT COMPLETED|Overall Study||0
2326466|NCT01829919|5711330|P1|COMPLETED|Overall Study||24
2326467|NCT01829919|5711330|P1|STARTED|Overall Study||24
2326468|NCT01829711|5711346|P1|NOT COMPLETED|Overall Study||80
2326469|NCT01829711|5711346|P1|COMPLETED|Overall Study||0
2326470|NCT01829711|5711346|P1|STARTED|Overall Study||80
2326471|NCT01829516|5711376|P2|NOT COMPLETED|2nd Intervention||0
2326472|NCT01829516|5711377|P1|NOT COMPLETED|2nd Intervention||0
2326473|NCT01829516|5711376|P2|COMPLETED|2nd Intervention||14
2326474|NCT01829516|5711377|P1|COMPLETED|2nd Intervention||18
2326475|NCT01829516|5711376|P2|STARTED|2nd Intervention||14
2326476|NCT01829516|5711377|P1|STARTED|2nd Intervention||18
2326477|NCT01829516|5711376|P2|NOT COMPLETED|Washout Period - 1 Week||0
2326478|NCT01829516|5711377|P1|NOT COMPLETED|Washout Period - 1 Week||0
2326479|NCT01829516|5711376|P2|COMPLETED|Washout Period - 1 Week||14
2326480|NCT01829516|5711377|P1|COMPLETED|Washout Period - 1 Week||18
2326481|NCT01829516|5711376|P2|STARTED|Washout Period - 1 Week||14
2326482|NCT01829516|5711377|P1|STARTED|Washout Period - 1 Week||18
2326483|NCT01829516|5711376|P2|NOT COMPLETED|First Intervention||0
2326484|NCT01829516|5711377|P1|NOT COMPLETED|First Intervention||0
2326485|NCT01829516|5711376|P2|COMPLETED|First Intervention||14
2326486|NCT01829516|5711377|P1|COMPLETED|First Intervention||18
2326487|NCT01829516|5711376|P2|STARTED|First Intervention||14
2326488|NCT01829516|5711377|P1|STARTED|First Intervention||18
2326489|NCT01829503|5711385|P1|NOT COMPLETED|Overall Study||0
2326490|NCT01829503|5711385|P1|COMPLETED|Overall Study||44
2326491|NCT01829503|5711385|P1|STARTED|Overall Study||44
2326492|NCT01829477|5711402|P2|NOT COMPLETED|Overall Study||15
2326493|NCT01829477|5711403|P1|NOT COMPLETED|Overall Study||16
2326494|NCT01829477|5711402|P2|COMPLETED|Overall Study||1
2326495|NCT01829477|5711403|P1|COMPLETED|Overall Study||1
2326496|NCT01829477|5711402|P2|STARTED|Overall Study||16
2326497|NCT01829477|5711403|P1|STARTED|Overall Study||17
2326498|NCT01829464|5711416|P3|NOT COMPLETED|Overall Study||26
2326499|NCT01829464|5711417|P2|NOT COMPLETED|Overall Study||29
2326500|NCT01829464|5711418|P1|NOT COMPLETED|Overall Study||28
2326501|NCT01829464|5711416|P3|COMPLETED|Overall Study||3
2326502|NCT01829464|5711417|P2|COMPLETED|Overall Study||2
2326503|NCT01829464|5711418|P1|COMPLETED|Overall Study||2
2326504|NCT01829464|5711416|P3|STARTED|Overall Study||29
2326505|NCT01829464|5711417|P2|STARTED|Overall Study||31
2326506|NCT01829464|5711418|P1|STARTED|Overall Study||30
2326507|NCT01829425|5711434|P2|NOT COMPLETED|Overall Study||4
2326508|NCT01829425|5711435|P1|NOT COMPLETED|Overall Study||6
2326509|NCT01829425|5711434|P2|COMPLETED|Overall Study|completed primary outcome 2 month f/u N=70|70
2326510|NCT01829425|5711435|P1|COMPLETED|Overall Study|completed primary outcome 2 month f/u N=72|72
2326511|NCT01829425|5711434|P2|STARTED|Overall Study||74
2326512|NCT01829425|5711435|P1|STARTED|Overall Study||78
2326513|NCT01829399|5711465|P2|NOT COMPLETED|Visit 2 (One Month Later)||0
2326514|NCT01829399|5711466|P1|NOT COMPLETED|Visit 2 (One Month Later)||0
2326515|NCT01829399|5711465|P2|COMPLETED|Visit 2 (One Month Later)||12
2326516|NCT01829399|5711466|P1|COMPLETED|Visit 2 (One Month Later)||12
2326517|NCT01829399|5711465|P2|STARTED|Visit 2 (One Month Later)||12
2326518|NCT01829399|5711466|P1|STARTED|Visit 2 (One Month Later)||12
2326519|NCT01829399|5711465|P2|NOT COMPLETED|Visit 1||0
2326520|NCT01829399|5711466|P1|NOT COMPLETED|Visit 1||0
2326521|NCT01829399|5711465|P2|COMPLETED|Visit 1||12
2326522|NCT01829399|5711466|P1|COMPLETED|Visit 1||12
2326523|NCT01829399|5711465|P2|STARTED|Visit 1||12
2326524|NCT01829399|5711466|P1|STARTED|Visit 1||12
2326525|NCT01829360|5711478|P4|NOT COMPLETED|Overall Study||0
2326526|NCT01829360|5711479|P3|NOT COMPLETED|Overall Study||1
2326527|NCT01829360|5711480|P2|NOT COMPLETED|Overall Study||0
2326528|NCT01829360|5711481|P1|NOT COMPLETED|Overall Study||0
2326529|NCT01829360|5711478|P4|COMPLETED|Overall Study||8
2326530|NCT01829360|5711479|P3|COMPLETED|Overall Study||9
2326531|NCT01829360|5711480|P2|COMPLETED|Overall Study||9
2326532|NCT01829360|5711481|P1|COMPLETED|Overall Study||8
2326533|NCT01829360|5711478|P4|STARTED|Overall Study||8
2326534|NCT01829360|5711479|P3|STARTED|Overall Study||10
2326535|NCT01829360|5711480|P2|STARTED|Overall Study||9
2326536|NCT01829360|5711481|P1|STARTED|Overall Study||8
2326537|NCT01829347|5711501|P2|NOT COMPLETED|VTI-210E||6
2326538|NCT01829347|5711502|P1|NOT COMPLETED|VTI-210E||3
2326539|NCT01829347|5711501|P2|COMPLETED|VTI-210E||0
2326540|NCT01829347|5711502|P1|COMPLETED|VTI-210E||0
2326541|NCT01829347|5711501|P2|STARTED|VTI-210E||6
2326542|NCT01829347|5711502|P1|STARTED|VTI-210E||3
2326543|NCT01829347|5711501|P2|NOT COMPLETED|VTI-210||3
2326544|NCT01829347|5711502|P1|NOT COMPLETED|VTI-210||6
2326545|NCT01829347|5711501|P2|COMPLETED|VTI-210||6
2326546|NCT01829347|5711502|P1|COMPLETED|VTI-210||3
2326547|NCT01829347|5711501|P2|STARTED|VTI-210||9
2326548|NCT01829347|5711502|P1|STARTED|VTI-210||9
2326549|NCT01829295|5711512|P4|NOT COMPLETED|6-12 Months||13
2326550|NCT01829295|5711513|P3|NOT COMPLETED|6-12 Months||12
2326551|NCT01829295|5711514|P2|NOT COMPLETED|6-12 Months||2
2326552|NCT01829295|5711515|P1|NOT COMPLETED|6-12 Months||4
2326553|NCT01829295|5711512|P4|COMPLETED|6-12 Months||29
2326554|NCT01829295|5711513|P3|COMPLETED|6-12 Months||20
2326555|NCT01829295|5711514|P2|COMPLETED|6-12 Months||54
2326556|NCT01829295|5711515|P1|COMPLETED|6-12 Months||60
2326557|NCT01829295|5711512|P4|STARTED|6-12 Months|42 patients failed on mycophenolate mofetil within the first 6 months|42
2326558|NCT01829295|5711513|P3|STARTED|6-12 Months|32 patients failed methotrexate within the first 6 months|32
2326559|NCT01829295|5711514|P2|STARTED|6-12 Months|56 patients were a treatment success on mycophenolate mofetil at 6 mo and had the option to continue|56
2326560|NCT01829295|5711515|P1|STARTED|6-12 Months|64 patients were a treatment success on methotrexate at 6 mo and had the option to continue|64
2326561|NCT01829295|5711512|P4|NOT COMPLETED|0-6 Months||0
2326562|NCT01829295|5711513|P3|NOT COMPLETED|0-6 Months||0
2326563|NCT01829295|5711514|P2|NOT COMPLETED|0-6 Months||11
2326564|NCT01829295|5711515|P1|NOT COMPLETED|0-6 Months||11
2326565|NCT01829295|5711512|P4|COMPLETED|0-6 Months||0
2326566|NCT01829295|5711513|P3|COMPLETED|0-6 Months||0
2326567|NCT01829295|5711514|P2|COMPLETED|0-6 Months||98
2326568|NCT01829295|5711515|P1|COMPLETED|0-6 Months||96
2326569|NCT01829295|5711512|P4|STARTED|0-6 Months||0
2326570|NCT01829295|5711513|P3|STARTED|0-6 Months||0
2326571|NCT01829295|5711514|P2|STARTED|0-6 Months||109
2326572|NCT01829295|5711515|P1|STARTED|0-6 Months||107
2326573|NCT01829243|5711525|P2|NOT COMPLETED|Second Intervention||0
2326574|NCT01829243|5711526|P1|NOT COMPLETED|Second Intervention||0
2326575|NCT01829243|5711525|P2|COMPLETED|Second Intervention||13
2326576|NCT01829243|5711526|P1|COMPLETED|Second Intervention||7
2326577|NCT01829243|5711525|P2|STARTED|Second Intervention||13
2326578|NCT01829243|5711526|P1|STARTED|Second Intervention||7
2326579|NCT01829243|5711525|P2|NOT COMPLETED|Washout Period of 1 Week||0
2326580|NCT01829243|5711526|P1|NOT COMPLETED|Washout Period of 1 Week||0
2326581|NCT01829243|5711525|P2|COMPLETED|Washout Period of 1 Week||13
2326582|NCT01829243|5711526|P1|COMPLETED|Washout Period of 1 Week||7
2326583|NCT01829243|5711525|P2|STARTED|Washout Period of 1 Week||13
2326584|NCT01829243|5711526|P1|STARTED|Washout Period of 1 Week||7
2326585|NCT01829243|5711525|P2|NOT COMPLETED|First Intervention||2
2326586|NCT01829243|5711526|P1|NOT COMPLETED|First Intervention||4
2326587|NCT01829243|5711525|P2|COMPLETED|First Intervention||13
2326588|NCT01829243|5711526|P1|COMPLETED|First Intervention||7
2326589|NCT01829243|5711525|P2|STARTED|First Intervention||15
2326590|NCT01829243|5711526|P1|STARTED|First Intervention||11
2326591|NCT01829230|5711540|P2|NOT COMPLETED|Overall Study||4
2326592|NCT01829230|5711541|P1|NOT COMPLETED|Overall Study||1
2326593|NCT01829230|5711540|P2|COMPLETED|Overall Study||38
2326594|NCT01829230|5711541|P1|COMPLETED|Overall Study||39
2326595|NCT01829230|5711540|P2|STARTED|Overall Study||42
2326596|NCT01829230|5711541|P1|STARTED|Overall Study||40
2326597|NCT01829217|5711549|P1|NOT COMPLETED|Overall Study||0
2326598|NCT01829217|5711549|P1|COMPLETED|Overall Study||13
2326599|NCT01829217|5711549|P1|STARTED|Overall Study||13
2326600|NCT01829191|5711555|P2|NOT COMPLETED|Overall Study||14
2326601|NCT01829191|5711556|P1|NOT COMPLETED|Overall Study||7
2326602|NCT01829191|5711555|P2|COMPLETED|Overall Study||50
2326603|NCT01829191|5711556|P1|COMPLETED|Overall Study||56
2326604|NCT01829191|5711555|P2|STARTED|Overall Study||64
2326605|NCT01829191|5711556|P1|STARTED|Overall Study||63
2326606|NCT01829165|5711565|P2|NOT COMPLETED|Overall Study||0
2326607|NCT01829165|5711566|P1|NOT COMPLETED|Overall Study||2
2326608|NCT01829165|5711565|P2|COMPLETED|Overall Study||13
2326609|NCT01829165|5711566|P1|COMPLETED|Overall Study||18
2326610|NCT01829165|5711565|P2|STARTED|Overall Study||13
2326611|NCT01829165|5711566|P1|STARTED|Overall Study||20
2326612|NCT01829113|5711574|P2|NOT COMPLETED|Overall Study||78
2326613|NCT01829113|5711575|P1|NOT COMPLETED|Overall Study||77
2326614|NCT01829113|5711574|P2|COMPLETED|Overall Study||0
2326615|NCT01829113|5711575|P1|COMPLETED|Overall Study||0
2326616|NCT01829113|5711574|P2|STARTED|Overall Study|Two patients were enrolled and randomized but never received treatment.|78
2326617|NCT01829113|5711575|P1|STARTED|Overall Study|Three patients were enrolled and randomized but never received treatment.|77
2326618|NCT01829048|5711592|P5|NOT COMPLETED|Overall Study||0
2326619|NCT01829048|5711593|P4|NOT COMPLETED|Overall Study||2
2326620|NCT01829048|5711594|P3|NOT COMPLETED|Overall Study||0
2326621|NCT01829048|5711595|P2|NOT COMPLETED|Overall Study||0
2326622|NCT01829048|5711596|P1|NOT COMPLETED|Overall Study||0
2326623|NCT01829048|5711592|P5|COMPLETED|Overall Study||2
2326624|NCT01829048|5711593|P4|COMPLETED|Overall Study||12
2326625|NCT01829048|5711594|P3|COMPLETED|Overall Study||7
2326626|NCT01829048|5711595|P2|COMPLETED|Overall Study||8
2326627|NCT01829048|5711596|P1|COMPLETED|Overall Study||6
2326628|NCT01829048|5711592|P5|STARTED|Overall Study||2
2326629|NCT01829048|5711593|P4|STARTED|Overall Study||14
2326630|NCT01829048|5711594|P3|STARTED|Overall Study||7
2326631|NCT01829048|5711595|P2|STARTED|Overall Study||8
2326632|NCT01829048|5711596|P1|STARTED|Overall Study||6
2326633|NCT01828983|5711670|P2|NOT COMPLETED|Overall Study||0
2326634|NCT01828983|5711671|P1|NOT COMPLETED|Overall Study||0
2326635|NCT01828983|5711670|P2|COMPLETED|Overall Study||81
2326636|NCT01828983|5711671|P1|COMPLETED|Overall Study||80
2326637|NCT01828983|5711670|P2|STARTED|Overall Study||81
2326638|NCT01828983|5711671|P1|STARTED|Overall Study||80
2326639|NCT01828593|5711684|P3|NOT COMPLETED|Placebo-Free Phase||6
2326640|NCT01828593|5711685|P2|NOT COMPLETED|Placebo-Free Phase||6
2326641|NCT01828593|5711686|P1|NOT COMPLETED|Placebo-Free Phase||0
2326642|NCT01828593|5711684|P3|COMPLETED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|41
2326643|NCT01828593|5711685|P2|COMPLETED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|49
2326644|NCT01828593|5711686|P1|COMPLETED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
2326645|NCT01828593|5711684|P3|STARTED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|47
2326646|NCT01828593|5711685|P2|STARTED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|55
2326647|NCT01828593|5711686|P1|STARTED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
2326648|NCT01828593|5711684|P3|NOT COMPLETED|Placebo-Controlled Phase||1
2326649|NCT01828593|5711685|P2|NOT COMPLETED|Placebo-Controlled Phase||0
2326650|NCT01828593|5711686|P1|NOT COMPLETED|Placebo-Controlled Phase||0
2326651|NCT01828593|5711684|P3|COMPLETED|Placebo-Controlled Phase||32
2326652|NCT01828593|5711685|P2|COMPLETED|Placebo-Controlled Phase||34
2326653|NCT01828593|5711686|P1|COMPLETED|Placebo-Controlled Phase||36
2326654|NCT01828593|5711684|P3|STARTED|Placebo-Controlled Phase||33
2326655|NCT01828593|5711685|P2|STARTED|Placebo-Controlled Phase||34
2326656|NCT01828593|5711686|P1|STARTED|Placebo-Controlled Phase||36
2326657|NCT01828567|5711709|P2|NOT COMPLETED|Overall Study||10
2326658|NCT01828567|5711710|P1|NOT COMPLETED|Overall Study||31
2326659|NCT01828567|5711709|P2|COMPLETED|Overall Study||199
2326660|NCT01828567|5711710|P1|COMPLETED|Overall Study||177
2326661|NCT01828567|5711709|P2|1 Month|Overall Study||192
2326662|NCT01828567|5711710|P1|1 Month|Overall Study||172
2326663|NCT01828567|5711709|P2|STARTED|Overall Study||209
2326664|NCT01828567|5711710|P1|STARTED|Overall Study||208
2326665|NCT01828554|5711726|P1|NOT COMPLETED|Overall Study||0
2326666|NCT01828554|5711726|P1|COMPLETED|Overall Study||8
2326667|NCT01828554|5711726|P1|STARTED|Overall Study||8
2326668|NCT01828515|5711733|P2|NOT COMPLETED|Second Intervention (19 Days)||3
2326669|NCT01828515|5711734|P1|NOT COMPLETED|Second Intervention (19 Days)||0
2326670|NCT01828515|5711733|P2|COMPLETED|Second Intervention (19 Days)||5
2326671|NCT01828515|5711734|P1|COMPLETED|Second Intervention (19 Days)||6
2326672|NCT01828515|5711733|P2|STARTED|Second Intervention (19 Days)||8
2326673|NCT01828515|5711734|P1|STARTED|Second Intervention (19 Days)||6
2326674|NCT01828515|5711733|P2|NOT COMPLETED|Washout (23 Days)||1
2326675|NCT01828515|5711734|P1|NOT COMPLETED|Washout (23 Days)||5
2326676|NCT01828515|5711733|P2|COMPLETED|Washout (23 Days)||8
2326677|NCT01828515|5711734|P1|COMPLETED|Washout (23 Days)||6
2326678|NCT01828515|5711733|P2|STARTED|Washout (23 Days)||9
2326679|NCT01828515|5711734|P1|STARTED|Washout (23 Days)||11
2326680|NCT01828515|5711733|P2|NOT COMPLETED|First Intervention (19 Days)||2
2326681|NCT01828515|5711734|P1|NOT COMPLETED|First Intervention (19 Days)||2
2326682|NCT01828515|5711733|P2|COMPLETED|First Intervention (19 Days)||9
2326683|NCT01828515|5711734|P1|COMPLETED|First Intervention (19 Days)||11
2326684|NCT01828515|5711733|P2|STARTED|First Intervention (19 Days)||11
2326685|NCT01828515|5711734|P1|STARTED|First Intervention (19 Days)||13
2326686|NCT01828476|5711742|P2|NOT COMPLETED|Overall Study||0
2326687|NCT01828476|5711743|P1|NOT COMPLETED|Overall Study||0
2326688|NCT01828476|5711742|P2|COMPLETED|Overall Study||0
2326689|NCT01828476|5711743|P1|COMPLETED|Overall Study||13
2326690|NCT01828476|5711742|P2|STARTED|Overall Study||0
2326691|NCT01828476|5711743|P1|STARTED|Overall Study||13
2326692|NCT01828281|5711765|P2|NOT COMPLETED|Overall Study||0
2326693|NCT01828281|5711766|P1|NOT COMPLETED|Overall Study||1
2326694|NCT01828281|5711765|P2|COMPLETED|Overall Study||45
2326695|NCT01828281|5711766|P1|COMPLETED|Overall Study||44
2326696|NCT01828281|5711765|P2|STARTED|Overall Study||45
2326697|NCT01828281|5711766|P1|STARTED|Overall Study||45
2326698|NCT01828216|5711778|P2|NOT COMPLETED|Overall Study||0
2326699|NCT01828216|5711779|P1|NOT COMPLETED|Overall Study||0
2326700|NCT01828216|5711778|P2|COMPLETED|Overall Study||157
2326701|NCT01828216|5711779|P1|COMPLETED|Overall Study||159
2326702|NCT01828216|5711778|P2|STARTED|Overall Study||157
2326703|NCT01828216|5711779|P1|STARTED|Overall Study||159
2326704|NCT01828164|5711787|P1|NOT COMPLETED|Overall Study||17
2326705|NCT01828164|5711787|P1|COMPLETED|Overall Study||32
2326706|NCT01828164|5711787|P1|STARTED|Overall Study|11 out of 60 subjects did not meet inclusion criteria after enrollment.|49
2326707|NCT01828112|5711799|P2|NOT COMPLETED|Overall Study||108
2326708|NCT01828112|5711800|P1|NOT COMPLETED|Overall Study||82
2326709|NCT01828112|5711799|P2|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|8
2326710|NCT01828112|5711800|P1|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|33
2326711|NCT01828112|5711799|P2|Treated|Overall Study||113
2326712|NCT01828112|5711800|P1|Treated|Overall Study||115
2326713|NCT01828112|5711799|P2|Untreated|Overall Study||3
2326714|NCT01828112|5711800|P1|Untreated|Overall Study||0
2326715|NCT01828112|5711799|P2|Untreated Patients|Overall Study|untreated = did not receive study drug|3
2326716|NCT01828112|5711800|P1|Untreated Patients|Overall Study||0
2326717|NCT01828112|5711799|P2|Discontinued From Study|Overall Study||10
2326718|NCT01828112|5711800|P1|Discontinued From Study|Overall Study||14
2326719|NCT01828112|5711799|P2|Entered Survival Follow-up Phase|Overall Study||19
2326720|NCT01828112|5711800|P1|Entered Survival Follow-up Phase|Overall Study||61
2326721|NCT01828112|5711799|P2|Entered Post-treatment Follow-up Phase|Overall Study||5
2326722|NCT01828112|5711800|P1|Entered Post-treatment Follow-up Phase|Overall Study||7
2326723|NCT01828112|5711799|P2|Entered Extension Treatment Phase|Overall Study||74
2326724|NCT01828112|5711800|P1|Entered Extension Treatment Phase|Overall Study||0
2326725|NCT01828112|5711799|P2|STARTED|Overall Study||116
2326726|NCT01828112|5711800|P1|STARTED|Overall Study||115
2326727|NCT01828099|5711808|P2|NOT COMPLETED|Overall Study||157
2326728|NCT01828099|5711809|P1|NOT COMPLETED|Overall Study||94
2326729|NCT01828099|5711808|P2|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|30
2326730|NCT01828099|5711809|P1|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|95
2326731|NCT01828099|5711808|P2|Discontinued From Study|Overall Study||29
2326732|NCT01828099|5711809|P1|Discontinued From Study|Overall Study||20
2326733|NCT01828099|5711808|P2|Entered Survival Follow-up Phase|Overall Study||31
2326734|NCT01828099|5711809|P1|Entered Survival Follow-up Phase|Overall Study||64
2326735|NCT01828099|5711808|P2|Entered Post-treatment Follow-up Phase|Overall Study||16
2326736|NCT01828099|5711809|P1|Entered Post-treatment Follow-up Phase|Overall Study||10
2326737|NCT01828099|5711808|P2|Entered Extension-treatment Phase|Overall Study||81
2326738|NCT01828099|5711809|P1|Entered Extension-treatment Phase|Overall Study||0
2326739|NCT01828099|5711808|P2|Discontinued From Treatment Phase|Overall Study||157
2326740|NCT01828099|5711809|P1|Discontinued From Treatment Phase|Overall Study||94
2326741|NCT01828099|5711808|P2|Treated|Overall Study||175
2326742|NCT01828099|5711809|P1|Treated|Overall Study|discontinued from treatment phase = Not completed|189
2326743|NCT01828099|5711808|P2|Untreated Patients|Overall Study||12
2326744|NCT01828099|5711809|P1|Untreated Patients|Overall Study||0
2326745|NCT01828099|5711808|P2|STARTED|Overall Study||187
2326746|NCT01828099|5711809|P1|STARTED|Overall Study||189
2326753|NCT01827839|5711838|P1|NOT COMPLETED|Overall Study||3
2326754|NCT01827839|5711838|P1|COMPLETED|Overall Study||93
2326755|NCT01827839|5711838|P1|STARTED|Overall Study||96
2326756|NCT01827787|5711862|P2|NOT COMPLETED|Overall Study||0
2326757|NCT01827787|5711863|P1|NOT COMPLETED|Overall Study||0
2326758|NCT01827787|5711862|P2|COMPLETED|Overall Study||38
2326759|NCT01827787|5711863|P1|COMPLETED|Overall Study||45
2326760|NCT01827787|5711862|P2|STARTED|Overall Study||38
2326761|NCT01827787|5711863|P1|STARTED|Overall Study||45
2326762|NCT01827670|5711883|P2|NOT COMPLETED|Overall Study||3
2326763|NCT01827670|5711884|P1|NOT COMPLETED|Overall Study||3
2326764|NCT01827670|5711883|P2|COMPLETED|Overall Study||56
2326765|NCT01827670|5711884|P1|COMPLETED|Overall Study||57
2326766|NCT01827670|5711883|P2|STARTED|Overall Study||59
2326767|NCT01827670|5711884|P1|STARTED|Overall Study||60
2326768|NCT01827592|5711903|P3|NOT COMPLETED|Overall Study||76
2326769|NCT01827592|5711904|P2|NOT COMPLETED|Overall Study||80
2326770|NCT01827592|5711905|P1|NOT COMPLETED|Overall Study||74
2326771|NCT01827592|5711903|P3|COMPLETED|Overall Study||48
2326772|NCT01827592|5711904|P2|COMPLETED|Overall Study||46
2326773|NCT01827592|5711905|P1|COMPLETED|Overall Study||52
2326774|NCT01827592|5711903|P3|Safety Analysis Set|Overall Study||124
2326775|NCT01827592|5711904|P2|Safety Analysis Set|Overall Study||126
2326776|NCT01827592|5711905|P1|Safety Analysis Set|Overall Study|1 patient withdrew consent before getting the treatment.|125
2326777|NCT01827592|5711903|P3|STARTED|Overall Study|Randomized patients.|124
2326778|NCT01827592|5711904|P2|STARTED|Overall Study|Randomized patients.|126
2326779|NCT01827592|5711905|P1|STARTED|Overall Study|Randomized patients.|126
2326780|NCT01827475|5711937|P3|NOT COMPLETED|Overall Study||0
2326781|NCT01827475|5711938|P2|NOT COMPLETED|Overall Study||0
2326782|NCT01827475|5711939|P1|NOT COMPLETED|Overall Study||0
2326783|NCT01827475|5711937|P3|COMPLETED|Overall Study||30
2326784|NCT01827475|5711938|P2|COMPLETED|Overall Study||30
2326785|NCT01827475|5711939|P1|COMPLETED|Overall Study||30
2326786|NCT01827475|5711937|P3|STARTED|Overall Study||30
2326787|NCT01827475|5711938|P2|STARTED|Overall Study||30
2326788|NCT01827475|5711939|P1|STARTED|Overall Study||30
2326789|NCT01827462|5711953|P3|NOT COMPLETED|Overall Study||28
2326790|NCT01827462|5711954|P2|NOT COMPLETED|Overall Study||18
2326791|NCT01827462|5711955|P1|NOT COMPLETED|Overall Study||41
2326792|NCT01827462|5711953|P3|COMPLETED|Overall Study||12
2326793|NCT01827462|5711954|P2|COMPLETED|Overall Study||19
2326794|NCT01827462|5711955|P1|COMPLETED|Overall Study||18
2326795|NCT01827462|5711953|P3|STARTED|Overall Study||40
2326796|NCT01827462|5711954|P2|STARTED|Overall Study||37
2326797|NCT01827462|5711955|P1|STARTED|Overall Study||59
2326798|NCT01827371|5711970|P4|NOT COMPLETED|Overall Study||23
2326799|NCT01827371|5711971|P3|NOT COMPLETED|Overall Study||11
2326800|NCT01827371|5711972|P2|NOT COMPLETED|Overall Study||7
2326801|NCT01827371|5711973|P1|NOT COMPLETED|Overall Study||13
2326802|NCT01827371|5711970|P4|COMPLETED|Overall Study||97
2326803|NCT01827371|5711971|P3|COMPLETED|Overall Study||93
2326804|NCT01827371|5711972|P2|COMPLETED|Overall Study||89
2326805|NCT01827371|5711973|P1|COMPLETED|Overall Study||102
2326806|NCT01827371|5711970|P4|STARTED|Overall Study||120
2326807|NCT01827371|5711971|P3|STARTED|Overall Study||104
2326808|NCT01827371|5711972|P2|STARTED|Overall Study||96
2326809|NCT01827371|5711973|P1|STARTED|Overall Study||115
2326810|NCT01827358|5711997|P2|NOT COMPLETED|Overall Study||31
2326811|NCT01827358|5711998|P1|NOT COMPLETED|Overall Study||35
2326812|NCT01827358|5711997|P2|COMPLETED|Overall Study||44
2326813|NCT01827358|5711998|P1|COMPLETED|Overall Study||45
2326814|NCT01827358|5711997|P2|STARTED|Overall Study||75
2326815|NCT01827358|5711998|P1|STARTED|Overall Study||80
2326816|NCT01827332|5712032|P2|NOT COMPLETED|Overall Study||1
2326817|NCT01827332|5712033|P1|NOT COMPLETED|Overall Study||2
2326818|NCT01827332|5712032|P2|COMPLETED|Overall Study||7
2326819|NCT01827332|5712033|P1|COMPLETED|Overall Study||6
2326820|NCT01827332|5712032|P2|STARTED|Overall Study||8
2326821|NCT01827332|5712033|P1|STARTED|Overall Study||8
2326822|NCT01827319|5712041|P1|NOT COMPLETED|Overall Study||3
2326823|NCT01827319|5712041|P1|COMPLETED|Overall Study||200
2326824|NCT01827319|5712041|P1|STARTED|Overall Study||203
2326825|NCT01827306|5712049|P2|NOT COMPLETED|Overall Study||5
2326826|NCT01827306|5712050|P1|NOT COMPLETED|Overall Study||11
2326827|NCT01827306|5712049|P2|COMPLETED|Overall Study||8
2326828|NCT01827306|5712050|P1|COMPLETED|Overall Study||10
2326829|NCT01827306|5712049|P2|STARTED|Overall Study||13
2326830|NCT01827306|5712050|P1|STARTED|Overall Study||21
2326831|NCT01827267|5712064|P2|NOT COMPLETED|Overall Study||12
2326832|NCT01827267|5712065|P1|NOT COMPLETED|Overall Study||5
2326833|NCT01827267|5712064|P2|COMPLETED|Overall Study||32
2326834|NCT01827267|5712065|P1|COMPLETED|Overall Study||13
2326835|NCT01827267|5712064|P2|Crossed Over to Neratinib + Temsirolimus|Overall Study||0
2326836|NCT01827267|5712065|P1|Crossed Over to Neratinib + Temsirolimus|Overall Study||11
2326837|NCT01827267|5712064|P2|Received Study Drug|Overall Study||43
2326838|NCT01827267|5712065|P1|Received Study Drug|Overall Study||17
2326839|NCT01827267|5712064|P2|STARTED|Overall Study|44 subjects were randomized; 43 subjects were treated.|44
2326840|NCT01827267|5712065|P1|STARTED|Overall Study|18 subjects were randomized but 17 received treatment.|18
2326841|NCT01827254|5712080|P1|NOT COMPLETED|Overall Study||59
2326842|NCT01827254|5712080|P1|COMPLETED|Overall Study||2
2326843|NCT01827254|5712080|P1|Evaluable Population|Overall Study||52
2326844|NCT01827254|5712080|P1|STARTED|Overall Study||61
2326845|NCT01827163|5712090|P1|NOT COMPLETED|Overall Study||11
2326846|NCT01827163|5712090|P1|COMPLETED|Overall Study||9
2326847|NCT01827163|5712090|P1|STARTED|Overall Study||20
2326848|NCT01827046|5712097|P2|NOT COMPLETED|Overall Study||9
2326849|NCT01827046|5712098|P1|NOT COMPLETED|Overall Study||1
2326850|NCT01827046|5712097|P2|COMPLETED|Overall Study||240
2326851|NCT01827046|5712098|P1|COMPLETED|Overall Study||249
2326852|NCT01827046|5712097|P2|STARTED|Overall Study||249
2326853|NCT01827046|5712098|P1|STARTED|Overall Study||250
2326854|NCT01826981|5712153|P15|NOT COMPLETED|Overall Study||0
2326855|NCT01826981|5712154|P14|NOT COMPLETED|Overall Study||5
2326856|NCT01826981|5712155|P13|NOT COMPLETED|Overall Study||1
2326857|NCT01826981|5712156|P12|NOT COMPLETED|Overall Study||2
2326858|NCT01826981|5712157|P11|NOT COMPLETED|Overall Study||2
2326859|NCT01826981|5712158|P10|NOT COMPLETED|Overall Study||1
2326860|NCT01826981|5712159|P9|NOT COMPLETED|Overall Study||7
2326861|NCT01826981|5712160|P8|NOT COMPLETED|Overall Study||11
2326862|NCT01826981|5712161|P7|NOT COMPLETED|Overall Study||1
2326863|NCT01826981|5712162|P6|NOT COMPLETED|Overall Study||1
2326864|NCT01826981|5712163|P5|NOT COMPLETED|Overall Study||7
2326865|NCT01826981|5712164|P4|NOT COMPLETED|Overall Study||0
2326866|NCT01826981|5712165|P3|NOT COMPLETED|Overall Study||0
2326867|NCT01826981|5712166|P2|NOT COMPLETED|Overall Study||1
2326868|NCT01826981|5712167|P1|NOT COMPLETED|Overall Study||0
2326869|NCT01826981|5712153|P15|COMPLETED|Overall Study||8
2326870|NCT01826981|5712154|P14|COMPLETED|Overall Study||15
2326871|NCT01826981|5712155|P13|COMPLETED|Overall Study||25
2326872|NCT01826981|5712156|P12|COMPLETED|Overall Study||25
2326873|NCT01826981|5712157|P11|COMPLETED|Overall Study||22
2326874|NCT01826981|5712158|P10|COMPLETED|Overall Study||26
2326875|NCT01826981|5712159|P9|COMPLETED|Overall Study||13
2326876|NCT01826981|5712160|P8|COMPLETED|Overall Study||40
2326877|NCT01826981|5712161|P7|COMPLETED|Overall Study||24
2326878|NCT01826981|5712162|P6|COMPLETED|Overall Study||25
2326879|NCT01826981|5712163|P5|COMPLETED|Overall Study||18
2326880|NCT01826981|5712164|P4|COMPLETED|Overall Study||26
2326881|NCT01826981|5712165|P3|COMPLETED|Overall Study||25
2326882|NCT01826981|5712166|P2|COMPLETED|Overall Study||9
2326883|NCT01826981|5712167|P1|COMPLETED|Overall Study||19
2326884|NCT01826981|5712153|P15|STARTED|Overall Study||8
2326885|NCT01826981|5712154|P14|STARTED|Overall Study||20
2326886|NCT01826981|5712155|P13|STARTED|Overall Study||26
2326887|NCT01826981|5712156|P12|STARTED|Overall Study||27
2326888|NCT01826981|5712157|P11|STARTED|Overall Study||24
2326889|NCT01826981|5712158|P10|STARTED|Overall Study||27
2326890|NCT01826981|5712159|P9|STARTED|Overall Study||20
2326891|NCT01826981|5712160|P8|STARTED|Overall Study||51
2326892|NCT01826981|5712161|P7|STARTED|Overall Study||25
2326893|NCT01826981|5712162|P6|STARTED|Overall Study||26
2326894|NCT01826981|5712163|P5|STARTED|Overall Study||25
2326895|NCT01826981|5712164|P4|STARTED|Overall Study||26
2326896|NCT01826981|5712165|P3|STARTED|Overall Study||25
2326897|NCT01826981|5712166|P2|STARTED|Overall Study||10
2326898|NCT01826981|5712167|P1|STARTED|Overall Study||19
2326899|NCT01826851|5712315|P2|NOT COMPLETED|Overall Study||0
2326900|NCT01826851|5712316|P1|NOT COMPLETED|Overall Study||0
2326901|NCT01826851|5712315|P2|COMPLETED|Overall Study||41
2326902|NCT01826851|5712316|P1|COMPLETED|Overall Study||38
2326903|NCT01826851|5712315|P2|STARTED|Overall Study||41
2326904|NCT01826851|5712316|P1|STARTED|Overall Study||38
2326905|NCT01826812|5712336|P2|NOT COMPLETED|Overall Study||1
2326906|NCT01826812|5712337|P1|NOT COMPLETED|Overall Study||0
2326907|NCT01826812|5712336|P2|COMPLETED|Overall Study||32
2326908|NCT01826812|5712337|P1|COMPLETED|Overall Study||167
2326909|NCT01826812|5712336|P2|STARTED|Overall Study||33
2326910|NCT01826812|5712337|P1|STARTED|Overall Study||167
2326911|NCT01826604|5712353|P2|NOT COMPLETED|Overall Study||9
2326912|NCT01826604|5712354|P1|NOT COMPLETED|Overall Study||8
2326913|NCT01826604|5712353|P2|COMPLETED|Overall Study||148
2326914|NCT01826604|5712354|P1|COMPLETED|Overall Study||136
2326915|NCT01826604|5712353|P2|STARTED|Overall Study||157
2326916|NCT01826604|5712354|P1|STARTED|Overall Study||144
2326917|NCT01826513|5712365|P3|NOT COMPLETED|Overall Study||0
2326918|NCT01826513|5712366|P2|NOT COMPLETED|Overall Study||0
2326919|NCT01826513|5712367|P1|NOT COMPLETED|Overall Study||0
2326920|NCT01826513|5712365|P3|COMPLETED|Overall Study||10
2326921|NCT01826513|5712366|P2|COMPLETED|Overall Study||10
2326922|NCT01826513|5712367|P1|COMPLETED|Overall Study||5
2326923|NCT01826513|5712365|P3|STARTED|Overall Study||10
2326924|NCT01826513|5712366|P2|STARTED|Overall Study||10
2326925|NCT01826513|5712367|P1|STARTED|Overall Study||5
2326926|NCT01826422|5712398|P2|NOT COMPLETED|Overall Study||3
2326927|NCT01826422|5712399|P1|NOT COMPLETED|Overall Study||1
2326928|NCT01826422|5712398|P2|COMPLETED|Overall Study||19
2326929|NCT01826422|5712399|P1|COMPLETED|Overall Study||17
2326930|NCT01826422|5712398|P2|STARTED|Overall Study||22
2326931|NCT01826422|5712399|P1|STARTED|Overall Study||18
2326932|NCT01826370|5712443|P1|NOT COMPLETED|Overall Study||20
2326933|NCT01826370|5712443|P1|COMPLETED|Overall Study||658
2326934|NCT01826370|5712443|P1|STARTED|Overall Study||678
2326935|NCT01826227|5712449|P1|NOT COMPLETED|Overall Study||0
2326936|NCT01826227|5712449|P1|COMPLETED|Overall Study||5
2326937|NCT01826227|5712449|P1|STARTED|Overall Study||5
2326938|NCT01826214|5712455|P2|NOT COMPLETED|Overall Study||34
2326939|NCT01826214|5712456|P1|NOT COMPLETED|Overall Study||35
2326940|NCT01826214|5712455|P2|COMPLETED|Overall Study||0
2326941|NCT01826214|5712456|P1|COMPLETED|Overall Study||0
2326942|NCT01826214|5712455|P2|Treated|Overall Study|Treated = received at least one dose of study drug|34
2326943|NCT01826214|5712456|P1|Treated|Overall Study|Treated = received at least one dose of study drug|35
2326944|NCT01826214|5712455|P2|Untreated|Overall Study|Untreated = did not receive study drug|1
2326945|NCT01826214|5712456|P1|Untreated|Overall Study|Untreated = did not receive study drug|0
2326946|NCT01826214|5712455|P2|STARTED|Overall Study|35 patients were randomized but only 34 patients received at least one dose of study drug|34
2326947|NCT01826214|5712456|P1|STARTED|Overall Study||35
2326948|NCT01826201|5712474|P1|NOT COMPLETED|Overall Study||4
2326949|NCT01826201|5712474|P1|COMPLETED|Overall Study||17
2326950|NCT01826201|5712474|P1|STARTED|Overall Study|Subjects in each arm are same|21
2326951|NCT01825941|5712482|P2|NOT COMPLETED|Overall Study||1
2326952|NCT01825941|5712483|P1|NOT COMPLETED|Overall Study||4
2326953|NCT01825941|5712482|P2|COMPLETED|Overall Study||103
2326954|NCT01825941|5712483|P1|COMPLETED|Overall Study||100
2326955|NCT01825941|5712482|P2|STARTED|Overall Study||104
2326956|NCT01825941|5712483|P1|STARTED|Overall Study||104
2326957|NCT01825889|5712491|P2|NOT COMPLETED|Overall Study||0
2326958|NCT01825889|5712492|P1|NOT COMPLETED|Overall Study||0
2326959|NCT01825889|5712491|P2|COMPLETED|Overall Study||10
2326960|NCT01825889|5712492|P1|COMPLETED|Overall Study||10
2326961|NCT01825889|5712491|P2|Received One Dose of Study Drug|Overall Study||10
2326962|NCT01825889|5712492|P1|Received One Dose of Study Drug|Overall Study||10
2326963|NCT01825889|5712491|P2|STARTED|Overall Study||10
2326964|NCT01825889|5712492|P1|STARTED|Overall Study||10
2326965|NCT01825876|5712502|P2|NOT COMPLETED|Period 2||1
2326966|NCT01825876|5712503|P1|NOT COMPLETED|Period 2||0
2326967|NCT01825876|5712502|P2|COMPLETED|Period 2||16
2326968|NCT01825876|5712503|P1|COMPLETED|Period 2||0
2326969|NCT01825876|5712502|P2|Received 1 Dose of Study Drug|Period 2||17
2326970|NCT01825876|5712503|P1|Received 1 Dose of Study Drug|Period 2||0
2326971|NCT01825876|5712502|P2|STARTED|Period 2|Participants received a different treatment in Period 1.|17
2326972|NCT01825876|5712503|P1|STARTED|Period 2|Participants received a different treatment in Period 2.|0
2326973|NCT01825876|5712502|P2|NOT COMPLETED|Period 1||0
2326974|NCT01825876|5712503|P1|NOT COMPLETED|Period 1||0
2326975|NCT01825876|5712502|P2|COMPLETED|Period 1||0
2326976|NCT01825876|5712503|P1|COMPLETED|Period 1||17
2326977|NCT01825876|5712502|P2|Received 1 Dose of Study Drug|Period 1||0
2326978|NCT01825876|5712503|P1|Received 1 Dose of Study Drug|Period 1||17
2326979|NCT01825876|5712502|P2|STARTED|Period 1||0
2326980|NCT01825876|5712503|P1|STARTED|Period 1||17
2326981|NCT01825837|5712524|P4|NOT COMPLETED|PART II||0
2326982|NCT01825837|5712525|P3|NOT COMPLETED|PART II||19
2326983|NCT01825837|5712526|P2|NOT COMPLETED|PART II||14
2326984|NCT01825837|5712527|P1|NOT COMPLETED|PART II||19
2326985|NCT01825837|5712524|P4|COMPLETED|PART II||0
2326986|NCT01825837|5712525|P3|COMPLETED|PART II||7
2326987|NCT01825837|5712526|P2|COMPLETED|PART II||12
2326988|NCT01825837|5712527|P1|COMPLETED|PART II||16
2326989|NCT01825837|5712524|P4|Per-Protocol Population|PART II||0
2326990|NCT01825837|5712525|P3|Per-Protocol Population|PART II||24
2326991|NCT01825837|5712526|P2|Per-Protocol Population|PART II||23
2326992|NCT01825837|5712527|P1|Per-Protocol Population|PART II||32
2326993|NCT01825837|5712524|P4|Intent-to-Treat Population|PART II||0
2326994|NCT01825837|5712525|P3|Intent-to-Treat Population|PART II||26
2326995|NCT01825837|5712526|P2|Intent-to-Treat Population|PART II||25
2326996|NCT01825837|5712527|P1|Intent-to-Treat Population|PART II||34
2326997|NCT01825837|5712524|P4|Safety Population (Double-Blind)|PART II||0
2326998|NCT01825837|5712525|P3|Safety Population (Double-Blind)|PART II||26
2326999|NCT01825837|5712526|P2|Safety Population (Double-Blind)|PART II||26
2327000|NCT01825837|5712527|P1|Safety Population (Double-Blind)|PART II||35
2327001|NCT01825837|5712524|P4|Randomized Patients|PART II||0
2327002|NCT01825837|5712525|P3|Randomized Patients|PART II||26
2327003|NCT01825837|5712526|P2|Randomized Patients|PART II||26
2327004|NCT01825837|5712527|P1|Randomized Patients|PART II||35
2327005|NCT01825837|5712524|P4|STARTED|PART II||0
2327006|NCT01825837|5712525|P3|STARTED|PART II||26
2327007|NCT01825837|5712526|P2|STARTED|PART II||26
2327008|NCT01825837|5712527|P1|STARTED|PART II||35
2327009|NCT01825837|5712524|P4|NOT COMPLETED|PART I||17
2327010|NCT01825837|5712525|P3|NOT COMPLETED|PART I||0
2327011|NCT01825837|5712526|P2|NOT COMPLETED|PART I||0
2327012|NCT01825837|5712527|P1|NOT COMPLETED|PART I||0
2327013|NCT01825837|5712524|P4|COMPLETED|PART I||87
2327014|NCT01825837|5712525|P3|COMPLETED|PART I||0
2327015|NCT01825837|5712526|P2|COMPLETED|PART I||0
2327016|NCT01825837|5712527|P1|COMPLETED|PART I||0
2327017|NCT01825837|5712524|P4|Safety Population (Open-Label)|PART I||104
2327018|NCT01825837|5712525|P3|Safety Population (Open-Label)|PART I||0
2327019|NCT01825837|5712526|P2|Safety Population (Open-Label)|PART I||0
2327020|NCT01825837|5712527|P1|Safety Population (Open-Label)|PART I||0
2327021|NCT01825837|5712524|P4|Enrolled|PART I||104
2327022|NCT01825837|5712525|P3|Enrolled|PART I||0
2327023|NCT01825837|5712526|P2|Enrolled|PART I||0
2327024|NCT01825837|5712527|P1|Enrolled|PART I||0
2327025|NCT01825837|5712524|P4|STARTED|PART I||104
2327026|NCT01825837|5712525|P3|STARTED|PART I||0
2327027|NCT01825837|5712526|P2|STARTED|PART I||0
2327028|NCT01825837|5712527|P1|STARTED|PART I||0
2327029|NCT01825798|5712537|P2|NOT COMPLETED|Overall Study||5
2327030|NCT01825798|5712538|P1|NOT COMPLETED|Overall Study||2
2327031|NCT01825798|5712537|P2|COMPLETED|Overall Study||23
2327032|NCT01825798|5712538|P1|COMPLETED|Overall Study||30
2327033|NCT01825798|5712537|P2|STARTED|Overall Study||28
2327034|NCT01825798|5712538|P1|STARTED|Overall Study||32
2327035|NCT01825785|5712573|P7|NOT COMPLETED|Overall Study||0
2327036|NCT01825785|5712574|P6|NOT COMPLETED|Overall Study||1
2327037|NCT01825785|5712575|P5|NOT COMPLETED|Overall Study||2
2327038|NCT01825785|5712576|P4|NOT COMPLETED|Overall Study||0
2327039|NCT01825785|5712577|P3|NOT COMPLETED|Overall Study||0
2327040|NCT01825785|5712578|P2|NOT COMPLETED|Overall Study||0
2327041|NCT01825785|5712579|P1|NOT COMPLETED|Overall Study||0
2327042|NCT01825785|5712573|P7|COMPLETED|Overall Study||6
2327043|NCT01825785|5712574|P6|COMPLETED|Overall Study||5
2327044|NCT01825785|5712575|P5|COMPLETED|Overall Study||4
2327045|NCT01825785|5712576|P4|COMPLETED|Overall Study||6
2327046|NCT01825785|5712577|P3|COMPLETED|Overall Study||6
2327047|NCT01825785|5712578|P2|COMPLETED|Overall Study||6
2327048|NCT01825785|5712579|P1|COMPLETED|Overall Study||12
2327049|NCT01825785|5712573|P7|STARTED|Overall Study||6
2327050|NCT01825785|5712574|P6|STARTED|Overall Study||6
2327051|NCT01825785|5712575|P5|STARTED|Overall Study||6
2327052|NCT01825785|5712576|P4|STARTED|Overall Study||6
2327053|NCT01825785|5712577|P3|STARTED|Overall Study||6
2327054|NCT01825785|5712578|P2|STARTED|Overall Study||6
2327055|NCT01825785|5712579|P1|STARTED|Overall Study||12
2327056|NCT01825655|5712725|P2|NOT COMPLETED|Overall Study||0
2327057|NCT01825655|5712726|P1|NOT COMPLETED|Overall Study||0
2327058|NCT01825655|5712725|P2|COMPLETED|Overall Study||2
2327059|NCT01825655|5712726|P1|COMPLETED|Overall Study||0
2327060|NCT01825655|5712725|P2|STARTED|Overall Study||2
2327061|NCT01825655|5712726|P1|STARTED|Overall Study||0
2327062|NCT01825577|5712732|P1|NOT COMPLETED|Overall Study||8
2327063|NCT01825577|5712732|P1|COMPLETED|Overall Study||6
2327064|NCT01825577|5712732|P1|STARTED|Overall Study||14
2327065|NCT01825408|5712741|P4|NOT COMPLETED|Overall Study||0
2327066|NCT01825408|5712742|P3|NOT COMPLETED|Overall Study||0
2327067|NCT01825408|5712743|P2|NOT COMPLETED|Overall Study||0
2327068|NCT01825408|5712744|P1|NOT COMPLETED|Overall Study||0
2327069|NCT01825408|5712741|P4|COMPLETED|Overall Study||12
2327070|NCT01825408|5712742|P3|COMPLETED|Overall Study||14
2327071|NCT01825408|5712743|P2|COMPLETED|Overall Study||7
2327072|NCT01825408|5712744|P1|COMPLETED|Overall Study||7
2327073|NCT01825408|5712741|P4|STARTED|Overall Study||12
2327074|NCT01825408|5712742|P3|STARTED|Overall Study||14
2327075|NCT01825408|5712743|P2|STARTED|Overall Study||7
2327076|NCT01825408|5712744|P1|STARTED|Overall Study||7
2327077|NCT01825200|5712756|P2|NOT COMPLETED|Overall Study||7
2327078|NCT01825200|5712757|P1|NOT COMPLETED|Overall Study||5
2327079|NCT01825200|5712756|P2|COMPLETED|Overall Study||1314
2327080|NCT01825200|5712757|P1|COMPLETED|Overall Study||1314
2327081|NCT01825200|5712756|P2|STARTED|Overall Study||1321
2327082|NCT01825200|5712757|P1|STARTED|Overall Study||1319
2327083|NCT01825122|5712771|P2|NOT COMPLETED|Overall Study||19
2327084|NCT01825122|5712772|P1|NOT COMPLETED|Overall Study||10
2327085|NCT01825122|5712771|P2|COMPLETED|Overall Study||59
2327086|NCT01825122|5712772|P1|COMPLETED|Overall Study||67
2327087|NCT01825122|5712771|P2|STARTED|Overall Study||78
2327088|NCT01825122|5712772|P1|STARTED|Overall Study||77
2327089|NCT01824979|5712780|P2|NOT COMPLETED|Overall Study||13
2327090|NCT01824979|5712781|P1|NOT COMPLETED|Overall Study||13
2327091|NCT01824979|5712780|P2|COMPLETED|Overall Study||37
2327092|NCT01824979|5712781|P1|COMPLETED|Overall Study||37
2327093|NCT01824979|5712780|P2|STARTED|Overall Study||50
2327094|NCT01824979|5712781|P1|STARTED|Overall Study||50
2327095|NCT01824901|5712789|P4|NOT COMPLETED|Overall Study||0
2327096|NCT01824901|5712790|P3|NOT COMPLETED|Overall Study||0
2327097|NCT01824901|5712791|P2|NOT COMPLETED|Overall Study||0
2327098|NCT01824901|5712792|P1|NOT COMPLETED|Overall Study||0
2327099|NCT01824901|5712789|P4|COMPLETED|Overall Study||0
2327100|NCT01824901|5712790|P3|COMPLETED|Overall Study||0
2327101|NCT01824901|5712791|P2|COMPLETED|Overall Study||0
2327102|NCT01824901|5712792|P1|COMPLETED|Overall Study||2
2327103|NCT01824901|5712789|P4|STARTED|Overall Study||0
2327104|NCT01824901|5712790|P3|STARTED|Overall Study||0
2327105|NCT01824901|5712791|P2|STARTED|Overall Study||0
2327106|NCT01824901|5712792|P1|STARTED|Overall Study||2
2327107|NCT01824823|5712798|P2|NOT COMPLETED|Overall Study||1
2327108|NCT01824823|5712799|P1|NOT COMPLETED|Overall Study||2
2327109|NCT01824823|5712798|P2|COMPLETED|Overall Study||0
2327110|NCT01824823|5712799|P1|COMPLETED|Overall Study||0
2327111|NCT01824823|5712798|P2|STARTED|Overall Study||1
2327112|NCT01824823|5712799|P1|STARTED|Overall Study||2
2327113|NCT01824693|5712808|P3|NOT COMPLETED|Overall Study||15
2327114|NCT01824693|5712809|P2|NOT COMPLETED|Overall Study||7
2327115|NCT01824693|5712810|P1|NOT COMPLETED|Overall Study||1
2327116|NCT01824693|5712808|P3|COMPLETED|Overall Study||0
2327117|NCT01824693|5712809|P2|COMPLETED|Overall Study||2
2327118|NCT01824693|5712810|P1|COMPLETED|Overall Study||5
2327119|NCT01824693|5712808|P3|STARTED|Overall Study||15
2327120|NCT01824693|5712809|P2|STARTED|Overall Study||9
2327121|NCT01824693|5712810|P1|STARTED|Overall Study||6
2327122|NCT01824602|5712827|P4|NOT COMPLETED|Overall Study||5
2327123|NCT01824602|5712828|P3|NOT COMPLETED|Overall Study||4
2327124|NCT01824602|5712829|P2|NOT COMPLETED|Overall Study||0
2327125|NCT01824602|5712830|P1|NOT COMPLETED|Overall Study||1
2327126|NCT01824602|5712827|P4|COMPLETED|Overall Study||5
2327127|NCT01824602|5712828|P3|COMPLETED|Overall Study||5
2327128|NCT01824602|5712829|P2|COMPLETED|Overall Study||8
2327129|NCT01824602|5712830|P1|COMPLETED|Overall Study||10
2327130|NCT01824602|5712827|P4|Intent-to-treat Population|Overall Study||9
2327131|NCT01824602|5712828|P3|Intent-to-treat Population|Overall Study||9
2327132|NCT01824602|5712829|P2|Intent-to-treat Population|Overall Study||8
2327133|NCT01824602|5712830|P1|Intent-to-treat Population|Overall Study||11
2327134|NCT01824602|5712827|P4|Safety Population|Overall Study||10
2327135|NCT01824602|5712828|P3|Safety Population|Overall Study||9
2327136|NCT01824602|5712829|P2|Safety Population|Overall Study||8
2327137|NCT01824602|5712830|P1|Safety Population|Overall Study||11
2327138|NCT01824602|5712827|P4|STARTED|Overall Study||10
2327139|NCT01824602|5712828|P3|STARTED|Overall Study||9
2327140|NCT01824602|5712829|P2|STARTED|Overall Study||8
2327141|NCT01824602|5712830|P1|STARTED|Overall Study||11
2327142|NCT01824589|5712844|P4|NOT COMPLETED|Overall Study||0
2327143|NCT01824589|5712845|P3|NOT COMPLETED|Overall Study||0
2327144|NCT01824589|5712846|P2|NOT COMPLETED|Overall Study||0
2327145|NCT01824589|5712847|P1|NOT COMPLETED|Overall Study||0
2327146|NCT01824589|5712844|P4|COMPLETED|Overall Study||0
2327147|NCT01824589|5712845|P3|COMPLETED|Overall Study||0
2327148|NCT01824589|5712846|P2|COMPLETED|Overall Study||0
2327149|NCT01824589|5712847|P1|COMPLETED|Overall Study||1
2327150|NCT01824589|5712844|P4|STARTED|Overall Study||0
2327151|NCT01824589|5712845|P3|STARTED|Overall Study||0
2327152|NCT01824589|5712846|P2|STARTED|Overall Study||0
2327153|NCT01824589|5712847|P1|STARTED|Overall Study||1
2327154|NCT01824576|5712869|P1|NOT COMPLETED|Overall Study||2
2327155|NCT01824576|5712869|P1|COMPLETED|Overall Study||7
2327156|NCT01824576|5712869|P1|STARTED|Overall Study||9
2327157|NCT01824498|5712887|P6|NOT COMPLETED|3rd Intervention (8 Weeks)||0
2327158|NCT01824498|5712888|P5|NOT COMPLETED|3rd Intervention (8 Weeks)||0
2327159|NCT01824498|5712889|P4|NOT COMPLETED|3rd Intervention (8 Weeks)||0
2327160|NCT01824498|5712890|P3|NOT COMPLETED|3rd Intervention (8 Weeks)||0
2327161|NCT01824498|5712891|P2|NOT COMPLETED|3rd Intervention (8 Weeks)||0
2327162|NCT01824498|5712892|P1|NOT COMPLETED|3rd Intervention (8 Weeks)||0
2327163|NCT01824498|5712887|P6|COMPLETED|3rd Intervention (8 Weeks)||4
2327164|NCT01824498|5712888|P5|COMPLETED|3rd Intervention (8 Weeks)||3
2327165|NCT01824498|5712889|P4|COMPLETED|3rd Intervention (8 Weeks)||2
2327166|NCT01824498|5712890|P3|COMPLETED|3rd Intervention (8 Weeks)||4
2327167|NCT01824498|5712891|P2|COMPLETED|3rd Intervention (8 Weeks)||2
2327168|NCT01824498|5712892|P1|COMPLETED|3rd Intervention (8 Weeks)||3
2327169|NCT01824498|5712887|P6|STARTED|3rd Intervention (8 Weeks)||4
2327170|NCT01824498|5712888|P5|STARTED|3rd Intervention (8 Weeks)||3
2327171|NCT01824498|5712889|P4|STARTED|3rd Intervention (8 Weeks)||2
2327172|NCT01824498|5712890|P3|STARTED|3rd Intervention (8 Weeks)||4
2327173|NCT01824498|5712891|P2|STARTED|3rd Intervention (8 Weeks)||2
2327174|NCT01824498|5712892|P1|STARTED|3rd Intervention (8 Weeks)||3
2327175|NCT01824498|5712887|P6|NOT COMPLETED|Washout (8 Weeks)||0
2327176|NCT01824498|5712888|P5|NOT COMPLETED|Washout (8 Weeks)||0
2327177|NCT01824498|5712889|P4|NOT COMPLETED|Washout (8 Weeks)||0
2327178|NCT01824498|5712890|P3|NOT COMPLETED|Washout (8 Weeks)||0
2327179|NCT01824498|5712891|P2|NOT COMPLETED|Washout (8 Weeks)||0
2327180|NCT01824498|5712892|P1|NOT COMPLETED|Washout (8 Weeks)||0
2327181|NCT01824498|5712887|P6|COMPLETED|Washout (8 Weeks)||4
2327182|NCT01824498|5712888|P5|COMPLETED|Washout (8 Weeks)||3
2327183|NCT01824498|5712889|P4|COMPLETED|Washout (8 Weeks)||2
2327184|NCT01824498|5712890|P3|COMPLETED|Washout (8 Weeks)||4
2327185|NCT01824498|5712891|P2|COMPLETED|Washout (8 Weeks)||2
2327186|NCT01824498|5712892|P1|COMPLETED|Washout (8 Weeks)||3
2327187|NCT01824498|5712887|P6|STARTED|Washout (8 Weeks)||4
2327188|NCT01824498|5712888|P5|STARTED|Washout (8 Weeks)||3
2327189|NCT01824498|5712889|P4|STARTED|Washout (8 Weeks)||2
2327190|NCT01824498|5712890|P3|STARTED|Washout (8 Weeks)||4
2327191|NCT01824498|5712891|P2|STARTED|Washout (8 Weeks)||2
2327192|NCT01824498|5712892|P1|STARTED|Washout (8 Weeks)||3
2327193|NCT01824498|5712887|P6|NOT COMPLETED|2nd Intervention (8 Weeks)||0
2327194|NCT01824498|5712888|P5|NOT COMPLETED|2nd Intervention (8 Weeks)||0
2327195|NCT01824498|5712889|P4|NOT COMPLETED|2nd Intervention (8 Weeks)||0
2327196|NCT01824498|5712890|P3|NOT COMPLETED|2nd Intervention (8 Weeks)||0
2327197|NCT01824498|5712891|P2|NOT COMPLETED|2nd Intervention (8 Weeks)||0
2327198|NCT01824498|5712892|P1|NOT COMPLETED|2nd Intervention (8 Weeks)||0
2327199|NCT01824498|5712887|P6|COMPLETED|2nd Intervention (8 Weeks)||4
2327200|NCT01824498|5712888|P5|COMPLETED|2nd Intervention (8 Weeks)||3
2327201|NCT01824498|5712889|P4|COMPLETED|2nd Intervention (8 Weeks)||2
2327202|NCT01824498|5712890|P3|COMPLETED|2nd Intervention (8 Weeks)||4
2327203|NCT01824498|5712891|P2|COMPLETED|2nd Intervention (8 Weeks)||2
2327204|NCT01824498|5712892|P1|COMPLETED|2nd Intervention (8 Weeks)||3
2327205|NCT01824498|5712887|P6|STARTED|2nd Intervention (8 Weeks)||4
2327206|NCT01824498|5712888|P5|STARTED|2nd Intervention (8 Weeks)||3
2327207|NCT01824498|5712889|P4|STARTED|2nd Intervention (8 Weeks)||2
2327208|NCT01824498|5712890|P3|STARTED|2nd Intervention (8 Weeks)||4
2327209|NCT01824498|5712891|P2|STARTED|2nd Intervention (8 Weeks)||2
2327210|NCT01824498|5712892|P1|STARTED|2nd Intervention (8 Weeks)||3
2327211|NCT01824498|5712887|P6|NOT COMPLETED|Washout (8 Weeks)||0
2327212|NCT01824498|5712888|P5|NOT COMPLETED|Washout (8 Weeks)||1
2327213|NCT01824498|5712889|P4|NOT COMPLETED|Washout (8 Weeks)||1
2327214|NCT01824498|5712890|P3|NOT COMPLETED|Washout (8 Weeks)||2
2327215|NCT01824498|5712891|P2|NOT COMPLETED|Washout (8 Weeks)||0
2327216|NCT01824498|5712892|P1|NOT COMPLETED|Washout (8 Weeks)||2
2327217|NCT01824498|5712887|P6|COMPLETED|Washout (8 Weeks)||4
2327218|NCT01824498|5712888|P5|COMPLETED|Washout (8 Weeks)||3
2327219|NCT01824498|5712889|P4|COMPLETED|Washout (8 Weeks)||2
2327220|NCT01824498|5712890|P3|COMPLETED|Washout (8 Weeks)||4
2327221|NCT01824498|5712891|P2|COMPLETED|Washout (8 Weeks)||2
2327222|NCT01824498|5712892|P1|COMPLETED|Washout (8 Weeks)||3
2327223|NCT01824498|5712887|P6|STARTED|Washout (8 Weeks)||4
2327224|NCT01824498|5712888|P5|STARTED|Washout (8 Weeks)|1 dropped out|4
2327225|NCT01824498|5712889|P4|STARTED|Washout (8 Weeks)|1 dropped out|3
2327226|NCT01824498|5712890|P3|STARTED|Washout (8 Weeks)|2 dropped out|6
2327227|NCT01824498|5712891|P2|STARTED|Washout (8 Weeks)||2
2327228|NCT01824498|5712892|P1|STARTED|Washout (8 Weeks)|2 dropped out|5
2327229|NCT01824498|5712887|P6|NOT COMPLETED|1st Intervention (8 Weeks)||0
2327230|NCT01824498|5712888|P5|NOT COMPLETED|1st Intervention (8 Weeks)||0
2327231|NCT01824498|5712889|P4|NOT COMPLETED|1st Intervention (8 Weeks)||0
2327232|NCT01824498|5712890|P3|NOT COMPLETED|1st Intervention (8 Weeks)||0
2327233|NCT01824498|5712891|P2|NOT COMPLETED|1st Intervention (8 Weeks)||0
2327234|NCT01824498|5712892|P1|NOT COMPLETED|1st Intervention (8 Weeks)||0
2327235|NCT01824498|5712887|P6|COMPLETED|1st Intervention (8 Weeks)||4
2327236|NCT01824498|5712888|P5|COMPLETED|1st Intervention (8 Weeks)||4
2327237|NCT01824498|5712889|P4|COMPLETED|1st Intervention (8 Weeks)||3
2327238|NCT01824498|5712890|P3|COMPLETED|1st Intervention (8 Weeks)||6
2327239|NCT01824498|5712891|P2|COMPLETED|1st Intervention (8 Weeks)||2
2327240|NCT01824498|5712892|P1|COMPLETED|1st Intervention (8 Weeks)||5
2327241|NCT01824498|5712887|P6|STARTED|1st Intervention (8 Weeks)||4
2327242|NCT01824498|5712888|P5|STARTED|1st Intervention (8 Weeks)||4
2327243|NCT01824498|5712889|P4|STARTED|1st Intervention (8 Weeks)||3
2327244|NCT01824498|5712890|P3|STARTED|1st Intervention (8 Weeks)||6
2327245|NCT01824498|5712891|P2|STARTED|1st Intervention (8 Weeks)||2
2327246|NCT01824498|5712892|P1|STARTED|1st Intervention (8 Weeks)||5
2327247|NCT01824446|5712900|P1|NOT COMPLETED|Overall Study||0
2327248|NCT01824446|5712900|P1|COMPLETED|Overall Study||6
2327249|NCT01824446|5712900|P1|STARTED|Overall Study||6
2327250|NCT01824394|5712926|P3|NOT COMPLETED|Overall Study||74
2327251|NCT01824394|5712927|P2|NOT COMPLETED|Overall Study||116
2327252|NCT01824394|5712928|P1|NOT COMPLETED|Overall Study||119
2327253|NCT01824394|5712926|P3|COMPLETED|Overall Study||51
2327254|NCT01824394|5712927|P2|COMPLETED|Overall Study||53
2327255|NCT01824394|5712928|P1|COMPLETED|Overall Study||55
2327256|NCT01824394|5712926|P3|Per-Protocol Population|Overall Study|Calibration Roll-in patients are not included in the per protocol population|0
2327257|NCT01824394|5712927|P2|Per-Protocol Population|Overall Study||148
2327258|NCT01824394|5712928|P1|Per-Protocol Population|Overall Study||150
2327259|NCT01824394|5712926|P3|Safety Population|Overall Study|Calibration Roll-in patients are included in the safety population|104
2327260|NCT01824394|5712927|P2|Safety Population|Overall Study||149
2327261|NCT01824394|5712928|P1|Safety Population|Overall Study||151
2327262|NCT01824394|5712926|P3|Intent to Treat Population|Overall Study|Calibration Roll-in patients are not included in the ITT|0
2327263|NCT01824394|5712927|P2|Intent to Treat Population|Overall Study||149
2327264|NCT01824394|5712928|P1|Intent to Treat Population|Overall Study||151
2327265|NCT01824394|5712926|P3|STARTED|Overall Study||125
2327266|NCT01824394|5712927|P2|STARTED|Overall Study||169
2327267|NCT01824394|5712928|P1|STARTED|Overall Study||174
2327268|NCT01824355|5712938|P1|NOT COMPLETED|Overall Study||3
2327269|NCT01824355|5712938|P1|COMPLETED|Overall Study||110
2327270|NCT01824355|5712938|P1|STARTED|Overall Study||113
2327271|NCT01824342|5712949|P2|NOT COMPLETED|Overall Study||5
2327272|NCT01824342|5712950|P1|NOT COMPLETED|Overall Study||9
2327273|NCT01824342|5712949|P2|COMPLETED|Overall Study||2
2327274|NCT01824342|5712950|P1|COMPLETED|Overall Study||2
2327275|NCT01824342|5712949|P2|STARTED|Overall Study||7
2327276|NCT01824342|5712950|P1|STARTED|Overall Study||11
2327277|NCT01824303|5712964|P2|NOT COMPLETED|Open Label Extension||0
2327278|NCT01824303|5712965|P1|NOT COMPLETED|Open Label Extension||0
2327279|NCT01824303|5712964|P2|COMPLETED|Open Label Extension||11
2327280|NCT01824303|5712965|P1|COMPLETED|Open Label Extension||12
2327281|NCT01824303|5712964|P2|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|11
2327282|NCT01824303|5712965|P1|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|12
2327283|NCT01824303|5712964|P2|NOT COMPLETED|Randomized Study||1
2327284|NCT01824303|5712965|P1|NOT COMPLETED|Randomized Study||2
2327285|NCT01824303|5712964|P2|COMPLETED|Randomized Study||13
2327286|NCT01824303|5712965|P1|COMPLETED|Randomized Study||14
2327287|NCT01824303|5712964|P2|STARTED|Randomized Study||14
2327288|NCT01824303|5712965|P1|STARTED|Randomized Study||16
2327289|NCT01824160|5712989|P1|NOT COMPLETED|Overall Study||0
2327290|NCT01824160|5712989|P1|COMPLETED|Overall Study||50
2327291|NCT01824160|5712989|P1|STARTED|Overall Study||50
2327292|NCT01823991|5712995|P2|NOT COMPLETED|Overall Study||5
2327293|NCT01823991|5712996|P1|NOT COMPLETED|Overall Study||8
2327294|NCT01823991|5712995|P2|COMPLETED|Overall Study||13
2327295|NCT01823991|5712996|P1|COMPLETED|Overall Study||10
2327296|NCT01823991|5712995|P2|STARTED|Overall Study||18
2327297|NCT01823991|5712996|P1|STARTED|Overall Study||18
2327298|NCT01823679|5713028|P1|NOT COMPLETED|Overall Study||1
2327299|NCT01823679|5713028|P1|COMPLETED|Overall Study||1
2327300|NCT01823679|5713028|P1|STARTED|Overall Study||2
2327301|NCT01823653|5713036|P1|NOT COMPLETED|Overall Study||0
2327302|NCT01823653|5713036|P1|COMPLETED|Overall Study||60
2327303|NCT01823653|5713036|P1|STARTED|Overall Study||60
2327304|NCT01823614|5713050|P6|NOT COMPLETED|Overall Study||0
2327305|NCT01823614|5713051|P5|NOT COMPLETED|Overall Study||0
2327306|NCT01823614|5713052|P4|NOT COMPLETED|Overall Study||0
2327307|NCT01823614|5713053|P3|NOT COMPLETED|Overall Study||0
2327308|NCT01823614|5713054|P2|NOT COMPLETED|Overall Study||0
2327309|NCT01823614|5713055|P1|NOT COMPLETED|Overall Study||0
2327310|NCT01823614|5713050|P6|COMPLETED|Overall Study||154
2327311|NCT01823614|5713051|P5|COMPLETED|Overall Study||172
2327312|NCT01823614|5713052|P4|COMPLETED|Overall Study||122
2327313|NCT01823614|5713053|P3|COMPLETED|Overall Study||176
2327314|NCT01823614|5713054|P2|COMPLETED|Overall Study||140
2327315|NCT01823614|5713055|P1|COMPLETED|Overall Study||179
2327316|NCT01823614|5713050|P6|STARTED|Overall Study||154
2327317|NCT01823614|5713051|P5|STARTED|Overall Study||172
2327318|NCT01823614|5713052|P4|STARTED|Overall Study||122
2327319|NCT01823614|5713053|P3|STARTED|Overall Study||176
2327320|NCT01823614|5713054|P2|STARTED|Overall Study||140
2327321|NCT01823614|5713055|P1|STARTED|Overall Study||179
2327322|NCT01823536|5713081|P6|NOT COMPLETED|Overall Study||0
2327323|NCT01823536|5713082|P5|NOT COMPLETED|Overall Study||2
2327324|NCT01823536|5713083|P4|NOT COMPLETED|Overall Study||2
2327325|NCT01823536|5713084|P3|NOT COMPLETED|Overall Study||1
2327326|NCT01823536|5713085|P2|NOT COMPLETED|Overall Study||2
2327327|NCT01823536|5713086|P1|NOT COMPLETED|Overall Study||2
2327328|NCT01823536|5713081|P6|COMPLETED|Overall Study||2
2327329|NCT01823536|5713082|P5|COMPLETED|Overall Study||99
2327330|NCT01823536|5713083|P4|COMPLETED|Overall Study||64
2327331|NCT01823536|5713084|P3|COMPLETED|Overall Study||119
2327332|NCT01823536|5713085|P2|COMPLETED|Overall Study||101
2327333|NCT01823536|5713086|P1|COMPLETED|Overall Study||71
2327334|NCT01823536|5713081|P6|STARTED|Overall Study||2
2327335|NCT01823536|5713082|P5|STARTED|Overall Study||101
2327336|NCT01823536|5713083|P4|STARTED|Overall Study||66
2327337|NCT01823536|5713084|P3|STARTED|Overall Study||120
2327338|NCT01823536|5713085|P2|STARTED|Overall Study||103
2327339|NCT01823536|5713086|P1|STARTED|Overall Study||73
2327340|NCT01823510|5713124|P2|NOT COMPLETED|Days 22-28||0
2327341|NCT01823510|5713125|P1|NOT COMPLETED|Days 22-28||0
2327342|NCT01823510|5713124|P2|COMPLETED|Days 22-28||10
2327343|NCT01823510|5713125|P1|COMPLETED|Days 22-28||10
2327344|NCT01823510|5713124|P2|STARTED|Days 22-28||10
2327345|NCT01823510|5713125|P1|STARTED|Days 22-28||10
2327346|NCT01823510|5713124|P2|NOT COMPLETED|Days 8-21||0
2327347|NCT01823510|5713125|P1|NOT COMPLETED|Days 8-21||0
2327348|NCT01823510|5713124|P2|COMPLETED|Days 8-21||10
2327349|NCT01823510|5713125|P1|COMPLETED|Days 8-21||10
2327350|NCT01823510|5713124|P2|STARTED|Days 8-21||10
2327351|NCT01823510|5713125|P1|STARTED|Days 8-21||10
2327352|NCT01823510|5713124|P2|NOT COMPLETED|Days 1-7||0
2327353|NCT01823510|5713125|P1|NOT COMPLETED|Days 1-7||0
2327354|NCT01823510|5713124|P2|COMPLETED|Days 1-7||10
2327355|NCT01823510|5713125|P1|COMPLETED|Days 1-7||10
2327356|NCT01823510|5713124|P2|STARTED|Days 1-7||10
2327357|NCT01823510|5713125|P1|STARTED|Days 1-7||10
2327358|NCT01823341|5713137|P1|NOT COMPLETED|Overall Study||15
2327359|NCT01823341|5713137|P1|COMPLETED|Overall Study||82
2327360|NCT01823341|5713137|P1|STARTED|Overall Study||97
2327361|NCT01823328|5713182|P2|NOT COMPLETED|Overall Study||6
2327362|NCT01823328|5713183|P1|NOT COMPLETED|Overall Study||8
2327363|NCT01823328|5713182|P2|COMPLETED|Overall Study||67
2327364|NCT01823328|5713183|P1|COMPLETED|Overall Study||62
2327365|NCT01823328|5713182|P2|STARTED|Overall Study||73
2327366|NCT01823328|5713183|P1|STARTED|Overall Study||70
2327367|NCT01823289|5713203|P1|NOT COMPLETED|Overall Study||24
2327368|NCT01823289|5713203|P1|COMPLETED|Overall Study||47
2327369|NCT01823289|5713203|P1|STARTED|Overall Study||71
2327370|NCT01823224|5713211|P2|NOT COMPLETED|Overall Study||11
2327371|NCT01823224|5713212|P1|NOT COMPLETED|Overall Study||6
2327372|NCT01823224|5713211|P2|COMPLETED|Overall Study||22
2327373|NCT01823224|5713212|P1|COMPLETED|Overall Study||28
2327374|NCT01823224|5713211|P2|STARTED|Overall Study||33
2327375|NCT01823224|5713212|P1|STARTED|Overall Study||34
2327376|NCT01823146|5713222|P2|NOT COMPLETED|Overall Study||2
2327377|NCT01823146|5713223|P1|NOT COMPLETED|Overall Study||2
2327378|NCT01823146|5713222|P2|COMPLETED|Overall Study||49
2327379|NCT01823146|5713223|P1|COMPLETED|Overall Study||53
2327380|NCT01823146|5713222|P2|STARTED|Overall Study||51
2327381|NCT01823146|5713223|P1|STARTED|Overall Study||55
2327382|NCT01823107|5713233|P1|NOT COMPLETED|Overall Study||1
2327383|NCT01823107|5713233|P1|COMPLETED|Overall Study||24
2327384|NCT01823107|5713233|P1|STARTED|Overall Study||25
2327385|NCT01822899|5713241|P2|NOT COMPLETED|Overall Study||18
2327386|NCT01822899|5713242|P1|NOT COMPLETED|Overall Study||24
2327387|NCT01822899|5713241|P2|COMPLETED|Overall Study||340
2327388|NCT01822899|5713242|P1|COMPLETED|Overall Study||334
2327389|NCT01822899|5713241|P2|STARTED|Overall Study||358
2327390|NCT01822899|5713242|P1|STARTED|Overall Study||358
2327391|NCT01822886|5713250|P1|NOT COMPLETED|Overall Study||15
2327392|NCT01822886|5713250|P1|COMPLETED|Overall Study||5
2327393|NCT01822886|5713250|P1|STARTED|Overall Study||20
2327394|NCT01822821|5713260|P2|NOT COMPLETED|Overall Study||1
2327395|NCT01822821|5713261|P1|NOT COMPLETED|Overall Study||2
2327396|NCT01822821|5713260|P2|COMPLETED|Overall Study||74
2327397|NCT01822821|5713261|P1|COMPLETED|Overall Study||73
2327398|NCT01822821|5713260|P2|STARTED|Overall Study||75
2327399|NCT01822821|5713261|P1|STARTED|Overall Study||75
2327400|NCT01822756|5713290|P5|NOT COMPLETED|Overall Study||7
2327401|NCT01822756|5713291|P4|NOT COMPLETED|Overall Study||4
2327402|NCT01822756|5713292|P3|NOT COMPLETED|Overall Study||10
2327403|NCT01822756|5713293|P2|NOT COMPLETED|Overall Study||4
2327404|NCT01822756|5713294|P1|NOT COMPLETED|Overall Study||16
2327405|NCT01822756|5713290|P5|COMPLETED|Overall Study||1
2327406|NCT01822756|5713291|P4|COMPLETED|Overall Study||0
2327407|NCT01822756|5713292|P3|COMPLETED|Overall Study||0
2327408|NCT01822756|5713293|P2|COMPLETED|Overall Study||0
2327409|NCT01822756|5713294|P1|COMPLETED|Overall Study||0
2327410|NCT01822756|5713290|P5|Discontinued From the Study|Overall Study||7
2327411|NCT01822756|5713291|P4|Discontinued From the Study|Overall Study||4
2327412|NCT01822756|5713292|P3|Discontinued From the Study|Overall Study||10
2327413|NCT01822756|5713293|P2|Discontinued From the Study|Overall Study||4
2327414|NCT01822756|5713294|P1|Discontinued From the Study|Overall Study||16
2327415|NCT01822756|5713290|P5|STARTED|Overall Study||8
2327416|NCT01822756|5713291|P4|STARTED|Overall Study||4
2327417|NCT01822756|5713292|P3|STARTED|Overall Study||10
2327418|NCT01822756|5713293|P2|STARTED|Overall Study||4
2327419|NCT01822756|5713294|P1|STARTED|Overall Study||16
2327420|NCT01822691|5713336|P1|NOT COMPLETED|Overall Study||2
2327421|NCT01822691|5713336|P1|COMPLETED|Overall Study||13
2327422|NCT01822691|5713336|P1|STARTED|Overall Study||15
2327423|NCT01822678|5713347|P3|NOT COMPLETED|Overall Study||11
2327424|NCT01822678|5713348|P2|NOT COMPLETED|Overall Study||15
2327425|NCT01822678|5713349|P1|NOT COMPLETED|Overall Study||12
2327426|NCT01822678|5713347|P3|COMPLETED|Overall Study||29
2327427|NCT01822678|5713348|P2|COMPLETED|Overall Study||49
2327428|NCT01822678|5713349|P1|COMPLETED|Overall Study||45
2327429|NCT01822678|5713347|P3|Per Protocol Population|Overall Study||34
2327430|NCT01822678|5713348|P2|Per Protocol Population|Overall Study||52
2327431|NCT01822678|5713349|P1|Per Protocol Population|Overall Study||45
2327432|NCT01822678|5713347|P3|Intention-to-Treat Population (ITT)|Overall Study||40
2327433|NCT01822678|5713348|P2|Intention-to-Treat Population (ITT)|Overall Study|1 patient was excluded from the ITT population because he did not have post baseline efficacy data|63
2327434|NCT01822678|5713349|P1|Intention-to-Treat Population (ITT)|Overall Study||57
2327435|NCT01822678|5713347|P3|Safety Population|Overall Study||40
2327436|NCT01822678|5713348|P2|Safety Population|Overall Study||64
2327437|NCT01822678|5713349|P1|Safety Population|Overall Study||57
2327438|NCT01822678|5713347|P3|Treated|Overall Study||40
2327439|NCT01822678|5713348|P2|Treated|Overall Study||64
2327440|NCT01822678|5713349|P1|Treated|Overall Study||57
2327441|NCT01822678|5713347|P3|STARTED|Overall Study||40
2327442|NCT01822678|5713348|P2|STARTED|Overall Study||64
2327443|NCT01822678|5713349|P1|STARTED|Overall Study||57
2327444|NCT01822665|5713357|P1|NOT COMPLETED|Overall Study||8
2327445|NCT01822665|5713357|P1|COMPLETED|Overall Study||20
2327446|NCT01822665|5713357|P1|Received Paracetamol Tablet (1000 mg)|Overall Study||28
2327447|NCT01822665|5713357|P1|Received Ibuprofen Capsule (400 mg)|Overall Study|Two participants, each in period 3 and period 4 did not complete treatment for 'other reason'.|24
2327448|NCT01822665|5713357|P1|Received Placebo Tablet|Overall Study|5 participants did not complete; Period 2(1:other reason); Period 4(3:adverse event; 1:other reason)|23
2327449|NCT01822665|5713357|P1|Received Ibuprofen Tablet (400 mg)|Overall Study|5 participants did not complete; Period 3(2:adverse events;1:other reason); Period 4(2:other reason)|23
2327450|NCT01822665|5713357|P1|STARTED|Overall Study||28
2327451|NCT01822587|5713384|P3|NOT COMPLETED|Overall Study||18
2327452|NCT01822587|5713385|P2|NOT COMPLETED|Overall Study||15
2327453|NCT01822587|5713386|P1|NOT COMPLETED|Overall Study||16
2327454|NCT01822587|5713384|P3|COMPLETED|Overall Study||44
2327455|NCT01822587|5713385|P2|COMPLETED|Overall Study||45
2327456|NCT01822587|5713386|P1|COMPLETED|Overall Study||43
2327457|NCT01822587|5713384|P3|STARTED|Overall Study||62
2327458|NCT01822587|5713385|P2|STARTED|Overall Study||60
2327459|NCT01822587|5713386|P1|STARTED|Overall Study||59
2327460|NCT01822574|5713409|P3|NOT COMPLETED|Overall Study||0
2327461|NCT01822574|5713410|P2|NOT COMPLETED|Overall Study||0
2327462|NCT01822574|5713411|P1|NOT COMPLETED|Overall Study||0
2327463|NCT01822574|5713409|P3|COMPLETED|Overall Study||30
2327464|NCT01822574|5713410|P2|COMPLETED|Overall Study||30
2327465|NCT01822574|5713411|P1|COMPLETED|Overall Study||30
2327466|NCT01822574|5713409|P3|STARTED|Overall Study||30
2327467|NCT01822574|5713410|P2|STARTED|Overall Study||30
2327468|NCT01822574|5713411|P1|STARTED|Overall Study||30
2327469|NCT01822561|5713425|P1|NOT COMPLETED|Overall Study||2
2327470|NCT01822561|5713425|P1|COMPLETED|Overall Study||13
2327471|NCT01822561|5713425|P1|STARTED|Overall Study||15
2327472|NCT01822548|5713435|P2|NOT COMPLETED|Overall Study||0
2327473|NCT01822548|5713436|P1|NOT COMPLETED|Overall Study||0
2327474|NCT01822548|5713435|P2|COMPLETED|Overall Study||24
2327475|NCT01822548|5713436|P1|COMPLETED|Overall Study||40
2327476|NCT01822548|5713435|P2|Discontinued Intervention|Overall Study||5
2327477|NCT01822548|5713436|P1|Discontinued Intervention|Overall Study||0
2327478|NCT01822548|5713435|P2|STARTED|Overall Study||24
2327479|NCT01822548|5713436|P1|STARTED|Overall Study|Received allocated intervention n=38 Did not receive allocated intervention (only metformin) n=2|40
2327480|NCT01822535|5713446|P2|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
2327481|NCT01822535|5713447|P1|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||1
2327482|NCT01822535|5713446|P2|COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
2327483|NCT01822535|5713447|P1|COMPLETED|Visit 2 - Tetraplegia Only - Drug||10
2327484|NCT01822535|5713446|P2|STARTED|Visit 2 - Tetraplegia Only - Drug|Able-bodied subjects were not enrolled for a second visit.|0
2327485|NCT01822535|5713447|P1|STARTED|Visit 2 - Tetraplegia Only - Drug|These subjects were individuals who completed Visit 1 of testing.|11
2327486|NCT01822535|5713446|P2|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||2
2327487|NCT01822535|5713447|P1|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||6
2327488|NCT01822535|5713446|P2|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
2327489|NCT01822535|5713447|P1|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
2327490|NCT01822535|5713446|P2|STARTED|Visit 1 - Tetraplegia and Able-Bodied||13
2327491|NCT01822535|5713447|P1|STARTED|Visit 1 - Tetraplegia and Able-Bodied||17
2327492|NCT01822496|5713463|P4|NOT COMPLETED|Overall Study||4
2327493|NCT01822496|5713464|P3|NOT COMPLETED|Overall Study||0
2327494|NCT01822496|5713465|P2|NOT COMPLETED|Overall Study||2
2327495|NCT01822496|5713466|P1|NOT COMPLETED|Overall Study||2
2327496|NCT01822496|5713463|P4|COMPLETED|Overall Study||7
2327497|NCT01822496|5713464|P3|COMPLETED|Overall Study||9
2327498|NCT01822496|5713465|P2|COMPLETED|Overall Study||21
2327499|NCT01822496|5713466|P1|COMPLETED|Overall Study||14
2327500|NCT01822496|5713463|P4|Eligible and Started Study Treatment|Overall Study||7
2327501|NCT01822496|5713464|P3|Eligible and Started Study Treatment|Overall Study||9
2327502|NCT01822496|5713465|P2|Eligible and Started Study Treatment|Overall Study||20
2327503|NCT01822496|5713466|P1|Eligible and Started Study Treatment|Overall Study||14
2327504|NCT01822496|5713463|P4|Eligible With Disease Assessment|Overall Study||4
2327505|NCT01822496|5713464|P3|Eligible With Disease Assessment|Overall Study||6
2327506|NCT01822496|5713465|P2|Eligible With Disease Assessment|Overall Study||15
2327507|NCT01822496|5713466|P1|Eligible With Disease Assessment|Overall Study||10
2327508|NCT01822496|5713463|P4|Eligible|Overall Study||7
2327509|NCT01822496|5713464|P3|Eligible|Overall Study||9
2327510|NCT01822496|5713465|P2|Eligible|Overall Study||21
2327511|NCT01822496|5713466|P1|Eligible|Overall Study||14
2327512|NCT01822496|5713463|P4|STARTED|Overall Study||11
2327513|NCT01822496|5713464|P3|STARTED|Overall Study||9
2327514|NCT01822496|5713465|P2|STARTED|Overall Study||23
2327515|NCT01822496|5713466|P1|STARTED|Overall Study||16
2327522|NCT01822366|5713519|P4|NOT COMPLETED|Overall Study||22
2327523|NCT01822366|5713520|P3|NOT COMPLETED|Overall Study||5
2327524|NCT01822366|5713521|P2|NOT COMPLETED|Overall Study||22
2327525|NCT01822366|5713522|P1|NOT COMPLETED|Overall Study||5
2327526|NCT01822366|5713519|P4|COMPLETED|Overall Study||298
2327527|NCT01822366|5713520|P3|COMPLETED|Overall Study||315
2327528|NCT01822366|5713521|P2|COMPLETED|Overall Study||298
2327529|NCT01822366|5713522|P1|COMPLETED|Overall Study||315
2327530|NCT01822366|5713519|P4|STARTED|Overall Study||320
2327531|NCT01822366|5713520|P3|STARTED|Overall Study||320
2327532|NCT01822366|5713521|P2|STARTED|Overall Study||320
2327533|NCT01822366|5713522|P1|STARTED|Overall Study||320
2327534|NCT01822353|5713553|P3|NOT COMPLETED|Overall Study||1
2327535|NCT01822353|5713554|P2|NOT COMPLETED|Overall Study||5
2327536|NCT01822353|5713555|P1|NOT COMPLETED|Overall Study||4
2327537|NCT01822353|5713553|P3|COMPLETED|Overall Study||3
2327538|NCT01822353|5713554|P2|COMPLETED|Overall Study||4
2327539|NCT01822353|5713555|P1|COMPLETED|Overall Study||6
2327540|NCT01822353|5713553|P3|STARTED|Overall Study||4
2327541|NCT01822353|5713554|P2|STARTED|Overall Study||9
2327542|NCT01822353|5713555|P1|STARTED|Overall Study||10
2327543|NCT01822301|5713563|P1|NOT COMPLETED|Overall Study||0
2327544|NCT01822301|5713563|P1|COMPLETED|Overall Study||5
2327545|NCT01822301|5713563|P1|STARTED|Overall Study||5
2327546|NCT01822223|5713575|P2|NOT COMPLETED|Overall Study||1
2327547|NCT01822223|5713576|P1|NOT COMPLETED|Overall Study||0
2327548|NCT01822223|5713575|P2|COMPLETED|Overall Study||9
2327549|NCT01822223|5713576|P1|COMPLETED|Overall Study||10
2327550|NCT01822223|5713575|P2|STARTED|Overall Study||10
2327551|NCT01822223|5713576|P1|STARTED|Overall Study||10
2327552|NCT01822197|5713592|P1|NOT COMPLETED|Overall Study||0
2327553|NCT01822197|5713592|P1|COMPLETED|Overall Study||30
2327554|NCT01822197|5713592|P1|STARTED|Overall Study||30
2327555|NCT01822132|5713600|P2|NOT COMPLETED|Overall Study||2
2327556|NCT01822132|5713601|P1|NOT COMPLETED|Overall Study||4
2327557|NCT01822132|5713600|P2|COMPLETED|Overall Study||25
2327558|NCT01822132|5713601|P1|COMPLETED|Overall Study||21
2327559|NCT01822132|5713600|P2|STARTED|Overall Study||27
2327560|NCT01822132|5713601|P1|STARTED|Overall Study||25
2327561|NCT01822119|5713615|P1|NOT COMPLETED|Overall Study||0
2327562|NCT01822119|5713615|P1|COMPLETED|Overall Study||27
2327563|NCT01822119|5713615|P1|STARTED|Overall Study||27
2327564|NCT01821963|5713638|P1|NOT COMPLETED|Overall Study||1
2327565|NCT01821963|5713638|P1|COMPLETED|Overall Study||0
2327566|NCT01821963|5713638|P1|STARTED|Overall Study||1
2327567|NCT01821937|5713644|P2|NOT COMPLETED|Overall Study||3
2327568|NCT01821937|5713645|P1|NOT COMPLETED|Overall Study||0
2327569|NCT01821937|5713644|P2|COMPLETED|Overall Study|2 patients discontinued during Single dose period,1 Patient discontinued during Multiple dose period|12
2327570|NCT01821937|5713645|P1|COMPLETED|Overall Study||10
2327571|NCT01821937|5713644|P2|STARTED|Overall Study||15
2327572|NCT01821937|5713645|P1|STARTED|Overall Study||10
2327573|NCT01821859|5713663|P1|NOT COMPLETED|Overall Study||5
2327574|NCT01821859|5713663|P1|COMPLETED|Overall Study||0
2327575|NCT01821859|5713663|P1|STARTED|Overall Study||5
2327576|NCT01821807|5713669|P2|NOT COMPLETED|Overall Study||1
2327577|NCT01821807|5713670|P1|NOT COMPLETED|Overall Study||3
2327578|NCT01821807|5713669|P2|COMPLETED|Overall Study||109
2327579|NCT01821807|5713670|P1|COMPLETED|Overall Study||147
2327580|NCT01821807|5713669|P2|STARTED|Overall Study||110
2327581|NCT01821807|5713670|P1|STARTED|Overall Study||150
2327582|NCT01821729|5713678|P1|NOT COMPLETED|Overall Study||1
2327583|NCT01821729|5713678|P1|COMPLETED|Overall Study||49
2327584|NCT01821729|5713678|P1|Underwent Attempted Surgery|Overall Study||42
2327585|NCT01821729|5713678|P1|Received Chemoradiotherapy|Overall Study||45
2327586|NCT01821729|5713678|P1|STARTED|Overall Study||50
2327587|NCT01821625|5713683|P1|NOT COMPLETED|Overall Study||6
2327588|NCT01821625|5713683|P1|COMPLETED|Overall Study||1
2327589|NCT01821625|5713683|P1|STARTED|Overall Study||7
2327590|NCT01821560|5713689|P2|NOT COMPLETED|Overall Study||7
2327591|NCT01821560|5713690|P1|NOT COMPLETED|Overall Study||6
2327592|NCT01821560|5713689|P2|COMPLETED|Overall Study||15
2327593|NCT01821560|5713690|P1|COMPLETED|Overall Study||16
2327594|NCT01821560|5713689|P2|STARTED|Overall Study||22
2327595|NCT01821560|5713690|P1|STARTED|Overall Study||22
2327596|NCT01821534|5713696|P1|NOT COMPLETED|Overall Study||0
2327597|NCT01821534|5713696|P1|COMPLETED|Overall Study||201
2327598|NCT01821534|5713696|P1|STARTED|Overall Study||201
2327599|NCT01821417|5713705|P2|NOT COMPLETED|Overall Study||0
2327600|NCT01821417|5713706|P1|NOT COMPLETED|Overall Study||0
2327601|NCT01821417|5713705|P2|COMPLETED|Overall Study||31
2327602|NCT01821417|5713706|P1|COMPLETED|Overall Study||37
2327603|NCT01821417|5713705|P2|STARTED|Overall Study||31
2327604|NCT01821417|5713706|P1|STARTED|Overall Study||37
2327605|NCT01821378|5713719|P3|NOT COMPLETED|Overall Study||42
2327606|NCT01821378|5713720|P2|NOT COMPLETED|Overall Study||54
2327607|NCT01821378|5713721|P1|NOT COMPLETED|Overall Study||27
2327608|NCT01821378|5713719|P3|COMPLETED|Overall Study||70
2327609|NCT01821378|5713720|P2|COMPLETED|Overall Study||145
2327610|NCT01821378|5713721|P1|COMPLETED|Overall Study||74
2327611|NCT01821378|5713719|P3|STARTED|Overall Study||112
2327612|NCT01821378|5713720|P2|STARTED|Overall Study||199
2327613|NCT01821378|5713721|P1|STARTED|Overall Study||101
2327614|NCT01821352|5713759|P2|NOT COMPLETED|Overall Study||0
2327615|NCT01821352|5713760|P1|NOT COMPLETED|Overall Study||0
2327616|NCT01821352|5713759|P2|COMPLETED|Overall Study||25
2327617|NCT01821352|5713760|P1|COMPLETED|Overall Study||28
2327618|NCT01821352|5713759|P2|STARTED|Overall Study||25
2327619|NCT01821352|5713760|P1|STARTED|Overall Study||28
2327620|NCT01821326|5713770|P1|NOT COMPLETED|Overall Study||0
2327621|NCT01821326|5713770|P1|COMPLETED|Overall Study||339
2327622|NCT01821326|5713770|P1|STARTED|Overall Study||339
2327623|NCT01821300|5713776|P2|NOT COMPLETED|Overall Study||0
2327624|NCT01821300|5713777|P1|NOT COMPLETED|Overall Study||0
2327625|NCT01821300|5713776|P2|COMPLETED|Overall Study||103
2327626|NCT01821300|5713777|P1|COMPLETED|Overall Study||154
2327627|NCT01821300|5713776|P2|STARTED|Overall Study||103
2327628|NCT01821300|5713777|P1|STARTED|Overall Study||154
2327629|NCT01821118|5713811|P2|NOT COMPLETED|Overall Study||1
2327630|NCT01821118|5713812|P1|NOT COMPLETED|Overall Study||0
2327631|NCT01821118|5713811|P2|COMPLETED|Overall Study||11
2327632|NCT01821118|5713812|P1|COMPLETED|Overall Study||24
2327633|NCT01821118|5713811|P2|STARTED|Overall Study||12
2327634|NCT01821118|5713812|P1|STARTED|Overall Study||24
2327635|NCT01821105|5713845|P1|NOT COMPLETED|Overall Study||0
2327636|NCT01821105|5713845|P1|COMPLETED|Overall Study||21
2327637|NCT01821105|5713845|P1|STARTED|Overall Study||21
2327638|NCT01820754|5713851|P1|NOT COMPLETED|Overall Study||0
2327639|NCT01820754|5713851|P1|COMPLETED|Overall Study||24
2327640|NCT01820754|5713851|P1|STARTED|Overall Study||24
2327641|NCT01820637|5713859|P1|NOT COMPLETED|Overall Study||3
2327642|NCT01820637|5713859|P1|COMPLETED|Overall Study||54
2327643|NCT01820637|5713859|P1|STARTED|Overall Study||57
2327644|NCT01820585|5713868|P4|NOT COMPLETED|Overall Study||49
2327645|NCT01820585|5713869|P3|NOT COMPLETED|Overall Study||34
2327646|NCT01820585|5713870|P2|NOT COMPLETED|Overall Study||32
2327647|NCT01820585|5713871|P1|NOT COMPLETED|Overall Study||27
2327648|NCT01820585|5713868|P4|COMPLETED|Overall Study||83
2327649|NCT01820585|5713869|P3|COMPLETED|Overall Study||101
2327650|NCT01820585|5713870|P2|COMPLETED|Overall Study||98
2327651|NCT01820585|5713871|P1|COMPLETED|Overall Study||104
2327652|NCT01820585|5713868|P4|Completed Maintenance Period|Overall Study||84
2327653|NCT01820585|5713869|P3|Completed Maintenance Period|Overall Study||101
2327654|NCT01820585|5713870|P2|Completed Maintenance Period|Overall Study||98
2327655|NCT01820585|5713871|P1|Completed Maintenance Period|Overall Study||105
2327656|NCT01820585|5713868|P4|Entered Maintenance Period|Overall Study||123
2327657|NCT01820585|5713869|P3|Entered Maintenance Period|Overall Study||131
2327658|NCT01820585|5713870|P2|Entered Maintenance Period|Overall Study||124
2327659|NCT01820585|5713871|P1|Entered Maintenance Period|Overall Study||128
2327660|NCT01820585|5713868|P4|Completed Titration Period|Overall Study||126
2327661|NCT01820585|5713869|P3|Completed Titration Period|Overall Study||131
2327662|NCT01820585|5713870|P2|Completed Titration Period|Overall Study||125
2327663|NCT01820585|5713871|P1|Completed Titration Period|Overall Study||128
2327664|NCT01820585|5713868|P4|Full Analysis Set|Overall Study||129
2327665|NCT01820585|5713869|P3|Full Analysis Set|Overall Study||135
2327666|NCT01820585|5713870|P2|Full Analysis Set|Overall Study||130
2327667|NCT01820585|5713871|P1|Full Analysis Set|Overall Study||131
2327668|NCT01820585|5713868|P4|Randomized and Treated|Overall Study||132
2327669|NCT01820585|5713869|P3|Randomized and Treated|Overall Study||135
2327670|NCT01820585|5713870|P2|Randomized and Treated|Overall Study||130
2327671|NCT01820585|5713871|P1|Randomized and Treated|Overall Study||131
2327672|NCT01820585|5713868|P4|STARTED|Overall Study||132
2327673|NCT01820585|5713869|P3|STARTED|Overall Study||135
2327674|NCT01820585|5713870|P2|STARTED|Overall Study||130
2327675|NCT01820585|5713871|P1|STARTED|Overall Study||131
2327676|NCT01820559|5713884|P3|NOT COMPLETED|Overall Study||29
2327677|NCT01820559|5713885|P2|NOT COMPLETED|Overall Study||13
2327678|NCT01820559|5713886|P1|NOT COMPLETED|Overall Study||14
2327679|NCT01820559|5713884|P3|COMPLETED|Overall Study||110
2327680|NCT01820559|5713885|P2|COMPLETED|Overall Study||122
2327681|NCT01820559|5713886|P1|COMPLETED|Overall Study||122
2327682|NCT01820559|5713884|P3|Completed Maintenance Period|Overall Study||110
2327683|NCT01820559|5713885|P2|Completed Maintenance Period|Overall Study||123
2327684|NCT01820559|5713886|P1|Completed Maintenance Period|Overall Study||122
2327685|NCT01820559|5713884|P3|Entered Maintenance Period|Overall Study||129
2327686|NCT01820559|5713885|P2|Entered Maintenance Period|Overall Study||133
2327687|NCT01820559|5713886|P1|Entered Maintenance Period|Overall Study||129
2327688|NCT01820559|5713884|P3|Completed Tutration Period|Overall Study||131
2327689|NCT01820559|5713885|P2|Completed Tutration Period|Overall Study||134
2327690|NCT01820559|5713886|P1|Completed Tutration Period|Overall Study||130
2327691|NCT01820559|5713884|P3|Randomized and Treated|Overall Study||139
2327692|NCT01820559|5713885|P2|Randomized and Treated|Overall Study||135
2327693|NCT01820559|5713886|P1|Randomized and Treated|Overall Study||136
2327694|NCT01820559|5713884|P3|STARTED|Overall Study||139
2327695|NCT01820559|5713885|P2|STARTED|Overall Study||135
2327696|NCT01820559|5713886|P1|STARTED|Overall Study||136
2327697|NCT01820416|5713897|P3|NOT COMPLETED|Overall Study||0
2327698|NCT01820416|5713898|P2|NOT COMPLETED|Overall Study||2
2327699|NCT01820416|5713899|P1|NOT COMPLETED|Overall Study||3
2327700|NCT01820416|5713897|P3|COMPLETED|Overall Study||11
2327701|NCT01820416|5713898|P2|COMPLETED|Overall Study||10
2327702|NCT01820416|5713899|P1|COMPLETED|Overall Study||9
2327703|NCT01820416|5713897|P3|STARTED|Overall Study||11
2327704|NCT01820416|5713898|P2|STARTED|Overall Study||12
2327705|NCT01820416|5713899|P1|STARTED|Overall Study||12
2327706|NCT01820364|5713907|P2|NOT COMPLETED|Part II: LGX818 + MEK162||1
2327707|NCT01820364|5713908|P1|NOT COMPLETED|Part II: LGX818 + MEK162||0
2327708|NCT01820364|5713907|P2|COMPLETED|Part II: LGX818 + MEK162||0
2327709|NCT01820364|5713908|P1|COMPLETED|Part II: LGX818 + MEK162||0
2327710|NCT01820364|5713907|P2|STARTED|Part II: LGX818 + MEK162||1
2327711|NCT01820364|5713908|P1|STARTED|Part II: LGX818 + MEK162||0
2327712|NCT01820364|5713907|P2|NOT COMPLETED|Part I: LGX818||0
2327713|NCT01820364|5713908|P1|NOT COMPLETED|Part I: LGX818||14
2327714|NCT01820364|5713907|P2|COMPLETED|Part I: LGX818||0
2327715|NCT01820364|5713908|P1|COMPLETED|Part I: LGX818||1
2327716|NCT01820364|5713907|P2|STARTED|Part I: LGX818||0
2327717|NCT01820364|5713908|P1|STARTED|Part I: LGX818||15
2327718|NCT01819935|5713922|P2|NOT COMPLETED|Overall Study||0
2327719|NCT01819935|5713923|P1|NOT COMPLETED|Overall Study||0
2327720|NCT01819935|5713922|P2|COMPLETED|Overall Study||4943
2327721|NCT01819935|5713923|P1|COMPLETED|Overall Study||328
2327722|NCT01819935|5713922|P2|STARTED|Overall Study||4943
2327723|NCT01819935|5713923|P1|STARTED|Overall Study||328
2327724|NCT01819922|5713943|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
2327725|NCT01819922|5713944|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
2327726|NCT01819922|5713943|P2|COMPLETED|Second Intervention Period (1 Day)||6
2327727|NCT01819922|5713944|P1|COMPLETED|Second Intervention Period (1 Day)||6
2327728|NCT01819922|5713943|P2|STARTED|Second Intervention Period (1 Day)||6
2327729|NCT01819922|5713944|P1|STARTED|Second Intervention Period (1 Day)||6
2327730|NCT01819922|5713943|P2|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
2327731|NCT01819922|5713944|P1|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
2327732|NCT01819922|5713943|P2|COMPLETED|Washout Period (at Least 7-10 Days)||6
2327733|NCT01819922|5713944|P1|COMPLETED|Washout Period (at Least 7-10 Days)||6
2327734|NCT01819922|5713943|P2|STARTED|Washout Period (at Least 7-10 Days)||6
2327735|NCT01819922|5713944|P1|STARTED|Washout Period (at Least 7-10 Days)||6
2327736|NCT01819922|5713943|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
2327737|NCT01819922|5713944|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
2327738|NCT01819922|5713943|P2|COMPLETED|First Intervention Period (1 Day)||6
2327739|NCT01819922|5713944|P1|COMPLETED|First Intervention Period (1 Day)||6
2327740|NCT01819922|5713943|P2|STARTED|First Intervention Period (1 Day)||6
2327741|NCT01819922|5713944|P1|STARTED|First Intervention Period (1 Day)||6
2327742|NCT01819883|5714030|P2|NOT COMPLETED|Overall Study||0
2327743|NCT01819883|5714031|P1|NOT COMPLETED|Overall Study||4
2327744|NCT01819883|5714030|P2|COMPLETED|Overall Study||20
2327745|NCT01819883|5714031|P1|COMPLETED|Overall Study||16
2327746|NCT01819883|5714030|P2|STARTED|Overall Study||20
2327747|NCT01819883|5714031|P1|STARTED|Overall Study||20
2327748|NCT01819844|5714037|P1|NOT COMPLETED|Overall Study||0
2327749|NCT01819844|5714037|P1|COMPLETED|Overall Study||12
2327750|NCT01819844|5714037|P1|STARTED|Overall Study||12
2327751|NCT01819727|5714052|P2|NOT COMPLETED|Overall Study||28
2327752|NCT01819727|5714053|P1|NOT COMPLETED|Overall Study||20
2327753|NCT01819727|5714052|P2|COMPLETED|Overall Study||102
2327754|NCT01819727|5714053|P1|COMPLETED|Overall Study||111
2327755|NCT01819727|5714052|P2|STARTED|Overall Study||130
2327756|NCT01819727|5714053|P1|STARTED|Overall Study||131
2327757|NCT01819597|5714063|P1|NOT COMPLETED|Overall Study||0
2327758|NCT01819597|5714063|P1|COMPLETED|Overall Study||52
2327759|NCT01819597|5714063|P1|STARTED|Overall Study||52
2327760|NCT01819506|5714075|P2|NOT COMPLETED|Overall Study||5
2327761|NCT01819506|5714076|P1|NOT COMPLETED|Overall Study||8
2327762|NCT01819506|5714075|P2|COMPLETED|Overall Study||47
2327763|NCT01819506|5714076|P1|COMPLETED|Overall Study||43
2327764|NCT01819506|5714075|P2|STARTED|Overall Study||52
2327765|NCT01819506|5714076|P1|STARTED|Overall Study||51
2327766|NCT01819415|5714090|P4|NOT COMPLETED|Overall Study||2
2327767|NCT01819415|5714091|P3|NOT COMPLETED|Overall Study||1
2327768|NCT01819415|5714092|P2|NOT COMPLETED|Overall Study||4
2327769|NCT01819415|5714093|P1|NOT COMPLETED|Overall Study||3
2327770|NCT01819415|5714090|P4|COMPLETED|Overall Study||8
2327771|NCT01819415|5714091|P3|COMPLETED|Overall Study||9
2327772|NCT01819415|5714092|P2|COMPLETED|Overall Study||6
2327773|NCT01819415|5714093|P1|COMPLETED|Overall Study||7
2327774|NCT01819415|5714090|P4|STARTED|Overall Study||10
2327775|NCT01819415|5714091|P3|STARTED|Overall Study||10
2327776|NCT01819415|5714092|P2|STARTED|Overall Study||10
2327777|NCT01819415|5714093|P1|STARTED|Overall Study||10
2327778|NCT01819311|5714105|P2|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
2327779|NCT01819311|5714106|P1|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
2327780|NCT01819311|5714105|P2|COMPLETED|Follow-up Phase (8 Weeks)||23
2327781|NCT01819311|5714106|P1|COMPLETED|Follow-up Phase (8 Weeks)||24
2327782|NCT01819311|5714105|P2|STARTED|Follow-up Phase (8 Weeks)||30
2327783|NCT01819311|5714106|P1|STARTED|Follow-up Phase (8 Weeks)||31
2327784|NCT01819311|5714105|P2|NOT COMPLETED|Treatment Phase (4 Weeks)||1
2327785|NCT01819311|5714106|P1|NOT COMPLETED|Treatment Phase (4 Weeks)||2
2327786|NCT01819311|5714105|P2|COMPLETED|Treatment Phase (4 Weeks)||30
2327787|NCT01819311|5714106|P1|COMPLETED|Treatment Phase (4 Weeks)||31
2327788|NCT01819311|5714105|P2|STARTED|Treatment Phase (4 Weeks)||31
2327789|NCT01819311|5714106|P1|STARTED|Treatment Phase (4 Weeks)||33
2327790|NCT01819272|5714128|P6|NOT COMPLETED|Overall Study||7
2327791|NCT01819272|5714129|P5|NOT COMPLETED|Overall Study||4
2327792|NCT01819272|5714130|P4|NOT COMPLETED|Overall Study||5
2327793|NCT01819272|5714131|P3|NOT COMPLETED|Overall Study||3
2327794|NCT01819272|5714132|P2|NOT COMPLETED|Overall Study||3
2327795|NCT01819272|5714133|P1|NOT COMPLETED|Overall Study||6
2327796|NCT01819272|5714128|P6|COMPLETED|Overall Study||33
2327797|NCT01819272|5714129|P5|COMPLETED|Overall Study||36
2327798|NCT01819272|5714130|P4|COMPLETED|Overall Study||35
2327799|NCT01819272|5714131|P3|COMPLETED|Overall Study||37
2327800|NCT01819272|5714132|P2|COMPLETED|Overall Study||36
2327801|NCT01819272|5714133|P1|COMPLETED|Overall Study||35
2327802|NCT01819272|5714128|P6|STARTED|Overall Study||40
2327803|NCT01819272|5714129|P5|STARTED|Overall Study||40
2327804|NCT01819272|5714130|P4|STARTED|Overall Study||40
2327805|NCT01819272|5714131|P3|STARTED|Overall Study||40
2327806|NCT01819272|5714132|P2|STARTED|Overall Study||39
2327807|NCT01819272|5714133|P1|STARTED|Overall Study||41
2327808|NCT01819233|5714159|P1|NOT COMPLETED|Overall Study||6
2327809|NCT01819233|5714159|P1|COMPLETED|Overall Study||32
2327810|NCT01819233|5714159|P1|STARTED|Overall Study||38
2327811|NCT01819194|5714171|P1|NOT COMPLETED|Overall Study||2
2327812|NCT01819194|5714171|P1|COMPLETED|Overall Study||60
2327813|NCT01819194|5714171|P1|STARTED|Overall Study||62
2327814|NCT01819129|5714178|P2|NOT COMPLETED|Overall Study||39
2327815|NCT01819129|5714179|P1|NOT COMPLETED|Overall Study||44
2327816|NCT01819129|5714178|P2|COMPLETED|Overall Study||305
2327817|NCT01819129|5714179|P1|COMPLETED|Overall Study||301
2327818|NCT01819129|5714178|P2|Exposed|Overall Study||341
2327819|NCT01819129|5714179|P1|Exposed|Overall Study||341
2327820|NCT01819129|5714178|P2|STARTED|Overall Study||344
2327821|NCT01819129|5714179|P1|STARTED|Overall Study||345
2327822|NCT01818765|5714191|P1|NOT COMPLETED|Overall Study||2
2327823|NCT01818765|5714191|P1|COMPLETED|Overall Study||18
2327824|NCT01818765|5714191|P1|STARTED|Overall Study||20
2327825|NCT01818752|5714204|P2|NOT COMPLETED|Overall Study||198
2327826|NCT01818752|5714205|P1|NOT COMPLETED|Overall Study||187
2327827|NCT01818752|5714204|P2|COMPLETED|Overall Study|Completed treatment|280
2327828|NCT01818752|5714205|P1|COMPLETED|Overall Study|Completed treatment|290
2327829|NCT01818752|5714204|P2|Received Treatment|Overall Study||474
2327830|NCT01818752|5714205|P1|Received Treatment|Overall Study||470
2327831|NCT01818752|5714204|P2|STARTED|Overall Study||478
2327832|NCT01818752|5714205|P1|STARTED|Overall Study||477
2327833|NCT01818726|5714225|P2|NOT COMPLETED|Overall Study||2
2327834|NCT01818726|5714226|P1|NOT COMPLETED|Overall Study||6
2327835|NCT01818726|5714225|P2|COMPLETED|Overall Study||3
2327836|NCT01818726|5714226|P1|COMPLETED|Overall Study||4
2327837|NCT01818726|5714225|P2|STARTED|Overall Study||5
2327838|NCT01818726|5714226|P1|STARTED|Overall Study||10
2327839|NCT01818700|5714236|P1|NOT COMPLETED|Overall Study||104
2327840|NCT01818700|5714236|P1|COMPLETED|Overall Study|104 subjects dropped out this study prior to study completion.|141
2327841|NCT01818700|5714236|P1|PP Set|Overall Study|105 subjects excluded from PP set due to various reasons.|105
2327842|NCT01818700|5714236|P1|FAS Set|Overall Study|31 subjects excluded from FAS due to no assessment of primary efficacy(26) and IC/EC violation(5).|210
2327843|NCT01818700|5714236|P1|Safety Set|Overall Study|4 subjects were not study drug administered.|241
2327844|NCT01818700|5714236|P1|STARTED|Overall Study|The No. of enrolled patients|245
2327845|NCT01818596|5714247|P2|NOT COMPLETED|Overall Study||0
2327846|NCT01818596|5714248|P1|NOT COMPLETED|Overall Study||31
2327847|NCT01818596|5714247|P2|COMPLETED|Overall Study||6
2327848|NCT01818596|5714248|P1|COMPLETED|Overall Study||215
2327849|NCT01818596|5714247|P2|STARTED|Overall Study||6
2327850|NCT01818596|5714248|P1|STARTED|Overall Study||246
2327851|NCT01818531|5714287|P2|NOT COMPLETED|Overall Study||2
2327852|NCT01818531|5714288|P1|NOT COMPLETED|Overall Study||1
2327853|NCT01818531|5714287|P2|COMPLETED|Overall Study||73
2327854|NCT01818531|5714288|P1|COMPLETED|Overall Study||74
2327855|NCT01818531|5714287|P2|STARTED|Overall Study||75
2327856|NCT01818531|5714288|P1|STARTED|Overall Study||75
2327857|NCT01818518|5714308|P6|NOT COMPLETED|Overall Study||0
2327858|NCT01818518|5714309|P5|NOT COMPLETED|Overall Study||0
2327859|NCT01818518|5714310|P4|NOT COMPLETED|Overall Study||0
2327860|NCT01818518|5714311|P3|NOT COMPLETED|Overall Study||0
2327861|NCT01818518|5714312|P2|NOT COMPLETED|Overall Study||0
2327862|NCT01818518|5714313|P1|NOT COMPLETED|Overall Study||0
2327863|NCT01818518|5714308|P6|COMPLETED|Overall Study||37
2327864|NCT01818518|5714309|P5|COMPLETED|Overall Study||38
2327865|NCT01818518|5714310|P4|COMPLETED|Overall Study||59
2327866|NCT01818518|5714311|P3|COMPLETED|Overall Study||288
2327867|NCT01818518|5714312|P2|COMPLETED|Overall Study||263
2327868|NCT01818518|5714313|P1|COMPLETED|Overall Study||310
2327869|NCT01818518|5714308|P6|STARTED|Overall Study||37
2327870|NCT01818518|5714309|P5|STARTED|Overall Study||38
2327871|NCT01818518|5714310|P4|STARTED|Overall Study||59
2327872|NCT01818518|5714311|P3|STARTED|Overall Study||288
2327873|NCT01818518|5714312|P2|STARTED|Overall Study||263
2327874|NCT01818518|5714313|P1|STARTED|Overall Study||310
2327875|NCT01818427|5714329|P2|NOT COMPLETED|Overall Study||13
2327876|NCT01818427|5714330|P1|NOT COMPLETED|Overall Study||9
2327877|NCT01818427|5714329|P2|COMPLETED|Overall Study||271
2327878|NCT01818427|5714330|P1|COMPLETED|Overall Study||230
2327879|NCT01818427|5714329|P2|STARTED|Overall Study||284
2327880|NCT01818427|5714330|P1|STARTED|Overall Study||239
2327881|NCT01818414|5714346|P2|NOT COMPLETED|Overall Study||0
2327882|NCT01818414|5714347|P1|NOT COMPLETED|Overall Study||0
2327883|NCT01818414|5714346|P2|COMPLETED|Overall Study||15
2327884|NCT01818414|5714347|P1|COMPLETED|Overall Study||14
2327885|NCT01818414|5714346|P2|STARTED|Overall Study||15
2327886|NCT01818414|5714347|P1|STARTED|Overall Study||14
2327887|NCT01818336|5714361|P2|NOT COMPLETED|Overall Study||12
2327888|NCT01818336|5714362|P1|NOT COMPLETED|Overall Study||0
2327889|NCT01818336|5714361|P2|COMPLETED|Overall Study||47
2327890|NCT01818336|5714362|P1|COMPLETED|Overall Study||391
2327891|NCT01818336|5714361|P2|STARTED|Overall Study||59
2327892|NCT01818336|5714362|P1|STARTED|Overall Study||391
2327893|NCT01818297|5714370|P2|NOT COMPLETED|Open Label Phase (3-12 Months)||10
2327894|NCT01818297|5714371|P1|NOT COMPLETED|Open Label Phase (3-12 Months)||18
2327895|NCT01818297|5714370|P2|COMPLETED|Open Label Phase (3-12 Months)||19
2327896|NCT01818297|5714371|P1|COMPLETED|Open Label Phase (3-12 Months)||14
2327897|NCT01818297|5714370|P2|STARTED|Open Label Phase (3-12 Months)||29
2327898|NCT01818297|5714371|P1|STARTED|Open Label Phase (3-12 Months)||32
2327899|NCT01818297|5714370|P2|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||1
2327900|NCT01818297|5714371|P1|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||0
2327901|NCT01818297|5714370|P2|COMPLETED|Blinded Phase (Randomization - 3 Months)||29
2327902|NCT01818297|5714371|P1|COMPLETED|Blinded Phase (Randomization - 3 Months)||32
2327903|NCT01818297|5714370|P2|Week 6|Blinded Phase (Randomization - 3 Months)||29
2327904|NCT01818297|5714371|P1|Week 6|Blinded Phase (Randomization - 3 Months)||32
2327905|NCT01818297|5714370|P2|Week 1|Blinded Phase (Randomization - 3 Months)||30
2327906|NCT01818297|5714371|P1|Week 1|Blinded Phase (Randomization - 3 Months)||32
2327907|NCT01818297|5714370|P2|STARTED|Blinded Phase (Randomization - 3 Months)||30
2327908|NCT01818297|5714371|P1|STARTED|Blinded Phase (Randomization - 3 Months)||32
2327909|NCT01818284|5714389|P2|NOT COMPLETED|Overall Study||6
2327910|NCT01818284|5714390|P1|NOT COMPLETED|Overall Study||4
2327911|NCT01818284|5714389|P2|COMPLETED|Overall Study||5
2327912|NCT01818284|5714390|P1|COMPLETED|Overall Study||7
2327913|NCT01818284|5714389|P2|STARTED|Overall Study||11
2327914|NCT01818284|5714390|P1|STARTED|Overall Study||11
2327915|NCT01818245|5714398|P2|NOT COMPLETED|Intervention C||0
2327916|NCT01818245|5714399|P1|NOT COMPLETED|Intervention C||0
2327917|NCT01818245|5714398|P2|COMPLETED|Intervention C||0
2327918|NCT01818245|5714399|P1|COMPLETED|Intervention C||30
2327919|NCT01818245|5714398|P2|STARTED|Intervention C||0
2327920|NCT01818245|5714399|P1|STARTED|Intervention C||30
2327921|NCT01818245|5714398|P2|NOT COMPLETED|Washout (16-28 Days)||0
2327922|NCT01818245|5714399|P1|NOT COMPLETED|Washout (16-28 Days)||0
2327923|NCT01818245|5714398|P2|COMPLETED|Washout (16-28 Days)||0
2327924|NCT01818245|5714399|P1|COMPLETED|Washout (16-28 Days)||30
2327925|NCT01818245|5714398|P2|STARTED|Washout (16-28 Days)||0
2327926|NCT01818245|5714399|P1|STARTED|Washout (16-28 Days)||30
2327927|NCT01818245|5714398|P2|NOT COMPLETED|Intervention B||0
2327928|NCT01818245|5714399|P1|NOT COMPLETED|Intervention B||0
2327929|NCT01818245|5714398|P2|COMPLETED|Intervention B||0
2327930|NCT01818245|5714399|P1|COMPLETED|Intervention B||30
2327931|NCT01818245|5714398|P2|STARTED|Intervention B||0
2327932|NCT01818245|5714399|P1|STARTED|Intervention B||30
2327933|NCT01818245|5714398|P2|NOT COMPLETED|Washout (16-28 Days)||0
2327934|NCT01818245|5714399|P1|NOT COMPLETED|Washout (16-28 Days)||0
2327935|NCT01818245|5714398|P2|COMPLETED|Washout (16-28 Days)||0
2327936|NCT01818245|5714399|P1|COMPLETED|Washout (16-28 Days)||30
2327937|NCT01818245|5714398|P2|STARTED|Washout (16-28 Days)||0
2327938|NCT01818245|5714399|P1|STARTED|Washout (16-28 Days)||30
2327939|NCT01818245|5714398|P2|NOT COMPLETED|Intervention A||0
2327940|NCT01818245|5714399|P1|NOT COMPLETED|Intervention A||0
2327941|NCT01818245|5714398|P2|COMPLETED|Intervention A||22
2327942|NCT01818245|5714399|P1|COMPLETED|Intervention A||30
2327943|NCT01818245|5714398|P2|Received One Dose of Study Drug|Intervention A||22
2327944|NCT01818245|5714399|P1|Received One Dose of Study Drug|Intervention A||30
2327945|NCT01818245|5714398|P2|STARTED|Intervention A|Participants didn't participate in separate interventions and received 1 dose of LY2605541 on Day 1.|22
2327946|NCT01818245|5714399|P1|STARTED|Intervention A||30
2327947|NCT01818141|5714423|P2|NOT COMPLETED|Overall Study||3
2327948|NCT01818141|5714424|P1|NOT COMPLETED|Overall Study||3
2327949|NCT01818141|5714423|P2|COMPLETED|Overall Study||13
2327950|NCT01818141|5714424|P1|COMPLETED|Overall Study||15
2327951|NCT01818141|5714423|P2|STARTED|Overall Study||16
2327952|NCT01818141|5714424|P1|STARTED|Overall Study||18
2327953|NCT01818063|5714434|P2|NOT COMPLETED|Overall Study||0
2327954|NCT01818063|5714435|P1|NOT COMPLETED|Overall Study||0
2327955|NCT01818063|5714434|P2|COMPLETED|Overall Study||4
2327956|NCT01818063|5714435|P1|COMPLETED|Overall Study||5
2327957|NCT01818063|5714434|P2|STARTED|Overall Study||4
2327958|NCT01818063|5714435|P1|STARTED|Overall Study||5
2327965|NCT01817907|5714494|P2|NOT COMPLETED|Second Intervention||0
2327966|NCT01817907|5714495|P1|NOT COMPLETED|Second Intervention||0
2327967|NCT01817907|5714494|P2|COMPLETED|Second Intervention||7
2327968|NCT01817907|5714495|P1|COMPLETED|Second Intervention||8
2327969|NCT01817907|5714494|P2|STARTED|Second Intervention||7
2327970|NCT01817907|5714495|P1|STARTED|Second Intervention||8
2327971|NCT01817907|5714494|P2|NOT COMPLETED|Washout Period||0
2327972|NCT01817907|5714495|P1|NOT COMPLETED|Washout Period||0
2327973|NCT01817907|5714494|P2|COMPLETED|Washout Period||7
2327974|NCT01817907|5714495|P1|COMPLETED|Washout Period||8
2327975|NCT01817907|5714494|P2|STARTED|Washout Period||7
2327976|NCT01817907|5714495|P1|STARTED|Washout Period||8
2327977|NCT01817907|5714494|P2|NOT COMPLETED|First Intervention||0
2327978|NCT01817907|5714495|P1|NOT COMPLETED|First Intervention||0
2327979|NCT01817907|5714494|P2|COMPLETED|First Intervention||7
2327980|NCT01817907|5714495|P1|COMPLETED|First Intervention||8
2327981|NCT01817907|5714494|P2|STARTED|First Intervention||7
2327982|NCT01817907|5714495|P1|STARTED|First Intervention||8
2327983|NCT01817855|5714507|P4|NOT COMPLETED|Overall Study||0
2327984|NCT01817855|5714508|P3|NOT COMPLETED|Overall Study||2
2327985|NCT01817855|5714509|P2|NOT COMPLETED|Overall Study||2
2327986|NCT01817855|5714510|P1|NOT COMPLETED|Overall Study||0
2327987|NCT01817855|5714507|P4|COMPLETED|Overall Study||5
2327988|NCT01817855|5714508|P3|COMPLETED|Overall Study||9
2327989|NCT01817855|5714509|P2|COMPLETED|Overall Study||6
2327990|NCT01817855|5714510|P1|COMPLETED|Overall Study||23
2327991|NCT01817855|5714507|P4|STARTED|Overall Study||5
2327992|NCT01817855|5714508|P3|STARTED|Overall Study||11
2327993|NCT01817855|5714509|P2|STARTED|Overall Study||8
2327994|NCT01817855|5714510|P1|STARTED|Overall Study||23
2327995|NCT01817790|5714540|P2|NOT COMPLETED|Overall Study||8
2327996|NCT01817790|5714541|P1|NOT COMPLETED|Overall Study||4
2327997|NCT01817790|5714540|P2|COMPLETED|Overall Study||304
2327998|NCT01817790|5714541|P1|COMPLETED|Overall Study||310
2327999|NCT01817790|5714540|P2|STARTED|Overall Study||312
2328000|NCT01817790|5714541|P1|STARTED|Overall Study||314
2328001|NCT01817777|5714585|P3|NOT COMPLETED|Interventional Phase (20 Weeks)||5
2328002|NCT01817777|5714586|P2|NOT COMPLETED|Interventional Phase (20 Weeks)||5
2328003|NCT01817777|5714587|P1|NOT COMPLETED|Interventional Phase (20 Weeks)||0
2328004|NCT01817777|5714585|P3|COMPLETED|Interventional Phase (20 Weeks)||10
2328005|NCT01817777|5714586|P2|COMPLETED|Interventional Phase (20 Weeks)||11
2328006|NCT01817777|5714587|P1|COMPLETED|Interventional Phase (20 Weeks)||0
2328007|NCT01817777|5714585|P3|STARTED|Interventional Phase (20 Weeks)||15
2328008|NCT01817777|5714586|P2|STARTED|Interventional Phase (20 Weeks)||16
2328009|NCT01817777|5714587|P1|STARTED|Interventional Phase (20 Weeks)||0
2328010|NCT01817777|5714585|P3|NOT COMPLETED|Observational Phase (8 Weeks)||0
2328011|NCT01817777|5714586|P2|NOT COMPLETED|Observational Phase (8 Weeks)||0
2328012|NCT01817777|5714587|P1|NOT COMPLETED|Observational Phase (8 Weeks)||5
2328013|NCT01817777|5714585|P3|COMPLETED|Observational Phase (8 Weeks)||0
2328014|NCT01817777|5714586|P2|COMPLETED|Observational Phase (8 Weeks)||0
2328015|NCT01817777|5714587|P1|COMPLETED|Observational Phase (8 Weeks)||31
2328016|NCT01817777|5714585|P3|STARTED|Observational Phase (8 Weeks)||0
2328017|NCT01817777|5714586|P2|STARTED|Observational Phase (8 Weeks)||0
2328018|NCT01817777|5714587|P1|STARTED|Observational Phase (8 Weeks)||36
2328019|NCT01817764|5714611|P2|NOT COMPLETED|Overall Study||38
2328020|NCT01817764|5714612|P1|NOT COMPLETED|Overall Study||34
2328021|NCT01817764|5714611|P2|COMPLETED|Overall Study||315
2328022|NCT01817764|5714612|P1|COMPLETED|Overall Study||319
2328023|NCT01817764|5714611|P2|STARTED|Overall Study||353
2328024|NCT01817764|5714612|P1|STARTED|Overall Study||353
2328025|NCT01817725|5714620|P1|NOT COMPLETED|Overall Study||1
2328026|NCT01817725|5714620|P1|COMPLETED|Overall Study||19
2328027|NCT01817725|5714620|P1|STARTED|Overall Study||20
2328028|NCT01817712|5714627|P2|NOT COMPLETED|Overall Study||30
2328029|NCT01817712|5714628|P1|NOT COMPLETED|Overall Study||21
2328030|NCT01817712|5714627|P2|COMPLETED|Overall Study|Primary Outcome assessed over 18 months|240
2328031|NCT01817712|5714628|P1|COMPLETED|Overall Study|Primary Outcome Assessed over 18 months|250
2328032|NCT01817712|5714627|P2|STARTED|Overall Study||270
2328033|NCT01817712|5714628|P1|STARTED|Overall Study||271
2328034|NCT01817582|5714641|P3|NOT COMPLETED|Overall Study||0
2328035|NCT01817582|5714642|P2|NOT COMPLETED|Overall Study||1
2328036|NCT01817582|5714643|P1|NOT COMPLETED|Overall Study||2
2328037|NCT01817582|5714641|P3|COMPLETED|Overall Study||33
2328038|NCT01817582|5714642|P2|COMPLETED|Overall Study||35
2328039|NCT01817582|5714643|P1|COMPLETED|Overall Study||31
2328040|NCT01817582|5714641|P3|Received at Least 1 Dose of Study Drug|Overall Study||33
2328041|NCT01817582|5714642|P2|Received at Least 1 Dose of Study Drug|Overall Study||36
2328042|NCT01817582|5714643|P1|Received at Least 1 Dose of Study Drug|Overall Study||33
2328043|NCT01817582|5714641|P3|STARTED|Overall Study||33
2328044|NCT01817582|5714642|P2|STARTED|Overall Study||36
2328045|NCT01817582|5714643|P1|STARTED|Overall Study||33
2328046|NCT01817491|5714707|P2|NOT COMPLETED|Overall Study||0
2328047|NCT01817491|5714708|P1|NOT COMPLETED|Overall Study||4
2328048|NCT01817491|5714707|P2|COMPLETED|Overall Study||28
2328049|NCT01817491|5714708|P1|COMPLETED|Overall Study||28
2328050|NCT01817491|5714707|P2|STARTED|Overall Study||28
2328051|NCT01817491|5714708|P1|STARTED|Overall Study||32
2328052|NCT01817374|5714754|P1|NOT COMPLETED|Overall Study||0
2328053|NCT01817374|5714754|P1|COMPLETED|Overall Study||6
2328054|NCT01817374|5714754|P1|STARTED|Overall Study||6
2328055|NCT01816906|5714768|P2|NOT COMPLETED|12 Months||5
2328056|NCT01816906|5714769|P1|NOT COMPLETED|12 Months||4
2328057|NCT01816906|5714768|P2|COMPLETED|12 Months||14
2328058|NCT01816906|5714769|P1|COMPLETED|12 Months||16
2328059|NCT01816906|5714768|P2|STARTED|12 Months||19
2328060|NCT01816906|5714769|P1|STARTED|12 Months||20
2328061|NCT01816906|5714768|P2|NOT COMPLETED|Six Months||22
2328062|NCT01816906|5714769|P1|NOT COMPLETED|Six Months||21
2328063|NCT01816906|5714768|P2|COMPLETED|Six Months||19
2328064|NCT01816906|5714769|P1|COMPLETED|Six Months||20
2328065|NCT01816906|5714768|P2|STARTED|Six Months||41
2328066|NCT01816906|5714769|P1|STARTED|Six Months||41
2328067|NCT01816893|5714787|P2|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0
2328068|NCT01816893|5714788|P1|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0
2328069|NCT01816893|5714787|P2|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||11
2328070|NCT01816893|5714788|P1|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||9
2328071|NCT01816893|5714787|P2|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||11
2328072|NCT01816893|5714788|P1|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||9
2328073|NCT01816893|5714787|P2|NOT COMPLETED|Washout Period||0
2328074|NCT01816893|5714788|P1|NOT COMPLETED|Washout Period||2
2328075|NCT01816893|5714787|P2|COMPLETED|Washout Period||11
2328076|NCT01816893|5714788|P1|COMPLETED|Washout Period||9
2328077|NCT01816893|5714787|P2|STARTED|Washout Period||11
2328078|NCT01816893|5714788|P1|STARTED|Washout Period||11
2328079|NCT01816893|5714787|P2|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0
2328080|NCT01816893|5714788|P1|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0
2328081|NCT01816893|5714787|P2|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11
2328082|NCT01816893|5714788|P1|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11
2328083|NCT01816893|5714787|P2|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11
2328084|NCT01816893|5714788|P1|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11
2328085|NCT01816776|5714800|P2|NOT COMPLETED|Overall Study||8
2328086|NCT01816776|5714801|P1|NOT COMPLETED|Overall Study||13
2328087|NCT01816776|5714800|P2|COMPLETED|Overall Study||70
2328088|NCT01816776|5714801|P1|COMPLETED|Overall Study||60
2328089|NCT01816776|5714800|P2|6 Month Primary Effectiveness Assessed|Overall Study||73
2328090|NCT01816776|5714801|P1|6 Month Primary Effectiveness Assessed|Overall Study||68
2328091|NCT01816776|5714800|P2|STARTED|Overall Study||78
2328092|NCT01816776|5714801|P1|STARTED|Overall Study||73
2328093|NCT01816763|5714824|P3|NOT COMPLETED|Overall Study||11
2328094|NCT01816763|5714825|P2|NOT COMPLETED|Overall Study||15
2328095|NCT01816763|5714826|P1|NOT COMPLETED|Overall Study||4
2328096|NCT01816763|5714824|P3|COMPLETED|Overall Study||169
2328097|NCT01816763|5714825|P2|COMPLETED|Overall Study||179
2328098|NCT01816763|5714826|P1|COMPLETED|Overall Study||191
2328099|NCT01816763|5714824|P3|STARTED|Overall Study||180
2328100|NCT01816763|5714825|P2|STARTED|Overall Study||194
2328101|NCT01816763|5714826|P1|STARTED|Overall Study||195
2328102|NCT01816685|5714842|P2|NOT COMPLETED|Overall Study||11
2328103|NCT01816685|5714843|P1|NOT COMPLETED|Overall Study||10
2328104|NCT01816685|5714842|P2|COMPLETED|Overall Study||56
2328105|NCT01816685|5714843|P1|COMPLETED|Overall Study||58
2328106|NCT01816685|5714842|P2|STARTED|Overall Study||67
2328107|NCT01816685|5714843|P1|STARTED|Overall Study||68
2328108|NCT01816594|5714853|P2|NOT COMPLETED|Overall Study||2
2328109|NCT01816594|5714854|P1|NOT COMPLETED|Overall Study||11
2328110|NCT01816594|5714853|P2|COMPLETED|Overall Study||23
2328111|NCT01816594|5714854|P1|COMPLETED|Overall Study||14
2328112|NCT01816594|5714853|P2|Randomized to the mt Cohort|Overall Study|mt = PIK3CA mutant|4
2328113|NCT01816594|5714854|P1|Randomized to the mt Cohort|Overall Study|mt = PIK3CA mutant|4
2328114|NCT01816594|5714853|P2|Randomized to the wt Cohort|Overall Study|wt = PIK3CA wild-type|21
2328115|NCT01816594|5714854|P1|Randomized to the wt Cohort|Overall Study|wt = PIK3CA wild-type|21
2328116|NCT01816594|5714853|P2|STARTED|Overall Study||25
2328117|NCT01816594|5714854|P1|STARTED|Overall Study||25
2328118|NCT01816477|5714892|P2|NOT COMPLETED|Overall Study||1
2328119|NCT01816477|5714893|P1|NOT COMPLETED|Overall Study||16
2328120|NCT01816477|5714892|P2|COMPLETED|Overall Study||41
2328121|NCT01816477|5714893|P1|COMPLETED|Overall Study||27
2328122|NCT01816477|5714892|P2|STARTED|Overall Study||42
2328123|NCT01816477|5714893|P1|STARTED|Overall Study||43
2328124|NCT01816451|5714906|P3|NOT COMPLETED|Overall Study||0
2328125|NCT01816451|5714907|P2|NOT COMPLETED|Overall Study||0
2328126|NCT01816451|5714908|P1|NOT COMPLETED|Overall Study||0
2328127|NCT01816451|5714906|P3|COMPLETED|Overall Study||8
2328128|NCT01816451|5714907|P2|COMPLETED|Overall Study||11
2328129|NCT01816451|5714908|P1|COMPLETED|Overall Study||13
2328130|NCT01816451|5714906|P3|STARTED|Overall Study||8
2328131|NCT01816451|5714907|P2|STARTED|Overall Study||11
2328132|NCT01816451|5714908|P1|STARTED|Overall Study||13
2328133|NCT01816295|5714947|P2|NOT COMPLETED|OLE Phase||56
2328134|NCT01816295|5714948|P1|NOT COMPLETED|OLE Phase||53
2328135|NCT01816295|5714947|P2|COMPLETED|OLE Phase||227
2328136|NCT01816295|5714948|P1|COMPLETED|OLE Phase||222
2328137|NCT01816295|5714947|P2|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|283
2328138|NCT01816295|5714948|P1|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|275
2328139|NCT01816295|5714947|P2|NOT COMPLETED|Double Blind Phase||56
2328140|NCT01816295|5714948|P1|NOT COMPLETED|Double Blind Phase||63
2328141|NCT01816295|5714947|P2|COMPLETED|Double Blind Phase||302
2328142|NCT01816295|5714948|P1|COMPLETED|Double Blind Phase||294
2328143|NCT01816295|5714947|P2|Received Study Drug|Double Blind Phase||354
2328144|NCT01816295|5714948|P1|Received Study Drug|Double Blind Phase||356
2328145|NCT01816295|5714947|P2|STARTED|Double Blind Phase||358
2328146|NCT01816295|5714948|P1|STARTED|Double Blind Phase||357
2328147|NCT01816243|5714963|P1|NOT COMPLETED|Overall Study||12
2328148|NCT01816243|5714963|P1|COMPLETED|Overall Study||27
2328149|NCT01816243|5714963|P1|STARTED|Overall Study||39
2328150|NCT01816074|5714974|P4|NOT COMPLETED|Phase 2||1
2328151|NCT01816074|5714975|P3|NOT COMPLETED|Phase 2||0
2328152|NCT01816074|5714976|P2|NOT COMPLETED|Phase 2||2
2328153|NCT01816074|5714977|P1|NOT COMPLETED|Phase 2||2
2328154|NCT01816074|5714974|P4|COMPLETED|Phase 2||9
2328155|NCT01816074|5714975|P3|COMPLETED|Phase 2||10
2328156|NCT01816074|5714976|P2|COMPLETED|Phase 2||7
2328157|NCT01816074|5714977|P1|COMPLETED|Phase 2||9
2328158|NCT01816074|5714974|P4|STARTED|Phase 2||10
2328159|NCT01816074|5714975|P3|STARTED|Phase 2||10
2328160|NCT01816074|5714976|P2|STARTED|Phase 2||9
2328161|NCT01816074|5714977|P1|STARTED|Phase 2||11
2328162|NCT01816074|5714974|P4|NOT COMPLETED|Phase 1||0
2328163|NCT01816074|5714975|P3|NOT COMPLETED|Phase 1||1
2328164|NCT01816074|5714976|P2|NOT COMPLETED|Phase 1||0
2328165|NCT01816074|5714977|P1|NOT COMPLETED|Phase 1||0
2328166|NCT01816074|5714974|P4|COMPLETED|Phase 1||10
2328167|NCT01816074|5714975|P3|COMPLETED|Phase 1||10
2328168|NCT01816074|5714976|P2|COMPLETED|Phase 1||9
2328169|NCT01816074|5714977|P1|COMPLETED|Phase 1||11
2328170|NCT01816074|5714974|P4|STARTED|Phase 1||10
2328171|NCT01816074|5714975|P3|STARTED|Phase 1||11
2328172|NCT01816074|5714976|P2|STARTED|Phase 1||9
2328173|NCT01816074|5714977|P1|STARTED|Phase 1||11
2328174|NCT01816061|5715007|P2|NOT COMPLETED|Overall Study||24
2328175|NCT01816061|5715008|P1|NOT COMPLETED|Overall Study||13
2328176|NCT01816061|5715007|P2|COMPLETED|Overall Study||27
2328177|NCT01816061|5715008|P1|COMPLETED|Overall Study||27
2328178|NCT01816061|5715007|P2|STARTED|Overall Study||51
2328179|NCT01816061|5715008|P1|STARTED|Overall Study||40
2328180|NCT01816048|5715016|P1|NOT COMPLETED|Overall Study||6
2328181|NCT01816048|5715016|P1|COMPLETED|Overall Study||2
2328182|NCT01816048|5715016|P1|STARTED|Overall Study||8
2328183|NCT01815918|5715031|P2|NOT COMPLETED|Overall Study||19
2328184|NCT01815918|5715032|P1|NOT COMPLETED|Overall Study||18
2328185|NCT01815918|5715031|P2|COMPLETED|Overall Study||11
2328186|NCT01815918|5715032|P1|COMPLETED|Overall Study||12
2328187|NCT01815918|5715031|P2|STARTED|Overall Study||30
2328188|NCT01815918|5715032|P1|STARTED|Overall Study||30
2328189|NCT01815840|5715048|P2|NOT COMPLETED|Overall Study||63
2328190|NCT01815840|5715049|P1|NOT COMPLETED|Overall Study||59
2328191|NCT01815840|5715048|P2|COMPLETED|Overall Study||50
2328192|NCT01815840|5715049|P1|COMPLETED|Overall Study||57
2328193|NCT01815840|5715048|P2|STARTED|Overall Study||113
2328194|NCT01815840|5715049|P1|STARTED|Overall Study||116
2328195|NCT01815736|5715079|P2|NOT COMPLETED|Overall Study||478
2328196|NCT01815736|5715080|P1|NOT COMPLETED|Overall Study||961
2328197|NCT01815736|5715079|P2|COMPLETED|Overall Study||2
2328198|NCT01815736|5715080|P1|COMPLETED|Overall Study||2
2328199|NCT01815736|5715079|P2|STARTED|Overall Study||480
2328200|NCT01815736|5715080|P1|STARTED|Overall Study||963
2328201|NCT01815671|5715096|P2|NOT COMPLETED|Overall Study||0
2328202|NCT01815671|5715097|P1|NOT COMPLETED|Overall Study||0
2328203|NCT01815671|5715096|P2|COMPLETED|Overall Study||85
2328204|NCT01815671|5715097|P1|COMPLETED|Overall Study||88
2328205|NCT01815671|5715096|P2|STARTED|Overall Study||85
2328206|NCT01815671|5715097|P1|STARTED|Overall Study||88
2328207|NCT01815645|5715109|P2|NOT COMPLETED|Overall Study||0
2328208|NCT01815645|5715110|P1|NOT COMPLETED|Overall Study||0
2328209|NCT01815645|5715109|P2|COMPLETED|Overall Study||33
2328210|NCT01815645|5715110|P1|COMPLETED|Overall Study||32
2328211|NCT01815645|5715109|P2|STARTED|Overall Study||33
2328212|NCT01815645|5715110|P1|STARTED|Overall Study||32
2328213|NCT01815515|5715126|P1|NOT COMPLETED|Overall Study||0
2328214|NCT01815515|5715126|P1|COMPLETED|Overall Study||17
2328215|NCT01815515|5715126|P1|STARTED|Overall Study||17
2328216|NCT01815502|5715133|P2|NOT COMPLETED|Overall Study||0
2328217|NCT01815502|5715134|P1|NOT COMPLETED|Overall Study||0
2328218|NCT01815502|5715133|P2|COMPLETED|Overall Study||10
2328219|NCT01815502|5715134|P1|COMPLETED|Overall Study||10
2328220|NCT01815502|5715133|P2|STARTED|Overall Study||10
2328221|NCT01815502|5715134|P1|STARTED|Overall Study||10
2328222|NCT01815424|5715149|P5|NOT COMPLETED|Week 16 to 52||3
2328223|NCT01815424|5715150|P4|NOT COMPLETED|Week 16 to 52||3
2328224|NCT01815424|5715151|P3|NOT COMPLETED|Week 16 to 52||0
2328225|NCT01815424|5715152|P2|NOT COMPLETED|Week 16 to 52||5
2328226|NCT01815424|5715153|P1|NOT COMPLETED|Week 16 to 52||2
2328227|NCT01815424|5715149|P5|COMPLETED|Week 16 to 52||36
2328228|NCT01815424|5715150|P4|COMPLETED|Week 16 to 52||35
2328229|NCT01815424|5715151|P3|COMPLETED|Week 16 to 52||0
2328230|NCT01815424|5715152|P2|COMPLETED|Week 16 to 52||79
2328231|NCT01815424|5715153|P1|COMPLETED|Week 16 to 52||81
2328232|NCT01815424|5715149|P5|STARTED|Week 16 to 52||39
2328233|NCT01815424|5715150|P4|STARTED|Week 16 to 52||38
2328234|NCT01815424|5715151|P3|STARTED|Week 16 to 52||0
2328235|NCT01815424|5715152|P2|STARTED|Week 16 to 52||84
2328236|NCT01815424|5715153|P1|STARTED|Week 16 to 52||83
2328237|NCT01815424|5715149|P5|NOT COMPLETED|Week 0 to 16||0
2328238|NCT01815424|5715150|P4|NOT COMPLETED|Week 0 to 16||0
2328239|NCT01815424|5715151|P3|NOT COMPLETED|Week 0 to 16||11
2328240|NCT01815424|5715152|P2|NOT COMPLETED|Week 0 to 16||4
2328241|NCT01815424|5715153|P1|NOT COMPLETED|Week 0 to 16||7
2328242|NCT01815424|5715149|P5|COMPLETED|Week 0 to 16||0
2328243|NCT01815424|5715150|P4|COMPLETED|Week 0 to 16||0
2328244|NCT01815424|5715151|P3|COMPLETED|Week 0 to 16||77
2328245|NCT01815424|5715152|P2|COMPLETED|Week 0 to 16||84
2328246|NCT01815424|5715153|P1|COMPLETED|Week 0 to 16||83
2328247|NCT01815424|5715149|P5|STARTED|Week 0 to 16||0
2328248|NCT01815424|5715150|P4|STARTED|Week 0 to 16||0
2328249|NCT01815424|5715151|P3|STARTED|Week 0 to 16||88
2328250|NCT01815424|5715152|P2|STARTED|Week 0 to 16||88
2328251|NCT01815424|5715153|P1|STARTED|Week 0 to 16||90
2328252|NCT01815229|5715352|P3|NOT COMPLETED|Overall Study||51
2328253|NCT01815229|5715353|P2|NOT COMPLETED|Overall Study||0
2328254|NCT01815229|5715354|P1|NOT COMPLETED|Overall Study||0
2328255|NCT01815229|5715352|P3|COMPLETED|Overall Study||0
2328256|NCT01815229|5715353|P2|COMPLETED|Overall Study||18
2328257|NCT01815229|5715354|P1|COMPLETED|Overall Study||13
2328258|NCT01815229|5715352|P3|STARTED|Overall Study||51
2328259|NCT01815229|5715353|P2|STARTED|Overall Study||18
2328260|NCT01815229|5715354|P1|STARTED|Overall Study||13
2328261|NCT01815138|5715365|P2|NOT COMPLETED|Overall Study||6
2328262|NCT01815138|5715366|P1|NOT COMPLETED|Overall Study||8
2328263|NCT01815138|5715365|P2|COMPLETED|Overall Study||31
2328264|NCT01815138|5715366|P1|COMPLETED|Overall Study||26
2328265|NCT01815138|5715365|P2|STARTED|Overall Study||37
2328266|NCT01815138|5715366|P1|STARTED|Overall Study||34
2328267|NCT01815099|5715378|P1|NOT COMPLETED|Overall Study||2
2328268|NCT01815099|5715378|P1|COMPLETED|Overall Study||2
2328269|NCT01815099|5715378|P1|Began rTMS Treatment|Overall Study||3
2328270|NCT01815099|5715378|P1|STARTED|Overall Study||4
2328271|NCT01815008|5715383|P1|NOT COMPLETED|Overall Study||4
2328272|NCT01815008|5715383|P1|COMPLETED|Overall Study|transcriptomic data was available on 9 participants only|15
2328273|NCT01815008|5715383|P1|STARTED|Overall Study|Had difficulty in completing enrollment|19
2328274|NCT01814878|5715392|P2|NOT COMPLETED|Overall Study||30
2328275|NCT01814878|5715393|P1|NOT COMPLETED|Overall Study||46
2328276|NCT01814878|5715392|P2|COMPLETED|Overall Study||128
2328277|NCT01814878|5715393|P1|COMPLETED|Overall Study||116
2328278|NCT01814878|5715392|P2|STARTED|Overall Study||158
2328279|NCT01814878|5715393|P1|STARTED|Overall Study||162
2328280|NCT01814813|5715416|P3|NOT COMPLETED|Overall Study||0
2328281|NCT01814813|5715417|P2|NOT COMPLETED|Overall Study||0
2328282|NCT01814813|5715418|P1|NOT COMPLETED|Overall Study||0
2328283|NCT01814813|5715416|P3|COMPLETED|Overall Study||31
2328284|NCT01814813|5715417|P2|COMPLETED|Overall Study||30
2328285|NCT01814813|5715418|P1|COMPLETED|Overall Study||29
2328286|NCT01814813|5715416|P3|STARTED|Overall Study||31
2328287|NCT01814813|5715417|P2|STARTED|Overall Study||30
2328288|NCT01814813|5715418|P1|STARTED|Overall Study||29
2328289|NCT01814800|5715432|P1|NOT COMPLETED|Overall Study||5
2328290|NCT01814800|5715432|P1|COMPLETED|Overall Study||54
2328291|NCT01814800|5715432|P1|STARTED|Overall Study||59
2328292|NCT01814787|5715471|P2|NOT COMPLETED|Overall Study||0
2328293|NCT01814787|5715472|P1|NOT COMPLETED|Overall Study||0
2328294|NCT01814787|5715471|P2|COMPLETED|Overall Study||684
2328295|NCT01814787|5715472|P1|COMPLETED|Overall Study||685
2328296|NCT01814787|5715471|P2|STARTED|Overall Study||684
2328297|NCT01814787|5715472|P1|STARTED|Overall Study||685
2328298|NCT01814774|5715478|P1|NOT COMPLETED|Overall Study||0
2328299|NCT01814774|5715478|P1|COMPLETED|Overall Study||48
2328300|NCT01814774|5715478|P1|STARTED|Overall Study||48
2328301|NCT01814761|5715492|P2|NOT COMPLETED|Overall Study||30
2328302|NCT01814761|5715493|P1|NOT COMPLETED|Overall Study||8
2328303|NCT01814761|5715492|P2|COMPLETED|Overall Study||240
2328304|NCT01814761|5715493|P1|COMPLETED|Overall Study||34
2328305|NCT01814761|5715492|P2|STARTED|Overall Study||270
2328306|NCT01814761|5715493|P1|STARTED|Overall Study||42
2328307|NCT01814748|5715507|P2|NOT COMPLETED|Overall Study||7
2328308|NCT01814748|5715508|P1|NOT COMPLETED|Overall Study||8
2328309|NCT01814748|5715507|P2|COMPLETED|Overall Study||94
2328310|NCT01814748|5715508|P1|COMPLETED|Overall Study||94
2328311|NCT01814748|5715507|P2|STARTED|Overall Study||101
2328312|NCT01814748|5715508|P1|STARTED|Overall Study||102
2328313|NCT01814722|5715531|P3|NOT COMPLETED|Overall Study||0
2328314|NCT01814722|5715532|P2|NOT COMPLETED|Overall Study||0
2328315|NCT01814722|5715533|P1|NOT COMPLETED|Overall Study||0
2328316|NCT01814722|5715531|P3|COMPLETED|Overall Study||6
2328317|NCT01814722|5715532|P2|COMPLETED|Overall Study||21
2328318|NCT01814722|5715533|P1|COMPLETED|Overall Study||36
2328319|NCT01814722|5715531|P3|STARTED|Overall Study||6
2328320|NCT01814722|5715532|P2|STARTED|Overall Study||21
2328321|NCT01814722|5715533|P1|STARTED|Overall Study||36
2328322|NCT01814696|5715552|P2|NOT COMPLETED|Overall Study||0
2328323|NCT01814696|5715553|P1|NOT COMPLETED|Overall Study||2
2328324|NCT01814696|5715552|P2|COMPLETED|Overall Study||11
2328325|NCT01814696|5715553|P1|COMPLETED|Overall Study||13
2328326|NCT01814696|5715552|P2|STARTED|Overall Study||11
2328327|NCT01814696|5715553|P1|STARTED|Overall Study||15
2328328|NCT01814670|5715571|P1|NOT COMPLETED|Overall Study||12
2328329|NCT01814670|5715571|P1|COMPLETED|Overall Study||173
2328330|NCT01814670|5715571|P1|STARTED|Overall Study||185
2328331|NCT01814553|5715581|P2|NOT COMPLETED|Overall Study||22
2328332|NCT01814553|5715582|P1|NOT COMPLETED|Overall Study||18
2328333|NCT01814553|5715581|P2|COMPLETED|Overall Study||0
2328334|NCT01814553|5715582|P1|COMPLETED|Overall Study||0
2328335|NCT01814553|5715581|P2|STARTED|Overall Study||22
2328336|NCT01814553|5715582|P1|STARTED|Overall Study||18
2328337|NCT01814397|5715596|P1|NOT COMPLETED|Overall Study||14
2328338|NCT01814397|5715596|P1|COMPLETED|Overall Study||36
2328339|NCT01814397|5715596|P1|3 Month Evaluation|Overall Study||43
2328340|NCT01814397|5715596|P1|STARTED|Overall Study||50
2328341|NCT01814371|5715605|P2|NOT COMPLETED|Overall Study||27
2328342|NCT01814371|5715606|P1|NOT COMPLETED|Overall Study||30
2328343|NCT01814371|5715605|P2|COMPLETED|Overall Study||199
2328344|NCT01814371|5715606|P1|COMPLETED|Overall Study||218
2328345|NCT01814371|5715605|P2|STARTED|Overall Study||226
2328346|NCT01814371|5715606|P1|STARTED|Overall Study||248
2328347|NCT01814332|5715641|P2|NOT COMPLETED|Overall Study||16
2328348|NCT01814332|5715642|P1|NOT COMPLETED|Overall Study||16
2328349|NCT01814332|5715641|P2|COMPLETED|Overall Study||49
2328350|NCT01814332|5715642|P1|COMPLETED|Overall Study||47
2328351|NCT01814332|5715641|P2|STARTED|Overall Study||65
2328352|NCT01814332|5715642|P1|STARTED|Overall Study||63
2328353|NCT01814241|5715654|P1|NOT COMPLETED|Overall Study||4
2328354|NCT01814241|5715654|P1|COMPLETED|Overall Study||16
2328355|NCT01814241|5715654|P1|STARTED|Overall Study||20
2328356|NCT01814137|5715664|P2|NOT COMPLETED|Overall Study||5
2328357|NCT01814137|5715665|P1|NOT COMPLETED|Overall Study||5
2328358|NCT01814137|5715664|P2|COMPLETED|Overall Study||15
2328359|NCT01814137|5715665|P1|COMPLETED|Overall Study||15
2328360|NCT01814137|5715664|P2|STARTED|Overall Study||20
2328361|NCT01814137|5715665|P1|STARTED|Overall Study||20
2328362|NCT01814046|5715681|P3|NOT COMPLETED|Retreatment||0
2328363|NCT01814046|5715682|P2|NOT COMPLETED|Retreatment||0
2328364|NCT01814046|5715683|P1|NOT COMPLETED|Retreatment||0
2328365|NCT01814046|5715681|P3|COMPLETED|Retreatment||3
2328366|NCT01814046|5715682|P2|COMPLETED|Retreatment||0
2328367|NCT01814046|5715683|P1|COMPLETED|Retreatment||0
2328368|NCT01814046|5715681|P3|STARTED|Retreatment||3
2328369|NCT01814046|5715682|P2|STARTED|Retreatment||0
2328370|NCT01814046|5715683|P1|STARTED|Retreatment||0
2328371|NCT01814046|5715681|P3|NOT COMPLETED|Drug Administration||0
2328372|NCT01814046|5715682|P2|NOT COMPLETED|Drug Administration||0
2328373|NCT01814046|5715683|P1|NOT COMPLETED|Drug Administration||1
2328374|NCT01814046|5715681|P3|COMPLETED|Drug Administration||0
2328375|NCT01814046|5715682|P2|COMPLETED|Drug Administration||2
2328376|NCT01814046|5715683|P1|COMPLETED|Drug Administration||21
2328377|NCT01814046|5715681|P3|STARTED|Drug Administration||0
2328378|NCT01814046|5715682|P2|STARTED|Drug Administration||2
2328379|NCT01814046|5715683|P1|STARTED|Drug Administration||22
2328380|NCT01813890|5715697|P3|NOT COMPLETED|Overall Study||6
2328381|NCT01813890|5715698|P2|NOT COMPLETED|Overall Study||4
2328382|NCT01813890|5715699|P1|NOT COMPLETED|Overall Study||9
2328383|NCT01813890|5715697|P3|COMPLETED|Overall Study||13
2328384|NCT01813890|5715698|P2|COMPLETED|Overall Study||17
2328385|NCT01813890|5715699|P1|COMPLETED|Overall Study||11
2328386|NCT01813890|5715697|P3|STARTED|Overall Study||19
2328387|NCT01813890|5715698|P2|STARTED|Overall Study||21
2328388|NCT01813890|5715699|P1|STARTED|Overall Study||20
2328389|NCT01813734|5715728|P1|NOT COMPLETED|Overall Study||0
2328390|NCT01813734|5715728|P1|COMPLETED|Overall Study||9
2328391|NCT01813734|5715728|P1|STARTED|Overall Study||9
2328392|NCT01813721|5715736|P1|NOT COMPLETED|Overall Study||64
2328393|NCT01813721|5715736|P1|COMPLETED|Overall Study||943
2328394|NCT01813721|5715736|P1|STARTED|Overall Study|Indicates number of participants enrolled|1007
2328395|NCT01813474|5715791|P3|NOT COMPLETED|Overall Study||11
2328396|NCT01813474|5715792|P2|NOT COMPLETED|Overall Study||7
2328397|NCT01813474|5715793|P1|NOT COMPLETED|Overall Study||3
2328398|NCT01813474|5715791|P3|COMPLETED|Overall Study|ongoing study at final data cut off|1
2328399|NCT01813474|5715792|P2|COMPLETED|Overall Study||0
2328400|NCT01813474|5715793|P1|COMPLETED|Overall Study|ongoing study at final data cut off|1
2328401|NCT01813474|5715791|P3|STARTED|Overall Study||12
2328402|NCT01813474|5715792|P2|STARTED|Overall Study||7
2328403|NCT01813474|5715793|P1|STARTED|Overall Study||4
2328404|NCT01813435|5715817|P2|NOT COMPLETED|Overall Study||1007
2328405|NCT01813435|5715818|P1|NOT COMPLETED|Overall Study||2170
2328406|NCT01813435|5715817|P2|COMPLETED|Overall Study||6981
2328407|NCT01813435|5715818|P1|COMPLETED|Overall Study||5810
2328408|NCT01813435|5715817|P2|STARTED|Overall Study|11 participants withdrew consent or objected to use further use of data|7988
2328409|NCT01813435|5715818|P1|STARTED|Overall Study|12 participants withdrew consent or objected to use further use of data|7980
2328410|NCT01813422|5715842|P2|NOT COMPLETED|Overall Study||16
2328411|NCT01813422|5715843|P1|NOT COMPLETED|Overall Study||20
2328412|NCT01813422|5715842|P2|COMPLETED|Overall Study||468
2328413|NCT01813422|5715843|P1|COMPLETED|Overall Study||466
2328414|NCT01813422|5715842|P2|Received Treatment|Overall Study||484
2328415|NCT01813422|5715843|P1|Received Treatment|Overall Study||484
2328416|NCT01813422|5715842|P2|STARTED|Overall Study||484
2328417|NCT01813422|5715843|P1|STARTED|Overall Study||486
2328418|NCT01813214|5715857|P2|NOT COMPLETED|Overall Study||0
2328419|NCT01813214|5715858|P1|NOT COMPLETED|Overall Study||0
2328420|NCT01813214|5715857|P2|COMPLETED|Overall Study||2
2328421|NCT01813214|5715858|P1|COMPLETED|Overall Study||3
2328422|NCT01813214|5715857|P2|STARTED|Overall Study||2
2328423|NCT01813214|5715858|P1|STARTED|Overall Study||3
2328424|NCT01813110|5715868|P2|NOT COMPLETED|Overall Study||1
2328425|NCT01813110|5715869|P1|NOT COMPLETED|Overall Study||0
2328426|NCT01813110|5715868|P2|COMPLETED|Overall Study||10
2328427|NCT01813110|5715869|P1|COMPLETED|Overall Study||10
2328428|NCT01813110|5715868|P2|STARTED|Overall Study||11
2328429|NCT01813110|5715869|P1|STARTED|Overall Study||10
2328430|NCT01813071|5715888|P9|NOT COMPLETED|Overall Study||3
2328431|NCT01813071|5715889|P8|NOT COMPLETED|Overall Study||5
2328432|NCT01813071|5715890|P7|NOT COMPLETED|Overall Study||3
2328433|NCT01813071|5715891|P6|NOT COMPLETED|Overall Study||7
2328434|NCT01813071|5715892|P5|NOT COMPLETED|Overall Study||1
2328435|NCT01813071|5715893|P4|NOT COMPLETED|Overall Study||0
2328436|NCT01813071|5715894|P3|NOT COMPLETED|Overall Study||0
2328437|NCT01813071|5715895|P2|NOT COMPLETED|Overall Study||0
2328438|NCT01813071|5715896|P1|NOT COMPLETED|Overall Study||0
2328439|NCT01813071|5715888|P9|COMPLETED|Overall Study||13
2328440|NCT01813071|5715889|P8|COMPLETED|Overall Study||7
2328441|NCT01813071|5715890|P7|COMPLETED|Overall Study||9
2328442|NCT01813071|5715891|P6|COMPLETED|Overall Study||5
2328443|NCT01813071|5715892|P5|COMPLETED|Overall Study||11
2328444|NCT01813071|5715893|P4|COMPLETED|Overall Study||9
2328445|NCT01813071|5715894|P3|COMPLETED|Overall Study||10
2328446|NCT01813071|5715895|P2|COMPLETED|Overall Study||10
2328447|NCT01813071|5715896|P1|COMPLETED|Overall Study||10
2328448|NCT01813071|5715888|P9|STARTED|Overall Study||16
2328449|NCT01813071|5715889|P8|STARTED|Overall Study||12
2328450|NCT01813071|5715890|P7|STARTED|Overall Study||12
2328451|NCT01813071|5715891|P6|STARTED|Overall Study||12
2328452|NCT01813071|5715892|P5|STARTED|Overall Study||12
2328453|NCT01813071|5715893|P4|STARTED|Overall Study||9
2328454|NCT01813071|5715894|P3|STARTED|Overall Study||10
2328455|NCT01813071|5715895|P2|STARTED|Overall Study||10
2328456|NCT01813071|5715896|P1|STARTED|Overall Study||10
2328457|NCT01813058|5716363|P2|NOT COMPLETED|Overall Study||4
2328458|NCT01813058|5716364|P1|NOT COMPLETED|Overall Study||5
2328459|NCT01813058|5716363|P2|COMPLETED|Overall Study||56
2328460|NCT01813058|5716364|P1|COMPLETED|Overall Study||55
2328461|NCT01813058|5716363|P2|STARTED|Overall Study||60
2328462|NCT01813058|5716364|P1|STARTED|Overall Study||60
2328463|NCT01813019|5716372|P2|NOT COMPLETED|Overall Study||6
2328464|NCT01813019|5716373|P1|NOT COMPLETED|Overall Study||7
2328465|NCT01813019|5716372|P2|COMPLETED|Overall Study||20
2328466|NCT01813019|5716373|P1|COMPLETED|Overall Study||17
2328467|NCT01813019|5716372|P2|STARTED|Overall Study||26
2328468|NCT01813019|5716373|P1|STARTED|Overall Study||24
2328469|NCT01812837|5716384|P3|NOT COMPLETED|Overall Study||0
2328470|NCT01812837|5716385|P2|NOT COMPLETED|Overall Study||1
2328471|NCT01812837|5716386|P1|NOT COMPLETED|Overall Study||2
2328472|NCT01812837|5716384|P3|COMPLETED|Overall Study||17
2328473|NCT01812837|5716385|P2|COMPLETED|Overall Study||16
2328474|NCT01812837|5716386|P1|COMPLETED|Overall Study||15
2328475|NCT01812837|5716384|P3|STARTED|Overall Study||17
2328476|NCT01812837|5716385|P2|STARTED|Overall Study||17
2328477|NCT01812837|5716386|P1|STARTED|Overall Study||17
2328478|NCT01812707|5716398|P4|NOT COMPLETED|Overall Study||2
2328479|NCT01812707|5716399|P3|NOT COMPLETED|Overall Study||0
2328480|NCT01812707|5716400|P2|NOT COMPLETED|Overall Study||0
2328481|NCT01812707|5716401|P1|NOT COMPLETED|Overall Study||2
2328482|NCT01812707|5716398|P4|COMPLETED|Overall Study||23
2328483|NCT01812707|5716399|P3|COMPLETED|Overall Study||25
2328484|NCT01812707|5716400|P2|COMPLETED|Overall Study||25
2328485|NCT01812707|5716401|P1|COMPLETED|Overall Study||23
2328486|NCT01812707|5716398|P4|Treated|Overall Study||25
2328487|NCT01812707|5716399|P3|Treated|Overall Study||25
2328488|NCT01812707|5716400|P2|Treated|Overall Study||25
2328489|NCT01812707|5716401|P1|Treated|Overall Study||25
2328490|NCT01812707|5716398|P4|STARTED|Overall Study||25
2328491|NCT01812707|5716399|P3|STARTED|Overall Study||25
2328492|NCT01812707|5716400|P2|STARTED|Overall Study||25
2328493|NCT01812707|5716401|P1|STARTED|Overall Study||25
2328494|NCT01812681|5716437|P2|NOT COMPLETED|Overall Study||0
2328495|NCT01812681|5716438|P1|NOT COMPLETED|Overall Study||3
2328496|NCT01812681|5716437|P2|COMPLETED|Overall Study||24
2328497|NCT01812681|5716438|P1|COMPLETED|Overall Study||57
2328498|NCT01812681|5716437|P2|STARTED|Overall Study||24
2328499|NCT01812681|5716438|P1|STARTED|Overall Study||60
2328500|NCT01812655|5716449|P3|NOT COMPLETED|Overall Study||0
2328501|NCT01812655|5716450|P2|NOT COMPLETED|Overall Study||1
2328502|NCT01812655|5716451|P1|NOT COMPLETED|Overall Study||1
2328503|NCT01812655|5716449|P3|COMPLETED|Overall Study||10
2328504|NCT01812655|5716450|P2|COMPLETED|Overall Study||10
2328505|NCT01812655|5716451|P1|COMPLETED|Overall Study||8
2328506|NCT01812655|5716449|P3|STARTED|Overall Study|Nurses provided their usual, standard care throughout the entire burn wound care.|10
2328507|NCT01812655|5716450|P2|STARTED|Overall Study|Passive Distraction-Patients watched a movie during their burn wound care.|11
2328508|NCT01812655|5716451|P1|STARTED|Overall Study|Virtual Reality-Patients used an interactive VR program during their burn wound care procedure.|9
2328509|NCT01812473|5716467|P2|NOT COMPLETED|Overall Study||0
2328510|NCT01812473|5716468|P1|NOT COMPLETED|Overall Study||0
2328511|NCT01812473|5716467|P2|COMPLETED|Overall Study||13
2328512|NCT01812473|5716468|P1|COMPLETED|Overall Study||22
2328513|NCT01812473|5716467|P2|STARTED|Overall Study||13
2328514|NCT01812473|5716468|P1|STARTED|Overall Study||22
2328515|NCT01812057|5716476|P2|NOT COMPLETED|Overall Study||0
2328516|NCT01812057|5716477|P1|NOT COMPLETED|Overall Study||2
2328517|NCT01812057|5716476|P2|COMPLETED|Overall Study||24
2328518|NCT01812057|5716477|P1|COMPLETED|Overall Study||23
2328519|NCT01812057|5716476|P2|STARTED|Overall Study||24
2328520|NCT01812057|5716477|P1|STARTED|Overall Study||25
2328521|NCT01812044|5716518|P3|NOT COMPLETED|Overall Study||0
2328522|NCT01812044|5716519|P2|NOT COMPLETED|Overall Study||0
2328523|NCT01812044|5716520|P1|NOT COMPLETED|Overall Study||0
2328524|NCT01812044|5716518|P3|COMPLETED|Overall Study||16
2328525|NCT01812044|5716519|P2|COMPLETED|Overall Study||17
2328526|NCT01812044|5716520|P1|COMPLETED|Overall Study||17
2328527|NCT01812044|5716518|P3|STARTED|Overall Study||16
2328528|NCT01812044|5716519|P2|STARTED|Overall Study||17
2328529|NCT01812044|5716520|P1|STARTED|Overall Study||17
2328530|NCT01812005|5716551|P2|NOT COMPLETED|Overall Study||0
2328531|NCT01812005|5716552|P1|NOT COMPLETED|Overall Study||0
2328532|NCT01812005|5716551|P2|COMPLETED|Overall Study||13
2328533|NCT01812005|5716552|P1|COMPLETED|Overall Study||1
2328534|NCT01812005|5716551|P2|STARTED|Overall Study||13
2328535|NCT01812005|5716552|P1|STARTED|Overall Study||1
2328536|NCT01811953|5716580|P6|NOT COMPLETED|Overall Study||1
2328537|NCT01811953|5716581|P5|NOT COMPLETED|Overall Study||1
2328538|NCT01811953|5716582|P4|NOT COMPLETED|Overall Study||1
2328539|NCT01811953|5716583|P3|NOT COMPLETED|Overall Study||0
2328540|NCT01811953|5716584|P2|NOT COMPLETED|Overall Study||0
2328541|NCT01811953|5716585|P1|NOT COMPLETED|Overall Study||0
2328542|NCT01811953|5716580|P6|COMPLETED|Overall Study||11
2328543|NCT01811953|5716581|P5|COMPLETED|Overall Study||11
2328544|NCT01811953|5716582|P4|COMPLETED|Overall Study||5
2328545|NCT01811953|5716583|P3|COMPLETED|Overall Study||6
2328546|NCT01811953|5716584|P2|COMPLETED|Overall Study||6
2328547|NCT01811953|5716585|P1|COMPLETED|Overall Study||6
2328548|NCT01811953|5716580|P6|STARTED|Overall Study||12
2328549|NCT01811953|5716581|P5|STARTED|Overall Study||12
2328550|NCT01811953|5716582|P4|STARTED|Overall Study||6
2328551|NCT01811953|5716583|P3|STARTED|Overall Study||6
2328552|NCT01811953|5716584|P2|STARTED|Overall Study||6
2328553|NCT01811953|5716585|P1|STARTED|Overall Study||6
2328554|NCT01811940|5716631|P2|NOT COMPLETED|Overall Study||26
2328555|NCT01811940|5716632|P1|NOT COMPLETED|Overall Study||22
2328556|NCT01811940|5716631|P2|COMPLETED|Overall Study||37
2328557|NCT01811940|5716632|P1|COMPLETED|Overall Study||42
2328558|NCT01811940|5716631|P2|STARTED|Overall Study||63
2328559|NCT01811940|5716632|P1|STARTED|Overall Study||64
2328560|NCT01811732|5716642|P2|NOT COMPLETED|Overall Study||58
2328561|NCT01811732|5716643|P1|NOT COMPLETED|Overall Study||55
2328562|NCT01811732|5716642|P2|COMPLETED|Overall Study||271
2328563|NCT01811732|5716643|P1|COMPLETED|Overall Study||276
2328564|NCT01811732|5716642|P2|STARTED|Overall Study||329
2328565|NCT01811732|5716643|P1|STARTED|Overall Study||331
2328566|NCT01811706|5716653|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
2328567|NCT01811706|5716654|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
2328568|NCT01811706|5716653|P2|COMPLETED|Second Intervention (4 Weeks)||10
2328569|NCT01811706|5716654|P1|COMPLETED|Second Intervention (4 Weeks)||9
2328570|NCT01811706|5716653|P2|STARTED|Second Intervention (4 Weeks)||10
2328571|NCT01811706|5716654|P1|STARTED|Second Intervention (4 Weeks)||9
2328572|NCT01811706|5716653|P2|NOT COMPLETED|Washout ( 2 Weeks)||0
2328573|NCT01811706|5716654|P1|NOT COMPLETED|Washout ( 2 Weeks)||0
2328574|NCT01811706|5716653|P2|COMPLETED|Washout ( 2 Weeks)||10
2328575|NCT01811706|5716654|P1|COMPLETED|Washout ( 2 Weeks)||9
2328576|NCT01811706|5716653|P2|STARTED|Washout ( 2 Weeks)||10
2328577|NCT01811706|5716654|P1|STARTED|Washout ( 2 Weeks)||9
2328578|NCT01811706|5716653|P2|NOT COMPLETED|First Intervention ( 4 Weeks)||0
2328579|NCT01811706|5716654|P1|NOT COMPLETED|First Intervention ( 4 Weeks)||1
2328580|NCT01811706|5716653|P2|COMPLETED|First Intervention ( 4 Weeks)||10
2328581|NCT01811706|5716654|P1|COMPLETED|First Intervention ( 4 Weeks)||9
2328582|NCT01811706|5716653|P2|STARTED|First Intervention ( 4 Weeks)||10
2328583|NCT01811706|5716654|P1|STARTED|First Intervention ( 4 Weeks)||10
2328584|NCT01811680|5716664|P1|NOT COMPLETED|Overall Study||0
2328585|NCT01811680|5716664|P1|COMPLETED|Overall Study||10
2328586|NCT01811680|5716664|P1|STARTED|Overall Study||10
2328593|NCT01811563|5716682|P2|NOT COMPLETED|Overall Study||3
2328594|NCT01811563|5716683|P1|NOT COMPLETED|Overall Study||5
2328595|NCT01811563|5716682|P2|COMPLETED|Overall Study||20
2328596|NCT01811563|5716683|P1|COMPLETED|Overall Study||20
2328597|NCT01811563|5716682|P2|STARTED|Overall Study||23
2328598|NCT01811563|5716683|P1|STARTED|Overall Study||25
2328599|NCT01811485|5716712|P3|NOT COMPLETED|Overall Study||5
2328600|NCT01811485|5716713|P2|NOT COMPLETED|Overall Study||4
2328601|NCT01811485|5716714|P1|NOT COMPLETED|Overall Study||2
2328602|NCT01811485|5716712|P3|COMPLETED|Overall Study||51
2328603|NCT01811485|5716713|P2|COMPLETED|Overall Study||55
2328604|NCT01811485|5716714|P1|COMPLETED|Overall Study||54
2328605|NCT01811485|5716712|P3|STARTED|Overall Study||56
2328606|NCT01811485|5716713|P2|STARTED|Overall Study||59
2328607|NCT01811485|5716714|P1|STARTED|Overall Study|"Started indicates randomized patients"|56
2328608|NCT01811472|5716734|P3|NOT COMPLETED|Overall Study||5
2328609|NCT01811472|5716735|P2|NOT COMPLETED|Overall Study||0
2328610|NCT01811472|5716736|P1|NOT COMPLETED|Overall Study||2
2328611|NCT01811472|5716734|P3|COMPLETED|Overall Study||16
2328612|NCT01811472|5716735|P2|COMPLETED|Overall Study||11
2328613|NCT01811472|5716736|P1|COMPLETED|Overall Study||18
2328614|NCT01811472|5716734|P3|STARTED|Overall Study||21
2328615|NCT01811472|5716735|P2|STARTED|Overall Study||11
2328616|NCT01811472|5716736|P1|STARTED|Overall Study||20
2328617|NCT01811355|5716781|P2|NOT COMPLETED|Second Dose||0
2328618|NCT01811355|5716782|P1|NOT COMPLETED|Second Dose||0
2328619|NCT01811355|5716781|P2|COMPLETED|Second Dose||12
2328620|NCT01811355|5716782|P1|COMPLETED|Second Dose||9
2328621|NCT01811355|5716781|P2|STARTED|Second Dose||12
2328622|NCT01811355|5716782|P1|STARTED|Second Dose||9
2328623|NCT01811355|5716781|P2|NOT COMPLETED|Washout||0
2328624|NCT01811355|5716782|P1|NOT COMPLETED|Washout||0
2328625|NCT01811355|5716781|P2|COMPLETED|Washout||12
2328626|NCT01811355|5716782|P1|COMPLETED|Washout||9
2328627|NCT01811355|5716781|P2|STARTED|Washout||12
2328628|NCT01811355|5716782|P1|STARTED|Washout||9
2328629|NCT01811355|5716781|P2|NOT COMPLETED|First Dose||0
2328630|NCT01811355|5716782|P1|NOT COMPLETED|First Dose||2
2328631|NCT01811355|5716781|P2|COMPLETED|First Dose||12
2328632|NCT01811355|5716782|P1|COMPLETED|First Dose||9
2328633|NCT01811355|5716781|P2|STARTED|First Dose||12
2328634|NCT01811355|5716782|P1|STARTED|First Dose||11
2328635|NCT01811316|5716793|P3|NOT COMPLETED|Overall Study||0
2328636|NCT01811316|5716794|P2|NOT COMPLETED|Overall Study||0
2328637|NCT01811316|5716795|P1|NOT COMPLETED|Overall Study||3
2328638|NCT01811316|5716793|P3|COMPLETED|Overall Study||19
2328639|NCT01811316|5716794|P2|COMPLETED|Overall Study||22
2328640|NCT01811316|5716795|P1|COMPLETED|Overall Study||18
2328641|NCT01811316|5716793|P3|Visit 12 Weeks|Overall Study||19
2328642|NCT01811316|5716794|P2|Visit 12 Weeks|Overall Study||22
2328643|NCT01811316|5716795|P1|Visit 12 Weeks|Overall Study||18
2328644|NCT01811316|5716793|P3|Visit 4 Weeks|Overall Study||19
2328645|NCT01811316|5716794|P2|Visit 4 Weeks|Overall Study||22
2328646|NCT01811316|5716795|P1|Visit 4 Weeks|Overall Study||19
2328647|NCT01811316|5716793|P3|STARTED|Overall Study||19
2328648|NCT01811316|5716794|P2|STARTED|Overall Study||22
2328649|NCT01811316|5716795|P1|STARTED|Overall Study||21
2328650|NCT01811303|5716812|P4|NOT COMPLETED|Fourth Intervention (1 Day)||0
2328651|NCT01811303|5716813|P3|NOT COMPLETED|Fourth Intervention (1 Day)||0
2328652|NCT01811303|5716814|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
2328653|NCT01811303|5716815|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
2328654|NCT01811303|5716812|P4|COMPLETED|Fourth Intervention (1 Day)||2
2328655|NCT01811303|5716813|P3|COMPLETED|Fourth Intervention (1 Day)||4
2328656|NCT01811303|5716814|P2|COMPLETED|Fourth Intervention (1 Day)||4
2328657|NCT01811303|5716815|P1|COMPLETED|Fourth Intervention (1 Day)||4
2328658|NCT01811303|5716812|P4|STARTED|Fourth Intervention (1 Day)||2
2328659|NCT01811303|5716813|P3|STARTED|Fourth Intervention (1 Day)||4
2328660|NCT01811303|5716814|P2|STARTED|Fourth Intervention (1 Day)||4
2328661|NCT01811303|5716815|P1|STARTED|Fourth Intervention (1 Day)||4
2328662|NCT01811303|5716812|P4|NOT COMPLETED|Washout (2 Days or More)||0
2328663|NCT01811303|5716813|P3|NOT COMPLETED|Washout (2 Days or More)||0
2328664|NCT01811303|5716814|P2|NOT COMPLETED|Washout (2 Days or More)||0
2328665|NCT01811303|5716815|P1|NOT COMPLETED|Washout (2 Days or More)||0
2328666|NCT01811303|5716812|P4|COMPLETED|Washout (2 Days or More)||2
2328667|NCT01811303|5716813|P3|COMPLETED|Washout (2 Days or More)||4
2328668|NCT01811303|5716814|P2|COMPLETED|Washout (2 Days or More)||4
2328669|NCT01811303|5716815|P1|COMPLETED|Washout (2 Days or More)||4
2328670|NCT01811303|5716812|P4|STARTED|Washout (2 Days or More)||2
2328671|NCT01811303|5716813|P3|STARTED|Washout (2 Days or More)||4
2328672|NCT01811303|5716814|P2|STARTED|Washout (2 Days or More)||4
2328673|NCT01811303|5716815|P1|STARTED|Washout (2 Days or More)||4
2328674|NCT01811303|5716812|P4|NOT COMPLETED|Third Intervention (1 Day)||0
2328675|NCT01811303|5716813|P3|NOT COMPLETED|Third Intervention (1 Day)||0
2328676|NCT01811303|5716814|P2|NOT COMPLETED|Third Intervention (1 Day)||0
2328677|NCT01811303|5716815|P1|NOT COMPLETED|Third Intervention (1 Day)||0
2328678|NCT01811303|5716812|P4|COMPLETED|Third Intervention (1 Day)||2
2328679|NCT01811303|5716813|P3|COMPLETED|Third Intervention (1 Day)||4
2328680|NCT01811303|5716814|P2|COMPLETED|Third Intervention (1 Day)||4
2328681|NCT01811303|5716815|P1|COMPLETED|Third Intervention (1 Day)||4
2328682|NCT01811303|5716812|P4|STARTED|Third Intervention (1 Day)||2
2328683|NCT01811303|5716813|P3|STARTED|Third Intervention (1 Day)||4
2328684|NCT01811303|5716814|P2|STARTED|Third Intervention (1 Day)||4
2328685|NCT01811303|5716815|P1|STARTED|Third Intervention (1 Day)||4
2328686|NCT01811303|5716812|P4|NOT COMPLETED|Washout (2 Days or More)||0
2328687|NCT01811303|5716813|P3|NOT COMPLETED|Washout (2 Days or More)||0
2328688|NCT01811303|5716814|P2|NOT COMPLETED|Washout (2 Days or More)||0
2328689|NCT01811303|5716815|P1|NOT COMPLETED|Washout (2 Days or More)||0
2328690|NCT01811303|5716812|P4|COMPLETED|Washout (2 Days or More)||2
2328691|NCT01811303|5716813|P3|COMPLETED|Washout (2 Days or More)||4
2328692|NCT01811303|5716814|P2|COMPLETED|Washout (2 Days or More)||4
2328693|NCT01811303|5716815|P1|COMPLETED|Washout (2 Days or More)||4
2328694|NCT01811303|5716812|P4|STARTED|Washout (2 Days or More)||2
2328695|NCT01811303|5716813|P3|STARTED|Washout (2 Days or More)||4
2328696|NCT01811303|5716814|P2|STARTED|Washout (2 Days or More)||4
2328697|NCT01811303|5716815|P1|STARTED|Washout (2 Days or More)||4
2328698|NCT01811303|5716812|P4|NOT COMPLETED|Second Intervention (1 Day)||0
2328699|NCT01811303|5716813|P3|NOT COMPLETED|Second Intervention (1 Day)||0
2328700|NCT01811303|5716814|P2|NOT COMPLETED|Second Intervention (1 Day)||0
2328701|NCT01811303|5716815|P1|NOT COMPLETED|Second Intervention (1 Day)||0
2328702|NCT01811303|5716812|P4|COMPLETED|Second Intervention (1 Day)||2
2328703|NCT01811303|5716813|P3|COMPLETED|Second Intervention (1 Day)||4
2328704|NCT01811303|5716814|P2|COMPLETED|Second Intervention (1 Day)||4
2328705|NCT01811303|5716815|P1|COMPLETED|Second Intervention (1 Day)||4
2328706|NCT01811303|5716812|P4|STARTED|Second Intervention (1 Day)||2
2328707|NCT01811303|5716813|P3|STARTED|Second Intervention (1 Day)||4
2328708|NCT01811303|5716814|P2|STARTED|Second Intervention (1 Day)||4
2328709|NCT01811303|5716815|P1|STARTED|Second Intervention (1 Day)||4
2328710|NCT01811303|5716812|P4|NOT COMPLETED|Washout (2 Days or More)||0
2328711|NCT01811303|5716813|P3|NOT COMPLETED|Washout (2 Days or More)||0
2328712|NCT01811303|5716814|P2|NOT COMPLETED|Washout (2 Days or More)||0
2328713|NCT01811303|5716815|P1|NOT COMPLETED|Washout (2 Days or More)||0
2328714|NCT01811303|5716812|P4|COMPLETED|Washout (2 Days or More)||2
2328715|NCT01811303|5716813|P3|COMPLETED|Washout (2 Days or More)||4
2328716|NCT01811303|5716814|P2|COMPLETED|Washout (2 Days or More)||4
2328717|NCT01811303|5716815|P1|COMPLETED|Washout (2 Days or More)||4
2328718|NCT01811303|5716812|P4|STARTED|Washout (2 Days or More)||2
2328719|NCT01811303|5716813|P3|STARTED|Washout (2 Days or More)||4
2328720|NCT01811303|5716814|P2|STARTED|Washout (2 Days or More)||4
2328721|NCT01811303|5716815|P1|STARTED|Washout (2 Days or More)||4
2328722|NCT01811303|5716812|P4|NOT COMPLETED|First Intervention (1 Day)||0
2328723|NCT01811303|5716813|P3|NOT COMPLETED|First Intervention (1 Day)||0
2328724|NCT01811303|5716814|P2|NOT COMPLETED|First Intervention (1 Day)||0
2328725|NCT01811303|5716815|P1|NOT COMPLETED|First Intervention (1 Day)||0
2328726|NCT01811303|5716812|P4|COMPLETED|First Intervention (1 Day)||2
2328727|NCT01811303|5716813|P3|COMPLETED|First Intervention (1 Day)||4
2328728|NCT01811303|5716814|P2|COMPLETED|First Intervention (1 Day)||4
2328729|NCT01811303|5716815|P1|COMPLETED|First Intervention (1 Day)||4
2328730|NCT01811303|5716812|P4|STARTED|First Intervention (1 Day)||2
2328731|NCT01811303|5716813|P3|STARTED|First Intervention (1 Day)||4
2328732|NCT01811303|5716814|P2|STARTED|First Intervention (1 Day)||4
2328733|NCT01811303|5716815|P1|STARTED|First Intervention (1 Day)||4
2328734|NCT01811238|5716823|P1|NOT COMPLETED|Overall Study||81
2328735|NCT01811238|5716823|P1|COMPLETED|Overall Study|159 subjects regardless PP set completed study visit.|159
2328736|NCT01811238|5716823|P1|PP Set|Overall Study|89 subjects excluded from PP set due to various reasons.|120
2328737|NCT01811238|5716823|P1|ITT Set|Overall Study|11 subjects excluded from ITT set due to no primary efficacy assessment(5) and IC/EC violation(6).|209
2328738|NCT01811238|5716823|P1|Safety Set|Overall Study|20 subjects excluded from the safety set due to study drug not administered.|220
2328739|NCT01811238|5716823|P1|STARTED|Overall Study|First patient was recruited on 26 Sep. 2012.|240
2328740|NCT01811212|5716832|P1|NOT COMPLETED|Overall Study||0
2328741|NCT01811212|5716832|P1|COMPLETED|Overall Study||25
2328742|NCT01811212|5716832|P1|STARTED|Overall Study||25
2328743|NCT01811186|5716847|P2|NOT COMPLETED|Overall Study||62
2328744|NCT01811186|5716848|P1|NOT COMPLETED|Overall Study||71
2328745|NCT01811186|5716847|P2|COMPLETED|Overall Study||64
2328746|NCT01811186|5716848|P1|COMPLETED|Overall Study||61
2328747|NCT01811186|5716847|P2|STARTED|Overall Study||126
2328748|NCT01811186|5716848|P1|STARTED|Overall Study||132
2328749|NCT01811147|5716868|P4|NOT COMPLETED|Overall Study||29
2328750|NCT01811147|5716869|P3|NOT COMPLETED|Overall Study||43
2328751|NCT01811147|5716870|P2|NOT COMPLETED|Overall Study||45
2328752|NCT01811147|5716871|P1|NOT COMPLETED|Overall Study||36
2328753|NCT01811147|5716868|P4|COMPLETED|Overall Study||4
2328754|NCT01811147|5716869|P3|COMPLETED|Overall Study||6
2328755|NCT01811147|5716870|P2|COMPLETED|Overall Study||11
2328756|NCT01811147|5716871|P1|COMPLETED|Overall Study||15
2328757|NCT01811147|5716868|P4|STARTED|Overall Study||33
2328758|NCT01811147|5716869|P3|STARTED|Overall Study||49
2328759|NCT01811147|5716870|P2|STARTED|Overall Study||56
2328760|NCT01811147|5716871|P1|STARTED|Overall Study||51
2328761|NCT01810952|5716887|P2|NOT COMPLETED|Overall Study||0
2328762|NCT01810952|5716888|P1|NOT COMPLETED|Overall Study||0
2328763|NCT01810952|5716887|P2|COMPLETED|Overall Study||17
2328764|NCT01810952|5716888|P1|COMPLETED|Overall Study||20
2328765|NCT01810952|5716887|P2|STARTED|Overall Study||17
2328766|NCT01810952|5716888|P1|STARTED|Overall Study||20
2328767|NCT01810939|5716902|P3|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||22
2328768|NCT01810939|5716903|P2|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||10
2328769|NCT01810939|5716904|P1|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||0
2328770|NCT01810939|5716902|P3|COMPLETED|Part B Placebo-Controlled Withdrawal||30
2328771|NCT01810939|5716903|P2|COMPLETED|Part B Placebo-Controlled Withdrawal||45
2328772|NCT01810939|5716904|P1|COMPLETED|Part B Placebo-Controlled Withdrawal||0
2328773|NCT01810939|5716902|P3|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|52
2328774|NCT01810939|5716903|P2|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|55
2328775|NCT01810939|5716904|P1|STARTED|Part B Placebo-Controlled Withdrawal||0
2328776|NCT01810939|5716902|P3|NOT COMPLETED|Part A Treatment Period||0
2328777|NCT01810939|5716903|P2|NOT COMPLETED|Part A Treatment Period||0
2328778|NCT01810939|5716904|P1|NOT COMPLETED|Part A Treatment Period||24
2328779|NCT01810939|5716902|P3|COMPLETED|Part A Treatment Period||0
2328780|NCT01810939|5716903|P2|COMPLETED|Part A Treatment Period||0
2328781|NCT01810939|5716904|P1|COMPLETED|Part A Treatment Period||219
2328782|NCT01810939|5716902|P3|STARTED|Part A Treatment Period||0
2328783|NCT01810939|5716903|P2|STARTED|Part A Treatment Period||0
2328784|NCT01810939|5716904|P1|STARTED|Part A Treatment Period||243
2328785|NCT01810783|5716917|P1|NOT COMPLETED|Overall Study||109
2328786|NCT01810783|5716917|P1|COMPLETED|Overall Study||101
2328787|NCT01810783|5716917|P1|STARTED|Overall Study||210
2328788|NCT01810692|5716923|P2|NOT COMPLETED|Overall Study||0
2328789|NCT01810692|5716924|P1|NOT COMPLETED|Overall Study||0
2328790|NCT01810692|5716923|P2|COMPLETED|Overall Study||77
2328791|NCT01810692|5716924|P1|COMPLETED|Overall Study||77
2328792|NCT01810692|5716923|P2|STARTED|Overall Study||77
2328793|NCT01810692|5716924|P1|STARTED|Overall Study||77
2328794|NCT01810666|5716936|P1|NOT COMPLETED|Overall Study||0
2328795|NCT01810666|5716936|P1|COMPLETED|Overall Study||30
2328796|NCT01810666|5716936|P1|STARTED|Overall Study||30
2328797|NCT01810432|5716942|P2|NOT COMPLETED|Period 2||2
2328798|NCT01810432|5716943|P1|NOT COMPLETED|Period 2||4
2328799|NCT01810432|5716942|P2|COMPLETED|Period 2||17
2328800|NCT01810432|5716943|P1|COMPLETED|Period 2||15
2328801|NCT01810432|5716942|P2|Received at Least 1 Dose of Study Drug|Period 2||19
2328802|NCT01810432|5716943|P1|Received at Least 1 Dose of Study Drug|Period 2||19
2328803|NCT01810432|5716942|P2|STARTED|Period 2||19
2328804|NCT01810432|5716943|P1|STARTED|Period 2||19
2328805|NCT01810432|5716942|P2|NOT COMPLETED|Washout||1
2328806|NCT01810432|5716943|P1|NOT COMPLETED|Washout||1
2328807|NCT01810432|5716942|P2|COMPLETED|Washout||19
2328808|NCT01810432|5716943|P1|COMPLETED|Washout||19
2328809|NCT01810432|5716942|P2|STARTED|Washout||20
2328810|NCT01810432|5716943|P1|STARTED|Washout||20
2328811|NCT01810432|5716942|P2|NOT COMPLETED|Period 1||0
2328812|NCT01810432|5716943|P1|NOT COMPLETED|Period 1||0
2328813|NCT01810432|5716942|P2|COMPLETED|Period 1||20
2328814|NCT01810432|5716943|P1|COMPLETED|Period 1||20
2328815|NCT01810432|5716942|P2|Received at Least 1 Dose of Study Drug|Period 1||20
2328816|NCT01810432|5716943|P1|Received at Least 1 Dose of Study Drug|Period 1||20
2328817|NCT01810432|5716942|P2|STARTED|Period 1||20
2328818|NCT01810432|5716943|P1|STARTED|Period 1||20
2328819|NCT01810380|5716956|P3|NOT COMPLETED|Overall Study||32
2328820|NCT01810380|5716957|P2|NOT COMPLETED|Overall Study||38
2328821|NCT01810380|5716958|P1|NOT COMPLETED|Overall Study||55
2328822|NCT01810380|5716956|P3|COMPLETED|Overall Study||122
2328823|NCT01810380|5716957|P2|COMPLETED|Overall Study||113
2328824|NCT01810380|5716958|P1|COMPLETED|Overall Study||108
2328825|NCT01810380|5716956|P3|Treated|Overall Study||153
2328826|NCT01810380|5716957|P2|Treated|Overall Study||150
2328827|NCT01810380|5716958|P1|Treated|Overall Study||161
2328828|NCT01810380|5716956|P3|STARTED|Overall Study||154
2328829|NCT01810380|5716957|P2|STARTED|Overall Study||151
2328830|NCT01810380|5716958|P1|STARTED|Overall Study||163
2328831|NCT01810302|5717019|P2|NOT COMPLETED|Overall Study||1
2328832|NCT01810302|5717020|P1|NOT COMPLETED|Overall Study||1
2328833|NCT01810302|5717019|P2|COMPLETED|Overall Study||0
2328834|NCT01810302|5717020|P1|COMPLETED|Overall Study||0
2328835|NCT01810302|5717019|P2|STARTED|Overall Study||1
2328836|NCT01810302|5717020|P1|STARTED|Overall Study||1
2328837|NCT01810289|5717030|P2|NOT COMPLETED|Overall Study||0
2328838|NCT01810289|5717031|P1|NOT COMPLETED|Overall Study||0
2328839|NCT01810289|5717030|P2|COMPLETED|Overall Study||4747
2328840|NCT01810289|5717031|P1|COMPLETED|Overall Study||7277
2328841|NCT01810289|5717030|P2|STARTED|Overall Study||4747
2328842|NCT01810289|5717031|P1|STARTED|Overall Study||7277
2328843|NCT01810263|5717047|P2|NOT COMPLETED|Overall Study||7
2328844|NCT01810263|5717048|P1|NOT COMPLETED|Overall Study||8
2328845|NCT01810263|5717047|P2|COMPLETED|Overall Study||11
2328846|NCT01810263|5717048|P1|COMPLETED|Overall Study|2014 July|8
2328847|NCT01810263|5717047|P2|STARTED|Overall Study||18
2328848|NCT01810263|5717048|P1|STARTED|Overall Study||16
2328849|NCT01810042|5717054|P1|NOT COMPLETED|Overall Study||10
2328850|NCT01810042|5717054|P1|COMPLETED|Overall Study||39
2328851|NCT01810042|5717054|P1|STARTED|Overall Study||49
2328852|NCT01810016|5717064|P3|NOT COMPLETED|Overall Study||1
2328853|NCT01810016|5717065|P2|NOT COMPLETED|Overall Study||1
2328854|NCT01810016|5717066|P1|NOT COMPLETED|Overall Study||1
2328855|NCT01810016|5717064|P3|COMPLETED|Overall Study||0
2328856|NCT01810016|5717065|P2|COMPLETED|Overall Study||1
2328857|NCT01810016|5717066|P1|COMPLETED|Overall Study||4
2328858|NCT01810016|5717064|P3|STARTED|Overall Study||1
2328859|NCT01810016|5717065|P2|STARTED|Overall Study||2
2328860|NCT01810016|5717066|P1|STARTED|Overall Study||5
2328861|NCT01809938|5717077|P2|NOT COMPLETED|Second Intervention (170 Minutes)||0
2328862|NCT01809938|5717078|P1|NOT COMPLETED|Second Intervention (170 Minutes)||0
2328863|NCT01809938|5717077|P2|COMPLETED|Second Intervention (170 Minutes)||5
2328864|NCT01809938|5717078|P1|COMPLETED|Second Intervention (170 Minutes)||5
2328865|NCT01809938|5717077|P2|STARTED|Second Intervention (170 Minutes)||5
2328866|NCT01809938|5717078|P1|STARTED|Second Intervention (170 Minutes)||5
2328867|NCT01809938|5717077|P2|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
2328868|NCT01809938|5717078|P1|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
2328869|NCT01809938|5717077|P2|COMPLETED|Washout (Not Less Than 24 Hours)||5
2328870|NCT01809938|5717078|P1|COMPLETED|Washout (Not Less Than 24 Hours)||5
2328871|NCT01809938|5717077|P2|STARTED|Washout (Not Less Than 24 Hours)||5
2328872|NCT01809938|5717078|P1|STARTED|Washout (Not Less Than 24 Hours)||5
2328873|NCT01809938|5717077|P2|NOT COMPLETED|First Intervention (170 Minutes)||0
2328874|NCT01809938|5717078|P1|NOT COMPLETED|First Intervention (170 Minutes)||0
2328875|NCT01809938|5717077|P2|COMPLETED|First Intervention (170 Minutes)||5
2328876|NCT01809938|5717078|P1|COMPLETED|First Intervention (170 Minutes)||5
2328877|NCT01809938|5717077|P2|STARTED|First Intervention (170 Minutes)||5
2328878|NCT01809938|5717078|P1|STARTED|First Intervention (170 Minutes)||5
2328879|NCT01809899|5717087|P2|NOT COMPLETED|Overall Study||0
2328880|NCT01809899|5717088|P1|NOT COMPLETED|Overall Study||0
2328881|NCT01809899|5717087|P2|COMPLETED|Overall Study||4
2328882|NCT01809899|5717088|P1|COMPLETED|Overall Study||8
2328883|NCT01809899|5717087|P2|STARTED|Overall Study||4
2328884|NCT01809899|5717088|P1|STARTED|Overall Study||8
2328885|NCT01809834|5717096|P1|NOT COMPLETED|Overall Study||0
2328886|NCT01809834|5717096|P1|COMPLETED|Overall Study||44
2328887|NCT01809834|5717096|P1|STARTED|Overall Study||44
2328888|NCT01809639|5717124|P2|NOT COMPLETED|Overall Study||0
2328889|NCT01809639|5717125|P1|NOT COMPLETED|Overall Study||0
2328890|NCT01809639|5717124|P2|COMPLETED|Overall Study||7
2328891|NCT01809639|5717125|P1|COMPLETED|Overall Study||18
2328892|NCT01809639|5717124|P2|STARTED|Overall Study||7
2328893|NCT01809639|5717125|P1|STARTED|Overall Study||18
2328894|NCT01809327|5717136|P5|NOT COMPLETED|Overall Study||25
2328895|NCT01809327|5717137|P4|NOT COMPLETED|Overall Study||12
2328896|NCT01809327|5717138|P3|NOT COMPLETED|Overall Study||22
2328897|NCT01809327|5717139|P2|NOT COMPLETED|Overall Study||26
2328898|NCT01809327|5717140|P1|NOT COMPLETED|Overall Study||32
2328899|NCT01809327|5717136|P5|COMPLETED|Overall Study||212
2328900|NCT01809327|5717137|P4|COMPLETED|Overall Study||225
2328901|NCT01809327|5717138|P3|COMPLETED|Overall Study||216
2328902|NCT01809327|5717139|P2|COMPLETED|Overall Study||211
2328903|NCT01809327|5717140|P1|COMPLETED|Overall Study||205
2328904|NCT01809327|5717136|P5|STARTED|Overall Study||237
2328905|NCT01809327|5717137|P4|STARTED|Overall Study||237
2328906|NCT01809327|5717138|P3|STARTED|Overall Study||238
2328907|NCT01809327|5717139|P2|STARTED|Overall Study||237
2328908|NCT01809327|5717140|P1|STARTED|Overall Study||237
2328909|NCT01809314|5717182|P1|NOT COMPLETED|Overall Study||745
2328910|NCT01809314|5717182|P1|COMPLETED|Overall Study||422
2328911|NCT01809314|5717182|P1|STARTED|Overall Study||1167
2328912|NCT01809262|5717188|P10|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
2328913|NCT01809262|5717189|P9|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
2328914|NCT01809262|5717190|P8|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
2328915|NCT01809262|5717191|P7|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
2328916|NCT01809262|5717192|P6|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
2328917|NCT01809262|5717193|P5|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
2328918|NCT01809262|5717194|P4|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
2328919|NCT01809262|5717195|P3|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
2328920|NCT01809262|5717196|P2|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
2328921|NCT01809262|5717197|P1|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
2328922|NCT01809262|5717188|P10|COMPLETED|Period 5 (Fifth Dose + Washout)||4
2328923|NCT01809262|5717189|P9|COMPLETED|Period 5 (Fifth Dose + Washout)||3
2328924|NCT01809262|5717190|P8|COMPLETED|Period 5 (Fifth Dose + Washout)||4
2328925|NCT01809262|5717191|P7|COMPLETED|Period 5 (Fifth Dose + Washout)||3
2328926|NCT01809262|5717192|P6|COMPLETED|Period 5 (Fifth Dose + Washout)||3
2328927|NCT01809262|5717193|P5|COMPLETED|Period 5 (Fifth Dose + Washout)||3
2328928|NCT01809262|5717194|P4|COMPLETED|Period 5 (Fifth Dose + Washout)||3
2328929|NCT01809262|5717195|P3|COMPLETED|Period 5 (Fifth Dose + Washout)||4
2328930|NCT01809262|5717196|P2|COMPLETED|Period 5 (Fifth Dose + Washout)||3
2328931|NCT01809262|5717197|P1|COMPLETED|Period 5 (Fifth Dose + Washout)||4
2328932|NCT01809262|5717188|P10|STARTED|Period 5 (Fifth Dose + Washout)||4
2328933|NCT01809262|5717189|P9|STARTED|Period 5 (Fifth Dose + Washout)||3
2328934|NCT01809262|5717190|P8|STARTED|Period 5 (Fifth Dose + Washout)||4
2328935|NCT01809262|5717191|P7|STARTED|Period 5 (Fifth Dose + Washout)||3
2328936|NCT01809262|5717192|P6|STARTED|Period 5 (Fifth Dose + Washout)||3
2328937|NCT01809262|5717193|P5|STARTED|Period 5 (Fifth Dose + Washout)||3
2328938|NCT01809262|5717194|P4|STARTED|Period 5 (Fifth Dose + Washout)||3
2328939|NCT01809262|5717195|P3|STARTED|Period 5 (Fifth Dose + Washout)||4
2328940|NCT01809262|5717196|P2|STARTED|Period 5 (Fifth Dose + Washout)||3
2328941|NCT01809262|5717197|P1|STARTED|Period 5 (Fifth Dose + Washout)||4
2328942|NCT01809262|5717188|P10|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
2328943|NCT01809262|5717189|P9|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
2328944|NCT01809262|5717190|P8|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
2328945|NCT01809262|5717191|P7|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
2328946|NCT01809262|5717192|P6|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
2328947|NCT01809262|5717193|P5|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
2328948|NCT01809262|5717194|P4|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
2328949|NCT01809262|5717195|P3|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
2328950|NCT01809262|5717196|P2|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
2328951|NCT01809262|5717197|P1|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
2328952|NCT01809262|5717188|P10|COMPLETED|Period 4 (Fourth Dose + Washout)||4
2328953|NCT01809262|5717189|P9|COMPLETED|Period 4 (Fourth Dose + Washout)||3
2328954|NCT01809262|5717190|P8|COMPLETED|Period 4 (Fourth Dose + Washout)||4
2328955|NCT01809262|5717191|P7|COMPLETED|Period 4 (Fourth Dose + Washout)||3
2328956|NCT01809262|5717192|P6|COMPLETED|Period 4 (Fourth Dose + Washout)||3
2328957|NCT01809262|5717193|P5|COMPLETED|Period 4 (Fourth Dose + Washout)||3
2328958|NCT01809262|5717194|P4|COMPLETED|Period 4 (Fourth Dose + Washout)||3
2328959|NCT01809262|5717195|P3|COMPLETED|Period 4 (Fourth Dose + Washout)||4
2328960|NCT01809262|5717196|P2|COMPLETED|Period 4 (Fourth Dose + Washout)||3
2328961|NCT01809262|5717197|P1|COMPLETED|Period 4 (Fourth Dose + Washout)||4
2328962|NCT01809262|5717188|P10|STARTED|Period 4 (Fourth Dose + Washout)||4
2328963|NCT01809262|5717189|P9|STARTED|Period 4 (Fourth Dose + Washout)||3
2328964|NCT01809262|5717190|P8|STARTED|Period 4 (Fourth Dose + Washout)||4
2328965|NCT01809262|5717191|P7|STARTED|Period 4 (Fourth Dose + Washout)||3
2328966|NCT01809262|5717192|P6|STARTED|Period 4 (Fourth Dose + Washout)||3
2328967|NCT01809262|5717193|P5|STARTED|Period 4 (Fourth Dose + Washout)||3
2328968|NCT01809262|5717194|P4|STARTED|Period 4 (Fourth Dose + Washout)||3
2328969|NCT01809262|5717195|P3|STARTED|Period 4 (Fourth Dose + Washout)||4
2328970|NCT01809262|5717196|P2|STARTED|Period 4 (Fourth Dose + Washout)||3
2328971|NCT01809262|5717197|P1|STARTED|Period 4 (Fourth Dose + Washout)||4
2328972|NCT01809262|5717188|P10|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
2328973|NCT01809262|5717189|P9|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
2328974|NCT01809262|5717190|P8|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
2328975|NCT01809262|5717191|P7|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
2328976|NCT01809262|5717192|P6|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
2328977|NCT01809262|5717193|P5|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
2328978|NCT01809262|5717194|P4|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
2328979|NCT01809262|5717195|P3|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
2328980|NCT01809262|5717196|P2|NOT COMPLETED|Period 3 (Third Dose + Washout)||1
2328981|NCT01809262|5717197|P1|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
2328982|NCT01809262|5717188|P10|COMPLETED|Period 3 (Third Dose + Washout)||4
2328983|NCT01809262|5717189|P9|COMPLETED|Period 3 (Third Dose + Washout)||3
2328984|NCT01809262|5717190|P8|COMPLETED|Period 3 (Third Dose + Washout)||4
2328985|NCT01809262|5717191|P7|COMPLETED|Period 3 (Third Dose + Washout)||3
2328986|NCT01809262|5717192|P6|COMPLETED|Period 3 (Third Dose + Washout)||3
2328987|NCT01809262|5717193|P5|COMPLETED|Period 3 (Third Dose + Washout)||3
2328988|NCT01809262|5717194|P4|COMPLETED|Period 3 (Third Dose + Washout)||3
2328989|NCT01809262|5717195|P3|COMPLETED|Period 3 (Third Dose + Washout)||4
2328990|NCT01809262|5717196|P2|COMPLETED|Period 3 (Third Dose + Washout)||3
2328991|NCT01809262|5717197|P1|COMPLETED|Period 3 (Third Dose + Washout)||4
2328992|NCT01809262|5717188|P10|STARTED|Period 3 (Third Dose + Washout)||4
2328993|NCT01809262|5717189|P9|STARTED|Period 3 (Third Dose + Washout)||3
2328994|NCT01809262|5717190|P8|STARTED|Period 3 (Third Dose + Washout)||4
2328995|NCT01809262|5717191|P7|STARTED|Period 3 (Third Dose + Washout)||3
2328996|NCT01809262|5717192|P6|STARTED|Period 3 (Third Dose + Washout)||3
2328997|NCT01809262|5717193|P5|STARTED|Period 3 (Third Dose + Washout)||3
2328998|NCT01809262|5717194|P4|STARTED|Period 3 (Third Dose + Washout)||3
2328999|NCT01809262|5717195|P3|STARTED|Period 3 (Third Dose + Washout)||4
2329000|NCT01809262|5717196|P2|STARTED|Period 3 (Third Dose + Washout)||4
2329001|NCT01809262|5717197|P1|STARTED|Period 3 (Third Dose + Washout)||4
2329002|NCT01809262|5717188|P10|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
2329003|NCT01809262|5717189|P9|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
2329004|NCT01809262|5717190|P8|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
2329005|NCT01809262|5717191|P7|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
2329006|NCT01809262|5717192|P6|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
2329007|NCT01809262|5717193|P5|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
2329008|NCT01809262|5717194|P4|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
2329009|NCT01809262|5717195|P3|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
2329010|NCT01809262|5717196|P2|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
2329011|NCT01809262|5717197|P1|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
2329012|NCT01809262|5717188|P10|COMPLETED|Period 2 (Second Dose + Washout)||4
2329013|NCT01809262|5717189|P9|COMPLETED|Period 2 (Second Dose + Washout)||3
2329014|NCT01809262|5717190|P8|COMPLETED|Period 2 (Second Dose + Washout)||4
2329015|NCT01809262|5717191|P7|COMPLETED|Period 2 (Second Dose + Washout)||3
2329016|NCT01809262|5717192|P6|COMPLETED|Period 2 (Second Dose + Washout)||3
2329017|NCT01809262|5717193|P5|COMPLETED|Period 2 (Second Dose + Washout)||3
2329018|NCT01809262|5717194|P4|COMPLETED|Period 2 (Second Dose + Washout)||3
2329019|NCT01809262|5717195|P3|COMPLETED|Period 2 (Second Dose + Washout)||4
2329020|NCT01809262|5717196|P2|COMPLETED|Period 2 (Second Dose + Washout)||4
2329021|NCT01809262|5717197|P1|COMPLETED|Period 2 (Second Dose + Washout)||4
2329022|NCT01809262|5717188|P10|STARTED|Period 2 (Second Dose + Washout)||4
2329023|NCT01809262|5717189|P9|STARTED|Period 2 (Second Dose + Washout)||3
2329024|NCT01809262|5717190|P8|STARTED|Period 2 (Second Dose + Washout)||4
2329025|NCT01809262|5717191|P7|STARTED|Period 2 (Second Dose + Washout)||3
2329026|NCT01809262|5717192|P6|STARTED|Period 2 (Second Dose + Washout)||3
2329027|NCT01809262|5717193|P5|STARTED|Period 2 (Second Dose + Washout)||3
2329028|NCT01809262|5717194|P4|STARTED|Period 2 (Second Dose + Washout)||3
2329029|NCT01809262|5717195|P3|STARTED|Period 2 (Second Dose + Washout)||4
2329030|NCT01809262|5717196|P2|STARTED|Period 2 (Second Dose + Washout)||4
2329031|NCT01809262|5717197|P1|STARTED|Period 2 (Second Dose + Washout)||4
2329032|NCT01809262|5717188|P10|NOT COMPLETED|Period 1 (First Dose + Washout)||0
2329033|NCT01809262|5717189|P9|NOT COMPLETED|Period 1 (First Dose + Washout)||0
2329034|NCT01809262|5717190|P8|NOT COMPLETED|Period 1 (First Dose + Washout)||0
2329035|NCT01809262|5717191|P7|NOT COMPLETED|Period 1 (First Dose + Washout)||0
2329036|NCT01809262|5717192|P6|NOT COMPLETED|Period 1 (First Dose + Washout)||0
2329037|NCT01809262|5717193|P5|NOT COMPLETED|Period 1 (First Dose + Washout)||1
2329038|NCT01809262|5717194|P4|NOT COMPLETED|Period 1 (First Dose + Washout)||0
2329039|NCT01809262|5717195|P3|NOT COMPLETED|Period 1 (First Dose + Washout)||0
2329040|NCT01809262|5717196|P2|NOT COMPLETED|Period 1 (First Dose + Washout)||0
2329041|NCT01809262|5717197|P1|NOT COMPLETED|Period 1 (First Dose + Washout)||0
2329042|NCT01809262|5717188|P10|COMPLETED|Period 1 (First Dose + Washout)||4
2329043|NCT01809262|5717189|P9|COMPLETED|Period 1 (First Dose + Washout)||3
2329044|NCT01809262|5717190|P8|COMPLETED|Period 1 (First Dose + Washout)||4
2329045|NCT01809262|5717191|P7|COMPLETED|Period 1 (First Dose + Washout)||3
2329046|NCT01809262|5717192|P6|COMPLETED|Period 1 (First Dose + Washout)||3
2329047|NCT01809262|5717193|P5|COMPLETED|Period 1 (First Dose + Washout)||3
2329048|NCT01809262|5717194|P4|COMPLETED|Period 1 (First Dose + Washout)||3
2329049|NCT01809262|5717195|P3|COMPLETED|Period 1 (First Dose + Washout)||4
2329050|NCT01809262|5717196|P2|COMPLETED|Period 1 (First Dose + Washout)||4
2329051|NCT01809262|5717197|P1|COMPLETED|Period 1 (First Dose + Washout)||4
2329052|NCT01809262|5717188|P10|STARTED|Period 1 (First Dose + Washout)||4
2329053|NCT01809262|5717189|P9|STARTED|Period 1 (First Dose + Washout)||3
2329054|NCT01809262|5717190|P8|STARTED|Period 1 (First Dose + Washout)||4
2329055|NCT01809262|5717191|P7|STARTED|Period 1 (First Dose + Washout)||3
2329056|NCT01809262|5717192|P6|STARTED|Period 1 (First Dose + Washout)||3
2329057|NCT01809262|5717193|P5|STARTED|Period 1 (First Dose + Washout)||4
2329058|NCT01809262|5717194|P4|STARTED|Period 1 (First Dose + Washout)||3
2329059|NCT01809262|5717195|P3|STARTED|Period 1 (First Dose + Washout)||4
2329060|NCT01809262|5717196|P2|STARTED|Period 1 (First Dose + Washout)||4
2329061|NCT01809262|5717197|P1|STARTED|Period 1 (First Dose + Washout)||4
2329062|NCT01809210|5717271|P7|NOT COMPLETED|Overall Study||5
2329063|NCT01809210|5717272|P6|NOT COMPLETED|Overall Study||3
2329064|NCT01809210|5717273|P5|NOT COMPLETED|Overall Study||2
2329065|NCT01809210|5717274|P4|NOT COMPLETED|Overall Study||1
2329066|NCT01809210|5717275|P3|NOT COMPLETED|Overall Study||3
2329067|NCT01809210|5717276|P2|NOT COMPLETED|Overall Study||1
2329068|NCT01809210|5717277|P1|NOT COMPLETED|Overall Study||1
2329069|NCT01809210|5717271|P7|COMPLETED|Overall Study||7
2329070|NCT01809210|5717272|P6|COMPLETED|Overall Study||12
2329071|NCT01809210|5717273|P5|COMPLETED|Overall Study||4
2329072|NCT01809210|5717274|P4|COMPLETED|Overall Study||2
2329073|NCT01809210|5717275|P3|COMPLETED|Overall Study||4
2329074|NCT01809210|5717276|P2|COMPLETED|Overall Study||8
2329075|NCT01809210|5717277|P1|COMPLETED|Overall Study||2
2329076|NCT01809210|5717271|P7|STARTED|Overall Study||12
2329077|NCT01809210|5717272|P6|STARTED|Overall Study||15
2329078|NCT01809210|5717273|P5|STARTED|Overall Study||6
2329079|NCT01809210|5717274|P4|STARTED|Overall Study||3
2329080|NCT01809210|5717275|P3|STARTED|Overall Study||7
2329081|NCT01809210|5717276|P2|STARTED|Overall Study||9
2329082|NCT01809210|5717277|P1|STARTED|Overall Study||3
2329083|NCT01809197|5717351|P2|NOT COMPLETED|Overall Study||8
2329084|NCT01809197|5717352|P1|NOT COMPLETED|Overall Study||10
2329085|NCT01809197|5717351|P2|COMPLETED|Overall Study||177
2329086|NCT01809197|5717352|P1|COMPLETED|Overall Study||177
2329087|NCT01809197|5717351|P2|STARTED|Overall Study||185
2329088|NCT01809197|5717352|P1|STARTED|Overall Study||187
2329089|NCT01809106|5717362|P4|NOT COMPLETED|Overall Study||4
2329090|NCT01809106|5717363|P3|NOT COMPLETED|Overall Study||3
2329091|NCT01809106|5717364|P2|NOT COMPLETED|Overall Study||5
2329092|NCT01809106|5717365|P1|NOT COMPLETED|Overall Study||8
2329093|NCT01809106|5717362|P4|COMPLETED|Overall Study||124
2329094|NCT01809106|5717363|P3|COMPLETED|Overall Study||127
2329095|NCT01809106|5717364|P2|COMPLETED|Overall Study||125
2329096|NCT01809106|5717365|P1|COMPLETED|Overall Study||122
2329097|NCT01809106|5717362|P4|STARTED|Overall Study||128
2329098|NCT01809106|5717363|P3|STARTED|Overall Study||130
2329099|NCT01809106|5717364|P2|STARTED|Overall Study||130
2329100|NCT01809106|5717365|P1|STARTED|Overall Study||130
2329101|NCT01809054|5717385|P2|NOT COMPLETED|Overall Study||0
2329102|NCT01809054|5717386|P1|NOT COMPLETED|Overall Study||0
2329103|NCT01809054|5717385|P2|COMPLETED|Overall Study||22
2329104|NCT01809054|5717386|P1|COMPLETED|Overall Study||27
2329105|NCT01809054|5717385|P2|STARTED|Overall Study||22
2329106|NCT01809054|5717386|P1|STARTED|Overall Study||27
2329107|NCT01808963|5717394|P1|NOT COMPLETED|Overall Study||0
2329108|NCT01808963|5717394|P1|COMPLETED|Overall Study||13
2329109|NCT01808963|5717394|P1|STARTED|Overall Study||13
2329110|NCT01808950|5717401|P3|NOT COMPLETED|Overall Study||0
2329111|NCT01808950|5717402|P2|NOT COMPLETED|Overall Study||0
2329112|NCT01808950|5717403|P1|NOT COMPLETED|Overall Study||0
2329113|NCT01808950|5717401|P3|COMPLETED|Overall Study||0
2329114|NCT01808950|5717402|P2|COMPLETED|Overall Study||3
2329115|NCT01808950|5717403|P1|COMPLETED|Overall Study||1
2329116|NCT01808950|5717401|P3|STARTED|Overall Study||0
2329117|NCT01808950|5717402|P2|STARTED|Overall Study||3
2329118|NCT01808950|5717403|P1|STARTED|Overall Study||1
2329125|NCT01808755|5717425|P2|NOT COMPLETED|Overall Study||0
2329126|NCT01808755|5717426|P1|NOT COMPLETED|Overall Study||0
2329127|NCT01808755|5717425|P2|COMPLETED|Overall Study||30
2329128|NCT01808755|5717426|P1|COMPLETED|Overall Study||30
2329129|NCT01808755|5717425|P2|STARTED|Overall Study||30
2329130|NCT01808755|5717426|P1|STARTED|Overall Study||30
2329131|NCT01808690|5717433|P2|NOT COMPLETED|Overall Study||2
2329132|NCT01808690|5717434|P1|NOT COMPLETED|Overall Study||1
2329133|NCT01808690|5717433|P2|COMPLETED|Overall Study||21
2329134|NCT01808690|5717434|P1|COMPLETED|Overall Study||24
2329135|NCT01808690|5717433|P2|STARTED|Overall Study||23
2329136|NCT01808690|5717434|P1|STARTED|Overall Study||25
2329137|NCT01808651|5717453|P3|NOT COMPLETED|Study Period 2||0
2329138|NCT01808651|5717454|P2|NOT COMPLETED|Study Period 2||0
2329139|NCT01808651|5717455|P1|NOT COMPLETED|Study Period 2||0
2329140|NCT01808651|5717453|P3|COMPLETED|Study Period 2|3 Pts who DC'd from Study Period 1 and 30 pts who completed Study Period 1 entered Study Period 2.|33
2329141|NCT01808651|5717454|P2|COMPLETED|Study Period 2|5 Pts who DC'd from Study Period 1 and 47 Pts who completed Study Period 1 entered Study Period 2.|52
2329142|NCT01808651|5717455|P1|COMPLETED|Study Period 2|9 Pts who DC'd from Study Period 1 and 68 Pts who completed Study Period 1 entered Study Period 2.|77
2329143|NCT01808651|5717453|P3|STARTED|Study Period 2||33
2329144|NCT01808651|5717454|P2|STARTED|Study Period 2||52
2329145|NCT01808651|5717455|P1|STARTED|Study Period 2||77
2329146|NCT01808651|5717453|P3|NOT COMPLETED|Study Period 1||5
2329147|NCT01808651|5717454|P2|NOT COMPLETED|Study Period 1||17
2329148|NCT01808651|5717455|P1|NOT COMPLETED|Study Period 1||26
2329149|NCT01808651|5717453|P3|COMPLETED|Study Period 1||31
2329150|NCT01808651|5717454|P2|COMPLETED|Study Period 1||48
2329151|NCT01808651|5717455|P1|COMPLETED|Study Period 1||73
2329152|NCT01808651|5717453|P3|Received at Least One Dose of Study Drug|Study Period 1||36
2329153|NCT01808651|5717454|P2|Received at Least One Dose of Study Drug|Study Period 1||65
2329154|NCT01808651|5717455|P1|Received at Least One Dose of Study Drug|Study Period 1||98
2329155|NCT01808651|5717453|P3|STARTED|Study Period 1||36
2329156|NCT01808651|5717454|P2|STARTED|Study Period 1||65
2329157|NCT01808651|5717455|P1|STARTED|Study Period 1||99
2329158|NCT01808612|5717490|P3|NOT COMPLETED|Discontinuation Period||0
2329159|NCT01808612|5717491|P2|NOT COMPLETED|Discontinuation Period||1
2329160|NCT01808612|5717492|P1|NOT COMPLETED|Discontinuation Period||2
2329161|NCT01808612|5717490|P3|COMPLETED|Discontinuation Period||145
2329162|NCT01808612|5717491|P2|COMPLETED|Discontinuation Period||37
2329163|NCT01808612|5717492|P1|COMPLETED|Discontinuation Period||85
2329164|NCT01808612|5717490|P3|STARTED|Discontinuation Period||145
2329165|NCT01808612|5717491|P2|STARTED|Discontinuation Period||38
2329166|NCT01808612|5717492|P1|STARTED|Discontinuation Period||87
2329167|NCT01808612|5717490|P3|NOT COMPLETED|Treatment Period||14
2329168|NCT01808612|5717491|P2|NOT COMPLETED|Treatment Period||7
2329169|NCT01808612|5717492|P1|NOT COMPLETED|Treatment Period||15
2329170|NCT01808612|5717490|P3|COMPLETED|Treatment Period|101 participants who completed the Treatment Period did not enter the Discontinuation Period.|246
2329171|NCT01808612|5717491|P2|COMPLETED|Treatment Period|39 participants who completed the Treatment Period did not enter the Discontinuation Period.|77
2329172|NCT01808612|5717492|P1|COMPLETED|Treatment Period|67 participants who completed the Treatment Period did not enter the Discontinuation Period.|154
2329173|NCT01808612|5717490|P3|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|259
2329174|NCT01808612|5717491|P2|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|83
2329175|NCT01808612|5717492|P1|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|168
2329176|NCT01808612|5717490|P3|STARTED|Treatment Period||260
2329177|NCT01808612|5717491|P2|STARTED|Treatment Period||84
2329178|NCT01808612|5717492|P1|STARTED|Treatment Period||169
2329179|NCT01808573|5717523|P2|NOT COMPLETED|Overall Study||99
2329180|NCT01808573|5717524|P1|NOT COMPLETED|Overall Study||122
2329181|NCT01808573|5717523|P2|COMPLETED|Overall Study||215
2329182|NCT01808573|5717524|P1|COMPLETED|Overall Study||185
2329183|NCT01808573|5717523|P2|Received Treatment|Overall Study||311
2329184|NCT01808573|5717524|P1|Received Treatment|Overall Study||303
2329185|NCT01808573|5717523|P2|STARTED|Overall Study||314
2329186|NCT01808573|5717524|P1|STARTED|Overall Study||307
2329187|NCT01808560|5717545|P3|NOT COMPLETED|4-Month After Cataract Surgery||0
2329188|NCT01808560|5717546|P2|NOT COMPLETED|4-Month After Cataract Surgery||0
2329189|NCT01808560|5717547|P1|NOT COMPLETED|4-Month After Cataract Surgery||0
2329190|NCT01808560|5717545|P3|COMPLETED|4-Month After Cataract Surgery||13
2329191|NCT01808560|5717546|P2|COMPLETED|4-Month After Cataract Surgery||0
2329192|NCT01808560|5717547|P1|COMPLETED|4-Month After Cataract Surgery||0
2329193|NCT01808560|5717545|P3|STARTED|4-Month After Cataract Surgery||13
2329194|NCT01808560|5717546|P2|STARTED|4-Month After Cataract Surgery||0
2329195|NCT01808560|5717547|P1|STARTED|4-Month After Cataract Surgery||0
2329196|NCT01808560|5717545|P3|NOT COMPLETED|Crossover Treatment||0
2329197|NCT01808560|5717546|P2|NOT COMPLETED|Crossover Treatment||0
2329198|NCT01808560|5717547|P1|NOT COMPLETED|Crossover Treatment||0
2329199|NCT01808560|5717545|P3|COMPLETED|Crossover Treatment||13
2329200|NCT01808560|5717546|P2|COMPLETED|Crossover Treatment||0
2329201|NCT01808560|5717547|P1|COMPLETED|Crossover Treatment||0
2329202|NCT01808560|5717545|P3|STARTED|Crossover Treatment|Post-Treatment Group Received Crossover LipiFlow treatment 3 Months after cataract surgery|13
2329203|NCT01808560|5717546|P2|STARTED|Crossover Treatment||0
2329204|NCT01808560|5717547|P1|STARTED|Crossover Treatment||0
2329205|NCT01808560|5717545|P3|NOT COMPLETED|3-Month After Cataract Surgery||0
2329206|NCT01808560|5717546|P2|NOT COMPLETED|3-Month After Cataract Surgery||0
2329207|NCT01808560|5717547|P1|NOT COMPLETED|3-Month After Cataract Surgery||0
2329208|NCT01808560|5717545|P3|COMPLETED|3-Month After Cataract Surgery||0
2329209|NCT01808560|5717546|P2|COMPLETED|3-Month After Cataract Surgery||13
2329210|NCT01808560|5717547|P1|COMPLETED|3-Month After Cataract Surgery||17
2329211|NCT01808560|5717545|P3|STARTED|3-Month After Cataract Surgery||0
2329212|NCT01808560|5717546|P2|STARTED|3-Month After Cataract Surgery||13
2329213|NCT01808560|5717547|P1|STARTED|3-Month After Cataract Surgery||17
2329214|NCT01808560|5717545|P3|NOT COMPLETED|1-Month After Cataract Surgery||0
2329215|NCT01808560|5717546|P2|NOT COMPLETED|1-Month After Cataract Surgery||0
2329216|NCT01808560|5717547|P1|NOT COMPLETED|1-Month After Cataract Surgery||0
2329217|NCT01808560|5717545|P3|COMPLETED|1-Month After Cataract Surgery||0
2329218|NCT01808560|5717546|P2|COMPLETED|1-Month After Cataract Surgery||13
2329219|NCT01808560|5717547|P1|COMPLETED|1-Month After Cataract Surgery||16
2329220|NCT01808560|5717545|P3|STARTED|1-Month After Cataract Surgery||0
2329221|NCT01808560|5717546|P2|STARTED|1-Month After Cataract Surgery|ITT: 3 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|13
2329222|NCT01808560|5717547|P1|STARTED|1-Month After Cataract Surgery|ITT: 2 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|16
2329223|NCT01808560|5717545|P3|NOT COMPLETED|Randomization and Treatment Allocation||0
2329224|NCT01808560|5717546|P2|NOT COMPLETED|Randomization and Treatment Allocation||0
2329225|NCT01808560|5717547|P1|NOT COMPLETED|Randomization and Treatment Allocation||0
2329226|NCT01808560|5717545|P3|COMPLETED|Randomization and Treatment Allocation||0
2329227|NCT01808560|5717546|P2|COMPLETED|Randomization and Treatment Allocation||16
2329228|NCT01808560|5717547|P1|COMPLETED|Randomization and Treatment Allocation||18
2329229|NCT01808560|5717545|P3|STARTED|Randomization and Treatment Allocation||0
2329230|NCT01808560|5717546|P2|STARTED|Randomization and Treatment Allocation||16
2329231|NCT01808560|5717547|P1|STARTED|Randomization and Treatment Allocation||18
2329232|NCT01808547|5717572|P2|NOT COMPLETED|Overall Study||46
2329233|NCT01808547|5717573|P1|NOT COMPLETED|Overall Study||37
2329234|NCT01808547|5717572|P2|COMPLETED|Overall Study||48
2329235|NCT01808547|5717573|P1|COMPLETED|Overall Study||137
2329236|NCT01808547|5717572|P2|mITT Population|Overall Study||85
2329237|NCT01808547|5717573|P1|mITT Population|Overall Study||168
2329238|NCT01808547|5717572|P2|Safety Population|Overall Study||85
2329239|NCT01808547|5717573|P1|Safety Population|Overall Study||170
2329240|NCT01808547|5717572|P2|STARTED|Overall Study||94
2329241|NCT01808547|5717573|P1|STARTED|Overall Study||174
2329242|NCT01808534|5717579|P1|NOT COMPLETED|Overall Study||4
2329243|NCT01808534|5717579|P1|COMPLETED|Overall Study||1
2329244|NCT01808534|5717579|P1|STARTED|Overall Study||5
2329245|NCT01808508|5717590|P3|NOT COMPLETED|Overall Study||0
2329246|NCT01808508|5717591|P2|NOT COMPLETED|Overall Study||0
2329247|NCT01808508|5717592|P1|NOT COMPLETED|Overall Study||1
2329248|NCT01808508|5717590|P3|COMPLETED|Overall Study||3
2329249|NCT01808508|5717591|P2|COMPLETED|Overall Study||9
2329250|NCT01808508|5717592|P1|COMPLETED|Overall Study||10
2329251|NCT01808508|5717590|P3|STARTED|Overall Study||3
2329252|NCT01808508|5717591|P2|STARTED|Overall Study||9
2329253|NCT01808508|5717592|P1|STARTED|Overall Study||11
2329254|NCT01808339|5717609|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||0
2329255|NCT01808339|5717610|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
2329256|NCT01808339|5717611|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
2329257|NCT01808339|5717612|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
2329258|NCT01808339|5717613|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||0
2329259|NCT01808339|5717614|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
2329260|NCT01808339|5717609|P6|COMPLETED|Treatment Period 3 (14 Days)||5
2329261|NCT01808339|5717610|P5|COMPLETED|Treatment Period 3 (14 Days)||4
2329262|NCT01808339|5717611|P4|COMPLETED|Treatment Period 3 (14 Days)||2
2329263|NCT01808339|5717612|P3|COMPLETED|Treatment Period 3 (14 Days)||3
2329264|NCT01808339|5717613|P2|COMPLETED|Treatment Period 3 (14 Days)||3
2329265|NCT01808339|5717614|P1|COMPLETED|Treatment Period 3 (14 Days)||4
2329266|NCT01808339|5717609|P6|STARTED|Treatment Period 3 (14 Days)||5
2329267|NCT01808339|5717610|P5|STARTED|Treatment Period 3 (14 Days)||4
2329268|NCT01808339|5717611|P4|STARTED|Treatment Period 3 (14 Days)||2
2329269|NCT01808339|5717612|P3|STARTED|Treatment Period 3 (14 Days)||4
2329270|NCT01808339|5717613|P2|STARTED|Treatment Period 3 (14 Days)||3
2329271|NCT01808339|5717614|P1|STARTED|Treatment Period 3 (14 Days)||4
2329272|NCT01808339|5717609|P6|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
2329273|NCT01808339|5717610|P5|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
2329274|NCT01808339|5717611|P4|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
2329275|NCT01808339|5717612|P3|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
2329276|NCT01808339|5717613|P2|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
2329277|NCT01808339|5717614|P1|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
2329278|NCT01808339|5717609|P6|COMPLETED|Washout Period 2 (14-21 Days)||5
2329279|NCT01808339|5717610|P5|COMPLETED|Washout Period 2 (14-21 Days)||4
2329280|NCT01808339|5717611|P4|COMPLETED|Washout Period 2 (14-21 Days)||2
2329281|NCT01808339|5717612|P3|COMPLETED|Washout Period 2 (14-21 Days)||4
2329282|NCT01808339|5717613|P2|COMPLETED|Washout Period 2 (14-21 Days)||3
2329283|NCT01808339|5717614|P1|COMPLETED|Washout Period 2 (14-21 Days)||4
2329284|NCT01808339|5717609|P6|STARTED|Washout Period 2 (14-21 Days)||5
2329285|NCT01808339|5717610|P5|STARTED|Washout Period 2 (14-21 Days)||4
2329286|NCT01808339|5717611|P4|STARTED|Washout Period 2 (14-21 Days)||2
2329287|NCT01808339|5717612|P3|STARTED|Washout Period 2 (14-21 Days)||4
2329288|NCT01808339|5717613|P2|STARTED|Washout Period 2 (14-21 Days)||3
2329289|NCT01808339|5717614|P1|STARTED|Washout Period 2 (14-21 Days)||4
2329290|NCT01808339|5717609|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
2329291|NCT01808339|5717610|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
2329292|NCT01808339|5717611|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||0
2329293|NCT01808339|5717612|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||0
2329294|NCT01808339|5717613|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||0
2329295|NCT01808339|5717614|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
2329296|NCT01808339|5717609|P6|COMPLETED|Treatment Period 2 (14 Days)||5
2329297|NCT01808339|5717610|P5|COMPLETED|Treatment Period 2 (14 Days)||4
2329298|NCT01808339|5717611|P4|COMPLETED|Treatment Period 2 (14 Days)||2
2329299|NCT01808339|5717612|P3|COMPLETED|Treatment Period 2 (14 Days)||4
2329300|NCT01808339|5717613|P2|COMPLETED|Treatment Period 2 (14 Days)||3
2329301|NCT01808339|5717614|P1|COMPLETED|Treatment Period 2 (14 Days)||4
2329302|NCT01808339|5717609|P6|STARTED|Treatment Period 2 (14 Days)||5
2329303|NCT01808339|5717610|P5|STARTED|Treatment Period 2 (14 Days)||4
2329304|NCT01808339|5717611|P4|STARTED|Treatment Period 2 (14 Days)||2
2329305|NCT01808339|5717612|P3|STARTED|Treatment Period 2 (14 Days)||4
2329306|NCT01808339|5717613|P2|STARTED|Treatment Period 2 (14 Days)||3
2329307|NCT01808339|5717614|P1|STARTED|Treatment Period 2 (14 Days)||4
2329308|NCT01808339|5717609|P6|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
2329309|NCT01808339|5717610|P5|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
2329310|NCT01808339|5717611|P4|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
2329311|NCT01808339|5717612|P3|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
2329312|NCT01808339|5717613|P2|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
2329313|NCT01808339|5717614|P1|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
2329314|NCT01808339|5717609|P6|COMPLETED|Washout Period 1 (14-21 Days)||5
2329315|NCT01808339|5717610|P5|COMPLETED|Washout Period 1 (14-21 Days)||4
2329316|NCT01808339|5717611|P4|COMPLETED|Washout Period 1 (14-21 Days)||2
2329317|NCT01808339|5717612|P3|COMPLETED|Washout Period 1 (14-21 Days)||4
2329318|NCT01808339|5717613|P2|COMPLETED|Washout Period 1 (14-21 Days)||3
2329319|NCT01808339|5717614|P1|COMPLETED|Washout Period 1 (14-21 Days)||4
2329320|NCT01808339|5717609|P6|STARTED|Washout Period 1 (14-21 Days)||5
2329321|NCT01808339|5717610|P5|STARTED|Washout Period 1 (14-21 Days)||4
2329322|NCT01808339|5717611|P4|STARTED|Washout Period 1 (14-21 Days)||2
2329323|NCT01808339|5717612|P3|STARTED|Washout Period 1 (14-21 Days)||4
2329324|NCT01808339|5717613|P2|STARTED|Washout Period 1 (14-21 Days)||3
2329325|NCT01808339|5717614|P1|STARTED|Washout Period 1 (14-21 Days)||4
2329326|NCT01808339|5717609|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||1
2329327|NCT01808339|5717610|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||2
2329328|NCT01808339|5717611|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||2
2329329|NCT01808339|5717612|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||0
2329330|NCT01808339|5717613|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
2329331|NCT01808339|5717614|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||0
2329332|NCT01808339|5717609|P6|COMPLETED|Treatment Period 1 (14 Days)||5
2329333|NCT01808339|5717610|P5|COMPLETED|Treatment Period 1 (14 Days)||4
2329334|NCT01808339|5717611|P4|COMPLETED|Treatment Period 1 (14 Days)||2
2329335|NCT01808339|5717612|P3|COMPLETED|Treatment Period 1 (14 Days)||4
2329336|NCT01808339|5717613|P2|COMPLETED|Treatment Period 1 (14 Days)||3
2329337|NCT01808339|5717614|P1|COMPLETED|Treatment Period 1 (14 Days)||4
2329338|NCT01808339|5717609|P6|STARTED|Treatment Period 1 (14 Days)||6
2329339|NCT01808339|5717610|P5|STARTED|Treatment Period 1 (14 Days)||6
2329340|NCT01808339|5717611|P4|STARTED|Treatment Period 1 (14 Days)||4
2329341|NCT01808339|5717612|P3|STARTED|Treatment Period 1 (14 Days)||4
2329342|NCT01808339|5717613|P2|STARTED|Treatment Period 1 (14 Days)||4
2329343|NCT01808339|5717614|P1|STARTED|Treatment Period 1 (14 Days)||4
2329344|NCT01808326|5717631|P1|NOT COMPLETED|Overall Study||0
2329345|NCT01808326|5717631|P1|COMPLETED|Overall Study||5
2329346|NCT01808326|5717631|P1|STARTED|Overall Study||5
2329347|NCT01808313|5717658|P1|NOT COMPLETED|Overall Study||10
2329348|NCT01808313|5717658|P1|COMPLETED|Overall Study||123
2329349|NCT01808313|5717658|P1|STARTED|Overall Study||133
2329350|NCT01808261|5717688|P2|NOT COMPLETED|Overall Study||33
2329351|NCT01808261|5717689|P1|NOT COMPLETED|Overall Study||36
2329352|NCT01808261|5717688|P2|COMPLETED|Overall Study||32
2329353|NCT01808261|5717689|P1|COMPLETED|Overall Study||32
2329354|NCT01808261|5717688|P2|STARTED|Overall Study||65
2329355|NCT01808261|5717689|P1|STARTED|Overall Study||68
2329356|NCT01808248|5717745|P1|NOT COMPLETED|Overall Study||5
2329357|NCT01808248|5717745|P1|COMPLETED|Overall Study||42
2329358|NCT01808248|5717745|P1|Completed Posttreatment Week 12 Visit|Overall Study||45
2329359|NCT01808248|5717745|P1|STARTED|Overall Study||47
2329360|NCT01808222|5717757|P1|NOT COMPLETED|Overall Study||1
2329361|NCT01808222|5717757|P1|COMPLETED|Overall Study||24
2329362|NCT01808222|5717757|P1|Completed mpMR Scan|Overall Study||24
2329363|NCT01808222|5717757|P1|Completed Fluciclovine PET-CT Scan|Overall Study||25
2329364|NCT01808222|5717757|P1|STARTED|Overall Study||25
2329365|NCT01808209|5717764|P2|NOT COMPLETED|Overall Study||1
2329366|NCT01808209|5717765|P1|NOT COMPLETED|Overall Study||0
2329367|NCT01808209|5717764|P2|COMPLETED|Overall Study||26
2329368|NCT01808209|5717765|P1|COMPLETED|Overall Study||33
2329369|NCT01808209|5717764|P2|STARTED|Overall Study||27
2329370|NCT01808209|5717765|P1|STARTED|Overall Study||33
2329371|NCT01808144|5717809|P2|NOT COMPLETED|Overall Study||48
2329372|NCT01808144|5717810|P1|NOT COMPLETED|Overall Study||40
2329373|NCT01808144|5717809|P2|COMPLETED|Overall Study||51
2329374|NCT01808144|5717810|P1|COMPLETED|Overall Study||57
2329375|NCT01808144|5717809|P2|STARTED|Overall Study||99
2329376|NCT01808144|5717810|P1|STARTED|Overall Study||97
2329377|NCT01808118|5717818|P3|NOT COMPLETED|Period 2||8
2329378|NCT01808118|5717819|P2|NOT COMPLETED|Period 2||13
2329379|NCT01808118|5717820|P1|NOT COMPLETED|Period 2||0
2329380|NCT01808118|5717818|P3|COMPLETED|Period 2||144
2329381|NCT01808118|5717819|P2|COMPLETED|Period 2||140
2329382|NCT01808118|5717820|P1|COMPLETED|Period 2||0
2329383|NCT01808118|5717818|P3|STARTED|Period 2||152
2329384|NCT01808118|5717819|P2|STARTED|Period 2||153
2329385|NCT01808118|5717820|P1|STARTED|Period 2||0
2329386|NCT01808118|5717818|P3|NOT COMPLETED|Period 1||0
2329387|NCT01808118|5717819|P2|NOT COMPLETED|Period 1||0
2329388|NCT01808118|5717820|P1|NOT COMPLETED|Period 1||368
2329389|NCT01808118|5717818|P3|COMPLETED|Period 1||0
2329390|NCT01808118|5717819|P2|COMPLETED|Period 1||0
2329391|NCT01808118|5717820|P1|COMPLETED|Period 1||305
2329392|NCT01808118|5717818|P3|STARTED|Period 1||0
2329393|NCT01808118|5717819|P2|STARTED|Period 1||0
2329394|NCT01808118|5717820|P1|STARTED|Period 1||673
2329395|NCT01808092|5717883|P2|NOT COMPLETED|Overall Study||45
2329396|NCT01808092|5717884|P1|NOT COMPLETED|Overall Study||54
2329397|NCT01808092|5717883|P2|COMPLETED|Overall Study||363
2329398|NCT01808092|5717884|P1|COMPLETED|Overall Study||355
2329399|NCT01808092|5717883|P2|STARTED|Overall Study||408
2329400|NCT01808092|5717884|P1|STARTED|Overall Study||409
2329401|NCT01808066|5717986|P1|NOT COMPLETED|Overall Study||15
2329402|NCT01808066|5717986|P1|COMPLETED|Overall Study||6
2329403|NCT01808066|5717986|P1|STARTED|Overall Study||21
2329404|NCT01807949|5717997|P3|NOT COMPLETED|Overall Study||9
2329405|NCT01807949|5717998|P2|NOT COMPLETED|Overall Study||7
2329406|NCT01807949|5717999|P1|NOT COMPLETED|Overall Study||2
2329407|NCT01807949|5717997|P3|COMPLETED|Overall Study||180
2329408|NCT01807949|5717998|P2|COMPLETED|Overall Study||180
2329409|NCT01807949|5717999|P1|COMPLETED|Overall Study||185
2329410|NCT01807949|5717997|P3|STARTED|Overall Study||189
2329411|NCT01807949|5717998|P2|STARTED|Overall Study||187
2329412|NCT01807949|5717999|P1|STARTED|Overall Study||187
2329413|NCT01807923|5718051|P3|NOT COMPLETED|Overall Study||11
2329414|NCT01807923|5718052|P2|NOT COMPLETED|Overall Study||6
2329415|NCT01807923|5718053|P1|NOT COMPLETED|Overall Study||5
2329416|NCT01807923|5718051|P3|COMPLETED|Overall Study||176
2329417|NCT01807923|5718052|P2|COMPLETED|Overall Study||179
2329418|NCT01807923|5718053|P1|COMPLETED|Overall Study||182
2329419|NCT01807923|5718051|P3|STARTED|Overall Study||187
2329420|NCT01807923|5718052|P2|STARTED|Overall Study||185
2329421|NCT01807923|5718053|P1|STARTED|Overall Study||187
2329422|NCT01807871|5718104|P2|NOT COMPLETED|Overall Study||218
2329423|NCT01807871|5718105|P1|NOT COMPLETED|Overall Study||178
2329424|NCT01807871|5718104|P2|COMPLETED|Overall Study||127
2329425|NCT01807871|5718105|P1|COMPLETED|Overall Study||178
2329426|NCT01807871|5718104|P2|STARTED|Overall Study||345
2329427|NCT01807871|5718105|P1|STARTED|Overall Study||356
2329428|NCT01807650|5718115|P1|NOT COMPLETED|Overall Study||20
2329429|NCT01807650|5718115|P1|COMPLETED|Overall Study||92
2329430|NCT01807650|5718115|P1|STARTED|Overall Study||112
2329431|NCT01807637|5718168|P2|NOT COMPLETED|One Month||0
2329432|NCT01807637|5718169|P1|NOT COMPLETED|One Month||0
2329433|NCT01807637|5718168|P2|COMPLETED|One Month||2
2329434|NCT01807637|5718169|P1|COMPLETED|One Month||4
2329435|NCT01807637|5718168|P2|STARTED|One Month||2
2329436|NCT01807637|5718169|P1|STARTED|One Month||4
2329437|NCT01807637|5718168|P2|NOT COMPLETED|One Week||0
2329438|NCT01807637|5718169|P1|NOT COMPLETED|One Week||0
2329439|NCT01807637|5718168|P2|COMPLETED|One Week||2
2329440|NCT01807637|5718169|P1|COMPLETED|One Week||4
2329441|NCT01807637|5718168|P2|STARTED|One Week||2
2329442|NCT01807637|5718169|P1|STARTED|One Week||4
2329443|NCT01807637|5718168|P2|NOT COMPLETED|Baseline||0
2329444|NCT01807637|5718169|P1|NOT COMPLETED|Baseline||0
2329445|NCT01807637|5718168|P2|COMPLETED|Baseline||2
2329446|NCT01807637|5718169|P1|COMPLETED|Baseline||4
2329447|NCT01807637|5718168|P2|STARTED|Baseline||2
2329448|NCT01807637|5718169|P1|STARTED|Baseline||4
2329449|NCT01807624|5718185|P1|NOT COMPLETED|Overall Study||0
2329450|NCT01807624|5718185|P1|COMPLETED|Overall Study||24
2329451|NCT01807624|5718185|P1|STARTED|Overall Study||24
2329452|NCT01807598|5718201|P1|NOT COMPLETED|Overall Study||6
2329453|NCT01807598|5718201|P1|COMPLETED|Overall Study||4
2329454|NCT01807598|5718201|P1|STARTED|Overall Study||10
2329455|NCT01807585|5718215|P3|NOT COMPLETED|Overall Study||6
2329456|NCT01807585|5718216|P2|NOT COMPLETED|Overall Study||4
2329457|NCT01807585|5718217|P1|NOT COMPLETED|Overall Study||1
2329458|NCT01807585|5718215|P3|COMPLETED|Overall Study||108
2329459|NCT01807585|5718216|P2|COMPLETED|Overall Study||104
2329460|NCT01807585|5718217|P1|COMPLETED|Overall Study||19
2329461|NCT01807585|5718215|P3|3 Mos|Overall Study||113
2329462|NCT01807585|5718216|P2|3 Mos|Overall Study||108
2329463|NCT01807585|5718217|P1|3 Mos|Overall Study||20
2329464|NCT01807585|5718215|P3|STARTED|Overall Study||114
2329465|NCT01807585|5718216|P2|STARTED|Overall Study||108
2329466|NCT01807585|5718217|P1|STARTED|Overall Study||20
2329467|NCT01807520|5718233|P7|NOT COMPLETED|Follow-up Period (132-140 Weeks)||1
2329468|NCT01807520|5718234|P6|NOT COMPLETED|Follow-up Period (132-140 Weeks)||4
2329469|NCT01807520|5718235|P5|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
2329470|NCT01807520|5718236|P4|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
2329471|NCT01807520|5718237|P3|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
2329472|NCT01807520|5718238|P2|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
2329473|NCT01807520|5718239|P1|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
2329474|NCT01807520|5718233|P7|COMPLETED|Follow-up Period (132-140 Weeks)||75
2329475|NCT01807520|5718234|P6|COMPLETED|Follow-up Period (132-140 Weeks)||77
2329476|NCT01807520|5718235|P5|COMPLETED|Follow-up Period (132-140 Weeks)||0
2329477|NCT01807520|5718236|P4|COMPLETED|Follow-up Period (132-140 Weeks)||0
2329478|NCT01807520|5718237|P3|COMPLETED|Follow-up Period (132-140 Weeks)||2
2329479|NCT01807520|5718238|P2|COMPLETED|Follow-up Period (132-140 Weeks)||0
2329480|NCT01807520|5718239|P1|COMPLETED|Follow-up Period (132-140 Weeks)||0
2329481|NCT01807520|5718233|P7|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457 300mg during treatment period 1 and/or treatment period 2.|76
2329482|NCT01807520|5718234|P6|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457150mg during treatment period 1 and/or treatment period 2.|81
2329483|NCT01807520|5718235|P5|STARTED|Follow-up Period (132-140 Weeks)||0
2329484|NCT01807520|5718236|P4|STARTED|Follow-up Period (132-140 Weeks)||0
2329485|NCT01807520|5718237|P3|STARTED|Follow-up Period (132-140 Weeks)|These participants discontinued from Treatment Period 1.|2
2329486|NCT01807520|5718238|P2|STARTED|Follow-up Period (132-140 Weeks)||0
2329487|NCT01807520|5718239|P1|STARTED|Follow-up Period (132-140 Weeks)||0
2329488|NCT01807520|5718233|P7|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
2329489|NCT01807520|5718234|P6|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
2329490|NCT01807520|5718235|P5|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||5
2329491|NCT01807520|5718236|P4|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||7
2329492|NCT01807520|5718237|P3|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
2329493|NCT01807520|5718238|P2|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||18
2329494|NCT01807520|5718239|P1|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||25
2329495|NCT01807520|5718233|P7|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
2329496|NCT01807520|5718234|P6|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
2329497|NCT01807520|5718235|P5|COMPLETED|Treatment Period 2 (16-132 Weeks)||24
2329498|NCT01807520|5718236|P4|COMPLETED|Treatment Period 2 (16-132 Weeks)||22
2329499|NCT01807520|5718237|P3|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
2329500|NCT01807520|5718238|P2|COMPLETED|Treatment Period 2 (16-132 Weeks)||47
2329501|NCT01807520|5718239|P1|COMPLETED|Treatment Period 2 (16-132 Weeks)||38
2329502|NCT01807520|5718233|P7|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
2329503|NCT01807520|5718234|P6|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
2329504|NCT01807520|5718235|P5|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29
2329505|NCT01807520|5718236|P4|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29
2329506|NCT01807520|5718237|P3|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
2329507|NCT01807520|5718238|P2|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||66
2329508|NCT01807520|5718239|P1|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||67
2329509|NCT01807520|5718233|P7|Safety Set|Treatment Period 2 (16-132 Weeks)||0
2329510|NCT01807520|5718234|P6|Safety Set|Treatment Period 2 (16-132 Weeks)||0
2329511|NCT01807520|5718235|P5|Safety Set|Treatment Period 2 (16-132 Weeks)||29
2329512|NCT01807520|5718236|P4|Safety Set|Treatment Period 2 (16-132 Weeks)||29
2329513|NCT01807520|5718237|P3|Safety Set|Treatment Period 2 (16-132 Weeks)||0
2329514|NCT01807520|5718238|P2|Safety Set|Treatment Period 2 (16-132 Weeks)||65
2329515|NCT01807520|5718239|P1|Safety Set|Treatment Period 2 (16-132 Weeks)||63
2329516|NCT01807520|5718233|P7|STARTED|Treatment Period 2 (16-132 Weeks)||0
2329517|NCT01807520|5718234|P6|STARTED|Treatment Period 2 (16-132 Weeks)||0
2329518|NCT01807520|5718235|P5|STARTED|Treatment Period 2 (16-132 Weeks)||29
2329519|NCT01807520|5718236|P4|STARTED|Treatment Period 2 (16-132 Weeks)||29
2329520|NCT01807520|5718237|P3|STARTED|Treatment Period 2 (16-132 Weeks)||0
2329521|NCT01807520|5718238|P2|STARTED|Treatment Period 2 (16-132 Weeks)||65
2329522|NCT01807520|5718239|P1|STARTED|Treatment Period 2 (16-132 Weeks)||63
2329523|NCT01807520|5718233|P7|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
2329524|NCT01807520|5718234|P6|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
2329525|NCT01807520|5718235|P5|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
2329526|NCT01807520|5718236|P4|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
2329527|NCT01807520|5718237|P3|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||7
2329528|NCT01807520|5718238|P2|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||1
2329529|NCT01807520|5718239|P1|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||4
2329530|NCT01807520|5718233|P7|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
2329531|NCT01807520|5718234|P6|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
2329532|NCT01807520|5718235|P5|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
2329533|NCT01807520|5718236|P4|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
2329534|NCT01807520|5718237|P3|COMPLETED|Treatment Period 1 (0-16 Weeks)||58
2329535|NCT01807520|5718238|P2|COMPLETED|Treatment Period 1 (0-16 Weeks)||65
2329536|NCT01807520|5718239|P1|COMPLETED|Treatment Period 1 (0-16 Weeks)||63
2329537|NCT01807520|5718233|P7|Safety Set|Treatment Period 1 (0-16 Weeks)||0
2329538|NCT01807520|5718234|P6|Safety Set|Treatment Period 1 (0-16 Weeks)||0
2329539|NCT01807520|5718235|P5|Safety Set|Treatment Period 1 (0-16 Weeks)||0
2329540|NCT01807520|5718236|P4|Safety Set|Treatment Period 1 (0-16 Weeks)||0
2329541|NCT01807520|5718237|P3|Safety Set|Treatment Period 1 (0-16 Weeks)||65
2329542|NCT01807520|5718238|P2|Safety Set|Treatment Period 1 (0-16 Weeks)||65
2329543|NCT01807520|5718239|P1|Safety Set|Treatment Period 1 (0-16 Weeks)||67
2329544|NCT01807520|5718233|P7|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
2329545|NCT01807520|5718234|P6|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
2329546|NCT01807520|5718235|P5|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
2329547|NCT01807520|5718236|P4|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
2329548|NCT01807520|5718237|P3|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||65
2329549|NCT01807520|5718238|P2|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||66
2329550|NCT01807520|5718239|P1|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||67
2329551|NCT01807520|5718233|P7|STARTED|Treatment Period 1 (0-16 Weeks)||0
2329552|NCT01807520|5718234|P6|STARTED|Treatment Period 1 (0-16 Weeks)||0
2329553|NCT01807520|5718235|P5|STARTED|Treatment Period 1 (0-16 Weeks)||0
2329554|NCT01807520|5718236|P4|STARTED|Treatment Period 1 (0-16 Weeks)||0
2329555|NCT01807520|5718237|P3|STARTED|Treatment Period 1 (0-16 Weeks)||65
2329556|NCT01807520|5718238|P2|STARTED|Treatment Period 1 (0-16 Weeks)||66
2329557|NCT01807520|5718239|P1|STARTED|Treatment Period 1 (0-16 Weeks)||67
2329558|NCT01807455|5718258|P1|NOT COMPLETED|Overall Study||0
2329559|NCT01807455|5718258|P1|COMPLETED|Overall Study||12
2329560|NCT01807455|5718258|P1|STARTED|Overall Study||12
2329561|NCT01807234|5718272|P6|NOT COMPLETED|Overall Study||4
2329562|NCT01807234|5718273|P5|NOT COMPLETED|Overall Study||4
2329563|NCT01807234|5718274|P4|NOT COMPLETED|Overall Study||2
2329564|NCT01807234|5718275|P3|NOT COMPLETED|Overall Study||2
2329565|NCT01807234|5718276|P2|NOT COMPLETED|Overall Study||6
2329566|NCT01807234|5718277|P1|NOT COMPLETED|Overall Study||5
2329567|NCT01807234|5718272|P6|COMPLETED|Overall Study||8
2329568|NCT01807234|5718273|P5|COMPLETED|Overall Study||8
2329569|NCT01807234|5718274|P4|COMPLETED|Overall Study||10
2329570|NCT01807234|5718275|P3|COMPLETED|Overall Study||10
2329571|NCT01807234|5718276|P2|COMPLETED|Overall Study||6
2329572|NCT01807234|5718277|P1|COMPLETED|Overall Study||7
2329573|NCT01807234|5718272|P6|Completed Only 1 Attack|Overall Study||1
2329574|NCT01807234|5718273|P5|Completed Only 1 Attack|Overall Study||0
2329575|NCT01807234|5718274|P4|Completed Only 1 Attack|Overall Study||1
2329576|NCT01807234|5718275|P3|Completed Only 1 Attack|Overall Study||0
2329577|NCT01807234|5718276|P2|Completed Only 1 Attack|Overall Study||1
2329578|NCT01807234|5718277|P1|Completed Only 1 Attack|Overall Study||2
2329579|NCT01807234|5718272|P6|Randomized, But Did Not Take Drug|Overall Study||3
2329580|NCT01807234|5718273|P5|Randomized, But Did Not Take Drug|Overall Study||4
2329581|NCT01807234|5718274|P4|Randomized, But Did Not Take Drug|Overall Study||1
2329582|NCT01807234|5718275|P3|Randomized, But Did Not Take Drug|Overall Study||2
2329583|NCT01807234|5718276|P2|Randomized, But Did Not Take Drug|Overall Study||5
2329584|NCT01807234|5718277|P1|Randomized, But Did Not Take Drug|Overall Study||3
2329585|NCT01807234|5718272|P6|STARTED|Overall Study||12
2329586|NCT01807234|5718273|P5|STARTED|Overall Study||12
2329587|NCT01807234|5718274|P4|STARTED|Overall Study||12
2329588|NCT01807234|5718275|P3|STARTED|Overall Study||12
2329589|NCT01807234|5718276|P2|STARTED|Overall Study||12
2329590|NCT01807234|5718277|P1|STARTED|Overall Study||12
2329591|NCT01807156|5718312|P1|NOT COMPLETED|Overall Study||1
2329592|NCT01807156|5718312|P1|COMPLETED|Overall Study||6
2329593|NCT01807156|5718312|P1|STARTED|Overall Study||7
2329594|NCT01807104|5718319|P2|NOT COMPLETED|Overall Study||4
2329595|NCT01807104|5718320|P1|NOT COMPLETED|Overall Study||4
2329596|NCT01807104|5718319|P2|COMPLETED|Overall Study||40
2329597|NCT01807104|5718320|P1|COMPLETED|Overall Study||39
2329598|NCT01807104|5718319|P2|STARTED|Overall Study||44
2329599|NCT01807104|5718320|P1|STARTED|Overall Study||43
2329600|NCT01807026|5718332|P6|NOT COMPLETED|Overall Study||0
2329601|NCT01807026|5718333|P5|NOT COMPLETED|Overall Study||0
2329602|NCT01807026|5718334|P4|NOT COMPLETED|Overall Study||0
2329603|NCT01807026|5718335|P3|NOT COMPLETED|Overall Study||0
2329604|NCT01807026|5718336|P2|NOT COMPLETED|Overall Study||0
2329605|NCT01807026|5718337|P1|NOT COMPLETED|Overall Study||0
2329606|NCT01807026|5718332|P6|COMPLETED|Overall Study||3
2329607|NCT01807026|5718333|P5|COMPLETED|Overall Study||9
2329608|NCT01807026|5718334|P4|COMPLETED|Overall Study||2
2329609|NCT01807026|5718335|P3|COMPLETED|Overall Study||10
2329610|NCT01807026|5718336|P2|COMPLETED|Overall Study||2
2329611|NCT01807026|5718337|P1|COMPLETED|Overall Study||10
2329612|NCT01807026|5718332|P6|Received at Least One Dose of Study Drug|Overall Study||3
2329613|NCT01807026|5718333|P5|Received at Least One Dose of Study Drug|Overall Study||9
2329614|NCT01807026|5718334|P4|Received at Least One Dose of Study Drug|Overall Study||2
2329615|NCT01807026|5718335|P3|Received at Least One Dose of Study Drug|Overall Study||10
2329616|NCT01807026|5718336|P2|Received at Least One Dose of Study Drug|Overall Study||2
2329617|NCT01807026|5718337|P1|Received at Least One Dose of Study Drug|Overall Study||10
2329618|NCT01807026|5718332|P6|STARTED|Overall Study||3
2329619|NCT01807026|5718333|P5|STARTED|Overall Study||9
2329620|NCT01807026|5718334|P4|STARTED|Overall Study||2
2329621|NCT01807026|5718335|P3|STARTED|Overall Study||10
2329622|NCT01807026|5718336|P2|STARTED|Overall Study||2
2329623|NCT01807026|5718337|P1|STARTED|Overall Study||10
2329624|NCT01807000|5718365|P1|NOT COMPLETED|Overall Study||0
2329625|NCT01807000|5718365|P1|COMPLETED|Overall Study||6
2329626|NCT01807000|5718365|P1|STARTED|Overall Study||6
2329627|NCT01806961|5718384|P1|NOT COMPLETED|Overall Study||16
2329628|NCT01806961|5718384|P1|COMPLETED|Overall Study||0
2329629|NCT01806961|5718384|P1|STARTED|Overall Study||16
2329630|NCT01806896|5718390|P2|NOT COMPLETED|Overall Study||0
2329631|NCT01806896|5718391|P1|NOT COMPLETED|Overall Study||3
2329632|NCT01806896|5718390|P2|COMPLETED|Overall Study||17
2329633|NCT01806896|5718391|P1|COMPLETED|Overall Study||17
2329634|NCT01806896|5718390|P2|Received Treatment|Overall Study||17
2329635|NCT01806896|5718391|P1|Received Treatment|Overall Study||19
2329636|NCT01806896|5718390|P2|STARTED|Overall Study||17
2329637|NCT01806896|5718391|P1|STARTED|Overall Study||20
2329638|NCT01806857|5718419|P2|NOT COMPLETED|Overall Study||0
2329639|NCT01806857|5718420|P1|NOT COMPLETED|Overall Study||1
2329640|NCT01806857|5718419|P2|COMPLETED|Overall Study||29
2329641|NCT01806857|5718420|P1|COMPLETED|Overall Study||30
2329642|NCT01806857|5718419|P2|STARTED|Overall Study||29
2329643|NCT01806857|5718420|P1|STARTED|Overall Study||31
2329644|NCT01806779|5718458|P3|NOT COMPLETED|Overall Study||23
2329645|NCT01806779|5718459|P2|NOT COMPLETED|Overall Study||44
2329646|NCT01806779|5718460|P1|NOT COMPLETED|Overall Study||42
2329647|NCT01806779|5718458|P3|COMPLETED|Overall Study||0
2329648|NCT01806779|5718459|P2|COMPLETED|Overall Study||40
2329649|NCT01806779|5718460|P1|COMPLETED|Overall Study||48
2329650|NCT01806779|5718458|P3|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|0
2329651|NCT01806779|5718459|P2|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|83
2329652|NCT01806779|5718460|P1|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|87
2329653|NCT01806779|5718458|P3|Randomized at Visit 2|Overall Study||0
2329654|NCT01806779|5718459|P2|Randomized at Visit 2|Overall Study||84
2329655|NCT01806779|5718460|P1|Randomized at Visit 2|Overall Study||90
2329656|NCT01806779|5718458|P3|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|2
2329657|NCT01806779|5718459|P2|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|84
2329658|NCT01806779|5718460|P1|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|90
2329659|NCT01806779|5718458|P3|STARTED|Overall Study|All 197 subjects received nicotine patches but 23 dropped before receiving other study drugs.|23
2329660|NCT01806779|5718459|P2|STARTED|Overall Study||84
2329661|NCT01806779|5718460|P1|STARTED|Overall Study||90
2329662|NCT01806740|5718473|P1|NOT COMPLETED|Overall Study||6
2329663|NCT01806740|5718473|P1|COMPLETED|Overall Study||31
2329664|NCT01806740|5718473|P1|STARTED|Overall Study||37
2329665|NCT01806714|5718484|P2|NOT COMPLETED|Overall Study||170
2329666|NCT01806714|5718485|P1|NOT COMPLETED|Overall Study||200
2329667|NCT01806714|5718484|P2|COMPLETED|Overall Study||1919
2329668|NCT01806714|5718485|P1|COMPLETED|Overall Study||1893
2329669|NCT01806714|5718484|P2|STARTED|Overall Study||2089
2329670|NCT01806714|5718485|P1|STARTED|Overall Study||2093
2329671|NCT01806675|5718498|P3|NOT COMPLETED|Overall Study||0
2329672|NCT01806675|5718499|P2|NOT COMPLETED|Overall Study||0
2329673|NCT01806675|5718500|P1|NOT COMPLETED|Overall Study||0
2329674|NCT01806675|5718498|P3|COMPLETED|Overall Study||8
2329675|NCT01806675|5718499|P2|COMPLETED|Overall Study||6
2329676|NCT01806675|5718500|P1|COMPLETED|Overall Study||11
2329677|NCT01806675|5718498|P3|STARTED|Overall Study||8
2329678|NCT01806675|5718499|P2|STARTED|Overall Study||6
2329679|NCT01806675|5718500|P1|STARTED|Overall Study||11
2329680|NCT01806662|5718520|P2|NOT COMPLETED|Second Intervention (Weeks 16-32)||4
2329681|NCT01806662|5718521|P1|NOT COMPLETED|Second Intervention (Weeks 16-32)||2
2329682|NCT01806662|5718520|P2|COMPLETED|Second Intervention (Weeks 16-32)||11
2329683|NCT01806662|5718521|P1|COMPLETED|Second Intervention (Weeks 16-32)||10
2329684|NCT01806662|5718520|P2|STARTED|Second Intervention (Weeks 16-32)||15
2329685|NCT01806662|5718521|P1|STARTED|Second Intervention (Weeks 16-32)||12
2329686|NCT01806662|5718520|P2|NOT COMPLETED|First Intervention (Weeks 0-16)||1
2329687|NCT01806662|5718521|P1|NOT COMPLETED|First Intervention (Weeks 0-16)||4
2329688|NCT01806662|5718520|P2|COMPLETED|First Intervention (Weeks 0-16)||15
2329689|NCT01806662|5718521|P1|COMPLETED|First Intervention (Weeks 0-16)||12
2329690|NCT01806662|5718520|P2|Received Intervention|First Intervention (Weeks 0-16)||15
2329691|NCT01806662|5718521|P1|Received Intervention|First Intervention (Weeks 0-16)||12
2329692|NCT01806662|5718520|P2|STARTED|First Intervention (Weeks 0-16)||16
2329693|NCT01806662|5718521|P1|STARTED|First Intervention (Weeks 0-16)||16
2329694|NCT01806623|5718527|P1|NOT COMPLETED|Overall Study||58
2329695|NCT01806623|5718527|P1|COMPLETED|Overall Study||99
2329696|NCT01806623|5718527|P1|STARTED|Overall Study||157
2329697|NCT01806597|5718547|P6|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||12
2329698|NCT01806597|5718548|P5|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
2329699|NCT01806597|5718549|P4|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
2329700|NCT01806597|5718550|P3|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
2329701|NCT01806597|5718551|P2|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
2329702|NCT01806597|5718552|P1|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
2329703|NCT01806597|5718547|P6|COMPLETED|Follow-up Period (Week 132 to Week 140)||149
2329704|NCT01806597|5718548|P5|COMPLETED|Follow-up Period (Week 132 to Week 140)||3
2329705|NCT01806597|5718549|P4|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
2329706|NCT01806597|5718550|P3|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
2329707|NCT01806597|5718551|P2|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
2329708|NCT01806597|5718552|P1|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
2329709|NCT01806597|5718547|P6|STARTED|Follow-up Period (Week 132 to Week 140)||161
2329710|NCT01806597|5718548|P5|STARTED|Follow-up Period (Week 132 to Week 140)||3
2329711|NCT01806597|5718549|P4|STARTED|Follow-up Period (Week 132 to Week 140)||0
2329712|NCT01806597|5718550|P3|STARTED|Follow-up Period (Week 132 to Week 140)||0
2329713|NCT01806597|5718551|P2|STARTED|Follow-up Period (Week 132 to Week 140)||0
2329714|NCT01806597|5718552|P1|STARTED|Follow-up Period (Week 132 to Week 140)||0
2329715|NCT01806597|5718547|P6|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
2329716|NCT01806597|5718548|P5|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||1
2329717|NCT01806597|5718549|P4|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||11
2329718|NCT01806597|5718550|P3|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||14
2329719|NCT01806597|5718551|P2|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20
2329720|NCT01806597|5718552|P1|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||39
2329721|NCT01806597|5718547|P6|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
2329722|NCT01806597|5718548|P5|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
2329723|NCT01806597|5718549|P4|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20
2329724|NCT01806597|5718550|P3|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||17
2329725|NCT01806597|5718551|P2|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||44
2329726|NCT01806597|5718552|P1|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||24
2329727|NCT01806597|5718547|P6|STARTED|Treatment Period 2 (Week 16 to Week 132)||0
2329728|NCT01806597|5718548|P5|STARTED|Treatment Period 2 (Week 16 to Week 132)||1
2329729|NCT01806597|5718549|P4|STARTED|Treatment Period 2 (Week 16 to Week 132)||31
2329730|NCT01806597|5718550|P3|STARTED|Treatment Period 2 (Week 16 to Week 132)||31
2329731|NCT01806597|5718551|P2|STARTED|Treatment Period 2 (Week 16 to Week 132)||64
2329732|NCT01806597|5718552|P1|STARTED|Treatment Period 2 (Week 16 to Week 132)||63
2329733|NCT01806597|5718547|P6|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
2329734|NCT01806597|5718548|P5|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
2329735|NCT01806597|5718549|P4|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
2329736|NCT01806597|5718550|P3|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
2329737|NCT01806597|5718551|P2|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
2329738|NCT01806597|5718552|P1|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
2329739|NCT01806597|5718547|P6|COMPLETED|Period 1 (Baseline to Week 16)||0
2329740|NCT01806597|5718548|P5|COMPLETED|Period 1 (Baseline to Week 16)||63
2329741|NCT01806597|5718549|P4|COMPLETED|Period 1 (Baseline to Week 16)||0
2329742|NCT01806597|5718550|P3|COMPLETED|Period 1 (Baseline to Week 16)||0
2329743|NCT01806597|5718551|P2|COMPLETED|Period 1 (Baseline to Week 16)||64
2329744|NCT01806597|5718552|P1|COMPLETED|Period 1 (Baseline to Week 16)||63
2329745|NCT01806597|5718547|P6|STARTED|Period 1 (Baseline to Week 16)||0
2329746|NCT01806597|5718548|P5|STARTED|Period 1 (Baseline to Week 16)||68
2329747|NCT01806597|5718549|P4|STARTED|Period 1 (Baseline to Week 16)||0
2329748|NCT01806597|5718550|P3|STARTED|Period 1 (Baseline to Week 16)||0
2329749|NCT01806597|5718551|P2|STARTED|Period 1 (Baseline to Week 16)||69
2329750|NCT01806597|5718552|P1|STARTED|Period 1 (Baseline to Week 16)||68
2329751|NCT01806584|5718588|P2|NOT COMPLETED|Overall Study||18
2329752|NCT01806584|5718589|P1|NOT COMPLETED|Overall Study||14
2329753|NCT01806584|5718588|P2|COMPLETED|Overall Study||0
2329754|NCT01806584|5718589|P1|COMPLETED|Overall Study||0
2329755|NCT01806584|5718588|P2|STARTED|Overall Study||18
2329756|NCT01806584|5718589|P1|STARTED|Overall Study||14
2329757|NCT01806571|5718601|P1|NOT COMPLETED|Overall Study||0
2329758|NCT01806571|5718601|P1|COMPLETED|Overall Study||34
2329759|NCT01806571|5718601|P1|STARTED|Overall Study||34
2329760|NCT01806545|5718611|P2|NOT COMPLETED|Overall Study||5
2329761|NCT01806545|5718612|P1|NOT COMPLETED|Overall Study||6
2329762|NCT01806545|5718611|P2|COMPLETED|Overall Study||30
2329763|NCT01806545|5718612|P1|COMPLETED|Overall Study||23
2329764|NCT01806545|5718611|P2|STARTED|Overall Study||35
2329765|NCT01806545|5718612|P1|STARTED|Overall Study||29
2329766|NCT01806506|5718636|P2|NOT COMPLETED|Overall Study||1
2329767|NCT01806506|5718637|P1|NOT COMPLETED|Overall Study||2
2329768|NCT01806506|5718636|P2|COMPLETED|Overall Study||35
2329769|NCT01806506|5718637|P1|COMPLETED|Overall Study||34
2329770|NCT01806506|5718636|P2|9 Months|Overall Study|1 patient (reason - lost contact)|35
2329771|NCT01806506|5718637|P1|9 Months|Overall Study||34
2329772|NCT01806506|5718636|P2|6 Months|Overall Study||36
2329773|NCT01806506|5718637|P1|6 Months|Overall Study|1 patient (reason - lost contact)|34
2329774|NCT01806506|5718636|P2|3 Months|Overall Study||36
2329775|NCT01806506|5718637|P1|3 Months|Overall Study|1 patient (reason - lost contact)|35
2329776|NCT01806506|5718636|P2|1 Month|Overall Study||36
2329777|NCT01806506|5718637|P1|1 Month|Overall Study||36
2329778|NCT01806506|5718636|P2|STARTED|Overall Study||36
2329779|NCT01806506|5718637|P1|STARTED|Overall Study||36
2329780|NCT01806389|5718643|P1|NOT COMPLETED|Overall Study||4
2329781|NCT01806389|5718643|P1|COMPLETED|Overall Study||10
2329782|NCT01806389|5718643|P1|STARTED|Overall Study||14
2329783|NCT01806298|5718657|P1|NOT COMPLETED|Overall Study||10
2329784|NCT01806298|5718657|P1|COMPLETED|Overall Study||68
2329785|NCT01806298|5718657|P1|STARTED|Overall Study||78
2329786|NCT01806259|5718669|P2|NOT COMPLETED|Overall Study||0
2329787|NCT01806259|5718670|P1|NOT COMPLETED|Overall Study||0
2329788|NCT01806259|5718669|P2|COMPLETED|Overall Study||107
2329789|NCT01806259|5718670|P1|COMPLETED|Overall Study||96
2329790|NCT01806259|5718669|P2|STARTED|Overall Study||107
2329791|NCT01806259|5718670|P1|STARTED|Overall Study||96
2329792|NCT01806051|5718678|P1|NOT COMPLETED|Overall Study||6
2329793|NCT01806051|5718678|P1|COMPLETED|Overall Study||0
2329794|NCT01806051|5718678|P1|STARTED|Overall Study||6
2329795|NCT01805895|5718686|P2|NOT COMPLETED|Overall Study||0
2329796|NCT01805895|5718687|P1|NOT COMPLETED|Overall Study||0
2329797|NCT01805895|5718686|P2|COMPLETED|Overall Study||8
2329798|NCT01805895|5718687|P1|COMPLETED|Overall Study||8
2329799|NCT01805895|5718686|P2|STARTED|Overall Study||8
2329800|NCT01805895|5718687|P1|STARTED|Overall Study||8
2329801|NCT01805882|5718704|P9|NOT COMPLETED|Overall Study||1
2329802|NCT01805882|5718705|P8|NOT COMPLETED|Overall Study||0
2329803|NCT01805882|5718706|P7|NOT COMPLETED|Overall Study||2
2329804|NCT01805882|5718707|P6|NOT COMPLETED|Overall Study||1
2329805|NCT01805882|5718708|P5|NOT COMPLETED|Overall Study||0
2329806|NCT01805882|5718709|P4|NOT COMPLETED|Overall Study||2
2329807|NCT01805882|5718710|P3|NOT COMPLETED|Overall Study||1
2329808|NCT01805882|5718711|P2|NOT COMPLETED|Overall Study||0
2329809|NCT01805882|5718712|P1|NOT COMPLETED|Overall Study||0
2329810|NCT01805882|5718704|P9|COMPLETED|Overall Study||24
2329811|NCT01805882|5718705|P8|COMPLETED|Overall Study||25
2329812|NCT01805882|5718706|P7|COMPLETED|Overall Study||48
2329813|NCT01805882|5718707|P6|COMPLETED|Overall Study||20
2329814|NCT01805882|5718708|P5|COMPLETED|Overall Study||14
2329815|NCT01805882|5718709|P4|COMPLETED|Overall Study||32
2329816|NCT01805882|5718710|P3|COMPLETED|Overall Study||19
2329817|NCT01805882|5718711|P2|COMPLETED|Overall Study||20
2329818|NCT01805882|5718712|P1|COMPLETED|Overall Study||20
2329819|NCT01805882|5718704|P9|STARTED|Overall Study||25
2329820|NCT01805882|5718705|P8|STARTED|Overall Study||25
2329821|NCT01805882|5718706|P7|STARTED|Overall Study||50
2329822|NCT01805882|5718707|P6|STARTED|Overall Study||21
2329823|NCT01805882|5718708|P5|STARTED|Overall Study||14
2329824|NCT01805882|5718709|P4|STARTED|Overall Study||34
2329825|NCT01805882|5718710|P3|STARTED|Overall Study||20
2329826|NCT01805882|5718711|P2|STARTED|Overall Study||20
2329827|NCT01805882|5718712|P1|STARTED|Overall Study||20
2329828|NCT01805791|5718735|P3|NOT COMPLETED|Overall Study||20
2329829|NCT01805791|5718736|P2|NOT COMPLETED|Overall Study||17
2329830|NCT01805791|5718737|P1|NOT COMPLETED|Overall Study||22
2329831|NCT01805791|5718735|P3|COMPLETED|Overall Study||48
2329832|NCT01805791|5718736|P2|COMPLETED|Overall Study||50
2329833|NCT01805791|5718737|P1|COMPLETED|Overall Study||44
2329834|NCT01805791|5718735|P3|STARTED|Overall Study||68
2329835|NCT01805791|5718736|P2|STARTED|Overall Study||67
2329836|NCT01805791|5718737|P1|STARTED|Overall Study||66
2329837|NCT01805687|5718751|P1|NOT COMPLETED|Overall Study||0
2329838|NCT01805687|5718751|P1|COMPLETED|Overall Study||25
2329839|NCT01805687|5718751|P1|STARTED|Overall Study||25
2329840|NCT01805440|5718758|P3|NOT COMPLETED|Overall Study||0
2329841|NCT01805440|5718759|P2|NOT COMPLETED|Overall Study||0
2329842|NCT01805440|5718760|P1|NOT COMPLETED|Overall Study||1
2329843|NCT01805440|5718758|P3|COMPLETED|Overall Study||26
2329844|NCT01805440|5718759|P2|COMPLETED|Overall Study||17
2329845|NCT01805440|5718760|P1|COMPLETED|Overall Study||18
2329846|NCT01805440|5718758|P3|STARTED|Overall Study||26
2329847|NCT01805440|5718759|P2|STARTED|Overall Study||17
2329848|NCT01805440|5718760|P1|STARTED|Overall Study||19
2329849|NCT01805323|5718773|P1|NOT COMPLETED|Overall Study||0
2329850|NCT01805323|5718773|P1|COMPLETED|Overall Study||101
2329851|NCT01805323|5718773|P1|STARTED|Overall Study||101
2329852|NCT01805297|5718780|P2|NOT COMPLETED|Overall Study||3
2329853|NCT01805297|5718781|P1|NOT COMPLETED|Overall Study||2
2329854|NCT01805297|5718780|P2|COMPLETED|Overall Study||3
2329855|NCT01805297|5718781|P1|COMPLETED|Overall Study||4
2329856|NCT01805297|5718780|P2|STARTED|Overall Study||6
2329857|NCT01805297|5718781|P1|STARTED|Overall Study||6
2329858|NCT01805180|5718795|P3|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
2329859|NCT01805180|5718796|P2|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
2329860|NCT01805180|5718797|P1|NOT COMPLETED|Pivotal Randomization Through Study Exit||0
2329861|NCT01805180|5718795|P3|COMPLETED|Pivotal Randomization Through Study Exit||15
2329862|NCT01805180|5718796|P2|COMPLETED|Pivotal Randomization Through Study Exit||17
2329863|NCT01805180|5718797|P1|COMPLETED|Pivotal Randomization Through Study Exit||0
2329864|NCT01805180|5718795|P3|STARTED|Pivotal Randomization Through Study Exit||20
2329865|NCT01805180|5718796|P2|STARTED|Pivotal Randomization Through Study Exit||22
2329866|NCT01805180|5718797|P1|STARTED|Pivotal Randomization Through Study Exit|lead-in donors were not randomized and did not participate in this period.|0
2329867|NCT01805180|5718795|P3|NOT COMPLETED|Lead-in Donor Phase||0
2329868|NCT01805180|5718796|P2|NOT COMPLETED|Lead-in Donor Phase||0
2329869|NCT01805180|5718797|P1|NOT COMPLETED|Lead-in Donor Phase||1
2329870|NCT01805180|5718795|P3|COMPLETED|Lead-in Donor Phase||0
2329871|NCT01805180|5718796|P2|COMPLETED|Lead-in Donor Phase||0
2329872|NCT01805180|5718797|P1|COMPLETED|Lead-in Donor Phase||6
2329873|NCT01805180|5718795|P3|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
2329874|NCT01805180|5718796|P2|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
2329875|NCT01805180|5718797|P1|STARTED|Lead-in Donor Phase||7
2329876|NCT01805154|5718820|P1|NOT COMPLETED|Overall Study||354
2329877|NCT01805154|5718820|P1|COMPLETED|Overall Study||1175
2329878|NCT01805154|5718820|P1|STARTED|Overall Study||1529
2329879|NCT01805089|5718830|P2|NOT COMPLETED|Overall Study||4
2329880|NCT01805089|5718831|P1|NOT COMPLETED|Overall Study||5
2329881|NCT01805089|5718830|P2|COMPLETED|Overall Study||43
2329882|NCT01805089|5718831|P1|COMPLETED|Overall Study||43
2329883|NCT01805089|5718830|P2|STARTED|Overall Study||47
2329884|NCT01805089|5718831|P1|STARTED|Overall Study||48
2329885|NCT01805024|5718845|P4|NOT COMPLETED|Overall Study||0
2329886|NCT01805024|5718846|P3|NOT COMPLETED|Overall Study||0
2329887|NCT01805024|5718847|P2|NOT COMPLETED|Overall Study||0
2329888|NCT01805024|5718848|P1|NOT COMPLETED|Overall Study||0
2329889|NCT01805024|5718845|P4|COMPLETED|Overall Study||8
2329890|NCT01805024|5718846|P3|COMPLETED|Overall Study||4
2329891|NCT01805024|5718847|P2|COMPLETED|Overall Study||4
2329892|NCT01805024|5718848|P1|COMPLETED|Overall Study||4
2329893|NCT01805024|5718845|P4|STARTED|Overall Study||8
2329894|NCT01805024|5718846|P3|STARTED|Overall Study||4
2329895|NCT01805024|5718847|P2|STARTED|Overall Study||4
2329896|NCT01805024|5718848|P1|STARTED|Overall Study||4
2329897|NCT01804946|5718872|P2|NOT COMPLETED|Overall Study||4
2329898|NCT01804946|5718873|P1|NOT COMPLETED|Overall Study||2
2329899|NCT01804946|5718872|P2|COMPLETED|Overall Study||76
2329900|NCT01804946|5718873|P1|COMPLETED|Overall Study||79
2329901|NCT01804946|5718872|P2|STARTED|Overall Study||80
2329902|NCT01804946|5718873|P1|STARTED|Overall Study||81
2329903|NCT01804881|5718897|P2|NOT COMPLETED|Overall Study||4
2329904|NCT01804881|5718898|P1|NOT COMPLETED|Overall Study||5
2329905|NCT01804881|5718897|P2|COMPLETED|Overall Study||10
2329906|NCT01804881|5718898|P1|COMPLETED|Overall Study||11
2329907|NCT01804881|5718897|P2|STARTED|Overall Study||14
2329908|NCT01804881|5718898|P1|STARTED|Overall Study||16
2329909|NCT01804842|5718911|P3|NOT COMPLETED|Overall Study||1
2329910|NCT01804842|5718912|P2|NOT COMPLETED|Overall Study||2
2329911|NCT01804842|5718913|P1|NOT COMPLETED|Overall Study||3
2329912|NCT01804842|5718911|P3|COMPLETED|Overall Study||8
2329913|NCT01804842|5718912|P2|COMPLETED|Overall Study||6
2329914|NCT01804842|5718913|P1|COMPLETED|Overall Study||6
2329915|NCT01804842|5718911|P3|Completed Treatment C|Overall Study||9
2329916|NCT01804842|5718912|P2|Completed Treatment C|Overall Study||7
2329917|NCT01804842|5718913|P1|Completed Treatment C|Overall Study||7
2329918|NCT01804842|5718911|P3|Completed Treatment B|Overall Study||8
2329919|NCT01804842|5718912|P2|Completed Treatment B|Overall Study||8
2329920|NCT01804842|5718913|P1|Completed Treatment B|Overall Study||8
2329921|NCT01804842|5718911|P3|Completed Treatment A|Overall Study||8
2329922|NCT01804842|5718912|P2|Completed Treatment A|Overall Study||6
2329923|NCT01804842|5718913|P1|Completed Treatment A|Overall Study||9
2329924|NCT01804842|5718911|P3|STARTED|Overall Study||9
2329925|NCT01804842|5718912|P2|STARTED|Overall Study||8
2329926|NCT01804842|5718913|P1|STARTED|Overall Study||9
2329927|NCT01804816|5718930|P1|NOT COMPLETED|Acupuncture (Second 5 Weeks)||1
2329928|NCT01804816|5718930|P1|COMPLETED|Acupuncture (Second 5 Weeks)||10
2329929|NCT01804816|5718930|P1|STARTED|Acupuncture (Second 5 Weeks)||11
2329930|NCT01804816|5718930|P1|NOT COMPLETED|No Acupuncture (Initial 5 Weeks)||3
2329931|NCT01804816|5718930|P1|COMPLETED|No Acupuncture (Initial 5 Weeks)||11
2329932|NCT01804816|5718930|P1|STARTED|No Acupuncture (Initial 5 Weeks)||14
2329933|NCT01804673|5718942|P1|NOT COMPLETED|Overall Study||140
2329934|NCT01804673|5718942|P1|COMPLETED|Overall Study||34
2329935|NCT01804673|5718942|P1|Completed Hour 72|Overall Study||36
2329936|NCT01804673|5718942|P1|Completed Hour 48|Overall Study||79
2329937|NCT01804673|5718942|P1|Completed Hour 24|Overall Study||170
2329938|NCT01804673|5718942|P1|STARTED|Overall Study||174
2329939|NCT01804582|5718960|P2|NOT COMPLETED|Overall Study||56
2329940|NCT01804582|5718961|P1|NOT COMPLETED|Overall Study||49
2329941|NCT01804582|5718960|P2|COMPLETED|Overall Study||117
2329942|NCT01804582|5718961|P1|COMPLETED|Overall Study||128
2329943|NCT01804582|5718960|P2|STARTED|Overall Study||173
2329944|NCT01804582|5718961|P1|STARTED|Overall Study||177
2329945|NCT01804257|5718977|P1|NOT COMPLETED|Overall Study||1
2329946|NCT01804257|5718977|P1|COMPLETED|Overall Study||27
2329947|NCT01804257|5718977|P1|STARTED|Overall Study||28
2329948|NCT01804140|5718981|P1|NOT COMPLETED|Overall Study||114
2329949|NCT01804140|5718981|P1|COMPLETED|Overall Study|This includes all the participants with mutation results from the sampling or biopsy procedures.|548
2329950|NCT01804140|5718981|P1|STARTED|Overall Study|This includes all the participants who were enrolled for this study.|662
2329951|NCT01804101|5718988|P2|NOT COMPLETED|Overall Study||0
2329952|NCT01804101|5718989|P1|NOT COMPLETED|Overall Study||0
2329953|NCT01804101|5718988|P2|COMPLETED|Overall Study||10
2329954|NCT01804101|5718989|P1|COMPLETED|Overall Study||38
2329955|NCT01804101|5718988|P2|STARTED|Overall Study||10
2329956|NCT01804101|5718989|P1|STARTED|Overall Study||38
2329957|NCT01804075|5718999|P2|NOT COMPLETED|Overall Study||0
2329958|NCT01804075|5719000|P1|NOT COMPLETED|Overall Study||0
2329959|NCT01804075|5718999|P2|COMPLETED|Overall Study||16
2329960|NCT01804075|5719000|P1|COMPLETED|Overall Study||15
2329961|NCT01804075|5718999|P2|STARTED|Overall Study||16
2329962|NCT01804075|5719000|P1|STARTED|Overall Study||15
2329963|NCT01804062|5719008|P1|NOT COMPLETED|Overall Study||0
2329964|NCT01804062|5719008|P1|COMPLETED|Overall Study||30
2329965|NCT01804062|5719008|P1|STARTED|Overall Study||30
2329966|NCT01804049|5719015|P2|NOT COMPLETED|Overall Study||32
2329967|NCT01804049|5719016|P1|NOT COMPLETED|Overall Study||11
2329968|NCT01804049|5719015|P2|COMPLETED|Overall Study||45
2329969|NCT01804049|5719016|P1|COMPLETED|Overall Study||32
2329970|NCT01804049|5719015|P2|STARTED|Overall Study||77
2329971|NCT01804049|5719016|P1|STARTED|Overall Study||43
2329972|NCT01804036|5719028|P2|NOT COMPLETED|Overall Study||20
2329973|NCT01804036|5719029|P1|NOT COMPLETED|Overall Study||13
2329974|NCT01804036|5719028|P2|COMPLETED|Overall Study||21
2329975|NCT01804036|5719029|P1|COMPLETED|Overall Study||18
2329976|NCT01804036|5719028|P2|STARTED|Overall Study||41
2329977|NCT01804036|5719029|P1|STARTED|Overall Study||31
2329978|NCT01803880|5719064|P3|NOT COMPLETED|Overall Study||15
2329979|NCT01803880|5719065|P2|NOT COMPLETED|Overall Study||10
2329980|NCT01803880|5719066|P1|NOT COMPLETED|Overall Study||6
2329981|NCT01803880|5719064|P3|COMPLETED|Overall Study||14
2329982|NCT01803880|5719065|P2|COMPLETED|Overall Study||18
2329983|NCT01803880|5719066|P1|COMPLETED|Overall Study||13
2329984|NCT01803880|5719064|P3|STARTED|Overall Study||29
2329985|NCT01803880|5719065|P2|STARTED|Overall Study||28
2329986|NCT01803880|5719066|P1|STARTED|Overall Study||19
2329987|NCT01803737|5719102|P2|NOT COMPLETED|Overall Study||3
2329988|NCT01803737|5719103|P1|NOT COMPLETED|Overall Study||1
2329989|NCT01803737|5719102|P2|COMPLETED|Overall Study||10
2329990|NCT01803737|5719103|P1|COMPLETED|Overall Study||12
2329991|NCT01803737|5719102|P2|STARTED|Overall Study||13
2329992|NCT01803737|5719103|P1|STARTED|Overall Study||13
2329993|NCT01803711|5719127|P2|NOT COMPLETED|Overall Study||1
2329994|NCT01803711|5719128|P1|NOT COMPLETED|Overall Study||1
2329995|NCT01803711|5719127|P2|COMPLETED|Overall Study||2
2329996|NCT01803711|5719128|P1|COMPLETED|Overall Study||1
2329997|NCT01803711|5719127|P2|STARTED|Overall Study||3
2329998|NCT01803711|5719128|P1|STARTED|Overall Study||2
2329999|NCT01803646|5719146|P2|NOT COMPLETED|Overall Study||10
2330000|NCT01803646|5719147|P1|NOT COMPLETED|Overall Study||17
2330001|NCT01803646|5719146|P2|COMPLETED|Overall Study||129
2330002|NCT01803646|5719147|P1|COMPLETED|Overall Study||187
2330003|NCT01803646|5719146|P2|STARTED|Overall Study||139
2330004|NCT01803646|5719147|P1|STARTED|Overall Study||204
2330005|NCT01803607|5719159|P2|NOT COMPLETED|Overall Study||67
2330006|NCT01803607|5719160|P1|NOT COMPLETED|Overall Study||68
2330007|NCT01803607|5719159|P2|COMPLETED|Overall Study||0
2330008|NCT01803607|5719160|P1|COMPLETED|Overall Study||0
2330009|NCT01803607|5719159|P2|STARTED|Overall Study||67
2330010|NCT01803607|5719160|P1|STARTED|Overall Study||68
2330011|NCT01803464|5719184|P4|NOT COMPLETED|Overall Study||0
2330012|NCT01803464|5719185|P3|NOT COMPLETED|Overall Study||4
2330013|NCT01803464|5719186|P2|NOT COMPLETED|Overall Study||0
2330014|NCT01803464|5719187|P1|NOT COMPLETED|Overall Study||1
2330015|NCT01803464|5719184|P4|COMPLETED|Overall Study||10
2330016|NCT01803464|5719185|P3|COMPLETED|Overall Study||6
2330017|NCT01803464|5719186|P2|COMPLETED|Overall Study||4
2330018|NCT01803464|5719187|P1|COMPLETED|Overall Study||4
2330019|NCT01803464|5719184|P4|STARTED|Overall Study||10
2330020|NCT01803464|5719185|P3|STARTED|Overall Study||10
2330021|NCT01803464|5719186|P2|STARTED|Overall Study||4
2330022|NCT01803464|5719187|P1|STARTED|Overall Study||5
2330023|NCT01803204|5719207|P2|NOT COMPLETED|Overall Study||0
2330024|NCT01803204|5719208|P1|NOT COMPLETED|Overall Study||0
2330025|NCT01803204|5719207|P2|COMPLETED|Overall Study||20
2330026|NCT01803204|5719208|P1|COMPLETED|Overall Study||20
2330027|NCT01803204|5719207|P2|STARTED|Overall Study||20
2330028|NCT01803204|5719208|P1|STARTED|Overall Study||20
2330029|NCT01803074|5719232|P14|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
2330030|NCT01803074|5719233|P13|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
2330031|NCT01803074|5719234|P12|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
2330032|NCT01803074|5719235|P11|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
2330033|NCT01803074|5719236|P10|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
2330034|NCT01803074|5719237|P9|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
2330035|NCT01803074|5719238|P8|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
2330036|NCT01803074|5719239|P7|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
2330037|NCT01803074|5719240|P6|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
2330038|NCT01803074|5719241|P5|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
2330039|NCT01803074|5719242|P4|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
2330040|NCT01803074|5719243|P3|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
2330041|NCT01803074|5719244|P2|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
2330042|NCT01803074|5719245|P1|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
2330043|NCT01803074|5719232|P14|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||4
2330044|NCT01803074|5719233|P13|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||7
2330045|NCT01803074|5719234|P12|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||8
2330046|NCT01803074|5719235|P11|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
2330047|NCT01803074|5719236|P10|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
2330048|NCT01803074|5719237|P9|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
2330049|NCT01803074|5719238|P8|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
2330050|NCT01803074|5719239|P7|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
2330051|NCT01803074|5719240|P6|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
2330052|NCT01803074|5719241|P5|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
2330053|NCT01803074|5719242|P4|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
2330054|NCT01803074|5719243|P3|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
2330055|NCT01803074|5719244|P2|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
2330056|NCT01803074|5719245|P1|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
2330057|NCT01803074|5719232|P14|STARTED|Period 3: Part C (HIV-1 Clade C Only)||4
2330058|NCT01803074|5719233|P13|STARTED|Period 3: Part C (HIV-1 Clade C Only)||7
2330059|NCT01803074|5719234|P12|STARTED|Period 3: Part C (HIV-1 Clade C Only)||8
2330060|NCT01803074|5719235|P11|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
2330061|NCT01803074|5719236|P10|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
2330062|NCT01803074|5719237|P9|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
2330063|NCT01803074|5719238|P8|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
2330064|NCT01803074|5719239|P7|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
2330065|NCT01803074|5719240|P6|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
2330066|NCT01803074|5719241|P5|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
2330067|NCT01803074|5719242|P4|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
2330068|NCT01803074|5719243|P3|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
2330069|NCT01803074|5719244|P2|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
2330070|NCT01803074|5719245|P1|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
2330071|NCT01803074|5719232|P14|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
2330072|NCT01803074|5719233|P13|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
2330073|NCT01803074|5719234|P12|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
2330074|NCT01803074|5719235|P11|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
2330075|NCT01803074|5719236|P10|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
2330076|NCT01803074|5719237|P9|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
2330077|NCT01803074|5719238|P8|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
2330078|NCT01803074|5719239|P7|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
2330079|NCT01803074|5719240|P6|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
2330080|NCT01803074|5719241|P5|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
2330081|NCT01803074|5719242|P4|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
2330082|NCT01803074|5719243|P3|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
2330083|NCT01803074|5719244|P2|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
2330084|NCT01803074|5719245|P1|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
2330085|NCT01803074|5719232|P14|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
2330086|NCT01803074|5719233|P13|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
2330087|NCT01803074|5719234|P12|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
2330088|NCT01803074|5719235|P11|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
2330089|NCT01803074|5719236|P10|COMPLETED|Period 2: Part B (HIV-1 Clade B)||4
2330090|NCT01803074|5719237|P9|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
2330091|NCT01803074|5719238|P8|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
2330092|NCT01803074|5719239|P7|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
2330093|NCT01803074|5719240|P6|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
2330094|NCT01803074|5719241|P5|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
2330095|NCT01803074|5719242|P4|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
2330096|NCT01803074|5719243|P3|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
2330097|NCT01803074|5719244|P2|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
2330098|NCT01803074|5719245|P1|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
2330099|NCT01803074|5719232|P14|STARTED|Period 2: Part B (HIV-1 Clade B)||0
2330100|NCT01803074|5719233|P13|STARTED|Period 2: Part B (HIV-1 Clade B)||0
2330101|NCT01803074|5719234|P12|STARTED|Period 2: Part B (HIV-1 Clade B)||0
2330102|NCT01803074|5719235|P11|STARTED|Period 2: Part B (HIV-1 Clade B)||8
2330103|NCT01803074|5719236|P10|STARTED|Period 2: Part B (HIV-1 Clade B)||4
2330104|NCT01803074|5719237|P9|STARTED|Period 2: Part B (HIV-1 Clade B)||8
2330105|NCT01803074|5719238|P8|STARTED|Period 2: Part B (HIV-1 Clade B)||8
2330106|NCT01803074|5719239|P7|STARTED|Period 2: Part B (HIV-1 Clade B)||0
2330107|NCT01803074|5719240|P6|STARTED|Period 2: Part B (HIV-1 Clade B)||0
2330108|NCT01803074|5719241|P5|STARTED|Period 2: Part B (HIV-1 Clade B)||0
2330109|NCT01803074|5719242|P4|STARTED|Period 2: Part B (HIV-1 Clade B)||0
2330110|NCT01803074|5719243|P3|STARTED|Period 2: Part B (HIV-1 Clade B)||0
2330111|NCT01803074|5719244|P2|STARTED|Period 2: Part B (HIV-1 Clade B)||0
2330112|NCT01803074|5719245|P1|STARTED|Period 2: Part B (HIV-1 Clade B)||0
2330113|NCT01803074|5719232|P14|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
2330114|NCT01803074|5719233|P13|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
2330115|NCT01803074|5719234|P12|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
2330116|NCT01803074|5719235|P11|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
2330117|NCT01803074|5719236|P10|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
2330118|NCT01803074|5719237|P9|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
2330119|NCT01803074|5719238|P8|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
2330120|NCT01803074|5719239|P7|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
2330121|NCT01803074|5719240|P6|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
2330122|NCT01803074|5719241|P5|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
2330123|NCT01803074|5719242|P4|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
2330124|NCT01803074|5719243|P3|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
2330125|NCT01803074|5719244|P2|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
2330126|NCT01803074|5719245|P1|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
2330127|NCT01803074|5719232|P14|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
2330128|NCT01803074|5719233|P13|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
2330129|NCT01803074|5719234|P12|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
2330130|NCT01803074|5719235|P11|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
2330131|NCT01803074|5719236|P10|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
2330132|NCT01803074|5719237|P9|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
2330133|NCT01803074|5719238|P8|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
2330134|NCT01803074|5719239|P7|COMPLETED|Period 1: Part A (HIV-1 Clade B)||12
2330135|NCT01803074|5719240|P6|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
2330136|NCT01803074|5719241|P5|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
2330137|NCT01803074|5719242|P4|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
2330138|NCT01803074|5719243|P3|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
2330139|NCT01803074|5719244|P2|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
2330140|NCT01803074|5719245|P1|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
2330141|NCT01803074|5719232|P14|STARTED|Period 1: Part A (HIV-1 Clade B)||0
2330142|NCT01803074|5719233|P13|STARTED|Period 1: Part A (HIV-1 Clade B)||0
2330143|NCT01803074|5719234|P12|STARTED|Period 1: Part A (HIV-1 Clade B)||0
2330144|NCT01803074|5719235|P11|STARTED|Period 1: Part A (HIV-1 Clade B)||0
2330145|NCT01803074|5719236|P10|STARTED|Period 1: Part A (HIV-1 Clade B)||0
2330146|NCT01803074|5719237|P9|STARTED|Period 1: Part A (HIV-1 Clade B)||0
2330147|NCT01803074|5719238|P8|STARTED|Period 1: Part A (HIV-1 Clade B)||0
2330148|NCT01803074|5719239|P7|STARTED|Period 1: Part A (HIV-1 Clade B)||12
2330149|NCT01803074|5719240|P6|STARTED|Period 1: Part A (HIV-1 Clade B)||8
2330150|NCT01803074|5719241|P5|STARTED|Period 1: Part A (HIV-1 Clade B)||8
2330151|NCT01803074|5719242|P4|STARTED|Period 1: Part A (HIV-1 Clade B)||8
2330152|NCT01803074|5719243|P3|STARTED|Period 1: Part A (HIV-1 Clade B)||8
2330153|NCT01803074|5719244|P2|STARTED|Period 1: Part A (HIV-1 Clade B)||8
2330154|NCT01803074|5719245|P1|STARTED|Period 1: Part A (HIV-1 Clade B)||8
2330155|NCT01802879|5719499|P1|NOT COMPLETED|Overall Study||8
2330156|NCT01802879|5719499|P1|COMPLETED|Overall Study||0
2330157|NCT01802879|5719499|P1|STARTED|Overall Study||8
2330158|NCT01802775|5719506|P2|NOT COMPLETED|Overall Study||12
2330159|NCT01802775|5719507|P1|NOT COMPLETED|Overall Study||6
2330160|NCT01802775|5719506|P2|COMPLETED|Overall Study||89
2330161|NCT01802775|5719507|P1|COMPLETED|Overall Study||96
2330162|NCT01802775|5719506|P2|Received Drug (Safety Analysis Set)|Overall Study||100
2330163|NCT01802775|5719507|P1|Received Drug (Safety Analysis Set)|Overall Study||101
2330164|NCT01802775|5719506|P2|STARTED|Overall Study||101
2330165|NCT01802775|5719507|P1|STARTED|Overall Study||102
2330166|NCT01802710|5719525|P2|NOT COMPLETED|From T1 to T2||2
2330167|NCT01802710|5719526|P1|NOT COMPLETED|From T1 to T2||2
2330168|NCT01802710|5719525|P2|COMPLETED|From T1 to T2||70
2330169|NCT01802710|5719526|P1|COMPLETED|From T1 to T2||58
2330170|NCT01802710|5719525|P2|STARTED|From T1 to T2||72
2330171|NCT01802710|5719526|P1|STARTED|From T1 to T2||60
2330172|NCT01802710|5719525|P2|NOT COMPLETED|From T0 to T1||10
2330173|NCT01802710|5719526|P1|NOT COMPLETED|From T0 to T1||16
2330174|NCT01802710|5719525|P2|COMPLETED|From T0 to T1||72
2330175|NCT01802710|5719526|P1|COMPLETED|From T0 to T1||60
2330176|NCT01802710|5719525|P2|STARTED|From T0 to T1||82
2330177|NCT01802710|5719526|P1|STARTED|From T0 to T1||76
2330178|NCT01802632|5719542|P6|NOT COMPLETED|Overall Study||28
2330179|NCT01802632|5719543|P5|NOT COMPLETED|Overall Study||12
2330180|NCT01802632|5719544|P4|NOT COMPLETED|Overall Study||60
2330181|NCT01802632|5719545|P3|NOT COMPLETED|Overall Study||271
2330182|NCT01802632|5719546|P2|NOT COMPLETED|Overall Study||31
2330183|NCT01802632|5719547|P1|NOT COMPLETED|Overall Study||201
2330184|NCT01802632|5719542|P6|COMPLETED|Overall Study||0
2330185|NCT01802632|5719543|P5|COMPLETED|Overall Study||0
2330186|NCT01802632|5719544|P4|COMPLETED|Overall Study||0
2330187|NCT01802632|5719545|P3|COMPLETED|Overall Study||0
2330188|NCT01802632|5719546|P2|COMPLETED|Overall Study||0
2330189|NCT01802632|5719547|P1|COMPLETED|Overall Study||0
2330190|NCT01802632|5719542|P6|STARTED|Overall Study||28
2330191|NCT01802632|5719543|P5|STARTED|Overall Study||12
2330192|NCT01802632|5719544|P4|STARTED|Overall Study||60
2330193|NCT01802632|5719545|P3|STARTED|Overall Study||271
2330194|NCT01802632|5719546|P2|STARTED|Overall Study||31
2330195|NCT01802632|5719547|P1|STARTED|Overall Study||201
2330196|NCT01802580|5719563|P2|NOT COMPLETED|Overall Study||11
2330197|NCT01802580|5719564|P1|NOT COMPLETED|Overall Study||9
2330198|NCT01802580|5719563|P2|COMPLETED|Overall Study||9
2330199|NCT01802580|5719564|P1|COMPLETED|Overall Study||11
2330200|NCT01802580|5719563|P2|STARTED|Overall Study||20
2330201|NCT01802580|5719564|P1|STARTED|Overall Study||20
2330202|NCT01802554|5719577|P2|NOT COMPLETED|Overall Study||6
2330203|NCT01802554|5719578|P1|NOT COMPLETED|Overall Study||8
2330204|NCT01802554|5719577|P2|COMPLETED|Overall Study||43
2330205|NCT01802554|5719578|P1|COMPLETED|Overall Study||43
2330206|NCT01802554|5719577|P2|STARTED|Overall Study||49
2330207|NCT01802554|5719578|P1|STARTED|Overall Study||51
2330208|NCT01802515|5719595|P3|NOT COMPLETED|Overall Study||0
2330209|NCT01802515|5719596|P2|NOT COMPLETED|Overall Study||0
2330210|NCT01802515|5719597|P1|NOT COMPLETED|Overall Study||3
2330211|NCT01802515|5719595|P3|COMPLETED|Overall Study||4
2330212|NCT01802515|5719596|P2|COMPLETED|Overall Study||5
2330213|NCT01802515|5719597|P1|COMPLETED|Overall Study||2
2330214|NCT01802515|5719595|P3|STARTED|Overall Study||4
2330215|NCT01802515|5719596|P2|STARTED|Overall Study||5
2330216|NCT01802515|5719597|P1|STARTED|Overall Study||5
2330217|NCT01802437|5719610|P2|NOT COMPLETED|Overall Study||4
2330218|NCT01802437|5719611|P1|NOT COMPLETED|Overall Study||4
2330219|NCT01802437|5719610|P2|COMPLETED|Overall Study||16
2330220|NCT01802437|5719611|P1|COMPLETED|Overall Study||16
2330221|NCT01802437|5719610|P2|STARTED|Overall Study||20
2330222|NCT01802437|5719611|P1|STARTED|Overall Study||20
2330223|NCT01802385|5719623|P2|NOT COMPLETED|Overall Study||120
2330224|NCT01802385|5719624|P1|NOT COMPLETED|Overall Study||106
2330225|NCT01802385|5719623|P2|COMPLETED|Overall Study||109
2330226|NCT01802385|5719624|P1|COMPLETED|Overall Study||125
2330227|NCT01802385|5719623|P2|STARTED|Overall Study||229
2330228|NCT01802385|5719624|P1|STARTED|Overall Study||231
2330229|NCT01802333|5719647|P3|NOT COMPLETED|Overall Study||63
2330230|NCT01802333|5719648|P2|NOT COMPLETED|Overall Study||61
2330231|NCT01802333|5719649|P1|NOT COMPLETED|Overall Study||49
2330232|NCT01802333|5719647|P3|COMPLETED|Overall Study||161
2330233|NCT01802333|5719648|P2|COMPLETED|Overall Study||206
2330234|NCT01802333|5719649|P1|COMPLETED|Overall Study||214
2330235|NCT01802333|5719647|P3|Known Cytogenetic Risk at Baseline|Overall Study||210
2330236|NCT01802333|5719648|P2|Known Cytogenetic Risk at Baseline|Overall Study||250
2330237|NCT01802333|5719649|P1|Known Cytogenetic Risk at Baseline|Overall Study||252
2330238|NCT01802333|5719647|P3|Known NPM1 Status at Baseline|Overall Study||142
2330239|NCT01802333|5719648|P2|Known NPM1 Status at Baseline|Overall Study||156
2330240|NCT01802333|5719649|P1|Known NPM1 Status at Baseline|Overall Study||169
2330241|NCT01802333|5719647|P3|High Risk Patients Achieved CR/CRi|Overall Study||29
2330242|NCT01802333|5719648|P2|High Risk Patients Achieved CR/CRi|Overall Study||40
2330243|NCT01802333|5719649|P1|High Risk Patients Achieved CR/CRi|Overall Study||38
2330244|NCT01802333|5719647|P3|High Risk Patients|Overall Study||38
2330245|NCT01802333|5719648|P2|High Risk Patients|Overall Study||61
2330246|NCT01802333|5719649|P1|High Risk Patients|Overall Study||60
2330247|NCT01802333|5719647|P3|STARTED|Overall Study||224
2330248|NCT01802333|5719648|P2|STARTED|Overall Study||267
2330249|NCT01802333|5719649|P1|STARTED|Overall Study||263
2330250|NCT01802320|5719676|P1|NOT COMPLETED|Overall Study||2
2330251|NCT01802320|5719676|P1|COMPLETED|Overall Study||16
2330252|NCT01802320|5719676|P1|STARTED|Overall Study||18
2330253|NCT01802216|5719686|P2|NOT COMPLETED|12 Month Visit||4
2330254|NCT01802216|5719687|P1|NOT COMPLETED|12 Month Visit||3
2330255|NCT01802216|5719686|P2|COMPLETED|12 Month Visit||30
2330256|NCT01802216|5719687|P1|COMPLETED|12 Month Visit||14
2330257|NCT01802216|5719686|P2|STARTED|12 Month Visit||34
2330258|NCT01802216|5719687|P1|STARTED|12 Month Visit||17
2330259|NCT01802216|5719686|P2|NOT COMPLETED|8 Month Visit||5
2330260|NCT01802216|5719687|P1|NOT COMPLETED|8 Month Visit||3
2330261|NCT01802216|5719686|P2|COMPLETED|8 Month Visit||29
2330262|NCT01802216|5719687|P1|COMPLETED|8 Month Visit||14
2330263|NCT01802216|5719686|P2|STARTED|8 Month Visit||34
2330264|NCT01802216|5719687|P1|STARTED|8 Month Visit||17
2330265|NCT01802216|5719686|P2|NOT COMPLETED|4 Month Visit||4
2330266|NCT01802216|5719687|P1|NOT COMPLETED|4 Month Visit||3
2330267|NCT01802216|5719686|P2|COMPLETED|4 Month Visit||30
2330268|NCT01802216|5719687|P1|COMPLETED|4 Month Visit||14
2330269|NCT01802216|5719686|P2|STARTED|4 Month Visit||34
2330270|NCT01802216|5719687|P1|STARTED|4 Month Visit||17
2330271|NCT01802216|5719686|P2|NOT COMPLETED|Baseline||0
2330272|NCT01802216|5719687|P1|NOT COMPLETED|Baseline||0
2330273|NCT01802216|5719686|P2|COMPLETED|Baseline||34
2330274|NCT01802216|5719687|P1|COMPLETED|Baseline||17
2330275|NCT01802216|5719686|P2|STARTED|Baseline||34
2330276|NCT01802216|5719687|P1|STARTED|Baseline||17
2330277|NCT01802151|5719699|P4|NOT COMPLETED|Overall Study||0
2330278|NCT01802151|5719700|P3|NOT COMPLETED|Overall Study||2
2330279|NCT01802151|5719701|P2|NOT COMPLETED|Overall Study||0
2330280|NCT01802151|5719702|P1|NOT COMPLETED|Overall Study||0
2330281|NCT01802151|5719699|P4|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
2330282|NCT01802151|5719700|P3|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
2330283|NCT01802151|5719701|P2|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|21
2330284|NCT01802151|5719702|P1|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
2330285|NCT01802151|5719699|P4|STARTED|Overall Study||20
2330286|NCT01802151|5719700|P3|STARTED|Overall Study||22
2330287|NCT01802151|5719701|P2|STARTED|Overall Study||21
2330288|NCT01802151|5719702|P1|STARTED|Overall Study||20
2330289|NCT01802073|5719766|P2|NOT COMPLETED|Overall Study||11
2330290|NCT01802073|5719767|P1|NOT COMPLETED|Overall Study||5
2330291|NCT01802073|5719766|P2|COMPLETED|Overall Study||9
2330292|NCT01802073|5719767|P1|COMPLETED|Overall Study||9
2330293|NCT01802073|5719766|P2|STARTED|Overall Study||20
2330294|NCT01802073|5719767|P1|STARTED|Overall Study||14
2330295|NCT01801982|5719783|P1|NOT COMPLETED|Overall Study||1
2330296|NCT01801982|5719783|P1|COMPLETED|Overall Study||0
2330297|NCT01801982|5719783|P1|STARTED|Overall Study||1
2330298|NCT01801917|5719797|P4|NOT COMPLETED|Extension - All Active||0
2330299|NCT01801917|5719798|P3|NOT COMPLETED|Extension - All Active||0
2330300|NCT01801917|5719799|P2|NOT COMPLETED|Extension - All Active||0
2330301|NCT01801917|5719800|P1|NOT COMPLETED|Extension - All Active||0
2330302|NCT01801917|5719797|P4|COMPLETED|Extension - All Active||0
2330303|NCT01801917|5719798|P3|COMPLETED|Extension - All Active||3
2330304|NCT01801917|5719799|P2|COMPLETED|Extension - All Active||0
2330305|NCT01801917|5719800|P1|COMPLETED|Extension - All Active||6
2330306|NCT01801917|5719797|P4|STARTED|Extension - All Active||0
2330307|NCT01801917|5719798|P3|STARTED|Extension - All Active||3
2330308|NCT01801917|5719799|P2|STARTED|Extension - All Active||0
2330309|NCT01801917|5719800|P1|STARTED|Extension - All Active||6
2330310|NCT01801917|5719797|P4|NOT COMPLETED|Period 1 - Randomized||0
2330311|NCT01801917|5719798|P3|NOT COMPLETED|Period 1 - Randomized||1
2330312|NCT01801917|5719799|P2|NOT COMPLETED|Period 1 - Randomized||0
2330313|NCT01801917|5719800|P1|NOT COMPLETED|Period 1 - Randomized||1
2330314|NCT01801917|5719797|P4|COMPLETED|Period 1 - Randomized||1
2330315|NCT01801917|5719798|P3|COMPLETED|Period 1 - Randomized||3
2330316|NCT01801917|5719799|P2|COMPLETED|Period 1 - Randomized||2
2330317|NCT01801917|5719800|P1|COMPLETED|Period 1 - Randomized||6
2330318|NCT01801917|5719797|P4|STARTED|Period 1 - Randomized||1
2330319|NCT01801917|5719798|P3|STARTED|Period 1 - Randomized||4
2330320|NCT01801917|5719799|P2|STARTED|Period 1 - Randomized||2
2330321|NCT01801917|5719800|P1|STARTED|Period 1 - Randomized||7
2330322|NCT01801735|5719820|P1|NOT COMPLETED|Overall Study||210
2330323|NCT01801735|5719820|P1|COMPLETED|Overall Study||390
2330324|NCT01801735|5719820|P1|STARTED|Overall Study||600
2330325|NCT01801475|5719827|P5|NOT COMPLETED|Overall Study||1
2330326|NCT01801475|5719828|P4|NOT COMPLETED|Overall Study||0
2330327|NCT01801475|5719829|P3|NOT COMPLETED|Overall Study||0
2330328|NCT01801475|5719830|P2|NOT COMPLETED|Overall Study||0
2330329|NCT01801475|5719831|P1|NOT COMPLETED|Overall Study||0
2330330|NCT01801475|5719827|P5|COMPLETED|Overall Study||39
2330331|NCT01801475|5719828|P4|COMPLETED|Overall Study||10
2330332|NCT01801475|5719829|P3|COMPLETED|Overall Study||10
2330333|NCT01801475|5719830|P2|COMPLETED|Overall Study||30
2330334|NCT01801475|5719831|P1|COMPLETED|Overall Study||10
2330335|NCT01801475|5719827|P5|STARTED|Overall Study||40
2330336|NCT01801475|5719828|P4|STARTED|Overall Study||10
2330337|NCT01801475|5719829|P3|STARTED|Overall Study||10
2330338|NCT01801475|5719830|P2|STARTED|Overall Study||30
2330339|NCT01801475|5719831|P1|STARTED|Overall Study||10
2330340|NCT01801449|5719842|P1|NOT COMPLETED|Overall Study||0
2330341|NCT01801449|5719842|P1|COMPLETED|Overall Study||6
2330342|NCT01801449|5719842|P1|STARTED|Overall Study||6
2330343|NCT01801436|5719856|P1|NOT COMPLETED|Overall Study||9
2330344|NCT01801436|5719856|P1|COMPLETED|Overall Study||5
2330345|NCT01801436|5719856|P1|STARTED|Overall Study||14
2330346|NCT01801358|5719894|P6|NOT COMPLETED|Overall Study||8
2330347|NCT01801358|5719895|P5|NOT COMPLETED|Overall Study||6
2330348|NCT01801358|5719896|P4|NOT COMPLETED|Overall Study||6
2330349|NCT01801358|5719897|P3|NOT COMPLETED|Overall Study||6
2330350|NCT01801358|5719898|P2|NOT COMPLETED|Overall Study||6
2330351|NCT01801358|5719899|P1|NOT COMPLETED|Overall Study||6
2330352|NCT01801358|5719894|P6|COMPLETED|Overall Study||0
2330353|NCT01801358|5719895|P5|COMPLETED|Overall Study||0
2330354|NCT01801358|5719896|P4|COMPLETED|Overall Study||0
2330355|NCT01801358|5719897|P3|COMPLETED|Overall Study||0
2330356|NCT01801358|5719898|P2|COMPLETED|Overall Study||0
2330357|NCT01801358|5719899|P1|COMPLETED|Overall Study||0
2330358|NCT01801358|5719894|P6|STARTED|Overall Study||8
2330359|NCT01801358|5719895|P5|STARTED|Overall Study||6
2330360|NCT01801358|5719896|P4|STARTED|Overall Study||6
2330361|NCT01801358|5719897|P3|STARTED|Overall Study||6
2330362|NCT01801358|5719898|P2|STARTED|Overall Study||6
2330363|NCT01801358|5719899|P1|STARTED|Overall Study||6
2330364|NCT01801280|5720021|P4|NOT COMPLETED|Period 4||0
2330365|NCT01801280|5720022|P3|NOT COMPLETED|Period 4||1
2330366|NCT01801280|5720023|P2|NOT COMPLETED|Period 4||0
2330367|NCT01801280|5720024|P1|NOT COMPLETED|Period 4||0
2330368|NCT01801280|5720021|P4|COMPLETED|Period 4||5
2330369|NCT01801280|5720022|P3|COMPLETED|Period 4||4
2330370|NCT01801280|5720023|P2|COMPLETED|Period 4||4
2330371|NCT01801280|5720024|P1|COMPLETED|Period 4||4
2330372|NCT01801280|5720021|P4|STARTED|Period 4||5
2330373|NCT01801280|5720022|P3|STARTED|Period 4||5
2330374|NCT01801280|5720023|P2|STARTED|Period 4||4
2330375|NCT01801280|5720024|P1|STARTED|Period 4||4
2330376|NCT01801280|5720021|P4|NOT COMPLETED|Period 3||0
2330377|NCT01801280|5720022|P3|NOT COMPLETED|Period 3||0
2330378|NCT01801280|5720023|P2|NOT COMPLETED|Period 3||0
2330379|NCT01801280|5720024|P1|NOT COMPLETED|Period 3||0
2330380|NCT01801280|5720021|P4|COMPLETED|Period 3||5
2330381|NCT01801280|5720022|P3|COMPLETED|Period 3||5
2330382|NCT01801280|5720023|P2|COMPLETED|Period 3||4
2330383|NCT01801280|5720024|P1|COMPLETED|Period 3||4
2330384|NCT01801280|5720021|P4|STARTED|Period 3||5
2330385|NCT01801280|5720022|P3|STARTED|Period 3||5
2330386|NCT01801280|5720023|P2|STARTED|Period 3||4
2330387|NCT01801280|5720024|P1|STARTED|Period 3||4
2330388|NCT01801280|5720021|P4|NOT COMPLETED|Period 2||0
2330389|NCT01801280|5720022|P3|NOT COMPLETED|Period 2||0
2330390|NCT01801280|5720023|P2|NOT COMPLETED|Period 2||0
2330391|NCT01801280|5720024|P1|NOT COMPLETED|Period 2||1
2330392|NCT01801280|5720021|P4|COMPLETED|Period 2||5
2330393|NCT01801280|5720022|P3|COMPLETED|Period 2||5
2330394|NCT01801280|5720023|P2|COMPLETED|Period 2||4
2330395|NCT01801280|5720024|P1|COMPLETED|Period 2||4
2330396|NCT01801280|5720021|P4|STARTED|Period 2||5
2330397|NCT01801280|5720022|P3|STARTED|Period 2||5
2330398|NCT01801280|5720023|P2|STARTED|Period 2||4
2330399|NCT01801280|5720024|P1|STARTED|Period 2||5
2330400|NCT01801280|5720021|P4|NOT COMPLETED|Period 1||0
2330401|NCT01801280|5720022|P3|NOT COMPLETED|Period 1||0
2330402|NCT01801280|5720023|P2|NOT COMPLETED|Period 1||1
2330403|NCT01801280|5720024|P1|NOT COMPLETED|Period 1||0
2330404|NCT01801280|5720021|P4|COMPLETED|Period 1||5
2330405|NCT01801280|5720022|P3|COMPLETED|Period 1||5
2330406|NCT01801280|5720023|P2|COMPLETED|Period 1||4
2330407|NCT01801280|5720024|P1|COMPLETED|Period 1||5
2330408|NCT01801280|5720021|P4|STARTED|Period 1||5
2330409|NCT01801280|5720022|P3|STARTED|Period 1||5
2330410|NCT01801280|5720023|P2|STARTED|Period 1||5
2330411|NCT01801280|5720024|P1|STARTED|Period 1|Each period lasted 10-14 weeks|5
2330412|NCT01801124|5720034|P1|NOT COMPLETED|Overall Study||0
2330413|NCT01801124|5720034|P1|COMPLETED|Overall Study||13
2330414|NCT01801124|5720034|P1|STARTED|Overall Study||13
2330415|NCT01801111|5720039|P1|NOT COMPLETED|Overall Study||138
2330416|NCT01801111|5720039|P1|COMPLETED|Overall Study||0
2330417|NCT01801111|5720039|P1|STARTED|Overall Study||138
2330418|NCT01800968|5720080|P2|NOT COMPLETED|Overall Study||32
2330419|NCT01800968|5720081|P1|NOT COMPLETED|Overall Study||36
2330420|NCT01800968|5720080|P2|COMPLETED|Overall Study||114
2330421|NCT01800968|5720081|P1|COMPLETED|Overall Study||118
2330422|NCT01800968|5720080|P2|STARTED|Overall Study||146
2330423|NCT01800968|5720081|P1|STARTED|Overall Study||154
2330424|NCT01800916|5720123|P9|NOT COMPLETED|Test Period 3 (1 Week)||0
2330425|NCT01800916|5720124|P8|NOT COMPLETED|Test Period 3 (1 Week)||0
2330426|NCT01800916|5720125|P7|NOT COMPLETED|Test Period 3 (1 Week)||0
2330427|NCT01800916|5720126|P6|NOT COMPLETED|Test Period 3 (1 Week)||0
2330428|NCT01800916|5720127|P5|NOT COMPLETED|Test Period 3 (1 Week)||0
2330429|NCT01800916|5720128|P4|NOT COMPLETED|Test Period 3 (1 Week)||0
2330430|NCT01800916|5720129|P3|NOT COMPLETED|Test Period 3 (1 Week)||0
2330431|NCT01800916|5720130|P2|NOT COMPLETED|Test Period 3 (1 Week)||0
2330432|NCT01800916|5720131|P1|NOT COMPLETED|Test Period 3 (1 Week)||0
2330433|NCT01800916|5720123|P9|COMPLETED|Test Period 3 (1 Week)||7
2330434|NCT01800916|5720124|P8|COMPLETED|Test Period 3 (1 Week)||7
2330435|NCT01800916|5720125|P7|COMPLETED|Test Period 3 (1 Week)||7
2330436|NCT01800916|5720126|P6|COMPLETED|Test Period 3 (1 Week)||7
2330437|NCT01800916|5720127|P5|COMPLETED|Test Period 3 (1 Week)||7
2330438|NCT01800916|5720128|P4|COMPLETED|Test Period 3 (1 Week)||6
2330439|NCT01800916|5720129|P3|COMPLETED|Test Period 3 (1 Week)||7
2330440|NCT01800916|5720130|P2|COMPLETED|Test Period 3 (1 Week)||7
2330441|NCT01800916|5720131|P1|COMPLETED|Test Period 3 (1 Week)||7
2330442|NCT01800916|5720123|P9|STARTED|Test Period 3 (1 Week)||7
2330443|NCT01800916|5720124|P8|STARTED|Test Period 3 (1 Week)||7
2330444|NCT01800916|5720125|P7|STARTED|Test Period 3 (1 Week)||7
2330445|NCT01800916|5720126|P6|STARTED|Test Period 3 (1 Week)||7
2330446|NCT01800916|5720127|P5|STARTED|Test Period 3 (1 Week)||7
2330447|NCT01800916|5720128|P4|STARTED|Test Period 3 (1 Week)||6
2330448|NCT01800916|5720129|P3|STARTED|Test Period 3 (1 Week)||7
2330449|NCT01800916|5720130|P2|STARTED|Test Period 3 (1 Week)||7
2330450|NCT01800916|5720131|P1|STARTED|Test Period 3 (1 Week)||7
2330451|NCT01800916|5720123|P9|NOT COMPLETED|Test Period 2 (1 Week)||0
2330452|NCT01800916|5720124|P8|NOT COMPLETED|Test Period 2 (1 Week)||0
2330453|NCT01800916|5720125|P7|NOT COMPLETED|Test Period 2 (1 Week)||0
2330454|NCT01800916|5720126|P6|NOT COMPLETED|Test Period 2 (1 Week)||0
2330455|NCT01800916|5720127|P5|NOT COMPLETED|Test Period 2 (1 Week)||0
2330456|NCT01800916|5720128|P4|NOT COMPLETED|Test Period 2 (1 Week)||0
2330457|NCT01800916|5720129|P3|NOT COMPLETED|Test Period 2 (1 Week)||0
2330458|NCT01800916|5720130|P2|NOT COMPLETED|Test Period 2 (1 Week)||0
2330459|NCT01800916|5720131|P1|NOT COMPLETED|Test Period 2 (1 Week)||0
2330460|NCT01800916|5720123|P9|COMPLETED|Test Period 2 (1 Week)||7
2330461|NCT01800916|5720124|P8|COMPLETED|Test Period 2 (1 Week)||7
2330462|NCT01800916|5720125|P7|COMPLETED|Test Period 2 (1 Week)||7
2330463|NCT01800916|5720126|P6|COMPLETED|Test Period 2 (1 Week)||7
2330464|NCT01800916|5720127|P5|COMPLETED|Test Period 2 (1 Week)||7
2330465|NCT01800916|5720128|P4|COMPLETED|Test Period 2 (1 Week)||6
2330466|NCT01800916|5720129|P3|COMPLETED|Test Period 2 (1 Week)||7
2330467|NCT01800916|5720130|P2|COMPLETED|Test Period 2 (1 Week)||7
2330468|NCT01800916|5720131|P1|COMPLETED|Test Period 2 (1 Week)||7
2330469|NCT01800916|5720123|P9|STARTED|Test Period 2 (1 Week)||7
2330470|NCT01800916|5720124|P8|STARTED|Test Period 2 (1 Week)||7
2330471|NCT01800916|5720125|P7|STARTED|Test Period 2 (1 Week)||7
2330472|NCT01800916|5720126|P6|STARTED|Test Period 2 (1 Week)||7
2330473|NCT01800916|5720127|P5|STARTED|Test Period 2 (1 Week)||7
2330474|NCT01800916|5720128|P4|STARTED|Test Period 2 (1 Week)||6
2330475|NCT01800916|5720129|P3|STARTED|Test Period 2 (1 Week)||7
2330476|NCT01800916|5720130|P2|STARTED|Test Period 2 (1 Week)||7
2330477|NCT01800916|5720131|P1|STARTED|Test Period 2 (1 Week)||7
2330478|NCT01800916|5720123|P9|NOT COMPLETED|Test Period 1 (1 Week)||0
2330479|NCT01800916|5720124|P8|NOT COMPLETED|Test Period 1 (1 Week)||0
2330480|NCT01800916|5720125|P7|NOT COMPLETED|Test Period 1 (1 Week)||0
2330481|NCT01800916|5720126|P6|NOT COMPLETED|Test Period 1 (1 Week)||0
2330482|NCT01800916|5720127|P5|NOT COMPLETED|Test Period 1 (1 Week)||1
2330483|NCT01800916|5720128|P4|NOT COMPLETED|Test Period 1 (1 Week)||1
2330484|NCT01800916|5720129|P3|NOT COMPLETED|Test Period 1 (1 Week)||0
2330485|NCT01800916|5720130|P2|NOT COMPLETED|Test Period 1 (1 Week)||0
2330486|NCT01800916|5720131|P1|NOT COMPLETED|Test Period 1 (1 Week)||0
2330487|NCT01800916|5720123|P9|COMPLETED|Test Period 1 (1 Week)||7
2330488|NCT01800916|5720124|P8|COMPLETED|Test Period 1 (1 Week)||7
2330489|NCT01800916|5720125|P7|COMPLETED|Test Period 1 (1 Week)||7
2330490|NCT01800916|5720126|P6|COMPLETED|Test Period 1 (1 Week)||7
2330491|NCT01800916|5720127|P5|COMPLETED|Test Period 1 (1 Week)||7
2330492|NCT01800916|5720128|P4|COMPLETED|Test Period 1 (1 Week)||6
2330493|NCT01800916|5720129|P3|COMPLETED|Test Period 1 (1 Week)||7
2330494|NCT01800916|5720130|P2|COMPLETED|Test Period 1 (1 Week)||7
2330495|NCT01800916|5720131|P1|COMPLETED|Test Period 1 (1 Week)||7
2330496|NCT01800916|5720123|P9|STARTED|Test Period 1 (1 Week)||7
2330497|NCT01800916|5720124|P8|STARTED|Test Period 1 (1 Week)||7
2330498|NCT01800916|5720125|P7|STARTED|Test Period 1 (1 Week)||7
2330499|NCT01800916|5720126|P6|STARTED|Test Period 1 (1 Week)||7
2330500|NCT01800916|5720127|P5|STARTED|Test Period 1 (1 Week)||8
2330501|NCT01800916|5720128|P4|STARTED|Test Period 1 (1 Week)||7
2330502|NCT01800916|5720129|P3|STARTED|Test Period 1 (1 Week)||7
2330503|NCT01800916|5720130|P2|STARTED|Test Period 1 (1 Week)||7
2330504|NCT01800916|5720131|P1|STARTED|Test Period 1 (1 Week)||7
2330505|NCT01800903|5720141|P6|NOT COMPLETED|Third Test Period||0
2330506|NCT01800903|5720142|P5|NOT COMPLETED|Third Test Period||0
2330507|NCT01800903|5720143|P4|NOT COMPLETED|Third Test Period||0
2330508|NCT01800903|5720144|P3|NOT COMPLETED|Third Test Period||0
2330509|NCT01800903|5720145|P2|NOT COMPLETED|Third Test Period||0
2330510|NCT01800903|5720146|P1|NOT COMPLETED|Third Test Period||0
2330511|NCT01800903|5720141|P6|COMPLETED|Third Test Period||6
2330512|NCT01800903|5720142|P5|COMPLETED|Third Test Period||6
2330513|NCT01800903|5720143|P4|COMPLETED|Third Test Period||7
2330514|NCT01800903|5720144|P3|COMPLETED|Third Test Period||4
2330515|NCT01800903|5720145|P2|COMPLETED|Third Test Period||6
2330516|NCT01800903|5720146|P1|COMPLETED|Third Test Period||6
2330517|NCT01800903|5720141|P6|STARTED|Third Test Period||6
2330518|NCT01800903|5720142|P5|STARTED|Third Test Period||6
2330519|NCT01800903|5720143|P4|STARTED|Third Test Period||7
2330520|NCT01800903|5720144|P3|STARTED|Third Test Period||4
2330521|NCT01800903|5720145|P2|STARTED|Third Test Period||6
2330522|NCT01800903|5720146|P1|STARTED|Third Test Period||6
2330523|NCT01800903|5720141|P6|NOT COMPLETED|Second Test Period||0
2330524|NCT01800903|5720142|P5|NOT COMPLETED|Second Test Period||0
2330525|NCT01800903|5720143|P4|NOT COMPLETED|Second Test Period||0
2330526|NCT01800903|5720144|P3|NOT COMPLETED|Second Test Period||0
2330527|NCT01800903|5720145|P2|NOT COMPLETED|Second Test Period||0
2330528|NCT01800903|5720146|P1|NOT COMPLETED|Second Test Period||1
2330529|NCT01800903|5720141|P6|COMPLETED|Second Test Period||6
2330530|NCT01800903|5720142|P5|COMPLETED|Second Test Period||6
2330531|NCT01800903|5720143|P4|COMPLETED|Second Test Period||7
2330532|NCT01800903|5720144|P3|COMPLETED|Second Test Period||4
2330533|NCT01800903|5720145|P2|COMPLETED|Second Test Period||6
2330534|NCT01800903|5720146|P1|COMPLETED|Second Test Period||6
2330535|NCT01800903|5720141|P6|STARTED|Second Test Period||6
2330536|NCT01800903|5720142|P5|STARTED|Second Test Period||6
2330537|NCT01800903|5720143|P4|STARTED|Second Test Period||7
2330538|NCT01800903|5720144|P3|STARTED|Second Test Period||4
2330539|NCT01800903|5720145|P2|STARTED|Second Test Period||6
2330540|NCT01800903|5720146|P1|STARTED|Second Test Period||7
2330541|NCT01800903|5720141|P6|NOT COMPLETED|First Test Period||0
2330542|NCT01800903|5720142|P5|NOT COMPLETED|First Test Period||0
2330543|NCT01800903|5720143|P4|NOT COMPLETED|First Test Period||0
2330544|NCT01800903|5720144|P3|NOT COMPLETED|First Test Period||0
2330545|NCT01800903|5720145|P2|NOT COMPLETED|First Test Period||0
2330546|NCT01800903|5720146|P1|NOT COMPLETED|First Test Period||0
2330547|NCT01800903|5720141|P6|COMPLETED|First Test Period||6
2330548|NCT01800903|5720142|P5|COMPLETED|First Test Period||6
2330549|NCT01800903|5720143|P4|COMPLETED|First Test Period||7
2330550|NCT01800903|5720144|P3|COMPLETED|First Test Period||4
2330551|NCT01800903|5720145|P2|COMPLETED|First Test Period||6
2330552|NCT01800903|5720146|P1|COMPLETED|First Test Period||7
2330553|NCT01800903|5720141|P6|STARTED|First Test Period||6
2330554|NCT01800903|5720142|P5|STARTED|First Test Period||6
2330555|NCT01800903|5720143|P4|STARTED|First Test Period||7
2330556|NCT01800903|5720144|P3|STARTED|First Test Period||4
2330557|NCT01800903|5720145|P2|STARTED|First Test Period||6
2330558|NCT01800903|5720146|P1|STARTED|First Test Period||7
2330559|NCT01800890|5720152|P9|NOT COMPLETED|Test Period 3||0
2330560|NCT01800890|5720153|P8|NOT COMPLETED|Test Period 3||0
2330561|NCT01800890|5720154|P7|NOT COMPLETED|Test Period 3||0
2330562|NCT01800890|5720155|P6|NOT COMPLETED|Test Period 3||0
2330563|NCT01800890|5720156|P5|NOT COMPLETED|Test Period 3||0
2330564|NCT01800890|5720157|P4|NOT COMPLETED|Test Period 3||0
2330565|NCT01800890|5720158|P3|NOT COMPLETED|Test Period 3||0
2330566|NCT01800890|5720159|P2|NOT COMPLETED|Test Period 3||0
2330567|NCT01800890|5720160|P1|NOT COMPLETED|Test Period 3||0
2330568|NCT01800890|5720152|P9|COMPLETED|Test Period 3||3
2330569|NCT01800890|5720153|P8|COMPLETED|Test Period 3||3
2330570|NCT01800890|5720154|P7|COMPLETED|Test Period 3||3
2330571|NCT01800890|5720155|P6|COMPLETED|Test Period 3||4
2330572|NCT01800890|5720156|P5|COMPLETED|Test Period 3||4
2330573|NCT01800890|5720157|P4|COMPLETED|Test Period 3||2
2330574|NCT01800890|5720158|P3|COMPLETED|Test Period 3||3
2330575|NCT01800890|5720159|P2|COMPLETED|Test Period 3||3
2330576|NCT01800890|5720160|P1|COMPLETED|Test Period 3||3
2330577|NCT01800890|5720152|P9|STARTED|Test Period 3||3
2330578|NCT01800890|5720153|P8|STARTED|Test Period 3||3
2330579|NCT01800890|5720154|P7|STARTED|Test Period 3||3
2330580|NCT01800890|5720155|P6|STARTED|Test Period 3||4
2330581|NCT01800890|5720156|P5|STARTED|Test Period 3||4
2330582|NCT01800890|5720157|P4|STARTED|Test Period 3||2
2330583|NCT01800890|5720158|P3|STARTED|Test Period 3||3
2330584|NCT01800890|5720159|P2|STARTED|Test Period 3||3
2330585|NCT01800890|5720160|P1|STARTED|Test Period 3||3
2330586|NCT01800890|5720152|P9|NOT COMPLETED|Test Period 2||0
2330587|NCT01800890|5720153|P8|NOT COMPLETED|Test Period 2||0
2330588|NCT01800890|5720154|P7|NOT COMPLETED|Test Period 2||0
2330589|NCT01800890|5720155|P6|NOT COMPLETED|Test Period 2||0
2330590|NCT01800890|5720156|P5|NOT COMPLETED|Test Period 2||0
2330591|NCT01800890|5720157|P4|NOT COMPLETED|Test Period 2||0
2330592|NCT01800890|5720158|P3|NOT COMPLETED|Test Period 2||0
2330593|NCT01800890|5720159|P2|NOT COMPLETED|Test Period 2||0
2330594|NCT01800890|5720160|P1|NOT COMPLETED|Test Period 2||0
2330595|NCT01800890|5720152|P9|COMPLETED|Test Period 2||3
2330596|NCT01800890|5720153|P8|COMPLETED|Test Period 2||3
2330597|NCT01800890|5720154|P7|COMPLETED|Test Period 2||3
2330598|NCT01800890|5720155|P6|COMPLETED|Test Period 2||4
2330599|NCT01800890|5720156|P5|COMPLETED|Test Period 2||4
2330600|NCT01800890|5720157|P4|COMPLETED|Test Period 2||2
2330601|NCT01800890|5720158|P3|COMPLETED|Test Period 2||3
2330602|NCT01800890|5720159|P2|COMPLETED|Test Period 2||3
2330603|NCT01800890|5720160|P1|COMPLETED|Test Period 2||3
2330604|NCT01800890|5720152|P9|STARTED|Test Period 2||3
2330605|NCT01800890|5720153|P8|STARTED|Test Period 2||3
2330606|NCT01800890|5720154|P7|STARTED|Test Period 2||3
2330607|NCT01800890|5720155|P6|STARTED|Test Period 2||4
2330608|NCT01800890|5720156|P5|STARTED|Test Period 2||4
2330609|NCT01800890|5720157|P4|STARTED|Test Period 2||2
2330610|NCT01800890|5720158|P3|STARTED|Test Period 2||3
2330611|NCT01800890|5720159|P2|STARTED|Test Period 2||3
2330612|NCT01800890|5720160|P1|STARTED|Test Period 2||3
2330613|NCT01800890|5720152|P9|NOT COMPLETED|Test Period 1||0
2330614|NCT01800890|5720153|P8|NOT COMPLETED|Test Period 1||0
2330615|NCT01800890|5720154|P7|NOT COMPLETED|Test Period 1||0
2330616|NCT01800890|5720155|P6|NOT COMPLETED|Test Period 1||0
2330617|NCT01800890|5720156|P5|NOT COMPLETED|Test Period 1||0
2330618|NCT01800890|5720157|P4|NOT COMPLETED|Test Period 1||1
2330619|NCT01800890|5720158|P3|NOT COMPLETED|Test Period 1||0
2330620|NCT01800890|5720159|P2|NOT COMPLETED|Test Period 1||0
2330621|NCT01800890|5720160|P1|NOT COMPLETED|Test Period 1||0
2330622|NCT01800890|5720152|P9|COMPLETED|Test Period 1||3
2330623|NCT01800890|5720153|P8|COMPLETED|Test Period 1||3
2330624|NCT01800890|5720154|P7|COMPLETED|Test Period 1||3
2330625|NCT01800890|5720155|P6|COMPLETED|Test Period 1||4
2330626|NCT01800890|5720156|P5|COMPLETED|Test Period 1||4
2330627|NCT01800890|5720157|P4|COMPLETED|Test Period 1||2
2330628|NCT01800890|5720158|P3|COMPLETED|Test Period 1||3
2330629|NCT01800890|5720159|P2|COMPLETED|Test Period 1||3
2330630|NCT01800890|5720160|P1|COMPLETED|Test Period 1||3
2330631|NCT01800890|5720152|P9|STARTED|Test Period 1||3
2330632|NCT01800890|5720153|P8|STARTED|Test Period 1||3
2330633|NCT01800890|5720154|P7|STARTED|Test Period 1||3
2330634|NCT01800890|5720155|P6|STARTED|Test Period 1||4
2330635|NCT01800890|5720156|P5|STARTED|Test Period 1||4
2330636|NCT01800890|5720157|P4|STARTED|Test Period 1||3
2330637|NCT01800890|5720158|P3|STARTED|Test Period 1||3
2330638|NCT01800890|5720159|P2|STARTED|Test Period 1||3
2330639|NCT01800890|5720160|P1|STARTED|Test Period 1||3
2330640|NCT01800877|5720172|P2|NOT COMPLETED|Overall Study||0
2330641|NCT01800877|5720173|P1|NOT COMPLETED|Overall Study||2
2330642|NCT01800877|5720172|P2|COMPLETED|Overall Study||60
2330643|NCT01800877|5720173|P1|COMPLETED|Overall Study||58
2330644|NCT01800877|5720172|P2|STARTED|Overall Study||60
2330645|NCT01800877|5720173|P1|STARTED|Overall Study||60
2330646|NCT01800838|5720183|P4|NOT COMPLETED|Overall Study||0
2330647|NCT01800838|5720184|P3|NOT COMPLETED|Overall Study||0
2330648|NCT01800838|5720185|P2|NOT COMPLETED|Overall Study||0
2330649|NCT01800838|5720186|P1|NOT COMPLETED|Overall Study||0
2330650|NCT01800838|5720183|P4|COMPLETED|Overall Study||2
2330651|NCT01800838|5720184|P3|COMPLETED|Overall Study||7
2330652|NCT01800838|5720185|P2|COMPLETED|Overall Study||1
2330653|NCT01800838|5720186|P1|COMPLETED|Overall Study||1
2330654|NCT01800838|5720183|P4|STARTED|Overall Study||2
2330655|NCT01800838|5720184|P3|STARTED|Overall Study||7
2330656|NCT01800838|5720185|P2|STARTED|Overall Study||1
2330657|NCT01800838|5720186|P1|STARTED|Overall Study||1
2330658|NCT01800786|5720193|P2|NOT COMPLETED|Overall Study||1
2330659|NCT01800786|5720194|P1|NOT COMPLETED|Overall Study||2
2330660|NCT01800786|5720193|P2|COMPLETED|Overall Study||15
2330661|NCT01800786|5720194|P1|COMPLETED|Overall Study||15
2330662|NCT01800786|5720193|P2|STARTED|Overall Study||16
2330663|NCT01800786|5720194|P1|STARTED|Overall Study||17
2330664|NCT01800318|5720204|P4|NOT COMPLETED|Overall Study||1
2330665|NCT01800318|5720205|P3|NOT COMPLETED|Overall Study||1
2330666|NCT01800318|5720206|P2|NOT COMPLETED|Overall Study||5
2330667|NCT01800318|5720207|P1|NOT COMPLETED|Overall Study||2
2330668|NCT01800318|5720204|P4|COMPLETED|Overall Study||39
2330669|NCT01800318|5720205|P3|COMPLETED|Overall Study||40
2330670|NCT01800318|5720206|P2|COMPLETED|Overall Study||37
2330671|NCT01800318|5720207|P1|COMPLETED|Overall Study||37
2330672|NCT01800318|5720204|P4|STARTED|Overall Study||40
2330673|NCT01800318|5720205|P3|STARTED|Overall Study||41
2330674|NCT01800318|5720206|P2|STARTED|Overall Study||42
2330675|NCT01800318|5720207|P1|STARTED|Overall Study||39
2330676|NCT01800201|5720235|P2|NOT COMPLETED|Overall Study||3
2330677|NCT01800201|5720236|P1|NOT COMPLETED|Overall Study||3
2330678|NCT01800201|5720235|P2|COMPLETED|Overall Study||1000
2330679|NCT01800201|5720236|P1|COMPLETED|Overall Study||503
2330680|NCT01800201|5720235|P2|STARTED|Overall Study||1003
2330681|NCT01800201|5720236|P1|STARTED|Overall Study||506
2330682|NCT01800162|5720251|P3|NOT COMPLETED|Overall Study||0
2330683|NCT01800162|5720252|P2|NOT COMPLETED|Overall Study||0
2330684|NCT01800162|5720253|P1|NOT COMPLETED|Overall Study||0
2330685|NCT01800162|5720251|P3|COMPLETED|Overall Study||1
2330686|NCT01800162|5720252|P2|COMPLETED|Overall Study||0
2330687|NCT01800162|5720253|P1|COMPLETED|Overall Study||1
2330688|NCT01800162|5720251|P3|STARTED|Overall Study|1 subject randomized to expectant management on 11/1/2013.|1
2330689|NCT01800162|5720252|P2|STARTED|Overall Study||0
2330690|NCT01800162|5720253|P1|STARTED|Overall Study|1 subject was randomized to uterine evacuation on 6/26/2013.|1
2330691|NCT01799993|5720279|P2|NOT COMPLETED|Overall Study||128
2330692|NCT01799993|5720280|P1|NOT COMPLETED|Overall Study||133
2330693|NCT01799993|5720279|P2|COMPLETED|Overall Study||235
2330694|NCT01799993|5720280|P1|COMPLETED|Overall Study||229
2330695|NCT01799993|5720279|P2|mITT Population|Overall Study||253
2330696|NCT01799993|5720280|P1|mITT Population|Overall Study||255
2330697|NCT01799993|5720279|P2|ITT Population|Overall Study||358
2330698|NCT01799993|5720280|P1|ITT Population|Overall Study||354
2330699|NCT01799993|5720279|P2|STARTED|Overall Study||363
2330700|NCT01799993|5720280|P1|STARTED|Overall Study||362
2330701|NCT01799941|5720312|P1|NOT COMPLETED|Overall Study||96
2330702|NCT01799941|5720312|P1|COMPLETED|Overall Study||271
2330703|NCT01799941|5720312|P1|STARTED|Overall Study||367
2330704|NCT01799720|5720369|P3|NOT COMPLETED|Overall Study||1
2330705|NCT01799720|5720370|P2|NOT COMPLETED|Overall Study||1
2330706|NCT01799720|5720371|P1|NOT COMPLETED|Overall Study||3
2330707|NCT01799720|5720369|P3|COMPLETED|Overall Study||18
2330708|NCT01799720|5720370|P2|COMPLETED|Overall Study||17
2330709|NCT01799720|5720371|P1|COMPLETED|Overall Study||17
2330710|NCT01799720|5720369|P3|Began the Treatment and Finished it|Overall Study||18
2330711|NCT01799720|5720370|P2|Began the Treatment and Finished it|Overall Study||17
2330712|NCT01799720|5720371|P1|Began the Treatment and Finished it|Overall Study||17
2330713|NCT01799720|5720369|P3|Began the Treatment|Overall Study||19
2330714|NCT01799720|5720370|P2|Began the Treatment|Overall Study||18
2330715|NCT01799720|5720371|P1|Began the Treatment|Overall Study||20
2330716|NCT01799720|5720369|P3|STARTED|Overall Study||19
2330717|NCT01799720|5720370|P2|STARTED|Overall Study||18
2330718|NCT01799720|5720371|P1|STARTED|Overall Study||20
2330719|NCT01799590|5720409|P3|NOT COMPLETED|Overall Study||14
2330720|NCT01799590|5720410|P2|NOT COMPLETED|Overall Study||16
2330721|NCT01799590|5720411|P1|NOT COMPLETED|Overall Study||26
2330722|NCT01799590|5720409|P3|COMPLETED|Overall Study||77
2330723|NCT01799590|5720410|P2|COMPLETED|Overall Study||78
2330724|NCT01799590|5720411|P1|COMPLETED|Overall Study||85
2330725|NCT01799590|5720409|P3|STARTED|Overall Study||91
2330726|NCT01799590|5720410|P2|STARTED|Overall Study||94
2330727|NCT01799590|5720411|P1|STARTED|Overall Study||111
2330728|NCT01799278|5720446|P1|NOT COMPLETED|Overall Study||0
2330729|NCT01799278|5720446|P1|COMPLETED|Overall Study||60
2330730|NCT01799278|5720446|P1|STARTED|Overall Study||60
2330731|NCT01799239|5720454|P2|NOT COMPLETED|Period 2 (7 Days)||1
2330732|NCT01799239|5720455|P1|NOT COMPLETED|Period 2 (7 Days)||2
2330733|NCT01799239|5720454|P2|COMPLETED|Period 2 (7 Days)||14
2330734|NCT01799239|5720455|P1|COMPLETED|Period 2 (7 Days)||11
2330735|NCT01799239|5720454|P2|STARTED|Period 2 (7 Days)||15
2330736|NCT01799239|5720455|P1|STARTED|Period 2 (7 Days)||13
2330737|NCT01799239|5720454|P2|NOT COMPLETED|Period 1 (7 Days)||1
2330738|NCT01799239|5720455|P1|NOT COMPLETED|Period 1 (7 Days)||3
2330739|NCT01799239|5720454|P2|COMPLETED|Period 1 (7 Days)||15
2330740|NCT01799239|5720455|P1|COMPLETED|Period 1 (7 Days)||12
2330741|NCT01799239|5720454|P2|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|16
2330833|NCT01798264|5720864|P3|NOT COMPLETED|Overall Study||0
2330742|NCT01799239|5720455|P1|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|15
2330743|NCT01799226|5720463|P2|NOT COMPLETED|Overall Study||0
2330744|NCT01799226|5720464|P1|NOT COMPLETED|Overall Study||2
2330745|NCT01799226|5720463|P2|COMPLETED|Overall Study||16
2330746|NCT01799226|5720464|P1|COMPLETED|Overall Study||14
2330747|NCT01799226|5720463|P2|Left Stent Side|Overall Study||8
2330748|NCT01799226|5720464|P1|Left Stent Side|Overall Study||8
2330749|NCT01799226|5720463|P2|Right Stent Side|Overall Study||8
2330750|NCT01799226|5720464|P1|Right Stent Side|Overall Study||8
2330751|NCT01799226|5720463|P2|STARTED|Overall Study||16
2330752|NCT01799226|5720464|P1|STARTED|Overall Study||16
2330753|NCT01799213|5720474|P2|NOT COMPLETED|Overall Study||6
2330754|NCT01799213|5720475|P1|NOT COMPLETED|Overall Study||7
2330755|NCT01799213|5720474|P2|COMPLETED|Overall Study||178
2330756|NCT01799213|5720475|P1|COMPLETED|Overall Study||173
2330757|NCT01799213|5720474|P2|STARTED|Overall Study||184
2330758|NCT01799213|5720475|P1|STARTED|Overall Study||180
2330759|NCT01798992|5720495|P4|NOT COMPLETED|Overall Study||1
2330760|NCT01798992|5720496|P3|NOT COMPLETED|Overall Study||2
2330761|NCT01798992|5720497|P2|NOT COMPLETED|Overall Study||2
2330762|NCT01798992|5720498|P1|NOT COMPLETED|Overall Study||0
2330763|NCT01798992|5720495|P4|COMPLETED|Overall Study||16
2330764|NCT01798992|5720496|P3|COMPLETED|Overall Study||14
2330765|NCT01798992|5720497|P2|COMPLETED|Overall Study||17
2330766|NCT01798992|5720498|P1|COMPLETED|Overall Study||4
2330767|NCT01798992|5720495|P4|STARTED|Overall Study||17
2330768|NCT01798992|5720496|P3|STARTED|Overall Study||16
2330769|NCT01798992|5720497|P2|STARTED|Overall Study||19
2330770|NCT01798992|5720498|P1|STARTED|Overall Study||4
2330771|NCT01798966|5720512|P1|NOT COMPLETED|Overall Study||0
2330772|NCT01798966|5720512|P1|COMPLETED|Overall Study||10
2330773|NCT01798966|5720512|P1|STARTED|Overall Study||10
2330774|NCT01798927|5720518|P1|NOT COMPLETED|Overall Study||1
2330775|NCT01798927|5720518|P1|COMPLETED|Overall Study||3
2330776|NCT01798927|5720518|P1|STARTED|Overall Study||4
2330777|NCT01798849|5720527|P3|NOT COMPLETED|Overall Study||1
2330778|NCT01798849|5720528|P2|NOT COMPLETED|Overall Study||0
2330779|NCT01798849|5720529|P1|NOT COMPLETED|Overall Study||0
2330780|NCT01798849|5720527|P3|COMPLETED|Overall Study||8
2330781|NCT01798849|5720528|P2|COMPLETED|Overall Study||8
2330782|NCT01798849|5720529|P1|COMPLETED|Overall Study||8
2330783|NCT01798849|5720527|P3|STARTED|Overall Study|1 participant discontinued after Period 1 and was replaced for Periods 2-4|9
2330784|NCT01798849|5720528|P2|STARTED|Overall Study||8
2330785|NCT01798849|5720529|P1|STARTED|Overall Study||8
2330786|NCT01798706|5720719|P2|NOT COMPLETED|Overall Study||21
2330787|NCT01798706|5720720|P1|NOT COMPLETED|Overall Study||21
2330788|NCT01798706|5720719|P2|COMPLETED|Overall Study||153
2330789|NCT01798706|5720720|P1|COMPLETED|Overall Study||155
2330790|NCT01798706|5720719|P2|STARTED|Overall Study||174
2330791|NCT01798706|5720720|P1|STARTED|Overall Study||176
2330792|NCT01798641|5720748|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
2330793|NCT01798641|5720749|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
2330794|NCT01798641|5720748|P2|COMPLETED|Second Intervention (6 Weeks)||19
2330795|NCT01798641|5720749|P1|COMPLETED|Second Intervention (6 Weeks)||19
2330796|NCT01798641|5720748|P2|STARTED|Second Intervention (6 Weeks)||19
2330797|NCT01798641|5720749|P1|STARTED|Second Intervention (6 Weeks)||19
2330798|NCT01798641|5720748|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
2330799|NCT01798641|5720749|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
2330800|NCT01798641|5720748|P2|COMPLETED|First Intervention (6 Weeks)||19
2330801|NCT01798641|5720749|P1|COMPLETED|First Intervention (6 Weeks)||19
2330802|NCT01798641|5720748|P2|STARTED|First Intervention (6 Weeks)||19
2330803|NCT01798641|5720749|P1|STARTED|First Intervention (6 Weeks)||19
2330804|NCT01798550|5720765|P2|NOT COMPLETED|Overall Study||6
2330805|NCT01798550|5720766|P1|NOT COMPLETED|Overall Study||2
2330806|NCT01798550|5720765|P2|COMPLETED|Overall Study||26
2330807|NCT01798550|5720766|P1|COMPLETED|Overall Study||28
2330808|NCT01798550|5720765|P2|STARTED|Overall Study||32
2330809|NCT01798550|5720766|P1|STARTED|Overall Study||30
2330810|NCT01798485|5720782|P2|NOT COMPLETED|Overall Study||290
2330811|NCT01798485|5720783|P1|NOT COMPLETED|Overall Study||346
2330812|NCT01798485|5720782|P2|COMPLETED|Overall Study||59
2330813|NCT01798485|5720783|P1|COMPLETED|Overall Study||1
2330814|NCT01798485|5720782|P2|Randomized as of 19 October 2015|Overall Study||337
2330815|NCT01798485|5720783|P1|Randomized as of 19 October 2015|Overall Study||335
2330816|NCT01798485|5720782|P2|Safety Population as of 23 Dec 2015|Overall Study||342
2330817|NCT01798485|5720783|P1|Safety Population as of 23 Dec 2015|Overall Study||338
2330818|NCT01798485|5720782|P2|STARTED|Overall Study||349
2330819|NCT01798485|5720783|P1|STARTED|Overall Study||347
2330820|NCT01798394|5720819|P2|NOT COMPLETED|Overall Study||3
2330821|NCT01798394|5720820|P1|NOT COMPLETED|Overall Study||3
2330822|NCT01798394|5720819|P2|COMPLETED|Overall Study||19
2330823|NCT01798394|5720820|P1|COMPLETED|Overall Study||21
2330824|NCT01798394|5720819|P2|STARTED|Overall Study||22
2330825|NCT01798394|5720820|P1|STARTED|Overall Study||24
2330826|NCT01798316|5720840|P2|NOT COMPLETED|Overall Study||0
2330827|NCT01798316|5720841|P1|NOT COMPLETED|Overall Study||0
2330828|NCT01798316|5720840|P2|COMPLETED|Overall Study||53
2330829|NCT01798316|5720841|P1|COMPLETED|Overall Study||52
2330830|NCT01798316|5720840|P2|STARTED|Overall Study||53
2330831|NCT01798316|5720841|P1|STARTED|Overall Study||52
2330832|NCT01798264|5720863|P4|NOT COMPLETED|Overall Study||4
2330834|NCT01798264|5720865|P2|NOT COMPLETED|Overall Study||0
2330835|NCT01798264|5720866|P1|NOT COMPLETED|Overall Study||1
2330836|NCT01798264|5720863|P4|COMPLETED|Overall Study||7
2330837|NCT01798264|5720864|P3|COMPLETED|Overall Study||10
2330838|NCT01798264|5720865|P2|COMPLETED|Overall Study||11
2330839|NCT01798264|5720866|P1|COMPLETED|Overall Study||11
2330840|NCT01798264|5720863|P4|STARTED|Overall Study||11
2330841|NCT01798264|5720864|P3|STARTED|Overall Study||10
2330842|NCT01798264|5720865|P2|STARTED|Overall Study||11
2330843|NCT01798264|5720866|P1|STARTED|Overall Study||12
2330844|NCT01798225|5720890|P2|NOT COMPLETED|Overall Study||3
2330845|NCT01798225|5720891|P1|NOT COMPLETED|Overall Study||0
2330846|NCT01798225|5720890|P2|COMPLETED|Overall Study||53
2330847|NCT01798225|5720891|P1|COMPLETED|Overall Study||57
2330848|NCT01798225|5720890|P2|STARTED|Overall Study||56
2330849|NCT01798225|5720891|P1|STARTED|Overall Study||57
2330850|NCT01798186|5720903|P4|NOT COMPLETED|Overall Study||0
2330851|NCT01798186|5720904|P3|NOT COMPLETED|Overall Study||0
2330852|NCT01798186|5720905|P2|NOT COMPLETED|Overall Study||0
2330853|NCT01798186|5720906|P1|NOT COMPLETED|Overall Study||0
2330854|NCT01798186|5720903|P4|COMPLETED|Overall Study||8
2330855|NCT01798186|5720904|P3|COMPLETED|Overall Study||6
2330856|NCT01798186|5720905|P2|COMPLETED|Overall Study||6
2330857|NCT01798186|5720906|P1|COMPLETED|Overall Study||6
2330858|NCT01798186|5720903|P4|STARTED|Overall Study||8
2330859|NCT01798186|5720904|P3|STARTED|Overall Study||6
2330860|NCT01798186|5720905|P2|STARTED|Overall Study||6
2330861|NCT01798186|5720906|P1|STARTED|Overall Study||6
2330862|NCT01798134|5720920|P1|NOT COMPLETED|Overall Study||16
2330863|NCT01798134|5720920|P1|COMPLETED|Overall Study||9
2330864|NCT01798134|5720920|P1|STARTED|Overall Study||25
2330865|NCT01798056|5720929|P2|NOT COMPLETED|Overall Study||25
2330866|NCT01798056|5720930|P1|NOT COMPLETED|Overall Study||27
2330867|NCT01798056|5720929|P2|COMPLETED|Overall Study||90
2330868|NCT01798056|5720930|P1|COMPLETED|Overall Study||90
2330869|NCT01798056|5720929|P2|STARTED|Overall Study||115
2330870|NCT01798056|5720930|P1|STARTED|Overall Study||117
2330871|NCT01798004|5720964|P1|NOT COMPLETED|Overall Study||87
2330872|NCT01798004|5720964|P1|COMPLETED|Overall Study||63
2330873|NCT01798004|5720964|P1|STARTED|Overall Study||150
2330874|NCT01797965|5720972|P4|NOT COMPLETED|Overall Study||73
2330875|NCT01797965|5720973|P3|NOT COMPLETED|Overall Study||8
2330876|NCT01797965|5720974|P2|NOT COMPLETED|Overall Study||569
2330877|NCT01797965|5720975|P1|NOT COMPLETED|Overall Study||549
2330878|NCT01797965|5720972|P4|COMPLETED|Overall Study||154
2330879|NCT01797965|5720973|P3|COMPLETED|Overall Study||62
2330880|NCT01797965|5720974|P2|COMPLETED|Overall Study||38
2330881|NCT01797965|5720975|P1|COMPLETED|Overall Study||48
2330882|NCT01797965|5720972|P4|STARTED|Overall Study||227
2330883|NCT01797965|5720973|P3|STARTED|Overall Study||70
2330884|NCT01797965|5720974|P2|STARTED|Overall Study||607
2330885|NCT01797965|5720975|P1|STARTED|Overall Study||597
2330886|NCT01797835|5721109|P2|NOT COMPLETED|Overall Study||27
2330887|NCT01797835|5721110|P1|NOT COMPLETED|Overall Study||31
2330888|NCT01797835|5721109|P2|COMPLETED|Overall Study||114
2330889|NCT01797835|5721110|P1|COMPLETED|Overall Study||122
2330890|NCT01797835|5721109|P2|STARTED|Overall Study||141
2330891|NCT01797835|5721110|P1|STARTED|Overall Study||153
2330892|NCT01797822|5721118|P1|NOT COMPLETED|Overall Study||0
2330893|NCT01797822|5721118|P1|COMPLETED|Overall Study|The protocol is now closed.|20
2330894|NCT01797822|5721118|P1|STARTED|Overall Study||20
2330895|NCT01797783|5721126|P2|NOT COMPLETED|Overall Study||1
2330896|NCT01797783|5721127|P1|NOT COMPLETED|Overall Study||2
2330897|NCT01797783|5721126|P2|COMPLETED|Overall Study||26
2330898|NCT01797783|5721127|P1|COMPLETED|Overall Study||50
2330899|NCT01797783|5721126|P2|STARTED|Overall Study||27
2330900|NCT01797783|5721127|P1|STARTED|Overall Study||52
2330901|NCT01797731|5721151|P2|NOT COMPLETED|Overall Study||3
2330902|NCT01797731|5721152|P1|NOT COMPLETED|Overall Study||3
2330903|NCT01797731|5721151|P2|COMPLETED|Overall Study|3 excluded due to not having proper radiographs for adequate follow up|47
2330904|NCT01797731|5721152|P1|COMPLETED|Overall Study|3 were excluded due to not having proper radiographs for adequate follow up|47
2330905|NCT01797731|5721151|P2|STARTED|Overall Study||50
2330906|NCT01797731|5721152|P1|STARTED|Overall Study||50
2330907|NCT01797705|5721160|P1|NOT COMPLETED|Overall Study||5
2330908|NCT01797705|5721160|P1|COMPLETED|Overall Study||28
2330909|NCT01797705|5721160|P1|STARTED|Overall Study||33
2330910|NCT01797575|5721168|P4|NOT COMPLETED|Week 8 Re-Randomization||3
2330911|NCT01797575|5721169|P3|NOT COMPLETED|Week 8 Re-Randomization||1
2330912|NCT01797575|5721170|P2|NOT COMPLETED|Week 8 Re-Randomization||0
2330913|NCT01797575|5721171|P1|NOT COMPLETED|Week 8 Re-Randomization||0
2330914|NCT01797575|5721168|P4|COMPLETED|Week 8 Re-Randomization||7
2330915|NCT01797575|5721169|P3|COMPLETED|Week 8 Re-Randomization||4
2330916|NCT01797575|5721170|P2|COMPLETED|Week 8 Re-Randomization||5
2330917|NCT01797575|5721171|P1|COMPLETED|Week 8 Re-Randomization||4
2330918|NCT01797575|5721168|P4|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|10
2330919|NCT01797575|5721169|P3|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5
2330920|NCT01797575|5721170|P2|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5
2330921|NCT01797575|5721171|P1|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|4
2330922|NCT01797575|5721168|P4|NOT COMPLETED|Baseline Allocation||7
2330923|NCT01797575|5721169|P3|NOT COMPLETED|Baseline Allocation||5
2330924|NCT01797575|5721170|P2|NOT COMPLETED|Baseline Allocation||1
2330925|NCT01797575|5721171|P1|NOT COMPLETED|Baseline Allocation||1
2330926|NCT01797575|5721168|P4|COMPLETED|Baseline Allocation||8
2330927|NCT01797575|5721169|P3|COMPLETED|Baseline Allocation||4
2330928|NCT01797575|5721170|P2|COMPLETED|Baseline Allocation||8
2330929|NCT01797575|5721171|P1|COMPLETED|Baseline Allocation||4
2330930|NCT01797575|5721168|P4|STARTED|Baseline Allocation||15
2330931|NCT01797575|5721169|P3|STARTED|Baseline Allocation||9
2330932|NCT01797575|5721170|P2|STARTED|Baseline Allocation||9
2330933|NCT01797575|5721171|P1|STARTED|Baseline Allocation||5
2330934|NCT01797536|5721225|P4|NOT COMPLETED|Overall Study||0
2330935|NCT01797536|5721226|P3|NOT COMPLETED|Overall Study||0
2330936|NCT01797536|5721227|P2|NOT COMPLETED|Overall Study||1
2330937|NCT01797536|5721228|P1|NOT COMPLETED|Overall Study||0
2330938|NCT01797536|5721225|P4|COMPLETED|Overall Study||8
2330939|NCT01797536|5721226|P3|COMPLETED|Overall Study||7
2330940|NCT01797536|5721227|P2|COMPLETED|Overall Study||10
2330941|NCT01797536|5721228|P1|COMPLETED|Overall Study||8
2330942|NCT01797536|5721225|P4|STARTED|Overall Study||8
2330943|NCT01797536|5721226|P3|STARTED|Overall Study||7
2330944|NCT01797536|5721227|P2|STARTED|Overall Study|Includes 3 participants from mild arm who were mistakenly re-enrolled and also dosed in moderate arm|11
2330945|NCT01797536|5721228|P1|STARTED|Overall Study||8
2330946|NCT01797484|5721260|P2|NOT COMPLETED|Overall Study||0
2330947|NCT01797484|5721261|P1|NOT COMPLETED|Overall Study||0
2330948|NCT01797484|5721260|P2|COMPLETED|Overall Study||10
2330949|NCT01797484|5721261|P1|COMPLETED|Overall Study||10
2330950|NCT01797484|5721260|P2|STARTED|Overall Study||10
2330951|NCT01797484|5721261|P1|STARTED|Overall Study||10
2330952|NCT01797471|5721267|P1|NOT COMPLETED|Overall Study||0
2330953|NCT01797471|5721267|P1|COMPLETED|Overall Study||1
2330954|NCT01797471|5721267|P1|STARTED|Overall Study||1
2330955|NCT01797458|5721279|P3|NOT COMPLETED|Overall Study||7
2330956|NCT01797458|5721280|P2|NOT COMPLETED|Overall Study||9
2330957|NCT01797458|5721281|P1|NOT COMPLETED|Overall Study||12
2330958|NCT01797458|5721279|P3|COMPLETED|Overall Study||58
2330959|NCT01797458|5721280|P2|COMPLETED|Overall Study||43
2330960|NCT01797458|5721281|P1|COMPLETED|Overall Study||40
2330961|NCT01797458|5721279|P3|STARTED|Overall Study||65
2330962|NCT01797458|5721280|P2|STARTED|Overall Study||52
2330963|NCT01797458|5721281|P1|STARTED|Overall Study||52
2330964|NCT01797445|5721300|P2|NOT COMPLETED|Open-Label Extension Phase||0
2330965|NCT01797445|5721301|P1|NOT COMPLETED|Open-Label Extension Phase||1
2330966|NCT01797445|5721300|P2|COMPLETED|Open-Label Extension Phase||119
2330967|NCT01797445|5721301|P1|COMPLETED|Open-Label Extension Phase||140
2330968|NCT01797445|5721300|P2|STARTED|Open-Label Extension Phase|229 participants completed the Double-Blind Phase, but did not enter the Open-Label Extension Phase.|119
2330969|NCT01797445|5721301|P1|STARTED|Open-Label Extension Phase|207 participants completed the Double-Blind Phase, but did not enter the Open-Label Extension Phase.|141
2330970|NCT01797445|5721300|P2|NOT COMPLETED|Double-Blind Phase||89
2330971|NCT01797445|5721301|P1|NOT COMPLETED|Double-Blind Phase||87
2330972|NCT01797445|5721300|P2|COMPLETED|Double-Blind Phase||348
2330973|NCT01797445|5721301|P1|COMPLETED|Double-Blind Phase||348
2330974|NCT01797445|5721300|P2|STARTED|Double-Blind Phase||437
2330975|NCT01797445|5721301|P1|STARTED|Double-Blind Phase||435
2330976|NCT01797380|5721343|P2|NOT COMPLETED|Overall Study||2
2330977|NCT01797380|5721344|P1|NOT COMPLETED|Overall Study||3
2330978|NCT01797380|5721343|P2|COMPLETED|Overall Study||0
2330979|NCT01797380|5721344|P1|COMPLETED|Overall Study|Terminated due to lack of enrollment|0
2330980|NCT01797380|5721343|P2|STARTED|Overall Study||2
2330981|NCT01797380|5721344|P1|STARTED|Overall Study|Terminated due to lack of enrollment|3
2330982|NCT01797328|5721352|P2|NOT COMPLETED|Overall Study||0
2330983|NCT01797328|5721353|P1|NOT COMPLETED|Overall Study||2
2330984|NCT01797328|5721352|P2|COMPLETED|Overall Study||12
2330985|NCT01797328|5721353|P1|COMPLETED|Overall Study||14
2330986|NCT01797328|5721352|P2|STARTED|Overall Study||12
2330987|NCT01797328|5721353|P1|STARTED|Overall Study||16
2331002|NCT01797185|5721397|P3|NOT COMPLETED|Overall Study||12
2331003|NCT01797185|5721398|P2|NOT COMPLETED|Overall Study||38
2331004|NCT01797185|5721399|P1|NOT COMPLETED|Overall Study||28
2331005|NCT01797185|5721397|P3|COMPLETED|Overall Study||38
2331006|NCT01797185|5721398|P2|COMPLETED|Overall Study||125
2331007|NCT01797185|5721399|P1|COMPLETED|Overall Study||134
2331008|NCT01797185|5721397|P3|STARTED|Overall Study||50
2331009|NCT01797185|5721398|P2|STARTED|Overall Study||163
2331010|NCT01797185|5721399|P1|STARTED|Overall Study||162
2331011|NCT01797120|5721409|P2|NOT COMPLETED|Overall Study||65
2331012|NCT01797120|5721410|P1|NOT COMPLETED|Overall Study||66
2331013|NCT01797120|5721409|P2|COMPLETED|Overall Study||0
2331014|NCT01797120|5721410|P1|COMPLETED|Overall Study||0
2331015|NCT01797120|5721409|P2|STARTED|Overall Study||65
2331016|NCT01797120|5721410|P1|STARTED|Overall Study||66
2331017|NCT01797094|5721424|P2|NOT COMPLETED|Overall Study||2
2331018|NCT01797094|5721425|P1|NOT COMPLETED|Overall Study||6
2331019|NCT01797094|5721424|P2|COMPLETED|Overall Study||51
2331020|NCT01797094|5721425|P1|COMPLETED|Overall Study||42
2331021|NCT01797094|5721424|P2|STARTED|Overall Study||53
2331022|NCT01797094|5721425|P1|STARTED|Overall Study||48
2331023|NCT01797081|5721447|P4|NOT COMPLETED|Overall Study||9
2331024|NCT01797081|5721448|P3|NOT COMPLETED|Overall Study||5
2331025|NCT01797081|5721449|P2|NOT COMPLETED|Overall Study||4
2331026|NCT01797081|5721450|P1|NOT COMPLETED|Overall Study||14
2331027|NCT01797081|5721447|P4|COMPLETED|Overall Study||40
2331028|NCT01797081|5721448|P3|COMPLETED|Overall Study||43
2331029|NCT01797081|5721449|P2|COMPLETED|Overall Study||95
2331030|NCT01797081|5721450|P1|COMPLETED|Overall Study||90
2331031|NCT01797081|5721447|P4|STARTED|Overall Study||49
2331032|NCT01797081|5721448|P3|STARTED|Overall Study||48
2331033|NCT01797081|5721449|P2|STARTED|Overall Study||99
2331034|NCT01797081|5721450|P1|STARTED|Overall Study||104
2331035|NCT01797029|5721469|P2|NOT COMPLETED|Overall Study||61
2331036|NCT01797029|5721470|P1|NOT COMPLETED|Overall Study||159
2331037|NCT01797029|5721469|P2|COMPLETED|Overall Study||526
2331038|NCT01797029|5721470|P1|COMPLETED|Overall Study||1015
2331039|NCT01797029|5721469|P2|STARTED|Overall Study||587
2331040|NCT01797029|5721470|P1|STARTED|Overall Study||1174
2331041|NCT01796977|5721478|P1|NOT COMPLETED|Overall Study||0
2331042|NCT01796977|5721478|P1|COMPLETED|Overall Study||27
2331043|NCT01796977|5721478|P1|STARTED|Overall Study||27
2331044|NCT01796964|5721491|P2|NOT COMPLETED|Overall Study||3
2331045|NCT01796964|5721492|P1|NOT COMPLETED|Overall Study||3
2331046|NCT01796964|5721491|P2|COMPLETED|Overall Study||42
2331047|NCT01796964|5721492|P1|COMPLETED|Overall Study||41
2331048|NCT01796964|5721491|P2|STARTED|Overall Study||45
2331049|NCT01796964|5721492|P1|STARTED|Overall Study||44
2331050|NCT01796912|5721514|P2|NOT COMPLETED|Second Intervention||0
2331051|NCT01796912|5721515|P1|NOT COMPLETED|Second Intervention||0
2331052|NCT01796912|5721514|P2|COMPLETED|Second Intervention||10
2331053|NCT01796912|5721515|P1|COMPLETED|Second Intervention||10
2331054|NCT01796912|5721514|P2|STARTED|Second Intervention||10
2331055|NCT01796912|5721515|P1|STARTED|Second Intervention||10
2331056|NCT01796912|5721514|P2|NOT COMPLETED|Washout||0
2331057|NCT01796912|5721515|P1|NOT COMPLETED|Washout||0
2331058|NCT01796912|5721514|P2|COMPLETED|Washout||10
2331059|NCT01796912|5721515|P1|COMPLETED|Washout||10
2331060|NCT01796912|5721514|P2|STARTED|Washout||10
2331061|NCT01796912|5721515|P1|STARTED|Washout||10
2331062|NCT01796912|5721514|P2|NOT COMPLETED|First Intervention||0
2331063|NCT01796912|5721515|P1|NOT COMPLETED|First Intervention||0
2331064|NCT01796912|5721514|P2|COMPLETED|First Intervention||10
2331065|NCT01796912|5721515|P1|COMPLETED|First Intervention||10
2331066|NCT01796912|5721514|P2|STARTED|First Intervention||10
2331067|NCT01796912|5721515|P1|STARTED|First Intervention||10
2331068|NCT01796860|5721533|P1|NOT COMPLETED|Overall Study||3
2331069|NCT01796860|5721533|P1|COMPLETED|Overall Study||7
2331070|NCT01796860|5721533|P1|STARTED|Overall Study||10
2331071|NCT01796548|5721539|P1|NOT COMPLETED|Overall Study||3
2331072|NCT01796548|5721539|P1|COMPLETED|Overall Study||14
2331073|NCT01796548|5721539|P1|Treated|Overall Study||15
2331074|NCT01796548|5721539|P1|STARTED|Overall Study||17
2331075|NCT01796392|5721553|P2|NOT COMPLETED|Overall Study||3
2331076|NCT01796392|5721554|P1|NOT COMPLETED|Overall Study||9
2331077|NCT01796392|5721553|P2|COMPLETED|Overall Study|59 active subjects at 12-months|59
2331078|NCT01796392|5721554|P1|COMPLETED|Overall Study|119 active subjects at 12-months|119
2331079|NCT01796392|5721553|P2|STARTED|Overall Study||62
2331080|NCT01796392|5721554|P1|STARTED|Overall Study||128
2331081|NCT01796301|5721568|P2|NOT COMPLETED|Overall Study||20
2331082|NCT01796301|5721569|P1|NOT COMPLETED|Overall Study||18
2331083|NCT01796301|5721568|P2|COMPLETED|Overall Study||198
2331084|NCT01796301|5721569|P1|COMPLETED|Overall Study||200
2331085|NCT01796301|5721568|P2|Received Treatment|Overall Study||218
2331086|NCT01796301|5721569|P1|Received Treatment|Overall Study||214
2331087|NCT01796301|5721568|P2|STARTED|Overall Study||218
2331088|NCT01796301|5721569|P1|STARTED|Overall Study||218
2331089|NCT01796236|5721605|P2|NOT COMPLETED|Overall Study||2
2331090|NCT01796236|5721606|P1|NOT COMPLETED|Overall Study||2
2331091|NCT01796236|5721605|P2|COMPLETED|Overall Study||50
2331092|NCT01796236|5721606|P1|COMPLETED|Overall Study||49
2331093|NCT01796236|5721605|P2|STARTED|Overall Study||52
2331094|NCT01796236|5721606|P1|STARTED|Overall Study||51
2331095|NCT01795937|5721655|P3|NOT COMPLETED|Overall Study||0
2331096|NCT01795937|5721656|P2|NOT COMPLETED|Overall Study||1
2331097|NCT01795937|5721657|P1|NOT COMPLETED|Overall Study||1
2331098|NCT01795937|5721655|P3|COMPLETED|Overall Study||17
2331099|NCT01795937|5721656|P2|COMPLETED|Overall Study||15
2331100|NCT01795937|5721657|P1|COMPLETED|Overall Study||17
2331101|NCT01795937|5721655|P3|STARTED|Overall Study||17
2331102|NCT01795937|5721656|P2|STARTED|Overall Study||16
2331103|NCT01795937|5721657|P1|STARTED|Overall Study||18
2331104|NCT01795898|5721686|P1|NOT COMPLETED|Overall Study||60
2331105|NCT01795898|5721686|P1|COMPLETED|Overall Study||177
2331106|NCT01795898|5721686|P1|STARTED|Overall Study||237
2331107|NCT01795859|5721696|P2|NOT COMPLETED|Overall Study||2
2331108|NCT01795859|5721697|P1|NOT COMPLETED|Overall Study||1
2331109|NCT01795859|5721696|P2|COMPLETED|Overall Study||43
2331110|NCT01795859|5721697|P1|COMPLETED|Overall Study||44
2331111|NCT01795859|5721696|P2|STARTED|Overall Study||45
2331112|NCT01795859|5721697|P1|STARTED|Overall Study||45
2331113|NCT01795833|5721715|P2|NOT COMPLETED|Overall Study||149
2331114|NCT01795833|5721716|P1|NOT COMPLETED|Overall Study||150
2331115|NCT01795833|5721715|P2|COMPLETED|Overall Study||882
2331116|NCT01795833|5721716|P1|COMPLETED|Overall Study||881
2331117|NCT01795833|5721715|P2|STARTED|Overall Study||1031
2331118|NCT01795833|5721716|P1|STARTED|Overall Study||1031
2331119|NCT01795716|5721736|P2|NOT COMPLETED|Second Intervention (13 Days)||0
2331120|NCT01795716|5721737|P1|NOT COMPLETED|Second Intervention (13 Days)||0
2331121|NCT01795716|5721736|P2|COMPLETED|Second Intervention (13 Days)||11
2331122|NCT01795716|5721737|P1|COMPLETED|Second Intervention (13 Days)||10
2331123|NCT01795716|5721736|P2|STARTED|Second Intervention (13 Days)||11
2331124|NCT01795716|5721737|P1|STARTED|Second Intervention (13 Days)||10
2331125|NCT01795716|5721736|P2|NOT COMPLETED|Washout (10 Days)||0
2331126|NCT01795716|5721737|P1|NOT COMPLETED|Washout (10 Days)||0
2331127|NCT01795716|5721736|P2|COMPLETED|Washout (10 Days)||11
2331128|NCT01795716|5721737|P1|COMPLETED|Washout (10 Days)||10
2331129|NCT01795716|5721736|P2|STARTED|Washout (10 Days)||11
2331130|NCT01795716|5721737|P1|STARTED|Washout (10 Days)||10
2331131|NCT01795716|5721736|P2|NOT COMPLETED|First Intervention (13 Days)||0
2331132|NCT01795716|5721737|P1|NOT COMPLETED|First Intervention (13 Days)||0
2331133|NCT01795716|5721736|P2|COMPLETED|First Intervention (13 Days)||11
2331134|NCT01795716|5721737|P1|COMPLETED|First Intervention (13 Days)||10
2331135|NCT01795716|5721736|P2|STARTED|First Intervention (13 Days)||11
2331136|NCT01795716|5721737|P1|STARTED|First Intervention (13 Days)||10
2331137|NCT01795547|5721745|P2|NOT COMPLETED|Overall Study||64
2331138|NCT01795547|5721746|P1|NOT COMPLETED|Overall Study||48
2331139|NCT01795547|5721745|P2|COMPLETED|Overall Study||83
2331140|NCT01795547|5721746|P1|COMPLETED|Overall Study||100
2331141|NCT01795547|5721745|P2|STARTED|Overall Study||147
2331142|NCT01795547|5721746|P1|STARTED|Overall Study||148
2331143|NCT01795534|5721768|P2|NOT COMPLETED|Second Intervention (Second Shot)||0
2331144|NCT01795534|5721769|P1|NOT COMPLETED|Second Intervention (Second Shot)||0
2331145|NCT01795534|5721768|P2|COMPLETED|Second Intervention (Second Shot)||5
2331146|NCT01795534|5721769|P1|COMPLETED|Second Intervention (Second Shot)||5
2331147|NCT01795534|5721768|P2|STARTED|Second Intervention (Second Shot)||5
2331148|NCT01795534|5721769|P1|STARTED|Second Intervention (Second Shot)||5
2331149|NCT01795534|5721768|P2|NOT COMPLETED|Wash Out Period (4 Days)||0
2331150|NCT01795534|5721769|P1|NOT COMPLETED|Wash Out Period (4 Days)||0
2331151|NCT01795534|5721768|P2|COMPLETED|Wash Out Period (4 Days)||5
2331152|NCT01795534|5721769|P1|COMPLETED|Wash Out Period (4 Days)||5
2331153|NCT01795534|5721768|P2|STARTED|Wash Out Period (4 Days)||5
2331154|NCT01795534|5721769|P1|STARTED|Wash Out Period (4 Days)||5
2331155|NCT01795534|5721768|P2|NOT COMPLETED|First Intervention (First Shot)||0
2331156|NCT01795534|5721769|P1|NOT COMPLETED|First Intervention (First Shot)||0
2331157|NCT01795534|5721768|P2|COMPLETED|First Intervention (First Shot)||5
2331158|NCT01795534|5721769|P1|COMPLETED|First Intervention (First Shot)||5
2331159|NCT01795534|5721768|P2|STARTED|First Intervention (First Shot)||5
2331160|NCT01795534|5721769|P1|STARTED|First Intervention (First Shot)||5
2331161|NCT01795495|5721778|P3|NOT COMPLETED|Overall Study||2
2331162|NCT01795495|5721779|P2|NOT COMPLETED|Overall Study||0
2331163|NCT01795495|5721780|P1|NOT COMPLETED|Overall Study||1
2331164|NCT01795495|5721778|P3|COMPLETED|Overall Study||19
2331165|NCT01795495|5721779|P2|COMPLETED|Overall Study||22
2331166|NCT01795495|5721780|P1|COMPLETED|Overall Study||19
2331167|NCT01795495|5721778|P3|STARTED|Overall Study||21
2331168|NCT01795495|5721779|P2|STARTED|Overall Study||22
2331169|NCT01795495|5721780|P1|STARTED|Overall Study||20
2331170|NCT01795105|5721791|P1|NOT COMPLETED|Overall Study||44
2331171|NCT01795105|5721791|P1|COMPLETED|Overall Study||648
2331172|NCT01795105|5721791|P1|STARTED|Overall Study||692
2331173|NCT01794949|5721800|P2|NOT COMPLETED|Overall Study||0
2331174|NCT01794949|5721801|P1|NOT COMPLETED|Overall Study||1
2331175|NCT01794949|5721800|P2|COMPLETED|Overall Study||1
2331176|NCT01794949|5721801|P1|COMPLETED|Overall Study||6
2331177|NCT01794949|5721800|P2|6 Month Follow-up|Overall Study||1
2331178|NCT01794949|5721801|P1|6 Month Follow-up|Overall Study||6
2331179|NCT01794949|5721800|P2|STARTED|Overall Study||1
2331180|NCT01794949|5721801|P1|STARTED|Overall Study||7
2331181|NCT01794936|5721807|P1|NOT COMPLETED|Overall Study||0
2331182|NCT01794936|5721807|P1|COMPLETED|Overall Study||9
2331183|NCT01794936|5721807|P1|STARTED|Overall Study||9
2331184|NCT01794845|5721812|P1|NOT COMPLETED|Overall Study||1
2331185|NCT01794845|5721812|P1|COMPLETED|Overall Study||4
2331186|NCT01794845|5721812|P1|STARTED|Overall Study||5
2331187|NCT01794806|5721821|P2|NOT COMPLETED|Overall Study||1
2331188|NCT01794806|5721822|P1|NOT COMPLETED|Overall Study||5
2331189|NCT01794806|5721821|P2|COMPLETED|Overall Study||27
2331190|NCT01794806|5721822|P1|COMPLETED|Overall Study||26
2331191|NCT01794806|5721821|P2|4 Weeks|Overall Study||27
2331192|NCT01794806|5721822|P1|4 Weeks|Overall Study||26
2331193|NCT01794806|5721821|P2|1 Week|Overall Study||28
2331194|NCT01794806|5721822|P1|1 Week|Overall Study||28
2331195|NCT01794806|5721821|P2|STARTED|Overall Study||28
2331196|NCT01794806|5721822|P1|STARTED|Overall Study||31
2331197|NCT01794780|5721840|P8|NOT COMPLETED|Overall Study||9
2331198|NCT01794780|5721841|P7|NOT COMPLETED|Overall Study||42
2331199|NCT01794780|5721842|P6|NOT COMPLETED|Overall Study||180
2331200|NCT01794780|5721843|P5|NOT COMPLETED|Overall Study||3
2331201|NCT01794780|5721844|P4|NOT COMPLETED|Overall Study||83
2331202|NCT01794780|5721845|P3|NOT COMPLETED|Overall Study||242
2331203|NCT01794780|5721846|P2|NOT COMPLETED|Overall Study||96
2331204|NCT01794780|5721847|P1|NOT COMPLETED|Overall Study||17
2331205|NCT01794780|5721840|P8|COMPLETED|Overall Study||21
2331206|NCT01794780|5721841|P7|COMPLETED|Overall Study||112
2331207|NCT01794780|5721842|P6|COMPLETED|Overall Study||452
2331208|NCT01794780|5721843|P5|COMPLETED|Overall Study||6
2331209|NCT01794780|5721844|P4|COMPLETED|Overall Study||200
2331210|NCT01794780|5721845|P3|COMPLETED|Overall Study||571
2331211|NCT01794780|5721846|P2|COMPLETED|Overall Study||180
2331212|NCT01794780|5721847|P1|COMPLETED|Overall Study||15
2331213|NCT01794780|5721840|P8|STARTED|Overall Study||30
2331214|NCT01794780|5721841|P7|STARTED|Overall Study||154
2331215|NCT01794780|5721842|P6|STARTED|Overall Study||632
2331216|NCT01794780|5721843|P5|STARTED|Overall Study||9
2331217|NCT01794780|5721844|P4|STARTED|Overall Study||283
2331218|NCT01794780|5721845|P3|STARTED|Overall Study||813
2331219|NCT01794780|5721846|P2|STARTED|Overall Study||276
2331220|NCT01794780|5721847|P1|STARTED|Overall Study||32
2331221|NCT01794741|5721897|P2|NOT COMPLETED|Overall Study||9
2331222|NCT01794741|5721898|P1|NOT COMPLETED|Overall Study||19
2331223|NCT01794741|5721897|P2|COMPLETED|Overall Study||92
2331224|NCT01794741|5721898|P1|COMPLETED|Overall Study||285
2331225|NCT01794741|5721897|P2|STARTED|Overall Study||101
2331226|NCT01794741|5721898|P1|STARTED|Overall Study||304
2331227|NCT01794702|5721907|P3|NOT COMPLETED|Overall Study||0
2331228|NCT01794702|5721908|P2|NOT COMPLETED|Overall Study||0
2331229|NCT01794702|5721909|P1|NOT COMPLETED|Overall Study||0
2331230|NCT01794702|5721907|P3|COMPLETED|Overall Study||47
2331231|NCT01794702|5721908|P2|COMPLETED|Overall Study||0
2331232|NCT01794702|5721909|P1|COMPLETED|Overall Study||18
2331233|NCT01794702|5721907|P3|STARTED|Overall Study||47
2331234|NCT01794702|5721908|P2|STARTED|Overall Study||0
2331235|NCT01794702|5721909|P1|STARTED|Overall Study||18
2331236|NCT01794689|5721923|P4|NOT COMPLETED|Intervention 2 (2 Nights)||0
2331237|NCT01794689|5721924|P3|NOT COMPLETED|Intervention 2 (2 Nights)||0
2331238|NCT01794689|5721925|P2|NOT COMPLETED|Intervention 2 (2 Nights)||0
2331239|NCT01794689|5721926|P1|NOT COMPLETED|Intervention 2 (2 Nights)||0
2331240|NCT01794689|5721923|P4|COMPLETED|Intervention 2 (2 Nights)||18
2331241|NCT01794689|5721924|P3|COMPLETED|Intervention 2 (2 Nights)||21
2331242|NCT01794689|5721925|P2|COMPLETED|Intervention 2 (2 Nights)||27
2331243|NCT01794689|5721926|P1|COMPLETED|Intervention 2 (2 Nights)||20
2331244|NCT01794689|5721923|P4|STARTED|Intervention 2 (2 Nights)||18
2331245|NCT01794689|5721924|P3|STARTED|Intervention 2 (2 Nights)||21
2331246|NCT01794689|5721925|P2|STARTED|Intervention 2 (2 Nights)||27
2331247|NCT01794689|5721926|P1|STARTED|Intervention 2 (2 Nights)||20
2331248|NCT01794689|5721923|P4|NOT COMPLETED|Washout (2 Weeks)||0
2331249|NCT01794689|5721924|P3|NOT COMPLETED|Washout (2 Weeks)||0
2331250|NCT01794689|5721925|P2|NOT COMPLETED|Washout (2 Weeks)||0
2331251|NCT01794689|5721926|P1|NOT COMPLETED|Washout (2 Weeks)||0
2331252|NCT01794689|5721923|P4|COMPLETED|Washout (2 Weeks)||18
2331253|NCT01794689|5721924|P3|COMPLETED|Washout (2 Weeks)||21
2331254|NCT01794689|5721925|P2|COMPLETED|Washout (2 Weeks)||27
2331255|NCT01794689|5721926|P1|COMPLETED|Washout (2 Weeks)||20
2331256|NCT01794689|5721923|P4|STARTED|Washout (2 Weeks)||18
2331257|NCT01794689|5721924|P3|STARTED|Washout (2 Weeks)||21
2331258|NCT01794689|5721925|P2|STARTED|Washout (2 Weeks)||27
2331259|NCT01794689|5721926|P1|STARTED|Washout (2 Weeks)||20
2331260|NCT01794689|5721923|P4|NOT COMPLETED|Intervention 1 (2 Nights)||4
2331261|NCT01794689|5721924|P3|NOT COMPLETED|Intervention 1 (2 Nights)||3
2331262|NCT01794689|5721925|P2|NOT COMPLETED|Intervention 1 (2 Nights)||2
2331263|NCT01794689|5721926|P1|NOT COMPLETED|Intervention 1 (2 Nights)||5
2331264|NCT01794689|5721923|P4|COMPLETED|Intervention 1 (2 Nights)||18
2331265|NCT01794689|5721924|P3|COMPLETED|Intervention 1 (2 Nights)||21
2331266|NCT01794689|5721925|P2|COMPLETED|Intervention 1 (2 Nights)||27
2331267|NCT01794689|5721926|P1|COMPLETED|Intervention 1 (2 Nights)||20
2331268|NCT01794689|5721923|P4|STARTED|Intervention 1 (2 Nights)||22
2331269|NCT01794689|5721924|P3|STARTED|Intervention 1 (2 Nights)||24
2331270|NCT01794689|5721925|P2|STARTED|Intervention 1 (2 Nights)||29
2331271|NCT01794689|5721926|P1|STARTED|Intervention 1 (2 Nights)||25
2331272|NCT01794455|5721950|P2|NOT COMPLETED|Overall Study||0
2331273|NCT01794455|5721951|P1|NOT COMPLETED|Overall Study||0
2331274|NCT01794455|5721950|P2|COMPLETED|Overall Study||1
2331275|NCT01794455|5721951|P1|COMPLETED|Overall Study||0
2331276|NCT01794455|5721950|P2|STARTED|Overall Study||1
2331277|NCT01794455|5721951|P1|STARTED|Overall Study||0
2331278|NCT01794312|5721969|P2|NOT COMPLETED|Overall Study||11
2331279|NCT01794312|5721970|P1|NOT COMPLETED|Overall Study||6
2331280|NCT01794312|5721969|P2|COMPLETED|Overall Study||67
2331281|NCT01794312|5721970|P1|COMPLETED|Overall Study||68
2331282|NCT01794312|5721969|P2|STARTED|Overall Study||78
2331283|NCT01794312|5721970|P1|STARTED|Overall Study||74
2331284|NCT01794039|5721982|P2|NOT COMPLETED|Overall Study||0
2331285|NCT01794039|5721983|P1|NOT COMPLETED|Overall Study||0
2331286|NCT01794039|5721982|P2|COMPLETED|Overall Study||4
2331287|NCT01794039|5721983|P1|COMPLETED|Overall Study||5
2331288|NCT01794039|5721982|P2|STARTED|Overall Study||4
2331289|NCT01794039|5721983|P1|STARTED|Overall Study||5
2331290|NCT01794000|5721995|P2|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
2331291|NCT01794000|5721996|P1|NOT COMPLETED|Open-Label Extension Phase (OLE)||3
2331292|NCT01794000|5721995|P2|COMPLETED|Open-Label Extension Phase (OLE)||0
2331293|NCT01794000|5721996|P1|COMPLETED|Open-Label Extension Phase (OLE)||0
2331294|NCT01794000|5721995|P2|STARTED|Open-Label Extension Phase (OLE)|Placebo arm was not applicable to Open-Label Extension Phase|0
2331295|NCT01794000|5721996|P1|STARTED|Open-Label Extension Phase (OLE)|Pts. who had not permanently discontinued study drug and concluded DBP were eligible to enter OLE|3
2331296|NCT01794000|5721995|P2|NOT COMPLETED|Double-Blind Phase (DBP)||166
2331297|NCT01794000|5721996|P1|NOT COMPLETED|Double-Blind Phase (DBP)||169
2331298|NCT01794000|5721995|P2|COMPLETED|Double-Blind Phase (DBP)||4
2331299|NCT01794000|5721996|P1|COMPLETED|Double-Blind Phase (DBP)||2
2331300|NCT01794000|5721995|P2|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||166
2331301|NCT01794000|5721996|P1|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||169
2331302|NCT01794000|5721995|P2|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
2331303|NCT01794000|5721996|P1|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
2331304|NCT01794000|5721995|P2|STARTED|Double-Blind Phase (DBP)||170
2331305|NCT01794000|5721996|P1|STARTED|Double-Blind Phase (DBP)||171
2331306|NCT01793935|5722029|P2|NOT COMPLETED|Overall Study||3
2331307|NCT01793935|5722030|P1|NOT COMPLETED|Overall Study||6
2331308|NCT01793935|5722029|P2|COMPLETED|Overall Study||31
2331309|NCT01793935|5722030|P1|COMPLETED|Overall Study||28
2331310|NCT01793935|5722029|P2|STARTED|Overall Study||34
2331311|NCT01793935|5722030|P1|STARTED|Overall Study||34
2331312|NCT01793909|5722066|P2|NOT COMPLETED|Overall Study||5
2331313|NCT01793909|5722067|P1|NOT COMPLETED|Overall Study||10
2331314|NCT01793909|5722066|P2|COMPLETED|Overall Study||20
2331315|NCT01793909|5722067|P1|COMPLETED|Overall Study||20
2331316|NCT01793909|5722066|P2|STARTED|Overall Study||25
2331317|NCT01793909|5722067|P1|STARTED|Overall Study||30
2331318|NCT01793883|5722076|P3|NOT COMPLETED|Overall Study||8
2331319|NCT01793883|5722077|P2|NOT COMPLETED|Overall Study||10
2331320|NCT01793883|5722078|P1|NOT COMPLETED|Overall Study||12
2331321|NCT01793883|5722076|P3|COMPLETED|Overall Study||204
2331322|NCT01793883|5722077|P2|COMPLETED|Overall Study||204
2331323|NCT01793883|5722078|P1|COMPLETED|Overall Study||201
2331324|NCT01793883|5722076|P3|STARTED|Overall Study||212
2331325|NCT01793883|5722077|P2|STARTED|Overall Study||214
2331326|NCT01793883|5722078|P1|STARTED|Overall Study||213
2331327|NCT01793792|5722086|P1|NOT COMPLETED|Overall Study||12
2331328|NCT01793792|5722086|P1|COMPLETED|Overall Study||141
2331329|NCT01793792|5722086|P1|Treated|Overall Study|153 Treated, 152 implanted with device, 1 attempted no device implanted|153
2331330|NCT01793792|5722086|P1|STARTED|Overall Study|153 treated: 1 attempted no device implanted, 152 device implanted.|153
2331331|NCT01793688|5722091|P1|NOT COMPLETED|Overall Study||2
2331332|NCT01793688|5722091|P1|COMPLETED|Overall Study||980
2331333|NCT01793688|5722091|P1|STARTED|Overall Study||982
2331334|NCT01793285|5722098|P1|NOT COMPLETED|Overall Study||0
2331335|NCT01793285|5722098|P1|COMPLETED|Overall Study||85
2331336|NCT01793285|5722098|P1|STARTED|Overall Study||85
2331337|NCT01793142|5722118|P1|NOT COMPLETED|Overall Study||7
2331338|NCT01793142|5722118|P1|COMPLETED|Overall Study||3423
2331339|NCT01793142|5722118|P1|Treated|Overall Study||3423
2331340|NCT01793142|5722118|P1|STARTED|Overall Study||3430
2331341|NCT01792986|5722129|P1|NOT COMPLETED|Overall Study||0
2331342|NCT01792986|5722129|P1|COMPLETED|Overall Study||12
2331343|NCT01792986|5722129|P1|STARTED|Overall Study||12
2331344|NCT01792830|5722148|P11|NOT COMPLETED|Overall Study||3
2331345|NCT01792830|5722149|P10|NOT COMPLETED|Overall Study||0
2331346|NCT01792830|5722150|P9|NOT COMPLETED|Overall Study||9
2331347|NCT01792830|5722151|P8|NOT COMPLETED|Overall Study||1
2331348|NCT01792830|5722152|P7|NOT COMPLETED|Overall Study||2
2331349|NCT01792830|5722153|P6|NOT COMPLETED|Overall Study||1
2331350|NCT01792830|5722154|P5|NOT COMPLETED|Overall Study||1
2331351|NCT01792830|5722155|P4|NOT COMPLETED|Overall Study||3
2331352|NCT01792830|5722156|P3|NOT COMPLETED|Overall Study||0
2331353|NCT01792830|5722157|P2|NOT COMPLETED|Overall Study||0
2331354|NCT01792830|5722158|P1|NOT COMPLETED|Overall Study||25
2331355|NCT01792830|5722148|P11|COMPLETED|Overall Study||9
2331356|NCT01792830|5722149|P10|COMPLETED|Overall Study||4
2331357|NCT01792830|5722150|P9|COMPLETED|Overall Study||11
2331358|NCT01792830|5722151|P8|COMPLETED|Overall Study||6
2331359|NCT01792830|5722152|P7|COMPLETED|Overall Study||12
2331360|NCT01792830|5722153|P6|COMPLETED|Overall Study||3
2331361|NCT01792830|5722154|P5|COMPLETED|Overall Study||1
2331362|NCT01792830|5722155|P4|COMPLETED|Overall Study||18
2331363|NCT01792830|5722156|P3|COMPLETED|Overall Study||4
2331364|NCT01792830|5722157|P2|COMPLETED|Overall Study||3
2331365|NCT01792830|5722158|P1|COMPLETED|Overall Study||59
2331366|NCT01792830|5722148|P11|STARTED|Overall Study||12
2331367|NCT01792830|5722149|P10|STARTED|Overall Study||4
2331368|NCT01792830|5722150|P9|STARTED|Overall Study||20
2331369|NCT01792830|5722151|P8|STARTED|Overall Study||7
2331370|NCT01792830|5722152|P7|STARTED|Overall Study||14
2331371|NCT01792830|5722153|P6|STARTED|Overall Study||4
2331372|NCT01792830|5722154|P5|STARTED|Overall Study||2
2331373|NCT01792830|5722155|P4|STARTED|Overall Study||21
2331374|NCT01792830|5722156|P3|STARTED|Overall Study||4
2331375|NCT01792830|5722157|P2|STARTED|Overall Study||3
2331376|NCT01792830|5722158|P1|STARTED|Overall Study||84
2331377|NCT01792817|5722227|P3|NOT COMPLETED|Phase 2 Open Label||26
2331378|NCT01792817|5722228|P2|NOT COMPLETED|Phase 2 Open Label||0
2331379|NCT01792817|5722229|P1|NOT COMPLETED|Phase 2 Open Label||0
2331380|NCT01792817|5722227|P3|COMPLETED|Phase 2 Open Label||74
2331381|NCT01792817|5722228|P2|COMPLETED|Phase 2 Open Label||0
2331382|NCT01792817|5722229|P1|COMPLETED|Phase 2 Open Label||0
2331383|NCT01792817|5722227|P3|STARTED|Phase 2 Open Label||100
2331384|NCT01792817|5722228|P2|STARTED|Phase 2 Open Label||0
2331385|NCT01792817|5722229|P1|STARTED|Phase 2 Open Label||0
2331386|NCT01792817|5722227|P3|NOT COMPLETED|Phase 1 Double Blind Period||0
2331387|NCT01792817|5722228|P2|NOT COMPLETED|Phase 1 Double Blind Period||31
2331388|NCT01792817|5722229|P1|NOT COMPLETED|Phase 1 Double Blind Period||19
2331389|NCT01792817|5722227|P3|COMPLETED|Phase 1 Double Blind Period||0
2331390|NCT01792817|5722228|P2|COMPLETED|Phase 1 Double Blind Period||42
2331391|NCT01792817|5722229|P1|COMPLETED|Phase 1 Double Blind Period||58
2331392|NCT01792817|5722227|P3|STARTED|Phase 1 Double Blind Period||0
2331393|NCT01792817|5722228|P2|STARTED|Phase 1 Double Blind Period||73
2331394|NCT01792817|5722229|P1|STARTED|Phase 1 Double Blind Period||77
2331395|NCT01792635|5722245|P3|NOT COMPLETED|Part B||4
2331396|NCT01792635|5722246|P2|NOT COMPLETED|Part B||4
2331397|NCT01792635|5722247|P1|NOT COMPLETED|Part B||0
2331398|NCT01792635|5722245|P3|COMPLETED|Part B||3
2331399|NCT01792635|5722246|P2|COMPLETED|Part B||2
2331400|NCT01792635|5722247|P1|COMPLETED|Part B||0
2331401|NCT01792635|5722245|P3|STARTED|Part B||7
2331402|NCT01792635|5722246|P2|STARTED|Part B||6
2331403|NCT01792635|5722247|P1|STARTED|Part B||0
2331404|NCT01792635|5722245|P3|NOT COMPLETED|Part A||0
2331405|NCT01792635|5722246|P2|NOT COMPLETED|Part A||0
2331406|NCT01792635|5722247|P1|NOT COMPLETED|Part A||0
2331407|NCT01792635|5722245|P3|COMPLETED|Part A||0
2331408|NCT01792635|5722246|P2|COMPLETED|Part A||0
2331409|NCT01792635|5722247|P1|COMPLETED|Part A||6
2331410|NCT01792635|5722245|P3|STARTED|Part A||0
2331411|NCT01792635|5722246|P2|STARTED|Part A||0
2331412|NCT01792635|5722247|P1|STARTED|Part A||6
2331413|NCT01792518|5722275|P2|NOT COMPLETED|Overall Study||7
2331414|NCT01792518|5722276|P1|NOT COMPLETED|Overall Study||8
2331415|NCT01792518|5722275|P2|COMPLETED|Overall Study||175
2331416|NCT01792518|5722276|P1|COMPLETED|Overall Study||170
2331417|NCT01792518|5722275|P2|STARTED|Overall Study||182
2331418|NCT01792518|5722276|P1|STARTED|Overall Study||178
2331419|NCT01792284|5722286|P3|NOT COMPLETED|Randomization Period 2||0
2331420|NCT01792284|5722287|P2|NOT COMPLETED|Randomization Period 2||3
2331421|NCT01792284|5722288|P1|NOT COMPLETED|Randomization Period 2||0
2331422|NCT01792284|5722286|P3|COMPLETED|Randomization Period 2||85
2331423|NCT01792284|5722287|P2|COMPLETED|Randomization Period 2||87
2331424|NCT01792284|5722288|P1|COMPLETED|Randomization Period 2||0
2331425|NCT01792284|5722286|P3|Received at Least 1 Dose of Study Drug|Randomization Period 2||85
2331426|NCT01792284|5722287|P2|Received at Least 1 Dose of Study Drug|Randomization Period 2||90
2331427|NCT01792284|5722288|P1|Received at Least 1 Dose of Study Drug|Randomization Period 2||0
2331428|NCT01792284|5722286|P3|STARTED|Randomization Period 2||85
2331429|NCT01792284|5722287|P2|STARTED|Randomization Period 2||90
2331430|NCT01792284|5722288|P1|STARTED|Randomization Period 2||0
2331431|NCT01792284|5722286|P3|NOT COMPLETED|Randomization Period 1||5
2331432|NCT01792284|5722287|P2|NOT COMPLETED|Randomization Period 1||2
2331433|NCT01792284|5722288|P1|NOT COMPLETED|Randomization Period 1||0
2331434|NCT01792284|5722286|P3|COMPLETED|Randomization Period 1||85
2331435|NCT01792284|5722287|P2|COMPLETED|Randomization Period 1||90
2331436|NCT01792284|5722288|P1|COMPLETED|Randomization Period 1||0
2331437|NCT01792284|5722286|P3|Received at Least 1 Dose of Study Drug|Randomization Period 1||90
2331438|NCT01792284|5722287|P2|Received at Least 1 Dose of Study Drug|Randomization Period 1||92
2331439|NCT01792284|5722288|P1|Received at Least 1 Dose of Study Drug|Randomization Period 1||0
2331440|NCT01792284|5722286|P3|STARTED|Randomization Period 1||90
2331441|NCT01792284|5722287|P2|STARTED|Randomization Period 1||92
2331442|NCT01792284|5722288|P1|STARTED|Randomization Period 1||0
2331443|NCT01792284|5722286|P3|NOT COMPLETED|Lead-in Period||0
2331444|NCT01792284|5722287|P2|NOT COMPLETED|Lead-in Period||0
2331445|NCT01792284|5722288|P1|NOT COMPLETED|Lead-in Period||30
2331446|NCT01792284|5722286|P3|COMPLETED|Lead-in Period||0
2331447|NCT01792284|5722287|P2|COMPLETED|Lead-in Period||0
2331448|NCT01792284|5722288|P1|COMPLETED|Lead-in Period|Participants that completed the Lead-in Period were randomized and entered Randomization Period 1.|182
2331449|NCT01792284|5722286|P3|STARTED|Lead-in Period||0
2331450|NCT01792284|5722287|P2|STARTED|Lead-in Period||0
2331451|NCT01792284|5722288|P1|STARTED|Lead-in Period||212
2331452|NCT01792024|5722326|P1|NOT COMPLETED|Overall Study||0
2331453|NCT01792024|5722326|P1|COMPLETED|Overall Study||27
2331454|NCT01792024|5722326|P1|STARTED|Overall Study||27
2331455|NCT01791972|5722336|P2|NOT COMPLETED|Overall Study||0
2331456|NCT01791972|5722337|P1|NOT COMPLETED|Overall Study||0
2331457|NCT01791972|5722336|P2|COMPLETED|Overall Study||19
2331458|NCT01791972|5722337|P1|COMPLETED|Overall Study||19
2331459|NCT01791972|5722336|P2|STARTED|Overall Study||19
2331460|NCT01791972|5722337|P1|STARTED|Overall Study||19
2331461|NCT01791894|5722347|P1|NOT COMPLETED|Overall Study||1
2331462|NCT01791894|5722347|P1|COMPLETED|Overall Study||4
2331463|NCT01791894|5722347|P1|STARTED|Overall Study||5
2331464|NCT01791803|5722358|P4|NOT COMPLETED|Overall Study||5
2331465|NCT01791803|5722359|P3|NOT COMPLETED|Overall Study||2
2331466|NCT01791803|5722360|P2|NOT COMPLETED|Overall Study||2
2331467|NCT01791803|5722361|P1|NOT COMPLETED|Overall Study||0
2331468|NCT01791803|5722358|P4|COMPLETED|Overall Study||37
2331469|NCT01791803|5722359|P3|COMPLETED|Overall Study||38
2331470|NCT01791803|5722360|P2|COMPLETED|Overall Study||39
2331471|NCT01791803|5722361|P1|COMPLETED|Overall Study||41
2331472|NCT01791803|5722358|P4|STARTED|Overall Study||42
2331473|NCT01791803|5722359|P3|STARTED|Overall Study||40
2331474|NCT01791803|5722360|P2|STARTED|Overall Study||41
2331475|NCT01791803|5722361|P1|STARTED|Overall Study||41
2331476|NCT01791725|5722379|P3|NOT COMPLETED|Overall Study||0
2331477|NCT01791725|5722380|P2|NOT COMPLETED|Overall Study||1
2331478|NCT01791725|5722381|P1|NOT COMPLETED|Overall Study||0
2331479|NCT01791725|5722379|P3|COMPLETED|Overall Study||6
2331480|NCT01791725|5722380|P2|COMPLETED|Overall Study||4
2331481|NCT01791725|5722381|P1|COMPLETED|Overall Study||12
2331482|NCT01791725|5722379|P3|STARTED|Overall Study||6
2331483|NCT01791725|5722380|P2|STARTED|Overall Study||5
2331484|NCT01791725|5722381|P1|STARTED|Overall Study||12
2331485|NCT01791517|5722404|P12|NOT COMPLETED|Phase II||1
2331486|NCT01791517|5722405|P11|NOT COMPLETED|Phase II||1
2331487|NCT01791517|5722406|P10|NOT COMPLETED|Phase II||3
2331488|NCT01791517|5722407|P9|NOT COMPLETED|Phase II||2
2331489|NCT01791517|5722408|P8|NOT COMPLETED|Phase II||3
2331490|NCT01791517|5722409|P7|NOT COMPLETED|Phase II||2
2331491|NCT01791517|5722410|P6|NOT COMPLETED|Phase II||4
2331492|NCT01791517|5722411|P5|NOT COMPLETED|Phase II||2
2331493|NCT01791517|5722412|P4|NOT COMPLETED|Phase II||0
2331494|NCT01791517|5722413|P3|NOT COMPLETED|Phase II||1
2331495|NCT01791517|5722414|P2|NOT COMPLETED|Phase II||0
2331496|NCT01791517|5722415|P1|NOT COMPLETED|Phase II||2
2331497|NCT01791517|5722404|P12|COMPLETED|Phase II||17
2331498|NCT01791517|5722405|P11|COMPLETED|Phase II||15
2331499|NCT01791517|5722406|P10|COMPLETED|Phase II||15
2331500|NCT01791517|5722407|P9|COMPLETED|Phase II||17
2331501|NCT01791517|5722408|P8|COMPLETED|Phase II||17
2331502|NCT01791517|5722409|P7|COMPLETED|Phase II||17
2331503|NCT01791517|5722410|P6|COMPLETED|Phase II||14
2331504|NCT01791517|5722411|P5|COMPLETED|Phase II||16
2331505|NCT01791517|5722412|P4|COMPLETED|Phase II||15
2331506|NCT01791517|5722413|P3|COMPLETED|Phase II||15
2331507|NCT01791517|5722414|P2|COMPLETED|Phase II||14
2331508|NCT01791517|5722415|P1|COMPLETED|Phase II||15
2331509|NCT01791517|5722404|P12|STARTED|Phase II||18
2331510|NCT01791517|5722405|P11|STARTED|Phase II||16
2331511|NCT01791517|5722406|P10|STARTED|Phase II||18
2331512|NCT01791517|5722407|P9|STARTED|Phase II||19
2331513|NCT01791517|5722408|P8|STARTED|Phase II||20
2331514|NCT01791517|5722409|P7|STARTED|Phase II||19
2331515|NCT01791517|5722410|P6|STARTED|Phase II||18
2331516|NCT01791517|5722411|P5|STARTED|Phase II||18
2331517|NCT01791517|5722412|P4|STARTED|Phase II||15
2331518|NCT01791517|5722413|P3|STARTED|Phase II||16
2331519|NCT01791517|5722414|P2|STARTED|Phase II||14
2331520|NCT01791517|5722415|P1|STARTED|Phase II||17
2331521|NCT01791517|5722404|P12|NOT COMPLETED|Phase I: Period 4||0
2331522|NCT01791517|5722405|P11|NOT COMPLETED|Phase I: Period 4||0
2331523|NCT01791517|5722406|P10|NOT COMPLETED|Phase I: Period 4||0
2331524|NCT01791517|5722407|P9|NOT COMPLETED|Phase I: Period 4||0
2331525|NCT01791517|5722408|P8|NOT COMPLETED|Phase I: Period 4||0
2331526|NCT01791517|5722409|P7|NOT COMPLETED|Phase I: Period 4||0
2331527|NCT01791517|5722410|P6|NOT COMPLETED|Phase I: Period 4||0
2331528|NCT01791517|5722411|P5|NOT COMPLETED|Phase I: Period 4||0
2331529|NCT01791517|5722412|P4|NOT COMPLETED|Phase I: Period 4||0
2331530|NCT01791517|5722413|P3|NOT COMPLETED|Phase I: Period 4||0
2331531|NCT01791517|5722414|P2|NOT COMPLETED|Phase I: Period 4||0
2331532|NCT01791517|5722415|P1|NOT COMPLETED|Phase I: Period 4||0
2331533|NCT01791517|5722404|P12|COMPLETED|Phase I: Period 4||18
2331534|NCT01791517|5722405|P11|COMPLETED|Phase I: Period 4||16
2331535|NCT01791517|5722406|P10|COMPLETED|Phase I: Period 4||18
2331536|NCT01791517|5722407|P9|COMPLETED|Phase I: Period 4||19
2331537|NCT01791517|5722408|P8|COMPLETED|Phase I: Period 4||20
2331538|NCT01791517|5722409|P7|COMPLETED|Phase I: Period 4||19
2331539|NCT01791517|5722410|P6|COMPLETED|Phase I: Period 4||18
2331540|NCT01791517|5722411|P5|COMPLETED|Phase I: Period 4||18
2331541|NCT01791517|5722412|P4|COMPLETED|Phase I: Period 4||15
2331542|NCT01791517|5722413|P3|COMPLETED|Phase I: Period 4||16
2331543|NCT01791517|5722414|P2|COMPLETED|Phase I: Period 4||14
2331544|NCT01791517|5722415|P1|COMPLETED|Phase I: Period 4||17
2331545|NCT01791517|5722404|P12|STARTED|Phase I: Period 4||18
2331546|NCT01791517|5722405|P11|STARTED|Phase I: Period 4||16
2331547|NCT01791517|5722406|P10|STARTED|Phase I: Period 4||18
2331548|NCT01791517|5722407|P9|STARTED|Phase I: Period 4||19
2331549|NCT01791517|5722408|P8|STARTED|Phase I: Period 4||20
2331550|NCT01791517|5722409|P7|STARTED|Phase I: Period 4||19
2331551|NCT01791517|5722410|P6|STARTED|Phase I: Period 4||18
2331552|NCT01791517|5722411|P5|STARTED|Phase I: Period 4||18
2331553|NCT01791517|5722412|P4|STARTED|Phase I: Period 4||15
2331554|NCT01791517|5722413|P3|STARTED|Phase I: Period 4||16
2331555|NCT01791517|5722414|P2|STARTED|Phase I: Period 4||14
2331556|NCT01791517|5722415|P1|STARTED|Phase I: Period 4||17
2331557|NCT01791517|5722404|P12|NOT COMPLETED|Phase I: Period 3||1
2331558|NCT01791517|5722405|P11|NOT COMPLETED|Phase I: Period 3||0
2331559|NCT01791517|5722406|P10|NOT COMPLETED|Phase I: Period 3||0
2331560|NCT01791517|5722407|P9|NOT COMPLETED|Phase I: Period 3||0
2331561|NCT01791517|5722408|P8|NOT COMPLETED|Phase I: Period 3||0
2331562|NCT01791517|5722409|P7|NOT COMPLETED|Phase I: Period 3||0
2331563|NCT01791517|5722410|P6|NOT COMPLETED|Phase I: Period 3||0
2331564|NCT01791517|5722411|P5|NOT COMPLETED|Phase I: Period 3||1
2331565|NCT01791517|5722412|P4|NOT COMPLETED|Phase I: Period 3||1
2331566|NCT01791517|5722413|P3|NOT COMPLETED|Phase I: Period 3||0
2331567|NCT01791517|5722414|P2|NOT COMPLETED|Phase I: Period 3||1
2331568|NCT01791517|5722415|P1|NOT COMPLETED|Phase I: Period 3||0
2331569|NCT01791517|5722404|P12|COMPLETED|Phase I: Period 3||18
2331570|NCT01791517|5722405|P11|COMPLETED|Phase I: Period 3||16
2331571|NCT01791517|5722406|P10|COMPLETED|Phase I: Period 3||18
2331572|NCT01791517|5722407|P9|COMPLETED|Phase I: Period 3||19
2331573|NCT01791517|5722408|P8|COMPLETED|Phase I: Period 3||20
2331574|NCT01791517|5722409|P7|COMPLETED|Phase I: Period 3||19
2331575|NCT01791517|5722410|P6|COMPLETED|Phase I: Period 3||18
2331576|NCT01791517|5722411|P5|COMPLETED|Phase I: Period 3||18
2331577|NCT01791517|5722412|P4|COMPLETED|Phase I: Period 3||15
2331578|NCT01791517|5722413|P3|COMPLETED|Phase I: Period 3||16
2331579|NCT01791517|5722414|P2|COMPLETED|Phase I: Period 3||14
2331580|NCT01791517|5722415|P1|COMPLETED|Phase I: Period 3||17
2331581|NCT01791517|5722404|P12|STARTED|Phase I: Period 3||19
2331582|NCT01791517|5722405|P11|STARTED|Phase I: Period 3||16
2331583|NCT01791517|5722406|P10|STARTED|Phase I: Period 3||18
2331584|NCT01791517|5722407|P9|STARTED|Phase I: Period 3||19
2331585|NCT01791517|5722408|P8|STARTED|Phase I: Period 3||20
2331586|NCT01791517|5722409|P7|STARTED|Phase I: Period 3||19
2331587|NCT01791517|5722410|P6|STARTED|Phase I: Period 3||18
2331588|NCT01791517|5722411|P5|STARTED|Phase I: Period 3||19
2331589|NCT01791517|5722412|P4|STARTED|Phase I: Period 3||16
2331590|NCT01791517|5722413|P3|STARTED|Phase I: Period 3||16
2331591|NCT01791517|5722414|P2|STARTED|Phase I: Period 3||15
2331592|NCT01791517|5722415|P1|STARTED|Phase I: Period 3||17
2331593|NCT01791517|5722404|P12|NOT COMPLETED|Phase I: Period 2||0
2331594|NCT01791517|5722405|P11|NOT COMPLETED|Phase I: Period 2||2
2331595|NCT01791517|5722406|P10|NOT COMPLETED|Phase I: Period 2||1
2331596|NCT01791517|5722407|P9|NOT COMPLETED|Phase I: Period 2||0
2331597|NCT01791517|5722408|P8|NOT COMPLETED|Phase I: Period 2||0
2331598|NCT01791517|5722409|P7|NOT COMPLETED|Phase I: Period 2||0
2331599|NCT01791517|5722410|P6|NOT COMPLETED|Phase I: Period 2||1
2331600|NCT01791517|5722411|P5|NOT COMPLETED|Phase I: Period 2||0
2331601|NCT01791517|5722412|P4|NOT COMPLETED|Phase I: Period 2||1
2331602|NCT01791517|5722413|P3|NOT COMPLETED|Phase I: Period 2||2
2331603|NCT01791517|5722414|P2|NOT COMPLETED|Phase I: Period 2||3
2331604|NCT01791517|5722415|P1|NOT COMPLETED|Phase I: Period 2||1
2331605|NCT01791517|5722404|P12|COMPLETED|Phase I: Period 2||19
2331606|NCT01791517|5722405|P11|COMPLETED|Phase I: Period 2||16
2331607|NCT01791517|5722406|P10|COMPLETED|Phase I: Period 2||18
2331608|NCT01791517|5722407|P9|COMPLETED|Phase I: Period 2||19
2331609|NCT01791517|5722408|P8|COMPLETED|Phase I: Period 2||20
2331610|NCT01791517|5722409|P7|COMPLETED|Phase I: Period 2||19
2331611|NCT01791517|5722410|P6|COMPLETED|Phase I: Period 2||18
2331612|NCT01791517|5722411|P5|COMPLETED|Phase I: Period 2||19
2331613|NCT01791517|5722412|P4|COMPLETED|Phase I: Period 2||16
2331614|NCT01791517|5722413|P3|COMPLETED|Phase I: Period 2||16
2331615|NCT01791517|5722414|P2|COMPLETED|Phase I: Period 2||15
2331616|NCT01791517|5722415|P1|COMPLETED|Phase I: Period 2||17
2331617|NCT01791517|5722404|P12|STARTED|Phase I: Period 2||19
2331618|NCT01791517|5722405|P11|STARTED|Phase I: Period 2||18
2331619|NCT01791517|5722406|P10|STARTED|Phase I: Period 2||19
2331620|NCT01791517|5722407|P9|STARTED|Phase I: Period 2||19
2331621|NCT01791517|5722408|P8|STARTED|Phase I: Period 2||20
2331622|NCT01791517|5722409|P7|STARTED|Phase I: Period 2||19
2331623|NCT01791517|5722410|P6|STARTED|Phase I: Period 2||19
2331624|NCT01791517|5722411|P5|STARTED|Phase I: Period 2||19
2331625|NCT01791517|5722412|P4|STARTED|Phase I: Period 2||17
2331626|NCT01791517|5722413|P3|STARTED|Phase I: Period 2||18
2331627|NCT01791517|5722414|P2|STARTED|Phase I: Period 2||18
2331628|NCT01791517|5722415|P1|STARTED|Phase I: Period 2||18
2331629|NCT01791517|5722404|P12|NOT COMPLETED|Phase I: Period 1||1
2331630|NCT01791517|5722405|P11|NOT COMPLETED|Phase I: Period 1||0
2331631|NCT01791517|5722406|P10|NOT COMPLETED|Phase I: Period 1||1
2331632|NCT01791517|5722407|P9|NOT COMPLETED|Phase I: Period 1||1
2331633|NCT01791517|5722408|P8|NOT COMPLETED|Phase I: Period 1||0
2331634|NCT01791517|5722409|P7|NOT COMPLETED|Phase I: Period 1||1
2331635|NCT01791517|5722410|P6|NOT COMPLETED|Phase I: Period 1||1
2331636|NCT01791517|5722411|P5|NOT COMPLETED|Phase I: Period 1||1
2331637|NCT01791517|5722412|P4|NOT COMPLETED|Phase I: Period 1||2
2331638|NCT01791517|5722413|P3|NOT COMPLETED|Phase I: Period 1||2
2331639|NCT01791517|5722414|P2|NOT COMPLETED|Phase I: Period 1||2
2331640|NCT01791517|5722415|P1|NOT COMPLETED|Phase I: Period 1||1
2331641|NCT01791517|5722404|P12|COMPLETED|Phase I: Period 1||19
2331642|NCT01791517|5722405|P11|COMPLETED|Phase I: Period 1||18
2331643|NCT01791517|5722406|P10|COMPLETED|Phase I: Period 1||19
2331644|NCT01791517|5722407|P9|COMPLETED|Phase I: Period 1||19
2331645|NCT01791517|5722408|P8|COMPLETED|Phase I: Period 1||20
2331646|NCT01791517|5722409|P7|COMPLETED|Phase I: Period 1||19
2331647|NCT01791517|5722410|P6|COMPLETED|Phase I: Period 1||19
2331648|NCT01791517|5722411|P5|COMPLETED|Phase I: Period 1||19
2331649|NCT01791517|5722412|P4|COMPLETED|Phase I: Period 1||17
2331650|NCT01791517|5722413|P3|COMPLETED|Phase I: Period 1||18
2331651|NCT01791517|5722414|P2|COMPLETED|Phase I: Period 1||18
2331652|NCT01791517|5722415|P1|COMPLETED|Phase I: Period 1||18
2331653|NCT01791517|5722404|P12|STARTED|Phase I: Period 1||20
2331654|NCT01791517|5722405|P11|STARTED|Phase I: Period 1||18
2331655|NCT01791517|5722406|P10|STARTED|Phase I: Period 1||20
2331656|NCT01791517|5722407|P9|STARTED|Phase I: Period 1||20
2331657|NCT01791517|5722408|P8|STARTED|Phase I: Period 1||20
2331658|NCT01791517|5722409|P7|STARTED|Phase I: Period 1||20
2331659|NCT01791517|5722410|P6|STARTED|Phase I: Period 1||20
2331660|NCT01791517|5722411|P5|STARTED|Phase I: Period 1||20
2331661|NCT01791517|5722412|P4|STARTED|Phase I: Period 1||19
2331662|NCT01791517|5722413|P3|STARTED|Phase I: Period 1||20
2331663|NCT01791517|5722414|P2|STARTED|Phase I: Period 1||20
2331664|NCT01791517|5722415|P1|STARTED|Phase I: Period 1||19
2331665|NCT01791491|5722441|P1|NOT COMPLETED|Overall Study||0
2331666|NCT01791491|5722441|P1|COMPLETED|Overall Study||9
2331667|NCT01791491|5722441|P1|STARTED|Overall Study|Reasons for enrollment and non-treatment: 1 withdrew consent and 6 no longer met study criteria.|9
2331668|NCT01791465|5722453|P1|NOT COMPLETED|Overall Study||0
2331669|NCT01791465|5722453|P1|COMPLETED|Overall Study||6
2331670|NCT01791465|5722453|P1|STARTED|Overall Study||6
2331671|NCT01791413|5722479|P2|NOT COMPLETED|Overall Study||1
2331672|NCT01791413|5722480|P1|NOT COMPLETED|Overall Study||5
2331673|NCT01791413|5722479|P2|COMPLETED|Overall Study||19
2331674|NCT01791413|5722480|P1|COMPLETED|Overall Study||15
2331675|NCT01791413|5722479|P2|STARTED|Overall Study||20
2331676|NCT01791413|5722480|P1|STARTED|Overall Study||20
2331677|NCT01791244|5722489|P2|NOT COMPLETED|Overall Study||18
2331678|NCT01791244|5722490|P1|NOT COMPLETED|Overall Study||15
2331679|NCT01791244|5722489|P2|COMPLETED|Overall Study||29
2331680|NCT01791244|5722490|P1|COMPLETED|Overall Study||31
2331681|NCT01791244|5722489|P2|Intent to Treat (ITT)|Overall Study||39
2331682|NCT01791244|5722490|P1|Intent to Treat (ITT)|Overall Study||38
2331683|NCT01791244|5722489|P2|STARTED|Overall Study||47
2331684|NCT01791244|5722490|P1|STARTED|Overall Study||46
2331685|NCT01791205|5722526|P2|NOT COMPLETED|Phase II||0
2331686|NCT01791205|5722527|P1|NOT COMPLETED|Phase II||12
2331687|NCT01791205|5722526|P2|COMPLETED|Phase II||0
2331688|NCT01791205|5722527|P1|COMPLETED|Phase II||92
2331689|NCT01791205|5722526|P2|STARTED|Phase II||0
2331690|NCT01791205|5722527|P1|STARTED|Phase II|Participants who received tocilizumab monotherapy in Phase I was observed in Phase II.|104
2331691|NCT01791205|5722526|P2|NOT COMPLETED|Phase I||0
2331692|NCT01791205|5722527|P1|NOT COMPLETED|Phase I||0
2331693|NCT01791205|5722526|P2|COMPLETED|Phase I||152
2331694|NCT01791205|5722527|P1|COMPLETED|Phase I||152
2331695|NCT01791205|5722526|P2|STARTED|Phase I||152
2331696|NCT01791205|5722527|P1|STARTED|Phase I||152
2331697|NCT01791153|5722611|P8|NOT COMPLETED|Part 2: Open-label Period||6
2331698|NCT01791153|5722612|P7|NOT COMPLETED|Part 2: Open-label Period||6
2331699|NCT01791153|5722613|P6|NOT COMPLETED|Part 2: Open-label Period||4
2331700|NCT01791153|5722614|P5|NOT COMPLETED|Part 2: Open-label Period||2
2331701|NCT01791153|5722615|P4|NOT COMPLETED|Part 2: Open-label Period||0
2331702|NCT01791153|5722616|P3|NOT COMPLETED|Part 2: Open-label Period||0
2331703|NCT01791153|5722617|P2|NOT COMPLETED|Part 2: Open-label Period||0
2331704|NCT01791153|5722618|P1|NOT COMPLETED|Part 2: Open-label Period||0
2331705|NCT01791153|5722611|P8|COMPLETED|Part 2: Open-label Period||61
2331706|NCT01791153|5722612|P7|COMPLETED|Part 2: Open-label Period||44
2331707|NCT01791153|5722613|P6|COMPLETED|Part 2: Open-label Period||54
2331708|NCT01791153|5722614|P5|COMPLETED|Part 2: Open-label Period||38
2331709|NCT01791153|5722615|P4|COMPLETED|Part 2: Open-label Period||0
2331710|NCT01791153|5722616|P3|COMPLETED|Part 2: Open-label Period||0
2331711|NCT01791153|5722617|P2|COMPLETED|Part 2: Open-label Period||0
2331712|NCT01791153|5722618|P1|COMPLETED|Part 2: Open-label Period||0
2331713|NCT01791153|5722611|P8|STARTED|Part 2: Open-label Period||67
2331714|NCT01791153|5722612|P7|STARTED|Part 2: Open-label Period||50
2331715|NCT01791153|5722613|P6|STARTED|Part 2: Open-label Period||58
2331716|NCT01791153|5722614|P5|STARTED|Part 2: Open-label Period||40
2331717|NCT01791153|5722615|P4|STARTED|Part 2: Open-label Period||0
2331718|NCT01791153|5722616|P3|STARTED|Part 2: Open-label Period||0
2331719|NCT01791153|5722617|P2|STARTED|Part 2: Open-label Period||0
2331720|NCT01791153|5722618|P1|STARTED|Part 2: Open-label Period||0
2331721|NCT01791153|5722611|P8|NOT COMPLETED|Part 1: Blinded Period||0
2331722|NCT01791153|5722612|P7|NOT COMPLETED|Part 1: Blinded Period||0
2331723|NCT01791153|5722613|P6|NOT COMPLETED|Part 1: Blinded Period||0
2331724|NCT01791153|5722614|P5|NOT COMPLETED|Part 1: Blinded Period||0
2331725|NCT01791153|5722615|P4|NOT COMPLETED|Part 1: Blinded Period||5
2331726|NCT01791153|5722616|P3|NOT COMPLETED|Part 1: Blinded Period||6
2331727|NCT01791153|5722617|P2|NOT COMPLETED|Part 1: Blinded Period||8
2331728|NCT01791153|5722618|P1|NOT COMPLETED|Part 1: Blinded Period||15
2331729|NCT01791153|5722611|P8|COMPLETED|Part 1: Blinded Period||0
2331730|NCT01791153|5722612|P7|COMPLETED|Part 1: Blinded Period||0
2331731|NCT01791153|5722613|P6|COMPLETED|Part 1: Blinded Period||0
2331732|NCT01791153|5722614|P5|COMPLETED|Part 1: Blinded Period||0
2331733|NCT01791153|5722615|P4|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|46
2331734|NCT01791153|5722616|P3|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|44
2331735|NCT01791153|5722617|P2|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|41
2331736|NCT01791153|5722618|P1|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|85
2331737|NCT01791153|5722611|P8|STARTED|Part 1: Blinded Period||0
2331738|NCT01791153|5722612|P7|STARTED|Part 1: Blinded Period||0
2331739|NCT01791153|5722613|P6|STARTED|Part 1: Blinded Period||0
2331740|NCT01791153|5722614|P5|STARTED|Part 1: Blinded Period||0
2331741|NCT01791153|5722615|P4|STARTED|Part 1: Blinded Period||51
2331742|NCT01791153|5722616|P3|STARTED|Part 1: Blinded Period||50
2331743|NCT01791153|5722617|P2|STARTED|Part 1: Blinded Period||49
2331744|NCT01791153|5722618|P1|STARTED|Part 1: Blinded Period||100
2331745|NCT01790932|5722678|P1|NOT COMPLETED|Overall Study||50
2331746|NCT01790932|5722678|P1|COMPLETED|Overall Study||0
2331747|NCT01790932|5722678|P1|STARTED|Overall Study||50
2331748|NCT01790828|5722684|P1|NOT COMPLETED|Overall Study||34
2331749|NCT01790828|5722684|P1|COMPLETED|Overall Study||8
2331750|NCT01790828|5722684|P1|STARTED|Overall Study||42
2331751|NCT01790750|5722707|P1|NOT COMPLETED|Overall Study||0
2331752|NCT01790750|5722707|P1|COMPLETED|Overall Study||50
2331753|NCT01790750|5722707|P1|STARTED|Overall Study||50
2331754|NCT01790685|5722714|P2|NOT COMPLETED|Overall Study||0
2331755|NCT01790685|5722715|P1|NOT COMPLETED|Overall Study||0
2331756|NCT01790685|5722714|P2|COMPLETED|Overall Study||17
2331757|NCT01790685|5722715|P1|COMPLETED|Overall Study||23
2331758|NCT01790685|5722714|P2|STARTED|Overall Study||17
2331759|NCT01790685|5722715|P1|STARTED|Overall Study||23
2331760|NCT01790659|5722723|P2|NOT COMPLETED|Overall Study||6
2331761|NCT01790659|5722724|P1|NOT COMPLETED|Overall Study||6
2331762|NCT01790659|5722723|P2|COMPLETED|Overall Study||192
2331763|NCT01790659|5722724|P1|COMPLETED|Overall Study||195
2331764|NCT01790659|5722723|P2|STARTED|Overall Study||198
2331765|NCT01790659|5722724|P1|STARTED|Overall Study||201
2331766|NCT01790633|5722742|P2|NOT COMPLETED|Overall Study||5
2331767|NCT01790633|5722743|P1|NOT COMPLETED|Overall Study||48
2331768|NCT01790633|5722742|P2|COMPLETED|Overall Study||159
2331769|NCT01790633|5722743|P1|COMPLETED|Overall Study||115
2331770|NCT01790633|5722742|P2|STARTED|Overall Study||164
2331771|NCT01790633|5722743|P1|STARTED|Overall Study||163
2331772|NCT01790594|5722756|P3|NOT COMPLETED|Overall Study||3
2331773|NCT01790594|5722757|P2|NOT COMPLETED|Overall Study||3
2331774|NCT01790594|5722758|P1|NOT COMPLETED|Overall Study||5
2331775|NCT01790594|5722756|P3|COMPLETED|Overall Study||0
2331776|NCT01790594|5722757|P2|COMPLETED|Overall Study||18
2331777|NCT01790594|5722758|P1|COMPLETED|Overall Study||17
2331778|NCT01790594|5722756|P3|STARTED|Overall Study||3
2331779|NCT01790594|5722757|P2|STARTED|Overall Study||21
2331780|NCT01790594|5722758|P1|STARTED|Overall Study||22
2331781|NCT01790581|5722826|P2|NOT COMPLETED|Overall Study||0
2331782|NCT01790581|5722827|P1|NOT COMPLETED|Overall Study||0
2331783|NCT01790581|5722826|P2|COMPLETED|Overall Study||12
2331784|NCT01790581|5722827|P1|COMPLETED|Overall Study||12
2331785|NCT01790581|5722826|P2|STARTED|Overall Study||12
2331786|NCT01790581|5722827|P1|STARTED|Overall Study||12
2331787|NCT01790568|5722835|P2|NOT COMPLETED|Overall Study||1
2331788|NCT01790568|5722836|P1|NOT COMPLETED|Overall Study||0
2331789|NCT01790568|5722835|P2|COMPLETED|Overall Study||25
2331790|NCT01790568|5722836|P1|COMPLETED|Overall Study||12
2331791|NCT01790568|5722835|P2|STARTED|Overall Study||26
2331792|NCT01790568|5722836|P1|STARTED|Overall Study||12
2331793|NCT01790516|5722844|P2|NOT COMPLETED|Overall Study||0
2331794|NCT01790516|5722845|P1|NOT COMPLETED|Overall Study||1
2331795|NCT01790516|5722844|P2|COMPLETED|Overall Study||1
2331796|NCT01790516|5722845|P1|COMPLETED|Overall Study||0
2331797|NCT01790516|5722844|P2|STARTED|Overall Study||1
2331798|NCT01790516|5722845|P1|STARTED|Overall Study||1
2331799|NCT01790503|5722862|P11|NOT COMPLETED|Overall Study||16
2331800|NCT01790503|5722863|P10|NOT COMPLETED|Overall Study||26
2331801|NCT01790503|5722864|P9|NOT COMPLETED|Overall Study||3
2331802|NCT01790503|5722865|P8|NOT COMPLETED|Overall Study||1
2331803|NCT01790503|5722866|P7|NOT COMPLETED|Overall Study||1
2331804|NCT01790503|5722867|P6|NOT COMPLETED|Overall Study||5
2331805|NCT01790503|5722868|P5|NOT COMPLETED|Overall Study||5
2331806|NCT01790503|5722869|P4|NOT COMPLETED|Overall Study||2
2331807|NCT01790503|5722870|P3|NOT COMPLETED|Overall Study||1
2331808|NCT01790503|5722871|P2|NOT COMPLETED|Overall Study||1
2331809|NCT01790503|5722872|P1|NOT COMPLETED|Overall Study||3
2331810|NCT01790503|5722862|P11|COMPLETED|Overall Study||0
2331811|NCT01790503|5722863|P10|COMPLETED|Overall Study||1
2331812|NCT01790503|5722864|P9|COMPLETED|Overall Study||0
2331813|NCT01790503|5722865|P8|COMPLETED|Overall Study||0
2331814|NCT01790503|5722866|P7|COMPLETED|Overall Study||0
2331815|NCT01790503|5722867|P6|COMPLETED|Overall Study||0
2331816|NCT01790503|5722868|P5|COMPLETED|Overall Study||0
2331817|NCT01790503|5722869|P4|COMPLETED|Overall Study||0
2331818|NCT01790503|5722870|P3|COMPLETED|Overall Study||0
2331819|NCT01790503|5722871|P2|COMPLETED|Overall Study||0
2331820|NCT01790503|5722872|P1|COMPLETED|Overall Study||0
2331821|NCT01790503|5722862|P11|STARTED|Overall Study||16
2331822|NCT01790503|5722863|P10|STARTED|Overall Study||27
2331823|NCT01790503|5722864|P9|STARTED|Overall Study||3
2331824|NCT01790503|5722865|P8|STARTED|Overall Study||1
2331825|NCT01790503|5722866|P7|STARTED|Overall Study||1
2331826|NCT01790503|5722867|P6|STARTED|Overall Study||5
2331827|NCT01790503|5722868|P5|STARTED|Overall Study||5
2331828|NCT01790503|5722869|P4|STARTED|Overall Study||2
2331829|NCT01790503|5722870|P3|STARTED|Overall Study||1
2331830|NCT01790503|5722871|P2|STARTED|Overall Study||1
2331831|NCT01790503|5722872|P1|STARTED|Overall Study||3
2331832|NCT01790490|5722927|P3|NOT COMPLETED|Overall Study||0
2331833|NCT01790490|5722928|P2|NOT COMPLETED|Overall Study||0
2331834|NCT01790490|5722929|P1|NOT COMPLETED|Overall Study||0
2331835|NCT01790490|5722927|P3|COMPLETED|Overall Study||2
2331836|NCT01790490|5722928|P2|COMPLETED|Overall Study||3
2331837|NCT01790490|5722929|P1|COMPLETED|Overall Study||3
2331838|NCT01790490|5722927|P3|STARTED|Overall Study||2
2331839|NCT01790490|5722928|P2|STARTED|Overall Study||3
2331840|NCT01790490|5722929|P1|STARTED|Overall Study||3
2331841|NCT01790438|5722942|P2|NOT COMPLETED|Overall Study||11
2331842|NCT01790438|5722943|P1|NOT COMPLETED|Overall Study||35
2331843|NCT01790438|5722942|P2|COMPLETED|Overall Study||202
2331844|NCT01790438|5722943|P1|COMPLETED|Overall Study||393
2331845|NCT01790438|5722942|P2|Received at Least One Dose of Study Drug|Overall Study||212
2331846|NCT01790438|5722943|P1|Received at Least One Dose of Study Drug|Overall Study||427
2331847|NCT01790438|5722942|P2|STARTED|Overall Study||213
2331848|NCT01790438|5722943|P1|STARTED|Overall Study||428
2331849|NCT01790295|5722993|P1|NOT COMPLETED|Overall Study||11
2331850|NCT01790295|5722993|P1|COMPLETED|Overall Study||10
2331851|NCT01790295|5722993|P1|STARTED|Overall Study||21
2331852|NCT01790178|5723018|P2|NOT COMPLETED|Overall Study||0
2331853|NCT01790178|5723019|P1|NOT COMPLETED|Overall Study||0
2331854|NCT01790178|5723018|P2|COMPLETED|Overall Study||24
2331855|NCT01790178|5723019|P1|COMPLETED|Overall Study||16
2331856|NCT01790178|5723018|P2|STARTED|Overall Study||24
2331857|NCT01790178|5723019|P1|STARTED|Overall Study||16
2331858|NCT01790048|5723035|P2|NOT COMPLETED|Overall Study||17
2331859|NCT01790048|5723036|P1|NOT COMPLETED|Overall Study||12
2331860|NCT01790048|5723035|P2|COMPLETED|Overall Study||1086
2331861|NCT01790048|5723036|P1|COMPLETED|Overall Study||1144
2331862|NCT01790048|5723035|P2|STARTED|Overall Study||1103
2331863|NCT01790048|5723036|P1|STARTED|Overall Study||1156
2331864|NCT01789970|5723054|P3|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||44
2331865|NCT01789970|5723055|P2|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||50
2331866|NCT01789970|5723056|P1|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
2331867|NCT01789970|5723054|P3|COMPLETED|Double-blind Treatment Period (12 Weeks)||147
2331868|NCT01789970|5723055|P2|COMPLETED|Double-blind Treatment Period (12 Weeks)||130
2331869|NCT01789970|5723056|P1|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
2331870|NCT01789970|5723054|P3|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||191
2331871|NCT01789970|5723055|P2|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)|One participant was randomized but not treated.|179
2331872|NCT01789970|5723056|P1|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||0
2331873|NCT01789970|5723054|P3|STARTED|Double-blind Treatment Period (12 Weeks)||191
2331874|NCT01789970|5723055|P2|STARTED|Double-blind Treatment Period (12 Weeks)||180
2331875|NCT01789970|5723056|P1|STARTED|Double-blind Treatment Period (12 Weeks)||0
2331876|NCT01789970|5723054|P3|NOT COMPLETED|Open-label Titration Period||0
2331877|NCT01789970|5723055|P2|NOT COMPLETED|Open-label Titration Period||0
2331878|NCT01789970|5723056|P1|NOT COMPLETED|Open-label Titration Period||254
2331879|NCT01789970|5723054|P3|COMPLETED|Open-label Titration Period||0
2331880|NCT01789970|5723055|P2|COMPLETED|Open-label Titration Period||0
2331881|NCT01789970|5723056|P1|COMPLETED|Open-label Titration Period||371
2331882|NCT01789970|5723054|P3|Safety Analysis Set|Open-label Titration Period||0
2331883|NCT01789970|5723055|P2|Safety Analysis Set|Open-label Titration Period||0
2331884|NCT01789970|5723056|P1|Safety Analysis Set|Open-label Titration Period|Two enrolled patients were not treated|623
2331885|NCT01789970|5723054|P3|STARTED|Open-label Titration Period||0
2331886|NCT01789970|5723055|P2|STARTED|Open-label Titration Period||0
2331887|NCT01789970|5723056|P1|STARTED|Open-label Titration Period||625
2331888|NCT01789905|5723088|P1|NOT COMPLETED|Overall Study||0
2331889|NCT01789905|5723088|P1|COMPLETED|Overall Study||116
2331890|NCT01789905|5723088|P1|STARTED|Overall Study||116
2331891|NCT01789814|5723096|P2|NOT COMPLETED|Overall Study||0
2331892|NCT01789814|5723097|P1|NOT COMPLETED|Overall Study||0
2331893|NCT01789814|5723096|P2|COMPLETED|Overall Study||12
2331894|NCT01789814|5723097|P1|COMPLETED|Overall Study||12
2331895|NCT01789814|5723096|P2|STARTED|Overall Study||12
2331896|NCT01789814|5723097|P1|STARTED|Overall Study||12
2331897|NCT01789775|5723105|P2|NOT COMPLETED|Overall Study||7
2331898|NCT01789775|5723106|P1|NOT COMPLETED|Overall Study||2
2331899|NCT01789775|5723105|P2|COMPLETED|Overall Study||50
2331900|NCT01789775|5723106|P1|COMPLETED|Overall Study||53
2331901|NCT01789775|5723105|P2|STARTED|Overall Study||57
2331902|NCT01789775|5723106|P1|STARTED|Overall Study||55
2331903|NCT01789606|5723114|P2|NOT COMPLETED|Overall Study||450
2331904|NCT01789606|5723115|P1|NOT COMPLETED|Overall Study||23
2331905|NCT01789606|5723114|P2|COMPLETED|Overall Study||382
2331906|NCT01789606|5723115|P1|COMPLETED|Overall Study||228
2331907|NCT01789606|5723114|P2|STARTED|Overall Study||832
2331908|NCT01789606|5723115|P1|STARTED|Overall Study||251
2331909|NCT01789567|5723133|P1|NOT COMPLETED|Overall Study||6
2331910|NCT01789567|5723133|P1|COMPLETED|Overall Study||14
2331911|NCT01789567|5723133|P1|STARTED|Overall Study||20
2331912|NCT01789476|5723142|P2|NOT COMPLETED|Overall Study||2
2331913|NCT01789476|5723143|P1|NOT COMPLETED|Overall Study||8
2331914|NCT01789476|5723142|P2|COMPLETED|Overall Study||15
2331915|NCT01789476|5723143|P1|COMPLETED|Overall Study||26
2331916|NCT01789476|5723142|P2|STARTED|Overall Study||17
2331917|NCT01789476|5723143|P1|STARTED|Overall Study||34
2331918|NCT01789255|5723153|P1|NOT COMPLETED|Overall Study||0
2331919|NCT01789255|5723153|P1|COMPLETED|Overall Study||12
2331920|NCT01789255|5723153|P1|STARTED|Overall Study||12
2331921|NCT01789203|5723165|P2|NOT COMPLETED|Overall Study||4
2331922|NCT01789203|5723166|P1|NOT COMPLETED|Overall Study||9
2331923|NCT01789203|5723165|P2|COMPLETED|Overall Study||63
2331924|NCT01789203|5723166|P1|COMPLETED|Overall Study||124
2331925|NCT01789203|5723165|P2|STARTED|Overall Study||67
2331926|NCT01789203|5723166|P1|STARTED|Overall Study||133
2331927|NCT01789138|5723196|P2|NOT COMPLETED|Overall Study||52
2331928|NCT01789138|5723197|P1|NOT COMPLETED|Overall Study||41
2331929|NCT01789138|5723196|P2|COMPLETED|Overall Study||206
2331930|NCT01789138|5723197|P1|COMPLETED|Overall Study||213
2331931|NCT01789138|5723196|P2|STARTED|Overall Study||258
2331932|NCT01789138|5723197|P1|STARTED|Overall Study||254
2331933|NCT01789047|5723207|P2|NOT COMPLETED|Overall Study||4
2331934|NCT01789047|5723208|P1|NOT COMPLETED|Overall Study||4
2331935|NCT01789047|5723207|P2|COMPLETED|Overall Study||17
2331936|NCT01789047|5723208|P1|COMPLETED|Overall Study||17
2331937|NCT01789047|5723207|P2|STARTED|Overall Study||21
2331938|NCT01789047|5723208|P1|STARTED|Overall Study||21
2331939|NCT01788943|5723216|P2|NOT COMPLETED|Overall Study||0
2331940|NCT01788943|5723217|P1|NOT COMPLETED|Overall Study||1
2331941|NCT01788943|5723216|P2|COMPLETED|Overall Study||12
2331942|NCT01788943|5723217|P1|COMPLETED|Overall Study|2FA-PET Brain Image Analysis Completion Date|12
2331943|NCT01788943|5723216|P2|STARTED|Overall Study||12
2331944|NCT01788943|5723217|P1|STARTED|Overall Study|Recruitment for study began.|13
2331945|NCT01788631|5723227|P2|NOT COMPLETED|Overall Study||1
2331946|NCT01788631|5723228|P1|NOT COMPLETED|Overall Study||3
2331947|NCT01788631|5723227|P2|COMPLETED|Overall Study||43
2331948|NCT01788631|5723228|P1|COMPLETED|Overall Study||49
2331949|NCT01788631|5723227|P2|Randomized|Overall Study||47
2331950|NCT01788631|5723228|P1|Randomized|Overall Study||53
2331951|NCT01788631|5723227|P2|STARTED|Overall Study||44
2331952|NCT01788631|5723228|P1|STARTED|Overall Study||52
2331953|NCT01788566|5723246|P1|NOT COMPLETED|Overall Study||8
2331954|NCT01788566|5723246|P1|COMPLETED|Overall Study||53
2331955|NCT01788566|5723246|P1|STARTED|Overall Study||61
2331956|NCT01788475|5723259|P3|NOT COMPLETED|Overall Study||0
2331957|NCT01788475|5723260|P2|NOT COMPLETED|Overall Study||0
2331958|NCT01788475|5723261|P1|NOT COMPLETED|Overall Study||3
2331959|NCT01788475|5723259|P3|COMPLETED|Overall Study||0
2331960|NCT01788475|5723260|P2|COMPLETED|Overall Study||0
2331961|NCT01788475|5723261|P1|COMPLETED|Overall Study||0
2331962|NCT01788475|5723259|P3|STARTED|Overall Study||0
2331963|NCT01788475|5723260|P2|STARTED|Overall Study||0
2331964|NCT01788475|5723261|P1|STARTED|Overall Study||3
2331965|NCT01788423|5723284|P3|NOT COMPLETED|Overall Study||5
2331966|NCT01788423|5723285|P2|NOT COMPLETED|Overall Study||4
2331967|NCT01788423|5723286|P1|NOT COMPLETED|Overall Study||0
2331968|NCT01788423|5723284|P3|COMPLETED|Overall Study|Three people developed unrelated health problems and two were unable to fit/use hearing aids.|50
2331969|NCT01788423|5723285|P2|COMPLETED|Overall Study|Four participants were unable to self-select hearing aids.|51
2331970|NCT01788423|5723286|P1|COMPLETED|Overall Study||53
2331971|NCT01788423|5723284|P3|STARTED|Overall Study||55
2331972|NCT01788423|5723285|P2|STARTED|Overall Study||55
2331973|NCT01788423|5723286|P1|STARTED|Overall Study||53
2331974|NCT01788358|5723297|P1|NOT COMPLETED|Overall Study||98
2331975|NCT01788358|5723297|P1|COMPLETED|Overall Study|217 subjects completed the study at Week 28 while the remaining 193 subjects completed at Week 52|410
2331976|NCT01788358|5723297|P1|Completed Week 52|Overall Study||193
2331977|NCT01788358|5723297|P1|Entered Extension to Week 52|Overall Study|Only the first 200 subjects who completed Week 28 visit, continued treatment up to 52 weeks.|200
2331978|NCT01788358|5723297|P1|Completed Week 28|Overall Study||417
2331979|NCT01788358|5723297|P1|Treated|Overall Study||508
2331980|NCT01788358|5723297|P1|STARTED|Overall Study||508
2331981|NCT01788228|5723311|P2|NOT COMPLETED|Overall Study||0
2331982|NCT01788228|5723312|P1|NOT COMPLETED|Overall Study||1
2331983|NCT01788228|5723311|P2|COMPLETED|Overall Study||1
2331984|NCT01788228|5723312|P1|COMPLETED|Overall Study||48
2331985|NCT01788228|5723311|P2|STARTED|Overall Study||1
2331986|NCT01788228|5723312|P1|STARTED|Overall Study||49
2331987|NCT01788215|5723331|P2|NOT COMPLETED|Overall Study||1
2331988|NCT01788215|5723332|P1|NOT COMPLETED|Overall Study||2
2331989|NCT01788215|5723331|P2|COMPLETED|Overall Study||4
2331990|NCT01788215|5723332|P1|COMPLETED|Overall Study||3
2331991|NCT01788215|5723331|P2|12 Weeks of Doxycycline or Placebo|Overall Study||5
2331992|NCT01788215|5723332|P1|12 Weeks of Doxycycline or Placebo|Overall Study||5
2331993|NCT01788215|5723331|P2|STARTED|Overall Study||5
2331994|NCT01788215|5723332|P1|STARTED|Overall Study||5
2331995|NCT01788163|5723361|P9|NOT COMPLETED|Overall Study||16
2331996|NCT01788163|5723362|P8|NOT COMPLETED|Overall Study||48
2331997|NCT01788163|5723363|P7|NOT COMPLETED|Overall Study||1
2331998|NCT01788163|5723364|P6|NOT COMPLETED|Overall Study||7
2331999|NCT01788163|5723365|P5|NOT COMPLETED|Overall Study||0
2332000|NCT01788163|5723366|P4|NOT COMPLETED|Overall Study||0
2332001|NCT01788163|5723367|P3|NOT COMPLETED|Overall Study||0
2332002|NCT01788163|5723368|P2|NOT COMPLETED|Overall Study||0
2332003|NCT01788163|5723369|P1|NOT COMPLETED|Overall Study||55
2332004|NCT01788163|5723361|P9|COMPLETED|Overall Study||956
2332005|NCT01788163|5723362|P8|COMPLETED|Overall Study||254
2332006|NCT01788163|5723363|P7|COMPLETED|Overall Study||49
2332007|NCT01788163|5723364|P6|COMPLETED|Overall Study||95
2332008|NCT01788163|5723365|P5|COMPLETED|Overall Study||94
2332009|NCT01788163|5723366|P4|COMPLETED|Overall Study||71
2332010|NCT01788163|5723367|P3|COMPLETED|Overall Study||62
2332011|NCT01788163|5723368|P2|COMPLETED|Overall Study||271
2332012|NCT01788163|5723369|P1|COMPLETED|Overall Study||1403
2332013|NCT01788163|5723361|P9|STARTED|Overall Study||972
2332014|NCT01788163|5723362|P8|STARTED|Overall Study||302
2332015|NCT01788163|5723363|P7|STARTED|Overall Study||50
2332016|NCT01788163|5723364|P6|STARTED|Overall Study||102
2332017|NCT01788163|5723365|P5|STARTED|Overall Study||94
2332018|NCT01788163|5723366|P4|STARTED|Overall Study||71
2332019|NCT01788163|5723367|P3|STARTED|Overall Study||62
2332020|NCT01788163|5723368|P2|STARTED|Overall Study||271
2332021|NCT01788163|5723369|P1|STARTED|Overall Study||1458
2332022|NCT01788046|5723532|P2|NOT COMPLETED|Overall Study||37
2332023|NCT01788046|5723533|P1|NOT COMPLETED|Overall Study||56
2332024|NCT01788046|5723532|P2|COMPLETED|Overall Study||218
2332025|NCT01788046|5723533|P1|COMPLETED|Overall Study||204
2332026|NCT01788046|5723532|P2|Received Treatment|Overall Study||252
2332027|NCT01788046|5723533|P1|Received Treatment|Overall Study||259
2332028|NCT01788046|5723532|P2|STARTED|Overall Study||255
2332029|NCT01788046|5723533|P1|STARTED|Overall Study||260
2332030|NCT01787916|5723549|P2|NOT COMPLETED|Second Intervention (24 Weeks)||0
2332031|NCT01787916|5723550|P1|NOT COMPLETED|Second Intervention (24 Weeks)||0
2332032|NCT01787916|5723549|P2|COMPLETED|Second Intervention (24 Weeks)||7
2332033|NCT01787916|5723550|P1|COMPLETED|Second Intervention (24 Weeks)||8
2332034|NCT01787916|5723549|P2|STARTED|Second Intervention (24 Weeks)||7
2332035|NCT01787916|5723550|P1|STARTED|Second Intervention (24 Weeks)||8
2332036|NCT01787916|5723549|P2|NOT COMPLETED|Washout (4 Weeks)||0
2332037|NCT01787916|5723550|P1|NOT COMPLETED|Washout (4 Weeks)||0
2332038|NCT01787916|5723549|P2|COMPLETED|Washout (4 Weeks)||7
2332039|NCT01787916|5723550|P1|COMPLETED|Washout (4 Weeks)||8
2332040|NCT01787916|5723549|P2|STARTED|Washout (4 Weeks)||7
2332041|NCT01787916|5723550|P1|STARTED|Washout (4 Weeks)||8
2332042|NCT01787916|5723549|P2|NOT COMPLETED|First Intervention (24 Weeks)||0
2332043|NCT01787916|5723550|P1|NOT COMPLETED|First Intervention (24 Weeks)||0
2332044|NCT01787916|5723549|P2|COMPLETED|First Intervention (24 Weeks)||7
2332045|NCT01787916|5723550|P1|COMPLETED|First Intervention (24 Weeks)||8
2332046|NCT01787916|5723549|P2|STARTED|First Intervention (24 Weeks)||7
2332047|NCT01787916|5723550|P1|STARTED|First Intervention (24 Weeks)||8
2332048|NCT01787838|5723556|P1|NOT COMPLETED|Overall Study||1413
2332049|NCT01787838|5723556|P1|COMPLETED|Overall Study|This is the number of patients successfully immunized in a one year period.|1096
2332050|NCT01787838|5723556|P1|STARTED|Overall Study|This is the number who met Centers for Disease Control and Prevention guidelines for vaccine.|2509
2332051|NCT01787825|5723560|P2|NOT COMPLETED|Overall Study||1
2332052|NCT01787825|5723561|P1|NOT COMPLETED|Overall Study||6
2332053|NCT01787825|5723560|P2|COMPLETED|Overall Study||60
2332054|NCT01787825|5723561|P1|COMPLETED|Overall Study||54
2332055|NCT01787825|5723560|P2|STARTED|Overall Study||61
2332056|NCT01787825|5723561|P1|STARTED|Overall Study||60
2332057|NCT01787799|5723572|P1|NOT COMPLETED|Overall Study||0
2332058|NCT01787799|5723572|P1|COMPLETED|Overall Study||100
2332059|NCT01787799|5723572|P1|STARTED|Overall Study||100
2332060|NCT01787760|5723579|P3|NOT COMPLETED|Overall Study||5
2332061|NCT01787760|5723580|P2|NOT COMPLETED|Overall Study||16
2332062|NCT01787760|5723581|P1|NOT COMPLETED|Overall Study||26
2332063|NCT01787760|5723579|P3|COMPLETED|Overall Study||46
2332064|NCT01787760|5723580|P2|COMPLETED|Overall Study||34
2332065|NCT01787760|5723581|P1|COMPLETED|Overall Study||25
2332066|NCT01787760|5723579|P3|STARTED|Overall Study||51
2332067|NCT01787760|5723580|P2|STARTED|Overall Study||50
2332068|NCT01787760|5723581|P1|STARTED|Overall Study||51
2332069|NCT01787604|5723595|P2|NOT COMPLETED|Overall Study||4
2332070|NCT01787604|5723596|P1|NOT COMPLETED|Overall Study||4
2332071|NCT01787604|5723595|P2|COMPLETED|Overall Study||28
2332072|NCT01787604|5723596|P1|COMPLETED|Overall Study||28
2332073|NCT01787604|5723595|P2|STARTED|Overall Study||32
2332074|NCT01787604|5723596|P1|STARTED|Overall Study||32
2332075|NCT01787591|5723606|P4|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
2332076|NCT01787591|5723607|P3|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
2332077|NCT01787591|5723608|P2|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
2332078|NCT01787591|5723609|P1|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
2332079|NCT01787591|5723606|P4|COMPLETED|Period 4 (Cross-over Arm 4)||5
2332080|NCT01787591|5723607|P3|COMPLETED|Period 4 (Cross-over Arm 4)||5
2332081|NCT01787591|5723608|P2|COMPLETED|Period 4 (Cross-over Arm 4)||5
2332082|NCT01787591|5723609|P1|COMPLETED|Period 4 (Cross-over Arm 4)||5
2332083|NCT01787591|5723606|P4|STARTED|Period 4 (Cross-over Arm 4)||5
2332084|NCT01787591|5723607|P3|STARTED|Period 4 (Cross-over Arm 4)||5
2332085|NCT01787591|5723608|P2|STARTED|Period 4 (Cross-over Arm 4)||5
2332086|NCT01787591|5723609|P1|STARTED|Period 4 (Cross-over Arm 4)||5
2332087|NCT01787591|5723606|P4|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
2332088|NCT01787591|5723607|P3|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
2332089|NCT01787591|5723608|P2|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
2332090|NCT01787591|5723609|P1|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
2332091|NCT01787591|5723606|P4|COMPLETED|Period 3 (Cross-over Arm 3)||5
2332092|NCT01787591|5723607|P3|COMPLETED|Period 3 (Cross-over Arm 3)||5
2332093|NCT01787591|5723608|P2|COMPLETED|Period 3 (Cross-over Arm 3)||5
2332094|NCT01787591|5723609|P1|COMPLETED|Period 3 (Cross-over Arm 3)||5
2332095|NCT01787591|5723606|P4|STARTED|Period 3 (Cross-over Arm 3)||5
2332096|NCT01787591|5723607|P3|STARTED|Period 3 (Cross-over Arm 3)||5
2332097|NCT01787591|5723608|P2|STARTED|Period 3 (Cross-over Arm 3)||5
2332098|NCT01787591|5723609|P1|STARTED|Period 3 (Cross-over Arm 3)||5
2332099|NCT01787591|5723606|P4|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
2332100|NCT01787591|5723607|P3|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
2332101|NCT01787591|5723608|P2|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
2332102|NCT01787591|5723609|P1|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
2332103|NCT01787591|5723606|P4|COMPLETED|Period 2 (Cross-over Arm 2)||5
2332104|NCT01787591|5723607|P3|COMPLETED|Period 2 (Cross-over Arm 2)||5
2332105|NCT01787591|5723608|P2|COMPLETED|Period 2 (Cross-over Arm 2)||5
2332106|NCT01787591|5723609|P1|COMPLETED|Period 2 (Cross-over Arm 2)||5
2332107|NCT01787591|5723606|P4|STARTED|Period 2 (Cross-over Arm 2)||5
2332108|NCT01787591|5723607|P3|STARTED|Period 2 (Cross-over Arm 2)||5
2332109|NCT01787591|5723608|P2|STARTED|Period 2 (Cross-over Arm 2)||5
2332110|NCT01787591|5723609|P1|STARTED|Period 2 (Cross-over Arm 2)||5
2332111|NCT01787591|5723606|P4|NOT COMPLETED|Period 1 (Cross-over Arm 1)||1
2332112|NCT01787591|5723607|P3|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
2332113|NCT01787591|5723608|P2|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
2332114|NCT01787591|5723609|P1|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
2332115|NCT01787591|5723606|P4|COMPLETED|Period 1 (Cross-over Arm 1)||5
2332116|NCT01787591|5723607|P3|COMPLETED|Period 1 (Cross-over Arm 1)||5
2332117|NCT01787591|5723608|P2|COMPLETED|Period 1 (Cross-over Arm 1)||5
2332118|NCT01787591|5723609|P1|COMPLETED|Period 1 (Cross-over Arm 1)||5
2332119|NCT01787591|5723606|P4|STARTED|Period 1 (Cross-over Arm 1)||6
2332120|NCT01787591|5723607|P3|STARTED|Period 1 (Cross-over Arm 1)||5
2332121|NCT01787591|5723608|P2|STARTED|Period 1 (Cross-over Arm 1)||5
2332122|NCT01787591|5723609|P1|STARTED|Period 1 (Cross-over Arm 1)||5
2332123|NCT01787461|5723637|P2|NOT COMPLETED|Overall Study||9
2332124|NCT01787461|5723638|P1|NOT COMPLETED|Overall Study||14
2332125|NCT01787461|5723637|P2|COMPLETED|Overall Study||89
2332126|NCT01787461|5723638|P1|COMPLETED|Overall Study||82
2332127|NCT01787461|5723637|P2|STARTED|Overall Study||98
2332128|NCT01787461|5723638|P1|STARTED|Overall Study||96
2332129|NCT01787383|5723666|P2|NOT COMPLETED|Overall Study||22
2332130|NCT01787383|5723667|P1|NOT COMPLETED|Overall Study||9
2332131|NCT01787383|5723666|P2|COMPLETED|Overall Study||76
2332132|NCT01787383|5723667|P1|COMPLETED|Overall Study||92
2332133|NCT01787383|5723666|P2|STARTED|Overall Study||98
2332134|NCT01787383|5723667|P1|STARTED|Overall Study||101
2332135|NCT01787331|5723687|P1|NOT COMPLETED|Overall Study||2
2332136|NCT01787331|5723687|P1|COMPLETED|Overall Study||19
2332137|NCT01787331|5723687|P1|STARTED|Overall Study||21
2332150|NCT01787279|5723717|P1|NOT COMPLETED|Overall Study||3
2332151|NCT01787279|5723717|P1|COMPLETED|Overall Study||56
2332152|NCT01787279|5723717|P1|STARTED|Overall Study||59
2332153|NCT01787240|5723728|P2|NOT COMPLETED|Overall Study||1
2332154|NCT01787240|5723729|P1|NOT COMPLETED|Overall Study||5
2332155|NCT01787240|5723728|P2|COMPLETED|Overall Study||4
2332156|NCT01787240|5723729|P1|COMPLETED|Overall Study||10
2332157|NCT01787240|5723728|P2|STARTED|Overall Study||5
2332158|NCT01787240|5723729|P1|STARTED|Overall Study||15
2332159|NCT01787188|5723743|P3|NOT COMPLETED|Overall Study||18
2332160|NCT01787188|5723744|P2|NOT COMPLETED|Overall Study||18
2332161|NCT01787188|5723745|P1|NOT COMPLETED|Overall Study||17
2332162|NCT01787188|5723743|P3|COMPLETED|Overall Study||116
2332163|NCT01787188|5723744|P2|COMPLETED|Overall Study||112
2332164|NCT01787188|5723745|P1|COMPLETED|Overall Study||122
2332165|NCT01787188|5723743|P3|STARTED|Overall Study||134
2332166|NCT01787188|5723744|P2|STARTED|Overall Study||130
2332167|NCT01787188|5723745|P1|STARTED|Overall Study||139
2332168|NCT01787175|5723800|P2|NOT COMPLETED|Overall Study||0
2332169|NCT01787175|5723801|P1|NOT COMPLETED|Overall Study||0
2332170|NCT01787175|5723800|P2|COMPLETED|Overall Study||28
2332171|NCT01787175|5723801|P1|COMPLETED|Overall Study||30
2332172|NCT01787175|5723800|P2|STARTED|Overall Study||28
2332173|NCT01787175|5723801|P1|STARTED|Overall Study||30
2332174|NCT01787032|5723817|P6|NOT COMPLETED|Overall Study||1
2332175|NCT01787032|5723818|P5|NOT COMPLETED|Overall Study||1
2332176|NCT01787032|5723819|P4|NOT COMPLETED|Overall Study||0
2332177|NCT01787032|5723820|P3|NOT COMPLETED|Overall Study||0
2332178|NCT01787032|5723821|P2|NOT COMPLETED|Overall Study||0
2332179|NCT01787032|5723822|P1|NOT COMPLETED|Overall Study||0
2332180|NCT01787032|5723817|P6|COMPLETED|Overall Study||3
2332181|NCT01787032|5723818|P5|COMPLETED|Overall Study||3
2332182|NCT01787032|5723819|P4|COMPLETED|Overall Study||3
2332183|NCT01787032|5723820|P3|COMPLETED|Overall Study||3
2332184|NCT01787032|5723821|P2|COMPLETED|Overall Study||3
2332185|NCT01787032|5723822|P1|COMPLETED|Overall Study||3
2332186|NCT01787032|5723817|P6|Received T2|Overall Study||4
2332187|NCT01787032|5723818|P5|Received T2|Overall Study||4
2332188|NCT01787032|5723819|P4|Received T2|Overall Study||3
2332189|NCT01787032|5723820|P3|Received T2|Overall Study||3
2332190|NCT01787032|5723821|P2|Received T2|Overall Study||3
2332191|NCT01787032|5723822|P1|Received T2|Overall Study||3
2332192|NCT01787032|5723817|P6|Received T1|Overall Study||4
2332193|NCT01787032|5723818|P5|Received T1|Overall Study||3
2332194|NCT01787032|5723819|P4|Received T1|Overall Study||3
2332195|NCT01787032|5723820|P3|Received T1|Overall Study||3
2332196|NCT01787032|5723821|P2|Received T1|Overall Study||3
2332197|NCT01787032|5723822|P1|Received T1|Overall Study||3
2332198|NCT01787032|5723817|P6|Received R|Overall Study||3
2332199|NCT01787032|5723818|P5|Received R|Overall Study||4
2332200|NCT01787032|5723819|P4|Received R|Overall Study||3
2332201|NCT01787032|5723820|P3|Received R|Overall Study||3
2332202|NCT01787032|5723821|P2|Received R|Overall Study||3
2332203|NCT01787032|5723822|P1|Received R|Overall Study||3
2332204|NCT01787032|5723817|P6|STARTED|Overall Study||4
2332205|NCT01787032|5723818|P5|STARTED|Overall Study||4
2332206|NCT01787032|5723819|P4|STARTED|Overall Study||3
2332207|NCT01787032|5723820|P3|STARTED|Overall Study||3
2332208|NCT01787032|5723821|P2|STARTED|Overall Study||3
2332209|NCT01787032|5723822|P1|STARTED|Overall Study||3
2332210|NCT01786993|5723846|P2|NOT COMPLETED|Overall Study||10
2332211|NCT01786993|5723847|P1|NOT COMPLETED|Overall Study||12
2332212|NCT01786993|5723846|P2|COMPLETED|Overall Study||170
2332213|NCT01786993|5723847|P1|COMPLETED|Overall Study||189
2332214|NCT01786993|5723846|P2|Per Protocol Population at 9 Months|Overall Study||170
2332215|NCT01786993|5723847|P1|Per Protocol Population at 9 Months|Overall Study||189
2332216|NCT01786993|5723846|P2|STARTED|Overall Study||180
2332217|NCT01786993|5723847|P1|STARTED|Overall Study||201
2332218|NCT01786967|5723854|P1|NOT COMPLETED|Overall Study||0
2332219|NCT01786967|5723854|P1|COMPLETED|Overall Study||61
2332220|NCT01786967|5723854|P1|Metabolizer Status Undetermined|Overall Study||3
2332221|NCT01786967|5723854|P1|Poor Metabolizers|Overall Study||4
2332222|NCT01786967|5723854|P1|Extensive Metabolizers|Overall Study||54
2332223|NCT01786967|5723854|P1|STARTED|Overall Study||61
2332224|NCT01786954|5723863|P2|NOT COMPLETED|Overall Study||0
2332225|NCT01786954|5723864|P1|NOT COMPLETED|Overall Study||0
2332226|NCT01786954|5723863|P2|COMPLETED|Overall Study||34
2332227|NCT01786954|5723864|P1|COMPLETED|Overall Study||34
2332228|NCT01786954|5723863|P2|STARTED|Overall Study||34
2332229|NCT01786954|5723864|P1|STARTED|Overall Study||34
2332230|NCT01786902|5723876|P2|NOT COMPLETED|Overall Study||3
2332231|NCT01786902|5723877|P1|NOT COMPLETED|Overall Study||4
2332232|NCT01786902|5723876|P2|COMPLETED|Overall Study||31
2332233|NCT01786902|5723877|P1|COMPLETED|Overall Study||32
2332234|NCT01786902|5723876|P2|STARTED|Overall Study||34
2332235|NCT01786902|5723877|P1|STARTED|Overall Study||36
2332236|NCT01786876|5723887|P1|NOT COMPLETED|Overall Study||0
2332237|NCT01786876|5723887|P1|COMPLETED|Overall Study||6
2332238|NCT01786876|5723887|P1|STARTED|Overall Study||6
2332239|NCT01786707|5723906|P2|NOT COMPLETED|Overall Study||1
2332240|NCT01786707|5723907|P1|NOT COMPLETED|Overall Study||1
2332241|NCT01786707|5723906|P2|COMPLETED|Overall Study||0
2332242|NCT01786707|5723907|P1|COMPLETED|Overall Study||0
2332243|NCT01786707|5723906|P2|STARTED|Overall Study||1
2332244|NCT01786707|5723907|P1|STARTED|Overall Study||1
2332245|NCT01786668|5723919|P4|NOT COMPLETED|Overall Study||4
2332246|NCT01786668|5723920|P3|NOT COMPLETED|Overall Study||5
2332247|NCT01786668|5723921|P2|NOT COMPLETED|Overall Study||1
2332248|NCT01786668|5723922|P1|NOT COMPLETED|Overall Study||1
2332249|NCT01786668|5723919|P4|COMPLETED|Overall Study||47
2332250|NCT01786668|5723920|P3|COMPLETED|Overall Study||47
2332251|NCT01786668|5723921|P2|COMPLETED|Overall Study||51
2332252|NCT01786668|5723922|P1|COMPLETED|Overall Study||51
2332253|NCT01786668|5723919|P4|STARTED|Overall Study||51
2332254|NCT01786668|5723920|P3|STARTED|Overall Study||52
2332255|NCT01786668|5723921|P2|STARTED|Overall Study||52
2332256|NCT01786668|5723922|P1|STARTED|Overall Study||52
2332257|NCT01786629|5724022|P2|NOT COMPLETED|Overall Study||5
2332258|NCT01786629|5724023|P1|NOT COMPLETED|Overall Study||0
2332259|NCT01786629|5724022|P2|COMPLETED|Overall Study||164
2332260|NCT01786629|5724023|P1|COMPLETED|Overall Study||169
2332261|NCT01786629|5724022|P2|STARTED|Overall Study||169
2332262|NCT01786629|5724023|P1|STARTED|Overall Study||169
2332263|NCT01786603|5724031|P2|NOT COMPLETED|Overall Study||12
2332264|NCT01786603|5724032|P1|NOT COMPLETED|Overall Study||18
2332265|NCT01786603|5724031|P2|COMPLETED|Overall Study||8
2332266|NCT01786603|5724032|P1|COMPLETED|Overall Study||42
2332267|NCT01786603|5724031|P2|STARTED|Overall Study||20
2332268|NCT01786603|5724032|P1|STARTED|Overall Study||60
2332269|NCT01786551|5724050|P1|NOT COMPLETED|Overall Study||2
2332270|NCT01786551|5724050|P1|COMPLETED|Overall Study||14
2332271|NCT01786551|5724050|P1|STARTED|Overall Study||16
2332272|NCT01786330|5724058|P2|NOT COMPLETED|Overall Study||3
2332273|NCT01786330|5724059|P1|NOT COMPLETED|Overall Study||1
2332274|NCT01786330|5724058|P2|COMPLETED|Overall Study||27
2332275|NCT01786330|5724059|P1|COMPLETED|Overall Study||29
2332276|NCT01786330|5724058|P2|STARTED|Overall Study||30
2332277|NCT01786330|5724059|P1|STARTED|Overall Study||30
2332278|NCT01786252|5724073|P2|NOT COMPLETED|Overall Study||0
2332279|NCT01786252|5724074|P1|NOT COMPLETED|Overall Study||0
2332280|NCT01786252|5724073|P2|COMPLETED|Overall Study||8
2332281|NCT01786252|5724074|P1|COMPLETED|Overall Study||7
2332282|NCT01786252|5724073|P2|STARTED|Overall Study||8
2332283|NCT01786252|5724074|P1|STARTED|Overall Study||7
2332284|NCT01786239|5724088|P2|NOT COMPLETED|Overall Study||11
2332285|NCT01786239|5724089|P1|NOT COMPLETED|Overall Study||11
2332286|NCT01786239|5724088|P2|COMPLETED|Overall Study||14
2332287|NCT01786239|5724089|P1|COMPLETED|Overall Study||14
2332288|NCT01786239|5724088|P2|STARTED|Overall Study||25
2332289|NCT01786239|5724089|P1|STARTED|Overall Study||25
2332290|NCT01786187|5724097|P2|NOT COMPLETED|Overall Study||10
2332291|NCT01786187|5724098|P1|NOT COMPLETED|Overall Study||5
2332292|NCT01786187|5724097|P2|COMPLETED|Overall Study||37
2332293|NCT01786187|5724098|P1|COMPLETED|Overall Study||35
2332294|NCT01786187|5724097|P2|STARTED|Overall Study||47
2332295|NCT01786187|5724098|P1|STARTED|Overall Study||40
2332296|NCT01786174|5724111|P2|NOT COMPLETED|Overall Study||0
2332297|NCT01786174|5724112|P1|NOT COMPLETED|Overall Study||2
2332298|NCT01786174|5724111|P2|COMPLETED|Overall Study||10
2332299|NCT01786174|5724112|P1|COMPLETED|Overall Study||16
2332300|NCT01786174|5724111|P2|Randomized|Overall Study||11
2332301|NCT01786174|5724112|P1|Randomized|Overall Study||19
2332302|NCT01786174|5724111|P2|STARTED|Overall Study||10
2332303|NCT01786174|5724112|P1|STARTED|Overall Study||18
2332304|NCT01786161|5724128|P2|NOT COMPLETED|Overall Study||0
2332305|NCT01786161|5724129|P1|NOT COMPLETED|Overall Study||0
2332306|NCT01786161|5724128|P2|COMPLETED|Overall Study||22
2332307|NCT01786161|5724129|P1|COMPLETED|Overall Study||22
2332308|NCT01786161|5724128|P2|STARTED|Overall Study||22
2332309|NCT01786161|5724129|P1|STARTED|Overall Study||22
2332310|NCT01786148|5724141|P2|NOT COMPLETED|Overall Study||22
2332311|NCT01786148|5724142|P1|NOT COMPLETED|Overall Study||22
2332312|NCT01786148|5724141|P2|COMPLETED|Overall Study||50
2332313|NCT01786148|5724142|P1|COMPLETED|Overall Study||55
2332314|NCT01786148|5724141|P2|STARTED|Overall Study||72
2332315|NCT01786148|5724142|P1|STARTED|Overall Study||77
2332316|NCT01786109|5724157|P3|NOT COMPLETED|Overall Study||2
2332317|NCT01786109|5724158|P2|NOT COMPLETED|Overall Study||0
2332318|NCT01786109|5724159|P1|NOT COMPLETED|Overall Study||1
2332319|NCT01786109|5724157|P3|COMPLETED|Overall Study||25
2332320|NCT01786109|5724158|P2|COMPLETED|Overall Study||24
2332321|NCT01786109|5724159|P1|COMPLETED|Overall Study||23
2332322|NCT01786109|5724157|P3|STARTED|Overall Study||27
2332323|NCT01786109|5724158|P2|STARTED|Overall Study||24
2332324|NCT01786109|5724159|P1|STARTED|Overall Study||24
2332325|NCT01785875|5724188|P3|NOT COMPLETED|Overall Study||107
2332326|NCT01785875|5724189|P2|NOT COMPLETED|Overall Study||289
2332327|NCT01785875|5724190|P1|NOT COMPLETED|Overall Study||294
2332328|NCT01785875|5724188|P3|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|16
2332329|NCT01785875|5724189|P2|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|95
2332330|NCT01785875|5724190|P1|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|90
2332331|NCT01785875|5724188|P3|Received Etelcalcetide|Overall Study||123
2332332|NCT01785875|5724189|P2|Received Etelcalcetide|Overall Study||384
2332333|NCT01785875|5724190|P1|Received Etelcalcetide|Overall Study||383
2332334|NCT01785875|5724188|P3|STARTED|Overall Study||123
2332335|NCT01785875|5724189|P2|STARTED|Overall Study||384
2332336|NCT01785875|5724190|P1|STARTED|Overall Study||384
2332337|NCT01785849|5724259|P2|NOT COMPLETED|Overall Study||34
2332338|NCT01785849|5724260|P1|NOT COMPLETED|Overall Study||61
2332339|NCT01785849|5724259|P2|COMPLETED|Overall Study||220
2332340|NCT01785849|5724260|P1|COMPLETED|Overall Study||193
2332341|NCT01785849|5724259|P2|Received Treatment|Overall Study||251
2332342|NCT01785849|5724260|P1|Received Treatment|Overall Study||254
2332343|NCT01785849|5724259|P2|STARTED|Overall Study||254
2332344|NCT01785849|5724260|P1|STARTED|Overall Study||254
2332345|NCT01785628|5724278|P2|NOT COMPLETED|Overall Study||3
2332346|NCT01785628|5724279|P1|NOT COMPLETED|Overall Study||2
2332347|NCT01785628|5724278|P2|COMPLETED|Overall Study||12
2332348|NCT01785628|5724279|P1|COMPLETED|Overall Study||13
2332349|NCT01785628|5724278|P2|STARTED|Overall Study||15
2332350|NCT01785628|5724279|P1|STARTED|Overall Study||15
2332351|NCT01785615|5724302|P4|NOT COMPLETED|Atorvastatin Phase||0
2332352|NCT01785615|5724303|P3|NOT COMPLETED|Atorvastatin Phase||0
2332353|NCT01785615|5724304|P2|NOT COMPLETED|Atorvastatin Phase||0
2332354|NCT01785615|5724305|P1|NOT COMPLETED|Atorvastatin Phase||0
2332355|NCT01785615|5724302|P4|COMPLETED|Atorvastatin Phase||0
2332356|NCT01785615|5724303|P3|COMPLETED|Atorvastatin Phase||0
2332357|NCT01785615|5724304|P2|COMPLETED|Atorvastatin Phase||44
2332358|NCT01785615|5724305|P1|COMPLETED|Atorvastatin Phase||44
2332359|NCT01785615|5724302|P4|STARTED|Atorvastatin Phase||0
2332360|NCT01785615|5724303|P3|STARTED|Atorvastatin Phase||0
2332361|NCT01785615|5724304|P2|STARTED|Atorvastatin Phase||44
2332362|NCT01785615|5724305|P1|STARTED|Atorvastatin Phase||44
2332363|NCT01785615|5724302|P4|NOT COMPLETED|Dietary Phase||24
2332364|NCT01785615|5724303|P3|NOT COMPLETED|Dietary Phase||0
2332365|NCT01785615|5724304|P2|NOT COMPLETED|Dietary Phase||0
2332366|NCT01785615|5724305|P1|NOT COMPLETED|Dietary Phase||0
2332367|NCT01785615|5724302|P4|COMPLETED|Dietary Phase||116
2332368|NCT01785615|5724303|P3|COMPLETED|Dietary Phase||35
2332369|NCT01785615|5724304|P2|COMPLETED|Dietary Phase||0
2332370|NCT01785615|5724305|P1|COMPLETED|Dietary Phase||0
2332371|NCT01785615|5724302|P4|STARTED|Dietary Phase||140
2332372|NCT01785615|5724303|P3|STARTED|Dietary Phase||35
2332373|NCT01785615|5724304|P2|STARTED|Dietary Phase||0
2332374|NCT01785615|5724305|P1|STARTED|Dietary Phase||0
2332375|NCT01785602|5724377|P2|NOT COMPLETED|Overall Study||9
2332376|NCT01785602|5724378|P1|NOT COMPLETED|Overall Study||13
2332377|NCT01785602|5724377|P2|COMPLETED|Overall Study||18
2332378|NCT01785602|5724378|P1|COMPLETED|Overall Study||63
2332379|NCT01785602|5724377|P2|STARTED|Overall Study||27
2332380|NCT01785602|5724378|P1|STARTED|Overall Study||76
2332381|NCT01785524|5724388|P2|NOT COMPLETED|Overall Study||2
2332382|NCT01785524|5724389|P1|NOT COMPLETED|Overall Study||2
2332383|NCT01785524|5724388|P2|COMPLETED|Overall Study||2
2332384|NCT01785524|5724389|P1|COMPLETED|Overall Study||5
2332385|NCT01785524|5724388|P2|STARTED|Overall Study||4
2332386|NCT01785524|5724389|P1|STARTED|Overall Study||7
2332387|NCT01785472|5724408|P3|NOT COMPLETED|Overall Study||22
2332388|NCT01785472|5724409|P2|NOT COMPLETED|Overall Study||19
2332389|NCT01785472|5724410|P1|NOT COMPLETED|Overall Study||24
2332390|NCT01785472|5724408|P3|COMPLETED|Overall Study||464
2332391|NCT01785472|5724409|P2|COMPLETED|Overall Study||454
2332392|NCT01785472|5724410|P1|COMPLETED|Overall Study||455
2332393|NCT01785472|5724408|P3|Safety Set (SAF)|Overall Study||484
2332394|NCT01785472|5724409|P2|Safety Set (SAF)|Overall Study||472
2332395|NCT01785472|5724410|P1|Safety Set (SAF)|Overall Study||478
2332396|NCT01785472|5724408|P3|Full Analysis Set (FAS)|Overall Study||484
2332397|NCT01785472|5724409|P2|Full Analysis Set (FAS)|Overall Study||472
2332398|NCT01785472|5724410|P1|Full Analysis Set (FAS)|Overall Study||479
2332399|NCT01785472|5724408|P3|STARTED|Overall Study||486
2332400|NCT01785472|5724409|P2|STARTED|Overall Study||473
2332401|NCT01785472|5724410|P1|STARTED|Overall Study||479
2332402|NCT01785459|5724454|P2|NOT COMPLETED|Overall Study||0
2332403|NCT01785459|5724455|P1|NOT COMPLETED|Overall Study||0
2332404|NCT01785459|5724454|P2|COMPLETED|Overall Study||12
2332405|NCT01785459|5724455|P1|COMPLETED|Overall Study||11
2332406|NCT01785459|5724454|P2|STARTED|Overall Study||12
2332407|NCT01785459|5724455|P1|STARTED|Overall Study||11
2332408|NCT01785186|5724470|P5|NOT COMPLETED|Overall Study||6
2332409|NCT01785186|5724471|P4|NOT COMPLETED|Overall Study||5
2332410|NCT01785186|5724472|P3|NOT COMPLETED|Overall Study||5
2332411|NCT01785186|5724473|P2|NOT COMPLETED|Overall Study||6
2332412|NCT01785186|5724474|P1|NOT COMPLETED|Overall Study||6
2332413|NCT01785186|5724470|P5|COMPLETED|Overall Study||117
2332414|NCT01785186|5724471|P4|COMPLETED|Overall Study||58
2332415|NCT01785186|5724472|P3|COMPLETED|Overall Study||52
2332416|NCT01785186|5724473|P2|COMPLETED|Overall Study||57
2332417|NCT01785186|5724474|P1|COMPLETED|Overall Study||53
2332418|NCT01785186|5724470|P5|STARTED|Overall Study||123
2332419|NCT01785186|5724471|P4|STARTED|Overall Study||63
2332420|NCT01785186|5724472|P3|STARTED|Overall Study||57
2332421|NCT01785186|5724473|P2|STARTED|Overall Study||63
2332422|NCT01785186|5724474|P1|STARTED|Overall Study||59
2332423|NCT01785160|5724496|P1|NOT COMPLETED|Treatment Period 2: Raltegravir + Faldap||0
2332424|NCT01785160|5724496|P1|COMPLETED|Treatment Period 2: Raltegravir + Faldap||23
2332425|NCT01785160|5724496|P1|STARTED|Treatment Period 2: Raltegravir + Faldap||23
2332426|NCT01785160|5724496|P1|NOT COMPLETED|Washout Period of at Least 7 Days||1
2332427|NCT01785160|5724496|P1|COMPLETED|Washout Period of at Least 7 Days||23
2332428|NCT01785160|5724496|P1|STARTED|Washout Period of at Least 7 Days||24
2332429|NCT01785160|5724496|P1|NOT COMPLETED|Treatment Period 1: Raltegravir||1
2332430|NCT01785160|5724496|P1|COMPLETED|Treatment Period 1: Raltegravir||24
2332431|NCT01785160|5724496|P1|STARTED|Treatment Period 1: Raltegravir||25
2332432|NCT01785134|5724506|P2|NOT COMPLETED|Overall Study||7
2332433|NCT01785134|5724507|P1|NOT COMPLETED|Overall Study||12
2332434|NCT01785134|5724506|P2|COMPLETED|Overall Study||33
2332435|NCT01785134|5724507|P1|COMPLETED|Overall Study||29
2332436|NCT01785134|5724506|P2|STARTED|Overall Study||40
2332437|NCT01785134|5724507|P1|STARTED|Overall Study||41
2332438|NCT01785095|5724521|P1|NOT COMPLETED|Overall Study||3
2332439|NCT01785095|5724521|P1|COMPLETED|Overall Study||24
2332440|NCT01785095|5724521|P1|STARTED|Overall Study||27
2332441|NCT01784965|5724531|P2|NOT COMPLETED|Overall Study||11
2332442|NCT01784965|5724532|P1|NOT COMPLETED|Overall Study||6
2332443|NCT01784965|5724531|P2|COMPLETED|Overall Study||24
2332444|NCT01784965|5724532|P1|COMPLETED|Overall Study||27
2332445|NCT01784965|5724531|P2|STARTED|Overall Study||35
2332446|NCT01784965|5724532|P1|STARTED|Overall Study||33
2332447|NCT01784926|5724544|P2|NOT COMPLETED|Overall Study||8
2332448|NCT01784926|5724545|P1|NOT COMPLETED|Overall Study||11
2332449|NCT01784926|5724544|P2|COMPLETED|Overall Study||42
2332450|NCT01784926|5724545|P1|COMPLETED|Overall Study||43
2332451|NCT01784926|5724544|P2|STARTED|Overall Study||50
2332452|NCT01784926|5724545|P1|STARTED|Overall Study||54
2332453|NCT01784848|5724563|P2|NOT COMPLETED|Overall Study||3
2332454|NCT01784848|5724564|P1|NOT COMPLETED|Overall Study||1
2332455|NCT01784848|5724563|P2|COMPLETED|Overall Study||47
2332456|NCT01784848|5724564|P1|COMPLETED|Overall Study||49
2332457|NCT01784848|5724563|P2|STARTED|Overall Study||50
2332458|NCT01784848|5724564|P1|STARTED|Overall Study||50
2332459|NCT01784796|5724572|P2|NOT COMPLETED|Overall Study||23
2332460|NCT01784796|5724573|P1|NOT COMPLETED|Overall Study||35
2332461|NCT01784796|5724572|P2|COMPLETED|Overall Study||35
2332462|NCT01784796|5724573|P1|COMPLETED|Overall Study||39
2332463|NCT01784796|5724572|P2|8 wk Data Collection|Overall Study||39
2332464|NCT01784796|5724573|P1|8 wk Data Collection|Overall Study||56
2332465|NCT01784796|5724572|P2|4 Week Data Collection|Overall Study||43
2332466|NCT01784796|5724573|P1|4 Week Data Collection|Overall Study||47
2332467|NCT01784796|5724572|P2|Baseline Data Collected|Overall Study||58
2332468|NCT01784796|5724573|P1|Baseline Data Collected|Overall Study||68
2332469|NCT01784796|5724572|P2|STARTED|Overall Study|These are participants who provided informed consent|58
2332470|NCT01784796|5724573|P1|STARTED|Overall Study|These are participants who provided informed consent|74
2332471|NCT01784770|5724585|P1|NOT COMPLETED|Overall Study||0
2332472|NCT01784770|5724585|P1|COMPLETED|Overall Study||21
2332473|NCT01784770|5724585|P1|STARTED|Overall Study||21
2332474|NCT01784666|5724593|P3|NOT COMPLETED|Overall Study||0
2332475|NCT01784666|5724594|P2|NOT COMPLETED|Overall Study||0
2332476|NCT01784666|5724595|P1|NOT COMPLETED|Overall Study||0
2332477|NCT01784666|5724593|P3|COMPLETED|Overall Study||1
2332478|NCT01784666|5724594|P2|COMPLETED|Overall Study||0
2332479|NCT01784666|5724595|P1|COMPLETED|Overall Study||1
2332480|NCT01784666|5724593|P3|STARTED|Overall Study||1
2332481|NCT01784666|5724594|P2|STARTED|Overall Study||0
2332482|NCT01784666|5724595|P1|STARTED|Overall Study||1
2332483|NCT01784614|5724603|P8|NOT COMPLETED|Period 4||0
2332484|NCT01784614|5724604|P7|NOT COMPLETED|Period 4||0
2332485|NCT01784614|5724605|P6|NOT COMPLETED|Period 4||0
2332486|NCT01784614|5724606|P5|NOT COMPLETED|Period 4||0
2332487|NCT01784614|5724607|P4|NOT COMPLETED|Period 4||0
2332488|NCT01784614|5724608|P3|NOT COMPLETED|Period 4||0
2332489|NCT01784614|5724609|P2|NOT COMPLETED|Period 4||0
2332490|NCT01784614|5724610|P1|NOT COMPLETED|Period 4||0
2332491|NCT01784614|5724603|P8|COMPLETED|Period 4||2
2332492|NCT01784614|5724604|P7|COMPLETED|Period 4||3
2332493|NCT01784614|5724605|P6|COMPLETED|Period 4||3
2332494|NCT01784614|5724606|P5|COMPLETED|Period 4||3
2332495|NCT01784614|5724607|P4|COMPLETED|Period 4||3
2332496|NCT01784614|5724608|P3|COMPLETED|Period 4||3
2332497|NCT01784614|5724609|P2|COMPLETED|Period 4||2
2332498|NCT01784614|5724610|P1|COMPLETED|Period 4||3
2332499|NCT01784614|5724603|P8|STARTED|Period 4||2
2332500|NCT01784614|5724604|P7|STARTED|Period 4||3
2332501|NCT01784614|5724605|P6|STARTED|Period 4||3
2332502|NCT01784614|5724606|P5|STARTED|Period 4||3
2332503|NCT01784614|5724607|P4|STARTED|Period 4||3
2332504|NCT01784614|5724608|P3|STARTED|Period 4||3
2332505|NCT01784614|5724609|P2|STARTED|Period 4||2
2332506|NCT01784614|5724610|P1|STARTED|Period 4||3
2332507|NCT01784614|5724603|P8|NOT COMPLETED|Period 3||0
2332508|NCT01784614|5724604|P7|NOT COMPLETED|Period 3||0
2332509|NCT01784614|5724605|P6|NOT COMPLETED|Period 3||0
2332510|NCT01784614|5724606|P5|NOT COMPLETED|Period 3||0
2332511|NCT01784614|5724607|P4|NOT COMPLETED|Period 3||0
2332512|NCT01784614|5724608|P3|NOT COMPLETED|Period 3||0
2332513|NCT01784614|5724609|P2|NOT COMPLETED|Period 3||0
2332514|NCT01784614|5724610|P1|NOT COMPLETED|Period 3||0
2332515|NCT01784614|5724603|P8|COMPLETED|Period 3||2
2332516|NCT01784614|5724604|P7|COMPLETED|Period 3||3
2332517|NCT01784614|5724605|P6|COMPLETED|Period 3||3
2332518|NCT01784614|5724606|P5|COMPLETED|Period 3||3
2332519|NCT01784614|5724607|P4|COMPLETED|Period 3||3
2332520|NCT01784614|5724608|P3|COMPLETED|Period 3||3
2332521|NCT01784614|5724609|P2|COMPLETED|Period 3||2
2332522|NCT01784614|5724610|P1|COMPLETED|Period 3||3
2332523|NCT01784614|5724603|P8|STARTED|Period 3||2
2332524|NCT01784614|5724604|P7|STARTED|Period 3||3
2332525|NCT01784614|5724605|P6|STARTED|Period 3||3
2332526|NCT01784614|5724606|P5|STARTED|Period 3||3
2332527|NCT01784614|5724607|P4|STARTED|Period 3||3
2332528|NCT01784614|5724608|P3|STARTED|Period 3||3
2332529|NCT01784614|5724609|P2|STARTED|Period 3||2
2332530|NCT01784614|5724610|P1|STARTED|Period 3||3
2332531|NCT01784614|5724603|P8|NOT COMPLETED|Period 2||0
2332532|NCT01784614|5724604|P7|NOT COMPLETED|Period 2||0
2332533|NCT01784614|5724605|P6|NOT COMPLETED|Period 2||0
2332534|NCT01784614|5724606|P5|NOT COMPLETED|Period 2||0
2332535|NCT01784614|5724607|P4|NOT COMPLETED|Period 2||0
2332536|NCT01784614|5724608|P3|NOT COMPLETED|Period 2||0
2332537|NCT01784614|5724609|P2|NOT COMPLETED|Period 2||0
2332538|NCT01784614|5724610|P1|NOT COMPLETED|Period 2||0
2332539|NCT01784614|5724603|P8|COMPLETED|Period 2||2
2332540|NCT01784614|5724604|P7|COMPLETED|Period 2||3
2332541|NCT01784614|5724605|P6|COMPLETED|Period 2||3
2332542|NCT01784614|5724606|P5|COMPLETED|Period 2||3
2332543|NCT01784614|5724607|P4|COMPLETED|Period 2||3
2332544|NCT01784614|5724608|P3|COMPLETED|Period 2||3
2332545|NCT01784614|5724609|P2|COMPLETED|Period 2|One participant withdrew consent after completed Period 2 and did not enter Period 3.|3
2332546|NCT01784614|5724610|P1|COMPLETED|Period 2||3
2332547|NCT01784614|5724603|P8|STARTED|Period 2||2
2332548|NCT01784614|5724604|P7|STARTED|Period 2||3
2332549|NCT01784614|5724605|P6|STARTED|Period 2||3
2332550|NCT01784614|5724606|P5|STARTED|Period 2||3
2332551|NCT01784614|5724607|P4|STARTED|Period 2||3
2332552|NCT01784614|5724608|P3|STARTED|Period 2||3
2332553|NCT01784614|5724609|P2|STARTED|Period 2||3
2332554|NCT01784614|5724610|P1|STARTED|Period 2||3
2332555|NCT01784614|5724603|P8|NOT COMPLETED|Period 1||0
2332556|NCT01784614|5724604|P7|NOT COMPLETED|Period 1||0
2332557|NCT01784614|5724605|P6|NOT COMPLETED|Period 1||0
2332558|NCT01784614|5724606|P5|NOT COMPLETED|Period 1||0
2332559|NCT01784614|5724607|P4|NOT COMPLETED|Period 1||0
2332560|NCT01784614|5724608|P3|NOT COMPLETED|Period 1||0
2332561|NCT01784614|5724609|P2|NOT COMPLETED|Period 1||0
2332562|NCT01784614|5724610|P1|NOT COMPLETED|Period 1||0
2332563|NCT01784614|5724603|P8|COMPLETED|Period 1|One participant withdrew consent after completed Period 1 and did not enter Period 2.|3
2332564|NCT01784614|5724604|P7|COMPLETED|Period 1||3
2332565|NCT01784614|5724605|P6|COMPLETED|Period 1||3
2332566|NCT01784614|5724606|P5|COMPLETED|Period 1||3
2332567|NCT01784614|5724607|P4|COMPLETED|Period 1||3
2332568|NCT01784614|5724608|P3|COMPLETED|Period 1||3
2332569|NCT01784614|5724609|P2|COMPLETED|Period 1||3
2332570|NCT01784614|5724610|P1|COMPLETED|Period 1||3
2332571|NCT01784614|5724603|P8|Received at Least 1 Dose of Study Drug|Period 1||3
2332572|NCT01784614|5724604|P7|Received at Least 1 Dose of Study Drug|Period 1||3
2332573|NCT01784614|5724605|P6|Received at Least 1 Dose of Study Drug|Period 1||3
2332574|NCT01784614|5724606|P5|Received at Least 1 Dose of Study Drug|Period 1||3
2332575|NCT01784614|5724607|P4|Received at Least 1 Dose of Study Drug|Period 1||3
2332576|NCT01784614|5724608|P3|Received at Least 1 Dose of Study Drug|Period 1||3
2332577|NCT01784614|5724609|P2|Received at Least 1 Dose of Study Drug|Period 1||3
2332578|NCT01784614|5724610|P1|Received at Least 1 Dose of Study Drug|Period 1||3
2332579|NCT01784614|5724603|P8|STARTED|Period 1||3
2332580|NCT01784614|5724604|P7|STARTED|Period 1||3
2332581|NCT01784614|5724605|P6|STARTED|Period 1||3
2332582|NCT01784614|5724606|P5|STARTED|Period 1||3
2332583|NCT01784614|5724607|P4|STARTED|Period 1||3
2332584|NCT01784614|5724608|P3|STARTED|Period 1||3
2332585|NCT01784614|5724609|P2|STARTED|Period 1||3
2332586|NCT01784614|5724610|P1|STARTED|Period 1||3
2332587|NCT01784588|5724646|P2|NOT COMPLETED|Overall Study||32
2332588|NCT01784588|5724647|P1|NOT COMPLETED|Overall Study||37
2332589|NCT01784588|5724646|P2|COMPLETED|Overall Study||108
2332590|NCT01784588|5724647|P1|COMPLETED|Overall Study||104
2332591|NCT01784588|5724646|P2|STARTED|Overall Study||140
2332592|NCT01784588|5724647|P1|STARTED|Overall Study||141
2332593|NCT01784211|5724655|P6|NOT COMPLETED|Part B (Days 16-21)||0
2332594|NCT01784211|5724656|P5|NOT COMPLETED|Part B (Days 16-21)||0
2332595|NCT01784211|5724657|P4|NOT COMPLETED|Part B (Days 16-21)||0
2332596|NCT01784211|5724658|P3|NOT COMPLETED|Part B (Days 16-21)||0
2332597|NCT01784211|5724659|P2|NOT COMPLETED|Part B (Days 16-21)||0
2332598|NCT01784211|5724660|P1|NOT COMPLETED|Part B (Days 16-21)||0
2332599|NCT01784211|5724655|P6|COMPLETED|Part B (Days 16-21)||10
2332600|NCT01784211|5724656|P5|COMPLETED|Part B (Days 16-21)||11
2332601|NCT01784211|5724657|P4|COMPLETED|Part B (Days 16-21)||9
2332602|NCT01784211|5724658|P3|COMPLETED|Part B (Days 16-21)||10
2332603|NCT01784211|5724659|P2|COMPLETED|Part B (Days 16-21)||0
2332604|NCT01784211|5724660|P1|COMPLETED|Part B (Days 16-21)||0
2332605|NCT01784211|5724655|P6|STARTED|Part B (Days 16-21)||10
2332606|NCT01784211|5724656|P5|STARTED|Part B (Days 16-21)||11
2332607|NCT01784211|5724657|P4|STARTED|Part B (Days 16-21)||9
2332608|NCT01784211|5724658|P3|STARTED|Part B (Days 16-21)||10
2332609|NCT01784211|5724659|P2|STARTED|Part B (Days 16-21)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|0
2332610|NCT01784211|5724660|P1|STARTED|Part B (Days 16-21)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|0
2332611|NCT01784211|5724655|P6|NOT COMPLETED|Part A (Days 1-15)||0
2332612|NCT01784211|5724656|P5|NOT COMPLETED|Part A (Days 1-15)||0
2332613|NCT01784211|5724657|P4|NOT COMPLETED|Part A (Days 1-15)||0
2332614|NCT01784211|5724658|P3|NOT COMPLETED|Part A (Days 1-15)||0
2332615|NCT01784211|5724659|P2|NOT COMPLETED|Part A (Days 1-15)||2
2332616|NCT01784211|5724660|P1|NOT COMPLETED|Part A (Days 1-15)||3
2332617|NCT01784211|5724655|P6|COMPLETED|Part A (Days 1-15)||0
2332618|NCT01784211|5724656|P5|COMPLETED|Part A (Days 1-15)||0
2332619|NCT01784211|5724657|P4|COMPLETED|Part A (Days 1-15)||0
2332620|NCT01784211|5724658|P3|COMPLETED|Part A (Days 1-15)||0
2332621|NCT01784211|5724659|P2|COMPLETED|Part A (Days 1-15)||36
2332622|NCT01784211|5724660|P1|COMPLETED|Part A (Days 1-15)||35
2332623|NCT01784211|5724655|P6|Entered Part B|Part A (Days 1-15)||0
2332624|NCT01784211|5724656|P5|Entered Part B|Part A (Days 1-15)||0
2332625|NCT01784211|5724657|P4|Entered Part B|Part A (Days 1-15)||0
2332626|NCT01784211|5724658|P3|Entered Part B|Part A (Days 1-15)||0
2332627|NCT01784211|5724659|P2|Entered Part B|Part A (Days 1-15)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|21
2332628|NCT01784211|5724660|P1|Entered Part B|Part A (Days 1-15)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|19
2332629|NCT01784211|5724655|P6|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
2332630|NCT01784211|5724656|P5|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
2332631|NCT01784211|5724657|P4|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
2332632|NCT01784211|5724658|P3|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
2332633|NCT01784211|5724659|P2|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||38
2332634|NCT01784211|5724660|P1|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||37
2332635|NCT01784211|5724655|P6|STARTED|Part A (Days 1-15)||0
2332636|NCT01784211|5724656|P5|STARTED|Part A (Days 1-15)||0
2332637|NCT01784211|5724657|P4|STARTED|Part A (Days 1-15)||0
2332638|NCT01784211|5724658|P3|STARTED|Part A (Days 1-15)||0
2332639|NCT01784211|5724659|P2|STARTED|Part A (Days 1-15)||38
2332640|NCT01784211|5724660|P1|STARTED|Part A (Days 1-15)||38
2332641|NCT01784055|5724678|P1|NOT COMPLETED|Overall Study||26
2332642|NCT01784055|5724678|P1|COMPLETED|Overall Study||100
2332643|NCT01784055|5724678|P1|STARTED|Overall Study||126
2332644|NCT01784029|5724685|P3|NOT COMPLETED|Overall Study||22
2332645|NCT01784029|5724686|P2|NOT COMPLETED|Overall Study||20
2332646|NCT01784029|5724687|P1|NOT COMPLETED|Overall Study||19
2332647|NCT01784029|5724685|P3|COMPLETED|Overall Study||41
2332648|NCT01784029|5724686|P2|COMPLETED|Overall Study||39
2332649|NCT01784029|5724687|P1|COMPLETED|Overall Study||42
2332650|NCT01784029|5724685|P3|STARTED|Overall Study||63
2332651|NCT01784029|5724686|P2|STARTED|Overall Study||59
2332652|NCT01784029|5724687|P1|STARTED|Overall Study||61
2332653|NCT01783938|5724697|P2|NOT COMPLETED|Overall Study||53
2332654|NCT01783938|5724698|P1|NOT COMPLETED|Overall Study||47
2332655|NCT01783938|5724697|P2|COMPLETED|Overall Study|Completed=continuing treatment; did not permanently discontinue both study drugs in treatment period|17
2332656|NCT01783938|5724698|P1|COMPLETED|Overall Study|Completed=continuing treatment; did not permanently discontinue both study drugs in treatment period|21
2332657|NCT01783938|5724697|P2|STARTED|Overall Study||70
2332658|NCT01783938|5724698|P1|STARTED|Overall Study||68
2332659|NCT01783912|5724713|P3|NOT COMPLETED|Overall Study||23
2332660|NCT01783912|5724714|P2|NOT COMPLETED|Overall Study||46
2332661|NCT01783912|5724715|P1|NOT COMPLETED|Overall Study||30
2332662|NCT01783912|5724713|P3|COMPLETED|Overall Study||25
2332663|NCT01783912|5724714|P2|COMPLETED|Overall Study||58
2332664|NCT01783912|5724715|P1|COMPLETED|Overall Study||88
2332665|NCT01783912|5724713|P3|STARTED|Overall Study||48
2332666|NCT01783912|5724714|P2|STARTED|Overall Study||104
2332667|NCT01783912|5724715|P1|STARTED|Overall Study||118
2332668|NCT01783886|5724726|P3|NOT COMPLETED|Overall Study||10
2332669|NCT01783886|5724727|P2|NOT COMPLETED|Overall Study||11
2332670|NCT01783886|5724728|P1|NOT COMPLETED|Overall Study||5
2332671|NCT01783886|5724726|P3|COMPLETED|Overall Study||117
2332672|NCT01783886|5724727|P2|COMPLETED|Overall Study||116
2332673|NCT01783886|5724728|P1|COMPLETED|Overall Study||122
2332674|NCT01783886|5724726|P3|Participants Received Treatment|Overall Study||124
2332675|NCT01783886|5724727|P2|Participants Received Treatment|Overall Study||127
2332676|NCT01783886|5724728|P1|Participants Received Treatment|Overall Study||127
2332677|NCT01783886|5724726|P3|STARTED|Overall Study||127
2332678|NCT01783886|5724727|P2|STARTED|Overall Study||127
2332679|NCT01783886|5724728|P1|STARTED|Overall Study||127
2332680|NCT01783860|5724756|P2|NOT COMPLETED|Overall Study||0
2332681|NCT01783860|5724757|P1|NOT COMPLETED|Overall Study||0
2332682|NCT01783860|5724756|P2|COMPLETED|Overall Study||50
2332683|NCT01783860|5724757|P1|COMPLETED|Overall Study||50
2332684|NCT01783860|5724756|P2|STARTED|Overall Study||50
2332685|NCT01783860|5724757|P1|STARTED|Overall Study||50
2332686|NCT01783847|5724776|P3|NOT COMPLETED|Overall Study||0
2332687|NCT01783847|5724777|P2|NOT COMPLETED|Overall Study||1
2332688|NCT01783847|5724778|P1|NOT COMPLETED|Overall Study||16
2332689|NCT01783847|5724776|P3|COMPLETED|Overall Study||16
2332690|NCT01783847|5724777|P2|COMPLETED|Overall Study||15
2332691|NCT01783847|5724778|P1|COMPLETED|Overall Study||69
2332692|NCT01783847|5724776|P3|STARTED|Overall Study||16
2332693|NCT01783847|5724777|P2|STARTED|Overall Study||16
2332694|NCT01783847|5724778|P1|STARTED|Overall Study||85
2332695|NCT01783821|5724791|P2|NOT COMPLETED|Overall Study||1
2332696|NCT01783821|5724792|P1|NOT COMPLETED|Overall Study||1
2332697|NCT01783821|5724791|P2|COMPLETED|Overall Study||30
2332698|NCT01783821|5724792|P1|COMPLETED|Overall Study||29
2332699|NCT01783821|5724791|P2|STARTED|Overall Study||31
2332700|NCT01783821|5724792|P1|STARTED|Overall Study||30
2332701|NCT01783743|5724810|P2|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10920
2332702|NCT01783743|5724811|P1|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10896
2332703|NCT01783743|5724810|P2|COMPLETED|Rescreening of Subjects by Senior Grader||3044
2332704|NCT01783743|5724811|P1|COMPLETED|Rescreening of Subjects by Senior Grader||2613
2332705|NCT01783743|5724810|P2|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||849
2332706|NCT01783743|5724811|P1|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||846
2332707|NCT01783743|5724810|P2|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1786
2332708|NCT01783743|5724811|P1|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1721
2332709|NCT01783743|5724810|P2|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||409
2332710|NCT01783743|5724811|P1|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||46
2332711|NCT01783743|5724810|P2|STARTED|Rescreening of Subjects by Senior Grader||13964
2332712|NCT01783743|5724811|P1|STARTED|Rescreening of Subjects by Senior Grader||13509
2332713|NCT01783743|5724810|P2|NOT COMPLETED|Screening of Subjects by CTA During MDA||4439
2332714|NCT01783743|5724811|P1|NOT COMPLETED|Screening of Subjects by CTA During MDA||3427
2332715|NCT01783743|5724810|P2|COMPLETED|Screening of Subjects by CTA During MDA||9525
2332716|NCT01783743|5724811|P1|COMPLETED|Screening of Subjects by CTA During MDA||10082
2332717|NCT01783743|5724810|P2|STARTED|Screening of Subjects by CTA During MDA||13964
2332718|NCT01783743|5724811|P1|STARTED|Screening of Subjects by CTA During MDA||13509
2332719|NCT01783730|5724825|P1|NOT COMPLETED|Overall Study||6
2332720|NCT01783730|5724825|P1|COMPLETED|Overall Study||157
2332721|NCT01783730|5724825|P1|STARTED|Overall Study||163
2332722|NCT01783678|5724850|P6|NOT COMPLETED|Overall Study||5
2332723|NCT01783678|5724851|P5|NOT COMPLETED|Overall Study||7
2332724|NCT01783678|5724852|P4|NOT COMPLETED|Overall Study||8
2332725|NCT01783678|5724853|P3|NOT COMPLETED|Overall Study||1
2332726|NCT01783678|5724854|P2|NOT COMPLETED|Overall Study||18
2332727|NCT01783678|5724855|P1|NOT COMPLETED|Overall Study||2
2332728|NCT01783678|5724850|P6|COMPLETED|Overall Study||26
2332729|NCT01783678|5724851|P5|COMPLETED|Overall Study||42
2332730|NCT01783678|5724852|P4|COMPLETED|Overall Study||50
2332731|NCT01783678|5724853|P3|COMPLETED|Overall Study||5
2332732|NCT01783678|5724854|P2|COMPLETED|Overall Study||94
2332733|NCT01783678|5724855|P1|COMPLETED|Overall Study||17
2332734|NCT01783678|5724850|P6|STARTED|Overall Study||31
2332735|NCT01783678|5724851|P5|STARTED|Overall Study||49
2332736|NCT01783678|5724852|P4|STARTED|Overall Study||58
2332737|NCT01783678|5724853|P3|STARTED|Overall Study||6
2332738|NCT01783678|5724854|P2|STARTED|Overall Study||112
2332739|NCT01783678|5724855|P1|STARTED|Overall Study||19
2332740|NCT01783639|5724927|P1|NOT COMPLETED|Overall Study||0
2332741|NCT01783639|5724927|P1|COMPLETED|Overall Study||120
2332742|NCT01783639|5724927|P1|STARTED|Overall Study||120
2332743|NCT01783574|5724933|P2|NOT COMPLETED|Overall Study||9
2332744|NCT01783574|5724934|P1|NOT COMPLETED|Overall Study||5
2332745|NCT01783574|5724933|P2|COMPLETED|Overall Study||41
2332746|NCT01783574|5724934|P1|COMPLETED|Overall Study||46
2332747|NCT01783574|5724933|P2|STARTED|Overall Study||50
2332748|NCT01783574|5724934|P1|STARTED|Overall Study||51
2332749|NCT01783561|5724946|P2|NOT COMPLETED|Overall Study||0
2332750|NCT01783561|5724947|P1|NOT COMPLETED|Overall Study||0
2332751|NCT01783561|5724946|P2|COMPLETED|Overall Study||10
2332752|NCT01783561|5724947|P1|COMPLETED|Overall Study||11
2332753|NCT01783561|5724946|P2|STARTED|Overall Study||10
2332754|NCT01783561|5724947|P1|STARTED|Overall Study||11
2332755|NCT01783548|5724959|P2|NOT COMPLETED|Overall Study||18
2332756|NCT01783548|5724960|P1|NOT COMPLETED|Overall Study||34
2332757|NCT01783548|5724959|P2|COMPLETED|Overall Study||167
2332758|NCT01783548|5724960|P1|COMPLETED|Overall Study||328
2332759|NCT01783548|5724959|P2|Full Analysis Set (FAS)|Overall Study||184
2332760|NCT01783548|5724960|P1|Full Analysis Set (FAS)|Overall Study||358
2332761|NCT01783548|5724959|P2|STARTED|Overall Study|Randomized|185
2332762|NCT01783548|5724960|P1|STARTED|Overall Study|Randomized|362
2332763|NCT01783522|5724974|P2|NOT COMPLETED|Overall Study||0
2332764|NCT01783522|5724975|P1|NOT COMPLETED|Overall Study||0
2332765|NCT01783522|5724974|P2|COMPLETED|Overall Study||5
2332766|NCT01783522|5724975|P1|COMPLETED|Overall Study||4
2332767|NCT01783522|5724974|P2|STARTED|Overall Study||5
2332768|NCT01783522|5724975|P1|STARTED|Overall Study||4
2332769|NCT01783496|5724993|P6|NOT COMPLETED|Overall Study||1
2332770|NCT01783496|5724994|P5|NOT COMPLETED|Overall Study||0
2332771|NCT01783496|5724995|P4|NOT COMPLETED|Overall Study||2
2332772|NCT01783496|5724996|P3|NOT COMPLETED|Overall Study||0
2332773|NCT01783496|5724997|P2|NOT COMPLETED|Overall Study||0
2332774|NCT01783496|5724998|P1|NOT COMPLETED|Overall Study||1
2332775|NCT01783496|5724993|P6|COMPLETED|Overall Study||4
2332776|NCT01783496|5724994|P5|COMPLETED|Overall Study||5
2332777|NCT01783496|5724995|P4|COMPLETED|Overall Study||8
2332778|NCT01783496|5724996|P3|COMPLETED|Overall Study||10
2332779|NCT01783496|5724997|P2|COMPLETED|Overall Study||10
2332780|NCT01783496|5724998|P1|COMPLETED|Overall Study||9
2332781|NCT01783496|5724993|P6|STARTED|Overall Study||5
2332782|NCT01783496|5724994|P5|STARTED|Overall Study||5
2332783|NCT01783496|5724995|P4|STARTED|Overall Study||10
2332784|NCT01783496|5724996|P3|STARTED|Overall Study||10
2332785|NCT01783496|5724997|P2|STARTED|Overall Study||10
2332786|NCT01783496|5724998|P1|STARTED|Overall Study||10
2332787|NCT01783483|5725026|P2|NOT COMPLETED|Overall Study||15
2332788|NCT01783483|5725027|P1|NOT COMPLETED|Overall Study||20
2332789|NCT01783483|5725026|P2|COMPLETED|Overall Study||101
2332790|NCT01783483|5725027|P1|COMPLETED|Overall Study||100
2332791|NCT01783483|5725026|P2|STARTED|Overall Study||116
2332792|NCT01783483|5725027|P1|STARTED|Overall Study||120
2332793|NCT01783470|5725055|P2|NOT COMPLETED|Overall Study||0
2332794|NCT01783470|5725056|P1|NOT COMPLETED|Overall Study||0
2332795|NCT01783470|5725055|P2|COMPLETED|Overall Study||6
2332796|NCT01783470|5725056|P1|COMPLETED|Overall Study||6
2332797|NCT01783470|5725055|P2|STARTED|Overall Study|Single-dose|6
2332798|NCT01783470|5725056|P1|STARTED|Overall Study||6
2332799|NCT01783418|5725065|P2|NOT COMPLETED|Overall Study||0
2332800|NCT01783418|5725066|P1|NOT COMPLETED|Overall Study||1
2332801|NCT01783418|5725065|P2|COMPLETED|Overall Study||6
2332802|NCT01783418|5725066|P1|COMPLETED|Overall Study||7
2332803|NCT01783418|5725065|P2|STARTED|Overall Study||6
2332804|NCT01783418|5725066|P1|STARTED|Overall Study||8
2332805|NCT01783236|5725086|P2|NOT COMPLETED|Overall Study||0
2332806|NCT01783236|5725087|P1|NOT COMPLETED|Overall Study||2
2332807|NCT01783236|5725086|P2|COMPLETED|Overall Study||8
2332808|NCT01783236|5725087|P1|COMPLETED|Overall Study||6
2332809|NCT01783236|5725086|P2|STARTED|Overall Study||8
2332810|NCT01783236|5725087|P1|STARTED|Overall Study||8
2332811|NCT01783080|5725101|P1|NOT COMPLETED|Overall Study||0
2332812|NCT01783080|5725101|P1|COMPLETED|Overall Study||16
2332813|NCT01783080|5725101|P1|STARTED|Overall Study||16
2332814|NCT01783054|5725108|P1|NOT COMPLETED|Overall Study||0
2332815|NCT01783054|5725108|P1|COMPLETED|Overall Study||2
2332816|NCT01783054|5725108|P1|STARTED|Overall Study||2
2332817|NCT01783015|5725119|P3|NOT COMPLETED|Open Label Treatment||6
2332818|NCT01783015|5725120|P2|NOT COMPLETED|Open Label Treatment||0
2332819|NCT01783015|5725121|P1|NOT COMPLETED|Open Label Treatment||0
2332820|NCT01783015|5725119|P3|COMPLETED|Open Label Treatment||5
2332821|NCT01783015|5725120|P2|COMPLETED|Open Label Treatment||0
2332822|NCT01783015|5725121|P1|COMPLETED|Open Label Treatment||0
2332823|NCT01783015|5725119|P3|STARTED|Open Label Treatment||11
2332824|NCT01783015|5725120|P2|STARTED|Open Label Treatment||0
2332825|NCT01783015|5725121|P1|STARTED|Open Label Treatment||0
2332826|NCT01783015|5725119|P3|NOT COMPLETED|Blinded Treatment||0
2332827|NCT01783015|5725120|P2|NOT COMPLETED|Blinded Treatment||3
2332828|NCT01783015|5725121|P1|NOT COMPLETED|Blinded Treatment||2
2332829|NCT01783015|5725119|P3|COMPLETED|Blinded Treatment||0
2332830|NCT01783015|5725120|P2|COMPLETED|Blinded Treatment||2
2332831|NCT01783015|5725121|P1|COMPLETED|Blinded Treatment||9
2332832|NCT01783015|5725119|P3|Treated|Blinded Treatment||0
2332833|NCT01783015|5725120|P2|Treated|Blinded Treatment||5
2332834|NCT01783015|5725121|P1|Treated|Blinded Treatment||11
2332835|NCT01783015|5725119|P3|STARTED|Blinded Treatment||0
2332836|NCT01783015|5725120|P2|STARTED|Blinded Treatment||5
2332837|NCT01783015|5725121|P1|STARTED|Blinded Treatment||11
2332838|NCT01782963|5725206|P1|NOT COMPLETED|Overall Study||0
2332839|NCT01782963|5725206|P1|COMPLETED|Overall Study||50
2332840|NCT01782963|5725206|P1|STARTED|Overall Study||50
2332841|NCT01782898|5725221|P2|NOT COMPLETED|Overall Study||6
2332842|NCT01782898|5725222|P1|NOT COMPLETED|Overall Study||6
2332843|NCT01782898|5725221|P2|COMPLETED|Overall Study||29
2332844|NCT01782898|5725222|P1|COMPLETED|Overall Study||29
2332845|NCT01782898|5725221|P2|STARTED|Overall Study||35
2332846|NCT01782898|5725222|P1|STARTED|Overall Study||35
2332847|NCT01782885|5725234|P2|NOT COMPLETED|Overall Study||6
2332848|NCT01782885|5725235|P1|NOT COMPLETED|Overall Study||4
2332849|NCT01782885|5725234|P2|COMPLETED|Overall Study||33
2332850|NCT01782885|5725235|P1|COMPLETED|Overall Study||32
2332851|NCT01782885|5725234|P2|STARTED|Overall Study||39
2332852|NCT01782885|5725235|P1|STARTED|Overall Study||36
2332853|NCT01782872|5725261|P4|NOT COMPLETED|Overall Study||1
2332854|NCT01782872|5725262|P3|NOT COMPLETED|Overall Study||0
2332855|NCT01782872|5725263|P2|NOT COMPLETED|Overall Study||1
2332856|NCT01782872|5725264|P1|NOT COMPLETED|Overall Study||0
2332857|NCT01782872|5725261|P4|COMPLETED|Overall Study||19
2332858|NCT01782872|5725262|P3|COMPLETED|Overall Study||20
2332859|NCT01782872|5725263|P2|COMPLETED|Overall Study||19
2332860|NCT01782872|5725264|P1|COMPLETED|Overall Study||20
2332861|NCT01782872|5725261|P4|STARTED|Overall Study||20
2332862|NCT01782872|5725262|P3|STARTED|Overall Study||20
2332863|NCT01782872|5725263|P2|STARTED|Overall Study||20
2332864|NCT01782872|5725264|P1|STARTED|Overall Study||20
2332865|NCT01782859|5725288|P2|NOT COMPLETED|Overall Study||7
2332866|NCT01782859|5725289|P1|NOT COMPLETED|Overall Study||6
2332867|NCT01782859|5725288|P2|COMPLETED|Overall Study||13
2332868|NCT01782859|5725289|P1|COMPLETED|Overall Study||14
2332869|NCT01782859|5725288|P2|STARTED|Overall Study||20
2332870|NCT01782859|5725289|P1|STARTED|Overall Study||20
2332871|NCT01782833|5725303|P1|NOT COMPLETED|Overall Study||270
2332872|NCT01782833|5725303|P1|COMPLETED|Overall Study||3365
2332873|NCT01782833|5725303|P1|STARTED|Overall Study||3635
2332874|NCT01782742|5725311|P2|NOT COMPLETED|Open Label Phase||0
2332875|NCT01782742|5725312|P1|NOT COMPLETED|Open Label Phase||0
2332876|NCT01782742|5725311|P2|COMPLETED|Open Label Phase||0
2332877|NCT01782742|5725312|P1|COMPLETED|Open Label Phase||19
2332878|NCT01782742|5725311|P2|STARTED|Open Label Phase||0
2332879|NCT01782742|5725312|P1|STARTED|Open Label Phase||19
2332880|NCT01782742|5725311|P2|NOT COMPLETED|Double-blind Treatment Phase||0
2332881|NCT01782742|5725312|P1|NOT COMPLETED|Double-blind Treatment Phase||1
2332882|NCT01782742|5725311|P2|COMPLETED|Double-blind Treatment Phase||4
2332883|NCT01782742|5725312|P1|COMPLETED|Double-blind Treatment Phase||15
2332884|NCT01782742|5725311|P2|STARTED|Double-blind Treatment Phase||4
2332885|NCT01782742|5725312|P1|STARTED|Double-blind Treatment Phase||16
2332886|NCT01782690|5725345|P1|NOT COMPLETED|Overall Study||299
2332887|NCT01782690|5725345|P1|COMPLETED|Overall Study||39
2332888|NCT01782690|5725345|P1|STARTED|Overall Study||338
2332889|NCT01782664|5725367|P6|NOT COMPLETED|Overall Study||0
2332890|NCT01782664|5725368|P5|NOT COMPLETED|Overall Study||0
2332891|NCT01782664|5725369|P4|NOT COMPLETED|Overall Study||5
2332892|NCT01782664|5725370|P3|NOT COMPLETED|Overall Study||4
2332893|NCT01782664|5725371|P2|NOT COMPLETED|Overall Study||5
2332894|NCT01782664|5725372|P1|NOT COMPLETED|Overall Study||6
2332895|NCT01782664|5725367|P6|COMPLETED|Overall Study||2
2332896|NCT01782664|5725368|P5|COMPLETED|Overall Study||6
2332897|NCT01782664|5725369|P4|COMPLETED|Overall Study||9
2332898|NCT01782664|5725370|P3|COMPLETED|Overall Study||12
2332899|NCT01782664|5725371|P2|COMPLETED|Overall Study||10
2332900|NCT01782664|5725372|P1|COMPLETED|Overall Study||8
2332901|NCT01782664|5725367|P6|STARTED|Overall Study||2
2332902|NCT01782664|5725368|P5|STARTED|Overall Study||6
2332903|NCT01782664|5725369|P4|STARTED|Overall Study||14
2332904|NCT01782664|5725370|P3|STARTED|Overall Study||16
2332905|NCT01782664|5725371|P2|STARTED|Overall Study||15
2332906|NCT01782664|5725372|P1|STARTED|Overall Study||14
2332907|NCT01782495|5725529|P11|NOT COMPLETED|Overall Study||0
2332908|NCT01782495|5725530|P10|NOT COMPLETED|Overall Study||0
2332909|NCT01782495|5725531|P9|NOT COMPLETED|Overall Study||0
2332910|NCT01782495|5725532|P8|NOT COMPLETED|Overall Study||3
2332911|NCT01782495|5725533|P7|NOT COMPLETED|Overall Study||0
2332912|NCT01782495|5725534|P6|NOT COMPLETED|Overall Study||0
2332913|NCT01782495|5725535|P5|NOT COMPLETED|Overall Study||0
2332914|NCT01782495|5725536|P4|NOT COMPLETED|Overall Study||0
2332915|NCT01782495|5725537|P3|NOT COMPLETED|Overall Study||0
2332916|NCT01782495|5725538|P2|NOT COMPLETED|Overall Study||1
2332917|NCT01782495|5725539|P1|NOT COMPLETED|Overall Study||0
2332918|NCT01782495|5725529|P11|COMPLETED|Overall Study||1
2332919|NCT01782495|5725530|P10|COMPLETED|Overall Study||2
2332920|NCT01782495|5725531|P9|COMPLETED|Overall Study||3
2332921|NCT01782495|5725532|P8|COMPLETED|Overall Study||6
2332922|NCT01782495|5725533|P7|COMPLETED|Overall Study||12
2332923|NCT01782495|5725534|P6|COMPLETED|Overall Study||22
2332924|NCT01782495|5725535|P5|COMPLETED|Overall Study||2
2332925|NCT01782495|5725536|P4|COMPLETED|Overall Study||4
2332926|NCT01782495|5725537|P3|COMPLETED|Overall Study||13
2332927|NCT01782495|5725538|P2|COMPLETED|Overall Study||26
2332928|NCT01782495|5725539|P1|COMPLETED|Overall Study||34
2332929|NCT01782495|5725529|P11|STARTED|Overall Study||1
2332930|NCT01782495|5725530|P10|STARTED|Overall Study||2
2332931|NCT01782495|5725531|P9|STARTED|Overall Study||3
2332932|NCT01782495|5725532|P8|STARTED|Overall Study||9
2332933|NCT01782495|5725533|P7|STARTED|Overall Study||12
2332934|NCT01782495|5725534|P6|STARTED|Overall Study||22
2332935|NCT01782495|5725535|P5|STARTED|Overall Study||2
2332936|NCT01782495|5725536|P4|STARTED|Overall Study||4
2332937|NCT01782495|5725537|P3|STARTED|Overall Study||13
2332938|NCT01782495|5725538|P2|STARTED|Overall Study||27
2332939|NCT01782495|5725539|P1|STARTED|Overall Study||34
2332940|NCT01782482|5725598|P2|NOT COMPLETED|Overall Study||10
2332941|NCT01782482|5725599|P1|NOT COMPLETED|Overall Study||10
2332942|NCT01782482|5725598|P2|COMPLETED|Overall Study||270
2332943|NCT01782482|5725599|P1|COMPLETED|Overall Study||271
2332944|NCT01782482|5725598|P2|STARTED|Overall Study||280
2332945|NCT01782482|5725599|P1|STARTED|Overall Study||281
2332946|NCT01782469|5725607|P1|NOT COMPLETED|Overall Study||1
2332947|NCT01782469|5725607|P1|COMPLETED|Overall Study||15
2332948|NCT01782469|5725607|P1|STARTED|Overall Study||16
2332949|NCT01782378|5725617|P2|NOT COMPLETED|Second Series||32
2332950|NCT01782378|5725618|P1|NOT COMPLETED|Second Series||26
2332951|NCT01782378|5725617|P2|COMPLETED|Second Series||0
2332952|NCT01782378|5725618|P1|COMPLETED|Second Series||5
2332953|NCT01782378|5725617|P2|STARTED|Second Series||32
2332954|NCT01782378|5725618|P1|STARTED|Second Series||31
2332955|NCT01782378|5725617|P2|NOT COMPLETED|First Series||8
2332956|NCT01782378|5725618|P1|NOT COMPLETED|First Series||7
2332957|NCT01782378|5725617|P2|COMPLETED|First Series||23
2332958|NCT01782378|5725618|P1|COMPLETED|First Series||25
2332959|NCT01782378|5725617|P2|STARTED|First Series||31
2332960|NCT01782378|5725618|P1|STARTED|First Series||32
2332961|NCT01782326|5725684|P2|NOT COMPLETED|Double-blind Treatment||320
2332962|NCT01782326|5725685|P1|NOT COMPLETED|Double-blind Treatment||278
2332963|NCT01782326|5725684|P2|COMPLETED|Double-blind Treatment||1360
2332964|NCT01782326|5725685|P1|COMPLETED|Double-blind Treatment||1400
2332965|NCT01782326|5725684|P2|STARTED|Double-blind Treatment||1680
2332966|NCT01782326|5725685|P1|STARTED|Double-blind Treatment||1678
2332967|NCT01782326|5725684|P2|NOT COMPLETED|Planned Treatment Epoch||208
2332968|NCT01782326|5725685|P1|NOT COMPLETED|Planned Treatment Epoch||202
2332969|NCT01782326|5725684|P2|COMPLETED|Planned Treatment Epoch||1474
2332970|NCT01782326|5725685|P1|COMPLETED|Planned Treatment Epoch||1478
2332971|NCT01782326|5725684|P2|Urine Cortisol Set|Planned Treatment Epoch||269
2332972|NCT01782326|5725685|P1|Urine Cortisol Set|Planned Treatment Epoch||266
2332973|NCT01782326|5725684|P2|Safety Set (SAF)|Planned Treatment Epoch||1680
2332974|NCT01782326|5725685|P1|Safety Set (SAF)|Planned Treatment Epoch||1678
2332975|NCT01782326|5725684|P2|Serial Spirometry Set|Planned Treatment Epoch||279
2332976|NCT01782326|5725685|P1|Serial Spirometry Set|Planned Treatment Epoch||280
2332977|NCT01782326|5725684|P2|Per-protocol Set (PPS)|Planned Treatment Epoch||1556
2332978|NCT01782326|5725685|P1|Per-protocol Set (PPS)|Planned Treatment Epoch||1528
2332979|NCT01782326|5725684|P2|Full Analysis Set (FAS)|Planned Treatment Epoch||1679
2332980|NCT01782326|5725685|P1|Full Analysis Set (FAS)|Planned Treatment Epoch||1675
2332981|NCT01782326|5725684|P2|STARTED|Planned Treatment Epoch||1682
2332982|NCT01782326|5725685|P1|STARTED|Planned Treatment Epoch||1680
2332983|NCT01782313|5725745|P1|NOT COMPLETED|Survival Follow up||1
2332984|NCT01782313|5725745|P1|COMPLETED|Survival Follow up||57
2332985|NCT01782313|5725745|P1|STARTED|Survival Follow up||58
2332986|NCT01782313|5725745|P1|NOT COMPLETED|Continued Treatment After 16 Weeks||7
2332987|NCT01782313|5725745|P1|COMPLETED|Continued Treatment After 16 Weeks||18
2332988|NCT01782313|5725745|P1|STARTED|Continued Treatment After 16 Weeks||25
2332989|NCT01782313|5725745|P1|NOT COMPLETED|Treated Cycle 4/Reached 16 Week Response||6
2332990|NCT01782313|5725745|P1|COMPLETED|Treated Cycle 4/Reached 16 Week Response||25
2332991|NCT01782313|5725745|P1|STARTED|Treated Cycle 4/Reached 16 Week Response||31
2332992|NCT01782313|5725745|P1|NOT COMPLETED|Treated Cycle 3||21
2332993|NCT01782313|5725745|P1|COMPLETED|Treated Cycle 3||31
2332994|NCT01782313|5725745|P1|STARTED|Treated Cycle 3||52
2332995|NCT01782313|5725745|P1|NOT COMPLETED|Reached First Response/Completed 2 Cycle||6
2332996|NCT01782313|5725745|P1|COMPLETED|Reached First Response/Completed 2 Cycle||52
2332997|NCT01782313|5725745|P1|STARTED|Reached First Response/Completed 2 Cycle||58
2332998|NCT01782222|5725759|P3|NOT COMPLETED|Overall Study||4
2332999|NCT01782222|5725760|P2|NOT COMPLETED|Overall Study||11
2333000|NCT01782222|5725761|P1|NOT COMPLETED|Overall Study||8
2333001|NCT01782222|5725759|P3|COMPLETED|Overall Study||37
2333002|NCT01782222|5725760|P2|COMPLETED|Overall Study||30
2333003|NCT01782222|5725761|P1|COMPLETED|Overall Study||32
2333004|NCT01782222|5725759|P3|STARTED|Overall Study||41
2333005|NCT01782222|5725760|P2|STARTED|Overall Study||41
2333006|NCT01782222|5725761|P1|STARTED|Overall Study||40
2333007|NCT01781975|5725795|P2|NOT COMPLETED|Overall Study||1
2333008|NCT01781975|5725796|P1|NOT COMPLETED|Overall Study||2
2333009|NCT01781975|5725795|P2|COMPLETED|Overall Study||21
2333010|NCT01781975|5725796|P1|COMPLETED|Overall Study||43
2333011|NCT01781975|5725795|P2|Follow-Up Period|Overall Study||21
2333012|NCT01781975|5725796|P1|Follow-Up Period|Overall Study||43
2333013|NCT01781975|5725795|P2|Treatment Period|Overall Study||22
2333014|NCT01781975|5725796|P1|Treatment Period|Overall Study||44
2333015|NCT01781975|5725795|P2|STARTED|Overall Study||22
2333016|NCT01781975|5725796|P1|STARTED|Overall Study||45
2333017|NCT01781962|5725812|P1|NOT COMPLETED|Overall Study||5
2333018|NCT01781962|5725812|P1|COMPLETED|Overall Study||201
2333019|NCT01781962|5725812|P1|STARTED|Overall Study||206
2333020|NCT01781832|5725818|P1|NOT COMPLETED|Overall Study||1
2333021|NCT01781832|5725818|P1|COMPLETED|Overall Study||25
2333022|NCT01781832|5725818|P1|STARTED|Overall Study||26
2333023|NCT01781806|5725825|P2|NOT COMPLETED|Overall Study||3
2333024|NCT01781806|5725826|P1|NOT COMPLETED|Overall Study||79
2333025|NCT01781806|5725825|P2|COMPLETED|Overall Study||1
2333026|NCT01781806|5725826|P1|COMPLETED|Overall Study||218
2333027|NCT01781806|5725825|P2|Week 48|Overall Study||1
2333028|NCT01781806|5725826|P1|Week 48|Overall Study||222
2333029|NCT01781806|5725825|P2|Week 36|Overall Study||1
2333030|NCT01781806|5725826|P1|Week 36|Overall Study||247
2333031|NCT01781806|5725825|P2|Week 24|Overall Study||1
2333032|NCT01781806|5725826|P1|Week 24|Overall Study||260
2333033|NCT01781806|5725825|P2|Week 12|Overall Study||2
2333034|NCT01781806|5725826|P1|Week 12|Overall Study||272
2333035|NCT01781806|5725825|P2|Week 8|Overall Study||4
2333036|NCT01781806|5725826|P1|Week 8|Overall Study||278
2333037|NCT01781806|5725825|P2|Week 4|Overall Study||4
2333038|NCT01781806|5725826|P1|Week 4|Overall Study||284
2333039|NCT01781806|5725825|P2|Week 0|Overall Study||4
2333040|NCT01781806|5725826|P1|Week 0|Overall Study||297
2333041|NCT01781806|5725825|P2|STARTED|Overall Study||4
2333042|NCT01781806|5725826|P1|STARTED|Overall Study||297
2333043|NCT01781637|5725838|P2|NOT COMPLETED|Overall Study||6
2333044|NCT01781637|5725839|P1|NOT COMPLETED|Overall Study||4
2333045|NCT01781637|5725838|P2|COMPLETED|Overall Study||2
2333046|NCT01781637|5725839|P1|COMPLETED|Overall Study||24
2333047|NCT01781637|5725838|P2|STARTED|Overall Study||8
2333048|NCT01781637|5725839|P1|STARTED|Overall Study||28
2333049|NCT01781481|5725847|P1|NOT COMPLETED|Overall Study||0
2333050|NCT01781481|5725847|P1|COMPLETED|Overall Study||148
2333051|NCT01781481|5725847|P1|STARTED|Overall Study||148
2333052|NCT01781403|5725906|P3|NOT COMPLETED|Overall Study||0
2333053|NCT01781403|5725907|P2|NOT COMPLETED|Overall Study||0
2333054|NCT01781403|5725908|P1|NOT COMPLETED|Overall Study||0
2333055|NCT01781403|5725906|P3|COMPLETED|Overall Study||18
2333056|NCT01781403|5725907|P2|COMPLETED|Overall Study||2
2333057|NCT01781403|5725908|P1|COMPLETED|Overall Study||2
2333058|NCT01781403|5725906|P3|STARTED|Overall Study||18
2333059|NCT01781403|5725907|P2|STARTED|Overall Study||2
2333060|NCT01781403|5725908|P1|STARTED|Overall Study||2
2333061|NCT01781299|5725926|P2|NOT COMPLETED|Overall Study||1
2333062|NCT01781299|5725927|P1|NOT COMPLETED|Overall Study||0
2333063|NCT01781299|5725926|P2|COMPLETED|Overall Study||4
2333064|NCT01781299|5725927|P1|COMPLETED|Overall Study||4
2333065|NCT01781299|5725926|P2|STARTED|Overall Study||5
2333066|NCT01781299|5725927|P1|STARTED|Overall Study||4
2333067|NCT01781286|5725935|P6|NOT COMPLETED|Overall Study||1
2333068|NCT01781286|5725936|P5|NOT COMPLETED|Overall Study||0
2333069|NCT01781286|5725937|P4|NOT COMPLETED|Overall Study||1
2333070|NCT01781286|5725938|P3|NOT COMPLETED|Overall Study||2
2333071|NCT01781286|5725939|P2|NOT COMPLETED|Overall Study||0
2333072|NCT01781286|5725940|P1|NOT COMPLETED|Overall Study||2
2333073|NCT01781286|5725935|P6|COMPLETED|Overall Study||2
2333074|NCT01781286|5725936|P5|COMPLETED|Overall Study||6
2333075|NCT01781286|5725937|P4|COMPLETED|Overall Study||7
2333076|NCT01781286|5725938|P3|COMPLETED|Overall Study||7
2333077|NCT01781286|5725939|P2|COMPLETED|Overall Study||4
2333078|NCT01781286|5725940|P1|COMPLETED|Overall Study||5
2333079|NCT01781286|5725935|P6|Started 3rd Intervention|Overall Study||2
2333080|NCT01781286|5725936|P5|Started 3rd Intervention|Overall Study||6
2333081|NCT01781286|5725937|P4|Started 3rd Intervention|Overall Study||7
2333082|NCT01781286|5725938|P3|Started 3rd Intervention|Overall Study||7
2333083|NCT01781286|5725939|P2|Started 3rd Intervention|Overall Study||4
2333084|NCT01781286|5725940|P1|Started 3rd Intervention|Overall Study||5
2333085|NCT01781286|5725935|P6|Started 2nd Intervention|Overall Study||2
2333086|NCT01781286|5725936|P5|Started 2nd Intervention|Overall Study||6
2333087|NCT01781286|5725937|P4|Started 2nd Intervention|Overall Study||8
2333088|NCT01781286|5725938|P3|Started 2nd Intervention|Overall Study||9
2333089|NCT01781286|5725939|P2|Started 2nd Intervention|Overall Study||4
2333090|NCT01781286|5725940|P1|Started 2nd Intervention|Overall Study||5
2333091|NCT01781286|5725935|P6|Started 1st Intervention|Overall Study||2
2333092|NCT01781286|5725936|P5|Started 1st Intervention|Overall Study||6
2333093|NCT01781286|5725937|P4|Started 1st Intervention|Overall Study||8
2333094|NCT01781286|5725938|P3|Started 1st Intervention|Overall Study||9
2333095|NCT01781286|5725939|P2|Started 1st Intervention|Overall Study||4
2333096|NCT01781286|5725940|P1|Started 1st Intervention|Overall Study||6
2333097|NCT01781286|5725935|P6|STARTED|Overall Study||3
2333098|NCT01781286|5725936|P5|STARTED|Overall Study||6
2333099|NCT01781286|5725937|P4|STARTED|Overall Study||8
2333100|NCT01781286|5725938|P3|STARTED|Overall Study||9
2333101|NCT01781286|5725939|P2|STARTED|Overall Study||4
2333102|NCT01781286|5725940|P1|STARTED|Overall Study||7
2333103|NCT01781234|5725965|P2|NOT COMPLETED|Overall Study||3
2333104|NCT01781234|5725966|P1|NOT COMPLETED|Overall Study||9
2333105|NCT01781234|5725965|P2|COMPLETED|Overall Study||21
2333106|NCT01781234|5725966|P1|COMPLETED|Overall Study||18
2333107|NCT01781234|5725965|P2|STARTED|Overall Study||24
2333108|NCT01781234|5725966|P1|STARTED|Overall Study||27
2333109|NCT01781208|5725976|P1|NOT COMPLETED|Overall Study||0
2333110|NCT01781208|5725976|P1|COMPLETED|Overall Study||62
2333111|NCT01781208|5725976|P1|Overall Study|Overall Study||62
2333112|NCT01781208|5725976|P1|STARTED|Overall Study||62
2333113|NCT01781169|5725983|P2|NOT COMPLETED|Overall Study||0
2333114|NCT01781169|5725984|P1|NOT COMPLETED|Overall Study||1
2333115|NCT01781169|5725983|P2|COMPLETED|Overall Study||21
2333116|NCT01781169|5725984|P1|COMPLETED|Overall Study||21
2333117|NCT01781169|5725983|P2|STARTED|Overall Study||21
2333118|NCT01781169|5725984|P1|STARTED|Overall Study||22
2333119|NCT01781078|5725992|P3|NOT COMPLETED|Overall Study||16
2333120|NCT01781078|5725993|P2|NOT COMPLETED|Overall Study||5
2333121|NCT01781078|5725994|P1|NOT COMPLETED|Overall Study||12
2333122|NCT01781078|5725992|P3|COMPLETED|Overall Study||0
2333123|NCT01781078|5725993|P2|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|113
2333124|NCT01781078|5725994|P1|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|217
2333125|NCT01781078|5725992|P3|STARTED|Overall Study||16
2333126|NCT01781078|5725993|P2|STARTED|Overall Study|Randomized post implantation|118
2333127|NCT01781078|5725994|P1|STARTED|Overall Study|Randomized post implantation|229
2333128|NCT01781026|5726004|P1|NOT COMPLETED|Overall Study||2
2333129|NCT01781026|5726004|P1|COMPLETED|Overall Study||0
2333130|NCT01781026|5726004|P1|STARTED|Overall Study||2
2333131|NCT01780987|5726010|P2|NOT COMPLETED|Overall Study||6
2333132|NCT01780987|5726011|P1|NOT COMPLETED|Overall Study||3
2333133|NCT01780987|5726010|P2|COMPLETED|Overall Study||34
2333134|NCT01780987|5726011|P1|COMPLETED|Overall Study||37
2333135|NCT01780987|5726010|P2|STARTED|Overall Study|Including one participant who withdrew from the study prior to receiving any study medication.|40
2333136|NCT01780987|5726011|P1|STARTED|Overall Study||40
2333137|NCT01780974|5726029|P2|NOT COMPLETED|Overall Study||3
2333138|NCT01780974|5726030|P1|NOT COMPLETED|Overall Study||2
2333139|NCT01780974|5726029|P2|COMPLETED|Overall Study||18
2333140|NCT01780974|5726030|P1|COMPLETED|Overall Study||19
2333141|NCT01780974|5726029|P2|STARTED|Overall Study||21
2333142|NCT01780974|5726030|P1|STARTED|Overall Study||21
2333143|NCT01780935|5726040|P2|NOT COMPLETED|Overall Study||336
2333144|NCT01780935|5726041|P1|NOT COMPLETED|Overall Study||335
2333145|NCT01780935|5726040|P2|COMPLETED|Overall Study||0
2333146|NCT01780935|5726041|P1|COMPLETED|Overall Study||0
2333147|NCT01780935|5726040|P2|Safety Set|Overall Study||336
2333148|NCT01780935|5726041|P1|Safety Set|Overall Study||334
2333149|NCT01780935|5726040|P2|STARTED|Overall Study||336
2333150|NCT01780935|5726041|P1|STARTED|Overall Study||335
2333151|NCT01780922|5726071|P6|NOT COMPLETED|Third Intervention (1 Day)||0
2333152|NCT01780922|5726072|P5|NOT COMPLETED|Third Intervention (1 Day)||0
2333153|NCT01780922|5726073|P4|NOT COMPLETED|Third Intervention (1 Day)||0
2333154|NCT01780922|5726074|P3|NOT COMPLETED|Third Intervention (1 Day)||0
2333155|NCT01780922|5726075|P2|NOT COMPLETED|Third Intervention (1 Day)||0
2333156|NCT01780922|5726076|P1|NOT COMPLETED|Third Intervention (1 Day)||0
2333157|NCT01780922|5726071|P6|COMPLETED|Third Intervention (1 Day)||2
2333158|NCT01780922|5726072|P5|COMPLETED|Third Intervention (1 Day)||2
2333159|NCT01780922|5726073|P4|COMPLETED|Third Intervention (1 Day)||2
2333160|NCT01780922|5726074|P3|COMPLETED|Third Intervention (1 Day)||2
2333161|NCT01780922|5726075|P2|COMPLETED|Third Intervention (1 Day)||2
2333162|NCT01780922|5726076|P1|COMPLETED|Third Intervention (1 Day)||2
2333163|NCT01780922|5726071|P6|STARTED|Third Intervention (1 Day)||2
2333164|NCT01780922|5726072|P5|STARTED|Third Intervention (1 Day)||2
2333165|NCT01780922|5726073|P4|STARTED|Third Intervention (1 Day)||2
2333166|NCT01780922|5726074|P3|STARTED|Third Intervention (1 Day)||2
2333167|NCT01780922|5726075|P2|STARTED|Third Intervention (1 Day)||2
2333168|NCT01780922|5726076|P1|STARTED|Third Intervention (1 Day)||2
2333169|NCT01780922|5726071|P6|NOT COMPLETED|Washout (7 Days)||0
2333170|NCT01780922|5726072|P5|NOT COMPLETED|Washout (7 Days)||0
2333171|NCT01780922|5726073|P4|NOT COMPLETED|Washout (7 Days)||0
2333172|NCT01780922|5726074|P3|NOT COMPLETED|Washout (7 Days)||0
2333173|NCT01780922|5726075|P2|NOT COMPLETED|Washout (7 Days)||0
2333174|NCT01780922|5726076|P1|NOT COMPLETED|Washout (7 Days)||0
2333175|NCT01780922|5726071|P6|COMPLETED|Washout (7 Days)||2
2333176|NCT01780922|5726072|P5|COMPLETED|Washout (7 Days)||2
2333177|NCT01780922|5726073|P4|COMPLETED|Washout (7 Days)||2
2333178|NCT01780922|5726074|P3|COMPLETED|Washout (7 Days)||2
2333179|NCT01780922|5726075|P2|COMPLETED|Washout (7 Days)||2
2333180|NCT01780922|5726076|P1|COMPLETED|Washout (7 Days)||2
2333181|NCT01780922|5726071|P6|STARTED|Washout (7 Days)||2
2333182|NCT01780922|5726072|P5|STARTED|Washout (7 Days)||2
2333183|NCT01780922|5726073|P4|STARTED|Washout (7 Days)||2
2333184|NCT01780922|5726074|P3|STARTED|Washout (7 Days)||2
2333185|NCT01780922|5726075|P2|STARTED|Washout (7 Days)||2
2333186|NCT01780922|5726076|P1|STARTED|Washout (7 Days)||2
2333187|NCT01780922|5726071|P6|NOT COMPLETED|Second Intervention (1 Day)||0
2333188|NCT01780922|5726072|P5|NOT COMPLETED|Second Intervention (1 Day)||0
2333189|NCT01780922|5726073|P4|NOT COMPLETED|Second Intervention (1 Day)||0
2333190|NCT01780922|5726074|P3|NOT COMPLETED|Second Intervention (1 Day)||0
2333191|NCT01780922|5726075|P2|NOT COMPLETED|Second Intervention (1 Day)||0
2333192|NCT01780922|5726076|P1|NOT COMPLETED|Second Intervention (1 Day)||0
2333193|NCT01780922|5726071|P6|COMPLETED|Second Intervention (1 Day)||2
2333194|NCT01780922|5726072|P5|COMPLETED|Second Intervention (1 Day)||2
2333195|NCT01780922|5726073|P4|COMPLETED|Second Intervention (1 Day)||2
2333196|NCT01780922|5726074|P3|COMPLETED|Second Intervention (1 Day)||2
2333197|NCT01780922|5726075|P2|COMPLETED|Second Intervention (1 Day)||2
2333198|NCT01780922|5726076|P1|COMPLETED|Second Intervention (1 Day)||2
2333199|NCT01780922|5726071|P6|STARTED|Second Intervention (1 Day)||2
2333200|NCT01780922|5726072|P5|STARTED|Second Intervention (1 Day)||2
2333201|NCT01780922|5726073|P4|STARTED|Second Intervention (1 Day)||2
2333202|NCT01780922|5726074|P3|STARTED|Second Intervention (1 Day)||2
2333203|NCT01780922|5726075|P2|STARTED|Second Intervention (1 Day)||2
2333204|NCT01780922|5726076|P1|STARTED|Second Intervention (1 Day)||2
2333205|NCT01780922|5726071|P6|NOT COMPLETED|Washout (7 Days)||0
2333206|NCT01780922|5726072|P5|NOT COMPLETED|Washout (7 Days)||0
2333207|NCT01780922|5726073|P4|NOT COMPLETED|Washout (7 Days)||0
2333208|NCT01780922|5726074|P3|NOT COMPLETED|Washout (7 Days)||0
2333209|NCT01780922|5726075|P2|NOT COMPLETED|Washout (7 Days)||0
2333210|NCT01780922|5726076|P1|NOT COMPLETED|Washout (7 Days)||0
2333211|NCT01780922|5726071|P6|COMPLETED|Washout (7 Days)||2
2333212|NCT01780922|5726072|P5|COMPLETED|Washout (7 Days)||2
2333213|NCT01780922|5726073|P4|COMPLETED|Washout (7 Days)||2
2333214|NCT01780922|5726074|P3|COMPLETED|Washout (7 Days)||2
2333215|NCT01780922|5726075|P2|COMPLETED|Washout (7 Days)||2
2333216|NCT01780922|5726076|P1|COMPLETED|Washout (7 Days)||2
2333217|NCT01780922|5726071|P6|STARTED|Washout (7 Days)||2
2333218|NCT01780922|5726072|P5|STARTED|Washout (7 Days)||2
2333219|NCT01780922|5726073|P4|STARTED|Washout (7 Days)||2
2333220|NCT01780922|5726074|P3|STARTED|Washout (7 Days)||2
2333221|NCT01780922|5726075|P2|STARTED|Washout (7 Days)||2
2333222|NCT01780922|5726076|P1|STARTED|Washout (7 Days)||2
2333223|NCT01780922|5726071|P6|NOT COMPLETED|First Intervention (1 Day)||0
2333224|NCT01780922|5726072|P5|NOT COMPLETED|First Intervention (1 Day)||0
2333225|NCT01780922|5726073|P4|NOT COMPLETED|First Intervention (1 Day)||0
2333226|NCT01780922|5726074|P3|NOT COMPLETED|First Intervention (1 Day)||0
2333227|NCT01780922|5726075|P2|NOT COMPLETED|First Intervention (1 Day)||0
2333228|NCT01780922|5726076|P1|NOT COMPLETED|First Intervention (1 Day)||0
2333229|NCT01780922|5726071|P6|COMPLETED|First Intervention (1 Day)||2
2333230|NCT01780922|5726072|P5|COMPLETED|First Intervention (1 Day)||2
2333231|NCT01780922|5726073|P4|COMPLETED|First Intervention (1 Day)||2
2333232|NCT01780922|5726074|P3|COMPLETED|First Intervention (1 Day)||2
2333233|NCT01780922|5726075|P2|COMPLETED|First Intervention (1 Day)||2
2333234|NCT01780922|5726076|P1|COMPLETED|First Intervention (1 Day)||2
2333235|NCT01780922|5726071|P6|STARTED|First Intervention (1 Day)||2
2333236|NCT01780922|5726072|P5|STARTED|First Intervention (1 Day)||2
2333237|NCT01780922|5726073|P4|STARTED|First Intervention (1 Day)||2
2333238|NCT01780922|5726074|P3|STARTED|First Intervention (1 Day)||2
2333239|NCT01780922|5726075|P2|STARTED|First Intervention (1 Day)||2
2333240|NCT01780922|5726076|P1|STARTED|First Intervention (1 Day)||2
2333241|NCT01780870|5726131|P2|NOT COMPLETED|Overall Study||0
2333242|NCT01780870|5726132|P1|NOT COMPLETED|Overall Study||0
2333243|NCT01780870|5726131|P2|COMPLETED|Overall Study||5
2333244|NCT01780870|5726132|P1|COMPLETED|Overall Study||0
2333245|NCT01780870|5726131|P2|STARTED|Overall Study||5
2333246|NCT01780870|5726132|P1|STARTED|Overall Study||0
2333247|NCT01780662|5726145|P3|NOT COMPLETED|Overall Study||10
2333248|NCT01780662|5726146|P2|NOT COMPLETED|Overall Study||6
2333249|NCT01780662|5726147|P1|NOT COMPLETED|Overall Study||1
2333250|NCT01780662|5726145|P3|COMPLETED|Overall Study||20
2333251|NCT01780662|5726146|P2|COMPLETED|Overall Study||7
2333252|NCT01780662|5726147|P1|COMPLETED|Overall Study||2
2333253|NCT01780662|5726145|P3|STARTED|Overall Study||30
2333254|NCT01780662|5726146|P2|STARTED|Overall Study||13
2333255|NCT01780662|5726147|P1|STARTED|Overall Study||3
2333256|NCT01780584|5726164|P3|NOT COMPLETED|Overall Study||2
2333257|NCT01780584|5726165|P2|NOT COMPLETED|Overall Study||1
2333258|NCT01780584|5726166|P1|NOT COMPLETED|Overall Study||1
2333259|NCT01780584|5726164|P3|COMPLETED|Overall Study||13
2333260|NCT01780584|5726165|P2|COMPLETED|Overall Study||14
2333261|NCT01780584|5726166|P1|COMPLETED|Overall Study||14
2333262|NCT01780584|5726164|P3|STARTED|Overall Study||15
2333263|NCT01780584|5726165|P2|STARTED|Overall Study||15
2333264|NCT01780584|5726166|P1|STARTED|Overall Study||15
2333265|NCT01780545|5726188|P2|NOT COMPLETED|Overall Study||2
2333266|NCT01780545|5726189|P1|NOT COMPLETED|Overall Study||4
2333267|NCT01780545|5726188|P2|COMPLETED|Overall Study||99
2333268|NCT01780545|5726189|P1|COMPLETED|Overall Study||95
2333269|NCT01780545|5726188|P2|STARTED|Overall Study||101
2333270|NCT01780545|5726189|P1|STARTED|Overall Study||99
2333271|NCT01780506|5726207|P2|NOT COMPLETED|Open-Label Extension Phase||1
2333272|NCT01780506|5726208|P1|NOT COMPLETED|Open-Label Extension Phase||0
2333273|NCT01780506|5726207|P2|COMPLETED|Open-Label Extension Phase||94
2333274|NCT01780506|5726208|P1|COMPLETED|Open-Label Extension Phase||90
2333275|NCT01780506|5726207|P2|STARTED|Open-Label Extension Phase|261 participants completed the Double-Blind Phase but did not enter the Open-Label Extension Phase|95
2333276|NCT01780506|5726208|P1|STARTED|Open-Label Extension Phase|278 participants completed the Double-Blind Phase but did not enter the Open-Label Extension Phase|90
2333277|NCT01780506|5726207|P2|NOT COMPLETED|Double-Blind Phase||78
2333278|NCT01780506|5726208|P1|NOT COMPLETED|Double-Blind Phase||70
2333279|NCT01780506|5726207|P2|COMPLETED|Double-Blind Phase||356
2333280|NCT01780506|5726208|P1|COMPLETED|Double-Blind Phase||368
2333281|NCT01780506|5726207|P2|STARTED|Double-Blind Phase||434
2333282|NCT01780506|5726208|P1|STARTED|Double-Blind Phase||438
2333283|NCT01780389|5726262|P1|NOT COMPLETED|Overall Study||1
2333284|NCT01780389|5726262|P1|COMPLETED|Overall Study|One patient discontinued due to adverse event.|4
2333285|NCT01780389|5726262|P1|STARTED|Overall Study||5
2333286|NCT01780350|5726273|P1|NOT COMPLETED|Overall Study||0
2333287|NCT01780350|5726273|P1|COMPLETED|Overall Study||200
2333288|NCT01780350|5726273|P1|STARTED|Overall Study||200
2333289|NCT01780337|5726280|P2|NOT COMPLETED|Overall Study||0
2333290|NCT01780337|5726281|P1|NOT COMPLETED|Overall Study||0
2333291|NCT01780337|5726280|P2|COMPLETED|Overall Study||6
2333292|NCT01780337|5726281|P1|COMPLETED|Overall Study||6
2333293|NCT01780337|5726280|P2|STARTED|Overall Study||6
2333294|NCT01780337|5726281|P1|STARTED|Overall Study||6
2333295|NCT01780324|5726293|P2|NOT COMPLETED|Overall Study||6
2333296|NCT01780324|5726294|P1|NOT COMPLETED|Overall Study||1
2333297|NCT01780324|5726293|P2|COMPLETED|Overall Study||33
2333298|NCT01780324|5726294|P1|COMPLETED|Overall Study||40
2333299|NCT01780324|5726293|P2|STARTED|Overall Study||39
2333300|NCT01780324|5726294|P1|STARTED|Overall Study||41
2333301|NCT01779869|5726300|P1|NOT COMPLETED|Overall Study||2
2333302|NCT01779869|5726300|P1|COMPLETED|Overall Study||14
2333303|NCT01779869|5726300|P1|STARTED|Overall Study||16
2333304|NCT01779700|5726306|P2|NOT COMPLETED|Overall Study||5
2333305|NCT01779700|5726307|P1|NOT COMPLETED|Overall Study||4
2333306|NCT01779700|5726306|P2|COMPLETED|Overall Study||17
2333307|NCT01779700|5726307|P1|COMPLETED|Overall Study||14
2333308|NCT01779700|5726306|P2|STARTED|Overall Study||22
2333309|NCT01779700|5726307|P1|STARTED|Overall Study||18
2333310|NCT01779648|5726347|P2|NOT COMPLETED|Overall Study||0
2333311|NCT01779648|5726348|P1|NOT COMPLETED|Overall Study||1
2333312|NCT01779648|5726347|P2|COMPLETED|Overall Study||27
2333313|NCT01779648|5726348|P1|COMPLETED|Overall Study||27
2333314|NCT01779648|5726347|P2|STARTED|Overall Study||27
2333315|NCT01779648|5726348|P1|STARTED|Overall Study||28
2333316|NCT01779440|5726378|P2|NOT COMPLETED|Overall Study||5
2333317|NCT01779440|5726379|P1|NOT COMPLETED|Overall Study||3
2333318|NCT01779440|5726378|P2|COMPLETED|Overall Study||23
2333319|NCT01779440|5726379|P1|COMPLETED|Overall Study||27
2333320|NCT01779440|5726378|P2|STARTED|Overall Study||28
2333321|NCT01779440|5726379|P1|STARTED|Overall Study||30
2333322|NCT01779375|5726389|P2|NOT COMPLETED|Overall Study||3
2333323|NCT01779375|5726390|P1|NOT COMPLETED|Overall Study||2
2333324|NCT01779375|5726389|P2|COMPLETED|Overall Study||41
2333325|NCT01779375|5726390|P1|COMPLETED|Overall Study||45
2333326|NCT01779375|5726389|P2|STARTED|Overall Study||44
2333327|NCT01779375|5726390|P1|STARTED|Overall Study||47
2333328|NCT01779219|5726406|P2|NOT COMPLETED|Overall Study||0
2333329|NCT01779219|5726407|P1|NOT COMPLETED|Overall Study||0
2333330|NCT01779219|5726406|P2|COMPLETED|Overall Study|First interim analysis|21
2333331|NCT01779219|5726407|P1|COMPLETED|Overall Study|First interim analysis|21
2333332|NCT01779219|5726406|P2|STARTED|Overall Study|First interim analysis|21
2333333|NCT01779219|5726407|P1|STARTED|Overall Study|First interim analysis|21
2333334|NCT01779167|5726419|P1|NOT COMPLETED|Overall Study||1
2333335|NCT01779167|5726419|P1|COMPLETED|Overall Study||3
2333336|NCT01779167|5726419|P1|STARTED|Overall Study||4
2333337|NCT01779141|5726428|P1|NOT COMPLETED|Overall Study||181
2333338|NCT01779141|5726428|P1|COMPLETED|Overall Study||300
2333339|NCT01779141|5726428|P1|STARTED|Overall Study||481
2333340|NCT01779024|5726435|P2|NOT COMPLETED|2nd Visit - Functional MRI||0
2333341|NCT01779024|5726436|P1|NOT COMPLETED|2nd Visit - Functional MRI||0
2333342|NCT01779024|5726435|P2|COMPLETED|2nd Visit - Functional MRI||6
2333343|NCT01779024|5726436|P1|COMPLETED|2nd Visit - Functional MRI||5
2333344|NCT01779024|5726435|P2|STARTED|2nd Visit - Functional MRI||6
2333345|NCT01779024|5726436|P1|STARTED|2nd Visit - Functional MRI||5
2333346|NCT01779024|5726435|P2|NOT COMPLETED|1st Visit - Functional MRI||2
2333347|NCT01779024|5726436|P1|NOT COMPLETED|1st Visit - Functional MRI||2
2333348|NCT01779024|5726435|P2|COMPLETED|1st Visit - Functional MRI||5
2333349|NCT01779024|5726436|P1|COMPLETED|1st Visit - Functional MRI||4
2333350|NCT01779024|5726435|P2|STARTED|1st Visit - Functional MRI||7
2333351|NCT01779024|5726436|P1|STARTED|1st Visit - Functional MRI||6
2333352|NCT01779024|5726435|P2|NOT COMPLETED|2nd Visit - Alcohol Self-Administration||0
2333353|NCT01779024|5726436|P1|NOT COMPLETED|2nd Visit - Alcohol Self-Administration||2
2333354|NCT01779024|5726435|P2|COMPLETED|2nd Visit - Alcohol Self-Administration||9
2333355|NCT01779024|5726436|P1|COMPLETED|2nd Visit - Alcohol Self-Administration||6
2333356|NCT01779024|5726435|P2|STARTED|2nd Visit - Alcohol Self-Administration||9
2333357|NCT01779024|5726436|P1|STARTED|2nd Visit - Alcohol Self-Administration||8
2333358|NCT01779024|5726435|P2|NOT COMPLETED|1st Visit - Alcohol Self-Administration||0
2333359|NCT01779024|5726436|P1|NOT COMPLETED|1st Visit - Alcohol Self-Administration||0
2333360|NCT01779024|5726435|P2|COMPLETED|1st Visit - Alcohol Self-Administration||9
2333361|NCT01779024|5726436|P1|COMPLETED|1st Visit - Alcohol Self-Administration||8
2333362|NCT01779024|5726435|P2|STARTED|1st Visit - Alcohol Self-Administration||9
2333363|NCT01779024|5726436|P1|STARTED|1st Visit - Alcohol Self-Administration||8
2333364|NCT01778985|5726444|P2|NOT COMPLETED|Overall Study||3
2333365|NCT01778985|5726445|P1|NOT COMPLETED|Overall Study||7
2333366|NCT01778985|5726444|P2|COMPLETED|Overall Study||12
2333367|NCT01778985|5726445|P1|COMPLETED|Overall Study||8
2333368|NCT01778985|5726444|P2|STARTED|Overall Study||15
2333369|NCT01778985|5726445|P1|STARTED|Overall Study||15
2333370|NCT01778855|5726491|P2|NOT COMPLETED|Overall Study||1
2333371|NCT01778855|5726492|P1|NOT COMPLETED|Overall Study||0
2333372|NCT01778855|5726491|P2|COMPLETED|Overall Study||3
2333373|NCT01778855|5726492|P1|COMPLETED|Overall Study||2
2333374|NCT01778855|5726491|P2|STARTED|Overall Study||4
2333375|NCT01778855|5726492|P1|STARTED|Overall Study||2
2333376|NCT01778751|5726500|P2|NOT COMPLETED|Overall Study||2
2333377|NCT01778751|5726501|P1|NOT COMPLETED|Overall Study||2
2333378|NCT01778751|5726500|P2|COMPLETED|Overall Study||23
2333379|NCT01778751|5726501|P1|COMPLETED|Overall Study||23
2333380|NCT01778751|5726500|P2|STARTED|Overall Study||25
2333381|NCT01778751|5726501|P1|STARTED|Overall Study||25
2333382|NCT01778634|5726515|P2|NOT COMPLETED|Overall Study||0
2333383|NCT01778634|5726516|P1|NOT COMPLETED|Overall Study||0
2333384|NCT01778634|5726515|P2|COMPLETED|Overall Study||60
2333385|NCT01778634|5726516|P1|COMPLETED|Overall Study||61
2333386|NCT01778634|5726515|P2|STARTED|Overall Study||60
2333387|NCT01778634|5726516|P1|STARTED|Overall Study||61
2333388|NCT01778556|5726554|P2|NOT COMPLETED|Long-term Follow-up||0
2333389|NCT01778556|5726555|P1|NOT COMPLETED|Long-term Follow-up||1
2333390|NCT01778556|5726554|P2|COMPLETED|Long-term Follow-up|no long-term follow-up period in on-leptin arm|0
2333391|NCT01778556|5726555|P1|COMPLETED|Long-term Follow-up||14
2333392|NCT01778556|5726554|P2|STARTED|Long-term Follow-up|no long-term follow-up period in on-leptin arm|0
2333393|NCT01778556|5726555|P1|STARTED|Long-term Follow-up||15
2333394|NCT01778556|5726554|P2|NOT COMPLETED|Intervention 2 (14 Days)||0
2333395|NCT01778556|5726555|P1|NOT COMPLETED|Intervention 2 (14 Days)||1
2333396|NCT01778556|5726554|P2|COMPLETED|Intervention 2 (14 Days)||8
2333397|NCT01778556|5726555|P1|COMPLETED|Intervention 2 (14 Days)||14
2333398|NCT01778556|5726554|P2|STARTED|Intervention 2 (14 Days)||8
2333399|NCT01778556|5726555|P1|STARTED|Intervention 2 (14 Days)||15
2333400|NCT01778556|5726554|P2|NOT COMPLETED|Intervention 1 (5 Days)||2
2333401|NCT01778556|5726555|P1|NOT COMPLETED|Intervention 1 (5 Days)||0
2333402|NCT01778556|5726554|P2|COMPLETED|Intervention 1 (5 Days)||8
2333403|NCT01778556|5726555|P1|COMPLETED|Intervention 1 (5 Days)||15
2333404|NCT01778556|5726554|P2|STARTED|Intervention 1 (5 Days)||10
2333405|NCT01778556|5726555|P1|STARTED|Intervention 1 (5 Days)||15
2333406|NCT01778530|5726568|P1|NOT COMPLETED|Overall Study||2
2333407|NCT01778530|5726568|P1|COMPLETED|Overall Study||0
2333408|NCT01778530|5726568|P1|STARTED|Overall Study||2
2333409|NCT01778426|5726575|P2|NOT COMPLETED|Intention-To-Treat (ITT) - Completer||0
2333410|NCT01778426|5726576|P1|NOT COMPLETED|Intention-To-Treat (ITT) - Completer||0
2333411|NCT01778426|5726575|P2|COMPLETED|Intention-To-Treat (ITT) - Completer|Not applicable: ITT-completer contains only primo-implant subjects.|0
2333412|NCT01778426|5726576|P1|COMPLETED|Intention-To-Treat (ITT) - Completer||198
2333413|NCT01778426|5726575|P2|STARTED|Intention-To-Treat (ITT) - Completer|Not applicable: ITT-completer contains only primo-implant subjects.|0
2333414|NCT01778426|5726576|P1|STARTED|Intention-To-Treat (ITT) - Completer||198
2333415|NCT01778426|5726575|P2|NOT COMPLETED|Overall Study - Full Analysis Set (FAS)||25
2333416|NCT01778426|5726576|P1|NOT COMPLETED|Overall Study - Full Analysis Set (FAS)||56
2333417|NCT01778426|5726575|P2|COMPLETED|Overall Study - Full Analysis Set (FAS)||113
2333418|NCT01778426|5726576|P1|COMPLETED|Overall Study - Full Analysis Set (FAS)||208
2333419|NCT01778426|5726575|P2|STARTED|Overall Study - Full Analysis Set (FAS)||138
2333420|NCT01778426|5726576|P1|STARTED|Overall Study - Full Analysis Set (FAS)||264
2333421|NCT01778296|5726592|P1|NOT COMPLETED|Overall Study||0
2333422|NCT01778296|5726592|P1|COMPLETED|Overall Study|No patient was lost to follow-up.|12
2333423|NCT01778296|5726592|P1|STARTED|Overall Study|There were 12 patients included in the study in the initial stage.|12
2333424|NCT01778127|5726599|P3|NOT COMPLETED|Overall Study||6
2333425|NCT01778127|5726600|P2|NOT COMPLETED|Overall Study||2
2333426|NCT01778127|5726601|P1|NOT COMPLETED|Overall Study||8
2333427|NCT01778127|5726599|P3|COMPLETED|Overall Study||26
2333428|NCT01778127|5726600|P2|COMPLETED|Overall Study||31
2333429|NCT01778127|5726601|P1|COMPLETED|Overall Study||25
2333430|NCT01778127|5726599|P3|STARTED|Overall Study||32
2333431|NCT01778127|5726600|P2|STARTED|Overall Study||33
2333432|NCT01778127|5726601|P1|STARTED|Overall Study||33
2333433|NCT01778062|5726644|P2|NOT COMPLETED|Overall Study||11
2333434|NCT01778062|5726645|P1|NOT COMPLETED|Overall Study||6
2333435|NCT01778062|5726644|P2|COMPLETED|Overall Study||57
2333436|NCT01778062|5726645|P1|COMPLETED|Overall Study||62
2333437|NCT01778062|5726644|P2|Intent to Treat (ITT)|Overall Study|One failed to perform primary efficacy evaluation and was excluded, 135 were included in the ITT set|67
2333438|NCT01778062|5726645|P1|Intent to Treat (ITT)|Overall Study||68
2333439|NCT01778062|5726644|P2|Safety Set|Overall Study||68
2333440|NCT01778062|5726645|P1|Safety Set|Overall Study||68
2333441|NCT01778062|5726644|P2|STARTED|Overall Study||68
2333442|NCT01778062|5726645|P1|STARTED|Overall Study||68
2333443|NCT01778049|5726659|P6|NOT COMPLETED|Double Blind Treatment Period||7
2333444|NCT01778049|5726660|P5|NOT COMPLETED|Double Blind Treatment Period||12
2333445|NCT01778049|5726661|P4|NOT COMPLETED|Double Blind Treatment Period||12
2333446|NCT01778049|5726662|P3|NOT COMPLETED|Double Blind Treatment Period||15
2333447|NCT01778049|5726663|P2|NOT COMPLETED|Double Blind Treatment Period||0
2333448|NCT01778049|5726664|P1|NOT COMPLETED|Double Blind Treatment Period||0
2333449|NCT01778049|5726659|P6|COMPLETED|Double Blind Treatment Period||105
2333450|NCT01778049|5726660|P5|COMPLETED|Double Blind Treatment Period||102
2333451|NCT01778049|5726661|P4|COMPLETED|Double Blind Treatment Period||118
2333452|NCT01778049|5726662|P3|COMPLETED|Double Blind Treatment Period||111
2333453|NCT01778049|5726663|P2|COMPLETED|Double Blind Treatment Period||0
2333454|NCT01778049|5726664|P1|COMPLETED|Double Blind Treatment Period||0
2333455|NCT01778049|5726659|P6|STARTED|Double Blind Treatment Period||112
2333456|NCT01778049|5726660|P5|STARTED|Double Blind Treatment Period||114
2333457|NCT01778049|5726661|P4|STARTED|Double Blind Treatment Period||130
2333458|NCT01778049|5726662|P3|STARTED|Double Blind Treatment Period||126
2333459|NCT01778049|5726663|P2|STARTED|Double Blind Treatment Period||0
2333460|NCT01778049|5726664|P1|STARTED|Double Blind Treatment Period||0
2333461|NCT01778049|5726659|P6|NOT COMPLETED|Open Label Treatment Period||0
2333462|NCT01778049|5726660|P5|NOT COMPLETED|Open Label Treatment Period||0
2333463|NCT01778049|5726661|P4|NOT COMPLETED|Open Label Treatment Period||0
2333464|NCT01778049|5726662|P3|NOT COMPLETED|Open Label Treatment Period||0
2333465|NCT01778049|5726663|P2|NOT COMPLETED|Open Label Treatment Period||129
2333466|NCT01778049|5726664|P1|NOT COMPLETED|Open Label Treatment Period||98
2333467|NCT01778049|5726659|P6|COMPLETED|Open Label Treatment Period||0
2333468|NCT01778049|5726660|P5|COMPLETED|Open Label Treatment Period||0
2333469|NCT01778049|5726661|P4|COMPLETED|Open Label Treatment Period||0
2333470|NCT01778049|5726662|P3|COMPLETED|Open Label Treatment Period||0
2333471|NCT01778049|5726663|P2|COMPLETED|Open Label Treatment Period||226
2333472|NCT01778049|5726664|P1|COMPLETED|Open Label Treatment Period||256
2333473|NCT01778049|5726659|P6|STARTED|Open Label Treatment Period||0
2333474|NCT01778049|5726660|P5|STARTED|Open Label Treatment Period||0
2333475|NCT01778049|5726661|P4|STARTED|Open Label Treatment Period||0
2333476|NCT01778049|5726662|P3|STARTED|Open Label Treatment Period||0
2333477|NCT01778049|5726663|P2|STARTED|Open Label Treatment Period||355
2333478|NCT01778049|5726664|P1|STARTED|Open Label Treatment Period||354
2333479|NCT01778023|5726682|P2|NOT COMPLETED|Overall Study||3
2333480|NCT01778023|5726683|P1|NOT COMPLETED|Overall Study||0
2333481|NCT01778023|5726682|P2|COMPLETED|Overall Study||15
2333482|NCT01778023|5726683|P1|COMPLETED|Overall Study||36
2333483|NCT01778023|5726682|P2|Exposed|Overall Study||15
2333484|NCT01778023|5726683|P1|Exposed|Overall Study||36
2333485|NCT01778023|5726682|P2|STARTED|Overall Study||18
2333486|NCT01778023|5726683|P1|STARTED|Overall Study||36
2333487|NCT01778010|5726700|P1|NOT COMPLETED|Overall Study||5
2333488|NCT01778010|5726700|P1|COMPLETED|Overall Study||8
2333489|NCT01778010|5726700|P1|STARTED|Overall Study||13
2333490|NCT01777997|5726741|P1|NOT COMPLETED|Weeks 48 to 72/96 on ART||2
2333491|NCT01777997|5726741|P1|COMPLETED|Weeks 48 to 72/96 on ART||26
2333492|NCT01777997|5726741|P1|STARTED|Weeks 48 to 72/96 on ART||28
2333493|NCT01777997|5726741|P1|NOT COMPLETED|Weeks 0 to 24/48 on ART||1
2333494|NCT01777997|5726741|P1|COMPLETED|Weeks 0 to 24/48 on ART|7 of these participants opted not to continue ART into next period|35
2333495|NCT01777997|5726741|P1|STARTED|Weeks 0 to 24/48 on ART||36
2333496|NCT01777997|5726741|P1|NOT COMPLETED|12 Week lead-in of no ART||2
2333497|NCT01777997|5726741|P1|COMPLETED|12 Week lead-in of no ART||36
2333498|NCT01777997|5726741|P1|STARTED|12 Week lead-in of no ART||38
2333499|NCT01777945|5726753|P1|NOT COMPLETED|Overall Study||0
2333500|NCT01777945|5726753|P1|COMPLETED|Overall Study||46
2333501|NCT01777945|5726753|P1|Evaluable Participants|Overall Study||45
2333502|NCT01777945|5726753|P1|STARTED|Overall Study||46
2333503|NCT01777932|5726763|P1|NOT COMPLETED|Overall Study||205
2333504|NCT01777932|5726763|P1|COMPLETED|Overall Study||15
2333505|NCT01777932|5726763|P1|STARTED|Overall Study||220
2333506|NCT01777854|5726777|P2|NOT COMPLETED|Overall Study||3
2333507|NCT01777854|5726778|P1|NOT COMPLETED|Overall Study||3
2333508|NCT01777854|5726777|P2|COMPLETED|Overall Study||0
2333509|NCT01777854|5726778|P1|COMPLETED|Overall Study||0
2333510|NCT01777854|5726777|P2|STARTED|Overall Study||3
2333511|NCT01777854|5726778|P1|STARTED|Overall Study||3
2333512|NCT01777776|5726786|P4|NOT COMPLETED|Overall Study||4
2333513|NCT01777776|5726787|P3|NOT COMPLETED|Overall Study||6
2333514|NCT01777776|5726788|P2|NOT COMPLETED|Overall Study||12
2333515|NCT01777776|5726789|P1|NOT COMPLETED|Overall Study||6
2333516|NCT01777776|5726786|P4|COMPLETED|Overall Study||0
2333517|NCT01777776|5726787|P3|COMPLETED|Overall Study||0
2333518|NCT01777776|5726788|P2|COMPLETED|Overall Study||0
2333519|NCT01777776|5726789|P1|COMPLETED|Overall Study||0
2333520|NCT01777776|5726786|P4|STARTED|Overall Study||4
2333521|NCT01777776|5726787|P3|STARTED|Overall Study||6
2333522|NCT01777776|5726788|P2|STARTED|Overall Study||12
2333523|NCT01777776|5726789|P1|STARTED|Overall Study||6
2333524|NCT01777763|5726848|P2|NOT COMPLETED|Overall Study||47
2333525|NCT01777763|5726849|P1|NOT COMPLETED|Overall Study||4
2333526|NCT01777763|5726848|P2|COMPLETED|Overall Study||163
2333527|NCT01777763|5726849|P1|COMPLETED|Overall Study||16
2333528|NCT01777763|5726848|P2|STARTED|Overall Study||210
2333529|NCT01777763|5726849|P1|STARTED|Overall Study||20
2333530|NCT01777620|5726873|P2|NOT COMPLETED|Overall Study||0
2333531|NCT01777620|5726874|P1|NOT COMPLETED|Overall Study||1
2333532|NCT01777620|5726873|P2|COMPLETED|Overall Study||62
2333533|NCT01777620|5726874|P1|COMPLETED|Overall Study||62
2333534|NCT01777620|5726873|P2|STARTED|Overall Study||62
2333535|NCT01777620|5726874|P1|STARTED|Overall Study||63
2333536|NCT01777581|5726900|P2|NOT COMPLETED|Overall Study||2
2333537|NCT01777581|5726901|P1|NOT COMPLETED|Overall Study||3
2333538|NCT01777581|5726900|P2|COMPLETED|Overall Study||3
2333539|NCT01777581|5726901|P1|COMPLETED|Overall Study||5
2333540|NCT01777581|5726900|P2|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|5
2333541|NCT01777581|5726901|P1|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|8
2333542|NCT01777568|5726921|P2|NOT COMPLETED|Overall Study||0
2333543|NCT01777568|5726922|P1|NOT COMPLETED|Overall Study||0
2333544|NCT01777568|5726921|P2|COMPLETED|Overall Study||2896
2333545|NCT01777568|5726922|P1|COMPLETED|Overall Study||2853
2333546|NCT01777568|5726921|P2|STARTED|Overall Study||2896
2333547|NCT01777568|5726922|P1|STARTED|Overall Study||2853
2333548|NCT01777542|5726930|P2|NOT COMPLETED|Second Intervention (20 Weeks)||1
2333549|NCT01777542|5726931|P1|NOT COMPLETED|Second Intervention (20 Weeks)||0
2333550|NCT01777542|5726930|P2|COMPLETED|Second Intervention (20 Weeks)||14
2333551|NCT01777542|5726931|P1|COMPLETED|Second Intervention (20 Weeks)||15
2333552|NCT01777542|5726930|P2|STARTED|Second Intervention (20 Weeks)||15
2333553|NCT01777542|5726931|P1|STARTED|Second Intervention (20 Weeks)||15
2333554|NCT01777542|5726930|P2|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0
2333555|NCT01777542|5726931|P1|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0
2333556|NCT01777542|5726930|P2|COMPLETED|Washout Period (28 +/- 2 Weeks)||15
2333557|NCT01777542|5726931|P1|COMPLETED|Washout Period (28 +/- 2 Weeks)||15
2333558|NCT01777542|5726930|P2|STARTED|Washout Period (28 +/- 2 Weeks)||15
2333559|NCT01777542|5726931|P1|STARTED|Washout Period (28 +/- 2 Weeks)||15
2333560|NCT01777542|5726930|P2|NOT COMPLETED|First Intervention (20 Weeks)||0
2333561|NCT01777542|5726931|P1|NOT COMPLETED|First Intervention (20 Weeks)||0
2333562|NCT01777542|5726930|P2|COMPLETED|First Intervention (20 Weeks)||15
2333563|NCT01777542|5726931|P1|COMPLETED|First Intervention (20 Weeks)||15
2333564|NCT01777542|5726930|P2|STARTED|First Intervention (20 Weeks)||15
2333565|NCT01777542|5726931|P1|STARTED|First Intervention (20 Weeks)||15
2333566|NCT01777490|5726974|P4|NOT COMPLETED|Overall Study||1
2333567|NCT01777490|5726975|P3|NOT COMPLETED|Overall Study||1
2333568|NCT01777490|5726976|P2|NOT COMPLETED|Overall Study||0
2333569|NCT01777490|5726977|P1|NOT COMPLETED|Overall Study||0
2333570|NCT01777490|5726974|P4|COMPLETED|Overall Study||118
2333571|NCT01777490|5726975|P3|COMPLETED|Overall Study||118
2333572|NCT01777490|5726976|P2|COMPLETED|Overall Study||123
2333573|NCT01777490|5726977|P1|COMPLETED|Overall Study||123
2333574|NCT01777490|5726974|P4|STARTED|Overall Study||119
2333575|NCT01777490|5726975|P3|STARTED|Overall Study||119
2333576|NCT01777490|5726976|P2|STARTED|Overall Study||123
2333577|NCT01777490|5726977|P1|STARTED|Overall Study||123
2333578|NCT01777438|5726995|P2|NOT COMPLETED|Overall Study||0
2333579|NCT01777438|5726996|P1|NOT COMPLETED|Overall Study||0
2333580|NCT01777438|5726995|P2|COMPLETED|Overall Study||82
2333581|NCT01777438|5726996|P1|COMPLETED|Overall Study||352
2333582|NCT01777438|5726995|P2|STARTED|Overall Study||82
2333583|NCT01777438|5726996|P1|STARTED|Overall Study||352
2333584|NCT01777425|5727008|P1|NOT COMPLETED|Overall Study||0
2333585|NCT01777425|5727008|P1|COMPLETED|Overall Study||389
2333586|NCT01777425|5727008|P1|STARTED|Overall Study||389
2333587|NCT01777412|5727014|P1|NOT COMPLETED|Overall Study||0
2333588|NCT01777412|5727014|P1|COMPLETED|Overall Study||10
2333589|NCT01777412|5727014|P1|STARTED|Overall Study||10
2333590|NCT01777334|5727022|P2|NOT COMPLETED|Overall Study||63
2333591|NCT01777334|5727023|P1|NOT COMPLETED|Overall Study||53
2333592|NCT01777334|5727022|P2|COMPLETED|Overall Study||388
2333593|NCT01777334|5727023|P1|COMPLETED|Overall Study||401
2333594|NCT01777334|5727022|P2|STARTED|Overall Study||451
2333595|NCT01777334|5727023|P1|STARTED|Overall Study||454
2333596|NCT01777321|5727033|P2|NOT COMPLETED|Overall Study||1
2333597|NCT01777321|5727034|P1|NOT COMPLETED|Overall Study||0
2333598|NCT01777321|5727033|P2|COMPLETED|Overall Study||29
2333599|NCT01777321|5727034|P1|COMPLETED|Overall Study||30
2333600|NCT01777321|5727033|P2|STARTED|Overall Study||30
2333601|NCT01777321|5727034|P1|STARTED|Overall Study||30
2333602|NCT01777308|5727072|P2|NOT COMPLETED|Overall Study||3
2333603|NCT01777308|5727073|P1|NOT COMPLETED|Overall Study||14
2333604|NCT01777308|5727072|P2|COMPLETED|Overall Study||34
2333605|NCT01777308|5727073|P1|COMPLETED|Overall Study||105
2333606|NCT01777308|5727072|P2|Completed up to Month 73|Overall Study||37
2333607|NCT01777308|5727073|P1|Completed up to Month 73|Overall Study||118
2333608|NCT01777308|5727072|P2|STARTED|Overall Study||37
2333609|NCT01777308|5727073|P1|STARTED|Overall Study||119
2333610|NCT01777295|5727105|P2|NOT COMPLETED|Overall Study||3
2333611|NCT01777295|5727106|P1|NOT COMPLETED|Overall Study||4
2333612|NCT01777295|5727105|P2|COMPLETED|Overall Study||38
2333613|NCT01777295|5727106|P1|COMPLETED|Overall Study||36
2333614|NCT01777295|5727105|P2|STARTED|Overall Study||41
2333615|NCT01777295|5727106|P1|STARTED|Overall Study||40
2333616|NCT01777282|5727313|P5|NOT COMPLETED|Overall Study||7
2333617|NCT01777282|5727314|P4|NOT COMPLETED|Overall Study||2
2333618|NCT01777282|5727315|P3|NOT COMPLETED|Overall Study||6
2333619|NCT01777282|5727316|P2|NOT COMPLETED|Overall Study||4
2333620|NCT01777282|5727317|P1|NOT COMPLETED|Overall Study||11
2333621|NCT01777282|5727313|P5|COMPLETED|Overall Study||54
2333622|NCT01777282|5727314|P4|COMPLETED|Overall Study||59
2333623|NCT01777282|5727315|P3|COMPLETED|Overall Study||59
2333624|NCT01777282|5727316|P2|COMPLETED|Overall Study||63
2333625|NCT01777282|5727317|P1|COMPLETED|Overall Study||109
2333626|NCT01777282|5727313|P5|Completing Follow-up Period|Overall Study||54
2333627|NCT01777282|5727314|P4|Completing Follow-up Period|Overall Study||59
2333628|NCT01777282|5727315|P3|Completing Follow-up Period|Overall Study||59
2333629|NCT01777282|5727316|P2|Completing Follow-up Period|Overall Study||63
2333630|NCT01777282|5727317|P1|Completing Follow-up Period|Overall Study||109
2333631|NCT01777282|5727313|P5|Completing Treatment Period|Overall Study||54
2333632|NCT01777282|5727314|P4|Completing Treatment Period|Overall Study||59
2333633|NCT01777282|5727315|P3|Completing Treatment Period|Overall Study||59
2333634|NCT01777282|5727316|P2|Completing Treatment Period|Overall Study||63
2333635|NCT01777282|5727317|P1|Completing Treatment Period|Overall Study||109
2333636|NCT01777282|5727313|P5|STARTED|Overall Study||61
2333637|NCT01777282|5727314|P4|STARTED|Overall Study||61
2333638|NCT01777282|5727315|P3|STARTED|Overall Study||65
2333639|NCT01777282|5727316|P2|STARTED|Overall Study||67
2333640|NCT01777282|5727317|P1|STARTED|Overall Study||120
2333641|NCT01777269|5727361|P2|NOT COMPLETED|Overall Study||59
2333642|NCT01777269|5727362|P1|NOT COMPLETED|Overall Study||55
2333643|NCT01777269|5727361|P2|COMPLETED|Overall Study||184
2333644|NCT01777269|5727362|P1|COMPLETED|Overall Study||191
2333645|NCT01777269|5727361|P2|STARTED|Overall Study||243
2333646|NCT01777269|5727362|P1|STARTED|Overall Study||246
2333647|NCT01777217|5727390|P2|NOT COMPLETED|Overall Study||0
2333648|NCT01777217|5727391|P1|NOT COMPLETED|Overall Study||0
2333649|NCT01777217|5727390|P2|COMPLETED|Overall Study||4
2333650|NCT01777217|5727391|P1|COMPLETED|Overall Study||4
2333651|NCT01777217|5727390|P2|STARTED|Overall Study||4
2333652|NCT01777217|5727391|P1|STARTED|Overall Study||4
2333653|NCT01777191|5727399|P2|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||13
2333654|NCT01777191|5727400|P1|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||9
2333655|NCT01777191|5727399|P2|COMPLETED|Safety Extension Per (Week 12-Week 48)||78
2333656|NCT01777191|5727400|P1|COMPLETED|Safety Extension Per (Week 12-Week 48)||85
2333657|NCT01777191|5727399|P2|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|91
2333658|NCT01777191|5727400|P1|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|94
2333659|NCT01777191|5727399|P2|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||8
2333660|NCT01777191|5727400|P1|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||6
2333661|NCT01777191|5727399|P2|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||94
2333662|NCT01777191|5727400|P1|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||96
2333663|NCT01777191|5727399|P2|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
2333664|NCT01777191|5727400|P1|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
2333665|NCT01777152|5727430|P2|NOT COMPLETED|Overall Study||226
2333666|NCT01777152|5727431|P1|NOT COMPLETED|Overall Study||226
2333667|NCT01777152|5727430|P2|COMPLETED|Overall Study||0
2333668|NCT01777152|5727431|P1|COMPLETED|Overall Study||0
2333669|NCT01777152|5727430|P2|STARTED|Overall Study||226
2333670|NCT01777152|5727431|P1|STARTED|Overall Study||226
2333671|NCT01777139|5727447|P2|NOT COMPLETED|SFUCP (Up to 1.4 Years)||4
2333672|NCT01777139|5727448|P1|NOT COMPLETED|SFUCP (Up to 1.4 Years)||0
2333673|NCT01777139|5727447|P2|COMPLETED|SFUCP (Up to 1.4 Years)||0
2333674|NCT01777139|5727448|P1|COMPLETED|SFUCP (Up to 1.4 Years)||0
2333675|NCT01777139|5727447|P2|STARTED|SFUCP (Up to 1.4 Years)||4
2333676|NCT01777139|5727448|P1|STARTED|SFUCP (Up to 1.4 Years)||0
2333677|NCT01777139|5727447|P2|NOT COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
2333678|NCT01777139|5727448|P1|NOT COMPLETED|Primary Reporting Phase (Up to 4 Years)||30
2333679|NCT01777139|5727447|P2|COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
2333680|NCT01777139|5727448|P1|COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
2333681|NCT01777139|5727447|P2|STARTED|Primary Reporting Phase (Up to 4 Years)||0
2333682|NCT01777139|5727448|P1|STARTED|Primary Reporting Phase (Up to 4 Years)||30
2333683|NCT01777126|5727489|P2|NOT COMPLETED|Overall Study||0
2333684|NCT01777126|5727490|P1|NOT COMPLETED|Overall Study||0
2333685|NCT01777126|5727489|P2|COMPLETED|Overall Study||46
2333686|NCT01777126|5727490|P1|COMPLETED|Overall Study||48
2333687|NCT01777126|5727489|P2|STARTED|Overall Study||46
2333688|NCT01777126|5727490|P1|STARTED|Overall Study||48
2333689|NCT01776645|5727513|P2|NOT COMPLETED|Overall Study||14
2333690|NCT01776645|5727514|P1|NOT COMPLETED|Overall Study||14
2333691|NCT01776645|5727513|P2|COMPLETED|Overall Study||14
2333692|NCT01776645|5727514|P1|COMPLETED|Overall Study||14
2333693|NCT01776645|5727513|P2|STARTED|Overall Study||28
2333694|NCT01776645|5727514|P1|STARTED|Overall Study||28
2333695|NCT01776632|5727522|P2|NOT COMPLETED|Overall Study||29
2333696|NCT01776632|5727523|P1|NOT COMPLETED|Overall Study||27
2333697|NCT01776632|5727522|P2|COMPLETED|Overall Study||190
2333698|NCT01776632|5727523|P1|COMPLETED|Overall Study||190
2333699|NCT01776632|5727522|P2|STARTED|Overall Study||219
2333700|NCT01776632|5727523|P1|STARTED|Overall Study||217
2333701|NCT01776554|5727537|P2|NOT COMPLETED|Overall Study||23
2333702|NCT01776554|5727538|P1|NOT COMPLETED|Overall Study||17
2333703|NCT01776554|5727537|P2|COMPLETED|Overall Study||307
2333704|NCT01776554|5727538|P1|COMPLETED|Overall Study||315
2333705|NCT01776554|5727537|P2|STARTED|Overall Study||330
2333706|NCT01776554|5727538|P1|STARTED|Overall Study||332
2333707|NCT01776541|5727581|P2|NOT COMPLETED|Overall Study||75
2333708|NCT01776541|5727582|P1|NOT COMPLETED|Overall Study||56
2333709|NCT01776541|5727581|P2|COMPLETED|Overall Study||416
2333710|NCT01776541|5727582|P1|COMPLETED|Overall Study||432
2333711|NCT01776541|5727581|P2|STARTED|Overall Study||491
2333712|NCT01776541|5727582|P1|STARTED|Overall Study||488
2333713|NCT01776424|5727604|P3|NOT COMPLETED|Overall Study||24
2333714|NCT01776424|5727605|P2|NOT COMPLETED|Overall Study||19
2333715|NCT01776424|5727606|P1|NOT COMPLETED|Overall Study||20
2333716|NCT01776424|5727604|P3|COMPLETED|Overall Study||9102
2333717|NCT01776424|5727605|P2|COMPLETED|Overall Study||9098
2333718|NCT01776424|5727606|P1|COMPLETED|Overall Study||9132
2333719|NCT01776424|5727604|P3|Treated|Overall Study||9107
2333720|NCT01776424|5727605|P2|Treated|Overall Study||9110
2333721|NCT01776424|5727606|P1|Treated|Overall Study||9134
2333722|NCT01776424|5727604|P3|STARTED|Overall Study||9126
2333723|NCT01776424|5727605|P2|STARTED|Overall Study||9117
2333724|NCT01776424|5727606|P1|STARTED|Overall Study||9152
2333725|NCT01776268|5727628|P2|NOT COMPLETED|Overall Study||0
2333726|NCT01776268|5727629|P1|NOT COMPLETED|Overall Study||0
2333727|NCT01776268|5727628|P2|COMPLETED|Overall Study||51
2333728|NCT01776268|5727629|P1|COMPLETED|Overall Study||48
2333729|NCT01776268|5727628|P2|STARTED|Overall Study||51
2333730|NCT01776268|5727629|P1|STARTED|Overall Study||48
2333731|NCT01776008|5727637|P1|NOT COMPLETED|Overall Study||2
2333732|NCT01776008|5727637|P1|COMPLETED|Overall Study||14
2333733|NCT01776008|5727637|P1|STARTED|Overall Study||16
2333734|NCT01775995|5727651|P2|NOT COMPLETED|Overall Study||1
2333735|NCT01775995|5727652|P1|NOT COMPLETED|Overall Study||1
2333736|NCT01775995|5727651|P2|COMPLETED|Overall Study|One control participant was unable to reach at 26 week follow up|13
2333737|NCT01775995|5727652|P1|COMPLETED|Overall Study|One experimental participant was unable to reach at 26 week follow up|20
2333738|NCT01775995|5727651|P2|STARTED|Overall Study||14
2333739|NCT01775995|5727652|P1|STARTED|Overall Study||21
2333740|NCT01775904|5727712|P1|NOT COMPLETED|LY2886721 ODT (Water, Fasting)||1
2333741|NCT01775904|5727712|P1|COMPLETED|LY2886721 ODT (Water, Fasting)||24
2333742|NCT01775904|5727712|P1|Received at Least One Dose of Drug|LY2886721 ODT (Water, Fasting)|One participant was not dosed in this period due to an adverse event (AE).|24
2333743|NCT01775904|5727712|P1|STARTED|LY2886721 ODT (Water, Fasting)||25
2333744|NCT01775904|5727712|P1|NOT COMPLETED|Third Washout (7 Days)||0
2333745|NCT01775904|5727712|P1|COMPLETED|Third Washout (7 Days)||25
2333746|NCT01775904|5727712|P1|STARTED|Third Washout (7 Days)||25
2333747|NCT01775904|5727712|P1|NOT COMPLETED|LY2886721 ODT (Water, Fed)||0
2333748|NCT01775904|5727712|P1|COMPLETED|LY2886721 ODT (Water, Fed)||25
2333749|NCT01775904|5727712|P1|Received at Least One Dose of Drug|LY2886721 ODT (Water, Fed)||25
2333750|NCT01775904|5727712|P1|STARTED|LY2886721 ODT (Water, Fed)||25
2333751|NCT01775904|5727712|P1|NOT COMPLETED|Second Washout (7 Days)||0
2333752|NCT01775904|5727712|P1|COMPLETED|Second Washout (7 Days)||25
2333753|NCT01775904|5727712|P1|STARTED|Second Washout (7 Days)||25
2333754|NCT01775904|5727712|P1|NOT COMPLETED|LY2886721 Capsule (Water, Fasting)||1
2333755|NCT01775904|5727712|P1|COMPLETED|LY2886721 Capsule (Water, Fasting)||25
2333756|NCT01775904|5727712|P1|Received at Least One Dose of Drug|LY2886721 Capsule (Water, Fasting)||26
2333757|NCT01775904|5727712|P1|STARTED|LY2886721 Capsule (Water, Fasting)||26
2333758|NCT01775904|5727712|P1|NOT COMPLETED|First Washout (7 Days)||0
2333759|NCT01775904|5727712|P1|COMPLETED|First Washout (7 Days)||26
2333760|NCT01775904|5727712|P1|STARTED|First Washout (7 Days)||26
2333761|NCT01775904|5727712|P1|NOT COMPLETED|LY2886721 ODT (no Water, Fasting)||0
2333762|NCT01775904|5727712|P1|COMPLETED|LY2886721 ODT (no Water, Fasting)||26
2333763|NCT01775904|5727712|P1|Received at Least One Dose of Drug|LY2886721 ODT (no Water, Fasting)||26
2333764|NCT01775904|5727712|P1|STARTED|LY2886721 ODT (no Water, Fasting)||26
2333765|NCT01775865|5727737|P3|NOT COMPLETED|Overall Study||0
2333766|NCT01775865|5727738|P2|NOT COMPLETED|Overall Study||1
2333767|NCT01775865|5727739|P1|NOT COMPLETED|Overall Study||3
2333768|NCT01775865|5727737|P3|COMPLETED|Overall Study||17
2333769|NCT01775865|5727738|P2|COMPLETED|Overall Study||13
2333770|NCT01775865|5727739|P1|COMPLETED|Overall Study||11
2333771|NCT01775865|5727737|P3|STARTED|Overall Study||17
2333772|NCT01775865|5727738|P2|STARTED|Overall Study||14
2333773|NCT01775865|5727739|P1|STARTED|Overall Study||14
2333774|NCT01775852|5727755|P2|NOT COMPLETED|Overall Study||1
2333775|NCT01775852|5727756|P1|NOT COMPLETED|Overall Study||0
2333776|NCT01775852|5727755|P2|COMPLETED|Overall Study||13
2333777|NCT01775852|5727756|P1|COMPLETED|Overall Study||31
2333778|NCT01775852|5727755|P2|STARTED|Overall Study||14
2333779|NCT01775852|5727756|P1|STARTED|Overall Study||31
2333780|NCT01775800|5727770|P2|NOT COMPLETED|Overall Study||0
2333781|NCT01775800|5727771|P1|NOT COMPLETED|Overall Study||0
2333782|NCT01775800|5727770|P2|COMPLETED|Overall Study||8
2333783|NCT01775800|5727771|P1|COMPLETED|Overall Study||8
2333784|NCT01775800|5727770|P2|STARTED|Overall Study||8
2333785|NCT01775800|5727771|P1|STARTED|Overall Study||8
2333786|NCT01775787|5727778|P2|NOT COMPLETED|Second 7-10 Days||2
2333787|NCT01775787|5727779|P1|NOT COMPLETED|Second 7-10 Days||0
2333788|NCT01775787|5727778|P2|COMPLETED|Second 7-10 Days||6
2333789|NCT01775787|5727779|P1|COMPLETED|Second 7-10 Days||12
2333790|NCT01775787|5727778|P2|STARTED|Second 7-10 Days||8
2333791|NCT01775787|5727779|P1|STARTED|Second 7-10 Days||12
2333792|NCT01775787|5727778|P2|NOT COMPLETED|First 7-10 Days||6
2333793|NCT01775787|5727779|P1|NOT COMPLETED|First 7-10 Days||1
2333794|NCT01775787|5727778|P2|COMPLETED|First 7-10 Days||8
2333795|NCT01775787|5727779|P1|COMPLETED|First 7-10 Days||12
2333796|NCT01775787|5727778|P2|STARTED|First 7-10 Days||14
2333797|NCT01775787|5727779|P1|STARTED|First 7-10 Days||13
2333798|NCT01775774|5727790|P3|NOT COMPLETED|Overall Study||0
2333799|NCT01775774|5727791|P2|NOT COMPLETED|Overall Study||0
2333800|NCT01775774|5727792|P1|NOT COMPLETED|Overall Study||0
2333801|NCT01775774|5727790|P3|COMPLETED|Overall Study||3
2333802|NCT01775774|5727791|P2|COMPLETED|Overall Study||3
2333803|NCT01775774|5727792|P1|COMPLETED|Overall Study||3
2333804|NCT01775774|5727790|P3|STARTED|Overall Study||3
2333805|NCT01775774|5727791|P2|STARTED|Overall Study||3
2333806|NCT01775774|5727792|P1|STARTED|Overall Study||3
2333807|NCT01775735|5727820|P2|NOT COMPLETED|Open Label (24 Months)||4
2333808|NCT01775735|5727821|P1|NOT COMPLETED|Open Label (24 Months)||1
2333809|NCT01775735|5727820|P2|COMPLETED|Open Label (24 Months)||3
2333810|NCT01775735|5727821|P1|COMPLETED|Open Label (24 Months)||7
2333811|NCT01775735|5727820|P2|STARTED|Open Label (24 Months)||7
2333812|NCT01775735|5727821|P1|STARTED|Open Label (24 Months)||8
2333813|NCT01775735|5727820|P2|NOT COMPLETED|Intervention (6 Months)||0
2333814|NCT01775735|5727821|P1|NOT COMPLETED|Intervention (6 Months)||0
2333815|NCT01775735|5727820|P2|COMPLETED|Intervention (6 Months)||7
2333816|NCT01775735|5727821|P1|COMPLETED|Intervention (6 Months)||8
2333817|NCT01775735|5727820|P2|STARTED|Intervention (6 Months)||7
2333818|NCT01775735|5727821|P1|STARTED|Intervention (6 Months)||8
2333819|NCT01775722|5727827|P1|NOT COMPLETED|Overall Study||2
2333820|NCT01775722|5727827|P1|COMPLETED|Overall Study||20
2333821|NCT01775722|5727827|P1|STARTED|Overall Study||22
2333822|NCT01775670|5727835|P2|NOT COMPLETED|Overall Study||1
2333823|NCT01775670|5727836|P1|NOT COMPLETED|Overall Study||1
2333824|NCT01775670|5727835|P2|COMPLETED|Overall Study||2
2333825|NCT01775670|5727836|P1|COMPLETED|Overall Study||0
2333826|NCT01775670|5727835|P2|STARTED|Overall Study||3
2333827|NCT01775670|5727836|P1|STARTED|Overall Study||1
2333828|NCT01775553|5727862|P1|NOT COMPLETED|Overall Study||13
2333829|NCT01775553|5727862|P1|COMPLETED|Overall Study||0
2333830|NCT01775553|5727862|P1|STARTED|Overall Study||13
2333831|NCT01775189|5727870|P7|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
2333832|NCT01775189|5727871|P6|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
2333833|NCT01775189|5727872|P5|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
2333834|NCT01775189|5727873|P4|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
2333835|NCT01775189|5727874|P3|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
2333836|NCT01775189|5727875|P2|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
2333837|NCT01775189|5727876|P1|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
2333838|NCT01775189|5727870|P7|COMPLETED|Treatment Phase: Fourth Intervention||7
2333839|NCT01775189|5727871|P6|COMPLETED|Treatment Phase: Fourth Intervention||7
2333840|NCT01775189|5727872|P5|COMPLETED|Treatment Phase: Fourth Intervention||8
2333841|NCT01775189|5727873|P4|COMPLETED|Treatment Phase: Fourth Intervention||6
2333842|NCT01775189|5727874|P3|COMPLETED|Treatment Phase: Fourth Intervention||0
2333843|NCT01775189|5727875|P2|COMPLETED|Treatment Phase: Fourth Intervention||0
2333844|NCT01775189|5727876|P1|COMPLETED|Treatment Phase: Fourth Intervention||0
2333845|NCT01775189|5727870|P7|STARTED|Treatment Phase: Fourth Intervention||7
2333846|NCT01775189|5727871|P6|STARTED|Treatment Phase: Fourth Intervention||7
2333847|NCT01775189|5727872|P5|STARTED|Treatment Phase: Fourth Intervention||8
2333848|NCT01775189|5727873|P4|STARTED|Treatment Phase: Fourth Intervention||6
2333849|NCT01775189|5727874|P3|STARTED|Treatment Phase: Fourth Intervention||0
2333850|NCT01775189|5727875|P2|STARTED|Treatment Phase: Fourth Intervention||0
2333851|NCT01775189|5727876|P1|STARTED|Treatment Phase: Fourth Intervention||0
2333852|NCT01775189|5727870|P7|NOT COMPLETED|Treatment Phase: Washout Period 3||1
2333853|NCT01775189|5727871|P6|NOT COMPLETED|Treatment Phase: Washout Period 3||0
2333854|NCT01775189|5727872|P5|NOT COMPLETED|Treatment Phase: Washout Period 3||0
2333855|NCT01775189|5727873|P4|NOT COMPLETED|Treatment Phase: Washout Period 3||1
2333856|NCT01775189|5727874|P3|NOT COMPLETED|Treatment Phase: Washout Period 3||0
2333857|NCT01775189|5727875|P2|NOT COMPLETED|Treatment Phase: Washout Period 3||0
2333858|NCT01775189|5727876|P1|NOT COMPLETED|Treatment Phase: Washout Period 3||0
2333859|NCT01775189|5727870|P7|COMPLETED|Treatment Phase: Washout Period 3||7
2333860|NCT01775189|5727871|P6|COMPLETED|Treatment Phase: Washout Period 3||7
2333861|NCT01775189|5727872|P5|COMPLETED|Treatment Phase: Washout Period 3||8
2333862|NCT01775189|5727873|P4|COMPLETED|Treatment Phase: Washout Period 3||6
2333863|NCT01775189|5727874|P3|COMPLETED|Treatment Phase: Washout Period 3||0
2333864|NCT01775189|5727875|P2|COMPLETED|Treatment Phase: Washout Period 3||0
2333865|NCT01775189|5727876|P1|COMPLETED|Treatment Phase: Washout Period 3||0
2333866|NCT01775189|5727870|P7|STARTED|Treatment Phase: Washout Period 3||8
2333867|NCT01775189|5727871|P6|STARTED|Treatment Phase: Washout Period 3||7
2333868|NCT01775189|5727872|P5|STARTED|Treatment Phase: Washout Period 3||8
2333869|NCT01775189|5727873|P4|STARTED|Treatment Phase: Washout Period 3||7
2333870|NCT01775189|5727874|P3|STARTED|Treatment Phase: Washout Period 3||0
2333871|NCT01775189|5727875|P2|STARTED|Treatment Phase: Washout Period 3||0
2333872|NCT01775189|5727876|P1|STARTED|Treatment Phase: Washout Period 3||0
2333873|NCT01775189|5727870|P7|NOT COMPLETED|Treatment Phase: Third Intervention||0
2333874|NCT01775189|5727871|P6|NOT COMPLETED|Treatment Phase: Third Intervention||0
2333875|NCT01775189|5727872|P5|NOT COMPLETED|Treatment Phase: Third Intervention||0
2333876|NCT01775189|5727873|P4|NOT COMPLETED|Treatment Phase: Third Intervention||0
2333877|NCT01775189|5727874|P3|NOT COMPLETED|Treatment Phase: Third Intervention||0
2333878|NCT01775189|5727875|P2|NOT COMPLETED|Treatment Phase: Third Intervention||0
2333879|NCT01775189|5727876|P1|NOT COMPLETED|Treatment Phase: Third Intervention||0
2333880|NCT01775189|5727870|P7|COMPLETED|Treatment Phase: Third Intervention||8
2333881|NCT01775189|5727871|P6|COMPLETED|Treatment Phase: Third Intervention||7
2333882|NCT01775189|5727872|P5|COMPLETED|Treatment Phase: Third Intervention||8
2333883|NCT01775189|5727873|P4|COMPLETED|Treatment Phase: Third Intervention||7
2333884|NCT01775189|5727874|P3|COMPLETED|Treatment Phase: Third Intervention||0
2333885|NCT01775189|5727875|P2|COMPLETED|Treatment Phase: Third Intervention||0
2333886|NCT01775189|5727876|P1|COMPLETED|Treatment Phase: Third Intervention||0
2333887|NCT01775189|5727870|P7|STARTED|Treatment Phase: Third Intervention||8
2333888|NCT01775189|5727871|P6|STARTED|Treatment Phase: Third Intervention||7
2333889|NCT01775189|5727872|P5|STARTED|Treatment Phase: Third Intervention||8
2333890|NCT01775189|5727873|P4|STARTED|Treatment Phase: Third Intervention||7
2333891|NCT01775189|5727874|P3|STARTED|Treatment Phase: Third Intervention||0
2333892|NCT01775189|5727875|P2|STARTED|Treatment Phase: Third Intervention||0
2333893|NCT01775189|5727876|P1|STARTED|Treatment Phase: Third Intervention||0
2333894|NCT01775189|5727870|P7|NOT COMPLETED|Treatment Phase: Washout Period 2||0
2333895|NCT01775189|5727871|P6|NOT COMPLETED|Treatment Phase: Washout Period 2||0
2333896|NCT01775189|5727872|P5|NOT COMPLETED|Treatment Phase: Washout Period 2||0
2333897|NCT01775189|5727873|P4|NOT COMPLETED|Treatment Phase: Washout Period 2||1
2333898|NCT01775189|5727874|P3|NOT COMPLETED|Treatment Phase: Washout Period 2||0
2333899|NCT01775189|5727875|P2|NOT COMPLETED|Treatment Phase: Washout Period 2||0
2333900|NCT01775189|5727876|P1|NOT COMPLETED|Treatment Phase: Washout Period 2||0
2333901|NCT01775189|5727870|P7|COMPLETED|Treatment Phase: Washout Period 2||8
2333902|NCT01775189|5727871|P6|COMPLETED|Treatment Phase: Washout Period 2||7
2333903|NCT01775189|5727872|P5|COMPLETED|Treatment Phase: Washout Period 2||8
2333904|NCT01775189|5727873|P4|COMPLETED|Treatment Phase: Washout Period 2||7
2333905|NCT01775189|5727874|P3|COMPLETED|Treatment Phase: Washout Period 2||0
2333906|NCT01775189|5727875|P2|COMPLETED|Treatment Phase: Washout Period 2||0
2333907|NCT01775189|5727876|P1|COMPLETED|Treatment Phase: Washout Period 2||0
2333908|NCT01775189|5727870|P7|STARTED|Treatment Phase: Washout Period 2||8
2333909|NCT01775189|5727871|P6|STARTED|Treatment Phase: Washout Period 2||7
2333910|NCT01775189|5727872|P5|STARTED|Treatment Phase: Washout Period 2||8
2333911|NCT01775189|5727873|P4|STARTED|Treatment Phase: Washout Period 2||8
2333912|NCT01775189|5727874|P3|STARTED|Treatment Phase: Washout Period 2||0
2333913|NCT01775189|5727875|P2|STARTED|Treatment Phase: Washout Period 2||0
2333914|NCT01775189|5727876|P1|STARTED|Treatment Phase: Washout Period 2||0
2333915|NCT01775189|5727870|P7|NOT COMPLETED|Treatment Phase: Second Intervention||0
2333916|NCT01775189|5727871|P6|NOT COMPLETED|Treatment Phase: Second Intervention||0
2333917|NCT01775189|5727872|P5|NOT COMPLETED|Treatment Phase: Second Intervention||0
2333918|NCT01775189|5727873|P4|NOT COMPLETED|Treatment Phase: Second Intervention||0
2333919|NCT01775189|5727874|P3|NOT COMPLETED|Treatment Phase: Second Intervention||0
2333920|NCT01775189|5727875|P2|NOT COMPLETED|Treatment Phase: Second Intervention||0
2333921|NCT01775189|5727876|P1|NOT COMPLETED|Treatment Phase: Second Intervention||0
2333922|NCT01775189|5727870|P7|COMPLETED|Treatment Phase: Second Intervention||8
2333923|NCT01775189|5727871|P6|COMPLETED|Treatment Phase: Second Intervention||7
2333924|NCT01775189|5727872|P5|COMPLETED|Treatment Phase: Second Intervention||8
2333925|NCT01775189|5727873|P4|COMPLETED|Treatment Phase: Second Intervention||8
2333926|NCT01775189|5727874|P3|COMPLETED|Treatment Phase: Second Intervention||0
2333927|NCT01775189|5727875|P2|COMPLETED|Treatment Phase: Second Intervention||0
2333928|NCT01775189|5727876|P1|COMPLETED|Treatment Phase: Second Intervention||0
2333929|NCT01775189|5727870|P7|STARTED|Treatment Phase: Second Intervention||8
2333930|NCT01775189|5727871|P6|STARTED|Treatment Phase: Second Intervention||7
2333931|NCT01775189|5727872|P5|STARTED|Treatment Phase: Second Intervention||8
2333932|NCT01775189|5727873|P4|STARTED|Treatment Phase: Second Intervention||8
2333933|NCT01775189|5727874|P3|STARTED|Treatment Phase: Second Intervention||0
2333934|NCT01775189|5727875|P2|STARTED|Treatment Phase: Second Intervention||0
2333935|NCT01775189|5727876|P1|STARTED|Treatment Phase: Second Intervention||0
2333936|NCT01775189|5727870|P7|NOT COMPLETED|Treatment Phase: Washout Period 1||0
2333937|NCT01775189|5727871|P6|NOT COMPLETED|Treatment Phase: Washout Period 1||1
2333938|NCT01775189|5727872|P5|NOT COMPLETED|Treatment Phase: Washout Period 1||0
2333939|NCT01775189|5727873|P4|NOT COMPLETED|Treatment Phase: Washout Period 1||0
2333940|NCT01775189|5727874|P3|NOT COMPLETED|Treatment Phase: Washout Period 1||0
2333941|NCT01775189|5727875|P2|NOT COMPLETED|Treatment Phase: Washout Period 1||0
2333942|NCT01775189|5727876|P1|NOT COMPLETED|Treatment Phase: Washout Period 1||0
2333943|NCT01775189|5727870|P7|COMPLETED|Treatment Phase: Washout Period 1||8
2333944|NCT01775189|5727871|P6|COMPLETED|Treatment Phase: Washout Period 1||7
2333945|NCT01775189|5727872|P5|COMPLETED|Treatment Phase: Washout Period 1||8
2333946|NCT01775189|5727873|P4|COMPLETED|Treatment Phase: Washout Period 1||8
2333947|NCT01775189|5727874|P3|COMPLETED|Treatment Phase: Washout Period 1||0
2333948|NCT01775189|5727875|P2|COMPLETED|Treatment Phase: Washout Period 1||0
2333949|NCT01775189|5727876|P1|COMPLETED|Treatment Phase: Washout Period 1||0
2333950|NCT01775189|5727870|P7|STARTED|Treatment Phase: Washout Period 1||8
2333951|NCT01775189|5727871|P6|STARTED|Treatment Phase: Washout Period 1||8
2333952|NCT01775189|5727872|P5|STARTED|Treatment Phase: Washout Period 1||8
2333953|NCT01775189|5727873|P4|STARTED|Treatment Phase: Washout Period 1||8
2333954|NCT01775189|5727874|P3|STARTED|Treatment Phase: Washout Period 1||0
2333955|NCT01775189|5727875|P2|STARTED|Treatment Phase: Washout Period 1||0
2333956|NCT01775189|5727876|P1|STARTED|Treatment Phase: Washout Period 1||0
2333957|NCT01775189|5727870|P7|NOT COMPLETED|Treatment Phase: First Intervention||0
2333958|NCT01775189|5727871|P6|NOT COMPLETED|Treatment Phase: First Intervention||0
2333959|NCT01775189|5727872|P5|NOT COMPLETED|Treatment Phase: First Intervention||0
2333960|NCT01775189|5727873|P4|NOT COMPLETED|Treatment Phase: First Intervention||0
2333961|NCT01775189|5727874|P3|NOT COMPLETED|Treatment Phase: First Intervention||0
2333962|NCT01775189|5727875|P2|NOT COMPLETED|Treatment Phase: First Intervention||0
2333963|NCT01775189|5727876|P1|NOT COMPLETED|Treatment Phase: First Intervention||0
2333964|NCT01775189|5727870|P7|COMPLETED|Treatment Phase: First Intervention||8
2333965|NCT01775189|5727871|P6|COMPLETED|Treatment Phase: First Intervention||8
2333966|NCT01775189|5727872|P5|COMPLETED|Treatment Phase: First Intervention||8
2333967|NCT01775189|5727873|P4|COMPLETED|Treatment Phase: First Intervention||8
2333968|NCT01775189|5727874|P3|COMPLETED|Treatment Phase: First Intervention||0
2333969|NCT01775189|5727875|P2|COMPLETED|Treatment Phase: First Intervention||0
2333970|NCT01775189|5727876|P1|COMPLETED|Treatment Phase: First Intervention||0
2333971|NCT01775189|5727870|P7|STARTED|Treatment Phase: First Intervention||8
2333972|NCT01775189|5727871|P6|STARTED|Treatment Phase: First Intervention||8
2333973|NCT01775189|5727872|P5|STARTED|Treatment Phase: First Intervention||8
2333974|NCT01775189|5727873|P4|STARTED|Treatment Phase: First Intervention||8
2333975|NCT01775189|5727874|P3|STARTED|Treatment Phase: First Intervention||0
2333976|NCT01775189|5727875|P2|STARTED|Treatment Phase: First Intervention||0
2333977|NCT01775189|5727876|P1|STARTED|Treatment Phase: First Intervention||0
2333978|NCT01775189|5727870|P7|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
2333979|NCT01775189|5727871|P6|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
2333980|NCT01775189|5727872|P5|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
2333981|NCT01775189|5727873|P4|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
2334067|NCT01774981|5728163|P3|NOT COMPLETED|Overall Study||0
2333982|NCT01775189|5727874|P3|NOT COMPLETED|Drug Discrimination Phase: Day 2||7
2333983|NCT01775189|5727875|P2|NOT COMPLETED|Drug Discrimination Phase: Day 2||3
2333984|NCT01775189|5727876|P1|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
2333985|NCT01775189|5727870|P7|COMPLETED|Drug Discrimination Phase: Day 2||0
2333986|NCT01775189|5727871|P6|COMPLETED|Drug Discrimination Phase: Day 2||0
2333987|NCT01775189|5727872|P5|COMPLETED|Drug Discrimination Phase: Day 2||0
2333988|NCT01775189|5727873|P4|COMPLETED|Drug Discrimination Phase: Day 2||0
2333989|NCT01775189|5727874|P3|COMPLETED|Drug Discrimination Phase: Day 2||16
2333990|NCT01775189|5727875|P2|COMPLETED|Drug Discrimination Phase: Day 2||16
2333991|NCT01775189|5727876|P1|COMPLETED|Drug Discrimination Phase: Day 2||0
2333992|NCT01775189|5727870|P7|STARTED|Drug Discrimination Phase: Day 2||0
2333993|NCT01775189|5727871|P6|STARTED|Drug Discrimination Phase: Day 2||0
2333994|NCT01775189|5727872|P5|STARTED|Drug Discrimination Phase: Day 2||0
2333995|NCT01775189|5727873|P4|STARTED|Drug Discrimination Phase: Day 2||0
2333996|NCT01775189|5727874|P3|STARTED|Drug Discrimination Phase: Day 2||23
2333997|NCT01775189|5727875|P2|STARTED|Drug Discrimination Phase: Day 2||19
2333998|NCT01775189|5727876|P1|STARTED|Drug Discrimination Phase: Day 2||0
2333999|NCT01775189|5727870|P7|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
2334000|NCT01775189|5727871|P6|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
2334001|NCT01775189|5727872|P5|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
2334002|NCT01775189|5727873|P4|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
2334003|NCT01775189|5727874|P3|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
2334004|NCT01775189|5727875|P2|NOT COMPLETED|Drug Discrimination Phase: Day 1||3
2334005|NCT01775189|5727876|P1|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
2334006|NCT01775189|5727870|P7|COMPLETED|Drug Discrimination Phase: Day 1||0
2334007|NCT01775189|5727871|P6|COMPLETED|Drug Discrimination Phase: Day 1||0
2334008|NCT01775189|5727872|P5|COMPLETED|Drug Discrimination Phase: Day 1||0
2334009|NCT01775189|5727873|P4|COMPLETED|Drug Discrimination Phase: Day 1||0
2334010|NCT01775189|5727874|P3|COMPLETED|Drug Discrimination Phase: Day 1||23
2334011|NCT01775189|5727875|P2|COMPLETED|Drug Discrimination Phase: Day 1||19
2334012|NCT01775189|5727876|P1|COMPLETED|Drug Discrimination Phase: Day 1||0
2334013|NCT01775189|5727870|P7|STARTED|Drug Discrimination Phase: Day 1||0
2334014|NCT01775189|5727871|P6|STARTED|Drug Discrimination Phase: Day 1||0
2334015|NCT01775189|5727872|P5|STARTED|Drug Discrimination Phase: Day 1||0
2334016|NCT01775189|5727873|P4|STARTED|Drug Discrimination Phase: Day 1||0
2334017|NCT01775189|5727874|P3|STARTED|Drug Discrimination Phase: Day 1||23
2334018|NCT01775189|5727875|P2|STARTED|Drug Discrimination Phase: Day 1||22
2334019|NCT01775189|5727876|P1|STARTED|Drug Discrimination Phase: Day 1||0
2334020|NCT01775189|5727870|P7|NOT COMPLETED|Naloxone Challenge Phase||0
2334021|NCT01775189|5727871|P6|NOT COMPLETED|Naloxone Challenge Phase||0
2334022|NCT01775189|5727872|P5|NOT COMPLETED|Naloxone Challenge Phase||0
2334023|NCT01775189|5727873|P4|NOT COMPLETED|Naloxone Challenge Phase||0
2334024|NCT01775189|5727874|P3|NOT COMPLETED|Naloxone Challenge Phase||0
2334025|NCT01775189|5727875|P2|NOT COMPLETED|Naloxone Challenge Phase||0
2334026|NCT01775189|5727876|P1|NOT COMPLETED|Naloxone Challenge Phase||0
2334027|NCT01775189|5727870|P7|COMPLETED|Naloxone Challenge Phase||0
2334028|NCT01775189|5727871|P6|COMPLETED|Naloxone Challenge Phase||0
2334029|NCT01775189|5727872|P5|COMPLETED|Naloxone Challenge Phase||0
2334030|NCT01775189|5727873|P4|COMPLETED|Naloxone Challenge Phase||0
2334031|NCT01775189|5727874|P3|COMPLETED|Naloxone Challenge Phase||0
2334032|NCT01775189|5727875|P2|COMPLETED|Naloxone Challenge Phase||0
2334033|NCT01775189|5727876|P1|COMPLETED|Naloxone Challenge Phase||45
2334034|NCT01775189|5727870|P7|STARTED|Naloxone Challenge Phase||0
2334035|NCT01775189|5727871|P6|STARTED|Naloxone Challenge Phase||0
2334036|NCT01775189|5727872|P5|STARTED|Naloxone Challenge Phase||0
2334037|NCT01775189|5727873|P4|STARTED|Naloxone Challenge Phase||0
2334038|NCT01775189|5727874|P3|STARTED|Naloxone Challenge Phase||0
2334039|NCT01775189|5727875|P2|STARTED|Naloxone Challenge Phase||0
2334040|NCT01775189|5727876|P1|STARTED|Naloxone Challenge Phase||45
2334041|NCT01775137|5728095|P1|NOT COMPLETED|Overall Study||11
2334042|NCT01775137|5728095|P1|COMPLETED|Overall Study||34
2334043|NCT01775137|5728095|P1|STARTED|Overall Study||45
2334044|NCT01775124|5728122|P2|NOT COMPLETED|Extension Period||18
2334045|NCT01775124|5728123|P1|NOT COMPLETED|Extension Period||12
2334046|NCT01775124|5728122|P2|COMPLETED|Extension Period||138
2334047|NCT01775124|5728123|P1|COMPLETED|Extension Period||145
2334048|NCT01775124|5728122|P2|STARTED|Extension Period||156
2334049|NCT01775124|5728123|P1|STARTED|Extension Period||157
2334050|NCT01775124|5728122|P2|NOT COMPLETED|Core Period||10
2334051|NCT01775124|5728123|P1|NOT COMPLETED|Core Period||11
2334052|NCT01775124|5728122|P2|COMPLETED|Core Period||156
2334053|NCT01775124|5728123|P1|COMPLETED|Core Period||157
2334054|NCT01775124|5728122|P2|Safety Set|Core Period||166
2334055|NCT01775124|5728123|P1|Safety Set|Core Period|1 patient was mis-randomized & 1 patient discontinued due to AE. No treatment given|166
2334056|NCT01775124|5728122|P2|Per Protocol Set|Core Period||155
2334057|NCT01775124|5728123|P1|Per Protocol Set|Core Period||157
2334058|NCT01775124|5728122|P2|Full Analysis Set|Core Period||166
2334059|NCT01775124|5728123|P1|Full Analysis Set|Core Period||167
2334060|NCT01775124|5728122|P2|STARTED|Core Period||166
2334061|NCT01775124|5728123|P1|STARTED|Core Period||168
2334062|NCT01774981|5728158|P8|NOT COMPLETED|Overall Study||1
2334063|NCT01774981|5728159|P7|NOT COMPLETED|Overall Study||0
2334064|NCT01774981|5728160|P6|NOT COMPLETED|Overall Study||1
2334065|NCT01774981|5728161|P5|NOT COMPLETED|Overall Study||1
2334066|NCT01774981|5728162|P4|NOT COMPLETED|Overall Study||0
2334068|NCT01774981|5728164|P2|NOT COMPLETED|Overall Study||0
2334069|NCT01774981|5728165|P1|NOT COMPLETED|Overall Study||0
2334070|NCT01774981|5728158|P8|COMPLETED|Overall Study||11
2334071|NCT01774981|5728159|P7|COMPLETED|Overall Study||13
2334072|NCT01774981|5728160|P6|COMPLETED|Overall Study||13
2334073|NCT01774981|5728161|P5|COMPLETED|Overall Study||5
2334074|NCT01774981|5728162|P4|COMPLETED|Overall Study||4
2334075|NCT01774981|5728163|P3|COMPLETED|Overall Study||4
2334076|NCT01774981|5728164|P2|COMPLETED|Overall Study||4
2334077|NCT01774981|5728165|P1|COMPLETED|Overall Study||3
2334078|NCT01774981|5728158|P8|Received at Least 1 Dose of Study Drug|Overall Study||12
2334079|NCT01774981|5728159|P7|Received at Least 1 Dose of Study Drug|Overall Study||13
2334080|NCT01774981|5728160|P6|Received at Least 1 Dose of Study Drug|Overall Study||14
2334081|NCT01774981|5728161|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
2334082|NCT01774981|5728162|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
2334083|NCT01774981|5728163|P3|Received at Least 1 Dose of Study Drug|Overall Study||4
2334084|NCT01774981|5728164|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
2334085|NCT01774981|5728165|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
2334086|NCT01774981|5728158|P8|STARTED|Overall Study||12
2334087|NCT01774981|5728159|P7|STARTED|Overall Study||13
2334088|NCT01774981|5728160|P6|STARTED|Overall Study||14
2334089|NCT01774981|5728161|P5|STARTED|Overall Study||6
2334090|NCT01774981|5728162|P4|STARTED|Overall Study||4
2334091|NCT01774981|5728163|P3|STARTED|Overall Study||4
2334092|NCT01774981|5728164|P2|STARTED|Overall Study||4
2334093|NCT01774981|5728165|P1|STARTED|Overall Study||3
2334094|NCT01774968|5728197|P2|NOT COMPLETED|Overall Study||35
2334095|NCT01774968|5728198|P1|NOT COMPLETED|Overall Study||30
2334096|NCT01774968|5728197|P2|COMPLETED|Overall Study||128
2334097|NCT01774968|5728198|P1|COMPLETED|Overall Study||132
2334098|NCT01774968|5728197|P2|Received at Least 1 Dose of Study Drug|Overall Study||161
2334099|NCT01774968|5728198|P1|Received at Least 1 Dose of Study Drug|Overall Study||162
2334100|NCT01774968|5728197|P2|STARTED|Overall Study||163
2334101|NCT01774968|5728198|P1|STARTED|Overall Study||162
2334102|NCT01774929|5728232|P1|NOT COMPLETED|Overall Study||3
2334103|NCT01774929|5728232|P1|COMPLETED|Overall Study||32
2334104|NCT01774929|5728232|P1|STARTED|Overall Study||35
2334105|NCT01774903|5728238|P1|NOT COMPLETED|Overall Study||11
2334106|NCT01774903|5728238|P1|COMPLETED|Overall Study||34
2334107|NCT01774903|5728238|P1|STARTED|Overall Study||45
2334108|NCT01774851|5728247|P2|NOT COMPLETED|Overall Study||0
2334109|NCT01774851|5728248|P1|NOT COMPLETED|Overall Study||0
2334110|NCT01774851|5728247|P2|COMPLETED|Overall Study||42
2334111|NCT01774851|5728248|P1|COMPLETED|Overall Study||42
2334112|NCT01774851|5728247|P2|STARTED|Overall Study||42
2334113|NCT01774851|5728248|P1|STARTED|Overall Study||42
2334114|NCT01774799|5728258|P4|NOT COMPLETED|Overall Study||0
2334115|NCT01774799|5728259|P3|NOT COMPLETED|Overall Study||0
2334116|NCT01774799|5728260|P2|NOT COMPLETED|Overall Study||1
2334117|NCT01774799|5728261|P1|NOT COMPLETED|Overall Study||1
2334118|NCT01774799|5728258|P4|COMPLETED|Overall Study||190
2334119|NCT01774799|5728259|P3|COMPLETED|Overall Study||212
2334120|NCT01774799|5728260|P2|COMPLETED|Overall Study||189
2334121|NCT01774799|5728261|P1|COMPLETED|Overall Study||211
2334122|NCT01774799|5728258|P4|STARTED|Overall Study||190
2334123|NCT01774799|5728259|P3|STARTED|Overall Study||212
2334124|NCT01774799|5728260|P2|STARTED|Overall Study||190
2334125|NCT01774799|5728261|P1|STARTED|Overall Study||212
2334126|NCT01774786|5728277|P2|NOT COMPLETED|Overall Study||392
2334127|NCT01774786|5728278|P1|NOT COMPLETED|Overall Study||388
2334128|NCT01774786|5728277|P2|COMPLETED|Overall Study||0
2334129|NCT01774786|5728278|P1|COMPLETED|Overall Study||0
2334130|NCT01774786|5728277|P2|Received at Least One Dose of Placebo|Overall Study||388
2334131|NCT01774786|5728278|P1|Received at Least One Dose of Placebo|Overall Study||0
2334132|NCT01774786|5728277|P2|Received at Least One Dose of Pertuzumab|Overall Study|One participant randomized to placebo arm received 1 dose of pertuzumab by error.|1
2334133|NCT01774786|5728278|P1|Received at Least One Dose of Pertuzumab|Overall Study||384
2334134|NCT01774786|5728277|P2|Did Not Receive Study Drug|Overall Study||3
2334135|NCT01774786|5728278|P1|Did Not Receive Study Drug|Overall Study||4
2334136|NCT01774786|5728277|P2|STARTED|Overall Study||392
2334137|NCT01774786|5728278|P1|STARTED|Overall Study||388
2334138|NCT01774760|5728306|P1|NOT COMPLETED|Overall Study||0
2334139|NCT01774760|5728306|P1|COMPLETED|Overall Study||10
2334140|NCT01774760|5728306|P1|STARTED|Overall Study||10
2334141|NCT01774721|5728312|P2|NOT COMPLETED|Overall Study||225
2334142|NCT01774721|5728313|P1|NOT COMPLETED|Overall Study||227
2334143|NCT01774721|5728312|P2|COMPLETED|Overall Study||0
2334144|NCT01774721|5728313|P1|COMPLETED|Overall Study||0
2334145|NCT01774721|5728312|P2|Treated|Overall Study||224
2334146|NCT01774721|5728313|P1|Treated|Overall Study||227
2334147|NCT01774721|5728312|P2|STARTED|Overall Study||225
2334148|NCT01774721|5728313|P1|STARTED|Overall Study||227
2334149|NCT01774604|5728357|P2|NOT COMPLETED|Overall Study||0
2334150|NCT01774604|5728358|P1|NOT COMPLETED|Overall Study||0
2334151|NCT01774604|5728357|P2|COMPLETED|Overall Study||226
2334152|NCT01774604|5728358|P1|COMPLETED|Overall Study||223
2334153|NCT01774604|5728357|P2|STARTED|Overall Study||226
2334154|NCT01774604|5728358|P1|STARTED|Overall Study||223
2334155|NCT01774591|5728378|P2|NOT COMPLETED|Overall Study||4
2334156|NCT01774591|5728379|P1|NOT COMPLETED|Overall Study||1
2334157|NCT01774591|5728378|P2|COMPLETED|Overall Study||7
2334158|NCT01774591|5728379|P1|COMPLETED|Overall Study||9
2334159|NCT01774591|5728378|P2|STARTED|Overall Study||11
2334160|NCT01774591|5728379|P1|STARTED|Overall Study||10
2334161|NCT01774370|5728389|P1|NOT COMPLETED|Overall Study||129
2334162|NCT01774370|5728389|P1|COMPLETED|Overall Study||3053
2334163|NCT01774370|5728389|P1|STARTED|Overall Study||3182
2334164|NCT01774344|5728397|P2|NOT COMPLETED|Overall Study||148
2334165|NCT01774344|5728398|P1|NOT COMPLETED|Overall Study||32
2334166|NCT01774344|5728397|P2|COMPLETED|Overall Study||231
2334167|NCT01774344|5728398|P1|COMPLETED|Overall Study||162
2334168|NCT01774344|5728397|P2|Treated|Overall Study||374
2334169|NCT01774344|5728398|P1|Treated|Overall Study||193
2334170|NCT01774344|5728397|P2|STARTED|Overall Study||379
2334171|NCT01774344|5728398|P1|STARTED|Overall Study||194
2334172|NCT01774305|5728414|P2|NOT COMPLETED|Overall Study||0
2334173|NCT01774305|5728415|P1|NOT COMPLETED|Overall Study||1
2334174|NCT01774305|5728414|P2|COMPLETED|Overall Study||71
2334175|NCT01774305|5728415|P1|COMPLETED|Overall Study||70
2334176|NCT01774305|5728414|P2|STARTED|Overall Study||71
2334177|NCT01774305|5728415|P1|STARTED|Overall Study||71
2334178|NCT01774253|5728423|P1|NOT COMPLETED|Overall Study||9
2334179|NCT01774253|5728423|P1|COMPLETED|Overall Study||0
2334180|NCT01774253|5728423|P1|STARTED|Overall Study||9
2334181|NCT01774149|5728433|P2|NOT COMPLETED|Overall Study||3
2334182|NCT01774149|5728434|P1|NOT COMPLETED|Overall Study||1
2334183|NCT01774149|5728433|P2|COMPLETED|Overall Study||12
2334184|NCT01774149|5728434|P1|COMPLETED|Overall Study||14
2334185|NCT01774149|5728433|P2|STARTED|Overall Study||15
2334186|NCT01774149|5728434|P1|STARTED|Overall Study||15
2334187|NCT01774110|5728442|P1|NOT COMPLETED|Overall Study||7
2334188|NCT01774110|5728442|P1|COMPLETED|Overall Study||5
2334189|NCT01774110|5728442|P1|STARTED|Overall Study||12
2334190|NCT01774097|5728450|P2|NOT COMPLETED|Overall Study||2
2334191|NCT01774097|5728451|P1|NOT COMPLETED|Overall Study||2
2334192|NCT01774097|5728450|P2|COMPLETED|Overall Study||40
2334193|NCT01774097|5728451|P1|COMPLETED|Overall Study||38
2334194|NCT01774097|5728450|P2|STARTED|Overall Study||42
2334195|NCT01774097|5728451|P1|STARTED|Overall Study||40
2334196|NCT01774084|5728481|P2|NOT COMPLETED|Overall Study||0
2334197|NCT01774084|5728482|P1|NOT COMPLETED|Overall Study||1
2334198|NCT01774084|5728481|P2|COMPLETED|Overall Study||12
2334199|NCT01774084|5728482|P1|COMPLETED|Overall Study||10
2334200|NCT01774084|5728481|P2|STARTED|Overall Study||12
2334201|NCT01774084|5728482|P1|STARTED|Overall Study||11
2334202|NCT01774045|5728492|P2|NOT COMPLETED|Overall Study||0
2334203|NCT01774045|5728493|P1|NOT COMPLETED|Overall Study||0
2334204|NCT01774045|5728492|P2|COMPLETED|Overall Study||7
2334205|NCT01774045|5728493|P1|COMPLETED|Overall Study||23
2334206|NCT01774045|5728492|P2|STARTED|Overall Study||7
2334207|NCT01774045|5728493|P1|STARTED|Overall Study||23
2334208|NCT01773993|5728507|P1|NOT COMPLETED|Overall Study||35
2334209|NCT01773993|5728507|P1|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|499
2334210|NCT01773993|5728507|P1|STARTED|Overall Study||534
2334211|NCT01773967|5728526|P2|NOT COMPLETED|Overall Study||13
2334212|NCT01773967|5728527|P1|NOT COMPLETED|Overall Study||15
2334213|NCT01773967|5728526|P2|COMPLETED|Overall Study||475
2334214|NCT01773967|5728527|P1|COMPLETED|Overall Study||468
2334215|NCT01773967|5728526|P2|STARTED|Overall Study||488
2334216|NCT01773967|5728527|P1|STARTED|Overall Study||483
2334217|NCT01773954|5728537|P1|NOT COMPLETED|Overall Study||9
2334218|NCT01773954|5728537|P1|COMPLETED|Overall Study||31
2334219|NCT01773954|5728537|P1|STARTED|Overall Study||40
2334220|NCT01773889|5728542|P1|NOT COMPLETED|Overall Study||2
2334221|NCT01773889|5728542|P1|COMPLETED|Overall Study||0
2334222|NCT01773889|5728542|P1|STARTED|Overall Study||2
2334223|NCT01773473|5728548|P2|NOT COMPLETED|Overall Study||19
2334224|NCT01773473|5728549|P1|NOT COMPLETED|Overall Study||16
2334225|NCT01773473|5728548|P2|COMPLETED|Overall Study||177
2334226|NCT01773473|5728549|P1|COMPLETED|Overall Study||191
2334227|NCT01773473|5728548|P2|Received at Least 1 Dose of Study Drug|Overall Study||196
2334228|NCT01773473|5728549|P1|Received at Least 1 Dose of Study Drug|Overall Study||207
2334229|NCT01773473|5728548|P2|STARTED|Overall Study||196
2334230|NCT01773473|5728549|P1|STARTED|Overall Study||207
2334231|NCT01773421|5728571|P7|NOT COMPLETED|Extension Phase||0
2334232|NCT01773421|5728572|P6|NOT COMPLETED|Extension Phase||2
2334233|NCT01773421|5728573|P5|NOT COMPLETED|Extension Phase||3
2334234|NCT01773421|5728574|P4|NOT COMPLETED|Extension Phase||0
2334235|NCT01773421|5728575|P3|NOT COMPLETED|Extension Phase||0
2334236|NCT01773421|5728576|P2|NOT COMPLETED|Extension Phase||0
2334237|NCT01773421|5728577|P1|NOT COMPLETED|Extension Phase||0
2334238|NCT01773421|5728571|P7|COMPLETED|Extension Phase||0
2334239|NCT01773421|5728572|P6|COMPLETED|Extension Phase||1
2334240|NCT01773421|5728573|P5|COMPLETED|Extension Phase||12
2334241|NCT01773421|5728574|P4|COMPLETED|Extension Phase||0
2334242|NCT01773421|5728575|P3|COMPLETED|Extension Phase||0
2334243|NCT01773421|5728576|P2|COMPLETED|Extension Phase||0
2334244|NCT01773421|5728577|P1|COMPLETED|Extension Phase||0
2334245|NCT01773421|5728571|P7|STARTED|Extension Phase||0
2334246|NCT01773421|5728572|P6|STARTED|Extension Phase||3
2334247|NCT01773421|5728573|P5|STARTED|Extension Phase||15
2334248|NCT01773421|5728574|P4|STARTED|Extension Phase||0
2334249|NCT01773421|5728575|P3|STARTED|Extension Phase||0
2334250|NCT01773421|5728576|P2|STARTED|Extension Phase||0
2334251|NCT01773421|5728577|P1|STARTED|Extension Phase||0
2334252|NCT01773421|5728571|P7|NOT COMPLETED|Treatment Phase||0
2334253|NCT01773421|5728572|P6|NOT COMPLETED|Treatment Phase||0
2334254|NCT01773421|5728573|P5|NOT COMPLETED|Treatment Phase||0
2334255|NCT01773421|5728574|P4|NOT COMPLETED|Treatment Phase||2
2334256|NCT01773421|5728575|P3|NOT COMPLETED|Treatment Phase||6
2334257|NCT01773421|5728576|P2|NOT COMPLETED|Treatment Phase||0
2334258|NCT01773421|5728577|P1|NOT COMPLETED|Treatment Phase||0
2334259|NCT01773421|5728571|P7|COMPLETED|Treatment Phase||0
2334260|NCT01773421|5728572|P6|COMPLETED|Treatment Phase||0
2334261|NCT01773421|5728573|P5|COMPLETED|Treatment Phase||0
2334262|NCT01773421|5728574|P4|COMPLETED|Treatment Phase||5
2334263|NCT01773421|5728575|P3|COMPLETED|Treatment Phase||13
2334264|NCT01773421|5728576|P2|COMPLETED|Treatment Phase||8
2334265|NCT01773421|5728577|P1|COMPLETED|Treatment Phase||7
2334266|NCT01773421|5728571|P7|STARTED|Treatment Phase||0
2334267|NCT01773421|5728572|P6|STARTED|Treatment Phase||0
2334268|NCT01773421|5728573|P5|STARTED|Treatment Phase||0
2334269|NCT01773421|5728574|P4|STARTED|Treatment Phase||7
2334270|NCT01773421|5728575|P3|STARTED|Treatment Phase||19
2334271|NCT01773421|5728576|P2|STARTED|Treatment Phase||8
2334272|NCT01773421|5728577|P1|STARTED|Treatment Phase||7
2334273|NCT01773291|5728608|P3|NOT COMPLETED|Overall Study||1
2334274|NCT01773291|5728609|P2|NOT COMPLETED|Overall Study||0
2334275|NCT01773291|5728610|P1|NOT COMPLETED|Overall Study||1
2334276|NCT01773291|5728608|P3|COMPLETED|Overall Study||6
2334277|NCT01773291|5728609|P2|COMPLETED|Overall Study||9
2334278|NCT01773291|5728610|P1|COMPLETED|Overall Study||7
2334279|NCT01773291|5728608|P3|STARTED|Overall Study||7
2334280|NCT01773291|5728609|P2|STARTED|Overall Study||9
2334281|NCT01773291|5728610|P1|STARTED|Overall Study||8
2334282|NCT01773226|5728621|P1|NOT COMPLETED|Overall Study||1
2334283|NCT01773226|5728621|P1|COMPLETED|Overall Study|Withdrawal of one subject after one-month assessment due to persistent OA symptoms|10
2334284|NCT01773226|5728621|P1|STARTED|Overall Study||11
2334285|NCT01773135|5728631|P1|NOT COMPLETED|Overall Study||0
2334286|NCT01773135|5728631|P1|COMPLETED|Overall Study||262
2334287|NCT01773135|5728631|P1|STARTED|Overall Study||262
2334288|NCT01773122|5728640|P4|NOT COMPLETED|Overall Study||1
2334289|NCT01773122|5728641|P3|NOT COMPLETED|Overall Study||0
2334290|NCT01773122|5728642|P2|NOT COMPLETED|Overall Study||1
2334291|NCT01773122|5728643|P1|NOT COMPLETED|Overall Study||3
2334292|NCT01773122|5728640|P4|COMPLETED|Overall Study||18
2334293|NCT01773122|5728641|P3|COMPLETED|Overall Study||19
2334294|NCT01773122|5728642|P2|COMPLETED|Overall Study||18
2334295|NCT01773122|5728643|P1|COMPLETED|Overall Study||17
2334296|NCT01773122|5728640|P4|STARTED|Overall Study||19
2334297|NCT01773122|5728641|P3|STARTED|Overall Study||19
2334298|NCT01773122|5728642|P2|STARTED|Overall Study||19
2334299|NCT01773122|5728643|P1|STARTED|Overall Study||20
2334300|NCT01773070|5728657|P1|NOT COMPLETED|Overall Study||81
2334301|NCT01773070|5728657|P1|COMPLETED|Overall Study||397
2334302|NCT01773070|5728657|P1|STARTED|Overall Study||478
2334303|NCT01772823|5728667|P2|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||9
2334304|NCT01772823|5728668|P1|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||10
2334305|NCT01772823|5728667|P2|COMPLETED|Extension Phase (Visits 24,48wks Post tx||33
2334306|NCT01772823|5728668|P1|COMPLETED|Extension Phase (Visits 24,48wks Post tx||53
2334307|NCT01772823|5728667|P2|STARTED|Extension Phase (Visits 24,48wks Post tx|10 of the 52 subjects that completed the Treatment Phase were not eligible for the Extension Phase|42
2334308|NCT01772823|5728668|P1|STARTED|Extension Phase (Visits 24,48wks Post tx|25 of the 88 subjects that completed the Treatment Phase were not eligible for the Extension Phase|63
2334309|NCT01772823|5728667|P2|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||18
2334310|NCT01772823|5728668|P1|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||28
2334311|NCT01772823|5728667|P2|COMPLETED|Treatment Phase (Week 0- Week 48)||52
2334312|NCT01772823|5728668|P1|COMPLETED|Treatment Phase (Week 0- Week 48)||88
2334313|NCT01772823|5728667|P2|STARTED|Treatment Phase (Week 0- Week 48)||70
2334314|NCT01772823|5728668|P1|STARTED|Treatment Phase (Week 0- Week 48)||116
2334315|NCT01772823|5728667|P2|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||2
2334316|NCT01772823|5728668|P1|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||12
2334317|NCT01772823|5728667|P2|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||70
2334318|NCT01772823|5728668|P1|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||116
2334319|NCT01772823|5728667|P2|STARTED|Behavioral Intervention (BL -3MV or PCC)||72
2334320|NCT01772823|5728668|P1|STARTED|Behavioral Intervention (BL -3MV or PCC)||128
2334321|NCT01772758|5728768|P4|NOT COMPLETED|Overall Study||0
2334322|NCT01772758|5728769|P3|NOT COMPLETED|Overall Study||0
2334323|NCT01772758|5728770|P2|NOT COMPLETED|Overall Study||0
2334324|NCT01772758|5728771|P1|NOT COMPLETED|Overall Study||0
2334325|NCT01772758|5728768|P4|COMPLETED|Overall Study||17
2334326|NCT01772758|5728769|P3|COMPLETED|Overall Study||12
2334327|NCT01772758|5728770|P2|COMPLETED|Overall Study||17
2334328|NCT01772758|5728771|P1|COMPLETED|Overall Study||18
2334329|NCT01772758|5728768|P4|STARTED|Overall Study||17
2334330|NCT01772758|5728769|P3|STARTED|Overall Study||12
2334331|NCT01772758|5728770|P2|STARTED|Overall Study||17
2334332|NCT01772758|5728771|P1|STARTED|Overall Study||18
2334333|NCT01772719|5728781|P1|NOT COMPLETED|Overall Study||7
2334334|NCT01772719|5728781|P1|COMPLETED|Overall Study||0
2334335|NCT01772719|5728781|P1|STARTED|Overall Study||7
2334336|NCT01772654|5728794|P2|NOT COMPLETED|Overall Study||0
2334337|NCT01772654|5728795|P1|NOT COMPLETED|Overall Study||0
2334338|NCT01772654|5728794|P2|COMPLETED|Overall Study||15
2334339|NCT01772654|5728795|P1|COMPLETED|Overall Study||2
2334340|NCT01772654|5728794|P2|STARTED|Overall Study||15
2334341|NCT01772654|5728795|P1|STARTED|Overall Study||2
2334342|NCT01772576|5728801|P1|NOT COMPLETED|Overall Study||34
2334343|NCT01772576|5728801|P1|COMPLETED|Overall Study||133
2334344|NCT01772576|5728801|P1|STARTED|Overall Study||167
2334345|NCT01772550|5728813|P3|NOT COMPLETED|Overall Study||6
2334346|NCT01772550|5728814|P2|NOT COMPLETED|Overall Study||1
2334347|NCT01772550|5728815|P1|NOT COMPLETED|Overall Study||1
2334348|NCT01772550|5728813|P3|COMPLETED|Overall Study||27
2334349|NCT01772550|5728814|P2|COMPLETED|Overall Study||102
2334350|NCT01772550|5728815|P1|COMPLETED|Overall Study||101
2334351|NCT01772550|5728813|P3|CT Cardiac|Overall Study||1
2334352|NCT01772550|5728814|P2|CT Cardiac|Overall Study||7
2334353|NCT01772550|5728815|P1|CT Cardiac|Overall Study||7
2334354|NCT01772550|5728813|P3|CT Kidney|Overall Study||6
2334355|NCT01772550|5728814|P2|CT Kidney|Overall Study||19
2334356|NCT01772550|5728815|P1|CT Kidney|Overall Study||12
2334357|NCT01772550|5728813|P3|CT Liver|Overall Study||8
2334358|NCT01772550|5728814|P2|CT Liver|Overall Study||14
2334359|NCT01772550|5728815|P1|CT Liver|Overall Study||18
2334360|NCT01772550|5728813|P3|CT Angiogram|Overall Study||4
2334361|NCT01772550|5728814|P2|CT Angiogram|Overall Study||25
2334362|NCT01772550|5728815|P1|CT Angiogram|Overall Study||24
2334363|NCT01772550|5728813|P3|CT Pancreas|Overall Study||8
2334364|NCT01772550|5728814|P2|CT Pancreas|Overall Study||36
2334365|NCT01772550|5728815|P1|CT Pancreas|Overall Study||40
2334366|NCT01772550|5728813|P3|STARTED|Overall Study||33
2334367|NCT01772550|5728814|P2|STARTED|Overall Study||103
2334368|NCT01772550|5728815|P1|STARTED|Overall Study||102
2334369|NCT01772537|5728856|P3|NOT COMPLETED|Overall Study||0
2334370|NCT01772537|5728857|P2|NOT COMPLETED|Overall Study||0
2334371|NCT01772537|5728858|P1|NOT COMPLETED|Overall Study||1
2334372|NCT01772537|5728856|P3|COMPLETED|Overall Study||6
2334373|NCT01772537|5728857|P2|COMPLETED|Overall Study||3
2334374|NCT01772537|5728858|P1|COMPLETED|Overall Study||4
2334375|NCT01772537|5728856|P3|STARTED|Overall Study||6
2334376|NCT01772537|5728857|P2|STARTED|Overall Study||3
2334377|NCT01772537|5728858|P1|STARTED|Overall Study||5
2334378|NCT01772472|5728874|P2|NOT COMPLETED|Overall Study||743
2334379|NCT01772472|5728875|P1|NOT COMPLETED|Overall Study||743
2334380|NCT01772472|5728874|P2|COMPLETED|Overall Study||0
2334381|NCT01772472|5728875|P1|COMPLETED|Overall Study||0
2334382|NCT01772472|5728874|P2|STARTED|Overall Study||743
2334383|NCT01772472|5728875|P1|STARTED|Overall Study||743
2334384|NCT01772368|5728887|P1|NOT COMPLETED|Overall Study||7
2334385|NCT01772368|5728887|P1|COMPLETED|Overall Study||65
2334386|NCT01772368|5728887|P1|Received Advair Diskus 100/50 mcg|Overall Study||66
2334387|NCT01772368|5728887|P1|Received FS MDPI 100/50 mcg|Overall Study||68
2334388|NCT01772368|5728887|P1|Received FS MDPI 100/25 mcg|Overall Study||67
2334389|NCT01772368|5728887|P1|Received FS MDPI 100/12.5mcg|Overall Study||69
2334390|NCT01772368|5728887|P1|Received FS MDPI 100/6.25 mcg|Overall Study||68
2334391|NCT01772368|5728887|P1|Received Fp MDPI 100 mcg|Overall Study||67
2334392|NCT01772368|5728887|P1|STARTED|Overall Study||72
2334393|NCT01772316|5728933|P1|NOT COMPLETED|Overall Study||7
2334394|NCT01772316|5728933|P1|COMPLETED|Overall Study||40
2334395|NCT01772316|5728933|P1|STARTED|Overall Study||47
2334396|NCT01772147|5728954|P3|NOT COMPLETED|Overall Study||18
2334397|NCT01772147|5728955|P2|NOT COMPLETED|Overall Study||25
2334398|NCT01772147|5728956|P1|NOT COMPLETED|Overall Study||31
2334399|NCT01772147|5728954|P3|COMPLETED|Overall Study||184
2334400|NCT01772147|5728955|P2|COMPLETED|Overall Study||178
2334401|NCT01772147|5728956|P1|COMPLETED|Overall Study||170
2334402|NCT01772147|5728954|P3|STARTED|Overall Study||202
2334403|NCT01772147|5728955|P2|STARTED|Overall Study||203
2334404|NCT01772147|5728956|P1|STARTED|Overall Study||201
2334405|NCT01772134|5728976|P3|NOT COMPLETED|Overall Study||22
2334406|NCT01772134|5728977|P2|NOT COMPLETED|Overall Study||14
2334407|NCT01772134|5728978|P1|NOT COMPLETED|Overall Study||29
2334408|NCT01772134|5728976|P3|COMPLETED|Overall Study||184
2334409|NCT01772134|5728977|P2|COMPLETED|Overall Study||190
2334410|NCT01772134|5728978|P1|COMPLETED|Overall Study||178
2334411|NCT01772134|5728976|P3|Received Randomized Study Medication|Overall Study||205
2334412|NCT01772134|5728977|P2|Received Randomized Study Medication|Overall Study||204
2334413|NCT01772134|5728978|P1|Received Randomized Study Medication|Overall Study||205
2334414|NCT01772134|5728976|P3|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|206
2334415|NCT01772134|5728977|P2|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|204
2334416|NCT01772134|5728978|P1|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|207
2334417|NCT01771991|5728997|P2|NOT COMPLETED|Overall Study||6
2334418|NCT01771991|5728998|P1|NOT COMPLETED|Overall Study||8
2334419|NCT01771991|5728997|P2|COMPLETED|Overall Study||30
2334420|NCT01771991|5728998|P1|COMPLETED|Overall Study||30
2334421|NCT01771991|5728997|P2|Started Treatment|Overall Study||34
2334422|NCT01771991|5728998|P1|Started Treatment|Overall Study||37
2334423|NCT01771991|5728997|P2|STARTED|Overall Study||36
2334424|NCT01771991|5728998|P1|STARTED|Overall Study||38
2334425|NCT01771965|5729012|P2|NOT COMPLETED|Overall Study||5
2334426|NCT01771965|5729013|P1|NOT COMPLETED|Overall Study||3
2334427|NCT01771965|5729012|P2|COMPLETED|Overall Study||4
2334428|NCT01771965|5729013|P1|COMPLETED|Overall Study||7
2334429|NCT01771965|5729012|P2|STARTED|Overall Study||9
2334430|NCT01771965|5729013|P1|STARTED|Overall Study||10
2334431|NCT01771913|5729021|P2|NOT COMPLETED|Overall Study||0
2334432|NCT01771913|5729022|P1|NOT COMPLETED|Overall Study||1
2334433|NCT01771913|5729021|P2|COMPLETED|Overall Study||11
2334434|NCT01771913|5729022|P1|COMPLETED|Overall Study||8
2334435|NCT01771913|5729021|P2|STARTED|Overall Study||11
2334436|NCT01771913|5729022|P1|STARTED|Overall Study||9
2334437|NCT01771809|5729034|P2|NOT COMPLETED|Overall Study||83
2334438|NCT01771809|5729035|P1|NOT COMPLETED|Overall Study||71
2334439|NCT01771809|5729034|P2|COMPLETED|Overall Study||83
2334440|NCT01771809|5729035|P1|COMPLETED|Overall Study||93
2334441|NCT01771809|5729034|P2|STARTED|Overall Study||166
2334442|NCT01771809|5729035|P1|STARTED|Overall Study||164
2334443|NCT01771666|5729049|P1|NOT COMPLETED|Overall Study||0
2334444|NCT01771666|5729049|P1|COMPLETED|Overall Study||23
2334445|NCT01771666|5729049|P1|STARTED|Overall Study||23
2334446|NCT01771250|5729054|P2|NOT COMPLETED|Period 2||0
2334447|NCT01771250|5729055|P1|NOT COMPLETED|Period 2||0
2334448|NCT01771250|5729054|P2|COMPLETED|Period 2||7
2334449|NCT01771250|5729055|P1|COMPLETED|Period 2||7
2334450|NCT01771250|5729054|P2|STARTED|Period 2||7
2334451|NCT01771250|5729055|P1|STARTED|Period 2||7
2334452|NCT01771250|5729054|P2|NOT COMPLETED|Period 1||0
2334453|NCT01771250|5729055|P1|NOT COMPLETED|Period 1||1
2334454|NCT01771250|5729054|P2|COMPLETED|Period 1||7
2334455|NCT01771250|5729055|P1|COMPLETED|Period 1||7
2334456|NCT01771250|5729054|P2|Received at Least One Dose of Study Drug|Period 1||7
2334457|NCT01771250|5729055|P1|Received at Least One Dose of Study Drug|Period 1||7
2334458|NCT01771250|5729054|P2|STARTED|Period 1||7
2334459|NCT01771250|5729055|P1|STARTED|Period 1||8
2334460|NCT01771172|5729067|P1|NOT COMPLETED|Overall Study||2
2334461|NCT01771172|5729067|P1|COMPLETED|Overall Study||46
2334462|NCT01771172|5729067|P1|STARTED|Overall Study||48
2334463|NCT01770860|5729071|P1|NOT COMPLETED|Overall Study||6
2334464|NCT01770860|5729071|P1|COMPLETED|Overall Study||40
2334465|NCT01770860|5729071|P1|Randomization|Overall Study|One participant withdrew before randomization|45
2334466|NCT01770860|5729071|P1|STARTED|Overall Study|Forty-six subjects were enrolled but one subject withdrew before randomization.|46
2334467|NCT01770743|5729119|P5|NOT COMPLETED|Overall Study||2
2334468|NCT01770743|5729120|P4|NOT COMPLETED|Overall Study||2
2334469|NCT01770743|5729121|P3|NOT COMPLETED|Overall Study||1
2334470|NCT01770743|5729122|P2|NOT COMPLETED|Overall Study||3
2334471|NCT01770743|5729123|P1|NOT COMPLETED|Overall Study||2
2334472|NCT01770743|5729119|P5|COMPLETED|Overall Study||21
2334473|NCT01770743|5729120|P4|COMPLETED|Overall Study||42
2334474|NCT01770743|5729121|P3|COMPLETED|Overall Study||22
2334475|NCT01770743|5729122|P2|COMPLETED|Overall Study||31
2334476|NCT01770743|5729123|P1|COMPLETED|Overall Study||42
2334477|NCT01770743|5729119|P5|Treated|Overall Study||23
2334478|NCT01770743|5729120|P4|Treated|Overall Study||44
2334479|NCT01770743|5729121|P3|Treated|Overall Study||23
2334480|NCT01770743|5729122|P2|Treated|Overall Study||34
2334481|NCT01770743|5729123|P1|Treated|Overall Study||44
2334482|NCT01770743|5729119|P5|STARTED|Overall Study||23
2334483|NCT01770743|5729120|P4|STARTED|Overall Study||44
2334484|NCT01770743|5729121|P3|STARTED|Overall Study||23
2334485|NCT01770743|5729122|P2|STARTED|Overall Study||34
2334486|NCT01770743|5729123|P1|STARTED|Overall Study||44
2334487|NCT01770691|5729175|P1|NOT COMPLETED|Overall Study||0
2334488|NCT01770691|5729175|P1|COMPLETED|Overall Study||7
2334489|NCT01770691|5729175|P1|STARTED|Overall Study||7
2334490|NCT01770652|5729186|P4|NOT COMPLETED|Overall Study||0
2334491|NCT01770652|5729187|P3|NOT COMPLETED|Overall Study||0
2334492|NCT01770652|5729188|P2|NOT COMPLETED|Overall Study||0
2334493|NCT01770652|5729189|P1|NOT COMPLETED|Overall Study||0
2334494|NCT01770652|5729186|P4|COMPLETED|Overall Study||8
2334495|NCT01770652|5729187|P3|COMPLETED|Overall Study||8
2334496|NCT01770652|5729188|P2|COMPLETED|Overall Study||8
2334497|NCT01770652|5729189|P1|COMPLETED|Overall Study||8
2334498|NCT01770652|5729186|P4|STARTED|Overall Study||8
2334499|NCT01770652|5729187|P3|STARTED|Overall Study||8
2334500|NCT01770652|5729188|P2|STARTED|Overall Study||8
2334501|NCT01770652|5729189|P1|STARTED|Overall Study||8
2334502|NCT01770509|5729225|P2|NOT COMPLETED|Overall Study||3
2334503|NCT01770509|5729226|P1|NOT COMPLETED|Overall Study||1
2334504|NCT01770509|5729225|P2|COMPLETED|Overall Study||14
2334505|NCT01770509|5729226|P1|COMPLETED|Overall Study||11
2334506|NCT01770509|5729225|P2|STARTED|Overall Study||17
2334507|NCT01770509|5729226|P1|STARTED|Overall Study||12
2334508|NCT01770483|5729242|P2|NOT COMPLETED|Overall Study||0
2334509|NCT01770483|5729243|P1|NOT COMPLETED|Overall Study||0
2334510|NCT01770483|5729242|P2|COMPLETED|Overall Study||33
2334511|NCT01770483|5729243|P1|COMPLETED|Overall Study||33
2334512|NCT01770483|5729242|P2|STARTED|Overall Study||33
2334513|NCT01770483|5729243|P1|STARTED|Overall Study||33
2334514|NCT01770431|5729253|P2|NOT COMPLETED|Overall Study||32
2334515|NCT01770431|5729254|P1|NOT COMPLETED|Overall Study||10
2334516|NCT01770431|5729253|P2|COMPLETED|Overall Study||316
2334517|NCT01770431|5729254|P1|COMPLETED|Overall Study||686
2334518|NCT01770431|5729253|P2|STARTED|Overall Study||348
2334519|NCT01770431|5729254|P1|STARTED|Overall Study||696
2334520|NCT01770392|5729262|P1|NOT COMPLETED|Nintedanib+ Rifampicin||0
2334521|NCT01770392|5729262|P1|COMPLETED|Nintedanib+ Rifampicin||25
2334522|NCT01770392|5729262|P1|STARTED|Nintedanib+ Rifampicin||25
2334523|NCT01770392|5729262|P1|NOT COMPLETED|Washout Period of at Least 14 Days||1
2334524|NCT01770392|5729262|P1|COMPLETED|Washout Period of at Least 14 Days||25
2334525|NCT01770392|5729262|P1|STARTED|Washout Period of at Least 14 Days||26
2334526|NCT01770392|5729262|P1|NOT COMPLETED|Nintedanib||0
2334527|NCT01770392|5729262|P1|COMPLETED|Nintedanib||26
2334528|NCT01770392|5729262|P1|STARTED|Nintedanib||26
2334529|NCT01770379|5729277|P3|NOT COMPLETED|Overall Study||42
2334530|NCT01770379|5729278|P2|NOT COMPLETED|Overall Study||44
2334531|NCT01770379|5729279|P1|NOT COMPLETED|Overall Study||39
2334532|NCT01770379|5729277|P3|COMPLETED|Overall Study||39
2334533|NCT01770379|5729278|P2|COMPLETED|Overall Study||37
2334534|NCT01770379|5729279|P1|COMPLETED|Overall Study||41
2334535|NCT01770379|5729277|P3|STARTED|Overall Study||81
2334536|NCT01770379|5729278|P2|STARTED|Overall Study||81
2334537|NCT01770379|5729279|P1|STARTED|Overall Study||80
2334538|NCT01770366|5729298|P2|NOT COMPLETED|Overall Study||2
2334539|NCT01770366|5729299|P1|NOT COMPLETED|Overall Study||2
2334540|NCT01770366|5729298|P2|COMPLETED|Overall Study||4
2334541|NCT01770366|5729299|P1|COMPLETED|Overall Study||2
2334542|NCT01770366|5729298|P2|STARTED|Overall Study||6
2334543|NCT01770366|5729299|P1|STARTED|Overall Study||4
2334544|NCT01770353|5729307|P2|NOT COMPLETED|Overall Study||12
2334545|NCT01770353|5729308|P1|NOT COMPLETED|Overall Study||6
2334546|NCT01770353|5729307|P2|COMPLETED|Overall Study||18
2334547|NCT01770353|5729308|P1|COMPLETED|Overall Study||9
2334548|NCT01770353|5729307|P2|Received FMX and MM-398|Overall Study||29
2334549|NCT01770353|5729308|P1|Received FMX and MM-398|Overall Study||13
2334550|NCT01770353|5729307|P2|Received FMX|Overall Study|1 subject excluded from MM-398 safety population.|30
2334551|NCT01770353|5729308|P1|Received FMX|Overall Study|2 subjects excluded from MM-398 safety population.|15
2334552|NCT01770353|5729307|P2|STARTED|Overall Study||30
2334553|NCT01770353|5729308|P1|STARTED|Overall Study||15
2334554|NCT01770314|5729358|P2|NOT COMPLETED|Overall Study||0
2334555|NCT01770314|5729359|P1|NOT COMPLETED|Overall Study||0
2334556|NCT01770314|5729358|P2|COMPLETED|Overall Study||90
2334557|NCT01770314|5729359|P1|COMPLETED|Overall Study||86
2334558|NCT01770314|5729358|P2|Contributed Data to One-month Follow-up|Overall Study||66
2334559|NCT01770314|5729359|P1|Contributed Data to One-month Follow-up|Overall Study||61
2334560|NCT01770314|5729358|P2|Contributed Data to Post-test|Overall Study||67
2334561|NCT01770314|5729359|P1|Contributed Data to Post-test|Overall Study||65
2334562|NCT01770314|5729358|P2|Contributed Data to Baseline|Overall Study||72
2334563|NCT01770314|5729359|P1|Contributed Data to Baseline|Overall Study||68
2334564|NCT01770314|5729358|P2|STARTED|Overall Study||90
2334565|NCT01770314|5729359|P1|STARTED|Overall Study||86
2334566|NCT01770145|5729367|P1|NOT COMPLETED|Treatment||4
2334567|NCT01770145|5729367|P1|COMPLETED|Treatment||97
2334568|NCT01770145|5729367|P1|STARTED|Treatment||101
2334569|NCT01770145|5729367|P1|NOT COMPLETED|Baseline||26
2334570|NCT01770145|5729367|P1|COMPLETED|Baseline||101
2334571|NCT01770145|5729367|P1|STARTED|Baseline||127
2334572|NCT01769612|5729372|P1|NOT COMPLETED|Overall Study||0
2334573|NCT01769612|5729372|P1|COMPLETED|Overall Study||168
2334574|NCT01769612|5729372|P1|STARTED|Overall Study||168
2334575|NCT01769586|5729380|P2|NOT COMPLETED|Overall Study||0
2334576|NCT01769586|5729381|P1|NOT COMPLETED|Overall Study||0
2334577|NCT01769586|5729380|P2|COMPLETED|Overall Study||100
2334578|NCT01769586|5729381|P1|COMPLETED|Overall Study||100
2334579|NCT01769586|5729380|P2|STARTED|Overall Study||100
2334580|NCT01769586|5729381|P1|STARTED|Overall Study||100
2334581|NCT01769573|5729392|P5|NOT COMPLETED|Overall Study||0
2334582|NCT01769573|5729393|P4|NOT COMPLETED|Overall Study||0
2334583|NCT01769573|5729394|P3|NOT COMPLETED|Overall Study||0
2334584|NCT01769573|5729395|P2|NOT COMPLETED|Overall Study||0
2334585|NCT01769573|5729396|P1|NOT COMPLETED|Overall Study||0
2334586|NCT01769573|5729392|P5|COMPLETED|Overall Study||10
2334587|NCT01769573|5729393|P4|COMPLETED|Overall Study||0
2334588|NCT01769573|5729394|P3|COMPLETED|Overall Study||10
2334589|NCT01769573|5729395|P2|COMPLETED|Overall Study||6
2334590|NCT01769573|5729396|P1|COMPLETED|Overall Study||10
2334591|NCT01769573|5729392|P5|STARTED|Overall Study||10
2334592|NCT01769573|5729393|P4|STARTED|Overall Study||0
2334593|NCT01769573|5729394|P3|STARTED|Overall Study||10
2334594|NCT01769573|5729395|P2|STARTED|Overall Study||6
2334595|NCT01769573|5729396|P1|STARTED|Overall Study||10
2334596|NCT01769508|5729423|P1|NOT COMPLETED|Overall Study||6
2334597|NCT01769508|5729423|P1|COMPLETED|Overall Study||6
2334598|NCT01769508|5729423|P1|STARTED|Overall Study||12
2334599|NCT01769469|5729432|P1|NOT COMPLETED|Overall Study||35
2334600|NCT01769469|5729432|P1|COMPLETED|Overall Study||66
2334601|NCT01769469|5729432|P1|STARTED|Overall Study||101
2334602|NCT01769456|5729592|P1|NOT COMPLETED|Overall Study||37
2334603|NCT01769456|5729592|P1|COMPLETED|Overall Study||41
2334604|NCT01769456|5729592|P1|STARTED|Overall Study|1 subject inadvertently enrolled, discontin'd after baseline, re-enrolled later and completed study|78
2334605|NCT01769443|5729613|P2|NOT COMPLETED|Overall Study||0
2334606|NCT01769443|5729614|P1|NOT COMPLETED|Overall Study||1
2334607|NCT01769443|5729613|P2|COMPLETED|Overall Study||1
2334608|NCT01769443|5729614|P1|COMPLETED|Overall Study||0
2334609|NCT01769443|5729613|P2|STARTED|Overall Study||1
2334610|NCT01769443|5729614|P1|STARTED|Overall Study||1
2334611|NCT01769404|5729656|P2|NOT COMPLETED|Treatment Period 2||0
2334612|NCT01769404|5729657|P1|NOT COMPLETED|Treatment Period 2||7
2334613|NCT01769404|5729656|P2|COMPLETED|Treatment Period 2||13
2334614|NCT01769404|5729657|P1|COMPLETED|Treatment Period 2||0
2334615|NCT01769404|5729656|P2|STARTED|Treatment Period 2||13
2334616|NCT01769404|5729657|P1|STARTED|Treatment Period 2||7
2334617|NCT01769404|5729656|P2|NOT COMPLETED|Treatment Period 1||0
2334618|NCT01769404|5729657|P1|NOT COMPLETED|Treatment Period 1||5
2334619|NCT01769404|5729656|P2|COMPLETED|Treatment Period 1||13
2334620|NCT01769404|5729657|P1|COMPLETED|Treatment Period 1||7
2334621|NCT01769404|5729656|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||13
2334622|NCT01769404|5729657|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
2334623|NCT01769404|5729656|P2|STARTED|Treatment Period 1||13
2334624|NCT01769404|5729657|P1|STARTED|Treatment Period 1||12
2334625|NCT01769391|5729679|P2|NOT COMPLETED|Overall Study||9
2334626|NCT01769391|5729680|P1|NOT COMPLETED|Overall Study||17
2334627|NCT01769391|5729679|P2|COMPLETED|Overall Study||48
2334628|NCT01769391|5729680|P1|COMPLETED|Overall Study||93
2334629|NCT01769391|5729679|P2|Received at Least One Dose of Study Drug|Overall Study||55
2334630|NCT01769391|5729680|P1|Received at Least One Dose of Study Drug|Overall Study||106
2334631|NCT01769391|5729679|P2|STARTED|Overall Study||57
2334632|NCT01769391|5729680|P1|STARTED|Overall Study||110
2334633|NCT01769378|5729699|P2|NOT COMPLETED|Overall Study||4
2334634|NCT01769378|5729700|P1|NOT COMPLETED|Overall Study||25
2334635|NCT01769378|5729699|P2|COMPLETED|Overall Study|Completed the study on study treatment|56
2334636|NCT01769378|5729700|P1|COMPLETED|Overall Study|Completed the study on study treatment|215
2334637|NCT01769378|5729699|P2|Received at Least 1 Dose of Study Drug|Overall Study||60
2334638|NCT01769378|5729700|P1|Received at Least 1 Dose of Study Drug|Overall Study||239
2334639|NCT01769378|5729699|P2|STARTED|Overall Study||60
2334640|NCT01769378|5729700|P1|STARTED|Overall Study||240
2334641|NCT01769365|5729738|P3|NOT COMPLETED|Overall Study||2
2334642|NCT01769365|5729739|P2|NOT COMPLETED|Overall Study||2
2334643|NCT01769365|5729740|P1|NOT COMPLETED|Overall Study||0
2334644|NCT01769365|5729738|P3|COMPLETED|Overall Study||101
2334645|NCT01769365|5729739|P2|COMPLETED|Overall Study||100
2334646|NCT01769365|5729740|P1|COMPLETED|Overall Study||102
2334647|NCT01769365|5729738|P3|STARTED|Overall Study||103
2334648|NCT01769365|5729739|P2|STARTED|Overall Study||102
2334649|NCT01769365|5729740|P1|STARTED|Overall Study||102
2334650|NCT01769352|5729752|P4|NOT COMPLETED|Overall Study||0
2334651|NCT01769352|5729753|P3|NOT COMPLETED|Overall Study||0
2334652|NCT01769352|5729754|P2|NOT COMPLETED|Overall Study||0
2334653|NCT01769352|5729755|P1|NOT COMPLETED|Overall Study||0
2334654|NCT01769352|5729752|P4|COMPLETED|Overall Study||8
2334655|NCT01769352|5729753|P3|COMPLETED|Overall Study||9
2334656|NCT01769352|5729754|P2|COMPLETED|Overall Study||12
2334657|NCT01769352|5729755|P1|COMPLETED|Overall Study||13
2334658|NCT01769352|5729752|P4|STARTED|Overall Study||8
2334659|NCT01769352|5729753|P3|STARTED|Overall Study||9
2334660|NCT01769352|5729754|P2|STARTED|Overall Study||12
2334661|NCT01769352|5729755|P1|STARTED|Overall Study||13
2334662|NCT01769339|5729780|P1|NOT COMPLETED|Overall Study||43
2334663|NCT01769339|5729780|P1|COMPLETED|Overall Study||72
2334664|NCT01769339|5729780|P1|STARTED|Overall Study||115
2334665|NCT01769326|5729791|P4|NOT COMPLETED|Overall Study||0
2334666|NCT01769326|5729792|P3|NOT COMPLETED|Overall Study||1
2334667|NCT01769326|5729793|P2|NOT COMPLETED|Overall Study||4
2334668|NCT01769326|5729794|P1|NOT COMPLETED|Overall Study||2
2334669|NCT01769326|5729791|P4|COMPLETED|Overall Study||8
2334670|NCT01769326|5729792|P3|COMPLETED|Overall Study||8
2334671|NCT01769326|5729793|P2|COMPLETED|Overall Study||8
2334672|NCT01769326|5729794|P1|COMPLETED|Overall Study||9
2334673|NCT01769326|5729791|P4|STARTED|Overall Study||8
2334674|NCT01769326|5729792|P3|STARTED|Overall Study||9
2334675|NCT01769326|5729793|P2|STARTED|Overall Study||12
2334676|NCT01769326|5729794|P1|STARTED|Overall Study||11
2334677|NCT01769274|5729804|P3|NOT COMPLETED|Part B:Treatment Session2-Period4||0
2334678|NCT01769274|5729805|P2|NOT COMPLETED|Part B:Treatment Session2-Period4||0
2334679|NCT01769274|5729806|P1|NOT COMPLETED|Part B:Treatment Session2-Period4||0
2334680|NCT01769274|5729804|P3|COMPLETED|Part B:Treatment Session2-Period4||3
2334681|NCT01769274|5729805|P2|COMPLETED|Part B:Treatment Session2-Period4||2
2334682|NCT01769274|5729806|P1|COMPLETED|Part B:Treatment Session2-Period4||0
2334683|NCT01769274|5729804|P3|STARTED|Part B:Treatment Session2-Period4||3
2334684|NCT01769274|5729805|P2|STARTED|Part B:Treatment Session2-Period4||2
2334685|NCT01769274|5729806|P1|STARTED|Part B:Treatment Session2-Period4||0
2334686|NCT01769274|5729804|P3|NOT COMPLETED|Washout Period||0
2334687|NCT01769274|5729805|P2|NOT COMPLETED|Washout Period||0
2334688|NCT01769274|5729806|P1|NOT COMPLETED|Washout Period||0
2334689|NCT01769274|5729804|P3|COMPLETED|Washout Period||3
2334690|NCT01769274|5729805|P2|COMPLETED|Washout Period||2
2334691|NCT01769274|5729806|P1|COMPLETED|Washout Period||0
2334692|NCT01769274|5729804|P3|STARTED|Washout Period||3
2334693|NCT01769274|5729805|P2|STARTED|Washout Period||2
2334694|NCT01769274|5729806|P1|STARTED|Washout Period||0
2334695|NCT01769274|5729804|P3|NOT COMPLETED|Part B:Treatment Session2-Period3||0
2334696|NCT01769274|5729805|P2|NOT COMPLETED|Part B:Treatment Session2-Period3||0
2334697|NCT01769274|5729806|P1|NOT COMPLETED|Part B:Treatment Session2-Period3||0
2334698|NCT01769274|5729804|P3|COMPLETED|Part B:Treatment Session2-Period3||3
2334699|NCT01769274|5729805|P2|COMPLETED|Part B:Treatment Session2-Period3||2
2334700|NCT01769274|5729806|P1|COMPLETED|Part B:Treatment Session2-Period3||0
2334701|NCT01769274|5729804|P3|STARTED|Part B:Treatment Session2-Period3||3
2334702|NCT01769274|5729805|P2|STARTED|Part B:Treatment Session2-Period3||2
2334703|NCT01769274|5729806|P1|STARTED|Part B:Treatment Session2-Period3||0
2334704|NCT01769274|5729804|P3|NOT COMPLETED|Washout Period||0
2334705|NCT01769274|5729805|P2|NOT COMPLETED|Washout Period||0
2334706|NCT01769274|5729806|P1|NOT COMPLETED|Washout Period||0
2334707|NCT01769274|5729804|P3|COMPLETED|Washout Period||3
2334708|NCT01769274|5729805|P2|COMPLETED|Washout Period||2
2334709|NCT01769274|5729806|P1|COMPLETED|Washout Period||0
2334710|NCT01769274|5729804|P3|STARTED|Washout Period||3
2334711|NCT01769274|5729805|P2|STARTED|Washout Period||2
2334712|NCT01769274|5729806|P1|STARTED|Washout Period||0
2334713|NCT01769274|5729804|P3|NOT COMPLETED|Part B:Treatment Session1-Period2||0
2334714|NCT01769274|5729805|P2|NOT COMPLETED|Part B:Treatment Session1-Period2||0
2334715|NCT01769274|5729806|P1|NOT COMPLETED|Part B:Treatment Session1-Period2||0
2334716|NCT01769274|5729804|P3|COMPLETED|Part B:Treatment Session1-Period2||3
2334717|NCT01769274|5729805|P2|COMPLETED|Part B:Treatment Session1-Period2||2
2334718|NCT01769274|5729806|P1|COMPLETED|Part B:Treatment Session1-Period2||0
2334719|NCT01769274|5729804|P3|STARTED|Part B:Treatment Session1-Period2||3
2334720|NCT01769274|5729805|P2|STARTED|Part B:Treatment Session1-Period2||2
2334721|NCT01769274|5729806|P1|STARTED|Part B:Treatment Session1-Period2||0
2334722|NCT01769274|5729804|P3|NOT COMPLETED|Washout Period||0
2334723|NCT01769274|5729805|P2|NOT COMPLETED|Washout Period||0
2334724|NCT01769274|5729806|P1|NOT COMPLETED|Washout Period||0
2334725|NCT01769274|5729804|P3|COMPLETED|Washout Period||3
2334726|NCT01769274|5729805|P2|COMPLETED|Washout Period||2
2334727|NCT01769274|5729806|P1|COMPLETED|Washout Period||0
2334728|NCT01769274|5729804|P3|STARTED|Washout Period||3
2334729|NCT01769274|5729805|P2|STARTED|Washout Period||2
2334730|NCT01769274|5729806|P1|STARTED|Washout Period||0
2334731|NCT01769274|5729804|P3|NOT COMPLETED|Part B:Treatment Session1-Period1||0
2334732|NCT01769274|5729805|P2|NOT COMPLETED|Part B:Treatment Session1-Period1||0
2334733|NCT01769274|5729806|P1|NOT COMPLETED|Part B:Treatment Session1-Period1||0
2334734|NCT01769274|5729804|P3|COMPLETED|Part B:Treatment Session1-Period1||3
2334735|NCT01769274|5729805|P2|COMPLETED|Part B:Treatment Session1-Period1||2
2334736|NCT01769274|5729806|P1|COMPLETED|Part B:Treatment Session1-Period1||0
2334737|NCT01769274|5729804|P3|STARTED|Part B:Treatment Session1-Period1||3
2334738|NCT01769274|5729805|P2|STARTED|Part B:Treatment Session1-Period1||2
2334739|NCT01769274|5729806|P1|STARTED|Part B:Treatment Session1-Period1||0
2334740|NCT01769274|5729804|P3|NOT COMPLETED|Part A||0
2334741|NCT01769274|5729805|P2|NOT COMPLETED|Part A||0
2334742|NCT01769274|5729806|P1|NOT COMPLETED|Part A||0
2334743|NCT01769274|5729804|P3|COMPLETED|Part A||0
2334744|NCT01769274|5729805|P2|COMPLETED|Part A||0
2334745|NCT01769274|5729806|P1|COMPLETED|Part A||5
2334746|NCT01769274|5729804|P3|STARTED|Part A||0
2334747|NCT01769274|5729805|P2|STARTED|Part A||0
2334748|NCT01769274|5729806|P1|STARTED|Part A||5
2334749|NCT01769248|5729898|P2|NOT COMPLETED|Overall Study||12
2334750|NCT01769248|5729899|P1|NOT COMPLETED|Overall Study||28
2334751|NCT01769248|5729898|P2|COMPLETED|Overall Study||58
2334752|NCT01769248|5729899|P1|COMPLETED|Overall Study||42
2334753|NCT01769248|5729898|P2|Participants Who Crossed-over|Overall Study||12
2334754|NCT01769248|5729899|P1|Participants Who Crossed-over|Overall Study||28
2334755|NCT01769248|5729898|P2|STARTED|Overall Study||70
2334756|NCT01769248|5729899|P1|STARTED|Overall Study||70
2334757|NCT01769222|5729911|P2|NOT COMPLETED|Overall Study||0
2334758|NCT01769222|5729912|P1|NOT COMPLETED|Overall Study||0
2334759|NCT01769222|5729911|P2|COMPLETED|Overall Study||0
2334760|NCT01769222|5729912|P1|COMPLETED|Overall Study||3
2334761|NCT01769222|5729911|P2|STARTED|Overall Study||0
2334762|NCT01769222|5729912|P1|STARTED|Overall Study||3
2334763|NCT01769209|5729926|P1|NOT COMPLETED|Overall Study||0
2334764|NCT01769209|5729926|P1|COMPLETED|Overall Study||18
2334765|NCT01769209|5729926|P1|STARTED|Overall Study||18
2334766|NCT01769196|5729939|P2|NOT COMPLETED|Overall Study||272
2334767|NCT01769196|5729940|P1|NOT COMPLETED|Overall Study||272
2334768|NCT01769196|5729939|P2|COMPLETED|Overall Study||0
2334769|NCT01769196|5729940|P1|COMPLETED|Overall Study||0
2334770|NCT01769196|5729939|P2|STARTED|Overall Study||272
2334771|NCT01769196|5729940|P1|STARTED|Overall Study||272
2334772|NCT01769105|5729970|P2|NOT COMPLETED|Cross-over||0
2334773|NCT01769105|5729971|P1|NOT COMPLETED|Cross-over||5
2334774|NCT01769105|5729970|P2|COMPLETED|Cross-over|Was not intended by the study protocol|0
2334775|NCT01769105|5729971|P1|COMPLETED|Cross-over||9
2334776|NCT01769105|5729970|P2|STARTED|Cross-over|Cross-over was only intended for the Lid margin hygiene group|0
2334777|NCT01769105|5729971|P1|STARTED|Cross-over||14
2334778|NCT01769105|5729970|P2|NOT COMPLETED|First Intervention||2
2334779|NCT01769105|5729971|P1|NOT COMPLETED|First Intervention||2
2334780|NCT01769105|5729970|P2|COMPLETED|First Intervention||17
2334781|NCT01769105|5729971|P1|COMPLETED|First Intervention||14
2334782|NCT01769105|5729970|P2|STARTED|First Intervention||19
2334783|NCT01769105|5729971|P1|STARTED|First Intervention||16
2334784|NCT01768858|5729990|P1|NOT COMPLETED|Overall Study||22
2334785|NCT01768858|5729990|P1|COMPLETED|Overall Study||74
2334786|NCT01768858|5729990|P1|STARTED|Overall Study||96
2334787|NCT01768832|5730005|P3|NOT COMPLETED|Overall Study||9
2334788|NCT01768832|5730006|P2|NOT COMPLETED|Overall Study||4
2334789|NCT01768832|5730007|P1|NOT COMPLETED|Overall Study||10
2334790|NCT01768832|5730005|P3|COMPLETED|Overall Study||26
2334791|NCT01768832|5730006|P2|COMPLETED|Overall Study||39
2334792|NCT01768832|5730007|P1|COMPLETED|Overall Study||31
2334793|NCT01768832|5730005|P3|STARTED|Overall Study||35
2334794|NCT01768832|5730006|P2|STARTED|Overall Study||43
2334795|NCT01768832|5730007|P1|STARTED|Overall Study||41
2334796|NCT01768676|5730041|P2|NOT COMPLETED|Overall Study||31
2334797|NCT01768676|5730042|P1|NOT COMPLETED|Overall Study||24
2334798|NCT01768676|5730041|P2|COMPLETED|Overall Study||60
2334799|NCT01768676|5730042|P1|COMPLETED|Overall Study||66
2334800|NCT01768676|5730041|P2|STARTED|Overall Study||91
2334801|NCT01768676|5730042|P1|STARTED|Overall Study||90
2334802|NCT01768637|5730058|P2|NOT COMPLETED|Overall Study||7
2334803|NCT01768637|5730059|P1|NOT COMPLETED|Overall Study||3
2334804|NCT01768637|5730058|P2|COMPLETED|Overall Study||12
2334805|NCT01768637|5730059|P1|COMPLETED|Overall Study||26
2334806|NCT01768637|5730058|P2|Completed Visit 2|Overall Study||13
2334807|NCT01768637|5730059|P1|Completed Visit 2|Overall Study||26
2334808|NCT01768637|5730058|P2|Completed Visit 1|Overall Study||16
2334809|NCT01768637|5730059|P1|Completed Visit 1|Overall Study||28
2334810|NCT01768637|5730058|P2|STARTED|Overall Study||19
2334811|NCT01768637|5730059|P1|STARTED|Overall Study||29
2334812|NCT01768572|5730072|P3|NOT COMPLETED|Overall Study||6
2334813|NCT01768572|5730073|P2|NOT COMPLETED|Overall Study||12
2334814|NCT01768572|5730074|P1|NOT COMPLETED|Overall Study||9
2334815|NCT01768572|5730072|P3|COMPLETED|Overall Study||96
2334816|NCT01768572|5730073|P2|COMPLETED|Overall Study||39
2334817|NCT01768572|5730074|P1|COMPLETED|Overall Study||40
2334818|NCT01768572|5730072|P3|STARTED|Overall Study||102
2334819|NCT01768572|5730073|P2|STARTED|Overall Study||51
2334820|NCT01768572|5730074|P1|STARTED|Overall Study||49
2334821|NCT01768559|5730085|P3|NOT COMPLETED|Overall Study||13
2334822|NCT01768559|5730086|P2|NOT COMPLETED|Overall Study||17
2334823|NCT01768559|5730087|P1|NOT COMPLETED|Overall Study||30
2334824|NCT01768559|5730085|P3|COMPLETED|Overall Study||285
2334825|NCT01768559|5730086|P2|COMPLETED|Overall Study||281
2334826|NCT01768559|5730087|P1|COMPLETED|Overall Study||268
2334827|NCT01768559|5730085|P3|Treated|Overall Study|4 participants received Insulin Glulisine QD (for more than 50%)|297
2334828|NCT01768559|5730086|P2|Treated|Overall Study|1 participant received Insulin Glulisine TID (for more than 50%)|298
2334829|NCT01768559|5730087|P1|Treated|Overall Study||298
2334830|NCT01768559|5730085|P3|STARTED|Overall Study||298
2334831|NCT01768559|5730086|P2|STARTED|Overall Study||298
2334832|NCT01768559|5730087|P1|STARTED|Overall Study||298
2334833|NCT01768520|5730138|P3|NOT COMPLETED|Overall Study||9
2334834|NCT01768520|5730139|P2|NOT COMPLETED|Overall Study||26
2334835|NCT01768520|5730140|P1|NOT COMPLETED|Overall Study||32
2334836|NCT01768520|5730138|P3|COMPLETED|Overall Study||30
2334837|NCT01768520|5730139|P2|COMPLETED|Overall Study||121
2334838|NCT01768520|5730140|P1|COMPLETED|Overall Study||120
2334839|NCT01768520|5730138|P3|STARTED|Overall Study||39
2334840|NCT01768520|5730139|P2|STARTED|Overall Study||147
2334841|NCT01768520|5730140|P1|STARTED|Overall Study||152
2334842|NCT01768325|5730153|P2|NOT COMPLETED|Overall Study||0
2334843|NCT01768325|5730154|P1|NOT COMPLETED|Overall Study||0
2334844|NCT01768325|5730153|P2|COMPLETED|Overall Study||41
2334845|NCT01768325|5730154|P1|COMPLETED|Overall Study||37
2334846|NCT01768325|5730153|P2|STARTED|Overall Study||41
2334847|NCT01768325|5730154|P1|STARTED|Overall Study||37
2334848|NCT01768286|5730168|P4|NOT COMPLETED|Overall Study||1
2334849|NCT01768286|5730169|P3|NOT COMPLETED|Overall Study||2
2334850|NCT01768286|5730170|P2|NOT COMPLETED|Overall Study||4
2334851|NCT01768286|5730171|P1|NOT COMPLETED|Overall Study||7
2334852|NCT01768286|5730168|P4|COMPLETED|Overall Study||110
2334853|NCT01768286|5730169|P3|COMPLETED|Overall Study||108
2334854|NCT01768286|5730170|P2|COMPLETED|Overall Study||107
2334855|NCT01768286|5730171|P1|COMPLETED|Overall Study||102
2334856|NCT01768286|5730168|P4|STARTED|Overall Study||111
2334857|NCT01768286|5730169|P3|STARTED|Overall Study||110
2334858|NCT01768286|5730170|P2|STARTED|Overall Study||111
2334859|NCT01768286|5730171|P1|STARTED|Overall Study||109
2334860|NCT01768117|5730233|P1|NOT COMPLETED|Overall Study||6
2334861|NCT01768117|5730233|P1|COMPLETED|Overall Study||7
2334862|NCT01768117|5730233|P1|STARTED|Overall Study||13
2334863|NCT01768013|5730241|P1|NOT COMPLETED|Overall Study||0
2334864|NCT01768013|5730241|P1|COMPLETED|Overall Study||13
2334865|NCT01768013|5730241|P1|STARTED|Overall Study||13
2334866|NCT01768000|5730274|P4|NOT COMPLETED|Overall Study||2
2334867|NCT01768000|5730275|P3|NOT COMPLETED|Overall Study||1
2334868|NCT01768000|5730276|P2|NOT COMPLETED|Overall Study||2
2334869|NCT01768000|5730277|P1|NOT COMPLETED|Overall Study||1
2334870|NCT01768000|5730274|P4|COMPLETED|Overall Study||8
2334871|NCT01768000|5730275|P3|COMPLETED|Overall Study||9
2334872|NCT01768000|5730276|P2|COMPLETED|Overall Study||8
2334873|NCT01768000|5730277|P1|COMPLETED|Overall Study||9
2334874|NCT01768000|5730274|P4|STARTED|Overall Study||10
2334875|NCT01768000|5730275|P3|STARTED|Overall Study||10
2334876|NCT01768000|5730276|P2|STARTED|Overall Study||10
2334877|NCT01768000|5730277|P1|STARTED|Overall Study||10
2334878|NCT01767987|5730297|P2|NOT COMPLETED|Overall Study||1
2334879|NCT01767987|5730298|P1|NOT COMPLETED|Overall Study||4
2334880|NCT01767987|5730297|P2|COMPLETED|Overall Study||1
2334881|NCT01767987|5730298|P1|COMPLETED|Overall Study||0
2334882|NCT01767987|5730297|P2|STARTED|Overall Study||2
2334883|NCT01767987|5730298|P1|STARTED|Overall Study||4
2334884|NCT01767935|5730320|P1|NOT COMPLETED|Overall Study||0
2334885|NCT01767935|5730320|P1|COMPLETED|Overall Study||1
2334886|NCT01767935|5730320|P1|STARTED|Overall Study||1
2334887|NCT01767701|5730328|P1|NOT COMPLETED|Overall Study||0
2334888|NCT01767701|5730328|P1|COMPLETED|Overall Study||20
2334889|NCT01767701|5730328|P1|STARTED|Overall Study|All 20 patients who entered the treatment phase completed the six months trial period.|20
2334890|NCT01767688|5730341|P2|NOT COMPLETED|Overall Study||0
2334891|NCT01767688|5730342|P1|NOT COMPLETED|Overall Study||0
2334892|NCT01767688|5730341|P2|COMPLETED|Overall Study||8
2334893|NCT01767688|5730342|P1|COMPLETED|Overall Study||8
2334894|NCT01767688|5730341|P2|STARTED|Overall Study||8
2334895|NCT01767688|5730342|P1|STARTED|Overall Study||8
2334896|NCT01767597|5730364|P2|NOT COMPLETED|Overall Study||1
2334897|NCT01767597|5730365|P1|NOT COMPLETED|Overall Study||4
2334898|NCT01767597|5730364|P2|COMPLETED|Overall Study||499
2334899|NCT01767597|5730365|P1|COMPLETED|Overall Study||496
2334900|NCT01767597|5730364|P2|STARTED|Overall Study||500
2334901|NCT01767597|5730365|P1|STARTED|Overall Study||500
2334902|NCT01767519|5730374|P3|NOT COMPLETED|Overall Study||5
2334903|NCT01767519|5730375|P2|NOT COMPLETED|Overall Study||13
2334904|NCT01767519|5730376|P1|NOT COMPLETED|Overall Study||14
2334905|NCT01767519|5730374|P3|COMPLETED|Overall Study||55
2334906|NCT01767519|5730375|P2|COMPLETED|Overall Study||138
2334907|NCT01767519|5730376|P1|COMPLETED|Overall Study||131
2334908|NCT01767519|5730374|P3|STARTED|Overall Study||60
2334909|NCT01767519|5730375|P2|STARTED|Overall Study||151
2334910|NCT01767519|5730376|P1|STARTED|Overall Study||145
2334911|NCT01767506|5730404|P2|NOT COMPLETED|Overall Study||0
2334912|NCT01767506|5730405|P1|NOT COMPLETED|Overall Study||0
2334913|NCT01767506|5730404|P2|COMPLETED|Overall Study|The study was conducted at the community level.|0
2334914|NCT01767506|5730405|P1|COMPLETED|Overall Study|The study was conducted at the community level.|0
2334915|NCT01767506|5730404|P2|STARTED|Overall Study|"26 communities were randomized to control group~The study was conducted at the community level."|0
2334916|NCT01767506|5730405|P1|STARTED|Overall Study|"26 communities were randomized to intervention group~The study was conducted at the community level."|0
2334917|NCT01767467|5730417|P2|NOT COMPLETED|End of Study Phase (up to Month 13)||63
2334918|NCT01767467|5730418|P1|NOT COMPLETED|End of Study Phase (up to Month 13)||47
2334919|NCT01767467|5730417|P2|COMPLETED|End of Study Phase (up to Month 13)||216
2334920|NCT01767467|5730418|P1|COMPLETED|End of Study Phase (up to Month 13)||236
2334921|NCT01767467|5730417|P2|STARTED|End of Study Phase (up to Month 13)||279
2334922|NCT01767467|5730418|P1|STARTED|End of Study Phase (up to Month 13)||283
2334923|NCT01767467|5730417|P2|NOT COMPLETED|Vaccination Phase (up to Month 2)||20
2334924|NCT01767467|5730418|P1|NOT COMPLETED|Vaccination Phase (up to Month 2)||17
2334925|NCT01767467|5730417|P2|COMPLETED|Vaccination Phase (up to Month 2)||259
2334926|NCT01767467|5730418|P1|COMPLETED|Vaccination Phase (up to Month 2)||266
2334927|NCT01767467|5730417|P2|STARTED|Vaccination Phase (up to Month 2)||279
2334928|NCT01767467|5730418|P1|STARTED|Vaccination Phase (up to Month 2)||283
2334929|NCT01767415|5730466|P1|NOT COMPLETED|Overall Study||0
2334930|NCT01767415|5730466|P1|COMPLETED|Overall Study||10
2334931|NCT01767415|5730466|P1|STARTED|Overall Study||10
2334932|NCT01767376|5730474|P3|NOT COMPLETED|Overall Study||0
2334933|NCT01767376|5730475|P2|NOT COMPLETED|Overall Study||3
2334934|NCT01767376|5730476|P1|NOT COMPLETED|Overall Study||4
2334935|NCT01767376|5730474|P3|COMPLETED|Overall Study||232
2334936|NCT01767376|5730475|P2|COMPLETED|Overall Study||225
2334937|NCT01767376|5730476|P1|COMPLETED|Overall Study||227
2334938|NCT01767376|5730474|P3|STARTED|Overall Study||232
2334939|NCT01767376|5730475|P2|STARTED|Overall Study||228
2334940|NCT01767376|5730476|P1|STARTED|Overall Study||231
2334941|NCT01767285|5730523|P2|NOT COMPLETED|Overall Study||6
2334942|NCT01767285|5730524|P1|NOT COMPLETED|Overall Study||7
2334943|NCT01767285|5730523|P2|COMPLETED|Overall Study||24
2334944|NCT01767285|5730524|P1|COMPLETED|Overall Study||22
2334945|NCT01767285|5730523|P2|STARTED|Overall Study||30
2334946|NCT01767285|5730524|P1|STARTED|Overall Study||29
2334947|NCT01767194|5730542|P2|NOT COMPLETED|Overall Study||43
2334948|NCT01767194|5730543|P1|NOT COMPLETED|Overall Study||18
2334949|NCT01767194|5730542|P2|COMPLETED|Overall Study||11
2334950|NCT01767194|5730543|P1|COMPLETED|Overall Study||1
2334951|NCT01767194|5730542|P2|STARTED|Overall Study||54
2334952|NCT01767194|5730543|P1|STARTED|Overall Study||19
2334953|NCT01767155|5730552|P2|NOT COMPLETED|Overall Study||15
2334954|NCT01767155|5730553|P1|NOT COMPLETED|Overall Study||13
2334955|NCT01767155|5730552|P2|COMPLETED|Overall Study||240
2334956|NCT01767155|5730553|P1|COMPLETED|Overall Study||243
2334957|NCT01767155|5730552|P2|Safety Population (SAF)|Overall Study||249
2334958|NCT01767155|5730553|P1|Safety Population (SAF)|Overall Study||252
2334959|NCT01767155|5730552|P2|Modified ITT (mITT)|Overall Study||249
2334960|NCT01767155|5730553|P1|Modified ITT (mITT)|Overall Study||252
2334961|NCT01767155|5730552|P2|STARTED|Overall Study|Patients allocated to doxorubicin|255
2334962|NCT01767155|5730553|P1|STARTED|Overall Study|Patients allocated to AEZS-108|256
2334963|NCT01767116|5730567|P2|NOT COMPLETED|Overall Study||2
2334964|NCT01767116|5730568|P1|NOT COMPLETED|Overall Study||2
2334965|NCT01767116|5730567|P2|COMPLETED|Overall Study||207
2334966|NCT01767116|5730568|P1|COMPLETED|Overall Study||208
2334967|NCT01767116|5730567|P2|STARTED|Overall Study||209
2334968|NCT01767116|5730568|P1|STARTED|Overall Study||210
2334969|NCT01767103|5730587|P3|NOT COMPLETED|Overall Study||0
2334970|NCT01767103|5730588|P2|NOT COMPLETED|Overall Study||0
2334971|NCT01767103|5730589|P1|NOT COMPLETED|Overall Study||0
2334972|NCT01767103|5730587|P3|COMPLETED|Overall Study||7
2334973|NCT01767103|5730588|P2|COMPLETED|Overall Study||7
2334974|NCT01767103|5730589|P1|COMPLETED|Overall Study||7
2334975|NCT01767103|5730587|P3|STARTED|Overall Study||7
2334976|NCT01767103|5730588|P2|STARTED|Overall Study||7
2334977|NCT01767103|5730589|P1|STARTED|Overall Study||7
2334978|NCT01767064|5730617|P2|NOT COMPLETED|Overall Study||0
2334979|NCT01767064|5730618|P1|NOT COMPLETED|Overall Study||0
2334980|NCT01767064|5730617|P2|COMPLETED|Overall Study||7
2334981|NCT01767064|5730618|P1|COMPLETED|Overall Study||7
2334982|NCT01767064|5730617|P2|STARTED|Overall Study||7
2334983|NCT01767064|5730618|P1|STARTED|Overall Study||7
2334984|NCT01766921|5730626|P2|NOT COMPLETED|Overall Study||17
2334985|NCT01766921|5730627|P1|NOT COMPLETED|Overall Study||24
2334986|NCT01766921|5730626|P2|COMPLETED|Overall Study||676
2334987|NCT01766921|5730627|P1|COMPLETED|Overall Study||676
2334988|NCT01766921|5730626|P2|STARTED|Overall Study||693
2334989|NCT01766921|5730627|P1|STARTED|Overall Study||700
2334990|NCT01766817|5730649|P3|NOT COMPLETED|Overall Study||13
2334991|NCT01766817|5730650|P2|NOT COMPLETED|Overall Study||11
2334992|NCT01766817|5730651|P1|NOT COMPLETED|Overall Study||11
2334993|NCT01766817|5730649|P3|COMPLETED|Overall Study||34
2334994|NCT01766817|5730650|P2|COMPLETED|Overall Study||37
2334995|NCT01766817|5730651|P1|COMPLETED|Overall Study||37
2334996|NCT01766817|5730649|P3|STARTED|Overall Study||47
2334997|NCT01766817|5730650|P2|STARTED|Overall Study||48
2334998|NCT01766817|5730651|P1|STARTED|Overall Study||48
2334999|NCT01766778|5730702|P2|NOT COMPLETED|Overall Study||4
2335000|NCT01766778|5730703|P1|NOT COMPLETED|Overall Study||5
2335001|NCT01766778|5730702|P2|COMPLETED|Overall Study||57
2335002|NCT01766778|5730703|P1|COMPLETED|Overall Study||51
2335003|NCT01766778|5730702|P2|STARTED|Overall Study||61
2335004|NCT01766778|5730703|P1|STARTED|Overall Study|Intent to treat population|56
2335005|NCT01766713|5730721|P2|NOT COMPLETED|Overall Study||2
2335006|NCT01766713|5730722|P1|NOT COMPLETED|Overall Study||2
2335007|NCT01766713|5730721|P2|COMPLETED|Overall Study||23
2335008|NCT01766713|5730722|P1|COMPLETED|Overall Study||23
2335009|NCT01766713|5730721|P2|STARTED|Overall Study||25
2335010|NCT01766713|5730722|P1|STARTED|Overall Study||25
2335011|NCT01766466|5730730|P4|NOT COMPLETED|Day 5||0
2335012|NCT01766466|5730731|P3|NOT COMPLETED|Day 5||0
2335013|NCT01766466|5730732|P2|NOT COMPLETED|Day 5||0
2335014|NCT01766466|5730733|P1|NOT COMPLETED|Day 5||0
2335015|NCT01766466|5730730|P4|COMPLETED|Day 5||6
2335016|NCT01766466|5730731|P3|COMPLETED|Day 5||0
2335017|NCT01766466|5730732|P2|COMPLETED|Day 5||6
2335018|NCT01766466|5730733|P1|COMPLETED|Day 5||0
2335019|NCT01766466|5730730|P4|STARTED|Day 5||6
2335020|NCT01766466|5730731|P3|STARTED|Day 5||0
2335021|NCT01766466|5730732|P2|STARTED|Day 5||6
2335022|NCT01766466|5730733|P1|STARTED|Day 5||0
2335023|NCT01766466|5730730|P4|NOT COMPLETED|Day 1||0
2335024|NCT01766466|5730731|P3|NOT COMPLETED|Day 1||0
2335025|NCT01766466|5730732|P2|NOT COMPLETED|Day 1||0
2335026|NCT01766466|5730733|P1|NOT COMPLETED|Day 1||0
2335027|NCT01766466|5730730|P4|COMPLETED|Day 1||0
2335028|NCT01766466|5730731|P3|COMPLETED|Day 1||6
2335029|NCT01766466|5730732|P2|COMPLETED|Day 1||0
2335030|NCT01766466|5730733|P1|COMPLETED|Day 1||6
2335031|NCT01766466|5730730|P4|STARTED|Day 1||0
2335032|NCT01766466|5730731|P3|STARTED|Day 1||6
2335033|NCT01766466|5730732|P2|STARTED|Day 1||0
2335034|NCT01766466|5730733|P1|STARTED|Day 1||6
2335035|NCT01766440|5730746|P1|NOT COMPLETED|Overall Study||1
2335036|NCT01766440|5730746|P1|COMPLETED|Overall Study||17
2335037|NCT01766440|5730746|P1|STARTED|Overall Study||18
2335038|NCT01766401|5730757|P2|NOT COMPLETED|Overall Study||56
2335039|NCT01766401|5730758|P1|NOT COMPLETED|Overall Study||37
2335040|NCT01766401|5730757|P2|COMPLETED|Overall Study||144
2335041|NCT01766401|5730758|P1|COMPLETED|Overall Study||161
2335042|NCT01766401|5730757|P2|STARTED|Overall Study||200
2335043|NCT01766401|5730758|P1|STARTED|Overall Study||198
2335044|NCT01766336|5730768|P2|NOT COMPLETED|Overall Study||75
2335045|NCT01766336|5730769|P1|NOT COMPLETED|Overall Study||90
2335046|NCT01766336|5730768|P2|COMPLETED|Overall Study||71
2335047|NCT01766336|5730769|P1|COMPLETED|Overall Study||60
2335048|NCT01766336|5730768|P2|STARTED|Overall Study||146
2335049|NCT01766336|5730769|P1|STARTED|Overall Study||150
2335050|NCT01766310|5730777|P2|NOT COMPLETED|Overall Study||3
2335051|NCT01766310|5730778|P1|NOT COMPLETED|Overall Study||1
2335052|NCT01766310|5730777|P2|COMPLETED|Overall Study||23
2335053|NCT01766310|5730778|P1|COMPLETED|Overall Study||23
2335054|NCT01766310|5730777|P2|STARTED|Overall Study||26
2335055|NCT01766310|5730778|P1|STARTED|Overall Study||24
2335056|NCT01766219|5730789|P3|NOT COMPLETED|Overall Study||0
2335057|NCT01766219|5730790|P2|NOT COMPLETED|Overall Study||0
2335058|NCT01766219|5730791|P1|NOT COMPLETED|Overall Study||0
2335059|NCT01766219|5730789|P3|COMPLETED|Overall Study||11
2335060|NCT01766219|5730790|P2|COMPLETED|Overall Study||2
2335061|NCT01766219|5730791|P1|COMPLETED|Overall Study||4
2335062|NCT01766219|5730789|P3|STARTED|Overall Study||11
2335063|NCT01766219|5730790|P2|STARTED|Overall Study||2
2335064|NCT01766219|5730791|P1|STARTED|Overall Study||4
2335065|NCT01766206|5730808|P1|NOT COMPLETED|Overall Study||51
2335066|NCT01766206|5730808|P1|COMPLETED|Overall Study||3888
2335067|NCT01766206|5730808|P1|STARTED|Overall Study||3939
2335068|NCT01766102|5730817|P2|NOT COMPLETED|Overall Study||0
2335069|NCT01766102|5730818|P1|NOT COMPLETED|Overall Study||0
2335070|NCT01766102|5730817|P2|COMPLETED|Overall Study||36
2335071|NCT01766102|5730818|P1|COMPLETED|Overall Study||36
2335072|NCT01766102|5730817|P2|STARTED|Overall Study||36
2335073|NCT01766102|5730818|P1|STARTED|Overall Study||36
2335074|NCT01766076|5730828|P2|NOT COMPLETED|Overall Study||0
2335075|NCT01766076|5730829|P1|NOT COMPLETED|Overall Study||0
2335076|NCT01766076|5730828|P2|COMPLETED|Overall Study||15
2335077|NCT01766076|5730829|P1|COMPLETED|Overall Study||15
2335078|NCT01766076|5730828|P2|STARTED|Overall Study||15
2335079|NCT01766076|5730829|P1|STARTED|Overall Study||15
2335080|NCT01766050|5730835|P1|NOT COMPLETED|Overall Study||4
2335081|NCT01766050|5730835|P1|COMPLETED|Overall Study||18
2335082|NCT01766050|5730835|P1|STARTED|Overall Study||22
2335083|NCT01766037|5730970|P2|NOT COMPLETED|Overall Study||29
2335084|NCT01766037|5730971|P1|NOT COMPLETED|Overall Study||29
2335085|NCT01766037|5730970|P2|COMPLETED|Overall Study||31
2335086|NCT01766037|5730971|P1|COMPLETED|Overall Study||82
2335087|NCT01766037|5730970|P2|STARTED|Overall Study||60
2335088|NCT01766037|5730971|P1|STARTED|Overall Study||111
2335089|NCT01766024|5731008|P2|NOT COMPLETED|Overall Study||0
2335090|NCT01766024|5731009|P1|NOT COMPLETED|Overall Study||0
2335091|NCT01766024|5731008|P2|COMPLETED|Overall Study||16
2335092|NCT01766024|5731009|P1|COMPLETED|Overall Study||16
2335093|NCT01766024|5731008|P2|STARTED|Overall Study||16
2335094|NCT01766024|5731009|P1|STARTED|Overall Study||16
2335095|NCT01765972|5731019|P4|NOT COMPLETED|Overall Study||0
2335096|NCT01765972|5731020|P3|NOT COMPLETED|Overall Study||0
2335097|NCT01765972|5731021|P2|NOT COMPLETED|Overall Study||0
2335098|NCT01765972|5731022|P1|NOT COMPLETED|Overall Study||0
2335099|NCT01765972|5731019|P4|COMPLETED|Overall Study||6
2335100|NCT01765972|5731020|P3|COMPLETED|Overall Study||6
2335101|NCT01765972|5731021|P2|COMPLETED|Overall Study||6
2335102|NCT01765972|5731022|P1|COMPLETED|Overall Study||6
2335103|NCT01765972|5731019|P4|STARTED|Overall Study||6
2335104|NCT01765972|5731020|P3|STARTED|Overall Study||6
2335105|NCT01765972|5731021|P2|STARTED|Overall Study||6
2335106|NCT01765972|5731022|P1|STARTED|Overall Study||6
2335107|NCT01765803|5731032|P1|NOT COMPLETED|Overall Study||0
2335108|NCT01765803|5731032|P1|COMPLETED|Overall Study||6
2335109|NCT01765803|5731032|P1|STARTED|Overall Study||6
2335110|NCT01765764|5731040|P3|NOT COMPLETED|Post-treatment Period||0
2335111|NCT01765764|5731041|P2|NOT COMPLETED|Post-treatment Period||0
2335112|NCT01765764|5731042|P1|NOT COMPLETED|Post-treatment Period||0
2335113|NCT01765764|5731040|P3|COMPLETED|Post-treatment Period||112
2335114|NCT01765764|5731041|P2|COMPLETED|Post-treatment Period||107
2335115|NCT01765764|5731042|P1|COMPLETED|Post-treatment Period||114
2335116|NCT01765764|5731040|P3|STARTED|Post-treatment Period|3 participants did not enter the Post-treatment Period [1 Personal Reasons,2 LFU].|112
2335117|NCT01765764|5731041|P2|STARTED|Post-treatment Period|2 participants did not enter the Post-treatment Period [2 Lost-to-Follow-up (LFU)]|107
2335118|NCT01765764|5731042|P1|STARTED|Post-treatment Period|1 participant did not enter the Post-treatment Period. [Personal Reasons]|114
2335119|NCT01765764|5731040|P3|NOT COMPLETED|Treatment Period||6
2335120|NCT01765764|5731041|P2|NOT COMPLETED|Treatment Period||9
2335121|NCT01765764|5731042|P1|NOT COMPLETED|Treatment Period||3
2335122|NCT01765764|5731040|P3|COMPLETED|Treatment Period||115
2335123|NCT01765764|5731041|P2|COMPLETED|Treatment Period||109
2335124|NCT01765764|5731042|P1|COMPLETED|Treatment Period||115
2335125|NCT01765764|5731040|P3|STARTED|Treatment Period||121
2335126|NCT01765764|5731041|P2|STARTED|Treatment Period||118
2335127|NCT01765764|5731042|P1|STARTED|Treatment Period||118
2335128|NCT01765751|5731062|P3|NOT COMPLETED|Overall Study||1
2335129|NCT01765751|5731063|P2|NOT COMPLETED|Overall Study||2
2335130|NCT01765751|5731064|P1|NOT COMPLETED|Overall Study||0
2335131|NCT01765751|5731062|P3|COMPLETED|Overall Study||15
2335132|NCT01765751|5731063|P2|COMPLETED|Overall Study||14
2335133|NCT01765751|5731064|P1|COMPLETED|Overall Study||16
2335134|NCT01765751|5731062|P3|STARTED|Overall Study||16
2335135|NCT01765751|5731063|P2|STARTED|Overall Study||16
2335136|NCT01765751|5731064|P1|STARTED|Overall Study||16
2335137|NCT01765673|5731096|P1|NOT COMPLETED|Overall Study||1
2335138|NCT01765673|5731096|P1|COMPLETED|Overall Study||11
2335139|NCT01765673|5731096|P1|STARTED|Overall Study||12
2335140|NCT01765647|5731119|P1|NOT COMPLETED|Overall Study||0
2335141|NCT01765647|5731119|P1|COMPLETED|Overall Study|10 entered the AGY treatment phase and all 10 completed treatment.|10
2335142|NCT01765647|5731119|P1|STARTED|Overall Study|One began the run-in period, but was withdrawn prior to beginning treatment with AGY|10
2335143|NCT01765582|5731129|P3|NOT COMPLETED|Overall Study||95
2335144|NCT01765582|5731130|P2|NOT COMPLETED|Overall Study||92
2335145|NCT01765582|5731131|P1|NOT COMPLETED|Overall Study||93
2335146|NCT01765582|5731129|P3|COMPLETED|Overall Study||0
2335147|NCT01765582|5731130|P2|COMPLETED|Overall Study||0
2335148|NCT01765582|5731131|P1|COMPLETED|Overall Study||0
2335149|NCT01765582|5731129|P3|STARTED|Overall Study||95
2335150|NCT01765582|5731130|P2|STARTED|Overall Study||92
2335151|NCT01765582|5731131|P1|STARTED|Overall Study||93
2335152|NCT01765569|5731164|P1|NOT COMPLETED|Period C||1
2335153|NCT01765569|5731164|P1|COMPLETED|Period C||27
2335154|NCT01765569|5731164|P1|STARTED|Period C||28
2335155|NCT01765569|5731164|P1|NOT COMPLETED|Period B||1
2335156|NCT01765569|5731164|P1|COMPLETED|Period B||28
2335157|NCT01765569|5731164|P1|STARTED|Period B||29
2335158|NCT01765569|5731164|P1|NOT COMPLETED|Period A||0
2335159|NCT01765569|5731164|P1|COMPLETED|Period A||29
2335160|NCT01765569|5731164|P1|STARTED|Period A||29
2335161|NCT01765543|5731185|P1|NOT COMPLETED|Overall Study||3
2335162|NCT01765543|5731185|P1|COMPLETED|Overall Study||24
2335163|NCT01765543|5731185|P1|STARTED|Overall Study||27
2335164|NCT01765530|5731209|P2|NOT COMPLETED|Overall Study||1
2335165|NCT01765530|5731210|P1|NOT COMPLETED|Overall Study||1
2335166|NCT01765530|5731209|P2|COMPLETED|Overall Study||36
2335167|NCT01765530|5731210|P1|COMPLETED|Overall Study||36
2335168|NCT01765530|5731209|P2|STARTED|Overall Study||37
2335169|NCT01765530|5731210|P1|STARTED|Overall Study||37
2335170|NCT01765465|5731220|P2|NOT COMPLETED|Overall Study||4
2335171|NCT01765465|5731221|P1|NOT COMPLETED|Overall Study||7
2335172|NCT01765465|5731220|P2|COMPLETED|Overall Study||63
2335173|NCT01765465|5731221|P1|COMPLETED|Overall Study||64
2335174|NCT01765465|5731220|P2|STARTED|Overall Study||67
2335175|NCT01765465|5731221|P1|STARTED|Overall Study||71
2335176|NCT01765426|5731237|P4|NOT COMPLETED|Overall Study||0
2335177|NCT01765426|5731238|P3|NOT COMPLETED|Overall Study||0
2335178|NCT01765426|5731239|P2|NOT COMPLETED|Overall Study||1
2335179|NCT01765426|5731240|P1|NOT COMPLETED|Overall Study||0
2335180|NCT01765426|5731237|P4|COMPLETED|Overall Study||15
2335181|NCT01765426|5731238|P3|COMPLETED|Overall Study||17
2335182|NCT01765426|5731239|P2|COMPLETED|Overall Study||16
2335183|NCT01765426|5731240|P1|COMPLETED|Overall Study||18
2335184|NCT01765426|5731237|P4|Completed All Vaccinations|Overall Study||15
2335185|NCT01765426|5731238|P3|Completed All Vaccinations|Overall Study||17
2335186|NCT01765426|5731239|P2|Completed All Vaccinations|Overall Study||16
2335187|NCT01765426|5731240|P1|Completed All Vaccinations|Overall Study||17
2335188|NCT01765426|5731237|P4|STARTED|Overall Study||15
2335189|NCT01765426|5731238|P3|STARTED|Overall Study||17
2335190|NCT01765426|5731239|P2|STARTED|Overall Study||17
2335191|NCT01765426|5731240|P1|STARTED|Overall Study||18
2335192|NCT01765270|5731296|P2|NOT COMPLETED|Overall Study||1
2335193|NCT01765270|5731297|P1|NOT COMPLETED|Overall Study||1
2335194|NCT01765270|5731296|P2|COMPLETED|Overall Study||6
2335195|NCT01765270|5731297|P1|COMPLETED|Overall Study||4
2335196|NCT01765270|5731296|P2|STARTED|Overall Study||7
2335197|NCT01765270|5731297|P1|STARTED|Overall Study||5
2335198|NCT01765192|5731319|P2|NOT COMPLETED|End of Treatment Period 2 to Final Visit||1
2335199|NCT01765192|5731320|P1|NOT COMPLETED|End of Treatment Period 2 to Final Visit||0
2335200|NCT01765192|5731319|P2|COMPLETED|End of Treatment Period 2 to Final Visit||27
2335201|NCT01765192|5731320|P1|COMPLETED|End of Treatment Period 2 to Final Visit||30
2335202|NCT01765192|5731319|P2|STARTED|End of Treatment Period 2 to Final Visit||28
2335203|NCT01765192|5731320|P1|STARTED|End of Treatment Period 2 to Final Visit||30
2335204|NCT01765192|5731319|P2|NOT COMPLETED|Treatment Period 2||2
2335205|NCT01765192|5731320|P1|NOT COMPLETED|Treatment Period 2||0
2335206|NCT01765192|5731319|P2|COMPLETED|Treatment Period 2||28
2335207|NCT01765192|5731320|P1|COMPLETED|Treatment Period 2||30
2335208|NCT01765192|5731319|P2|STARTED|Treatment Period 2||30
2335209|NCT01765192|5731320|P1|STARTED|Treatment Period 2||30
2335210|NCT01765192|5731319|P2|NOT COMPLETED|Washout Period||1
2335211|NCT01765192|5731320|P1|NOT COMPLETED|Washout Period||2
2335212|NCT01765192|5731319|P2|COMPLETED|Washout Period||30
2335213|NCT01765192|5731320|P1|COMPLETED|Washout Period||30
2335214|NCT01765192|5731319|P2|STARTED|Washout Period||31
2335215|NCT01765192|5731320|P1|STARTED|Washout Period||32
2335216|NCT01765192|5731319|P2|NOT COMPLETED|Treatment Period 1||1
2335217|NCT01765192|5731320|P1|NOT COMPLETED|Treatment Period 1||0
2335218|NCT01765192|5731319|P2|COMPLETED|Treatment Period 1||31
2335219|NCT01765192|5731320|P1|COMPLETED|Treatment Period 1||32
2335220|NCT01765192|5731319|P2|STARTED|Treatment Period 1||32
2335221|NCT01765192|5731320|P1|STARTED|Treatment Period 1||32
2335222|NCT01765179|5731338|P1|NOT COMPLETED|Overall Study||27
2335223|NCT01765179|5731338|P1|COMPLETED|Overall Study||117
2335224|NCT01765179|5731338|P1|STARTED|Overall Study||144
2335225|NCT01765153|5731345|P2|NOT COMPLETED|Rest Phase 2||1
2335226|NCT01765153|5731346|P1|NOT COMPLETED|Rest Phase 2||2
2335227|NCT01765153|5731345|P2|COMPLETED|Rest Phase 2||7
2335228|NCT01765153|5731346|P1|COMPLETED|Rest Phase 2||8
2335229|NCT01765153|5731345|P2|STARTED|Rest Phase 2||8
2335230|NCT01765153|5731346|P1|STARTED|Rest Phase 2||10
2335231|NCT01765153|5731345|P2|NOT COMPLETED|Training Phase 2||1
2335232|NCT01765153|5731346|P1|NOT COMPLETED|Training Phase 2||0
2335233|NCT01765153|5731345|P2|COMPLETED|Training Phase 2||8
2335234|NCT01765153|5731346|P1|COMPLETED|Training Phase 2||10
2335235|NCT01765153|5731345|P2|STARTED|Training Phase 2||9
2335236|NCT01765153|5731346|P1|STARTED|Training Phase 2|1st subject didn't use same training(phase 1) as subsequent participants Phase 1 and 2 data removed.|10
2335237|NCT01765153|5731345|P2|NOT COMPLETED|Rest Phase 1||1
2335238|NCT01765153|5731346|P1|NOT COMPLETED|Rest Phase 1||0
2335239|NCT01765153|5731345|P2|COMPLETED|Rest Phase 1||9
2335240|NCT01765153|5731346|P1|COMPLETED|Rest Phase 1||9
2335241|NCT01765153|5731345|P2|STARTED|Rest Phase 1||10
2335242|NCT01765153|5731346|P1|STARTED|Rest Phase 1||9
2335243|NCT01765153|5731345|P2|NOT COMPLETED|Training Phase 1||1
2335244|NCT01765153|5731346|P1|NOT COMPLETED|Training Phase 1||1
2335245|NCT01765153|5731345|P2|COMPLETED|Training Phase 1||10
2335246|NCT01765153|5731346|P1|COMPLETED|Training Phase 1||9
2335247|NCT01765153|5731345|P2|STARTED|Training Phase 1||11
2335248|NCT01765153|5731346|P1|STARTED|Training Phase 1||10
2335249|NCT01764997|5731453|P5|NOT COMPLETED|Study Drug Treatment Period||36
2335250|NCT01764997|5731454|P4|NOT COMPLETED|Study Drug Treatment Period||0
2335251|NCT01764997|5731455|P3|NOT COMPLETED|Study Drug Treatment Period||0
2335252|NCT01764997|5731456|P2|NOT COMPLETED|Study Drug Treatment Period||1
2335253|NCT01764997|5731457|P1|NOT COMPLETED|Study Drug Treatment Period||0
2335254|NCT01764997|5731453|P5|COMPLETED|Study Drug Treatment Period||286
2335255|NCT01764997|5731454|P4|COMPLETED|Study Drug Treatment Period||13
2335256|NCT01764997|5731455|P3|COMPLETED|Study Drug Treatment Period||13
2335257|NCT01764997|5731456|P2|COMPLETED|Study Drug Treatment Period||16
2335258|NCT01764997|5731457|P1|COMPLETED|Study Drug Treatment Period||0
2335259|NCT01764997|5731453|P5|STARTED|Study Drug Treatment Period||322
2335260|NCT01764997|5731454|P4|STARTED|Study Drug Treatment Period||13
2335261|NCT01764997|5731455|P3|STARTED|Study Drug Treatment Period||13
2335262|NCT01764997|5731456|P2|STARTED|Study Drug Treatment Period||17
2335263|NCT01764997|5731457|P1|STARTED|Study Drug Treatment Period||0
2335264|NCT01764997|5731453|P5|NOT COMPLETED|Run-in Period||0
2335265|NCT01764997|5731454|P4|NOT COMPLETED|Run-in Period||0
2335266|NCT01764997|5731455|P3|NOT COMPLETED|Run-in Period||0
2335267|NCT01764997|5731456|P2|NOT COMPLETED|Run-in Period||0
2335268|NCT01764997|5731457|P1|NOT COMPLETED|Run-in Period||38
2335269|NCT01764997|5731453|P5|COMPLETED|Run-in Period||0
2335270|NCT01764997|5731454|P4|COMPLETED|Run-in Period||0
2335271|NCT01764997|5731455|P3|COMPLETED|Run-in Period||0
2335272|NCT01764997|5731456|P2|COMPLETED|Run-in Period||0
2335273|NCT01764997|5731457|P1|COMPLETED|Run-in Period|43 participants proceeded to randomized treatment and 322 proceeded to open-label sub-study.|738
2335274|NCT01764997|5731453|P5|STARTED|Run-in Period||0
2335275|NCT01764997|5731454|P4|STARTED|Run-in Period||0
2335276|NCT01764997|5731455|P3|STARTED|Run-in Period||0
2335277|NCT01764997|5731456|P2|STARTED|Run-in Period||0
2335278|NCT01764997|5731457|P1|STARTED|Run-in Period||776
2335279|NCT01764945|5731484|P8|NOT COMPLETED|Overall Study||0
2335280|NCT01764945|5731485|P7|NOT COMPLETED|Overall Study||1
2335281|NCT01764945|5731486|P6|NOT COMPLETED|Overall Study||0
2335282|NCT01764945|5731487|P5|NOT COMPLETED|Overall Study||0
2335283|NCT01764945|5731488|P4|NOT COMPLETED|Overall Study||0
2335284|NCT01764945|5731489|P3|NOT COMPLETED|Overall Study||0
2335285|NCT01764945|5731490|P2|NOT COMPLETED|Overall Study||1
2335286|NCT01764945|5731491|P1|NOT COMPLETED|Overall Study||0
2335287|NCT01764945|5731484|P8|COMPLETED|Overall Study||9
2335288|NCT01764945|5731485|P7|COMPLETED|Overall Study||8
2335289|NCT01764945|5731486|P6|COMPLETED|Overall Study||8
2335290|NCT01764945|5731487|P5|COMPLETED|Overall Study||10
2335291|NCT01764945|5731488|P4|COMPLETED|Overall Study||5
2335292|NCT01764945|5731489|P3|COMPLETED|Overall Study||5
2335293|NCT01764945|5731490|P2|COMPLETED|Overall Study||4
2335294|NCT01764945|5731491|P1|COMPLETED|Overall Study||5
2335295|NCT01764945|5731484|P8|STARTED|Overall Study||9
2335296|NCT01764945|5731485|P7|STARTED|Overall Study||9
2335297|NCT01764945|5731486|P6|STARTED|Overall Study||8
2335298|NCT01764945|5731487|P5|STARTED|Overall Study||10
2335299|NCT01764945|5731488|P4|STARTED|Overall Study||5
2335300|NCT01764945|5731489|P3|STARTED|Overall Study||5
2335301|NCT01764945|5731490|P2|STARTED|Overall Study||5
2335302|NCT01764945|5731491|P1|STARTED|Overall Study||5
2335303|NCT01764919|5731525|P1|NOT COMPLETED|Overall Study||0
2335304|NCT01764919|5731525|P1|COMPLETED|Overall Study||4
2335305|NCT01764919|5731525|P1|STARTED|Overall Study||4
2335306|NCT01764841|5731537|P4|NOT COMPLETED|Overall Study||19
2335307|NCT01764841|5731538|P3|NOT COMPLETED|Overall Study||14
2335308|NCT01764841|5731539|P2|NOT COMPLETED|Overall Study||26
2335309|NCT01764841|5731540|P1|NOT COMPLETED|Overall Study||23
2335310|NCT01764841|5731537|P4|COMPLETED|Overall Study||49
2335311|NCT01764841|5731538|P3|COMPLETED|Overall Study||56
2335312|NCT01764841|5731539|P2|COMPLETED|Overall Study||111
2335313|NCT01764841|5731540|P1|COMPLETED|Overall Study||118
2335314|NCT01764841|5731537|P4|Participants Received Treatment|Overall Study|safety population|68
2335315|NCT01764841|5731538|P3|Participants Received Treatment|Overall Study|safety population|69
2335316|NCT01764841|5731539|P2|Participants Received Treatment|Overall Study|safety population|136
2335317|NCT01764841|5731540|P1|Participants Received Treatment|Overall Study|safety population|141
2335318|NCT01764841|5731537|P4|STARTED|Overall Study||68
2335319|NCT01764841|5731538|P3|STARTED|Overall Study||70
2335320|NCT01764841|5731539|P2|STARTED|Overall Study||137
2335321|NCT01764841|5731540|P1|STARTED|Overall Study||141
2335322|NCT01764685|5731574|P2|NOT COMPLETED|Overall Study||1
2335323|NCT01764685|5731575|P1|NOT COMPLETED|Overall Study||0
2335324|NCT01764685|5731574|P2|COMPLETED|Overall Study||3
2335325|NCT01764685|5731575|P1|COMPLETED|Overall Study||0
2335326|NCT01764685|5731574|P2|STARTED|Overall Study||4
2335327|NCT01764685|5731575|P1|STARTED|Overall Study||0
2335328|NCT01764633|5731583|P2|NOT COMPLETED|Overall Study||93
2335329|NCT01764633|5731584|P1|NOT COMPLETED|Overall Study||118
2335330|NCT01764633|5731583|P2|COMPLETED|Overall Study||13691
2335331|NCT01764633|5731584|P1|COMPLETED|Overall Study||13662
2335332|NCT01764633|5731583|P2|Received Treatment|Overall Study||13769
2335333|NCT01764633|5731584|P1|Received Treatment|Overall Study||13756
2335334|NCT01764633|5731583|P2|STARTED|Overall Study||13784
2335335|NCT01764633|5731584|P1|STARTED|Overall Study||13780
2335336|NCT01764607|5731606|P1|NOT COMPLETED|Overall Study||0
2335337|NCT01764607|5731606|P1|COMPLETED|Overall Study||1
2335338|NCT01764607|5731606|P1|STARTED|Overall Study||1
2335339|NCT01764464|5731613|P2|NOT COMPLETED|Second Intervention (Cross-over)||0
2335340|NCT01764464|5731614|P1|NOT COMPLETED|Second Intervention (Cross-over)||2
2335341|NCT01764464|5731613|P2|COMPLETED|Second Intervention (Cross-over)|Completed Gralise|13
2335342|NCT01764464|5731614|P1|COMPLETED|Second Intervention (Cross-over)|Completed Placebo|12
2335343|NCT01764464|5731613|P2|STARTED|Second Intervention (Cross-over)|Started Gralise|13
2335344|NCT01764464|5731614|P1|STARTED|Second Intervention (Cross-over)|Started Placebo|14
2335345|NCT01764464|5731613|P2|NOT COMPLETED|First Intervention||3
2335346|NCT01764464|5731614|P1|NOT COMPLETED|First Intervention||2
2335347|NCT01764464|5731613|P2|COMPLETED|First Intervention|Completed Placebo|13
2335348|NCT01764464|5731614|P1|COMPLETED|First Intervention|Completed Gralise|14
2335349|NCT01764464|5731613|P2|STARTED|First Intervention|Started Placebo|16
2335350|NCT01764464|5731614|P1|STARTED|First Intervention|Started Gralise|16
2335351|NCT01764386|5731632|P2|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||53
2335352|NCT01764386|5731633|P1|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||16
2335353|NCT01764386|5731632|P2|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|28
2335354|NCT01764386|5731633|P1|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|55
2335355|NCT01764386|5731632|P2|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||35
2335356|NCT01764386|5731633|P1|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||61
2335357|NCT01764386|5731632|P2|STARTED|Uncontrolled Treatment Period (UTP)|One subject completed the 26-week CTP, but did not continue in the UTP.|81
2335358|NCT01764386|5731633|P1|STARTED|Uncontrolled Treatment Period (UTP)||71
2335359|NCT01764386|5731632|P2|NOT COMPLETED|Controlled Treatment Period (CTP)||7
2335360|NCT01764386|5731633|P1|NOT COMPLETED|Controlled Treatment Period (CTP)||82
2335361|NCT01764386|5731632|P2|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|82
2335362|NCT01764386|5731633|P1|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|71
2335363|NCT01764386|5731632|P2|STARTED|Controlled Treatment Period (CTP)||89
2335364|NCT01764386|5731633|P1|STARTED|Controlled Treatment Period (CTP)||153
2335365|NCT01764256|5731678|P4|NOT COMPLETED|Completed Study||1
2335366|NCT01764256|5731679|P3|NOT COMPLETED|Completed Study||0
2335367|NCT01764256|5731680|P2|NOT COMPLETED|Completed Study||0
2335368|NCT01764256|5731681|P1|NOT COMPLETED|Completed Study||0
2335369|NCT01764256|5731678|P4|COMPLETED|Completed Study||11
2335370|NCT01764256|5731679|P3|COMPLETED|Completed Study||11
2335371|NCT01764256|5731680|P2|COMPLETED|Completed Study||11
2335372|NCT01764256|5731681|P1|COMPLETED|Completed Study||10
2335373|NCT01764256|5731678|P4|STARTED|Completed Study||12
2335374|NCT01764256|5731679|P3|STARTED|Completed Study||11
2335375|NCT01764256|5731680|P2|STARTED|Completed Study||11
2335376|NCT01764256|5731681|P1|STARTED|Completed Study||10
2335377|NCT01764256|5731678|P4|NOT COMPLETED|Received All Vaccinations||0
2335378|NCT01764256|5731679|P3|NOT COMPLETED|Received All Vaccinations||1
2335379|NCT01764256|5731680|P2|NOT COMPLETED|Received All Vaccinations||1
2335380|NCT01764256|5731681|P1|NOT COMPLETED|Received All Vaccinations||2
2335381|NCT01764256|5731678|P4|COMPLETED|Received All Vaccinations||12
2335382|NCT01764256|5731679|P3|COMPLETED|Received All Vaccinations||11
2335383|NCT01764256|5731680|P2|COMPLETED|Received All Vaccinations||11
2335384|NCT01764256|5731681|P1|COMPLETED|Received All Vaccinations||10
2335385|NCT01764256|5731678|P4|STARTED|Received All Vaccinations||12
2335386|NCT01764256|5731679|P3|STARTED|Received All Vaccinations||12
2335387|NCT01764256|5731680|P2|STARTED|Received All Vaccinations||12
2335388|NCT01764256|5731681|P1|STARTED|Received All Vaccinations||12
2335389|NCT01764022|5731724|P2|NOT COMPLETED|Overall Study||14
2335390|NCT01764022|5731725|P1|NOT COMPLETED|Overall Study||8
2335391|NCT01764022|5731724|P2|COMPLETED|Overall Study||96
2335392|NCT01764022|5731725|P1|COMPLETED|Overall Study||107
2335393|NCT01764022|5731724|P2|Received at Least 1 Dose of Study Drug|Overall Study||110
2335394|NCT01764022|5731725|P1|Received at Least 1 Dose of Study Drug|Overall Study||113
2335395|NCT01764022|5731724|P2|STARTED|Overall Study||110
2335396|NCT01764022|5731725|P1|STARTED|Overall Study||115
2335397|NCT01763996|5731757|P2|NOT COMPLETED|Treatment Period 2||1
2335398|NCT01763996|5731758|P1|NOT COMPLETED|Treatment Period 2||0
2335399|NCT01763996|5731757|P2|COMPLETED|Treatment Period 2||14
2335400|NCT01763996|5731758|P1|COMPLETED|Treatment Period 2||15
2335401|NCT01763996|5731757|P2|STARTED|Treatment Period 2||15
2335402|NCT01763996|5731758|P1|STARTED|Treatment Period 2||15
2335403|NCT01763996|5731757|P2|NOT COMPLETED|Treatment Period 1||0
2335404|NCT01763996|5731758|P1|NOT COMPLETED|Treatment Period 1||0
2335405|NCT01763996|5731757|P2|COMPLETED|Treatment Period 1||15
2335406|NCT01763996|5731758|P1|COMPLETED|Treatment Period 1||15
2335407|NCT01763996|5731757|P2|STARTED|Treatment Period 1||15
2335408|NCT01763996|5731758|P1|STARTED|Treatment Period 1||15
2335409|NCT01763931|5731786|P2|NOT COMPLETED|Overall Study||1
2335410|NCT01763931|5731787|P1|NOT COMPLETED|Overall Study||0
2335411|NCT01763931|5731786|P2|COMPLETED|Overall Study||3
2335412|NCT01763931|5731787|P1|COMPLETED|Overall Study||2
2335413|NCT01763931|5731786|P2|STARTED|Overall Study||4
2335414|NCT01763931|5731787|P1|STARTED|Overall Study||2
2335415|NCT01763918|5731799|P4|NOT COMPLETED|Overall Study||2
2335416|NCT01763918|5731800|P3|NOT COMPLETED|Overall Study||10
2335417|NCT01763918|5731801|P2|NOT COMPLETED|Overall Study||1
2335418|NCT01763918|5731802|P1|NOT COMPLETED|Overall Study||6
2335419|NCT01763918|5731799|P4|COMPLETED|Overall Study||108
2335420|NCT01763918|5731800|P3|COMPLETED|Overall Study||101
2335421|NCT01763918|5731801|P2|COMPLETED|Overall Study||54
2335422|NCT01763918|5731802|P1|COMPLETED|Overall Study||49
2335423|NCT01763918|5731799|P4|Received Treatment|Overall Study||110
2335424|NCT01763918|5731800|P3|Received Treatment|Overall Study||110
2335425|NCT01763918|5731801|P2|Received Treatment|Overall Study||55
2335426|NCT01763918|5731802|P1|Received Treatment|Overall Study||54
2335427|NCT01763918|5731799|P4|STARTED|Overall Study||110
2335428|NCT01763918|5731800|P3|STARTED|Overall Study||111
2335429|NCT01763918|5731801|P2|STARTED|Overall Study||55
2335430|NCT01763918|5731802|P1|STARTED|Overall Study||55
2335431|NCT01763905|5731900|P4|NOT COMPLETED|Overall Study||1
2335432|NCT01763905|5731901|P3|NOT COMPLETED|Overall Study||9
2335433|NCT01763905|5731902|P2|NOT COMPLETED|Overall Study||1
2335434|NCT01763905|5731903|P1|NOT COMPLETED|Overall Study||6
2335435|NCT01763905|5731900|P4|COMPLETED|Overall Study||101
2335436|NCT01763905|5731901|P3|COMPLETED|Overall Study||94
2335437|NCT01763905|5731902|P2|COMPLETED|Overall Study||50
2335438|NCT01763905|5731903|P1|COMPLETED|Overall Study||45
2335439|NCT01763905|5731900|P4|STARTED|Overall Study||102
2335440|NCT01763905|5731901|P3|STARTED|Overall Study||103
2335441|NCT01763905|5731902|P2|STARTED|Overall Study||51
2335442|NCT01763905|5731903|P1|STARTED|Overall Study||51
2335443|NCT01763866|5732021|P24|NOT COMPLETED|Overall Study||2
2335444|NCT01763866|5732022|P23|NOT COMPLETED|Overall Study||3
2335445|NCT01763866|5732023|P22|NOT COMPLETED|Overall Study||1
2335446|NCT01763866|5732024|P21|NOT COMPLETED|Overall Study||4
2335447|NCT01763866|5732025|P20|NOT COMPLETED|Overall Study||2
2335448|NCT01763866|5732026|P19|NOT COMPLETED|Overall Study||6
2335449|NCT01763866|5732027|P18|NOT COMPLETED|Overall Study||1
2335450|NCT01763866|5732028|P17|NOT COMPLETED|Overall Study||1
2335451|NCT01763866|5732029|P16|NOT COMPLETED|Overall Study||3
2335452|NCT01763866|5732030|P15|NOT COMPLETED|Overall Study||12
2335453|NCT01763866|5732031|P14|NOT COMPLETED|Overall Study||0
2335454|NCT01763866|5732032|P13|NOT COMPLETED|Overall Study||4
2335455|NCT01763866|5732033|P12|NOT COMPLETED|Overall Study||2
2335456|NCT01763866|5732034|P11|NOT COMPLETED|Overall Study||8
2335457|NCT01763866|5732035|P10|NOT COMPLETED|Overall Study||1
2335458|NCT01763866|5732036|P9|NOT COMPLETED|Overall Study||3
2335459|NCT01763866|5732037|P8|NOT COMPLETED|Overall Study||0
2335460|NCT01763866|5732038|P7|NOT COMPLETED|Overall Study||7
2335461|NCT01763866|5732039|P6|NOT COMPLETED|Overall Study||3
2335462|NCT01763866|5732040|P5|NOT COMPLETED|Overall Study||2
2335463|NCT01763866|5732041|P4|NOT COMPLETED|Overall Study||0
2335464|NCT01763866|5732042|P3|NOT COMPLETED|Overall Study||5
2335465|NCT01763866|5732043|P2|NOT COMPLETED|Overall Study||1
2335466|NCT01763866|5732044|P1|NOT COMPLETED|Overall Study||2
2335467|NCT01763866|5732021|P24|COMPLETED|Overall Study||113
2335468|NCT01763866|5732022|P23|COMPLETED|Overall Study||109
2335469|NCT01763866|5732023|P22|COMPLETED|Overall Study||54
2335470|NCT01763866|5732024|P21|COMPLETED|Overall Study||52
2335471|NCT01763866|5732025|P20|COMPLETED|Overall Study||110
2335472|NCT01763866|5732026|P19|COMPLETED|Overall Study||105
2335473|NCT01763866|5732027|P18|COMPLETED|Overall Study||55
2335474|NCT01763866|5732028|P17|COMPLETED|Overall Study||55
2335475|NCT01763866|5732029|P16|COMPLETED|Overall Study||112
2335476|NCT01763866|5732030|P15|COMPLETED|Overall Study||102
2335477|NCT01763866|5732031|P14|COMPLETED|Overall Study||57
2335478|NCT01763866|5732032|P13|COMPLETED|Overall Study||54
2335479|NCT01763866|5732033|P12|COMPLETED|Overall Study||108
2335480|NCT01763866|5732034|P11|COMPLETED|Overall Study||102
2335481|NCT01763866|5732035|P10|COMPLETED|Overall Study||53
2335482|NCT01763866|5732036|P9|COMPLETED|Overall Study||53
2335483|NCT01763866|5732037|P8|COMPLETED|Overall Study||55
2335484|NCT01763866|5732038|P7|COMPLETED|Overall Study||48
2335485|NCT01763866|5732039|P6|COMPLETED|Overall Study||107
2335486|NCT01763866|5732040|P5|COMPLETED|Overall Study||108
2335487|NCT01763866|5732041|P4|COMPLETED|Overall Study||55
2335488|NCT01763866|5732042|P3|COMPLETED|Overall Study||51
2335489|NCT01763866|5732043|P2|COMPLETED|Overall Study||54
2335490|NCT01763866|5732044|P1|COMPLETED|Overall Study||54
2335491|NCT01763866|5732021|P24|Received Treatment|Overall Study||115
2335492|NCT01763866|5732022|P23|Received Treatment|Overall Study||112
2335493|NCT01763866|5732023|P22|Received Treatment|Overall Study||55
2335494|NCT01763866|5732024|P21|Received Treatment|Overall Study||56
2335495|NCT01763866|5732025|P20|Received Treatment|Overall Study||112
2335496|NCT01763866|5732026|P19|Received Treatment|Overall Study||111
2335497|NCT01763866|5732027|P18|Received Treatment|Overall Study||55
2335498|NCT01763866|5732028|P17|Received Treatment|Overall Study||56
2335499|NCT01763866|5732029|P16|Received Treatment|Overall Study||115
2335500|NCT01763866|5732030|P15|Received Treatment|Overall Study||113
2335501|NCT01763866|5732031|P14|Received Treatment|Overall Study||57
2335502|NCT01763866|5732032|P13|Received Treatment|Overall Study||58
2335503|NCT01763866|5732033|P12|Received Treatment|Overall Study||110
2335504|NCT01763866|5732034|P11|Received Treatment|Overall Study||109
2335505|NCT01763866|5732035|P10|Received Treatment|Overall Study||54
2335506|NCT01763866|5732036|P9|Received Treatment|Overall Study||56
2335507|NCT01763866|5732037|P8|Received Treatment|Overall Study||55
2335508|NCT01763866|5732038|P7|Received Treatment|Overall Study||55
2335509|NCT01763866|5732039|P6|Received Treatment|Overall Study||110
2335510|NCT01763866|5732040|P5|Received Treatment|Overall Study||110
2335511|NCT01763866|5732041|P4|Received Treatment|Overall Study||55
2335512|NCT01763866|5732042|P3|Received Treatment|Overall Study||56
2335513|NCT01763866|5732043|P2|Received Treatment|Overall Study||55
2335514|NCT01763866|5732044|P1|Received Treatment|Overall Study||56
2335515|NCT01763866|5732021|P24|STARTED|Overall Study||115
2335516|NCT01763866|5732022|P23|STARTED|Overall Study||112
2335517|NCT01763866|5732023|P22|STARTED|Overall Study||55
2335518|NCT01763866|5732024|P21|STARTED|Overall Study||56
2335519|NCT01763866|5732025|P20|STARTED|Overall Study||112
2335520|NCT01763866|5732026|P19|STARTED|Overall Study||111
2335521|NCT01763866|5732027|P18|STARTED|Overall Study||56
2335522|NCT01763866|5732028|P17|STARTED|Overall Study||56
2335523|NCT01763866|5732029|P16|STARTED|Overall Study||115
2335524|NCT01763866|5732030|P15|STARTED|Overall Study||114
2335525|NCT01763866|5732031|P14|STARTED|Overall Study||57
2335526|NCT01763866|5732032|P13|STARTED|Overall Study||58
2335527|NCT01763866|5732033|P12|STARTED|Overall Study||110
2335528|NCT01763866|5732034|P11|STARTED|Overall Study||110
2335529|NCT01763866|5732035|P10|STARTED|Overall Study||54
2335530|NCT01763866|5732036|P9|STARTED|Overall Study||56
2335531|NCT01763866|5732037|P8|STARTED|Overall Study||55
2335532|NCT01763866|5732038|P7|STARTED|Overall Study||55
2335533|NCT01763866|5732039|P6|STARTED|Overall Study||110
2335534|NCT01763866|5732040|P5|STARTED|Overall Study||110
2335535|NCT01763866|5732041|P4|STARTED|Overall Study||55
2335536|NCT01763866|5732042|P3|STARTED|Overall Study||56
2335537|NCT01763866|5732043|P2|STARTED|Overall Study||55
2335538|NCT01763866|5732044|P1|STARTED|Overall Study||56
2335539|NCT01763827|5732604|P6|NOT COMPLETED|Overall Study||2
2335540|NCT01763827|5732605|P5|NOT COMPLETED|Overall Study||6
2335541|NCT01763827|5732606|P4|NOT COMPLETED|Overall Study||1
2335542|NCT01763827|5732607|P3|NOT COMPLETED|Overall Study||4
2335543|NCT01763827|5732608|P2|NOT COMPLETED|Overall Study||1
2335544|NCT01763827|5732609|P1|NOT COMPLETED|Overall Study||3
2335545|NCT01763827|5732604|P6|COMPLETED|Overall Study||151
2335546|NCT01763827|5732605|P5|COMPLETED|Overall Study||147
2335547|NCT01763827|5732606|P4|COMPLETED|Overall Study||76
2335548|NCT01763827|5732607|P3|COMPLETED|Overall Study||73
2335549|NCT01763827|5732608|P2|COMPLETED|Overall Study||77
2335550|NCT01763827|5732609|P1|COMPLETED|Overall Study||74
2335551|NCT01763827|5732604|P6|Received at Least 1 Dose of Study Drug|Overall Study||153
2335552|NCT01763827|5732605|P5|Received at Least 1 Dose of Study Drug|Overall Study||153
2335553|NCT01763827|5732606|P4|Received at Least 1 Dose of Study Drug|Overall Study||77
2335554|NCT01763827|5732607|P3|Received at Least 1 Dose of Study Drug|Overall Study||77
2335555|NCT01763827|5732608|P2|Received at Least 1 Dose of Study Drug|Overall Study||78
2335556|NCT01763827|5732609|P1|Received at Least 1 Dose of Study Drug|Overall Study||76
2335557|NCT01763827|5732604|P6|STARTED|Overall Study||153
2335558|NCT01763827|5732605|P5|STARTED|Overall Study||153
2335559|NCT01763827|5732606|P4|STARTED|Overall Study||77
2335560|NCT01763827|5732607|P3|STARTED|Overall Study||77
2335561|NCT01763827|5732608|P2|STARTED|Overall Study||78
2335562|NCT01763827|5732609|P1|STARTED|Overall Study||77
2335563|NCT01763788|5732753|P4|NOT COMPLETED|Overall Study||0
2335564|NCT01763788|5732754|P3|NOT COMPLETED|Overall Study||1
2335565|NCT01763788|5732755|P2|NOT COMPLETED|Overall Study||0
2335566|NCT01763788|5732756|P1|NOT COMPLETED|Overall Study||0
2335567|NCT01763788|5732753|P4|COMPLETED|Overall Study||92
2335568|NCT01763788|5732754|P3|COMPLETED|Overall Study||90
2335569|NCT01763788|5732755|P2|COMPLETED|Overall Study||6
2335570|NCT01763788|5732756|P1|COMPLETED|Overall Study||3
2335571|NCT01763788|5732753|P4|Received at Least 1dose of Study Drug|Overall Study||91
2335572|NCT01763788|5732754|P3|Received at Least 1dose of Study Drug|Overall Study||90
2335573|NCT01763788|5732755|P2|Received at Least 1dose of Study Drug|Overall Study||6
2335574|NCT01763788|5732756|P1|Received at Least 1dose of Study Drug|Overall Study||3
2335575|NCT01763788|5732753|P4|STARTED|Overall Study||92
2335576|NCT01763788|5732754|P3|STARTED|Overall Study||91
2335577|NCT01763788|5732755|P2|STARTED|Overall Study||6
2335578|NCT01763788|5732756|P1|STARTED|Overall Study||3
2335579|NCT01763645|5732792|P2|NOT COMPLETED|Overall Study||24
2335580|NCT01763645|5732793|P1|NOT COMPLETED|Overall Study||26
2335581|NCT01763645|5732792|P2|COMPLETED|Overall Study|Completed the study according the protocol.|45
2335582|NCT01763645|5732793|P1|COMPLETED|Overall Study|Completed the study according the protocol.|43
2335583|NCT01763645|5732792|P2|Received at Least 1 Dose of Study Drug|Overall Study||66
2335584|NCT01763645|5732793|P1|Received at Least 1 Dose of Study Drug|Overall Study||68
2335585|NCT01763645|5732792|P2|STARTED|Overall Study||69
2335586|NCT01763645|5732793|P1|STARTED|Overall Study||69
2335587|NCT01763567|5732811|P1|NOT COMPLETED|Overall Study||0
2335588|NCT01763567|5732811|P1|COMPLETED|Overall Study||19
2335589|NCT01763567|5732811|P1|STARTED|Overall Study||19
2335590|NCT01763346|5732821|P2|NOT COMPLETED|Overall Study||8
2335591|NCT01763346|5732822|P1|NOT COMPLETED|Overall Study||10
2335592|NCT01763346|5732821|P2|COMPLETED|Overall Study||36
2335593|NCT01763346|5732822|P1|COMPLETED|Overall Study||34
2335594|NCT01763346|5732821|P2|Received Intervention|Overall Study||38
2335595|NCT01763346|5732822|P1|Received Intervention|Overall Study||39
2335596|NCT01763346|5732821|P2|STARTED|Overall Study|"Six subjects randomized to gastric banding refused the banding surgery and, thus, did not start"|44
2335597|NCT01763346|5732822|P1|STARTED|Overall Study|"Five subjects who enrolled in the study refused to initiate metformin therapy, thus did not start"|44
2335598|NCT01763333|5732846|P14|NOT COMPLETED|Overall Study||0
2335599|NCT01763333|5732847|P13|NOT COMPLETED|Overall Study||0
2335600|NCT01763333|5732848|P12|NOT COMPLETED|Overall Study||0
2335601|NCT01763333|5732849|P11|NOT COMPLETED|Overall Study||0
2335602|NCT01763333|5732850|P10|NOT COMPLETED|Overall Study||0
2335603|NCT01763333|5732851|P9|NOT COMPLETED|Overall Study||0
2335604|NCT01763333|5732852|P8|NOT COMPLETED|Overall Study||0
2335605|NCT01763333|5732853|P7|NOT COMPLETED|Overall Study||0
2335606|NCT01763333|5732854|P6|NOT COMPLETED|Overall Study||0
2335607|NCT01763333|5732855|P5|NOT COMPLETED|Overall Study||0
2335608|NCT01763333|5732856|P4|NOT COMPLETED|Overall Study||0
2335609|NCT01763333|5732857|P3|NOT COMPLETED|Overall Study||0
2335610|NCT01763333|5732858|P2|NOT COMPLETED|Overall Study||0
2335611|NCT01763333|5732859|P1|NOT COMPLETED|Overall Study||0
2335612|NCT01763333|5732846|P14|COMPLETED|Overall Study||3
2335613|NCT01763333|5732847|P13|COMPLETED|Overall Study||3
2335614|NCT01763333|5732848|P12|COMPLETED|Overall Study||3
2335615|NCT01763333|5732849|P11|COMPLETED|Overall Study||3
2335616|NCT01763333|5732850|P10|COMPLETED|Overall Study||18
2335617|NCT01763333|5732851|P9|COMPLETED|Overall Study||5
2335618|NCT01763333|5732852|P8|COMPLETED|Overall Study||6
2335619|NCT01763333|5732853|P7|COMPLETED|Overall Study||5
2335620|NCT01763333|5732854|P6|COMPLETED|Overall Study||6
2335621|NCT01763333|5732855|P5|COMPLETED|Overall Study||4
2335622|NCT01763333|5732856|P4|COMPLETED|Overall Study||6
2335623|NCT01763333|5732857|P3|COMPLETED|Overall Study||6
2335624|NCT01763333|5732858|P2|COMPLETED|Overall Study||6
2335625|NCT01763333|5732859|P1|COMPLETED|Overall Study||6
2335626|NCT01763333|5732846|P14|STARTED|Overall Study||3
2335627|NCT01763333|5732847|P13|STARTED|Overall Study||3
2335628|NCT01763333|5732848|P12|STARTED|Overall Study||3
2335629|NCT01763333|5732849|P11|STARTED|Overall Study||3
2335630|NCT01763333|5732850|P10|STARTED|Overall Study||18
2335631|NCT01763333|5732851|P9|STARTED|Overall Study||5
2335632|NCT01763333|5732852|P8|STARTED|Overall Study||6
2335633|NCT01763333|5732853|P7|STARTED|Overall Study||5
2335634|NCT01763333|5732854|P6|STARTED|Overall Study||6
2335635|NCT01763333|5732855|P5|STARTED|Overall Study||4
2335636|NCT01763333|5732856|P4|STARTED|Overall Study||6
2335637|NCT01763333|5732857|P3|STARTED|Overall Study||6
2335638|NCT01763333|5732858|P2|STARTED|Overall Study||6
2335639|NCT01763333|5732859|P1|STARTED|Overall Study||6
2335640|NCT01763203|5732965|P2|NOT COMPLETED|Overall Study||42
2335641|NCT01763203|5732966|P1|NOT COMPLETED|Overall Study||33
2335642|NCT01763203|5732965|P2|COMPLETED|Overall Study||204
2335643|NCT01763203|5732966|P1|COMPLETED|Overall Study||208
2335644|NCT01763203|5732965|P2|STARTED|Overall Study||246
2335645|NCT01763203|5732966|P1|STARTED|Overall Study||241
2335646|NCT01763047|5733012|P2|NOT COMPLETED|Period 2||5
2335647|NCT01763047|5733013|P1|NOT COMPLETED|Period 2||4
2335648|NCT01763047|5733012|P2|COMPLETED|Period 2||121
2335649|NCT01763047|5733013|P1|COMPLETED|Period 2||126
2335650|NCT01763047|5733012|P2|Hyperopes|Period 2||54
2335651|NCT01763047|5733013|P1|Hyperopes|Period 2||56
2335652|NCT01763047|5733012|P2|Myopes|Period 2||72
2335653|NCT01763047|5733013|P1|Myopes|Period 2||74
2335654|NCT01763047|5733012|P2|STARTED|Period 2||126
2335655|NCT01763047|5733013|P1|STARTED|Period 2||130
2335656|NCT01763047|5733012|P2|NOT COMPLETED|Period 1||11
2335657|NCT01763047|5733013|P1|NOT COMPLETED|Period 1||9
2335658|NCT01763047|5733012|P2|COMPLETED|Period 1||126
2335659|NCT01763047|5733013|P1|COMPLETED|Period 1||130
2335660|NCT01763047|5733012|P2|Hyperopes|Period 1||61
2335661|NCT01763047|5733013|P1|Hyperopes|Period 1||62
2335662|NCT01763047|5733012|P2|Myopes|Period 1||76
2335663|NCT01763047|5733013|P1|Myopes|Period 1||77
2335664|NCT01763047|5733012|P2|STARTED|Period 1||137
2335665|NCT01763047|5733013|P1|STARTED|Period 1||139
2335666|NCT01762982|5733029|P1|NOT COMPLETED|Overall Study||0
2335667|NCT01762982|5733029|P1|COMPLETED|Overall Study||36
2335668|NCT01762982|5733029|P1|Received Empty Finn Chamber|Overall Study||36
2335669|NCT01762982|5733029|P1|Received SLS|Overall Study||36
2335670|NCT01762982|5733029|P1|Received Benzalkonium Chloride|Overall Study||36
2335671|NCT01762982|5733029|P1|Received Saline Water|Overall Study||36
2335672|NCT01762982|5733029|P1|STARTED|Overall Study||36
2335673|NCT01762943|5733052|P2|NOT COMPLETED|Overall Study||2
2335674|NCT01762943|5733053|P1|NOT COMPLETED|Overall Study||4
2335675|NCT01762943|5733052|P2|COMPLETED|Overall Study||15
2335676|NCT01762943|5733053|P1|COMPLETED|Overall Study||15
2335677|NCT01762943|5733052|P2|Withdrawal|Overall Study||15
2335678|NCT01762943|5733053|P1|Withdrawal|Overall Study||15
2335679|NCT01762943|5733052|P2|Addback|Overall Study||15
2335680|NCT01762943|5733053|P1|Addback|Overall Study||16
2335681|NCT01762943|5733052|P2|Hypogonadism|Overall Study||15
2335682|NCT01762943|5733053|P1|Hypogonadism|Overall Study||18
2335683|NCT01762943|5733052|P2|STARTED|Overall Study||17
2335684|NCT01762943|5733053|P1|STARTED|Overall Study||19
2335685|NCT01762904|5733061|P1|NOT COMPLETED|Overall Study||0
2335686|NCT01762904|5733061|P1|COMPLETED|Overall Study|October, 2013|135
2335687|NCT01762904|5733061|P1|STARTED|Overall Study|January, 2013|135
2335688|NCT01762800|5733070|P2|NOT COMPLETED|Overall Study||21
2335689|NCT01762800|5733071|P1|NOT COMPLETED|Overall Study||19
2335690|NCT01762800|5733070|P2|COMPLETED|Overall Study||183
2335691|NCT01762800|5733071|P1|COMPLETED|Overall Study||183
2335692|NCT01762800|5733070|P2|STARTED|Overall Study||204
2335693|NCT01762800|5733071|P1|STARTED|Overall Study||202
2335694|NCT01762761|5733145|P2|NOT COMPLETED|Overall Study||65
2335695|NCT01762761|5733146|P1|NOT COMPLETED|Overall Study||39
2335696|NCT01762761|5733145|P2|COMPLETED|Overall Study||39
2335697|NCT01762761|5733146|P1|COMPLETED|Overall Study||12
2335698|NCT01762761|5733145|P2|STARTED|Overall Study||104
2335699|NCT01762761|5733146|P1|STARTED|Overall Study||51
2335700|NCT01762722|5733202|P2|NOT COMPLETED|Overall Study||0
2335701|NCT01762722|5733203|P1|NOT COMPLETED|Overall Study||0
2335702|NCT01762722|5733202|P2|COMPLETED|Overall Study||11
2335703|NCT01762722|5733203|P1|COMPLETED|Overall Study||12
2335704|NCT01762722|5733202|P2|STARTED|Overall Study||11
2335705|NCT01762722|5733203|P1|STARTED|Overall Study||12
2335706|NCT01762631|5733211|P2|NOT COMPLETED|Overall Study||0
2335707|NCT01762631|5733212|P1|NOT COMPLETED|Overall Study||0
2335708|NCT01762631|5733211|P2|COMPLETED|Overall Study||22
2335709|NCT01762631|5733212|P1|COMPLETED|Overall Study||53
2335710|NCT01762631|5733211|P2|STARTED|Overall Study||22
2335711|NCT01762631|5733212|P1|STARTED|Overall Study||53
2335712|NCT01762501|5733230|P2|NOT COMPLETED|Overall Study||23
2335713|NCT01762501|5733231|P1|NOT COMPLETED|Overall Study||27
2335714|NCT01762501|5733230|P2|COMPLETED|Overall Study||336
2335715|NCT01762501|5733231|P1|COMPLETED|Overall Study||332
2335716|NCT01762501|5733230|P2|STARTED|Overall Study||359
2335717|NCT01762501|5733231|P1|STARTED|Overall Study||359
2335718|NCT01762345|5733245|P1|NOT COMPLETED|Overall Study||7
2335719|NCT01762345|5733245|P1|COMPLETED|Overall Study||76
2335720|NCT01762345|5733245|P1|STARTED|Overall Study||83
2335721|NCT01762059|5733255|P1|NOT COMPLETED|Overall Study||0
2335722|NCT01762059|5733255|P1|COMPLETED|Overall Study||20
2335723|NCT01762059|5733255|P1|STARTED|Overall Study||20
2335724|NCT01761747|5733282|P1|NOT COMPLETED|Overall Study||1
2335725|NCT01761747|5733282|P1|COMPLETED|Overall Study||2
2335726|NCT01761747|5733282|P1|STARTED|Overall Study||3
2335727|NCT01761565|5733293|P1|NOT COMPLETED|40 Consecutive Doses of SUF 15 mcg||1
2335728|NCT01761565|5733293|P1|COMPLETED|40 Consecutive Doses of SUF 15 mcg||38
2335729|NCT01761565|5733293|P1|STARTED|40 Consecutive Doses of SUF 15 mcg|Subject was withdrawn from the study prior to the second arm/period due to non-compliance|39
2335730|NCT01761565|5733293|P1|NOT COMPLETED|Single Dose of SUF NT 15 mcg||0
2335731|NCT01761565|5733293|P1|COMPLETED|Single Dose of SUF NT 15 mcg||40
2335732|NCT01761565|5733293|P1|STARTED|Single Dose of SUF NT 15 mcg||40
2335733|NCT01761279|5733302|P1|NOT COMPLETED|Overall Study||0
2335734|NCT01761279|5733302|P1|COMPLETED|Overall Study||84
2335735|NCT01761279|5733302|P1|STARTED|Overall Study||84
2335736|NCT01761266|5733317|P2|NOT COMPLETED|Overall Study||476
2335737|NCT01761266|5733318|P1|NOT COMPLETED|Overall Study||478
2335738|NCT01761266|5733317|P2|COMPLETED|Overall Study||0
2335739|NCT01761266|5733318|P1|COMPLETED|Overall Study||0
2335740|NCT01761266|5733317|P2|Treated|Overall Study||475
2335741|NCT01761266|5733318|P1|Treated|Overall Study||476
2335742|NCT01761266|5733317|P2|STARTED|Overall Study||476
2335743|NCT01761266|5733318|P1|STARTED|Overall Study||478
2335744|NCT01761175|5733346|P2|NOT COMPLETED|Overall Study||0
2335745|NCT01761175|5733347|P1|NOT COMPLETED|Overall Study||0
2335746|NCT01761175|5733346|P2|COMPLETED|Overall Study||112
2335747|NCT01761175|5733347|P1|COMPLETED|Overall Study||112
2335748|NCT01761175|5733346|P2|STARTED|Overall Study||112
2335749|NCT01761175|5733347|P1|STARTED|Overall Study||112
2335750|NCT01761162|5733375|P1|NOT COMPLETED|Overall Study||3
2335751|NCT01761162|5733375|P1|COMPLETED|Overall Study||226
2335752|NCT01761162|5733375|P1|STARTED|Overall Study||229
2335753|NCT01761084|5733385|P2|NOT COMPLETED|Overall Study||6
2335754|NCT01761084|5733386|P1|NOT COMPLETED|Overall Study||5
2335755|NCT01761084|5733385|P2|COMPLETED|Overall Study||64
2335756|NCT01761084|5733386|P1|COMPLETED|Overall Study||66
2335757|NCT01761084|5733385|P2|STARTED|Overall Study||70
2335758|NCT01761084|5733386|P1|STARTED|Overall Study||71
2335759|NCT01761019|5733435|P1|NOT COMPLETED|Overall Study||0
2335760|NCT01761019|5733435|P1|COMPLETED|Overall Study||8
2335761|NCT01761019|5733435|P1|STARTED|Overall Study||8
2335762|NCT01760993|5733443|P1|NOT COMPLETED|Overall Study||0
2335763|NCT01760993|5733443|P1|COMPLETED|Overall Study||0
2335764|NCT01760993|5733443|P1|STARTED|Overall Study||0
2335765|NCT01760954|5733464|P4|NOT COMPLETED|Post-treatment Follow-up (12 Months)||20
2335766|NCT01760954|5733465|P3|NOT COMPLETED|Post-treatment Follow-up (12 Months)||21
2335767|NCT01760954|5733466|P2|NOT COMPLETED|Post-treatment Follow-up (12 Months)||35
2335768|NCT01760954|5733467|P1|NOT COMPLETED|Post-treatment Follow-up (12 Months)||30
2335769|NCT01760954|5733464|P4|COMPLETED|Post-treatment Follow-up (12 Months)||67
2335770|NCT01760954|5733465|P3|COMPLETED|Post-treatment Follow-up (12 Months)||65
2335771|NCT01760954|5733466|P2|COMPLETED|Post-treatment Follow-up (12 Months)||83
2335772|NCT01760954|5733467|P1|COMPLETED|Post-treatment Follow-up (12 Months)||96
2335773|NCT01760954|5733464|P4|STARTED|Post-treatment Follow-up (12 Months)||87
2335774|NCT01760954|5733465|P3|STARTED|Post-treatment Follow-up (12 Months)||86
2335775|NCT01760954|5733466|P2|STARTED|Post-treatment Follow-up (12 Months)||118
2335776|NCT01760954|5733467|P1|STARTED|Post-treatment Follow-up (12 Months)||126
2335777|NCT01760954|5733464|P4|NOT COMPLETED|Treatment Period (6 Months)||26
2335778|NCT01760954|5733465|P3|NOT COMPLETED|Treatment Period (6 Months)||21
2335779|NCT01760954|5733466|P2|NOT COMPLETED|Treatment Period (6 Months)||28
2335780|NCT01760954|5733467|P1|NOT COMPLETED|Treatment Period (6 Months)||33
2335781|NCT01760954|5733464|P4|COMPLETED|Treatment Period (6 Months)||83
2335782|NCT01760954|5733465|P3|COMPLETED|Treatment Period (6 Months)||87
2335783|NCT01760954|5733466|P2|COMPLETED|Treatment Period (6 Months)||110
2335784|NCT01760954|5733467|P1|COMPLETED|Treatment Period (6 Months)||116
2335785|NCT01760954|5733464|P4|STARTED|Treatment Period (6 Months)||109
2335786|NCT01760954|5733465|P3|STARTED|Treatment Period (6 Months)||108
2335787|NCT01760954|5733466|P2|STARTED|Treatment Period (6 Months)||138
2335788|NCT01760954|5733467|P1|STARTED|Treatment Period (6 Months)||149
2335789|NCT01760941|5733545|P1|NOT COMPLETED|Overall Study||0
2335790|NCT01760941|5733545|P1|COMPLETED|Overall Study||1
2335791|NCT01760941|5733545|P1|STARTED|Overall Study||1
2335792|NCT01760889|5733555|P3|NOT COMPLETED|Overall Study||0
2335793|NCT01760889|5733556|P2|NOT COMPLETED|Overall Study||0
2335794|NCT01760889|5733557|P1|NOT COMPLETED|Overall Study||0
2335795|NCT01760889|5733555|P3|COMPLETED|Overall Study||0
2335796|NCT01760889|5733556|P2|COMPLETED|Overall Study||0
2335797|NCT01760889|5733557|P1|COMPLETED|Overall Study||0
2335798|NCT01760889|5733555|P3|STARTED|Overall Study||0
2335799|NCT01760889|5733556|P2|STARTED|Overall Study||0
2335800|NCT01760889|5733557|P1|STARTED|Overall Study||0
2335801|NCT01760876|5733604|P1|NOT COMPLETED|Overall Study||6
2335802|NCT01760876|5733604|P1|COMPLETED|Overall Study|12 months clinical FU of last patient in July 2015.|100
2335803|NCT01760876|5733604|P1|STARTED|Overall Study||106
2335804|NCT01760785|5733610|P2|NOT COMPLETED|Overall Study||0
2335805|NCT01760785|5733611|P1|NOT COMPLETED|Overall Study||0
2335806|NCT01760785|5733610|P2|COMPLETED|Overall Study||27
2335807|NCT01760785|5733611|P1|COMPLETED|Overall Study||23
2335808|NCT01760785|5733610|P2|STARTED|Overall Study||27
2335809|NCT01760785|5733611|P1|STARTED|Overall Study||23
2335810|NCT01760473|5733619|P1|NOT COMPLETED|Overall Study||15
2335811|NCT01760473|5733619|P1|COMPLETED|Overall Study||12
2335812|NCT01760473|5733619|P1|STARTED|Overall Study||27
2335813|NCT01760304|5733642|P2|NOT COMPLETED|Overall Study||0
2335814|NCT01760304|5733643|P1|NOT COMPLETED|Overall Study||0
2335815|NCT01760304|5733642|P2|COMPLETED|Overall Study||3
2335816|NCT01760304|5733643|P1|COMPLETED|Overall Study||2
2335817|NCT01760304|5733642|P2|STARTED|Overall Study||3
2335818|NCT01760304|5733643|P1|STARTED|Overall Study||2
2335819|NCT01760239|5733655|P2|NOT COMPLETED|Overall Study||14316
2335820|NCT01760239|5733656|P1|NOT COMPLETED|Overall Study||16741
2335821|NCT01760239|5733655|P2|COMPLETED|Overall Study||226
2335822|NCT01760239|5733656|P1|COMPLETED|Overall Study||296
2335823|NCT01760239|5733655|P2|STARTED|Overall Study||14542
2335824|NCT01760239|5733656|P1|STARTED|Overall Study||17037
2335825|NCT01760187|5733676|P5|NOT COMPLETED|Overall Study||0
2335826|NCT01760187|5733677|P4|NOT COMPLETED|Overall Study||2
2335827|NCT01760187|5733678|P3|NOT COMPLETED|Overall Study||0
2335828|NCT01760187|5733679|P2|NOT COMPLETED|Overall Study||0
2335829|NCT01760187|5733680|P1|NOT COMPLETED|Overall Study||1
2335830|NCT01760187|5733676|P5|COMPLETED|Overall Study||16
2335831|NCT01760187|5733677|P4|COMPLETED|Overall Study||10
2335832|NCT01760187|5733678|P3|COMPLETED|Overall Study||12
2335833|NCT01760187|5733679|P2|COMPLETED|Overall Study||12
2335834|NCT01760187|5733680|P1|COMPLETED|Overall Study||19
2335835|NCT01760187|5733676|P5|STARTED|Overall Study||16
2335836|NCT01760187|5733677|P4|STARTED|Overall Study||12
2335837|NCT01760187|5733678|P3|STARTED|Overall Study||12
2335838|NCT01760187|5733679|P2|STARTED|Overall Study||12
2335839|NCT01760187|5733680|P1|STARTED|Overall Study||20
2335840|NCT01759862|5733910|P2|NOT COMPLETED|Overall Study||2
2335841|NCT01759862|5733911|P1|NOT COMPLETED|Overall Study||3
2335842|NCT01759862|5733910|P2|COMPLETED|Overall Study||25
2335843|NCT01759862|5733911|P1|COMPLETED|Overall Study||20
2335844|NCT01759862|5733910|P2|STARTED|Overall Study||27
2335845|NCT01759862|5733911|P1|STARTED|Overall Study||23
2335846|NCT01759602|5733921|P1|NOT COMPLETED|Overall Study||0
2335847|NCT01759602|5733921|P1|COMPLETED|Overall Study||10
2335848|NCT01759602|5733921|P1|STARTED|Overall Study||10
2335849|NCT01759511|5733929|P1|NOT COMPLETED|Overall Study||34
2335850|NCT01759511|5733929|P1|COMPLETED|Overall Study||0
2335851|NCT01759511|5733929|P1|STARTED|Overall Study||34
2335852|NCT01759446|5733942|P5|NOT COMPLETED|Overall Study||0
2335853|NCT01759446|5733943|P4|NOT COMPLETED|Overall Study||1
2335854|NCT01759446|5733944|P3|NOT COMPLETED|Overall Study||1
2335855|NCT01759446|5733945|P2|NOT COMPLETED|Overall Study||1
2335856|NCT01759446|5733946|P1|NOT COMPLETED|Overall Study||1
2335857|NCT01759446|5733942|P5|COMPLETED|Overall Study||8
2335858|NCT01759446|5733943|P4|COMPLETED|Overall Study||8
2335859|NCT01759446|5733944|P3|COMPLETED|Overall Study||8
2335860|NCT01759446|5733945|P2|COMPLETED|Overall Study||8
2335861|NCT01759446|5733946|P1|COMPLETED|Overall Study||8
2335862|NCT01759446|5733942|P5|STARTED|Overall Study||8
2335863|NCT01759446|5733943|P4|STARTED|Overall Study||9
2335864|NCT01759446|5733944|P3|STARTED|Overall Study||9
2335865|NCT01759446|5733945|P2|STARTED|Overall Study||9
2335866|NCT01759446|5733946|P1|STARTED|Overall Study||9
2335867|NCT01759420|5733958|P1|NOT COMPLETED|Overall Study||6
2335868|NCT01759420|5733958|P1|COMPLETED|Overall Study||22
2335869|NCT01759420|5733958|P1|STARTED|Overall Study||28
2335870|NCT01759407|5733965|P2|NOT COMPLETED|Overall Study||2
2335871|NCT01759407|5733966|P1|NOT COMPLETED|Overall Study||0
2335872|NCT01759407|5733965|P2|COMPLETED|Overall Study||7
2335873|NCT01759407|5733966|P1|COMPLETED|Overall Study||10
2335874|NCT01759407|5733965|P2|STARTED|Overall Study||9
2335875|NCT01759407|5733966|P1|STARTED|Overall Study||10
2335876|NCT01759381|5733978|P2|NOT COMPLETED|Overall Study||0
2335877|NCT01759381|5733979|P1|NOT COMPLETED|Overall Study||1
2335878|NCT01759381|5733978|P2|COMPLETED|Overall Study||11
2335879|NCT01759381|5733979|P1|COMPLETED|Overall Study||7
2335880|NCT01759381|5733978|P2|STARTED|Overall Study||11
2335881|NCT01759381|5733979|P1|STARTED|Overall Study||8
2335882|NCT01759368|5733987|P2|NOT COMPLETED|Overall Study||0
2335883|NCT01759368|5733988|P1|NOT COMPLETED|Overall Study||1
2335884|NCT01759368|5733987|P2|COMPLETED|Overall Study||47
2335885|NCT01759368|5733988|P1|COMPLETED|Overall Study||46
2335886|NCT01759368|5733987|P2|STARTED|Overall Study||47
2335887|NCT01759368|5733988|P1|STARTED|Overall Study||47
2335888|NCT01759290|5734006|P1|NOT COMPLETED|Overall Study||81
2335889|NCT01759290|5734006|P1|COMPLETED|Overall Study||1719
2335890|NCT01759290|5734006|P1|STARTED|Overall Study||1800
2335897|NCT01759264|5734075|P1|NOT COMPLETED|Overall Study||10
2335898|NCT01759264|5734075|P1|COMPLETED|Overall Study||91
2335899|NCT01759264|5734075|P1|STARTED|Overall Study||101
2335900|NCT01759251|5734088|P1|NOT COMPLETED|Follow-up Period||0
2335901|NCT01759251|5734088|P1|COMPLETED|Follow-up Period||305
2335902|NCT01759251|5734088|P1|STARTED|Follow-up Period||305
2335903|NCT01759251|5734088|P1|NOT COMPLETED|60 Days Treatment Period||0
2335904|NCT01759251|5734088|P1|COMPLETED|60 Days Treatment Period||305
2335905|NCT01759251|5734088|P1|STARTED|60 Days Treatment Period||305
2335906|NCT01759251|5734088|P1|NOT COMPLETED|30 Days Treatment Period||4
2335907|NCT01759251|5734088|P1|COMPLETED|30 Days Treatment Period||305
2335908|NCT01759251|5734088|P1|STARTED|30 Days Treatment Period||309
2335909|NCT01759160|5734094|P2|NOT COMPLETED|Overall Study||0
2335910|NCT01759160|5734095|P1|NOT COMPLETED|Overall Study||0
2335911|NCT01759160|5734094|P2|COMPLETED|Overall Study||30
2335912|NCT01759160|5734095|P1|COMPLETED|Overall Study||30
2335913|NCT01759160|5734094|P2|STARTED|Overall Study||30
2335914|NCT01759160|5734095|P1|STARTED|Overall Study||30
2335915|NCT01758900|5734103|P2|NOT COMPLETED|Overall Study||8
2335916|NCT01758900|5734104|P1|NOT COMPLETED|Overall Study||7
2335917|NCT01758900|5734103|P2|COMPLETED|Overall Study||100
2335918|NCT01758900|5734104|P1|COMPLETED|Overall Study||99
2335919|NCT01758900|5734103|P2|STARTED|Overall Study||108
2335920|NCT01758900|5734104|P1|STARTED|Overall Study||106
2335921|NCT01758731|5734122|P1|NOT COMPLETED|Overall Study||1
2335922|NCT01758731|5734122|P1|COMPLETED|Overall Study||16
2335923|NCT01758731|5734122|P1|STARTED|Overall Study||17
2335924|NCT01758588|5734128|P2|NOT COMPLETED|Overall Study||0
2335925|NCT01758588|5734129|P1|NOT COMPLETED|Overall Study||0
2335926|NCT01758588|5734128|P2|COMPLETED|Overall Study||3
2335927|NCT01758588|5734129|P1|COMPLETED|Overall Study||5
2335928|NCT01758588|5734128|P2|STARTED|Overall Study||3
2335929|NCT01758588|5734129|P1|STARTED|Overall Study||5
2335930|NCT01758523|5734141|P2|NOT COMPLETED|Overall Study||14
2335931|NCT01758523|5734142|P1|NOT COMPLETED|Overall Study||21
2335932|NCT01758523|5734141|P2|COMPLETED|Overall Study||54
2335933|NCT01758523|5734142|P1|COMPLETED|Overall Study||53
2335934|NCT01758523|5734141|P2|Attended >/= 1 Visit Post-randomization|Overall Study||67
2335935|NCT01758523|5734142|P1|Attended >/= 1 Visit Post-randomization|Overall Study||68
2335936|NCT01758523|5734141|P2|STARTED|Overall Study||68
2335937|NCT01758523|5734142|P1|STARTED|Overall Study||74
2335938|NCT01758432|5734167|P7|NOT COMPLETED|Overall Study||0
2335939|NCT01758432|5734168|P6|NOT COMPLETED|Overall Study||0
2335940|NCT01758432|5734169|P5|NOT COMPLETED|Overall Study||0
2335941|NCT01758432|5734170|P4|NOT COMPLETED|Overall Study||0
2335942|NCT01758432|5734171|P3|NOT COMPLETED|Overall Study||0
2335943|NCT01758432|5734172|P2|NOT COMPLETED|Overall Study||0
2335944|NCT01758432|5734173|P1|NOT COMPLETED|Overall Study||0
2335945|NCT01758432|5734167|P7|COMPLETED|Overall Study||6
2335946|NCT01758432|5734168|P6|COMPLETED|Overall Study||6
2335947|NCT01758432|5734169|P5|COMPLETED|Overall Study||6
2335948|NCT01758432|5734170|P4|COMPLETED|Overall Study||6
2335949|NCT01758432|5734171|P3|COMPLETED|Overall Study||6
2335950|NCT01758432|5734172|P2|COMPLETED|Overall Study||6
2335951|NCT01758432|5734173|P1|COMPLETED|Overall Study||18
2335952|NCT01758432|5734167|P7|STARTED|Overall Study||6
2335953|NCT01758432|5734168|P6|STARTED|Overall Study||6
2335954|NCT01758432|5734169|P5|STARTED|Overall Study||6
2335955|NCT01758432|5734170|P4|STARTED|Overall Study||6
2335956|NCT01758432|5734171|P3|STARTED|Overall Study||6
2335957|NCT01758432|5734172|P2|STARTED|Overall Study||6
2335958|NCT01758432|5734173|P1|STARTED|Overall Study||18
2335959|NCT01758289|5734245|P1|NOT COMPLETED|Overall Study||53
2335960|NCT01758289|5734245|P1|COMPLETED|Overall Study||52
2335961|NCT01758289|5734245|P1|STARTED|Overall Study||105
2335962|NCT01757964|5734264|P2|NOT COMPLETED|Overall Study||0
2335963|NCT01757964|5734265|P1|NOT COMPLETED|Overall Study||0
2335964|NCT01757964|5734264|P2|COMPLETED|Overall Study||4
2335965|NCT01757964|5734265|P1|COMPLETED|Overall Study||9
2335966|NCT01757964|5734264|P2|STARTED|Overall Study||4
2335967|NCT01757964|5734265|P1|STARTED|Overall Study||9
2335968|NCT01757847|5734271|P2|NOT COMPLETED|Overall Study||4
2335969|NCT01757847|5734272|P1|NOT COMPLETED|Overall Study||3
2335970|NCT01757847|5734271|P2|COMPLETED|Overall Study||42
2335971|NCT01757847|5734272|P1|COMPLETED|Overall Study||41
2335972|NCT01757847|5734271|P2|STARTED|Overall Study||46
2335973|NCT01757847|5734272|P1|STARTED|Overall Study||44
2335974|NCT01757821|5734280|P1|NOT COMPLETED|Overall Study||1
2335975|NCT01757821|5734280|P1|COMPLETED|Overall Study|10 subjects|10
2335976|NCT01757821|5734280|P1|STARTED|Overall Study|11 subjects|11
2335977|NCT01757717|5734288|P1|NOT COMPLETED|Overall Study||0
2335978|NCT01757717|5734288|P1|COMPLETED|Overall Study||3
2335979|NCT01757717|5734288|P1|STARTED|Overall Study||3
2335980|NCT01757704|5734295|P2|NOT COMPLETED|Overall Study||3
2335981|NCT01757704|5734296|P1|NOT COMPLETED|Overall Study||1
2335982|NCT01757704|5734295|P2|COMPLETED|Overall Study||10
2335983|NCT01757704|5734296|P1|COMPLETED|Overall Study||10
2335984|NCT01757704|5734295|P2|STARTED|Overall Study|Two patients excluded intraoperatively due to failure to obtain TCD signals and one due to adhesion.|13
2335985|NCT01757704|5734296|P1|STARTED|Overall Study|One patient was excluded at start of surgery due to opening of the pleurae during sternotomy.|11
2335986|NCT01757691|5734314|P2|NOT COMPLETED|Overall Study||0
2335987|NCT01757691|5734315|P1|NOT COMPLETED|Overall Study||2
2335988|NCT01757691|5734314|P2|COMPLETED|Overall Study||0
2335989|NCT01757691|5734315|P1|COMPLETED|Overall Study||0
2335990|NCT01757691|5734314|P2|STARTED|Overall Study||0
2335991|NCT01757691|5734315|P1|STARTED|Overall Study||2
2335992|NCT01757678|5734328|P1|NOT COMPLETED|Overall Study||0
2335993|NCT01757678|5734328|P1|COMPLETED|Overall Study||276
2335994|NCT01757678|5734328|P1|STARTED|Overall Study||276
2335995|NCT01757665|5734342|P2|NOT COMPLETED|Overall Study||83
2335996|NCT01757665|5734343|P1|NOT COMPLETED|Overall Study||694
2335997|NCT01757665|5734342|P2|COMPLETED|Overall Study||0
2335998|NCT01757665|5734343|P1|COMPLETED|Overall Study||0
2335999|NCT01757665|5734342|P2|Implanted With Device|Overall Study||82
2336000|NCT01757665|5734343|P1|Implanted With Device|Overall Study||689
2336001|NCT01757665|5734342|P2|STARTED|Overall Study||83
2336002|NCT01757665|5734343|P1|STARTED|Overall Study||694
2336003|NCT01757561|5734496|P4|NOT COMPLETED|Overall Study||9
2336004|NCT01757561|5734497|P3|NOT COMPLETED|Overall Study||7
2336005|NCT01757561|5734498|P2|NOT COMPLETED|Overall Study||6
2336006|NCT01757561|5734499|P1|NOT COMPLETED|Overall Study||6
2336007|NCT01757561|5734496|P4|COMPLETED|Overall Study||25
2336008|NCT01757561|5734497|P3|COMPLETED|Overall Study||31
2336009|NCT01757561|5734498|P2|COMPLETED|Overall Study||28
2336010|NCT01757561|5734499|P1|COMPLETED|Overall Study||32
2336011|NCT01757561|5734496|P4|STARTED|Overall Study||34
2336012|NCT01757561|5734497|P3|STARTED|Overall Study||38
2336013|NCT01757561|5734498|P2|STARTED|Overall Study||34
2336014|NCT01757561|5734499|P1|STARTED|Overall Study||38
2336015|NCT01757405|5734515|P2|NOT COMPLETED|Overall Study||2
2336016|NCT01757405|5734516|P1|NOT COMPLETED|Overall Study||1
2336017|NCT01757405|5734515|P2|COMPLETED|Overall Study||18
2336018|NCT01757405|5734516|P1|COMPLETED|Overall Study||17
2336019|NCT01757405|5734515|P2|STARTED|Overall Study||20
2336020|NCT01757405|5734516|P1|STARTED|Overall Study||18
2336021|NCT01757301|5734534|P2|NOT COMPLETED|Overall Study||14
2336022|NCT01757301|5734535|P1|NOT COMPLETED|Overall Study||13
2336023|NCT01757301|5734534|P2|COMPLETED|Overall Study||133
2336024|NCT01757301|5734535|P1|COMPLETED|Overall Study||134
2336025|NCT01757301|5734534|P2|STARTED|Overall Study||147
2336026|NCT01757301|5734535|P1|STARTED|Overall Study||147
2336027|NCT01757275|5734551|P2|NOT COMPLETED|Overall Study||13
2336028|NCT01757275|5734552|P1|NOT COMPLETED|Overall Study||9
2336029|NCT01757275|5734551|P2|COMPLETED|Overall Study||98
2336030|NCT01757275|5734552|P1|COMPLETED|Overall Study||102
2336031|NCT01757275|5734551|P2|STARTED|Overall Study||111
2336032|NCT01757275|5734552|P1|STARTED|Overall Study||111
2336033|NCT01757197|5734574|P1|NOT COMPLETED|Overall Study||2
2336034|NCT01757197|5734574|P1|COMPLETED|Overall Study||0
2336035|NCT01757197|5734574|P1|STARTED|Overall Study||2
2336036|NCT01757184|5734583|P4|NOT COMPLETED|Open-label Period||3
2336037|NCT01757184|5734584|P3|NOT COMPLETED|Open-label Period||4
2336038|NCT01757184|5734585|P2|NOT COMPLETED|Open-label Period||0
2336039|NCT01757184|5734586|P1|NOT COMPLETED|Open-label Period||0
2336040|NCT01757184|5734583|P4|COMPLETED|Open-label Period||27
2336041|NCT01757184|5734584|P3|COMPLETED|Open-label Period||32
2336042|NCT01757184|5734585|P2|COMPLETED|Open-label Period||0
2336043|NCT01757184|5734586|P1|COMPLETED|Open-label Period||0
2336044|NCT01757184|5734583|P4|Received at Least 1 Dose of Study Drug|Open-label Period||30
2336045|NCT01757184|5734584|P3|Received at Least 1 Dose of Study Drug|Open-label Period||36
2336046|NCT01757184|5734585|P2|Received at Least 1 Dose of Study Drug|Open-label Period||0
2336047|NCT01757184|5734586|P1|Received at Least 1 Dose of Study Drug|Open-label Period||0
2336048|NCT01757184|5734583|P4|STARTED|Open-label Period||30
2336049|NCT01757184|5734584|P3|STARTED|Open-label Period|1 participant who did not complete Double-blind Period due to AE rechallenged for Open-label Period|36
2336050|NCT01757184|5734585|P2|STARTED|Open-label Period||0
2336051|NCT01757184|5734586|P1|STARTED|Open-label Period||0
2336052|NCT01757184|5734583|P4|NOT COMPLETED|Double-blind Period||0
2336053|NCT01757184|5734584|P3|NOT COMPLETED|Double-blind Period||0
2336054|NCT01757184|5734585|P2|NOT COMPLETED|Double-blind Period||0
2336055|NCT01757184|5734586|P1|NOT COMPLETED|Double-blind Period||1
2336056|NCT01757184|5734583|P4|COMPLETED|Double-blind Period||0
2336057|NCT01757184|5734584|P3|COMPLETED|Double-blind Period||0
2336058|NCT01757184|5734585|P2|COMPLETED|Double-blind Period||30
2336059|NCT01757184|5734586|P1|COMPLETED|Double-blind Period||35
2336060|NCT01757184|5734583|P4|Received at Least 1 Dose of Study Drug|Double-blind Period||0
2336061|NCT01757184|5734584|P3|Received at Least 1 Dose of Study Drug|Double-blind Period||0
2336062|NCT01757184|5734585|P2|Received at Least 1 Dose of Study Drug|Double-blind Period||30
2336063|NCT01757184|5734586|P1|Received at Least 1 Dose of Study Drug|Double-blind Period||36
2336064|NCT01757184|5734583|P4|STARTED|Double-blind Period||0
2336065|NCT01757184|5734584|P3|STARTED|Double-blind Period||0
2336066|NCT01757184|5734585|P2|STARTED|Double-blind Period||30
2336067|NCT01757184|5734586|P1|STARTED|Double-blind Period||36
2336068|NCT01757171|5734630|P2|NOT COMPLETED|Overall Study||1
2336069|NCT01757171|5734631|P1|NOT COMPLETED|Overall Study||8
2336070|NCT01757171|5734630|P2|COMPLETED|Overall Study||23
2336071|NCT01757171|5734631|P1|COMPLETED|Overall Study||53
2336072|NCT01757171|5734630|P2|STARTED|Overall Study||24
2336073|NCT01757171|5734631|P1|STARTED|Overall Study||61
2336074|NCT01756976|5734645|P2|NOT COMPLETED|Overall Study||0
2336075|NCT01756976|5734646|P1|NOT COMPLETED|Overall Study||3
2336076|NCT01756976|5734645|P2|COMPLETED|Overall Study||8
2336077|NCT01756976|5734646|P1|COMPLETED|Overall Study||73
2336078|NCT01756976|5734645|P2|STARTED|Overall Study||8
2336079|NCT01756976|5734646|P1|STARTED|Overall Study||76
2336080|NCT01756885|5734654|P2|NOT COMPLETED|Overall Study||26
2336081|NCT01756885|5734655|P1|NOT COMPLETED|Overall Study||23
2336082|NCT01756885|5734654|P2|COMPLETED|Overall Study||79
2336083|NCT01756885|5734655|P1|COMPLETED|Overall Study||79
2336084|NCT01756885|5734654|P2|STARTED|Overall Study||105
2336085|NCT01756885|5734655|P1|STARTED|Overall Study||102
2336086|NCT01756846|5734667|P2|NOT COMPLETED|Overall Study||12
2336087|NCT01756846|5734668|P1|NOT COMPLETED|Overall Study||6
2336088|NCT01756846|5734667|P2|COMPLETED|Overall Study||1821
2336089|NCT01756846|5734668|P1|COMPLETED|Overall Study||1827
2336090|NCT01756846|5734667|P2|STARTED|Overall Study||1833
2336091|NCT01756846|5734668|P1|STARTED|Overall Study||1833
2336092|NCT01756586|5734678|P2|NOT COMPLETED|Overall Study||2
2336093|NCT01756586|5734679|P1|NOT COMPLETED|Overall Study||2
2336094|NCT01756586|5734678|P2|COMPLETED|Overall Study||0
2336095|NCT01756586|5734679|P1|COMPLETED|Overall Study||0
2336096|NCT01756586|5734678|P2|STARTED|Overall Study||2
2336097|NCT01756586|5734679|P1|STARTED|Overall Study||2
2336098|NCT01756573|5734688|P3|NOT COMPLETED|Overall Study||0
2336099|NCT01756573|5734689|P2|NOT COMPLETED|Overall Study||0
2336100|NCT01756573|5734690|P1|NOT COMPLETED|Overall Study||0
2336101|NCT01756573|5734688|P3|COMPLETED|Overall Study||1
2336102|NCT01756573|5734689|P2|COMPLETED|Overall Study||1
2336103|NCT01756573|5734690|P1|COMPLETED|Overall Study||3
2336104|NCT01756573|5734688|P3|STARTED|Overall Study||1
2336105|NCT01756573|5734689|P2|STARTED|Overall Study||1
2336106|NCT01756573|5734690|P1|STARTED|Overall Study||3
2336107|NCT01756560|5734700|P2|NOT COMPLETED|Overall Study||0
2336108|NCT01756560|5734701|P1|NOT COMPLETED|Overall Study||2
2336109|NCT01756560|5734700|P2|COMPLETED|Overall Study||0
2336110|NCT01756560|5734701|P1|COMPLETED|Overall Study||0
2336111|NCT01756560|5734700|P2|STARTED|Overall Study||0
2336112|NCT01756560|5734701|P1|STARTED|Overall Study||2
2336113|NCT01756456|5734713|P6|NOT COMPLETED|Follow Up Period Phase I/II||33
2336114|NCT01756456|5734714|P5|NOT COMPLETED|Follow Up Period Phase I/II||26
2336115|NCT01756456|5734715|P4|NOT COMPLETED|Follow Up Period Phase I/II||33
2336116|NCT01756456|5734716|P3|NOT COMPLETED|Follow Up Period Phase I/II||1
2336117|NCT01756456|5734717|P2|NOT COMPLETED|Follow Up Period Phase I/II||1
2336118|NCT01756456|5734718|P1|NOT COMPLETED|Follow Up Period Phase I/II||1
2336119|NCT01756456|5734713|P6|COMPLETED|Follow Up Period Phase I/II||15
2336120|NCT01756456|5734714|P5|COMPLETED|Follow Up Period Phase I/II||13
2336121|NCT01756456|5734715|P4|COMPLETED|Follow Up Period Phase I/II||12
2336122|NCT01756456|5734716|P3|COMPLETED|Follow Up Period Phase I/II||1
2336123|NCT01756456|5734717|P2|COMPLETED|Follow Up Period Phase I/II||5
2336124|NCT01756456|5734718|P1|COMPLETED|Follow Up Period Phase I/II||5
2336125|NCT01756456|5734713|P6|STARTED|Follow Up Period Phase I/II||48
2336126|NCT01756456|5734714|P5|STARTED|Follow Up Period Phase I/II||39
2336127|NCT01756456|5734715|P4|STARTED|Follow Up Period Phase I/II||45
2336128|NCT01756456|5734716|P3|STARTED|Follow Up Period Phase I/II||2
2336129|NCT01756456|5734717|P2|STARTED|Follow Up Period Phase I/II||6
2336130|NCT01756456|5734718|P1|STARTED|Follow Up Period Phase I/II||6
2336131|NCT01756456|5734713|P6|NOT COMPLETED|Treatment Period: Phase I/II||4
2336132|NCT01756456|5734714|P5|NOT COMPLETED|Treatment Period: Phase I/II||13
2336133|NCT01756456|5734715|P4|NOT COMPLETED|Treatment Period: Phase I/II||7
2336134|NCT01756456|5734716|P3|NOT COMPLETED|Treatment Period: Phase I/II||2
2336135|NCT01756456|5734717|P2|NOT COMPLETED|Treatment Period: Phase I/II||1
2336136|NCT01756456|5734718|P1|NOT COMPLETED|Treatment Period: Phase I/II||1
2336137|NCT01756456|5734713|P6|COMPLETED|Treatment Period: Phase I/II||48
2336138|NCT01756456|5734714|P5|COMPLETED|Treatment Period: Phase I/II||39
2336139|NCT01756456|5734715|P4|COMPLETED|Treatment Period: Phase I/II||45
2336140|NCT01756456|5734716|P3|COMPLETED|Treatment Period: Phase I/II||2
2336141|NCT01756456|5734717|P2|COMPLETED|Treatment Period: Phase I/II||6
2336142|NCT01756456|5734718|P1|COMPLETED|Treatment Period: Phase I/II||6
2336143|NCT01756456|5734713|P6|STARTED|Treatment Period: Phase I/II||52
2336144|NCT01756456|5734714|P5|STARTED|Treatment Period: Phase I/II||52
2336145|NCT01756456|5734715|P4|STARTED|Treatment Period: Phase I/II||52
2336146|NCT01756456|5734716|P3|STARTED|Treatment Period: Phase I/II||4
2336147|NCT01756456|5734717|P2|STARTED|Treatment Period: Phase I/II||7
2336148|NCT01756456|5734718|P1|STARTED|Treatment Period: Phase I/II||7
2336149|NCT01756391|5734816|P1|NOT COMPLETED|Overall Study||32
2336150|NCT01756391|5734816|P1|COMPLETED|Overall Study||319
2336151|NCT01756391|5734816|P1|STARTED|Overall Study||351
2336152|NCT01756352|5734820|P1|NOT COMPLETED|Overall Study||1
2336153|NCT01756352|5734820|P1|COMPLETED|Overall Study||12
2336154|NCT01756352|5734820|P1|STARTED|Overall Study||13
2336155|NCT01756300|5734825|P1|NOT COMPLETED|Overall Study||2
2336156|NCT01756300|5734825|P1|COMPLETED|Overall Study|Subjects with follow up available at 12 months|33
2336157|NCT01756300|5734825|P1|STARTED|Overall Study|Subjects underwent renal denervation treatment with the study catheter.|35
2336158|NCT01756274|5734847|P1|NOT COMPLETED|Overall Study||3
2336159|NCT01756274|5734847|P1|COMPLETED|Overall Study||159
2336160|NCT01756274|5734847|P1|STARTED|Overall Study||162
2336161|NCT01756235|5734854|P1|NOT COMPLETED|Overall Study||2
2336162|NCT01756235|5734854|P1|COMPLETED|Overall Study||460
2336163|NCT01756235|5734854|P1|STARTED|Overall Study||462
2336164|NCT01756157|5734875|P2|NOT COMPLETED|Second Intervention Period||0
2336165|NCT01756157|5734876|P1|NOT COMPLETED|Second Intervention Period||0
2336166|NCT01756157|5734875|P2|COMPLETED|Second Intervention Period||22
2336167|NCT01756157|5734876|P1|COMPLETED|Second Intervention Period||22
2336168|NCT01756157|5734875|P2|STARTED|Second Intervention Period||22
2336169|NCT01756157|5734876|P1|STARTED|Second Intervention Period||22
2336170|NCT01756157|5734875|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2336171|NCT01756157|5734876|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2336172|NCT01756157|5734875|P2|COMPLETED|Washout Period (at Least 7 Days)||22
2336173|NCT01756157|5734876|P1|COMPLETED|Washout Period (at Least 7 Days)||22
2336174|NCT01756157|5734875|P2|STARTED|Washout Period (at Least 7 Days)||22
2336175|NCT01756157|5734876|P1|STARTED|Washout Period (at Least 7 Days)||22
2336176|NCT01756157|5734875|P2|NOT COMPLETED|First Intervention Period||2
2336177|NCT01756157|5734876|P1|NOT COMPLETED|First Intervention Period||1
2336178|NCT01756157|5734875|P2|COMPLETED|First Intervention Period||22
2336179|NCT01756157|5734876|P1|COMPLETED|First Intervention Period||22
2336180|NCT01756157|5734875|P2|STARTED|First Intervention Period||24
2336181|NCT01756157|5734876|P1|STARTED|First Intervention Period||23
2336182|NCT01756079|5734890|P1|NOT COMPLETED|Treatment / Follow-up: Week 4 to Week 72||35
2336183|NCT01756079|5734890|P1|COMPLETED|Treatment / Follow-up: Week 4 to Week 72||23
2336184|NCT01756079|5734890|P1|Treated in Treatment Period|Treatment / Follow-up: Week 4 to Week 72||54
2336185|NCT01756079|5734890|P1|STARTED|Treatment / Follow-up: Week 4 to Week 72||58
2336186|NCT01756079|5734890|P1|NOT COMPLETED|Lead-in: Day 0 to Week 4||0
2336187|NCT01756079|5734890|P1|COMPLETED|Lead-in: Day 0 to Week 4||58
2336188|NCT01756079|5734890|P1|STARTED|Lead-in: Day 0 to Week 4||58
2336189|NCT01756053|5734896|P2|NOT COMPLETED|Period 2 (10 Days)||2
2336190|NCT01756053|5734897|P1|NOT COMPLETED|Period 2 (10 Days)||0
2336191|NCT01756053|5734896|P2|COMPLETED|Period 2 (10 Days)||6
2336192|NCT01756053|5734897|P1|COMPLETED|Period 2 (10 Days)||7
2336193|NCT01756053|5734896|P2|STARTED|Period 2 (10 Days)||8
2336194|NCT01756053|5734897|P1|STARTED|Period 2 (10 Days)||7
2336195|NCT01756053|5734896|P2|NOT COMPLETED|Washout Period (~21 Days)||0
2336196|NCT01756053|5734897|P1|NOT COMPLETED|Washout Period (~21 Days)||0
2336197|NCT01756053|5734896|P2|COMPLETED|Washout Period (~21 Days)||8
2336198|NCT01756053|5734897|P1|COMPLETED|Washout Period (~21 Days)||7
2336199|NCT01756053|5734896|P2|STARTED|Washout Period (~21 Days)||8
2336200|NCT01756053|5734897|P1|STARTED|Washout Period (~21 Days)||7
2336201|NCT01756053|5734896|P2|NOT COMPLETED|Period 1 (10 Days)||1
2336202|NCT01756053|5734897|P1|NOT COMPLETED|Period 1 (10 Days)||1
2336203|NCT01756053|5734896|P2|COMPLETED|Period 1 (10 Days)||8
2336204|NCT01756053|5734897|P1|COMPLETED|Period 1 (10 Days)||7
2336205|NCT01756053|5734896|P2|STARTED|Period 1 (10 Days)||9
2336206|NCT01756053|5734897|P1|STARTED|Period 1 (10 Days)||8
2336207|NCT01755949|5734923|P6|NOT COMPLETED|Overall Study||0
2336208|NCT01755949|5734924|P5|NOT COMPLETED|Overall Study||0
2336209|NCT01755949|5734925|P4|NOT COMPLETED|Overall Study||0
2336210|NCT01755949|5734926|P3|NOT COMPLETED|Overall Study||0
2336211|NCT01755949|5734927|P2|NOT COMPLETED|Overall Study||0
2336212|NCT01755949|5734928|P1|NOT COMPLETED|Overall Study||0
2336213|NCT01755949|5734923|P6|COMPLETED|Overall Study||3
2336214|NCT01755949|5734924|P5|COMPLETED|Overall Study||4
2336215|NCT01755949|5734925|P4|COMPLETED|Overall Study||5
2336216|NCT01755949|5734926|P3|COMPLETED|Overall Study||4
2336217|NCT01755949|5734927|P2|COMPLETED|Overall Study||5
2336218|NCT01755949|5734928|P1|COMPLETED|Overall Study||5
2336219|NCT01755949|5734923|P6|STARTED|Overall Study||3
2336220|NCT01755949|5734924|P5|STARTED|Overall Study||4
2336221|NCT01755949|5734925|P4|STARTED|Overall Study||5
2336222|NCT01755949|5734926|P3|STARTED|Overall Study||4
2336223|NCT01755949|5734927|P2|STARTED|Overall Study||5
2336224|NCT01755949|5734928|P1|STARTED|Overall Study||5
2336225|NCT01755702|5734954|P1|NOT COMPLETED|Period III||0
2336226|NCT01755702|5734954|P1|COMPLETED|Period III||58
2336227|NCT01755702|5734954|P1|Received Ibuprofen|Period III||18
2336228|NCT01755702|5734954|P1|Received Paracetamol/Caffeine|Period III||10
2336229|NCT01755702|5734954|P1|Received Placebo|Period III||13
2336230|NCT01755702|5734954|P1|Received Paracetamol|Period III||17
2336231|NCT01755702|5734954|P1|STARTED|Period III||58
2336232|NCT01755702|5734954|P1|NOT COMPLETED|Washout Period II||5
2336233|NCT01755702|5734954|P1|COMPLETED|Washout Period II||58
2336234|NCT01755702|5734954|P1|STARTED|Washout Period II||63
2336235|NCT01755702|5734954|P1|NOT COMPLETED|Period II||0
2336236|NCT01755702|5734954|P1|COMPLETED|Period II||63
2336237|NCT01755702|5734954|P1|Received Paracetamol|Period II||17
2336238|NCT01755702|5734954|P1|Received Paracetamol/Caffeine|Period II||20
2336239|NCT01755702|5734954|P1|Received Placebo|Period II||15
2336240|NCT01755702|5734954|P1|Received Ibuprofen|Period II||11
2336241|NCT01755702|5734954|P1|STARTED|Period II||63
2336242|NCT01755702|5734954|P1|NOT COMPLETED|Wash Out Period I||3
2336243|NCT01755702|5734954|P1|COMPLETED|Wash Out Period I||63
2336244|NCT01755702|5734954|P1|STARTED|Wash Out Period I||66
2336245|NCT01755702|5734954|P1|NOT COMPLETED|Period I||0
2336246|NCT01755702|5734954|P1|COMPLETED|Period I||66
2336247|NCT01755702|5734954|P1|Received Paracetamol/Caffeine|Period I||17
2336248|NCT01755702|5734954|P1|Received Ibuprofen|Period I||16
2336249|NCT01755702|5734954|P1|Received Placebo|Period I||17
2336250|NCT01755702|5734954|P1|Received Paracetamol|Period I||16
2336251|NCT01755702|5734954|P1|STARTED|Period I||66
2336252|NCT01755689|5735001|P5|NOT COMPLETED|Overall Study||6
2336253|NCT01755689|5735002|P4|NOT COMPLETED|Overall Study||6
2336254|NCT01755689|5735003|P3|NOT COMPLETED|Overall Study||6
2336255|NCT01755689|5735004|P2|NOT COMPLETED|Overall Study||5
2336256|NCT01755689|5735005|P1|NOT COMPLETED|Overall Study||3
2336257|NCT01755689|5735001|P5|COMPLETED|Overall Study||255
2336258|NCT01755689|5735002|P4|COMPLETED|Overall Study||254
2336259|NCT01755689|5735003|P3|COMPLETED|Overall Study||255
2336260|NCT01755689|5735004|P2|COMPLETED|Overall Study||254
2336261|NCT01755689|5735005|P1|COMPLETED|Overall Study||256
2336262|NCT01755689|5735001|P5|STARTED|Overall Study||261
2336263|NCT01755689|5735002|P4|STARTED|Overall Study||260
2336264|NCT01755689|5735003|P3|STARTED|Overall Study||261
2336265|NCT01755689|5735004|P2|STARTED|Overall Study||259
2336266|NCT01755689|5735005|P1|STARTED|Overall Study||259
2336267|NCT01755637|5735080|P2|NOT COMPLETED|Period 2||0
2336268|NCT01755637|5735081|P1|NOT COMPLETED|Period 2||0
2336269|NCT01755637|5735080|P2|COMPLETED|Period 2||27
2336270|NCT01755637|5735081|P1|COMPLETED|Period 2||28
2336271|NCT01755637|5735080|P2|STARTED|Period 2||27
2336272|NCT01755637|5735081|P1|STARTED|Period 2||28
2336273|NCT01755637|5735080|P2|NOT COMPLETED|Period 1||1
2336274|NCT01755637|5735081|P1|NOT COMPLETED|Period 1||0
2336275|NCT01755637|5735080|P2|COMPLETED|Period 1||27
2336276|NCT01755637|5735081|P1|COMPLETED|Period 1||28
2336277|NCT01755637|5735080|P2|STARTED|Period 1||28
2336278|NCT01755637|5735081|P1|STARTED|Period 1||28
2336279|NCT01755598|5735101|P2|NOT COMPLETED|Overall Study||283
2336280|NCT01755598|5735102|P1|NOT COMPLETED|Overall Study||265
2336281|NCT01755598|5735101|P2|COMPLETED|Overall Study||1504
2336282|NCT01755598|5735102|P1|COMPLETED|Overall Study||1521
2336283|NCT01755598|5735101|P2|STARTED|Overall Study||1787
2336284|NCT01755598|5735102|P1|STARTED|Overall Study||1786
2336285|NCT01755546|5735136|P1|NOT COMPLETED|Long Term Treatment||121
2336286|NCT01755546|5735136|P1|COMPLETED|Long Term Treatment||103
2336287|NCT01755546|5735136|P1|STARTED|Long Term Treatment||224
2336288|NCT01755546|5735136|P1|NOT COMPLETED|Titration Phase||70
2336289|NCT01755546|5735136|P1|COMPLETED|Titration Phase||224
2336290|NCT01755546|5735136|P1|STARTED|Titration Phase||294
2336291|NCT01755546|5735136|P1|NOT COMPLETED|Screened and Taper (Rollover and DeNovo)||10
2336292|NCT01755546|5735136|P1|COMPLETED|Screened and Taper (Rollover and DeNovo)||294
2336293|NCT01755546|5735136|P1|STARTED|Screened and Taper (Rollover and DeNovo)||304
2336294|NCT01755455|5735140|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
2336295|NCT01755455|5735141|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
2336296|NCT01755455|5735140|P2|COMPLETED|Second Intervention (6 Weeks)||11
2336297|NCT01755455|5735141|P1|COMPLETED|Second Intervention (6 Weeks)||11
2336298|NCT01755455|5735140|P2|STARTED|Second Intervention (6 Weeks)||11
2336299|NCT01755455|5735141|P1|STARTED|Second Intervention (6 Weeks)||11
2336300|NCT01755455|5735140|P2|NOT COMPLETED|Washout (4 Weeks)||0
2336301|NCT01755455|5735141|P1|NOT COMPLETED|Washout (4 Weeks)||0
2336302|NCT01755455|5735140|P2|COMPLETED|Washout (4 Weeks)||11
2336303|NCT01755455|5735141|P1|COMPLETED|Washout (4 Weeks)||11
2336304|NCT01755455|5735140|P2|STARTED|Washout (4 Weeks)||11
2336305|NCT01755455|5735141|P1|STARTED|Washout (4 Weeks)||11
2336306|NCT01755455|5735140|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
2336307|NCT01755455|5735141|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
2336308|NCT01755455|5735140|P2|COMPLETED|First Intervention (6 Weeks)||11
2336309|NCT01755455|5735141|P1|COMPLETED|First Intervention (6 Weeks)||11
2336310|NCT01755455|5735140|P2|STARTED|First Intervention (6 Weeks)||11
2336311|NCT01755455|5735141|P1|STARTED|First Intervention (6 Weeks)||11
2336312|NCT01755416|5735153|P2|NOT COMPLETED|Second Intervention (Upto 2 Days)||0
2336313|NCT01755416|5735154|P1|NOT COMPLETED|Second Intervention (Upto 2 Days)||0
2336314|NCT01755416|5735153|P2|COMPLETED|Second Intervention (Upto 2 Days)||7
2336315|NCT01755416|5735154|P1|COMPLETED|Second Intervention (Upto 2 Days)||8
2336316|NCT01755416|5735153|P2|STARTED|Second Intervention (Upto 2 Days)||7
2336317|NCT01755416|5735154|P1|STARTED|Second Intervention (Upto 2 Days)||8
2336318|NCT01755416|5735153|P2|NOT COMPLETED|First Intervention ( Upto 2 Days)||2
2336319|NCT01755416|5735154|P1|NOT COMPLETED|First Intervention ( Upto 2 Days)||1
2336320|NCT01755416|5735153|P2|COMPLETED|First Intervention ( Upto 2 Days)||7
2336321|NCT01755416|5735154|P1|COMPLETED|First Intervention ( Upto 2 Days)||8
2336322|NCT01755416|5735153|P2|STARTED|First Intervention ( Upto 2 Days)||9
2336323|NCT01755416|5735154|P1|STARTED|First Intervention ( Upto 2 Days)||9
2336324|NCT01755234|5735162|P2|NOT COMPLETED|Overall Study||8
2336325|NCT01755234|5735163|P1|NOT COMPLETED|Overall Study||15
2336326|NCT01755234|5735162|P2|COMPLETED|Overall Study||37
2336327|NCT01755234|5735163|P1|COMPLETED|Overall Study||30
2336328|NCT01755234|5735162|P2|STARTED|Overall Study||45
2336329|NCT01755234|5735163|P1|STARTED|Overall Study||45
2336330|NCT01755169|5735179|P4|NOT COMPLETED|Overall Study||0
2336331|NCT01755169|5735180|P3|NOT COMPLETED|Overall Study||0
2336332|NCT01755169|5735181|P2|NOT COMPLETED|Overall Study||0
2336333|NCT01755169|5735182|P1|NOT COMPLETED|Overall Study||0
2336334|NCT01755169|5735179|P4|COMPLETED|Overall Study||1
2336335|NCT01755169|5735180|P3|COMPLETED|Overall Study||0
2336336|NCT01755169|5735181|P2|COMPLETED|Overall Study||1
2336337|NCT01755169|5735182|P1|COMPLETED|Overall Study||2
2336338|NCT01755169|5735179|P4|STARTED|Overall Study||1
2336339|NCT01755169|5735180|P3|STARTED|Overall Study||0
2336340|NCT01755169|5735181|P2|STARTED|Overall Study||1
2336341|NCT01755169|5735182|P1|STARTED|Overall Study||2
2336342|NCT01755156|5735194|P2|NOT COMPLETED|Phase B (Weeks 24-104)||36
2336343|NCT01755156|5735195|P1|NOT COMPLETED|Phase B (Weeks 24-104)||39
2336344|NCT01755156|5735194|P2|COMPLETED|Phase B (Weeks 24-104)||141
2336345|NCT01755156|5735195|P1|COMPLETED|Phase B (Weeks 24-104)||144
2336346|NCT01755156|5735194|P2|STARTED|Phase B (Weeks 24-104)||177
2336347|NCT01755156|5735195|P1|STARTED|Phase B (Weeks 24-104)|1 participant who completed Phase A did not continue to Phase B.|183
2336348|NCT01755156|5735194|P2|NOT COMPLETED|Phase A (Weeks 0-24)||24
2336349|NCT01755156|5735195|P1|NOT COMPLETED|Phase A (Weeks 0-24)||17
2336350|NCT01755156|5735194|P2|COMPLETED|Phase A (Weeks 0-24)||177
2336351|NCT01755156|5735195|P1|COMPLETED|Phase A (Weeks 0-24)||184
2336352|NCT01755156|5735194|P2|STARTED|Phase A (Weeks 0-24)||201
2336353|NCT01755156|5735195|P1|STARTED|Phase A (Weeks 0-24)||201
2336354|NCT01755143|5735241|P2|NOT COMPLETED|Overall Study||3
2336355|NCT01755143|5735242|P1|NOT COMPLETED|Overall Study||11
2336356|NCT01755143|5735241|P2|COMPLETED|Overall Study||86
2336357|NCT01755143|5735242|P1|COMPLETED|Overall Study||166
2336358|NCT01755143|5735241|P2|STARTED|Overall Study||89
2336359|NCT01755143|5735242|P1|STARTED|Overall Study||177
2336360|NCT01755091|5735259|P3|NOT COMPLETED|Overall Study||7
2336361|NCT01755091|5735260|P2|NOT COMPLETED|Overall Study||3
2336362|NCT01755091|5735261|P1|NOT COMPLETED|Overall Study||9
2336363|NCT01755091|5735259|P3|COMPLETED|Overall Study||20
2336364|NCT01755091|5735260|P2|COMPLETED|Overall Study||19
2336365|NCT01755091|5735261|P1|COMPLETED|Overall Study||17
2336366|NCT01755091|5735259|P3|STARTED|Overall Study||27
2336367|NCT01755091|5735260|P2|STARTED|Overall Study||22
2336368|NCT01755091|5735261|P1|STARTED|Overall Study||26
2336369|NCT01755026|5735286|P2|NOT COMPLETED|Overall Study||1
2336370|NCT01755026|5735287|P1|NOT COMPLETED|Overall Study||2
2336371|NCT01755026|5735286|P2|COMPLETED|Overall Study||11
2336372|NCT01755026|5735287|P1|COMPLETED|Overall Study||9
2336373|NCT01755026|5735286|P2|STARTED|Overall Study||12
2336374|NCT01755026|5735287|P1|STARTED|Overall Study||11
2336375|NCT01754987|5735295|P2|NOT COMPLETED|Overall Study||0
2336376|NCT01754987|5735296|P1|NOT COMPLETED|Overall Study||0
2336377|NCT01754987|5735295|P2|COMPLETED|Overall Study||0
2336378|NCT01754987|5735296|P1|COMPLETED|Overall Study||5
2336379|NCT01754987|5735295|P2|STARTED|Overall Study||0
2336380|NCT01754987|5735296|P1|STARTED|Overall Study||5
2336381|NCT01754922|5735310|P2|NOT COMPLETED|Overall Study||1
2336382|NCT01754922|5735311|P1|NOT COMPLETED|Overall Study||0
2336383|NCT01754922|5735310|P2|COMPLETED|Overall Study||17
2336384|NCT01754922|5735311|P1|COMPLETED|Overall Study||32
2336385|NCT01754922|5735310|P2|STARTED|Overall Study||18
2336386|NCT01754922|5735311|P1|STARTED|Overall Study||32
2336387|NCT01754909|5735323|P2|NOT COMPLETED|Overall Study||0
2336388|NCT01754909|5735324|P1|NOT COMPLETED|Overall Study||0
2336389|NCT01754909|5735323|P2|COMPLETED|Overall Study||23
2336390|NCT01754909|5735324|P1|COMPLETED|Overall Study||20
2336391|NCT01754909|5735323|P2|STARTED|Overall Study||23
2336392|NCT01754909|5735324|P1|STARTED|Overall Study||20
2336393|NCT01754766|5735337|P3|NOT COMPLETED|Overall Study||0
2336394|NCT01754766|5735338|P2|NOT COMPLETED|Overall Study||1
2336395|NCT01754766|5735339|P1|NOT COMPLETED|Overall Study||1
2336396|NCT01754766|5735337|P3|COMPLETED|Overall Study||30
2336397|NCT01754766|5735338|P2|COMPLETED|Overall Study||28
2336398|NCT01754766|5735339|P1|COMPLETED|Overall Study||30
2336399|NCT01754766|5735337|P3|STARTED|Overall Study||30
2336400|NCT01754766|5735338|P2|STARTED|Overall Study||29
2336401|NCT01754766|5735339|P1|STARTED|Overall Study||31
2336402|NCT01754727|5735353|P1|NOT COMPLETED|Overall Study||2
2336403|NCT01754727|5735353|P1|COMPLETED|Overall Study||450
2336404|NCT01754727|5735353|P1|STARTED|Overall Study||452
2336405|NCT01754714|5735371|P4|NOT COMPLETED|Overall Study||1
2336406|NCT01754714|5735372|P3|NOT COMPLETED|Overall Study||2
2336407|NCT01754714|5735373|P2|NOT COMPLETED|Overall Study||1
2336408|NCT01754714|5735374|P1|NOT COMPLETED|Overall Study||0
2336409|NCT01754714|5735371|P4|COMPLETED|Overall Study||27
2336410|NCT01754714|5735372|P3|COMPLETED|Overall Study||24
2336411|NCT01754714|5735373|P2|COMPLETED|Overall Study||26
2336412|NCT01754714|5735374|P1|COMPLETED|Overall Study||27
2336413|NCT01754714|5735371|P4|STARTED|Overall Study||28
2336414|NCT01754714|5735372|P3|STARTED|Overall Study||26
2336415|NCT01754714|5735373|P2|STARTED|Overall Study||27
2336416|NCT01754714|5735374|P1|STARTED|Overall Study||27
2336417|NCT01754688|5735464|P1|NOT COMPLETED|Overall Study||0
2336418|NCT01754688|5735464|P1|COMPLETED|Overall Study||624
2336419|NCT01754688|5735464|P1|STARTED|Overall Study||624
2336420|NCT01754623|5735469|P1|NOT COMPLETED|Overall Study||0
2336421|NCT01754623|5735469|P1|COMPLETED|Overall Study||9
2336422|NCT01754623|5735469|P1|STARTED|Overall Study||9
2336423|NCT01754519|5735476|P1|NOT COMPLETED|Overall Study||0
2336424|NCT01754519|5735476|P1|COMPLETED|Overall Study||1
2336425|NCT01754519|5735476|P1|STARTED|Overall Study||1
2336426|NCT01754493|5735485|P1|NOT COMPLETED|Overall Study||7
2336427|NCT01754493|5735485|P1|COMPLETED|Overall Study||10
2336428|NCT01754493|5735485|P1|STARTED|Overall Study||17
2336429|NCT01754480|5735495|P2|NOT COMPLETED|Primary Part II||11
2336430|NCT01754480|5735496|P1|NOT COMPLETED|Primary Part II||15
2336431|NCT01754480|5735495|P2|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|102
2336432|NCT01754480|5735496|P1|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|96
2336433|NCT01754480|5735495|P2|Completed Study up to Week 6|Primary Part II||108
2336434|NCT01754480|5735496|P1|Completed Study up to Week 6|Primary Part II||100
2336435|NCT01754480|5735495|P2|STARTED|Primary Part II||113
2336436|NCT01754480|5735496|P1|STARTED|Primary Part II||111
2336437|NCT01754480|5735495|P2|NOT COMPLETED|Part I + Part II (Overall Study)||23
2336438|NCT01754480|5735496|P1|NOT COMPLETED|Part I + Part II (Overall Study)||25
2336439|NCT01754480|5735495|P2|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 3 pediatric subjects)|139
2336440|NCT01754480|5735496|P1|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 2 pediatric subjects)|138
2336441|NCT01754480|5735495|P2|Completed Study up to Week 6|Part I + Part II (Overall Study)||153
2336532|NCT01753557|5735737|P1|COMPLETED|Overall Study||35
2336442|NCT01754480|5735496|P1|Completed Study up to Week 6|Part I + Part II (Overall Study)||147
2336443|NCT01754480|5735495|P2|STARTED|Part I + Part II (Overall Study)||162
2336444|NCT01754480|5735496|P1|STARTED|Part I + Part II (Overall Study)||163
2336445|NCT01754467|5735510|P1|NOT COMPLETED|Overall Study||1
2336446|NCT01754467|5735510|P1|COMPLETED|Overall Study||8
2336447|NCT01754467|5735510|P1|STARTED|Overall Study||9
2336448|NCT01754402|5735520|P3|NOT COMPLETED|Overall Study||4
2336449|NCT01754402|5735521|P2|NOT COMPLETED|Overall Study||2
2336450|NCT01754402|5735522|P1|NOT COMPLETED|Overall Study||2
2336451|NCT01754402|5735520|P3|COMPLETED|Overall Study||26
2336452|NCT01754402|5735521|P2|COMPLETED|Overall Study||0
2336453|NCT01754402|5735522|P1|COMPLETED|Overall Study||4
2336454|NCT01754402|5735520|P3|STARTED|Overall Study||30
2336455|NCT01754402|5735521|P2|STARTED|Overall Study||2
2336456|NCT01754402|5735522|P1|STARTED|Overall Study||6
2336457|NCT01754389|5735534|P3|NOT COMPLETED|Overall Study||0
2336458|NCT01754389|5735535|P2|NOT COMPLETED|Overall Study||0
2336459|NCT01754389|5735536|P1|NOT COMPLETED|Overall Study||0
2336460|NCT01754389|5735534|P3|COMPLETED|Overall Study||47
2336461|NCT01754389|5735535|P2|COMPLETED|Overall Study||45
2336462|NCT01754389|5735536|P1|COMPLETED|Overall Study||46
2336463|NCT01754389|5735534|P3|STARTED|Overall Study||47
2336464|NCT01754389|5735535|P2|STARTED|Overall Study||45
2336465|NCT01754389|5735536|P1|STARTED|Overall Study||46
2336466|NCT01754376|5735556|P1|NOT COMPLETED|Overall Study||3
2336467|NCT01754376|5735556|P1|COMPLETED|Overall Study||3
2336468|NCT01754376|5735556|P1|Completed 2-week Lead in of Vemurafenib|Overall Study||6
2336469|NCT01754376|5735556|P1|STARTED|Overall Study||6
2336470|NCT01754259|5735567|P2|NOT COMPLETED|Overall Study||6
2336471|NCT01754259|5735568|P1|NOT COMPLETED|Overall Study||5
2336472|NCT01754259|5735567|P2|COMPLETED|Overall Study||18
2336473|NCT01754259|5735568|P1|COMPLETED|Overall Study||18
2336474|NCT01754259|5735567|P2|STARTED|Overall Study||24
2336475|NCT01754259|5735568|P1|STARTED|Overall Study||23
2336476|NCT01754194|5735578|P2|NOT COMPLETED|Overall Study||27
2336477|NCT01754194|5735579|P1|NOT COMPLETED|Overall Study||52
2336478|NCT01754194|5735578|P2|COMPLETED|Overall Study||97
2336479|NCT01754194|5735579|P1|COMPLETED|Overall Study||117
2336480|NCT01754194|5735578|P2|STARTED|Overall Study||124
2336481|NCT01754194|5735579|P1|STARTED|Overall Study||169
2336482|NCT01754129|5735599|P1|NOT COMPLETED|Overall Study||33
2336483|NCT01754129|5735599|P1|COMPLETED|Overall Study||115
2336484|NCT01754129|5735599|P1|Visit 3 (Year 2)|Overall Study||115
2336485|NCT01754129|5735599|P1|Visit 2 (Year 1)|Overall Study||129
2336486|NCT01754129|5735599|P1|Visit 1 (Enrollment Day)|Overall Study||145
2336487|NCT01754129|5735599|P1|STARTED|Overall Study||148
2336488|NCT01753999|5735622|P2|NOT COMPLETED|Period 2 -Cross to Alternate Arm||23
2336489|NCT01753999|5735623|P1|NOT COMPLETED|Period 2 -Cross to Alternate Arm||17
2336490|NCT01753999|5735622|P2|COMPLETED|Period 2 -Cross to Alternate Arm||89
2336491|NCT01753999|5735623|P1|COMPLETED|Period 2 -Cross to Alternate Arm||99
2336492|NCT01753999|5735622|P2|Received Intervention|Period 2 -Cross to Alternate Arm||95
2336493|NCT01753999|5735623|P1|Received Intervention|Period 2 -Cross to Alternate Arm||103
2336494|NCT01753999|5735622|P2|STARTED|Period 2 -Cross to Alternate Arm||112
2336495|NCT01753999|5735623|P1|STARTED|Period 2 -Cross to Alternate Arm||116
2336496|NCT01753999|5735622|P2|NOT COMPLETED|Period 1 - Initial Assignment||50
2336497|NCT01753999|5735623|P1|NOT COMPLETED|Period 1 - Initial Assignment||39
2336498|NCT01753999|5735622|P2|COMPLETED|Period 1 - Initial Assignment||112
2336499|NCT01753999|5735623|P1|COMPLETED|Period 1 - Initial Assignment||116
2336500|NCT01753999|5735622|P2|Received Intervention|Period 1 - Initial Assignment||146
2336501|NCT01753999|5735623|P1|Received Intervention|Period 1 - Initial Assignment||144
2336502|NCT01753999|5735622|P2|STARTED|Period 1 - Initial Assignment||162
2336503|NCT01753999|5735623|P1|STARTED|Period 1 - Initial Assignment||155
2336504|NCT01753856|5735637|P2|NOT COMPLETED|Overall Study||2
2336505|NCT01753856|5735638|P1|NOT COMPLETED|Overall Study||3
2336506|NCT01753856|5735637|P2|COMPLETED|Overall Study||34
2336507|NCT01753856|5735638|P1|COMPLETED|Overall Study||30
2336508|NCT01753856|5735637|P2|Completed 3-Month Bone Biopsy|Overall Study||35
2336509|NCT01753856|5735638|P1|Completed 3-Month Bone Biopsy|Overall Study||31
2336510|NCT01753856|5735637|P2|Received at Least 1 Dose of Study Drug|Overall Study||36
2336511|NCT01753856|5735638|P1|Received at Least 1 Dose of Study Drug|Overall Study||33
2336512|NCT01753856|5735637|P2|STARTED|Overall Study||36
2336513|NCT01753856|5735638|P1|STARTED|Overall Study||33
2336514|NCT01753713|5735690|P2|NOT COMPLETED|Overall Study||0
2336515|NCT01753713|5735691|P1|NOT COMPLETED|Overall Study||0
2336516|NCT01753713|5735690|P2|COMPLETED|Overall Study||19
2336517|NCT01753713|5735691|P1|COMPLETED|Overall Study||14
2336518|NCT01753713|5735690|P2|STARTED|Overall Study||19
2336519|NCT01753713|5735691|P1|STARTED|Overall Study||14
2336520|NCT01753570|5735710|P3|NOT COMPLETED|Overall Study||1
2336521|NCT01753570|5735711|P2|NOT COMPLETED|Overall Study||5
2336522|NCT01753570|5735712|P1|NOT COMPLETED|Overall Study||2
2336523|NCT01753570|5735710|P3|COMPLETED|Overall Study||13
2336524|NCT01753570|5735711|P2|COMPLETED|Overall Study||25
2336525|NCT01753570|5735712|P1|COMPLETED|Overall Study||28
2336526|NCT01753570|5735710|P3|STARTED|Overall Study||14
2336527|NCT01753570|5735711|P2|STARTED|Overall Study||30
2336528|NCT01753570|5735712|P1|STARTED|Overall Study||30
2336529|NCT01753557|5735736|P2|NOT COMPLETED|Overall Study||0
2336530|NCT01753557|5735737|P1|NOT COMPLETED|Overall Study||0
2336531|NCT01753557|5735736|P2|COMPLETED|Overall Study||19
2336533|NCT01753557|5735736|P2|STARTED|Overall Study||19
2336534|NCT01753557|5735737|P1|STARTED|Overall Study||35
2336535|NCT01753518|5735755|P2|NOT COMPLETED|Postpartum Follow-up||15
2336536|NCT01753518|5735756|P1|NOT COMPLETED|Postpartum Follow-up||22
2336537|NCT01753518|5735755|P2|COMPLETED|Postpartum Follow-up||88
2336538|NCT01753518|5735756|P1|COMPLETED|Postpartum Follow-up||81
2336539|NCT01753518|5735755|P2|STARTED|Postpartum Follow-up||103
2336540|NCT01753518|5735756|P1|STARTED|Postpartum Follow-up||103
2336541|NCT01753518|5735755|P2|NOT COMPLETED|Intention-to-Treat Analysis||7
2336542|NCT01753518|5735756|P1|NOT COMPLETED|Intention-to-Treat Analysis||7
2336543|NCT01753518|5735755|P2|COMPLETED|Intention-to-Treat Analysis||103
2336544|NCT01753518|5735756|P1|COMPLETED|Intention-to-Treat Analysis||103
2336545|NCT01753518|5735755|P2|STARTED|Intention-to-Treat Analysis||110
2336546|NCT01753518|5735756|P1|STARTED|Intention-to-Treat Analysis||110
2336547|NCT01753362|5735780|P2|NOT COMPLETED|Overall Study||8
2336548|NCT01753362|5735781|P1|NOT COMPLETED|Overall Study||10
2336549|NCT01753362|5735780|P2|COMPLETED|Overall Study||40
2336550|NCT01753362|5735781|P1|COMPLETED|Overall Study||26
2336551|NCT01753362|5735780|P2|STARTED|Overall Study||48
2336552|NCT01753362|5735781|P1|STARTED|Overall Study||36
2336553|NCT01753336|5735789|P1|NOT COMPLETED|Overall Study||20
2336554|NCT01753336|5735789|P1|COMPLETED|Overall Study||92
2336555|NCT01753336|5735789|P1|Cycle 3|Overall Study||93
2336556|NCT01753336|5735789|P1|Cycle 2|Overall Study||98
2336557|NCT01753336|5735789|P1|Cycle 1|Overall Study||112
2336558|NCT01753336|5735789|P1|STARTED|Overall Study||112
2336559|NCT01753323|5735801|P3|NOT COMPLETED|Overall Study||9
2336560|NCT01753323|5735802|P2|NOT COMPLETED|Overall Study||0
2336561|NCT01753323|5735803|P1|NOT COMPLETED|Overall Study||1
2336562|NCT01753323|5735801|P3|COMPLETED|Overall Study||13
2336563|NCT01753323|5735802|P2|COMPLETED|Overall Study||10
2336564|NCT01753323|5735803|P1|COMPLETED|Overall Study||10
2336565|NCT01753323|5735801|P3|Intent-to-treat Analysis Set|Overall Study||22
2336566|NCT01753323|5735802|P2|Intent-to-treat Analysis Set|Overall Study||10
2336567|NCT01753323|5735803|P1|Intent-to-treat Analysis Set|Overall Study||11
2336568|NCT01753323|5735801|P3|Safety Set|Overall Study||22
2336569|NCT01753323|5735802|P2|Safety Set|Overall Study||10
2336570|NCT01753323|5735803|P1|Safety Set|Overall Study||11
2336571|NCT01753323|5735801|P3|Pharmacokinetic(PK) Set|Overall Study||21
2336572|NCT01753323|5735802|P2|Pharmacokinetic(PK) Set|Overall Study||10
2336573|NCT01753323|5735803|P1|Pharmacokinetic(PK) Set|Overall Study||10
2336574|NCT01753323|5735801|P3|Pharmacodynamic (PD) Set|Overall Study||21
2336575|NCT01753323|5735802|P2|Pharmacodynamic (PD) Set|Overall Study||10
2336576|NCT01753323|5735803|P1|Pharmacodynamic (PD) Set|Overall Study||10
2336577|NCT01753323|5735801|P3|STARTED|Overall Study||22
2336578|NCT01753323|5735802|P2|STARTED|Overall Study||10
2336579|NCT01753323|5735803|P1|STARTED|Overall Study||11
2336580|NCT01753310|5735841|P2|NOT COMPLETED|Overall Study||24
2336581|NCT01753310|5735842|P1|NOT COMPLETED|Overall Study||32
2336582|NCT01753310|5735841|P2|COMPLETED|Overall Study||21
2336583|NCT01753310|5735842|P1|COMPLETED|Overall Study||57
2336584|NCT01753310|5735841|P2|STARTED|Overall Study||45
2336585|NCT01753310|5735842|P1|STARTED|Overall Study||89
2336586|NCT01753193|5735862|P1|NOT COMPLETED|Overall Study||46
2336587|NCT01753193|5735862|P1|COMPLETED|Overall Study||172
2336588|NCT01753193|5735862|P1|STARTED|Overall Study||218
2336589|NCT01753115|5735877|P3|NOT COMPLETED|Overall Study||14
2336590|NCT01753115|5735878|P2|NOT COMPLETED|Overall Study||15
2336591|NCT01753115|5735879|P1|NOT COMPLETED|Overall Study||12
2336592|NCT01753115|5735877|P3|COMPLETED|Overall Study||56
2336593|NCT01753115|5735878|P2|COMPLETED|Overall Study||25
2336594|NCT01753115|5735879|P1|COMPLETED|Overall Study||32
2336595|NCT01753115|5735877|P3|Treated|Overall Study||67
2336596|NCT01753115|5735878|P2|Treated|Overall Study||39
2336597|NCT01753115|5735879|P1|Treated|Overall Study||38
2336598|NCT01753115|5735877|P3|STARTED|Overall Study||70
2336599|NCT01753115|5735878|P2|STARTED|Overall Study||40
2336600|NCT01753115|5735879|P1|STARTED|Overall Study||44
2336601|NCT01753076|5735889|P2|NOT COMPLETED|Overall Study||46
2336602|NCT01753076|5735890|P1|NOT COMPLETED|Overall Study||41
2336603|NCT01753076|5735889|P2|COMPLETED|Overall Study||106
2336604|NCT01753076|5735890|P1|COMPLETED|Overall Study||110
2336605|NCT01753076|5735889|P2|STARTED|Overall Study||152
2336606|NCT01753076|5735890|P1|STARTED|Overall Study||151
2336607|NCT01752985|5735917|P3|NOT COMPLETED|Follow-up Period||0
2336608|NCT01752985|5735918|P2|NOT COMPLETED|Follow-up Period||0
2336609|NCT01752985|5735919|P1|NOT COMPLETED|Follow-up Period||0
2336610|NCT01752985|5735917|P3|COMPLETED|Follow-up Period||26
2336611|NCT01752985|5735918|P2|COMPLETED|Follow-up Period||27
2336612|NCT01752985|5735919|P1|COMPLETED|Follow-up Period||28
2336613|NCT01752985|5735917|P3|STARTED|Follow-up Period|Includes 24 participants in this period and 2 participants re-joined for follow-up|26
2336614|NCT01752985|5735918|P2|STARTED|Follow-up Period||27
2336615|NCT01752985|5735919|P1|STARTED|Follow-up Period|Includes 25 participants in this period and 3 participants re-joined for follow-up|28
2336616|NCT01752985|5735917|P3|NOT COMPLETED|Treatment Period||5
2336617|NCT01752985|5735918|P2|NOT COMPLETED|Treatment Period||3
2336618|NCT01752985|5735919|P1|NOT COMPLETED|Treatment Period||4
2336619|NCT01752985|5735917|P3|COMPLETED|Treatment Period||24
2336620|NCT01752985|5735918|P2|COMPLETED|Treatment Period||27
2336621|NCT01752985|5735919|P1|COMPLETED|Treatment Period||25
2336622|NCT01752985|5735917|P3|STARTED|Treatment Period||29
2336623|NCT01752985|5735918|P2|STARTED|Treatment Period||30
2336624|NCT01752985|5735919|P1|STARTED|Treatment Period||29
2336625|NCT01752933|5735947|P2|NOT COMPLETED|Overall Study and Follow-up||46
2336626|NCT01752933|5735948|P1|NOT COMPLETED|Overall Study and Follow-up||4
2336627|NCT01752933|5735947|P2|COMPLETED|Overall Study and Follow-up|Completion not applicable for this survival study|0
2336628|NCT01752933|5735948|P1|COMPLETED|Overall Study and Follow-up|Completion not applicable for this survival study|0
2336629|NCT01752933|5735947|P2|STARTED|Overall Study and Follow-up|Includes all patients who received any treatment|46
2336630|NCT01752933|5735948|P1|STARTED|Overall Study and Follow-up|Includes all patients who received any treatment|4
2336631|NCT01752933|5735947|P2|NOT COMPLETED|Treatment||46
2336632|NCT01752933|5735948|P1|NOT COMPLETED|Treatment||4
2336633|NCT01752933|5735947|P2|COMPLETED|Treatment|Completion not applicable for this survival study|0
2336634|NCT01752933|5735948|P1|COMPLETED|Treatment|Completion not applicable for this survival study|0
2336635|NCT01752933|5735947|P2|STARTED|Treatment|Includes all patients who received any treatment|46
2336636|NCT01752933|5735948|P1|STARTED|Treatment|Includes all patients who received any treatment|4
2336637|NCT01752907|5735966|P2|NOT COMPLETED|Overall Study||20
2336638|NCT01752907|5735967|P1|NOT COMPLETED|Overall Study||12
2336639|NCT01752907|5735966|P2|COMPLETED|Overall Study||133
2336640|NCT01752907|5735967|P1|COMPLETED|Overall Study||139
2336641|NCT01752907|5735966|P2|Received Pegfilgrastim|Overall Study||151
2336642|NCT01752907|5735967|P1|Received Pegfilgrastim|Overall Study||149
2336643|NCT01752907|5735966|P2|STARTED|Overall Study||153
2336644|NCT01752907|5735967|P1|STARTED|Overall Study||151
2336645|NCT01752855|5735987|P2|NOT COMPLETED|Overall Study||4
2336646|NCT01752855|5735988|P1|NOT COMPLETED|Overall Study||1
2336647|NCT01752855|5735987|P2|COMPLETED|Overall Study||40
2336648|NCT01752855|5735988|P1|COMPLETED|Overall Study||43
2336649|NCT01752855|5735987|P2|STARTED|Overall Study||44
2336650|NCT01752855|5735988|P1|STARTED|Overall Study||44
2336651|NCT01752842|5736004|P2|NOT COMPLETED|Overall Study||2
2336652|NCT01752842|5736005|P1|NOT COMPLETED|Overall Study||3
2336653|NCT01752842|5736004|P2|COMPLETED|Overall Study||34
2336654|NCT01752842|5736005|P1|COMPLETED|Overall Study||31
2336655|NCT01752842|5736004|P2|STARTED|Overall Study||36
2336656|NCT01752842|5736005|P1|STARTED|Overall Study||34
2336657|NCT01752712|5736017|P2|NOT COMPLETED|Overall Study||10
2336658|NCT01752712|5736018|P1|NOT COMPLETED|Overall Study||9
2336659|NCT01752712|5736017|P2|COMPLETED|Overall Study||21
2336660|NCT01752712|5736018|P1|COMPLETED|Overall Study||22
2336661|NCT01752712|5736017|P2|STARTED|Overall Study||31
2336662|NCT01752712|5736018|P1|STARTED|Overall Study||31
2336666|NCT01752400|5736039|P1|NOT COMPLETED|Overall Study||0
2336667|NCT01752400|5736039|P1|COMPLETED|Overall Study||6
2336668|NCT01752400|5736039|P1|STARTED|Overall Study||6
2336669|NCT01752023|5736052|P2|NOT COMPLETED|Overall Study||1
2336670|NCT01752023|5736053|P1|NOT COMPLETED|Overall Study||2
2336671|NCT01752023|5736052|P2|COMPLETED|Overall Study||0
2336672|NCT01752023|5736053|P1|COMPLETED|Overall Study||0
2336673|NCT01752023|5736052|P2|STARTED|Overall Study||1
2336674|NCT01752023|5736053|P1|STARTED|Overall Study||2
2336675|NCT01751971|5736071|P2|NOT COMPLETED|Overall Study||1
2336676|NCT01751971|5736072|P1|NOT COMPLETED|Overall Study||2
2336677|NCT01751971|5736071|P2|COMPLETED|Overall Study||24
2336678|NCT01751971|5736072|P1|COMPLETED|Overall Study||20
2336679|NCT01751971|5736071|P2|STARTED|Overall Study||25
2336680|NCT01751971|5736072|P1|STARTED|Overall Study||22
2336681|NCT01751906|5736089|P2|NOT COMPLETED|Overall Study||47
2336682|NCT01751906|5736090|P1|NOT COMPLETED|Overall Study||84
2336683|NCT01751906|5736089|P2|COMPLETED|Overall Study||639
2336684|NCT01751906|5736090|P1|COMPLETED|Overall Study||1238
2336685|NCT01751906|5736089|P2|STARTED|Overall Study||686
2336686|NCT01751906|5736090|P1|STARTED|Overall Study||1322
2336687|NCT01751867|5736294|P2|NOT COMPLETED|Overall Study||99
2336688|NCT01751867|5736295|P1|NOT COMPLETED|Overall Study||36
2336689|NCT01751867|5736294|P2|COMPLETED|Overall Study||0
2336690|NCT01751867|5736295|P1|COMPLETED|Overall Study||0
2336691|NCT01751867|5736294|P2|Treated|Overall Study||98
2336692|NCT01751867|5736295|P1|Treated|Overall Study||34
2336693|NCT01751867|5736294|P2|STARTED|Overall Study||99
2336694|NCT01751867|5736295|P1|STARTED|Overall Study||36
2336695|NCT01751802|5736315|P2|NOT COMPLETED|Overall Study||2
2336696|NCT01751802|5736316|P1|NOT COMPLETED|Overall Study||4
2336697|NCT01751802|5736315|P2|COMPLETED|Overall Study||2
2336698|NCT01751802|5736316|P1|COMPLETED|Overall Study||1
2336699|NCT01751802|5736315|P2|Completed Period 3|Overall Study||1
2336700|NCT01751802|5736316|P1|Completed Period 3|Overall Study||2
2336701|NCT01751802|5736315|P2|Completed Period 2|Overall Study||1
2336702|NCT01751802|5736316|P1|Completed Period 2|Overall Study||2
2336703|NCT01751802|5736315|P2|Completed Period 1|Overall Study||4
2336704|NCT01751802|5736316|P1|Completed Period 1|Overall Study||2
2336705|NCT01751802|5736315|P2|STARTED|Overall Study||4
2336706|NCT01751802|5736316|P1|STARTED|Overall Study||5
2336707|NCT01751724|5736330|P2|NOT COMPLETED|Overall Study||2
2336708|NCT01751724|5736331|P1|NOT COMPLETED|Overall Study||1
2336709|NCT01751724|5736330|P2|COMPLETED|Overall Study||42
2336710|NCT01751724|5736331|P1|COMPLETED|Overall Study||41
2336711|NCT01751724|5736330|P2|STARTED|Overall Study||44
2336712|NCT01751724|5736331|P1|STARTED|Overall Study||42
2336713|NCT01751646|5736359|P2|NOT COMPLETED|Overall Study||18
2336714|NCT01751646|5736360|P1|NOT COMPLETED|Overall Study||11
2336715|NCT01751646|5736359|P2|COMPLETED|Overall Study||87
2336716|NCT01751646|5736360|P1|COMPLETED|Overall Study||98
2336717|NCT01751646|5736359|P2|STARTED|Overall Study||105
2336718|NCT01751646|5736360|P1|STARTED|Overall Study||109
2336719|NCT01751412|5736508|P1|NOT COMPLETED|Overall Study||1
2336720|NCT01751412|5736508|P1|COMPLETED|Overall Study||11
2336721|NCT01751412|5736508|P1|STARTED|Overall Study||12
2336722|NCT01751399|5736522|P4|NOT COMPLETED|Overall Study||0
2336723|NCT01751399|5736523|P3|NOT COMPLETED|Overall Study||0
2336724|NCT01751399|5736524|P2|NOT COMPLETED|Overall Study||0
2336725|NCT01751399|5736525|P1|NOT COMPLETED|Overall Study||0
2336726|NCT01751399|5736522|P4|COMPLETED|Overall Study||7
2336727|NCT01751399|5736523|P3|COMPLETED|Overall Study||8
2336728|NCT01751399|5736524|P2|COMPLETED|Overall Study||8
2336729|NCT01751399|5736525|P1|COMPLETED|Overall Study||12
2336730|NCT01751399|5736522|P4|Received 1 Dose of Study Drug|Overall Study||7
2336731|NCT01751399|5736523|P3|Received 1 Dose of Study Drug|Overall Study||8
2336732|NCT01751399|5736524|P2|Received 1 Dose of Study Drug|Overall Study||8
2336733|NCT01751399|5736525|P1|Received 1 Dose of Study Drug|Overall Study||12
2336734|NCT01751399|5736522|P4|STARTED|Overall Study||7
2336735|NCT01751399|5736523|P3|STARTED|Overall Study||8
2336736|NCT01751399|5736524|P2|STARTED|Overall Study||8
2336737|NCT01751399|5736525|P1|STARTED|Overall Study||12
2336738|NCT01751386|5736541|P2|NOT COMPLETED|Overall Study||3
2336739|NCT01751386|5736542|P1|NOT COMPLETED|Overall Study||2
2336740|NCT01751386|5736541|P2|COMPLETED|Overall Study||16
2336741|NCT01751386|5736542|P1|COMPLETED|Overall Study||18
2336742|NCT01751386|5736541|P2|STARTED|Overall Study||19
2336743|NCT01751386|5736542|P1|STARTED|Overall Study||20
2336744|NCT01751308|5736553|P5|NOT COMPLETED|Phase 2||0
2336745|NCT01751308|5736554|P4|NOT COMPLETED|Phase 2||0
2336746|NCT01751308|5736555|P3|NOT COMPLETED|Phase 2||0
2336747|NCT01751308|5736556|P2|NOT COMPLETED|Phase 2||0
2336748|NCT01751308|5736557|P1|NOT COMPLETED|Phase 2||0
2336749|NCT01751308|5736553|P5|COMPLETED|Phase 2|DP, AE and death were considered as completed (defined in protocol)|16
2336750|NCT01751308|5736554|P4|COMPLETED|Phase 2||0
2336751|NCT01751308|5736555|P3|COMPLETED|Phase 2||0
2336752|NCT01751308|5736556|P2|COMPLETED|Phase 2||0
2336753|NCT01751308|5736557|P1|COMPLETED|Phase 2||0
2336754|NCT01751308|5736553|P5|STARTED|Phase 2|Phase 1 and Phase 2 were separate populations.|16
2336755|NCT01751308|5736554|P4|STARTED|Phase 2||0
2336756|NCT01751308|5736555|P3|STARTED|Phase 2||0
2336757|NCT01751308|5736556|P2|STARTED|Phase 2||0
2336758|NCT01751308|5736557|P1|STARTED|Phase 2||0
2336759|NCT01751308|5736553|P5|NOT COMPLETED|Phase 1||0
2336760|NCT01751308|5736554|P4|NOT COMPLETED|Phase 1||0
2336761|NCT01751308|5736555|P3|NOT COMPLETED|Phase 1||0
2336762|NCT01751308|5736556|P2|NOT COMPLETED|Phase 1||0
2336763|NCT01751308|5736557|P1|NOT COMPLETED|Phase 1||0
2336764|NCT01751308|5736553|P5|COMPLETED|Phase 1||0
2336765|NCT01751308|5736554|P4|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
2336766|NCT01751308|5736555|P3|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
2336767|NCT01751308|5736556|P2|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|3
2336768|NCT01751308|5736557|P1|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|6
2336769|NCT01751308|5736553|P5|STARTED|Phase 1|Phase 1 and Phase 2 were separate populations.|0
2336770|NCT01751308|5736554|P4|STARTED|Phase 1||7
2336771|NCT01751308|5736555|P3|STARTED|Phase 1||7
2336772|NCT01751308|5736556|P2|STARTED|Phase 1||3
2336773|NCT01751308|5736557|P1|STARTED|Phase 1||6
2336774|NCT01751230|5736596|P2|NOT COMPLETED|Overall Study||4
2336775|NCT01751230|5736597|P1|NOT COMPLETED|Overall Study||1
2336776|NCT01751230|5736596|P2|COMPLETED|Overall Study||16
2336777|NCT01751230|5736597|P1|COMPLETED|Overall Study||19
2336778|NCT01751230|5736596|P2|STARTED|Overall Study||20
2336779|NCT01751230|5736597|P1|STARTED|Overall Study||20
2336780|NCT01751178|5736618|P3|NOT COMPLETED|Overall Study||2
2336781|NCT01751178|5736619|P2|NOT COMPLETED|Overall Study||0
2336782|NCT01751178|5736620|P1|NOT COMPLETED|Overall Study||3
2336783|NCT01751178|5736618|P3|COMPLETED|Overall Study||105
2336784|NCT01751178|5736619|P2|COMPLETED|Overall Study||109
2336785|NCT01751178|5736620|P1|COMPLETED|Overall Study||105
2336786|NCT01751178|5736618|P3|STARTED|Overall Study||107
2336787|NCT01751178|5736619|P2|STARTED|Overall Study||109
2336788|NCT01751178|5736620|P1|STARTED|Overall Study||108
2336789|NCT01751165|5736640|P3|NOT COMPLETED|Overall Study||3
2336790|NCT01751165|5736641|P2|NOT COMPLETED|Overall Study||3
2336791|NCT01751165|5736642|P1|NOT COMPLETED|Overall Study||2
2336792|NCT01751165|5736640|P3|COMPLETED|Overall Study||113
2336793|NCT01751165|5736641|P2|COMPLETED|Overall Study||116
2336794|NCT01751165|5736642|P1|COMPLETED|Overall Study||117
2336795|NCT01751165|5736640|P3|STARTED|Overall Study||116
2336796|NCT01751165|5736641|P2|STARTED|Overall Study||119
2336797|NCT01751165|5736642|P1|STARTED|Overall Study||119
2336798|NCT01751113|5736682|P6|NOT COMPLETED|Treatment Period 3 (4 Weeks)||1
2336799|NCT01751113|5736683|P5|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
2336800|NCT01751113|5736684|P4|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
2336801|NCT01751113|5736685|P3|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
2336802|NCT01751113|5736686|P2|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
2336803|NCT01751113|5736687|P1|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
2336804|NCT01751113|5736682|P6|COMPLETED|Treatment Period 3 (4 Weeks)||9
2336805|NCT01751113|5736683|P5|COMPLETED|Treatment Period 3 (4 Weeks)||8
2336806|NCT01751113|5736684|P4|COMPLETED|Treatment Period 3 (4 Weeks)||8
2336807|NCT01751113|5736685|P3|COMPLETED|Treatment Period 3 (4 Weeks)||9
2336808|NCT01751113|5736686|P2|COMPLETED|Treatment Period 3 (4 Weeks)||8
2336809|NCT01751113|5736687|P1|COMPLETED|Treatment Period 3 (4 Weeks)||8
2336810|NCT01751113|5736682|P6|STARTED|Treatment Period 3 (4 Weeks)||10
2336811|NCT01751113|5736683|P5|STARTED|Treatment Period 3 (4 Weeks)||8
2336812|NCT01751113|5736684|P4|STARTED|Treatment Period 3 (4 Weeks)||8
2336813|NCT01751113|5736685|P3|STARTED|Treatment Period 3 (4 Weeks)||9
2336814|NCT01751113|5736686|P2|STARTED|Treatment Period 3 (4 Weeks)||8
2336815|NCT01751113|5736687|P1|STARTED|Treatment Period 3 (4 Weeks)||8
2336816|NCT01751113|5736682|P6|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
2336817|NCT01751113|5736683|P5|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
2336818|NCT01751113|5736684|P4|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
2336819|NCT01751113|5736685|P3|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
2336820|NCT01751113|5736686|P2|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
2336821|NCT01751113|5736687|P1|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
2336822|NCT01751113|5736682|P6|COMPLETED|Washout Period 2 (2 Weeks)||10
2336823|NCT01751113|5736683|P5|COMPLETED|Washout Period 2 (2 Weeks)||8
2336824|NCT01751113|5736684|P4|COMPLETED|Washout Period 2 (2 Weeks)||8
2336825|NCT01751113|5736685|P3|COMPLETED|Washout Period 2 (2 Weeks)||9
2336826|NCT01751113|5736686|P2|COMPLETED|Washout Period 2 (2 Weeks)||8
2336827|NCT01751113|5736687|P1|COMPLETED|Washout Period 2 (2 Weeks)||8
2336828|NCT01751113|5736682|P6|STARTED|Washout Period 2 (2 Weeks)||10
2336829|NCT01751113|5736683|P5|STARTED|Washout Period 2 (2 Weeks)||8
2336830|NCT01751113|5736684|P4|STARTED|Washout Period 2 (2 Weeks)||8
2336831|NCT01751113|5736685|P3|STARTED|Washout Period 2 (2 Weeks)||9
2336832|NCT01751113|5736686|P2|STARTED|Washout Period 2 (2 Weeks)||8
2336833|NCT01751113|5736687|P1|STARTED|Washout Period 2 (2 Weeks)||8
2336834|NCT01751113|5736682|P6|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
2336835|NCT01751113|5736683|P5|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
2336836|NCT01751113|5736684|P4|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
2336837|NCT01751113|5736685|P3|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
2336838|NCT01751113|5736686|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
2336839|NCT01751113|5736687|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
2336840|NCT01751113|5736682|P6|COMPLETED|Treatment Period 2 (4 Weeks)||10
2336841|NCT01751113|5736683|P5|COMPLETED|Treatment Period 2 (4 Weeks)||8
2336842|NCT01751113|5736684|P4|COMPLETED|Treatment Period 2 (4 Weeks)||8
2336843|NCT01751113|5736685|P3|COMPLETED|Treatment Period 2 (4 Weeks)||9
2336844|NCT01751113|5736686|P2|COMPLETED|Treatment Period 2 (4 Weeks)||8
2336845|NCT01751113|5736687|P1|COMPLETED|Treatment Period 2 (4 Weeks)||8
2336846|NCT01751113|5736682|P6|STARTED|Treatment Period 2 (4 Weeks)||10
2336847|NCT01751113|5736683|P5|STARTED|Treatment Period 2 (4 Weeks)||8
2336848|NCT01751113|5736684|P4|STARTED|Treatment Period 2 (4 Weeks)||8
2336849|NCT01751113|5736685|P3|STARTED|Treatment Period 2 (4 Weeks)||9
2336850|NCT01751113|5736686|P2|STARTED|Treatment Period 2 (4 Weeks)||8
2336851|NCT01751113|5736687|P1|STARTED|Treatment Period 2 (4 Weeks)||8
2336852|NCT01751113|5736682|P6|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
2336853|NCT01751113|5736683|P5|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
2336854|NCT01751113|5736684|P4|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
2336855|NCT01751113|5736685|P3|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
2336856|NCT01751113|5736686|P2|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
2336857|NCT01751113|5736687|P1|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
2336858|NCT01751113|5736682|P6|COMPLETED|Washout Period 1 (2 Weeks)||10
2336859|NCT01751113|5736683|P5|COMPLETED|Washout Period 1 (2 Weeks)||8
2336860|NCT01751113|5736684|P4|COMPLETED|Washout Period 1 (2 Weeks)||8
2336861|NCT01751113|5736685|P3|COMPLETED|Washout Period 1 (2 Weeks)||9
2336862|NCT01751113|5736686|P2|COMPLETED|Washout Period 1 (2 Weeks)||8
2336863|NCT01751113|5736687|P1|COMPLETED|Washout Period 1 (2 Weeks)||8
2336864|NCT01751113|5736682|P6|STARTED|Washout Period 1 (2 Weeks)||10
2336865|NCT01751113|5736683|P5|STARTED|Washout Period 1 (2 Weeks)||8
2336866|NCT01751113|5736684|P4|STARTED|Washout Period 1 (2 Weeks)||8
2336867|NCT01751113|5736685|P3|STARTED|Washout Period 1 (2 Weeks)||9
2336868|NCT01751113|5736686|P2|STARTED|Washout Period 1 (2 Weeks)||8
2336869|NCT01751113|5736687|P1|STARTED|Washout Period 1 (2 Weeks)||8
2336870|NCT01751113|5736682|P6|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
2336871|NCT01751113|5736683|P5|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
2336872|NCT01751113|5736684|P4|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
2336873|NCT01751113|5736685|P3|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
2336874|NCT01751113|5736686|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
2336875|NCT01751113|5736687|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
2336876|NCT01751113|5736682|P6|COMPLETED|Treatment Period 1 (4 Weeks)||10
2336877|NCT01751113|5736683|P5|COMPLETED|Treatment Period 1 (4 Weeks)||8
2336878|NCT01751113|5736684|P4|COMPLETED|Treatment Period 1 (4 Weeks)||8
2336879|NCT01751113|5736685|P3|COMPLETED|Treatment Period 1 (4 Weeks)||9
2336880|NCT01751113|5736686|P2|COMPLETED|Treatment Period 1 (4 Weeks)||8
2336881|NCT01751113|5736687|P1|COMPLETED|Treatment Period 1 (4 Weeks)||8
2336882|NCT01751113|5736682|P6|STARTED|Treatment Period 1 (4 Weeks)||10
2336883|NCT01751113|5736683|P5|STARTED|Treatment Period 1 (4 Weeks)||9
2336884|NCT01751113|5736684|P4|STARTED|Treatment Period 1 (4 Weeks)||9
2336885|NCT01751113|5736685|P3|STARTED|Treatment Period 1 (4 Weeks)||9
2336886|NCT01751113|5736686|P2|STARTED|Treatment Period 1 (4 Weeks)||8
2336887|NCT01751113|5736687|P1|STARTED|Treatment Period 1 (4 Weeks)||8
2336888|NCT01751087|5736728|P3|NOT COMPLETED|Overall Study||1
2336889|NCT01751087|5736729|P2|NOT COMPLETED|Overall Study||0
2336890|NCT01751087|5736730|P1|NOT COMPLETED|Overall Study||1
2336891|NCT01751087|5736728|P3|COMPLETED|Overall Study||99
2336892|NCT01751087|5736729|P2|COMPLETED|Overall Study||100
2336893|NCT01751087|5736730|P1|COMPLETED|Overall Study||99
2336894|NCT01751087|5736728|P3|STARTED|Overall Study||100
2336895|NCT01751087|5736729|P2|STARTED|Overall Study||100
2336896|NCT01751087|5736730|P1|STARTED|Overall Study||100
2336897|NCT01751061|5736764|P2|NOT COMPLETED|Overall Study||34
2336898|NCT01751061|5736765|P1|NOT COMPLETED|Overall Study||56
2336899|NCT01751061|5736764|P2|COMPLETED|Overall Study||172
2336900|NCT01751061|5736765|P1|COMPLETED|Overall Study||154
2336901|NCT01751061|5736764|P2|STARTED|Overall Study||206
2336902|NCT01751061|5736765|P1|STARTED|Overall Study||210
2336903|NCT01751022|5736786|P3|NOT COMPLETED|Overall Study||27
2336904|NCT01751022|5736787|P2|NOT COMPLETED|Overall Study||44
2336905|NCT01751022|5736788|P1|NOT COMPLETED|Overall Study||56
2336906|NCT01751022|5736786|P3|COMPLETED|Overall Study|6 month visit|273
2336907|NCT01751022|5736787|P2|COMPLETED|Overall Study|6 month visit|282
2336908|NCT01751022|5736788|P1|COMPLETED|Overall Study|6 month visit|443
2336909|NCT01751022|5736786|P3|STARTED|Overall Study||300
2336910|NCT01751022|5736787|P2|STARTED|Overall Study||326
2336911|NCT01751022|5736788|P1|STARTED|Overall Study||499
2336912|NCT01750931|5736820|P2|NOT COMPLETED|Period 2||0
2336913|NCT01750931|5736821|P1|NOT COMPLETED|Period 2||0
2336914|NCT01750931|5736820|P2|COMPLETED|Period 2||14
2336915|NCT01750931|5736821|P1|COMPLETED|Period 2||14
2336916|NCT01750931|5736820|P2|STARTED|Period 2||14
2336917|NCT01750931|5736821|P1|STARTED|Period 2||14
2336918|NCT01750931|5736820|P2|NOT COMPLETED|Wash Out||0
2336919|NCT01750931|5736821|P1|NOT COMPLETED|Wash Out||0
2336920|NCT01750931|5736820|P2|COMPLETED|Wash Out||14
2336921|NCT01750931|5736821|P1|COMPLETED|Wash Out||14
2336922|NCT01750931|5736820|P2|STARTED|Wash Out||14
2336923|NCT01750931|5736821|P1|STARTED|Wash Out||14
2336924|NCT01750931|5736820|P2|NOT COMPLETED|Period 1||0
2336925|NCT01750931|5736821|P1|NOT COMPLETED|Period 1||0
2336926|NCT01750931|5736820|P2|COMPLETED|Period 1||14
2336927|NCT01750931|5736821|P1|COMPLETED|Period 1||14
2336928|NCT01750931|5736820|P2|STARTED|Period 1||14
2336929|NCT01750931|5736821|P1|STARTED|Period 1||14
2336930|NCT01750840|5736839|P1|NOT COMPLETED|Overall Study||4
2336931|NCT01750840|5736839|P1|COMPLETED|Overall Study||4
2336932|NCT01750840|5736839|P1|STARTED|Overall Study||8
2336933|NCT01750697|5736844|P1|NOT COMPLETED|Overall Study||9
2336934|NCT01750697|5736844|P1|COMPLETED|Overall Study|Completed to CCO. 6 participants entered Extended Safety Follow-up, 10 participants completed Study.|16
2336935|NCT01750697|5736844|P1|Follow-up Phase|Overall Study|Completed required follow-up|24
2336936|NCT01750697|5736844|P1|Completed|Overall Study||25
2336937|NCT01750697|5736844|P1|STARTED|Overall Study||25
2336938|NCT01750684|5736856|P2|NOT COMPLETED|Overall Study||2
2336939|NCT01750684|5736857|P1|NOT COMPLETED|Overall Study||2
2336940|NCT01750684|5736856|P2|COMPLETED|Overall Study||5
2336941|NCT01750684|5736857|P1|COMPLETED|Overall Study||4
2336942|NCT01750684|5736856|P2|STARTED|Overall Study||7
2336943|NCT01750684|5736857|P1|STARTED|Overall Study||6
2336944|NCT01750502|5736867|P2|NOT COMPLETED|Overall Study||0
2336945|NCT01750502|5736868|P1|NOT COMPLETED|Overall Study||0
2336946|NCT01750502|5736867|P2|COMPLETED|Overall Study||186
2336947|NCT01750502|5736868|P1|COMPLETED|Overall Study||70
2336948|NCT01750502|5736867|P2|STARTED|Overall Study||186
2336949|NCT01750502|5736868|P1|STARTED|Overall Study||70
2336950|NCT01750398|5736881|P1|NOT COMPLETED|Bipolar Androgen Thearpy Phase||3
2336951|NCT01750398|5736881|P1|COMPLETED|Bipolar Androgen Thearpy Phase||26
2336952|NCT01750398|5736881|P1|STARTED|Bipolar Androgen Thearpy Phase||29
2336953|NCT01750398|5736881|P1|NOT COMPLETED|ADT Lead In Phase||4
2336954|NCT01750398|5736881|P1|COMPLETED|ADT Lead In Phase||29
2336955|NCT01750398|5736881|P1|STARTED|ADT Lead In Phase||33
2336956|NCT01750346|5736894|P3|NOT COMPLETED|Overall Study||0
2336957|NCT01750346|5736895|P2|NOT COMPLETED|Overall Study||0
2336958|NCT01750346|5736896|P1|NOT COMPLETED|Overall Study||1
2336959|NCT01750346|5736894|P3|COMPLETED|Overall Study||3
2336960|NCT01750346|5736895|P2|COMPLETED|Overall Study||2
2336961|NCT01750346|5736896|P1|COMPLETED|Overall Study||2
2336962|NCT01750346|5736894|P3|STARTED|Overall Study||3
2336963|NCT01750346|5736895|P2|STARTED|Overall Study||2
2336964|NCT01750346|5736896|P1|STARTED|Overall Study||3
2336965|NCT01750294|5736922|P1|NOT COMPLETED|Overall Study||2
2336966|NCT01750294|5736922|P1|COMPLETED|Overall Study||12
2336967|NCT01750294|5736922|P1|STARTED|Overall Study||14
2336968|NCT01750281|5736929|P3|NOT COMPLETED|Overall Study||84
2336969|NCT01750281|5736930|P2|NOT COMPLETED|Overall Study||85
2336970|NCT01750281|5736931|P1|NOT COMPLETED|Overall Study||43
2336971|NCT01750281|5736929|P3|COMPLETED|Overall Study||0
2336972|NCT01750281|5736930|P2|COMPLETED|Overall Study||0
2336973|NCT01750281|5736931|P1|COMPLETED|Overall Study||0
2336974|NCT01750281|5736929|P3|Did Not Receive Treatment|Overall Study||0
2336975|NCT01750281|5736930|P2|Did Not Receive Treatment|Overall Study||1
2336976|NCT01750281|5736931|P1|Did Not Receive Treatment|Overall Study||0
2336977|NCT01750281|5736929|P3|Received Treatment|Overall Study||84
2336978|NCT01750281|5736930|P2|Received Treatment|Overall Study||84
2336979|NCT01750281|5736931|P1|Received Treatment|Overall Study||43
2336980|NCT01750281|5736929|P3|STARTED|Overall Study||84
2336981|NCT01750281|5736930|P2|STARTED|Overall Study||85
2336982|NCT01750281|5736931|P1|STARTED|Overall Study||43
2336983|NCT01750255|5736944|P2|NOT COMPLETED|Overall Study||5
2336984|NCT01750255|5736945|P1|NOT COMPLETED|Overall Study||6
2336985|NCT01750255|5736944|P2|COMPLETED|Overall Study||38
2336986|NCT01750255|5736945|P1|COMPLETED|Overall Study||43
2336987|NCT01750255|5736944|P2|STARTED|Overall Study||43
2336988|NCT01750255|5736945|P1|STARTED|Overall Study||49
2336989|NCT01750242|5736961|P1|NOT COMPLETED|Overall Study||3
2336990|NCT01750242|5736961|P1|COMPLETED|Overall Study||20
2336991|NCT01750242|5736961|P1|Readable Images|Overall Study|Subjects with readable images were analyzed and there were 3 subjects with unreadable images.|20
2336992|NCT01750242|5736961|P1|STARTED|Overall Study||23
2336993|NCT01750229|5736966|P1|NOT COMPLETED|Long-term Follow-up Phase||3
2336994|NCT01750229|5736966|P1|COMPLETED|Long-term Follow-up Phase||25
2336995|NCT01750229|5736966|P1|STARTED|Long-term Follow-up Phase|Four subjects who had protocol violations continued to be followed in long-term follow-up phase.|28
2336996|NCT01750229|5736966|P1|NOT COMPLETED|Randomized Crossover Phase||2
2336997|NCT01750229|5736966|P1|COMPLETED|Randomized Crossover Phase||28
2336998|NCT01750229|5736966|P1|Protocol Violation|Randomized Crossover Phase||4
2336999|NCT01750229|5736966|P1|Subjects Received 5882 Hz|Randomized Crossover Phase||24
2337000|NCT01750229|5736966|P1|Subjects Received 3030 Hz|Randomized Crossover Phase||24
2337001|NCT01750229|5736966|P1|Subjects Received 1200 Hz|Randomized Crossover Phase||24
2337002|NCT01750229|5736966|P1|Subject Received Sham|Randomized Crossover Phase||24
2337003|NCT01750229|5736966|P1|STARTED|Randomized Crossover Phase||30
2337004|NCT01750086|5736978|P2|NOT COMPLETED|Overall Study||1
2337005|NCT01750086|5736979|P1|NOT COMPLETED|Overall Study||1
2337006|NCT01750086|5736978|P2|COMPLETED|Overall Study||13
2337007|NCT01750086|5736979|P1|COMPLETED|Overall Study||12
2337008|NCT01750086|5736978|P2|STARTED|Overall Study||14
2337009|NCT01750086|5736979|P1|STARTED|Overall Study||13
2337010|NCT01749995|5736985|P1|NOT COMPLETED|Overall Study||4
2337011|NCT01749995|5736985|P1|COMPLETED|Overall Study||196
2337012|NCT01749995|5736985|P1|STARTED|Overall Study||200
2337013|NCT01749982|5736993|P4|NOT COMPLETED|Overall Study||3
2337014|NCT01749982|5736994|P3|NOT COMPLETED|Overall Study||0
2337015|NCT01749982|5736995|P2|NOT COMPLETED|Overall Study||0
2337016|NCT01749982|5736996|P1|NOT COMPLETED|Overall Study||0
2337017|NCT01749982|5736993|P4|COMPLETED|Overall Study||12
2337018|NCT01749982|5736994|P3|COMPLETED|Overall Study||15
2337019|NCT01749982|5736995|P2|COMPLETED|Overall Study||15
2337020|NCT01749982|5736996|P1|COMPLETED|Overall Study||15
2337021|NCT01749982|5736993|P4|STARTED|Overall Study||15
2337022|NCT01749982|5736994|P3|STARTED|Overall Study||15
2337023|NCT01749982|5736995|P2|STARTED|Overall Study||15
2337024|NCT01749982|5736996|P1|STARTED|Overall Study||15
2337025|NCT01749956|5737014|P1|NOT COMPLETED|Overall Study||15
2337026|NCT01749956|5737014|P1|COMPLETED|Overall Study||24
2337027|NCT01749956|5737014|P1|STARTED|Overall Study||39
2337028|NCT01749930|5737026|P2|NOT COMPLETED|Overall Study||12
2337029|NCT01749930|5737027|P1|NOT COMPLETED|Overall Study||30
2337030|NCT01749930|5737026|P2|COMPLETED|Overall Study|randomized population|125
2337031|NCT01749930|5737027|P1|COMPLETED|Overall Study|randomized population|253
2337032|NCT01749930|5737026|P2|STARTED|Overall Study|randomized population|137
2337033|NCT01749930|5737027|P1|STARTED|Overall Study|randomized population|283
2337034|NCT01749904|5737043|P2|NOT COMPLETED|Overall Study||11
2337035|NCT01749904|5737044|P1|NOT COMPLETED|Overall Study||22
2337036|NCT01749904|5737043|P2|COMPLETED|Overall Study|randomized population|123
2337037|NCT01749904|5737044|P1|COMPLETED|Overall Study|randomized population|264
2337038|NCT01749904|5737043|P2|STARTED|Overall Study|randomized population|134
2337039|NCT01749904|5737044|P1|STARTED|Overall Study|randomized population|286
2337040|NCT01749826|5737060|P2|NOT COMPLETED|Overall Study||0
2337041|NCT01749826|5737061|P1|NOT COMPLETED|Overall Study||20
2337042|NCT01749826|5737060|P2|COMPLETED|Overall Study||0
2337043|NCT01749826|5737061|P1|COMPLETED|Overall Study||0
2337044|NCT01749826|5737060|P2|STARTED|Overall Study||0
2337045|NCT01749826|5737061|P1|STARTED|Overall Study||20
2337046|NCT01749800|5737076|P3|NOT COMPLETED|Overall Study||0
2337047|NCT01749800|5737077|P2|NOT COMPLETED|Overall Study||1
2337048|NCT01749800|5737078|P1|NOT COMPLETED|Overall Study||3
2337049|NCT01749800|5737076|P3|COMPLETED|Overall Study||0
2337050|NCT01749800|5737077|P2|COMPLETED|Overall Study||0
2337051|NCT01749800|5737078|P1|COMPLETED|Overall Study||3
2337052|NCT01749800|5737076|P3|STARTED|Overall Study||0
2337053|NCT01749800|5737077|P2|STARTED|Overall Study|1 subject showed significant motor impairments but decided to undergo therapy (exclusion criterion)|1
2337054|NCT01749800|5737078|P1|STARTED|Overall Study|3 subjects did not show significant attention span deficit (required inclusion criterion)|6
2337055|NCT01749735|5737088|P2|NOT COMPLETED|Overall Study||0
2337056|NCT01749735|5737089|P1|NOT COMPLETED|Overall Study||1
2337057|NCT01749735|5737088|P2|COMPLETED|Overall Study||0
2337058|NCT01749735|5737089|P1|COMPLETED|Overall Study||1
2337059|NCT01749735|5737088|P2|STARTED|Overall Study||0
2337060|NCT01749735|5737089|P1|STARTED|Overall Study||2
2337061|NCT01749631|5737097|P1|NOT COMPLETED|Overall Study||0
2337062|NCT01749631|5737097|P1|COMPLETED|Overall Study||97
2337063|NCT01749631|5737097|P1|STARTED|Overall Study||97
2337064|NCT01749605|5737109|P2|NOT COMPLETED|Overall Study||3
2337065|NCT01749605|5737110|P1|NOT COMPLETED|Overall Study||4
2337066|NCT01749605|5737109|P2|COMPLETED|Overall Study||14
2337067|NCT01749605|5737110|P1|COMPLETED|Overall Study||14
2337068|NCT01749605|5737109|P2|STARTED|Overall Study||17
2337069|NCT01749605|5737110|P1|STARTED|Overall Study||18
2337070|NCT01749501|5737118|P2|NOT COMPLETED|Overall Study||0
2337071|NCT01749501|5737119|P1|NOT COMPLETED|Overall Study||0
2337072|NCT01749501|5737118|P2|COMPLETED|Overall Study||23
2337073|NCT01749501|5737119|P1|COMPLETED|Overall Study||22
2337074|NCT01749501|5737118|P2|STARTED|Overall Study||23
2337075|NCT01749501|5737119|P1|STARTED|Overall Study||22
2337076|NCT01749410|5737127|P1|NOT COMPLETED|Overall Study||0
2337077|NCT01749410|5737127|P1|COMPLETED|Overall Study||33
2337078|NCT01749410|5737127|P1|STARTED|Overall Study||33
2337082|NCT01749033|5737140|P3|NOT COMPLETED|Overall Study||1
2337083|NCT01749033|5737141|P2|NOT COMPLETED|Overall Study||5
2337084|NCT01749033|5737142|P1|NOT COMPLETED|Overall Study||3
2337085|NCT01749033|5737140|P3|COMPLETED|Overall Study||149
2337086|NCT01749033|5737141|P2|COMPLETED|Overall Study||145
2337087|NCT01749033|5737142|P1|COMPLETED|Overall Study||147
2337088|NCT01749033|5737140|P3|STARTED|Overall Study||150
2337089|NCT01749033|5737141|P2|STARTED|Overall Study||150
2337090|NCT01749033|5737142|P1|STARTED|Overall Study||150
2337091|NCT01748955|5737167|P2|NOT COMPLETED|Overall Study||5
2337092|NCT01748955|5737168|P1|NOT COMPLETED|Overall Study||3
2337093|NCT01748955|5737167|P2|COMPLETED|Overall Study||4
2337094|NCT01748955|5737168|P1|COMPLETED|Overall Study||3
2337095|NCT01748955|5737167|P2|STARTED|Overall Study||9
2337096|NCT01748955|5737168|P1|STARTED|Overall Study||6
2337097|NCT01748942|5737178|P2|NOT COMPLETED|Overall Study||4
2337098|NCT01748942|5737179|P1|NOT COMPLETED|Overall Study||4
2337099|NCT01748942|5737178|P2|COMPLETED|Overall Study||33
2337100|NCT01748942|5737179|P1|COMPLETED|Overall Study||35
2337101|NCT01748942|5737178|P2|STARTED|Overall Study||37
2337102|NCT01748942|5737179|P1|STARTED|Overall Study||39
2337103|NCT01748916|5737199|P6|NOT COMPLETED|Overall Study||0
2337104|NCT01748916|5737200|P5|NOT COMPLETED|Overall Study||0
2337105|NCT01748916|5737201|P4|NOT COMPLETED|Overall Study||0
2337106|NCT01748916|5737202|P3|NOT COMPLETED|Overall Study||0
2337107|NCT01748916|5737203|P2|NOT COMPLETED|Overall Study||0
2337108|NCT01748916|5737204|P1|NOT COMPLETED|Overall Study||0
2337109|NCT01748916|5737199|P6|COMPLETED|Overall Study||3
2337110|NCT01748916|5737200|P5|COMPLETED|Overall Study||3
2337111|NCT01748916|5737201|P4|COMPLETED|Overall Study||3
2337112|NCT01748916|5737202|P3|COMPLETED|Overall Study||2
2337113|NCT01748916|5737203|P2|COMPLETED|Overall Study||3
2337114|NCT01748916|5737204|P1|COMPLETED|Overall Study||2
2337115|NCT01748916|5737199|P6|STARTED|Overall Study||3
2337116|NCT01748916|5737200|P5|STARTED|Overall Study||3
2337117|NCT01748916|5737201|P4|STARTED|Overall Study||3
2337118|NCT01748916|5737202|P3|STARTED|Overall Study||2
2337119|NCT01748916|5737203|P2|STARTED|Overall Study||3
2337120|NCT01748916|5737204|P1|STARTED|Overall Study||2
2337121|NCT01748890|5737212|P1|NOT COMPLETED|Overall Study||4
2337122|NCT01748890|5737212|P1|COMPLETED|Overall Study|Insufficient recruitment for analysis|0
2337123|NCT01748890|5737212|P1|STARTED|Overall Study||4
2337124|NCT01748799|5737224|P8|NOT COMPLETED|Overall Study||0
2337125|NCT01748799|5737225|P7|NOT COMPLETED|Overall Study||1
2337126|NCT01748799|5737226|P6|NOT COMPLETED|Overall Study||1
2337127|NCT01748799|5737227|P5|NOT COMPLETED|Overall Study||0
2337128|NCT01748799|5737228|P4|NOT COMPLETED|Overall Study||0
2337129|NCT01748799|5737229|P3|NOT COMPLETED|Overall Study||0
2337130|NCT01748799|5737230|P2|NOT COMPLETED|Overall Study||0
2337131|NCT01748799|5737231|P1|NOT COMPLETED|Overall Study||5
2337132|NCT01748799|5737224|P8|COMPLETED|Overall Study||1
2337133|NCT01748799|5737225|P7|COMPLETED|Overall Study||1
2337134|NCT01748799|5737226|P6|COMPLETED|Overall Study||1
2337135|NCT01748799|5737227|P5|COMPLETED|Overall Study||1
2337136|NCT01748799|5737228|P4|COMPLETED|Overall Study||2
2337137|NCT01748799|5737229|P3|COMPLETED|Overall Study||1
2337138|NCT01748799|5737230|P2|COMPLETED|Overall Study||1
2337139|NCT01748799|5737231|P1|COMPLETED|Overall Study||1
2337140|NCT01748799|5737224|P8|Completed Self-titrated Sativex|Overall Study||1
2337141|NCT01748799|5737225|P7|Completed Self-titrated Sativex|Overall Study||1
2337142|NCT01748799|5737226|P6|Completed Self-titrated Sativex|Overall Study||1
2337143|NCT01748799|5737227|P5|Completed Self-titrated Sativex|Overall Study||1
2337144|NCT01748799|5737228|P4|Completed Self-titrated Sativex|Overall Study||2
2337145|NCT01748799|5737229|P3|Completed Self-titrated Sativex|Overall Study||1
2337146|NCT01748799|5737230|P2|Completed Self-titrated Sativex|Overall Study||1
2337147|NCT01748799|5737231|P1|Completed Self-titrated Sativex|Overall Study||1
2337148|NCT01748799|5737224|P8|Completed SAU of Self-titrated Sativex|Overall Study||1
2337149|NCT01748799|5737225|P7|Completed SAU of Self-titrated Sativex|Overall Study||1
2337150|NCT01748799|5737226|P6|Completed SAU of Self-titrated Sativex|Overall Study||2
2337151|NCT01748799|5737227|P5|Completed SAU of Self-titrated Sativex|Overall Study||1
2337152|NCT01748799|5737228|P4|Completed SAU of Self-titrated Sativex|Overall Study||2
2337153|NCT01748799|5737229|P3|Completed SAU of Self-titrated Sativex|Overall Study||1
2337154|NCT01748799|5737230|P2|Completed SAU of Self-titrated Sativex|Overall Study||1
2337155|NCT01748799|5737231|P1|Completed SAU of Self-titrated Sativex|Overall Study||2
2337156|NCT01748799|5737224|P8|Completed Self-titrated Placebo|Overall Study||1
2337157|NCT01748799|5737225|P7|Completed Self-titrated Placebo|Overall Study||1
2337158|NCT01748799|5737226|P6|Completed Self-titrated Placebo|Overall Study||2
2337159|NCT01748799|5737227|P5|Completed Self-titrated Placebo|Overall Study||1
2337160|NCT01748799|5737228|P4|Completed Self-titrated Placebo|Overall Study||2
2337161|NCT01748799|5737229|P3|Completed Self-titrated Placebo|Overall Study||1
2337162|NCT01748799|5737230|P2|Completed Self-titrated Placebo|Overall Study||1
2337163|NCT01748799|5737231|P1|Completed Self-titrated Placebo|Overall Study||4
2337164|NCT01748799|5737224|P8|Completed SAU of Self-titrated Placebo|Overall Study||1
2337165|NCT01748799|5737225|P7|Completed SAU of Self-titrated Placebo|Overall Study||1
2337166|NCT01748799|5737226|P6|Completed SAU of Self-titrated Placebo|Overall Study||2
2337167|NCT01748799|5737227|P5|Completed SAU of Self-titrated Placebo|Overall Study||1
2337168|NCT01748799|5737228|P4|Completed SAU of Self-titrated Placebo|Overall Study||2
2337169|NCT01748799|5737229|P3|Completed SAU of Self-titrated Placebo|Overall Study||1
2337170|NCT01748799|5737230|P2|Completed SAU of Self-titrated Placebo|Overall Study||1
2337171|NCT01748799|5737231|P1|Completed SAU of Self-titrated Placebo|Overall Study||5
2337172|NCT01748799|5737224|P8|Completed Fixed Dose Sativex|Overall Study||1
2337173|NCT01748799|5737225|P7|Completed Fixed Dose Sativex|Overall Study||1
2337174|NCT01748799|5737226|P6|Completed Fixed Dose Sativex|Overall Study||1
2337175|NCT01748799|5737227|P5|Completed Fixed Dose Sativex|Overall Study||1
2337176|NCT01748799|5737228|P4|Completed Fixed Dose Sativex|Overall Study||2
2337177|NCT01748799|5737229|P3|Completed Fixed Dose Sativex|Overall Study||1
2337178|NCT01748799|5737230|P2|Completed Fixed Dose Sativex|Overall Study||1
2337179|NCT01748799|5737231|P1|Completed Fixed Dose Sativex|Overall Study||1
2337180|NCT01748799|5737224|P8|Completed SAU of Fixed Dose Sativex|Overall Study||1
2337181|NCT01748799|5737225|P7|Completed SAU of Fixed Dose Sativex|Overall Study||1
2337182|NCT01748799|5737226|P6|Completed SAU of Fixed Dose Sativex|Overall Study||1
2337183|NCT01748799|5737227|P5|Completed SAU of Fixed Dose Sativex|Overall Study||1
2337184|NCT01748799|5737228|P4|Completed SAU of Fixed Dose Sativex|Overall Study||2
2337185|NCT01748799|5737229|P3|Completed SAU of Fixed Dose Sativex|Overall Study||1
2337186|NCT01748799|5737230|P2|Completed SAU of Fixed Dose Sativex|Overall Study||1
2337187|NCT01748799|5737231|P1|Completed SAU of Fixed Dose Sativex|Overall Study||1
2337188|NCT01748799|5737224|P8|Completed Fixed Dose Placebo|Overall Study||1
2337189|NCT01748799|5737225|P7|Completed Fixed Dose Placebo|Overall Study||1
2337190|NCT01748799|5737226|P6|Completed Fixed Dose Placebo|Overall Study||1
2337191|NCT01748799|5737227|P5|Completed Fixed Dose Placebo|Overall Study||1
2337192|NCT01748799|5737228|P4|Completed Fixed Dose Placebo|Overall Study||2
2337193|NCT01748799|5737229|P3|Completed Fixed Dose Placebo|Overall Study||1
2337194|NCT01748799|5737230|P2|Completed Fixed Dose Placebo|Overall Study||1
2337195|NCT01748799|5737231|P1|Completed Fixed Dose Placebo|Overall Study||2
2337196|NCT01748799|5737224|P8|Completed SAU of Fixed Dose Placebo|Overall Study||1
2337197|NCT01748799|5737225|P7|Completed SAU of Fixed Dose Placebo|Overall Study||1
2337198|NCT01748799|5737226|P6|Completed SAU of Fixed Dose Placebo|Overall Study||1
2337199|NCT01748799|5737227|P5|Completed SAU of Fixed Dose Placebo|Overall Study||1
2337200|NCT01748799|5737228|P4|Completed SAU of Fixed Dose Placebo|Overall Study||2
2337201|NCT01748799|5737229|P3|Completed SAU of Fixed Dose Placebo|Overall Study||1
2337202|NCT01748799|5737230|P2|Completed SAU of Fixed Dose Placebo|Overall Study||1
2337203|NCT01748799|5737231|P1|Completed SAU of Fixed Dose Placebo|Overall Study||2
2337204|NCT01748799|5737224|P8|STARTED|Overall Study||1
2337205|NCT01748799|5737225|P7|STARTED|Overall Study||2
2337206|NCT01748799|5737226|P6|STARTED|Overall Study||2
2337207|NCT01748799|5737227|P5|STARTED|Overall Study||1
2337208|NCT01748799|5737228|P4|STARTED|Overall Study||2
2337209|NCT01748799|5737229|P3|STARTED|Overall Study||1
2337210|NCT01748799|5737230|P2|STARTED|Overall Study||1
2337211|NCT01748799|5737231|P1|STARTED|Overall Study||6
2337212|NCT01748760|5737267|P2|NOT COMPLETED|Overall Study||2
2337213|NCT01748760|5737268|P1|NOT COMPLETED|Overall Study||6
2337214|NCT01748760|5737267|P2|COMPLETED|Overall Study||23
2337215|NCT01748760|5737268|P1|COMPLETED|Overall Study||19
2337216|NCT01748760|5737267|P2|STARTED|Overall Study||25
2337217|NCT01748760|5737268|P1|STARTED|Overall Study||25
2337218|NCT01748695|5737274|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
2337219|NCT01748695|5737275|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
2337220|NCT01748695|5737274|P2|COMPLETED|Second Intervention (4 Weeks)||11
2337221|NCT01748695|5737275|P1|COMPLETED|Second Intervention (4 Weeks)||14
2337222|NCT01748695|5737274|P2|STARTED|Second Intervention (4 Weeks)||11
2337223|NCT01748695|5737275|P1|STARTED|Second Intervention (4 Weeks)||14
2337224|NCT01748695|5737274|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
2337225|NCT01748695|5737275|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
2337226|NCT01748695|5737274|P2|COMPLETED|First Intervention (4 Weeks)||11
2337227|NCT01748695|5737275|P1|COMPLETED|First Intervention (4 Weeks)||14
2337228|NCT01748695|5737274|P2|STARTED|First Intervention (4 Weeks)||11
2337229|NCT01748695|5737275|P1|STARTED|First Intervention (4 Weeks)||14
2337230|NCT01748643|5737285|P2|NOT COMPLETED|Overall Study||0
2337231|NCT01748643|5737286|P1|NOT COMPLETED|Overall Study||0
2337232|NCT01748643|5737285|P2|COMPLETED|Overall Study||30
2337233|NCT01748643|5737286|P1|COMPLETED|Overall Study||30
2337234|NCT01748643|5737285|P2|STARTED|Overall Study||30
2337235|NCT01748643|5737286|P1|STARTED|Overall Study||30
2337236|NCT01748552|5737314|P12|NOT COMPLETED|Intervention Period 3 and Washout||0
2337237|NCT01748552|5737315|P11|NOT COMPLETED|Intervention Period 3 and Washout||0
2337238|NCT01748552|5737316|P10|NOT COMPLETED|Intervention Period 3 and Washout||0
2337239|NCT01748552|5737317|P9|NOT COMPLETED|Intervention Period 3 and Washout||0
2337240|NCT01748552|5737318|P8|NOT COMPLETED|Intervention Period 3 and Washout||0
2337241|NCT01748552|5737319|P7|NOT COMPLETED|Intervention Period 3 and Washout||0
2337242|NCT01748552|5737320|P6|NOT COMPLETED|Intervention Period 3 and Washout||0
2337243|NCT01748552|5737321|P5|NOT COMPLETED|Intervention Period 3 and Washout||0
2337244|NCT01748552|5737322|P4|NOT COMPLETED|Intervention Period 3 and Washout||0
2337245|NCT01748552|5737323|P3|NOT COMPLETED|Intervention Period 3 and Washout||0
2337246|NCT01748552|5737324|P2|NOT COMPLETED|Intervention Period 3 and Washout||0
2337247|NCT01748552|5737325|P1|NOT COMPLETED|Intervention Period 3 and Washout||0
2337248|NCT01748552|5737314|P12|COMPLETED|Intervention Period 3 and Washout||3
2337249|NCT01748552|5737315|P11|COMPLETED|Intervention Period 3 and Washout||3
2337250|NCT01748552|5737316|P10|COMPLETED|Intervention Period 3 and Washout||3
2337251|NCT01748552|5737317|P9|COMPLETED|Intervention Period 3 and Washout||0
2337252|NCT01748552|5737318|P8|COMPLETED|Intervention Period 3 and Washout||0
2337253|NCT01748552|5737319|P7|COMPLETED|Intervention Period 3 and Washout||0
2337254|NCT01748552|5737320|P6|COMPLETED|Intervention Period 3 and Washout||3
2337255|NCT01748552|5737321|P5|COMPLETED|Intervention Period 3 and Washout||3
2337256|NCT01748552|5737322|P4|COMPLETED|Intervention Period 3 and Washout||3
2337257|NCT01748552|5737323|P3|COMPLETED|Intervention Period 3 and Washout||2
2337258|NCT01748552|5737324|P2|COMPLETED|Intervention Period 3 and Washout||3
2337259|NCT01748552|5737325|P1|COMPLETED|Intervention Period 3 and Washout||3
2337260|NCT01748552|5737314|P12|STARTED|Intervention Period 3 and Washout||3
2337261|NCT01748552|5737315|P11|STARTED|Intervention Period 3 and Washout||3
2337262|NCT01748552|5737316|P10|STARTED|Intervention Period 3 and Washout||3
2337263|NCT01748552|5737317|P9|STARTED|Intervention Period 3 and Washout||0
2337264|NCT01748552|5737318|P8|STARTED|Intervention Period 3 and Washout||0
2337265|NCT01748552|5737319|P7|STARTED|Intervention Period 3 and Washout||0
2337266|NCT01748552|5737320|P6|STARTED|Intervention Period 3 and Washout||3
2337267|NCT01748552|5737321|P5|STARTED|Intervention Period 3 and Washout||3
2337268|NCT01748552|5737322|P4|STARTED|Intervention Period 3 and Washout||3
2337269|NCT01748552|5737323|P3|STARTED|Intervention Period 3 and Washout||2
2337270|NCT01748552|5737324|P2|STARTED|Intervention Period 3 and Washout||3
2337271|NCT01748552|5737325|P1|STARTED|Intervention Period 3 and Washout||3
2337272|NCT01748552|5737314|P12|NOT COMPLETED|Intervention Period 2 and Washout||0
2337273|NCT01748552|5737315|P11|NOT COMPLETED|Intervention Period 2 and Washout||0
2337274|NCT01748552|5737316|P10|NOT COMPLETED|Intervention Period 2 and Washout||0
2337275|NCT01748552|5737317|P9|NOT COMPLETED|Intervention Period 2 and Washout||3
2337276|NCT01748552|5737318|P8|NOT COMPLETED|Intervention Period 2 and Washout||3
2337277|NCT01748552|5737319|P7|NOT COMPLETED|Intervention Period 2 and Washout||3
2337278|NCT01748552|5737320|P6|NOT COMPLETED|Intervention Period 2 and Washout||0
2337279|NCT01748552|5737321|P5|NOT COMPLETED|Intervention Period 2 and Washout||0
2337280|NCT01748552|5737322|P4|NOT COMPLETED|Intervention Period 2 and Washout||0
2337281|NCT01748552|5737323|P3|NOT COMPLETED|Intervention Period 2 and Washout||1
2337282|NCT01748552|5737324|P2|NOT COMPLETED|Intervention Period 2 and Washout||0
2337283|NCT01748552|5737325|P1|NOT COMPLETED|Intervention Period 2 and Washout||0
2337284|NCT01748552|5737314|P12|COMPLETED|Intervention Period 2 and Washout||3
2337285|NCT01748552|5737315|P11|COMPLETED|Intervention Period 2 and Washout||3
2337286|NCT01748552|5737316|P10|COMPLETED|Intervention Period 2 and Washout||3
2337287|NCT01748552|5737317|P9|COMPLETED|Intervention Period 2 and Washout||0
2337288|NCT01748552|5737318|P8|COMPLETED|Intervention Period 2 and Washout||0
2337289|NCT01748552|5737319|P7|COMPLETED|Intervention Period 2 and Washout||0
2337290|NCT01748552|5737320|P6|COMPLETED|Intervention Period 2 and Washout||3
2337291|NCT01748552|5737321|P5|COMPLETED|Intervention Period 2 and Washout||3
2337292|NCT01748552|5737322|P4|COMPLETED|Intervention Period 2 and Washout||3
2337293|NCT01748552|5737323|P3|COMPLETED|Intervention Period 2 and Washout||2
2337294|NCT01748552|5737324|P2|COMPLETED|Intervention Period 2 and Washout||3
2337295|NCT01748552|5737325|P1|COMPLETED|Intervention Period 2 and Washout||3
2337296|NCT01748552|5737314|P12|STARTED|Intervention Period 2 and Washout||3
2337297|NCT01748552|5737315|P11|STARTED|Intervention Period 2 and Washout||3
2337298|NCT01748552|5737316|P10|STARTED|Intervention Period 2 and Washout||3
2337299|NCT01748552|5737317|P9|STARTED|Intervention Period 2 and Washout||3
2337300|NCT01748552|5737318|P8|STARTED|Intervention Period 2 and Washout||3
2337301|NCT01748552|5737319|P7|STARTED|Intervention Period 2 and Washout||3
2337302|NCT01748552|5737320|P6|STARTED|Intervention Period 2 and Washout||3
2337303|NCT01748552|5737321|P5|STARTED|Intervention Period 2 and Washout||3
2337304|NCT01748552|5737322|P4|STARTED|Intervention Period 2 and Washout||3
2337305|NCT01748552|5737323|P3|STARTED|Intervention Period 2 and Washout||3
2337306|NCT01748552|5737324|P2|STARTED|Intervention Period 2 and Washout||3
2337307|NCT01748552|5737325|P1|STARTED|Intervention Period 2 and Washout||3
2337308|NCT01748552|5737314|P12|NOT COMPLETED|Intervention Period 1 and Washout||0
2337309|NCT01748552|5737315|P11|NOT COMPLETED|Intervention Period 1 and Washout||0
2337310|NCT01748552|5737316|P10|NOT COMPLETED|Intervention Period 1 and Washout||0
2337311|NCT01748552|5737317|P9|NOT COMPLETED|Intervention Period 1 and Washout||0
2337312|NCT01748552|5737318|P8|NOT COMPLETED|Intervention Period 1 and Washout||0
2337313|NCT01748552|5737319|P7|NOT COMPLETED|Intervention Period 1 and Washout||0
2337314|NCT01748552|5737320|P6|NOT COMPLETED|Intervention Period 1 and Washout||0
2337315|NCT01748552|5737321|P5|NOT COMPLETED|Intervention Period 1 and Washout||0
2337316|NCT01748552|5737322|P4|NOT COMPLETED|Intervention Period 1 and Washout||0
2337317|NCT01748552|5737323|P3|NOT COMPLETED|Intervention Period 1 and Washout||0
2337318|NCT01748552|5737324|P2|NOT COMPLETED|Intervention Period 1 and Washout||0
2337319|NCT01748552|5737325|P1|NOT COMPLETED|Intervention Period 1 and Washout||0
2337320|NCT01748552|5737314|P12|COMPLETED|Intervention Period 1 and Washout||3
2337321|NCT01748552|5737315|P11|COMPLETED|Intervention Period 1 and Washout||3
2337322|NCT01748552|5737316|P10|COMPLETED|Intervention Period 1 and Washout||3
2337323|NCT01748552|5737317|P9|COMPLETED|Intervention Period 1 and Washout||3
2337324|NCT01748552|5737318|P8|COMPLETED|Intervention Period 1 and Washout||3
2337325|NCT01748552|5737319|P7|COMPLETED|Intervention Period 1 and Washout||3
2337326|NCT01748552|5737320|P6|COMPLETED|Intervention Period 1 and Washout||3
2337327|NCT01748552|5737321|P5|COMPLETED|Intervention Period 1 and Washout||3
2337328|NCT01748552|5737322|P4|COMPLETED|Intervention Period 1 and Washout||3
2337329|NCT01748552|5737323|P3|COMPLETED|Intervention Period 1 and Washout||3
2337330|NCT01748552|5737324|P2|COMPLETED|Intervention Period 1 and Washout||3
2337331|NCT01748552|5737325|P1|COMPLETED|Intervention Period 1 and Washout||3
2337332|NCT01748552|5737314|P12|STARTED|Intervention Period 1 and Washout||3
2337333|NCT01748552|5737315|P11|STARTED|Intervention Period 1 and Washout||3
2337334|NCT01748552|5737316|P10|STARTED|Intervention Period 1 and Washout||3
2337335|NCT01748552|5737317|P9|STARTED|Intervention Period 1 and Washout||3
2337336|NCT01748552|5737318|P8|STARTED|Intervention Period 1 and Washout||3
2337337|NCT01748552|5737319|P7|STARTED|Intervention Period 1 and Washout||3
2337338|NCT01748552|5737320|P6|STARTED|Intervention Period 1 and Washout||3
2337339|NCT01748552|5737321|P5|STARTED|Intervention Period 1 and Washout||3
2337340|NCT01748552|5737322|P4|STARTED|Intervention Period 1 and Washout||3
2337341|NCT01748552|5737323|P3|STARTED|Intervention Period 1 and Washout||3
2337342|NCT01748552|5737324|P2|STARTED|Intervention Period 1 and Washout||3
2337343|NCT01748552|5737325|P1|STARTED|Intervention Period 1 and Washout||3
2337344|NCT01748292|5737395|P2|NOT COMPLETED|Overall Study||12
2337345|NCT01748292|5737396|P1|NOT COMPLETED|Overall Study||2
2337346|NCT01748292|5737395|P2|COMPLETED|Overall Study||28
2337347|NCT01748292|5737396|P1|COMPLETED|Overall Study||18
2337348|NCT01748292|5737395|P2|STARTED|Overall Study||40
2337349|NCT01748292|5737396|P1|STARTED|Overall Study||20
2337350|NCT01748240|5737416|P1|NOT COMPLETED|Overall Study||0
2337351|NCT01748240|5737416|P1|COMPLETED|Overall Study||21
2337352|NCT01748240|5737416|P1|STARTED|Overall Study||21
2337353|NCT01748227|5737420|P1|NOT COMPLETED|Overall Study||3
2337354|NCT01748227|5737420|P1|COMPLETED|Overall Study||17
2337355|NCT01748227|5737420|P1|STARTED|Overall Study||20
2337356|NCT01748162|5737430|P2|NOT COMPLETED|Overall Study||5
2337357|NCT01748162|5737431|P1|NOT COMPLETED|Overall Study||5
2337358|NCT01748162|5737430|P2|COMPLETED|Overall Study||0
2337359|NCT01748162|5737431|P1|COMPLETED|Overall Study||0
2337360|NCT01748162|5737430|P2|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0
2337361|NCT01748162|5737431|P1|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0
2337362|NCT01748162|5737430|P2|Completed 6 Month Initial Treatment|Overall Study||0
2337363|NCT01748162|5737431|P1|Completed 6 Month Initial Treatment|Overall Study||0
2337364|NCT01748162|5737430|P2|Started 6 Month Initial Treatment Plan|Overall Study||2
2337365|NCT01748162|5737431|P1|Started 6 Month Initial Treatment Plan|Overall Study||2
2337366|NCT01748162|5737430|P2|STARTED|Overall Study||5
2337367|NCT01748162|5737431|P1|STARTED|Overall Study||5
2337368|NCT01748071|5737442|P3|NOT COMPLETED|Overall Study||0
2337369|NCT01748071|5737443|P2|NOT COMPLETED|Overall Study||2
2337370|NCT01748071|5737444|P1|NOT COMPLETED|Overall Study||2
2337371|NCT01748071|5737442|P3|COMPLETED|Overall Study||40
2337372|NCT01748071|5737443|P2|COMPLETED|Overall Study||38
2337373|NCT01748071|5737444|P1|COMPLETED|Overall Study||38
2337374|NCT01748071|5737442|P3|STARTED|Overall Study||40
2337375|NCT01748071|5737443|P2|STARTED|Overall Study||40
2337376|NCT01748071|5737444|P1|STARTED|Overall Study||40
2337377|NCT01748045|5737466|P2|NOT COMPLETED|Overall Study||0
2337378|NCT01748045|5737467|P1|NOT COMPLETED|Overall Study||0
2337379|NCT01748045|5737466|P2|COMPLETED|Overall Study||1
2337380|NCT01748045|5737467|P1|COMPLETED|Overall Study||2
2337381|NCT01748045|5737466|P2|STARTED|Overall Study||1
2337382|NCT01748045|5737467|P1|STARTED|Overall Study||2
2337383|NCT01747928|5737493|P8|NOT COMPLETED|Overall Study||0
2337384|NCT01747928|5737494|P7|NOT COMPLETED|Overall Study||0
2337385|NCT01747928|5737495|P6|NOT COMPLETED|Overall Study||0
2337386|NCT01747928|5737496|P5|NOT COMPLETED|Overall Study||0
2337387|NCT01747928|5737497|P4|NOT COMPLETED|Overall Study||0
2337388|NCT01747928|5737498|P3|NOT COMPLETED|Overall Study||0
2337389|NCT01747928|5737499|P2|NOT COMPLETED|Overall Study||0
2337390|NCT01747928|5737500|P1|NOT COMPLETED|Overall Study||0
2337391|NCT01747928|5737493|P8|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
2337392|NCT01747928|5737494|P7|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
2337393|NCT01747928|5737495|P6|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
2337394|NCT01747928|5737496|P5|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
2337395|NCT01747928|5737497|P4|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
2337396|NCT01747928|5737498|P3|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
2337475|NCT01747629|5737866|P1|STARTED|Overall Study||85
2337397|NCT01747928|5737499|P2|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
2337398|NCT01747928|5737500|P1|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
2337399|NCT01747928|5737493|P8|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
2337400|NCT01747928|5737494|P7|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
2337401|NCT01747928|5737495|P6|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
2337402|NCT01747928|5737496|P5|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
2337403|NCT01747928|5737497|P4|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
2337404|NCT01747928|5737498|P3|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
2337405|NCT01747928|5737499|P2|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
2337406|NCT01747928|5737500|P1|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
2337407|NCT01747915|5737707|P3|NOT COMPLETED|Overall Study||6
2337408|NCT01747915|5737708|P2|NOT COMPLETED|Overall Study||11
2337409|NCT01747915|5737709|P1|NOT COMPLETED|Overall Study||15
2337410|NCT01747915|5737707|P3|COMPLETED|Overall Study||66
2337411|NCT01747915|5737708|P2|COMPLETED|Overall Study||61
2337412|NCT01747915|5737709|P1|COMPLETED|Overall Study||60
2337413|NCT01747915|5737707|P3|STARTED|Overall Study||72
2337414|NCT01747915|5737708|P2|STARTED|Overall Study||72
2337415|NCT01747915|5737709|P1|STARTED|Overall Study||75
2337416|NCT01747876|5737723|P3|NOT COMPLETED|Overall Study||12
2337417|NCT01747876|5737724|P2|NOT COMPLETED|Overall Study||15
2337418|NCT01747876|5737725|P1|NOT COMPLETED|Overall Study||5
2337419|NCT01747876|5737723|P3|COMPLETED|Overall Study||0
2337420|NCT01747876|5737724|P2|COMPLETED|Overall Study||0
2337421|NCT01747876|5737725|P1|COMPLETED|Overall Study||0
2337422|NCT01747876|5737723|P3|STARTED|Overall Study||12
2337423|NCT01747876|5737724|P2|STARTED|Overall Study||15
2337424|NCT01747876|5737725|P1|STARTED|Overall Study||5
2337425|NCT01747850|5737754|P3|NOT COMPLETED|Overall Study||6
2337426|NCT01747850|5737755|P2|NOT COMPLETED|Overall Study||7
2337427|NCT01747850|5737756|P1|NOT COMPLETED|Overall Study||1
2337428|NCT01747850|5737754|P3|COMPLETED|Overall Study||14
2337429|NCT01747850|5737755|P2|COMPLETED|Overall Study||13
2337430|NCT01747850|5737756|P1|COMPLETED|Overall Study||4
2337431|NCT01747850|5737754|P3|STARTED|Overall Study||20
2337432|NCT01747850|5737755|P2|STARTED|Overall Study||20
2337433|NCT01747850|5737756|P1|STARTED|Overall Study||5
2337434|NCT01747837|5737778|P2|NOT COMPLETED|Overall Study||6
2337435|NCT01747837|5737779|P1|NOT COMPLETED|Overall Study||9
2337436|NCT01747837|5737778|P2|COMPLETED|Overall Study||17
2337437|NCT01747837|5737779|P1|COMPLETED|Overall Study||16
2337438|NCT01747837|5737778|P2|STARTED|Overall Study||23
2337439|NCT01747837|5737779|P1|STARTED|Overall Study||25
2337440|NCT01747811|5737809|P2|NOT COMPLETED|Overall Study||4
2337441|NCT01747811|5737810|P1|NOT COMPLETED|Overall Study||2
2337442|NCT01747811|5737809|P2|COMPLETED|Overall Study||12
2337443|NCT01747811|5737810|P1|COMPLETED|Overall Study||14
2337444|NCT01747811|5737809|P2|STARTED|Overall Study||16
2337445|NCT01747811|5737810|P1|STARTED|Overall Study||16
2337446|NCT01747772|5737826|P1|NOT COMPLETED|Overall Study||9
2337447|NCT01747772|5737826|P1|COMPLETED|Overall Study||171
2337448|NCT01747772|5737826|P1|Analysis Population|Overall Study|All participants who completed the study and had adequate SWE and liver biopsy data.|164
2337449|NCT01747772|5737826|P1|STARTED|Overall Study||180
2337450|NCT01747655|5737834|P2|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
2337451|NCT01747655|5737835|P1|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
2337452|NCT01747655|5737834|P2|COMPLETED|PEG-J Period (Continued Treatment)||15
2337453|NCT01747655|5737835|P1|COMPLETED|PEG-J Period (Continued Treatment)||41
2337454|NCT01747655|5737834|P2|STARTED|PEG-J Period (Continued Treatment)|SoC MAS: 6 SoC participants plus 9 participants who received Duodopa via PEG-J then returned to SoC|15
2337455|NCT01747655|5737835|P1|STARTED|PEG-J Period (Continued Treatment)||41
2337456|NCT01747655|5737834|P2|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||0
2337457|NCT01747655|5737835|P1|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||14
2337458|NCT01747655|5737834|P2|COMPLETED|PEG-J Period (Duodopa Treatment)||6
2337459|NCT01747655|5737835|P1|COMPLETED|PEG-J Period (Duodopa Treatment)||44
2337460|NCT01747655|5737834|P2|STARTED|PEG-J Period (Duodopa Treatment)|Participants in the MAS that returned to SoC (no PEG-J introduced; did not meet selection criteria)|6
2337461|NCT01747655|5737835|P1|STARTED|PEG-J Period (Duodopa Treatment)|Dudopa MAS: Participants in the MAS that received Duodopa via PEG-J.|58
2337462|NCT01747655|5737834|P2|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
2337463|NCT01747655|5737835|P1|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
2337464|NCT01747655|5737834|P2|COMPLETED|Temporary Naso-jejunal Tube Period||0
2337465|NCT01747655|5737835|P1|COMPLETED|Temporary Naso-jejunal Tube Period||64
2337466|NCT01747655|5737834|P2|STARTED|Temporary Naso-jejunal Tube Period||0
2337467|NCT01747655|5737835|P1|STARTED|Temporary Naso-jejunal Tube Period|Main Analysis Set (MAS): participants with baseline and 1 further visit and ≥ 1 Duodopa treatment|64
2337468|NCT01747629|5737865|P2|NOT COMPLETED|Overall Study||6
2337469|NCT01747629|5737866|P1|NOT COMPLETED|Overall Study||8
2337470|NCT01747629|5737865|P2|COMPLETED|Overall Study||69
2337471|NCT01747629|5737866|P1|COMPLETED|Overall Study||77
2337472|NCT01747629|5737865|P2|Treated|Overall Study|Safety set and full analysis set|75
2337473|NCT01747629|5737866|P1|Treated|Overall Study|Safety set and full analysis set|84
2337474|NCT01747629|5737865|P2|STARTED|Overall Study||75
2337476|NCT01747551|5737900|P2|NOT COMPLETED|Overall Study||21
2337477|NCT01747551|5737901|P1|NOT COMPLETED|Overall Study||43
2337478|NCT01747551|5737900|P2|COMPLETED|Overall Study||0
2337479|NCT01747551|5737901|P1|COMPLETED|Overall Study||0
2337480|NCT01747551|5737900|P2|STARTED|Overall Study||21
2337481|NCT01747551|5737901|P1|STARTED|Overall Study||43
2337482|NCT01747499|5737918|P5|NOT COMPLETED|Overall Study||15
2337483|NCT01747499|5737919|P4|NOT COMPLETED|Overall Study||2
2337484|NCT01747499|5737920|P3|NOT COMPLETED|Overall Study||0
2337485|NCT01747499|5737921|P2|NOT COMPLETED|Overall Study||1
2337486|NCT01747499|5737922|P1|NOT COMPLETED|Overall Study||1
2337487|NCT01747499|5737918|P5|COMPLETED|Overall Study||24
2337488|NCT01747499|5737919|P4|COMPLETED|Overall Study||4
2337489|NCT01747499|5737920|P3|COMPLETED|Overall Study||3
2337490|NCT01747499|5737921|P2|COMPLETED|Overall Study||2
2337491|NCT01747499|5737922|P1|COMPLETED|Overall Study||2
2337492|NCT01747499|5737918|P5|STARTED|Overall Study||39
2337493|NCT01747499|5737919|P4|STARTED|Overall Study||6
2337494|NCT01747499|5737920|P3|STARTED|Overall Study||3
2337495|NCT01747499|5737921|P2|STARTED|Overall Study||3
2337496|NCT01747499|5737922|P1|STARTED|Overall Study||3
2337497|NCT01747486|5737958|P2|NOT COMPLETED|Stage 2||0
2337498|NCT01747486|5737959|P1|NOT COMPLETED|Stage 2||9
2337499|NCT01747486|5737958|P2|COMPLETED|Stage 2||0
2337500|NCT01747486|5737959|P1|COMPLETED|Stage 2||3
2337501|NCT01747486|5737958|P2|STARTED|Stage 2||0
2337502|NCT01747486|5737959|P1|STARTED|Stage 2||12
2337503|NCT01747486|5737958|P2|NOT COMPLETED|Stage 1||13
2337504|NCT01747486|5737959|P1|NOT COMPLETED|Stage 1||12
2337505|NCT01747486|5737958|P2|COMPLETED|Stage 1||2
2337506|NCT01747486|5737959|P1|COMPLETED|Stage 1||3
2337507|NCT01747486|5737958|P2|STARTED|Stage 1||15
2337508|NCT01747486|5737959|P1|STARTED|Stage 1||15
2337509|NCT01747343|5737965|P1|NOT COMPLETED|Underwear/Differential Reinforcement||0
2337510|NCT01747343|5737965|P1|COMPLETED|Underwear/Differential Reinforcement||4
2337511|NCT01747343|5737965|P1|STARTED|Underwear/Differential Reinforcement||4
2337512|NCT01747343|5737965|P1|NOT COMPLETED|Underwear||0
2337513|NCT01747343|5737965|P1|COMPLETED|Underwear||4
2337514|NCT01747343|5737965|P1|STARTED|Underwear||4
2337515|NCT01747343|5737965|P1|NOT COMPLETED|Baseline||0
2337516|NCT01747343|5737965|P1|COMPLETED|Baseline||4
2337517|NCT01747343|5737965|P1|STARTED|Baseline||4
2337518|NCT01747330|5737971|P1|NOT COMPLETED|Overall Study||0
2337519|NCT01747330|5737971|P1|COMPLETED|Overall Study||40
2337520|NCT01747330|5737971|P1|STARTED|Overall Study||40
2337521|NCT01746979|5737985|P2|NOT COMPLETED|Overall Study||347
2337522|NCT01746979|5737986|P1|NOT COMPLETED|Overall Study||346
2337523|NCT01746979|5737985|P2|COMPLETED|Overall Study||0
2337524|NCT01746979|5737986|P1|COMPLETED|Overall Study||0
2337525|NCT01746979|5737985|P2|STARTED|Overall Study||347
2337526|NCT01746979|5737986|P1|STARTED|Overall Study||346
2337527|NCT01746940|5737998|P4|NOT COMPLETED|Safety Second Phase||0
2337528|NCT01746940|5737999|P3|NOT COMPLETED|Safety Second Phase||0
2337529|NCT01746940|5738000|P2|NOT COMPLETED|Safety Second Phase||0
2337530|NCT01746940|5738001|P1|NOT COMPLETED|Safety Second Phase||0
2337531|NCT01746940|5737998|P4|COMPLETED|Safety Second Phase||0
2337532|NCT01746940|5737999|P3|COMPLETED|Safety Second Phase||0
2337533|NCT01746940|5738000|P2|COMPLETED|Safety Second Phase||18
2337534|NCT01746940|5738001|P1|COMPLETED|Safety Second Phase||18
2337535|NCT01746940|5737998|P4|STARTED|Safety Second Phase||0
2337536|NCT01746940|5737999|P3|STARTED|Safety Second Phase||0
2337537|NCT01746940|5738000|P2|STARTED|Safety Second Phase||18
2337538|NCT01746940|5738001|P1|STARTED|Safety Second Phase||18
2337539|NCT01746940|5737998|P4|NOT COMPLETED|Safety and Efficacy First Phase||3
2337540|NCT01746940|5737999|P3|NOT COMPLETED|Safety and Efficacy First Phase||0
2337541|NCT01746940|5738000|P2|NOT COMPLETED|Safety and Efficacy First Phase||0
2337542|NCT01746940|5738001|P1|NOT COMPLETED|Safety and Efficacy First Phase||0
2337543|NCT01746940|5737998|P4|COMPLETED|Safety and Efficacy First Phase||0
2337544|NCT01746940|5737999|P3|COMPLETED|Safety and Efficacy First Phase||40
2337545|NCT01746940|5738000|P2|COMPLETED|Safety and Efficacy First Phase||41
2337546|NCT01746940|5738001|P1|COMPLETED|Safety and Efficacy First Phase||39
2337547|NCT01746940|5737998|P4|STARTED|Safety and Efficacy First Phase||3
2337548|NCT01746940|5737999|P3|STARTED|Safety and Efficacy First Phase||40
2337549|NCT01746940|5738000|P2|STARTED|Safety and Efficacy First Phase||41
2337550|NCT01746940|5738001|P1|STARTED|Safety and Efficacy First Phase||39
2337551|NCT01746901|5738009|P9|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
2337552|NCT01746901|5738010|P8|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
2337553|NCT01746901|5738011|P7|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
2337554|NCT01746901|5738012|P6|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
2337555|NCT01746901|5738013|P5|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
2337556|NCT01746901|5738014|P4|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
2337557|NCT01746901|5738015|P3|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
2337558|NCT01746901|5738016|P2|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
2337559|NCT01746901|5738017|P1|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
2337560|NCT01746901|5738009|P9|COMPLETED|Treatment Phase: Sixth Intervention||5
2337561|NCT01746901|5738010|P8|COMPLETED|Treatment Phase: Sixth Intervention||6
2337562|NCT01746901|5738011|P7|COMPLETED|Treatment Phase: Sixth Intervention||5
2337563|NCT01746901|5738012|P6|COMPLETED|Treatment Phase: Sixth Intervention||5
2337564|NCT01746901|5738013|P5|COMPLETED|Treatment Phase: Sixth Intervention||6
2337565|NCT01746901|5738014|P4|COMPLETED|Treatment Phase: Sixth Intervention||5
2337566|NCT01746901|5738015|P3|COMPLETED|Treatment Phase: Sixth Intervention||0
2337567|NCT01746901|5738016|P2|COMPLETED|Treatment Phase: Sixth Intervention||0
2337568|NCT01746901|5738017|P1|COMPLETED|Treatment Phase: Sixth Intervention||0
2337569|NCT01746901|5738009|P9|STARTED|Treatment Phase: Sixth Intervention||5
2337570|NCT01746901|5738010|P8|STARTED|Treatment Phase: Sixth Intervention||6
2337571|NCT01746901|5738011|P7|STARTED|Treatment Phase: Sixth Intervention||5
2337572|NCT01746901|5738012|P6|STARTED|Treatment Phase: Sixth Intervention||5
2337573|NCT01746901|5738013|P5|STARTED|Treatment Phase: Sixth Intervention||6
2337574|NCT01746901|5738014|P4|STARTED|Treatment Phase: Sixth Intervention||5
2337575|NCT01746901|5738015|P3|STARTED|Treatment Phase: Sixth Intervention||0
2337576|NCT01746901|5738016|P2|STARTED|Treatment Phase: Sixth Intervention||0
2337577|NCT01746901|5738017|P1|STARTED|Treatment Phase: Sixth Intervention||0
2337578|NCT01746901|5738009|P9|NOT COMPLETED|Treatment Phase: Washout Period 5||0
2337579|NCT01746901|5738010|P8|NOT COMPLETED|Treatment Phase: Washout Period 5||0
2337580|NCT01746901|5738011|P7|NOT COMPLETED|Treatment Phase: Washout Period 5||0
2337581|NCT01746901|5738012|P6|NOT COMPLETED|Treatment Phase: Washout Period 5||0
2337582|NCT01746901|5738013|P5|NOT COMPLETED|Treatment Phase: Washout Period 5||0
2337583|NCT01746901|5738014|P4|NOT COMPLETED|Treatment Phase: Washout Period 5||0
2337584|NCT01746901|5738015|P3|NOT COMPLETED|Treatment Phase: Washout Period 5||0
2337585|NCT01746901|5738016|P2|NOT COMPLETED|Treatment Phase: Washout Period 5||0
2337586|NCT01746901|5738017|P1|NOT COMPLETED|Treatment Phase: Washout Period 5||0
2337587|NCT01746901|5738009|P9|COMPLETED|Treatment Phase: Washout Period 5||5
2337588|NCT01746901|5738010|P8|COMPLETED|Treatment Phase: Washout Period 5||6
2337589|NCT01746901|5738011|P7|COMPLETED|Treatment Phase: Washout Period 5||5
2337590|NCT01746901|5738012|P6|COMPLETED|Treatment Phase: Washout Period 5||5
2337591|NCT01746901|5738013|P5|COMPLETED|Treatment Phase: Washout Period 5||6
2337592|NCT01746901|5738014|P4|COMPLETED|Treatment Phase: Washout Period 5||5
2337593|NCT01746901|5738015|P3|COMPLETED|Treatment Phase: Washout Period 5||0
2337594|NCT01746901|5738016|P2|COMPLETED|Treatment Phase: Washout Period 5||0
2337595|NCT01746901|5738017|P1|COMPLETED|Treatment Phase: Washout Period 5||0
2337596|NCT01746901|5738009|P9|STARTED|Treatment Phase: Washout Period 5||5
2337597|NCT01746901|5738010|P8|STARTED|Treatment Phase: Washout Period 5||6
2337598|NCT01746901|5738011|P7|STARTED|Treatment Phase: Washout Period 5||5
2337599|NCT01746901|5738012|P6|STARTED|Treatment Phase: Washout Period 5||5
2337600|NCT01746901|5738013|P5|STARTED|Treatment Phase: Washout Period 5||6
2337601|NCT01746901|5738014|P4|STARTED|Treatment Phase: Washout Period 5||5
2337602|NCT01746901|5738015|P3|STARTED|Treatment Phase: Washout Period 5||0
2337603|NCT01746901|5738016|P2|STARTED|Treatment Phase: Washout Period 5||0
2337604|NCT01746901|5738017|P1|STARTED|Treatment Phase: Washout Period 5||0
2337605|NCT01746901|5738009|P9|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
2337606|NCT01746901|5738010|P8|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
2337607|NCT01746901|5738011|P7|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
2337608|NCT01746901|5738012|P6|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
2337609|NCT01746901|5738013|P5|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
2337610|NCT01746901|5738014|P4|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
2337611|NCT01746901|5738015|P3|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
2337612|NCT01746901|5738016|P2|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
2337613|NCT01746901|5738017|P1|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
2337614|NCT01746901|5738009|P9|COMPLETED|Treatment Phase: Fifth Intervention||5
2337615|NCT01746901|5738010|P8|COMPLETED|Treatment Phase: Fifth Intervention||6
2337616|NCT01746901|5738011|P7|COMPLETED|Treatment Phase: Fifth Intervention||5
2337617|NCT01746901|5738012|P6|COMPLETED|Treatment Phase: Fifth Intervention||5
2337618|NCT01746901|5738013|P5|COMPLETED|Treatment Phase: Fifth Intervention||6
2337619|NCT01746901|5738014|P4|COMPLETED|Treatment Phase: Fifth Intervention||5
2337620|NCT01746901|5738015|P3|COMPLETED|Treatment Phase: Fifth Intervention||0
2337621|NCT01746901|5738016|P2|COMPLETED|Treatment Phase: Fifth Intervention||0
2337622|NCT01746901|5738017|P1|COMPLETED|Treatment Phase: Fifth Intervention||0
2337623|NCT01746901|5738009|P9|STARTED|Treatment Phase: Fifth Intervention||5
2337624|NCT01746901|5738010|P8|STARTED|Treatment Phase: Fifth Intervention||6
2337625|NCT01746901|5738011|P7|STARTED|Treatment Phase: Fifth Intervention||5
2337626|NCT01746901|5738012|P6|STARTED|Treatment Phase: Fifth Intervention||5
2337627|NCT01746901|5738013|P5|STARTED|Treatment Phase: Fifth Intervention||6
2337628|NCT01746901|5738014|P4|STARTED|Treatment Phase: Fifth Intervention||5
2337629|NCT01746901|5738015|P3|STARTED|Treatment Phase: Fifth Intervention||0
2337630|NCT01746901|5738016|P2|STARTED|Treatment Phase: Fifth Intervention||0
2337631|NCT01746901|5738017|P1|STARTED|Treatment Phase: Fifth Intervention||0
2337632|NCT01746901|5738009|P9|NOT COMPLETED|Treatment Phase: Washout Period 4||0
2337633|NCT01746901|5738010|P8|NOT COMPLETED|Treatment Phase: Washout Period 4||0
2337634|NCT01746901|5738011|P7|NOT COMPLETED|Treatment Phase: Washout Period 4||0
2337635|NCT01746901|5738012|P6|NOT COMPLETED|Treatment Phase: Washout Period 4||0
2337636|NCT01746901|5738013|P5|NOT COMPLETED|Treatment Phase: Washout Period 4||0
2337637|NCT01746901|5738014|P4|NOT COMPLETED|Treatment Phase: Washout Period 4||0
2337638|NCT01746901|5738015|P3|NOT COMPLETED|Treatment Phase: Washout Period 4||0
2337639|NCT01746901|5738016|P2|NOT COMPLETED|Treatment Phase: Washout Period 4||0
2337640|NCT01746901|5738017|P1|NOT COMPLETED|Treatment Phase: Washout Period 4||0
2337641|NCT01746901|5738009|P9|COMPLETED|Treatment Phase: Washout Period 4||5
2337642|NCT01746901|5738010|P8|COMPLETED|Treatment Phase: Washout Period 4||6
2337643|NCT01746901|5738011|P7|COMPLETED|Treatment Phase: Washout Period 4||5
2337644|NCT01746901|5738012|P6|COMPLETED|Treatment Phase: Washout Period 4||5
2337645|NCT01746901|5738013|P5|COMPLETED|Treatment Phase: Washout Period 4||6
2337646|NCT01746901|5738014|P4|COMPLETED|Treatment Phase: Washout Period 4||5
2337647|NCT01746901|5738015|P3|COMPLETED|Treatment Phase: Washout Period 4||0
2337648|NCT01746901|5738016|P2|COMPLETED|Treatment Phase: Washout Period 4||0
2337649|NCT01746901|5738017|P1|COMPLETED|Treatment Phase: Washout Period 4||0
2337650|NCT01746901|5738009|P9|STARTED|Treatment Phase: Washout Period 4||5
2337651|NCT01746901|5738010|P8|STARTED|Treatment Phase: Washout Period 4||6
2337652|NCT01746901|5738011|P7|STARTED|Treatment Phase: Washout Period 4||5
2337653|NCT01746901|5738012|P6|STARTED|Treatment Phase: Washout Period 4||5
2337654|NCT01746901|5738013|P5|STARTED|Treatment Phase: Washout Period 4||6
2337655|NCT01746901|5738014|P4|STARTED|Treatment Phase: Washout Period 4||5
2337656|NCT01746901|5738015|P3|STARTED|Treatment Phase: Washout Period 4||0
2337657|NCT01746901|5738016|P2|STARTED|Treatment Phase: Washout Period 4||0
2337658|NCT01746901|5738017|P1|STARTED|Treatment Phase: Washout Period 4||0
2337659|NCT01746901|5738009|P9|NOT COMPLETED|Treatment Phase: Fourth Intervention||2
2337660|NCT01746901|5738010|P8|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
2337661|NCT01746901|5738011|P7|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
2337662|NCT01746901|5738012|P6|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
2337663|NCT01746901|5738013|P5|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
2337664|NCT01746901|5738014|P4|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
2337665|NCT01746901|5738015|P3|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
2337666|NCT01746901|5738016|P2|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
2337667|NCT01746901|5738017|P1|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
2337668|NCT01746901|5738009|P9|COMPLETED|Treatment Phase: Fourth Intervention||5
2337669|NCT01746901|5738010|P8|COMPLETED|Treatment Phase: Fourth Intervention||6
2337670|NCT01746901|5738011|P7|COMPLETED|Treatment Phase: Fourth Intervention||5
2337671|NCT01746901|5738012|P6|COMPLETED|Treatment Phase: Fourth Intervention||5
2337672|NCT01746901|5738013|P5|COMPLETED|Treatment Phase: Fourth Intervention||6
2337673|NCT01746901|5738014|P4|COMPLETED|Treatment Phase: Fourth Intervention||5
2337674|NCT01746901|5738015|P3|COMPLETED|Treatment Phase: Fourth Intervention||0
2337675|NCT01746901|5738016|P2|COMPLETED|Treatment Phase: Fourth Intervention||0
2337676|NCT01746901|5738017|P1|COMPLETED|Treatment Phase: Fourth Intervention||0
2337677|NCT01746901|5738009|P9|STARTED|Treatment Phase: Fourth Intervention||7
2337678|NCT01746901|5738010|P8|STARTED|Treatment Phase: Fourth Intervention||6
2337679|NCT01746901|5738011|P7|STARTED|Treatment Phase: Fourth Intervention||6
2337680|NCT01746901|5738012|P6|STARTED|Treatment Phase: Fourth Intervention||6
2337681|NCT01746901|5738013|P5|STARTED|Treatment Phase: Fourth Intervention||6
2337682|NCT01746901|5738014|P4|STARTED|Treatment Phase: Fourth Intervention||6
2337683|NCT01746901|5738015|P3|STARTED|Treatment Phase: Fourth Intervention||0
2337684|NCT01746901|5738016|P2|STARTED|Treatment Phase: Fourth Intervention||0
2337685|NCT01746901|5738017|P1|STARTED|Treatment Phase: Fourth Intervention||0
2337686|NCT01746901|5738009|P9|NOT COMPLETED|Treatment Phase: Washout Period 3||0
2337687|NCT01746901|5738010|P8|NOT COMPLETED|Treatment Phase: Washout Period 3||0
2337688|NCT01746901|5738011|P7|NOT COMPLETED|Treatment Phase: Washout Period 3||0
2337689|NCT01746901|5738012|P6|NOT COMPLETED|Treatment Phase: Washout Period 3||0
2337690|NCT01746901|5738013|P5|NOT COMPLETED|Treatment Phase: Washout Period 3||0
2337691|NCT01746901|5738014|P4|NOT COMPLETED|Treatment Phase: Washout Period 3||0
2337692|NCT01746901|5738015|P3|NOT COMPLETED|Treatment Phase: Washout Period 3||0
2337693|NCT01746901|5738016|P2|NOT COMPLETED|Treatment Phase: Washout Period 3||0
2337694|NCT01746901|5738017|P1|NOT COMPLETED|Treatment Phase: Washout Period 3||0
2337695|NCT01746901|5738009|P9|COMPLETED|Treatment Phase: Washout Period 3||7
2337696|NCT01746901|5738010|P8|COMPLETED|Treatment Phase: Washout Period 3||6
2337697|NCT01746901|5738011|P7|COMPLETED|Treatment Phase: Washout Period 3||6
2337698|NCT01746901|5738012|P6|COMPLETED|Treatment Phase: Washout Period 3||6
2337699|NCT01746901|5738013|P5|COMPLETED|Treatment Phase: Washout Period 3||6
2337700|NCT01746901|5738014|P4|COMPLETED|Treatment Phase: Washout Period 3||6
2337701|NCT01746901|5738015|P3|COMPLETED|Treatment Phase: Washout Period 3||0
2337702|NCT01746901|5738016|P2|COMPLETED|Treatment Phase: Washout Period 3||0
2337703|NCT01746901|5738017|P1|COMPLETED|Treatment Phase: Washout Period 3||0
2337704|NCT01746901|5738009|P9|STARTED|Treatment Phase: Washout Period 3||7
2337705|NCT01746901|5738010|P8|STARTED|Treatment Phase: Washout Period 3||6
2337706|NCT01746901|5738011|P7|STARTED|Treatment Phase: Washout Period 3||6
2337707|NCT01746901|5738012|P6|STARTED|Treatment Phase: Washout Period 3||6
2337708|NCT01746901|5738013|P5|STARTED|Treatment Phase: Washout Period 3||6
2337709|NCT01746901|5738014|P4|STARTED|Treatment Phase: Washout Period 3||6
2337710|NCT01746901|5738015|P3|STARTED|Treatment Phase: Washout Period 3||0
2337711|NCT01746901|5738016|P2|STARTED|Treatment Phase: Washout Period 3||0
2337712|NCT01746901|5738017|P1|STARTED|Treatment Phase: Washout Period 3||0
2337713|NCT01746901|5738009|P9|NOT COMPLETED|Treatment Phase: Third Intervention||0
2337714|NCT01746901|5738010|P8|NOT COMPLETED|Treatment Phase: Third Intervention||0
2337715|NCT01746901|5738011|P7|NOT COMPLETED|Treatment Phase: Third Intervention||1
2337716|NCT01746901|5738012|P6|NOT COMPLETED|Treatment Phase: Third Intervention||1
2337717|NCT01746901|5738013|P5|NOT COMPLETED|Treatment Phase: Third Intervention||0
2337718|NCT01746901|5738014|P4|NOT COMPLETED|Treatment Phase: Third Intervention||0
2337719|NCT01746901|5738015|P3|NOT COMPLETED|Treatment Phase: Third Intervention||0
2337720|NCT01746901|5738016|P2|NOT COMPLETED|Treatment Phase: Third Intervention||0
2337721|NCT01746901|5738017|P1|NOT COMPLETED|Treatment Phase: Third Intervention||0
2337722|NCT01746901|5738009|P9|COMPLETED|Treatment Phase: Third Intervention||7
2337723|NCT01746901|5738010|P8|COMPLETED|Treatment Phase: Third Intervention||6
2337724|NCT01746901|5738011|P7|COMPLETED|Treatment Phase: Third Intervention||6
2337725|NCT01746901|5738012|P6|COMPLETED|Treatment Phase: Third Intervention||6
2337726|NCT01746901|5738013|P5|COMPLETED|Treatment Phase: Third Intervention||6
2337727|NCT01746901|5738014|P4|COMPLETED|Treatment Phase: Third Intervention||6
2337728|NCT01746901|5738015|P3|COMPLETED|Treatment Phase: Third Intervention||0
2337729|NCT01746901|5738016|P2|COMPLETED|Treatment Phase: Third Intervention||0
2337730|NCT01746901|5738017|P1|COMPLETED|Treatment Phase: Third Intervention||0
2337731|NCT01746901|5738009|P9|STARTED|Treatment Phase: Third Intervention||7
2337732|NCT01746901|5738010|P8|STARTED|Treatment Phase: Third Intervention||6
2337733|NCT01746901|5738011|P7|STARTED|Treatment Phase: Third Intervention||7
2337734|NCT01746901|5738012|P6|STARTED|Treatment Phase: Third Intervention||7
2337735|NCT01746901|5738013|P5|STARTED|Treatment Phase: Third Intervention||6
2337736|NCT01746901|5738014|P4|STARTED|Treatment Phase: Third Intervention||6
2337737|NCT01746901|5738015|P3|STARTED|Treatment Phase: Third Intervention||0
2337738|NCT01746901|5738016|P2|STARTED|Treatment Phase: Third Intervention||0
2337739|NCT01746901|5738017|P1|STARTED|Treatment Phase: Third Intervention||0
2337740|NCT01746901|5738009|P9|NOT COMPLETED|Treatment Phase: Washout Period 2||0
2337741|NCT01746901|5738010|P8|NOT COMPLETED|Treatment Phase: Washout Period 2||0
2337742|NCT01746901|5738011|P7|NOT COMPLETED|Treatment Phase: Washout Period 2||0
2337743|NCT01746901|5738012|P6|NOT COMPLETED|Treatment Phase: Washout Period 2||0
2337744|NCT01746901|5738013|P5|NOT COMPLETED|Treatment Phase: Washout Period 2||0
2337745|NCT01746901|5738014|P4|NOT COMPLETED|Treatment Phase: Washout Period 2||0
2337746|NCT01746901|5738015|P3|NOT COMPLETED|Treatment Phase: Washout Period 2||0
2337747|NCT01746901|5738016|P2|NOT COMPLETED|Treatment Phase: Washout Period 2||0
2337748|NCT01746901|5738017|P1|NOT COMPLETED|Treatment Phase: Washout Period 2||0
2337749|NCT01746901|5738009|P9|COMPLETED|Treatment Phase: Washout Period 2||7
2337750|NCT01746901|5738010|P8|COMPLETED|Treatment Phase: Washout Period 2||6
2337751|NCT01746901|5738011|P7|COMPLETED|Treatment Phase: Washout Period 2||7
2337752|NCT01746901|5738012|P6|COMPLETED|Treatment Phase: Washout Period 2||7
2337753|NCT01746901|5738013|P5|COMPLETED|Treatment Phase: Washout Period 2||6
2337754|NCT01746901|5738014|P4|COMPLETED|Treatment Phase: Washout Period 2||6
2337755|NCT01746901|5738015|P3|COMPLETED|Treatment Phase: Washout Period 2||0
2337756|NCT01746901|5738016|P2|COMPLETED|Treatment Phase: Washout Period 2||0
2337757|NCT01746901|5738017|P1|COMPLETED|Treatment Phase: Washout Period 2||0
2337758|NCT01746901|5738009|P9|STARTED|Treatment Phase: Washout Period 2||7
2337759|NCT01746901|5738010|P8|STARTED|Treatment Phase: Washout Period 2||6
2337760|NCT01746901|5738011|P7|STARTED|Treatment Phase: Washout Period 2||7
2337761|NCT01746901|5738012|P6|STARTED|Treatment Phase: Washout Period 2||7
2337762|NCT01746901|5738013|P5|STARTED|Treatment Phase: Washout Period 2||6
2337763|NCT01746901|5738014|P4|STARTED|Treatment Phase: Washout Period 2||6
2337764|NCT01746901|5738015|P3|STARTED|Treatment Phase: Washout Period 2||0
2337765|NCT01746901|5738016|P2|STARTED|Treatment Phase: Washout Period 2||0
2337766|NCT01746901|5738017|P1|STARTED|Treatment Phase: Washout Period 2||0
2337767|NCT01746901|5738009|P9|NOT COMPLETED|Treatment Phase: Second Intervention||0
2337768|NCT01746901|5738010|P8|NOT COMPLETED|Treatment Phase: Second Intervention||1
2337769|NCT01746901|5738011|P7|NOT COMPLETED|Treatment Phase: Second Intervention||0
2337770|NCT01746901|5738012|P6|NOT COMPLETED|Treatment Phase: Second Intervention||0
2337771|NCT01746901|5738013|P5|NOT COMPLETED|Treatment Phase: Second Intervention||0
2337772|NCT01746901|5738014|P4|NOT COMPLETED|Treatment Phase: Second Intervention||0
2337773|NCT01746901|5738015|P3|NOT COMPLETED|Treatment Phase: Second Intervention||0
2337774|NCT01746901|5738016|P2|NOT COMPLETED|Treatment Phase: Second Intervention||0
2337775|NCT01746901|5738017|P1|NOT COMPLETED|Treatment Phase: Second Intervention||0
2337776|NCT01746901|5738009|P9|COMPLETED|Treatment Phase: Second Intervention||7
2337777|NCT01746901|5738010|P8|COMPLETED|Treatment Phase: Second Intervention||6
2337778|NCT01746901|5738011|P7|COMPLETED|Treatment Phase: Second Intervention||7
2337779|NCT01746901|5738012|P6|COMPLETED|Treatment Phase: Second Intervention||7
2337780|NCT01746901|5738013|P5|COMPLETED|Treatment Phase: Second Intervention||6
2337781|NCT01746901|5738014|P4|COMPLETED|Treatment Phase: Second Intervention||6
2337782|NCT01746901|5738015|P3|COMPLETED|Treatment Phase: Second Intervention||0
2337783|NCT01746901|5738016|P2|COMPLETED|Treatment Phase: Second Intervention||0
2337784|NCT01746901|5738017|P1|COMPLETED|Treatment Phase: Second Intervention||0
2337785|NCT01746901|5738009|P9|STARTED|Treatment Phase: Second Intervention||7
2337786|NCT01746901|5738010|P8|STARTED|Treatment Phase: Second Intervention||7
2337787|NCT01746901|5738011|P7|STARTED|Treatment Phase: Second Intervention||7
2337788|NCT01746901|5738012|P6|STARTED|Treatment Phase: Second Intervention||7
2337789|NCT01746901|5738013|P5|STARTED|Treatment Phase: Second Intervention||6
2337790|NCT01746901|5738014|P4|STARTED|Treatment Phase: Second Intervention||6
2337791|NCT01746901|5738015|P3|STARTED|Treatment Phase: Second Intervention||0
2337792|NCT01746901|5738016|P2|STARTED|Treatment Phase: Second Intervention||0
2337793|NCT01746901|5738017|P1|STARTED|Treatment Phase: Second Intervention||0
2337794|NCT01746901|5738009|P9|NOT COMPLETED|Treatment Phase: Washout Period 1||0
2337795|NCT01746901|5738010|P8|NOT COMPLETED|Treatment Phase: Washout Period 1||0
2337796|NCT01746901|5738011|P7|NOT COMPLETED|Treatment Phase: Washout Period 1||0
2337797|NCT01746901|5738012|P6|NOT COMPLETED|Treatment Phase: Washout Period 1||0
2337798|NCT01746901|5738013|P5|NOT COMPLETED|Treatment Phase: Washout Period 1||0
2337799|NCT01746901|5738014|P4|NOT COMPLETED|Treatment Phase: Washout Period 1||0
2337800|NCT01746901|5738015|P3|NOT COMPLETED|Treatment Phase: Washout Period 1||0
2337801|NCT01746901|5738016|P2|NOT COMPLETED|Treatment Phase: Washout Period 1||0
2337802|NCT01746901|5738017|P1|NOT COMPLETED|Treatment Phase: Washout Period 1||0
2337803|NCT01746901|5738009|P9|COMPLETED|Treatment Phase: Washout Period 1||7
2337804|NCT01746901|5738010|P8|COMPLETED|Treatment Phase: Washout Period 1||7
2337805|NCT01746901|5738011|P7|COMPLETED|Treatment Phase: Washout Period 1||7
2337806|NCT01746901|5738012|P6|COMPLETED|Treatment Phase: Washout Period 1||7
2337807|NCT01746901|5738013|P5|COMPLETED|Treatment Phase: Washout Period 1||6
2337808|NCT01746901|5738014|P4|COMPLETED|Treatment Phase: Washout Period 1||6
2337809|NCT01746901|5738015|P3|COMPLETED|Treatment Phase: Washout Period 1||0
2337810|NCT01746901|5738016|P2|COMPLETED|Treatment Phase: Washout Period 1||0
2337811|NCT01746901|5738017|P1|COMPLETED|Treatment Phase: Washout Period 1||0
2337812|NCT01746901|5738009|P9|STARTED|Treatment Phase: Washout Period 1||7
2337813|NCT01746901|5738010|P8|STARTED|Treatment Phase: Washout Period 1||7
2337814|NCT01746901|5738011|P7|STARTED|Treatment Phase: Washout Period 1||7
2337815|NCT01746901|5738012|P6|STARTED|Treatment Phase: Washout Period 1||7
2337816|NCT01746901|5738013|P5|STARTED|Treatment Phase: Washout Period 1||6
2337817|NCT01746901|5738014|P4|STARTED|Treatment Phase: Washout Period 1||6
2337818|NCT01746901|5738015|P3|STARTED|Treatment Phase: Washout Period 1||0
2337819|NCT01746901|5738016|P2|STARTED|Treatment Phase: Washout Period 1||0
2337820|NCT01746901|5738017|P1|STARTED|Treatment Phase: Washout Period 1||0
2337821|NCT01746901|5738009|P9|NOT COMPLETED|Treatment Phase: First Intervention||0
2337822|NCT01746901|5738010|P8|NOT COMPLETED|Treatment Phase: First Intervention||0
2337823|NCT01746901|5738011|P7|NOT COMPLETED|Treatment Phase: First Intervention||1
2337824|NCT01746901|5738012|P6|NOT COMPLETED|Treatment Phase: First Intervention||0
2337825|NCT01746901|5738013|P5|NOT COMPLETED|Treatment Phase: First Intervention||0
2337826|NCT01746901|5738014|P4|NOT COMPLETED|Treatment Phase: First Intervention||0
2337827|NCT01746901|5738015|P3|NOT COMPLETED|Treatment Phase: First Intervention||0
2337828|NCT01746901|5738016|P2|NOT COMPLETED|Treatment Phase: First Intervention||0
2337829|NCT01746901|5738017|P1|NOT COMPLETED|Treatment Phase: First Intervention||0
2337830|NCT01746901|5738009|P9|COMPLETED|Treatment Phase: First Intervention||7
2337831|NCT01746901|5738010|P8|COMPLETED|Treatment Phase: First Intervention||7
2337832|NCT01746901|5738011|P7|COMPLETED|Treatment Phase: First Intervention||7
2337833|NCT01746901|5738012|P6|COMPLETED|Treatment Phase: First Intervention||7
2337834|NCT01746901|5738013|P5|COMPLETED|Treatment Phase: First Intervention||6
2337835|NCT01746901|5738014|P4|COMPLETED|Treatment Phase: First Intervention||6
2337836|NCT01746901|5738015|P3|COMPLETED|Treatment Phase: First Intervention||0
2337837|NCT01746901|5738016|P2|COMPLETED|Treatment Phase: First Intervention||0
2337838|NCT01746901|5738017|P1|COMPLETED|Treatment Phase: First Intervention||0
2337839|NCT01746901|5738009|P9|STARTED|Treatment Phase: First Intervention||7
2337840|NCT01746901|5738010|P8|STARTED|Treatment Phase: First Intervention||7
2337841|NCT01746901|5738011|P7|STARTED|Treatment Phase: First Intervention||8
2337842|NCT01746901|5738012|P6|STARTED|Treatment Phase: First Intervention||7
2337843|NCT01746901|5738013|P5|STARTED|Treatment Phase: First Intervention||6
2337844|NCT01746901|5738014|P4|STARTED|Treatment Phase: First Intervention||6
2337845|NCT01746901|5738015|P3|STARTED|Treatment Phase: First Intervention||0
2337846|NCT01746901|5738016|P2|STARTED|Treatment Phase: First Intervention||0
2337847|NCT01746901|5738017|P1|STARTED|Treatment Phase: First Intervention||0
2337848|NCT01746901|5738009|P9|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
2337849|NCT01746901|5738010|P8|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
2337850|NCT01746901|5738011|P7|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
2337851|NCT01746901|5738012|P6|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
2337852|NCT01746901|5738013|P5|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
2337853|NCT01746901|5738014|P4|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
2337854|NCT01746901|5738015|P3|NOT COMPLETED|Drug Discrimination Phase: Day 2||14
2337855|NCT01746901|5738016|P2|NOT COMPLETED|Drug Discrimination Phase: Day 2||14
2337856|NCT01746901|5738017|P1|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
2337857|NCT01746901|5738009|P9|COMPLETED|Drug Discrimination Phase: Day 2||0
2337858|NCT01746901|5738010|P8|COMPLETED|Drug Discrimination Phase: Day 2||0
2337859|NCT01746901|5738011|P7|COMPLETED|Drug Discrimination Phase: Day 2||0
2337860|NCT01746901|5738012|P6|COMPLETED|Drug Discrimination Phase: Day 2||0
2337861|NCT01746901|5738013|P5|COMPLETED|Drug Discrimination Phase: Day 2||0
2337862|NCT01746901|5738014|P4|COMPLETED|Drug Discrimination Phase: Day 2||0
2337863|NCT01746901|5738015|P3|COMPLETED|Drug Discrimination Phase: Day 2||22
2337864|NCT01746901|5738016|P2|COMPLETED|Drug Discrimination Phase: Day 2||19
2337865|NCT01746901|5738017|P1|COMPLETED|Drug Discrimination Phase: Day 2||0
2337866|NCT01746901|5738009|P9|STARTED|Drug Discrimination Phase: Day 2||0
2337867|NCT01746901|5738010|P8|STARTED|Drug Discrimination Phase: Day 2||0
2337868|NCT01746901|5738011|P7|STARTED|Drug Discrimination Phase: Day 2||0
2337869|NCT01746901|5738012|P6|STARTED|Drug Discrimination Phase: Day 2||0
2337870|NCT01746901|5738013|P5|STARTED|Drug Discrimination Phase: Day 2||0
2337871|NCT01746901|5738014|P4|STARTED|Drug Discrimination Phase: Day 2||0
2337872|NCT01746901|5738015|P3|STARTED|Drug Discrimination Phase: Day 2||36
2337873|NCT01746901|5738016|P2|STARTED|Drug Discrimination Phase: Day 2||33
2337874|NCT01746901|5738017|P1|STARTED|Drug Discrimination Phase: Day 2||0
2337875|NCT01746901|5738009|P9|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
2337964|NCT01746732|5738405|P3|COMPLETED|Period 2||7
2337876|NCT01746901|5738010|P8|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
2337877|NCT01746901|5738011|P7|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
2337878|NCT01746901|5738012|P6|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
2337879|NCT01746901|5738013|P5|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
2337880|NCT01746901|5738014|P4|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
2337881|NCT01746901|5738015|P3|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
2337882|NCT01746901|5738016|P2|NOT COMPLETED|Drug Discrimination Phase: Day 1||3
2337883|NCT01746901|5738017|P1|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
2337884|NCT01746901|5738009|P9|COMPLETED|Drug Discrimination Phase: Day 1||0
2337885|NCT01746901|5738010|P8|COMPLETED|Drug Discrimination Phase: Day 1||0
2337886|NCT01746901|5738011|P7|COMPLETED|Drug Discrimination Phase: Day 1||0
2337887|NCT01746901|5738012|P6|COMPLETED|Drug Discrimination Phase: Day 1||0
2337888|NCT01746901|5738013|P5|COMPLETED|Drug Discrimination Phase: Day 1||0
2337889|NCT01746901|5738014|P4|COMPLETED|Drug Discrimination Phase: Day 1||0
2337890|NCT01746901|5738015|P3|COMPLETED|Drug Discrimination Phase: Day 1||36
2337891|NCT01746901|5738016|P2|COMPLETED|Drug Discrimination Phase: Day 1||33
2337892|NCT01746901|5738017|P1|COMPLETED|Drug Discrimination Phase: Day 1||0
2337893|NCT01746901|5738009|P9|STARTED|Drug Discrimination Phase: Day 1||0
2337894|NCT01746901|5738010|P8|STARTED|Drug Discrimination Phase: Day 1||0
2337895|NCT01746901|5738011|P7|STARTED|Drug Discrimination Phase: Day 1||0
2337896|NCT01746901|5738012|P6|STARTED|Drug Discrimination Phase: Day 1||0
2337897|NCT01746901|5738013|P5|STARTED|Drug Discrimination Phase: Day 1||0
2337898|NCT01746901|5738014|P4|STARTED|Drug Discrimination Phase: Day 1||0
2337899|NCT01746901|5738015|P3|STARTED|Drug Discrimination Phase: Day 1||36
2337900|NCT01746901|5738016|P2|STARTED|Drug Discrimination Phase: Day 1||36
2337901|NCT01746901|5738017|P1|STARTED|Drug Discrimination Phase: Day 1||0
2337902|NCT01746901|5738009|P9|NOT COMPLETED|Naloxone Challenge Phase||0
2337903|NCT01746901|5738010|P8|NOT COMPLETED|Naloxone Challenge Phase||0
2337904|NCT01746901|5738011|P7|NOT COMPLETED|Naloxone Challenge Phase||0
2337905|NCT01746901|5738012|P6|NOT COMPLETED|Naloxone Challenge Phase||0
2337906|NCT01746901|5738013|P5|NOT COMPLETED|Naloxone Challenge Phase||0
2337907|NCT01746901|5738014|P4|NOT COMPLETED|Naloxone Challenge Phase||0
2337908|NCT01746901|5738015|P3|NOT COMPLETED|Naloxone Challenge Phase||0
2337909|NCT01746901|5738016|P2|NOT COMPLETED|Naloxone Challenge Phase||0
2337910|NCT01746901|5738017|P1|NOT COMPLETED|Naloxone Challenge Phase||3
2337911|NCT01746901|5738009|P9|COMPLETED|Naloxone Challenge Phase||0
2337912|NCT01746901|5738010|P8|COMPLETED|Naloxone Challenge Phase||0
2337913|NCT01746901|5738011|P7|COMPLETED|Naloxone Challenge Phase||0
2337914|NCT01746901|5738012|P6|COMPLETED|Naloxone Challenge Phase||0
2337915|NCT01746901|5738013|P5|COMPLETED|Naloxone Challenge Phase||0
2337916|NCT01746901|5738014|P4|COMPLETED|Naloxone Challenge Phase||0
2337917|NCT01746901|5738015|P3|COMPLETED|Naloxone Challenge Phase||0
2337918|NCT01746901|5738016|P2|COMPLETED|Naloxone Challenge Phase||0
2337919|NCT01746901|5738017|P1|COMPLETED|Naloxone Challenge Phase||72
2337920|NCT01746901|5738009|P9|STARTED|Naloxone Challenge Phase||0
2337921|NCT01746901|5738010|P8|STARTED|Naloxone Challenge Phase||0
2337922|NCT01746901|5738011|P7|STARTED|Naloxone Challenge Phase||0
2337923|NCT01746901|5738012|P6|STARTED|Naloxone Challenge Phase||0
2337924|NCT01746901|5738013|P5|STARTED|Naloxone Challenge Phase||0
2337925|NCT01746901|5738014|P4|STARTED|Naloxone Challenge Phase||0
2337926|NCT01746901|5738015|P3|STARTED|Naloxone Challenge Phase||0
2337927|NCT01746901|5738016|P2|STARTED|Naloxone Challenge Phase||0
2337928|NCT01746901|5738017|P1|STARTED|Naloxone Challenge Phase||75
2337929|NCT01746862|5738340|P2|NOT COMPLETED|Overall Study||3
2337930|NCT01746862|5738341|P1|NOT COMPLETED|Overall Study||8
2337931|NCT01746862|5738340|P2|COMPLETED|Overall Study||27
2337932|NCT01746862|5738341|P1|COMPLETED|Overall Study||52
2337933|NCT01746862|5738340|P2|Treated|Overall Study||30
2337934|NCT01746862|5738341|P1|Treated|Overall Study||59
2337935|NCT01746862|5738340|P2|STARTED|Overall Study||30
2337936|NCT01746862|5738341|P1|STARTED|Overall Study||60
2337937|NCT01746784|5738366|P5|NOT COMPLETED|Overall Study||0
2337938|NCT01746784|5738367|P4|NOT COMPLETED|Overall Study||0
2337939|NCT01746784|5738368|P3|NOT COMPLETED|Overall Study||0
2337940|NCT01746784|5738369|P2|NOT COMPLETED|Overall Study||0
2337941|NCT01746784|5738370|P1|NOT COMPLETED|Overall Study||0
2337942|NCT01746784|5738366|P5|COMPLETED|Overall Study||19
2337943|NCT01746784|5738367|P4|COMPLETED|Overall Study||9
2337944|NCT01746784|5738368|P3|COMPLETED|Overall Study||9
2337945|NCT01746784|5738369|P2|COMPLETED|Overall Study||10
2337946|NCT01746784|5738370|P1|COMPLETED|Overall Study||19
2337947|NCT01746784|5738366|P5|Enrolled|Overall Study||19
2337948|NCT01746784|5738367|P4|Enrolled|Overall Study||9
2337949|NCT01746784|5738368|P3|Enrolled|Overall Study||9
2337950|NCT01746784|5738369|P2|Enrolled|Overall Study||10
2337951|NCT01746784|5738370|P1|Enrolled|Overall Study||19
2337952|NCT01746784|5738366|P5|STARTED|Overall Study||19
2337953|NCT01746784|5738367|P4|STARTED|Overall Study||9
2337954|NCT01746784|5738368|P3|STARTED|Overall Study||9
2337955|NCT01746784|5738369|P2|STARTED|Overall Study||10
2337956|NCT01746784|5738370|P1|STARTED|Overall Study||19
2337957|NCT01746745|5738392|P1|NOT COMPLETED|Overall Study||0
2337958|NCT01746745|5738392|P1|COMPLETED|Overall Study||6
2337959|NCT01746745|5738392|P1|Received Study Drug|Overall Study||6
2337960|NCT01746745|5738392|P1|STARTED|Overall Study||6
2337961|NCT01746732|5738405|P3|NOT COMPLETED|Period 2||4
2337962|NCT01746732|5738406|P2|NOT COMPLETED|Period 2||0
2337963|NCT01746732|5738407|P1|NOT COMPLETED|Period 2||0
2337965|NCT01746732|5738406|P2|COMPLETED|Period 2||10
2337966|NCT01746732|5738407|P1|COMPLETED|Period 2||0
2337967|NCT01746732|5738405|P3|STARTED|Period 2||11
2337968|NCT01746732|5738406|P2|STARTED|Period 2||10
2337969|NCT01746732|5738407|P1|STARTED|Period 2||0
2337970|NCT01746732|5738405|P3|NOT COMPLETED|Period 1||0
2337971|NCT01746732|5738406|P2|NOT COMPLETED|Period 1||1
2337972|NCT01746732|5738407|P1|NOT COMPLETED|Period 1||0
2337973|NCT01746732|5738405|P3|COMPLETED|Period 1||11
2337974|NCT01746732|5738406|P2|COMPLETED|Period 1||10
2337975|NCT01746732|5738407|P1|COMPLETED|Period 1||0
2337976|NCT01746732|5738405|P3|STARTED|Period 1||11
2337977|NCT01746732|5738406|P2|STARTED|Period 1||11
2337978|NCT01746732|5738407|P1|STARTED|Period 1||0
2337979|NCT01746732|5738405|P3|NOT COMPLETED|Lead-In Period||0
2337980|NCT01746732|5738406|P2|NOT COMPLETED|Lead-In Period||0
2337981|NCT01746732|5738407|P1|NOT COMPLETED|Lead-In Period||1
2337982|NCT01746732|5738405|P3|COMPLETED|Lead-In Period||0
2337983|NCT01746732|5738406|P2|COMPLETED|Lead-In Period||0
2337984|NCT01746732|5738407|P1|COMPLETED|Lead-In Period||22
2337985|NCT01746732|5738405|P3|Participants Received at Least 1 Dose|Lead-In Period||0
2337986|NCT01746732|5738406|P2|Participants Received at Least 1 Dose|Lead-In Period||0
2337987|NCT01746732|5738407|P1|Participants Received at Least 1 Dose|Lead-In Period||22
2337988|NCT01746732|5738405|P3|STARTED|Lead-In Period||0
2337989|NCT01746732|5738406|P2|STARTED|Lead-In Period||0
2337990|NCT01746732|5738407|P1|STARTED|Lead-In Period||23
2337991|NCT01746511|5738430|P2|NOT COMPLETED|Overall Study||0
2337992|NCT01746511|5738431|P1|NOT COMPLETED|Overall Study||0
2337993|NCT01746511|5738430|P2|COMPLETED|Overall Study||39
2337994|NCT01746511|5738431|P1|COMPLETED|Overall Study||40
2337995|NCT01746511|5738430|P2|STARTED|Overall Study||39
2337996|NCT01746511|5738431|P1|STARTED|Overall Study||40
2337997|NCT01746420|5738450|P5|NOT COMPLETED|Overall Study||0
2337998|NCT01746420|5738451|P4|NOT COMPLETED|Overall Study||0
2337999|NCT01746420|5738452|P3|NOT COMPLETED|Overall Study||3
2338000|NCT01746420|5738453|P2|NOT COMPLETED|Overall Study||2
2338001|NCT01746420|5738454|P1|NOT COMPLETED|Overall Study||3
2338002|NCT01746420|5738450|P5|COMPLETED|Overall Study||20
2338003|NCT01746420|5738451|P4|COMPLETED|Overall Study||20
2338004|NCT01746420|5738452|P3|COMPLETED|Overall Study||17
2338005|NCT01746420|5738453|P2|COMPLETED|Overall Study||18
2338006|NCT01746420|5738454|P1|COMPLETED|Overall Study||17
2338007|NCT01746420|5738450|P5|STARTED|Overall Study||20
2338008|NCT01746420|5738451|P4|STARTED|Overall Study||20
2338009|NCT01746420|5738452|P3|STARTED|Overall Study||20
2338010|NCT01746420|5738453|P2|STARTED|Overall Study||20
2338011|NCT01746420|5738454|P1|STARTED|Overall Study||20
2338012|NCT01746368|5738488|P2|NOT COMPLETED|Overall Study||1
2338013|NCT01746368|5738489|P1|NOT COMPLETED|Overall Study||2
2338014|NCT01746368|5738488|P2|COMPLETED|Overall Study||16
2338015|NCT01746368|5738489|P1|COMPLETED|Overall Study||31
2338016|NCT01746368|5738488|P2|Analyzed for Satisfaction|Overall Study||16
2338017|NCT01746368|5738489|P1|Analyzed for Satisfaction|Overall Study||30
2338018|NCT01746368|5738488|P2|Analyzed for AD Completion Rate|Overall Study||17
2338019|NCT01746368|5738489|P1|Analyzed for AD Completion Rate|Overall Study||32
2338020|NCT01746368|5738488|P2|Assessment Completed|Overall Study||16
2338021|NCT01746368|5738489|P1|Assessment Completed|Overall Study||31
2338022|NCT01746368|5738488|P2|Recieved Allocated Intervention|Overall Study||8
2338023|NCT01746368|5738489|P1|Recieved Allocated Intervention|Overall Study||31
2338024|NCT01746368|5738488|P2|STARTED|Overall Study||17
2338025|NCT01746368|5738489|P1|STARTED|Overall Study||33
2338026|NCT01746264|5738497|P1|NOT COMPLETED|Overall Study||0
2338027|NCT01746264|5738497|P1|COMPLETED|Overall Study||19
2338028|NCT01746264|5738497|P1|STARTED|Overall Study||19
2338029|NCT01746173|5738516|P1|NOT COMPLETED|Overall Study||2
2338030|NCT01746173|5738516|P1|COMPLETED|Overall Study||3
2338031|NCT01746173|5738516|P1|STARTED|Overall Study||5
2338032|NCT01746108|5738524|P3|NOT COMPLETED|Overall Study||0
2338033|NCT01746108|5738525|P2|NOT COMPLETED|Overall Study||4
2338034|NCT01746108|5738526|P1|NOT COMPLETED|Overall Study||0
2338035|NCT01746108|5738524|P3|COMPLETED|Overall Study||6
2338036|NCT01746108|5738525|P2|COMPLETED|Overall Study||24
2338037|NCT01746108|5738526|P1|COMPLETED|Overall Study||18
2338038|NCT01746108|5738524|P3|STARTED|Overall Study||6
2338039|NCT01746108|5738525|P2|STARTED|Overall Study||28
2338040|NCT01746108|5738526|P1|STARTED|Overall Study||18
2338041|NCT01746095|5738566|P4|NOT COMPLETED|Overall Study||8
2338042|NCT01746095|5738567|P3|NOT COMPLETED|Overall Study||13
2338043|NCT01746095|5738568|P2|NOT COMPLETED|Overall Study||4
2338044|NCT01746095|5738569|P1|NOT COMPLETED|Overall Study||4
2338045|NCT01746095|5738566|P4|COMPLETED|Overall Study||15
2338046|NCT01746095|5738567|P3|COMPLETED|Overall Study||11
2338047|NCT01746095|5738568|P2|COMPLETED|Overall Study||16
2338048|NCT01746095|5738569|P1|COMPLETED|Overall Study||16
2338049|NCT01746095|5738566|P4|STARTED|Overall Study||23
2338050|NCT01746095|5738567|P3|STARTED|Overall Study||24
2338051|NCT01746095|5738568|P2|STARTED|Overall Study||20
2338052|NCT01746095|5738569|P1|STARTED|Overall Study||20
2338053|NCT01746043|5738619|P4|NOT COMPLETED|Overall Study||0
2338054|NCT01746043|5738620|P3|NOT COMPLETED|Overall Study||0
2338055|NCT01746043|5738621|P2|NOT COMPLETED|Overall Study||0
2338056|NCT01746043|5738622|P1|NOT COMPLETED|Overall Study||0
2338057|NCT01746043|5738619|P4|COMPLETED|Overall Study||5
2338058|NCT01746043|5738620|P3|COMPLETED|Overall Study||5
2338059|NCT01746043|5738621|P2|COMPLETED|Overall Study||4
2338060|NCT01746043|5738622|P1|COMPLETED|Overall Study||5
2338061|NCT01746043|5738619|P4|STARTED|Overall Study||5
2338062|NCT01746043|5738620|P3|STARTED|Overall Study||5
2338063|NCT01746043|5738621|P2|STARTED|Overall Study||4
2338064|NCT01746043|5738622|P1|STARTED|Overall Study||5
2338065|NCT01746017|5738643|P11|NOT COMPLETED|Period 4||0
2338066|NCT01746017|5738644|P10|NOT COMPLETED|Period 4||0
2338067|NCT01746017|5738645|P9|NOT COMPLETED|Period 4||0
2338068|NCT01746017|5738646|P8|NOT COMPLETED|Period 4||0
2338069|NCT01746017|5738647|P7|NOT COMPLETED|Period 4||0
2338070|NCT01746017|5738648|P6|NOT COMPLETED|Period 4||0
2338071|NCT01746017|5738649|P5|NOT COMPLETED|Period 4||0
2338072|NCT01746017|5738650|P4|NOT COMPLETED|Period 4||0
2338073|NCT01746017|5738651|P3|NOT COMPLETED|Period 4||0
2338074|NCT01746017|5738652|P2|NOT COMPLETED|Period 4||0
2338075|NCT01746017|5738653|P1|NOT COMPLETED|Period 4||0
2338076|NCT01746017|5738643|P11|COMPLETED|Period 4||0
2338077|NCT01746017|5738644|P10|COMPLETED|Period 4||0
2338078|NCT01746017|5738645|P9|COMPLETED|Period 4||0
2338079|NCT01746017|5738646|P8|COMPLETED|Period 4||2
2338080|NCT01746017|5738647|P7|COMPLETED|Period 4||2
2338081|NCT01746017|5738648|P6|COMPLETED|Period 4||1
2338082|NCT01746017|5738649|P5|COMPLETED|Period 4||2
2338083|NCT01746017|5738650|P4|COMPLETED|Period 4||2
2338084|NCT01746017|5738651|P3|COMPLETED|Period 4||2
2338085|NCT01746017|5738652|P2|COMPLETED|Period 4||2
2338086|NCT01746017|5738653|P1|COMPLETED|Period 4||2
2338087|NCT01746017|5738643|P11|STARTED|Period 4|Part B occurred only for 3 periods.|0
2338088|NCT01746017|5738644|P10|STARTED|Period 4|Part B occurred only for 3 periods.|0
2338089|NCT01746017|5738645|P9|STARTED|Period 4|Part B occurred only for 3 periods.|0
2338090|NCT01746017|5738646|P8|STARTED|Period 4||2
2338091|NCT01746017|5738647|P7|STARTED|Period 4||2
2338092|NCT01746017|5738648|P6|STARTED|Period 4||1
2338093|NCT01746017|5738649|P5|STARTED|Period 4||2
2338094|NCT01746017|5738650|P4|STARTED|Period 4||2
2338095|NCT01746017|5738651|P3|STARTED|Period 4||2
2338096|NCT01746017|5738652|P2|STARTED|Period 4||2
2338097|NCT01746017|5738653|P1|STARTED|Period 4||2
2338098|NCT01746017|5738643|P11|NOT COMPLETED|Period 3||0
2338099|NCT01746017|5738644|P10|NOT COMPLETED|Period 3||0
2338100|NCT01746017|5738645|P9|NOT COMPLETED|Period 3||0
2338101|NCT01746017|5738646|P8|NOT COMPLETED|Period 3||0
2338102|NCT01746017|5738647|P7|NOT COMPLETED|Period 3||0
2338103|NCT01746017|5738648|P6|NOT COMPLETED|Period 3||1
2338104|NCT01746017|5738649|P5|NOT COMPLETED|Period 3||0
2338105|NCT01746017|5738650|P4|NOT COMPLETED|Period 3||0
2338106|NCT01746017|5738651|P3|NOT COMPLETED|Period 3||0
2338107|NCT01746017|5738652|P2|NOT COMPLETED|Period 3||0
2338108|NCT01746017|5738653|P1|NOT COMPLETED|Period 3||0
2338109|NCT01746017|5738643|P11|COMPLETED|Period 3||3
2338110|NCT01746017|5738644|P10|COMPLETED|Period 3||3
2338111|NCT01746017|5738645|P9|COMPLETED|Period 3||3
2338112|NCT01746017|5738646|P8|COMPLETED|Period 3||2
2338113|NCT01746017|5738647|P7|COMPLETED|Period 3||2
2338114|NCT01746017|5738648|P6|COMPLETED|Period 3||1
2338115|NCT01746017|5738649|P5|COMPLETED|Period 3||2
2338116|NCT01746017|5738650|P4|COMPLETED|Period 3||2
2338117|NCT01746017|5738651|P3|COMPLETED|Period 3||2
2338118|NCT01746017|5738652|P2|COMPLETED|Period 3||2
2338119|NCT01746017|5738653|P1|COMPLETED|Period 3||2
2338120|NCT01746017|5738643|P11|STARTED|Period 3||3
2338121|NCT01746017|5738644|P10|STARTED|Period 3||3
2338122|NCT01746017|5738645|P9|STARTED|Period 3||3
2338123|NCT01746017|5738646|P8|STARTED|Period 3||2
2338124|NCT01746017|5738647|P7|STARTED|Period 3||2
2338125|NCT01746017|5738648|P6|STARTED|Period 3||2
2338126|NCT01746017|5738649|P5|STARTED|Period 3||2
2338127|NCT01746017|5738650|P4|STARTED|Period 3||2
2338128|NCT01746017|5738651|P3|STARTED|Period 3||2
2338129|NCT01746017|5738652|P2|STARTED|Period 3||2
2338130|NCT01746017|5738653|P1|STARTED|Period 3||2
2338131|NCT01746017|5738643|P11|NOT COMPLETED|Period 2||0
2338132|NCT01746017|5738644|P10|NOT COMPLETED|Period 2||0
2338133|NCT01746017|5738645|P9|NOT COMPLETED|Period 2||0
2338134|NCT01746017|5738646|P8|NOT COMPLETED|Period 2||0
2338135|NCT01746017|5738647|P7|NOT COMPLETED|Period 2||0
2338136|NCT01746017|5738648|P6|NOT COMPLETED|Period 2||0
2338137|NCT01746017|5738649|P5|NOT COMPLETED|Period 2||0
2338138|NCT01746017|5738650|P4|NOT COMPLETED|Period 2||0
2338139|NCT01746017|5738651|P3|NOT COMPLETED|Period 2||0
2338140|NCT01746017|5738652|P2|NOT COMPLETED|Period 2||0
2338141|NCT01746017|5738653|P1|NOT COMPLETED|Period 2||0
2338142|NCT01746017|5738643|P11|COMPLETED|Period 2||3
2338143|NCT01746017|5738644|P10|COMPLETED|Period 2||3
2338144|NCT01746017|5738645|P9|COMPLETED|Period 2||3
2338145|NCT01746017|5738646|P8|COMPLETED|Period 2||2
2338146|NCT01746017|5738647|P7|COMPLETED|Period 2||2
2338147|NCT01746017|5738648|P6|COMPLETED|Period 2||2
2338148|NCT01746017|5738649|P5|COMPLETED|Period 2||2
2338149|NCT01746017|5738650|P4|COMPLETED|Period 2||2
2338150|NCT01746017|5738651|P3|COMPLETED|Period 2||2
2338151|NCT01746017|5738652|P2|COMPLETED|Period 2||2
2338152|NCT01746017|5738653|P1|COMPLETED|Period 2||2
2338153|NCT01746017|5738643|P11|STARTED|Period 2||3
2338154|NCT01746017|5738644|P10|STARTED|Period 2||3
2338155|NCT01746017|5738645|P9|STARTED|Period 2||3
2338156|NCT01746017|5738646|P8|STARTED|Period 2||2
2338157|NCT01746017|5738647|P7|STARTED|Period 2||2
2338158|NCT01746017|5738648|P6|STARTED|Period 2||2
2338159|NCT01746017|5738649|P5|STARTED|Period 2||2
2338160|NCT01746017|5738650|P4|STARTED|Period 2||2
2338161|NCT01746017|5738651|P3|STARTED|Period 2||2
2338162|NCT01746017|5738652|P2|STARTED|Period 2||2
2338163|NCT01746017|5738653|P1|STARTED|Period 2||2
2338164|NCT01746017|5738643|P11|NOT COMPLETED|Period 1||0
2338165|NCT01746017|5738644|P10|NOT COMPLETED|Period 1||0
2338166|NCT01746017|5738645|P9|NOT COMPLETED|Period 1||0
2338167|NCT01746017|5738646|P8|NOT COMPLETED|Period 1||0
2338168|NCT01746017|5738647|P7|NOT COMPLETED|Period 1||1
2338169|NCT01746017|5738648|P6|NOT COMPLETED|Period 1||0
2338170|NCT01746017|5738649|P5|NOT COMPLETED|Period 1||0
2338171|NCT01746017|5738650|P4|NOT COMPLETED|Period 1||0
2338172|NCT01746017|5738651|P3|NOT COMPLETED|Period 1||0
2338173|NCT01746017|5738652|P2|NOT COMPLETED|Period 1||0
2338174|NCT01746017|5738653|P1|NOT COMPLETED|Period 1||0
2338175|NCT01746017|5738643|P11|COMPLETED|Period 1||3
2338176|NCT01746017|5738644|P10|COMPLETED|Period 1||3
2338177|NCT01746017|5738645|P9|COMPLETED|Period 1||3
2338178|NCT01746017|5738646|P8|COMPLETED|Period 1||2
2338179|NCT01746017|5738647|P7|COMPLETED|Period 1||2
2338180|NCT01746017|5738648|P6|COMPLETED|Period 1||2
2338181|NCT01746017|5738649|P5|COMPLETED|Period 1||2
2338182|NCT01746017|5738650|P4|COMPLETED|Period 1||2
2338183|NCT01746017|5738651|P3|COMPLETED|Period 1||2
2338184|NCT01746017|5738652|P2|COMPLETED|Period 1||2
2338185|NCT01746017|5738653|P1|COMPLETED|Period 1||2
2338186|NCT01746017|5738643|P11|Received at Least 1 Dose of Study Drug|Period 1||3
2338187|NCT01746017|5738644|P10|Received at Least 1 Dose of Study Drug|Period 1||3
2338188|NCT01746017|5738645|P9|Received at Least 1 Dose of Study Drug|Period 1||3
2338189|NCT01746017|5738646|P8|Received at Least 1 Dose of Study Drug|Period 1||2
2338190|NCT01746017|5738647|P7|Received at Least 1 Dose of Study Drug|Period 1||3
2338191|NCT01746017|5738648|P6|Received at Least 1 Dose of Study Drug|Period 1||2
2338192|NCT01746017|5738649|P5|Received at Least 1 Dose of Study Drug|Period 1||2
2338193|NCT01746017|5738650|P4|Received at Least 1 Dose of Study Drug|Period 1||2
2338194|NCT01746017|5738651|P3|Received at Least 1 Dose of Study Drug|Period 1||2
2338195|NCT01746017|5738652|P2|Received at Least 1 Dose of Study Drug|Period 1||2
2338196|NCT01746017|5738653|P1|Received at Least 1 Dose of Study Drug|Period 1||2
2338197|NCT01746017|5738643|P11|STARTED|Period 1||3
2338198|NCT01746017|5738644|P10|STARTED|Period 1||3
2338199|NCT01746017|5738645|P9|STARTED|Period 1||3
2338200|NCT01746017|5738646|P8|STARTED|Period 1||2
2338201|NCT01746017|5738647|P7|STARTED|Period 1||3
2338202|NCT01746017|5738648|P6|STARTED|Period 1||2
2338203|NCT01746017|5738649|P5|STARTED|Period 1||2
2338204|NCT01746017|5738650|P4|STARTED|Period 1||2
2338205|NCT01746017|5738651|P3|STARTED|Period 1||2
2338206|NCT01746017|5738652|P2|STARTED|Period 1||2
2338207|NCT01746017|5738653|P1|STARTED|Period 1||2
2338208|NCT01745952|5738729|P3|NOT COMPLETED|Overall Study||0
2338209|NCT01745952|5738730|P2|NOT COMPLETED|Overall Study||1
2338210|NCT01745952|5738731|P1|NOT COMPLETED|Overall Study||1
2338211|NCT01745952|5738729|P3|COMPLETED|Overall Study||3
2338212|NCT01745952|5738730|P2|COMPLETED|Overall Study|data of one patient not used due to no seizure diary entries on multiple occasions|3
2338213|NCT01745952|5738731|P1|COMPLETED|Overall Study||3
2338214|NCT01745952|5738729|P3|STARTED|Overall Study||3
2338215|NCT01745952|5738730|P2|STARTED|Overall Study||4
2338216|NCT01745952|5738731|P1|STARTED|Overall Study||4
2338217|NCT01745913|5738757|P2|NOT COMPLETED|Overall Study||1
2338218|NCT01745913|5738758|P1|NOT COMPLETED|Overall Study||1
2338219|NCT01745913|5738757|P2|COMPLETED|Overall Study||0
2338220|NCT01745913|5738758|P1|COMPLETED|Overall Study||0
2338221|NCT01745913|5738757|P2|STARTED|Overall Study||1
2338222|NCT01745913|5738758|P1|STARTED|Overall Study||1
2338223|NCT01745848|5738774|P1|NOT COMPLETED|Overall Study||6
2338224|NCT01745848|5738774|P1|COMPLETED|Overall Study||20
2338225|NCT01745848|5738774|P1|STARTED|Overall Study||26
2338226|NCT01745393|5738781|P2|NOT COMPLETED|12-month Follow-up||5
2338227|NCT01745393|5738782|P1|NOT COMPLETED|12-month Follow-up||6
2338228|NCT01745393|5738781|P2|COMPLETED|12-month Follow-up||151
2338229|NCT01745393|5738782|P1|COMPLETED|12-month Follow-up||136
2338230|NCT01745393|5738781|P2|STARTED|12-month Follow-up||156
2338231|NCT01745393|5738782|P1|STARTED|12-month Follow-up||142
2338232|NCT01745393|5738781|P2|NOT COMPLETED|Treatment to End-of-treatment Assessment||8
2338233|NCT01745393|5738782|P1|NOT COMPLETED|Treatment to End-of-treatment Assessment||21
2338234|NCT01745393|5738781|P2|COMPLETED|Treatment to End-of-treatment Assessment||156
2338235|NCT01745393|5738782|P1|COMPLETED|Treatment to End-of-treatment Assessment||142
2338236|NCT01745393|5738781|P2|Received Treatment|Treatment to End-of-treatment Assessment|Attention control = nutrition education via telephone|144
2338237|NCT01745393|5738782|P1|Received Treatment|Treatment to End-of-treatment Assessment|Behavioral counseling = TSE-reduction and cessation counseling via telephone|147
2338238|NCT01745393|5738781|P2|STARTED|Treatment to End-of-treatment Assessment||164
2338239|NCT01745393|5738782|P1|STARTED|Treatment to End-of-treatment Assessment||163
2338240|NCT01745380|5738794|P2|NOT COMPLETED|Overall Study||1
2338241|NCT01745380|5738795|P1|NOT COMPLETED|Overall Study||1
2338242|NCT01745380|5738794|P2|COMPLETED|Overall Study||49
2338243|NCT01745380|5738795|P1|COMPLETED|Overall Study||99
2338244|NCT01745380|5738794|P2|STARTED|Overall Study||50
2338245|NCT01745380|5738795|P1|STARTED|Overall Study||100
2338246|NCT01745146|5738833|P2|NOT COMPLETED|Overall Study||3
2338247|NCT01745146|5738834|P1|NOT COMPLETED|Overall Study||3
2338248|NCT01745146|5738833|P2|COMPLETED|Overall Study||57
2338249|NCT01745146|5738834|P1|COMPLETED|Overall Study||27
2338250|NCT01745146|5738833|P2|Analysis|Overall Study||57
2338251|NCT01745146|5738834|P1|Analysis|Overall Study||27
2338252|NCT01745146|5738833|P2|Primary Outcome Assessment|Overall Study||57
2338253|NCT01745146|5738834|P1|Primary Outcome Assessment|Overall Study||27
2338254|NCT01745146|5738833|P2|Allocation to Intervention|Overall Study||60
2338255|NCT01745146|5738834|P1|Allocation to Intervention|Overall Study||30
2338256|NCT01745146|5738833|P2|STARTED|Overall Study||60
2338257|NCT01745146|5738834|P1|STARTED|Overall Study||30
2338258|NCT01745133|5738844|P3|NOT COMPLETED|Overall Study||4
2338259|NCT01745133|5738845|P2|NOT COMPLETED|Overall Study||4
2338260|NCT01745133|5738846|P1|NOT COMPLETED|Overall Study||6
2338261|NCT01745133|5738844|P3|COMPLETED|Overall Study||15
2338262|NCT01745133|5738845|P2|COMPLETED|Overall Study||16
2338263|NCT01745133|5738846|P1|COMPLETED|Overall Study||13
2338264|NCT01745133|5738844|P3|STARTED|Overall Study||19
2338265|NCT01745133|5738845|P2|STARTED|Overall Study||20
2338266|NCT01745133|5738846|P1|STARTED|Overall Study||19
2338267|NCT01745120|5738856|P2|NOT COMPLETED|Overall Study||0
2338268|NCT01745120|5738857|P1|NOT COMPLETED|Overall Study||1
2338269|NCT01745120|5738856|P2|COMPLETED|Overall Study||8
2338270|NCT01745120|5738857|P1|COMPLETED|Overall Study||10
2338271|NCT01745120|5738856|P2|STARTED|Overall Study||8
2338272|NCT01745120|5738857|P1|STARTED|Overall Study||11
2338273|NCT01745094|5738915|P4|NOT COMPLETED|Overall Study||3
2338274|NCT01745094|5738916|P3|NOT COMPLETED|Overall Study||12
2338275|NCT01745094|5738917|P2|NOT COMPLETED|Overall Study||0
2338276|NCT01745094|5738918|P1|NOT COMPLETED|Overall Study||5
2338277|NCT01745094|5738915|P4|COMPLETED|Overall Study||90
2338278|NCT01745094|5738916|P3|COMPLETED|Overall Study||46
2338279|NCT01745094|5738917|P2|COMPLETED|Overall Study||37
2338280|NCT01745094|5738918|P1|COMPLETED|Overall Study||30
2338281|NCT01745094|5738915|P4|STARTED|Overall Study||93
2338282|NCT01745094|5738916|P3|STARTED|Overall Study||58
2338283|NCT01745094|5738917|P2|STARTED|Overall Study||37
2338284|NCT01745094|5738918|P1|STARTED|Overall Study||35
2338285|NCT01745055|5738984|P1|NOT COMPLETED|Overall Study||0
2338286|NCT01745055|5738984|P1|COMPLETED|Overall Study||12
2338287|NCT01745055|5738984|P1|STARTED|Overall Study||12
2338288|NCT01744977|5739019|P2|NOT COMPLETED|Overall Study||5
2338289|NCT01744977|5739020|P1|NOT COMPLETED|Overall Study||11
2338290|NCT01744977|5739019|P2|COMPLETED|Overall Study||115
2338291|NCT01744977|5739020|P1|COMPLETED|Overall Study||109
2338292|NCT01744977|5739019|P2|6 Month Completed|Overall Study||115
2338293|NCT01744977|5739020|P1|6 Month Completed|Overall Study||113
2338294|NCT01744977|5739019|P2|STARTED|Overall Study||120
2338295|NCT01744977|5739020|P1|STARTED|Overall Study||120
2338296|NCT01744860|5739028|P1|NOT COMPLETED|Overall Study||0
2338297|NCT01744860|5739028|P1|COMPLETED|Overall Study||420
2338298|NCT01744860|5739028|P1|STARTED|Overall Study||420
2338299|NCT01744821|5739066|P4|NOT COMPLETED|Overall Study||0
2338300|NCT01744821|5739067|P3|NOT COMPLETED|Overall Study||0
2338301|NCT01744821|5739068|P2|NOT COMPLETED|Overall Study||0
2338302|NCT01744821|5739069|P1|NOT COMPLETED|Overall Study||0
2338303|NCT01744821|5739066|P4|COMPLETED|Overall Study||1
2338304|NCT01744821|5739067|P3|COMPLETED|Overall Study||2
2338305|NCT01744821|5739068|P2|COMPLETED|Overall Study||3
2338306|NCT01744821|5739069|P1|COMPLETED|Overall Study||1
2338307|NCT01744821|5739066|P4|STARTED|Overall Study||1
2338308|NCT01744821|5739067|P3|STARTED|Overall Study||2
2338309|NCT01744821|5739068|P2|STARTED|Overall Study||3
2338310|NCT01744821|5739069|P1|STARTED|Overall Study||1
2338311|NCT01744782|5739091|P1|NOT COMPLETED|Overall Study||1
2338312|NCT01744782|5739091|P1|COMPLETED|Overall Study||16
2338313|NCT01744782|5739091|P1|STARTED|Overall Study||17
2338314|NCT01744730|5739104|P5|NOT COMPLETED|Overall Study||0
2338315|NCT01744730|5739105|P4|NOT COMPLETED|Overall Study||0
2338316|NCT01744730|5739106|P3|NOT COMPLETED|Overall Study||0
2338317|NCT01744730|5739107|P2|NOT COMPLETED|Overall Study||0
2338318|NCT01744730|5739108|P1|NOT COMPLETED|Overall Study||0
2338319|NCT01744730|5739104|P5|COMPLETED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
2338320|NCT01744730|5739105|P4|COMPLETED|Overall Study||11
2338321|NCT01744730|5739106|P3|COMPLETED|Overall Study||4
2338322|NCT01744730|5739107|P2|COMPLETED|Overall Study||3
2338323|NCT01744730|5739108|P1|COMPLETED|Overall Study||4
2338324|NCT01744730|5739104|P5|STARTED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
2338325|NCT01744730|5739105|P4|STARTED|Overall Study||11
2338326|NCT01744730|5739106|P3|STARTED|Overall Study||4
2338327|NCT01744730|5739107|P2|STARTED|Overall Study||3
2338328|NCT01744730|5739108|P1|STARTED|Overall Study||4
2338329|NCT01744704|5739162|P12|NOT COMPLETED|Overall Study||0
2338330|NCT01744704|5739163|P11|NOT COMPLETED|Overall Study||0
2338331|NCT01744704|5739164|P10|NOT COMPLETED|Overall Study||0
2338332|NCT01744704|5739165|P9|NOT COMPLETED|Overall Study||0
2338333|NCT01744704|5739166|P8|NOT COMPLETED|Overall Study||0
2338334|NCT01744704|5739167|P7|NOT COMPLETED|Overall Study||0
2338335|NCT01744704|5739168|P6|NOT COMPLETED|Overall Study||0
2338336|NCT01744704|5739169|P5|NOT COMPLETED|Overall Study||0
2338337|NCT01744704|5739170|P4|NOT COMPLETED|Overall Study||0
2338338|NCT01744704|5739171|P3|NOT COMPLETED|Overall Study||0
2338339|NCT01744704|5739172|P2|NOT COMPLETED|Overall Study||0
2338340|NCT01744704|5739173|P1|NOT COMPLETED|Overall Study||0
2338341|NCT01744704|5739162|P12|COMPLETED|Overall Study||10
2338342|NCT01744704|5739163|P11|COMPLETED|Overall Study||9
2338343|NCT01744704|5739164|P10|COMPLETED|Overall Study||9
2338344|NCT01744704|5739165|P9|COMPLETED|Overall Study||3
2338345|NCT01744704|5739166|P8|COMPLETED|Overall Study||9
2338346|NCT01744704|5739167|P7|COMPLETED|Overall Study||6
2338347|NCT01744704|5739168|P6|COMPLETED|Overall Study||7
2338348|NCT01744704|5739169|P5|COMPLETED|Overall Study||6
2338349|NCT01744704|5739170|P4|COMPLETED|Overall Study||6
2338350|NCT01744704|5739171|P3|COMPLETED|Overall Study||3
2338351|NCT01744704|5739172|P2|COMPLETED|Overall Study||3
2338352|NCT01744704|5739173|P1|COMPLETED|Overall Study||3
2338353|NCT01744704|5739162|P12|STARTED|Overall Study||10
2338354|NCT01744704|5739163|P11|STARTED|Overall Study||9
2338355|NCT01744704|5739164|P10|STARTED|Overall Study||9
2338356|NCT01744704|5739165|P9|STARTED|Overall Study||3
2338357|NCT01744704|5739166|P8|STARTED|Overall Study||9
2338358|NCT01744704|5739167|P7|STARTED|Overall Study||6
2338359|NCT01744704|5739168|P6|STARTED|Overall Study||7
2338360|NCT01744704|5739169|P5|STARTED|Overall Study||6
2338361|NCT01744704|5739170|P4|STARTED|Overall Study||6
2338362|NCT01744704|5739171|P3|STARTED|Overall Study||3
2338363|NCT01744704|5739172|P2|STARTED|Overall Study||3
2338364|NCT01744704|5739173|P1|STARTED|Overall Study||3
2338365|NCT01744691|5739252|P1|NOT COMPLETED|Overall Study||43
2338366|NCT01744691|5739252|P1|COMPLETED|Overall Study|Participants who were on study treatment at the time of the primary analysis|101
2338367|NCT01744691|5739252|P1|STARTED|Overall Study|Participants who received study treatment|144
2338368|NCT01744574|5739261|P4|NOT COMPLETED|Overall Study||11
2338369|NCT01744574|5739262|P3|NOT COMPLETED|Overall Study||20
2338370|NCT01744574|5739263|P2|NOT COMPLETED|Overall Study||25
2338371|NCT01744574|5739264|P1|NOT COMPLETED|Overall Study||24
2338372|NCT01744574|5739261|P4|COMPLETED|Overall Study||40
2338373|NCT01744574|5739262|P3|COMPLETED|Overall Study||32
2338374|NCT01744574|5739263|P2|COMPLETED|Overall Study||31
2338375|NCT01744574|5739264|P1|COMPLETED|Overall Study||33
2338376|NCT01744574|5739261|P4|STARTED|Overall Study||51
2338377|NCT01744574|5739262|P3|STARTED|Overall Study||52
2338378|NCT01744574|5739263|P2|STARTED|Overall Study||56
2338379|NCT01744574|5739264|P1|STARTED|Overall Study||57
2338380|NCT01744496|5739300|P2|NOT COMPLETED|Maintenance Period||4
2338381|NCT01744496|5739301|P1|NOT COMPLETED|Maintenance Period||4
2338382|NCT01744496|5739300|P2|COMPLETED|Maintenance Period||29
2338383|NCT01744496|5739301|P1|COMPLETED|Maintenance Period||27
2338384|NCT01744496|5739300|P2|STARTED|Maintenance Period||33
2338385|NCT01744496|5739301|P1|STARTED|Maintenance Period||31
2338386|NCT01744496|5739300|P2|NOT COMPLETED|Titration Period||2
2338387|NCT01744496|5739301|P1|NOT COMPLETED|Titration Period||2
2338388|NCT01744496|5739300|P2|COMPLETED|Titration Period||33
2338389|NCT01744496|5739301|P1|COMPLETED|Titration Period||31
2338390|NCT01744496|5739300|P2|STARTED|Titration Period||35
2338391|NCT01744496|5739301|P1|STARTED|Titration Period||33
2338392|NCT01744483|5739322|P3|NOT COMPLETED|Overall Study||28
2338393|NCT01744483|5739323|P2|NOT COMPLETED|Overall Study||22
2338394|NCT01744483|5739324|P1|NOT COMPLETED|Overall Study||29
2338395|NCT01744483|5739322|P3|COMPLETED|Overall Study||10
2338396|NCT01744483|5739323|P2|COMPLETED|Overall Study||13
2338397|NCT01744483|5739324|P1|COMPLETED|Overall Study||15
2338398|NCT01744483|5739322|P3|STARTED|Overall Study||38
2338399|NCT01744483|5739323|P2|STARTED|Overall Study||35
2338400|NCT01744483|5739324|P1|STARTED|Overall Study||44
2338401|NCT01744392|5739332|P1|NOT COMPLETED|Overall Study||1
2338402|NCT01744392|5739332|P1|COMPLETED|Overall Study||22
2338403|NCT01744392|5739332|P1|STARTED|Overall Study||23
2338419|NCT01744197|5739372|P2|NOT COMPLETED|Overall Study||3
2338420|NCT01744197|5739373|P1|NOT COMPLETED|Overall Study||4
2338421|NCT01744197|5739372|P2|COMPLETED|Overall Study||26
2338422|NCT01744197|5739373|P1|COMPLETED|Overall Study||28
2338423|NCT01744197|5739372|P2|STARTED|Overall Study||29
2338424|NCT01744197|5739373|P1|STARTED|Overall Study||32
2338425|NCT01744093|5739385|P2|NOT COMPLETED|Overall Study||1
2338426|NCT01744093|5739386|P1|NOT COMPLETED|Overall Study||6
2338427|NCT01744093|5739385|P2|COMPLETED|Overall Study||8
2338428|NCT01744093|5739386|P1|COMPLETED|Overall Study||12
2338429|NCT01744093|5739385|P2|STARTED|Overall Study||9
2338430|NCT01744093|5739386|P1|STARTED|Overall Study||18
2338431|NCT01743963|5739396|P2|NOT COMPLETED|Overall Study||0
2338432|NCT01743963|5739397|P1|NOT COMPLETED|Overall Study||0
2338433|NCT01743963|5739396|P2|COMPLETED|Overall Study||17
2338434|NCT01743963|5739397|P1|COMPLETED|Overall Study||21
2338435|NCT01743963|5739396|P2|STARTED|Overall Study||17
2338436|NCT01743963|5739397|P1|STARTED|Overall Study||21
2338437|NCT01743859|5739403|P1|NOT COMPLETED|Overall Study||9
2338438|NCT01743859|5739403|P1|COMPLETED|Overall Study||28
2338439|NCT01743859|5739403|P1|STARTED|Overall Study||37
2338440|NCT01743729|5739415|P2|NOT COMPLETED|Overall Study||12
2338441|NCT01743729|5739416|P1|NOT COMPLETED|Overall Study||37
2338442|NCT01743729|5739415|P2|COMPLETED|Overall Study||348
2338443|NCT01743729|5739416|P1|COMPLETED|Overall Study||321
2338444|NCT01743729|5739415|P2|STARTED|Overall Study|One placebo participant was considered for Lifitegrast arm; Placebo safety analysis set (N= 359).|360
2338445|NCT01743729|5739416|P1|STARTED|Overall Study|One participant from placebo arm included in Lifitegrast arm for safety analysis set (N=359).|358
2338446|NCT01743560|5739424|P1|NOT COMPLETED|Overall Study||43
2338447|NCT01743560|5739424|P1|COMPLETED|Overall Study||9
2338448|NCT01743560|5739424|P1|Safety Analysis Set (SAF)|Overall Study|≥ 1 dose study drug +1 post baseline safety assessment|49
2338449|NCT01743560|5739424|P1|Full Analysis Set (FAS)|Overall Study|≥ 1 dose study drug|49
2338450|NCT01743560|5739424|P1|STARTED|Overall Study||52
2338451|NCT01743521|5739451|P4|NOT COMPLETED|Overall Study||0
2338452|NCT01743521|5739452|P3|NOT COMPLETED|Overall Study||0
2338453|NCT01743521|5739453|P2|NOT COMPLETED|Overall Study||0
2338454|NCT01743521|5739454|P1|NOT COMPLETED|Overall Study||0
2338455|NCT01743521|5739451|P4|COMPLETED|Overall Study||2
2338456|NCT01743521|5739452|P3|COMPLETED|Overall Study||2
2338457|NCT01743521|5739453|P2|COMPLETED|Overall Study||3
2338458|NCT01743521|5739454|P1|COMPLETED|Overall Study||7
2338459|NCT01743521|5739451|P4|STARTED|Overall Study||2
2338460|NCT01743521|5739452|P3|STARTED|Overall Study||2
2338461|NCT01743521|5739453|P2|STARTED|Overall Study||3
2338462|NCT01743521|5739454|P1|STARTED|Overall Study||7
2338463|NCT01743469|5739508|P4|NOT COMPLETED|Follow-up Period - Post-Treatment||16
2338464|NCT01743469|5739509|P3|NOT COMPLETED|Follow-up Period - Post-Treatment||23
2338465|NCT01743469|5739510|P2|NOT COMPLETED|Follow-up Period - Post-Treatment||48
2338466|NCT01743469|5739511|P1|NOT COMPLETED|Follow-up Period - Post-Treatment||45
2338467|NCT01743469|5739508|P4|COMPLETED|Follow-up Period - Post-Treatment||5
2338468|NCT01743469|5739509|P3|COMPLETED|Follow-up Period - Post-Treatment||14
2338469|NCT01743469|5739510|P2|COMPLETED|Follow-up Period - Post-Treatment||5
2338470|NCT01743469|5739511|P1|COMPLETED|Follow-up Period - Post-Treatment||6
2338471|NCT01743469|5739508|P4|STARTED|Follow-up Period - Post-Treatment||21
2338472|NCT01743469|5739509|P3|STARTED|Follow-up Period - Post-Treatment||37
2338473|NCT01743469|5739510|P2|STARTED|Follow-up Period - Post-Treatment||53
2338474|NCT01743469|5739511|P1|STARTED|Follow-up Period - Post-Treatment||51
2338475|NCT01743469|5739508|P4|NOT COMPLETED|Active Treatment Phase||21
2338476|NCT01743469|5739509|P3|NOT COMPLETED|Active Treatment Phase||38
2338477|NCT01743469|5739510|P2|NOT COMPLETED|Active Treatment Phase||55
2338478|NCT01743469|5739511|P1|NOT COMPLETED|Active Treatment Phase||53
2338479|NCT01743469|5739508|P4|COMPLETED|Active Treatment Phase||0
2338480|NCT01743469|5739509|P3|COMPLETED|Active Treatment Phase||0
2338481|NCT01743469|5739510|P2|COMPLETED|Active Treatment Phase||0
2338482|NCT01743469|5739511|P1|COMPLETED|Active Treatment Phase||0
2338483|NCT01743469|5739508|P4|STARTED|Active Treatment Phase||21
2338484|NCT01743469|5739509|P3|STARTED|Active Treatment Phase||38
2338485|NCT01743469|5739510|P2|STARTED|Active Treatment Phase||55
2338486|NCT01743469|5739511|P1|STARTED|Active Treatment Phase||53
2338487|NCT01743092|5739551|P2|NOT COMPLETED|Overall Study||15
2338488|NCT01743092|5739552|P1|NOT COMPLETED|Overall Study||14
2338489|NCT01743092|5739551|P2|COMPLETED|Overall Study||11
2338490|NCT01743092|5739552|P1|COMPLETED|Overall Study||19
2338491|NCT01743092|5739551|P2|STARTED|Overall Study||26
2338492|NCT01743092|5739552|P1|STARTED|Overall Study||33
2338493|NCT01743027|5739564|P4|NOT COMPLETED|Overall Study||1
2338494|NCT01743027|5739565|P3|NOT COMPLETED|Overall Study||9
2338495|NCT01743027|5739566|P2|NOT COMPLETED|Overall Study||5
2338496|NCT01743027|5739567|P1|NOT COMPLETED|Overall Study||5
2338497|NCT01743027|5739564|P4|COMPLETED|Overall Study||48
2338498|NCT01743027|5739565|P3|COMPLETED|Overall Study||90
2338499|NCT01743027|5739566|P2|COMPLETED|Overall Study||94
2338500|NCT01743027|5739567|P1|COMPLETED|Overall Study||93
2338501|NCT01743027|5739564|P4|STARTED|Overall Study||49
2338502|NCT01743027|5739565|P3|STARTED|Overall Study||99
2338503|NCT01743027|5739566|P2|STARTED|Overall Study||99
2338504|NCT01743027|5739567|P1|STARTED|Overall Study||98
2338505|NCT01743001|5739607|P2|NOT COMPLETED|Overall Study||0
2338506|NCT01743001|5739608|P1|NOT COMPLETED|Overall Study||3
2338507|NCT01743001|5739607|P2|COMPLETED|Overall Study||112
2338508|NCT01743001|5739608|P1|COMPLETED|Overall Study||111
2338509|NCT01743001|5739607|P2|STARTED|Overall Study||112
2338510|NCT01743001|5739608|P1|STARTED|Overall Study||114
2338511|NCT01742949|5739620|P2|NOT COMPLETED|Overall Study||0
2338512|NCT01742949|5739621|P1|NOT COMPLETED|Overall Study||0
2338513|NCT01742949|5739620|P2|COMPLETED|Overall Study||20
2338514|NCT01742949|5739621|P1|COMPLETED|Overall Study||20
2338515|NCT01742949|5739620|P2|STARTED|Overall Study||20
2338516|NCT01742949|5739621|P1|STARTED|Overall Study||20
2338517|NCT01742936|5739642|P2|NOT COMPLETED|Overall Study||0
2338518|NCT01742936|5739643|P1|NOT COMPLETED|Overall Study||0
2338519|NCT01742936|5739642|P2|COMPLETED|Overall Study||50
2338520|NCT01742936|5739643|P1|COMPLETED|Overall Study||50
2338521|NCT01742936|5739642|P2|STARTED|Overall Study||50
2338522|NCT01742936|5739643|P1|STARTED|Overall Study||50
2338523|NCT01742897|5739651|P1|NOT COMPLETED|Overall Study||5
2338524|NCT01742897|5739651|P1|COMPLETED|Overall Study||30
2338525|NCT01742897|5739651|P1|Treated|Overall Study||33
2338526|NCT01742897|5739651|P1|STARTED|Overall Study||35
2338527|NCT01742832|5739657|P2|NOT COMPLETED|Overall Study||5
2338528|NCT01742832|5739658|P1|NOT COMPLETED|Overall Study||1
2338529|NCT01742832|5739657|P2|COMPLETED|Overall Study||23
2338530|NCT01742832|5739658|P1|COMPLETED|Overall Study||19
2338531|NCT01742832|5739657|P2|STARTED|Overall Study||28
2338532|NCT01742832|5739658|P1|STARTED|Overall Study||20
2338533|NCT01742364|5739668|P4|NOT COMPLETED|Overall Study||0
2338534|NCT01742364|5739669|P3|NOT COMPLETED|Overall Study||0
2338535|NCT01742364|5739670|P2|NOT COMPLETED|Overall Study||0
2338536|NCT01742364|5739671|P1|NOT COMPLETED|Overall Study||0
2338537|NCT01742364|5739668|P4|COMPLETED|Overall Study||15
2338538|NCT01742364|5739669|P3|COMPLETED|Overall Study||15
2338539|NCT01742364|5739670|P2|COMPLETED|Overall Study||33
2338540|NCT01742364|5739671|P1|COMPLETED|Overall Study||33
2338541|NCT01742364|5739668|P4|STARTED|Overall Study||15
2338542|NCT01742364|5739669|P3|STARTED|Overall Study||15
2338543|NCT01742364|5739670|P2|STARTED|Overall Study||33
2338544|NCT01742364|5739671|P1|STARTED|Overall Study||33
2338545|NCT01742208|5739700|P3|NOT COMPLETED|Overall Study||0
2338546|NCT01742208|5739701|P2|NOT COMPLETED|Overall Study||0
2338547|NCT01742208|5739702|P1|NOT COMPLETED|Overall Study||0
2338548|NCT01742208|5739700|P3|COMPLETED|Overall Study||16
2338549|NCT01742208|5739701|P2|COMPLETED|Overall Study||17
2338550|NCT01742208|5739702|P1|COMPLETED|Overall Study||3
2338551|NCT01742208|5739700|P3|STARTED|Overall Study||16
2338552|NCT01742208|5739701|P2|STARTED|Overall Study||17
2338553|NCT01742208|5739702|P1|STARTED|Overall Study||3
2338554|NCT01742091|5739732|P6|NOT COMPLETED|Overall Study||2
2338555|NCT01742091|5739733|P5|NOT COMPLETED|Overall Study||1
2338556|NCT01742091|5739734|P4|NOT COMPLETED|Overall Study||1
2338557|NCT01742091|5739735|P3|NOT COMPLETED|Overall Study||0
2338558|NCT01742091|5739736|P2|NOT COMPLETED|Overall Study||0
2338559|NCT01742091|5739737|P1|NOT COMPLETED|Overall Study||0
2338560|NCT01742091|5739732|P6|COMPLETED|Overall Study||10
2338561|NCT01742091|5739733|P5|COMPLETED|Overall Study||7
2338562|NCT01742091|5739734|P4|COMPLETED|Overall Study||8
2338563|NCT01742091|5739735|P3|COMPLETED|Overall Study||10
2338564|NCT01742091|5739736|P2|COMPLETED|Overall Study||11
2338565|NCT01742091|5739737|P1|COMPLETED|Overall Study||9
2338566|NCT01742091|5739732|P6|RECEIVED STUDY DRUG|Overall Study||12
2338567|NCT01742091|5739733|P5|RECEIVED STUDY DRUG|Overall Study||8
2338568|NCT01742091|5739734|P4|RECEIVED STUDY DRUG|Overall Study||9
2338569|NCT01742091|5739735|P3|RECEIVED STUDY DRUG|Overall Study||10
2338570|NCT01742091|5739736|P2|RECEIVED STUDY DRUG|Overall Study||11
2338571|NCT01742091|5739737|P1|RECEIVED STUDY DRUG|Overall Study||9
2338572|NCT01742091|5739732|P6|STARTED|Overall Study||12
2338573|NCT01742091|5739733|P5|STARTED|Overall Study||8
2338574|NCT01742091|5739734|P4|STARTED|Overall Study||9
2338575|NCT01742091|5739735|P3|STARTED|Overall Study||10
2338576|NCT01742091|5739736|P2|STARTED|Overall Study||11
2338577|NCT01742091|5739737|P1|STARTED|Overall Study||9
2338578|NCT01742078|5739783|P9|NOT COMPLETED|Overall Study||0
2338579|NCT01742078|5739784|P8|NOT COMPLETED|Overall Study||0
2338580|NCT01742078|5739785|P7|NOT COMPLETED|Overall Study||0
2338581|NCT01742078|5739786|P6|NOT COMPLETED|Overall Study||0
2338582|NCT01742078|5739787|P5|NOT COMPLETED|Overall Study||0
2338583|NCT01742078|5739788|P4|NOT COMPLETED|Overall Study||1
2338584|NCT01742078|5739789|P3|NOT COMPLETED|Overall Study||0
2338585|NCT01742078|5739790|P2|NOT COMPLETED|Overall Study||0
2338586|NCT01742078|5739791|P1|NOT COMPLETED|Overall Study||0
2338587|NCT01742078|5739783|P9|COMPLETED|Overall Study||12
2338588|NCT01742078|5739784|P8|COMPLETED|Overall Study||6
2338589|NCT01742078|5739785|P7|COMPLETED|Overall Study||6
2338590|NCT01742078|5739786|P6|COMPLETED|Overall Study||6
2338591|NCT01742078|5739787|P5|COMPLETED|Overall Study||6
2338592|NCT01742078|5739788|P4|COMPLETED|Overall Study||5
2338593|NCT01742078|5739789|P3|COMPLETED|Overall Study||6
2338594|NCT01742078|5739790|P2|COMPLETED|Overall Study||6
2338595|NCT01742078|5739791|P1|COMPLETED|Overall Study||6
2338596|NCT01742078|5739783|P9|RECEIVED STUDY DRUG|Overall Study||12
2338597|NCT01742078|5739784|P8|RECEIVED STUDY DRUG|Overall Study||6
2338598|NCT01742078|5739785|P7|RECEIVED STUDY DRUG|Overall Study||6
2338599|NCT01742078|5739786|P6|RECEIVED STUDY DRUG|Overall Study||6
2338600|NCT01742078|5739787|P5|RECEIVED STUDY DRUG|Overall Study||6
2338601|NCT01742078|5739788|P4|RECEIVED STUDY DRUG|Overall Study||6
2338602|NCT01742078|5739789|P3|RECEIVED STUDY DRUG|Overall Study||6
2338603|NCT01742078|5739790|P2|RECEIVED STUDY DRUG|Overall Study||6
2338604|NCT01742078|5739791|P1|RECEIVED STUDY DRUG|Overall Study||6
2338605|NCT01742078|5739783|P9|STARTED|Overall Study||12
2338606|NCT01742078|5739784|P8|STARTED|Overall Study||6
2338607|NCT01742078|5739785|P7|STARTED|Overall Study||6
2338608|NCT01742078|5739786|P6|STARTED|Overall Study||6
2338609|NCT01742078|5739787|P5|STARTED|Overall Study||6
2338610|NCT01742078|5739788|P4|STARTED|Overall Study||6
2338611|NCT01742078|5739789|P3|STARTED|Overall Study||6
2338612|NCT01742078|5739790|P2|STARTED|Overall Study||6
2338613|NCT01742078|5739791|P1|STARTED|Overall Study||6
2338614|NCT01742065|5739848|P2|NOT COMPLETED|Overall Study||0
2338615|NCT01742065|5739849|P1|NOT COMPLETED|Overall Study||0
2338616|NCT01742065|5739848|P2|COMPLETED|Overall Study|21134 patients were analyzed in 13 clinics.|21134
2338617|NCT01742065|5739849|P1|COMPLETED|Overall Study|20059 patients were analyzed in 13 clinics.|20059
2338618|NCT01742065|5739848|P2|STARTED|Overall Study|21134 patients were analyzed in 13 clinics.|21134
2338619|NCT01742065|5739849|P1|STARTED|Overall Study|20059 patients were analyzed in 13 clinics.|20059
2338620|NCT01741792|5739860|P3|NOT COMPLETED|Overall Study||12
2338621|NCT01741792|5739861|P2|NOT COMPLETED|Overall Study||1
2338622|NCT01741792|5739862|P1|NOT COMPLETED|Overall Study||6
2338623|NCT01741792|5739860|P3|COMPLETED|Overall Study||2
2338624|NCT01741792|5739861|P2|COMPLETED|Overall Study||1
2338625|NCT01741792|5739862|P1|COMPLETED|Overall Study||3
2338626|NCT01741792|5739860|P3|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|13
2338627|NCT01741792|5739861|P2|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|1
2338628|NCT01741792|5739862|P1|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|7
2338629|NCT01741792|5739860|P3|STARTED|Overall Study||14
2338630|NCT01741792|5739861|P2|STARTED|Overall Study|Cohort 2 was closed to enrollment on recommendation of the data monitoring committee|2
2338631|NCT01741792|5739862|P1|STARTED|Overall Study|3 participants were not considered evaluable and were replaced as specified in the protocol.|9
2338632|NCT01741701|5739929|P2|NOT COMPLETED|Overall Study||2
2338633|NCT01741701|5739930|P1|NOT COMPLETED|Overall Study||5
2338634|NCT01741701|5739929|P2|COMPLETED|Overall Study||13
2338635|NCT01741701|5739930|P1|COMPLETED|Overall Study||13
2338636|NCT01741701|5739929|P2|STARTED|Overall Study||15
2338637|NCT01741701|5739930|P1|STARTED|Overall Study||18
2338638|NCT01741688|5739946|P1|NOT COMPLETED|Overall Study||3
2338639|NCT01741688|5739946|P1|COMPLETED|Overall Study||13
2338640|NCT01741688|5739946|P1|STARTED|Overall Study||16
2338641|NCT01741545|5739965|P2|NOT COMPLETED|Follow-up Period (24 Weeks)||2
2338642|NCT01741545|5739966|P1|NOT COMPLETED|Follow-up Period (24 Weeks)||1
2338643|NCT01741545|5739965|P2|COMPLETED|Follow-up Period (24 Weeks)||37
2338644|NCT01741545|5739966|P1|COMPLETED|Follow-up Period (24 Weeks)||11
2338645|NCT01741545|5739965|P2|STARTED|Follow-up Period (24 Weeks)|4 participants re-joined Cohort B in follow-up period.|39
2338646|NCT01741545|5739966|P1|STARTED|Follow-up Period (24 Weeks)|1 participant re-joined Cohort A in follow-up period.|12
2338647|NCT01741545|5739965|P2|NOT COMPLETED|Treatment Period||4
2338648|NCT01741545|5739966|P1|NOT COMPLETED|Treatment Period||1
2338649|NCT01741545|5739965|P2|COMPLETED|Treatment Period||35
2338650|NCT01741545|5739966|P1|COMPLETED|Treatment Period||11
2338651|NCT01741545|5739965|P2|STARTED|Treatment Period||39
2338652|NCT01741545|5739966|P1|STARTED|Treatment Period||12
2338653|NCT01741532|5739990|P2|NOT COMPLETED|Overall Study||3
2338654|NCT01741532|5739991|P1|NOT COMPLETED|Overall Study||10
2338655|NCT01741532|5739990|P2|COMPLETED|Overall Study||27
2338656|NCT01741532|5739991|P1|COMPLETED|Overall Study||49
2338657|NCT01741532|5739990|P2|Provided Post-baseline Efficacy Data|Overall Study||28
2338658|NCT01741532|5739991|P1|Provided Post-baseline Efficacy Data|Overall Study||58
2338659|NCT01741532|5739990|P2|Exposed|Overall Study||30
2338660|NCT01741532|5739991|P1|Exposed|Overall Study||58
2338661|NCT01741532|5739990|P2|STARTED|Overall Study||30
2338662|NCT01741532|5739991|P1|STARTED|Overall Study||59
2338663|NCT01741480|5740013|P2|NOT COMPLETED|Overall Study||0
2338664|NCT01741480|5740014|P1|NOT COMPLETED|Overall Study||0
2338665|NCT01741480|5740013|P2|COMPLETED|Overall Study||286
2338666|NCT01741480|5740014|P1|COMPLETED|Overall Study||285
2338667|NCT01741480|5740013|P2|STARTED|Overall Study||286
2338668|NCT01741480|5740014|P1|STARTED|Overall Study||285
2338669|NCT01741454|5740024|P4|NOT COMPLETED|Overall Study||22
2338670|NCT01741454|5740025|P3|NOT COMPLETED|Overall Study||17
2338671|NCT01741454|5740026|P2|NOT COMPLETED|Overall Study||6
2338672|NCT01741454|5740027|P1|NOT COMPLETED|Overall Study||13
2338673|NCT01741454|5740024|P4|COMPLETED|Overall Study||21
2338674|NCT01741454|5740025|P3|COMPLETED|Overall Study||22
2338675|NCT01741454|5740026|P2|COMPLETED|Overall Study||44
2338676|NCT01741454|5740027|P1|COMPLETED|Overall Study||36
2338677|NCT01741454|5740024|P4|STARTED|Overall Study||43
2338678|NCT01741454|5740025|P3|STARTED|Overall Study||39
2338679|NCT01741454|5740026|P2|STARTED|Overall Study||50
2338680|NCT01741454|5740027|P1|STARTED|Overall Study||49
2338681|NCT01741350|5740051|P2|NOT COMPLETED|12-Month Follow-up Assessment||2
2338682|NCT01741350|5740052|P1|NOT COMPLETED|12-Month Follow-up Assessment||3
2338683|NCT01741350|5740051|P2|COMPLETED|12-Month Follow-up Assessment||109
2338684|NCT01741350|5740052|P1|COMPLETED|12-Month Follow-up Assessment||111
2338685|NCT01741350|5740051|P2|STARTED|12-Month Follow-up Assessment||111
2338686|NCT01741350|5740052|P1|STARTED|12-Month Follow-up Assessment||114
2338687|NCT01741350|5740051|P2|NOT COMPLETED|6-Month Follow-up Assessment||8
2338688|NCT01741350|5740052|P1|NOT COMPLETED|6-Month Follow-up Assessment||15
2338689|NCT01741350|5740051|P2|COMPLETED|6-Month Follow-up Assessment||111
2338690|NCT01741350|5740052|P1|COMPLETED|6-Month Follow-up Assessment||114
2338691|NCT01741350|5740051|P2|STARTED|6-Month Follow-up Assessment||119
2338692|NCT01741350|5740052|P1|STARTED|6-Month Follow-up Assessment||129
2338693|NCT01741350|5740051|P2|NOT COMPLETED|3-Month Follow-up Assessment||22
2338694|NCT01741350|5740052|P1|NOT COMPLETED|3-Month Follow-up Assessment||6
2338695|NCT01741350|5740051|P2|COMPLETED|3-Month Follow-up Assessment||119
2338696|NCT01741350|5740052|P1|COMPLETED|3-Month Follow-up Assessment||129
2338697|NCT01741350|5740051|P2|STARTED|3-Month Follow-up Assessment||141
2338698|NCT01741350|5740052|P1|STARTED|3-Month Follow-up Assessment||135
2338699|NCT01741350|5740051|P2|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
2338700|NCT01741350|5740052|P1|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
2338701|NCT01741350|5740051|P2|COMPLETED|Post Intervention Assessment (at Week 4)||141
2338702|NCT01741350|5740052|P1|COMPLETED|Post Intervention Assessment (at Week 4)||135
2338703|NCT01741350|5740051|P2|STARTED|Post Intervention Assessment (at Week 4)||155
2338704|NCT01741350|5740052|P1|STARTED|Post Intervention Assessment (at Week 4)||149
2338705|NCT01741350|5740051|P2|NOT COMPLETED|Study Intervention||0
2338706|NCT01741350|5740052|P1|NOT COMPLETED|Study Intervention||0
2338707|NCT01741350|5740051|P2|COMPLETED|Study Intervention||155
2338708|NCT01741350|5740052|P1|COMPLETED|Study Intervention||149
2338709|NCT01741350|5740051|P2|STARTED|Study Intervention||155
2338710|NCT01741350|5740052|P1|STARTED|Study Intervention||149
2338711|NCT01741272|5740188|P2|NOT COMPLETED|Overall Study||0
2338712|NCT01741272|5740189|P1|NOT COMPLETED|Overall Study||0
2338713|NCT01741272|5740188|P2|COMPLETED|Overall Study||97
2338714|NCT01741272|5740189|P1|COMPLETED|Overall Study||92
2338715|NCT01741272|5740188|P2|STARTED|Overall Study||97
2338716|NCT01741272|5740189|P1|STARTED|Overall Study||92
2338717|NCT01741259|5740205|P2|NOT COMPLETED|Overall Study||6
2338718|NCT01741259|5740206|P1|NOT COMPLETED|Overall Study||6
2338719|NCT01741259|5740205|P2|COMPLETED|Overall Study||129
2338720|NCT01741259|5740206|P1|COMPLETED|Overall Study||127
2338721|NCT01741259|5740205|P2|STARTED|Overall Study||135
2338722|NCT01741259|5740206|P1|STARTED|Overall Study||133
2338723|NCT01741012|5740260|P1|NOT COMPLETED|Overall Study||3
2338724|NCT01741012|5740260|P1|COMPLETED|Overall Study||34
2338725|NCT01741012|5740260|P1|STARTED|Overall Study||37
2338726|NCT01740817|5740267|P2|NOT COMPLETED|Second Intervention (48 h)||0
2338727|NCT01740817|5740268|P1|NOT COMPLETED|Second Intervention (48 h)||0
2338728|NCT01740817|5740267|P2|COMPLETED|Second Intervention (48 h)||4
2338729|NCT01740817|5740268|P1|COMPLETED|Second Intervention (48 h)||8
2338730|NCT01740817|5740267|P2|STARTED|Second Intervention (48 h)||4
2338731|NCT01740817|5740268|P1|STARTED|Second Intervention (48 h)||8
2338732|NCT01740817|5740267|P2|NOT COMPLETED|Washout (4-6 Weeks)||0
2338733|NCT01740817|5740268|P1|NOT COMPLETED|Washout (4-6 Weeks)||0
2338734|NCT01740817|5740267|P2|COMPLETED|Washout (4-6 Weeks)||4
2338735|NCT01740817|5740268|P1|COMPLETED|Washout (4-6 Weeks)||8
2338736|NCT01740817|5740267|P2|STARTED|Washout (4-6 Weeks)||4
2338737|NCT01740817|5740268|P1|STARTED|Washout (4-6 Weeks)||8
2338738|NCT01740817|5740267|P2|NOT COMPLETED|First Intervention (48 h)||0
2338739|NCT01740817|5740268|P1|NOT COMPLETED|First Intervention (48 h)||0
2338740|NCT01740817|5740267|P2|COMPLETED|First Intervention (48 h)||4
2338741|NCT01740817|5740268|P1|COMPLETED|First Intervention (48 h)||8
2338742|NCT01740817|5740267|P2|STARTED|First Intervention (48 h)||4
2338743|NCT01740817|5740268|P1|STARTED|First Intervention (48 h)||8
2338744|NCT01740726|5740280|P2|NOT COMPLETED|Overall Study||0
2338745|NCT01740726|5740281|P1|NOT COMPLETED|Overall Study||0
2338746|NCT01740726|5740280|P2|COMPLETED|Overall Study||1
2338747|NCT01740726|5740281|P1|COMPLETED|Overall Study||0
2338748|NCT01740726|5740280|P2|STARTED|Overall Study||1
2338749|NCT01740726|5740281|P1|STARTED|Overall Study||0
2338750|NCT01740713|5740306|P3|NOT COMPLETED|Overall Study||1
2338751|NCT01740713|5740307|P2|NOT COMPLETED|Overall Study||2
2338752|NCT01740713|5740308|P1|NOT COMPLETED|Overall Study||0
2338753|NCT01740713|5740306|P3|COMPLETED|Overall Study||6
2338754|NCT01740713|5740307|P2|COMPLETED|Overall Study||6
2338755|NCT01740713|5740308|P1|COMPLETED|Overall Study||6
2338756|NCT01740713|5740306|P3|STARTED|Overall Study||7
2338757|NCT01740713|5740307|P2|STARTED|Overall Study||8
2338758|NCT01740713|5740308|P1|STARTED|Overall Study||6
2338759|NCT01740440|5740332|P1|NOT COMPLETED|Overall Study||3
2338760|NCT01740440|5740332|P1|COMPLETED|Overall Study||27
2338761|NCT01740440|5740332|P1|STARTED|Overall Study||30
2338768|NCT01740414|5740370|P2|NOT COMPLETED|Overall Study||8
2338769|NCT01740414|5740371|P1|NOT COMPLETED|Overall Study||9
2338770|NCT01740414|5740370|P2|COMPLETED|Overall Study||8
2338771|NCT01740414|5740371|P1|COMPLETED|Overall Study||3
2338772|NCT01740414|5740370|P2|STARTED|Overall Study||16
2338773|NCT01740414|5740371|P1|STARTED|Overall Study||12
2338774|NCT01740401|5740393|P1|NOT COMPLETED|Overall Study||10
2338775|NCT01740401|5740393|P1|COMPLETED|Overall Study||0
2338776|NCT01740401|5740393|P1|STARTED|Overall Study||10
2338777|NCT01740388|5740402|P2|NOT COMPLETED|Overall Study||44
2338778|NCT01740388|5740403|P1|NOT COMPLETED|Overall Study||46
2338779|NCT01740388|5740402|P2|COMPLETED|Overall Study||28
2338780|NCT01740388|5740403|P1|COMPLETED|Overall Study||18
2338781|NCT01740388|5740402|P2|STARTED|Overall Study||72
2338782|NCT01740388|5740403|P1|STARTED|Overall Study||64
2338783|NCT01740362|5740423|P4|NOT COMPLETED|Overall Study||0
2338784|NCT01740362|5740424|P3|NOT COMPLETED|Overall Study||0
2338785|NCT01740362|5740425|P2|NOT COMPLETED|Overall Study||0
2338786|NCT01740362|5740426|P1|NOT COMPLETED|Overall Study||0
2338787|NCT01740362|5740423|P4|COMPLETED|Overall Study||6
2338788|NCT01740362|5740424|P3|COMPLETED|Overall Study||6
2338789|NCT01740362|5740425|P2|COMPLETED|Overall Study||6
2338790|NCT01740362|5740426|P1|COMPLETED|Overall Study||6
2338791|NCT01740362|5740423|P4|STARTED|Overall Study||6
2338792|NCT01740362|5740424|P3|STARTED|Overall Study||6
2338793|NCT01740362|5740425|P2|STARTED|Overall Study||6
2338794|NCT01740362|5740426|P1|STARTED|Overall Study||6
2338795|NCT01740323|5740454|P2|NOT COMPLETED|Overall Study||0
2338796|NCT01740323|5740455|P1|NOT COMPLETED|Overall Study||2
2338797|NCT01740323|5740454|P2|COMPLETED|Overall Study||15
2338798|NCT01740323|5740455|P1|COMPLETED|Overall Study||13
2338799|NCT01740323|5740454|P2|STARTED|Overall Study||15
2338800|NCT01740323|5740455|P1|STARTED|Overall Study||15
2338801|NCT01740297|5740476|P3|NOT COMPLETED|Overall Study||98
2338802|NCT01740297|5740477|P2|NOT COMPLETED|Overall Study||100
2338803|NCT01740297|5740478|P1|NOT COMPLETED|Overall Study||19
2338804|NCT01740297|5740476|P3|COMPLETED|Overall Study||0
2338805|NCT01740297|5740477|P2|COMPLETED|Overall Study||0
2338806|NCT01740297|5740478|P1|COMPLETED|Overall Study||0
2338807|NCT01740297|5740476|P3|Received Ipilimumab|Overall Study||92
2338808|NCT01740297|5740477|P2|Received Ipilimumab|Overall Study||95
2338809|NCT01740297|5740478|P1|Received Ipilimumab|Overall Study||18
2338810|NCT01740297|5740476|P3|Received Talimogene Laherparepvec|Overall Study||95
2338811|NCT01740297|5740477|P2|Received Talimogene Laherparepvec|Overall Study||0
2338812|NCT01740297|5740478|P1|Received Talimogene Laherparepvec|Overall Study||19
2338813|NCT01740297|5740476|P3|STARTED|Overall Study||98
2338814|NCT01740297|5740477|P2|STARTED|Overall Study||100
2338815|NCT01740297|5740478|P1|STARTED|Overall Study||19
2338816|NCT01740206|5740510|P2|NOT COMPLETED|Overall Study||0
2338817|NCT01740206|5740511|P1|NOT COMPLETED|Overall Study||0
2338818|NCT01740206|5740510|P2|COMPLETED|Overall Study||34
2338819|NCT01740206|5740511|P1|COMPLETED|Overall Study||14
2338820|NCT01740206|5740510|P2|STARTED|Overall Study||34
2338821|NCT01740206|5740511|P1|STARTED|Overall Study||14
2338822|NCT01740154|5740527|P1|NOT COMPLETED|Overall Study||1
2338823|NCT01740154|5740527|P1|COMPLETED|Overall Study||12
2338824|NCT01740154|5740527|P1|STARTED|Overall Study||13
2338825|NCT01740128|5740535|P2|NOT COMPLETED|Overall Study||7
2338826|NCT01740128|5740536|P1|NOT COMPLETED|Overall Study||6
2338827|NCT01740128|5740535|P2|COMPLETED|Overall Study||4
2338828|NCT01740128|5740536|P1|COMPLETED|Overall Study||4
2338829|NCT01740128|5740535|P2|STARTED|Overall Study||11
2338830|NCT01740128|5740536|P1|STARTED|Overall Study||10
2338831|NCT01740089|5740565|P3|NOT COMPLETED|After 12 Weeks||11
2338832|NCT01740089|5740566|P2|NOT COMPLETED|After 12 Weeks||3
2338833|NCT01740089|5740567|P1|NOT COMPLETED|After 12 Weeks||7
2338834|NCT01740089|5740565|P3|COMPLETED|After 12 Weeks|"Withdrawn due to:~No EVR (n=4) AE (n=5) Non-attendance of visit (n=1) Withdrawn consent (n=1)"|37
2338835|NCT01740089|5740566|P2|COMPLETED|After 12 Weeks|"Withdrawn due to:~Withdrawn consent (n=1) No EVR (n=1) Non-compliance (n=1)"|45
2338836|NCT01740089|5740567|P1|COMPLETED|After 12 Weeks|"Withdrawn due to:~No EVR (n=3) AE (n=2) No EOT (n=1) Non-compliance (n=1)"|43
2338837|NCT01740089|5740565|P3|STARTED|After 12 Weeks||48
2338838|NCT01740089|5740566|P2|STARTED|After 12 Weeks||48
2338839|NCT01740089|5740567|P1|STARTED|After 12 Weeks||50
2338840|NCT01740089|5740565|P3|NOT COMPLETED|First 12 Weeks of Treatment||2
2338841|NCT01740089|5740566|P2|NOT COMPLETED|First 12 Weeks of Treatment||2
2338842|NCT01740089|5740567|P1|NOT COMPLETED|First 12 Weeks of Treatment||0
2338843|NCT01740089|5740565|P3|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:~AE before W12 (n=2)"|48
2338844|NCT01740089|5740566|P2|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:~AE before W12 (n=1) Withdrew consent before W12 (n=1)"|48
2338845|NCT01740089|5740567|P1|COMPLETED|First 12 Weeks of Treatment||50
2338846|NCT01740089|5740565|P3|STARTED|First 12 Weeks of Treatment||50
2338847|NCT01740089|5740566|P2|STARTED|First 12 Weeks of Treatment||50
2338848|NCT01740089|5740567|P1|STARTED|First 12 Weeks of Treatment||50
2338849|NCT01739803|5740585|P2|NOT COMPLETED|Overall Study||6
2338850|NCT01739803|5740586|P1|NOT COMPLETED|Overall Study||9
2338851|NCT01739803|5740585|P2|COMPLETED|Overall Study||68
2338852|NCT01739803|5740586|P1|COMPLETED|Overall Study||67
2338853|NCT01739803|5740585|P2|STARTED|Overall Study||74
2338854|NCT01739803|5740586|P1|STARTED|Overall Study||76
2338855|NCT01739790|5740598|P2|NOT COMPLETED|Overall Study||4
2338856|NCT01739790|5740599|P1|NOT COMPLETED|Overall Study||2
2338857|NCT01739790|5740598|P2|COMPLETED|Overall Study||23
2338858|NCT01739790|5740599|P1|COMPLETED|Overall Study||22
2338859|NCT01739790|5740598|P2|STARTED|Overall Study||27
2338860|NCT01739790|5740599|P1|STARTED|Overall Study||24
2338861|NCT01739595|5740608|P3|NOT COMPLETED|Overall Study||2
2338862|NCT01739595|5740609|P2|NOT COMPLETED|Overall Study||1
2338863|NCT01739595|5740610|P1|NOT COMPLETED|Overall Study||13
2338864|NCT01739595|5740608|P3|COMPLETED|Overall Study||45
2338865|NCT01739595|5740609|P2|COMPLETED|Overall Study||21
2338866|NCT01739595|5740610|P1|COMPLETED|Overall Study||99
2338867|NCT01739595|5740608|P3|STARTED|Overall Study||47
2338868|NCT01739595|5740609|P2|STARTED|Overall Study||22
2338869|NCT01739595|5740610|P1|STARTED|Overall Study||112
2338870|NCT01739400|5740620|P2|NOT COMPLETED|Overall Study||9
2338871|NCT01739400|5740621|P1|NOT COMPLETED|Overall Study||17
2338872|NCT01739400|5740620|P2|COMPLETED|Overall Study||99
2338873|NCT01739400|5740621|P1|COMPLETED|Overall Study||92
2338874|NCT01739400|5740620|P2|Treated With 10 mg Macitentan|Overall Study||108
2338875|NCT01739400|5740621|P1|Treated With 10 mg Macitentan|Overall Study||109
2338876|NCT01739400|5740620|P2|STARTED|Overall Study||108
2338877|NCT01739400|5740621|P1|STARTED|Overall Study||109
2338878|NCT01739361|5740634|P2|NOT COMPLETED|Overall Study||1
2338879|NCT01739361|5740635|P1|NOT COMPLETED|Overall Study||3
2338880|NCT01739361|5740634|P2|COMPLETED|Overall Study||22
2338881|NCT01739361|5740635|P1|COMPLETED|Overall Study||18
2338882|NCT01739361|5740634|P2|STARTED|Overall Study||23
2338883|NCT01739361|5740635|P1|STARTED|Overall Study||21
2338884|NCT01739348|5740649|P4|NOT COMPLETED|Part II (Extension Study)||396
2338885|NCT01739348|5740650|P3|NOT COMPLETED|Part II (Extension Study)||61
2338886|NCT01739348|5740651|P2|NOT COMPLETED|Part II (Extension Study)||366
2338887|NCT01739348|5740652|P1|NOT COMPLETED|Part II (Extension Study)||379
2338888|NCT01739348|5740649|P4|COMPLETED|Part II (Extension Study)||0
2338889|NCT01739348|5740650|P3|COMPLETED|Part II (Extension Study)||0
2338890|NCT01739348|5740651|P2|COMPLETED|Part II (Extension Study)||0
2338891|NCT01739348|5740652|P1|COMPLETED|Part II (Extension Study)||0
2338892|NCT01739348|5740649|P4|Treated|Part II (Extension Study)||394
2338893|NCT01739348|5740650|P3|Treated|Part II (Extension Study)||61
2338894|NCT01739348|5740651|P2|Treated|Part II (Extension Study)||365
2338895|NCT01739348|5740652|P1|Treated|Part II (Extension Study)||379
2338896|NCT01739348|5740649|P4|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|396
2338897|NCT01739348|5740650|P3|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|61
2338898|NCT01739348|5740651|P2|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|366
2338899|NCT01739348|5740652|P1|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|379
2338900|NCT01739348|5740649|P4|NOT COMPLETED|Part I (Base Study)||189
2338901|NCT01739348|5740650|P3|NOT COMPLETED|Part I (Base Study)||26
2338902|NCT01739348|5740651|P2|NOT COMPLETED|Part I (Base Study)||203
2338903|NCT01739348|5740652|P1|NOT COMPLETED|Part I (Base Study)||202
2338904|NCT01739348|5740649|P4|COMPLETED|Part I (Base Study)||516
2338905|NCT01739348|5740650|P3|COMPLETED|Part I (Base Study)||77
2338906|NCT01739348|5740651|P2|COMPLETED|Part I (Base Study)||497
2338907|NCT01739348|5740652|P1|COMPLETED|Part I (Base Study)||501
2338908|NCT01739348|5740649|P4|Treated|Part I (Base Study)||705
2338909|NCT01739348|5740650|P3|Treated|Part I (Base Study)||103
2338910|NCT01739348|5740651|P2|Treated|Part I (Base Study)||700
2338911|NCT01739348|5740652|P1|Treated|Part I (Base Study)||702
2338912|NCT01739348|5740649|P4|STARTED|Part I (Base Study)||705
2338913|NCT01739348|5740650|P3|STARTED|Part I (Base Study)||103
2338914|NCT01739348|5740651|P2|STARTED|Part I (Base Study)||700
2338915|NCT01739348|5740652|P1|STARTED|Part I (Base Study)||703
2338916|NCT01739335|5740724|P2|NOT COMPLETED|Overall Study||5
2338917|NCT01739335|5740725|P1|NOT COMPLETED|Overall Study||7
2338918|NCT01739335|5740724|P2|COMPLETED|Overall Study||35
2338919|NCT01739335|5740725|P1|COMPLETED|Overall Study||34
2338920|NCT01739335|5740724|P2|STARTED|Overall Study||40
2338921|NCT01739335|5740725|P1|STARTED|Overall Study||41
2338922|NCT01739309|5740757|P1|NOT COMPLETED|Overall Study||3
2338923|NCT01739309|5740757|P1|COMPLETED|Overall Study||25
2338924|NCT01739309|5740757|P1|Alive and on Study, Off Treatment|Overall Study||8
2338925|NCT01739309|5740757|P1|Death Due to Any Cause|Overall Study||17
2338926|NCT01739309|5740757|P1|Received at Least One Dose of Study Drug|Overall Study||28
2338927|NCT01739309|5740757|P1|STARTED|Overall Study||28
2338928|NCT01739231|5740780|P4|NOT COMPLETED|Part B||2
2338929|NCT01739231|5740781|P3|NOT COMPLETED|Part B||2
2338930|NCT01739231|5740782|P2|NOT COMPLETED|Part B||5
2338931|NCT01739231|5740783|P1|NOT COMPLETED|Part B||7
2338932|NCT01739231|5740780|P4|COMPLETED|Part B||19
2338933|NCT01739231|5740781|P3|COMPLETED|Part B||10
2338934|NCT01739231|5740782|P2|COMPLETED|Part B||12
2338935|NCT01739231|5740783|P1|COMPLETED|Part B||13
2338936|NCT01739231|5740780|P4|Challenged|Part B||21
2338937|NCT01739231|5740781|P3|Challenged|Part B||10
2338938|NCT01739231|5740782|P2|Challenged|Part B||13
2338939|NCT01739231|5740783|P1|Challenged|Part B||13
2338940|NCT01739231|5740780|P4|STARTED|Part B||21
2338941|NCT01739231|5740781|P3|STARTED|Part B||12
2338942|NCT01739231|5740782|P2|STARTED|Part B||17
2338943|NCT01739231|5740783|P1|STARTED|Part B||20
2338944|NCT01739231|5740780|P4|NOT COMPLETED|Part A||0
2338945|NCT01739231|5740781|P3|NOT COMPLETED|Part A||0
2338946|NCT01739231|5740782|P2|NOT COMPLETED|Part A||7
2338947|NCT01739231|5740783|P1|NOT COMPLETED|Part A||4
2338948|NCT01739231|5740780|P4|COMPLETED|Part A||0
2338949|NCT01739231|5740781|P3|COMPLETED|Part A||12
2338950|NCT01739231|5740782|P2|COMPLETED|Part A||17
2338951|NCT01739231|5740783|P1|COMPLETED|Part A||20
2338952|NCT01739231|5740780|P4|Received All 3 Vaccinations|Part A||0
2338953|NCT01739231|5740781|P3|Received All 3 Vaccinations|Part A||12
2338954|NCT01739231|5740782|P2|Received All 3 Vaccinations|Part A||20
2338955|NCT01739231|5740783|P1|Received All 3 Vaccinations|Part A||21
2338956|NCT01739231|5740780|P4|STARTED|Part A||0
2338957|NCT01739231|5740781|P3|STARTED|Part A||12
2338958|NCT01739231|5740782|P2|STARTED|Part A||24
2338959|NCT01739231|5740783|P1|STARTED|Part A||24
2338960|NCT01738984|5740952|P2|NOT COMPLETED|Overall Study||39
2338961|NCT01738984|5740953|P1|NOT COMPLETED|Overall Study||64
2338962|NCT01738984|5740952|P2|COMPLETED|Overall Study||210
2338963|NCT01738984|5740953|P1|COMPLETED|Overall Study||186
2338964|NCT01738984|5740952|P2|STARTED|Overall Study||249
2338965|NCT01738984|5740953|P1|STARTED|Overall Study||250
2338966|NCT01738971|5740966|P3|NOT COMPLETED|Overall Study||17
2338967|NCT01738971|5740967|P2|NOT COMPLETED|Overall Study||30
2338968|NCT01738971|5740968|P1|NOT COMPLETED|Overall Study||19
2338969|NCT01738971|5740966|P3|COMPLETED|Overall Study|39 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|39
2338970|NCT01738971|5740967|P2|COMPLETED|Overall Study|28 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|28
2338971|NCT01738971|5740968|P1|COMPLETED|Overall Study|35 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|35
2338972|NCT01738971|5740966|P3|STARTED|Overall Study|56 participants recruited to this arm|56
2338973|NCT01738971|5740967|P2|STARTED|Overall Study|58 participants recruited to this arm|58
2338974|NCT01738971|5740968|P1|STARTED|Overall Study|54 participants recruited to this arm|54
2338975|NCT01738919|5740984|P2|NOT COMPLETED|Overall Study||3
2338976|NCT01738919|5740985|P1|NOT COMPLETED|Overall Study||1
2338977|NCT01738919|5740984|P2|COMPLETED|Overall Study||14
2338978|NCT01738919|5740985|P1|COMPLETED|Overall Study||14
2338979|NCT01738919|5740984|P2|STARTED|Overall Study||17
2338980|NCT01738919|5740985|P1|STARTED|Overall Study||15
2338981|NCT01738750|5741003|P2|NOT COMPLETED|Overall Study||0
2338982|NCT01738750|5741004|P1|NOT COMPLETED|Overall Study||0
2338983|NCT01738750|5741003|P2|COMPLETED|Overall Study||51
2338984|NCT01738750|5741004|P1|COMPLETED|Overall Study||49
2338985|NCT01738750|5741003|P2|STARTED|Overall Study||51
2338986|NCT01738750|5741004|P1|STARTED|Overall Study||49
2338987|NCT01738737|5741017|P5|NOT COMPLETED|Overall Study||4
2338988|NCT01738737|5741018|P4|NOT COMPLETED|Overall Study||4
2338989|NCT01738737|5741019|P3|NOT COMPLETED|Overall Study||4
2338990|NCT01738737|5741020|P2|NOT COMPLETED|Overall Study||4
2338991|NCT01738737|5741021|P1|NOT COMPLETED|Overall Study||4
2338992|NCT01738737|5741017|P5|COMPLETED|Overall Study||25
2338993|NCT01738737|5741018|P4|COMPLETED|Overall Study||25
2338994|NCT01738737|5741019|P3|COMPLETED|Overall Study||25
2338995|NCT01738737|5741020|P2|COMPLETED|Overall Study||25
2338996|NCT01738737|5741021|P1|COMPLETED|Overall Study||25
2338997|NCT01738737|5741017|P5|STARTED|Overall Study||29
2338998|NCT01738737|5741018|P4|STARTED|Overall Study||29
2338999|NCT01738737|5741019|P3|STARTED|Overall Study||29
2339000|NCT01738737|5741020|P2|STARTED|Overall Study||29
2339001|NCT01738737|5741021|P1|STARTED|Overall Study||29
2339002|NCT01738698|5741057|P4|NOT COMPLETED|Overall Study||0
2339003|NCT01738698|5741058|P3|NOT COMPLETED|Overall Study||0
2339004|NCT01738698|5741059|P2|NOT COMPLETED|Overall Study||0
2339005|NCT01738698|5741060|P1|NOT COMPLETED|Overall Study||0
2339006|NCT01738698|5741057|P4|COMPLETED|Overall Study||0
2339007|NCT01738698|5741058|P3|COMPLETED|Overall Study||0
2339008|NCT01738698|5741059|P2|COMPLETED|Overall Study||0
2339009|NCT01738698|5741060|P1|COMPLETED|Overall Study||0
2339010|NCT01738698|5741057|P4|STARTED|Overall Study||0
2339011|NCT01738698|5741058|P3|STARTED|Overall Study||0
2339012|NCT01738698|5741059|P2|STARTED|Overall Study||0
2339013|NCT01738698|5741060|P1|STARTED|Overall Study||0
2339014|NCT01738672|5741126|P1|NOT COMPLETED|Overall Study||5
2339015|NCT01738672|5741126|P1|COMPLETED|Overall Study||11
2339016|NCT01738672|5741126|P1|STARTED|Overall Study||16
2339017|NCT01738646|5741135|P1|NOT COMPLETED|Overall Study||2
2339018|NCT01738646|5741135|P1|COMPLETED|Overall Study|Participants who discontinued study drug for any reason.|38
2339019|NCT01738646|5741135|P1|STARTED|Overall Study||40
2339020|NCT01738594|5741146|P8|NOT COMPLETED|Follow up for 1 Year||0
2339021|NCT01738594|5741147|P7|NOT COMPLETED|Follow up for 1 Year||0
2339022|NCT01738594|5741148|P6|NOT COMPLETED|Follow up for 1 Year||3
2339023|NCT01738594|5741149|P5|NOT COMPLETED|Follow up for 1 Year||0
2339024|NCT01738594|5741150|P4|NOT COMPLETED|Follow up for 1 Year||0
2339025|NCT01738594|5741151|P3|NOT COMPLETED|Follow up for 1 Year||0
2339026|NCT01738594|5741152|P2|NOT COMPLETED|Follow up for 1 Year||0
2339027|NCT01738594|5741153|P1|NOT COMPLETED|Follow up for 1 Year||0
2339028|NCT01738594|5741146|P8|COMPLETED|Follow up for 1 Year||0
2339029|NCT01738594|5741147|P7|COMPLETED|Follow up for 1 Year||0
2339030|NCT01738594|5741148|P6|COMPLETED|Follow up for 1 Year||0
2339031|NCT01738594|5741149|P5|COMPLETED|Follow up for 1 Year||1
2339032|NCT01738594|5741150|P4|COMPLETED|Follow up for 1 Year||0
2339033|NCT01738594|5741151|P3|COMPLETED|Follow up for 1 Year||0
2339034|NCT01738594|5741152|P2|COMPLETED|Follow up for 1 Year||2
2339035|NCT01738594|5741153|P1|COMPLETED|Follow up for 1 Year||0
2339036|NCT01738594|5741146|P8|STARTED|Follow up for 1 Year||0
2339037|NCT01738594|5741147|P7|STARTED|Follow up for 1 Year||0
2339038|NCT01738594|5741148|P6|STARTED|Follow up for 1 Year||3
2339039|NCT01738594|5741149|P5|STARTED|Follow up for 1 Year||1
2339040|NCT01738594|5741150|P4|STARTED|Follow up for 1 Year||0
2339041|NCT01738594|5741151|P3|STARTED|Follow up for 1 Year||0
2339042|NCT01738594|5741152|P2|STARTED|Follow up for 1 Year||2
2339043|NCT01738594|5741153|P1|STARTED|Follow up for 1 Year||0
2339044|NCT01738594|5741146|P8|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
2339045|NCT01738594|5741147|P7|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
2339046|NCT01738594|5741148|P6|NOT COMPLETED|Went on to Continue Treatment Cycle 5||1
2339047|NCT01738594|5741149|P5|NOT COMPLETED|Went on to Continue Treatment Cycle 5||1
2339048|NCT01738594|5741150|P4|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
2339049|NCT01738594|5741151|P3|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
2339050|NCT01738594|5741152|P2|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
2339051|NCT01738594|5741153|P1|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
2339052|NCT01738594|5741146|P8|COMPLETED|Went on to Continue Treatment Cycle 5||0
2339053|NCT01738594|5741147|P7|COMPLETED|Went on to Continue Treatment Cycle 5||0
2339054|NCT01738594|5741148|P6|COMPLETED|Went on to Continue Treatment Cycle 5||0
2339055|NCT01738594|5741149|P5|COMPLETED|Went on to Continue Treatment Cycle 5||0
2339056|NCT01738594|5741150|P4|COMPLETED|Went on to Continue Treatment Cycle 5||0
2339057|NCT01738594|5741151|P3|COMPLETED|Went on to Continue Treatment Cycle 5||0
2339058|NCT01738594|5741152|P2|COMPLETED|Went on to Continue Treatment Cycle 5||0
2339059|NCT01738594|5741153|P1|COMPLETED|Went on to Continue Treatment Cycle 5||0
2339060|NCT01738594|5741146|P8|STARTED|Went on to Continue Treatment Cycle 5||0
2339061|NCT01738594|5741147|P7|STARTED|Went on to Continue Treatment Cycle 5||0
2339062|NCT01738594|5741148|P6|STARTED|Went on to Continue Treatment Cycle 5||1
2339063|NCT01738594|5741149|P5|STARTED|Went on to Continue Treatment Cycle 5||1
2339064|NCT01738594|5741150|P4|STARTED|Went on to Continue Treatment Cycle 5||0
2339065|NCT01738594|5741151|P3|STARTED|Went on to Continue Treatment Cycle 5||0
2339066|NCT01738594|5741152|P2|STARTED|Went on to Continue Treatment Cycle 5||0
2339067|NCT01738594|5741153|P1|STARTED|Went on to Continue Treatment Cycle 5||0
2339068|NCT01738594|5741146|P8|NOT COMPLETED|Completed 4 Cycles of Treatment||0
2339069|NCT01738594|5741147|P7|NOT COMPLETED|Completed 4 Cycles of Treatment||0
2339070|NCT01738594|5741148|P6|NOT COMPLETED|Completed 4 Cycles of Treatment||1
2339071|NCT01738594|5741149|P5|NOT COMPLETED|Completed 4 Cycles of Treatment||0
2339072|NCT01738594|5741150|P4|NOT COMPLETED|Completed 4 Cycles of Treatment||0
2339073|NCT01738594|5741151|P3|NOT COMPLETED|Completed 4 Cycles of Treatment||0
2339074|NCT01738594|5741152|P2|NOT COMPLETED|Completed 4 Cycles of Treatment||2
2339075|NCT01738594|5741153|P1|NOT COMPLETED|Completed 4 Cycles of Treatment||0
2339076|NCT01738594|5741146|P8|COMPLETED|Completed 4 Cycles of Treatment||0
2339077|NCT01738594|5741147|P7|COMPLETED|Completed 4 Cycles of Treatment||0
2339078|NCT01738594|5741148|P6|COMPLETED|Completed 4 Cycles of Treatment||1
2339079|NCT01738594|5741149|P5|COMPLETED|Completed 4 Cycles of Treatment||1
2339080|NCT01738594|5741150|P4|COMPLETED|Completed 4 Cycles of Treatment||0
2339081|NCT01738594|5741151|P3|COMPLETED|Completed 4 Cycles of Treatment||0
2339082|NCT01738594|5741152|P2|COMPLETED|Completed 4 Cycles of Treatment||0
2339083|NCT01738594|5741153|P1|COMPLETED|Completed 4 Cycles of Treatment||0
2339084|NCT01738594|5741146|P8|STARTED|Completed 4 Cycles of Treatment||0
2339085|NCT01738594|5741147|P7|STARTED|Completed 4 Cycles of Treatment||0
2339086|NCT01738594|5741148|P6|STARTED|Completed 4 Cycles of Treatment||2
2339087|NCT01738594|5741149|P5|STARTED|Completed 4 Cycles of Treatment||1
2339088|NCT01738594|5741150|P4|STARTED|Completed 4 Cycles of Treatment||0
2339089|NCT01738594|5741151|P3|STARTED|Completed 4 Cycles of Treatment||0
2339090|NCT01738594|5741152|P2|STARTED|Completed 4 Cycles of Treatment||2
2339091|NCT01738594|5741153|P1|STARTED|Completed 4 Cycles of Treatment||0
2339092|NCT01738594|5741146|P8|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
2339093|NCT01738594|5741147|P7|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
2339094|NCT01738594|5741148|P6|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||1
2339095|NCT01738594|5741149|P5|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
2339096|NCT01738594|5741150|P4|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
2339097|NCT01738594|5741151|P3|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
2339098|NCT01738594|5741152|P2|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
2339099|NCT01738594|5741153|P1|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
2339100|NCT01738594|5741146|P8|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
2339101|NCT01738594|5741147|P7|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
2339102|NCT01738594|5741148|P6|COMPLETED|Completed 2 Cycles/Reached 1st Response||2
2339103|NCT01738594|5741149|P5|COMPLETED|Completed 2 Cycles/Reached 1st Response||1
2339104|NCT01738594|5741150|P4|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
2339105|NCT01738594|5741151|P3|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
2339106|NCT01738594|5741152|P2|COMPLETED|Completed 2 Cycles/Reached 1st Response||2
2339107|NCT01738594|5741153|P1|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
2339108|NCT01738594|5741146|P8|STARTED|Completed 2 Cycles/Reached 1st Response||0
2339109|NCT01738594|5741147|P7|STARTED|Completed 2 Cycles/Reached 1st Response||0
2339110|NCT01738594|5741148|P6|STARTED|Completed 2 Cycles/Reached 1st Response||3
2339111|NCT01738594|5741149|P5|STARTED|Completed 2 Cycles/Reached 1st Response||1
2339112|NCT01738594|5741150|P4|STARTED|Completed 2 Cycles/Reached 1st Response||0
2339113|NCT01738594|5741151|P3|STARTED|Completed 2 Cycles/Reached 1st Response||0
2339114|NCT01738594|5741152|P2|STARTED|Completed 2 Cycles/Reached 1st Response||2
2339115|NCT01738594|5741153|P1|STARTED|Completed 2 Cycles/Reached 1st Response||0
2339116|NCT01738594|5741146|P8|NOT COMPLETED|Registration and Treatment Start||0
2339117|NCT01738594|5741147|P7|NOT COMPLETED|Registration and Treatment Start||0
2339118|NCT01738594|5741148|P6|NOT COMPLETED|Registration and Treatment Start||0
2339119|NCT01738594|5741149|P5|NOT COMPLETED|Registration and Treatment Start||0
2339120|NCT01738594|5741150|P4|NOT COMPLETED|Registration and Treatment Start||0
2339121|NCT01738594|5741151|P3|NOT COMPLETED|Registration and Treatment Start||0
2339122|NCT01738594|5741152|P2|NOT COMPLETED|Registration and Treatment Start||1
2339123|NCT01738594|5741153|P1|NOT COMPLETED|Registration and Treatment Start||0
2339124|NCT01738594|5741146|P8|COMPLETED|Registration and Treatment Start||0
2339125|NCT01738594|5741147|P7|COMPLETED|Registration and Treatment Start||0
2339126|NCT01738594|5741148|P6|COMPLETED|Registration and Treatment Start||3
2339127|NCT01738594|5741149|P5|COMPLETED|Registration and Treatment Start||1
2339128|NCT01738594|5741150|P4|COMPLETED|Registration and Treatment Start||0
2339129|NCT01738594|5741151|P3|COMPLETED|Registration and Treatment Start||0
2339130|NCT01738594|5741152|P2|COMPLETED|Registration and Treatment Start||2
2339131|NCT01738594|5741153|P1|COMPLETED|Registration and Treatment Start||0
2339132|NCT01738594|5741146|P8|Treatment Started|Registration and Treatment Start||0
2339133|NCT01738594|5741147|P7|Treatment Started|Registration and Treatment Start||0
2339134|NCT01738594|5741148|P6|Treatment Started|Registration and Treatment Start||3
2339135|NCT01738594|5741149|P5|Treatment Started|Registration and Treatment Start||1
2339136|NCT01738594|5741150|P4|Treatment Started|Registration and Treatment Start||0
2339137|NCT01738594|5741151|P3|Treatment Started|Registration and Treatment Start||0
2339138|NCT01738594|5741152|P2|Treatment Started|Registration and Treatment Start||2
2339139|NCT01738594|5741153|P1|Treatment Started|Registration and Treatment Start||0
2339140|NCT01738594|5741146|P8|Registered to Study|Registration and Treatment Start||0
2339141|NCT01738594|5741147|P7|Registered to Study|Registration and Treatment Start||0
2339142|NCT01738594|5741148|P6|Registered to Study|Registration and Treatment Start||3
2339143|NCT01738594|5741149|P5|Registered to Study|Registration and Treatment Start||1
2339144|NCT01738594|5741150|P4|Registered to Study|Registration and Treatment Start||0
2339145|NCT01738594|5741151|P3|Registered to Study|Registration and Treatment Start||0
2339146|NCT01738594|5741152|P2|Registered to Study|Registration and Treatment Start||3
2339147|NCT01738594|5741153|P1|Registered to Study|Registration and Treatment Start||0
2339148|NCT01738594|5741146|P8|STARTED|Registration and Treatment Start||0
2339149|NCT01738594|5741147|P7|STARTED|Registration and Treatment Start||0
2339150|NCT01738594|5741148|P6|STARTED|Registration and Treatment Start||3
2339151|NCT01738594|5741149|P5|STARTED|Registration and Treatment Start||1
2339152|NCT01738594|5741150|P4|STARTED|Registration and Treatment Start||0
2339153|NCT01738594|5741151|P3|STARTED|Registration and Treatment Start||0
2339154|NCT01738594|5741152|P2|STARTED|Registration and Treatment Start||3
2339155|NCT01738594|5741153|P1|STARTED|Registration and Treatment Start||0
2339156|NCT01738581|5741171|P2|NOT COMPLETED|Overall Study||0
2339157|NCT01738581|5741172|P1|NOT COMPLETED|Overall Study||1
2339158|NCT01738581|5741171|P2|COMPLETED|Overall Study||4
2339159|NCT01738581|5741172|P1|COMPLETED|Overall Study||4
2339160|NCT01738581|5741171|P2|STARTED|Overall Study||4
2339161|NCT01738581|5741172|P1|STARTED|Overall Study||5
2339162|NCT01738503|5741196|P7|NOT COMPLETED|PET Imaging Sub-study||1
2339163|NCT01738503|5741197|P6|NOT COMPLETED|PET Imaging Sub-study||2
2339164|NCT01738503|5741198|P5|NOT COMPLETED|PET Imaging Sub-study||0
2339165|NCT01738503|5741199|P4|NOT COMPLETED|PET Imaging Sub-study||0
2339166|NCT01738503|5741200|P3|NOT COMPLETED|PET Imaging Sub-study||0
2339167|NCT01738503|5741201|P2|NOT COMPLETED|PET Imaging Sub-study||0
2339168|NCT01738503|5741202|P1|NOT COMPLETED|PET Imaging Sub-study||0
2339169|NCT01738503|5741196|P7|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 6 injections plus all PET images|1
2339170|NCT01738503|5741197|P6|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 12 injections plus all PET images|1
2339171|NCT01738503|5741198|P5|COMPLETED|PET Imaging Sub-study||0
2339172|NCT01738503|5741199|P4|COMPLETED|PET Imaging Sub-study||0
2339173|NCT01738503|5741200|P3|COMPLETED|PET Imaging Sub-study||0
2339174|NCT01738503|5741201|P2|COMPLETED|PET Imaging Sub-study||0
2339175|NCT01738503|5741202|P1|COMPLETED|PET Imaging Sub-study||0
2339176|NCT01738503|5741196|P7|STARTED|PET Imaging Sub-study||2
2339177|NCT01738503|5741197|P6|STARTED|PET Imaging Sub-study||3
2339178|NCT01738503|5741198|P5|STARTED|PET Imaging Sub-study||0
2339179|NCT01738503|5741199|P4|STARTED|PET Imaging Sub-study||0
2339180|NCT01738503|5741200|P3|STARTED|PET Imaging Sub-study||0
2339181|NCT01738503|5741201|P2|STARTED|PET Imaging Sub-study||0
2339182|NCT01738503|5741202|P1|STARTED|PET Imaging Sub-study||0
2339183|NCT01738503|5741196|P7|NOT COMPLETED|Treatment Period||8
2339184|NCT01738503|5741197|P6|NOT COMPLETED|Treatment Period||6
2339185|NCT01738503|5741198|P5|NOT COMPLETED|Treatment Period||8
2339186|NCT01738503|5741199|P4|NOT COMPLETED|Treatment Period||6
2339187|NCT01738503|5741200|P3|NOT COMPLETED|Treatment Period||5
2339188|NCT01738503|5741201|P2|NOT COMPLETED|Treatment Period||5
2339189|NCT01738503|5741202|P1|NOT COMPLETED|Treatment Period||0
2339190|NCT01738503|5741196|P7|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|6
2339191|NCT01738503|5741197|P6|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9
2339192|NCT01738503|5741198|P5|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|7
2339193|NCT01738503|5741199|P4|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9
2339194|NCT01738503|5741200|P3|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10
2339195|NCT01738503|5741201|P2|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10
2339196|NCT01738503|5741202|P1|COMPLETED|Treatment Period||0
2339197|NCT01738503|5741196|P7|STARTED|Treatment Period||14
2339198|NCT01738503|5741197|P6|STARTED|Treatment Period||15
2339199|NCT01738503|5741198|P5|STARTED|Treatment Period||15
2339200|NCT01738503|5741199|P4|STARTED|Treatment Period||15
2339201|NCT01738503|5741200|P3|STARTED|Treatment Period||15
2339202|NCT01738503|5741201|P2|STARTED|Treatment Period||15
2339203|NCT01738503|5741202|P1|STARTED|Treatment Period||0
2339204|NCT01738503|5741196|P7|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
2339205|NCT01738503|5741197|P6|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
2339206|NCT01738503|5741198|P5|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
2339207|NCT01738503|5741199|P4|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
2339208|NCT01738503|5741200|P3|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
2339209|NCT01738503|5741201|P2|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
2339210|NCT01738503|5741202|P1|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||35
2339211|NCT01738503|5741196|P7|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
2339212|NCT01738503|5741197|P6|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
2339213|NCT01738503|5741198|P5|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
2339214|NCT01738503|5741199|P4|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
2339215|NCT01738503|5741200|P3|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
2339216|NCT01738503|5741201|P2|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
2339217|NCT01738503|5741202|P1|COMPLETED|Induction/Stabilization (Days -14 to -1)||89
2339218|NCT01738503|5741196|P7|STARTED|Induction/Stabilization (Days -14 to -1)||0
2339219|NCT01738503|5741197|P6|STARTED|Induction/Stabilization (Days -14 to -1)||0
2339220|NCT01738503|5741198|P5|STARTED|Induction/Stabilization (Days -14 to -1)||0
2339221|NCT01738503|5741199|P4|STARTED|Induction/Stabilization (Days -14 to -1)||0
2339222|NCT01738503|5741200|P3|STARTED|Induction/Stabilization (Days -14 to -1)||0
2339223|NCT01738503|5741201|P2|STARTED|Induction/Stabilization (Days -14 to -1)||0
2339224|NCT01738503|5741202|P1|STARTED|Induction/Stabilization (Days -14 to -1)||124
2339225|NCT01738477|5741400|P2|NOT COMPLETED|Overall Study||4
2339226|NCT01738477|5741401|P1|NOT COMPLETED|Overall Study||1
2339227|NCT01738477|5741400|P2|COMPLETED|Overall Study||124
2339228|NCT01738477|5741401|P1|COMPLETED|Overall Study||36
2339229|NCT01738477|5741400|P2|STARTED|Overall Study||128
2339230|NCT01738477|5741401|P1|STARTED|Overall Study||37
2339231|NCT01738438|5741429|P1|NOT COMPLETED|Overall Study||35
2339232|NCT01738438|5741429|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
2339233|NCT01738438|5741429|P1|STARTED|Overall Study||35
2339234|NCT01738321|5741437|P2|NOT COMPLETED|Overall Study||0
2339235|NCT01738321|5741438|P1|NOT COMPLETED|Overall Study||0
2339236|NCT01738321|5741437|P2|COMPLETED|Overall Study||30
2339237|NCT01738321|5741438|P1|COMPLETED|Overall Study||33
2339238|NCT01738321|5741437|P2|STARTED|Overall Study||30
2339239|NCT01738321|5741438|P1|STARTED|Overall Study||33
2339240|NCT01738191|5741446|P2|NOT COMPLETED|Overall Study||1
2339241|NCT01738191|5741447|P1|NOT COMPLETED|Overall Study||4
2339242|NCT01738191|5741446|P2|COMPLETED|Overall Study||14
2339243|NCT01738191|5741447|P1|COMPLETED|Overall Study||11
2339244|NCT01738191|5741446|P2|STARTED|Overall Study||15
2339245|NCT01738191|5741447|P1|STARTED|Overall Study||15
2339246|NCT01737996|5741470|P3|NOT COMPLETED|Overall Study||2
2339247|NCT01737996|5741471|P2|NOT COMPLETED|Overall Study||1
2339248|NCT01737996|5741472|P1|NOT COMPLETED|Overall Study||0
2339249|NCT01737996|5741470|P3|COMPLETED|Overall Study|One patient withdrew consent after the first dose due to private reasons.|14
2339250|NCT01737996|5741471|P2|COMPLETED|Overall Study||7
2339251|NCT01737996|5741472|P1|COMPLETED|Overall Study||8
2339252|NCT01737996|5741470|P3|STARTED|Overall Study||16
2339253|NCT01737996|5741471|P2|STARTED|Overall Study||8
2339254|NCT01737996|5741472|P1|STARTED|Overall Study||8
2339255|NCT01737944|5741513|P4|NOT COMPLETED|Overall Study||0
2339256|NCT01737944|5741514|P3|NOT COMPLETED|Overall Study||0
2339257|NCT01737944|5741515|P2|NOT COMPLETED|Overall Study||0
2339258|NCT01737944|5741516|P1|NOT COMPLETED|Overall Study||0
2339259|NCT01737944|5741513|P4|COMPLETED|Overall Study||9
2339260|NCT01737944|5741514|P3|COMPLETED|Overall Study||9
2339261|NCT01737944|5741515|P2|COMPLETED|Overall Study||9
2339262|NCT01737944|5741516|P1|COMPLETED|Overall Study||9
2339263|NCT01737944|5741513|P4|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
2339264|NCT01737944|5741514|P3|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
2339265|NCT01737944|5741515|P2|STARTED|Overall Study||9
2339266|NCT01737944|5741516|P1|STARTED|Overall Study||9
2339267|NCT01737931|5741534|P3|NOT COMPLETED|Overall Study||1
2339268|NCT01737931|5741535|P2|NOT COMPLETED|Overall Study||2
2339269|NCT01737931|5741536|P1|NOT COMPLETED|Overall Study||0
2339270|NCT01737931|5741534|P3|COMPLETED|Overall Study||38
2339271|NCT01737931|5741535|P2|COMPLETED|Overall Study||38
2339272|NCT01737931|5741536|P1|COMPLETED|Overall Study||38
2339273|NCT01737931|5741534|P3|STARTED|Overall Study||39
2339274|NCT01737931|5741535|P2|STARTED|Overall Study||40
2339275|NCT01737931|5741536|P1|STARTED|Overall Study||38
2339276|NCT01737879|5741551|P1|NOT COMPLETED|Overall Study||41
2339277|NCT01737879|5741551|P1|COMPLETED|Overall Study||0
2339278|NCT01737879|5741551|P1|Transitioned to Epoetin Alfa|Overall Study||0
2339279|NCT01737879|5741551|P1|Received Peginesatide|Overall Study||34
2339280|NCT01737879|5741551|P1|STARTED|Overall Study||41
2339281|NCT01737840|5741560|P2|NOT COMPLETED|Overall Study||2
2339282|NCT01737840|5741561|P1|NOT COMPLETED|Overall Study||2
2339283|NCT01737840|5741560|P2|COMPLETED|Overall Study||33
2339284|NCT01737840|5741561|P1|COMPLETED|Overall Study||33
2339285|NCT01737840|5741560|P2|STARTED|Overall Study||35
2339286|NCT01737840|5741561|P1|STARTED|Overall Study||35
2339287|NCT01737762|5741571|P2|NOT COMPLETED|Overall Study||17
2339288|NCT01737762|5741572|P1|NOT COMPLETED|Overall Study||20
2339289|NCT01737762|5741571|P2|COMPLETED|Overall Study||61
2339290|NCT01737762|5741572|P1|COMPLETED|Overall Study||57
2339291|NCT01737762|5741571|P2|STARTED|Overall Study||78
2339292|NCT01737762|5741572|P1|STARTED|Overall Study||77
2339293|NCT01737710|5741585|P5|NOT COMPLETED|Overall Study||0
2339294|NCT01737710|5741586|P4|NOT COMPLETED|Overall Study||0
2339295|NCT01737710|5741587|P3|NOT COMPLETED|Overall Study||3
2339296|NCT01737710|5741588|P2|NOT COMPLETED|Overall Study||4
2339297|NCT01737710|5741589|P1|NOT COMPLETED|Overall Study||2
2339298|NCT01737710|5741585|P5|COMPLETED|Overall Study||21
2339299|NCT01737710|5741586|P4|COMPLETED|Overall Study||23
2339300|NCT01737710|5741587|P3|COMPLETED|Overall Study||102
2339301|NCT01737710|5741588|P2|COMPLETED|Overall Study||101
2339302|NCT01737710|5741589|P1|COMPLETED|Overall Study||112
2339303|NCT01737710|5741585|P5|STARTED|Overall Study||21
2339304|NCT01737710|5741586|P4|STARTED|Overall Study||23
2339305|NCT01737710|5741587|P3|STARTED|Overall Study||105
2339306|NCT01737710|5741588|P2|STARTED|Overall Study||105
2339307|NCT01737710|5741589|P1|STARTED|Overall Study||114
2339308|NCT01737697|5741631|P15|NOT COMPLETED|Subacute Phase||1
2339309|NCT01737697|5741632|P14|NOT COMPLETED|Subacute Phase||2
2339310|NCT01737697|5741633|P13|NOT COMPLETED|Subacute Phase||2
2339311|NCT01737697|5741634|P12|NOT COMPLETED|Subacute Phase||3
2339312|NCT01737697|5741635|P11|NOT COMPLETED|Subacute Phase||6
2339313|NCT01737697|5741636|P10|NOT COMPLETED|Subacute Phase||2
2339314|NCT01737697|5741637|P9|NOT COMPLETED|Subacute Phase||2
2339315|NCT01737697|5741638|P8|NOT COMPLETED|Subacute Phase||3
2339316|NCT01737697|5741639|P7|NOT COMPLETED|Subacute Phase||1
2339317|NCT01737697|5741640|P6|NOT COMPLETED|Subacute Phase||3
2339318|NCT01737697|5741641|P5|NOT COMPLETED|Subacute Phase||0
2339319|NCT01737697|5741642|P4|NOT COMPLETED|Subacute Phase||0
2339320|NCT01737697|5741643|P3|NOT COMPLETED|Subacute Phase||0
2339321|NCT01737697|5741644|P2|NOT COMPLETED|Subacute Phase||0
2339322|NCT01737697|5741645|P1|NOT COMPLETED|Subacute Phase||0
2339323|NCT01737697|5741631|P15|COMPLETED|Subacute Phase||49
2339324|NCT01737697|5741632|P14|COMPLETED|Subacute Phase||44
2339325|NCT01737697|5741633|P13|COMPLETED|Subacute Phase||61
2339326|NCT01737697|5741634|P12|COMPLETED|Subacute Phase||58
2339327|NCT01737697|5741635|P11|COMPLETED|Subacute Phase||59
2339328|NCT01737697|5741636|P10|COMPLETED|Subacute Phase||66
2339329|NCT01737697|5741637|P9|COMPLETED|Subacute Phase||52
2339330|NCT01737697|5741638|P8|COMPLETED|Subacute Phase||43
2339331|NCT01737697|5741639|P7|COMPLETED|Subacute Phase||48
2339332|NCT01737697|5741640|P6|COMPLETED|Subacute Phase||38
2339333|NCT01737697|5741641|P5|COMPLETED|Subacute Phase||0
2339334|NCT01737697|5741642|P4|COMPLETED|Subacute Phase||0
2339335|NCT01737697|5741643|P3|COMPLETED|Subacute Phase||0
2339336|NCT01737697|5741644|P2|COMPLETED|Subacute Phase||0
2339337|NCT01737697|5741645|P1|COMPLETED|Subacute Phase||0
2339338|NCT01737697|5741631|P15|STARTED|Subacute Phase||50
2339339|NCT01737697|5741632|P14|STARTED|Subacute Phase||46
2339340|NCT01737697|5741633|P13|STARTED|Subacute Phase||63
2339341|NCT01737697|5741634|P12|STARTED|Subacute Phase||61
2339342|NCT01737697|5741635|P11|STARTED|Subacute Phase||65
2339343|NCT01737697|5741636|P10|STARTED|Subacute Phase||68
2339344|NCT01737697|5741637|P9|STARTED|Subacute Phase||54
2339345|NCT01737697|5741638|P8|STARTED|Subacute Phase||46
2339346|NCT01737697|5741639|P7|STARTED|Subacute Phase||49
2339347|NCT01737697|5741640|P6|STARTED|Subacute Phase||41
2339348|NCT01737697|5741641|P5|STARTED|Subacute Phase||0
2339349|NCT01737697|5741642|P4|STARTED|Subacute Phase||0
2339350|NCT01737697|5741643|P3|STARTED|Subacute Phase||0
2339351|NCT01737697|5741644|P2|STARTED|Subacute Phase||0
2339352|NCT01737697|5741645|P1|STARTED|Subacute Phase||0
2339353|NCT01737697|5741631|P15|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
2339354|NCT01737697|5741632|P14|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
2339355|NCT01737697|5741633|P13|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
2339356|NCT01737697|5741634|P12|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
2339357|NCT01737697|5741635|P11|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
2339358|NCT01737697|5741636|P10|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
2339359|NCT01737697|5741637|P9|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
2339360|NCT01737697|5741638|P8|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
2339361|NCT01737697|5741639|P7|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
2339362|NCT01737697|5741640|P6|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
2339363|NCT01737697|5741641|P5|NOT COMPLETED|Acute Phase-Initial 48 Hours||3
2339364|NCT01737697|5741642|P4|NOT COMPLETED|Acute Phase-Initial 48 Hours||6
2339365|NCT01737697|5741643|P3|NOT COMPLETED|Acute Phase-Initial 48 Hours||4
2339366|NCT01737697|5741644|P2|NOT COMPLETED|Acute Phase-Initial 48 Hours||4
2339367|NCT01737697|5741645|P1|NOT COMPLETED|Acute Phase-Initial 48 Hours||1
2339368|NCT01737697|5741631|P15|COMPLETED|Acute Phase-Initial 48 Hours||0
2339369|NCT01737697|5741632|P14|COMPLETED|Acute Phase-Initial 48 Hours||0
2339370|NCT01737697|5741633|P13|COMPLETED|Acute Phase-Initial 48 Hours||0
2339371|NCT01737697|5741634|P12|COMPLETED|Acute Phase-Initial 48 Hours||0
2339372|NCT01737697|5741635|P11|COMPLETED|Acute Phase-Initial 48 Hours||0
2339373|NCT01737697|5741636|P10|COMPLETED|Acute Phase-Initial 48 Hours||0
2339374|NCT01737697|5741637|P9|COMPLETED|Acute Phase-Initial 48 Hours||0
2339375|NCT01737697|5741638|P8|COMPLETED|Acute Phase-Initial 48 Hours||0
2339376|NCT01737697|5741639|P7|COMPLETED|Acute Phase-Initial 48 Hours||0
2339377|NCT01737697|5741640|P6|COMPLETED|Acute Phase-Initial 48 Hours||0
2339378|NCT01737697|5741641|P5|COMPLETED|Acute Phase-Initial 48 Hours||140
2339379|NCT01737697|5741642|P4|COMPLETED|Acute Phase-Initial 48 Hours||152
2339380|NCT01737697|5741643|P3|COMPLETED|Acute Phase-Initial 48 Hours||137
2339381|NCT01737697|5741644|P2|COMPLETED|Acute Phase-Initial 48 Hours||150
2339382|NCT01737697|5741645|P1|COMPLETED|Acute Phase-Initial 48 Hours||157
2339383|NCT01737697|5741631|P15|STARTED|Acute Phase-Initial 48 Hours||0
2339384|NCT01737697|5741632|P14|STARTED|Acute Phase-Initial 48 Hours||0
2339385|NCT01737697|5741633|P13|STARTED|Acute Phase-Initial 48 Hours||0
2339386|NCT01737697|5741634|P12|STARTED|Acute Phase-Initial 48 Hours||0
2339387|NCT01737697|5741635|P11|STARTED|Acute Phase-Initial 48 Hours||0
2339388|NCT01737697|5741636|P10|STARTED|Acute Phase-Initial 48 Hours||0
2339389|NCT01737697|5741637|P9|STARTED|Acute Phase-Initial 48 Hours||0
2339390|NCT01737697|5741638|P8|STARTED|Acute Phase-Initial 48 Hours||0
2339391|NCT01737697|5741639|P7|STARTED|Acute Phase-Initial 48 Hours||0
2339392|NCT01737697|5741640|P6|STARTED|Acute Phase-Initial 48 Hours||0
2339393|NCT01737697|5741641|P5|STARTED|Acute Phase-Initial 48 Hours||143
2339394|NCT01737697|5741642|P4|STARTED|Acute Phase-Initial 48 Hours||158
2339395|NCT01737697|5741643|P3|STARTED|Acute Phase-Initial 48 Hours||141
2339396|NCT01737697|5741644|P2|STARTED|Acute Phase-Initial 48 Hours||154
2339397|NCT01737697|5741645|P1|STARTED|Acute Phase-Initial 48 Hours||158
2339398|NCT01737684|5741734|P3|NOT COMPLETED|Overall Study||0
2339399|NCT01737684|5741735|P2|NOT COMPLETED|Overall Study||0
2339400|NCT01737684|5741736|P1|NOT COMPLETED|Overall Study||0
2339401|NCT01737684|5741734|P3|COMPLETED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
2339402|NCT01737684|5741735|P2|COMPLETED|Overall Study||8
2339403|NCT01737684|5741736|P1|COMPLETED|Overall Study||8
2339404|NCT01737684|5741734|P3|STARTED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
2339405|NCT01737684|5741735|P2|STARTED|Overall Study||8
2339406|NCT01737684|5741736|P1|STARTED|Overall Study||8
2339407|NCT01737593|5741755|P3|NOT COMPLETED|Overall Study||0
2339408|NCT01737593|5741756|P2|NOT COMPLETED|Overall Study||0
2339409|NCT01737593|5741757|P1|NOT COMPLETED|Overall Study||0
2339410|NCT01737593|5741755|P3|COMPLETED|Overall Study||39
2339411|NCT01737593|5741756|P2|COMPLETED|Overall Study||32
2339412|NCT01737593|5741757|P1|COMPLETED|Overall Study||37
2339413|NCT01737593|5741755|P3|STARTED|Overall Study||39
2339414|NCT01737593|5741756|P2|STARTED|Overall Study||32
2339415|NCT01737593|5741757|P1|STARTED|Overall Study||37
2339416|NCT01737398|5741788|P2|NOT COMPLETED|Overall Study||8
2339417|NCT01737398|5741789|P1|NOT COMPLETED|Overall Study||26
2339418|NCT01737398|5741788|P2|COMPLETED|Overall Study||52
2339419|NCT01737398|5741789|P1|COMPLETED|Overall Study||87
2339420|NCT01737398|5741788|P2|Safety Set|Overall Study||60
2339421|NCT01737398|5741789|P1|Safety Set|Overall Study||112
2339422|NCT01737398|5741788|P2|Received at Least 1 Dose of Study Drug|Overall Study||60
2339423|NCT01737398|5741789|P1|Received at Least 1 Dose of Study Drug|Overall Study||112
2339424|NCT01737398|5741788|P2|STARTED|Overall Study||60
2339425|NCT01737398|5741789|P1|STARTED|Overall Study||113
2339426|NCT01737281|5741833|P2|NOT COMPLETED|Overall Study||280
2339427|NCT01737281|5741834|P1|NOT COMPLETED|Overall Study||366
2339428|NCT01737281|5741833|P2|COMPLETED|Overall Study||689
2339429|NCT01737281|5741834|P1|COMPLETED|Overall Study||603
2339430|NCT01737281|5741833|P2|STARTED|Overall Study||969
2339431|NCT01737281|5741834|P1|STARTED|Overall Study||969
2339432|NCT01737268|5741842|P1|NOT COMPLETED|Overall Study||9
2339433|NCT01737268|5741842|P1|COMPLETED|Overall Study||11
2339434|NCT01737268|5741842|P1|Treated|Overall Study||20
2339435|NCT01737268|5741842|P1|STARTED|Overall Study||20
2339436|NCT01737021|5741856|P2|NOT COMPLETED|Overall Study||3
2339437|NCT01737021|5741857|P1|NOT COMPLETED|Overall Study||5
2339438|NCT01737021|5741856|P2|COMPLETED|Overall Study||6
2339439|NCT01737021|5741857|P1|COMPLETED|Overall Study||17
2339440|NCT01737021|5741856|P2|STARTED|Overall Study||9
2339441|NCT01737021|5741857|P1|STARTED|Overall Study||22
2339442|NCT01736930|5741863|P1|NOT COMPLETED|Overall Study||1
2339443|NCT01736930|5741863|P1|COMPLETED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|19
2339444|NCT01736930|5741863|P1|STARTED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|20
2339445|NCT01736917|5741903|P1|NOT COMPLETED|Overall Study||11
2339446|NCT01736917|5741903|P1|COMPLETED|Overall Study||54
2339447|NCT01736917|5741903|P1|STARTED|Overall Study||65
2339448|NCT01736865|5741912|P2|NOT COMPLETED|Overall Study||0
2339449|NCT01736865|5741913|P1|NOT COMPLETED|Overall Study||0
2339450|NCT01736865|5741912|P2|COMPLETED|Overall Study||66
2339451|NCT01736865|5741913|P1|COMPLETED|Overall Study||61
2339452|NCT01736865|5741912|P2|STARTED|Overall Study||66
2339453|NCT01736865|5741913|P1|STARTED|Overall Study||61
2339454|NCT01736696|5741932|P7|NOT COMPLETED|Overall Study||0
2339455|NCT01736696|5741933|P6|NOT COMPLETED|Overall Study||0
2339456|NCT01736696|5741934|P5|NOT COMPLETED|Overall Study||0
2339457|NCT01736696|5741935|P4|NOT COMPLETED|Overall Study||0
2339458|NCT01736696|5741936|P3|NOT COMPLETED|Overall Study||1
2339459|NCT01736696|5741937|P2|NOT COMPLETED|Overall Study||0
2339460|NCT01736696|5741938|P1|NOT COMPLETED|Overall Study||0
2339461|NCT01736696|5741932|P7|COMPLETED|Overall Study||13
2339462|NCT01736696|5741933|P6|COMPLETED|Overall Study||8
2339463|NCT01736696|5741934|P5|COMPLETED|Overall Study||9
2339464|NCT01736696|5741935|P4|COMPLETED|Overall Study||9
2339465|NCT01736696|5741936|P3|COMPLETED|Overall Study||9
2339466|NCT01736696|5741937|P2|COMPLETED|Overall Study||5
2339467|NCT01736696|5741938|P1|COMPLETED|Overall Study||5
2339468|NCT01736696|5741932|P7|STARTED|Overall Study||13
2339469|NCT01736696|5741933|P6|STARTED|Overall Study||8
2339470|NCT01736696|5741934|P5|STARTED|Overall Study||9
2339471|NCT01736696|5741935|P4|STARTED|Overall Study||9
2339472|NCT01736696|5741936|P3|STARTED|Overall Study||10
2339473|NCT01736696|5741937|P2|STARTED|Overall Study||5
2339474|NCT01736696|5741938|P1|STARTED|Overall Study||5
2339475|NCT01736683|5742260|P5|NOT COMPLETED|Overall Study||5
2339476|NCT01736683|5742261|P4|NOT COMPLETED|Overall Study||35
2339477|NCT01736683|5742262|P3|NOT COMPLETED|Overall Study||21
2339478|NCT01736683|5742263|P2|NOT COMPLETED|Overall Study||6
2339479|NCT01736683|5742264|P1|NOT COMPLETED|Overall Study||7
2339480|NCT01736683|5742260|P5|COMPLETED|Overall Study|# who completed treatment|0
2339481|NCT01736683|5742261|P4|COMPLETED|Overall Study|# who completed treatment|0
2339482|NCT01736683|5742262|P3|COMPLETED|Overall Study|# who completed treatment|0
2339483|NCT01736683|5742263|P2|COMPLETED|Overall Study|# who completed treatment|0
2339484|NCT01736683|5742264|P1|COMPLETED|Overall Study|# who completed treatment|0
2339485|NCT01736683|5742260|P5|STARTED|Overall Study||5
2339486|NCT01736683|5742261|P4|STARTED|Overall Study||35
2339487|NCT01736683|5742262|P3|STARTED|Overall Study||21
2339488|NCT01736683|5742263|P2|STARTED|Overall Study||6
2339489|NCT01736683|5742264|P1|STARTED|Overall Study||7
2339490|NCT01736657|5742326|P1|NOT COMPLETED|Overall Study||1
2339491|NCT01736657|5742326|P1|COMPLETED|Overall Study||72
2339492|NCT01736657|5742326|P1|STARTED|Overall Study||73
2339493|NCT01736579|5742335|P2|NOT COMPLETED|Overall Study||2
2339494|NCT01736579|5742336|P1|NOT COMPLETED|Overall Study||2
2339495|NCT01736579|5742335|P2|COMPLETED|Overall Study||0
2339496|NCT01736579|5742336|P1|COMPLETED|Overall Study||0
2339497|NCT01736579|5742335|P2|STARTED|Overall Study||2
2339498|NCT01736579|5742336|P1|STARTED|Overall Study||2
2339499|NCT01736566|5742375|P5|NOT COMPLETED|Long Term Follow-up||1
2339500|NCT01736566|5742376|P4|NOT COMPLETED|Long Term Follow-up||0
2339501|NCT01736566|5742377|P3|NOT COMPLETED|Long Term Follow-up||49
2339502|NCT01736566|5742378|P2|NOT COMPLETED|Long Term Follow-up||0
2339503|NCT01736566|5742379|P1|NOT COMPLETED|Long Term Follow-up||42
2339504|NCT01736566|5742375|P5|COMPLETED|Long Term Follow-up||0
2339505|NCT01736566|5742376|P4|COMPLETED|Long Term Follow-up||0
2339506|NCT01736566|5742377|P3|COMPLETED|Long Term Follow-up||0
2339507|NCT01736566|5742378|P2|COMPLETED|Long Term Follow-up||0
2339508|NCT01736566|5742379|P1|COMPLETED|Long Term Follow-up||0
2339509|NCT01736566|5742375|P5|STARTED|Long Term Follow-up||1
2339510|NCT01736566|5742376|P4|STARTED|Long Term Follow-up||0
2339511|NCT01736566|5742377|P3|STARTED|Long Term Follow-up||49
2339512|NCT01736566|5742378|P2|STARTED|Long Term Follow-up||0
2339513|NCT01736566|5742379|P1|STARTED|Long Term Follow-up||42
2339514|NCT01736566|5742375|P5|NOT COMPLETED|Main Study||4
2339515|NCT01736566|5742376|P4|NOT COMPLETED|Main Study||1
2339516|NCT01736566|5742377|P3|NOT COMPLETED|Main Study||1
2339517|NCT01736566|5742378|P2|NOT COMPLETED|Main Study||0
2339518|NCT01736566|5742379|P1|NOT COMPLETED|Main Study||1
2339519|NCT01736566|5742375|P5|COMPLETED|Main Study||6
2339520|NCT01736566|5742376|P4|COMPLETED|Main Study||51
2339521|NCT01736566|5742377|P3|COMPLETED|Main Study||49
2339522|NCT01736566|5742378|P2|COMPLETED|Main Study||50
2339523|NCT01736566|5742379|P1|COMPLETED|Main Study||50
2339524|NCT01736566|5742375|P5|STARTED|Main Study||10
2339525|NCT01736566|5742376|P4|STARTED|Main Study||52
2339526|NCT01736566|5742377|P3|STARTED|Main Study||50
2339527|NCT01736566|5742378|P2|STARTED|Main Study||50
2339528|NCT01736566|5742379|P1|STARTED|Main Study||51
2339529|NCT01736553|5742464|P2|NOT COMPLETED|Overall Study||4
2339530|NCT01736553|5742465|P1|NOT COMPLETED|Overall Study||19
2339531|NCT01736553|5742464|P2|COMPLETED|Overall Study||23
2339532|NCT01736553|5742465|P1|COMPLETED|Overall Study||7
2339533|NCT01736553|5742464|P2|STARTED|Overall Study||27
2339534|NCT01736553|5742465|P1|STARTED|Overall Study||26
2339535|NCT01736540|5742516|P1|NOT COMPLETED|Overall Study||15
2339536|NCT01736540|5742516|P1|COMPLETED|Overall Study||228
2339537|NCT01736540|5742516|P1|STARTED|Overall Study||243
2339538|NCT01736527|5742573|P1|NOT COMPLETED|Overall Study||0
2339539|NCT01736527|5742573|P1|COMPLETED|Overall Study||12
2339540|NCT01736527|5742573|P1|STARTED|Overall Study||12
2339541|NCT01736475|5742582|P2|NOT COMPLETED|Overall Study||0
2339542|NCT01736475|5742583|P1|NOT COMPLETED|Overall Study||12
2339543|NCT01736475|5742582|P2|COMPLETED|Overall Study||17
2339544|NCT01736475|5742583|P1|COMPLETED|Overall Study||109
2339545|NCT01736475|5742582|P2|STARTED|Overall Study||17
2339546|NCT01736475|5742583|P1|STARTED|Overall Study||121
2339547|NCT01736397|5742638|P2|NOT COMPLETED|Overall Study||24
2339548|NCT01736397|5742639|P1|NOT COMPLETED|Overall Study||14
2339549|NCT01736397|5742638|P2|COMPLETED|Overall Study||50
2339550|NCT01736397|5742639|P1|COMPLETED|Overall Study||61
2339551|NCT01736397|5742638|P2|STARTED|Overall Study||74
2339552|NCT01736397|5742639|P1|STARTED|Overall Study||75
2339553|NCT01736358|5742653|P2|NOT COMPLETED|Overall Study||2
2339554|NCT01736358|5742654|P1|NOT COMPLETED|Overall Study||5
2339555|NCT01736358|5742653|P2|COMPLETED|Overall Study||23
2339556|NCT01736358|5742654|P1|COMPLETED|Overall Study||20
2339557|NCT01736358|5742653|P2|STARTED|Overall Study||25
2339558|NCT01736358|5742654|P1|STARTED|Overall Study||25
2339559|NCT01736254|5742668|P1|NOT COMPLETED|Period 3 (Days 13 to 23)||1
2339560|NCT01736254|5742668|P1|COMPLETED|Period 3 (Days 13 to 23)||20
2339561|NCT01736254|5742668|P1|STARTED|Period 3 (Days 13 to 23)||21
2339562|NCT01736254|5742668|P1|NOT COMPLETED|Period 2 (Days 2 to 12)||3
2339563|NCT01736254|5742668|P1|COMPLETED|Period 2 (Days 2 to 12)||21
2339564|NCT01736254|5742668|P1|STARTED|Period 2 (Days 2 to 12)||24
2339565|NCT01736254|5742668|P1|NOT COMPLETED|Period 1 (Day 1)||0
2339566|NCT01736254|5742668|P1|COMPLETED|Period 1 (Day 1)||24
2339567|NCT01736254|5742668|P1|Received at Least One Dose of Study Drug|Period 1 (Day 1)||24
2339568|NCT01736254|5742668|P1|STARTED|Period 1 (Day 1)||24
2339569|NCT01736241|5742692|P7|NOT COMPLETED|Overall Study||0
2339570|NCT01736241|5742693|P6|NOT COMPLETED|Overall Study||0
2339571|NCT01736241|5742694|P5|NOT COMPLETED|Overall Study||0
2339572|NCT01736241|5742695|P4|NOT COMPLETED|Overall Study||0
2339573|NCT01736241|5742696|P3|NOT COMPLETED|Overall Study||0
2339574|NCT01736241|5742697|P2|NOT COMPLETED|Overall Study||0
2339575|NCT01736241|5742698|P1|NOT COMPLETED|Overall Study||0
2339576|NCT01736241|5742692|P7|COMPLETED|Overall Study||6
2339577|NCT01736241|5742693|P6|COMPLETED|Overall Study||6
2339578|NCT01736241|5742694|P5|COMPLETED|Overall Study||6
2339579|NCT01736241|5742695|P4|COMPLETED|Overall Study||5
2339580|NCT01736241|5742696|P3|COMPLETED|Overall Study||6
2339581|NCT01736241|5742697|P2|COMPLETED|Overall Study||6
2339582|NCT01736241|5742698|P1|COMPLETED|Overall Study||6
2339583|NCT01736241|5742692|P7|Received at Least One Dose of Study Drug|Overall Study||6
2339584|NCT01736241|5742693|P6|Received at Least One Dose of Study Drug|Overall Study||6
2339585|NCT01736241|5742694|P5|Received at Least One Dose of Study Drug|Overall Study||6
2339586|NCT01736241|5742695|P4|Received at Least One Dose of Study Drug|Overall Study||5
2339587|NCT01736241|5742696|P3|Received at Least One Dose of Study Drug|Overall Study||6
2339588|NCT01736241|5742697|P2|Received at Least One Dose of Study Drug|Overall Study||6
2339589|NCT01736241|5742698|P1|Received at Least One Dose of Study Drug|Overall Study||6
2339590|NCT01736241|5742692|P7|STARTED|Overall Study||6
2339591|NCT01736241|5742693|P6|STARTED|Overall Study||6
2339592|NCT01736241|5742694|P5|STARTED|Overall Study||6
2339593|NCT01736241|5742695|P4|STARTED|Overall Study||5
2339594|NCT01736241|5742696|P3|STARTED|Overall Study||6
2339595|NCT01736241|5742697|P2|STARTED|Overall Study||6
2339596|NCT01736241|5742698|P1|STARTED|Overall Study||6
2339597|NCT01736215|5742733|P1|NOT COMPLETED|Overall Study||14
2339598|NCT01736215|5742733|P1|COMPLETED|Overall Study||19
2339599|NCT01736215|5742733|P1|Treated|Overall Study||25
2339600|NCT01736215|5742733|P1|STARTED|Overall Study||33
2339601|NCT01736189|5742745|P1|NOT COMPLETED|Overall Study||46
2339602|NCT01736189|5742745|P1|COMPLETED|Overall Study||300
2339603|NCT01736189|5742745|P1|STARTED|Overall Study||346
2339604|NCT01736176|5742754|P1|NOT COMPLETED|Overall Study||11
2339605|NCT01736176|5742754|P1|COMPLETED|Overall Study||28
2339606|NCT01736176|5742754|P1|Received LCIG|Overall Study||38
2339607|NCT01736176|5742754|P1|STARTED|Overall Study|Enrolled participants who underwent the PEG-J placement procedure|39
2339626|NCT01735994|5742825|P2|NOT COMPLETED|Overall Study||66
2339627|NCT01735994|5742826|P1|NOT COMPLETED|Overall Study||63
2339628|NCT01735994|5742825|P2|COMPLETED|Overall Study||152
2339629|NCT01735994|5742826|P1|COMPLETED|Overall Study||200
2339630|NCT01735994|5742825|P2|Follow-Up #2 (12 Months)|Overall Study||174
2339631|NCT01735994|5742826|P1|Follow-Up #2 (12 Months)|Overall Study||212
2339632|NCT01735994|5742825|P2|Follow-Up #1 (6 Months)|Overall Study||163
2339633|NCT01735994|5742826|P1|Follow-Up #1 (6 Months)|Overall Study||213
2339634|NCT01735994|5742825|P2|Post Intervention (3 Weeks)|Overall Study||198
2339635|NCT01735994|5742826|P1|Post Intervention (3 Weeks)|Overall Study||239
2339636|NCT01735994|5742825|P2|STARTED|Overall Study||218
2339637|NCT01735994|5742826|P1|STARTED|Overall Study||263
2339638|NCT01735916|5742841|P3|NOT COMPLETED|Overall Study||7
2339639|NCT01735916|5742842|P2|NOT COMPLETED|Overall Study||19
2339640|NCT01735916|5742843|P1|NOT COMPLETED|Overall Study||18
2339641|NCT01735916|5742841|P3|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
2339642|NCT01735916|5742842|P2|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
2339643|NCT01735916|5742843|P1|COMPLETED|Overall Study||0
2339644|NCT01735916|5742841|P3|STARTED|Overall Study||7
2339645|NCT01735916|5742842|P2|STARTED|Overall Study||19
2339646|NCT01735916|5742843|P1|STARTED|Overall Study||18
2339647|NCT01735877|5742864|P2|NOT COMPLETED|Overall Study||0
2339648|NCT01735877|5742865|P1|NOT COMPLETED|Overall Study||1
2339649|NCT01735877|5742864|P2|COMPLETED|Overall Study||21
2339650|NCT01735877|5742865|P1|COMPLETED|Overall Study||26
2339651|NCT01735877|5742864|P2|STARTED|Overall Study||21
2339652|NCT01735877|5742865|P1|STARTED|Overall Study||27
2339653|NCT01735630|5742881|P2|NOT COMPLETED|Overall Study||18
2339654|NCT01735630|5742882|P1|NOT COMPLETED|Overall Study||18
2339655|NCT01735630|5742881|P2|COMPLETED|Overall Study||157
2339656|NCT01735630|5742882|P1|COMPLETED|Overall Study||157
2339657|NCT01735630|5742881|P2|STARTED|Overall Study||175
2339658|NCT01735630|5742882|P1|STARTED|Overall Study||175
2339659|NCT01735617|5742896|P1|NOT COMPLETED|Overall Study||0
2339660|NCT01735617|5742896|P1|COMPLETED|Overall Study||16
2339661|NCT01735617|5742896|P1|STARTED|Overall Study||16
2339662|NCT01735396|5742909|P1|NOT COMPLETED|Overall Study||1
2339663|NCT01735396|5742909|P1|COMPLETED|Overall Study||10
2339664|NCT01735396|5742909|P1|STARTED|Overall Study||11
2339665|NCT01735214|5742918|P1|NOT COMPLETED|Overall Study||0
2339666|NCT01735214|5742918|P1|COMPLETED|Overall Study||358
2339667|NCT01735214|5742918|P1|STARTED|Overall Study||358
2339668|NCT01735201|5742938|P8|NOT COMPLETED|Overall Study||2
2339669|NCT01735201|5742939|P7|NOT COMPLETED|Overall Study||3
2339670|NCT01735201|5742940|P6|NOT COMPLETED|Overall Study||5
2339671|NCT01735201|5742941|P5|NOT COMPLETED|Overall Study||1
2339672|NCT01735201|5742942|P4|NOT COMPLETED|Overall Study||2
2339673|NCT01735201|5742943|P3|NOT COMPLETED|Overall Study||0
2339674|NCT01735201|5742944|P2|NOT COMPLETED|Overall Study||1
2339675|NCT01735201|5742945|P1|NOT COMPLETED|Overall Study||3
2339676|NCT01735201|5742938|P8|COMPLETED|Overall Study||42
2339677|NCT01735201|5742939|P7|COMPLETED|Overall Study||42
2339678|NCT01735201|5742940|P6|COMPLETED|Overall Study||40
2339679|NCT01735201|5742941|P5|COMPLETED|Overall Study||44
2339680|NCT01735201|5742942|P4|COMPLETED|Overall Study||42
2339681|NCT01735201|5742943|P3|COMPLETED|Overall Study||44
2339682|NCT01735201|5742944|P2|COMPLETED|Overall Study||43
2339683|NCT01735201|5742945|P1|COMPLETED|Overall Study||42
2339684|NCT01735201|5742938|P8|STARTED|Overall Study||44
2339685|NCT01735201|5742939|P7|STARTED|Overall Study||45
2339686|NCT01735201|5742940|P6|STARTED|Overall Study||45
2339687|NCT01735201|5742941|P5|STARTED|Overall Study||45
2339688|NCT01735201|5742942|P4|STARTED|Overall Study||44
2339689|NCT01735201|5742943|P3|STARTED|Overall Study||44
2339690|NCT01735201|5742944|P2|STARTED|Overall Study||44
2339691|NCT01735201|5742945|P1|STARTED|Overall Study||45
2339692|NCT01735175|5742981|P2|NOT COMPLETED|Overall Study||13
2339693|NCT01735175|5742982|P1|NOT COMPLETED|Overall Study||29
2339694|NCT01735175|5742981|P2|COMPLETED|Overall Study||144
2339695|NCT01735175|5742982|P1|COMPLETED|Overall Study||130
2339696|NCT01735175|5742981|P2|Completed the 6-month SFU Visit|Overall Study||138
2339697|NCT01735175|5742982|P1|Completed the 6-month SFU Visit|Overall Study||120
2339698|NCT01735175|5742981|P2|Completed All Treatments as Planned|Overall Study||150
2339699|NCT01735175|5742982|P1|Completed All Treatments as Planned|Overall Study||140
2339700|NCT01735175|5742981|P2|Completed All Cycles|Overall Study||150
2339701|NCT01735175|5742982|P1|Completed All Cycles|Overall Study||141
2339702|NCT01735175|5742981|P2|STARTED|Overall Study||157
2339703|NCT01735175|5742982|P1|STARTED|Overall Study||159
2339704|NCT01734993|5743002|P1|NOT COMPLETED|Overall Study||2
2339705|NCT01734993|5743002|P1|COMPLETED|Overall Study||9
2339706|NCT01734993|5743002|P1|STARTED|Overall Study||11
2339707|NCT01734902|5743030|P2|NOT COMPLETED|Overall Study||2
2339708|NCT01734902|5743031|P1|NOT COMPLETED|Overall Study||0
2339709|NCT01734902|5743030|P2|COMPLETED|Overall Study||14
2339710|NCT01734902|5743031|P1|COMPLETED|Overall Study||14
2339711|NCT01734902|5743030|P2|STARTED|Overall Study||16
2339712|NCT01734902|5743031|P1|STARTED|Overall Study||14
2339713|NCT01734889|5743041|P1|NOT COMPLETED|Overall Study||0
2339714|NCT01734889|5743041|P1|COMPLETED|Overall Study||18
2339715|NCT01734889|5743041|P1|STARTED|Overall Study||18
2339716|NCT01734785|5743052|P4|NOT COMPLETED|Double−Blind Period||0
2339717|NCT01734785|5743053|P3|NOT COMPLETED|Double−Blind Period||5
2339718|NCT01734785|5743054|P2|NOT COMPLETED|Double−Blind Period||9
2339719|NCT01734785|5743055|P1|NOT COMPLETED|Double−Blind Period||5
2339720|NCT01734785|5743052|P4|COMPLETED|Double−Blind Period||0
2339721|NCT01734785|5743053|P3|COMPLETED|Double−Blind Period||105
2339722|NCT01734785|5743054|P2|COMPLETED|Double−Blind Period||103
2339723|NCT01734785|5743055|P1|COMPLETED|Double−Blind Period||106
2339724|NCT01734785|5743052|P4|STARTED|Double−Blind Period||0
2339725|NCT01734785|5743053|P3|STARTED|Double−Blind Period||110
2339726|NCT01734785|5743054|P2|STARTED|Double−Blind Period||112
2339727|NCT01734785|5743055|P1|STARTED|Double−Blind Period||111
2339728|NCT01734785|5743052|P4|NOT COMPLETED|Open−Label Period||273
2339729|NCT01734785|5743053|P3|NOT COMPLETED|Open−Label Period||0
2339730|NCT01734785|5743054|P2|NOT COMPLETED|Open−Label Period||0
2339731|NCT01734785|5743055|P1|NOT COMPLETED|Open−Label Period||0
2339732|NCT01734785|5743052|P4|COMPLETED|Open−Label Period||333
2339733|NCT01734785|5743053|P3|COMPLETED|Open−Label Period||0
2339734|NCT01734785|5743054|P2|COMPLETED|Open−Label Period||0
2339735|NCT01734785|5743055|P1|COMPLETED|Open−Label Period||0
2339736|NCT01734785|5743052|P4|STARTED|Open−Label Period||606
2339737|NCT01734785|5743053|P3|STARTED|Open−Label Period||0
2339738|NCT01734785|5743054|P2|STARTED|Open−Label Period||0
2339739|NCT01734785|5743055|P1|STARTED|Open−Label Period||0
2339740|NCT01734772|5743072|P2|NOT COMPLETED|Overall Study||3
2339741|NCT01734772|5743073|P1|NOT COMPLETED|Overall Study||1
2339742|NCT01734772|5743072|P2|COMPLETED|Overall Study||21
2339743|NCT01734772|5743073|P1|COMPLETED|Overall Study||23
2339744|NCT01734772|5743072|P2|STARTED|Overall Study||24
2339745|NCT01734772|5743073|P1|STARTED|Overall Study||24
2339746|NCT01734746|5743090|P1|NOT COMPLETED|Overall Study||1
2339747|NCT01734746|5743090|P1|COMPLETED|Overall Study||21
2339748|NCT01734746|5743090|P1|STARTED|Overall Study||22
2339749|NCT01734655|5743096|P1|NOT COMPLETED|Overall Study||0
2339750|NCT01734655|5743096|P1|COMPLETED|Overall Study||40
2339751|NCT01734655|5743096|P1|STARTED|Overall Study||40
2339752|NCT01734551|5743107|P2|NOT COMPLETED|Overall Study||0
2339753|NCT01734551|5743108|P1|NOT COMPLETED|Overall Study||0
2339754|NCT01734551|5743107|P2|COMPLETED|Overall Study||16
2339755|NCT01734551|5743108|P1|COMPLETED|Overall Study||15
2339756|NCT01734551|5743107|P2|STARTED|Overall Study||16
2339757|NCT01734551|5743108|P1|STARTED|Overall Study||15
2339758|NCT01734525|5743120|P1|NOT COMPLETED|Overall Study||0
2339759|NCT01734525|5743120|P1|COMPLETED|Overall Study||85
2339760|NCT01734525|5743120|P1|STARTED|Overall Study||85
2339761|NCT01734434|5743128|P4|NOT COMPLETED|Overall Study||23
2339762|NCT01734434|5743129|P3|NOT COMPLETED|Overall Study||129
2339763|NCT01734434|5743130|P2|NOT COMPLETED|Overall Study||12
2339764|NCT01734434|5743131|P1|NOT COMPLETED|Overall Study||10
2339765|NCT01734434|5743128|P4|COMPLETED|Overall Study||228
2339766|NCT01734434|5743129|P3|COMPLETED|Overall Study||1863
2339767|NCT01734434|5743130|P2|COMPLETED|Overall Study||488
2339768|NCT01734434|5743131|P1|COMPLETED|Overall Study||490
2339769|NCT01734434|5743128|P4|STARTED|Overall Study||251
2339770|NCT01734434|5743129|P3|STARTED|Overall Study||1992
2339771|NCT01734434|5743130|P2|STARTED|Overall Study||500
2339772|NCT01734434|5743131|P1|STARTED|Overall Study||500
2339773|NCT01734395|5743153|P1|NOT COMPLETED|Overall Study||410
2339774|NCT01734395|5743153|P1|COMPLETED|Overall Study||1472
2339775|NCT01734395|5743153|P1|STARTED|Overall Study||1882
2339776|NCT01734317|5743159|P1|NOT COMPLETED|Overall Study||0
2339777|NCT01734317|5743159|P1|COMPLETED|Overall Study||10
2339778|NCT01734317|5743159|P1|STARTED|Overall Study||10
2339779|NCT01734239|5743165|P2|NOT COMPLETED|Overall Study||0
2339780|NCT01734239|5743166|P1|NOT COMPLETED|Overall Study||0
2339781|NCT01734239|5743165|P2|COMPLETED|Overall Study||50
2339782|NCT01734239|5743166|P1|COMPLETED|Overall Study||52
2339783|NCT01734239|5743165|P2|STARTED|Overall Study||50
2339784|NCT01734239|5743166|P1|STARTED|Overall Study||52
2339785|NCT01734161|5743181|P2|NOT COMPLETED|Overall Study||8
2339786|NCT01734161|5743182|P1|NOT COMPLETED|Overall Study||6
2339787|NCT01734161|5743181|P2|COMPLETED|Overall Study||53
2339788|NCT01734161|5743182|P1|COMPLETED|Overall Study||55
2339789|NCT01734161|5743181|P2|STARTED|Overall Study||61
2339790|NCT01734161|5743182|P1|STARTED|Overall Study||61
2339791|NCT01733953|5743190|P2|NOT COMPLETED|Overall Study||7
2339792|NCT01733953|5743191|P1|NOT COMPLETED|Overall Study||5
2339793|NCT01733953|5743190|P2|COMPLETED|Overall Study||6
2339794|NCT01733953|5743191|P1|COMPLETED|Overall Study||9
2339795|NCT01733953|5743190|P2|STARTED|Overall Study||13
2339796|NCT01733953|5743191|P1|STARTED|Overall Study||14
2339797|NCT01733758|5743211|P4|NOT COMPLETED|Overall Study||8
2339798|NCT01733758|5743212|P3|NOT COMPLETED|Overall Study||15
2339799|NCT01733758|5743213|P2|NOT COMPLETED|Overall Study||12
2339800|NCT01733758|5743214|P1|NOT COMPLETED|Overall Study||15
2339801|NCT01733758|5743211|P4|COMPLETED|Overall Study||95
2339802|NCT01733758|5743212|P3|COMPLETED|Overall Study||135
2339803|NCT01733758|5743213|P2|COMPLETED|Overall Study||148
2339804|NCT01733758|5743214|P1|COMPLETED|Overall Study||62
2339805|NCT01733758|5743211|P4|STARTED|Overall Study||103
2339806|NCT01733758|5743212|P3|STARTED|Overall Study||150
2339807|NCT01733758|5743213|P2|STARTED|Overall Study||160
2339808|NCT01733758|5743214|P1|STARTED|Overall Study||77
2339809|NCT01733745|5743267|P2|NOT COMPLETED|Overall Study||0
2339810|NCT01733745|5743268|P1|NOT COMPLETED|Overall Study||0
2339811|NCT01733745|5743267|P2|COMPLETED|Overall Study||13
2339812|NCT01733745|5743268|P1|COMPLETED|Overall Study||13
2339813|NCT01733745|5743267|P2|STARTED|Overall Study||13
2339814|NCT01733745|5743268|P1|STARTED|Overall Study||13
2339815|NCT01733732|5743280|P2|NOT COMPLETED|Overall Study||0
2339816|NCT01733732|5743281|P1|NOT COMPLETED|Overall Study||2
2339817|NCT01733732|5743280|P2|COMPLETED|Overall Study||27
2339818|NCT01733732|5743281|P1|COMPLETED|Overall Study||25
2339819|NCT01733732|5743280|P2|STARTED|Overall Study||27
2339820|NCT01733732|5743281|P1|STARTED|Overall Study||27
2339821|NCT01733680|5743317|P2|NOT COMPLETED|Overall Study||1
2339822|NCT01733680|5743318|P1|NOT COMPLETED|Overall Study||0
2339823|NCT01733680|5743317|P2|COMPLETED|Overall Study||0
2339824|NCT01733680|5743318|P1|COMPLETED|Overall Study||2
2339825|NCT01733680|5743317|P2|STARTED|Overall Study||1
2339826|NCT01733680|5743318|P1|STARTED|Overall Study||2
2339827|NCT01733628|5743328|P1|NOT COMPLETED|Overall Study||0
2339828|NCT01733628|5743328|P1|COMPLETED|Overall Study||143
2339829|NCT01733628|5743328|P1|STARTED|Overall Study||143
2339830|NCT01733472|5743337|P2|NOT COMPLETED|Overall Study||0
2339831|NCT01733472|5743338|P1|NOT COMPLETED|Overall Study||0
2339832|NCT01733472|5743337|P2|COMPLETED|Overall Study||60
2339833|NCT01733472|5743338|P1|COMPLETED|Overall Study||60
2339834|NCT01733472|5743337|P2|STARTED|Overall Study||60
2339835|NCT01733472|5743338|P1|STARTED|Overall Study||60
2339836|NCT01733407|5743350|P2|NOT COMPLETED|Overall Study||0
2339837|NCT01733407|5743351|P1|NOT COMPLETED|Overall Study||2
2339838|NCT01733407|5743350|P2|COMPLETED|Overall Study||9
2339839|NCT01733407|5743351|P1|COMPLETED|Overall Study||7
2339840|NCT01733407|5743350|P2|STARTED|Overall Study||9
2339841|NCT01733407|5743351|P1|STARTED|Overall Study||9
2339842|NCT01733368|5743367|P1|NOT COMPLETED|Overall Study||31
2339843|NCT01733368|5743367|P1|COMPLETED|Overall Study||167
2339844|NCT01733368|5743367|P1|STARTED|Overall Study||198
2339845|NCT01733329|5743377|P2|NOT COMPLETED|Overall Study||1
2339846|NCT01733329|5743378|P1|NOT COMPLETED|Overall Study||2
2339847|NCT01733329|5743377|P2|COMPLETED|Overall Study||60
2339848|NCT01733329|5743378|P1|COMPLETED|Overall Study||60
2339849|NCT01733329|5743377|P2|STARTED|Overall Study||61
2339850|NCT01733329|5743378|P1|STARTED|Overall Study||62
2339851|NCT01733316|5743390|P1|NOT COMPLETED|Long Term Extension Phase||5
2339852|NCT01733316|5743390|P1|COMPLETED|Long Term Extension Phase||33
2339853|NCT01733316|5743390|P1|STARTED|Long Term Extension Phase|Two participants did not enter the long term follow up period.|38
2339854|NCT01733316|5743390|P1|NOT COMPLETED|RP103 Phase||1
2339855|NCT01733316|5743390|P1|COMPLETED|RP103 Phase||40
2339856|NCT01733316|5743390|P1|STARTED|RP103 Phase||41
2339857|NCT01733316|5743390|P1|NOT COMPLETED|Cystagon® Phase||0
2339858|NCT01733316|5743390|P1|COMPLETED|Cystagon® Phase||41
2339859|NCT01733316|5743390|P1|STARTED|Cystagon® Phase||41
2339860|NCT01733277|5743406|P2|NOT COMPLETED|Overall Study||0
2339861|NCT01733277|5743407|P1|NOT COMPLETED|Overall Study||0
2339862|NCT01733277|5743406|P2|COMPLETED|Overall Study||25
2339863|NCT01733277|5743407|P1|COMPLETED|Overall Study||25
2339864|NCT01733277|5743406|P2|STARTED|Overall Study||25
2339865|NCT01733277|5743407|P1|STARTED|Overall Study||25
2339866|NCT01733212|5743419|P2|NOT COMPLETED|Overall Study||0
2339867|NCT01733212|5743420|P1|NOT COMPLETED|Overall Study||0
2339868|NCT01733212|5743419|P2|COMPLETED|Overall Study||123
2339869|NCT01733212|5743420|P1|COMPLETED|Overall Study||116
2339870|NCT01733212|5743419|P2|STARTED|Overall Study||123
2339871|NCT01733212|5743420|P1|STARTED|Overall Study||116
2339872|NCT01733121|5743428|P2|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
2339873|NCT01733121|5743429|P1|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
2339874|NCT01733121|5743428|P2|COMPLETED|Follow-Up Period (Week 6 to 8)||46
2339875|NCT01733121|5743429|P1|COMPLETED|Follow-Up Period (Week 6 to 8)||44
2339876|NCT01733121|5743428|P2|STARTED|Follow-Up Period (Week 6 to 8)||46
2339877|NCT01733121|5743429|P1|STARTED|Follow-Up Period (Week 6 to 8)||44
2339878|NCT01733121|5743428|P2|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||5
2339879|NCT01733121|5743429|P1|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
2339880|NCT01733121|5743428|P2|COMPLETED|Double-Blind Period (Week 0 to 6)||46
2339881|NCT01733121|5743429|P1|COMPLETED|Double-Blind Period (Week 0 to 6)||44
2339882|NCT01733121|5743428|P2|STARTED|Double-Blind Period (Week 0 to 6)||51
2339883|NCT01733121|5743429|P1|STARTED|Double-Blind Period (Week 0 to 6)||51
2339884|NCT01733069|5743443|P2|NOT COMPLETED|Overall Study||0
2339885|NCT01733069|5743444|P1|NOT COMPLETED|Overall Study||0
2339886|NCT01733069|5743443|P2|COMPLETED|Overall Study||1598
2339887|NCT01733069|5743444|P1|COMPLETED|Overall Study||264
2339888|NCT01733069|5743443|P2|STARTED|Overall Study||1598
2339889|NCT01733069|5743444|P1|STARTED|Overall Study||264
2339890|NCT01733056|5743453|P3|NOT COMPLETED|Overall Study||0
2339891|NCT01733056|5743454|P2|NOT COMPLETED|Overall Study||0
2339892|NCT01733056|5743455|P1|NOT COMPLETED|Overall Study||0
2339893|NCT01733056|5743453|P3|COMPLETED|Overall Study||12
2339894|NCT01733056|5743454|P2|COMPLETED|Overall Study||10
2339895|NCT01733056|5743455|P1|COMPLETED|Overall Study||21
2339896|NCT01733056|5743453|P3|STARTED|Overall Study||12
2339897|NCT01733056|5743454|P2|STARTED|Overall Study||10
2339898|NCT01733056|5743455|P1|STARTED|Overall Study||21
2339899|NCT01732926|5743471|P2|NOT COMPLETED|Overall Study||110
2339900|NCT01732926|5743472|P1|NOT COMPLETED|Overall Study||267
2339901|NCT01732926|5743471|P2|COMPLETED|Overall Study||45
2339902|NCT01732926|5743472|P1|COMPLETED|Overall Study||53
2339903|NCT01732926|5743471|P2|STARTED|Overall Study||155
2339904|NCT01732926|5743472|P1|STARTED|Overall Study||320
2339905|NCT01732913|5743488|P2|NOT COMPLETED|Overall Study||69
2339906|NCT01732913|5743489|P1|NOT COMPLETED|Overall Study||156
2339907|NCT01732913|5743488|P2|COMPLETED|Overall Study||28
2339908|NCT01732913|5743489|P1|COMPLETED|Overall Study||42
2339909|NCT01732913|5743488|P2|STARTED|Overall Study||97
2339910|NCT01732913|5743489|P1|STARTED|Overall Study||198
2339911|NCT01732835|5743503|P1|NOT COMPLETED|2-year Extended Follow-up||5
2339912|NCT01732835|5743503|P1|COMPLETED|2-year Extended Follow-up||39
2339913|NCT01732835|5743503|P1|STARTED|2-year Extended Follow-up||44
2339914|NCT01732835|5743503|P1|NOT COMPLETED|6-month Primary Endpoint||24
2339915|NCT01732835|5743503|P1|COMPLETED|6-month Primary Endpoint||44
2339916|NCT01732835|5743503|P1|STARTED|6-month Primary Endpoint||68
2339917|NCT01732822|5743536|P2|NOT COMPLETED|Overall Study||113
2339918|NCT01732822|5743537|P1|NOT COMPLETED|Overall Study||123
2339919|NCT01732822|5743536|P2|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6842
2339920|NCT01732822|5743537|P1|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6807
2339921|NCT01732822|5743536|P2|STARTED|Overall Study||6955
2339922|NCT01732822|5743537|P1|STARTED|Overall Study||6930
2339923|NCT01732796|5743610|P3|NOT COMPLETED|Overall Study||13
2339924|NCT01732796|5743611|P2|NOT COMPLETED|Overall Study||42
2339925|NCT01732796|5743612|P1|NOT COMPLETED|Overall Study||46
2339926|NCT01732796|5743610|P3|COMPLETED|Overall Study||38
2339927|NCT01732796|5743611|P2|COMPLETED|Overall Study||169
2339928|NCT01732796|5743612|P1|COMPLETED|Overall Study||162
2339929|NCT01732796|5743610|P3|STARTED|Overall Study||51
2339930|NCT01732796|5743611|P2|STARTED|Overall Study||211
2339931|NCT01732796|5743612|P1|STARTED|Overall Study||208
2339932|NCT01732783|5743631|P3|NOT COMPLETED|Overall Study||10
2339933|NCT01732783|5743632|P2|NOT COMPLETED|Overall Study||32
2339934|NCT01732783|5743633|P1|NOT COMPLETED|Overall Study||135
2339935|NCT01732783|5743631|P3|COMPLETED|Overall Study|Completed 12-month observation period.|2
2339936|NCT01732783|5743632|P2|COMPLETED|Overall Study|Completed 12-month observation period.|5
2339937|NCT01732783|5743633|P1|COMPLETED|Overall Study|Completed 12-month observation period.|29
2339938|NCT01732783|5743631|P3|STARTED|Overall Study||12
2339939|NCT01732783|5743632|P2|STARTED|Overall Study||37
2339940|NCT01732783|5743633|P1|STARTED|Overall Study||164
2339941|NCT01732770|5743697|P2|NOT COMPLETED|Overall Study||8
2339942|NCT01732770|5743698|P1|NOT COMPLETED|Overall Study||10
2339943|NCT01732770|5743697|P2|COMPLETED|Overall Study||313
2339944|NCT01732770|5743698|P1|COMPLETED|Overall Study||312
2339945|NCT01732770|5743697|P2|Received Study Treatment|Overall Study||320
2339946|NCT01732770|5743698|P1|Received Study Treatment|Overall Study||320
2339947|NCT01732770|5743697|P2|STARTED|Overall Study||321
2339948|NCT01732770|5743698|P1|STARTED|Overall Study||322
2339949|NCT01732757|5743713|P3|NOT COMPLETED|Overall Study||0
2339950|NCT01732757|5743714|P2|NOT COMPLETED|Overall Study||0
2339951|NCT01732757|5743715|P1|NOT COMPLETED|Overall Study||1
2339952|NCT01732757|5743713|P3|COMPLETED|Overall Study||52
2339953|NCT01732757|5743714|P2|COMPLETED|Overall Study||52
2339954|NCT01732757|5743715|P1|COMPLETED|Overall Study||52
2339955|NCT01732757|5743713|P3|STARTED|Overall Study||52
2339956|NCT01732757|5743714|P2|STARTED|Overall Study||52
2339957|NCT01732757|5743715|P1|STARTED|Overall Study||53
2339958|NCT01732718|5743753|P2|NOT COMPLETED|Second Intervention||0
2339959|NCT01732718|5743754|P1|NOT COMPLETED|Second Intervention||0
2339960|NCT01732718|5743753|P2|COMPLETED|Second Intervention||6
2339961|NCT01732718|5743754|P1|COMPLETED|Second Intervention||7
2339962|NCT01732718|5743753|P2|STARTED|Second Intervention||6
2339963|NCT01732718|5743754|P1|STARTED|Second Intervention||7
2339964|NCT01732718|5743753|P2|NOT COMPLETED|Washout (4 Weeks)||0
2339965|NCT01732718|5743754|P1|NOT COMPLETED|Washout (4 Weeks)||0
2339966|NCT01732718|5743753|P2|COMPLETED|Washout (4 Weeks)||6
2339967|NCT01732718|5743754|P1|COMPLETED|Washout (4 Weeks)||7
2339968|NCT01732718|5743753|P2|STARTED|Washout (4 Weeks)||6
2339969|NCT01732718|5743754|P1|STARTED|Washout (4 Weeks)||7
2339970|NCT01732718|5743753|P2|NOT COMPLETED|First Intervention||0
2339971|NCT01732718|5743754|P1|NOT COMPLETED|First Intervention||0
2339972|NCT01732718|5743753|P2|COMPLETED|First Intervention||6
2339973|NCT01732718|5743754|P1|COMPLETED|First Intervention||7
2339974|NCT01732718|5743753|P2|STARTED|First Intervention||6
2339975|NCT01732718|5743754|P1|STARTED|First Intervention||7
2339976|NCT01732692|5743792|P2|NOT COMPLETED|Overall Study||1
2339977|NCT01732692|5743793|P1|NOT COMPLETED|Overall Study||0
2339978|NCT01732692|5743792|P2|COMPLETED|Overall Study||69
2339979|NCT01732692|5743793|P1|COMPLETED|Overall Study||70
2339980|NCT01732692|5743792|P2|STARTED|Overall Study||70
2339981|NCT01732692|5743793|P1|STARTED|Overall Study||70
2339982|NCT01732640|5743807|P2|NOT COMPLETED|Overall Study||2
2339983|NCT01732640|5743808|P1|NOT COMPLETED|Overall Study||0
2339984|NCT01732640|5743807|P2|COMPLETED|Overall Study||1
2339985|NCT01732640|5743808|P1|COMPLETED|Overall Study||6
2339986|NCT01732640|5743807|P2|STARTED|Overall Study||3
2339987|NCT01732640|5743808|P1|STARTED|Overall Study||6
2339988|NCT01732588|5743826|P3|NOT COMPLETED|Third Intervention (7 Days)||0
2339989|NCT01732588|5743827|P2|NOT COMPLETED|Third Intervention (7 Days)||0
2339990|NCT01732588|5743828|P1|NOT COMPLETED|Third Intervention (7 Days)||0
2339991|NCT01732588|5743826|P3|COMPLETED|Third Intervention (7 Days)||4
2339992|NCT01732588|5743827|P2|COMPLETED|Third Intervention (7 Days)||2
2339993|NCT01732588|5743828|P1|COMPLETED|Third Intervention (7 Days)||4
2339994|NCT01732588|5743826|P3|STARTED|Third Intervention (7 Days)||4
2339995|NCT01732588|5743827|P2|STARTED|Third Intervention (7 Days)||2
2339996|NCT01732588|5743828|P1|STARTED|Third Intervention (7 Days)||4
2339997|NCT01732588|5743826|P3|NOT COMPLETED|Second Intervention (7 Days)||0
2339998|NCT01732588|5743827|P2|NOT COMPLETED|Second Intervention (7 Days)||0
2339999|NCT01732588|5743828|P1|NOT COMPLETED|Second Intervention (7 Days)||0
2340000|NCT01732588|5743826|P3|COMPLETED|Second Intervention (7 Days)||4
2340001|NCT01732588|5743827|P2|COMPLETED|Second Intervention (7 Days)||2
2340002|NCT01732588|5743828|P1|COMPLETED|Second Intervention (7 Days)||4
2340003|NCT01732588|5743826|P3|STARTED|Second Intervention (7 Days)||4
2340004|NCT01732588|5743827|P2|STARTED|Second Intervention (7 Days)||2
2340005|NCT01732588|5743828|P1|STARTED|Second Intervention (7 Days)||4
2340006|NCT01732588|5743826|P3|NOT COMPLETED|First Intervention (7 Days)||0
2340007|NCT01732588|5743827|P2|NOT COMPLETED|First Intervention (7 Days)||1
2340008|NCT01732588|5743828|P1|NOT COMPLETED|First Intervention (7 Days)||0
2340009|NCT01732588|5743826|P3|COMPLETED|First Intervention (7 Days)||4
2340010|NCT01732588|5743827|P2|COMPLETED|First Intervention (7 Days)||2
2340011|NCT01732588|5743828|P1|COMPLETED|First Intervention (7 Days)||4
2340012|NCT01732588|5743826|P3|STARTED|First Intervention (7 Days)||4
2340013|NCT01732588|5743827|P2|STARTED|First Intervention (7 Days)||3
2340014|NCT01732588|5743828|P1|STARTED|First Intervention (7 Days)||4
2340015|NCT01732549|5743844|P2|NOT COMPLETED|Overall Study||73
2340016|NCT01732549|5743845|P1|NOT COMPLETED|Overall Study||71
2340017|NCT01732549|5743844|P2|COMPLETED|Overall Study||0
2340018|NCT01732549|5743845|P1|COMPLETED|Overall Study||0
2340019|NCT01732549|5743844|P2|Withdrawn During Treatment:Final Analysi|Overall Study||73
2340020|NCT01732549|5743845|P1|Withdrawn During Treatment:Final Analysi|Overall Study||71
2340021|NCT01732549|5743844|P2|Ongoing Treatment Period:Final Analysis|Overall Study||0
2340022|NCT01732549|5743845|P1|Ongoing Treatment Period:Final Analysis|Overall Study||0
2340023|NCT01732549|5743844|P2|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 61 (AE 3, Consent withdrawn 6, Disease progression 46, Other 6)|61
2340024|NCT01732549|5743845|P1|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 59 (AE 13, Consent withdrawn 13, Disease progression 31, Other 2)|59
2340025|NCT01732549|5743844|P2|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
2340026|NCT01732549|5743845|P1|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
2340027|NCT01732549|5743844|P2|STARTED|Overall Study||73
2340028|NCT01732549|5743845|P1|STARTED|Overall Study||71
2340029|NCT01732536|5743867|P2|NOT COMPLETED|Overall Study||1
2340030|NCT01732536|5743868|P1|NOT COMPLETED|Overall Study||1
2340031|NCT01732536|5743867|P2|COMPLETED|Overall Study||46
2340032|NCT01732536|5743868|P1|COMPLETED|Overall Study||52
2340033|NCT01732536|5743867|P2|STARTED|Overall Study||47
2340034|NCT01732536|5743868|P1|STARTED|Overall Study||53
2340035|NCT01732510|5743891|P7|NOT COMPLETED|Overall Study||8
2340036|NCT01732510|5743892|P6|NOT COMPLETED|Overall Study||13
2340037|NCT01732510|5743893|P5|NOT COMPLETED|Overall Study||5
2340038|NCT01732510|5743894|P4|NOT COMPLETED|Overall Study||5
2340039|NCT01732510|5743895|P3|NOT COMPLETED|Overall Study||4
2340040|NCT01732510|5743896|P2|NOT COMPLETED|Overall Study||5
2340041|NCT01732510|5743897|P1|NOT COMPLETED|Overall Study||1
2340042|NCT01732510|5743891|P7|COMPLETED|Overall Study||0
2340043|NCT01732510|5743892|P6|COMPLETED|Overall Study||0
2340044|NCT01732510|5743893|P5|COMPLETED|Overall Study||3
2340045|NCT01732510|5743894|P4|COMPLETED|Overall Study||5
2340046|NCT01732510|5743895|P3|COMPLETED|Overall Study||4
2340047|NCT01732510|5743896|P2|COMPLETED|Overall Study||4
2340048|NCT01732510|5743897|P1|COMPLETED|Overall Study||8
2340049|NCT01732510|5743891|P7|STARTED|Overall Study||8
2340050|NCT01732510|5743892|P6|STARTED|Overall Study||13
2340051|NCT01732510|5743893|P5|STARTED|Overall Study||8
2340052|NCT01732510|5743894|P4|STARTED|Overall Study||10
2340053|NCT01732510|5743895|P3|STARTED|Overall Study||8
2340054|NCT01732510|5743896|P2|STARTED|Overall Study||9
2340055|NCT01732510|5743897|P1|STARTED|Overall Study||9
2340056|NCT01732484|5743976|P1|NOT COMPLETED|Overall Study||26
2340057|NCT01732484|5743976|P1|COMPLETED|Overall Study||74
2340058|NCT01732484|5743976|P1|Allocation|Overall Study||100
2340059|NCT01732484|5743976|P1|Randomized|Overall Study|Randomized implantation SN60WF IOL in on eye and iMics NY-60 in the other eye.|100
2340060|NCT01732484|5743976|P1|STARTED|Overall Study||100
2340061|NCT01732471|5743984|P1|NOT COMPLETED|Overall Study||1
2340062|NCT01732471|5743984|P1|COMPLETED|Overall Study||89
2340063|NCT01732471|5743984|P1|STARTED|Overall Study||90
2340064|NCT01732458|5743995|P4|NOT COMPLETED|Overall Study||2
2340065|NCT01732458|5743996|P3|NOT COMPLETED|Overall Study||3
2340066|NCT01732458|5743997|P2|NOT COMPLETED|Overall Study||5
2340067|NCT01732458|5743998|P1|NOT COMPLETED|Overall Study||3
2340068|NCT01732458|5743995|P4|COMPLETED|Overall Study||50
2340069|NCT01732458|5743996|P3|COMPLETED|Overall Study||55
2340070|NCT01732458|5743997|P2|COMPLETED|Overall Study||53
2340071|NCT01732458|5743998|P1|COMPLETED|Overall Study||57
2340072|NCT01732458|5743995|P4|Treated|Overall Study||52
2340073|NCT01732458|5743996|P3|Treated|Overall Study||56
2340074|NCT01732458|5743997|P2|Treated|Overall Study||55
2340075|NCT01732458|5743998|P1|Treated|Overall Study||57
2340076|NCT01732458|5743995|P4|STARTED|Overall Study||52
2340077|NCT01732458|5743996|P3|STARTED|Overall Study||58
2340078|NCT01732458|5743997|P2|STARTED|Overall Study||58
2340079|NCT01732458|5743998|P1|STARTED|Overall Study||60
2340080|NCT01732445|5744060|P1|NOT COMPLETED|Overall Study||0
2340081|NCT01732445|5744060|P1|COMPLETED|Overall Study||14
2340082|NCT01732445|5744060|P1|STARTED|Overall Study||14
2340083|NCT01732419|5744069|P2|NOT COMPLETED|Overall Study||4
2340084|NCT01732419|5744070|P1|NOT COMPLETED|Overall Study||8
2340085|NCT01732419|5744069|P2|COMPLETED|Overall Study||41
2340086|NCT01732419|5744070|P1|COMPLETED|Overall Study||37
2340087|NCT01732419|5744069|P2|STARTED|Overall Study||45
2340088|NCT01732419|5744070|P1|STARTED|Overall Study||45
2340089|NCT01732406|5744087|P3|NOT COMPLETED|Overall Study||0
2340090|NCT01732406|5744088|P2|NOT COMPLETED|Overall Study||0
2340091|NCT01732406|5744089|P1|NOT COMPLETED|Overall Study||0
2340092|NCT01732406|5744087|P3|COMPLETED|Overall Study||35
2340093|NCT01732406|5744088|P2|COMPLETED|Overall Study||60
2340094|NCT01732406|5744089|P1|COMPLETED|Overall Study||31
2340095|NCT01732406|5744087|P3|STARTED|Overall Study||35
2340096|NCT01732406|5744088|P2|STARTED|Overall Study||60
2340097|NCT01732406|5744089|P1|STARTED|Overall Study||31
2340098|NCT01732263|5744108|P2|NOT COMPLETED|Overall Study||0
2340099|NCT01732263|5744109|P1|NOT COMPLETED|Overall Study||0
2340100|NCT01732263|5744108|P2|COMPLETED|Overall Study||20
2340101|NCT01732263|5744109|P1|COMPLETED|Overall Study||23
2340102|NCT01732263|5744108|P2|STARTED|Overall Study||20
2340103|NCT01732263|5744109|P1|STARTED|Overall Study||23
2340104|NCT01732211|5744149|P1|NOT COMPLETED|Overall Study||0
2340105|NCT01732211|5744149|P1|COMPLETED|Overall Study||1
2340106|NCT01732211|5744149|P1|STARTED|Overall Study||1
2340107|NCT01732107|5744160|P1|NOT COMPLETED|Overall Study||13
2340108|NCT01732107|5744160|P1|COMPLETED|Overall Study||0
2340109|NCT01732107|5744160|P1|STARTED|Overall Study||13
2340110|NCT01731990|5744177|P2|NOT COMPLETED|Overall Study||8
2340111|NCT01731990|5744178|P1|NOT COMPLETED|Overall Study||4
2340112|NCT01731990|5744177|P2|COMPLETED|Overall Study||12
2340113|NCT01731990|5744178|P1|COMPLETED|Overall Study||14
2340114|NCT01731990|5744177|P2|STARTED|Overall Study||20
2340115|NCT01731990|5744178|P1|STARTED|Overall Study|"Started indicates Safety and Pharmacodynamics set ."|18
2340116|NCT01731938|5744194|P2|NOT COMPLETED|Primary Part II||13
2340117|NCT01731938|5744195|P1|NOT COMPLETED|Primary Part II||13
2340118|NCT01731938|5744194|P2|COMPLETED|Primary Part II||95
2340119|NCT01731938|5744195|P1|COMPLETED|Primary Part II||103
2340120|NCT01731938|5744194|P2|STARTED|Primary Part II|Subjects from Preliminary Part I were not carried over to Primary Part II to assess safety/efficacy.|108
2340121|NCT01731938|5744195|P1|STARTED|Primary Part II|Preliminary Part I was for study team familiarization with FS Grifols application.|116
2340122|NCT01731938|5744194|P2|NOT COMPLETED|Preliminary Part I||8
2340123|NCT01731938|5744195|P1|NOT COMPLETED|Preliminary Part I||3
2340124|NCT01731938|5744194|P2|COMPLETED|Preliminary Part I||44
2340125|NCT01731938|5744195|P1|COMPLETED|Preliminary Part I||48
2340126|NCT01731938|5744194|P2|STARTED|Preliminary Part I||52
2340127|NCT01731938|5744195|P1|STARTED|Preliminary Part I||51
2340128|NCT01731912|5744207|P1|NOT COMPLETED|Overall Study||2
2340129|NCT01731912|5744207|P1|COMPLETED|Overall Study||14
2340130|NCT01731912|5744207|P1|STARTED|Overall Study||16
2340131|NCT01731886|5744214|P2|NOT COMPLETED|Overall Study||1
2340132|NCT01731886|5744215|P1|NOT COMPLETED|Overall Study||2
2340133|NCT01731886|5744214|P2|COMPLETED|Overall Study||28
2340134|NCT01731886|5744215|P1|COMPLETED|Overall Study||29
2340135|NCT01731886|5744214|P2|STARTED|Overall Study||29
2340136|NCT01731886|5744215|P1|STARTED|Overall Study||31
2340137|NCT01731678|5744229|P1|NOT COMPLETED|Overall Study||7
2340138|NCT01731678|5744229|P1|COMPLETED|Overall Study||32
2340139|NCT01731678|5744229|P1|STARTED|Overall Study||39
2340140|NCT01731600|5744235|P2|NOT COMPLETED|Overall Study||0
2340141|NCT01731600|5744236|P1|NOT COMPLETED|Overall Study||6
2340142|NCT01731600|5744235|P2|COMPLETED|Overall Study||34
2340143|NCT01731600|5744236|P1|COMPLETED|Overall Study||28
2340144|NCT01731600|5744235|P2|STARTED|Overall Study||34
2340145|NCT01731600|5744236|P1|STARTED|Overall Study||34
2340146|NCT01731470|5744290|P1|NOT COMPLETED|Overall Study||2
2340147|NCT01731470|5744290|P1|COMPLETED|Overall Study|Number of patients enrolled in the study|14
2340148|NCT01731470|5744290|P1|STARTED|Overall Study|Number of patients consented to participate in the study|16
2340149|NCT01731171|5744297|P2|NOT COMPLETED|Overall Study||7
2340150|NCT01731171|5744298|P1|NOT COMPLETED|Overall Study||7
2340151|NCT01731171|5744297|P2|COMPLETED|Overall Study||26
2340152|NCT01731171|5744298|P1|COMPLETED|Overall Study||26
2340153|NCT01731171|5744297|P2|STARTED|Overall Study||33
2340154|NCT01731171|5744298|P1|STARTED|Overall Study||33
2340155|NCT01731119|5744310|P1|NOT COMPLETED|Overall Study||2
2340156|NCT01731119|5744310|P1|COMPLETED|Overall Study||7
2340157|NCT01731119|5744310|P1|STARTED|Overall Study||9
2340158|NCT01731041|5744320|P2|NOT COMPLETED|Overall Study||0
2340159|NCT01731041|5744321|P1|NOT COMPLETED|Overall Study||0
2340160|NCT01731041|5744320|P2|COMPLETED|Overall Study||30
2340161|NCT01731041|5744321|P1|COMPLETED|Overall Study||30
2340162|NCT01731041|5744320|P2|STARTED|Overall Study||30
2340163|NCT01731041|5744321|P1|STARTED|Overall Study||30
2340164|NCT01731002|5744332|P3|NOT COMPLETED|Overall Study||3
2340165|NCT01731002|5744333|P2|NOT COMPLETED|Overall Study||4
2340166|NCT01731002|5744334|P1|NOT COMPLETED|Overall Study||4
2340167|NCT01731002|5744332|P3|COMPLETED|Overall Study||74
2340168|NCT01731002|5744333|P2|COMPLETED|Overall Study||68
2340169|NCT01731002|5744334|P1|COMPLETED|Overall Study||71
2340170|NCT01731002|5744332|P3|STARTED|Overall Study||77
2340171|NCT01731002|5744333|P2|STARTED|Overall Study||72
2340172|NCT01731002|5744334|P1|STARTED|Overall Study||75
2340173|NCT01730872|5744348|P3|NOT COMPLETED|Overall Study||0
2340174|NCT01730872|5744349|P2|NOT COMPLETED|Overall Study||0
2340175|NCT01730872|5744350|P1|NOT COMPLETED|Overall Study||0
2340176|NCT01730872|5744348|P3|COMPLETED|Overall Study||3
2340177|NCT01730872|5744349|P2|COMPLETED|Overall Study||5
2340178|NCT01730872|5744350|P1|COMPLETED|Overall Study||8
2340179|NCT01730872|5744348|P3|Full Analysis Set|Overall Study||0
2340180|NCT01730872|5744349|P2|Full Analysis Set|Overall Study|1 subject did not complete the last post-CAE measurement on Day 6 and was excluded from the FAS|4
2340181|NCT01730872|5744350|P1|Full Analysis Set|Overall Study||8
2340182|NCT01730872|5744348|P3|STARTED|Overall Study||3
2340183|NCT01730872|5744349|P2|STARTED|Overall Study||5
2340184|NCT01730872|5744350|P1|STARTED|Overall Study||8
2340185|NCT01730846|5744364|P3|NOT COMPLETED|Overall Study||0
2340186|NCT01730846|5744365|P2|NOT COMPLETED|Overall Study||0
2340187|NCT01730846|5744366|P1|NOT COMPLETED|Overall Study||0
2340188|NCT01730846|5744364|P3|COMPLETED|Overall Study||13
2340189|NCT01730846|5744365|P2|COMPLETED|Overall Study||11
2340190|NCT01730846|5744366|P1|COMPLETED|Overall Study||11
2340191|NCT01730846|5744364|P3|STARTED|Overall Study||13
2340192|NCT01730846|5744365|P2|STARTED|Overall Study||11
2340193|NCT01730846|5744366|P1|STARTED|Overall Study||11
2340194|NCT01730729|5744377|P1|NOT COMPLETED|Overall Study||14
2340195|NCT01730729|5744377|P1|COMPLETED|Overall Study||6
2340196|NCT01730729|5744377|P1|Treated Cycle 3 and Beyond|Overall Study||6
2340197|NCT01730729|5744377|P1|Completed 2 Cycles/Reached 1st Response|Overall Study||18
2340198|NCT01730729|5744377|P1|STARTED|Overall Study||20
2340199|NCT01730586|5744391|P1|NOT COMPLETED|Overall Study||13
2340200|NCT01730586|5744391|P1|COMPLETED|Overall Study||21
2340201|NCT01730586|5744391|P1|STARTED|Overall Study||34
2340202|NCT01730534|5744400|P2|NOT COMPLETED|Overall Study||145
2340203|NCT01730534|5744401|P1|NOT COMPLETED|Overall Study||109
2340204|NCT01730534|5744400|P2|COMPLETED|Overall Study||8433
2340205|NCT01730534|5744401|P1|COMPLETED|Overall Study||8473
2340206|NCT01730534|5744400|P2|STARTED|Overall Study||8578
2340207|NCT01730534|5744401|P1|STARTED|Overall Study||8582
2340208|NCT01730378|5744415|P2|NOT COMPLETED|Overall Study||0
2340209|NCT01730378|5744416|P1|NOT COMPLETED|Overall Study||1
2340210|NCT01730378|5744415|P2|COMPLETED|Overall Study||47
2340211|NCT01730378|5744416|P1|COMPLETED|Overall Study||83
2340212|NCT01730378|5744415|P2|STARTED|Overall Study||47
2340213|NCT01730378|5744416|P1|STARTED|Overall Study||84
2340214|NCT01730339|5744447|P2|NOT COMPLETED|Overall Study||3
2340215|NCT01730339|5744448|P1|NOT COMPLETED|Overall Study||5
2340216|NCT01730339|5744447|P2|COMPLETED|Overall Study||52
2340217|NCT01730339|5744448|P1|COMPLETED|Overall Study||40
2340218|NCT01730339|5744447|P2|STARTED|Overall Study||55
2340219|NCT01730339|5744448|P1|STARTED|Overall Study||45
2340220|NCT01730053|5744488|P6|NOT COMPLETED|Overall Study||13
2340221|NCT01730053|5744489|P5|NOT COMPLETED|Overall Study||9
2340222|NCT01730053|5744490|P4|NOT COMPLETED|Overall Study||8
2340223|NCT01730053|5744491|P3|NOT COMPLETED|Overall Study||11
2340224|NCT01730053|5744492|P2|NOT COMPLETED|Overall Study||14
2340225|NCT01730053|5744493|P1|NOT COMPLETED|Overall Study||5
2340226|NCT01730053|5744488|P6|COMPLETED|Overall Study||41
2340227|NCT01730053|5744489|P5|COMPLETED|Overall Study||44
2340228|NCT01730053|5744490|P4|COMPLETED|Overall Study||45
2340229|NCT01730053|5744491|P3|COMPLETED|Overall Study||38
2340230|NCT01730053|5744492|P2|COMPLETED|Overall Study||34
2340231|NCT01730053|5744493|P1|COMPLETED|Overall Study||43
2340232|NCT01730053|5744488|P6|Treated|Overall Study||54
2340233|NCT01730053|5744489|P5|Treated|Overall Study||53
2340234|NCT01730053|5744490|P4|Treated|Overall Study||53
2340235|NCT01730053|5744491|P3|Treated|Overall Study||49
2340236|NCT01730053|5744492|P2|Treated|Overall Study||48
2340237|NCT01730053|5744493|P1|Treated|Overall Study||48
2340238|NCT01730053|5744488|P6|STARTED|Overall Study||54
2340239|NCT01730053|5744489|P5|STARTED|Overall Study||53
2340240|NCT01730053|5744490|P4|STARTED|Overall Study||53
2340241|NCT01730053|5744491|P3|STARTED|Overall Study||49
2340242|NCT01730053|5744492|P2|STARTED|Overall Study||48
2340243|NCT01730053|5744493|P1|STARTED|Overall Study||48
2340244|NCT01730040|5744652|P7|NOT COMPLETED|Overall Study||9
2340245|NCT01730040|5744653|P6|NOT COMPLETED|Overall Study||7
2340246|NCT01730040|5744654|P5|NOT COMPLETED|Overall Study||6
2340247|NCT01730040|5744655|P4|NOT COMPLETED|Overall Study||8
2340248|NCT01730040|5744656|P3|NOT COMPLETED|Overall Study||11
2340249|NCT01730040|5744657|P2|NOT COMPLETED|Overall Study||15
2340250|NCT01730040|5744658|P1|NOT COMPLETED|Overall Study||13
2340251|NCT01730040|5744652|P7|COMPLETED|Overall Study||38
2340252|NCT01730040|5744653|P6|COMPLETED|Overall Study||40
2340253|NCT01730040|5744654|P5|COMPLETED|Overall Study||39
2340254|NCT01730040|5744655|P4|COMPLETED|Overall Study||39
2340255|NCT01730040|5744656|P3|COMPLETED|Overall Study||46
2340256|NCT01730040|5744657|P2|COMPLETED|Overall Study||40
2340257|NCT01730040|5744658|P1|COMPLETED|Overall Study||44
2340258|NCT01730040|5744652|P7|Treated|Overall Study||47
2340259|NCT01730040|5744653|P6|Treated|Overall Study||46
2340260|NCT01730040|5744654|P5|Treated|Overall Study||45
2340261|NCT01730040|5744655|P4|Treated|Overall Study||47
2340262|NCT01730040|5744656|P3|Treated|Overall Study||57
2340263|NCT01730040|5744657|P2|Treated|Overall Study||55
2340264|NCT01730040|5744658|P1|Treated|Overall Study||57
2340265|NCT01730040|5744652|P7|STARTED|Overall Study||47
2340266|NCT01730040|5744653|P6|STARTED|Overall Study||47
2340267|NCT01730040|5744654|P5|STARTED|Overall Study||45
2340268|NCT01730040|5744655|P4|STARTED|Overall Study||47
2340269|NCT01730040|5744656|P3|STARTED|Overall Study||57
2340270|NCT01730040|5744657|P2|STARTED|Overall Study||55
2340271|NCT01730040|5744658|P1|STARTED|Overall Study||57
2340272|NCT01729923|5744835|P1|NOT COMPLETED|Overall Study||27
2340273|NCT01729923|5744835|P1|COMPLETED|Overall Study||0
2340274|NCT01729923|5744835|P1|STARTED|Overall Study||27
2340275|NCT01729871|5744847|P2|NOT COMPLETED|Overall Study||23
2340276|NCT01729871|5744848|P1|NOT COMPLETED|Overall Study||12
2340277|NCT01729871|5744847|P2|COMPLETED|Overall Study||101
2340278|NCT01729871|5744848|P1|COMPLETED|Overall Study||112
2340279|NCT01729871|5744847|P2|STARTED|Overall Study||124
2340280|NCT01729871|5744848|P1|STARTED|Overall Study||124
2340281|NCT01729845|5744867|P3|NOT COMPLETED|Efficacy of Dec/MEC||0
2340282|NCT01729845|5744868|P2|NOT COMPLETED|Efficacy of Dec/MEC||0
2340283|NCT01729845|5744869|P1|NOT COMPLETED|Efficacy of Dec/MEC||0
2340284|NCT01729845|5744867|P3|COMPLETED|Efficacy of Dec/MEC||0
2340285|NCT01729845|5744868|P2|COMPLETED|Efficacy of Dec/MEC||22
2340286|NCT01729845|5744869|P1|COMPLETED|Efficacy of Dec/MEC||0
2340287|NCT01729845|5744867|P3|STARTED|Efficacy of Dec/MEC||0
2340288|NCT01729845|5744868|P2|STARTED|Efficacy of Dec/MEC||22
2340289|NCT01729845|5744869|P1|STARTED|Efficacy of Dec/MEC||0
2340290|NCT01729845|5744867|P3|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
2340291|NCT01729845|5744868|P2|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
2340292|NCT01729845|5744869|P1|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
2340293|NCT01729845|5744867|P3|COMPLETED|Safety/Tolerability of Dec/MEC||12
2340294|NCT01729845|5744868|P2|COMPLETED|Safety/Tolerability of Dec/MEC||34
2340295|NCT01729845|5744869|P1|COMPLETED|Safety/Tolerability of Dec/MEC||6
2340296|NCT01729845|5744867|P3|STARTED|Safety/Tolerability of Dec/MEC||12
2340297|NCT01729845|5744868|P2|STARTED|Safety/Tolerability of Dec/MEC||34
2340298|NCT01729845|5744869|P1|STARTED|Safety/Tolerability of Dec/MEC||6
2340299|NCT01729819|5744882|P2|NOT COMPLETED|Overall Study||7
2340300|NCT01729819|5744883|P1|NOT COMPLETED|Overall Study||6
2340301|NCT01729819|5744882|P2|COMPLETED|Overall Study||50
2340302|NCT01729819|5744883|P1|COMPLETED|Overall Study||43
2340303|NCT01729819|5744882|P2|STARTED|Overall Study||57
2340304|NCT01729819|5744883|P1|STARTED|Overall Study||49
2340305|NCT01729754|5744902|P10|NOT COMPLETED|Part 3||7
2340306|NCT01729754|5744903|P9|NOT COMPLETED|Part 3||1
2340307|NCT01729754|5744904|P8|NOT COMPLETED|Part 3||3
2340308|NCT01729754|5744905|P7|NOT COMPLETED|Part 3||0
2340309|NCT01729754|5744906|P6|NOT COMPLETED|Part 3||13
2340310|NCT01729754|5744907|P5|NOT COMPLETED|Part 3||4
2340311|NCT01729754|5744908|P4|NOT COMPLETED|Part 3||0
2340312|NCT01729754|5744909|P3|NOT COMPLETED|Part 3||5
2340313|NCT01729754|5744910|P2|NOT COMPLETED|Part 3||5
2340314|NCT01729754|5744911|P1|NOT COMPLETED|Part 3||0
2340315|NCT01729754|5744902|P10|COMPLETED|Part 3||114
2340316|NCT01729754|5744903|P9|COMPLETED|Part 3||65
2340317|NCT01729754|5744904|P8|COMPLETED|Part 3||66
2340318|NCT01729754|5744905|P7|COMPLETED|Part 3||0
2340319|NCT01729754|5744906|P6|COMPLETED|Part 3||224
2340320|NCT01729754|5744907|P5|COMPLETED|Part 3||17
2340321|NCT01729754|5744908|P4|COMPLETED|Part 3||0
2340322|NCT01729754|5744909|P3|COMPLETED|Part 3||105
2340323|NCT01729754|5744910|P2|COMPLETED|Part 3||165
2340324|NCT01729754|5744911|P1|COMPLETED|Part 3||0
2340325|NCT01729754|5744902|P10|STARTED|Part 3|156 participants completed Part 2 but did not enter Part 3|121
2340326|NCT01729754|5744903|P9|STARTED|Part 3||66
2340327|NCT01729754|5744904|P8|STARTED|Part 3||69
2340328|NCT01729754|5744905|P7|STARTED|Part 3||0
2340329|NCT01729754|5744906|P6|STARTED|Part 3|31 participants completed Part 2 but did not enter Part 3|237
2340330|NCT01729754|5744907|P5|STARTED|Part 3||21
2340331|NCT01729754|5744908|P4|STARTED|Part 3||0
2340332|NCT01729754|5744909|P3|STARTED|Part 3||110
2340333|NCT01729754|5744910|P2|STARTED|Part 3|14 participants completed Part 2 but did not enter Part 3|170
2340334|NCT01729754|5744911|P1|STARTED|Part 3||0
2340335|NCT01729754|5744902|P10|NOT COMPLETED|Part 2||12
2340336|NCT01729754|5744903|P9|NOT COMPLETED|Part 2||4
2340337|NCT01729754|5744904|P8|NOT COMPLETED|Part 2||3
2340338|NCT01729754|5744905|P7|NOT COMPLETED|Part 2||0
2340339|NCT01729754|5744906|P6|NOT COMPLETED|Part 2||0
2340340|NCT01729754|5744907|P5|NOT COMPLETED|Part 2||0
2340341|NCT01729754|5744908|P4|NOT COMPLETED|Part 2||5
2340342|NCT01729754|5744909|P3|NOT COMPLETED|Part 2||0
2340343|NCT01729754|5744910|P2|NOT COMPLETED|Part 2||0
2340344|NCT01729754|5744911|P1|NOT COMPLETED|Part 2||6
2340345|NCT01729754|5744902|P10|COMPLETED|Part 2||277
2340346|NCT01729754|5744903|P9|COMPLETED|Part 2||66
2340347|NCT01729754|5744904|P8|COMPLETED|Part 2||69
2340348|NCT01729754|5744905|P7|COMPLETED|Part 2||0
2340349|NCT01729754|5744906|P6|COMPLETED|Part 2||268
2340350|NCT01729754|5744907|P5|COMPLETED|Part 2||21
2340351|NCT01729754|5744908|P4|COMPLETED|Part 2||0
2340352|NCT01729754|5744909|P3|COMPLETED|Part 2||110
2340353|NCT01729754|5744910|P2|COMPLETED|Part 2||184
2340354|NCT01729754|5744911|P1|COMPLETED|Part 2||0
2340355|NCT01729754|5744902|P10|STARTED|Part 2||289
2340356|NCT01729754|5744903|P9|STARTED|Part 2||70
2340357|NCT01729754|5744904|P8|STARTED|Part 2||72
2340358|NCT01729754|5744905|P7|STARTED|Part 2||0
2340359|NCT01729754|5744906|P6|STARTED|Part 2||268
2340360|NCT01729754|5744907|P5|STARTED|Part 2||21
2340361|NCT01729754|5744908|P4|STARTED|Part 2|1 participant completed Part 1 but did not enter Part 2|5
2340362|NCT01729754|5744909|P3|STARTED|Part 2||110
2340363|NCT01729754|5744910|P2|STARTED|Part 2||184
2340364|NCT01729754|5744911|P1|STARTED|Part 2||6
2340365|NCT01729754|5744902|P10|NOT COMPLETED|Part 1||24
2340366|NCT01729754|5744903|P9|NOT COMPLETED|Part 1||0
2340367|NCT01729754|5744904|P8|NOT COMPLETED|Part 1||0
2340368|NCT01729754|5744905|P7|NOT COMPLETED|Part 1||14
2340369|NCT01729754|5744906|P6|NOT COMPLETED|Part 1||0
2340370|NCT01729754|5744907|P5|NOT COMPLETED|Part 1||0
2340371|NCT01729754|5744908|P4|NOT COMPLETED|Part 1||12
2340372|NCT01729754|5744909|P3|NOT COMPLETED|Part 1||0
2340373|NCT01729754|5744910|P2|NOT COMPLETED|Part 1||0
2340374|NCT01729754|5744911|P1|NOT COMPLETED|Part 1||14
2340375|NCT01729754|5744902|P10|COMPLETED|Part 1||289
2340376|NCT01729754|5744903|P9|COMPLETED|Part 1||70
2340377|NCT01729754|5744904|P8|COMPLETED|Part 1||72
2340378|NCT01729754|5744905|P7|COMPLETED|Part 1||0
2340379|NCT01729754|5744906|P6|COMPLETED|Part 1||268
2340380|NCT01729754|5744907|P5|COMPLETED|Part 1||21
2340381|NCT01729754|5744908|P4|COMPLETED|Part 1||6
2340382|NCT01729754|5744909|P3|COMPLETED|Part 1||110
2340383|NCT01729754|5744910|P2|COMPLETED|Part 1||184
2340384|NCT01729754|5744911|P1|COMPLETED|Part 1||6
2340385|NCT01729754|5744902|P10|STARTED|Part 1||313
2340386|NCT01729754|5744903|P9|STARTED|Part 1||70
2340387|NCT01729754|5744904|P8|STARTED|Part 1||72
2340388|NCT01729754|5744905|P7|STARTED|Part 1||14
2340389|NCT01729754|5744906|P6|STARTED|Part 1||268
2340390|NCT01729754|5744907|P5|STARTED|Part 1||21
2340391|NCT01729754|5744908|P4|STARTED|Part 1||18
2340392|NCT01729754|5744909|P3|STARTED|Part 1||110
2340393|NCT01729754|5744910|P2|STARTED|Part 1||184
2340394|NCT01729754|5744911|P1|STARTED|Part 1||20
2340395|NCT01729728|5745118|P3|NOT COMPLETED|Overall Study||1
2340396|NCT01729728|5745119|P2|NOT COMPLETED|Overall Study||6
2340397|NCT01729728|5745120|P1|NOT COMPLETED|Overall Study||1
2340398|NCT01729728|5745118|P3|COMPLETED|Overall Study||16
2340399|NCT01729728|5745119|P2|COMPLETED|Overall Study||22
2340400|NCT01729728|5745120|P1|COMPLETED|Overall Study||20
2340401|NCT01729728|5745118|P3|STARTED|Overall Study||17
2340402|NCT01729728|5745119|P2|STARTED|Overall Study||28
2340403|NCT01729728|5745120|P1|STARTED|Overall Study||21
2340404|NCT01729598|5745253|P2|NOT COMPLETED|Overall Study||0
2340405|NCT01729598|5745254|P1|NOT COMPLETED|Overall Study||0
2340406|NCT01729598|5745253|P2|COMPLETED|Overall Study||4
2340407|NCT01729598|5745254|P1|COMPLETED|Overall Study||10
2340408|NCT01729598|5745253|P2|STARTED|Overall Study||4
2340409|NCT01729598|5745254|P1|STARTED|Overall Study||10
2340410|NCT01729559|5745270|P2|NOT COMPLETED|Overall Study||28
2340411|NCT01729559|5745271|P1|NOT COMPLETED|Overall Study||31
2340412|NCT01729559|5745270|P2|COMPLETED|Overall Study||216
2340413|NCT01729559|5745271|P1|COMPLETED|Overall Study||220
2340414|NCT01729559|5745270|P2|STARTED|Overall Study||244
2340415|NCT01729559|5745271|P1|STARTED|Overall Study||251
2340416|NCT01729338|5745283|P1|NOT COMPLETED|Overall Study||2
2340417|NCT01729338|5745283|P1|COMPLETED|Overall Study||14
2340418|NCT01729338|5745283|P1|STARTED|Overall Study||16
2340419|NCT01729247|5745298|P1|NOT COMPLETED|Overall Study||0
2340420|NCT01729247|5745298|P1|COMPLETED|Overall Study||50
2340421|NCT01729247|5745298|P1|STARTED|Overall Study||50
2340446|NCT01729156|5745348|P3|NOT COMPLETED|Overall Study||0
2340447|NCT01729156|5745349|P2|NOT COMPLETED|Overall Study||0
2340448|NCT01729156|5745350|P1|NOT COMPLETED|Overall Study||1
2340449|NCT01729156|5745348|P3|COMPLETED|Overall Study||12
2340450|NCT01729156|5745349|P2|COMPLETED|Overall Study||12
2340451|NCT01729156|5745350|P1|COMPLETED|Overall Study||11
2340452|NCT01729156|5745348|P3|STARTED|Overall Study||12
2340453|NCT01729156|5745349|P2|STARTED|Overall Study||12
2340454|NCT01729156|5745350|P1|STARTED|Overall Study||12
2340455|NCT01729039|5745378|P2|NOT COMPLETED|Overall Study||12
2340456|NCT01729039|5745379|P1|NOT COMPLETED|Overall Study||10
2340457|NCT01729039|5745378|P2|COMPLETED|Overall Study||14
2340458|NCT01729039|5745379|P1|COMPLETED|Overall Study||13
2340459|NCT01729039|5745378|P2|STARTED|Overall Study||26
2340460|NCT01729039|5745379|P1|STARTED|Overall Study||23
2340461|NCT01729026|5745395|P2|NOT COMPLETED|3-month to 6-month (Final) Follow-up||2
2340462|NCT01729026|5745396|P1|NOT COMPLETED|3-month to 6-month (Final) Follow-up||1
2340463|NCT01729026|5745395|P2|COMPLETED|3-month to 6-month (Final) Follow-up||6
2340464|NCT01729026|5745396|P1|COMPLETED|3-month to 6-month (Final) Follow-up||6
2340465|NCT01729026|5745395|P2|STARTED|3-month to 6-month (Final) Follow-up||8
2340466|NCT01729026|5745396|P1|STARTED|3-month to 6-month (Final) Follow-up||7
2340467|NCT01729026|5745395|P2|NOT COMPLETED|Randomization to 3-month Follow-up||2
2340468|NCT01729026|5745396|P1|NOT COMPLETED|Randomization to 3-month Follow-up||2
2340469|NCT01729026|5745395|P2|COMPLETED|Randomization to 3-month Follow-up||8
2340470|NCT01729026|5745396|P1|COMPLETED|Randomization to 3-month Follow-up||7
2340471|NCT01729026|5745395|P2|STARTED|Randomization to 3-month Follow-up||10
2340472|NCT01729026|5745396|P1|STARTED|Randomization to 3-month Follow-up||9
2340473|NCT01728805|5745404|P3|NOT COMPLETED|Crossover Period||0
2340474|NCT01728805|5745405|P2|NOT COMPLETED|Crossover Period||0
2340475|NCT01728805|5745406|P1|NOT COMPLETED|Crossover Period||0
2340476|NCT01728805|5745404|P3|COMPLETED|Crossover Period||136
2340477|NCT01728805|5745405|P2|COMPLETED|Crossover Period||0
2340478|NCT01728805|5745406|P1|COMPLETED|Crossover Period||0
2340479|NCT01728805|5745404|P3|STARTED|Crossover Period||136
2340480|NCT01728805|5745405|P2|STARTED|Crossover Period||0
2340481|NCT01728805|5745406|P1|STARTED|Crossover Period||0
2340482|NCT01728805|5745404|P3|NOT COMPLETED|Randomization Period||0
2340483|NCT01728805|5745405|P2|NOT COMPLETED|Randomization Period||0
2340484|NCT01728805|5745406|P1|NOT COMPLETED|Randomization Period||0
2340485|NCT01728805|5745404|P3|COMPLETED|Randomization Period||0
2340486|NCT01728805|5745405|P2|COMPLETED|Randomization Period||186
2340487|NCT01728805|5745406|P1|COMPLETED|Randomization Period||186
2340488|NCT01728805|5745404|P3|STARTED|Randomization Period||0
2340489|NCT01728805|5745405|P2|STARTED|Randomization Period||186
2340490|NCT01728805|5745406|P1|STARTED|Randomization Period||186
2340491|NCT01728792|5745424|P5|NOT COMPLETED|Overall Study||0
2340492|NCT01728792|5745425|P4|NOT COMPLETED|Overall Study||3
2340493|NCT01728792|5745426|P3|NOT COMPLETED|Overall Study||4
2340494|NCT01728792|5745427|P2|NOT COMPLETED|Overall Study||2
2340495|NCT01728792|5745428|P1|NOT COMPLETED|Overall Study||3
2340496|NCT01728792|5745424|P5|COMPLETED|Overall Study||16
2340497|NCT01728792|5745425|P4|COMPLETED|Overall Study||14
2340498|NCT01728792|5745426|P3|COMPLETED|Overall Study||13
2340499|NCT01728792|5745427|P2|COMPLETED|Overall Study||14
2340500|NCT01728792|5745428|P1|COMPLETED|Overall Study||11
2340501|NCT01728792|5745424|P5|STARTED|Overall Study||16
2340502|NCT01728792|5745425|P4|STARTED|Overall Study||17
2340503|NCT01728792|5745426|P3|STARTED|Overall Study||17
2340504|NCT01728792|5745427|P2|STARTED|Overall Study||16
2340505|NCT01728792|5745428|P1|STARTED|Overall Study||14
2340506|NCT01728584|5745479|P4|NOT COMPLETED|Overall Study||1
2340507|NCT01728584|5745480|P3|NOT COMPLETED|Overall Study||1
2340508|NCT01728584|5745481|P2|NOT COMPLETED|Overall Study||0
2340509|NCT01728584|5745482|P1|NOT COMPLETED|Overall Study||8
2340510|NCT01728584|5745479|P4|COMPLETED|Overall Study||29
2340511|NCT01728584|5745480|P3|COMPLETED|Overall Study||30
2340512|NCT01728584|5745481|P2|COMPLETED|Overall Study||30
2340513|NCT01728584|5745482|P1|COMPLETED|Overall Study||28
2340514|NCT01728584|5745479|P4|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 5 (all to Deep/Std)|30
2340515|NCT01728584|5745480|P3|STARTED|Overall Study|Randomized|31
2340516|NCT01728584|5745481|P2|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 7 (2 to Std/Std, 4 to Deep/Std, 1 to Deep/Low)|30
2340517|NCT01728584|5745482|P1|STARTED|Overall Study|Randomized|36
2340518|NCT01728454|5745537|P3|NOT COMPLETED|Stage 3||4
2340519|NCT01728454|5745538|P2|NOT COMPLETED|Stage 3||4
2340520|NCT01728454|5745539|P1|NOT COMPLETED|Stage 3||3
2340521|NCT01728454|5745537|P3|COMPLETED|Stage 3||7
2340522|NCT01728454|5745538|P2|COMPLETED|Stage 3||1
2340523|NCT01728454|5745539|P1|COMPLETED|Stage 3||3
2340524|NCT01728454|5745537|P3|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|11
2340525|NCT01728454|5745538|P2|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|5
2340526|NCT01728454|5745539|P1|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|6
2340527|NCT01728454|5745537|P3|NOT COMPLETED|Stage 1 and 2||4
2340528|NCT01728454|5745538|P2|NOT COMPLETED|Stage 1 and 2||4
2340529|NCT01728454|5745539|P1|NOT COMPLETED|Stage 1 and 2||5
2340530|NCT01728454|5745537|P3|COMPLETED|Stage 1 and 2||19
2340531|NCT01728454|5745538|P2|COMPLETED|Stage 1 and 2||16
2340532|NCT01728454|5745539|P1|COMPLETED|Stage 1 and 2||12
2340533|NCT01728454|5745537|P3|STARTED|Stage 1 and 2||23
2340534|NCT01728454|5745538|P2|STARTED|Stage 1 and 2||20
2340535|NCT01728454|5745539|P1|STARTED|Stage 1 and 2||17
2340536|NCT01728376|5745589|P6|NOT COMPLETED|Overall Study||2
2340537|NCT01728376|5745590|P5|NOT COMPLETED|Overall Study||2
2340538|NCT01728376|5745591|P4|NOT COMPLETED|Overall Study||2
2340539|NCT01728376|5745592|P3|NOT COMPLETED|Overall Study||2
2340540|NCT01728376|5745593|P2|NOT COMPLETED|Overall Study||2
2340541|NCT01728376|5745594|P1|NOT COMPLETED|Overall Study||4
2340542|NCT01728376|5745589|P6|COMPLETED|Overall Study||5
2340543|NCT01728376|5745590|P5|COMPLETED|Overall Study||12
2340544|NCT01728376|5745591|P4|COMPLETED|Overall Study||7
2340545|NCT01728376|5745592|P3|COMPLETED|Overall Study||17
2340546|NCT01728376|5745593|P2|COMPLETED|Overall Study||9
2340547|NCT01728376|5745594|P1|COMPLETED|Overall Study||18
2340548|NCT01728376|5745589|P6|Treated|Overall Study||7
2340549|NCT01728376|5745590|P5|Treated|Overall Study||14
2340550|NCT01728376|5745591|P4|Treated|Overall Study||9
2340551|NCT01728376|5745592|P3|Treated|Overall Study||19
2340552|NCT01728376|5745593|P2|Treated|Overall Study||10
2340553|NCT01728376|5745594|P1|Treated|Overall Study||22
2340554|NCT01728376|5745589|P6|STARTED|Overall Study||7
2340555|NCT01728376|5745590|P5|STARTED|Overall Study||14
2340556|NCT01728376|5745591|P4|STARTED|Overall Study||9
2340557|NCT01728376|5745592|P3|STARTED|Overall Study||19
2340558|NCT01728376|5745593|P2|STARTED|Overall Study||11
2340559|NCT01728376|5745594|P1|STARTED|Overall Study||22
2340560|NCT01728337|5745656|P1|NOT COMPLETED|Overall Study||0
2340561|NCT01728337|5745656|P1|COMPLETED|Overall Study||80
2340562|NCT01728337|5745656|P1|STARTED|Overall Study||80
2340563|NCT01728324|5745667|P3|NOT COMPLETED|Termination of RBV||15
2340564|NCT01728324|5745668|P2|NOT COMPLETED|Termination of RBV||37
2340565|NCT01728324|5745669|P1|NOT COMPLETED|Termination of RBV||39
2340566|NCT01728324|5745667|P3|COMPLETED|Termination of RBV||57
2340567|NCT01728324|5745668|P2|COMPLETED|Termination of RBV||176
2340568|NCT01728324|5745669|P1|COMPLETED|Termination of RBV||172
2340569|NCT01728324|5745667|P3|STARTED|Termination of RBV||72
2340570|NCT01728324|5745668|P2|STARTED|Termination of RBV||213
2340571|NCT01728324|5745669|P1|STARTED|Termination of RBV||211
2340572|NCT01728324|5745667|P3|NOT COMPLETED|Termination of FDV||14
2340573|NCT01728324|5745668|P2|NOT COMPLETED|Termination of FDV||36
2340574|NCT01728324|5745669|P1|NOT COMPLETED|Termination of FDV||38
2340575|NCT01728324|5745667|P3|COMPLETED|Termination of FDV||58
2340576|NCT01728324|5745668|P2|COMPLETED|Termination of FDV||177
2340577|NCT01728324|5745669|P1|COMPLETED|Termination of FDV||173
2340578|NCT01728324|5745667|P3|STARTED|Termination of FDV||72
2340579|NCT01728324|5745668|P2|STARTED|Termination of FDV||213
2340580|NCT01728324|5745669|P1|STARTED|Termination of FDV||211
2340581|NCT01728324|5745667|P3|NOT COMPLETED|Termination of DBV||14
2340582|NCT01728324|5745668|P2|NOT COMPLETED|Termination of DBV||36
2340583|NCT01728324|5745669|P1|NOT COMPLETED|Termination of DBV||38
2340584|NCT01728324|5745667|P3|COMPLETED|Termination of DBV||58
2340585|NCT01728324|5745668|P2|COMPLETED|Termination of DBV||177
2340586|NCT01728324|5745669|P1|COMPLETED|Termination of DBV||173
2340587|NCT01728324|5745667|P3|STARTED|Termination of DBV||72
2340588|NCT01728324|5745668|P2|STARTED|Termination of DBV||213
2340589|NCT01728324|5745669|P1|STARTED|Termination of DBV||211
2340590|NCT01728246|5745690|P2|NOT COMPLETED|Overall Study||36
2340591|NCT01728246|5745691|P1|NOT COMPLETED|Overall Study||36
2340592|NCT01728246|5745690|P2|COMPLETED|Overall Study||195
2340593|NCT01728246|5745691|P1|COMPLETED|Overall Study||206
2340594|NCT01728246|5745690|P2|STARTED|Overall Study||231
2340595|NCT01728246|5745691|P1|STARTED|Overall Study||242
2340596|NCT01728116|5745709|P2|NOT COMPLETED|Overall Study||47
2340597|NCT01728116|5745710|P1|NOT COMPLETED|Overall Study||161
2340598|NCT01728116|5745709|P2|COMPLETED|Overall Study|Completed to Week 52|60
2340599|NCT01728116|5745710|P1|COMPLETED|Overall Study|Completed to Week 78|52
2340600|NCT01728116|5745709|P2|STARTED|Overall Study|Sham mITT subjects|107
2340601|NCT01728116|5745710|P1|STARTED|Overall Study|EndoBarrier mITT Subjects|213
2340602|NCT01728077|5745735|P2|NOT COMPLETED|Overall Study||5
2340603|NCT01728077|5745736|P1|NOT COMPLETED|Overall Study||8
2340604|NCT01728077|5745735|P2|COMPLETED|Overall Study||2
2340605|NCT01728077|5745736|P1|COMPLETED|Overall Study||11
2340606|NCT01728077|5745735|P2|STARTED|Overall Study||7
2340607|NCT01728077|5745736|P1|STARTED|Overall Study||19
2340608|NCT01727895|5745751|P2|NOT COMPLETED|Overall Study||0
2340609|NCT01727895|5745752|P1|NOT COMPLETED|Overall Study||0
2340610|NCT01727895|5745751|P2|COMPLETED|Overall Study||5
2340611|NCT01727895|5745752|P1|COMPLETED|Overall Study||10
2340612|NCT01727895|5745751|P2|STARTED|Overall Study||5
2340613|NCT01727895|5745752|P1|STARTED|Overall Study||10
2340614|NCT01727791|5745758|P1|NOT COMPLETED|Overall Study||0
2340615|NCT01727791|5745758|P1|COMPLETED|Overall Study||10
2340616|NCT01727791|5745758|P1|STARTED|Overall Study||10
2340617|NCT01727765|5745790|P2|NOT COMPLETED|Overall Study||0
2340618|NCT01727765|5745791|P1|NOT COMPLETED|Overall Study||0
2340619|NCT01727765|5745790|P2|COMPLETED|Overall Study||8
2340620|NCT01727765|5745791|P1|COMPLETED|Overall Study||8
2340621|NCT01727765|5745790|P2|STARTED|Overall Study||8
2340622|NCT01727765|5745791|P1|STARTED|Overall Study||8
2340623|NCT01727726|5745800|P3|NOT COMPLETED|Overall Study||20
2340624|NCT01727726|5745801|P2|NOT COMPLETED|Overall Study||14
2340625|NCT01727726|5745802|P1|NOT COMPLETED|Overall Study||26
2340626|NCT01727726|5745800|P3|COMPLETED|Overall Study||186
2340627|NCT01727726|5745801|P2|COMPLETED|Overall Study||86
2340628|NCT01727726|5745802|P1|COMPLETED|Overall Study||171
2340629|NCT01727726|5745800|P3|STARTED|Overall Study||206
2340630|NCT01727726|5745801|P2|STARTED|Overall Study||100
2340631|NCT01727726|5745802|P1|STARTED|Overall Study||197
2340632|NCT01727713|5745834|P1|NOT COMPLETED|Overall Study||35
2340633|NCT01727713|5745834|P1|COMPLETED|Overall Study||75
2340634|NCT01727713|5745834|P1|STARTED|Overall Study||110
2340635|NCT01727700|5745861|P3|NOT COMPLETED|Overall Study||2
2340636|NCT01727700|5745862|P2|NOT COMPLETED|Overall Study||10
2340637|NCT01727700|5745863|P1|NOT COMPLETED|Overall Study||2
2340638|NCT01727700|5745861|P3|COMPLETED|Overall Study||42
2340639|NCT01727700|5745862|P2|COMPLETED|Overall Study||35
2340640|NCT01727700|5745863|P1|COMPLETED|Overall Study||42
2340641|NCT01727700|5745861|P3|STARTED|Overall Study||44
2340642|NCT01727700|5745862|P2|STARTED|Overall Study||45
2340643|NCT01727700|5745863|P1|STARTED|Overall Study||44
2340644|NCT01727505|5745886|P2|NOT COMPLETED|Second 24 Hours||1
2340645|NCT01727505|5745887|P1|NOT COMPLETED|Second 24 Hours||0
2340646|NCT01727505|5745886|P2|COMPLETED|Second 24 Hours||10
2340647|NCT01727505|5745887|P1|COMPLETED|Second 24 Hours||14
2340648|NCT01727505|5745886|P2|STARTED|Second 24 Hours||11
2340649|NCT01727505|5745887|P1|STARTED|Second 24 Hours||14
2340650|NCT01727505|5745886|P2|NOT COMPLETED|First 24 Hours||1
2340651|NCT01727505|5745887|P1|NOT COMPLETED|First 24 Hours||0
2340652|NCT01727505|5745886|P2|COMPLETED|First 24 Hours||11
2340653|NCT01727505|5745887|P1|COMPLETED|First 24 Hours||14
2340654|NCT01727505|5745886|P2|STARTED|First 24 Hours||12
2340655|NCT01727505|5745887|P1|STARTED|First 24 Hours||14
2340656|NCT01727414|5745905|P2|NOT COMPLETED|Overall Study||0
2340657|NCT01727414|5745906|P1|NOT COMPLETED|Overall Study||3
2340658|NCT01727414|5745905|P2|COMPLETED|Overall Study||45
2340659|NCT01727414|5745906|P1|COMPLETED|Overall Study||123
2340660|NCT01727414|5745905|P2|STARTED|Overall Study||45
2340661|NCT01727414|5745906|P1|STARTED|Overall Study||126
2340662|NCT01727297|5745912|P2|NOT COMPLETED|Overall Study||51
2340663|NCT01727297|5745913|P1|NOT COMPLETED|Overall Study||102
2340664|NCT01727297|5745912|P2|COMPLETED|Overall Study||0
2340665|NCT01727297|5745913|P1|COMPLETED|Overall Study||293
2340666|NCT01727297|5745912|P2|STARTED|Overall Study||51
2340667|NCT01727297|5745913|P1|STARTED|Overall Study||395
2340668|NCT01727258|5745929|P3|NOT COMPLETED|Overall Study||1
2340669|NCT01727258|5745930|P2|NOT COMPLETED|Overall Study||3
2340670|NCT01727258|5745931|P1|NOT COMPLETED|Overall Study||2
2340671|NCT01727258|5745929|P3|COMPLETED|Overall Study||50
2340672|NCT01727258|5745930|P2|COMPLETED|Overall Study||48
2340673|NCT01727258|5745931|P1|COMPLETED|Overall Study||49
2340674|NCT01727258|5745929|P3|STARTED|Overall Study||51
2340675|NCT01727258|5745930|P2|STARTED|Overall Study||51
2340676|NCT01727258|5745931|P1|STARTED|Overall Study||51
2340677|NCT01727180|5745954|P1|NOT COMPLETED|Overall Study||0
2340678|NCT01727180|5745954|P1|COMPLETED|Overall Study||108
2340679|NCT01727180|5745954|P1|STARTED|Overall Study||108
2340680|NCT01727167|5745960|P2|NOT COMPLETED|Overall Study||0
2340681|NCT01727167|5745961|P1|NOT COMPLETED|Overall Study||0
2340682|NCT01727167|5745960|P2|COMPLETED|Overall Study||0
2340683|NCT01727167|5745961|P1|COMPLETED|Overall Study||1
2340684|NCT01727167|5745960|P2|STARTED|Overall Study||0
2340685|NCT01727167|5745961|P1|STARTED|Overall Study||1
2340686|NCT01727154|5745969|P1|NOT COMPLETED|Overall Study||59
2340687|NCT01727154|5745969|P1|COMPLETED|Overall Study||80
2340688|NCT01727154|5745969|P1|STARTED|Overall Study||139
2340689|NCT01727141|5745977|P4|NOT COMPLETED|Overall Study||15
2340690|NCT01727141|5745978|P3|NOT COMPLETED|Overall Study||3
2340691|NCT01727141|5745979|P2|NOT COMPLETED|Overall Study||9
2340692|NCT01727141|5745980|P1|NOT COMPLETED|Overall Study||5
2340693|NCT01727141|5745977|P4|COMPLETED|Overall Study||246
2340694|NCT01727141|5745978|P3|COMPLETED|Overall Study||258
2340695|NCT01727141|5745979|P2|COMPLETED|Overall Study||251
2340696|NCT01727141|5745980|P1|COMPLETED|Overall Study||255
2340697|NCT01727141|5745977|P4|Full Analysis Set|Overall Study||261
2340698|NCT01727141|5745978|P3|Full Analysis Set|Overall Study||261
2340699|NCT01727141|5745979|P2|Full Analysis Set|Overall Study||260
2340700|NCT01727141|5745980|P1|Full Analysis Set|Overall Study||258
2340701|NCT01727141|5745977|P4|Safety Set|Overall Study||260
2340702|NCT01727141|5745978|P3|Safety Set|Overall Study||262
2340703|NCT01727141|5745979|P2|Safety Set|Overall Study||260
2340704|NCT01727141|5745980|P1|Safety Set|Overall Study||258
2340705|NCT01727141|5745977|P4|STARTED|Overall Study||261
2340706|NCT01727141|5745978|P3|STARTED|Overall Study||261
2340707|NCT01727141|5745979|P2|STARTED|Overall Study||260
2340708|NCT01727141|5745980|P1|STARTED|Overall Study||260
2340709|NCT01727089|5746032|P2|NOT COMPLETED|Overall Study||0
2340710|NCT01727089|5746033|P1|NOT COMPLETED|Overall Study||0
2340711|NCT01727089|5746032|P2|COMPLETED|Overall Study||30
2340712|NCT01727089|5746033|P1|COMPLETED|Overall Study||29
2340713|NCT01727089|5746032|P2|STARTED|Overall Study||30
2340714|NCT01727089|5746033|P1|STARTED|Overall Study||29
2340715|NCT01727024|5746045|P2|NOT COMPLETED|Period 2||0
2340716|NCT01727024|5746046|P1|NOT COMPLETED|Period 2||0
2340717|NCT01727024|5746045|P2|COMPLETED|Period 2||64
2340718|NCT01727024|5746046|P1|COMPLETED|Period 2||68
2340719|NCT01727024|5746045|P2|STARTED|Period 2||64
2340720|NCT01727024|5746046|P1|STARTED|Period 2||68
2340721|NCT01727024|5746045|P2|NOT COMPLETED|Period 1||4
2340722|NCT01727024|5746046|P1|NOT COMPLETED|Period 1||3
2340723|NCT01727024|5746045|P2|COMPLETED|Period 1||64
2340724|NCT01727024|5746046|P1|COMPLETED|Period 1||68
2340725|NCT01727024|5746045|P2|STARTED|Period 1||68
2340726|NCT01727024|5746046|P1|STARTED|Period 1||71
2340727|NCT01726803|5746061|P2|NOT COMPLETED|Overall Study||1
2340728|NCT01726803|5746062|P1|NOT COMPLETED|Overall Study||7
2340729|NCT01726803|5746061|P2|COMPLETED|Overall Study||107
2340730|NCT01726803|5746062|P1|COMPLETED|Overall Study||105
2340731|NCT01726803|5746061|P2|STARTED|Overall Study||108
2340732|NCT01726803|5746062|P1|STARTED|Overall Study||112
2340733|NCT01726673|5746084|P2|NOT COMPLETED|Overall Study||3
2340734|NCT01726673|5746085|P1|NOT COMPLETED|Overall Study||6
2340735|NCT01726673|5746084|P2|COMPLETED|Overall Study||21
2340736|NCT01726673|5746085|P1|COMPLETED|Overall Study||24
2340737|NCT01726673|5746084|P2|STARTED|Overall Study||24
2340738|NCT01726673|5746085|P1|STARTED|Overall Study||30
2340739|NCT01726621|5746095|P1|NOT COMPLETED|Overall Study||4
2340740|NCT01726621|5746095|P1|COMPLETED|Overall Study||51
2340741|NCT01726621|5746095|P1|STARTED|Overall Study||55
2340742|NCT01726517|5746104|P5|NOT COMPLETED|Overall Study||0
2340743|NCT01726517|5746105|P4|NOT COMPLETED|Overall Study||0
2340744|NCT01726517|5746106|P3|NOT COMPLETED|Overall Study||1
2340745|NCT01726517|5746107|P2|NOT COMPLETED|Overall Study||0
2340746|NCT01726517|5746108|P1|NOT COMPLETED|Overall Study||0
2340747|NCT01726517|5746104|P5|COMPLETED|Overall Study||21
2340748|NCT01726517|5746105|P4|COMPLETED|Overall Study||19
2340749|NCT01726517|5746106|P3|COMPLETED|Overall Study||18
2340750|NCT01726517|5746107|P2|COMPLETED|Overall Study||21
2340751|NCT01726517|5746108|P1|COMPLETED|Overall Study||20
2340752|NCT01726517|5746104|P5|STARTED|Overall Study||21
2340753|NCT01726517|5746105|P4|STARTED|Overall Study||19
2340754|NCT01726517|5746106|P3|STARTED|Overall Study||19
2340755|NCT01726517|5746107|P2|STARTED|Overall Study||21
2340756|NCT01726517|5746108|P1|STARTED|Overall Study||20
2340757|NCT01726504|5746137|P2|NOT COMPLETED|Overall Study||28
2340758|NCT01726504|5746138|P1|NOT COMPLETED|Overall Study||12
2340759|NCT01726504|5746137|P2|COMPLETED|Overall Study||511
2340760|NCT01726504|5746138|P1|COMPLETED|Overall Study||524
2340761|NCT01726504|5746137|P2|STARTED|Overall Study||539
2340762|NCT01726504|5746138|P1|STARTED|Overall Study||536
2340763|NCT01726335|5746164|P1|NOT COMPLETED|Overall Study||24
2340764|NCT01726335|5746164|P1|COMPLETED|Overall Study||29
2340765|NCT01726335|5746164|P1|STARTED|Overall Study||53
2340766|NCT01726049|5746182|P2|NOT COMPLETED|Overall Study||4
2340767|NCT01726049|5746183|P1|NOT COMPLETED|Overall Study||5
2340768|NCT01726049|5746182|P2|COMPLETED|Overall Study||22
2340769|NCT01726049|5746183|P1|COMPLETED|Overall Study||21
2340770|NCT01726049|5746182|P2|STARTED|Overall Study||26
2340771|NCT01726049|5746183|P1|STARTED|Overall Study||26
2340772|NCT01726036|5746197|P2|NOT COMPLETED|Overall Study||7
2340773|NCT01726036|5746198|P1|NOT COMPLETED|Overall Study||16
2340774|NCT01726036|5746197|P2|COMPLETED|Overall Study||130
2340775|NCT01726036|5746198|P1|COMPLETED|Overall Study||121
2340776|NCT01726036|5746197|P2|STARTED|Overall Study||137
2340777|NCT01726036|5746198|P1|STARTED|Overall Study||137
2340778|NCT01726023|5746208|P2|NOT COMPLETED|Overall Study||26
2340779|NCT01726023|5746209|P1|NOT COMPLETED|Overall Study||29
2340780|NCT01726023|5746208|P2|COMPLETED|Overall Study||196
2340781|NCT01726023|5746209|P1|COMPLETED|Overall Study||190
2340782|NCT01726023|5746208|P2|STARTED|Overall Study||222
2340783|NCT01726023|5746209|P1|STARTED|Overall Study||219
2340784|NCT01725984|5746301|P2|NOT COMPLETED|Overall Study||0
2340785|NCT01725984|5746302|P1|NOT COMPLETED|Overall Study||0
2340786|NCT01725984|5746301|P2|COMPLETED|Overall Study||41
2340787|NCT01725984|5746302|P1|COMPLETED|Overall Study||39
2340788|NCT01725984|5746301|P2|STARTED|Overall Study||41
2340789|NCT01725984|5746302|P1|STARTED|Overall Study||39
2340790|NCT01725815|5746328|P2|NOT COMPLETED|Overall Study||0
2340791|NCT01725815|5746329|P1|NOT COMPLETED|Overall Study||0
2340792|NCT01725815|5746328|P2|COMPLETED|Overall Study||202
2340793|NCT01725815|5746329|P1|COMPLETED|Overall Study||198
2340794|NCT01725815|5746328|P2|STARTED|Overall Study||202
2340795|NCT01725815|5746329|P1|STARTED|Overall Study||198
2340796|NCT01725750|5746343|P2|NOT COMPLETED|Overall Study||10
2340797|NCT01725750|5746344|P1|NOT COMPLETED|Overall Study||2
2340798|NCT01725750|5746343|P2|COMPLETED|Overall Study||34
2340799|NCT01725750|5746344|P1|COMPLETED|Overall Study||42
2340800|NCT01725750|5746343|P2|STARTED|Overall Study||44
2340801|NCT01725750|5746344|P1|STARTED|Overall Study||44
2340802|NCT01725529|5746377|P3|NOT COMPLETED|Overall Study||10
2340803|NCT01725529|5746378|P2|NOT COMPLETED|Overall Study||16
2340804|NCT01725529|5746379|P1|NOT COMPLETED|Overall Study||15
2340805|NCT01725529|5746377|P3|COMPLETED|Overall Study||142
2340806|NCT01725529|5746378|P2|COMPLETED|Overall Study||137
2340807|NCT01725529|5746379|P1|COMPLETED|Overall Study||137
2340808|NCT01725529|5746377|P3|STARTED|Overall Study||152
2340809|NCT01725529|5746378|P2|STARTED|Overall Study||153
2340810|NCT01725529|5746379|P1|STARTED|Overall Study||152
2340811|NCT01725451|5746405|P4|NOT COMPLETED|Period 6||0
2340812|NCT01725451|5746406|P3|NOT COMPLETED|Period 6||0
2340813|NCT01725451|5746407|P2|NOT COMPLETED|Period 6||0
2340814|NCT01725451|5746408|P1|NOT COMPLETED|Period 6||0
2340815|NCT01725451|5746405|P4|COMPLETED|Period 6||7
2340816|NCT01725451|5746406|P3|COMPLETED|Period 6||6
2340817|NCT01725451|5746407|P2|COMPLETED|Period 6||6
2340818|NCT01725451|5746408|P1|COMPLETED|Period 6||7
2340819|NCT01725451|5746405|P4|STARTED|Period 6||7
2340820|NCT01725451|5746406|P3|STARTED|Period 6||6
2340821|NCT01725451|5746407|P2|STARTED|Period 6||6
2340822|NCT01725451|5746408|P1|STARTED|Period 6||7
2340823|NCT01725451|5746405|P4|NOT COMPLETED|Washout From Period 5||0
2340824|NCT01725451|5746406|P3|NOT COMPLETED|Washout From Period 5||0
2340825|NCT01725451|5746407|P2|NOT COMPLETED|Washout From Period 5||0
2340826|NCT01725451|5746408|P1|NOT COMPLETED|Washout From Period 5||0
2340827|NCT01725451|5746405|P4|COMPLETED|Washout From Period 5||7
2340828|NCT01725451|5746406|P3|COMPLETED|Washout From Period 5||6
2340829|NCT01725451|5746407|P2|COMPLETED|Washout From Period 5||6
2340830|NCT01725451|5746408|P1|COMPLETED|Washout From Period 5||7
2340831|NCT01725451|5746405|P4|STARTED|Washout From Period 5||7
2340832|NCT01725451|5746406|P3|STARTED|Washout From Period 5||6
2340833|NCT01725451|5746407|P2|STARTED|Washout From Period 5||6
2340834|NCT01725451|5746408|P1|STARTED|Washout From Period 5||7
2340835|NCT01725451|5746405|P4|NOT COMPLETED|Period 5||0
2340836|NCT01725451|5746406|P3|NOT COMPLETED|Period 5||0
2340837|NCT01725451|5746407|P2|NOT COMPLETED|Period 5||0
2340838|NCT01725451|5746408|P1|NOT COMPLETED|Period 5||0
2340839|NCT01725451|5746405|P4|COMPLETED|Period 5||7
2340840|NCT01725451|5746406|P3|COMPLETED|Period 5||6
2340841|NCT01725451|5746407|P2|COMPLETED|Period 5||6
2340842|NCT01725451|5746408|P1|COMPLETED|Period 5||7
2340843|NCT01725451|5746405|P4|STARTED|Period 5||7
2340844|NCT01725451|5746406|P3|STARTED|Period 5||6
2340845|NCT01725451|5746407|P2|STARTED|Period 5||6
2340846|NCT01725451|5746408|P1|STARTED|Period 5||7
2340847|NCT01725451|5746405|P4|NOT COMPLETED|Washout From Period 4||0
2340848|NCT01725451|5746406|P3|NOT COMPLETED|Washout From Period 4||0
2340849|NCT01725451|5746407|P2|NOT COMPLETED|Washout From Period 4||0
2340850|NCT01725451|5746408|P1|NOT COMPLETED|Washout From Period 4||0
2340851|NCT01725451|5746405|P4|COMPLETED|Washout From Period 4||7
2340852|NCT01725451|5746406|P3|COMPLETED|Washout From Period 4||6
2340853|NCT01725451|5746407|P2|COMPLETED|Washout From Period 4||6
2340854|NCT01725451|5746408|P1|COMPLETED|Washout From Period 4||7
2340855|NCT01725451|5746405|P4|STARTED|Washout From Period 4||7
2340856|NCT01725451|5746406|P3|STARTED|Washout From Period 4||6
2340857|NCT01725451|5746407|P2|STARTED|Washout From Period 4||6
2340858|NCT01725451|5746408|P1|STARTED|Washout From Period 4||7
2340859|NCT01725451|5746405|P4|NOT COMPLETED|Period 4||0
2340860|NCT01725451|5746406|P3|NOT COMPLETED|Period 4||1
2340861|NCT01725451|5746407|P2|NOT COMPLETED|Period 4||0
2340862|NCT01725451|5746408|P1|NOT COMPLETED|Period 4||0
2340863|NCT01725451|5746405|P4|COMPLETED|Period 4||7
2340864|NCT01725451|5746406|P3|COMPLETED|Period 4||6
2340865|NCT01725451|5746407|P2|COMPLETED|Period 4||6
2340866|NCT01725451|5746408|P1|COMPLETED|Period 4||7
2340867|NCT01725451|5746405|P4|STARTED|Period 4||7
2340868|NCT01725451|5746406|P3|STARTED|Period 4||7
2340869|NCT01725451|5746407|P2|STARTED|Period 4||6
2340870|NCT01725451|5746408|P1|STARTED|Period 4||7
2340871|NCT01725451|5746405|P4|NOT COMPLETED|Washout From Period 3||0
2340872|NCT01725451|5746406|P3|NOT COMPLETED|Washout From Period 3||1
2340873|NCT01725451|5746407|P2|NOT COMPLETED|Washout From Period 3||1
2340874|NCT01725451|5746408|P1|NOT COMPLETED|Washout From Period 3||0
2340875|NCT01725451|5746405|P4|COMPLETED|Washout From Period 3||7
2340876|NCT01725451|5746406|P3|COMPLETED|Washout From Period 3||7
2340877|NCT01725451|5746407|P2|COMPLETED|Washout From Period 3||6
2340878|NCT01725451|5746408|P1|COMPLETED|Washout From Period 3||7
2340879|NCT01725451|5746405|P4|STARTED|Washout From Period 3||7
2340880|NCT01725451|5746406|P3|STARTED|Washout From Period 3||8
2340881|NCT01725451|5746407|P2|STARTED|Washout From Period 3||7
2340882|NCT01725451|5746408|P1|STARTED|Washout From Period 3||7
2340883|NCT01725451|5746405|P4|NOT COMPLETED|Period 3||0
2340884|NCT01725451|5746406|P3|NOT COMPLETED|Period 3||0
2340885|NCT01725451|5746407|P2|NOT COMPLETED|Period 3||0
2340886|NCT01725451|5746408|P1|NOT COMPLETED|Period 3||0
2340887|NCT01725451|5746405|P4|COMPLETED|Period 3||7
2340888|NCT01725451|5746406|P3|COMPLETED|Period 3||8
2340889|NCT01725451|5746407|P2|COMPLETED|Period 3||7
2340890|NCT01725451|5746408|P1|COMPLETED|Period 3||7
2340891|NCT01725451|5746405|P4|STARTED|Period 3||7
2340892|NCT01725451|5746406|P3|STARTED|Period 3||8
2340893|NCT01725451|5746407|P2|STARTED|Period 3||7
2340894|NCT01725451|5746408|P1|STARTED|Period 3||7
2340895|NCT01725451|5746405|P4|NOT COMPLETED|Washout From Period 2||0
2340896|NCT01725451|5746406|P3|NOT COMPLETED|Washout From Period 2||0
2340897|NCT01725451|5746407|P2|NOT COMPLETED|Washout From Period 2||0
2340898|NCT01725451|5746408|P1|NOT COMPLETED|Washout From Period 2||0
2340899|NCT01725451|5746405|P4|COMPLETED|Washout From Period 2||7
2340900|NCT01725451|5746406|P3|COMPLETED|Washout From Period 2||8
2340901|NCT01725451|5746407|P2|COMPLETED|Washout From Period 2||7
2340902|NCT01725451|5746408|P1|COMPLETED|Washout From Period 2||7
2340903|NCT01725451|5746405|P4|STARTED|Washout From Period 2||7
2340904|NCT01725451|5746406|P3|STARTED|Washout From Period 2||8
2340905|NCT01725451|5746407|P2|STARTED|Washout From Period 2||7
2340906|NCT01725451|5746408|P1|STARTED|Washout From Period 2||7
2340907|NCT01725451|5746405|P4|NOT COMPLETED|Period 2||0
2340908|NCT01725451|5746406|P3|NOT COMPLETED|Period 2||0
2340909|NCT01725451|5746407|P2|NOT COMPLETED|Period 2||0
2340910|NCT01725451|5746408|P1|NOT COMPLETED|Period 2||0
2340911|NCT01725451|5746405|P4|COMPLETED|Period 2||7
2340912|NCT01725451|5746406|P3|COMPLETED|Period 2||8
2340913|NCT01725451|5746407|P2|COMPLETED|Period 2||7
2340914|NCT01725451|5746408|P1|COMPLETED|Period 2||7
2340915|NCT01725451|5746405|P4|STARTED|Period 2||7
2340916|NCT01725451|5746406|P3|STARTED|Period 2||8
2340917|NCT01725451|5746407|P2|STARTED|Period 2||7
2340918|NCT01725451|5746408|P1|STARTED|Period 2||7
2340919|NCT01725451|5746405|P4|NOT COMPLETED|Washout From Period 1||0
2340920|NCT01725451|5746406|P3|NOT COMPLETED|Washout From Period 1||0
2340921|NCT01725451|5746407|P2|NOT COMPLETED|Washout From Period 1||0
2340922|NCT01725451|5746408|P1|NOT COMPLETED|Washout From Period 1||0
2340923|NCT01725451|5746405|P4|COMPLETED|Washout From Period 1||7
2340924|NCT01725451|5746406|P3|COMPLETED|Washout From Period 1||8
2340925|NCT01725451|5746407|P2|COMPLETED|Washout From Period 1||7
2340926|NCT01725451|5746408|P1|COMPLETED|Washout From Period 1||7
2340927|NCT01725451|5746405|P4|STARTED|Washout From Period 1||7
2340928|NCT01725451|5746406|P3|STARTED|Washout From Period 1||8
2340929|NCT01725451|5746407|P2|STARTED|Washout From Period 1||7
2340930|NCT01725451|5746408|P1|STARTED|Washout From Period 1||7
2340931|NCT01725451|5746405|P4|NOT COMPLETED|Period 1||0
2340932|NCT01725451|5746406|P3|NOT COMPLETED|Period 1||0
2340933|NCT01725451|5746407|P2|NOT COMPLETED|Period 1||0
2340934|NCT01725451|5746408|P1|NOT COMPLETED|Period 1||1
2340935|NCT01725451|5746405|P4|COMPLETED|Period 1||7
2340936|NCT01725451|5746406|P3|COMPLETED|Period 1||8
2340937|NCT01725451|5746407|P2|COMPLETED|Period 1||7
2340938|NCT01725451|5746408|P1|COMPLETED|Period 1||7
2340939|NCT01725451|5746405|P4|STARTED|Period 1||7
2340940|NCT01725451|5746406|P3|STARTED|Period 1||8
2340941|NCT01725451|5746407|P2|STARTED|Period 1||7
2340942|NCT01725451|5746408|P1|STARTED|Period 1||8
2340943|NCT01725386|5746430|P2|NOT COMPLETED|Overall Study||46
2340944|NCT01725386|5746431|P1|NOT COMPLETED|Overall Study||175
2340945|NCT01725386|5746430|P2|COMPLETED|Overall Study||17
2340946|NCT01725386|5746431|P1|COMPLETED|Overall Study||13
2340947|NCT01725386|5746430|P2|STARTED|Overall Study||63
2340948|NCT01725386|5746431|P1|STARTED|Overall Study||188
2340949|NCT01725308|5746450|P3|NOT COMPLETED|Treatment Period II||64
2340950|NCT01725308|5746451|P2|NOT COMPLETED|Treatment Period II||29
2340951|NCT01725308|5746452|P1|NOT COMPLETED|Treatment Period II||55
2340952|NCT01725308|5746450|P3|COMPLETED|Treatment Period II||74
2340953|NCT01725308|5746451|P2|COMPLETED|Treatment Period II||31
2340954|NCT01725308|5746452|P1|COMPLETED|Treatment Period II||79
2340955|NCT01725308|5746450|P3|Treated|Treatment Period II||130
2340956|NCT01725308|5746451|P2|Treated|Treatment Period II||53
2340957|NCT01725308|5746452|P1|Treated|Treatment Period II||120
2340958|NCT01725308|5746450|P3|STARTED|Treatment Period II||138
2340959|NCT01725308|5746451|P2|STARTED|Treatment Period II||60
2340960|NCT01725308|5746452|P1|STARTED|Treatment Period II||134
2340961|NCT01725308|5746450|P3|NOT COMPLETED|Treatment Period I||41
2340962|NCT01725308|5746451|P2|NOT COMPLETED|Treatment Period I||14
2340963|NCT01725308|5746452|P1|NOT COMPLETED|Treatment Period I||44
2340964|NCT01725308|5746450|P3|COMPLETED|Treatment Period I||138
2340965|NCT01725308|5746451|P2|COMPLETED|Treatment Period I||60
2340966|NCT01725308|5746452|P1|COMPLETED|Treatment Period I||134
2340967|NCT01725308|5746450|P3|Treated|Treatment Period I||179
2340968|NCT01725308|5746451|P2|Treated|Treatment Period I||74
2340969|NCT01725308|5746452|P1|Treated|Treatment Period I||177
2340970|NCT01725308|5746450|P3|STARTED|Treatment Period I||179
2340971|NCT01725308|5746451|P2|STARTED|Treatment Period I||74
2340972|NCT01725308|5746452|P1|STARTED|Treatment Period I||178
2340973|NCT01725282|5746599|P4|NOT COMPLETED|Overall Study||7
2340974|NCT01725282|5746600|P3|NOT COMPLETED|Overall Study||8
2340975|NCT01725282|5746601|P2|NOT COMPLETED|Overall Study||5
2340976|NCT01725282|5746602|P1|NOT COMPLETED|Overall Study||2
2340977|NCT01725282|5746599|P4|COMPLETED|Overall Study||36
2340978|NCT01725282|5746600|P3|COMPLETED|Overall Study||33
2340979|NCT01725282|5746601|P2|COMPLETED|Overall Study||39
2340980|NCT01725282|5746602|P1|COMPLETED|Overall Study||42
2340981|NCT01725282|5746599|P4|STARTED|Overall Study||43
2340982|NCT01725282|5746600|P3|STARTED|Overall Study||41
2340983|NCT01725282|5746601|P2|STARTED|Overall Study||44
2340984|NCT01725282|5746602|P1|STARTED|Overall Study||44
2340985|NCT01725217|5746635|P3|NOT COMPLETED|Overall Study||0
2340986|NCT01725217|5746636|P2|NOT COMPLETED|Overall Study||0
2340987|NCT01725217|5746637|P1|NOT COMPLETED|Overall Study||1
2340988|NCT01725217|5746635|P3|COMPLETED|Overall Study||66
2340989|NCT01725217|5746636|P2|COMPLETED|Overall Study||66
2340990|NCT01725217|5746637|P1|COMPLETED|Overall Study||65
2340991|NCT01725217|5746635|P3|STARTED|Overall Study||66
2340992|NCT01725217|5746636|P2|STARTED|Overall Study||66
2340993|NCT01725217|5746637|P1|STARTED|Overall Study||66
2340994|NCT01725126|5746671|P6|NOT COMPLETED|Overall Study||0
2340995|NCT01725126|5746672|P5|NOT COMPLETED|Overall Study||0
2340996|NCT01725126|5746673|P4|NOT COMPLETED|Overall Study||1
2340997|NCT01725126|5746674|P3|NOT COMPLETED|Overall Study||0
2340998|NCT01725126|5746675|P2|NOT COMPLETED|Overall Study||1
2340999|NCT01725126|5746676|P1|NOT COMPLETED|Overall Study||0
2341000|NCT01725126|5746671|P6|COMPLETED|Overall Study||12
2341001|NCT01725126|5746672|P5|COMPLETED|Overall Study||6
2341002|NCT01725126|5746673|P4|COMPLETED|Overall Study||13
2341003|NCT01725126|5746674|P3|COMPLETED|Overall Study||6
2341004|NCT01725126|5746675|P2|COMPLETED|Overall Study||10
2341005|NCT01725126|5746676|P1|COMPLETED|Overall Study||4
2341006|NCT01725126|5746671|P6|STARTED|Overall Study||12
2341007|NCT01725126|5746672|P5|STARTED|Overall Study||6
2341008|NCT01725126|5746673|P4|STARTED|Overall Study||14
2341009|NCT01725126|5746674|P3|STARTED|Overall Study||6
2341010|NCT01725126|5746675|P2|STARTED|Overall Study||11
2341011|NCT01725126|5746676|P1|STARTED|Overall Study||4
2341012|NCT01724528|5746874|P2|NOT COMPLETED|Overall Study||3
2341013|NCT01724528|5746875|P1|NOT COMPLETED|Overall Study||4
2341014|NCT01724528|5746874|P2|COMPLETED|Overall Study||170
2341015|NCT01724528|5746875|P1|COMPLETED|Overall Study||169
2341016|NCT01724528|5746874|P2|STARTED|Overall Study||173
2341017|NCT01724528|5746875|P1|STARTED|Overall Study||173
2341018|NCT01724489|5746891|P2|NOT COMPLETED|Overall Study||12
2341019|NCT01724489|5746892|P1|NOT COMPLETED|Overall Study||16
2341020|NCT01724489|5746891|P2|COMPLETED|Overall Study||26
2341021|NCT01724489|5746892|P1|COMPLETED|Overall Study||23
2341022|NCT01724489|5746891|P2|STARTED|Overall Study||38
2341023|NCT01724489|5746892|P1|STARTED|Overall Study||39
2341024|NCT01724359|5746898|P1|NOT COMPLETED|Overall Study||31
2341025|NCT01724359|5746898|P1|COMPLETED|Overall Study||64
2341026|NCT01724359|5746898|P1|STARTED|Overall Study||95
2341027|NCT01724216|5746911|P1|NOT COMPLETED|Overall Study||1
2341028|NCT01724216|5746911|P1|COMPLETED|Overall Study||10
2341029|NCT01724216|5746911|P1|STARTED|Overall Study||11
2341030|NCT01724177|5746915|P1|NOT COMPLETED|Overall Study||26
2341031|NCT01724177|5746915|P1|COMPLETED|Overall Study||0
2341032|NCT01724177|5746915|P1|Safety Population|Overall Study|Safety Population includes participants who received at least one dose of lenalidomide|26
2341033|NCT01724177|5746915|P1|STARTED|Overall Study||26
2341034|NCT01724021|5746928|P2|NOT COMPLETED|Overall Study||133
2341035|NCT01724021|5746929|P1|NOT COMPLETED|Overall Study||127
2341036|NCT01724021|5746928|P2|COMPLETED|Overall Study||236
2341037|NCT01724021|5746929|P1|COMPLETED|Overall Study||244
2341038|NCT01724021|5746928|P2|STARTED|Overall Study||369
2341039|NCT01724021|5746929|P1|STARTED|Overall Study||371
2341040|NCT01723904|5746961|P1|NOT COMPLETED|Overall Study||11
2341041|NCT01723904|5746961|P1|COMPLETED|Overall Study||79
2341042|NCT01723904|5746961|P1|STARTED|Overall Study||90
2341055|NCT01723722|5747010|P2|NOT COMPLETED|Overall Study||0
2341056|NCT01723722|5747011|P1|NOT COMPLETED|Overall Study||0
2341057|NCT01723722|5747010|P2|COMPLETED|Overall Study||20
2341058|NCT01723722|5747011|P1|COMPLETED|Overall Study||20
2341059|NCT01723722|5747010|P2|STARTED|Overall Study||20
2341060|NCT01723722|5747011|P1|STARTED|Overall Study||20
2341061|NCT01723696|5747019|P2|NOT COMPLETED|Overall Study||13
2341062|NCT01723696|5747020|P1|NOT COMPLETED|Overall Study||17
2341063|NCT01723696|5747019|P2|COMPLETED|Overall Study||113
2341064|NCT01723696|5747020|P1|COMPLETED|Overall Study||109
2341065|NCT01723696|5747019|P2|STARTED|Overall Study||126
2341066|NCT01723696|5747020|P1|STARTED|Overall Study||126
2341067|NCT01723514|5747040|P8|NOT COMPLETED|Overall Study||0
2341068|NCT01723514|5747041|P7|NOT COMPLETED|Overall Study||0
2341069|NCT01723514|5747042|P6|NOT COMPLETED|Overall Study||0
2341070|NCT01723514|5747043|P5|NOT COMPLETED|Overall Study||0
2341071|NCT01723514|5747044|P4|NOT COMPLETED|Overall Study||0
2341072|NCT01723514|5747045|P3|NOT COMPLETED|Overall Study||0
2341073|NCT01723514|5747046|P2|NOT COMPLETED|Overall Study||0
2341074|NCT01723514|5747047|P1|NOT COMPLETED|Overall Study||0
2341075|NCT01723514|5747040|P8|COMPLETED|Overall Study||6
2341076|NCT01723514|5747041|P7|COMPLETED|Overall Study||6
2341077|NCT01723514|5747042|P6|COMPLETED|Overall Study||4
2341078|NCT01723514|5747043|P5|COMPLETED|Overall Study||6
2341079|NCT01723514|5747044|P4|COMPLETED|Overall Study||6
2341080|NCT01723514|5747045|P3|COMPLETED|Overall Study||6
2341081|NCT01723514|5747046|P2|COMPLETED|Overall Study||6
2341082|NCT01723514|5747047|P1|COMPLETED|Overall Study||8
2341083|NCT01723514|5747040|P8|STARTED|Overall Study||6
2341084|NCT01723514|5747041|P7|STARTED|Overall Study||6
2341085|NCT01723514|5747042|P6|STARTED|Overall Study||4
2341086|NCT01723514|5747043|P5|STARTED|Overall Study||6
2341087|NCT01723514|5747044|P4|STARTED|Overall Study||6
2341088|NCT01723514|5747045|P3|STARTED|Overall Study||6
2341089|NCT01723514|5747046|P2|STARTED|Overall Study||6
2341090|NCT01723514|5747047|P1|STARTED|Overall Study||8
2341091|NCT01723397|5747123|P2|NOT COMPLETED|Study Period 2||1
2341092|NCT01723397|5747124|P1|NOT COMPLETED|Study Period 2||0
2341093|NCT01723397|5747123|P2|COMPLETED|Study Period 2||5
2341094|NCT01723397|5747124|P1|COMPLETED|Study Period 2||7
2341095|NCT01723397|5747123|P2|STARTED|Study Period 2||6
2341096|NCT01723397|5747124|P1|STARTED|Study Period 2||7
2341097|NCT01723397|5747123|P2|NOT COMPLETED|Washout||0
2341098|NCT01723397|5747124|P1|NOT COMPLETED|Washout||0
2341099|NCT01723397|5747123|P2|COMPLETED|Washout||6
2341100|NCT01723397|5747124|P1|COMPLETED|Washout||7
2341101|NCT01723397|5747123|P2|STARTED|Washout||6
2341102|NCT01723397|5747124|P1|STARTED|Washout||7
2341103|NCT01723397|5747123|P2|NOT COMPLETED|Study Period 1||1
2341104|NCT01723397|5747124|P1|NOT COMPLETED|Study Period 1||0
2341105|NCT01723397|5747123|P2|COMPLETED|Study Period 1||6
2341106|NCT01723397|5747124|P1|COMPLETED|Study Period 1||7
2341107|NCT01723397|5747123|P2|STARTED|Study Period 1||7
2341108|NCT01723397|5747124|P1|STARTED|Study Period 1||7
2341109|NCT01723384|5747132|P2|NOT COMPLETED|Overall Study||0
2341110|NCT01723384|5747133|P1|NOT COMPLETED|Overall Study||0
2341111|NCT01723384|5747132|P2|COMPLETED|Overall Study||15
2341112|NCT01723384|5747133|P1|COMPLETED|Overall Study||15
2341113|NCT01723384|5747132|P2|STARTED|Overall Study||15
2341114|NCT01723384|5747133|P1|STARTED|Overall Study||15
2341115|NCT01723254|5747151|P8|NOT COMPLETED|Overall Study||3
2341116|NCT01723254|5747152|P7|NOT COMPLETED|Overall Study||1
2341117|NCT01723254|5747153|P6|NOT COMPLETED|Overall Study||2
2341118|NCT01723254|5747154|P5|NOT COMPLETED|Overall Study||2
2341119|NCT01723254|5747155|P4|NOT COMPLETED|Overall Study||2
2341120|NCT01723254|5747156|P3|NOT COMPLETED|Overall Study||3
2341121|NCT01723254|5747157|P2|NOT COMPLETED|Overall Study||3
2341122|NCT01723254|5747158|P1|NOT COMPLETED|Overall Study||1
2341123|NCT01723254|5747151|P8|COMPLETED|Overall Study||60
2341124|NCT01723254|5747152|P7|COMPLETED|Overall Study||19
2341125|NCT01723254|5747153|P6|COMPLETED|Overall Study||18
2341126|NCT01723254|5747154|P5|COMPLETED|Overall Study||18
2341127|NCT01723254|5747155|P4|COMPLETED|Overall Study||18
2341128|NCT01723254|5747156|P3|COMPLETED|Overall Study||17
2341129|NCT01723254|5747157|P2|COMPLETED|Overall Study||18
2341130|NCT01723254|5747158|P1|COMPLETED|Overall Study||5
2341131|NCT01723254|5747151|P8|STARTED|Overall Study||63
2341132|NCT01723254|5747152|P7|STARTED|Overall Study||20
2341133|NCT01723254|5747153|P6|STARTED|Overall Study||20
2341134|NCT01723254|5747154|P5|STARTED|Overall Study||20
2341135|NCT01723254|5747155|P4|STARTED|Overall Study||20
2341136|NCT01723254|5747156|P3|STARTED|Overall Study||20
2341137|NCT01723254|5747157|P2|STARTED|Overall Study||21
2341138|NCT01723254|5747158|P1|STARTED|Overall Study||6
2341139|NCT01723228|5747210|P2|NOT COMPLETED|Overall Study||11
2341140|NCT01723228|5747211|P1|NOT COMPLETED|Overall Study||8
2341141|NCT01723228|5747210|P2|COMPLETED|Overall Study||73
2341142|NCT01723228|5747211|P1|COMPLETED|Overall Study||78
2341143|NCT01723228|5747210|P2|STARTED|Overall Study||84
2341144|NCT01723228|5747211|P1|STARTED|Overall Study||86
2341145|NCT01723163|5747229|P2|NOT COMPLETED|12-Month Follow-up||28
2341146|NCT01723163|5747230|P1|NOT COMPLETED|12-Month Follow-up||24
2341147|NCT01723163|5747229|P2|COMPLETED|12-Month Follow-up||119
2341148|NCT01723163|5747230|P1|COMPLETED|12-Month Follow-up||111
2341149|NCT01723163|5747229|P2|STARTED|12-Month Follow-up||147
2341150|NCT01723163|5747230|P1|STARTED|12-Month Follow-up||135
2341151|NCT01723163|5747229|P2|NOT COMPLETED|6-Month Follow-up||15
2341152|NCT01723163|5747230|P1|NOT COMPLETED|6-Month Follow-up||18
2341153|NCT01723163|5747229|P2|COMPLETED|6-Month Follow-up||132
2341154|NCT01723163|5747230|P1|COMPLETED|6-Month Follow-up||118
2341155|NCT01723163|5747229|P2|STARTED|6-Month Follow-up||147
2341156|NCT01723163|5747230|P1|STARTED|6-Month Follow-up||136
2341157|NCT01723163|5747229|P2|NOT COMPLETED|3-Month Follow-up||19
2341158|NCT01723163|5747230|P1|NOT COMPLETED|3-Month Follow-up||13
2341159|NCT01723163|5747229|P2|COMPLETED|3-Month Follow-up||128
2341160|NCT01723163|5747230|P1|COMPLETED|3-Month Follow-up||124
2341161|NCT01723163|5747229|P2|STARTED|3-Month Follow-up||147
2341162|NCT01723163|5747230|P1|STARTED|3-Month Follow-up||137
2341163|NCT01723163|5747229|P2|NOT COMPLETED|Treatment Phase||7
2341164|NCT01723163|5747230|P1|NOT COMPLETED|Treatment Phase||19
2341165|NCT01723163|5747229|P2|COMPLETED|Treatment Phase||147
2341166|NCT01723163|5747230|P1|COMPLETED|Treatment Phase||137
2341167|NCT01723163|5747229|P2|STARTED|Treatment Phase||154
2341168|NCT01723163|5747230|P1|STARTED|Treatment Phase||156
2341169|NCT01723163|5747229|P2|NOT COMPLETED|Baseline||0
2341170|NCT01723163|5747230|P1|NOT COMPLETED|Baseline||0
2341171|NCT01723163|5747229|P2|COMPLETED|Baseline||154
2341172|NCT01723163|5747230|P1|COMPLETED|Baseline||156
2341173|NCT01723163|5747229|P2|STARTED|Baseline||154
2341174|NCT01723163|5747230|P1|STARTED|Baseline||156
2341175|NCT01722994|5747238|P2|NOT COMPLETED|Overall Study||17
2341176|NCT01722994|5747239|P1|NOT COMPLETED|Overall Study||25
2341177|NCT01722994|5747238|P2|COMPLETED|Overall Study||31
2341178|NCT01722994|5747239|P1|COMPLETED|Overall Study||24
2341179|NCT01722994|5747238|P2|STARTED|Overall Study||48
2341180|NCT01722994|5747239|P1|STARTED|Overall Study||49
2341181|NCT01722929|5747253|P1|NOT COMPLETED|Overall Study||0
2341182|NCT01722929|5747253|P1|COMPLETED|Overall Study||4
2341183|NCT01722929|5747253|P1|STARTED|Overall Study||4
2341184|NCT01722877|5747258|P1|NOT COMPLETED|Overall Study||2
2341185|NCT01722877|5747258|P1|COMPLETED|Overall Study||27
2341186|NCT01722877|5747258|P1|STARTED|Overall Study||29
2341187|NCT01722734|5747268|P3|NOT COMPLETED|Overall Study||2
2341188|NCT01722734|5747269|P2|NOT COMPLETED|Overall Study||1
2341189|NCT01722734|5747270|P1|NOT COMPLETED|Overall Study||2
2341190|NCT01722734|5747268|P3|COMPLETED|Overall Study||307
2341191|NCT01722734|5747269|P2|COMPLETED|Overall Study||276
2341192|NCT01722734|5747270|P1|COMPLETED|Overall Study||552
2341193|NCT01722734|5747268|P3|STARTED|Overall Study||309
2341194|NCT01722734|5747269|P2|STARTED|Overall Study||277
2341195|NCT01722734|5747270|P1|STARTED|Overall Study||554
2341196|NCT01722643|5747280|P2|NOT COMPLETED|Overall Study||1
2341197|NCT01722643|5747281|P1|NOT COMPLETED|Overall Study||0
2341198|NCT01722643|5747280|P2|COMPLETED|Overall Study||30
2341199|NCT01722643|5747281|P1|COMPLETED|Overall Study||30
2341200|NCT01722643|5747280|P2|STARTED|Overall Study||31
2341201|NCT01722643|5747281|P1|STARTED|Overall Study||30
2341202|NCT01722552|5747289|P1|NOT COMPLETED|Overall Study||4
2341203|NCT01722552|5747289|P1|COMPLETED|Overall Study|Number of subjects who completed the intervention|116
2341204|NCT01722552|5747289|P1|STARTED|Overall Study|Number of subjects enrolled|120
2341205|NCT01722487|5747299|P2|NOT COMPLETED|Overall Study||7
2341206|NCT01722487|5747300|P1|NOT COMPLETED|Overall Study||2
2341207|NCT01722487|5747299|P2|COMPLETED|Overall Study|Participants who were still on study or died at study closure|126
2341208|NCT01722487|5747300|P1|COMPLETED|Overall Study|Participants who were still on study or died at study closure|134
2341209|NCT01722487|5747299|P2|STARTED|Overall Study||133
2341210|NCT01722487|5747300|P1|STARTED|Overall Study||136
2341211|NCT01722435|5747318|P1|NOT COMPLETED|Overall Study||0
2341212|NCT01722435|5747318|P1|COMPLETED|Overall Study||78
2341213|NCT01722435|5747318|P1|STARTED|Overall Study||78
2341214|NCT01722331|5747329|P7|NOT COMPLETED|Part 3||2
2341215|NCT01722331|5747330|P6|NOT COMPLETED|Part 3||3
2341216|NCT01722331|5747331|P5|NOT COMPLETED|Part 3||0
2341217|NCT01722331|5747332|P4|NOT COMPLETED|Part 3||1
2341218|NCT01722331|5747333|P3|NOT COMPLETED|Part 3||0
2341219|NCT01722331|5747334|P2|NOT COMPLETED|Part 3||17
2341220|NCT01722331|5747335|P1|NOT COMPLETED|Part 3||15
2341221|NCT01722331|5747329|P7|COMPLETED|Part 3||65
2341222|NCT01722331|5747330|P6|COMPLETED|Part 3||59
2341223|NCT01722331|5747331|P5|COMPLETED|Part 3||0
2341224|NCT01722331|5747332|P4|COMPLETED|Part 3||18
2341225|NCT01722331|5747333|P3|COMPLETED|Part 3||0
2341226|NCT01722331|5747334|P2|COMPLETED|Part 3||232
2341227|NCT01722331|5747335|P1|COMPLETED|Part 3||264
2341228|NCT01722331|5747329|P7|STARTED|Part 3||67
2341229|NCT01722331|5747330|P6|STARTED|Part 3||62
2341230|NCT01722331|5747331|P5|STARTED|Part 3||0
2341231|NCT01722331|5747332|P4|STARTED|Part 3||19
2341232|NCT01722331|5747333|P3|STARTED|Part 3||0
2341233|NCT01722331|5747334|P2|STARTED|Part 3||249
2341234|NCT01722331|5747335|P1|STARTED|Part 3||279
2341235|NCT01722331|5747329|P7|NOT COMPLETED|Part 2||7
2341236|NCT01722331|5747330|P6|NOT COMPLETED|Part 2||10
2341237|NCT01722331|5747331|P5|NOT COMPLETED|Part 2||0
2341238|NCT01722331|5747332|P4|NOT COMPLETED|Part 2||0
2341239|NCT01722331|5747333|P3|NOT COMPLETED|Part 2||31
2341240|NCT01722331|5747334|P2|NOT COMPLETED|Part 2||0
2341241|NCT01722331|5747335|P1|NOT COMPLETED|Part 2||19
2341242|NCT01722331|5747329|P7|COMPLETED|Part 2||67
2341243|NCT01722331|5747330|P6|COMPLETED|Part 2||62
2341244|NCT01722331|5747331|P5|COMPLETED|Part 2||0
2341245|NCT01722331|5747332|P4|COMPLETED|Part 2||19
2341246|NCT01722331|5747333|P3|COMPLETED|Part 2||0
2341247|NCT01722331|5747334|P2|COMPLETED|Part 2||249
2341248|NCT01722331|5747335|P1|COMPLETED|Part 2||279
2341249|NCT01722331|5747329|P7|STARTED|Part 2||74
2341250|NCT01722331|5747330|P6|STARTED|Part 2||72
2341251|NCT01722331|5747331|P5|STARTED|Part 2||0
2341252|NCT01722331|5747332|P4|STARTED|Part 2||19
2341253|NCT01722331|5747333|P3|STARTED|Part 2|1 participant who completed Part 1 did not enter Part 2|31
2341254|NCT01722331|5747334|P2|STARTED|Part 2||249
2341255|NCT01722331|5747335|P1|STARTED|Part 2||298
2341256|NCT01722331|5747329|P7|NOT COMPLETED|Part 1||0
2341257|NCT01722331|5747330|P6|NOT COMPLETED|Part 1||0
2341258|NCT01722331|5747331|P5|NOT COMPLETED|Part 1||9
2341259|NCT01722331|5747332|P4|NOT COMPLETED|Part 1||0
2341260|NCT01722331|5747333|P3|NOT COMPLETED|Part 1||9
2341261|NCT01722331|5747334|P2|NOT COMPLETED|Part 1||0
2341262|NCT01722331|5747335|P1|NOT COMPLETED|Part 1||10
2341263|NCT01722331|5747329|P7|COMPLETED|Part 1||74
2341264|NCT01722331|5747330|P6|COMPLETED|Part 1||72
2341265|NCT01722331|5747331|P5|COMPLETED|Part 1||0
2341266|NCT01722331|5747332|P4|COMPLETED|Part 1||19
2341267|NCT01722331|5747333|P3|COMPLETED|Part 1||32
2341268|NCT01722331|5747334|P2|COMPLETED|Part 1||249
2341269|NCT01722331|5747335|P1|COMPLETED|Part 1||298
2341270|NCT01722331|5747329|P7|STARTED|Part 1||74
2341271|NCT01722331|5747330|P6|STARTED|Part 1||72
2341272|NCT01722331|5747331|P5|STARTED|Part 1||9
2341273|NCT01722331|5747332|P4|STARTED|Part 1||19
2341274|NCT01722331|5747333|P3|STARTED|Part 1||41
2341275|NCT01722331|5747334|P2|STARTED|Part 1||249
2341276|NCT01722331|5747335|P1|STARTED|Part 1||308
2341277|NCT01722318|5747379|P5|NOT COMPLETED|Overall Study||18
2341278|NCT01722318|5747380|P4|NOT COMPLETED|Overall Study||20
2341279|NCT01722318|5747381|P3|NOT COMPLETED|Overall Study||20
2341280|NCT01722318|5747382|P2|NOT COMPLETED|Overall Study||20
2341281|NCT01722318|5747383|P1|NOT COMPLETED|Overall Study||14
2341282|NCT01722318|5747379|P5|COMPLETED|Overall Study||68
2341283|NCT01722318|5747380|P4|COMPLETED|Overall Study||65
2341284|NCT01722318|5747381|P3|COMPLETED|Overall Study||66
2341285|NCT01722318|5747382|P2|COMPLETED|Overall Study||65
2341286|NCT01722318|5747383|P1|COMPLETED|Overall Study||72
2341287|NCT01722318|5747379|P5|STARTED|Overall Study||86
2341288|NCT01722318|5747380|P4|STARTED|Overall Study||85
2341289|NCT01722318|5747381|P3|STARTED|Overall Study||86
2341290|NCT01722318|5747382|P2|STARTED|Overall Study||85
2341291|NCT01722318|5747383|P1|STARTED|Overall Study||86
2341292|NCT01722292|5747413|P3|NOT COMPLETED|Overall Study||0
2341293|NCT01722292|5747414|P2|NOT COMPLETED|Overall Study||0
2341294|NCT01722292|5747415|P1|NOT COMPLETED|Overall Study||0
2341295|NCT01722292|5747413|P3|COMPLETED|Overall Study||14
2341296|NCT01722292|5747414|P2|COMPLETED|Overall Study||6
2341297|NCT01722292|5747415|P1|COMPLETED|Overall Study||6
2341298|NCT01722292|5747413|P3|Received at Least One Dose of Study Drug|Overall Study||14
2341299|NCT01722292|5747414|P2|Received at Least One Dose of Study Drug|Overall Study||6
2341300|NCT01722292|5747415|P1|Received at Least One Dose of Study Drug|Overall Study||6
2341301|NCT01722292|5747413|P3|STARTED|Overall Study||14
2341302|NCT01722292|5747414|P2|STARTED|Overall Study||6
2341303|NCT01722292|5747415|P1|STARTED|Overall Study||6
2341304|NCT01722266|5747451|P4|NOT COMPLETED|Overall Study||0
2341305|NCT01722266|5747452|P3|NOT COMPLETED|Overall Study||5
2341306|NCT01722266|5747453|P2|NOT COMPLETED|Overall Study||3
2341307|NCT01722266|5747454|P1|NOT COMPLETED|Overall Study||1
2341308|NCT01722266|5747451|P4|COMPLETED|Overall Study|3 subjects randomized to 1.2 mg group and 1 to 1.8 mg group tolerated only 0.6 mg|18
2341309|NCT01722266|5747452|P3|COMPLETED|Overall Study||13
2341310|NCT01722266|5747453|P2|COMPLETED|Overall Study||15
2341311|NCT01722266|5747454|P1|COMPLETED|Overall Study||17
2341312|NCT01722266|5747451|P4|STARTED|Overall Study|3 withdrew consent; 1 dropped out due to nausea|18
2341313|NCT01722266|5747452|P3|STARTED|Overall Study||18
2341314|NCT01722266|5747453|P2|STARTED|Overall Study||18
2341315|NCT01722266|5747454|P1|STARTED|Overall Study||18
2341316|NCT01722162|5747482|P2|NOT COMPLETED|Overall Study||6
2341317|NCT01722162|5747483|P1|NOT COMPLETED|Overall Study||5
2341318|NCT01722162|5747482|P2|COMPLETED|Overall Study||18
2341319|NCT01722162|5747483|P1|COMPLETED|Overall Study||18
2341320|NCT01722162|5747482|P2|STARTED|Overall Study||24
2341321|NCT01722162|5747483|P1|STARTED|Overall Study||23
2341322|NCT01722097|5747493|P2|NOT COMPLETED|Overall Study||5
2341323|NCT01722097|5747494|P1|NOT COMPLETED|Overall Study||6
2341324|NCT01722097|5747493|P2|COMPLETED|Overall Study||50
2341325|NCT01722097|5747494|P1|COMPLETED|Overall Study||49
2341326|NCT01722097|5747493|P2|STARTED|Overall Study||55
2341327|NCT01722097|5747494|P1|STARTED|Overall Study||55
2341328|NCT01722071|5747502|P2|NOT COMPLETED|Overall Study||0
2341329|NCT01722071|5747503|P1|NOT COMPLETED|Overall Study||1
2341330|NCT01722071|5747502|P2|COMPLETED|Overall Study||10
2341331|NCT01722071|5747503|P1|COMPLETED|Overall Study||9
2341332|NCT01722071|5747502|P2|STARTED|Overall Study||10
2341333|NCT01722071|5747503|P1|STARTED|Overall Study||10
2341334|NCT01722045|5747509|P1|NOT COMPLETED|Overall Study||28
2341335|NCT01722045|5747509|P1|COMPLETED|Overall Study||126
2341336|NCT01722045|5747509|P1|STARTED|Overall Study||154
2341337|NCT01721967|5747519|P1|NOT COMPLETED|Overall Study||3
2341338|NCT01721967|5747519|P1|COMPLETED|Overall Study||11
2341339|NCT01721967|5747519|P1|STARTED|Overall Study||14
2341340|NCT01721954|5747530|P2|NOT COMPLETED|Overall Study||69
2341341|NCT01721954|5747531|P1|NOT COMPLETED|Overall Study||70
2341342|NCT01721954|5747530|P2|COMPLETED|Overall Study||35
2341343|NCT01721954|5747531|P1|COMPLETED|Overall Study||35
2341344|NCT01721954|5747530|P2|STARTED|Overall Study||104
2341345|NCT01721954|5747531|P1|STARTED|Overall Study||105
2341346|NCT01721837|5747539|P1|NOT COMPLETED|Overall Study||0
2341347|NCT01721837|5747539|P1|COMPLETED|Overall Study||2120
2341348|NCT01721837|5747539|P1|STARTED|Overall Study||2120
2341349|NCT01721772|5747545|P2|NOT COMPLETED|Overall Study||192
2341350|NCT01721772|5747546|P1|NOT COMPLETED|Overall Study||111
2341351|NCT01721772|5747545|P2|COMPLETED|Overall Study|Continuing in treatment period|13
2341352|NCT01721772|5747546|P1|COMPLETED|Overall Study|Continuing in treatment period|95
2341353|NCT01721772|5747545|P2|STARTED|Overall Study||205
2341354|NCT01721772|5747546|P1|STARTED|Overall Study||206
2341355|NCT01721759|5747566|P1|NOT COMPLETED|Overall Study||102
2341356|NCT01721759|5747566|P1|COMPLETED|Overall Study|Completed=continuing to receive treatment|15
2341357|NCT01721759|5747566|P1|STARTED|Overall Study||117
2341358|NCT01721746|5747574|P3|NOT COMPLETED|Follow-Up Period||0
2341359|NCT01721746|5747575|P2|NOT COMPLETED|Follow-Up Period||0
2341360|NCT01721746|5747576|P1|NOT COMPLETED|Follow-Up Period||0
2341361|NCT01721746|5747574|P3|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|19
2341362|NCT01721746|5747575|P2|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|11
2341363|NCT01721746|5747576|P1|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|92
2341364|NCT01721746|5747574|P3|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|19
2341458|NCT01721161|5747798|P1|STARTED|Overall Study||41
2341459|NCT01721109|5747821|P1|NOT COMPLETED|Overall Study||7
2341365|NCT01721746|5747575|P2|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|11
2341366|NCT01721746|5747576|P1|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|92
2341367|NCT01721746|5747574|P3|NOT COMPLETED|Treatment Period||57
2341368|NCT01721746|5747575|P2|NOT COMPLETED|Treatment Period||45
2341369|NCT01721746|5747576|P1|NOT COMPLETED|Treatment Period||233
2341370|NCT01721746|5747574|P3|COMPLETED|Treatment Period||0
2341371|NCT01721746|5747575|P2|COMPLETED|Treatment Period||0
2341372|NCT01721746|5747576|P1|COMPLETED|Treatment Period|Completed=Continuing in Treatment Period|35
2341373|NCT01721746|5747574|P3|STARTED|Treatment Period||57
2341374|NCT01721746|5747575|P2|STARTED|Treatment Period||45
2341375|NCT01721746|5747576|P1|STARTED|Treatment Period||268
2341376|NCT01721681|5747592|P1|NOT COMPLETED|Overall Study||0
2341377|NCT01721681|5747592|P1|COMPLETED|Overall Study||9
2341378|NCT01721681|5747592|P1|STARTED|Overall Study||9
2341379|NCT01721603|5747598|P1|NOT COMPLETED|Overall Study||0
2341380|NCT01721603|5747598|P1|COMPLETED|Overall Study||2
2341381|NCT01721603|5747598|P1|STARTED|Overall Study||2
2341382|NCT01721564|5747609|P1|NOT COMPLETED|Overall Study||0
2341383|NCT01721564|5747609|P1|COMPLETED|Overall Study||8
2341384|NCT01721564|5747609|P1|STARTED|Overall Study||8
2341385|NCT01721486|5747616|P2|NOT COMPLETED|Overall Study||1
2341386|NCT01721486|5747617|P1|NOT COMPLETED|Overall Study||1
2341387|NCT01721486|5747616|P2|COMPLETED|Overall Study||19
2341388|NCT01721486|5747617|P1|COMPLETED|Overall Study||20
2341389|NCT01721486|5747616|P2|STARTED|Overall Study||20
2341390|NCT01721486|5747617|P1|STARTED|Overall Study||21
2341391|NCT01721473|5747635|P6|NOT COMPLETED|Overall Study||0
2341392|NCT01721473|5747636|P5|NOT COMPLETED|Overall Study||0
2341393|NCT01721473|5747637|P4|NOT COMPLETED|Overall Study||0
2341394|NCT01721473|5747638|P3|NOT COMPLETED|Overall Study||0
2341395|NCT01721473|5747639|P2|NOT COMPLETED|Overall Study||0
2341396|NCT01721473|5747640|P1|NOT COMPLETED|Overall Study||0
2341397|NCT01721473|5747635|P6|COMPLETED|Overall Study||18
2341398|NCT01721473|5747636|P5|COMPLETED|Overall Study||22
2341399|NCT01721473|5747637|P4|COMPLETED|Overall Study||34
2341400|NCT01721473|5747638|P3|COMPLETED|Overall Study||41
2341401|NCT01721473|5747639|P2|COMPLETED|Overall Study||22
2341402|NCT01721473|5747640|P1|COMPLETED|Overall Study||47
2341403|NCT01721473|5747635|P6|STARTED|Overall Study||18
2341404|NCT01721473|5747636|P5|STARTED|Overall Study||22
2341405|NCT01721473|5747637|P4|STARTED|Overall Study||34
2341406|NCT01721473|5747638|P3|STARTED|Overall Study||41
2341407|NCT01721473|5747639|P2|STARTED|Overall Study||22
2341408|NCT01721473|5747640|P1|STARTED|Overall Study||47
2341409|NCT01721460|5747649|P1|NOT COMPLETED|Overall Study||1
2341410|NCT01721460|5747649|P1|COMPLETED|Overall Study||5
2341411|NCT01721460|5747649|P1|STARTED|Overall Study||6
2341412|NCT01721447|5747656|P1|NOT COMPLETED|Overall Study||0
2341413|NCT01721447|5747656|P1|COMPLETED|Overall Study||100
2341414|NCT01721447|5747656|P1|STARTED|Overall Study||100
2341415|NCT01721408|5747665|P2|NOT COMPLETED|Overall Study||24
2341416|NCT01721408|5747666|P1|NOT COMPLETED|Overall Study||36
2341417|NCT01721408|5747665|P2|COMPLETED|Overall Study||207
2341418|NCT01721408|5747666|P1|COMPLETED|Overall Study||196
2341419|NCT01721408|5747665|P2|STARTED|Overall Study|Number of participants treated.|231
2341420|NCT01721408|5747666|P1|STARTED|Overall Study|Number of participants treated.|232
2341421|NCT01721330|5747682|P2|NOT COMPLETED|Overall Study||1
2341422|NCT01721330|5747683|P1|NOT COMPLETED|Overall Study||0
2341423|NCT01721330|5747682|P2|COMPLETED|Overall Study||1
2341424|NCT01721330|5747683|P1|COMPLETED|Overall Study||1
2341425|NCT01721330|5747682|P2|STARTED|Overall Study||2
2341426|NCT01721330|5747683|P1|STARTED|Overall Study||1
2341427|NCT01721317|5747691|P2|NOT COMPLETED|Overall Study||4
2341428|NCT01721317|5747692|P1|NOT COMPLETED|Overall Study||2
2341429|NCT01721317|5747691|P2|COMPLETED|Overall Study||0
2341430|NCT01721317|5747692|P1|COMPLETED|Overall Study||0
2341431|NCT01721317|5747691|P2|STARTED|Overall Study||4
2341432|NCT01721317|5747692|P1|STARTED|Overall Study||2
2341433|NCT01721226|5747760|P2|NOT COMPLETED|Overall Study||7
2341434|NCT01721226|5747761|P1|NOT COMPLETED|Overall Study||5
2341435|NCT01721226|5747760|P2|COMPLETED|Overall Study||50
2341436|NCT01721226|5747761|P1|COMPLETED|Overall Study||50
2341437|NCT01721226|5747760|P2|Week 24|Overall Study||50
2341438|NCT01721226|5747761|P1|Week 24|Overall Study||50
2341439|NCT01721226|5747760|P2|Week 12|Overall Study||53
2341440|NCT01721226|5747761|P1|Week 12|Overall Study||48
2341441|NCT01721226|5747760|P2|Baseline|Overall Study||57
2341442|NCT01721226|5747761|P1|Baseline|Overall Study||53
2341443|NCT01721226|5747760|P2|STARTED|Overall Study||57
2341444|NCT01721226|5747761|P1|STARTED|Overall Study||55
2341445|NCT01721200|5747771|P2|NOT COMPLETED|Overall Study||5
2341446|NCT01721200|5747772|P1|NOT COMPLETED|Overall Study||3
2341447|NCT01721200|5747771|P2|COMPLETED|Overall Study||58
2341448|NCT01721200|5747772|P1|COMPLETED|Overall Study||59
2341449|NCT01721200|5747771|P2|Completed 2 Week Follow-up|Overall Study||61
2341450|NCT01721200|5747772|P1|Completed 2 Week Follow-up|Overall Study||60
2341451|NCT01721200|5747771|P2|STARTED|Overall Study||63
2341452|NCT01721200|5747772|P1|STARTED|Overall Study||62
2341453|NCT01721161|5747797|P2|NOT COMPLETED|Overall Study||7
2341454|NCT01721161|5747798|P1|NOT COMPLETED|Overall Study||4
2341455|NCT01721161|5747797|P2|COMPLETED|Overall Study||34
2341456|NCT01721161|5747798|P1|COMPLETED|Overall Study||37
2341457|NCT01721161|5747797|P2|STARTED|Overall Study||41
2341460|NCT01721109|5747821|P1|COMPLETED|Overall Study|34 participants transitioned to commercial Stribild or to an individual patient use (IPU) program|43
2341461|NCT01721109|5747821|P1|STARTED|Overall Study||50
2341462|NCT01721096|5747836|P2|NOT COMPLETED|Overall Study||204
2341463|NCT01721096|5747837|P1|NOT COMPLETED|Overall Study||320
2341464|NCT01721096|5747836|P2|COMPLETED|Overall Study||9
2341465|NCT01721096|5747837|P1|COMPLETED|Overall Study||3
2341466|NCT01721096|5747836|P2|STARTED|Overall Study||213
2341467|NCT01721096|5747837|P1|STARTED|Overall Study||323
2341468|NCT01721070|5748016|P1|NOT COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||1
2341469|NCT01721070|5748016|P1|COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||18
2341470|NCT01721070|5748016|P1|STARTED|Ketoconazole 400 mg and SUF NT 15 mcg||19
2341471|NCT01721070|5748016|P1|NOT COMPLETED|SUF NT 15 mcg||0
2341472|NCT01721070|5748016|P1|COMPLETED|SUF NT 15 mcg||19
2341473|NCT01721070|5748016|P1|STARTED|SUF NT 15 mcg||19
2341474|NCT01721057|5748027|P7|NOT COMPLETED|Follow Up||0
2341475|NCT01721057|5748028|P6|NOT COMPLETED|Follow Up||0
2341476|NCT01721057|5748029|P5|NOT COMPLETED|Follow Up||0
2341477|NCT01721057|5748030|P4|NOT COMPLETED|Follow Up||0
2341478|NCT01721057|5748031|P3|NOT COMPLETED|Follow Up||0
2341479|NCT01721057|5748032|P2|NOT COMPLETED|Follow Up||0
2341480|NCT01721057|5748033|P1|NOT COMPLETED|Follow Up||0
2341481|NCT01721057|5748027|P7|COMPLETED|Follow Up||22
2341482|NCT01721057|5748028|P6|COMPLETED|Follow Up||19
2341483|NCT01721057|5748029|P5|COMPLETED|Follow Up||17
2341484|NCT01721057|5748030|P4|COMPLETED|Follow Up||0
2341485|NCT01721057|5748031|P3|COMPLETED|Follow Up||0
2341486|NCT01721057|5748032|P2|COMPLETED|Follow Up||0
2341487|NCT01721057|5748033|P1|COMPLETED|Follow Up||0
2341488|NCT01721057|5748027|P7|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|22
2341489|NCT01721057|5748028|P6|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
2341490|NCT01721057|5748029|P5|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|17
2341491|NCT01721057|5748030|P4|STARTED|Follow Up|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4 mg FollowUp|0
2341492|NCT01721057|5748031|P3|STARTED|Follow Up||0
2341493|NCT01721057|5748032|P2|STARTED|Follow Up||0
2341494|NCT01721057|5748033|P1|STARTED|Follow Up||0
2341495|NCT01721057|5748027|P7|NOT COMPLETED|Rescue Period||0
2341496|NCT01721057|5748028|P6|NOT COMPLETED|Rescue Period||0
2341497|NCT01721057|5748029|P5|NOT COMPLETED|Rescue Period||0
2341498|NCT01721057|5748030|P4|NOT COMPLETED|Rescue Period||3
2341499|NCT01721057|5748031|P3|NOT COMPLETED|Rescue Period||0
2341500|NCT01721057|5748032|P2|NOT COMPLETED|Rescue Period||0
2341501|NCT01721057|5748033|P1|NOT COMPLETED|Rescue Period||0
2341502|NCT01721057|5748027|P7|COMPLETED|Rescue Period||0
2341503|NCT01721057|5748028|P6|COMPLETED|Rescue Period||0
2341504|NCT01721057|5748029|P5|COMPLETED|Rescue Period||0
2341505|NCT01721057|5748030|P4|COMPLETED|Rescue Period||88
2341506|NCT01721057|5748031|P3|COMPLETED|Rescue Period||0
2341507|NCT01721057|5748032|P2|COMPLETED|Rescue Period||0
2341508|NCT01721057|5748033|P1|COMPLETED|Rescue Period||0
2341509|NCT01721057|5748027|P7|STARTED|Rescue Period||0
2341510|NCT01721057|5748028|P6|STARTED|Rescue Period||0
2341511|NCT01721057|5748029|P5|STARTED|Rescue Period||0
2341512|NCT01721057|5748030|P4|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|91
2341513|NCT01721057|5748031|P3|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
2341514|NCT01721057|5748032|P2|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
2341515|NCT01721057|5748033|P1|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
2341516|NCT01721057|5748027|P7|NOT COMPLETED|Treatment Period||0
2341517|NCT01721057|5748028|P6|NOT COMPLETED|Treatment Period||0
2341518|NCT01721057|5748029|P5|NOT COMPLETED|Treatment Period||0
2341519|NCT01721057|5748030|P4|NOT COMPLETED|Treatment Period||0
2341520|NCT01721057|5748031|P3|NOT COMPLETED|Treatment Period||23
2341521|NCT01721057|5748032|P2|NOT COMPLETED|Treatment Period||19
2341522|NCT01721057|5748033|P1|NOT COMPLETED|Treatment Period||28
2341523|NCT01721057|5748027|P7|COMPLETED|Treatment Period||0
2341524|NCT01721057|5748028|P6|COMPLETED|Treatment Period||0
2341525|NCT01721057|5748029|P5|COMPLETED|Treatment Period||0
2341526|NCT01721057|5748030|P4|COMPLETED|Treatment Period||0
2341527|NCT01721057|5748031|P3|COMPLETED|Treatment Period|"Completers include rescued participants."|204
2341528|NCT01721057|5748032|P2|COMPLETED|Treatment Period|"Completers include rescued participants."|210
2341529|NCT01721057|5748033|P1|COMPLETED|Treatment Period|"Completers include rescued participants."|200
2341530|NCT01721057|5748027|P7|Rescued|Treatment Period||0
2341531|NCT01721057|5748028|P6|Rescued|Treatment Period||0
2341532|NCT01721057|5748029|P5|Rescued|Treatment Period||0
2341533|NCT01721057|5748030|P4|Rescued|Treatment Period||0
2341534|NCT01721057|5748031|P3|Rescued|Treatment Period||15
2341535|NCT01721057|5748032|P2|Rescued|Treatment Period||21
2341536|NCT01721057|5748033|P1|Rescued|Treatment Period||55
2341537|NCT01721057|5748027|P7|Received at Least 1 Dose of Study Drug|Treatment Period||0
2341538|NCT01721057|5748028|P6|Received at Least 1 Dose of Study Drug|Treatment Period||0
2341539|NCT01721057|5748029|P5|Received at Least 1 Dose of Study Drug|Treatment Period||0
2341540|NCT01721057|5748030|P4|Received at Least 1 Dose of Study Drug|Treatment Period||0
2341541|NCT01721057|5748031|P3|Received at Least 1 Dose of Study Drug|Treatment Period||227
2341542|NCT01721057|5748032|P2|Received at Least 1 Dose of Study Drug|Treatment Period||229
2341543|NCT01721057|5748033|P1|Received at Least 1 Dose of Study Drug|Treatment Period||228
2341544|NCT01721057|5748027|P7|STARTED|Treatment Period||0
2341545|NCT01721057|5748028|P6|STARTED|Treatment Period||0
2341546|NCT01721057|5748029|P5|STARTED|Treatment Period||0
2341547|NCT01721057|5748030|P4|STARTED|Treatment Period||0
2341548|NCT01721057|5748031|P3|STARTED|Treatment Period||227
2341549|NCT01721057|5748032|P2|STARTED|Treatment Period||229
2341550|NCT01721057|5748033|P1|STARTED|Treatment Period||228
2341551|NCT01721044|5748106|P3|NOT COMPLETED|Follow Up||0
2341552|NCT01721044|5748107|P2|NOT COMPLETED|Follow Up||0
2341553|NCT01721044|5748108|P1|NOT COMPLETED|Follow Up||0
2341554|NCT01721044|5748106|P3|COMPLETED|Follow Up||20
2341555|NCT01721044|5748107|P2|COMPLETED|Follow Up||9
2341556|NCT01721044|5748108|P1|COMPLETED|Follow Up||19
2341557|NCT01721044|5748106|P3|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|20
2341558|NCT01721044|5748107|P2|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|9
2341559|NCT01721044|5748108|P1|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
2341560|NCT01721044|5748106|P3|NOT COMPLETED|Treatment Period||19
2341561|NCT01721044|5748107|P2|NOT COMPLETED|Treatment Period||17
2341562|NCT01721044|5748108|P1|NOT COMPLETED|Treatment Period||32
2341563|NCT01721044|5748106|P3|COMPLETED|Treatment Period||158
2341564|NCT01721044|5748107|P2|COMPLETED|Treatment Period||157
2341565|NCT01721044|5748108|P1|COMPLETED|Treatment Period||144
2341566|NCT01721044|5748106|P3|Rescue Week 16-24|Treatment Period||33
2341567|NCT01721044|5748107|P2|Rescue Week 16-24|Treatment Period||38
2341568|NCT01721044|5748108|P1|Rescue Week 16-24|Treatment Period||56
2341569|NCT01721044|5748106|P3|STARTED|Treatment Period||177
2341570|NCT01721044|5748107|P2|STARTED|Treatment Period|Randomized to 4mg (N=11) but received 2mg due to moderate renal impairment were included in 4mg arm|174
2341571|NCT01721044|5748108|P1|STARTED|Treatment Period||176
2341572|NCT01720797|5748181|P2|NOT COMPLETED|Overall Study||0
2341573|NCT01720797|5748182|P1|NOT COMPLETED|Overall Study||3
2341574|NCT01720797|5748181|P2|COMPLETED|Overall Study||9
2341575|NCT01720797|5748182|P1|COMPLETED|Overall Study||9
2341576|NCT01720797|5748181|P2|STARTED|Overall Study||9
2341577|NCT01720797|5748182|P1|STARTED|Overall Study||12
2341578|NCT01720667|5748190|P2|NOT COMPLETED|Overall Study||1
2341579|NCT01720667|5748191|P1|NOT COMPLETED|Overall Study||4
2341580|NCT01720667|5748190|P2|COMPLETED|Overall Study||41
2341581|NCT01720667|5748191|P1|COMPLETED|Overall Study||60
2341582|NCT01720667|5748190|P2|Modified ITT|Overall Study||30
2341583|NCT01720667|5748191|P1|Modified ITT|Overall Study||53
2341584|NCT01720667|5748190|P2|Received 2nd Infusion of Alternate Drug|Overall Study||6
2341585|NCT01720667|5748191|P1|Received 2nd Infusion of Alternate Drug|Overall Study||27
2341586|NCT01720667|5748190|P2|Recieved Alternate Intervention|Overall Study||10
2341587|NCT01720667|5748191|P1|Recieved Alternate Intervention|Overall Study||45
2341588|NCT01720667|5748190|P2|Recieved Second Infusion of Same Drug|Overall Study||20
2341589|NCT01720667|5748191|P1|Recieved Second Infusion of Same Drug|Overall Study||50
2341590|NCT01720667|5748190|P2|STARTED|Overall Study||42
2341591|NCT01720667|5748191|P1|STARTED|Overall Study||64
2341592|NCT01720602|5748205|P1|NOT COMPLETED|Overall Study||5
2341593|NCT01720602|5748205|P1|COMPLETED|Overall Study||10
2341594|NCT01720602|5748205|P1|STARTED|Overall Study||15
2341595|NCT01720446|5748217|P4|NOT COMPLETED|Overall Study||20
2341596|NCT01720446|5748218|P3|NOT COMPLETED|Overall Study||20
2341597|NCT01720446|5748219|P2|NOT COMPLETED|Overall Study||11
2341598|NCT01720446|5748220|P1|NOT COMPLETED|Overall Study||14
2341599|NCT01720446|5748217|P4|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|805
2341600|NCT01720446|5748218|P3|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|804
2341601|NCT01720446|5748219|P2|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|811
2341602|NCT01720446|5748220|P1|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|812
2341603|NCT01720446|5748217|P4|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|159
2341604|NCT01720446|5748218|P3|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|151
2341605|NCT01720446|5748219|P2|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|186
2341606|NCT01720446|5748220|P1|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|164
2341607|NCT01720446|5748217|P4|STARTED|Overall Study||825
2341608|NCT01720446|5748218|P3|STARTED|Overall Study||824
2341609|NCT01720446|5748219|P2|STARTED|Overall Study||822
2341610|NCT01720446|5748220|P1|STARTED|Overall Study||826
2341611|NCT01720316|5748281|P2|NOT COMPLETED|Open-label Glycine||0
2341612|NCT01720316|5748282|P1|NOT COMPLETED|Open-label Glycine||0
2341613|NCT01720316|5748281|P2|COMPLETED|Open-label Glycine||1
2341614|NCT01720316|5748282|P1|COMPLETED|Open-label Glycine||1
2341615|NCT01720316|5748281|P2|STARTED|Open-label Glycine||1
2341616|NCT01720316|5748282|P1|STARTED|Open-label Glycine||1
2341617|NCT01720316|5748281|P2|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
2341618|NCT01720316|5748282|P1|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
2341619|NCT01720316|5748281|P2|COMPLETED|Double-Blind Glycine Placebo Crossover||1
2341620|NCT01720316|5748282|P1|COMPLETED|Double-Blind Glycine Placebo Crossover||1
2341621|NCT01720316|5748281|P2|STARTED|Double-Blind Glycine Placebo Crossover||1
2341622|NCT01720316|5748282|P1|STARTED|Double-Blind Glycine Placebo Crossover||1
2341623|NCT01720277|5748330|P2|NOT COMPLETED|Overall Study||558
2341624|NCT01720277|5748331|P1|NOT COMPLETED|Overall Study||503
2341625|NCT01720277|5748330|P2|COMPLETED|Overall Study|intent-to-treat approach|938
2341626|NCT01720277|5748331|P1|COMPLETED|Overall Study|intent-to-treat approach|958
2341627|NCT01720277|5748330|P2|STARTED|Overall Study||1496
2341628|NCT01720277|5748331|P1|STARTED|Overall Study||1461
2341629|NCT01720264|5748341|P1|NOT COMPLETED|Post-transplant (Day 16) to 1 Year||12
2341630|NCT01720264|5748341|P1|COMPLETED|Post-transplant (Day 16) to 1 Year||2
2341631|NCT01720264|5748341|P1|STARTED|Post-transplant (Day 16) to 1 Year||14
2341632|NCT01720264|5748341|P1|NOT COMPLETED|Transplant With Sitagliptin for 15 Days||1
2341633|NCT01720264|5748341|P1|COMPLETED|Transplant With Sitagliptin for 15 Days||14
2341634|NCT01720264|5748341|P1|STARTED|Transplant With Sitagliptin for 15 Days||15
2341635|NCT01720251|5748351|P3|NOT COMPLETED|Overall Study||0
2341636|NCT01720251|5748352|P2|NOT COMPLETED|Overall Study||2
2341637|NCT01720251|5748353|P1|NOT COMPLETED|Overall Study||1
2341638|NCT01720251|5748351|P3|COMPLETED|Overall Study||82
2341639|NCT01720251|5748352|P2|COMPLETED|Overall Study||77
2341640|NCT01720251|5748353|P1|COMPLETED|Overall Study||78
2341641|NCT01720251|5748351|P3|STARTED|Overall Study||82
2341642|NCT01720251|5748352|P2|STARTED|Overall Study||79
2341643|NCT01720251|5748353|P1|STARTED|Overall Study||79
2341644|NCT01720173|5748361|P1|NOT COMPLETED|Overall Study||0
2341645|NCT01720173|5748361|P1|COMPLETED|Overall Study||30
2341646|NCT01720173|5748361|P1|STARTED|Overall Study||30
2341647|NCT01720043|5748369|P1|NOT COMPLETED|Overall Study||1
2341648|NCT01720043|5748369|P1|COMPLETED|Overall Study||7
2341649|NCT01720043|5748369|P1|STARTED|Overall Study||8
2341650|NCT01719900|5748375|P2|NOT COMPLETED|Overall Study||2
2341651|NCT01719900|5748376|P1|NOT COMPLETED|Overall Study||7
2341652|NCT01719900|5748375|P2|COMPLETED|Overall Study||22
2341653|NCT01719900|5748376|P1|COMPLETED|Overall Study||22
2341654|NCT01719900|5748375|P2|STARTED|Overall Study||24
2341655|NCT01719900|5748376|P1|STARTED|Overall Study||29
2341656|NCT01719861|5748398|P1|NOT COMPLETED|Cycle 2||1
2341657|NCT01719861|5748398|P1|COMPLETED|Cycle 2||1
2341658|NCT01719861|5748398|P1|STARTED|Cycle 2||2
2341659|NCT01719861|5748398|P1|NOT COMPLETED|Cycle 1||4
2341660|NCT01719861|5748398|P1|COMPLETED|Cycle 1||2
2341661|NCT01719861|5748398|P1|STARTED|Cycle 1||6
2341662|NCT01719783|5748408|P2|NOT COMPLETED|Dose 2||0
2341663|NCT01719783|5748409|P1|NOT COMPLETED|Dose 2||1
2341664|NCT01719783|5748408|P2|COMPLETED|Dose 2||10
2341665|NCT01719783|5748409|P1|COMPLETED|Dose 2||29
2341666|NCT01719783|5748408|P2|STARTED|Dose 2||10
2341667|NCT01719783|5748409|P1|STARTED|Dose 2||30
2341668|NCT01719783|5748408|P2|NOT COMPLETED|Dose 1||0
2341669|NCT01719783|5748409|P1|NOT COMPLETED|Dose 1||0
2341670|NCT01719783|5748408|P2|COMPLETED|Dose 1||10
2341671|NCT01719783|5748409|P1|COMPLETED|Dose 1||30
2341672|NCT01719783|5748408|P2|STARTED|Dose 1||10
2341673|NCT01719783|5748409|P1|STARTED|Dose 1||30
2341674|NCT01719757|5748495|P1|NOT COMPLETED|Overall Study||101
2341675|NCT01719757|5748495|P1|COMPLETED|Overall Study||258
2341676|NCT01719757|5748495|P1|STARTED|Overall Study||359
2341677|NCT01719744|5748503|P1|NOT COMPLETED|Overall Study||0
2341678|NCT01719744|5748503|P1|COMPLETED|Overall Study||25
2341679|NCT01719744|5748503|P1|STARTED|Overall Study||25
2341680|NCT01719653|5748514|P5|NOT COMPLETED|Overall Study||21
2341681|NCT01719653|5748515|P4|NOT COMPLETED|Overall Study||18
2341682|NCT01719653|5748516|P3|NOT COMPLETED|Overall Study||18
2341683|NCT01719653|5748517|P2|NOT COMPLETED|Overall Study||13
2341684|NCT01719653|5748518|P1|NOT COMPLETED|Overall Study||9
2341685|NCT01719653|5748514|P5|COMPLETED|Overall Study||200
2341686|NCT01719653|5748515|P4|COMPLETED|Overall Study||200
2341687|NCT01719653|5748516|P3|COMPLETED|Overall Study||200
2341688|NCT01719653|5748517|P2|COMPLETED|Overall Study||200
2341689|NCT01719653|5748518|P1|COMPLETED|Overall Study||200
2341690|NCT01719653|5748514|P5|STARTED|Overall Study||221
2341691|NCT01719653|5748515|P4|STARTED|Overall Study||218
2341692|NCT01719653|5748516|P3|STARTED|Overall Study||218
2341693|NCT01719653|5748517|P2|STARTED|Overall Study||213
2341694|NCT01719653|5748518|P1|STARTED|Overall Study||209
2341695|NCT01719367|5748540|P2|NOT COMPLETED|Overall Study||0
2341696|NCT01719367|5748541|P1|NOT COMPLETED|Overall Study||0
2341697|NCT01719367|5748540|P2|COMPLETED|Overall Study||19
2341698|NCT01719367|5748541|P1|COMPLETED|Overall Study||19
2341699|NCT01719367|5748540|P2|STARTED|Overall Study||19
2341700|NCT01719367|5748541|P1|STARTED|Overall Study||19
2341701|NCT01719224|5748549|P2|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0
2341702|NCT01719224|5748550|P1|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0
2341703|NCT01719224|5748549|P2|COMPLETED|Intervention 2: Position Change(At 3.5h)||16
2341704|NCT01719224|5748550|P1|COMPLETED|Intervention 2: Position Change(At 3.5h)||14
2341705|NCT01719224|5748549|P2|STARTED|Intervention 2: Position Change(At 3.5h)||16
2341706|NCT01719224|5748550|P1|STARTED|Intervention 2: Position Change(At 3.5h)||14
2341707|NCT01719224|5748549|P2|NOT COMPLETED|Intervention 1: Sleeping Position 1||2
2341708|NCT01719224|5748550|P1|NOT COMPLETED|Intervention 1: Sleeping Position 1||4
2341709|NCT01719224|5748549|P2|COMPLETED|Intervention 1: Sleeping Position 1||16
2341710|NCT01719224|5748550|P1|COMPLETED|Intervention 1: Sleeping Position 1||14
2341711|NCT01719224|5748549|P2|STARTED|Intervention 1: Sleeping Position 1||18
2341712|NCT01719224|5748550|P1|STARTED|Intervention 1: Sleeping Position 1||18
2341713|NCT01719172|5748559|P1|NOT COMPLETED|Overall Study||2
2341714|NCT01719172|5748559|P1|COMPLETED|Overall Study||28
2341715|NCT01719172|5748559|P1|STARTED|Overall Study||30
2341716|NCT01719003|5748573|P9|NOT COMPLETED|Overall Study||4
2341717|NCT01719003|5748574|P8|NOT COMPLETED|Overall Study||20
2341718|NCT01719003|5748575|P7|NOT COMPLETED|Overall Study||20
2341719|NCT01719003|5748576|P6|NOT COMPLETED|Overall Study||12
2341720|NCT01719003|5748577|P5|NOT COMPLETED|Overall Study||17
2341721|NCT01719003|5748578|P4|NOT COMPLETED|Overall Study||13
2341722|NCT01719003|5748579|P3|NOT COMPLETED|Overall Study||17
2341723|NCT01719003|5748580|P2|NOT COMPLETED|Overall Study||17
2341724|NCT01719003|5748581|P1|NOT COMPLETED|Overall Study||9
2341725|NCT01719003|5748573|P9|COMPLETED|Overall Study||49
2341726|NCT01719003|5748574|P8|COMPLETED|Overall Study||151
2341727|NCT01719003|5748575|P7|COMPLETED|Overall Study||150
2341728|NCT01719003|5748576|P6|COMPLETED|Overall Study||160
2341729|NCT01719003|5748577|P5|COMPLETED|Overall Study||150
2341730|NCT01719003|5748578|P4|COMPLETED|Overall Study||156
2341731|NCT01719003|5748579|P3|COMPLETED|Overall Study||154
2341732|NCT01719003|5748580|P2|COMPLETED|Overall Study||153
2341733|NCT01719003|5748581|P1|COMPLETED|Overall Study||161
2341734|NCT01719003|5748573|P9|STARTED|Overall Study||53
2341735|NCT01719003|5748574|P8|STARTED|Overall Study||171
2341736|NCT01719003|5748575|P7|STARTED|Overall Study||170
2341737|NCT01719003|5748576|P6|STARTED|Overall Study||172
2341738|NCT01719003|5748577|P5|STARTED|Overall Study||167
2341739|NCT01719003|5748578|P4|STARTED|Overall Study||169
2341740|NCT01719003|5748579|P3|STARTED|Overall Study||171
2341741|NCT01719003|5748580|P2|STARTED|Overall Study||170
2341742|NCT01719003|5748581|P1|STARTED|Overall Study||170
2341743|NCT01718691|5748618|P2|NOT COMPLETED|Overall Study||1
2341744|NCT01718691|5748619|P1|NOT COMPLETED|Overall Study||18
2341745|NCT01718691|5748618|P2|COMPLETED|Overall Study||9
2341746|NCT01718691|5748619|P1|COMPLETED|Overall Study||42
2341747|NCT01718691|5748618|P2|STARTED|Overall Study||10
2341748|NCT01718691|5748619|P1|STARTED|Overall Study||60
2341749|NCT01718535|5748662|P10|NOT COMPLETED|Overall Study||0
2341750|NCT01718535|5748663|P9|NOT COMPLETED|Overall Study||0
2341751|NCT01718535|5748664|P8|NOT COMPLETED|Overall Study||0
2341752|NCT01718535|5748665|P7|NOT COMPLETED|Overall Study||0
2341753|NCT01718535|5748666|P6|NOT COMPLETED|Overall Study||0
2341754|NCT01718535|5748667|P5|NOT COMPLETED|Overall Study||0
2341755|NCT01718535|5748668|P4|NOT COMPLETED|Overall Study||1
2341756|NCT01718535|5748669|P3|NOT COMPLETED|Overall Study||0
2341757|NCT01718535|5748670|P2|NOT COMPLETED|Overall Study||0
2341758|NCT01718535|5748671|P1|NOT COMPLETED|Overall Study||1
2341759|NCT01718535|5748662|P10|COMPLETED|Overall Study||1
2341760|NCT01718535|5748663|P9|COMPLETED|Overall Study||15
2341761|NCT01718535|5748664|P8|COMPLETED|Overall Study||6
2341762|NCT01718535|5748665|P7|COMPLETED|Overall Study||11
2341763|NCT01718535|5748666|P6|COMPLETED|Overall Study||40
2341764|NCT01718535|5748667|P5|COMPLETED|Overall Study||1
2341765|NCT01718535|5748668|P4|COMPLETED|Overall Study||7
2341766|NCT01718535|5748669|P3|COMPLETED|Overall Study||19
2341767|NCT01718535|5748670|P2|COMPLETED|Overall Study||95
2341768|NCT01718535|5748671|P1|COMPLETED|Overall Study||130
2341769|NCT01718535|5748662|P10|First Pass|Overall Study||1
2341770|NCT01718535|5748663|P9|First Pass|Overall Study||15
2341771|NCT01718535|5748664|P8|First Pass|Overall Study||6
2341772|NCT01718535|5748665|P7|First Pass|Overall Study||11
2341773|NCT01718535|5748666|P6|First Pass|Overall Study||39
2341774|NCT01718535|5748667|P5|First Pass|Overall Study||1
2341775|NCT01718535|5748668|P4|First Pass|Overall Study||7
2341776|NCT01718535|5748669|P3|First Pass|Overall Study||19
2341777|NCT01718535|5748670|P2|First Pass|Overall Study||94
2341778|NCT01718535|5748671|P1|First Pass|Overall Study||128
2341779|NCT01718535|5748662|P10|STARTED|Overall Study||1
2341780|NCT01718535|5748663|P9|STARTED|Overall Study||15
2341781|NCT01718535|5748664|P8|STARTED|Overall Study||6
2341782|NCT01718535|5748665|P7|STARTED|Overall Study||11
2341783|NCT01718535|5748666|P6|STARTED|Overall Study||40
2341784|NCT01718535|5748667|P5|STARTED|Overall Study||1
2341785|NCT01718535|5748668|P4|STARTED|Overall Study||8
2341786|NCT01718535|5748669|P3|STARTED|Overall Study||19
2341787|NCT01718535|5748670|P2|STARTED|Overall Study||95
2341788|NCT01718535|5748671|P1|STARTED|Overall Study||131
2341789|NCT01718522|5748693|P1|NOT COMPLETED|Overall Study||8
2341790|NCT01718522|5748693|P1|COMPLETED|Overall Study||67
2341791|NCT01718522|5748693|P1|STARTED|Overall Study||75
2341792|NCT01718509|5748709|P2|NOT COMPLETED|Overall Study||48
2341793|NCT01718509|5748710|P1|NOT COMPLETED|Overall Study||48
2341794|NCT01718509|5748709|P2|COMPLETED|Overall Study||147
2341795|NCT01718509|5748710|P1|COMPLETED|Overall Study||147
2341796|NCT01718509|5748709|P2|STARTED|Overall Study||195
2341797|NCT01718509|5748710|P1|STARTED|Overall Study||195
2341798|NCT01718483|5748756|P2|NOT COMPLETED|Overall Study||34
2341799|NCT01718483|5748757|P1|NOT COMPLETED|Overall Study||34
2341800|NCT01718483|5748756|P2|COMPLETED|Overall Study||158
2341801|NCT01718483|5748757|P1|COMPLETED|Overall Study||157
2341802|NCT01718483|5748756|P2|Treated|Overall Study||192
2341803|NCT01718483|5748757|P1|Treated|Overall Study||187
2341804|NCT01718483|5748756|P2|STARTED|Overall Study||192
2341805|NCT01718483|5748757|P1|STARTED|Overall Study||191
2341806|NCT01718353|5748803|P2|NOT COMPLETED|Overall Study||5
2341807|NCT01718353|5748804|P1|NOT COMPLETED|Overall Study||12
2341808|NCT01718353|5748803|P2|COMPLETED|Overall Study|Participants at study cut-off, AE, DP and consent withdrawn were considered completed.|17
2341887|NCT01717768|5748988|P4|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
2341809|NCT01718353|5748804|P1|COMPLETED|Overall Study|Participants at study cut-off, Adverse Event (AE), DP & consent withdrawn were considered completed.|29
2341810|NCT01718353|5748803|P2|Treated From Cycle 5|Overall Study|3 participants switched from Treatment B to A & 12 participants switched from Treatment A to B.|25
2341811|NCT01718353|5748804|P1|Treated From Cycle 5|Overall Study|12 participants switched from Treatment A to B & 3 participants switched from Treatment B to A.|23
2341812|NCT01718353|5748803|P2|Treated up to End of Cycle 4|Overall Study|6 participants discontinued before Cycle 5|16
2341813|NCT01718353|5748804|P1|Treated up to End of Cycle 4|Overall Study|7 participants discontinued before Cycle 5|32
2341814|NCT01718353|5748803|P2|Treated|Overall Study||22
2341815|NCT01718353|5748804|P1|Treated|Overall Study||39
2341816|NCT01718353|5748803|P2|STARTED|Overall Study||22
2341817|NCT01718353|5748804|P1|STARTED|Overall Study||41
2341818|NCT01718028|5748822|P2|NOT COMPLETED|Overall Study||0
2341819|NCT01718028|5748823|P1|NOT COMPLETED|Overall Study||0
2341820|NCT01718028|5748822|P2|COMPLETED|Overall Study||24
2341821|NCT01718028|5748823|P1|COMPLETED|Overall Study||25
2341822|NCT01718028|5748822|P2|STARTED|Overall Study||24
2341823|NCT01718028|5748823|P1|STARTED|Overall Study||25
2341824|NCT01717989|5748835|P1|NOT COMPLETED|Overall Study||1066
2341825|NCT01717989|5748835|P1|COMPLETED|Overall Study||1182
2341826|NCT01717989|5748835|P1|STARTED|Overall Study||2248
2341827|NCT01717976|5748903|P2|NOT COMPLETED|Overall Study||1
2341828|NCT01717976|5748904|P1|NOT COMPLETED|Overall Study||0
2341829|NCT01717976|5748903|P2|COMPLETED|Overall Study||256
2341830|NCT01717976|5748904|P1|COMPLETED|Overall Study||257
2341831|NCT01717976|5748903|P2|STARTED|Overall Study||257
2341832|NCT01717976|5748904|P1|STARTED|Overall Study||257
2341833|NCT01717898|5748918|P4|NOT COMPLETED|Overall Study||0
2341834|NCT01717898|5748919|P3|NOT COMPLETED|Overall Study||0
2341835|NCT01717898|5748920|P2|NOT COMPLETED|Overall Study||0
2341836|NCT01717898|5748921|P1|NOT COMPLETED|Overall Study||6
2341837|NCT01717898|5748918|P4|COMPLETED|Overall Study||0
2341838|NCT01717898|5748919|P3|COMPLETED|Overall Study||0
2341839|NCT01717898|5748920|P2|COMPLETED|Overall Study||0
2341840|NCT01717898|5748921|P1|COMPLETED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
2341841|NCT01717898|5748918|P4|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
2341842|NCT01717898|5748919|P3|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
2341843|NCT01717898|5748920|P2|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
2341844|NCT01717898|5748921|P1|STARTED|Overall Study||6
2341845|NCT01717872|5748948|P2|NOT COMPLETED|Overall Study||0
2341846|NCT01717872|5748949|P1|NOT COMPLETED|Overall Study||0
2341847|NCT01717872|5748948|P2|COMPLETED|Overall Study||25
2341848|NCT01717872|5748949|P1|COMPLETED|Overall Study||25
2341849|NCT01717872|5748948|P2|STARTED|Overall Study||25
2341850|NCT01717872|5748949|P1|STARTED|Overall Study||25
2341851|NCT01717859|5748959|P1|NOT COMPLETED|Overall Study||10
2341852|NCT01717859|5748959|P1|COMPLETED|Overall Study||44
2341853|NCT01717859|5748959|P1|3 Month|Overall Study||50
2341854|NCT01717859|5748959|P1|STARTED|Overall Study||54
2341855|NCT01717768|5748980|P12|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
2341856|NCT01717768|5748981|P11|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
2341857|NCT01717768|5748982|P10|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||1
2341858|NCT01717768|5748983|P9|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
2341859|NCT01717768|5748984|P8|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||2
2341860|NCT01717768|5748985|P7|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
2341861|NCT01717768|5748986|P6|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
2341862|NCT01717768|5748987|P5|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
2341863|NCT01717768|5748988|P4|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
2341864|NCT01717768|5748989|P3|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
2341865|NCT01717768|5748990|P2|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
2341866|NCT01717768|5748991|P1|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
2341867|NCT01717768|5748980|P12|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
2341868|NCT01717768|5748981|P11|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
2341869|NCT01717768|5748982|P10|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
2341870|NCT01717768|5748983|P9|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
2341871|NCT01717768|5748984|P8|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
2341872|NCT01717768|5748985|P7|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
2341873|NCT01717768|5748986|P6|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
2341874|NCT01717768|5748987|P5|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
2341875|NCT01717768|5748988|P4|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
2341876|NCT01717768|5748989|P3|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
2341877|NCT01717768|5748990|P2|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
2341878|NCT01717768|5748991|P1|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
2341879|NCT01717768|5748980|P12|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
2341880|NCT01717768|5748981|P11|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
2341881|NCT01717768|5748982|P10|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||16
2341882|NCT01717768|5748983|P9|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
2341883|NCT01717768|5748984|P8|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||17
2341884|NCT01717768|5748985|P7|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
2341885|NCT01717768|5748986|P6|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
2341886|NCT01717768|5748987|P5|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
2341888|NCT01717768|5748989|P3|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
2341889|NCT01717768|5748990|P2|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
2341890|NCT01717768|5748991|P1|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
2341891|NCT01717768|5748980|P12|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||1
2341892|NCT01717768|5748981|P11|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
2341893|NCT01717768|5748982|P10|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
2341894|NCT01717768|5748983|P9|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
2341895|NCT01717768|5748984|P8|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
2341896|NCT01717768|5748985|P7|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
2341897|NCT01717768|5748986|P6|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
2341898|NCT01717768|5748987|P5|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
2341899|NCT01717768|5748988|P4|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
2341900|NCT01717768|5748989|P3|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
2341901|NCT01717768|5748990|P2|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
2341902|NCT01717768|5748991|P1|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
2341903|NCT01717768|5748980|P12|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||15
2341904|NCT01717768|5748981|P11|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
2341905|NCT01717768|5748982|P10|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
2341906|NCT01717768|5748983|P9|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
2341907|NCT01717768|5748984|P8|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
2341908|NCT01717768|5748985|P7|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||17
2341909|NCT01717768|5748986|P6|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
2341910|NCT01717768|5748987|P5|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
2341911|NCT01717768|5748988|P4|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
2341912|NCT01717768|5748989|P3|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
2341913|NCT01717768|5748990|P2|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
2341914|NCT01717768|5748991|P1|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
2341915|NCT01717768|5748980|P12|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
2341916|NCT01717768|5748981|P11|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
2341917|NCT01717768|5748982|P10|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
2341918|NCT01717768|5748983|P9|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
2341919|NCT01717768|5748984|P8|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
2341920|NCT01717768|5748985|P7|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||17
2341921|NCT01717768|5748986|P6|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
2341922|NCT01717768|5748987|P5|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
2341923|NCT01717768|5748988|P4|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
2341924|NCT01717768|5748989|P3|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
2341925|NCT01717768|5748990|P2|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
2341926|NCT01717768|5748991|P1|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
2341927|NCT01717768|5748980|P12|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
2341928|NCT01717768|5748981|P11|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
2341929|NCT01717768|5748982|P10|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
2341930|NCT01717768|5748983|P9|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
2341931|NCT01717768|5748984|P8|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
2341932|NCT01717768|5748985|P7|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
2341933|NCT01717768|5748986|P6|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
2341934|NCT01717768|5748987|P5|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
2341935|NCT01717768|5748988|P4|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
2341936|NCT01717768|5748989|P3|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
2341937|NCT01717768|5748990|P2|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
2341938|NCT01717768|5748991|P1|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
2341939|NCT01717768|5748980|P12|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
2341940|NCT01717768|5748981|P11|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
2341941|NCT01717768|5748982|P10|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
2341942|NCT01717768|5748983|P9|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
2341943|NCT01717768|5748984|P8|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
2341944|NCT01717768|5748985|P7|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
2341945|NCT01717768|5748986|P6|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
2341946|NCT01717768|5748987|P5|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
2341947|NCT01717768|5748988|P4|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||4
2341948|NCT01717768|5748989|P3|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
2341949|NCT01717768|5748990|P2|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
2341950|NCT01717768|5748991|P1|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
2341951|NCT01717768|5748980|P12|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
2341952|NCT01717768|5748981|P11|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
2341953|NCT01717768|5748982|P10|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
2341954|NCT01717768|5748983|P9|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
2341955|NCT01717768|5748984|P8|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
2341956|NCT01717768|5748985|P7|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
2341957|NCT01717768|5748986|P6|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
2341958|NCT01717768|5748987|P5|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
2341959|NCT01717768|5748988|P4|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||4
2341960|NCT01717768|5748989|P3|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
2341961|NCT01717768|5748990|P2|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
2341962|NCT01717768|5748991|P1|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
2341963|NCT01717768|5748980|P12|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
2341964|NCT01717768|5748981|P11|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
2341965|NCT01717768|5748982|P10|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
2341966|NCT01717768|5748983|P9|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
2341967|NCT01717768|5748984|P8|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
2341968|NCT01717768|5748985|P7|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
2341969|NCT01717768|5748986|P6|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
2341970|NCT01717768|5748987|P5|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
2341971|NCT01717768|5748988|P4|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
2341972|NCT01717768|5748989|P3|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
2341973|NCT01717768|5748990|P2|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
2341974|NCT01717768|5748991|P1|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
2341975|NCT01717768|5748980|P12|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
2341976|NCT01717768|5748981|P11|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
2341977|NCT01717768|5748982|P10|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
2341978|NCT01717768|5748983|P9|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
2341979|NCT01717768|5748984|P8|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
2341980|NCT01717768|5748985|P7|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
2341981|NCT01717768|5748986|P6|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
2341982|NCT01717768|5748987|P5|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
2341983|NCT01717768|5748988|P4|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||4
2341984|NCT01717768|5748989|P3|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
2341985|NCT01717768|5748990|P2|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
2341986|NCT01717768|5748991|P1|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
2341987|NCT01717768|5748980|P12|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
2341988|NCT01717768|5748981|P11|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
2341989|NCT01717768|5748982|P10|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
2341990|NCT01717768|5748983|P9|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
2341991|NCT01717768|5748984|P8|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
2341992|NCT01717768|5748985|P7|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
2341993|NCT01717768|5748986|P6|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
2341994|NCT01717768|5748987|P5|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
2341995|NCT01717768|5748988|P4|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||4
2341996|NCT01717768|5748989|P3|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
2341997|NCT01717768|5748990|P2|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
2341998|NCT01717768|5748991|P1|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
2341999|NCT01717768|5748980|P12|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
2342000|NCT01717768|5748981|P11|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
2342001|NCT01717768|5748982|P10|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
2342002|NCT01717768|5748983|P9|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
2342003|NCT01717768|5748984|P8|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
2342004|NCT01717768|5748985|P7|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
2342005|NCT01717768|5748986|P6|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
2342006|NCT01717768|5748987|P5|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
2342007|NCT01717768|5748988|P4|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
2342008|NCT01717768|5748989|P3|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
2342009|NCT01717768|5748990|P2|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
2342010|NCT01717768|5748991|P1|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
2342011|NCT01717768|5748980|P12|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
2342012|NCT01717768|5748981|P11|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
2342013|NCT01717768|5748982|P10|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
2342014|NCT01717768|5748983|P9|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
2342015|NCT01717768|5748984|P8|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
2342016|NCT01717768|5748985|P7|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
2342017|NCT01717768|5748986|P6|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
2342018|NCT01717768|5748987|P5|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
2342019|NCT01717768|5748988|P4|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||4
2342020|NCT01717768|5748989|P3|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
2342021|NCT01717768|5748990|P2|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
2342022|NCT01717768|5748991|P1|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
2342023|NCT01717768|5748980|P12|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
2342024|NCT01717768|5748981|P11|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
2342025|NCT01717768|5748982|P10|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
2342026|NCT01717768|5748983|P9|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
2342027|NCT01717768|5748984|P8|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
2342028|NCT01717768|5748985|P7|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
2342029|NCT01717768|5748986|P6|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
2342030|NCT01717768|5748987|P5|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
2342031|NCT01717768|5748988|P4|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||4
2342032|NCT01717768|5748989|P3|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
2342033|NCT01717768|5748990|P2|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
2342034|NCT01717768|5748991|P1|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
2342035|NCT01717768|5748980|P12|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
2342036|NCT01717768|5748981|P11|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
2342037|NCT01717768|5748982|P10|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
2342038|NCT01717768|5748983|P9|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
2342039|NCT01717768|5748984|P8|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
2342040|NCT01717768|5748985|P7|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
2342041|NCT01717768|5748986|P6|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
2342042|NCT01717768|5748987|P5|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
2342043|NCT01717768|5748988|P4|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
2342044|NCT01717768|5748989|P3|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
2342045|NCT01717768|5748990|P2|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
2342046|NCT01717768|5748991|P1|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
2342047|NCT01717768|5748980|P12|COMPLETED|Part 2 (Duration of 15 Days)||0
2342048|NCT01717768|5748981|P11|COMPLETED|Part 2 (Duration of 15 Days)||0
2342049|NCT01717768|5748982|P10|COMPLETED|Part 2 (Duration of 15 Days)||0
2342050|NCT01717768|5748983|P9|COMPLETED|Part 2 (Duration of 15 Days)||0
2342051|NCT01717768|5748984|P8|COMPLETED|Part 2 (Duration of 15 Days)||0
2342052|NCT01717768|5748985|P7|COMPLETED|Part 2 (Duration of 15 Days)||0
2342053|NCT01717768|5748986|P6|COMPLETED|Part 2 (Duration of 15 Days)||0
2342054|NCT01717768|5748987|P5|COMPLETED|Part 2 (Duration of 15 Days)||0
2342055|NCT01717768|5748988|P4|COMPLETED|Part 2 (Duration of 15 Days)||0
2342056|NCT01717768|5748989|P3|COMPLETED|Part 2 (Duration of 15 Days)||17
2342057|NCT01717768|5748990|P2|COMPLETED|Part 2 (Duration of 15 Days)||0
2342058|NCT01717768|5748991|P1|COMPLETED|Part 2 (Duration of 15 Days)||0
2342059|NCT01717768|5748980|P12|STARTED|Part 2 (Duration of 15 Days)||0
2342060|NCT01717768|5748981|P11|STARTED|Part 2 (Duration of 15 Days)||0
2342061|NCT01717768|5748982|P10|STARTED|Part 2 (Duration of 15 Days)||0
2342062|NCT01717768|5748983|P9|STARTED|Part 2 (Duration of 15 Days)||0
2342063|NCT01717768|5748984|P8|STARTED|Part 2 (Duration of 15 Days)||0
2342064|NCT01717768|5748985|P7|STARTED|Part 2 (Duration of 15 Days)||0
2342065|NCT01717768|5748986|P6|STARTED|Part 2 (Duration of 15 Days)||0
2342066|NCT01717768|5748987|P5|STARTED|Part 2 (Duration of 15 Days)||0
2342067|NCT01717768|5748988|P4|STARTED|Part 2 (Duration of 15 Days)||0
2342068|NCT01717768|5748989|P3|STARTED|Part 2 (Duration of 15 Days)||17
2342069|NCT01717768|5748990|P2|STARTED|Part 2 (Duration of 15 Days)||0
2342070|NCT01717768|5748991|P1|STARTED|Part 2 (Duration of 15 Days)||0
2342071|NCT01717768|5748980|P12|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
2342072|NCT01717768|5748981|P11|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
2342073|NCT01717768|5748982|P10|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
2342074|NCT01717768|5748983|P9|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
2342075|NCT01717768|5748984|P8|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
2342076|NCT01717768|5748985|P7|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
2342077|NCT01717768|5748986|P6|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
2342078|NCT01717768|5748987|P5|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
2342079|NCT01717768|5748988|P4|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
2342080|NCT01717768|5748989|P3|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
2342081|NCT01717768|5748990|P2|NOT COMPLETED|Part 1 (Duration of 15 Days)||1
2342082|NCT01717768|5748991|P1|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
2342083|NCT01717768|5748980|P12|COMPLETED|Part 1 (Duration of 15 Days)||0
2342084|NCT01717768|5748981|P11|COMPLETED|Part 1 (Duration of 15 Days)||0
2342085|NCT01717768|5748982|P10|COMPLETED|Part 1 (Duration of 15 Days)||0
2342086|NCT01717768|5748983|P9|COMPLETED|Part 1 (Duration of 15 Days)||0
2342087|NCT01717768|5748984|P8|COMPLETED|Part 1 (Duration of 15 Days)||0
2342088|NCT01717768|5748985|P7|COMPLETED|Part 1 (Duration of 15 Days)||0
2342089|NCT01717768|5748986|P6|COMPLETED|Part 1 (Duration of 15 Days)||0
2342090|NCT01717768|5748987|P5|COMPLETED|Part 1 (Duration of 15 Days)||0
2342091|NCT01717768|5748988|P4|COMPLETED|Part 1 (Duration of 15 Days)||0
2342092|NCT01717768|5748989|P3|COMPLETED|Part 1 (Duration of 15 Days)||0
2342093|NCT01717768|5748990|P2|COMPLETED|Part 1 (Duration of 15 Days)||16
2342094|NCT01717768|5748991|P1|COMPLETED|Part 1 (Duration of 15 Days)||17
2342095|NCT01717768|5748980|P12|STARTED|Part 1 (Duration of 15 Days)||0
2342096|NCT01717768|5748981|P11|STARTED|Part 1 (Duration of 15 Days)||0
2342097|NCT01717768|5748982|P10|STARTED|Part 1 (Duration of 15 Days)||0
2342098|NCT01717768|5748983|P9|STARTED|Part 1 (Duration of 15 Days)||0
2342099|NCT01717768|5748984|P8|STARTED|Part 1 (Duration of 15 Days)||0
2342100|NCT01717768|5748985|P7|STARTED|Part 1 (Duration of 15 Days)||0
2342101|NCT01717768|5748986|P6|STARTED|Part 1 (Duration of 15 Days)||0
2342102|NCT01717768|5748987|P5|STARTED|Part 1 (Duration of 15 Days)||0
2342103|NCT01717768|5748988|P4|STARTED|Part 1 (Duration of 15 Days)||0
2342104|NCT01717768|5748989|P3|STARTED|Part 1 (Duration of 15 Days)||0
2342105|NCT01717768|5748990|P2|STARTED|Part 1 (Duration of 15 Days)||17
2342106|NCT01717768|5748991|P1|STARTED|Part 1 (Duration of 15 Days)||17
2342107|NCT01717638|5749042|P13|NOT COMPLETED|Overall Study||19
2342108|NCT01717638|5749043|P12|NOT COMPLETED|Overall Study||0
2342109|NCT01717638|5749044|P11|NOT COMPLETED|Overall Study||0
2342110|NCT01717638|5749045|P10|NOT COMPLETED|Overall Study||1
2342111|NCT01717638|5749046|P9|NOT COMPLETED|Overall Study||2
2342112|NCT01717638|5749047|P8|NOT COMPLETED|Overall Study||1
2342113|NCT01717638|5749048|P7|NOT COMPLETED|Overall Study||2
2342114|NCT01717638|5749049|P6|NOT COMPLETED|Overall Study||1
2342115|NCT01717638|5749050|P5|NOT COMPLETED|Overall Study||1
2342116|NCT01717638|5749051|P4|NOT COMPLETED|Overall Study||0
2342117|NCT01717638|5749052|P3|NOT COMPLETED|Overall Study||1
2342118|NCT01717638|5749053|P2|NOT COMPLETED|Overall Study||1
2342119|NCT01717638|5749054|P1|NOT COMPLETED|Overall Study||0
2342120|NCT01717638|5749042|P13|COMPLETED|Overall Study||190
2342121|NCT01717638|5749043|P12|COMPLETED|Overall Study||12
2342122|NCT01717638|5749044|P11|COMPLETED|Overall Study||11
2342123|NCT01717638|5749045|P10|COMPLETED|Overall Study||99
2342124|NCT01717638|5749046|P9|COMPLETED|Overall Study||26
2342125|NCT01717638|5749047|P8|COMPLETED|Overall Study||28
2342126|NCT01717638|5749048|P7|COMPLETED|Overall Study||41
2342127|NCT01717638|5749049|P6|COMPLETED|Overall Study||54
2342128|NCT01717638|5749050|P5|COMPLETED|Overall Study||63
2342129|NCT01717638|5749051|P4|COMPLETED|Overall Study||66
2342130|NCT01717638|5749052|P3|COMPLETED|Overall Study||59
2342131|NCT01717638|5749053|P2|COMPLETED|Overall Study||60
2342132|NCT01717638|5749054|P1|COMPLETED|Overall Study||67
2342133|NCT01717638|5749042|P13|STARTED|Overall Study||209
2342134|NCT01717638|5749043|P12|STARTED|Overall Study||12
2342135|NCT01717638|5749044|P11|STARTED|Overall Study||11
2342136|NCT01717638|5749045|P10|STARTED|Overall Study||100
2342137|NCT01717638|5749046|P9|STARTED|Overall Study||28
2342138|NCT01717638|5749047|P8|STARTED|Overall Study||29
2342139|NCT01717638|5749048|P7|STARTED|Overall Study||43
2342140|NCT01717638|5749049|P6|STARTED|Overall Study||55
2342141|NCT01717638|5749050|P5|STARTED|Overall Study||64
2342142|NCT01717638|5749051|P4|STARTED|Overall Study||66
2342143|NCT01717638|5749052|P3|STARTED|Overall Study||60
2342144|NCT01717638|5749053|P2|STARTED|Overall Study||61
2342145|NCT01717638|5749054|P1|STARTED|Overall Study||67
2342146|NCT01717521|5749196|P1|NOT COMPLETED|Overall Study||0
2342147|NCT01717521|5749196|P1|COMPLETED|Overall Study||20
2342148|NCT01717521|5749196|P1|STARTED|Overall Study||20
2342149|NCT01717482|5749215|P2|NOT COMPLETED|Overall Study||0
2342150|NCT01717482|5749216|P1|NOT COMPLETED|Overall Study||4
2342151|NCT01717482|5749215|P2|COMPLETED|Overall Study||2
2342152|NCT01717482|5749216|P1|COMPLETED|Overall Study||0
2342153|NCT01717482|5749215|P2|STARTED|Overall Study||2
2342154|NCT01717482|5749216|P1|STARTED|Overall Study||4
2342155|NCT01717456|5749224|P2|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
2342156|NCT01717456|5749225|P1|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
2342157|NCT01717456|5749224|P2|COMPLETED|Follow-Up 6 Months After End of Tx||2
2342158|NCT01717456|5749225|P1|COMPLETED|Follow-Up 6 Months After End of Tx||7
2342159|NCT01717456|5749224|P2|STARTED|Follow-Up 6 Months After End of Tx||6
2342160|NCT01717456|5749225|P1|STARTED|Follow-Up 6 Months After End of Tx||11
2342161|NCT01717456|5749224|P2|NOT COMPLETED|End of Treatment||2
2342162|NCT01717456|5749225|P1|NOT COMPLETED|End of Treatment||0
2342163|NCT01717456|5749224|P2|COMPLETED|End of Treatment||6
2342164|NCT01717456|5749225|P1|COMPLETED|End of Treatment||11
2342165|NCT01717456|5749224|P2|STARTED|End of Treatment||8
2342166|NCT01717456|5749225|P1|STARTED|End of Treatment||11
2342167|NCT01717391|5749293|P1|NOT COMPLETED|Overall Study||9
2342168|NCT01717391|5749293|P1|COMPLETED|Overall Study||27
2342169|NCT01717391|5749293|P1|STARTED|Overall Study||36
2342170|NCT01717326|5749322|P20|NOT COMPLETED|Overall Study||6
2342171|NCT01717326|5749323|P19|NOT COMPLETED|Overall Study||4
2342172|NCT01717326|5749324|P18|NOT COMPLETED|Overall Study||0
2342173|NCT01717326|5749325|P17|NOT COMPLETED|Overall Study||1
2342174|NCT01717326|5749326|P16|NOT COMPLETED|Overall Study||3
2342175|NCT01717326|5749327|P15|NOT COMPLETED|Overall Study||0
2342176|NCT01717326|5749328|P14|NOT COMPLETED|Overall Study||0
2342177|NCT01717326|5749329|P13|NOT COMPLETED|Overall Study||1
2342178|NCT01717326|5749330|P12|NOT COMPLETED|Overall Study||0
2342179|NCT01717326|5749331|P11|NOT COMPLETED|Overall Study||2
2342180|NCT01717326|5749332|P10|NOT COMPLETED|Overall Study||2
2342181|NCT01717326|5749333|P9|NOT COMPLETED|Overall Study||0
2342182|NCT01717326|5749334|P8|NOT COMPLETED|Overall Study||0
2342183|NCT01717326|5749335|P7|NOT COMPLETED|Overall Study||1
2342184|NCT01717326|5749336|P6|NOT COMPLETED|Overall Study||0
2342185|NCT01717326|5749337|P5|NOT COMPLETED|Overall Study||2
2342186|NCT01717326|5749338|P4|NOT COMPLETED|Overall Study||2
2342187|NCT01717326|5749339|P3|NOT COMPLETED|Overall Study||0
2342188|NCT01717326|5749340|P2|NOT COMPLETED|Overall Study||1
2342189|NCT01717326|5749341|P1|NOT COMPLETED|Overall Study||3
2342190|NCT01717326|5749322|P20|COMPLETED|Overall Study||15
2342191|NCT01717326|5749323|P19|COMPLETED|Overall Study||16
2342192|NCT01717326|5749324|P18|COMPLETED|Overall Study||31
2342193|NCT01717326|5749325|P17|COMPLETED|Overall Study||29
2342194|NCT01717326|5749326|P16|COMPLETED|Overall Study||27
2342195|NCT01717326|5749327|P15|COMPLETED|Overall Study||29
2342196|NCT01717326|5749328|P14|COMPLETED|Overall Study||32
2342197|NCT01717326|5749329|P13|COMPLETED|Overall Study||32
2342198|NCT01717326|5749330|P12|COMPLETED|Overall Study||33
2342199|NCT01717326|5749331|P11|COMPLETED|Overall Study||30
2342200|NCT01717326|5749332|P10|COMPLETED|Overall Study||29
2342201|NCT01717326|5749333|P9|COMPLETED|Overall Study||32
2342202|NCT01717326|5749334|P8|COMPLETED|Overall Study||29
2342203|NCT01717326|5749335|P7|COMPLETED|Overall Study||30
2342204|NCT01717326|5749336|P6|COMPLETED|Overall Study||31
2342205|NCT01717326|5749337|P5|COMPLETED|Overall Study||31
2342206|NCT01717326|5749338|P4|COMPLETED|Overall Study||28
2342207|NCT01717326|5749339|P3|COMPLETED|Overall Study||13
2342208|NCT01717326|5749340|P2|COMPLETED|Overall Study||26
2342209|NCT01717326|5749341|P1|COMPLETED|Overall Study||22
2342210|NCT01717326|5749322|P20|Treated|Overall Study||21
2342211|NCT01717326|5749323|P19|Treated|Overall Study||20
2342212|NCT01717326|5749324|P18|Treated|Overall Study||31
2342213|NCT01717326|5749325|P17|Treated|Overall Study||30
2342214|NCT01717326|5749326|P16|Treated|Overall Study||30
2342215|NCT01717326|5749327|P15|Treated|Overall Study||29
2342216|NCT01717326|5749328|P14|Treated|Overall Study||32
2342217|NCT01717326|5749329|P13|Treated|Overall Study||33
2342218|NCT01717326|5749330|P12|Treated|Overall Study||33
2342219|NCT01717326|5749331|P11|Treated|Overall Study||32
2342220|NCT01717326|5749332|P10|Treated|Overall Study||31
2342221|NCT01717326|5749333|P9|Treated|Overall Study||32
2342222|NCT01717326|5749334|P8|Treated|Overall Study||29
2342223|NCT01717326|5749335|P7|Treated|Overall Study||31
2342224|NCT01717326|5749336|P6|Treated|Overall Study||31
2342225|NCT01717326|5749337|P5|Treated|Overall Study||33
2342226|NCT01717326|5749338|P4|Treated|Overall Study||30
2342227|NCT01717326|5749339|P3|Treated|Overall Study|Number excludes 1 participant randomized to A3 but treated on Arm A2|12
2342228|NCT01717326|5749340|P2|Treated|Overall Study|Number includes 1 additional participant randomized to A3 but treated on A2|28
2342229|NCT01717326|5749341|P1|Treated|Overall Study||25
2342230|NCT01717326|5749322|P20|STARTED|Overall Study||21
2342231|NCT01717326|5749323|P19|STARTED|Overall Study||20
2342232|NCT01717326|5749324|P18|STARTED|Overall Study||31
2342233|NCT01717326|5749325|P17|STARTED|Overall Study||30
2342234|NCT01717326|5749326|P16|STARTED|Overall Study||30
2342235|NCT01717326|5749327|P15|STARTED|Overall Study||29
2342236|NCT01717326|5749328|P14|STARTED|Overall Study||32
2342237|NCT01717326|5749329|P13|STARTED|Overall Study||33
2342238|NCT01717326|5749330|P12|STARTED|Overall Study||33
2342239|NCT01717326|5749331|P11|STARTED|Overall Study||32
2342240|NCT01717326|5749332|P10|STARTED|Overall Study||31
2342241|NCT01717326|5749333|P9|STARTED|Overall Study||32
2342242|NCT01717326|5749334|P8|STARTED|Overall Study||29
2342243|NCT01717326|5749335|P7|STARTED|Overall Study||31
2342244|NCT01717326|5749336|P6|STARTED|Overall Study||31
2342245|NCT01717326|5749337|P5|STARTED|Overall Study||33
2342246|NCT01717326|5749338|P4|STARTED|Overall Study||30
2342247|NCT01717326|5749339|P3|STARTED|Overall Study||13
2342248|NCT01717326|5749340|P2|STARTED|Overall Study||27
2342249|NCT01717326|5749341|P1|STARTED|Overall Study||25
2342250|NCT01717313|5749605|P2|NOT COMPLETED|Phase B (Weeks 24 to 54)||16
2342251|NCT01717313|5749606|P1|NOT COMPLETED|Phase B (Weeks 24 to 54)||12
2342252|NCT01717313|5749605|P2|COMPLETED|Phase B (Weeks 24 to 54)||135
2342253|NCT01717313|5749606|P1|COMPLETED|Phase B (Weeks 24 to 54)||134
2342254|NCT01717313|5749605|P2|STARTED|Phase B (Weeks 24 to 54)||151
2342255|NCT01717313|5749606|P1|STARTED|Phase B (Weeks 24 to 54)||146
2342256|NCT01717313|5749605|P2|NOT COMPLETED|Interphase||0
2342257|NCT01717313|5749606|P1|NOT COMPLETED|Interphase||1
2342258|NCT01717313|5749605|P2|COMPLETED|Interphase||151
2342259|NCT01717313|5749606|P1|COMPLETED|Interphase||146
2342260|NCT01717313|5749605|P2|STARTED|Interphase||151
2342261|NCT01717313|5749606|P1|STARTED|Interphase||147
2342262|NCT01717313|5749605|P2|NOT COMPLETED|Phase A (Weeks 0 to 24)||13
2342263|NCT01717313|5749606|P1|NOT COMPLETED|Phase A (Weeks 0 to 24)||18
2342264|NCT01717313|5749605|P2|COMPLETED|Phase A (Weeks 0 to 24)||151
2342265|NCT01717313|5749606|P1|COMPLETED|Phase A (Weeks 0 to 24)||147
2342266|NCT01717313|5749605|P2|STARTED|Phase A (Weeks 0 to 24)||164
2342267|NCT01717313|5749606|P1|STARTED|Phase A (Weeks 0 to 24)||165
2342268|NCT01717287|5749644|P2|NOT COMPLETED|Overall Study||3
2342269|NCT01717287|5749645|P1|NOT COMPLETED|Overall Study||0
2342270|NCT01717287|5749644|P2|COMPLETED|Overall Study||25
2342271|NCT01717287|5749645|P1|COMPLETED|Overall Study||4
2342272|NCT01717287|5749644|P2|STARTED|Overall Study||28
2342273|NCT01717287|5749645|P1|STARTED|Overall Study||4
2342274|NCT01717209|5749667|P1|NOT COMPLETED|Overall Study||0
2342275|NCT01717209|5749667|P1|COMPLETED|Overall Study||14
2342276|NCT01717209|5749667|P1|STARTED|Overall Study||14
2342277|NCT01717053|5749676|P1|NOT COMPLETED|Overall Study||4
2342278|NCT01717053|5749676|P1|COMPLETED|Overall Study||33
2342279|NCT01717053|5749676|P1|STARTED|Overall Study||37
2342280|NCT01717040|5749685|P2|NOT COMPLETED|Overall Study||5
2342281|NCT01717040|5749686|P1|NOT COMPLETED|Overall Study||5
2342282|NCT01717040|5749685|P2|COMPLETED|Overall Study||15
2342283|NCT01717040|5749686|P1|COMPLETED|Overall Study||12
2342284|NCT01717040|5749685|P2|STARTED|Overall Study||20
2342285|NCT01717040|5749686|P1|STARTED|Overall Study||17
2342286|NCT01717014|5749692|P1|NOT COMPLETED|Overall Study||0
2342287|NCT01717014|5749692|P1|COMPLETED|Overall Study||8
2342288|NCT01717014|5749692|P1|STARTED|Overall Study||8
2342289|NCT01716754|5749704|P4|NOT COMPLETED|Overall Study||8
2342290|NCT01716754|5749705|P3|NOT COMPLETED|Overall Study||14
2342291|NCT01716754|5749706|P2|NOT COMPLETED|Overall Study||4
2342292|NCT01716754|5749707|P1|NOT COMPLETED|Overall Study||11
2342293|NCT01716754|5749704|P4|COMPLETED|Overall Study||89
2342294|NCT01716754|5749705|P3|COMPLETED|Overall Study||121
2342295|NCT01716754|5749706|P2|COMPLETED|Overall Study||36
2342296|NCT01716754|5749707|P1|COMPLETED|Overall Study||188
2342297|NCT01716754|5749704|P4|Safety Set|Overall Study||96
2342298|NCT01716754|5749705|P3|Safety Set|Overall Study||131
2342299|NCT01716754|5749706|P2|Safety Set|Overall Study||40
2342300|NCT01716754|5749707|P1|Safety Set|Overall Study||199
2342301|NCT01716754|5749704|P4|FAS|Overall Study||96
2342302|NCT01716754|5749705|P3|FAS|Overall Study||131
2342303|NCT01716754|5749706|P2|FAS|Overall Study||40
2342304|NCT01716754|5749707|P1|FAS|Overall Study||199
2342305|NCT01716754|5749704|P4|STARTED|Overall Study||97
2342306|NCT01716754|5749705|P3|STARTED|Overall Study||135
2342307|NCT01716754|5749706|P2|STARTED|Overall Study||40
2342308|NCT01716754|5749707|P1|STARTED|Overall Study||199
2342309|NCT01716663|5749728|P1|NOT COMPLETED|Overall Study||6
2342310|NCT01716663|5749728|P1|COMPLETED|Overall Study|Effectiveness population = enrolled and treated (study device inserted and RF energy applied)|228
2342311|NCT01716663|5749728|P1|Safety|Overall Study|Enrolled patients who had a study device inserted.|230
2342312|NCT01716663|5749728|P1|STARTED|Overall Study|Enrolled = signed informed consent and met eligibility requirements|234
2342313|NCT01716585|5749738|P2|NOT COMPLETED|Open-label Treatment||7
2342314|NCT01716585|5749739|P1|NOT COMPLETED|Open-label Treatment||0
2342315|NCT01716585|5749738|P2|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|150
2342316|NCT01716585|5749739|P1|COMPLETED|Open-label Treatment|not applicable to this arm|0
2342317|NCT01716585|5749738|P2|STARTED|Open-label Treatment||157
2342318|NCT01716585|5749739|P1|STARTED|Open-label Treatment|not applicable to this arm|0
2342319|NCT01716585|5749738|P2|NOT COMPLETED|Double-blind Treatment||2
2342320|NCT01716585|5749739|P1|NOT COMPLETED|Double-blind Treatment||13
2342321|NCT01716585|5749738|P2|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|157
2342322|NCT01716585|5749739|P1|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|464
2342323|NCT01716585|5749738|P2|Randomized But Not Treated|Double-blind Treatment||1
2342324|NCT01716585|5749739|P1|Randomized But Not Treated|Double-blind Treatment||4
2342325|NCT01716585|5749738|P2|STARTED|Double-blind Treatment||159
2342326|NCT01716585|5749739|P1|STARTED|Double-blind Treatment||477
2342327|NCT01716559|5749751|P1|NOT COMPLETED|Overall Study||111
2342328|NCT01716559|5749751|P1|COMPLETED|Overall Study||49
2342329|NCT01716559|5749751|P1|STARTED|Overall Study||160
2342330|NCT01716533|5749763|P4|NOT COMPLETED|Overall Study||8
2342331|NCT01716533|5749764|P3|NOT COMPLETED|Overall Study||5
2342332|NCT01716533|5749765|P2|NOT COMPLETED|Overall Study||0
2342333|NCT01716533|5749766|P1|NOT COMPLETED|Overall Study||0
2342334|NCT01716533|5749763|P4|COMPLETED|Overall Study||1
2342335|NCT01716533|5749764|P3|COMPLETED|Overall Study||0
2342336|NCT01716533|5749765|P2|COMPLETED|Overall Study||25
2342337|NCT01716533|5749766|P1|COMPLETED|Overall Study||7
2342338|NCT01716533|5749763|P4|STARTED|Overall Study||9
2342339|NCT01716533|5749764|P3|STARTED|Overall Study||5
2342340|NCT01716533|5749765|P2|STARTED|Overall Study||25
2342341|NCT01716533|5749766|P1|STARTED|Overall Study||7
2342342|NCT01716520|5749820|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||2
2342343|NCT01716520|5749821|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
2342344|NCT01716520|5749822|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
2342345|NCT01716520|5749823|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
2342346|NCT01716520|5749824|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||0
2342347|NCT01716520|5749825|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
2342348|NCT01716520|5749820|P6|COMPLETED|Treatment Period 3 (14 Days)||23
2342349|NCT01716520|5749821|P5|COMPLETED|Treatment Period 3 (14 Days)||29
2342350|NCT01716520|5749822|P4|COMPLETED|Treatment Period 3 (14 Days)||28
2342351|NCT01716520|5749823|P3|COMPLETED|Treatment Period 3 (14 Days)||25
2342352|NCT01716520|5749824|P2|COMPLETED|Treatment Period 3 (14 Days)||27
2342353|NCT01716520|5749825|P1|COMPLETED|Treatment Period 3 (14 Days)||27
2342354|NCT01716520|5749820|P6|STARTED|Treatment Period 3 (14 Days)||25
2342355|NCT01716520|5749821|P5|STARTED|Treatment Period 3 (14 Days)||29
2342356|NCT01716520|5749822|P4|STARTED|Treatment Period 3 (14 Days)||28
2342357|NCT01716520|5749823|P3|STARTED|Treatment Period 3 (14 Days)||26
2342358|NCT01716520|5749824|P2|STARTED|Treatment Period 3 (14 Days)||27
2342359|NCT01716520|5749825|P1|STARTED|Treatment Period 3 (14 Days)||27
2342360|NCT01716520|5749820|P6|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
2342361|NCT01716520|5749821|P5|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
2342362|NCT01716520|5749822|P4|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
2342363|NCT01716520|5749823|P3|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
2342364|NCT01716520|5749824|P2|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
2342365|NCT01716520|5749825|P1|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
2342366|NCT01716520|5749820|P6|COMPLETED|Washout Period 2 (10 to 14 Days)||25
2342367|NCT01716520|5749821|P5|COMPLETED|Washout Period 2 (10 to 14 Days)||29
2342368|NCT01716520|5749822|P4|COMPLETED|Washout Period 2 (10 to 14 Days)||28
2342369|NCT01716520|5749823|P3|COMPLETED|Washout Period 2 (10 to 14 Days)||26
2342370|NCT01716520|5749824|P2|COMPLETED|Washout Period 2 (10 to 14 Days)||27
2342371|NCT01716520|5749825|P1|COMPLETED|Washout Period 2 (10 to 14 Days)||27
2342372|NCT01716520|5749820|P6|STARTED|Washout Period 2 (10 to 14 Days)||27
2342373|NCT01716520|5749821|P5|STARTED|Washout Period 2 (10 to 14 Days)||29
2342374|NCT01716520|5749822|P4|STARTED|Washout Period 2 (10 to 14 Days)||28
2342375|NCT01716520|5749823|P3|STARTED|Washout Period 2 (10 to 14 Days)||27
2342376|NCT01716520|5749824|P2|STARTED|Washout Period 2 (10 to 14 Days)||28
2342377|NCT01716520|5749825|P1|STARTED|Washout Period 2 (10 to 14 Days)||29
2342378|NCT01716520|5749820|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
2342379|NCT01716520|5749821|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||2
2342380|NCT01716520|5749822|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
2342381|NCT01716520|5749823|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||0
2342382|NCT01716520|5749824|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||0
2342383|NCT01716520|5749825|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
2342384|NCT01716520|5749820|P6|COMPLETED|Treatment Period 2 (14 Days)||27
2342385|NCT01716520|5749821|P5|COMPLETED|Treatment Period 2 (14 Days)||29
2342386|NCT01716520|5749822|P4|COMPLETED|Treatment Period 2 (14 Days)||28
2342387|NCT01716520|5749823|P3|COMPLETED|Treatment Period 2 (14 Days)||27
2342388|NCT01716520|5749824|P2|COMPLETED|Treatment Period 2 (14 Days)||28
2342389|NCT01716520|5749825|P1|COMPLETED|Treatment Period 2 (14 Days)||29
2342390|NCT01716520|5749820|P6|STARTED|Treatment Period 2 (14 Days)||27
2342391|NCT01716520|5749821|P5|STARTED|Treatment Period 2 (14 Days)||31
2342392|NCT01716520|5749822|P4|STARTED|Treatment Period 2 (14 Days)||29
2342393|NCT01716520|5749823|P3|STARTED|Treatment Period 2 (14 Days)||27
2342394|NCT01716520|5749824|P2|STARTED|Treatment Period 2 (14 Days)||28
2342395|NCT01716520|5749825|P1|STARTED|Treatment Period 2 (14 Days)||29
2342396|NCT01716520|5749820|P6|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||2
2342397|NCT01716520|5749821|P5|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
2342398|NCT01716520|5749822|P4|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
2342399|NCT01716520|5749823|P3|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
2342400|NCT01716520|5749824|P2|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
2342401|NCT01716520|5749825|P1|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
2342402|NCT01716520|5749820|P6|COMPLETED|Washout Period 1 (10 to 14 Days)||27
2342403|NCT01716520|5749821|P5|COMPLETED|Washout Period 1 (10 to 14 Days)||31
2342404|NCT01716520|5749822|P4|COMPLETED|Washout Period 1 (10 to 14 Days)||29
2342405|NCT01716520|5749823|P3|COMPLETED|Washout Period 1 (10 to 14 Days)||27
2342406|NCT01716520|5749824|P2|COMPLETED|Washout Period 1 (10 to 14 Days)||28
2342407|NCT01716520|5749825|P1|COMPLETED|Washout Period 1 (10 to 14 Days)||29
2342408|NCT01716520|5749820|P6|STARTED|Washout Period 1 (10 to 14 Days)||29
2342409|NCT01716520|5749821|P5|STARTED|Washout Period 1 (10 to 14 Days)||31
2342410|NCT01716520|5749822|P4|STARTED|Washout Period 1 (10 to 14 Days)||29
2342411|NCT01716520|5749823|P3|STARTED|Washout Period 1 (10 to 14 Days)||28
2342412|NCT01716520|5749824|P2|STARTED|Washout Period 1 (10 to 14 Days)||29
2342413|NCT01716520|5749825|P1|STARTED|Washout Period 1 (10 to 14 Days)||29
2342414|NCT01716520|5749820|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||1
2342415|NCT01716520|5749821|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||0
2342416|NCT01716520|5749822|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||1
2342417|NCT01716520|5749823|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||2
2342418|NCT01716520|5749824|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
2342419|NCT01716520|5749825|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
2342420|NCT01716520|5749820|P6|COMPLETED|Treatment Period 1 (14 Days)||29
2342421|NCT01716520|5749821|P5|COMPLETED|Treatment Period 1 (14 Days)||31
2342422|NCT01716520|5749822|P4|COMPLETED|Treatment Period 1 (14 Days)||29
2342423|NCT01716520|5749823|P3|COMPLETED|Treatment Period 1 (14 Days)||28
2342424|NCT01716520|5749824|P2|COMPLETED|Treatment Period 1 (14 Days)||29
2342425|NCT01716520|5749825|P1|COMPLETED|Treatment Period 1 (14 Days)||29
2342426|NCT01716520|5749820|P6|STARTED|Treatment Period 1 (14 Days)||30
2342427|NCT01716520|5749821|P5|STARTED|Treatment Period 1 (14 Days)||31
2342428|NCT01716520|5749822|P4|STARTED|Treatment Period 1 (14 Days)||30
2342429|NCT01716520|5749823|P3|STARTED|Treatment Period 1 (14 Days)||30
2342430|NCT01716520|5749824|P2|STARTED|Treatment Period 1 (14 Days)||30
2342431|NCT01716520|5749825|P1|STARTED|Treatment Period 1 (14 Days)||31
2342432|NCT01716468|5749841|P1|NOT COMPLETED|Overall Study||6
2342433|NCT01716468|5749841|P1|COMPLETED|Overall Study||11
2342434|NCT01716468|5749841|P1|STARTED|Overall Study||17
2342435|NCT01716455|5749851|P6|NOT COMPLETED|Overall Study||0
2342436|NCT01716455|5749852|P5|NOT COMPLETED|Overall Study||0
2342437|NCT01716455|5749853|P4|NOT COMPLETED|Overall Study||0
2342438|NCT01716455|5749854|P3|NOT COMPLETED|Overall Study||0
2342439|NCT01716455|5749855|P2|NOT COMPLETED|Overall Study||0
2342440|NCT01716455|5749856|P1|NOT COMPLETED|Overall Study||0
2342441|NCT01716455|5749851|P6|COMPLETED|Overall Study||8
2342442|NCT01716455|5749852|P5|COMPLETED|Overall Study||26
2342443|NCT01716455|5749853|P4|COMPLETED|Overall Study||8
2342444|NCT01716455|5749854|P3|COMPLETED|Overall Study||8
2342445|NCT01716455|5749855|P2|COMPLETED|Overall Study||8
2342446|NCT01716455|5749856|P1|COMPLETED|Overall Study||8
2342447|NCT01716455|5749851|P6|STARTED|Overall Study||8
2342448|NCT01716455|5749852|P5|STARTED|Overall Study||26
2342449|NCT01716455|5749853|P4|STARTED|Overall Study||8
2342450|NCT01716455|5749854|P3|STARTED|Overall Study||8
2342451|NCT01716455|5749855|P2|STARTED|Overall Study||8
2342452|NCT01716455|5749856|P1|STARTED|Overall Study||8
2342453|NCT01716234|5749880|P7|NOT COMPLETED|Overall Study||0
2342454|NCT01716234|5749881|P6|NOT COMPLETED|Overall Study||14
2342455|NCT01716234|5749882|P5|NOT COMPLETED|Overall Study||5
2342456|NCT01716234|5749883|P4|NOT COMPLETED|Overall Study||12
2342457|NCT01716234|5749884|P3|NOT COMPLETED|Overall Study||5
2342458|NCT01716234|5749885|P2|NOT COMPLETED|Overall Study||10
2342459|NCT01716234|5749886|P1|NOT COMPLETED|Overall Study||10
2342460|NCT01716234|5749880|P7|COMPLETED|Overall Study||1
2342461|NCT01716234|5749881|P6|COMPLETED|Overall Study||18
2342462|NCT01716234|5749882|P5|COMPLETED|Overall Study||10
2342463|NCT01716234|5749883|P4|COMPLETED|Overall Study||16
2342464|NCT01716234|5749884|P3|COMPLETED|Overall Study||15
2342465|NCT01716234|5749885|P2|COMPLETED|Overall Study||12
2342466|NCT01716234|5749886|P1|COMPLETED|Overall Study||14
2342467|NCT01716234|5749880|P7|Treated|Overall Study||1
2342468|NCT01716234|5749881|P6|Treated|Overall Study||30
2342469|NCT01716234|5749882|P5|Treated|Overall Study||15
2342470|NCT01716234|5749883|P4|Treated|Overall Study||28
2342471|NCT01716234|5749884|P3|Treated|Overall Study||19
2342472|NCT01716234|5749885|P2|Treated|Overall Study||21
2342473|NCT01716234|5749886|P1|Treated|Overall Study||22
2342474|NCT01716234|5749880|P7|STARTED|Overall Study||1
2342475|NCT01716234|5749881|P6|STARTED|Overall Study||32
2342476|NCT01716234|5749882|P5|STARTED|Overall Study||15
2342477|NCT01716234|5749883|P4|STARTED|Overall Study||28
2342478|NCT01716234|5749884|P3|STARTED|Overall Study||20
2342479|NCT01716234|5749885|P2|STARTED|Overall Study||22
2342480|NCT01716234|5749886|P1|STARTED|Overall Study||24
2342481|NCT01716221|5749923|P1|NOT COMPLETED|Overall Study||0
2342482|NCT01716221|5749923|P1|COMPLETED|Overall Study||1
2342483|NCT01716221|5749923|P1|STARTED|Overall Study||1
2342484|NCT01716169|5749949|P1|NOT COMPLETED|Overall Study||4
2342485|NCT01716169|5749949|P1|COMPLETED|Overall Study||6
2342486|NCT01716169|5749949|P1|Standard of Care Dressings Used|Overall Study||7
2342487|NCT01716169|5749949|P1|STARTED|Overall Study||10
2342488|NCT01716156|5749958|P3|NOT COMPLETED|Overall Study||2
2342489|NCT01716156|5749959|P2|NOT COMPLETED|Overall Study||1
2342490|NCT01716156|5749960|P1|NOT COMPLETED|Overall Study||2
2342491|NCT01716156|5749958|P3|COMPLETED|Overall Study||11
2342492|NCT01716156|5749959|P2|COMPLETED|Overall Study||3
2342493|NCT01716156|5749960|P1|COMPLETED|Overall Study||7
2342494|NCT01716156|5749958|P3|STARTED|Overall Study||13
2342495|NCT01716156|5749959|P2|STARTED|Overall Study||4
2342496|NCT01716156|5749960|P1|STARTED|Overall Study||9
2342497|NCT01716117|5749986|P2|NOT COMPLETED|Overall Study||2
2342498|NCT01716117|5749987|P1|NOT COMPLETED|Overall Study||7
2342499|NCT01716117|5749986|P2|COMPLETED|Overall Study||31
2342500|NCT01716117|5749987|P1|COMPLETED|Overall Study||173
2342501|NCT01716117|5749986|P2|6-Month Visit|Overall Study||32
2342502|NCT01716117|5749987|P1|6-Month Visit|Overall Study||174
2342503|NCT01716117|5749986|P2|1-Month Visit|Overall Study||33
2342504|NCT01716117|5749987|P1|1-Month Visit|Overall Study||176
2342505|NCT01716117|5749986|P2|Discharge|Overall Study||33
2342506|NCT01716117|5749987|P1|Discharge|Overall Study||177
2342507|NCT01716117|5749986|P2|STARTED|Overall Study||33
2342508|NCT01716117|5749987|P1|STARTED|Overall Study||180
2342509|NCT01716104|5750006|P2|NOT COMPLETED|Overall Study||7
2342510|NCT01716104|5750007|P1|NOT COMPLETED|Overall Study||6
2342511|NCT01716104|5750006|P2|COMPLETED|Overall Study||117
2342512|NCT01716104|5750007|P1|COMPLETED|Overall Study||119
2342513|NCT01716104|5750006|P2|STARTED|Overall Study||124
2342514|NCT01716104|5750007|P1|STARTED|Overall Study||125
2342515|NCT01716052|5750033|P2|NOT COMPLETED|Overall Study||1
2342516|NCT01716052|5750034|P1|NOT COMPLETED|Overall Study||1
2342517|NCT01716052|5750033|P2|COMPLETED|Overall Study||0
2342518|NCT01716052|5750034|P1|COMPLETED|Overall Study||0
2342519|NCT01716052|5750033|P2|STARTED|Overall Study||1
2342520|NCT01716052|5750034|P1|STARTED|Overall Study||1
2342521|NCT01716013|5750042|P2|NOT COMPLETED|Overall Study||0
2342522|NCT01716013|5750043|P1|NOT COMPLETED|Overall Study||3
2342523|NCT01716013|5750042|P2|COMPLETED|Overall Study||54
2342524|NCT01716013|5750043|P1|COMPLETED|Overall Study||105
2342525|NCT01716013|5750042|P2|STARTED|Overall Study||54
2342526|NCT01716013|5750043|P1|STARTED|Overall Study||108
2342527|NCT01715948|5750055|P1|NOT COMPLETED|Overall Study||1
2342528|NCT01715948|5750055|P1|COMPLETED|Overall Study||8
2342529|NCT01715948|5750055|P1|STARTED|Overall Study||9
2342530|NCT01715896|5750076|P2|NOT COMPLETED|Overall Study||11
2342531|NCT01715896|5750077|P1|NOT COMPLETED|Overall Study||3
2342532|NCT01715896|5750076|P2|COMPLETED|Overall Study||59
2342533|NCT01715896|5750077|P1|COMPLETED|Overall Study||65
2342534|NCT01715896|5750076|P2|STARTED|Overall Study||70
2342535|NCT01715896|5750077|P1|STARTED|Overall Study||68
2342536|NCT01715883|5750140|P1|NOT COMPLETED|Overall Study||1
2342537|NCT01715883|5750140|P1|COMPLETED|Overall Study||2
2342538|NCT01715883|5750140|P1|STARTED|Overall Study||3
2342539|NCT01715857|5750150|P1|NOT COMPLETED|Overall Study||96
2342540|NCT01715857|5750150|P1|COMPLETED|Overall Study||4004
2342541|NCT01715857|5750150|P1|STARTED|Overall Study||4100
2342542|NCT01715831|5750160|P1|NOT COMPLETED|Overall Study||1
2342543|NCT01715831|5750160|P1|COMPLETED|Overall Study||25
2342544|NCT01715831|5750160|P1|STARTED|Overall Study||26
2342545|NCT01715805|5750176|P4|NOT COMPLETED|Double-Blind or Continued Treatment||48
2342546|NCT01715805|5750177|P3|NOT COMPLETED|Double-Blind or Continued Treatment||56
2342547|NCT01715805|5750178|P2|NOT COMPLETED|Double-Blind or Continued Treatment||39
2342548|NCT01715805|5750179|P1|NOT COMPLETED|Double-Blind or Continued Treatment||0
2342549|NCT01715805|5750176|P4|COMPLETED|Double-Blind or Continued Treatment||222
2342550|NCT01715805|5750177|P3|COMPLETED|Double-Blind or Continued Treatment||213
2342551|NCT01715805|5750178|P2|COMPLETED|Double-Blind or Continued Treatment||222
2342552|NCT01715805|5750179|P1|COMPLETED|Double-Blind or Continued Treatment||0
2342553|NCT01715805|5750176|P4|Double-Blind Safety Population|Double-Blind or Continued Treatment||0
2342554|NCT01715805|5750177|P3|Double-Blind Safety Population|Double-Blind or Continued Treatment||269
2342555|NCT01715805|5750178|P2|Double-Blind Safety Population|Double-Blind or Continued Treatment||258
2342556|NCT01715805|5750179|P1|Double-Blind Safety Population|Double-Blind or Continued Treatment||0
2342557|NCT01715805|5750176|P4|STARTED|Double-Blind or Continued Treatment||270
2342558|NCT01715805|5750177|P3|STARTED|Double-Blind or Continued Treatment||269
2342559|NCT01715805|5750178|P2|STARTED|Double-Blind or Continued Treatment||261
2342560|NCT01715805|5750179|P1|STARTED|Double-Blind or Continued Treatment||0
2342561|NCT01715805|5750176|P4|NOT COMPLETED|Placebo + ADT Lead-in Period||0
2342562|NCT01715805|5750177|P3|NOT COMPLETED|Placebo + ADT Lead-in Period||0
2342563|NCT01715805|5750178|P2|NOT COMPLETED|Placebo + ADT Lead-in Period||0
2342564|NCT01715805|5750179|P1|NOT COMPLETED|Placebo + ADT Lead-in Period||215
2342565|NCT01715805|5750176|P4|COMPLETED|Placebo + ADT Lead-in Period||0
2342566|NCT01715805|5750177|P3|COMPLETED|Placebo + ADT Lead-in Period||0
2342567|NCT01715805|5750178|P2|COMPLETED|Placebo + ADT Lead-in Period||0
2342568|NCT01715805|5750179|P1|COMPLETED|Placebo + ADT Lead-in Period||807
2342569|NCT01715805|5750176|P4|STARTED|Placebo + ADT Lead-in Period||0
2342570|NCT01715805|5750177|P3|STARTED|Placebo + ADT Lead-in Period||0
2342571|NCT01715805|5750178|P2|STARTED|Placebo + ADT Lead-in Period||0
2342572|NCT01715805|5750179|P1|STARTED|Placebo + ADT Lead-in Period||1022
2342573|NCT01715415|5750193|P2|NOT COMPLETED|Open-label Treatment||2
2342574|NCT01715415|5750194|P1|NOT COMPLETED|Open-label Treatment||0
2342575|NCT01715415|5750193|P2|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|94
2342576|NCT01715415|5750194|P1|COMPLETED|Open-label Treatment|not applicable to this arm|0
2342577|NCT01715415|5750193|P2|STARTED|Open-label Treatment||96
2342578|NCT01715415|5750194|P1|STARTED|Open-label Treatment|not applicable to this arm|0
2342579|NCT01715415|5750193|P2|NOT COMPLETED|Double-blind Treatment||2
2342580|NCT01715415|5750194|P1|NOT COMPLETED|Double-blind Treatment||5
2342581|NCT01715415|5750193|P2|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|96
2342582|NCT01715415|5750194|P1|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|292
2342583|NCT01715415|5750193|P2|Randomized But Not Treated|Double-blind Treatment||1
2342584|NCT01715415|5750194|P1|Randomized But Not Treated|Double-blind Treatment||0
2342585|NCT01715415|5750193|P2|STARTED|Double-blind Treatment||98
2342586|NCT01715415|5750194|P1|STARTED|Double-blind Treatment||297
2342587|NCT01715298|5750208|P2|NOT COMPLETED|Overall Study||11
2342588|NCT01715298|5750209|P1|NOT COMPLETED|Overall Study||7
2342589|NCT01715298|5750208|P2|COMPLETED|Overall Study||205
2342590|NCT01715298|5750209|P1|COMPLETED|Overall Study||209
2342591|NCT01715298|5750208|P2|Full Analysis Set (FAS)|Overall Study||214
2342592|NCT01715298|5750209|P1|Full Analysis Set (FAS)|Overall Study|patients were analyzed according to the treatment to which they were randomized|215
2342593|NCT01715298|5750208|P2|STARTED|Overall Study||216
2342594|NCT01715298|5750209|P1|STARTED|Overall Study||216
2342595|NCT01715285|5750247|P3|NOT COMPLETED|Open-label (OL) Extension Phase||72
2342596|NCT01715285|5750248|P2|NOT COMPLETED|Open-label (OL) Extension Phase||0
2342597|NCT01715285|5750249|P1|NOT COMPLETED|Open-label (OL) Extension Phase||157
2342598|NCT01715285|5750247|P3|COMPLETED|Open-label (OL) Extension Phase||0
2342599|NCT01715285|5750248|P2|COMPLETED|Open-label (OL) Extension Phase||0
2342600|NCT01715285|5750249|P1|COMPLETED|Open-label (OL) Extension Phase||0
2342601|NCT01715285|5750247|P3|STARTED|Open-label (OL) Extension Phase||72
2342602|NCT01715285|5750248|P2|STARTED|Open-label (OL) Extension Phase||0
2342603|NCT01715285|5750249|P1|STARTED|Open-label (OL) Extension Phase||157
2342604|NCT01715285|5750247|P3|NOT COMPLETED|Treatment Period||0
2342605|NCT01715285|5750248|P2|NOT COMPLETED|Treatment Period||602
2342606|NCT01715285|5750249|P1|NOT COMPLETED|Treatment Period||597
2342607|NCT01715285|5750247|P3|COMPLETED|Treatment Period||0
2342608|NCT01715285|5750248|P2|COMPLETED|Treatment Period||0
2342609|NCT01715285|5750249|P1|COMPLETED|Treatment Period||0
2342610|NCT01715285|5750247|P3|Safety Population|Treatment Period||0
2342611|NCT01715285|5750248|P2|Safety Population|Treatment Period||602
2342612|NCT01715285|5750249|P1|Safety Population|Treatment Period||597
2342613|NCT01715285|5750247|P3|ITT Population|Treatment Period||0
2342614|NCT01715285|5750248|P2|ITT Population|Treatment Period||602
2342615|NCT01715285|5750249|P1|ITT Population|Treatment Period||597
2342616|NCT01715285|5750247|P3|STARTED|Treatment Period||0
2342617|NCT01715285|5750248|P2|STARTED|Treatment Period||602
2342618|NCT01715285|5750249|P1|STARTED|Treatment Period||597
2342619|NCT01715233|5750268|P1|NOT COMPLETED|Overall Study||0
2342620|NCT01715233|5750268|P1|COMPLETED|Overall Study||21
2342621|NCT01715233|5750268|P1|STARTED|Overall Study||21
2342622|NCT01715207|5750276|P2|NOT COMPLETED|Overall Study||1
2342623|NCT01715207|5750277|P1|NOT COMPLETED|Overall Study||1
2342624|NCT01715207|5750276|P2|COMPLETED|Overall Study||14
2342625|NCT01715207|5750277|P1|COMPLETED|Overall Study||14
2342626|NCT01715207|5750276|P2|STARTED|Overall Study||15
2342627|NCT01715207|5750277|P1|STARTED|Overall Study||15
2342628|NCT01715129|5750285|P1|NOT COMPLETED|Overall Study||9
2342629|NCT01715129|5750285|P1|COMPLETED|Overall Study||117
2342630|NCT01715129|5750285|P1|STARTED|Overall Study||126
2342631|NCT01715064|5750304|P2|NOT COMPLETED|Overall Study||0
2342632|NCT01715064|5750305|P1|NOT COMPLETED|Overall Study||0
2342633|NCT01715064|5750304|P2|COMPLETED|Overall Study||18
2342634|NCT01715064|5750305|P1|COMPLETED|Overall Study||18
2342635|NCT01715064|5750304|P2|STARTED|Overall Study||18
2342636|NCT01715064|5750305|P1|STARTED|Overall Study||18
2342637|NCT01714947|5750311|P1|NOT COMPLETED|Part B||3
2342638|NCT01714947|5750311|P1|COMPLETED|Part B||0
2342639|NCT01714947|5750311|P1|STARTED|Part B||3
2342640|NCT01714947|5750311|P1|NOT COMPLETED|Part A||0
2342641|NCT01714947|5750311|P1|COMPLETED|Part A||3
2342642|NCT01714947|5750311|P1|STARTED|Part A||3
2342643|NCT01714921|5750340|P1|NOT COMPLETED|Overall Study||193
2342644|NCT01714921|5750340|P1|COMPLETED|Overall Study||311
2342645|NCT01714921|5750340|P1|STARTED|Overall Study||504
2342646|NCT01714817|5750352|P2|NOT COMPLETED|Overall Study||42
2342647|NCT01714817|5750353|P1|NOT COMPLETED|Overall Study||48
2342648|NCT01714817|5750352|P2|COMPLETED|Overall Study|Completed = continued study through Year 1|161
2342649|NCT01714817|5750353|P1|COMPLETED|Overall Study|Completed = continued study through Year 1|155
2342650|NCT01714817|5750352|P2|Treated|Overall Study||203
2342651|NCT01714817|5750353|P1|Treated|Overall Study||202
2342652|NCT01714817|5750352|P2|STARTED|Overall Study||203
2342653|NCT01714817|5750353|P1|STARTED|Overall Study||203
2342654|NCT01714804|5750374|P2|NOT COMPLETED|Overall Study||0
2342655|NCT01714804|5750375|P1|NOT COMPLETED|Overall Study||1
2342656|NCT01714804|5750374|P2|COMPLETED|Overall Study||30
2342657|NCT01714804|5750375|P1|COMPLETED|Overall Study||29
2342658|NCT01714804|5750374|P2|STARTED|Overall Study||30
2342659|NCT01714804|5750375|P1|STARTED|Overall Study||30
2342660|NCT01714726|5750385|P4|NOT COMPLETED|Open-Label Period||28
2342661|NCT01714726|5750386|P3|NOT COMPLETED|Open-Label Period||19
2342662|NCT01714726|5750387|P2|NOT COMPLETED|Open-Label Period||0
2342663|NCT01714726|5750388|P1|NOT COMPLETED|Open-Label Period||0
2342664|NCT01714726|5750385|P4|COMPLETED|Open-Label Period||24
2342665|NCT01714726|5750386|P3|COMPLETED|Open-Label Period||33
2342666|NCT01714726|5750387|P2|COMPLETED|Open-Label Period||0
2342667|NCT01714726|5750388|P1|COMPLETED|Open-Label Period||0
2342668|NCT01714726|5750385|P4|STARTED|Open-Label Period||52
2342669|NCT01714726|5750386|P3|STARTED|Open-Label Period||52
2342670|NCT01714726|5750387|P2|STARTED|Open-Label Period||0
2342671|NCT01714726|5750388|P1|STARTED|Open-Label Period||0
2342672|NCT01714726|5750385|P4|NOT COMPLETED|Double-Blinded Induction Period||0
2342673|NCT01714726|5750386|P3|NOT COMPLETED|Double-Blinded Induction Period||0
2342674|NCT01714726|5750387|P2|NOT COMPLETED|Double-Blinded Induction Period||7
2342675|NCT01714726|5750388|P1|NOT COMPLETED|Double-Blinded Induction Period||8
2342676|NCT01714726|5750385|P4|COMPLETED|Double-Blinded Induction Period||0
2342677|NCT01714726|5750386|P3|COMPLETED|Double-Blinded Induction Period||0
2342678|NCT01714726|5750387|P2|COMPLETED|Double-Blinded Induction Period||52
2342679|NCT01714726|5750388|P1|COMPLETED|Double-Blinded Induction Period||52
2342680|NCT01714726|5750385|P4|STARTED|Double-Blinded Induction Period||0
2342681|NCT01714726|5750386|P3|STARTED|Double-Blinded Induction Period||0
2342682|NCT01714726|5750387|P2|STARTED|Double-Blinded Induction Period||59
2342683|NCT01714726|5750388|P1|STARTED|Double-Blinded Induction Period||60
2342684|NCT01714687|5750468|P2|NOT COMPLETED|Overall Study||4
2342685|NCT01714687|5750469|P1|NOT COMPLETED|Overall Study||3
2342686|NCT01714687|5750468|P2|COMPLETED|Overall Study||26
2342687|NCT01714687|5750469|P1|COMPLETED|Overall Study||26
2342688|NCT01714687|5750468|P2|STARTED|Overall Study||30
2342689|NCT01714687|5750469|P1|STARTED|Overall Study||29
2342690|NCT01714635|5750493|P3|NOT COMPLETED|Overall Study||2
2342691|NCT01714635|5750494|P2|NOT COMPLETED|Overall Study||0
2342692|NCT01714635|5750495|P1|NOT COMPLETED|Overall Study||2
2342693|NCT01714635|5750493|P3|COMPLETED|Overall Study||146
2342694|NCT01714635|5750494|P2|COMPLETED|Overall Study||150
2342695|NCT01714635|5750495|P1|COMPLETED|Overall Study||145
2342696|NCT01714635|5750493|P3|STARTED|Overall Study||148
2342697|NCT01714635|5750494|P2|STARTED|Overall Study||150
2342698|NCT01714635|5750495|P1|STARTED|Overall Study||147
2342699|NCT01714609|5750511|P2|NOT COMPLETED|Overall Study||0
2342700|NCT01714609|5750512|P1|NOT COMPLETED|Overall Study||1
2342701|NCT01714609|5750511|P2|COMPLETED|Overall Study||5
2342702|NCT01714609|5750512|P1|COMPLETED|Overall Study||4
2342703|NCT01714609|5750511|P2|STARTED|Overall Study||5
2342704|NCT01714609|5750512|P1|STARTED|Overall Study||5
2342705|NCT01714544|5750518|P1|NOT COMPLETED|Overall Study||3
2342706|NCT01714544|5750518|P1|COMPLETED|Overall Study||57
2342707|NCT01714544|5750518|P1|STARTED|Overall Study||60
2342708|NCT01714505|5750522|P2|NOT COMPLETED|Admission 2 (40 Hours)||0
2342709|NCT01714505|5750523|P1|NOT COMPLETED|Admission 2 (40 Hours)||0
2342710|NCT01714505|5750522|P2|COMPLETED|Admission 2 (40 Hours)||9
2342711|NCT01714505|5750523|P1|COMPLETED|Admission 2 (40 Hours)||9
2342712|NCT01714505|5750522|P2|STARTED|Admission 2 (40 Hours)||9
2342713|NCT01714505|5750523|P1|STARTED|Admission 2 (40 Hours)||9
2342714|NCT01714505|5750522|P2|NOT COMPLETED|Admission 1 (40 Hours)||1
2342715|NCT01714505|5750523|P1|NOT COMPLETED|Admission 1 (40 Hours)||1
2342716|NCT01714505|5750522|P2|COMPLETED|Admission 1 (40 Hours)||9
2342717|NCT01714505|5750523|P1|COMPLETED|Admission 1 (40 Hours)||9
2342718|NCT01714505|5750522|P2|STARTED|Admission 1 (40 Hours)||10
2342719|NCT01714505|5750523|P1|STARTED|Admission 1 (40 Hours)||10
2342720|NCT01714492|5750533|P1|NOT COMPLETED|Overall Study||0
2342721|NCT01714492|5750533|P1|COMPLETED|Overall Study||8
2342722|NCT01714492|5750533|P1|STARTED|Overall Study||8
2342723|NCT01714336|5750544|P2|NOT COMPLETED|Overall Study||0
2342724|NCT01714336|5750545|P1|NOT COMPLETED|Overall Study||0
2342725|NCT01714336|5750544|P2|COMPLETED|Overall Study||69
2342726|NCT01714336|5750545|P1|COMPLETED|Overall Study||69
2342727|NCT01714336|5750544|P2|STARTED|Overall Study||69
2342728|NCT01714336|5750545|P1|STARTED|Overall Study||69
2342729|NCT01714323|5750567|P2|NOT COMPLETED|Overall Study||172
2342730|NCT01714323|5750568|P1|NOT COMPLETED|Overall Study||164
2342731|NCT01714323|5750567|P2|COMPLETED|Overall Study||508
2342732|NCT01714323|5750568|P1|COMPLETED|Overall Study||513
2342733|NCT01714323|5750567|P2|STARTED|Overall Study||680
2342734|NCT01714323|5750568|P1|STARTED|Overall Study||677
2342735|NCT01714310|5750589|P3|NOT COMPLETED|Double Blind Adjunctive Treatment||0
2342736|NCT01714310|5750590|P2|NOT COMPLETED|Double Blind Adjunctive Treatment||3
2342737|NCT01714310|5750591|P1|NOT COMPLETED|Double Blind Adjunctive Treatment||2
2342738|NCT01714310|5750589|P3|COMPLETED|Double Blind Adjunctive Treatment||0
2342739|NCT01714310|5750590|P2|COMPLETED|Double Blind Adjunctive Treatment||11
2342740|NCT01714310|5750591|P1|COMPLETED|Double Blind Adjunctive Treatment||10
2342741|NCT01714310|5750589|P3|STARTED|Double Blind Adjunctive Treatment|No one remained on lisdexamfetamine alone in Period 2.|0
2342742|NCT01714310|5750590|P2|STARTED|Double Blind Adjunctive Treatment|Adjunctive placebo was initiated at beginning of Period 2, at study week 4.|14
2342743|NCT01714310|5750591|P1|STARTED|Double Blind Adjunctive Treatment|Adjunctive fluoxetine treatment was initiated at beginning of Period 2, at study week 4.|12
2342744|NCT01714310|5750589|P3|NOT COMPLETED|Open Lisdexamfetamine Titration||4
2342745|NCT01714310|5750590|P2|NOT COMPLETED|Open Lisdexamfetamine Titration||0
2342746|NCT01714310|5750591|P1|NOT COMPLETED|Open Lisdexamfetamine Titration||0
2342747|NCT01714310|5750589|P3|COMPLETED|Open Lisdexamfetamine Titration||30
2342748|NCT01714310|5750590|P2|COMPLETED|Open Lisdexamfetamine Titration||0
2342749|NCT01714310|5750591|P1|COMPLETED|Open Lisdexamfetamine Titration||0
2342750|NCT01714310|5750589|P3|STARTED|Open Lisdexamfetamine Titration||34
2342751|NCT01714310|5750590|P2|STARTED|Open Lisdexamfetamine Titration||0
2342752|NCT01714310|5750591|P1|STARTED|Open Lisdexamfetamine Titration||0
2342753|NCT01714232|5750638|P1|NOT COMPLETED|Overall Study||0
2342754|NCT01714232|5750638|P1|COMPLETED|Overall Study||106
2342755|NCT01714232|5750638|P1|STARTED|Overall Study||106
2342756|NCT01714063|5750644|P1|NOT COMPLETED|Overall Study||2
2342757|NCT01714063|5750644|P1|COMPLETED|Overall Study||32
2342758|NCT01714063|5750644|P1|STARTED|Overall Study||34
2342759|NCT01714024|5750659|P3|NOT COMPLETED|Overall Study||3
2342760|NCT01714024|5750660|P2|NOT COMPLETED|Overall Study||6
2342761|NCT01714024|5750661|P1|NOT COMPLETED|Overall Study||1
2342762|NCT01714024|5750659|P3|COMPLETED|Overall Study||8
2342763|NCT01714024|5750660|P2|COMPLETED|Overall Study||12
2342764|NCT01714024|5750661|P1|COMPLETED|Overall Study||12
2342765|NCT01714024|5750659|P3|STARTED|Overall Study||11
2342766|NCT01714024|5750660|P2|STARTED|Overall Study||18
2342767|NCT01714024|5750661|P1|STARTED|Overall Study||13
2342768|NCT01713998|5750681|P3|NOT COMPLETED|Overall Study||2
2342769|NCT01713998|5750682|P2|NOT COMPLETED|Overall Study||0
2342770|NCT01713998|5750683|P1|NOT COMPLETED|Overall Study||3
2342771|NCT01713998|5750681|P3|COMPLETED|Overall Study||14
2342772|NCT01713998|5750682|P2|COMPLETED|Overall Study||15
2342773|NCT01713998|5750683|P1|COMPLETED|Overall Study||13
2342774|NCT01713998|5750681|P3|STARTED|Overall Study||16
2342775|NCT01713998|5750682|P2|STARTED|Overall Study||15
2342776|NCT01713998|5750683|P1|STARTED|Overall Study||16
2342777|NCT01713946|5750704|P3|NOT COMPLETED|Overall Study||44
2342778|NCT01713946|5750705|P2|NOT COMPLETED|Overall Study||45
2342779|NCT01713946|5750706|P1|NOT COMPLETED|Overall Study||43
2342780|NCT01713946|5750704|P3|COMPLETED|Overall Study||75
2342781|NCT01713946|5750705|P2|COMPLETED|Overall Study||85
2342782|NCT01713946|5750706|P1|COMPLETED|Overall Study||74
2342783|NCT01713946|5750704|P3|Did Not Cont. in Post-Ext Phase|Overall Study||0
2342784|NCT01713946|5750705|P2|Did Not Cont. in Post-Ext Phase|Overall Study||2
2342785|NCT01713946|5750706|P1|Did Not Cont. in Post-Ext Phase|Overall Study||1
2342786|NCT01713946|5750704|P3|Did Not Continue in Ext Phase|Overall Study||0
2342787|NCT01713946|5750705|P2|Did Not Continue in Ext Phase|Overall Study||3
2342788|NCT01713946|5750706|P1|Did Not Continue in Ext Phase|Overall Study||0
2342789|NCT01713946|5750704|P3|Completed Post-Ext Phase|Overall Study||75
2342790|NCT01713946|5750705|P2|Completed Post-Ext Phase|Overall Study||85
2342791|NCT01713946|5750706|P1|Completed Post-Ext Phase|Overall Study||74
2342792|NCT01713946|5750704|P3|Continued in Post-Ext. Phase|Overall Study||81
2342793|NCT01713946|5750705|P2|Continued in Post-Ext. Phase|Overall Study||90
2342794|NCT01713946|5750706|P1|Continued in Post-Ext. Phase|Overall Study||78
2342795|NCT01713946|5750704|P3|Completed Ext. Phase|Overall Study||81
2342796|NCT01713946|5750705|P2|Completed Ext. Phase|Overall Study||92
2342797|NCT01713946|5750706|P1|Completed Ext. Phase|Overall Study||79
2342798|NCT01713946|5750704|P3|Continued in Ext. Phase|Overall Study||114
2342799|NCT01713946|5750705|P2|Continued in Ext. Phase|Overall Study||119
2342800|NCT01713946|5750706|P1|Continued in Ext. Phase|Overall Study||110
2342801|NCT01713946|5750704|P3|Completed Core Phase|Overall Study||114
2342802|NCT01713946|5750705|P2|Completed Core Phase|Overall Study||122
2342803|NCT01713946|5750706|P1|Completed Core Phase|Overall Study||110
2342804|NCT01713946|5750704|P3|STARTED|Overall Study|Of the 119 patients initially randomized to the Placebo arm, 5 patients never switched to everolimus|119
2342805|NCT01713946|5750705|P2|STARTED|Overall Study||130
2342806|NCT01713946|5750706|P1|STARTED|Overall Study||117
2342807|NCT01713933|5750797|P1|NOT COMPLETED|Overall Study||6
2342808|NCT01713933|5750797|P1|COMPLETED|Overall Study||31
2342809|NCT01713933|5750797|P1|STARTED|Overall Study||37
2342810|NCT01713868|5750813|P4|NOT COMPLETED|Overall Study||95
2342811|NCT01713868|5750814|P3|NOT COMPLETED|Overall Study||80
2342812|NCT01713868|5750815|P2|NOT COMPLETED|Overall Study||65
2342813|NCT01713868|5750816|P1|NOT COMPLETED|Overall Study||97
2342814|NCT01713868|5750813|P4|COMPLETED|Overall Study||305
2342815|NCT01713868|5750814|P3|COMPLETED|Overall Study||320
2342816|NCT01713868|5750815|P2|COMPLETED|Overall Study||335
2342817|NCT01713868|5750816|P1|COMPLETED|Overall Study||303
2342818|NCT01713868|5750813|P4|STARTED|Overall Study||400
2342819|NCT01713868|5750814|P3|STARTED|Overall Study||400
2342820|NCT01713868|5750815|P2|STARTED|Overall Study||400
2342821|NCT01713868|5750816|P1|STARTED|Overall Study||400
2342822|NCT01713686|5750846|P1|NOT COMPLETED|Overall Study||15
2342823|NCT01713686|5750846|P1|COMPLETED|Overall Study||110
2343009|NCT01712399|5751391|P1|COMPLETED|Overall Study||0
2342824|NCT01713686|5750846|P1|STARTED|Overall Study|129 enrolled, 125 treated. 2 withdrew consent prior to treatment; 2 excluded after enrollment.|125
2342825|NCT01713660|5750855|P1|NOT COMPLETED|Overall Study||0
2342826|NCT01713660|5750855|P1|COMPLETED|Overall Study||37
2342827|NCT01713660|5750855|P1|STARTED|Overall Study||37
2342828|NCT01713621|5750863|P2|NOT COMPLETED|Overall Study||16
2342829|NCT01713621|5750864|P1|NOT COMPLETED|Overall Study||7
2342830|NCT01713621|5750863|P2|COMPLETED|Overall Study||1
2342831|NCT01713621|5750864|P1|COMPLETED|Overall Study||1
2342832|NCT01713621|5750863|P2|STARTED|Overall Study||17
2342833|NCT01713621|5750864|P1|STARTED|Overall Study||8
2342834|NCT01713608|5750874|P4|NOT COMPLETED|Overall Study||0
2342835|NCT01713608|5750875|P3|NOT COMPLETED|Overall Study||0
2342836|NCT01713608|5750876|P2|NOT COMPLETED|Overall Study||0
2342837|NCT01713608|5750877|P1|NOT COMPLETED|Overall Study||0
2342838|NCT01713608|5750874|P4|COMPLETED|Overall Study||12
2342839|NCT01713608|5750875|P3|COMPLETED|Overall Study||8
2342840|NCT01713608|5750876|P2|COMPLETED|Overall Study||6
2342841|NCT01713608|5750877|P1|COMPLETED|Overall Study||8
2342842|NCT01713608|5750874|P4|STARTED|Overall Study||12
2342843|NCT01713608|5750875|P3|STARTED|Overall Study||8
2342844|NCT01713608|5750876|P2|STARTED|Overall Study||6
2342845|NCT01713608|5750877|P1|STARTED|Overall Study||8
2342846|NCT01713582|5750916|P21|NOT COMPLETED|Overall Study||15
2342847|NCT01713582|5750917|P20|NOT COMPLETED|Overall Study||5
2342848|NCT01713582|5750918|P19|NOT COMPLETED|Overall Study||5
2342849|NCT01713582|5750919|P18|NOT COMPLETED|Overall Study||3
2342850|NCT01713582|5750920|P17|NOT COMPLETED|Overall Study||7
2342851|NCT01713582|5750921|P16|NOT COMPLETED|Overall Study||6
2342852|NCT01713582|5750922|P15|NOT COMPLETED|Overall Study||7
2342853|NCT01713582|5750923|P14|NOT COMPLETED|Overall Study||4
2342854|NCT01713582|5750924|P13|NOT COMPLETED|Overall Study||3
2342855|NCT01713582|5750925|P12|NOT COMPLETED|Overall Study||5
2342856|NCT01713582|5750926|P11|NOT COMPLETED|Overall Study||16
2342857|NCT01713582|5750927|P10|NOT COMPLETED|Overall Study||18
2342858|NCT01713582|5750928|P9|NOT COMPLETED|Overall Study||6
2342859|NCT01713582|5750929|P8|NOT COMPLETED|Overall Study||6
2342860|NCT01713582|5750930|P7|NOT COMPLETED|Overall Study||7
2342861|NCT01713582|5750931|P6|NOT COMPLETED|Overall Study||8
2342862|NCT01713582|5750932|P5|NOT COMPLETED|Overall Study||4
2342863|NCT01713582|5750933|P4|NOT COMPLETED|Overall Study||3
2342864|NCT01713582|5750934|P3|NOT COMPLETED|Overall Study||4
2342865|NCT01713582|5750935|P2|NOT COMPLETED|Overall Study||3
2342866|NCT01713582|5750936|P1|NOT COMPLETED|Overall Study||3
2342867|NCT01713582|5750916|P21|COMPLETED|Overall Study||0
2342868|NCT01713582|5750917|P20|COMPLETED|Overall Study||0
2342869|NCT01713582|5750918|P19|COMPLETED|Overall Study||0
2342870|NCT01713582|5750919|P18|COMPLETED|Overall Study||0
2342871|NCT01713582|5750920|P17|COMPLETED|Overall Study||0
2342872|NCT01713582|5750921|P16|COMPLETED|Overall Study||0
2342873|NCT01713582|5750922|P15|COMPLETED|Overall Study||0
2342874|NCT01713582|5750923|P14|COMPLETED|Overall Study||0
2342875|NCT01713582|5750924|P13|COMPLETED|Overall Study||0
2342876|NCT01713582|5750925|P12|COMPLETED|Overall Study||0
2342877|NCT01713582|5750926|P11|COMPLETED|Overall Study||0
2342878|NCT01713582|5750927|P10|COMPLETED|Overall Study||0
2342879|NCT01713582|5750928|P9|COMPLETED|Overall Study||0
2342880|NCT01713582|5750929|P8|COMPLETED|Overall Study||0
2342881|NCT01713582|5750930|P7|COMPLETED|Overall Study||0
2342882|NCT01713582|5750931|P6|COMPLETED|Overall Study||0
2342883|NCT01713582|5750932|P5|COMPLETED|Overall Study||0
2342884|NCT01713582|5750933|P4|COMPLETED|Overall Study||0
2342885|NCT01713582|5750934|P3|COMPLETED|Overall Study||0
2342886|NCT01713582|5750935|P2|COMPLETED|Overall Study||0
2342887|NCT01713582|5750936|P1|COMPLETED|Overall Study||0
2342888|NCT01713582|5750916|P21|STARTED|Overall Study|Number treated|15
2342889|NCT01713582|5750917|P20|STARTED|Overall Study|Number treated|5
2342890|NCT01713582|5750918|P19|STARTED|Overall Study|Number treated|5
2342891|NCT01713582|5750919|P18|STARTED|Overall Study|Number treated|3
2342892|NCT01713582|5750920|P17|STARTED|Overall Study|Number treated|7
2342893|NCT01713582|5750921|P16|STARTED|Overall Study|Number treated|6
2342894|NCT01713582|5750922|P15|STARTED|Overall Study|Number treated|7
2342895|NCT01713582|5750923|P14|STARTED|Overall Study|Number treated|4
2342896|NCT01713582|5750924|P13|STARTED|Overall Study|Number treated|3
2342897|NCT01713582|5750925|P12|STARTED|Overall Study|Number treated|5
2342898|NCT01713582|5750926|P11|STARTED|Overall Study|Number treated|16
2342899|NCT01713582|5750927|P10|STARTED|Overall Study|Number treated|18
2342900|NCT01713582|5750928|P9|STARTED|Overall Study|Number treated|6
2342901|NCT01713582|5750929|P8|STARTED|Overall Study|Number treated|6
2342902|NCT01713582|5750930|P7|STARTED|Overall Study|Number treated|7
2342903|NCT01713582|5750931|P6|STARTED|Overall Study|Number treated|8
2342904|NCT01713582|5750932|P5|STARTED|Overall Study|Number treated|4
2342905|NCT01713582|5750933|P4|STARTED|Overall Study|Number treated|3
2342906|NCT01713582|5750934|P3|STARTED|Overall Study|Number treated|4
2342907|NCT01713582|5750935|P2|STARTED|Overall Study|Number treated|3
2342908|NCT01713582|5750936|P1|STARTED|Overall Study|Number treated|3
2342909|NCT01713530|5751099|P2|NOT COMPLETED|Overall Study||19
2342910|NCT01713530|5751100|P1|NOT COMPLETED|Overall Study||25
2342911|NCT01713530|5751099|P2|COMPLETED|Overall Study||117
2342912|NCT01713530|5751100|P1|COMPLETED|Overall Study||113
2342913|NCT01713530|5751099|P2|Exposed|Overall Study|One (1) subject was withdrawn by the investigator|135
2343010|NCT01712399|5751391|P1|STARTED|Overall Study||397
2342914|NCT01713530|5751100|P1|Exposed|Overall Study|One (1) subject was randomised in error and 1 subject withdrew consent|136
2342915|NCT01713530|5751099|P2|STARTED|Overall Study||136
2342916|NCT01713530|5751100|P1|STARTED|Overall Study||138
2342917|NCT01713400|5751118|P2|NOT COMPLETED|Overall Study||0
2342918|NCT01713400|5751119|P1|NOT COMPLETED|Overall Study||0
2342919|NCT01713400|5751118|P2|COMPLETED|Overall Study||15
2342920|NCT01713400|5751119|P1|COMPLETED|Overall Study||15
2342921|NCT01713400|5751118|P2|STARTED|Overall Study||15
2342922|NCT01713400|5751119|P1|STARTED|Overall Study||15
2342923|NCT01713348|5751131|P4|NOT COMPLETED|Overall Study||0
2342924|NCT01713348|5751132|P3|NOT COMPLETED|Overall Study||2
2342925|NCT01713348|5751133|P2|NOT COMPLETED|Overall Study||2
2342926|NCT01713348|5751134|P1|NOT COMPLETED|Overall Study||4
2342927|NCT01713348|5751131|P4|COMPLETED|Overall Study||15
2342928|NCT01713348|5751132|P3|COMPLETED|Overall Study||28
2342929|NCT01713348|5751133|P2|COMPLETED|Overall Study||11
2342930|NCT01713348|5751134|P1|COMPLETED|Overall Study||25
2342931|NCT01713348|5751131|P4|STARTED|Overall Study||15
2342932|NCT01713348|5751132|P3|STARTED|Overall Study||30
2342933|NCT01713348|5751133|P2|STARTED|Overall Study||13
2342934|NCT01713348|5751134|P1|STARTED|Overall Study||29
2342935|NCT01713283|5751164|P2|NOT COMPLETED|Overall Study||3
2342936|NCT01713283|5751165|P1|NOT COMPLETED|Overall Study||11
2342937|NCT01713283|5751164|P2|COMPLETED|Overall Study||26
2342938|NCT01713283|5751165|P1|COMPLETED|Overall Study||20
2342939|NCT01713283|5751164|P2|STARTED|Overall Study||29
2342940|NCT01713283|5751165|P1|STARTED|Overall Study||31
2342941|NCT01713036|5751187|P1|NOT COMPLETED|Overall Study||1
2342942|NCT01713036|5751187|P1|COMPLETED|Overall Study||5
2342943|NCT01713036|5751187|P1|STARTED|Overall Study||6
2342944|NCT01712984|5751227|P3|NOT COMPLETED|Overall Study||10
2342945|NCT01712984|5751228|P2|NOT COMPLETED|Overall Study||16
2342946|NCT01712984|5751229|P1|NOT COMPLETED|Overall Study||16
2342947|NCT01712984|5751227|P3|COMPLETED|Overall Study||836
2342948|NCT01712984|5751228|P2|COMPLETED|Overall Study||821
2342949|NCT01712984|5751229|P1|COMPLETED|Overall Study||1656
2342950|NCT01712984|5751227|P3|STARTED|Overall Study||846
2342951|NCT01712984|5751228|P2|STARTED|Overall Study||837
2342952|NCT01712984|5751229|P1|STARTED|Overall Study||1672
2342953|NCT01712854|5751249|P1|NOT COMPLETED|Overall Study||1
2342954|NCT01712854|5751249|P1|COMPLETED|Overall Study||8
2342955|NCT01712854|5751249|P1|STARTED|Overall Study||9
2342956|NCT01712776|5751256|P2|NOT COMPLETED|Overall Study||0
2342957|NCT01712776|5751257|P1|NOT COMPLETED|Overall Study||0
2342958|NCT01712776|5751256|P2|COMPLETED|Overall Study||50
2342959|NCT01712776|5751257|P1|COMPLETED|Overall Study|trial to enroll 50 in each group for total of 100|50
2342960|NCT01712776|5751256|P2|STARTED|Overall Study||50
2342961|NCT01712776|5751257|P1|STARTED|Overall Study||50
2342962|NCT01712711|5751265|P2|NOT COMPLETED|Overall Study||0
2342963|NCT01712711|5751266|P1|NOT COMPLETED|Overall Study||0
2342964|NCT01712711|5751265|P2|COMPLETED|Overall Study||20
2342965|NCT01712711|5751266|P1|COMPLETED|Overall Study||20
2342966|NCT01712711|5751265|P2|STARTED|Overall Study||20
2342967|NCT01712711|5751266|P1|STARTED|Overall Study||20
2342968|NCT01712685|5751272|P1|NOT COMPLETED|Overall Study||1
2342969|NCT01712685|5751272|P1|COMPLETED|Overall Study||11
2342970|NCT01712685|5751272|P1|STARTED|Overall Study||12
2342971|NCT01712516|5751288|P4|NOT COMPLETED|Overall Study||13
2342972|NCT01712516|5751289|P3|NOT COMPLETED|Overall Study||6
2342973|NCT01712516|5751290|P2|NOT COMPLETED|Overall Study||10
2342974|NCT01712516|5751291|P1|NOT COMPLETED|Overall Study||6
2342975|NCT01712516|5751288|P4|COMPLETED|Overall Study||236
2342976|NCT01712516|5751289|P3|COMPLETED|Overall Study||245
2342977|NCT01712516|5751290|P2|COMPLETED|Overall Study||241
2342978|NCT01712516|5751291|P1|COMPLETED|Overall Study||244
2342979|NCT01712516|5751288|P4|Full Analysis Set|Overall Study||247
2342980|NCT01712516|5751289|P3|Full Analysis Set|Overall Study||250
2342981|NCT01712516|5751290|P2|Full Analysis Set|Overall Study||251
2342982|NCT01712516|5751291|P1|Full Analysis Set|Overall Study||250
2342983|NCT01712516|5751288|P4|Safety Set|Overall Study||248
2342984|NCT01712516|5751289|P3|Safety Set|Overall Study||251
2342985|NCT01712516|5751290|P2|Safety Set|Overall Study||251
2342986|NCT01712516|5751291|P1|Safety Set|Overall Study||250
2342987|NCT01712516|5751288|P4|STARTED|Overall Study||249
2342988|NCT01712516|5751289|P3|STARTED|Overall Study||251
2342989|NCT01712516|5751290|P2|STARTED|Overall Study||251
2342990|NCT01712516|5751291|P1|STARTED|Overall Study||250
2342991|NCT01712490|5751343|P2|NOT COMPLETED|Overall Study||670
2342992|NCT01712490|5751344|P1|NOT COMPLETED|Overall Study||664
2342993|NCT01712490|5751343|P2|COMPLETED|Overall Study||0
2342994|NCT01712490|5751344|P1|COMPLETED|Overall Study||0
2342995|NCT01712490|5751343|P2|Treated|Overall Study||659
2342996|NCT01712490|5751344|P1|Treated|Overall Study||662
2342997|NCT01712490|5751343|P2|STARTED|Overall Study||670
2342998|NCT01712490|5751344|P1|STARTED|Overall Study||664
2342999|NCT01712438|5751381|P1|NOT COMPLETED|Overall Study||37
2343000|NCT01712438|5751381|P1|COMPLETED|Overall Study||73
2343001|NCT01712438|5751381|P1|SURG Population|Overall Study||24
2343002|NCT01712438|5751381|P1|BLEED Population|Overall Study||94
2343003|NCT01712438|5751381|P1|PROPH Population|Overall Study||103
2343004|NCT01712438|5751381|P1|PP Population|Overall Study||95
2343005|NCT01712438|5751381|P1|ITT Population|Overall Study||108
2343006|NCT01712438|5751381|P1|SAF Population|Overall Study||108
2343007|NCT01712438|5751381|P1|STARTED|Overall Study||110
2343008|NCT01712399|5751391|P1|NOT COMPLETED|Overall Study||397
2343011|NCT01712360|5751408|P4|NOT COMPLETED|Overall Study||2
2343012|NCT01712360|5751409|P3|NOT COMPLETED|Overall Study||0
2343013|NCT01712360|5751410|P2|NOT COMPLETED|Overall Study||1
2343014|NCT01712360|5751411|P1|NOT COMPLETED|Overall Study||0
2343015|NCT01712360|5751408|P4|COMPLETED|Overall Study||4
2343016|NCT01712360|5751409|P3|COMPLETED|Overall Study||6
2343017|NCT01712360|5751410|P2|COMPLETED|Overall Study||21
2343018|NCT01712360|5751411|P1|COMPLETED|Overall Study||22
2343019|NCT01712360|5751408|P4|STARTED|Overall Study||6
2343020|NCT01712360|5751409|P3|STARTED|Overall Study||6
2343021|NCT01712360|5751410|P2|STARTED|Overall Study||22
2343022|NCT01712360|5751411|P1|STARTED|Overall Study||22
2343023|NCT01712334|5751437|P2|NOT COMPLETED|Treatment Period 2||0
2343024|NCT01712334|5751438|P1|NOT COMPLETED|Treatment Period 2||0
2343025|NCT01712334|5751437|P2|COMPLETED|Treatment Period 2||41
2343026|NCT01712334|5751438|P1|COMPLETED|Treatment Period 2||44
2343027|NCT01712334|5751437|P2|STARTED|Treatment Period 2||41
2343028|NCT01712334|5751438|P1|STARTED|Treatment Period 2||44
2343029|NCT01712334|5751437|P2|NOT COMPLETED|Treatment Period 1||2
2343030|NCT01712334|5751438|P1|NOT COMPLETED|Treatment Period 1||0
2343031|NCT01712334|5751437|P2|COMPLETED|Treatment Period 1||41
2343032|NCT01712334|5751438|P1|COMPLETED|Treatment Period 1||44
2343033|NCT01712334|5751437|P2|Received Treatment|Treatment Period 1||41
2343034|NCT01712334|5751438|P1|Received Treatment|Treatment Period 1||44
2343035|NCT01712334|5751437|P2|STARTED|Treatment Period 1||43
2343036|NCT01712334|5751438|P1|STARTED|Treatment Period 1||44
2343037|NCT01712256|5751446|P1|NOT COMPLETED|Overall Study||1
2343038|NCT01712256|5751446|P1|COMPLETED|Overall Study||32
2343039|NCT01712256|5751446|P1|STARTED|Overall Study||33
2343040|NCT01712230|5751458|P3|NOT COMPLETED|Overall Study||7
2343041|NCT01712230|5751459|P2|NOT COMPLETED|Overall Study||4
2343042|NCT01712230|5751460|P1|NOT COMPLETED|Overall Study||2
2343043|NCT01712230|5751458|P3|COMPLETED|Overall Study||11
2343044|NCT01712230|5751459|P2|COMPLETED|Overall Study||14
2343045|NCT01712230|5751460|P1|COMPLETED|Overall Study||9
2343046|NCT01712230|5751458|P3|STARTED|Overall Study||18
2343047|NCT01712230|5751459|P2|STARTED|Overall Study||18
2343048|NCT01712230|5751460|P1|STARTED|Overall Study||11
2343049|NCT01712204|5751476|P2|NOT COMPLETED|Overall Study||5
2343050|NCT01712204|5751477|P1|NOT COMPLETED|Overall Study||8
2343051|NCT01712204|5751476|P2|COMPLETED|Overall Study||36
2343052|NCT01712204|5751477|P1|COMPLETED|Overall Study||33
2343053|NCT01712204|5751476|P2|STARTED|Overall Study||41
2343054|NCT01712204|5751477|P1|STARTED|Overall Study||41
2343055|NCT01712178|5751485|P2|NOT COMPLETED|Overall Study||3
2343056|NCT01712178|5751486|P1|NOT COMPLETED|Overall Study||1
2343057|NCT01712178|5751485|P2|COMPLETED|Overall Study||47
2343058|NCT01712178|5751486|P1|COMPLETED|Overall Study||49
2343059|NCT01712178|5751485|P2|STARTED|Overall Study||50
2343060|NCT01712178|5751486|P1|STARTED|Overall Study||50
2343061|NCT01712074|5751511|P3|NOT COMPLETED|Double Blind Period||8
2343062|NCT01712074|5751512|P2|NOT COMPLETED|Double Blind Period||14
2343063|NCT01712074|5751513|P1|NOT COMPLETED|Double Blind Period||0
2343064|NCT01712074|5751511|P3|COMPLETED|Double Blind Period||86
2343065|NCT01712074|5751512|P2|COMPLETED|Double Blind Period||77
2343066|NCT01712074|5751513|P1|COMPLETED|Double Blind Period||0
2343067|NCT01712074|5751511|P3|STARTED|Double Blind Period||94
2343068|NCT01712074|5751512|P2|STARTED|Double Blind Period||91
2343069|NCT01712074|5751513|P1|STARTED|Double Blind Period||0
2343070|NCT01712074|5751511|P3|NOT COMPLETED|Placebo Run-in Period||0
2343071|NCT01712074|5751512|P2|NOT COMPLETED|Placebo Run-in Period||0
2343072|NCT01712074|5751513|P1|NOT COMPLETED|Placebo Run-in Period||10
2343073|NCT01712074|5751511|P3|COMPLETED|Placebo Run-in Period||0
2343074|NCT01712074|5751512|P2|COMPLETED|Placebo Run-in Period||0
2343075|NCT01712074|5751513|P1|COMPLETED|Placebo Run-in Period||185
2343076|NCT01712074|5751511|P3|STARTED|Placebo Run-in Period||0
2343077|NCT01712074|5751512|P2|STARTED|Placebo Run-in Period||0
2343078|NCT01712074|5751513|P1|STARTED|Placebo Run-in Period||195
2343079|NCT01712061|5751569|P3|NOT COMPLETED|Overall Study||11
2343080|NCT01712061|5751570|P2|NOT COMPLETED|Overall Study||26
2343081|NCT01712061|5751571|P1|NOT COMPLETED|Overall Study||10
2343082|NCT01712061|5751569|P3|COMPLETED|Overall Study||45
2343083|NCT01712061|5751570|P2|COMPLETED|Overall Study||114
2343084|NCT01712061|5751571|P1|COMPLETED|Overall Study||20
2343085|NCT01712061|5751569|P3|STARTED|Overall Study||56
2343086|NCT01712061|5751570|P2|STARTED|Overall Study||140
2343087|NCT01712061|5751571|P1|STARTED|Overall Study||30
2343088|NCT01712009|5751611|P3|NOT COMPLETED|Overall Study||21
2343089|NCT01712009|5751612|P2|NOT COMPLETED|Overall Study||29
2343090|NCT01712009|5751613|P1|NOT COMPLETED|Overall Study||38
2343091|NCT01712009|5751611|P3|COMPLETED|Overall Study||181
2343092|NCT01712009|5751612|P2|COMPLETED|Overall Study||171
2343093|NCT01712009|5751613|P1|COMPLETED|Overall Study||160
2343094|NCT01712009|5751611|P3|Received Naproxen / Loratadine|Overall Study||198
2343095|NCT01712009|5751612|P2|Received Naproxen / Loratadine|Overall Study||193
2343096|NCT01712009|5751613|P1|Received Naproxen / Loratadine|Overall Study||0
2343097|NCT01712009|5751611|P3|Received Pegfilgrastim|Overall Study||200
2343098|NCT01712009|5751612|P2|Received Pegfilgrastim|Overall Study||196
2343099|NCT01712009|5751613|P1|Received Pegfilgrastim|Overall Study||191
2343100|NCT01712009|5751611|P3|STARTED|Overall Study||202
2343101|NCT01712009|5751612|P2|STARTED|Overall Study||200
2343102|NCT01712009|5751613|P1|STARTED|Overall Study||198
2343103|NCT01711918|5751639|P1|NOT COMPLETED|Overall Study||2
2343104|NCT01711918|5751639|P1|COMPLETED|Overall Study||7
2343105|NCT01711918|5751639|P1|STARTED|Overall Study||9
2343106|NCT01711866|5751647|P1|NOT COMPLETED|Overall Study||8
2343107|NCT01711866|5751647|P1|COMPLETED|Overall Study||79
2343108|NCT01711866|5751647|P1|STARTED|Overall Study||87
2343109|NCT01711853|5751652|P1|NOT COMPLETED|Overall Study||3
2343110|NCT01711853|5751652|P1|COMPLETED|Overall Study||16
2343111|NCT01711853|5751652|P1|STARTED|Overall Study||19
2343112|NCT01711736|5751659|P2|NOT COMPLETED|Overall Study||8
2343113|NCT01711736|5751660|P1|NOT COMPLETED|Overall Study||12
2343114|NCT01711736|5751659|P2|COMPLETED|Overall Study|Up to Day 180|294
2343115|NCT01711736|5751660|P1|COMPLETED|Overall Study|Up to Day 180|287
2343116|NCT01711736|5751659|P2|STARTED|Overall Study||302
2343117|NCT01711736|5751660|P1|STARTED|Overall Study||299
2343118|NCT01711645|5751688|P1|NOT COMPLETED|Overall Study||19
2343119|NCT01711645|5751688|P1|COMPLETED|Overall Study||36
2343120|NCT01711645|5751688|P1|STARTED|Overall Study||55
2343121|NCT01711619|5751725|P2|NOT COMPLETED|Overall Study||24
2343122|NCT01711619|5751726|P1|NOT COMPLETED|Overall Study||18
2343123|NCT01711619|5751725|P2|COMPLETED|Overall Study||36
2343124|NCT01711619|5751726|P1|COMPLETED|Overall Study||38
2343125|NCT01711619|5751725|P2|STARTED|Overall Study||60
2343126|NCT01711619|5751726|P1|STARTED|Overall Study||56
2343127|NCT01711541|5751743|P5|NOT COMPLETED|Overall Study||0
2343128|NCT01711541|5751744|P4|NOT COMPLETED|Overall Study||1
2343129|NCT01711541|5751745|P3|NOT COMPLETED|Overall Study||0
2343130|NCT01711541|5751746|P2|NOT COMPLETED|Overall Study||1
2343131|NCT01711541|5751747|P1|NOT COMPLETED|Overall Study||0
2343132|NCT01711541|5751743|P5|COMPLETED|Overall Study||7
2343133|NCT01711541|5751744|P4|COMPLETED|Overall Study||5
2343134|NCT01711541|5751745|P3|COMPLETED|Overall Study||3
2343135|NCT01711541|5751746|P2|COMPLETED|Overall Study||3
2343136|NCT01711541|5751747|P1|COMPLETED|Overall Study||4
2343137|NCT01711541|5751743|P5|STARTED|Overall Study||7
2343138|NCT01711541|5751744|P4|STARTED|Overall Study||6
2343139|NCT01711541|5751745|P3|STARTED|Overall Study||3
2343140|NCT01711541|5751746|P2|STARTED|Overall Study||4
2343141|NCT01711541|5751747|P1|STARTED|Overall Study||4
2343142|NCT01711424|5751776|P1|NOT COMPLETED|Overall Study||0
2343143|NCT01711424|5751776|P1|COMPLETED|Overall Study||1209
2343144|NCT01711424|5751776|P1|STARTED|Overall Study||1209
2343145|NCT01711372|5751785|P2|NOT COMPLETED|Overall Study||0
2343146|NCT01711372|5751786|P1|NOT COMPLETED|Overall Study||0
2343147|NCT01711372|5751785|P2|COMPLETED|Overall Study||47
2343148|NCT01711372|5751786|P1|COMPLETED|Overall Study||66
2343149|NCT01711372|5751785|P2|STARTED|Overall Study||47
2343150|NCT01711372|5751786|P1|STARTED|Overall Study||66
2343151|NCT01711359|5751796|P3|NOT COMPLETED|Follow Up||28
2343152|NCT01711359|5751797|P2|NOT COMPLETED|Follow Up||15
2343153|NCT01711359|5751798|P1|NOT COMPLETED|Follow Up||25
2343154|NCT01711359|5751796|P3|COMPLETED|Follow Up||0
2343155|NCT01711359|5751797|P2|COMPLETED|Follow Up||0
2343156|NCT01711359|5751798|P1|COMPLETED|Follow Up||0
2343157|NCT01711359|5751796|P3|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|28
2343158|NCT01711359|5751797|P2|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|15
2343159|NCT01711359|5751798|P1|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|25
2343160|NCT01711359|5751796|P3|NOT COMPLETED|Treatment Period||42
2343161|NCT01711359|5751797|P2|NOT COMPLETED|Treatment Period||24
2343162|NCT01711359|5751798|P1|NOT COMPLETED|Treatment Period||52
2343163|NCT01711359|5751796|P3|COMPLETED|Treatment Period||173
2343164|NCT01711359|5751797|P2|COMPLETED|Treatment Period||136
2343165|NCT01711359|5751798|P1|COMPLETED|Treatment Period||161
2343166|NCT01711359|5751796|P3|Rescued|Treatment Period||6
2343167|NCT01711359|5751797|P2|Rescued|Treatment Period||7
2343168|NCT01711359|5751798|P1|Rescued|Treatment Period||26
2343169|NCT01711359|5751796|P3|Received at Least One Dose of Study Drug|Treatment Period||215
2343170|NCT01711359|5751797|P2|Received at Least One Dose of Study Drug|Treatment Period||159
2343171|NCT01711359|5751798|P1|Received at Least One Dose of Study Drug|Treatment Period||210
2343172|NCT01711359|5751796|P3|STARTED|Treatment Period||215
2343173|NCT01711359|5751797|P2|STARTED|Treatment Period||160
2343174|NCT01711359|5751798|P1|STARTED|Treatment Period||213
2343175|NCT01711216|5751869|P1|NOT COMPLETED|Overall Study||217
2343176|NCT01711216|5751869|P1|COMPLETED|Overall Study||782
2343177|NCT01711216|5751869|P1|STARTED|Overall Study||999
2343178|NCT01711177|5751893|P3|NOT COMPLETED|Overall Study||0
2343179|NCT01711177|5751894|P2|NOT COMPLETED|Overall Study||0
2343180|NCT01711177|5751895|P1|NOT COMPLETED|Overall Study||0
2343181|NCT01711177|5751893|P3|COMPLETED|Overall Study||3
2343182|NCT01711177|5751894|P2|COMPLETED|Overall Study||3
2343183|NCT01711177|5751895|P1|COMPLETED|Overall Study||10
2343184|NCT01711177|5751893|P3|STARTED|Overall Study||3
2343185|NCT01711177|5751894|P2|STARTED|Overall Study||3
2343186|NCT01711177|5751895|P1|STARTED|Overall Study||10
2343187|NCT01710891|5751905|P2|NOT COMPLETED|Overall Study||0
2343188|NCT01710891|5751906|P1|NOT COMPLETED|Overall Study||0
2343189|NCT01710891|5751905|P2|COMPLETED|Overall Study||103
2343190|NCT01710891|5751906|P1|COMPLETED|Overall Study||95
2343191|NCT01710891|5751905|P2|STARTED|Overall Study||103
2343192|NCT01710891|5751906|P1|STARTED|Overall Study||95
2343193|NCT01710839|5751924|P2|NOT COMPLETED|Overall Study||6
2343194|NCT01710839|5751925|P1|NOT COMPLETED|Overall Study||1
2343195|NCT01710839|5751924|P2|COMPLETED|Overall Study||0
2343196|NCT01710839|5751925|P1|COMPLETED|Overall Study||23
2343197|NCT01710839|5751924|P2|STARTED|Overall Study||6
2343198|NCT01710839|5751925|P1|STARTED|Overall Study||24
2343199|NCT01710800|5751947|P1|NOT COMPLETED|Overall Study||22
2343200|NCT01710800|5751947|P1|COMPLETED|Overall Study|22 drop outs(consented but did not participate, refused 2nd intervention)|41
2343201|NCT01710800|5751947|P1|Received Placebo Intervention|Overall Study||45
2343202|NCT01710800|5751947|P1|Received PPI Intervention|Overall Study||44
2343203|NCT01710800|5751947|P1|STARTED|Overall Study|63 patients consented to be part of the study|63
2343204|NCT01710787|5751956|P3|NOT COMPLETED|Overall Study||0
2343205|NCT01710787|5751957|P2|NOT COMPLETED|Overall Study||0
2343206|NCT01710787|5751958|P1|NOT COMPLETED|Overall Study||0
2343207|NCT01710787|5751956|P3|COMPLETED|Overall Study||22
2343208|NCT01710787|5751957|P2|COMPLETED|Overall Study||44
2343209|NCT01710787|5751958|P1|COMPLETED|Overall Study||44
2343210|NCT01710787|5751956|P3|STARTED|Overall Study||22
2343211|NCT01710787|5751957|P2|STARTED|Overall Study||44
2343212|NCT01710787|5751958|P1|STARTED|Overall Study||44
2343213|NCT01710709|5752011|P1|NOT COMPLETED|Overall Study||173
2343214|NCT01710709|5752011|P1|COMPLETED|Overall Study||291
2343215|NCT01710709|5752011|P1|STARTED|Overall Study||464
2343216|NCT01710657|5752026|P3|NOT COMPLETED|Overall Study||32
2343217|NCT01710657|5752027|P2|NOT COMPLETED|Overall Study||12
2343218|NCT01710657|5752028|P1|NOT COMPLETED|Overall Study||18
2343219|NCT01710657|5752026|P3|COMPLETED|Overall Study||148
2343220|NCT01710657|5752027|P2|COMPLETED|Overall Study||171
2343221|NCT01710657|5752028|P1|COMPLETED|Overall Study||166
2343222|NCT01710657|5752026|P3|Maintenance Period (12 Weeks)|Overall Study||168
2343223|NCT01710657|5752027|P2|Maintenance Period (12 Weeks)|Overall Study||175
2343224|NCT01710657|5752028|P1|Maintenance Period (12 Weeks)|Overall Study||176
2343225|NCT01710657|5752026|P3|Titration Period (4 Weeks)|Overall Study||180
2343226|NCT01710657|5752027|P2|Titration Period (4 Weeks)|Overall Study||183
2343227|NCT01710657|5752028|P1|Titration Period (4 Weeks)|Overall Study||184
2343228|NCT01710657|5752026|P3|STARTED|Overall Study||180
2343229|NCT01710657|5752027|P2|STARTED|Overall Study||183
2343230|NCT01710657|5752028|P1|STARTED|Overall Study||184
2343231|NCT01710527|5752045|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
2343232|NCT01710527|5752046|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
2343233|NCT01710527|5752045|P2|COMPLETED|Period 3: Intervention Period 2||15
2343234|NCT01710527|5752046|P1|COMPLETED|Period 3: Intervention Period 2||16
2343235|NCT01710527|5752045|P2|STARTED|Period 3: Intervention Period 2||15
2343236|NCT01710527|5752046|P1|STARTED|Period 3: Intervention Period 2||16
2343237|NCT01710527|5752045|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||1
2343238|NCT01710527|5752046|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
2343239|NCT01710527|5752045|P2|COMPLETED|Period 2: Washout Period (7 Days)||15
2343240|NCT01710527|5752046|P1|COMPLETED|Period 2: Washout Period (7 Days)||16
2343241|NCT01710527|5752045|P2|STARTED|Period 2: Washout Period (7 Days)||16
2343242|NCT01710527|5752046|P1|STARTED|Period 2: Washout Period (7 Days)||16
2343243|NCT01710527|5752045|P2|NOT COMPLETED|Period 1: Intervention Period 1||0
2343244|NCT01710527|5752046|P1|NOT COMPLETED|Period 1: Intervention Period 1||0
2343245|NCT01710527|5752045|P2|COMPLETED|Period 1: Intervention Period 1||16
2343246|NCT01710527|5752046|P1|COMPLETED|Period 1: Intervention Period 1||16
2343247|NCT01710527|5752045|P2|STARTED|Period 1: Intervention Period 1||16
2343248|NCT01710527|5752046|P1|STARTED|Period 1: Intervention Period 1||16
2343249|NCT01710514|5752072|P2|NOT COMPLETED|Overall Study||7
2343250|NCT01710514|5752073|P1|NOT COMPLETED|Overall Study||7
2343251|NCT01710514|5752072|P2|COMPLETED|Overall Study||47
2343252|NCT01710514|5752073|P1|COMPLETED|Overall Study||47
2343253|NCT01710514|5752072|P2|Safety Analysis Set|Overall Study|All subjects received at least one dose of IMP.|54
2343254|NCT01710514|5752073|P1|Safety Analysis Set|Overall Study|All subjects received at least one dose of Investigational Medicinal Product (IMP).|54
2343255|NCT01710514|5752072|P2|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|47
2343256|NCT01710514|5752073|P1|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|43
2343257|NCT01710514|5752072|P2|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|48
2343258|NCT01710514|5752073|P1|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|46
2343259|NCT01710514|5752072|P2|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the ITT analysis set.|54
2343260|NCT01710514|5752073|P1|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the Intent-To-Treat (ITT) analysis set.|54
2343261|NCT01710514|5752072|P2|STARTED|Overall Study||54
2343262|NCT01710514|5752073|P1|STARTED|Overall Study||54
2343263|NCT01710501|5752094|P3|NOT COMPLETED|Overall Study||0
2343264|NCT01710501|5752095|P2|NOT COMPLETED|Overall Study||0
2343265|NCT01710501|5752096|P1|NOT COMPLETED|Overall Study||2
2343266|NCT01710501|5752094|P3|COMPLETED|Overall Study||30
2343267|NCT01710501|5752095|P2|COMPLETED|Overall Study||28
2343268|NCT01710501|5752096|P1|COMPLETED|Overall Study||27
2343269|NCT01710501|5752094|P3|STARTED|Overall Study||30
2343270|NCT01710501|5752095|P2|STARTED|Overall Study||28
2343271|NCT01710501|5752096|P1|STARTED|Overall Study||29
2343272|NCT01710358|5752128|P3|NOT COMPLETED|Follow-up Period||0
2343273|NCT01710358|5752129|P2|NOT COMPLETED|Follow-up Period||0
2343274|NCT01710358|5752130|P1|NOT COMPLETED|Follow-up Period||0
2343275|NCT01710358|5752128|P3|COMPLETED|Follow-up Period||20
2343276|NCT01710358|5752129|P2|COMPLETED|Follow-up Period||76
2343277|NCT01710358|5752130|P1|COMPLETED|Follow-up Period||33
2343278|NCT01710358|5752128|P3|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|20
2343279|NCT01710358|5752129|P2|STARTED|Follow-up Period|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4mg follow up.|76
2343280|NCT01710358|5752130|P1|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|33
2343281|NCT01710358|5752128|P3|NOT COMPLETED|Rescue Period||0
2343282|NCT01710358|5752129|P2|NOT COMPLETED|Rescue Period||31
2343283|NCT01710358|5752130|P1|NOT COMPLETED|Rescue Period||0
2343284|NCT01710358|5752128|P3|COMPLETED|Rescue Period||0
2343285|NCT01710358|5752129|P2|COMPLETED|Rescue Period||196
2343286|NCT01710358|5752130|P1|COMPLETED|Rescue Period||0
2343287|NCT01710358|5752128|P3|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
2343288|NCT01710358|5752129|P2|STARTED|Rescue Period|Baricitinib 4 mg administered PO QD through Week 52. Participants continued background MTX therapy.|227
2343289|NCT01710358|5752130|P1|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
2343290|NCT01710358|5752128|P3|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||15
2343291|NCT01710358|5752129|P2|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||22
2343292|NCT01710358|5752130|P1|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||16
2343293|NCT01710358|5752128|P3|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|252
2343294|NCT01710358|5752129|P2|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|402
2343295|NCT01710358|5752130|P1|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|294
2343296|NCT01710358|5752128|P3|Rescued|Treatment Period Part B (Weeks 24 to 52)||11
2343297|NCT01710358|5752129|P2|Rescued|Treatment Period Part B (Weeks 24 to 52)||8
2343298|NCT01710358|5752130|P1|Rescued|Treatment Period Part B (Weeks 24 to 52)||5
2343299|NCT01710358|5752128|P3|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||267
2343300|NCT01710358|5752129|P2|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||424
2343301|NCT01710358|5752130|P1|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)|Participants originally randomized to placebo received baricitinib during Part B.|306
2343302|NCT01710358|5752128|P3|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|267
2343303|NCT01710358|5752129|P2|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|424
2343304|NCT01710358|5752130|P1|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|310
2343305|NCT01710358|5752128|P3|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||23
2343306|NCT01710358|5752129|P2|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||29
2343307|NCT01710358|5752130|P1|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||51
2343308|NCT01710358|5752128|P3|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|307
2343309|NCT01710358|5752129|P2|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|459
2343310|NCT01710358|5752130|P1|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|438
2343311|NCT01710358|5752128|P3|Rescued|Treatment Period Part A (Weeks 0 to 24)||40
2343312|NCT01710358|5752129|P2|Rescued|Treatment Period Part A (Weeks 0 to 24)||35
2343313|NCT01710358|5752130|P1|Rescued|Treatment Period Part A (Weeks 0 to 24)||128
2343314|NCT01710358|5752128|P3|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||330
2343315|NCT01710358|5752129|P2|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||487
2343316|NCT01710358|5752130|P1|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||488
2343317|NCT01710358|5752128|P3|STARTED|Treatment Period Part A (Weeks 0 to 24)||330
2343318|NCT01710358|5752129|P2|STARTED|Treatment Period Part A (Weeks 0 to 24)||488
2343319|NCT01710358|5752130|P1|STARTED|Treatment Period Part A (Weeks 0 to 24)||489
2343320|NCT01710345|5752201|P3|NOT COMPLETED|Overall Study||1
2343321|NCT01710345|5752202|P2|NOT COMPLETED|Overall Study||5
2343322|NCT01710345|5752203|P1|NOT COMPLETED|Overall Study||3
2343323|NCT01710345|5752201|P3|COMPLETED|Overall Study||19
2343324|NCT01710345|5752202|P2|COMPLETED|Overall Study||35
2343325|NCT01710345|5752203|P1|COMPLETED|Overall Study||37
2343326|NCT01710345|5752201|P3|STARTED|Overall Study||20
2343327|NCT01710345|5752202|P2|STARTED|Overall Study||40
2343328|NCT01710345|5752203|P1|STARTED|Overall Study|41 patients were randomized to sufentanil 20 mcg, one patient not dosed due to damaged medication.|40
2343329|NCT01710332|5752213|P2|NOT COMPLETED|Overall Study||0
2343330|NCT01710332|5752214|P1|NOT COMPLETED|Overall Study||0
2343331|NCT01710332|5752213|P2|COMPLETED|Overall Study||6
2343332|NCT01710332|5752214|P1|COMPLETED|Overall Study||6
2343333|NCT01710332|5752213|P2|STARTED|Overall Study||6
2343334|NCT01710332|5752214|P1|STARTED|Overall Study||6
2343335|NCT01710306|5752224|P2|NOT COMPLETED|Overall Study||30
2343336|NCT01710306|5752225|P1|NOT COMPLETED|Overall Study||18
2343337|NCT01710306|5752224|P2|COMPLETED|Overall Study||55
2343338|NCT01710306|5752225|P1|COMPLETED|Overall Study||68
2343339|NCT01710306|5752224|P2|STARTED|Overall Study||85
2343340|NCT01710306|5752225|P1|STARTED|Overall Study||86
2343341|NCT01710254|5752233|P1|NOT COMPLETED|Overall Study||0
2343342|NCT01710254|5752233|P1|COMPLETED|Overall Study||30
2343343|NCT01710254|5752233|P1|STARTED|Overall Study||30
2343344|NCT01710137|5752241|P2|NOT COMPLETED|Overall Study||14
2343345|NCT01710137|5752242|P1|NOT COMPLETED|Overall Study||24
2343346|NCT01710137|5752241|P2|COMPLETED|Overall Study||76
2343347|NCT01710137|5752242|P1|COMPLETED|Overall Study||65
2343348|NCT01710137|5752241|P2|STARTED|Overall Study||90
2343349|NCT01710137|5752242|P1|STARTED|Overall Study||89
2343350|NCT01710046|5752262|P2|NOT COMPLETED|Overall Study||0
2343351|NCT01710046|5752263|P1|NOT COMPLETED|Overall Study||1
2343352|NCT01710046|5752262|P2|COMPLETED|Overall Study||3
2343353|NCT01710046|5752263|P1|COMPLETED|Overall Study||8
2343354|NCT01710046|5752262|P2|STARTED|Overall Study||3
2343355|NCT01710046|5752263|P1|STARTED|Overall Study||9
2343356|NCT01710033|5752303|P5|NOT COMPLETED|Stage 2||1
2343357|NCT01710033|5752304|P4|NOT COMPLETED|Stage 2||0
2343358|NCT01710033|5752305|P3|NOT COMPLETED|Stage 2||0
2343359|NCT01710033|5752306|P2|NOT COMPLETED|Stage 2||0
2343360|NCT01710033|5752307|P1|NOT COMPLETED|Stage 2||0
2343361|NCT01710033|5752303|P5|COMPLETED|Stage 2||3
2343362|NCT01710033|5752304|P4|COMPLETED|Stage 2||0
2343363|NCT01710033|5752305|P3|COMPLETED|Stage 2||0
2343364|NCT01710033|5752306|P2|COMPLETED|Stage 2||0
2343365|NCT01710033|5752307|P1|COMPLETED|Stage 2||0
2343366|NCT01710033|5752303|P5|STARTED|Stage 2||4
2343367|NCT01710033|5752304|P4|STARTED|Stage 2||0
2343368|NCT01710033|5752305|P3|STARTED|Stage 2||0
2343369|NCT01710033|5752306|P2|STARTED|Stage 2||0
2343370|NCT01710033|5752307|P1|STARTED|Stage 2||0
2343371|NCT01710033|5752303|P5|NOT COMPLETED|Stage 1||0
2343372|NCT01710033|5752304|P4|NOT COMPLETED|Stage 1||0
2343373|NCT01710033|5752305|P3|NOT COMPLETED|Stage 1||0
2343374|NCT01710033|5752306|P2|NOT COMPLETED|Stage 1||0
2343375|NCT01710033|5752307|P1|NOT COMPLETED|Stage 1||0
2343376|NCT01710033|5752303|P5|COMPLETED|Stage 1||0
2343377|NCT01710033|5752304|P4|COMPLETED|Stage 1||6
2343378|NCT01710033|5752305|P3|COMPLETED|Stage 1||6
2343379|NCT01710033|5752306|P2|COMPLETED|Stage 1||6
2343380|NCT01710033|5752307|P1|COMPLETED|Stage 1||6
2343381|NCT01710033|5752303|P5|STARTED|Stage 1||0
2343382|NCT01710033|5752304|P4|STARTED|Stage 1||6
2343383|NCT01710033|5752305|P3|STARTED|Stage 1||6
2343384|NCT01710033|5752306|P2|STARTED|Stage 1||6
2343385|NCT01710033|5752307|P1|STARTED|Stage 1||6
2343386|NCT01710020|5752388|P1|NOT COMPLETED|Period 2||0
2343387|NCT01710020|5752388|P1|COMPLETED|Period 2||11
2343388|NCT01710020|5752388|P1|STARTED|Period 2||11
2343389|NCT01710020|5752388|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2343390|NCT01710020|5752388|P1|COMPLETED|Washout Period (at Least 14 Days)||11
2343391|NCT01710020|5752388|P1|STARTED|Washout Period (at Least 14 Days)||11
2343392|NCT01710020|5752388|P1|NOT COMPLETED|Period 1||1
2343393|NCT01710020|5752388|P1|COMPLETED|Period 1||11
2343394|NCT01710020|5752388|P1|STARTED|Period 1||12
2343395|NCT01709903|5752407|P2|NOT COMPLETED|Overall Study||39
2343396|NCT01709903|5752408|P1|NOT COMPLETED|Overall Study||29
2343397|NCT01709903|5752407|P2|COMPLETED|Overall Study||333
2343398|NCT01709903|5752408|P1|COMPLETED|Overall Study||343
2343399|NCT01709903|5752407|P2|STARTED|Overall Study|Randomized set|372
2343400|NCT01709903|5752408|P1|STARTED|Overall Study|Randomized set|372
2343401|NCT01709864|5752432|P2|NOT COMPLETED|Overall Study||11
2343402|NCT01709864|5752433|P1|NOT COMPLETED|Overall Study||7
2343403|NCT01709864|5752432|P2|COMPLETED|Overall Study||208
2343404|NCT01709864|5752433|P1|COMPLETED|Overall Study||215
2343405|NCT01709864|5752432|P2|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|201
2343406|NCT01709864|5752433|P1|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|204
2343407|NCT01709864|5752432|P2|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|216
2343408|NCT01709864|5752433|P1|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|222
2343409|NCT01709864|5752432|P2|STARTED|Overall Study||219
2343410|NCT01709864|5752433|P1|STARTED|Overall Study||222
2343411|NCT01709838|5752467|P1|NOT COMPLETED|Overall Study||67
2343412|NCT01709838|5752467|P1|COMPLETED|Overall Study||67
2343413|NCT01709838|5752467|P1|STARTED|Overall Study||134
2343414|NCT01709799|5752490|P3|NOT COMPLETED|Overall Study||3
2343415|NCT01709799|5752491|P2|NOT COMPLETED|Overall Study||3
2343416|NCT01709799|5752492|P1|NOT COMPLETED|Overall Study||3
2343417|NCT01709799|5752490|P3|COMPLETED|Overall Study||15
2343418|NCT01709799|5752491|P2|COMPLETED|Overall Study||18
2343419|NCT01709799|5752492|P1|COMPLETED|Overall Study||22
2343420|NCT01709799|5752490|P3|STARTED|Overall Study||18
2343421|NCT01709799|5752491|P2|STARTED|Overall Study||21
2343422|NCT01709799|5752492|P1|STARTED|Overall Study||25
2343423|NCT01709786|5752515|P1|NOT COMPLETED|Overall Study||0
2343424|NCT01709786|5752515|P1|COMPLETED|Overall Study||88
2343425|NCT01709786|5752515|P1|STARTED|Overall Study||88
2343426|NCT01709708|5752524|P2|NOT COMPLETED|Overall Study||2
2343427|NCT01709708|5752525|P1|NOT COMPLETED|Overall Study||1
2343428|NCT01709708|5752524|P2|COMPLETED|Overall Study||12
2343429|NCT01709708|5752525|P1|COMPLETED|Overall Study||26
2343430|NCT01709708|5752524|P2|STARTED|Overall Study||14
2343431|NCT01709708|5752525|P1|STARTED|Overall Study||27
2343432|NCT01709695|5752549|P2|NOT COMPLETED|Overall Study||1
2343433|NCT01709695|5752550|P1|NOT COMPLETED|Overall Study||1
2343434|NCT01709695|5752549|P2|COMPLETED|Overall Study||13
2343435|NCT01709695|5752550|P1|COMPLETED|Overall Study||12
2343436|NCT01709695|5752549|P2|STARTED|Overall Study||14
2343437|NCT01709695|5752550|P1|STARTED|Overall Study||13
2343438|NCT01709578|5752575|P3|NOT COMPLETED|Overall Study||51
2343439|NCT01709578|5752576|P2|NOT COMPLETED|Overall Study||56
2343440|NCT01709578|5752577|P1|NOT COMPLETED|Overall Study||80
2343441|NCT01709578|5752575|P3|COMPLETED|Overall Study||133
2343442|NCT01709578|5752576|P2|COMPLETED|Overall Study||125
2343443|NCT01709578|5752577|P1|COMPLETED|Overall Study||101
2343444|NCT01709578|5752575|P3|STARTED|Overall Study||184
2343445|NCT01709578|5752576|P2|STARTED|Overall Study||181
2343446|NCT01709578|5752577|P1|STARTED|Overall Study||181
2343447|NCT01709513|5752708|P3|NOT COMPLETED|Overall Study||30
2343448|NCT01709513|5752709|P2|NOT COMPLETED|Overall Study||43
2343449|NCT01709513|5752710|P1|NOT COMPLETED|Overall Study||21
2343450|NCT01709513|5752708|P3|COMPLETED|Overall Study||96
2343451|NCT01709513|5752709|P2|COMPLETED|Overall Study||82
2343452|NCT01709513|5752710|P1|COMPLETED|Overall Study||42
2343453|NCT01709513|5752708|P3|Treated|Overall Study||126
2343454|NCT01709513|5752709|P2|Treated|Overall Study||124
2343455|NCT01709513|5752710|P1|Treated|Overall Study||63
2343456|NCT01709513|5752708|P3|STARTED|Overall Study||126
2343457|NCT01709513|5752709|P2|STARTED|Overall Study||125
2343458|NCT01709513|5752710|P1|STARTED|Overall Study||63
2343459|NCT01709500|5752771|P2|NOT COMPLETED|Overall Study||82
2343460|NCT01709500|5752772|P1|NOT COMPLETED|Overall Study||167
2343461|NCT01709500|5752771|P2|COMPLETED|Overall Study||0
2343462|NCT01709500|5752772|P1|COMPLETED|Overall Study||0
2343463|NCT01709500|5752771|P2|Treated|Overall Study||81
2343464|NCT01709500|5752772|P1|Treated|Overall Study||167
2343465|NCT01709500|5752771|P2|STARTED|Overall Study||82
2343466|NCT01709500|5752772|P1|STARTED|Overall Study||167
2343467|NCT01709474|5752828|P2|NOT COMPLETED|Overall Study||0
2343468|NCT01709474|5752829|P1|NOT COMPLETED|Overall Study||0
2343469|NCT01709474|5752828|P2|COMPLETED|Overall Study||4
2343470|NCT01709474|5752829|P1|COMPLETED|Overall Study||3
2343471|NCT01709474|5752828|P2|STARTED|Overall Study||4
2343472|NCT01709474|5752829|P1|STARTED|Overall Study||3
2343473|NCT01709422|5752839|P2|NOT COMPLETED|Overall Study||0
2343474|NCT01709422|5752840|P1|NOT COMPLETED|Overall Study||0
2343475|NCT01709422|5752839|P2|COMPLETED|Overall Study||70
2343476|NCT01709422|5752840|P1|COMPLETED|Overall Study||70
2343477|NCT01709422|5752839|P2|STARTED|Overall Study||70
2343478|NCT01709422|5752840|P1|STARTED|Overall Study||70
2343479|NCT01709409|5752850|P2|NOT COMPLETED|Overall Study||0
2343480|NCT01709409|5752851|P1|NOT COMPLETED|Overall Study||1
2343481|NCT01709409|5752850|P2|COMPLETED|Overall Study||45
2343482|NCT01709409|5752851|P1|COMPLETED|Overall Study||42
2343483|NCT01709409|5752850|P2|STARTED|Overall Study||45
2343484|NCT01709409|5752851|P1|STARTED|Overall Study||43
2343485|NCT01709383|5752859|P2|NOT COMPLETED|Overall Study||0
2343486|NCT01709383|5752860|P1|NOT COMPLETED|Overall Study||1
2343487|NCT01709383|5752859|P2|COMPLETED|Overall Study||14
2343488|NCT01709383|5752860|P1|COMPLETED|Overall Study||23
2343489|NCT01709383|5752859|P2|Included in Analysis|Overall Study||13
2343490|NCT01709383|5752860|P1|Included in Analysis|Overall Study||22
2343491|NCT01709383|5752859|P2|Completed Follow-ups|Overall Study||14
2343492|NCT01709383|5752860|P1|Completed Follow-ups|Overall Study||23
2343493|NCT01709383|5752859|P2|Completed Treatment|Overall Study||14
2343494|NCT01709383|5752860|P1|Completed Treatment|Overall Study||24
2343495|NCT01709383|5752859|P2|STARTED|Overall Study||14
2343496|NCT01709383|5752860|P1|STARTED|Overall Study||24
2343497|NCT01709331|5752878|P1|NOT COMPLETED|Overall Study||1
2343498|NCT01709331|5752878|P1|COMPLETED|Overall Study||17
2343499|NCT01709331|5752878|P1|STARTED|Overall Study||18
2343500|NCT01709318|5752891|P7|NOT COMPLETED|Overall Study||11
2343501|NCT01709318|5752892|P6|NOT COMPLETED|Overall Study||4
2343502|NCT01709318|5752893|P5|NOT COMPLETED|Overall Study||4
2343503|NCT01709318|5752894|P4|NOT COMPLETED|Overall Study||6
2343504|NCT01709318|5752895|P3|NOT COMPLETED|Overall Study||6
2343505|NCT01709318|5752896|P2|NOT COMPLETED|Overall Study||7
2343506|NCT01709318|5752897|P1|NOT COMPLETED|Overall Study||9
2343507|NCT01709318|5752891|P7|COMPLETED|Overall Study||171
2343508|NCT01709318|5752892|P6|COMPLETED|Overall Study||80
2343509|NCT01709318|5752893|P5|COMPLETED|Overall Study||74
2343510|NCT01709318|5752894|P4|COMPLETED|Overall Study||72
2343511|NCT01709318|5752895|P3|COMPLETED|Overall Study||71
2343512|NCT01709318|5752896|P2|COMPLETED|Overall Study||78
2343513|NCT01709318|5752897|P1|COMPLETED|Overall Study||73
2343514|NCT01709318|5752891|P7|Treated|Overall Study||178
2343515|NCT01709318|5752892|P6|Treated|Overall Study||86
2343516|NCT01709318|5752893|P5|Treated|Overall Study||77
2343517|NCT01709318|5752894|P4|Treated|Overall Study||77
2343518|NCT01709318|5752895|P3|Treated|Overall Study||78
2343519|NCT01709318|5752896|P2|Treated|Overall Study||85
2343520|NCT01709318|5752897|P1|Treated|Overall Study||79
2343521|NCT01709318|5752891|P7|STARTED|Overall Study||182
2343522|NCT01709318|5752892|P6|STARTED|Overall Study||84
2343523|NCT01709318|5752893|P5|STARTED|Overall Study||78
2343524|NCT01709318|5752894|P4|STARTED|Overall Study||78
2343525|NCT01709318|5752895|P3|STARTED|Overall Study||77
2343526|NCT01709318|5752896|P2|STARTED|Overall Study||85
2343527|NCT01709318|5752897|P1|STARTED|Overall Study||82
2343528|NCT01709305|5752990|P5|NOT COMPLETED|Phase 2||47
2343529|NCT01709305|5752991|P4|NOT COMPLETED|Phase 2||48
2343530|NCT01709305|5752992|P3|NOT COMPLETED|Phase 2||45
2343531|NCT01709305|5752993|P2|NOT COMPLETED|Phase 2||52
2343532|NCT01709305|5752994|P1|NOT COMPLETED|Phase 2||0
2343533|NCT01709305|5752990|P5|COMPLETED|Phase 2||507
2343534|NCT01709305|5752991|P4|COMPLETED|Phase 2||508
2343535|NCT01709305|5752992|P3|COMPLETED|Phase 2||505
2343536|NCT01709305|5752993|P2|COMPLETED|Phase 2||500
2343537|NCT01709305|5752994|P1|COMPLETED|Phase 2||0
2343538|NCT01709305|5752990|P5|STARTED|Phase 2||554
2343539|NCT01709305|5752991|P4|STARTED|Phase 2||556
2343540|NCT01709305|5752992|P3|STARTED|Phase 2||550
2343541|NCT01709305|5752993|P2|STARTED|Phase 2||552
2343542|NCT01709305|5752994|P1|STARTED|Phase 2||0
2343543|NCT01709305|5752990|P5|NOT COMPLETED|Phase 1||0
2343544|NCT01709305|5752991|P4|NOT COMPLETED|Phase 1||0
2343545|NCT01709305|5752992|P3|NOT COMPLETED|Phase 1||0
2343546|NCT01709305|5752993|P2|NOT COMPLETED|Phase 1||0
2343547|NCT01709305|5752994|P1|NOT COMPLETED|Phase 1||637
2343548|NCT01709305|5752990|P5|COMPLETED|Phase 1||0
2343549|NCT01709305|5752991|P4|COMPLETED|Phase 1||0
2343550|NCT01709305|5752992|P3|COMPLETED|Phase 1||0
2343551|NCT01709305|5752993|P2|COMPLETED|Phase 1||0
2343552|NCT01709305|5752994|P1|COMPLETED|Phase 1||4933
2343553|NCT01709305|5752990|P5|STARTED|Phase 1||0
2343554|NCT01709305|5752991|P4|STARTED|Phase 1||0
2343555|NCT01709305|5752992|P3|STARTED|Phase 1||0
2343556|NCT01709305|5752993|P2|STARTED|Phase 1||0
2343557|NCT01709305|5752994|P1|STARTED|Phase 1||5570
2343558|NCT01709227|5753031|P2|NOT COMPLETED|Overall Study||9
2343559|NCT01709227|5753032|P1|NOT COMPLETED|Overall Study||1
2343560|NCT01709227|5753031|P2|COMPLETED|Overall Study||32
2343561|NCT01709227|5753032|P1|COMPLETED|Overall Study||31
2343562|NCT01709227|5753031|P2|STARTED|Overall Study||41
2343563|NCT01709227|5753032|P1|STARTED|Overall Study||32
2343564|NCT01709162|5753058|P2|NOT COMPLETED|Overall Study||5
2343565|NCT01709162|5753059|P1|NOT COMPLETED|Overall Study||6
2343566|NCT01709162|5753058|P2|COMPLETED|Overall Study|Completed treatment as per protocol|0
2343567|NCT01709162|5753059|P1|COMPLETED|Overall Study|Completed treatment as per protocol|12
2343568|NCT01709162|5753058|P2|Still Receiving Treatment|Overall Study||0
2343569|NCT01709162|5753059|P1|Still Receiving Treatment|Overall Study||0
2343570|NCT01709162|5753058|P2|Received Treatment|Overall Study||4
2343571|NCT01709162|5753059|P1|Received Treatment|Overall Study||18
2343572|NCT01709162|5753058|P2|STARTED|Overall Study|Randomized|5
2343573|NCT01709162|5753059|P1|STARTED|Overall Study|Randomized|18
2343574|NCT01709136|5753071|P1|NOT COMPLETED|Overall Study||0
2343575|NCT01709136|5753071|P1|COMPLETED|Overall Study||3
2343576|NCT01709136|5753071|P1|STARTED|Overall Study||3
2343577|NCT01709110|5753080|P2|NOT COMPLETED|Overall Study||168
2343578|NCT01709110|5753081|P1|NOT COMPLETED|Overall Study||185
2343579|NCT01709110|5753080|P2|COMPLETED|Overall Study||515
2343580|NCT01709110|5753081|P1|COMPLETED|Overall Study||498
2343581|NCT01709110|5753080|P2|Received at Least One Dose of Study Drug|Overall Study||680
2343582|NCT01709110|5753081|P1|Received at Least One Dose of Study Drug|Overall Study||680
2343583|NCT01709110|5753080|P2|STARTED|Overall Study||683
2343584|NCT01709110|5753081|P1|STARTED|Overall Study||683
2343585|NCT01709084|5753111|P2|NOT COMPLETED|Overall Study||15
2343586|NCT01709084|5753112|P1|NOT COMPLETED|Overall Study||16
2343587|NCT01709084|5753111|P2|COMPLETED|Overall Study||198
2343588|NCT01709084|5753112|P1|COMPLETED|Overall Study||197
2343589|NCT01709084|5753111|P2|Treated|Overall Study||211
2343590|NCT01709084|5753112|P1|Treated|Overall Study||213
2343591|NCT01709084|5753111|P2|STARTED|Overall Study||213
2343592|NCT01709084|5753112|P1|STARTED|Overall Study||213
2343593|NCT01709032|5753128|P1|NOT COMPLETED|Overall Study||3
2343594|NCT01709032|5753128|P1|COMPLETED|Overall Study||6
2343595|NCT01709032|5753128|P1|STARTED|Overall Study||9
2343596|NCT01708967|5753135|P2|NOT COMPLETED|Overall Study||7
2343597|NCT01708967|5753136|P1|NOT COMPLETED|Overall Study||0
2343598|NCT01708967|5753135|P2|COMPLETED|Overall Study||43
2343599|NCT01708967|5753136|P1|COMPLETED|Overall Study||50
2343600|NCT01708967|5753135|P2|STARTED|Overall Study||50
2343601|NCT01708967|5753136|P1|STARTED|Overall Study||50
2343602|NCT01708954|5753145|P3|NOT COMPLETED|Step 2||0
2343603|NCT01708954|5753146|P2|NOT COMPLETED|Step 2||7
2343604|NCT01708954|5753147|P1|NOT COMPLETED|Step 2||13
2343605|NCT01708954|5753145|P3|COMPLETED|Step 2||0
2343606|NCT01708954|5753146|P2|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
2343607|NCT01708954|5753147|P1|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
2343608|NCT01708954|5753145|P3|STARTED|Step 2|Only patients with disease progression on Arms A and B were allowed to register to Step 2.|0
2343609|NCT01708954|5753146|P2|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|7
2343610|NCT01708954|5753147|P1|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|13
2343611|NCT01708954|5753145|P3|NOT COMPLETED|Step 1||43
2343612|NCT01708954|5753146|P2|NOT COMPLETED|Step 1||40
2343613|NCT01708954|5753147|P1|NOT COMPLETED|Step 1||42
2343614|NCT01708954|5753145|P3|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
2343615|NCT01708954|5753146|P2|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
2343616|NCT01708954|5753147|P1|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
2343617|NCT01708954|5753145|P3|Patients With MET Status Data Available|Step 1||24
2343618|NCT01708954|5753146|P2|Patients With MET Status Data Available|Step 1||32
2343619|NCT01708954|5753147|P1|Patients With MET Status Data Available|Step 1||30
2343620|NCT01708954|5753145|P3|Eligible and Treated|Step 1||35
2343621|NCT01708954|5753146|P2|Eligible and Treated|Step 1||38
2343622|NCT01708954|5753147|P1|Eligible and Treated|Step 1||38
2343623|NCT01708954|5753145|P3|Started Protocol Therapy|Step 1||39
2343624|NCT01708954|5753146|P2|Started Protocol Therapy|Step 1||40
2343625|NCT01708954|5753147|P1|Started Protocol Therapy|Step 1||40
2343626|NCT01708954|5753145|P3|STARTED|Step 1||43
2343627|NCT01708954|5753146|P2|STARTED|Step 1||40
2343628|NCT01708954|5753147|P1|STARTED|Step 1||42
2343629|NCT01708941|5753172|P4|NOT COMPLETED|Overall Study||18
2343630|NCT01708941|5753173|P3|NOT COMPLETED|Overall Study||19
2343631|NCT01708941|5753174|P2|NOT COMPLETED|Overall Study||18
2343632|NCT01708941|5753175|P1|NOT COMPLETED|Overall Study||18
2343633|NCT01708941|5753172|P4|COMPLETED|Overall Study||4
2343634|NCT01708941|5753173|P3|COMPLETED|Overall Study||3
2343635|NCT01708941|5753174|P2|COMPLETED|Overall Study||5
2343636|NCT01708941|5753175|P1|COMPLETED|Overall Study||3
2343637|NCT01708941|5753172|P4|Eligible and Started Treatment|Overall Study||22
2343638|NCT01708941|5753173|P3|Eligible and Started Treatment|Overall Study||19
2343639|NCT01708941|5753174|P2|Eligible and Started Treatment|Overall Study||22
2343640|NCT01708941|5753175|P1|Eligible and Started Treatment|Overall Study||18
2343641|NCT01708941|5753172|P4|STARTED|Overall Study||22
2343642|NCT01708941|5753173|P3|STARTED|Overall Study||22
2343643|NCT01708941|5753174|P2|STARTED|Overall Study||23
2343644|NCT01708941|5753175|P1|STARTED|Overall Study||21
2343645|NCT01708915|5753193|P4|NOT COMPLETED|Overall Study||33
2343646|NCT01708915|5753194|P3|NOT COMPLETED|Overall Study||46
2343647|NCT01708915|5753195|P2|NOT COMPLETED|Overall Study||62
2343648|NCT01708915|5753196|P1|NOT COMPLETED|Overall Study||86
2343649|NCT01708915|5753193|P4|COMPLETED|Overall Study||169
2343650|NCT01708915|5753194|P3|COMPLETED|Overall Study||152
2343651|NCT01708915|5753195|P2|COMPLETED|Overall Study||139
2343652|NCT01708915|5753196|P1|COMPLETED|Overall Study||118
2343653|NCT01708915|5753193|P4|STARTED|Overall Study||202
2343654|NCT01708915|5753194|P3|STARTED|Overall Study||198
2343655|NCT01708915|5753195|P2|STARTED|Overall Study||201
2343656|NCT01708915|5753196|P1|STARTED|Overall Study||204
2343657|NCT01708902|5753225|P7|NOT COMPLETED|Overall Study||7
2343658|NCT01708902|5753226|P6|NOT COMPLETED|Overall Study||7
2343659|NCT01708902|5753227|P5|NOT COMPLETED|Overall Study||16
2343660|NCT01708902|5753228|P4|NOT COMPLETED|Overall Study||10
2343661|NCT01708902|5753229|P3|NOT COMPLETED|Overall Study||17
2343662|NCT01708902|5753230|P2|NOT COMPLETED|Overall Study||8
2343663|NCT01708902|5753231|P1|NOT COMPLETED|Overall Study||17
2343664|NCT01708902|5753225|P7|COMPLETED|Overall Study||65
2343665|NCT01708902|5753226|P6|COMPLETED|Overall Study||64
2343666|NCT01708902|5753227|P5|COMPLETED|Overall Study||131
2343667|NCT01708902|5753228|P4|COMPLETED|Overall Study||137
2343668|NCT01708902|5753229|P3|COMPLETED|Overall Study||127
2343669|NCT01708902|5753230|P2|COMPLETED|Overall Study||137
2343670|NCT01708902|5753231|P1|COMPLETED|Overall Study||130
2343671|NCT01708902|5753225|P7|STARTED|Overall Study||72
2343672|NCT01708902|5753226|P6|STARTED|Overall Study||71
2343673|NCT01708902|5753227|P5|STARTED|Overall Study||147
2343674|NCT01708902|5753228|P4|STARTED|Overall Study||147
2343675|NCT01708902|5753229|P3|STARTED|Overall Study||144
2343676|NCT01708902|5753230|P2|STARTED|Overall Study||145
2343677|NCT01708902|5753231|P1|STARTED|Overall Study||147
2343678|NCT01708629|5753294|P4|NOT COMPLETED|Overall Study||14
2343679|NCT01708629|5753295|P3|NOT COMPLETED|Overall Study||10
2343680|NCT01708629|5753296|P2|NOT COMPLETED|Overall Study||25
2343681|NCT01708629|5753297|P1|NOT COMPLETED|Overall Study||16
2343682|NCT01708629|5753294|P4|COMPLETED|Overall Study||301
2343683|NCT01708629|5753295|P3|COMPLETED|Overall Study||303
2343684|NCT01708629|5753296|P2|COMPLETED|Overall Study||604
2343685|NCT01708629|5753297|P1|COMPLETED|Overall Study||608
2343686|NCT01708629|5753294|P4|STARTED|Overall Study||315
2343687|NCT01708629|5753295|P3|STARTED|Overall Study||313
2343688|NCT01708629|5753296|P2|STARTED|Overall Study||629
2343689|NCT01708629|5753297|P1|STARTED|Overall Study||624
2343690|NCT01708603|5753314|P4|NOT COMPLETED|Overall Study||9
2343691|NCT01708603|5753315|P3|NOT COMPLETED|Overall Study||9
2343692|NCT01708603|5753316|P2|NOT COMPLETED|Overall Study||22
2343693|NCT01708603|5753317|P1|NOT COMPLETED|Overall Study||15
2343694|NCT01708603|5753314|P4|COMPLETED|Overall Study||300
2343695|NCT01708603|5753315|P3|COMPLETED|Overall Study||291
2343696|NCT01708603|5753316|P2|COMPLETED|Overall Study||588
2343697|NCT01708603|5753317|P1|COMPLETED|Overall Study||597
2343698|NCT01708603|5753314|P4|STARTED|Overall Study||309
2343699|NCT01708603|5753315|P3|STARTED|Overall Study||300
2343700|NCT01708603|5753316|P2|STARTED|Overall Study||610
2343701|NCT01708603|5753317|P1|STARTED|Overall Study||612
2343702|NCT01708590|5753338|P7|NOT COMPLETED|Withdrawal Phase||9
2343703|NCT01708590|5753339|P6|NOT COMPLETED|Withdrawal Phase||82
2343704|NCT01708590|5753340|P5|NOT COMPLETED|Withdrawal Phase||12
2343705|NCT01708590|5753341|P4|NOT COMPLETED|Withdrawal Phase||53
2343706|NCT01708590|5753342|P3|NOT COMPLETED|Withdrawal Phase||0
2343707|NCT01708590|5753343|P2|NOT COMPLETED|Withdrawal Phase||0
2343708|NCT01708590|5753344|P1|NOT COMPLETED|Withdrawal Phase||0
2343709|NCT01708590|5753338|P7|COMPLETED|Withdrawal Phase||74
2343710|NCT01708590|5753339|P6|COMPLETED|Withdrawal Phase||2
2343711|NCT01708590|5753340|P5|COMPLETED|Withdrawal Phase||45
2343712|NCT01708590|5753341|P4|COMPLETED|Withdrawal Phase||6
2343713|NCT01708590|5753342|P3|COMPLETED|Withdrawal Phase||0
2343714|NCT01708590|5753343|P2|COMPLETED|Withdrawal Phase||0
2343715|NCT01708590|5753344|P1|COMPLETED|Withdrawal Phase||0
2343716|NCT01708590|5753338|P7|STARTED|Withdrawal Phase||83
2343717|NCT01708590|5753339|P6|STARTED|Withdrawal Phase||84
2343718|NCT01708590|5753340|P5|STARTED|Withdrawal Phase||57
2343719|NCT01708590|5753341|P4|STARTED|Withdrawal Phase||59
2343720|NCT01708590|5753342|P3|STARTED|Withdrawal Phase||0
2343721|NCT01708590|5753343|P2|STARTED|Withdrawal Phase||0
2343722|NCT01708590|5753344|P1|STARTED|Withdrawal Phase||0
2343723|NCT01708590|5753338|P7|NOT COMPLETED|Induction Phase||0
2343724|NCT01708590|5753339|P6|NOT COMPLETED|Induction Phase||0
2343725|NCT01708590|5753340|P5|NOT COMPLETED|Induction Phase||0
2343726|NCT01708590|5753341|P4|NOT COMPLETED|Induction Phase||0
2343727|NCT01708590|5753342|P3|NOT COMPLETED|Induction Phase||11
2343728|NCT01708590|5753343|P2|NOT COMPLETED|Induction Phase||7
2343729|NCT01708590|5753344|P1|NOT COMPLETED|Induction Phase||10
2343730|NCT01708590|5753338|P7|COMPLETED|Induction Phase||0
2343731|NCT01708590|5753339|P6|COMPLETED|Induction Phase||0
2343732|NCT01708590|5753340|P5|COMPLETED|Induction Phase||0
2343733|NCT01708590|5753341|P4|COMPLETED|Induction Phase||0
2343734|NCT01708590|5753342|P3|COMPLETED|Induction Phase||209
2343735|NCT01708590|5753343|P2|COMPLETED|Induction Phase||212
2343736|NCT01708590|5753344|P1|COMPLETED|Induction Phase||212
2343737|NCT01708590|5753338|P7|STARTED|Induction Phase||0
2343738|NCT01708590|5753339|P6|STARTED|Induction Phase||0
2343739|NCT01708590|5753340|P5|STARTED|Induction Phase||0
2343740|NCT01708590|5753341|P4|STARTED|Induction Phase||0
2343741|NCT01708590|5753342|P3|STARTED|Induction Phase||220
2343742|NCT01708590|5753343|P2|STARTED|Induction Phase||219
2343743|NCT01708590|5753344|P1|STARTED|Induction Phase||222
2343744|NCT01708525|5753359|P1|NOT COMPLETED|Overall Study||0
2343745|NCT01708525|5753359|P1|COMPLETED|Overall Study||2
2343746|NCT01708525|5753359|P1|STARTED|Overall Study||2
2343747|NCT01708317|5753364|P1|NOT COMPLETED|Final Education Period||0
2343748|NCT01708317|5753364|P1|COMPLETED|Final Education Period||909
2343749|NCT01708317|5753364|P1|STARTED|Final Education Period|# of ED patients eligible for ACASI, had it been available, in final education period|909
2343750|NCT01708317|5753364|P1|NOT COMPLETED|ACASI + Education Period||0
2343751|NCT01708317|5753364|P1|COMPLETED|ACASI + Education Period||2601
2343752|NCT01708317|5753364|P1|STARTED|ACASI + Education Period|# of ED patients eligible for ACASI in the period the ACASI was actually available.|2601
2343753|NCT01708317|5753364|P1|NOT COMPLETED|Initial Education Period||0
2343754|NCT01708317|5753364|P1|COMPLETED|Initial Education Period||982
2343755|NCT01708317|5753364|P1|STARTED|Initial Education Period|# of ED patients eligible for ACASI, had it been available, in initial education period|982
2343756|NCT01708317|5753364|P1|NOT COMPLETED|2010 Control Period||0
2343757|NCT01708317|5753364|P1|COMPLETED|2010 Control Period||3929
2343758|NCT01708317|5753364|P1|STARTED|2010 Control Period|# of ED patients eligible for ACASI, had it been available, in control period|3929
2343759|NCT01708291|5753373|P2|NOT COMPLETED|Overall Study||1
2343760|NCT01708291|5753374|P1|NOT COMPLETED|Overall Study||2
2343761|NCT01708291|5753373|P2|COMPLETED|Overall Study||20
2343762|NCT01708291|5753374|P1|COMPLETED|Overall Study||19
2343763|NCT01708291|5753373|P2|STARTED|Overall Study||21
2343764|NCT01708291|5753374|P1|STARTED|Overall Study||21
2343765|NCT01708278|5753386|P6|NOT COMPLETED|Overall Study||0
2343766|NCT01708278|5753387|P5|NOT COMPLETED|Overall Study||0
2343767|NCT01708278|5753388|P4|NOT COMPLETED|Overall Study||0
2343768|NCT01708278|5753389|P3|NOT COMPLETED|Overall Study||0
2343769|NCT01708278|5753390|P2|NOT COMPLETED|Overall Study||0
2343770|NCT01708278|5753391|P1|NOT COMPLETED|Overall Study||0
2343771|NCT01708278|5753386|P6|COMPLETED|Overall Study||1
2343772|NCT01708278|5753387|P5|COMPLETED|Overall Study||1
2343773|NCT01708278|5753388|P4|COMPLETED|Overall Study||2
2343774|NCT01708278|5753389|P3|COMPLETED|Overall Study||2
2343775|NCT01708278|5753390|P2|COMPLETED|Overall Study||2
2343776|NCT01708278|5753391|P1|COMPLETED|Overall Study||1
2343777|NCT01708278|5753386|P6|STARTED|Overall Study||1
2343778|NCT01708278|5753387|P5|STARTED|Overall Study||1
2343779|NCT01708278|5753388|P4|STARTED|Overall Study||2
2343780|NCT01708278|5753389|P3|STARTED|Overall Study||2
2343781|NCT01708278|5753390|P2|STARTED|Overall Study||2
2343782|NCT01708278|5753391|P1|STARTED|Overall Study||1
2343783|NCT01708213|5753405|P1|NOT COMPLETED|Overall Study||1
2343784|NCT01708213|5753405|P1|COMPLETED|Overall Study||71
2343785|NCT01708213|5753405|P1|STARTED|Overall Study||72
2343786|NCT01708187|5753413|P2|NOT COMPLETED|Overall Study||1
2343787|NCT01708187|5753414|P1|NOT COMPLETED|Overall Study||0
2343788|NCT01708187|5753413|P2|COMPLETED|Overall Study||0
2343789|NCT01708187|5753414|P1|COMPLETED|Overall Study||1
2343790|NCT01708187|5753413|P2|STARTED|Overall Study||1
2343791|NCT01708187|5753414|P1|STARTED|Overall Study||1
2343792|NCT01708174|5753423|P3|NOT COMPLETED|Survival Follow-up||0
2343793|NCT01708174|5753424|P2|NOT COMPLETED|Survival Follow-up||0
2343794|NCT01708174|5753425|P1|NOT COMPLETED|Survival Follow-up||0
2343795|NCT01708174|5753423|P3|COMPLETED|Survival Follow-up||0
2343796|NCT01708174|5753424|P2|COMPLETED|Survival Follow-up||10
2343797|NCT01708174|5753425|P1|COMPLETED|Survival Follow-up||1
2343798|NCT01708174|5753423|P3|STARTED|Survival Follow-up||0
2343799|NCT01708174|5753424|P2|STARTED|Survival Follow-up||10
2343800|NCT01708174|5753425|P1|STARTED|Survival Follow-up||1
2343801|NCT01708174|5753423|P3|NOT COMPLETED|Treatment Period||1
2343802|NCT01708174|5753424|P2|NOT COMPLETED|Treatment Period||2
2343803|NCT01708174|5753425|P1|NOT COMPLETED|Treatment Period||1
2343804|NCT01708174|5753423|P3|COMPLETED|Treatment Period||3
2343805|NCT01708174|5753424|P2|COMPLETED|Treatment Period||14
2343806|NCT01708174|5753425|P1|COMPLETED|Treatment Period||1
2343807|NCT01708174|5753423|P3|Pharmacokinetic Analysis Set|Treatment Period||0
2343808|NCT01708174|5753424|P2|Pharmacokinetic Analysis Set|Treatment Period||13
2343809|NCT01708174|5753425|P1|Pharmacokinetic Analysis Set|Treatment Period||2
2343810|NCT01708174|5753423|P3|STARTED|Treatment Period||4
2343811|NCT01708174|5753424|P2|STARTED|Treatment Period||16
2343812|NCT01708174|5753425|P1|STARTED|Treatment Period||2
2343813|NCT01708161|5753457|P6|NOT COMPLETED|Overall Study||1
2343814|NCT01708161|5753458|P5|NOT COMPLETED|Overall Study||6
2343815|NCT01708161|5753459|P4|NOT COMPLETED|Overall Study||16
2343816|NCT01708161|5753460|P3|NOT COMPLETED|Overall Study||10
2343817|NCT01708161|5753461|P2|NOT COMPLETED|Overall Study||10
2343818|NCT01708161|5753462|P1|NOT COMPLETED|Overall Study||4
2343819|NCT01708161|5753457|P6|COMPLETED|Overall Study||0
2343820|NCT01708161|5753458|P5|COMPLETED|Overall Study||0
2343821|NCT01708161|5753459|P4|COMPLETED|Overall Study||0
2343822|NCT01708161|5753460|P3|COMPLETED|Overall Study||0
2343823|NCT01708161|5753461|P2|COMPLETED|Overall Study||0
2343824|NCT01708161|5753462|P1|COMPLETED|Overall Study||0
2343825|NCT01708161|5753457|P6|STARTED|Overall Study||1
2343826|NCT01708161|5753458|P5|STARTED|Overall Study||6
2343827|NCT01708161|5753459|P4|STARTED|Overall Study||16
2343828|NCT01708161|5753460|P3|STARTED|Overall Study||10
2343829|NCT01708161|5753461|P2|STARTED|Overall Study||10
2343830|NCT01708161|5753462|P1|STARTED|Overall Study||4
2343831|NCT01708122|5753504|P2|NOT COMPLETED|Overall Study||0
2343832|NCT01708122|5753505|P1|NOT COMPLETED|Overall Study||0
2343833|NCT01708122|5753504|P2|COMPLETED|Overall Study||26
2343834|NCT01708122|5753505|P1|COMPLETED|Overall Study||27
2343835|NCT01708122|5753504|P2|STARTED|Overall Study||26
2343836|NCT01708122|5753505|P1|STARTED|Overall Study||27
2343837|NCT01708057|5753513|P3|NOT COMPLETED|Overall Study||1
2343838|NCT01708057|5753514|P2|NOT COMPLETED|Overall Study||1
2343839|NCT01708057|5753515|P1|NOT COMPLETED|Overall Study||1
2343840|NCT01708057|5753513|P3|COMPLETED|Overall Study||0
2343841|NCT01708057|5753514|P2|COMPLETED|Overall Study||0
2343842|NCT01708057|5753515|P1|COMPLETED|Overall Study||0
2343843|NCT01708057|5753513|P3|STARTED|Overall Study||1
2343844|NCT01708057|5753514|P2|STARTED|Overall Study||1
2343845|NCT01708057|5753515|P1|STARTED|Overall Study||1
2343846|NCT01707992|5753574|P6|NOT COMPLETED|Active Treatment Phase (24 Months)||215
2343847|NCT01707992|5753575|P5|NOT COMPLETED|Active Treatment Phase (24 Months)||494
2343848|NCT01707992|5753576|P4|NOT COMPLETED|Active Treatment Phase (24 Months)||884
2343849|NCT01707992|5753577|P3|NOT COMPLETED|Active Treatment Phase (24 Months)||0
2343850|NCT01707992|5753578|P2|NOT COMPLETED|Active Treatment Phase (24 Months)||0
2343851|NCT01707992|5753579|P1|NOT COMPLETED|Active Treatment Phase (24 Months)||0
2343852|NCT01707992|5753574|P6|COMPLETED|Active Treatment Phase (24 Months)||0
2343853|NCT01707992|5753575|P5|COMPLETED|Active Treatment Phase (24 Months)||10
2343854|NCT01707992|5753576|P4|COMPLETED|Active Treatment Phase (24 Months)||7
2343855|NCT01707992|5753577|P3|COMPLETED|Active Treatment Phase (24 Months)||0
2343856|NCT01707992|5753578|P2|COMPLETED|Active Treatment Phase (24 Months)||0
2343857|NCT01707992|5753579|P1|COMPLETED|Active Treatment Phase (24 Months)||0
2343858|NCT01707992|5753574|P6|STARTED|Active Treatment Phase (24 Months)||215
2343859|NCT01707992|5753575|P5|STARTED|Active Treatment Phase (24 Months)||504
2343860|NCT01707992|5753576|P4|STARTED|Active Treatment Phase (24 Months)||891
2343861|NCT01707992|5753577|P3|STARTED|Active Treatment Phase (24 Months)||0
2343862|NCT01707992|5753578|P2|STARTED|Active Treatment Phase (24 Months)||0
2343863|NCT01707992|5753579|P1|STARTED|Active Treatment Phase (24 Months)||0
2343864|NCT01707992|5753574|P6|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
2343865|NCT01707992|5753575|P5|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
2343866|NCT01707992|5753576|P4|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
2343867|NCT01707992|5753577|P3|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||200
2343868|NCT01707992|5753578|P2|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||104
2343869|NCT01707992|5753579|P1|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||144
2343870|NCT01707992|5753574|P6|COMPLETED|Placebo-Controlled Phase (24 Months)||0
2343871|NCT01707992|5753575|P5|COMPLETED|Placebo-Controlled Phase (24 Months)||0
2343872|NCT01707992|5753576|P4|COMPLETED|Placebo-Controlled Phase (24 Months)||0
2343873|NCT01707992|5753577|P3|COMPLETED|Placebo-Controlled Phase (24 Months)||532
2343874|NCT01707992|5753578|P2|COMPLETED|Placebo-Controlled Phase (24 Months)||623
2343875|NCT01707992|5753579|P1|COMPLETED|Placebo-Controlled Phase (24 Months)||596
2343876|NCT01707992|5753574|P6|STARTED|Placebo-Controlled Phase (24 Months)||0
2343877|NCT01707992|5753575|P5|STARTED|Placebo-Controlled Phase (24 Months)||0
2343878|NCT01707992|5753576|P4|STARTED|Placebo-Controlled Phase (24 Months)||0
2343879|NCT01707992|5753577|P3|STARTED|Placebo-Controlled Phase (24 Months)||732
2343880|NCT01707992|5753578|P2|STARTED|Placebo-Controlled Phase (24 Months)||727
2343881|NCT01707992|5753579|P1|STARTED|Placebo-Controlled Phase (24 Months)||740
2343882|NCT01707693|5753631|P2|NOT COMPLETED|Time 3 Measures @ 6 Mth||5
2343883|NCT01707693|5753632|P1|NOT COMPLETED|Time 3 Measures @ 6 Mth||0
2343884|NCT01707693|5753631|P2|COMPLETED|Time 3 Measures @ 6 Mth||49
2343885|NCT01707693|5753632|P1|COMPLETED|Time 3 Measures @ 6 Mth||46
2343886|NCT01707693|5753631|P2|STARTED|Time 3 Measures @ 6 Mth||54
2343887|NCT01707693|5753632|P1|STARTED|Time 3 Measures @ 6 Mth||46
2343888|NCT01707693|5753631|P2|NOT COMPLETED|Overall Study Allocation||8
2343889|NCT01707693|5753632|P1|NOT COMPLETED|Overall Study Allocation||13
2343890|NCT01707693|5753631|P2|COMPLETED|Overall Study Allocation||54
2343891|NCT01707693|5753632|P1|COMPLETED|Overall Study Allocation||46
2343892|NCT01707693|5753631|P2|STARTED|Overall Study Allocation||62
2343893|NCT01707693|5753632|P1|STARTED|Overall Study Allocation||59
2343894|NCT01707667|5753646|P2|NOT COMPLETED|Period 2||0
2343895|NCT01707667|5753647|P1|NOT COMPLETED|Period 2||0
2343896|NCT01707667|5753646|P2|COMPLETED|Period 2||6
2343897|NCT01707667|5753647|P1|COMPLETED|Period 2||6
2343898|NCT01707667|5753646|P2|STARTED|Period 2||6
2343899|NCT01707667|5753647|P1|STARTED|Period 2||6
2343900|NCT01707667|5753646|P2|NOT COMPLETED|Period 1||0
2343901|NCT01707667|5753647|P1|NOT COMPLETED|Period 1||1
2343902|NCT01707667|5753646|P2|COMPLETED|Period 1||6
2343903|NCT01707667|5753647|P1|COMPLETED|Period 1||6
2343904|NCT01707667|5753646|P2|STARTED|Period 1||6
2343905|NCT01707667|5753647|P1|STARTED|Period 1||7
2343906|NCT01707654|5753665|P1|NOT COMPLETED|Overall Study||0
2343907|NCT01707654|5753665|P1|COMPLETED|Overall Study||9
2343908|NCT01707654|5753665|P1|STARTED|Overall Study||9
2343909|NCT01707472|5753672|P3|NOT COMPLETED|Overall Study||0
2343910|NCT01707472|5753673|P2|NOT COMPLETED|Overall Study||0
2343911|NCT01707472|5753674|P1|NOT COMPLETED|Overall Study||0
2343912|NCT01707472|5753672|P3|COMPLETED|Overall Study||8
2343913|NCT01707472|5753673|P2|COMPLETED|Overall Study||6
2343914|NCT01707472|5753674|P1|COMPLETED|Overall Study||4
2343915|NCT01707472|5753672|P3|STARTED|Overall Study||8
2343916|NCT01707472|5753673|P2|STARTED|Overall Study||6
2343917|NCT01707472|5753674|P1|STARTED|Overall Study||4
2343918|NCT01707381|5753697|P2|NOT COMPLETED|Period 2||0
2343919|NCT01707381|5753698|P1|NOT COMPLETED|Period 2||0
2343920|NCT01707381|5753697|P2|COMPLETED|Period 2||11
2343921|NCT01707381|5753698|P1|COMPLETED|Period 2||10
2343922|NCT01707381|5753697|P2|STARTED|Period 2||11
2343923|NCT01707381|5753698|P1|STARTED|Period 2||10
2343924|NCT01707381|5753697|P2|NOT COMPLETED|Period 1||2
2343925|NCT01707381|5753698|P1|NOT COMPLETED|Period 1||2
2343926|NCT01707381|5753697|P2|COMPLETED|Period 1||11
2343927|NCT01707381|5753698|P1|COMPLETED|Period 1||10
2343928|NCT01707381|5753697|P2|STARTED|Period 1||13
2343929|NCT01707381|5753698|P1|STARTED|Period 1||12
2343930|NCT01707368|5753708|P1|NOT COMPLETED|Overall Study||168
2343931|NCT01707368|5753708|P1|COMPLETED|Overall Study||393
2343932|NCT01707368|5753708|P1|STARTED|Overall Study||561
2343933|NCT01707290|5753717|P2|NOT COMPLETED|Overall Study||1
2343934|NCT01707290|5753718|P1|NOT COMPLETED|Overall Study||86
2343935|NCT01707290|5753717|P2|COMPLETED|Overall Study||3
2343936|NCT01707290|5753718|P1|COMPLETED|Overall Study||35
2343937|NCT01707290|5753717|P2|STARTED|Overall Study||4
2343938|NCT01707290|5753718|P1|STARTED|Overall Study||121
2343939|NCT01707238|5753741|P2|NOT COMPLETED|Overall Study||0
2343940|NCT01707238|5753742|P1|NOT COMPLETED|Overall Study||0
2343941|NCT01707238|5753741|P2|COMPLETED|Overall Study||52
2343942|NCT01707238|5753742|P1|COMPLETED|Overall Study||48
2343943|NCT01707238|5753741|P2|STARTED|Overall Study||52
2343944|NCT01707238|5753742|P1|STARTED|Overall Study||48
2343945|NCT01707225|5753758|P1|NOT COMPLETED|Overall Study||0
2343946|NCT01707225|5753758|P1|COMPLETED|Overall Study||10
2343947|NCT01707225|5753758|P1|STARTED|Overall Study||10
2343948|NCT01707147|5753763|P1|NOT COMPLETED|Overall Study||100
2343949|NCT01707147|5753763|P1|COMPLETED|Overall Study||3119
2343950|NCT01707147|5753763|P1|STARTED|Overall Study||3219
2343951|NCT01707095|5753773|P2|NOT COMPLETED|Overall Study||0
2343952|NCT01707095|5753774|P1|NOT COMPLETED|Overall Study||0
2343953|NCT01707095|5753773|P2|COMPLETED|Overall Study||42
2343954|NCT01707095|5753774|P1|COMPLETED|Overall Study||42
2343955|NCT01707095|5753773|P2|STARTED|Overall Study||42
2343956|NCT01707095|5753774|P1|STARTED|Overall Study||42
2343957|NCT01707043|5753784|P2|NOT COMPLETED|Overall Study||0
2343958|NCT01707043|5753785|P1|NOT COMPLETED|Overall Study||0
2343959|NCT01707043|5753784|P2|COMPLETED|Overall Study||10
2343960|NCT01707043|5753785|P1|COMPLETED|Overall Study||10
2343961|NCT01707043|5753784|P2|STARTED|Overall Study||10
2343962|NCT01707043|5753785|P1|STARTED|Overall Study||10
2343963|NCT01707030|5753795|P2|NOT COMPLETED|Overall Study||17
2343964|NCT01707030|5753796|P1|NOT COMPLETED|Overall Study||11
2343965|NCT01707030|5753795|P2|COMPLETED|Overall Study||54
2343966|NCT01707030|5753796|P1|COMPLETED|Overall Study||56
2343967|NCT01707030|5753795|P2|STARTED|Overall Study||71
2343968|NCT01707030|5753796|P1|STARTED|Overall Study||67
2343969|NCT01707004|5753812|P1|NOT COMPLETED|Overall Study||3
2343970|NCT01707004|5753812|P1|COMPLETED|Overall Study|3 participants were not eligible to proceed to Bone Marrow Transplant due to significant infections.|17
2343971|NCT01707004|5753812|P1|STARTED|Overall Study||20
2343972|NCT01706965|5753826|P2|NOT COMPLETED|Overall Study||1
2343973|NCT01706965|5753827|P1|NOT COMPLETED|Overall Study||1
2343974|NCT01706965|5753826|P2|COMPLETED|Overall Study||12
2343975|NCT01706965|5753827|P1|COMPLETED|Overall Study||13
2343976|NCT01706965|5753826|P2|STARTED|Overall Study||13
2343977|NCT01706965|5753827|P1|STARTED|Overall Study||14
2343978|NCT01706952|5753835|P1|NOT COMPLETED|Overall Study||8
2343979|NCT01706952|5753835|P1|COMPLETED|Overall Study||37
2343980|NCT01706952|5753835|P1|STARTED|Overall Study||45
2343981|NCT01706926|5753851|P4|NOT COMPLETED|Overall Study||5
2343982|NCT01706926|5753852|P3|NOT COMPLETED|Overall Study||6
2343983|NCT01706926|5753853|P2|NOT COMPLETED|Overall Study||4
2343984|NCT01706926|5753854|P1|NOT COMPLETED|Overall Study||6
2343985|NCT01706926|5753851|P4|COMPLETED|Overall Study||74
2343986|NCT01706926|5753852|P3|COMPLETED|Overall Study||79
2343987|NCT01706926|5753853|P2|COMPLETED|Overall Study||77
2343988|NCT01706926|5753854|P1|COMPLETED|Overall Study||75
2343989|NCT01706926|5753851|P4|STARTED|Overall Study||79
2343990|NCT01706926|5753852|P3|STARTED|Overall Study||85
2343991|NCT01706926|5753853|P2|STARTED|Overall Study||81
2343992|NCT01706926|5753854|P1|STARTED|Overall Study||81
2343993|NCT01706822|5753963|P1|NOT COMPLETED|Overall Study||0
2343994|NCT01706822|5753963|P1|COMPLETED|Overall Study||8
2343995|NCT01706822|5753963|P1|STARTED|Overall Study||8
2343996|NCT01706770|5753973|P2|NOT COMPLETED|Overall Study||0
2343997|NCT01706770|5753974|P1|NOT COMPLETED|Overall Study||2
2343998|NCT01706770|5753973|P2|COMPLETED|Overall Study||17
2343999|NCT01706770|5753974|P1|COMPLETED|Overall Study||31
2344000|NCT01706770|5753973|P2|STARTED|Overall Study||17
2344001|NCT01706770|5753974|P1|STARTED|Overall Study||33
2344002|NCT01706666|5753985|P3|NOT COMPLETED|Overall Study||0
2344003|NCT01706666|5753986|P2|NOT COMPLETED|Overall Study||0
2344004|NCT01706666|5753987|P1|NOT COMPLETED|Overall Study||0
2344005|NCT01706666|5753985|P3|COMPLETED|Overall Study||1
2344006|NCT01706666|5753986|P2|COMPLETED|Overall Study||1
2344007|NCT01706666|5753987|P1|COMPLETED|Overall Study||1
2344008|NCT01706666|5753985|P3|STARTED|Overall Study||1
2344009|NCT01706666|5753986|P2|STARTED|Overall Study||1
2344010|NCT01706666|5753987|P1|STARTED|Overall Study||1
2344011|NCT01706588|5754006|P5|NOT COMPLETED|Overall Study||0
2344012|NCT01706588|5754007|P4|NOT COMPLETED|Overall Study||0
2344013|NCT01706588|5754008|P3|NOT COMPLETED|Overall Study||0
2344014|NCT01706588|5754009|P2|NOT COMPLETED|Overall Study||0
2344015|NCT01706588|5754010|P1|NOT COMPLETED|Overall Study||0
2344016|NCT01706588|5754006|P5|COMPLETED|Overall Study||16
2344017|NCT01706588|5754007|P4|COMPLETED|Overall Study||14
2344018|NCT01706588|5754008|P3|COMPLETED|Overall Study||15
2344019|NCT01706588|5754009|P2|COMPLETED|Overall Study||15
2344020|NCT01706588|5754010|P1|COMPLETED|Overall Study||15
2344021|NCT01706588|5754006|P5|STARTED|Overall Study||16
2344022|NCT01706588|5754007|P4|STARTED|Overall Study||14
2344023|NCT01706588|5754008|P3|STARTED|Overall Study||15
2344024|NCT01706588|5754009|P2|STARTED|Overall Study||15
2344025|NCT01706588|5754010|P1|STARTED|Overall Study||15
2344026|NCT01706575|5754022|P1|NOT COMPLETED|Overall Study||12
2344027|NCT01706575|5754022|P1|COMPLETED|Overall Study||64
2344028|NCT01706575|5754022|P1|Treated|Overall Study||70
2344029|NCT01706575|5754022|P1|STARTED|Overall Study||76
2344030|NCT01706549|5754033|P1|NOT COMPLETED|Overall Study||0
2344031|NCT01706549|5754033|P1|COMPLETED|Overall Study||16
2344032|NCT01706549|5754033|P1|STARTED|Overall Study||16
2344033|NCT01706536|5754043|P5|NOT COMPLETED|Overall Study||2
2344034|NCT01706536|5754044|P4|NOT COMPLETED|Overall Study||4
2344035|NCT01706536|5754045|P3|NOT COMPLETED|Overall Study||5
2344036|NCT01706536|5754046|P2|NOT COMPLETED|Overall Study||4
2344037|NCT01706536|5754047|P1|NOT COMPLETED|Overall Study||4
2344038|NCT01706536|5754043|P5|COMPLETED|Overall Study||57
2344039|NCT01706536|5754044|P4|COMPLETED|Overall Study||53
2344040|NCT01706536|5754045|P3|COMPLETED|Overall Study||49
2344041|NCT01706536|5754046|P2|COMPLETED|Overall Study||51
2344042|NCT01706536|5754047|P1|COMPLETED|Overall Study||53
2344043|NCT01706536|5754043|P5|STARTED|Overall Study||59
2344044|NCT01706536|5754044|P4|STARTED|Overall Study||57
2344045|NCT01706536|5754045|P3|STARTED|Overall Study||54
2344046|NCT01706536|5754046|P2|STARTED|Overall Study||55
2344047|NCT01706536|5754047|P1|STARTED|Overall Study||57
2344048|NCT01706497|5754104|P1|NOT COMPLETED|Overall Study||0
2344049|NCT01706497|5754104|P1|COMPLETED|Overall Study||177
2344050|NCT01706497|5754104|P1|STARTED|Overall Study||177
2344051|NCT01706458|5754114|P2|NOT COMPLETED|Overall Study||4
2344052|NCT01706458|5754115|P1|NOT COMPLETED|Overall Study||3
2344053|NCT01706458|5754114|P2|COMPLETED|Overall Study||5
2344054|NCT01706458|5754115|P1|COMPLETED|Overall Study||6
2344055|NCT01706458|5754114|P2|STARTED|Overall Study||9
2344056|NCT01706458|5754115|P1|STARTED|Overall Study||9
2344057|NCT01706328|5754139|P3|NOT COMPLETED|12-week Double-blind Treatment Period||45
2344058|NCT01706328|5754140|P2|NOT COMPLETED|12-week Double-blind Treatment Period||46
2344059|NCT01706328|5754141|P1|NOT COMPLETED|12-week Double-blind Treatment Period||0
2344060|NCT01706328|5754139|P3|COMPLETED|12-week Double-blind Treatment Period||371
2344061|NCT01706328|5754140|P2|COMPLETED|12-week Double-blind Treatment Period||366
2344062|NCT01706328|5754141|P1|COMPLETED|12-week Double-blind Treatment Period||0
2344063|NCT01706328|5754139|P3|STARTED|12-week Double-blind Treatment Period||416
2344064|NCT01706328|5754140|P2|STARTED|12-week Double-blind Treatment Period||412
2344065|NCT01706328|5754141|P1|STARTED|12-week Double-blind Treatment Period||0
2344066|NCT01706328|5754139|P3|NOT COMPLETED|2-week Run-in Period||0
2344067|NCT01706328|5754140|P2|NOT COMPLETED|2-week Run-in Period||0
2344068|NCT01706328|5754141|P1|NOT COMPLETED|2-week Run-in Period||165
2344069|NCT01706328|5754139|P3|COMPLETED|2-week Run-in Period||0
2344070|NCT01706328|5754140|P2|COMPLETED|2-week Run-in Period||0
2344071|NCT01706328|5754141|P1|COMPLETED|2-week Run-in Period||828
2344072|NCT01706328|5754139|P3|STARTED|2-week Run-in Period||0
2344073|NCT01706328|5754140|P2|STARTED|2-week Run-in Period||0
2344074|NCT01706328|5754141|P1|STARTED|2-week Run-in Period||993
2344075|NCT01706263|5754151|P1|NOT COMPLETED|Overall Study||0
2344076|NCT01706263|5754151|P1|COMPLETED|Overall Study||28
2344077|NCT01706263|5754151|P1|STARTED|Overall Study||28
2344078|NCT01706250|5754160|P1|NOT COMPLETED|Overall Study||2
2344079|NCT01706250|5754160|P1|COMPLETED|Overall Study||18
2344080|NCT01706250|5754160|P1|STARTED|Overall Study||20
2344081|NCT01706198|5754191|P2|NOT COMPLETED|Overall Study||194
2344082|NCT01706198|5754192|P1|NOT COMPLETED|Overall Study||173
2344083|NCT01706198|5754191|P2|COMPLETED|Overall Study||1920
2344084|NCT01706198|5754192|P1|COMPLETED|Overall Study||1946
2344085|NCT01706198|5754191|P2|STARTED|Overall Study||2114
2344086|NCT01706198|5754192|P1|STARTED|Overall Study||2119
2344087|NCT01706159|5754244|P2|NOT COMPLETED|Overall Study||2
2344088|NCT01706159|5754245|P1|NOT COMPLETED|Overall Study||8
2344089|NCT01706159|5754244|P2|COMPLETED|Overall Study||4
2344090|NCT01706159|5754245|P1|COMPLETED|Overall Study||6
2344091|NCT01706159|5754244|P2|Completers (With Baron Score at Week 8)|Overall Study||3
2344092|NCT01706159|5754245|P1|Completers (With Baron Score at Week 8)|Overall Study||6
2344093|NCT01706159|5754244|P2|Exposed|Overall Study|One subject was not exposed to placebo.|5
2344094|NCT01706159|5754245|P1|Exposed|Overall Study|One subject was not exposed to rFXIII.|13
2344095|NCT01706159|5754244|P2|STARTED|Overall Study||6
2344096|NCT01706159|5754245|P1|STARTED|Overall Study||14
2344097|NCT01706146|5754259|P1|NOT COMPLETED|Overall Study||6
2344098|NCT01706146|5754259|P1|COMPLETED|Overall Study|1 pt developed permanent AF; 1 pt needed dual antiplatelet therapy; 3 possible TIA; 1 withdraw|53
2344099|NCT01706146|5754259|P1|STARTED|Overall Study||59
2344100|NCT01706081|5754266|P2|NOT COMPLETED|Overall Study||0
2344101|NCT01706081|5754267|P1|NOT COMPLETED|Overall Study||0
2344102|NCT01706081|5754266|P2|COMPLETED|Overall Study||42
2344103|NCT01706081|5754267|P1|COMPLETED|Overall Study||40
2344104|NCT01706081|5754266|P2|STARTED|Overall Study||42
2344105|NCT01706081|5754267|P1|STARTED|Overall Study||40
2344106|NCT01706003|5754279|P2|NOT COMPLETED|Overall Study||4
2344107|NCT01706003|5754280|P1|NOT COMPLETED|Overall Study||11
2344108|NCT01706003|5754279|P2|COMPLETED|Overall Study||18
2344109|NCT01706003|5754280|P1|COMPLETED|Overall Study||12
2344110|NCT01706003|5754279|P2|STARTED|Overall Study||22
2344111|NCT01706003|5754280|P1|STARTED|Overall Study||23
2344112|NCT01705977|5754288|P2|NOT COMPLETED|Overall Study||260
2344113|NCT01705977|5754289|P1|NOT COMPLETED|Overall Study||273
2344114|NCT01705977|5754288|P2|COMPLETED|Overall Study||1741
2344115|NCT01705977|5754289|P1|COMPLETED|Overall Study||1729
2344116|NCT01705977|5754288|P2|STARTED|Overall Study||2001
2344117|NCT01705977|5754289|P1|STARTED|Overall Study||2002
2344118|NCT01705730|5754307|P1|NOT COMPLETED|Overall Study||9
2344119|NCT01705730|5754307|P1|COMPLETED|Overall Study||59
2344120|NCT01705730|5754307|P1|STARTED|Overall Study|Participants who received study drug|68
2344121|NCT01705717|5754347|P2|NOT COMPLETED|Overall Study||5
2344122|NCT01705717|5754348|P1|NOT COMPLETED|Overall Study||2
2344123|NCT01705717|5754347|P2|COMPLETED|Overall Study||7
2344124|NCT01705717|5754348|P1|COMPLETED|Overall Study||35
2344125|NCT01705717|5754347|P2|STARTED|Overall Study||12
2344126|NCT01705717|5754348|P1|STARTED|Overall Study||37
2344127|NCT01705691|5754365|P2|NOT COMPLETED|Overall Study||6
2344128|NCT01705691|5754366|P1|NOT COMPLETED|Overall Study||3
2344129|NCT01705691|5754365|P2|COMPLETED|Overall Study||24
2344130|NCT01705691|5754366|P1|COMPLETED|Overall Study||16
2344131|NCT01705691|5754365|P2|STARTED|Overall Study||30
2344132|NCT01705691|5754366|P1|STARTED|Overall Study||19
2344133|NCT01705652|5754386|P2|NOT COMPLETED|Overall Study||3
2344134|NCT01705652|5754387|P1|NOT COMPLETED|Overall Study||3
2344135|NCT01705652|5754386|P2|COMPLETED|Overall Study||9
2344136|NCT01705652|5754387|P1|COMPLETED|Overall Study||6
2344137|NCT01705652|5754386|P2|STARTED|Overall Study||12
2344138|NCT01705652|5754387|P1|STARTED|Overall Study||9
2344139|NCT01705587|5754395|P2|NOT COMPLETED|Overall Study||1
2344140|NCT01705587|5754396|P1|NOT COMPLETED|Overall Study||0
2344141|NCT01705587|5754395|P2|COMPLETED|Overall Study||5
2344142|NCT01705587|5754396|P1|COMPLETED|Overall Study||7
2344143|NCT01705587|5754395|P2|STARTED|Overall Study||6
2344144|NCT01705587|5754396|P1|STARTED|Overall Study||7
2344145|NCT01705574|5754414|P4|NOT COMPLETED|Open-Label Extension Phase||5
2344146|NCT01705574|5754415|P3|NOT COMPLETED|Open-Label Extension Phase||11
2344147|NCT01705574|5754416|P2|NOT COMPLETED|Open-Label Extension Phase||0
2344148|NCT01705574|5754417|P1|NOT COMPLETED|Open-Label Extension Phase||15
2344149|NCT01705574|5754414|P4|COMPLETED|Open-Label Extension Phase||48
2344150|NCT01705574|5754415|P3|COMPLETED|Open-Label Extension Phase||148
2344151|NCT01705574|5754416|P2|COMPLETED|Open-Label Extension Phase||0
2344152|NCT01705574|5754417|P1|COMPLETED|Open-Label Extension Phase||231
2344153|NCT01705574|5754414|P4|STARTED|Open-Label Extension Phase|53 participants entered from the DB ATV+ RTV + TVD arm.|53
2344154|NCT01705574|5754415|P3|STARTED|Open-Label Extension Phase|159 participants entered from the DB ATV+RTV+TVD arm.|159
2344155|NCT01705574|5754416|P2|STARTED|Open-Label Extension Phase|Participants either entered the OL GEN arm or OL ATV+RTV+TVD arm.|0
2344156|NCT01705574|5754417|P1|STARTED|Open-Label Extension Phase||246
2344157|NCT01705574|5754414|P4|NOT COMPLETED|Double-Blind Phase||0
2344158|NCT01705574|5754415|P3|NOT COMPLETED|Double-Blind Phase||0
2344159|NCT01705574|5754416|P2|NOT COMPLETED|Double-Blind Phase||41
2344160|NCT01705574|5754417|P1|NOT COMPLETED|Double-Blind Phase||33
2344161|NCT01705574|5754414|P4|COMPLETED|Double-Blind Phase||0
2344162|NCT01705574|5754415|P3|COMPLETED|Double-Blind Phase||0
2344163|NCT01705574|5754416|P2|COMPLETED|Double-Blind Phase||249
2344164|NCT01705574|5754417|P1|COMPLETED|Double-Blind Phase||260
2344165|NCT01705574|5754414|P4|STARTED|Double-Blind Phase||0
2344166|NCT01705574|5754415|P3|STARTED|Double-Blind Phase||0
2344167|NCT01705574|5754416|P2|STARTED|Double-Blind Phase||290
2344168|NCT01705574|5754417|P1|STARTED|Double-Blind Phase||293
2344175|NCT01705496|5754438|P1|NOT COMPLETED|Overall Study||4
2344176|NCT01705496|5754438|P1|COMPLETED|Overall Study||19
2344177|NCT01705496|5754438|P1|STARTED|Overall Study||23
2344184|NCT01705145|5754461|P1|NOT COMPLETED|Part B||1
2344185|NCT01705145|5754461|P1|COMPLETED|Part B||33
2344186|NCT01705145|5754461|P1|STARTED|Part B|Eight participants from Part A continued in Part B of the study.|34
2344187|NCT01705145|5754461|P1|NOT COMPLETED|Part A||0
2344188|NCT01705145|5754461|P1|COMPLETED|Part A||9
2344189|NCT01705145|5754461|P1|STARTED|Part A||9
2344190|NCT01705106|5754489|P1|NOT COMPLETED|Overall Study||0
2344191|NCT01705106|5754489|P1|COMPLETED|Overall Study||21
2344192|NCT01705106|5754489|P1|STARTED|Overall Study||21
2344193|NCT01705080|5754501|P4|NOT COMPLETED|Overall Study||42
2344194|NCT01705080|5754502|P3|NOT COMPLETED|Overall Study||5
2344195|NCT01705080|5754503|P2|NOT COMPLETED|Overall Study||16
2344196|NCT01705080|5754504|P1|NOT COMPLETED|Overall Study||15
2344197|NCT01705080|5754501|P4|COMPLETED|Overall Study||9
2344198|NCT01705080|5754502|P3|COMPLETED|Overall Study||27
2344199|NCT01705080|5754503|P2|COMPLETED|Overall Study||98
2344200|NCT01705080|5754504|P1|COMPLETED|Overall Study||142
2344201|NCT01705080|5754501|P4|1 Month|Overall Study||10
2344202|NCT01705080|5754502|P3|1 Month|Overall Study||27
2344203|NCT01705080|5754503|P2|1 Month|Overall Study||97
2344204|NCT01705080|5754504|P1|1 Month|Overall Study||148
2344205|NCT01705080|5754501|P4|Procedure|Overall Study||10
2344206|NCT01705080|5754502|P3|Procedure|Overall Study||29
2344207|NCT01705080|5754503|P2|Procedure|Overall Study||103
2344208|NCT01705080|5754504|P1|Procedure|Overall Study||149
2344209|NCT01705080|5754501|P4|STARTED|Overall Study||51
2344210|NCT01705080|5754502|P3|STARTED|Overall Study||32
2344211|NCT01705080|5754503|P2|STARTED|Overall Study||114
2344212|NCT01705080|5754504|P1|STARTED|Overall Study||157
2344213|NCT01704976|5754516|P2|NOT COMPLETED|Overall Study||2
2344214|NCT01704976|5754517|P1|NOT COMPLETED|Overall Study||1
2344215|NCT01704976|5754516|P2|COMPLETED|Overall Study|2 participants completed < 11 SR-WBV sessions, they were excluded from statistical analysis|11
2344216|NCT01704976|5754517|P1|COMPLETED|Overall Study|One participant completed < 11 SR-WBV sessions and was excluded from the statistical analysis|13
2344217|NCT01704976|5754516|P2|STARTED|Overall Study||13
2344218|NCT01704976|5754517|P1|STARTED|Overall Study||14
2344219|NCT01704846|5754533|P2|NOT COMPLETED|Treatment Period 4||0
2344220|NCT01704846|5754534|P1|NOT COMPLETED|Treatment Period 4||0
2344221|NCT01704846|5754533|P2|COMPLETED|Treatment Period 4||29
2344222|NCT01704846|5754534|P1|COMPLETED|Treatment Period 4||30
2344223|NCT01704846|5754533|P2|STARTED|Treatment Period 4||29
2344224|NCT01704846|5754534|P1|STARTED|Treatment Period 4||30
2344225|NCT01704846|5754533|P2|NOT COMPLETED|Treatment Period 3||0
2344226|NCT01704846|5754534|P1|NOT COMPLETED|Treatment Period 3||0
2344227|NCT01704846|5754533|P2|COMPLETED|Treatment Period 3||29
2344228|NCT01704846|5754534|P1|COMPLETED|Treatment Period 3||30
2344229|NCT01704846|5754533|P2|STARTED|Treatment Period 3||29
2344230|NCT01704846|5754534|P1|STARTED|Treatment Period 3||30
2344231|NCT01704846|5754533|P2|NOT COMPLETED|Treatment Period 2||1
2344232|NCT01704846|5754534|P1|NOT COMPLETED|Treatment Period 2||0
2344233|NCT01704846|5754533|P2|COMPLETED|Treatment Period 2||29
2344234|NCT01704846|5754534|P1|COMPLETED|Treatment Period 2||30
2344235|NCT01704846|5754533|P2|STARTED|Treatment Period 2||30
2344236|NCT01704846|5754534|P1|STARTED|Treatment Period 2||30
2344237|NCT01704846|5754533|P2|NOT COMPLETED|Treatment Period 1||0
2344238|NCT01704846|5754534|P1|NOT COMPLETED|Treatment Period 1||0
2344239|NCT01704846|5754533|P2|COMPLETED|Treatment Period 1||30
2344240|NCT01704846|5754534|P1|COMPLETED|Treatment Period 1||30
2344241|NCT01704846|5754533|P2|STARTED|Treatment Period 1||30
2344242|NCT01704846|5754534|P1|STARTED|Treatment Period 1||30
2344243|NCT01704781|5754557|P5|NOT COMPLETED|Overall Study||0
2344244|NCT01704781|5754558|P4|NOT COMPLETED|Overall Study||0
2344245|NCT01704781|5754559|P3|NOT COMPLETED|Overall Study||0
2344246|NCT01704781|5754560|P2|NOT COMPLETED|Overall Study||0
2344247|NCT01704781|5754561|P1|NOT COMPLETED|Overall Study||0
2344248|NCT01704781|5754557|P5|COMPLETED|Overall Study||12
2344249|NCT01704781|5754558|P4|COMPLETED|Overall Study||12
2344250|NCT01704781|5754559|P3|COMPLETED|Overall Study||6
2344251|NCT01704781|5754560|P2|COMPLETED|Overall Study||3
2344252|NCT01704781|5754561|P1|COMPLETED|Overall Study||3
2344253|NCT01704781|5754557|P5|STARTED|Overall Study||12
2344254|NCT01704781|5754558|P4|STARTED|Overall Study||12
2344255|NCT01704781|5754559|P3|STARTED|Overall Study||6
2344256|NCT01704781|5754560|P2|STARTED|Overall Study||3
2344257|NCT01704781|5754561|P1|STARTED|Overall Study||3
2344258|NCT01704755|5754589|P2|NOT COMPLETED|Overall Study||7
2344259|NCT01704755|5754590|P1|NOT COMPLETED|Overall Study||12
2344260|NCT01704755|5754589|P2|COMPLETED|Overall Study||165
2344261|NCT01704755|5754590|P1|COMPLETED|Overall Study||196
2344262|NCT01704755|5754589|P2|Completed Study Drug|Overall Study||163
2344263|NCT01704755|5754590|P1|Completed Study Drug|Overall Study||204
2344264|NCT01704755|5754589|P2|STARTED|Overall Study||172
2344265|NCT01704755|5754590|P1|STARTED|Overall Study||208
2344266|NCT01704651|5754604|P2|NOT COMPLETED|Overall Study||7
2344267|NCT01704651|5754605|P1|NOT COMPLETED|Overall Study||5
2344268|NCT01704651|5754604|P2|COMPLETED|Overall Study||68
2344269|NCT01704651|5754605|P1|COMPLETED|Overall Study||66
2344270|NCT01704651|5754604|P2|STARTED|Overall Study||75
2344271|NCT01704651|5754605|P1|STARTED|Overall Study||71
2344272|NCT01704599|5754613|P1|NOT COMPLETED|Overall Study||1
2344273|NCT01704599|5754613|P1|COMPLETED|Overall Study|11 screened 8 entered study 1 terminated.|7
2344274|NCT01704599|5754613|P1|STARTED|Overall Study|Study was started January 22, 2010|8
2344275|NCT01704521|5754642|P2|NOT COMPLETED|Overall Study||0
2344276|NCT01704521|5754643|P1|NOT COMPLETED|Overall Study||0
2344277|NCT01704521|5754642|P2|COMPLETED|Overall Study||2
2344278|NCT01704521|5754643|P1|COMPLETED|Overall Study||3
2344279|NCT01704521|5754642|P2|STARTED|Overall Study||2
2344280|NCT01704521|5754643|P1|STARTED|Overall Study||3
2344281|NCT01704495|5754653|P4|NOT COMPLETED|Optional Safety Extension||31
2344282|NCT01704495|5754654|P3|NOT COMPLETED|Optional Safety Extension||31
2344283|NCT01704495|5754655|P2|NOT COMPLETED|Optional Safety Extension||33
2344284|NCT01704495|5754656|P1|NOT COMPLETED|Optional Safety Extension||29
2344285|NCT01704495|5754653|P4|COMPLETED|Optional Safety Extension||85
2344286|NCT01704495|5754654|P3|COMPLETED|Optional Safety Extension||83
2344287|NCT01704495|5754655|P2|COMPLETED|Optional Safety Extension||88
2344288|NCT01704495|5754656|P1|COMPLETED|Optional Safety Extension||87
2344289|NCT01704495|5754653|P4|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
2344290|NCT01704495|5754654|P3|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|114
2344291|NCT01704495|5754655|P2|STARTED|Optional Safety Extension|35 subjects did not enter safety extension|121
2344292|NCT01704495|5754656|P1|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
2344293|NCT01704495|5754653|P4|NOT COMPLETED|Subjects Randomized||17
2344294|NCT01704495|5754654|P3|NOT COMPLETED|Subjects Randomized||16
2344295|NCT01704495|5754655|P2|NOT COMPLETED|Subjects Randomized||15
2344296|NCT01704495|5754656|P1|NOT COMPLETED|Subjects Randomized||22
2344297|NCT01704495|5754653|P4|COMPLETED|Subjects Randomized||145
2344298|NCT01704495|5754654|P3|COMPLETED|Subjects Randomized||144
2344299|NCT01704495|5754655|P2|COMPLETED|Subjects Randomized||141
2344300|NCT01704495|5754656|P1|COMPLETED|Subjects Randomized||140
2344301|NCT01704495|5754653|P4|STARTED|Subjects Randomized||162
2344302|NCT01704495|5754654|P3|STARTED|Subjects Randomized||160
2344303|NCT01704495|5754655|P2|STARTED|Subjects Randomized||156
2344304|NCT01704495|5754656|P1|STARTED|Subjects Randomized||162
2344305|NCT01704404|5754830|P6|NOT COMPLETED|Overall Study||0
2344306|NCT01704404|5754831|P5|NOT COMPLETED|Overall Study||1
2344307|NCT01704404|5754832|P4|NOT COMPLETED|Overall Study||3
2344308|NCT01704404|5754833|P3|NOT COMPLETED|Overall Study||1
2344309|NCT01704404|5754834|P2|NOT COMPLETED|Overall Study||1
2344310|NCT01704404|5754835|P1|NOT COMPLETED|Overall Study||1
2344311|NCT01704404|5754830|P6|COMPLETED|Overall Study||9
2344312|NCT01704404|5754831|P5|COMPLETED|Overall Study||10
2344313|NCT01704404|5754832|P4|COMPLETED|Overall Study||8
2344314|NCT01704404|5754833|P3|COMPLETED|Overall Study||9
2344315|NCT01704404|5754834|P2|COMPLETED|Overall Study||9
2344316|NCT01704404|5754835|P1|COMPLETED|Overall Study||10
2344317|NCT01704404|5754830|P6|STARTED|Overall Study||9
2344318|NCT01704404|5754831|P5|STARTED|Overall Study||11
2344319|NCT01704404|5754832|P4|STARTED|Overall Study||11
2344320|NCT01704404|5754833|P3|STARTED|Overall Study||10
2344321|NCT01704404|5754834|P2|STARTED|Overall Study||10
2344322|NCT01704404|5754835|P1|STARTED|Overall Study||11
2344323|NCT01704287|5754872|P5|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||38
2344324|NCT01704287|5754873|P4|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||38
2344325|NCT01704287|5754874|P3|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
2344326|NCT01704287|5754875|P2|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
2344327|NCT01704287|5754876|P1|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
2344328|NCT01704287|5754872|P5|COMPLETED|Switch to Pembrolizumab Treatment Period||7
2344329|NCT01704287|5754873|P4|COMPLETED|Switch to Pembrolizumab Treatment Period||15
2344330|NCT01704287|5754874|P3|COMPLETED|Switch to Pembrolizumab Treatment Period||0
2344331|NCT01704287|5754875|P2|COMPLETED|Switch to Pembrolizumab Treatment Period||0
2344332|NCT01704287|5754876|P1|COMPLETED|Switch to Pembrolizumab Treatment Period||0
2344333|NCT01704287|5754872|P5|STARTED|Switch to Pembrolizumab Treatment Period||45
2344334|NCT01704287|5754873|P4|STARTED|Switch to Pembrolizumab Treatment Period||53
2344335|NCT01704287|5754874|P3|STARTED|Switch to Pembrolizumab Treatment Period||0
2344336|NCT01704287|5754875|P2|STARTED|Switch to Pembrolizumab Treatment Period||0
2344337|NCT01704287|5754876|P1|STARTED|Switch to Pembrolizumab Treatment Period||0
2344338|NCT01704287|5754872|P5|NOT COMPLETED|Initial Treatment Period||0
2344339|NCT01704287|5754873|P4|NOT COMPLETED|Initial Treatment Period||0
2344340|NCT01704287|5754874|P3|NOT COMPLETED|Initial Treatment Period||173
2344341|NCT01704287|5754875|P2|NOT COMPLETED|Initial Treatment Period||134
2344342|NCT01704287|5754876|P1|NOT COMPLETED|Initial Treatment Period||147
2344343|NCT01704287|5754872|P5|COMPLETED|Initial Treatment Period||0
2344344|NCT01704287|5754873|P4|COMPLETED|Initial Treatment Period||0
2344345|NCT01704287|5754874|P3|COMPLETED|Initial Treatment Period||6
2344346|NCT01704287|5754875|P2|COMPLETED|Initial Treatment Period||47
2344347|NCT01704287|5754876|P1|COMPLETED|Initial Treatment Period||33
2344348|NCT01704287|5754872|P5|Treated|Initial Treatment Period||0
2344349|NCT01704287|5754873|P4|Treated|Initial Treatment Period||0
2344350|NCT01704287|5754874|P3|Treated|Initial Treatment Period||171
2344351|NCT01704287|5754875|P2|Treated|Initial Treatment Period||179
2344352|NCT01704287|5754876|P1|Treated|Initial Treatment Period||178
2344353|NCT01704287|5754872|P5|STARTED|Initial Treatment Period||0
2344354|NCT01704287|5754873|P4|STARTED|Initial Treatment Period||0
2344355|NCT01704287|5754874|P3|STARTED|Initial Treatment Period||179
2344356|NCT01704287|5754875|P2|STARTED|Initial Treatment Period||181
2344357|NCT01704287|5754876|P1|STARTED|Initial Treatment Period||180
2344358|NCT01704261|5754924|P2|NOT COMPLETED|Overall Study||15
2344359|NCT01704261|5754925|P1|NOT COMPLETED|Overall Study||13
2344360|NCT01704261|5754924|P2|COMPLETED|Overall Study||138
2344361|NCT01704261|5754925|P1|COMPLETED|Overall Study||141
2344362|NCT01704261|5754924|P2|STARTED|Overall Study||153
2344363|NCT01704261|5754925|P1|STARTED|Overall Study||154
2344364|NCT01704196|5754941|P2|NOT COMPLETED|Overall Study||24
2344365|NCT01704196|5754942|P1|NOT COMPLETED|Overall Study||19
2344366|NCT01704196|5754941|P2|COMPLETED|Overall Study||65
2344367|NCT01704196|5754942|P1|COMPLETED|Overall Study||71
2344368|NCT01704196|5754941|P2|STARTED|Overall Study||89
2344369|NCT01704196|5754942|P1|STARTED|Overall Study||90
2344370|NCT01704079|5754952|P2|NOT COMPLETED|Overall Study||23
2344371|NCT01704079|5754953|P1|NOT COMPLETED|Overall Study||14
2344372|NCT01704079|5754952|P2|COMPLETED|Overall Study||121
2344373|NCT01704079|5754953|P1|COMPLETED|Overall Study||58
2344374|NCT01704079|5754952|P2|Entered Extension Study|Overall Study||102
2344375|NCT01704079|5754953|P1|Entered Extension Study|Overall Study||53
2344376|NCT01704079|5754952|P2|STARTED|Overall Study||144
2344377|NCT01704079|5754953|P1|STARTED|Overall Study||72
2344378|NCT01703988|5754969|P4|NOT COMPLETED|Overall Study||1
2344379|NCT01703988|5754970|P3|NOT COMPLETED|Overall Study||0
2344380|NCT01703988|5754971|P2|NOT COMPLETED|Overall Study||0
2344381|NCT01703988|5754972|P1|NOT COMPLETED|Overall Study||0
2344382|NCT01703988|5754969|P4|COMPLETED|Overall Study||8
2344383|NCT01703988|5754970|P3|COMPLETED|Overall Study||9
2344384|NCT01703988|5754971|P2|COMPLETED|Overall Study||8
2344385|NCT01703988|5754972|P1|COMPLETED|Overall Study||8
2344386|NCT01703988|5754969|P4|STARTED|Overall Study||9
2344387|NCT01703988|5754970|P3|STARTED|Overall Study||9
2344388|NCT01703988|5754971|P2|STARTED|Overall Study||8
2344389|NCT01703988|5754972|P1|STARTED|Overall Study||8
2344390|NCT01703858|5755002|P3|NOT COMPLETED|Overall Study||0
2344391|NCT01703858|5755003|P2|NOT COMPLETED|Overall Study||1
2344392|NCT01703858|5755004|P1|NOT COMPLETED|Overall Study||0
2344393|NCT01703858|5755002|P3|COMPLETED|Overall Study||5
2344394|NCT01703858|5755003|P2|COMPLETED|Overall Study||4
2344395|NCT01703858|5755004|P1|COMPLETED|Overall Study||5
2344396|NCT01703858|5755002|P3|STARTED|Overall Study||5
2344397|NCT01703858|5755003|P2|STARTED|Overall Study||5
2344398|NCT01703858|5755004|P1|STARTED|Overall Study||5
2344399|NCT01703845|5755029|P2|NOT COMPLETED|Overall Study||0
2344400|NCT01703845|5755030|P1|NOT COMPLETED|Overall Study||3
2344401|NCT01703845|5755029|P2|COMPLETED|Overall Study||16
2344402|NCT01703845|5755030|P1|COMPLETED|Overall Study||13
2344403|NCT01703845|5755029|P2|STARTED|Overall Study|started are actually the randomized|16
2344404|NCT01703845|5755030|P1|STARTED|Overall Study|started are actually the randomized|16
2344405|NCT01703832|5755067|P2|NOT COMPLETED|Overall Study||0
2344406|NCT01703832|5755068|P1|NOT COMPLETED|Overall Study||1
2344407|NCT01703832|5755067|P2|COMPLETED|Overall Study||32
2344408|NCT01703832|5755068|P1|COMPLETED|Overall Study||32
2344409|NCT01703832|5755067|P2|STARTED|Overall Study||32
2344410|NCT01703832|5755068|P1|STARTED|Overall Study||33
2344411|NCT01703819|5755100|P2|NOT COMPLETED|Overall Study||2
2344412|NCT01703819|5755101|P1|NOT COMPLETED|Overall Study||0
2344413|NCT01703819|5755100|P2|COMPLETED|Overall Study||30
2344414|NCT01703819|5755101|P1|COMPLETED|Overall Study||34
2344415|NCT01703819|5755100|P2|STARTED|Overall Study||32
2344416|NCT01703819|5755101|P1|STARTED|Overall Study||34
2344417|NCT01703741|5755131|P1|NOT COMPLETED|Overall Study||18
2344418|NCT01703741|5755131|P1|COMPLETED|Overall Study||127
2344419|NCT01703741|5755131|P1|Per Protocol (PP) Population|Overall Study|Subjects having 24 hr pharmacokinetic (PK) data for testosterone, with no major protocol violations.|106
2344420|NCT01703741|5755131|P1|STARTED|Overall Study||145
2344421|NCT01703702|5755149|P2|NOT COMPLETED|Overall Study||22
2344422|NCT01703702|5755150|P1|NOT COMPLETED|Overall Study||36
2344423|NCT01703702|5755149|P2|COMPLETED|Overall Study||288
2344424|NCT01703702|5755150|P1|COMPLETED|Overall Study||272
2344425|NCT01703702|5755149|P2|STARTED|Overall Study||310
2344426|NCT01703702|5755150|P1|STARTED|Overall Study||308
2344427|NCT01703663|5755167|P2|NOT COMPLETED|Second Treatment Period||0
2344428|NCT01703663|5755168|P1|NOT COMPLETED|Second Treatment Period||0
2344429|NCT01703663|5755167|P2|COMPLETED|Second Treatment Period||8
2344430|NCT01703663|5755168|P1|COMPLETED|Second Treatment Period||11
2344431|NCT01703663|5755167|P2|STARTED|Second Treatment Period||8
2344432|NCT01703663|5755168|P1|STARTED|Second Treatment Period||11
2344433|NCT01703663|5755167|P2|NOT COMPLETED|First Treatment Period||0
2344434|NCT01703663|5755168|P1|NOT COMPLETED|First Treatment Period||0
2344435|NCT01703663|5755167|P2|COMPLETED|First Treatment Period||20
2344436|NCT01703663|5755168|P1|COMPLETED|First Treatment Period||20
2344437|NCT01703663|5755167|P2|STARTED|First Treatment Period||20
2344438|NCT01703663|5755168|P1|STARTED|First Treatment Period||20
2344439|NCT01703598|5755174|P1|NOT COMPLETED|Overall Study||0
2344440|NCT01703598|5755174|P1|COMPLETED|Overall Study||69
2344441|NCT01703598|5755174|P1|STARTED|Overall Study||69
2344442|NCT01703507|5755180|P2|NOT COMPLETED|Overall Study||0
2344443|NCT01703507|5755181|P1|NOT COMPLETED|Overall Study||1
2344444|NCT01703507|5755180|P2|COMPLETED|Overall Study||11
2344445|NCT01703507|5755181|P1|COMPLETED|Overall Study||5
2344446|NCT01703507|5755180|P2|STARTED|Overall Study||11
2344447|NCT01703507|5755181|P1|STARTED|Overall Study||6
2344448|NCT01703286|5755197|P6|NOT COMPLETED|Period 3 Including Washout||0
2344449|NCT01703286|5755198|P5|NOT COMPLETED|Period 3 Including Washout||0
2344450|NCT01703286|5755199|P4|NOT COMPLETED|Period 3 Including Washout||0
2344451|NCT01703286|5755200|P3|NOT COMPLETED|Period 3 Including Washout||0
2344452|NCT01703286|5755201|P2|NOT COMPLETED|Period 3 Including Washout||0
2344453|NCT01703286|5755202|P1|NOT COMPLETED|Period 3 Including Washout||0
2344454|NCT01703286|5755197|P6|COMPLETED|Period 3 Including Washout||6
2344455|NCT01703286|5755198|P5|COMPLETED|Period 3 Including Washout||7
2344456|NCT01703286|5755199|P4|COMPLETED|Period 3 Including Washout||5
2344457|NCT01703286|5755200|P3|COMPLETED|Period 3 Including Washout||7
2344458|NCT01703286|5755201|P2|COMPLETED|Period 3 Including Washout||7
2344459|NCT01703286|5755202|P1|COMPLETED|Period 3 Including Washout||7
2344460|NCT01703286|5755197|P6|STARTED|Period 3 Including Washout||6
2344461|NCT01703286|5755198|P5|STARTED|Period 3 Including Washout||7
2344462|NCT01703286|5755199|P4|STARTED|Period 3 Including Washout||5
2344463|NCT01703286|5755200|P3|STARTED|Period 3 Including Washout||7
2344464|NCT01703286|5755201|P2|STARTED|Period 3 Including Washout||7
2344465|NCT01703286|5755202|P1|STARTED|Period 3 Including Washout||7
2344466|NCT01703286|5755197|P6|NOT COMPLETED|Period 2 Including Washout||0
2344467|NCT01703286|5755198|P5|NOT COMPLETED|Period 2 Including Washout||0
2344468|NCT01703286|5755199|P4|NOT COMPLETED|Period 2 Including Washout||1
2344469|NCT01703286|5755200|P3|NOT COMPLETED|Period 2 Including Washout||0
2344470|NCT01703286|5755201|P2|NOT COMPLETED|Period 2 Including Washout||0
2344471|NCT01703286|5755202|P1|NOT COMPLETED|Period 2 Including Washout||0
2344472|NCT01703286|5755197|P6|COMPLETED|Period 2 Including Washout||6
2344473|NCT01703286|5755198|P5|COMPLETED|Period 2 Including Washout||7
2344474|NCT01703286|5755199|P4|COMPLETED|Period 2 Including Washout||5
2344475|NCT01703286|5755200|P3|COMPLETED|Period 2 Including Washout||7
2344476|NCT01703286|5755201|P2|COMPLETED|Period 2 Including Washout||7
2344477|NCT01703286|5755202|P1|COMPLETED|Period 2 Including Washout||7
2344478|NCT01703286|5755197|P6|STARTED|Period 2 Including Washout||6
2344479|NCT01703286|5755198|P5|STARTED|Period 2 Including Washout||7
2344480|NCT01703286|5755199|P4|STARTED|Period 2 Including Washout||6
2344481|NCT01703286|5755200|P3|STARTED|Period 2 Including Washout||7
2344482|NCT01703286|5755201|P2|STARTED|Period 2 Including Washout||7
2344483|NCT01703286|5755202|P1|STARTED|Period 2 Including Washout||7
2344484|NCT01703286|5755197|P6|NOT COMPLETED|Period 1 Including Washout||1
2344485|NCT01703286|5755198|P5|NOT COMPLETED|Period 1 Including Washout||0
2344486|NCT01703286|5755199|P4|NOT COMPLETED|Period 1 Including Washout||1
2344487|NCT01703286|5755200|P3|NOT COMPLETED|Period 1 Including Washout||0
2344488|NCT01703286|5755201|P2|NOT COMPLETED|Period 1 Including Washout||0
2344489|NCT01703286|5755202|P1|NOT COMPLETED|Period 1 Including Washout||0
2344490|NCT01703286|5755197|P6|COMPLETED|Period 1 Including Washout||6
2344491|NCT01703286|5755198|P5|COMPLETED|Period 1 Including Washout||7
2344492|NCT01703286|5755199|P4|COMPLETED|Period 1 Including Washout||6
2344493|NCT01703286|5755200|P3|COMPLETED|Period 1 Including Washout||7
2344494|NCT01703286|5755201|P2|COMPLETED|Period 1 Including Washout||7
2344495|NCT01703286|5755202|P1|COMPLETED|Period 1 Including Washout||7
2344496|NCT01703286|5755197|P6|STARTED|Period 1 Including Washout||7
2344497|NCT01703286|5755198|P5|STARTED|Period 1 Including Washout||7
2344498|NCT01703286|5755199|P4|STARTED|Period 1 Including Washout||7
2344499|NCT01703286|5755200|P3|STARTED|Period 1 Including Washout||7
2344500|NCT01703286|5755201|P2|STARTED|Period 1 Including Washout||7
2344501|NCT01703286|5755202|P1|STARTED|Period 1 Including Washout||7
2344502|NCT01703260|5755225|P3|NOT COMPLETED|Overall Study||3
2344503|NCT01703260|5755226|P2|NOT COMPLETED|Overall Study||4
2344504|NCT01703260|5755227|P1|NOT COMPLETED|Overall Study||3
2344505|NCT01703260|5755225|P3|COMPLETED|Overall Study||3
2344506|NCT01703260|5755226|P2|COMPLETED|Overall Study||3
2344507|NCT01703260|5755227|P1|COMPLETED|Overall Study||4
2344508|NCT01703260|5755225|P3|STARTED|Overall Study||6
2344509|NCT01703260|5755226|P2|STARTED|Overall Study||7
2344510|NCT01703260|5755227|P1|STARTED|Overall Study||7
2344511|NCT01703221|5755253|P3|NOT COMPLETED|Phase B - (Week 25 to 52)||5
2344512|NCT01703221|5755254|P2|NOT COMPLETED|Phase B - (Week 25 to 52)||14
2344513|NCT01703221|5755255|P1|NOT COMPLETED|Phase B - (Week 25 to 52)||16
2344514|NCT01703221|5755253|P3|COMPLETED|Phase B - (Week 25 to 52)||75
2344515|NCT01703221|5755254|P2|COMPLETED|Phase B - (Week 25 to 52)||147
2344516|NCT01703221|5755255|P1|COMPLETED|Phase B - (Week 25 to 52)||143
2344517|NCT01703221|5755253|P3|STARTED|Phase B - (Week 25 to 52)||80
2344518|NCT01703221|5755254|P2|STARTED|Phase B - (Week 25 to 52)||161
2344519|NCT01703221|5755255|P1|STARTED|Phase B - (Week 25 to 52)||159
2344520|NCT01703221|5755253|P3|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
2344521|NCT01703221|5755254|P2|NOT COMPLETED|Phase A (Up to 24 Weeks)||4
2344522|NCT01703221|5755255|P1|NOT COMPLETED|Phase A (Up to 24 Weeks)||7
2344523|NCT01703221|5755253|P3|COMPLETED|Phase A (Up to 24 Weeks)||80
2344524|NCT01703221|5755254|P2|COMPLETED|Phase A (Up to 24 Weeks)||161
2344525|NCT01703221|5755255|P1|COMPLETED|Phase A (Up to 24 Weeks)||159
2344526|NCT01703221|5755253|P3|STARTED|Phase A (Up to 24 Weeks)||83
2344527|NCT01703221|5755254|P2|STARTED|Phase A (Up to 24 Weeks)||165
2344528|NCT01703221|5755255|P1|STARTED|Phase A (Up to 24 Weeks)||166
2344529|NCT01703208|5755286|P2|NOT COMPLETED|Overall Study||2102
2344530|NCT01703208|5755287|P1|NOT COMPLETED|Overall Study||2100
2344531|NCT01703208|5755286|P2|COMPLETED|Overall Study||0
2344532|NCT01703208|5755287|P1|COMPLETED|Overall Study||0
2344533|NCT01703208|5755286|P2|Treated|Overall Study||2100
2344534|NCT01703208|5755287|P1|Treated|Overall Study||2092
2344535|NCT01703208|5755286|P2|STARTED|Overall Study||2102
2344536|NCT01703208|5755287|P1|STARTED|Overall Study||2100
2344537|NCT01703169|5755341|P1|NOT COMPLETED|Overall Study||0
2344538|NCT01703169|5755341|P1|COMPLETED|Overall Study||13
2344539|NCT01703169|5755341|P1|STARTED|Overall Study||13
2344540|NCT01703091|5755351|P2|NOT COMPLETED|Overall Study||4
2344541|NCT01703091|5755352|P1|NOT COMPLETED|Overall Study||9
2344542|NCT01703091|5755351|P2|COMPLETED|Overall Study||95
2344543|NCT01703091|5755352|P1|COMPLETED|Overall Study||89
2344544|NCT01703091|5755351|P2|Received at Least One Dose of Study Drug|Overall Study||98
2344545|NCT01703091|5755352|P1|Received at Least One Dose of Study Drug|Overall Study||94
2344546|NCT01703091|5755351|P2|STARTED|Overall Study||99
2344547|NCT01703091|5755352|P1|STARTED|Overall Study||98
2344548|NCT01703065|5755370|P2|NOT COMPLETED|Overall Study||0
2344549|NCT01703065|5755371|P1|NOT COMPLETED|Overall Study||1
2344550|NCT01703065|5755370|P2|COMPLETED|Overall Study||0
2344551|NCT01703065|5755371|P1|COMPLETED|Overall Study||8
2344552|NCT01703065|5755370|P2|STARTED|Overall Study||0
2344553|NCT01703065|5755371|P1|STARTED|Overall Study||9
2344554|NCT01703039|5755386|P2|NOT COMPLETED|Overall Study||5
2344555|NCT01703039|5755387|P1|NOT COMPLETED|Overall Study||3
2344556|NCT01703039|5755386|P2|COMPLETED|Overall Study||7
2344557|NCT01703039|5755387|P1|COMPLETED|Overall Study||6
2344558|NCT01703039|5755386|P2|STARTED|Overall Study||12
2344559|NCT01703039|5755387|P1|STARTED|Overall Study||9
2344560|NCT01703000|5755401|P1|NOT COMPLETED|Overall Study||1
2344561|NCT01703000|5755401|P1|COMPLETED|Overall Study||99
2344562|NCT01703000|5755401|P1|STARTED|Overall Study||100
2344563|NCT01702987|5755434|P2|NOT COMPLETED|Overall Study||0
2344564|NCT01702987|5755435|P1|NOT COMPLETED|Overall Study||1
2344565|NCT01702987|5755434|P2|COMPLETED|Overall Study||12
2344566|NCT01702987|5755435|P1|COMPLETED|Overall Study||9
2344567|NCT01702987|5755434|P2|STARTED|Overall Study||12
2344568|NCT01702987|5755435|P1|STARTED|Overall Study||10
2344569|NCT01702961|5755441|P1|NOT COMPLETED|Overall Study||47
2344570|NCT01702961|5755441|P1|COMPLETED|Overall Study||28
2344571|NCT01702961|5755441|P1|STARTED|Overall Study||75
2344572|NCT01702909|5755447|P1|NOT COMPLETED|Overall Study||0
2344573|NCT01702909|5755447|P1|COMPLETED|Overall Study||7
2344574|NCT01702909|5755447|P1|STARTED|Overall Study||7
2344575|NCT01702896|5755453|P1|NOT COMPLETED|Overall Study||8
2344576|NCT01702896|5755453|P1|COMPLETED|Overall Study||0
2344577|NCT01702896|5755453|P1|STARTED|Overall Study||8
2344578|NCT01702558|5755464|P5|NOT COMPLETED|Overall Study||42
2344579|NCT01702558|5755465|P4|NOT COMPLETED|Overall Study||47
2344580|NCT01702558|5755466|P3|NOT COMPLETED|Overall Study||5
2344581|NCT01702558|5755467|P2|NOT COMPLETED|Overall Study||4
2344582|NCT01702558|5755468|P1|NOT COMPLETED|Overall Study||4
2344583|NCT01702558|5755464|P5|COMPLETED|Overall Study||38
2344584|NCT01702558|5755465|P4|COMPLETED|Overall Study||34
2344585|NCT01702558|5755466|P3|COMPLETED|Overall Study||1
2344586|NCT01702558|5755467|P2|COMPLETED|Overall Study||1
2344587|NCT01702558|5755468|P1|COMPLETED|Overall Study||3
2344588|NCT01702558|5755464|P5|STARTED|Overall Study||80
2344589|NCT01702558|5755465|P4|STARTED|Overall Study||81
2344590|NCT01702558|5755466|P3|STARTED|Overall Study||6
2344591|NCT01702558|5755467|P2|STARTED|Overall Study||5
2344592|NCT01702558|5755468|P1|STARTED|Overall Study||7
2344593|NCT01702532|5755533|P2|NOT COMPLETED|Overall Study||1
2344594|NCT01702532|5755534|P1|NOT COMPLETED|Overall Study||0
2344595|NCT01702532|5755533|P2|COMPLETED|Overall Study||160
2344596|NCT01702532|5755534|P1|COMPLETED|Overall Study||161
2344597|NCT01702532|5755533|P2|Safety Population|Overall Study|One subject randomized but did not receive the study treatment.|160
2344598|NCT01702532|5755534|P1|Safety Population|Overall Study||161
2344599|NCT01702532|5755533|P2|STARTED|Overall Study||161
2344600|NCT01702532|5755534|P1|STARTED|Overall Study||161
2344601|NCT01702519|5755544|P2|NOT COMPLETED|Period 2||0
2344602|NCT01702519|5755545|P1|NOT COMPLETED|Period 2||0
2344603|NCT01702519|5755544|P2|COMPLETED|Period 2||18
2344604|NCT01702519|5755545|P1|COMPLETED|Period 2||19
2344605|NCT01702519|5755544|P2|STARTED|Period 2||18
2344606|NCT01702519|5755545|P1|STARTED|Period 2||19
2344607|NCT01702519|5755544|P2|NOT COMPLETED|Washout Period||2
2344608|NCT01702519|5755545|P1|NOT COMPLETED|Washout Period||1
2344609|NCT01702519|5755544|P2|COMPLETED|Washout Period||18
2344610|NCT01702519|5755545|P1|COMPLETED|Washout Period||19
2344611|NCT01702519|5755544|P2|STARTED|Washout Period||20
2344612|NCT01702519|5755545|P1|STARTED|Washout Period||20
2344613|NCT01702519|5755544|P2|NOT COMPLETED|Period 1||0
2344614|NCT01702519|5755545|P1|NOT COMPLETED|Period 1||0
2344615|NCT01702519|5755544|P2|COMPLETED|Period 1||20
2344616|NCT01702519|5755545|P1|COMPLETED|Period 1||20
2344617|NCT01702519|5755544|P2|STARTED|Period 1||20
2344618|NCT01702519|5755545|P1|STARTED|Period 1||20
2344619|NCT01702454|5755563|P2|NOT COMPLETED|Overall Study||8
2344620|NCT01702454|5755564|P1|NOT COMPLETED|Overall Study||3
2344621|NCT01702454|5755563|P2|COMPLETED|Overall Study||221
2344622|NCT01702454|5755564|P1|COMPLETED|Overall Study||238
2344623|NCT01702454|5755563|P2|STARTED|Overall Study||229
2344624|NCT01702454|5755564|P1|STARTED|Overall Study||241
2344625|NCT01702428|5755646|P4|NOT COMPLETED|Overall Study||57
2344626|NCT01702428|5755647|P3|NOT COMPLETED|Overall Study||53
2344627|NCT01702428|5755648|P2|NOT COMPLETED|Overall Study||70
2344628|NCT01702428|5755649|P1|NOT COMPLETED|Overall Study||64
2344629|NCT01702428|5755646|P4|COMPLETED|Overall Study||1232
2344630|NCT01702428|5755647|P3|COMPLETED|Overall Study||1190
2344631|NCT01702428|5755648|P2|COMPLETED|Overall Study||1162
2344632|NCT01702428|5755649|P1|COMPLETED|Overall Study||1175
2344633|NCT01702428|5755646|P4|STARTED|Overall Study||1289
2344634|NCT01702428|5755647|P3|STARTED|Overall Study||1243
2344635|NCT01702428|5755648|P2|STARTED|Overall Study||1232
2344636|NCT01702428|5755649|P1|STARTED|Overall Study||1239
2344637|NCT01702363|5755736|P1|NOT COMPLETED|Overall Study||20
2344638|NCT01702363|5755736|P1|COMPLETED|Overall Study||111
2344639|NCT01702363|5755736|P1|STARTED|Overall Study||131
2344640|NCT01702311|5755753|P2|NOT COMPLETED|Overall Study||13
2344641|NCT01702311|5755754|P1|NOT COMPLETED|Overall Study||16
2344642|NCT01702311|5755753|P2|COMPLETED|Overall Study||100
2344643|NCT01702311|5755754|P1|COMPLETED|Overall Study||106
2344644|NCT01702311|5755753|P2|STARTED|Overall Study||113
2344645|NCT01702311|5755754|P1|STARTED|Overall Study||122
2344646|NCT01702298|5755784|P1|NOT COMPLETED|Overall Study||1
2344647|NCT01702298|5755784|P1|COMPLETED|Overall Study||41
2344648|NCT01702298|5755784|P1|STARTED|Overall Study||42
2344649|NCT01702259|5755797|P2|NOT COMPLETED|Overall Study||0
2344650|NCT01702259|5755798|P1|NOT COMPLETED|Overall Study||0
2344651|NCT01702259|5755797|P2|COMPLETED|Overall Study||34
2344652|NCT01702259|5755798|P1|COMPLETED|Overall Study||34
2344653|NCT01702259|5755797|P2|STARTED|Overall Study||34
2344654|NCT01702259|5755798|P1|STARTED|Overall Study||34
2344655|NCT01702246|5755812|P1|NOT COMPLETED|Overall Study||5
2344656|NCT01702246|5755812|P1|COMPLETED|Overall Study||19
2344657|NCT01702246|5755812|P1|STARTED|Overall Study||24
2344658|NCT01702233|5755824|P3|NOT COMPLETED|Overall Study||5
2344659|NCT01702233|5755825|P2|NOT COMPLETED|Overall Study||3
2344660|NCT01702233|5755826|P1|NOT COMPLETED|Overall Study||6
2344661|NCT01702233|5755824|P3|COMPLETED|Overall Study||31
2344662|NCT01702233|5755825|P2|COMPLETED|Overall Study|One of these Patient completed the Trial but had no valid outcome measure after enrolment|64
2344663|NCT01702233|5755826|P1|COMPLETED|Overall Study||66
2344664|NCT01702233|5755824|P3|Per Protocol Set|Overall Study||27
2344665|NCT01702233|5755825|P2|Per Protocol Set|Overall Study||58
2344666|NCT01702233|5755826|P1|Per Protocol Set|Overall Study||58
2344667|NCT01702233|5755824|P3|Full Analysis Set (ITT)|Overall Study||31
2344668|NCT01702233|5755825|P2|Full Analysis Set (ITT)|Overall Study||63
2344669|NCT01702233|5755826|P1|Full Analysis Set (ITT)|Overall Study||66
2344670|NCT01702233|5755824|P3|STARTED|Overall Study||36
2344671|NCT01702233|5755825|P2|STARTED|Overall Study||67
2344672|NCT01702233|5755826|P1|STARTED|Overall Study||72
2344673|NCT01702025|5755866|P4|NOT COMPLETED|Overall Study||0
2344674|NCT01702025|5755867|P3|NOT COMPLETED|Overall Study||1
2344675|NCT01702025|5755868|P2|NOT COMPLETED|Overall Study||1
2344676|NCT01702025|5755869|P1|NOT COMPLETED|Overall Study||2
2344677|NCT01702025|5755866|P4|COMPLETED|Overall Study||10
2344678|NCT01702025|5755867|P3|COMPLETED|Overall Study||9
2344679|NCT01702025|5755868|P2|COMPLETED|Overall Study||9
2344680|NCT01702025|5755869|P1|COMPLETED|Overall Study||9
2344681|NCT01702025|5755866|P4|STARTED|Overall Study||10
2344682|NCT01702025|5755867|P3|STARTED|Overall Study||10
2344683|NCT01702025|5755868|P2|STARTED|Overall Study||10
2344684|NCT01702025|5755869|P1|STARTED|Overall Study||11
2344685|NCT01701999|5755885|P2|NOT COMPLETED|Overall Study||0
2344686|NCT01701999|5755886|P1|NOT COMPLETED|Overall Study||0
2344687|NCT01701999|5755885|P2|COMPLETED|Overall Study||37
2344688|NCT01701999|5755886|P1|COMPLETED|Overall Study||8
2344689|NCT01701999|5755885|P2|STARTED|Overall Study||37
2344690|NCT01701999|5755886|P1|STARTED|Overall Study||8
2344691|NCT01701973|5755898|P8|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
2344692|NCT01701973|5755899|P7|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
2344693|NCT01701973|5755900|P6|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
2344694|NCT01701973|5755901|P5|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
2344695|NCT01701973|5755902|P4|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
2344696|NCT01701973|5755903|P3|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
2344697|NCT01701973|5755904|P2|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
2344698|NCT01701973|5755905|P1|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
2344699|NCT01701973|5755898|P8|COMPLETED|Aim 2: Second Intervention (1 Day)||3
2344700|NCT01701973|5755899|P7|COMPLETED|Aim 2: Second Intervention (1 Day)||5
2344701|NCT01701973|5755900|P6|COMPLETED|Aim 2: Second Intervention (1 Day)||3
2344702|NCT01701973|5755901|P5|COMPLETED|Aim 2: Second Intervention (1 Day)||2
2344703|NCT01701973|5755902|P4|COMPLETED|Aim 2: Second Intervention (1 Day)||4
2344704|NCT01701973|5755903|P3|COMPLETED|Aim 2: Second Intervention (1 Day)||5
2344705|NCT01701973|5755904|P2|COMPLETED|Aim 2: Second Intervention (1 Day)||0
2344706|NCT01701973|5755905|P1|COMPLETED|Aim 2: Second Intervention (1 Day)||0
2344707|NCT01701973|5755898|P8|STARTED|Aim 2: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 3 and 4.|3
2344708|NCT01701973|5755899|P7|STARTED|Aim 2: Second Intervention (1 Day)||5
2344709|NCT01701973|5755900|P6|STARTED|Aim 2: Second Intervention (1 Day)||3
2344710|NCT01701973|5755901|P5|STARTED|Aim 2: Second Intervention (1 Day)||2
2344711|NCT01701973|5755902|P4|STARTED|Aim 2: Second Intervention (1 Day)||4
2344712|NCT01701973|5755903|P3|STARTED|Aim 2: Second Intervention (1 Day)||5
2344713|NCT01701973|5755904|P2|STARTED|Aim 2: Second Intervention (1 Day)||0
2344714|NCT01701973|5755905|P1|STARTED|Aim 2: Second Intervention (1 Day)||0
2344715|NCT01701973|5755898|P8|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
2344795|NCT01701505|5755972|P4|NOT COMPLETED|Overall Study||0
2344716|NCT01701973|5755899|P7|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
2344717|NCT01701973|5755900|P6|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
2344718|NCT01701973|5755901|P5|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
2344719|NCT01701973|5755902|P4|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
2344720|NCT01701973|5755903|P3|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
2344721|NCT01701973|5755904|P2|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
2344722|NCT01701973|5755905|P1|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
2344723|NCT01701973|5755898|P8|COMPLETED|Aim 2: First Intervention (1 Day)||4
2344724|NCT01701973|5755899|P7|COMPLETED|Aim 2: First Intervention (1 Day)||5
2344725|NCT01701973|5755900|P6|COMPLETED|Aim 2: First Intervention (1 Day)||3
2344726|NCT01701973|5755901|P5|COMPLETED|Aim 2: First Intervention (1 Day)||2
2344727|NCT01701973|5755902|P4|COMPLETED|Aim 2: First Intervention (1 Day)||4
2344728|NCT01701973|5755903|P3|COMPLETED|Aim 2: First Intervention (1 Day)||5
2344729|NCT01701973|5755904|P2|COMPLETED|Aim 2: First Intervention (1 Day)||0
2344730|NCT01701973|5755905|P1|COMPLETED|Aim 2: First Intervention (1 Day)||0
2344731|NCT01701973|5755898|P8|STARTED|Aim 2: First Intervention (1 Day)||4
2344732|NCT01701973|5755899|P7|STARTED|Aim 2: First Intervention (1 Day)||5
2344733|NCT01701973|5755900|P6|STARTED|Aim 2: First Intervention (1 Day)||3
2344734|NCT01701973|5755901|P5|STARTED|Aim 2: First Intervention (1 Day)||2
2344735|NCT01701973|5755902|P4|STARTED|Aim 2: First Intervention (1 Day)||4
2344736|NCT01701973|5755903|P3|STARTED|Aim 2: First Intervention (1 Day)||5
2344737|NCT01701973|5755904|P2|STARTED|Aim 2: First Intervention (1 Day)||0
2344738|NCT01701973|5755905|P1|STARTED|Aim 2: First Intervention (1 Day)||0
2344739|NCT01701973|5755898|P8|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
2344740|NCT01701973|5755899|P7|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
2344741|NCT01701973|5755900|P6|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
2344742|NCT01701973|5755901|P5|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
2344743|NCT01701973|5755902|P4|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
2344744|NCT01701973|5755903|P3|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
2344745|NCT01701973|5755904|P2|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
2344746|NCT01701973|5755905|P1|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
2344747|NCT01701973|5755898|P8|COMPLETED|Aim 1: Second Intervention (1 Day)||0
2344748|NCT01701973|5755899|P7|COMPLETED|Aim 1: Second Intervention (1 Day)||0
2344749|NCT01701973|5755900|P6|COMPLETED|Aim 1: Second Intervention (1 Day)||0
2344750|NCT01701973|5755901|P5|COMPLETED|Aim 1: Second Intervention (1 Day)||0
2344751|NCT01701973|5755902|P4|COMPLETED|Aim 1: Second Intervention (1 Day)||0
2344752|NCT01701973|5755903|P3|COMPLETED|Aim 1: Second Intervention (1 Day)||0
2344753|NCT01701973|5755904|P2|COMPLETED|Aim 1: Second Intervention (1 Day)||17
2344754|NCT01701973|5755905|P1|COMPLETED|Aim 1: Second Intervention (1 Day)||22
2344755|NCT01701973|5755898|P8|STARTED|Aim 1: Second Intervention (1 Day)||0
2344756|NCT01701973|5755899|P7|STARTED|Aim 1: Second Intervention (1 Day)||0
2344757|NCT01701973|5755900|P6|STARTED|Aim 1: Second Intervention (1 Day)||0
2344758|NCT01701973|5755901|P5|STARTED|Aim 1: Second Intervention (1 Day)||0
2344759|NCT01701973|5755902|P4|STARTED|Aim 1: Second Intervention (1 Day)||0
2344760|NCT01701973|5755903|P3|STARTED|Aim 1: Second Intervention (1 Day)||0
2344761|NCT01701973|5755904|P2|STARTED|Aim 1: Second Intervention (1 Day)|3 subjects were lost to follow-up in between Periods 1 and 2.|17
2344762|NCT01701973|5755905|P1|STARTED|Aim 1: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 1 and 2.|22
2344763|NCT01701973|5755898|P8|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
2344764|NCT01701973|5755899|P7|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
2344765|NCT01701973|5755900|P6|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
2344766|NCT01701973|5755901|P5|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
2344767|NCT01701973|5755902|P4|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
2344768|NCT01701973|5755903|P3|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
2344769|NCT01701973|5755904|P2|NOT COMPLETED|Aim 1: First Intervention (1 Day)||1
2344770|NCT01701973|5755905|P1|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
2344771|NCT01701973|5755898|P8|COMPLETED|Aim 1: First Intervention (1 Day)||0
2344772|NCT01701973|5755899|P7|COMPLETED|Aim 1: First Intervention (1 Day)||0
2344773|NCT01701973|5755900|P6|COMPLETED|Aim 1: First Intervention (1 Day)||0
2344774|NCT01701973|5755901|P5|COMPLETED|Aim 1: First Intervention (1 Day)||0
2344775|NCT01701973|5755902|P4|COMPLETED|Aim 1: First Intervention (1 Day)||0
2344776|NCT01701973|5755903|P3|COMPLETED|Aim 1: First Intervention (1 Day)||0
2344777|NCT01701973|5755904|P2|COMPLETED|Aim 1: First Intervention (1 Day)||20
2344778|NCT01701973|5755905|P1|COMPLETED|Aim 1: First Intervention (1 Day)||23
2344779|NCT01701973|5755898|P8|STARTED|Aim 1: First Intervention (1 Day)||0
2344780|NCT01701973|5755899|P7|STARTED|Aim 1: First Intervention (1 Day)||0
2344781|NCT01701973|5755900|P6|STARTED|Aim 1: First Intervention (1 Day)||0
2344782|NCT01701973|5755901|P5|STARTED|Aim 1: First Intervention (1 Day)||0
2344783|NCT01701973|5755902|P4|STARTED|Aim 1: First Intervention (1 Day)||0
2344784|NCT01701973|5755903|P3|STARTED|Aim 1: First Intervention (1 Day)||0
2344785|NCT01701973|5755904|P2|STARTED|Aim 1: First Intervention (1 Day)||21
2344786|NCT01701973|5755905|P1|STARTED|Aim 1: First Intervention (1 Day)||23
2344787|NCT01701674|5755952|P1|NOT COMPLETED|Overall Study||1
2344788|NCT01701674|5755952|P1|COMPLETED|Overall Study||12
2344789|NCT01701674|5755952|P1|STARTED|Overall Study||13
2344790|NCT01701622|5755959|P1|NOT COMPLETED|Overall Study||0
2344791|NCT01701622|5755959|P1|COMPLETED|Overall Study||1
2344792|NCT01701622|5755959|P1|STARTED|Overall Study||1
2344793|NCT01701505|5755970|P6|NOT COMPLETED|Overall Study||0
2344794|NCT01701505|5755971|P5|NOT COMPLETED|Overall Study||0
2344796|NCT01701505|5755973|P3|NOT COMPLETED|Overall Study||0
2344797|NCT01701505|5755974|P2|NOT COMPLETED|Overall Study||0
2344798|NCT01701505|5755975|P1|NOT COMPLETED|Overall Study||0
2344799|NCT01701505|5755970|P6|COMPLETED|Overall Study||8
2344800|NCT01701505|5755971|P5|COMPLETED|Overall Study||8
2344801|NCT01701505|5755972|P4|COMPLETED|Overall Study||8
2344802|NCT01701505|5755973|P3|COMPLETED|Overall Study||8
2344803|NCT01701505|5755974|P2|COMPLETED|Overall Study||8
2344804|NCT01701505|5755975|P1|COMPLETED|Overall Study||8
2344805|NCT01701505|5755970|P6|STARTED|Overall Study||8
2344806|NCT01701505|5755971|P5|STARTED|Overall Study||8
2344807|NCT01701505|5755972|P4|STARTED|Overall Study||8
2344808|NCT01701505|5755973|P3|STARTED|Overall Study||8
2344809|NCT01701505|5755974|P2|STARTED|Overall Study||8
2344810|NCT01701505|5755975|P1|STARTED|Overall Study||8
2344811|NCT01701414|5756027|P2|NOT COMPLETED|Overall Study||1
2344812|NCT01701414|5756028|P1|NOT COMPLETED|Overall Study||1
2344813|NCT01701414|5756027|P2|COMPLETED|Overall Study||18
2344814|NCT01701414|5756028|P1|COMPLETED|Overall Study||18
2344815|NCT01701414|5756027|P2|STARTED|Overall Study||19
2344816|NCT01701414|5756028|P1|STARTED|Overall Study||19
2344817|NCT01701401|5756038|P4|NOT COMPLETED|Overall Study||6
2344818|NCT01701401|5756039|P3|NOT COMPLETED|Overall Study||5
2344819|NCT01701401|5756040|P2|NOT COMPLETED|Overall Study||9
2344820|NCT01701401|5756041|P1|NOT COMPLETED|Overall Study||10
2344821|NCT01701401|5756038|P4|COMPLETED|Overall Study||212
2344822|NCT01701401|5756039|P3|COMPLETED|Overall Study||212
2344823|NCT01701401|5756040|P2|COMPLETED|Overall Study||209
2344824|NCT01701401|5756041|P1|COMPLETED|Overall Study||207
2344825|NCT01701401|5756038|P4|STARTED|Overall Study||218
2344826|NCT01701401|5756039|P3|STARTED|Overall Study||217
2344827|NCT01701401|5756040|P2|STARTED|Overall Study||218
2344828|NCT01701401|5756041|P1|STARTED|Overall Study||217
2344829|NCT01701375|5756087|P1|NOT COMPLETED|Overall Study||0
2344830|NCT01701375|5756087|P1|COMPLETED|Overall Study||2
2344831|NCT01701375|5756087|P1|STARTED|Overall Study||2
2344832|NCT01701362|5756093|P2|NOT COMPLETED|Overall Study||56
2344833|NCT01701362|5756094|P1|NOT COMPLETED|Overall Study||42
2344834|NCT01701362|5756093|P2|COMPLETED|Overall Study||211
2344835|NCT01701362|5756094|P1|COMPLETED|Overall Study||233
2344836|NCT01701362|5756093|P2|TREATED|Overall Study||265
2344837|NCT01701362|5756094|P1|TREATED|Overall Study||274
2344838|NCT01701362|5756093|P2|STARTED|Overall Study||267
2344839|NCT01701362|5756094|P1|STARTED|Overall Study||275
2344840|NCT01701271|5756122|P1|NOT COMPLETED|Overall Study||0
2344841|NCT01701271|5756122|P1|COMPLETED|Overall Study||20
2344842|NCT01701271|5756122|P1|STARTED|Overall Study||20
2344843|NCT01701258|5756132|P13|NOT COMPLETED|EEG (Session 4)||0
2344844|NCT01701258|5756133|P12|NOT COMPLETED|EEG (Session 4)||0
2344845|NCT01701258|5756134|P11|NOT COMPLETED|EEG (Session 4)||0
2344846|NCT01701258|5756135|P10|NOT COMPLETED|EEG (Session 4)||0
2344847|NCT01701258|5756136|P9|NOT COMPLETED|EEG (Session 4)||0
2344848|NCT01701258|5756137|P8|NOT COMPLETED|EEG (Session 4)||0
2344849|NCT01701258|5756138|P7|NOT COMPLETED|EEG (Session 4)||0
2344850|NCT01701258|5756139|P6|NOT COMPLETED|EEG (Session 4)||0
2344851|NCT01701258|5756140|P5|NOT COMPLETED|EEG (Session 4)||0
2344852|NCT01701258|5756141|P4|NOT COMPLETED|EEG (Session 4)||0
2344853|NCT01701258|5756142|P3|NOT COMPLETED|EEG (Session 4)||0
2344854|NCT01701258|5756143|P2|NOT COMPLETED|EEG (Session 4)||0
2344855|NCT01701258|5756144|P1|NOT COMPLETED|EEG (Session 4)||0
2344856|NCT01701258|5756132|P13|COMPLETED|EEG (Session 4)||0
2344857|NCT01701258|5756133|P12|COMPLETED|EEG (Session 4)||0
2344858|NCT01701258|5756134|P11|COMPLETED|EEG (Session 4)||17
2344859|NCT01701258|5756135|P10|COMPLETED|EEG (Session 4)||0
2344860|NCT01701258|5756136|P9|COMPLETED|EEG (Session 4)||0
2344861|NCT01701258|5756137|P8|COMPLETED|EEG (Session 4)||16
2344862|NCT01701258|5756138|P7|COMPLETED|EEG (Session 4)||0
2344863|NCT01701258|5756139|P6|COMPLETED|EEG (Session 4)||0
2344864|NCT01701258|5756140|P5|COMPLETED|EEG (Session 4)||14
2344865|NCT01701258|5756141|P4|COMPLETED|EEG (Session 4)||0
2344866|NCT01701258|5756142|P3|COMPLETED|EEG (Session 4)||0
2344867|NCT01701258|5756143|P2|COMPLETED|EEG (Session 4)||19
2344868|NCT01701258|5756144|P1|COMPLETED|EEG (Session 4)||0
2344869|NCT01701258|5756132|P13|STARTED|EEG (Session 4)||0
2344870|NCT01701258|5756133|P12|STARTED|EEG (Session 4)||0
2344871|NCT01701258|5756134|P11|STARTED|EEG (Session 4)||17
2344872|NCT01701258|5756135|P10|STARTED|EEG (Session 4)||0
2344873|NCT01701258|5756136|P9|STARTED|EEG (Session 4)||0
2344874|NCT01701258|5756137|P8|STARTED|EEG (Session 4)||16
2344875|NCT01701258|5756138|P7|STARTED|EEG (Session 4)||0
2344876|NCT01701258|5756139|P6|STARTED|EEG (Session 4)||0
2344877|NCT01701258|5756140|P5|STARTED|EEG (Session 4)||14
2344878|NCT01701258|5756141|P4|STARTED|EEG (Session 4)||0
2344879|NCT01701258|5756142|P3|STARTED|EEG (Session 4)||0
2344880|NCT01701258|5756143|P2|STARTED|EEG (Session 4)||19
2344881|NCT01701258|5756144|P1|STARTED|EEG (Session 4)||0
2344882|NCT01701258|5756132|P13|NOT COMPLETED|PET (Session 3)||0
2344883|NCT01701258|5756133|P12|NOT COMPLETED|PET (Session 3)||0
2344884|NCT01701258|5756134|P11|NOT COMPLETED|PET (Session 3)||0
2344885|NCT01701258|5756135|P10|NOT COMPLETED|PET (Session 3)||0
2344886|NCT01701258|5756136|P9|NOT COMPLETED|PET (Session 3)||0
2344887|NCT01701258|5756137|P8|NOT COMPLETED|PET (Session 3)||0
2344888|NCT01701258|5756138|P7|NOT COMPLETED|PET (Session 3)||0
2344889|NCT01701258|5756139|P6|NOT COMPLETED|PET (Session 3)||0
2344890|NCT01701258|5756140|P5|NOT COMPLETED|PET (Session 3)||0
2344891|NCT01701258|5756141|P4|NOT COMPLETED|PET (Session 3)||0
2344892|NCT01701258|5756142|P3|NOT COMPLETED|PET (Session 3)||0
2344893|NCT01701258|5756143|P2|NOT COMPLETED|PET (Session 3)||0
2344894|NCT01701258|5756144|P1|NOT COMPLETED|PET (Session 3)||0
2344895|NCT01701258|5756132|P13|COMPLETED|PET (Session 3)||0
2344896|NCT01701258|5756133|P12|COMPLETED|PET (Session 3)||0
2344897|NCT01701258|5756134|P11|COMPLETED|PET (Session 3)||18
2344898|NCT01701258|5756135|P10|COMPLETED|PET (Session 3)||0
2344899|NCT01701258|5756136|P9|COMPLETED|PET (Session 3)||0
2344900|NCT01701258|5756137|P8|COMPLETED|PET (Session 3)||19
2344901|NCT01701258|5756138|P7|COMPLETED|PET (Session 3)||0
2344902|NCT01701258|5756139|P6|COMPLETED|PET (Session 3)||0
2344903|NCT01701258|5756140|P5|COMPLETED|PET (Session 3)||16
2344904|NCT01701258|5756141|P4|COMPLETED|PET (Session 3)||0
2344905|NCT01701258|5756142|P3|COMPLETED|PET (Session 3)||0
2344906|NCT01701258|5756143|P2|COMPLETED|PET (Session 3)||20
2344907|NCT01701258|5756144|P1|COMPLETED|PET (Session 3)||0
2344908|NCT01701258|5756132|P13|STARTED|PET (Session 3)||0
2344909|NCT01701258|5756133|P12|STARTED|PET (Session 3)||0
2344910|NCT01701258|5756134|P11|STARTED|PET (Session 3)||18
2344911|NCT01701258|5756135|P10|STARTED|PET (Session 3)||0
2344912|NCT01701258|5756136|P9|STARTED|PET (Session 3)||0
2344913|NCT01701258|5756137|P8|STARTED|PET (Session 3)||19
2344914|NCT01701258|5756138|P7|STARTED|PET (Session 3)||0
2344915|NCT01701258|5756139|P6|STARTED|PET (Session 3)||0
2344916|NCT01701258|5756140|P5|STARTED|PET (Session 3)||16
2344917|NCT01701258|5756141|P4|STARTED|PET (Session 3)||0
2344918|NCT01701258|5756142|P3|STARTED|PET (Session 3)||0
2344919|NCT01701258|5756143|P2|STARTED|PET (Session 3)||20
2344920|NCT01701258|5756144|P1|STARTED|PET (Session 3)||0
2344921|NCT01701258|5756132|P13|NOT COMPLETED|Drug+fMRI (Session 2)||0
2344922|NCT01701258|5756133|P12|NOT COMPLETED|Drug+fMRI (Session 2)||0
2344923|NCT01701258|5756134|P11|NOT COMPLETED|Drug+fMRI (Session 2)||0
2344924|NCT01701258|5756135|P10|NOT COMPLETED|Drug+fMRI (Session 2)||0
2344925|NCT01701258|5756136|P9|NOT COMPLETED|Drug+fMRI (Session 2)||0
2344926|NCT01701258|5756137|P8|NOT COMPLETED|Drug+fMRI (Session 2)||0
2344927|NCT01701258|5756138|P7|NOT COMPLETED|Drug+fMRI (Session 2)||0
2344928|NCT01701258|5756139|P6|NOT COMPLETED|Drug+fMRI (Session 2)||0
2344929|NCT01701258|5756140|P5|NOT COMPLETED|Drug+fMRI (Session 2)||0
2344930|NCT01701258|5756141|P4|NOT COMPLETED|Drug+fMRI (Session 2)||0
2344931|NCT01701258|5756142|P3|NOT COMPLETED|Drug+fMRI (Session 2)||0
2344932|NCT01701258|5756143|P2|NOT COMPLETED|Drug+fMRI (Session 2)||0
2344933|NCT01701258|5756144|P1|NOT COMPLETED|Drug+fMRI (Session 2)||0
2344934|NCT01701258|5756132|P13|COMPLETED|Drug+fMRI (Session 2)||7
2344935|NCT01701258|5756133|P12|COMPLETED|Drug+fMRI (Session 2)||10
2344936|NCT01701258|5756134|P11|COMPLETED|Drug+fMRI (Session 2)||0
2344937|NCT01701258|5756135|P10|COMPLETED|Drug+fMRI (Session 2)||6
2344938|NCT01701258|5756136|P9|COMPLETED|Drug+fMRI (Session 2)||6
2344939|NCT01701258|5756137|P8|COMPLETED|Drug+fMRI (Session 2)||0
2344940|NCT01701258|5756138|P7|COMPLETED|Drug+fMRI (Session 2)||8
2344941|NCT01701258|5756139|P6|COMPLETED|Drug+fMRI (Session 2)||9
2344942|NCT01701258|5756140|P5|COMPLETED|Drug+fMRI (Session 2)||0
2344943|NCT01701258|5756141|P4|COMPLETED|Drug+fMRI (Session 2)||11
2344944|NCT01701258|5756142|P3|COMPLETED|Drug+fMRI (Session 2)||11
2344945|NCT01701258|5756143|P2|COMPLETED|Drug+fMRI (Session 2)||0
2344946|NCT01701258|5756144|P1|COMPLETED|Drug+fMRI (Session 2)||0
2344947|NCT01701258|5756132|P13|Received Drug Challenge|Drug+fMRI (Session 2)||7
2344948|NCT01701258|5756133|P12|Received Drug Challenge|Drug+fMRI (Session 2)||10
2344949|NCT01701258|5756134|P11|Received Drug Challenge|Drug+fMRI (Session 2)||0
2344950|NCT01701258|5756135|P10|Received Drug Challenge|Drug+fMRI (Session 2)||6
2344951|NCT01701258|5756136|P9|Received Drug Challenge|Drug+fMRI (Session 2)||6
2344952|NCT01701258|5756137|P8|Received Drug Challenge|Drug+fMRI (Session 2)||0
2344953|NCT01701258|5756138|P7|Received Drug Challenge|Drug+fMRI (Session 2)||8
2344954|NCT01701258|5756139|P6|Received Drug Challenge|Drug+fMRI (Session 2)||9
2344955|NCT01701258|5756140|P5|Received Drug Challenge|Drug+fMRI (Session 2)||0
2344956|NCT01701258|5756141|P4|Received Drug Challenge|Drug+fMRI (Session 2)||11
2344957|NCT01701258|5756142|P3|Received Drug Challenge|Drug+fMRI (Session 2)||11
2344958|NCT01701258|5756143|P2|Received Drug Challenge|Drug+fMRI (Session 2)||0
2344959|NCT01701258|5756144|P1|Received Drug Challenge|Drug+fMRI (Session 2)||0
2344960|NCT01701258|5756132|P13|STARTED|Drug+fMRI (Session 2)||7
2344961|NCT01701258|5756133|P12|STARTED|Drug+fMRI (Session 2)||10
2344962|NCT01701258|5756134|P11|STARTED|Drug+fMRI (Session 2)||0
2344963|NCT01701258|5756135|P10|STARTED|Drug+fMRI (Session 2)||6
2344964|NCT01701258|5756136|P9|STARTED|Drug+fMRI (Session 2)||6
2344965|NCT01701258|5756137|P8|STARTED|Drug+fMRI (Session 2)||0
2344966|NCT01701258|5756138|P7|STARTED|Drug+fMRI (Session 2)||8
2344967|NCT01701258|5756139|P6|STARTED|Drug+fMRI (Session 2)||9
2344968|NCT01701258|5756140|P5|STARTED|Drug+fMRI (Session 2)||0
2344969|NCT01701258|5756141|P4|STARTED|Drug+fMRI (Session 2)||11
2344970|NCT01701258|5756142|P3|STARTED|Drug+fMRI (Session 2)||11
2344971|NCT01701258|5756143|P2|STARTED|Drug+fMRI (Session 2)||0
2344972|NCT01701258|5756144|P1|STARTED|Drug+fMRI (Session 2)||0
2344973|NCT01701258|5756132|P13|NOT COMPLETED|Assessment and Scheduling||0
2344974|NCT01701258|5756133|P12|NOT COMPLETED|Assessment and Scheduling||0
2344975|NCT01701258|5756134|P11|NOT COMPLETED|Assessment and Scheduling||0
2344976|NCT01701258|5756135|P10|NOT COMPLETED|Assessment and Scheduling||0
2344977|NCT01701258|5756136|P9|NOT COMPLETED|Assessment and Scheduling||0
2344978|NCT01701258|5756137|P8|NOT COMPLETED|Assessment and Scheduling||0
2344979|NCT01701258|5756138|P7|NOT COMPLETED|Assessment and Scheduling||0
2344980|NCT01701258|5756139|P6|NOT COMPLETED|Assessment and Scheduling||0
2344981|NCT01701258|5756140|P5|NOT COMPLETED|Assessment and Scheduling||0
2344982|NCT01701258|5756141|P4|NOT COMPLETED|Assessment and Scheduling||0
2344983|NCT01701258|5756142|P3|NOT COMPLETED|Assessment and Scheduling||0
2344984|NCT01701258|5756143|P2|NOT COMPLETED|Assessment and Scheduling||0
2344985|NCT01701258|5756144|P1|NOT COMPLETED|Assessment and Scheduling||83
2344986|NCT01701258|5756132|P13|COMPLETED|Assessment and Scheduling||0
2344987|NCT01701258|5756133|P12|COMPLETED|Assessment and Scheduling||0
2344988|NCT01701258|5756134|P11|COMPLETED|Assessment and Scheduling||0
2344989|NCT01701258|5756135|P10|COMPLETED|Assessment and Scheduling||0
2344990|NCT01701258|5756136|P9|COMPLETED|Assessment and Scheduling||0
2344991|NCT01701258|5756137|P8|COMPLETED|Assessment and Scheduling||0
2344992|NCT01701258|5756138|P7|COMPLETED|Assessment and Scheduling||0
2344993|NCT01701258|5756139|P6|COMPLETED|Assessment and Scheduling||0
2344994|NCT01701258|5756140|P5|COMPLETED|Assessment and Scheduling||0
2344995|NCT01701258|5756141|P4|COMPLETED|Assessment and Scheduling||0
2344996|NCT01701258|5756142|P3|COMPLETED|Assessment and Scheduling||0
2344997|NCT01701258|5756143|P2|COMPLETED|Assessment and Scheduling||0
2344998|NCT01701258|5756144|P1|COMPLETED|Assessment and Scheduling||70
2344999|NCT01701258|5756132|P13|Returned for EEG (Session 4)|Assessment and Scheduling||0
2345000|NCT01701258|5756133|P12|Returned for EEG (Session 4)|Assessment and Scheduling||0
2345001|NCT01701258|5756134|P11|Returned for EEG (Session 4)|Assessment and Scheduling||0
2345002|NCT01701258|5756135|P10|Returned for EEG (Session 4)|Assessment and Scheduling||0
2345003|NCT01701258|5756136|P9|Returned for EEG (Session 4)|Assessment and Scheduling||0
2345004|NCT01701258|5756137|P8|Returned for EEG (Session 4)|Assessment and Scheduling||0
2345005|NCT01701258|5756138|P7|Returned for EEG (Session 4)|Assessment and Scheduling||0
2345006|NCT01701258|5756139|P6|Returned for EEG (Session 4)|Assessment and Scheduling||0
2345007|NCT01701258|5756140|P5|Returned for EEG (Session 4)|Assessment and Scheduling||0
2345008|NCT01701258|5756141|P4|Returned for EEG (Session 4)|Assessment and Scheduling||0
2345009|NCT01701258|5756142|P3|Returned for EEG (Session 4)|Assessment and Scheduling||0
2345010|NCT01701258|5756143|P2|Returned for EEG (Session 4)|Assessment and Scheduling||0
2345011|NCT01701258|5756144|P1|Returned for EEG (Session 4)|Assessment and Scheduling||66
2345012|NCT01701258|5756132|P13|Returned for PET (Session 3)|Assessment and Scheduling||0
2345013|NCT01701258|5756133|P12|Returned for PET (Session 3)|Assessment and Scheduling||0
2345014|NCT01701258|5756134|P11|Returned for PET (Session 3)|Assessment and Scheduling||0
2345015|NCT01701258|5756135|P10|Returned for PET (Session 3)|Assessment and Scheduling||0
2345016|NCT01701258|5756136|P9|Returned for PET (Session 3)|Assessment and Scheduling||0
2345017|NCT01701258|5756137|P8|Returned for PET (Session 3)|Assessment and Scheduling||0
2345018|NCT01701258|5756138|P7|Returned for PET (Session 3)|Assessment and Scheduling||0
2345019|NCT01701258|5756139|P6|Returned for PET (Session 3)|Assessment and Scheduling||0
2345020|NCT01701258|5756140|P5|Returned for PET (Session 3)|Assessment and Scheduling||0
2345021|NCT01701258|5756141|P4|Returned for PET (Session 3)|Assessment and Scheduling||0
2345022|NCT01701258|5756142|P3|Returned for PET (Session 3)|Assessment and Scheduling||0
2345023|NCT01701258|5756143|P2|Returned for PET (Session 3)|Assessment and Scheduling||0
2345024|NCT01701258|5756144|P1|Returned for PET (Session 3)|Assessment and Scheduling||73
2345025|NCT01701258|5756132|P13|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
2345026|NCT01701258|5756133|P12|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
2345027|NCT01701258|5756134|P11|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
2345028|NCT01701258|5756135|P10|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
2345029|NCT01701258|5756136|P9|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
2345030|NCT01701258|5756137|P8|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
2345031|NCT01701258|5756138|P7|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
2345032|NCT01701258|5756139|P6|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
2345033|NCT01701258|5756140|P5|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
2345034|NCT01701258|5756141|P4|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
2345035|NCT01701258|5756142|P3|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
2345036|NCT01701258|5756143|P2|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
2345037|NCT01701258|5756144|P1|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||68
2345038|NCT01701258|5756132|P13|Eligible After Screening Visit|Assessment and Scheduling||0
2345039|NCT01701258|5756133|P12|Eligible After Screening Visit|Assessment and Scheduling||0
2345040|NCT01701258|5756134|P11|Eligible After Screening Visit|Assessment and Scheduling||0
2345041|NCT01701258|5756135|P10|Eligible After Screening Visit|Assessment and Scheduling||0
2345042|NCT01701258|5756136|P9|Eligible After Screening Visit|Assessment and Scheduling||0
2345043|NCT01701258|5756137|P8|Eligible After Screening Visit|Assessment and Scheduling||0
2345044|NCT01701258|5756138|P7|Eligible After Screening Visit|Assessment and Scheduling||0
2345045|NCT01701258|5756139|P6|Eligible After Screening Visit|Assessment and Scheduling||0
2345046|NCT01701258|5756140|P5|Eligible After Screening Visit|Assessment and Scheduling||0
2345047|NCT01701258|5756141|P4|Eligible After Screening Visit|Assessment and Scheduling||0
2345048|NCT01701258|5756142|P3|Eligible After Screening Visit|Assessment and Scheduling||0
2345049|NCT01701258|5756143|P2|Eligible After Screening Visit|Assessment and Scheduling||0
2345050|NCT01701258|5756144|P1|Eligible After Screening Visit|Assessment and Scheduling||96
2345051|NCT01701258|5756132|P13|STARTED|Assessment and Scheduling||0
2345052|NCT01701258|5756133|P12|STARTED|Assessment and Scheduling||0
2345053|NCT01701258|5756134|P11|STARTED|Assessment and Scheduling||0
2345054|NCT01701258|5756135|P10|STARTED|Assessment and Scheduling||0
2345055|NCT01701258|5756136|P9|STARTED|Assessment and Scheduling||0
2345056|NCT01701258|5756137|P8|STARTED|Assessment and Scheduling||0
2345057|NCT01701258|5756138|P7|STARTED|Assessment and Scheduling||0
2345058|NCT01701258|5756139|P6|STARTED|Assessment and Scheduling||0
2345059|NCT01701258|5756140|P5|STARTED|Assessment and Scheduling||0
2345060|NCT01701258|5756141|P4|STARTED|Assessment and Scheduling||0
2345061|NCT01701258|5756142|P3|STARTED|Assessment and Scheduling||0
2345062|NCT01701258|5756143|P2|STARTED|Assessment and Scheduling||0
2345063|NCT01701258|5756144|P1|STARTED|Assessment and Scheduling||153
2345064|NCT01701245|5756198|P2|NOT COMPLETED|Overall Study||15
2345065|NCT01701245|5756199|P1|NOT COMPLETED|Overall Study||12
2345066|NCT01701245|5756198|P2|COMPLETED|Overall Study||33
2345067|NCT01701245|5756199|P1|COMPLETED|Overall Study||37
2345068|NCT01701245|5756198|P2|FAS Matched Data|Overall Study||32
2345069|NCT01701245|5756199|P1|FAS Matched Data|Overall Study||42
2345070|NCT01701245|5756198|P2|FAS Unmatched Data|Overall Study|3 patients protocol violation|45
2345071|NCT01701245|5756199|P1|FAS Unmatched Data|Overall Study|1 patient protocol violation|48
2345072|NCT01701245|5756198|P2|STARTED|Overall Study||48
2345073|NCT01701245|5756199|P1|STARTED|Overall Study||49
2345074|NCT01701115|5756213|P2|NOT COMPLETED|Overall Study||0
2345075|NCT01701115|5756214|P1|NOT COMPLETED|Overall Study||2
2345076|NCT01701115|5756213|P2|COMPLETED|Overall Study||77
2345077|NCT01701115|5756214|P1|COMPLETED|Overall Study||75
2345078|NCT01701115|5756213|P2|STARTED|Overall Study||77
2345079|NCT01701115|5756214|P1|STARTED|Overall Study||77
2345080|NCT01701102|5756230|P4|NOT COMPLETED|Overall Study||0
2345081|NCT01701102|5756231|P3|NOT COMPLETED|Overall Study||0
2345082|NCT01701102|5756232|P2|NOT COMPLETED|Overall Study||0
2345083|NCT01701102|5756233|P1|NOT COMPLETED|Overall Study||0
2345084|NCT01701102|5756230|P4|COMPLETED|Overall Study||18
2345085|NCT01701102|5756231|P3|COMPLETED|Overall Study||10
2345086|NCT01701102|5756232|P2|COMPLETED|Overall Study||6
2345087|NCT01701102|5756233|P1|COMPLETED|Overall Study||22
2345088|NCT01701102|5756230|P4|STARTED|Overall Study||18
2345089|NCT01701102|5756231|P3|STARTED|Overall Study||10
2345090|NCT01701102|5756232|P2|STARTED|Overall Study||6
2345091|NCT01701102|5756233|P1|STARTED|Overall Study||22
2345092|NCT01701063|5756246|P3|NOT COMPLETED|Overall Study||2
2345093|NCT01701063|5756247|P2|NOT COMPLETED|Overall Study||1
2345094|NCT01701063|5756248|P1|NOT COMPLETED|Overall Study||0
2345095|NCT01701063|5756246|P3|COMPLETED|Overall Study||8
2345096|NCT01701063|5756247|P2|COMPLETED|Overall Study||18
2345097|NCT01701063|5756248|P1|COMPLETED|Overall Study||13
2345098|NCT01701063|5756246|P3|STARTED|Overall Study||10
2345099|NCT01701063|5756247|P2|STARTED|Overall Study||19
2345100|NCT01701063|5756248|P1|STARTED|Overall Study||13
2345101|NCT01701037|5756290|P1|NOT COMPLETED|Overall Study||0
2345102|NCT01701037|5756290|P1|COMPLETED|Overall Study||13
2345103|NCT01701037|5756290|P1|STARTED|Overall Study||13
2345104|NCT01701024|5756301|P2|NOT COMPLETED|Overall Study||9
2345105|NCT01701024|5756302|P1|NOT COMPLETED|Overall Study||10
2345106|NCT01701024|5756301|P2|COMPLETED|Overall Study||236
2345107|NCT01701024|5756302|P1|COMPLETED|Overall Study||243
2345108|NCT01701024|5756301|P2|STARTED|Overall Study||245
2345109|NCT01701024|5756302|P1|STARTED|Overall Study||253
2345110|NCT01701011|5756317|P3|NOT COMPLETED|Overall Study||34
2345111|NCT01701011|5756318|P2|NOT COMPLETED|Overall Study||24
2345112|NCT01701011|5756319|P1|NOT COMPLETED|Overall Study||35
2345113|NCT01701011|5756317|P3|COMPLETED|Overall Study||90
2345114|NCT01701011|5756318|P2|COMPLETED|Overall Study||102
2345115|NCT01701011|5756319|P1|COMPLETED|Overall Study||92
2345116|NCT01701011|5756317|P3|STARTED|Overall Study||124
2345117|NCT01701011|5756318|P2|STARTED|Overall Study||126
2345118|NCT01701011|5756319|P1|STARTED|Overall Study||127
2345119|NCT01700985|5756332|P2|NOT COMPLETED|Overall Study||1
2345120|NCT01700985|5756333|P1|NOT COMPLETED|Overall Study||0
2345121|NCT01700985|5756332|P2|COMPLETED|Overall Study||20
2345122|NCT01700985|5756333|P1|COMPLETED|Overall Study||23
2345123|NCT01700985|5756332|P2|STARTED|Overall Study||21
2345124|NCT01700985|5756333|P1|STARTED|Overall Study||23
2345125|NCT01700959|5756355|P6|NOT COMPLETED|Overall Study||25
2345126|NCT01700959|5756356|P5|NOT COMPLETED|Overall Study||27
2345127|NCT01700959|5756357|P4|NOT COMPLETED|Overall Study||35
2345128|NCT01700959|5756358|P3|NOT COMPLETED|Overall Study||40
2345129|NCT01700959|5756359|P2|NOT COMPLETED|Overall Study||24
2345130|NCT01700959|5756360|P1|NOT COMPLETED|Overall Study||27
2345131|NCT01700959|5756355|P6|COMPLETED|Overall Study||72
2345132|NCT01700959|5756356|P5|COMPLETED|Overall Study||69
2345133|NCT01700959|5756357|P4|COMPLETED|Overall Study||70
2345134|NCT01700959|5756358|P3|COMPLETED|Overall Study||65
2345135|NCT01700959|5756359|P2|COMPLETED|Overall Study||64
2345136|NCT01700959|5756360|P1|COMPLETED|Overall Study||62
2345137|NCT01700959|5756355|P6|STARTED|Overall Study||97
2345138|NCT01700959|5756356|P5|STARTED|Overall Study||96
2345139|NCT01700959|5756357|P4|STARTED|Overall Study||105
2345140|NCT01700959|5756358|P3|STARTED|Overall Study||105
2345141|NCT01700959|5756359|P2|STARTED|Overall Study||88
2345142|NCT01700959|5756360|P1|STARTED|Overall Study||89
2345143|NCT01700907|5756384|P2|NOT COMPLETED|Overall Study||0
2345144|NCT01700907|5756385|P1|NOT COMPLETED|Overall Study||0
2345145|NCT01700907|5756384|P2|COMPLETED|Overall Study||10
2345146|NCT01700907|5756385|P1|COMPLETED|Overall Study||10
2345147|NCT01700907|5756384|P2|STARTED|Overall Study||10
2345148|NCT01700907|5756385|P1|STARTED|Overall Study||10
2345149|NCT01700816|5756401|P2|NOT COMPLETED|Overall Study||0
2345150|NCT01700816|5756402|P1|NOT COMPLETED|Overall Study||0
2345151|NCT01700816|5756401|P2|COMPLETED|Overall Study||19
2345152|NCT01700816|5756402|P1|COMPLETED|Overall Study||21
2345153|NCT01700816|5756401|P2|STARTED|Overall Study||19
2345154|NCT01700816|5756402|P1|STARTED|Overall Study||21
2345155|NCT01700725|5756431|P3|NOT COMPLETED|Overall Study||0
2345156|NCT01700725|5756432|P2|NOT COMPLETED|Overall Study||0
2345157|NCT01700725|5756433|P1|NOT COMPLETED|Overall Study||0
2345158|NCT01700725|5756431|P3|COMPLETED|Overall Study||12
2345159|NCT01700725|5756432|P2|COMPLETED|Overall Study||14
2345160|NCT01700725|5756433|P1|COMPLETED|Overall Study||14
2345161|NCT01700725|5756431|P3|STARTED|Overall Study||12
2345162|NCT01700725|5756432|P2|STARTED|Overall Study||14
2345163|NCT01700725|5756433|P1|STARTED|Overall Study||14
2345164|NCT01700621|5756449|P2|NOT COMPLETED|Analyzed for Immunogenicity||7
2345165|NCT01700621|5756450|P1|NOT COMPLETED|Analyzed for Immunogenicity||13
2345166|NCT01700621|5756449|P2|COMPLETED|Analyzed for Immunogenicity||233
2345167|NCT01700621|5756450|P1|COMPLETED|Analyzed for Immunogenicity||227
2345168|NCT01700621|5756449|P2|STARTED|Analyzed for Immunogenicity||240
2345169|NCT01700621|5756450|P1|STARTED|Analyzed for Immunogenicity||240
2345170|NCT01700621|5756449|P2|NOT COMPLETED|Received Study Vaccines||0
2345171|NCT01700621|5756450|P1|NOT COMPLETED|Received Study Vaccines||0
2345172|NCT01700621|5756449|P2|COMPLETED|Received Study Vaccines||240
2345173|NCT01700621|5756450|P1|COMPLETED|Received Study Vaccines||240
2345174|NCT01700621|5756449|P2|STARTED|Received Study Vaccines||240
2345175|NCT01700621|5756450|P1|STARTED|Received Study Vaccines||240
2345176|NCT01700530|5756488|P3|NOT COMPLETED|Overall Study||1
2345177|NCT01700530|5756489|P2|NOT COMPLETED|Overall Study||3
2345178|NCT01700530|5756490|P1|NOT COMPLETED|Overall Study||0
2345179|NCT01700530|5756488|P3|COMPLETED|Overall Study||19
2345180|NCT01700530|5756489|P2|COMPLETED|Overall Study||18
2345181|NCT01700530|5756490|P1|COMPLETED|Overall Study||9
2345182|NCT01700530|5756488|P3|STARTED|Overall Study||20
2345183|NCT01700530|5756489|P2|STARTED|Overall Study||21
2345184|NCT01700530|5756490|P1|STARTED|Overall Study||9
2345185|NCT01700517|5756504|P3|NOT COMPLETED|Overall Study||0
2345186|NCT01700517|5756505|P2|NOT COMPLETED|Overall Study||0
2345187|NCT01700517|5756506|P1|NOT COMPLETED|Overall Study||0
2345188|NCT01700517|5756504|P3|COMPLETED|Overall Study||40
2345189|NCT01700517|5756505|P2|COMPLETED|Overall Study||40
2345190|NCT01700517|5756506|P1|COMPLETED|Overall Study||40
2345191|NCT01700517|5756504|P3|STARTED|Overall Study||40
2345192|NCT01700517|5756505|P2|STARTED|Overall Study||40
2345193|NCT01700517|5756506|P1|STARTED|Overall Study||40
2345194|NCT01700439|5756514|P1|NOT COMPLETED|Overall Study||889
2345195|NCT01700439|5756514|P1|COMPLETED|Overall Study||0
2345196|NCT01700439|5756514|P1|2 Year|Overall Study||215
2345197|NCT01700439|5756514|P1|1 Year|Overall Study||573
2345198|NCT01700439|5756514|P1|3 Month|Overall Study||778
2345199|NCT01700439|5756514|P1|Discharge|Overall Study||831
2345200|NCT01700439|5756514|P1|Study Valve Group|Overall Study|Received the Edwards INTUITY surgical aortic heart valve.|839
2345201|NCT01700439|5756514|P1|STARTED|Overall Study||889
2345202|NCT01700387|5756539|P2|NOT COMPLETED|Overall Study||4
2345203|NCT01700387|5756540|P1|NOT COMPLETED|Overall Study||4
2345204|NCT01700387|5756539|P2|COMPLETED|Overall Study||6
2345205|NCT01700387|5756540|P1|COMPLETED|Overall Study||6
2345206|NCT01700387|5756539|P2|STARTED|Overall Study||10
2345207|NCT01700387|5756540|P1|STARTED|Overall Study||10
2345208|NCT01700348|5756550|P1|NOT COMPLETED|Overall Study||23
2345209|NCT01700348|5756550|P1|COMPLETED|Overall Study||93
2345210|NCT01700348|5756550|P1|STARTED|Overall Study||116
2345211|NCT01700335|5756559|P2|NOT COMPLETED|Overall Study||4
2345212|NCT01700335|5756560|P1|NOT COMPLETED|Overall Study||1
2345213|NCT01700335|5756559|P2|COMPLETED|Overall Study||2
2345214|NCT01700335|5756560|P1|COMPLETED|Overall Study||2
2345215|NCT01700335|5756559|P2|STARTED|Overall Study||6
2345216|NCT01700335|5756560|P1|STARTED|Overall Study||3
2345217|NCT01700205|5756573|P2|NOT COMPLETED|Overall Study||15
2345218|NCT01700205|5756574|P1|NOT COMPLETED|Overall Study||15
2345219|NCT01700205|5756573|P2|COMPLETED|Overall Study|Mother-Infant Dyads|39
2345220|NCT01700205|5756574|P1|COMPLETED|Overall Study|Mother-Infant Dyads|44
2345221|NCT01700205|5756573|P2|STARTED|Overall Study|Mother-Infant Dyads|54
2345222|NCT01700205|5756574|P1|STARTED|Overall Study|Mother-Infant Dyads|59
2345223|NCT01700192|5756596|P2|NOT COMPLETED|Overall Study||128
2345224|NCT01700192|5756597|P1|NOT COMPLETED|Overall Study||180
2345225|NCT01700192|5756596|P2|COMPLETED|Overall Study||613
2345226|NCT01700192|5756597|P1|COMPLETED|Overall Study||561
2345227|NCT01700192|5756596|P2|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|738
2345228|NCT01700192|5756597|P1|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|743
2345229|NCT01700192|5756596|P2|Treated|Overall Study||741
2345230|NCT01700192|5756597|P1|Treated|Overall Study||740
2345231|NCT01700192|5756596|P2|STARTED|Overall Study||741
2345232|NCT01700192|5756597|P1|STARTED|Overall Study||741
2345233|NCT01700179|5756615|P1|NOT COMPLETED|Overall Study||2
2345234|NCT01700179|5756615|P1|COMPLETED|Overall Study||6
2345235|NCT01700179|5756615|P1|STARTED|Overall Study||8
2345236|NCT01700140|5756622|P3|NOT COMPLETED|Overall Study||1
2345237|NCT01700140|5756623|P2|NOT COMPLETED|Overall Study||9
2345238|NCT01700140|5756624|P1|NOT COMPLETED|Overall Study||6
2345239|NCT01700140|5756622|P3|COMPLETED|Overall Study||61
2345240|NCT01700140|5756623|P2|COMPLETED|Overall Study||57
2345241|NCT01700140|5756624|P1|COMPLETED|Overall Study||55
2345242|NCT01700140|5756622|P3|STARTED|Overall Study||62
2345243|NCT01700140|5756623|P2|STARTED|Overall Study||66
2345244|NCT01700140|5756624|P1|STARTED|Overall Study||61
2345245|NCT01700049|5756656|P1|NOT COMPLETED|Overall Study||1
2345246|NCT01700049|5756656|P1|COMPLETED|Overall Study||27
2345247|NCT01700049|5756656|P1|STARTED|Overall Study||28
2345248|NCT01700036|5756662|P1|NOT COMPLETED|Overall Study||0
2345249|NCT01700036|5756662|P1|COMPLETED|Overall Study||40
2345250|NCT01700036|5756662|P1|STARTED|Overall Study||40
2345251|NCT01699867|5756671|P1|NOT COMPLETED|Overall Study||3
2345252|NCT01699867|5756671|P1|COMPLETED|Overall Study||47
2345253|NCT01699867|5756671|P1|STARTED|Overall Study||50
2345254|NCT01699815|5756678|P2|NOT COMPLETED|Overall Study||8
2345255|NCT01699815|5756679|P1|NOT COMPLETED|Overall Study||5
2345256|NCT01699815|5756678|P2|COMPLETED|Overall Study||56
2345257|NCT01699815|5756679|P1|COMPLETED|Overall Study||57
2345258|NCT01699815|5756678|P2|STARTED|Overall Study||64
2345259|NCT01699815|5756679|P1|STARTED|Overall Study||62
2345260|NCT01699789|5756691|P2|NOT COMPLETED|Overall Study||126
2345261|NCT01699789|5756692|P1|NOT COMPLETED|Overall Study||102
2345262|NCT01699789|5756691|P2|COMPLETED|Overall Study|Clients in 46 programs with complete or partially complete data at baseline, 6 and 12 mo FU analyzed|514
2345263|NCT01699789|5756692|P1|COMPLETED|Overall Study|Clients in 44 programs with complete or partially complete data at baseline, 6 and 12 mo FU analyzed|504
2345264|NCT01699789|5756691|P2|12-Month Follow-Up|Overall Study||369
2345265|NCT01699789|5756692|P1|12-Month Follow-Up|Overall Study||364
2345266|NCT01699789|5756691|P2|6-Month Follow-Up|Overall Study||379
2345267|NCT01699789|5756692|P1|6-Month Follow-Up|Overall Study||380
2345268|NCT01699789|5756691|P2|Baseline|Overall Study||488
2345269|NCT01699789|5756692|P1|Baseline|Overall Study||492
2345270|NCT01699789|5756691|P2|STARTED|Overall Study|640 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in CEP arm|640
2345271|NCT01699789|5756692|P1|STARTED|Overall Study|606 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in RS arm|606
2345272|NCT01699763|5756754|P1|NOT COMPLETED|Overall Study||0
2345273|NCT01699763|5756754|P1|COMPLETED|Overall Study||112
2345274|NCT01699763|5756754|P1|STARTED|Overall Study||112
2345275|NCT01699750|5756762|P2|NOT COMPLETED|Overall Study||3
2345276|NCT01699750|5756763|P1|NOT COMPLETED|Overall Study||0
2345277|NCT01699750|5756762|P2|COMPLETED|Overall Study||33
2345278|NCT01699750|5756763|P1|COMPLETED|Overall Study||34
2345279|NCT01699750|5756762|P2|STARTED|Overall Study||36
2345280|NCT01699750|5756763|P1|STARTED|Overall Study||34
2345281|NCT01699698|5756787|P2|NOT COMPLETED|Overall Study||5
2345282|NCT01699698|5756788|P1|NOT COMPLETED|Overall Study||2
2345283|NCT01699698|5756787|P2|COMPLETED|Overall Study||56
2345284|NCT01699698|5756788|P1|COMPLETED|Overall Study||42
2345285|NCT01699698|5756787|P2|STARTED|Overall Study||61
2345286|NCT01699698|5756788|P1|STARTED|Overall Study||44
2345287|NCT01699685|5756798|P2|NOT COMPLETED|Period 2||0
2345288|NCT01699685|5756799|P1|NOT COMPLETED|Period 2||1
2345289|NCT01699685|5756798|P2|COMPLETED|Period 2||36
2345290|NCT01699685|5756799|P1|COMPLETED|Period 2||35
2345291|NCT01699685|5756798|P2|STARTED|Period 2||36
2345292|NCT01699685|5756799|P1|STARTED|Period 2||36
2345293|NCT01699685|5756798|P2|NOT COMPLETED|Period 1||3
2345294|NCT01699685|5756799|P1|NOT COMPLETED|Period 1||3
2345295|NCT01699685|5756798|P2|COMPLETED|Period 1||36
2345296|NCT01699685|5756799|P1|COMPLETED|Period 1||36
2345297|NCT01699685|5756798|P2|Full Analysis Population (FAS)|Period 1||38
2345298|NCT01699685|5756799|P1|Full Analysis Population (FAS)|Period 1||38
2345299|NCT01699685|5756798|P2|Safety Population|Period 1||38
2345300|NCT01699685|5756799|P1|Safety Population|Period 1||39
2345301|NCT01699685|5756798|P2|STARTED|Period 1||39
2345302|NCT01699685|5756799|P1|STARTED|Period 1||39
2345303|NCT01699607|5756817|P2|NOT COMPLETED|Overall Study||0
2345304|NCT01699607|5756818|P1|NOT COMPLETED|Overall Study||0
2345305|NCT01699607|5756817|P2|COMPLETED|Overall Study||4
2345306|NCT01699607|5756818|P1|COMPLETED|Overall Study||6
2345307|NCT01699607|5756817|P2|STARTED|Overall Study||4
2345308|NCT01699607|5756818|P1|STARTED|Overall Study||6
2345309|NCT01699503|5756825|P2|NOT COMPLETED|Overall Study||1005
2345310|NCT01699503|5756826|P1|NOT COMPLETED|Overall Study||1000
2345311|NCT01699503|5756825|P2|COMPLETED|Overall Study||992
2345312|NCT01699503|5756826|P1|COMPLETED|Overall Study||1008
2345313|NCT01699503|5756825|P2|6 Month Follow-up|Overall Study||893
2345314|NCT01699503|5756826|P1|6 Month Follow-up|Overall Study||903
2345315|NCT01699503|5756825|P2|1 Month Follow-up|Overall Study||1022
2345316|NCT01699503|5756826|P1|1 Month Follow-up|Overall Study||998
2345317|NCT01699503|5756825|P2|Baseline|Overall Study||1693
2345318|NCT01699503|5756826|P1|Baseline|Overall Study||1723
2345319|NCT01699503|5756825|P2|STARTED|Overall Study||1997
2345320|NCT01699503|5756826|P1|STARTED|Overall Study||2008
2345321|NCT01699373|5756842|P2|NOT COMPLETED|Overall Study||0
2345322|NCT01699373|5756843|P1|NOT COMPLETED|Overall Study||0
2345323|NCT01699373|5756842|P2|COMPLETED|Overall Study||85
2345324|NCT01699373|5756843|P1|COMPLETED|Overall Study||85
2345325|NCT01699373|5756842|P2|STARTED|Overall Study||85
2345326|NCT01699373|5756843|P1|STARTED|Overall Study||85
2345327|NCT01699178|5756851|P2|NOT COMPLETED|Overall Study||32
2345328|NCT01699178|5756852|P1|NOT COMPLETED|Overall Study||19
2345329|NCT01699178|5756851|P2|COMPLETED|Overall Study||62
2345330|NCT01699178|5756852|P1|COMPLETED|Overall Study||69
2345331|NCT01699178|5756851|P2|STARTED|Overall Study||94
2345332|NCT01699178|5756852|P1|STARTED|Overall Study||88
2345333|NCT01699087|5756868|P1|NOT COMPLETED|Overall Study||24
2345334|NCT01699087|5756868|P1|COMPLETED|Overall Study||152
2345335|NCT01699087|5756868|P1|Treated|Overall Study||161
2345336|NCT01699087|5756868|P1|STARTED|Overall Study||176
2345337|NCT01699022|5756882|P1|NOT COMPLETED|Overall Study||3
2345338|NCT01699022|5756882|P1|COMPLETED|Overall Study||14
2345339|NCT01699022|5756882|P1|STARTED|Overall Study||17
2345340|NCT01698814|5756897|P2|NOT COMPLETED|Overall Study||3
2345341|NCT01698814|5756898|P1|NOT COMPLETED|Overall Study||2
2345342|NCT01698814|5756897|P2|COMPLETED|Overall Study||166
2345343|NCT01698814|5756898|P1|COMPLETED|Overall Study||329
2345344|NCT01698814|5756897|P2|STARTED|Overall Study||169
2345345|NCT01698814|5756898|P1|STARTED|Overall Study||331
2345346|NCT01698801|5756904|P1|NOT COMPLETED|Follow Up Phase||5
2345347|NCT01698801|5756904|P1|COMPLETED|Follow Up Phase|Completed includes participants who remain in follow-up for up to 5 years from start of treatment|6
2345348|NCT01698801|5756904|P1|STARTED|Follow Up Phase|11 participants did not complete the study and moved into the follow up phase lasting up to 5 years.|11
2345349|NCT01698801|5756904|P1|NOT COMPLETED|Treatment Phase||11
2345350|NCT01698801|5756904|P1|COMPLETED|Treatment Phase|Completed includes participants who continued to receive study medication and treatment is ongoing.|15
2345351|NCT01698801|5756904|P1|STARTED|Treatment Phase||26
2345352|NCT01698775|5756915|P2|NOT COMPLETED|Phase B||11
2345353|NCT01698775|5756916|P1|NOT COMPLETED|Phase B||14
2345354|NCT01698775|5756915|P2|COMPLETED|Phase B||86
2345355|NCT01698775|5756916|P1|COMPLETED|Phase B||84
2345356|NCT01698775|5756915|P2|STARTED|Phase B||97
2345357|NCT01698775|5756916|P1|STARTED|Phase B||98
2345358|NCT01698775|5756915|P2|NOT COMPLETED|Phase A||9
2345359|NCT01698775|5756916|P1|NOT COMPLETED|Phase A||9
2345360|NCT01698775|5756915|P2|COMPLETED|Phase A||97
2345361|NCT01698775|5756916|P1|COMPLETED|Phase A||98
2345362|NCT01698775|5756915|P2|STARTED|Phase A||106
2345363|NCT01698775|5756916|P1|STARTED|Phase A||107
2345364|NCT01698710|5756942|P1|NOT COMPLETED|Overall Study||0
2345365|NCT01698710|5756942|P1|COMPLETED|Overall Study||5
2345366|NCT01698710|5756942|P1|STARTED|Overall Study||5
2345367|NCT01698684|5756951|P3|NOT COMPLETED|Overall Study||21
2345368|NCT01698684|5756952|P2|NOT COMPLETED|Overall Study||23
2345369|NCT01698684|5756953|P1|NOT COMPLETED|Overall Study||29
2345370|NCT01698684|5756951|P3|COMPLETED|Overall Study||127
2345371|NCT01698684|5756952|P2|COMPLETED|Overall Study||124
2345372|NCT01698684|5756953|P1|COMPLETED|Overall Study||116
2345373|NCT01698684|5756951|P3|Safety Population|Overall Study||146
2345374|NCT01698684|5756952|P2|Safety Population|Overall Study||146
2345375|NCT01698684|5756953|P1|Safety Population|Overall Study||143
2345376|NCT01698684|5756951|P3|ITT Population|Overall Study||139
2345377|NCT01698684|5756952|P2|ITT Population|Overall Study||139
2345378|NCT01698684|5756953|P1|ITT Population|Overall Study||136
2345379|NCT01698684|5756951|P3|STARTED|Overall Study||148
2345380|NCT01698684|5756952|P2|STARTED|Overall Study||147
2345381|NCT01698684|5756953|P1|STARTED|Overall Study||145
2345382|NCT01698554|5756965|P4|NOT COMPLETED|Overall Study||2
2345383|NCT01698554|5756966|P3|NOT COMPLETED|Overall Study||2
2345384|NCT01698554|5756967|P2|NOT COMPLETED|Overall Study||10
2345385|NCT01698554|5756968|P1|NOT COMPLETED|Overall Study||6
2345386|NCT01698554|5756965|P4|COMPLETED|Overall Study||77
2345387|NCT01698554|5756966|P3|COMPLETED|Overall Study||73
2345388|NCT01698554|5756967|P2|COMPLETED|Overall Study||147
2345389|NCT01698554|5756968|P1|COMPLETED|Overall Study||147
2345390|NCT01698554|5756965|P4|STARTED|Overall Study||79
2345391|NCT01698554|5756966|P3|STARTED|Overall Study||75
2345392|NCT01698554|5756967|P2|STARTED|Overall Study||157
2345393|NCT01698554|5756968|P1|STARTED|Overall Study||153
2345394|NCT01698528|5756996|P2|NOT COMPLETED|Overall Study||4
2345395|NCT01698528|5756997|P1|NOT COMPLETED|Overall Study||1
2345396|NCT01698528|5756996|P2|COMPLETED|Overall Study||16
2345397|NCT01698528|5756997|P1|COMPLETED|Overall Study||19
2345398|NCT01698528|5756996|P2|STARTED|Overall Study||20
2345399|NCT01698528|5756997|P1|STARTED|Overall Study||20
2345400|NCT01698502|5757013|P2|NOT COMPLETED|Overall Study||0
2345401|NCT01698502|5757014|P1|NOT COMPLETED|Overall Study||0
2345402|NCT01698502|5757013|P2|COMPLETED|Overall Study||10
2345403|NCT01698502|5757014|P1|COMPLETED|Overall Study||11
2345404|NCT01698502|5757013|P2|STARTED|Overall Study||10
2345405|NCT01698502|5757014|P1|STARTED|Overall Study||11
2345406|NCT01698463|5757022|P1|NOT COMPLETED|Overall Study||0
2345407|NCT01698463|5757022|P1|COMPLETED|Overall Study||11
2345408|NCT01698463|5757022|P1|STARTED|Overall Study||11
2345409|NCT01698333|5757032|P1|NOT COMPLETED|Overall Study||0
2345410|NCT01698333|5757032|P1|COMPLETED|Overall Study||25
2345411|NCT01698333|5757032|P1|STARTED|Overall Study||25
2345412|NCT01698320|5757038|P3|NOT COMPLETED|40-Week Open-Label Period||10
2345413|NCT01698320|5757039|P2|NOT COMPLETED|40-Week Open-Label Period||19
2345414|NCT01698320|5757040|P1|NOT COMPLETED|40-Week Open-Label Period||0
2345415|NCT01698320|5757038|P3|COMPLETED|40-Week Open-Label Period||146
2345416|NCT01698320|5757039|P2|COMPLETED|40-Week Open-Label Period||146
2345417|NCT01698320|5757040|P1|COMPLETED|40-Week Open-Label Period||0
2345418|NCT01698320|5757038|P3|STARTED|40-Week Open-Label Period||156
2345419|NCT01698320|5757039|P2|STARTED|40-Week Open-Label Period||165
2345420|NCT01698320|5757040|P1|STARTED|40-Week Open-Label Period||0
2345421|NCT01698320|5757038|P3|NOT COMPLETED|12-Week Double-Blind Period||12
2345422|NCT01698320|5757039|P2|NOT COMPLETED|12-Week Double-Blind Period||4
2345423|NCT01698320|5757040|P1|NOT COMPLETED|12-Week Double-Blind Period||0
2345424|NCT01698320|5757038|P3|COMPLETED|12-Week Double-Blind Period||156
2345425|NCT01698320|5757039|P2|COMPLETED|12-Week Double-Blind Period||165
2345426|NCT01698320|5757040|P1|COMPLETED|12-Week Double-Blind Period||0
2345427|NCT01698320|5757038|P3|Safety Population|12-Week Double-Blind Period||168
2345428|NCT01698320|5757039|P2|Safety Population|12-Week Double-Blind Period|One participant took both placebo and albuterol so is counted in both treatment groups for safety.|170
2345429|NCT01698320|5757040|P1|Safety Population|12-Week Double-Blind Period||0
2345430|NCT01698320|5757038|P3|STARTED|12-Week Double-Blind Period||168
2345431|NCT01698320|5757039|P2|STARTED|12-Week Double-Blind Period||169
2345432|NCT01698320|5757040|P1|STARTED|12-Week Double-Blind Period||0
2345433|NCT01698320|5757038|P3|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
2345434|NCT01698320|5757039|P2|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
2345435|NCT01698320|5757040|P1|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||27
2345436|NCT01698320|5757038|P3|COMPLETED|Run-In Period (Week -1 to Day 0)||0
2345437|NCT01698320|5757039|P2|COMPLETED|Run-In Period (Week -1 to Day 0)||0
2345438|NCT01698320|5757040|P1|COMPLETED|Run-In Period (Week -1 to Day 0)||337
2345439|NCT01698320|5757038|P3|STARTED|Run-In Period (Week -1 to Day 0)||0
2345440|NCT01698320|5757039|P2|STARTED|Run-In Period (Week -1 to Day 0)||0
2345441|NCT01698320|5757040|P1|STARTED|Run-In Period (Week -1 to Day 0)||364
2345442|NCT01698268|5757060|P2|NOT COMPLETED|Overall Study||1
2345443|NCT01698268|5757061|P1|NOT COMPLETED|Overall Study||2
2345444|NCT01698268|5757060|P2|COMPLETED|Overall Study||24
2345445|NCT01698268|5757061|P1|COMPLETED|Overall Study||23
2345446|NCT01698268|5757060|P2|STARTED|Overall Study||25
2345447|NCT01698268|5757061|P1|STARTED|Overall Study||25
2345448|NCT01698008|5757069|P2|NOT COMPLETED|Overall Study||2
2345449|NCT01698008|5757070|P1|NOT COMPLETED|Overall Study||1
2345450|NCT01698008|5757069|P2|COMPLETED|Overall Study||0
2345451|NCT01698008|5757070|P1|COMPLETED|Overall Study||2
2345452|NCT01698008|5757069|P2|STARTED|Overall Study||2
2345453|NCT01698008|5757070|P1|STARTED|Overall Study||3
2345454|NCT01697969|5757076|P1|NOT COMPLETED|Overall Study||3
2345455|NCT01697969|5757076|P1|COMPLETED|Overall Study||10
2345456|NCT01697969|5757076|P1|STARTED|Overall Study||13
2345457|NCT01697956|5757083|P2|NOT COMPLETED|Overall Study||1
2345458|NCT01697956|5757084|P1|NOT COMPLETED|Overall Study||1
2345459|NCT01697956|5757083|P2|COMPLETED|Overall Study||31
2345460|NCT01697956|5757084|P1|COMPLETED|Overall Study||66
2345461|NCT01697956|5757083|P2|Per Protocol Population|Overall Study||31
2345462|NCT01697956|5757084|P1|Per Protocol Population|Overall Study||66
2345463|NCT01697956|5757083|P2|STARTED|Overall Study|enrolled and randomized|32
2345464|NCT01697956|5757084|P1|STARTED|Overall Study|enrolled and randomized|67
2345465|NCT01697748|5757114|P2|NOT COMPLETED|Overall Study||68
2345466|NCT01697748|5757115|P1|NOT COMPLETED|Overall Study||58
2345467|NCT01697748|5757114|P2|COMPLETED|Overall Study||260
2345468|NCT01697748|5757115|P1|COMPLETED|Overall Study||271
2345469|NCT01697748|5757114|P2|STARTED|Overall Study||328
2345470|NCT01697748|5757115|P1|STARTED|Overall Study||329
2345471|NCT01697709|5757133|P2|NOT COMPLETED|Overall Study||28
2345472|NCT01697709|5757134|P1|NOT COMPLETED|Overall Study||30
2345473|NCT01697709|5757133|P2|COMPLETED|Overall Study||38
2345474|NCT01697709|5757134|P1|COMPLETED|Overall Study||34
2345475|NCT01697709|5757133|P2|STARTED|Overall Study||66
2345476|NCT01697709|5757134|P1|STARTED|Overall Study||64
2345477|NCT01697696|5757144|P2|NOT COMPLETED|Overall Study||47
2345478|NCT01697696|5757145|P1|NOT COMPLETED|Overall Study||47
2345479|NCT01697696|5757144|P2|COMPLETED|Overall Study||210
2345480|NCT01697696|5757145|P1|COMPLETED|Overall Study||207
2345481|NCT01697696|5757144|P2|Full Analysis Set (FAS)|Overall Study||255
2345482|NCT01697696|5757145|P1|Full Analysis Set (FAS)|Overall Study||251
2345483|NCT01697696|5757144|P2|Safety Set|Overall Study|Safety set included a patient that was treated, but not randomized|256
2345484|NCT01697696|5757145|P1|Safety Set|Overall Study||251
2345485|NCT01697696|5757144|P2|STARTED|Overall Study||257
2345486|NCT01697696|5757145|P1|STARTED|Overall Study||254
2345487|NCT01697592|5757177|P10|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
2345488|NCT01697592|5757178|P9|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
2345489|NCT01697592|5757179|P8|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
2345490|NCT01697592|5757180|P7|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
2345491|NCT01697592|5757181|P6|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
2345492|NCT01697592|5757182|P5|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
2345493|NCT01697592|5757183|P4|NOT COMPLETED|Phase B (Week 25 to Week 52)||3
2345494|NCT01697592|5757184|P3|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
2345495|NCT01697592|5757185|P2|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
2345496|NCT01697592|5757186|P1|NOT COMPLETED|Phase B (Week 25 to Week 52)||5
2345497|NCT01697592|5757177|P10|COMPLETED|Phase B (Week 25 to Week 52)||30
2345498|NCT01697592|5757178|P9|COMPLETED|Phase B (Week 25 to Week 52)||32
2345499|NCT01697592|5757179|P8|COMPLETED|Phase B (Week 25 to Week 52)||32
2345500|NCT01697592|5757180|P7|COMPLETED|Phase B (Week 25 to Week 52)||31
2345501|NCT01697592|5757181|P6|COMPLETED|Phase B (Week 25 to Week 52)||60
2345502|NCT01697592|5757182|P5|COMPLETED|Phase B (Week 25 to Week 52)||67
2345503|NCT01697592|5757183|P4|COMPLETED|Phase B (Week 25 to Week 52)||60
2345504|NCT01697592|5757184|P3|COMPLETED|Phase B (Week 25 to Week 52)||64
2345505|NCT01697592|5757185|P2|COMPLETED|Phase B (Week 25 to Week 52)||61
2345506|NCT01697592|5757186|P1|COMPLETED|Phase B (Week 25 to Week 52)||118
2345507|NCT01697592|5757177|P10|STARTED|Phase B (Week 25 to Week 52)||30
2345508|NCT01697592|5757178|P9|STARTED|Phase B (Week 25 to Week 52)||34
2345509|NCT01697592|5757179|P8|STARTED|Phase B (Week 25 to Week 52)||33
2345510|NCT01697592|5757180|P7|STARTED|Phase B (Week 25 to Week 52)||32
2345511|NCT01697592|5757181|P6|STARTED|Phase B (Week 25 to Week 52)||62
2345512|NCT01697592|5757182|P5|STARTED|Phase B (Week 25 to Week 52)||67
2345513|NCT01697592|5757183|P4|STARTED|Phase B (Week 25 to Week 52)||63
2345514|NCT01697592|5757184|P3|STARTED|Phase B (Week 25 to Week 52)||65
2345515|NCT01697592|5757185|P2|STARTED|Phase B (Week 25 to Week 52)||62
2345516|NCT01697592|5757186|P1|STARTED|Phase B (Week 25 to Week 52)||123
2345517|NCT01697592|5757177|P10|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
2345518|NCT01697592|5757178|P9|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
2345519|NCT01697592|5757179|P8|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
2345520|NCT01697592|5757180|P7|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
2345521|NCT01697592|5757181|P6|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
2345522|NCT01697592|5757182|P5|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
2345523|NCT01697592|5757183|P4|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
2345524|NCT01697592|5757184|P3|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
2345525|NCT01697592|5757185|P2|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
2345526|NCT01697592|5757186|P1|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
2345527|NCT01697592|5757177|P10|COMPLETED|Phase A (Up to 24 Weeks)||30
2345528|NCT01697592|5757178|P9|COMPLETED|Phase A (Up to 24 Weeks)||34
2345529|NCT01697592|5757179|P8|COMPLETED|Phase A (Up to 24 Weeks)||33
2345530|NCT01697592|5757180|P7|COMPLETED|Phase A (Up to 24 Weeks)||32
2345531|NCT01697592|5757181|P6|COMPLETED|Phase A (Up to 24 Weeks)||62
2345532|NCT01697592|5757182|P5|COMPLETED|Phase A (Up to 24 Weeks)||67
2345533|NCT01697592|5757183|P4|COMPLETED|Phase A (Up to 24 Weeks)||63
2345534|NCT01697592|5757184|P3|COMPLETED|Phase A (Up to 24 Weeks)||65
2345535|NCT01697592|5757185|P2|COMPLETED|Phase A (Up to 24 Weeks)||62
2345536|NCT01697592|5757186|P1|COMPLETED|Phase A (Up to 24 Weeks)||123
2345537|NCT01697592|5757177|P10|STARTED|Phase A (Up to 24 Weeks)||32
2345538|NCT01697592|5757178|P9|STARTED|Phase A (Up to 24 Weeks)||34
2345539|NCT01697592|5757179|P8|STARTED|Phase A (Up to 24 Weeks)||33
2345540|NCT01697592|5757180|P7|STARTED|Phase A (Up to 24 Weeks)||34
2345541|NCT01697592|5757181|P6|STARTED|Phase A (Up to 24 Weeks)||63
2345542|NCT01697592|5757182|P5|STARTED|Phase A (Up to 24 Weeks)||67
2345543|NCT01697592|5757183|P4|STARTED|Phase A (Up to 24 Weeks)||65
2345544|NCT01697592|5757184|P3|STARTED|Phase A (Up to 24 Weeks)||66
2345545|NCT01697592|5757185|P2|STARTED|Phase A (Up to 24 Weeks)||65
2345546|NCT01697592|5757186|P1|STARTED|Phase A (Up to 24 Weeks)||126
2345547|NCT01697579|5757255|P7|NOT COMPLETED|Optional Extension-Cycles 2-6||69
2345548|NCT01697579|5757256|P6|NOT COMPLETED|Optional Extension-Cycles 2-6||35
2345549|NCT01697579|5757257|P5|NOT COMPLETED|Optional Extension-Cycles 2-6||0
2345550|NCT01697579|5757258|P4|NOT COMPLETED|Optional Extension-Cycles 2-6||0
2345551|NCT01697579|5757259|P3|NOT COMPLETED|Optional Extension-Cycles 2-6||0
2345552|NCT01697579|5757260|P2|NOT COMPLETED|Optional Extension-Cycles 2-6||0
2345553|NCT01697579|5757261|P1|NOT COMPLETED|Optional Extension-Cycles 2-6||0
2345554|NCT01697579|5757255|P7|COMPLETED|Optional Extension-Cycles 2-6||37
2345555|NCT01697579|5757256|P6|COMPLETED|Optional Extension-Cycles 2-6||12
2345556|NCT01697579|5757257|P5|COMPLETED|Optional Extension-Cycles 2-6||0
2345557|NCT01697579|5757258|P4|COMPLETED|Optional Extension-Cycles 2-6||0
2345558|NCT01697579|5757259|P3|COMPLETED|Optional Extension-Cycles 2-6||0
2345559|NCT01697579|5757260|P2|COMPLETED|Optional Extension-Cycles 2-6||0
2345560|NCT01697579|5757261|P1|COMPLETED|Optional Extension-Cycles 2-6||0
2345561|NCT01697579|5757255|P7|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|106
2345562|NCT01697579|5757256|P6|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|47
2345563|NCT01697579|5757257|P5|STARTED|Optional Extension-Cycles 2-6|21 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
2345564|NCT01697579|5757258|P4|STARTED|Optional Extension-Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
2345565|NCT01697579|5757259|P3|STARTED|Optional Extension-Cycles 2-6|25 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
2345566|NCT01697579|5757260|P2|STARTED|Optional Extension-Cycles 2-6|33 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
2345567|NCT01697579|5757261|P1|STARTED|Optional Extension-Cycles 2-6|47 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 5 mg/kg|0
2345568|NCT01697579|5757255|P7|NOT COMPLETED|Base Study-Cycle 1||0
2345569|NCT01697579|5757256|P6|NOT COMPLETED|Base Study-Cycle 1||0
2345570|NCT01697579|5757257|P5|NOT COMPLETED|Base Study-Cycle 1||3
2345571|NCT01697579|5757258|P4|NOT COMPLETED|Base Study-Cycle 1||1
2345572|NCT01697579|5757259|P3|NOT COMPLETED|Base Study-Cycle 1||1
2345573|NCT01697579|5757260|P2|NOT COMPLETED|Base Study-Cycle 1||1
2345574|NCT01697579|5757261|P1|NOT COMPLETED|Base Study-Cycle 1||2
2345575|NCT01697579|5757255|P7|COMPLETED|Base Study-Cycle 1||0
2345576|NCT01697579|5757256|P6|COMPLETED|Base Study-Cycle 1||0
2345577|NCT01697579|5757257|P5|COMPLETED|Base Study-Cycle 1||35
2345578|NCT01697579|5757258|P4|COMPLETED|Base Study-Cycle 1||40
2345579|NCT01697579|5757259|P3|COMPLETED|Base Study-Cycle 1||43
2345580|NCT01697579|5757260|P2|COMPLETED|Base Study-Cycle 1||42
2345581|NCT01697579|5757261|P1|COMPLETED|Base Study-Cycle 1||72
2345582|NCT01697579|5757255|P7|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0
2345583|NCT01697579|5757256|P6|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0
2345668|NCT01696773|5757624|P1|NOT COMPLETED|Day 28, Second Intervention||0
2345584|NCT01697579|5757257|P5|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|38
2345585|NCT01697579|5757258|P4|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|41
2345586|NCT01697579|5757259|P3|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|44
2345587|NCT01697579|5757260|P2|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|43
2345588|NCT01697579|5757261|P1|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|74
2345589|NCT01697501|5757373|P1|NOT COMPLETED|Overall Study||2
2345590|NCT01697501|5757373|P1|COMPLETED|Overall Study||86
2345591|NCT01697501|5757373|P1|STARTED|Overall Study||88
2345592|NCT01697462|5757416|P1|NOT COMPLETED|Overall Study||77
2345593|NCT01697462|5757416|P1|COMPLETED|Overall Study||181
2345594|NCT01697462|5757416|P1|STARTED|Overall Study||258
2345595|NCT01697449|5757423|P1|NOT COMPLETED|Overall Study||90
2345596|NCT01697449|5757423|P1|COMPLETED|Overall Study||101
2345597|NCT01697449|5757423|P1|STARTED|Overall Study||191
2345598|NCT01697358|5757434|P2|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||55
2345599|NCT01697358|5757435|P1|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||49
2345600|NCT01697358|5757434|P2|COMPLETED|Period II: 6-24M Long-term Follow-up||52
2345601|NCT01697358|5757435|P1|COMPLETED|Period II: 6-24M Long-term Follow-up||48
2345602|NCT01697358|5757434|P2|STARTED|Period II: 6-24M Long-term Follow-up||107
2345603|NCT01697358|5757435|P1|STARTED|Period II: 6-24M Long-term Follow-up||97
2345604|NCT01697358|5757434|P2|NOT COMPLETED|Period I: Randomization to 6 Months||1
2345605|NCT01697358|5757435|P1|NOT COMPLETED|Period I: Randomization to 6 Months||13
2345606|NCT01697358|5757434|P2|COMPLETED|Period I: Randomization to 6 Months||107
2345607|NCT01697358|5757435|P1|COMPLETED|Period I: Randomization to 6 Months||97
2345608|NCT01697358|5757434|P2|STARTED|Period I: Randomization to 6 Months||108
2345609|NCT01697358|5757435|P1|STARTED|Period I: Randomization to 6 Months||110
2345610|NCT01697345|5757451|P1|NOT COMPLETED|Overall Study||1
2345611|NCT01697345|5757451|P1|COMPLETED|Overall Study|One patient withdrew due to symptoms of recurrent Gardnerella vaginalis.|12
2345612|NCT01697345|5757451|P1|STARTED|Overall Study||13
2345613|NCT01697332|5757470|P1|NOT COMPLETED|Overall Study||0
2345614|NCT01697332|5757470|P1|COMPLETED|Overall Study||1
2345615|NCT01697332|5757470|P1|STARTED|Overall Study||1
2345616|NCT01697319|5757476|P1|NOT COMPLETED|Extension Phase||15
2345617|NCT01697319|5757476|P1|COMPLETED|Extension Phase||0
2345618|NCT01697319|5757476|P1|STARTED|Extension Phase||15
2345619|NCT01697319|5757476|P1|NOT COMPLETED|Primary Phase||1
2345620|NCT01697319|5757476|P1|COMPLETED|Primary Phase||15
2345621|NCT01697319|5757476|P1|STARTED|Primary Phase|One subject enrolled but did not receive a single dose of study drug|16
2345622|NCT01696994|5757485|P2|NOT COMPLETED|Overall Study||8437
2345623|NCT01696994|5757486|P1|NOT COMPLETED|Overall Study||5192
2345624|NCT01696994|5757485|P2|COMPLETED|Overall Study||30668
2345625|NCT01696994|5757486|P1|COMPLETED|Overall Study||33919
2345626|NCT01696994|5757485|P2|STARTED|Overall Study||39105
2345627|NCT01696994|5757486|P1|STARTED|Overall Study||39111
2345628|NCT01696981|5757514|P2|NOT COMPLETED|Overall Study||10374
2345629|NCT01696981|5757515|P1|NOT COMPLETED|Overall Study||1201
2345630|NCT01696981|5757514|P2|COMPLETED|Overall Study||67071
2345631|NCT01696981|5757515|P1|COMPLETED|Overall Study||76254
2345632|NCT01696981|5757514|P2|STARTED|Overall Study||77445
2345633|NCT01696981|5757515|P1|STARTED|Overall Study||77455
2345634|NCT01696968|5757535|P2|NOT COMPLETED|Overall Study||6812
2345635|NCT01696968|5757536|P1|NOT COMPLETED|Overall Study||1201
2345636|NCT01696968|5757535|P2|COMPLETED|Overall Study||70633
2345637|NCT01696968|5757536|P1|COMPLETED|Overall Study||76255
2345638|NCT01696968|5757535|P2|STARTED|Overall Study||77445
2345639|NCT01696968|5757536|P1|STARTED|Overall Study||77456
2345640|NCT01696955|5757558|P2|NOT COMPLETED|Failure on Cetuximab-Received Tivantinib||0
2345641|NCT01696955|5757559|P1|NOT COMPLETED|Failure on Cetuximab-Received Tivantinib||0
2345642|NCT01696955|5757558|P2|COMPLETED|Failure on Cetuximab-Received Tivantinib|23 patients did not cross over|15
2345643|NCT01696955|5757559|P1|COMPLETED|Failure on Cetuximab-Received Tivantinib||0
2345644|NCT01696955|5757558|P2|STARTED|Failure on Cetuximab-Received Tivantinib||15
2345645|NCT01696955|5757559|P1|STARTED|Failure on Cetuximab-Received Tivantinib||0
2345646|NCT01696955|5757558|P2|NOT COMPLETED|Main Study||1
2345647|NCT01696955|5757559|P1|NOT COMPLETED|Main Study||2
2345648|NCT01696955|5757558|P2|COMPLETED|Main Study||38
2345649|NCT01696955|5757559|P1|COMPLETED|Main Study||40
2345650|NCT01696955|5757558|P2|STARTED|Main Study||39
2345651|NCT01696955|5757559|P1|STARTED|Main Study||42
2345652|NCT01696942|5757584|P2|NOT COMPLETED|Overall Study||3
2345653|NCT01696942|5757585|P1|NOT COMPLETED|Overall Study||2
2345654|NCT01696942|5757584|P2|COMPLETED|Overall Study||2
2345655|NCT01696942|5757585|P1|COMPLETED|Overall Study||3
2345656|NCT01696942|5757584|P2|STARTED|Overall Study||5
2345657|NCT01696942|5757585|P1|STARTED|Overall Study||5
2345658|NCT01696929|5757593|P1|NOT COMPLETED|Overall Study||1
2345659|NCT01696929|5757593|P1|COMPLETED|Overall Study||5
2345660|NCT01696929|5757593|P1|STARTED|Overall Study||6
2345661|NCT01696877|5757600|P2|NOT COMPLETED|Overall Study||1
2345662|NCT01696877|5757601|P1|NOT COMPLETED|Overall Study||0
2345663|NCT01696877|5757600|P2|COMPLETED|Overall Study||13
2345664|NCT01696877|5757601|P1|COMPLETED|Overall Study||15
2345665|NCT01696877|5757600|P2|STARTED|Overall Study||14
2345666|NCT01696877|5757601|P1|STARTED|Overall Study||15
2345667|NCT01696773|5757623|P2|NOT COMPLETED|Day 28, Second Intervention||0
2345669|NCT01696773|5757623|P2|COMPLETED|Day 28, Second Intervention||6
2345670|NCT01696773|5757624|P1|COMPLETED|Day 28, Second Intervention||5
2345671|NCT01696773|5757623|P2|STARTED|Day 28, Second Intervention||6
2345672|NCT01696773|5757624|P1|STARTED|Day 28, Second Intervention||5
2345673|NCT01696773|5757623|P2|NOT COMPLETED|Days 15-27, Washout||0
2345674|NCT01696773|5757624|P1|NOT COMPLETED|Days 15-27, Washout||1
2345675|NCT01696773|5757623|P2|COMPLETED|Days 15-27, Washout||6
2345676|NCT01696773|5757624|P1|COMPLETED|Days 15-27, Washout||5
2345677|NCT01696773|5757623|P2|STARTED|Days 15-27, Washout||6
2345678|NCT01696773|5757624|P1|STARTED|Days 15-27, Washout||6
2345679|NCT01696773|5757623|P2|NOT COMPLETED|Day 14, First Intervention||0
2345680|NCT01696773|5757624|P1|NOT COMPLETED|Day 14, First Intervention||0
2345681|NCT01696773|5757623|P2|COMPLETED|Day 14, First Intervention||6
2345682|NCT01696773|5757624|P1|COMPLETED|Day 14, First Intervention||6
2345683|NCT01696773|5757623|P2|STARTED|Day 14, First Intervention||6
2345684|NCT01696773|5757624|P1|STARTED|Day 14, First Intervention||6
2345685|NCT01696773|5757623|P2|NOT COMPLETED|Days 1-13, Washout||0
2345686|NCT01696773|5757624|P1|NOT COMPLETED|Days 1-13, Washout||0
2345687|NCT01696773|5757623|P2|COMPLETED|Days 1-13, Washout||6
2345688|NCT01696773|5757624|P1|COMPLETED|Days 1-13, Washout||6
2345689|NCT01696773|5757623|P2|STARTED|Days 1-13, Washout||6
2345690|NCT01696773|5757624|P1|STARTED|Days 1-13, Washout||6
2345691|NCT01696760|5757632|P2|NOT COMPLETED|Overall Study||0
2345692|NCT01696760|5757633|P1|NOT COMPLETED|Overall Study||0
2345693|NCT01696760|5757632|P2|COMPLETED|Overall Study||3
2345694|NCT01696760|5757633|P1|COMPLETED|Overall Study||9
2345695|NCT01696760|5757632|P2|STARTED|Overall Study||3
2345696|NCT01696760|5757633|P1|STARTED|Overall Study||9
2345697|NCT01696695|5757651|P1|NOT COMPLETED|Overall Study||882
2345698|NCT01696695|5757651|P1|COMPLETED|Overall Study||0
2345699|NCT01696695|5757651|P1|STARTED|Overall Study||882
2345700|NCT01696643|5757663|P2|NOT COMPLETED|Overall Study||535
2345701|NCT01696643|5757664|P1|NOT COMPLETED|Overall Study||529
2345702|NCT01696643|5757663|P2|COMPLETED|Overall Study||169
2345703|NCT01696643|5757664|P1|COMPLETED|Overall Study||174
2345704|NCT01696643|5757663|P2|Received at Least 1 Dose of Study Drug|Overall Study|2 participants randomized to placebo took CB-5945. Their results are included in the CB-5945 group.|702
2345705|NCT01696643|5757664|P1|Received at Least 1 Dose of Study Drug|Overall Study||701
2345706|NCT01696643|5757663|P2|STARTED|Overall Study||704
2345707|NCT01696643|5757664|P1|STARTED|Overall Study||703
2345708|NCT01696396|5757683|P4|NOT COMPLETED|Overall Study||14
2345709|NCT01696396|5757684|P3|NOT COMPLETED|Overall Study||26
2345710|NCT01696396|5757685|P2|NOT COMPLETED|Overall Study||7
2345711|NCT01696396|5757686|P1|NOT COMPLETED|Overall Study||31
2345712|NCT01696396|5757683|P4|COMPLETED|Overall Study||28
2345713|NCT01696396|5757684|P3|COMPLETED|Overall Study||59
2345714|NCT01696396|5757685|P2|COMPLETED|Overall Study||20
2345715|NCT01696396|5757686|P1|COMPLETED|Overall Study||69
2345716|NCT01696396|5757683|P4|Entered Open-label Period|Overall Study||37
2345717|NCT01696396|5757684|P3|Entered Open-label Period|Overall Study||75
2345718|NCT01696396|5757685|P2|Entered Open-label Period|Overall Study||21
2345719|NCT01696396|5757686|P1|Entered Open-label Period|Overall Study||84
2345720|NCT01696396|5757683|P4|Received Study Drug|Overall Study||41
2345721|NCT01696396|5757684|P3|Received Study Drug|Overall Study||84
2345722|NCT01696396|5757685|P2|Received Study Drug|Overall Study||26
2345723|NCT01696396|5757686|P1|Received Study Drug|Overall Study||98
2345724|NCT01696396|5757683|P4|STARTED|Overall Study||42
2345725|NCT01696396|5757684|P3|STARTED|Overall Study||85
2345726|NCT01696396|5757685|P2|STARTED|Overall Study||27
2345727|NCT01696396|5757686|P1|STARTED|Overall Study||100
2345728|NCT01696357|5757730|P2|NOT COMPLETED|Overall Study||1
2345729|NCT01696357|5757731|P1|NOT COMPLETED|Overall Study||2
2345730|NCT01696357|5757730|P2|COMPLETED|Overall Study||41
2345731|NCT01696357|5757731|P1|COMPLETED|Overall Study||40
2345732|NCT01696357|5757730|P2|STARTED|Overall Study||42
2345733|NCT01696357|5757731|P1|STARTED|Overall Study||42
2345734|NCT01696279|5757737|P4|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||8
2345735|NCT01696279|5757738|P3|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
2345736|NCT01696279|5757739|P2|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
2345737|NCT01696279|5757740|P1|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
2345738|NCT01696279|5757737|P4|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||34
2345739|NCT01696279|5757738|P3|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
2345740|NCT01696279|5757739|P2|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
2345741|NCT01696279|5757740|P1|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
2345742|NCT01696279|5757737|P4|STARTED|Part 3: Lanthanum Carbonate (6 Months)|34 participants from Part 2a and 8 participants from Part 2b continued to Part 3|42
2345743|NCT01696279|5757738|P3|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
2345744|NCT01696279|5757739|P2|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
2345745|NCT01696279|5757740|P1|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
2345746|NCT01696279|5757737|P4|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
2345747|NCT01696279|5757738|P3|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||1
2345748|NCT01696279|5757739|P2|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
2345749|NCT01696279|5757740|P1|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
2345750|NCT01696279|5757737|P4|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
2345751|NCT01696279|5757738|P3|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||8
2345752|NCT01696279|5757739|P2|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
2345753|NCT01696279|5757740|P1|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
2345754|NCT01696279|5757737|P4|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
2345755|NCT01696279|5757738|P3|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||9
2345756|NCT01696279|5757739|P2|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
2345757|NCT01696279|5757740|P1|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
2345758|NCT01696279|5757737|P4|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
2345759|NCT01696279|5757738|P3|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
2345760|NCT01696279|5757739|P2|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
2345761|NCT01696279|5757740|P1|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
2345762|NCT01696279|5757737|P4|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
2345763|NCT01696279|5757738|P3|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||9
2345764|NCT01696279|5757739|P2|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
2345765|NCT01696279|5757740|P1|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
2345766|NCT01696279|5757737|P4|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
2345767|NCT01696279|5757738|P3|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||9
2345768|NCT01696279|5757739|P2|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
2345769|NCT01696279|5757740|P1|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
2345770|NCT01696279|5757737|P4|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
2345771|NCT01696279|5757738|P3|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)|9 new participants were enrolled in Part 2b|9
2345772|NCT01696279|5757739|P2|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
2345773|NCT01696279|5757740|P1|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
2345774|NCT01696279|5757737|P4|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
2345775|NCT01696279|5757738|P3|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
2345776|NCT01696279|5757739|P2|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||19
2345777|NCT01696279|5757740|P1|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
2345778|NCT01696279|5757737|P4|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
2345779|NCT01696279|5757738|P3|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
2345780|NCT01696279|5757739|P2|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||34
2345781|NCT01696279|5757740|P1|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
2345782|NCT01696279|5757737|P4|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
2345783|NCT01696279|5757738|P3|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
2345784|NCT01696279|5757739|P2|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||34
2345785|NCT01696279|5757740|P1|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
2345786|NCT01696279|5757737|P4|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
2345787|NCT01696279|5757738|P3|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
2345788|NCT01696279|5757739|P2|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||25
2345789|NCT01696279|5757740|P1|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
2345790|NCT01696279|5757737|P4|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
2345791|NCT01696279|5757738|P3|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
2345792|NCT01696279|5757739|P2|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||17
2345793|NCT01696279|5757740|P1|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
2345794|NCT01696279|5757737|P4|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
2345795|NCT01696279|5757738|P3|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
2345796|NCT01696279|5757739|P2|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||53
2345797|NCT01696279|5757740|P1|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
2345798|NCT01696279|5757737|P4|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
2345799|NCT01696279|5757738|P3|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
2345800|NCT01696279|5757739|P2|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||37
2345801|NCT01696279|5757740|P1|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
2345802|NCT01696279|5757737|P4|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
2345803|NCT01696279|5757738|P3|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
2345804|NCT01696279|5757739|P2|STARTED|Part 2a: Calcium Carbonate + Lanthanum|19 participants enrolled from Part 1 and 34 new participants enrolled in Part 2a|53
2345805|NCT01696279|5757740|P1|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
2345806|NCT01696279|5757737|P4|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
2345807|NCT01696279|5757738|P3|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
2345808|NCT01696279|5757739|P2|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
2345809|NCT01696279|5757740|P1|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||1
2345810|NCT01696279|5757737|P4|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
2345811|NCT01696279|5757738|P3|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
2345812|NCT01696279|5757739|P2|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
2345813|NCT01696279|5757740|P1|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||19
2345814|NCT01696279|5757737|P4|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
2345815|NCT01696279|5757738|P3|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
2345816|NCT01696279|5757739|P2|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
2345817|NCT01696279|5757740|P1|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||19
2345818|NCT01696279|5757737|P4|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
2345819|NCT01696279|5757738|P3|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
2345820|NCT01696279|5757739|P2|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
2345821|NCT01696279|5757740|P1|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||20
2345822|NCT01696279|5757737|P4|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
2345823|NCT01696279|5757738|P3|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
2345824|NCT01696279|5757739|P2|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
2345825|NCT01696279|5757740|P1|STARTED|Part 1: Single Dose Lanthanum Carbonate||20
2345826|NCT01696214|5757778|P4|NOT COMPLETED|Overall Study||0
2345827|NCT01696214|5757779|P3|NOT COMPLETED|Overall Study||0
2345828|NCT01696214|5757780|P2|NOT COMPLETED|Overall Study||0
2345829|NCT01696214|5757781|P1|NOT COMPLETED|Overall Study||1
2345830|NCT01696214|5757778|P4|COMPLETED|Overall Study||5
2345831|NCT01696214|5757779|P3|COMPLETED|Overall Study||5
2345832|NCT01696214|5757780|P2|COMPLETED|Overall Study||5
2345833|NCT01696214|5757781|P1|COMPLETED|Overall Study||4
2345834|NCT01696214|5757778|P4|STARTED|Overall Study||5
2345835|NCT01696214|5757779|P3|STARTED|Overall Study||5
2345836|NCT01696214|5757780|P2|STARTED|Overall Study||5
2345837|NCT01696214|5757781|P1|STARTED|Overall Study||5
2345838|NCT01696188|5757801|P2|NOT COMPLETED|Overall Study||1
2345839|NCT01696188|5757802|P1|NOT COMPLETED|Overall Study||1
2345840|NCT01696188|5757801|P2|COMPLETED|Overall Study||42
2345841|NCT01696188|5757802|P1|COMPLETED|Overall Study||40
2345842|NCT01696188|5757801|P2|STARTED|Overall Study||43
2345843|NCT01696188|5757802|P1|STARTED|Overall Study||41
2345844|NCT01696084|5757816|P2|NOT COMPLETED|Overall Study||146
2345845|NCT01696084|5757817|P1|NOT COMPLETED|Overall Study||131
2345846|NCT01696084|5757816|P2|COMPLETED|Overall Study||10
2345847|NCT01696084|5757817|P1|COMPLETED|Overall Study||22
2345848|NCT01696084|5757816|P2|STARTED|Overall Study||156
2345849|NCT01696084|5757817|P1|STARTED|Overall Study||153
2345850|NCT01696071|5757833|P2|NOT COMPLETED|Treatment Period 2: 4 Weeks||0
2345851|NCT01696071|5757834|P1|NOT COMPLETED|Treatment Period 2: 4 Weeks||1
2345852|NCT01696071|5757833|P2|COMPLETED|Treatment Period 2: 4 Weeks||47
2345853|NCT01696071|5757834|P1|COMPLETED|Treatment Period 2: 4 Weeks||50
2345854|NCT01696071|5757833|P2|STARTED|Treatment Period 2: 4 Weeks||47
2345855|NCT01696071|5757834|P1|STARTED|Treatment Period 2: 4 Weeks||51
2345856|NCT01696071|5757833|P2|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
2345857|NCT01696071|5757834|P1|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
2345858|NCT01696071|5757833|P2|COMPLETED|Treatment Period 1: 4 Weeks||47
2345859|NCT01696071|5757834|P1|COMPLETED|Treatment Period 1: 4 Weeks||51
2345860|NCT01696071|5757833|P2|STARTED|Treatment Period 1: 4 Weeks||47
2345861|NCT01696071|5757834|P1|STARTED|Treatment Period 1: 4 Weeks||51
2345862|NCT01696058|5757862|P2|NOT COMPLETED|Overall Study||31
2345863|NCT01696058|5757863|P1|NOT COMPLETED|Overall Study||43
2345864|NCT01696058|5757862|P2|COMPLETED|Overall Study||538
2345865|NCT01696058|5757863|P1|COMPLETED|Overall Study||523
2345866|NCT01696058|5757862|P2|STARTED|Overall Study||569
2345867|NCT01696058|5757863|P1|STARTED|Overall Study||566
2345868|NCT01696045|5757891|P2|NOT COMPLETED|Overall Study||7
2345869|NCT01696045|5757892|P1|NOT COMPLETED|Overall Study||3
2345870|NCT01696045|5757891|P2|COMPLETED|Overall Study||1
2345871|NCT01696045|5757892|P1|COMPLETED|Overall Study||1
2345872|NCT01696045|5757891|P2|STARTED|Overall Study||8
2345873|NCT01696045|5757892|P1|STARTED|Overall Study||4
2345874|NCT01695993|5757911|P3|NOT COMPLETED|Overall Study||6
2345875|NCT01695993|5757912|P2|NOT COMPLETED|Overall Study||5
2345876|NCT01695993|5757913|P1|NOT COMPLETED|Overall Study||5
2345877|NCT01695993|5757911|P3|COMPLETED|Overall Study||75
2345878|NCT01695993|5757912|P2|COMPLETED|Overall Study||75
2345879|NCT01695993|5757913|P1|COMPLETED|Overall Study||76
2345880|NCT01695993|5757911|P3|STARTED|Overall Study||81
2345881|NCT01695993|5757912|P2|STARTED|Overall Study||80
2345882|NCT01695993|5757913|P1|STARTED|Overall Study||81
2345883|NCT01695772|5757921|P1|NOT COMPLETED|Overall Study||38
2345884|NCT01695772|5757921|P1|COMPLETED|Overall Study||12
2345885|NCT01695772|5757921|P1|STARTED|Overall Study||50
2345886|NCT01695746|5757933|P1|NOT COMPLETED|Overall Study||12
2345887|NCT01695746|5757933|P1|COMPLETED|Overall Study||96
2345888|NCT01695746|5757933|P1|STARTED|Overall Study||108
2345889|NCT01695668|5757949|P2|NOT COMPLETED|Overall Study||17
2345890|NCT01695668|5757950|P1|NOT COMPLETED|Overall Study||15
2345891|NCT01695668|5757949|P2|COMPLETED|Overall Study||20
2345892|NCT01695668|5757950|P1|COMPLETED|Overall Study||23
2345893|NCT01695668|5757949|P2|STARTED|Overall Study||37
2345894|NCT01695668|5757950|P1|STARTED|Overall Study||38
2345895|NCT01695369|5757956|P1|NOT COMPLETED|Overall Study||0
2345896|NCT01695369|5757956|P1|COMPLETED|Overall Study||61
2345897|NCT01695369|5757956|P1|STARTED|Overall Study||61
2345898|NCT01695330|5757962|P2|NOT COMPLETED|Overall Study||0
2345899|NCT01695330|5757963|P1|NOT COMPLETED|Overall Study||47
2345900|NCT01695330|5757962|P2|COMPLETED|Overall Study||0
2345901|NCT01695330|5757963|P1|COMPLETED|Overall Study||5
2345902|NCT01695330|5757962|P2|STARTED|Overall Study||0
2345903|NCT01695330|5757963|P1|STARTED|Overall Study||52
2345904|NCT01695304|5757969|P2|NOT COMPLETED|Overall Study||0
2345905|NCT01695304|5757970|P1|NOT COMPLETED|Overall Study||0
2345906|NCT01695304|5757969|P2|COMPLETED|Overall Study|3 deaths & 2 drop out in the intervention group, contributed some information over the 26 weeks|120
2345907|NCT01695304|5757970|P1|COMPLETED|Overall Study|2 deaths & 1 drop out in the intervention group, contributed some information over the 26 weeks|120
2345908|NCT01695304|5757969|P2|STARTED|Overall Study||120
2345909|NCT01695304|5757970|P1|STARTED|Overall Study||120
2345910|NCT01695291|5757980|P2|NOT COMPLETED|Overall Study||7
2345911|NCT01695291|5757981|P1|NOT COMPLETED|Overall Study||2
2345912|NCT01695291|5757980|P2|COMPLETED|Overall Study||14
2345913|NCT01695291|5757981|P1|COMPLETED|Overall Study||8
2345914|NCT01695291|5757980|P2|STARTED|Overall Study||21
2345915|NCT01695291|5757981|P1|STARTED|Overall Study||10
2345916|NCT01695239|5757993|P14|NOT COMPLETED|Post-Treatment Follow-Up Period||5
2345917|NCT01695239|5757994|P13|NOT COMPLETED|Post-Treatment Follow-Up Period||9
2345918|NCT01695239|5757995|P12|NOT COMPLETED|Post-Treatment Follow-Up Period||1
2345919|NCT01695239|5757996|P11|NOT COMPLETED|Post-Treatment Follow-Up Period||0
2345920|NCT01695239|5757997|P10|NOT COMPLETED|Post-Treatment Follow-Up Period||0
2345921|NCT01695239|5757998|P9|NOT COMPLETED|Post-Treatment Follow-Up Period||0
2345922|NCT01695239|5757999|P8|NOT COMPLETED|Post-Treatment Follow-Up Period||0
2345923|NCT01695239|5758000|P7|NOT COMPLETED|Post-Treatment Follow-Up Period||0
2345924|NCT01695239|5758001|P6|NOT COMPLETED|Post-Treatment Follow-Up Period||0
2345925|NCT01695239|5758002|P5|NOT COMPLETED|Post-Treatment Follow-Up Period||0
2345926|NCT01695239|5758003|P4|NOT COMPLETED|Post-Treatment Follow-Up Period||0
2345927|NCT01695239|5758004|P3|NOT COMPLETED|Post-Treatment Follow-Up Period||0
2345928|NCT01695239|5758005|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||0
2345929|NCT01695239|5758006|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||0
2345930|NCT01695239|5757993|P14|COMPLETED|Post-Treatment Follow-Up Period||166
2345931|NCT01695239|5757994|P13|COMPLETED|Post-Treatment Follow-Up Period||156
2345932|NCT01695239|5757995|P12|COMPLETED|Post-Treatment Follow-Up Period||0
2345933|NCT01695239|5757996|P11|COMPLETED|Post-Treatment Follow-Up Period||20
2345934|NCT01695239|5757997|P10|COMPLETED|Post-Treatment Follow-Up Period||0
2345935|NCT01695239|5757998|P9|COMPLETED|Post-Treatment Follow-Up Period||0
2345936|NCT01695239|5757999|P8|COMPLETED|Post-Treatment Follow-Up Period||0
2345937|NCT01695239|5758000|P7|COMPLETED|Post-Treatment Follow-Up Period||0
2345938|NCT01695239|5758001|P6|COMPLETED|Post-Treatment Follow-Up Period||0
2345939|NCT01695239|5758002|P5|COMPLETED|Post-Treatment Follow-Up Period||0
2345940|NCT01695239|5758003|P4|COMPLETED|Post-Treatment Follow-Up Period||0
2345941|NCT01695239|5758004|P3|COMPLETED|Post-Treatment Follow-Up Period||0
2345942|NCT01695239|5758005|P2|COMPLETED|Post-Treatment Follow-Up Period||0
2345943|NCT01695239|5758006|P1|COMPLETED|Post-Treatment Follow-Up Period||0
2345944|NCT01695239|5757993|P14|STARTED|Post-Treatment Follow-Up Period|IxeQ2W participants who entered post-treatment follow-up.|171
2345945|NCT01695239|5757994|P13|STARTED|Post-Treatment Follow-Up Period|IxeQ4W participants who entered post-treatment follow-up.|165
2345946|NCT01695239|5757995|P12|STARTED|Post-Treatment Follow-Up Period|Participants who discontinued early and received adalimumab.|1
2345947|NCT01695239|5757996|P11|STARTED|Post-Treatment Follow-Up Period|Participants who discontinued early and received PBO.|20
2345948|NCT01695239|5757997|P10|STARTED|Post-Treatment Follow-Up Period|Only included post-treatment follow-up participants.|0
2345949|NCT01695239|5757998|P9|STARTED|Post-Treatment Follow-Up Period|Only included post-treatment follow-up participants.|0
2345950|NCT01695239|5757999|P8|STARTED|Post-Treatment Follow-Up Period||0
2345951|NCT01695239|5758000|P7|STARTED|Post-Treatment Follow-Up Period||0
2345952|NCT01695239|5758001|P6|STARTED|Post-Treatment Follow-Up Period||0
2345953|NCT01695239|5758002|P5|STARTED|Post-Treatment Follow-Up Period||0
2345954|NCT01695239|5758003|P4|STARTED|Post-Treatment Follow-Up Period||0
2345955|NCT01695239|5758004|P3|STARTED|Post-Treatment Follow-Up Period||0
2345956|NCT01695239|5758005|P2|STARTED|Post-Treatment Follow-Up Period||0
2345957|NCT01695239|5758006|P1|STARTED|Post-Treatment Follow-Up Period||0
2345958|NCT01695239|5757993|P14|NOT COMPLETED|Extension Long-Term Extension Periods||0
2345959|NCT01695239|5757994|P13|NOT COMPLETED|Extension Long-Term Extension Periods||0
2345960|NCT01695239|5757995|P12|NOT COMPLETED|Extension Long-Term Extension Periods||0
2345961|NCT01695239|5757996|P11|NOT COMPLETED|Extension Long-Term Extension Periods||0
2345962|NCT01695239|5757997|P10|NOT COMPLETED|Extension Long-Term Extension Periods||61
2345963|NCT01695239|5757998|P9|NOT COMPLETED|Extension Long-Term Extension Periods||66
2345964|NCT01695239|5757999|P8|NOT COMPLETED|Extension Long-Term Extension Periods||0
2345965|NCT01695239|5758000|P7|NOT COMPLETED|Extension Long-Term Extension Periods||0
2345966|NCT01695239|5758001|P6|NOT COMPLETED|Extension Long-Term Extension Periods||0
2345967|NCT01695239|5758002|P5|NOT COMPLETED|Extension Long-Term Extension Periods||0
2345968|NCT01695239|5758003|P4|NOT COMPLETED|Extension Long-Term Extension Periods||0
2345969|NCT01695239|5758004|P3|NOT COMPLETED|Extension Long-Term Extension Periods||0
2345970|NCT01695239|5758005|P2|NOT COMPLETED|Extension Long-Term Extension Periods||0
2345971|NCT01695239|5758006|P1|NOT COMPLETED|Extension Long-Term Extension Periods||0
2345972|NCT01695239|5757993|P14|COMPLETED|Extension Long-Term Extension Periods||0
2345973|NCT01695239|5757994|P13|COMPLETED|Extension Long-Term Extension Periods||0
2345974|NCT01695239|5757995|P12|COMPLETED|Extension Long-Term Extension Periods||0
2345975|NCT01695239|5757996|P11|COMPLETED|Extension Long-Term Extension Periods||0
2345976|NCT01695239|5757997|P10|COMPLETED|Extension Long-Term Extension Periods||122
2345977|NCT01695239|5757998|P9|COMPLETED|Extension Long-Term Extension Periods||121
2345978|NCT01695239|5757999|P8|COMPLETED|Extension Long-Term Extension Periods||0
2345979|NCT01695239|5758000|P7|COMPLETED|Extension Long-Term Extension Periods||0
2345980|NCT01695239|5758001|P6|COMPLETED|Extension Long-Term Extension Periods||0
2345981|NCT01695239|5758002|P5|COMPLETED|Extension Long-Term Extension Periods||0
2345982|NCT01695239|5758003|P4|COMPLETED|Extension Long-Term Extension Periods||0
2345983|NCT01695239|5758004|P3|COMPLETED|Extension Long-Term Extension Periods||0
2345984|NCT01695239|5758005|P2|COMPLETED|Extension Long-Term Extension Periods||0
2345985|NCT01695239|5758006|P1|COMPLETED|Extension Long-Term Extension Periods||0
2345986|NCT01695239|5757993|P14|STARTED|Extension Long-Term Extension Periods||0
2345987|NCT01695239|5757994|P13|STARTED|Extension Long-Term Extension Periods||0
2345988|NCT01695239|5757995|P12|STARTED|Extension Long-Term Extension Periods||0
2345989|NCT01695239|5757996|P11|STARTED|Extension Long-Term Extension Periods||0
2345990|NCT01695239|5757997|P10|STARTED|Extension Long-Term Extension Periods|IxeQ2W who re-randomized to ixeQ2W.|183
2345991|NCT01695239|5757998|P9|STARTED|Extension Long-Term Extension Periods|IxeQ4W who re-randomized to ixeQ4W.|187
2345992|NCT01695239|5757999|P8|STARTED|Extension Long-Term Extension Periods|Only included combined extension participants.|0
2345993|NCT01695239|5758000|P7|STARTED|Extension Long-Term Extension Periods||0
2345994|NCT01695239|5758001|P6|STARTED|Extension Long-Term Extension Periods||0
2345995|NCT01695239|5758002|P5|STARTED|Extension Long-Term Extension Periods||0
2345996|NCT01695239|5758003|P4|STARTED|Extension Long-Term Extension Periods||0
2345997|NCT01695239|5758004|P3|STARTED|Extension Long-Term Extension Periods||0
2345998|NCT01695239|5758005|P2|STARTED|Extension Long-Term Extension Periods||0
2345999|NCT01695239|5758006|P1|STARTED|Extension Long-Term Extension Periods||0
2346000|NCT01695239|5757993|P14|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
2346001|NCT01695239|5757994|P13|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
2346002|NCT01695239|5757995|P12|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
2346003|NCT01695239|5757996|P11|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
2346004|NCT01695239|5757997|P10|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
2346005|NCT01695239|5757998|P9|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
2346006|NCT01695239|5757999|P8|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||11
2346007|NCT01695239|5758000|P7|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
2346008|NCT01695239|5758001|P6|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
2346009|NCT01695239|5758002|P5|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
2346010|NCT01695239|5758003|P4|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
2346011|NCT01695239|5758004|P3|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
2346012|NCT01695239|5758005|P2|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
2346013|NCT01695239|5758006|P1|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
2346014|NCT01695239|5757993|P14|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
2346015|NCT01695239|5757994|P13|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
2346016|NCT01695239|5757995|P12|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
2346017|NCT01695239|5757996|P11|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
2346018|NCT01695239|5757997|P10|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
2346019|NCT01695239|5757998|P9|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
2346020|NCT01695239|5757999|P8|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||77
2346021|NCT01695239|5758000|P7|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
2346022|NCT01695239|5758001|P6|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
2346023|NCT01695239|5758002|P5|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
2346024|NCT01695239|5758003|P4|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
2346025|NCT01695239|5758004|P3|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
2346026|NCT01695239|5758005|P2|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
2346027|NCT01695239|5758006|P1|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
2346028|NCT01695239|5757993|P14|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
2346029|NCT01695239|5757994|P13|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
2346030|NCT01695239|5757995|P12|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
2346031|NCT01695239|5757996|P11|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
2346032|NCT01695239|5757997|P10|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
2346033|NCT01695239|5757998|P9|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
2346034|NCT01695239|5757999|P8|STARTED|Placebo Washout (Week 24 Up To Week 32)|Adalimumab Q2W responders who re-randomized to IxeQ2W or IxeQ4W and PBO for ixe and adalimumab.|88
2346035|NCT01695239|5758000|P7|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
2346036|NCT01695239|5758001|P6|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
2346037|NCT01695239|5758002|P5|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
2346038|NCT01695239|5758003|P4|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
2346039|NCT01695239|5758004|P3|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
2346040|NCT01695239|5758005|P2|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
2346041|NCT01695239|5758006|P1|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
2346042|NCT01695239|5757993|P14|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
2346043|NCT01695239|5757994|P13|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
2346044|NCT01695239|5757995|P12|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
2346045|NCT01695239|5757996|P11|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
2346046|NCT01695239|5757997|P10|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
2346047|NCT01695239|5757998|P9|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
2346048|NCT01695239|5757999|P8|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
2346049|NCT01695239|5758000|P7|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
2346050|NCT01695239|5758001|P6|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
2346051|NCT01695239|5758002|P5|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
2346052|NCT01695239|5758003|P4|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
2346053|NCT01695239|5758004|P3|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
2346054|NCT01695239|5758005|P2|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
2346055|NCT01695239|5758006|P1|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
2346056|NCT01695239|5757993|P14|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
2346057|NCT01695239|5757994|P13|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
2346058|NCT01695239|5757995|P12|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
2346059|NCT01695239|5757996|P11|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
2346060|NCT01695239|5757997|P10|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
2346061|NCT01695239|5757998|P9|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
2346062|NCT01695239|5757999|P8|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
2346063|NCT01695239|5758000|P7|COMPLETED|IR Participants (Week 16 Up To Week 24)||9
2346064|NCT01695239|5758001|P6|COMPLETED|IR Participants (Week 16 Up To Week 24)||24
2346065|NCT01695239|5758002|P5|COMPLETED|IR Participants (Week 16 Up To Week 24)||24
2346066|NCT01695239|5758003|P4|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
2346067|NCT01695239|5758004|P3|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
2346068|NCT01695239|5758005|P2|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
2346069|NCT01695239|5758006|P1|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
2346070|NCT01695239|5757993|P14|STARTED|IR Participants (Week 16 Up To Week 24)||0
2346071|NCT01695239|5757994|P13|STARTED|IR Participants (Week 16 Up To Week 24)||0
2346072|NCT01695239|5757995|P12|STARTED|IR Participants (Week 16 Up To Week 24)||0
2346073|NCT01695239|5757996|P11|STARTED|IR Participants (Week 16 Up To Week 24)||0
2346074|NCT01695239|5757997|P10|STARTED|IR Participants (Week 16 Up To Week 24)||0
2346075|NCT01695239|5757998|P9|STARTED|IR Participants (Week 16 Up To Week 24)||0
2346076|NCT01695239|5757999|P8|STARTED|IR Participants (Week 16 Up To Week 24)||0
2346077|NCT01695239|5758000|P7|STARTED|IR Participants (Week 16 Up To Week 24)|Adalimumab Q2W (IR) who re-randomized to IxeQ2W or IxeQ4W and PBO for ixe and adalimumab.|9
2346078|NCT01695239|5758001|P6|STARTED|IR Participants (Week 16 Up To Week 24)|IR from placebo who re-randomized to ixeQ2W and IR from ixeQ2W.|24
2346079|NCT01695239|5758002|P5|STARTED|IR Participants (Week 16 Up To Week 24)|IR from placebo who re-randomized to ixeQ4W and IR from ixeQ4W.|24
2346080|NCT01695239|5758003|P4|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
2346081|NCT01695239|5758004|P3|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
2346082|NCT01695239|5758005|P2|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
2346083|NCT01695239|5758006|P1|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
2346084|NCT01695239|5757993|P14|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
2346085|NCT01695239|5757994|P13|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
2346086|NCT01695239|5757995|P12|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
2346087|NCT01695239|5757996|P11|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
2346088|NCT01695239|5757997|P10|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
2346089|NCT01695239|5757998|P9|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
2346090|NCT01695239|5757999|P8|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
2346091|NCT01695239|5758000|P7|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
2346092|NCT01695239|5758001|P6|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
2346093|NCT01695239|5758002|P5|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
2346094|NCT01695239|5758003|P4|NOT COMPLETED|Double-Blind (DB) Treatment Period||7
2346095|NCT01695239|5758004|P3|NOT COMPLETED|Double-Blind (DB) Treatment Period||10
2346096|NCT01695239|5758005|P2|NOT COMPLETED|Double-Blind (DB) Treatment Period||4
2346097|NCT01695239|5758006|P1|NOT COMPLETED|Double-Blind (DB) Treatment Period||15
2346098|NCT01695239|5757993|P14|COMPLETED|Double-Blind (DB) Treatment Period||0
2346099|NCT01695239|5757994|P13|COMPLETED|Double-Blind (DB) Treatment Period||0
2346100|NCT01695239|5757995|P12|COMPLETED|Double-Blind (DB) Treatment Period||0
2346101|NCT01695239|5757996|P11|COMPLETED|Double-Blind (DB) Treatment Period||0
2346102|NCT01695239|5757997|P10|COMPLETED|Double-Blind (DB) Treatment Period||0
2346103|NCT01695239|5757998|P9|COMPLETED|Double-Blind (DB) Treatment Period||0
2346104|NCT01695239|5757999|P8|COMPLETED|Double-Blind (DB) Treatment Period||0
2346105|NCT01695239|5758000|P7|COMPLETED|Double-Blind (DB) Treatment Period||0
2346106|NCT01695239|5758001|P6|COMPLETED|Double-Blind (DB) Treatment Period||0
2346107|NCT01695239|5758002|P5|COMPLETED|Double-Blind (DB) Treatment Period||0
2346108|NCT01695239|5758003|P4|COMPLETED|Double-Blind (DB) Treatment Period||96
2346109|NCT01695239|5758004|P3|COMPLETED|Double-Blind (DB) Treatment Period||97
2346110|NCT01695239|5758005|P2|COMPLETED|Double-Blind (DB) Treatment Period||97
2346111|NCT01695239|5758006|P1|COMPLETED|Double-Blind (DB) Treatment Period||91
2346112|NCT01695239|5757993|P14|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
2346113|NCT01695239|5757994|P13|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
2346114|NCT01695239|5757995|P12|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
2346115|NCT01695239|5757996|P11|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
2346116|NCT01695239|5757997|P10|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
2346117|NCT01695239|5757998|P9|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
2346118|NCT01695239|5757999|P8|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
2346119|NCT01695239|5758000|P7|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
2346120|NCT01695239|5758001|P6|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
2346121|NCT01695239|5758002|P5|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
2346122|NCT01695239|5758003|P4|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||10
2346123|NCT01695239|5758004|P3|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||11
2346124|NCT01695239|5758005|P2|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||9
2346125|NCT01695239|5758006|P1|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||27
2346126|NCT01695239|5757993|P14|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
2346127|NCT01695239|5757994|P13|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
2346128|NCT01695239|5757995|P12|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
2346129|NCT01695239|5757996|P11|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
2346130|NCT01695239|5757997|P10|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
2346131|NCT01695239|5757998|P9|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
2346132|NCT01695239|5757999|P8|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
2346133|NCT01695239|5758000|P7|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
2346134|NCT01695239|5758001|P6|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
2346135|NCT01695239|5758002|P5|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
2346136|NCT01695239|5758003|P4|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||102
2346137|NCT01695239|5758004|P3|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||107
2346138|NCT01695239|5758005|P2|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||101
2346139|NCT01695239|5758006|P1|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||106
2346140|NCT01695239|5757993|P14|STARTED|Double-Blind (DB) Treatment Period||0
2346141|NCT01695239|5757994|P13|STARTED|Double-Blind (DB) Treatment Period||0
2346142|NCT01695239|5757995|P12|STARTED|Double-Blind (DB) Treatment Period||0
2346143|NCT01695239|5757996|P11|STARTED|Double-Blind (DB) Treatment Period||0
2346144|NCT01695239|5757997|P10|STARTED|Double-Blind (DB) Treatment Period||0
2346145|NCT01695239|5757998|P9|STARTED|Double-Blind (DB) Treatment Period||0
2346146|NCT01695239|5757999|P8|STARTED|Double-Blind (DB) Treatment Period||0
2346147|NCT01695239|5758000|P7|STARTED|Double-Blind (DB) Treatment Period||0
2346148|NCT01695239|5758001|P6|STARTED|Double-Blind (DB) Treatment Period||0
2346149|NCT01695239|5758002|P5|STARTED|Double-Blind (DB) Treatment Period||0
2346150|NCT01695239|5758003|P4|STARTED|Double-Blind (DB) Treatment Period||103
2346151|NCT01695239|5758004|P3|STARTED|Double-Blind (DB) Treatment Period||107
2346152|NCT01695239|5758005|P2|STARTED|Double-Blind (DB) Treatment Period||101
2346153|NCT01695239|5758006|P1|STARTED|Double-Blind (DB) Treatment Period||106
2346154|NCT01695135|5758147|P4|NOT COMPLETED|Open Label Extension Treatment Phase||70
2346155|NCT01695135|5758148|P3|NOT COMPLETED|Open Label Extension Treatment Phase||40
2346156|NCT01695135|5758149|P2|NOT COMPLETED|Open Label Extension Treatment Phase||0
2346157|NCT01695135|5758150|P1|NOT COMPLETED|Open Label Extension Treatment Phase||0
2346158|NCT01695135|5758147|P4|COMPLETED|Open Label Extension Treatment Phase||10
2346159|NCT01695135|5758148|P3|COMPLETED|Open Label Extension Treatment Phase||9
2346160|NCT01695135|5758149|P2|COMPLETED|Open Label Extension Treatment Phase||0
2346161|NCT01695135|5758150|P1|COMPLETED|Open Label Extension Treatment Phase||0
2346162|NCT01695135|5758147|P4|STARTED|Open Label Extension Treatment Phase||80
2346163|NCT01695135|5758148|P3|STARTED|Open Label Extension Treatment Phase||49
2346164|NCT01695135|5758149|P2|STARTED|Open Label Extension Treatment Phase||0
2346165|NCT01695135|5758150|P1|STARTED|Open Label Extension Treatment Phase||0
2346166|NCT01695135|5758147|P4|NOT COMPLETED|Double-blind Treatment Phase||0
2346167|NCT01695135|5758148|P3|NOT COMPLETED|Double-blind Treatment Phase||0
2346168|NCT01695135|5758149|P2|NOT COMPLETED|Double-blind Treatment Phase||139
2346169|NCT01695135|5758150|P1|NOT COMPLETED|Double-blind Treatment Phase||71
2346170|NCT01695135|5758147|P4|COMPLETED|Double-blind Treatment Phase||0
2346171|NCT01695135|5758148|P3|COMPLETED|Double-blind Treatment Phase||0
2346172|NCT01695135|5758149|P2|COMPLETED|Double-blind Treatment Phase||4
2346173|NCT01695135|5758150|P1|COMPLETED|Double-blind Treatment Phase||0
2346174|NCT01695135|5758147|P4|STARTED|Double-blind Treatment Phase||0
2346175|NCT01695135|5758148|P3|STARTED|Double-blind Treatment Phase||0
2346176|NCT01695135|5758149|P2|STARTED|Double-blind Treatment Phase||143
2346177|NCT01695135|5758150|P1|STARTED|Double-blind Treatment Phase||71
2346178|NCT01695044|5758174|P1|NOT COMPLETED|Overall Study||102
2346179|NCT01695044|5758174|P1|COMPLETED|Overall Study||17
2346180|NCT01695044|5758174|P1|STARTED|Overall Study||119
2346181|NCT01694966|5758187|P3|NOT COMPLETED|Overall Study||34
2346182|NCT01694966|5758188|P2|NOT COMPLETED|Overall Study||15
2346183|NCT01694966|5758189|P1|NOT COMPLETED|Overall Study||34
2346184|NCT01694966|5758187|P3|COMPLETED|Overall Study||464
2346185|NCT01694966|5758188|P2|COMPLETED|Overall Study||232
2346186|NCT01694966|5758189|P1|COMPLETED|Overall Study||470
2346187|NCT01694966|5758187|P3|STARTED|Overall Study||498
2346188|NCT01694966|5758188|P2|STARTED|Overall Study||247
2346189|NCT01694966|5758189|P1|STARTED|Overall Study||504
2346190|NCT01694771|5758199|P2|NOT COMPLETED|Overall Study||40
2346191|NCT01694771|5758200|P1|NOT COMPLETED|Overall Study||40
2346192|NCT01694771|5758199|P2|COMPLETED|Overall Study||525
2346193|NCT01694771|5758200|P1|COMPLETED|Overall Study||527
2346194|NCT01694771|5758199|P2|STARTED|Overall Study||565
2346195|NCT01694771|5758200|P1|STARTED|Overall Study||567
2346196|NCT01694706|5758224|P3|NOT COMPLETED|Overall Study||0
2346197|NCT01694706|5758225|P2|NOT COMPLETED|Overall Study||1
2346198|NCT01694706|5758226|P1|NOT COMPLETED|Overall Study||1
2346199|NCT01694706|5758224|P3|COMPLETED|Overall Study||5
2346200|NCT01694706|5758225|P2|COMPLETED|Overall Study||4
2346201|NCT01694706|5758226|P1|COMPLETED|Overall Study||4
2346202|NCT01694706|5758224|P3|Received Faldaprevir Fed|Overall Study||5
2346203|NCT01694706|5758225|P2|Received Faldaprevir Fed|Overall Study||5
2346204|NCT01694706|5758226|P1|Received Faldaprevir Fed|Overall Study||4
2346205|NCT01694706|5758224|P3|Received Faldaprevir +OMP|Overall Study||5
2346206|NCT01694706|5758225|P2|Received Faldaprevir +OMP|Overall Study||5
2346207|NCT01694706|5758226|P1|Received Faldaprevir +OMP|Overall Study||5
2346208|NCT01694706|5758224|P3|Received Faldaprevir|Overall Study||5
2346209|NCT01694706|5758225|P2|Received Faldaprevir|Overall Study||5
2346210|NCT01694706|5758226|P1|Received Faldaprevir|Overall Study||5
2346211|NCT01694706|5758224|P3|STARTED|Overall Study||5
2346212|NCT01694706|5758225|P2|STARTED|Overall Study||5
2346213|NCT01694706|5758226|P1|STARTED|Overall Study||5
2346214|NCT01694667|5758243|P2|NOT COMPLETED|Overall Study||0
2346215|NCT01694667|5758244|P1|NOT COMPLETED|Overall Study||0
2346216|NCT01694667|5758243|P2|COMPLETED|Overall Study||28
2346217|NCT01694667|5758244|P1|COMPLETED|Overall Study||29
2346218|NCT01694667|5758243|P2|STARTED|Overall Study||28
2346219|NCT01694667|5758244|P1|STARTED|Overall Study||29
2346220|NCT01694641|5758262|P2|NOT COMPLETED|Overall Study||10
2346221|NCT01694641|5758263|P1|NOT COMPLETED|Overall Study||12
2346222|NCT01694641|5758262|P2|COMPLETED|Overall Study||71
2346223|NCT01694641|5758263|P1|COMPLETED|Overall Study||68
2346224|NCT01694641|5758262|P2|STARTED|Overall Study||81
2346225|NCT01694641|5758263|P1|STARTED|Overall Study||80
2346226|NCT01694563|5758271|P1|NOT COMPLETED|Overall Study||87
2346227|NCT01694563|5758271|P1|COMPLETED|Overall Study||278
2346228|NCT01694563|5758271|P1|STARTED|Overall Study||365
2346229|NCT01694485|5758283|P5|NOT COMPLETED|Overall Study||25
2346230|NCT01694485|5758284|P4|NOT COMPLETED|Overall Study||38
2346231|NCT01694485|5758285|P3|NOT COMPLETED|Overall Study||13
2346232|NCT01694485|5758286|P2|NOT COMPLETED|Overall Study||7
2346233|NCT01694485|5758287|P1|NOT COMPLETED|Overall Study||33
2346234|NCT01694485|5758283|P5|COMPLETED|Overall Study||55
2346235|NCT01694485|5758284|P4|COMPLETED|Overall Study||62
2346236|NCT01694485|5758285|P3|COMPLETED|Overall Study||27
2346237|NCT01694485|5758286|P2|COMPLETED|Overall Study||15
2346238|NCT01694485|5758287|P1|COMPLETED|Overall Study||84
2346239|NCT01694485|5758283|P5|Entered Open-label Period|Overall Study||68
2346240|NCT01694485|5758284|P4|Entered Open-label Period|Overall Study||88
2346241|NCT01694485|5758285|P3|Entered Open-label Period|Overall Study||36
2346242|NCT01694485|5758286|P2|Entered Open-label Period|Overall Study||19
2346243|NCT01694485|5758287|P1|Entered Open-label Period|Overall Study||100
2346244|NCT01694485|5758283|P5|Completed Week 8 Assessment|Overall Study||76
2346245|NCT01694485|5758284|P4|Completed Week 8 Assessment|Overall Study||94
2346246|NCT01694485|5758285|P3|Completed Week 8 Assessment|Overall Study||38
2346247|NCT01694485|5758286|P2|Completed Week 8 Assessment|Overall Study||18
2346248|NCT01694485|5758287|P1|Completed Week 8 Assessment|Overall Study||106
2346249|NCT01694485|5758283|P5|Received Treatment|Overall Study||79
2346250|NCT01694485|5758284|P4|Received Treatment|Overall Study||98
2346251|NCT01694485|5758285|P3|Received Treatment|Overall Study||40
2346252|NCT01694485|5758286|P2|Received Treatment|Overall Study||21
2346253|NCT01694485|5758287|P1|Received Treatment|Overall Study||116
2346254|NCT01694485|5758283|P5|STARTED|Overall Study||80
2346255|NCT01694485|5758284|P4|STARTED|Overall Study||100
2346256|NCT01694485|5758285|P3|STARTED|Overall Study||40
2346257|NCT01694485|5758286|P2|STARTED|Overall Study||22
2346258|NCT01694485|5758287|P1|STARTED|Overall Study||117
2346259|NCT01694433|5758321|P2|NOT COMPLETED|Overall Study||4
2346260|NCT01694433|5758322|P1|NOT COMPLETED|Overall Study||11
2346261|NCT01694433|5758321|P2|COMPLETED|Overall Study||29
2346262|NCT01694433|5758322|P1|COMPLETED|Overall Study||22
2346263|NCT01694433|5758321|P2|Baseline Visit|Overall Study||32
2346264|NCT01694433|5758322|P1|Baseline Visit|Overall Study||33
2346265|NCT01694433|5758321|P2|STARTED|Overall Study||33
2346266|NCT01694433|5758322|P1|STARTED|Overall Study||33
2346267|NCT01694420|5758330|P1|NOT COMPLETED|Overall Study||3
2346268|NCT01694420|5758330|P1|COMPLETED|Overall Study||30
2346269|NCT01694420|5758330|P1|STARTED|Overall Study||33
2346270|NCT01694199|5758341|P2|NOT COMPLETED|Overall Study||0
2346271|NCT01694199|5758342|P1|NOT COMPLETED|Overall Study||0
2346272|NCT01694199|5758341|P2|COMPLETED|Overall Study||68
2346273|NCT01694199|5758342|P1|COMPLETED|Overall Study||71
2346274|NCT01694199|5758341|P2|STARTED|Overall Study||68
2346275|NCT01694199|5758342|P1|STARTED|Overall Study||71
2346276|NCT01694121|5758358|P2|NOT COMPLETED|Overall Study||0
2346277|NCT01694121|5758359|P1|NOT COMPLETED|Overall Study||1
2346278|NCT01694121|5758358|P2|COMPLETED|Overall Study||227
2346279|NCT01694121|5758359|P1|COMPLETED|Overall Study||227
2346280|NCT01694121|5758358|P2|STARTED|Overall Study||227
2346281|NCT01694121|5758359|P1|STARTED|Overall Study||228
2346282|NCT01694108|5758373|P2|NOT COMPLETED|Overall Study||0
2346283|NCT01694108|5758374|P1|NOT COMPLETED|Overall Study||0
2346284|NCT01694108|5758373|P2|COMPLETED|Overall Study|100% follow-up|2133
2346285|NCT01694108|5758374|P1|COMPLETED|Overall Study|100% follow-up|2129
2346286|NCT01694108|5758373|P2|STARTED|Overall Study||2133
2346287|NCT01694108|5758374|P1|STARTED|Overall Study||2129
2346288|NCT01693900|5758430|P2|NOT COMPLETED|Overall Study||0
2346289|NCT01693900|5758431|P1|NOT COMPLETED|Overall Study||0
2346290|NCT01693900|5758430|P2|COMPLETED|Overall Study||25
2346291|NCT01693900|5758431|P1|COMPLETED|Overall Study||25
2346292|NCT01693900|5758430|P2|STARTED|Overall Study||25
2346293|NCT01693900|5758431|P1|STARTED|Overall Study||25
2346294|NCT01693653|5758445|P2|NOT COMPLETED|Overall Study||0
2346295|NCT01693653|5758446|P1|NOT COMPLETED|Overall Study||0
2346296|NCT01693653|5758445|P2|COMPLETED|Overall Study||0
2346297|NCT01693653|5758446|P1|COMPLETED|Overall Study||1
2346298|NCT01693653|5758445|P2|STARTED|Overall Study||0
2346299|NCT01693653|5758446|P1|STARTED|Overall Study||1
2346300|NCT01693614|5758473|P3|NOT COMPLETED|Overall Study||24
2346301|NCT01693614|5758474|P2|NOT COMPLETED|Overall Study||22
2346302|NCT01693614|5758475|P1|NOT COMPLETED|Overall Study||26
2346303|NCT01693614|5758473|P3|COMPLETED|Overall Study||0
2346304|NCT01693614|5758474|P2|COMPLETED|Overall Study||0
2346305|NCT01693614|5758475|P1|COMPLETED|Overall Study||0
2346306|NCT01693614|5758473|P3|STARTED|Overall Study||24
2346307|NCT01693614|5758474|P2|STARTED|Overall Study||22
2346308|NCT01693614|5758475|P1|STARTED|Overall Study||26
2346318|NCT01693484|5758512|P1|NOT COMPLETED|Overall Study||13
2346319|NCT01693484|5758512|P1|COMPLETED|Overall Study|Study closed by PI|0
2346320|NCT01693484|5758512|P1|STARTED|Overall Study||13
2346321|NCT01693367|5758518|P2|NOT COMPLETED|Overall Study||2
2346322|NCT01693367|5758519|P1|NOT COMPLETED|Overall Study||1
2346323|NCT01693367|5758518|P2|COMPLETED|Overall Study||1
2346324|NCT01693367|5758519|P1|COMPLETED|Overall Study||1
2346325|NCT01693367|5758518|P2|STARTED|Overall Study||3
2346326|NCT01693367|5758519|P1|STARTED|Overall Study||2
2346327|NCT01693250|5758537|P2|NOT COMPLETED|Overall Study||2
2346328|NCT01693250|5758538|P1|NOT COMPLETED|Overall Study||2
2346329|NCT01693250|5758537|P2|COMPLETED|Overall Study|15 teens completed 6 months post baseline assessment|15
2346330|NCT01693250|5758538|P1|COMPLETED|Overall Study|21 teens completed 6 months post baseline assessment|21
2346331|NCT01693250|5758537|P2|STARTED|Overall Study|three month post baseline assessment|17
2346332|NCT01693250|5758538|P1|STARTED|Overall Study|3 months post baseline assessment|23
2346333|NCT01693185|5758548|P2|NOT COMPLETED|Overall Study||6
2346334|NCT01693185|5758549|P1|NOT COMPLETED|Overall Study||0
2346335|NCT01693185|5758548|P2|COMPLETED|Overall Study||27
2346336|NCT01693185|5758549|P1|COMPLETED|Overall Study||27
2346337|NCT01693185|5758548|P2|STARTED|Overall Study||33
2346338|NCT01693185|5758549|P1|STARTED|Overall Study||27
2346339|NCT01693120|5758565|P1|NOT COMPLETED|Phased RF Study Procedure and Follow-up||17
2346340|NCT01693120|5758565|P1|COMPLETED|Phased RF Study Procedure and Follow-up|112 of the 129 subjects with a Phased RF procedure completed the 6-month follow-up visit|112
2346341|NCT01693120|5758565|P1|STARTED|Phased RF Study Procedure and Follow-up||129
2346342|NCT01693120|5758565|P1|NOT COMPLETED|Enrollment||70
2346343|NCT01693120|5758565|P1|COMPLETED|Enrollment|129 of the 199 enrolled subjects underwent a Phased RF study procedure|129
2346344|NCT01693120|5758565|P1|STARTED|Enrollment|70 subjects exited the study after consent, but prior to undergoing a study ablation procedure.|199
2346345|NCT01693068|5758574|P3|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||1
2346346|NCT01693068|5758575|P2|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
2346347|NCT01693068|5758576|P1|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
2346348|NCT01693068|5758574|P3|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||40
2346349|NCT01693068|5758575|P2|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
2346350|NCT01693068|5758576|P1|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
2346351|NCT01693068|5758574|P3|Treated|Cross-over (Dacarbazine To Pimasertib)||41
2346352|NCT01693068|5758575|P2|Treated|Cross-over (Dacarbazine To Pimasertib)||0
2346353|NCT01693068|5758576|P1|Treated|Cross-over (Dacarbazine To Pimasertib)||0
2346354|NCT01693068|5758574|P3|STARTED|Cross-over (Dacarbazine To Pimasertib)||41
2346355|NCT01693068|5758575|P2|STARTED|Cross-over (Dacarbazine To Pimasertib)||0
2346356|NCT01693068|5758576|P1|STARTED|Cross-over (Dacarbazine To Pimasertib)||0
2346357|NCT01693068|5758574|P3|NOT COMPLETED|Randomization Period||0
2346358|NCT01693068|5758575|P2|NOT COMPLETED|Randomization Period||5
2346359|NCT01693068|5758576|P1|NOT COMPLETED|Randomization Period||2
2346360|NCT01693068|5758574|P3|COMPLETED|Randomization Period||0
2346361|NCT01693068|5758575|P2|COMPLETED|Randomization Period||125
2346362|NCT01693068|5758576|P1|COMPLETED|Randomization Period||62
2346363|NCT01693068|5758574|P3|Treated|Randomization Period||0
2346364|NCT01693068|5758575|P2|Treated|Randomization Period||130
2346365|NCT01693068|5758576|P1|Treated|Randomization Period||61
2346366|NCT01693068|5758574|P3|STARTED|Randomization Period||0
2346367|NCT01693068|5758575|P2|STARTED|Randomization Period||130
2346368|NCT01693068|5758576|P1|STARTED|Randomization Period||64
2346369|NCT01693029|5758608|P2|NOT COMPLETED|Overall Study||57
2346370|NCT01693029|5758609|P1|NOT COMPLETED|Overall Study||44
2346371|NCT01693029|5758608|P2|COMPLETED|Overall Study||161
2346372|NCT01693029|5758609|P1|COMPLETED|Overall Study||173
2346373|NCT01693029|5758608|P2|STARTED|Overall Study||218
2346374|NCT01693029|5758609|P1|STARTED|Overall Study||217
2346375|NCT01692951|5758625|P4|NOT COMPLETED|Overall Study||0
2346376|NCT01692951|5758626|P3|NOT COMPLETED|Overall Study||0
2346377|NCT01692951|5758627|P2|NOT COMPLETED|Overall Study||0
2346378|NCT01692951|5758628|P1|NOT COMPLETED|Overall Study||0
2346379|NCT01692951|5758625|P4|COMPLETED|Overall Study||54
2346380|NCT01692951|5758626|P3|COMPLETED|Overall Study||18
2346381|NCT01692951|5758627|P2|COMPLETED|Overall Study||111
2346382|NCT01692951|5758628|P1|COMPLETED|Overall Study||37
2346383|NCT01692951|5758625|P4|STARTED|Overall Study||54
2346384|NCT01692951|5758626|P3|STARTED|Overall Study||18
2346385|NCT01692951|5758627|P2|STARTED|Overall Study||111
2346386|NCT01692951|5758628|P1|STARTED|Overall Study||37
2346387|NCT01692938|5758640|P2|NOT COMPLETED|Overall Study||4
2346388|NCT01692938|5758641|P1|NOT COMPLETED|Overall Study||4
2346389|NCT01692938|5758640|P2|COMPLETED|Overall Study||12
2346390|NCT01692938|5758641|P1|COMPLETED|Overall Study||12
2346391|NCT01692938|5758640|P2|STARTED|Overall Study||16
2346392|NCT01692938|5758641|P1|STARTED|Overall Study||16
2346393|NCT01692782|5758652|P3|NOT COMPLETED|Overall Study||10
2346394|NCT01692782|5758653|P2|NOT COMPLETED|Overall Study||56
2346395|NCT01692782|5758654|P1|NOT COMPLETED|Overall Study||20
2346396|NCT01692782|5758652|P3|COMPLETED|Overall Study||100
2346397|NCT01692782|5758653|P2|COMPLETED|Overall Study||59
2346398|NCT01692782|5758654|P1|COMPLETED|Overall Study||96
2346399|NCT01692782|5758652|P3|STARTED|Overall Study||110
2346400|NCT01692782|5758653|P2|STARTED|Overall Study||115
2346401|NCT01692782|5758654|P1|STARTED|Overall Study||116
2346402|NCT01692756|5758681|P4|NOT COMPLETED|Overall Study||0
2346403|NCT01692756|5758682|P3|NOT COMPLETED|Overall Study||2
2346404|NCT01692756|5758683|P2|NOT COMPLETED|Overall Study||1
2346405|NCT01692756|5758684|P1|NOT COMPLETED|Overall Study||1
2346406|NCT01692756|5758681|P4|COMPLETED|Overall Study||12
2346407|NCT01692756|5758682|P3|COMPLETED|Overall Study||11
2346408|NCT01692756|5758683|P2|COMPLETED|Overall Study||11
2346409|NCT01692756|5758684|P1|COMPLETED|Overall Study||11
2346410|NCT01692756|5758681|P4|STARTED|Overall Study||12
2346411|NCT01692756|5758682|P3|STARTED|Overall Study||13
2346412|NCT01692756|5758683|P2|STARTED|Overall Study||12
2346413|NCT01692756|5758684|P1|STARTED|Overall Study||12
2346414|NCT01692743|5758745|P3|NOT COMPLETED|Overall Study||27
2346415|NCT01692743|5758746|P2|NOT COMPLETED|Overall Study||35
2346416|NCT01692743|5758747|P1|NOT COMPLETED|Overall Study||27
2346417|NCT01692743|5758745|P3|COMPLETED|Overall Study||88
2346418|NCT01692743|5758746|P2|COMPLETED|Overall Study||81
2346419|NCT01692743|5758747|P1|COMPLETED|Overall Study||90
2346420|NCT01692743|5758745|P3|STARTED|Overall Study||115
2346421|NCT01692743|5758746|P2|STARTED|Overall Study||116
2346422|NCT01692743|5758747|P1|STARTED|Overall Study||117
2346423|NCT01692730|5758763|P2|NOT COMPLETED|Overall Study||227
2346424|NCT01692730|5758764|P1|NOT COMPLETED|Overall Study||225
2346425|NCT01692730|5758763|P2|COMPLETED|Overall Study||502
2346426|NCT01692730|5758764|P1|COMPLETED|Overall Study||498
2346427|NCT01692730|5758763|P2|STARTED|Overall Study||729
2346428|NCT01692730|5758764|P1|STARTED|Overall Study||723
2346429|NCT01692691|5758772|P1|NOT COMPLETED|Overall Study||0
2346430|NCT01692691|5758772|P1|COMPLETED|Overall Study||1
2346431|NCT01692691|5758772|P1|STARTED|Overall Study||1
2346432|NCT01692626|5758778|P2|NOT COMPLETED|Overall Study||6
2346433|NCT01692626|5758779|P1|NOT COMPLETED|Overall Study||4
2346434|NCT01692626|5758778|P2|COMPLETED|Overall Study||1
2346435|NCT01692626|5758779|P1|COMPLETED|Overall Study||2
2346436|NCT01692626|5758778|P2|STARTED|Overall Study||7
2346437|NCT01692626|5758779|P1|STARTED|Overall Study||6
2346438|NCT01692340|5758787|P3|NOT COMPLETED|Overall Study||0
2346439|NCT01692340|5758788|P2|NOT COMPLETED|Overall Study||0
2346440|NCT01692340|5758789|P1|NOT COMPLETED|Overall Study||0
2346441|NCT01692340|5758787|P3|COMPLETED|Overall Study||0
2346442|NCT01692340|5758788|P2|COMPLETED|Overall Study||4
2346443|NCT01692340|5758789|P1|COMPLETED|Overall Study||8
2346444|NCT01692340|5758787|P3|STARTED|Overall Study||0
2346445|NCT01692340|5758788|P2|STARTED|Overall Study||4
2346446|NCT01692340|5758789|P1|STARTED|Overall Study||8
2346447|NCT01692301|5758804|P2|NOT COMPLETED|Overall Study||42
2346448|NCT01692301|5758805|P1|NOT COMPLETED|Overall Study||45
2346449|NCT01692301|5758804|P2|COMPLETED|Overall Study||183
2346450|NCT01692301|5758805|P1|COMPLETED|Overall Study||184
2346451|NCT01692301|5758804|P2|STARTED|Overall Study||225
2346452|NCT01692301|5758805|P1|STARTED|Overall Study|"Started indicates patients in randomized, full analysis and safety set"|229
2346453|NCT01692275|5758837|P2|NOT COMPLETED|Overall Study||59
2346454|NCT01692275|5758838|P1|NOT COMPLETED|Overall Study||66
2346455|NCT01692275|5758837|P2|COMPLETED|Overall Study||316
2346456|NCT01692275|5758838|P1|COMPLETED|Overall Study||309
2346457|NCT01692275|5758837|P2|STARTED|Overall Study||375
2346458|NCT01692275|5758838|P1|STARTED|Overall Study||375
2346459|NCT01692197|5758898|P1|NOT COMPLETED|Overall Study||3
2346460|NCT01692197|5758898|P1|COMPLETED|Overall Study||40
2346461|NCT01692197|5758898|P1|STARTED|Overall Study||43
2346486|NCT01691885|5759079|P2|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
2346487|NCT01691885|5759080|P1|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
2346488|NCT01691885|5759079|P2|COMPLETED|Treatment Period 2 (7-14 Days)||21
2346489|NCT01691885|5759080|P1|COMPLETED|Treatment Period 2 (7-14 Days)||21
2346490|NCT01691885|5759079|P2|STARTED|Treatment Period 2 (7-14 Days)||21
2346491|NCT01691885|5759080|P1|STARTED|Treatment Period 2 (7-14 Days)||21
2346492|NCT01691885|5759079|P2|NOT COMPLETED|Washout Period (7-9 Days)||1
2346493|NCT01691885|5759080|P1|NOT COMPLETED|Washout Period (7-9 Days)||0
2346494|NCT01691885|5759079|P2|COMPLETED|Washout Period (7-9 Days)||21
2346495|NCT01691885|5759080|P1|COMPLETED|Washout Period (7-9 Days)||21
2346496|NCT01691885|5759079|P2|STARTED|Washout Period (7-9 Days)||22
2346497|NCT01691885|5759080|P1|STARTED|Washout Period (7-9 Days)||21
2346498|NCT01691885|5759079|P2|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
2346499|NCT01691885|5759080|P1|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
2346500|NCT01691885|5759079|P2|COMPLETED|Treatment Period 1(7-14 Days)||22
2346501|NCT01691885|5759080|P1|COMPLETED|Treatment Period 1(7-14 Days)||21
2346502|NCT01691885|5759079|P2|STARTED|Treatment Period 1(7-14 Days)||23
2346503|NCT01691885|5759080|P1|STARTED|Treatment Period 1(7-14 Days)||22
2346504|NCT01691859|5759086|P1|NOT COMPLETED|Overall Study||347
2346505|NCT01691859|5759086|P1|COMPLETED|Overall Study||0
2346506|NCT01691859|5759086|P1|STARTED|Overall Study||347
2346507|NCT01691833|5759108|P3|NOT COMPLETED|Overall Study||0
2346508|NCT01691833|5759109|P2|NOT COMPLETED|Overall Study||1
2346509|NCT01691833|5759110|P1|NOT COMPLETED|Overall Study||1
2346510|NCT01691833|5759108|P3|COMPLETED|Overall Study||13
2346511|NCT01691833|5759109|P2|COMPLETED|Overall Study||49
2346512|NCT01691833|5759110|P1|COMPLETED|Overall Study||49
2346513|NCT01691833|5759108|P3|STARTED|Overall Study||13
2346514|NCT01691833|5759109|P2|STARTED|Overall Study||50
2346515|NCT01691833|5759110|P1|STARTED|Overall Study||50
2346516|NCT01691820|5759133|P3|NOT COMPLETED|Overall Study||1
2346517|NCT01691820|5759134|P2|NOT COMPLETED|Overall Study||34
2346518|NCT01691820|5759135|P1|NOT COMPLETED|Overall Study||29
2346519|NCT01691820|5759133|P3|COMPLETED|Overall Study||2
2346520|NCT01691820|5759134|P2|COMPLETED|Overall Study||110
2346521|NCT01691820|5759135|P1|COMPLETED|Overall Study||187
2346522|NCT01691820|5759133|P3|STARTED|Overall Study||3
2346523|NCT01691820|5759134|P2|STARTED|Overall Study||144
2346524|NCT01691820|5759135|P1|STARTED|Overall Study||216
2346525|NCT01691794|5759173|P3|NOT COMPLETED|Overall Study||10
2346526|NCT01691794|5759174|P2|NOT COMPLETED|Overall Study||18
2346527|NCT01691794|5759175|P1|NOT COMPLETED|Overall Study||1
2346528|NCT01691794|5759173|P3|COMPLETED|Overall Study|Completed baseline to End of Study|13
2346529|NCT01691794|5759174|P2|COMPLETED|Overall Study|Completed baseline to End of Study|15
2346530|NCT01691794|5759175|P1|COMPLETED|Overall Study|Completed baseline to End of Study|2
2346531|NCT01691794|5759173|P3|STARTED|Overall Study||23
2346532|NCT01691794|5759174|P2|STARTED|Overall Study||33
2346533|NCT01691794|5759175|P1|STARTED|Overall Study||3
2346534|NCT01691781|5759191|P2|NOT COMPLETED|Overall Study||7
2346535|NCT01691781|5759192|P1|NOT COMPLETED|Overall Study||7
2346536|NCT01691781|5759191|P2|COMPLETED|Overall Study||15
2346537|NCT01691781|5759192|P1|COMPLETED|Overall Study||12
2346538|NCT01691781|5759191|P2|STARTED|Overall Study||22
2346539|NCT01691781|5759192|P1|STARTED|Overall Study||19
2346540|NCT01691768|5759204|P2|NOT COMPLETED|Overall Study||16
2346541|NCT01691768|5759205|P1|NOT COMPLETED|Overall Study||15
2346542|NCT01691768|5759204|P2|COMPLETED|Overall Study||167
2346543|NCT01691768|5759205|P1|COMPLETED|Overall Study||174
2346544|NCT01691768|5759204|P2|STARTED|Overall Study||183
2346545|NCT01691768|5759205|P1|STARTED|Overall Study||189
2346546|NCT01691690|5759229|P2|NOT COMPLETED|Overall Study||4
2346547|NCT01691690|5759230|P1|NOT COMPLETED|Overall Study||7
2346548|NCT01691690|5759229|P2|COMPLETED|Overall Study||121
2346549|NCT01691690|5759230|P1|COMPLETED|Overall Study||118
2346550|NCT01691690|5759229|P2|STARTED|Overall Study||125
2346551|NCT01691690|5759230|P1|STARTED|Overall Study||125
2346552|NCT01691612|5759240|P1|NOT COMPLETED|Overall Study||7
2346553|NCT01691612|5759240|P1|COMPLETED|Overall Study||7
2346554|NCT01691612|5759240|P1|Second Visit (Bronchoscopy)|Overall Study||7
2346555|NCT01691612|5759240|P1|First Visit (Allergen Challenge)|Overall Study||8
2346556|NCT01691612|5759240|P1|STARTED|Overall Study||14
2346557|NCT01691560|5759251|P4|NOT COMPLETED|Overall Study||0
2346558|NCT01691560|5759252|P3|NOT COMPLETED|Overall Study||0
2346559|NCT01691560|5759253|P2|NOT COMPLETED|Overall Study||0
2346560|NCT01691560|5759254|P1|NOT COMPLETED|Overall Study||0
2346561|NCT01691560|5759251|P4|COMPLETED|Overall Study||33
2346562|NCT01691560|5759252|P3|COMPLETED|Overall Study||34
2346563|NCT01691560|5759253|P2|COMPLETED|Overall Study||33
2346564|NCT01691560|5759254|P1|COMPLETED|Overall Study||34
2346565|NCT01691560|5759251|P4|STARTED|Overall Study||33
2346566|NCT01691560|5759252|P3|STARTED|Overall Study||34
2346567|NCT01691560|5759253|P2|STARTED|Overall Study||33
2346568|NCT01691560|5759254|P1|STARTED|Overall Study||34
2346569|NCT01691534|5759291|P7|NOT COMPLETED|Overall Study||1
2346570|NCT01691534|5759292|P6|NOT COMPLETED|Overall Study||1
2346571|NCT01691534|5759293|P5|NOT COMPLETED|Overall Study||0
2346572|NCT01691534|5759294|P4|NOT COMPLETED|Overall Study||1
2346573|NCT01691534|5759295|P3|NOT COMPLETED|Overall Study||1
2346574|NCT01691534|5759296|P2|NOT COMPLETED|Overall Study||1
2346575|NCT01691534|5759297|P1|NOT COMPLETED|Overall Study||0
2346576|NCT01691534|5759291|P7|COMPLETED|Overall Study||14
2346577|NCT01691534|5759292|P6|COMPLETED|Overall Study||14
2346578|NCT01691534|5759293|P5|COMPLETED|Overall Study||15
2346579|NCT01691534|5759294|P4|COMPLETED|Overall Study||14
2346580|NCT01691534|5759295|P3|COMPLETED|Overall Study||14
2346581|NCT01691534|5759296|P2|COMPLETED|Overall Study||14
2346582|NCT01691534|5759297|P1|COMPLETED|Overall Study||15
2346583|NCT01691534|5759291|P7|STARTED|Overall Study||15
2346584|NCT01691534|5759292|P6|STARTED|Overall Study||15
2346585|NCT01691534|5759293|P5|STARTED|Overall Study||15
2346586|NCT01691534|5759294|P4|STARTED|Overall Study||15
2346587|NCT01691534|5759295|P3|STARTED|Overall Study||15
2346588|NCT01691534|5759296|P2|STARTED|Overall Study||15
2346589|NCT01691534|5759297|P1|STARTED|Overall Study||15
2346590|NCT01691521|5759351|P3|NOT COMPLETED|Overall Study||9
2346591|NCT01691521|5759352|P2|NOT COMPLETED|Overall Study||16
2346592|NCT01691521|5759353|P1|NOT COMPLETED|Overall Study||12
2346593|NCT01691521|5759351|P3|COMPLETED|Overall Study||185
2346594|NCT01691521|5759352|P2|COMPLETED|Overall Study||175
2346595|NCT01691521|5759353|P1|COMPLETED|Overall Study||179
2346596|NCT01691521|5759351|P3|STARTED|Overall Study||194
2346597|NCT01691521|5759352|P2|STARTED|Overall Study||191
2346598|NCT01691521|5759353|P1|STARTED|Overall Study||191
2346599|NCT01691508|5759375|P2|NOT COMPLETED|Overall Study||3
2346600|NCT01691508|5759376|P1|NOT COMPLETED|Overall Study||4
2346601|NCT01691508|5759375|P2|COMPLETED|Overall Study||66
2346602|NCT01691508|5759376|P1|COMPLETED|Overall Study||62
2346603|NCT01691508|5759375|P2|STARTED|Overall Study||69
2346604|NCT01691508|5759376|P1|STARTED|Overall Study||66
2346605|NCT01691482|5759390|P2|NOT COMPLETED|Treatment Period 2||2
2346606|NCT01691482|5759391|P1|NOT COMPLETED|Treatment Period 2||1
2346607|NCT01691482|5759390|P2|COMPLETED|Treatment Period 2||26
2346608|NCT01691482|5759391|P1|COMPLETED|Treatment Period 2||27
2346609|NCT01691482|5759390|P2|STARTED|Treatment Period 2||28
2346610|NCT01691482|5759391|P1|STARTED|Treatment Period 2||28
2346611|NCT01691482|5759390|P2|NOT COMPLETED|Treatment Period 1||0
2346612|NCT01691482|5759391|P1|NOT COMPLETED|Treatment Period 1||0
2346613|NCT01691482|5759390|P2|COMPLETED|Treatment Period 1||28
2346614|NCT01691482|5759391|P1|COMPLETED|Treatment Period 1||28
2346615|NCT01691482|5759390|P2|STARTED|Treatment Period 1||28
2346616|NCT01691482|5759391|P1|STARTED|Treatment Period 1||28
2346617|NCT01691430|5759409|P2|NOT COMPLETED|Overall Study||20
2346618|NCT01691430|5759410|P1|NOT COMPLETED|Overall Study||22
2346619|NCT01691430|5759409|P2|COMPLETED|Overall Study||73
2346620|NCT01691430|5759410|P1|COMPLETED|Overall Study||70
2346621|NCT01691430|5759409|P2|Received Medication|Overall Study||93
2346622|NCT01691430|5759410|P1|Received Medication|Overall Study||92
2346623|NCT01691430|5759409|P2|STARTED|Overall Study||93
2346624|NCT01691430|5759410|P1|STARTED|Overall Study||92
2346625|NCT01691378|5759436|P2|NOT COMPLETED|Overall Study||2
2346626|NCT01691378|5759437|P1|NOT COMPLETED|Overall Study||7
2346627|NCT01691378|5759436|P2|COMPLETED|Overall Study||20
2346628|NCT01691378|5759437|P1|COMPLETED|Overall Study||15
2346629|NCT01691378|5759436|P2|STARTED|Overall Study||22
2346630|NCT01691378|5759437|P1|STARTED|Overall Study||22
2346631|NCT01691339|5759451|P4|NOT COMPLETED|Overall Study||0
2346632|NCT01691339|5759452|P3|NOT COMPLETED|Overall Study||0
2346633|NCT01691339|5759453|P2|NOT COMPLETED|Overall Study||0
2346634|NCT01691339|5759454|P1|NOT COMPLETED|Overall Study||0
2346635|NCT01691339|5759451|P4|COMPLETED|Overall Study||49
2346636|NCT01691339|5759452|P3|COMPLETED|Overall Study||51
2346637|NCT01691339|5759453|P2|COMPLETED|Overall Study||50
2346638|NCT01691339|5759454|P1|COMPLETED|Overall Study||50
2346639|NCT01691339|5759451|P4|STARTED|Overall Study||49
2346640|NCT01691339|5759452|P3|STARTED|Overall Study||51
2346641|NCT01691339|5759453|P2|STARTED|Overall Study||50
2346642|NCT01691339|5759454|P1|STARTED|Overall Study||50
2346643|NCT01691326|5759482|P2|NOT COMPLETED|Overall Study||0
2346644|NCT01691326|5759483|P1|NOT COMPLETED|Overall Study||0
2346645|NCT01691326|5759482|P2|COMPLETED|Overall Study||30
2346646|NCT01691326|5759483|P1|COMPLETED|Overall Study||30
2346647|NCT01691326|5759482|P2|STARTED|Overall Study||30
2346648|NCT01691326|5759483|P1|STARTED|Overall Study||30
2346649|NCT01691313|5759501|P4|NOT COMPLETED|Overall Study||0
2346650|NCT01691313|5759502|P3|NOT COMPLETED|Overall Study||0
2346651|NCT01691313|5759503|P2|NOT COMPLETED|Overall Study||0
2346652|NCT01691313|5759504|P1|NOT COMPLETED|Overall Study||0
2346653|NCT01691313|5759501|P4|COMPLETED|Overall Study||25
2346654|NCT01691313|5759502|P3|COMPLETED|Overall Study||25
2346655|NCT01691313|5759503|P2|COMPLETED|Overall Study||32
2346656|NCT01691313|5759504|P1|COMPLETED|Overall Study||22
2346657|NCT01691313|5759501|P4|STARTED|Overall Study||25
2346658|NCT01691313|5759502|P3|STARTED|Overall Study||25
2346659|NCT01691313|5759503|P2|STARTED|Overall Study||32
2346660|NCT01691313|5759504|P1|STARTED|Overall Study||22
2346661|NCT01691248|5759520|P2|NOT COMPLETED|Overall Study||114
2346662|NCT01691248|5759521|P1|NOT COMPLETED|Overall Study||111
2346663|NCT01691248|5759520|P2|COMPLETED|Overall Study||192
2346664|NCT01691248|5759521|P1|COMPLETED|Overall Study||194
2346665|NCT01691248|5759520|P2|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
2346666|NCT01691248|5759521|P1|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
2346667|NCT01691248|5759520|P2|Treated|Overall Study|Received at least 1 dose of study drug|299
2346668|NCT01691248|5759521|P1|Treated|Overall Study|Received at least 1 dose of study drug|301
2346669|NCT01691248|5759520|P2|STARTED|Overall Study|Randomized|306
2346670|NCT01691248|5759521|P1|STARTED|Overall Study|Randomized|305
2346671|NCT01691105|5759533|P2|NOT COMPLETED|12 Month Biochemical Verification||502
2346672|NCT01691105|5759534|P1|NOT COMPLETED|12 Month Biochemical Verification||424
2346673|NCT01691105|5759533|P2|COMPLETED|12 Month Biochemical Verification||65
2346674|NCT01691105|5759534|P1|COMPLETED|12 Month Biochemical Verification||53
2346675|NCT01691105|5759533|P2|STARTED|12 Month Biochemical Verification||567
2346676|NCT01691105|5759534|P1|STARTED|12 Month Biochemical Verification||477
2346677|NCT01691105|5759533|P2|NOT COMPLETED|12 Month Follow-up||101
2346678|NCT01691105|5759534|P1|NOT COMPLETED|12 Month Follow-up||72
2346679|NCT01691105|5759533|P2|COMPLETED|12 Month Follow-up||466
2346680|NCT01691105|5759534|P1|COMPLETED|12 Month Follow-up||405
2346681|NCT01691105|5759533|P2|STARTED|12 Month Follow-up||567
2346682|NCT01691105|5759534|P1|STARTED|12 Month Follow-up||477
2346683|NCT01691105|5759533|P2|NOT COMPLETED|6 Month Follow-up||71
2346684|NCT01691105|5759534|P1|NOT COMPLETED|6 Month Follow-up||52
2346685|NCT01691105|5759533|P2|COMPLETED|6 Month Follow-up||496
2346686|NCT01691105|5759534|P1|COMPLETED|6 Month Follow-up||425
2346687|NCT01691105|5759533|P2|STARTED|6 Month Follow-up||567
2346688|NCT01691105|5759534|P1|STARTED|6 Month Follow-up||477
2346689|NCT01691105|5759533|P2|NOT COMPLETED|1 Month Follow-up||41
2346690|NCT01691105|5759534|P1|NOT COMPLETED|1 Month Follow-up||43
2346691|NCT01691105|5759533|P2|COMPLETED|1 Month Follow-up||526
2346692|NCT01691105|5759534|P1|COMPLETED|1 Month Follow-up||434
2346693|NCT01691105|5759533|P2|STARTED|1 Month Follow-up||567
2346694|NCT01691105|5759534|P1|STARTED|1 Month Follow-up||477
2346695|NCT01691105|5759533|P2|NOT COMPLETED|Baseline||0
2346696|NCT01691105|5759534|P1|NOT COMPLETED|Baseline||0
2346697|NCT01691105|5759533|P2|COMPLETED|Baseline||567
2346698|NCT01691105|5759534|P1|COMPLETED|Baseline||477
2346699|NCT01691105|5759533|P2|STARTED|Baseline||567
2346700|NCT01691105|5759534|P1|STARTED|Baseline||477
2346701|NCT01691092|5759554|P1|NOT COMPLETED|Overall Study||41
2346702|NCT01691092|5759554|P1|COMPLETED|Overall Study||38
2346703|NCT01691092|5759554|P1|STARTED|Overall Study||79
2346704|NCT01691027|5759558|P1|NOT COMPLETED|Video Games Training||0
2346705|NCT01691027|5759558|P1|COMPLETED|Video Games Training|Four subjects were able to complete video games training module|4
2346706|NCT01691027|5759558|P1|STARTED|Video Games Training|Four subjects started video game training module|4
2346707|NCT01691027|5759558|P1|NOT COMPLETED|Line and Circle Tracing Training||0
2346708|NCT01691027|5759558|P1|COMPLETED|Line and Circle Tracing Training|Four subjects were able to complete line and circle tracing training module.|4
2346709|NCT01691027|5759558|P1|STARTED|Line and Circle Tracing Training|Four subjects started line and circle tracing training module|4
2346710|NCT01691027|5759558|P1|NOT COMPLETED|Scotoma Awareness||0
2346711|NCT01691027|5759558|P1|COMPLETED|Scotoma Awareness|Four subjects were able to complete scotoma awareness training module|4
2346712|NCT01691027|5759558|P1|STARTED|Scotoma Awareness|Four subjects started scotoma awareness training module|4
2346713|NCT01691014|5759567|P4|NOT COMPLETED|Overall Study||5
2346714|NCT01691014|5759568|P3|NOT COMPLETED|Overall Study||11
2346715|NCT01691014|5759569|P2|NOT COMPLETED|Overall Study||15
2346716|NCT01691014|5759570|P1|NOT COMPLETED|Overall Study||3
2346717|NCT01691014|5759567|P4|COMPLETED|Overall Study||4
2346718|NCT01691014|5759568|P3|COMPLETED|Overall Study||25
2346719|NCT01691014|5759569|P2|COMPLETED|Overall Study||11
2346720|NCT01691014|5759570|P1|COMPLETED|Overall Study||5
2346721|NCT01691014|5759567|P4|STARTED|Overall Study||9
2346722|NCT01691014|5759568|P3|STARTED|Overall Study||36
2346723|NCT01691014|5759569|P2|STARTED|Overall Study||26
2346724|NCT01691014|5759570|P1|STARTED|Overall Study||8
2346725|NCT01690988|5759615|P3|NOT COMPLETED|Overall Study||7
2346726|NCT01690988|5759616|P2|NOT COMPLETED|Overall Study||5
2346727|NCT01690988|5759617|P1|NOT COMPLETED|Overall Study||6
2346728|NCT01690988|5759615|P3|COMPLETED|Overall Study||216
2346729|NCT01690988|5759616|P2|COMPLETED|Overall Study||217
2346730|NCT01690988|5759617|P1|COMPLETED|Overall Study||221
2346731|NCT01690988|5759615|P3|STARTED|Overall Study||223
2346732|NCT01690988|5759616|P2|STARTED|Overall Study||222
2346733|NCT01690988|5759617|P1|STARTED|Overall Study||227
2346734|NCT01690923|5759642|P2|NOT COMPLETED|Overall Study||1
2346735|NCT01690923|5759643|P1|NOT COMPLETED|Overall Study||0
2346736|NCT01690923|5759642|P2|COMPLETED|Overall Study||10
2346737|NCT01690923|5759643|P1|COMPLETED|Overall Study||10
2346738|NCT01690923|5759642|P2|STARTED|Overall Study|1 participant was withdrawn and excluded due to poor fit with the pillows mask|11
2346739|NCT01690923|5759643|P1|STARTED|Overall Study||10
2346740|NCT01690663|5759652|P4|NOT COMPLETED|Overall Study||4
2346741|NCT01690663|5759653|P3|NOT COMPLETED|Overall Study||3
2346742|NCT01690663|5759654|P2|NOT COMPLETED|Overall Study||3
2346743|NCT01690663|5759655|P1|NOT COMPLETED|Overall Study||3
2346744|NCT01690663|5759652|P4|COMPLETED|Overall Study||20
2346745|NCT01690663|5759653|P3|COMPLETED|Overall Study||19
2346746|NCT01690663|5759654|P2|COMPLETED|Overall Study||17
2346747|NCT01690663|5759655|P1|COMPLETED|Overall Study||20
2346748|NCT01690663|5759652|P4|STARTED|Overall Study||24
2346749|NCT01690663|5759653|P3|STARTED|Overall Study||22
2346750|NCT01690663|5759654|P2|STARTED|Overall Study||20
2346751|NCT01690663|5759655|P1|STARTED|Overall Study||23
2346752|NCT01690546|5759669|P1|NOT COMPLETED|Overall Study||9
2346753|NCT01690546|5759669|P1|COMPLETED|Overall Study||26
2346754|NCT01690546|5759669|P1|Extended Release Injectable NTX|Overall Study||27
2346755|NCT01690546|5759669|P1|STARTED|Overall Study||35
2346756|NCT01690299|5759685|P6|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||30
2346757|NCT01690299|5759686|P5|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||33
2346758|NCT01690299|5759687|P4|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||26
2346759|NCT01690299|5759688|P3|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
2346760|NCT01690299|5759689|P2|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
2346761|NCT01690299|5759690|P1|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
2346762|NCT01690299|5759685|P6|COMPLETED|Apremilast Extension Phase (Weeks16-104)||50
2346763|NCT01690299|5759686|P5|COMPLETED|Apremilast Extension Phase (Weeks16-104)||41
2346764|NCT01690299|5759687|P4|COMPLETED|Apremilast Extension Phase (Weeks16-104)||47
2346765|NCT01690299|5759688|P3|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
2346766|NCT01690299|5759689|P2|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
2346767|NCT01690299|5759690|P1|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
2346768|NCT01690299|5759685|P6|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|79
2346769|NCT01690299|5759686|P5|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|74
2346770|NCT01690299|5759687|P4|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|73
2346771|NCT01690299|5759688|P3|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
2346772|NCT01690299|5759689|P2|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
2346773|NCT01690299|5759690|P1|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
2346774|NCT01690299|5759685|P6|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|80
2346775|NCT01690299|5759686|P5|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|74
2346776|NCT01690299|5759687|P4|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|73
2346777|NCT01690299|5759688|P3|STARTED|Apremilast Extension Phase (Weeks16-104)||0
2346778|NCT01690299|5759689|P2|STARTED|Apremilast Extension Phase (Weeks16-104)||0
2346779|NCT01690299|5759690|P1|STARTED|Apremilast Extension Phase (Weeks16-104)||0
2346780|NCT01690299|5759685|P6|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
2346781|NCT01690299|5759686|P5|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
2346782|NCT01690299|5759687|P4|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
2346783|NCT01690299|5759688|P3|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||2
2346784|NCT01690299|5759689|P2|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||6
2346785|NCT01690299|5759690|P1|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||9
2346786|NCT01690299|5759685|P6|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
2346787|NCT01690299|5759686|P5|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
2346788|NCT01690299|5759687|P4|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
2346789|NCT01690299|5759688|P3|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||81
2346790|NCT01690299|5759689|P2|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||77
2346791|NCT01690299|5759690|P1|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||75
2346792|NCT01690299|5759685|P6|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
2346793|NCT01690299|5759686|P5|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
2346794|NCT01690299|5759687|P4|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
2346795|NCT01690299|5759688|P3|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
2346796|NCT01690299|5759689|P2|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
2346797|NCT01690299|5759690|P1|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|84
2346798|NCT01690299|5759685|P6|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
2346799|NCT01690299|5759686|P5|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
2346800|NCT01690299|5759687|P4|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
2346801|NCT01690299|5759688|P3|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
2346802|NCT01690299|5759689|P2|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
2346803|NCT01690299|5759690|P1|STARTED|Placebo-controlled Phase (Weeks 0-16)||84
2346804|NCT01690273|5759735|P3|NOT COMPLETED|Overall Study||0
2346805|NCT01690273|5759736|P2|NOT COMPLETED|Overall Study||0
2346806|NCT01690273|5759737|P1|NOT COMPLETED|Overall Study||0
2346807|NCT01690273|5759735|P3|COMPLETED|Overall Study||20
2346808|NCT01690273|5759736|P2|COMPLETED|Overall Study||17
2346809|NCT01690273|5759737|P1|COMPLETED|Overall Study||18
2346810|NCT01690273|5759735|P3|STARTED|Overall Study||20
2346811|NCT01690273|5759736|P2|STARTED|Overall Study||17
2346812|NCT01690273|5759737|P1|STARTED|Overall Study||18
2346813|NCT01690143|5759787|P1|NOT COMPLETED|Overall Study||1
2346814|NCT01690143|5759787|P1|COMPLETED|Overall Study||44
2346815|NCT01690143|5759787|P1|STARTED|Overall Study||45
2346816|NCT01690130|5759797|P2|NOT COMPLETED|Overall Study||0
2346817|NCT01690130|5759798|P1|NOT COMPLETED|Overall Study||1
2346818|NCT01690130|5759797|P2|COMPLETED|Overall Study||9
2346819|NCT01690130|5759798|P1|COMPLETED|Overall Study||9
2346820|NCT01690130|5759797|P2|STARTED|Overall Study||9
2346821|NCT01690130|5759798|P1|STARTED|Overall Study||10
2346822|NCT01690117|5759808|P2|NOT COMPLETED|Overall Study||14
2346823|NCT01690117|5759809|P1|NOT COMPLETED|Overall Study||16
2346824|NCT01690117|5759808|P2|COMPLETED|Overall Study||31
2346825|NCT01690117|5759809|P1|COMPLETED|Overall Study||31
2346826|NCT01690117|5759808|P2|Post-Measurement|Overall Study||40
2346827|NCT01690117|5759809|P1|Post-Measurement|Overall Study||41
2346828|NCT01690117|5759808|P2|STARTED|Overall Study||45
2346829|NCT01690117|5759809|P1|STARTED|Overall Study||47
2346830|NCT01690052|5759845|P2|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
2346831|NCT01690052|5759846|P1|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
2346832|NCT01690052|5759845|P2|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
2346833|NCT01690052|5759846|P1|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
2346834|NCT01690052|5759845|P2|STARTED|SECOND INTERVENTION: 4 WEEKS||6
2346835|NCT01690052|5759846|P1|STARTED|SECOND INTERVENTION: 4 WEEKS||6
2346836|NCT01690052|5759845|P2|NOT COMPLETED|Washout Period of 1 Week||0
2346837|NCT01690052|5759846|P1|NOT COMPLETED|Washout Period of 1 Week||0
2346838|NCT01690052|5759845|P2|COMPLETED|Washout Period of 1 Week||6
2346839|NCT01690052|5759846|P1|COMPLETED|Washout Period of 1 Week||6
2346840|NCT01690052|5759845|P2|STARTED|Washout Period of 1 Week||6
2346841|NCT01690052|5759846|P1|STARTED|Washout Period of 1 Week||6
2346842|NCT01690052|5759845|P2|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||2
2346843|NCT01690052|5759846|P1|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||1
2346844|NCT01690052|5759845|P2|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
2346845|NCT01690052|5759846|P1|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
2346846|NCT01690052|5759845|P2|STARTED|FIRST INTERVENTION: 4 WEEKS||8
2346847|NCT01690052|5759846|P1|STARTED|FIRST INTERVENTION: 4 WEEKS||7
2346848|NCT01690000|5759854|P2|NOT COMPLETED|Overall Study||6
2346849|NCT01690000|5759855|P1|NOT COMPLETED|Overall Study||3
2346850|NCT01690000|5759854|P2|COMPLETED|Overall Study||35
2346851|NCT01690000|5759855|P1|COMPLETED|Overall Study||37
2346852|NCT01690000|5759854|P2|STARTED|Overall Study||41
2346853|NCT01690000|5759855|P1|STARTED|Overall Study||40
2346854|NCT01689974|5759863|P2|NOT COMPLETED|Overall Study||5
2346855|NCT01689974|5759864|P1|NOT COMPLETED|Overall Study||5
2346856|NCT01689974|5759863|P2|COMPLETED|Overall Study||0
2346857|NCT01689974|5759864|P1|COMPLETED|Overall Study||0
2346858|NCT01689974|5759863|P2|STARTED|Overall Study||5
2346859|NCT01689974|5759864|P1|STARTED|Overall Study||5
2346860|NCT01689909|5759872|P2|NOT COMPLETED|Overall Study||0
2346861|NCT01689909|5759873|P1|NOT COMPLETED|Overall Study||0
2346862|NCT01689909|5759872|P2|COMPLETED|Overall Study||52
2346863|NCT01689909|5759873|P1|COMPLETED|Overall Study||51
2346864|NCT01689909|5759872|P2|STARTED|Overall Study||52
2346865|NCT01689909|5759873|P1|STARTED|Overall Study||51
2346866|NCT01689857|5759895|P2|NOT COMPLETED|Overall Study||2
2346867|NCT01689857|5759896|P1|NOT COMPLETED|Overall Study||5
2346868|NCT01689857|5759895|P2|COMPLETED|Overall Study||18
2346869|NCT01689857|5759896|P1|COMPLETED|Overall Study||15
2346870|NCT01689857|5759895|P2|STARTED|Overall Study||20
2346871|NCT01689857|5759896|P1|STARTED|Overall Study||20
2346872|NCT01689779|5759904|P2|NOT COMPLETED|Overall Study||0
2346873|NCT01689779|5759905|P1|NOT COMPLETED|Overall Study||0
2346874|NCT01689779|5759904|P2|COMPLETED|Overall Study||32
2346875|NCT01689779|5759905|P1|COMPLETED|Overall Study||28
2346876|NCT01689779|5759904|P2|STARTED|Overall Study||32
2346877|NCT01689779|5759905|P1|STARTED|Overall Study||28
2346878|NCT01689701|5759923|P2|NOT COMPLETED|Overall Study||6
2346879|NCT01689701|5759924|P1|NOT COMPLETED|Overall Study||5
2346880|NCT01689701|5759923|P2|COMPLETED|Overall Study||21
2346881|NCT01689701|5759924|P1|COMPLETED|Overall Study||22
2346882|NCT01689701|5759923|P2|STARTED|Overall Study||27
2346883|NCT01689701|5759924|P1|STARTED|Overall Study||27
2346884|NCT01689649|5759944|P1|NOT COMPLETED|Overall Study||22
2346885|NCT01689649|5759944|P1|COMPLETED|Overall Study||117
2346886|NCT01689649|5759944|P1|STARTED|Overall Study||139
2346887|NCT01689532|5759956|P2|NOT COMPLETED|Overall Study||9
2346888|NCT01689532|5759957|P1|NOT COMPLETED|Overall Study||14
2346889|NCT01689532|5759956|P2|COMPLETED|Overall Study||52
2346890|NCT01689532|5759957|P1|COMPLETED|Overall Study||47
2346891|NCT01689532|5759956|P2|STARTED|Overall Study||61
2346892|NCT01689532|5759957|P1|STARTED|Overall Study||61
2346893|NCT01689519|5760021|P2|NOT COMPLETED|Overall Study||138
2346894|NCT01689519|5760022|P1|NOT COMPLETED|Overall Study||166
2346895|NCT01689519|5760021|P2|COMPLETED|Overall Study||109
2346896|NCT01689519|5760022|P1|COMPLETED|Overall Study||82
2346897|NCT01689519|5760021|P2|Received Treatment|Overall Study||246
2346898|NCT01689519|5760022|P1|Received Treatment|Overall Study||247
2346899|NCT01689519|5760021|P2|STARTED|Overall Study||247
2346900|NCT01689519|5760022|P1|STARTED|Overall Study||248
2346901|NCT01689441|5760038|P2|NOT COMPLETED|Overall Study||0
2346902|NCT01689441|5760039|P1|NOT COMPLETED|Overall Study||0
2346903|NCT01689441|5760038|P2|COMPLETED|Overall Study||31
2346904|NCT01689441|5760039|P1|COMPLETED|Overall Study||36
2346905|NCT01689441|5760038|P2|STARTED|Overall Study||31
2346906|NCT01689441|5760039|P1|STARTED|Overall Study||36
2346907|NCT01689363|5760049|P8|NOT COMPLETED|Overall Study||0
2346908|NCT01689363|5760050|P7|NOT COMPLETED|Overall Study||0
2346909|NCT01689363|5760051|P6|NOT COMPLETED|Overall Study||0
2346910|NCT01689363|5760052|P5|NOT COMPLETED|Overall Study||0
2346911|NCT01689363|5760053|P4|NOT COMPLETED|Overall Study||0
2346912|NCT01689363|5760054|P3|NOT COMPLETED|Overall Study||0
2346913|NCT01689363|5760055|P2|NOT COMPLETED|Overall Study||1
2346914|NCT01689363|5760056|P1|NOT COMPLETED|Overall Study||0
2346915|NCT01689363|5760049|P8|COMPLETED|Overall Study||32
2346916|NCT01689363|5760050|P7|COMPLETED|Overall Study||32
2346917|NCT01689363|5760051|P6|COMPLETED|Overall Study||31
2346918|NCT01689363|5760052|P5|COMPLETED|Overall Study||31
2346919|NCT01689363|5760053|P4|COMPLETED|Overall Study||31
2346920|NCT01689363|5760054|P3|COMPLETED|Overall Study||32
2346921|NCT01689363|5760055|P2|COMPLETED|Overall Study||31
2346922|NCT01689363|5760056|P1|COMPLETED|Overall Study||32
2346923|NCT01689363|5760049|P8|STARTED|Overall Study||32
2346924|NCT01689363|5760050|P7|STARTED|Overall Study||32
2346925|NCT01689363|5760051|P6|STARTED|Overall Study||31
2346926|NCT01689363|5760052|P5|STARTED|Overall Study||31
2346927|NCT01689363|5760053|P4|STARTED|Overall Study||31
2346928|NCT01689363|5760054|P3|STARTED|Overall Study||32
2346929|NCT01689363|5760055|P2|STARTED|Overall Study||32
2346930|NCT01689363|5760056|P1|STARTED|Overall Study||32
2346931|NCT01689350|5760102|P2|NOT COMPLETED|Overall Study||0
2346932|NCT01689350|5760103|P1|NOT COMPLETED|Overall Study||0
2346933|NCT01689350|5760102|P2|COMPLETED|Overall Study||45
2346934|NCT01689350|5760103|P1|COMPLETED|Overall Study||47
2346935|NCT01689350|5760102|P2|STARTED|Overall Study||45
2346936|NCT01689350|5760103|P1|STARTED|Overall Study||47
2346937|NCT01689337|5760111|P1|NOT COMPLETED|Overall Study||1
2346938|NCT01689337|5760111|P1|COMPLETED|Overall Study||0
2346939|NCT01689337|5760111|P1|STARTED|Overall Study||1
2346940|NCT01689324|5760126|P1|NOT COMPLETED|Overall Study||0
2346941|NCT01689324|5760126|P1|COMPLETED|Overall Study||43
2346942|NCT01689324|5760126|P1|STARTED|Overall Study||43
2346943|NCT01689207|5760150|P11|NOT COMPLETED|Overall Study||0
2346944|NCT01689207|5760151|P10|NOT COMPLETED|Overall Study||0
2346945|NCT01689207|5760152|P9|NOT COMPLETED|Overall Study||1
2346946|NCT01689207|5760153|P8|NOT COMPLETED|Overall Study||0
2346947|NCT01689207|5760154|P7|NOT COMPLETED|Overall Study||0
2346948|NCT01689207|5760155|P6|NOT COMPLETED|Overall Study||1
2346949|NCT01689207|5760156|P5|NOT COMPLETED|Overall Study||2
2346950|NCT01689207|5760157|P4|NOT COMPLETED|Overall Study||0
2346951|NCT01689207|5760158|P3|NOT COMPLETED|Overall Study||0
2346952|NCT01689207|5760159|P2|NOT COMPLETED|Overall Study||1
2346953|NCT01689207|5760160|P1|NOT COMPLETED|Overall Study||0
2346954|NCT01689207|5760150|P11|COMPLETED|Overall Study|Subjects completed study|8
2346955|NCT01689207|5760151|P10|COMPLETED|Overall Study|Subjects completed study|10
2346956|NCT01689207|5760152|P9|COMPLETED|Overall Study|Subjects completed study|5
2346957|NCT01689207|5760153|P8|COMPLETED|Overall Study|Subjects completed study|10
2346958|NCT01689207|5760154|P7|COMPLETED|Overall Study|Subjects completed study|10
2346959|NCT01689207|5760155|P6|COMPLETED|Overall Study|Subjects completed study|7
2346960|NCT01689207|5760156|P5|COMPLETED|Overall Study|Subjects completed study|2
2346961|NCT01689207|5760157|P4|COMPLETED|Overall Study|Subjects completed study|8
2346962|NCT01689207|5760158|P3|COMPLETED|Overall Study|Subjects completed study|16
2346963|NCT01689207|5760159|P2|COMPLETED|Overall Study|Subjects completed study|7
2346964|NCT01689207|5760160|P1|COMPLETED|Overall Study|Subjects completed study|4
2346965|NCT01689207|5760150|P11|STARTED|Overall Study|Subjects randomised|8
2346966|NCT01689207|5760151|P10|STARTED|Overall Study|Subjects randomised|10
2346967|NCT01689207|5760152|P9|STARTED|Overall Study|Subjects randomised|6
2346968|NCT01689207|5760153|P8|STARTED|Overall Study|Subjects randomised|10
2346969|NCT01689207|5760154|P7|STARTED|Overall Study|Subjects randomised|10
2346970|NCT01689207|5760155|P6|STARTED|Overall Study|Subjects randomised|8
2346971|NCT01689207|5760156|P5|STARTED|Overall Study|Subjects randomised|4
2346972|NCT01689207|5760157|P4|STARTED|Overall Study|Subjects randomised|8
2346973|NCT01689207|5760158|P3|STARTED|Overall Study|Subjects randomised|16
2346974|NCT01689207|5760159|P2|STARTED|Overall Study|Subjects randomised|8
2346975|NCT01689207|5760160|P1|STARTED|Overall Study|Subjects randomised|4
2346976|NCT01689155|5760256|P1|NOT COMPLETED|Overall Study||0
2346977|NCT01689155|5760256|P1|COMPLETED|Overall Study||116
2346978|NCT01689155|5760256|P1|STARTED|Overall Study||116
2346979|NCT01688973|5760267|P2|NOT COMPLETED|Overall Study||3
2346980|NCT01688973|5760268|P1|NOT COMPLETED|Overall Study||2
2346981|NCT01688973|5760267|P2|COMPLETED|Overall Study||25
2346982|NCT01688973|5760268|P1|COMPLETED|Overall Study||25
2346983|NCT01688973|5760267|P2|Eligible/Evaluable Patients|Overall Study||25
2346984|NCT01688973|5760268|P1|Eligible/Evaluable Patients|Overall Study||25
2346985|NCT01688973|5760267|P2|STARTED|Overall Study||28
2346986|NCT01688973|5760268|P1|STARTED|Overall Study||27
2346987|NCT01688921|5760282|P2|NOT COMPLETED|Overall Study||15
2346988|NCT01688921|5760283|P1|NOT COMPLETED|Overall Study||16
2346989|NCT01688921|5760282|P2|COMPLETED|Overall Study||608
2346990|NCT01688921|5760283|P1|COMPLETED|Overall Study||611
2346991|NCT01688921|5760282|P2|STARTED|Overall Study||623
2346992|NCT01688921|5760283|P1|STARTED|Overall Study||627
2346993|NCT01688882|5760308|P2|NOT COMPLETED|Overall Study||1
2346994|NCT01688882|5760309|P1|NOT COMPLETED|Overall Study||3
2346995|NCT01688882|5760308|P2|COMPLETED|Overall Study|The one patient that discontinued was already switched to open-label QGE031 treatment.|6
2346996|NCT01688882|5760309|P1|COMPLETED|Overall Study||10
2346997|NCT01688882|5760308|P2|Safety Follow-up|Overall Study||5
2346998|NCT01688882|5760309|P1|Safety Follow-up|Overall Study||11
2346999|NCT01688882|5760308|P2|STARTED|Overall Study|4 patients who completed 12 weeks of placebo changed to open-label QGE031 treatment.|7
2347000|NCT01688882|5760309|P1|STARTED|Overall Study||13
2347001|NCT01688856|5760326|P3|NOT COMPLETED|Overall Study||3
2347002|NCT01688856|5760327|P2|NOT COMPLETED|Overall Study||4
2347003|NCT01688856|5760328|P1|NOT COMPLETED|Overall Study||7
2347004|NCT01688856|5760326|P3|COMPLETED|Overall Study||8
2347005|NCT01688856|5760327|P2|COMPLETED|Overall Study||24
2347006|NCT01688856|5760328|P1|COMPLETED|Overall Study||21
2347007|NCT01688856|5760326|P3|STARTED|Overall Study||11
2347008|NCT01688856|5760327|P2|STARTED|Overall Study||28
2347009|NCT01688856|5760328|P1|STARTED|Overall Study||28
2347010|NCT01688843|5760348|P1|NOT COMPLETED|Overall Study||0
2347011|NCT01688843|5760348|P1|COMPLETED|Overall Study||1060
2347012|NCT01688843|5760348|P1|STARTED|Overall Study||1060
2347013|NCT01688830|5760379|P21|NOT COMPLETED|Overall Study||0
2347014|NCT01688830|5760380|P20|NOT COMPLETED|Overall Study||0
2347015|NCT01688830|5760381|P19|NOT COMPLETED|Overall Study||0
2347016|NCT01688830|5760382|P18|NOT COMPLETED|Overall Study||0
2347017|NCT01688830|5760383|P17|NOT COMPLETED|Overall Study||0
2347018|NCT01688830|5760384|P16|NOT COMPLETED|Overall Study||0
2347019|NCT01688830|5760385|P15|NOT COMPLETED|Overall Study||0
2347020|NCT01688830|5760386|P14|NOT COMPLETED|Overall Study||0
2347021|NCT01688830|5760387|P13|NOT COMPLETED|Overall Study||0
2347022|NCT01688830|5760388|P12|NOT COMPLETED|Overall Study||0
2347023|NCT01688830|5760389|P11|NOT COMPLETED|Overall Study||1
2347024|NCT01688830|5760390|P10|NOT COMPLETED|Overall Study||0
2347025|NCT01688830|5760391|P9|NOT COMPLETED|Overall Study||0
2347026|NCT01688830|5760392|P8|NOT COMPLETED|Overall Study||0
2347027|NCT01688830|5760393|P7|NOT COMPLETED|Overall Study||0
2347028|NCT01688830|5760394|P6|NOT COMPLETED|Overall Study||0
2347029|NCT01688830|5760395|P5|NOT COMPLETED|Overall Study||0
2347030|NCT01688830|5760396|P4|NOT COMPLETED|Overall Study||0
2347031|NCT01688830|5760397|P3|NOT COMPLETED|Overall Study||0
2347032|NCT01688830|5760398|P2|NOT COMPLETED|Overall Study||0
2347033|NCT01688830|5760399|P1|NOT COMPLETED|Overall Study||0
2347034|NCT01688830|5760379|P21|COMPLETED|Overall Study||9
2347035|NCT01688830|5760380|P20|COMPLETED|Overall Study||3
2347036|NCT01688830|5760381|P19|COMPLETED|Overall Study||8
2347037|NCT01688830|5760382|P18|COMPLETED|Overall Study||9
2347038|NCT01688830|5760383|P17|COMPLETED|Overall Study||9
2347039|NCT01688830|5760384|P16|COMPLETED|Overall Study||9
2347040|NCT01688830|5760385|P15|COMPLETED|Overall Study||6
2347041|NCT01688830|5760386|P14|COMPLETED|Overall Study||6
2347042|NCT01688830|5760387|P13|COMPLETED|Overall Study||6
2347043|NCT01688830|5760388|P12|COMPLETED|Overall Study||6
2347044|NCT01688830|5760389|P11|COMPLETED|Overall Study||5
2347045|NCT01688830|5760390|P10|COMPLETED|Overall Study||6
2347046|NCT01688830|5760391|P9|COMPLETED|Overall Study||6
2347047|NCT01688830|5760392|P8|COMPLETED|Overall Study||6
2347048|NCT01688830|5760393|P7|COMPLETED|Overall Study||12
2347049|NCT01688830|5760394|P6|COMPLETED|Overall Study||6
2347050|NCT01688830|5760395|P5|COMPLETED|Overall Study||5
2347051|NCT01688830|5760396|P4|COMPLETED|Overall Study||6
2347052|NCT01688830|5760397|P3|COMPLETED|Overall Study||6
2347053|NCT01688830|5760398|P2|COMPLETED|Overall Study||6
2347054|NCT01688830|5760399|P1|COMPLETED|Overall Study||21
2347055|NCT01688830|5760379|P21|STARTED|Overall Study||9
2347056|NCT01688830|5760380|P20|STARTED|Overall Study||3
2347057|NCT01688830|5760381|P19|STARTED|Overall Study||8
2347058|NCT01688830|5760382|P18|STARTED|Overall Study||9
2347059|NCT01688830|5760383|P17|STARTED|Overall Study||9
2347060|NCT01688830|5760384|P16|STARTED|Overall Study||9
2347061|NCT01688830|5760385|P15|STARTED|Overall Study||6
2347062|NCT01688830|5760386|P14|STARTED|Overall Study||6
2347063|NCT01688830|5760387|P13|STARTED|Overall Study||6
2347064|NCT01688830|5760388|P12|STARTED|Overall Study||6
2347065|NCT01688830|5760389|P11|STARTED|Overall Study||6
2347066|NCT01688830|5760390|P10|STARTED|Overall Study||6
2347067|NCT01688830|5760391|P9|STARTED|Overall Study||6
2347068|NCT01688830|5760392|P8|STARTED|Overall Study||6
2347069|NCT01688830|5760393|P7|STARTED|Overall Study||12
2347070|NCT01688830|5760394|P6|STARTED|Overall Study||6
2347071|NCT01688830|5760395|P5|STARTED|Overall Study||5
2347072|NCT01688830|5760396|P4|STARTED|Overall Study||6
2347073|NCT01688830|5760397|P3|STARTED|Overall Study||6
2347074|NCT01688830|5760398|P2|STARTED|Overall Study||6
2347075|NCT01688830|5760399|P1|STARTED|Overall Study||21
2347076|NCT01688739|5760553|P10|NOT COMPLETED|Overall Study||0
2347077|NCT01688739|5760554|P9|NOT COMPLETED|Overall Study||0
2347078|NCT01688739|5760555|P8|NOT COMPLETED|Overall Study||0
2347079|NCT01688739|5760556|P7|NOT COMPLETED|Overall Study||0
2347080|NCT01688739|5760557|P6|NOT COMPLETED|Overall Study||0
2347081|NCT01688739|5760558|P5|NOT COMPLETED|Overall Study||0
2347082|NCT01688739|5760559|P4|NOT COMPLETED|Overall Study||0
2347083|NCT01688739|5760560|P3|NOT COMPLETED|Overall Study||0
2347084|NCT01688739|5760561|P2|NOT COMPLETED|Overall Study||0
2347085|NCT01688739|5760562|P1|NOT COMPLETED|Overall Study||1
2347086|NCT01688739|5760553|P10|COMPLETED|Overall Study||6
2347087|NCT01688739|5760554|P9|COMPLETED|Overall Study||6
2347088|NCT01688739|5760555|P8|COMPLETED|Overall Study||6
2347089|NCT01688739|5760556|P7|COMPLETED|Overall Study||6
2347090|NCT01688739|5760557|P6|COMPLETED|Overall Study||6
2347091|NCT01688739|5760558|P5|COMPLETED|Overall Study||6
2347092|NCT01688739|5760559|P4|COMPLETED|Overall Study||6
2347093|NCT01688739|5760560|P3|COMPLETED|Overall Study||3
2347094|NCT01688739|5760561|P2|COMPLETED|Overall Study||3
2347095|NCT01688739|5760562|P1|COMPLETED|Overall Study||12
2347096|NCT01688739|5760553|P10|Received Study Drug|Overall Study||6
2347097|NCT01688739|5760554|P9|Received Study Drug|Overall Study||6
2347098|NCT01688739|5760555|P8|Received Study Drug|Overall Study||6
2347099|NCT01688739|5760556|P7|Received Study Drug|Overall Study||6
2347100|NCT01688739|5760557|P6|Received Study Drug|Overall Study||6
2347101|NCT01688739|5760558|P5|Received Study Drug|Overall Study||6
2347102|NCT01688739|5760559|P4|Received Study Drug|Overall Study||6
2347103|NCT01688739|5760560|P3|Received Study Drug|Overall Study||3
2347104|NCT01688739|5760561|P2|Received Study Drug|Overall Study||3
2347105|NCT01688739|5760562|P1|Received Study Drug|Overall Study||12
2347106|NCT01688739|5760553|P10|STARTED|Overall Study||6
2347107|NCT01688739|5760554|P9|STARTED|Overall Study||6
2347108|NCT01688739|5760555|P8|STARTED|Overall Study||6
2347109|NCT01688739|5760556|P7|STARTED|Overall Study||6
2347110|NCT01688739|5760557|P6|STARTED|Overall Study||6
2347111|NCT01688739|5760558|P5|STARTED|Overall Study||6
2347112|NCT01688739|5760559|P4|STARTED|Overall Study||6
2347113|NCT01688739|5760560|P3|STARTED|Overall Study||3
2347114|NCT01688739|5760561|P2|STARTED|Overall Study||3
2347115|NCT01688739|5760562|P1|STARTED|Overall Study||13
2347116|NCT01688726|5760638|P2|NOT COMPLETED|Overall Study||1
2347117|NCT01688726|5760639|P1|NOT COMPLETED|Overall Study||1
2347118|NCT01688726|5760638|P2|COMPLETED|Overall Study||44
2347119|NCT01688726|5760639|P1|COMPLETED|Overall Study||45
2347120|NCT01688726|5760638|P2|STARTED|Overall Study||45
2347121|NCT01688726|5760639|P1|STARTED|Overall Study||46
2347122|NCT01688635|5760651|P2|NOT COMPLETED|Period 4||0
2347123|NCT01688635|5760652|P1|NOT COMPLETED|Period 4||0
2347124|NCT01688635|5760651|P2|COMPLETED|Period 4||42
2347125|NCT01688635|5760652|P1|COMPLETED|Period 4||40
2347126|NCT01688635|5760651|P2|STARTED|Period 4||42
2347127|NCT01688635|5760652|P1|STARTED|Period 4||40
2347128|NCT01688635|5760651|P2|NOT COMPLETED|Washout 3||0
2347129|NCT01688635|5760652|P1|NOT COMPLETED|Washout 3||1
2347130|NCT01688635|5760651|P2|COMPLETED|Washout 3||42
2347131|NCT01688635|5760652|P1|COMPLETED|Washout 3||40
2347132|NCT01688635|5760651|P2|STARTED|Washout 3||42
2347133|NCT01688635|5760652|P1|STARTED|Washout 3||41
2347134|NCT01688635|5760651|P2|NOT COMPLETED|Period 3||0
2347135|NCT01688635|5760652|P1|NOT COMPLETED|Period 3||0
2347136|NCT01688635|5760651|P2|COMPLETED|Period 3||42
2347137|NCT01688635|5760652|P1|COMPLETED|Period 3||41
2347138|NCT01688635|5760651|P2|STARTED|Period 3||42
2347139|NCT01688635|5760652|P1|STARTED|Period 3||41
2347140|NCT01688635|5760651|P2|NOT COMPLETED|Washout 2||2
2347141|NCT01688635|5760652|P1|NOT COMPLETED|Washout 2||3
2347142|NCT01688635|5760651|P2|COMPLETED|Washout 2||42
2347143|NCT01688635|5760652|P1|COMPLETED|Washout 2||41
2347144|NCT01688635|5760651|P2|STARTED|Washout 2||44
2347145|NCT01688635|5760652|P1|STARTED|Washout 2||44
2347146|NCT01688635|5760651|P2|NOT COMPLETED|Period 2||0
2347147|NCT01688635|5760652|P1|NOT COMPLETED|Period 2||0
2347148|NCT01688635|5760651|P2|COMPLETED|Period 2||44
2347149|NCT01688635|5760652|P1|COMPLETED|Period 2||44
2347150|NCT01688635|5760651|P2|STARTED|Period 2||44
2347151|NCT01688635|5760652|P1|STARTED|Period 2||44
2347152|NCT01688635|5760651|P2|NOT COMPLETED|Washout 1||2
2347153|NCT01688635|5760652|P1|NOT COMPLETED|Washout 1||1
2347154|NCT01688635|5760651|P2|COMPLETED|Washout 1||44
2347155|NCT01688635|5760652|P1|COMPLETED|Washout 1||44
2347156|NCT01688635|5760651|P2|STARTED|Washout 1||46
2347157|NCT01688635|5760652|P1|STARTED|Washout 1||45
2347158|NCT01688635|5760651|P2|NOT COMPLETED|Period 1||0
2347159|NCT01688635|5760652|P1|NOT COMPLETED|Period 1||0
2347160|NCT01688635|5760651|P2|COMPLETED|Period 1||46
2347161|NCT01688635|5760652|P1|COMPLETED|Period 1||45
2347162|NCT01688635|5760651|P2|Received at Least 1 Dose of Study Drug|Period 1||46
2347163|NCT01688635|5760652|P1|Received at Least 1 Dose of Study Drug|Period 1||45
2347164|NCT01688635|5760651|P2|STARTED|Period 1||46
2347165|NCT01688635|5760652|P1|STARTED|Period 1||45
2347166|NCT01688609|5760664|P1|NOT COMPLETED|Overall Study||0
2347167|NCT01688609|5760664|P1|COMPLETED|Overall Study||18
2347168|NCT01688609|5760664|P1|STARTED|Overall Study||18
2347169|NCT01688596|5760674|P2|NOT COMPLETED|Overall Study||9
2347170|NCT01688596|5760675|P1|NOT COMPLETED|Overall Study||8
2347171|NCT01688596|5760674|P2|COMPLETED|Overall Study||59
2347172|NCT01688596|5760675|P1|COMPLETED|Overall Study||59
2347173|NCT01688596|5760674|P2|STARTED|Overall Study||68
2347174|NCT01688596|5760675|P1|STARTED|Overall Study||67
2347175|NCT01688466|5760699|P2|NOT COMPLETED|Overall Study||7
2347176|NCT01688466|5760700|P1|NOT COMPLETED|Overall Study||2
2347177|NCT01688466|5760699|P2|COMPLETED|Overall Study||10
2347178|NCT01688466|5760700|P1|COMPLETED|Overall Study||15
2347179|NCT01688466|5760699|P2|STARTED|Overall Study||17
2347180|NCT01688466|5760700|P1|STARTED|Overall Study||17
2347181|NCT01688336|5760708|P1|NOT COMPLETED|Overall Study||0
2347182|NCT01688336|5760708|P1|COMPLETED|Overall Study||9
2347183|NCT01688336|5760708|P1|STARTED|Overall Study||9
2347184|NCT01688310|5760720|P2|NOT COMPLETED|Overall Study||0
2347185|NCT01688310|5760721|P1|NOT COMPLETED|Overall Study||0
2347186|NCT01688310|5760720|P2|COMPLETED|Overall Study||100
2347187|NCT01688310|5760721|P1|COMPLETED|Overall Study||100
2347188|NCT01688310|5760720|P2|STARTED|Overall Study||100
2347189|NCT01688310|5760721|P1|STARTED|Overall Study||100
2347190|NCT01688102|5760741|P2|NOT COMPLETED|Overall Study||18
2347191|NCT01688102|5760742|P1|NOT COMPLETED|Overall Study||16
2347192|NCT01688102|5760741|P2|COMPLETED|Overall Study||40
2347193|NCT01688102|5760742|P1|COMPLETED|Overall Study||44
2347194|NCT01688102|5760741|P2|STARTED|Overall Study||58
2347195|NCT01688102|5760742|P1|STARTED|Overall Study||60
2347196|NCT01688050|5760770|P1|NOT COMPLETED|Overall Study||50
2347197|NCT01688050|5760770|P1|COMPLETED|Overall Study||0
2347198|NCT01688050|5760770|P1|30 Days|Overall Study||50
2347199|NCT01688050|5760770|P1|STARTED|Overall Study||50
2347200|NCT01688037|5760779|P3|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0
2347201|NCT01688037|5760780|P2|NOT COMPLETED|Follow-up Period (Week 12 to 16)||1
2347202|NCT01688037|5760781|P1|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0
2347203|NCT01688037|5760779|P3|COMPLETED|Follow-up Period (Week 12 to 16)||17
2347204|NCT01688037|5760780|P2|COMPLETED|Follow-up Period (Week 12 to 16)||21
2347205|NCT01688037|5760781|P1|COMPLETED|Follow-up Period (Week 12 to 16)||42
2347206|NCT01688037|5760779|P3|STARTED|Follow-up Period (Week 12 to 16)||17
2347207|NCT01688037|5760780|P2|STARTED|Follow-up Period (Week 12 to 16)||22
2347208|NCT01688037|5760781|P1|STARTED|Follow-up Period (Week 12 to 16)||42
2347209|NCT01688037|5760779|P3|NOT COMPLETED|Open-Label Period (Week 6 to 12)||4
2347210|NCT01688037|5760780|P2|NOT COMPLETED|Open-Label Period (Week 6 to 12)||3
2347211|NCT01688037|5760781|P1|NOT COMPLETED|Open-Label Period (Week 6 to 12)||5
2347212|NCT01688037|5760779|P3|COMPLETED|Open-Label Period (Week 6 to 12)||17
2347213|NCT01688037|5760780|P2|COMPLETED|Open-Label Period (Week 6 to 12)||22
2347214|NCT01688037|5760781|P1|COMPLETED|Open-Label Period (Week 6 to 12)||42
2347215|NCT01688037|5760779|P3|STARTED|Open-Label Period (Week 6 to 12)||21
2347216|NCT01688037|5760780|P2|STARTED|Open-Label Period (Week 6 to 12)||25
2347217|NCT01688037|5760781|P1|STARTED|Open-Label Period (Week 6 to 12)||47
2347218|NCT01688037|5760779|P3|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||6
2347219|NCT01688037|5760780|P2|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||3
2347220|NCT01688037|5760781|P1|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
2347221|NCT01688037|5760779|P3|COMPLETED|Double-Blind Period (Week 0 to 6)||21
2347222|NCT01688037|5760780|P2|COMPLETED|Double-Blind Period (Week 0 to 6)||25
2347223|NCT01688037|5760781|P1|COMPLETED|Double-Blind Period (Week 0 to 6)||47
2347224|NCT01688037|5760779|P3|STARTED|Double-Blind Period (Week 0 to 6)||27
2347225|NCT01688037|5760780|P2|STARTED|Double-Blind Period (Week 0 to 6)||28
2347226|NCT01688037|5760781|P1|STARTED|Double-Blind Period (Week 0 to 6)||54
2347227|NCT01687998|5760797|P2|NOT COMPLETED|Overall Study||120
2347228|NCT01687998|5760798|P1|NOT COMPLETED|Overall Study||112
2347229|NCT01687998|5760797|P2|COMPLETED|Overall Study||5934
2347230|NCT01687998|5760798|P1|COMPLETED|Overall Study||5926
2347231|NCT01687998|5760797|P2|Received at Least One Dose of Study Drug|Overall Study||6052
2347232|NCT01687998|5760798|P1|Received at Least One Dose of Study Drug|Overall Study||6036
2347233|NCT01687998|5760797|P2|STARTED|Overall Study||6054
2347234|NCT01687998|5760798|P1|STARTED|Overall Study||6038
2347235|NCT01687972|5760816|P2|NOT COMPLETED|Overall Study||0
2347236|NCT01687972|5760817|P1|NOT COMPLETED|Overall Study||0
2347237|NCT01687972|5760816|P2|COMPLETED|Overall Study||44
2347238|NCT01687972|5760817|P1|COMPLETED|Overall Study||44
2347239|NCT01687972|5760816|P2|STARTED|Overall Study||44
2347240|NCT01687972|5760817|P1|STARTED|Overall Study||44
2347241|NCT01687790|5760827|P1|NOT COMPLETED|Overall Study||0
2347242|NCT01687790|5760827|P1|COMPLETED|Overall Study||60
2347243|NCT01687790|5760827|P1|STARTED|Overall Study||60
2347244|NCT01687712|5760834|P2|NOT COMPLETED|Cycle 3||24
2347245|NCT01687712|5760835|P1|NOT COMPLETED|Cycle 3||24
2347246|NCT01687712|5760834|P2|COMPLETED|Cycle 3||0
2347247|NCT01687712|5760835|P1|COMPLETED|Cycle 3||4
2347248|NCT01687712|5760834|P2|Clinical Pregnancy|Cycle 3||0
2347249|NCT01687712|5760835|P1|Clinical Pregnancy|Cycle 3||5
2347250|NCT01687712|5760834|P2|Biochemically Pregnant|Cycle 3||2
2347251|NCT01687712|5760835|P1|Biochemically Pregnant|Cycle 3||7
2347252|NCT01687712|5760834|P2|Embryo Transfer|Cycle 3||24
2347253|NCT01687712|5760835|P1|Embryo Transfer|Cycle 3||26
2347254|NCT01687712|5760834|P2|Fertilization Performed|Cycle 3||24
2347255|NCT01687712|5760835|P1|Fertilization Performed|Cycle 3||27
2347256|NCT01687712|5760834|P2|Ooctye/Ovum Pick-Up|Cycle 3||24
2347257|NCT01687712|5760835|P1|Ooctye/Ovum Pick-Up|Cycle 3||27
2347258|NCT01687712|5760834|P2|Received hCG|Cycle 3||24
2347259|NCT01687712|5760835|P1|Received hCG|Cycle 3||27
2347260|NCT01687712|5760834|P2|STARTED|Cycle 3||24
2347261|NCT01687712|5760835|P1|STARTED|Cycle 3||28
2347262|NCT01687712|5760834|P2|NOT COMPLETED|Cycle 2||95
2347263|NCT01687712|5760835|P1|NOT COMPLETED|Cycle 2||93
2347264|NCT01687712|5760834|P2|COMPLETED|Cycle 2||25
2347265|NCT01687712|5760835|P1|COMPLETED|Cycle 2||16
2347266|NCT01687712|5760834|P2|Clinical Pregnancy|Cycle 2||26
2347267|NCT01687712|5760835|P1|Clinical Pregnancy|Cycle 2||17
2347268|NCT01687712|5760834|P2|Biochemical Pregnancy|Cycle 2||43
2347269|NCT01687712|5760835|P1|Biochemical Pregnancy|Cycle 2||35
2347270|NCT01687712|5760834|P2|Embryo Transfer|Cycle 2||117
2347271|NCT01687712|5760835|P1|Embryo Transfer|Cycle 2||101
2347272|NCT01687712|5760834|P2|Fertilization Performed|Cycle 2||119
2347273|NCT01687712|5760835|P1|Fertilization Performed|Cycle 2||106
2347274|NCT01687712|5760834|P2|Oocyte/Ovum Pick Up|Cycle 2||119
2347275|NCT01687712|5760835|P1|Oocyte/Ovum Pick Up|Cycle 2||107
2347276|NCT01687712|5760834|P2|Received hCG|Cycle 2||119
2347277|NCT01687712|5760835|P1|Received hCG|Cycle 2||107
2347278|NCT01687712|5760834|P2|STARTED|Cycle 2||120
2347279|NCT01687712|5760835|P1|STARTED|Cycle 2||109
2347280|NCT01687712|5760834|P2|NOT COMPLETED|Cycle 1||429
2347281|NCT01687712|5760835|P1|NOT COMPLETED|Cycle 1||448
2347282|NCT01687712|5760834|P2|COMPLETED|Cycle 1||122
2347283|NCT01687712|5760835|P1|COMPLETED|Cycle 1||101
2347284|NCT01687712|5760834|P2|Clinical Pregnancy|Cycle 1||138
2347285|NCT01687712|5760835|P1|Clinical Pregnancy|Cycle 1||114
2347286|NCT01687712|5760834|P2|Biochemical Pregnancy|Cycle 1||203
2347287|NCT01687712|5760835|P1|Biochemical Pregnancy|Cycle 1||163
2347288|NCT01687712|5760834|P2|Embryo Transfer|Cycle 1||483
2347289|NCT01687712|5760835|P1|Embryo Transfer|Cycle 1||466
2347290|NCT01687712|5760834|P2|Fertilization Performed|Cycle 1||512
2347291|NCT01687712|5760835|P1|Fertilization Performed|Cycle 1||508
2347292|NCT01687712|5760834|P2|Oocyte/Ovum Pick Up|Cycle 1||517
2347293|NCT01687712|5760835|P1|Oocyte/Ovum Pick Up|Cycle 1||513
2347294|NCT01687712|5760834|P2|Received hCG|Cycle 1||520
2347295|NCT01687712|5760835|P1|Received hCG|Cycle 1||516
2347296|NCT01687712|5760834|P2|STARTED|Cycle 1||551
2347297|NCT01687712|5760835|P1|STARTED|Cycle 1||549
2347298|NCT01687478|5760875|P2|NOT COMPLETED|Overall Study||39
2347299|NCT01687478|5760876|P1|NOT COMPLETED|Overall Study||32
2347300|NCT01687478|5760875|P2|COMPLETED|Overall Study||49
2347301|NCT01687478|5760876|P1|COMPLETED|Overall Study||56
2347302|NCT01687478|5760875|P2|Safety Analysis Set|Overall Study||87
2347303|NCT01687478|5760876|P1|Safety Analysis Set|Overall Study||88
2347304|NCT01687478|5760875|P2|STARTED|Overall Study||88
2347305|NCT01687478|5760876|P1|STARTED|Overall Study||88
2347306|NCT01687400|5760898|P1|NOT COMPLETED|Overall Study||0
2347307|NCT01687400|5760898|P1|COMPLETED|Overall Study||114
2347308|NCT01687400|5760898|P1|STARTED|Overall Study||114
2347309|NCT01687387|5760912|P3|NOT COMPLETED|Overall Study||38
2347310|NCT01687387|5760913|P2|NOT COMPLETED|Overall Study||38
2347311|NCT01687387|5760914|P1|NOT COMPLETED|Overall Study||41
2347312|NCT01687387|5760912|P3|COMPLETED|Overall Study||13
2347313|NCT01687387|5760913|P2|COMPLETED|Overall Study||12
2347314|NCT01687387|5760914|P1|COMPLETED|Overall Study||10
2347315|NCT01687387|5760912|P3|STARTED|Overall Study||51
2347316|NCT01687387|5760913|P2|STARTED|Overall Study||50
2347317|NCT01687387|5760914|P1|STARTED|Overall Study||51
2347318|NCT01687296|5760927|P2|NOT COMPLETED|Overall Study||5
2347319|NCT01687296|5760928|P1|NOT COMPLETED|Overall Study||7
2347320|NCT01687296|5760927|P2|COMPLETED|Overall Study||123
2347321|NCT01687296|5760928|P1|COMPLETED|Overall Study||116
2347322|NCT01687296|5760927|P2|STARTED|Overall Study||128
2347323|NCT01687296|5760928|P1|STARTED|Overall Study||123
2347324|NCT01687283|5760950|P2|NOT COMPLETED|Overall Study||27
2347325|NCT01687283|5760951|P1|NOT COMPLETED|Overall Study||35
2347326|NCT01687283|5760950|P2|COMPLETED|Overall Study||130
2347327|NCT01687283|5760951|P1|COMPLETED|Overall Study||123
2347328|NCT01687283|5760950|P2|STARTED|Overall Study||157
2347329|NCT01687283|5760951|P1|STARTED|Overall Study||158
2347330|NCT01687270|5760974|P1|NOT COMPLETED|Overall Study||12
2347331|NCT01687270|5760974|P1|COMPLETED|Overall Study||28
2347332|NCT01687270|5760974|P1|STARTED|Overall Study||40
2347333|NCT01687257|5760985|P3|NOT COMPLETED|Overall Study||6
2347334|NCT01687257|5760986|P2|NOT COMPLETED|Overall Study||4
2347335|NCT01687257|5760987|P1|NOT COMPLETED|Overall Study||8
2347336|NCT01687257|5760985|P3|COMPLETED|Overall Study||15
2347337|NCT01687257|5760986|P2|COMPLETED|Overall Study||0
2347338|NCT01687257|5760987|P1|COMPLETED|Overall Study||17
2347339|NCT01687257|5760985|P3|STARTED|Overall Study||21
2347340|NCT01687257|5760986|P2|STARTED|Overall Study||4
2347341|NCT01687257|5760987|P1|STARTED|Overall Study||25
2347342|NCT01687244|5761015|P2|NOT COMPLETED|Overall Study||0
2347343|NCT01687244|5761016|P1|NOT COMPLETED|Overall Study||0
2347344|NCT01687244|5761015|P2|COMPLETED|Overall Study||19
2347345|NCT01687244|5761016|P1|COMPLETED|Overall Study||21
2347346|NCT01687244|5761015|P2|STARTED|Overall Study||19
2347347|NCT01687244|5761016|P1|STARTED|Overall Study||21
2347348|NCT01687218|5761052|P6|NOT COMPLETED|Overall Study||0
2347349|NCT01687218|5761053|P5|NOT COMPLETED|Overall Study||1
2347350|NCT01687218|5761054|P4|NOT COMPLETED|Overall Study||2
2347351|NCT01687218|5761055|P3|NOT COMPLETED|Overall Study||1
2347352|NCT01687218|5761056|P2|NOT COMPLETED|Overall Study||3
2347353|NCT01687218|5761057|P1|NOT COMPLETED|Overall Study||3
2347354|NCT01687218|5761052|P6|COMPLETED|Overall Study||32
2347355|NCT01687218|5761053|P5|COMPLETED|Overall Study||32
2347356|NCT01687218|5761054|P4|COMPLETED|Overall Study||32
2347357|NCT01687218|5761055|P3|COMPLETED|Overall Study||30
2347358|NCT01687218|5761056|P2|COMPLETED|Overall Study||29
2347359|NCT01687218|5761057|P1|COMPLETED|Overall Study||30
2347360|NCT01687218|5761052|P6|STARTED|Overall Study||32
2347361|NCT01687218|5761053|P5|STARTED|Overall Study||33
2347362|NCT01687218|5761054|P4|STARTED|Overall Study||34
2347363|NCT01687218|5761055|P3|STARTED|Overall Study||31
2347364|NCT01687218|5761056|P2|STARTED|Overall Study||32
2347365|NCT01687218|5761057|P1|STARTED|Overall Study||33
2347366|NCT01687179|5761077|P2|NOT COMPLETED|Overall Study||4
2347367|NCT01687179|5761078|P1|NOT COMPLETED|Overall Study||1
2347368|NCT01687179|5761077|P2|COMPLETED|Overall Study||6
2347369|NCT01687179|5761078|P1|COMPLETED|Overall Study||2
2347370|NCT01687179|5761077|P2|STARTED|Overall Study||10
2347371|NCT01687179|5761078|P1|STARTED|Overall Study||3
2347372|NCT01687166|5761088|P4|NOT COMPLETED|Overall Study||2
2347373|NCT01687166|5761089|P3|NOT COMPLETED|Overall Study||14
2347374|NCT01687166|5761090|P2|NOT COMPLETED|Overall Study||27
2347375|NCT01687166|5761091|P1|NOT COMPLETED|Overall Study||28
2347376|NCT01687166|5761088|P4|COMPLETED|Overall Study||1
2347377|NCT01687166|5761089|P3|COMPLETED|Overall Study||42
2347378|NCT01687166|5761090|P2|COMPLETED|Overall Study||145
2347379|NCT01687166|5761091|P1|COMPLETED|Overall Study||139
2347380|NCT01687166|5761088|P4|STARTED|Overall Study||3
2347381|NCT01687166|5761089|P3|STARTED|Overall Study||56
2347382|NCT01687166|5761090|P2|STARTED|Overall Study||172
2347383|NCT01687166|5761091|P1|STARTED|Overall Study||167
2347384|NCT01687114|5761103|P1|NOT COMPLETED|Overall Study||0
2347385|NCT01687114|5761103|P1|COMPLETED|Overall Study||5
2347386|NCT01687114|5761103|P1|STARTED|Overall Study||5
2347387|NCT01687101|5761107|P1|NOT COMPLETED|Overall Study||7
2347388|NCT01687101|5761107|P1|COMPLETED|Overall Study||25
2347389|NCT01687101|5761107|P1|STARTED|Overall Study||32
2347390|NCT01687088|5761113|P2|NOT COMPLETED|Overall Study||0
2347391|NCT01687088|5761114|P1|NOT COMPLETED|Overall Study||0
2347392|NCT01687088|5761113|P2|COMPLETED|Overall Study||50
2347393|NCT01687088|5761114|P1|COMPLETED|Overall Study||50
2347394|NCT01687088|5761113|P2|STARTED|Overall Study||50
2347395|NCT01687088|5761114|P1|STARTED|Overall Study||50
2347396|NCT01687036|5761120|P1|NOT COMPLETED|Overall Study||0
2347397|NCT01687036|5761120|P1|COMPLETED|Overall Study||10
2347398|NCT01687036|5761120|P1|STARTED|Overall Study||10
2347399|NCT01686958|5761132|P1|NOT COMPLETED|Overall Study||1
2347400|NCT01686958|5761132|P1|COMPLETED|Overall Study|No. of patients who completed ALL assessments at 12 months post treatment; 1 pt only had PSA test.|29
2347401|NCT01686958|5761132|P1|STARTED|Overall Study||30
2347402|NCT01686932|5761145|P2|NOT COMPLETED|Period 2||0
2347403|NCT01686932|5761146|P1|NOT COMPLETED|Period 2||0
2347404|NCT01686932|5761145|P2|COMPLETED|Period 2||25
2347405|NCT01686932|5761146|P1|COMPLETED|Period 2||24
2347406|NCT01686932|5761145|P2|STARTED|Period 2||25
2347407|NCT01686932|5761146|P1|STARTED|Period 2||24
2347408|NCT01686932|5761145|P2|NOT COMPLETED|Period 1||1
2347409|NCT01686932|5761146|P1|NOT COMPLETED|Period 1||1
2347410|NCT01686932|5761145|P2|COMPLETED|Period 1||25
2347411|NCT01686932|5761146|P1|COMPLETED|Period 1||24
2347412|NCT01686932|5761145|P2|STARTED|Period 1||26
2347413|NCT01686932|5761146|P1|STARTED|Period 1||25
2347414|NCT01686828|5761176|P4|NOT COMPLETED|Overall Study||0
2347415|NCT01686828|5761177|P3|NOT COMPLETED|Overall Study||1
2347416|NCT01686828|5761178|P2|NOT COMPLETED|Overall Study||1
2347417|NCT01686828|5761179|P1|NOT COMPLETED|Overall Study||1
2347418|NCT01686828|5761176|P4|COMPLETED|Overall Study||13
2347419|NCT01686828|5761177|P3|COMPLETED|Overall Study||12
2347420|NCT01686828|5761178|P2|COMPLETED|Overall Study||13
2347421|NCT01686828|5761179|P1|COMPLETED|Overall Study||12
2347422|NCT01686828|5761176|P4|STARTED|Overall Study||13
2347423|NCT01686828|5761177|P3|STARTED|Overall Study||13
2347424|NCT01686828|5761178|P2|STARTED|Overall Study||14
2347425|NCT01686828|5761179|P1|STARTED|Overall Study||13
2347426|NCT01686750|5761199|P2|NOT COMPLETED|Overall Study||0
2347427|NCT01686750|5761200|P1|NOT COMPLETED|Overall Study||0
2347428|NCT01686750|5761199|P2|COMPLETED|Overall Study||10725
2347429|NCT01686750|5761200|P1|COMPLETED|Overall Study||11001
2347430|NCT01686750|5761199|P2|STARTED|Overall Study||10725
2347431|NCT01686750|5761200|P1|STARTED|Overall Study||11001
2347432|NCT01686646|5761240|P4|NOT COMPLETED|Overall Study||0
2347433|NCT01686646|5761241|P3|NOT COMPLETED|Overall Study||0
2347434|NCT01686646|5761242|P2|NOT COMPLETED|Overall Study||0
2347435|NCT01686646|5761243|P1|NOT COMPLETED|Overall Study||0
2347436|NCT01686646|5761240|P4|COMPLETED|Overall Study||75
2347437|NCT01686646|5761241|P3|COMPLETED|Overall Study||75
2347438|NCT01686646|5761242|P2|COMPLETED|Overall Study||45
2347439|NCT01686646|5761243|P1|COMPLETED|Overall Study||45
2347440|NCT01686646|5761240|P4|Safety Population|Overall Study||75
2347441|NCT01686646|5761241|P3|Safety Population|Overall Study||74
2347442|NCT01686646|5761242|P2|Safety Population|Overall Study||45
2347443|NCT01686646|5761243|P1|Safety Population|Overall Study|One subject randomized to Paracetamol+Caffeine (500/65) group but received 1000/130 combination.|46
2347444|NCT01686646|5761240|P4|Intent to Treat Population|Overall Study||75
2347445|NCT01686646|5761241|P3|Intent to Treat Population|Overall Study||75
2347446|NCT01686646|5761242|P2|Intent to Treat Population|Overall Study||45
2347447|NCT01686646|5761243|P1|Intent to Treat Population|Overall Study||45
2347448|NCT01686646|5761240|P4|STARTED|Overall Study||75
2347449|NCT01686646|5761241|P3|STARTED|Overall Study||75
2347450|NCT01686646|5761242|P2|STARTED|Overall Study||45
2347451|NCT01686646|5761243|P1|STARTED|Overall Study||45
2347452|NCT01686633|5761292|P3|NOT COMPLETED|Overall Study||25
2347453|NCT01686633|5761293|P2|NOT COMPLETED|Overall Study||32
2347454|NCT01686633|5761294|P1|NOT COMPLETED|Overall Study||51
2347455|NCT01686633|5761292|P3|COMPLETED|Overall Study||321
2347456|NCT01686633|5761293|P2|COMPLETED|Overall Study||314
2347457|NCT01686633|5761294|P1|COMPLETED|Overall Study||296
2347458|NCT01686633|5761292|P3|STARTED|Overall Study||346
2347459|NCT01686633|5761293|P2|STARTED|Overall Study||346
2347460|NCT01686633|5761294|P1|STARTED|Overall Study||347
2347461|NCT01686581|5761317|P1|NOT COMPLETED|Overall Study||177
2347462|NCT01686581|5761317|P1|COMPLETED|Overall Study||464
2347463|NCT01686581|5761317|P1|Completed 24 Months|Overall Study||128
2347464|NCT01686581|5761317|P1|Safety Analysis Set; Received Study Drug|Overall Study||633
2347465|NCT01686581|5761317|P1|STARTED|Overall Study||641
2347466|NCT01686568|5761330|P2|NOT COMPLETED|Sub-Study||2
2347467|NCT01686568|5761331|P1|NOT COMPLETED|Sub-Study||2
2347468|NCT01686568|5761330|P2|COMPLETED|Sub-Study||9
2347469|NCT01686568|5761331|P1|COMPLETED|Sub-Study||12
2347470|NCT01686568|5761330|P2|STARTED|Sub-Study||11
2347471|NCT01686568|5761331|P1|STARTED|Sub-Study||14
2347472|NCT01686568|5761330|P2|NOT COMPLETED|Main Study||4
2347473|NCT01686568|5761331|P1|NOT COMPLETED|Main Study||2
2347474|NCT01686568|5761330|P2|COMPLETED|Main Study||11
2347475|NCT01686568|5761331|P1|COMPLETED|Main Study||14
2347476|NCT01686568|5761330|P2|STARTED|Main Study||15
2347477|NCT01686568|5761331|P1|STARTED|Main Study||16
2347478|NCT01686503|5761357|P4|NOT COMPLETED|Overall Study||1
2347479|NCT01686503|5761358|P3|NOT COMPLETED|Overall Study||2
2347480|NCT01686503|5761359|P2|NOT COMPLETED|Overall Study||3
2347481|NCT01686503|5761360|P1|NOT COMPLETED|Overall Study||1
2347482|NCT01686503|5761357|P4|COMPLETED|Overall Study||32
2347483|NCT01686503|5761358|P3|COMPLETED|Overall Study||64
2347484|NCT01686503|5761359|P2|COMPLETED|Overall Study||63
2347485|NCT01686503|5761360|P1|COMPLETED|Overall Study||65
2347486|NCT01686503|5761357|P4|STARTED|Overall Study||33
2347487|NCT01686503|5761358|P3|STARTED|Overall Study||66
2347488|NCT01686503|5761359|P2|STARTED|Overall Study||66
2347489|NCT01686503|5761360|P1|STARTED|Overall Study||66
2347490|NCT01686451|5761376|P2|NOT COMPLETED|Overall Study||0
2347491|NCT01686451|5761377|P1|NOT COMPLETED|Overall Study||0
2347492|NCT01686451|5761376|P2|COMPLETED|Overall Study||27
2347493|NCT01686451|5761377|P1|COMPLETED|Overall Study||33
2347494|NCT01686451|5761376|P2|STARTED|Overall Study||27
2347495|NCT01686451|5761377|P1|STARTED|Overall Study||33
2347496|NCT01686438|5761408|P3|NOT COMPLETED|Overall Study||13
2347497|NCT01686438|5761409|P2|NOT COMPLETED|Overall Study||9
2347498|NCT01686438|5761410|P1|NOT COMPLETED|Overall Study||8
2347499|NCT01686438|5761408|P3|COMPLETED|Overall Study||24
2347500|NCT01686438|5761409|P2|COMPLETED|Overall Study||26
2347501|NCT01686438|5761410|P1|COMPLETED|Overall Study||7
2347502|NCT01686438|5761408|P3|6-Month Follow Up|Overall Study||24
2347503|NCT01686438|5761409|P2|6-Month Follow Up|Overall Study||26
2347504|NCT01686438|5761410|P1|6-Month Follow Up|Overall Study||7
2347505|NCT01686438|5761408|P3|3-Month Follow Up|Overall Study||17
2347506|NCT01686438|5761409|P2|3-Month Follow Up|Overall Study||21
2347507|NCT01686438|5761410|P1|3-Month Follow Up|Overall Study||7
2347508|NCT01686438|5761408|P3|2-Week Follow Up|Overall Study||27
2347509|NCT01686438|5761409|P2|2-Week Follow Up|Overall Study||31
2347510|NCT01686438|5761410|P1|2-Week Follow Up|Overall Study||12
2347511|NCT01686438|5761408|P3|STARTED|Overall Study||37
2347512|NCT01686438|5761409|P2|STARTED|Overall Study||35
2347513|NCT01686438|5761410|P1|STARTED|Overall Study||15
2347514|NCT01686373|5761458|P2|NOT COMPLETED|Overall Study||2
2347515|NCT01686373|5761459|P1|NOT COMPLETED|Overall Study||3
2347516|NCT01686373|5761458|P2|COMPLETED|Overall Study||38
2347517|NCT01686373|5761459|P1|COMPLETED|Overall Study||31
2347518|NCT01686373|5761458|P2|Received 15 Treatment Sessions|Overall Study||39
2347519|NCT01686373|5761459|P1|Received 15 Treatment Sessions|Overall Study||33
2347520|NCT01686373|5761458|P2|STARTED|Overall Study||40
2347521|NCT01686373|5761459|P1|STARTED|Overall Study||34
2347522|NCT01686165|5761465|P1|NOT COMPLETED|Overall Study||0
2347523|NCT01686165|5761465|P1|COMPLETED|Overall Study||5
2347524|NCT01686165|5761465|P1|STARTED|Overall Study||5
2347525|NCT01685996|5761474|P2|NOT COMPLETED|Overall Study||13
2347526|NCT01685996|5761475|P1|NOT COMPLETED|Overall Study||16
2347527|NCT01685996|5761474|P2|COMPLETED|Overall Study||27
2347528|NCT01685996|5761475|P1|COMPLETED|Overall Study||18
2347529|NCT01685996|5761474|P2|STARTED|Overall Study||40
2347530|NCT01685996|5761475|P1|STARTED|Overall Study||34
2347531|NCT01685983|5761483|P1|NOT COMPLETED|Overall Study||82
2347532|NCT01685983|5761483|P1|COMPLETED|Overall Study||0
2347533|NCT01685983|5761483|P1|STARTED|Overall Study||82
2347534|NCT01685840|5761495|P2|NOT COMPLETED|Overall Study||332
2347535|NCT01685840|5761496|P1|NOT COMPLETED|Overall Study||329
2347536|NCT01685840|5761495|P2|COMPLETED|Overall Study||114
2347537|NCT01685840|5761496|P1|COMPLETED|Overall Study||119
2347538|NCT01685840|5761495|P2|STARTED|Overall Study||446
2347539|NCT01685840|5761496|P1|STARTED|Overall Study||448
2347540|NCT01685801|5761540|P4|NOT COMPLETED|Open-label Period (8 Weeks)||0
2347541|NCT01685801|5761541|P3|NOT COMPLETED|Open-label Period (8 Weeks)||0
2347542|NCT01685801|5761542|P2|NOT COMPLETED|Open-label Period (8 Weeks)||0
2347543|NCT01685801|5761543|P1|NOT COMPLETED|Open-label Period (8 Weeks)||0
2347544|NCT01685801|5761540|P4|COMPLETED|Open-label Period (8 Weeks)||4
2347545|NCT01685801|5761541|P3|COMPLETED|Open-label Period (8 Weeks)||7
2347546|NCT01685801|5761542|P2|COMPLETED|Open-label Period (8 Weeks)||5
2347547|NCT01685801|5761543|P1|COMPLETED|Open-label Period (8 Weeks)||5
2347548|NCT01685801|5761540|P4|STARTED|Open-label Period (8 Weeks)||4
2347549|NCT01685801|5761541|P3|STARTED|Open-label Period (8 Weeks)||7
2347550|NCT01685801|5761542|P2|STARTED|Open-label Period (8 Weeks)||5
2347551|NCT01685801|5761543|P1|STARTED|Open-label Period (8 Weeks)||5
2347552|NCT01685801|5761540|P4|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
2347553|NCT01685801|5761541|P3|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
2347554|NCT01685801|5761542|P2|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
2347555|NCT01685801|5761543|P1|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
2347556|NCT01685801|5761540|P4|COMPLETED|Washout Period 2 (4 Weeks)||4
2347557|NCT01685801|5761541|P3|COMPLETED|Washout Period 2 (4 Weeks)||7
2347558|NCT01685801|5761542|P2|COMPLETED|Washout Period 2 (4 Weeks)||5
2347559|NCT01685801|5761543|P1|COMPLETED|Washout Period 2 (4 Weeks)||5
2347560|NCT01685801|5761540|P4|STARTED|Washout Period 2 (4 Weeks)||4
2347561|NCT01685801|5761541|P3|STARTED|Washout Period 2 (4 Weeks)||7
2347562|NCT01685801|5761542|P2|STARTED|Washout Period 2 (4 Weeks)||5
2347563|NCT01685801|5761543|P1|STARTED|Washout Period 2 (4 Weeks)||5
2347564|NCT01685801|5761540|P4|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
2347565|NCT01685801|5761541|P3|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
2347566|NCT01685801|5761542|P2|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
2347567|NCT01685801|5761543|P1|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
2347568|NCT01685801|5761540|P4|COMPLETED|Cycle 2 Period 2 (2 Weeks)||4
2347569|NCT01685801|5761541|P3|COMPLETED|Cycle 2 Period 2 (2 Weeks)||7
2347570|NCT01685801|5761542|P2|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
2347571|NCT01685801|5761543|P1|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
2347572|NCT01685801|5761540|P4|STARTED|Cycle 2 Period 2 (2 Weeks)||5
2347573|NCT01685801|5761541|P3|STARTED|Cycle 2 Period 2 (2 Weeks)||7
2347574|NCT01685801|5761542|P2|STARTED|Cycle 2 Period 2 (2 Weeks)||6
2347575|NCT01685801|5761543|P1|STARTED|Cycle 2 Period 2 (2 Weeks)||5
2347576|NCT01685801|5761540|P4|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
2347577|NCT01685801|5761541|P3|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
2347578|NCT01685801|5761542|P2|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
2347579|NCT01685801|5761543|P1|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
2347580|NCT01685801|5761540|P4|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
2347581|NCT01685801|5761541|P3|COMPLETED|Cycle 2 Period 1 (2 Weeks)||7
2347582|NCT01685801|5761542|P2|COMPLETED|Cycle 2 Period 1 (2 Weeks)||6
2347583|NCT01685801|5761543|P1|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
2347584|NCT01685801|5761540|P4|STARTED|Cycle 2 Period 1 (2 Weeks)||5
2347585|NCT01685801|5761541|P3|STARTED|Cycle 2 Period 1 (2 Weeks)||7
2347586|NCT01685801|5761542|P2|STARTED|Cycle 2 Period 1 (2 Weeks)||6
2347587|NCT01685801|5761543|P1|STARTED|Cycle 2 Period 1 (2 Weeks)||5
2347588|NCT01685801|5761540|P4|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
2347589|NCT01685801|5761541|P3|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
2347590|NCT01685801|5761542|P2|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
2347591|NCT01685801|5761543|P1|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
2347592|NCT01685801|5761540|P4|COMPLETED|Washout Period 1 (4 Weeks)||5
2347593|NCT01685801|5761541|P3|COMPLETED|Washout Period 1 (4 Weeks)||7
2347594|NCT01685801|5761542|P2|COMPLETED|Washout Period 1 (4 Weeks)||6
2347595|NCT01685801|5761543|P1|COMPLETED|Washout Period 1 (4 Weeks)||5
2347596|NCT01685801|5761540|P4|STARTED|Washout Period 1 (4 Weeks)||5
2347597|NCT01685801|5761541|P3|STARTED|Washout Period 1 (4 Weeks)||7
2347598|NCT01685801|5761542|P2|STARTED|Washout Period 1 (4 Weeks)||6
2347599|NCT01685801|5761543|P1|STARTED|Washout Period 1 (4 Weeks)||5
2347600|NCT01685801|5761540|P4|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||1
2347601|NCT01685801|5761541|P3|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
2347602|NCT01685801|5761542|P2|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
2347603|NCT01685801|5761543|P1|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
2347604|NCT01685801|5761540|P4|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
2347605|NCT01685801|5761541|P3|COMPLETED|Cycle 1 Period 2 (2 Weeks)||7
2347606|NCT01685801|5761542|P2|COMPLETED|Cycle 1 Period 2 (2 Weeks)||6
2347607|NCT01685801|5761543|P1|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
2347608|NCT01685801|5761540|P4|STARTED|Cycle 1 Period 2 (2 Weeks)||6
2347609|NCT01685801|5761541|P3|STARTED|Cycle 1 Period 2 (2 Weeks)||7
2347610|NCT01685801|5761542|P2|STARTED|Cycle 1 Period 2 (2 Weeks)||6
2347611|NCT01685801|5761543|P1|STARTED|Cycle 1 Period 2 (2 Weeks)||5
2347612|NCT01685801|5761540|P4|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
2347613|NCT01685801|5761541|P3|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
2347614|NCT01685801|5761542|P2|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
2347615|NCT01685801|5761543|P1|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
2347616|NCT01685801|5761540|P4|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
2347617|NCT01685801|5761541|P3|COMPLETED|Cycle 1 Period 1 (2 Weeks)||7
2347618|NCT01685801|5761542|P2|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
2347619|NCT01685801|5761543|P1|COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
2347620|NCT01685801|5761540|P4|STARTED|Cycle 1 Period 1 (2 Weeks)||6
2347621|NCT01685801|5761541|P3|STARTED|Cycle 1 Period 1 (2 Weeks)||7
2347622|NCT01685801|5761542|P2|STARTED|Cycle 1 Period 1 (2 Weeks)||6
2347623|NCT01685801|5761543|P1|STARTED|Cycle 1 Period 1 (2 Weeks)||5
2347624|NCT01685697|5761565|P2|NOT COMPLETED|Overall Study||3
2347625|NCT01685697|5761566|P1|NOT COMPLETED|Overall Study||3
2347626|NCT01685697|5761565|P2|COMPLETED|Overall Study||28
2347627|NCT01685697|5761566|P1|COMPLETED|Overall Study||28
2347628|NCT01685697|5761565|P2|STARTED|Overall Study||31
2347629|NCT01685697|5761566|P1|STARTED|Overall Study||31
2347630|NCT01685684|5761574|P3|NOT COMPLETED|Double-blind Maintenance Phase||96
2347631|NCT01685684|5761575|P2|NOT COMPLETED|Double-blind Maintenance Phase||71
2347632|NCT01685684|5761576|P1|NOT COMPLETED|Double-blind Maintenance Phase||0
2347633|NCT01685684|5761574|P3|COMPLETED|Double-blind Maintenance Phase||100
2347634|NCT01685684|5761575|P2|COMPLETED|Double-blind Maintenance Phase||122
2347635|NCT01685684|5761576|P1|COMPLETED|Double-blind Maintenance Phase||0
2347636|NCT01685684|5761574|P3|STARTED|Double-blind Maintenance Phase||196
2347637|NCT01685684|5761575|P2|STARTED|Double-blind Maintenance Phase||193
2347638|NCT01685684|5761576|P1|STARTED|Double-blind Maintenance Phase||0
2347639|NCT01685684|5761574|P3|NOT COMPLETED|Titration Phase||0
2347640|NCT01685684|5761575|P2|NOT COMPLETED|Titration Phase||0
2347641|NCT01685684|5761576|P1|NOT COMPLETED|Titration Phase||351
2347642|NCT01685684|5761574|P3|COMPLETED|Titration Phase||0
2347643|NCT01685684|5761575|P2|COMPLETED|Titration Phase||0
2347644|NCT01685684|5761576|P1|COMPLETED|Titration Phase||389
2347645|NCT01685684|5761574|P3|STARTED|Titration Phase||0
2347646|NCT01685684|5761575|P2|STARTED|Titration Phase||0
2347647|NCT01685684|5761576|P1|STARTED|Titration Phase||740
2347648|NCT01685606|5761600|P1|NOT COMPLETED|Overall Study||1
2347649|NCT01685606|5761600|P1|COMPLETED|Overall Study||5
2347650|NCT01685606|5761600|P1|STARTED|Overall Study||6
2347651|NCT01685567|5761605|P1|NOT COMPLETED|Overall Study||0
2347652|NCT01685567|5761605|P1|COMPLETED|Overall Study||219
2347653|NCT01685567|5761605|P1|STARTED|Overall Study||219
2347654|NCT01685463|5761615|P2|NOT COMPLETED|Overall Study||0
2347655|NCT01685463|5761616|P1|NOT COMPLETED|Overall Study||0
2347656|NCT01685463|5761615|P2|COMPLETED|Overall Study||8
2347657|NCT01685463|5761616|P1|COMPLETED|Overall Study||10
2347658|NCT01685463|5761615|P2|STARTED|Overall Study||8
2347659|NCT01685463|5761616|P1|STARTED|Overall Study||10
2347660|NCT01685437|5761628|P1|NOT COMPLETED|Overall Study||31
2347661|NCT01685437|5761628|P1|COMPLETED|Overall Study||158
2347662|NCT01685437|5761628|P1|STARTED|Overall Study||189
2347663|NCT01685372|5761642|P2|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4
2347664|NCT01685372|5761643|P1|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||3
2347665|NCT01685372|5761642|P2|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||5
2347666|NCT01685372|5761643|P1|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4
2347667|NCT01685372|5761642|P2|STARTED|Timepoint 3 (T3): 3rd Blood Draw||9
2347668|NCT01685372|5761643|P1|STARTED|Timepoint 3 (T3): 3rd Blood Draw||7
2347669|NCT01685372|5761642|P2|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0
2347670|NCT01685372|5761643|P1|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0
2347671|NCT01685372|5761642|P2|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||9
2347672|NCT01685372|5761643|P1|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||7
2347673|NCT01685372|5761642|P2|STARTED|Timepoint 2 (T2): 2nd Blood Draw||9
2347674|NCT01685372|5761643|P1|STARTED|Timepoint 2 (T2): 2nd Blood Draw||7
2347675|NCT01685372|5761642|P2|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0
2347676|NCT01685372|5761643|P1|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0
2347677|NCT01685372|5761642|P2|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9
2347678|NCT01685372|5761643|P1|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7
2347679|NCT01685372|5761642|P2|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9
2347680|NCT01685372|5761643|P1|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7
2347681|NCT01685320|5761665|P2|NOT COMPLETED|Overall Study||0
2347682|NCT01685320|5761666|P1|NOT COMPLETED|Overall Study||0
2347683|NCT01685320|5761665|P2|COMPLETED|Overall Study||15
2347684|NCT01685320|5761666|P1|COMPLETED|Overall Study||15
2347685|NCT01685320|5761665|P2|STARTED|Overall Study||15
2347686|NCT01685320|5761666|P1|STARTED|Overall Study||15
2347687|NCT01685242|5761676|P2|NOT COMPLETED|Overall Study||3
2347688|NCT01685242|5761677|P1|NOT COMPLETED|Overall Study||1
2347689|NCT01685242|5761676|P2|COMPLETED|Overall Study||47
2347690|NCT01685242|5761677|P1|COMPLETED|Overall Study||49
2347691|NCT01685242|5761676|P2|STARTED|Overall Study||50
2347692|NCT01685242|5761677|P1|STARTED|Overall Study||50
2347693|NCT01685229|5761733|P2|NOT COMPLETED|Overall Study||16
2347694|NCT01685229|5761734|P1|NOT COMPLETED|Overall Study||26
2347695|NCT01685229|5761733|P2|COMPLETED|Overall Study||36
2347696|NCT01685229|5761734|P1|COMPLETED|Overall Study||120
2347697|NCT01685229|5761733|P2|STARTED|Overall Study||52
2347698|NCT01685229|5761734|P1|STARTED|Overall Study||146
2347699|NCT01685216|5761760|P1|NOT COMPLETED|Overall Study||1
2347700|NCT01685216|5761760|P1|COMPLETED|Overall Study||6
2347701|NCT01685216|5761760|P1|STARTED|Overall Study||7
2347702|NCT01685203|5761777|P7|NOT COMPLETED|Overall Study||0
2347703|NCT01685203|5761778|P6|NOT COMPLETED|Overall Study||3
2347704|NCT01685203|5761779|P5|NOT COMPLETED|Overall Study||0
2347705|NCT01685203|5761780|P4|NOT COMPLETED|Overall Study||1
2347706|NCT01685203|5761781|P3|NOT COMPLETED|Overall Study||0
2347707|NCT01685203|5761782|P2|NOT COMPLETED|Overall Study||3
2347708|NCT01685203|5761783|P1|NOT COMPLETED|Overall Study||4
2347709|NCT01685203|5761777|P7|COMPLETED|Overall Study||52
2347710|NCT01685203|5761778|P6|COMPLETED|Overall Study||44
2347711|NCT01685203|5761779|P5|COMPLETED|Overall Study||49
2347712|NCT01685203|5761780|P4|COMPLETED|Overall Study||41
2347713|NCT01685203|5761781|P3|COMPLETED|Overall Study||40
2347714|NCT01685203|5761782|P2|COMPLETED|Overall Study||39
2347715|NCT01685203|5761783|P1|COMPLETED|Overall Study||40
2347716|NCT01685203|5761777|P7|Completed Study Drug|Overall Study||52
2347717|NCT01685203|5761778|P6|Completed Study Drug|Overall Study||43
2347718|NCT01685203|5761779|P5|Completed Study Drug|Overall Study||49
2347719|NCT01685203|5761780|P4|Completed Study Drug|Overall Study||42
2347720|NCT01685203|5761781|P3|Completed Study Drug|Overall Study||39
2347721|NCT01685203|5761782|P2|Completed Study Drug|Overall Study||40
2347722|NCT01685203|5761783|P1|Completed Study Drug|Overall Study||42
2347723|NCT01685203|5761777|P7|STARTED|Overall Study||52
2347724|NCT01685203|5761778|P6|STARTED|Overall Study||47
2347725|NCT01685203|5761779|P5|STARTED|Overall Study||49
2347726|NCT01685203|5761780|P4|STARTED|Overall Study||42
2347727|NCT01685203|5761781|P3|STARTED|Overall Study||40
2347728|NCT01685203|5761782|P2|STARTED|Overall Study||42
2347729|NCT01685203|5761783|P1|STARTED|Overall Study||44
2347730|NCT01685138|5761827|P1|NOT COMPLETED|Overall Study||92
2347731|NCT01685138|5761827|P1|COMPLETED|Overall Study||32
2347732|NCT01685138|5761827|P1|Discontinued From Study|Overall Study||51
2347733|NCT01685138|5761827|P1|Entered Survival Follow-up|Overall Study||63
2347734|NCT01685138|5761827|P1|Entered Post-treatment Efficacy f/up|Overall Study||10
2347735|NCT01685138|5761827|P1|Discontinued From Treatment Phase|Overall Study||124
2347736|NCT01685138|5761827|P1|STARTED|Overall Study||124
2347737|NCT01685073|5761843|P2|NOT COMPLETED|Overall Study||32
2347738|NCT01685073|5761844|P1|NOT COMPLETED|Overall Study||30
2347739|NCT01685073|5761843|P2|COMPLETED|Overall Study|Retained in treatment through 12 weeks|33
2347740|NCT01685073|5761844|P1|COMPLETED|Overall Study|Retained in treatment through 12 weeks|32
2347741|NCT01685073|5761843|P2|STARTED|Overall Study|Randomized|65
2347742|NCT01685073|5761844|P1|STARTED|Overall Study|Randomized|62
2347743|NCT01685060|5761852|P1|NOT COMPLETED|Overall Study||140
2347744|NCT01685060|5761852|P1|COMPLETED|Overall Study||0
2347745|NCT01685060|5761852|P1|Discontinued From Study|Overall Study||35
2347746|NCT01685060|5761852|P1|Entered Survival Follow up|Overall Study||98
2347747|NCT01685060|5761852|P1|Entered Post-treatment Efficacy f/u|Overall Study||7
2347748|NCT01685060|5761852|P1|STARTED|Overall Study||140
2347749|NCT01685047|5761867|P1|NOT COMPLETED|Overall Study||85
2347750|NCT01685047|5761867|P1|COMPLETED|Overall Study||396
2347751|NCT01685047|5761867|P1|STARTED|Overall Study|481 subjects signed the consent. 1 subject was withdrawn prior to the baseline visit.|481
2347752|NCT01685021|5761871|P1|NOT COMPLETED|Overall Study||16
2347753|NCT01685021|5761871|P1|COMPLETED|Overall Study|Last patient last visit date. Study was Terminated prematurely.|6
2347754|NCT01685021|5761871|P1|STARTED|Overall Study||22
2347755|NCT01684943|5761883|P3|NOT COMPLETED|Overall Study||1
2347756|NCT01684943|5761884|P2|NOT COMPLETED|Overall Study||1
2347757|NCT01684943|5761885|P1|NOT COMPLETED|Overall Study||9
2347758|NCT01684943|5761883|P3|COMPLETED|Overall Study||0
2347759|NCT01684943|5761884|P2|COMPLETED|Overall Study||2
2347760|NCT01684943|5761885|P1|COMPLETED|Overall Study||20
2347761|NCT01684943|5761883|P3|STARTED|Overall Study||1
2347762|NCT01684943|5761884|P2|STARTED|Overall Study||3
2347763|NCT01684943|5761885|P1|STARTED|Overall Study||29
2347764|NCT01684930|5761904|P2|NOT COMPLETED|Overall Study||1
2347765|NCT01684930|5761905|P1|NOT COMPLETED|Overall Study||3
2347766|NCT01684930|5761904|P2|COMPLETED|Overall Study||13
2347767|NCT01684930|5761905|P1|COMPLETED|Overall Study||9
2347768|NCT01684930|5761904|P2|STARTED|Overall Study||14
2347769|NCT01684930|5761905|P1|STARTED|Overall Study||12
2347770|NCT01684917|5761925|P4|NOT COMPLETED|Overall Study||0
2347771|NCT01684917|5761926|P3|NOT COMPLETED|Overall Study||0
2347772|NCT01684917|5761927|P2|NOT COMPLETED|Overall Study||0
2347773|NCT01684917|5761928|P1|NOT COMPLETED|Overall Study||0
2347774|NCT01684917|5761925|P4|COMPLETED|Overall Study||5
2347775|NCT01684917|5761926|P3|COMPLETED|Overall Study||13
2347776|NCT01684917|5761927|P2|COMPLETED|Overall Study||7
2347777|NCT01684917|5761928|P1|COMPLETED|Overall Study||11
2347778|NCT01684917|5761925|P4|STARTED|Overall Study||5
2347779|NCT01684917|5761926|P3|STARTED|Overall Study||13
2347780|NCT01684917|5761927|P2|STARTED|Overall Study||7
2347781|NCT01684917|5761928|P1|STARTED|Overall Study||11
2347782|NCT01684878|5761962|P4|NOT COMPLETED|Part 2: Randomized Phase||78
2347783|NCT01684878|5761963|P3|NOT COMPLETED|Part 2: Randomized Phase||78
2347784|NCT01684878|5761964|P2|NOT COMPLETED|Part 2: Randomized Phase||0
2347785|NCT01684878|5761965|P1|NOT COMPLETED|Part 2: Randomized Phase||0
2347786|NCT01684878|5761962|P4|COMPLETED|Part 2: Randomized Phase||0
2347787|NCT01684878|5761963|P3|COMPLETED|Part 2: Randomized Phase||0
2347788|NCT01684878|5761964|P2|COMPLETED|Part 2: Randomized Phase||0
2347789|NCT01684878|5761965|P1|COMPLETED|Part 2: Randomized Phase||0
2347790|NCT01684878|5761962|P4|Participants Mis-randomized|Part 2: Randomized Phase||0
2347791|NCT01684878|5761963|P3|Participants Mis-randomized|Part 2: Randomized Phase||2
2347792|NCT01684878|5761964|P2|Participants Mis-randomized|Part 2: Randomized Phase||0
2347793|NCT01684878|5761965|P1|Participants Mis-randomized|Part 2: Randomized Phase||0
2347794|NCT01684878|5761962|P4|Participants Randomized But Not Treated|Part 2: Randomized Phase||2
2347795|NCT01684878|5761963|P3|Participants Randomized But Not Treated|Part 2: Randomized Phase||1
2347796|NCT01684878|5761964|P2|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
2347797|NCT01684878|5761965|P1|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
2347798|NCT01684878|5761962|P4|STARTED|Part 2: Randomized Phase||78
2347799|NCT01684878|5761963|P3|STARTED|Part 2: Randomized Phase||78
2347800|NCT01684878|5761964|P2|STARTED|Part 2: Randomized Phase||0
2347801|NCT01684878|5761965|P1|STARTED|Part 2: Randomized Phase||0
2347802|NCT01684878|5761962|P4|NOT COMPLETED|Part 1: Safety Run in Phase||0
2347803|NCT01684878|5761963|P3|NOT COMPLETED|Part 1: Safety Run in Phase||0
2347804|NCT01684878|5761964|P2|NOT COMPLETED|Part 1: Safety Run in Phase||23
2347805|NCT01684878|5761965|P1|NOT COMPLETED|Part 1: Safety Run in Phase||16
2347806|NCT01684878|5761962|P4|COMPLETED|Part 1: Safety Run in Phase||0
2347807|NCT01684878|5761963|P3|COMPLETED|Part 1: Safety Run in Phase||0
2347808|NCT01684878|5761964|P2|COMPLETED|Part 1: Safety Run in Phase||5
2347809|NCT01684878|5761965|P1|COMPLETED|Part 1: Safety Run in Phase||6
2347810|NCT01684878|5761962|P4|STARTED|Part 1: Safety Run in Phase||0
2347811|NCT01684878|5761963|P3|STARTED|Part 1: Safety Run in Phase||0
2347812|NCT01684878|5761964|P2|STARTED|Part 1: Safety Run in Phase||28
2347813|NCT01684878|5761965|P1|STARTED|Part 1: Safety Run in Phase||22
2347814|NCT01684839|5761989|P1|NOT COMPLETED|Overall Study||0
2347815|NCT01684839|5761989|P1|COMPLETED|Overall Study||9
2347816|NCT01684839|5761989|P1|STARTED|Overall Study||9
2347817|NCT01684826|5761993|P1|NOT COMPLETED|Overall Study||10
2347818|NCT01684826|5761993|P1|COMPLETED|Overall Study||39
2347819|NCT01684826|5761993|P1|Collected Dose and Image Information|Overall Study||39
2347820|NCT01684826|5761993|P1|STARTED|Overall Study||49
2347821|NCT01684748|5762001|P2|NOT COMPLETED|Second Intervention - 8 Weeks||0
2347822|NCT01684748|5762002|P1|NOT COMPLETED|Second Intervention - 8 Weeks||0
2347823|NCT01684748|5762001|P2|COMPLETED|Second Intervention - 8 Weeks||8
2347824|NCT01684748|5762002|P1|COMPLETED|Second Intervention - 8 Weeks||8
2347825|NCT01684748|5762001|P2|STARTED|Second Intervention - 8 Weeks||8
2347826|NCT01684748|5762002|P1|STARTED|Second Intervention - 8 Weeks||8
2347827|NCT01684748|5762001|P2|NOT COMPLETED|First Intervention - 8 Weeks||2
2347828|NCT01684748|5762002|P1|NOT COMPLETED|First Intervention - 8 Weeks||2
2347829|NCT01684748|5762001|P2|COMPLETED|First Intervention - 8 Weeks||8
2347830|NCT01684748|5762002|P1|COMPLETED|First Intervention - 8 Weeks||8
2347831|NCT01684748|5762001|P2|STARTED|First Intervention - 8 Weeks||10
2347832|NCT01684748|5762002|P1|STARTED|First Intervention - 8 Weeks||10
2347833|NCT01684592|5762011|P2|NOT COMPLETED|Overall Study||24
2347834|NCT01684592|5762012|P1|NOT COMPLETED|Overall Study||26
2347835|NCT01684592|5762011|P2|COMPLETED|Overall Study||40
2347836|NCT01684592|5762012|P1|COMPLETED|Overall Study||38
2347837|NCT01684592|5762011|P2|STARTED|Overall Study||64
2347838|NCT01684592|5762012|P1|STARTED|Overall Study||64
2347839|NCT01684566|5762032|P2|NOT COMPLETED|Overall Study||7
2347840|NCT01684566|5762033|P1|NOT COMPLETED|Overall Study||16
2347841|NCT01684566|5762032|P2|COMPLETED|Overall Study||49
2347842|NCT01684566|5762033|P1|COMPLETED|Overall Study||44
2347843|NCT01684566|5762032|P2|Treated (ITT)|Overall Study||52
2347844|NCT01684566|5762033|P1|Treated (ITT)|Overall Study||57
2347845|NCT01684566|5762032|P2|STARTED|Overall Study||56
2347846|NCT01684566|5762033|P1|STARTED|Overall Study||60
2347847|NCT01684436|5762055|P1|NOT COMPLETED|Overall Study||1
2347848|NCT01684436|5762055|P1|COMPLETED|Overall Study||29
2347849|NCT01684436|5762055|P1|STARTED|Overall Study||30
2347850|NCT01684423|5762069|P5|NOT COMPLETED|Overall Study||0
2347851|NCT01684423|5762070|P4|NOT COMPLETED|Overall Study||0
2347852|NCT01684423|5762071|P3|NOT COMPLETED|Overall Study||1
2347853|NCT01684423|5762072|P2|NOT COMPLETED|Overall Study||0
2347854|NCT01684423|5762073|P1|NOT COMPLETED|Overall Study||0
2347855|NCT01684423|5762069|P5|COMPLETED|Overall Study||7
2347856|NCT01684423|5762070|P4|COMPLETED|Overall Study||19
2347857|NCT01684423|5762071|P3|COMPLETED|Overall Study||12
2347858|NCT01684423|5762072|P2|COMPLETED|Overall Study||13
2347859|NCT01684423|5762073|P1|COMPLETED|Overall Study||11
2347860|NCT01684423|5762069|P5|STARTED|Overall Study||7
2347861|NCT01684423|5762070|P4|STARTED|Overall Study||19
2347862|NCT01684423|5762071|P3|STARTED|Overall Study||13
2347863|NCT01684423|5762072|P2|STARTED|Overall Study||13
2347864|NCT01684423|5762073|P1|STARTED|Overall Study||11
2347865|NCT01684410|5762110|P3|NOT COMPLETED|Overall Study||0
2347866|NCT01684410|5762111|P2|NOT COMPLETED|Overall Study||0
2347867|NCT01684410|5762112|P1|NOT COMPLETED|Overall Study||0
2347868|NCT01684410|5762110|P3|COMPLETED|Overall Study||10
2347869|NCT01684410|5762111|P2|COMPLETED|Overall Study||10
2347870|NCT01684410|5762112|P1|COMPLETED|Overall Study||10
2347871|NCT01684410|5762110|P3|STARTED|Overall Study||10
2347872|NCT01684410|5762111|P2|STARTED|Overall Study||10
2347873|NCT01684410|5762112|P1|STARTED|Overall Study||10
2347874|NCT01684215|5762130|P4|NOT COMPLETED|Phase 2||43
2347875|NCT01684215|5762131|P3|NOT COMPLETED|Phase 2||0
2347876|NCT01684215|5762132|P2|NOT COMPLETED|Phase 2||0
2347877|NCT01684215|5762133|P1|NOT COMPLETED|Phase 2||0
2347878|NCT01684215|5762130|P4|COMPLETED|Phase 2||0
2347879|NCT01684215|5762131|P3|COMPLETED|Phase 2||0
2347880|NCT01684215|5762132|P2|COMPLETED|Phase 2||0
2347881|NCT01684215|5762133|P1|COMPLETED|Phase 2||0
2347882|NCT01684215|5762130|P4|Treated|Phase 2||42
2347883|NCT01684215|5762131|P3|Treated|Phase 2||0
2347884|NCT01684215|5762132|P2|Treated|Phase 2||0
2347885|NCT01684215|5762133|P1|Treated|Phase 2||0
2347886|NCT01684215|5762130|P4|STARTED|Phase 2|Eligible participants who consented for Phase 2.|43
2347887|NCT01684215|5762131|P3|STARTED|Phase 2||0
2347888|NCT01684215|5762132|P2|STARTED|Phase 2||0
2347889|NCT01684215|5762133|P1|STARTED|Phase 2||0
2347890|NCT01684215|5762130|P4|NOT COMPLETED|Phase 1, Part 2||0
2347891|NCT01684215|5762131|P3|NOT COMPLETED|Phase 1, Part 2||6
2347892|NCT01684215|5762132|P2|NOT COMPLETED|Phase 1, Part 2||0
2347893|NCT01684215|5762133|P1|NOT COMPLETED|Phase 1, Part 2||0
2347894|NCT01684215|5762130|P4|COMPLETED|Phase 1, Part 2||0
2347895|NCT01684215|5762131|P3|COMPLETED|Phase 1, Part 2||0
2347896|NCT01684215|5762132|P2|COMPLETED|Phase 1, Part 2||0
2347897|NCT01684215|5762133|P1|COMPLETED|Phase 1, Part 2||0
2347898|NCT01684215|5762130|P4|STARTED|Phase 1, Part 2||0
2347899|NCT01684215|5762131|P3|STARTED|Phase 1, Part 2|Eligible participants who consented for Phase 1 Part 2.|6
2347900|NCT01684215|5762132|P2|STARTED|Phase 1, Part 2||0
2347901|NCT01684215|5762133|P1|STARTED|Phase 1, Part 2||0
2347902|NCT01684215|5762130|P4|NOT COMPLETED|Phase 1, Part 1||0
2347903|NCT01684215|5762131|P3|NOT COMPLETED|Phase 1, Part 1||0
2347904|NCT01684215|5762132|P2|NOT COMPLETED|Phase 1, Part 1||6
2347905|NCT01684215|5762133|P1|NOT COMPLETED|Phase 1, Part 1||6
2347906|NCT01684215|5762130|P4|COMPLETED|Phase 1, Part 1||0
2347907|NCT01684215|5762131|P3|COMPLETED|Phase 1, Part 1||0
2347908|NCT01684215|5762132|P2|COMPLETED|Phase 1, Part 1||0
2347909|NCT01684215|5762133|P1|COMPLETED|Phase 1, Part 1||0
2347910|NCT01684215|5762130|P4|Treated|Phase 1, Part 1||0
2347911|NCT01684215|5762131|P3|Treated|Phase 1, Part 1||0
2347912|NCT01684215|5762132|P2|Treated|Phase 1, Part 1||6
2347913|NCT01684215|5762133|P1|Treated|Phase 1, Part 1||6
2347914|NCT01684215|5762130|P4|STARTED|Phase 1, Part 1||0
2347915|NCT01684215|5762131|P3|STARTED|Phase 1, Part 1||0
2347916|NCT01684215|5762132|P2|STARTED|Phase 1, Part 1||6
2347917|NCT01684215|5762133|P1|STARTED|Phase 1, Part 1||6
2347918|NCT01684046|5762207|P2|NOT COMPLETED|Period 2, Second 30 Days||0
2347919|NCT01684046|5762208|P1|NOT COMPLETED|Period 2, Second 30 Days||0
2347920|NCT01684046|5762207|P2|COMPLETED|Period 2, Second 30 Days||93
2347921|NCT01684046|5762208|P1|COMPLETED|Period 2, Second 30 Days||97
2347922|NCT01684046|5762207|P2|STARTED|Period 2, Second 30 Days||93
2347923|NCT01684046|5762208|P1|STARTED|Period 2, Second 30 Days||97
2347924|NCT01684046|5762207|P2|NOT COMPLETED|Period 1, First 30 Days||2
2347925|NCT01684046|5762208|P1|NOT COMPLETED|Period 1, First 30 Days||0
2347926|NCT01684046|5762207|P2|COMPLETED|Period 1, First 30 Days||93
2347927|NCT01684046|5762208|P1|COMPLETED|Period 1, First 30 Days||97
2347928|NCT01684046|5762207|P2|STARTED|Period 1, First 30 Days||95
2347929|NCT01684046|5762208|P1|STARTED|Period 1, First 30 Days||97
2347930|NCT01684033|5762214|P2|NOT COMPLETED|Period 2, Second 30 Days||0
2347931|NCT01684033|5762215|P1|NOT COMPLETED|Period 2, Second 30 Days||1
2347932|NCT01684033|5762214|P2|COMPLETED|Period 2, Second 30 Days||98
2347933|NCT01684033|5762215|P1|COMPLETED|Period 2, Second 30 Days||94
2347934|NCT01684033|5762214|P2|STARTED|Period 2, Second 30 Days||98
2347935|NCT01684033|5762215|P1|STARTED|Period 2, Second 30 Days||95
2347936|NCT01684033|5762214|P2|NOT COMPLETED|Period 1, First 30 Days||1
2347937|NCT01684033|5762215|P1|NOT COMPLETED|Period 1, First 30 Days||4
2347938|NCT01684033|5762214|P2|COMPLETED|Period 1, First 30 Days||98
2347939|NCT01684033|5762215|P1|COMPLETED|Period 1, First 30 Days||95
2347940|NCT01684033|5762214|P2|STARTED|Period 1, First 30 Days||99
2347941|NCT01684033|5762215|P1|STARTED|Period 1, First 30 Days||99
2347942|NCT01684007|5762225|P2|NOT COMPLETED|Overall Study||0
2347943|NCT01684007|5762226|P1|NOT COMPLETED|Overall Study||0
2347944|NCT01684007|5762225|P2|COMPLETED|Overall Study||50
2347945|NCT01684007|5762226|P1|COMPLETED|Overall Study||53
2347946|NCT01684007|5762225|P2|STARTED|Overall Study||50
2347947|NCT01684007|5762226|P1|STARTED|Overall Study||53
2347948|NCT01683994|5762239|P5|NOT COMPLETED|Overall Study||1
2347949|NCT01683994|5762240|P4|NOT COMPLETED|Overall Study||3
2347950|NCT01683994|5762241|P3|NOT COMPLETED|Overall Study||0
2347951|NCT01683994|5762242|P2|NOT COMPLETED|Overall Study||0
2347952|NCT01683994|5762243|P1|NOT COMPLETED|Overall Study||1
2347953|NCT01683994|5762239|P5|COMPLETED|Overall Study||12
2347954|NCT01683994|5762240|P4|COMPLETED|Overall Study||10
2347955|NCT01683994|5762241|P3|COMPLETED|Overall Study||7
2347956|NCT01683994|5762242|P2|COMPLETED|Overall Study||8
2347957|NCT01683994|5762243|P1|COMPLETED|Overall Study||3
2347958|NCT01683994|5762239|P5|# of Patients Who Received Treatment|Overall Study||13
2347959|NCT01683994|5762240|P4|# of Patients Who Received Treatment|Overall Study||12
2347960|NCT01683994|5762241|P3|# of Patients Who Received Treatment|Overall Study||7
2347961|NCT01683994|5762242|P2|# of Patients Who Received Treatment|Overall Study||8
2347962|NCT01683994|5762243|P1|# of Patients Who Received Treatment|Overall Study||4
2347963|NCT01683994|5762239|P5|STARTED|Overall Study||13
2347964|NCT01683994|5762240|P4|STARTED|Overall Study||13
2347965|NCT01683994|5762241|P3|STARTED|Overall Study||7
2347966|NCT01683994|5762242|P2|STARTED|Overall Study||8
2347967|NCT01683994|5762243|P1|STARTED|Overall Study||4
2347968|NCT01683864|5762272|P3|NOT COMPLETED|Overall Study||0
2347969|NCT01683864|5762273|P2|NOT COMPLETED|Overall Study||0
2347970|NCT01683864|5762274|P1|NOT COMPLETED|Overall Study||0
2347971|NCT01683864|5762272|P3|COMPLETED|Overall Study||0
2347972|NCT01683864|5762273|P2|COMPLETED|Overall Study||0
2347973|NCT01683864|5762274|P1|COMPLETED|Overall Study||0
2347974|NCT01683864|5762272|P3|STARTED|Overall Study||0
2347975|NCT01683864|5762273|P2|STARTED|Overall Study||0
2347976|NCT01683864|5762274|P1|STARTED|Overall Study||0
2347977|NCT01683838|5762284|P2|NOT COMPLETED|Overall Study||12
2347978|NCT01683838|5762285|P1|NOT COMPLETED|Overall Study||26
2347979|NCT01683838|5762284|P2|COMPLETED|Overall Study||88
2347980|NCT01683838|5762285|P1|COMPLETED|Overall Study||78
2347981|NCT01683838|5762284|P2|Efficacy Population|Overall Study||93
2347982|NCT01683838|5762285|P1|Efficacy Population|Overall Study||89
2347983|NCT01683838|5762284|P2|Safety Population|Overall Study||100
2347984|NCT01683838|5762285|P1|Safety Population|Overall Study||103
2347985|NCT01683838|5762284|P2|Intent to Treat (ITT) Population|Overall Study||100
2347986|NCT01683838|5762285|P1|Intent to Treat (ITT) Population|Overall Study||103
2347987|NCT01683838|5762284|P2|STARTED|Overall Study||100
2347988|NCT01683838|5762285|P1|STARTED|Overall Study||104
2347989|NCT01683812|5762307|P1|NOT COMPLETED|Overall Study||0
2347990|NCT01683812|5762307|P1|COMPLETED|Overall Study||23
2347991|NCT01683812|5762307|P1|STARTED|Overall Study||23
2347992|NCT01683630|5762314|P2|NOT COMPLETED|Overall Study||0
2347993|NCT01683630|5762315|P1|NOT COMPLETED|Overall Study||0
2347994|NCT01683630|5762314|P2|COMPLETED|Overall Study||445
2347995|NCT01683630|5762315|P1|COMPLETED|Overall Study||1404
2347996|NCT01683630|5762314|P2|STARTED|Overall Study||445
2347997|NCT01683630|5762315|P1|STARTED|Overall Study||1404
2347998|NCT01683604|5762325|P1|NOT COMPLETED|Overall Study||5
2347999|NCT01683604|5762325|P1|COMPLETED|Overall Study||32
2348000|NCT01683604|5762325|P1|STARTED|Overall Study||37
2348001|NCT01683565|5762490|P2|NOT COMPLETED|Overall Study||1
2348002|NCT01683565|5762491|P1|NOT COMPLETED|Overall Study||3
2348003|NCT01683565|5762490|P2|COMPLETED|Overall Study||15
2348004|NCT01683565|5762491|P1|COMPLETED|Overall Study||12
2348005|NCT01683565|5762490|P2|STARTED|Overall Study||16
2348006|NCT01683565|5762491|P1|STARTED|Overall Study||15
2348007|NCT01683526|5762505|P2|NOT COMPLETED|Overall Study||0
2348008|NCT01683526|5762506|P1|NOT COMPLETED|Overall Study||0
2348009|NCT01683526|5762505|P2|COMPLETED|Overall Study||57
2348010|NCT01683526|5762506|P1|COMPLETED|Overall Study||60
2348011|NCT01683526|5762505|P2|STARTED|Overall Study||57
2348012|NCT01683526|5762506|P1|STARTED|Overall Study||60
2348013|NCT01683409|5762525|P5|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||3
2348014|NCT01683409|5762526|P4|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
2348015|NCT01683409|5762527|P3|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||1
2348016|NCT01683409|5762528|P2|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
2348017|NCT01683409|5762529|P1|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
2348018|NCT01683409|5762525|P5|COMPLETED|Washout Period 2 (Weeks 29-32)||9
2348019|NCT01683409|5762526|P4|COMPLETED|Washout Period 2 (Weeks 29-32)||6
2348020|NCT01683409|5762527|P3|COMPLETED|Washout Period 2 (Weeks 29-32)||7
2348021|NCT01683409|5762528|P2|COMPLETED|Washout Period 2 (Weeks 29-32)||6
2348022|NCT01683409|5762529|P1|COMPLETED|Washout Period 2 (Weeks 29-32)||6
2348023|NCT01683409|5762525|P5|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 8 participants.|12
2348024|NCT01683409|5762526|P4|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 16 participants.|6
2348025|NCT01683409|5762527|P3|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 17 participants.|8
2348026|NCT01683409|5762528|P2|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 11 participants.|6
2348027|NCT01683409|5762529|P1|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 18 participants.|6
2348028|NCT01683409|5762525|P5|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
2348029|NCT01683409|5762526|P4|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||2
2348030|NCT01683409|5762527|P3|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||1
2348031|NCT01683409|5762528|P2|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||4
2348032|NCT01683409|5762529|P1|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
2348033|NCT01683409|5762525|P5|COMPLETED|Washout Period 1 (Weeks 25-28)||20
2348034|NCT01683409|5762526|P4|COMPLETED|Washout Period 1 (Weeks 25-28)||22
2348035|NCT01683409|5762527|P3|COMPLETED|Washout Period 1 (Weeks 25-28)||25
2348036|NCT01683409|5762528|P2|COMPLETED|Washout Period 1 (Weeks 25-28)||17
2348037|NCT01683409|5762529|P1|COMPLETED|Washout Period 1 (Weeks 25-28)||24
2348038|NCT01683409|5762525|P5|STARTED|Washout Period 1 (Weeks 25-28)||23
2348039|NCT01683409|5762526|P4|STARTED|Washout Period 1 (Weeks 25-28)||24
2348040|NCT01683409|5762527|P3|STARTED|Washout Period 1 (Weeks 25-28)||26
2348041|NCT01683409|5762528|P2|STARTED|Washout Period 1 (Weeks 25-28)||21
2348042|NCT01683409|5762529|P1|STARTED|Washout Period 1 (Weeks 25-28)||27
2348043|NCT01683409|5762525|P5|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
2348044|NCT01683409|5762526|P4|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
2348045|NCT01683409|5762527|P3|NOT COMPLETED|Treatment Period (Weeks 1-24)||1
2348046|NCT01683409|5762528|P2|NOT COMPLETED|Treatment Period (Weeks 1-24)||4
2348047|NCT01683409|5762529|P1|NOT COMPLETED|Treatment Period (Weeks 1-24)||0
2348048|NCT01683409|5762525|P5|COMPLETED|Treatment Period (Weeks 1-24)||23
2348049|NCT01683409|5762526|P4|COMPLETED|Treatment Period (Weeks 1-24)||24
2348050|NCT01683409|5762527|P3|COMPLETED|Treatment Period (Weeks 1-24)||26
2348051|NCT01683409|5762528|P2|COMPLETED|Treatment Period (Weeks 1-24)||21
2348052|NCT01683409|5762529|P1|COMPLETED|Treatment Period (Weeks 1-24)||27
2348053|NCT01683409|5762525|P5|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
2348054|NCT01683409|5762526|P4|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
2348055|NCT01683409|5762527|P3|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
2348056|NCT01683409|5762528|P2|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
2348057|NCT01683409|5762529|P1|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||27
2348058|NCT01683409|5762525|P5|STARTED|Treatment Period (Weeks 1-24)||25
2348059|NCT01683409|5762526|P4|STARTED|Treatment Period (Weeks 1-24)||26
2348060|NCT01683409|5762527|P3|STARTED|Treatment Period (Weeks 1-24)||27
2348061|NCT01683409|5762528|P2|STARTED|Treatment Period (Weeks 1-24)||25
2348062|NCT01683409|5762529|P1|STARTED|Treatment Period (Weeks 1-24)||27
2348063|NCT01683383|5762572|P2|NOT COMPLETED|Overall Study||0
2348064|NCT01683383|5762573|P1|NOT COMPLETED|Overall Study||1
2348065|NCT01683383|5762572|P2|COMPLETED|Overall Study||51
2348066|NCT01683383|5762573|P1|COMPLETED|Overall Study||49
2348067|NCT01683383|5762572|P2|Transported and Treated|Overall Study||51
2348068|NCT01683383|5762573|P1|Transported and Treated|Overall Study||49
2348069|NCT01683383|5762572|P2|STARTED|Overall Study||51
2348070|NCT01683383|5762573|P1|STARTED|Overall Study||50
2348071|NCT01683331|5762589|P2|NOT COMPLETED|Overall Study||0
2348072|NCT01683331|5762590|P1|NOT COMPLETED|Overall Study||0
2348073|NCT01683331|5762589|P2|COMPLETED|Overall Study||18
2348074|NCT01683331|5762590|P1|COMPLETED|Overall Study||18
2348075|NCT01683331|5762589|P2|24 Months|Overall Study||18
2348076|NCT01683331|5762590|P1|24 Months|Overall Study||18
2348077|NCT01683331|5762589|P2|12 Months|Overall Study||18
2348078|NCT01683331|5762590|P1|12 Months|Overall Study||18
2348079|NCT01683331|5762589|P2|Began Dosage|Overall Study||18
2348080|NCT01683331|5762590|P1|Began Dosage|Overall Study||18
2348081|NCT01683331|5762589|P2|STARTED|Overall Study||18
2348082|NCT01683331|5762590|P1|STARTED|Overall Study||18
2348083|NCT01683266|5762600|P2|NOT COMPLETED|Overall Study||50
2348084|NCT01683266|5762601|P1|NOT COMPLETED|Overall Study||55
2348085|NCT01683266|5762600|P2|COMPLETED|Overall Study||225
2348086|NCT01683266|5762601|P1|COMPLETED|Overall Study||219
2348087|NCT01683266|5762600|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
2348088|NCT01683266|5762601|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
2348089|NCT01683266|5762600|P2|STARTED|Overall Study||275
2348090|NCT01683266|5762601|P1|STARTED|Overall Study||274
2348091|NCT01683058|5762629|P1|NOT COMPLETED|Overall Study||29
2348092|NCT01683058|5762629|P1|COMPLETED|Overall Study||45
2348093|NCT01683058|5762629|P1|STARTED|Overall Study||74
2348094|NCT01683019|5762660|P3|NOT COMPLETED|Overall Study||4
2348095|NCT01683019|5762661|P2|NOT COMPLETED|Overall Study||1
2348096|NCT01683019|5762662|P1|NOT COMPLETED|Overall Study||2
2348097|NCT01683019|5762660|P3|COMPLETED|Overall Study||15
2348098|NCT01683019|5762661|P2|COMPLETED|Overall Study||14
2348099|NCT01683019|5762662|P1|COMPLETED|Overall Study||16
2348100|NCT01683019|5762660|P3|STARTED|Overall Study||19
2348101|NCT01683019|5762661|P2|STARTED|Overall Study||15
2348102|NCT01683019|5762662|P1|STARTED|Overall Study||18
2348103|NCT01682954|5762672|P2|NOT COMPLETED|Overall Study||5
2348104|NCT01682954|5762673|P1|NOT COMPLETED|Overall Study||5
2348105|NCT01682954|5762672|P2|COMPLETED|Overall Study||33
2348106|NCT01682954|5762673|P1|COMPLETED|Overall Study||35
2348107|NCT01682954|5762672|P2|STARTED|Overall Study||38
2348108|NCT01682954|5762673|P1|STARTED|Overall Study||40
2348109|NCT01682876|5762685|P4|NOT COMPLETED|Overall Study||19
2348110|NCT01682876|5762686|P3|NOT COMPLETED|Overall Study||11
2348111|NCT01682876|5762687|P2|NOT COMPLETED|Overall Study||20
2348112|NCT01682876|5762688|P1|NOT COMPLETED|Overall Study||21
2348113|NCT01682876|5762685|P4|COMPLETED|Overall Study||157
2348114|NCT01682876|5762686|P3|COMPLETED|Overall Study||169
2348115|NCT01682876|5762687|P2|COMPLETED|Overall Study||163
2348116|NCT01682876|5762688|P1|COMPLETED|Overall Study||155
2348117|NCT01682876|5762685|P4|STARTED|Overall Study||176
2348118|NCT01682876|5762686|P3|STARTED|Overall Study||180
2348119|NCT01682876|5762687|P2|STARTED|Overall Study||183
2348120|NCT01682876|5762688|P1|STARTED|Overall Study||176
2348121|NCT01682863|5762734|P3|NOT COMPLETED|Overall Study||24
2348122|NCT01682863|5762735|P2|NOT COMPLETED|Overall Study||17
2348123|NCT01682863|5762736|P1|NOT COMPLETED|Overall Study||27
2348124|NCT01682863|5762734|P3|COMPLETED|Overall Study||183
2348125|NCT01682863|5762735|P2|COMPLETED|Overall Study||187
2348126|NCT01682863|5762736|P1|COMPLETED|Overall Study||177
2348127|NCT01682863|5762734|P3|Randomized Set|Overall Study|1 randomized patient was not treated; experienced an AE prior to receiving any study drug|207
2348128|NCT01682863|5762735|P2|Randomized Set|Overall Study||204
2348129|NCT01682863|5762736|P1|Randomized Set|Overall Study||204
2348130|NCT01682863|5762734|P3|Full Analysis Set (FAS)|Overall Study||206
2348131|NCT01682863|5762735|P2|Full Analysis Set (FAS)|Overall Study||204
2348132|NCT01682863|5762736|P1|Full Analysis Set (FAS)|Overall Study|included all randomized patients who received at least one dose of study medication|204
2348133|NCT01682863|5762734|P3|Safety Set|Overall Study||206
2348134|NCT01682863|5762735|P2|Safety Set|Overall Study||204
2348135|NCT01682863|5762736|P1|Safety Set|Overall Study||204
2348136|NCT01682863|5762734|P3|STARTED|Overall Study||207
2348137|NCT01682863|5762735|P2|STARTED|Overall Study||204
2348138|NCT01682863|5762736|P1|STARTED|Overall Study||204
2348139|NCT01682837|5762765|P1|NOT COMPLETED|Fourth Intervention (4 Weeks)||0
2348140|NCT01682837|5762765|P1|COMPLETED|Fourth Intervention (4 Weeks)||30
2348141|NCT01682837|5762765|P1|Received Placebo|Fourth Intervention (4 Weeks)||7
2348142|NCT01682837|5762765|P1|Received KCl|Fourth Intervention (4 Weeks)||8
2348143|NCT01682837|5762765|P1|Received KCit|Fourth Intervention (4 Weeks)||9
2348144|NCT01682837|5762765|P1|Received KMgCit|Fourth Intervention (4 Weeks)||6
2348145|NCT01682837|5762765|P1|STARTED|Fourth Intervention (4 Weeks)||30
2348146|NCT01682837|5762765|P1|NOT COMPLETED|Third Intervention (4 Weeks)||0
2348147|NCT01682837|5762765|P1|COMPLETED|Third Intervention (4 Weeks)||30
2348148|NCT01682837|5762765|P1|Received Placebo|Third Intervention (4 Weeks)||7
2348149|NCT01682837|5762765|P1|Received KCl|Third Intervention (4 Weeks)||7
2348150|NCT01682837|5762765|P1|Received KCit|Third Intervention (4 Weeks)||7
2348151|NCT01682837|5762765|P1|Received KMgCit|Third Intervention (4 Weeks)||9
2348152|NCT01682837|5762765|P1|STARTED|Third Intervention (4 Weeks)||30
2348153|NCT01682837|5762765|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
2348154|NCT01682837|5762765|P1|COMPLETED|Second Intervention (4 Weeks)||30
2348155|NCT01682837|5762765|P1|Received Placebo|Second Intervention (4 Weeks)||9
2348156|NCT01682837|5762765|P1|Received KCl|Second Intervention (4 Weeks)||8
2348157|NCT01682837|5762765|P1|Received KCit|Second Intervention (4 Weeks)||6
2348158|NCT01682837|5762765|P1|Received KMgCit|Second Intervention (4 Weeks)||7
2348159|NCT01682837|5762765|P1|STARTED|Second Intervention (4 Weeks)||30
2348160|NCT01682837|5762765|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
2348161|NCT01682837|5762765|P1|COMPLETED|First Intervention (4 Weeks)||30
2348162|NCT01682837|5762765|P1|Received Placebo|First Intervention (4 Weeks)||7
2348163|NCT01682837|5762765|P1|Received KCl|First Intervention (4 Weeks)||7
2348164|NCT01682837|5762765|P1|Received KCit|First Intervention (4 Weeks)||8
2348165|NCT01682837|5762765|P1|Received KMgCit|First Intervention (4 Weeks)||8
2348166|NCT01682837|5762765|P1|STARTED|First Intervention (4 Weeks)||30
2348167|NCT01682837|5762765|P1|NOT COMPLETED|Baseline||5
2348168|NCT01682837|5762765|P1|COMPLETED|Baseline||30
2348169|NCT01682837|5762765|P1|STARTED|Baseline||35
2348170|NCT01682759|5762809|P2|NOT COMPLETED|Overall Study||70
2348171|NCT01682759|5762810|P1|NOT COMPLETED|Overall Study||69
2348172|NCT01682759|5762809|P2|COMPLETED|Overall Study||305
2348173|NCT01682759|5762810|P1|COMPLETED|Overall Study||307
2348174|NCT01682759|5762809|P2|Treated|Overall Study||375
2348175|NCT01682759|5762810|P1|Treated|Overall Study||375
2348176|NCT01682759|5762809|P2|STARTED|Overall Study||375
2348177|NCT01682759|5762810|P1|STARTED|Overall Study||376
2348178|NCT01682720|5762834|P4|NOT COMPLETED|Overall Study||39
2348179|NCT01682720|5762835|P3|NOT COMPLETED|Overall Study||7
2348180|NCT01682720|5762836|P2|NOT COMPLETED|Overall Study||5
2348181|NCT01682720|5762837|P1|NOT COMPLETED|Overall Study||85
2348182|NCT01682720|5762834|P4|COMPLETED|Overall Study||211
2348183|NCT01682720|5762835|P3|COMPLETED|Overall Study||5
2348184|NCT01682720|5762836|P2|COMPLETED|Overall Study||69
2348185|NCT01682720|5762837|P1|COMPLETED|Overall Study||0
2348186|NCT01682720|5762834|P4|Included in Full Analysis Set|Overall Study||250
2348187|NCT01682720|5762835|P3|Included in Full Analysis Set|Overall Study||11
2348188|NCT01682720|5762836|P2|Included in Full Analysis Set|Overall Study||73
2348189|NCT01682720|5762837|P1|Included in Full Analysis Set|Overall Study||0
2348190|NCT01682720|5762834|P4|STARTED|Overall Study||250
2348191|NCT01682720|5762835|P3|STARTED|Overall Study||12
2348192|NCT01682720|5762836|P2|STARTED|Overall Study||74
2348193|NCT01682720|5762837|P1|STARTED|Overall Study||85
2348194|NCT01682681|5762854|P1|NOT COMPLETED|Overall Study||332
2348195|NCT01682681|5762854|P1|COMPLETED|Overall Study||902
2348196|NCT01682681|5762854|P1|Treated|Overall Study|2 Participants were not compliant with eligibility criteria|1232
2348197|NCT01682681|5762854|P1|STARTED|Overall Study||1234
2348198|NCT01682642|5762864|P2|NOT COMPLETED|Overall Study||1
2348199|NCT01682642|5762865|P1|NOT COMPLETED|Overall Study||0
2348200|NCT01682642|5762864|P2|COMPLETED|Overall Study||58
2348201|NCT01682642|5762865|P1|COMPLETED|Overall Study||61
2348202|NCT01682642|5762864|P2|STARTED|Overall Study||59
2348203|NCT01682642|5762865|P1|STARTED|Overall Study||61
2348204|NCT01682603|5762883|P1|NOT COMPLETED|Overall Study||3
2348205|NCT01682603|5762883|P1|COMPLETED|Overall Study||34
2348206|NCT01682603|5762883|P1|STARTED|Overall Study||37
2348207|NCT01682538|5762897|P1|NOT COMPLETED|Overall Study||0
2348208|NCT01682538|5762897|P1|COMPLETED|Overall Study||12
2348209|NCT01682538|5762897|P1|STARTED|Overall Study||12
2348210|NCT01682512|5762928|P3|NOT COMPLETED|Overall Study||18
2348211|NCT01682512|5762929|P2|NOT COMPLETED|Overall Study||71
2348212|NCT01682512|5762930|P1|NOT COMPLETED|Overall Study||72
2348213|NCT01682512|5762928|P3|COMPLETED|Overall Study||48
2348214|NCT01682512|5762929|P2|COMPLETED|Overall Study||40
2348215|NCT01682512|5762930|P1|COMPLETED|Overall Study||44
2348216|NCT01682512|5762928|P3|Randomized in Part-II|Overall Study||0
2348217|NCT01682512|5762929|P2|Randomized in Part-II|Overall Study||46
2348218|NCT01682512|5762930|P1|Randomized in Part-II|Overall Study||50
2348219|NCT01682512|5762928|P3|Randomized in Part-I|Overall Study||66
2348220|NCT01682512|5762929|P2|Randomized in Part-I|Overall Study||65
2348221|NCT01682512|5762930|P1|Randomized in Part-I|Overall Study||66
2348222|NCT01682512|5762928|P3|STARTED|Overall Study||66
2348223|NCT01682512|5762929|P2|STARTED|Overall Study||111
2348224|NCT01682512|5762930|P1|STARTED|Overall Study||116
2348225|NCT01682460|5762955|P1|NOT COMPLETED|Overall Study||4
2348226|NCT01682460|5762955|P1|COMPLETED|Overall Study||11
2348227|NCT01682460|5762955|P1|STARTED|Overall Study||15
2348228|NCT01682148|5762972|P2|NOT COMPLETED|Overall Study||3
2348229|NCT01682148|5762973|P1|NOT COMPLETED|Overall Study||4
2348230|NCT01682148|5762972|P2|COMPLETED|Overall Study||41
2348231|NCT01682148|5762973|P1|COMPLETED|Overall Study||40
2348232|NCT01682148|5762972|P2|STARTED|Overall Study||44
2348233|NCT01682148|5762973|P1|STARTED|Overall Study||44
2348234|NCT01682135|5762997|P3|NOT COMPLETED|Overall Study||0
2348235|NCT01682135|5762998|P2|NOT COMPLETED|Overall Study||0
2348236|NCT01682135|5762999|P1|NOT COMPLETED|Overall Study||0
2348237|NCT01682135|5762997|P3|COMPLETED|Overall Study||12
2348238|NCT01682135|5762998|P2|COMPLETED|Overall Study||10
2348239|NCT01682135|5762999|P1|COMPLETED|Overall Study||6
2348240|NCT01682135|5762997|P3|Received at Least 1 Dose of Study Drug|Overall Study||12
2348241|NCT01682135|5762998|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
2348242|NCT01682135|5762999|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
2348243|NCT01682135|5762997|P3|STARTED|Overall Study||12
2348244|NCT01682135|5762998|P2|STARTED|Overall Study||10
2348245|NCT01682135|5762999|P1|STARTED|Overall Study||6
2348246|NCT01682083|5763033|P2|NOT COMPLETED|Overall Study||155
2348247|NCT01682083|5763034|P1|NOT COMPLETED|Overall Study||107
2348248|NCT01682083|5763033|P2|COMPLETED|Overall Study|Ongoing patients at the time of data cut-off.|277
2348249|NCT01682083|5763034|P1|COMPLETED|Overall Study|Ongoing patients at the time of data cut-off. 3 patients were untreated|331
2348250|NCT01682083|5763033|P2|STARTED|Overall Study||432
2348251|NCT01682083|5763034|P1|STARTED|Overall Study||438
2348252|NCT01682044|5763046|P1|NOT COMPLETED|Overall Study||4
2348253|NCT01682044|5763046|P1|COMPLETED|Overall Study||16
2348254|NCT01682044|5763046|P1|STARTED|Overall Study||20
2348255|NCT01682031|5763058|P2|NOT COMPLETED|Overall Study||5
2348256|NCT01682031|5763059|P1|NOT COMPLETED|Overall Study||1
2348257|NCT01682031|5763058|P2|COMPLETED|Overall Study||5
2348258|NCT01682031|5763059|P1|COMPLETED|Overall Study||7
2348259|NCT01682031|5763058|P2|STARTED|Overall Study||10
2348260|NCT01682031|5763059|P1|STARTED|Overall Study||8
2348261|NCT01681992|5763082|P3|NOT COMPLETED|Overall Study||83
2348262|NCT01681992|5763083|P2|NOT COMPLETED|Overall Study||70
2348263|NCT01681992|5763084|P1|NOT COMPLETED|Overall Study||66
2348264|NCT01681992|5763082|P3|COMPLETED|Overall Study||1443
2348265|NCT01681992|5763083|P2|COMPLETED|Overall Study||1427
2348266|NCT01681992|5763084|P1|COMPLETED|Overall Study||1427
2348267|NCT01681992|5763082|P3|STARTED|Overall Study||1526
2348268|NCT01681992|5763083|P2|STARTED|Overall Study||1497
2348269|NCT01681992|5763084|P1|STARTED|Overall Study||1493
2348270|NCT01681849|5763173|P3|NOT COMPLETED|Overall Study||39
2348271|NCT01681849|5763174|P2|NOT COMPLETED|Overall Study||7
2348272|NCT01681849|5763175|P1|NOT COMPLETED|Overall Study||8
2348273|NCT01681849|5763173|P3|COMPLETED|Overall Study||17
2348274|NCT01681849|5763174|P2|COMPLETED|Overall Study||6
2348275|NCT01681849|5763175|P1|COMPLETED|Overall Study||7
2348276|NCT01681849|5763173|P3|STARTED|Overall Study||56
2348277|NCT01681849|5763174|P2|STARTED|Overall Study||13
2348278|NCT01681849|5763175|P1|STARTED|Overall Study||15
2348279|NCT01681836|5763184|P2|NOT COMPLETED|Second Intervention||1
2348280|NCT01681836|5763185|P1|NOT COMPLETED|Second Intervention||0
2348281|NCT01681836|5763184|P2|COMPLETED|Second Intervention||4
2348282|NCT01681836|5763185|P1|COMPLETED|Second Intervention||6
2348283|NCT01681836|5763184|P2|STARTED|Second Intervention||5
2348284|NCT01681836|5763185|P1|STARTED|Second Intervention||6
2348285|NCT01681836|5763184|P2|NOT COMPLETED|Washout Period of 3-7 Days||0
2348286|NCT01681836|5763185|P1|NOT COMPLETED|Washout Period of 3-7 Days||0
2348287|NCT01681836|5763184|P2|COMPLETED|Washout Period of 3-7 Days||5
2348288|NCT01681836|5763185|P1|COMPLETED|Washout Period of 3-7 Days||6
2348289|NCT01681836|5763184|P2|STARTED|Washout Period of 3-7 Days||5
2348290|NCT01681836|5763185|P1|STARTED|Washout Period of 3-7 Days||6
2348291|NCT01681836|5763184|P2|NOT COMPLETED|First Intervention||0
2348292|NCT01681836|5763185|P1|NOT COMPLETED|First Intervention||0
2348293|NCT01681836|5763184|P2|COMPLETED|First Intervention||5
2348294|NCT01681836|5763185|P1|COMPLETED|First Intervention||6
2348295|NCT01681836|5763184|P2|STARTED|First Intervention||5
2348296|NCT01681836|5763185|P1|STARTED|First Intervention||6
2348297|NCT01681810|5763209|P1|NOT COMPLETED|Overall Study||0
2348298|NCT01681810|5763209|P1|COMPLETED|Overall Study||20
2348299|NCT01681810|5763209|P1|STARTED|Overall Study||20
2348300|NCT01681771|5763219|P2|NOT COMPLETED|Overall Study||2
2348301|NCT01681771|5763220|P1|NOT COMPLETED|Overall Study||4
2348302|NCT01681771|5763219|P2|COMPLETED|Overall Study||23
2348303|NCT01681771|5763220|P1|COMPLETED|Overall Study||21
2348304|NCT01681771|5763219|P2|STARTED|Overall Study||25
2348305|NCT01681771|5763220|P1|STARTED|Overall Study||25
2348306|NCT01681628|5763228|P2|NOT COMPLETED|19 Months Follow-up||43
2348307|NCT01681628|5763229|P1|NOT COMPLETED|19 Months Follow-up||62
2348308|NCT01681628|5763228|P2|COMPLETED|19 Months Follow-up||64
2348309|NCT01681628|5763229|P1|COMPLETED|19 Months Follow-up||52
2348310|NCT01681628|5763228|P2|STARTED|19 Months Follow-up||107
2348311|NCT01681628|5763229|P1|STARTED|19 Months Follow-up||114
2348312|NCT01681628|5763228|P2|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||15
2348313|NCT01681628|5763229|P1|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||0
2348314|NCT01681628|5763228|P2|COMPLETED|Time 2 to Time 3 (One Week Later).||107
2348315|NCT01681628|5763229|P1|COMPLETED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
2348316|NCT01681628|5763228|P2|STARTED|Time 2 to Time 3 (One Week Later).||122
2348317|NCT01681628|5763229|P1|STARTED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
2348318|NCT01681628|5763228|P2|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||6
2348319|NCT01681628|5763229|P1|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||14
2348320|NCT01681628|5763228|P2|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||122
2348321|NCT01681628|5763229|P1|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||114
2348322|NCT01681628|5763228|P2|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
2348323|NCT01681628|5763229|P1|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
2348324|NCT01681576|5763242|P2|NOT COMPLETED|Period 2||1
2348325|NCT01681576|5763243|P1|NOT COMPLETED|Period 2||4
2348326|NCT01681576|5763242|P2|COMPLETED|Period 2||35
2348327|NCT01681576|5763243|P1|COMPLETED|Period 2||30
2348328|NCT01681576|5763242|P2|STARTED|Period 2|Period 2: LCZ696 400mg|36
2348329|NCT01681576|5763243|P1|STARTED|Period 2|Period 2: Valsartan 320mg|34
2348330|NCT01681576|5763242|P2|NOT COMPLETED|Period 1||0
2348331|NCT01681576|5763243|P1|NOT COMPLETED|Period 1||2
2348332|NCT01681576|5763242|P2|COMPLETED|Period 1||36
2348333|NCT01681576|5763243|P1|COMPLETED|Period 1||34
2348334|NCT01681576|5763242|P2|STARTED|Period 1||36
2348335|NCT01681576|5763243|P1|STARTED|Period 1||36
2348336|NCT01681511|5763259|P2|NOT COMPLETED|Overall Study||14
2348337|NCT01681511|5763260|P1|NOT COMPLETED|Overall Study||18
2348338|NCT01681511|5763259|P2|COMPLETED|Overall Study||35
2348339|NCT01681511|5763260|P1|COMPLETED|Overall Study||28
2348340|NCT01681511|5763259|P2|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the TIC arm of this population.|14
2348341|NCT01681511|5763260|P1|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the Lubri-Sil arm of this population.|16
2348342|NCT01681511|5763259|P2|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the TIC treatment after randomization.|46
2348343|NCT01681511|5763260|P1|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the Lubri-Sil treatment after randomization.|45
2348344|NCT01681511|5763259|P2|STARTED|Overall Study|All randomized subjects in the TIC arm.|49
2348345|NCT01681511|5763260|P1|STARTED|Overall Study|All randomized subjects in the Lubri-Sil arm.|46
2348346|NCT01681472|5763278|P4|NOT COMPLETED|Overall Study||0
2348347|NCT01681472|5763279|P3|NOT COMPLETED|Overall Study||0
2348348|NCT01681472|5763280|P2|NOT COMPLETED|Overall Study||1
2348349|NCT01681472|5763281|P1|NOT COMPLETED|Overall Study||0
2348350|NCT01681472|5763278|P4|COMPLETED|Overall Study||8
2348351|NCT01681472|5763279|P3|COMPLETED|Overall Study||8
2348352|NCT01681472|5763280|P2|COMPLETED|Overall Study||7
2348353|NCT01681472|5763281|P1|COMPLETED|Overall Study||8
2348354|NCT01681472|5763278|P4|STARTED|Overall Study||8
2348355|NCT01681472|5763279|P3|STARTED|Overall Study||8
2348356|NCT01681472|5763280|P2|STARTED|Overall Study||8
2348357|NCT01681472|5763281|P1|STARTED|Overall Study||8
2348358|NCT01681433|5763461|P2|NOT COMPLETED|Overall Study||33
2348359|NCT01681433|5763462|P1|NOT COMPLETED|Overall Study||32
2348360|NCT01681433|5763461|P2|COMPLETED|Overall Study||3
2348361|NCT01681433|5763462|P1|COMPLETED|Overall Study||4
2348362|NCT01681433|5763461|P2|STARTED|Overall Study||36
2348363|NCT01681433|5763462|P1|STARTED|Overall Study||36
2348364|NCT01681368|5763480|P1|NOT COMPLETED|Overall Study||2
2348365|NCT01681368|5763480|P1|COMPLETED|Overall Study||9
2348366|NCT01681368|5763480|P1|STARTED|Overall Study||11
2348367|NCT01681277|5763497|P5|NOT COMPLETED|Overall Study||0
2348368|NCT01681277|5763498|P4|NOT COMPLETED|Overall Study||0
2348369|NCT01681277|5763499|P3|NOT COMPLETED|Overall Study||0
2348370|NCT01681277|5763500|P2|NOT COMPLETED|Overall Study||0
2348371|NCT01681277|5763501|P1|NOT COMPLETED|Overall Study||1
2348372|NCT01681277|5763497|P5|COMPLETED|Overall Study||9
2348373|NCT01681277|5763498|P4|COMPLETED|Overall Study||9
2348374|NCT01681277|5763499|P3|COMPLETED|Overall Study||9
2348375|NCT01681277|5763500|P2|COMPLETED|Overall Study||9
2348376|NCT01681277|5763501|P1|COMPLETED|Overall Study||11
2348377|NCT01681277|5763497|P5|STARTED|Overall Study||9
2348378|NCT01681277|5763498|P4|STARTED|Overall Study||9
2348379|NCT01681277|5763499|P3|STARTED|Overall Study||9
2348380|NCT01681277|5763500|P2|STARTED|Overall Study||9
2348381|NCT01681277|5763501|P1|STARTED|Overall Study||12
2348382|NCT01681212|5763542|P1|NOT COMPLETED|Overall Study||6
2348383|NCT01681212|5763542|P1|COMPLETED|Overall Study|Completed=patients who received treatment; not completed=patients who did not receive treatment|15
2348384|NCT01681212|5763542|P1|Received Treatment|Overall Study||15
2348385|NCT01681212|5763542|P1|STARTED|Overall Study|Enrolled|21
2348386|NCT01681186|5763556|P8|NOT COMPLETED|Fourth Intervention||1
2348387|NCT01681186|5763557|P7|NOT COMPLETED|Fourth Intervention||0
2348388|NCT01681186|5763558|P6|NOT COMPLETED|Fourth Intervention||0
2348389|NCT01681186|5763559|P5|NOT COMPLETED|Fourth Intervention||0
2348390|NCT01681186|5763560|P4|NOT COMPLETED|Fourth Intervention||0
2348391|NCT01681186|5763561|P3|NOT COMPLETED|Fourth Intervention||0
2348392|NCT01681186|5763562|P2|NOT COMPLETED|Fourth Intervention||0
2348393|NCT01681186|5763563|P1|NOT COMPLETED|Fourth Intervention||0
2348394|NCT01681186|5763556|P8|COMPLETED|Fourth Intervention||5
2348395|NCT01681186|5763557|P7|COMPLETED|Fourth Intervention||5
2348396|NCT01681186|5763558|P6|COMPLETED|Fourth Intervention||0
2348397|NCT01681186|5763559|P5|COMPLETED|Fourth Intervention||0
2348398|NCT01681186|5763560|P4|COMPLETED|Fourth Intervention||0
2348399|NCT01681186|5763561|P3|COMPLETED|Fourth Intervention||0
2348400|NCT01681186|5763562|P2|COMPLETED|Fourth Intervention||0
2348401|NCT01681186|5763563|P1|COMPLETED|Fourth Intervention||0
2348402|NCT01681186|5763556|P8|STARTED|Fourth Intervention||6
2348403|NCT01681186|5763557|P7|STARTED|Fourth Intervention||5
2348404|NCT01681186|5763558|P6|STARTED|Fourth Intervention||0
2348405|NCT01681186|5763559|P5|STARTED|Fourth Intervention||0
2348406|NCT01681186|5763560|P4|STARTED|Fourth Intervention||0
2348407|NCT01681186|5763561|P3|STARTED|Fourth Intervention||0
2348408|NCT01681186|5763562|P2|STARTED|Fourth Intervention||0
2348409|NCT01681186|5763563|P1|STARTED|Fourth Intervention||0
2348410|NCT01681186|5763556|P8|NOT COMPLETED|Washout Period From Third Intervention||0
2348411|NCT01681186|5763557|P7|NOT COMPLETED|Washout Period From Third Intervention||1
2348412|NCT01681186|5763558|P6|NOT COMPLETED|Washout Period From Third Intervention||0
2348413|NCT01681186|5763559|P5|NOT COMPLETED|Washout Period From Third Intervention||0
2348414|NCT01681186|5763560|P4|NOT COMPLETED|Washout Period From Third Intervention||0
2348415|NCT01681186|5763561|P3|NOT COMPLETED|Washout Period From Third Intervention||0
2348416|NCT01681186|5763562|P2|NOT COMPLETED|Washout Period From Third Intervention||0
2348417|NCT01681186|5763563|P1|NOT COMPLETED|Washout Period From Third Intervention||0
2348418|NCT01681186|5763556|P8|COMPLETED|Washout Period From Third Intervention||6
2348419|NCT01681186|5763557|P7|COMPLETED|Washout Period From Third Intervention||5
2348420|NCT01681186|5763558|P6|COMPLETED|Washout Period From Third Intervention||0
2348421|NCT01681186|5763559|P5|COMPLETED|Washout Period From Third Intervention||0
2348422|NCT01681186|5763560|P4|COMPLETED|Washout Period From Third Intervention||0
2348423|NCT01681186|5763561|P3|COMPLETED|Washout Period From Third Intervention||0
2348424|NCT01681186|5763562|P2|COMPLETED|Washout Period From Third Intervention||0
2348425|NCT01681186|5763563|P1|COMPLETED|Washout Period From Third Intervention||0
2348426|NCT01681186|5763556|P8|STARTED|Washout Period From Third Intervention||6
2348427|NCT01681186|5763557|P7|STARTED|Washout Period From Third Intervention||6
2348428|NCT01681186|5763558|P6|STARTED|Washout Period From Third Intervention||0
2348429|NCT01681186|5763559|P5|STARTED|Washout Period From Third Intervention||0
2348430|NCT01681186|5763560|P4|STARTED|Washout Period From Third Intervention||0
2348431|NCT01681186|5763561|P3|STARTED|Washout Period From Third Intervention||0
2348432|NCT01681186|5763562|P2|STARTED|Washout Period From Third Intervention||0
2348433|NCT01681186|5763563|P1|STARTED|Washout Period From Third Intervention||0
2348434|NCT01681186|5763556|P8|NOT COMPLETED|Third Intervention||0
2348435|NCT01681186|5763557|P7|NOT COMPLETED|Third Intervention||0
2348436|NCT01681186|5763558|P6|NOT COMPLETED|Third Intervention||0
2348437|NCT01681186|5763559|P5|NOT COMPLETED|Third Intervention||0
2348438|NCT01681186|5763560|P4|NOT COMPLETED|Third Intervention||0
2348439|NCT01681186|5763561|P3|NOT COMPLETED|Third Intervention||0
2348440|NCT01681186|5763562|P2|NOT COMPLETED|Third Intervention||0
2348441|NCT01681186|5763563|P1|NOT COMPLETED|Third Intervention||0
2348442|NCT01681186|5763556|P8|COMPLETED|Third Intervention||6
2348443|NCT01681186|5763557|P7|COMPLETED|Third Intervention||6
2348444|NCT01681186|5763558|P6|COMPLETED|Third Intervention||0
2348445|NCT01681186|5763559|P5|COMPLETED|Third Intervention||0
2348446|NCT01681186|5763560|P4|COMPLETED|Third Intervention||0
2348447|NCT01681186|5763561|P3|COMPLETED|Third Intervention||0
2348448|NCT01681186|5763562|P2|COMPLETED|Third Intervention||0
2348449|NCT01681186|5763563|P1|COMPLETED|Third Intervention||0
2348450|NCT01681186|5763556|P8|STARTED|Third Intervention||6
2348451|NCT01681186|5763557|P7|STARTED|Third Intervention||6
2348452|NCT01681186|5763558|P6|STARTED|Third Intervention||0
2348453|NCT01681186|5763559|P5|STARTED|Third Intervention||0
2348454|NCT01681186|5763560|P4|STARTED|Third Intervention||0
2348455|NCT01681186|5763561|P3|STARTED|Third Intervention||0
2348456|NCT01681186|5763562|P2|STARTED|Third Intervention||0
2348457|NCT01681186|5763563|P1|STARTED|Third Intervention||0
2348458|NCT01681186|5763556|P8|NOT COMPLETED|Washout Period From Second Intervention||1
2348459|NCT01681186|5763557|P7|NOT COMPLETED|Washout Period From Second Intervention||1
2348460|NCT01681186|5763558|P6|NOT COMPLETED|Washout Period From Second Intervention||0
2348461|NCT01681186|5763559|P5|NOT COMPLETED|Washout Period From Second Intervention||0
2348462|NCT01681186|5763560|P4|NOT COMPLETED|Washout Period From Second Intervention||0
2348463|NCT01681186|5763561|P3|NOT COMPLETED|Washout Period From Second Intervention||0
2348464|NCT01681186|5763562|P2|NOT COMPLETED|Washout Period From Second Intervention||0
2348465|NCT01681186|5763563|P1|NOT COMPLETED|Washout Period From Second Intervention||0
2348466|NCT01681186|5763556|P8|COMPLETED|Washout Period From Second Intervention||6
2348467|NCT01681186|5763557|P7|COMPLETED|Washout Period From Second Intervention||6
2348468|NCT01681186|5763558|P6|COMPLETED|Washout Period From Second Intervention||0
2348469|NCT01681186|5763559|P5|COMPLETED|Washout Period From Second Intervention||0
2348470|NCT01681186|5763560|P4|COMPLETED|Washout Period From Second Intervention||0
2348471|NCT01681186|5763561|P3|COMPLETED|Washout Period From Second Intervention||0
2348472|NCT01681186|5763562|P2|COMPLETED|Washout Period From Second Intervention||0
2348473|NCT01681186|5763563|P1|COMPLETED|Washout Period From Second Intervention||0
2348474|NCT01681186|5763556|P8|STARTED|Washout Period From Second Intervention||7
2348475|NCT01681186|5763557|P7|STARTED|Washout Period From Second Intervention||7
2348476|NCT01681186|5763558|P6|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
2348477|NCT01681186|5763559|P5|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
2348478|NCT01681186|5763560|P4|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
2348479|NCT01681186|5763561|P3|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
2348480|NCT01681186|5763562|P2|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
2348481|NCT01681186|5763563|P1|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
2348482|NCT01681186|5763556|P8|NOT COMPLETED|Second Intervention||0
2348483|NCT01681186|5763557|P7|NOT COMPLETED|Second Intervention||0
2348484|NCT01681186|5763558|P6|NOT COMPLETED|Second Intervention||0
2348485|NCT01681186|5763559|P5|NOT COMPLETED|Second Intervention||0
2348486|NCT01681186|5763560|P4|NOT COMPLETED|Second Intervention||0
2348487|NCT01681186|5763561|P3|NOT COMPLETED|Second Intervention||0
2348488|NCT01681186|5763562|P2|NOT COMPLETED|Second Intervention||0
2348489|NCT01681186|5763563|P1|NOT COMPLETED|Second Intervention||0
2348490|NCT01681186|5763556|P8|COMPLETED|Second Intervention||7
2348491|NCT01681186|5763557|P7|COMPLETED|Second Intervention||7
2348492|NCT01681186|5763558|P6|COMPLETED|Second Intervention||2
2348493|NCT01681186|5763559|P5|COMPLETED|Second Intervention||3
2348494|NCT01681186|5763560|P4|COMPLETED|Second Intervention||3
2348495|NCT01681186|5763561|P3|COMPLETED|Second Intervention||2
2348496|NCT01681186|5763562|P2|COMPLETED|Second Intervention||2
2348497|NCT01681186|5763563|P1|COMPLETED|Second Intervention||4
2348498|NCT01681186|5763556|P8|STARTED|Second Intervention||7
2348499|NCT01681186|5763557|P7|STARTED|Second Intervention||7
2348500|NCT01681186|5763558|P6|STARTED|Second Intervention||2
2348501|NCT01681186|5763559|P5|STARTED|Second Intervention||3
2348502|NCT01681186|5763560|P4|STARTED|Second Intervention||3
2348503|NCT01681186|5763561|P3|STARTED|Second Intervention||2
2348504|NCT01681186|5763562|P2|STARTED|Second Intervention||2
2348505|NCT01681186|5763563|P1|STARTED|Second Intervention||4
2348506|NCT01681186|5763556|P8|NOT COMPLETED|Washout Period From First Intervention||0
2348507|NCT01681186|5763557|P7|NOT COMPLETED|Washout Period From First Intervention||0
2348508|NCT01681186|5763558|P6|NOT COMPLETED|Washout Period From First Intervention||0
2348509|NCT01681186|5763559|P5|NOT COMPLETED|Washout Period From First Intervention||0
2348510|NCT01681186|5763560|P4|NOT COMPLETED|Washout Period From First Intervention||0
2348511|NCT01681186|5763561|P3|NOT COMPLETED|Washout Period From First Intervention||0
2348512|NCT01681186|5763562|P2|NOT COMPLETED|Washout Period From First Intervention||0
2348513|NCT01681186|5763563|P1|NOT COMPLETED|Washout Period From First Intervention||0
2348514|NCT01681186|5763556|P8|COMPLETED|Washout Period From First Intervention||7
2348515|NCT01681186|5763557|P7|COMPLETED|Washout Period From First Intervention||7
2348516|NCT01681186|5763558|P6|COMPLETED|Washout Period From First Intervention||2
2348517|NCT01681186|5763559|P5|COMPLETED|Washout Period From First Intervention||3
2348518|NCT01681186|5763560|P4|COMPLETED|Washout Period From First Intervention||3
2348519|NCT01681186|5763561|P3|COMPLETED|Washout Period From First Intervention||2
2348520|NCT01681186|5763562|P2|COMPLETED|Washout Period From First Intervention||2
2348521|NCT01681186|5763563|P1|COMPLETED|Washout Period From First Intervention||4
2348522|NCT01681186|5763556|P8|STARTED|Washout Period From First Intervention||7
2348523|NCT01681186|5763557|P7|STARTED|Washout Period From First Intervention||7
2348524|NCT01681186|5763558|P6|STARTED|Washout Period From First Intervention||2
2348525|NCT01681186|5763559|P5|STARTED|Washout Period From First Intervention||3
2348526|NCT01681186|5763560|P4|STARTED|Washout Period From First Intervention||3
2348527|NCT01681186|5763561|P3|STARTED|Washout Period From First Intervention||2
2348528|NCT01681186|5763562|P2|STARTED|Washout Period From First Intervention||2
2348529|NCT01681186|5763563|P1|STARTED|Washout Period From First Intervention||4
2348530|NCT01681186|5763556|P8|NOT COMPLETED|First Intervention||0
2348531|NCT01681186|5763557|P7|NOT COMPLETED|First Intervention||0
2348532|NCT01681186|5763558|P6|NOT COMPLETED|First Intervention||0
2348533|NCT01681186|5763559|P5|NOT COMPLETED|First Intervention||0
2348534|NCT01681186|5763560|P4|NOT COMPLETED|First Intervention||0
2348535|NCT01681186|5763561|P3|NOT COMPLETED|First Intervention||0
2348536|NCT01681186|5763562|P2|NOT COMPLETED|First Intervention||0
2348537|NCT01681186|5763563|P1|NOT COMPLETED|First Intervention||0
2348538|NCT01681186|5763556|P8|COMPLETED|First Intervention||7
2348539|NCT01681186|5763557|P7|COMPLETED|First Intervention||7
2348540|NCT01681186|5763558|P6|COMPLETED|First Intervention||2
2348541|NCT01681186|5763559|P5|COMPLETED|First Intervention||3
2348542|NCT01681186|5763560|P4|COMPLETED|First Intervention||3
2348543|NCT01681186|5763561|P3|COMPLETED|First Intervention||2
2348544|NCT01681186|5763562|P2|COMPLETED|First Intervention||2
2348545|NCT01681186|5763563|P1|COMPLETED|First Intervention||4
2348546|NCT01681186|5763556|P8|STARTED|First Intervention||7
2348547|NCT01681186|5763557|P7|STARTED|First Intervention||7
2348548|NCT01681186|5763558|P6|STARTED|First Intervention||2
2348549|NCT01681186|5763559|P5|STARTED|First Intervention||3
2348550|NCT01681186|5763560|P4|STARTED|First Intervention||3
2348551|NCT01681186|5763561|P3|STARTED|First Intervention||2
2348552|NCT01681186|5763562|P2|STARTED|First Intervention||2
2348553|NCT01681186|5763563|P1|STARTED|First Intervention||4
2348554|NCT01681121|5763616|P2|NOT COMPLETED|Overall Study||11
2348555|NCT01681121|5763617|P1|NOT COMPLETED|Overall Study||8
2348556|NCT01681121|5763616|P2|COMPLETED|Overall Study||38
2348557|NCT01681121|5763617|P1|COMPLETED|Overall Study||36
2348558|NCT01681121|5763616|P2|STARTED|Overall Study||49
2348559|NCT01681121|5763617|P1|STARTED|Overall Study||44
2348560|NCT01681095|5763625|P2|NOT COMPLETED|Overall Study||0
2348561|NCT01681095|5763626|P1|NOT COMPLETED|Overall Study||0
2348562|NCT01681095|5763625|P2|COMPLETED|Overall Study||55
2348563|NCT01681095|5763626|P1|COMPLETED|Overall Study||55
2348564|NCT01681095|5763625|P2|STARTED|Overall Study||55
2348565|NCT01681095|5763626|P1|STARTED|Overall Study||55
2348566|NCT01681069|5763666|P2|NOT COMPLETED|Overall Study||7
2348567|NCT01681069|5763667|P1|NOT COMPLETED|Overall Study||5
2348568|NCT01681069|5763666|P2|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|53
2348569|NCT01681069|5763667|P1|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|55
2348570|NCT01681069|5763666|P2|Full Analysis Set (FAS)|Overall Study||60
2348571|NCT01681069|5763667|P1|Full Analysis Set (FAS)|Overall Study||57
2348572|NCT01681069|5763666|P2|STARTED|Overall Study||60
2348573|NCT01681069|5763667|P1|STARTED|Overall Study||60
2348574|NCT01681030|5763680|P3|NOT COMPLETED|Overall Study||0
2348575|NCT01681030|5763681|P2|NOT COMPLETED|Overall Study||0
2348576|NCT01681030|5763682|P1|NOT COMPLETED|Overall Study||0
2348577|NCT01681030|5763680|P3|COMPLETED|Overall Study||11
2348578|NCT01681030|5763681|P2|COMPLETED|Overall Study||18
2348579|NCT01681030|5763682|P1|COMPLETED|Overall Study||13
2348580|NCT01681030|5763680|P3|STARTED|Overall Study||11
2348581|NCT01681030|5763681|P2|STARTED|Overall Study||18
2348582|NCT01681030|5763682|P1|STARTED|Overall Study||13
2348583|NCT01681004|5763704|P2|NOT COMPLETED|Study Completion||8
2348584|NCT01681004|5763705|P1|NOT COMPLETED|Study Completion||12
2348585|NCT01681004|5763704|P2|COMPLETED|Study Completion||36
2348586|NCT01681004|5763705|P1|COMPLETED|Study Completion||89
2348587|NCT01681004|5763704|P2|STARTED|Study Completion||44
2348588|NCT01681004|5763705|P1|STARTED|Study Completion||101
2348589|NCT01681004|5763704|P2|NOT COMPLETED|Primary Endpoint: 6 Months||2
2348590|NCT01681004|5763705|P1|NOT COMPLETED|Primary Endpoint: 6 Months||1
2348591|NCT01681004|5763704|P2|COMPLETED|Primary Endpoint: 6 Months||44
2348592|NCT01681004|5763705|P1|COMPLETED|Primary Endpoint: 6 Months||101
2348593|NCT01681004|5763704|P2|Crossover to Surgical Treatment|Primary Endpoint: 6 Months|Crossover to surgical treatment allowed per study protocol after the 6-month visit was complete.|39
2348594|NCT01681004|5763705|P1|Crossover to Surgical Treatment|Primary Endpoint: 6 Months||0
2348595|NCT01681004|5763704|P2|STARTED|Primary Endpoint: 6 Months||46
2348596|NCT01681004|5763705|P1|STARTED|Primary Endpoint: 6 Months||102
2348597|NCT01680991|5763762|P3|NOT COMPLETED|Overall Study||4
2348598|NCT01680991|5763763|P2|NOT COMPLETED|Overall Study||19
2348599|NCT01680991|5763764|P1|NOT COMPLETED|Overall Study||8
2348600|NCT01680991|5763762|P3|COMPLETED|Overall Study||9
2348601|NCT01680991|5763763|P2|COMPLETED|Overall Study||4
2348602|NCT01680991|5763764|P1|COMPLETED|Overall Study||4
2348603|NCT01680991|5763762|P3|STARTED|Overall Study||13
2348604|NCT01680991|5763763|P2|STARTED|Overall Study||23
2348605|NCT01680991|5763764|P1|STARTED|Overall Study||12
2348606|NCT01680900|5763825|P2|NOT COMPLETED|Overall Study||1
2348607|NCT01680900|5763826|P1|NOT COMPLETED|Overall Study||4
2348608|NCT01680900|5763825|P2|COMPLETED|Overall Study||11
2348609|NCT01680900|5763826|P1|COMPLETED|Overall Study||20
2348610|NCT01680900|5763825|P2|STARTED|Overall Study||12
2348611|NCT01680900|5763826|P1|STARTED|Overall Study||24
2348612|NCT01680887|5763844|P2|NOT COMPLETED|Overall Study||24
2348613|NCT01680887|5763845|P1|NOT COMPLETED|Overall Study||29
2348614|NCT01680887|5763844|P2|COMPLETED|Overall Study||52
2348615|NCT01680887|5763845|P1|COMPLETED|Overall Study||51
2348616|NCT01680887|5763844|P2|STARTED|Overall Study||76
2348617|NCT01680887|5763845|P1|STARTED|Overall Study||80
2348618|NCT01680861|5763855|P2|NOT COMPLETED|First 12 Months Post-transplant||0
2348619|NCT01680861|5763856|P1|NOT COMPLETED|First 12 Months Post-transplant||0
2348620|NCT01680861|5763855|P2|COMPLETED|First 12 Months Post-transplant||15
2348621|NCT01680861|5763856|P1|COMPLETED|First 12 Months Post-transplant||15
2348622|NCT01680861|5763855|P2|STARTED|First 12 Months Post-transplant||15
2348623|NCT01680861|5763856|P1|STARTED|First 12 Months Post-transplant||15
2348624|NCT01680861|5763855|P2|NOT COMPLETED|Early Post-transplant Period||1
2348625|NCT01680861|5763856|P1|NOT COMPLETED|Early Post-transplant Period||1
2348626|NCT01680861|5763855|P2|COMPLETED|Early Post-transplant Period||15
2348627|NCT01680861|5763856|P1|COMPLETED|Early Post-transplant Period||15
2348628|NCT01680861|5763855|P2|STARTED|Early Post-transplant Period|One patient developed immediate DGF (delayed graft function) and was therefore ineligible.|16
2348629|NCT01680861|5763856|P1|STARTED|Early Post-transplant Period|One patient didn't produce sufficient urine during first 24hr post-transplant (ineligible).|16
2348630|NCT01680848|5763874|P1|NOT COMPLETED|Overall Study||93
2348631|NCT01680848|5763874|P1|COMPLETED|Overall Study||189
2348632|NCT01680848|5763874|P1|STARTED|Overall Study||282
2348633|NCT01680835|5763878|P1|NOT COMPLETED|Overall Study||25
2348634|NCT01680835|5763878|P1|COMPLETED|Overall Study||83
2348635|NCT01680835|5763878|P1|STARTED|Overall Study||108
2348636|NCT01680783|5763894|P2|NOT COMPLETED|Overall Study||0
2348637|NCT01680783|5763895|P1|NOT COMPLETED|Overall Study||0
2348638|NCT01680783|5763894|P2|COMPLETED|Overall Study||44
2348639|NCT01680783|5763895|P1|COMPLETED|Overall Study||39
2348640|NCT01680783|5763894|P2|STARTED|Overall Study||44
2348641|NCT01680783|5763895|P1|STARTED|Overall Study||39
2348642|NCT01680666|5763903|P2|NOT COMPLETED|Overall Study||0
2348643|NCT01680666|5763904|P1|NOT COMPLETED|Overall Study||0
2348644|NCT01680666|5763903|P2|COMPLETED|Overall Study||66
2348645|NCT01680666|5763904|P1|COMPLETED|Overall Study||84
2348646|NCT01680666|5763903|P2|STARTED|Overall Study||66
2348647|NCT01680666|5763904|P1|STARTED|Overall Study||84
2348648|NCT01680653|5763918|P1|NOT COMPLETED|Overall Study||0
2348649|NCT01680653|5763918|P1|COMPLETED|Overall Study||57
2348650|NCT01680653|5763918|P1|STARTED|Overall Study||57
2348651|NCT01680549|5763930|P2|NOT COMPLETED|Overall Study||8
2348652|NCT01680549|5763931|P1|NOT COMPLETED|Overall Study||5
2348653|NCT01680549|5763930|P2|COMPLETED|Overall Study||17
2348654|NCT01680549|5763931|P1|COMPLETED|Overall Study||20
2348655|NCT01680549|5763930|P2|STARTED|Overall Study||25
2348656|NCT01680549|5763931|P1|STARTED|Overall Study||25
2348657|NCT01680497|5763943|P1|NOT COMPLETED|Overall Study||2
2348658|NCT01680497|5763943|P1|COMPLETED|Overall Study||68
2348659|NCT01680497|5763943|P1|STARTED|Overall Study||70
2348660|NCT01680458|5763953|P1|NOT COMPLETED|Overall Study||3
2348661|NCT01680458|5763953|P1|COMPLETED|Overall Study||27
2348662|NCT01680458|5763953|P1|STARTED|Overall Study||30
2348663|NCT01680341|5763964|P2|NOT COMPLETED|Overall Study||17
2348664|NCT01680341|5763965|P1|NOT COMPLETED|Overall Study||21
2348665|NCT01680341|5763964|P2|COMPLETED|Overall Study||119
2348666|NCT01680341|5763965|P1|COMPLETED|Overall Study||115
2348667|NCT01680341|5763964|P2|Exposed|Overall Study|Two (2) subjects withdrew consent prior to exposure to trial product.|134
2348668|NCT01680341|5763965|P1|Exposed|Overall Study|One (1) subject withdrew consent prior to exposure to trial product.|135
2348669|NCT01680341|5763964|P2|STARTED|Overall Study||136
2348670|NCT01680341|5763965|P1|STARTED|Overall Study||136
2348671|NCT01680328|5763985|P1|NOT COMPLETED|Overall Study||2
2348672|NCT01680328|5763985|P1|COMPLETED|Overall Study||80
2348673|NCT01680328|5763985|P1|Subjects Missing Injections|Overall Study|One missed the [1600 μL, 450 μL/s; thighs]; one missed the [400 μL, 300 μL/s; abdomen]|2
2348674|NCT01680328|5763985|P1|STARTED|Overall Study||82
2348675|NCT01680172|5764023|P2|NOT COMPLETED|Overall Study||0
2348676|NCT01680172|5764024|P1|NOT COMPLETED|Overall Study||0
2348677|NCT01680172|5764023|P2|COMPLETED|Overall Study||2
2348678|NCT01680172|5764024|P1|COMPLETED|Overall Study||3
2348679|NCT01680172|5764023|P2|STARTED|Overall Study||2
2348680|NCT01680172|5764024|P1|STARTED|Overall Study||3
2348681|NCT01680159|5764036|P1|NOT COMPLETED|Increased Dose Period||8
2348682|NCT01680159|5764036|P1|COMPLETED|Increased Dose Period||43
2348683|NCT01680159|5764036|P1|STARTED|Increased Dose Period||51
2348684|NCT01680159|5764036|P1|NOT COMPLETED|Screening Period||7
2348685|NCT01680159|5764036|P1|COMPLETED|Screening Period||39
2348686|NCT01680159|5764036|P1|STARTED|Screening Period||46
2348687|NCT01680016|5764063|P4|NOT COMPLETED|Overall Study||5
2348688|NCT01680016|5764064|P3|NOT COMPLETED|Overall Study||5
2348689|NCT01680016|5764065|P2|NOT COMPLETED|Overall Study||8
2348690|NCT01680016|5764066|P1|NOT COMPLETED|Overall Study||6
2348691|NCT01680016|5764063|P4|COMPLETED|Overall Study||195
2348692|NCT01680016|5764064|P3|COMPLETED|Overall Study||196
2348693|NCT01680016|5764065|P2|COMPLETED|Overall Study||114
2348694|NCT01680016|5764066|P1|COMPLETED|Overall Study||115
2348695|NCT01680016|5764063|P4|STARTED|Overall Study||200
2348696|NCT01680016|5764064|P3|STARTED|Overall Study||201
2348697|NCT01680016|5764065|P2|STARTED|Overall Study||122
2348698|NCT01680016|5764066|P1|STARTED|Overall Study||121
2348699|NCT01679613|5764128|P4|NOT COMPLETED|Overall Study||2
2348700|NCT01679613|5764129|P3|NOT COMPLETED|Overall Study||2
2348701|NCT01679613|5764130|P2|NOT COMPLETED|Overall Study||1
2348702|NCT01679613|5764131|P1|NOT COMPLETED|Overall Study||0
2348703|NCT01679613|5764128|P4|COMPLETED|Overall Study||11
2348704|NCT01679613|5764129|P3|COMPLETED|Overall Study||11
2348705|NCT01679613|5764130|P2|COMPLETED|Overall Study||3
2348706|NCT01679613|5764131|P1|COMPLETED|Overall Study||4
2348707|NCT01679613|5764128|P4|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
2348708|NCT01679613|5764129|P3|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
2348709|NCT01679613|5764130|P2|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
2348710|NCT01679613|5764131|P1|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
2348711|NCT01679613|5764128|P4|Received Nintedanib (Main)|Overall Study||11
2348712|NCT01679613|5764129|P3|Received Nintedanib (Main)|Overall Study||13
2348713|NCT01679613|5764130|P2|Received Nintedanib (Main)|Overall Study||0
2348714|NCT01679613|5764131|P1|Received Nintedanib (Main)|Overall Study||0
2348715|NCT01679613|5764128|P4|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
2348716|NCT01679613|5764129|P3|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
2348717|NCT01679613|5764130|P2|Received Nintedanib+Ketoconazole (Pilot)|Overall Study|One subject received only ketoconazole not nintedanib|4
2348718|NCT01679613|5764131|P1|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||4
2348719|NCT01679613|5764128|P4|Received Nintedanib (Pilot)|Overall Study||0
2348720|NCT01679613|5764129|P3|Received Nintedanib (Pilot)|Overall Study||0
2348721|NCT01679613|5764130|P2|Received Nintedanib (Pilot)|Overall Study||3
2348722|NCT01679613|5764131|P1|Received Nintedanib (Pilot)|Overall Study||4
2348723|NCT01679613|5764128|P4|STARTED|Overall Study||13
2348724|NCT01679613|5764129|P3|STARTED|Overall Study||13
2348725|NCT01679613|5764130|P2|STARTED|Overall Study||4
2348726|NCT01679613|5764131|P1|STARTED|Overall Study||4
2348727|NCT01679600|5764144|P2|NOT COMPLETED|Overall Study||0
2348728|NCT01679600|5764145|P1|NOT COMPLETED|Overall Study||0
2348729|NCT01679600|5764144|P2|COMPLETED|Overall Study||7
2348730|NCT01679600|5764145|P1|COMPLETED|Overall Study||7
2348731|NCT01679600|5764144|P2|STARTED|Overall Study||7
2348732|NCT01679600|5764145|P1|STARTED|Overall Study||7
2348733|NCT01679405|5764153|P2|NOT COMPLETED|Overall Study||5
2348734|NCT01679405|5764154|P1|NOT COMPLETED|Overall Study||2
2348735|NCT01679405|5764153|P2|COMPLETED|Overall Study||1
2348736|NCT01679405|5764154|P1|COMPLETED|Overall Study||1
2348737|NCT01679405|5764153|P2|STARTED|Overall Study||6
2348738|NCT01679405|5764154|P1|STARTED|Overall Study||3
2348739|NCT01679314|5764170|P2|NOT COMPLETED|Overall Study||0
2348740|NCT01679314|5764171|P1|NOT COMPLETED|Overall Study||2
2348741|NCT01679314|5764170|P2|COMPLETED|Overall Study||28
2348742|NCT01679314|5764171|P1|COMPLETED|Overall Study||24
2348743|NCT01679314|5764170|P2|STARTED|Overall Study||28
2348744|NCT01679314|5764171|P1|STARTED|Overall Study||26
2348745|NCT01679301|5764189|P3|NOT COMPLETED|Study Period||0
2348746|NCT01679301|5764190|P2|NOT COMPLETED|Study Period||0
2348747|NCT01679301|5764191|P1|NOT COMPLETED|Study Period||0
2348748|NCT01679301|5764189|P3|COMPLETED|Study Period||4
2348749|NCT01679301|5764190|P2|COMPLETED|Study Period||4
2348750|NCT01679301|5764191|P1|COMPLETED|Study Period||0
2348751|NCT01679301|5764189|P3|STARTED|Study Period||4
2348752|NCT01679301|5764190|P2|STARTED|Study Period||4
2348753|NCT01679301|5764191|P1|STARTED|Study Period||0
2348754|NCT01679301|5764189|P3|NOT COMPLETED|Screening Period||0
2348755|NCT01679301|5764190|P2|NOT COMPLETED|Screening Period||0
2348756|NCT01679301|5764191|P1|NOT COMPLETED|Screening Period||3
2348757|NCT01679301|5764189|P3|COMPLETED|Screening Period||0
2348758|NCT01679301|5764190|P2|COMPLETED|Screening Period||0
2348759|NCT01679301|5764191|P1|COMPLETED|Screening Period||8
2348760|NCT01679301|5764189|P3|STARTED|Screening Period||0
2348761|NCT01679301|5764190|P2|STARTED|Screening Period||0
2348762|NCT01679301|5764191|P1|STARTED|Screening Period||11
2348763|NCT01679236|5764199|P2|NOT COMPLETED|Overall Study||15
2348764|NCT01679236|5764200|P1|NOT COMPLETED|Overall Study||15
2348765|NCT01679236|5764199|P2|COMPLETED|Overall Study||10
2348766|NCT01679236|5764200|P1|COMPLETED|Overall Study||15
2348767|NCT01679236|5764199|P2|STARTED|Overall Study||25
2348768|NCT01679236|5764200|P1|STARTED|Overall Study||30
2348769|NCT01679197|5764206|P1|NOT COMPLETED|Overall Study||4
2348770|NCT01679197|5764206|P1|COMPLETED|Overall Study||19
2348771|NCT01679197|5764206|P1|STARTED|Overall Study||23
2348772|NCT01679028|5764225|P6|NOT COMPLETED|Overall Study||0
2348773|NCT01679028|5764226|P5|NOT COMPLETED|Overall Study||0
2348774|NCT01679028|5764227|P4|NOT COMPLETED|Overall Study||0
2348775|NCT01679028|5764228|P3|NOT COMPLETED|Overall Study||0
2348776|NCT01679028|5764229|P2|NOT COMPLETED|Overall Study||0
2348777|NCT01679028|5764230|P1|NOT COMPLETED|Overall Study||0
2348778|NCT01679028|5764225|P6|COMPLETED|Overall Study||6
2348779|NCT01679028|5764226|P5|COMPLETED|Overall Study||2
2348780|NCT01679028|5764227|P4|COMPLETED|Overall Study||4
2348781|NCT01679028|5764228|P3|COMPLETED|Overall Study||2
2348782|NCT01679028|5764229|P2|COMPLETED|Overall Study||4
2348783|NCT01679028|5764230|P1|COMPLETED|Overall Study||2
2348784|NCT01679028|5764225|P6|STARTED|Overall Study||6
2348785|NCT01679028|5764226|P5|STARTED|Overall Study||2
2348786|NCT01679028|5764227|P4|STARTED|Overall Study||4
2348787|NCT01679028|5764228|P3|STARTED|Overall Study||2
2348788|NCT01679028|5764229|P2|STARTED|Overall Study||4
2348789|NCT01679028|5764230|P1|STARTED|Overall Study||2
2348790|NCT01679002|5764247|P3|NOT COMPLETED|Overall Study||0
2348791|NCT01679002|5764248|P2|NOT COMPLETED|Overall Study||1
2348792|NCT01679002|5764249|P1|NOT COMPLETED|Overall Study||1
2348793|NCT01679002|5764247|P3|COMPLETED|Overall Study||4
2348794|NCT01679002|5764248|P2|COMPLETED|Overall Study||3
2348795|NCT01679002|5764249|P1|COMPLETED|Overall Study||3
2348796|NCT01679002|5764247|P3|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
2348797|NCT01679002|5764248|P2|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
2348798|NCT01679002|5764249|P1|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||3
2348799|NCT01679002|5764247|P3|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
2348800|NCT01679002|5764248|P2|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
2348801|NCT01679002|5764249|P1|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
2348802|NCT01679002|5764247|P3|BIA 2-093 900 mg Once-daily Period|Overall Study||4
2348803|NCT01679002|5764248|P2|BIA 2-093 900 mg Once-daily Period|Overall Study||3
2348804|NCT01679002|5764249|P1|BIA 2-093 900 mg Once-daily Period|Overall Study||4
2348805|NCT01679002|5764247|P3|STARTED|Overall Study||4
2348806|NCT01679002|5764248|P2|STARTED|Overall Study||4
2348807|NCT01679002|5764249|P1|STARTED|Overall Study||4
2348808|NCT01678976|5764265|P2|NOT COMPLETED|Second Period||0
2348809|NCT01678976|5764266|P1|NOT COMPLETED|Second Period||0
2348810|NCT01678976|5764265|P2|COMPLETED|Second Period||6
2348811|NCT01678976|5764266|P1|COMPLETED|Second Period||6
2348812|NCT01678976|5764265|P2|STARTED|Second Period||6
2348813|NCT01678976|5764266|P1|STARTED|Second Period||6
2348814|NCT01678976|5764265|P2|NOT COMPLETED|First Period||1
2348815|NCT01678976|5764266|P1|NOT COMPLETED|First Period||0
2348816|NCT01678976|5764265|P2|COMPLETED|First Period||6
2348817|NCT01678976|5764266|P1|COMPLETED|First Period||6
2348818|NCT01678976|5764265|P2|STARTED|First Period||7
2348819|NCT01678976|5764266|P1|STARTED|First Period||6
2348820|NCT01678924|5764280|P4|NOT COMPLETED|Overall Study||18
2348821|NCT01678924|5764281|P3|NOT COMPLETED|Overall Study||2
2348822|NCT01678924|5764282|P2|NOT COMPLETED|Overall Study||12
2348823|NCT01678924|5764283|P1|NOT COMPLETED|Overall Study||10
2348824|NCT01678924|5764280|P4|COMPLETED|Overall Study||105
2348825|NCT01678924|5764281|P3|COMPLETED|Overall Study||28
2348826|NCT01678924|5764282|P2|COMPLETED|Overall Study||51
2348827|NCT01678924|5764283|P1|COMPLETED|Overall Study||54
2348828|NCT01678924|5764280|P4|STARTED|Overall Study||123
2348829|NCT01678924|5764281|P3|STARTED|Overall Study||30
2348830|NCT01678924|5764282|P2|STARTED|Overall Study||63
2348831|NCT01678924|5764283|P1|STARTED|Overall Study||64
2348832|NCT01678911|5764414|P2|NOT COMPLETED|Second Intervention||0
2348833|NCT01678911|5764415|P1|NOT COMPLETED|Second Intervention||2
2348834|NCT01678911|5764414|P2|COMPLETED|Second Intervention||1
2348835|NCT01678911|5764415|P1|COMPLETED|Second Intervention||2
2348836|NCT01678911|5764414|P2|STARTED|Second Intervention||1
2348837|NCT01678911|5764415|P1|STARTED|Second Intervention||4
2348838|NCT01678911|5764414|P2|NOT COMPLETED|First Intervention||0
2348839|NCT01678911|5764415|P1|NOT COMPLETED|First Intervention||0
2348840|NCT01678911|5764414|P2|COMPLETED|First Intervention||1
2348841|NCT01678911|5764415|P1|COMPLETED|First Intervention||4
2348842|NCT01678911|5764414|P2|Cross Over|First Intervention||1
2348843|NCT01678911|5764415|P1|Cross Over|First Intervention||4
2348844|NCT01678911|5764414|P2|STARTED|First Intervention||1
2348845|NCT01678911|5764415|P1|STARTED|First Intervention||4
2348846|NCT01678898|5764432|P3|NOT COMPLETED|PB-102-F02||0
2348847|NCT01678898|5764433|P2|NOT COMPLETED|PB-102-F02||0
2348848|NCT01678898|5764434|P1|NOT COMPLETED|PB-102-F02||0
2348849|NCT01678898|5764432|P3|COMPLETED|PB-102-F02||4
2348850|NCT01678898|5764433|P2|COMPLETED|PB-102-F02||6
2348851|NCT01678898|5764434|P1|COMPLETED|PB-102-F02||6
2348852|NCT01678898|5764432|P3|STARTED|PB-102-F02||4
2348853|NCT01678898|5764433|P2|STARTED|PB-102-F02||6
2348854|NCT01678898|5764434|P1|STARTED|PB-102-F02||6
2348855|NCT01678898|5764432|P3|NOT COMPLETED|PB-102-F01||0
2348856|NCT01678898|5764433|P2|NOT COMPLETED|PB-102-F01||2
2348857|NCT01678898|5764434|P1|NOT COMPLETED|PB-102-F01||0
2348858|NCT01678898|5764432|P3|COMPLETED|PB-102-F01||4
2348859|NCT01678898|5764433|P2|COMPLETED|PB-102-F01||6
2348860|NCT01678898|5764434|P1|COMPLETED|PB-102-F01||6
2348861|NCT01678898|5764432|P3|STARTED|PB-102-F01||4
2348862|NCT01678898|5764433|P2|STARTED|PB-102-F01||8
2348863|NCT01678898|5764434|P1|STARTED|PB-102-F01||6
2348864|NCT01678885|5764514|P5|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||17
2348865|NCT01678885|5764515|P4|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
2348866|NCT01678885|5764516|P3|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
2348867|NCT01678885|5764517|P2|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
2348868|NCT01678885|5764518|P1|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
2348869|NCT01678885|5764514|P5|COMPLETED|Phase II; 8 Week Low Calorie Diet||70
2348870|NCT01678885|5764515|P4|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
2348871|NCT01678885|5764516|P3|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
2348872|NCT01678885|5764517|P2|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
2348873|NCT01678885|5764518|P1|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
2348874|NCT01678885|5764514|P5|STARTED|Phase II; 8 Week Low Calorie Diet||87
2348875|NCT01678885|5764515|P4|STARTED|Phase II; 8 Week Low Calorie Diet||0
2348876|NCT01678885|5764516|P3|STARTED|Phase II; 8 Week Low Calorie Diet||0
2348877|NCT01678885|5764517|P2|STARTED|Phase II; 8 Week Low Calorie Diet||0
2348878|NCT01678885|5764518|P1|STARTED|Phase II; 8 Week Low Calorie Diet||0
2348879|NCT01678885|5764514|P5|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
2348880|NCT01678885|5764515|P4|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
2348881|NCT01678885|5764516|P3|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||1
2348882|NCT01678885|5764517|P2|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
2348883|NCT01678885|5764518|P1|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
2348884|NCT01678885|5764514|P5|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
2348885|NCT01678885|5764515|P4|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||21
2348886|NCT01678885|5764516|P3|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
2348887|NCT01678885|5764517|P2|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||15
2348888|NCT01678885|5764518|P1|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
2348889|NCT01678885|5764514|P5|STARTED|Phase I; 2 Wks Duration, Both Sub-study||0
2348890|NCT01678885|5764515|P4|STARTED|Phase I; 2 Wks Duration, Both Sub-study||24
2348891|NCT01678885|5764516|P3|STARTED|Phase I; 2 Wks Duration, Both Sub-study||23
2348892|NCT01678885|5764517|P2|STARTED|Phase I; 2 Wks Duration, Both Sub-study||18
2348893|NCT01678885|5764518|P1|STARTED|Phase I; 2 Wks Duration, Both Sub-study||22
2348894|NCT01678846|5764528|P2|NOT COMPLETED|Overall Study||0
2348895|NCT01678846|5764529|P1|NOT COMPLETED|Overall Study||0
2348896|NCT01678846|5764528|P2|COMPLETED|Overall Study||1899
2348897|NCT01678846|5764529|P1|COMPLETED|Overall Study||1921
2348898|NCT01678846|5764528|P2|STARTED|Overall Study||1899
2348899|NCT01678846|5764529|P1|STARTED|Overall Study|Whole school implementation. Started and completed shows number of students in the end-line survey.|1921
2348900|NCT01678820|5764544|P3|NOT COMPLETED|Overall Study||57
2348901|NCT01678820|5764545|P2|NOT COMPLETED|Overall Study||63
2348902|NCT01678820|5764546|P1|NOT COMPLETED|Overall Study||62
2348903|NCT01678820|5764544|P3|COMPLETED|Overall Study||43
2348904|NCT01678820|5764545|P2|COMPLETED|Overall Study||36
2348905|NCT01678820|5764546|P1|COMPLETED|Overall Study||38
2348906|NCT01678820|5764544|P3|Treated With Double-blind Study Drug|Overall Study||98
2348907|NCT01678820|5764545|P2|Treated With Double-blind Study Drug|Overall Study||97
2348908|NCT01678820|5764546|P1|Treated With Double-blind Study Drug|Overall Study||100
2348909|NCT01678820|5764544|P3|STARTED|Overall Study||100
2348910|NCT01678820|5764545|P2|STARTED|Overall Study||99
2348911|NCT01678820|5764546|P1|STARTED|Overall Study||100
2348912|NCT01678807|5764591|P3|NOT COMPLETED|Overall Study||0
2348913|NCT01678807|5764592|P2|NOT COMPLETED|Overall Study||5
2348914|NCT01678807|5764593|P1|NOT COMPLETED|Overall Study||4
2348915|NCT01678807|5764591|P3|COMPLETED|Overall Study||65
2348916|NCT01678807|5764592|P2|COMPLETED|Overall Study||60
2348917|NCT01678807|5764593|P1|COMPLETED|Overall Study||61
2348918|NCT01678807|5764591|P3|STARTED|Overall Study||65
2348919|NCT01678807|5764592|P2|STARTED|Overall Study||65
2348920|NCT01678807|5764593|P1|STARTED|Overall Study||65
2348921|NCT01678560|5764606|P2|NOT COMPLETED|Overall Study||6
2348922|NCT01678560|5764607|P1|NOT COMPLETED|Overall Study||4
2348923|NCT01678560|5764606|P2|COMPLETED|Overall Study||20
2348924|NCT01678560|5764607|P1|COMPLETED|Overall Study||22
2348925|NCT01678560|5764606|P2|STARTED|Overall Study||26
2348926|NCT01678560|5764607|P1|STARTED|Overall Study||26
2348927|NCT01678443|5764621|P1|NOT COMPLETED|Overall Study||0
2348928|NCT01678443|5764621|P1|COMPLETED|Overall Study||2
2348929|NCT01678443|5764621|P1|STARTED|Overall Study||2
2348930|NCT01678313|5764628|P2|NOT COMPLETED|Prostate Biopsy at 3 Months||12
2348931|NCT01678313|5764629|P1|NOT COMPLETED|Prostate Biopsy at 3 Months||11
2348932|NCT01678313|5764628|P2|COMPLETED|Prostate Biopsy at 3 Months||37
2348933|NCT01678313|5764629|P1|COMPLETED|Prostate Biopsy at 3 Months||45
2348934|NCT01678313|5764628|P2|STARTED|Prostate Biopsy at 3 Months||49
2348935|NCT01678313|5764629|P1|STARTED|Prostate Biopsy at 3 Months||56
2348936|NCT01678313|5764628|P2|NOT COMPLETED|PSA >4 ng/dL at 3 Months||9
2348937|NCT01678313|5764629|P1|NOT COMPLETED|PSA >4 ng/dL at 3 Months||8
2348938|NCT01678313|5764628|P2|COMPLETED|PSA >4 ng/dL at 3 Months||49
2348939|NCT01678313|5764629|P1|COMPLETED|PSA >4 ng/dL at 3 Months||56
2348940|NCT01678313|5764628|P2|STARTED|PSA >4 ng/dL at 3 Months||58
2348941|NCT01678313|5764629|P1|STARTED|PSA >4 ng/dL at 3 Months||64
2348942|NCT01678313|5764628|P2|NOT COMPLETED|Completed the 3-month Therapy||12
2348943|NCT01678313|5764629|P1|NOT COMPLETED|Completed the 3-month Therapy||6
2348944|NCT01678313|5764628|P2|COMPLETED|Completed the 3-month Therapy||58
2348945|NCT01678313|5764629|P1|COMPLETED|Completed the 3-month Therapy||64
2348946|NCT01678313|5764628|P2|STARTED|Completed the 3-month Therapy||70
2348947|NCT01678313|5764629|P1|STARTED|Completed the 3-month Therapy||70
2348948|NCT01678196|5764647|P2|NOT COMPLETED|Overall Study||0
2348949|NCT01678196|5764648|P1|NOT COMPLETED|Overall Study||0
2348950|NCT01678196|5764647|P2|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|32
2348951|NCT01678196|5764648|P1|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|34
2348952|NCT01678196|5764647|P2|STARTED|Overall Study||32
2348953|NCT01678196|5764648|P1|STARTED|Overall Study||34
2348954|NCT01678144|5764660|P1|NOT COMPLETED|Stage 2: MAR Regular and MAR Expanded||0
2348955|NCT01678144|5764660|P1|COMPLETED|Stage 2: MAR Regular and MAR Expanded||5
2348956|NCT01678144|5764660|P1|STARTED|Stage 2: MAR Regular and MAR Expanded||5
2348957|NCT01678144|5764660|P1|NOT COMPLETED|Stage 1: MAR Classic||1
2348958|NCT01678144|5764660|P1|COMPLETED|Stage 1: MAR Classic||6
2348959|NCT01678144|5764660|P1|STARTED|Stage 1: MAR Classic||7
2348960|NCT01678131|5764679|P3|NOT COMPLETED|Overall Study||2
2348961|NCT01678131|5764680|P2|NOT COMPLETED|Overall Study||1
2348962|NCT01678131|5764681|P1|NOT COMPLETED|Overall Study||0
2348963|NCT01678131|5764679|P3|COMPLETED|Overall Study||9
2348964|NCT01678131|5764680|P2|COMPLETED|Overall Study||9
2348965|NCT01678131|5764681|P1|COMPLETED|Overall Study||10
2348966|NCT01678131|5764679|P3|STARTED|Overall Study||11
2348967|NCT01678131|5764680|P2|STARTED|Overall Study||10
2348968|NCT01678131|5764681|P1|STARTED|Overall Study||10
2348969|NCT01677988|5764689|P1|NOT COMPLETED|Overall Study||2
2348970|NCT01677988|5764689|P1|COMPLETED|Overall Study||1
2348971|NCT01677988|5764689|P1|STARTED|Overall Study||3
2348972|NCT01677936|5764702|P2|NOT COMPLETED|Overall Study||5
2348973|NCT01677936|5764703|P1|NOT COMPLETED|Overall Study||9
2348974|NCT01677936|5764702|P2|COMPLETED|Overall Study|Full analysis dataset completers|15
2348975|NCT01677936|5764703|P1|COMPLETED|Overall Study|Full analysis dataset completers|22
2348976|NCT01677936|5764702|P2|STARTED|Overall Study|20 randomized to snacks; 1 excluded due to lack of post-baseline evaluation; 19 = full dataset|20
2348977|NCT01677936|5764703|P1|STARTED|Overall Study|31 randomized to raisins; 4 excluded due to lack of post-baseline evaluation; 27 = full dataset|31
2348978|NCT01677910|5764714|P4|NOT COMPLETED|Open-Label Extension Period (OLE)||36
2348979|NCT01677910|5764715|P3|NOT COMPLETED|Open-Label Extension Period (OLE)||0
2348980|NCT01677910|5764716|P2|NOT COMPLETED|Open-Label Extension Period (OLE)||0
2348981|NCT01677910|5764717|P1|NOT COMPLETED|Open-Label Extension Period (OLE)||0
2348982|NCT01677910|5764714|P4|COMPLETED|Open-Label Extension Period (OLE)||79
2348983|NCT01677910|5764715|P3|COMPLETED|Open-Label Extension Period (OLE)||0
2348984|NCT01677910|5764716|P2|COMPLETED|Open-Label Extension Period (OLE)||0
2348985|NCT01677910|5764717|P1|COMPLETED|Open-Label Extension Period (OLE)||0
2348986|NCT01677910|5764714|P4|STARTED|Open-Label Extension Period (OLE)||115
2348987|NCT01677910|5764715|P3|STARTED|Open-Label Extension Period (OLE)||0
2348988|NCT01677910|5764716|P2|STARTED|Open-Label Extension Period (OLE)||0
2348989|NCT01677910|5764717|P1|STARTED|Open-Label Extension Period (OLE)||0
2348990|NCT01677910|5764714|P4|NOT COMPLETED|Double-Blind Treatment Period||0
2348991|NCT01677910|5764715|P3|NOT COMPLETED|Double-Blind Treatment Period||7
2348992|NCT01677910|5764716|P2|NOT COMPLETED|Double-Blind Treatment Period||3
2348993|NCT01677910|5764717|P1|NOT COMPLETED|Double-Blind Treatment Period||7
2348994|NCT01677910|5764714|P4|COMPLETED|Double-Blind Treatment Period||0
2348995|NCT01677910|5764715|P3|COMPLETED|Double-Blind Treatment Period||38
2348996|NCT01677910|5764716|P2|COMPLETED|Double-Blind Treatment Period||42
2348997|NCT01677910|5764717|P1|COMPLETED|Double-Blind Treatment Period||38
2348998|NCT01677910|5764714|P4|STARTED|Double-Blind Treatment Period||0
2348999|NCT01677910|5764715|P3|STARTED|Double-Blind Treatment Period||45
2349000|NCT01677910|5764716|P2|STARTED|Double-Blind Treatment Period||45
2349001|NCT01677910|5764717|P1|STARTED|Double-Blind Treatment Period||45
2349002|NCT01677858|5764744|P5|NOT COMPLETED|Overall Study||85
2349003|NCT01677858|5764745|P4|NOT COMPLETED|Overall Study||6
2349004|NCT01677858|5764746|P3|NOT COMPLETED|Overall Study||14
2349005|NCT01677858|5764747|P2|NOT COMPLETED|Overall Study||2
2349006|NCT01677858|5764748|P1|NOT COMPLETED|Overall Study||3
2349007|NCT01677858|5764744|P5|COMPLETED|Overall Study|Completed indicates participants ongoing in study|4
2349008|NCT01677858|5764745|P4|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
2349009|NCT01677858|5764746|P3|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
2349010|NCT01677858|5764747|P2|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
2349011|NCT01677858|5764748|P1|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
2349012|NCT01677858|5764744|P5|STARTED|Overall Study||89
2349013|NCT01677858|5764745|P4|STARTED|Overall Study||6
2349014|NCT01677858|5764746|P3|STARTED|Overall Study||15
2349015|NCT01677858|5764747|P2|STARTED|Overall Study||3
2349016|NCT01677858|5764748|P1|STARTED|Overall Study||3
2349017|NCT01677767|5764821|P1|NOT COMPLETED|Overall Study||22
2349018|NCT01677767|5764821|P1|COMPLETED|Overall Study||102
2349019|NCT01677767|5764821|P1|STARTED|Overall Study||124
2349020|NCT01677624|5764835|P1|NOT COMPLETED|Overall Study||1
2349021|NCT01677624|5764835|P1|COMPLETED|Overall Study||27
2349022|NCT01677624|5764835|P1|STARTED|Overall Study||28
2349023|NCT01677507|5764840|P2|NOT COMPLETED|Second Assigment||5
2349024|NCT01677507|5764841|P1|NOT COMPLETED|Second Assigment||3
2349025|NCT01677507|5764840|P2|COMPLETED|Second Assigment||51
2349026|NCT01677507|5764841|P1|COMPLETED|Second Assigment||60
2349027|NCT01677507|5764840|P2|STARTED|Second Assigment||56
2349028|NCT01677507|5764841|P1|STARTED|Second Assigment||63
2349029|NCT01677507|5764840|P2|NOT COMPLETED|Initial Assignment||2
2349030|NCT01677507|5764841|P1|NOT COMPLETED|Initial Assignment||0
2349031|NCT01677507|5764840|P2|COMPLETED|Initial Assignment||56
2349032|NCT01677507|5764841|P1|COMPLETED|Initial Assignment||63
2349033|NCT01677507|5764840|P2|STARTED|Initial Assignment||58
2349034|NCT01677507|5764841|P1|STARTED|Initial Assignment||63
2349035|NCT01677377|5764854|P3|NOT COMPLETED|Overall Study||6
2349036|NCT01677377|5764855|P2|NOT COMPLETED|Overall Study||1
2349037|NCT01677377|5764856|P1|NOT COMPLETED|Overall Study||1
2349038|NCT01677377|5764854|P3|COMPLETED|Overall Study||9
2349039|NCT01677377|5764855|P2|COMPLETED|Overall Study||14
2349040|NCT01677377|5764856|P1|COMPLETED|Overall Study||14
2349041|NCT01677377|5764854|P3|STARTED|Overall Study||15
2349042|NCT01677377|5764855|P2|STARTED|Overall Study||15
2349043|NCT01677377|5764856|P1|STARTED|Overall Study||15
2349044|NCT01677299|5765057|P4|NOT COMPLETED|Overall Study||1
2349045|NCT01677299|5765058|P3|NOT COMPLETED|Overall Study||1
2349046|NCT01677299|5765059|P2|NOT COMPLETED|Overall Study||3
2349047|NCT01677299|5765060|P1|NOT COMPLETED|Overall Study||0
2349048|NCT01677299|5765057|P4|COMPLETED|Overall Study||5
2349049|NCT01677299|5765058|P3|COMPLETED|Overall Study||5
2349050|NCT01677299|5765059|P2|COMPLETED|Overall Study||3
2349051|NCT01677299|5765060|P1|COMPLETED|Overall Study||6
2349052|NCT01677299|5765057|P4|STARTED|Overall Study||6
2349053|NCT01677299|5765058|P3|STARTED|Overall Study||6
2349054|NCT01677299|5765059|P2|STARTED|Overall Study||6
2349055|NCT01677299|5765060|P1|STARTED|Overall Study||6
2349056|NCT01677286|5765082|P1|NOT COMPLETED|Overall Study||11
2349057|NCT01677286|5765082|P1|COMPLETED|Overall Study||14
2349058|NCT01677286|5765082|P1|STARTED|Overall Study||25
2349059|NCT01677195|5765092|P3|NOT COMPLETED|Overall Study||30
2349060|NCT01677195|5765093|P2|NOT COMPLETED|Overall Study||32
2349061|NCT01677195|5765094|P1|NOT COMPLETED|Overall Study||29
2349062|NCT01677195|5765092|P3|COMPLETED|Overall Study||50
2349063|NCT01677195|5765093|P2|COMPLETED|Overall Study||51
2349064|NCT01677195|5765094|P1|COMPLETED|Overall Study||42
2349065|NCT01677195|5765092|P3|STARTED|Overall Study||80
2349066|NCT01677195|5765093|P2|STARTED|Overall Study||83
2349067|NCT01677195|5765094|P1|STARTED|Overall Study||71
2349068|NCT01677182|5765105|P3|NOT COMPLETED|Overall Study||39
2349069|NCT01677182|5765106|P2|NOT COMPLETED|Overall Study||28
2349070|NCT01677182|5765107|P1|NOT COMPLETED|Overall Study||34
2349071|NCT01677182|5765105|P3|COMPLETED|Overall Study||143
2349072|NCT01677182|5765106|P2|COMPLETED|Overall Study||141
2349073|NCT01677182|5765107|P1|COMPLETED|Overall Study||150
2349074|NCT01677182|5765105|P3|STARTED|Overall Study||182
2349075|NCT01677182|5765106|P2|STARTED|Overall Study||169
2349076|NCT01677182|5765107|P1|STARTED|Overall Study||184
2349077|NCT01676961|5765139|P1|NOT COMPLETED|Overall Study||5
2349078|NCT01676961|5765139|P1|COMPLETED|Overall Study||0
2349079|NCT01676961|5765139|P1|STARTED|Overall Study||5
2349080|NCT01676909|5765146|P2|NOT COMPLETED|Overall Study||14
2349081|NCT01676909|5765147|P1|NOT COMPLETED|Overall Study||18
2349082|NCT01676909|5765146|P2|COMPLETED|Overall Study|14 not completed (5 withdrawn, 9 timed out|104
2349083|NCT01676909|5765147|P1|COMPLETED|Overall Study|18 not completed (3 withdrawn, 15 timed out)|106
2349084|NCT01676909|5765146|P2|Post-Treatment Assessment|Overall Study|11 not completed (5 withdrawn, 6 timed out)|107
2349085|NCT01676909|5765147|P1|Post-Treatment Assessment|Overall Study|19 not completed (3 withdrawn, 15 timed out, 1 declined)|105
2349086|NCT01676909|5765146|P2|STARTED|Overall Study||118
2349087|NCT01676909|5765147|P1|STARTED|Overall Study||124
2349088|NCT01676896|5765212|P3|NOT COMPLETED|Overall Study||19
2349089|NCT01676896|5765213|P2|NOT COMPLETED|Overall Study||7
2349090|NCT01676896|5765214|P1|NOT COMPLETED|Overall Study||12
2349091|NCT01676896|5765212|P3|COMPLETED|Overall Study||81
2349092|NCT01676896|5765213|P2|COMPLETED|Overall Study||89
2349093|NCT01676896|5765214|P1|COMPLETED|Overall Study||84
2349094|NCT01676896|5765212|P3|STARTED|Overall Study||100
2349095|NCT01676896|5765213|P2|STARTED|Overall Study||96
2349096|NCT01676896|5765214|P1|STARTED|Overall Study||96
2349097|NCT01676831|5765311|P2|NOT COMPLETED|Overall Study||1
2349098|NCT01676831|5765312|P1|NOT COMPLETED|Overall Study||0
2349099|NCT01676831|5765311|P2|COMPLETED|Overall Study||4
2349100|NCT01676831|5765312|P1|COMPLETED|Overall Study||8
2349101|NCT01676831|5765311|P2|STARTED|Overall Study||5
2349102|NCT01676831|5765312|P1|STARTED|Overall Study||8
2349103|NCT01676727|5765322|P1|NOT COMPLETED|Overall Study||32
2349104|NCT01676727|5765322|P1|COMPLETED|Overall Study||68
2349105|NCT01676727|5765322|P1|Implanted|Overall Study||92
2349106|NCT01676727|5765322|P1|STARTED|Overall Study||100
2349107|NCT01676714|5765327|P1|NOT COMPLETED|Overall Study||0
2349108|NCT01676714|5765327|P1|COMPLETED|Overall Study||10
2349109|NCT01676714|5765327|P1|STARTED|Overall Study||10
2349110|NCT01676701|5765336|P2|NOT COMPLETED|Overall Study||4
2349111|NCT01676701|5765337|P1|NOT COMPLETED|Overall Study||4
2349112|NCT01676701|5765336|P2|COMPLETED|Overall Study||0
2349113|NCT01676701|5765337|P1|COMPLETED|Overall Study||0
2349114|NCT01676701|5765336|P2|Completed Post-Treatment Follow-Up|Overall Study||4
2349115|NCT01676701|5765337|P1|Completed Post-Treatment Follow-Up|Overall Study||4
2349116|NCT01676701|5765336|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
2349117|NCT01676701|5765337|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
2349118|NCT01676701|5765336|P2|STARTED|Overall Study||4
2349119|NCT01676701|5765337|P1|STARTED|Overall Study||4
2349120|NCT01676532|5765363|P1|NOT COMPLETED|Overall Study||0
2349121|NCT01676532|5765363|P1|COMPLETED|Overall Study||127
2349122|NCT01676532|5765363|P1|STARTED|Overall Study||127
2349123|NCT01676415|5765374|P2|NOT COMPLETED|Overall Study||0
2349124|NCT01676415|5765375|P1|NOT COMPLETED|Overall Study||0
2349125|NCT01676415|5765374|P2|COMPLETED|Overall Study||5
2349126|NCT01676415|5765375|P1|COMPLETED|Overall Study||4
2349127|NCT01676415|5765374|P2|STARTED|Overall Study||5
2349128|NCT01676415|5765375|P1|STARTED|Overall Study||4
2349129|NCT01676311|5765389|P2|NOT COMPLETED|Overall Study||2
2349130|NCT01676311|5765390|P1|NOT COMPLETED|Overall Study||0
2349131|NCT01676311|5765389|P2|COMPLETED|Overall Study||5
2349132|NCT01676311|5765390|P1|COMPLETED|Overall Study||7
2349133|NCT01676311|5765389|P2|STARTED|Overall Study||7
2349134|NCT01676311|5765390|P1|STARTED|Overall Study||7
2349135|NCT01676298|5765412|P8|NOT COMPLETED|Overall Study||0
2349136|NCT01676298|5765413|P7|NOT COMPLETED|Overall Study||0
2349137|NCT01676298|5765414|P6|NOT COMPLETED|Overall Study||0
2349138|NCT01676298|5765415|P5|NOT COMPLETED|Overall Study||0
2349139|NCT01676298|5765416|P4|NOT COMPLETED|Overall Study||0
2349140|NCT01676298|5765417|P3|NOT COMPLETED|Overall Study||0
2349141|NCT01676298|5765418|P2|NOT COMPLETED|Overall Study||0
2349142|NCT01676298|5765419|P1|NOT COMPLETED|Overall Study||0
2349143|NCT01676298|5765412|P8|COMPLETED|Overall Study||1
2349144|NCT01676298|5765413|P7|COMPLETED|Overall Study||1
2349145|NCT01676298|5765414|P6|COMPLETED|Overall Study||1
2349146|NCT01676298|5765415|P5|COMPLETED|Overall Study||1
2349147|NCT01676298|5765416|P4|COMPLETED|Overall Study||1
2349148|NCT01676298|5765417|P3|COMPLETED|Overall Study||1
2349149|NCT01676298|5765418|P2|COMPLETED|Overall Study||1
2349150|NCT01676298|5765419|P1|COMPLETED|Overall Study||1
2349151|NCT01676298|5765412|P8|Participated in All Tests|Overall Study||1
2349152|NCT01676298|5765413|P7|Participated in All Tests|Overall Study||1
2349153|NCT01676298|5765414|P6|Participated in All Tests|Overall Study||1
2349154|NCT01676298|5765415|P5|Participated in All Tests|Overall Study||1
2349155|NCT01676298|5765416|P4|Participated in All Tests|Overall Study||1
2349156|NCT01676298|5765417|P3|Participated in All Tests|Overall Study||1
2349157|NCT01676298|5765418|P2|Participated in All Tests|Overall Study||1
2349158|NCT01676298|5765419|P1|Participated in All Tests|Overall Study||1
2349159|NCT01676298|5765412|P8|All Genotypes Confirmed With Reference|Overall Study||1
2349160|NCT01676298|5765413|P7|All Genotypes Confirmed With Reference|Overall Study||1
2349161|NCT01676298|5765414|P6|All Genotypes Confirmed With Reference|Overall Study||1
2349162|NCT01676298|5765415|P5|All Genotypes Confirmed With Reference|Overall Study||1
2349163|NCT01676298|5765416|P4|All Genotypes Confirmed With Reference|Overall Study||1
2349164|NCT01676298|5765417|P3|All Genotypes Confirmed With Reference|Overall Study||1
2349165|NCT01676298|5765418|P2|All Genotypes Confirmed With Reference|Overall Study||1
2349166|NCT01676298|5765419|P1|All Genotypes Confirmed With Reference|Overall Study||1
2349167|NCT01676298|5765412|P8|STARTED|Overall Study||1
2349168|NCT01676298|5765413|P7|STARTED|Overall Study||1
2349169|NCT01676298|5765414|P6|STARTED|Overall Study||1
2349170|NCT01676298|5765415|P5|STARTED|Overall Study||1
2349171|NCT01676298|5765416|P4|STARTED|Overall Study||1
2349172|NCT01676298|5765417|P3|STARTED|Overall Study||1
2349173|NCT01676298|5765418|P2|STARTED|Overall Study||1
2349174|NCT01676298|5765419|P1|STARTED|Overall Study||1
2349175|NCT01676220|5765439|P2|NOT COMPLETED|Overall Study||125
2349176|NCT01676220|5765440|P1|NOT COMPLETED|Overall Study||102
2349177|NCT01676220|5765439|P2|COMPLETED|Overall Study||314
2349178|NCT01676220|5765440|P1|COMPLETED|Overall Study||337
2349179|NCT01676220|5765439|P2|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post­baseline data|430
2349180|NCT01676220|5765440|P1|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post­baseline data|432
2349181|NCT01676220|5765439|P2|Treated|Overall Study||438
2349182|NCT01676220|5765440|P1|Treated|Overall Study||435
2349183|NCT01676220|5765439|P2|STARTED|Overall Study||439
2349184|NCT01676220|5765440|P1|STARTED|Overall Study||439
2349185|NCT01676116|5765472|P2|NOT COMPLETED|Overall Study||29
2349186|NCT01676116|5765473|P1|NOT COMPLETED|Overall Study||16
2349187|NCT01676116|5765472|P2|COMPLETED|Overall Study||117
2349188|NCT01676116|5765473|P1|COMPLETED|Overall Study||276
2349189|NCT01676116|5765472|P2|STARTED|Overall Study||146
2349190|NCT01676116|5765473|P1|STARTED|Overall Study||292
2349191|NCT01676012|5765495|P1|NOT COMPLETED|Overall Study||3
2349192|NCT01676012|5765495|P1|COMPLETED|Overall Study||29
2349193|NCT01676012|5765495|P1|STARTED|Overall Study||32
2349194|NCT01675960|5765501|P2|NOT COMPLETED|Overall Study||0
2349195|NCT01675960|5765502|P1|NOT COMPLETED|Overall Study||0
2349196|NCT01675960|5765501|P2|COMPLETED|Overall Study||0
2349197|NCT01675960|5765502|P1|COMPLETED|Overall Study||2
2349198|NCT01675960|5765501|P2|STARTED|Overall Study||0
2349199|NCT01675960|5765502|P1|STARTED|Overall Study||2
2349200|NCT01675830|5765510|P1|NOT COMPLETED|Overall Study||0
2349201|NCT01675830|5765510|P1|COMPLETED|Overall Study||10
2349202|NCT01675830|5765510|P1|STARTED|Overall Study||10
2349203|NCT01675661|5765517|P2|NOT COMPLETED|Overall Study||46
2349204|NCT01675661|5765518|P1|NOT COMPLETED|Overall Study||40
2349205|NCT01675661|5765517|P2|COMPLETED|Overall Study||103
2349206|NCT01675661|5765518|P1|COMPLETED|Overall Study||113
2349207|NCT01675661|5765517|P2|STARTED|Overall Study||149
2349208|NCT01675661|5765518|P1|STARTED|Overall Study||153
2349209|NCT01675635|5765526|P2|NOT COMPLETED|Overall Study||0
2349210|NCT01675635|5765527|P1|NOT COMPLETED|Overall Study||0
2349211|NCT01675635|5765526|P2|COMPLETED|Overall Study||117
2349212|NCT01675635|5765527|P1|COMPLETED|Overall Study||117
2349213|NCT01675635|5765526|P2|STARTED|Overall Study||117
2349214|NCT01675635|5765527|P1|STARTED|Overall Study||117
2349215|NCT01675622|5765547|P2|NOT COMPLETED|Overall Study||24
2349216|NCT01675622|5765548|P1|NOT COMPLETED|Overall Study||26
2349217|NCT01675622|5765547|P2|COMPLETED|Overall Study||96
2349218|NCT01675622|5765548|P1|COMPLETED|Overall Study||96
2349219|NCT01675622|5765547|P2|STARTED|Overall Study||120
2349220|NCT01675622|5765548|P1|STARTED|Overall Study||122
2349221|NCT01675596|5765572|P1|NOT COMPLETED|Overall Study||8
2349222|NCT01675596|5765572|P1|COMPLETED|Overall Study||191
2349223|NCT01675596|5765572|P1|STARTED|Overall Study|One patient did not receive the study device.|199
2349224|NCT01675544|5765578|P1|NOT COMPLETED|Overall Study||2
2349225|NCT01675544|5765578|P1|COMPLETED|Overall Study||44
2349226|NCT01675544|5765578|P1|STARTED|Overall Study||46
2349227|NCT01675531|5765583|P1|NOT COMPLETED|Overall Study||25
2349228|NCT01675531|5765583|P1|COMPLETED|Overall Study||41
2349229|NCT01675531|5765583|P1|STARTED|Overall Study||66
2349230|NCT01675492|5765590|P1|NOT COMPLETED|Overall Study||42
2349231|NCT01675492|5765590|P1|COMPLETED|Overall Study||42
2349232|NCT01675492|5765590|P1|STARTED|Overall Study||84
2349233|NCT01675479|5765595|P1|NOT COMPLETED|Overall Study||11
2349234|NCT01675479|5765595|P1|COMPLETED|Overall Study||58
2349235|NCT01675479|5765595|P1|STARTED|Overall Study||69
2349236|NCT01675453|5765602|P2|NOT COMPLETED|Overall Study||0
2349237|NCT01675453|5765603|P1|NOT COMPLETED|Overall Study||0
2349238|NCT01675453|5765602|P2|COMPLETED|Overall Study||20
2349239|NCT01675453|5765603|P1|COMPLETED|Overall Study||20
2349240|NCT01675453|5765602|P2|STARTED|Overall Study||20
2349241|NCT01675453|5765603|P1|STARTED|Overall Study||20
2349242|NCT01675427|5765609|P1|NOT COMPLETED|Overall Study||34
2349243|NCT01675427|5765609|P1|COMPLETED|Overall Study||4732
2349244|NCT01675427|5765609|P1|STARTED|Overall Study||4766
2349245|NCT01675297|5765896|P2|NOT COMPLETED|Overall Study||48
2349246|NCT01675297|5765897|P1|NOT COMPLETED|Overall Study||164
2349247|NCT01675297|5765896|P2|COMPLETED|Overall Study||199
2349248|NCT01675297|5765897|P1|COMPLETED|Overall Study||642
2349249|NCT01675297|5765896|P2|STARTED|Overall Study||247
2349250|NCT01675297|5765897|P1|STARTED|Overall Study||806
2349251|NCT01675167|5765909|P3|NOT COMPLETED|Double-blind Treatment Phase||110
2349252|NCT01675167|5765910|P2|NOT COMPLETED|Double-blind Treatment Phase||48
2349253|NCT01675167|5765911|P1|NOT COMPLETED|Double-blind Treatment Phase||0
2349254|NCT01675167|5765909|P3|COMPLETED|Double-blind Treatment Phase||147
2349255|NCT01675167|5765910|P2|COMPLETED|Double-blind Treatment Phase||206
2349256|NCT01675167|5765911|P1|COMPLETED|Double-blind Treatment Phase||0
2349257|NCT01675167|5765909|P3|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|257
2349258|NCT01675167|5765910|P2|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|254
2349259|NCT01675167|5765911|P1|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
2349260|NCT01675167|5765909|P3|NOT COMPLETED|Open-label Titration Phase||0
2349261|NCT01675167|5765910|P2|NOT COMPLETED|Open-label Titration Phase||0
2349262|NCT01675167|5765911|P1|NOT COMPLETED|Open-label Titration Phase||304
2349263|NCT01675167|5765909|P3|COMPLETED|Open-label Titration Phase||0
2349264|NCT01675167|5765910|P2|COMPLETED|Open-label Titration Phase||0
2349265|NCT01675167|5765911|P1|COMPLETED|Open-label Titration Phase||511
2349266|NCT01675167|5765909|P3|STARTED|Open-label Titration Phase||0
2349267|NCT01675167|5765910|P2|STARTED|Open-label Titration Phase||0
2349268|NCT01675167|5765911|P1|STARTED|Open-label Titration Phase||815
2349269|NCT01675141|5765933|P1|NOT COMPLETED|Overall Study||11
2349270|NCT01675141|5765933|P1|COMPLETED|Overall Study||0
2349271|NCT01675141|5765933|P1|STARTED|Overall Study||11
2349272|NCT01675128|5765946|P3|NOT COMPLETED|Overall Study||1
2349273|NCT01675128|5765947|P2|NOT COMPLETED|Overall Study||2
2349274|NCT01675128|5765948|P1|NOT COMPLETED|Overall Study||2
2349275|NCT01675128|5765946|P3|COMPLETED|Overall Study||9
2349276|NCT01675128|5765947|P2|COMPLETED|Overall Study||8
2349277|NCT01675128|5765948|P1|COMPLETED|Overall Study||2
2349278|NCT01675128|5765946|P3|STARTED|Overall Study||10
2349279|NCT01675128|5765947|P2|STARTED|Overall Study||10
2349280|NCT01675128|5765948|P1|STARTED|Overall Study||4
2349281|NCT01675063|5765970|P1|NOT COMPLETED|Overall Study||0
2349282|NCT01675063|5765970|P1|COMPLETED|Overall Study||77
2349283|NCT01675063|5765970|P1|STARTED|Overall Study||77
2349284|NCT01675050|5765976|P2|NOT COMPLETED|Second Period Treatment||0
2349285|NCT01675050|5765977|P1|NOT COMPLETED|Second Period Treatment||0
2349286|NCT01675050|5765976|P2|COMPLETED|Second Period Treatment||2
2349287|NCT01675050|5765977|P1|COMPLETED|Second Period Treatment||1
2349288|NCT01675050|5765976|P2|STARTED|Second Period Treatment||2
2349289|NCT01675050|5765977|P1|STARTED|Second Period Treatment||1
2349290|NCT01675050|5765976|P2|NOT COMPLETED|Wash Out Period||0
2349291|NCT01675050|5765977|P1|NOT COMPLETED|Wash Out Period||0
2349292|NCT01675050|5765976|P2|COMPLETED|Wash Out Period||2
2349293|NCT01675050|5765977|P1|COMPLETED|Wash Out Period||1
2349294|NCT01675050|5765976|P2|STARTED|Wash Out Period||2
2349295|NCT01675050|5765977|P1|STARTED|Wash Out Period||1
2349296|NCT01675050|5765976|P2|NOT COMPLETED|Period One Treatment||0
2349297|NCT01675050|5765977|P1|NOT COMPLETED|Period One Treatment||1
2349298|NCT01675050|5765976|P2|COMPLETED|Period One Treatment||2
2349299|NCT01675050|5765977|P1|COMPLETED|Period One Treatment||1
2349300|NCT01675050|5765976|P2|STARTED|Period One Treatment||2
2349301|NCT01675050|5765977|P1|STARTED|Period One Treatment||2
2349302|NCT01675011|5765987|P2|NOT COMPLETED|Overall Study||1
2349303|NCT01675011|5765988|P1|NOT COMPLETED|Overall Study||3
2349304|NCT01675011|5765987|P2|COMPLETED|Overall Study||0
2349305|NCT01675011|5765988|P1|COMPLETED|Overall Study||0
2349306|NCT01675011|5765987|P2|STARTED|Overall Study||1
2349307|NCT01675011|5765988|P1|STARTED|Overall Study||3
2349308|NCT01674725|5765996|P2|NOT COMPLETED|Overall Study||1
2349309|NCT01674725|5765997|P1|NOT COMPLETED|Overall Study||3
2349310|NCT01674725|5765996|P2|COMPLETED|Overall Study||94
2349311|NCT01674725|5765997|P1|COMPLETED|Overall Study||89
2349312|NCT01674725|5765996|P2|STARTED|Overall Study||95
2349313|NCT01674725|5765997|P1|STARTED|Overall Study||92
2349314|NCT01674712|5766016|P5|NOT COMPLETED|Overall Study||11
2349315|NCT01674712|5766017|P4|NOT COMPLETED|Overall Study||8
2349316|NCT01674712|5766018|P3|NOT COMPLETED|Overall Study||9
2349317|NCT01674712|5766019|P2|NOT COMPLETED|Overall Study||9
2349318|NCT01674712|5766020|P1|NOT COMPLETED|Overall Study||10
2349319|NCT01674712|5766016|P5|COMPLETED|Overall Study||102
2349320|NCT01674712|5766017|P4|COMPLETED|Overall Study||108
2349321|NCT01674712|5766018|P3|COMPLETED|Overall Study||106
2349322|NCT01674712|5766019|P2|COMPLETED|Overall Study||108
2349323|NCT01674712|5766020|P1|COMPLETED|Overall Study||104
2349324|NCT01674712|5766016|P5|Safety Subject Sample|Overall Study||112
2349325|NCT01674712|5766017|P4|Safety Subject Sample|Overall Study||115
2349326|NCT01674712|5766018|P3|Safety Subject Sample|Overall Study||113
2349327|NCT01674712|5766019|P2|Safety Subject Sample|Overall Study||117
2349328|NCT01674712|5766020|P1|Safety Subject Sample|Overall Study||111
2349329|NCT01674712|5766016|P5|Full Analysis Subject Sample|Overall Study||111
2349330|NCT01674712|5766017|P4|Full Analysis Subject Sample|Overall Study||112
2349331|NCT01674712|5766018|P3|Full Analysis Subject Sample|Overall Study||110
2349332|NCT01674712|5766019|P2|Full Analysis Subject Sample|Overall Study||114
2349333|NCT01674712|5766020|P1|Full Analysis Subject Sample|Overall Study||109
2349334|NCT01674712|5766016|P5|STARTED|Overall Study||113
2349335|NCT01674712|5766017|P4|STARTED|Overall Study||116
2349336|NCT01674712|5766018|P3|STARTED|Overall Study||115
2349337|NCT01674712|5766019|P2|STARTED|Overall Study||117
2349338|NCT01674712|5766020|P1|STARTED|Overall Study||114
2349339|NCT01674647|5766044|P2|NOT COMPLETED|30-day Safety Follow-up Period||41
2349340|NCT01674647|5766045|P1|NOT COMPLETED|30-day Safety Follow-up Period||58
2349341|NCT01674647|5766044|P2|COMPLETED|30-day Safety Follow-up Period||446
2349342|NCT01674647|5766045|P1|COMPLETED|30-day Safety Follow-up Period||924
2349343|NCT01674647|5766044|P2|STARTED|30-day Safety Follow-up Period||487
2349344|NCT01674647|5766045|P1|STARTED|30-day Safety Follow-up Period||982
2349345|NCT01674647|5766044|P2|NOT COMPLETED|Treatment Period||102
2349346|NCT01674647|5766045|P1|NOT COMPLETED|Treatment Period||156
2349347|NCT01674647|5766044|P2|COMPLETED|Treatment Period||400
2349348|NCT01674647|5766045|P1|COMPLETED|Treatment Period||846
2349349|NCT01674647|5766044|P2|Subjects Received Treatment|Treatment Period||499
2349350|NCT01674647|5766045|P1|Subjects Received Treatment|Treatment Period||988
2349351|NCT01674647|5766044|P2|STARTED|Treatment Period||502
2349352|NCT01674647|5766045|P1|STARTED|Treatment Period||1002
2349353|NCT01674634|5766071|P1|NOT COMPLETED|Overall Study||6
2349354|NCT01674634|5766071|P1|COMPLETED|Overall Study||709
2349355|NCT01674634|5766071|P1|STARTED|Overall Study||715
2349356|NCT01674621|5766091|P5|NOT COMPLETED|Overall Study||6
2349357|NCT01674621|5766092|P4|NOT COMPLETED|Overall Study||7
2349358|NCT01674621|5766093|P3|NOT COMPLETED|Overall Study||8
2349359|NCT01674621|5766094|P2|NOT COMPLETED|Overall Study||5
2349360|NCT01674621|5766095|P1|NOT COMPLETED|Overall Study||6
2349361|NCT01674621|5766091|P5|COMPLETED|Overall Study||45
2349362|NCT01674621|5766092|P4|COMPLETED|Overall Study||41
2349363|NCT01674621|5766093|P3|COMPLETED|Overall Study||43
2349364|NCT01674621|5766094|P2|COMPLETED|Overall Study||45
2349365|NCT01674621|5766095|P1|COMPLETED|Overall Study||44
2349366|NCT01674621|5766091|P5|STARTED|Overall Study||51
2349367|NCT01674621|5766092|P4|STARTED|Overall Study||48
2349368|NCT01674621|5766093|P3|STARTED|Overall Study||51
2349369|NCT01674621|5766094|P2|STARTED|Overall Study||50
2349370|NCT01674621|5766095|P1|STARTED|Overall Study||50
2349371|NCT01674569|5766117|P6|NOT COMPLETED|Overall Study||2
2349372|NCT01674569|5766118|P5|NOT COMPLETED|Overall Study||2
2349373|NCT01674569|5766119|P4|NOT COMPLETED|Overall Study||1
2349374|NCT01674569|5766120|P3|NOT COMPLETED|Overall Study||2
2349375|NCT01674569|5766121|P2|NOT COMPLETED|Overall Study||3
2349376|NCT01674569|5766122|P1|NOT COMPLETED|Overall Study||0
2349377|NCT01674569|5766117|P6|COMPLETED|Overall Study||1
2349378|NCT01674569|5766118|P5|COMPLETED|Overall Study||5
2349379|NCT01674569|5766119|P4|COMPLETED|Overall Study||9
2349380|NCT01674569|5766120|P3|COMPLETED|Overall Study||2
2349381|NCT01674569|5766121|P2|COMPLETED|Overall Study||5
2349382|NCT01674569|5766122|P1|COMPLETED|Overall Study||3
2349383|NCT01674569|5766117|P6|STARTED|Overall Study||3
2349384|NCT01674569|5766118|P5|STARTED|Overall Study||7
2349385|NCT01674569|5766119|P4|STARTED|Overall Study||10
2349386|NCT01674569|5766120|P3|STARTED|Overall Study||4
2349387|NCT01674569|5766121|P2|STARTED|Overall Study||8
2349388|NCT01674569|5766122|P1|STARTED|Overall Study||3
2349389|NCT01674478|5766128|P2|NOT COMPLETED|Overall Study||0
2349390|NCT01674478|5766129|P1|NOT COMPLETED|Overall Study||0
2349391|NCT01674478|5766128|P2|COMPLETED|Overall Study||9
2349392|NCT01674478|5766129|P1|COMPLETED|Overall Study||9
2349393|NCT01674478|5766128|P2|STARTED|Overall Study||9
2349394|NCT01674478|5766129|P1|STARTED|Overall Study||9
2349395|NCT01674062|5766143|P2|NOT COMPLETED|Overall Study||29
2349396|NCT01674062|5766144|P1|NOT COMPLETED|Overall Study||66
2349397|NCT01674062|5766143|P2|COMPLETED|Overall Study||0
2349398|NCT01674062|5766144|P1|COMPLETED|Overall Study||0
2349399|NCT01674062|5766143|P2|STARTED|Overall Study||29
2349400|NCT01674062|5766144|P1|STARTED|Overall Study||66
2349401|NCT01674010|5766159|P3|NOT COMPLETED|Randomization Phase 2||61
2349402|NCT01674010|5766160|P2|NOT COMPLETED|Randomization Phase 2||62
2349403|NCT01674010|5766161|P1|NOT COMPLETED|Randomization Phase 2||0
2349404|NCT01674010|5766159|P3|COMPLETED|Randomization Phase 2||3
2349405|NCT01674010|5766160|P2|COMPLETED|Randomization Phase 2||3
2349406|NCT01674010|5766161|P1|COMPLETED|Randomization Phase 2||0
2349407|NCT01674010|5766159|P3|STARTED|Randomization Phase 2||64
2349408|NCT01674010|5766160|P2|STARTED|Randomization Phase 2||65
2349409|NCT01674010|5766161|P1|STARTED|Randomization Phase 2||0
2349410|NCT01674010|5766159|P3|NOT COMPLETED|Open Treatment Phase 1||0
2349411|NCT01674010|5766160|P2|NOT COMPLETED|Open Treatment Phase 1||0
2349412|NCT01674010|5766161|P1|NOT COMPLETED|Open Treatment Phase 1||180
2349413|NCT01674010|5766159|P3|COMPLETED|Open Treatment Phase 1||0
2349414|NCT01674010|5766160|P2|COMPLETED|Open Treatment Phase 1||0
2349415|NCT01674010|5766161|P1|COMPLETED|Open Treatment Phase 1||129
2349416|NCT01674010|5766159|P3|STARTED|Open Treatment Phase 1||0
2349417|NCT01674010|5766160|P2|STARTED|Open Treatment Phase 1||0
2349418|NCT01674010|5766161|P1|STARTED|Open Treatment Phase 1||309
2349419|NCT01673984|5766180|P2|NOT COMPLETED|Overall Study||6
2349420|NCT01673984|5766181|P1|NOT COMPLETED|Overall Study||10
2349421|NCT01673984|5766180|P2|COMPLETED|Overall Study||1
2349422|NCT01673984|5766181|P1|COMPLETED|Overall Study||4
2349423|NCT01673984|5766180|P2|STARTED|Overall Study||7
2349424|NCT01673984|5766181|P1|STARTED|Overall Study||14
2349425|NCT01673919|5766199|P1|NOT COMPLETED|Overall Study||0
2349426|NCT01673919|5766199|P1|COMPLETED|Overall Study||7
2349427|NCT01673919|5766199|P1|STARTED|Overall Study||7
2349428|NCT01673893|5766223|P1|NOT COMPLETED|Overall Study||0
2349429|NCT01673893|5766223|P1|COMPLETED|Overall Study||59
2349430|NCT01673893|5766223|P1|STARTED|Overall Study||59
2349431|NCT01673867|5766231|P2|NOT COMPLETED|Treatment||268
2349432|NCT01673867|5766232|P1|NOT COMPLETED|Treatment||244
2349433|NCT01673867|5766231|P2|COMPLETED|Treatment||0
2349434|NCT01673867|5766232|P1|COMPLETED|Treatment||43
2349435|NCT01673867|5766231|P2|STARTED|Treatment||268
2349436|NCT01673867|5766232|P1|STARTED|Treatment||287
2349437|NCT01673867|5766231|P2|NOT COMPLETED|Randomization||22
2349438|NCT01673867|5766232|P1|NOT COMPLETED|Randomization||5
2349439|NCT01673867|5766231|P2|COMPLETED|Randomization||268
2349440|NCT01673867|5766232|P1|COMPLETED|Randomization||287
2349441|NCT01673867|5766231|P2|STARTED|Randomization||290
2349442|NCT01673867|5766232|P1|STARTED|Randomization||292
2349443|NCT01673854|5766258|P1|NOT COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||19
2349444|NCT01673854|5766258|P1|COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||0
2349445|NCT01673854|5766258|P1|STARTED|Vem 2 Phase (Vemurafenib Retreatment)||19
2349446|NCT01673854|5766258|P1|NOT COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||27
2349447|NCT01673854|5766258|P1|COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||19
2349448|NCT01673854|5766258|P1|STARTED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||46
2349449|NCT01673854|5766258|P1|NOT COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||0
2349450|NCT01673854|5766258|P1|COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||46
2349451|NCT01673854|5766258|P1|STARTED|Vem 1 Phase (Vemurafenib, 960 mg)||46
2349452|NCT01673828|5766268|P2|NOT COMPLETED|Overall Study||0
2349453|NCT01673828|5766269|P1|NOT COMPLETED|Overall Study||0
2349454|NCT01673828|5766268|P2|COMPLETED|Overall Study||6
2349455|NCT01673828|5766269|P1|COMPLETED|Overall Study||7
2349456|NCT01673828|5766268|P2|STARTED|Overall Study||6
2349457|NCT01673828|5766269|P1|STARTED|Overall Study||7
2349458|NCT01673802|5766275|P1|NOT COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||0
2349459|NCT01673802|5766275|P1|COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||10
2349460|NCT01673802|5766275|P1|STARTED|Gadoxetate Double Dose 0.050 mmol/kg||10
2349461|NCT01673802|5766275|P1|NOT COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||0
2349462|NCT01673802|5766275|P1|COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||8
2349463|NCT01673802|5766275|P1|STARTED|Gadoxetate Standard Dose 0.025 mmol/kg||8
2349464|NCT01673698|5766281|P2|NOT COMPLETED|Overall Study||13
2349465|NCT01673698|5766282|P1|NOT COMPLETED|Overall Study||51
2349466|NCT01673698|5766281|P2|COMPLETED|Overall Study||126
2349467|NCT01673698|5766282|P1|COMPLETED|Overall Study||136
2349468|NCT01673698|5766281|P2|STARTED|Overall Study||139
2349469|NCT01673698|5766282|P1|STARTED|Overall Study||187
2349470|NCT01673646|5766293|P3|NOT COMPLETED|Overall Study||4
2349471|NCT01673646|5766294|P2|NOT COMPLETED|Overall Study||7
2349472|NCT01673646|5766295|P1|NOT COMPLETED|Overall Study||4
2349473|NCT01673646|5766293|P3|COMPLETED|Overall Study||7
2349474|NCT01673646|5766294|P2|COMPLETED|Overall Study||4
2349475|NCT01673646|5766295|P1|COMPLETED|Overall Study||7
2349476|NCT01673646|5766293|P3|Discontinued Beyond 24 Months|Overall Study||1
2349477|NCT01673646|5766294|P2|Discontinued Beyond 24 Months|Overall Study||4
2349478|NCT01673646|5766295|P1|Discontinued Beyond 24 Months|Overall Study||0
2349479|NCT01673646|5766293|P3|Treated Beyond 24 Months|Overall Study||8
2349480|NCT01673646|5766294|P2|Treated Beyond 24 Months|Overall Study||8
2349481|NCT01673646|5766295|P1|Treated Beyond 24 Months|Overall Study||7
2349482|NCT01673646|5766293|P3|Did Not Enter Ext. Phase|Overall Study||1
2349483|NCT01673646|5766294|P2|Did Not Enter Ext. Phase|Overall Study||1
2349484|NCT01673646|5766295|P1|Did Not Enter Ext. Phase|Overall Study||2
2349485|NCT01673646|5766293|P3|Entered Ext. Phase|Overall Study||9
2349486|NCT01673646|5766294|P2|Entered Ext. Phase|Overall Study||9
2349487|NCT01673646|5766295|P1|Entered Ext. Phase|Overall Study||7
2349488|NCT01673646|5766293|P3|Completed Core Phase|Overall Study||10
2349489|NCT01673646|5766294|P2|Completed Core Phase|Overall Study||10
2349490|NCT01673646|5766295|P1|Completed Core Phase|Overall Study||9
2349491|NCT01673646|5766293|P3|Entered/Treated in Core Phase|Overall Study||11
2349492|NCT01673646|5766294|P2|Entered/Treated in Core Phase|Overall Study||11
2349493|NCT01673646|5766295|P1|Entered/Treated in Core Phase|Overall Study||11
2349494|NCT01673646|5766293|P3|STARTED|Overall Study||11
2349495|NCT01673646|5766294|P2|STARTED|Overall Study||11
2349496|NCT01673646|5766295|P1|STARTED|Overall Study||11
2349497|NCT01673620|5766334|P2|NOT COMPLETED|Overall Study||0
2349498|NCT01673620|5766335|P1|NOT COMPLETED|Overall Study||1
2349499|NCT01673620|5766334|P2|COMPLETED|Overall Study||22
2349500|NCT01673620|5766335|P1|COMPLETED|Overall Study||46
2349501|NCT01673620|5766334|P2|STARTED|Overall Study||22
2349502|NCT01673620|5766335|P1|STARTED|Overall Study||47
2349503|NCT01673594|5766345|P2|NOT COMPLETED|Overall Study||6
2349504|NCT01673594|5766346|P1|NOT COMPLETED|Overall Study||6
2349505|NCT01673594|5766345|P2|COMPLETED|Overall Study||13
2349506|NCT01673594|5766346|P1|COMPLETED|Overall Study||12
2349507|NCT01673594|5766345|P2|STARTED|Overall Study||19
2349508|NCT01673594|5766346|P1|STARTED|Overall Study||18
2349509|NCT01673568|5766356|P2|NOT COMPLETED|Overall Study||0
2349510|NCT01673568|5766357|P1|NOT COMPLETED|Overall Study||0
2349511|NCT01673568|5766356|P2|COMPLETED|Overall Study||28
2349512|NCT01673568|5766357|P1|COMPLETED|Overall Study||28
2349513|NCT01673568|5766356|P2|STARTED|Overall Study||28
2349514|NCT01673568|5766357|P1|STARTED|Overall Study||28
2349515|NCT01673490|5766365|P1|NOT COMPLETED|Overall Study||7
2349516|NCT01673490|5766365|P1|COMPLETED|Overall Study||52
2349517|NCT01673490|5766365|P1|STARTED|Overall Study||59
2349518|NCT01673425|5766378|P1|NOT COMPLETED|Overall Study||1
2349519|NCT01673425|5766378|P1|COMPLETED|Overall Study||4
2349520|NCT01673425|5766378|P1|STARTED|Overall Study||5
2349521|NCT01673373|5766382|P1|NOT COMPLETED|Overall Study||2
2349522|NCT01673373|5766382|P1|COMPLETED|Overall Study|Completed primary endpoint follow up.|66
2349523|NCT01673373|5766382|P1|STARTED|Overall Study||68
2349524|NCT01673347|5766398|P1|NOT COMPLETED|Overall Study||7
2349525|NCT01673347|5766398|P1|COMPLETED|Overall Study||17
2349526|NCT01673347|5766398|P1|STARTED|Overall Study||24
2349527|NCT01673282|5766407|P2|NOT COMPLETED|Overall Study||26
2349528|NCT01673282|5766408|P1|NOT COMPLETED|Overall Study||33
2349529|NCT01673282|5766407|P2|COMPLETED|Overall Study||132
2349530|NCT01673282|5766408|P1|COMPLETED|Overall Study||120
2349531|NCT01673282|5766407|P2|STARTED|Overall Study||158
2349532|NCT01673282|5766408|P1|STARTED|Overall Study||153
2349533|NCT01673256|5766414|P1|NOT COMPLETED|Overall Study||0
2349534|NCT01673256|5766414|P1|COMPLETED|Overall Study||90
2349535|NCT01673256|5766414|P1|STARTED|Overall Study||90
2349536|NCT01673191|5766420|P2|NOT COMPLETED|Overall Study||0
2349537|NCT01673191|5766421|P1|NOT COMPLETED|Overall Study||0
2349538|NCT01673191|5766420|P2|COMPLETED|Overall Study||11
2349539|NCT01673191|5766421|P1|COMPLETED|Overall Study||26
2349540|NCT01673191|5766420|P2|STARTED|Overall Study||11
2349541|NCT01673191|5766421|P1|STARTED|Overall Study||26
2349542|NCT01673178|5766444|P5|NOT COMPLETED|Overall Study||2
2349543|NCT01673178|5766445|P4|NOT COMPLETED|Overall Study||8
2349544|NCT01673178|5766446|P3|NOT COMPLETED|Overall Study||3
2349545|NCT01673178|5766447|P2|NOT COMPLETED|Overall Study||2
2349546|NCT01673178|5766448|P1|NOT COMPLETED|Overall Study||3
2349547|NCT01673178|5766444|P5|COMPLETED|Overall Study||19
2349548|NCT01673178|5766445|P4|COMPLETED|Overall Study||14
2349549|NCT01673178|5766446|P3|COMPLETED|Overall Study||18
2349550|NCT01673178|5766447|P2|COMPLETED|Overall Study||19
2349551|NCT01673178|5766448|P1|COMPLETED|Overall Study||19
2349552|NCT01673178|5766444|P5|STARTED|Overall Study||21
2349553|NCT01673178|5766445|P4|STARTED|Overall Study||22
2349554|NCT01673178|5766446|P3|STARTED|Overall Study||21
2349555|NCT01673178|5766447|P2|STARTED|Overall Study||21
2349556|NCT01673178|5766448|P1|STARTED|Overall Study||22
2349557|NCT01673126|5766687|P2|NOT COMPLETED|Overall Study||3
2349558|NCT01673126|5766688|P1|NOT COMPLETED|Overall Study||4
2349559|NCT01673126|5766687|P2|COMPLETED|Overall Study||23
2349560|NCT01673126|5766688|P1|COMPLETED|Overall Study||32
2349561|NCT01673126|5766687|P2|STARTED|Overall Study|First stimulation (20 minutes) Washout (2days) Second stimulation (20 minutes)|26
2349562|NCT01673126|5766688|P1|STARTED|Overall Study|First stimulation (20 minutes) Washout (2 days) Second stimulation (20 minutes)|36
2349563|NCT01673113|5766696|P2|NOT COMPLETED|Overall Study||0
2349564|NCT01673113|5766697|P1|NOT COMPLETED|Overall Study||0
2349565|NCT01673113|5766696|P2|COMPLETED|Overall Study||11
2349566|NCT01673113|5766697|P1|COMPLETED|Overall Study||11
2349567|NCT01673113|5766696|P2|STARTED|Overall Study||11
2349568|NCT01673113|5766697|P1|STARTED|Overall Study||11
2349569|NCT01673022|5766704|P1|NOT COMPLETED|Overall Study||8
2349570|NCT01673022|5766704|P1|COMPLETED|Overall Study||422
2349571|NCT01673022|5766704|P1|STARTED|Overall Study||430
2349572|NCT01673009|5766708|P1|NOT COMPLETED|Overall Study||13
2349573|NCT01673009|5766708|P1|COMPLETED|Overall Study||23
2349574|NCT01673009|5766708|P1|STARTED|Overall Study||36
2349575|NCT01672996|5766720|P3|NOT COMPLETED|Overall Study||0
2349576|NCT01672996|5766721|P2|NOT COMPLETED|Overall Study||0
2349577|NCT01672996|5766722|P1|NOT COMPLETED|Overall Study||0
2349578|NCT01672996|5766720|P3|COMPLETED|Overall Study||6
2349579|NCT01672996|5766721|P2|COMPLETED|Overall Study||30
2349580|NCT01672996|5766722|P1|COMPLETED|Overall Study||30
2349581|NCT01672996|5766720|P3|STARTED|Overall Study||6
2349582|NCT01672996|5766721|P2|STARTED|Overall Study||30
2349583|NCT01672996|5766722|P1|STARTED|Overall Study||30
2349584|NCT01672983|5766758|P6|NOT COMPLETED|Overall Study||0
2349585|NCT01672983|5766759|P5|NOT COMPLETED|Overall Study||0
2349586|NCT01672983|5766760|P4|NOT COMPLETED|Overall Study||0
2349587|NCT01672983|5766761|P3|NOT COMPLETED|Overall Study||0
2349588|NCT01672983|5766762|P2|NOT COMPLETED|Overall Study||0
2349589|NCT01672983|5766763|P1|NOT COMPLETED|Overall Study||0
2349590|NCT01672983|5766758|P6|COMPLETED|Overall Study||18
2349591|NCT01672983|5766759|P5|COMPLETED|Overall Study||19
2349592|NCT01672983|5766760|P4|COMPLETED|Overall Study||18
2349593|NCT01672983|5766761|P3|COMPLETED|Overall Study||19
2349594|NCT01672983|5766762|P2|COMPLETED|Overall Study||18
2349595|NCT01672983|5766763|P1|COMPLETED|Overall Study||18
2349596|NCT01672983|5766758|P6|Completed Study Drug|Overall Study||17
2349597|NCT01672983|5766759|P5|Completed Study Drug|Overall Study||12
2349598|NCT01672983|5766760|P4|Completed Study Drug|Overall Study||18
2349599|NCT01672983|5766761|P3|Completed Study Drug|Overall Study||18
2349600|NCT01672983|5766762|P2|Completed Study Drug|Overall Study||17
2349601|NCT01672983|5766763|P1|Completed Study Drug|Overall Study||18
2349602|NCT01672983|5766758|P6|STARTED|Overall Study||18
2349603|NCT01672983|5766759|P5|STARTED|Overall Study||19
2349604|NCT01672983|5766760|P4|STARTED|Overall Study||18
2349605|NCT01672983|5766761|P3|STARTED|Overall Study||19
2349606|NCT01672983|5766762|P2|STARTED|Overall Study||18
2349607|NCT01672983|5766763|P1|STARTED|Overall Study||18
2349608|NCT01672970|5766793|P1|NOT COMPLETED|Overall Study||47
2349609|NCT01672970|5766793|P1|COMPLETED|Overall Study||244
2349610|NCT01672970|5766793|P1|Treated|Overall Study||290
2349611|NCT01672970|5766793|P1|STARTED|Overall Study||291
2349612|NCT01672957|5766829|P1|NOT COMPLETED|Overall Study||55
2349613|NCT01672957|5766829|P1|COMPLETED|Overall Study||73
2349614|NCT01672957|5766829|P1|Intent-to-treat (ITT) Population|Overall Study|All enrolled participants who had no major protocol violation.|123
2349615|NCT01672957|5766829|P1|STARTED|Overall Study||128
2349616|NCT01672892|5766844|P2|NOT COMPLETED|Overall Study||3
2349617|NCT01672892|5766845|P1|NOT COMPLETED|Overall Study||8
2349618|NCT01672892|5766844|P2|COMPLETED|Overall Study|Eligible subjects available for analysis|149
2349619|NCT01672892|5766845|P1|COMPLETED|Overall Study|Eligible subjects available for analysis|129
2349620|NCT01672892|5766844|P2|STARTED|Overall Study||152
2349621|NCT01672892|5766845|P1|STARTED|Overall Study||137
2349622|NCT01672879|5766864|P3|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||8
2349623|NCT01672879|5766865|P2|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||17
2349624|NCT01672879|5766866|P1|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||15
2349625|NCT01672879|5766864|P3|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
2349626|NCT01672879|5766865|P2|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
2349627|NCT01672879|5766866|P1|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
2349628|NCT01672879|5766864|P3|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|8
2349629|NCT01672879|5766865|P2|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|17
2349630|NCT01672879|5766866|P1|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|15
2349631|NCT01672879|5766864|P3|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||86
2349632|NCT01672879|5766865|P2|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||86
2349633|NCT01672879|5766866|P1|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||87
2349634|NCT01672879|5766864|P3|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
2349635|NCT01672879|5766865|P2|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
2349636|NCT01672879|5766866|P1|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
2349637|NCT01672879|5766864|P3|STARTED|Blinded Phase (Up to 240 Weeks)||86
2349638|NCT01672879|5766865|P2|STARTED|Blinded Phase (Up to 240 Weeks)||86
2349639|NCT01672879|5766866|P1|STARTED|Blinded Phase (Up to 240 Weeks)||87
2349640|NCT01672866|5766881|P3|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||16
2349641|NCT01672866|5766882|P2|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||15
2349642|NCT01672866|5766883|P1|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||11
2349643|NCT01672866|5766881|P3|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
2349644|NCT01672866|5766882|P2|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
2349645|NCT01672866|5766883|P1|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
2349646|NCT01672866|5766881|P3|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|16
2349647|NCT01672866|5766882|P2|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|15
2349648|NCT01672866|5766883|P1|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|11
2349649|NCT01672866|5766881|P3|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
2349650|NCT01672866|5766882|P2|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
2349651|NCT01672866|5766883|P1|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
2349652|NCT01672866|5766881|P3|COMPLETED|Blinded Phase (up to 240 Weeks)||0
2349653|NCT01672866|5766882|P2|COMPLETED|Blinded Phase (up to 240 Weeks)||0
2349654|NCT01672866|5766883|P1|COMPLETED|Blinded Phase (up to 240 Weeks)||0
2349655|NCT01672866|5766881|P3|STARTED|Blinded Phase (up to 240 Weeks)||74
2349656|NCT01672866|5766882|P2|STARTED|Blinded Phase (up to 240 Weeks)||74
2349657|NCT01672866|5766883|P1|STARTED|Blinded Phase (up to 240 Weeks)||74
2349658|NCT01672853|5766898|P3|NOT COMPLETED|Overall Study||14
2349659|NCT01672853|5766899|P2|NOT COMPLETED|Overall Study||17
2349660|NCT01672853|5766900|P1|NOT COMPLETED|Overall Study||10
2349661|NCT01672853|5766898|P3|COMPLETED|Overall Study||65
2349662|NCT01672853|5766899|P2|COMPLETED|Overall Study||60
2349663|NCT01672853|5766900|P1|COMPLETED|Overall Study||69
2349664|NCT01672853|5766898|P3|STARTED|Overall Study||79
2349665|NCT01672853|5766899|P2|STARTED|Overall Study||77
2349666|NCT01672853|5766900|P1|STARTED|Overall Study||79
2349667|NCT01672827|5766917|P1|NOT COMPLETED|Overall Study||0
2349668|NCT01672827|5766917|P1|COMPLETED|Overall Study||276
2349669|NCT01672827|5766917|P1|STARTED|Overall Study||276
2349670|NCT01672788|5766923|P4|NOT COMPLETED|Treatment Period 4 (3 Days)||0
2349671|NCT01672788|5766924|P3|NOT COMPLETED|Treatment Period 4 (3 Days)||0
2349672|NCT01672788|5766925|P2|NOT COMPLETED|Treatment Period 4 (3 Days)||0
2349673|NCT01672788|5766926|P1|NOT COMPLETED|Treatment Period 4 (3 Days)||0
2349674|NCT01672788|5766923|P4|COMPLETED|Treatment Period 4 (3 Days)||8
2349675|NCT01672788|5766924|P3|COMPLETED|Treatment Period 4 (3 Days)||9
2349676|NCT01672788|5766925|P2|COMPLETED|Treatment Period 4 (3 Days)||9
2349677|NCT01672788|5766926|P1|COMPLETED|Treatment Period 4 (3 Days)||9
2349678|NCT01672788|5766923|P4|STARTED|Treatment Period 4 (3 Days)||8
2349679|NCT01672788|5766924|P3|STARTED|Treatment Period 4 (3 Days)||9
2349680|NCT01672788|5766925|P2|STARTED|Treatment Period 4 (3 Days)||9
2349681|NCT01672788|5766926|P1|STARTED|Treatment Period 4 (3 Days)||9
2349682|NCT01672788|5766923|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
2349683|NCT01672788|5766924|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
2349684|NCT01672788|5766925|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
2349685|NCT01672788|5766926|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
2349686|NCT01672788|5766923|P4|COMPLETED|Washout Period 3 (7 Days)||8
2349687|NCT01672788|5766924|P3|COMPLETED|Washout Period 3 (7 Days)||9
2349688|NCT01672788|5766925|P2|COMPLETED|Washout Period 3 (7 Days)||9
2349689|NCT01672788|5766926|P1|COMPLETED|Washout Period 3 (7 Days)||9
2349690|NCT01672788|5766923|P4|STARTED|Washout Period 3 (7 Days)||8
2349691|NCT01672788|5766924|P3|STARTED|Washout Period 3 (7 Days)||9
2349692|NCT01672788|5766925|P2|STARTED|Washout Period 3 (7 Days)||9
2349693|NCT01672788|5766926|P1|STARTED|Washout Period 3 (7 Days)||9
2349694|NCT01672788|5766923|P4|NOT COMPLETED|Treatment Period 3 (3 Days)||0
2349695|NCT01672788|5766924|P3|NOT COMPLETED|Treatment Period 3 (3 Days)||0
2349696|NCT01672788|5766925|P2|NOT COMPLETED|Treatment Period 3 (3 Days)||0
2349697|NCT01672788|5766926|P1|NOT COMPLETED|Treatment Period 3 (3 Days)||0
2349698|NCT01672788|5766923|P4|COMPLETED|Treatment Period 3 (3 Days)||8
2349699|NCT01672788|5766924|P3|COMPLETED|Treatment Period 3 (3 Days)||9
2349700|NCT01672788|5766925|P2|COMPLETED|Treatment Period 3 (3 Days)||9
2349701|NCT01672788|5766926|P1|COMPLETED|Treatment Period 3 (3 Days)||9
2349702|NCT01672788|5766923|P4|STARTED|Treatment Period 3 (3 Days)||8
2349703|NCT01672788|5766924|P3|STARTED|Treatment Period 3 (3 Days)||9
2349704|NCT01672788|5766925|P2|STARTED|Treatment Period 3 (3 Days)||9
2349705|NCT01672788|5766926|P1|STARTED|Treatment Period 3 (3 Days)||9
2349706|NCT01672788|5766923|P4|NOT COMPLETED|Washout Period 2 (7 Days)||1
2349707|NCT01672788|5766924|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
2349708|NCT01672788|5766925|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
2349709|NCT01672788|5766926|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
2349710|NCT01672788|5766923|P4|COMPLETED|Washout Period 2 (7 Days)||8
2349711|NCT01672788|5766924|P3|COMPLETED|Washout Period 2 (7 Days)||9
2349712|NCT01672788|5766925|P2|COMPLETED|Washout Period 2 (7 Days)||9
2349713|NCT01672788|5766926|P1|COMPLETED|Washout Period 2 (7 Days)||9
2349714|NCT01672788|5766923|P4|STARTED|Washout Period 2 (7 Days)||9
2349715|NCT01672788|5766924|P3|STARTED|Washout Period 2 (7 Days)||9
2349716|NCT01672788|5766925|P2|STARTED|Washout Period 2 (7 Days)||9
2349717|NCT01672788|5766926|P1|STARTED|Washout Period 2 (7 Days)||9
2349718|NCT01672788|5766923|P4|NOT COMPLETED|Treatment Period 2 (3 Days)||0
2349719|NCT01672788|5766924|P3|NOT COMPLETED|Treatment Period 2 (3 Days)||0
2349720|NCT01672788|5766925|P2|NOT COMPLETED|Treatment Period 2 (3 Days)||0
2349721|NCT01672788|5766926|P1|NOT COMPLETED|Treatment Period 2 (3 Days)||0
2349722|NCT01672788|5766923|P4|COMPLETED|Treatment Period 2 (3 Days)||9
2349723|NCT01672788|5766924|P3|COMPLETED|Treatment Period 2 (3 Days)||9
2349724|NCT01672788|5766925|P2|COMPLETED|Treatment Period 2 (3 Days)||9
2349725|NCT01672788|5766926|P1|COMPLETED|Treatment Period 2 (3 Days)||9
2349726|NCT01672788|5766923|P4|STARTED|Treatment Period 2 (3 Days)||9
2349727|NCT01672788|5766924|P3|STARTED|Treatment Period 2 (3 Days)||9
2349728|NCT01672788|5766925|P2|STARTED|Treatment Period 2 (3 Days)||9
2349729|NCT01672788|5766926|P1|STARTED|Treatment Period 2 (3 Days)||9
2349730|NCT01672788|5766923|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
2349731|NCT01672788|5766924|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
2349732|NCT01672788|5766925|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
2349733|NCT01672788|5766926|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
2349734|NCT01672788|5766923|P4|COMPLETED|Washout Period 1 (7 Days)||9
2349735|NCT01672788|5766924|P3|COMPLETED|Washout Period 1 (7 Days)||9
2349736|NCT01672788|5766925|P2|COMPLETED|Washout Period 1 (7 Days)||9
2349737|NCT01672788|5766926|P1|COMPLETED|Washout Period 1 (7 Days)||9
2349738|NCT01672788|5766923|P4|STARTED|Washout Period 1 (7 Days)||9
2349739|NCT01672788|5766924|P3|STARTED|Washout Period 1 (7 Days)||9
2349740|NCT01672788|5766925|P2|STARTED|Washout Period 1 (7 Days)||9
2349741|NCT01672788|5766926|P1|STARTED|Washout Period 1 (7 Days)||9
2349742|NCT01672788|5766923|P4|NOT COMPLETED|Treatment Period 1 (3 Days)||0
2349743|NCT01672788|5766924|P3|NOT COMPLETED|Treatment Period 1 (3 Days)||0
2349744|NCT01672788|5766925|P2|NOT COMPLETED|Treatment Period 1 (3 Days)||0
2349745|NCT01672788|5766926|P1|NOT COMPLETED|Treatment Period 1 (3 Days)||0
2349746|NCT01672788|5766923|P4|COMPLETED|Treatment Period 1 (3 Days)||9
2349747|NCT01672788|5766924|P3|COMPLETED|Treatment Period 1 (3 Days)||9
2349748|NCT01672788|5766925|P2|COMPLETED|Treatment Period 1 (3 Days)||9
2349749|NCT01672788|5766926|P1|COMPLETED|Treatment Period 1 (3 Days)||9
2349750|NCT01672788|5766923|P4|STARTED|Treatment Period 1 (3 Days)||9
2349751|NCT01672788|5766924|P3|STARTED|Treatment Period 1 (3 Days)||9
2349752|NCT01672788|5766925|P2|STARTED|Treatment Period 1 (3 Days)||9
2349753|NCT01672788|5766926|P1|STARTED|Treatment Period 1 (3 Days)||9
2349754|NCT01672736|5766956|P1|NOT COMPLETED|Overall Study||3
2349755|NCT01672736|5766956|P1|COMPLETED|Overall Study|3 patients taken off study due to non-availability of further study (Linsitinib) drug supply.|16
2349756|NCT01672736|5766956|P1|STARTED|Overall Study|Phase I study part stopped early due to manufacturer's decision to stop further drug development.|19
2349757|NCT01672723|5766960|P2|NOT COMPLETED|Second Intervention||0
2349758|NCT01672723|5766961|P1|NOT COMPLETED|Second Intervention||0
2349759|NCT01672723|5766960|P2|COMPLETED|Second Intervention||15
2349760|NCT01672723|5766961|P1|COMPLETED|Second Intervention||16
2349761|NCT01672723|5766960|P2|STARTED|Second Intervention||15
2349762|NCT01672723|5766961|P1|STARTED|Second Intervention||16
2349763|NCT01672723|5766960|P2|NOT COMPLETED|Washout Period of 10 Days||0
2349764|NCT01672723|5766961|P1|NOT COMPLETED|Washout Period of 10 Days||0
2349765|NCT01672723|5766960|P2|COMPLETED|Washout Period of 10 Days||15
2349766|NCT01672723|5766961|P1|COMPLETED|Washout Period of 10 Days||16
2349767|NCT01672723|5766960|P2|STARTED|Washout Period of 10 Days||15
2349768|NCT01672723|5766961|P1|STARTED|Washout Period of 10 Days||16
2349769|NCT01672723|5766960|P2|NOT COMPLETED|First Intervention||0
2349770|NCT01672723|5766961|P1|NOT COMPLETED|First Intervention||3
2349771|NCT01672723|5766960|P2|COMPLETED|First Intervention||15
2349772|NCT01672723|5766961|P1|COMPLETED|First Intervention||16
2349773|NCT01672723|5766960|P2|STARTED|First Intervention||15
2349774|NCT01672723|5766961|P1|STARTED|First Intervention||19
2349775|NCT01672710|5766973|P2|NOT COMPLETED|3 Month Follow up||4
2349776|NCT01672710|5766974|P1|NOT COMPLETED|3 Month Follow up||6
2349777|NCT01672710|5766973|P2|COMPLETED|3 Month Follow up||5
2349778|NCT01672710|5766974|P1|COMPLETED|3 Month Follow up||16
2349779|NCT01672710|5766973|P2|STARTED|3 Month Follow up||9
2349780|NCT01672710|5766974|P1|STARTED|3 Month Follow up||22
2349781|NCT01672710|5766973|P2|NOT COMPLETED|Waitlist Assessed After Sauna Regimen||1
2349782|NCT01672710|5766974|P1|NOT COMPLETED|Waitlist Assessed After Sauna Regimen||0
2349783|NCT01672710|5766973|P2|COMPLETED|Waitlist Assessed After Sauna Regimen||9
2349784|NCT01672710|5766974|P1|COMPLETED|Waitlist Assessed After Sauna Regimen|non applicable, cannot compare the immediate start and waitlist in this period|22
2349785|NCT01672710|5766973|P2|STARTED|Waitlist Assessed After Sauna Regimen|waitlisted group receive the 4 week intervention and complete 7 day assessments|10
2349786|NCT01672710|5766974|P1|STARTED|Waitlist Assessed After Sauna Regimen|immediate start group no further assessments until 3 month follow up|22
2349787|NCT01672710|5766973|P2|NOT COMPLETED|Controlled Comparison 5 Week Follow-up||0
2349788|NCT01672710|5766974|P1|NOT COMPLETED|Controlled Comparison 5 Week Follow-up||0
2349789|NCT01672710|5766973|P2|COMPLETED|Controlled Comparison 5 Week Follow-up|waitlist group repeat baseline assessments after 4 week time period then begin sauna|10
2349790|NCT01672710|5766974|P1|COMPLETED|Controlled Comparison 5 Week Follow-up|sauna intervention group repeat all assessments 7 days after complete the regimen|22
2349791|NCT01672710|5766973|P2|STARTED|Controlled Comparison 5 Week Follow-up||10
2349792|NCT01672710|5766974|P1|STARTED|Controlled Comparison 5 Week Follow-up||22
2349793|NCT01672658|5766986|P2|NOT COMPLETED|Overall Study||1
2349794|NCT01672658|5766987|P1|NOT COMPLETED|Overall Study||0
2349795|NCT01672658|5766986|P2|COMPLETED|Overall Study||14
2349796|NCT01672658|5766987|P1|COMPLETED|Overall Study||16
2349797|NCT01672658|5766986|P2|STARTED|Overall Study||15
2349798|NCT01672658|5766987|P1|STARTED|Overall Study||16
2349799|NCT01672294|5767011|P4|NOT COMPLETED|Overall Study||13
2349800|NCT01672294|5767012|P3|NOT COMPLETED|Overall Study||11
2349801|NCT01672294|5767013|P2|NOT COMPLETED|Overall Study||21
2349802|NCT01672294|5767014|P1|NOT COMPLETED|Overall Study||6
2349803|NCT01672294|5767011|P4|COMPLETED|Overall Study||59
2349804|NCT01672294|5767012|P3|COMPLETED|Overall Study||61
2349805|NCT01672294|5767013|P2|COMPLETED|Overall Study||50
2349806|NCT01672294|5767014|P1|COMPLETED|Overall Study||65
2349807|NCT01672294|5767011|P4|STARTED|Overall Study||72
2349808|NCT01672294|5767012|P3|STARTED|Overall Study||72
2349809|NCT01672294|5767013|P2|STARTED|Overall Study||71
2349810|NCT01672294|5767014|P1|STARTED|Overall Study||71
2349811|NCT01672242|5767036|P2|NOT COMPLETED|Period 2||0
2349812|NCT01672242|5767037|P1|NOT COMPLETED|Period 2||0
2349813|NCT01672242|5767036|P2|COMPLETED|Period 2||2
2349814|NCT01672242|5767037|P1|COMPLETED|Period 2||4
2349815|NCT01672242|5767036|P2|STARTED|Period 2||2
2349816|NCT01672242|5767037|P1|STARTED|Period 2||4
2349817|NCT01672242|5767036|P2|NOT COMPLETED|Period 1||0
2349818|NCT01672242|5767037|P1|NOT COMPLETED|Period 1||0
2349819|NCT01672242|5767036|P2|COMPLETED|Period 1||2
2349820|NCT01672242|5767037|P1|COMPLETED|Period 1||4
2349821|NCT01672242|5767036|P2|STARTED|Period 1||2
2349822|NCT01672242|5767037|P1|STARTED|Period 1||4
2349823|NCT01671839|5767043|P1|NOT COMPLETED|Overall Study||18
2349824|NCT01671839|5767043|P1|COMPLETED|Overall Study||37
2349825|NCT01671839|5767043|P1|5-year Follow-up|Overall Study||37
2349826|NCT01671839|5767043|P1|3-year Follow-up|Overall Study||45
2349827|NCT01671839|5767043|P1|STARTED|Overall Study||55
2349828|NCT01671748|5767059|P2|NOT COMPLETED|12 Week Treatment Phase||0
2349829|NCT01671748|5767060|P1|NOT COMPLETED|12 Week Treatment Phase||0
2349830|NCT01671748|5767059|P2|COMPLETED|12 Week Treatment Phase||17
2349831|NCT01671748|5767060|P1|COMPLETED|12 Week Treatment Phase||19
2349832|NCT01671748|5767059|P2|STARTED|12 Week Treatment Phase||17
2349833|NCT01671748|5767060|P1|STARTED|12 Week Treatment Phase||19
2349834|NCT01671748|5767059|P2|NOT COMPLETED|4 Week run-in Phase||0
2349835|NCT01671748|5767060|P1|NOT COMPLETED|4 Week run-in Phase||11
2349836|NCT01671748|5767059|P2|COMPLETED|4 Week run-in Phase||0
2349837|NCT01671748|5767060|P1|COMPLETED|4 Week run-in Phase||36
2349838|NCT01671748|5767059|P2|STARTED|4 Week run-in Phase||0
2349839|NCT01671748|5767060|P1|STARTED|4 Week run-in Phase||47
2349840|NCT01671605|5767080|P2|NOT COMPLETED|Overall Study||0
2349841|NCT01671605|5767081|P1|NOT COMPLETED|Overall Study||0
2349842|NCT01671605|5767080|P2|COMPLETED|Overall Study||31
2349843|NCT01671605|5767081|P1|COMPLETED|Overall Study||72
2349844|NCT01671605|5767080|P2|STARTED|Overall Study||31
2349845|NCT01671605|5767081|P1|STARTED|Overall Study||72
2349849|NCT01671345|5767095|P2|NOT COMPLETED|Overall Study||9
2349850|NCT01671345|5767096|P1|NOT COMPLETED|Overall Study||13
2349851|NCT01671345|5767095|P2|COMPLETED|Overall Study||83
2349852|NCT01671345|5767096|P1|COMPLETED|Overall Study||64
2349853|NCT01671345|5767095|P2|STARTED|Overall Study||92
2349854|NCT01671345|5767096|P1|STARTED|Overall Study||77
2349855|NCT01671319|5767108|P1|NOT COMPLETED|Overall Study||1
2349856|NCT01671319|5767108|P1|COMPLETED|Overall Study||41
2349857|NCT01671319|5767108|P1|STARTED|Overall Study||42
2349858|NCT01671293|5767116|P2|NOT COMPLETED|Overall Study||2
2349859|NCT01671293|5767117|P1|NOT COMPLETED|Overall Study||3
2349860|NCT01671293|5767116|P2|COMPLETED|Overall Study||32
2349861|NCT01671293|5767117|P1|COMPLETED|Overall Study||33
2349862|NCT01671293|5767116|P2|STARTED|Overall Study||34
2349863|NCT01671293|5767117|P1|STARTED|Overall Study||36
2349864|NCT01671280|5767123|P1|NOT COMPLETED|Overall Study||2
2349865|NCT01671280|5767123|P1|COMPLETED|Overall Study||401
2349866|NCT01671280|5767123|P1|STARTED|Overall Study|The number is enrollment.|403
2349867|NCT01671176|5767129|P1|NOT COMPLETED|Overall Study||0
2349868|NCT01671176|5767129|P1|COMPLETED|Overall Study||30
2349869|NCT01671176|5767129|P1|STARTED|Overall Study||30
2349870|NCT01671111|5767134|P1|NOT COMPLETED|Overall Study||30
2349871|NCT01671111|5767134|P1|COMPLETED|Overall Study||0
2349872|NCT01671111|5767134|P1|STARTED|Overall Study||30
2349873|NCT01671085|5767146|P2|NOT COMPLETED|Overall Study||0
2349874|NCT01671085|5767147|P1|NOT COMPLETED|Overall Study||1
2349875|NCT01671085|5767146|P2|COMPLETED|Overall Study||2
2349876|NCT01671085|5767147|P1|COMPLETED|Overall Study||10
2349877|NCT01671085|5767146|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
2349878|NCT01671085|5767147|P1|Received at Least 1 Dose of Study Drug|Overall Study||11
2349879|NCT01671085|5767146|P2|STARTED|Overall Study||2
2349880|NCT01671085|5767147|P1|STARTED|Overall Study|1 participant who dropped out was replaced.|11
2349881|NCT01671059|5767158|P1|NOT COMPLETED|Overall Study||5
2349882|NCT01671059|5767158|P1|COMPLETED|Overall Study||75
2349883|NCT01671059|5767158|P1|STARTED|Overall Study||80
2349884|NCT01670825|5767183|P2|NOT COMPLETED|Overall Study||0
2349885|NCT01670825|5767184|P1|NOT COMPLETED|Overall Study||0
2349886|NCT01670825|5767183|P2|COMPLETED|Overall Study||39
2349887|NCT01670825|5767184|P1|COMPLETED|Overall Study||42
2349888|NCT01670825|5767183|P2|STARTED|Overall Study||39
2349889|NCT01670825|5767184|P1|STARTED|Overall Study||42
2349890|NCT01670721|5767250|P1|NOT COMPLETED|Overall Study||53
2349891|NCT01670721|5767250|P1|COMPLETED|Overall Study|81 participants with DP and 41 with adverse events were considered as completed.|122
2349892|NCT01670721|5767250|P1|STARTED|Overall Study||175
2349893|NCT01670656|5767262|P5|NOT COMPLETED|Overall Study||11
2349894|NCT01670656|5767263|P4|NOT COMPLETED|Overall Study||6
2349895|NCT01670656|5767264|P3|NOT COMPLETED|Overall Study||8
2349896|NCT01670656|5767265|P2|NOT COMPLETED|Overall Study||7
2349897|NCT01670656|5767266|P1|NOT COMPLETED|Overall Study||3
2349898|NCT01670656|5767262|P5|COMPLETED|Overall Study||79
2349899|NCT01670656|5767263|P4|COMPLETED|Overall Study||79
2349900|NCT01670656|5767264|P3|COMPLETED|Overall Study||79
2349901|NCT01670656|5767265|P2|COMPLETED|Overall Study||84
2349902|NCT01670656|5767266|P1|COMPLETED|Overall Study||83
2349903|NCT01670656|5767262|P5|Treated|Overall Study||90
2349904|NCT01670656|5767263|P4|Treated|Overall Study||85
2349905|NCT01670656|5767264|P3|Treated|Overall Study||86
2349906|NCT01670656|5767265|P2|Treated|Overall Study||91
2349907|NCT01670656|5767266|P1|Treated|Overall Study||86
2349908|NCT01670656|5767262|P5|STARTED|Overall Study||90
2349909|NCT01670656|5767263|P4|STARTED|Overall Study||85
2349910|NCT01670656|5767264|P3|STARTED|Overall Study||87
2349911|NCT01670656|5767265|P2|STARTED|Overall Study||91
2349912|NCT01670656|5767266|P1|STARTED|Overall Study||86
2349913|NCT01670526|5767295|P2|NOT COMPLETED|Overall Study||6
2349914|NCT01670526|5767296|P1|NOT COMPLETED|Overall Study||12
2349915|NCT01670526|5767295|P2|COMPLETED|Overall Study||39
2349916|NCT01670526|5767296|P1|COMPLETED|Overall Study||37
2349917|NCT01670526|5767295|P2|STARTED|Overall Study||45
2349918|NCT01670526|5767296|P1|STARTED|Overall Study||49
2349919|NCT01670487|5767310|P2|NOT COMPLETED|Overall Study||0
2349920|NCT01670487|5767311|P1|NOT COMPLETED|Overall Study||0
2349921|NCT01670487|5767310|P2|COMPLETED|Overall Study||150
2349922|NCT01670487|5767311|P1|COMPLETED|Overall Study||150
2349923|NCT01670487|5767310|P2|STARTED|Overall Study||150
2349924|NCT01670487|5767311|P1|STARTED|Overall Study||150
2349925|NCT01670292|5767317|P1|NOT COMPLETED|Overall Study||14
2349926|NCT01670292|5767317|P1|COMPLETED|Overall Study||68
2349927|NCT01670292|5767317|P1|STARTED|Overall Study||82
2349928|NCT01670279|5767358|P4|NOT COMPLETED|Overall Study||1
2349929|NCT01670279|5767359|P3|NOT COMPLETED|Overall Study||0
2349930|NCT01670279|5767360|P2|NOT COMPLETED|Overall Study||2
2349931|NCT01670279|5767361|P1|NOT COMPLETED|Overall Study||0
2349932|NCT01670279|5767358|P4|COMPLETED|Overall Study||4
2349933|NCT01670279|5767359|P3|COMPLETED|Overall Study||0
2349934|NCT01670279|5767360|P2|COMPLETED|Overall Study||5
2349935|NCT01670279|5767361|P1|COMPLETED|Overall Study||6
2349936|NCT01670279|5767358|P4|STARTED|Overall Study||5
2349937|NCT01670279|5767359|P3|STARTED|Overall Study||0
2349938|NCT01670279|5767360|P2|STARTED|Overall Study||7
2349939|NCT01670279|5767361|P1|STARTED|Overall Study||6
2349940|NCT01670201|5767396|P1|NOT COMPLETED|Overall Study||0
2349941|NCT01670201|5767396|P1|COMPLETED|Overall Study||8
2349942|NCT01670201|5767396|P1|STARTED|Overall Study||8
2349943|NCT01670188|5767403|P2|NOT COMPLETED|Overall Study||1
2349944|NCT01670188|5767404|P1|NOT COMPLETED|Overall Study||0
2349945|NCT01670188|5767403|P2|COMPLETED|Overall Study||39
2349946|NCT01670188|5767404|P1|COMPLETED|Overall Study||38
2349947|NCT01670188|5767403|P2|STARTED|Overall Study||40
2349948|NCT01670188|5767404|P1|STARTED|Overall Study||38
2349949|NCT01670045|5767410|P1|NOT COMPLETED|Overall Study||16
2349950|NCT01670045|5767410|P1|COMPLETED|Overall Study||27
2349951|NCT01670045|5767410|P1|STARTED|Overall Study||43
2349952|NCT01670019|5767428|P2|NOT COMPLETED|Overall Study||0
2349953|NCT01670019|5767429|P1|NOT COMPLETED|Overall Study||9
2349954|NCT01670019|5767428|P2|COMPLETED|Overall Study||23
2349955|NCT01670019|5767429|P1|COMPLETED|Overall Study||14
2349956|NCT01670019|5767428|P2|STARTED|Overall Study||23
2349957|NCT01670019|5767429|P1|STARTED|Overall Study||23
2349958|NCT01669902|5767443|P1|NOT COMPLETED|Overall Study||29
2349959|NCT01669902|5767443|P1|COMPLETED|Overall Study||78
2349960|NCT01669902|5767443|P1|STARTED|Overall Study||107
2349961|NCT01669863|5767470|P1|NOT COMPLETED|Overall Study||0
2349962|NCT01669863|5767470|P1|COMPLETED|Overall Study||6
2349963|NCT01669863|5767470|P1|STARTED|Overall Study||6
2349964|NCT01669811|5767478|P2|NOT COMPLETED|Overall Study||11
2349965|NCT01669811|5767479|P1|NOT COMPLETED|Overall Study||3
2349966|NCT01669811|5767478|P2|COMPLETED|Overall Study||131
2349967|NCT01669811|5767479|P1|COMPLETED|Overall Study||142
2349968|NCT01669811|5767478|P2|STARTED|Overall Study||142
2349969|NCT01669811|5767479|P1|STARTED|Overall Study||145
2349970|NCT01669798|5767497|P1|NOT COMPLETED|Overall Study||5
2349971|NCT01669798|5767497|P1|COMPLETED|Overall Study||27
2349972|NCT01669798|5767497|P1|STARTED|Overall Study||32
2349973|NCT01669785|5767513|P3|NOT COMPLETED|Overall Study||0
2349974|NCT01669785|5767514|P2|NOT COMPLETED|Overall Study||0
2349975|NCT01669785|5767515|P1|NOT COMPLETED|Overall Study||0
2349976|NCT01669785|5767513|P3|COMPLETED|Overall Study||46
2349977|NCT01669785|5767514|P2|COMPLETED|Overall Study||48
2349978|NCT01669785|5767515|P1|COMPLETED|Overall Study||45
2349979|NCT01669785|5767513|P3|STARTED|Overall Study||46
2349980|NCT01669785|5767514|P2|STARTED|Overall Study||48
2349981|NCT01669785|5767515|P1|STARTED|Overall Study||45
2349988|NCT01669642|5767566|P6|NOT COMPLETED|Overall Study||10
2349989|NCT01669642|5767567|P5|NOT COMPLETED|Overall Study||0
2349990|NCT01669642|5767568|P4|NOT COMPLETED|Overall Study||1
2349991|NCT01669642|5767569|P3|NOT COMPLETED|Overall Study||0
2349992|NCT01669642|5767570|P2|NOT COMPLETED|Overall Study||0
2349993|NCT01669642|5767571|P1|NOT COMPLETED|Overall Study||0
2349994|NCT01669642|5767566|P6|COMPLETED|Overall Study||0
2349995|NCT01669642|5767567|P5|COMPLETED|Overall Study||20
2349996|NCT01669642|5767568|P4|COMPLETED|Overall Study||20
2349997|NCT01669642|5767569|P3|COMPLETED|Overall Study||20
2349998|NCT01669642|5767570|P2|COMPLETED|Overall Study||20
2349999|NCT01669642|5767571|P1|COMPLETED|Overall Study||20
2350000|NCT01669642|5767566|P6|STARTED|Overall Study||10
2350001|NCT01669642|5767567|P5|STARTED|Overall Study||20
2350002|NCT01669642|5767568|P4|STARTED|Overall Study||21
2350003|NCT01669642|5767569|P3|STARTED|Overall Study||20
2350004|NCT01669642|5767570|P2|STARTED|Overall Study||20
2350005|NCT01669642|5767571|P1|STARTED|Overall Study||20
2350006|NCT01669629|5767603|P2|NOT COMPLETED|Period 2||0
2350007|NCT01669629|5767604|P1|NOT COMPLETED|Period 2||0
2350008|NCT01669629|5767603|P2|COMPLETED|Period 2||89
2350009|NCT01669629|5767604|P1|COMPLETED|Period 2||91
2350010|NCT01669629|5767603|P2|STARTED|Period 2||89
2350011|NCT01669629|5767604|P1|STARTED|Period 2||91
2350012|NCT01669629|5767603|P2|NOT COMPLETED|Period 1||2
2350013|NCT01669629|5767604|P1|NOT COMPLETED|Period 1||1
2350014|NCT01669629|5767603|P2|COMPLETED|Period 1||89
2350015|NCT01669629|5767604|P1|COMPLETED|Period 1||91
2350016|NCT01669629|5767603|P2|STARTED|Period 1||91
2350017|NCT01669629|5767604|P1|STARTED|Period 1||92
2350018|NCT01669603|5767620|P2|NOT COMPLETED|Overall Study||38
2350019|NCT01669603|5767621|P1|NOT COMPLETED|Overall Study||37
2350020|NCT01669603|5767620|P2|COMPLETED|Overall Study||57
2350021|NCT01669603|5767621|P1|COMPLETED|Overall Study||58
2350022|NCT01669603|5767620|P2|STARTED|Overall Study||95
2350023|NCT01669603|5767621|P1|STARTED|Overall Study||95
2350024|NCT01669577|5767627|P1|NOT COMPLETED|Overall Study||134
2350025|NCT01669577|5767627|P1|COMPLETED|Overall Study|complete case analysis (data missing completely at random)|200
2350026|NCT01669577|5767627|P1|STARTED|Overall Study|calculated ISS<16, no informed consent, not enough data(complete case analysis), were excluded|334
2350027|NCT01669538|5767633|P2|NOT COMPLETED|Overall Study||9
2350028|NCT01669538|5767634|P1|NOT COMPLETED|Overall Study||12
2350029|NCT01669538|5767633|P2|COMPLETED|Overall Study||33
2350030|NCT01669538|5767634|P1|COMPLETED|Overall Study||28
2350031|NCT01669538|5767633|P2|STARTED|Overall Study||42
2350032|NCT01669538|5767634|P1|STARTED|Overall Study||40
2350033|NCT01669434|5767648|P2|NOT COMPLETED|Overall Study||7
2350034|NCT01669434|5767649|P1|NOT COMPLETED|Overall Study||9
2350035|NCT01669434|5767648|P2|COMPLETED|Overall Study||138
2350036|NCT01669434|5767649|P1|COMPLETED|Overall Study||137
2350037|NCT01669434|5767648|P2|STARTED|Overall Study||145
2350038|NCT01669434|5767649|P1|STARTED|Overall Study||146
2350039|NCT01669421|5767665|P1|NOT COMPLETED|Phase 3: Standard Dose Therapy||0
2350040|NCT01669421|5767665|P1|COMPLETED|Phase 3: Standard Dose Therapy||8
2350041|NCT01669421|5767665|P1|STARTED|Phase 3: Standard Dose Therapy||8
2350042|NCT01669421|5767665|P1|NOT COMPLETED|Phase 2: Double Dose Therapy||0
2350043|NCT01669421|5767665|P1|COMPLETED|Phase 2: Double Dose Therapy||8
2350044|NCT01669421|5767665|P1|STARTED|Phase 2: Double Dose Therapy||8
2350045|NCT01669421|5767665|P1|NOT COMPLETED|Phase 1: Standard Dose Therapy||2
2350046|NCT01669421|5767665|P1|COMPLETED|Phase 1: Standard Dose Therapy||8
2350047|NCT01669421|5767665|P1|STARTED|Phase 1: Standard Dose Therapy||10
2350048|NCT01669174|5767684|P2|NOT COMPLETED|Overall Study||6
2350049|NCT01669174|5767685|P1|NOT COMPLETED|Overall Study||6
2350050|NCT01669174|5767684|P2|COMPLETED|Overall Study||28
2350051|NCT01669174|5767685|P1|COMPLETED|Overall Study||27
2350052|NCT01669174|5767684|P2|STARTED|Overall Study||34
2350053|NCT01669174|5767685|P1|STARTED|Overall Study||33
2350054|NCT01669148|5767696|P1|NOT COMPLETED|Overall Study||70
2350055|NCT01669148|5767696|P1|COMPLETED|Overall Study||426
2350056|NCT01669148|5767696|P1|STARTED|Overall Study||496
2350057|NCT01669122|5767701|P1|NOT COMPLETED|Period IV||0
2350058|NCT01669122|5767701|P1|COMPLETED|Period IV||37
2350059|NCT01669122|5767701|P1|STARTED|Period IV|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=9, Reference Lozenge=9|37
2350060|NCT01669122|5767701|P1|NOT COMPLETED|Period III||0
2350061|NCT01669122|5767701|P1|COMPLETED|Period III||37
2350062|NCT01669122|5767701|P1|STARTED|Period III|Participants who received Lozenge A=10, Lozenge B=8, Lozenge C=10, Reference Lozenge=9|37
2350063|NCT01669122|5767701|P1|NOT COMPLETED|Washout Period III||0
2350064|NCT01669122|5767701|P1|COMPLETED|Washout Period III||37
2350065|NCT01669122|5767701|P1|STARTED|Washout Period III||37
2350066|NCT01669122|5767701|P1|NOT COMPLETED|Washout Period II||2
2350067|NCT01669122|5767701|P1|COMPLETED|Washout Period II||37
2350068|NCT01669122|5767701|P1|STARTED|Washout Period II||39
2350069|NCT01669122|5767701|P1|NOT COMPLETED|Period II||0
2350070|NCT01669122|5767701|P1|COMPLETED|Period II||39
2350071|NCT01669122|5767701|P1|STARTED|Period II|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|39
2350072|NCT01669122|5767701|P1|NOT COMPLETED|Washout Period I||0
2350073|NCT01669122|5767701|P1|COMPLETED|Washout Period I||39
2350074|NCT01669122|5767701|P1|STARTED|Washout Period I||39
2350075|NCT01669122|5767701|P1|NOT COMPLETED|Period I||1
2350076|NCT01669122|5767701|P1|COMPLETED|Period I||39
2350077|NCT01669122|5767701|P1|Safety Population|Period I||39
2350078|NCT01669122|5767701|P1|STARTED|Period I|Participants who received Lozenge A=10, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|40
2350079|NCT01669096|5767731|P1|NOT COMPLETED|Overall Study||0
2350080|NCT01669096|5767731|P1|COMPLETED|Overall Study||20
2350081|NCT01669096|5767731|P1|STARTED|Overall Study||20
2350082|NCT01668966|5767768|P1|NOT COMPLETED|Overall Study||4
2350083|NCT01668966|5767768|P1|COMPLETED|Overall Study||19
2350084|NCT01668966|5767768|P1|Treated|Overall Study||21
2350085|NCT01668966|5767768|P1|STARTED|Overall Study||23
2350086|NCT01668940|5767788|P4|NOT COMPLETED|Overall Study||0
2350087|NCT01668940|5767789|P3|NOT COMPLETED|Overall Study||0
2350088|NCT01668940|5767790|P2|NOT COMPLETED|Overall Study||0
2350089|NCT01668940|5767791|P1|NOT COMPLETED|Overall Study||0
2350090|NCT01668940|5767788|P4|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|14
2350091|NCT01668940|5767789|P3|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|9
2350092|NCT01668940|5767790|P2|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|14
2350093|NCT01668940|5767791|P1|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|17
2350094|NCT01668940|5767788|P4|STARTED|Overall Study||14
2350095|NCT01668940|5767789|P3|STARTED|Overall Study||9
2350096|NCT01668940|5767790|P2|STARTED|Overall Study||14
2350097|NCT01668940|5767791|P1|STARTED|Overall Study||17
2350098|NCT01668836|5767805|P4|NOT COMPLETED|Overall Study||0
2350099|NCT01668836|5767806|P3|NOT COMPLETED|Overall Study||0
2350100|NCT01668836|5767807|P2|NOT COMPLETED|Overall Study||0
2350101|NCT01668836|5767808|P1|NOT COMPLETED|Overall Study||0
2350102|NCT01668836|5767805|P4|COMPLETED|Overall Study||12
2350103|NCT01668836|5767806|P3|COMPLETED|Overall Study||12
2350104|NCT01668836|5767807|P2|COMPLETED|Overall Study||12
2350105|NCT01668836|5767808|P1|COMPLETED|Overall Study||12
2350106|NCT01668836|5767805|P4|STARTED|Overall Study||12
2350107|NCT01668836|5767806|P3|STARTED|Overall Study||12
2350108|NCT01668836|5767807|P2|STARTED|Overall Study||12
2350109|NCT01668836|5767808|P1|STARTED|Overall Study||12
2350110|NCT01668797|5767864|P4|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||96
2350111|NCT01668797|5767865|P3|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||83
2350112|NCT01668797|5767866|P2|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
2350113|NCT01668797|5767867|P1|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
2350114|NCT01668797|5767864|P4|COMPLETED|Phase C (Double-Blind Maintenance Phase)||9
2350115|NCT01668797|5767865|P3|COMPLETED|Phase C (Double-Blind Maintenance Phase)||14
2350116|NCT01668797|5767866|P2|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
2350117|NCT01668797|5767867|P1|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
2350118|NCT01668797|5767864|P4|STARTED|Phase C (Double-Blind Maintenance Phase)||105
2350119|NCT01668797|5767865|P3|STARTED|Phase C (Double-Blind Maintenance Phase)|N= 202 rolled over from Phase B|97
2350120|NCT01668797|5767866|P2|STARTED|Phase C (Double-Blind Maintenance Phase)||0
2350121|NCT01668797|5767867|P1|STARTED|Phase C (Double-Blind Maintenance Phase)||0
2350122|NCT01668797|5767864|P4|NOT COMPLETED|Phase B (Stabilization Phase)||0
2350123|NCT01668797|5767865|P3|NOT COMPLETED|Phase B (Stabilization Phase)||0
2350124|NCT01668797|5767866|P2|NOT COMPLETED|Phase B (Stabilization Phase)||262
2350125|NCT01668797|5767867|P1|NOT COMPLETED|Phase B (Stabilization Phase)||0
2350126|NCT01668797|5767864|P4|COMPLETED|Phase B (Stabilization Phase)||0
2350127|NCT01668797|5767865|P3|COMPLETED|Phase B (Stabilization Phase)||0
2350128|NCT01668797|5767866|P2|COMPLETED|Phase B (Stabilization Phase)||202
2350129|NCT01668797|5767867|P1|COMPLETED|Phase B (Stabilization Phase)||0
2350130|NCT01668797|5767864|P4|STARTED|Phase B (Stabilization Phase)||0
2350131|NCT01668797|5767865|P3|STARTED|Phase B (Stabilization Phase)||0
2350132|NCT01668797|5767866|P2|STARTED|Phase B (Stabilization Phase)|N= 464; 346 rolled over from Phase A and 118 entered directly into Phase B|464
2350133|NCT01668797|5767867|P1|STARTED|Phase B (Stabilization Phase)||0
2350134|NCT01668797|5767864|P4|NOT COMPLETED|Phase A (Conversion Phase)||0
2350135|NCT01668797|5767865|P3|NOT COMPLETED|Phase A (Conversion Phase)||0
2350136|NCT01668797|5767866|P2|NOT COMPLETED|Phase A (Conversion Phase)||0
2350137|NCT01668797|5767867|P1|NOT COMPLETED|Phase A (Conversion Phase)||60
2350138|NCT01668797|5767864|P4|COMPLETED|Phase A (Conversion Phase)||0
2350139|NCT01668797|5767865|P3|COMPLETED|Phase A (Conversion Phase)||0
2350140|NCT01668797|5767866|P2|COMPLETED|Phase A (Conversion Phase)||0
2350141|NCT01668797|5767867|P1|COMPLETED|Phase A (Conversion Phase)||346
2350142|NCT01668797|5767864|P4|STARTED|Phase A (Conversion Phase)||0
2350143|NCT01668797|5767865|P3|STARTED|Phase A (Conversion Phase)||0
2350144|NCT01668797|5767866|P2|STARTED|Phase A (Conversion Phase)||0
2350145|NCT01668797|5767867|P1|STARTED|Phase A (Conversion Phase)||406
2350146|NCT01668784|5767932|P2|NOT COMPLETED|Treated (Overall)||369
2350147|NCT01668784|5767933|P1|NOT COMPLETED|Treated (Overall)||339
2350148|NCT01668784|5767932|P2|COMPLETED|Treated (Overall)||28
2350149|NCT01668784|5767933|P1|COMPLETED|Treated (Overall)||67
2350150|NCT01668784|5767932|P2|STARTED|Treated (Overall)||397
2350151|NCT01668784|5767933|P1|STARTED|Treated (Overall)||406
2350152|NCT01668784|5767932|P2|NOT COMPLETED|Randomized (Pre-treatment)||14
2350153|NCT01668784|5767933|P1|NOT COMPLETED|Randomized (Pre-treatment)||4
2350154|NCT01668784|5767932|P2|COMPLETED|Randomized (Pre-treatment)||397
2350155|NCT01668784|5767933|P1|COMPLETED|Randomized (Pre-treatment)||406
2350156|NCT01668784|5767932|P2|STARTED|Randomized (Pre-treatment)||411
2350157|NCT01668784|5767933|P1|STARTED|Randomized (Pre-treatment)||410
2350158|NCT01668667|5767961|P4|NOT COMPLETED|Overall Study||23
2350159|NCT01668667|5767962|P3|NOT COMPLETED|Overall Study||31
2350160|NCT01668667|5767963|P2|NOT COMPLETED|Overall Study||26
2350161|NCT01668667|5767964|P1|NOT COMPLETED|Overall Study||31
2350162|NCT01668667|5767961|P4|COMPLETED|Overall Study||102
2350163|NCT01668667|5767962|P3|COMPLETED|Overall Study||94
2350164|NCT01668667|5767963|P2|COMPLETED|Overall Study||99
2350165|NCT01668667|5767964|P1|COMPLETED|Overall Study||95
2350166|NCT01668667|5767961|P4|STARTED|Overall Study||125
2350167|NCT01668667|5767962|P3|STARTED|Overall Study||125
2350168|NCT01668667|5767963|P2|STARTED|Overall Study||125
2350169|NCT01668667|5767964|P1|STARTED|Overall Study||126
2350170|NCT01668654|5767986|P1|NOT COMPLETED|Overall Study||4
2350171|NCT01668654|5767986|P1|COMPLETED|Overall Study||0
2350172|NCT01668654|5767986|P1|STARTED|Overall Study||4
2350173|NCT01668628|5768029|P3|NOT COMPLETED|Overall Study||0
2350174|NCT01668628|5768030|P2|NOT COMPLETED|Overall Study||0
2350175|NCT01668628|5768031|P1|NOT COMPLETED|Overall Study||2
2350176|NCT01668628|5768029|P3|COMPLETED|Overall Study||367
2350177|NCT01668628|5768030|P2|COMPLETED|Overall Study||359
2350178|NCT01668628|5768031|P1|COMPLETED|Overall Study||347
2350179|NCT01668628|5768029|P3|STARTED|Overall Study|2 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|367
2350180|NCT01668628|5768030|P2|STARTED|Overall Study||359
2350181|NCT01668628|5768031|P1|STARTED|Overall Study|5 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|349
2350182|NCT01668589|5768047|P4|NOT COMPLETED|Overall Study||35
2350183|NCT01668589|5768048|P3|NOT COMPLETED|Overall Study||35
2350184|NCT01668589|5768049|P2|NOT COMPLETED|Overall Study||58
2350185|NCT01668589|5768050|P1|NOT COMPLETED|Overall Study||139
2350186|NCT01668589|5768047|P4|COMPLETED|Overall Study||266
2350187|NCT01668589|5768048|P3|COMPLETED|Overall Study||265
2350188|NCT01668589|5768049|P2|COMPLETED|Overall Study||242
2350189|NCT01668589|5768050|P1|COMPLETED|Overall Study||461
2350190|NCT01668589|5768047|P4|Received Denosumab|Overall Study||301
2350191|NCT01668589|5768048|P3|Received Denosumab|Overall Study||300
2350192|NCT01668589|5768049|P2|Received Denosumab|Overall Study||300
2350193|NCT01668589|5768050|P1|Received Denosumab|Overall Study||599
2350194|NCT01668589|5768047|P4|STARTED|Overall Study||301
2350195|NCT01668589|5768048|P3|STARTED|Overall Study||300
2350196|NCT01668589|5768049|P2|STARTED|Overall Study||300
2350197|NCT01668589|5768050|P1|STARTED|Overall Study||600
2350198|NCT01668173|5768088|P1|NOT COMPLETED|Overall Study||7
2350199|NCT01668173|5768088|P1|COMPLETED|Overall Study||0
2350200|NCT01668173|5768088|P1|STARTED|Overall Study||7
2350201|NCT01668147|5768092|P1|NOT COMPLETED|Overall Study||6
2350202|NCT01668147|5768092|P1|COMPLETED|Overall Study||7
2350203|NCT01668147|5768092|P1|STARTED|Overall Study||13
2350204|NCT01668030|5768100|P2|NOT COMPLETED|Overall Study||0
2350205|NCT01668030|5768101|P1|NOT COMPLETED|Overall Study||0
2350206|NCT01668030|5768100|P2|COMPLETED|Overall Study||10
2350207|NCT01668030|5768101|P1|COMPLETED|Overall Study||10
2350208|NCT01668030|5768100|P2|STARTED|Overall Study||10
2350209|NCT01668030|5768101|P1|STARTED|Overall Study||10
2350210|NCT01668017|5768111|P5|NOT COMPLETED|Overall Study||0
2350211|NCT01668017|5768112|P4|NOT COMPLETED|Overall Study||0
2350212|NCT01668017|5768113|P3|NOT COMPLETED|Overall Study||0
2350213|NCT01668017|5768114|P2|NOT COMPLETED|Overall Study||0
2350214|NCT01668017|5768115|P1|NOT COMPLETED|Overall Study||0
2350215|NCT01668017|5768111|P5|COMPLETED|Overall Study||2
2350216|NCT01668017|5768112|P4|COMPLETED|Overall Study||5
2350217|NCT01668017|5768113|P3|COMPLETED|Overall Study||6
2350218|NCT01668017|5768114|P2|COMPLETED|Overall Study||9
2350219|NCT01668017|5768115|P1|COMPLETED|Overall Study||4
2350220|NCT01668017|5768111|P5|STARTED|Overall Study||2
2350221|NCT01668017|5768112|P4|STARTED|Overall Study||5
2350222|NCT01668017|5768113|P3|STARTED|Overall Study||6
2350223|NCT01668017|5768114|P2|STARTED|Overall Study||9
2350224|NCT01668017|5768115|P1|STARTED|Overall Study||4
2350225|NCT01668004|5768222|P1|NOT COMPLETED|Overall Study||25
2350226|NCT01668004|5768222|P1|COMPLETED|Overall Study||76
2350227|NCT01668004|5768222|P1|Treated|Overall Study||101
2350228|NCT01668004|5768222|P1|STARTED|Overall Study||101
2350229|NCT01667978|5768235|P2|NOT COMPLETED|Overall Study||0
2350230|NCT01667978|5768236|P1|NOT COMPLETED|Overall Study||2
2350231|NCT01667978|5768235|P2|COMPLETED|Overall Study||17
2350232|NCT01667978|5768236|P1|COMPLETED|Overall Study||16
2350233|NCT01667978|5768235|P2|STARTED|Overall Study||17
2350234|NCT01667978|5768236|P1|STARTED|Overall Study||18
2350235|NCT01667926|5768244|P3|NOT COMPLETED|Overall Study||11
2350236|NCT01667926|5768245|P2|NOT COMPLETED|Overall Study||4
2350237|NCT01667926|5768246|P1|NOT COMPLETED|Overall Study||5
2350238|NCT01667926|5768244|P3|COMPLETED|Overall Study|Participants in the screen fail group were not randomized in the study.|0
2350239|NCT01667926|5768245|P2|COMPLETED|Overall Study||9
2350240|NCT01667926|5768246|P1|COMPLETED|Overall Study||8
2350241|NCT01667926|5768244|P3|STARTED|Overall Study||11
2350242|NCT01667926|5768245|P2|STARTED|Overall Study||13
2350243|NCT01667926|5768246|P1|STARTED|Overall Study||13
2350244|NCT01667900|5768259|P20|NOT COMPLETED|Part B||0
2350245|NCT01667900|5768260|P19|NOT COMPLETED|Part B||0
2350246|NCT01667900|5768261|P18|NOT COMPLETED|Part B||0
2350247|NCT01667900|5768262|P17|NOT COMPLETED|Part B||1
2350248|NCT01667900|5768263|P16|NOT COMPLETED|Part B||0
2350249|NCT01667900|5768264|P15|NOT COMPLETED|Part B||0
2350250|NCT01667900|5768265|P14|NOT COMPLETED|Part B||0
2350251|NCT01667900|5768266|P13|NOT COMPLETED|Part B||0
2350252|NCT01667900|5768267|P12|NOT COMPLETED|Part B||0
2350253|NCT01667900|5768268|P11|NOT COMPLETED|Part B||0
2350254|NCT01667900|5768269|P10|NOT COMPLETED|Part B||0
2350255|NCT01667900|5768270|P9|NOT COMPLETED|Part B||0
2350256|NCT01667900|5768271|P8|NOT COMPLETED|Part B||0
2350257|NCT01667900|5768272|P7|NOT COMPLETED|Part B||0
2350258|NCT01667900|5768273|P6|NOT COMPLETED|Part B||0
2350259|NCT01667900|5768274|P5|NOT COMPLETED|Part B||0
2350260|NCT01667900|5768275|P4|NOT COMPLETED|Part B||0
2350261|NCT01667900|5768276|P3|NOT COMPLETED|Part B||0
2350262|NCT01667900|5768277|P2|NOT COMPLETED|Part B||0
2350263|NCT01667900|5768278|P1|NOT COMPLETED|Part B||0
2350264|NCT01667900|5768259|P20|COMPLETED|Part B||10
2350265|NCT01667900|5768260|P19|COMPLETED|Part B||10
2350266|NCT01667900|5768261|P18|COMPLETED|Part B||11
2350267|NCT01667900|5768262|P17|COMPLETED|Part B||10
2350268|NCT01667900|5768263|P16|COMPLETED|Part B||0
2350269|NCT01667900|5768264|P15|COMPLETED|Part B||0
2350270|NCT01667900|5768265|P14|COMPLETED|Part B||0
2350271|NCT01667900|5768266|P13|COMPLETED|Part B||0
2350272|NCT01667900|5768267|P12|COMPLETED|Part B||0
2350273|NCT01667900|5768268|P11|COMPLETED|Part B||0
2350274|NCT01667900|5768269|P10|COMPLETED|Part B||0
2350275|NCT01667900|5768270|P9|COMPLETED|Part B||0
2350276|NCT01667900|5768271|P8|COMPLETED|Part B||0
2350277|NCT01667900|5768272|P7|COMPLETED|Part B||0
2350278|NCT01667900|5768273|P6|COMPLETED|Part B||0
2350279|NCT01667900|5768274|P5|COMPLETED|Part B||0
2350280|NCT01667900|5768275|P4|COMPLETED|Part B||0
2350281|NCT01667900|5768276|P3|COMPLETED|Part B||0
2350282|NCT01667900|5768277|P2|COMPLETED|Part B||0
2350283|NCT01667900|5768278|P1|COMPLETED|Part B||0
2350284|NCT01667900|5768259|P20|STARTED|Part B||10
2350285|NCT01667900|5768260|P19|STARTED|Part B||10
2350286|NCT01667900|5768261|P18|STARTED|Part B||11
2350287|NCT01667900|5768262|P17|STARTED|Part B||11
2350288|NCT01667900|5768263|P16|STARTED|Part B|Part A participants did not participate in Part B.|0
2350289|NCT01667900|5768264|P15|STARTED|Part B|Part A participants did not participate in Part B.|0
2350290|NCT01667900|5768265|P14|STARTED|Part B|Part A participants did not participate in Part B.|0
2350291|NCT01667900|5768266|P13|STARTED|Part B|Part A participants did not participate in Part B.|0
2350292|NCT01667900|5768267|P12|STARTED|Part B|Part A participants did not participate in Part B.|0
2350293|NCT01667900|5768268|P11|STARTED|Part B|Part A participants did not participate in Part B.|0
2350294|NCT01667900|5768269|P10|STARTED|Part B|Part A participants did not participate in Part B.|0
2350295|NCT01667900|5768270|P9|STARTED|Part B|Part A participants did not participate in Part B.|0
2350296|NCT01667900|5768271|P8|STARTED|Part B|Part A participants did not participate in Part B.|0
2350297|NCT01667900|5768272|P7|STARTED|Part B|Part A participants did not participate in Part B.|0
2350298|NCT01667900|5768273|P6|STARTED|Part B|Part A participants did not participate in Part B.|0
2350389|NCT01667900|5768264|P15|COMPLETED|Part A, Washout 2||1
2350299|NCT01667900|5768274|P5|STARTED|Part B|Part A participants did not participate in Part B.|0
2350300|NCT01667900|5768275|P4|STARTED|Part B|Part A participants did not participate in Part B.|0
2350301|NCT01667900|5768276|P3|STARTED|Part B|Part A participants did not participate in Part B.|0
2350302|NCT01667900|5768277|P2|STARTED|Part B|Part A participants did not participate in Part B.|0
2350303|NCT01667900|5768278|P1|STARTED|Part B|Part A participants did not participate in Part B.|0
2350304|NCT01667900|5768259|P20|NOT COMPLETED|Part A, Period 3||0
2350305|NCT01667900|5768260|P19|NOT COMPLETED|Part A, Period 3||0
2350306|NCT01667900|5768261|P18|NOT COMPLETED|Part A, Period 3||0
2350307|NCT01667900|5768262|P17|NOT COMPLETED|Part A, Period 3||0
2350308|NCT01667900|5768263|P16|NOT COMPLETED|Part A, Period 3||0
2350309|NCT01667900|5768264|P15|NOT COMPLETED|Part A, Period 3||0
2350310|NCT01667900|5768265|P14|NOT COMPLETED|Part A, Period 3||0
2350311|NCT01667900|5768266|P13|NOT COMPLETED|Part A, Period 3||0
2350312|NCT01667900|5768267|P12|NOT COMPLETED|Part A, Period 3||0
2350313|NCT01667900|5768268|P11|NOT COMPLETED|Part A, Period 3||0
2350314|NCT01667900|5768269|P10|NOT COMPLETED|Part A, Period 3||0
2350315|NCT01667900|5768270|P9|NOT COMPLETED|Part A, Period 3||0
2350316|NCT01667900|5768271|P8|NOT COMPLETED|Part A, Period 3||0
2350317|NCT01667900|5768272|P7|NOT COMPLETED|Part A, Period 3||0
2350318|NCT01667900|5768273|P6|NOT COMPLETED|Part A, Period 3||0
2350319|NCT01667900|5768274|P5|NOT COMPLETED|Part A, Period 3||0
2350320|NCT01667900|5768275|P4|NOT COMPLETED|Part A, Period 3||0
2350321|NCT01667900|5768276|P3|NOT COMPLETED|Part A, Period 3||0
2350322|NCT01667900|5768277|P2|NOT COMPLETED|Part A, Period 3||0
2350323|NCT01667900|5768278|P1|NOT COMPLETED|Part A, Period 3||0
2350324|NCT01667900|5768259|P20|COMPLETED|Part A, Period 3||0
2350325|NCT01667900|5768260|P19|COMPLETED|Part A, Period 3||0
2350326|NCT01667900|5768261|P18|COMPLETED|Part A, Period 3||0
2350327|NCT01667900|5768262|P17|COMPLETED|Part A, Period 3||0
2350328|NCT01667900|5768263|P16|COMPLETED|Part A, Period 3||1
2350329|NCT01667900|5768264|P15|COMPLETED|Part A, Period 3||1
2350330|NCT01667900|5768265|P14|COMPLETED|Part A, Period 3||1
2350331|NCT01667900|5768266|P13|COMPLETED|Part A, Period 3||1
2350332|NCT01667900|5768267|P12|COMPLETED|Part A, Period 3||1
2350333|NCT01667900|5768268|P11|COMPLETED|Part A, Period 3||1
2350334|NCT01667900|5768269|P10|COMPLETED|Part A, Period 3||1
2350335|NCT01667900|5768270|P9|COMPLETED|Part A, Period 3||1
2350336|NCT01667900|5768271|P8|COMPLETED|Part A, Period 3||1
2350337|NCT01667900|5768272|P7|COMPLETED|Part A, Period 3||1
2350338|NCT01667900|5768273|P6|COMPLETED|Part A, Period 3||1
2350339|NCT01667900|5768274|P5|COMPLETED|Part A, Period 3||1
2350340|NCT01667900|5768275|P4|COMPLETED|Part A, Period 3||1
2350341|NCT01667900|5768276|P3|COMPLETED|Part A, Period 3||1
2350342|NCT01667900|5768277|P2|COMPLETED|Part A, Period 3||1
2350343|NCT01667900|5768278|P1|COMPLETED|Part A, Period 3||1
2350344|NCT01667900|5768259|P20|STARTED|Part A, Period 3||0
2350345|NCT01667900|5768260|P19|STARTED|Part A, Period 3||0
2350346|NCT01667900|5768261|P18|STARTED|Part A, Period 3||0
2350347|NCT01667900|5768262|P17|STARTED|Part A, Period 3||0
2350348|NCT01667900|5768263|P16|STARTED|Part A, Period 3||1
2350349|NCT01667900|5768264|P15|STARTED|Part A, Period 3||1
2350350|NCT01667900|5768265|P14|STARTED|Part A, Period 3||1
2350351|NCT01667900|5768266|P13|STARTED|Part A, Period 3||1
2350352|NCT01667900|5768267|P12|STARTED|Part A, Period 3||1
2350353|NCT01667900|5768268|P11|STARTED|Part A, Period 3||1
2350354|NCT01667900|5768269|P10|STARTED|Part A, Period 3||1
2350355|NCT01667900|5768270|P9|STARTED|Part A, Period 3||1
2350356|NCT01667900|5768271|P8|STARTED|Part A, Period 3||1
2350357|NCT01667900|5768272|P7|STARTED|Part A, Period 3||1
2350358|NCT01667900|5768273|P6|STARTED|Part A, Period 3||1
2350359|NCT01667900|5768274|P5|STARTED|Part A, Period 3||1
2350360|NCT01667900|5768275|P4|STARTED|Part A, Period 3||1
2350361|NCT01667900|5768276|P3|STARTED|Part A, Period 3||1
2350362|NCT01667900|5768277|P2|STARTED|Part A, Period 3||1
2350363|NCT01667900|5768278|P1|STARTED|Part A, Period 3||1
2350364|NCT01667900|5768259|P20|NOT COMPLETED|Part A, Washout 2||0
2350365|NCT01667900|5768260|P19|NOT COMPLETED|Part A, Washout 2||0
2350366|NCT01667900|5768261|P18|NOT COMPLETED|Part A, Washout 2||0
2350367|NCT01667900|5768262|P17|NOT COMPLETED|Part A, Washout 2||0
2350368|NCT01667900|5768263|P16|NOT COMPLETED|Part A, Washout 2||0
2350369|NCT01667900|5768264|P15|NOT COMPLETED|Part A, Washout 2||0
2350370|NCT01667900|5768265|P14|NOT COMPLETED|Part A, Washout 2||0
2350371|NCT01667900|5768266|P13|NOT COMPLETED|Part A, Washout 2||0
2350372|NCT01667900|5768267|P12|NOT COMPLETED|Part A, Washout 2||0
2350373|NCT01667900|5768268|P11|NOT COMPLETED|Part A, Washout 2||0
2350374|NCT01667900|5768269|P10|NOT COMPLETED|Part A, Washout 2||0
2350375|NCT01667900|5768270|P9|NOT COMPLETED|Part A, Washout 2||0
2350376|NCT01667900|5768271|P8|NOT COMPLETED|Part A, Washout 2||0
2350377|NCT01667900|5768272|P7|NOT COMPLETED|Part A, Washout 2||0
2350378|NCT01667900|5768273|P6|NOT COMPLETED|Part A, Washout 2||0
2350379|NCT01667900|5768274|P5|NOT COMPLETED|Part A, Washout 2||0
2350380|NCT01667900|5768275|P4|NOT COMPLETED|Part A, Washout 2||0
2350381|NCT01667900|5768276|P3|NOT COMPLETED|Part A, Washout 2||0
2350382|NCT01667900|5768277|P2|NOT COMPLETED|Part A, Washout 2||0
2350383|NCT01667900|5768278|P1|NOT COMPLETED|Part A, Washout 2||0
2350384|NCT01667900|5768259|P20|COMPLETED|Part A, Washout 2||0
2350385|NCT01667900|5768260|P19|COMPLETED|Part A, Washout 2||0
2350386|NCT01667900|5768261|P18|COMPLETED|Part A, Washout 2||0
2350387|NCT01667900|5768262|P17|COMPLETED|Part A, Washout 2||0
2350388|NCT01667900|5768263|P16|COMPLETED|Part A, Washout 2||1
2350390|NCT01667900|5768265|P14|COMPLETED|Part A, Washout 2||1
2350391|NCT01667900|5768266|P13|COMPLETED|Part A, Washout 2||1
2350392|NCT01667900|5768267|P12|COMPLETED|Part A, Washout 2||1
2350393|NCT01667900|5768268|P11|COMPLETED|Part A, Washout 2||1
2350394|NCT01667900|5768269|P10|COMPLETED|Part A, Washout 2||1
2350395|NCT01667900|5768270|P9|COMPLETED|Part A, Washout 2||1
2350396|NCT01667900|5768271|P8|COMPLETED|Part A, Washout 2||1
2350397|NCT01667900|5768272|P7|COMPLETED|Part A, Washout 2||1
2350398|NCT01667900|5768273|P6|COMPLETED|Part A, Washout 2||1
2350399|NCT01667900|5768274|P5|COMPLETED|Part A, Washout 2||1
2350400|NCT01667900|5768275|P4|COMPLETED|Part A, Washout 2||1
2350401|NCT01667900|5768276|P3|COMPLETED|Part A, Washout 2||1
2350402|NCT01667900|5768277|P2|COMPLETED|Part A, Washout 2||1
2350403|NCT01667900|5768278|P1|COMPLETED|Part A, Washout 2||1
2350404|NCT01667900|5768259|P20|STARTED|Part A, Washout 2||0
2350405|NCT01667900|5768260|P19|STARTED|Part A, Washout 2||0
2350406|NCT01667900|5768261|P18|STARTED|Part A, Washout 2||0
2350407|NCT01667900|5768262|P17|STARTED|Part A, Washout 2||0
2350408|NCT01667900|5768263|P16|STARTED|Part A, Washout 2||1
2350409|NCT01667900|5768264|P15|STARTED|Part A, Washout 2||1
2350410|NCT01667900|5768265|P14|STARTED|Part A, Washout 2||1
2350411|NCT01667900|5768266|P13|STARTED|Part A, Washout 2||1
2350412|NCT01667900|5768267|P12|STARTED|Part A, Washout 2||1
2350413|NCT01667900|5768268|P11|STARTED|Part A, Washout 2||1
2350414|NCT01667900|5768269|P10|STARTED|Part A, Washout 2||1
2350415|NCT01667900|5768270|P9|STARTED|Part A, Washout 2||1
2350416|NCT01667900|5768271|P8|STARTED|Part A, Washout 2||1
2350417|NCT01667900|5768272|P7|STARTED|Part A, Washout 2||1
2350418|NCT01667900|5768273|P6|STARTED|Part A, Washout 2||1
2350419|NCT01667900|5768274|P5|STARTED|Part A, Washout 2||1
2350420|NCT01667900|5768275|P4|STARTED|Part A, Washout 2||1
2350421|NCT01667900|5768276|P3|STARTED|Part A, Washout 2||1
2350422|NCT01667900|5768277|P2|STARTED|Part A, Washout 2||1
2350423|NCT01667900|5768278|P1|STARTED|Part A, Washout 2||1
2350424|NCT01667900|5768259|P20|NOT COMPLETED|Part A, Period 2||0
2350425|NCT01667900|5768260|P19|NOT COMPLETED|Part A, Period 2||0
2350426|NCT01667900|5768261|P18|NOT COMPLETED|Part A, Period 2||0
2350427|NCT01667900|5768262|P17|NOT COMPLETED|Part A, Period 2||0
2350428|NCT01667900|5768263|P16|NOT COMPLETED|Part A, Period 2||0
2350429|NCT01667900|5768264|P15|NOT COMPLETED|Part A, Period 2||0
2350430|NCT01667900|5768265|P14|NOT COMPLETED|Part A, Period 2||0
2350431|NCT01667900|5768266|P13|NOT COMPLETED|Part A, Period 2||0
2350432|NCT01667900|5768267|P12|NOT COMPLETED|Part A, Period 2||0
2350433|NCT01667900|5768268|P11|NOT COMPLETED|Part A, Period 2||0
2350434|NCT01667900|5768269|P10|NOT COMPLETED|Part A, Period 2||0
2350435|NCT01667900|5768270|P9|NOT COMPLETED|Part A, Period 2||0
2350436|NCT01667900|5768271|P8|NOT COMPLETED|Part A, Period 2||0
2350437|NCT01667900|5768272|P7|NOT COMPLETED|Part A, Period 2||0
2350438|NCT01667900|5768273|P6|NOT COMPLETED|Part A, Period 2||0
2350439|NCT01667900|5768274|P5|NOT COMPLETED|Part A, Period 2||0
2350440|NCT01667900|5768275|P4|NOT COMPLETED|Part A, Period 2||0
2350441|NCT01667900|5768276|P3|NOT COMPLETED|Part A, Period 2||0
2350442|NCT01667900|5768277|P2|NOT COMPLETED|Part A, Period 2||0
2350443|NCT01667900|5768278|P1|NOT COMPLETED|Part A, Period 2||0
2350444|NCT01667900|5768259|P20|COMPLETED|Part A, Period 2||0
2350445|NCT01667900|5768260|P19|COMPLETED|Part A, Period 2||0
2350446|NCT01667900|5768261|P18|COMPLETED|Part A, Period 2||0
2350447|NCT01667900|5768262|P17|COMPLETED|Part A, Period 2||0
2350448|NCT01667900|5768263|P16|COMPLETED|Part A, Period 2||1
2350449|NCT01667900|5768264|P15|COMPLETED|Part A, Period 2||1
2350450|NCT01667900|5768265|P14|COMPLETED|Part A, Period 2||1
2350451|NCT01667900|5768266|P13|COMPLETED|Part A, Period 2||1
2350452|NCT01667900|5768267|P12|COMPLETED|Part A, Period 2||1
2350453|NCT01667900|5768268|P11|COMPLETED|Part A, Period 2||1
2350454|NCT01667900|5768269|P10|COMPLETED|Part A, Period 2||1
2350455|NCT01667900|5768270|P9|COMPLETED|Part A, Period 2||1
2350456|NCT01667900|5768271|P8|COMPLETED|Part A, Period 2||1
2350457|NCT01667900|5768272|P7|COMPLETED|Part A, Period 2||1
2350458|NCT01667900|5768273|P6|COMPLETED|Part A, Period 2||1
2350459|NCT01667900|5768274|P5|COMPLETED|Part A, Period 2||1
2350460|NCT01667900|5768275|P4|COMPLETED|Part A, Period 2||1
2350461|NCT01667900|5768276|P3|COMPLETED|Part A, Period 2||1
2350462|NCT01667900|5768277|P2|COMPLETED|Part A, Period 2||1
2350463|NCT01667900|5768278|P1|COMPLETED|Part A, Period 2||1
2350464|NCT01667900|5768259|P20|STARTED|Part A, Period 2||0
2350465|NCT01667900|5768260|P19|STARTED|Part A, Period 2||0
2350466|NCT01667900|5768261|P18|STARTED|Part A, Period 2||0
2350467|NCT01667900|5768262|P17|STARTED|Part A, Period 2||0
2350468|NCT01667900|5768263|P16|STARTED|Part A, Period 2||1
2350469|NCT01667900|5768264|P15|STARTED|Part A, Period 2||1
2350470|NCT01667900|5768265|P14|STARTED|Part A, Period 2||1
2350471|NCT01667900|5768266|P13|STARTED|Part A, Period 2||1
2350472|NCT01667900|5768267|P12|STARTED|Part A, Period 2||1
2350473|NCT01667900|5768268|P11|STARTED|Part A, Period 2||1
2350474|NCT01667900|5768269|P10|STARTED|Part A, Period 2||1
2350475|NCT01667900|5768270|P9|STARTED|Part A, Period 2||1
2350476|NCT01667900|5768271|P8|STARTED|Part A, Period 2||1
2350477|NCT01667900|5768272|P7|STARTED|Part A, Period 2||1
2350478|NCT01667900|5768273|P6|STARTED|Part A, Period 2||1
2350479|NCT01667900|5768274|P5|STARTED|Part A, Period 2||1
2350480|NCT01667900|5768275|P4|STARTED|Part A, Period 2||1
2350481|NCT01667900|5768276|P3|STARTED|Part A, Period 2||1
2350482|NCT01667900|5768277|P2|STARTED|Part A, Period 2||1
2350483|NCT01667900|5768278|P1|STARTED|Part A, Period 2||1
2350484|NCT01667900|5768259|P20|NOT COMPLETED|Part A, Washout 1||0
2350485|NCT01667900|5768260|P19|NOT COMPLETED|Part A, Washout 1||0
2350486|NCT01667900|5768261|P18|NOT COMPLETED|Part A, Washout 1||0
2350487|NCT01667900|5768262|P17|NOT COMPLETED|Part A, Washout 1||0
2350488|NCT01667900|5768263|P16|NOT COMPLETED|Part A, Washout 1||0
2350489|NCT01667900|5768264|P15|NOT COMPLETED|Part A, Washout 1||0
2350490|NCT01667900|5768265|P14|NOT COMPLETED|Part A, Washout 1||0
2350491|NCT01667900|5768266|P13|NOT COMPLETED|Part A, Washout 1||0
2350492|NCT01667900|5768267|P12|NOT COMPLETED|Part A, Washout 1||0
2350493|NCT01667900|5768268|P11|NOT COMPLETED|Part A, Washout 1||0
2350494|NCT01667900|5768269|P10|NOT COMPLETED|Part A, Washout 1||0
2350495|NCT01667900|5768270|P9|NOT COMPLETED|Part A, Washout 1||0
2350496|NCT01667900|5768271|P8|NOT COMPLETED|Part A, Washout 1||0
2350497|NCT01667900|5768272|P7|NOT COMPLETED|Part A, Washout 1||0
2350498|NCT01667900|5768273|P6|NOT COMPLETED|Part A, Washout 1||0
2350499|NCT01667900|5768274|P5|NOT COMPLETED|Part A, Washout 1||0
2350500|NCT01667900|5768275|P4|NOT COMPLETED|Part A, Washout 1||0
2350501|NCT01667900|5768276|P3|NOT COMPLETED|Part A, Washout 1||0
2350502|NCT01667900|5768277|P2|NOT COMPLETED|Part A, Washout 1||0
2350503|NCT01667900|5768278|P1|NOT COMPLETED|Part A, Washout 1||0
2350504|NCT01667900|5768259|P20|COMPLETED|Part A, Washout 1||0
2350505|NCT01667900|5768260|P19|COMPLETED|Part A, Washout 1||0
2350506|NCT01667900|5768261|P18|COMPLETED|Part A, Washout 1||0
2350507|NCT01667900|5768262|P17|COMPLETED|Part A, Washout 1||0
2350508|NCT01667900|5768263|P16|COMPLETED|Part A, Washout 1||1
2350509|NCT01667900|5768264|P15|COMPLETED|Part A, Washout 1||1
2350510|NCT01667900|5768265|P14|COMPLETED|Part A, Washout 1||1
2350511|NCT01667900|5768266|P13|COMPLETED|Part A, Washout 1||1
2350512|NCT01667900|5768267|P12|COMPLETED|Part A, Washout 1||1
2350513|NCT01667900|5768268|P11|COMPLETED|Part A, Washout 1||1
2350514|NCT01667900|5768269|P10|COMPLETED|Part A, Washout 1||1
2350515|NCT01667900|5768270|P9|COMPLETED|Part A, Washout 1||1
2350516|NCT01667900|5768271|P8|COMPLETED|Part A, Washout 1||1
2350517|NCT01667900|5768272|P7|COMPLETED|Part A, Washout 1||1
2350518|NCT01667900|5768273|P6|COMPLETED|Part A, Washout 1||1
2350519|NCT01667900|5768274|P5|COMPLETED|Part A, Washout 1||1
2350520|NCT01667900|5768275|P4|COMPLETED|Part A, Washout 1||1
2350521|NCT01667900|5768276|P3|COMPLETED|Part A, Washout 1||1
2350522|NCT01667900|5768277|P2|COMPLETED|Part A, Washout 1||1
2350523|NCT01667900|5768278|P1|COMPLETED|Part A, Washout 1||1
2350524|NCT01667900|5768259|P20|STARTED|Part A, Washout 1||0
2350525|NCT01667900|5768260|P19|STARTED|Part A, Washout 1||0
2350526|NCT01667900|5768261|P18|STARTED|Part A, Washout 1||0
2350527|NCT01667900|5768262|P17|STARTED|Part A, Washout 1||0
2350528|NCT01667900|5768263|P16|STARTED|Part A, Washout 1||1
2350529|NCT01667900|5768264|P15|STARTED|Part A, Washout 1||1
2350530|NCT01667900|5768265|P14|STARTED|Part A, Washout 1||1
2350531|NCT01667900|5768266|P13|STARTED|Part A, Washout 1||1
2350532|NCT01667900|5768267|P12|STARTED|Part A, Washout 1||1
2350533|NCT01667900|5768268|P11|STARTED|Part A, Washout 1||1
2350534|NCT01667900|5768269|P10|STARTED|Part A, Washout 1||1
2350535|NCT01667900|5768270|P9|STARTED|Part A, Washout 1||1
2350536|NCT01667900|5768271|P8|STARTED|Part A, Washout 1||1
2350537|NCT01667900|5768272|P7|STARTED|Part A, Washout 1||1
2350538|NCT01667900|5768273|P6|STARTED|Part A, Washout 1||1
2350539|NCT01667900|5768274|P5|STARTED|Part A, Washout 1||1
2350540|NCT01667900|5768275|P4|STARTED|Part A, Washout 1||1
2350541|NCT01667900|5768276|P3|STARTED|Part A, Washout 1||1
2350542|NCT01667900|5768277|P2|STARTED|Part A, Washout 1||1
2350543|NCT01667900|5768278|P1|STARTED|Part A, Washout 1||1
2350544|NCT01667900|5768259|P20|NOT COMPLETED|Part A, Period 1||0
2350545|NCT01667900|5768260|P19|NOT COMPLETED|Part A, Period 1||0
2350546|NCT01667900|5768261|P18|NOT COMPLETED|Part A, Period 1||0
2350547|NCT01667900|5768262|P17|NOT COMPLETED|Part A, Period 1||0
2350548|NCT01667900|5768263|P16|NOT COMPLETED|Part A, Period 1||0
2350549|NCT01667900|5768264|P15|NOT COMPLETED|Part A, Period 1||0
2350550|NCT01667900|5768265|P14|NOT COMPLETED|Part A, Period 1||0
2350551|NCT01667900|5768266|P13|NOT COMPLETED|Part A, Period 1||0
2350552|NCT01667900|5768267|P12|NOT COMPLETED|Part A, Period 1||0
2350553|NCT01667900|5768268|P11|NOT COMPLETED|Part A, Period 1||0
2350554|NCT01667900|5768269|P10|NOT COMPLETED|Part A, Period 1||0
2350555|NCT01667900|5768270|P9|NOT COMPLETED|Part A, Period 1||0
2350556|NCT01667900|5768271|P8|NOT COMPLETED|Part A, Period 1||0
2350557|NCT01667900|5768272|P7|NOT COMPLETED|Part A, Period 1||0
2350558|NCT01667900|5768273|P6|NOT COMPLETED|Part A, Period 1||0
2350559|NCT01667900|5768274|P5|NOT COMPLETED|Part A, Period 1||0
2350560|NCT01667900|5768275|P4|NOT COMPLETED|Part A, Period 1||0
2350561|NCT01667900|5768276|P3|NOT COMPLETED|Part A, Period 1||0
2350562|NCT01667900|5768277|P2|NOT COMPLETED|Part A, Period 1||0
2350563|NCT01667900|5768278|P1|NOT COMPLETED|Part A, Period 1||0
2350564|NCT01667900|5768259|P20|COMPLETED|Part A, Period 1||0
2350565|NCT01667900|5768260|P19|COMPLETED|Part A, Period 1||0
2350566|NCT01667900|5768261|P18|COMPLETED|Part A, Period 1||0
2350567|NCT01667900|5768262|P17|COMPLETED|Part A, Period 1||0
2350568|NCT01667900|5768263|P16|COMPLETED|Part A, Period 1||1
2350569|NCT01667900|5768264|P15|COMPLETED|Part A, Period 1||1
2350570|NCT01667900|5768265|P14|COMPLETED|Part A, Period 1||1
2350571|NCT01667900|5768266|P13|COMPLETED|Part A, Period 1||1
2350572|NCT01667900|5768267|P12|COMPLETED|Part A, Period 1||1
2350573|NCT01667900|5768268|P11|COMPLETED|Part A, Period 1||1
2350574|NCT01667900|5768269|P10|COMPLETED|Part A, Period 1||1
2350575|NCT01667900|5768270|P9|COMPLETED|Part A, Period 1||1
2350576|NCT01667900|5768271|P8|COMPLETED|Part A, Period 1||1
2350577|NCT01667900|5768272|P7|COMPLETED|Part A, Period 1||1
2350578|NCT01667900|5768273|P6|COMPLETED|Part A, Period 1||1
2350579|NCT01667900|5768274|P5|COMPLETED|Part A, Period 1||1
2350580|NCT01667900|5768275|P4|COMPLETED|Part A, Period 1||1
2350581|NCT01667900|5768276|P3|COMPLETED|Part A, Period 1||1
2350582|NCT01667900|5768277|P2|COMPLETED|Part A, Period 1||1
2350583|NCT01667900|5768278|P1|COMPLETED|Part A, Period 1||1
2350584|NCT01667900|5768259|P20|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
2350585|NCT01667900|5768260|P19|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
2350586|NCT01667900|5768261|P18|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
2350587|NCT01667900|5768262|P17|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
2350588|NCT01667900|5768263|P16|STARTED|Part A, Period 1||1
2350589|NCT01667900|5768264|P15|STARTED|Part A, Period 1||1
2350590|NCT01667900|5768265|P14|STARTED|Part A, Period 1||1
2350591|NCT01667900|5768266|P13|STARTED|Part A, Period 1||1
2350592|NCT01667900|5768267|P12|STARTED|Part A, Period 1||1
2350593|NCT01667900|5768268|P11|STARTED|Part A, Period 1||1
2350594|NCT01667900|5768269|P10|STARTED|Part A, Period 1||1
2350595|NCT01667900|5768270|P9|STARTED|Part A, Period 1||1
2350596|NCT01667900|5768271|P8|STARTED|Part A, Period 1||1
2350597|NCT01667900|5768272|P7|STARTED|Part A, Period 1||1
2350598|NCT01667900|5768273|P6|STARTED|Part A, Period 1||1
2350599|NCT01667900|5768274|P5|STARTED|Part A, Period 1||1
2350600|NCT01667900|5768275|P4|STARTED|Part A, Period 1||1
2350601|NCT01667900|5768276|P3|STARTED|Part A, Period 1||1
2350602|NCT01667900|5768277|P2|STARTED|Part A, Period 1||1
2350603|NCT01667900|5768278|P1|STARTED|Part A, Period 1||1
2350604|NCT01667848|5768318|P2|NOT COMPLETED|Overall Study||0
2350605|NCT01667848|5768319|P1|NOT COMPLETED|Overall Study||0
2350606|NCT01667848|5768318|P2|COMPLETED|Overall Study||81
2350607|NCT01667848|5768319|P1|COMPLETED|Overall Study||67
2350608|NCT01667848|5768318|P2|STARTED|Overall Study||81
2350609|NCT01667848|5768319|P1|STARTED|Overall Study||67
2350610|NCT01667796|5768329|P2|NOT COMPLETED|Overall Study||1
2350611|NCT01667796|5768330|P1|NOT COMPLETED|Overall Study||3
2350612|NCT01667796|5768329|P2|COMPLETED|Overall Study||29
2350613|NCT01667796|5768330|P1|COMPLETED|Overall Study||24
2350614|NCT01667796|5768329|P2|STARTED|Overall Study||30
2350615|NCT01667796|5768330|P1|STARTED|Overall Study||27
2350616|NCT01667731|5768348|P5|NOT COMPLETED|Overall Study||28
2350617|NCT01667731|5768349|P4|NOT COMPLETED|Overall Study||2
2350618|NCT01667731|5768350|P3|NOT COMPLETED|Overall Study||2
2350619|NCT01667731|5768351|P2|NOT COMPLETED|Overall Study||16
2350620|NCT01667731|5768352|P1|NOT COMPLETED|Overall Study||5
2350621|NCT01667731|5768348|P5|COMPLETED|Overall Study||87
2350622|NCT01667731|5768349|P4|COMPLETED|Overall Study||15
2350623|NCT01667731|5768350|P3|COMPLETED|Overall Study||22
2350624|NCT01667731|5768351|P2|COMPLETED|Overall Study||26
2350625|NCT01667731|5768352|P1|COMPLETED|Overall Study||21
2350626|NCT01667731|5768348|P5|STARTED|Overall Study||115
2350627|NCT01667731|5768349|P4|STARTED|Overall Study||17
2350628|NCT01667731|5768350|P3|STARTED|Overall Study||24
2350629|NCT01667731|5768351|P2|STARTED|Overall Study||42
2350630|NCT01667731|5768352|P1|STARTED|Overall Study||26
2350631|NCT01667679|5768407|P2|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
2350632|NCT01667679|5768408|P1|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
2350633|NCT01667679|5768407|P2|COMPLETED|Treatment Period 2 (<=12 Weeks)||85
2350634|NCT01667679|5768408|P1|COMPLETED|Treatment Period 2 (<=12 Weeks)||100
2350635|NCT01667679|5768407|P2|STARTED|Treatment Period 2 (<=12 Weeks)||107
2350636|NCT01667679|5768408|P1|STARTED|Treatment Period 2 (<=12 Weeks)||122
2350637|NCT01667679|5768407|P2|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||30
2350638|NCT01667679|5768408|P1|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||16
2350639|NCT01667679|5768407|P2|COMPLETED|Treatment Period 1 (<=12 Weeks)||107
2350640|NCT01667679|5768408|P1|COMPLETED|Treatment Period 1 (<=12 Weeks)||122
2350641|NCT01667679|5768407|P2|STARTED|Treatment Period 1 (<=12 Weeks)||137
2350642|NCT01667679|5768408|P1|STARTED|Treatment Period 1 (<=12 Weeks)||138
2350643|NCT01667562|5768466|P2|NOT COMPLETED|Erlotinib Phase||3
2350644|NCT01667562|5768467|P1|NOT COMPLETED|Erlotinib Phase||0
2350645|NCT01667562|5768466|P2|COMPLETED|Erlotinib Phase||27
2350646|NCT01667562|5768467|P1|COMPLETED|Erlotinib Phase||0
2350647|NCT01667562|5768466|P2|STARTED|Erlotinib Phase||30
2350648|NCT01667562|5768467|P1|STARTED|Erlotinib Phase||0
2350649|NCT01667562|5768466|P2|NOT COMPLETED|Diagnostic Phase||0
2350650|NCT01667562|5768467|P1|NOT COMPLETED|Diagnostic Phase||30
2350651|NCT01667562|5768466|P2|COMPLETED|Diagnostic Phase||0
2350652|NCT01667562|5768467|P1|COMPLETED|Diagnostic Phase||345
2350653|NCT01667562|5768466|P2|STARTED|Diagnostic Phase||0
2350654|NCT01667562|5768467|P1|STARTED|Diagnostic Phase||375
2350655|NCT01667549|5768481|P5|NOT COMPLETED|Overall Study||1
2350656|NCT01667549|5768482|P4|NOT COMPLETED|Overall Study||6
2350657|NCT01667549|5768483|P3|NOT COMPLETED|Overall Study||7
2350658|NCT01667549|5768484|P2|NOT COMPLETED|Overall Study||5
2350659|NCT01667549|5768485|P1|NOT COMPLETED|Overall Study||3
2350660|NCT01667549|5768481|P5|COMPLETED|Overall Study|15 dyads=15 infants, 15 mothers|15
2350661|NCT01667549|5768482|P4|COMPLETED|Overall Study|14 dyads= 14 infants, 14 mothers|14
2350662|NCT01667549|5768483|P3|COMPLETED|Overall Study|14 dyads=14 infants, 14 mothers|14
2350663|NCT01667549|5768484|P2|COMPLETED|Overall Study|15 dyads=15 infants, 15 mothers|15
2350664|NCT01667549|5768485|P1|COMPLETED|Overall Study|17 dyads=17 infants, 17 mothers|17
2350665|NCT01667549|5768481|P5|STARTED|Overall Study|16 dyads=16 infants, 16 mothers|16
2350666|NCT01667549|5768482|P4|STARTED|Overall Study|20 dyads= 20 infants, 20 mothers|20
2350667|NCT01667549|5768483|P3|STARTED|Overall Study|21 dyads=21 infants, 21 mothers|21
2350668|NCT01667549|5768484|P2|STARTED|Overall Study|20 dyads=20 infants, 20 mothers|20
2350669|NCT01667549|5768485|P1|STARTED|Overall Study|20 dyads=20 infants, 20 mothers|20
2350670|NCT01667536|5768517|P1|NOT COMPLETED|Overall Study||0
2350671|NCT01667536|5768517|P1|COMPLETED|Overall Study|105 subjects comprised the safety popn, defined as all subjects who received an MIP-1404 injection.|105
2350672|NCT01667536|5768517|P1|STARTED|Overall Study||105
2350673|NCT01667471|5768528|P1|NOT COMPLETED|Overall Study||0
2350674|NCT01667471|5768528|P1|COMPLETED|Overall Study||7
2350675|NCT01667471|5768528|P1|STARTED|Overall Study||7
2350676|NCT01667432|5768544|P1|NOT COMPLETED|Overall Study||57
2350677|NCT01667432|5768544|P1|COMPLETED|Overall Study||84
2350678|NCT01667432|5768544|P1|STARTED|Overall Study||141
2350679|NCT01667419|5768553|P4|NOT COMPLETED|Overall Study||39
2350680|NCT01667419|5768554|P3|NOT COMPLETED|Overall Study||36
2350681|NCT01667419|5768555|P2|NOT COMPLETED|Overall Study||47
2350682|NCT01667419|5768556|P1|NOT COMPLETED|Overall Study||43
2350683|NCT01667419|5768553|P4|COMPLETED|Overall Study||52
2350684|NCT01667419|5768554|P3|COMPLETED|Overall Study||57
2350685|NCT01667419|5768555|P2|COMPLETED|Overall Study||110
2350686|NCT01667419|5768556|P1|COMPLETED|Overall Study||114
2350687|NCT01667419|5768553|P4|STARTED|Overall Study||91
2350688|NCT01667419|5768554|P3|STARTED|Overall Study||93
2350689|NCT01667419|5768555|P2|STARTED|Overall Study||157
2350690|NCT01667419|5768556|P1|STARTED|Overall Study||157
2350691|NCT01667250|5768586|P3|NOT COMPLETED|Randomised Period||0
2350692|NCT01667250|5768587|P2|NOT COMPLETED|Randomised Period||1
2350693|NCT01667250|5768588|P1|NOT COMPLETED|Randomised Period||1
2350694|NCT01667250|5768586|P3|COMPLETED|Randomised Period||0
2350695|NCT01667250|5768587|P2|COMPLETED|Randomised Period||28
2350696|NCT01667250|5768588|P1|COMPLETED|Randomised Period||29
2350697|NCT01667250|5768586|P3|STARTED|Randomised Period||0
2350698|NCT01667250|5768587|P2|STARTED|Randomised Period||29
2350699|NCT01667250|5768588|P1|STARTED|Randomised Period||30
2350700|NCT01667250|5768586|P3|NOT COMPLETED|Run-in (no Treatment)||14
2350701|NCT01667250|5768587|P2|NOT COMPLETED|Run-in (no Treatment)||0
2350702|NCT01667250|5768588|P1|NOT COMPLETED|Run-in (no Treatment)||0
2350703|NCT01667250|5768586|P3|COMPLETED|Run-in (no Treatment)||59
2350704|NCT01667250|5768587|P2|COMPLETED|Run-in (no Treatment)||0
2350705|NCT01667250|5768588|P1|COMPLETED|Run-in (no Treatment)||0
2350706|NCT01667250|5768586|P3|STARTED|Run-in (no Treatment)||73
2350707|NCT01667250|5768587|P2|STARTED|Run-in (no Treatment)||0
2350708|NCT01667250|5768588|P1|STARTED|Run-in (no Treatment)||0
2350709|NCT01667224|5768604|P2|NOT COMPLETED|Overall Study||2
2350710|NCT01667224|5768605|P1|NOT COMPLETED|Overall Study||4
2350711|NCT01667224|5768604|P2|COMPLETED|Overall Study||38
2350712|NCT01667224|5768605|P1|COMPLETED|Overall Study||36
2350713|NCT01667224|5768604|P2|STARTED|Overall Study||40
2350714|NCT01667224|5768605|P1|STARTED|Overall Study||40
2350715|NCT01667107|5768619|P2|NOT COMPLETED|Overall Study||7
2350716|NCT01667107|5768620|P1|NOT COMPLETED|Overall Study||4
2350717|NCT01667107|5768619|P2|COMPLETED|Overall Study||11
2350718|NCT01667107|5768620|P1|COMPLETED|Overall Study||4
2350719|NCT01667107|5768619|P2|STARTED|Overall Study||18
2350720|NCT01667107|5768620|P1|STARTED|Overall Study||8
2350721|NCT01667029|5768636|P2|NOT COMPLETED|Overall Study||1
2350722|NCT01667029|5768637|P1|NOT COMPLETED|Overall Study||1
2350723|NCT01667029|5768636|P2|COMPLETED|Overall Study||3
2350724|NCT01667029|5768637|P1|COMPLETED|Overall Study||3
2350725|NCT01667029|5768636|P2|STARTED|Overall Study||4
2350726|NCT01667029|5768637|P1|STARTED|Overall Study||4
2350727|NCT01666951|5768679|P2|NOT COMPLETED|Overall Study||1
2350728|NCT01666951|5768680|P1|NOT COMPLETED|Overall Study||1
2350729|NCT01666951|5768679|P2|COMPLETED|Overall Study||17
2350730|NCT01666951|5768680|P1|COMPLETED|Overall Study||17
2350731|NCT01666951|5768679|P2|STARTED|Overall Study||18
2350732|NCT01666951|5768680|P1|STARTED|Overall Study||18
2350733|NCT01666912|5768718|P2|NOT COMPLETED|Overall Study||11
2350734|NCT01666912|5768719|P1|NOT COMPLETED|Overall Study||21
2350735|NCT01666912|5768718|P2|COMPLETED|Overall Study||37
2350736|NCT01666912|5768719|P1|COMPLETED|Overall Study||27
2350737|NCT01666912|5768718|P2|STARTED|Overall Study||48
2350738|NCT01666912|5768719|P1|STARTED|Overall Study||48
2350739|NCT01666782|5768731|P2|NOT COMPLETED|Overall Study||1
2350740|NCT01666782|5768732|P1|NOT COMPLETED|Overall Study||4
2350741|NCT01666782|5768731|P2|COMPLETED|Overall Study||50
2350742|NCT01666782|5768732|P1|COMPLETED|Overall Study||50
2350743|NCT01666782|5768731|P2|STARTED|Overall Study||51
2350744|NCT01666782|5768732|P1|STARTED|Overall Study||54
2350745|NCT01666652|5768753|P5|NOT COMPLETED|Overall Study||1
2350746|NCT01666652|5768754|P4|NOT COMPLETED|Overall Study||4
2350747|NCT01666652|5768755|P3|NOT COMPLETED|Overall Study||1
2350748|NCT01666652|5768756|P2|NOT COMPLETED|Overall Study||1
2350749|NCT01666652|5768757|P1|NOT COMPLETED|Overall Study||2
2350750|NCT01666652|5768753|P5|COMPLETED|Overall Study||19
2350751|NCT01666652|5768754|P4|COMPLETED|Overall Study||16
2350752|NCT01666652|5768755|P3|COMPLETED|Overall Study||19
2350753|NCT01666652|5768756|P2|COMPLETED|Overall Study||19
2350754|NCT01666652|5768757|P1|COMPLETED|Overall Study||18
2350755|NCT01666652|5768753|P5|STARTED|Overall Study||20
2350756|NCT01666652|5768754|P4|STARTED|Overall Study||20
2350757|NCT01666652|5768755|P3|STARTED|Overall Study||20
2350758|NCT01666652|5768756|P2|STARTED|Overall Study||20
2350759|NCT01666652|5768757|P1|STARTED|Overall Study||20
2350760|NCT01666444|5768806|P2|NOT COMPLETED|Overall Study||1
2350761|NCT01666444|5768807|P1|NOT COMPLETED|Overall Study||2
2350762|NCT01666444|5768806|P2|COMPLETED|Overall Study||147
2350763|NCT01666444|5768807|P1|COMPLETED|Overall Study||147
2350764|NCT01666444|5768806|P2|STARTED|Overall Study||148
2350765|NCT01666444|5768807|P1|STARTED|Overall Study||149
2350766|NCT01666314|5768825|P4|NOT COMPLETED|Overall Study||36
2350767|NCT01666314|5768826|P3|NOT COMPLETED|Overall Study||36
2350768|NCT01666314|5768827|P2|NOT COMPLETED|Overall Study||32
2350769|NCT01666314|5768828|P1|NOT COMPLETED|Overall Study||33
2350770|NCT01666314|5768825|P4|COMPLETED|Overall Study||0
2350771|NCT01666314|5768826|P3|COMPLETED|Overall Study||0
2350772|NCT01666314|5768827|P2|COMPLETED|Overall Study||0
2350773|NCT01666314|5768828|P1|COMPLETED|Overall Study||0
2350774|NCT01666314|5768825|P4|STARTED|Overall Study||36
2350775|NCT01666314|5768826|P3|STARTED|Overall Study||36
2350776|NCT01666314|5768827|P2|STARTED|Overall Study||32
2350777|NCT01666314|5768828|P1|STARTED|Overall Study||33
2350778|NCT01666210|5768939|P2|NOT COMPLETED|Overall Study||1
2350779|NCT01666210|5768940|P1|NOT COMPLETED|Overall Study||2
2350780|NCT01666210|5768939|P2|COMPLETED|Overall Study||29
2350781|NCT01666210|5768940|P1|COMPLETED|Overall Study||28
2350782|NCT01666210|5768939|P2|STARTED|Overall Study||30
2350783|NCT01666210|5768940|P1|STARTED|Overall Study||30
2350784|NCT01666197|5768952|P2|NOT COMPLETED|Overall Study||0
2350785|NCT01666197|5768953|P1|NOT COMPLETED|Overall Study||0
2350786|NCT01666197|5768952|P2|COMPLETED|Overall Study||50
2350787|NCT01666197|5768953|P1|COMPLETED|Overall Study||50
2350788|NCT01666197|5768952|P2|STARTED|Overall Study||50
2350789|NCT01666197|5768953|P1|STARTED|Overall Study||50
2350790|NCT01666145|5768959|P1|NOT COMPLETED|Overall Study||0
2350791|NCT01666145|5768959|P1|COMPLETED|Overall Study||14
2350792|NCT01666145|5768959|P1|STARTED|Overall Study||14
2350793|NCT01666119|5768964|P1|NOT COMPLETED|Overall Study||52
2350794|NCT01666119|5768964|P1|COMPLETED|Overall Study||197
2350795|NCT01666119|5768964|P1|STARTED|Overall Study||249
2350796|NCT01666002|5768971|P2|NOT COMPLETED|Overall Study||0
2350797|NCT01666002|5768972|P1|NOT COMPLETED|Overall Study||5
2350798|NCT01666002|5768971|P2|COMPLETED|Overall Study||10
2350799|NCT01666002|5768972|P1|COMPLETED|Overall Study||12
2350800|NCT01666002|5768971|P2|STARTED|Overall Study||10
2350801|NCT01666002|5768972|P1|STARTED|Overall Study||17
2350802|NCT01665950|5768983|P3|NOT COMPLETED|Overall Study||1
2350803|NCT01665950|5768984|P2|NOT COMPLETED|Overall Study||0
2350804|NCT01665950|5768985|P1|NOT COMPLETED|Overall Study||1
2350805|NCT01665950|5768983|P3|COMPLETED|Overall Study||1
2350806|NCT01665950|5768984|P2|COMPLETED|Overall Study||0
2350807|NCT01665950|5768985|P1|COMPLETED|Overall Study||1
2350808|NCT01665950|5768983|P3|STARTED|Overall Study||2
2350809|NCT01665950|5768984|P2|STARTED|Overall Study||0
2350810|NCT01665950|5768985|P1|STARTED|Overall Study||2
2350811|NCT01665911|5768993|P1|NOT COMPLETED|Overall Study||6
2350812|NCT01665911|5768993|P1|COMPLETED|Overall Study||22
2350813|NCT01665911|5768993|P1|3.0 mg Sodium Fluoride in 200 ml Milk|Overall Study||22
2350814|NCT01665911|5768993|P1|3.0 mg Sodium Fluoride in 100 ml Milk|Overall Study||22
2350815|NCT01665911|5768993|P1|1.5 mg Sodium Fluoride in 200 ml Milk|Overall Study||25
2350816|NCT01665911|5768993|P1|1.5 mg Sodium Fluoride in 100 ml Milk|Overall Study||23
2350817|NCT01665911|5768993|P1|0 mg Fluoride in 200 ml Milk|Overall Study||22
2350818|NCT01665911|5768993|P1|STARTED|Overall Study||28
2350819|NCT01665872|5769001|P2|NOT COMPLETED|12 Month Follow-up||3
2350820|NCT01665872|5769002|P1|NOT COMPLETED|12 Month Follow-up||14
2350821|NCT01665872|5769001|P2|COMPLETED|12 Month Follow-up||47
2350822|NCT01665872|5769002|P1|COMPLETED|12 Month Follow-up||58
2350823|NCT01665872|5769001|P2|STARTED|12 Month Follow-up||50
2350824|NCT01665872|5769002|P1|STARTED|12 Month Follow-up||72
2350825|NCT01665872|5769001|P2|NOT COMPLETED|6 Month Follow-up||1
2350826|NCT01665872|5769002|P1|NOT COMPLETED|6 Month Follow-up||6
2350827|NCT01665872|5769001|P2|COMPLETED|6 Month Follow-up||49
2350828|NCT01665872|5769002|P1|COMPLETED|6 Month Follow-up||66
2350829|NCT01665872|5769001|P2|STARTED|6 Month Follow-up||50
2350830|NCT01665872|5769002|P1|STARTED|6 Month Follow-up||72
2350831|NCT01665872|5769001|P2|NOT COMPLETED|Treatment||17
2350832|NCT01665872|5769002|P1|NOT COMPLETED|Treatment||15
2350833|NCT01665872|5769001|P2|COMPLETED|Treatment||50
2350834|NCT01665872|5769002|P1|COMPLETED|Treatment||72
2350835|NCT01665872|5769001|P2|STARTED|Treatment||67
2350836|NCT01665872|5769002|P1|STARTED|Treatment||87
2350837|NCT01665872|5769001|P2|NOT COMPLETED|Screening||0
2350838|NCT01665872|5769002|P1|NOT COMPLETED|Screening||0
2350839|NCT01665872|5769001|P2|COMPLETED|Screening||172
2350840|NCT01665872|5769002|P1|COMPLETED|Screening||172
2350841|NCT01665872|5769001|P2|STARTED|Screening||172
2350842|NCT01665872|5769002|P1|STARTED|Screening||172
2350843|NCT01665807|5769019|P3|NOT COMPLETED|Overall Study||1
2350844|NCT01665807|5769020|P2|NOT COMPLETED|Overall Study||0
2350845|NCT01665807|5769021|P1|NOT COMPLETED|Overall Study||2
2350846|NCT01665807|5769019|P3|COMPLETED|Overall Study||401
2350847|NCT01665807|5769020|P2|COMPLETED|Overall Study||58
2350848|NCT01665807|5769021|P1|COMPLETED|Overall Study||409
2350849|NCT01665807|5769019|P3|STARTED|Overall Study||402
2350850|NCT01665807|5769020|P2|STARTED|Overall Study||58
2350851|NCT01665807|5769021|P1|STARTED|Overall Study||411
2350855|NCT01665599|5769037|P1|NOT COMPLETED|Overall Study||8
2350856|NCT01665599|5769037|P1|COMPLETED|Overall Study||172
2350857|NCT01665599|5769037|P1|STARTED|Overall Study||180
2350858|NCT01665508|5769057|P1|NOT COMPLETED|Overall Study||5
2350859|NCT01665508|5769057|P1|COMPLETED|Overall Study||7
2350860|NCT01665508|5769057|P1|STARTED|Overall Study||12
2350861|NCT01665430|5769073|P1|NOT COMPLETED|Overall Study||9
2350862|NCT01665430|5769073|P1|COMPLETED|Overall Study||29
2350863|NCT01665430|5769073|P1|STARTED|Overall Study||38
2350864|NCT01665170|5769089|P2|NOT COMPLETED|Overall Study||0
2350865|NCT01665170|5769090|P1|NOT COMPLETED|Overall Study||0
2350866|NCT01665170|5769089|P2|COMPLETED|Overall Study||30
2350867|NCT01665170|5769090|P1|COMPLETED|Overall Study|Last TSST/ last patient out|30
2350868|NCT01665170|5769089|P2|After TSST|Overall Study||30
2350869|NCT01665170|5769090|P1|After TSST|Overall Study||30
2350870|NCT01665170|5769089|P2|During TSST|Overall Study||30
2350871|NCT01665170|5769090|P1|During TSST|Overall Study||30
2350872|NCT01665170|5769089|P2|Bevore TSST|Overall Study||30
2350873|NCT01665170|5769090|P1|Bevore TSST|Overall Study||30
2350874|NCT01665170|5769089|P2|STARTED|Overall Study||30
2350875|NCT01665170|5769090|P1|STARTED|Overall Study|First patient in|30
2350876|NCT01665157|5769141|P3|NOT COMPLETED|Overall Study||0
2350877|NCT01665157|5769142|P2|NOT COMPLETED|Overall Study||0
2350878|NCT01665157|5769143|P1|NOT COMPLETED|Overall Study||0
2350879|NCT01665157|5769141|P3|COMPLETED|Overall Study||60
2350880|NCT01665157|5769142|P2|COMPLETED|Overall Study||60
2350881|NCT01665157|5769143|P1|COMPLETED|Overall Study||60
2350882|NCT01665157|5769141|P3|STARTED|Overall Study||60
2350883|NCT01665157|5769142|P2|STARTED|Overall Study||60
2350884|NCT01665157|5769143|P1|STARTED|Overall Study||60
2350895|NCT01665092|5769182|P4|NOT COMPLETED|Overall Study||1
2350896|NCT01665092|5769183|P3|NOT COMPLETED|Overall Study||2
2350897|NCT01665092|5769184|P2|NOT COMPLETED|Overall Study||0
2350898|NCT01665092|5769185|P1|NOT COMPLETED|Overall Study||0
2350899|NCT01665092|5769182|P4|COMPLETED|Overall Study||105
2350900|NCT01665092|5769183|P3|COMPLETED|Overall Study||32
2350901|NCT01665092|5769184|P2|COMPLETED|Overall Study||35
2350902|NCT01665092|5769185|P1|COMPLETED|Overall Study||75
2350903|NCT01665092|5769182|P4|STARTED|Overall Study||106
2350904|NCT01665092|5769183|P3|STARTED|Overall Study||34
2350905|NCT01665092|5769184|P2|STARTED|Overall Study||35
2350906|NCT01665092|5769185|P1|STARTED|Overall Study||75
2350907|NCT01665053|5769197|P2|NOT COMPLETED|Overall Study||15
2350908|NCT01665053|5769198|P1|NOT COMPLETED|Overall Study||32
2350909|NCT01665053|5769197|P2|COMPLETED|Overall Study||831
2350910|NCT01665053|5769198|P1|COMPLETED|Overall Study||806
2350911|NCT01665053|5769197|P2|Death With No 12-month Clinical FU|Overall Study||9
2350912|NCT01665053|5769198|P1|Death With No 12-month Clinical FU|Overall Study||9
2350913|NCT01665053|5769197|P2|No 12-Month F/U|Overall Study||15
2350914|NCT01665053|5769198|P1|No 12-Month F/U|Overall Study||32
2350915|NCT01665053|5769197|P2|Completed 12-Month Clinical F/U|Overall Study||822
2350916|NCT01665053|5769198|P1|Completed 12-Month Clinical F/U|Overall Study||797
2350917|NCT01665053|5769197|P2|STARTED|Overall Study||846
2350918|NCT01665053|5769198|P1|STARTED|Overall Study||838
2350919|NCT01665040|5769236|P1|NOT COMPLETED|Overall Study||4
2350920|NCT01665040|5769236|P1|COMPLETED|Overall Study||36
2350921|NCT01665040|5769236|P1|STARTED|Overall Study||40
2350922|NCT01664975|5769243|P2|NOT COMPLETED|Overall Study||3
2350923|NCT01664975|5769244|P1|NOT COMPLETED|Overall Study||5
2350924|NCT01664975|5769243|P2|COMPLETED|Overall Study||51
2350925|NCT01664975|5769244|P1|COMPLETED|Overall Study||52
2350926|NCT01664975|5769243|P2|STARTED|Overall Study||54
2350927|NCT01664975|5769244|P1|STARTED|Overall Study||57
2350928|NCT01664949|5769252|P2|NOT COMPLETED|Overall Study||25
2350929|NCT01664949|5769253|P1|NOT COMPLETED|Overall Study||24
2350930|NCT01664949|5769252|P2|COMPLETED|Overall Study||211
2350931|NCT01664949|5769253|P1|COMPLETED|Overall Study||200
2350932|NCT01664949|5769252|P2|STARTED|Overall Study||236
2350933|NCT01664949|5769253|P1|STARTED|Overall Study||224
2350934|NCT01664923|5769269|P2|NOT COMPLETED|Period 2: Open-label Phase-36 Months||23
2350935|NCT01664923|5769270|P1|NOT COMPLETED|Period 2: Open-label Phase-36 Months||41
2350936|NCT01664923|5769269|P2|COMPLETED|Period 2: Open-label Phase-36 Months||15
2350937|NCT01664923|5769270|P1|COMPLETED|Period 2: Open-label Phase-36 Months||52
2350938|NCT01664923|5769269|P2|Treated|Period 2: Open-label Phase-36 Months||37
2350939|NCT01664923|5769270|P1|Treated|Period 2: Open-label Phase-36 Months||93
2350940|NCT01664923|5769269|P2|STARTED|Period 2: Open-label Phase-36 Months||38
2350941|NCT01664923|5769270|P1|STARTED|Period 2: Open-label Phase-36 Months||93
2350942|NCT01664923|5769269|P2|NOT COMPLETED|Period1:Double Blind Phase-29 Months||160
2350943|NCT01664923|5769270|P1|NOT COMPLETED|Period1:Double Blind Phase-29 Months||105
2350944|NCT01664923|5769269|P2|COMPLETED|Period1:Double Blind Phase-29 Months||38
2350945|NCT01664923|5769270|P1|COMPLETED|Period1:Double Blind Phase-29 Months||93
2350946|NCT01664923|5769269|P2|Received Study Treatment|Period1:Double Blind Phase-29 Months||198
2350947|NCT01664923|5769270|P1|Received Study Treatment|Period1:Double Blind Phase-29 Months||197
2350948|NCT01664923|5769269|P2|STARTED|Period1:Double Blind Phase-29 Months||198
2350949|NCT01664923|5769270|P1|STARTED|Period1:Double Blind Phase-29 Months||198
2350950|NCT01664897|5769290|P1|NOT COMPLETED|Overall Study||0
2350951|NCT01664897|5769290|P1|COMPLETED|Overall Study||29
2350952|NCT01664897|5769290|P1|STARTED|Overall Study||29
2350953|NCT01664858|5769301|P3|NOT COMPLETED|Overall Study||6
2350954|NCT01664858|5769302|P2|NOT COMPLETED|Overall Study||13
2350955|NCT01664858|5769303|P1|NOT COMPLETED|Overall Study||14
2350956|NCT01664858|5769301|P3|COMPLETED|Overall Study||234
2350957|NCT01664858|5769302|P2|COMPLETED|Overall Study||468
2350958|NCT01664858|5769303|P1|COMPLETED|Overall Study||467
2350959|NCT01664858|5769301|P3|STARTED|Overall Study||240
2350960|NCT01664858|5769302|P2|STARTED|Overall Study||481
2350961|NCT01664858|5769303|P1|STARTED|Overall Study||481
2350962|NCT01664806|5769319|P2|NOT COMPLETED|Overall Study||0
2350963|NCT01664806|5769320|P1|NOT COMPLETED|Overall Study||0
2350964|NCT01664806|5769319|P2|COMPLETED|Overall Study||20
2350965|NCT01664806|5769320|P1|COMPLETED|Overall Study||20
2350966|NCT01664806|5769319|P2|STARTED|Overall Study||20
2350967|NCT01664806|5769320|P1|STARTED|Overall Study||20
2350968|NCT01664793|5769330|P2|NOT COMPLETED|Overall Study||0
2350969|NCT01664793|5769331|P1|NOT COMPLETED|Overall Study||0
2350970|NCT01664793|5769330|P2|COMPLETED|Overall Study||38626
2350971|NCT01664793|5769331|P1|COMPLETED|Overall Study||49039
2350972|NCT01664793|5769330|P2|STARTED|Overall Study||38626
2350973|NCT01664793|5769331|P1|STARTED|Overall Study||49039
2350974|NCT01664741|5769342|P3|NOT COMPLETED|Overall Study||0
2350975|NCT01664741|5769343|P2|NOT COMPLETED|Overall Study||0
2350976|NCT01664741|5769344|P1|NOT COMPLETED|Overall Study||0
2350977|NCT01664741|5769342|P3|COMPLETED|Overall Study||13
2350978|NCT01664741|5769343|P2|COMPLETED|Overall Study||6
2350979|NCT01664741|5769344|P1|COMPLETED|Overall Study||6
2350980|NCT01664741|5769342|P3|STARTED|Overall Study||13
2350981|NCT01664741|5769343|P2|STARTED|Overall Study||6
2350982|NCT01664741|5769344|P1|STARTED|Overall Study||6
2350983|NCT01664624|5769361|P4|NOT COMPLETED|Overall Study||0
2350984|NCT01664624|5769362|P3|NOT COMPLETED|Overall Study||0
2350985|NCT01664624|5769363|P2|NOT COMPLETED|Overall Study||1
2350986|NCT01664624|5769364|P1|NOT COMPLETED|Overall Study||0
2350987|NCT01664624|5769361|P4|COMPLETED|Overall Study||9
2350988|NCT01664624|5769362|P3|COMPLETED|Overall Study||10
2350989|NCT01664624|5769363|P2|COMPLETED|Overall Study||10
2350990|NCT01664624|5769364|P1|COMPLETED|Overall Study||10
2350991|NCT01664624|5769361|P4|STARTED|Overall Study||9
2350992|NCT01664624|5769362|P3|STARTED|Overall Study||10
2350993|NCT01664624|5769363|P2|STARTED|Overall Study||11
2350994|NCT01664624|5769364|P1|STARTED|Overall Study||10
2350995|NCT01664559|5769396|P2|NOT COMPLETED|Overall Study||0
2350996|NCT01664559|5769397|P1|NOT COMPLETED|Overall Study||0
2350997|NCT01664559|5769396|P2|COMPLETED|Overall Study||33
2350998|NCT01664559|5769397|P1|COMPLETED|Overall Study||34
2350999|NCT01664559|5769396|P2|STARTED|Overall Study||33
2351000|NCT01664559|5769397|P1|STARTED|Overall Study||34
2351001|NCT01664533|5769411|P1|NOT COMPLETED|Overall Study||57
2351002|NCT01664533|5769411|P1|COMPLETED|Overall Study||0
2351003|NCT01664533|5769411|P1|STARTED|Overall Study||57
2351004|NCT01664494|5769419|P1|NOT COMPLETED|Overall Study||193
2351005|NCT01664494|5769419|P1|COMPLETED|Overall Study||370
2351006|NCT01664494|5769419|P1|STARTED|Overall Study||563
2351007|NCT01664247|5769426|P2|NOT COMPLETED|Overall Study||41
2351008|NCT01664247|5769427|P1|NOT COMPLETED|Overall Study||14
2351009|NCT01664247|5769426|P2|COMPLETED|Overall Study||131
2351010|NCT01664247|5769427|P1|COMPLETED|Overall Study||160
2351011|NCT01664247|5769426|P2|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|170
2351012|NCT01664247|5769427|P1|Exposed|Overall Study|1 subject was randomised in error and withdrew before exposure to the drug|173
2351013|NCT01664247|5769426|P2|STARTED|Overall Study||172
2351014|NCT01664247|5769427|P1|STARTED|Overall Study||174
2351015|NCT01664130|5769449|P1|NOT COMPLETED|Overall Study||2
2351016|NCT01664130|5769449|P1|COMPLETED|Overall Study||33
2351017|NCT01664130|5769449|P1|STARTED|Overall Study||35
2351018|NCT01664117|5769472|P1|NOT COMPLETED|Overall Study||0
2351019|NCT01664117|5769472|P1|COMPLETED|Overall Study||209
2351020|NCT01664117|5769472|P1|STARTED|Overall Study||209
2351021|NCT01664104|5769527|P1|NOT COMPLETED|Overall Study||16
2351022|NCT01664104|5769527|P1|COMPLETED|Overall Study||120
2351023|NCT01664104|5769527|P1|STARTED|Overall Study||136
2351024|NCT01664091|5769594|P1|NOT COMPLETED|Overall Study||6
2351025|NCT01664091|5769594|P1|COMPLETED|Overall Study||26
2351026|NCT01664091|5769594|P1|STARTED|Overall Study||32
2351027|NCT01664052|5769604|P2|NOT COMPLETED|Phase 2||4
2351028|NCT01664052|5769605|P1|NOT COMPLETED|Phase 2||0
2351029|NCT01664052|5769604|P2|COMPLETED|Phase 2||31
2351030|NCT01664052|5769605|P1|COMPLETED|Phase 2||0
2351031|NCT01664052|5769604|P2|Repeat HSG and Hysterectomy at 90 Days|Phase 2||10
2351032|NCT01664052|5769605|P1|Repeat HSG and Hysterectomy at 90 Days|Phase 2||0
2351033|NCT01664052|5769604|P2|Repeat HSG and Hysterectomy at 60 Days|Phase 2||10
2351034|NCT01664052|5769605|P1|Repeat HSG and Hysterectomy at 60 Days|Phase 2||0
2351035|NCT01664052|5769604|P2|Repeat HSG and Hysterectomy at 30 Days|Phase 2||10
2351036|NCT01664052|5769605|P1|Repeat HSG and Hysterectomy at 30 Days|Phase 2||0
2351037|NCT01664052|5769604|P2|HSG 1 Hour Post Placement|Phase 2||31
2351038|NCT01664052|5769605|P1|HSG 1 Hour Post Placement|Phase 2||0
2351039|NCT01664052|5769604|P2|Insert Placed|Phase 2||31
2351040|NCT01664052|5769605|P1|Insert Placed|Phase 2||0
2351041|NCT01664052|5769604|P2|STARTED|Phase 2||35
2351042|NCT01664052|5769605|P1|STARTED|Phase 2|Screened and enrolled|0
2351043|NCT01664052|5769604|P2|NOT COMPLETED|Phase 1||0
2351044|NCT01664052|5769605|P1|NOT COMPLETED|Phase 1||7
2351045|NCT01664052|5769604|P2|COMPLETED|Phase 1||0
2351046|NCT01664052|5769605|P1|COMPLETED|Phase 1||24
2351047|NCT01664052|5769604|P2|Repeat HSG and Hysterectomy at 90 Days|Phase 1||0
2351048|NCT01664052|5769605|P1|Repeat HSG and Hysterectomy at 90 Days|Phase 1||7
2351049|NCT01664052|5769604|P2|Repeat HSG and Hysterectomy at 60 Days|Phase 1||0
2351050|NCT01664052|5769605|P1|Repeat HSG and Hysterectomy at 60 Days|Phase 1||8
2351051|NCT01664052|5769604|P2|Repeat HSG and Hysterectomy at 30 Days|Phase 1||0
2351052|NCT01664052|5769605|P1|Repeat HSG and Hysterectomy at 30 Days|Phase 1||9
2351053|NCT01664052|5769604|P2|HSG 1 Hour Post Placement|Phase 1||0
2351054|NCT01664052|5769605|P1|HSG 1 Hour Post Placement|Phase 1||24
2351055|NCT01664052|5769604|P2|Insert Placed in at Least One Tube|Phase 1||0
2351056|NCT01664052|5769605|P1|Insert Placed in at Least One Tube|Phase 1||25
2351057|NCT01664052|5769604|P2|STARTED|Phase 1||0
2351058|NCT01664052|5769605|P1|STARTED|Phase 1|Screening and enrollment|31
2351059|NCT01664039|5769623|P2|NOT COMPLETED|Overall Study||9
2351060|NCT01664039|5769624|P1|NOT COMPLETED|Overall Study||6
2351061|NCT01664039|5769623|P2|COMPLETED|Overall Study||43
2351062|NCT01664039|5769624|P1|COMPLETED|Overall Study||46
2351063|NCT01664039|5769623|P2|STARTED|Overall Study||52
2351064|NCT01664039|5769624|P1|STARTED|Overall Study||52
2351065|NCT01663987|5769646|P2|NOT COMPLETED|Overall Study||6
2351066|NCT01663987|5769647|P1|NOT COMPLETED|Overall Study||13
2351067|NCT01663987|5769646|P2|COMPLETED|Overall Study||34
2351068|NCT01663987|5769647|P1|COMPLETED|Overall Study||26
2351069|NCT01663987|5769646|P2|STARTED|Overall Study||40
2351070|NCT01663987|5769647|P1|STARTED|Overall Study||39
2351071|NCT01663935|5769675|P1|NOT COMPLETED|Overall Study||0
2351072|NCT01663935|5769675|P1|COMPLETED|Overall Study||20
2351073|NCT01663935|5769675|P1|STARTED|Overall Study||20
2351074|NCT01663922|5769680|P2|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
2351075|NCT01663922|5769681|P1|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
2351076|NCT01663922|5769680|P2|COMPLETED|Third Intervention (14 Days or 5 Days)||9
2351077|NCT01663922|5769681|P1|COMPLETED|Third Intervention (14 Days or 5 Days)||8
2351078|NCT01663922|5769680|P2|STARTED|Third Intervention (14 Days or 5 Days)||9
2351079|NCT01663922|5769681|P1|STARTED|Third Intervention (14 Days or 5 Days)||8
2351080|NCT01663922|5769680|P2|NOT COMPLETED|Washout (7 Days)||0
2351081|NCT01663922|5769681|P1|NOT COMPLETED|Washout (7 Days)||0
2351082|NCT01663922|5769680|P2|COMPLETED|Washout (7 Days)||9
2351083|NCT01663922|5769681|P1|COMPLETED|Washout (7 Days)||8
2351084|NCT01663922|5769680|P2|STARTED|Washout (7 Days)||9
2351085|NCT01663922|5769681|P1|STARTED|Washout (7 Days)||8
2351086|NCT01663922|5769680|P2|NOT COMPLETED|Second Intervention (14 Days)||0
2351087|NCT01663922|5769681|P1|NOT COMPLETED|Second Intervention (14 Days)||0
2351088|NCT01663922|5769680|P2|COMPLETED|Second Intervention (14 Days)||9
2351089|NCT01663922|5769681|P1|COMPLETED|Second Intervention (14 Days)||8
2351090|NCT01663922|5769680|P2|STARTED|Second Intervention (14 Days)||9
2351091|NCT01663922|5769681|P1|STARTED|Second Intervention (14 Days)||8
2351092|NCT01663922|5769680|P2|NOT COMPLETED|Washout (7 Days)||0
2351093|NCT01663922|5769681|P1|NOT COMPLETED|Washout (7 Days)||0
2351094|NCT01663922|5769680|P2|COMPLETED|Washout (7 Days)||9
2351095|NCT01663922|5769681|P1|COMPLETED|Washout (7 Days)||8
2351096|NCT01663922|5769680|P2|STARTED|Washout (7 Days)||9
2351097|NCT01663922|5769681|P1|STARTED|Washout (7 Days)||8
2351098|NCT01663922|5769680|P2|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
2351099|NCT01663922|5769681|P1|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
2351100|NCT01663922|5769680|P2|COMPLETED|First Intervention (14 Days or 5 Days)||9
2351101|NCT01663922|5769681|P1|COMPLETED|First Intervention (14 Days or 5 Days)||8
2351102|NCT01663922|5769680|P2|STARTED|First Intervention (14 Days or 5 Days)||9
2351103|NCT01663922|5769681|P1|STARTED|First Intervention (14 Days or 5 Days)||8
2351104|NCT01663857|5769690|P4|NOT COMPLETED|Overall Study||4
2351105|NCT01663857|5769691|P3|NOT COMPLETED|Overall Study||10
2351106|NCT01663857|5769692|P2|NOT COMPLETED|Overall Study||1
2351107|NCT01663857|5769693|P1|NOT COMPLETED|Overall Study||0
2351108|NCT01663857|5769690|P4|COMPLETED|Overall Study||48
2351109|NCT01663857|5769691|P3|COMPLETED|Overall Study||48
2351110|NCT01663857|5769692|P2|COMPLETED|Overall Study||1
2351111|NCT01663857|5769693|P1|COMPLETED|Overall Study||6
2351112|NCT01663857|5769690|P4|Received at Least One Dose of Study Drug|Overall Study||52
2351113|NCT01663857|5769691|P3|Received at Least One Dose of Study Drug|Overall Study||58
2351114|NCT01663857|5769692|P2|Received at Least One Dose of Study Drug|Overall Study||2
2351115|NCT01663857|5769693|P1|Received at Least One Dose of Study Drug|Overall Study||6
2351116|NCT01663857|5769690|P4|STARTED|Overall Study||52
2351117|NCT01663857|5769691|P3|STARTED|Overall Study||58
2351118|NCT01663857|5769692|P2|STARTED|Overall Study||2
2351119|NCT01663857|5769693|P1|STARTED|Overall Study||6
2351120|NCT01663779|5769712|P2|NOT COMPLETED|Overall Study||0
2351121|NCT01663779|5769713|P1|NOT COMPLETED|Overall Study||0
2351122|NCT01663779|5769712|P2|COMPLETED|Overall Study||23
2351123|NCT01663779|5769713|P1|COMPLETED|Overall Study||27
2351124|NCT01663779|5769712|P2|STARTED|Overall Study||23
2351125|NCT01663779|5769713|P1|STARTED|Overall Study||27
2351126|NCT01663740|5769721|P2|NOT COMPLETED|Overall Study||8
2351127|NCT01663740|5769722|P1|NOT COMPLETED|Overall Study||16
2351128|NCT01663740|5769721|P2|COMPLETED|Overall Study||13
2351129|NCT01663740|5769722|P1|COMPLETED|Overall Study||22
2351130|NCT01663740|5769721|P2|STARTED|Overall Study|Safety Population|21
2351131|NCT01663740|5769722|P1|STARTED|Overall Study|Safety Population|38
2351132|NCT01663727|5769782|P2|NOT COMPLETED|Overall Study||238
2351133|NCT01663727|5769783|P1|NOT COMPLETED|Overall Study||242
2351134|NCT01663727|5769782|P2|COMPLETED|Overall Study||1
2351135|NCT01663727|5769783|P1|COMPLETED|Overall Study||0
2351136|NCT01663727|5769782|P2|STARTED|Overall Study||239
2351137|NCT01663727|5769783|P1|STARTED|Overall Study||242
2351138|NCT01663714|5769815|P1|NOT COMPLETED|Long-Term Follow-Up||6
2351139|NCT01663714|5769815|P1|COMPLETED|Long-Term Follow-Up||16
2351140|NCT01663714|5769815|P1|STARTED|Long-Term Follow-Up|22 of the30 participants withdrawing from Study BEX104514 enrolled in the LTFU study.|22
2351141|NCT01663714|5769815|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||30
2351142|NCT01663714|5769815|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
2351143|NCT01663714|5769815|P1|STARTED|Dosimetric and Therapeutic Treatment||30
2351144|NCT01663636|5769844|P2|NOT COMPLETED|Parent SMS Acceptability Assessment||0
2351145|NCT01663636|5769845|P1|NOT COMPLETED|Parent SMS Acceptability Assessment||0
2351146|NCT01663636|5769844|P2|COMPLETED|Parent SMS Acceptability Assessment||130
2351147|NCT01663636|5769845|P1|COMPLETED|Parent SMS Acceptability Assessment||135
2351148|NCT01663636|5769844|P2|STARTED|Parent SMS Acceptability Assessment||130
2351149|NCT01663636|5769845|P1|STARTED|Parent SMS Acceptability Assessment||135
2351150|NCT01663636|5769844|P2|NOT COMPLETED|Infant SMS Reminder Feasibility Study||31
2351151|NCT01663636|5769845|P1|NOT COMPLETED|Infant SMS Reminder Feasibility Study||25
2351152|NCT01663636|5769844|P2|COMPLETED|Infant SMS Reminder Feasibility Study||130
2351153|NCT01663636|5769845|P1|COMPLETED|Infant SMS Reminder Feasibility Study||135
2351154|NCT01663636|5769844|P2|STARTED|Infant SMS Reminder Feasibility Study||161
2351155|NCT01663636|5769845|P1|STARTED|Infant SMS Reminder Feasibility Study||160
2351156|NCT01663623|5769853|P2|NOT COMPLETED|Overall Study||20
2351157|NCT01663623|5769854|P1|NOT COMPLETED|Overall Study||12
2351158|NCT01663623|5769853|P2|COMPLETED|Overall Study||33
2351159|NCT01663623|5769854|P1|COMPLETED|Overall Study||40
2351160|NCT01663623|5769853|P2|STARTED|Overall Study||53
2351161|NCT01663623|5769854|P1|STARTED|Overall Study||52
2351162|NCT01663532|5769864|P2|NOT COMPLETED|Overall Study||107
2351163|NCT01663532|5769865|P1|NOT COMPLETED|Overall Study||74
2351164|NCT01663532|5769864|P2|COMPLETED|Overall Study||65
2351165|NCT01663532|5769865|P1|COMPLETED|Overall Study||94
2351166|NCT01663532|5769864|P2|STARTED|Overall Study||172
2351167|NCT01663532|5769865|P1|STARTED|Overall Study||168
2351168|NCT01663506|5769883|P1|NOT COMPLETED|Overall Study||8
2351169|NCT01663506|5769883|P1|COMPLETED|Overall Study||15
2351170|NCT01663506|5769883|P1|STARTED|Overall Study||23
2351171|NCT01663402|5769914|P2|NOT COMPLETED|Overall Study||2084
2351172|NCT01663402|5769915|P1|NOT COMPLETED|Overall Study||1515
2351173|NCT01663402|5769914|P2|COMPLETED|Overall Study||7378
2351174|NCT01663402|5769915|P1|COMPLETED|Overall Study||7947
2351175|NCT01663402|5769914|P2|Treated|Overall Study||9451
2351176|NCT01663402|5769915|P1|Treated|Overall Study||9443
2351177|NCT01663402|5769914|P2|STARTED|Overall Study||9462
2351178|NCT01663402|5769915|P1|STARTED|Overall Study||9462
2351179|NCT01663363|5769949|P1|NOT COMPLETED|Overall Study||0
2351180|NCT01663363|5769949|P1|COMPLETED|Overall Study|334 Eyes were treated among 170 participants|170
2351181|NCT01663363|5769949|P1|STARTED|Overall Study|334 Eyes were treated among 170 participants|170
2351182|NCT01663285|5769954|P1|NOT COMPLETED|Overall Study||0
2351183|NCT01663285|5769954|P1|COMPLETED|Overall Study||1
2351184|NCT01663285|5769954|P1|STARTED|Overall Study||1
2351185|NCT01663272|5769960|P3|NOT COMPLETED|Overall Study||0
2351186|NCT01663272|5769961|P2|NOT COMPLETED|Overall Study||0
2351187|NCT01663272|5769962|P1|NOT COMPLETED|Overall Study||0
2351188|NCT01663272|5769960|P3|COMPLETED|Overall Study||1
2351189|NCT01663272|5769961|P2|COMPLETED|Overall Study||6
2351190|NCT01663272|5769962|P1|COMPLETED|Overall Study||5
2351191|NCT01663272|5769960|P3|STARTED|Overall Study||1
2351192|NCT01663272|5769961|P2|STARTED|Overall Study||6
2351193|NCT01663272|5769962|P1|STARTED|Overall Study||5
2351194|NCT01663233|5769969|P2|NOT COMPLETED|Overall Study||7
2351195|NCT01663233|5769970|P1|NOT COMPLETED|Overall Study||4
2351196|NCT01663233|5769969|P2|COMPLETED|Overall Study||129
2351197|NCT01663233|5769970|P1|COMPLETED|Overall Study||126
2351198|NCT01663233|5769969|P2|STARTED|Overall Study||136
2351199|NCT01663233|5769970|P1|STARTED|Overall Study||130
2351200|NCT01663103|5769994|P2|NOT COMPLETED|Overall Study||2
2351201|NCT01663103|5769995|P1|NOT COMPLETED|Overall Study||3
2351202|NCT01663103|5769994|P2|COMPLETED|Overall Study||19
2351203|NCT01663103|5769995|P1|COMPLETED|Overall Study||18
2351204|NCT01663103|5769994|P2|STARTED|Overall Study||21
2351205|NCT01663103|5769995|P1|STARTED|Overall Study||21
2351206|NCT01663012|5770011|P1|NOT COMPLETED|Overall Study||0
2351207|NCT01663012|5770011|P1|COMPLETED|Overall Study||20
2351208|NCT01663012|5770011|P1|STARTED|Overall Study||20
2351209|NCT01662999|5770023|P6|NOT COMPLETED|Period 3||0
2351210|NCT01662999|5770024|P5|NOT COMPLETED|Period 3||0
2351211|NCT01662999|5770025|P4|NOT COMPLETED|Period 3||0
2351212|NCT01662999|5770026|P3|NOT COMPLETED|Period 3||0
2351213|NCT01662999|5770027|P2|NOT COMPLETED|Period 3||1
2351214|NCT01662999|5770028|P1|NOT COMPLETED|Period 3||0
2351215|NCT01662999|5770023|P6|COMPLETED|Period 3||7
2351216|NCT01662999|5770024|P5|COMPLETED|Period 3||7
2351217|NCT01662999|5770025|P4|COMPLETED|Period 3||7
2351218|NCT01662999|5770026|P3|COMPLETED|Period 3||7
2351219|NCT01662999|5770027|P2|COMPLETED|Period 3|Participant did not provide 36, 48, or 60 hour samples in this period for Treatment B.|6
2351220|NCT01662999|5770028|P1|COMPLETED|Period 3||7
2351221|NCT01662999|5770023|P6|STARTED|Period 3||7
2351222|NCT01662999|5770024|P5|STARTED|Period 3||7
2351223|NCT01662999|5770025|P4|STARTED|Period 3||7
2351224|NCT01662999|5770026|P3|STARTED|Period 3||7
2351225|NCT01662999|5770027|P2|STARTED|Period 3||7
2351226|NCT01662999|5770028|P1|STARTED|Period 3||7
2351227|NCT01662999|5770023|P6|NOT COMPLETED|Period 2||0
2351228|NCT01662999|5770024|P5|NOT COMPLETED|Period 2||0
2351229|NCT01662999|5770025|P4|NOT COMPLETED|Period 2||0
2351230|NCT01662999|5770026|P3|NOT COMPLETED|Period 2||0
2351231|NCT01662999|5770027|P2|NOT COMPLETED|Period 2||0
2351232|NCT01662999|5770028|P1|NOT COMPLETED|Period 2||0
2351233|NCT01662999|5770023|P6|COMPLETED|Period 2||7
2351234|NCT01662999|5770024|P5|COMPLETED|Period 2||7
2351235|NCT01662999|5770025|P4|COMPLETED|Period 2||7
2351236|NCT01662999|5770026|P3|COMPLETED|Period 2||7
2351237|NCT01662999|5770027|P2|COMPLETED|Period 2||7
2351238|NCT01662999|5770028|P1|COMPLETED|Period 2||7
2351239|NCT01662999|5770023|P6|STARTED|Period 2||7
2351240|NCT01662999|5770024|P5|STARTED|Period 2||7
2351241|NCT01662999|5770025|P4|STARTED|Period 2||7
2351242|NCT01662999|5770026|P3|STARTED|Period 2||7
2351243|NCT01662999|5770027|P2|STARTED|Period 2||7
2351244|NCT01662999|5770028|P1|STARTED|Period 2||7
2351245|NCT01662999|5770023|P6|NOT COMPLETED|Period 1||0
2351246|NCT01662999|5770024|P5|NOT COMPLETED|Period 1||0
2351247|NCT01662999|5770025|P4|NOT COMPLETED|Period 1||0
2351248|NCT01662999|5770026|P3|NOT COMPLETED|Period 1||0
2351249|NCT01662999|5770027|P2|NOT COMPLETED|Period 1||0
2351250|NCT01662999|5770028|P1|NOT COMPLETED|Period 1||0
2351251|NCT01662999|5770023|P6|COMPLETED|Period 1||7
2351252|NCT01662999|5770024|P5|COMPLETED|Period 1||7
2351253|NCT01662999|5770025|P4|COMPLETED|Period 1||7
2351254|NCT01662999|5770026|P3|COMPLETED|Period 1||7
2351255|NCT01662999|5770027|P2|COMPLETED|Period 1||7
2351256|NCT01662999|5770028|P1|COMPLETED|Period 1||7
2351257|NCT01662999|5770023|P6|STARTED|Period 1||7
2351258|NCT01662999|5770024|P5|STARTED|Period 1||7
2351259|NCT01662999|5770025|P4|STARTED|Period 1||7
2351260|NCT01662999|5770026|P3|STARTED|Period 1||7
2351261|NCT01662999|5770027|P2|STARTED|Period 1||7
2351262|NCT01662999|5770028|P1|STARTED|Period 1||7
2351263|NCT01662986|5770099|P2|NOT COMPLETED|Overall Study||13
2351264|NCT01662986|5770100|P1|NOT COMPLETED|Overall Study||18
2351265|NCT01662986|5770099|P2|COMPLETED|Overall Study||26
2351266|NCT01662986|5770100|P1|COMPLETED|Overall Study||22
2351267|NCT01662986|5770099|P2|STARTED|Overall Study||39
2351268|NCT01662986|5770100|P1|STARTED|Overall Study||40
2351269|NCT01662960|5770136|P4|NOT COMPLETED|3 Month Follow-up||2
2351270|NCT01662960|5770137|P3|NOT COMPLETED|3 Month Follow-up||3
2351271|NCT01662960|5770138|P2|NOT COMPLETED|3 Month Follow-up||3
2351272|NCT01662960|5770139|P1|NOT COMPLETED|3 Month Follow-up||3
2351273|NCT01662960|5770136|P4|COMPLETED|3 Month Follow-up||13
2351274|NCT01662960|5770137|P3|COMPLETED|3 Month Follow-up||5
2351275|NCT01662960|5770138|P2|COMPLETED|3 Month Follow-up||16
2351276|NCT01662960|5770139|P1|COMPLETED|3 Month Follow-up||21
2351277|NCT01662960|5770136|P4|STARTED|3 Month Follow-up||15
2351278|NCT01662960|5770137|P3|STARTED|3 Month Follow-up||8
2351279|NCT01662960|5770138|P2|STARTED|3 Month Follow-up||19
2351280|NCT01662960|5770139|P1|STARTED|3 Month Follow-up||24
2351281|NCT01662960|5770136|P4|NOT COMPLETED|End of 4 Week Treatment Period||0
2351282|NCT01662960|5770137|P3|NOT COMPLETED|End of 4 Week Treatment Period||1
2351283|NCT01662960|5770138|P2|NOT COMPLETED|End of 4 Week Treatment Period||4
2351284|NCT01662960|5770139|P1|NOT COMPLETED|End of 4 Week Treatment Period||1
2351285|NCT01662960|5770136|P4|COMPLETED|End of 4 Week Treatment Period||15
2351286|NCT01662960|5770137|P3|COMPLETED|End of 4 Week Treatment Period||8
2351287|NCT01662960|5770138|P2|COMPLETED|End of 4 Week Treatment Period||19
2351288|NCT01662960|5770139|P1|COMPLETED|End of 4 Week Treatment Period||24
2351289|NCT01662960|5770136|P4|STARTED|End of 4 Week Treatment Period||15
2351290|NCT01662960|5770137|P3|STARTED|End of 4 Week Treatment Period||9
2351291|NCT01662960|5770138|P2|STARTED|End of 4 Week Treatment Period||23
2351292|NCT01662960|5770139|P1|STARTED|End of 4 Week Treatment Period||25
2351293|NCT01662908|5770171|P2|NOT COMPLETED|Overall Study||5
2351294|NCT01662908|5770172|P1|NOT COMPLETED|Overall Study||6
2351295|NCT01662908|5770171|P2|COMPLETED|Overall Study||23
2351296|NCT01662908|5770172|P1|COMPLETED|Overall Study||50
2351297|NCT01662908|5770171|P2|STARTED|Overall Study||28
2351298|NCT01662908|5770172|P1|STARTED|Overall Study||56
2351299|NCT01662895|5770188|P2|NOT COMPLETED|Overall Study||1
2351300|NCT01662895|5770189|P1|NOT COMPLETED|Overall Study||0
2351301|NCT01662895|5770188|P2|COMPLETED|Overall Study||20
2351302|NCT01662895|5770189|P1|COMPLETED|Overall Study||21
2351303|NCT01662895|5770188|P2|Initiated Study Drug|Overall Study||21
2351304|NCT01662895|5770189|P1|Initiated Study Drug|Overall Study||21
2351305|NCT01662895|5770188|P2|STARTED|Overall Study||21
2351306|NCT01662895|5770189|P1|STARTED|Overall Study||21
2351307|NCT01662882|5770212|P3|NOT COMPLETED|Overall Study||0
2351308|NCT01662882|5770213|P2|NOT COMPLETED|Overall Study||0
2351309|NCT01662882|5770214|P1|NOT COMPLETED|Overall Study||0
2351310|NCT01662882|5770212|P3|COMPLETED|Overall Study||15
2351311|NCT01662882|5770213|P2|COMPLETED|Overall Study||18
2351312|NCT01662882|5770214|P1|COMPLETED|Overall Study||15
2351313|NCT01662882|5770212|P3|STARTED|Overall Study||15
2351314|NCT01662882|5770213|P2|STARTED|Overall Study||18
2351315|NCT01662882|5770214|P1|STARTED|Overall Study||15
2351316|NCT01662856|5770227|P2|NOT COMPLETED|Primary Part II||2
2351317|NCT01662856|5770228|P1|NOT COMPLETED|Primary Part II||10
2351318|NCT01662856|5770227|P2|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|55
2351319|NCT01662856|5770228|P1|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|99
2351320|NCT01662856|5770227|P2|Completed Study up to Week 6|Primary Part II||56
2351321|NCT01662856|5770228|P1|Completed Study up to Week 6|Primary Part II||106
2351322|NCT01662856|5770227|P2|STARTED|Primary Part II||57
2351323|NCT01662856|5770228|P1|STARTED|Primary Part II||109
2351324|NCT01662856|5770227|P2|NOT COMPLETED|Part I + Part II (Overall Study)||2
2351325|NCT01662856|5770228|P1|NOT COMPLETED|Part I + Part II (Overall Study)||16
2351326|NCT01662856|5770227|P2|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|55
2351327|NCT01662856|5770228|P1|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|152
2351328|NCT01662856|5770227|P2|Completed Study up to Week 6|Part I + Part II (Overall Study)||56
2351329|NCT01662856|5770228|P1|Completed Study up to Week 6|Part I + Part II (Overall Study)||164
2351330|NCT01662856|5770227|P2|STARTED|Part I + Part II (Overall Study)||57
2351331|NCT01662856|5770228|P1|STARTED|Part I + Part II (Overall Study)||168
2351332|NCT01662791|5770242|P2|NOT COMPLETED|Part 2 - Interventional||0
2351333|NCT01662791|5770243|P1|NOT COMPLETED|Part 2 - Interventional||0
2351334|NCT01662791|5770242|P2|COMPLETED|Part 2 - Interventional||0
2351335|NCT01662791|5770243|P1|COMPLETED|Part 2 - Interventional||8
2351336|NCT01662791|5770242|P2|STARTED|Part 2 - Interventional|The Control Group did not take part in the second part of the study.|0
2351337|NCT01662791|5770243|P1|STARTED|Part 2 - Interventional||8
2351338|NCT01662791|5770242|P2|NOT COMPLETED|Part 1 - Observational||0
2351339|NCT01662791|5770243|P1|NOT COMPLETED|Part 1 - Observational||0
2351340|NCT01662791|5770242|P2|COMPLETED|Part 1 - Observational||41
2351341|NCT01662791|5770243|P1|COMPLETED|Part 1 - Observational||8
2351342|NCT01662791|5770242|P2|STARTED|Part 1 - Observational||41
2351343|NCT01662791|5770243|P1|STARTED|Part 1 - Observational||8
2351344|NCT01662778|5770265|P4|NOT COMPLETED|Period 4||0
2351345|NCT01662778|5770266|P3|NOT COMPLETED|Period 4||0
2351346|NCT01662778|5770267|P2|NOT COMPLETED|Period 4||0
2351347|NCT01662778|5770268|P1|NOT COMPLETED|Period 4||0
2351348|NCT01662778|5770265|P4|COMPLETED|Period 4||4
2351349|NCT01662778|5770266|P3|COMPLETED|Period 4||6
2351350|NCT01662778|5770267|P2|COMPLETED|Period 4||5
2351351|NCT01662778|5770268|P1|COMPLETED|Period 4||6
2351352|NCT01662778|5770265|P4|STARTED|Period 4||4
2351353|NCT01662778|5770266|P3|STARTED|Period 4||6
2351354|NCT01662778|5770267|P2|STARTED|Period 4||5
2351355|NCT01662778|5770268|P1|STARTED|Period 4||6
2351356|NCT01662778|5770265|P4|NOT COMPLETED|Period 3||0
2351357|NCT01662778|5770266|P3|NOT COMPLETED|Period 3||0
2351358|NCT01662778|5770267|P2|NOT COMPLETED|Period 3||0
2351359|NCT01662778|5770268|P1|NOT COMPLETED|Period 3||0
2351360|NCT01662778|5770265|P4|COMPLETED|Period 3||4
2351361|NCT01662778|5770266|P3|COMPLETED|Period 3||6
2351362|NCT01662778|5770267|P2|COMPLETED|Period 3||5
2351363|NCT01662778|5770268|P1|COMPLETED|Period 3||6
2351364|NCT01662778|5770265|P4|STARTED|Period 3||4
2351365|NCT01662778|5770266|P3|STARTED|Period 3||6
2351366|NCT01662778|5770267|P2|STARTED|Period 3||5
2351367|NCT01662778|5770268|P1|STARTED|Period 3||6
2351368|NCT01662778|5770265|P4|NOT COMPLETED|Period 2||0
2351369|NCT01662778|5770266|P3|NOT COMPLETED|Period 2||0
2351370|NCT01662778|5770267|P2|NOT COMPLETED|Period 2||0
2351371|NCT01662778|5770268|P1|NOT COMPLETED|Period 2||0
2351372|NCT01662778|5770265|P4|COMPLETED|Period 2||4
2351373|NCT01662778|5770266|P3|COMPLETED|Period 2||6
2351374|NCT01662778|5770267|P2|COMPLETED|Period 2||5
2351375|NCT01662778|5770268|P1|COMPLETED|Period 2||6
2351376|NCT01662778|5770265|P4|STARTED|Period 2||4
2351377|NCT01662778|5770266|P3|STARTED|Period 2||6
2351378|NCT01662778|5770267|P2|STARTED|Period 2||5
2351379|NCT01662778|5770268|P1|STARTED|Period 2||6
2351380|NCT01662778|5770265|P4|NOT COMPLETED|Period 1||0
2351381|NCT01662778|5770266|P3|NOT COMPLETED|Period 1||0
2351382|NCT01662778|5770267|P2|NOT COMPLETED|Period 1||0
2351383|NCT01662778|5770268|P1|NOT COMPLETED|Period 1||0
2351384|NCT01662778|5770265|P4|COMPLETED|Period 1||4
2351385|NCT01662778|5770266|P3|COMPLETED|Period 1||6
2351386|NCT01662778|5770267|P2|COMPLETED|Period 1||5
2351387|NCT01662778|5770268|P1|COMPLETED|Period 1||6
2351388|NCT01662778|5770265|P4|STARTED|Period 1||4
2351389|NCT01662778|5770266|P3|STARTED|Period 1||6
2351390|NCT01662778|5770267|P2|STARTED|Period 1||5
2351391|NCT01662778|5770268|P1|STARTED|Period 1||6
2351392|NCT01662765|5770292|P2|NOT COMPLETED|Overall Study||2
2351393|NCT01662765|5770293|P1|NOT COMPLETED|Overall Study||1
2351394|NCT01662765|5770292|P2|COMPLETED|Overall Study||40
2351395|NCT01662765|5770293|P1|COMPLETED|Overall Study||41
2351396|NCT01662765|5770292|P2|STARTED|Overall Study||42
2351397|NCT01662765|5770293|P1|STARTED|Overall Study||42
2351398|NCT01662752|5770305|P1|NOT COMPLETED|Overall Study||0
2351399|NCT01662752|5770305|P1|COMPLETED|Overall Study||30
2351400|NCT01662752|5770305|P1|STARTED|Overall Study||30
2351401|NCT01662648|5770313|P2|NOT COMPLETED|Overall Study||178
2351402|NCT01662648|5770314|P1|NOT COMPLETED|Overall Study||147
2351403|NCT01662648|5770313|P2|COMPLETED|Overall Study||419
2351404|NCT01662648|5770314|P1|COMPLETED|Overall Study||373
2351405|NCT01662648|5770313|P2|STARTED|Overall Study||597
2351406|NCT01662648|5770314|P1|STARTED|Overall Study||520
2351407|NCT01662635|5770336|P1|NOT COMPLETED|Overall Study||30
2351408|NCT01662635|5770336|P1|COMPLETED|Overall Study||200
2351409|NCT01662635|5770336|P1|STARTED|Overall Study||230
2351410|NCT01662583|5770345|P3|NOT COMPLETED|Overall Study||0
2351411|NCT01662583|5770346|P2|NOT COMPLETED|Overall Study||0
2351412|NCT01662583|5770347|P1|NOT COMPLETED|Overall Study||0
2351413|NCT01662583|5770345|P3|COMPLETED|Overall Study||219
2351414|NCT01662583|5770346|P2|COMPLETED|Overall Study||225
2351415|NCT01662583|5770347|P1|COMPLETED|Overall Study||216
2351416|NCT01662583|5770345|P3|STARTED|Overall Study||219
2351417|NCT01662583|5770346|P2|STARTED|Overall Study||225
2351418|NCT01662583|5770347|P1|STARTED|Overall Study||216
2351419|NCT01662531|5770360|P1|NOT COMPLETED|Overall Study||0
2351420|NCT01662531|5770360|P1|COMPLETED|Overall Study||27
2351421|NCT01662531|5770360|P1|STARTED|Overall Study||27
2351422|NCT01662505|5770387|P3|NOT COMPLETED|Overall Study||8
2351423|NCT01662505|5770388|P2|NOT COMPLETED|Overall Study||4
2351424|NCT01662505|5770389|P1|NOT COMPLETED|Overall Study||7
2351425|NCT01662505|5770387|P3|COMPLETED|Overall Study||0
2351426|NCT01662505|5770388|P2|COMPLETED|Overall Study||0
2351427|NCT01662505|5770389|P1|COMPLETED|Overall Study||0
2351428|NCT01662505|5770387|P3|STARTED|Overall Study||8
2351429|NCT01662505|5770388|P2|STARTED|Overall Study||4
2351430|NCT01662505|5770389|P1|STARTED|Overall Study||7
2351431|NCT01662492|5770413|P3|NOT COMPLETED|Overall Study||6
2351432|NCT01662492|5770414|P2|NOT COMPLETED|Overall Study||1
2351433|NCT01662492|5770415|P1|NOT COMPLETED|Overall Study||3
2351434|NCT01662492|5770413|P3|COMPLETED|Overall Study||31
2351435|NCT01662492|5770414|P2|COMPLETED|Overall Study||42
2351436|NCT01662492|5770415|P1|COMPLETED|Overall Study||42
2351437|NCT01662492|5770413|P3|STARTED|Overall Study||37
2351438|NCT01662492|5770414|P2|STARTED|Overall Study||43
2351439|NCT01662492|5770415|P1|STARTED|Overall Study||45
2351440|NCT01662440|5770439|P4|NOT COMPLETED|Overall Study||4
2351441|NCT01662440|5770440|P3|NOT COMPLETED|Overall Study||6
2351442|NCT01662440|5770441|P2|NOT COMPLETED|Overall Study||6
2351443|NCT01662440|5770442|P1|NOT COMPLETED|Overall Study||9
2351444|NCT01662440|5770439|P4|COMPLETED|Overall Study||52
2351445|NCT01662440|5770440|P3|COMPLETED|Overall Study||215
2351446|NCT01662440|5770441|P2|COMPLETED|Overall Study||211
2351447|NCT01662440|5770442|P1|COMPLETED|Overall Study||158
2351448|NCT01662440|5770439|P4|STARTED|Overall Study||56
2351449|NCT01662440|5770440|P3|STARTED|Overall Study||221
2351450|NCT01662440|5770441|P2|STARTED|Overall Study||217
2351451|NCT01662440|5770442|P1|STARTED|Overall Study||167
2351452|NCT01662362|5770490|P1|NOT COMPLETED|Overall Study||38
2351453|NCT01662362|5770490|P1|COMPLETED|Overall Study||25
2351454|NCT01662362|5770490|P1|STARTED|Overall Study||63
2351455|NCT01662336|5770495|P1|NOT COMPLETED|Overall Study||66
2351456|NCT01662336|5770495|P1|COMPLETED|Overall Study||107
2351457|NCT01662336|5770495|P1|Completed Month 12 Visit|Overall Study||109
2351458|NCT01662336|5770495|P1|Completed Month 6 Visit|Overall Study||142
2351459|NCT01662336|5770495|P1|STARTED|Overall Study||173
2351460|NCT01662310|5770521|P5|NOT COMPLETED|Open-Label Extension Phase||10
2351461|NCT01662310|5770522|P4|NOT COMPLETED|Open-Label Extension Phase||11
2351462|NCT01662310|5770523|P3|NOT COMPLETED|Open-Label Extension Phase||0
2351463|NCT01662310|5770524|P2|NOT COMPLETED|Open-Label Extension Phase||0
2351464|NCT01662310|5770525|P1|NOT COMPLETED|Open-Label Extension Phase||0
2351465|NCT01662310|5770521|P5|COMPLETED|Open-Label Extension Phase||49
2351466|NCT01662310|5770522|P4|COMPLETED|Open-Label Extension Phase||36
2351467|NCT01662310|5770523|P3|COMPLETED|Open-Label Extension Phase||0
2351468|NCT01662310|5770524|P2|COMPLETED|Open-Label Extension Phase||0
2351469|NCT01662310|5770525|P1|COMPLETED|Open-Label Extension Phase||0
2351470|NCT01662310|5770521|P5|STARTED|Open-Label Extension Phase||59
2351471|NCT01662310|5770522|P4|STARTED|Open-Label Extension Phase||47
2351472|NCT01662310|5770523|P3|STARTED|Open-Label Extension Phase||0
2351473|NCT01662310|5770524|P2|STARTED|Open-Label Extension Phase||0
2351474|NCT01662310|5770525|P1|STARTED|Open-Label Extension Phase||0
2351475|NCT01662310|5770521|P5|NOT COMPLETED|Double-Blind Phase||0
2351476|NCT01662310|5770522|P4|NOT COMPLETED|Double-Blind Phase||0
2351477|NCT01662310|5770523|P3|NOT COMPLETED|Double-Blind Phase||5
2351478|NCT01662310|5770524|P2|NOT COMPLETED|Double-Blind Phase||15
2351479|NCT01662310|5770525|P1|NOT COMPLETED|Double-Blind Phase||0
2351480|NCT01662310|5770521|P5|COMPLETED|Double-Blind Phase||0
2351481|NCT01662310|5770522|P4|COMPLETED|Double-Blind Phase||0
2351482|NCT01662310|5770523|P3|COMPLETED|Double-Blind Phase||66
2351483|NCT01662310|5770524|P2|COMPLETED|Double-Blind Phase||50
2351484|NCT01662310|5770525|P1|COMPLETED|Double-Blind Phase||0
2351485|NCT01662310|5770521|P5|Treated|Double-Blind Phase||0
2351486|NCT01662310|5770522|P4|Treated|Double-Blind Phase||0
2351487|NCT01662310|5770523|P3|Treated|Double-Blind Phase||71
2351488|NCT01662310|5770524|P2|Treated|Double-Blind Phase||64
2351489|NCT01662310|5770525|P1|Treated|Double-Blind Phase||0
2351490|NCT01662310|5770521|P5|STARTED|Double-Blind Phase||0
2351491|NCT01662310|5770522|P4|STARTED|Double-Blind Phase||0
2351492|NCT01662310|5770523|P3|STARTED|Double-Blind Phase||71
2351493|NCT01662310|5770524|P2|STARTED|Double-Blind Phase||65
2351494|NCT01662310|5770525|P1|STARTED|Double-Blind Phase||0
2351495|NCT01662310|5770521|P5|NOT COMPLETED|Run-In or Stabilization Phase||0
2351496|NCT01662310|5770522|P4|NOT COMPLETED|Run-In or Stabilization Phase||0
2351497|NCT01662310|5770523|P3|NOT COMPLETED|Run-In or Stabilization Phase||0
2351498|NCT01662310|5770524|P2|NOT COMPLETED|Run-In or Stabilization Phase||0
2351499|NCT01662310|5770525|P1|NOT COMPLETED|Run-In or Stabilization Phase||65
2351500|NCT01662310|5770521|P5|COMPLETED|Run-In or Stabilization Phase||0
2351501|NCT01662310|5770522|P4|COMPLETED|Run-In or Stabilization Phase||0
2351502|NCT01662310|5770523|P3|COMPLETED|Run-In or Stabilization Phase||0
2351503|NCT01662310|5770524|P2|COMPLETED|Run-In or Stabilization Phase||0
2351504|NCT01662310|5770525|P1|COMPLETED|Run-In or Stabilization Phase||136
2351505|NCT01662310|5770521|P5|STARTED|Run-In or Stabilization Phase||0
2351506|NCT01662310|5770522|P4|STARTED|Run-In or Stabilization Phase||0
2351507|NCT01662310|5770523|P3|STARTED|Run-In or Stabilization Phase||0
2351508|NCT01662310|5770524|P2|STARTED|Run-In or Stabilization Phase||0
2351509|NCT01662310|5770525|P1|STARTED|Run-In or Stabilization Phase||201
2351510|NCT01662297|5770559|P2|NOT COMPLETED|Overall Study||0
2351511|NCT01662297|5770560|P1|NOT COMPLETED|Overall Study||0
2351512|NCT01662297|5770559|P2|COMPLETED|Overall Study||1
2351513|NCT01662297|5770560|P1|COMPLETED|Overall Study||0
2351514|NCT01662297|5770559|P2|STARTED|Overall Study||1
2351515|NCT01662297|5770560|P1|STARTED|Overall Study||0
2351516|NCT01662115|5770585|P3|NOT COMPLETED|Overall Study||0
2351517|NCT01662115|5770586|P2|NOT COMPLETED|Overall Study||0
2351518|NCT01662115|5770587|P1|NOT COMPLETED|Overall Study||0
2351519|NCT01662115|5770585|P3|COMPLETED|Overall Study||0
2351520|NCT01662115|5770586|P2|COMPLETED|Overall Study||2
2351521|NCT01662115|5770587|P1|COMPLETED|Overall Study||2
2351522|NCT01662115|5770585|P3|STARTED|Overall Study||0
2351523|NCT01662115|5770586|P2|STARTED|Overall Study||2
2351524|NCT01662115|5770587|P1|STARTED|Overall Study||2
2351525|NCT01662102|5770606|P2|NOT COMPLETED|Overall Study||0
2351526|NCT01662102|5770607|P1|NOT COMPLETED|Overall Study||1
2351527|NCT01662102|5770606|P2|COMPLETED|Overall Study||0
2351528|NCT01662102|5770607|P1|COMPLETED|Overall Study||0
2351529|NCT01662102|5770606|P2|STARTED|Overall Study||0
2351530|NCT01662102|5770607|P1|STARTED|Overall Study||1
2351531|NCT01662063|5770615|P3|NOT COMPLETED|Overall Study||1
2351532|NCT01662063|5770616|P2|NOT COMPLETED|Overall Study||29
2351533|NCT01662063|5770617|P1|NOT COMPLETED|Overall Study||5
2351534|NCT01662063|5770615|P3|COMPLETED|Overall Study||0
2351535|NCT01662063|5770616|P2|COMPLETED|Overall Study||144
2351536|NCT01662063|5770617|P1|COMPLETED|Overall Study||39
2351537|NCT01662063|5770615|P3|STARTED|Overall Study||1
2351538|NCT01662063|5770616|P2|STARTED|Overall Study||173
2351539|NCT01662063|5770617|P1|STARTED|Overall Study||44
2351540|NCT01662024|5770696|P1|NOT COMPLETED|Overall Study||5
2351541|NCT01662024|5770696|P1|COMPLETED|Overall Study||15
2351542|NCT01662024|5770696|P1|STARTED|Overall Study||20
2351543|NCT01661972|5770708|P2|NOT COMPLETED|Overall Study||4
2351544|NCT01661972|5770709|P1|NOT COMPLETED|Overall Study||2
2351545|NCT01661972|5770708|P2|COMPLETED|Overall Study||46
2351546|NCT01661972|5770709|P1|COMPLETED|Overall Study||11
2351547|NCT01661972|5770708|P2|STARTED|Overall Study||50
2351548|NCT01661972|5770709|P1|STARTED|Overall Study||13
2351549|NCT01661946|5770721|P2|NOT COMPLETED|Overall Study||0
2351550|NCT01661946|5770722|P1|NOT COMPLETED|Overall Study||0
2351551|NCT01661946|5770721|P2|COMPLETED|Overall Study||5
2351552|NCT01661946|5770722|P1|COMPLETED|Overall Study||5
2351553|NCT01661946|5770721|P2|STARTED|Overall Study||5
2351554|NCT01661946|5770722|P1|STARTED|Overall Study||5
2351555|NCT01661933|5770728|P1|NOT COMPLETED|High-dose Gluten Challenge||2
2351556|NCT01661933|5770728|P1|COMPLETED|High-dose Gluten Challenge||8
2351557|NCT01661933|5770728|P1|STARTED|High-dose Gluten Challenge|2 of 10 available after post-GC-1g did not enroll for reasons unrelated to gluten.|10
2351558|NCT01661933|5770728|P1|NOT COMPLETED|Low-dose Gluten Challenge||2
2351559|NCT01661933|5770728|P1|COMPLETED|Low-dose Gluten Challenge|Two had challenge interrupted for 1-2 weeks. All completed challenge.|10
2351560|NCT01661933|5770728|P1|STARTED|Low-dose Gluten Challenge|One was symptomatically intolerant to gluten >25 mg. One had active CeD pre- & post-micro-challenge|12
2351561|NCT01661933|5770728|P1|NOT COMPLETED|Gluten Micro-challenge||0
2351562|NCT01661933|5770728|P1|COMPLETED|Gluten Micro-challenge|Two gluten intolerant participants did not proceed to the low-dose challenge.|12
2351563|NCT01661933|5770728|P1|STARTED|Gluten Micro-challenge|All 12 enrolled completed hookworm inoculation and gluten micro-challenge.|12
2351564|NCT01661881|5770735|P1|NOT COMPLETED|Overall Study||1
2351565|NCT01661881|5770735|P1|COMPLETED|Overall Study||22
2351566|NCT01661881|5770735|P1|STARTED|Overall Study||23
2351567|NCT01661790|5770743|P2|NOT COMPLETED|Overall Study||2
2351568|NCT01661790|5770744|P1|NOT COMPLETED|Overall Study||0
2351569|NCT01661790|5770743|P2|COMPLETED|Overall Study||34
2351570|NCT01661790|5770744|P1|COMPLETED|Overall Study||36
2351571|NCT01661790|5770743|P2|STARTED|Overall Study||36
2351572|NCT01661790|5770744|P1|STARTED|Overall Study||36
2351573|NCT01661764|5770756|P6|NOT COMPLETED|Overall Study||2
2351574|NCT01661764|5770757|P5|NOT COMPLETED|Overall Study||3
2351575|NCT01661764|5770758|P4|NOT COMPLETED|Overall Study||2
2351576|NCT01661764|5770759|P3|NOT COMPLETED|Overall Study||3
2351577|NCT01661764|5770760|P2|NOT COMPLETED|Overall Study||5
2351578|NCT01661764|5770761|P1|NOT COMPLETED|Overall Study||2
2351579|NCT01661764|5770756|P6|COMPLETED|Overall Study||18
2351580|NCT01661764|5770757|P5|COMPLETED|Overall Study||16
2351581|NCT01661764|5770758|P4|COMPLETED|Overall Study||24
2351582|NCT01661764|5770759|P3|COMPLETED|Overall Study||22
2351583|NCT01661764|5770760|P2|COMPLETED|Overall Study||20
2351584|NCT01661764|5770761|P1|COMPLETED|Overall Study||24
2351585|NCT01661764|5770756|P6|STARTED|Overall Study||20
2351586|NCT01661764|5770757|P5|STARTED|Overall Study||19
2351587|NCT01661764|5770758|P4|STARTED|Overall Study||26
2351588|NCT01661764|5770759|P3|STARTED|Overall Study||25
2351589|NCT01661764|5770760|P2|STARTED|Overall Study||25
2351590|NCT01661764|5770761|P1|STARTED|Overall Study||26
2351591|NCT01661712|5770825|P2|NOT COMPLETED|Overall Study||0
2351592|NCT01661712|5770826|P1|NOT COMPLETED|Overall Study||0
2351593|NCT01661712|5770825|P2|COMPLETED|Overall Study|sham stimulation night|18
2351594|NCT01661712|5770826|P1|COMPLETED|Overall Study|night on transcutaneous electrical stimulation|18
2351595|NCT01661712|5770825|P2|Washout Period|Overall Study|>Three nights of no stimulation/sham stimulation|18
2351596|NCT01661712|5770826|P1|Washout Period|Overall Study|>Three nights of no stimulation/sham stimulation|18
2351597|NCT01661712|5770825|P2|STARTED|Overall Study|initial night on transcutaneous electrical stimulation|18
2351598|NCT01661712|5770826|P1|STARTED|Overall Study|initial sham stimulation night|18
2351599|NCT01661686|5770844|P2|NOT COMPLETED|Overall Study||2
2351600|NCT01661686|5770845|P1|NOT COMPLETED|Overall Study||2
2351601|NCT01661686|5770844|P2|COMPLETED|Overall Study||47
2351602|NCT01661686|5770845|P1|COMPLETED|Overall Study||47
2351603|NCT01661686|5770844|P2|STARTED|Overall Study||49
2351604|NCT01661686|5770845|P1|STARTED|Overall Study||49
2351605|NCT01661621|5770861|P2|NOT COMPLETED|Overall Study||0
2351606|NCT01661621|5770862|P1|NOT COMPLETED|Overall Study||0
2351607|NCT01661621|5770861|P2|COMPLETED|Overall Study||279
2351608|NCT01661621|5770862|P1|COMPLETED|Overall Study||116
2351609|NCT01661621|5770861|P2|STARTED|Overall Study||279
2351610|NCT01661621|5770862|P1|STARTED|Overall Study||116
2351611|NCT01661595|5770886|P4|NOT COMPLETED|Phase 2: Week 5-8.||0
2351612|NCT01661595|5770887|P3|NOT COMPLETED|Phase 2: Week 5-8.||1
2351613|NCT01661595|5770888|P2|NOT COMPLETED|Phase 2: Week 5-8.||0
2351614|NCT01661595|5770889|P1|NOT COMPLETED|Phase 2: Week 5-8.||0
2351615|NCT01661595|5770886|P4|COMPLETED|Phase 2: Week 5-8.||4
2351616|NCT01661595|5770887|P3|COMPLETED|Phase 2: Week 5-8.||4
2351617|NCT01661595|5770888|P2|COMPLETED|Phase 2: Week 5-8.||4
2351618|NCT01661595|5770889|P1|COMPLETED|Phase 2: Week 5-8.||4
2351619|NCT01661595|5770886|P4|STARTED|Phase 2: Week 5-8.||4
2351620|NCT01661595|5770887|P3|STARTED|Phase 2: Week 5-8.||5
2351621|NCT01661595|5770888|P2|STARTED|Phase 2: Week 5-8.||4
2351622|NCT01661595|5770889|P1|STARTED|Phase 2: Week 5-8.||4
2351623|NCT01661595|5770886|P4|NOT COMPLETED|Phase 1: Week 0-4||0
2351624|NCT01661595|5770887|P3|NOT COMPLETED|Phase 1: Week 0-4||0
2351625|NCT01661595|5770888|P2|NOT COMPLETED|Phase 1: Week 0-4||0
2351626|NCT01661595|5770889|P1|NOT COMPLETED|Phase 1: Week 0-4||1
2351627|NCT01661595|5770886|P4|COMPLETED|Phase 1: Week 0-4||4
2351628|NCT01661595|5770887|P3|COMPLETED|Phase 1: Week 0-4||5
2351629|NCT01661595|5770888|P2|COMPLETED|Phase 1: Week 0-4||4
2351630|NCT01661595|5770889|P1|COMPLETED|Phase 1: Week 0-4||4
2351631|NCT01661595|5770886|P4|STARTED|Phase 1: Week 0-4||4
2351632|NCT01661595|5770887|P3|STARTED|Phase 1: Week 0-4||5
2351633|NCT01661595|5770888|P2|STARTED|Phase 1: Week 0-4||4
2351634|NCT01661595|5770889|P1|STARTED|Phase 1: Week 0-4||5
2351635|NCT01661283|5770994|P1|NOT COMPLETED|Overall Study||0
2351636|NCT01661283|5770994|P1|COMPLETED|Overall Study||25
2351637|NCT01661283|5770994|P1|STARTED|Overall Study|15 patients enrolled in the first stage; 10 patients enrolled in the second stage|25
2351638|NCT01661270|5771005|P2|NOT COMPLETED|Overall Study||0
2351639|NCT01661270|5771006|P1|NOT COMPLETED|Overall Study||0
2351640|NCT01661270|5771005|P2|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|223
2351641|NCT01661270|5771006|P1|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|109
2351642|NCT01661270|5771005|P2|Other Reasons|Overall Study||2
2351643|NCT01661270|5771006|P1|Other Reasons|Overall Study||0
2351644|NCT01661270|5771005|P2|Participant’s Request|Overall Study|Met EOT criteria|48
2351645|NCT01661270|5771006|P1|Participant’s Request|Overall Study|Met EOT criteria|15
2351646|NCT01661270|5771005|P2|Physician Decision|Overall Study|Met EOT criteria|8
2351647|NCT01661270|5771006|P1|Physician Decision|Overall Study|Met EOT criteria|1
2351648|NCT01661270|5771005|P2|Disease Progression|Overall Study|Met EOT criteria|118
2351649|NCT01661270|5771006|P1|Disease Progression|Overall Study|Met EOT criteria|67
2351650|NCT01661270|5771005|P2|Adverse Event|Overall Study|Met EOT criteria|47
2351651|NCT01661270|5771006|P1|Adverse Event|Overall Study|Met end of treatment (EOT) criteria.|26
2351652|NCT01661270|5771005|P2|STARTED|Overall Study||223
2351653|NCT01661270|5771006|P1|STARTED|Overall Study||109
2351654|NCT01661205|5771017|P1|NOT COMPLETED|Overall Study||2
2351655|NCT01661205|5771017|P1|COMPLETED|Overall Study||24
2351656|NCT01661205|5771017|P1|STARTED|Overall Study||26
2351657|NCT01661179|5771028|P1|NOT COMPLETED|Overall Study||6
2351658|NCT01661179|5771028|P1|COMPLETED|Overall Study||8
2351659|NCT01661179|5771028|P1|STARTED|Overall Study||14
2351660|NCT01661140|5771032|P3|NOT COMPLETED|Double-Blind Period||50
2351661|NCT01661140|5771033|P2|NOT COMPLETED|Double-Blind Period||41
2351662|NCT01661140|5771034|P1|NOT COMPLETED|Double-Blind Period||0
2351663|NCT01661140|5771032|P3|COMPLETED|Double-Blind Period||86
2351664|NCT01661140|5771033|P2|COMPLETED|Double-Blind Period||95
2351665|NCT01661140|5771034|P1|COMPLETED|Double-Blind Period||0
2351666|NCT01661140|5771032|P3|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
2351760|NCT01660334|5771260|P1|NOT COMPLETED|Overall Study||1
2351667|NCT01661140|5771033|P2|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
2351668|NCT01661140|5771034|P1|STARTED|Double-Blind Period|Those with a good/moderate disease response in the initial phase were randomized to the MTX arms.|0
2351669|NCT01661140|5771032|P3|NOT COMPLETED|Open-Label Period||0
2351670|NCT01661140|5771033|P2|NOT COMPLETED|Open-Label Period||0
2351671|NCT01661140|5771034|P1|NOT COMPLETED|Open-Label Period||76
2351672|NCT01661140|5771032|P3|COMPLETED|Open-Label Period||0
2351673|NCT01661140|5771033|P2|COMPLETED|Open-Label Period||0
2351674|NCT01661140|5771034|P1|COMPLETED|Open-Label Period||351
2351675|NCT01661140|5771032|P3|STARTED|Open-Label Period||0
2351676|NCT01661140|5771033|P2|STARTED|Open-Label Period||0
2351677|NCT01661140|5771034|P1|STARTED|Open-Label Period|All participants entered the study in the initial phase for 24 weeks of open label treatment.|427
2351678|NCT01661114|5771075|P1|NOT COMPLETED|Overall Study||0
2351679|NCT01661114|5771075|P1|COMPLETED|Overall Study||39
2351680|NCT01661114|5771075|P1|STARTED|Overall Study||39
2351681|NCT01661088|5771080|P1|NOT COMPLETED|IMRT With FDR Gemcitabine||2
2351682|NCT01661088|5771080|P1|COMPLETED|IMRT With FDR Gemcitabine||19
2351683|NCT01661088|5771080|P1|STARTED|IMRT With FDR Gemcitabine||21
2351684|NCT01661088|5771080|P1|NOT COMPLETED|FOLFIRINOX||4
2351685|NCT01661088|5771080|P1|COMPLETED|FOLFIRINOX||21
2351686|NCT01661088|5771080|P1|STARTED|FOLFIRINOX||25
2351687|NCT01661062|5771086|P1|NOT COMPLETED|Overall Study||5
2351688|NCT01661062|5771086|P1|COMPLETED|Overall Study||18
2351689|NCT01661062|5771086|P1|STARTED|Overall Study||23
2351690|NCT01660906|5771091|P1|NOT COMPLETED|Overall Study||3
2351691|NCT01660906|5771091|P1|COMPLETED|Overall Study||36
2351692|NCT01660906|5771091|P1|STARTED|Overall Study||39
2351693|NCT01660893|5771103|P3|NOT COMPLETED|Overall Study||0
2351694|NCT01660893|5771104|P2|NOT COMPLETED|Overall Study||0
2351695|NCT01660893|5771105|P1|NOT COMPLETED|Overall Study||0
2351696|NCT01660893|5771103|P3|COMPLETED|Overall Study||6
2351697|NCT01660893|5771104|P2|COMPLETED|Overall Study||10
2351698|NCT01660893|5771105|P1|COMPLETED|Overall Study||10
2351699|NCT01660893|5771103|P3|STARTED|Overall Study||6
2351700|NCT01660893|5771104|P2|STARTED|Overall Study||10
2351701|NCT01660893|5771105|P1|STARTED|Overall Study||10
2351702|NCT01660815|5771152|P1|NOT COMPLETED|Overall Study||0
2351703|NCT01660815|5771152|P1|COMPLETED|Overall Study||7
2351704|NCT01660815|5771152|P1|STARTED|Overall Study||7
2351705|NCT01660802|5771159|P2|NOT COMPLETED|Overall Study||11
2351706|NCT01660802|5771160|P1|NOT COMPLETED|Overall Study||4
2351707|NCT01660802|5771159|P2|COMPLETED|Overall Study||121
2351708|NCT01660802|5771160|P1|COMPLETED|Overall Study||126
2351709|NCT01660802|5771159|P2|STARTED|Overall Study||132
2351710|NCT01660802|5771160|P1|STARTED|Overall Study||130
2351711|NCT01660763|5771174|P2|NOT COMPLETED|Overall Study||61
2351712|NCT01660763|5771175|P1|NOT COMPLETED|Overall Study||100
2351713|NCT01660763|5771174|P2|COMPLETED|Overall Study||43
2351714|NCT01660763|5771175|P1|COMPLETED|Overall Study||215
2351715|NCT01660763|5771174|P2|STARTED|Overall Study||104
2351716|NCT01660763|5771175|P1|STARTED|Overall Study||315
2351717|NCT01660737|5771181|P1|NOT COMPLETED|Overall Study||0
2351718|NCT01660737|5771181|P1|COMPLETED|Overall Study||123
2351719|NCT01660737|5771181|P1|STARTED|Overall Study||123
2351720|NCT01660698|5771198|P2|NOT COMPLETED|Overall Study||0
2351721|NCT01660698|5771199|P1|NOT COMPLETED|Overall Study||0
2351722|NCT01660698|5771198|P2|COMPLETED|Overall Study||10
2351723|NCT01660698|5771199|P1|COMPLETED|Overall Study||10
2351724|NCT01660698|5771198|P2|STARTED|Overall Study||10
2351725|NCT01660698|5771199|P1|STARTED|Overall Study||10
2351726|NCT01660672|5771209|P1|NOT COMPLETED|Overall Study||0
2351727|NCT01660672|5771209|P1|COMPLETED|Overall Study||7
2351728|NCT01660672|5771209|P1|STARTED|Overall Study||7
2351729|NCT01660451|5771223|P3|NOT COMPLETED|Overall Study||105
2351730|NCT01660451|5771224|P2|NOT COMPLETED|Overall Study||17
2351731|NCT01660451|5771225|P1|NOT COMPLETED|Overall Study||17
2351732|NCT01660451|5771223|P3|COMPLETED|Overall Study||37
2351733|NCT01660451|5771224|P2|COMPLETED|Overall Study||34
2351734|NCT01660451|5771225|P1|COMPLETED|Overall Study||16
2351735|NCT01660451|5771223|P3|STARTED|Overall Study||142
2351736|NCT01660451|5771224|P2|STARTED|Overall Study||51
2351737|NCT01660451|5771225|P1|STARTED|Overall Study||33
2351738|NCT01660412|5771253|P2|NOT COMPLETED|Overall Study||3
2351739|NCT01660412|5771254|P1|NOT COMPLETED|Overall Study||0
2351740|NCT01660412|5771253|P2|COMPLETED|Overall Study||28
2351741|NCT01660412|5771254|P1|COMPLETED|Overall Study||29
2351742|NCT01660412|5771253|P2|Injection 4|Overall Study||31
2351743|NCT01660412|5771254|P1|Injection 4|Overall Study||29
2351744|NCT01660412|5771253|P2|Injection 3|Overall Study||31
2351745|NCT01660412|5771254|P1|Injection 3|Overall Study||29
2351746|NCT01660412|5771253|P2|Injection 2|Overall Study||31
2351747|NCT01660412|5771254|P1|Injection 2|Overall Study||29
2351748|NCT01660412|5771253|P2|Injection 1|Overall Study||31
2351749|NCT01660412|5771254|P1|Injection 1|Overall Study||29
2351750|NCT01660412|5771253|P2|Other|Overall Study||4
2351751|NCT01660412|5771254|P1|Other|Overall Study||2
2351752|NCT01660412|5771253|P2|Appendicular Structures|Overall Study||11
2351753|NCT01660412|5771254|P1|Appendicular Structures|Overall Study||17
2351754|NCT01660412|5771253|P2|Thorax|Overall Study||9
2351755|NCT01660412|5771254|P1|Thorax|Overall Study||9
2351756|NCT01660412|5771253|P2|Head|Overall Study||4
2351757|NCT01660412|5771254|P1|Head|Overall Study||1
2351758|NCT01660412|5771253|P2|STARTED|Overall Study||31
2351759|NCT01660412|5771254|P1|STARTED|Overall Study||29
2351761|NCT01660334|5771260|P1|COMPLETED|Overall Study||12
2351762|NCT01660334|5771260|P1|STARTED|Overall Study||13
2351763|NCT01660321|5771265|P1|NOT COMPLETED|Overall Study||0
2351764|NCT01660321|5771265|P1|COMPLETED|Overall Study||26
2351765|NCT01660321|5771265|P1|STARTED|Overall Study||26
2351766|NCT01660230|5771289|P12|NOT COMPLETED|Overall Study||0
2351767|NCT01660230|5771290|P11|NOT COMPLETED|Overall Study||0
2351768|NCT01660230|5771291|P10|NOT COMPLETED|Overall Study||0
2351769|NCT01660230|5771292|P9|NOT COMPLETED|Overall Study||0
2351770|NCT01660230|5771293|P8|NOT COMPLETED|Overall Study||0
2351771|NCT01660230|5771294|P7|NOT COMPLETED|Overall Study||0
2351772|NCT01660230|5771295|P6|NOT COMPLETED|Overall Study||0
2351773|NCT01660230|5771296|P5|NOT COMPLETED|Overall Study||0
2351774|NCT01660230|5771297|P4|NOT COMPLETED|Overall Study||0
2351775|NCT01660230|5771298|P3|NOT COMPLETED|Overall Study||0
2351776|NCT01660230|5771299|P2|NOT COMPLETED|Overall Study||0
2351777|NCT01660230|5771300|P1|NOT COMPLETED|Overall Study||0
2351778|NCT01660230|5771289|P12|COMPLETED|Overall Study||14
2351779|NCT01660230|5771290|P11|COMPLETED|Overall Study||6
2351780|NCT01660230|5771291|P10|COMPLETED|Overall Study||6
2351781|NCT01660230|5771292|P9|COMPLETED|Overall Study||6
2351782|NCT01660230|5771293|P8|COMPLETED|Overall Study||6
2351783|NCT01660230|5771294|P7|COMPLETED|Overall Study||4
2351784|NCT01660230|5771295|P6|COMPLETED|Overall Study||2
2351785|NCT01660230|5771296|P5|COMPLETED|Overall Study||4
2351786|NCT01660230|5771297|P4|COMPLETED|Overall Study||4
2351787|NCT01660230|5771298|P3|COMPLETED|Overall Study||4
2351788|NCT01660230|5771299|P2|COMPLETED|Overall Study||4
2351789|NCT01660230|5771300|P1|COMPLETED|Overall Study||4
2351790|NCT01660230|5771289|P12|STARTED|Overall Study||14
2351791|NCT01660230|5771290|P11|STARTED|Overall Study||6
2351792|NCT01660230|5771291|P10|STARTED|Overall Study||6
2351793|NCT01660230|5771292|P9|STARTED|Overall Study||6
2351794|NCT01660230|5771293|P8|STARTED|Overall Study||6
2351795|NCT01660230|5771294|P7|STARTED|Overall Study||4
2351796|NCT01660230|5771295|P6|STARTED|Overall Study||2
2351797|NCT01660230|5771296|P5|STARTED|Overall Study||4
2351798|NCT01660230|5771297|P4|STARTED|Overall Study||4
2351799|NCT01660230|5771298|P3|STARTED|Overall Study||4
2351800|NCT01660230|5771299|P2|STARTED|Overall Study||4
2351801|NCT01660230|5771300|P1|STARTED|Overall Study||4
2351802|NCT01660191|5771472|P3|NOT COMPLETED|End of Treatment||1
2351803|NCT01660191|5771473|P2|NOT COMPLETED|End of Treatment||6
2351804|NCT01660191|5771474|P1|NOT COMPLETED|End of Treatment||1
2351805|NCT01660191|5771472|P3|COMPLETED|End of Treatment||43
2351806|NCT01660191|5771473|P2|COMPLETED|End of Treatment||39
2351807|NCT01660191|5771474|P1|COMPLETED|End of Treatment||44
2351808|NCT01660191|5771472|P3|STARTED|End of Treatment||44
2351809|NCT01660191|5771473|P2|STARTED|End of Treatment||45
2351810|NCT01660191|5771474|P1|STARTED|End of Treatment||45
2351811|NCT01660191|5771472|P3|NOT COMPLETED|Randomization||0
2351812|NCT01660191|5771473|P2|NOT COMPLETED|Randomization||0
2351813|NCT01660191|5771474|P1|NOT COMPLETED|Randomization||0
2351814|NCT01660191|5771472|P3|COMPLETED|Randomization||44
2351815|NCT01660191|5771473|P2|COMPLETED|Randomization||45
2351816|NCT01660191|5771474|P1|COMPLETED|Randomization||45
2351817|NCT01660191|5771472|P3|STARTED|Randomization||44
2351818|NCT01660191|5771473|P2|STARTED|Randomization||45
2351819|NCT01660191|5771474|P1|STARTED|Randomization||45
2351820|NCT01660191|5771472|P3|NOT COMPLETED|Enrollment and Washout||0
2351821|NCT01660191|5771473|P2|NOT COMPLETED|Enrollment and Washout||0
2351822|NCT01660191|5771474|P1|NOT COMPLETED|Enrollment and Washout||0
2351823|NCT01660191|5771472|P3|COMPLETED|Enrollment and Washout||44
2351824|NCT01660191|5771473|P2|COMPLETED|Enrollment and Washout||45
2351825|NCT01660191|5771474|P1|COMPLETED|Enrollment and Washout||45
2351826|NCT01660191|5771472|P3|STARTED|Enrollment and Washout||44
2351827|NCT01660191|5771473|P2|STARTED|Enrollment and Washout||45
2351828|NCT01660191|5771474|P1|STARTED|Enrollment and Washout||45
2351829|NCT01660022|5771503|P6|NOT COMPLETED|Second Sequence (42 Days)||0
2351830|NCT01660022|5771504|P5|NOT COMPLETED|Second Sequence (42 Days)||0
2351831|NCT01660022|5771505|P4|NOT COMPLETED|Second Sequence (42 Days)||0
2351832|NCT01660022|5771506|P3|NOT COMPLETED|Second Sequence (42 Days)||0
2351833|NCT01660022|5771507|P2|NOT COMPLETED|Second Sequence (42 Days)||0
2351834|NCT01660022|5771508|P1|NOT COMPLETED|Second Sequence (42 Days)||0
2351835|NCT01660022|5771503|P6|COMPLETED|Second Sequence (42 Days)||16
2351836|NCT01660022|5771504|P5|COMPLETED|Second Sequence (42 Days)||6
2351837|NCT01660022|5771505|P4|COMPLETED|Second Sequence (42 Days)||7
2351838|NCT01660022|5771506|P3|COMPLETED|Second Sequence (42 Days)||8
2351839|NCT01660022|5771507|P2|COMPLETED|Second Sequence (42 Days)||7
2351840|NCT01660022|5771508|P1|COMPLETED|Second Sequence (42 Days)||8
2351841|NCT01660022|5771503|P6|STARTED|Second Sequence (42 Days)||16
2351842|NCT01660022|5771504|P5|STARTED|Second Sequence (42 Days)||6
2351843|NCT01660022|5771505|P4|STARTED|Second Sequence (42 Days)||7
2351844|NCT01660022|5771506|P3|STARTED|Second Sequence (42 Days)||8
2351845|NCT01660022|5771507|P2|STARTED|Second Sequence (42 Days)||7
2351846|NCT01660022|5771508|P1|STARTED|Second Sequence (42 Days)||8
2351847|NCT01660022|5771503|P6|NOT COMPLETED|First Sequence (7 Days)||4
2351848|NCT01660022|5771504|P5|NOT COMPLETED|First Sequence (7 Days)||1
2351849|NCT01660022|5771505|P4|NOT COMPLETED|First Sequence (7 Days)||1
2351850|NCT01660022|5771506|P3|NOT COMPLETED|First Sequence (7 Days)||0
2351851|NCT01660022|5771507|P2|NOT COMPLETED|First Sequence (7 Days)||1
2351852|NCT01660022|5771508|P1|NOT COMPLETED|First Sequence (7 Days)||0
2351853|NCT01660022|5771503|P6|COMPLETED|First Sequence (7 Days)||16
2351854|NCT01660022|5771504|P5|COMPLETED|First Sequence (7 Days)||6
2351855|NCT01660022|5771505|P4|COMPLETED|First Sequence (7 Days)||7
2351856|NCT01660022|5771506|P3|COMPLETED|First Sequence (7 Days)||8
2351857|NCT01660022|5771507|P2|COMPLETED|First Sequence (7 Days)||7
2351858|NCT01660022|5771508|P1|COMPLETED|First Sequence (7 Days)||8
2351859|NCT01660022|5771503|P6|STARTED|First Sequence (7 Days)||20
2351860|NCT01660022|5771504|P5|STARTED|First Sequence (7 Days)||7
2351861|NCT01660022|5771505|P4|STARTED|First Sequence (7 Days)||8
2351862|NCT01660022|5771506|P3|STARTED|First Sequence (7 Days)||8
2351863|NCT01660022|5771507|P2|STARTED|First Sequence (7 Days)||8
2351864|NCT01660022|5771508|P1|STARTED|First Sequence (7 Days)||8
2351865|NCT01659996|5771567|P3|NOT COMPLETED|Overall Study||11
2351866|NCT01659996|5771568|P2|NOT COMPLETED|Overall Study||7
2351867|NCT01659996|5771569|P1|NOT COMPLETED|Overall Study||8
2351868|NCT01659996|5771567|P3|COMPLETED|Overall Study||461
2351869|NCT01659996|5771568|P2|COMPLETED|Overall Study||388
2351870|NCT01659996|5771569|P1|COMPLETED|Overall Study||413
2351871|NCT01659996|5771567|P3|STARTED|Overall Study||472
2351872|NCT01659996|5771568|P2|STARTED|Overall Study||395
2351873|NCT01659996|5771569|P1|STARTED|Overall Study||421
2351874|NCT01659866|5771603|P2|NOT COMPLETED|Overall Study||0
2351875|NCT01659866|5771604|P1|NOT COMPLETED|Overall Study||0
2351876|NCT01659866|5771603|P2|COMPLETED|Overall Study||80
2351877|NCT01659866|5771604|P1|COMPLETED|Overall Study||430
2351878|NCT01659866|5771603|P2|STARTED|Overall Study||80
2351879|NCT01659866|5771604|P1|STARTED|Overall Study||430
2351880|NCT01659853|5771610|P2|NOT COMPLETED|Treatment Period 2||0
2351881|NCT01659853|5771611|P1|NOT COMPLETED|Treatment Period 2||0
2351882|NCT01659853|5771610|P2|COMPLETED|Treatment Period 2||35
2351883|NCT01659853|5771611|P1|COMPLETED|Treatment Period 2||33
2351884|NCT01659853|5771610|P2|STARTED|Treatment Period 2||35
2351885|NCT01659853|5771611|P1|STARTED|Treatment Period 2||33
2351886|NCT01659853|5771610|P2|NOT COMPLETED|Washout , 3 to 7 Days||0
2351887|NCT01659853|5771611|P1|NOT COMPLETED|Washout , 3 to 7 Days||2
2351888|NCT01659853|5771610|P2|COMPLETED|Washout , 3 to 7 Days||35
2351889|NCT01659853|5771611|P1|COMPLETED|Washout , 3 to 7 Days||33
2351890|NCT01659853|5771610|P2|STARTED|Washout , 3 to 7 Days||35
2351891|NCT01659853|5771611|P1|STARTED|Washout , 3 to 7 Days||35
2351892|NCT01659853|5771610|P2|NOT COMPLETED|Treatment Period 1||0
2351893|NCT01659853|5771611|P1|NOT COMPLETED|Treatment Period 1||0
2351894|NCT01659853|5771610|P2|COMPLETED|Treatment Period 1||35
2351895|NCT01659853|5771611|P1|COMPLETED|Treatment Period 1||35
2351896|NCT01659853|5771610|P2|STARTED|Treatment Period 1||35
2351897|NCT01659853|5771611|P1|STARTED|Treatment Period 1||35
2351898|NCT01659736|5771621|P2|NOT COMPLETED|3-month Follow-up||1
2351899|NCT01659736|5771622|P1|NOT COMPLETED|3-month Follow-up||0
2351900|NCT01659736|5771621|P2|COMPLETED|3-month Follow-up||9
2351901|NCT01659736|5771622|P1|COMPLETED|3-month Follow-up||9
2351902|NCT01659736|5771621|P2|STARTED|3-month Follow-up||10
2351903|NCT01659736|5771622|P1|STARTED|3-month Follow-up||9
2351904|NCT01659736|5771621|P2|NOT COMPLETED|Treatment Period||2
2351905|NCT01659736|5771622|P1|NOT COMPLETED|Treatment Period||5
2351906|NCT01659736|5771621|P2|COMPLETED|Treatment Period||10
2351907|NCT01659736|5771622|P1|COMPLETED|Treatment Period|n = 10, but data from one completer was excluded from all analyses due to protocol violation.|9
2351908|NCT01659736|5771621|P2|STARTED|Treatment Period||12
2351909|NCT01659736|5771622|P1|STARTED|Treatment Period||14
2351910|NCT01659567|5771636|P1|NOT COMPLETED|Overall Study||123
2351911|NCT01659567|5771636|P1|COMPLETED|Overall Study||393
2351912|NCT01659567|5771636|P1|STARTED|Overall Study||516
2351913|NCT01659554|5771653|P1|NOT COMPLETED|Overall Study||4
2351914|NCT01659554|5771653|P1|COMPLETED|Overall Study||0
2351915|NCT01659554|5771653|P1|STARTED|Overall Study|4 subjects enrolled; 4 subjects treated and 4 did not complete protocol schema|4
2351916|NCT01659320|5771660|P1|NOT COMPLETED|Overall Study||3
2351917|NCT01659320|5771660|P1|COMPLETED|Overall Study||13
2351918|NCT01659320|5771660|P1|STARTED|Overall Study||16
2351919|NCT01659268|5771666|P2|NOT COMPLETED|Overall Study||0
2351920|NCT01659268|5771667|P1|NOT COMPLETED|Overall Study||0
2351921|NCT01659268|5771666|P2|COMPLETED|Overall Study||8
2351922|NCT01659268|5771667|P1|COMPLETED|Overall Study||9
2351923|NCT01659268|5771666|P2|STARTED|Overall Study||8
2351924|NCT01659268|5771667|P1|STARTED|Overall Study||9
2351925|NCT01659125|5771679|P1|NOT COMPLETED|Overall Study||14
2351926|NCT01659125|5771679|P1|COMPLETED|Overall Study||12
2351927|NCT01659125|5771679|P1|Completed 6-month Follow-up|Overall Study||12
2351928|NCT01659125|5771679|P1|Completed 3-month Follow-up|Overall Study||16
2351929|NCT01659125|5771679|P1|Completed the Posttreatment Assessment|Overall Study||17
2351930|NCT01659125|5771679|P1|Initiated Treatment|Overall Study||24
2351931|NCT01659125|5771679|P1|STARTED|Overall Study||26
2351932|NCT01659021|5771686|P2|NOT COMPLETED|Long-Term Follow Up||4
2351933|NCT01659021|5771687|P1|NOT COMPLETED|Long-Term Follow Up||5
2351934|NCT01659021|5771686|P2|COMPLETED|Long-Term Follow Up||65
2351935|NCT01659021|5771687|P1|COMPLETED|Long-Term Follow Up||133
2351936|NCT01659021|5771686|P2|STARTED|Long-Term Follow Up|Participants did not have to complete the main study to enter the Long-Term Follow Up period.|69
2351937|NCT01659021|5771687|P1|STARTED|Long-Term Follow Up|Participants did not have to complete the main study to enter the Long-Term Follow Up period.|138
2351938|NCT01659021|5771686|P2|NOT COMPLETED|Main Study||37
2351939|NCT01659021|5771687|P1|NOT COMPLETED|Main Study||74
2351940|NCT01659021|5771686|P2|COMPLETED|Main Study||50
2351941|NCT01659021|5771687|P1|COMPLETED|Main Study||100
2351942|NCT01659021|5771686|P2|Randomized and Treated|Main Study||86
2351943|NCT01659021|5771687|P1|Randomized and Treated|Main Study||173
2351944|NCT01659021|5771686|P2|STARTED|Main Study||87
2351945|NCT01659021|5771687|P1|STARTED|Main Study||174
2351946|NCT01658943|5771705|P2|NOT COMPLETED|Overall Study||67
2351947|NCT01658943|5771706|P1|NOT COMPLETED|Overall Study||70
2351948|NCT01658943|5771705|P2|COMPLETED|Overall Study||0
2351949|NCT01658943|5771706|P1|COMPLETED|Overall Study||0
2351950|NCT01658943|5771705|P2|Eligible and Began Protocol Therapy|Overall Study||58
2351951|NCT01658943|5771706|P1|Eligible and Began Protocol Therapy|Overall Study||62
2351952|NCT01658943|5771705|P2|Eligible|Overall Study||58
2351953|NCT01658943|5771706|P1|Eligible|Overall Study||63
2351954|NCT01658943|5771705|P2|STARTED|Overall Study||67
2351955|NCT01658943|5771706|P1|STARTED|Overall Study||70
2351956|NCT01658904|5771721|P3|NOT COMPLETED|Overall Study||0
2351957|NCT01658904|5771722|P2|NOT COMPLETED|Overall Study||0
2351958|NCT01658904|5771723|P1|NOT COMPLETED|Overall Study||2
2351959|NCT01658904|5771721|P3|COMPLETED|Overall Study||0
2351960|NCT01658904|5771722|P2|COMPLETED|Overall Study||0
2351961|NCT01658904|5771723|P1|COMPLETED|Overall Study||1
2351962|NCT01658904|5771721|P3|STARTED|Overall Study||0
2351963|NCT01658904|5771722|P2|STARTED|Overall Study||0
2351964|NCT01658904|5771723|P1|STARTED|Overall Study||3
2351965|NCT01658839|5771740|P1|NOT COMPLETED|Overall Study||0
2351966|NCT01658839|5771740|P1|COMPLETED|Overall Study||25
2351967|NCT01658839|5771740|P1|STARTED|Overall Study||25
2351968|NCT01658813|5771749|P1|NOT COMPLETED|Overall Study||3
2351969|NCT01658813|5771749|P1|COMPLETED|Overall Study||15
2351970|NCT01658813|5771749|P1|Treated|Overall Study||18
2351971|NCT01658813|5771749|P1|Eligible|Overall Study||18
2351972|NCT01658813|5771749|P1|STARTED|Overall Study||18
2351973|NCT01658735|5771760|P3|NOT COMPLETED|Overall Study||4
2351974|NCT01658735|5771761|P2|NOT COMPLETED|Overall Study||7
2351975|NCT01658735|5771762|P1|NOT COMPLETED|Overall Study||5
2351976|NCT01658735|5771760|P3|COMPLETED|Overall Study||34
2351977|NCT01658735|5771761|P2|COMPLETED|Overall Study||29
2351978|NCT01658735|5771762|P1|COMPLETED|Overall Study||34
2351979|NCT01658735|5771760|P3|STARTED|Overall Study||38
2351980|NCT01658735|5771761|P2|STARTED|Overall Study||36
2351981|NCT01658735|5771762|P1|STARTED|Overall Study||39
2351982|NCT01658657|5771793|P2|NOT COMPLETED|Overall Study||3
2351983|NCT01658657|5771794|P1|NOT COMPLETED|Overall Study||3
2351984|NCT01658657|5771793|P2|COMPLETED|Overall Study||7
2351985|NCT01658657|5771794|P1|COMPLETED|Overall Study||4
2351986|NCT01658657|5771793|P2|STARTED|Overall Study||10
2351987|NCT01658657|5771794|P1|STARTED|Overall Study||7
2351988|NCT01658579|5771804|P4|NOT COMPLETED|Treatment Period B||1
2351989|NCT01658579|5771805|P3|NOT COMPLETED|Treatment Period B||0
2351990|NCT01658579|5771806|P2|NOT COMPLETED|Treatment Period B||0
2351991|NCT01658579|5771807|P1|NOT COMPLETED|Treatment Period B||0
2351992|NCT01658579|5771804|P4|COMPLETED|Treatment Period B||12
2351993|NCT01658579|5771805|P3|COMPLETED|Treatment Period B||14
2351994|NCT01658579|5771806|P2|COMPLETED|Treatment Period B||15
2351995|NCT01658579|5771807|P1|COMPLETED|Treatment Period B||14
2351996|NCT01658579|5771804|P4|STARTED|Treatment Period B||13
2351997|NCT01658579|5771805|P3|STARTED|Treatment Period B||14
2351998|NCT01658579|5771806|P2|STARTED|Treatment Period B||15
2351999|NCT01658579|5771807|P1|STARTED|Treatment Period B||14
2352000|NCT01658579|5771804|P4|NOT COMPLETED|Treatment Period A||1
2352001|NCT01658579|5771805|P3|NOT COMPLETED|Treatment Period A||1
2352002|NCT01658579|5771806|P2|NOT COMPLETED|Treatment Period A||0
2352003|NCT01658579|5771807|P1|NOT COMPLETED|Treatment Period A||1
2352004|NCT01658579|5771804|P4|COMPLETED|Treatment Period A||13
2352005|NCT01658579|5771805|P3|COMPLETED|Treatment Period A||14
2352006|NCT01658579|5771806|P2|COMPLETED|Treatment Period A||15
2352007|NCT01658579|5771807|P1|COMPLETED|Treatment Period A||14
2352008|NCT01658579|5771804|P4|STARTED|Treatment Period A||14
2352009|NCT01658579|5771805|P3|STARTED|Treatment Period A||15
2352010|NCT01658579|5771806|P2|STARTED|Treatment Period A||15
2352011|NCT01658579|5771807|P1|STARTED|Treatment Period A||15
2352012|NCT01658514|5771835|P3|NOT COMPLETED|Overall Study||2
2352013|NCT01658514|5771836|P2|NOT COMPLETED|Overall Study||0
2352014|NCT01658514|5771837|P1|NOT COMPLETED|Overall Study||1
2352015|NCT01658514|5771835|P3|COMPLETED|Overall Study||12
2352016|NCT01658514|5771836|P2|COMPLETED|Overall Study||11
2352017|NCT01658514|5771837|P1|COMPLETED|Overall Study||13
2352018|NCT01658514|5771835|P3|Completed - Severe RI Cohort Only|Overall Study||3
2352019|NCT01658514|5771836|P2|Completed - Severe RI Cohort Only|Overall Study||2
2352020|NCT01658514|5771837|P1|Completed - Severe RI Cohort Only|Overall Study||3
2352021|NCT01658514|5771835|P3|Started - Severe RI Cohort Only|Overall Study||3
2352022|NCT01658514|5771836|P2|Started - Severe RI Cohort Only|Overall Study||2
2352023|NCT01658514|5771837|P1|Started - Severe RI Cohort Only|Overall Study||3
2352024|NCT01658514|5771835|P3|Completed - Moderate RI Cohort Only|Overall Study||2
2352025|NCT01658514|5771836|P2|Completed - Moderate RI Cohort Only|Overall Study||4
2352026|NCT01658514|5771837|P1|Completed - Moderate RI Cohort Only|Overall Study||3
2352027|NCT01658514|5771835|P3|Started - Moderate RI Cohort Only|Overall Study||4
2352028|NCT01658514|5771836|P2|Started - Moderate RI Cohort Only|Overall Study||4
2352029|NCT01658514|5771837|P1|Started - Moderate RI Cohort Only|Overall Study||4
2352030|NCT01658514|5771835|P3|Completed - Mild RI Cohort Only|Overall Study||4
2352031|NCT01658514|5771836|P2|Completed - Mild RI Cohort Only|Overall Study||3
2352032|NCT01658514|5771837|P1|Completed - Mild RI Cohort Only|Overall Study||4
2352033|NCT01658514|5771835|P3|Started - Mild RI Cohort Only|Overall Study||4
2352034|NCT01658514|5771836|P2|Started - Mild RI Cohort Only|Overall Study||3
2352035|NCT01658514|5771837|P1|Started - Mild RI Cohort Only|Overall Study||4
2352036|NCT01658514|5771835|P3|Completed - Normal RF Cohort Only|Overall Study||3
2352037|NCT01658514|5771836|P2|Completed - Normal RF Cohort Only|Overall Study||2
2352038|NCT01658514|5771837|P1|Completed - Normal RF Cohort Only|Overall Study||3
2352039|NCT01658514|5771835|P3|Started - Normal RF Cohort Only|Overall Study||3
2352040|NCT01658514|5771836|P2|Started - Normal RF Cohort Only|Overall Study||2
2352041|NCT01658514|5771837|P1|Started - Normal RF Cohort Only|Overall Study||3
2352042|NCT01658514|5771835|P3|Completed Treatment C|Overall Study||12
2352043|NCT01658514|5771836|P2|Completed Treatment C|Overall Study||11
2352044|NCT01658514|5771837|P1|Completed Treatment C|Overall Study||13
2352045|NCT01658514|5771835|P3|Completed Treatment B|Overall Study||14
2352046|NCT01658514|5771836|P2|Completed Treatment B|Overall Study||11
2352047|NCT01658514|5771837|P1|Completed Treatment B|Overall Study||13
2352048|NCT01658514|5771835|P3|Completed Treatment A|Overall Study||12
2352049|NCT01658514|5771836|P2|Completed Treatment A|Overall Study||11
2352050|NCT01658514|5771837|P1|Completed Treatment A|Overall Study||14
2352051|NCT01658514|5771835|P3|STARTED|Overall Study||14
2352052|NCT01658514|5771836|P2|STARTED|Overall Study||11
2352053|NCT01658514|5771837|P1|STARTED|Overall Study||14
2352054|NCT01658436|5771848|P2|NOT COMPLETED|Overall Study||11
2352055|NCT01658436|5771849|P1|NOT COMPLETED|Overall Study||20
2352056|NCT01658436|5771848|P2|COMPLETED|Overall Study||0
2352057|NCT01658436|5771849|P1|COMPLETED|Overall Study||0
2352058|NCT01658436|5771848|P2|STARTED|Overall Study||11
2352059|NCT01658436|5771849|P1|STARTED|Overall Study||20
2352060|NCT01658228|5771858|P2|NOT COMPLETED|Overall Study||8
2352061|NCT01658228|5771859|P1|NOT COMPLETED|Overall Study||7
2352062|NCT01658228|5771858|P2|COMPLETED|Overall Study||23
2352063|NCT01658228|5771859|P1|COMPLETED|Overall Study||23
2352064|NCT01658228|5771858|P2|STARTED|Overall Study||31
2352065|NCT01658228|5771859|P1|STARTED|Overall Study||30
2352066|NCT01658150|5771869|P1|NOT COMPLETED|Overall Study||1
2352067|NCT01658150|5771869|P1|COMPLETED|Overall Study||10
2352068|NCT01658150|5771869|P1|STARTED|Overall Study||11
2352069|NCT01658072|5771891|P2|NOT COMPLETED|Overall Study||2
2352070|NCT01658072|5771892|P1|NOT COMPLETED|Overall Study||4
2352071|NCT01658072|5771891|P2|COMPLETED|Overall Study||43
2352072|NCT01658072|5771892|P1|COMPLETED|Overall Study||41
2352073|NCT01658072|5771891|P2|STARTED|Overall Study||45
2352074|NCT01658072|5771892|P1|STARTED|Overall Study||45
2352075|NCT01658059|5771898|P2|NOT COMPLETED|Second Intervention- 2 Days||0
2352076|NCT01658059|5771899|P1|NOT COMPLETED|Second Intervention- 2 Days||0
2352077|NCT01658059|5771898|P2|COMPLETED|Second Intervention- 2 Days||5
2352078|NCT01658059|5771899|P1|COMPLETED|Second Intervention- 2 Days||6
2352079|NCT01658059|5771898|P2|STARTED|Second Intervention- 2 Days||5
2352080|NCT01658059|5771899|P1|STARTED|Second Intervention- 2 Days||6
2352081|NCT01658059|5771898|P2|NOT COMPLETED|Washout Period- 14 Days||0
2352082|NCT01658059|5771899|P1|NOT COMPLETED|Washout Period- 14 Days||0
2352083|NCT01658059|5771898|P2|COMPLETED|Washout Period- 14 Days||5
2352084|NCT01658059|5771899|P1|COMPLETED|Washout Period- 14 Days||6
2352085|NCT01658059|5771898|P2|STARTED|Washout Period- 14 Days||5
2352086|NCT01658059|5771899|P1|STARTED|Washout Period- 14 Days||6
2352087|NCT01658059|5771898|P2|NOT COMPLETED|First Intervention- 2 Days||5
2352088|NCT01658059|5771899|P1|NOT COMPLETED|First Intervention- 2 Days||6
2352089|NCT01658059|5771898|P2|COMPLETED|First Intervention- 2 Days||5
2352090|NCT01658059|5771899|P1|COMPLETED|First Intervention- 2 Days||6
2352091|NCT01658059|5771898|P2|STARTED|First Intervention- 2 Days||10
2352092|NCT01658059|5771899|P1|STARTED|First Intervention- 2 Days||12
2352093|NCT01658020|5771907|P2|NOT COMPLETED|Overall Study||9
2352094|NCT01658020|5771908|P1|NOT COMPLETED|Overall Study||8
2352095|NCT01658020|5771907|P2|COMPLETED|Overall Study||158
2352096|NCT01658020|5771908|P1|COMPLETED|Overall Study||167
2352097|NCT01658020|5771907|P2|STARTED|Overall Study||167
2352098|NCT01658020|5771908|P1|STARTED|Overall Study||175
2352099|NCT01657903|5771924|P1|NOT COMPLETED|Overall Study||2
2352100|NCT01657903|5771924|P1|COMPLETED|Overall Study||54
2352101|NCT01657903|5771924|P1|Received NaF/KNO3 Toothpaste 2|Overall Study||55
2352102|NCT01657903|5771924|P1|Received NaF/KNO3 Toothpaste 3|Overall Study||54
2352103|NCT01657903|5771924|P1|Received NaF/KNO3 Toothpaste 1|Overall Study|One participant withdrew consent in study period 3|55
2352104|NCT01657903|5771924|P1|Received Placebo (No NaF/KNO3)Toothpaste|Overall Study|One participant was lost to follow up in study period 1|56
2352105|NCT01657903|5771924|P1|STARTED|Overall Study||56
2352106|NCT01657877|5771946|P1|NOT COMPLETED|Overall Study||14
2352107|NCT01657877|5771946|P1|COMPLETED|Overall Study||65
2352108|NCT01657877|5771946|P1|Received 1500ppm Fluoride as SMFP+0% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and 1 withdrawal of consent and AE in P3|71
2352109|NCT01657877|5771946|P1|Received 0ppm Fluoride+ 0% CSP|Overall Study|Discontinuation: 1 in P4 due to other reasons|69
2352110|NCT01657877|5771946|P1|Received 0ppm Fluoride+ 5% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and P2 each and 1 withdrawal of consent in P1.|71
2352111|NCT01657877|5771946|P1|Received 1500ppm Fluoride as SMFP+5% CSP|Overall Study|Discontinuations:2 withdrawal of consent in period (P) 1; 1 AE in P2;1 protocol violation in P3 & P4|75
2352112|NCT01657877|5771946|P1|Received 500ppm Fluoride as SMFP+ 0% CSP|Overall Study|Discontinuations: 1 due to other reason in P2 and 1 protocol violation in P4|70
2352113|NCT01657877|5771946|P1|STARTED|Overall Study||79
2352114|NCT01657799|5771966|P3|NOT COMPLETED|Overall Study||102
2352115|NCT01657799|5771967|P2|NOT COMPLETED|Overall Study||103
2352116|NCT01657799|5771968|P1|NOT COMPLETED|Overall Study||102
2352117|NCT01657799|5771966|P3|COMPLETED|Overall Study||0
2352118|NCT01657799|5771967|P2|COMPLETED|Overall Study||0
2352119|NCT01657799|5771968|P1|COMPLETED|Overall Study||0
2352120|NCT01657799|5771966|P3|Received Treatment|Overall Study||102
2352121|NCT01657799|5771967|P2|Received Treatment|Overall Study||103
2352122|NCT01657799|5771968|P1|Received Treatment|Overall Study||101
2352123|NCT01657799|5771966|P3|STARTED|Overall Study||102
2352124|NCT01657799|5771967|P2|STARTED|Overall Study||103
2352125|NCT01657799|5771968|P1|STARTED|Overall Study||102
2352126|NCT01657760|5771987|P4|NOT COMPLETED|Overall Study||3
2352127|NCT01657760|5771988|P3|NOT COMPLETED|Overall Study||1
2352128|NCT01657760|5771989|P2|NOT COMPLETED|Overall Study||1
2352129|NCT01657760|5771990|P1|NOT COMPLETED|Overall Study||1
2352130|NCT01657760|5771987|P4|COMPLETED|Overall Study||4
2352131|NCT01657760|5771988|P3|COMPLETED|Overall Study||6
2352132|NCT01657760|5771989|P2|COMPLETED|Overall Study||6
2352133|NCT01657760|5771990|P1|COMPLETED|Overall Study||4
2352134|NCT01657760|5771987|P4|STARTED|Overall Study||7
2352135|NCT01657760|5771988|P3|STARTED|Overall Study||7
2352136|NCT01657760|5771989|P2|STARTED|Overall Study||7
2352137|NCT01657760|5771990|P1|STARTED|Overall Study||5
2352138|NCT01657617|5772002|P1|NOT COMPLETED|Overall Study||0
2352139|NCT01657617|5772002|P1|COMPLETED|Overall Study||35
2352140|NCT01657617|5772002|P1|STARTED|Overall Study||35
2352141|NCT01657461|5772009|P2|NOT COMPLETED|Overall Study||20
2352142|NCT01657461|5772010|P1|NOT COMPLETED|Overall Study||10
2352143|NCT01657461|5772009|P2|COMPLETED|Overall Study||78
2352144|NCT01657461|5772010|P1|COMPLETED|Overall Study||88
2352145|NCT01657461|5772009|P2|STARTED|Overall Study||98
2352146|NCT01657461|5772010|P1|STARTED|Overall Study||98
2352147|NCT01657370|5772040|P6|NOT COMPLETED|Overall Study||4
2352148|NCT01657370|5772041|P5|NOT COMPLETED|Overall Study||7
2352149|NCT01657370|5772042|P4|NOT COMPLETED|Overall Study||5
2352150|NCT01657370|5772043|P3|NOT COMPLETED|Overall Study||7
2352151|NCT01657370|5772044|P2|NOT COMPLETED|Overall Study||4
2352152|NCT01657370|5772045|P1|NOT COMPLETED|Overall Study||6
2352153|NCT01657370|5772040|P6|COMPLETED|Overall Study||27
2352154|NCT01657370|5772041|P5|COMPLETED|Overall Study||27
2352155|NCT01657370|5772042|P4|COMPLETED|Overall Study||28
2352156|NCT01657370|5772043|P3|COMPLETED|Overall Study||25
2352157|NCT01657370|5772044|P2|COMPLETED|Overall Study||28
2352158|NCT01657370|5772045|P1|COMPLETED|Overall Study||27
2352159|NCT01657370|5772040|P6|STARTED|Overall Study||31
2352160|NCT01657370|5772041|P5|STARTED|Overall Study||34
2352161|NCT01657370|5772042|P4|STARTED|Overall Study||33
2352162|NCT01657370|5772043|P3|STARTED|Overall Study||32
2352163|NCT01657370|5772044|P2|STARTED|Overall Study||32
2352164|NCT01657370|5772045|P1|STARTED|Overall Study||33
2352165|NCT01657344|5772127|P7|NOT COMPLETED|Overall Study||0
2352166|NCT01657344|5772128|P6|NOT COMPLETED|Overall Study||0
2352167|NCT01657344|5772129|P5|NOT COMPLETED|Overall Study||0
2352168|NCT01657344|5772130|P4|NOT COMPLETED|Overall Study||0
2352169|NCT01657344|5772131|P3|NOT COMPLETED|Overall Study||0
2352170|NCT01657344|5772132|P2|NOT COMPLETED|Overall Study||0
2352171|NCT01657344|5772133|P1|NOT COMPLETED|Overall Study||0
2352172|NCT01657344|5772127|P7|COMPLETED|Overall Study||140776
2352173|NCT01657344|5772128|P6|COMPLETED|Overall Study||316477
2352174|NCT01657344|5772129|P5|COMPLETED|Overall Study||157802
2352175|NCT01657344|5772130|P4|COMPLETED|Overall Study||376517
2352176|NCT01657344|5772131|P3|COMPLETED|Overall Study||196300
2352177|NCT01657344|5772132|P2|COMPLETED|Overall Study||409967
2352178|NCT01657344|5772133|P1|COMPLETED|Overall Study||421622
2352179|NCT01657344|5772127|P7|STARTED|Overall Study||140776
2352180|NCT01657344|5772128|P6|STARTED|Overall Study||316477
2352181|NCT01657344|5772129|P5|STARTED|Overall Study||157802
2352182|NCT01657344|5772130|P4|STARTED|Overall Study||376517
2352183|NCT01657344|5772131|P3|STARTED|Overall Study||196300
2352184|NCT01657344|5772132|P2|STARTED|Overall Study||409967
2352185|NCT01657344|5772133|P1|STARTED|Overall Study||421622
2352186|NCT01657305|5772143|P1|NOT COMPLETED|Overall Study||25
2352187|NCT01657305|5772143|P1|COMPLETED|Overall Study||82
2352188|NCT01657305|5772143|P1|STARTED|Overall Study||107
2352189|NCT01657292|5772193|P1|NOT COMPLETED|Overall Study||10
2352190|NCT01657292|5772193|P1|COMPLETED|Overall Study||51
2352191|NCT01657292|5772193|P1|STARTED|Overall Study||61
2352192|NCT01657266|5772202|P2|NOT COMPLETED|Overall Study||5
2352193|NCT01657266|5772203|P1|NOT COMPLETED|Overall Study||4
2352194|NCT01657266|5772202|P2|COMPLETED|Overall Study||70
2352195|NCT01657266|5772203|P1|COMPLETED|Overall Study||69
2352196|NCT01657266|5772202|P2|STARTED|Overall Study||75
2352197|NCT01657266|5772203|P1|STARTED|Overall Study||73
2352198|NCT01657253|5772225|P2|NOT COMPLETED|Overall Study||18
2352199|NCT01657253|5772226|P1|NOT COMPLETED|Overall Study||17
2352200|NCT01657253|5772225|P2|COMPLETED|Overall Study||72
2352201|NCT01657253|5772226|P1|COMPLETED|Overall Study||76
2352202|NCT01657253|5772225|P2|STARTED|Overall Study||90
2352203|NCT01657253|5772226|P1|STARTED|Overall Study||93
2352204|NCT01657032|5772238|P2|NOT COMPLETED|Overall Study||7
2352205|NCT01657032|5772239|P1|NOT COMPLETED|Overall Study||0
2352206|NCT01657032|5772238|P2|COMPLETED|Overall Study||37
2352207|NCT01657032|5772239|P1|COMPLETED|Overall Study||44
2352208|NCT01657032|5772238|P2|STARTED|Overall Study||44
2352209|NCT01657032|5772239|P1|STARTED|Overall Study||44
2352210|NCT01657019|5772265|P1|NOT COMPLETED|Overall Study||235
2352211|NCT01657019|5772265|P1|COMPLETED|Overall Study||369
2352212|NCT01657019|5772265|P1|STARTED|Overall Study||604
2352213|NCT01656967|5772279|P2|NOT COMPLETED|Overall Study||2
2352214|NCT01656967|5772280|P1|NOT COMPLETED|Overall Study||4
2352215|NCT01656967|5772279|P2|COMPLETED|Overall Study||31
2352216|NCT01656967|5772280|P1|COMPLETED|Overall Study||29
2352217|NCT01656967|5772279|P2|ETT Insertion|Overall Study||31
2352218|NCT01656967|5772280|P1|ETT Insertion|Overall Study||29
2352219|NCT01656967|5772279|P2|SGA Placement|Overall Study||33
2352220|NCT01656967|5772280|P1|SGA Placement|Overall Study||32
2352221|NCT01656967|5772279|P2|STARTED|Overall Study||33
2352222|NCT01656967|5772280|P1|STARTED|Overall Study||33
2352223|NCT01656889|5772306|P2|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||9
2352224|NCT01656889|5772307|P1|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||4
2352225|NCT01656889|5772306|P2|COMPLETED|Post Treatment Follow-Up, 3 Months||204
2352226|NCT01656889|5772307|P1|COMPLETED|Post Treatment Follow-Up, 3 Months||206
2352227|NCT01656889|5772306|P2|STARTED|Post Treatment Follow-Up, 3 Months||213
2352228|NCT01656889|5772307|P1|STARTED|Post Treatment Follow-Up, 3 Months||210
2352229|NCT01656889|5772306|P2|NOT COMPLETED|Treatment Period, 12 Weeks||11
2352230|NCT01656889|5772307|P1|NOT COMPLETED|Treatment Period, 12 Weeks||12
2352231|NCT01656889|5772306|P2|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|214
2352232|NCT01656889|5772307|P1|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|210
2352233|NCT01656889|5772306|P2|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|225
2352234|NCT01656889|5772307|P1|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|222
2352235|NCT01656850|5772327|P2|NOT COMPLETED|Second Intervention (3 Months)||0
2352236|NCT01656850|5772328|P1|NOT COMPLETED|Second Intervention (3 Months)||0
2352237|NCT01656850|5772327|P2|COMPLETED|Second Intervention (3 Months)||16
2352238|NCT01656850|5772328|P1|COMPLETED|Second Intervention (3 Months)||17
2352239|NCT01656850|5772327|P2|STARTED|Second Intervention (3 Months)||16
2352240|NCT01656850|5772328|P1|STARTED|Second Intervention (3 Months)||17
2352241|NCT01656850|5772327|P2|NOT COMPLETED|Washout (2 Weeks)||0
2352242|NCT01656850|5772328|P1|NOT COMPLETED|Washout (2 Weeks)||0
2352243|NCT01656850|5772327|P2|COMPLETED|Washout (2 Weeks)||16
2352244|NCT01656850|5772328|P1|COMPLETED|Washout (2 Weeks)||17
2352245|NCT01656850|5772327|P2|STARTED|Washout (2 Weeks)||16
2352246|NCT01656850|5772328|P1|STARTED|Washout (2 Weeks)||17
2352247|NCT01656850|5772327|P2|NOT COMPLETED|First Intervention (3 Months)||4
2352248|NCT01656850|5772328|P1|NOT COMPLETED|First Intervention (3 Months)||3
2352249|NCT01656850|5772327|P2|COMPLETED|First Intervention (3 Months)||16
2352250|NCT01656850|5772328|P1|COMPLETED|First Intervention (3 Months)||17
2352251|NCT01656850|5772327|P2|STARTED|First Intervention (3 Months)||20
2352252|NCT01656850|5772328|P1|STARTED|First Intervention (3 Months)||20
2352253|NCT01656772|5772408|P2|NOT COMPLETED|Overall Study||0
2352254|NCT01656772|5772409|P1|NOT COMPLETED|Overall Study||0
2352255|NCT01656772|5772408|P2|COMPLETED|Overall Study||77
2352256|NCT01656772|5772409|P1|COMPLETED|Overall Study||43
2352257|NCT01656772|5772408|P2|STARTED|Overall Study||77
2352258|NCT01656772|5772409|P1|STARTED|Overall Study||43
2352259|NCT01656759|5772419|P2|NOT COMPLETED|Overall Study||3
2352260|NCT01656759|5772420|P1|NOT COMPLETED|Overall Study||2
2352261|NCT01656759|5772419|P2|COMPLETED|Overall Study||22
2352262|NCT01656759|5772420|P1|COMPLETED|Overall Study||25
2352263|NCT01656759|5772419|P2|STARTED|Overall Study||25
2352264|NCT01656759|5772420|P1|STARTED|Overall Study||27
2352265|NCT01656733|5772434|P2|NOT COMPLETED|Overall Study||4
2352266|NCT01656733|5772435|P1|NOT COMPLETED|Overall Study||0
2352267|NCT01656733|5772434|P2|COMPLETED|Overall Study||66
2352268|NCT01656733|5772435|P1|COMPLETED|Overall Study||67
2352269|NCT01656733|5772434|P2|Visit 8 (6 Months Postpartum)|Overall Study||28
2352270|NCT01656733|5772435|P1|Visit 8 (6 Months Postpartum)|Overall Study||30
2352271|NCT01656733|5772434|P2|Visit 7 (1 Month Postpartum) Phone Call|Overall Study||50
2352272|NCT01656733|5772435|P1|Visit 7 (1 Month Postpartum) Phone Call|Overall Study||47
2352273|NCT01656733|5772434|P2|Participants With Perinatal Outcomes|Overall Study||66
2352274|NCT01656733|5772435|P1|Participants With Perinatal Outcomes|Overall Study||67
2352275|NCT01656733|5772434|P2|Visit 6 ( 32-36 Weeks Gestation)|Overall Study||47
2352276|NCT01656733|5772435|P1|Visit 6 ( 32-36 Weeks Gestation)|Overall Study||39
2352277|NCT01656733|5772434|P2|Visit 5 (6 Weeks After Quit Date)|Overall Study||36
2352278|NCT01656733|5772435|P1|Visit 5 (6 Weeks After Quit Date)|Overall Study||37
2352279|NCT01656733|5772434|P2|Visit 4 (4 Weeks After Quit Date)|Overall Study||30
2352280|NCT01656733|5772435|P1|Visit 4 (4 Weeks After Quit Date)|Overall Study||32
2352281|NCT01656733|5772434|P2|Visit 3 (3 Weeks After Quit Date)|Overall Study||34
2352282|NCT01656733|5772435|P1|Visit 3 (3 Weeks After Quit Date)|Overall Study||33
2352283|NCT01656733|5772434|P2|Visit 2 (2 Weeks After Quit Date)|Overall Study||44
2352284|NCT01656733|5772435|P1|Visit 2 (2 Weeks After Quit Date)|Overall Study||32
2352285|NCT01656733|5772434|P2|Visit 1 (1 Week After Quit Date)|Overall Study||42
2352286|NCT01656733|5772435|P1|Visit 1 (1 Week After Quit Date)|Overall Study||45
2352287|NCT01656733|5772434|P2|STARTED|Overall Study|5 discontinued after BL visit ( lost to follow up)|70
2352288|NCT01656733|5772435|P1|STARTED|Overall Study|4 discontinued after BL visit (lost to follow up)|67
2352289|NCT01656629|5772450|P3|NOT COMPLETED|Overall Study||2
2352290|NCT01656629|5772451|P2|NOT COMPLETED|Overall Study||2
2352291|NCT01656629|5772452|P1|NOT COMPLETED|Overall Study||5
2352292|NCT01656629|5772450|P3|COMPLETED|Overall Study||14
2352293|NCT01656629|5772451|P2|COMPLETED|Overall Study||16
2352294|NCT01656629|5772452|P1|COMPLETED|Overall Study||16
2352295|NCT01656629|5772450|P3|STARTED|Overall Study||16
2352296|NCT01656629|5772451|P2|STARTED|Overall Study||18
2352297|NCT01656629|5772452|P1|STARTED|Overall Study||21
2352298|NCT01656486|5772460|P1|NOT COMPLETED|Overall Study||0
2352299|NCT01656486|5772460|P1|COMPLETED|Overall Study||1
2352300|NCT01656486|5772460|P1|STARTED|Overall Study||1
2352301|NCT01656460|5772464|P4|NOT COMPLETED|Overall Study||0
2352302|NCT01656460|5772465|P3|NOT COMPLETED|Overall Study||0
2352303|NCT01656460|5772466|P2|NOT COMPLETED|Overall Study||0
2352304|NCT01656460|5772467|P1|NOT COMPLETED|Overall Study||0
2352305|NCT01656460|5772464|P4|COMPLETED|Overall Study||3
2352306|NCT01656460|5772465|P3|COMPLETED|Overall Study||3
2352307|NCT01656460|5772466|P2|COMPLETED|Overall Study||3
2352308|NCT01656460|5772467|P1|COMPLETED|Overall Study||3
2352309|NCT01656460|5772464|P4|STARTED|Overall Study||3
2352310|NCT01656460|5772465|P3|STARTED|Overall Study||3
2352311|NCT01656460|5772466|P2|STARTED|Overall Study||3
2352312|NCT01656460|5772467|P1|STARTED|Overall Study||3
2352313|NCT01656434|5772479|P2|NOT COMPLETED|Overall Study||580
2352314|NCT01656434|5772480|P1|NOT COMPLETED|Overall Study||2401
2352315|NCT01656434|5772479|P2|COMPLETED|Overall Study||40
2352316|NCT01656434|5772480|P1|COMPLETED|Overall Study||152
2352317|NCT01656434|5772479|P2|Treated|Overall Study||604
2352318|NCT01656434|5772480|P1|Treated|Overall Study|One treated participant had incomplete data and was not included in the Safety Analyses.|2466
2352319|NCT01656434|5772479|P2|STARTED|Overall Study||620
2352320|NCT01656434|5772480|P1|STARTED|Overall Study||2553
2352321|NCT01656408|5772506|P10|NOT COMPLETED|Overall Study||3
2352322|NCT01656408|5772507|P9|NOT COMPLETED|Overall Study||2
2352323|NCT01656408|5772508|P8|NOT COMPLETED|Overall Study||1
2352324|NCT01656408|5772509|P7|NOT COMPLETED|Overall Study||1
2352325|NCT01656408|5772510|P6|NOT COMPLETED|Overall Study||2
2352326|NCT01656408|5772511|P5|NOT COMPLETED|Overall Study||1
2352327|NCT01656408|5772512|P4|NOT COMPLETED|Overall Study||0
2352328|NCT01656408|5772513|P3|NOT COMPLETED|Overall Study||2
2352329|NCT01656408|5772514|P2|NOT COMPLETED|Overall Study||0
2352330|NCT01656408|5772515|P1|NOT COMPLETED|Overall Study||1
2352331|NCT01656408|5772506|P10|COMPLETED|Overall Study||15
2352332|NCT01656408|5772507|P9|COMPLETED|Overall Study||16
2352333|NCT01656408|5772508|P8|COMPLETED|Overall Study||7
2352334|NCT01656408|5772509|P7|COMPLETED|Overall Study||9
2352335|NCT01656408|5772510|P6|COMPLETED|Overall Study||7
2352336|NCT01656408|5772511|P5|COMPLETED|Overall Study||8
2352337|NCT01656408|5772512|P4|COMPLETED|Overall Study||7
2352338|NCT01656408|5772513|P3|COMPLETED|Overall Study||6
2352339|NCT01656408|5772514|P2|COMPLETED|Overall Study||8
2352340|NCT01656408|5772515|P1|COMPLETED|Overall Study||7
2352341|NCT01656408|5772506|P10|STARTED|Overall Study||18
2352342|NCT01656408|5772507|P9|STARTED|Overall Study||18
2352343|NCT01656408|5772508|P8|STARTED|Overall Study||8
2352344|NCT01656408|5772509|P7|STARTED|Overall Study||10
2352345|NCT01656408|5772510|P6|STARTED|Overall Study||9
2352346|NCT01656408|5772511|P5|STARTED|Overall Study||9
2352347|NCT01656408|5772512|P4|STARTED|Overall Study||7
2352348|NCT01656408|5772513|P3|STARTED|Overall Study||8
2352349|NCT01656408|5772514|P2|STARTED|Overall Study||8
2352350|NCT01656408|5772515|P1|STARTED|Overall Study||8
2352351|NCT01656395|5772710|P8|NOT COMPLETED|Overall Study||0
2352352|NCT01656395|5772711|P7|NOT COMPLETED|Overall Study||0
2352353|NCT01656395|5772712|P6|NOT COMPLETED|Overall Study||40
2352354|NCT01656395|5772713|P5|NOT COMPLETED|Overall Study||14
2352355|NCT01656395|5772714|P4|NOT COMPLETED|Overall Study||12
2352356|NCT01656395|5772715|P3|NOT COMPLETED|Overall Study||36
2352357|NCT01656395|5772716|P2|NOT COMPLETED|Overall Study||34
2352358|NCT01656395|5772717|P1|NOT COMPLETED|Overall Study||17
2352359|NCT01656395|5772710|P8|COMPLETED|Overall Study||0
2352360|NCT01656395|5772711|P7|COMPLETED|Overall Study||0
2352361|NCT01656395|5772712|P6|COMPLETED|Overall Study||94
2352362|NCT01656395|5772713|P5|COMPLETED|Overall Study||46
2352363|NCT01656395|5772714|P4|COMPLETED|Overall Study||41
2352364|NCT01656395|5772715|P3|COMPLETED|Overall Study||106
2352365|NCT01656395|5772716|P2|COMPLETED|Overall Study||93
2352366|NCT01656395|5772717|P1|COMPLETED|Overall Study||43
2352367|NCT01656395|5772710|P8|Treated Participants|Overall Study||0
2352368|NCT01656395|5772711|P7|Treated Participants|Overall Study||0
2352369|NCT01656395|5772712|P6|Treated Participants|Overall Study||126
2352370|NCT01656395|5772713|P5|Treated Participants|Overall Study||60
2352371|NCT01656395|5772714|P4|Treated Participants|Overall Study||52
2352372|NCT01656395|5772715|P3|Treated Participants|Overall Study||135
2352373|NCT01656395|5772716|P2|Treated Participants|Overall Study||126
2352374|NCT01656395|5772717|P1|Treated Participants|Overall Study||58
2352375|NCT01656395|5772710|P8|STARTED|Overall Study||0
2352376|NCT01656395|5772711|P7|STARTED|Overall Study||0
2352377|NCT01656395|5772712|P6|STARTED|Overall Study||134
2352378|NCT01656395|5772713|P5|STARTED|Overall Study||60
2352379|NCT01656395|5772714|P4|STARTED|Overall Study||53
2352380|NCT01656395|5772715|P3|STARTED|Overall Study||142
2352381|NCT01656395|5772716|P2|STARTED|Overall Study||127
2352382|NCT01656395|5772717|P1|STARTED|Overall Study||60
2352383|NCT01656304|5772803|P1|NOT COMPLETED|Overall Study||1
2352384|NCT01656304|5772803|P1|COMPLETED|Overall Study||15
2352385|NCT01656304|5772803|P1|STARTED|Overall Study||16
2352386|NCT01656252|5772812|P1|NOT COMPLETED|Phase II||0
2352387|NCT01656252|5772812|P1|COMPLETED|Phase II||0
2352388|NCT01656252|5772812|P1|STARTED|Phase II||0
2352389|NCT01656252|5772812|P1|NOT COMPLETED|Phase I||0
2352390|NCT01656252|5772812|P1|COMPLETED|Phase I||14
2352391|NCT01656252|5772812|P1|STARTED|Phase I||14
2352392|NCT01656200|5772844|P1|NOT COMPLETED|Overall Study||1
2352393|NCT01656200|5772844|P1|COMPLETED|Overall Study||16
2352394|NCT01656200|5772844|P1|STARTED|Overall Study||17
2352395|NCT01656187|5772852|P2|NOT COMPLETED|Second Intervention (24 Weeks)||3
2352396|NCT01656187|5772853|P1|NOT COMPLETED|Second Intervention (24 Weeks)||1
2352397|NCT01656187|5772852|P2|COMPLETED|Second Intervention (24 Weeks)||19
2352398|NCT01656187|5772853|P1|COMPLETED|Second Intervention (24 Weeks)||13
2352399|NCT01656187|5772852|P2|STARTED|Second Intervention (24 Weeks)||22
2352400|NCT01656187|5772853|P1|STARTED|Second Intervention (24 Weeks)||14
2352401|NCT01656187|5772852|P2|NOT COMPLETED|Washout (4 Weeks)||1
2352402|NCT01656187|5772853|P1|NOT COMPLETED|Washout (4 Weeks)||0
2352403|NCT01656187|5772852|P2|COMPLETED|Washout (4 Weeks)||22
2352404|NCT01656187|5772853|P1|COMPLETED|Washout (4 Weeks)||14
2352405|NCT01656187|5772852|P2|STARTED|Washout (4 Weeks)||23
2352406|NCT01656187|5772853|P1|STARTED|Washout (4 Weeks)||14
2352407|NCT01656187|5772852|P2|NOT COMPLETED|First Intervention (24 Weeks)||3
2352408|NCT01656187|5772853|P1|NOT COMPLETED|First Intervention (24 Weeks)||6
2352409|NCT01656187|5772852|P2|COMPLETED|First Intervention (24 Weeks)||23
2352410|NCT01656187|5772853|P1|COMPLETED|First Intervention (24 Weeks)||14
2352411|NCT01656187|5772852|P2|STARTED|First Intervention (24 Weeks)||26
2352412|NCT01656187|5772853|P1|STARTED|First Intervention (24 Weeks)||20
2352413|NCT01656161|5772859|P1|NOT COMPLETED|Overall Study||7
2352414|NCT01656161|5772859|P1|COMPLETED|Overall Study|Per protocol analysis set|113
2352415|NCT01656161|5772859|P1|Received Triptorelin at Day 169|Overall Study||115
2352416|NCT01656161|5772859|P1|Received Triptorelin at Day 1|Overall Study|Safety analysis set|120
2352417|NCT01656161|5772859|P1|STARTED|Overall Study|Intention to treat analysis set|120
2352418|NCT01656031|5772873|P1|NOT COMPLETED|Overall Study||0
2352419|NCT01656031|5772873|P1|COMPLETED|Overall Study||39
2352420|NCT01656031|5772873|P1|STARTED|Overall Study||39
2352421|NCT01655901|5772877|P6|NOT COMPLETED|Third Intervention (Hour 3)||0
2352422|NCT01655901|5772878|P5|NOT COMPLETED|Third Intervention (Hour 3)||1
2352423|NCT01655901|5772879|P4|NOT COMPLETED|Third Intervention (Hour 3)||0
2352424|NCT01655901|5772880|P3|NOT COMPLETED|Third Intervention (Hour 3)||1
2352425|NCT01655901|5772881|P2|NOT COMPLETED|Third Intervention (Hour 3)||1
2352426|NCT01655901|5772882|P1|NOT COMPLETED|Third Intervention (Hour 3)||1
2352427|NCT01655901|5772877|P6|COMPLETED|Third Intervention (Hour 3)||5
2352428|NCT01655901|5772878|P5|COMPLETED|Third Intervention (Hour 3)||4
2352429|NCT01655901|5772879|P4|COMPLETED|Third Intervention (Hour 3)||5
2352430|NCT01655901|5772880|P3|COMPLETED|Third Intervention (Hour 3)||4
2352431|NCT01655901|5772881|P2|COMPLETED|Third Intervention (Hour 3)||4
2352432|NCT01655901|5772882|P1|COMPLETED|Third Intervention (Hour 3)||4
2352433|NCT01655901|5772877|P6|STARTED|Third Intervention (Hour 3)||5
2352434|NCT01655901|5772878|P5|STARTED|Third Intervention (Hour 3)||5
2352435|NCT01655901|5772879|P4|STARTED|Third Intervention (Hour 3)||5
2352436|NCT01655901|5772880|P3|STARTED|Third Intervention (Hour 3)||5
2352437|NCT01655901|5772881|P2|STARTED|Third Intervention (Hour 3)||5
2352438|NCT01655901|5772882|P1|STARTED|Third Intervention (Hour 3)||5
2352439|NCT01655901|5772877|P6|NOT COMPLETED|Washout (1 Week)||0
2352440|NCT01655901|5772878|P5|NOT COMPLETED|Washout (1 Week)||0
2352441|NCT01655901|5772879|P4|NOT COMPLETED|Washout (1 Week)||0
2352442|NCT01655901|5772880|P3|NOT COMPLETED|Washout (1 Week)||0
2352443|NCT01655901|5772881|P2|NOT COMPLETED|Washout (1 Week)||0
2352444|NCT01655901|5772882|P1|NOT COMPLETED|Washout (1 Week)||0
2352445|NCT01655901|5772877|P6|COMPLETED|Washout (1 Week)||5
2352446|NCT01655901|5772878|P5|COMPLETED|Washout (1 Week)||5
2352447|NCT01655901|5772879|P4|COMPLETED|Washout (1 Week)||5
2352448|NCT01655901|5772880|P3|COMPLETED|Washout (1 Week)||5
2352449|NCT01655901|5772881|P2|COMPLETED|Washout (1 Week)||5
2352450|NCT01655901|5772882|P1|COMPLETED|Washout (1 Week)||5
2352451|NCT01655901|5772877|P6|STARTED|Washout (1 Week)||5
2352452|NCT01655901|5772878|P5|STARTED|Washout (1 Week)||5
2352453|NCT01655901|5772879|P4|STARTED|Washout (1 Week)||5
2352454|NCT01655901|5772880|P3|STARTED|Washout (1 Week)||5
2352455|NCT01655901|5772881|P2|STARTED|Washout (1 Week)||5
2352456|NCT01655901|5772882|P1|STARTED|Washout (1 Week)||5
2352457|NCT01655901|5772877|P6|NOT COMPLETED|Second Intervention (Hour 2)||0
2352458|NCT01655901|5772878|P5|NOT COMPLETED|Second Intervention (Hour 2)||0
2352459|NCT01655901|5772879|P4|NOT COMPLETED|Second Intervention (Hour 2)||0
2352460|NCT01655901|5772880|P3|NOT COMPLETED|Second Intervention (Hour 2)||0
2352461|NCT01655901|5772881|P2|NOT COMPLETED|Second Intervention (Hour 2)||0
2352462|NCT01655901|5772882|P1|NOT COMPLETED|Second Intervention (Hour 2)||0
2352463|NCT01655901|5772877|P6|COMPLETED|Second Intervention (Hour 2)||5
2352464|NCT01655901|5772878|P5|COMPLETED|Second Intervention (Hour 2)||5
2352465|NCT01655901|5772879|P4|COMPLETED|Second Intervention (Hour 2)||5
2352466|NCT01655901|5772880|P3|COMPLETED|Second Intervention (Hour 2)||5
2352467|NCT01655901|5772881|P2|COMPLETED|Second Intervention (Hour 2)||5
2352468|NCT01655901|5772882|P1|COMPLETED|Second Intervention (Hour 2)||5
2352469|NCT01655901|5772877|P6|STARTED|Second Intervention (Hour 2)||5
2352470|NCT01655901|5772878|P5|STARTED|Second Intervention (Hour 2)||5
2352471|NCT01655901|5772879|P4|STARTED|Second Intervention (Hour 2)||5
2352472|NCT01655901|5772880|P3|STARTED|Second Intervention (Hour 2)||5
2352473|NCT01655901|5772881|P2|STARTED|Second Intervention (Hour 2)||5
2352474|NCT01655901|5772882|P1|STARTED|Second Intervention (Hour 2)||5
2352475|NCT01655901|5772877|P6|NOT COMPLETED|Washout (1 Week)||0
2352476|NCT01655901|5772878|P5|NOT COMPLETED|Washout (1 Week)||0
2352477|NCT01655901|5772879|P4|NOT COMPLETED|Washout (1 Week)||0
2352478|NCT01655901|5772880|P3|NOT COMPLETED|Washout (1 Week)||0
2352479|NCT01655901|5772881|P2|NOT COMPLETED|Washout (1 Week)||0
2352480|NCT01655901|5772882|P1|NOT COMPLETED|Washout (1 Week)||0
2352481|NCT01655901|5772877|P6|COMPLETED|Washout (1 Week)||5
2352482|NCT01655901|5772878|P5|COMPLETED|Washout (1 Week)||5
2352483|NCT01655901|5772879|P4|COMPLETED|Washout (1 Week)||5
2352484|NCT01655901|5772880|P3|COMPLETED|Washout (1 Week)||5
2352485|NCT01655901|5772881|P2|COMPLETED|Washout (1 Week)||5
2352486|NCT01655901|5772882|P1|COMPLETED|Washout (1 Week)||5
2352487|NCT01655901|5772877|P6|STARTED|Washout (1 Week)||5
2352488|NCT01655901|5772878|P5|STARTED|Washout (1 Week)||5
2352489|NCT01655901|5772879|P4|STARTED|Washout (1 Week)||5
2352490|NCT01655901|5772880|P3|STARTED|Washout (1 Week)||5
2352491|NCT01655901|5772881|P2|STARTED|Washout (1 Week)||5
2352492|NCT01655901|5772882|P1|STARTED|Washout (1 Week)||5
2352493|NCT01655901|5772877|P6|NOT COMPLETED|First Intervention (Hour 1)||0
2352494|NCT01655901|5772878|P5|NOT COMPLETED|First Intervention (Hour 1)||0
2352495|NCT01655901|5772879|P4|NOT COMPLETED|First Intervention (Hour 1)||0
2352496|NCT01655901|5772880|P3|NOT COMPLETED|First Intervention (Hour 1)||0
2352497|NCT01655901|5772881|P2|NOT COMPLETED|First Intervention (Hour 1)||0
2352498|NCT01655901|5772882|P1|NOT COMPLETED|First Intervention (Hour 1)||0
2352499|NCT01655901|5772877|P6|COMPLETED|First Intervention (Hour 1)||5
2352500|NCT01655901|5772878|P5|COMPLETED|First Intervention (Hour 1)||5
2352501|NCT01655901|5772879|P4|COMPLETED|First Intervention (Hour 1)||5
2352502|NCT01655901|5772880|P3|COMPLETED|First Intervention (Hour 1)||5
2352503|NCT01655901|5772881|P2|COMPLETED|First Intervention (Hour 1)||5
2352504|NCT01655901|5772882|P1|COMPLETED|First Intervention (Hour 1)||5
2352505|NCT01655901|5772877|P6|STARTED|First Intervention (Hour 1)||5
2352506|NCT01655901|5772878|P5|STARTED|First Intervention (Hour 1)||5
2352507|NCT01655901|5772879|P4|STARTED|First Intervention (Hour 1)||5
2352508|NCT01655901|5772880|P3|STARTED|First Intervention (Hour 1)||5
2352509|NCT01655901|5772881|P2|STARTED|First Intervention (Hour 1)||5
2352510|NCT01655901|5772882|P1|STARTED|First Intervention (Hour 1)||5
2352511|NCT01655823|5772896|P5|NOT COMPLETED|Overall Study||1
2352512|NCT01655823|5772897|P4|NOT COMPLETED|Overall Study||1
2352513|NCT01655823|5772898|P3|NOT COMPLETED|Overall Study||0
2352514|NCT01655823|5772899|P2|NOT COMPLETED|Overall Study||2
2352515|NCT01655823|5772900|P1|NOT COMPLETED|Overall Study||0
2352516|NCT01655823|5772896|P5|COMPLETED|Overall Study||25
2352517|NCT01655823|5772897|P4|COMPLETED|Overall Study||24
2352518|NCT01655823|5772898|P3|COMPLETED|Overall Study||24
2352519|NCT01655823|5772899|P2|COMPLETED|Overall Study||23
2352520|NCT01655823|5772900|P1|COMPLETED|Overall Study||25
2352521|NCT01655823|5772896|P5|STARTED|Overall Study||26
2352522|NCT01655823|5772897|P4|STARTED|Overall Study||25
2352523|NCT01655823|5772898|P3|STARTED|Overall Study||24
2352524|NCT01655823|5772899|P2|STARTED|Overall Study||25
2352525|NCT01655823|5772900|P1|STARTED|Overall Study||25
2352526|NCT01655719|5772912|P1|NOT COMPLETED|Overall Study||0
2352527|NCT01655719|5772912|P1|COMPLETED|Overall Study||1
2352528|NCT01655719|5772912|P1|STARTED|Overall Study||1
2352529|NCT01655563|5772920|P2|NOT COMPLETED|Overall Study||0
2352530|NCT01655563|5772921|P1|NOT COMPLETED|Overall Study||0
2352531|NCT01655563|5772920|P2|COMPLETED|Overall Study||35
2352532|NCT01655563|5772921|P1|COMPLETED|Overall Study||18
2352533|NCT01655563|5772920|P2|STARTED|Overall Study||35
2352534|NCT01655563|5772921|P1|STARTED|Overall Study||18
2352535|NCT01655498|5772931|P1|NOT COMPLETED|Overall Study||5
2352536|NCT01655498|5772931|P1|COMPLETED|Overall Study||56
2352537|NCT01655498|5772931|P1|STARTED|Overall Study||61
2352538|NCT01655381|5772938|P1|NOT COMPLETED|Overall Study||3
2352539|NCT01655381|5772938|P1|COMPLETED|Overall Study||12
2352540|NCT01655381|5772938|P1|STARTED|Overall Study||15
2352541|NCT01655329|5772958|P1|NOT COMPLETED|Overall Study||0
2352542|NCT01655329|5772958|P1|COMPLETED|Overall Study||10
2352543|NCT01655329|5772958|P1|STARTED|Overall Study|The same 10 radiologists are interpreting images in both arms.|10
2352544|NCT01655069|5772978|P4|NOT COMPLETED|Overall Study||4
2352545|NCT01655069|5772979|P3|NOT COMPLETED|Overall Study||2
2352546|NCT01655069|5772980|P2|NOT COMPLETED|Overall Study||12
2352547|NCT01655069|5772981|P1|NOT COMPLETED|Overall Study||8
2352548|NCT01655069|5772978|P4|COMPLETED|Overall Study||11
2352549|NCT01655069|5772979|P3|COMPLETED|Overall Study||12
2352550|NCT01655069|5772980|P2|COMPLETED|Overall Study||46
2352551|NCT01655069|5772981|P1|COMPLETED|Overall Study||53
2352552|NCT01655069|5772978|P4|Full Analysis Set (FAS)|Overall Study||15
2352553|NCT01655069|5772979|P3|Full Analysis Set (FAS)|Overall Study||14
2352554|NCT01655069|5772980|P2|Full Analysis Set (FAS)|Overall Study||57
2352555|NCT01655069|5772981|P1|Full Analysis Set (FAS)|Overall Study||60
2352556|NCT01655069|5772978|P4|Safety Analysis Set (SAF)|Overall Study||15
2352557|NCT01655069|5772979|P3|Safety Analysis Set (SAF)|Overall Study||14
2352558|NCT01655069|5772980|P2|Safety Analysis Set (SAF)|Overall Study||57
2352559|NCT01655069|5772981|P1|Safety Analysis Set (SAF)|Overall Study||61
2352560|NCT01655069|5772978|P4|STARTED|Overall Study||15
2352561|NCT01655069|5772979|P3|STARTED|Overall Study||14
2352562|NCT01655069|5772980|P2|STARTED|Overall Study||58
2352563|NCT01655069|5772981|P1|STARTED|Overall Study||61
2352564|NCT01655043|5772996|P1|NOT COMPLETED|Overall Study||0
2352565|NCT01655043|5772996|P1|COMPLETED|Overall Study||20
2352566|NCT01655043|5772996|P1|STARTED|Overall Study||20
2352567|NCT01654887|5773002|P2|NOT COMPLETED|Overall Study||0
2352568|NCT01654887|5773003|P1|NOT COMPLETED|Overall Study||0
2352569|NCT01654887|5773002|P2|COMPLETED|Overall Study||88
2352570|NCT01654887|5773003|P1|COMPLETED|Overall Study||103
2352571|NCT01654887|5773002|P2|STARTED|Overall Study||88
2352572|NCT01654887|5773003|P1|STARTED|Overall Study||103
2352573|NCT01654861|5773019|P1|NOT COMPLETED|Overall Study||0
2352574|NCT01654861|5773019|P1|COMPLETED|Overall Study||3
2352575|NCT01654861|5773019|P1|STARTED|Overall Study||3
2352576|NCT01654796|5773027|P3|NOT COMPLETED|Overall Study||1
2352577|NCT01654796|5773028|P2|NOT COMPLETED|Overall Study||3
2352578|NCT01654796|5773029|P1|NOT COMPLETED|Overall Study||1
2352579|NCT01654796|5773027|P3|COMPLETED|Overall Study||28
2352580|NCT01654796|5773028|P2|COMPLETED|Overall Study||26
2352581|NCT01654796|5773029|P1|COMPLETED|Overall Study||25
2352582|NCT01654796|5773027|P3|STARTED|Overall Study||29
2352583|NCT01654796|5773028|P2|STARTED|Overall Study||29
2352584|NCT01654796|5773029|P1|STARTED|Overall Study||26
2352585|NCT01654666|5773041|P3|NOT COMPLETED|Overall Study||14
2352586|NCT01654666|5773042|P2|NOT COMPLETED|Overall Study||13
2352587|NCT01654666|5773043|P1|NOT COMPLETED|Overall Study||15
2352588|NCT01654666|5773041|P3|COMPLETED|Overall Study||49
2352589|NCT01654666|5773042|P2|COMPLETED|Overall Study||50
2352590|NCT01654666|5773043|P1|COMPLETED|Overall Study||48
2352591|NCT01654666|5773041|P3|Primary Analysis|Overall Study||54
2352592|NCT01654666|5773042|P2|Primary Analysis|Overall Study||56
2352593|NCT01654666|5773043|P1|Primary Analysis|Overall Study||52
2352594|NCT01654666|5773041|P3|STARTED|Overall Study||63
2352595|NCT01654666|5773042|P2|STARTED|Overall Study||63
2352596|NCT01654666|5773043|P1|STARTED|Overall Study||63
2352597|NCT01654601|5773068|P2|NOT COMPLETED|2nd Administration||1
2352598|NCT01654601|5773069|P1|NOT COMPLETED|2nd Administration||1
2352599|NCT01654601|5773068|P2|COMPLETED|2nd Administration||11
2352600|NCT01654601|5773069|P1|COMPLETED|2nd Administration||11
2352601|NCT01654601|5773068|P2|STARTED|2nd Administration||12
2352602|NCT01654601|5773069|P1|STARTED|2nd Administration||12
2352603|NCT01654601|5773068|P2|NOT COMPLETED|1st Administration||2
2352604|NCT01654601|5773069|P1|NOT COMPLETED|1st Administration||2
2352605|NCT01654601|5773068|P2|COMPLETED|1st Administration||12
2352606|NCT01654601|5773069|P1|COMPLETED|1st Administration||12
2352607|NCT01654601|5773068|P2|STARTED|1st Administration||14
2352608|NCT01654601|5773069|P1|STARTED|1st Administration||14
2352609|NCT01654549|5773083|P2|NOT COMPLETED|Overall Study||1
2352610|NCT01654549|5773084|P1|NOT COMPLETED|Overall Study||0
2352611|NCT01654549|5773083|P2|COMPLETED|Overall Study||19
2352612|NCT01654549|5773084|P1|COMPLETED|Overall Study||20
2352613|NCT01654549|5773083|P2|STARTED|Overall Study||20
2352614|NCT01654549|5773084|P1|STARTED|Overall Study||20
2352615|NCT01654536|5773096|P2|NOT COMPLETED|Overall Study||38
2352616|NCT01654536|5773097|P1|NOT COMPLETED|Overall Study||44
2352617|NCT01654536|5773096|P2|COMPLETED|Overall Study||331
2352618|NCT01654536|5773097|P1|COMPLETED|Overall Study||324
2352619|NCT01654536|5773096|P2|STARTED|Overall Study||369
2352620|NCT01654536|5773097|P1|STARTED|Overall Study||368
2352621|NCT01654523|5773133|P1|NOT COMPLETED|Overall Study||1
2352622|NCT01654523|5773133|P1|COMPLETED|Overall Study||19
2352623|NCT01654523|5773133|P1|STARTED|Overall Study||20
2352624|NCT01654380|5773139|P4|NOT COMPLETED|Part B, Period 4||0
2352625|NCT01654380|5773140|P3|NOT COMPLETED|Part B, Period 4||0
2352626|NCT01654380|5773141|P2|NOT COMPLETED|Part B, Period 4||0
2352627|NCT01654380|5773142|P1|NOT COMPLETED|Part B, Period 4||0
2352628|NCT01654380|5773139|P4|COMPLETED|Part B, Period 4||7
2352629|NCT01654380|5773140|P3|COMPLETED|Part B, Period 4||6
2352630|NCT01654380|5773141|P2|COMPLETED|Part B, Period 4||0
2352631|NCT01654380|5773142|P1|COMPLETED|Part B, Period 4||0
2352632|NCT01654380|5773139|P4|STARTED|Part B, Period 4||7
2352633|NCT01654380|5773140|P3|STARTED|Part B, Period 4||6
2352634|NCT01654380|5773141|P2|STARTED|Part B, Period 4||0
2352635|NCT01654380|5773142|P1|STARTED|Part B, Period 4||0
2352636|NCT01654380|5773139|P4|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
2352637|NCT01654380|5773140|P3|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
2352638|NCT01654380|5773141|P2|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
2352639|NCT01654380|5773142|P1|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
2352640|NCT01654380|5773139|P4|COMPLETED|Part B, Washout of at Least 6 Days||7
2352641|NCT01654380|5773140|P3|COMPLETED|Part B, Washout of at Least 6 Days||6
2352642|NCT01654380|5773141|P2|COMPLETED|Part B, Washout of at Least 6 Days||0
2352643|NCT01654380|5773142|P1|COMPLETED|Part B, Washout of at Least 6 Days||0
2352644|NCT01654380|5773139|P4|STARTED|Part B, Washout of at Least 6 Days||7
2352645|NCT01654380|5773140|P3|STARTED|Part B, Washout of at Least 6 Days||6
2352646|NCT01654380|5773141|P2|STARTED|Part B, Washout of at Least 6 Days||0
2352647|NCT01654380|5773142|P1|STARTED|Part B, Washout of at Least 6 Days||0
2352648|NCT01654380|5773139|P4|NOT COMPLETED|Part B, Period 3||0
2352649|NCT01654380|5773140|P3|NOT COMPLETED|Part B, Period 3||0
2352650|NCT01654380|5773141|P2|NOT COMPLETED|Part B, Period 3||0
2352651|NCT01654380|5773142|P1|NOT COMPLETED|Part B, Period 3||0
2352652|NCT01654380|5773139|P4|COMPLETED|Part B, Period 3||7
2352653|NCT01654380|5773140|P3|COMPLETED|Part B, Period 3||6
2352654|NCT01654380|5773141|P2|COMPLETED|Part B, Period 3||0
2352655|NCT01654380|5773142|P1|COMPLETED|Part B, Period 3||0
2352656|NCT01654380|5773139|P4|STARTED|Part B, Period 3||7
2352657|NCT01654380|5773140|P3|STARTED|Part B, Period 3||6
2352658|NCT01654380|5773141|P2|STARTED|Part B, Period 3||0
2352659|NCT01654380|5773142|P1|STARTED|Part B, Period 3||0
2352660|NCT01654380|5773139|P4|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
2352661|NCT01654380|5773140|P3|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
2352662|NCT01654380|5773141|P2|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
2352663|NCT01654380|5773142|P1|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
2352664|NCT01654380|5773139|P4|COMPLETED|Part B, Washout of at Least 6 Days||7
2352665|NCT01654380|5773140|P3|COMPLETED|Part B, Washout of at Least 6 Days||6
2352666|NCT01654380|5773141|P2|COMPLETED|Part B, Washout of at Least 6 Days||0
2352667|NCT01654380|5773142|P1|COMPLETED|Part B, Washout of at Least 6 Days||0
2352668|NCT01654380|5773139|P4|STARTED|Part B, Washout of at Least 6 Days||7
2352669|NCT01654380|5773140|P3|STARTED|Part B, Washout of at Least 6 Days||6
2352670|NCT01654380|5773141|P2|STARTED|Part B, Washout of at Least 6 Days||0
2352671|NCT01654380|5773142|P1|STARTED|Part B, Washout of at Least 6 Days||0
2352672|NCT01654380|5773139|P4|NOT COMPLETED|Part B, Period 2||0
2352673|NCT01654380|5773140|P3|NOT COMPLETED|Part B, Period 2||0
2352674|NCT01654380|5773141|P2|NOT COMPLETED|Part B, Period 2||0
2352675|NCT01654380|5773142|P1|NOT COMPLETED|Part B, Period 2||0
2352676|NCT01654380|5773139|P4|COMPLETED|Part B, Period 2||7
2352677|NCT01654380|5773140|P3|COMPLETED|Part B, Period 2||6
2352678|NCT01654380|5773141|P2|COMPLETED|Part B, Period 2||0
2352679|NCT01654380|5773142|P1|COMPLETED|Part B, Period 2||0
2352680|NCT01654380|5773139|P4|STARTED|Part B, Period 2||7
2352681|NCT01654380|5773140|P3|STARTED|Part B, Period 2||6
2352682|NCT01654380|5773141|P2|STARTED|Part B, Period 2||0
2352683|NCT01654380|5773142|P1|STARTED|Part B, Period 2||0
2352684|NCT01654380|5773139|P4|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
2352685|NCT01654380|5773140|P3|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
2352686|NCT01654380|5773141|P2|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
2352687|NCT01654380|5773142|P1|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
2352688|NCT01654380|5773139|P4|COMPLETED|Part B, Washout of at Least 6 Days||7
2352689|NCT01654380|5773140|P3|COMPLETED|Part B, Washout of at Least 6 Days||6
2352690|NCT01654380|5773141|P2|COMPLETED|Part B, Washout of at Least 6 Days||0
2352691|NCT01654380|5773142|P1|COMPLETED|Part B, Washout of at Least 6 Days||0
2352692|NCT01654380|5773139|P4|STARTED|Part B, Washout of at Least 6 Days||7
2352693|NCT01654380|5773140|P3|STARTED|Part B, Washout of at Least 6 Days||6
2352694|NCT01654380|5773141|P2|STARTED|Part B, Washout of at Least 6 Days||0
2352695|NCT01654380|5773142|P1|STARTED|Part B, Washout of at Least 6 Days||0
2352696|NCT01654380|5773139|P4|NOT COMPLETED|Part B, Period 1||0
2352697|NCT01654380|5773140|P3|NOT COMPLETED|Part B, Period 1||1
2352698|NCT01654380|5773141|P2|NOT COMPLETED|Part B, Period 1||0
2352699|NCT01654380|5773142|P1|NOT COMPLETED|Part B, Period 1||0
2352700|NCT01654380|5773139|P4|COMPLETED|Part B, Period 1||7
2352701|NCT01654380|5773140|P3|COMPLETED|Part B, Period 1|Participant who did not complete received only 1 dose of LY2605541 74.1 mU/min IV for 8 hours|6
2352702|NCT01654380|5773141|P2|COMPLETED|Part B, Period 1||0
2352703|NCT01654380|5773142|P1|COMPLETED|Part B, Period 1||0
2352704|NCT01654380|5773139|P4|Received at Least 1 Dose of Study Drug|Part B, Period 1||7
2352705|NCT01654380|5773140|P3|Received at Least 1 Dose of Study Drug|Part B, Period 1||7
2352706|NCT01654380|5773141|P2|Received at Least 1 Dose of Study Drug|Part B, Period 1||0
2352707|NCT01654380|5773142|P1|Received at Least 1 Dose of Study Drug|Part B, Period 1||0
2352708|NCT01654380|5773139|P4|STARTED|Part B, Period 1|Participants in Part B were not included in Part A.|7
2352709|NCT01654380|5773140|P3|STARTED|Part B, Period 1|Participants in Part B were not included in Part A.|7
2352710|NCT01654380|5773141|P2|STARTED|Part B, Period 1|Participants in Part A were not included in Part B.|0
2352711|NCT01654380|5773142|P1|STARTED|Part B, Period 1|Participants in Part A were not included in Part B.|0
2352712|NCT01654380|5773139|P4|NOT COMPLETED|Part A, Period 4||0
2352713|NCT01654380|5773140|P3|NOT COMPLETED|Part A, Period 4||0
2352714|NCT01654380|5773141|P2|NOT COMPLETED|Part A, Period 4||0
2352715|NCT01654380|5773142|P1|NOT COMPLETED|Part A, Period 4||0
2352716|NCT01654380|5773139|P4|COMPLETED|Part A, Period 4||0
2352717|NCT01654380|5773140|P3|COMPLETED|Part A, Period 4||0
2352718|NCT01654380|5773141|P2|COMPLETED|Part A, Period 4||4
2352719|NCT01654380|5773142|P1|COMPLETED|Part A, Period 4||4
2352720|NCT01654380|5773139|P4|STARTED|Part A, Period 4||0
2352721|NCT01654380|5773140|P3|STARTED|Part A, Period 4||0
2352722|NCT01654380|5773141|P2|STARTED|Part A, Period 4||4
2352723|NCT01654380|5773142|P1|STARTED|Part A, Period 4||4
2352724|NCT01654380|5773139|P4|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
2352725|NCT01654380|5773140|P3|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
2352726|NCT01654380|5773141|P2|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
2352727|NCT01654380|5773142|P1|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
2352728|NCT01654380|5773139|P4|COMPLETED|Part A, Washout of at Least 6 Days||0
2352729|NCT01654380|5773140|P3|COMPLETED|Part A, Washout of at Least 6 Days||0
2352730|NCT01654380|5773141|P2|COMPLETED|Part A, Washout of at Least 6 Days||4
2352731|NCT01654380|5773142|P1|COMPLETED|Part A, Washout of at Least 6 Days||4
2352732|NCT01654380|5773139|P4|STARTED|Part A, Washout of at Least 6 Days||0
2352733|NCT01654380|5773140|P3|STARTED|Part A, Washout of at Least 6 Days||0
2352734|NCT01654380|5773141|P2|STARTED|Part A, Washout of at Least 6 Days||4
2352735|NCT01654380|5773142|P1|STARTED|Part A, Washout of at Least 6 Days||4
2352736|NCT01654380|5773139|P4|NOT COMPLETED|Part A, Period 3||0
2352737|NCT01654380|5773140|P3|NOT COMPLETED|Part A, Period 3||0
2352738|NCT01654380|5773141|P2|NOT COMPLETED|Part A, Period 3||0
2352739|NCT01654380|5773142|P1|NOT COMPLETED|Part A, Period 3||0
2352740|NCT01654380|5773139|P4|COMPLETED|Part A, Period 3||0
2352741|NCT01654380|5773140|P3|COMPLETED|Part A, Period 3||0
2352742|NCT01654380|5773141|P2|COMPLETED|Part A, Period 3||4
2352743|NCT01654380|5773142|P1|COMPLETED|Part A, Period 3||4
2352744|NCT01654380|5773139|P4|STARTED|Part A, Period 3||0
2352745|NCT01654380|5773140|P3|STARTED|Part A, Period 3||0
2352746|NCT01654380|5773141|P2|STARTED|Part A, Period 3||4
2352747|NCT01654380|5773142|P1|STARTED|Part A, Period 3||4
2352748|NCT01654380|5773139|P4|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
2352749|NCT01654380|5773140|P3|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
2352750|NCT01654380|5773141|P2|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
2352751|NCT01654380|5773142|P1|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
2352752|NCT01654380|5773139|P4|COMPLETED|Part A, Washout of at Least 6 Days||0
2352753|NCT01654380|5773140|P3|COMPLETED|Part A, Washout of at Least 6 Days||0
2352754|NCT01654380|5773141|P2|COMPLETED|Part A, Washout of at Least 6 Days||4
2352755|NCT01654380|5773142|P1|COMPLETED|Part A, Washout of at Least 6 Days||4
2352756|NCT01654380|5773139|P4|STARTED|Part A, Washout of at Least 6 Days||0
2352757|NCT01654380|5773140|P3|STARTED|Part A, Washout of at Least 6 Days||0
2352758|NCT01654380|5773141|P2|STARTED|Part A, Washout of at Least 6 Days||4
2352759|NCT01654380|5773142|P1|STARTED|Part A, Washout of at Least 6 Days||4
2352760|NCT01654380|5773139|P4|NOT COMPLETED|Part A, Period 2||0
2352761|NCT01654380|5773140|P3|NOT COMPLETED|Part A, Period 2||0
2352762|NCT01654380|5773141|P2|NOT COMPLETED|Part A, Period 2||0
2352763|NCT01654380|5773142|P1|NOT COMPLETED|Part A, Period 2||0
2352764|NCT01654380|5773139|P4|COMPLETED|Part A, Period 2||0
2352765|NCT01654380|5773140|P3|COMPLETED|Part A, Period 2||0
2352766|NCT01654380|5773141|P2|COMPLETED|Part A, Period 2||4
2352767|NCT01654380|5773142|P1|COMPLETED|Part A, Period 2||4
2352768|NCT01654380|5773139|P4|STARTED|Part A, Period 2||0
2352769|NCT01654380|5773140|P3|STARTED|Part A, Period 2||0
2352770|NCT01654380|5773141|P2|STARTED|Part A, Period 2||4
2352771|NCT01654380|5773142|P1|STARTED|Part A, Period 2||4
2352772|NCT01654380|5773139|P4|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
2352773|NCT01654380|5773140|P3|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
2352774|NCT01654380|5773141|P2|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
2352775|NCT01654380|5773142|P1|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
2352776|NCT01654380|5773139|P4|COMPLETED|Part A, Washout of at Least 6 Days||0
2352777|NCT01654380|5773140|P3|COMPLETED|Part A, Washout of at Least 6 Days||0
2352778|NCT01654380|5773141|P2|COMPLETED|Part A, Washout of at Least 6 Days||4
2352779|NCT01654380|5773142|P1|COMPLETED|Part A, Washout of at Least 6 Days||4
2352780|NCT01654380|5773139|P4|STARTED|Part A, Washout of at Least 6 Days||0
2352781|NCT01654380|5773140|P3|STARTED|Part A, Washout of at Least 6 Days||0
2352782|NCT01654380|5773141|P2|STARTED|Part A, Washout of at Least 6 Days||4
2352783|NCT01654380|5773142|P1|STARTED|Part A, Washout of at Least 6 Days||4
2352784|NCT01654380|5773139|P4|NOT COMPLETED|Part A, Period 1||0
2352785|NCT01654380|5773140|P3|NOT COMPLETED|Part A, Period 1||0
2352786|NCT01654380|5773141|P2|NOT COMPLETED|Part A, Period 1||0
2352787|NCT01654380|5773142|P1|NOT COMPLETED|Part A, Period 1||0
2352788|NCT01654380|5773139|P4|COMPLETED|Part A, Period 1||0
2352789|NCT01654380|5773140|P3|COMPLETED|Part A, Period 1||0
2352790|NCT01654380|5773141|P2|COMPLETED|Part A, Period 1||4
2352791|NCT01654380|5773142|P1|COMPLETED|Part A, Period 1||4
2352792|NCT01654380|5773139|P4|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
2352793|NCT01654380|5773140|P3|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
2352794|NCT01654380|5773141|P2|Received at Least 1 Dose of Study Drug|Part A, Period 1||4
2352795|NCT01654380|5773142|P1|Received at Least 1 Dose of Study Drug|Part A, Period 1||4
2352796|NCT01654380|5773139|P4|STARTED|Part A, Period 1||0
2352797|NCT01654380|5773140|P3|STARTED|Part A, Period 1||0
2352798|NCT01654380|5773141|P2|STARTED|Part A, Period 1||4
2352799|NCT01654380|5773142|P1|STARTED|Part A, Period 1||4
2352800|NCT01654315|5773170|P3|NOT COMPLETED|Overall Study||0
2352801|NCT01654315|5773171|P2|NOT COMPLETED|Overall Study||0
2352802|NCT01654315|5773172|P1|NOT COMPLETED|Overall Study||0
2352803|NCT01654315|5773170|P3|COMPLETED|Overall Study||9
2352804|NCT01654315|5773171|P2|COMPLETED|Overall Study||10
2352805|NCT01654315|5773172|P1|COMPLETED|Overall Study||15
2352806|NCT01654315|5773170|P3|STARTED|Overall Study||9
2352807|NCT01654315|5773171|P2|STARTED|Overall Study||10
2352808|NCT01654315|5773172|P1|STARTED|Overall Study||15
2352809|NCT01654302|5773185|P2|NOT COMPLETED|Second Intervention (Day 7)||1
2352810|NCT01654302|5773186|P1|NOT COMPLETED|Second Intervention (Day 7)||1
2352811|NCT01654302|5773185|P2|COMPLETED|Second Intervention (Day 7)||19
2352812|NCT01654302|5773186|P1|COMPLETED|Second Intervention (Day 7)||19
2352813|NCT01654302|5773185|P2|STARTED|Second Intervention (Day 7)||20
2352814|NCT01654302|5773186|P1|STARTED|Second Intervention (Day 7)||20
2352815|NCT01654302|5773185|P2|NOT COMPLETED|First Intervention (Day 1)||0
2352816|NCT01654302|5773186|P1|NOT COMPLETED|First Intervention (Day 1)||0
2352817|NCT01654302|5773185|P2|COMPLETED|First Intervention (Day 1)||20
2352818|NCT01654302|5773186|P1|COMPLETED|First Intervention (Day 1)||20
2352819|NCT01654302|5773185|P2|STARTED|First Intervention (Day 1)||20
2352820|NCT01654302|5773186|P1|STARTED|First Intervention (Day 1)||20
2352821|NCT01654289|5773195|P3|NOT COMPLETED|Overall Study||5
2352822|NCT01654289|5773196|P2|NOT COMPLETED|Overall Study||28
2352823|NCT01654289|5773197|P1|NOT COMPLETED|Overall Study||27
2352824|NCT01654289|5773195|P3|COMPLETED|Overall Study||133
2352825|NCT01654289|5773196|P2|COMPLETED|Overall Study||109
2352826|NCT01654289|5773197|P1|COMPLETED|Overall Study||111
2352827|NCT01654289|5773195|P3|STARTED|Overall Study||138
2352828|NCT01654289|5773196|P2|STARTED|Overall Study||137
2352829|NCT01654289|5773197|P1|STARTED|Overall Study||138
2352830|NCT01654276|5773235|P1|NOT COMPLETED|Overall Study||6
2352831|NCT01654276|5773235|P1|COMPLETED|Overall Study||18
2352832|NCT01654276|5773235|P1|Visit 4 (6months)|Overall Study||18
2352833|NCT01654276|5773235|P1|Visit 3 (4 Months)|Overall Study||18
2352834|NCT01654276|5773235|P1|Visit 2 (2 Months)|Overall Study||19
2352835|NCT01654276|5773235|P1|STARTED|Overall Study||24
2352836|NCT01654263|5773259|P6|NOT COMPLETED|Overall Study||1
2352837|NCT01654263|5773260|P5|NOT COMPLETED|Overall Study||1
2352838|NCT01654263|5773261|P4|NOT COMPLETED|Overall Study||1
2352839|NCT01654263|5773262|P3|NOT COMPLETED|Overall Study||2
2352840|NCT01654263|5773263|P2|NOT COMPLETED|Overall Study||0
2352841|NCT01654263|5773264|P1|NOT COMPLETED|Overall Study||0
2352842|NCT01654263|5773259|P6|COMPLETED|Overall Study||148
2352843|NCT01654263|5773260|P5|COMPLETED|Overall Study||139
2352844|NCT01654263|5773261|P4|COMPLETED|Overall Study||144
2352845|NCT01654263|5773262|P3|COMPLETED|Overall Study||137
2352846|NCT01654263|5773263|P2|COMPLETED|Overall Study||147
2352847|NCT01654263|5773264|P1|COMPLETED|Overall Study||164
2352848|NCT01654263|5773259|P6|STARTED|Overall Study||149
2352849|NCT01654263|5773260|P5|STARTED|Overall Study||140
2352850|NCT01654263|5773261|P4|STARTED|Overall Study||145
2352851|NCT01654263|5773262|P3|STARTED|Overall Study||139
2352852|NCT01654263|5773263|P2|STARTED|Overall Study||147
2352853|NCT01654263|5773264|P1|STARTED|Overall Study||164
2352854|NCT01654250|5773289|P2|NOT COMPLETED|Overall Study||0
2352855|NCT01654250|5773290|P1|NOT COMPLETED|Overall Study||1
2352856|NCT01654250|5773289|P2|COMPLETED|Overall Study||42
2352857|NCT01654250|5773290|P1|COMPLETED|Overall Study||43
2352858|NCT01654250|5773289|P2|STARTED|Overall Study||42
2352859|NCT01654250|5773290|P1|STARTED|Overall Study||44
2352860|NCT01654224|5773307|P2|NOT COMPLETED|Overall Study||12
2352861|NCT01654224|5773308|P1|NOT COMPLETED|Overall Study||6
2352862|NCT01654224|5773307|P2|COMPLETED|Overall Study||98
2352863|NCT01654224|5773308|P1|COMPLETED|Overall Study||89
2352864|NCT01654224|5773307|P2|STARTED|Overall Study||110
2352865|NCT01654224|5773308|P1|STARTED|Overall Study||95
2352866|NCT01654107|5773320|P2|NOT COMPLETED|Overall Study||8
2352867|NCT01654107|5773321|P1|NOT COMPLETED|Overall Study||3
2352868|NCT01654107|5773320|P2|COMPLETED|Overall Study||22
2352869|NCT01654107|5773321|P1|COMPLETED|Overall Study||25
2352870|NCT01654107|5773320|P2|STARTED|Overall Study||30
2352871|NCT01654107|5773321|P1|STARTED|Overall Study||28
2352872|NCT01654068|5773327|P1|NOT COMPLETED|Overall Study||0
2352873|NCT01654068|5773327|P1|COMPLETED|Overall Study||14
2352874|NCT01654068|5773327|P1|STARTED|Overall Study||14
2352875|NCT01653964|5773333|P1|NOT COMPLETED|Overall Study||0
2352876|NCT01653964|5773333|P1|COMPLETED|Overall Study||82
2352877|NCT01653964|5773333|P1|STARTED|Overall Study||82
2352878|NCT01653912|5773339|P6|NOT COMPLETED|Phase 2: GSK2110183 125 mg||8
2352879|NCT01653912|5773340|P5|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
2352880|NCT01653912|5773341|P4|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
2352881|NCT01653912|5773342|P3|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
2352882|NCT01653912|5773343|P2|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
2352883|NCT01653912|5773344|P1|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
2352884|NCT01653912|5773339|P6|COMPLETED|Phase 2: GSK2110183 125 mg||22
2352885|NCT01653912|5773340|P5|COMPLETED|Phase 2: GSK2110183 125 mg||0
2352886|NCT01653912|5773341|P4|COMPLETED|Phase 2: GSK2110183 125 mg||0
2352887|NCT01653912|5773342|P3|COMPLETED|Phase 2: GSK2110183 125 mg||0
2352888|NCT01653912|5773343|P2|COMPLETED|Phase 2: GSK2110183 125 mg||0
2352889|NCT01653912|5773344|P1|COMPLETED|Phase 2: GSK2110183 125 mg||0
2352890|NCT01653912|5773339|P6|STARTED|Phase 2: GSK2110183 125 mg|Per SAP, Cohort B (n=2) data was summarized in phase 2 total column as cohort B had <10 subjects.|30
2352891|NCT01653912|5773340|P5|STARTED|Phase 2: GSK2110183 125 mg||0
2352892|NCT01653912|5773341|P4|STARTED|Phase 2: GSK2110183 125 mg||0
2352893|NCT01653912|5773342|P3|STARTED|Phase 2: GSK2110183 125 mg||0
2352894|NCT01653912|5773343|P2|STARTED|Phase 2: GSK2110183 125 mg||0
2352895|NCT01653912|5773344|P1|STARTED|Phase 2: GSK2110183 125 mg||0
2352896|NCT01653912|5773339|P6|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
2352897|NCT01653912|5773340|P5|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
2352898|NCT01653912|5773341|P4|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
2352899|NCT01653912|5773342|P3|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
2352900|NCT01653912|5773343|P2|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
2352901|NCT01653912|5773344|P1|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
2352902|NCT01653912|5773339|P6|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
2352903|NCT01653912|5773340|P5|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||3
2352904|NCT01653912|5773341|P4|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
2352905|NCT01653912|5773342|P3|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
2352906|NCT01653912|5773343|P2|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
2352907|NCT01653912|5773344|P1|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
2352908|NCT01653912|5773339|P6|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
2352909|NCT01653912|5773340|P5|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||3
2352910|NCT01653912|5773341|P4|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
2352911|NCT01653912|5773342|P3|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
2352912|NCT01653912|5773343|P2|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
2352913|NCT01653912|5773344|P1|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
2352914|NCT01653912|5773339|P6|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
2352915|NCT01653912|5773340|P5|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
2352916|NCT01653912|5773341|P4|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||2
2352917|NCT01653912|5773342|P3|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
2352918|NCT01653912|5773343|P2|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
2352919|NCT01653912|5773344|P1|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
2352920|NCT01653912|5773339|P6|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
2352921|NCT01653912|5773340|P5|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
2352922|NCT01653912|5773341|P4|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||10
2352923|NCT01653912|5773342|P3|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
2352924|NCT01653912|5773343|P2|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
2352925|NCT01653912|5773344|P1|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
2352926|NCT01653912|5773339|P6|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
2352927|NCT01653912|5773340|P5|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
2352928|NCT01653912|5773341|P4|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||12
2352929|NCT01653912|5773342|P3|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
2352930|NCT01653912|5773343|P2|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
2352931|NCT01653912|5773344|P1|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
2352932|NCT01653912|5773339|P6|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
2352933|NCT01653912|5773340|P5|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
2352934|NCT01653912|5773341|P4|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
2352935|NCT01653912|5773342|P3|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||2
2352936|NCT01653912|5773343|P2|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
2352937|NCT01653912|5773344|P1|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
2352938|NCT01653912|5773339|P6|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
2352939|NCT01653912|5773340|P5|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
2352940|NCT01653912|5773341|P4|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
2352941|NCT01653912|5773342|P3|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||4
2352942|NCT01653912|5773343|P2|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
2352943|NCT01653912|5773344|P1|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
2352944|NCT01653912|5773339|P6|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
2352945|NCT01653912|5773340|P5|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
2352946|NCT01653912|5773341|P4|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
2352947|NCT01653912|5773342|P3|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||6
2352948|NCT01653912|5773343|P2|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
2352949|NCT01653912|5773344|P1|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
2352950|NCT01653912|5773339|P6|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
2352951|NCT01653912|5773340|P5|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
2352952|NCT01653912|5773341|P4|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
2352953|NCT01653912|5773342|P3|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
2352954|NCT01653912|5773343|P2|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||1
2352955|NCT01653912|5773344|P1|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
2352956|NCT01653912|5773339|P6|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
2352957|NCT01653912|5773340|P5|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
2352958|NCT01653912|5773341|P4|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
2352959|NCT01653912|5773342|P3|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
2352960|NCT01653912|5773343|P2|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||3
2352961|NCT01653912|5773344|P1|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
2352962|NCT01653912|5773339|P6|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
2352963|NCT01653912|5773340|P5|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
2352964|NCT01653912|5773341|P4|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
2352965|NCT01653912|5773342|P3|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
2352966|NCT01653912|5773343|P2|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||4
2352967|NCT01653912|5773344|P1|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
2352968|NCT01653912|5773339|P6|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
2352969|NCT01653912|5773340|P5|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
2352970|NCT01653912|5773341|P4|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
2352971|NCT01653912|5773342|P3|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
2352972|NCT01653912|5773343|P2|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
2352973|NCT01653912|5773344|P1|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
2352974|NCT01653912|5773339|P6|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
2352975|NCT01653912|5773340|P5|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
2352976|NCT01653912|5773341|P4|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
2352977|NCT01653912|5773342|P3|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
2352978|NCT01653912|5773343|P2|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
2352979|NCT01653912|5773344|P1|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||4
2352980|NCT01653912|5773339|P6|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
2352981|NCT01653912|5773340|P5|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
2352982|NCT01653912|5773341|P4|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
2352983|NCT01653912|5773342|P3|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
2352984|NCT01653912|5773343|P2|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
2352985|NCT01653912|5773344|P1|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||4
2352986|NCT01653782|5773362|P3|NOT COMPLETED|Overall Study||6
2352987|NCT01653782|5773363|P2|NOT COMPLETED|Overall Study||18
2352988|NCT01653782|5773364|P1|NOT COMPLETED|Overall Study||16
2352989|NCT01653782|5773362|P3|COMPLETED|Overall Study||46
2352990|NCT01653782|5773363|P2|COMPLETED|Overall Study||37
2352991|NCT01653782|5773364|P1|COMPLETED|Overall Study||36
2352992|NCT01653782|5773362|P3|STARTED|Overall Study||52
2352993|NCT01653782|5773363|P2|STARTED|Overall Study||55
2352994|NCT01653782|5773364|P1|STARTED|Overall Study||52
2352995|NCT01653743|5773374|P2|NOT COMPLETED|Overall Study||0
2352996|NCT01653743|5773375|P1|NOT COMPLETED|Overall Study||4
2352997|NCT01653743|5773374|P2|COMPLETED|Overall Study||27
2352998|NCT01653743|5773375|P1|COMPLETED|Overall Study||50
2352999|NCT01653743|5773374|P2|STARTED|Overall Study||27
2353000|NCT01653743|5773375|P1|STARTED|Overall Study||54
2353001|NCT01653704|5773391|P2|NOT COMPLETED|Overall Study||1
2353002|NCT01653704|5773392|P1|NOT COMPLETED|Overall Study||2
2353003|NCT01653704|5773391|P2|COMPLETED|Overall Study||20
2353004|NCT01653704|5773392|P1|COMPLETED|Overall Study||19
2353005|NCT01653704|5773391|P2|STARTED|Overall Study||21
2353006|NCT01653704|5773392|P1|STARTED|Overall Study||21
2353007|NCT01653587|5773400|P2|NOT COMPLETED|Overall Study||0
2353008|NCT01653587|5773401|P1|NOT COMPLETED|Overall Study||0
2353009|NCT01653587|5773400|P2|COMPLETED|Overall Study||120
2353010|NCT01653587|5773401|P1|COMPLETED|Overall Study||120
2353011|NCT01653587|5773400|P2|STARTED|Overall Study||120
2353012|NCT01653587|5773401|P1|STARTED|Overall Study||120
2353013|NCT01653509|5773413|P2|NOT COMPLETED|Overall Study||0
2353014|NCT01653509|5773414|P1|NOT COMPLETED|Overall Study||0
2353015|NCT01653509|5773413|P2|COMPLETED|Overall Study||13
2353016|NCT01653509|5773414|P1|COMPLETED|Overall Study||12
2353017|NCT01653509|5773413|P2|STARTED|Overall Study||13
2353018|NCT01653509|5773414|P1|STARTED|Overall Study||12
2353019|NCT01653418|5773432|P1|NOT COMPLETED|Overall Study||0
2353020|NCT01653418|5773432|P1|COMPLETED|Overall Study||10
2353021|NCT01653418|5773432|P1|STARTED|Overall Study||10
2353022|NCT01653405|5773446|P2|NOT COMPLETED|Overall Study||1068803
2353023|NCT01653405|5773447|P1|NOT COMPLETED|Overall Study||3765
2353024|NCT01653405|5773446|P2|COMPLETED|Overall Study|These patients had enough data to calculate TTR.|179979
2353025|NCT01653405|5773447|P1|COMPLETED|Overall Study|These patients had enough data to calculate TTR.|8029
2353026|NCT01653405|5773446|P2|STARTED|Overall Study||1248782
2353027|NCT01653405|5773447|P1|STARTED|Overall Study||11794
2353028|NCT01653327|5773461|P1|NOT COMPLETED|Overall Study||1
2353029|NCT01653327|5773461|P1|COMPLETED|Overall Study||10
2353030|NCT01653327|5773461|P1|STARTED|Overall Study||11
2353031|NCT01653288|5773471|P2|NOT COMPLETED|Overall Study||1
2353032|NCT01653288|5773472|P1|NOT COMPLETED|Overall Study||10
2353033|NCT01653288|5773471|P2|COMPLETED|Overall Study||35
2353034|NCT01653288|5773472|P1|COMPLETED|Overall Study||26
2353035|NCT01653288|5773471|P2|STARTED|Overall Study||36
2353036|NCT01653288|5773472|P1|STARTED|Overall Study||36
2353037|NCT01653262|5773486|P1|NOT COMPLETED|Overall Study||3
2353038|NCT01653262|5773486|P1|COMPLETED|Overall Study||26
2353039|NCT01653262|5773486|P1|STARTED|Overall Study||29
2353040|NCT01653158|5773499|P8|NOT COMPLETED|Overall Study||15
2353041|NCT01653158|5773500|P7|NOT COMPLETED|Overall Study||2
2353042|NCT01653158|5773501|P6|NOT COMPLETED|Overall Study||1
2353043|NCT01653158|5773502|P5|NOT COMPLETED|Overall Study||1
2353044|NCT01653158|5773503|P4|NOT COMPLETED|Overall Study||2
2353045|NCT01653158|5773504|P3|NOT COMPLETED|Overall Study||0
2353046|NCT01653158|5773505|P2|NOT COMPLETED|Overall Study||0
2353047|NCT01653158|5773506|P1|NOT COMPLETED|Overall Study||1
2353048|NCT01653158|5773499|P8|COMPLETED|Overall Study||4
2353049|NCT01653158|5773500|P7|COMPLETED|Overall Study||7
2353050|NCT01653158|5773501|P6|COMPLETED|Overall Study||2
2353051|NCT01653158|5773502|P5|COMPLETED|Overall Study||2
2353052|NCT01653158|5773503|P4|COMPLETED|Overall Study||1
2353053|NCT01653158|5773504|P3|COMPLETED|Overall Study||3
2353054|NCT01653158|5773505|P2|COMPLETED|Overall Study||3
2353055|NCT01653158|5773506|P1|COMPLETED|Overall Study||2
2353056|NCT01653158|5773499|P8|STARTED|Overall Study|Six (6) and 13 participants were enrolled in dose escalation and expansion cohorts, respectively.|19
2353057|NCT01653158|5773500|P7|STARTED|Overall Study||9
2353058|NCT01653158|5773501|P6|STARTED|Overall Study||3
2353059|NCT01653158|5773502|P5|STARTED|Overall Study||3
2353060|NCT01653158|5773503|P4|STARTED|Overall Study||3
2353061|NCT01653158|5773504|P3|STARTED|Overall Study||3
2353062|NCT01653158|5773505|P2|STARTED|Overall Study||3
2353063|NCT01653158|5773506|P1|STARTED|Overall Study||3
2353064|NCT01653132|5773778|P2|NOT COMPLETED|Second Intervention||0
2353065|NCT01653132|5773779|P1|NOT COMPLETED|Second Intervention||0
2353066|NCT01653132|5773778|P2|COMPLETED|Second Intervention||5
2353067|NCT01653132|5773779|P1|COMPLETED|Second Intervention||4
2353068|NCT01653132|5773778|P2|STARTED|Second Intervention||5
2353069|NCT01653132|5773779|P1|STARTED|Second Intervention||4
2353070|NCT01653132|5773778|P2|NOT COMPLETED|Washout 1-2 Months||0
2353071|NCT01653132|5773779|P1|NOT COMPLETED|Washout 1-2 Months||0
2353072|NCT01653132|5773778|P2|COMPLETED|Washout 1-2 Months||5
2353073|NCT01653132|5773779|P1|COMPLETED|Washout 1-2 Months||4
2353074|NCT01653132|5773778|P2|STARTED|Washout 1-2 Months||5
2353075|NCT01653132|5773779|P1|STARTED|Washout 1-2 Months||4
2353076|NCT01653132|5773778|P2|NOT COMPLETED|First Intervention||0
2353077|NCT01653132|5773779|P1|NOT COMPLETED|First Intervention||1
2353078|NCT01653132|5773778|P2|COMPLETED|First Intervention||5
2353079|NCT01653132|5773779|P1|COMPLETED|First Intervention|one dropped out: wanted to start anticholinergic drug for tremor that could affect saliva volume|4
2353080|NCT01653132|5773778|P2|STARTED|First Intervention||5
2353081|NCT01653132|5773779|P1|STARTED|First Intervention||5
2353082|NCT01653028|5773798|P5|NOT COMPLETED|Overall Study||0
2353083|NCT01653028|5773799|P4|NOT COMPLETED|Overall Study||0
2353084|NCT01653028|5773800|P3|NOT COMPLETED|Overall Study||0
2353085|NCT01653028|5773801|P2|NOT COMPLETED|Overall Study||0
2353086|NCT01653028|5773802|P1|NOT COMPLETED|Overall Study||0
2353087|NCT01653028|5773798|P5|COMPLETED|Overall Study||29
2353088|NCT01653028|5773799|P4|COMPLETED|Overall Study||10
2353089|NCT01653028|5773800|P3|COMPLETED|Overall Study||11
2353090|NCT01653028|5773801|P2|COMPLETED|Overall Study||10
2353091|NCT01653028|5773802|P1|COMPLETED|Overall Study||12
2353092|NCT01653028|5773798|P5|STARTED|Overall Study||29
2353093|NCT01653028|5773799|P4|STARTED|Overall Study||10
2353094|NCT01653028|5773800|P3|STARTED|Overall Study||11
2353095|NCT01653028|5773801|P2|STARTED|Overall Study||10
2353096|NCT01653028|5773802|P1|STARTED|Overall Study||12
2353097|NCT01652976|5773829|P1|NOT COMPLETED|Overall Study||0
2353098|NCT01652976|5773829|P1|COMPLETED|Overall Study||44
2353099|NCT01652976|5773829|P1|STARTED|Overall Study||44
2353100|NCT01652885|5773843|P1|NOT COMPLETED|Overall Study||1
2353101|NCT01652885|5773843|P1|COMPLETED|Overall Study||22
2353102|NCT01652885|5773843|P1|STARTED|Overall Study||23
2353103|NCT01652872|5773870|P2|NOT COMPLETED|Overall Study||153
2353104|NCT01652872|5773871|P1|NOT COMPLETED|Overall Study||145
2353105|NCT01652872|5773870|P2|COMPLETED|Overall Study||226
2353106|NCT01652872|5773871|P1|COMPLETED|Overall Study||232
2353107|NCT01652872|5773870|P2|Received Investigational Product|Overall Study||377
2353108|NCT01652872|5773871|P1|Received Investigational Product|Overall Study||377
2353109|NCT01652872|5773870|P2|STARTED|Overall Study||379
2353110|NCT01652872|5773871|P1|STARTED|Overall Study||377
2353111|NCT01652729|5773888|P3|NOT COMPLETED|Overall Study||14
2353112|NCT01652729|5773889|P2|NOT COMPLETED|Overall Study||13
2353113|NCT01652729|5773890|P1|NOT COMPLETED|Overall Study||27
2353114|NCT01652729|5773888|P3|COMPLETED|Overall Study||47
2353115|NCT01652729|5773889|P2|COMPLETED|Overall Study||109
2353116|NCT01652729|5773890|P1|COMPLETED|Overall Study|The double-enrolled subject’s reasons for withdrawal were LTFU and PV. Only PV is shown below.|155
2353117|NCT01652729|5773888|P3|Meal Test Evaluable|Overall Study||15
2353118|NCT01652729|5773889|P2|Meal Test Evaluable|Overall Study||31
2353119|NCT01652729|5773890|P1|Meal Test Evaluable|Overall Study|ITT subjects who ate >=75% of meal and did not miss 2-hour postprandial glucose measures at V3 and 8|44
2353120|NCT01652729|5773888|P3|Meal Test Subjects|Overall Study||20
2353121|NCT01652729|5773889|P2|Meal Test Subjects|Overall Study||41
2353122|NCT01652729|5773890|P1|Meal Test Subjects|Overall Study||60
2353123|NCT01652729|5773888|P3|Evaluable|Overall Study||43
2353124|NCT01652729|5773889|P2|Evaluable|Overall Study||91
2353125|NCT01652729|5773890|P1|Evaluable|Overall Study|Subjects who completed study procedures to Week 24 or beyond and had adequate study drug exposure|143
2353126|NCT01652729|5773888|P3|Treated|Overall Study||61
2353127|NCT01652729|5773889|P2|Treated|Overall Study||122
2353128|NCT01652729|5773890|P1|Treated|Overall Study|All subjects who received at least one dose of study medication even if not randomized.|181
2353129|NCT01652729|5773888|P3|Modified Intent-to-Treat|Overall Study||61
2353130|NCT01652729|5773889|P2|Modified Intent-to-Treat|Overall Study||122
2353131|NCT01652729|5773890|P1|Modified Intent-to-Treat|Overall Study|All randomized subjects who received at least one dose of study drug.|181
2353132|NCT01652729|5773888|P3|STARTED|Overall Study||61
2353133|NCT01652729|5773889|P2|STARTED|Overall Study||122
2353134|NCT01652729|5773890|P1|STARTED|Overall Study|One subject was enrolled twice at different sites. He was randomized to exenatide at both sites.|182
2353135|NCT01652716|5773912|P2|NOT COMPLETED|Overall Study||46
2353136|NCT01652716|5773913|P1|NOT COMPLETED|Overall Study||56
2353137|NCT01652716|5773912|P2|COMPLETED|Overall Study|* completed study|102
2353138|NCT01652716|5773913|P1|COMPLETED|Overall Study|* completed study|173
2353139|NCT01652716|5773912|P2|Completed 28-week|Overall Study||118
2353140|NCT01652716|5773913|P1|Completed 28-week|Overall Study||197
2353141|NCT01652716|5773912|P2|STARTED|Overall Study|Two subjects in the exenatide BID group withdrew from the study before receiving study drug.|148
2353142|NCT01652716|5773913|P1|STARTED|Overall Study||229
2353143|NCT01652703|5773933|P6|NOT COMPLETED|Overall Study||2
2353144|NCT01652703|5773934|P5|NOT COMPLETED|Overall Study||1
2353145|NCT01652703|5773935|P4|NOT COMPLETED|Overall Study||2
2353146|NCT01652703|5773936|P3|NOT COMPLETED|Overall Study||3
2353147|NCT01652703|5773937|P2|NOT COMPLETED|Overall Study||1
2353148|NCT01652703|5773938|P1|NOT COMPLETED|Overall Study||0
2353149|NCT01652703|5773933|P6|COMPLETED|Overall Study||51
2353150|NCT01652703|5773934|P5|COMPLETED|Overall Study||51
2353151|NCT01652703|5773935|P4|COMPLETED|Overall Study||50
2353152|NCT01652703|5773936|P3|COMPLETED|Overall Study||47
2353153|NCT01652703|5773937|P2|COMPLETED|Overall Study||50
2353154|NCT01652703|5773938|P1|COMPLETED|Overall Study||52
2353155|NCT01652703|5773933|P6|Received Treatment|Overall Study||53
2353156|NCT01652703|5773934|P5|Received Treatment|Overall Study||51
2353157|NCT01652703|5773935|P4|Received Treatment|Overall Study||52
2353158|NCT01652703|5773936|P3|Received Treatment|Overall Study||49
2353159|NCT01652703|5773937|P2|Received Treatment|Overall Study||50
2353160|NCT01652703|5773938|P1|Received Treatment|Overall Study||52
2353161|NCT01652703|5773933|P6|STARTED|Overall Study||53
2353162|NCT01652703|5773934|P5|STARTED|Overall Study||52
2353163|NCT01652703|5773935|P4|STARTED|Overall Study||52
2353164|NCT01652703|5773936|P3|STARTED|Overall Study||50
2353165|NCT01652703|5773937|P2|STARTED|Overall Study||51
2353166|NCT01652703|5773938|P1|STARTED|Overall Study||52
2353167|NCT01652690|5773996|P2|NOT COMPLETED|Overall Study||21
2353168|NCT01652690|5773997|P1|NOT COMPLETED|Overall Study||35
2353169|NCT01652690|5773996|P2|COMPLETED|Overall Study||279
2353170|NCT01652690|5773997|P1|COMPLETED|Overall Study||265
2353171|NCT01652690|5773996|P2|STARTED|Overall Study||300
2353172|NCT01652690|5773997|P1|STARTED|Overall Study||300
2353173|NCT01652664|5774031|P2|NOT COMPLETED|Overall Study||1
2353174|NCT01652664|5774032|P1|NOT COMPLETED|Overall Study||6
2353175|NCT01652664|5774031|P2|COMPLETED|Overall Study||74
2353176|NCT01652664|5774032|P1|COMPLETED|Overall Study||71
2353177|NCT01652664|5774031|P2|STARTED|Overall Study||75
2353178|NCT01652664|5774032|P1|STARTED|Overall Study||77
2353179|NCT01652573|5774041|P2|NOT COMPLETED|Overall Study||1
2353180|NCT01652573|5774042|P1|NOT COMPLETED|Overall Study||0
2353181|NCT01652573|5774041|P2|COMPLETED|Overall Study||10
2353182|NCT01652573|5774042|P1|COMPLETED|Overall Study||10
2353183|NCT01652573|5774041|P2|STARTED|Overall Study||11
2353184|NCT01652573|5774042|P1|STARTED|Overall Study||10
2353185|NCT01652534|5774084|P2|NOT COMPLETED|Overall Study||0
2353186|NCT01652534|5774085|P1|NOT COMPLETED|Overall Study||1
2353187|NCT01652534|5774084|P2|COMPLETED|Overall Study||1
2353188|NCT01652534|5774085|P1|COMPLETED|Overall Study||1
2353189|NCT01652534|5774084|P2|STARTED|Overall Study||1
2353190|NCT01652534|5774085|P1|STARTED|Overall Study||2
2353191|NCT01652495|5774113|P2|NOT COMPLETED|Overall Study||2
2353192|NCT01652495|5774114|P1|NOT COMPLETED|Overall Study||2
2353193|NCT01652495|5774113|P2|COMPLETED|Overall Study||20
2353194|NCT01652495|5774114|P1|COMPLETED|Overall Study||20
2353195|NCT01652495|5774113|P2|STARTED|Overall Study||22
2353196|NCT01652495|5774114|P1|STARTED|Overall Study||22
2353197|NCT01652469|5774126|P2|NOT COMPLETED|Overall Study||6
2353198|NCT01652469|5774127|P1|NOT COMPLETED|Overall Study||1
2353199|NCT01652469|5774126|P2|COMPLETED|Overall Study||36
2353200|NCT01652469|5774127|P1|COMPLETED|Overall Study||37
2353201|NCT01652469|5774126|P2|STARTED|Overall Study||42
2353202|NCT01652469|5774127|P1|STARTED|Overall Study||38
2353203|NCT01652287|5774143|P2|NOT COMPLETED|Overall Study||0
2353204|NCT01652287|5774144|P1|NOT COMPLETED|Overall Study||2
2353205|NCT01652287|5774143|P2|COMPLETED|Overall Study||31
2353206|NCT01652287|5774144|P1|COMPLETED|Overall Study|• Did not receive allocated intervention (withdrew consent) (n=2)|29
2353207|NCT01652287|5774143|P2|STARTED|Overall Study||31
2353208|NCT01652287|5774144|P1|STARTED|Overall Study||31
2353209|NCT01652040|5774152|P2|NOT COMPLETED|Overall Study||2
2353210|NCT01652040|5774153|P1|NOT COMPLETED|Overall Study||2
2353211|NCT01652040|5774152|P2|COMPLETED|Overall Study||11
2353212|NCT01652040|5774153|P1|COMPLETED|Overall Study||11
2353213|NCT01652040|5774152|P2|STARTED|Overall Study||13
2353214|NCT01652040|5774153|P1|STARTED|Overall Study||13
2353215|NCT01652001|5774163|P2|NOT COMPLETED|Overall Study||6
2353216|NCT01652001|5774164|P1|NOT COMPLETED|Overall Study||9
2353217|NCT01652001|5774163|P2|COMPLETED|Overall Study||79
2353218|NCT01652001|5774164|P1|COMPLETED|Overall Study||91
2353219|NCT01652001|5774163|P2|STARTED|Overall Study||85
2353220|NCT01652001|5774164|P1|STARTED|Overall Study||100
2353221|NCT01651949|5774175|P3|NOT COMPLETED|Overall Study||31
2353222|NCT01651949|5774176|P2|NOT COMPLETED|Overall Study||86
2353223|NCT01651949|5774177|P1|NOT COMPLETED|Overall Study||53
2353224|NCT01651949|5774175|P3|COMPLETED|Overall Study||282
2353225|NCT01651949|5774176|P2|COMPLETED|Overall Study||1015
2353226|NCT01651949|5774177|P1|COMPLETED|Overall Study||1053
2353227|NCT01651949|5774175|P3|Vaccination 3|Overall Study||291
2353228|NCT01651949|5774176|P2|Vaccination 3|Overall Study||1037
2353229|NCT01651949|5774177|P1|Vaccination 3|Overall Study||1067
2353230|NCT01651949|5774175|P3|Vaccination 2|Overall Study||298
2353231|NCT01651949|5774176|P2|Vaccination 2|Overall Study||1069
2353232|NCT01651949|5774177|P1|Vaccination 2|Overall Study||1089
2353233|NCT01651949|5774175|P3|Vaccination 1|Overall Study||313
2353234|NCT01651949|5774176|P2|Vaccination 1|Overall Study||1099
2353235|NCT01651949|5774177|P1|Vaccination 1|Overall Study||1103
2353236|NCT01651949|5774175|P3|STARTED|Overall Study||313
2353237|NCT01651949|5774176|P2|STARTED|Overall Study||1101
2353238|NCT01651949|5774177|P1|STARTED|Overall Study||1106
2353239|NCT01651936|5774197|P3|NOT COMPLETED|Extension Study||14
2353240|NCT01651936|5774198|P2|NOT COMPLETED|Extension Study||0
2353241|NCT01651936|5774199|P1|NOT COMPLETED|Extension Study||0
2353242|NCT01651936|5774197|P3|COMPLETED|Extension Study||0
2353243|NCT01651936|5774198|P2|COMPLETED|Extension Study||0
2353244|NCT01651936|5774199|P1|COMPLETED|Extension Study||0
2353245|NCT01651936|5774197|P3|STARTED|Extension Study|Includes completers and early escapees from the Base Study|14
2353246|NCT01651936|5774198|P2|STARTED|Extension Study||0
2353247|NCT01651936|5774199|P1|STARTED|Extension Study||0
2353248|NCT01651936|5774197|P3|NOT COMPLETED|Base Study||0
2353249|NCT01651936|5774198|P2|NOT COMPLETED|Base Study||25
2353250|NCT01651936|5774199|P1|NOT COMPLETED|Base Study||27
2353251|NCT01651936|5774197|P3|COMPLETED|Base Study||0
2353252|NCT01651936|5774198|P2|COMPLETED|Base Study||1
2353253|NCT01651936|5774199|P1|COMPLETED|Base Study||3
2353254|NCT01651936|5774197|P3|STARTED|Base Study||0
2353255|NCT01651936|5774198|P2|STARTED|Base Study||26
2353256|NCT01651936|5774199|P1|STARTED|Base Study||30
2353257|NCT01651806|5774225|P5|NOT COMPLETED|Overall Study||0
2353258|NCT01651806|5774226|P4|NOT COMPLETED|Overall Study||0
2353259|NCT01651806|5774227|P3|NOT COMPLETED|Overall Study||0
2353260|NCT01651806|5774228|P2|NOT COMPLETED|Overall Study||0
2353261|NCT01651806|5774229|P1|NOT COMPLETED|Overall Study||0
2353262|NCT01651806|5774225|P5|COMPLETED|Overall Study||8
2353263|NCT01651806|5774226|P4|COMPLETED|Overall Study||7
2353264|NCT01651806|5774227|P3|COMPLETED|Overall Study||25
2353265|NCT01651806|5774228|P2|COMPLETED|Overall Study||12
2353266|NCT01651806|5774229|P1|COMPLETED|Overall Study||13
2353267|NCT01651806|5774225|P5|STARTED|Overall Study||8
2353268|NCT01651806|5774226|P4|STARTED|Overall Study||7
2353269|NCT01651806|5774227|P3|STARTED|Overall Study||25
2353270|NCT01651806|5774228|P2|STARTED|Overall Study||12
2353271|NCT01651806|5774229|P1|STARTED|Overall Study||13
2353272|NCT01651793|5774246|P4|NOT COMPLETED|Overall Study||1
2353273|NCT01651793|5774247|P3|NOT COMPLETED|Overall Study||0
2353274|NCT01651793|5774248|P2|NOT COMPLETED|Overall Study||0
2353275|NCT01651793|5774249|P1|NOT COMPLETED|Overall Study||0
2353276|NCT01651793|5774246|P4|COMPLETED|Overall Study||5
2353277|NCT01651793|5774247|P3|COMPLETED|Overall Study||6
2353278|NCT01651793|5774248|P2|COMPLETED|Overall Study||6
2353279|NCT01651793|5774249|P1|COMPLETED|Overall Study||6
2353280|NCT01651793|5774246|P4|STARTED|Overall Study||6
2353281|NCT01651793|5774247|P3|STARTED|Overall Study||6
2353282|NCT01651793|5774248|P2|STARTED|Overall Study||6
2353283|NCT01651793|5774249|P1|STARTED|Overall Study||6
2353284|NCT01651780|5774269|P2|NOT COMPLETED|Overall Study||10
2353285|NCT01651780|5774270|P1|NOT COMPLETED|Overall Study||11
2353286|NCT01651780|5774269|P2|COMPLETED|Overall Study||388
2353287|NCT01651780|5774270|P1|COMPLETED|Overall Study||394
2353288|NCT01651780|5774269|P2|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|0
2353289|NCT01651780|5774270|P1|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|65
2353290|NCT01651780|5774269|P2|Received at Least 1 Dose of Study Drug|Overall Study||394
2353291|NCT01651780|5774270|P1|Received at Least 1 Dose of Study Drug|Overall Study|All but 1 participant in the bivalirudin group (withdrew consent) comprised the ITT population.|393
2353292|NCT01651780|5774269|P2|Intent-To-Treat (ITT) Population|Overall Study||398
2353293|NCT01651780|5774270|P1|Intent-To-Treat (ITT) Population|Overall Study||404
2353294|NCT01651780|5774269|P2|STARTED|Overall Study||398
2353295|NCT01651780|5774270|P1|STARTED|Overall Study||405
2353296|NCT01651442|5774302|P6|NOT COMPLETED|Phase II Treatment||10
2353297|NCT01651442|5774303|P5|NOT COMPLETED|Phase II Treatment||6
2353298|NCT01651442|5774304|P4|NOT COMPLETED|Phase II Treatment||12
2353299|NCT01651442|5774305|P3|NOT COMPLETED|Phase II Treatment||2
2353300|NCT01651442|5774306|P2|NOT COMPLETED|Phase II Treatment||0
2353301|NCT01651442|5774307|P1|NOT COMPLETED|Phase II Treatment||0
2353302|NCT01651442|5774302|P6|COMPLETED|Phase II Treatment||17
2353303|NCT01651442|5774303|P5|COMPLETED|Phase II Treatment||21
2353304|NCT01651442|5774304|P4|COMPLETED|Phase II Treatment||15
2353305|NCT01651442|5774305|P3|COMPLETED|Phase II Treatment||25
2353306|NCT01651442|5774306|P2|COMPLETED|Phase II Treatment||0
2353307|NCT01651442|5774307|P1|COMPLETED|Phase II Treatment||0
2353308|NCT01651442|5774302|P6|STARTED|Phase II Treatment||27
2353309|NCT01651442|5774303|P5|STARTED|Phase II Treatment||27
2353310|NCT01651442|5774304|P4|STARTED|Phase II Treatment||27
2353311|NCT01651442|5774305|P3|STARTED|Phase II Treatment||27
2353312|NCT01651442|5774306|P2|STARTED|Phase II Treatment||0
2353313|NCT01651442|5774307|P1|STARTED|Phase II Treatment||0
2353314|NCT01651442|5774302|P6|NOT COMPLETED|Phase I Treatment||0
2353315|NCT01651442|5774303|P5|NOT COMPLETED|Phase I Treatment||0
2353316|NCT01651442|5774304|P4|NOT COMPLETED|Phase I Treatment||0
2353317|NCT01651442|5774305|P3|NOT COMPLETED|Phase I Treatment||0
2353318|NCT01651442|5774306|P2|NOT COMPLETED|Phase I Treatment||27
2353319|NCT01651442|5774307|P1|NOT COMPLETED|Phase I Treatment||16
2353320|NCT01651442|5774302|P6|COMPLETED|Phase I Treatment||0
2353321|NCT01651442|5774303|P5|COMPLETED|Phase I Treatment||0
2353322|NCT01651442|5774304|P4|COMPLETED|Phase I Treatment||0
2353323|NCT01651442|5774305|P3|COMPLETED|Phase I Treatment||0
2353324|NCT01651442|5774306|P2|COMPLETED|Phase I Treatment||80
2353325|NCT01651442|5774307|P1|COMPLETED|Phase I Treatment||88
2353326|NCT01651442|5774302|P6|STARTED|Phase I Treatment||0
2353327|NCT01651442|5774303|P5|STARTED|Phase I Treatment||0
2353328|NCT01651442|5774304|P4|STARTED|Phase I Treatment||0
2353329|NCT01651442|5774305|P3|STARTED|Phase I Treatment||0
2353330|NCT01651442|5774306|P2|STARTED|Phase I Treatment||107
2353331|NCT01651442|5774307|P1|STARTED|Phase I Treatment||104
2353332|NCT01651403|5774321|P2|NOT COMPLETED|Open-Label TDF Phase (Weeks 49/73-96)||22
2353333|NCT01651403|5774322|P1|NOT COMPLETED|Open-Label TDF Phase (Weeks 49/73-96)||47
2353334|NCT01651403|5774321|P2|COMPLETED|Open-Label TDF Phase (Weeks 49/73-96)||3
2353335|NCT01651403|5774322|P1|COMPLETED|Open-Label TDF Phase (Weeks 49/73-96)||9
2353336|NCT01651403|5774321|P2|STARTED|Open-Label TDF Phase (Weeks 49/73-96)|1 participant completed the Double-Blind Phase but did not enter the Open-Label TDF Phase.|25
2353337|NCT01651403|5774322|P1|STARTED|Open-Label TDF Phase (Weeks 49/73-96)||56
2353338|NCT01651403|5774321|P2|NOT COMPLETED|Double-Blind Period (Through Week 48/72)||4
2353339|NCT01651403|5774322|P1|NOT COMPLETED|Double-Blind Period (Through Week 48/72)||4
2353340|NCT01651403|5774321|P2|COMPLETED|Double-Blind Period (Through Week 48/72)||26
2353341|NCT01651403|5774322|P1|COMPLETED|Double-Blind Period (Through Week 48/72)||56
2353342|NCT01651403|5774321|P2|STARTED|Double-Blind Period (Through Week 48/72)||30
2353343|NCT01651403|5774322|P1|STARTED|Double-Blind Period (Through Week 48/72)||60
2353344|NCT01651351|5774352|P2|NOT COMPLETED|Overall Study||0
2353345|NCT01651351|5774353|P1|NOT COMPLETED|Overall Study||0
2353346|NCT01651351|5774352|P2|COMPLETED|Overall Study||15
2353347|NCT01651351|5774353|P1|COMPLETED|Overall Study||15
2353348|NCT01651351|5774352|P2|STARTED|Overall Study||15
2353349|NCT01651351|5774353|P1|STARTED|Overall Study||15
2353350|NCT01651260|5774370|P1|NOT COMPLETED|Overall Study||3
2353351|NCT01651260|5774370|P1|COMPLETED|Overall Study||62
2353352|NCT01651260|5774370|P1|STARTED|Overall Study||65
2353353|NCT01651208|5774377|P2|NOT COMPLETED|Overall Study||16
2353354|NCT01651208|5774378|P1|NOT COMPLETED|Overall Study||14
2353355|NCT01651208|5774377|P2|COMPLETED|Overall Study|16 subjects had no pharmacy claims data to analyze primary outcome|209
2353356|NCT01651208|5774378|P1|COMPLETED|Overall Study|14 patients had no pharmacy claims data to analyze primary outcome|213
2353357|NCT01651208|5774377|P2|STARTED|Overall Study||225
2353358|NCT01651208|5774378|P1|STARTED|Overall Study||227
2353359|NCT01651117|5774390|P4|NOT COMPLETED|Overall Study||2
2353360|NCT01651117|5774391|P3|NOT COMPLETED|Overall Study||2
2353361|NCT01651117|5774392|P2|NOT COMPLETED|Overall Study||3
2353362|NCT01651117|5774393|P1|NOT COMPLETED|Overall Study||2
2353363|NCT01651117|5774390|P4|COMPLETED|Overall Study||68
2353364|NCT01651117|5774391|P3|COMPLETED|Overall Study||47
2353365|NCT01651117|5774392|P2|COMPLETED|Overall Study||202
2353366|NCT01651117|5774393|P1|COMPLETED|Overall Study||154
2353367|NCT01651117|5774390|P4|STARTED|Overall Study||70
2353368|NCT01651117|5774391|P3|STARTED|Overall Study||49
2353369|NCT01651117|5774392|P2|STARTED|Overall Study||205
2353370|NCT01651117|5774393|P1|STARTED|Overall Study||156
2353371|NCT01651104|5774459|P1|NOT COMPLETED|Overall Study||0
2353372|NCT01651104|5774459|P1|COMPLETED|Overall Study||63
2353373|NCT01651104|5774459|P1|STARTED|Overall Study||63
2353374|NCT01651078|5774466|P1|NOT COMPLETED|Overall Study||26
2353375|NCT01651078|5774466|P1|COMPLETED|Overall Study||16
2353376|NCT01651078|5774466|P1|STARTED|Overall Study|Two (2) out of 44 patients were enrolled but did not go on to have the NeuroBlate Procedure.|42
2353377|NCT01651052|5774473|P1|NOT COMPLETED|Overall Study||26
2353378|NCT01651052|5774473|P1|COMPLETED|Overall Study||107
2353379|NCT01651052|5774473|P1|Study Valve Group|Overall Study||133
2353380|NCT01651052|5774473|P1|STARTED|Overall Study||133
2353381|NCT01651039|5774493|P1|NOT COMPLETED|Overall Study||30
2353382|NCT01651039|5774493|P1|COMPLETED|Overall Study||2
2353383|NCT01651039|5774493|P1|STARTED|Overall Study||32
2353384|NCT01651000|5774506|P2|NOT COMPLETED|Overall Study||28
2353385|NCT01651000|5774507|P1|NOT COMPLETED|Overall Study||10
2353386|NCT01651000|5774506|P2|COMPLETED|Overall Study||113
2353387|NCT01651000|5774507|P1|COMPLETED|Overall Study||62
2353388|NCT01651000|5774506|P2|Entered Extension Study|Overall Study||93
2353389|NCT01651000|5774507|P1|Entered Extension Study|Overall Study||50
2353390|NCT01651000|5774506|P2|STARTED|Overall Study||141
2353391|NCT01651000|5774507|P1|STARTED|Overall Study||72
2353392|NCT01650844|5774521|P2|NOT COMPLETED|Overall Study||4
2353393|NCT01650844|5774522|P1|NOT COMPLETED|Overall Study||1
2353394|NCT01650844|5774521|P2|COMPLETED|Overall Study||196
2353395|NCT01650844|5774522|P1|COMPLETED|Overall Study||199
2353396|NCT01650844|5774521|P2|STARTED|Overall Study||200
2353397|NCT01650844|5774522|P1|STARTED|Overall Study||200
2353398|NCT01650831|5774528|P1|NOT COMPLETED|Overall Study||1
2353399|NCT01650831|5774528|P1|COMPLETED|Overall Study||112
2353400|NCT01650831|5774528|P1|STARTED|Overall Study||113
2353401|NCT01650805|5774538|P2|NOT COMPLETED|Overall Study||0
2353402|NCT01650805|5774539|P1|NOT COMPLETED|Overall Study||1
2353403|NCT01650805|5774538|P2|COMPLETED|Overall Study||152
2353404|NCT01650805|5774539|P1|COMPLETED|Overall Study|Completed means patient initiated and discontinued study treatment.|154
2353405|NCT01650805|5774538|P2|STARTED|Overall Study||152
2353406|NCT01650805|5774539|P1|STARTED|Overall Study|Started means patient has been randomized.|155
2353407|NCT01650779|5774549|P1|NOT COMPLETED|Overall Study||1
2353408|NCT01650779|5774549|P1|COMPLETED|Overall Study||14
2353409|NCT01650779|5774549|P1|STARTED|Overall Study||15
2353410|NCT01650636|5774558|P2|NOT COMPLETED|9 Month Visit||0
2353411|NCT01650636|5774559|P1|NOT COMPLETED|9 Month Visit||0
2353412|NCT01650636|5774558|P2|COMPLETED|9 Month Visit||129
2353413|NCT01650636|5774559|P1|COMPLETED|9 Month Visit||135
2353414|NCT01650636|5774558|P2|STARTED|9 Month Visit||129
2353415|NCT01650636|5774559|P1|STARTED|9 Month Visit||135
2353416|NCT01650636|5774558|P2|NOT COMPLETED|Washout up to 9 Months||3
2353417|NCT01650636|5774559|P1|NOT COMPLETED|Washout up to 9 Months||6
2353418|NCT01650636|5774558|P2|COMPLETED|Washout up to 9 Months||129
2353419|NCT01650636|5774559|P1|COMPLETED|Washout up to 9 Months||135
2353420|NCT01650636|5774558|P2|STARTED|Washout up to 9 Months||132
2353421|NCT01650636|5774559|P1|STARTED|Washout up to 9 Months||141
2353422|NCT01650636|5774558|P2|NOT COMPLETED|5 Month Visit||0
2353423|NCT01650636|5774559|P1|NOT COMPLETED|5 Month Visit||0
2353424|NCT01650636|5774558|P2|COMPLETED|5 Month Visit||132
2353425|NCT01650636|5774559|P1|COMPLETED|5 Month Visit||141
2353426|NCT01650636|5774558|P2|STARTED|5 Month Visit||132
2353427|NCT01650636|5774559|P1|STARTED|5 Month Visit||141
2353428|NCT01650636|5774558|P2|NOT COMPLETED|Washout up to 5 Months||18
2353429|NCT01650636|5774559|P1|NOT COMPLETED|Washout up to 5 Months||9
2353430|NCT01650636|5774558|P2|COMPLETED|Washout up to 5 Months||132
2353431|NCT01650636|5774559|P1|COMPLETED|Washout up to 5 Months||141
2353432|NCT01650636|5774558|P2|STARTED|Washout up to 5 Months||150
2353433|NCT01650636|5774559|P1|STARTED|Washout up to 5 Months||150
2353434|NCT01650636|5774558|P2|NOT COMPLETED|Intervention Phase||0
2353435|NCT01650636|5774559|P1|NOT COMPLETED|Intervention Phase||0
2353436|NCT01650636|5774558|P2|COMPLETED|Intervention Phase||150
2353437|NCT01650636|5774559|P1|COMPLETED|Intervention Phase||150
2353438|NCT01650636|5774558|P2|STARTED|Intervention Phase||150
2353439|NCT01650636|5774559|P1|STARTED|Intervention Phase||150
2353440|NCT01650545|5774579|P2|NOT COMPLETED|Overall Study||0
2353441|NCT01650545|5774580|P1|NOT COMPLETED|Overall Study||0
2353442|NCT01650545|5774579|P2|COMPLETED|Overall Study||10
2353443|NCT01650545|5774580|P1|COMPLETED|Overall Study||11
2353444|NCT01650545|5774579|P2|STARTED|Overall Study||10
2353445|NCT01650545|5774580|P1|STARTED|Overall Study||11
2353446|NCT01650519|5774592|P2|NOT COMPLETED|Overall Study||0
2353447|NCT01650519|5774593|P1|NOT COMPLETED|Overall Study||1
2353448|NCT01650519|5774592|P2|COMPLETED|Overall Study||31
2353449|NCT01650519|5774593|P1|COMPLETED|Overall Study||19
2353450|NCT01650519|5774592|P2|STARTED|Overall Study||31
2353451|NCT01650519|5774593|P1|STARTED|Overall Study||20
2353452|NCT01650350|5774611|P1|NOT COMPLETED|Overall Study||0
2353453|NCT01650350|5774611|P1|COMPLETED|Overall Study||7
2353454|NCT01650350|5774611|P1|STARTED|Overall Study||7
2353455|NCT01650324|5774622|P5|NOT COMPLETED|Overall Study||0
2353456|NCT01650324|5774623|P4|NOT COMPLETED|Overall Study||0
2353457|NCT01650324|5774624|P3|NOT COMPLETED|Overall Study||0
2353458|NCT01650324|5774625|P2|NOT COMPLETED|Overall Study||0
2353459|NCT01650324|5774626|P1|NOT COMPLETED|Overall Study||0
2353460|NCT01650324|5774622|P5|COMPLETED|Overall Study||6
2353461|NCT01650324|5774623|P4|COMPLETED|Overall Study||6
2353462|NCT01650324|5774624|P3|COMPLETED|Overall Study||6
2353463|NCT01650324|5774625|P2|COMPLETED|Overall Study||6
2353464|NCT01650324|5774626|P1|COMPLETED|Overall Study||8
2353465|NCT01650324|5774622|P5|STARTED|Overall Study||6
2353466|NCT01650324|5774623|P4|STARTED|Overall Study||6
2353467|NCT01650324|5774624|P3|STARTED|Overall Study||6
2353468|NCT01650324|5774625|P2|STARTED|Overall Study||6
2353469|NCT01650324|5774626|P1|STARTED|Overall Study||8
2353470|NCT01650285|5774655|P1|NOT COMPLETED|Overall Study||1
2353471|NCT01650285|5774655|P1|COMPLETED|Overall Study||4
2353472|NCT01650285|5774655|P1|STARTED|Overall Study||5
2353473|NCT01650259|5774662|P2|NOT COMPLETED|Overall Study||235
2353474|NCT01650259|5774663|P1|NOT COMPLETED|Overall Study||1043
2353475|NCT01650259|5774662|P2|COMPLETED|Overall Study||2128
2353476|NCT01650259|5774663|P1|COMPLETED|Overall Study||1470
2353477|NCT01650259|5774662|P2|STARTED|Overall Study|Started are the registered patients|2363
2353478|NCT01650259|5774663|P1|STARTED|Overall Study|Started are the registered patients|2513
2353479|NCT01650246|5774668|P1|NOT COMPLETED|Overall Study||143
2353480|NCT01650246|5774668|P1|COMPLETED|Overall Study||0
2353481|NCT01650246|5774668|P1|STARTED|Overall Study||143
2353482|NCT01650194|5774673|P1|NOT COMPLETED|Overall Study||47
2353483|NCT01650194|5774673|P1|COMPLETED|Overall Study||13
2353484|NCT01650194|5774673|P1|Treated|Overall Study||60
2353485|NCT01650194|5774673|P1|STARTED|Overall Study||60
2353486|NCT01649947|5774698|P2|NOT COMPLETED|Overall Study||18
2353487|NCT01649947|5774699|P1|NOT COMPLETED|Overall Study||12
2353488|NCT01649947|5774698|P2|COMPLETED|Overall Study||2
2353489|NCT01649947|5774699|P1|COMPLETED|Overall Study||0
2353490|NCT01649947|5774698|P2|STARTED|Overall Study||20
2353491|NCT01649947|5774699|P1|STARTED|Overall Study||12
2353492|NCT01649856|5774709|P2|NOT COMPLETED|Overall Study||78
2353493|NCT01649856|5774710|P1|NOT COMPLETED|Overall Study||139
2353494|NCT01649856|5774709|P2|COMPLETED|Overall Study||125
2353495|NCT01649856|5774710|P1|COMPLETED|Overall Study||230
2353496|NCT01649856|5774709|P2|STARTED|Overall Study||203
2353497|NCT01649856|5774710|P1|STARTED|Overall Study||369
2353498|NCT01649804|5774742|P1|NOT COMPLETED|Overall Study||8
2353499|NCT01649804|5774742|P1|COMPLETED|Overall Study||4
2353500|NCT01649804|5774742|P1|STARTED|Overall Study||12
2353501|NCT01649791|5774754|P1|NOT COMPLETED|Overall Study||3
2353502|NCT01649791|5774754|P1|COMPLETED|Overall Study||5
2353503|NCT01649791|5774754|P1|STARTED|Overall Study||8
2353510|NCT01649609|5774792|P2|NOT COMPLETED|Overall Study||0
2353511|NCT01649609|5774793|P1|NOT COMPLETED|Overall Study||0
2353512|NCT01649609|5774792|P2|COMPLETED|Overall Study||20
2353513|NCT01649609|5774793|P1|COMPLETED|Overall Study||20
2353514|NCT01649609|5774792|P2|STARTED|Overall Study||20
2353515|NCT01649609|5774793|P1|STARTED|Overall Study||20
2353516|NCT01649596|5774803|P2|NOT COMPLETED|Overall Study||0
2353517|NCT01649596|5774804|P1|NOT COMPLETED|Overall Study||0
2353518|NCT01649596|5774803|P2|COMPLETED|Overall Study||48
2353519|NCT01649596|5774804|P1|COMPLETED|Overall Study||46
2353520|NCT01649596|5774803|P2|STARTED|Overall Study||48
2353521|NCT01649596|5774804|P1|STARTED|Overall Study||46
2353522|NCT01649557|5774815|P3|NOT COMPLETED|Overall Study||9
2353523|NCT01649557|5774816|P2|NOT COMPLETED|Overall Study||14
2353524|NCT01649557|5774817|P1|NOT COMPLETED|Overall Study||44
2353525|NCT01649557|5774815|P3|COMPLETED|Overall Study||15
2353526|NCT01649557|5774816|P2|COMPLETED|Overall Study||27
2353527|NCT01649557|5774817|P1|COMPLETED|Overall Study||135
2353528|NCT01649557|5774815|P3|52-week Enrollers|Overall Study||2
2353529|NCT01649557|5774816|P2|52-week Enrollers|Overall Study||6
2353530|NCT01649557|5774817|P1|52-week Enrollers|Overall Study||20
2353531|NCT01649557|5774815|P3|6-week Enrollers|Overall Study||22
2353532|NCT01649557|5774816|P2|6-week Enrollers|Overall Study||35
2353533|NCT01649557|5774817|P1|6-week Enrollers|Overall Study||159
2353534|NCT01649557|5774815|P3|STARTED|Overall Study||24
2353535|NCT01649557|5774816|P2|STARTED|Overall Study||41
2353536|NCT01649557|5774817|P1|STARTED|Overall Study||179
2353537|NCT01649505|5774854|P2|NOT COMPLETED|Overall Study||1
2353538|NCT01649505|5774855|P1|NOT COMPLETED|Overall Study||1
2353539|NCT01649505|5774854|P2|COMPLETED|Overall Study||0
2353540|NCT01649505|5774855|P1|COMPLETED|Overall Study||0
2353541|NCT01649505|5774854|P2|STARTED|Overall Study||1
2353542|NCT01649505|5774855|P1|STARTED|Overall Study||1
2353543|NCT01649427|5774863|P2|NOT COMPLETED|Overall Study||12
2353544|NCT01649427|5774864|P1|NOT COMPLETED|Overall Study||11
2353545|NCT01649427|5774863|P2|COMPLETED|Overall Study||26
2353546|NCT01649427|5774864|P1|COMPLETED|Overall Study||24
2353547|NCT01649427|5774863|P2|STARTED|Overall Study||38
2353548|NCT01649427|5774864|P1|STARTED|Overall Study||35
2353549|NCT01649375|5774883|P5|NOT COMPLETED|Week 16 up to Week 260||5
2353550|NCT01649375|5774884|P4|NOT COMPLETED|Week 16 up to Week 260||12
2353551|NCT01649375|5774885|P3|NOT COMPLETED|Week 16 up to Week 260||0
2353552|NCT01649375|5774886|P2|NOT COMPLETED|Week 16 up to Week 260||13
2353553|NCT01649375|5774887|P1|NOT COMPLETED|Week 16 up to Week 260||20
2353554|NCT01649375|5774883|P5|COMPLETED|Week 16 up to Week 260||29
2353555|NCT01649375|5774884|P4|COMPLETED|Week 16 up to Week 260||20
2353556|NCT01649375|5774885|P3|COMPLETED|Week 16 up to Week 260||0
2353557|NCT01649375|5774886|P2|COMPLETED|Week 16 up to Week 260||53
2353558|NCT01649375|5774887|P1|COMPLETED|Week 16 up to Week 260||48
2353559|NCT01649375|5774883|P5|STARTED|Week 16 up to Week 260||34
2353560|NCT01649375|5774884|P4|STARTED|Week 16 up to Week 260||32
2353561|NCT01649375|5774885|P3|STARTED|Week 16 up to Week 260||0
2353562|NCT01649375|5774886|P2|STARTED|Week 16 up to Week 260||66
2353563|NCT01649375|5774887|P1|STARTED|Week 16 up to Week 260||68
2353564|NCT01649375|5774883|P5|NOT COMPLETED|Up to Week 16||0
2353565|NCT01649375|5774884|P4|NOT COMPLETED|Up to Week 16||0
2353566|NCT01649375|5774885|P3|NOT COMPLETED|Up to Week 16||8
2353567|NCT01649375|5774886|P2|NOT COMPLETED|Up to Week 16||6
2353568|NCT01649375|5774887|P1|NOT COMPLETED|Up to Week 16||5
2353569|NCT01649375|5774883|P5|COMPLETED|Up to Week 16||0
2353570|NCT01649375|5774884|P4|COMPLETED|Up to Week 16||0
2353571|NCT01649375|5774885|P3|COMPLETED|Up to Week 16||66
2353572|NCT01649375|5774886|P2|COMPLETED|Up to Week 16||66
2353573|NCT01649375|5774887|P1|COMPLETED|Up to Week 16||68
2353574|NCT01649375|5774883|P5|STARTED|Up to Week 16||0
2353575|NCT01649375|5774884|P4|STARTED|Up to Week 16||0
2353576|NCT01649375|5774885|P3|STARTED|Up to Week 16||74
2353577|NCT01649375|5774886|P2|STARTED|Up to Week 16||72
2353578|NCT01649375|5774887|P1|STARTED|Up to Week 16||73
2353579|NCT01649362|5774918|P2|NOT COMPLETED|Overall Study||14
2353580|NCT01649362|5774919|P1|NOT COMPLETED|Overall Study||1
2353581|NCT01649362|5774918|P2|COMPLETED|Overall Study||40
2353582|NCT01649362|5774919|P1|COMPLETED|Overall Study||46
2353583|NCT01649362|5774918|P2|STARTED|Overall Study||54
2353584|NCT01649362|5774919|P1|STARTED|Overall Study||47
2353585|NCT01649297|5774934|P5|NOT COMPLETED|Overall Study||4
2353586|NCT01649297|5774935|P4|NOT COMPLETED|Overall Study||19
2353587|NCT01649297|5774936|P3|NOT COMPLETED|Overall Study||17
2353588|NCT01649297|5774937|P2|NOT COMPLETED|Overall Study||13
2353589|NCT01649297|5774938|P1|NOT COMPLETED|Overall Study||14
2353590|NCT01649297|5774934|P5|COMPLETED|Overall Study||103
2353591|NCT01649297|5774935|P4|COMPLETED|Overall Study||201
2353592|NCT01649297|5774936|P3|COMPLETED|Overall Study||202
2353593|NCT01649297|5774937|P2|COMPLETED|Overall Study||205
2353594|NCT01649297|5774938|P1|COMPLETED|Overall Study||205
2353595|NCT01649297|5774934|P5|STARTED|Overall Study|randomised|107
2353596|NCT01649297|5774935|P4|STARTED|Overall Study|randomised|220
2353597|NCT01649297|5774936|P3|STARTED|Overall Study|randomised|219
2353598|NCT01649297|5774937|P2|STARTED|Overall Study|randomised|218
2353599|NCT01649297|5774938|P1|STARTED|Overall Study|randomised|219
2353600|NCT01649271|5774957|P2|NOT COMPLETED|Overall Study||7
2353601|NCT01649271|5774958|P1|NOT COMPLETED|Overall Study||6
2353602|NCT01649271|5774957|P2|COMPLETED|Overall Study||0
2353603|NCT01649271|5774958|P1|COMPLETED|Overall Study||0
2353604|NCT01649271|5774957|P2|STARTED|Overall Study||7
2353605|NCT01649271|5774958|P1|STARTED|Overall Study||6
2353606|NCT01649232|5774973|P2|NOT COMPLETED|Overall Study||0
2353607|NCT01649232|5774974|P1|NOT COMPLETED|Overall Study||2
2353608|NCT01649232|5774973|P2|COMPLETED|Overall Study||30
2353609|NCT01649232|5774974|P1|COMPLETED|Overall Study|technical problems or excessive artifacts, two data sets were excluded from further analysis.|28
2353610|NCT01649232|5774973|P2|STARTED|Overall Study||30
2353611|NCT01649232|5774974|P1|STARTED|Overall Study||30
2353612|NCT01649180|5774994|P1|NOT COMPLETED|Overall Study||0
2353613|NCT01649180|5774994|P1|COMPLETED|Overall Study||3
2353614|NCT01649180|5774994|P1|STARTED|Overall Study||3
2353615|NCT01648920|5775002|P1|NOT COMPLETED|Overall Study||0
2353616|NCT01648920|5775002|P1|COMPLETED|Overall Study||50
2353617|NCT01648920|5775002|P1|STARTED|Overall Study||50
2353618|NCT01648790|5775026|P5|NOT COMPLETED|Treatment 5||0
2353619|NCT01648790|5775027|P4|NOT COMPLETED|Treatment 5||0
2353620|NCT01648790|5775028|P3|NOT COMPLETED|Treatment 5||0
2353621|NCT01648790|5775029|P2|NOT COMPLETED|Treatment 5||0
2353622|NCT01648790|5775030|P1|NOT COMPLETED|Treatment 5||0
2353623|NCT01648790|5775026|P5|COMPLETED|Treatment 5||4
2353624|NCT01648790|5775027|P4|COMPLETED|Treatment 5||3
2353625|NCT01648790|5775028|P3|COMPLETED|Treatment 5||4
2353626|NCT01648790|5775029|P2|COMPLETED|Treatment 5||4
2353627|NCT01648790|5775030|P1|COMPLETED|Treatment 5||4
2353628|NCT01648790|5775026|P5|STARTED|Treatment 5||4
2353629|NCT01648790|5775027|P4|STARTED|Treatment 5||3
2353630|NCT01648790|5775028|P3|STARTED|Treatment 5||4
2353631|NCT01648790|5775029|P2|STARTED|Treatment 5||4
2353632|NCT01648790|5775030|P1|STARTED|Treatment 5||4
2353633|NCT01648790|5775026|P5|NOT COMPLETED|Treatment 4||0
2353634|NCT01648790|5775027|P4|NOT COMPLETED|Treatment 4||0
2353635|NCT01648790|5775028|P3|NOT COMPLETED|Treatment 4||0
2353636|NCT01648790|5775029|P2|NOT COMPLETED|Treatment 4||0
2353637|NCT01648790|5775030|P1|NOT COMPLETED|Treatment 4||0
2353638|NCT01648790|5775026|P5|COMPLETED|Treatment 4||4
2353639|NCT01648790|5775027|P4|COMPLETED|Treatment 4||3
2353640|NCT01648790|5775028|P3|COMPLETED|Treatment 4||4
2353641|NCT01648790|5775029|P2|COMPLETED|Treatment 4||4
2353642|NCT01648790|5775030|P1|COMPLETED|Treatment 4||4
2353643|NCT01648790|5775026|P5|STARTED|Treatment 4||4
2353644|NCT01648790|5775027|P4|STARTED|Treatment 4||3
2353645|NCT01648790|5775028|P3|STARTED|Treatment 4||4
2353646|NCT01648790|5775029|P2|STARTED|Treatment 4||4
2353647|NCT01648790|5775030|P1|STARTED|Treatment 4||4
2353648|NCT01648790|5775026|P5|NOT COMPLETED|Treatment 3||0
2353649|NCT01648790|5775027|P4|NOT COMPLETED|Treatment 3||1
2353650|NCT01648790|5775028|P3|NOT COMPLETED|Treatment 3||0
2353651|NCT01648790|5775029|P2|NOT COMPLETED|Treatment 3||0
2353652|NCT01648790|5775030|P1|NOT COMPLETED|Treatment 3||0
2353653|NCT01648790|5775026|P5|COMPLETED|Treatment 3||4
2353654|NCT01648790|5775027|P4|COMPLETED|Treatment 3||3
2353655|NCT01648790|5775028|P3|COMPLETED|Treatment 3||4
2353656|NCT01648790|5775029|P2|COMPLETED|Treatment 3||4
2353657|NCT01648790|5775030|P1|COMPLETED|Treatment 3||4
2353658|NCT01648790|5775026|P5|STARTED|Treatment 3||4
2353659|NCT01648790|5775027|P4|STARTED|Treatment 3|Withdrew consent prior to dosing on this treatment day.|4
2353660|NCT01648790|5775028|P3|STARTED|Treatment 3||4
2353661|NCT01648790|5775029|P2|STARTED|Treatment 3||4
2353662|NCT01648790|5775030|P1|STARTED|Treatment 3||4
2353663|NCT01648790|5775026|P5|NOT COMPLETED|Treatment 2||0
2353664|NCT01648790|5775027|P4|NOT COMPLETED|Treatment 2||0
2353665|NCT01648790|5775028|P3|NOT COMPLETED|Treatment 2||0
2353666|NCT01648790|5775029|P2|NOT COMPLETED|Treatment 2||0
2353667|NCT01648790|5775030|P1|NOT COMPLETED|Treatment 2||0
2353668|NCT01648790|5775026|P5|COMPLETED|Treatment 2||4
2353669|NCT01648790|5775027|P4|COMPLETED|Treatment 2||4
2353670|NCT01648790|5775028|P3|COMPLETED|Treatment 2||4
2353671|NCT01648790|5775029|P2|COMPLETED|Treatment 2||4
2353672|NCT01648790|5775030|P1|COMPLETED|Treatment 2||4
2353673|NCT01648790|5775026|P5|STARTED|Treatment 2||4
2353674|NCT01648790|5775027|P4|STARTED|Treatment 2||4
2353675|NCT01648790|5775028|P3|STARTED|Treatment 2||4
2353676|NCT01648790|5775029|P2|STARTED|Treatment 2||4
2353677|NCT01648790|5775030|P1|STARTED|Treatment 2||4
2353678|NCT01648790|5775026|P5|NOT COMPLETED|Treatment 1||0
2353679|NCT01648790|5775027|P4|NOT COMPLETED|Treatment 1||0
2353680|NCT01648790|5775028|P3|NOT COMPLETED|Treatment 1||0
2353681|NCT01648790|5775029|P2|NOT COMPLETED|Treatment 1||0
2353682|NCT01648790|5775030|P1|NOT COMPLETED|Treatment 1||0
2353683|NCT01648790|5775026|P5|COMPLETED|Treatment 1||4
2353684|NCT01648790|5775027|P4|COMPLETED|Treatment 1||4
2353685|NCT01648790|5775028|P3|COMPLETED|Treatment 1||4
2353686|NCT01648790|5775029|P2|COMPLETED|Treatment 1||4
2353687|NCT01648790|5775030|P1|COMPLETED|Treatment 1||4
2353688|NCT01648790|5775026|P5|Received at Least 1 Dose of Study Drug|Treatment 1||4
2353689|NCT01648790|5775027|P4|Received at Least 1 Dose of Study Drug|Treatment 1||4
2353690|NCT01648790|5775028|P3|Received at Least 1 Dose of Study Drug|Treatment 1||4
2353691|NCT01648790|5775029|P2|Received at Least 1 Dose of Study Drug|Treatment 1||4
2353692|NCT01648790|5775030|P1|Received at Least 1 Dose of Study Drug|Treatment 1||4
2353693|NCT01648790|5775026|P5|STARTED|Treatment 1||4
2353694|NCT01648790|5775027|P4|STARTED|Treatment 1||4
2353695|NCT01648790|5775028|P3|STARTED|Treatment 1||4
2353696|NCT01648790|5775029|P2|STARTED|Treatment 1||4
2353697|NCT01648790|5775030|P1|STARTED|Treatment 1||4
2353698|NCT01648764|5775065|P14|NOT COMPLETED|Overall Study||3
2353699|NCT01648764|5775066|P13|NOT COMPLETED|Overall Study||4
2353700|NCT01648764|5775067|P12|NOT COMPLETED|Overall Study||5
2353701|NCT01648764|5775068|P11|NOT COMPLETED|Overall Study||0
2353702|NCT01648764|5775069|P10|NOT COMPLETED|Overall Study||3
2353703|NCT01648764|5775070|P9|NOT COMPLETED|Overall Study||0
2353704|NCT01648764|5775071|P8|NOT COMPLETED|Overall Study||0
2353705|NCT01648764|5775072|P7|NOT COMPLETED|Overall Study||5
2353706|NCT01648764|5775073|P6|NOT COMPLETED|Overall Study||2
2353707|NCT01648764|5775074|P5|NOT COMPLETED|Overall Study||0
2353708|NCT01648764|5775075|P4|NOT COMPLETED|Overall Study||0
2353709|NCT01648764|5775076|P3|NOT COMPLETED|Overall Study||0
2353710|NCT01648764|5775077|P2|NOT COMPLETED|Overall Study||1
2353711|NCT01648764|5775078|P1|NOT COMPLETED|Overall Study||0
2353712|NCT01648764|5775065|P14|COMPLETED|Overall Study||9
2353713|NCT01648764|5775066|P13|COMPLETED|Overall Study||3
2353714|NCT01648764|5775067|P12|COMPLETED|Overall Study||4
2353715|NCT01648764|5775068|P11|COMPLETED|Overall Study||3
2353716|NCT01648764|5775069|P10|COMPLETED|Overall Study||4
2353717|NCT01648764|5775070|P9|COMPLETED|Overall Study||3
2353718|NCT01648764|5775071|P8|COMPLETED|Overall Study||3
2353719|NCT01648764|5775072|P7|COMPLETED|Overall Study||4
2353720|NCT01648764|5775073|P6|COMPLETED|Overall Study||3
2353721|NCT01648764|5775074|P5|COMPLETED|Overall Study||3
2353722|NCT01648764|5775075|P4|COMPLETED|Overall Study||3
2353723|NCT01648764|5775076|P3|COMPLETED|Overall Study||3
2353724|NCT01648764|5775077|P2|COMPLETED|Overall Study||2
2353725|NCT01648764|5775078|P1|COMPLETED|Overall Study||3
2353726|NCT01648764|5775065|P14|Received at Least 1 Dose of Study Drug|Overall Study||12
2353727|NCT01648764|5775066|P13|Received at Least 1 Dose of Study Drug|Overall Study||7
2353728|NCT01648764|5775067|P12|Received at Least 1 Dose of Study Drug|Overall Study||9
2353729|NCT01648764|5775068|P11|Received at Least 1 Dose of Study Drug|Overall Study||3
2353730|NCT01648764|5775069|P10|Received at Least 1 Dose of Study Drug|Overall Study||7
2353731|NCT01648764|5775070|P9|Received at Least 1 Dose of Study Drug|Overall Study||3
2353732|NCT01648764|5775071|P8|Received at Least 1 Dose of Study Drug|Overall Study||3
2353733|NCT01648764|5775072|P7|Received at Least 1 Dose of Study Drug|Overall Study||9
2353734|NCT01648764|5775073|P6|Received at Least 1 Dose of Study Drug|Overall Study||5
2353735|NCT01648764|5775074|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
2353736|NCT01648764|5775075|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
2353737|NCT01648764|5775076|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
2353738|NCT01648764|5775077|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
2353739|NCT01648764|5775078|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
2353740|NCT01648764|5775065|P14|STARTED|Overall Study||12
2353741|NCT01648764|5775066|P13|STARTED|Overall Study||7
2353742|NCT01648764|5775067|P12|STARTED|Overall Study||9
2353743|NCT01648764|5775068|P11|STARTED|Overall Study||3
2353744|NCT01648764|5775069|P10|STARTED|Overall Study||7
2353745|NCT01648764|5775070|P9|STARTED|Overall Study||3
2353746|NCT01648764|5775071|P8|STARTED|Overall Study||3
2353747|NCT01648764|5775072|P7|STARTED|Overall Study||9
2353748|NCT01648764|5775073|P6|STARTED|Overall Study||5
2353749|NCT01648764|5775074|P5|STARTED|Overall Study||3
2353750|NCT01648764|5775075|P4|STARTED|Overall Study||3
2353751|NCT01648764|5775076|P3|STARTED|Overall Study||3
2353752|NCT01648764|5775077|P2|STARTED|Overall Study||3
2353753|NCT01648764|5775078|P1|STARTED|Overall Study||3
2353754|NCT01648699|5775230|P1|NOT COMPLETED|Overall Study||5
2353755|NCT01648699|5775230|P1|COMPLETED|Overall Study||15
2353756|NCT01648699|5775230|P1|STARTED|Overall Study||20
2353757|NCT01648582|5775259|P3|NOT COMPLETED|Overall Study||32
2353758|NCT01648582|5775260|P2|NOT COMPLETED|Overall Study||38
2353759|NCT01648582|5775261|P1|NOT COMPLETED|Overall Study||32
2353760|NCT01648582|5775259|P3|COMPLETED|Overall Study||227
2353761|NCT01648582|5775260|P2|COMPLETED|Overall Study||219
2353762|NCT01648582|5775261|P1|COMPLETED|Overall Study||226
2353763|NCT01648582|5775259|P3|Modified Intent-to-Treat Population|Overall Study||250
2353764|NCT01648582|5775260|P2|Modified Intent-to-Treat Population|Overall Study||252
2353765|NCT01648582|5775261|P1|Modified Intent-to-Treat Population|Overall Study||253
2353766|NCT01648582|5775259|P3|Received at Least One Dose of Study Drug|Overall Study||259
2353767|NCT01648582|5775260|P2|Received at Least One Dose of Study Drug|Overall Study||257
2353768|NCT01648582|5775261|P1|Received at Least One Dose of Study Drug|Overall Study||258
2353769|NCT01648582|5775259|P3|STARTED|Overall Study||259
2353770|NCT01648582|5775260|P2|STARTED|Overall Study||257
2353771|NCT01648582|5775261|P1|STARTED|Overall Study||258
2353772|NCT01648530|5775330|P1|NOT COMPLETED|Overall Study||10874
2353773|NCT01648530|5775330|P1|COMPLETED|Overall Study||5915
2353774|NCT01648530|5775330|P1|STARTED|Overall Study||16789
2353775|NCT01648491|5775336|P1|NOT COMPLETED|Overall Study||0
2353776|NCT01648491|5775336|P1|COMPLETED|Overall Study||1
2353777|NCT01648491|5775336|P1|STARTED|Overall Study||1
2353778|NCT01648452|5775343|P1|NOT COMPLETED|Overall Study||0
2353779|NCT01648452|5775343|P1|COMPLETED|Overall Study|One participant was explanted due to an adverse event. Remainder kept implant at study completion.|5
2353780|NCT01648452|5775343|P1|STARTED|Overall Study||5
2353781|NCT01648348|5775364|P6|NOT COMPLETED|Overall Study||6
2353782|NCT01648348|5775365|P5|NOT COMPLETED|Overall Study||3
2353783|NCT01648348|5775366|P4|NOT COMPLETED|Overall Study||0
2353784|NCT01648348|5775367|P3|NOT COMPLETED|Overall Study||1
2353785|NCT01648348|5775368|P2|NOT COMPLETED|Overall Study||0
2353786|NCT01648348|5775369|P1|NOT COMPLETED|Overall Study||2
2353787|NCT01648348|5775364|P6|COMPLETED|Overall Study||43
2353788|NCT01648348|5775365|P5|COMPLETED|Overall Study||49
2353789|NCT01648348|5775366|P4|COMPLETED|Overall Study||3
2353790|NCT01648348|5775367|P3|COMPLETED|Overall Study||3
2353791|NCT01648348|5775368|P2|COMPLETED|Overall Study||3
2353792|NCT01648348|5775369|P1|COMPLETED|Overall Study||3
2353793|NCT01648348|5775364|P6|STARTED|Overall Study||49
2353794|NCT01648348|5775365|P5|STARTED|Overall Study||52
2353795|NCT01648348|5775366|P4|STARTED|Overall Study||3
2353796|NCT01648348|5775367|P3|STARTED|Overall Study||4
2353797|NCT01648348|5775368|P2|STARTED|Overall Study||3
2353798|NCT01648348|5775369|P1|STARTED|Overall Study||5
2353799|NCT01648322|5775398|P4|NOT COMPLETED|Overall Study||4
2353800|NCT01648322|5775399|P3|NOT COMPLETED|Overall Study||5
2353801|NCT01648322|5775400|P2|NOT COMPLETED|Overall Study||5
2353802|NCT01648322|5775401|P1|NOT COMPLETED|Overall Study||2
2353803|NCT01648322|5775398|P4|COMPLETED|Overall Study||61
2353804|NCT01648322|5775399|P3|COMPLETED|Overall Study||60
2353805|NCT01648322|5775400|P2|COMPLETED|Overall Study||62
2353806|NCT01648322|5775401|P1|COMPLETED|Overall Study||33
2353807|NCT01648322|5775398|P4|STARTED|Overall Study||65
2353808|NCT01648322|5775399|P3|STARTED|Overall Study||65
2353809|NCT01648322|5775400|P2|STARTED|Overall Study||67
2353810|NCT01648322|5775401|P1|STARTED|Overall Study||35
2353817|NCT01648283|5775456|P1|NOT COMPLETED|Overall Study||14
2353818|NCT01648283|5775456|P1|COMPLETED|Overall Study||64
2353819|NCT01648283|5775456|P1|STARTED|Overall Study||78
2353820|NCT01648270|5775462|P1|NOT COMPLETED|Cyclosporine + Sublingual Buprenorphine||0
2353821|NCT01648270|5775462|P1|COMPLETED|Cyclosporine + Sublingual Buprenorphine||13
2353822|NCT01648270|5775462|P1|STARTED|Cyclosporine + Sublingual Buprenorphine||13
2353823|NCT01648270|5775462|P1|NOT COMPLETED|Cyclosporine Plus IV Buprenorphine||0
2353824|NCT01648270|5775462|P1|COMPLETED|Cyclosporine Plus IV Buprenorphine||13
2353825|NCT01648270|5775462|P1|STARTED|Cyclosporine Plus IV Buprenorphine||13
2353826|NCT01648270|5775462|P1|NOT COMPLETED|Sublingual Buprenorphine||0
2353827|NCT01648270|5775462|P1|COMPLETED|Sublingual Buprenorphine||13
2353828|NCT01648270|5775462|P1|STARTED|Sublingual Buprenorphine||13
2353829|NCT01648270|5775462|P1|NOT COMPLETED|Intravenous Buprenorphine||12
2353830|NCT01648270|5775462|P1|COMPLETED|Intravenous Buprenorphine||13
2353831|NCT01648270|5775462|P1|STARTED|Intravenous Buprenorphine||25
2353832|NCT01648166|5775474|P2|NOT COMPLETED|Overall Study||100
2353833|NCT01648166|5775475|P1|NOT COMPLETED|Overall Study||53
2353834|NCT01648166|5775474|P2|COMPLETED|Overall Study||267
2353835|NCT01648166|5775475|P1|COMPLETED|Overall Study||100
2353836|NCT01648166|5775474|P2|STARTED|Overall Study||367
2353837|NCT01648166|5775475|P1|STARTED|Overall Study||153
2353838|NCT01648140|5775485|P4|NOT COMPLETED|Overall Study||2
2353839|NCT01648140|5775486|P3|NOT COMPLETED|Overall Study||8
2353840|NCT01648140|5775487|P2|NOT COMPLETED|Overall Study||12
2353841|NCT01648140|5775488|P1|NOT COMPLETED|Overall Study||12
2353842|NCT01648140|5775485|P4|COMPLETED|Overall Study||11
2353843|NCT01648140|5775486|P3|COMPLETED|Overall Study||9
2353844|NCT01648140|5775487|P2|COMPLETED|Overall Study||28
2353845|NCT01648140|5775488|P1|COMPLETED|Overall Study||29
2353846|NCT01648140|5775485|P4|STARTED|Overall Study||13
2353847|NCT01648140|5775486|P3|STARTED|Overall Study||17
2353848|NCT01648140|5775487|P2|STARTED|Overall Study||40
2353849|NCT01648140|5775488|P1|STARTED|Overall Study||41
2353850|NCT01648101|5775653|P3|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
2353851|NCT01648101|5775654|P2|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
2353852|NCT01648101|5775655|P1|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
2353853|NCT01648101|5775653|P3|COMPLETED|Taper/Follow-up Phase (4 Weeks)||3
2353854|NCT01648101|5775654|P2|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
2353855|NCT01648101|5775655|P1|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
2353856|NCT01648101|5775653|P3|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|3
2353857|NCT01648101|5775654|P2|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|2
2353858|NCT01648101|5775655|P1|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|1
2353859|NCT01648101|5775653|P3|NOT COMPLETED|Transition Phase (4 Weeks)||4
2353860|NCT01648101|5775654|P2|NOT COMPLETED|Transition Phase (4 Weeks)||5
2353861|NCT01648101|5775655|P1|NOT COMPLETED|Transition Phase (4 Weeks)||5
2353862|NCT01648101|5775653|P3|COMPLETED|Transition Phase (4 Weeks)||5
2353863|NCT01648101|5775654|P2|COMPLETED|Transition Phase (4 Weeks)||13
2353864|NCT01648101|5775655|P1|COMPLETED|Transition Phase (4 Weeks)||12
2353865|NCT01648101|5775653|P3|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|9
2353866|NCT01648101|5775654|P2|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|18
2353867|NCT01648101|5775655|P1|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|17
2353868|NCT01648101|5775653|P3|NOT COMPLETED|Maintenance Phase (12 Weeks)||6
2353869|NCT01648101|5775654|P2|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
2353870|NCT01648101|5775655|P1|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
2353871|NCT01648101|5775653|P3|COMPLETED|Maintenance Phase (12 Weeks)||12
2353872|NCT01648101|5775654|P2|COMPLETED|Maintenance Phase (12 Weeks)||20
2353873|NCT01648101|5775655|P1|COMPLETED|Maintenance Phase (12 Weeks)||20
2353874|NCT01648101|5775653|P3|STARTED|Maintenance Phase (12 Weeks)||18
2353875|NCT01648101|5775654|P2|STARTED|Maintenance Phase (12 Weeks)||23
2353876|NCT01648101|5775655|P1|STARTED|Maintenance Phase (12 Weeks)||23
2353877|NCT01648101|5775653|P3|NOT COMPLETED|Titration Phase (4 Weeks)||6
2353878|NCT01648101|5775654|P2|NOT COMPLETED|Titration Phase (4 Weeks)||3
2353879|NCT01648101|5775655|P1|NOT COMPLETED|Titration Phase (4 Weeks)||2
2353880|NCT01648101|5775653|P3|COMPLETED|Titration Phase (4 Weeks)||18
2353881|NCT01648101|5775654|P2|COMPLETED|Titration Phase (4 Weeks)||23
2353882|NCT01648101|5775655|P1|COMPLETED|Titration Phase (4 Weeks)||23
2353883|NCT01648101|5775653|P3|STARTED|Titration Phase (4 Weeks)||24
2353884|NCT01648101|5775654|P2|STARTED|Titration Phase (4 Weeks)||26
2353885|NCT01648101|5775655|P1|STARTED|Titration Phase (4 Weeks)||25
2353886|NCT01647945|5775707|P4|NOT COMPLETED|Overall Study||1
2353887|NCT01647945|5775708|P3|NOT COMPLETED|Overall Study||2
2353888|NCT01647945|5775709|P2|NOT COMPLETED|Overall Study||0
2353889|NCT01647945|5775710|P1|NOT COMPLETED|Overall Study||0
2353890|NCT01647945|5775707|P4|COMPLETED|Overall Study||5
2353891|NCT01647945|5775708|P3|COMPLETED|Overall Study||3
2353892|NCT01647945|5775709|P2|COMPLETED|Overall Study||6
2353893|NCT01647945|5775710|P1|COMPLETED|Overall Study||6
2353894|NCT01647945|5775707|P4|STARTED|Overall Study||6
2353895|NCT01647945|5775708|P3|STARTED|Overall Study||5
2353896|NCT01647945|5775709|P2|STARTED|Overall Study||6
2353897|NCT01647945|5775710|P1|STARTED|Overall Study||6
2353898|NCT01647737|5775730|P2|NOT COMPLETED|Overall Study||5
2353899|NCT01647737|5775731|P1|NOT COMPLETED|Overall Study||4
2353900|NCT01647737|5775730|P2|COMPLETED|Overall Study||25
2353901|NCT01647737|5775731|P1|COMPLETED|Overall Study||26
2353902|NCT01647737|5775730|P2|STARTED|Overall Study||30
2353903|NCT01647737|5775731|P1|STARTED|Overall Study||30
2353904|NCT01647711|5775742|P5|NOT COMPLETED|Overall Study||6
2353905|NCT01647711|5775743|P4|NOT COMPLETED|Overall Study||11
2353906|NCT01647711|5775744|P3|NOT COMPLETED|Overall Study||9
2353907|NCT01647711|5775745|P2|NOT COMPLETED|Overall Study||3
2353908|NCT01647711|5775746|P1|NOT COMPLETED|Overall Study||6
2353909|NCT01647711|5775742|P5|COMPLETED|Overall Study||0
2353910|NCT01647711|5775743|P4|COMPLETED|Overall Study||0
2353911|NCT01647711|5775744|P3|COMPLETED|Overall Study||0
2353912|NCT01647711|5775745|P2|COMPLETED|Overall Study||0
2353913|NCT01647711|5775746|P1|COMPLETED|Overall Study||0
2353914|NCT01647711|5775742|P5|STARTED|Overall Study||6
2353915|NCT01647711|5775743|P4|STARTED|Overall Study||11
2353916|NCT01647711|5775744|P3|STARTED|Overall Study||9
2353917|NCT01647711|5775745|P2|STARTED|Overall Study||3
2353918|NCT01647711|5775746|P1|STARTED|Overall Study||6
2353919|NCT01647581|5775773|P2|NOT COMPLETED|Overall Study||31
2353920|NCT01647581|5775774|P1|NOT COMPLETED|Overall Study||17
2353921|NCT01647581|5775773|P2|COMPLETED|Overall Study||520
2353922|NCT01647581|5775774|P1|COMPLETED|Overall Study||530
2353923|NCT01647581|5775773|P2|STARTED|Overall Study||551
2353924|NCT01647581|5775774|P1|STARTED|Overall Study||547
2353925|NCT01647542|5775783|P3|NOT COMPLETED|Overall Study||72
2353926|NCT01647542|5775784|P2|NOT COMPLETED|Overall Study||73
2353927|NCT01647542|5775785|P1|NOT COMPLETED|Overall Study||76
2353928|NCT01647542|5775783|P3|COMPLETED|Overall Study||59
2353929|NCT01647542|5775784|P2|COMPLETED|Overall Study||58
2353930|NCT01647542|5775785|P1|COMPLETED|Overall Study||55
2353931|NCT01647542|5775783|P3|STARTED|Overall Study||131
2353932|NCT01647542|5775784|P2|STARTED|Overall Study||131
2353933|NCT01647542|5775785|P1|STARTED|Overall Study||131
2353934|NCT01647464|5775802|P1|NOT COMPLETED|Overall Study||0
2353935|NCT01647464|5775802|P1|COMPLETED|Overall Study||10
2353936|NCT01647464|5775802|P1|STARTED|Overall Study||10
2353937|NCT01647438|5775808|P2|NOT COMPLETED|Overall Study||0
2353938|NCT01647438|5775809|P1|NOT COMPLETED|Overall Study||0
2353939|NCT01647438|5775808|P2|COMPLETED|Overall Study||31
2353940|NCT01647438|5775809|P1|COMPLETED|Overall Study||32
2353941|NCT01647438|5775808|P2|STARTED|Overall Study||31
2353942|NCT01647438|5775809|P1|STARTED|Overall Study||32
2353943|NCT01647282|5775819|P2|NOT COMPLETED|Overall Study||5
2353944|NCT01647282|5775820|P1|NOT COMPLETED|Overall Study||7
2353945|NCT01647282|5775819|P2|COMPLETED|Overall Study||25
2353946|NCT01647282|5775820|P1|COMPLETED|Overall Study||23
2353947|NCT01647282|5775819|P2|STARTED|Overall Study||30
2353948|NCT01647282|5775820|P1|STARTED|Overall Study||30
2353949|NCT01647217|5775830|P2|NOT COMPLETED|Overall Study||1
2353950|NCT01647217|5775831|P1|NOT COMPLETED|Overall Study||1
2353951|NCT01647217|5775830|P2|COMPLETED|Overall Study||8
2353952|NCT01647217|5775831|P1|COMPLETED|Overall Study||7
2353953|NCT01647217|5775830|P2|STARTED|Overall Study||9
2353954|NCT01647217|5775831|P1|STARTED|Overall Study||8
2353955|NCT01646827|5775841|P2|NOT COMPLETED|Overall Study||5
2353956|NCT01646827|5775842|P1|NOT COMPLETED|Overall Study||2
2353957|NCT01646827|5775841|P2|COMPLETED|Overall Study||14
2353958|NCT01646827|5775842|P1|COMPLETED|Overall Study||16
2353959|NCT01646827|5775841|P2|STARTED|Overall Study||19
2353960|NCT01646827|5775842|P1|STARTED|Overall Study||18
2353961|NCT01646814|5775872|P2|NOT COMPLETED|Overall Study||6
2353962|NCT01646814|5775873|P1|NOT COMPLETED|Overall Study||11
2353963|NCT01646814|5775872|P2|COMPLETED|Overall Study||120
2353964|NCT01646814|5775873|P1|COMPLETED|Overall Study||110
2353965|NCT01646814|5775872|P2|STARTED|Overall Study||126
2353966|NCT01646814|5775873|P1|STARTED|Overall Study||121
2353967|NCT01646762|5775879|P1|NOT COMPLETED|Overall Study||0
2353968|NCT01646762|5775879|P1|COMPLETED|Overall Study||13
2353969|NCT01646762|5775879|P1|STARTED|Overall Study||13
2353970|NCT01646671|5775891|P3|NOT COMPLETED|Overall Study||0
2353971|NCT01646671|5775892|P2|NOT COMPLETED|Overall Study||0
2353972|NCT01646671|5775893|P1|NOT COMPLETED|Overall Study||0
2353973|NCT01646671|5775891|P3|COMPLETED|Overall Study||21
2353974|NCT01646671|5775892|P2|COMPLETED|Overall Study||11
2353975|NCT01646671|5775893|P1|COMPLETED|Overall Study||3
2353976|NCT01646671|5775891|P3|STARTED|Overall Study||21
2353977|NCT01646671|5775892|P2|STARTED|Overall Study||11
2353978|NCT01646671|5775893|P1|STARTED|Overall Study||3
2353979|NCT01646398|5775929|P2|NOT COMPLETED|Overall Study||0
2353980|NCT01646398|5775930|P1|NOT COMPLETED|Overall Study||1
2353981|NCT01646398|5775929|P2|COMPLETED|Overall Study||382
2353982|NCT01646398|5775930|P1|COMPLETED|Overall Study||381
2353983|NCT01646398|5775929|P2|STARTED|Overall Study||382
2353984|NCT01646398|5775930|P1|STARTED|Overall Study||382
2353985|NCT01646385|5775946|P2|NOT COMPLETED|Overall Study||871
2353986|NCT01646385|5775947|P1|NOT COMPLETED|Overall Study||838
2353987|NCT01646385|5775946|P2|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|1993
2353988|NCT01646385|5775947|P1|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|2691
2353989|NCT01646385|5775946|P2|STARTED|Overall Study||2864
2353990|NCT01646385|5775947|P1|STARTED|Overall Study||3529
2353991|NCT01646346|5775978|P1|NOT COMPLETED|Overall Study||0
2353992|NCT01646346|5775978|P1|COMPLETED|Overall Study||46
2353993|NCT01646346|5775978|P1|STARTED|Overall Study||46
2353994|NCT01646320|5775990|P2|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||7
2353995|NCT01646320|5775991|P1|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||6
2353996|NCT01646320|5775990|P2|COMPLETED|Long-term Period (Weeks 24 to 52)||140
2353997|NCT01646320|5775991|P1|COMPLETED|Long-term Period (Weeks 24 to 52)||141
2353998|NCT01646320|5775990|P2|STARTED|Long-term Period (Weeks 24 to 52)||147
2353999|NCT01646320|5775991|P1|STARTED|Long-term Period (Weeks 24 to 52)||147
2354000|NCT01646320|5775990|P2|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||7
2354001|NCT01646320|5775991|P1|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||12
2354002|NCT01646320|5775990|P2|COMPLETED|Short-term Period (Day 1 to Week 24)||153
2354003|NCT01646320|5775991|P1|COMPLETED|Short-term Period (Day 1 to Week 24)||148
2354004|NCT01646320|5775990|P2|STARTED|Short-term Period (Day 1 to Week 24)||160
2354005|NCT01646320|5775991|P1|STARTED|Short-term Period (Day 1 to Week 24)||160
2354006|NCT01646268|5776007|P2|NOT COMPLETED|Overall Study||16
2354007|NCT01646268|5776008|P1|NOT COMPLETED|Overall Study||11
2354008|NCT01646268|5776007|P2|COMPLETED|Overall Study||107
2354009|NCT01646268|5776008|P1|COMPLETED|Overall Study||113
2354010|NCT01646268|5776007|P2|STARTED|Overall Study||123
2354011|NCT01646268|5776008|P1|STARTED|Overall Study||124
2354012|NCT01646255|5776022|P2|NOT COMPLETED|Overall Study||14
2354013|NCT01646255|5776023|P1|NOT COMPLETED|Overall Study||21
2354014|NCT01646255|5776022|P2|COMPLETED|Overall Study||160
2354015|NCT01646255|5776023|P1|COMPLETED|Overall Study||151
2354016|NCT01646255|5776022|P2|STARTED|Overall Study||174
2354017|NCT01646255|5776023|P1|STARTED|Overall Study||172
2354018|NCT01646216|5776055|P2|NOT COMPLETED|Overall Study||13
2354019|NCT01646216|5776056|P1|NOT COMPLETED|Overall Study||11
2354020|NCT01646216|5776055|P2|COMPLETED|Overall Study||4
2354021|NCT01646216|5776056|P1|COMPLETED|Overall Study||6
2354022|NCT01646216|5776055|P2|STARTED|Overall Study||17
2354023|NCT01646216|5776056|P1|STARTED|Overall Study||17
2354024|NCT01646203|5776078|P3|NOT COMPLETED|Overall Study||1
2354025|NCT01646203|5776079|P2|NOT COMPLETED|Overall Study||2
2354026|NCT01646203|5776080|P1|NOT COMPLETED|Overall Study||2
2354027|NCT01646203|5776078|P3|COMPLETED|Overall Study||6
2354028|NCT01646203|5776079|P2|COMPLETED|Overall Study||3
2354029|NCT01646203|5776080|P1|COMPLETED|Overall Study||0
2354030|NCT01646203|5776078|P3|Received at Least One Dose of Study Drug|Overall Study||7
2354031|NCT01646203|5776079|P2|Received at Least One Dose of Study Drug|Overall Study||5
2354032|NCT01646203|5776080|P1|Received at Least One Dose of Study Drug|Overall Study||2
2354033|NCT01646203|5776078|P3|STARTED|Overall Study||7
2354034|NCT01646203|5776079|P2|STARTED|Overall Study||5
2354035|NCT01646203|5776080|P1|STARTED|Overall Study||2
2354036|NCT01646177|5776109|P4|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
2354037|NCT01646177|5776110|P3|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
2354038|NCT01646177|5776111|P2|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
2354039|NCT01646177|5776112|P1|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
2354040|NCT01646177|5776109|P4|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
2354041|NCT01646177|5776110|P3|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
2354042|NCT01646177|5776111|P2|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
2354043|NCT01646177|5776112|P1|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
2354044|NCT01646177|5776109|P4|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
2354045|NCT01646177|5776110|P3|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
2354046|NCT01646177|5776111|P2|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
2354047|NCT01646177|5776112|P1|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
2354048|NCT01646177|5776109|P4|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||22
2354049|NCT01646177|5776110|P3|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||26
2354050|NCT01646177|5776111|P2|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||13
2354051|NCT01646177|5776112|P1|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||10
2354052|NCT01646177|5776109|P4|COMPLETED|Blinded Induction Dosing (Week 0-12)||363
2354053|NCT01646177|5776110|P3|COMPLETED|Blinded Induction Dosing (Week 0-12)||360
2354054|NCT01646177|5776111|P2|COMPLETED|Blinded Induction Dosing (Week 0-12)||369
2354055|NCT01646177|5776112|P1|COMPLETED|Blinded Induction Dosing (Week 0-12)||183
2354056|NCT01646177|5776109|P4|STARTED|Blinded Induction Dosing (Week 0-12)||385
2354057|NCT01646177|5776110|P3|STARTED|Blinded Induction Dosing (Week 0-12)||386
2354058|NCT01646177|5776111|P2|STARTED|Blinded Induction Dosing (Week 0-12)||382
2354059|NCT01646177|5776112|P1|STARTED|Blinded Induction Dosing (Week 0-12)||193
2354060|NCT01646151|5776190|P1|NOT COMPLETED|Overall Study||170
2354061|NCT01646151|5776190|P1|COMPLETED|Overall Study||2410
2354062|NCT01646151|5776190|P1|STARTED|Overall Study||2580
2354063|NCT01646138|5776206|P5|NOT COMPLETED|Overall Study||2
2354064|NCT01646138|5776207|P4|NOT COMPLETED|Overall Study||0
2354065|NCT01646138|5776208|P3|NOT COMPLETED|Overall Study||0
2354066|NCT01646138|5776209|P2|NOT COMPLETED|Overall Study||0
2354067|NCT01646138|5776210|P1|NOT COMPLETED|Overall Study||0
2354068|NCT01646138|5776206|P5|COMPLETED|Overall Study||13
2354069|NCT01646138|5776207|P4|COMPLETED|Overall Study||19
2354070|NCT01646138|5776208|P3|COMPLETED|Overall Study||5
2354071|NCT01646138|5776209|P2|COMPLETED|Overall Study||4
2354072|NCT01646138|5776210|P1|COMPLETED|Overall Study||5
2354073|NCT01646138|5776206|P5|STARTED|Overall Study||15
2354074|NCT01646138|5776207|P4|STARTED|Overall Study||19
2354075|NCT01646138|5776208|P3|STARTED|Overall Study||5
2354076|NCT01646138|5776209|P2|STARTED|Overall Study||4
2354077|NCT01646138|5776210|P1|STARTED|Overall Study||5
2354078|NCT01646125|5776224|P2|NOT COMPLETED|Overall Study||28
2354079|NCT01646125|5776225|P1|NOT COMPLETED|Overall Study||31
2354080|NCT01646125|5776224|P2|COMPLETED|Overall Study||0
2354081|NCT01646125|5776225|P1|COMPLETED|Overall Study||0
2354082|NCT01646125|5776224|P2|STARTED|Overall Study||28
2354083|NCT01646125|5776225|P1|STARTED|Overall Study||31
2354084|NCT01646073|5776250|P2|NOT COMPLETED|Period B (12 Weeks)||13
2354085|NCT01646073|5776251|P1|NOT COMPLETED|Period B (12 Weeks)||1
2354086|NCT01646073|5776250|P2|COMPLETED|Period B (12 Weeks)||320
2354087|NCT01646073|5776251|P1|COMPLETED|Period B (12 Weeks)||84
2354088|NCT01646073|5776250|P2|STARTED|Period B (12 Weeks)||333
2354089|NCT01646073|5776251|P1|STARTED|Period B (12 Weeks)||85
2354090|NCT01646073|5776250|P2|NOT COMPLETED|Period A (12 Weeks)||5
2354091|NCT01646073|5776251|P1|NOT COMPLETED|Period A (12 Weeks)||2
2354092|NCT01646073|5776250|P2|COMPLETED|Period A (12 Weeks)||333
2354093|NCT01646073|5776251|P1|COMPLETED|Period A (12 Weeks)||85
2354094|NCT01646073|5776250|P2|STARTED|Period A (12 Weeks)||338
2354095|NCT01646073|5776251|P1|STARTED|Period A (12 Weeks)||87
2354096|NCT01646021|5776292|P2|NOT COMPLETED|Overall Study||141
2354097|NCT01646021|5776293|P1|NOT COMPLETED|Overall Study||139
2354098|NCT01646021|5776292|P2|COMPLETED|Overall Study||0
2354099|NCT01646021|5776293|P1|COMPLETED|Overall Study||0
2354100|NCT01646021|5776292|P2|Treated|Overall Study||139
2354101|NCT01646021|5776293|P1|Treated|Overall Study||139
2354102|NCT01646021|5776292|P2|STARTED|Overall Study||141
2354103|NCT01646021|5776293|P1|STARTED|Overall Study||139
2354104|NCT01645930|5776330|P1|NOT COMPLETED|Overall Study||43
2354105|NCT01645930|5776330|P1|COMPLETED|Overall Study||0
2354106|NCT01645930|5776330|P1|STARTED|Overall Study||43
2354107|NCT01645735|5776347|P2|NOT COMPLETED|Overall Study||1
2354108|NCT01645735|5776348|P1|NOT COMPLETED|Overall Study||4
2354109|NCT01645735|5776347|P2|COMPLETED|Overall Study||16
2354110|NCT01645735|5776348|P1|COMPLETED|Overall Study||28
2354111|NCT01645735|5776347|P2|STARTED|Overall Study||17
2354112|NCT01645735|5776348|P1|STARTED|Overall Study||32
2354113|NCT01645709|5776362|P2|NOT COMPLETED|Overall Study||0
2354114|NCT01645709|5776363|P1|NOT COMPLETED|Overall Study||0
2354115|NCT01645709|5776362|P2|COMPLETED|Overall Study|Study was terminated; not made unblind|0
2354116|NCT01645709|5776363|P1|COMPLETED|Overall Study|Study was terminated; not made unblind|0
2354117|NCT01645709|5776362|P2|STARTED|Overall Study|Study was terminated; not made unblind|0
2354118|NCT01645709|5776363|P1|STARTED|Overall Study|Study was terminated; not made unblind|0
2354119|NCT01645280|5776390|P5|NOT COMPLETED|Overall Study||8
2354120|NCT01645280|5776391|P4|NOT COMPLETED|Overall Study||6
2354121|NCT01645280|5776392|P3|NOT COMPLETED|Overall Study||6
2354122|NCT01645280|5776393|P2|NOT COMPLETED|Overall Study||3
2354123|NCT01645280|5776394|P1|NOT COMPLETED|Overall Study||6
2354124|NCT01645280|5776390|P5|COMPLETED|Overall Study||47
2354125|NCT01645280|5776391|P4|COMPLETED|Overall Study||48
2354126|NCT01645280|5776392|P3|COMPLETED|Overall Study||49
2354127|NCT01645280|5776393|P2|COMPLETED|Overall Study||51
2354128|NCT01645280|5776394|P1|COMPLETED|Overall Study||49
2354129|NCT01645280|5776390|P5|STARTED|Overall Study||55
2354130|NCT01645280|5776391|P4|STARTED|Overall Study||54
2354131|NCT01645280|5776392|P3|STARTED|Overall Study||55
2354132|NCT01645280|5776393|P2|STARTED|Overall Study||54
2354133|NCT01645280|5776394|P1|STARTED|Overall Study|16 participants in placebo group early escaped to receive Ustekinmab; included in safety population.|55
2354134|NCT01645176|5776422|P1|NOT COMPLETED|Overall Study||5
2354135|NCT01645176|5776422|P1|COMPLETED|Overall Study||16
2354136|NCT01645176|5776422|P1|STARTED|Overall Study||21
2354137|NCT01645111|5776426|P1|NOT COMPLETED|Overall Study||15
2354138|NCT01645111|5776426|P1|COMPLETED|Overall Study||35
2354139|NCT01645111|5776426|P1|STARTED|Overall Study||50
2354140|NCT01645098|5776432|P2|NOT COMPLETED|Overall Study||0
2354141|NCT01645098|5776433|P1|NOT COMPLETED|Overall Study||0
2354142|NCT01645098|5776432|P2|COMPLETED|Overall Study||29
2354143|NCT01645098|5776433|P1|COMPLETED|Overall Study||24
2354144|NCT01645098|5776432|P2|STARTED|Overall Study||29
2354145|NCT01645098|5776433|P1|STARTED|Overall Study||24
2354146|NCT01645059|5776447|P1|NOT COMPLETED|Overall Study||0
2354147|NCT01645059|5776447|P1|COMPLETED|Overall Study||129
2354148|NCT01645059|5776447|P1|STARTED|Overall Study||129
2354149|NCT01644890|5776467|P2|NOT COMPLETED|Overall Study||215
2354150|NCT01644890|5776468|P1|NOT COMPLETED|Overall Study||216
2354151|NCT01644890|5776467|P2|COMPLETED|Overall Study||3
2354152|NCT01644890|5776468|P1|COMPLETED|Overall Study||2
2354153|NCT01644890|5776467|P2|STARTED|Overall Study||218
2354154|NCT01644890|5776468|P1|STARTED|Overall Study||218
2354155|NCT01644734|5776478|P1|NOT COMPLETED|Overall Study||266
2354156|NCT01644734|5776478|P1|COMPLETED|Overall Study||1016
2354157|NCT01644734|5776478|P1|STARTED|Overall Study|Patients with documentation of treatment.|1282
2354158|NCT01644695|5776483|P1|NOT COMPLETED|Overall Study||0
2354159|NCT01644695|5776483|P1|COMPLETED|Overall Study||85
2354160|NCT01644695|5776483|P1|STARTED|Overall Study||85
2354161|NCT01644643|5776492|P4|NOT COMPLETED|Overall Study||10
2354162|NCT01644643|5776493|P3|NOT COMPLETED|Overall Study||5
2354163|NCT01644643|5776494|P2|NOT COMPLETED|Overall Study||0
2354164|NCT01644643|5776495|P1|NOT COMPLETED|Overall Study||2
2354165|NCT01644643|5776492|P4|COMPLETED|Overall Study||143
2354166|NCT01644643|5776493|P3|COMPLETED|Overall Study||148
2354167|NCT01644643|5776494|P2|COMPLETED|Overall Study||12
2354168|NCT01644643|5776495|P1|COMPLETED|Overall Study||13
2354169|NCT01644643|5776492|P4|STARTED|Overall Study||153
2354170|NCT01644643|5776493|P3|STARTED|Overall Study||153
2354171|NCT01644643|5776494|P2|STARTED|Overall Study||12
2354172|NCT01644643|5776495|P1|STARTED|Overall Study||15
2354173|NCT01644617|5776660|P3|NOT COMPLETED|Overall Study||7
2354174|NCT01644617|5776661|P2|NOT COMPLETED|Overall Study||5
2354175|NCT01644617|5776662|P1|NOT COMPLETED|Overall Study||6
2354176|NCT01644617|5776660|P3|COMPLETED|Overall Study||34
2354177|NCT01644617|5776661|P2|COMPLETED|Overall Study||36
2354178|NCT01644617|5776662|P1|COMPLETED|Overall Study||36
2354179|NCT01644617|5776660|P3|STARTED|Overall Study||41
2354180|NCT01644617|5776661|P2|STARTED|Overall Study||41
2354181|NCT01644617|5776662|P1|STARTED|Overall Study||42
2354182|NCT01644565|5776712|P9|NOT COMPLETED|Overall Study||1
2354183|NCT01644565|5776713|P8|NOT COMPLETED|Overall Study||2
2354184|NCT01644565|5776714|P7|NOT COMPLETED|Overall Study||0
2354185|NCT01644565|5776715|P6|NOT COMPLETED|Overall Study||0
2354186|NCT01644565|5776716|P5|NOT COMPLETED|Overall Study||1
2354187|NCT01644565|5776717|P4|NOT COMPLETED|Overall Study||1
2354188|NCT01644565|5776718|P3|NOT COMPLETED|Overall Study||0
2354189|NCT01644565|5776719|P2|NOT COMPLETED|Overall Study||0
2354190|NCT01644565|5776720|P1|NOT COMPLETED|Overall Study||1
2354191|NCT01644565|5776712|P9|COMPLETED|Overall Study||7
2354192|NCT01644565|5776713|P8|COMPLETED|Overall Study||8
2354193|NCT01644565|5776714|P7|COMPLETED|Overall Study||7
2354194|NCT01644565|5776715|P6|COMPLETED|Overall Study||7
2354195|NCT01644565|5776716|P5|COMPLETED|Overall Study||4
2354196|NCT01644565|5776717|P4|COMPLETED|Overall Study||4
2354197|NCT01644565|5776718|P3|COMPLETED|Overall Study||5
2354198|NCT01644565|5776719|P2|COMPLETED|Overall Study||5
2354199|NCT01644565|5776720|P1|COMPLETED|Overall Study||4
2354200|NCT01644565|5776712|P9|STARTED|Overall Study||8
2354201|NCT01644565|5776713|P8|STARTED|Overall Study||10
2354202|NCT01644565|5776714|P7|STARTED|Overall Study||7
2354203|NCT01644565|5776715|P6|STARTED|Overall Study||7
2354204|NCT01644565|5776716|P5|STARTED|Overall Study||5
2354205|NCT01644565|5776717|P4|STARTED|Overall Study||5
2354206|NCT01644565|5776718|P3|STARTED|Overall Study||5
2354207|NCT01644565|5776719|P2|STARTED|Overall Study||5
2354208|NCT01644565|5776720|P1|STARTED|Overall Study||5
2354209|NCT01644500|5776761|P3|NOT COMPLETED|Overall Study||15
2354210|NCT01644500|5776762|P2|NOT COMPLETED|Overall Study||24
2354211|NCT01644500|5776763|P1|NOT COMPLETED|Overall Study||22
2354212|NCT01644500|5776761|P3|COMPLETED|Overall Study||230
2354213|NCT01644500|5776762|P2|COMPLETED|Overall Study||224
2354214|NCT01644500|5776763|P1|COMPLETED|Overall Study||222
2354215|NCT01644500|5776761|P3|Modified Intent-to-treat Population|Overall Study||242
2354216|NCT01644500|5776762|P2|Modified Intent-to-treat Population|Overall Study||239
2354217|NCT01644500|5776763|P1|Modified Intent-to-treat Population|Overall Study||239
2354218|NCT01644500|5776761|P3|Received at Least One Dose of Study Drug|Overall Study||243
2354219|NCT01644500|5776762|P2|Received at Least One Dose of Study Drug|Overall Study||248
2354220|NCT01644500|5776763|P1|Received at Least One Dose of Study Drug|Overall Study||244
2354221|NCT01644500|5776761|P3|STARTED|Overall Study||245
2354222|NCT01644500|5776762|P2|STARTED|Overall Study||248
2354223|NCT01644500|5776763|P1|STARTED|Overall Study||244
2354224|NCT01644474|5776833|P2|NOT COMPLETED|Overall Study||8
2354225|NCT01644474|5776834|P1|NOT COMPLETED|Overall Study||7
2354226|NCT01644474|5776833|P2|COMPLETED|Overall Study||44
2354227|NCT01644474|5776834|P1|COMPLETED|Overall Study||44
2354228|NCT01644474|5776833|P2|Treated|Overall Study||52
2354229|NCT01644474|5776834|P1|Treated|Overall Study||51
2354230|NCT01644474|5776833|P2|STARTED|Overall Study|Randomized|52
2354231|NCT01644474|5776834|P1|STARTED|Overall Study|Randomized|51
2354232|NCT01644396|5776874|P1|NOT COMPLETED|Overall Study||0
2354233|NCT01644396|5776874|P1|COMPLETED|Overall Study||50
2354234|NCT01644396|5776874|P1|STARTED|Overall Study||50
2354235|NCT01644331|5776918|P2|NOT COMPLETED|Overall Study||10
2354236|NCT01644331|5776919|P1|NOT COMPLETED|Overall Study||11
2354237|NCT01644331|5776918|P2|COMPLETED|Overall Study||118
2354238|NCT01644331|5776919|P1|COMPLETED|Overall Study||118
2354239|NCT01644331|5776918|P2|STARTED|Overall Study||128
2354240|NCT01644331|5776919|P1|STARTED|Overall Study||129
2354241|NCT01644292|5776951|P1|NOT COMPLETED|Overall Study||0
2354242|NCT01644292|5776951|P1|COMPLETED|Overall Study||2
2354243|NCT01644292|5776951|P1|STARTED|Overall Study||2
2354244|NCT01644240|5776958|P3|NOT COMPLETED|Overall Study||0
2354245|NCT01644240|5776959|P2|NOT COMPLETED|Overall Study||0
2354246|NCT01644240|5776960|P1|NOT COMPLETED|Overall Study||0
2354247|NCT01644240|5776958|P3|COMPLETED|Overall Study||6
2354248|NCT01644240|5776959|P2|COMPLETED|Overall Study||4
2354249|NCT01644240|5776960|P1|COMPLETED|Overall Study||6
2354250|NCT01644240|5776958|P3|STARTED|Overall Study||6
2354251|NCT01644240|5776959|P2|STARTED|Overall Study||4
2354252|NCT01644240|5776960|P1|STARTED|Overall Study||6
2354253|NCT01644188|5777018|P2|NOT COMPLETED|Overall Study||75
2354254|NCT01644188|5777019|P1|NOT COMPLETED|Overall Study||122
2354255|NCT01644188|5777018|P2|COMPLETED|Overall Study||166
2354256|NCT01644188|5777019|P1|COMPLETED|Overall Study||357
2354257|NCT01644188|5777018|P2|Treated|Overall Study||241
2354258|NCT01644188|5777019|P1|Treated|Overall Study||479
2354259|NCT01644188|5777018|P2|STARTED|Overall Study|Randomized|241
2354260|NCT01644188|5777019|P1|STARTED|Overall Study|Randomized|479
2354261|NCT01644175|5777077|P2|NOT COMPLETED|Overall Study||53
2354262|NCT01644175|5777078|P1|NOT COMPLETED|Overall Study||32
2354263|NCT01644175|5777077|P2|COMPLETED|Overall Study||156
2354264|NCT01644175|5777078|P1|COMPLETED|Overall Study||75
2354265|NCT01644175|5777077|P2|Treated|Overall Study||207
2354266|NCT01644175|5777078|P1|Treated|Overall Study||107
2354267|NCT01644175|5777077|P2|STARTED|Overall Study|Randomized|209
2354268|NCT01644175|5777078|P1|STARTED|Overall Study|Randomized|107
2354269|NCT01644149|5777130|P2|NOT COMPLETED|Overall Study||1
2354270|NCT01644149|5777131|P1|NOT COMPLETED|Overall Study||4
2354271|NCT01644149|5777130|P2|COMPLETED|Overall Study|28 day serum samples were not obtained from one NS subject.|39
2354272|NCT01644149|5777131|P1|COMPLETED|Overall Study|One subject discontinued prior to vaccination. 28 day serum samples not obtained from 3 subjects.|39
2354273|NCT01644149|5777130|P2|STARTED|Overall Study||40
2354274|NCT01644149|5777131|P1|STARTED|Overall Study||43
2354275|NCT01644058|5777141|P1|NOT COMPLETED|Overall Study||0
2354276|NCT01644058|5777141|P1|COMPLETED|Overall Study||18
2354277|NCT01644058|5777141|P1|STARTED|Overall Study||18
2354278|NCT01643928|5777151|P5|NOT COMPLETED|Overall Study||2
2354279|NCT01643928|5777152|P4|NOT COMPLETED|Overall Study||3
2354280|NCT01643928|5777153|P3|NOT COMPLETED|Overall Study||3
2354281|NCT01643928|5777154|P2|NOT COMPLETED|Overall Study||2
2354282|NCT01643928|5777155|P1|NOT COMPLETED|Overall Study||10
2354283|NCT01643928|5777151|P5|COMPLETED|Overall Study||28
2354284|NCT01643928|5777152|P4|COMPLETED|Overall Study||27
2354285|NCT01643928|5777153|P3|COMPLETED|Overall Study||30
2354286|NCT01643928|5777154|P2|COMPLETED|Overall Study||30
2354287|NCT01643928|5777155|P1|COMPLETED|Overall Study||48
2354288|NCT01643928|5777151|P5|STARTED|Overall Study||30
2354289|NCT01643928|5777152|P4|STARTED|Overall Study||30
2354290|NCT01643928|5777153|P3|STARTED|Overall Study||33
2354291|NCT01643928|5777154|P2|STARTED|Overall Study||32
2354292|NCT01643928|5777155|P1|STARTED|Overall Study||58
2354293|NCT01643902|5777440|P1|NOT COMPLETED|Overall Study||0
2354294|NCT01643902|5777440|P1|COMPLETED|Overall Study||20
2354295|NCT01643902|5777440|P1|STARTED|Overall Study||20
2354296|NCT01643876|5777445|P1|NOT COMPLETED|Overall Study||0
2354297|NCT01643876|5777445|P1|COMPLETED|Overall Study||48
2354298|NCT01643876|5777445|P1|STARTED|Overall Study||48
2354299|NCT01643798|5777450|P2|NOT COMPLETED|Pretreatment 2 and Stimulation||0
2354300|NCT01643798|5777451|P1|NOT COMPLETED|Pretreatment 2 and Stimulation||0
2354301|NCT01643798|5777450|P2|COMPLETED|Pretreatment 2 and Stimulation||8
2354302|NCT01643798|5777451|P1|COMPLETED|Pretreatment 2 and Stimulation||6
2354303|NCT01643798|5777450|P2|STARTED|Pretreatment 2 and Stimulation||8
2354304|NCT01643798|5777451|P1|STARTED|Pretreatment 2 and Stimulation||6
2354305|NCT01643798|5777450|P2|NOT COMPLETED|Pretreatment 1 and Stimulation||0
2354306|NCT01643798|5777451|P1|NOT COMPLETED|Pretreatment 1 and Stimulation||1
2354307|NCT01643798|5777450|P2|COMPLETED|Pretreatment 1 and Stimulation||8
2354308|NCT01643798|5777451|P1|COMPLETED|Pretreatment 1 and Stimulation||6
2354309|NCT01643798|5777450|P2|STARTED|Pretreatment 1 and Stimulation||8
2354310|NCT01643798|5777451|P1|STARTED|Pretreatment 1 and Stimulation||7
2354311|NCT01643772|5777466|P4|NOT COMPLETED|Overall Study||2
2354312|NCT01643772|5777467|P3|NOT COMPLETED|Overall Study||0
2354313|NCT01643772|5777468|P2|NOT COMPLETED|Overall Study||0
2354314|NCT01643772|5777469|P1|NOT COMPLETED|Overall Study||0
2354315|NCT01643772|5777466|P4|COMPLETED|Overall Study||14
2354316|NCT01643772|5777467|P3|COMPLETED|Overall Study||15
2354317|NCT01643772|5777468|P2|COMPLETED|Overall Study||15
2354318|NCT01643772|5777469|P1|COMPLETED|Overall Study||15
2354319|NCT01643772|5777466|P4|STARTED|Overall Study||16
2354320|NCT01643772|5777467|P3|STARTED|Overall Study||15
2354321|NCT01643772|5777468|P2|STARTED|Overall Study||15
2354322|NCT01643772|5777469|P1|STARTED|Overall Study||15
2354323|NCT01643668|5777509|P1|NOT COMPLETED|Overall Study||1
2354324|NCT01643668|5777509|P1|COMPLETED|Overall Study||33
2354325|NCT01643668|5777509|P1|STARTED|Overall Study||34
2354326|NCT01643616|5777523|P2|NOT COMPLETED|Overall Study||0
2354327|NCT01643616|5777524|P1|NOT COMPLETED|Overall Study||0
2354328|NCT01643616|5777523|P2|COMPLETED|Overall Study||125
2354329|NCT01643616|5777524|P1|COMPLETED|Overall Study||125
2354330|NCT01643616|5777523|P2|STARTED|Overall Study||125
2354331|NCT01643616|5777524|P1|STARTED|Overall Study||125
2354332|NCT01643525|5777534|P1|NOT COMPLETED|Overall Study||0
2354333|NCT01643525|5777534|P1|COMPLETED|Overall Study||29
2354334|NCT01643525|5777534|P1|STARTED|Overall Study||29
2354335|NCT01643473|5777540|P2|NOT COMPLETED|Overall Study||0
2354336|NCT01643473|5777541|P1|NOT COMPLETED|Overall Study||1
2354337|NCT01643473|5777540|P2|COMPLETED|Overall Study||21
2354338|NCT01643473|5777541|P1|COMPLETED|Overall Study||20
2354339|NCT01643473|5777540|P2|STARTED|Overall Study||21
2354340|NCT01643473|5777541|P1|STARTED|Overall Study||21
2354341|NCT01643213|5777555|P2|NOT COMPLETED|Overall Study||0
2354342|NCT01643213|5777556|P1|NOT COMPLETED|Overall Study||1
2354343|NCT01643213|5777555|P2|COMPLETED|Overall Study||14
2354344|NCT01643213|5777556|P1|COMPLETED|Overall Study||12
2354345|NCT01643213|5777555|P2|STARTED|Overall Study||14
2354346|NCT01643213|5777556|P1|STARTED|Overall Study||13
2354347|NCT01643044|5777564|P2|NOT COMPLETED|Overall Study||5
2354348|NCT01643044|5777565|P1|NOT COMPLETED|Overall Study||4
2354349|NCT01643044|5777564|P2|COMPLETED|Overall Study||19
2354350|NCT01643044|5777565|P1|COMPLETED|Overall Study||20
2354351|NCT01643044|5777564|P2|STARTED|Overall Study||24
2354352|NCT01643044|5777565|P1|STARTED|Overall Study||24
2354353|NCT01642914|5777574|P3|NOT COMPLETED|Overall Study||40
2354354|NCT01642914|5777575|P2|NOT COMPLETED|Overall Study||32
2354355|NCT01642914|5777576|P1|NOT COMPLETED|Overall Study||46
2354356|NCT01642914|5777574|P3|COMPLETED|Overall Study||120
2354357|NCT01642914|5777575|P2|COMPLETED|Overall Study||122
2354358|NCT01642914|5777576|P1|COMPLETED|Overall Study||127
2354359|NCT01642914|5777574|P3|STARTED|Overall Study||160
2354360|NCT01642914|5777575|P2|STARTED|Overall Study||154
2354361|NCT01642914|5777576|P1|STARTED|Overall Study||173
2354362|NCT01642732|5777651|P1|NOT COMPLETED|Overall Study||1
2354363|NCT01642732|5777651|P1|COMPLETED|Overall Study||0
2354364|NCT01642732|5777651|P1|STARTED|Overall Study||1
2354365|NCT01642615|5777656|P3|NOT COMPLETED|Double Blind Maintenance Phase||6
2354366|NCT01642615|5777657|P2|NOT COMPLETED|Double Blind Maintenance Phase||7
2354367|NCT01642615|5777658|P1|NOT COMPLETED|Double Blind Maintenance Phase||0
2354368|NCT01642615|5777656|P3|COMPLETED|Double Blind Maintenance Phase||20
2354369|NCT01642615|5777657|P2|COMPLETED|Double Blind Maintenance Phase||18
2354370|NCT01642615|5777658|P1|COMPLETED|Double Blind Maintenance Phase||0
2354371|NCT01642615|5777656|P3|STARTED|Double Blind Maintenance Phase||26
2354372|NCT01642615|5777657|P2|STARTED|Double Blind Maintenance Phase||25
2354373|NCT01642615|5777658|P1|STARTED|Double Blind Maintenance Phase||0
2354374|NCT01642615|5777656|P3|NOT COMPLETED|Open Label Maintenance Phase||0
2354375|NCT01642615|5777657|P2|NOT COMPLETED|Open Label Maintenance Phase||0
2354376|NCT01642615|5777658|P1|NOT COMPLETED|Open Label Maintenance Phase||5
2354377|NCT01642615|5777656|P3|COMPLETED|Open Label Maintenance Phase||0
2354378|NCT01642615|5777657|P2|COMPLETED|Open Label Maintenance Phase||0
2354379|NCT01642615|5777658|P1|COMPLETED|Open Label Maintenance Phase||58
2354380|NCT01642615|5777656|P3|Safety Analysis Set|Open Label Maintenance Phase||0
2354381|NCT01642615|5777657|P2|Safety Analysis Set|Open Label Maintenance Phase||0
2354382|NCT01642615|5777658|P1|Safety Analysis Set|Open Label Maintenance Phase||62
2354383|NCT01642615|5777656|P3|STARTED|Open Label Maintenance Phase||0
2354384|NCT01642615|5777657|P2|STARTED|Open Label Maintenance Phase||0
2354385|NCT01642615|5777658|P1|STARTED|Open Label Maintenance Phase||63
2354386|NCT01642602|5777672|P1|NOT COMPLETED|Overall Study||2
2354387|NCT01642602|5777672|P1|COMPLETED|Overall Study||102
2354388|NCT01642602|5777672|P1|STARTED|Overall Study||104
2354389|NCT01642589|5777679|P2|NOT COMPLETED|Overall Study||1
2354390|NCT01642589|5777680|P1|NOT COMPLETED|Overall Study||1
2354391|NCT01642589|5777679|P2|COMPLETED|Overall Study||99
2354392|NCT01642589|5777680|P1|COMPLETED|Overall Study||199
2354393|NCT01642589|5777679|P2|STARTED|Overall Study||100
2354394|NCT01642589|5777680|P1|STARTED|Overall Study||200
2354395|NCT01642485|5777694|P8|NOT COMPLETED|Period 2, Day 3||0
2354396|NCT01642485|5777695|P7|NOT COMPLETED|Period 2, Day 3||0
2354397|NCT01642485|5777696|P6|NOT COMPLETED|Period 2, Day 3||0
2354398|NCT01642485|5777697|P5|NOT COMPLETED|Period 2, Day 3||0
2354399|NCT01642485|5777698|P4|NOT COMPLETED|Period 2, Day 3||0
2354400|NCT01642485|5777699|P3|NOT COMPLETED|Period 2, Day 3||0
2354401|NCT01642485|5777700|P2|NOT COMPLETED|Period 2, Day 3||0
2354402|NCT01642485|5777701|P1|NOT COMPLETED|Period 2, Day 3||0
2354403|NCT01642485|5777694|P8|COMPLETED|Period 2, Day 3||4
2354404|NCT01642485|5777695|P7|COMPLETED|Period 2, Day 3||4
2354405|NCT01642485|5777696|P6|COMPLETED|Period 2, Day 3||4
2354406|NCT01642485|5777697|P5|COMPLETED|Period 2, Day 3||4
2354407|NCT01642485|5777698|P4|COMPLETED|Period 2, Day 3||4
2354408|NCT01642485|5777699|P3|COMPLETED|Period 2, Day 3||4
2354409|NCT01642485|5777700|P2|COMPLETED|Period 2, Day 3||4
2354410|NCT01642485|5777701|P1|COMPLETED|Period 2, Day 3||4
2354411|NCT01642485|5777694|P8|STARTED|Period 2, Day 3||4
2354412|NCT01642485|5777695|P7|STARTED|Period 2, Day 3||4
2354413|NCT01642485|5777696|P6|STARTED|Period 2, Day 3||4
2354414|NCT01642485|5777697|P5|STARTED|Period 2, Day 3||4
2354415|NCT01642485|5777698|P4|STARTED|Period 2, Day 3||4
2354416|NCT01642485|5777699|P3|STARTED|Period 2, Day 3||4
2354417|NCT01642485|5777700|P2|STARTED|Period 2, Day 3||4
2354418|NCT01642485|5777701|P1|STARTED|Period 2, Day 3||4
2354419|NCT01642485|5777694|P8|NOT COMPLETED|Period 2, Day 2||0
2354420|NCT01642485|5777695|P7|NOT COMPLETED|Period 2, Day 2||0
2354421|NCT01642485|5777696|P6|NOT COMPLETED|Period 2, Day 2||0
2354422|NCT01642485|5777697|P5|NOT COMPLETED|Period 2, Day 2||0
2354423|NCT01642485|5777698|P4|NOT COMPLETED|Period 2, Day 2||0
2354424|NCT01642485|5777699|P3|NOT COMPLETED|Period 2, Day 2||0
2354425|NCT01642485|5777700|P2|NOT COMPLETED|Period 2, Day 2||0
2354426|NCT01642485|5777701|P1|NOT COMPLETED|Period 2, Day 2||0
2354427|NCT01642485|5777694|P8|COMPLETED|Period 2, Day 2||4
2354428|NCT01642485|5777695|P7|COMPLETED|Period 2, Day 2||4
2354429|NCT01642485|5777696|P6|COMPLETED|Period 2, Day 2||4
2354430|NCT01642485|5777697|P5|COMPLETED|Period 2, Day 2||4
2354431|NCT01642485|5777698|P4|COMPLETED|Period 2, Day 2||4
2354432|NCT01642485|5777699|P3|COMPLETED|Period 2, Day 2||4
2354433|NCT01642485|5777700|P2|COMPLETED|Period 2, Day 2||4
2354434|NCT01642485|5777701|P1|COMPLETED|Period 2, Day 2||4
2354435|NCT01642485|5777694|P8|STARTED|Period 2, Day 2||4
2354436|NCT01642485|5777695|P7|STARTED|Period 2, Day 2||4
2354437|NCT01642485|5777696|P6|STARTED|Period 2, Day 2||4
2354438|NCT01642485|5777697|P5|STARTED|Period 2, Day 2||4
2354439|NCT01642485|5777698|P4|STARTED|Period 2, Day 2||4
2354440|NCT01642485|5777699|P3|STARTED|Period 2, Day 2||4
2354441|NCT01642485|5777700|P2|STARTED|Period 2, Day 2||4
2354442|NCT01642485|5777701|P1|STARTED|Period 2, Day 2||4
2354443|NCT01642485|5777694|P8|NOT COMPLETED|Period 2, Day 1||0
2354444|NCT01642485|5777695|P7|NOT COMPLETED|Period 2, Day 1||0
2354445|NCT01642485|5777696|P6|NOT COMPLETED|Period 2, Day 1||0
2354446|NCT01642485|5777697|P5|NOT COMPLETED|Period 2, Day 1||0
2354447|NCT01642485|5777698|P4|NOT COMPLETED|Period 2, Day 1||0
2354448|NCT01642485|5777699|P3|NOT COMPLETED|Period 2, Day 1||0
2354449|NCT01642485|5777700|P2|NOT COMPLETED|Period 2, Day 1||0
2354450|NCT01642485|5777701|P1|NOT COMPLETED|Period 2, Day 1||0
2354451|NCT01642485|5777694|P8|COMPLETED|Period 2, Day 1||4
2354452|NCT01642485|5777695|P7|COMPLETED|Period 2, Day 1||4
2354453|NCT01642485|5777696|P6|COMPLETED|Period 2, Day 1||4
2354454|NCT01642485|5777697|P5|COMPLETED|Period 2, Day 1||4
2354455|NCT01642485|5777698|P4|COMPLETED|Period 2, Day 1||4
2354456|NCT01642485|5777699|P3|COMPLETED|Period 2, Day 1||4
2354457|NCT01642485|5777700|P2|COMPLETED|Period 2, Day 1||4
2354458|NCT01642485|5777701|P1|COMPLETED|Period 2, Day 1||4
2354459|NCT01642485|5777694|P8|STARTED|Period 2, Day 1||4
2354460|NCT01642485|5777695|P7|STARTED|Period 2, Day 1||4
2354461|NCT01642485|5777696|P6|STARTED|Period 2, Day 1||4
2354462|NCT01642485|5777697|P5|STARTED|Period 2, Day 1||4
2354463|NCT01642485|5777698|P4|STARTED|Period 2, Day 1||4
2354464|NCT01642485|5777699|P3|STARTED|Period 2, Day 1||4
2354465|NCT01642485|5777700|P2|STARTED|Period 2, Day 1||4
2354466|NCT01642485|5777701|P1|STARTED|Period 2, Day 1||4
2354467|NCT01642485|5777694|P8|NOT COMPLETED|Period 1, Day 3||0
2354468|NCT01642485|5777695|P7|NOT COMPLETED|Period 1, Day 3||0
2354469|NCT01642485|5777696|P6|NOT COMPLETED|Period 1, Day 3||0
2354470|NCT01642485|5777697|P5|NOT COMPLETED|Period 1, Day 3||0
2354471|NCT01642485|5777698|P4|NOT COMPLETED|Period 1, Day 3||0
2354472|NCT01642485|5777699|P3|NOT COMPLETED|Period 1, Day 3||0
2354473|NCT01642485|5777700|P2|NOT COMPLETED|Period 1, Day 3||0
2354474|NCT01642485|5777701|P1|NOT COMPLETED|Period 1, Day 3||0
2354475|NCT01642485|5777694|P8|COMPLETED|Period 1, Day 3||4
2354476|NCT01642485|5777695|P7|COMPLETED|Period 1, Day 3||4
2354477|NCT01642485|5777696|P6|COMPLETED|Period 1, Day 3||4
2354478|NCT01642485|5777697|P5|COMPLETED|Period 1, Day 3||4
2354479|NCT01642485|5777698|P4|COMPLETED|Period 1, Day 3||4
2354480|NCT01642485|5777699|P3|COMPLETED|Period 1, Day 3||4
2354481|NCT01642485|5777700|P2|COMPLETED|Period 1, Day 3||4
2354482|NCT01642485|5777701|P1|COMPLETED|Period 1, Day 3||4
2354483|NCT01642485|5777694|P8|STARTED|Period 1, Day 3||4
2354484|NCT01642485|5777695|P7|STARTED|Period 1, Day 3||4
2354485|NCT01642485|5777696|P6|STARTED|Period 1, Day 3||4
2354486|NCT01642485|5777697|P5|STARTED|Period 1, Day 3||4
2354487|NCT01642485|5777698|P4|STARTED|Period 1, Day 3||4
2354488|NCT01642485|5777699|P3|STARTED|Period 1, Day 3||4
2354489|NCT01642485|5777700|P2|STARTED|Period 1, Day 3||4
2354490|NCT01642485|5777701|P1|STARTED|Period 1, Day 3||4
2354491|NCT01642485|5777694|P8|NOT COMPLETED|Period 1, Day 2||0
2354492|NCT01642485|5777695|P7|NOT COMPLETED|Period 1, Day 2||0
2354493|NCT01642485|5777696|P6|NOT COMPLETED|Period 1, Day 2||0
2354494|NCT01642485|5777697|P5|NOT COMPLETED|Period 1, Day 2||0
2354495|NCT01642485|5777698|P4|NOT COMPLETED|Period 1, Day 2||0
2354496|NCT01642485|5777699|P3|NOT COMPLETED|Period 1, Day 2||0
2354497|NCT01642485|5777700|P2|NOT COMPLETED|Period 1, Day 2||0
2354498|NCT01642485|5777701|P1|NOT COMPLETED|Period 1, Day 2||0
2354499|NCT01642485|5777694|P8|COMPLETED|Period 1, Day 2||4
2354500|NCT01642485|5777695|P7|COMPLETED|Period 1, Day 2||4
2354501|NCT01642485|5777696|P6|COMPLETED|Period 1, Day 2||4
2354502|NCT01642485|5777697|P5|COMPLETED|Period 1, Day 2||4
2354503|NCT01642485|5777698|P4|COMPLETED|Period 1, Day 2||4
2354504|NCT01642485|5777699|P3|COMPLETED|Period 1, Day 2||4
2354505|NCT01642485|5777700|P2|COMPLETED|Period 1, Day 2||4
2354506|NCT01642485|5777701|P1|COMPLETED|Period 1, Day 2||4
2354507|NCT01642485|5777694|P8|STARTED|Period 1, Day 2||4
2354508|NCT01642485|5777695|P7|STARTED|Period 1, Day 2||4
2354509|NCT01642485|5777696|P6|STARTED|Period 1, Day 2||4
2354510|NCT01642485|5777697|P5|STARTED|Period 1, Day 2||4
2354511|NCT01642485|5777698|P4|STARTED|Period 1, Day 2||4
2354512|NCT01642485|5777699|P3|STARTED|Period 1, Day 2||4
2354513|NCT01642485|5777700|P2|STARTED|Period 1, Day 2||4
2354514|NCT01642485|5777701|P1|STARTED|Period 1, Day 2||4
2354515|NCT01642485|5777694|P8|NOT COMPLETED|Period 1, Day 1||0
2354516|NCT01642485|5777695|P7|NOT COMPLETED|Period 1, Day 1||0
2354517|NCT01642485|5777696|P6|NOT COMPLETED|Period 1, Day 1||0
2354518|NCT01642485|5777697|P5|NOT COMPLETED|Period 1, Day 1||0
2354519|NCT01642485|5777698|P4|NOT COMPLETED|Period 1, Day 1||0
2354520|NCT01642485|5777699|P3|NOT COMPLETED|Period 1, Day 1||0
2354521|NCT01642485|5777700|P2|NOT COMPLETED|Period 1, Day 1||0
2354522|NCT01642485|5777701|P1|NOT COMPLETED|Period 1, Day 1||0
2354523|NCT01642485|5777694|P8|COMPLETED|Period 1, Day 1||4
2354524|NCT01642485|5777695|P7|COMPLETED|Period 1, Day 1||4
2354525|NCT01642485|5777696|P6|COMPLETED|Period 1, Day 1||4
2354526|NCT01642485|5777697|P5|COMPLETED|Period 1, Day 1||4
2354527|NCT01642485|5777698|P4|COMPLETED|Period 1, Day 1||4
2354528|NCT01642485|5777699|P3|COMPLETED|Period 1, Day 1||4
2354529|NCT01642485|5777700|P2|COMPLETED|Period 1, Day 1||4
2354530|NCT01642485|5777701|P1|COMPLETED|Period 1, Day 1||4
2354531|NCT01642485|5777694|P8|STARTED|Period 1, Day 1||4
2354532|NCT01642485|5777695|P7|STARTED|Period 1, Day 1||4
2354533|NCT01642485|5777696|P6|STARTED|Period 1, Day 1||4
2354534|NCT01642485|5777697|P5|STARTED|Period 1, Day 1||4
2354535|NCT01642485|5777698|P4|STARTED|Period 1, Day 1||4
2354536|NCT01642485|5777699|P3|STARTED|Period 1, Day 1||4
2354537|NCT01642485|5777700|P2|STARTED|Period 1, Day 1||4
2354538|NCT01642485|5777701|P1|STARTED|Period 1, Day 1|crossover so all subjects had this treatment|4
2354539|NCT01642407|5777719|P1|NOT COMPLETED|Part 2(Week17 to Maximum of 119.6 Weeks)||2
2354540|NCT01642407|5777719|P1|COMPLETED|Part 2(Week17 to Maximum of 119.6 Weeks)||1
2354541|NCT01642407|5777719|P1|STARTED|Part 2(Week17 to Maximum of 119.6 Weeks)||3
2354542|NCT01642407|5777719|P1|NOT COMPLETED|Part 1 (Screening Till Week 16)||3
2354543|NCT01642407|5777719|P1|COMPLETED|Part 1 (Screening Till Week 16)||3
2354544|NCT01642407|5777719|P1|STARTED|Part 1 (Screening Till Week 16)||6
2354545|NCT01642277|5777766|P2|NOT COMPLETED|Overall Study||0
2354546|NCT01642277|5777767|P1|NOT COMPLETED|Overall Study||24
2354547|NCT01642277|5777766|P2|COMPLETED|Overall Study||60
2354548|NCT01642277|5777767|P1|COMPLETED|Overall Study||50
2354549|NCT01642277|5777766|P2|STARTED|Overall Study||60
2354550|NCT01642277|5777767|P1|STARTED|Overall Study||74
2354551|NCT01642251|5777779|P4|NOT COMPLETED|Overall Study||23
2354552|NCT01642251|5777780|P3|NOT COMPLETED|Overall Study||22
2354553|NCT01642251|5777781|P2|NOT COMPLETED|Overall Study||0
2354554|NCT01642251|5777782|P1|NOT COMPLETED|Overall Study||0
2354555|NCT01642251|5777779|P4|COMPLETED|Overall Study||49
2354556|NCT01642251|5777780|P3|COMPLETED|Overall Study||53
2354557|NCT01642251|5777781|P2|COMPLETED|Overall Study||6
2354558|NCT01642251|5777782|P1|COMPLETED|Overall Study||3
2354559|NCT01642251|5777779|P4|Eligible and Treated|Overall Study||64
2354560|NCT01642251|5777780|P3|Eligible and Treated|Overall Study||64
2354561|NCT01642251|5777781|P2|Eligible and Treated|Overall Study||6
2354562|NCT01642251|5777782|P1|Eligible and Treated|Overall Study||3
2354563|NCT01642251|5777779|P4|Eligible|Overall Study||69
2354564|NCT01642251|5777780|P3|Eligible|Overall Study||72
2354565|NCT01642251|5777781|P2|Eligible|Overall Study||6
2354566|NCT01642251|5777782|P1|Eligible|Overall Study||3
2354567|NCT01642251|5777779|P4|Started Protocol Therapy|Overall Study||66
2354568|NCT01642251|5777780|P3|Started Protocol Therapy|Overall Study||66
2354569|NCT01642251|5777781|P2|Started Protocol Therapy|Overall Study||6
2354570|NCT01642251|5777782|P1|Started Protocol Therapy|Overall Study||3
2354571|NCT01642251|5777779|P4|STARTED|Overall Study||72
2354572|NCT01642251|5777780|P3|STARTED|Overall Study||75
2354573|NCT01642251|5777781|P2|STARTED|Overall Study||6
2354574|NCT01642251|5777782|P1|STARTED|Overall Study||3
2354575|NCT01642238|5777797|P2|NOT COMPLETED|Second Intervention (1 Day)||0
2354576|NCT01642238|5777798|P1|NOT COMPLETED|Second Intervention (1 Day)||0
2354577|NCT01642238|5777797|P2|COMPLETED|Second Intervention (1 Day)||8
2354578|NCT01642238|5777798|P1|COMPLETED|Second Intervention (1 Day)||7
2354579|NCT01642238|5777797|P2|STARTED|Second Intervention (1 Day)||8
2354580|NCT01642238|5777798|P1|STARTED|Second Intervention (1 Day)||7
2354581|NCT01642238|5777797|P2|NOT COMPLETED|Washout (1-2 Weeks)||0
2354582|NCT01642238|5777798|P1|NOT COMPLETED|Washout (1-2 Weeks)||0
2354583|NCT01642238|5777797|P2|COMPLETED|Washout (1-2 Weeks)||8
2354584|NCT01642238|5777798|P1|COMPLETED|Washout (1-2 Weeks)||7
2354585|NCT01642238|5777797|P2|STARTED|Washout (1-2 Weeks)||8
2354586|NCT01642238|5777798|P1|STARTED|Washout (1-2 Weeks)||7
2354587|NCT01642238|5777797|P2|NOT COMPLETED|First Intervention (1 Day)||0
2354588|NCT01642238|5777798|P1|NOT COMPLETED|First Intervention (1 Day)||0
2354589|NCT01642238|5777797|P2|COMPLETED|First Intervention (1 Day)||8
2354590|NCT01642238|5777798|P1|COMPLETED|First Intervention (1 Day)||7
2354591|NCT01642238|5777797|P2|STARTED|First Intervention (1 Day)||8
2354592|NCT01642238|5777798|P1|STARTED|First Intervention (1 Day)||7
2354593|NCT01642212|5777820|P5|NOT COMPLETED|Open-label Extension||8
2354594|NCT01642212|5777821|P4|NOT COMPLETED|Open-label Extension||10
2354595|NCT01642212|5777822|P3|NOT COMPLETED|Open-label Extension||0
2354596|NCT01642212|5777823|P2|NOT COMPLETED|Open-label Extension||0
2354597|NCT01642212|5777824|P1|NOT COMPLETED|Open-label Extension||0
2354598|NCT01642212|5777820|P5|COMPLETED|Open-label Extension||37
2354599|NCT01642212|5777821|P4|COMPLETED|Open-label Extension||27
2354600|NCT01642212|5777822|P3|COMPLETED|Open-label Extension||0
2354601|NCT01642212|5777823|P2|COMPLETED|Open-label Extension||0
2354602|NCT01642212|5777824|P1|COMPLETED|Open-label Extension||0
2354603|NCT01642212|5777820|P5|STARTED|Open-label Extension|Four participants completed double-blind treatment but did not enter the open-label extension.|45
2354604|NCT01642212|5777821|P4|STARTED|Open-label Extension|Two participants completed double-blind treatment but did not enter the open-label extension.|37
2354605|NCT01642212|5777822|P3|STARTED|Open-label Extension||0
2354606|NCT01642212|5777823|P2|STARTED|Open-label Extension||0
2354607|NCT01642212|5777824|P1|STARTED|Open-label Extension||0
2354608|NCT01642212|5777820|P5|NOT COMPLETED|Double-blind Treatment||0
2354609|NCT01642212|5777821|P4|NOT COMPLETED|Double-blind Treatment||0
2354610|NCT01642212|5777822|P3|NOT COMPLETED|Double-blind Treatment||2
2354611|NCT01642212|5777823|P2|NOT COMPLETED|Double-blind Treatment||3
2354612|NCT01642212|5777824|P1|NOT COMPLETED|Double-blind Treatment||0
2354613|NCT01642212|5777820|P5|COMPLETED|Double-blind Treatment||0
2354614|NCT01642212|5777821|P4|COMPLETED|Double-blind Treatment||0
2354615|NCT01642212|5777822|P3|COMPLETED|Double-blind Treatment||49
2354616|NCT01642212|5777823|P2|COMPLETED|Double-blind Treatment||39
2354617|NCT01642212|5777824|P1|COMPLETED|Double-blind Treatment||0
2354618|NCT01642212|5777820|P5|STARTED|Double-blind Treatment||0
2354619|NCT01642212|5777821|P4|STARTED|Double-blind Treatment||0
2354620|NCT01642212|5777822|P3|STARTED|Double-blind Treatment||51
2354621|NCT01642212|5777823|P2|STARTED|Double-blind Treatment||42
2354622|NCT01642212|5777824|P1|STARTED|Double-blind Treatment||0
2354623|NCT01642212|5777820|P5|NOT COMPLETED|Single-blind Baseline||0
2354624|NCT01642212|5777821|P4|NOT COMPLETED|Single-blind Baseline||0
2354625|NCT01642212|5777822|P3|NOT COMPLETED|Single-blind Baseline||0
2354626|NCT01642212|5777823|P2|NOT COMPLETED|Single-blind Baseline||0
2354627|NCT01642212|5777824|P1|NOT COMPLETED|Single-blind Baseline||26
2354628|NCT01642212|5777820|P5|COMPLETED|Single-blind Baseline||0
2354629|NCT01642212|5777821|P4|COMPLETED|Single-blind Baseline||0
2354630|NCT01642212|5777822|P3|COMPLETED|Single-blind Baseline||0
2354631|NCT01642212|5777823|P2|COMPLETED|Single-blind Baseline||0
2354632|NCT01642212|5777824|P1|COMPLETED|Single-blind Baseline||93
2354633|NCT01642212|5777820|P5|STARTED|Single-blind Baseline||0
2354634|NCT01642212|5777821|P4|STARTED|Single-blind Baseline||0
2354635|NCT01642212|5777822|P3|STARTED|Single-blind Baseline||0
2354636|NCT01642212|5777823|P2|STARTED|Single-blind Baseline||0
2354637|NCT01642212|5777824|P1|STARTED|Single-blind Baseline||119
2354638|NCT01642147|5777874|P2|NOT COMPLETED|Overall Study||0
2354639|NCT01642147|5777875|P1|NOT COMPLETED|Overall Study||0
2354640|NCT01642147|5777874|P2|COMPLETED|Overall Study||30
2354641|NCT01642147|5777875|P1|COMPLETED|Overall Study||30
2354642|NCT01642147|5777874|P2|STARTED|Overall Study||30
2354643|NCT01642147|5777875|P1|STARTED|Overall Study||30
2354644|NCT01642082|5777903|P1|NOT COMPLETED|Overall Study||0
2354645|NCT01642082|5777903|P1|COMPLETED|Overall Study||28
2354646|NCT01642082|5777903|P1|STARTED|Overall Study||28
2354647|NCT01642004|5777919|P2|NOT COMPLETED|Treatment||127
2354648|NCT01642004|5777920|P1|NOT COMPLETED|Treatment||110
2354649|NCT01642004|5777919|P2|COMPLETED|Treatment||2
2354650|NCT01642004|5777920|P1|COMPLETED|Treatment||21
2354651|NCT01642004|5777919|P2|STARTED|Treatment||129
2354652|NCT01642004|5777920|P1|STARTED|Treatment||131
2354653|NCT01642004|5777919|P2|NOT COMPLETED|Randomization||8
2354654|NCT01642004|5777920|P1|NOT COMPLETED|Randomization||4
2354655|NCT01642004|5777919|P2|COMPLETED|Randomization||129
2354656|NCT01642004|5777920|P1|COMPLETED|Randomization||131
2354657|NCT01642004|5777919|P2|STARTED|Randomization||137
2354658|NCT01642004|5777920|P1|STARTED|Randomization||135
2354659|NCT01641991|5777954|P4|NOT COMPLETED|Overall Study||16
2354660|NCT01641991|5777955|P3|NOT COMPLETED|Overall Study||17
2354661|NCT01641991|5777956|P2|NOT COMPLETED|Overall Study||8
2354662|NCT01641991|5777957|P1|NOT COMPLETED|Overall Study||9
2354663|NCT01641991|5777954|P4|COMPLETED|Overall Study||66
2354664|NCT01641991|5777955|P3|COMPLETED|Overall Study||65
2354665|NCT01641991|5777956|P2|COMPLETED|Overall Study||74
2354666|NCT01641991|5777957|P1|COMPLETED|Overall Study||73
2354667|NCT01641991|5777954|P4|STARTED|Overall Study||82
2354668|NCT01641991|5777955|P3|STARTED|Overall Study||82
2354669|NCT01641991|5777956|P2|STARTED|Overall Study||82
2354670|NCT01641991|5777957|P1|STARTED|Overall Study||82
2354671|NCT01641978|5778033|P1|NOT COMPLETED|Overall Study||0
2354672|NCT01641978|5778033|P1|COMPLETED|Overall Study||125
2354673|NCT01641978|5778033|P1|STARTED|Overall Study||125
2354674|NCT01641952|5778041|P1|NOT COMPLETED|Overall Study||34
2354675|NCT01641952|5778041|P1|COMPLETED|Overall Study||471
2354676|NCT01641952|5778041|P1|Treated|Overall Study||504
2354677|NCT01641952|5778041|P1|STARTED|Overall Study||505
2354678|NCT01641939|5778057|P3|NOT COMPLETED|Overall Study||70
2354679|NCT01641939|5778058|P2|NOT COMPLETED|Overall Study||228
2354680|NCT01641939|5778059|P1|NOT COMPLETED|Overall Study||117
2354681|NCT01641939|5778057|P3|COMPLETED|Overall Study||0
2354682|NCT01641939|5778058|P2|COMPLETED|Overall Study||0
2354683|NCT01641939|5778059|P1|COMPLETED|Overall Study||0
2354684|NCT01641939|5778057|P3|Stage 2|Overall Study||0
2354685|NCT01641939|5778058|P2|Stage 2|Overall Study||153
2354686|NCT01641939|5778059|P1|Stage 2|Overall Study||80
2354687|NCT01641939|5778057|P3|Stage 1|Overall Study||70
2354688|NCT01641939|5778058|P2|Stage 1|Overall Study||75
2354689|NCT01641939|5778059|P1|Stage 1|Overall Study||37
2354690|NCT01641939|5778057|P3|STARTED|Overall Study||70
2354691|NCT01641939|5778058|P2|STARTED|Overall Study||228
2354692|NCT01641939|5778059|P1|STARTED|Overall Study||117
2354693|NCT01641926|5778102|P4|NOT COMPLETED|Overall Study||4
2354694|NCT01641926|5778103|P3|NOT COMPLETED|Overall Study||11
2354695|NCT01641926|5778104|P2|NOT COMPLETED|Overall Study||15
2354696|NCT01641926|5778105|P1|NOT COMPLETED|Overall Study||28
2354697|NCT01641926|5778102|P4|COMPLETED|Overall Study||53
2354698|NCT01641926|5778103|P3|COMPLETED|Overall Study||46
2354699|NCT01641926|5778104|P2|COMPLETED|Overall Study||130
2354700|NCT01641926|5778105|P1|COMPLETED|Overall Study||115
2354701|NCT01641926|5778102|P4|Treated (All Participants as Treated)|Overall Study||57
2354702|NCT01641926|5778103|P3|Treated (All Participants as Treated)|Overall Study||56
2354703|NCT01641926|5778104|P2|Treated (All Participants as Treated)|Overall Study||144
2354704|NCT01641926|5778105|P1|Treated (All Participants as Treated)|Overall Study||142
2354705|NCT01641926|5778102|P4|STARTED|Overall Study||57
2354706|NCT01641926|5778103|P3|STARTED|Overall Study||57
2354707|NCT01641926|5778104|P2|STARTED|Overall Study||145
2354708|NCT01641926|5778105|P1|STARTED|Overall Study||143
2354709|NCT01641900|5778133|P2|NOT COMPLETED|Overall Study||2
2354710|NCT01641900|5778134|P1|NOT COMPLETED|Overall Study||2
2354711|NCT01641900|5778133|P2|COMPLETED|Overall Study||29
2354712|NCT01641900|5778134|P1|COMPLETED|Overall Study||26
2354713|NCT01641900|5778133|P2|Completed Drug Intervention|Overall Study||29
2354789|NCT01641692|5778382|P4|NOT COMPLETED|Washout Period 3 or Follow-up||1
2354714|NCT01641900|5778134|P1|Completed Drug Intervention|Overall Study|n=1,assigned to drug intervention first, completed the session and dropped out of the study.|26
2354715|NCT01641900|5778133|P2|Completed Placebo Intervention|Overall Study|n=2,both assigned to placebo intervention first, completed the session and dropped out of the study.|29
2354716|NCT01641900|5778134|P1|Completed Placebo Intervention|Overall Study|n=1,assigned to placebo intervention first, completed the session and dropped out of the study.|27
2354717|NCT01641900|5778133|P2|STARTED|Overall Study||31
2354718|NCT01641900|5778134|P1|STARTED|Overall Study||28
2354719|NCT01641861|5778146|P2|NOT COMPLETED|Overall Study||25
2354720|NCT01641861|5778147|P1|NOT COMPLETED|Overall Study||35
2354721|NCT01641861|5778146|P2|COMPLETED|Overall Study||217
2354722|NCT01641861|5778147|P1|COMPLETED|Overall Study||211
2354723|NCT01641861|5778146|P2|STARTED|Overall Study||242
2354724|NCT01641861|5778147|P1|STARTED|Overall Study||246
2354725|NCT01641835|5778161|P1|NOT COMPLETED|Overall Study||0
2354726|NCT01641835|5778161|P1|COMPLETED|Overall Study||303
2354727|NCT01641835|5778161|P1|STARTED|Overall Study||303
2354728|NCT01641822|5778168|P3|NOT COMPLETED|Comparative Phase||10
2354729|NCT01641822|5778169|P2|NOT COMPLETED|Comparative Phase||6
2354730|NCT01641822|5778170|P1|NOT COMPLETED|Comparative Phase||0
2354731|NCT01641822|5778168|P3|COMPLETED|Comparative Phase||37
2354732|NCT01641822|5778169|P2|COMPLETED|Comparative Phase||37
2354733|NCT01641822|5778170|P1|COMPLETED|Comparative Phase||0
2354734|NCT01641822|5778168|P3|Received Randomized Study Drug Treatment|Comparative Phase||46
2354735|NCT01641822|5778169|P2|Received Randomized Study Drug Treatment|Comparative Phase||42
2354736|NCT01641822|5778170|P1|Received Randomized Study Drug Treatment|Comparative Phase||0
2354737|NCT01641822|5778168|P3|STARTED|Comparative Phase||47
2354738|NCT01641822|5778169|P2|STARTED|Comparative Phase||43
2354739|NCT01641822|5778170|P1|STARTED|Comparative Phase|Participants continuing into the Comparative Phase were randomized to the AZLI or Placebo group.|0
2354740|NCT01641822|5778168|P3|NOT COMPLETED|Run-in Phase||0
2354741|NCT01641822|5778169|P2|NOT COMPLETED|Run-in Phase||0
2354742|NCT01641822|5778170|P1|NOT COMPLETED|Run-in Phase||14
2354743|NCT01641822|5778168|P3|COMPLETED|Run-in Phase||0
2354744|NCT01641822|5778169|P2|COMPLETED|Run-in Phase||0
2354745|NCT01641822|5778170|P1|COMPLETED|Run-in Phase|3 participants who completed the TIS Run-In Phase did not continue to the Comparative Phase.|93
2354746|NCT01641822|5778168|P3|STARTED|Run-in Phase||0
2354747|NCT01641822|5778169|P2|STARTED|Run-in Phase||0
2354748|NCT01641822|5778170|P1|STARTED|Run-in Phase||107
2354749|NCT01641809|5778191|P4|NOT COMPLETED|Open-label (Week 96 to Week 324)||0
2354750|NCT01641809|5778192|P3|NOT COMPLETED|Open-label (Week 96 to Week 324)||8
2354751|NCT01641809|5778193|P2|NOT COMPLETED|Open-label (Week 96 to Week 324)||12
2354752|NCT01641809|5778194|P1|NOT COMPLETED|Open-label (Week 96 to Week 324)||16
2354753|NCT01641809|5778191|P4|COMPLETED|Open-label (Week 96 to Week 324)||0
2354754|NCT01641809|5778192|P3|COMPLETED|Open-label (Week 96 to Week 324)||43
2354755|NCT01641809|5778193|P2|COMPLETED|Open-label (Week 96 to Week 324)||35
2354756|NCT01641809|5778194|P1|COMPLETED|Open-label (Week 96 to Week 324)||30
2354757|NCT01641809|5778191|P4|STARTED|Open-label (Week 96 to Week 324)|Participants completed study at Week 96 and did not enter open-label phase|0
2354758|NCT01641809|5778192|P3|STARTED|Open-label (Week 96 to Week 324)|1 participant completed study as per protocol at Week 96 and opted to not enter open-label phase|51
2354759|NCT01641809|5778193|P2|STARTED|Open-label (Week 96 to Week 324)|1 participant completed study as per protocol at Week 96 and opted to not enter open-label phase|47
2354760|NCT01641809|5778194|P1|STARTED|Open-label (Week 96 to Week 324)||46
2354761|NCT01641809|5778191|P4|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||6
2354762|NCT01641809|5778192|P3|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||3
2354763|NCT01641809|5778193|P2|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||5
2354764|NCT01641809|5778194|P1|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||6
2354765|NCT01641809|5778191|P4|COMPLETED|Maintenance Phase (Week 24 to Week 96)||41
2354766|NCT01641809|5778192|P3|COMPLETED|Maintenance Phase (Week 24 to Week 96)||52
2354767|NCT01641809|5778193|P2|COMPLETED|Maintenance Phase (Week 24 to Week 96)||48
2354768|NCT01641809|5778194|P1|COMPLETED|Maintenance Phase (Week 24 to Week 96)||46
2354769|NCT01641809|5778191|P4|STARTED|Maintenance Phase (Week 24 to Week 96)||47
2354770|NCT01641809|5778192|P3|STARTED|Maintenance Phase (Week 24 to Week 96)||55
2354771|NCT01641809|5778193|P2|STARTED|Maintenance Phase (Week 24 to Week 96)||53
2354772|NCT01641809|5778194|P1|STARTED|Maintenance Phase (Week 24 to Week 96)||52
2354773|NCT01641809|5778191|P4|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||15
2354774|NCT01641809|5778192|P3|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||6
2354775|NCT01641809|5778193|P2|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||7
2354776|NCT01641809|5778194|P1|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||8
2354777|NCT01641809|5778191|P4|COMPLETED|Induction Phase (Day 1 to Week 24)||47
2354778|NCT01641809|5778192|P3|COMPLETED|Induction Phase (Day 1 to Week 24)||55
2354779|NCT01641809|5778193|P2|COMPLETED|Induction Phase (Day 1 to Week 24)||53
2354780|NCT01641809|5778194|P1|COMPLETED|Induction Phase (Day 1 to Week 24)||52
2354781|NCT01641809|5778191|P4|STARTED|Induction Phase (Day 1 to Week 24)||62
2354782|NCT01641809|5778192|P3|STARTED|Induction Phase (Day 1 to Week 24)||61
2354783|NCT01641809|5778193|P2|STARTED|Induction Phase (Day 1 to Week 24)||60
2354784|NCT01641809|5778194|P1|STARTED|Induction Phase (Day 1 to Week 24)||60
2354785|NCT01641692|5778378|P8|NOT COMPLETED|Washout Period 3 or Follow-up||0
2354786|NCT01641692|5778379|P7|NOT COMPLETED|Washout Period 3 or Follow-up||1
2354787|NCT01641692|5778380|P6|NOT COMPLETED|Washout Period 3 or Follow-up||2
2354788|NCT01641692|5778381|P5|NOT COMPLETED|Washout Period 3 or Follow-up||0
2354790|NCT01641692|5778383|P3|NOT COMPLETED|Washout Period 3 or Follow-up||1
2354791|NCT01641692|5778384|P2|NOT COMPLETED|Washout Period 3 or Follow-up||0
2354792|NCT01641692|5778385|P1|NOT COMPLETED|Washout Period 3 or Follow-up||1
2354793|NCT01641692|5778378|P8|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|38
2354794|NCT01641692|5778379|P7|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
2354795|NCT01641692|5778380|P6|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|37
2354796|NCT01641692|5778381|P5|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|40
2354797|NCT01641692|5778382|P4|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|41
2354798|NCT01641692|5778383|P3|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|36
2354799|NCT01641692|5778384|P2|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
2354800|NCT01641692|5778385|P1|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|42
2354801|NCT01641692|5778378|P8|STARTED|Washout Period 3 or Follow-up||38
2354802|NCT01641692|5778379|P7|STARTED|Washout Period 3 or Follow-up||33
2354803|NCT01641692|5778380|P6|STARTED|Washout Period 3 or Follow-up||39
2354804|NCT01641692|5778381|P5|STARTED|Washout Period 3 or Follow-up||40
2354805|NCT01641692|5778382|P4|STARTED|Washout Period 3 or Follow-up||42
2354806|NCT01641692|5778383|P3|STARTED|Washout Period 3 or Follow-up||37
2354807|NCT01641692|5778384|P2|STARTED|Washout Period 3 or Follow-up||32
2354808|NCT01641692|5778385|P1|STARTED|Washout Period 3 or Follow-up||43
2354809|NCT01641692|5778378|P8|NOT COMPLETED|Treatment Period 3||0
2354810|NCT01641692|5778379|P7|NOT COMPLETED|Treatment Period 3||2
2354811|NCT01641692|5778380|P6|NOT COMPLETED|Treatment Period 3||0
2354812|NCT01641692|5778381|P5|NOT COMPLETED|Treatment Period 3||0
2354813|NCT01641692|5778382|P4|NOT COMPLETED|Treatment Period 3||0
2354814|NCT01641692|5778383|P3|NOT COMPLETED|Treatment Period 3||1
2354815|NCT01641692|5778384|P2|NOT COMPLETED|Treatment Period 3||1
2354816|NCT01641692|5778385|P1|NOT COMPLETED|Treatment Period 3||0
2354817|NCT01641692|5778378|P8|COMPLETED|Treatment Period 3||38
2354818|NCT01641692|5778379|P7|COMPLETED|Treatment Period 3||33
2354819|NCT01641692|5778380|P6|COMPLETED|Treatment Period 3||39
2354820|NCT01641692|5778381|P5|COMPLETED|Treatment Period 3||40
2354821|NCT01641692|5778382|P4|COMPLETED|Treatment Period 3||42
2354822|NCT01641692|5778383|P3|COMPLETED|Treatment Period 3||37
2354823|NCT01641692|5778384|P2|COMPLETED|Treatment Period 3||32
2354824|NCT01641692|5778385|P1|COMPLETED|Treatment Period 3||43
2354825|NCT01641692|5778378|P8|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
2354826|NCT01641692|5778379|P7|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|35
2354827|NCT01641692|5778380|P6|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|39
2354828|NCT01641692|5778381|P5|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|40
2354829|NCT01641692|5778382|P4|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|42
2354830|NCT01641692|5778383|P3|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
2354831|NCT01641692|5778384|P2|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|33
2354832|NCT01641692|5778385|P1|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|43
2354833|NCT01641692|5778378|P8|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
2354834|NCT01641692|5778379|P7|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
2354835|NCT01641692|5778380|P6|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
2354836|NCT01641692|5778381|P5|NOT COMPLETED|Washout Period 2 (12-14 Days)||3
2354837|NCT01641692|5778382|P4|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
2354838|NCT01641692|5778383|P3|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
2354839|NCT01641692|5778384|P2|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
2354840|NCT01641692|5778385|P1|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
2354841|NCT01641692|5778378|P8|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
2354842|NCT01641692|5778379|P7|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
2354843|NCT01641692|5778380|P6|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
2354844|NCT01641692|5778381|P5|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
2354845|NCT01641692|5778382|P4|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|41
2354846|NCT01641692|5778383|P3|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
2354847|NCT01641692|5778384|P2|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|46
2354848|NCT01641692|5778385|P1|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|30
2354849|NCT01641692|5778378|P8|STARTED|Washout Period 2 (12-14 Days)||35
2354850|NCT01641692|5778379|P7|STARTED|Washout Period 2 (12-14 Days)||43
2354851|NCT01641692|5778380|P6|STARTED|Washout Period 2 (12-14 Days)||43
2354852|NCT01641692|5778381|P5|STARTED|Washout Period 2 (12-14 Days)||37
2354853|NCT01641692|5778382|P4|STARTED|Washout Period 2 (12-14 Days)||41
2354854|NCT01641692|5778383|P3|STARTED|Washout Period 2 (12-14 Days)||40
2354855|NCT01641692|5778384|P2|STARTED|Washout Period 2 (12-14 Days)||46
2354856|NCT01641692|5778385|P1|STARTED|Washout Period 2 (12-14 Days)||30
2354857|NCT01641692|5778378|P8|NOT COMPLETED|Treatment Period 2||1
2354858|NCT01641692|5778379|P7|NOT COMPLETED|Treatment Period 2||0
2354859|NCT01641692|5778380|P6|NOT COMPLETED|Treatment Period 2||2
2354860|NCT01641692|5778381|P5|NOT COMPLETED|Treatment Period 2||0
2354861|NCT01641692|5778382|P4|NOT COMPLETED|Treatment Period 2||0
2354862|NCT01641692|5778383|P3|NOT COMPLETED|Treatment Period 2||0
2354863|NCT01641692|5778384|P2|NOT COMPLETED|Treatment Period 2||0
2354864|NCT01641692|5778385|P1|NOT COMPLETED|Treatment Period 2||3
2354865|NCT01641692|5778378|P8|COMPLETED|Treatment Period 2||35
2354866|NCT01641692|5778379|P7|COMPLETED|Treatment Period 2||43
2354867|NCT01641692|5778380|P6|COMPLETED|Treatment Period 2||43
2354868|NCT01641692|5778381|P5|COMPLETED|Treatment Period 2||37
2354869|NCT01641692|5778382|P4|COMPLETED|Treatment Period 2||41
2354870|NCT01641692|5778383|P3|COMPLETED|Treatment Period 2||40
2354871|NCT01641692|5778384|P2|COMPLETED|Treatment Period 2||46
2354872|NCT01641692|5778385|P1|COMPLETED|Treatment Period 2||30
2354873|NCT01641692|5778378|P8|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|36
2354874|NCT01641692|5778379|P7|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|43
2354875|NCT01641692|5778380|P6|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|45
2354876|NCT01641692|5778381|P5|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|37
2354877|NCT01641692|5778382|P4|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|41
2354878|NCT01641692|5778383|P3|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|40
2354879|NCT01641692|5778384|P2|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|46
2354880|NCT01641692|5778385|P1|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|33
2354881|NCT01641692|5778378|P8|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
2354882|NCT01641692|5778379|P7|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
2354883|NCT01641692|5778380|P6|NOT COMPLETED|Washout Period 1 (12-14 Days)||0
2354884|NCT01641692|5778381|P5|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
2354885|NCT01641692|5778382|P4|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
2354886|NCT01641692|5778383|P3|NOT COMPLETED|Washout Period 1 (12-14 Days)||3
2354887|NCT01641692|5778384|P2|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
2354888|NCT01641692|5778385|P1|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
2354889|NCT01641692|5778378|P8|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
2354890|NCT01641692|5778379|P7|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
2354891|NCT01641692|5778380|P6|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|37
2354892|NCT01641692|5778381|P5|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|35
2354893|NCT01641692|5778382|P4|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
2354894|NCT01641692|5778383|P3|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
2354895|NCT01641692|5778384|P2|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|44
2354896|NCT01641692|5778385|P1|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
2354897|NCT01641692|5778378|P8|STARTED|Washout Period 1 (12-14 Days)||48
2354898|NCT01641692|5778379|P7|STARTED|Washout Period 1 (12-14 Days)||38
2354899|NCT01641692|5778380|P6|STARTED|Washout Period 1 (12-14 Days)||37
2354900|NCT01641692|5778381|P5|STARTED|Washout Period 1 (12-14 Days)||39
2354901|NCT01641692|5778382|P4|STARTED|Washout Period 1 (12-14 Days)||41
2354902|NCT01641692|5778383|P3|STARTED|Washout Period 1 (12-14 Days)||50
2354903|NCT01641692|5778384|P2|STARTED|Washout Period 1 (12-14 Days)||45
2354904|NCT01641692|5778385|P1|STARTED|Washout Period 1 (12-14 Days)||40
2354905|NCT01641692|5778378|P8|NOT COMPLETED|Treatment Period 1||3
2354906|NCT01641692|5778379|P7|NOT COMPLETED|Treatment Period 1||0
2354907|NCT01641692|5778380|P6|NOT COMPLETED|Treatment Period 1||2
2354908|NCT01641692|5778381|P5|NOT COMPLETED|Treatment Period 1||4
2354909|NCT01641692|5778382|P4|NOT COMPLETED|Treatment Period 1||0
2354910|NCT01641692|5778383|P3|NOT COMPLETED|Treatment Period 1||1
2354911|NCT01641692|5778384|P2|NOT COMPLETED|Treatment Period 1||0
2354912|NCT01641692|5778385|P1|NOT COMPLETED|Treatment Period 1||2
2354913|NCT01641692|5778378|P8|COMPLETED|Treatment Period 1||48
2354914|NCT01641692|5778379|P7|COMPLETED|Treatment Period 1||38
2354915|NCT01641692|5778380|P6|COMPLETED|Treatment Period 1||37
2354916|NCT01641692|5778381|P5|COMPLETED|Treatment Period 1||39
2354917|NCT01641692|5778382|P4|COMPLETED|Treatment Period 1||41
2354918|NCT01641692|5778383|P3|COMPLETED|Treatment Period 1||50
2354919|NCT01641692|5778384|P2|COMPLETED|Treatment Period 1||45
2354920|NCT01641692|5778385|P1|COMPLETED|Treatment Period 1||40
2354921|NCT01641692|5778378|P8|STARTED|Treatment Period 1||51
2354922|NCT01641692|5778379|P7|STARTED|Treatment Period 1||38
2354923|NCT01641692|5778380|P6|STARTED|Treatment Period 1||39
2354924|NCT01641692|5778381|P5|STARTED|Treatment Period 1||43
2354925|NCT01641692|5778382|P4|STARTED|Treatment Period 1||41
2354926|NCT01641692|5778383|P3|STARTED|Treatment Period 1||51
2354927|NCT01641692|5778384|P2|STARTED|Treatment Period 1||45
2354928|NCT01641692|5778385|P1|STARTED|Treatment Period 1||42
2354929|NCT01641653|5778574|P2|NOT COMPLETED|Overall Study||0
2354930|NCT01641653|5778575|P1|NOT COMPLETED|Overall Study||0
2354931|NCT01641653|5778574|P2|COMPLETED|Overall Study||30
2354932|NCT01641653|5778575|P1|COMPLETED|Overall Study||30
2354933|NCT01641653|5778574|P2|STARTED|Overall Study||30
2354934|NCT01641653|5778575|P1|STARTED|Overall Study||30
2354935|NCT01641640|5778585|P1|NOT COMPLETED|Overall Study||36
2354936|NCT01641640|5778585|P1|COMPLETED|Overall Study||292
2354937|NCT01641640|5778585|P1|Enrolled and Treated|Overall Study||327
2354938|NCT01641640|5778585|P1|STARTED|Overall Study||328
2354939|NCT01641471|5778596|P2|NOT COMPLETED|Overall Study||27
2354940|NCT01641471|5778597|P1|NOT COMPLETED|Overall Study||23
2354941|NCT01641471|5778596|P2|COMPLETED|Overall Study||31
2354942|NCT01641471|5778597|P1|COMPLETED|Overall Study||35
2354943|NCT01641471|5778596|P2|STARTED|Overall Study||58
2354944|NCT01641471|5778597|P1|STARTED|Overall Study||58
2354945|NCT01641380|5778611|P2|NOT COMPLETED|Third Injection Cycle||5
2354946|NCT01641380|5778612|P1|NOT COMPLETED|Third Injection Cycle||3
2354947|NCT01641380|5778611|P2|COMPLETED|Third Injection Cycle||33
2354948|NCT01641380|5778612|P1|COMPLETED|Third Injection Cycle||36
2354949|NCT01641380|5778611|P2|STARTED|Third Injection Cycle||38
2354950|NCT01641380|5778612|P1|STARTED|Third Injection Cycle||39
2354951|NCT01641380|5778611|P2|NOT COMPLETED|Second Injection Cycle||6
2354952|NCT01641380|5778612|P1|NOT COMPLETED|Second Injection Cycle||4
2354953|NCT01641380|5778611|P2|COMPLETED|Second Injection Cycle||38
2354954|NCT01641380|5778612|P1|COMPLETED|Second Injection Cycle||39
2354955|NCT01641380|5778611|P2|STARTED|Second Injection Cycle||44
2354956|NCT01641380|5778612|P1|STARTED|Second Injection Cycle||43
2354957|NCT01641380|5778611|P2|NOT COMPLETED|First Injection Cycle||6
2354958|NCT01641380|5778612|P1|NOT COMPLETED|First Injection Cycle||7
2354959|NCT01641380|5778611|P2|COMPLETED|First Injection Cycle||44
2354960|NCT01641380|5778612|P1|COMPLETED|First Injection Cycle||43
2354961|NCT01641380|5778611|P2|STARTED|First Injection Cycle||50
2354962|NCT01641380|5778612|P1|STARTED|First Injection Cycle||50
2354963|NCT01641367|5778629|P8|NOT COMPLETED|Randomized Adherence Intervention||24
2354964|NCT01641367|5778630|P7|NOT COMPLETED|Randomized Adherence Intervention||19
2354965|NCT01641367|5778631|P6|NOT COMPLETED|Randomized Adherence Intervention||0
2354966|NCT01641367|5778632|P5|NOT COMPLETED|Randomized Adherence Intervention||0
2354967|NCT01641367|5778633|P4|NOT COMPLETED|Randomized Adherence Intervention||0
2354968|NCT01641367|5778634|P3|NOT COMPLETED|Randomized Adherence Intervention||0
2354969|NCT01641367|5778635|P2|NOT COMPLETED|Randomized Adherence Intervention||0
2354970|NCT01641367|5778636|P1|NOT COMPLETED|Randomized Adherence Intervention||0
2354971|NCT01641367|5778629|P8|COMPLETED|Randomized Adherence Intervention||240
2354972|NCT01641367|5778630|P7|COMPLETED|Randomized Adherence Intervention||238
2354973|NCT01641367|5778631|P6|COMPLETED|Randomized Adherence Intervention||0
2354974|NCT01641367|5778632|P5|COMPLETED|Randomized Adherence Intervention||0
2354975|NCT01641367|5778633|P4|COMPLETED|Randomized Adherence Intervention||0
2354976|NCT01641367|5778634|P3|COMPLETED|Randomized Adherence Intervention||0
2354977|NCT01641367|5778635|P2|COMPLETED|Randomized Adherence Intervention||0
2354978|NCT01641367|5778636|P1|COMPLETED|Randomized Adherence Intervention||0
2354979|NCT01641367|5778629|P8|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||202
2354980|NCT01641367|5778630|P7|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||196
2354981|NCT01641367|5778631|P6|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
2354982|NCT01641367|5778632|P5|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
2354983|NCT01641367|5778633|P4|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
2354984|NCT01641367|5778634|P3|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
2354985|NCT01641367|5778635|P2|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
2354986|NCT01641367|5778636|P1|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
2354987|NCT01641367|5778629|P8|STARTED|Randomized Adherence Intervention||264
2354988|NCT01641367|5778630|P7|STARTED|Randomized Adherence Intervention||257
2354989|NCT01641367|5778631|P6|STARTED|Randomized Adherence Intervention||0
2354990|NCT01641367|5778632|P5|STARTED|Randomized Adherence Intervention||0
2354991|NCT01641367|5778633|P4|STARTED|Randomized Adherence Intervention||0
2354992|NCT01641367|5778634|P3|STARTED|Randomized Adherence Intervention||0
2354993|NCT01641367|5778635|P2|STARTED|Randomized Adherence Intervention||0
2354994|NCT01641367|5778636|P1|STARTED|Randomized Adherence Intervention||0
2354995|NCT01641367|5778629|P8|NOT COMPLETED|Cohorts||0
2354996|NCT01641367|5778630|P7|NOT COMPLETED|Cohorts||0
2354997|NCT01641367|5778631|P6|NOT COMPLETED|Cohorts||1
2354998|NCT01641367|5778632|P5|NOT COMPLETED|Cohorts||3
2354999|NCT01641367|5778633|P4|NOT COMPLETED|Cohorts||0
2355000|NCT01641367|5778634|P3|NOT COMPLETED|Cohorts||4
2355001|NCT01641367|5778635|P2|NOT COMPLETED|Cohorts||1
2355002|NCT01641367|5778636|P1|NOT COMPLETED|Cohorts||34
2355003|NCT01641367|5778629|P8|COMPLETED|Cohorts||0
2355004|NCT01641367|5778630|P7|COMPLETED|Cohorts||0
2355005|NCT01641367|5778631|P6|COMPLETED|Cohorts||33
2355006|NCT01641367|5778632|P5|COMPLETED|Cohorts||67
2355007|NCT01641367|5778633|P4|COMPLETED|Cohorts||8
2355008|NCT01641367|5778634|P3|COMPLETED|Cohorts||68
2355009|NCT01641367|5778635|P2|COMPLETED|Cohorts||73
2355010|NCT01641367|5778636|P1|COMPLETED|Cohorts||253
2355011|NCT01641367|5778629|P8|Followed 72 Weeks on Step 1/2|Cohorts||0
2355012|NCT01641367|5778630|P7|Followed 72 Weeks on Step 1/2|Cohorts||0
2355013|NCT01641367|5778631|P6|Followed 72 Weeks on Step 1/2|Cohorts||30
2355014|NCT01641367|5778632|P5|Followed 72 Weeks on Step 1/2|Cohorts||52
2355015|NCT01641367|5778633|P4|Followed 72 Weeks on Step 1/2|Cohorts||6
2355016|NCT01641367|5778634|P3|Followed 72 Weeks on Step 1/2|Cohorts||60
2355017|NCT01641367|5778635|P2|Followed 72 Weeks on Step 1/2|Cohorts||60
2355018|NCT01641367|5778636|P1|Followed 72 Weeks on Step 1/2|Cohorts||211
2355019|NCT01641367|5778629|P8|STARTED|Cohorts||0
2355020|NCT01641367|5778630|P7|STARTED|Cohorts||0
2355021|NCT01641367|5778631|P6|STARTED|Cohorts||34
2355022|NCT01641367|5778632|P5|STARTED|Cohorts||70
2355023|NCT01641367|5778633|P4|STARTED|Cohorts||8
2355024|NCT01641367|5778634|P3|STARTED|Cohorts||72
2355025|NCT01641367|5778635|P2|STARTED|Cohorts||74
2355026|NCT01641367|5778636|P1|STARTED|Cohorts||287
2355027|NCT01641237|5778887|P4|NOT COMPLETED|Period IV||0
2355028|NCT01641237|5778888|P3|NOT COMPLETED|Period IV||0
2355029|NCT01641237|5778889|P2|NOT COMPLETED|Period IV||0
2355030|NCT01641237|5778890|P1|NOT COMPLETED|Period IV||0
2355031|NCT01641237|5778887|P4|COMPLETED|Period IV||15
2355032|NCT01641237|5778888|P3|COMPLETED|Period IV||15
2355033|NCT01641237|5778889|P2|COMPLETED|Period IV||15
2355034|NCT01641237|5778890|P1|COMPLETED|Period IV||15
2355035|NCT01641237|5778887|P4|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
2355036|NCT01641237|5778888|P3|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
2355037|NCT01641237|5778889|P2|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
2355038|NCT01641237|5778890|P1|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
2355039|NCT01641237|5778887|P4|NOT COMPLETED|Period III||0
2355040|NCT01641237|5778888|P3|NOT COMPLETED|Period III||0
2355041|NCT01641237|5778889|P2|NOT COMPLETED|Period III||0
2355042|NCT01641237|5778890|P1|NOT COMPLETED|Period III||1
2355043|NCT01641237|5778887|P4|COMPLETED|Period III||16
2355044|NCT01641237|5778888|P3|COMPLETED|Period III||15
2355045|NCT01641237|5778889|P2|COMPLETED|Period III||14
2355046|NCT01641237|5778890|P1|COMPLETED|Period III||15
2355047|NCT01641237|5778887|P4|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
2355048|NCT01641237|5778888|P3|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|15
2355049|NCT01641237|5778889|P2|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
2355050|NCT01641237|5778890|P1|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
2355051|NCT01641237|5778887|P4|NOT COMPLETED|Period II||0
2355052|NCT01641237|5778888|P3|NOT COMPLETED|Period II||0
2355053|NCT01641237|5778889|P2|NOT COMPLETED|Period II||0
2355054|NCT01641237|5778890|P1|NOT COMPLETED|Period II||1
2355055|NCT01641237|5778887|P4|COMPLETED|Period II||15
2355056|NCT01641237|5778888|P3|COMPLETED|Period II||16
2355057|NCT01641237|5778889|P2|COMPLETED|Period II||16
2355058|NCT01641237|5778890|P1|COMPLETED|Period II||14
2355059|NCT01641237|5778887|P4|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
2355060|NCT01641237|5778888|P3|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
2355061|NCT01641237|5778889|P2|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
2355062|NCT01641237|5778890|P1|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
2355063|NCT01641237|5778887|P4|NOT COMPLETED|Period I||0
2355064|NCT01641237|5778888|P3|NOT COMPLETED|Period I||0
2355065|NCT01641237|5778889|P2|NOT COMPLETED|Period I||0
2355066|NCT01641237|5778890|P1|NOT COMPLETED|Period I||0
2355067|NCT01641237|5778887|P4|COMPLETED|Period I||15
2355068|NCT01641237|5778888|P3|COMPLETED|Period I||15
2355069|NCT01641237|5778889|P2|COMPLETED|Period I||16
2355070|NCT01641237|5778890|P1|COMPLETED|Period I||16
2355071|NCT01641237|5778887|P4|STARTED|Period I||15
2355072|NCT01641237|5778888|P3|STARTED|Period I||15
2355073|NCT01641237|5778889|P2|STARTED|Period I||16
2355074|NCT01641237|5778890|P1|STARTED|Period I||16
2355075|NCT01641198|5778915|P3|NOT COMPLETED|At 15-20 Years of Function||2
2355076|NCT01641198|5778916|P2|NOT COMPLETED|At 15-20 Years of Function||1
2355077|NCT01641198|5778917|P1|NOT COMPLETED|At 15-20 Years of Function||6
2355078|NCT01641198|5778915|P3|COMPLETED|At 15-20 Years of Function|Participants: 1 interval violation, 1 death|9
2355079|NCT01641198|5778916|P2|COMPLETED|At 15-20 Years of Function|Participants: 1 interval violation|6
2355080|NCT01641198|5778917|P1|COMPLETED|At 15-20 Years of Function|Participants: 5 interval violation, 1 death|6
2355081|NCT01641198|5778915|P3|STARTED|At 15-20 Years of Function||11
2355082|NCT01641198|5778916|P2|STARTED|At 15-20 Years of Function||7
2355083|NCT01641198|5778917|P1|STARTED|At 15-20 Years of Function||12
2355084|NCT01641198|5778915|P3|NOT COMPLETED|After 24 Months of Function||6
2355085|NCT01641198|5778916|P2|NOT COMPLETED|After 24 Months of Function||9
2355086|NCT01641198|5778917|P1|NOT COMPLETED|After 24 Months of Function||4
2355087|NCT01641198|5778915|P3|COMPLETED|After 24 Months of Function|Participants: 6 interval violation. Implants: 2 bone loss not measurable|11
2355088|NCT01641198|5778916|P2|COMPLETED|After 24 Months of Function|Participants: 9 interval violation|7
2355089|NCT01641198|5778917|P1|COMPLETED|After 24 Months of Function|Participants: 4 interval violation. Implants: 3 bone loss not measurable|12
2355090|NCT01641198|5778915|P3|STARTED|After 24 Months of Function||17
2355091|NCT01641198|5778916|P2|STARTED|After 24 Months of Function||16
2355092|NCT01641198|5778917|P1|STARTED|After 24 Months of Function||16
2355093|NCT01641198|5778915|P3|NOT COMPLETED|After 12 Months of Function||2
2355094|NCT01641198|5778916|P2|NOT COMPLETED|After 12 Months of Function||3
2355095|NCT01641198|5778917|P1|NOT COMPLETED|After 12 Months of Function||4
2355096|NCT01641198|5778915|P3|COMPLETED|After 12 Months of Function|Participants: 2 interval violation. Implants: 3 bone loss not measurable|17
2355097|NCT01641198|5778916|P2|COMPLETED|After 12 Months of Function|Participants: 2 interval violation, 1 adverse event. Implants: 3 bone loss not measurable|16
2355098|NCT01641198|5778917|P1|COMPLETED|After 12 Months of Function|Participants: 3 interval violation, 1 protocol violation. Implants: 13 bone loss not measurable|16
2355099|NCT01641198|5778915|P3|STARTED|After 12 Months of Function||19
2355100|NCT01641198|5778916|P2|STARTED|After 12 Months of Function||19
2355101|NCT01641198|5778917|P1|STARTED|After 12 Months of Function||20
2355102|NCT01641159|5778933|P2|NOT COMPLETED|Overall Study||2
2355103|NCT01641159|5778934|P1|NOT COMPLETED|Overall Study||2
2355104|NCT01641159|5778933|P2|COMPLETED|Overall Study||25
2355105|NCT01641159|5778934|P1|COMPLETED|Overall Study||33
2355106|NCT01641159|5778933|P2|STARTED|Overall Study||27
2355107|NCT01641159|5778934|P1|STARTED|Overall Study||35
2355108|NCT01641133|5778945|P3|NOT COMPLETED|Overall Study||8
2355109|NCT01641133|5778946|P2|NOT COMPLETED|Overall Study||9
2355110|NCT01641133|5778947|P1|NOT COMPLETED|Overall Study||10
2355111|NCT01641133|5778945|P3|COMPLETED|Overall Study||90
2355112|NCT01641133|5778946|P2|COMPLETED|Overall Study||90
2355113|NCT01641133|5778947|P1|COMPLETED|Overall Study||87
2355114|NCT01641133|5778945|P3|STARTED|Overall Study||98
2355115|NCT01641133|5778946|P2|STARTED|Overall Study||99
2355116|NCT01641133|5778947|P1|STARTED|Overall Study||97
2355117|NCT01641120|5778988|P1|NOT COMPLETED|30 Gauge Needle Weeks 2 and 3||0
2355118|NCT01641120|5778988|P1|COMPLETED|30 Gauge Needle Weeks 2 and 3||20
2355119|NCT01641120|5778988|P1|STARTED|30 Gauge Needle Weeks 2 and 3||20
2355120|NCT01641120|5778988|P1|NOT COMPLETED|25 Gauge Needle Weeks 1, 4, 5||0
2355121|NCT01641120|5778988|P1|COMPLETED|25 Gauge Needle Weeks 1, 4, 5||20
2355122|NCT01641120|5778988|P1|STARTED|25 Gauge Needle Weeks 1, 4, 5||20
2355123|NCT01641081|5779000|P10|NOT COMPLETED|Period 5||0
2355124|NCT01641081|5779001|P9|NOT COMPLETED|Period 5||0
2355125|NCT01641081|5779002|P8|NOT COMPLETED|Period 5||0
2355126|NCT01641081|5779003|P7|NOT COMPLETED|Period 5||0
2355127|NCT01641081|5779004|P6|NOT COMPLETED|Period 5||0
2355128|NCT01641081|5779005|P5|NOT COMPLETED|Period 5||0
2355129|NCT01641081|5779006|P4|NOT COMPLETED|Period 5||0
2355130|NCT01641081|5779007|P3|NOT COMPLETED|Period 5||2
2355131|NCT01641081|5779008|P2|NOT COMPLETED|Period 5||0
2355132|NCT01641081|5779009|P1|NOT COMPLETED|Period 5||0
2355133|NCT01641081|5779000|P10|COMPLETED|Period 5||14
2355134|NCT01641081|5779001|P9|COMPLETED|Period 5||14
2355135|NCT01641081|5779002|P8|COMPLETED|Period 5||14
2355136|NCT01641081|5779003|P7|COMPLETED|Period 5||16
2355137|NCT01641081|5779004|P6|COMPLETED|Period 5||18
2355138|NCT01641081|5779005|P5|COMPLETED|Period 5||16
2355139|NCT01641081|5779006|P4|COMPLETED|Period 5||20
2355140|NCT01641081|5779007|P3|COMPLETED|Period 5||12
2355141|NCT01641081|5779008|P2|COMPLETED|Period 5||17
2355142|NCT01641081|5779009|P1|COMPLETED|Period 5||16
2355143|NCT01641081|5779000|P10|STARTED|Period 5||14
2355144|NCT01641081|5779001|P9|STARTED|Period 5||14
2355145|NCT01641081|5779002|P8|STARTED|Period 5||14
2355146|NCT01641081|5779003|P7|STARTED|Period 5||16
2355147|NCT01641081|5779004|P6|STARTED|Period 5||18
2355148|NCT01641081|5779005|P5|STARTED|Period 5||16
2355149|NCT01641081|5779006|P4|STARTED|Period 5||20
2355150|NCT01641081|5779007|P3|STARTED|Period 5||14
2355151|NCT01641081|5779008|P2|STARTED|Period 5||17
2355152|NCT01641081|5779009|P1|STARTED|Period 5||16
2355153|NCT01641081|5779000|P10|NOT COMPLETED|Period 4||0
2355154|NCT01641081|5779001|P9|NOT COMPLETED|Period 4||0
2355155|NCT01641081|5779002|P8|NOT COMPLETED|Period 4||0
2355156|NCT01641081|5779003|P7|NOT COMPLETED|Period 4||0
2355157|NCT01641081|5779004|P6|NOT COMPLETED|Period 4||0
2355158|NCT01641081|5779005|P5|NOT COMPLETED|Period 4||0
2355159|NCT01641081|5779006|P4|NOT COMPLETED|Period 4||1
2355160|NCT01641081|5779007|P3|NOT COMPLETED|Period 4||0
2355161|NCT01641081|5779008|P2|NOT COMPLETED|Period 4||1
2355162|NCT01641081|5779009|P1|NOT COMPLETED|Period 4||0
2355163|NCT01641081|5779000|P10|COMPLETED|Period 4||14
2355164|NCT01641081|5779001|P9|COMPLETED|Period 4||14
2355165|NCT01641081|5779002|P8|COMPLETED|Period 4||14
2355166|NCT01641081|5779003|P7|COMPLETED|Period 4||16
2355167|NCT01641081|5779004|P6|COMPLETED|Period 4||18
2355168|NCT01641081|5779005|P5|COMPLETED|Period 4||16
2355169|NCT01641081|5779006|P4|COMPLETED|Period 4||20
2355170|NCT01641081|5779007|P3|COMPLETED|Period 4||14
2355171|NCT01641081|5779008|P2|COMPLETED|Period 4||17
2355172|NCT01641081|5779009|P1|COMPLETED|Period 4||16
2355173|NCT01641081|5779000|P10|STARTED|Period 4||14
2355174|NCT01641081|5779001|P9|STARTED|Period 4||14
2355175|NCT01641081|5779002|P8|STARTED|Period 4||14
2355176|NCT01641081|5779003|P7|STARTED|Period 4||16
2355177|NCT01641081|5779004|P6|STARTED|Period 4||18
2355178|NCT01641081|5779005|P5|STARTED|Period 4||16
2355179|NCT01641081|5779006|P4|STARTED|Period 4||21
2355180|NCT01641081|5779007|P3|STARTED|Period 4||14
2355181|NCT01641081|5779008|P2|STARTED|Period 4||18
2355182|NCT01641081|5779009|P1|STARTED|Period 4||16
2355183|NCT01641081|5779000|P10|NOT COMPLETED|Period 3||0
2355184|NCT01641081|5779001|P9|NOT COMPLETED|Period 3||1
2355185|NCT01641081|5779002|P8|NOT COMPLETED|Period 3||0
2355186|NCT01641081|5779003|P7|NOT COMPLETED|Period 3||0
2355187|NCT01641081|5779004|P6|NOT COMPLETED|Period 3||0
2355188|NCT01641081|5779005|P5|NOT COMPLETED|Period 3||0
2355189|NCT01641081|5779006|P4|NOT COMPLETED|Period 3||0
2355190|NCT01641081|5779007|P3|NOT COMPLETED|Period 3||1
2355191|NCT01641081|5779008|P2|NOT COMPLETED|Period 3||0
2355192|NCT01641081|5779009|P1|NOT COMPLETED|Period 3||0
2355193|NCT01641081|5779000|P10|COMPLETED|Period 3||14
2355194|NCT01641081|5779001|P9|COMPLETED|Period 3||14
2355195|NCT01641081|5779002|P8|COMPLETED|Period 3||14
2355196|NCT01641081|5779003|P7|COMPLETED|Period 3||16
2355197|NCT01641081|5779004|P6|COMPLETED|Period 3||18
2355198|NCT01641081|5779005|P5|COMPLETED|Period 3||16
2355199|NCT01641081|5779006|P4|COMPLETED|Period 3||21
2355200|NCT01641081|5779007|P3|COMPLETED|Period 3||14
2355201|NCT01641081|5779008|P2|COMPLETED|Period 3||18
2355202|NCT01641081|5779009|P1|COMPLETED|Period 3||16
2355203|NCT01641081|5779000|P10|STARTED|Period 3||14
2355204|NCT01641081|5779001|P9|STARTED|Period 3||15
2355205|NCT01641081|5779002|P8|STARTED|Period 3||14
2355206|NCT01641081|5779003|P7|STARTED|Period 3||16
2355207|NCT01641081|5779004|P6|STARTED|Period 3||18
2355208|NCT01641081|5779005|P5|STARTED|Period 3||16
2355209|NCT01641081|5779006|P4|STARTED|Period 3||21
2355210|NCT01641081|5779007|P3|STARTED|Period 3||15
2355211|NCT01641081|5779008|P2|STARTED|Period 3||18
2355212|NCT01641081|5779009|P1|STARTED|Period 3||16
2355213|NCT01641081|5779000|P10|NOT COMPLETED|Period 2||0
2355214|NCT01641081|5779001|P9|NOT COMPLETED|Period 2||0
2355215|NCT01641081|5779002|P8|NOT COMPLETED|Period 2||0
2355216|NCT01641081|5779003|P7|NOT COMPLETED|Period 2||2
2355217|NCT01641081|5779004|P6|NOT COMPLETED|Period 2||1
2355218|NCT01641081|5779005|P5|NOT COMPLETED|Period 2||0
2355219|NCT01641081|5779006|P4|NOT COMPLETED|Period 2||1
2355220|NCT01641081|5779007|P3|NOT COMPLETED|Period 2||0
2355221|NCT01641081|5779008|P2|NOT COMPLETED|Period 2||0
2355222|NCT01641081|5779009|P1|NOT COMPLETED|Period 2||1
2355223|NCT01641081|5779000|P10|COMPLETED|Period 2||14
2355224|NCT01641081|5779001|P9|COMPLETED|Period 2||15
2355225|NCT01641081|5779002|P8|COMPLETED|Period 2||14
2355226|NCT01641081|5779003|P7|COMPLETED|Period 2||16
2355227|NCT01641081|5779004|P6|COMPLETED|Period 2||18
2355228|NCT01641081|5779005|P5|COMPLETED|Period 2||16
2355229|NCT01641081|5779006|P4|COMPLETED|Period 2||21
2355230|NCT01641081|5779007|P3|COMPLETED|Period 2||15
2355231|NCT01641081|5779008|P2|COMPLETED|Period 2||18
2355232|NCT01641081|5779009|P1|COMPLETED|Period 2||16
2355233|NCT01641081|5779000|P10|STARTED|Period 2||14
2355234|NCT01641081|5779001|P9|STARTED|Period 2||15
2355235|NCT01641081|5779002|P8|STARTED|Period 2||14
2355236|NCT01641081|5779003|P7|STARTED|Period 2||18
2355237|NCT01641081|5779004|P6|STARTED|Period 2||19
2355238|NCT01641081|5779005|P5|STARTED|Period 2||16
2355239|NCT01641081|5779006|P4|STARTED|Period 2||22
2355240|NCT01641081|5779007|P3|STARTED|Period 2||15
2355241|NCT01641081|5779008|P2|STARTED|Period 2||18
2355242|NCT01641081|5779009|P1|STARTED|Period 2||17
2355243|NCT01641081|5779000|P10|NOT COMPLETED|Period 1||0
2355244|NCT01641081|5779001|P9|NOT COMPLETED|Period 1||0
2355245|NCT01641081|5779002|P8|NOT COMPLETED|Period 1||3
2355246|NCT01641081|5779003|P7|NOT COMPLETED|Period 1||1
2355247|NCT01641081|5779004|P6|NOT COMPLETED|Period 1||0
2355248|NCT01641081|5779005|P5|NOT COMPLETED|Period 1||1
2355249|NCT01641081|5779006|P4|NOT COMPLETED|Period 1||0
2355250|NCT01641081|5779007|P3|NOT COMPLETED|Period 1||0
2355251|NCT01641081|5779008|P2|NOT COMPLETED|Period 1||0
2355252|NCT01641081|5779009|P1|NOT COMPLETED|Period 1||1
2355253|NCT01641081|5779000|P10|COMPLETED|Period 1||14
2355254|NCT01641081|5779001|P9|COMPLETED|Period 1||15
2355255|NCT01641081|5779002|P8|COMPLETED|Period 1||14
2355256|NCT01641081|5779003|P7|COMPLETED|Period 1||18
2355257|NCT01641081|5779004|P6|COMPLETED|Period 1||19
2355258|NCT01641081|5779005|P5|COMPLETED|Period 1||16
2355259|NCT01641081|5779006|P4|COMPLETED|Period 1||22
2355260|NCT01641081|5779007|P3|COMPLETED|Period 1||15
2355261|NCT01641081|5779008|P2|COMPLETED|Period 1||18
2355262|NCT01641081|5779009|P1|COMPLETED|Period 1||17
2355263|NCT01641081|5779000|P10|STARTED|Period 1||14
2355264|NCT01641081|5779001|P9|STARTED|Period 1||15
2355265|NCT01641081|5779002|P8|STARTED|Period 1||17
2355266|NCT01641081|5779003|P7|STARTED|Period 1||19
2355267|NCT01641081|5779004|P6|STARTED|Period 1||19
2355268|NCT01641081|5779005|P5|STARTED|Period 1||17
2355269|NCT01641081|5779006|P4|STARTED|Period 1||22
2355270|NCT01641081|5779007|P3|STARTED|Period 1||15
2355271|NCT01641081|5779008|P2|STARTED|Period 1||18
2355272|NCT01641081|5779009|P1|STARTED|Period 1||18
2355273|NCT01641042|5779028|P2|NOT COMPLETED|Overall Study||0
2355274|NCT01641042|5779029|P1|NOT COMPLETED|Overall Study||0
2355275|NCT01641042|5779028|P2|COMPLETED|Overall Study||43
2355276|NCT01641042|5779029|P1|COMPLETED|Overall Study||43
2355277|NCT01641042|5779028|P2|STARTED|Overall Study||43
2355278|NCT01641042|5779029|P1|STARTED|Overall Study||43
2355279|NCT01640964|5779078|P3|NOT COMPLETED|Overall Study||3
2355280|NCT01640964|5779079|P2|NOT COMPLETED|Overall Study||1
2355281|NCT01640964|5779080|P1|NOT COMPLETED|Overall Study||1
2355282|NCT01640964|5779078|P3|COMPLETED|Overall Study||3
2355283|NCT01640964|5779079|P2|COMPLETED|Overall Study||19
2355284|NCT01640964|5779080|P1|COMPLETED|Overall Study||19
2355285|NCT01640964|5779078|P3|STARTED|Overall Study||6
2355286|NCT01640964|5779079|P2|STARTED|Overall Study||20
2355287|NCT01640964|5779080|P1|STARTED|Overall Study||20
2355288|NCT01640951|5779103|P8|NOT COMPLETED|Overall Study||16
2355289|NCT01640951|5779104|P7|NOT COMPLETED|Overall Study||18
2355290|NCT01640951|5779105|P6|NOT COMPLETED|Overall Study||47
2355291|NCT01640951|5779106|P5|NOT COMPLETED|Overall Study||13
2355292|NCT01640951|5779107|P4|NOT COMPLETED|Overall Study||45
2355293|NCT01640951|5779108|P3|NOT COMPLETED|Overall Study||42
2355294|NCT01640951|5779109|P2|NOT COMPLETED|Overall Study||15
2355295|NCT01640951|5779110|P1|NOT COMPLETED|Overall Study||46
2355296|NCT01640951|5779103|P8|COMPLETED|Overall Study||17
2355297|NCT01640951|5779104|P7|COMPLETED|Overall Study||94
2355298|NCT01640951|5779105|P6|COMPLETED|Overall Study||13
2355299|NCT01640951|5779106|P5|COMPLETED|Overall Study||82
2355300|NCT01640951|5779107|P4|COMPLETED|Overall Study||10
2355301|NCT01640951|5779108|P3|COMPLETED|Overall Study||126
2355302|NCT01640951|5779109|P2|COMPLETED|Overall Study||60
2355303|NCT01640951|5779110|P1|COMPLETED|Overall Study||31
2355304|NCT01640951|5779103|P8|STARTED|Overall Study||33
2355305|NCT01640951|5779104|P7|STARTED|Overall Study||112
2355306|NCT01640951|5779105|P6|STARTED|Overall Study||60
2355307|NCT01640951|5779106|P5|STARTED|Overall Study||95
2355308|NCT01640951|5779107|P4|STARTED|Overall Study||55
2355309|NCT01640951|5779108|P3|STARTED|Overall Study||168
2355310|NCT01640951|5779109|P2|STARTED|Overall Study||75
2355311|NCT01640951|5779110|P1|STARTED|Overall Study||77
2355312|NCT01640925|5779212|P2|NOT COMPLETED|Overall Study||11
2355313|NCT01640925|5779213|P1|NOT COMPLETED|Overall Study||14
2355314|NCT01640925|5779212|P2|COMPLETED|Overall Study||164
2355315|NCT01640925|5779213|P1|COMPLETED|Overall Study||161
2355316|NCT01640925|5779212|P2|STARTED|Overall Study||175
2355317|NCT01640925|5779213|P1|STARTED|Overall Study||175
2355318|NCT01640873|5779227|P2|NOT COMPLETED|Overall Study||1
2355319|NCT01640873|5779228|P1|NOT COMPLETED|Overall Study||2
2355320|NCT01640873|5779227|P2|COMPLETED|Overall Study||10
2355321|NCT01640873|5779228|P1|COMPLETED|Overall Study||20
2355322|NCT01640873|5779227|P2|STARTED|Overall Study||11
2355323|NCT01640873|5779228|P1|STARTED|Overall Study||22
2355324|NCT01640834|5779247|P3|NOT COMPLETED|Overall Study||0
2355325|NCT01640834|5779248|P2|NOT COMPLETED|Overall Study||0
2355326|NCT01640834|5779249|P1|NOT COMPLETED|Overall Study||0
2355327|NCT01640834|5779247|P3|COMPLETED|Overall Study||4
2355328|NCT01640834|5779248|P2|COMPLETED|Overall Study||8
2355329|NCT01640834|5779249|P1|COMPLETED|Overall Study||8
2355330|NCT01640834|5779247|P3|Received at Least 1 Dose of Study Drug|Overall Study||4
2355331|NCT01640834|5779248|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
2355332|NCT01640834|5779249|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
2355333|NCT01640834|5779247|P3|STARTED|Overall Study||4
2355334|NCT01640834|5779248|P2|STARTED|Overall Study||8
2355335|NCT01640834|5779249|P1|STARTED|Overall Study||8
2355336|NCT01640548|5779276|P1|NOT COMPLETED|Overall Study||0
2355337|NCT01640548|5779276|P1|COMPLETED|Overall Study||309
2355338|NCT01640548|5779276|P1|STARTED|Overall Study||309
2355339|NCT01640379|5779292|P2|NOT COMPLETED|Overall Study||12
2355340|NCT01640379|5779293|P1|NOT COMPLETED|Overall Study||14
2355341|NCT01640379|5779292|P2|COMPLETED|Overall Study||125
2355342|NCT01640379|5779293|P1|COMPLETED|Overall Study||135
2355343|NCT01640379|5779292|P2|STARTED|Overall Study||137
2355344|NCT01640379|5779293|P1|STARTED|Overall Study||149
2355345|NCT01640353|5779301|P1|NOT COMPLETED|Overall Study||45
2355346|NCT01640353|5779301|P1|COMPLETED|Overall Study||149
2355347|NCT01640353|5779301|P1|Month 18|Overall Study||150
2355348|NCT01640353|5779301|P1|Month 12|Overall Study||160
2355349|NCT01640353|5779301|P1|Month 6|Overall Study||168
2355350|NCT01640353|5779301|P1|Month 3|Overall Study||169
2355351|NCT01640353|5779301|P1|Month 1|Overall Study||171
2355352|NCT01640353|5779301|P1|Treated|Overall Study||172
2355353|NCT01640353|5779301|P1|STARTED|Overall Study||194
2355354|NCT01640340|5779313|P2|NOT COMPLETED|Overall Study||0
2355355|NCT01640340|5779314|P1|NOT COMPLETED|Overall Study||0
2355356|NCT01640340|5779313|P2|COMPLETED|Overall Study||20
2355357|NCT01640340|5779314|P1|COMPLETED|Overall Study||20
2355358|NCT01640340|5779313|P2|Overall Complete Response Rate|Overall Study||20
2355359|NCT01640340|5779314|P1|Overall Complete Response Rate|Overall Study||20
2355360|NCT01640340|5779313|P2|STARTED|Overall Study||20
2355361|NCT01640340|5779314|P1|STARTED|Overall Study||20
2355362|NCT01640327|5779334|P2|NOT COMPLETED|Overall Study||0
2355363|NCT01640327|5779335|P1|NOT COMPLETED|Overall Study||0
2355364|NCT01640327|5779334|P2|COMPLETED|Overall Study||63
2355365|NCT01640327|5779335|P1|COMPLETED|Overall Study||63
2355366|NCT01640327|5779334|P2|STARTED|Overall Study||63
2355367|NCT01640327|5779335|P1|STARTED|Overall Study||63
2355368|NCT01640314|5779349|P2|NOT COMPLETED|Overall Study||1
2355369|NCT01640314|5779350|P1|NOT COMPLETED|Overall Study||0
2355370|NCT01640314|5779349|P2|COMPLETED|Overall Study||62
2355371|NCT01640314|5779350|P1|COMPLETED|Overall Study||63
2355372|NCT01640314|5779349|P2|STARTED|Overall Study||63
2355373|NCT01640314|5779350|P1|STARTED|Overall Study||63
2355374|NCT01640249|5779371|P7|NOT COMPLETED|Period 3||0
2355375|NCT01640249|5779372|P6|NOT COMPLETED|Period 3||0
2355376|NCT01640249|5779373|P5|NOT COMPLETED|Period 3||0
2355377|NCT01640249|5779374|P4|NOT COMPLETED|Period 3||1
2355378|NCT01640249|5779375|P3|NOT COMPLETED|Period 3||0
2355379|NCT01640249|5779376|P2|NOT COMPLETED|Period 3||0
2355380|NCT01640249|5779377|P1|NOT COMPLETED|Period 3||0
2355381|NCT01640249|5779371|P7|COMPLETED|Period 3||0
2355382|NCT01640249|5779372|P6|COMPLETED|Period 3||0
2355383|NCT01640249|5779373|P5|COMPLETED|Period 3||0
2355384|NCT01640249|5779374|P4|COMPLETED|Period 3||1
2355385|NCT01640249|5779375|P3|COMPLETED|Period 3||2
2355386|NCT01640249|5779376|P2|COMPLETED|Period 3||2
2355387|NCT01640249|5779377|P1|COMPLETED|Period 3||2
2355388|NCT01640249|5779371|P7|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
2355389|NCT01640249|5779372|P6|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
2355390|NCT01640249|5779373|P5|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
2355391|NCT01640249|5779374|P4|STARTED|Period 3||2
2355392|NCT01640249|5779375|P3|STARTED|Period 3||2
2355393|NCT01640249|5779376|P2|STARTED|Period 3||2
2355394|NCT01640249|5779377|P1|STARTED|Period 3||2
2355395|NCT01640249|5779371|P7|NOT COMPLETED|Period 2||0
2355396|NCT01640249|5779372|P6|NOT COMPLETED|Period 2||0
2355397|NCT01640249|5779373|P5|NOT COMPLETED|Period 2||0
2355398|NCT01640249|5779374|P4|NOT COMPLETED|Period 2||0
2355399|NCT01640249|5779375|P3|NOT COMPLETED|Period 2||0
2355400|NCT01640249|5779376|P2|NOT COMPLETED|Period 2||0
2355401|NCT01640249|5779377|P1|NOT COMPLETED|Period 2||0
2355402|NCT01640249|5779371|P7|COMPLETED|Period 2||2
2355403|NCT01640249|5779372|P6|COMPLETED|Period 2||4
2355404|NCT01640249|5779373|P5|COMPLETED|Period 2||2
2355405|NCT01640249|5779374|P4|COMPLETED|Period 2||2
2355406|NCT01640249|5779375|P3|COMPLETED|Period 2||2
2355407|NCT01640249|5779376|P2|COMPLETED|Period 2||2
2355408|NCT01640249|5779377|P1|COMPLETED|Period 2||2
2355409|NCT01640249|5779371|P7|STARTED|Period 2||2
2355410|NCT01640249|5779372|P6|STARTED|Period 2||4
2355411|NCT01640249|5779373|P5|STARTED|Period 2||2
2355412|NCT01640249|5779374|P4|STARTED|Period 2||2
2355413|NCT01640249|5779375|P3|STARTED|Period 2||2
2355414|NCT01640249|5779376|P2|STARTED|Period 2||2
2355415|NCT01640249|5779377|P1|STARTED|Period 2||2
2355416|NCT01640249|5779371|P7|NOT COMPLETED|Period 1||0
2355417|NCT01640249|5779372|P6|NOT COMPLETED|Period 1||1
2355418|NCT01640249|5779373|P5|NOT COMPLETED|Period 1||0
2355419|NCT01640249|5779374|P4|NOT COMPLETED|Period 1||0
2355420|NCT01640249|5779375|P3|NOT COMPLETED|Period 1||0
2355421|NCT01640249|5779376|P2|NOT COMPLETED|Period 1||0
2355422|NCT01640249|5779377|P1|NOT COMPLETED|Period 1||1
2355423|NCT01640249|5779371|P7|COMPLETED|Period 1||2
2355424|NCT01640249|5779372|P6|COMPLETED|Period 1||4
2355425|NCT01640249|5779373|P5|COMPLETED|Period 1||2
2355426|NCT01640249|5779374|P4|COMPLETED|Period 1||2
2355427|NCT01640249|5779375|P3|COMPLETED|Period 1||2
2355428|NCT01640249|5779376|P2|COMPLETED|Period 1||2
2355429|NCT01640249|5779377|P1|COMPLETED|Period 1||2
2355430|NCT01640249|5779371|P7|Received at Least 1 Dose of Study Drug|Period 1||2
2355431|NCT01640249|5779372|P6|Received at Least 1 Dose of Study Drug|Period 1||5
2355432|NCT01640249|5779373|P5|Received at Least 1 Dose of Study Drug|Period 1||2
2355433|NCT01640249|5779374|P4|Received at Least 1 Dose of Study Drug|Period 1||2
2355434|NCT01640249|5779375|P3|Received at Least 1 Dose of Study Drug|Period 1||2
2355435|NCT01640249|5779376|P2|Received at Least 1 Dose of Study Drug|Period 1||2
2355436|NCT01640249|5779377|P1|Received at Least 1 Dose of Study Drug|Period 1||3
2355437|NCT01640249|5779371|P7|STARTED|Period 1||2
2355438|NCT01640249|5779372|P6|STARTED|Period 1||5
2355439|NCT01640249|5779373|P5|STARTED|Period 1||2
2355440|NCT01640249|5779374|P4|STARTED|Period 1||2
2355441|NCT01640249|5779375|P3|STARTED|Period 1||2
2355442|NCT01640249|5779376|P2|STARTED|Period 1||2
2355443|NCT01640249|5779377|P1|STARTED|Period 1||3
2355444|NCT01640197|5779403|P2|NOT COMPLETED|Overall Study||0
2355445|NCT01640197|5779404|P1|NOT COMPLETED|Overall Study||0
2355446|NCT01640197|5779403|P2|COMPLETED|Overall Study||30
2355447|NCT01640197|5779404|P1|COMPLETED|Overall Study||30
2355448|NCT01640197|5779403|P2|STARTED|Overall Study||30
2355449|NCT01640197|5779404|P1|STARTED|Overall Study||30
2355450|NCT01640184|5779425|P3|NOT COMPLETED|Overall Study||2
2355451|NCT01640184|5779426|P2|NOT COMPLETED|Overall Study||2
2355452|NCT01640184|5779427|P1|NOT COMPLETED|Overall Study||8
2355453|NCT01640184|5779425|P3|COMPLETED|Overall Study||20
2355454|NCT01640184|5779426|P2|COMPLETED|Overall Study||21
2355455|NCT01640184|5779427|P1|COMPLETED|Overall Study||26
2355456|NCT01640184|5779425|P3|STARTED|Overall Study||22
2355457|NCT01640184|5779426|P2|STARTED|Overall Study||23
2355458|NCT01640184|5779427|P1|STARTED|Overall Study||34
2355459|NCT01640171|5779449|P1|NOT COMPLETED|Overall Study||0
2355460|NCT01640171|5779449|P1|COMPLETED|Overall Study||57
2355461|NCT01640171|5779449|P1|STARTED|Overall Study||57
2355462|NCT01640054|5779456|P1|NOT COMPLETED|Overall Study||6
2355463|NCT01640054|5779456|P1|COMPLETED|Overall Study|Number of patients on treatment when the study was stopped.|109
2355464|NCT01640054|5779456|P1|Did Not Receive Treatment|Overall Study||0
2355465|NCT01640054|5779456|P1|STARTED|Overall Study|Patients who received treatment|115
2355466|NCT01639872|5779466|P2|NOT COMPLETED|Overall Study||5
2355467|NCT01639872|5779467|P1|NOT COMPLETED|Overall Study||11
2355468|NCT01639872|5779466|P2|COMPLETED|Overall Study||20
2355469|NCT01639872|5779467|P1|COMPLETED|Overall Study||14
2355470|NCT01639872|5779466|P2|STARTED|Overall Study||25
2355471|NCT01639872|5779467|P1|STARTED|Overall Study||25
2355472|NCT01639833|5779477|P2|NOT COMPLETED|Overall Study||4
2355473|NCT01639833|5779478|P1|NOT COMPLETED|Overall Study||6
2355474|NCT01639833|5779477|P2|COMPLETED|Overall Study||41
2355475|NCT01639833|5779478|P1|COMPLETED|Overall Study||39
2355476|NCT01639833|5779477|P2|STARTED|Overall Study||45
2355477|NCT01639833|5779478|P1|STARTED|Overall Study||45
2355478|NCT01639755|5779486|P1|NOT COMPLETED|Overall Study||19
2355479|NCT01639755|5779486|P1|COMPLETED|Overall Study||0
2355480|NCT01639755|5779486|P1|STARTED|Overall Study||19
2355481|NCT01639742|5779494|P1|NOT COMPLETED|Overall Study||18
2355482|NCT01639742|5779494|P1|COMPLETED|Overall Study||0
2355483|NCT01639742|5779494|P1|STARTED|Overall Study||18
2355484|NCT01639729|5779502|P6|NOT COMPLETED|Overall Study||0
2355485|NCT01639729|5779503|P5|NOT COMPLETED|Overall Study||0
2355486|NCT01639729|5779504|P4|NOT COMPLETED|Overall Study||1
2355487|NCT01639729|5779505|P3|NOT COMPLETED|Overall Study||1
2355488|NCT01639729|5779506|P2|NOT COMPLETED|Overall Study||0
2355489|NCT01639729|5779507|P1|NOT COMPLETED|Overall Study||1
2355490|NCT01639729|5779502|P6|COMPLETED|Overall Study||4
2355491|NCT01639729|5779503|P5|COMPLETED|Overall Study||4
2355492|NCT01639729|5779504|P4|COMPLETED|Overall Study||4
2355493|NCT01639729|5779505|P3|COMPLETED|Overall Study||3
2355494|NCT01639729|5779506|P2|COMPLETED|Overall Study||4
2355495|NCT01639729|5779507|P1|COMPLETED|Overall Study||3
2355496|NCT01639729|5779502|P6|STARTED|Overall Study||4
2355497|NCT01639729|5779503|P5|STARTED|Overall Study||4
2355498|NCT01639729|5779504|P4|STARTED|Overall Study||5
2355499|NCT01639729|5779505|P3|STARTED|Overall Study||4
2355500|NCT01639729|5779506|P2|STARTED|Overall Study||4
2355501|NCT01639729|5779507|P1|STARTED|Overall Study||4
2355502|NCT01639703|5779529|P1|NOT COMPLETED|Overall Study||12
2355503|NCT01639703|5779529|P1|COMPLETED|Overall Study||84
2355504|NCT01639703|5779529|P1|STARTED|Overall Study||96
2355505|NCT01639560|5779572|P2|NOT COMPLETED|Overall Study||29
2355506|NCT01639560|5779573|P1|NOT COMPLETED|Overall Study||19
2355507|NCT01639560|5779572|P2|COMPLETED|Overall Study||19
2355508|NCT01639560|5779573|P1|COMPLETED|Overall Study||26
2355509|NCT01639560|5779572|P2|End of Treatment|Overall Study||20
2355510|NCT01639560|5779573|P1|End of Treatment|Overall Study||28
2355511|NCT01639560|5779572|P2|STARTED|Overall Study||48
2355512|NCT01639560|5779573|P1|STARTED|Overall Study||45
2355513|NCT01639495|5779585|P1|NOT COMPLETED|Overall Study||16
2355514|NCT01639495|5779585|P1|COMPLETED|Overall Study||132
2355515|NCT01639495|5779585|P1|Primary Effectiveness Cohort|Overall Study||138
2355516|NCT01639495|5779585|P1|Safety Cohort|Overall Study||144
2355517|NCT01639495|5779585|P1|STARTED|Overall Study|Patients who signed the informed consent.|148
2355518|NCT01639469|5779595|P2|NOT COMPLETED|Overall Study||3
2355519|NCT01639469|5779596|P1|NOT COMPLETED|Overall Study||5
2355520|NCT01639469|5779595|P2|COMPLETED|Overall Study||77
2355521|NCT01639469|5779596|P1|COMPLETED|Overall Study||84
2355522|NCT01639469|5779595|P2|STARTED|Overall Study||80
2355523|NCT01639469|5779596|P1|STARTED|Overall Study||89
2355524|NCT01639443|5779604|P2|NOT COMPLETED|Overall Study||0
2355525|NCT01639443|5779605|P1|NOT COMPLETED|Overall Study||0
2355526|NCT01639443|5779604|P2|COMPLETED|Overall Study|These individuals all booked appointments using typical booking.|4855
2355527|NCT01639443|5779605|P1|COMPLETED|Overall Study|Intervention is limited to appointment booking, and all completed.|180
2355528|NCT01639443|5779604|P2|STARTED|Overall Study|These individuals opted to not participate in Fast-tracked group, and were not consented.|4855
2355529|NCT01639443|5779605|P1|STARTED|Overall Study|These individuals opted into Fast-tracked group and were consented.|180
2355530|NCT01639352|5779621|P1|NOT COMPLETED|Overall Study||0
2355531|NCT01639352|5779621|P1|COMPLETED|Overall Study||20
2355532|NCT01639352|5779621|P1|STARTED|Overall Study||20
2355533|NCT01639222|5779630|P1|NOT COMPLETED|Overall Study||0
2355534|NCT01639222|5779630|P1|COMPLETED|Overall Study||55
2355535|NCT01639222|5779630|P1|STARTED|Overall Study||55
2355536|NCT01639157|5779640|P2|NOT COMPLETED|Overall Study||0
2355537|NCT01639157|5779641|P1|NOT COMPLETED|Overall Study||0
2355538|NCT01639157|5779640|P2|COMPLETED|Overall Study||5
2355539|NCT01639157|5779641|P1|COMPLETED|Overall Study||4
2355540|NCT01639157|5779640|P2|STARTED|Overall Study||5
2355541|NCT01639157|5779641|P1|STARTED|Overall Study||4
2355542|NCT01639144|5779701|P2|NOT COMPLETED|Overall Study||5
2355543|NCT01639144|5779702|P1|NOT COMPLETED|Overall Study||10
2355544|NCT01639144|5779701|P2|COMPLETED|Overall Study||250
2355545|NCT01639144|5779702|P1|COMPLETED|Overall Study||250
2355546|NCT01639144|5779701|P2|STARTED|Overall Study||255
2355547|NCT01639144|5779702|P1|STARTED|Overall Study||260
2355548|NCT01639040|5779710|P2|NOT COMPLETED|Overall Study||0
2355549|NCT01639040|5779711|P1|NOT COMPLETED|Overall Study||1
2355550|NCT01639040|5779710|P2|COMPLETED|Overall Study||21
2355551|NCT01639040|5779711|P1|COMPLETED|Overall Study||9
2355552|NCT01639040|5779710|P2|STARTED|Overall Study||21
2355553|NCT01639040|5779711|P1|STARTED|Overall Study||10
2355554|NCT01639001|5779729|P2|NOT COMPLETED|Overall Study||103
2355555|NCT01639001|5779730|P1|NOT COMPLETED|Overall Study||104
2355556|NCT01639001|5779729|P2|COMPLETED|Overall Study||0
2355557|NCT01639001|5779730|P1|COMPLETED|Overall Study||0
2355558|NCT01639001|5779729|P2|Treated|Overall Study||101
2355559|NCT01639001|5779730|P1|Treated|Overall Study||104
2355560|NCT01639001|5779729|P2|STARTED|Overall Study||103
2355561|NCT01639001|5779730|P1|STARTED|Overall Study||104
2355562|NCT01638819|5779776|P2|NOT COMPLETED|Overall Study||0
2355563|NCT01638819|5779777|P1|NOT COMPLETED|Overall Study||1
2355564|NCT01638819|5779776|P2|COMPLETED|Overall Study||15
2355565|NCT01638819|5779777|P1|COMPLETED|Overall Study||14
2355566|NCT01638819|5779776|P2|Second Intervention (24 Weeks)|Overall Study||15
2355567|NCT01638819|5779777|P1|Second Intervention (24 Weeks)|Overall Study||14
2355568|NCT01638819|5779776|P2|First Intervention (8 Weeks)|Overall Study||15
2355569|NCT01638819|5779777|P1|First Intervention (8 Weeks)|Overall Study||15
2355570|NCT01638819|5779776|P2|STARTED|Overall Study||15
2355571|NCT01638819|5779777|P1|STARTED|Overall Study||15
2355572|NCT01638559|5779786|P1|NOT COMPLETED|Overall Study||3
2355573|NCT01638559|5779786|P1|COMPLETED|Overall Study|Completion through the time of the primary endpoint (outcome).|85
2355574|NCT01638559|5779786|P1|STARTED|Overall Study||88
2355575|NCT01638546|5779804|P2|NOT COMPLETED|Overall Study||3
2355576|NCT01638546|5779805|P1|NOT COMPLETED|Overall Study||1
2355577|NCT01638546|5779804|P2|COMPLETED|Overall Study||42
2355578|NCT01638546|5779805|P1|COMPLETED|Overall Study||51
2355579|NCT01638546|5779804|P2|STARTED|Overall Study||45
2355580|NCT01638546|5779805|P1|STARTED|Overall Study||52
2355581|NCT01638507|5779817|P1|NOT COMPLETED|Overall Study||6
2355582|NCT01638507|5779817|P1|COMPLETED|Overall Study||224
2355583|NCT01638507|5779817|P1|STARTED|Overall Study||230
2355584|NCT01638468|5779830|P1|NOT COMPLETED|Overall Study||0
2355585|NCT01638468|5779830|P1|COMPLETED|Overall Study||7
2355586|NCT01638468|5779830|P1|STARTED|Overall Study||7
2355587|NCT01638429|5779844|P1|NOT COMPLETED|Overall Study||1
2355588|NCT01638429|5779844|P1|COMPLETED|Overall Study||11
2355589|NCT01638429|5779844|P1|Post-treatment Testing|Overall Study||11
2355590|NCT01638429|5779844|P1|Antibiotic Treatment|Overall Study||11
2355591|NCT01638429|5779844|P1|Pre-treatment Testing|Overall Study||11
2355592|NCT01638429|5779844|P1|STARTED|Overall Study||12
2355593|NCT01638390|5779872|P1|NOT COMPLETED|Overall Study||21
2355594|NCT01638390|5779872|P1|COMPLETED|Overall Study|treated eyes|336
2355595|NCT01638390|5779872|P1|STARTED|Overall Study|enrolled|357
2355596|NCT01638312|5779886|P2|NOT COMPLETED|Overall Study||0
2355597|NCT01638312|5779887|P1|NOT COMPLETED|Overall Study||0
2355598|NCT01638312|5779886|P2|COMPLETED|Overall Study||30
2355599|NCT01638312|5779887|P1|COMPLETED|Overall Study||20
2355600|NCT01638312|5779886|P2|STARTED|Overall Study||30
2355601|NCT01638312|5779887|P1|STARTED|Overall Study||20
2355602|NCT01638000|5779895|P2|NOT COMPLETED|Overall Study||71
2355603|NCT01638000|5779896|P1|NOT COMPLETED|Overall Study||60
2355604|NCT01638000|5779895|P2|COMPLETED|Overall Study||873
2355605|NCT01638000|5779896|P1|COMPLETED|Overall Study||883
2355606|NCT01638000|5779895|P2|Received at Least 1 Double-Blind Dose|Overall Study||934
2355607|NCT01638000|5779896|P1|Received at Least 1 Double-Blind Dose|Overall Study||936
2355608|NCT01638000|5779895|P2|STARTED|Overall Study||944
2355609|NCT01638000|5779896|P1|STARTED|Overall Study||943
2355610|NCT01637961|5779994|P1|NOT COMPLETED|Overall Study||2
2355611|NCT01637961|5779994|P1|COMPLETED|Overall Study|Eligible and treated patients.|21
2355612|NCT01637961|5779994|P1|STARTED|Overall Study||23
2355613|NCT01637935|5780009|P2|NOT COMPLETED|Overall Study||0
2355614|NCT01637935|5780010|P1|NOT COMPLETED|Overall Study||0
2355615|NCT01637935|5780009|P2|COMPLETED|Overall Study||158918
2355616|NCT01637935|5780010|P1|COMPLETED|Overall Study||34181
2355617|NCT01637935|5780009|P2|STARTED|Overall Study||158918
2355618|NCT01637935|5780010|P1|STARTED|Overall Study||34181
2355619|NCT01637922|5780026|P2|NOT COMPLETED|Overall Study||5
2355620|NCT01637922|5780027|P1|NOT COMPLETED|Overall Study||2
2355621|NCT01637922|5780026|P2|COMPLETED|Overall Study||14
2355622|NCT01637922|5780027|P1|COMPLETED|Overall Study||13
2355623|NCT01637922|5780026|P2|STARTED|Overall Study||19
2355624|NCT01637922|5780027|P1|STARTED|Overall Study||15
2355625|NCT01637870|5780050|P1|NOT COMPLETED|Overall Study||0
2355626|NCT01637870|5780050|P1|COMPLETED|Overall Study||110
2355627|NCT01637870|5780050|P1|STARTED|Overall Study||110
2355628|NCT01637584|5780056|P2|NOT COMPLETED|Overall Study||3
2355629|NCT01637584|5780057|P1|NOT COMPLETED|Overall Study||1
2355630|NCT01637584|5780056|P2|COMPLETED|Overall Study||17
2355631|NCT01637584|5780057|P1|COMPLETED|Overall Study||19
2355632|NCT01637584|5780056|P2|STARTED|Overall Study||20
2355633|NCT01637584|5780057|P1|STARTED|Overall Study||20
2355634|NCT01637272|5780064|P1|NOT COMPLETED|Overall Study||20
2355635|NCT01637272|5780064|P1|COMPLETED|Overall Study||23
2355636|NCT01637272|5780064|P1|Completed Core But Did no Enter Ext..|Overall Study||4
2355637|NCT01637272|5780064|P1|Entered Extension Phase|Overall Study||27
2355638|NCT01637272|5780064|P1|Completed Core Phase (sc + LAR)|Overall Study||31
2355639|NCT01637272|5780064|P1|Completed sc Phase|Overall Study||33
2355640|NCT01637272|5780064|P1|STARTED|Overall Study||43
2355641|NCT01637246|5780126|P1|NOT COMPLETED|Overall Study||2139
2355642|NCT01637246|5780126|P1|COMPLETED|Overall Study||2246
2355643|NCT01637246|5780126|P1|STARTED|Overall Study||4385
2355644|NCT01637090|5780134|P1|NOT COMPLETED|Overall Study||3
2355645|NCT01637090|5780134|P1|COMPLETED|Overall Study||0
2355646|NCT01637090|5780134|P1|STARTED|Overall Study||3
2355647|NCT01637077|5780144|P2|NOT COMPLETED|Overall Study||1
2355648|NCT01637077|5780145|P1|NOT COMPLETED|Overall Study||4
2355649|NCT01637077|5780144|P2|COMPLETED|Overall Study||22
2355650|NCT01637077|5780145|P1|COMPLETED|Overall Study||19
2355651|NCT01637077|5780144|P2|STARTED|Overall Study||23
2355652|NCT01637077|5780145|P1|STARTED|Overall Study||23
2355653|NCT01636986|5780173|P2|NOT COMPLETED|Overall Study||2
2355654|NCT01636986|5780174|P1|NOT COMPLETED|Overall Study||0
2355655|NCT01636986|5780173|P2|COMPLETED|Overall Study||30
2355656|NCT01636986|5780174|P1|COMPLETED|Overall Study||30
2355657|NCT01636986|5780173|P2|STARTED|Overall Study||32
2355658|NCT01636986|5780174|P1|STARTED|Overall Study||30
2355659|NCT01636960|5780180|P1|NOT COMPLETED|Maintenance Phase||7
2355660|NCT01636960|5780180|P1|COMPLETED|Maintenance Phase||0
2355661|NCT01636960|5780180|P1|STARTED|Maintenance Phase||7
2355662|NCT01636960|5780180|P1|NOT COMPLETED|Induction Phase||2
2355663|NCT01636960|5780180|P1|COMPLETED|Induction Phase|Participants continuing into Maintenance Phase|7
2355664|NCT01636960|5780180|P1|STARTED|Induction Phase||9
2355665|NCT01636947|5780188|P2|NOT COMPLETED|Overall Study||11
2355666|NCT01636947|5780189|P1|NOT COMPLETED|Overall Study||12
2355667|NCT01636947|5780188|P2|COMPLETED|Overall Study||239
2355668|NCT01636947|5780189|P1|COMPLETED|Overall Study||232
2355669|NCT01636947|5780188|P2|Treated|Overall Study||248
2355670|NCT01636947|5780189|P1|Treated|Overall Study||242
2355671|NCT01636947|5780188|P2|STARTED|Overall Study||250
2355672|NCT01636947|5780189|P1|STARTED|Overall Study||244
2355673|NCT01636882|5780209|P1|NOT COMPLETED|Overall Study||0
2355674|NCT01636882|5780209|P1|COMPLETED|Overall Study||16
2355675|NCT01636882|5780209|P1|STARTED|Overall Study||16
2355676|NCT01636778|5780213|P3|NOT COMPLETED|Follow-up Period After Part 2||4
2355677|NCT01636778|5780214|P2|NOT COMPLETED|Follow-up Period After Part 2||0
2355678|NCT01636778|5780215|P1|NOT COMPLETED|Follow-up Period After Part 2||0
2355679|NCT01636778|5780213|P3|COMPLETED|Follow-up Period After Part 2||37
2355680|NCT01636778|5780214|P2|COMPLETED|Follow-up Period After Part 2||0
2355681|NCT01636778|5780215|P1|COMPLETED|Follow-up Period After Part 2||0
2355682|NCT01636778|5780213|P3|STARTED|Follow-up Period After Part 2||41
2355683|NCT01636778|5780214|P2|STARTED|Follow-up Period After Part 2||0
2355684|NCT01636778|5780215|P1|STARTED|Follow-up Period After Part 2||0
2355685|NCT01636778|5780213|P3|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
2355686|NCT01636778|5780214|P2|NOT COMPLETED|Antiviral Treatment Period (Part 2)||10
2355687|NCT01636778|5780215|P1|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
2355688|NCT01636778|5780213|P3|COMPLETED|Antiviral Treatment Period (Part 2)||0
2355689|NCT01636778|5780214|P2|COMPLETED|Antiviral Treatment Period (Part 2)||31
2355690|NCT01636778|5780215|P1|COMPLETED|Antiviral Treatment Period (Part 2)||0
2355691|NCT01636778|5780213|P3|STARTED|Antiviral Treatment Period (Part 2)||0
2355692|NCT01636778|5780214|P2|STARTED|Antiviral Treatment Period (Part 2)||41
2355693|NCT01636778|5780215|P1|STARTED|Antiviral Treatment Period (Part 2)||0
2355694|NCT01636778|5780213|P3|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
2355695|NCT01636778|5780214|P2|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
2355696|NCT01636778|5780215|P1|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||4
2355697|NCT01636778|5780213|P3|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
2355698|NCT01636778|5780214|P2|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
2355699|NCT01636778|5780215|P1|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||41
2355700|NCT01636778|5780213|P3|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
2355701|NCT01636778|5780214|P2|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
2355702|NCT01636778|5780215|P1|STARTED|Pre-Antiviral Treatment Period (Part 1)||45
2355703|NCT01636765|5780278|P1|NOT COMPLETED|Overall Study||0
2355704|NCT01636765|5780278|P1|COMPLETED|Overall Study||104
2355705|NCT01636765|5780278|P1|STARTED|Overall Study||104
2355706|NCT01636713|5780286|P3|NOT COMPLETED|Overall Study||23
2355707|NCT01636713|5780287|P2|NOT COMPLETED|Overall Study||28
2355708|NCT01636713|5780288|P1|NOT COMPLETED|Overall Study||32
2355709|NCT01636713|5780286|P3|COMPLETED|Overall Study||170
2355710|NCT01636713|5780287|P2|COMPLETED|Overall Study||166
2355711|NCT01636713|5780288|P1|COMPLETED|Overall Study||161
2355712|NCT01636713|5780286|P3|STARTED|Overall Study||193
2355713|NCT01636713|5780287|P2|STARTED|Overall Study||194
2355714|NCT01636713|5780288|P1|STARTED|Overall Study||193
2355715|NCT01636687|5780305|P5|NOT COMPLETED|Follow-up Period||1
2355716|NCT01636687|5780306|P4|NOT COMPLETED|Follow-up Period||0
2355717|NCT01636687|5780307|P3|NOT COMPLETED|Follow-up Period||0
2355718|NCT01636687|5780308|P2|NOT COMPLETED|Follow-up Period||0
2355719|NCT01636687|5780309|P1|NOT COMPLETED|Follow-up Period||1
2355720|NCT01636687|5780305|P5|COMPLETED|Follow-up Period||1
2355721|NCT01636687|5780306|P4|COMPLETED|Follow-up Period||20
2355722|NCT01636687|5780307|P3|COMPLETED|Follow-up Period||21
2355723|NCT01636687|5780308|P2|COMPLETED|Follow-up Period||45
2355724|NCT01636687|5780309|P1|COMPLETED|Follow-up Period||37
2355725|NCT01636687|5780305|P5|STARTED|Follow-up Period||2
2355726|NCT01636687|5780306|P4|STARTED|Follow-up Period||20
2355727|NCT01636687|5780307|P3|STARTED|Follow-up Period||21
2355728|NCT01636687|5780308|P2|STARTED|Follow-up Period||45
2355729|NCT01636687|5780309|P1|STARTED|Follow-up Period||38
2355730|NCT01636687|5780305|P5|NOT COMPLETED|Extension Period||0
2355731|NCT01636687|5780306|P4|NOT COMPLETED|Extension Period||28
2355732|NCT01636687|5780307|P3|NOT COMPLETED|Extension Period||25
2355733|NCT01636687|5780308|P2|NOT COMPLETED|Extension Period||54
2355734|NCT01636687|5780309|P1|NOT COMPLETED|Extension Period||47
2355735|NCT01636687|5780305|P5|COMPLETED|Extension Period||0
2355736|NCT01636687|5780306|P4|COMPLETED|Extension Period||0
2355737|NCT01636687|5780307|P3|COMPLETED|Extension Period||0
2355738|NCT01636687|5780308|P2|COMPLETED|Extension Period||0
2355739|NCT01636687|5780309|P1|COMPLETED|Extension Period||0
2355740|NCT01636687|5780305|P5|STARTED|Extension Period||0
2355741|NCT01636687|5780306|P4|STARTED|Extension Period||28
2355742|NCT01636687|5780307|P3|STARTED|Extension Period||25
2355743|NCT01636687|5780308|P2|STARTED|Extension Period||54
2355744|NCT01636687|5780309|P1|STARTED|Extension Period||47
2355745|NCT01636687|5780305|P5|NOT COMPLETED|Maintenance Period||2
2355746|NCT01636687|5780306|P4|NOT COMPLETED|Maintenance Period||0
2355747|NCT01636687|5780307|P3|NOT COMPLETED|Maintenance Period||2
2355748|NCT01636687|5780308|P2|NOT COMPLETED|Maintenance Period||2
2355749|NCT01636687|5780309|P1|NOT COMPLETED|Maintenance Period||8
2355750|NCT01636687|5780305|P5|COMPLETED|Maintenance Period||1
2355751|NCT01636687|5780306|P4|COMPLETED|Maintenance Period||28
2355752|NCT01636687|5780307|P3|COMPLETED|Maintenance Period||26
2355753|NCT01636687|5780308|P2|COMPLETED|Maintenance Period||58
2355754|NCT01636687|5780309|P1|COMPLETED|Maintenance Period||50
2355755|NCT01636687|5780305|P5|STARTED|Maintenance Period||3
2355756|NCT01636687|5780306|P4|STARTED|Maintenance Period||28
2355757|NCT01636687|5780307|P3|STARTED|Maintenance Period||28
2355758|NCT01636687|5780308|P2|STARTED|Maintenance Period||60
2355759|NCT01636687|5780309|P1|STARTED|Maintenance Period||58
2355760|NCT01636687|5780305|P5|NOT COMPLETED|Induction Period||2
2355761|NCT01636687|5780306|P4|NOT COMPLETED|Induction Period||0
2355762|NCT01636687|5780307|P3|NOT COMPLETED|Induction Period||0
2355763|NCT01636687|5780308|P2|NOT COMPLETED|Induction Period||0
2355764|NCT01636687|5780309|P1|NOT COMPLETED|Induction Period||3
2355765|NCT01636687|5780305|P5|COMPLETED|Induction Period||59
2355766|NCT01636687|5780306|P4|COMPLETED|Induction Period||0
2355767|NCT01636687|5780307|P3|COMPLETED|Induction Period||0
2355768|NCT01636687|5780308|P2|COMPLETED|Induction Period||60
2355769|NCT01636687|5780309|P1|COMPLETED|Induction Period||58
2355770|NCT01636687|5780305|P5|STARTED|Induction Period||61
2355771|NCT01636687|5780306|P4|STARTED|Induction Period||0
2355772|NCT01636687|5780307|P3|STARTED|Induction Period||0
2355773|NCT01636687|5780308|P2|STARTED|Induction Period||60
2355774|NCT01636687|5780309|P1|STARTED|Induction Period||61
2355775|NCT01636661|5780398|P2|NOT COMPLETED|Overall Study||0
2355776|NCT01636661|5780399|P1|NOT COMPLETED|Overall Study||0
2355777|NCT01636661|5780398|P2|COMPLETED|Overall Study||6
2355778|NCT01636661|5780399|P1|COMPLETED|Overall Study||5
2355779|NCT01636661|5780398|P2|STARTED|Overall Study||6
2355780|NCT01636661|5780399|P1|STARTED|Overall Study||5
2355781|NCT01636466|5780409|P2|NOT COMPLETED|Overall Study||0
2355782|NCT01636466|5780410|P1|NOT COMPLETED|Overall Study||1
2355783|NCT01636466|5780409|P2|COMPLETED|Overall Study||0
2355784|NCT01636466|5780410|P1|COMPLETED|Overall Study||0
2355785|NCT01636466|5780409|P2|STARTED|Overall Study||0
2355786|NCT01636466|5780410|P1|STARTED|Overall Study||1
2355787|NCT01636453|5780418|P1|NOT COMPLETED|Overall Study||8
2355788|NCT01636453|5780418|P1|COMPLETED|Overall Study||112
2355789|NCT01636453|5780418|P1|STARTED|Overall Study||120
2355790|NCT01636414|5780437|P3|NOT COMPLETED|Overall Study||9
2355791|NCT01636414|5780438|P2|NOT COMPLETED|Overall Study||6
2355792|NCT01636414|5780439|P1|NOT COMPLETED|Overall Study||3
2355793|NCT01636414|5780437|P3|COMPLETED|Overall Study||65
2355794|NCT01636414|5780438|P2|COMPLETED|Overall Study||60
2355795|NCT01636414|5780439|P1|COMPLETED|Overall Study||61
2355796|NCT01636414|5780437|P3|STARTED|Overall Study||74
2355797|NCT01636414|5780438|P2|STARTED|Overall Study||66
2355798|NCT01636414|5780439|P1|STARTED|Overall Study||64
2355799|NCT01636362|5780450|P1|NOT COMPLETED|Overall Study||8
2355800|NCT01636362|5780450|P1|COMPLETED|Overall Study||37
2355801|NCT01636362|5780450|P1|STARTED|Overall Study||45
2355802|NCT01636297|5780459|P3|NOT COMPLETED|Overall Study||1
2355803|NCT01636297|5780460|P2|NOT COMPLETED|Overall Study||4
2355804|NCT01636297|5780461|P1|NOT COMPLETED|Overall Study||4
2355805|NCT01636297|5780459|P3|COMPLETED|Overall Study||19
2355806|NCT01636297|5780460|P2|COMPLETED|Overall Study||36
2355807|NCT01636297|5780461|P1|COMPLETED|Overall Study||36
2355808|NCT01636297|5780459|P3|STARTED|Overall Study||20
2355809|NCT01636297|5780460|P2|STARTED|Overall Study||40
2355810|NCT01636297|5780461|P1|STARTED|Overall Study||40
2355811|NCT01636258|5780477|P2|NOT COMPLETED|Overall Study||0
2355812|NCT01636258|5780478|P1|NOT COMPLETED|Overall Study||1
2355813|NCT01636258|5780477|P2|COMPLETED|Overall Study||14
2355814|NCT01636258|5780478|P1|COMPLETED|Overall Study||12
2355815|NCT01636258|5780477|P2|STARTED|Overall Study||14
2355816|NCT01636258|5780478|P1|STARTED|Overall Study||13
2355817|NCT01636206|5780494|P2|NOT COMPLETED|Overall Study||51
2355818|NCT01636206|5780495|P1|NOT COMPLETED|Overall Study||19
2355819|NCT01636206|5780494|P2|COMPLETED|Overall Study||170
2355820|NCT01636206|5780495|P1|COMPLETED|Overall Study||92
2355821|NCT01636206|5780494|P2|STARTED|Overall Study||221
2355822|NCT01636206|5780495|P1|STARTED|Overall Study||111
2355823|NCT01636102|5780503|P2|NOT COMPLETED|Overall Study||0
2355824|NCT01636102|5780504|P1|NOT COMPLETED|Overall Study||0
2355825|NCT01636102|5780503|P2|COMPLETED|Overall Study||63
2355826|NCT01636102|5780504|P1|COMPLETED|Overall Study||63
2355827|NCT01636102|5780503|P2|STARTED|Overall Study||63
2355828|NCT01636102|5780504|P1|STARTED|Overall Study||63
2355829|NCT01636076|5780518|P2|NOT COMPLETED|Overall Study||25
2355830|NCT01636076|5780519|P1|NOT COMPLETED|Overall Study||17
2355831|NCT01636076|5780518|P2|COMPLETED|Overall Study||288
2355832|NCT01636076|5780519|P1|COMPLETED|Overall Study||299
2355833|NCT01636076|5780518|P2|STARTED|Overall Study||313
2355834|NCT01636076|5780519|P1|STARTED|Overall Study||316
2355835|NCT01636063|5780581|P2|NOT COMPLETED|Overall Study||0
2355836|NCT01636063|5780582|P1|NOT COMPLETED|Overall Study||0
2355837|NCT01636063|5780581|P2|COMPLETED|Overall Study||21
2355838|NCT01636063|5780582|P1|COMPLETED|Overall Study||21
2355839|NCT01636063|5780581|P2|STARTED|Overall Study||21
2355840|NCT01636063|5780582|P1|STARTED|Overall Study||21
2355841|NCT01635933|5780590|P2|NOT COMPLETED|Overall Study||8
2355842|NCT01635933|5780591|P1|NOT COMPLETED|Overall Study||2
2355843|NCT01635933|5780590|P2|COMPLETED|Overall Study||177
2355844|NCT01635933|5780591|P1|COMPLETED|Overall Study||176
2355845|NCT01635933|5780590|P2|STARTED|Overall Study||185
2355846|NCT01635933|5780591|P1|STARTED|Overall Study||178
2355847|NCT01635920|5780603|P2|NOT COMPLETED|Overall Study||1
2355848|NCT01635920|5780604|P1|NOT COMPLETED|Overall Study||3
2355849|NCT01635920|5780603|P2|COMPLETED|Overall Study||125
2355850|NCT01635920|5780604|P1|COMPLETED|Overall Study||122
2355851|NCT01635920|5780603|P2|STARTED|Overall Study||126
2355852|NCT01635920|5780604|P1|STARTED|Overall Study||125
2355853|NCT01635881|5780612|P1|NOT COMPLETED|Overall Study||0
2355854|NCT01635881|5780612|P1|COMPLETED|Overall Study||60
2355855|NCT01635881|5780612|P1|STARTED|Overall Study||60
2355856|NCT01635855|5780617|P1|NOT COMPLETED|Overall Study||4
2355857|NCT01635855|5780617|P1|COMPLETED|Overall Study||113
2355858|NCT01635855|5780617|P1|STARTED|Overall Study||117
2355859|NCT01635764|5780626|P1|NOT COMPLETED|Overall Study||273
2355860|NCT01635764|5780626|P1|COMPLETED|Overall Study||235
2355861|NCT01635764|5780626|P1|STARTED|Overall Study||508
2355862|NCT01635504|5780654|P1|NOT COMPLETED|Overall Study||0
2355863|NCT01635504|5780654|P1|COMPLETED|Overall Study||5
2355864|NCT01635504|5780654|P1|STARTED|Overall Study||5
2355865|NCT01635439|5780661|P2|NOT COMPLETED|Overall Study||0
2355866|NCT01635439|5780662|P1|NOT COMPLETED|Overall Study||0
2355867|NCT01635439|5780661|P2|COMPLETED|Overall Study||100
2355868|NCT01635439|5780662|P1|COMPLETED|Overall Study||100
2355869|NCT01635439|5780661|P2|STARTED|Overall Study||100
2355870|NCT01635439|5780662|P1|STARTED|Overall Study||100
2355871|NCT01635244|5780679|P3|NOT COMPLETED|Overall Study||2
2355872|NCT01635244|5780680|P2|NOT COMPLETED|Overall Study||1
2355873|NCT01635244|5780681|P1|NOT COMPLETED|Overall Study||1
2355874|NCT01635244|5780679|P3|COMPLETED|Overall Study||18
2355875|NCT01635244|5780680|P2|COMPLETED|Overall Study||21
2355876|NCT01635244|5780681|P1|COMPLETED|Overall Study||17
2355877|NCT01635244|5780679|P3|STARTED|Overall Study||20
2355878|NCT01635244|5780680|P2|STARTED|Overall Study||22
2355879|NCT01635244|5780681|P1|STARTED|Overall Study||18
2355880|NCT01635218|5780692|P3|NOT COMPLETED|Overall Study||6
2355881|NCT01635218|5780693|P2|NOT COMPLETED|Overall Study||7
2355882|NCT01635218|5780694|P1|NOT COMPLETED|Overall Study||3
2355883|NCT01635218|5780692|P3|COMPLETED|Overall Study||37
2355884|NCT01635218|5780693|P2|COMPLETED|Overall Study||39
2355885|NCT01635218|5780694|P1|COMPLETED|Overall Study||41
2355886|NCT01635218|5780692|P3|STARTED|Overall Study||43
2355887|NCT01635218|5780693|P2|STARTED|Overall Study||46
2355888|NCT01635218|5780694|P1|STARTED|Overall Study||44
2355889|NCT01635101|5780717|P3|NOT COMPLETED|Overall Study||17
2355890|NCT01635101|5780718|P2|NOT COMPLETED|Overall Study||12
2355891|NCT01635101|5780719|P1|NOT COMPLETED|Overall Study||9
2355892|NCT01635101|5780717|P3|COMPLETED|Overall Study||52
2355893|NCT01635101|5780718|P2|COMPLETED|Overall Study||55
2355894|NCT01635101|5780719|P1|COMPLETED|Overall Study||52
2355895|NCT01635101|5780717|P3|Pharmacokinetics Evaluable Population|Overall Study||58
2355896|NCT01635101|5780718|P2|Pharmacokinetics Evaluable Population|Overall Study||59
2355897|NCT01635101|5780719|P1|Pharmacokinetics Evaluable Population|Overall Study||50
2355898|NCT01635101|5780717|P3|Modified Intent to Treat (mITT)|Overall Study||69
2355899|NCT01635101|5780718|P2|Modified Intent to Treat (mITT)|Overall Study||67
2355900|NCT01635101|5780719|P1|Modified Intent to Treat (mITT)|Overall Study||61
2355901|NCT01635101|5780717|P3|Safety Population|Overall Study||69
2355902|NCT01635101|5780718|P2|Safety Population|Overall Study||67
2355903|NCT01635101|5780719|P1|Safety Population|Overall Study||61
2355904|NCT01635101|5780717|P3|STARTED|Overall Study||69
2355905|NCT01635101|5780718|P2|STARTED|Overall Study||67
2355906|NCT01635101|5780719|P1|STARTED|Overall Study||61
2355907|NCT01635062|5780744|P2|NOT COMPLETED|Overall Study||0
2355908|NCT01635062|5780745|P1|NOT COMPLETED|Overall Study||0
2355909|NCT01635062|5780744|P2|COMPLETED|Overall Study||9
2355910|NCT01635062|5780745|P1|COMPLETED|Overall Study||9
2355911|NCT01635062|5780744|P2|Post-Randomization Sodium Loaded|Overall Study||9
2355912|NCT01635062|5780745|P1|Post-Randomization Sodium Loaded|Overall Study||9
2355913|NCT01635062|5780744|P2|Post-randomization Sodium Restriction|Overall Study||9
2355914|NCT01635062|5780745|P1|Post-randomization Sodium Restriction|Overall Study||9
2355915|NCT01635062|5780744|P2|Sodium Loading Baseline Visit|Overall Study||9
2355916|NCT01635062|5780745|P1|Sodium Loading Baseline Visit|Overall Study||9
2355917|NCT01635062|5780744|P2|Sodium Restriction Baseline Visit|Overall Study||9
2355918|NCT01635062|5780745|P1|Sodium Restriction Baseline Visit|Overall Study||9
2355919|NCT01635062|5780744|P2|STARTED|Overall Study||9
2355920|NCT01635062|5780745|P1|STARTED|Overall Study||9
2355921|NCT01634854|5780757|P2|NOT COMPLETED|Overall Study||7
2355922|NCT01634854|5780758|P1|NOT COMPLETED|Overall Study||2
2355923|NCT01634854|5780757|P2|COMPLETED|Overall Study||59
2355924|NCT01634854|5780758|P1|COMPLETED|Overall Study||62
2355925|NCT01634854|5780757|P2|STARTED|Overall Study||66
2355926|NCT01634854|5780758|P1|STARTED|Overall Study||64
2355927|NCT01634659|5780778|P2|NOT COMPLETED|Period 2 - Second 8 Days of Wear||0
2355928|NCT01634659|5780779|P1|NOT COMPLETED|Period 2 - Second 8 Days of Wear||3
2355929|NCT01634659|5780778|P2|COMPLETED|Period 2 - Second 8 Days of Wear||158
2355930|NCT01634659|5780779|P1|COMPLETED|Period 2 - Second 8 Days of Wear||152
2355931|NCT01634659|5780778|P2|STARTED|Period 2 - Second 8 Days of Wear||158
2355932|NCT01634659|5780779|P1|STARTED|Period 2 - Second 8 Days of Wear||155
2355933|NCT01634659|5780778|P2|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
2355934|NCT01634659|5780779|P1|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
2355935|NCT01634659|5780778|P2|COMPLETED|Period 1 - First 8 Days of Wear||158
2355936|NCT01634659|5780779|P1|COMPLETED|Period 1 - First 8 Days of Wear||155
2355937|NCT01634659|5780778|P2|STARTED|Period 1 - First 8 Days of Wear||158
2355938|NCT01634659|5780779|P1|STARTED|Period 1 - First 8 Days of Wear||155
2355939|NCT01634620|5780789|P1|NOT COMPLETED|Overall Study||0
2355940|NCT01634620|5780789|P1|COMPLETED|Overall Study||200
2355941|NCT01634620|5780789|P1|STARTED|Overall Study||200
2355942|NCT01634555|5780809|P1|NOT COMPLETED|Overall Study||4
2355943|NCT01634555|5780809|P1|COMPLETED|Overall Study|Completed the required treatment and assessment.|25
2355944|NCT01634555|5780809|P1|Drug-Drug Interaction (DDI) Population|Overall Study|Completed the required treatment in Cycle 1, Day 1 and Cycle 2, Day 1.|25
2355945|NCT01634555|5780809|P1|Received at Least 1 Dose of Study Drug|Overall Study||29
2355946|NCT01634555|5780809|P1|STARTED|Overall Study||29
2355947|NCT01634360|5780820|P2|NOT COMPLETED|Overall Study||136
2355948|NCT01634360|5780821|P1|NOT COMPLETED|Overall Study||49
2355949|NCT01634360|5780820|P2|COMPLETED|Overall Study||0
2355950|NCT01634360|5780821|P1|COMPLETED|Overall Study||0
2355951|NCT01634360|5780820|P2|STARTED|Overall Study||136
2355952|NCT01634360|5780821|P1|STARTED|Overall Study||49
2355953|NCT01634269|5780831|P1|NOT COMPLETED|Overall Study||2
2355954|NCT01634269|5780831|P1|COMPLETED|Overall Study||18
2355955|NCT01634269|5780831|P1|24 Month|Overall Study||18
2355956|NCT01634269|5780831|P1|12 Month|Overall Study||20
2355957|NCT01634269|5780831|P1|6 Month|Overall Study||20
2355958|NCT01634269|5780831|P1|30 Days|Overall Study||20
2355959|NCT01634269|5780831|P1|STARTED|Overall Study||20
2355960|NCT01634256|5780878|P2|NOT COMPLETED|Overall Study||8
2355961|NCT01634256|5780879|P1|NOT COMPLETED|Overall Study||4
2355962|NCT01634256|5780878|P2|COMPLETED|Overall Study||22
2355963|NCT01634256|5780879|P1|COMPLETED|Overall Study||26
2355964|NCT01634256|5780878|P2|STARTED|Overall Study||30
2355965|NCT01634256|5780879|P1|STARTED|Overall Study||30
2355966|NCT01634243|5780895|P2|NOT COMPLETED|Overall Study||5
2355967|NCT01634243|5780896|P1|NOT COMPLETED|Overall Study||6
2355968|NCT01634243|5780895|P2|COMPLETED|Overall Study||38
2355969|NCT01634243|5780896|P1|COMPLETED|Overall Study||15
2355970|NCT01634243|5780895|P2|STARTED|Overall Study||43
2355971|NCT01634243|5780896|P1|STARTED|Overall Study||21
2355972|NCT01634165|5780922|P4|NOT COMPLETED|Period 4||0
2355973|NCT01634165|5780923|P3|NOT COMPLETED|Period 4||0
2355974|NCT01634165|5780924|P2|NOT COMPLETED|Period 4||0
2355975|NCT01634165|5780925|P1|NOT COMPLETED|Period 4||0
2355976|NCT01634165|5780922|P4|COMPLETED|Period 4||6
2355977|NCT01634165|5780923|P3|COMPLETED|Period 4||6
2355978|NCT01634165|5780924|P2|COMPLETED|Period 4||5
2355979|NCT01634165|5780925|P1|COMPLETED|Period 4||6
2355980|NCT01634165|5780922|P4|STARTED|Period 4||6
2355981|NCT01634165|5780923|P3|STARTED|Period 4||6
2355982|NCT01634165|5780924|P2|STARTED|Period 4||5
2355983|NCT01634165|5780925|P1|STARTED|Period 4||6
2355984|NCT01634165|5780922|P4|NOT COMPLETED|Period 3||0
2355985|NCT01634165|5780923|P3|NOT COMPLETED|Period 3||0
2355986|NCT01634165|5780924|P2|NOT COMPLETED|Period 3||0
2355987|NCT01634165|5780925|P1|NOT COMPLETED|Period 3||0
2355988|NCT01634165|5780922|P4|COMPLETED|Period 3||6
2355989|NCT01634165|5780923|P3|COMPLETED|Period 3||6
2355990|NCT01634165|5780924|P2|COMPLETED|Period 3||5
2355991|NCT01634165|5780925|P1|COMPLETED|Period 3||6
2355992|NCT01634165|5780922|P4|STARTED|Period 3||6
2355993|NCT01634165|5780923|P3|STARTED|Period 3||6
2355994|NCT01634165|5780924|P2|STARTED|Period 3||5
2355995|NCT01634165|5780925|P1|STARTED|Period 3||6
2355996|NCT01634165|5780922|P4|NOT COMPLETED|Period 2||0
2355997|NCT01634165|5780923|P3|NOT COMPLETED|Period 2||0
2355998|NCT01634165|5780924|P2|NOT COMPLETED|Period 2||1
2355999|NCT01634165|5780925|P1|NOT COMPLETED|Period 2||0
2356000|NCT01634165|5780922|P4|COMPLETED|Period 2||6
2356001|NCT01634165|5780923|P3|COMPLETED|Period 2||6
2356002|NCT01634165|5780924|P2|COMPLETED|Period 2||5
2356003|NCT01634165|5780925|P1|COMPLETED|Period 2||6
2356004|NCT01634165|5780922|P4|STARTED|Period 2||6
2356005|NCT01634165|5780923|P3|STARTED|Period 2||6
2356006|NCT01634165|5780924|P2|STARTED|Period 2||6
2356007|NCT01634165|5780925|P1|STARTED|Period 2||6
2356008|NCT01634165|5780922|P4|NOT COMPLETED|Period 1||0
2356009|NCT01634165|5780923|P3|NOT COMPLETED|Period 1||0
2356010|NCT01634165|5780924|P2|NOT COMPLETED|Period 1||0
2356011|NCT01634165|5780925|P1|NOT COMPLETED|Period 1||0
2356012|NCT01634165|5780922|P4|COMPLETED|Period 1||6
2356013|NCT01634165|5780923|P3|COMPLETED|Period 1||6
2356014|NCT01634165|5780924|P2|COMPLETED|Period 1||6
2356015|NCT01634165|5780925|P1|COMPLETED|Period 1||6
2356016|NCT01634165|5780922|P4|Received at Least 1 Dose of Study Drug|Period 1||6
2356017|NCT01634165|5780923|P3|Received at Least 1 Dose of Study Drug|Period 1||6
2356018|NCT01634165|5780924|P2|Received at Least 1 Dose of Study Drug|Period 1||6
2356019|NCT01634165|5780925|P1|Received at Least 1 Dose of Study Drug|Period 1||6
2356020|NCT01634165|5780922|P4|STARTED|Period 1||6
2356021|NCT01634165|5780923|P3|STARTED|Period 1||6
2356022|NCT01634165|5780924|P2|STARTED|Period 1||6
2356023|NCT01634165|5780925|P1|STARTED|Period 1||6
2356024|NCT01634152|5780958|P3|NOT COMPLETED|Overall Study||4
2356025|NCT01634152|5780959|P2|NOT COMPLETED|Overall Study||1
2356026|NCT01634152|5780960|P1|NOT COMPLETED|Overall Study||4
2356027|NCT01634152|5780958|P3|COMPLETED|Overall Study||126
2356028|NCT01634152|5780959|P2|COMPLETED|Overall Study||136
2356029|NCT01634152|5780960|P1|COMPLETED|Overall Study||130
2356030|NCT01634152|5780958|P3|STARTED|Overall Study||130
2356031|NCT01634152|5780959|P2|STARTED|Overall Study||137
2356032|NCT01634152|5780960|P1|STARTED|Overall Study||134
2356033|NCT01634139|5781043|P3|NOT COMPLETED|Overall Study||5
2356034|NCT01634139|5781044|P2|NOT COMPLETED|Overall Study||6
2356035|NCT01634139|5781045|P1|NOT COMPLETED|Overall Study||10
2356036|NCT01634139|5781043|P3|COMPLETED|Overall Study||130
2356037|NCT01634139|5781044|P2|COMPLETED|Overall Study||130
2356038|NCT01634139|5781045|P1|COMPLETED|Overall Study||122
2356039|NCT01634139|5781043|P3|STARTED|Overall Study||135
2356040|NCT01634139|5781044|P2|STARTED|Overall Study||136
2356041|NCT01634139|5781045|P1|STARTED|Overall Study||132
2356042|NCT01634113|5781146|P3|NOT COMPLETED|Overall Study||1
2356043|NCT01634113|5781147|P2|NOT COMPLETED|Overall Study||0
2356044|NCT01634113|5781148|P1|NOT COMPLETED|Overall Study||0
2356045|NCT01634113|5781146|P3|COMPLETED|Overall Study||31
2356046|NCT01634113|5781147|P2|COMPLETED|Overall Study||36
2356047|NCT01634113|5781148|P1|COMPLETED|Overall Study||34
2356048|NCT01634113|5781146|P3|STARTED|Overall Study||32
2356049|NCT01634113|5781147|P2|STARTED|Overall Study||36
2356050|NCT01634113|5781148|P1|STARTED|Overall Study||34
2356051|NCT01634100|5781192|P6|NOT COMPLETED|Overall Study||0
2356052|NCT01634100|5781193|P5|NOT COMPLETED|Overall Study||0
2356053|NCT01634100|5781194|P4|NOT COMPLETED|Overall Study||0
2356054|NCT01634100|5781195|P3|NOT COMPLETED|Overall Study||1
2356055|NCT01634100|5781196|P2|NOT COMPLETED|Overall Study||0
2356056|NCT01634100|5781197|P1|NOT COMPLETED|Overall Study||1
2356057|NCT01634100|5781192|P6|COMPLETED|Overall Study||3
2356058|NCT01634100|5781193|P5|COMPLETED|Overall Study||3
2356059|NCT01634100|5781194|P4|COMPLETED|Overall Study||3
2356060|NCT01634100|5781195|P3|COMPLETED|Overall Study||2
2356061|NCT01634100|5781196|P2|COMPLETED|Overall Study||3
2356062|NCT01634100|5781197|P1|COMPLETED|Overall Study||2
2356063|NCT01634100|5781192|P6|Received Empa + Probenecid|Overall Study||3
2356064|NCT01634100|5781193|P5|Received Empa + Probenecid|Overall Study||3
2356065|NCT01634100|5781194|P4|Received Empa + Probenecid|Overall Study||3
2356066|NCT01634100|5781195|P3|Received Empa + Probenecid|Overall Study||2
2356067|NCT01634100|5781196|P2|Received Empa + Probenecid|Overall Study||3
2356068|NCT01634100|5781197|P1|Received Empa + Probenecid|Overall Study||2
2356069|NCT01634100|5781192|P6|Received Empa + Rifampicin|Overall Study||3
2356070|NCT01634100|5781193|P5|Received Empa + Rifampicin|Overall Study||3
2356071|NCT01634100|5781194|P4|Received Empa + Rifampicin|Overall Study||3
2356072|NCT01634100|5781195|P3|Received Empa + Rifampicin|Overall Study||3
2356073|NCT01634100|5781196|P2|Received Empa + Rifampicin|Overall Study||3
2356074|NCT01634100|5781197|P1|Received Empa + Rifampicin|Overall Study||3
2356075|NCT01634100|5781192|P6|Received Empa Alone|Overall Study||3
2356076|NCT01634100|5781193|P5|Received Empa Alone|Overall Study||3
2356077|NCT01634100|5781194|P4|Received Empa Alone|Overall Study||3
2356078|NCT01634100|5781195|P3|Received Empa Alone|Overall Study||3
2356079|NCT01634100|5781196|P2|Received Empa Alone|Overall Study||3
2356080|NCT01634100|5781197|P1|Received Empa Alone|Overall Study||3
2356081|NCT01634100|5781192|P6|STARTED|Overall Study||3
2356082|NCT01634100|5781193|P5|STARTED|Overall Study||3
2356083|NCT01634100|5781194|P4|STARTED|Overall Study||3
2356084|NCT01634100|5781195|P3|STARTED|Overall Study||3
2356085|NCT01634100|5781196|P2|STARTED|Overall Study||3
2356086|NCT01634100|5781197|P1|STARTED|Overall Study||3
2356087|NCT01633944|5781213|P3|NOT COMPLETED|Double-blind Treatment Phase||58
2356088|NCT01633944|5781214|P2|NOT COMPLETED|Double-blind Treatment Phase||54
2356089|NCT01633944|5781215|P1|NOT COMPLETED|Double-blind Treatment Phase||0
2356090|NCT01633944|5781213|P3|COMPLETED|Double-blind Treatment Phase||174
2356091|NCT01633944|5781214|P2|COMPLETED|Double-blind Treatment Phase||176
2356092|NCT01633944|5781215|P1|COMPLETED|Double-blind Treatment Phase||0
2356093|NCT01633944|5781213|P3|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|232
2356094|NCT01633944|5781214|P2|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|230
2356095|NCT01633944|5781215|P1|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
2356096|NCT01633944|5781213|P3|NOT COMPLETED|Open-label Titration Phase||0
2356097|NCT01633944|5781214|P2|NOT COMPLETED|Open-label Titration Phase||0
2356098|NCT01633944|5781215|P1|NOT COMPLETED|Open-label Titration Phase||290
2356099|NCT01633944|5781213|P3|COMPLETED|Open-label Titration Phase||0
2356100|NCT01633944|5781214|P2|COMPLETED|Open-label Titration Phase||0
2356101|NCT01633944|5781215|P1|COMPLETED|Open-label Titration Phase||462
2356102|NCT01633944|5781213|P3|STARTED|Open-label Titration Phase||0
2356103|NCT01633944|5781214|P2|STARTED|Open-label Titration Phase||0
2356104|NCT01633944|5781215|P1|STARTED|Open-label Titration Phase||752
2356105|NCT01633892|5781235|P1|NOT COMPLETED|Overall Study||0
2356106|NCT01633892|5781235|P1|COMPLETED|Overall Study||5
2356107|NCT01633892|5781235|P1|STARTED|Overall Study||5
2356108|NCT01633853|5781245|P2|NOT COMPLETED|Overall Study||0
2356109|NCT01633853|5781246|P1|NOT COMPLETED|Overall Study||0
2356110|NCT01633853|5781245|P2|COMPLETED|Overall Study||100
2356111|NCT01633853|5781246|P1|COMPLETED|Overall Study||104
2356112|NCT01633853|5781245|P2|STARTED|Overall Study||100
2356113|NCT01633853|5781246|P1|STARTED|Overall Study||104
2356114|NCT01633827|5781260|P2|NOT COMPLETED|Second Intervention||0
2356115|NCT01633827|5781261|P1|NOT COMPLETED|Second Intervention||0
2356116|NCT01633827|5781260|P2|COMPLETED|Second Intervention||11
2356117|NCT01633827|5781261|P1|COMPLETED|Second Intervention||11
2356118|NCT01633827|5781260|P2|STARTED|Second Intervention||11
2356119|NCT01633827|5781261|P1|STARTED|Second Intervention||11
2356120|NCT01633827|5781260|P2|NOT COMPLETED|Washout Period||0
2356121|NCT01633827|5781261|P1|NOT COMPLETED|Washout Period||0
2356122|NCT01633827|5781260|P2|COMPLETED|Washout Period||11
2356123|NCT01633827|5781261|P1|COMPLETED|Washout Period||11
2356124|NCT01633827|5781260|P2|STARTED|Washout Period||11
2356125|NCT01633827|5781261|P1|STARTED|Washout Period||11
2356126|NCT01633827|5781260|P2|NOT COMPLETED|First Intervention||0
2356127|NCT01633827|5781261|P1|NOT COMPLETED|First Intervention||0
2356128|NCT01633827|5781260|P2|COMPLETED|First Intervention||11
2356129|NCT01633827|5781261|P1|COMPLETED|First Intervention||11
2356130|NCT01633827|5781260|P2|STARTED|First Intervention||11
2356131|NCT01633827|5781261|P1|STARTED|First Intervention||11
2356132|NCT01633814|5781274|P1|NOT COMPLETED|Overall Study||0
2356133|NCT01633814|5781274|P1|COMPLETED|Overall Study||4
2356134|NCT01633814|5781274|P1|STARTED|Overall Study||4
2356135|NCT01633788|5781283|P4|NOT COMPLETED|Overall Study||13
2356136|NCT01633788|5781284|P3|NOT COMPLETED|Overall Study||10
2356137|NCT01633788|5781285|P2|NOT COMPLETED|Overall Study||8
2356138|NCT01633788|5781286|P1|NOT COMPLETED|Overall Study||7
2356139|NCT01633788|5781283|P4|COMPLETED|Overall Study||45
2356140|NCT01633788|5781284|P3|COMPLETED|Overall Study||49
2356141|NCT01633788|5781285|P2|COMPLETED|Overall Study||50
2356142|NCT01633788|5781286|P1|COMPLETED|Overall Study||50
2356143|NCT01633788|5781283|P4|STARTED|Overall Study||58
2356144|NCT01633788|5781284|P3|STARTED|Overall Study||59
2356145|NCT01633788|5781285|P2|STARTED|Overall Study||58
2356146|NCT01633788|5781286|P1|STARTED|Overall Study||57
2356147|NCT01633320|5781306|P2|NOT COMPLETED|Overall Study||0
2356148|NCT01633320|5781307|P1|NOT COMPLETED|Overall Study||0
2356149|NCT01633320|5781306|P2|COMPLETED|Overall Study||68
2356150|NCT01633320|5781307|P1|COMPLETED|Overall Study||132
2356151|NCT01633320|5781306|P2|STARTED|Overall Study||68
2356152|NCT01633320|5781307|P1|STARTED|Overall Study||132
2356153|NCT01633112|5781318|P3|NOT COMPLETED|Overall Study||92
2356154|NCT01633112|5781319|P2|NOT COMPLETED|Overall Study||60
2356155|NCT01633112|5781320|P1|NOT COMPLETED|Overall Study||53
2356156|NCT01633112|5781318|P3|COMPLETED|Overall Study||250
2356157|NCT01633112|5781319|P2|COMPLETED|Overall Study||310
2356158|NCT01633112|5781320|P1|COMPLETED|Overall Study||299
2356159|NCT01633112|5781318|P3|STARTED|Overall Study||342
2356160|NCT01633112|5781319|P2|STARTED|Overall Study||370
2356161|NCT01633112|5781320|P1|STARTED|Overall Study||352
2356162|NCT01633060|5781355|P2|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
2356163|NCT01633060|5781356|P1|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||16
2356164|NCT01633060|5781355|P2|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
2356165|NCT01633060|5781356|P1|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
2356166|NCT01633060|5781355|P2|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
2356167|NCT01633060|5781356|P1|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|16
2356168|NCT01633060|5781355|P2|NOT COMPLETED|Treatment Phase||140
2356169|NCT01633060|5781356|P1|NOT COMPLETED|Treatment Phase||288
2356170|NCT01633060|5781355|P2|COMPLETED|Treatment Phase||0
2356171|NCT01633060|5781356|P1|COMPLETED|Treatment Phase||0
2356172|NCT01633060|5781355|P2|Pharmacokinetic Analysis Set (PAS)|Treatment Phase||0
2356173|NCT01633060|5781356|P1|Pharmacokinetic Analysis Set (PAS)|Treatment Phase||63
2356174|NCT01633060|5781355|P2|Safety Set (SS)|Treatment Phase||140
2356175|NCT01633060|5781356|P1|Safety Set (SS)|Treatment Phase||288
2356176|NCT01633060|5781355|P2|FAS - ctDNA PIK3CA Non-mutant|Treatment Phase||81
2356177|NCT01633060|5781356|P1|FAS - ctDNA PIK3CA Non-mutant|Treatment Phase||132
2356178|NCT01633060|5781355|P2|FAS - ctDNA PIK3CA Mutant|Treatment Phase||35
2356179|NCT01633060|5781356|P1|FAS - ctDNA PIK3CA Mutant|Treatment Phase||100
2356180|NCT01633060|5781355|P2|STARTED|Treatment Phase||140
2356181|NCT01633060|5781356|P1|STARTED|Treatment Phase||288
2356182|NCT01633060|5781355|P2|NOT COMPLETED|Randomization Phase||3
2356183|NCT01633060|5781356|P1|NOT COMPLETED|Randomization Phase||1
2356184|NCT01633060|5781355|P2|COMPLETED|Randomization Phase||140
2356185|NCT01633060|5781356|P1|COMPLETED|Randomization Phase||288
2356186|NCT01633060|5781355|P2|STARTED|Randomization Phase|All randomized patients|143
2356187|NCT01633060|5781356|P1|STARTED|Randomization Phase|All randomized patients|289
2356188|NCT01632995|5781381|P1|NOT COMPLETED|Main Study Follow-up Period||120
2356189|NCT01632995|5781381|P1|COMPLETED|Main Study Follow-up Period||437
2356190|NCT01632995|5781381|P1|STARTED|Main Study Follow-up Period||557
2356191|NCT01632995|5781381|P1|NOT COMPLETED|Pre-screening to Enrollment Period||512
2356192|NCT01632995|5781381|P1|COMPLETED|Pre-screening to Enrollment Period||557
2356193|NCT01632995|5781381|P1|STARTED|Pre-screening to Enrollment Period||1069
2356194|NCT01632904|5781396|P2|NOT COMPLETED|Overall Study||6
2356195|NCT01632904|5781397|P1|NOT COMPLETED|Overall Study||7
2356196|NCT01632904|5781396|P2|COMPLETED|Overall Study|Patients still in the study as of 27MAR2014, including those who crossed over to ruxolitinib|50
2356197|NCT01632904|5781397|P1|COMPLETED|Overall Study|Patients still in the study as of data cutoff, 27MAR2014.|47
2356198|NCT01632904|5781396|P2|STARTED|Overall Study||56
2356199|NCT01632904|5781397|P1|STARTED|Overall Study||54
2356200|NCT01632891|5781408|P2|NOT COMPLETED|Overall Study||1
2356201|NCT01632891|5781409|P1|NOT COMPLETED|Overall Study||1
2356202|NCT01632891|5781408|P2|COMPLETED|Overall Study||25
2356203|NCT01632891|5781409|P1|COMPLETED|Overall Study||25
2356204|NCT01632891|5781408|P2|STARTED|Overall Study||26
2356205|NCT01632891|5781409|P1|STARTED|Overall Study||26
2356206|NCT01632878|5781433|P1|NOT COMPLETED|Treatment||158
2356207|NCT01632878|5781433|P1|COMPLETED|Treatment||1105
2356208|NCT01632878|5781433|P1|STARTED|Treatment||1263
2356209|NCT01632878|5781433|P1|NOT COMPLETED|Screening||268
2356210|NCT01632878|5781433|P1|COMPLETED|Screening||1263
2356211|NCT01632878|5781433|P1|STARTED|Screening||1531
2356212|NCT01632800|5781437|P1|NOT COMPLETED|Overall Study||1
2356213|NCT01632800|5781437|P1|COMPLETED|Overall Study||25
2356214|NCT01632800|5781437|P1|STARTED|Overall Study||26
2356215|NCT01632735|5781443|P2|NOT COMPLETED|Overall Study||3
2356216|NCT01632735|5781444|P1|NOT COMPLETED|Overall Study||4
2356217|NCT01632735|5781443|P2|COMPLETED|Overall Study||37
2356218|NCT01632735|5781444|P1|COMPLETED|Overall Study||36
2356219|NCT01632735|5781443|P2|STARTED|Overall Study||40
2356220|NCT01632735|5781444|P1|STARTED|Overall Study||40
2356221|NCT01632709|5781460|P4|NOT COMPLETED|Overall Study||1
2356222|NCT01632709|5781461|P3|NOT COMPLETED|Overall Study||0
2356223|NCT01632709|5781462|P2|NOT COMPLETED|Overall Study||1
2356224|NCT01632709|5781463|P1|NOT COMPLETED|Overall Study||2
2356225|NCT01632709|5781460|P4|COMPLETED|Overall Study||3
2356226|NCT01632709|5781461|P3|COMPLETED|Overall Study||5
2356227|NCT01632709|5781462|P2|COMPLETED|Overall Study||2
2356228|NCT01632709|5781463|P1|COMPLETED|Overall Study||2
2356229|NCT01632709|5781460|P4|Completed Visit 2 (Received Injection)|Overall Study||3
2356230|NCT01632709|5781461|P3|Completed Visit 2 (Received Injection)|Overall Study||5
2356231|NCT01632709|5781462|P2|Completed Visit 2 (Received Injection)|Overall Study||2
2356232|NCT01632709|5781463|P1|Completed Visit 2 (Received Injection)|Overall Study||4
2356233|NCT01632709|5781460|P4|STARTED|Overall Study||4
2356234|NCT01632709|5781461|P3|STARTED|Overall Study||5
2356235|NCT01632709|5781462|P2|STARTED|Overall Study||3
2356236|NCT01632709|5781463|P1|STARTED|Overall Study||4
2356237|NCT01632683|5781489|P2|NOT COMPLETED|Overall Study||0
2356238|NCT01632683|5781490|P1|NOT COMPLETED|Overall Study||0
2356239|NCT01632683|5781489|P2|COMPLETED|Overall Study||552
2356240|NCT01632683|5781490|P1|COMPLETED|Overall Study||548
2356241|NCT01632683|5781489|P2|STARTED|Overall Study||552
2356242|NCT01632683|5781490|P1|STARTED|Overall Study||548
2356243|NCT01632579|5781504|P9|NOT COMPLETED|Period 3 (Third Intervention)||0
2356244|NCT01632579|5781505|P8|NOT COMPLETED|Period 3 (Third Intervention)||0
2356245|NCT01632579|5781506|P7|NOT COMPLETED|Period 3 (Third Intervention)||0
2356246|NCT01632579|5781507|P6|NOT COMPLETED|Period 3 (Third Intervention)||0
2356247|NCT01632579|5781508|P5|NOT COMPLETED|Period 3 (Third Intervention)||0
2356248|NCT01632579|5781509|P4|NOT COMPLETED|Period 3 (Third Intervention)||0
2356249|NCT01632579|5781510|P3|NOT COMPLETED|Period 3 (Third Intervention)||0
2356250|NCT01632579|5781511|P2|NOT COMPLETED|Period 3 (Third Intervention)||0
2356251|NCT01632579|5781512|P1|NOT COMPLETED|Period 3 (Third Intervention)||0
2356252|NCT01632579|5781504|P9|COMPLETED|Period 3 (Third Intervention)||2
2356253|NCT01632579|5781505|P8|COMPLETED|Period 3 (Third Intervention)||6
2356254|NCT01632579|5781506|P7|COMPLETED|Period 3 (Third Intervention)||2
2356255|NCT01632579|5781507|P6|COMPLETED|Period 3 (Third Intervention)||2
2356256|NCT01632579|5781508|P5|COMPLETED|Period 3 (Third Intervention)||6
2356257|NCT01632579|5781509|P4|COMPLETED|Period 3 (Third Intervention)||2
2356258|NCT01632579|5781510|P3|COMPLETED|Period 3 (Third Intervention)||2
2356259|NCT01632579|5781511|P2|COMPLETED|Period 3 (Third Intervention)||6
2356260|NCT01632579|5781512|P1|COMPLETED|Period 3 (Third Intervention)||0
2356261|NCT01632579|5781504|P9|Received at Least 1 Dose|Period 3 (Third Intervention)||2
2356262|NCT01632579|5781505|P8|Received at Least 1 Dose|Period 3 (Third Intervention)||6
2356263|NCT01632579|5781506|P7|Received at Least 1 Dose|Period 3 (Third Intervention)||2
2356264|NCT01632579|5781507|P6|Received at Least 1 Dose|Period 3 (Third Intervention)||2
2356265|NCT01632579|5781508|P5|Received at Least 1 Dose|Period 3 (Third Intervention)||6
2356266|NCT01632579|5781509|P4|Received at Least 1 Dose|Period 3 (Third Intervention)||2
2356267|NCT01632579|5781510|P3|Received at Least 1 Dose|Period 3 (Third Intervention)||2
2356268|NCT01632579|5781511|P2|Received at Least 1 Dose|Period 3 (Third Intervention)||6
2356269|NCT01632579|5781512|P1|Received at Least 1 Dose|Period 3 (Third Intervention)||0
2356270|NCT01632579|5781504|P9|STARTED|Period 3 (Third Intervention)||2
2356271|NCT01632579|5781505|P8|STARTED|Period 3 (Third Intervention)||6
2356272|NCT01632579|5781506|P7|STARTED|Period 3 (Third Intervention)||2
2356273|NCT01632579|5781507|P6|STARTED|Period 3 (Third Intervention)||2
2356274|NCT01632579|5781508|P5|STARTED|Period 3 (Third Intervention)||6
2356275|NCT01632579|5781509|P4|STARTED|Period 3 (Third Intervention)||2
2356276|NCT01632579|5781510|P3|STARTED|Period 3 (Third Intervention)||2
2356277|NCT01632579|5781511|P2|STARTED|Period 3 (Third Intervention)||6
2356278|NCT01632579|5781512|P1|STARTED|Period 3 (Third Intervention)||0
2356279|NCT01632579|5781504|P9|NOT COMPLETED|Washout Period||0
2356280|NCT01632579|5781505|P8|NOT COMPLETED|Washout Period||0
2356281|NCT01632579|5781506|P7|NOT COMPLETED|Washout Period||0
2356282|NCT01632579|5781507|P6|NOT COMPLETED|Washout Period||0
2356283|NCT01632579|5781508|P5|NOT COMPLETED|Washout Period||0
2356284|NCT01632579|5781509|P4|NOT COMPLETED|Washout Period||0
2356285|NCT01632579|5781510|P3|NOT COMPLETED|Washout Period||0
2356286|NCT01632579|5781511|P2|NOT COMPLETED|Washout Period||0
2356287|NCT01632579|5781512|P1|NOT COMPLETED|Washout Period||0
2356288|NCT01632579|5781504|P9|COMPLETED|Washout Period||2
2356289|NCT01632579|5781505|P8|COMPLETED|Washout Period||6
2356290|NCT01632579|5781506|P7|COMPLETED|Washout Period||2
2356291|NCT01632579|5781507|P6|COMPLETED|Washout Period||2
2356292|NCT01632579|5781508|P5|COMPLETED|Washout Period||6
2356293|NCT01632579|5781509|P4|COMPLETED|Washout Period||2
2356294|NCT01632579|5781510|P3|COMPLETED|Washout Period||2
2356295|NCT01632579|5781511|P2|COMPLETED|Washout Period||6
2356296|NCT01632579|5781512|P1|COMPLETED|Washout Period||0
2356297|NCT01632579|5781504|P9|STARTED|Washout Period||2
2356298|NCT01632579|5781505|P8|STARTED|Washout Period||6
2356299|NCT01632579|5781506|P7|STARTED|Washout Period||2
2356300|NCT01632579|5781507|P6|STARTED|Washout Period||2
2356301|NCT01632579|5781508|P5|STARTED|Washout Period||6
2356302|NCT01632579|5781509|P4|STARTED|Washout Period||2
2356303|NCT01632579|5781510|P3|STARTED|Washout Period||2
2356304|NCT01632579|5781511|P2|STARTED|Washout Period||6
2356305|NCT01632579|5781512|P1|STARTED|Washout Period||0
2356306|NCT01632579|5781504|P9|NOT COMPLETED|Period 2 (Second Intervention)||0
2356307|NCT01632579|5781505|P8|NOT COMPLETED|Period 2 (Second Intervention)||0
2356308|NCT01632579|5781506|P7|NOT COMPLETED|Period 2 (Second Intervention)||0
2356309|NCT01632579|5781507|P6|NOT COMPLETED|Period 2 (Second Intervention)||0
2356310|NCT01632579|5781508|P5|NOT COMPLETED|Period 2 (Second Intervention)||0
2356311|NCT01632579|5781509|P4|NOT COMPLETED|Period 2 (Second Intervention)||0
2356312|NCT01632579|5781510|P3|NOT COMPLETED|Period 2 (Second Intervention)||0
2356313|NCT01632579|5781511|P2|NOT COMPLETED|Period 2 (Second Intervention)||0
2356314|NCT01632579|5781512|P1|NOT COMPLETED|Period 2 (Second Intervention)||1
2356315|NCT01632579|5781504|P9|COMPLETED|Period 2 (Second Intervention)||2
2356316|NCT01632579|5781505|P8|COMPLETED|Period 2 (Second Intervention)||6
2356317|NCT01632579|5781506|P7|COMPLETED|Period 2 (Second Intervention)||2
2356318|NCT01632579|5781507|P6|COMPLETED|Period 2 (Second Intervention)||2
2356319|NCT01632579|5781508|P5|COMPLETED|Period 2 (Second Intervention)||6
2356320|NCT01632579|5781509|P4|COMPLETED|Period 2 (Second Intervention)||2
2356321|NCT01632579|5781510|P3|COMPLETED|Period 2 (Second Intervention)||2
2356322|NCT01632579|5781511|P2|COMPLETED|Period 2 (Second Intervention)||6
2356323|NCT01632579|5781512|P1|COMPLETED|Period 2 (Second Intervention)||0
2356324|NCT01632579|5781504|P9|Received at Least 1 Dose|Period 2 (Second Intervention)||2
2356325|NCT01632579|5781505|P8|Received at Least 1 Dose|Period 2 (Second Intervention)||6
2356326|NCT01632579|5781506|P7|Received at Least 1 Dose|Period 2 (Second Intervention)||2
2356327|NCT01632579|5781507|P6|Received at Least 1 Dose|Period 2 (Second Intervention)||2
2356328|NCT01632579|5781508|P5|Received at Least 1 Dose|Period 2 (Second Intervention)||6
2356329|NCT01632579|5781509|P4|Received at Least 1 Dose|Period 2 (Second Intervention)||2
2356330|NCT01632579|5781510|P3|Received at Least 1 Dose|Period 2 (Second Intervention)||2
2356331|NCT01632579|5781511|P2|Received at Least 1 Dose|Period 2 (Second Intervention)||6
2356332|NCT01632579|5781512|P1|Received at Least 1 Dose|Period 2 (Second Intervention)||1
2356333|NCT01632579|5781504|P9|STARTED|Period 2 (Second Intervention)||2
2356334|NCT01632579|5781505|P8|STARTED|Period 2 (Second Intervention)||6
2356335|NCT01632579|5781506|P7|STARTED|Period 2 (Second Intervention)||2
2356336|NCT01632579|5781507|P6|STARTED|Period 2 (Second Intervention)||2
2356337|NCT01632579|5781508|P5|STARTED|Period 2 (Second Intervention)||6
2356338|NCT01632579|5781509|P4|STARTED|Period 2 (Second Intervention)||2
2356339|NCT01632579|5781510|P3|STARTED|Period 2 (Second Intervention)||2
2356340|NCT01632579|5781511|P2|STARTED|Period 2 (Second Intervention)||6
2356341|NCT01632579|5781512|P1|STARTED|Period 2 (Second Intervention)||1
2356342|NCT01632579|5781504|P9|NOT COMPLETED|Washout Period||0
2356343|NCT01632579|5781505|P8|NOT COMPLETED|Washout Period||0
2356344|NCT01632579|5781506|P7|NOT COMPLETED|Washout Period||0
2356345|NCT01632579|5781507|P6|NOT COMPLETED|Washout Period||0
2356346|NCT01632579|5781508|P5|NOT COMPLETED|Washout Period||0
2356347|NCT01632579|5781509|P4|NOT COMPLETED|Washout Period||0
2356348|NCT01632579|5781510|P3|NOT COMPLETED|Washout Period||0
2356349|NCT01632579|5781511|P2|NOT COMPLETED|Washout Period||0
2356350|NCT01632579|5781512|P1|NOT COMPLETED|Washout Period||1
2356351|NCT01632579|5781504|P9|COMPLETED|Washout Period||2
2356352|NCT01632579|5781505|P8|COMPLETED|Washout Period||6
2356353|NCT01632579|5781506|P7|COMPLETED|Washout Period||2
2356354|NCT01632579|5781507|P6|COMPLETED|Washout Period||2
2356355|NCT01632579|5781508|P5|COMPLETED|Washout Period||6
2356356|NCT01632579|5781509|P4|COMPLETED|Washout Period||2
2356357|NCT01632579|5781510|P3|COMPLETED|Washout Period||2
2356358|NCT01632579|5781511|P2|COMPLETED|Washout Period||6
2356359|NCT01632579|5781512|P1|COMPLETED|Washout Period||1
2356360|NCT01632579|5781504|P9|STARTED|Washout Period||2
2356361|NCT01632579|5781505|P8|STARTED|Washout Period||6
2356362|NCT01632579|5781506|P7|STARTED|Washout Period||2
2356363|NCT01632579|5781507|P6|STARTED|Washout Period||2
2356364|NCT01632579|5781508|P5|STARTED|Washout Period||6
2356365|NCT01632579|5781509|P4|STARTED|Washout Period||2
2356366|NCT01632579|5781510|P3|STARTED|Washout Period||2
2356367|NCT01632579|5781511|P2|STARTED|Washout Period||6
2356368|NCT01632579|5781512|P1|STARTED|Washout Period||2
2356369|NCT01632579|5781504|P9|NOT COMPLETED|Period 1 (First Intervention)||0
2356370|NCT01632579|5781505|P8|NOT COMPLETED|Period 1 (First Intervention)||0
2356371|NCT01632579|5781506|P7|NOT COMPLETED|Period 1 (First Intervention)||0
2356372|NCT01632579|5781507|P6|NOT COMPLETED|Period 1 (First Intervention)||0
2356373|NCT01632579|5781508|P5|NOT COMPLETED|Period 1 (First Intervention)||0
2356374|NCT01632579|5781509|P4|NOT COMPLETED|Period 1 (First Intervention)||0
2356375|NCT01632579|5781510|P3|NOT COMPLETED|Period 1 (First Intervention)||0
2356376|NCT01632579|5781511|P2|NOT COMPLETED|Period 1 (First Intervention)||0
2356377|NCT01632579|5781512|P1|NOT COMPLETED|Period 1 (First Intervention)||0
2356378|NCT01632579|5781504|P9|COMPLETED|Period 1 (First Intervention)||2
2356379|NCT01632579|5781505|P8|COMPLETED|Period 1 (First Intervention)||6
2356380|NCT01632579|5781506|P7|COMPLETED|Period 1 (First Intervention)||2
2356381|NCT01632579|5781507|P6|COMPLETED|Period 1 (First Intervention)||2
2356382|NCT01632579|5781508|P5|COMPLETED|Period 1 (First Intervention)||6
2356383|NCT01632579|5781509|P4|COMPLETED|Period 1 (First Intervention)||2
2356384|NCT01632579|5781510|P3|COMPLETED|Period 1 (First Intervention)||2
2356385|NCT01632579|5781511|P2|COMPLETED|Period 1 (First Intervention)||6
2356386|NCT01632579|5781512|P1|COMPLETED|Period 1 (First Intervention)||2
2356387|NCT01632579|5781504|P9|Received at Least 1 Dose|Period 1 (First Intervention)||2
2356388|NCT01632579|5781505|P8|Received at Least 1 Dose|Period 1 (First Intervention)||6
2356389|NCT01632579|5781506|P7|Received at Least 1 Dose|Period 1 (First Intervention)||2
2356390|NCT01632579|5781507|P6|Received at Least 1 Dose|Period 1 (First Intervention)||2
2356391|NCT01632579|5781508|P5|Received at Least 1 Dose|Period 1 (First Intervention)||6
2356392|NCT01632579|5781509|P4|Received at Least 1 Dose|Period 1 (First Intervention)||2
2356393|NCT01632579|5781510|P3|Received at Least 1 Dose|Period 1 (First Intervention)||2
2356394|NCT01632579|5781511|P2|Received at Least 1 Dose|Period 1 (First Intervention)||6
2356395|NCT01632579|5781512|P1|Received at Least 1 Dose|Period 1 (First Intervention)||2
2356396|NCT01632579|5781504|P9|STARTED|Period 1 (First Intervention)||2
2356397|NCT01632579|5781505|P8|STARTED|Period 1 (First Intervention)||6
2356398|NCT01632579|5781506|P7|STARTED|Period 1 (First Intervention)||2
2356399|NCT01632579|5781507|P6|STARTED|Period 1 (First Intervention)||2
2356400|NCT01632579|5781508|P5|STARTED|Period 1 (First Intervention)||6
2356401|NCT01632579|5781509|P4|STARTED|Period 1 (First Intervention)||2
2356402|NCT01632579|5781510|P3|STARTED|Period 1 (First Intervention)||2
2356403|NCT01632579|5781511|P2|STARTED|Period 1 (First Intervention)||6
2356404|NCT01632579|5781512|P1|STARTED|Period 1 (First Intervention)||2
2356405|NCT01632566|5781579|P5|NOT COMPLETED|Overall Study||2
2356406|NCT01632566|5781580|P4|NOT COMPLETED|Overall Study||2
2356407|NCT01632566|5781581|P3|NOT COMPLETED|Overall Study||9
2356408|NCT01632566|5781582|P2|NOT COMPLETED|Overall Study||3
2356409|NCT01632566|5781583|P1|NOT COMPLETED|Overall Study||0
2356410|NCT01632566|5781579|P5|COMPLETED|Overall Study||4
2356411|NCT01632566|5781580|P4|COMPLETED|Overall Study||4
2356412|NCT01632566|5781581|P3|COMPLETED|Overall Study||0
2356413|NCT01632566|5781582|P2|COMPLETED|Overall Study||7
2356414|NCT01632566|5781583|P1|COMPLETED|Overall Study||8
2356415|NCT01632566|5781579|P5|Received at Least One Dose Simvastatin|Overall Study||4
2356416|NCT01632566|5781580|P4|Received at Least One Dose Simvastatin|Overall Study||4
2356417|NCT01632566|5781581|P3|Received at Least One Dose Simvastatin|Overall Study||9
2356418|NCT01632566|5781582|P2|Received at Least One Dose Simvastatin|Overall Study||10
2356419|NCT01632566|5781583|P1|Received at Least One Dose Simvastatin|Overall Study||0
2356420|NCT01632566|5781579|P5|Received at Least One Dose LY3031207|Overall Study||0
2356421|NCT01632566|5781580|P4|Received at Least One Dose LY3031207|Overall Study||0
2356422|NCT01632566|5781581|P3|Received at Least One Dose LY3031207|Overall Study||9
2356423|NCT01632566|5781582|P2|Received at Least One Dose LY3031207|Overall Study||10
2356424|NCT01632566|5781583|P1|Received at Least One Dose LY3031207|Overall Study||8
2356425|NCT01632566|5781579|P5|STARTED|Overall Study||6
2356426|NCT01632566|5781580|P4|STARTED|Overall Study||6
2356427|NCT01632566|5781581|P3|STARTED|Overall Study||9
2356428|NCT01632566|5781582|P2|STARTED|Overall Study||10
2356429|NCT01632566|5781583|P1|STARTED|Overall Study||8
2356430|NCT01632423|5781621|P1|NOT COMPLETED|Overall Study||246
2356431|NCT01632423|5781621|P1|COMPLETED|Overall Study||10091
2356432|NCT01632423|5781621|P1|STARTED|Overall Study||10337
2356433|NCT01632345|5781634|P7|NOT COMPLETED|Treatment: Part II||11
2356434|NCT01632345|5781635|P6|NOT COMPLETED|Treatment: Part II||11
2356435|NCT01632345|5781636|P5|NOT COMPLETED|Treatment: Part II||0
2356436|NCT01632345|5781637|P4|NOT COMPLETED|Treatment: Part II||0
2356437|NCT01632345|5781638|P3|NOT COMPLETED|Treatment: Part II||0
2356438|NCT01632345|5781639|P2|NOT COMPLETED|Treatment: Part II||0
2356439|NCT01632345|5781640|P1|NOT COMPLETED|Treatment: Part II||0
2356440|NCT01632345|5781634|P7|COMPLETED|Treatment: Part II||55
2356441|NCT01632345|5781635|P6|COMPLETED|Treatment: Part II||55
2356442|NCT01632345|5781636|P5|COMPLETED|Treatment: Part II||0
2356443|NCT01632345|5781637|P4|COMPLETED|Treatment: Part II||0
2356444|NCT01632345|5781638|P3|COMPLETED|Treatment: Part II||0
2356445|NCT01632345|5781639|P2|COMPLETED|Treatment: Part II||0
2356446|NCT01632345|5781640|P1|COMPLETED|Treatment: Part II||0
2356447|NCT01632345|5781634|P7|Treated|Treatment: Part II||66
2356448|NCT01632345|5781635|P6|Treated|Treatment: Part II||66
2356449|NCT01632345|5781636|P5|Treated|Treatment: Part II||0
2356450|NCT01632345|5781637|P4|Treated|Treatment: Part II||0
2356451|NCT01632345|5781638|P3|Treated|Treatment: Part II||0
2356452|NCT01632345|5781639|P2|Treated|Treatment: Part II||0
2356453|NCT01632345|5781640|P1|Treated|Treatment: Part II||0
2356454|NCT01632345|5781634|P7|STARTED|Treatment: Part II|66 new participants enrolled at efavirenz treatment in Part II.|66
2356455|NCT01632345|5781635|P6|STARTED|Treatment: Part II|66 new participants enrolled at 100 mg dose in Part II.|66
2356456|NCT01632345|5781636|P5|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
2356457|NCT01632345|5781637|P4|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
2356458|NCT01632345|5781638|P3|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
2356459|NCT01632345|5781639|P2|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
2356460|NCT01632345|5781640|P1|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
2356461|NCT01632345|5781634|P7|NOT COMPLETED|Treatment: Part I||0
2356462|NCT01632345|5781635|P6|NOT COMPLETED|Treatment: Part I||0
2356463|NCT01632345|5781636|P5|NOT COMPLETED|Treatment: Part I||13
2356464|NCT01632345|5781637|P4|NOT COMPLETED|Treatment: Part I||8
2356465|NCT01632345|5781638|P3|NOT COMPLETED|Treatment: Part I||10
2356466|NCT01632345|5781639|P2|NOT COMPLETED|Treatment: Part I||15
2356467|NCT01632345|5781640|P1|NOT COMPLETED|Treatment: Part I||12
2356468|NCT01632345|5781634|P7|COMPLETED|Treatment: Part I||0
2356469|NCT01632345|5781635|P6|COMPLETED|Treatment: Part I||0
2356470|NCT01632345|5781636|P5|COMPLETED|Treatment: Part I||30
2356471|NCT01632345|5781637|P4|COMPLETED|Treatment: Part I||33
2356472|NCT01632345|5781638|P3|COMPLETED|Treatment: Part I||32
2356473|NCT01632345|5781639|P2|COMPLETED|Treatment: Part I||28
2356474|NCT01632345|5781640|P1|COMPLETED|Treatment: Part I||29
2356475|NCT01632345|5781634|P7|Treated|Treatment: Part I||0
2356476|NCT01632345|5781635|P6|Treated|Treatment: Part I||0
2356477|NCT01632345|5781636|P5|Treated|Treatment: Part I||43
2356478|NCT01632345|5781637|P4|Treated|Treatment: Part I||41
2356479|NCT01632345|5781638|P3|Treated|Treatment: Part I||42
2356480|NCT01632345|5781639|P2|Treated|Treatment: Part I||43
2356481|NCT01632345|5781640|P1|Treated|Treatment: Part I||40
2356482|NCT01632345|5781634|P7|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0
2356483|NCT01632345|5781635|P6|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0
2356484|NCT01632345|5781636|P5|STARTED|Treatment: Part I||43
2356485|NCT01632345|5781637|P4|STARTED|Treatment: Part I||41
2356486|NCT01632345|5781638|P3|STARTED|Treatment: Part I||42
2356487|NCT01632345|5781639|P2|STARTED|Treatment: Part I||43
2356488|NCT01632345|5781640|P1|STARTED|Treatment: Part I||41
2356489|NCT01632345|5781634|P7|NOT COMPLETED|Randomized Participants||0
2356490|NCT01632345|5781635|P6|NOT COMPLETED|Randomized Participants||0
2356491|NCT01632345|5781636|P5|NOT COMPLETED|Randomized Participants||0
2356492|NCT01632345|5781637|P4|NOT COMPLETED|Randomized Participants||0
2356493|NCT01632345|5781638|P3|NOT COMPLETED|Randomized Participants||0
2356494|NCT01632345|5781639|P2|NOT COMPLETED|Randomized Participants||0
2356495|NCT01632345|5781640|P1|NOT COMPLETED|Randomized Participants||0
2356496|NCT01632345|5781634|P7|COMPLETED|Randomized Participants||66
2356497|NCT01632345|5781635|P6|COMPLETED|Randomized Participants||66
2356498|NCT01632345|5781636|P5|COMPLETED|Randomized Participants||43
2356499|NCT01632345|5781637|P4|COMPLETED|Randomized Participants||41
2356500|NCT01632345|5781638|P3|COMPLETED|Randomized Participants||42
2356501|NCT01632345|5781639|P2|COMPLETED|Randomized Participants||43
2356502|NCT01632345|5781640|P1|COMPLETED|Randomized Participants||41
2356503|NCT01632345|5781634|P7|STARTED|Randomized Participants||66
2356504|NCT01632345|5781635|P6|STARTED|Randomized Participants||66
2356505|NCT01632345|5781636|P5|STARTED|Randomized Participants||43
2356506|NCT01632345|5781637|P4|STARTED|Randomized Participants||41
2356507|NCT01632345|5781638|P3|STARTED|Randomized Participants||42
2356508|NCT01632345|5781639|P2|STARTED|Randomized Participants||43
2356509|NCT01632345|5781640|P1|STARTED|Randomized Participants||41
2356510|NCT01632306|5781702|P3|NOT COMPLETED|Overall Study||0
2356511|NCT01632306|5781703|P2|NOT COMPLETED|Overall Study||0
2356512|NCT01632306|5781704|P1|NOT COMPLETED|Overall Study||1
2356513|NCT01632306|5781702|P3|COMPLETED|Overall Study||0
2356514|NCT01632306|5781703|P2|COMPLETED|Overall Study||10
2356515|NCT01632306|5781704|P1|COMPLETED|Overall Study||2
2356516|NCT01632306|5781702|P3|Received at Least One Dose of Study Drug|Overall Study||0
2356517|NCT01632306|5781703|P2|Received at Least One Dose of Study Drug|Overall Study||10
2356518|NCT01632306|5781704|P1|Received at Least One Dose of Study Drug|Overall Study||3
2356519|NCT01632306|5781702|P3|STARTED|Overall Study||0
2356520|NCT01632306|5781703|P2|STARTED|Overall Study||10
2356521|NCT01632306|5781704|P1|STARTED|Overall Study||3
2356522|NCT01632280|5781720|P2|NOT COMPLETED|Overall Study||0
2356523|NCT01632280|5781721|P1|NOT COMPLETED|Overall Study||1
2356524|NCT01632280|5781720|P2|COMPLETED|Overall Study||6
2356525|NCT01632280|5781721|P1|COMPLETED|Overall Study||5
2356526|NCT01632280|5781720|P2|STARTED|Overall Study||6
2356527|NCT01632280|5781721|P1|STARTED|Overall Study||6
2356528|NCT01632267|5781731|P1|NOT COMPLETED|Overall Study||7
2356529|NCT01632267|5781731|P1|COMPLETED|Overall Study||97
2356530|NCT01632267|5781731|P1|STARTED|Overall Study||104
2356531|NCT01632241|5781737|P2|NOT COMPLETED|Open-label (Week 52 to Week 76)||22
2356532|NCT01632241|5781738|P1|NOT COMPLETED|Open-label (Week 52 to Week 76)||10
2356533|NCT01632241|5781737|P2|COMPLETED|Open-label (Week 52 to Week 76)||220
2356534|NCT01632241|5781738|P1|COMPLETED|Open-label (Week 52 to Week 76)||107
2356535|NCT01632241|5781737|P2|STARTED|Open-label (Week 52 to Week 76)|As the OL phase was optional, participants did not choose to enter the OL Phase.|242
2356536|NCT01632241|5781738|P1|STARTED|Open-label (Week 52 to Week 76)|As the OL phase was optional, participants did not choose to enter the OL Phase.|117
2356537|NCT01632241|5781737|P2|NOT COMPLETED|Double-blinded (Up to Week 52)||79
2356538|NCT01632241|5781738|P1|NOT COMPLETED|Double-blinded (Up to Week 52)||44
2356539|NCT01632241|5781737|P2|COMPLETED|Double-blinded (Up to Week 52)||252
2356540|NCT01632241|5781738|P1|COMPLETED|Double-blinded (Up to Week 52)||121
2356541|NCT01632241|5781737|P2|STARTED|Double-blinded (Up to Week 52)||331
2356542|NCT01632241|5781738|P1|STARTED|Double-blinded (Up to Week 52)||165
2356543|NCT01632215|5781788|P2|NOT COMPLETED|Overall Study||1
2356544|NCT01632215|5781789|P1|NOT COMPLETED|Overall Study||2
2356545|NCT01632215|5781788|P2|COMPLETED|Overall Study||19
2356546|NCT01632215|5781789|P1|COMPLETED|Overall Study||18
2356547|NCT01632215|5781788|P2|STARTED|Overall Study||20
2356548|NCT01632215|5781789|P1|STARTED|Overall Study||20
2356549|NCT01632150|5781797|P1|NOT COMPLETED|Overall Study||40
2356550|NCT01632150|5781797|P1|COMPLETED|Overall Study|Completed=still receiving treatment|0
2356551|NCT01632150|5781797|P1|Received Cyclophosphamide|Overall Study||11
2356552|NCT01632150|5781797|P1|STARTED|Overall Study||40
2356553|NCT01632020|5781806|P2|NOT COMPLETED|Overall Study||0
2356554|NCT01632020|5781807|P1|NOT COMPLETED|Overall Study||2
2356555|NCT01632020|5781806|P2|COMPLETED|Overall Study||3
2356556|NCT01632020|5781807|P1|COMPLETED|Overall Study||2
2356557|NCT01632020|5781806|P2|STARTED|Overall Study||3
2356558|NCT01632020|5781807|P1|STARTED|Overall Study||4
2356559|NCT01631929|5781817|P2|NOT COMPLETED|Overall Study||0
2356560|NCT01631929|5781818|P1|NOT COMPLETED|Overall Study||0
2356561|NCT01631929|5781817|P2|COMPLETED|Overall Study||6
2356562|NCT01631929|5781818|P1|COMPLETED|Overall Study||6
2356563|NCT01631929|5781817|P2|STARTED|Overall Study||6
2356564|NCT01631929|5781818|P1|STARTED|Overall Study||6
2356565|NCT01631864|5781826|P2|NOT COMPLETED|Overall Study||4
2356566|NCT01631864|5781827|P1|NOT COMPLETED|Overall Study||2
2356567|NCT01631864|5781826|P2|COMPLETED|Overall Study||44
2356568|NCT01631864|5781827|P1|COMPLETED|Overall Study||48
2356569|NCT01631864|5781826|P2|STARTED|Overall Study||48
2356570|NCT01631864|5781827|P1|STARTED|Overall Study||50
2356571|NCT01631825|5781839|P1|NOT COMPLETED|Overall Study||65
2356572|NCT01631825|5781839|P1|COMPLETED|Overall Study||256
2356573|NCT01631825|5781839|P1|STARTED|Overall Study||321
2356574|NCT01631812|5781859|P1|NOT COMPLETED|Overall Study||37
2356575|NCT01631812|5781859|P1|COMPLETED|Overall Study||93
2356576|NCT01631812|5781859|P1|STARTED|Overall Study||130
2356577|NCT01631747|5781869|P2|NOT COMPLETED|One Year Infant Outcomes||9
2356578|NCT01631747|5781870|P1|NOT COMPLETED|One Year Infant Outcomes||13
2356579|NCT01631747|5781869|P2|COMPLETED|One Year Infant Outcomes||130
2356580|NCT01631747|5781870|P1|COMPLETED|One Year Infant Outcomes||123
2356581|NCT01631747|5781869|P2|STARTED|One Year Infant Outcomes||139
2356582|NCT01631747|5781870|P1|STARTED|One Year Infant Outcomes||136
2356583|NCT01631747|5781869|P2|NOT COMPLETED|Live Birth||1
2356584|NCT01631747|5781870|P1|NOT COMPLETED|Live Birth||4
2356585|NCT01631747|5781869|P2|COMPLETED|Live Birth||139
2356586|NCT01631747|5781870|P1|COMPLETED|Live Birth||136
2356587|NCT01631747|5781869|P2|STARTED|Live Birth||140
2356588|NCT01631747|5781870|P1|STARTED|Live Birth||140
2356589|NCT01631747|5781869|P2|NOT COMPLETED|Randomization Through End of Pregnancy||0
2356590|NCT01631747|5781870|P1|NOT COMPLETED|Randomization Through End of Pregnancy||1
2356591|NCT01631747|5781869|P2|COMPLETED|Randomization Through End of Pregnancy||140
2356592|NCT01631747|5781870|P1|COMPLETED|Randomization Through End of Pregnancy||140
2356593|NCT01631747|5781869|P2|STARTED|Randomization Through End of Pregnancy||140
2356594|NCT01631747|5781870|P1|STARTED|Randomization Through End of Pregnancy||141
2356595|NCT01631682|5781912|P4|NOT COMPLETED|Overall Study||2
2356596|NCT01631682|5781913|P3|NOT COMPLETED|Overall Study||31
2356597|NCT01631682|5781914|P2|NOT COMPLETED|Overall Study||45
2356598|NCT01631682|5781915|P1|NOT COMPLETED|Overall Study||31
2356599|NCT01631682|5781912|P4|COMPLETED|Overall Study||5
2356600|NCT01631682|5781913|P3|COMPLETED|Overall Study||13
2356601|NCT01631682|5781914|P2|COMPLETED|Overall Study||21
2356602|NCT01631682|5781915|P1|COMPLETED|Overall Study||24
2356603|NCT01631682|5781912|P4|STARTED|Overall Study||7
2356604|NCT01631682|5781913|P3|STARTED|Overall Study||44
2356605|NCT01631682|5781914|P2|STARTED|Overall Study||66
2356606|NCT01631682|5781915|P1|STARTED|Overall Study||55
2356607|NCT01631656|5781927|P2|NOT COMPLETED|Overall Study||0
2356608|NCT01631656|5781928|P1|NOT COMPLETED|Overall Study||0
2356609|NCT01631656|5781927|P2|COMPLETED|Overall Study||5
2356610|NCT01631656|5781928|P1|COMPLETED|Overall Study||5
2356611|NCT01631656|5781927|P2|STARTED|Overall Study||5
2356612|NCT01631656|5781928|P1|STARTED|Overall Study||5
2356613|NCT01631630|5781936|P2|NOT COMPLETED|Overall Study||0
2356614|NCT01631630|5781937|P1|NOT COMPLETED|Overall Study||3
2356615|NCT01631630|5781936|P2|COMPLETED|Overall Study||8
2356616|NCT01631630|5781937|P1|COMPLETED|Overall Study||5
2356617|NCT01631630|5781936|P2|STARTED|Overall Study||8
2356618|NCT01631630|5781937|P1|STARTED|Overall Study||8
2356619|NCT01631435|5782047|P1|NOT COMPLETED|Overall Study||9
2356620|NCT01631435|5782047|P1|COMPLETED|Overall Study||66
2356621|NCT01631435|5782047|P1|STARTED|Overall Study||75
2356622|NCT01631331|5782052|P1|NOT COMPLETED|Overall Study||4
2356623|NCT01631331|5782052|P1|COMPLETED|Overall Study||11
2356624|NCT01631331|5782052|P1|STARTED|Overall Study||15
2356625|NCT01631227|5782061|P2|NOT COMPLETED|Overall Study||22
2356626|NCT01631227|5782062|P1|NOT COMPLETED|Overall Study||30
2356627|NCT01631227|5782061|P2|COMPLETED|Overall Study||310
2356628|NCT01631227|5782062|P1|COMPLETED|Overall Study||303
2356629|NCT01631227|5782061|P2|Full Analysis Set Population|Overall Study|1 patient not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|331
2356630|NCT01631227|5782062|P1|Full Analysis Set Population|Overall Study|2 patients not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|330
2356631|NCT01631227|5782061|P2|Safety Subject Sample|Overall Study||332
2356632|NCT01631227|5782062|P1|Safety Subject Sample|Overall Study|1 patient was randomized by mistake and never received study medication.|332
2356633|NCT01631227|5782061|P2|STARTED|Overall Study||332
2356634|NCT01631227|5782062|P1|STARTED|Overall Study||333
2356635|NCT01631214|5782070|P2|NOT COMPLETED|Overall Study||523
2356636|NCT01631214|5782071|P1|NOT COMPLETED|Overall Study||544
2356637|NCT01631214|5782070|P2|COMPLETED|Overall Study||1523
2356638|NCT01631214|5782071|P1|COMPLETED|Overall Study||1503
2356639|NCT01631214|5782070|P2|Completed Primary Analysis Period|Overall Study||1574
2356640|NCT01631214|5782071|P1|Completed Primary Analysis Period|Overall Study||1576
2356641|NCT01631214|5782070|P2|Completed Double-blind Period|Overall Study||1831
2356642|NCT01631214|5782071|P1|Completed Double-blind Period|Overall Study||1823
2356643|NCT01631214|5782070|P2|Received Double-blind Treatment|Overall Study||2038
2356644|NCT01631214|5782071|P1|Received Double-blind Treatment|Overall Study||2040
2356645|NCT01631214|5782070|P2|STARTED|Overall Study||2046
2356646|NCT01631214|5782071|P1|STARTED|Overall Study||2047
2356647|NCT01631149|5782135|P2|NOT COMPLETED|Overall Study||0
2356648|NCT01631149|5782136|P1|NOT COMPLETED|Overall Study||0
2356649|NCT01631149|5782135|P2|COMPLETED|Overall Study||12
2356650|NCT01631149|5782136|P1|COMPLETED|Overall Study||12
2356651|NCT01631149|5782135|P2|STARTED|Overall Study||12
2356652|NCT01631149|5782136|P1|STARTED|Overall Study||12
2356653|NCT01631110|5782152|P2|NOT COMPLETED|Overall Study||0
2356654|NCT01631110|5782153|P1|NOT COMPLETED|Overall Study||0
2356655|NCT01631110|5782152|P2|COMPLETED|Overall Study||55
2356656|NCT01631110|5782153|P1|COMPLETED|Overall Study||55
2356657|NCT01631110|5782152|P2|STARTED|Overall Study||55
2356658|NCT01631110|5782153|P1|STARTED|Overall Study||55
2356659|NCT01631071|5782167|P2|NOT COMPLETED|Overall Study||0
2356660|NCT01631071|5782168|P1|NOT COMPLETED|Overall Study||0
2356661|NCT01631071|5782167|P2|COMPLETED|Overall Study||55
2356662|NCT01631071|5782168|P1|COMPLETED|Overall Study||55
2356663|NCT01631071|5782167|P2|STARTED|Overall Study||55
2356664|NCT01631071|5782168|P1|STARTED|Overall Study||55
2356665|NCT01630811|5782180|P2|NOT COMPLETED|Second Washout (4 Weeks)||0
2356666|NCT01630811|5782181|P1|NOT COMPLETED|Second Washout (4 Weeks)||0
2356667|NCT01630811|5782180|P2|COMPLETED|Second Washout (4 Weeks)||6
2356668|NCT01630811|5782181|P1|COMPLETED|Second Washout (4 Weeks)||6
2356669|NCT01630811|5782180|P2|STARTED|Second Washout (4 Weeks)||6
2356670|NCT01630811|5782181|P1|STARTED|Second Washout (4 Weeks)||6
2356671|NCT01630811|5782180|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
2356672|NCT01630811|5782181|P1|NOT COMPLETED|Second Intervention (8 Weeks)||1
2356673|NCT01630811|5782180|P2|COMPLETED|Second Intervention (8 Weeks)||6
2356674|NCT01630811|5782181|P1|COMPLETED|Second Intervention (8 Weeks)||6
2356675|NCT01630811|5782180|P2|STARTED|Second Intervention (8 Weeks)||6
2356676|NCT01630811|5782181|P1|STARTED|Second Intervention (8 Weeks)||7
2356677|NCT01630811|5782180|P2|NOT COMPLETED|Washout (4 Weeks)||0
2356678|NCT01630811|5782181|P1|NOT COMPLETED|Washout (4 Weeks)||0
2356679|NCT01630811|5782180|P2|COMPLETED|Washout (4 Weeks)||6
2356680|NCT01630811|5782181|P1|COMPLETED|Washout (4 Weeks)||7
2356681|NCT01630811|5782180|P2|STARTED|Washout (4 Weeks)||6
2356682|NCT01630811|5782181|P1|STARTED|Washout (4 Weeks)||7
2356683|NCT01630811|5782180|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
2356684|NCT01630811|5782181|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
2356685|NCT01630811|5782180|P2|COMPLETED|First Intervention (8 Weeks)||6
2356686|NCT01630811|5782181|P1|COMPLETED|First Intervention (8 Weeks)||7
2356687|NCT01630811|5782180|P2|STARTED|First Intervention (8 Weeks)||6
2356688|NCT01630811|5782181|P1|STARTED|First Intervention (8 Weeks)||7
2356689|NCT01630694|5782193|P2|NOT COMPLETED|Overall Study||0
2356690|NCT01630694|5782194|P1|NOT COMPLETED|Overall Study||0
2356691|NCT01630694|5782193|P2|COMPLETED|Overall Study||16
2356692|NCT01630694|5782194|P1|COMPLETED|Overall Study||12
2356693|NCT01630694|5782193|P2|STARTED|Overall Study||16
2356694|NCT01630694|5782194|P1|STARTED|Overall Study||12
2356695|NCT01630616|5782208|P6|NOT COMPLETED|Overall Study||0
2356696|NCT01630616|5782209|P5|NOT COMPLETED|Overall Study||0
2356697|NCT01630616|5782210|P4|NOT COMPLETED|Overall Study||3
2356698|NCT01630616|5782211|P3|NOT COMPLETED|Overall Study||0
2356699|NCT01630616|5782212|P2|NOT COMPLETED|Overall Study||0
2356700|NCT01630616|5782213|P1|NOT COMPLETED|Overall Study||0
2356701|NCT01630616|5782208|P6|COMPLETED|Overall Study||2
2356702|NCT01630616|5782209|P5|COMPLETED|Overall Study||6
2356703|NCT01630616|5782210|P4|COMPLETED|Overall Study||9
2356704|NCT01630616|5782211|P3|COMPLETED|Overall Study||3
2356705|NCT01630616|5782212|P2|COMPLETED|Overall Study||3
2356706|NCT01630616|5782213|P1|COMPLETED|Overall Study||5
2356707|NCT01630616|5782208|P6|STARTED|Overall Study||2
2356708|NCT01630616|5782209|P5|STARTED|Overall Study||6
2356709|NCT01630616|5782210|P4|STARTED|Overall Study||12
2356710|NCT01630616|5782211|P3|STARTED|Overall Study||3
2356711|NCT01630616|5782212|P2|STARTED|Overall Study||3
2356712|NCT01630616|5782213|P1|STARTED|Overall Study||5
2356713|NCT01630200|5782288|P2|NOT COMPLETED|Overall Study||6
2356714|NCT01630200|5782289|P1|NOT COMPLETED|Overall Study||7
2356715|NCT01630200|5782288|P2|COMPLETED|Overall Study||34
2356716|NCT01630200|5782289|P1|COMPLETED|Overall Study||33
2356717|NCT01630200|5782288|P2|STARTED|Overall Study||40
2356718|NCT01630200|5782289|P1|STARTED|Overall Study||40
2356719|NCT01630135|5782313|P2|NOT COMPLETED|Overall Study||2
2356720|NCT01630135|5782314|P1|NOT COMPLETED|Overall Study||0
2356721|NCT01630135|5782313|P2|COMPLETED|Overall Study||128
2356722|NCT01630135|5782314|P1|COMPLETED|Overall Study||131
2356723|NCT01630135|5782313|P2|STARTED|Overall Study||130
2356724|NCT01630135|5782314|P1|STARTED|Overall Study||131
2356725|NCT01630109|5782353|P3|NOT COMPLETED|Overall Study||0
2356726|NCT01630109|5782354|P2|NOT COMPLETED|Overall Study||0
2356727|NCT01630109|5782355|P1|NOT COMPLETED|Overall Study||0
2356728|NCT01630109|5782353|P3|COMPLETED|Overall Study||3
2356729|NCT01630109|5782354|P2|COMPLETED|Overall Study||1
2356730|NCT01630109|5782355|P1|COMPLETED|Overall Study||1
2356731|NCT01630109|5782353|P3|STARTED|Overall Study||3
2356732|NCT01630109|5782354|P2|STARTED|Overall Study||1
2356733|NCT01630109|5782355|P1|STARTED|Overall Study||1
2356734|NCT01629966|5782378|P3|NOT COMPLETED|Overall Study||66
2356735|NCT01629966|5782379|P2|NOT COMPLETED|Overall Study||52
2356736|NCT01629966|5782380|P1|NOT COMPLETED|Overall Study||41
2356737|NCT01629966|5782378|P3|COMPLETED|Overall Study||159
2356738|NCT01629966|5782379|P2|COMPLETED|Overall Study||175
2356739|NCT01629966|5782380|P1|COMPLETED|Overall Study||180
2356740|NCT01629966|5782378|P3|STARTED|Overall Study||225
2356741|NCT01629966|5782379|P2|STARTED|Overall Study||227
2356742|NCT01629966|5782380|P1|STARTED|Overall Study||221
2356743|NCT01629953|5782393|P2|NOT COMPLETED|Overall Study||15
2356744|NCT01629953|5782394|P1|NOT COMPLETED|Overall Study||13
2356745|NCT01629953|5782393|P2|COMPLETED|Overall Study||60
2356746|NCT01629953|5782394|P1|COMPLETED|Overall Study||52
2356747|NCT01629953|5782393|P2|STARTED|Overall Study||75
2356748|NCT01629953|5782394|P1|STARTED|Overall Study||65
2356749|NCT01629862|5782404|P2|NOT COMPLETED|Overall Study||2
2356750|NCT01629862|5782405|P1|NOT COMPLETED|Overall Study||2
2356751|NCT01629862|5782404|P2|COMPLETED|Overall Study||23
2356752|NCT01629862|5782405|P1|COMPLETED|Overall Study||26
2356753|NCT01629862|5782404|P2|STARTED|Overall Study||25
2356754|NCT01629862|5782405|P1|STARTED|Overall Study||28
2356755|NCT01629823|5782414|P3|NOT COMPLETED|Washout Period||0
2356756|NCT01629823|5782415|P2|NOT COMPLETED|Washout Period||6
2356757|NCT01629823|5782416|P1|NOT COMPLETED|Washout Period||3
2356758|NCT01629823|5782414|P3|COMPLETED|Washout Period||50
2356759|NCT01629823|5782415|P2|COMPLETED|Washout Period||51
2356760|NCT01629823|5782416|P1|COMPLETED|Washout Period||51
2356761|NCT01629823|5782414|P3|STARTED|Washout Period||50
2356762|NCT01629823|5782415|P2|STARTED|Washout Period||57
2356763|NCT01629823|5782416|P1|STARTED|Washout Period||54
2356764|NCT01629823|5782414|P3|NOT COMPLETED|Trial Period||10
2356765|NCT01629823|5782415|P2|NOT COMPLETED|Trial Period||13
2356766|NCT01629823|5782416|P1|NOT COMPLETED|Trial Period||13
2356767|NCT01629823|5782414|P3|COMPLETED|Trial Period||49
2356768|NCT01629823|5782415|P2|COMPLETED|Trial Period||56
2356769|NCT01629823|5782416|P1|COMPLETED|Trial Period||53
2356770|NCT01629823|5782414|P3|STARTED|Trial Period||59
2356771|NCT01629823|5782415|P2|STARTED|Trial Period||69
2356772|NCT01629823|5782416|P1|STARTED|Trial Period||66
2356773|NCT01629797|5782424|P1|NOT COMPLETED|Overall Study||18
2356774|NCT01629797|5782424|P1|COMPLETED|Overall Study||82
2356775|NCT01629797|5782424|P1|STARTED|Overall Study||100
2356776|NCT01629784|5782431|P1|NOT COMPLETED|Overall Study||6
2356777|NCT01629784|5782431|P1|COMPLETED|Overall Study||25
2356778|NCT01629784|5782431|P1|STARTED|Overall Study||31
2356779|NCT01629771|5782440|P2|NOT COMPLETED|Overall Study||0
2356780|NCT01629771|5782441|P1|NOT COMPLETED|Overall Study||0
2356781|NCT01629771|5782440|P2|COMPLETED|Overall Study||36
2356782|NCT01629771|5782441|P1|COMPLETED|Overall Study||36
2356783|NCT01629771|5782440|P2|STARTED|Overall Study||36
2356784|NCT01629771|5782441|P1|STARTED|Overall Study||36
2356785|NCT01629706|5782451|P1|NOT COMPLETED|Phase 2 Habitual||10
2356786|NCT01629706|5782451|P1|COMPLETED|Phase 2 Habitual||48
2356787|NCT01629706|5782451|P1|STARTED|Phase 2 Habitual|Phase 2 enrolled 48 new participants, plus 10 participants from Phase 1|58
2356788|NCT01629706|5782451|P1|NOT COMPLETED|Phase 1 PureVision||9
2356789|NCT01629706|5782451|P1|COMPLETED|Phase 1 PureVision||35
2356790|NCT01629706|5782451|P1|STARTED|Phase 1 PureVision||44
2356791|NCT01629693|5782479|P2|NOT COMPLETED|Overall Study||10
2356792|NCT01629693|5782480|P1|NOT COMPLETED|Overall Study||5
2356793|NCT01629693|5782479|P2|COMPLETED|Overall Study||178
2356794|NCT01629693|5782480|P1|COMPLETED|Overall Study||188
2356795|NCT01629693|5782479|P2|STARTED|Overall Study||188
2356796|NCT01629693|5782480|P1|STARTED|Overall Study||193
2356797|NCT01629667|5782489|P3|NOT COMPLETED|Overall Study||45
2356798|NCT01629667|5782490|P2|NOT COMPLETED|Overall Study||41
2356799|NCT01629667|5782491|P1|NOT COMPLETED|Overall Study||47
2356800|NCT01629667|5782489|P3|COMPLETED|Overall Study||14
2356801|NCT01629667|5782490|P2|COMPLETED|Overall Study||17
2356802|NCT01629667|5782491|P1|COMPLETED|Overall Study||12
2356803|NCT01629667|5782489|P3|Randomized and Treated|Overall Study||59
2356804|NCT01629667|5782490|P2|Randomized and Treated|Overall Study||57
2356805|NCT01629667|5782491|P1|Randomized and Treated|Overall Study||57
2356806|NCT01629667|5782489|P3|STARTED|Overall Study||59
2356807|NCT01629667|5782490|P2|STARTED|Overall Study||58
2356808|NCT01629667|5782491|P1|STARTED|Overall Study||59
2356809|NCT01629589|5782575|P2|NOT COMPLETED|Overall Study||7
2356810|NCT01629589|5782576|P1|NOT COMPLETED|Overall Study||8
2356811|NCT01629589|5782575|P2|COMPLETED|Overall Study||204
2356812|NCT01629589|5782576|P1|COMPLETED|Overall Study|A participant received the Boostrix vaccine. Study data reported for the Boostrix vaccine group.|204
2356813|NCT01629589|5782575|P2|STARTED|Overall Study||211
2356814|NCT01629589|5782576|P1|STARTED|Overall Study||212
2356815|NCT01629563|5782594|P2|NOT COMPLETED|Overall Study||53
2356816|NCT01629563|5782595|P1|NOT COMPLETED|Overall Study||61
2356817|NCT01629563|5782594|P2|COMPLETED|Overall Study||170
2356818|NCT01629563|5782595|P1|COMPLETED|Overall Study||167
2356819|NCT01629563|5782594|P2|Started Treatment Course 4|Overall Study||176
2356820|NCT01629563|5782595|P1|Started Treatment Course 4|Overall Study||178
2356821|NCT01629563|5782594|P2|Started Treatment Course 3|Overall Study||190
2356822|NCT01629563|5782595|P1|Started Treatment Course 3|Overall Study||191
2356823|NCT01629563|5782594|P2|Started Treatment Course 2|Overall Study||207
2356824|NCT01629563|5782595|P1|Started Treatment Course 2|Overall Study||213
2356825|NCT01629563|5782594|P2|Safety Population|Overall Study||221
2356826|NCT01629563|5782595|P1|Safety Population|Overall Study||230
2356827|NCT01629563|5782594|P2|STARTED|Overall Study|2 subjects randomised to 10mg received 5mg treatment in error (FAS 1: 10mg, Safety Set: 5mg)|223
2356828|NCT01629563|5782595|P1|STARTED|Overall Study||228
2356841|NCT01629290|5782650|P1|NOT COMPLETED|Overall Study||0
2356842|NCT01629290|5782650|P1|COMPLETED|Overall Study||15
2356843|NCT01629290|5782650|P1|STARTED|Overall Study||15
2356844|NCT01629134|5782660|P1|NOT COMPLETED|Overall Study||0
2356845|NCT01629134|5782660|P1|COMPLETED|Overall Study||62
2356846|NCT01629134|5782660|P1|STARTED|Overall Study||62
2356847|NCT01628965|5782673|P1|NOT COMPLETED|Overall Study||49
2356848|NCT01628965|5782673|P1|COMPLETED|Overall Study||94
2356849|NCT01628965|5782673|P1|STARTED|Overall Study||143
2356850|NCT01628926|5782682|P3|NOT COMPLETED|Overall Study||17
2356851|NCT01628926|5782683|P2|NOT COMPLETED|Overall Study||23
2356852|NCT01628926|5782684|P1|NOT COMPLETED|Overall Study||26
2356853|NCT01628926|5782682|P3|COMPLETED|Overall Study||68
2356854|NCT01628926|5782683|P2|COMPLETED|Overall Study||144
2356855|NCT01628926|5782684|P1|COMPLETED|Overall Study||142
2356856|NCT01628926|5782682|P3|STARTED|Overall Study||85
2356857|NCT01628926|5782683|P2|STARTED|Overall Study||167
2356858|NCT01628926|5782684|P1|STARTED|Overall Study||168
2356859|NCT01628913|5782733|P2|NOT COMPLETED|Overall Study||31
2356860|NCT01628913|5782734|P1|NOT COMPLETED|Overall Study||31
2356861|NCT01628913|5782733|P2|COMPLETED|Overall Study||0
2356862|NCT01628913|5782734|P1|COMPLETED|Overall Study||0
2356863|NCT01628913|5782733|P2|STARTED|Overall Study||31
2356864|NCT01628913|5782734|P1|STARTED|Overall Study||31
2356865|NCT01628874|5782748|P2|NOT COMPLETED|Overall Study||3
2356866|NCT01628874|5782749|P1|NOT COMPLETED|Overall Study||5
2356867|NCT01628874|5782748|P2|COMPLETED|Overall Study||29
2356868|NCT01628874|5782749|P1|COMPLETED|Overall Study||29
2356869|NCT01628874|5782748|P2|STARTED|Overall Study||32
2356870|NCT01628874|5782749|P1|STARTED|Overall Study||34
2356871|NCT01628848|5782765|P2|NOT COMPLETED|Overall Study||14
2356872|NCT01628848|5782766|P1|NOT COMPLETED|Overall Study||12
2356873|NCT01628848|5782765|P2|COMPLETED|Overall Study||73
2356874|NCT01628848|5782766|P1|COMPLETED|Overall Study||75
2356875|NCT01628848|5782765|P2|STARTED|Overall Study||87
2356876|NCT01628848|5782766|P1|STARTED|Overall Study||87
2356877|NCT01628692|5782800|P6|NOT COMPLETED|Overall Study||9
2356878|NCT01628692|5782801|P5|NOT COMPLETED|Overall Study||4
2356879|NCT01628692|5782802|P4|NOT COMPLETED|Overall Study||1
2356880|NCT01628692|5782803|P3|NOT COMPLETED|Overall Study||8
2356881|NCT01628692|5782804|P2|NOT COMPLETED|Overall Study||6
2356882|NCT01628692|5782805|P1|NOT COMPLETED|Overall Study||7
2356883|NCT01628692|5782800|P6|COMPLETED|Overall Study||0
2356884|NCT01628692|5782801|P5|COMPLETED|Overall Study||8
2356885|NCT01628692|5782802|P4|COMPLETED|Overall Study||19
2356886|NCT01628692|5782803|P3|COMPLETED|Overall Study||43
2356887|NCT01628692|5782804|P2|COMPLETED|Overall Study||17
2356888|NCT01628692|5782805|P1|COMPLETED|Overall Study||46
2356889|NCT01628692|5782800|P6|STARTED|Overall Study||9
2356890|NCT01628692|5782801|P5|STARTED|Overall Study||12
2356891|NCT01628692|5782802|P4|STARTED|Overall Study||20
2356892|NCT01628692|5782803|P3|STARTED|Overall Study||51
2356893|NCT01628692|5782804|P2|STARTED|Overall Study||23
2356894|NCT01628692|5782805|P1|STARTED|Overall Study||53
2356895|NCT01628614|5782849|P1|NOT COMPLETED|Overall Study||1775
2356896|NCT01628614|5782849|P1|COMPLETED|Overall Study||3037
2356897|NCT01628614|5782849|P1|STARTED|Overall Study||4812
2356898|NCT01628601|5782855|P1|NOT COMPLETED|Overall Study||41
2356899|NCT01628601|5782855|P1|COMPLETED|Overall Study||351
2356900|NCT01628601|5782855|P1|STARTED|Overall Study||392
2356901|NCT01628588|5782863|P1|NOT COMPLETED|Overall Study||16
2356902|NCT01628588|5782863|P1|COMPLETED|Overall Study||838
2356903|NCT01628588|5782863|P1|STARTED|Overall Study||854
2356904|NCT01628549|5782875|P4|NOT COMPLETED|Overall Study||9
2356905|NCT01628549|5782876|P3|NOT COMPLETED|Overall Study||10
2356906|NCT01628549|5782877|P2|NOT COMPLETED|Overall Study||12
2356907|NCT01628549|5782878|P1|NOT COMPLETED|Overall Study||9
2356908|NCT01628549|5782875|P4|COMPLETED|Overall Study||57
2356909|NCT01628549|5782876|P3|COMPLETED|Overall Study||60
2356910|NCT01628549|5782877|P2|COMPLETED|Overall Study||64
2356911|NCT01628549|5782878|P1|COMPLETED|Overall Study||64
2356912|NCT01628549|5782875|P4|STARTED|Overall Study||66
2356913|NCT01628549|5782876|P3|STARTED|Overall Study||70
2356914|NCT01628549|5782877|P2|STARTED|Overall Study||76
2356915|NCT01628549|5782878|P1|STARTED|Overall Study||73
2356916|NCT01628510|5782914|P2|NOT COMPLETED|Overall Study||5
2356917|NCT01628510|5782915|P1|NOT COMPLETED|Overall Study||3
2356918|NCT01628510|5782914|P2|COMPLETED|Overall Study||44
2356919|NCT01628510|5782915|P1|COMPLETED|Overall Study||48
2356920|NCT01628510|5782914|P2|STARTED|Overall Study||49
2356921|NCT01628510|5782915|P1|STARTED|Overall Study||51
2356922|NCT01628367|5782925|P2|NOT COMPLETED|Overall Study||0
2356923|NCT01628367|5782926|P1|NOT COMPLETED|Overall Study||1
2356924|NCT01628367|5782925|P2|COMPLETED|Overall Study||16
2356925|NCT01628367|5782926|P1|COMPLETED|Overall Study||15
2356926|NCT01628367|5782925|P2|STARTED|Overall Study||16
2356927|NCT01628367|5782926|P1|STARTED|Overall Study||16
2356928|NCT01628250|5782938|P2|NOT COMPLETED|Overall Study||0
2356929|NCT01628250|5782939|P1|NOT COMPLETED|Overall Study||0
2356930|NCT01628250|5782938|P2|COMPLETED|Overall Study||50
2356931|NCT01628250|5782939|P1|COMPLETED|Overall Study||49
2356932|NCT01628250|5782938|P2|STARTED|Overall Study||50
2356933|NCT01628250|5782939|P1|STARTED|Overall Study||49
2356934|NCT01628198|5782945|P1|NOT COMPLETED|Overall Study||18
2356935|NCT01628198|5782945|P1|COMPLETED|Overall Study||20
2356936|NCT01628198|5782945|P1|STARTED|Overall Study||38
2356937|NCT01628120|5782958|P1|NOT COMPLETED|Overall Study||44
2356938|NCT01628120|5782958|P1|COMPLETED|Overall Study||129
2356939|NCT01628120|5782958|P1|Treated|Overall Study||170
2356940|NCT01628120|5782958|P1|STARTED|Overall Study||173
2356941|NCT01628107|5782983|P1|NOT COMPLETED|Overall Study||119
2356942|NCT01628107|5782983|P1|COMPLETED|Overall Study||295
2356943|NCT01628107|5782983|P1|Treated|Overall Study||406
2356944|NCT01628107|5782983|P1|STARTED|Overall Study||414
2356945|NCT01628042|5783012|P4|NOT COMPLETED|Overall Study||0
2356946|NCT01628042|5783013|P3|NOT COMPLETED|Overall Study||0
2356947|NCT01628042|5783014|P2|NOT COMPLETED|Overall Study||0
2356948|NCT01628042|5783015|P1|NOT COMPLETED|Overall Study||0
2356949|NCT01628042|5783012|P4|COMPLETED|Overall Study||8
2356950|NCT01628042|5783013|P3|COMPLETED|Overall Study||8
2356951|NCT01628042|5783014|P2|COMPLETED|Overall Study||8
2356952|NCT01628042|5783015|P1|COMPLETED|Overall Study||8
2356953|NCT01628042|5783012|P4|STARTED|Overall Study||8
2356954|NCT01628042|5783013|P3|STARTED|Overall Study||8
2356955|NCT01628042|5783014|P2|STARTED|Overall Study||8
2356956|NCT01628042|5783015|P1|STARTED|Overall Study||8
2356957|NCT01628016|5783036|P3|NOT COMPLETED|Posttraining to 5 Follow-ups||5
2356958|NCT01628016|5783037|P2|NOT COMPLETED|Posttraining to 5 Follow-ups||7
2356959|NCT01628016|5783038|P1|NOT COMPLETED|Posttraining to 5 Follow-ups||4
2356960|NCT01628016|5783036|P3|COMPLETED|Posttraining to 5 Follow-ups||18
2356961|NCT01628016|5783037|P2|COMPLETED|Posttraining to 5 Follow-ups||20
2356962|NCT01628016|5783038|P1|COMPLETED|Posttraining to 5 Follow-ups||23
2356963|NCT01628016|5783036|P3|STARTED|Posttraining to 5 Follow-ups||23
2356964|NCT01628016|5783037|P2|STARTED|Posttraining to 5 Follow-ups||27
2356965|NCT01628016|5783038|P1|STARTED|Posttraining to 5 Follow-ups||27
2356966|NCT01628016|5783036|P3|NOT COMPLETED|Pretraining to Posttraining||0
2356967|NCT01628016|5783037|P2|NOT COMPLETED|Pretraining to Posttraining||0
2356968|NCT01628016|5783038|P1|NOT COMPLETED|Pretraining to Posttraining||0
2356969|NCT01628016|5783036|P3|COMPLETED|Pretraining to Posttraining||23
2356970|NCT01628016|5783037|P2|COMPLETED|Pretraining to Posttraining||27
2356971|NCT01628016|5783038|P1|COMPLETED|Pretraining to Posttraining||27
2356972|NCT01628016|5783036|P3|STARTED|Pretraining to Posttraining||23
2356973|NCT01628016|5783037|P2|STARTED|Pretraining to Posttraining||27
2356974|NCT01628016|5783038|P1|STARTED|Pretraining to Posttraining||27
2356975|NCT01627899|5783049|P1|NOT COMPLETED|Overall Study||5
2356976|NCT01627899|5783049|P1|COMPLETED|Overall Study||0
2356977|NCT01627899|5783049|P1|STARTED|Overall Study||5
2356978|NCT01627860|5783059|P2|NOT COMPLETED|Overall Study||6
2356979|NCT01627860|5783060|P1|NOT COMPLETED|Overall Study||12
2356980|NCT01627860|5783059|P2|COMPLETED|Overall Study||14
2356981|NCT01627860|5783060|P1|COMPLETED|Overall Study||23
2356982|NCT01627860|5783059|P2|STARTED|Overall Study||20
2356983|NCT01627860|5783060|P1|STARTED|Overall Study||35
2356984|NCT01627782|5783074|P4|NOT COMPLETED|Overall Study||6
2356985|NCT01627782|5783075|P3|NOT COMPLETED|Overall Study||15
2356986|NCT01627782|5783076|P2|NOT COMPLETED|Overall Study||6
2356987|NCT01627782|5783077|P1|NOT COMPLETED|Overall Study||16
2356988|NCT01627782|5783074|P4|COMPLETED|Overall Study||11
2356989|NCT01627782|5783075|P3|COMPLETED|Overall Study||1
2356990|NCT01627782|5783076|P2|COMPLETED|Overall Study||12
2356991|NCT01627782|5783077|P1|COMPLETED|Overall Study||1
2356992|NCT01627782|5783074|P4|Treated|Overall Study||17
2356993|NCT01627782|5783075|P3|Treated|Overall Study||16
2356994|NCT01627782|5783076|P2|Treated|Overall Study||18
2356995|NCT01627782|5783077|P1|Treated|Overall Study||16
2356996|NCT01627782|5783074|P4|STARTED|Overall Study||17
2356997|NCT01627782|5783075|P3|STARTED|Overall Study||16
2356998|NCT01627782|5783076|P2|STARTED|Overall Study||18
2356999|NCT01627782|5783077|P1|STARTED|Overall Study||17
2357000|NCT01627691|5783133|P1|NOT COMPLETED|Overall Study||18
2357001|NCT01627691|5783133|P1|COMPLETED|Overall Study||232
2357002|NCT01627691|5783133|P1|Primary Endpoint (30days)|Overall Study||239
2357003|NCT01627691|5783133|P1|STARTED|Overall Study||250
2357004|NCT01627561|5783140|P2|NOT COMPLETED|Overall Study||3
2357005|NCT01627561|5783141|P1|NOT COMPLETED|Overall Study||0
2357006|NCT01627561|5783140|P2|COMPLETED|Overall Study||71
2357007|NCT01627561|5783141|P1|COMPLETED|Overall Study||74
2357008|NCT01627561|5783140|P2|STARTED|Overall Study||74
2357009|NCT01627561|5783141|P1|STARTED|Overall Study||74
2357010|NCT01627340|5783189|P2|NOT COMPLETED|Overall Study||4
2357011|NCT01627340|5783190|P1|NOT COMPLETED|Overall Study||12
2357012|NCT01627340|5783189|P2|COMPLETED|Overall Study||254
2357013|NCT01627340|5783190|P1|COMPLETED|Overall Study||404
2357014|NCT01627340|5783189|P2|STARTED|Overall Study||258
2357015|NCT01627340|5783190|P1|STARTED|Overall Study||416
2357016|NCT01627327|5783208|P2|NOT COMPLETED|Overall Study||39
2357017|NCT01627327|5783209|P1|NOT COMPLETED|Overall Study||19
2357018|NCT01627327|5783208|P2|COMPLETED|Overall Study||274
2357019|NCT01627327|5783209|P1|COMPLETED|Overall Study||291
2357020|NCT01627327|5783208|P2|STARTED|Overall Study||313
2357021|NCT01627327|5783209|P1|STARTED|Overall Study||310
2357022|NCT01627249|5783222|P3|NOT COMPLETED|Overall Study||12
2357023|NCT01627249|5783223|P2|NOT COMPLETED|Overall Study||12
2357024|NCT01627249|5783224|P1|NOT COMPLETED|Overall Study||16
2357025|NCT01627249|5783222|P3|COMPLETED|Overall Study||206
2357026|NCT01627249|5783223|P2|COMPLETED|Overall Study||206
2357027|NCT01627249|5783224|P1|COMPLETED|Overall Study||208
2357028|NCT01627249|5783222|P3|STARTED|Overall Study||218
2357029|NCT01627249|5783223|P2|STARTED|Overall Study||218
2357030|NCT01627249|5783224|P1|STARTED|Overall Study||224
2357031|NCT01627002|5783261|P9|NOT COMPLETED|Overall Study||0
2357032|NCT01627002|5783262|P8|NOT COMPLETED|Overall Study||0
2357033|NCT01627002|5783263|P7|NOT COMPLETED|Overall Study||0
2357034|NCT01627002|5783264|P6|NOT COMPLETED|Overall Study||0
2357035|NCT01627002|5783265|P5|NOT COMPLETED|Overall Study||0
2357036|NCT01627002|5783266|P4|NOT COMPLETED|Overall Study||0
2357037|NCT01627002|5783267|P3|NOT COMPLETED|Overall Study||0
2357038|NCT01627002|5783268|P2|NOT COMPLETED|Overall Study||0
2357039|NCT01627002|5783269|P1|NOT COMPLETED|Overall Study||0
2357040|NCT01627002|5783261|P9|COMPLETED|Overall Study||7
2357041|NCT01627002|5783262|P8|COMPLETED|Overall Study||5
2357042|NCT01627002|5783263|P7|COMPLETED|Overall Study||10
2357043|NCT01627002|5783264|P6|COMPLETED|Overall Study||9
2357044|NCT01627002|5783265|P5|COMPLETED|Overall Study||2
2357045|NCT01627002|5783266|P4|COMPLETED|Overall Study||4
2357046|NCT01627002|5783267|P3|COMPLETED|Overall Study||4
2357047|NCT01627002|5783268|P2|COMPLETED|Overall Study||4
2357048|NCT01627002|5783269|P1|COMPLETED|Overall Study||4
2357049|NCT01627002|5783261|P9|STARTED|Overall Study||7
2357050|NCT01627002|5783262|P8|STARTED|Overall Study||5
2357051|NCT01627002|5783263|P7|STARTED|Overall Study||10
2357052|NCT01627002|5783264|P6|STARTED|Overall Study||9
2357053|NCT01627002|5783265|P5|STARTED|Overall Study||2
2357054|NCT01627002|5783266|P4|STARTED|Overall Study||4
2357055|NCT01627002|5783267|P3|STARTED|Overall Study||4
2357056|NCT01627002|5783268|P2|STARTED|Overall Study||4
2357057|NCT01627002|5783269|P1|STARTED|Overall Study||4
2357058|NCT01626989|5783320|P3|NOT COMPLETED|Second Intervention (Night 2)||0
2357059|NCT01626989|5783321|P2|NOT COMPLETED|Second Intervention (Night 2)||0
2357060|NCT01626989|5783322|P1|NOT COMPLETED|Second Intervention (Night 2)||0
2357061|NCT01626989|5783320|P3|COMPLETED|Second Intervention (Night 2)||12
2357062|NCT01626989|5783321|P2|COMPLETED|Second Intervention (Night 2)||15
2357063|NCT01626989|5783322|P1|COMPLETED|Second Intervention (Night 2)||0
2357064|NCT01626989|5783320|P3|STARTED|Second Intervention (Night 2)||12
2357065|NCT01626989|5783321|P2|STARTED|Second Intervention (Night 2)||15
2357066|NCT01626989|5783322|P1|STARTED|Second Intervention (Night 2)||0
2357067|NCT01626989|5783320|P3|NOT COMPLETED|Fist Intervention (Night 1)||0
2357068|NCT01626989|5783321|P2|NOT COMPLETED|Fist Intervention (Night 1)||0
2357069|NCT01626989|5783322|P1|NOT COMPLETED|Fist Intervention (Night 1)||0
2357070|NCT01626989|5783320|P3|COMPLETED|Fist Intervention (Night 1)||12
2357071|NCT01626989|5783321|P2|COMPLETED|Fist Intervention (Night 1)||15
2357072|NCT01626989|5783322|P1|COMPLETED|Fist Intervention (Night 1)||0
2357073|NCT01626989|5783320|P3|STARTED|Fist Intervention (Night 1)||12
2357074|NCT01626989|5783321|P2|STARTED|Fist Intervention (Night 1)||15
2357075|NCT01626989|5783322|P1|STARTED|Fist Intervention (Night 1)||0
2357076|NCT01626989|5783320|P3|NOT COMPLETED|Screening Period||0
2357077|NCT01626989|5783321|P2|NOT COMPLETED|Screening Period||0
2357078|NCT01626989|5783322|P1|NOT COMPLETED|Screening Period||17
2357079|NCT01626989|5783320|P3|COMPLETED|Screening Period||0
2357080|NCT01626989|5783321|P2|COMPLETED|Screening Period||0
2357081|NCT01626989|5783322|P1|COMPLETED|Screening Period||27
2357082|NCT01626989|5783320|P3|STARTED|Screening Period||0
2357083|NCT01626989|5783321|P2|STARTED|Screening Period||0
2357084|NCT01626989|5783322|P1|STARTED|Screening Period||44
2357085|NCT01626820|5783371|P2|NOT COMPLETED|Overall Study||0
2357086|NCT01626820|5783372|P1|NOT COMPLETED|Overall Study||0
2357087|NCT01626820|5783371|P2|COMPLETED|Overall Study||57
2357088|NCT01626820|5783372|P1|COMPLETED|Overall Study||56
2357089|NCT01626820|5783371|P2|STARTED|Overall Study||57
2357090|NCT01626820|5783372|P1|STARTED|Overall Study||56
2357091|NCT01626690|5783394|P2|NOT COMPLETED|Overall Study||0
2357092|NCT01626690|5783395|P1|NOT COMPLETED|Overall Study||2
2357093|NCT01626690|5783394|P2|COMPLETED|Overall Study||51
2357094|NCT01626690|5783395|P1|COMPLETED|Overall Study||47
2357095|NCT01626690|5783394|P2|STARTED|Overall Study||51
2357096|NCT01626690|5783395|P1|STARTED|Overall Study||49
2357097|NCT01626664|5783417|P3|NOT COMPLETED|Crossover Period||0
2357098|NCT01626664|5783418|P2|NOT COMPLETED|Crossover Period||0
2357099|NCT01626664|5783419|P1|NOT COMPLETED|Crossover Period||0
2357100|NCT01626664|5783417|P3|COMPLETED|Crossover Period||18
2357101|NCT01626664|5783418|P2|COMPLETED|Crossover Period||0
2357102|NCT01626664|5783419|P1|COMPLETED|Crossover Period||0
2357103|NCT01626664|5783417|P3|STARTED|Crossover Period||18
2357104|NCT01626664|5783418|P2|STARTED|Crossover Period||0
2357105|NCT01626664|5783419|P1|STARTED|Crossover Period||0
2357106|NCT01626664|5783417|P3|NOT COMPLETED|Randomization Period||0
2357107|NCT01626664|5783418|P2|NOT COMPLETED|Randomization Period||0
2357108|NCT01626664|5783419|P1|NOT COMPLETED|Randomization Period||0
2357109|NCT01626664|5783417|P3|COMPLETED|Randomization Period||0
2357110|NCT01626664|5783418|P2|COMPLETED|Randomization Period||24
2357111|NCT01626664|5783419|P1|COMPLETED|Randomization Period||47
2357112|NCT01626664|5783417|P3|STARTED|Randomization Period||0
2357113|NCT01626664|5783418|P2|STARTED|Randomization Period||24
2357114|NCT01626664|5783419|P1|STARTED|Randomization Period||47
2357115|NCT01626456|5783434|P2|NOT COMPLETED|Overall Study||117
2357116|NCT01626456|5783435|P1|NOT COMPLETED|Overall Study||35
2357117|NCT01626456|5783434|P2|COMPLETED|Overall Study||251
2357118|NCT01626456|5783435|P1|COMPLETED|Overall Study||75
2357119|NCT01626456|5783434|P2|STARTED|Overall Study||368
2357120|NCT01626456|5783435|P1|STARTED|Overall Study||110
2357121|NCT01626391|5783465|P2|NOT COMPLETED|Overall Study||0
2357122|NCT01626391|5783466|P1|NOT COMPLETED|Overall Study||2
2357123|NCT01626391|5783465|P2|COMPLETED|Overall Study||4
2357124|NCT01626391|5783466|P1|COMPLETED|Overall Study||3
2357125|NCT01626391|5783465|P2|STARTED|Overall Study||4
2357126|NCT01626391|5783466|P1|STARTED|Overall Study||5
2357127|NCT01626352|5783472|P1|NOT COMPLETED|Overall Study||10
2357128|NCT01626352|5783472|P1|COMPLETED|Overall Study||12
2357129|NCT01626352|5783472|P1|STARTED|Overall Study||22
2357130|NCT01626118|5783486|P4|NOT COMPLETED|Overall Study||3
2357131|NCT01626118|5783487|P3|NOT COMPLETED|Overall Study||2
2357132|NCT01626118|5783488|P2|NOT COMPLETED|Overall Study||2
2357133|NCT01626118|5783489|P1|NOT COMPLETED|Overall Study||2
2357134|NCT01626118|5783486|P4|COMPLETED|Overall Study||91
2357135|NCT01626118|5783487|P3|COMPLETED|Overall Study||90
2357136|NCT01626118|5783488|P2|COMPLETED|Overall Study||91
2357137|NCT01626118|5783489|P1|COMPLETED|Overall Study||92
2357138|NCT01626118|5783486|P4|STARTED|Overall Study||94
2357139|NCT01626118|5783487|P3|STARTED|Overall Study||92
2357140|NCT01626118|5783488|P2|STARTED|Overall Study||93
2357141|NCT01626118|5783489|P1|STARTED|Overall Study||94
2357142|NCT01626092|5783527|P1|NOT COMPLETED|Overall Study||0
2357143|NCT01626092|5783527|P1|COMPLETED|Overall Study||3
2357144|NCT01626092|5783527|P1|STARTED|Overall Study||3
2357145|NCT01625988|5783535|P2|NOT COMPLETED|Overall Study||13
2357146|NCT01625988|5783536|P1|NOT COMPLETED|Overall Study||14
2357147|NCT01625988|5783535|P2|COMPLETED|Overall Study||97
2357148|NCT01625988|5783536|P1|COMPLETED|Overall Study||94
2357149|NCT01625988|5783535|P2|Received at Least One Dose of Study Drug|Overall Study||110
2357150|NCT01625988|5783536|P1|Received at Least One Dose of Study Drug|Overall Study||107
2357151|NCT01625988|5783535|P2|STARTED|Overall Study||110
2357152|NCT01625988|5783536|P1|STARTED|Overall Study|One participant was randomized inappropriately and was discontinued before start of study treatment.|108
2357153|NCT01625923|5783550|P1|NOT COMPLETED|Overall Study||0
2357154|NCT01625923|5783550|P1|COMPLETED|Overall Study||3
2357155|NCT01625923|5783550|P1|STARTED|Overall Study||3
2357156|NCT01625910|5783560|P2|NOT COMPLETED|Overall Study||4
2357157|NCT01625910|5783561|P1|NOT COMPLETED|Overall Study||3
2357158|NCT01625910|5783560|P2|COMPLETED|Overall Study||33
2357159|NCT01625910|5783561|P1|COMPLETED|Overall Study||32
2357160|NCT01625910|5783560|P2|STARTED|Overall Study||37
2357161|NCT01625910|5783561|P1|STARTED|Overall Study||35
2357162|NCT01625845|5783571|P2|NOT COMPLETED|Overall Study||3
2357163|NCT01625845|5783572|P1|NOT COMPLETED|Overall Study||5
2357164|NCT01625845|5783571|P2|COMPLETED|Overall Study||3
2357165|NCT01625845|5783572|P1|COMPLETED|Overall Study||5
2357166|NCT01625845|5783571|P2|STARTED|Overall Study||6
2357167|NCT01625845|5783572|P1|STARTED|Overall Study||10
2357168|NCT01625689|5783592|P2|NOT COMPLETED|Overall Study||1
2357169|NCT01625689|5783593|P1|NOT COMPLETED|Overall Study||2
2357170|NCT01625689|5783592|P2|COMPLETED|Overall Study||149
2357171|NCT01625689|5783593|P1|COMPLETED|Overall Study||148
2357172|NCT01625689|5783592|P2|STARTED|Overall Study||150
2357173|NCT01625689|5783593|P1|STARTED|Overall Study||150
2357174|NCT01625507|5783603|P1|NOT COMPLETED|Overall Study||10
2357175|NCT01625507|5783603|P1|COMPLETED|Overall Study||63
2357176|NCT01625507|5783603|P1|STARTED|Overall Study||73
2357177|NCT01625455|5783618|P2|NOT COMPLETED|Overall Study||0
2357178|NCT01625455|5783619|P1|NOT COMPLETED|Overall Study||0
2357179|NCT01625455|5783618|P2|COMPLETED|Overall Study||3
2357180|NCT01625455|5783619|P1|COMPLETED|Overall Study||2
2357181|NCT01625455|5783618|P2|STARTED|Overall Study||3
2357182|NCT01625455|5783619|P1|STARTED|Overall Study||2
2357183|NCT01625416|5783629|P2|NOT COMPLETED|Overall Study||7
2357184|NCT01625416|5783630|P1|NOT COMPLETED|Overall Study||9
2357185|NCT01625416|5783629|P2|COMPLETED|Overall Study||54
2357186|NCT01625416|5783630|P1|COMPLETED|Overall Study||51
2357187|NCT01625416|5783629|P2|STARTED|Overall Study||61
2357188|NCT01625416|5783630|P1|STARTED|Overall Study||60
2357189|NCT01625377|5783648|P2|NOT COMPLETED|Overall Study||22
2357190|NCT01625377|5783649|P1|NOT COMPLETED|Overall Study||7
2357191|NCT01625377|5783648|P2|COMPLETED|Overall Study||71
2357192|NCT01625377|5783649|P1|COMPLETED|Overall Study||88
2357193|NCT01625377|5783648|P2|Intent to Treat Population|Overall Study||90
2357194|NCT01625377|5783649|P1|Intent to Treat Population|Overall Study||93
2357195|NCT01625377|5783648|P2|Safety Set of Population|Overall Study||90
2357196|NCT01625377|5783649|P1|Safety Set of Population|Overall Study||94
2357197|NCT01625377|5783648|P2|STARTED|Overall Study||93
2357198|NCT01625377|5783649|P1|STARTED|Overall Study|"Started indicates randomized patients."|95
2357199|NCT01625338|5783682|P3|NOT COMPLETED|Overall Study||39
2357200|NCT01625338|5783683|P2|NOT COMPLETED|Overall Study||44
2357201|NCT01625338|5783684|P1|NOT COMPLETED|Overall Study||32
2357202|NCT01625338|5783682|P3|COMPLETED|Overall Study||181
2357203|NCT01625338|5783683|P2|COMPLETED|Overall Study||156
2357204|NCT01625338|5783684|P1|COMPLETED|Overall Study||82
2357205|NCT01625338|5783682|P3|STARTED|Overall Study||220
2357206|NCT01625338|5783683|P2|STARTED|Overall Study||200
2357207|NCT01625338|5783684|P1|STARTED|Overall Study||114
2357208|NCT01625286|5783711|P7|NOT COMPLETED|Overall Study||56
2357209|NCT01625286|5783712|P6|NOT COMPLETED|Overall Study||54
2357210|NCT01625286|5783713|P5|NOT COMPLETED|Overall Study||6
2357211|NCT01625286|5783714|P4|NOT COMPLETED|Overall Study||7
2357212|NCT01625286|5783715|P3|NOT COMPLETED|Overall Study||5
2357213|NCT01625286|5783716|P2|NOT COMPLETED|Overall Study||8
2357214|NCT01625286|5783717|P1|NOT COMPLETED|Overall Study||12
2357215|NCT01625286|5783711|P7|COMPLETED|Overall Study||0
2357216|NCT01625286|5783712|P6|COMPLETED|Overall Study||0
2357217|NCT01625286|5783713|P5|COMPLETED|Overall Study||0
2357218|NCT01625286|5783714|P4|COMPLETED|Overall Study||0
2357219|NCT01625286|5783715|P3|COMPLETED|Overall Study||0
2357220|NCT01625286|5783716|P2|COMPLETED|Overall Study||0
2357221|NCT01625286|5783717|P1|COMPLETED|Overall Study||0
2357222|NCT01625286|5783711|P7|Did Not Receive AZD5363/Placebo Trt|Overall Study||1
2357223|NCT01625286|5783712|P6|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
2357224|NCT01625286|5783713|P5|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
2357225|NCT01625286|5783714|P4|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
2357226|NCT01625286|5783715|P3|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
2357227|NCT01625286|5783716|P2|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
2357228|NCT01625286|5783717|P1|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
2357229|NCT01625286|5783711|P7|Received AZD5363/Placebo Treatment|Overall Study||55
2357230|NCT01625286|5783712|P6|Received AZD5363/Placebo Treatment|Overall Study||54
2357231|NCT01625286|5783713|P5|Received AZD5363/Placebo Treatment|Overall Study||6
2357232|NCT01625286|5783714|P4|Received AZD5363/Placebo Treatment|Overall Study||7
2357233|NCT01625286|5783715|P3|Received AZD5363/Placebo Treatment|Overall Study||5
2357234|NCT01625286|5783716|P2|Received AZD5363/Placebo Treatment|Overall Study||8
2357235|NCT01625286|5783717|P1|Received AZD5363/Placebo Treatment|Overall Study||12
2357236|NCT01625286|5783711|P7|STARTED|Overall Study||56
2357237|NCT01625286|5783712|P6|STARTED|Overall Study||54
2357238|NCT01625286|5783713|P5|STARTED|Overall Study||6
2357239|NCT01625286|5783714|P4|STARTED|Overall Study||7
2357240|NCT01625286|5783715|P3|STARTED|Overall Study||5
2357241|NCT01625286|5783716|P2|STARTED|Overall Study||8
2357242|NCT01625286|5783717|P1|STARTED|Overall Study||12
2357243|NCT01625221|5783796|P1|NOT COMPLETED|Overall Study||7
2357244|NCT01625221|5783796|P1|COMPLETED|Overall Study||28
2357245|NCT01625221|5783796|P1|STARTED|Overall Study||35
2357246|NCT01625182|5783803|P2|NOT COMPLETED|Overall Study||11
2357247|NCT01625182|5783804|P1|NOT COMPLETED|Overall Study||20
2357248|NCT01625182|5783803|P2|COMPLETED|Overall Study||41
2357249|NCT01625182|5783804|P1|COMPLETED|Overall Study||34
2357250|NCT01625182|5783803|P2|STARTED|Overall Study||52
2357251|NCT01625182|5783804|P1|STARTED|Overall Study||54
2357252|NCT01625169|5783817|P1|NOT COMPLETED|Overall Study||0
2357253|NCT01625169|5783817|P1|COMPLETED|Overall Study||9
2357254|NCT01625169|5783817|P1|STARTED|Overall Study||9
2357255|NCT01625104|5783832|P2|NOT COMPLETED|Overall Study||0
2357256|NCT01625104|5783833|P1|NOT COMPLETED|Overall Study||0
2357257|NCT01625104|5783832|P2|COMPLETED|Overall Study||434
2357258|NCT01625104|5783833|P1|COMPLETED|Overall Study||448
2357259|NCT01625104|5783832|P2|STARTED|Overall Study||434
2357260|NCT01625104|5783833|P1|STARTED|Overall Study||448
2357261|NCT01625091|5783841|P2|NOT COMPLETED|Post-intervention||2
2357262|NCT01625091|5783842|P1|NOT COMPLETED|Post-intervention||4
2357263|NCT01625091|5783841|P2|COMPLETED|Post-intervention||85
2357264|NCT01625091|5783842|P1|COMPLETED|Post-intervention||81
2357265|NCT01625091|5783841|P2|7 Months|Post-intervention||85
2357266|NCT01625091|5783842|P1|7 Months|Post-intervention||81
2357267|NCT01625091|5783841|P2|STARTED|Post-intervention||87
2357268|NCT01625091|5783842|P1|STARTED|Post-intervention||85
2357269|NCT01625091|5783841|P2|NOT COMPLETED|Intervention||11
2357270|NCT01625091|5783842|P1|NOT COMPLETED|Intervention||11
2357271|NCT01625091|5783841|P2|COMPLETED|Intervention||87
2357272|NCT01625091|5783842|P1|COMPLETED|Intervention||85
2357273|NCT01625091|5783841|P2|4 Months|Intervention||87
2357274|NCT01625091|5783842|P1|4 Months|Intervention||85
2357275|NCT01625091|5783841|P2|2 Months|Intervention||93
2357276|NCT01625091|5783842|P1|2 Months|Intervention||90
2357277|NCT01625091|5783841|P2|STARTED|Intervention||98
2357278|NCT01625091|5783842|P1|STARTED|Intervention||96
2357279|NCT01624974|5783856|P2|NOT COMPLETED|Period V of Treatment (4 Weeks)||0
2357280|NCT01624974|5783857|P1|NOT COMPLETED|Period V of Treatment (4 Weeks)||5
2357281|NCT01624974|5783856|P2|COMPLETED|Period V of Treatment (4 Weeks)||42
2357282|NCT01624974|5783857|P1|COMPLETED|Period V of Treatment (4 Weeks)||39
2357283|NCT01624974|5783856|P2|STARTED|Period V of Treatment (4 Weeks)||42
2357284|NCT01624974|5783857|P1|STARTED|Period V of Treatment (4 Weeks)||44
2357285|NCT01624974|5783856|P2|NOT COMPLETED|Period IV Washout (4 Weeks)||3
2357286|NCT01624974|5783857|P1|NOT COMPLETED|Period IV Washout (4 Weeks)||3
2357287|NCT01624974|5783856|P2|COMPLETED|Period IV Washout (4 Weeks)||42
2357288|NCT01624974|5783857|P1|COMPLETED|Period IV Washout (4 Weeks)||44
2357289|NCT01624974|5783856|P2|STARTED|Period IV Washout (4 Weeks)||45
2357290|NCT01624974|5783857|P1|STARTED|Period IV Washout (4 Weeks)||47
2357291|NCT01624974|5783856|P2|NOT COMPLETED|Period III of Treatment (4 Weeks)||8
2357292|NCT01624974|5783857|P1|NOT COMPLETED|Period III of Treatment (4 Weeks)||7
2357293|NCT01624974|5783856|P2|COMPLETED|Period III of Treatment (4 Weeks)||45
2357294|NCT01624974|5783857|P1|COMPLETED|Period III of Treatment (4 Weeks)||47
2357295|NCT01624974|5783856|P2|STARTED|Period III of Treatment (4 Weeks)||53
2357296|NCT01624974|5783857|P1|STARTED|Period III of Treatment (4 Weeks)||54
2357297|NCT01624948|5783881|P2|NOT COMPLETED|Overall Study||0
2357298|NCT01624948|5783882|P1|NOT COMPLETED|Overall Study||0
2357299|NCT01624948|5783881|P2|COMPLETED|Overall Study||20
2357300|NCT01624948|5783882|P1|COMPLETED|Overall Study||20
2357301|NCT01624948|5783881|P2|STARTED|Overall Study||20
2357302|NCT01624948|5783882|P1|STARTED|Overall Study||20
2357303|NCT01624870|5783898|P1|NOT COMPLETED|Overall Study||27
2357304|NCT01624870|5783898|P1|COMPLETED|Overall Study|Completed 6 month follow up|173
2357305|NCT01624870|5783898|P1|STARTED|Overall Study|provided informed consent|200
2357306|NCT01624740|5783906|P2|NOT COMPLETED|Second Intervention (3-4 Days)||0
2357307|NCT01624740|5783907|P1|NOT COMPLETED|Second Intervention (3-4 Days)||1
2357308|NCT01624740|5783906|P2|COMPLETED|Second Intervention (3-4 Days)||9
2357309|NCT01624740|5783907|P1|COMPLETED|Second Intervention (3-4 Days)||8
2357310|NCT01624740|5783906|P2|STARTED|Second Intervention (3-4 Days)||9
2357311|NCT01624740|5783907|P1|STARTED|Second Intervention (3-4 Days)||9
2357312|NCT01624740|5783906|P2|NOT COMPLETED|Washout (1 Hour)||0
2357313|NCT01624740|5783907|P1|NOT COMPLETED|Washout (1 Hour)||0
2357314|NCT01624740|5783906|P2|COMPLETED|Washout (1 Hour)||9
2357315|NCT01624740|5783907|P1|COMPLETED|Washout (1 Hour)||9
2357316|NCT01624740|5783906|P2|STARTED|Washout (1 Hour)||9
2357317|NCT01624740|5783907|P1|STARTED|Washout (1 Hour)||9
2357318|NCT01624740|5783906|P2|NOT COMPLETED|First Intervention (3-4 Days)||0
2357319|NCT01624740|5783907|P1|NOT COMPLETED|First Intervention (3-4 Days)||0
2357320|NCT01624740|5783906|P2|COMPLETED|First Intervention (3-4 Days)||9
2357321|NCT01624740|5783907|P1|COMPLETED|First Intervention (3-4 Days)||9
2357322|NCT01624740|5783906|P2|STARTED|First Intervention (3-4 Days)||9
2357323|NCT01624740|5783907|P1|STARTED|First Intervention (3-4 Days)||9
2357324|NCT01624662|5783918|P4|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
2357325|NCT01624662|5783919|P3|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
2357326|NCT01624662|5783920|P2|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
2357327|NCT01624662|5783921|P1|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
2357328|NCT01624662|5783918|P4|COMPLETED|Open-Label Extension Phase (Wks 17-24)||78
2357329|NCT01624662|5783919|P3|COMPLETED|Open-Label Extension Phase (Wks 17-24)||71
2357330|NCT01624662|5783920|P2|COMPLETED|Open-Label Extension Phase (Wks 17-24)||76
2357331|NCT01624662|5783921|P1|COMPLETED|Open-Label Extension Phase (Wks 17-24)||69
2357332|NCT01624662|5783918|P4|STARTED|Open-Label Extension Phase (Wks 17-24)||79
2357333|NCT01624662|5783919|P3|STARTED|Open-Label Extension Phase (Wks 17-24)||72
2357334|NCT01624662|5783920|P2|STARTED|Open-Label Extension Phase (Wks 17-24)||78
2357335|NCT01624662|5783921|P1|STARTED|Open-Label Extension Phase (Wks 17-24)||70
2357336|NCT01624662|5783918|P4|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||0
2357337|NCT01624662|5783919|P3|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||4
2357338|NCT01624662|5783920|P2|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||3
2357339|NCT01624662|5783921|P1|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||10
2357340|NCT01624662|5783918|P4|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||82
2357341|NCT01624662|5783919|P3|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||76
2357342|NCT01624662|5783920|P2|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||78
2357343|NCT01624662|5783921|P1|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||70
2357344|NCT01624662|5783918|P4|STARTED|Double-Blind Treatment Phase (Wks 1-16)||82
2357345|NCT01624662|5783919|P3|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
2357346|NCT01624662|5783920|P2|STARTED|Double-Blind Treatment Phase (Wks 1-16)||81
2357347|NCT01624662|5783921|P1|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
2357348|NCT01624467|5783992|P1|NOT COMPLETED|Overall Study||31
2357349|NCT01624467|5783992|P1|COMPLETED|Overall Study||44
2357350|NCT01624467|5783992|P1|Received at Least One Dose of Study Drug|Overall Study||75
2357351|NCT01624467|5783992|P1|STARTED|Overall Study||75
2357352|NCT01624363|5784005|P1|NOT COMPLETED|Overall Study||0
2357353|NCT01624363|5784005|P1|COMPLETED|Overall Study||341
2357354|NCT01624363|5784005|P1|STARTED|Overall Study||341
2357355|NCT01624350|5784009|P1|NOT COMPLETED|Overall Study||25
2357356|NCT01624350|5784009|P1|COMPLETED|Overall Study||75
2357357|NCT01624350|5784009|P1|STARTED|Overall Study||100
2357358|NCT01624259|5784031|P2|NOT COMPLETED|Overall Study||31
2357359|NCT01624259|5784032|P1|NOT COMPLETED|Overall Study||30
2357360|NCT01624259|5784031|P2|COMPLETED|Overall Study|Completed the study on study treatment|269
2357361|NCT01624259|5784032|P1|COMPLETED|Overall Study|Completed the study on study treatment|269
2357362|NCT01624259|5784031|P2|Received at Least One Dose of Study Drug|Overall Study||300
2357363|NCT01624259|5784032|P1|Received at Least One Dose of Study Drug|Overall Study||299
2357364|NCT01624259|5784031|P2|STARTED|Overall Study||300
2357365|NCT01624259|5784032|P1|STARTED|Overall Study||299
2357366|NCT01624233|5784081|P1|NOT COMPLETED|Period 6: Follow-up||9
2357367|NCT01624233|5784081|P1|COMPLETED|Period 6: Follow-up||79
2357368|NCT01624233|5784081|P1|STARTED|Period 6: Follow-up|Period 6 included participants received a dose of drug and exhibited the required neutrophil count.|88
2357369|NCT01624233|5784081|P1|NOT COMPLETED|Period 5 - Retreatment Period||10
2357370|NCT01624233|5784081|P1|COMPLETED|Period 5 - Retreatment Period||70
2357371|NCT01624233|5784081|P1|STARTED|Period 5 - Retreatment Period|Period 5 included (participants with erythrodermic Ps or pustular Ps) or Period 4 completers.|80
2357372|NCT01624233|5784081|P1|NOT COMPLETED|Period 4 - Drug Free Period||61
2357373|NCT01624233|5784081|P1|COMPLETED|Period 4 - Drug Free Period||9
2357374|NCT01624233|5784081|P1|Physician Decision|Period 4 - Drug Free Period|1 participant who discontinued due to physician decision is included in the participants relapsed.|1
2357375|NCT01624233|5784081|P1|Adverse Event|Period 4 - Drug Free Period|1 participant who discontinued due to adverse event is included in the participants who relapsed.|1
2357376|NCT01624233|5784081|P1|STARTED|Period 4 - Drug Free Period|Only responders in participants with plaque Ps moved to the Drug Free Period 4.|70
2357377|NCT01624233|5784081|P1|NOT COMPLETED|Period 3 - Maintenance||7
2357378|NCT01624233|5784081|P1|COMPLETED|Period 3 - Maintenance||83
2357379|NCT01624233|5784081|P1|Received at Least 1 Dose of Study Drug|Period 3 - Maintenance||90
2357380|NCT01624233|5784081|P1|STARTED|Period 3 - Maintenance||90
2357381|NCT01624233|5784081|P1|NOT COMPLETED|Period 2 - Induction||1
2357382|NCT01624233|5784081|P1|COMPLETED|Period 2 - Induction||90
2357383|NCT01624233|5784081|P1|Plaque Ps|Period 2 - Induction||78
2357384|NCT01624233|5784081|P1|Pustular Ps|Period 2 - Induction||5
2357385|NCT01624233|5784081|P1|Erythrodermic Psoriasis (Ps)|Period 2 - Induction||8
2357386|NCT01624233|5784081|P1|Received at Least 1 Dose of Study Drug|Period 2 - Induction||91
2357387|NCT01624233|5784081|P1|STARTED|Period 2 - Induction||91
2357388|NCT01624194|5784113|P2|NOT COMPLETED|Overall Study||0
2357389|NCT01624194|5784114|P1|NOT COMPLETED|Overall Study||2
2357390|NCT01624194|5784113|P2|COMPLETED|Overall Study||18
2357391|NCT01624194|5784114|P1|COMPLETED|Overall Study||14
2357392|NCT01624194|5784113|P2|STARTED|Overall Study||18
2357393|NCT01624194|5784114|P1|STARTED|Overall Study||16
2357394|NCT01624168|5784155|P3|NOT COMPLETED|Overall Study||6
2357395|NCT01624168|5784156|P2|NOT COMPLETED|Overall Study||12
2357396|NCT01624168|5784157|P1|NOT COMPLETED|Overall Study||4
2357397|NCT01624168|5784155|P3|COMPLETED|Overall Study||22
2357398|NCT01624168|5784156|P2|COMPLETED|Overall Study||16
2357399|NCT01624168|5784157|P1|COMPLETED|Overall Study||15
2357400|NCT01624168|5784155|P3|STARTED|Overall Study||28
2357401|NCT01624168|5784156|P2|STARTED|Overall Study||28
2357402|NCT01624168|5784157|P1|STARTED|Overall Study||19
2357403|NCT01624142|5784182|P2|NOT COMPLETED|Overall Study||16
2357404|NCT01624142|5784183|P1|NOT COMPLETED|Overall Study||32
2357405|NCT01624142|5784182|P2|COMPLETED|Overall Study||178
2357406|NCT01624142|5784183|P1|COMPLETED|Overall Study||74
2357407|NCT01624142|5784182|P2|STARTED|Overall Study||194
2357408|NCT01624142|5784183|P1|STARTED|Overall Study||106
2357409|NCT01624090|5784208|P4|NOT COMPLETED|Overall Study||0
2357410|NCT01624090|5784209|P3|NOT COMPLETED|Overall Study||7
2357411|NCT01624090|5784210|P2|NOT COMPLETED|Overall Study||2
2357412|NCT01624090|5784211|P1|NOT COMPLETED|Overall Study||0
2357413|NCT01624090|5784208|P4|COMPLETED|Overall Study||2
2357414|NCT01624090|5784209|P3|COMPLETED|Overall Study||3
2357415|NCT01624090|5784210|P2|COMPLETED|Overall Study||0
2357416|NCT01624090|5784211|P1|COMPLETED|Overall Study||2
2357417|NCT01624090|5784208|P4|STARTED|Overall Study||2
2357418|NCT01624090|5784209|P3|STARTED|Overall Study||10
2357419|NCT01624090|5784210|P2|STARTED|Overall Study||2
2357420|NCT01624090|5784211|P1|STARTED|Overall Study||2
2357421|NCT01623869|5784225|P1|NOT COMPLETED|Overall Study||0
2357422|NCT01623869|5784225|P1|COMPLETED|Overall Study||16
2357423|NCT01623869|5784225|P1|STARTED|Overall Study||16
2357424|NCT01623830|5784233|P2|NOT COMPLETED|Overall Study||9
2357425|NCT01623830|5784234|P1|NOT COMPLETED|Overall Study||7
2357426|NCT01623830|5784233|P2|COMPLETED|Overall Study||35
2357427|NCT01623830|5784234|P1|COMPLETED|Overall Study||38
2357428|NCT01623830|5784233|P2|STARTED|Overall Study||44
2357429|NCT01623830|5784234|P1|STARTED|Overall Study||45
2357430|NCT01623752|5784251|P3|NOT COMPLETED|Phase 2 (78 Weeks)||0
2357431|NCT01623752|5784252|P2|NOT COMPLETED|Phase 2 (78 Weeks)||18
2357432|NCT01623752|5784253|P1|NOT COMPLETED|Phase 2 (78 Weeks)||66
2357433|NCT01623752|5784251|P3|COMPLETED|Phase 2 (78 Weeks)||0
2357434|NCT01623752|5784252|P2|COMPLETED|Phase 2 (78 Weeks)||98
2357435|NCT01623752|5784253|P1|COMPLETED|Phase 2 (78 Weeks)||225
2357436|NCT01623752|5784251|P3|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|0
2357437|NCT01623752|5784252|P2|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|116
2357438|NCT01623752|5784253|P1|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|291
2357439|NCT01623752|5784251|P3|NOT COMPLETED|Phase 1 (78 Weeks)||2
2357440|NCT01623752|5784252|P2|NOT COMPLETED|Phase 1 (78 Weeks)||207
2357441|NCT01623752|5784253|P1|NOT COMPLETED|Phase 1 (78 Weeks)||631
2357442|NCT01623752|5784251|P3|COMPLETED|Phase 1 (78 Weeks)||1
2357443|NCT01623752|5784252|P2|COMPLETED|Phase 1 (78 Weeks)||233
2357444|NCT01623752|5784253|P1|COMPLETED|Phase 1 (78 Weeks)||747
2357445|NCT01623752|5784251|P3|STARTED|Phase 1 (78 Weeks)||3
2357446|NCT01623752|5784252|P2|STARTED|Phase 1 (78 Weeks)||440
2357447|NCT01623752|5784253|P1|STARTED|Phase 1 (78 Weeks)||1378
2357448|NCT01623739|5784338|P2|NOT COMPLETED|Overall Study||4
2357449|NCT01623739|5784339|P1|NOT COMPLETED|Overall Study||2
2357450|NCT01623739|5784338|P2|COMPLETED|Overall Study||15
2357451|NCT01623739|5784339|P1|COMPLETED|Overall Study||17
2357452|NCT01623739|5784338|P2|STARTED|Overall Study||19
2357453|NCT01623739|5784339|P1|STARTED|Overall Study||19
2357454|NCT01623596|5784356|P2|NOT COMPLETED|Overall Study||100
2357455|NCT01623596|5784357|P1|NOT COMPLETED|Overall Study||62
2357456|NCT01623596|5784356|P2|COMPLETED|Overall Study||339
2357457|NCT01623596|5784357|P1|COMPLETED|Overall Study||374
2357458|NCT01623596|5784356|P2|On Switched Treatment|Overall Study||214
2357459|NCT01623596|5784357|P1|On Switched Treatment|Overall Study||22
2357460|NCT01623596|5784356|P2|On Randomized Treatment|Overall Study||125
2357461|NCT01623596|5784357|P1|On Randomized Treatment|Overall Study||352
2357462|NCT01623596|5784356|P2|STARTED|Overall Study||439
2357463|NCT01623596|5784357|P1|STARTED|Overall Study||436
2357464|NCT01623479|5784373|P1|NOT COMPLETED|Overall Study||0
2357465|NCT01623479|5784373|P1|COMPLETED|Overall Study||585
2357466|NCT01623479|5784373|P1|STARTED|Overall Study||585
2357467|NCT01623466|5784381|P2|NOT COMPLETED|Overall Study||0
2357468|NCT01623466|5784382|P1|NOT COMPLETED|Overall Study||1
2357469|NCT01623466|5784381|P2|COMPLETED|Overall Study||18
2357470|NCT01623466|5784382|P1|COMPLETED|Overall Study||17
2357471|NCT01623466|5784381|P2|STARTED|Overall Study||18
2357472|NCT01623466|5784382|P1|STARTED|Overall Study||18
2357473|NCT01623323|5784396|P1|NOT COMPLETED|Overall Study||104
2357474|NCT01623323|5784396|P1|COMPLETED|Overall Study||601
2357475|NCT01623323|5784396|P1|STARTED|Overall Study||705
2357476|NCT01623310|5784400|P1|NOT COMPLETED|Overall Study||79
2357477|NCT01623310|5784400|P1|COMPLETED|Overall Study||144
2357478|NCT01623310|5784400|P1|STARTED|Overall Study||223
2357479|NCT01623271|5784409|P1|NOT COMPLETED|Overall Study||2
2357480|NCT01623271|5784409|P1|COMPLETED|Overall Study||3
2357481|NCT01623271|5784409|P1|STARTED|Overall Study||5
2357482|NCT01623154|5784413|P1|NOT COMPLETED|Overall Study||4
2357483|NCT01623154|5784413|P1|COMPLETED|Overall Study||95
2357484|NCT01623154|5784413|P1|Available for Analysis|Overall Study||95
2357485|NCT01623154|5784413|P1|STARTED|Overall Study||99
2357486|NCT01623115|5784421|P2|NOT COMPLETED|Overall Study||77
2357487|NCT01623115|5784422|P1|NOT COMPLETED|Overall Study||33
2357488|NCT01623115|5784421|P2|COMPLETED|Overall Study||246
2357489|NCT01623115|5784422|P1|COMPLETED|Overall Study||130
2357490|NCT01623115|5784421|P2|Treated|Overall Study||322
2357491|NCT01623115|5784422|P1|Treated|Overall Study||163
2357492|NCT01623115|5784421|P2|STARTED|Overall Study|Randomized|323
2357493|NCT01623115|5784422|P1|STARTED|Overall Study|Randomized|163
2357494|NCT01623050|5784482|P1|NOT COMPLETED|Overall Study||9
2357495|NCT01623050|5784482|P1|COMPLETED|Overall Study||27
2357496|NCT01623050|5784482|P1|Treated|Overall Study||34
2357497|NCT01623050|5784482|P1|STARTED|Overall Study||36
2357498|NCT01622699|5784492|P2|NOT COMPLETED|Overall Study||0
2357499|NCT01622699|5784493|P1|NOT COMPLETED|Overall Study||0
2357500|NCT01622699|5784492|P2|COMPLETED|Overall Study||217
2357501|NCT01622699|5784493|P1|COMPLETED|Overall Study||213
2357502|NCT01622699|5784492|P2|STARTED|Overall Study||217
2357503|NCT01622699|5784493|P1|STARTED|Overall Study||213
2357504|NCT01622673|5784511|P6|NOT COMPLETED|Treatment Period 5||0
2357505|NCT01622673|5784512|P5|NOT COMPLETED|Treatment Period 5||0
2357506|NCT01622673|5784513|P4|NOT COMPLETED|Treatment Period 5||0
2357507|NCT01622673|5784514|P3|NOT COMPLETED|Treatment Period 5||0
2357508|NCT01622673|5784515|P2|NOT COMPLETED|Treatment Period 5||0
2357509|NCT01622673|5784516|P1|NOT COMPLETED|Treatment Period 5||0
2357510|NCT01622673|5784511|P6|COMPLETED|Treatment Period 5||4
2357511|NCT01622673|5784512|P5|COMPLETED|Treatment Period 5||4
2357512|NCT01622673|5784513|P4|COMPLETED|Treatment Period 5||4
2357513|NCT01622673|5784514|P3|COMPLETED|Treatment Period 5||4
2357514|NCT01622673|5784515|P2|COMPLETED|Treatment Period 5||3
2357515|NCT01622673|5784516|P1|COMPLETED|Treatment Period 5||4
2357516|NCT01622673|5784511|P6|STARTED|Treatment Period 5||4
2357517|NCT01622673|5784512|P5|STARTED|Treatment Period 5||4
2357518|NCT01622673|5784513|P4|STARTED|Treatment Period 5||4
2357519|NCT01622673|5784514|P3|STARTED|Treatment Period 5||4
2357520|NCT01622673|5784515|P2|STARTED|Treatment Period 5||3
2357521|NCT01622673|5784516|P1|STARTED|Treatment Period 5||4
2357522|NCT01622673|5784511|P6|NOT COMPLETED|Treatment Period 4||0
2357523|NCT01622673|5784512|P5|NOT COMPLETED|Treatment Period 4||0
2357524|NCT01622673|5784513|P4|NOT COMPLETED|Treatment Period 4||0
2357525|NCT01622673|5784514|P3|NOT COMPLETED|Treatment Period 4||0
2357526|NCT01622673|5784515|P2|NOT COMPLETED|Treatment Period 4||0
2357527|NCT01622673|5784516|P1|NOT COMPLETED|Treatment Period 4||0
2357528|NCT01622673|5784511|P6|COMPLETED|Treatment Period 4||4
2357529|NCT01622673|5784512|P5|COMPLETED|Treatment Period 4||4
2357530|NCT01622673|5784513|P4|COMPLETED|Treatment Period 4||4
2357531|NCT01622673|5784514|P3|COMPLETED|Treatment Period 4||4
2357532|NCT01622673|5784515|P2|COMPLETED|Treatment Period 4||3
2357533|NCT01622673|5784516|P1|COMPLETED|Treatment Period 4||4
2357534|NCT01622673|5784511|P6|STARTED|Treatment Period 4||4
2357535|NCT01622673|5784512|P5|STARTED|Treatment Period 4||4
2357536|NCT01622673|5784513|P4|STARTED|Treatment Period 4||4
2357537|NCT01622673|5784514|P3|STARTED|Treatment Period 4||4
2357538|NCT01622673|5784515|P2|STARTED|Treatment Period 4||3
2357539|NCT01622673|5784516|P1|STARTED|Treatment Period 4||4
2357540|NCT01622673|5784511|P6|NOT COMPLETED|Treatment Period 3||0
2357541|NCT01622673|5784512|P5|NOT COMPLETED|Treatment Period 3||0
2357542|NCT01622673|5784513|P4|NOT COMPLETED|Treatment Period 3||0
2357543|NCT01622673|5784514|P3|NOT COMPLETED|Treatment Period 3||0
2357544|NCT01622673|5784515|P2|NOT COMPLETED|Treatment Period 3||1
2357545|NCT01622673|5784516|P1|NOT COMPLETED|Treatment Period 3||0
2357546|NCT01622673|5784511|P6|COMPLETED|Treatment Period 3||4
2357547|NCT01622673|5784512|P5|COMPLETED|Treatment Period 3||4
2357548|NCT01622673|5784513|P4|COMPLETED|Treatment Period 3||4
2357549|NCT01622673|5784514|P3|COMPLETED|Treatment Period 3||4
2357550|NCT01622673|5784515|P2|COMPLETED|Treatment Period 3||3
2357551|NCT01622673|5784516|P1|COMPLETED|Treatment Period 3||4
2357552|NCT01622673|5784511|P6|STARTED|Treatment Period 3||4
2357553|NCT01622673|5784512|P5|STARTED|Treatment Period 3||4
2357554|NCT01622673|5784513|P4|STARTED|Treatment Period 3||4
2357555|NCT01622673|5784514|P3|STARTED|Treatment Period 3||4
2357556|NCT01622673|5784515|P2|STARTED|Treatment Period 3||4
2357557|NCT01622673|5784516|P1|STARTED|Treatment Period 3||4
2357558|NCT01622673|5784511|P6|NOT COMPLETED|Treatment Period 2||0
2357559|NCT01622673|5784512|P5|NOT COMPLETED|Treatment Period 2||0
2357560|NCT01622673|5784513|P4|NOT COMPLETED|Treatment Period 2||1
2357561|NCT01622673|5784514|P3|NOT COMPLETED|Treatment Period 2||0
2357562|NCT01622673|5784515|P2|NOT COMPLETED|Treatment Period 2||0
2357563|NCT01622673|5784516|P1|NOT COMPLETED|Treatment Period 2||0
2357564|NCT01622673|5784511|P6|COMPLETED|Treatment Period 2||4
2357565|NCT01622673|5784512|P5|COMPLETED|Treatment Period 2||4
2357566|NCT01622673|5784513|P4|COMPLETED|Treatment Period 2||4
2357567|NCT01622673|5784514|P3|COMPLETED|Treatment Period 2||4
2357568|NCT01622673|5784515|P2|COMPLETED|Treatment Period 2||4
2357569|NCT01622673|5784516|P1|COMPLETED|Treatment Period 2||4
2357570|NCT01622673|5784511|P6|STARTED|Treatment Period 2||4
2357571|NCT01622673|5784512|P5|STARTED|Treatment Period 2||4
2357572|NCT01622673|5784513|P4|STARTED|Treatment Period 2||5
2357573|NCT01622673|5784514|P3|STARTED|Treatment Period 2||4
2357574|NCT01622673|5784515|P2|STARTED|Treatment Period 2||4
2357575|NCT01622673|5784516|P1|STARTED|Treatment Period 2||4
2357576|NCT01622673|5784511|P6|NOT COMPLETED|Treatment Period 1||0
2357577|NCT01622673|5784512|P5|NOT COMPLETED|Treatment Period 1||0
2357578|NCT01622673|5784513|P4|NOT COMPLETED|Treatment Period 1||1
2357579|NCT01622673|5784514|P3|NOT COMPLETED|Treatment Period 1||0
2357580|NCT01622673|5784515|P2|NOT COMPLETED|Treatment Period 1||1
2357581|NCT01622673|5784516|P1|NOT COMPLETED|Treatment Period 1||0
2357582|NCT01622673|5784511|P6|COMPLETED|Treatment Period 1||4
2357583|NCT01622673|5784512|P5|COMPLETED|Treatment Period 1||4
2357584|NCT01622673|5784513|P4|COMPLETED|Treatment Period 1||5
2357585|NCT01622673|5784514|P3|COMPLETED|Treatment Period 1||4
2357586|NCT01622673|5784515|P2|COMPLETED|Treatment Period 1||4
2357587|NCT01622673|5784516|P1|COMPLETED|Treatment Period 1||4
2357588|NCT01622673|5784511|P6|STARTED|Treatment Period 1||4
2357589|NCT01622673|5784512|P5|STARTED|Treatment Period 1||4
2357590|NCT01622673|5784513|P4|STARTED|Treatment Period 1||6
2357591|NCT01622673|5784514|P3|STARTED|Treatment Period 1||4
2357592|NCT01622673|5784515|P2|STARTED|Treatment Period 1||5
2357593|NCT01622673|5784516|P1|STARTED|Treatment Period 1||4
2357594|NCT01622660|5784551|P1|NOT COMPLETED|Overall Study||1
2357595|NCT01622660|5784551|P1|COMPLETED|Overall Study||1
2357596|NCT01622660|5784551|P1|STARTED|Overall Study||2
2357597|NCT01622569|5784559|P4|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
2357598|NCT01622569|5784560|P3|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||3
2357599|NCT01622569|5784561|P2|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
2357600|NCT01622569|5784562|P1|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
2357601|NCT01622569|5784559|P4|COMPLETED|Open-Label Extension Phase (Wks 17-24)||73
2357602|NCT01622569|5784560|P3|COMPLETED|Open-Label Extension Phase (Wks 17-24)||64
2357603|NCT01622569|5784561|P2|COMPLETED|Open-Label Extension Phase (Wks 17-24)||70
2357604|NCT01622569|5784562|P1|COMPLETED|Open-Label Extension Phase (Wks 17-24)||67
2357605|NCT01622569|5784559|P4|STARTED|Open-Label Extension Phase (Wks 17-24)||75
2357606|NCT01622569|5784560|P3|STARTED|Open-Label Extension Phase (Wks 17-24)||67
2357607|NCT01622569|5784561|P2|STARTED|Open-Label Extension Phase (Wks 17-24)||72
2357608|NCT01622569|5784562|P1|STARTED|Open-Label Extension Phase (Wks 17-24)||68
2357609|NCT01622569|5784559|P4|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||4
2357610|NCT01622569|5784560|P3|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||9
2357611|NCT01622569|5784561|P2|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||6
2357612|NCT01622569|5784562|P1|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||12
2357613|NCT01622569|5784559|P4|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||76
2357614|NCT01622569|5784560|P3|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||71
2357615|NCT01622569|5784561|P2|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||75
2357616|NCT01622569|5784562|P1|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||70
2357617|NCT01622569|5784559|P4|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
2357618|NCT01622569|5784560|P3|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
2357619|NCT01622569|5784561|P2|STARTED|Double-Blind Treatment Phase (Wks 1-16)||81
2357620|NCT01622569|5784562|P1|STARTED|Double-Blind Treatment Phase (Wks 1-16)||82
2357621|NCT01622543|5784631|P2|NOT COMPLETED|Overall Study||0
2357622|NCT01622543|5784632|P1|NOT COMPLETED|Overall Study||0
2357623|NCT01622543|5784631|P2|COMPLETED|Overall Study||52
2357624|NCT01622543|5784632|P1|COMPLETED|Overall Study||51
2357625|NCT01622543|5784631|P2|STARTED|Overall Study||52
2357626|NCT01622543|5784632|P1|STARTED|Overall Study||51
2357627|NCT01622348|5784647|P3|NOT COMPLETED|Overall Study||1
2357628|NCT01622348|5784648|P2|NOT COMPLETED|Overall Study||0
2357629|NCT01622348|5784649|P1|NOT COMPLETED|Overall Study||1
2357630|NCT01622348|5784647|P3|COMPLETED|Overall Study||14
2357631|NCT01622348|5784648|P2|COMPLETED|Overall Study||14
2357632|NCT01622348|5784649|P1|COMPLETED|Overall Study||14
2357633|NCT01622348|5784647|P3|STARTED|Overall Study||15
2357634|NCT01622348|5784648|P2|STARTED|Overall Study||14
2357635|NCT01622348|5784649|P1|STARTED|Overall Study||15
2357636|NCT01622296|5784657|P2|NOT COMPLETED|Second Intervention||0
2357637|NCT01622296|5784658|P1|NOT COMPLETED|Second Intervention||0
2357638|NCT01622296|5784657|P2|COMPLETED|Second Intervention||10
2357639|NCT01622296|5784658|P1|COMPLETED|Second Intervention||10
2357640|NCT01622296|5784657|P2|STARTED|Second Intervention||10
2357641|NCT01622296|5784658|P1|STARTED|Second Intervention||10
2357642|NCT01622296|5784657|P2|NOT COMPLETED|Washout Period of at Least 1 Week||0
2357643|NCT01622296|5784658|P1|NOT COMPLETED|Washout Period of at Least 1 Week||0
2357644|NCT01622296|5784657|P2|COMPLETED|Washout Period of at Least 1 Week||10
2357645|NCT01622296|5784658|P1|COMPLETED|Washout Period of at Least 1 Week||10
2357646|NCT01622296|5784657|P2|STARTED|Washout Period of at Least 1 Week||10
2357647|NCT01622296|5784658|P1|STARTED|Washout Period of at Least 1 Week||10
2357648|NCT01622296|5784657|P2|NOT COMPLETED|First Intervention||0
2357649|NCT01622296|5784658|P1|NOT COMPLETED|First Intervention||0
2357650|NCT01622296|5784657|P2|COMPLETED|First Intervention||10
2357651|NCT01622296|5784658|P1|COMPLETED|First Intervention||10
2357652|NCT01622296|5784657|P2|STARTED|First Intervention||10
2357653|NCT01622296|5784658|P1|STARTED|First Intervention||10
2357654|NCT01622257|5784666|P3|NOT COMPLETED|Overall Study||0
2357655|NCT01622257|5784667|P2|NOT COMPLETED|Overall Study||0
2357656|NCT01622257|5784668|P1|NOT COMPLETED|Overall Study||0
2357657|NCT01622257|5784666|P3|COMPLETED|Overall Study||66
2357658|NCT01622257|5784667|P2|COMPLETED|Overall Study||66
2357659|NCT01622257|5784668|P1|COMPLETED|Overall Study||66
2357660|NCT01622257|5784666|P3|STARTED|Overall Study||66
2357661|NCT01622257|5784667|P2|STARTED|Overall Study||66
2357662|NCT01622257|5784668|P1|STARTED|Overall Study||66
2357663|NCT01622231|5784688|P1|NOT COMPLETED|Overall Study||2
2357664|NCT01622231|5784688|P1|COMPLETED|Overall Study||59
2357665|NCT01622231|5784688|P1|STARTED|Overall Study||61
2357666|NCT01621880|5784718|P2|NOT COMPLETED|Overall Study||5
2357667|NCT01621880|5784719|P1|NOT COMPLETED|Overall Study||10
2357668|NCT01621880|5784718|P2|COMPLETED|Overall Study||49
2357669|NCT01621880|5784719|P1|COMPLETED|Overall Study||48
2357670|NCT01621880|5784718|P2|STARTED|Overall Study||54
2357671|NCT01621880|5784719|P1|STARTED|Overall Study||58
2357672|NCT01621802|5784733|P6|NOT COMPLETED|Overall Study||12
2357673|NCT01621802|5784734|P5|NOT COMPLETED|Overall Study||35
2357674|NCT01621802|5784735|P4|NOT COMPLETED|Overall Study||11
2357675|NCT01621802|5784736|P3|NOT COMPLETED|Overall Study||33
2357676|NCT01621802|5784737|P2|NOT COMPLETED|Overall Study||23
2357677|NCT01621802|5784738|P1|NOT COMPLETED|Overall Study||47
2357678|NCT01621802|5784733|P6|COMPLETED|Overall Study||477
2357679|NCT01621802|5784734|P5|COMPLETED|Overall Study||1284
2357680|NCT01621802|5784735|P4|COMPLETED|Overall Study||292
2357681|NCT01621802|5784736|P3|COMPLETED|Overall Study||763
2357682|NCT01621802|5784737|P2|COMPLETED|Overall Study||275
2357683|NCT01621802|5784738|P1|COMPLETED|Overall Study||755
2357684|NCT01621802|5784733|P6|STARTED|Overall Study||489
2357685|NCT01621802|5784734|P5|STARTED|Overall Study||1319
2357686|NCT01621802|5784735|P4|STARTED|Overall Study||303
2357687|NCT01621802|5784736|P3|STARTED|Overall Study||796
2357688|NCT01621802|5784737|P2|STARTED|Overall Study||298
2357689|NCT01621802|5784738|P1|STARTED|Overall Study||802
2357690|NCT01621776|5784845|P3|NOT COMPLETED|Overall Study||0
2357691|NCT01621776|5784846|P2|NOT COMPLETED|Overall Study||0
2357692|NCT01621776|5784847|P1|NOT COMPLETED|Overall Study||0
2357693|NCT01621776|5784845|P3|COMPLETED|Overall Study||18
2357694|NCT01621776|5784846|P2|COMPLETED|Overall Study||40
2357695|NCT01621776|5784847|P1|COMPLETED|Overall Study||41
2357696|NCT01621776|5784845|P3|STARTED|Overall Study||18
2357697|NCT01621776|5784846|P2|STARTED|Overall Study||40
2357698|NCT01621776|5784847|P1|STARTED|Overall Study||41
2357699|NCT01621737|5784861|P1|NOT COMPLETED|Overall Study||0
2357700|NCT01621737|5784861|P1|COMPLETED|Overall Study||0
2357701|NCT01621737|5784861|P1|STARTED|Overall Study||0
2357702|NCT01621672|5784881|P2|NOT COMPLETED|Overall Study||0
2357703|NCT01621672|5784882|P1|NOT COMPLETED|Overall Study||0
2357704|NCT01621672|5784881|P2|COMPLETED|Overall Study||17
2357705|NCT01621672|5784882|P1|COMPLETED|Overall Study||25
2357706|NCT01621672|5784881|P2|STARTED|Overall Study||17
2357707|NCT01621672|5784882|P1|STARTED|Overall Study||25
2357708|NCT01621633|5784892|P4|NOT COMPLETED|Overall Study||0
2357709|NCT01621633|5784893|P3|NOT COMPLETED|Overall Study||0
2357710|NCT01621633|5784894|P2|NOT COMPLETED|Overall Study||0
2357711|NCT01621633|5784895|P1|NOT COMPLETED|Overall Study||0
2357712|NCT01621633|5784892|P4|COMPLETED|Overall Study||8
2357713|NCT01621633|5784893|P3|COMPLETED|Overall Study||8
2357714|NCT01621633|5784894|P2|COMPLETED|Overall Study||8
2357715|NCT01621633|5784895|P1|COMPLETED|Overall Study||8
2357716|NCT01621633|5784892|P4|STARTED|Overall Study||8
2357717|NCT01621633|5784893|P3|STARTED|Overall Study||8
2357718|NCT01621633|5784894|P2|STARTED|Overall Study||8
2357719|NCT01621633|5784895|P1|STARTED|Overall Study||8
2357720|NCT01621542|5784923|P6|NOT COMPLETED|Overall Study||9
2357721|NCT01621542|5784924|P5|NOT COMPLETED|Overall Study||9
2357722|NCT01621542|5784925|P4|NOT COMPLETED|Overall Study||28
2357723|NCT01621542|5784926|P3|NOT COMPLETED|Overall Study||6
2357724|NCT01621542|5784927|P2|NOT COMPLETED|Overall Study||5
2357725|NCT01621542|5784928|P1|NOT COMPLETED|Overall Study||5
2357726|NCT01621542|5784923|P6|COMPLETED|Overall Study||0
2357727|NCT01621542|5784924|P5|COMPLETED|Overall Study||0
2357728|NCT01621542|5784925|P4|COMPLETED|Overall Study||0
2357729|NCT01621542|5784926|P3|COMPLETED|Overall Study||0
2357730|NCT01621542|5784927|P2|COMPLETED|Overall Study||0
2357731|NCT01621542|5784928|P1|COMPLETED|Overall Study||0
2357732|NCT01621542|5784923|P6|STARTED|Overall Study||9
2357733|NCT01621542|5784924|P5|STARTED|Overall Study||9
2357734|NCT01621542|5784925|P4|STARTED|Overall Study||28
2357735|NCT01621542|5784926|P3|STARTED|Overall Study||6
2357736|NCT01621542|5784927|P2|STARTED|Overall Study||5
2357737|NCT01621542|5784928|P1|STARTED|Overall Study||5
2357738|NCT01621490|5784969|P9|NOT COMPLETED|Overall Study||8
2357739|NCT01621490|5784970|P8|NOT COMPLETED|Overall Study||10
2357740|NCT01621490|5784971|P7|NOT COMPLETED|Overall Study||11
2357741|NCT01621490|5784972|P6|NOT COMPLETED|Overall Study||24
2357742|NCT01621490|5784973|P5|NOT COMPLETED|Overall Study||6
2357743|NCT01621490|5784974|P4|NOT COMPLETED|Overall Study||9
2357744|NCT01621490|5784975|P3|NOT COMPLETED|Overall Study||11
2357745|NCT01621490|5784976|P2|NOT COMPLETED|Overall Study||44
2357746|NCT01621490|5784977|P1|NOT COMPLETED|Overall Study||41
2357747|NCT01621490|5784969|P9|COMPLETED|Overall Study||2
2357748|NCT01621490|5784970|P8|COMPLETED|Overall Study||0
2357749|NCT01621490|5784971|P7|COMPLETED|Overall Study||0
2357750|NCT01621490|5784972|P6|COMPLETED|Overall Study||1
2357751|NCT01621490|5784973|P5|COMPLETED|Overall Study||0
2357752|NCT01621490|5784974|P4|COMPLETED|Overall Study||1
2357753|NCT01621490|5784975|P3|COMPLETED|Overall Study||0
2357754|NCT01621490|5784976|P2|COMPLETED|Overall Study||0
2357755|NCT01621490|5784977|P1|COMPLETED|Overall Study||0
2357756|NCT01621490|5784969|P9|STARTED|Overall Study||10
2357757|NCT01621490|5784970|P8|STARTED|Overall Study||10
2357758|NCT01621490|5784971|P7|STARTED|Overall Study||11
2357759|NCT01621490|5784972|P6|STARTED|Overall Study||25
2357760|NCT01621490|5784973|P5|STARTED|Overall Study||6
2357761|NCT01621490|5784974|P4|STARTED|Overall Study||10
2357762|NCT01621490|5784975|P3|STARTED|Overall Study||11
2357763|NCT01621490|5784976|P2|STARTED|Overall Study||44
2357764|NCT01621490|5784977|P1|STARTED|Overall Study||41
2357765|NCT01621477|5785203|P1|NOT COMPLETED|Overall Study||0
2357766|NCT01621477|5785203|P1|COMPLETED|Overall Study||17
2357767|NCT01621477|5785203|P1|STARTED|Overall Study||17
2357768|NCT01621191|5785213|P1|NOT COMPLETED|Overall Study||25
2357769|NCT01621191|5785213|P1|COMPLETED|Overall Study||124
2357770|NCT01621191|5785213|P1|Had at Least 1 Post-Baseline Observation|Overall Study||148
2357771|NCT01621191|5785213|P1|Received at Least 1 Dose of Study Drug|Overall Study||149
2357772|NCT01621191|5785213|P1|STARTED|Overall Study||149
2357773|NCT01621178|5785227|P3|NOT COMPLETED|Overall Study||36
2357774|NCT01621178|5785228|P2|NOT COMPLETED|Overall Study||30
2357775|NCT01621178|5785229|P1|NOT COMPLETED|Overall Study||31
2357776|NCT01621178|5785227|P3|COMPLETED|Overall Study||157
2357777|NCT01621178|5785228|P2|COMPLETED|Overall Study||160
2357778|NCT01621178|5785229|P1|COMPLETED|Overall Study||163
2357779|NCT01621178|5785227|P3|Modified Intent to Treat Population|Overall Study||183
2357780|NCT01621178|5785228|P2|Modified Intent to Treat Population|Overall Study||180
2357781|NCT01621178|5785229|P1|Modified Intent to Treat Population|Overall Study||186
2357782|NCT01621178|5785227|P3|Received at Least One Dose of Study Drug|Overall Study||192
2357783|NCT01621178|5785228|P2|Received at Least One Dose of Study Drug|Overall Study||190
2357784|NCT01621178|5785229|P1|Received at Least One Dose of Study Drug|Overall Study||194
2357785|NCT01621178|5785227|P3|STARTED|Overall Study||193
2357786|NCT01621178|5785228|P2|STARTED|Overall Study||190
2357787|NCT01621178|5785229|P1|STARTED|Overall Study||194
2357788|NCT01621126|5785321|P1|NOT COMPLETED|Overall Study||6
2357789|NCT01621126|5785321|P1|COMPLETED|Overall Study||34
2357790|NCT01621126|5785321|P1|STARTED|Overall Study||40
2357791|NCT01621009|5785329|P4|NOT COMPLETED|Overall Study||53
2357792|NCT01621009|5785330|P3|NOT COMPLETED|Overall Study||63
2357793|NCT01621009|5785331|P2|NOT COMPLETED|Overall Study||51
2357794|NCT01621009|5785332|P1|NOT COMPLETED|Overall Study||43
2357795|NCT01621009|5785329|P4|COMPLETED|Overall Study||60
2357796|NCT01621009|5785330|P3|COMPLETED|Overall Study||58
2357797|NCT01621009|5785331|P2|COMPLETED|Overall Study||65
2357798|NCT01621009|5785332|P1|COMPLETED|Overall Study||70
2357799|NCT01621009|5785329|P4|STARTED|Overall Study||113
2357800|NCT01621009|5785330|P3|STARTED|Overall Study||121
2357801|NCT01621009|5785331|P2|STARTED|Overall Study||116
2357802|NCT01621009|5785332|P1|STARTED|Overall Study||113
2357803|NCT01620983|5785343|P3|NOT COMPLETED|Overall Study||15
2357804|NCT01620983|5785344|P2|NOT COMPLETED|Overall Study||22
2357805|NCT01620983|5785345|P1|NOT COMPLETED|Overall Study||19
2357806|NCT01620983|5785343|P3|COMPLETED|Overall Study||122
2357807|NCT01620983|5785344|P2|COMPLETED|Overall Study||113
2357808|NCT01620983|5785345|P1|COMPLETED|Overall Study||111
2357809|NCT01620983|5785343|P3|STARTED|Overall Study||137
2357810|NCT01620983|5785344|P2|STARTED|Overall Study||135
2357811|NCT01620983|5785345|P1|STARTED|Overall Study||130
2357812|NCT01620762|5785374|P3|NOT COMPLETED|Overall Study||53
2357813|NCT01620762|5785375|P2|NOT COMPLETED|Overall Study||58
2357814|NCT01620762|5785376|P1|NOT COMPLETED|Overall Study||48
2357815|NCT01620762|5785374|P3|COMPLETED|Overall Study||417
2357816|NCT01620762|5785375|P2|COMPLETED|Overall Study||412
2357817|NCT01620762|5785376|P1|COMPLETED|Overall Study||420
2357818|NCT01620762|5785374|P3|STARTED|Overall Study||470
2357819|NCT01620762|5785375|P2|STARTED|Overall Study||470
2357820|NCT01620762|5785376|P1|STARTED|Overall Study||468
2357821|NCT01620593|5785404|P2|NOT COMPLETED|Overall Study||1
2357822|NCT01620593|5785405|P1|NOT COMPLETED|Overall Study||4
2357823|NCT01620593|5785404|P2|COMPLETED|Overall Study||19
2357824|NCT01620593|5785405|P1|COMPLETED|Overall Study||17
2357825|NCT01620593|5785404|P2|STARTED|Overall Study||20
2357826|NCT01620593|5785405|P1|STARTED|Overall Study||21
2357827|NCT01620567|5785421|P2|NOT COMPLETED|Overall Study||5
2357828|NCT01620567|5785422|P1|NOT COMPLETED|Overall Study||3
2357829|NCT01620567|5785421|P2|COMPLETED|Overall Study||20
2357830|NCT01620567|5785422|P1|COMPLETED|Overall Study||20
2357831|NCT01620567|5785421|P2|STARTED|Overall Study||25
2357832|NCT01620567|5785422|P1|STARTED|Overall Study||23
2357833|NCT01620528|5785437|P3|NOT COMPLETED|Post-Treatment Follow-Up Period||14
2357834|NCT01620528|5785438|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||17
2357835|NCT01620528|5785439|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||20
2357836|NCT01620528|5785437|P3|COMPLETED|Post-Treatment Follow-Up Period||37
2357837|NCT01620528|5785438|P2|COMPLETED|Post-Treatment Follow-Up Period||31
2357838|NCT01620528|5785439|P1|COMPLETED|Post-Treatment Follow-Up Period||48
2357839|NCT01620528|5785437|P3|Completed PTFU Month 12|Post-Treatment Follow-Up Period||19
2357840|NCT01620528|5785438|P2|Completed PTFU Month 12|Post-Treatment Follow-Up Period||5
2357841|NCT01620528|5785439|P1|Completed PTFU Month 12|Post-Treatment Follow-Up Period||2
2357842|NCT01620528|5785437|P3|Completed PTFU Month 6|Post-Treatment Follow-Up Period|Met criteria (reported a post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|18
2357843|NCT01620528|5785438|P2|Completed PTFU Month 6|Post-Treatment Follow-Up Period|Met criteria (reported a post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|26
2357844|NCT01620528|5785439|P1|Completed PTFU Month 6|Post-Treatment Follow-Up Period||46
2357845|NCT01620528|5785437|P3|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|51
2357846|NCT01620528|5785438|P2|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|48
2357847|NCT01620528|5785439|P1|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|68
2357848|NCT01620528|5785437|P3|NOT COMPLETED|Treatment Period||66
2357849|NCT01620528|5785438|P2|NOT COMPLETED|Treatment Period||53
2357850|NCT01620528|5785439|P1|NOT COMPLETED|Treatment Period||100
2357851|NCT01620528|5785437|P3|COMPLETED|Treatment Period||183
2357852|NCT01620528|5785438|P2|COMPLETED|Treatment Period||196
2357853|NCT01620528|5785439|P1|COMPLETED|Treatment Period||274
2357854|NCT01620528|5785437|P3|STARTED|Treatment Period|1 subject did not receive study drug|249
2357855|NCT01620528|5785438|P2|STARTED|Treatment Period||249
2357856|NCT01620528|5785439|P1|STARTED|Treatment Period||374
2357857|NCT01620489|5785779|P2|NOT COMPLETED|Overall Study||34
2357858|NCT01620489|5785780|P1|NOT COMPLETED|Overall Study||35
2357859|NCT01620489|5785779|P2|COMPLETED|Overall Study|2 subjects did not take trial product|105
2357860|NCT01620489|5785780|P1|COMPLETED|Overall Study||105
2357861|NCT01620489|5785779|P2|Exposed|Overall Study|2 subjects did not take trial product|137
2357862|NCT01620489|5785780|P1|Exposed|Overall Study||140
2357863|NCT01620489|5785779|P2|STARTED|Overall Study||139
2357864|NCT01620489|5785780|P1|STARTED|Overall Study||140
2357865|NCT01620255|5785801|P5|NOT COMPLETED|Overall Study||6
2357866|NCT01620255|5785802|P4|NOT COMPLETED|Overall Study||3
2357867|NCT01620255|5785803|P3|NOT COMPLETED|Overall Study||2
2357868|NCT01620255|5785804|P2|NOT COMPLETED|Overall Study||6
2357869|NCT01620255|5785805|P1|NOT COMPLETED|Overall Study||4
2357870|NCT01620255|5785801|P5|COMPLETED|Overall Study||64
2357871|NCT01620255|5785802|P4|COMPLETED|Overall Study||70
2357872|NCT01620255|5785803|P3|COMPLETED|Overall Study||68
2357873|NCT01620255|5785804|P2|COMPLETED|Overall Study||65
2357874|NCT01620255|5785805|P1|COMPLETED|Overall Study||69
2357875|NCT01620255|5785801|P5|Treated|Overall Study||70
2357876|NCT01620255|5785802|P4|Treated|Overall Study||73
2357877|NCT01620255|5785803|P3|Treated|Overall Study||70
2357878|NCT01620255|5785804|P2|Treated|Overall Study||71
2357879|NCT01620255|5785805|P1|Treated|Overall Study||73
2357880|NCT01620255|5785801|P5|STARTED|Overall Study||70
2357881|NCT01620255|5785802|P4|STARTED|Overall Study||73
2357882|NCT01620255|5785803|P3|STARTED|Overall Study||70
2357883|NCT01620255|5785804|P2|STARTED|Overall Study||71
2357884|NCT01620255|5785805|P1|STARTED|Overall Study||73
2357885|NCT01620177|5785882|P1|NOT COMPLETED|Overall Study||79
2357886|NCT01620177|5785882|P1|COMPLETED|Overall Study||19
2357887|NCT01620177|5785882|P1|STARTED|Overall Study||98
2357888|NCT01620138|5785907|P2|NOT COMPLETED|Overall Study||0
2357889|NCT01620138|5785908|P1|NOT COMPLETED|Overall Study||6
2357890|NCT01620138|5785907|P2|COMPLETED|Overall Study||9
2357891|NCT01620138|5785908|P1|COMPLETED|Overall Study||6
2357892|NCT01620138|5785907|P2|STARTED|Overall Study||9
2357893|NCT01620138|5785908|P1|STARTED|Overall Study||12
2357894|NCT01620086|5785916|P3|NOT COMPLETED|Overall Study||0
2357895|NCT01620086|5785917|P2|NOT COMPLETED|Overall Study||7
2357896|NCT01620086|5785918|P1|NOT COMPLETED|Overall Study||5
2357897|NCT01620086|5785916|P3|COMPLETED|Overall Study||2
2357898|NCT01620086|5785917|P2|COMPLETED|Overall Study||4
2357899|NCT01620086|5785918|P1|COMPLETED|Overall Study||8
2357900|NCT01620086|5785916|P3|STARTED|Overall Study||2
2357901|NCT01620086|5785917|P2|STARTED|Overall Study||11
2357902|NCT01620086|5785918|P1|STARTED|Overall Study||13
2357903|NCT01620060|5785937|P1|NOT COMPLETED|Overall Study||15
2357904|NCT01620060|5785937|P1|COMPLETED|Overall Study||90
2357905|NCT01620060|5785937|P1|STARTED|Overall Study||105
2357906|NCT01620047|5785946|P3|NOT COMPLETED|Overall Study||0
2357907|NCT01620047|5785947|P2|NOT COMPLETED|Overall Study||0
2357908|NCT01620047|5785948|P1|NOT COMPLETED|Overall Study||0
2357909|NCT01620047|5785946|P3|COMPLETED|Overall Study||20
2357910|NCT01620047|5785947|P2|COMPLETED|Overall Study||20
2357911|NCT01620047|5785948|P1|COMPLETED|Overall Study||20
2357912|NCT01620047|5785946|P3|STARTED|Overall Study||20
2357913|NCT01620047|5785947|P2|STARTED|Overall Study||20
2357914|NCT01620047|5785948|P1|STARTED|Overall Study||20
2357915|NCT01619982|5785958|P2|NOT COMPLETED|Overall Study||0
2357916|NCT01619982|5785959|P1|NOT COMPLETED|Overall Study||0
2357917|NCT01619982|5785958|P2|COMPLETED|Overall Study||12
2357918|NCT01619982|5785959|P1|COMPLETED|Overall Study||20
2357919|NCT01619982|5785958|P2|STARTED|Overall Study||12
2357920|NCT01619982|5785959|P1|STARTED|Overall Study||20
2357921|NCT01619878|5785975|P1|NOT COMPLETED|Follow-up at 12 Months of Age||3
2357922|NCT01619878|5785975|P1|COMPLETED|Follow-up at 12 Months of Age||17
2357923|NCT01619878|5785975|P1|STARTED|Follow-up at 12 Months of Age||20
2357924|NCT01619878|5785975|P1|NOT COMPLETED|6 Week Follow-up Phase||1
2357925|NCT01619878|5785975|P1|COMPLETED|6 Week Follow-up Phase||19
2357926|NCT01619878|5785975|P1|STARTED|6 Week Follow-up Phase||20
2357927|NCT01619852|5785989|P2|NOT COMPLETED|3 Month Follow up||34
2357928|NCT01619852|5785990|P1|NOT COMPLETED|3 Month Follow up||31
2357929|NCT01619852|5785989|P2|COMPLETED|3 Month Follow up||40
2357930|NCT01619852|5785990|P1|COMPLETED|3 Month Follow up||43
2357931|NCT01619852|5785989|P2|STARTED|3 Month Follow up||74
2357932|NCT01619852|5785990|P1|STARTED|3 Month Follow up||74
2357933|NCT01619852|5785989|P2|NOT COMPLETED|24 Hour Assessment||1
2357934|NCT01619852|5785990|P1|NOT COMPLETED|24 Hour Assessment||1
2357935|NCT01619852|5785989|P2|COMPLETED|24 Hour Assessment||74
2357936|NCT01619852|5785990|P1|COMPLETED|24 Hour Assessment||74
2357937|NCT01619852|5785989|P2|STARTED|24 Hour Assessment||75
2357938|NCT01619852|5785990|P1|STARTED|24 Hour Assessment||75
2357939|NCT01619800|5786006|P2|NOT COMPLETED|Overall Study||0
2357940|NCT01619800|5786007|P1|NOT COMPLETED|Overall Study||2
2357941|NCT01619800|5786006|P2|COMPLETED|Overall Study||0
2357942|NCT01619800|5786007|P1|COMPLETED|Overall Study||0
2357943|NCT01619800|5786006|P2|STARTED|Overall Study||0
2357944|NCT01619800|5786007|P1|STARTED|Overall Study||2
2357945|NCT01619787|5786015|P1|NOT COMPLETED|Overall Study||5
2357946|NCT01619787|5786015|P1|COMPLETED|Overall Study||212
2357947|NCT01619787|5786015|P1|STARTED|Overall Study||217
2357948|NCT01619774|5786024|P1|NOT COMPLETED|Overall Study||0
2357949|NCT01619774|5786024|P1|COMPLETED|Overall Study||23
2357950|NCT01619774|5786024|P1|STARTED|Overall Study||23
2357951|NCT01619579|5786032|P2|NOT COMPLETED|Overall Study||3
2357952|NCT01619579|5786033|P1|NOT COMPLETED|Overall Study||0
2357953|NCT01619579|5786032|P2|COMPLETED|Overall Study||14
2357954|NCT01619579|5786033|P1|COMPLETED|Overall Study||5
2357955|NCT01619579|5786032|P2|STARTED|Overall Study||17
2357956|NCT01619579|5786033|P1|STARTED|Overall Study||5
2357957|NCT01619423|5786047|P4|NOT COMPLETED|Part 2b||0
2357958|NCT01619423|5786048|P3|NOT COMPLETED|Part 2b||0
2357959|NCT01619423|5786049|P2|NOT COMPLETED|Part 2b||0
2357960|NCT01619423|5786050|P1|NOT COMPLETED|Part 2b||0
2357961|NCT01619423|5786047|P4|COMPLETED|Part 2b||0
2357962|NCT01619423|5786048|P3|COMPLETED|Part 2b||45
2357963|NCT01619423|5786049|P2|COMPLETED|Part 2b||44
2357964|NCT01619423|5786050|P1|COMPLETED|Part 2b||45
2357965|NCT01619423|5786047|P4|STARTED|Part 2b||0
2357966|NCT01619423|5786048|P3|STARTED|Part 2b||45
2357967|NCT01619423|5786049|P2|STARTED|Part 2b||44
2357968|NCT01619423|5786050|P1|STARTED|Part 2b||45
2357969|NCT01619423|5786047|P4|NOT COMPLETED|Part 2a||0
2357970|NCT01619423|5786048|P3|NOT COMPLETED|Part 2a||0
2357971|NCT01619423|5786049|P2|NOT COMPLETED|Part 2a||0
2357972|NCT01619423|5786050|P1|NOT COMPLETED|Part 2a||0
2357973|NCT01619423|5786047|P4|COMPLETED|Part 2a||11
2357974|NCT01619423|5786048|P3|COMPLETED|Part 2a||0
2357975|NCT01619423|5786049|P2|COMPLETED|Part 2a||13
2357976|NCT01619423|5786050|P1|COMPLETED|Part 2a||15
2357977|NCT01619423|5786047|P4|STARTED|Part 2a||11
2357978|NCT01619423|5786048|P3|STARTED|Part 2a||0
2357979|NCT01619423|5786049|P2|STARTED|Part 2a||13
2357980|NCT01619423|5786050|P1|STARTED|Part 2a||15
2357981|NCT01619423|5786047|P4|NOT COMPLETED|Part 1 (Dose Escalation)||0
2357982|NCT01619423|5786048|P3|NOT COMPLETED|Part 1 (Dose Escalation)||0
2357983|NCT01619423|5786049|P2|NOT COMPLETED|Part 1 (Dose Escalation)||2
2357984|NCT01619423|5786050|P1|NOT COMPLETED|Part 1 (Dose Escalation)||0
2357985|NCT01619423|5786047|P4|COMPLETED|Part 1 (Dose Escalation)||5
2357986|NCT01619423|5786048|P3|COMPLETED|Part 1 (Dose Escalation)||3
2357987|NCT01619423|5786049|P2|COMPLETED|Part 1 (Dose Escalation)||3
2357988|NCT01619423|5786050|P1|COMPLETED|Part 1 (Dose Escalation)||0
2357989|NCT01619423|5786047|P4|STARTED|Part 1 (Dose Escalation)||5
2357990|NCT01619423|5786048|P3|STARTED|Part 1 (Dose Escalation)||3
2357991|NCT01619423|5786049|P2|STARTED|Part 1 (Dose Escalation)||5
2357992|NCT01619423|5786050|P1|STARTED|Part 1 (Dose Escalation)||0
2357993|NCT01619410|5786063|P2|NOT COMPLETED|Overall Study||4
2357994|NCT01619410|5786064|P1|NOT COMPLETED|Overall Study||7
2357995|NCT01619410|5786063|P2|COMPLETED|Overall Study||7
2357996|NCT01619410|5786064|P1|COMPLETED|Overall Study||7
2357997|NCT01619410|5786063|P2|STARTED|Overall Study||11
2357998|NCT01619410|5786064|P1|STARTED|Overall Study||14
2358002|NCT01619059|5786082|P2|NOT COMPLETED|Long-Term (LT) Treatment Period||9
2358003|NCT01619059|5786083|P1|NOT COMPLETED|Long-Term (LT) Treatment Period||8
2358004|NCT01619059|5786082|P2|COMPLETED|Long-Term (LT) Treatment Period||133
2358005|NCT01619059|5786083|P1|COMPLETED|Long-Term (LT) Treatment Period||147
2358006|NCT01619059|5786082|P2|STARTED|Long-Term (LT) Treatment Period||142
2358007|NCT01619059|5786083|P1|STARTED|Long-Term (LT) Treatment Period||155
2358008|NCT01619059|5786082|P2|NOT COMPLETED|Short-Term (ST) Treatment Period||11
2358009|NCT01619059|5786083|P1|NOT COMPLETED|Short-Term (ST) Treatment Period||6
2358010|NCT01619059|5786082|P2|COMPLETED|Short-Term (ST) Treatment Period||142
2358011|NCT01619059|5786083|P1|COMPLETED|Short-Term (ST) Treatment Period||156
2358012|NCT01619059|5786082|P2|STARTED|Short-Term (ST) Treatment Period||153
2358013|NCT01619059|5786083|P1|STARTED|Short-Term (ST) Treatment Period||162
2358014|NCT01618968|5786099|P4|NOT COMPLETED|Overall Study||1
2358015|NCT01618968|5786100|P3|NOT COMPLETED|Overall Study||0
2358016|NCT01618968|5786101|P2|NOT COMPLETED|Overall Study||0
2358017|NCT01618968|5786102|P1|NOT COMPLETED|Overall Study||1
2358018|NCT01618968|5786099|P4|COMPLETED|Overall Study||11
2358019|NCT01618968|5786100|P3|COMPLETED|Overall Study||12
2358020|NCT01618968|5786101|P2|COMPLETED|Overall Study||12
2358021|NCT01618968|5786102|P1|COMPLETED|Overall Study||12
2358022|NCT01618968|5786099|P4|Received Treatment C|Overall Study||11
2358023|NCT01618968|5786100|P3|Received Treatment C|Overall Study||12
2358024|NCT01618968|5786101|P2|Received Treatment C|Overall Study||12
2358025|NCT01618968|5786102|P1|Received Treatment C|Overall Study||12
2358026|NCT01618968|5786099|P4|Received Treatment B|Overall Study||12
2358027|NCT01618968|5786100|P3|Received Treatment B|Overall Study||12
2358028|NCT01618968|5786101|P2|Received Treatment B|Overall Study||12
2358029|NCT01618968|5786102|P1|Received Treatment B|Overall Study||13
2358030|NCT01618968|5786099|P4|Received Treatment A|Overall Study||11
2358031|NCT01618968|5786100|P3|Received Treatment A|Overall Study||12
2358032|NCT01618968|5786101|P2|Received Treatment A|Overall Study||12
2358033|NCT01618968|5786102|P1|Received Treatment A|Overall Study||12
2358034|NCT01618968|5786099|P4|STARTED|Overall Study||12
2358035|NCT01618968|5786100|P3|STARTED|Overall Study||12
2358036|NCT01618968|5786101|P2|STARTED|Overall Study||12
2358037|NCT01618968|5786102|P1|STARTED|Overall Study||13
2358038|NCT01618955|5786121|P4|NOT COMPLETED|Overall Study||0
2358039|NCT01618955|5786122|P3|NOT COMPLETED|Overall Study||0
2358040|NCT01618955|5786123|P2|NOT COMPLETED|Overall Study||0
2358041|NCT01618955|5786124|P1|NOT COMPLETED|Overall Study||0
2358042|NCT01618955|5786121|P4|COMPLETED|Overall Study||20
2358043|NCT01618955|5786122|P3|COMPLETED|Overall Study||31
2358044|NCT01618955|5786123|P2|COMPLETED|Overall Study||30
2358045|NCT01618955|5786124|P1|COMPLETED|Overall Study||20
2358046|NCT01618955|5786121|P4|STARTED|Overall Study||20
2358047|NCT01618955|5786122|P3|STARTED|Overall Study||31
2358048|NCT01618955|5786123|P2|STARTED|Overall Study||30
2358049|NCT01618955|5786124|P1|STARTED|Overall Study||20
2358050|NCT01618942|5786148|P2|NOT COMPLETED|Overall Study||0
2358051|NCT01618942|5786149|P1|NOT COMPLETED|Overall Study||0
2358052|NCT01618942|5786148|P2|COMPLETED|Overall Study||50
2358053|NCT01618942|5786149|P1|COMPLETED|Overall Study||50
2358054|NCT01618942|5786148|P2|STARTED|Overall Study||50
2358055|NCT01618942|5786149|P1|STARTED|Overall Study||50
2358056|NCT01618916|5786175|P6|NOT COMPLETED|Overall Study||0
2358057|NCT01618916|5786176|P5|NOT COMPLETED|Overall Study||1
2358058|NCT01618916|5786177|P4|NOT COMPLETED|Overall Study||2
2358059|NCT01618916|5786178|P3|NOT COMPLETED|Overall Study||1
2358060|NCT01618916|5786179|P2|NOT COMPLETED|Overall Study||1
2358061|NCT01618916|5786180|P1|NOT COMPLETED|Overall Study||2
2358062|NCT01618916|5786175|P6|COMPLETED|Overall Study||4
2358063|NCT01618916|5786176|P5|COMPLETED|Overall Study||4
2358064|NCT01618916|5786177|P4|COMPLETED|Overall Study||7
2358065|NCT01618916|5786178|P3|COMPLETED|Overall Study||10
2358066|NCT01618916|5786179|P2|COMPLETED|Overall Study||9
2358067|NCT01618916|5786180|P1|COMPLETED|Overall Study||10
2358068|NCT01618916|5786175|P6|Received At Least 1 Dose of Study Drug|Overall Study||4
2358069|NCT01618916|5786176|P5|Received At Least 1 Dose of Study Drug|Overall Study||5
2358070|NCT01618916|5786177|P4|Received At Least 1 Dose of Study Drug|Overall Study||9
2358071|NCT01618916|5786178|P3|Received At Least 1 Dose of Study Drug|Overall Study||11
2358072|NCT01618916|5786179|P2|Received At Least 1 Dose of Study Drug|Overall Study||10
2358073|NCT01618916|5786180|P1|Received At Least 1 Dose of Study Drug|Overall Study||12
2358074|NCT01618916|5786175|P6|STARTED|Overall Study||4
2358075|NCT01618916|5786176|P5|STARTED|Overall Study||5
2358076|NCT01618916|5786177|P4|STARTED|Overall Study||9
2358077|NCT01618916|5786178|P3|STARTED|Overall Study||11
2358078|NCT01618916|5786179|P2|STARTED|Overall Study||10
2358079|NCT01618916|5786180|P1|STARTED|Overall Study||12
2358080|NCT01618864|5786210|P1|NOT COMPLETED|Overall Study||4
2358081|NCT01618864|5786210|P1|COMPLETED|Overall Study|Completed 4 weeks and 8 weeks of treatment|19
2358082|NCT01618864|5786210|P1|Completed 2 Weeks|Overall Study||19
2358083|NCT01618864|5786210|P1|STARTED|Overall Study||23
2358084|NCT01618838|5786219|P1|NOT COMPLETED|Overall Study||4
2358085|NCT01618838|5786219|P1|COMPLETED|Overall Study||0
2358086|NCT01618838|5786219|P1|STARTED|Overall Study||4
2358087|NCT01618708|5786227|P2|NOT COMPLETED|Overall Study||46
2358088|NCT01618708|5786228|P1|NOT COMPLETED|Overall Study||44
2358089|NCT01618708|5786227|P2|COMPLETED|Overall Study||136
2358090|NCT01618708|5786228|P1|COMPLETED|Overall Study||131
2358091|NCT01618708|5786227|P2|Treated|Overall Study||180
2358092|NCT01618708|5786228|P1|Treated|Overall Study||172
2358093|NCT01618708|5786227|P2|STARTED|Overall Study||182
2358094|NCT01618708|5786228|P1|STARTED|Overall Study||175
2358095|NCT01618669|5786242|P2|NOT COMPLETED|Overall Study||23
2358096|NCT01618669|5786243|P1|NOT COMPLETED|Overall Study||34
2358097|NCT01618669|5786242|P2|COMPLETED|Overall Study||546
2358098|NCT01618669|5786243|P1|COMPLETED|Overall Study||544
2358099|NCT01618669|5786242|P2|Received Treatment|Overall Study||567
2358100|NCT01618669|5786243|P1|Received Treatment|Overall Study||575
2358101|NCT01618669|5786242|P2|STARTED|Overall Study||569
2358102|NCT01618669|5786243|P1|STARTED|Overall Study||578
2358103|NCT01618422|5786289|P2|NOT COMPLETED|Overall Study||0
2358104|NCT01618422|5786290|P1|NOT COMPLETED|Overall Study||0
2358105|NCT01618422|5786289|P2|COMPLETED|Overall Study||111
2358106|NCT01618422|5786290|P1|COMPLETED|Overall Study||114
2358107|NCT01618422|5786289|P2|STARTED|Overall Study||111
2358108|NCT01618422|5786290|P1|STARTED|Overall Study||114
2358109|NCT01618344|5786296|P1|NOT COMPLETED|Overall Study||9
2358110|NCT01618344|5786296|P1|COMPLETED|Overall Study||23
2358111|NCT01618344|5786296|P1|STARTED|Overall Study||32
2358112|NCT01618305|5786302|P2|NOT COMPLETED|Overall Study||10
2358113|NCT01618305|5786303|P1|NOT COMPLETED|Overall Study||15
2358114|NCT01618305|5786302|P2|COMPLETED|Overall Study||196
2358115|NCT01618305|5786303|P1|COMPLETED|Overall Study||187
2358116|NCT01618305|5786302|P2|STARTED|Overall Study||206
2358117|NCT01618305|5786303|P1|STARTED|Overall Study||202
2358118|NCT01618266|5786345|P1|NOT COMPLETED|Overall Study||96
2358119|NCT01618266|5786345|P1|COMPLETED|Overall Study||279
2358120|NCT01618266|5786345|P1|STARTED|Overall Study||375
2358121|NCT01618240|5786360|P1|NOT COMPLETED|Overall Study||0
2358122|NCT01618240|5786360|P1|COMPLETED|Overall Study||30
2358123|NCT01618240|5786360|P1|STARTED|Overall Study||30
2358124|NCT01618227|5786367|P2|NOT COMPLETED|Overall Study||2
2358125|NCT01618227|5786368|P1|NOT COMPLETED|Overall Study||0
2358126|NCT01618227|5786367|P2|COMPLETED|Overall Study||0
2358127|NCT01618227|5786368|P1|COMPLETED|Overall Study||2
2358128|NCT01618227|5786367|P2|STARTED|Overall Study||2
2358129|NCT01618227|5786368|P1|STARTED|Overall Study||2
2358130|NCT01618214|5786382|P2|NOT COMPLETED|Overall Study||13
2358131|NCT01618214|5786383|P1|NOT COMPLETED|Overall Study||10
2358132|NCT01618214|5786382|P2|COMPLETED|Overall Study||159
2358133|NCT01618214|5786383|P1|COMPLETED|Overall Study||162
2358134|NCT01618214|5786382|P2|Exposed|Overall Study||172
2358135|NCT01618214|5786383|P1|Exposed|Overall Study||172
2358136|NCT01618214|5786382|P2|STARTED|Overall Study||172
2358137|NCT01618214|5786383|P1|STARTED|Overall Study||172
2358138|NCT01618162|5786399|P2|NOT COMPLETED|Overall Study||35
2358139|NCT01618162|5786400|P1|NOT COMPLETED|Overall Study||38
2358140|NCT01618162|5786399|P2|COMPLETED|Overall Study||111
2358141|NCT01618162|5786400|P1|COMPLETED|Overall Study||251
2358142|NCT01618162|5786399|P2|Exposed|Overall Study||146
2358143|NCT01618162|5786400|P1|Exposed|Overall Study||288
2358144|NCT01618162|5786399|P2|STARTED|Overall Study||146
2358145|NCT01618162|5786400|P1|STARTED|Overall Study||289
2358146|NCT01618019|5786420|P2|NOT COMPLETED|Overall Study||14
2358147|NCT01618019|5786421|P1|NOT COMPLETED|Overall Study||14
2358148|NCT01618019|5786420|P2|COMPLETED|Overall Study||40
2358149|NCT01618019|5786421|P1|COMPLETED|Overall Study||41
2358150|NCT01618019|5786420|P2|STARTED|Overall Study||54
2358151|NCT01618019|5786421|P1|STARTED|Overall Study||55
2358152|NCT01617967|5786447|P6|NOT COMPLETED|Overall Study||1
2358153|NCT01617967|5786448|P5|NOT COMPLETED|Overall Study||0
2358154|NCT01617967|5786449|P4|NOT COMPLETED|Overall Study||1
2358155|NCT01617967|5786450|P3|NOT COMPLETED|Overall Study||0
2358156|NCT01617967|5786451|P2|NOT COMPLETED|Overall Study||0
2358157|NCT01617967|5786452|P1|NOT COMPLETED|Overall Study||1
2358158|NCT01617967|5786447|P6|COMPLETED|Overall Study||8
2358159|NCT01617967|5786448|P5|COMPLETED|Overall Study||3
2358160|NCT01617967|5786449|P4|COMPLETED|Overall Study||6
2358161|NCT01617967|5786450|P3|COMPLETED|Overall Study||3
2358162|NCT01617967|5786451|P2|COMPLETED|Overall Study||3
2358163|NCT01617967|5786452|P1|COMPLETED|Overall Study||3
2358164|NCT01617967|5786447|P6|STARTED|Overall Study||9
2358165|NCT01617967|5786448|P5|STARTED|Overall Study||3
2358166|NCT01617967|5786449|P4|STARTED|Overall Study||7
2358167|NCT01617967|5786450|P3|STARTED|Overall Study||3
2358168|NCT01617967|5786451|P2|STARTED|Overall Study||3
2358169|NCT01617967|5786452|P1|STARTED|Overall Study||4
2358170|NCT01617681|5786506|P5|NOT COMPLETED|Period 2 Open Label||6
2358171|NCT01617681|5786507|P4|NOT COMPLETED|Period 2 Open Label||0
2358172|NCT01617681|5786508|P3|NOT COMPLETED|Period 2 Open Label||0
2358173|NCT01617681|5786509|P2|NOT COMPLETED|Period 2 Open Label||0
2358174|NCT01617681|5786510|P1|NOT COMPLETED|Period 2 Open Label||0
2358175|NCT01617681|5786506|P5|COMPLETED|Period 2 Open Label||114
2358176|NCT01617681|5786507|P4|COMPLETED|Period 2 Open Label||0
2358177|NCT01617681|5786508|P3|COMPLETED|Period 2 Open Label||0
2358178|NCT01617681|5786509|P2|COMPLETED|Period 2 Open Label||0
2358179|NCT01617681|5786510|P1|COMPLETED|Period 2 Open Label||0
2358180|NCT01617681|5786506|P5|STARTED|Period 2 Open Label||120
2358181|NCT01617681|5786507|P4|STARTED|Period 2 Open Label||0
2358182|NCT01617681|5786508|P3|STARTED|Period 2 Open Label||0
2358183|NCT01617681|5786509|P2|STARTED|Period 2 Open Label||0
2358184|NCT01617681|5786510|P1|STARTED|Period 2 Open Label||0
2358185|NCT01617681|5786506|P5|NOT COMPLETED|Period 1 Double Blind||0
2358186|NCT01617681|5786507|P4|NOT COMPLETED|Period 1 Double Blind||2
2358187|NCT01617681|5786508|P3|NOT COMPLETED|Period 1 Double Blind||1
2358188|NCT01617681|5786509|P2|NOT COMPLETED|Period 1 Double Blind||1
2358189|NCT01617681|5786510|P1|NOT COMPLETED|Period 1 Double Blind||3
2358190|NCT01617681|5786506|P5|COMPLETED|Period 1 Double Blind||0
2358191|NCT01617681|5786507|P4|COMPLETED|Period 1 Double Blind||29
2358192|NCT01617681|5786508|P3|COMPLETED|Period 1 Double Blind||32
2358193|NCT01617681|5786509|P2|COMPLETED|Period 1 Double Blind||30
2358194|NCT01617681|5786510|P1|COMPLETED|Period 1 Double Blind||29
2358195|NCT01617681|5786506|P5|Full Analysis Set (FAS)|Period 1 Double Blind||0
2358196|NCT01617681|5786507|P4|Full Analysis Set (FAS)|Period 1 Double Blind||31
2358197|NCT01617681|5786508|P3|Full Analysis Set (FAS)|Period 1 Double Blind||33
2358198|NCT01617681|5786509|P2|Full Analysis Set (FAS)|Period 1 Double Blind||31
2358199|NCT01617681|5786510|P1|Full Analysis Set (FAS)|Period 1 Double Blind||31
2358200|NCT01617681|5786506|P5|STARTED|Period 1 Double Blind||0
2358201|NCT01617681|5786507|P4|STARTED|Period 1 Double Blind||31
2358202|NCT01617681|5786508|P3|STARTED|Period 1 Double Blind||33
2358203|NCT01617681|5786509|P2|STARTED|Period 1 Double Blind||31
2358204|NCT01617681|5786510|P1|STARTED|Period 1 Double Blind||32
2358205|NCT01617668|5786531|P4|NOT COMPLETED|Overall Study||15
2358206|NCT01617668|5786532|P3|NOT COMPLETED|Overall Study||23
2358207|NCT01617668|5786533|P2|NOT COMPLETED|Overall Study||9
2358208|NCT01617668|5786534|P1|NOT COMPLETED|Overall Study||13
2358209|NCT01617668|5786531|P4|COMPLETED|Overall Study||38
2358210|NCT01617668|5786532|P3|COMPLETED|Overall Study||32
2358211|NCT01617668|5786533|P2|COMPLETED|Overall Study||41
2358212|NCT01617668|5786534|P1|COMPLETED|Overall Study||38
2358213|NCT01617668|5786531|P4|Randomized Patients|Overall Study||55
2358214|NCT01617668|5786532|P3|Randomized Patients|Overall Study||55
2358215|NCT01617668|5786533|P2|Randomized Patients|Overall Study||54
2358216|NCT01617668|5786534|P1|Randomized Patients|Overall Study||51
2358217|NCT01617668|5786531|P4|STARTED|Overall Study|55 patients were randomized and only 53 received study treatment.|53
2358218|NCT01617668|5786532|P3|STARTED|Overall Study||55
2358219|NCT01617668|5786533|P2|STARTED|Overall Study|54 patients were randomized and only 50 received study treatment.|50
2358220|NCT01617668|5786534|P1|STARTED|Overall Study||51
2358221|NCT01617655|5786575|P2|NOT COMPLETED|Overall Study||29
2358222|NCT01617655|5786576|P1|NOT COMPLETED|Overall Study||9
2358223|NCT01617655|5786575|P2|COMPLETED|Overall Study||43
2358224|NCT01617655|5786576|P1|COMPLETED|Overall Study||26
2358225|NCT01617655|5786575|P2|Treated|Overall Study||72
2358226|NCT01617655|5786576|P1|Treated|Overall Study||35
2358227|NCT01617655|5786575|P2|STARTED|Overall Study|Randomized|72
2358228|NCT01617655|5786576|P1|STARTED|Overall Study|Randomized|35
2358229|NCT01617629|5786636|P1|NOT COMPLETED|Overall Study||6
2358230|NCT01617629|5786636|P1|COMPLETED|Overall Study||3
2358231|NCT01617629|5786636|P1|STARTED|Overall Study||9
2358232|NCT01617603|5786644|P3|NOT COMPLETED|Overall Study||1
2358233|NCT01617603|5786645|P2|NOT COMPLETED|Overall Study||2
2358234|NCT01617603|5786646|P1|NOT COMPLETED|Overall Study||3
2358235|NCT01617603|5786644|P3|COMPLETED|Overall Study||20
2358236|NCT01617603|5786645|P2|COMPLETED|Overall Study||19
2358237|NCT01617603|5786646|P1|COMPLETED|Overall Study||17
2358238|NCT01617603|5786644|P3|STARTED|Overall Study||21
2358239|NCT01617603|5786645|P2|STARTED|Overall Study||21
2358240|NCT01617603|5786646|P1|STARTED|Overall Study||20
2358241|NCT01617577|5786656|P2|NOT COMPLETED|Overall Study||0
2358242|NCT01617577|5786657|P1|NOT COMPLETED|Overall Study||0
2358243|NCT01617577|5786656|P2|COMPLETED|Overall Study||3
2358244|NCT01617577|5786657|P1|COMPLETED|Overall Study||5
2358245|NCT01617577|5786656|P2|STARTED|Overall Study||3
2358246|NCT01617577|5786657|P1|STARTED|Overall Study||5
2358247|NCT01617460|5786664|P1|NOT COMPLETED|Overall Study||40
2358248|NCT01617460|5786664|P1|COMPLETED|Overall Study||46
2358249|NCT01617460|5786664|P1|STARTED|Overall Study||86
2358250|NCT01617447|5786670|P2|NOT COMPLETED|Overall Study||3
2358251|NCT01617447|5786671|P1|NOT COMPLETED|Overall Study||0
2358252|NCT01617447|5786670|P2|COMPLETED|Overall Study||42
2358253|NCT01617447|5786671|P1|COMPLETED|Overall Study||47
2358254|NCT01617447|5786670|P2|STARTED|Overall Study||45
2358255|NCT01617447|5786671|P1|STARTED|Overall Study||47
2358256|NCT01617434|5786679|P2|NOT COMPLETED|Overall Study||51
2358257|NCT01617434|5786680|P1|NOT COMPLETED|Overall Study||35
2358258|NCT01617434|5786679|P2|COMPLETED|Overall Study||174
2358259|NCT01617434|5786680|P1|COMPLETED|Overall Study||191
2358260|NCT01617434|5786679|P2|Exposed|Overall Study||225
2358261|NCT01617434|5786680|P1|Exposed|Overall Study||225
2358262|NCT01617434|5786679|P2|STARTED|Overall Study||225
2358263|NCT01617434|5786680|P1|STARTED|Overall Study||226
2358264|NCT01617421|5786702|P1|NOT COMPLETED|Overall Study||6
2358265|NCT01617421|5786702|P1|COMPLETED|Overall Study||12
2358266|NCT01617421|5786702|P1|STARTED|Overall Study||18
2358267|NCT01617369|5786709|P1|NOT COMPLETED|Overall Study||0
2358268|NCT01617369|5786709|P1|COMPLETED|Overall Study||12
2358269|NCT01617369|5786709|P1|STARTED|Overall Study||12
2358270|NCT01617187|5786719|P4|NOT COMPLETED|Treatment Through Study Completion||10
2358271|NCT01617187|5786720|P3|NOT COMPLETED|Treatment Through Study Completion||5
2358272|NCT01617187|5786721|P2|NOT COMPLETED|Treatment Through Study Completion||11
2358273|NCT01617187|5786722|P1|NOT COMPLETED|Treatment Through Study Completion||11
2358274|NCT01617187|5786719|P4|COMPLETED|Treatment Through Study Completion||91
2358275|NCT01617187|5786720|P3|COMPLETED|Treatment Through Study Completion||41
2358276|NCT01617187|5786721|P2|COMPLETED|Treatment Through Study Completion||102
2358359|NCT01616693|5786869|P3|COMPLETED|Received Both Vaccines||142
2358277|NCT01617187|5786722|P1|COMPLETED|Treatment Through Study Completion|Excludes the participant who did not receive study drug but completed study in database|86
2358278|NCT01617187|5786719|P4|STARTED|Treatment Through Study Completion|Treated|101
2358279|NCT01617187|5786720|P3|STARTED|Treatment Through Study Completion|Treated|46
2358280|NCT01617187|5786721|P2|STARTED|Treatment Through Study Completion|Treated|113
2358281|NCT01617187|5786722|P1|STARTED|Treatment Through Study Completion|Treated|97
2358282|NCT01617187|5786719|P4|NOT COMPLETED|Randomization Through Start Treatment||2
2358283|NCT01617187|5786720|P3|NOT COMPLETED|Randomization Through Start Treatment||0
2358284|NCT01617187|5786721|P2|NOT COMPLETED|Randomization Through Start Treatment||0
2358285|NCT01617187|5786722|P1|NOT COMPLETED|Randomization Through Start Treatment||1
2358286|NCT01617187|5786719|P4|COMPLETED|Randomization Through Start Treatment||101
2358287|NCT01617187|5786720|P3|COMPLETED|Randomization Through Start Treatment||46
2358288|NCT01617187|5786721|P2|COMPLETED|Randomization Through Start Treatment||113
2358289|NCT01617187|5786722|P1|COMPLETED|Randomization Through Start Treatment||97
2358290|NCT01617187|5786719|P4|STARTED|Randomization Through Start Treatment|Randomized|103
2358291|NCT01617187|5786720|P3|STARTED|Randomization Through Start Treatment|Randomized|46
2358292|NCT01617187|5786721|P2|STARTED|Randomization Through Start Treatment|Randomized|113
2358293|NCT01617187|5786722|P1|STARTED|Randomization Through Start Treatment|Randomized|98
2358294|NCT01617148|5786792|P1|NOT COMPLETED|Overall Study||0
2358295|NCT01617148|5786792|P1|COMPLETED|Overall Study||26
2358296|NCT01617148|5786792|P1|STARTED|Overall Study||26
2358297|NCT01617083|5786806|P3|NOT COMPLETED|Overall Study||0
2358298|NCT01617083|5786807|P2|NOT COMPLETED|Overall Study||0
2358299|NCT01617083|5786808|P1|NOT COMPLETED|Overall Study||0
2358300|NCT01617083|5786806|P3|COMPLETED|Overall Study||15
2358301|NCT01617083|5786807|P2|COMPLETED|Overall Study||14
2358302|NCT01617083|5786808|P1|COMPLETED|Overall Study||18
2358303|NCT01617083|5786806|P3|STARTED|Overall Study||15
2358304|NCT01617083|5786807|P2|STARTED|Overall Study||14
2358305|NCT01617083|5786808|P1|STARTED|Overall Study||18
2358306|NCT01617070|5786819|P1|NOT COMPLETED|BH4 and LNAA (4 Weeks)||1
2358307|NCT01617070|5786819|P1|COMPLETED|BH4 and LNAA (4 Weeks)||9
2358308|NCT01617070|5786819|P1|STARTED|BH4 and LNAA (4 Weeks)||10
2358309|NCT01617070|5786819|P1|NOT COMPLETED|BH4 Therapy (4 Weeks)||0
2358310|NCT01617070|5786819|P1|COMPLETED|BH4 Therapy (4 Weeks)||10
2358311|NCT01617070|5786819|P1|STARTED|BH4 Therapy (4 Weeks)||10
2358312|NCT01617070|5786819|P1|NOT COMPLETED|Washout (4 Weeks)||0
2358313|NCT01617070|5786819|P1|COMPLETED|Washout (4 Weeks)||10
2358314|NCT01617070|5786819|P1|STARTED|Washout (4 Weeks)||10
2358315|NCT01617070|5786819|P1|NOT COMPLETED|LNAA (4 Weeks)||0
2358316|NCT01617070|5786819|P1|COMPLETED|LNAA (4 Weeks)||10
2358317|NCT01617070|5786819|P1|STARTED|LNAA (4 Weeks)||10
2358318|NCT01617005|5786837|P1|NOT COMPLETED|Overall Study||2
2358319|NCT01617005|5786837|P1|COMPLETED|Overall Study||48
2358320|NCT01617005|5786837|P1|STARTED|Overall Study||50
2358321|NCT01616953|5786846|P2|NOT COMPLETED|Overall Study||0
2358322|NCT01616953|5786847|P1|NOT COMPLETED|Overall Study||2
2358323|NCT01616953|5786846|P2|COMPLETED|Overall Study||8
2358324|NCT01616953|5786847|P1|COMPLETED|Overall Study||8
2358325|NCT01616953|5786846|P2|6 Months Post-loading|Overall Study||8
2358326|NCT01616953|5786847|P1|6 Months Post-loading|Overall Study||8
2358327|NCT01616953|5786846|P2|Implant Uncovery|Overall Study||8
2358328|NCT01616953|5786847|P1|Implant Uncovery|Overall Study||8
2358329|NCT01616953|5786846|P2|Implant Placement Surgery|Overall Study||8
2358330|NCT01616953|5786847|P1|Implant Placement Surgery|Overall Study||9
2358331|NCT01616953|5786846|P2|STARTED|Overall Study||8
2358332|NCT01616953|5786847|P1|STARTED|Overall Study||10
2358333|NCT01616771|5786855|P1|NOT COMPLETED|Smaller Sized GVL for 5 Sec||4
2358334|NCT01616771|5786855|P1|COMPLETED|Smaller Sized GVL for 5 Sec||19
2358335|NCT01616771|5786855|P1|STARTED|Smaller Sized GVL for 5 Sec|Four of 23 patients could not be evaluated by smaller sized GVL, because there was no smaller one.|23
2358336|NCT01616771|5786855|P1|NOT COMPLETED|GVL Selected by Weight for 5 Sec||0
2358337|NCT01616771|5786855|P1|COMPLETED|GVL Selected by Weight for 5 Sec||23
2358338|NCT01616771|5786855|P1|STARTED|GVL Selected by Weight for 5 Sec||23
2358339|NCT01616771|5786855|P1|NOT COMPLETED|Macintosh Laryngoscopy for 5 Sec||0
2358340|NCT01616771|5786855|P1|COMPLETED|Macintosh Laryngoscopy for 5 Sec||23
2358341|NCT01616771|5786855|P1|STARTED|Macintosh Laryngoscopy for 5 Sec||23
2358342|NCT01616693|5786868|P4|NOT COMPLETED|Blood Analyzed for Immunogenicity||1
2358343|NCT01616693|5786869|P3|NOT COMPLETED|Blood Analyzed for Immunogenicity||6
2358344|NCT01616693|5786870|P2|NOT COMPLETED|Blood Analyzed for Immunogenicity||2
2358345|NCT01616693|5786871|P1|NOT COMPLETED|Blood Analyzed for Immunogenicity||4
2358346|NCT01616693|5786868|P4|COMPLETED|Blood Analyzed for Immunogenicity||135
2358347|NCT01616693|5786869|P3|COMPLETED|Blood Analyzed for Immunogenicity||136
2358348|NCT01616693|5786870|P2|COMPLETED|Blood Analyzed for Immunogenicity||143
2358349|NCT01616693|5786871|P1|COMPLETED|Blood Analyzed for Immunogenicity||137
2358350|NCT01616693|5786868|P4|STARTED|Blood Analyzed for Immunogenicity||136
2358351|NCT01616693|5786869|P3|STARTED|Blood Analyzed for Immunogenicity||142
2358352|NCT01616693|5786870|P2|STARTED|Blood Analyzed for Immunogenicity||145
2358353|NCT01616693|5786871|P1|STARTED|Blood Analyzed for Immunogenicity||141
2358354|NCT01616693|5786868|P4|NOT COMPLETED|Received Both Vaccines||19
2358355|NCT01616693|5786869|P3|NOT COMPLETED|Received Both Vaccines||12
2358356|NCT01616693|5786870|P2|NOT COMPLETED|Received Both Vaccines||10
2358357|NCT01616693|5786871|P1|NOT COMPLETED|Received Both Vaccines||13
2358358|NCT01616693|5786868|P4|COMPLETED|Received Both Vaccines||136
2358360|NCT01616693|5786870|P2|COMPLETED|Received Both Vaccines||145
2358361|NCT01616693|5786871|P1|COMPLETED|Received Both Vaccines||141
2358362|NCT01616693|5786868|P4|STARTED|Received Both Vaccines||155
2358363|NCT01616693|5786869|P3|STARTED|Received Both Vaccines||154
2358364|NCT01616693|5786870|P2|STARTED|Received Both Vaccines||155
2358365|NCT01616693|5786871|P1|STARTED|Received Both Vaccines||154
2358366|NCT01616693|5786868|P4|NOT COMPLETED|Evaluated for Safety||0
2358367|NCT01616693|5786869|P3|NOT COMPLETED|Evaluated for Safety||1
2358368|NCT01616693|5786870|P2|NOT COMPLETED|Evaluated for Safety||0
2358369|NCT01616693|5786871|P1|NOT COMPLETED|Evaluated for Safety||1
2358370|NCT01616693|5786868|P4|COMPLETED|Evaluated for Safety||155
2358371|NCT01616693|5786869|P3|COMPLETED|Evaluated for Safety||154
2358372|NCT01616693|5786870|P2|COMPLETED|Evaluated for Safety||155
2358373|NCT01616693|5786871|P1|COMPLETED|Evaluated for Safety||154
2358374|NCT01616693|5786868|P4|STARTED|Evaluated for Safety||155
2358375|NCT01616693|5786869|P3|STARTED|Evaluated for Safety||155
2358376|NCT01616693|5786870|P2|STARTED|Evaluated for Safety||155
2358377|NCT01616693|5786871|P1|STARTED|Evaluated for Safety||155
2358378|NCT01616576|5786923|P2|NOT COMPLETED|Overall Study||0
2358379|NCT01616576|5786924|P1|NOT COMPLETED|Overall Study||0
2358380|NCT01616576|5786923|P2|COMPLETED|Overall Study||18
2358381|NCT01616576|5786924|P1|COMPLETED|Overall Study||18
2358382|NCT01616576|5786923|P2|STARTED|Overall Study||18
2358383|NCT01616576|5786924|P1|STARTED|Overall Study||18
2358384|NCT01616459|5786937|P4|NOT COMPLETED|Overall Study||8
2358385|NCT01616459|5786938|P3|NOT COMPLETED|Overall Study||10
2358386|NCT01616459|5786939|P2|NOT COMPLETED|Overall Study||17
2358387|NCT01616459|5786940|P1|NOT COMPLETED|Overall Study||4
2358388|NCT01616459|5786937|P4|COMPLETED|Overall Study||233
2358389|NCT01616459|5786938|P3|COMPLETED|Overall Study||220
2358390|NCT01616459|5786939|P2|COMPLETED|Overall Study||223
2358391|NCT01616459|5786940|P1|COMPLETED|Overall Study||236
2358392|NCT01616459|5786937|P4|STARTED|Overall Study||241
2358393|NCT01616459|5786938|P3|STARTED|Overall Study||230
2358394|NCT01616459|5786939|P2|STARTED|Overall Study||240
2358395|NCT01616459|5786940|P1|STARTED|Overall Study||240
2358396|NCT01616173|5787041|P3|NOT COMPLETED|Overall Study||0
2358397|NCT01616173|5787042|P2|NOT COMPLETED|Overall Study||2
2358398|NCT01616173|5787043|P1|NOT COMPLETED|Overall Study||0
2358399|NCT01616173|5787041|P3|COMPLETED|Overall Study||27
2358400|NCT01616173|5787042|P2|COMPLETED|Overall Study||24
2358401|NCT01616173|5787043|P1|COMPLETED|Overall Study||27
2358402|NCT01616173|5787041|P3|STARTED|Overall Study||27
2358403|NCT01616173|5787042|P2|STARTED|Overall Study||26
2358404|NCT01616173|5787043|P1|STARTED|Overall Study||27
2358405|NCT01616160|5787057|P1|NOT COMPLETED|Overall Study||2
2358406|NCT01616160|5787057|P1|COMPLETED|Overall Study||9
2358407|NCT01616160|5787057|P1|STARTED|Overall Study||11
2358408|NCT01616056|5787062|P1|NOT COMPLETED|Overall Study||1
2358409|NCT01616056|5787062|P1|COMPLETED|Overall Study||19
2358410|NCT01616056|5787062|P1|STARTED|Overall Study||20
2358411|NCT01615939|5787076|P2|NOT COMPLETED|Overall Study||0
2358412|NCT01615939|5787077|P1|NOT COMPLETED|Overall Study||5
2358413|NCT01615939|5787076|P2|COMPLETED|Overall Study||4
2358414|NCT01615939|5787077|P1|COMPLETED|Overall Study||8
2358415|NCT01615939|5787076|P2|STARTED|Overall Study||4
2358416|NCT01615939|5787077|P1|STARTED|Overall Study||13
2358417|NCT01615822|5787090|P3|NOT COMPLETED|Period 2||2
2358418|NCT01615822|5787091|P2|NOT COMPLETED|Period 2||1
2358419|NCT01615822|5787092|P1|NOT COMPLETED|Period 2||0
2358420|NCT01615822|5787090|P3|COMPLETED|Period 2||4
2358421|NCT01615822|5787091|P2|COMPLETED|Period 2||8
2358422|NCT01615822|5787092|P1|COMPLETED|Period 2||7
2358423|NCT01615822|5787090|P3|STARTED|Period 2||6
2358424|NCT01615822|5787091|P2|STARTED|Period 2||9
2358425|NCT01615822|5787092|P1|STARTED|Period 2||7
2358426|NCT01615822|5787090|P3|NOT COMPLETED|Period 1||0
2358427|NCT01615822|5787091|P2|NOT COMPLETED|Period 1||2
2358428|NCT01615822|5787092|P1|NOT COMPLETED|Period 1||1
2358429|NCT01615822|5787090|P3|COMPLETED|Period 1||6
2358430|NCT01615822|5787091|P2|COMPLETED|Period 1||9
2358431|NCT01615822|5787092|P1|COMPLETED|Period 1||7
2358432|NCT01615822|5787090|P3|STARTED|Period 1||6
2358433|NCT01615822|5787091|P2|STARTED|Period 1||11
2358434|NCT01615822|5787092|P1|STARTED|Period 1||8
2358435|NCT01615809|5787109|P1|NOT COMPLETED|Overall Study||10
2358436|NCT01615809|5787109|P1|COMPLETED|Overall Study||22
2358437|NCT01615809|5787109|P1|STARTED|Overall Study|basal visit|32
2358438|NCT01615731|5787117|P2|NOT COMPLETED|Overall Study||2
2358439|NCT01615731|5787118|P1|NOT COMPLETED|Overall Study||3
2358440|NCT01615731|5787117|P2|COMPLETED|Overall Study||24
2358441|NCT01615731|5787118|P1|COMPLETED|Overall Study||21
2358442|NCT01615731|5787117|P2|STARTED|Overall Study||26
2358443|NCT01615731|5787118|P1|STARTED|Overall Study||24
2358444|NCT01615484|5787140|P2|NOT COMPLETED|Overall Study||0
2358445|NCT01615484|5787141|P1|NOT COMPLETED|Overall Study||0
2358446|NCT01615484|5787140|P2|COMPLETED|Overall Study||24
2358447|NCT01615484|5787141|P1|COMPLETED|Overall Study||0
2358448|NCT01615484|5787140|P2|STARTED|Overall Study||24
2358449|NCT01615484|5787141|P1|STARTED|Overall Study||0
2358450|NCT01615367|5787159|P2|NOT COMPLETED|Overall Study||6
2358451|NCT01615367|5787160|P1|NOT COMPLETED|Overall Study||5
2358452|NCT01615367|5787159|P2|COMPLETED|Overall Study|11 TAU participants chose to participate in NEW Tx after the completion of the waitlist period.|13
2358453|NCT01615367|5787160|P1|COMPLETED|Overall Study||14
2358454|NCT01615367|5787159|P2|STARTED|Overall Study||19
2358455|NCT01615367|5787160|P1|STARTED|Overall Study||19
2358456|NCT01615328|5787180|P2|NOT COMPLETED|Overall Study||5
2358457|NCT01615328|5787181|P1|NOT COMPLETED|Overall Study||3
2358458|NCT01615328|5787180|P2|COMPLETED|Overall Study||38
2358459|NCT01615328|5787181|P1|COMPLETED|Overall Study||39
2358460|NCT01615328|5787180|P2|STARTED|Overall Study||43
2358461|NCT01615328|5787181|P1|STARTED|Overall Study||42
2358462|NCT01615263|5787193|P2|NOT COMPLETED|Overall Study||2
2358463|NCT01615263|5787194|P1|NOT COMPLETED|Overall Study||0
2358464|NCT01615263|5787193|P2|COMPLETED|Overall Study||18
2358465|NCT01615263|5787194|P1|COMPLETED|Overall Study||20
2358466|NCT01615263|5787193|P2|STARTED|Overall Study||20
2358467|NCT01615263|5787194|P1|STARTED|Overall Study||20
2358468|NCT01615198|5787208|P2|NOT COMPLETED|Overall Study||19
2358469|NCT01615198|5787209|P1|NOT COMPLETED|Overall Study||24
2358470|NCT01615198|5787208|P2|COMPLETED|Overall Study||273
2358471|NCT01615198|5787209|P1|COMPLETED|Overall Study||272
2358472|NCT01615198|5787208|P2|ABPM Dipper Status Subset|Overall Study||84
2358473|NCT01615198|5787209|P1|ABPM Dipper Status Subset|Overall Study||82
2358474|NCT01615198|5787208|P2|Safety Set|Overall Study||292
2358475|NCT01615198|5787209|P1|Safety Set|Overall Study||296
2358476|NCT01615198|5787208|P2|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||157
2358477|NCT01615198|5787209|P1|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||154
2358478|NCT01615198|5787208|P2|Full Analysis Set|Overall Study||292
2358479|NCT01615198|5787209|P1|Full Analysis Set|Overall Study||296
2358480|NCT01615198|5787208|P2|STARTED|Overall Study||292
2358481|NCT01615198|5787209|P1|STARTED|Overall Study||296
2358497|NCT01614912|5787267|P1|NOT COMPLETED|Overall Study||125
2358498|NCT01614912|5787267|P1|COMPLETED|Overall Study||159
2358499|NCT01614912|5787267|P1|STARTED|Overall Study||284
2358500|NCT01614899|5787281|P3|NOT COMPLETED|Overall Study||42
2358501|NCT01614899|5787282|P2|NOT COMPLETED|Overall Study||39
2358502|NCT01614899|5787283|P1|NOT COMPLETED|Overall Study||44
2358503|NCT01614899|5787281|P3|COMPLETED|Overall Study||110
2358504|NCT01614899|5787282|P2|COMPLETED|Overall Study||116
2358505|NCT01614899|5787283|P1|COMPLETED|Overall Study||106
2358506|NCT01614899|5787281|P3|STARTED|Overall Study||152
2358507|NCT01614899|5787282|P2|STARTED|Overall Study||155
2358508|NCT01614899|5787283|P1|STARTED|Overall Study||150
2358509|NCT01614886|5787314|P2|NOT COMPLETED|Overall Study||26
2358510|NCT01614886|5787315|P1|NOT COMPLETED|Overall Study||20
2358511|NCT01614886|5787314|P2|COMPLETED|Overall Study||83
2358512|NCT01614886|5787315|P1|COMPLETED|Overall Study||87
2358513|NCT01614886|5787314|P2|Full Analysis Set (FAS)|Overall Study||105
2358514|NCT01614886|5787315|P1|Full Analysis Set (FAS)|Overall Study||104
2358515|NCT01614886|5787314|P2|Safety Population (SAF)|Overall Study||108
2358516|NCT01614886|5787315|P1|Safety Population (SAF)|Overall Study||107
2358517|NCT01614886|5787314|P2|STARTED|Overall Study||109
2358518|NCT01614886|5787315|P1|STARTED|Overall Study||107
2358519|NCT01614821|5787329|P1|NOT COMPLETED|Overall Study||0
2358520|NCT01614821|5787329|P1|COMPLETED|Overall Study||63
2358521|NCT01614821|5787329|P1|STARTED|Overall Study||63
2358522|NCT01614795|5787342|P4|NOT COMPLETED|Overall Study||12
2358523|NCT01614795|5787343|P3|NOT COMPLETED|Overall Study||11
2358524|NCT01614795|5787344|P2|NOT COMPLETED|Overall Study||12
2358525|NCT01614795|5787345|P1|NOT COMPLETED|Overall Study||11
2358526|NCT01614795|5787342|P4|COMPLETED|Overall Study||0
2358527|NCT01614795|5787343|P3|COMPLETED|Overall Study||0
2358528|NCT01614795|5787344|P2|COMPLETED|Overall Study||0
2358529|NCT01614795|5787345|P1|COMPLETED|Overall Study||0
2358530|NCT01614795|5787342|P4|STARTED|Overall Study||12
2358531|NCT01614795|5787343|P3|STARTED|Overall Study||11
2358532|NCT01614795|5787344|P2|STARTED|Overall Study||12
2358533|NCT01614795|5787345|P1|STARTED|Overall Study||11
2358534|NCT01614769|5787365|P6|NOT COMPLETED|Period 3||0
2358535|NCT01614769|5787366|P5|NOT COMPLETED|Period 3||0
2358536|NCT01614769|5787367|P4|NOT COMPLETED|Period 3||0
2358537|NCT01614769|5787368|P3|NOT COMPLETED|Period 3||1
2358538|NCT01614769|5787369|P2|NOT COMPLETED|Period 3||0
2358539|NCT01614769|5787370|P1|NOT COMPLETED|Period 3||0
2358540|NCT01614769|5787365|P6|COMPLETED|Period 3||1
2358541|NCT01614769|5787366|P5|COMPLETED|Period 3||1
2358542|NCT01614769|5787367|P4|COMPLETED|Period 3||0
2358543|NCT01614769|5787368|P3|COMPLETED|Period 3||1
2358544|NCT01614769|5787369|P2|COMPLETED|Period 3||1
2358545|NCT01614769|5787370|P1|COMPLETED|Period 3||1
2358546|NCT01614769|5787365|P6|STARTED|Period 3||1
2358547|NCT01614769|5787366|P5|STARTED|Period 3||1
2358548|NCT01614769|5787367|P4|STARTED|Period 3||0
2358549|NCT01614769|5787368|P3|STARTED|Period 3||2
2358550|NCT01614769|5787369|P2|STARTED|Period 3||1
2358551|NCT01614769|5787370|P1|STARTED|Period 3||1
2358552|NCT01614769|5787365|P6|NOT COMPLETED|7-Day Washout||0
2358553|NCT01614769|5787366|P5|NOT COMPLETED|7-Day Washout||0
2358554|NCT01614769|5787367|P4|NOT COMPLETED|7-Day Washout||0
2358555|NCT01614769|5787368|P3|NOT COMPLETED|7-Day Washout||0
2358556|NCT01614769|5787369|P2|NOT COMPLETED|7-Day Washout||0
2358557|NCT01614769|5787370|P1|NOT COMPLETED|7-Day Washout||0
2358558|NCT01614769|5787365|P6|COMPLETED|7-Day Washout||1
2358559|NCT01614769|5787366|P5|COMPLETED|7-Day Washout||1
2358560|NCT01614769|5787367|P4|COMPLETED|7-Day Washout||0
2358561|NCT01614769|5787368|P3|COMPLETED|7-Day Washout||2
2358562|NCT01614769|5787369|P2|COMPLETED|7-Day Washout||1
2358563|NCT01614769|5787370|P1|COMPLETED|7-Day Washout||1
2358564|NCT01614769|5787365|P6|STARTED|7-Day Washout||1
2358565|NCT01614769|5787366|P5|STARTED|7-Day Washout||1
2358566|NCT01614769|5787367|P4|STARTED|7-Day Washout||0
2358567|NCT01614769|5787368|P3|STARTED|7-Day Washout||2
2358568|NCT01614769|5787369|P2|STARTED|7-Day Washout||1
2358569|NCT01614769|5787370|P1|STARTED|7-Day Washout||1
2358570|NCT01614769|5787365|P6|NOT COMPLETED|Period 2||0
2358571|NCT01614769|5787366|P5|NOT COMPLETED|Period 2||0
2358572|NCT01614769|5787367|P4|NOT COMPLETED|Period 2||0
2358573|NCT01614769|5787368|P3|NOT COMPLETED|Period 2||0
2358574|NCT01614769|5787369|P2|NOT COMPLETED|Period 2||0
2358575|NCT01614769|5787370|P1|NOT COMPLETED|Period 2||0
2358576|NCT01614769|5787365|P6|COMPLETED|Period 2||1
2358577|NCT01614769|5787366|P5|COMPLETED|Period 2||1
2358578|NCT01614769|5787367|P4|COMPLETED|Period 2||0
2358579|NCT01614769|5787368|P3|COMPLETED|Period 2||2
2358580|NCT01614769|5787369|P2|COMPLETED|Period 2||1
2358581|NCT01614769|5787370|P1|COMPLETED|Period 2||1
2358582|NCT01614769|5787365|P6|STARTED|Period 2||1
2358583|NCT01614769|5787366|P5|STARTED|Period 2||1
2358584|NCT01614769|5787367|P4|STARTED|Period 2||0
2358585|NCT01614769|5787368|P3|STARTED|Period 2||2
2358586|NCT01614769|5787369|P2|STARTED|Period 2||1
2358587|NCT01614769|5787370|P1|STARTED|Period 2||1
2358588|NCT01614769|5787365|P6|NOT COMPLETED|7-Day Washout||0
2358589|NCT01614769|5787366|P5|NOT COMPLETED|7-Day Washout||0
2358590|NCT01614769|5787367|P4|NOT COMPLETED|7-Day Washout||0
2358591|NCT01614769|5787368|P3|NOT COMPLETED|7-Day Washout||0
2358592|NCT01614769|5787369|P2|NOT COMPLETED|7-Day Washout||0
2358593|NCT01614769|5787370|P1|NOT COMPLETED|7-Day Washout||0
2358594|NCT01614769|5787365|P6|COMPLETED|7-Day Washout||1
2358595|NCT01614769|5787366|P5|COMPLETED|7-Day Washout||1
2358596|NCT01614769|5787367|P4|COMPLETED|7-Day Washout||0
2358597|NCT01614769|5787368|P3|COMPLETED|7-Day Washout||2
2358598|NCT01614769|5787369|P2|COMPLETED|7-Day Washout||1
2358599|NCT01614769|5787370|P1|COMPLETED|7-Day Washout||1
2358600|NCT01614769|5787365|P6|STARTED|7-Day Washout||1
2358601|NCT01614769|5787366|P5|STARTED|7-Day Washout||1
2358602|NCT01614769|5787367|P4|STARTED|7-Day Washout||0
2358603|NCT01614769|5787368|P3|STARTED|7-Day Washout||2
2358604|NCT01614769|5787369|P2|STARTED|7-Day Washout||1
2358605|NCT01614769|5787370|P1|STARTED|7-Day Washout||1
2358606|NCT01614769|5787365|P6|NOT COMPLETED|Period 1||1
2358607|NCT01614769|5787366|P5|NOT COMPLETED|Period 1||0
2358608|NCT01614769|5787367|P4|NOT COMPLETED|Period 1||2
2358609|NCT01614769|5787368|P3|NOT COMPLETED|Period 1||0
2358610|NCT01614769|5787369|P2|NOT COMPLETED|Period 1||0
2358611|NCT01614769|5787370|P1|NOT COMPLETED|Period 1||1
2358612|NCT01614769|5787365|P6|COMPLETED|Period 1||1
2358613|NCT01614769|5787366|P5|COMPLETED|Period 1||1
2358614|NCT01614769|5787367|P4|COMPLETED|Period 1||0
2358615|NCT01614769|5787368|P3|COMPLETED|Period 1||2
2358616|NCT01614769|5787369|P2|COMPLETED|Period 1||1
2358617|NCT01614769|5787370|P1|COMPLETED|Period 1||1
2358618|NCT01614769|5787365|P6|STARTED|Period 1||2
2358619|NCT01614769|5787366|P5|STARTED|Period 1||1
2358620|NCT01614769|5787367|P4|STARTED|Period 1||2
2358621|NCT01614769|5787368|P3|STARTED|Period 1||2
2358622|NCT01614769|5787369|P2|STARTED|Period 1||1
2358623|NCT01614769|5787370|P1|STARTED|Period 1||2
2358624|NCT01614613|5787384|P1|NOT COMPLETED|Overall Study||0
2358625|NCT01614613|5787384|P1|COMPLETED|Overall Study||146
2358626|NCT01614613|5787384|P1|STARTED|Overall Study||146
2358627|NCT01614600|5787392|P1|NOT COMPLETED|Overall Study||4
2358628|NCT01614600|5787392|P1|COMPLETED|Overall Study||84
2358629|NCT01614600|5787392|P1|STARTED|Overall Study||88
2358630|NCT01614574|5787396|P1|NOT COMPLETED|Overall Study||0
2358631|NCT01614574|5787396|P1|COMPLETED|Overall Study||6
2358632|NCT01614574|5787396|P1|STARTED|Overall Study||6
2358633|NCT01614509|5787412|P2|NOT COMPLETED|Overall Study||3
2358634|NCT01614509|5787413|P1|NOT COMPLETED|Overall Study||1
2358635|NCT01614509|5787412|P2|COMPLETED|Overall Study||18
2358636|NCT01614509|5787413|P1|COMPLETED|Overall Study||23
2358637|NCT01614509|5787412|P2|STARTED|Overall Study||21
2358638|NCT01614509|5787413|P1|STARTED|Overall Study||24
2358639|NCT01614470|5787423|P3|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
2358640|NCT01614470|5787424|P2|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
2358641|NCT01614470|5787425|P1|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
2358642|NCT01614470|5787423|P3|COMPLETED|Part 2: Open-label Period (16 Weeks)||36
2358643|NCT01614470|5787424|P2|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
2358644|NCT01614470|5787425|P1|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
2358645|NCT01614470|5787423|P3|STARTED|Part 2: Open-label Period (16 Weeks)||36
2358646|NCT01614470|5787424|P2|STARTED|Part 2: Open-label Period (16 Weeks)||0
2358647|NCT01614470|5787425|P1|STARTED|Part 2: Open-label Period (16 Weeks)||0
2358648|NCT01614470|5787423|P3|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
2358649|NCT01614470|5787424|P2|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
2358650|NCT01614470|5787425|P1|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
2358651|NCT01614470|5787423|P3|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
2358652|NCT01614470|5787424|P2|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
2358653|NCT01614470|5787425|P1|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
2358654|NCT01614470|5787423|P3|STARTED|Part 1: Treatment Period 2 (8 Weeks)||0
2358655|NCT01614470|5787424|P2|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
2358656|NCT01614470|5787425|P1|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
2358657|NCT01614470|5787423|P3|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
2358658|NCT01614470|5787424|P2|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
2358659|NCT01614470|5787425|P1|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
2358660|NCT01614470|5787423|P3|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
2358661|NCT01614470|5787424|P2|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
2358662|NCT01614470|5787425|P1|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
2358663|NCT01614470|5787423|P3|STARTED|Part 1: Washout Period (4 to 8 Weeks)||0
2358664|NCT01614470|5787424|P2|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
2358665|NCT01614470|5787425|P1|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
2358666|NCT01614470|5787423|P3|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
2358667|NCT01614470|5787424|P2|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||1
2358668|NCT01614470|5787425|P1|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||2
2358669|NCT01614470|5787423|P3|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
2358670|NCT01614470|5787424|P2|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
2358671|NCT01614470|5787425|P1|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
2358672|NCT01614470|5787423|P3|STARTED|Part 1: Treatment Period 1 (8 Weeks)||0
2358673|NCT01614470|5787424|P2|STARTED|Part 1: Treatment Period 1 (8 Weeks)||19
2358674|NCT01614470|5787425|P1|STARTED|Part 1: Treatment Period 1 (8 Weeks)||20
2358675|NCT01614457|5787447|P2|NOT COMPLETED|Overall Study||0
2358676|NCT01614457|5787448|P1|NOT COMPLETED|Overall Study||2
2358677|NCT01614457|5787447|P2|COMPLETED|Overall Study||35
2358678|NCT01614457|5787448|P1|COMPLETED|Overall Study||32
2358679|NCT01614457|5787447|P2|STARTED|Overall Study||35
2358680|NCT01614457|5787448|P1|STARTED|Overall Study||34
2358681|NCT01614392|5787466|P2|NOT COMPLETED|Overall Study||3
2358682|NCT01614392|5787467|P1|NOT COMPLETED|Overall Study||1
2358683|NCT01614392|5787466|P2|COMPLETED|Overall Study||24
2358684|NCT01614392|5787467|P1|COMPLETED|Overall Study||24
2358685|NCT01614392|5787466|P2|STARTED|Overall Study||27
2358686|NCT01614392|5787467|P1|STARTED|Overall Study||25
2358687|NCT01614249|5787475|P2|NOT COMPLETED|Overall Study||23
2358688|NCT01614249|5787476|P1|NOT COMPLETED|Overall Study||11
2358689|NCT01614249|5787475|P2|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|86
2358690|NCT01614249|5787476|P1|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|96
2358691|NCT01614249|5787475|P2|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|86
2358692|NCT01614249|5787476|P1|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|96
2358693|NCT01614249|5787475|P2|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|92
2358694|NCT01614249|5787476|P1|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|98
2358695|NCT01614249|5787475|P2|STARTED|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|109
2358696|NCT01614249|5787476|P1|STARTED|Overall Study|Participants received every two-weeks supply and monitored regularly on cell-phone and face-to-face.|107
2358697|NCT01614210|5787482|P1|NOT COMPLETED|Overall Study||0
2358698|NCT01614210|5787482|P1|COMPLETED|Overall Study||52
2358699|NCT01614210|5787482|P1|STARTED|Overall Study||52
2358700|NCT01614093|5787490|P1|NOT COMPLETED|Overall Study||1
2358701|NCT01614093|5787490|P1|COMPLETED|Overall Study||16
2358702|NCT01614093|5787490|P1|STARTED|Overall Study||17
2358703|NCT01613768|5787495|P1|NOT COMPLETED|Overall Study||0
2358704|NCT01613768|5787495|P1|COMPLETED|Overall Study||29
2358705|NCT01613768|5787495|P1|STARTED|Overall Study||29
2358706|NCT01613716|5787503|P1|NOT COMPLETED|Overall Study||7
2358707|NCT01613716|5787503|P1|COMPLETED|Overall Study||23
2358708|NCT01613716|5787503|P1|STARTED|Overall Study||30
2358709|NCT01613599|5787508|P1|NOT COMPLETED|Overall Study||25
2358710|NCT01613599|5787508|P1|COMPLETED|Overall Study||72
2358711|NCT01613599|5787508|P1|STARTED|Overall Study||97
2358712|NCT01613417|5787523|P2|NOT COMPLETED|Second Injection||0
2358713|NCT01613417|5787524|P1|NOT COMPLETED|Second Injection||0
2358714|NCT01613417|5787523|P2|COMPLETED|Second Injection||109
2358715|NCT01613417|5787524|P1|COMPLETED|Second Injection||100
2358716|NCT01613417|5787523|P2|STARTED|Second Injection||109
2358717|NCT01613417|5787524|P1|STARTED|Second Injection||100
2358718|NCT01613417|5787523|P2|NOT COMPLETED|Washout (no Second Injection/MRI)||7
2358719|NCT01613417|5787524|P1|NOT COMPLETED|Washout (no Second Injection/MRI)||13
2358720|NCT01613417|5787523|P2|COMPLETED|Washout (no Second Injection/MRI)||109
2358721|NCT01613417|5787524|P1|COMPLETED|Washout (no Second Injection/MRI)||100
2358722|NCT01613417|5787523|P2|STARTED|Washout (no Second Injection/MRI)||116
2358723|NCT01613417|5787524|P1|STARTED|Washout (no Second Injection/MRI)||113
2358724|NCT01613417|5787523|P2|NOT COMPLETED|First Injection||0
2358725|NCT01613417|5787524|P1|NOT COMPLETED|First Injection||0
2358726|NCT01613417|5787523|P2|COMPLETED|First Injection||116
2358727|NCT01613417|5787524|P1|COMPLETED|First Injection||113
2358728|NCT01613417|5787523|P2|STARTED|First Injection||116
2358729|NCT01613417|5787524|P1|STARTED|First Injection||113
2358730|NCT01613378|5787561|P1|NOT COMPLETED|Overall Study||39
2358731|NCT01613378|5787561|P1|COMPLETED|Overall Study||161
2358732|NCT01613378|5787561|P1|STARTED|Overall Study||200
2358733|NCT01613339|5787579|P2|NOT COMPLETED|Overall Study||1
2358734|NCT01613339|5787580|P1|NOT COMPLETED|Overall Study||3
2358735|NCT01613339|5787579|P2|COMPLETED|Overall Study||21
2358736|NCT01613339|5787580|P1|COMPLETED|Overall Study||21
2358737|NCT01613339|5787579|P2|STARTED|Overall Study||22
2358738|NCT01613339|5787580|P1|STARTED|Overall Study||24
2358739|NCT01613326|5787591|P2|NOT COMPLETED|Overall Study||14
2358740|NCT01613326|5787592|P1|NOT COMPLETED|Overall Study||13
2358741|NCT01613326|5787591|P2|COMPLETED|Overall Study||316
2358742|NCT01613326|5787592|P1|COMPLETED|Overall Study||314
2358743|NCT01613326|5787591|P2|STARTED|Overall Study||330
2358744|NCT01613326|5787592|P1|STARTED|Overall Study||327
2358745|NCT01613313|5787626|P4|NOT COMPLETED|Overall Study||0
2358746|NCT01613313|5787627|P3|NOT COMPLETED|Overall Study||0
2358747|NCT01613313|5787628|P2|NOT COMPLETED|Overall Study||0
2358748|NCT01613313|5787629|P1|NOT COMPLETED|Overall Study||0
2358749|NCT01613313|5787626|P4|COMPLETED|Overall Study||4
2358750|NCT01613313|5787627|P3|COMPLETED|Overall Study||4
2358751|NCT01613313|5787628|P2|COMPLETED|Overall Study||4
2358752|NCT01613313|5787629|P1|COMPLETED|Overall Study||2
2358753|NCT01613313|5787626|P4|STARTED|Overall Study||4
2358754|NCT01613313|5787627|P3|STARTED|Overall Study||4
2358755|NCT01613313|5787628|P2|STARTED|Overall Study||4
2358756|NCT01613313|5787629|P1|STARTED|Overall Study||2
2358757|NCT01613248|5787649|P6|NOT COMPLETED|Overall Study||38
2358758|NCT01613248|5787650|P5|NOT COMPLETED|Overall Study||35
2358759|NCT01613248|5787651|P4|NOT COMPLETED|Overall Study||38
2358760|NCT01613248|5787652|P3|NOT COMPLETED|Overall Study||33
2358761|NCT01613248|5787653|P2|NOT COMPLETED|Overall Study||34
2358762|NCT01613248|5787654|P1|NOT COMPLETED|Overall Study||29
2358763|NCT01613248|5787649|P6|COMPLETED|Overall Study||102
2358764|NCT01613248|5787650|P5|COMPLETED|Overall Study||104
2358765|NCT01613248|5787651|P4|COMPLETED|Overall Study||101
2358766|NCT01613248|5787652|P3|COMPLETED|Overall Study||106
2358767|NCT01613248|5787653|P2|COMPLETED|Overall Study||104
2358768|NCT01613248|5787654|P1|COMPLETED|Overall Study||110
2358769|NCT01613248|5787649|P6|STARTED|Overall Study||140
2358770|NCT01613248|5787650|P5|STARTED|Overall Study||139
2358771|NCT01613248|5787651|P4|STARTED|Overall Study||139
2358772|NCT01613248|5787652|P3|STARTED|Overall Study||139
2358773|NCT01613248|5787653|P2|STARTED|Overall Study||138
2358774|NCT01613248|5787654|P1|STARTED|Overall Study||139
2358775|NCT01613222|5787752|P1|NOT COMPLETED|Overall Study||12
2358776|NCT01613222|5787752|P1|COMPLETED|Overall Study||51
2358777|NCT01613222|5787752|P1|STARTED|Overall Study||63
2358778|NCT01613131|5787767|P2|NOT COMPLETED|Overall Study||5
2358779|NCT01613131|5787768|P1|NOT COMPLETED|Overall Study||3
2358780|NCT01613131|5787767|P2|COMPLETED|Overall Study||13
2358781|NCT01613131|5787768|P1|COMPLETED|Overall Study||17
2358782|NCT01613131|5787767|P2|STARTED|Overall Study||18
2358783|NCT01613131|5787768|P1|STARTED|Overall Study||20
2358784|NCT01613027|5787796|P1|NOT COMPLETED|Overall Study||8
2358785|NCT01613027|5787796|P1|COMPLETED|Overall Study||127
2358786|NCT01613027|5787796|P1|STARTED|Overall Study||135
2358787|NCT01613014|5787817|P2|NOT COMPLETED|Overall Study||12
2358788|NCT01613014|5787818|P1|NOT COMPLETED|Overall Study||18
2358789|NCT01613014|5787817|P2|COMPLETED|Overall Study||63
2358790|NCT01613014|5787818|P1|COMPLETED|Overall Study||57
2358791|NCT01613014|5787817|P2|STARTED|Overall Study||75
2358792|NCT01613014|5787818|P1|STARTED|Overall Study||75
2358793|NCT01612884|5787826|P2|NOT COMPLETED|Overall Study||0
2358794|NCT01612884|5787827|P1|NOT COMPLETED|Overall Study||0
2358795|NCT01612884|5787826|P2|COMPLETED|Overall Study||18
2358796|NCT01612884|5787827|P1|COMPLETED|Overall Study||19
2358797|NCT01612884|5787826|P2|STARTED|Overall Study||18
2358798|NCT01612884|5787827|P1|STARTED|Overall Study||19
2358799|NCT01612858|5787839|P2|NOT COMPLETED|Overall Study||1
2358800|NCT01612858|5787840|P1|NOT COMPLETED|Overall Study||5
2358801|NCT01612858|5787839|P2|COMPLETED|Overall Study||3
2358802|NCT01612858|5787840|P1|COMPLETED|Overall Study||11
2358803|NCT01612858|5787839|P2|STARTED|Overall Study||4
2358804|NCT01612858|5787840|P1|STARTED|Overall Study||16
2358805|NCT01612793|5787850|P2|NOT COMPLETED|Overall Study||0
2358806|NCT01612793|5787851|P1|NOT COMPLETED|Overall Study||0
2358807|NCT01612793|5787850|P2|COMPLETED|Overall Study||2
2358808|NCT01612793|5787851|P1|COMPLETED|Overall Study||2
2358809|NCT01612793|5787850|P2|STARTED|Overall Study||2
2358810|NCT01612793|5787851|P1|STARTED|Overall Study||2
2358811|NCT01612767|5787857|P1|NOT COMPLETED|Overall Study||42
2358812|NCT01612767|5787857|P1|COMPLETED|Overall Study||287
2358813|NCT01612767|5787857|P1|STARTED|Overall Study||329
2358814|NCT01612702|5787913|P2|NOT COMPLETED|Overall Study||11
2358815|NCT01612702|5787914|P1|NOT COMPLETED|Overall Study||11
2358816|NCT01612702|5787913|P2|COMPLETED|Overall Study||134
2358817|NCT01612702|5787914|P1|COMPLETED|Overall Study||135
2358818|NCT01612702|5787913|P2|STARTED|Overall Study||145
2358819|NCT01612702|5787914|P1|STARTED|Overall Study||146
2358820|NCT01612676|5787928|P4|NOT COMPLETED|Overall Study||3
2358821|NCT01612676|5787929|P3|NOT COMPLETED|Overall Study||1
2358822|NCT01612676|5787930|P2|NOT COMPLETED|Overall Study||4
2358823|NCT01612676|5787931|P1|NOT COMPLETED|Overall Study||2
2358824|NCT01612676|5787928|P4|COMPLETED|Overall Study||10
2358825|NCT01612676|5787929|P3|COMPLETED|Overall Study||4
2358826|NCT01612676|5787930|P2|COMPLETED|Overall Study||3
2358827|NCT01612676|5787931|P1|COMPLETED|Overall Study||4
2358828|NCT01612676|5787928|P4|Dosed|Overall Study||13
2358829|NCT01612676|5787929|P3|Dosed|Overall Study||5
2358830|NCT01612676|5787930|P2|Dosed|Overall Study||7
2358831|NCT01612676|5787931|P1|Dosed|Overall Study||5
2358832|NCT01612676|5787928|P4|STARTED|Overall Study||13
2358833|NCT01612676|5787929|P3|STARTED|Overall Study||5
2358834|NCT01612676|5787930|P2|STARTED|Overall Study||7
2358835|NCT01612676|5787931|P1|STARTED|Overall Study||6
2358836|NCT01612546|5787987|P1|NOT COMPLETED|Overall Study||0
2358837|NCT01612546|5787987|P1|COMPLETED|Overall Study||10
2358838|NCT01612546|5787987|P1|STARTED|Overall Study||10
2358839|NCT01612494|5787997|P2|NOT COMPLETED|Overall Study||0
2358840|NCT01612494|5787998|P1|NOT COMPLETED|Overall Study||0
2358841|NCT01612494|5787997|P2|COMPLETED|Overall Study||23
2358842|NCT01612494|5787998|P1|COMPLETED|Overall Study||21
2358843|NCT01612494|5787997|P2|STARTED|Overall Study||23
2358844|NCT01612494|5787998|P1|STARTED|Overall Study||21
2358845|NCT01612351|5788004|P1|NOT COMPLETED|Post-Operative Treatment||0
2358846|NCT01612351|5788004|P1|COMPLETED|Post-Operative Treatment|One patient completed chemotherapy then withdrew before surgery.|39
2358847|NCT01612351|5788004|P1|STARTED|Post-Operative Treatment||39
2358848|NCT01612351|5788004|P1|NOT COMPLETED|Transoral Surgery||0
2358849|NCT01612351|5788004|P1|COMPLETED|Transoral Surgery||39
2358850|NCT01612351|5788004|P1|STARTED|Transoral Surgery|One patient completed chemotherapy then withdrew before surgery.|39
2358851|NCT01612351|5788004|P1|NOT COMPLETED|Chemotherapy||0
2358852|NCT01612351|5788004|P1|COMPLETED|Chemotherapy||40
2358853|NCT01612351|5788004|P1|STARTED|Chemotherapy||40
2358854|NCT01612221|5788018|P2|NOT COMPLETED|Overall Study||0
2358855|NCT01612221|5788019|P1|NOT COMPLETED|Overall Study||0
2358856|NCT01612221|5788018|P2|COMPLETED|Overall Study||50
2358857|NCT01612221|5788019|P1|COMPLETED|Overall Study||50
2358858|NCT01612221|5788018|P2|STARTED|Overall Study||50
2358859|NCT01612221|5788019|P1|STARTED|Overall Study||50
2358860|NCT01612156|5788029|P2|NOT COMPLETED|Overall Study||0
2358861|NCT01612156|5788030|P1|NOT COMPLETED|Overall Study||2
2358862|NCT01612156|5788029|P2|COMPLETED|Overall Study||48
2358863|NCT01612156|5788030|P1|COMPLETED|Overall Study|Contraindication to urodynamics (urinary tract infection) diagnosed after randomization|40
2358864|NCT01612156|5788029|P2|STARTED|Overall Study||48
2358865|NCT01612156|5788030|P1|STARTED|Overall Study||42
2358866|NCT01612000|5788042|P4|NOT COMPLETED|Overall Study||10
2358867|NCT01612000|5788043|P3|NOT COMPLETED|Overall Study||7
2358868|NCT01612000|5788044|P2|NOT COMPLETED|Overall Study||5
2358869|NCT01612000|5788045|P1|NOT COMPLETED|Overall Study||9
2358870|NCT01612000|5788042|P4|COMPLETED|Overall Study||76
2358871|NCT01612000|5788043|P3|COMPLETED|Overall Study||78
2358872|NCT01612000|5788044|P2|COMPLETED|Overall Study||81
2358873|NCT01612000|5788045|P1|COMPLETED|Overall Study||75
2358874|NCT01612000|5788042|P4|STARTED|Overall Study||86
2358875|NCT01612000|5788043|P3|STARTED|Overall Study||85
2358876|NCT01612000|5788044|P2|STARTED|Overall Study||86
2358877|NCT01612000|5788045|P1|STARTED|Overall Study||84
2358878|NCT01611974|5788070|P3|NOT COMPLETED|Overall Study||16
2358879|NCT01611974|5788071|P2|NOT COMPLETED|Overall Study||15
2358880|NCT01611974|5788072|P1|NOT COMPLETED|Overall Study||15
2358881|NCT01611974|5788070|P3|COMPLETED|Overall Study||24
2358882|NCT01611974|5788071|P2|COMPLETED|Overall Study||25
2358883|NCT01611974|5788072|P1|COMPLETED|Overall Study||25
2358884|NCT01611974|5788070|P3|STARTED|Overall Study||40
2358885|NCT01611974|5788071|P2|STARTED|Overall Study||40
2358886|NCT01611974|5788072|P1|STARTED|Overall Study||40
2358887|NCT01611948|5788109|P2|NOT COMPLETED|Overall Study||12
2358888|NCT01611948|5788110|P1|NOT COMPLETED|Overall Study||14
2358889|NCT01611948|5788109|P2|COMPLETED|Overall Study||26
2358890|NCT01611948|5788110|P1|COMPLETED|Overall Study||18
2358891|NCT01611948|5788109|P2|STARTED|Overall Study||38
2358892|NCT01611948|5788110|P1|STARTED|Overall Study||32
2358893|NCT01611935|5788118|P2|NOT COMPLETED|Overall Study||0
2358894|NCT01611935|5788119|P1|NOT COMPLETED|Overall Study||1
2358895|NCT01611935|5788118|P2|COMPLETED|Overall Study||51
2358896|NCT01611935|5788119|P1|COMPLETED|Overall Study||49
2358897|NCT01611935|5788118|P2|STARTED|Overall Study||51
2358898|NCT01611935|5788119|P1|STARTED|Overall Study||50
2358899|NCT01611883|5788131|P2|NOT COMPLETED|Overall Study||1
2358900|NCT01611883|5788132|P1|NOT COMPLETED|Overall Study||1
2358901|NCT01611883|5788131|P2|COMPLETED|Overall Study||76
2358902|NCT01611883|5788132|P1|COMPLETED|Overall Study||74
2358903|NCT01611883|5788131|P2|STARTED|Overall Study||77
2358904|NCT01611883|5788132|P1|STARTED|Overall Study||75
2358905|NCT01611857|5788158|P2|NOT COMPLETED|Overall Study||2
2358906|NCT01611857|5788159|P1|NOT COMPLETED|Overall Study||0
2358907|NCT01611857|5788158|P2|COMPLETED|Overall Study||32
2358908|NCT01611857|5788159|P1|COMPLETED|Overall Study||15
2358909|NCT01611857|5788158|P2|Tivantinib 360 mg|Overall Study|Two participants withdrew prior to receiving drug.|32
2358910|NCT01611857|5788159|P1|Tivantinib 360 mg|Overall Study||7
2358911|NCT01611857|5788158|P2|Tivantinib 240 mg|Overall Study||0
2358912|NCT01611857|5788159|P1|Tivantinib 240 mg|Overall Study||3
2358913|NCT01611857|5788158|P2|Tivantinib 120 mg|Overall Study||0
2358914|NCT01611857|5788159|P1|Tivantinib 120 mg|Overall Study||5
2358915|NCT01611857|5788158|P2|STARTED|Overall Study||34
2358916|NCT01611857|5788159|P1|STARTED|Overall Study|Three dose levels of tivantinib (120 mg, 240 mg, and 360 mg) were evaluated to determine the MTD.|15
2358917|NCT01611792|5788171|P2|NOT COMPLETED|Followup: at 6 Months||13
2358918|NCT01611792|5788172|P1|NOT COMPLETED|Followup: at 6 Months||6
2358919|NCT01611792|5788171|P2|COMPLETED|Followup: at 6 Months||7
2358920|NCT01611792|5788172|P1|COMPLETED|Followup: at 6 Months||11
2358921|NCT01611792|5788171|P2|STARTED|Followup: at 6 Months||20
2358922|NCT01611792|5788172|P1|STARTED|Followup: at 6 Months||17
2358923|NCT01611792|5788171|P2|NOT COMPLETED|Follow-up: at 11 Weeks||0
2358924|NCT01611792|5788172|P1|NOT COMPLETED|Follow-up: at 11 Weeks||0
2358925|NCT01611792|5788171|P2|COMPLETED|Follow-up: at 11 Weeks||20
2358926|NCT01611792|5788172|P1|COMPLETED|Follow-up: at 11 Weeks||17
2358927|NCT01611792|5788171|P2|STARTED|Follow-up: at 11 Weeks||20
2358928|NCT01611792|5788172|P1|STARTED|Follow-up: at 11 Weeks||17
2358929|NCT01611792|5788171|P2|NOT COMPLETED|Initial Period: Time 0||9
2358930|NCT01611792|5788172|P1|NOT COMPLETED|Initial Period: Time 0||12
2358931|NCT01611792|5788171|P2|COMPLETED|Initial Period: Time 0||20
2358932|NCT01611792|5788172|P1|COMPLETED|Initial Period: Time 0||17
2358933|NCT01611792|5788171|P2|STARTED|Initial Period: Time 0||29
2358934|NCT01611792|5788172|P1|STARTED|Initial Period: Time 0||29
2358935|NCT01611779|5788188|P1|NOT COMPLETED|Overall Study||0
2358936|NCT01611779|5788188|P1|COMPLETED|Overall Study||5
2358937|NCT01611779|5788188|P1|STARTED|Overall Study||5
2358938|NCT01611662|5788197|P1|NOT COMPLETED|Overall Study||1
2358939|NCT01611662|5788197|P1|COMPLETED|Overall Study||31
2358940|NCT01611662|5788197|P1|STARTED|Overall Study||32
2358941|NCT01611571|5788204|P3|NOT COMPLETED|Overall Study||1
2358942|NCT01611571|5788205|P2|NOT COMPLETED|Overall Study||0
2358943|NCT01611571|5788206|P1|NOT COMPLETED|Overall Study||1
2358944|NCT01611571|5788204|P3|COMPLETED|Overall Study||9
2358945|NCT01611571|5788205|P2|COMPLETED|Overall Study||10
2358946|NCT01611571|5788206|P1|COMPLETED|Overall Study||10
2358947|NCT01611571|5788204|P3|STARTED|Overall Study||10
2358948|NCT01611571|5788205|P2|STARTED|Overall Study||10
2358949|NCT01611571|5788206|P1|STARTED|Overall Study||11
2358950|NCT01611558|5788226|P1|NOT COMPLETED|Maintenance Phase||2
2358951|NCT01611558|5788226|P1|COMPLETED|Maintenance Phase||0
2358952|NCT01611558|5788226|P1|STARTED|Maintenance Phase||2
2358953|NCT01611558|5788226|P1|NOT COMPLETED|Induction Phase||38
2358954|NCT01611558|5788226|P1|COMPLETED|Induction Phase||2
2358955|NCT01611558|5788226|P1|STARTED|Induction Phase||40
2358956|NCT01611259|5788232|P1|NOT COMPLETED|Overall Study||14
2358957|NCT01611259|5788232|P1|COMPLETED|Overall Study||34
2358958|NCT01611259|5788232|P1|STARTED|Overall Study||48
2358959|NCT01611194|5788238|P2|NOT COMPLETED|Overall Study||3
2358960|NCT01611194|5788239|P1|NOT COMPLETED|Overall Study||0
2358961|NCT01611194|5788238|P2|COMPLETED|Overall Study||32
2358962|NCT01611194|5788239|P1|COMPLETED|Overall Study||36
2358963|NCT01611194|5788238|P2|STARTED|Overall Study||35
2358964|NCT01611194|5788239|P1|STARTED|Overall Study||36
2358965|NCT01611155|5788277|P2|NOT COMPLETED|Overall Study||7
2358966|NCT01611155|5788278|P1|NOT COMPLETED|Overall Study||9
2358967|NCT01611155|5788277|P2|COMPLETED|Overall Study||18
2358968|NCT01611155|5788278|P1|COMPLETED|Overall Study||16
2358969|NCT01611155|5788277|P2|Received Treatment|Overall Study||25
2358970|NCT01611155|5788278|P1|Received Treatment|Overall Study||25
2358971|NCT01611155|5788277|P2|STARTED|Overall Study||25
2358972|NCT01611155|5788278|P1|STARTED|Overall Study||25
2358973|NCT01610791|5788286|P1|NOT COMPLETED|Overall Study||21
2358974|NCT01610791|5788286|P1|COMPLETED|Overall Study||100
2358975|NCT01610791|5788286|P1|STARTED|Overall Study||121
2358976|NCT01610752|5788310|P3|NOT COMPLETED|Overall Study||4
2358977|NCT01610752|5788311|P2|NOT COMPLETED|Overall Study||0
2358978|NCT01610752|5788312|P1|NOT COMPLETED|Overall Study||0
2358979|NCT01610752|5788310|P3|COMPLETED|Overall Study||13
2358980|NCT01610752|5788311|P2|COMPLETED|Overall Study||19
2358981|NCT01610752|5788312|P1|COMPLETED|Overall Study||18
2358982|NCT01610752|5788310|P3|STARTED|Overall Study||17
2358983|NCT01610752|5788311|P2|STARTED|Overall Study||19
2358984|NCT01610752|5788312|P1|STARTED|Overall Study||18
2358985|NCT01610713|5788334|P2|NOT COMPLETED|Overall Study||1
2358986|NCT01610713|5788335|P1|NOT COMPLETED|Overall Study||6
2358987|NCT01610713|5788334|P2|COMPLETED|Overall Study||76
2358988|NCT01610713|5788335|P1|COMPLETED|Overall Study||71
2358989|NCT01610713|5788334|P2|STARTED|Overall Study||77
2358990|NCT01610713|5788335|P1|STARTED|Overall Study||77
2358991|NCT01610700|5788393|P2|NOT COMPLETED|Overall Study||3
2358992|NCT01610700|5788394|P1|NOT COMPLETED|Overall Study||3
2358993|NCT01610700|5788393|P2|COMPLETED|Overall Study||77
2358994|NCT01610700|5788394|P1|COMPLETED|Overall Study||77
2358995|NCT01610700|5788393|P2|STARTED|Overall Study||80
2358996|NCT01610700|5788394|P1|STARTED|Overall Study||80
2358997|NCT01610687|5788448|P1|NOT COMPLETED|Overall Study||67
2358998|NCT01610687|5788448|P1|COMPLETED|Overall Study||70
2358999|NCT01610687|5788448|P1|STARTED|Overall Study||137
2359000|NCT01610596|5788461|P2|NOT COMPLETED|Overall Study||1
2359001|NCT01610596|5788462|P1|NOT COMPLETED|Overall Study||0
2359002|NCT01610596|5788461|P2|COMPLETED|Overall Study||35
2359003|NCT01610596|5788462|P1|COMPLETED|Overall Study||36
2359004|NCT01610596|5788461|P2|STARTED|Overall Study||36
2359005|NCT01610596|5788462|P1|STARTED|Overall Study||36
2359006|NCT01610570|5788478|P4|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
2359007|NCT01610570|5788479|P3|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
2359008|NCT01610570|5788480|P2|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
2359009|NCT01610570|5788481|P1|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
2359010|NCT01610570|5788478|P4|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
2359011|NCT01610570|5788479|P3|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
2359012|NCT01610570|5788480|P2|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
2359013|NCT01610570|5788481|P1|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
2359014|NCT01610570|5788478|P4|STARTED|Ph II >/= 12 mo. & </=17yrs||0
2359015|NCT01610570|5788479|P3|STARTED|Ph II >/= 12 mo. & </=17yrs||0
2359016|NCT01610570|5788480|P2|STARTED|Ph II >/= 12 mo. & </=17yrs||0
2359017|NCT01610570|5788481|P1|STARTED|Ph II >/= 12 mo. & </=17yrs||0
2359018|NCT01610570|5788478|P4|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
2359019|NCT01610570|5788479|P3|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
2359020|NCT01610570|5788480|P2|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
2359021|NCT01610570|5788481|P1|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
2359022|NCT01610570|5788478|P4|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||6
2359023|NCT01610570|5788479|P3|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
2359024|NCT01610570|5788480|P2|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
2359025|NCT01610570|5788481|P1|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
2359026|NCT01610570|5788478|P4|STARTED|Ph II >/= 18yrs of Age at Enrollment||6
2359027|NCT01610570|5788479|P3|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
2359028|NCT01610570|5788480|P2|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
2359029|NCT01610570|5788481|P1|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
2359030|NCT01610570|5788478|P4|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
2359031|NCT01610570|5788479|P3|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
2359032|NCT01610570|5788480|P2|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
2359033|NCT01610570|5788481|P1|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
2359034|NCT01610570|5788478|P4|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
2359035|NCT01610570|5788479|P3|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
2359036|NCT01610570|5788480|P2|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||2
2359037|NCT01610570|5788481|P1|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
2359038|NCT01610570|5788478|P4|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
2359039|NCT01610570|5788479|P3|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
2359040|NCT01610570|5788480|P2|STARTED|Ph I >/= 12 mo. Children & Adolescents||2
2359041|NCT01610570|5788481|P1|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
2359042|NCT01610557|5788520|P5|NOT COMPLETED|Post-36-Week Extension Phase||3
2359043|NCT01610557|5788521|P4|NOT COMPLETED|Post-36-Week Extension Phase||0
2359044|NCT01610557|5788522|P3|NOT COMPLETED|Post-36-Week Extension Phase||0
2359045|NCT01610557|5788523|P2|NOT COMPLETED|Post-36-Week Extension Phase||0
2359046|NCT01610557|5788524|P1|NOT COMPLETED|Post-36-Week Extension Phase||0
2359047|NCT01610557|5788520|P5|COMPLETED|Post-36-Week Extension Phase|2 bilateral participants withdrew before their first post-36-week extension visit|52
2359048|NCT01610557|5788521|P4|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
2359049|NCT01610557|5788522|P3|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
2359050|NCT01610557|5788523|P2|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
2359051|NCT01610557|5788524|P1|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
2359052|NCT01610557|5788520|P5|STARTED|Post-36-Week Extension Phase||55
2359053|NCT01610557|5788521|P4|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
2359054|NCT01610557|5788522|P3|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
2359055|NCT01610557|5788523|P2|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
2359056|NCT01610557|5788524|P1|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
2359057|NCT01610557|5788520|P5|NOT COMPLETED|36-Week Randomized Crossover Phase||0
2359058|NCT01610557|5788521|P4|NOT COMPLETED|36-Week Randomized Crossover Phase||0
2359059|NCT01610557|5788522|P3|NOT COMPLETED|36-Week Randomized Crossover Phase||0
2359060|NCT01610557|5788523|P2|NOT COMPLETED|36-Week Randomized Crossover Phase||1
2359061|NCT01610557|5788524|P1|NOT COMPLETED|36-Week Randomized Crossover Phase||0
2359062|NCT01610557|5788520|P5|COMPLETED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
2359063|NCT01610557|5788521|P4|COMPLETED|36-Week Randomized Crossover Phase||13
2359064|NCT01610557|5788522|P3|COMPLETED|36-Week Randomized Crossover Phase||14
2359065|NCT01610557|5788523|P2|COMPLETED|36-Week Randomized Crossover Phase|Unilateral participant unable to return for visits after Wk 4 due to recovery from an adverse event|12
2359066|NCT01610557|5788524|P1|COMPLETED|36-Week Randomized Crossover Phase||16
2359067|NCT01610557|5788520|P5|STARTED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
2359068|NCT01610557|5788521|P4|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 4: 11 unilateral and 2 bilateral (left eye assigned to Grp 2)|13
2359069|NCT01610557|5788522|P3|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 3: 13 unilateral and 1 bilateral (left eye assigned to Grp 1)|14
2359070|NCT01610557|5788523|P2|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 2: 12 unilateral and 1 bilateral (left eye assigned to Grp 4)|13
2359071|NCT01610557|5788524|P1|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 1: 14 unilateral and 2 bilateral (left eye assigned to Grp 3)|16
2359072|NCT01610492|5788537|P1|NOT COMPLETED|Overall Study||6
2359073|NCT01610492|5788537|P1|COMPLETED|Overall Study||8
2359074|NCT01610492|5788537|P1|STARTED|Overall Study||14
2359075|NCT01610453|5788581|P1|NOT COMPLETED|Overall Study||0
2359076|NCT01610453|5788581|P1|COMPLETED|Overall Study||150
2359077|NCT01610453|5788581|P1|STARTED|Overall Study||150
2359078|NCT01610414|5788588|P2|NOT COMPLETED|After Month 25||53
2359079|NCT01610414|5788589|P1|NOT COMPLETED|After Month 25||48
2359080|NCT01610414|5788588|P2|COMPLETED|After Month 25||871
2359081|NCT01610414|5788589|P1|COMPLETED|After Month 25||874
2359082|NCT01610414|5788588|P2|STARTED|After Month 25||924
2359083|NCT01610414|5788589|P1|STARTED|After Month 25||922
2359084|NCT01610414|5788588|P2|NOT COMPLETED|Month 13 - Month 25||70
2359085|NCT01610414|5788589|P1|NOT COMPLETED|Month 13 - Month 25||65
2359086|NCT01610414|5788588|P2|COMPLETED|Month 13 - Month 25||854
2359087|NCT01610414|5788589|P1|COMPLETED|Month 13 - Month 25||857
2359088|NCT01610414|5788588|P2|STARTED|Month 13 - Month 25||924
2359089|NCT01610414|5788589|P1|STARTED|Month 13 - Month 25||922
2359090|NCT01610414|5788588|P2|NOT COMPLETED|Study Start - Month 13||129
2359091|NCT01610414|5788589|P1|NOT COMPLETED|Study Start - Month 13||115
2359092|NCT01610414|5788588|P2|COMPLETED|Study Start - Month 13||795
2359093|NCT01610414|5788589|P1|COMPLETED|Study Start - Month 13||807
2359094|NCT01610414|5788588|P2|STARTED|Study Start - Month 13||924
2359095|NCT01610414|5788589|P1|STARTED|Study Start - Month 13||922
2359096|NCT01610297|5788618|P1|NOT COMPLETED|Overall Study||1
2359097|NCT01610297|5788618|P1|COMPLETED|Overall Study||26
2359098|NCT01610297|5788618|P1|STARTED|Overall Study||27
2359099|NCT01610271|5788628|P2|NOT COMPLETED|Overall Study||4
2359100|NCT01610271|5788629|P1|NOT COMPLETED|Overall Study||2
2359101|NCT01610271|5788628|P2|COMPLETED|Overall Study||146
2359102|NCT01610271|5788629|P1|COMPLETED|Overall Study||148
2359103|NCT01610271|5788628|P2|STARTED|Overall Study||150
2359104|NCT01610271|5788629|P1|STARTED|Overall Study||150
2359105|NCT01610167|5788644|P3|NOT COMPLETED|Overall Study||2
2359106|NCT01610167|5788645|P2|NOT COMPLETED|Overall Study||0
2359107|NCT01610167|5788646|P1|NOT COMPLETED|Overall Study||0
2359108|NCT01610167|5788644|P3|COMPLETED|Overall Study||48
2359109|NCT01610167|5788645|P2|COMPLETED|Overall Study||49
2359110|NCT01610167|5788646|P1|COMPLETED|Overall Study||52
2359111|NCT01610167|5788644|P3|STARTED|Overall Study||50
2359112|NCT01610167|5788645|P2|STARTED|Overall Study||49
2359113|NCT01610167|5788646|P1|STARTED|Overall Study||52
2359114|NCT01610154|5788666|P1|NOT COMPLETED|Overall Study||1
2359115|NCT01610154|5788666|P1|COMPLETED|Overall Study||84
2359116|NCT01610154|5788666|P1|STARTED|Overall Study||85
2359117|NCT01610076|5788683|P2|NOT COMPLETED|Overall Study||5
2359118|NCT01610076|5788684|P1|NOT COMPLETED|Overall Study||3
2359119|NCT01610076|5788683|P2|COMPLETED|Overall Study||100
2359120|NCT01610076|5788684|P1|COMPLETED|Overall Study||100
2359121|NCT01610076|5788683|P2|STARTED|Overall Study||105
2359122|NCT01610076|5788684|P1|STARTED|Overall Study||103
2359123|NCT01610063|5788695|P2|NOT COMPLETED|Overall Study||20
2359124|NCT01610063|5788696|P1|NOT COMPLETED|Overall Study||42
2359125|NCT01610063|5788695|P2|COMPLETED|Overall Study||93
2359126|NCT01610063|5788696|P1|COMPLETED|Overall Study||72
2359127|NCT01610063|5788695|P2|Completed 8-week|Overall Study||93
2359128|NCT01610063|5788696|P1|Completed 8-week|Overall Study||72
2359129|NCT01610063|5788695|P2|Completed 4-week|Overall Study||98
2359130|NCT01610063|5788696|P1|Completed 4-week|Overall Study||86
2359131|NCT01610063|5788695|P2|Completed 2-week|Overall Study||105
2359132|NCT01610063|5788696|P1|Completed 2-week|Overall Study||97
2359133|NCT01610063|5788695|P2|Baseline|Overall Study||113
2359134|NCT01610063|5788696|P1|Baseline|Overall Study||114
2359135|NCT01610063|5788695|P2|STARTED|Overall Study||113
2359136|NCT01610063|5788696|P1|STARTED|Overall Study||114
2359137|NCT01610037|5788719|P3|NOT COMPLETED|Treatment and Follow up Period||26
2359138|NCT01610037|5788720|P2|NOT COMPLETED|Treatment and Follow up Period||28
2359139|NCT01610037|5788721|P1|NOT COMPLETED|Treatment and Follow up Period||25
2359140|NCT01610037|5788719|P3|COMPLETED|Treatment and Follow up Period||378
2359141|NCT01610037|5788720|P2|COMPLETED|Treatment and Follow up Period||377
2359142|NCT01610037|5788721|P1|COMPLETED|Treatment and Follow up Period||382
2359143|NCT01610037|5788719|P3|STARTED|Treatment and Follow up Period||404
2359144|NCT01610037|5788720|P2|STARTED|Treatment and Follow up Period||405
2359145|NCT01610037|5788721|P1|STARTED|Treatment and Follow up Period||407
2359146|NCT01610037|5788719|P3|NOT COMPLETED|All Patients||84
2359147|NCT01610037|5788720|P2|NOT COMPLETED|All Patients||51
2359148|NCT01610037|5788721|P1|NOT COMPLETED|All Patients||59
2359149|NCT01610037|5788719|P3|COMPLETED|All Patients||320
2359150|NCT01610037|5788720|P2|COMPLETED|All Patients||354
2359151|NCT01610037|5788721|P1|COMPLETED|All Patients||348
2359152|NCT01610037|5788719|P3|Full Analysis Set (FAS)|All Patients||403
2359153|NCT01610037|5788720|P2|Full Analysis Set (FAS)|All Patients||405
2359154|NCT01610037|5788721|P1|Full Analysis Set (FAS)|All Patients||407
2359155|NCT01610037|5788719|P3|Randomized Set (RAN)|All Patients||404
2359156|NCT01610037|5788720|P2|Randomized Set (RAN)|All Patients||405
2359157|NCT01610037|5788721|P1|Randomized Set (RAN)|All Patients||407
2359158|NCT01610037|5788719|P3|STARTED|All Patients||404
2359159|NCT01610037|5788720|P2|STARTED|All Patients||405
2359160|NCT01610037|5788721|P1|STARTED|All Patients||407
2359161|NCT01610011|5788764|P2|NOT COMPLETED|Overall Study||0
2359162|NCT01610011|5788765|P1|NOT COMPLETED|Overall Study||10
2359163|NCT01610011|5788764|P2|COMPLETED|Overall Study||2
2359164|NCT01610011|5788765|P1|COMPLETED|Overall Study||9
2359165|NCT01610011|5788764|P2|STARTED|Overall Study||2
2359166|NCT01610011|5788765|P1|STARTED|Overall Study||19
2359167|NCT01609933|5788771|P1|NOT COMPLETED|Overall Study||4
2359168|NCT01609933|5788771|P1|COMPLETED|Overall Study||28
2359169|NCT01609933|5788771|P1|STARTED|Overall Study||32
2359170|NCT01609842|5788782|P2|NOT COMPLETED|Concurrent Intervention Control||0
2359171|NCT01609842|5788783|P1|NOT COMPLETED|Concurrent Intervention Control||2
2359172|NCT01609842|5788782|P2|COMPLETED|Concurrent Intervention Control||4869
2359173|NCT01609842|5788783|P1|COMPLETED|Concurrent Intervention Control||706
2359174|NCT01609842|5788782|P2|STARTED|Concurrent Intervention Control|Nonintervention sites patients during the period prior and post enrollment at the intervention sites|4869
2359175|NCT01609842|5788783|P1|STARTED|Concurrent Intervention Control||708
2359176|NCT01609842|5788782|P2|NOT COMPLETED|Post-Intervention Control||0
2359177|NCT01609842|5788783|P1|NOT COMPLETED|Post-Intervention Control||0
2359178|NCT01609842|5788782|P2|COMPLETED|Post-Intervention Control||2917
2359179|NCT01609842|5788783|P1|COMPLETED|Post-Intervention Control||0
2359180|NCT01609842|5788782|P2|STARTED|Post-Intervention Control|Intervention sites patients after enrollment period ended who did not receive the intervention.|2917
2359181|NCT01609842|5788783|P1|STARTED|Post-Intervention Control||0
2359182|NCT01609842|5788782|P2|NOT COMPLETED|Pre-Intervention Control||0
2359183|NCT01609842|5788783|P1|NOT COMPLETED|Pre-Intervention Control||0
2359184|NCT01609842|5788782|P2|COMPLETED|Pre-Intervention Control||6081
2359185|NCT01609842|5788783|P1|COMPLETED|Pre-Intervention Control||0
2359186|NCT01609842|5788782|P2|STARTED|Pre-Intervention Control|Intervention sites patients prior to enrollment period who did not receive the intervention|6081
2359187|NCT01609842|5788783|P1|STARTED|Pre-Intervention Control||0
2359188|NCT01609790|5788810|P3|NOT COMPLETED|Overall Study||8
2359189|NCT01609790|5788811|P2|NOT COMPLETED|Overall Study||7
2359190|NCT01609790|5788812|P1|NOT COMPLETED|Overall Study||1
2359191|NCT01609790|5788810|P3|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|57
2359192|NCT01609790|5788811|P2|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
2359193|NCT01609790|5788812|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|6
2359194|NCT01609790|5788810|P3|STARTED|Overall Study||65
2359195|NCT01609790|5788811|P2|STARTED|Overall Study||65
2359196|NCT01609790|5788812|P1|STARTED|Overall Study||7
2359197|NCT01609582|5788831|P2|NOT COMPLETED|Overall Study||1604
2359198|NCT01609582|5788832|P1|NOT COMPLETED|Overall Study||1603
2359199|NCT01609582|5788831|P2|COMPLETED|Overall Study||0
2359200|NCT01609582|5788832|P1|COMPLETED|Overall Study||0
2359201|NCT01609582|5788831|P2|Treated|Overall Study||1601
2359202|NCT01609582|5788832|P1|Treated|Overall Study||1603
2359203|NCT01609582|5788831|P2|STARTED|Overall Study||1604
2359204|NCT01609582|5788832|P1|STARTED|Overall Study||1603
2359205|NCT01609543|5788840|P1|NOT COMPLETED|Overall Study||42
2359206|NCT01609543|5788840|P1|COMPLETED|Overall Study||20
2359207|NCT01609543|5788840|P1|STARTED|Overall Study||62
2359208|NCT01609478|5788849|P3|NOT COMPLETED|Overall Study||9
2359209|NCT01609478|5788850|P2|NOT COMPLETED|Overall Study||2
2359210|NCT01609478|5788851|P1|NOT COMPLETED|Overall Study||7
2359211|NCT01609478|5788849|P3|COMPLETED|Overall Study||107
2359212|NCT01609478|5788850|P2|COMPLETED|Overall Study||106
2359213|NCT01609478|5788851|P1|COMPLETED|Overall Study||104
2359214|NCT01609478|5788849|P3|Full Analysis Set (FAS)|Overall Study||115
2359215|NCT01609478|5788850|P2|Full Analysis Set (FAS)|Overall Study||108
2359216|NCT01609478|5788851|P1|Full Analysis Set (FAS)|Overall Study||110
2359217|NCT01609478|5788849|P3|STARTED|Overall Study||116
2359218|NCT01609478|5788850|P2|STARTED|Overall Study||108
2359219|NCT01609478|5788851|P1|STARTED|Overall Study||111
2359220|NCT01609348|5788917|P2|NOT COMPLETED|Overall Study||0
2359221|NCT01609348|5788918|P1|NOT COMPLETED|Overall Study||0
2359222|NCT01609348|5788917|P2|COMPLETED|Overall Study||2
2359223|NCT01609348|5788918|P1|COMPLETED|Overall Study||3
2359224|NCT01609348|5788917|P2|STARTED|Overall Study||2
2359225|NCT01609348|5788918|P1|STARTED|Overall Study||3
2359226|NCT01609296|5788924|P1|NOT COMPLETED|Overall Study||120
2359227|NCT01609296|5788924|P1|COMPLETED|Overall Study||1286
2359228|NCT01609296|5788924|P1|STARTED|Overall Study||1406
2359229|NCT01609257|5788937|P2|NOT COMPLETED|Overall Study||8
2359230|NCT01609257|5788938|P1|NOT COMPLETED|Overall Study||6
2359231|NCT01609257|5788937|P2|COMPLETED|Overall Study||57
2359232|NCT01609257|5788938|P1|COMPLETED|Overall Study||61
2359233|NCT01609257|5788937|P2|Received Challenge Product|Overall Study||53
2359234|NCT01609257|5788938|P1|Received Challenge Product|Overall Study||56
2359235|NCT01609257|5788937|P2|Received 2 Doses|Overall Study||64
2359236|NCT01609257|5788938|P1|Received 2 Doses|Overall Study||63
2359237|NCT01609257|5788937|P2|STARTED|Overall Study||65
2359238|NCT01609257|5788938|P1|STARTED|Overall Study||67
2359239|NCT01609062|5789010|P2|NOT COMPLETED|Extension Phase||10
2359240|NCT01609062|5789011|P1|NOT COMPLETED|Extension Phase||15
2359241|NCT01609062|5789010|P2|COMPLETED|Extension Phase|EAP = Expanded Access Program|0
2359242|NCT01609062|5789011|P1|COMPLETED|Extension Phase||0
2359243|NCT01609062|5789010|P2|STARTED|Extension Phase||10
2359244|NCT01609062|5789011|P1|STARTED|Extension Phase||15
2359245|NCT01609062|5789010|P2|NOT COMPLETED|Primary Phase||0
2359246|NCT01609062|5789011|P1|NOT COMPLETED|Primary Phase||0
2359247|NCT01609062|5789010|P2|COMPLETED|Primary Phase||10
2359248|NCT01609062|5789011|P1|COMPLETED|Primary Phase||15
2359249|NCT01609062|5789010|P2|STARTED|Primary Phase||10
2359250|NCT01609062|5789011|P1|STARTED|Primary Phase||15
2359251|NCT01609023|5789054|P1|NOT COMPLETED|Overall Study||33
2359252|NCT01609023|5789054|P1|COMPLETED|Overall Study||34
2359253|NCT01609023|5789054|P1|STARTED|Overall Study||67
2359254|NCT01609010|5789066|P2|NOT COMPLETED|Overall Study||37
2359255|NCT01609010|5789067|P1|NOT COMPLETED|Overall Study||43
2359256|NCT01609010|5789066|P2|COMPLETED|Overall Study||120
2359257|NCT01609010|5789067|P1|COMPLETED|Overall Study||113
2359258|NCT01609010|5789066|P2|Entering Cycle 2|Overall Study||124
2359259|NCT01609010|5789067|P1|Entering Cycle 2|Overall Study||120
2359260|NCT01609010|5789066|P2|STARTED|Overall Study||157
2359261|NCT01609010|5789067|P1|STARTED|Overall Study||156
2359262|NCT01608971|5789093|P2|NOT COMPLETED|Overall Study||0
2359263|NCT01608971|5789094|P1|NOT COMPLETED|Overall Study||0
2359264|NCT01608971|5789093|P2|COMPLETED|Overall Study||15
2359265|NCT01608971|5789094|P1|COMPLETED|Overall Study||15
2359266|NCT01608971|5789093|P2|STARTED|Overall Study||15
2359267|NCT01608971|5789094|P1|STARTED|Overall Study||15
2359268|NCT01608815|5789109|P3|NOT COMPLETED|Overall Study||0
2359269|NCT01608815|5789110|P2|NOT COMPLETED|Overall Study||0
2359270|NCT01608815|5789111|P1|NOT COMPLETED|Overall Study||0
2359271|NCT01608815|5789109|P3|COMPLETED|Overall Study||5
2359272|NCT01608815|5789110|P2|COMPLETED|Overall Study||7
2359273|NCT01608815|5789111|P1|COMPLETED|Overall Study||188
2359274|NCT01608815|5789109|P3|STARTED|Overall Study||5
2359275|NCT01608815|5789110|P2|STARTED|Overall Study||7
2359276|NCT01608815|5789111|P1|STARTED|Overall Study||188
2359277|NCT01608724|5789128|P1|NOT COMPLETED|Overall Study||243
2359278|NCT01608724|5789128|P1|COMPLETED|Overall Study||1180
2359279|NCT01608724|5789128|P1|Treated|Overall Study||1361
2359280|NCT01608724|5789128|P1|STARTED|Overall Study|One patient was excluded because the Informed Consent Form was destroyed by site staff by mistake.|1423
2359281|NCT01608672|5789135|P1|NOT COMPLETED|Overall Study||0
2359282|NCT01608672|5789135|P1|COMPLETED|Overall Study||207
2359283|NCT01608672|5789135|P1|STARTED|Overall Study||207
2359284|NCT01608659|5789141|P1|NOT COMPLETED|Overall Study||16
2359285|NCT01608659|5789141|P1|COMPLETED|Overall Study||94
2359286|NCT01608659|5789141|P1|STARTED|Overall Study||110
2359287|NCT01608490|5789149|P2|NOT COMPLETED|Overall Study||0
2359288|NCT01608490|5789150|P1|NOT COMPLETED|Overall Study||0
2359289|NCT01608490|5789149|P2|COMPLETED|Overall Study||157
2359290|NCT01608490|5789150|P1|COMPLETED|Overall Study||158
2359291|NCT01608490|5789149|P2|STARTED|Overall Study||157
2359292|NCT01608490|5789150|P1|STARTED|Overall Study||158
2359293|NCT01608321|5789160|P2|NOT COMPLETED|Overall Study||0
2359294|NCT01608321|5789161|P1|NOT COMPLETED|Overall Study||1
2359295|NCT01608321|5789160|P2|COMPLETED|Overall Study||4
2359296|NCT01608321|5789161|P1|COMPLETED|Overall Study||12
2359297|NCT01608321|5789160|P2|STARTED|Overall Study||4
2359298|NCT01608321|5789161|P1|STARTED|Overall Study||13
2359299|NCT01608308|5789169|P2|NOT COMPLETED|Overall Study||2
2359300|NCT01608308|5789170|P1|NOT COMPLETED|Overall Study||0
2359301|NCT01608308|5789169|P2|COMPLETED|Overall Study||29
2359302|NCT01608308|5789170|P1|COMPLETED|Overall Study||31
2359303|NCT01608308|5789169|P2|STARTED|Overall Study||31
2359304|NCT01608308|5789170|P1|STARTED|Overall Study||31
2359305|NCT01608295|5789194|P2|NOT COMPLETED|Overall Study||5
2359306|NCT01608295|5789195|P1|NOT COMPLETED|Overall Study||6
2359307|NCT01608295|5789194|P2|COMPLETED|Overall Study||25
2359308|NCT01608295|5789195|P1|COMPLETED|Overall Study||20
2359309|NCT01608295|5789194|P2|STARTED|Overall Study||30
2359310|NCT01608295|5789195|P1|STARTED|Overall Study||26
2359311|NCT01608100|5789206|P1|NOT COMPLETED|Overall Study||0
2359312|NCT01608100|5789206|P1|COMPLETED|Overall Study||1101
2359313|NCT01608100|5789206|P1|STARTED|Overall Study||1101
2359314|NCT01608087|5789233|P3|NOT COMPLETED|Overall Study||0
2359315|NCT01608087|5789234|P2|NOT COMPLETED|Overall Study||2
2359316|NCT01608087|5789235|P1|NOT COMPLETED|Overall Study||0
2359317|NCT01608087|5789233|P3|COMPLETED|Overall Study||31
2359318|NCT01608087|5789234|P2|COMPLETED|Overall Study||28
2359319|NCT01608087|5789235|P1|COMPLETED|Overall Study||30
2359320|NCT01608087|5789233|P3|STARTED|Overall Study||31
2359321|NCT01608087|5789234|P2|STARTED|Overall Study||30
2359322|NCT01608087|5789235|P1|STARTED|Overall Study||30
2359323|NCT01607957|5789251|P2|NOT COMPLETED|Overall Study||215
2359324|NCT01607957|5789252|P1|NOT COMPLETED|Overall Study||372
2359325|NCT01607957|5789251|P2|COMPLETED|Overall Study||51
2359326|NCT01607957|5789252|P1|COMPLETED|Overall Study||162
2359327|NCT01607957|5789251|P2|Treated|Overall Study||265
2359328|NCT01607957|5789252|P1|Treated|Overall Study||533
2359329|NCT01607957|5789251|P2|STARTED|Overall Study||266
2359330|NCT01607957|5789252|P1|STARTED|Overall Study||534
2359331|NCT01607853|5789262|P1|NOT COMPLETED|Overall Study||0
2359332|NCT01607853|5789262|P1|COMPLETED|Overall Study||24
2359333|NCT01607853|5789262|P1|STARTED|Overall Study||24
2359334|NCT01607658|5789373|P4|NOT COMPLETED|Overall Study||11
2359335|NCT01607658|5789374|P3|NOT COMPLETED|Overall Study||11
2359336|NCT01607658|5789375|P2|NOT COMPLETED|Overall Study||11
2359337|NCT01607658|5789376|P1|NOT COMPLETED|Overall Study||9
2359338|NCT01607658|5789373|P4|COMPLETED|Overall Study||52
2359339|NCT01607658|5789374|P3|COMPLETED|Overall Study||47
2359340|NCT01607658|5789375|P2|COMPLETED|Overall Study||56
2359341|NCT01607658|5789376|P1|COMPLETED|Overall Study||56
2359342|NCT01607658|5789373|P4|STARTED|Overall Study||63
2359343|NCT01607658|5789374|P3|STARTED|Overall Study||58
2359344|NCT01607658|5789375|P2|STARTED|Overall Study||67
2359345|NCT01607658|5789376|P1|STARTED|Overall Study||65
2359346|NCT01607645|5789400|P2|NOT COMPLETED|Overall Study||0
2359347|NCT01607645|5789401|P1|NOT COMPLETED|Overall Study||0
2359348|NCT01607645|5789400|P2|COMPLETED|Overall Study||3
2359349|NCT01607645|5789401|P1|COMPLETED|Overall Study||4
2359350|NCT01607645|5789400|P2|STARTED|Overall Study||3
2359351|NCT01607645|5789401|P1|STARTED|Overall Study||4
2359352|NCT01607593|5789431|P1|NOT COMPLETED|Overall Study||93
2359353|NCT01607593|5789431|P1|COMPLETED|Overall Study||29
2359354|NCT01607593|5789431|P1|STARTED|Overall Study||122
2359355|NCT01607554|5789437|P1|NOT COMPLETED|Overall Study||2
2359356|NCT01607554|5789437|P1|COMPLETED|Overall Study||0
2359357|NCT01607554|5789437|P1|STARTED|Overall Study||2
2359358|NCT01607476|5789450|P3|NOT COMPLETED|Overall Study||3
2359359|NCT01607476|5789451|P2|NOT COMPLETED|Overall Study||0
2359360|NCT01607476|5789452|P1|NOT COMPLETED|Overall Study||1
2359361|NCT01607476|5789450|P3|COMPLETED|Overall Study||30
2359362|NCT01607476|5789451|P2|COMPLETED|Overall Study||30
2359363|NCT01607476|5789452|P1|COMPLETED|Overall Study||24
2359364|NCT01607476|5789450|P3|STARTED|Overall Study||33
2359365|NCT01607476|5789451|P2|STARTED|Overall Study||30
2359366|NCT01607476|5789452|P1|STARTED|Overall Study||25
2359367|NCT01607450|5789470|P7|NOT COMPLETED|Overall Study||0
2359368|NCT01607450|5789471|P6|NOT COMPLETED|Overall Study||0
2359369|NCT01607450|5789472|P5|NOT COMPLETED|Overall Study||0
2359370|NCT01607450|5789473|P4|NOT COMPLETED|Overall Study||0
2359371|NCT01607450|5789474|P3|NOT COMPLETED|Overall Study||0
2359372|NCT01607450|5789475|P2|NOT COMPLETED|Overall Study||0
2359373|NCT01607450|5789476|P1|NOT COMPLETED|Overall Study||0
2359374|NCT01607450|5789470|P7|COMPLETED|Overall Study||0
2359375|NCT01607450|5789471|P6|COMPLETED|Overall Study||0
2359376|NCT01607450|5789472|P5|COMPLETED|Overall Study||1
2359377|NCT01607450|5789473|P4|COMPLETED|Overall Study||11
2359378|NCT01607450|5789474|P3|COMPLETED|Overall Study||7
2359379|NCT01607450|5789475|P2|COMPLETED|Overall Study||8
2359380|NCT01607450|5789476|P1|COMPLETED|Overall Study||6
2359381|NCT01607450|5789470|P7|STARTED|Overall Study||0
2359382|NCT01607450|5789471|P6|STARTED|Overall Study||0
2359383|NCT01607450|5789472|P5|STARTED|Overall Study||1
2359384|NCT01607450|5789473|P4|STARTED|Overall Study||11
2359385|NCT01607450|5789474|P3|STARTED|Overall Study||7
2359386|NCT01607450|5789475|P2|STARTED|Overall Study||8
2359387|NCT01607450|5789476|P1|STARTED|Overall Study||6
2359388|NCT01607411|5789520|P4|NOT COMPLETED|Period IV||0
2359389|NCT01607411|5789521|P3|NOT COMPLETED|Period IV||0
2359390|NCT01607411|5789522|P2|NOT COMPLETED|Period IV||0
2359391|NCT01607411|5789523|P1|NOT COMPLETED|Period IV||0
2359392|NCT01607411|5789520|P4|COMPLETED|Period IV||14
2359393|NCT01607411|5789521|P3|COMPLETED|Period IV||14
2359394|NCT01607411|5789522|P2|COMPLETED|Period IV||14
2359395|NCT01607411|5789523|P1|COMPLETED|Period IV||13
2359396|NCT01607411|5789520|P4|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
2359397|NCT01607411|5789521|P3|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
2359398|NCT01607411|5789522|P2|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
2359399|NCT01607411|5789523|P1|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|13
2359400|NCT01607411|5789520|P4|NOT COMPLETED|Period III||0
2359401|NCT01607411|5789521|P3|NOT COMPLETED|Period III||0
2359402|NCT01607411|5789522|P2|NOT COMPLETED|Period III||0
2359403|NCT01607411|5789523|P1|NOT COMPLETED|Period III||0
2359404|NCT01607411|5789520|P4|COMPLETED|Period III||13
2359405|NCT01607411|5789521|P3|COMPLETED|Period III||14
2359406|NCT01607411|5789522|P2|COMPLETED|Period III||14
2359407|NCT01607411|5789523|P1|COMPLETED|Period III||14
2359408|NCT01607411|5789520|P4|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|13
2359409|NCT01607411|5789521|P3|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
2359410|NCT01607411|5789522|P2|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
2359411|NCT01607411|5789523|P1|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
2359412|NCT01607411|5789520|P4|NOT COMPLETED|Period II||0
2359413|NCT01607411|5789521|P3|NOT COMPLETED|Period II||0
2359414|NCT01607411|5789522|P2|NOT COMPLETED|Period II||0
2359415|NCT01607411|5789523|P1|NOT COMPLETED|Period II||0
2359416|NCT01607411|5789520|P4|COMPLETED|Period II||14
2359417|NCT01607411|5789521|P3|COMPLETED|Period II||13
2359418|NCT01607411|5789522|P2|COMPLETED|Period II||14
2359419|NCT01607411|5789523|P1|COMPLETED|Period II||14
2359420|NCT01607411|5789520|P4|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
2359421|NCT01607411|5789521|P3|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|13
2359422|NCT01607411|5789522|P2|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
2359423|NCT01607411|5789523|P1|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
2359424|NCT01607411|5789520|P4|NOT COMPLETED|Period I||0
2359425|NCT01607411|5789521|P3|NOT COMPLETED|Period I||0
2359426|NCT01607411|5789522|P2|NOT COMPLETED|Period I||0
2359427|NCT01607411|5789523|P1|NOT COMPLETED|Period I||0
2359428|NCT01607411|5789520|P4|COMPLETED|Period I||14
2359429|NCT01607411|5789521|P3|COMPLETED|Period I||14
2359430|NCT01607411|5789522|P2|COMPLETED|Period I||13
2359431|NCT01607411|5789523|P1|COMPLETED|Period I||14
2359432|NCT01607411|5789520|P4|STARTED|Period I||14
2359433|NCT01607411|5789521|P3|STARTED|Period I||14
2359434|NCT01607411|5789522|P2|STARTED|Period I||13
2359435|NCT01607411|5789523|P1|STARTED|Period I||14
2359436|NCT01607398|5789546|P2|NOT COMPLETED|Overall Study||2
2359437|NCT01607398|5789547|P1|NOT COMPLETED|Overall Study||2
2359438|NCT01607398|5789546|P2|COMPLETED|Overall Study||26
2359439|NCT01607398|5789547|P1|COMPLETED|Overall Study||26
2359440|NCT01607398|5789546|P2|STARTED|Overall Study||28
2359441|NCT01607398|5789547|P1|STARTED|Overall Study||28
2359442|NCT01607346|5789591|P1|NOT COMPLETED|Overall Study||3
2359443|NCT01607346|5789591|P1|COMPLETED|Overall Study||7
2359444|NCT01607346|5789591|P1|STARTED|Overall Study||10
2359445|NCT01607320|5789607|P2|NOT COMPLETED|Overall Study||0
2359446|NCT01607320|5789608|P1|NOT COMPLETED|Overall Study||0
2359447|NCT01607320|5789607|P2|COMPLETED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
2359448|NCT01607320|5789608|P1|COMPLETED|Overall Study|The study was randomized between the 2 treatments and was never unblinded,so unknown.|0
2359449|NCT01607320|5789607|P2|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
2359450|NCT01607320|5789608|P1|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
2359451|NCT01607255|5789616|P3|NOT COMPLETED|Overall Study||0
2359452|NCT01607255|5789617|P2|NOT COMPLETED|Overall Study||0
2359453|NCT01607255|5789618|P1|NOT COMPLETED|Overall Study||0
2359454|NCT01607255|5789616|P3|COMPLETED|Overall Study||159
2359455|NCT01607255|5789617|P2|COMPLETED|Overall Study||160
2359456|NCT01607255|5789618|P1|COMPLETED|Overall Study||161
2359457|NCT01607255|5789616|P3|STARTED|Overall Study||159
2359458|NCT01607255|5789617|P2|STARTED|Overall Study||160
2359459|NCT01607255|5789618|P1|STARTED|Overall Study||161
2359460|NCT01607203|5789628|P2|NOT COMPLETED|Overall Study||0
2359461|NCT01607203|5789629|P1|NOT COMPLETED|Overall Study||0
2359462|NCT01607203|5789628|P2|COMPLETED|Overall Study||61
2359463|NCT01607203|5789629|P1|COMPLETED|Overall Study||59
2359464|NCT01607203|5789628|P2|STARTED|Overall Study||61
2359465|NCT01607203|5789629|P1|STARTED|Overall Study||59
2359466|NCT01607112|5789641|P2|NOT COMPLETED|Overall Study||0
2359467|NCT01607112|5789642|P1|NOT COMPLETED|Overall Study||0
2359468|NCT01607112|5789641|P2|COMPLETED|Overall Study||59
2359469|NCT01607112|5789642|P1|COMPLETED|Overall Study||60
2359470|NCT01607112|5789641|P2|STARTED|Overall Study||59
2359471|NCT01607112|5789642|P1|STARTED|Overall Study||60
2359472|NCT01606852|5789678|P2|NOT COMPLETED|Overall Study||0
2359473|NCT01606852|5789679|P1|NOT COMPLETED|Overall Study||0
2359474|NCT01606852|5789678|P2|COMPLETED|Overall Study||8
2359475|NCT01606852|5789679|P1|COMPLETED|Overall Study||7
2359476|NCT01606852|5789678|P2|STARTED|Overall Study||8
2359477|NCT01606852|5789679|P1|STARTED|Overall Study||7
2359478|NCT01606800|5789689|P2|NOT COMPLETED|Overall Study||2
2359479|NCT01606800|5789690|P1|NOT COMPLETED|Overall Study||5
2359480|NCT01606800|5789689|P2|COMPLETED|Overall Study||21
2359481|NCT01606800|5789690|P1|COMPLETED|Overall Study||17
2359482|NCT01606800|5789689|P2|Treated|Overall Study||23
2359483|NCT01606800|5789690|P1|Treated|Overall Study||22
2359484|NCT01606800|5789689|P2|STARTED|Overall Study||23
2359485|NCT01606800|5789690|P1|STARTED|Overall Study||22
2359486|NCT01606787|5789698|P2|NOT COMPLETED|Overall Study||7
2359487|NCT01606787|5789699|P1|NOT COMPLETED|Overall Study||4
2359488|NCT01606787|5789698|P2|COMPLETED|Overall Study||98
2359489|NCT01606787|5789699|P1|COMPLETED|Overall Study||101
2359490|NCT01606787|5789698|P2|STARTED|Overall Study||105
2359491|NCT01606787|5789699|P1|STARTED|Overall Study||105
2359492|NCT01606761|5789710|P5|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||8
2359493|NCT01606761|5789711|P4|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||2
2359494|NCT01606761|5789712|P3|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||17
2359495|NCT01606761|5789713|P2|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||10
2359496|NCT01606761|5789714|P1|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||4
2359497|NCT01606761|5789710|P5|COMPLETED|Safety Follow-up Period (Week 52-68)||11
2359498|NCT01606761|5789711|P4|COMPLETED|Safety Follow-up Period (Week 52-68)||7
2359499|NCT01606761|5789712|P3|COMPLETED|Safety Follow-up Period (Week 52-68)||45
2359500|NCT01606761|5789713|P2|COMPLETED|Safety Follow-up Period (Week 52-68)||55
2359501|NCT01606761|5789714|P1|COMPLETED|Safety Follow-up Period (Week 52-68)||24
2359502|NCT01606761|5789710|P5|Safety Population|Safety Follow-up Period (Week 52-68)||19
2359503|NCT01606761|5789711|P4|Safety Population|Safety Follow-up Period (Week 52-68)||7
2359504|NCT01606761|5789712|P3|Safety Population|Safety Follow-up Period (Week 52-68)||62
2359505|NCT01606761|5789713|P2|Safety Population|Safety Follow-up Period (Week 52-68)||65
2359506|NCT01606761|5789714|P1|Safety Population|Safety Follow-up Period (Week 52-68)||28
2359507|NCT01606761|5789710|P5|STARTED|Safety Follow-up Period (Week 52-68)||19
2359508|NCT01606761|5789711|P4|STARTED|Safety Follow-up Period (Week 52-68)||9
2359509|NCT01606761|5789712|P3|STARTED|Safety Follow-up Period (Week 52-68)||62
2359510|NCT01606761|5789713|P2|STARTED|Safety Follow-up Period (Week 52-68)||65
2359511|NCT01606761|5789714|P1|STARTED|Safety Follow-up Period (Week 52-68)||28
2359512|NCT01606761|5789710|P5|NOT COMPLETED|Week 24 to Week 52||20
2359513|NCT01606761|5789711|P4|NOT COMPLETED|Week 24 to Week 52||17
2359514|NCT01606761|5789712|P3|NOT COMPLETED|Week 24 to Week 52||33
2359515|NCT01606761|5789713|P2|NOT COMPLETED|Week 24 to Week 52||33
2359516|NCT01606761|5789714|P1|NOT COMPLETED|Week 24 to Week 52||0
2359517|NCT01606761|5789710|P5|COMPLETED|Week 24 to Week 52||106
2359518|NCT01606761|5789711|P4|COMPLETED|Week 24 to Week 52||109
2359519|NCT01606761|5789712|P3|COMPLETED|Week 24 to Week 52||212
2359520|NCT01606761|5789713|P2|COMPLETED|Week 24 to Week 52||204
2359521|NCT01606761|5789714|P1|COMPLETED|Week 24 to Week 52||0
2359522|NCT01606761|5789710|P5|Treated|Week 24 to Week 52||126
2359523|NCT01606761|5789711|P4|Treated|Week 24 to Week 52||124
2359524|NCT01606761|5789712|P3|Treated|Week 24 to Week 52||245
2359525|NCT01606761|5789713|P2|Treated|Week 24 to Week 52||237
2359526|NCT01606761|5789714|P1|Treated|Week 24 to Week 52||0
2359527|NCT01606761|5789710|P5|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (48) and Week 24 (78) were included.|126
2359528|NCT01606761|5789711|P4|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (46) and Week 24 (80) were included.|126
2359529|NCT01606761|5789712|P3|STARTED|Week 24 to Week 52||245
2359530|NCT01606761|5789713|P2|STARTED|Week 24 to Week 52||237
2359531|NCT01606761|5789714|P1|STARTED|Week 24 to Week 52||0
2359532|NCT01606761|5789710|P5|NOT COMPLETED|Prior to Week 24||0
2359533|NCT01606761|5789711|P4|NOT COMPLETED|Prior to Week 24||0
2359534|NCT01606761|5789712|P3|NOT COMPLETED|Prior to Week 24||47
2359535|NCT01606761|5789713|P2|NOT COMPLETED|Prior to Week 24||55
2359536|NCT01606761|5789714|P1|NOT COMPLETED|Prior to Week 24||42
2359537|NCT01606761|5789710|P5|COMPLETED|Prior to Week 24||0
2359538|NCT01606761|5789711|P4|COMPLETED|Prior to Week 24||0
2359539|NCT01606761|5789712|P3|COMPLETED|Prior to Week 24||245
2359540|NCT01606761|5789713|P2|COMPLETED|Prior to Week 24||237
2359541|NCT01606761|5789714|P1|COMPLETED|Prior to Week 24||252
2359542|NCT01606761|5789710|P5|Participants Re-randomized at Week 18|Prior to Week 24||0
2359543|NCT01606761|5789711|P4|Participants Re-randomized at Week 18|Prior to Week 24||0
2359544|NCT01606761|5789712|P3|Participants Re-randomized at Week 18|Prior to Week 24||0
2359545|NCT01606761|5789713|P2|Participants Re-randomized at Week 18|Prior to Week 24||0
2359546|NCT01606761|5789714|P1|Participants Re-randomized at Week 18|Prior to Week 24|Out of 94, 46 were re-randomized to sirukumab 50 mg and 48 were re-randomized to 100 mg group.|94
2359547|NCT01606761|5789710|P5|STARTED|Prior to Week 24||0
2359548|NCT01606761|5789711|P4|STARTED|Prior to Week 24||0
2359549|NCT01606761|5789712|P3|STARTED|Prior to Week 24||292
2359550|NCT01606761|5789713|P2|STARTED|Prior to Week 24||292
2359551|NCT01606761|5789714|P1|STARTED|Prior to Week 24||294
2359552|NCT01606748|5789740|P2|NOT COMPLETED|Overall Study||0
2359553|NCT01606748|5789741|P1|NOT COMPLETED|Overall Study||3
2359554|NCT01606748|5789740|P2|COMPLETED|Overall Study||17
2359555|NCT01606748|5789741|P1|COMPLETED|Overall Study||15
2359556|NCT01606748|5789740|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
2359557|NCT01606748|5789741|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
2359558|NCT01606748|5789740|P2|STARTED|Overall Study||17
2359559|NCT01606748|5789741|P1|STARTED|Overall Study||18
2359560|NCT01606735|5789772|P3|NOT COMPLETED|Overall Study||0
2359561|NCT01606735|5789773|P2|NOT COMPLETED|Overall Study||0
2359562|NCT01606735|5789774|P1|NOT COMPLETED|Overall Study||0
2359563|NCT01606735|5789772|P3|COMPLETED|Overall Study||58
2359564|NCT01606735|5789773|P2|COMPLETED|Overall Study||56
2359565|NCT01606735|5789774|P1|COMPLETED|Overall Study||58
2359566|NCT01606735|5789772|P3|STARTED|Overall Study||58
2359567|NCT01606735|5789773|P2|STARTED|Overall Study||56
2359568|NCT01606735|5789774|P1|STARTED|Overall Study||58
2359569|NCT01606709|5789784|P2|NOT COMPLETED|Overall Study||0
2359570|NCT01606709|5789785|P1|NOT COMPLETED|Overall Study||0
2359571|NCT01606709|5789784|P2|COMPLETED|Overall Study||3
2359572|NCT01606709|5789785|P1|COMPLETED|Overall Study||4
2359573|NCT01606709|5789784|P2|STARTED|Overall Study||3
2359574|NCT01606709|5789785|P1|STARTED|Overall Study||4
2359575|NCT01606670|5789793|P1|NOT COMPLETED|Overall Study||16
2359576|NCT01606670|5789793|P1|COMPLETED|Overall Study||77
2359577|NCT01606670|5789793|P1|Full Analysis Set|Overall Study||70
2359578|NCT01606670|5789793|P1|Safety Set|Overall Study||93
2359579|NCT01606670|5789793|P1|STARTED|Overall Study||93
2359580|NCT01606319|5789803|P2|NOT COMPLETED|Overall Study||40
2359581|NCT01606319|5789804|P1|NOT COMPLETED|Overall Study||34
2359582|NCT01606319|5789803|P2|COMPLETED|Overall Study||110
2359583|NCT01606319|5789804|P1|COMPLETED|Overall Study||116
2359584|NCT01606319|5789803|P2|STARTED|Overall Study||150
2359585|NCT01606319|5789804|P1|STARTED|Overall Study||150
2359586|NCT01606306|5789822|P6|NOT COMPLETED|Overall Study||11
2359587|NCT01606306|5789823|P5|NOT COMPLETED|Overall Study||11
2359588|NCT01606306|5789824|P4|NOT COMPLETED|Overall Study||13
2359589|NCT01606306|5789825|P3|NOT COMPLETED|Overall Study||14
2359590|NCT01606306|5789826|P2|NOT COMPLETED|Overall Study||10
2359591|NCT01606306|5789827|P1|NOT COMPLETED|Overall Study||15
2359592|NCT01606306|5789822|P6|COMPLETED|Overall Study||36
2359593|NCT01606306|5789823|P5|COMPLETED|Overall Study||41
2359594|NCT01606306|5789824|P4|COMPLETED|Overall Study||38
2359595|NCT01606306|5789825|P3|COMPLETED|Overall Study||37
2359596|NCT01606306|5789826|P2|COMPLETED|Overall Study||39
2359597|NCT01606306|5789827|P1|COMPLETED|Overall Study||35
2359598|NCT01606306|5789822|P6|Completed Third Treatment Period|Overall Study||36
2359599|NCT01606306|5789823|P5|Completed Third Treatment Period|Overall Study||41
2359600|NCT01606306|5789824|P4|Completed Third Treatment Period|Overall Study||38
2359601|NCT01606306|5789825|P3|Completed Third Treatment Period|Overall Study||37
2359602|NCT01606306|5789826|P2|Completed Third Treatment Period|Overall Study||39
2359603|NCT01606306|5789827|P1|Completed Third Treatment Period|Overall Study||35
2359604|NCT01606306|5789822|P6|Completed Second Treatment Period|Overall Study||41
2359605|NCT01606306|5789823|P5|Completed Second Treatment Period|Overall Study||46
2359606|NCT01606306|5789824|P4|Completed Second Treatment Period|Overall Study||44
2359607|NCT01606306|5789825|P3|Completed Second Treatment Period|Overall Study||43
2359608|NCT01606306|5789826|P2|Completed Second Treatment Period|Overall Study||38
2359609|NCT01606306|5789827|P1|Completed Second Treatment Period|Overall Study||41
2359610|NCT01606306|5789822|P6|Completed First Treatment Period|Overall Study||44
2359611|NCT01606306|5789823|P5|Completed First Treatment Period|Overall Study||47
2359612|NCT01606306|5789824|P4|Completed First Treatment Period|Overall Study||45
2359613|NCT01606306|5789825|P3|Completed First Treatment Period|Overall Study||47
2359614|NCT01606306|5789826|P2|Completed First Treatment Period|Overall Study||47
2359615|NCT01606306|5789827|P1|Completed First Treatment Period|Overall Study||43
2359616|NCT01606306|5789822|P6|STARTED|Overall Study||47
2359617|NCT01606306|5789823|P5|STARTED|Overall Study||52
2359618|NCT01606306|5789824|P4|STARTED|Overall Study||51
2359619|NCT01606306|5789825|P3|STARTED|Overall Study||51
2359620|NCT01606306|5789826|P2|STARTED|Overall Study||49
2359621|NCT01606306|5789827|P1|STARTED|Overall Study||50
2359622|NCT01606254|5789837|P4|NOT COMPLETED|Overall Study||3
2359623|NCT01606254|5789838|P3|NOT COMPLETED|Overall Study||0
2359624|NCT01606254|5789839|P2|NOT COMPLETED|Overall Study||4
2359625|NCT01606254|5789840|P1|NOT COMPLETED|Overall Study||2
2359626|NCT01606254|5789837|P4|COMPLETED|Overall Study||11
2359627|NCT01606254|5789838|P3|COMPLETED|Overall Study||14
2359628|NCT01606254|5789839|P2|COMPLETED|Overall Study||10
2359629|NCT01606254|5789840|P1|COMPLETED|Overall Study||12
2359630|NCT01606254|5789837|P4|STARTED|Overall Study||14
2359631|NCT01606254|5789838|P3|STARTED|Overall Study||14
2359632|NCT01606254|5789839|P2|STARTED|Overall Study||14
2359633|NCT01606254|5789840|P1|STARTED|Overall Study||14
2359634|NCT01606228|5789922|P1|NOT COMPLETED|Overall Study||29
2359635|NCT01606228|5789922|P1|COMPLETED|Overall Study||159
2359636|NCT01606228|5789922|P1|STARTED|Overall Study||188
2359637|NCT01606202|5789939|P2|NOT COMPLETED|Overall Study||3
2359638|NCT01606202|5789940|P1|NOT COMPLETED|Overall Study||7
2359639|NCT01606202|5789939|P2|COMPLETED|Overall Study||57
2359640|NCT01606202|5789940|P1|COMPLETED|Overall Study||49
2359641|NCT01606202|5789939|P2|STARTED|Overall Study||60
2359642|NCT01606202|5789940|P1|STARTED|Overall Study||56
2359643|NCT01606189|5789972|P6|NOT COMPLETED|Third Intenvention (14-20 Days)||1
2359644|NCT01606189|5789973|P5|NOT COMPLETED|Third Intenvention (14-20 Days)||0
2359645|NCT01606189|5789974|P4|NOT COMPLETED|Third Intenvention (14-20 Days)||0
2359646|NCT01606189|5789975|P3|NOT COMPLETED|Third Intenvention (14-20 Days)||0
2359647|NCT01606189|5789976|P2|NOT COMPLETED|Third Intenvention (14-20 Days)||0
2359648|NCT01606189|5789977|P1|NOT COMPLETED|Third Intenvention (14-20 Days)||0
2359649|NCT01606189|5789972|P6|COMPLETED|Third Intenvention (14-20 Days)||6
2359650|NCT01606189|5789973|P5|COMPLETED|Third Intenvention (14-20 Days)||8
2359651|NCT01606189|5789974|P4|COMPLETED|Third Intenvention (14-20 Days)||8
2359652|NCT01606189|5789975|P3|COMPLETED|Third Intenvention (14-20 Days)||8
2359653|NCT01606189|5789976|P2|COMPLETED|Third Intenvention (14-20 Days)||8
2359654|NCT01606189|5789977|P1|COMPLETED|Third Intenvention (14-20 Days)||8
2359655|NCT01606189|5789972|P6|STARTED|Third Intenvention (14-20 Days)||7
2359656|NCT01606189|5789973|P5|STARTED|Third Intenvention (14-20 Days)||8
2359657|NCT01606189|5789974|P4|STARTED|Third Intenvention (14-20 Days)||8
2359658|NCT01606189|5789975|P3|STARTED|Third Intenvention (14-20 Days)||8
2359659|NCT01606189|5789976|P2|STARTED|Third Intenvention (14-20 Days)||8
2359660|NCT01606189|5789977|P1|STARTED|Third Intenvention (14-20 Days)||8
2359661|NCT01606189|5789972|P6|NOT COMPLETED|Second Intenvention (14-20 Days)||1
2359662|NCT01606189|5789973|P5|NOT COMPLETED|Second Intenvention (14-20 Days)||0
2359663|NCT01606189|5789974|P4|NOT COMPLETED|Second Intenvention (14-20 Days)||0
2359664|NCT01606189|5789975|P3|NOT COMPLETED|Second Intenvention (14-20 Days)||0
2359665|NCT01606189|5789976|P2|NOT COMPLETED|Second Intenvention (14-20 Days)||0
2359666|NCT01606189|5789977|P1|NOT COMPLETED|Second Intenvention (14-20 Days)||0
2359667|NCT01606189|5789972|P6|COMPLETED|Second Intenvention (14-20 Days)||7
2359668|NCT01606189|5789973|P5|COMPLETED|Second Intenvention (14-20 Days)||8
2359669|NCT01606189|5789974|P4|COMPLETED|Second Intenvention (14-20 Days)||8
2359670|NCT01606189|5789975|P3|COMPLETED|Second Intenvention (14-20 Days)||8
2359671|NCT01606189|5789976|P2|COMPLETED|Second Intenvention (14-20 Days)||8
2359672|NCT01606189|5789977|P1|COMPLETED|Second Intenvention (14-20 Days)||8
2359673|NCT01606189|5789972|P6|STARTED|Second Intenvention (14-20 Days)||8
2359674|NCT01606189|5789973|P5|STARTED|Second Intenvention (14-20 Days)||8
2359675|NCT01606189|5789974|P4|STARTED|Second Intenvention (14-20 Days)||8
2359676|NCT01606189|5789975|P3|STARTED|Second Intenvention (14-20 Days)||8
2359677|NCT01606189|5789976|P2|STARTED|Second Intenvention (14-20 Days)||8
2359678|NCT01606189|5789977|P1|STARTED|Second Intenvention (14-20 Days)||8
2359679|NCT01606189|5789972|P6|NOT COMPLETED|First Intenvention (14-20 Days)||0
2359680|NCT01606189|5789973|P5|NOT COMPLETED|First Intenvention (14-20 Days)||0
2359681|NCT01606189|5789974|P4|NOT COMPLETED|First Intenvention (14-20 Days)||0
2359682|NCT01606189|5789975|P3|NOT COMPLETED|First Intenvention (14-20 Days)||0
2359683|NCT01606189|5789976|P2|NOT COMPLETED|First Intenvention (14-20 Days)||0
2359684|NCT01606189|5789977|P1|NOT COMPLETED|First Intenvention (14-20 Days)||0
2359685|NCT01606189|5789972|P6|COMPLETED|First Intenvention (14-20 Days)||8
2359686|NCT01606189|5789973|P5|COMPLETED|First Intenvention (14-20 Days)||8
2359687|NCT01606189|5789974|P4|COMPLETED|First Intenvention (14-20 Days)||8
2359688|NCT01606189|5789975|P3|COMPLETED|First Intenvention (14-20 Days)||8
2359689|NCT01606189|5789976|P2|COMPLETED|First Intenvention (14-20 Days)||8
2359690|NCT01606189|5789977|P1|COMPLETED|First Intenvention (14-20 Days)||8
2359691|NCT01606189|5789972|P6|STARTED|First Intenvention (14-20 Days)||8
2359692|NCT01606189|5789973|P5|STARTED|First Intenvention (14-20 Days)||8
2359693|NCT01606189|5789974|P4|STARTED|First Intenvention (14-20 Days)||8
2359694|NCT01606189|5789975|P3|STARTED|First Intenvention (14-20 Days)||8
2359695|NCT01606189|5789976|P2|STARTED|First Intenvention (14-20 Days)||8
2359696|NCT01606189|5789977|P1|STARTED|First Intenvention (14-20 Days)||8
2359697|NCT01606176|5790011|P2|NOT COMPLETED|Overall Study||3
2359698|NCT01606176|5790012|P1|NOT COMPLETED|Overall Study||4
2359699|NCT01606176|5790011|P2|COMPLETED|Overall Study||31
2359700|NCT01606176|5790012|P1|COMPLETED|Overall Study||32
2359701|NCT01606176|5790011|P2|STARTED|Overall Study||34
2359702|NCT01606176|5790012|P1|STARTED|Overall Study||36
2359703|NCT01606150|5790048|P2|NOT COMPLETED|Overall Study||0
2359704|NCT01606150|5790049|P1|NOT COMPLETED|Overall Study||0
2359705|NCT01606150|5790048|P2|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
2359706|NCT01606150|5790049|P1|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
2359707|NCT01606150|5790048|P2|STARTED|Overall Study||0
2359708|NCT01606150|5790049|P1|STARTED|Overall Study||0
2359709|NCT01606137|5790057|P1|NOT COMPLETED|Overall Study||262
2359710|NCT01606137|5790057|P1|COMPLETED|Overall Study||245
2359711|NCT01606137|5790057|P1|STARTED|Overall Study||507
2359712|NCT01606124|5790079|P2|NOT COMPLETED|Overall Study||0
2359713|NCT01606124|5790080|P1|NOT COMPLETED|Overall Study||0
2359714|NCT01606124|5790079|P2|COMPLETED|Overall Study||20
2359715|NCT01606124|5790080|P1|COMPLETED|Overall Study||19
2359716|NCT01606124|5790079|P2|STARTED|Overall Study||20
2359717|NCT01606124|5790080|P1|STARTED|Overall Study||19
2359718|NCT01606007|5790091|P3|NOT COMPLETED|Overall Study||10
2359719|NCT01606007|5790092|P2|NOT COMPLETED|Overall Study||19
2359720|NCT01606007|5790093|P1|NOT COMPLETED|Overall Study||15
2359721|NCT01606007|5790091|P3|COMPLETED|Overall Study||169
2359722|NCT01606007|5790092|P2|COMPLETED|Overall Study||160
2359723|NCT01606007|5790093|P1|COMPLETED|Overall Study||161
2359724|NCT01606007|5790091|P3|STARTED|Overall Study||179
2359725|NCT01606007|5790092|P2|STARTED|Overall Study||179
2359726|NCT01606007|5790093|P1|STARTED|Overall Study||176
2359727|NCT01605942|5790115|P2|NOT COMPLETED|Overall Study||0
2359728|NCT01605942|5790116|P1|NOT COMPLETED|Overall Study||0
2359729|NCT01605942|5790115|P2|COMPLETED|Overall Study||2
2359730|NCT01605942|5790116|P1|COMPLETED|Overall Study||6
2359731|NCT01605942|5790115|P2|STARTED|Overall Study||2
2359732|NCT01605942|5790116|P1|STARTED|Overall Study||6
2359733|NCT01605916|5790128|P5|NOT COMPLETED|Overall Study||6
2359734|NCT01605916|5790129|P4|NOT COMPLETED|Overall Study||6
2359735|NCT01605916|5790130|P3|NOT COMPLETED|Overall Study||3
2359736|NCT01605916|5790131|P2|NOT COMPLETED|Overall Study||4
2359737|NCT01605916|5790132|P1|NOT COMPLETED|Overall Study||4
2359738|NCT01605916|5790128|P5|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
2359739|NCT01605916|5790129|P4|COMPLETED|Overall Study||0
2359740|NCT01605916|5790130|P3|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
2359741|NCT01605916|5790131|P2|COMPLETED|Overall Study||0
2359742|NCT01605916|5790132|P1|COMPLETED|Overall Study||0
2359743|NCT01605916|5790128|P5|STARTED|Overall Study||7
2359744|NCT01605916|5790129|P4|STARTED|Overall Study||6
2359745|NCT01605916|5790130|P3|STARTED|Overall Study||4
2359746|NCT01605916|5790131|P2|STARTED|Overall Study||4
2359747|NCT01605916|5790132|P1|STARTED|Overall Study||4
2359748|NCT01605903|5790207|P2|NOT COMPLETED|Overall Study||0
2359749|NCT01605903|5790208|P1|NOT COMPLETED|Overall Study||0
2359750|NCT01605903|5790207|P2|COMPLETED|Overall Study||343
2359751|NCT01605903|5790208|P1|COMPLETED|Overall Study||345
2359752|NCT01605903|5790207|P2|STARTED|Overall Study||343
2359753|NCT01605903|5790208|P1|STARTED|Overall Study||345
2359754|NCT01605890|5790214|P1|NOT COMPLETED|Overall Study||2
2359755|NCT01605890|5790214|P1|COMPLETED|Overall Study||28
2359756|NCT01605890|5790214|P1|STARTED|Overall Study||30
2359757|NCT01605877|5790229|P1|NOT COMPLETED|Overall Study||1
2359758|NCT01605877|5790229|P1|COMPLETED|Overall Study||63
2359759|NCT01605877|5790229|P1|STARTED|Overall Study||64
2359760|NCT01605825|5790293|P2|NOT COMPLETED|Overall Study||3
2359761|NCT01605825|5790294|P1|NOT COMPLETED|Overall Study||10
2359762|NCT01605825|5790293|P2|COMPLETED|Overall Study||25
2359763|NCT01605825|5790294|P1|COMPLETED|Overall Study||45
2359764|NCT01605825|5790293|P2|STARTED|Overall Study||28
2359765|NCT01605825|5790294|P1|STARTED|Overall Study||55
2359766|NCT01605799|5790302|P2|NOT COMPLETED|Overall Study||1
2359767|NCT01605799|5790303|P1|NOT COMPLETED|Overall Study||2
2359768|NCT01605799|5790302|P2|COMPLETED|Overall Study||15
2359769|NCT01605799|5790303|P1|COMPLETED|Overall Study||15
2359770|NCT01605799|5790302|P2|STARTED|Overall Study||16
2359771|NCT01605799|5790303|P1|STARTED|Overall Study||17
2359772|NCT01605669|5790311|P1|NOT COMPLETED|Overall Study||0
2359773|NCT01605669|5790311|P1|COMPLETED|Overall Study||50
2359774|NCT01605669|5790311|P1|STARTED|Overall Study||50
2359775|NCT01605617|5790318|P2|NOT COMPLETED|Second Intervention||0
2359776|NCT01605617|5790319|P1|NOT COMPLETED|Second Intervention||0
2359777|NCT01605617|5790318|P2|COMPLETED|Second Intervention||0
2359778|NCT01605617|5790319|P1|COMPLETED|Second Intervention||0
2359779|NCT01605617|5790318|P2|STARTED|Second Intervention||0
2359780|NCT01605617|5790319|P1|STARTED|Second Intervention||0
2359781|NCT01605617|5790318|P2|NOT COMPLETED|Washout Period of 4 Weeks||1
2359782|NCT01605617|5790319|P1|NOT COMPLETED|Washout Period of 4 Weeks||2
2359783|NCT01605617|5790318|P2|COMPLETED|Washout Period of 4 Weeks||0
2359784|NCT01605617|5790319|P1|COMPLETED|Washout Period of 4 Weeks||0
2359785|NCT01605617|5790318|P2|STARTED|Washout Period of 4 Weeks||1
2359786|NCT01605617|5790319|P1|STARTED|Washout Period of 4 Weeks||2
2359787|NCT01605617|5790318|P2|NOT COMPLETED|First Intervention||1
2359788|NCT01605617|5790319|P1|NOT COMPLETED|First Intervention||0
2359789|NCT01605617|5790318|P2|COMPLETED|First Intervention||1
2359790|NCT01605617|5790319|P1|COMPLETED|First Intervention||2
2359791|NCT01605617|5790318|P2|STARTED|First Intervention||2
2359792|NCT01605617|5790319|P1|STARTED|First Intervention||2
2359793|NCT01605552|5790339|P2|NOT COMPLETED|Overall Study||2
2359794|NCT01605552|5790340|P1|NOT COMPLETED|Overall Study||6
2359795|NCT01605552|5790339|P2|COMPLETED|Overall Study||14
2359796|NCT01605552|5790340|P1|COMPLETED|Overall Study|4 dropped out before the first BtB visit; it is unlikely that the treatment was the cause of dropout|7
2359797|NCT01605552|5790339|P2|STARTED|Overall Study||16
2359798|NCT01605552|5790340|P1|STARTED|Overall Study||13
2359799|NCT01605539|5790354|P3|NOT COMPLETED|Overall Study||0
2359800|NCT01605539|5790355|P2|NOT COMPLETED|Overall Study||1
2359801|NCT01605539|5790356|P1|NOT COMPLETED|Overall Study||0
2359802|NCT01605539|5790354|P3|COMPLETED|Overall Study||4
2359803|NCT01605539|5790355|P2|COMPLETED|Overall Study||2
2359804|NCT01605539|5790356|P1|COMPLETED|Overall Study||3
2359805|NCT01605539|5790354|P3|STARTED|Overall Study||4
2359806|NCT01605539|5790355|P2|STARTED|Overall Study||3
2359807|NCT01605539|5790356|P1|STARTED|Overall Study||3
2359808|NCT01605461|5790378|P1|NOT COMPLETED|Overall Study||4
2359809|NCT01605461|5790378|P1|COMPLETED|Overall Study||8
2359810|NCT01605461|5790378|P1|STARTED|Overall Study||12
2359811|NCT01605435|5790387|P2|NOT COMPLETED|Overall Study||0
2359812|NCT01605435|5790388|P1|NOT COMPLETED|Overall Study||0
2359813|NCT01605435|5790387|P2|COMPLETED|Overall Study||3
2359814|NCT01605435|5790388|P1|COMPLETED|Overall Study||2
2359815|NCT01605435|5790387|P2|STARTED|Overall Study||3
2359816|NCT01605435|5790388|P1|STARTED|Overall Study||2
2359817|NCT01605396|5790437|P2|NOT COMPLETED|Overall Study||40
2359818|NCT01605396|5790438|P1|NOT COMPLETED|Overall Study||40
2359819|NCT01605396|5790437|P2|COMPLETED|Overall Study||0
2359820|NCT01605396|5790438|P1|COMPLETED|Overall Study||0
2359821|NCT01605396|5790437|P2|Treated|Overall Study||40
2359822|NCT01605396|5790438|P1|Treated|Overall Study||39
2359823|NCT01605396|5790437|P2|STARTED|Overall Study||40
2359824|NCT01605396|5790438|P1|STARTED|Overall Study||40
2359825|NCT01605370|5790452|P2|NOT COMPLETED|Overall Study||0
2359826|NCT01605370|5790453|P1|NOT COMPLETED|Overall Study||1
2359827|NCT01605370|5790452|P2|COMPLETED|Overall Study||0
2359828|NCT01605370|5790453|P1|COMPLETED|Overall Study||0
2359829|NCT01605370|5790452|P2|STARTED|Overall Study||0
2359830|NCT01605370|5790453|P1|STARTED|Overall Study||1
2359831|NCT01605292|5790461|P2|NOT COMPLETED|Overall Study||0
2359832|NCT01605292|5790462|P1|NOT COMPLETED|Overall Study||0
2359833|NCT01605292|5790461|P2|COMPLETED|Overall Study||347
2359834|NCT01605292|5790462|P1|COMPLETED|Overall Study||351
2359835|NCT01605292|5790461|P2|STARTED|Overall Study||347
2359836|NCT01605292|5790462|P1|STARTED|Overall Study||351
2359837|NCT01605227|5790488|P2|NOT COMPLETED|Overall Study||329
2359838|NCT01605227|5790489|P1|NOT COMPLETED|Overall Study||621
2359839|NCT01605227|5790488|P2|COMPLETED|Overall Study||17
2359840|NCT01605227|5790489|P1|COMPLETED|Overall Study||61
2359841|NCT01605227|5790488|P2|STARTED|Overall Study||346
2359842|NCT01605227|5790489|P1|STARTED|Overall Study||682
2359843|NCT01605136|5790501|P2|NOT COMPLETED|Safety Follow-Up Period||2
2359844|NCT01605136|5790502|P1|NOT COMPLETED|Safety Follow-Up Period||1
2359845|NCT01605136|5790501|P2|COMPLETED|Safety Follow-Up Period||40
2359846|NCT01605136|5790502|P1|COMPLETED|Safety Follow-Up Period||44
2359847|NCT01605136|5790501|P2|STARTED|Safety Follow-Up Period||42
2359848|NCT01605136|5790502|P1|STARTED|Safety Follow-Up Period||45
2359849|NCT01605136|5790501|P2|NOT COMPLETED|Study Period||3
2359850|NCT01605136|5790502|P1|NOT COMPLETED|Study Period||3
2359851|NCT01605136|5790501|P2|COMPLETED|Study Period||42
2359852|NCT01605136|5790502|P1|COMPLETED|Study Period||45
2359853|NCT01605136|5790501|P2|STARTED|Study Period||45
2359854|NCT01605136|5790502|P1|STARTED|Study Period||48
2359855|NCT01605019|5790522|P2|NOT COMPLETED|Overall Study||0
2359856|NCT01605019|5790523|P1|NOT COMPLETED|Overall Study||3
2359857|NCT01605019|5790522|P2|COMPLETED|Overall Study||0
2359858|NCT01605019|5790523|P1|COMPLETED|Overall Study||1
2359859|NCT01605019|5790522|P2|STARTED|Overall Study||0
2359860|NCT01605019|5790523|P1|STARTED|Overall Study||4
2359861|NCT01604941|5790533|P6|NOT COMPLETED|Overall Study||7
2359862|NCT01604941|5790534|P5|NOT COMPLETED|Overall Study||1
2359863|NCT01604941|5790535|P4|NOT COMPLETED|Overall Study||3
2359864|NCT01604941|5790536|P3|NOT COMPLETED|Overall Study||3
2359865|NCT01604941|5790537|P2|NOT COMPLETED|Overall Study||4
2359866|NCT01604941|5790538|P1|NOT COMPLETED|Overall Study||11
2359867|NCT01604941|5790533|P6|COMPLETED|Overall Study||0
2359868|NCT01604941|5790534|P5|COMPLETED|Overall Study||3
2359869|NCT01604941|5790535|P4|COMPLETED|Overall Study||0
2359870|NCT01604941|5790536|P3|COMPLETED|Overall Study||0
2359871|NCT01604941|5790537|P2|COMPLETED|Overall Study||0
2359872|NCT01604941|5790538|P1|COMPLETED|Overall Study||0
2359873|NCT01604941|5790533|P6|STARTED|Overall Study||7
2359874|NCT01604941|5790534|P5|STARTED|Overall Study||4
2359875|NCT01604941|5790535|P4|STARTED|Overall Study||3
2359876|NCT01604941|5790536|P3|STARTED|Overall Study||3
2359877|NCT01604941|5790537|P2|STARTED|Overall Study||4
2359878|NCT01604941|5790538|P1|STARTED|Overall Study||11
2359879|NCT01604850|5790566|P2|NOT COMPLETED|Overall Study||30
2359880|NCT01604850|5790567|P1|NOT COMPLETED|Overall Study||52
2359881|NCT01604850|5790566|P2|COMPLETED|Overall Study||69
2359882|NCT01604850|5790567|P1|COMPLETED|Overall Study||51
2359883|NCT01604850|5790566|P2|Enrolled and Treated|Overall Study||98
2359884|NCT01604850|5790567|P1|Enrolled and Treated|Overall Study||103
2359885|NCT01604850|5790566|P2|STARTED|Overall Study||99
2359886|NCT01604850|5790567|P1|STARTED|Overall Study||103
2359887|NCT01604785|5790585|P2|NOT COMPLETED|Overall Study||1
2359888|NCT01604785|5790586|P1|NOT COMPLETED|Overall Study||7
2359889|NCT01604785|5790585|P2|COMPLETED|Overall Study||36
2359890|NCT01604785|5790586|P1|COMPLETED|Overall Study||30
2359891|NCT01604785|5790585|P2|STARTED|Overall Study||37
2359892|NCT01604785|5790586|P1|STARTED|Overall Study||37
2359893|NCT01604772|5790596|P1|NOT COMPLETED|Overall Study||0
2359894|NCT01604772|5790596|P1|COMPLETED|Overall Study||16
2359895|NCT01604772|5790596|P1|STARTED|Overall Study||16
2359896|NCT01604408|5790605|P2|NOT COMPLETED|Observation Period||3
2359897|NCT01604408|5790606|P1|NOT COMPLETED|Observation Period||1
2359898|NCT01604408|5790605|P2|COMPLETED|Observation Period||84
2359899|NCT01604408|5790606|P1|COMPLETED|Observation Period||85
2359900|NCT01604408|5790605|P2|STARTED|Observation Period||87
2359901|NCT01604408|5790606|P1|STARTED|Observation Period||86
2359902|NCT01604408|5790605|P2|NOT COMPLETED|Treatment Period 6||2
2359903|NCT01604408|5790606|P1|NOT COMPLETED|Treatment Period 6||2
2359904|NCT01604408|5790605|P2|COMPLETED|Treatment Period 6||87
2359905|NCT01604408|5790606|P1|COMPLETED|Treatment Period 6||86
2359906|NCT01604408|5790605|P2|STARTED|Treatment Period 6||89
2359907|NCT01604408|5790606|P1|STARTED|Treatment Period 6||88
2359908|NCT01604408|5790605|P2|NOT COMPLETED|Treatment Period 5||0
2359909|NCT01604408|5790606|P1|NOT COMPLETED|Treatment Period 5||4
2359910|NCT01604408|5790605|P2|COMPLETED|Treatment Period 5||89
2359911|NCT01604408|5790606|P1|COMPLETED|Treatment Period 5||88
2359912|NCT01604408|5790605|P2|STARTED|Treatment Period 5||89
2359913|NCT01604408|5790606|P1|STARTED|Treatment Period 5||92
2359914|NCT01604408|5790605|P2|NOT COMPLETED|Treatment Period 4||2
2359915|NCT01604408|5790606|P1|NOT COMPLETED|Treatment Period 4||3
2359916|NCT01604408|5790605|P2|COMPLETED|Treatment Period 4||89
2359917|NCT01604408|5790606|P1|COMPLETED|Treatment Period 4||92
2359918|NCT01604408|5790605|P2|STARTED|Treatment Period 4||91
2359919|NCT01604408|5790606|P1|STARTED|Treatment Period 4||95
2359920|NCT01604408|5790605|P2|NOT COMPLETED|Treatment Period 3||5
2359921|NCT01604408|5790606|P1|NOT COMPLETED|Treatment Period 3||5
2359922|NCT01604408|5790605|P2|COMPLETED|Treatment Period 3||91
2359923|NCT01604408|5790606|P1|COMPLETED|Treatment Period 3||95
2359924|NCT01604408|5790605|P2|STARTED|Treatment Period 3||96
2359925|NCT01604408|5790606|P1|STARTED|Treatment Period 3||100
2359926|NCT01604408|5790605|P2|NOT COMPLETED|Treatment Period 2||2
2359927|NCT01604408|5790606|P1|NOT COMPLETED|Treatment Period 2||2
2359928|NCT01604408|5790605|P2|COMPLETED|Treatment Period 2||96
2359929|NCT01604408|5790606|P1|COMPLETED|Treatment Period 2||100
2359930|NCT01604408|5790605|P2|STARTED|Treatment Period 2||98
2359931|NCT01604408|5790606|P1|STARTED|Treatment Period 2||102
2359932|NCT01604408|5790605|P2|NOT COMPLETED|Treatment Period 1||1
2359933|NCT01604408|5790606|P1|NOT COMPLETED|Treatment Period 1||0
2359934|NCT01604408|5790605|P2|COMPLETED|Treatment Period 1||98
2359935|NCT01604408|5790606|P1|COMPLETED|Treatment Period 1||102
2359936|NCT01604408|5790605|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||99
2359937|NCT01604408|5790606|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||102
2359938|NCT01604408|5790605|P2|STARTED|Treatment Period 1||99
2359939|NCT01604408|5790606|P1|STARTED|Treatment Period 1||102
2359940|NCT01604343|5790621|P5|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||29
2359941|NCT01604343|5790622|P4|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||10
2359942|NCT01604343|5790623|P3|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||33
2359943|NCT01604343|5790624|P2|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||7
2359944|NCT01604343|5790625|P1|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||30
2359945|NCT01604343|5790621|P5|COMPLETED|Safety Follow-up Period (Week 104-120)||85
2359946|NCT01604343|5790622|P4|COMPLETED|Safety Follow-up Period (Week 104-120)||26
2359947|NCT01604343|5790623|P3|COMPLETED|Safety Follow-up Period (Week 104-120)||72
2359948|NCT01604343|5790624|P2|COMPLETED|Safety Follow-up Period (Week 104-120)||20
2359949|NCT01604343|5790625|P1|COMPLETED|Safety Follow-up Period (Week 104-120)||79
2359950|NCT01604343|5790621|P5|Safety Population|Safety Follow-up Period (Week 104-120)||114
2359951|NCT01604343|5790622|P4|Safety Population|Safety Follow-up Period (Week 104-120)||36
2359952|NCT01604343|5790623|P3|Safety Population|Safety Follow-up Period (Week 104-120)||105
2359953|NCT01604343|5790624|P2|Safety Population|Safety Follow-up Period (Week 104-120)||26
2359954|NCT01604343|5790625|P1|Safety Population|Safety Follow-up Period (Week 104-120)||109
2359955|NCT01604343|5790621|P5|STARTED|Safety Follow-up Period (Week 104-120)||114
2359956|NCT01604343|5790622|P4|STARTED|Safety Follow-up Period (Week 104-120)||36
2359957|NCT01604343|5790623|P3|STARTED|Safety Follow-up Period (Week 104-120)||105
2359958|NCT01604343|5790624|P2|STARTED|Safety Follow-up Period (Week 104-120)||27
2359959|NCT01604343|5790625|P1|STARTED|Safety Follow-up Period (Week 104-120)||109
2359960|NCT01604343|5790621|P5|NOT COMPLETED|Week 52 to Week 104||41
2359961|NCT01604343|5790622|P4|NOT COMPLETED|Week 52 to Week 104||46
2359962|NCT01604343|5790623|P3|NOT COMPLETED|Week 52 to Week 104||67
2359963|NCT01604343|5790624|P2|NOT COMPLETED|Week 52 to Week 104||43
2359964|NCT01604343|5790625|P1|NOT COMPLETED|Week 52 to Week 104||0
2359965|NCT01604343|5790621|P5|COMPLETED|Week 52 to Week 104||429
2359966|NCT01604343|5790622|P4|COMPLETED|Week 52 to Week 104||195
2359967|NCT01604343|5790623|P3|COMPLETED|Week 52 to Week 104||414
2359968|NCT01604343|5790624|P2|COMPLETED|Week 52 to Week 104||200
2359969|NCT01604343|5790625|P1|COMPLETED|Week 52 to Week 104||0
2359970|NCT01604343|5790621|P5|Treated|Week 52 to Week 104||470
2359971|NCT01604343|5790622|P4|Treated|Week 52 to Week 104||241
2359972|NCT01604343|5790623|P3|Treated|Week 52 to Week 104||481
2359973|NCT01604343|5790624|P2|Treated|Week 52 to Week 104||242
2359974|NCT01604343|5790625|P1|Treated|Week 52 to Week 104||0
2359975|NCT01604343|5790621|P5|STARTED|Week 52 to Week 104||470
2359976|NCT01604343|5790622|P4|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (92), 40 (12) and 52 were included|241
2359977|NCT01604343|5790623|P3|STARTED|Week 52 to Week 104||481
2359978|NCT01604343|5790624|P2|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (95), 40 (12) and 52 were included|243
2359979|NCT01604343|5790625|P1|STARTED|Week 52 to Week 104||0
2359980|NCT01604343|5790621|P5|NOT COMPLETED|Prior to W52 Administration(Through W52)||87
2359981|NCT01604343|5790622|P4|NOT COMPLETED|Prior to W52 Administration(Through W52)||0
2359982|NCT01604343|5790623|P3|NOT COMPLETED|Prior to W52 Administration(Through W52)||76
2359983|NCT01604343|5790624|P2|NOT COMPLETED|Prior to W52 Administration(Through W52)||0
2359984|NCT01604343|5790625|P1|NOT COMPLETED|Prior to W52 Administration(Through W52)||98
2359985|NCT01604343|5790621|P5|COMPLETED|Prior to W52 Administration(Through W52)||470
2359986|NCT01604343|5790622|P4|COMPLETED|Prior to W52 Administration(Through W52)||0
2359987|NCT01604343|5790623|P3|COMPLETED|Prior to W52 Administration(Through W52)||481
2359988|NCT01604343|5790624|P2|COMPLETED|Prior to W52 Administration(Through W52)||0
2359989|NCT01604343|5790625|P1|COMPLETED|Prior to W52 Administration(Through W52)||458
2359990|NCT01604343|5790621|P5|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
2359991|NCT01604343|5790622|P4|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
2359992|NCT01604343|5790623|P3|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
2359993|NCT01604343|5790624|P2|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
2359994|NCT01604343|5790625|P1|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)|Out of 24, 12 were re-randomized to sirukumab 50 mg and 12 were re-randomized to 100 mg group.|24
2359995|NCT01604343|5790621|P5|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
2359996|NCT01604343|5790622|P4|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
2359997|NCT01604343|5790623|P3|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
2359998|NCT01604343|5790624|P2|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
2359999|NCT01604343|5790625|P1|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)|Out of 187, 95 were re-randomized to sirukumab 50 mg and 92 were re-randomized to 100 mg group.|187
2360000|NCT01604343|5790621|P5|STARTED|Prior to W52 Administration(Through W52)||557
2360001|NCT01604343|5790622|P4|STARTED|Prior to W52 Administration(Through W52)||0
2360002|NCT01604343|5790623|P3|STARTED|Prior to W52 Administration(Through W52)||557
2360003|NCT01604343|5790624|P2|STARTED|Prior to W52 Administration(Through W52)||0
2360004|NCT01604343|5790625|P1|STARTED|Prior to W52 Administration(Through W52)||556
2360005|NCT01604291|5790738|P4|NOT COMPLETED|Overall Study||0
2360006|NCT01604291|5790739|P3|NOT COMPLETED|Overall Study||0
2360007|NCT01604291|5790740|P2|NOT COMPLETED|Overall Study||0
2360008|NCT01604291|5790741|P1|NOT COMPLETED|Overall Study||0
2360009|NCT01604291|5790738|P4|COMPLETED|Overall Study||44
2360010|NCT01604291|5790739|P3|COMPLETED|Overall Study||193
2360011|NCT01604291|5790740|P2|COMPLETED|Overall Study||443
2360012|NCT01604291|5790741|P1|COMPLETED|Overall Study||311
2360013|NCT01604291|5790738|P4|STARTED|Overall Study||44
2360014|NCT01604291|5790739|P3|STARTED|Overall Study||193
2360015|NCT01604291|5790740|P2|STARTED|Overall Study||443
2360016|NCT01604291|5790741|P1|STARTED|Overall Study||311
2360017|NCT01604278|5790790|P2|NOT COMPLETED|Overall Study||13
2360018|NCT01604278|5790791|P1|NOT COMPLETED|Overall Study||14
2360019|NCT01604278|5790790|P2|COMPLETED|Overall Study||210
2360020|NCT01604278|5790791|P1|COMPLETED|Overall Study||212
2360021|NCT01604278|5790790|P2|Full Analysis Set|Overall Study|Three randomized participants excluded: 2 who did not receive study drug; 1 with a major deviation.|220
2360022|NCT01604278|5790791|P1|Full Analysis Set|Overall Study||226
2360023|NCT01604278|5790790|P2|Safety Set|Overall Study|Two randomized participants who did not receive study drug were excluded from this set.|221
2360024|NCT01604278|5790791|P1|Safety Set|Overall Study||226
2360025|NCT01604278|5790790|P2|STARTED|Overall Study||223
2360026|NCT01604278|5790791|P1|STARTED|Overall Study||226
2360027|NCT01604265|5790817|P2|NOT COMPLETED|Overall Study||0
2360028|NCT01604265|5790818|P1|NOT COMPLETED|Overall Study||2
2360029|NCT01604265|5790817|P2|COMPLETED|Overall Study||32
2360030|NCT01604265|5790818|P1|COMPLETED|Overall Study||32
2360031|NCT01604265|5790817|P2|STARTED|Overall Study||32
2360032|NCT01604265|5790818|P1|STARTED|Overall Study||34
2360033|NCT01604122|5790854|P2|NOT COMPLETED|Overall Study||0
2360034|NCT01604122|5790855|P1|NOT COMPLETED|Overall Study||0
2360035|NCT01604122|5790854|P2|COMPLETED|Overall Study||32
2360036|NCT01604122|5790855|P1|COMPLETED|Overall Study||60
2360037|NCT01604122|5790854|P2|STARTED|Overall Study||32
2360038|NCT01604122|5790855|P1|STARTED|Overall Study||60
2360039|NCT01604109|5790902|P2|NOT COMPLETED|Overall Study||34
2360040|NCT01604109|5790903|P1|NOT COMPLETED|Overall Study||33
2360041|NCT01604109|5790902|P2|COMPLETED|Overall Study||112
2360042|NCT01604109|5790903|P1|COMPLETED|Overall Study||117
2360043|NCT01604109|5790902|P2|STARTED|Overall Study||146
2360044|NCT01604109|5790903|P1|STARTED|Overall Study||150
2360045|NCT01603940|5790911|P2|NOT COMPLETED|Overall Study||0
2360046|NCT01603940|5790912|P1|NOT COMPLETED|Overall Study||0
2360047|NCT01603940|5790911|P2|COMPLETED|Overall Study||14
2360048|NCT01603940|5790912|P1|COMPLETED|Overall Study||16
2360049|NCT01603940|5790911|P2|STARTED|Overall Study||14
2360050|NCT01603940|5790912|P1|STARTED|Overall Study||16
2360051|NCT01603875|5790929|P3|NOT COMPLETED|Overall Study||9
2360052|NCT01603875|5790930|P2|NOT COMPLETED|Overall Study||8
2360053|NCT01603875|5790931|P1|NOT COMPLETED|Overall Study||7
2360054|NCT01603875|5790929|P3|COMPLETED|Overall Study||26
2360055|NCT01603875|5790930|P2|COMPLETED|Overall Study||27
2360056|NCT01603875|5790931|P1|COMPLETED|Overall Study||28
2360057|NCT01603875|5790929|P3|STARTED|Overall Study||35
2360058|NCT01603875|5790930|P2|STARTED|Overall Study||35
2360059|NCT01603875|5790931|P1|STARTED|Overall Study||35
2360060|NCT01603641|5790951|P1|NOT COMPLETED|Overall Study||35
2360061|NCT01603641|5790951|P1|COMPLETED|Overall Study||335
2360062|NCT01603641|5790951|P1|Modified Intent-to-treat Population|Overall Study||366
2360063|NCT01603641|5790951|P1|Safety Population (Treated)|Overall Study||367
2360064|NCT01603641|5790951|P1|STARTED|Overall Study||370
2360065|NCT01603628|5790958|P3|NOT COMPLETED|Overall Study||2
2360066|NCT01603628|5790959|P2|NOT COMPLETED|Overall Study||3
2360067|NCT01603628|5790960|P1|NOT COMPLETED|Overall Study||3
2360068|NCT01603628|5790958|P3|COMPLETED|Overall Study||128
2360069|NCT01603628|5790959|P2|COMPLETED|Overall Study||123
2360070|NCT01603628|5790960|P1|COMPLETED|Overall Study||125
2360071|NCT01603628|5790958|P3|Safety Population: Received Treatment|Overall Study||128
2360072|NCT01603628|5790959|P2|Safety Population: Received Treatment|Overall Study||126
2360073|NCT01603628|5790960|P1|Safety Population: Received Treatment|Overall Study||128
2360074|NCT01603628|5790958|P3|STARTED|Overall Study||130
2360075|NCT01603628|5790959|P2|STARTED|Overall Study||126
2360076|NCT01603628|5790960|P1|STARTED|Overall Study||128
2360077|NCT01603615|5790977|P1|NOT COMPLETED|Overall Study||34
2360078|NCT01603615|5790977|P1|COMPLETED|Overall Study||186
2360079|NCT01603615|5790977|P1|Safety Population (Treated)|Overall Study||213
2360080|NCT01603615|5790977|P1|STARTED|Overall Study||220
2360081|NCT01603602|5790984|P3|NOT COMPLETED|Overall Study||1
2360082|NCT01603602|5790985|P2|NOT COMPLETED|Overall Study||0
2360083|NCT01603602|5790986|P1|NOT COMPLETED|Overall Study||2
2360084|NCT01603602|5790984|P3|COMPLETED|Overall Study||79
2360085|NCT01603602|5790985|P2|COMPLETED|Overall Study||78
2360086|NCT01603602|5790986|P1|COMPLETED|Overall Study||75
2360087|NCT01603602|5790984|P3|STARTED|Overall Study||80
2360088|NCT01603602|5790985|P2|STARTED|Overall Study||78
2360089|NCT01603602|5790986|P1|STARTED|Overall Study||77
2360090|NCT01603459|5791006|P1|NOT COMPLETED|Overall Study||18
2360091|NCT01603459|5791006|P1|COMPLETED|Overall Study||137
2360092|NCT01603459|5791006|P1|STARTED|Overall Study||155
2360093|NCT01603420|5791128|P2|NOT COMPLETED|Overall Study||0
2360094|NCT01603420|5791129|P1|NOT COMPLETED|Overall Study||0
2360095|NCT01603420|5791128|P2|COMPLETED|Overall Study||1
2360096|NCT01603420|5791129|P1|COMPLETED|Overall Study||1
2360097|NCT01603420|5791128|P2|STARTED|Overall Study||1
2360098|NCT01603420|5791129|P1|STARTED|Overall Study||1
2360099|NCT01603394|5791157|P1|NOT COMPLETED|Overall Study||1
2360100|NCT01603394|5791157|P1|COMPLETED|Overall Study||8
2360101|NCT01603394|5791157|P1|STARTED|Overall Study||9
2360102|NCT01603355|5791172|P1|NOT COMPLETED|Overall Study||2
2360103|NCT01603355|5791172|P1|COMPLETED|Overall Study||1
2360104|NCT01603355|5791172|P1|STARTED|Overall Study||3
2360105|NCT01603277|5791178|P2|NOT COMPLETED|Overall Study||18
2360106|NCT01603277|5791179|P1|NOT COMPLETED|Overall Study||14
2360107|NCT01603277|5791178|P2|COMPLETED|Overall Study||64
2360108|NCT01603277|5791179|P1|COMPLETED|Overall Study||64
2360109|NCT01603277|5791178|P2|STARTED|Overall Study||82
2360110|NCT01603277|5791179|P1|STARTED|Overall Study||78
2360111|NCT01603121|5791185|P2|NOT COMPLETED|Second Intervention, 10 Hours||0
2360112|NCT01603121|5791186|P1|NOT COMPLETED|Second Intervention, 10 Hours||1
2360113|NCT01603121|5791185|P2|COMPLETED|Second Intervention, 10 Hours||0
2360114|NCT01603121|5791186|P1|COMPLETED|Second Intervention, 10 Hours||0
2360115|NCT01603121|5791185|P2|STARTED|Second Intervention, 10 Hours||0
2360116|NCT01603121|5791186|P1|STARTED|Second Intervention, 10 Hours||1
2360117|NCT01603121|5791185|P2|NOT COMPLETED|First Intervention, 10 Hours||0
2360118|NCT01603121|5791186|P1|NOT COMPLETED|First Intervention, 10 Hours||0
2360119|NCT01603121|5791185|P2|COMPLETED|First Intervention, 10 Hours||0
2360120|NCT01603121|5791186|P1|COMPLETED|First Intervention, 10 Hours||1
2360121|NCT01603121|5791185|P2|STARTED|First Intervention, 10 Hours||0
2360122|NCT01603121|5791186|P1|STARTED|First Intervention, 10 Hours||1
2360123|NCT01603082|5791198|P2|NOT COMPLETED|Overall Study||1
2360124|NCT01603082|5791199|P1|NOT COMPLETED|Overall Study||2
2360125|NCT01603082|5791198|P2|COMPLETED|Overall Study|Completed the study|48
2360126|NCT01603082|5791199|P1|COMPLETED|Overall Study|Completed the study.|49
2360127|NCT01603082|5791198|P2|STARTED|Overall Study|Randomized|49
2360128|NCT01603082|5791199|P1|STARTED|Overall Study|Randomized|51
2360129|NCT01603056|5791209|P2|NOT COMPLETED|Overall Study||14
2360130|NCT01603056|5791210|P1|NOT COMPLETED|Overall Study||34
2360131|NCT01603056|5791209|P2|COMPLETED|Overall Study||190
2360132|NCT01603056|5791210|P1|COMPLETED|Overall Study||379
2360133|NCT01603056|5791209|P2|STARTED|Overall Study||204
2360134|NCT01603056|5791210|P1|STARTED|Overall Study||413
2360135|NCT01603043|5791240|P2|NOT COMPLETED|Overall Study||3
2360136|NCT01603043|5791241|P1|NOT COMPLETED|Overall Study||7
2360137|NCT01603043|5791240|P2|COMPLETED|Overall Study||0
2360138|NCT01603043|5791241|P1|COMPLETED|Overall Study||0
2360139|NCT01603043|5791240|P2|STARTED|Overall Study||3
2360140|NCT01603043|5791241|P1|STARTED|Overall Study||7
2360141|NCT01602965|5791253|P2|NOT COMPLETED|Overall Study||2
2360142|NCT01602965|5791254|P1|NOT COMPLETED|Overall Study||4
2360143|NCT01602965|5791253|P2|COMPLETED|Overall Study||18
2360144|NCT01602965|5791254|P1|COMPLETED|Overall Study||16
2360145|NCT01602965|5791253|P2|STARTED|Overall Study||20
2360146|NCT01602965|5791254|P1|STARTED|Overall Study||20
2360147|NCT01602744|5791262|P2|NOT COMPLETED|Overall Study||23
2360148|NCT01602744|5791263|P1|NOT COMPLETED|Overall Study||30
2360149|NCT01602744|5791262|P2|COMPLETED|Overall Study||160
2360150|NCT01602744|5791263|P1|COMPLETED|Overall Study||146
2360151|NCT01602744|5791262|P2|STARTED|Overall Study||183
2360152|NCT01602744|5791263|P1|STARTED|Overall Study||176
2360153|NCT01602731|5791279|P1|NOT COMPLETED|Overall Study||30
2360154|NCT01602731|5791279|P1|COMPLETED|Overall Study||15
2360155|NCT01602731|5791279|P1|Poor Medication Adherence|Overall Study|24 out of 35 patients who completed 1-month pill counts had medication adherence <88%.|24
2360156|NCT01602731|5791279|P1|Cognitive Impairment|Overall Study|After repeat cognitive testing, additional 1 patient had no cognitive impairment and did not proceed|44
2360157|NCT01602731|5791279|P1|STARTED|Overall Study||45
2360158|NCT01602679|5791287|P2|NOT COMPLETED|Overall Study||0
2360159|NCT01602679|5791288|P1|NOT COMPLETED|Overall Study||0
2360160|NCT01602679|5791287|P2|COMPLETED|Overall Study||3
2360161|NCT01602679|5791288|P1|COMPLETED|Overall Study||4
2360162|NCT01602679|5791287|P2|STARTED|Overall Study||3
2360163|NCT01602679|5791288|P1|STARTED|Overall Study||4
2360164|NCT01602562|5791300|P2|NOT COMPLETED|Overall Study||3
2360165|NCT01602562|5791301|P1|NOT COMPLETED|Overall Study||5
2360166|NCT01602562|5791300|P2|COMPLETED|Overall Study||16
2360167|NCT01602562|5791301|P1|COMPLETED|Overall Study||16
2360168|NCT01602562|5791300|P2|STARTED|Overall Study||19
2360169|NCT01602562|5791301|P1|STARTED|Overall Study||21
2360170|NCT01602549|5791337|P2|NOT COMPLETED|Overall Study||1
2360171|NCT01602549|5791338|P1|NOT COMPLETED|Overall Study||1
2360172|NCT01602549|5791337|P2|COMPLETED|Overall Study||37
2360173|NCT01602549|5791338|P1|COMPLETED|Overall Study||18
2360174|NCT01602549|5791337|P2|STARTED|Overall Study||38
2360175|NCT01602549|5791338|P1|STARTED|Overall Study||19
2360176|NCT01602510|5791417|P3|NOT COMPLETED|Randomized Phase||73
2360177|NCT01602510|5791418|P2|NOT COMPLETED|Randomized Phase||74
2360178|NCT01602510|5791419|P1|NOT COMPLETED|Randomized Phase||0
2360179|NCT01602510|5791417|P3|COMPLETED|Randomized Phase||58
2360180|NCT01602510|5791418|P2|COMPLETED|Randomized Phase||59
2360181|NCT01602510|5791419|P1|COMPLETED|Randomized Phase||0
2360182|NCT01602510|5791417|P3|STARTED|Randomized Phase||131
2360183|NCT01602510|5791418|P2|STARTED|Randomized Phase||133
2360184|NCT01602510|5791419|P1|STARTED|Randomized Phase||0
2360185|NCT01602510|5791417|P3|NOT COMPLETED|Open Label Phase||0
2360186|NCT01602510|5791418|P2|NOT COMPLETED|Open Label Phase||0
2360187|NCT01602510|5791419|P1|NOT COMPLETED|Open Label Phase||303
2360188|NCT01602510|5791417|P3|COMPLETED|Open Label Phase||0
2360189|NCT01602510|5791418|P2|COMPLETED|Open Label Phase||0
2360190|NCT01602510|5791419|P1|COMPLETED|Open Label Phase||117
2360191|NCT01602510|5791417|P3|STARTED|Open Label Phase||0
2360192|NCT01602510|5791418|P2|STARTED|Open Label Phase||0
2360193|NCT01602510|5791419|P1|STARTED|Open Label Phase||420
2360194|NCT01602484|5791445|P2|NOT COMPLETED|Overall Study||1
2360195|NCT01602484|5791446|P1|NOT COMPLETED|Overall Study||0
2360196|NCT01602484|5791445|P2|COMPLETED|Overall Study||24
2360197|NCT01602484|5791446|P1|COMPLETED|Overall Study||25
2360198|NCT01602484|5791445|P2|STARTED|Overall Study||25
2360199|NCT01602484|5791446|P1|STARTED|Overall Study||25
2360200|NCT01602471|5791458|P1|NOT COMPLETED|Overall Study||0
2360201|NCT01602471|5791458|P1|COMPLETED|Overall Study||4
2360202|NCT01602471|5791458|P1|STARTED|Overall Study||4
2360203|NCT01602419|5791462|P1|NOT COMPLETED|Overall Study||29
2360204|NCT01602419|5791462|P1|COMPLETED|Overall Study||91
2360205|NCT01602419|5791462|P1|EFF Population|Overall Study||91
2360206|NCT01602419|5791462|P1|ITT Population|Overall Study||102
2360207|NCT01602419|5791462|P1|SAF Population|Overall Study||111
2360208|NCT01602419|5791462|P1|STARTED|Overall Study||120
2360209|NCT01602380|5791517|P2|NOT COMPLETED|Overall Study||101
2360210|NCT01602380|5791518|P1|NOT COMPLETED|Overall Study||93
2360211|NCT01602380|5791517|P2|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|131
2360212|NCT01602380|5791518|P1|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|137
2360213|NCT01602380|5791517|P2|STARTED|Overall Study||232
2360214|NCT01602380|5791518|P1|STARTED|Overall Study||230
2360215|NCT01602341|5791542|P2|NOT COMPLETED|Overall Study||1
2360216|NCT01602341|5791543|P1|NOT COMPLETED|Overall Study||0
2360217|NCT01602341|5791542|P2|COMPLETED|Overall Study||41
2360218|NCT01602341|5791543|P1|COMPLETED|Overall Study||44
2360219|NCT01602341|5791542|P2|STARTED|Overall Study||42
2360220|NCT01602341|5791543|P1|STARTED|Overall Study||44
2360221|NCT01602315|5791584|P7|NOT COMPLETED|Overall Study||29
2360222|NCT01602315|5791585|P6|NOT COMPLETED|Overall Study||35
2360223|NCT01602315|5791586|P5|NOT COMPLETED|Overall Study||71
2360224|NCT01602315|5791587|P4|NOT COMPLETED|Overall Study||6
2360225|NCT01602315|5791588|P3|NOT COMPLETED|Overall Study||18
2360226|NCT01602315|5791589|P2|NOT COMPLETED|Overall Study||5
2360227|NCT01602315|5791590|P1|NOT COMPLETED|Overall Study||16
2360228|NCT01602315|5791584|P7|COMPLETED|Overall Study||0
2360229|NCT01602315|5791585|P6|COMPLETED|Overall Study||0
2360230|NCT01602315|5791586|P5|COMPLETED|Overall Study||0
2360231|NCT01602315|5791587|P4|COMPLETED|Overall Study||0
2360232|NCT01602315|5791588|P3|COMPLETED|Overall Study||0
2360233|NCT01602315|5791589|P2|COMPLETED|Overall Study||0
2360234|NCT01602315|5791590|P1|COMPLETED|Overall Study||0
2360235|NCT01602315|5791584|P7|STARTED|Overall Study||29
2360236|NCT01602315|5791585|P6|STARTED|Overall Study||35
2360237|NCT01602315|5791586|P5|STARTED|Overall Study||71
2360238|NCT01602315|5791587|P4|STARTED|Overall Study||6
2360239|NCT01602315|5791588|P3|STARTED|Overall Study||18
2360240|NCT01602315|5791589|P2|STARTED|Overall Study||5
2360241|NCT01602315|5791590|P1|STARTED|Overall Study||16
2360242|NCT01602224|5791679|P3|NOT COMPLETED|Overall Study||6
2360243|NCT01602224|5791680|P2|NOT COMPLETED|Overall Study||8
2360244|NCT01602224|5791681|P1|NOT COMPLETED|Overall Study||8
2360245|NCT01602224|5791679|P3|COMPLETED|Overall Study||66
2360246|NCT01602224|5791680|P2|COMPLETED|Overall Study||66
2360247|NCT01602224|5791681|P1|COMPLETED|Overall Study||66
2360248|NCT01602224|5791679|P3|Received at Least 1 Dose of Study Drug|Overall Study||72
2360249|NCT01602224|5791680|P2|Received at Least 1 Dose of Study Drug|Overall Study||74
2360250|NCT01602224|5791681|P1|Received at Least 1 Dose of Study Drug|Overall Study||73
2360251|NCT01602224|5791679|P3|STARTED|Overall Study||72
2360252|NCT01602224|5791680|P2|STARTED|Overall Study||74
2360253|NCT01602224|5791681|P1|STARTED|Overall Study||74
2360254|NCT01602198|5791727|P2|NOT COMPLETED|Overall Study||0
2360255|NCT01602198|5791728|P1|NOT COMPLETED|Overall Study||0
2360256|NCT01602198|5791727|P2|COMPLETED|Overall Study||1
2360257|NCT01602198|5791728|P1|COMPLETED|Overall Study||0
2360258|NCT01602198|5791727|P2|STARTED|Overall Study||1
2360259|NCT01602198|5791728|P1|STARTED|Overall Study||0
2360260|NCT01602172|5791737|P3|NOT COMPLETED|Overall Study||0
2360261|NCT01602172|5791738|P2|NOT COMPLETED|Overall Study||6
2360262|NCT01602172|5791739|P1|NOT COMPLETED|Overall Study||5
2360263|NCT01602172|5791737|P3|COMPLETED|Overall Study||22
2360264|NCT01602172|5791738|P2|COMPLETED|Overall Study||17
2360265|NCT01602172|5791739|P1|COMPLETED|Overall Study||32
2360266|NCT01602172|5791737|P3|STARTED|Overall Study||22
2360267|NCT01602172|5791738|P2|STARTED|Overall Study||23
2360268|NCT01602172|5791739|P1|STARTED|Overall Study||37
2360269|NCT01602120|5791766|P4|NOT COMPLETED|Overall Study||53
2360270|NCT01602120|5791767|P3|NOT COMPLETED|Overall Study||17
2360271|NCT01602120|5791768|P2|NOT COMPLETED|Overall Study||60
2360272|NCT01602120|5791769|P1|NOT COMPLETED|Overall Study||29
2360273|NCT01602120|5791766|P4|COMPLETED|Overall Study||0
2360274|NCT01602120|5791767|P3|COMPLETED|Overall Study||0
2360275|NCT01602120|5791768|P2|COMPLETED|Overall Study||0
2360276|NCT01602120|5791769|P1|COMPLETED|Overall Study||0
2360277|NCT01602120|5791766|P4|STARTED|Overall Study||53
2360278|NCT01602120|5791767|P3|STARTED|Overall Study||17
2360279|NCT01602120|5791768|P2|STARTED|Overall Study||60
2360280|NCT01602120|5791769|P1|STARTED|Overall Study||29
2360281|NCT01602068|5791783|P2|NOT COMPLETED|Overall Study||0
2360282|NCT01602068|5791784|P1|NOT COMPLETED|Overall Study||0
2360283|NCT01602068|5791783|P2|COMPLETED|Overall Study||22
2360284|NCT01602068|5791784|P1|COMPLETED|Overall Study||23
2360285|NCT01602068|5791783|P2|STARTED|Overall Study|Day before surgery|22
2360286|NCT01602068|5791784|P1|STARTED|Overall Study|Day before surgery|23
2360287|NCT01602016|5791790|P1|NOT COMPLETED|Overall Study||0
2360288|NCT01602016|5791790|P1|COMPLETED|Overall Study||0
2360289|NCT01602016|5791790|P1|STARTED|Overall Study||0
2360290|NCT01601977|5791797|P1|NOT COMPLETED|Overall Study||0
2360291|NCT01601977|5791797|P1|COMPLETED|Overall Study||10
2360292|NCT01601977|5791797|P1|STARTED|Overall Study|5 patients consented for study participation but did not attend for study assessments.|10
2360293|NCT01601873|5791817|P2|NOT COMPLETED|Overall Study||3
2360294|NCT01601873|5791818|P1|NOT COMPLETED|Overall Study||2
2360295|NCT01601873|5791817|P2|COMPLETED|Overall Study||44
2360296|NCT01601873|5791818|P1|COMPLETED|Overall Study||48
2360297|NCT01601873|5791817|P2|STARTED|Overall Study||47
2360298|NCT01601873|5791818|P1|STARTED|Overall Study||50
2360299|NCT01601847|5791844|P2|NOT COMPLETED|Overall Study||10
2360300|NCT01601847|5791845|P1|NOT COMPLETED|Overall Study||13
2360301|NCT01601847|5791844|P2|COMPLETED|Overall Study||137
2360302|NCT01601847|5791845|P1|COMPLETED|Overall Study||140
2360303|NCT01601847|5791844|P2|STARTED|Overall Study||147
2360304|NCT01601847|5791845|P1|STARTED|Overall Study||153
2360305|NCT01601821|5791857|P2|NOT COMPLETED|Overall Study||29
2360306|NCT01601821|5791858|P1|NOT COMPLETED|Overall Study||29
2360307|NCT01601821|5791857|P2|COMPLETED|Overall Study||91
2360308|NCT01601821|5791858|P1|COMPLETED|Overall Study||96
2360309|NCT01601821|5791857|P2|STARTED|Overall Study||120
2360310|NCT01601821|5791858|P1|STARTED|Overall Study||125
2360311|NCT01601782|5791888|P1|NOT COMPLETED|Overall Study||0
2360312|NCT01601782|5791888|P1|COMPLETED|Overall Study||16
2360313|NCT01601782|5791888|P1|STARTED|Overall Study||16
2360314|NCT01601704|5791894|P2|NOT COMPLETED|Overall Study||4
2360315|NCT01601704|5791895|P1|NOT COMPLETED|Overall Study||1
2360316|NCT01601704|5791894|P2|COMPLETED|Overall Study||4450
2360317|NCT01601704|5791895|P1|COMPLETED|Overall Study||4455
2360318|NCT01601704|5791894|P2|Treated|Overall Study||4450
2360319|NCT01601704|5791895|P1|Treated|Overall Study||4455
2360320|NCT01601704|5791894|P2|STARTED|Overall Study||4454
2360321|NCT01601704|5791895|P1|STARTED|Overall Study||4456
2360322|NCT01601691|5791909|P1|NOT COMPLETED|Overall Study||0
2360323|NCT01601691|5791909|P1|COMPLETED|Overall Study||10
2360324|NCT01601691|5791909|P1|STARTED|Overall Study||10
2360325|NCT01601626|5791916|P3|NOT COMPLETED|Overall Study||2
2360326|NCT01601626|5791917|P2|NOT COMPLETED|Overall Study||5
2360327|NCT01601626|5791918|P1|NOT COMPLETED|Overall Study||3
2360328|NCT01601626|5791916|P3|COMPLETED|Overall Study||21
2360329|NCT01601626|5791917|P2|COMPLETED|Overall Study||19
2360330|NCT01601626|5791918|P1|COMPLETED|Overall Study||21
2360331|NCT01601626|5791916|P3|STARTED|Overall Study||23
2360332|NCT01601626|5791917|P2|STARTED|Overall Study||24
2360333|NCT01601626|5791918|P1|STARTED|Overall Study||24
2360334|NCT01601535|5792007|P6|NOT COMPLETED|Phase 2||12
2360335|NCT01601535|5792008|P5|NOT COMPLETED|Phase 2||19
2360336|NCT01601535|5792009|P4|NOT COMPLETED|Phase 2||0
2360337|NCT01601535|5792010|P3|NOT COMPLETED|Phase 2||0
2360338|NCT01601535|5792011|P2|NOT COMPLETED|Phase 2||0
2360339|NCT01601535|5792012|P1|NOT COMPLETED|Phase 2||0
2360340|NCT01601535|5792007|P6|COMPLETED|Phase 2||0
2360341|NCT01601535|5792008|P5|COMPLETED|Phase 2||1
2360342|NCT01601535|5792009|P4|COMPLETED|Phase 2||0
2360343|NCT01601535|5792010|P3|COMPLETED|Phase 2||0
2360344|NCT01601535|5792011|P2|COMPLETED|Phase 2||0
2360345|NCT01601535|5792012|P1|COMPLETED|Phase 2||0
2360346|NCT01601535|5792007|P6|STARTED|Phase 2||12
2360347|NCT01601535|5792008|P5|STARTED|Phase 2||20
2360348|NCT01601535|5792009|P4|STARTED|Phase 2||0
2360349|NCT01601535|5792010|P3|STARTED|Phase 2||0
2360350|NCT01601535|5792011|P2|STARTED|Phase 2||0
2360351|NCT01601535|5792012|P1|STARTED|Phase 2||0
2360352|NCT01601535|5792007|P6|NOT COMPLETED|Phase 1||0
2360353|NCT01601535|5792008|P5|NOT COMPLETED|Phase 1||0
2360354|NCT01601535|5792009|P4|NOT COMPLETED|Phase 1||4
2360355|NCT01601535|5792010|P3|NOT COMPLETED|Phase 1||5
2360356|NCT01601535|5792011|P2|NOT COMPLETED|Phase 1||6
2360357|NCT01601535|5792012|P1|NOT COMPLETED|Phase 1||6
2360358|NCT01601535|5792007|P6|COMPLETED|Phase 1||0
2360359|NCT01601535|5792008|P5|COMPLETED|Phase 1||0
2360360|NCT01601535|5792009|P4|COMPLETED|Phase 1||0
2360361|NCT01601535|5792010|P3|COMPLETED|Phase 1||1
2360362|NCT01601535|5792011|P2|COMPLETED|Phase 1||0
2360363|NCT01601535|5792012|P1|COMPLETED|Phase 1||0
2360364|NCT01601535|5792007|P6|STARTED|Phase 1||0
2360365|NCT01601535|5792008|P5|STARTED|Phase 1||0
2360366|NCT01601535|5792009|P4|STARTED|Phase 1||4
2360367|NCT01601535|5792010|P3|STARTED|Phase 1||6
2360368|NCT01601535|5792011|P2|STARTED|Phase 1||6
2360369|NCT01601535|5792012|P1|STARTED|Phase 1||6
2360370|NCT01601470|5792068|P1|NOT COMPLETED|Period 3 - LCZ696+Sildenafil||0
2360371|NCT01601470|5792068|P1|COMPLETED|Period 3 - LCZ696+Sildenafil||27
2360372|NCT01601470|5792068|P1|Safety Set|Period 3 - LCZ696+Sildenafil||27
2360373|NCT01601470|5792068|P1|PK Analysis Set|Period 3 - LCZ696+Sildenafil||27
2360374|NCT01601470|5792068|P1|STARTED|Period 3 - LCZ696+Sildenafil||27
2360375|NCT01601470|5792068|P1|NOT COMPLETED|Period 2 - LCZ696||1
2360376|NCT01601470|5792068|P1|COMPLETED|Period 2 - LCZ696||27
2360377|NCT01601470|5792068|P1|Safety Set|Period 2 - LCZ696||27
2360378|NCT01601470|5792068|P1|PK Analysis Set|Period 2 - LCZ696||27
2360379|NCT01601470|5792068|P1|STARTED|Period 2 - LCZ696||28
2360380|NCT01601470|5792068|P1|NOT COMPLETED|Period 1 - Sildenafil||0
2360381|NCT01601470|5792068|P1|COMPLETED|Period 1 - Sildenafil||28
2360382|NCT01601470|5792068|P1|Safety Set|Period 1 - Sildenafil||28
2360383|NCT01601470|5792068|P1|PK Analysis Set|Period 1 - Sildenafil||28
2360384|NCT01601470|5792068|P1|STARTED|Period 1 - Sildenafil||28
2360385|NCT01601431|5792085|P2|NOT COMPLETED|Overall Study||3
2360386|NCT01601431|5792086|P1|NOT COMPLETED|Overall Study||12
2360387|NCT01601431|5792085|P2|COMPLETED|Overall Study||214
2360388|NCT01601431|5792086|P1|COMPLETED|Overall Study||211
2360389|NCT01601431|5792085|P2|STARTED|Overall Study||217
2360390|NCT01601431|5792086|P1|STARTED|Overall Study||223
2360391|NCT01601236|5792098|P6|NOT COMPLETED|Overall Study||1
2360392|NCT01601236|5792099|P5|NOT COMPLETED|Overall Study||3
2360393|NCT01601236|5792100|P4|NOT COMPLETED|Overall Study||2
2360394|NCT01601236|5792101|P3|NOT COMPLETED|Overall Study||6
2360395|NCT01601236|5792102|P2|NOT COMPLETED|Overall Study||1
2360396|NCT01601236|5792103|P1|NOT COMPLETED|Overall Study||5
2360397|NCT01601236|5792098|P6|COMPLETED|Overall Study||0
2360398|NCT01601236|5792099|P5|COMPLETED|Overall Study||0
2360399|NCT01601236|5792100|P4|COMPLETED|Overall Study||4
2360400|NCT01601236|5792101|P3|COMPLETED|Overall Study||8
2360401|NCT01601236|5792102|P2|COMPLETED|Overall Study||2
2360402|NCT01601236|5792103|P1|COMPLETED|Overall Study||2
2360403|NCT01601236|5792098|P6|STARTED|Overall Study||1
2360404|NCT01601236|5792099|P5|STARTED|Overall Study||3
2360405|NCT01601236|5792100|P4|STARTED|Overall Study||6
2360406|NCT01601236|5792101|P3|STARTED|Overall Study||14
2360407|NCT01601236|5792102|P2|STARTED|Overall Study||3
2360408|NCT01601236|5792103|P1|STARTED|Overall Study||7
2360409|NCT01601132|5792139|P1|NOT COMPLETED|Overall Study||2
2360410|NCT01601132|5792139|P1|COMPLETED|Overall Study||28
2360411|NCT01601132|5792139|P1|STARTED|Overall Study||30
2360412|NCT01601067|5792158|P2|NOT COMPLETED|Overall Study||22
2360413|NCT01601067|5792159|P1|NOT COMPLETED|Overall Study||33
2360414|NCT01601067|5792158|P2|COMPLETED|Overall Study||34
2360415|NCT01601067|5792159|P1|COMPLETED|Overall Study||30
2360416|NCT01601067|5792158|P2|STARTED|Overall Study||56
2360417|NCT01601067|5792159|P1|STARTED|Overall Study||63
2360418|NCT01600950|5792167|P2|NOT COMPLETED|Period 2||0
2360419|NCT01600950|5792168|P1|NOT COMPLETED|Period 2||0
2360420|NCT01600950|5792167|P2|COMPLETED|Period 2||10
2360421|NCT01600950|5792168|P1|COMPLETED|Period 2||10
2360422|NCT01600950|5792167|P2|STARTED|Period 2||10
2360423|NCT01600950|5792168|P1|STARTED|Period 2||10
2360424|NCT01600950|5792167|P2|NOT COMPLETED|Period 1||0
2360425|NCT01600950|5792168|P1|NOT COMPLETED|Period 1||0
2360426|NCT01600950|5792167|P2|COMPLETED|Period 1||10
2360427|NCT01600950|5792168|P1|COMPLETED|Period 1||10
2360428|NCT01600950|5792167|P2|STARTED|Period 1||10
2360429|NCT01600950|5792168|P1|STARTED|Period 1||10
2360430|NCT01600885|5792184|P2|NOT COMPLETED|Second Period||0
2360431|NCT01600885|5792185|P1|NOT COMPLETED|Second Period||0
2360432|NCT01600885|5792184|P2|COMPLETED|Second Period||8
2360433|NCT01600885|5792185|P1|COMPLETED|Second Period||8
2360434|NCT01600885|5792184|P2|STARTED|Second Period||8
2360435|NCT01600885|5792185|P1|STARTED|Second Period||8
2360436|NCT01600885|5792184|P2|NOT COMPLETED|Wash Out Period||0
2360437|NCT01600885|5792185|P1|NOT COMPLETED|Wash Out Period||0
2360438|NCT01600885|5792184|P2|COMPLETED|Wash Out Period||8
2360439|NCT01600885|5792185|P1|COMPLETED|Wash Out Period||8
2360440|NCT01600885|5792184|P2|STARTED|Wash Out Period||8
2360441|NCT01600885|5792185|P1|STARTED|Wash Out Period||8
2360442|NCT01600885|5792184|P2|NOT COMPLETED|First Period||1
2360443|NCT01600885|5792185|P1|NOT COMPLETED|First Period||2
2360444|NCT01600885|5792184|P2|COMPLETED|First Period||8
2360445|NCT01600885|5792185|P1|COMPLETED|First Period||8
2360446|NCT01600885|5792184|P2|STARTED|First Period||9
2360447|NCT01600885|5792185|P1|STARTED|First Period||10
2360448|NCT01600729|5792195|P1|NOT COMPLETED|Overall Study||1
2360449|NCT01600729|5792195|P1|COMPLETED|Overall Study||65
2360450|NCT01600729|5792195|P1|STARTED|Overall Study||66
2360451|NCT01600716|5792202|P2|NOT COMPLETED|Overall Study||7
2360452|NCT01600716|5792203|P1|NOT COMPLETED|Overall Study||7
2360453|NCT01600716|5792202|P2|COMPLETED|Overall Study||71
2360454|NCT01600716|5792203|P1|COMPLETED|Overall Study||59
2360455|NCT01600716|5792202|P2|STARTED|Overall Study||78
2360456|NCT01600716|5792203|P1|STARTED|Overall Study||66
2360457|NCT01600703|5792219|P2|NOT COMPLETED|Second Intervention||0
2360458|NCT01600703|5792220|P1|NOT COMPLETED|Second Intervention||0
2360459|NCT01600703|5792219|P2|COMPLETED|Second Intervention||8
2360460|NCT01600703|5792220|P1|COMPLETED|Second Intervention||7
2360461|NCT01600703|5792219|P2|STARTED|Second Intervention||8
2360462|NCT01600703|5792220|P1|STARTED|Second Intervention||7
2360463|NCT01600703|5792219|P2|NOT COMPLETED|First Intervention||0
2360464|NCT01600703|5792220|P1|NOT COMPLETED|First Intervention||0
2360465|NCT01600703|5792219|P2|COMPLETED|First Intervention||8
2360466|NCT01600703|5792220|P1|COMPLETED|First Intervention||7
2360467|NCT01600703|5792219|P2|STARTED|First Intervention||8
2360468|NCT01600703|5792220|P1|STARTED|First Intervention||7
2360469|NCT01600677|5792230|P2|NOT COMPLETED|Overall Study||0
2360470|NCT01600677|5792231|P1|NOT COMPLETED|Overall Study||0
2360471|NCT01600677|5792230|P2|COMPLETED|Overall Study||4
2360472|NCT01600677|5792231|P1|COMPLETED|Overall Study||7
2360473|NCT01600677|5792230|P2|STARTED|Overall Study||4
2360474|NCT01600677|5792231|P1|STARTED|Overall Study||7
2360475|NCT01600586|5792243|P2|NOT COMPLETED|Overall Study||3
2360476|NCT01600586|5792244|P1|NOT COMPLETED|Overall Study||3
2360477|NCT01600586|5792243|P2|COMPLETED|Overall Study||48
2360478|NCT01600586|5792244|P1|COMPLETED|Overall Study||46
2360479|NCT01600586|5792243|P2|STARTED|Overall Study||51
2360480|NCT01600586|5792244|P1|STARTED|Overall Study||49
2360481|NCT01600495|5792260|P2|NOT COMPLETED|Overall Study||0
2360482|NCT01600495|5792261|P1|NOT COMPLETED|Overall Study||0
2360483|NCT01600495|5792260|P2|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
2360484|NCT01600495|5792261|P1|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
2360485|NCT01600495|5792260|P2|STARTED|Overall Study|We start with the prediction of collecting 20 control patients|23
2360486|NCT01600495|5792261|P1|STARTED|Overall Study|We start with the prediction of collecting 20 patients in the treated group|23
2360487|NCT01600482|5792275|P2|NOT COMPLETED|Overall Study||0
2360488|NCT01600482|5792276|P1|NOT COMPLETED|Overall Study||0
2360489|NCT01600482|5792275|P2|COMPLETED|Overall Study||59
2360490|NCT01600482|5792276|P1|COMPLETED|Overall Study|Last 26 patients allocated to CELT ACD|148
2360491|NCT01600482|5792275|P2|STARTED|Overall Study|Last 26 patients allocated to CELT ACD|59
2360492|NCT01600482|5792276|P1|STARTED|Overall Study||148
2360493|NCT01600326|5792296|P2|NOT COMPLETED|Overall Study||1
2360494|NCT01600326|5792297|P1|NOT COMPLETED|Overall Study||1
2360495|NCT01600326|5792296|P2|COMPLETED|Overall Study||14
2360496|NCT01600326|5792297|P1|COMPLETED|Overall Study||14
2360497|NCT01600326|5792296|P2|Primary Outcome Measure Data Collection|Overall Study||15
2360498|NCT01600326|5792297|P1|Primary Outcome Measure Data Collection|Overall Study||15
2360499|NCT01600326|5792296|P2|STARTED|Overall Study||15
2360500|NCT01600326|5792297|P1|STARTED|Overall Study||15
2360501|NCT01600287|5792307|P2|NOT COMPLETED|Overall Study||0
2360502|NCT01600287|5792308|P1|NOT COMPLETED|Overall Study||0
2360503|NCT01600287|5792307|P2|COMPLETED|Overall Study||20
2360504|NCT01600287|5792308|P1|COMPLETED|Overall Study||20
2360505|NCT01600287|5792307|P2|STARTED|Overall Study||20
2360506|NCT01600287|5792308|P1|STARTED|Overall Study||20
2360507|NCT01600222|5792348|P1|NOT COMPLETED|Overall Study||2
2360508|NCT01600222|5792348|P1|COMPLETED|Overall Study||35
2360509|NCT01600222|5792348|P1|STARTED|Overall Study||37
2360510|NCT01600105|5792373|P2|NOT COMPLETED|Sub Study V||0
2360511|NCT01600105|5792374|P1|NOT COMPLETED|Sub Study V||2
2360512|NCT01600105|5792373|P2|COMPLETED|Sub Study V||0
2360513|NCT01600105|5792374|P1|COMPLETED|Sub Study V||50
2360514|NCT01600105|5792373|P2|STARTED|Sub Study V||0
2360515|NCT01600105|5792374|P1|STARTED|Sub Study V||52
2360516|NCT01600105|5792373|P2|NOT COMPLETED|Sub Study IV||0
2360517|NCT01600105|5792374|P1|NOT COMPLETED|Sub Study IV||0
2360518|NCT01600105|5792373|P2|COMPLETED|Sub Study IV||8
2360519|NCT01600105|5792374|P1|COMPLETED|Sub Study IV||41
2360520|NCT01600105|5792373|P2|STARTED|Sub Study IV||8
2360521|NCT01600105|5792374|P1|STARTED|Sub Study IV||41
2360522|NCT01600105|5792373|P2|NOT COMPLETED|Sub Study III||0
2360523|NCT01600105|5792374|P1|NOT COMPLETED|Sub Study III||5
2360524|NCT01600105|5792373|P2|COMPLETED|Sub Study III||0
2360525|NCT01600105|5792374|P1|COMPLETED|Sub Study III||34
2360526|NCT01600105|5792373|P2|STARTED|Sub Study III||0
2360527|NCT01600105|5792374|P1|STARTED|Sub Study III||39
2360528|NCT01600105|5792373|P2|NOT COMPLETED|Sub Study II||0
2360529|NCT01600105|5792374|P1|NOT COMPLETED|Sub Study II||5
2360530|NCT01600105|5792373|P2|COMPLETED|Sub Study II||0
2360531|NCT01600105|5792374|P1|COMPLETED|Sub Study II||60
2360532|NCT01600105|5792373|P2|STARTED|Sub Study II||0
2360533|NCT01600105|5792374|P1|STARTED|Sub Study II||65
2360534|NCT01600105|5792373|P2|NOT COMPLETED|Sub Study I||10
2360535|NCT01600105|5792374|P1|NOT COMPLETED|Sub Study I||0
2360536|NCT01600105|5792373|P2|COMPLETED|Sub Study I||11
2360537|NCT01600105|5792374|P1|COMPLETED|Sub Study I||19
2360538|NCT01600105|5792373|P2|STARTED|Sub Study I||21
2360539|NCT01600105|5792374|P1|STARTED|Sub Study I||19
2360540|NCT01600105|5792373|P2|NOT COMPLETED|Total Participants||10
2360541|NCT01600105|5792374|P1|NOT COMPLETED|Total Participants||41
2360542|NCT01600105|5792373|P2|COMPLETED|Total Participants||11
2360543|NCT01600105|5792374|P1|COMPLETED|Total Participants||214
2360544|NCT01600105|5792373|P2|STARTED|Total Participants||21
2360545|NCT01600105|5792374|P1|STARTED|Total Participants||255
2360546|NCT01600092|5792402|P2|NOT COMPLETED|Overall Study||16
2360547|NCT01600092|5792403|P1|NOT COMPLETED|Overall Study||18
2360548|NCT01600092|5792402|P2|COMPLETED|Overall Study||491
2360549|NCT01600092|5792403|P1|COMPLETED|Overall Study||495
2360550|NCT01600092|5792402|P2|Received All 3 Vaccinations|Overall Study||494
2360551|NCT01600092|5792403|P1|Received All 3 Vaccinations|Overall Study||500
2360552|NCT01600092|5792402|P2|Received at Least 1 Vaccination|Overall Study||504
2360553|NCT01600092|5792403|P1|Received at Least 1 Vaccination|Overall Study|1 participant received RotaTeq™ existing formulation as their first vaccination|510
2360554|NCT01600092|5792402|P2|STARTED|Overall Study||507
2360555|NCT01600092|5792403|P1|STARTED|Overall Study||513
2360556|NCT01600053|5792417|P1|NOT COMPLETED|Overall Study||11
2360557|NCT01600053|5792417|P1|COMPLETED|Overall Study||0
2360558|NCT01600053|5792417|P1|STARTED|Overall Study||11
2360559|NCT01600014|5792422|P2|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||0
2360560|NCT01600014|5792423|P1|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||3
2360561|NCT01600014|5792422|P2|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||20
2360562|NCT01600014|5792423|P1|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||39
2360563|NCT01600014|5792422|P2|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||20
2360564|NCT01600014|5792423|P1|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||42
2360565|NCT01600014|5792422|P2|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||10
2360566|NCT01600014|5792423|P1|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||12
2360567|NCT01600014|5792422|P2|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||39
2360568|NCT01600014|5792423|P1|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||80
2360569|NCT01600014|5792422|P2|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||49
2360570|NCT01600014|5792423|P1|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||92
2360571|NCT01600014|5792422|P2|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||0
2360572|NCT01600014|5792423|P1|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||288
2360573|NCT01600014|5792422|P2|COMPLETED|1. Cycle & Observation Period D1 to W52||0
2360574|NCT01600014|5792423|P1|COMPLETED|1. Cycle & Observation Period D1 to W52||162
2360575|NCT01600014|5792422|P2|STARTED|1. Cycle & Observation Period D1 to W52||0
2360576|NCT01600014|5792423|P1|STARTED|1. Cycle & Observation Period D1 to W52|Subjects completing W52 without having been administered a 2nd cycle are counted as completers.|450
2360577|NCT01599832|5792441|P1|NOT COMPLETED|Overall Study||0
2360578|NCT01599832|5792441|P1|COMPLETED|Overall Study||20
2360579|NCT01599832|5792441|P1|STARTED|Overall Study||20
2360580|NCT01599806|5792451|P2|NOT COMPLETED|Overall Study||41
2360581|NCT01599806|5792452|P1|NOT COMPLETED|Overall Study||43
2360582|NCT01599806|5792451|P2|COMPLETED|Overall Study||476
2360583|NCT01599806|5792452|P1|COMPLETED|Overall Study||473
2360584|NCT01599806|5792451|P2|STARTED|Overall Study||517
2360585|NCT01599806|5792452|P1|STARTED|Overall Study||516
2360586|NCT01599754|5792578|P2|NOT COMPLETED|Overall Study||360
2360587|NCT01599754|5792579|P1|NOT COMPLETED|Overall Study||363
2360588|NCT01599754|5792578|P2|COMPLETED|Overall Study||1
2360589|NCT01599754|5792579|P1|COMPLETED|Overall Study||0
2360590|NCT01599754|5792578|P2|Treated|Overall Study||360
2360591|NCT01599754|5792579|P1|Treated|Overall Study||360
2360592|NCT01599754|5792578|P2|STARTED|Overall Study||361
2360593|NCT01599754|5792579|P1|STARTED|Overall Study||363
2360594|NCT01599741|5792601|P1|NOT COMPLETED|Overall Study||3
2360595|NCT01599741|5792601|P1|COMPLETED|Overall Study||48
2360596|NCT01599741|5792601|P1|Collected Dose and Image Information|Overall Study||48
2360597|NCT01599741|5792601|P1|STARTED|Overall Study||51
2360598|NCT01599650|5792610|P3|NOT COMPLETED|Overall Study||27
2360599|NCT01599650|5792611|P2|NOT COMPLETED|Overall Study||26
2360600|NCT01599650|5792612|P1|NOT COMPLETED|Overall Study||22
2360601|NCT01599650|5792610|P3|COMPLETED|Overall Study||65
2360602|NCT01599650|5792611|P2|COMPLETED|Overall Study||154
2360603|NCT01599650|5792612|P1|COMPLETED|Overall Study||161
2360604|NCT01599650|5792610|P3|Completed 6 Mos|Overall Study||80
2360605|NCT01599650|5792611|P2|Completed 6 Mos|Overall Study||170
2360606|NCT01599650|5792612|P1|Completed 6 Mos|Overall Study||174
2360607|NCT01599650|5792610|P3|STARTED|Overall Study||92
2360608|NCT01599650|5792611|P2|STARTED|Overall Study||180
2360609|NCT01599650|5792612|P1|STARTED|Overall Study||183
2360610|NCT01599637|5792651|P3|NOT COMPLETED|Overall Study||0
2360611|NCT01599637|5792652|P2|NOT COMPLETED|Overall Study||2
2360612|NCT01599637|5792653|P1|NOT COMPLETED|Overall Study||1
2360613|NCT01599637|5792651|P3|COMPLETED|Overall Study||10
2360614|NCT01599637|5792652|P2|COMPLETED|Overall Study||8
2360615|NCT01599637|5792653|P1|COMPLETED|Overall Study||19
2360616|NCT01599637|5792651|P3|STARTED|Overall Study||10
2360617|NCT01599637|5792652|P2|STARTED|Overall Study||10
2360618|NCT01599637|5792653|P1|STARTED|Overall Study|" started indicates randomized safety, pharmacodynamics and pharmocokinetics set"|20
2360619|NCT01599585|5792700|P2|NOT COMPLETED|Overall Study||17
2360620|NCT01599585|5792701|P1|NOT COMPLETED|Overall Study||22
2360621|NCT01599585|5792700|P2|COMPLETED|Overall Study||42
2360622|NCT01599585|5792701|P1|COMPLETED|Overall Study||40
2360623|NCT01599585|5792700|P2|STARTED|Overall Study||59
2360624|NCT01599585|5792701|P1|STARTED|Overall Study||62
2360625|NCT01599325|5792739|P1|NOT COMPLETED|Extension Phase||15
2360626|NCT01599325|5792739|P1|COMPLETED|Extension Phase||0
2360627|NCT01599325|5792739|P1|STARTED|Extension Phase||15
2360628|NCT01599325|5792739|P1|NOT COMPLETED|Primary Parent Phase||57
2360629|NCT01599325|5792739|P1|COMPLETED|Primary Parent Phase|Participants still on study treatment at time of study closure|15
2360630|NCT01599325|5792739|P1|Pharmacokinetic (PK) Population|Primary Parent Phase|Includes all participants with evaluable azacitidine plasma PK profiles.|12
2360631|NCT01599325|5792739|P1|Intent to Treat (ITT) Population|Primary Parent Phase|Includes all participants who were enrolled into the study|72
2360632|NCT01599325|5792739|P1|STARTED|Primary Parent Phase||72
2360633|NCT01599234|5792763|P2|NOT COMPLETED|Overall Study||15
2360634|NCT01599234|5792764|P1|NOT COMPLETED|Overall Study||17
2360635|NCT01599234|5792763|P2|COMPLETED|Overall Study||155
2360636|NCT01599234|5792764|P1|COMPLETED|Overall Study||150
2360637|NCT01599234|5792763|P2|STARTED|Overall Study||170
2360638|NCT01599234|5792764|P1|STARTED|Overall Study||167
2360639|NCT01599104|5792789|P3|NOT COMPLETED|Overall Study||26
2360640|NCT01599104|5792790|P2|NOT COMPLETED|Overall Study||14
2360641|NCT01599104|5792791|P1|NOT COMPLETED|Overall Study||16
2360642|NCT01599104|5792789|P3|COMPLETED|Overall Study||363
2360643|NCT01599104|5792790|P2|COMPLETED|Overall Study||371
2360644|NCT01599104|5792791|P1|COMPLETED|Overall Study||371
2360645|NCT01599104|5792789|P3|STARTED|Overall Study||389
2360646|NCT01599104|5792790|P2|STARTED|Overall Study||385
2360647|NCT01599104|5792791|P1|STARTED|Overall Study||387
2360648|NCT01598987|5792829|P1|NOT COMPLETED|Baseline to 24 Month||8
2360649|NCT01598987|5792829|P1|COMPLETED|Baseline to 24 Month||48
2360650|NCT01598987|5792829|P1|STARTED|Baseline to 24 Month||56
2360651|NCT01598987|5792829|P1|NOT COMPLETED|Baseline to Month 12||6
2360652|NCT01598987|5792829|P1|COMPLETED|Baseline to Month 12||50
2360653|NCT01598987|5792829|P1|STARTED|Baseline to Month 12||56
2360654|NCT01598896|5792865|P2|NOT COMPLETED|Overall Study||2
2360655|NCT01598896|5792866|P1|NOT COMPLETED|Overall Study||0
2360656|NCT01598896|5792865|P2|COMPLETED|Overall Study||2
2360657|NCT01598896|5792866|P1|COMPLETED|Overall Study||3
2360658|NCT01598896|5792865|P2|STARTED|Overall Study||4
2360659|NCT01598896|5792866|P1|STARTED|Overall Study||3
2360660|NCT01598779|5792878|P1|NOT COMPLETED|Overall Study||0
2360661|NCT01598779|5792878|P1|COMPLETED|Overall Study||150
2360662|NCT01598779|5792878|P1|STARTED|Overall Study||150
2360663|NCT01598753|5792886|P4|NOT COMPLETED|Overall Study||15
2360664|NCT01598753|5792887|P3|NOT COMPLETED|Overall Study||8
2360665|NCT01598753|5792888|P2|NOT COMPLETED|Overall Study||15
2360666|NCT01598753|5792889|P1|NOT COMPLETED|Overall Study||12
2360667|NCT01598753|5792886|P4|COMPLETED|Overall Study||19
2360668|NCT01598753|5792887|P3|COMPLETED|Overall Study||24
2360669|NCT01598753|5792888|P2|COMPLETED|Overall Study||16
2360670|NCT01598753|5792889|P1|COMPLETED|Overall Study||25
2360671|NCT01598753|5792886|P4|STARTED|Overall Study||34
2360672|NCT01598753|5792887|P3|STARTED|Overall Study||32
2360673|NCT01598753|5792888|P2|STARTED|Overall Study||31
2360674|NCT01598753|5792889|P1|STARTED|Overall Study||37
2360675|NCT01598740|5792901|P2|NOT COMPLETED|Period 2||0
2360676|NCT01598740|5792902|P1|NOT COMPLETED|Period 2||1
2360677|NCT01598740|5792901|P2|COMPLETED|Period 2||9
2360678|NCT01598740|5792902|P1|COMPLETED|Period 2||7
2360679|NCT01598740|5792901|P2|STARTED|Period 2||9
2360680|NCT01598740|5792902|P1|STARTED|Period 2|1 subject discontinued during the washout period prior to starting treatment period 2.|8
2360681|NCT01598740|5792901|P2|NOT COMPLETED|Period 1||0
2360682|NCT01598740|5792902|P1|NOT COMPLETED|Period 1||0
2360683|NCT01598740|5792901|P2|COMPLETED|Period 1||9
2360684|NCT01598740|5792902|P1|COMPLETED|Period 1||9
2360685|NCT01598740|5792901|P2|STARTED|Period 1||9
2360686|NCT01598740|5792902|P1|STARTED|Period 1||9
2360687|NCT01598701|5792912|P2|NOT COMPLETED|Overall Study||9
2360688|NCT01598701|5792913|P1|NOT COMPLETED|Overall Study||5
2360689|NCT01598701|5792912|P2|COMPLETED|Overall Study||41
2360690|NCT01598701|5792913|P1|COMPLETED|Overall Study||45
2360691|NCT01598701|5792912|P2|STARTED|Overall Study||50
2360692|NCT01598701|5792913|P1|STARTED|Overall Study||50
2360693|NCT01598662|5792929|P2|NOT COMPLETED|Overall Study||21
2360694|NCT01598662|5792930|P1|NOT COMPLETED|Overall Study||11
2360695|NCT01598662|5792929|P2|COMPLETED|Overall Study||0
2360696|NCT01598662|5792930|P1|COMPLETED|Overall Study||0
2360697|NCT01598662|5792929|P2|Patients Returned for 6 wk Postpartum|Overall Study||2
2360698|NCT01598662|5792930|P1|Patients Returned for 6 wk Postpartum|Overall Study||0
2360699|NCT01598662|5792929|P2|Patients Who Received IUD|Overall Study||18
2360700|NCT01598662|5792930|P1|Patients Who Received IUD|Overall Study|Subjects did not return at 6 weeks for IUD insertion.|0
2360701|NCT01598662|5792929|P2|STARTED|Overall Study||21
2360702|NCT01598662|5792930|P1|STARTED|Overall Study||11
2360703|NCT01598610|5792936|P1|NOT COMPLETED|Overall Study||1
2360704|NCT01598610|5792936|P1|COMPLETED|Overall Study||219
2360705|NCT01598610|5792936|P1|STARTED|Overall Study||220
2360706|NCT01598545|5792945|P1|NOT COMPLETED|Overall Study||0
2360707|NCT01598545|5792945|P1|COMPLETED|Overall Study||20
2360708|NCT01598545|5792945|P1|STARTED|Overall Study||20
2360709|NCT01598532|5792953|P1|NOT COMPLETED|Overall Study||11
2360710|NCT01598532|5792953|P1|COMPLETED|Overall Study||11
2360711|NCT01598532|5792953|P1|STARTED|Overall Study||22
2360712|NCT01598506|5792962|P1|NOT COMPLETED|Overall Study||2
2360713|NCT01598506|5792962|P1|COMPLETED|Overall Study||20
2360714|NCT01598506|5792962|P1|STARTED|Overall Study||22
2360715|NCT01598428|5792967|P1|NOT COMPLETED|Overall Study||0
2360716|NCT01598428|5792967|P1|COMPLETED|Overall Study||20
2360717|NCT01598428|5792967|P1|STARTED|Overall Study||20
2360718|NCT01598350|5792976|P1|NOT COMPLETED|Overall Study||0
2360719|NCT01598350|5792976|P1|COMPLETED|Overall Study||6
2360720|NCT01598350|5792976|P1|STARTED|Overall Study||6
2360721|NCT01598311|5792982|P2|NOT COMPLETED|Overall Study||61
2360722|NCT01598311|5792983|P1|NOT COMPLETED|Overall Study||47
2360723|NCT01598311|5792982|P2|COMPLETED|Overall Study||244
2360724|NCT01598311|5792983|P1|COMPLETED|Overall Study||256
2360725|NCT01598311|5792982|P2|Treated and Confirmed CDAD|Overall Study||292
2360726|NCT01598311|5792983|P1|Treated and Confirmed CDAD|Overall Study||285
2360727|NCT01598311|5792982|P2|Treated|Overall Study||301
2360728|NCT01598311|5792983|P1|Treated|Overall Study||294
2360729|NCT01598311|5792982|P2|STARTED|Overall Study||305
2360730|NCT01598311|5792983|P1|STARTED|Overall Study||303
2360731|NCT01598298|5792999|P2|NOT COMPLETED|Overall Study||41
2360732|NCT01598298|5793000|P1|NOT COMPLETED|Overall Study||40
2360733|NCT01598298|5792999|P2|COMPLETED|Overall Study||108
2360734|NCT01598298|5793000|P1|COMPLETED|Overall Study||110
2360735|NCT01598298|5792999|P2|Patients Evaluable for Adverse Events|Overall Study||141
2360736|NCT01598298|5793000|P1|Patients Evaluable for Adverse Events|Overall Study||138
2360737|NCT01598298|5792999|P2|Patients Evaluable for Primary Endpoint|Overall Study||128
2360738|NCT01598298|5793000|P1|Patients Evaluable for Primary Endpoint|Overall Study||127
2360739|NCT01598298|5792999|P2|STARTED|Overall Study||149
2360740|NCT01598298|5793000|P1|STARTED|Overall Study||150
2360741|NCT01598207|5793012|P2|NOT COMPLETED|Overall Study||0
2360742|NCT01598207|5793013|P1|NOT COMPLETED|Overall Study||1
2360743|NCT01598207|5793012|P2|COMPLETED|Overall Study||6
2360744|NCT01598207|5793013|P1|COMPLETED|Overall Study||6
2360745|NCT01598207|5793012|P2|STARTED|Overall Study||6
2360746|NCT01598207|5793013|P1|STARTED|Overall Study||7
2360747|NCT01598194|5793033|P2|NOT COMPLETED|Overall Study||0
2360748|NCT01598194|5793034|P1|NOT COMPLETED|Overall Study||0
2360749|NCT01598194|5793033|P2|COMPLETED|Overall Study||30
2360750|NCT01598194|5793034|P1|COMPLETED|Overall Study||30
2360751|NCT01598194|5793033|P2|1 Pass With 22Gpc for Histology|Overall Study|1 participant's pass could not be performed|29
2360752|NCT01598194|5793034|P1|1 Pass With 22Gpc for Histology|Overall Study|3 participants passes could not be performed|27
2360753|NCT01598194|5793033|P2|1 Pass With 22Gpc for Cytology|Overall Study||30
2360754|NCT01598194|5793034|P1|1 Pass With 22Gpc for Cytology|Overall Study|1 participant's pass could not be performed|29
2360755|NCT01598194|5793033|P2|2 Passes With 25G for Cytology|Overall Study||30
2360756|NCT01598194|5793034|P1|2 Passes With 25G for Cytology|Overall Study||30
2360757|NCT01598194|5793033|P2|STARTED|Overall Study||30
2360758|NCT01598194|5793034|P1|STARTED|Overall Study||30
2360759|NCT01598129|5793044|P1|NOT COMPLETED|Overall Study||9
2360760|NCT01598129|5793044|P1|COMPLETED|Overall Study||3
2360761|NCT01598129|5793044|P1|STARTED|Overall Study||12
2360762|NCT01598090|5793056|P3|NOT COMPLETED|Follow-up Period||28
2360763|NCT01598090|5793057|P2|NOT COMPLETED|Follow-up Period||35
2360764|NCT01598090|5793058|P1|NOT COMPLETED|Follow-up Period||5
2360765|NCT01598090|5793056|P3|COMPLETED|Follow-up Period||171
2360766|NCT01598090|5793057|P2|COMPLETED|Follow-up Period||364
2360767|NCT01598090|5793058|P1|COMPLETED|Follow-up Period||21
2360768|NCT01598090|5793056|P3|STARTED|Follow-up Period|Includes 28 participants who re-joined from treatment period to follow-up period.|199
2360769|NCT01598090|5793057|P2|STARTED|Follow-up Period|Includes 60 participants who re-joined from treatment period to follow-up period.|399
2360770|NCT01598090|5793058|P1|STARTED|Follow-up Period|Includes 10 participants who re-joined from treatment period to follow-up period.|26
2360771|NCT01598090|5793056|P3|NOT COMPLETED|Treatment Period||35
2360772|NCT01598090|5793057|P2|NOT COMPLETED|Treatment Period||72
2360773|NCT01598090|5793058|P1|NOT COMPLETED|Treatment Period||11
2360774|NCT01598090|5793056|P3|COMPLETED|Treatment Period||171
2360775|NCT01598090|5793057|P2|COMPLETED|Treatment Period||339
2360776|NCT01598090|5793058|P1|COMPLETED|Treatment Period||16
2360777|NCT01598090|5793056|P3|STARTED|Treatment Period||206
2360778|NCT01598090|5793057|P2|STARTED|Treatment Period||411
2360779|NCT01598090|5793058|P1|STARTED|Treatment Period||27
2360780|NCT01598064|5793084|P2|NOT COMPLETED|Overall Study||0
2360781|NCT01598064|5793085|P1|NOT COMPLETED|Overall Study||0
2360782|NCT01598064|5793084|P2|COMPLETED|Overall Study||24
2360783|NCT01598064|5793085|P1|COMPLETED|Overall Study||25
2360784|NCT01598064|5793084|P2|STARTED|Overall Study||24
2360785|NCT01598064|5793085|P1|STARTED|Overall Study||25
2360786|NCT01598025|5793095|P2|NOT COMPLETED|Overall Study||3
2360787|NCT01598025|5793096|P1|NOT COMPLETED|Overall Study||0
2360788|NCT01598025|5793095|P2|COMPLETED|Overall Study||0
2360789|NCT01598025|5793096|P1|COMPLETED|Overall Study||0
2360790|NCT01598025|5793095|P2|STARTED|Overall Study||3
2360791|NCT01598025|5793096|P1|STARTED|Overall Study||0
2360792|NCT01597908|5793105|P2|NOT COMPLETED|Overall Study||352
2360793|NCT01597908|5793106|P1|NOT COMPLETED|Overall Study||352
2360794|NCT01597908|5793105|P2|COMPLETED|Overall Study||0
2360795|NCT01597908|5793106|P1|COMPLETED|Overall Study||0
2360796|NCT01597908|5793105|P2|Ongoing|Overall Study||202
2360797|NCT01597908|5793106|P1|Ongoing|Overall Study||236
2360798|NCT01597908|5793105|P2|STARTED|Overall Study||352
2360799|NCT01597908|5793106|P1|STARTED|Overall Study||352
2360800|NCT01597856|5793121|P3|NOT COMPLETED|Overall Study||54
2360801|NCT01597856|5793122|P2|NOT COMPLETED|Overall Study||26
2360802|NCT01597856|5793123|P1|NOT COMPLETED|Overall Study||22
2360803|NCT01597856|5793121|P3|COMPLETED|Overall Study||120
2360804|NCT01597856|5793122|P2|COMPLETED|Overall Study||61
2360805|NCT01597856|5793123|P1|COMPLETED|Overall Study||63
2360806|NCT01597856|5793121|P3|Week 4 Follow-up|Overall Study||129
2360807|NCT01597856|5793122|P2|Week 4 Follow-up|Overall Study||67
2360808|NCT01597856|5793123|P1|Week 4 Follow-up|Overall Study||62
2360809|NCT01597856|5793121|P3|STARTED|Overall Study||174
2360810|NCT01597856|5793122|P2|STARTED|Overall Study||87
2360811|NCT01597856|5793123|P1|STARTED|Overall Study||85
2360812|NCT01597843|5793140|P3|NOT COMPLETED|Overall Study||0
2360813|NCT01597843|5793141|P2|NOT COMPLETED|Overall Study||0
2360814|NCT01597843|5793142|P1|NOT COMPLETED|Overall Study||0
2360815|NCT01597843|5793140|P3|COMPLETED|Overall Study||81
2360816|NCT01597843|5793141|P2|COMPLETED|Overall Study||122
2360817|NCT01597843|5793142|P1|COMPLETED|Overall Study||79
2360818|NCT01597843|5793140|P3|Survey 3 Responses|Overall Study||76
2360819|NCT01597843|5793141|P2|Survey 3 Responses|Overall Study||56
2360820|NCT01597843|5793142|P1|Survey 3 Responses|Overall Study||65
2360821|NCT01597843|5793140|P3|Survey 2 Responses|Overall Study||58
2360822|NCT01597843|5793141|P2|Survey 2 Responses|Overall Study||42
2360823|NCT01597843|5793142|P1|Survey 2 Responses|Overall Study||52
2360824|NCT01597843|5793140|P3|Survey 1 Responses|Overall Study||59
2360825|NCT01597843|5793141|P2|Survey 1 Responses|Overall Study||71
2360826|NCT01597843|5793142|P1|Survey 1 Responses|Overall Study||45
2360827|NCT01597843|5793140|P3|STARTED|Overall Study||81
2360828|NCT01597843|5793141|P2|STARTED|Overall Study||122
2360829|NCT01597843|5793142|P1|STARTED|Overall Study||79
2360830|NCT01597791|5793152|P2|NOT COMPLETED|Overall Study||10
2360831|NCT01597791|5793153|P1|NOT COMPLETED|Overall Study||8
2360832|NCT01597791|5793152|P2|COMPLETED|Overall Study||18
2360833|NCT01597791|5793153|P1|COMPLETED|Overall Study||20
2360834|NCT01597791|5793152|P2|STARTED|Overall Study||28
2360835|NCT01597791|5793153|P1|STARTED|Overall Study||28
2360836|NCT01597687|5793162|P3|NOT COMPLETED|Overall Study||0
2360837|NCT01597687|5793163|P2|NOT COMPLETED|Overall Study||0
2360838|NCT01597687|5793164|P1|NOT COMPLETED|Overall Study||0
2360839|NCT01597687|5793162|P3|COMPLETED|Overall Study||147
2360840|NCT01597687|5793163|P2|COMPLETED|Overall Study||89
2360841|NCT01597687|5793164|P1|COMPLETED|Overall Study||76
2360842|NCT01597687|5793162|P3|STARTED|Overall Study||147
2360843|NCT01597687|5793163|P2|STARTED|Overall Study||89
2360844|NCT01597687|5793164|P1|STARTED|Overall Study||76
2360845|NCT01597635|5793240|P3|NOT COMPLETED|Part B||4
2360846|NCT01597635|5793241|P2|NOT COMPLETED|Part B||6
2360847|NCT01597635|5793242|P1|NOT COMPLETED|Part B||0
2360848|NCT01597635|5793240|P3|COMPLETED|Part B||15
2360849|NCT01597635|5793241|P2|COMPLETED|Part B||14
2360850|NCT01597635|5793242|P1|COMPLETED|Part B||0
2360851|NCT01597635|5793240|P3|STARTED|Part B||19
2360852|NCT01597635|5793241|P2|STARTED|Part B||20
2360853|NCT01597635|5793242|P1|STARTED|Part B||0
2360854|NCT01597635|5793240|P3|NOT COMPLETED|Part A||0
2360855|NCT01597635|5793241|P2|NOT COMPLETED|Part A||0
2360856|NCT01597635|5793242|P1|NOT COMPLETED|Part A||3
2360857|NCT01597635|5793240|P3|COMPLETED|Part A||0
2360858|NCT01597635|5793241|P2|COMPLETED|Part A||0
2360859|NCT01597635|5793242|P1|COMPLETED|Part A||2
2360860|NCT01597635|5793240|P3|STARTED|Part A||0
2360861|NCT01597635|5793241|P2|STARTED|Part A||0
2360862|NCT01597635|5793242|P1|STARTED|Part A||5
2360863|NCT01597622|5793305|P1|NOT COMPLETED|Overall Study||38
2360864|NCT01597622|5793305|P1|COMPLETED|Overall Study||104
2360865|NCT01597622|5793305|P1|STARTED|Overall Study||142
2360866|NCT01597596|5793312|P2|NOT COMPLETED|Overall Study||1
2360867|NCT01597596|5793313|P1|NOT COMPLETED|Overall Study||1
2360868|NCT01597596|5793312|P2|COMPLETED|Overall Study||2
2360869|NCT01597596|5793313|P1|COMPLETED|Overall Study||0
2360870|NCT01597596|5793312|P2|STARTED|Overall Study||3
2360871|NCT01597596|5793313|P1|STARTED|Overall Study||1
2360872|NCT01597505|5793327|P2|NOT COMPLETED|Overall Study||33
2360873|NCT01597505|5793328|P1|NOT COMPLETED|Overall Study||44
2360874|NCT01597505|5793327|P2|COMPLETED|Overall Study||265
2360875|NCT01597505|5793328|P1|COMPLETED|Overall Study||264
2360876|NCT01597505|5793327|P2|Treated|Overall Study||286
2360877|NCT01597505|5793328|P1|Treated|Overall Study|One participant was instead randomized to vancomycin|305
2360878|NCT01597505|5793327|P2|STARTED|Overall Study|Randomized participants|298
2360879|NCT01597505|5793328|P1|STARTED|Overall Study|Randomized participants|308
2360880|NCT01597492|5793362|P2|NOT COMPLETED|Overall Study||4
2360881|NCT01597492|5793363|P1|NOT COMPLETED|Overall Study||6
2360882|NCT01597492|5793362|P2|COMPLETED|Overall Study||41
2360883|NCT01597492|5793363|P1|COMPLETED|Overall Study||28
2360884|NCT01597492|5793362|P2|STARTED|Overall Study||45
2360885|NCT01597492|5793363|P1|STARTED|Overall Study||34
2360886|NCT01597479|5793371|P2|NOT COMPLETED|Overall Study||0
2360887|NCT01597479|5793372|P1|NOT COMPLETED|Overall Study||2
2360888|NCT01597479|5793371|P2|COMPLETED|Overall Study||26
2360889|NCT01597479|5793372|P1|COMPLETED|Overall Study||24
2360890|NCT01597479|5793371|P2|STARTED|Overall Study||26
2360891|NCT01597479|5793372|P1|STARTED|Overall Study||26
2360892|NCT01597440|5793381|P2|NOT COMPLETED|Overall Study||0
2360893|NCT01597440|5793382|P1|NOT COMPLETED|Overall Study||0
2360894|NCT01597440|5793381|P2|COMPLETED|Overall Study||0
2360895|NCT01597440|5793382|P1|COMPLETED|Overall Study||1
2360896|NCT01597440|5793381|P2|STARTED|Overall Study||0
2360897|NCT01597440|5793382|P1|STARTED|Overall Study||1
2360898|NCT01597388|5793399|P9|NOT COMPLETED|Overall Study||0
2360899|NCT01597388|5793400|P8|NOT COMPLETED|Overall Study||0
2360900|NCT01597388|5793401|P7|NOT COMPLETED|Overall Study||0
2360901|NCT01597388|5793402|P6|NOT COMPLETED|Overall Study||0
2360902|NCT01597388|5793403|P5|NOT COMPLETED|Overall Study||0
2360903|NCT01597388|5793404|P4|NOT COMPLETED|Overall Study||0
2360904|NCT01597388|5793405|P3|NOT COMPLETED|Overall Study||0
2360905|NCT01597388|5793406|P2|NOT COMPLETED|Overall Study||0
2360906|NCT01597388|5793407|P1|NOT COMPLETED|Overall Study||0
2360907|NCT01597388|5793399|P9|COMPLETED|Overall Study||2
2360908|NCT01597388|5793400|P8|COMPLETED|Overall Study||5
2360909|NCT01597388|5793401|P7|COMPLETED|Overall Study||8
2360910|NCT01597388|5793402|P6|COMPLETED|Overall Study||4
2360911|NCT01597388|5793403|P5|COMPLETED|Overall Study||37
2360912|NCT01597388|5793404|P4|COMPLETED|Overall Study||10
2360913|NCT01597388|5793405|P3|COMPLETED|Overall Study||14
2360914|NCT01597388|5793406|P2|COMPLETED|Overall Study||13
2360915|NCT01597388|5793407|P1|COMPLETED|Overall Study||6
2360916|NCT01597388|5793399|P9|STARTED|Overall Study||2
2360917|NCT01597388|5793400|P8|STARTED|Overall Study||5
2360918|NCT01597388|5793401|P7|STARTED|Overall Study||8
2360919|NCT01597388|5793402|P6|STARTED|Overall Study||4
2360920|NCT01597388|5793403|P5|STARTED|Overall Study||37
2360921|NCT01597388|5793404|P4|STARTED|Overall Study||10
2360922|NCT01597388|5793405|P3|STARTED|Overall Study||14
2360923|NCT01597388|5793406|P2|STARTED|Overall Study||13
2360924|NCT01597388|5793407|P1|STARTED|Overall Study||6
2360925|NCT01597375|5793658|P2|NOT COMPLETED|Second Intervention||1
2360926|NCT01597375|5793659|P1|NOT COMPLETED|Second Intervention||1
2360927|NCT01597375|5793658|P2|COMPLETED|Second Intervention||21
2360928|NCT01597375|5793659|P1|COMPLETED|Second Intervention||19
2360929|NCT01597375|5793658|P2|STARTED|Second Intervention||22
2360930|NCT01597375|5793659|P1|STARTED|Second Intervention||20
2360931|NCT01597375|5793658|P2|NOT COMPLETED|Washout (2 Weeks)||0
2360932|NCT01597375|5793659|P1|NOT COMPLETED|Washout (2 Weeks)||1
2360933|NCT01597375|5793658|P2|COMPLETED|Washout (2 Weeks)||22
2360934|NCT01597375|5793659|P1|COMPLETED|Washout (2 Weeks)||20
2360935|NCT01597375|5793658|P2|STARTED|Washout (2 Weeks)||22
2360936|NCT01597375|5793659|P1|STARTED|Washout (2 Weeks)||21
2360937|NCT01597375|5793658|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
2360938|NCT01597375|5793659|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
2360939|NCT01597375|5793658|P2|COMPLETED|First Intervention (4 Weeks)||22
2360940|NCT01597375|5793659|P1|COMPLETED|First Intervention (4 Weeks)||21
2360941|NCT01597375|5793658|P2|STARTED|First Intervention (4 Weeks)||23
2360942|NCT01597375|5793659|P1|STARTED|First Intervention (4 Weeks)||23
2360943|NCT01597258|5793676|P1|NOT COMPLETED|Overall Study||1
2360944|NCT01597258|5793676|P1|COMPLETED|Overall Study||2028
2360945|NCT01597258|5793676|P1|STARTED|Overall Study||2029
2360946|NCT01597245|5793685|P13|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||12
2360947|NCT01597245|5793686|P12|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||19
2360948|NCT01597245|5793687|P11|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||22
2360949|NCT01597245|5793688|P10|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||118
2360950|NCT01597245|5793689|P9|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||20
2360951|NCT01597245|5793690|P8|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||3
2360952|NCT01597245|5793691|P7|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||37
2360953|NCT01597245|5793692|P6|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||89
2360954|NCT01597245|5793693|P5|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||159
2360955|NCT01597245|5793694|P4|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
2360956|NCT01597245|5793695|P3|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
2360957|NCT01597245|5793696|P2|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
2360958|NCT01597245|5793697|P1|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
2360959|NCT01597245|5793685|P13|COMPLETED|Maintenance Period (Week 12 to Week 60)||37
2360960|NCT01597245|5793686|P12|COMPLETED|Maintenance Period (Week 12 to Week 60)||56
2360961|NCT01597245|5793687|P11|COMPLETED|Maintenance Period (Week 12 to Week 60)||178
2360962|NCT01597245|5793688|P10|COMPLETED|Maintenance Period (Week 12 to Week 60)||14
2360963|NCT01597245|5793689|P9|COMPLETED|Maintenance Period (Week 12 to Week 60)||135
2360964|NCT01597245|5793690|P8|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
2360965|NCT01597245|5793691|P7|COMPLETED|Maintenance Period (Week 12 to Week 60)||150
2360966|NCT01597245|5793692|P6|COMPLETED|Maintenance Period (Week 12 to Week 60)||92
2360967|NCT01597245|5793693|P5|COMPLETED|Maintenance Period (Week 12 to Week 60)||17
2360968|NCT01597245|5793694|P4|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
2360969|NCT01597245|5793695|P3|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
2360970|NCT01597245|5793696|P2|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
2360971|NCT01597245|5793697|P1|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
2360972|NCT01597245|5793685|P13|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||49
2360973|NCT01597245|5793686|P12|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||75
2360974|NCT01597245|5793687|P11|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||200
2360975|NCT01597245|5793688|P10|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||132
2360976|NCT01597245|5793689|P9|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||155
2360977|NCT01597245|5793690|P8|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||3
2360978|NCT01597245|5793691|P7|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||187
2360979|NCT01597245|5793692|P6|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||181
2360980|NCT01597245|5793693|P5|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||176
2360981|NCT01597245|5793694|P4|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
2360982|NCT01597245|5793695|P3|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
2360983|NCT01597245|5793696|P2|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
2360984|NCT01597245|5793697|P1|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
2360985|NCT01597245|5793685|P13|STARTED|Maintenance Period (Week 12 to Week 60)||49
2360986|NCT01597245|5793686|P12|STARTED|Maintenance Period (Week 12 to Week 60)||75
2360987|NCT01597245|5793687|P11|STARTED|Maintenance Period (Week 12 to Week 60)||200
2360988|NCT01597245|5793688|P10|STARTED|Maintenance Period (Week 12 to Week 60)||132
2360989|NCT01597245|5793689|P9|STARTED|Maintenance Period (Week 12 to Week 60)||155
2360990|NCT01597245|5793690|P8|STARTED|Maintenance Period (Week 12 to Week 60)||3
2360991|NCT01597245|5793691|P7|STARTED|Maintenance Period (Week 12 to Week 60)||187
2360992|NCT01597245|5793692|P6|STARTED|Maintenance Period (Week 12 to Week 60)||181
2360993|NCT01597245|5793693|P5|STARTED|Maintenance Period (Week 12 to Week 60)||176
2360994|NCT01597245|5793694|P4|STARTED|Maintenance Period (Week 12 to Week 60)||0
2360995|NCT01597245|5793695|P3|STARTED|Maintenance Period (Week 12 to Week 60)||0
2360996|NCT01597245|5793696|P2|STARTED|Maintenance Period (Week 12 to Week 60)||0
2360997|NCT01597245|5793697|P1|STARTED|Maintenance Period (Week 12 to Week 60)||0
2360998|NCT01597245|5793685|P13|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
2360999|NCT01597245|5793686|P12|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
2361000|NCT01597245|5793687|P11|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
2361001|NCT01597245|5793688|P10|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
2361002|NCT01597245|5793689|P9|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
2361003|NCT01597245|5793690|P8|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
2361004|NCT01597245|5793691|P7|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
2361005|NCT01597245|5793692|P6|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
2361006|NCT01597245|5793693|P5|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
2361007|NCT01597245|5793694|P4|NOT COMPLETED|Induction Period (Week 0 - Week 12)||9
2361008|NCT01597245|5793695|P3|NOT COMPLETED|Induction Period (Week 0 - Week 12)||19
2361009|NCT01597245|5793696|P2|NOT COMPLETED|Induction Period (Week 0 - Week 12)||25
2361010|NCT01597245|5793697|P1|NOT COMPLETED|Induction Period (Week 0 - Week 12)||10
2361011|NCT01597245|5793685|P13|COMPLETED|Induction Period (Week 0 - Week 12)||0
2361012|NCT01597245|5793686|P12|COMPLETED|Induction Period (Week 0 - Week 12)||0
2361013|NCT01597245|5793687|P11|COMPLETED|Induction Period (Week 0 - Week 12)||0
2361014|NCT01597245|5793688|P10|COMPLETED|Induction Period (Week 0 - Week 12)||0
2361015|NCT01597245|5793689|P9|COMPLETED|Induction Period (Week 0 - Week 12)||0
2361016|NCT01597245|5793690|P8|COMPLETED|Induction Period (Week 0 - Week 12)||0
2361017|NCT01597245|5793691|P7|COMPLETED|Induction Period (Week 0 - Week 12)||0
2361018|NCT01597245|5793692|P6|COMPLETED|Induction Period (Week 0 - Week 12)||0
2361019|NCT01597245|5793693|P5|COMPLETED|Induction Period (Week 0 - Week 12)||0
2361020|NCT01597245|5793694|P4|COMPLETED|Induction Period (Week 0 - Week 12)|2 participants discontinued after IND completion and prior to randomizing into maintenance period.|342
2361021|NCT01597245|5793695|P3|COMPLETED|Induction Period (Week 0 - Week 12)||328
2361022|NCT01597245|5793696|P2|COMPLETED|Induction Period (Week 0 - Week 12)|1 participant randomized to maintenance period but did not receive a dose in the maintenance period.|333
2361023|NCT01597245|5793697|P1|COMPLETED|Induction Period (Week 0 - Week 12)||158
2361024|NCT01597245|5793685|P13|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
2361025|NCT01597245|5793686|P12|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
2361026|NCT01597245|5793687|P11|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
2361027|NCT01597245|5793688|P10|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
2361028|NCT01597245|5793689|P9|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
2361029|NCT01597245|5793690|P8|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
2361030|NCT01597245|5793691|P7|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
2361031|NCT01597245|5793692|P6|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
2361032|NCT01597245|5793693|P5|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
2361033|NCT01597245|5793694|P4|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||350
2361034|NCT01597245|5793695|P3|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||347
2361035|NCT01597245|5793696|P2|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||357
2361036|NCT01597245|5793697|P1|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||167
2361037|NCT01597245|5793685|P13|STARTED|Induction Period (Week 0 - Week 12)||0
2361038|NCT01597245|5793686|P12|STARTED|Induction Period (Week 0 - Week 12)||0
2361039|NCT01597245|5793687|P11|STARTED|Induction Period (Week 0 - Week 12)||0
2361040|NCT01597245|5793688|P10|STARTED|Induction Period (Week 0 - Week 12)||0
2361041|NCT01597245|5793689|P9|STARTED|Induction Period (Week 0 - Week 12)||0
2361042|NCT01597245|5793690|P8|STARTED|Induction Period (Week 0 - Week 12)||0
2361043|NCT01597245|5793691|P7|STARTED|Induction Period (Week 0 - Week 12)||0
2361044|NCT01597245|5793692|P6|STARTED|Induction Period (Week 0 - Week 12)||0
2361045|NCT01597245|5793693|P5|STARTED|Induction Period (Week 0 - Week 12)||0
2361046|NCT01597245|5793694|P4|STARTED|Induction Period (Week 0 - Week 12)||351
2361047|NCT01597245|5793695|P3|STARTED|Induction Period (Week 0 - Week 12)||347
2361048|NCT01597245|5793696|P2|STARTED|Induction Period (Week 0 - Week 12)||358
2361049|NCT01597245|5793697|P1|STARTED|Induction Period (Week 0 - Week 12)||168
2361050|NCT01597193|5793787|P7|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||11
2361051|NCT01597193|5793788|P6|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||23
2361052|NCT01597193|5793789|P5|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||16
2361053|NCT01597193|5793790|P4|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||20
2361054|NCT01597193|5793791|P3|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||14
2361055|NCT01597193|5793792|P2|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
2361056|NCT01597193|5793793|P1|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
2361057|NCT01597193|5793787|P7|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
2361058|NCT01597193|5793788|P6|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
2361059|NCT01597193|5793789|P5|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
2361060|NCT01597193|5793790|P4|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
2361061|NCT01597193|5793791|P3|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
2361062|NCT01597193|5793792|P2|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
2361063|NCT01597193|5793793|P1|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
2361064|NCT01597193|5793787|P7|STARTED|Stage 2: Dose Expansion (1067 Days)||11
2361065|NCT01597193|5793788|P6|STARTED|Stage 2: Dose Expansion (1067 Days)||23
2361066|NCT01597193|5793789|P5|STARTED|Stage 2: Dose Expansion (1067 Days)||16
2361067|NCT01597193|5793790|P4|STARTED|Stage 2: Dose Expansion (1067 Days)||20
2361068|NCT01597193|5793791|P3|STARTED|Stage 2: Dose Expansion (1067 Days)||14
2361069|NCT01597193|5793792|P2|STARTED|Stage 2: Dose Expansion (1067 Days)||0
2361070|NCT01597193|5793793|P1|STARTED|Stage 2: Dose Expansion (1067 Days)||0
2361071|NCT01597193|5793787|P7|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
2361072|NCT01597193|5793788|P6|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
2361073|NCT01597193|5793789|P5|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
2361074|NCT01597193|5793790|P4|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
2361075|NCT01597193|5793791|P3|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
2361076|NCT01597193|5793792|P2|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||8
2361077|NCT01597193|5793793|P1|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||7
2361078|NCT01597193|5793787|P7|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
2361079|NCT01597193|5793788|P6|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
2361080|NCT01597193|5793789|P5|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
2361081|NCT01597193|5793790|P4|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
2361082|NCT01597193|5793791|P3|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
2361083|NCT01597193|5793792|P2|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
2361084|NCT01597193|5793793|P1|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
2361085|NCT01597193|5793787|P7|STARTED|Stage 1: Dose Escalation (141 Days)||0
2361086|NCT01597193|5793788|P6|STARTED|Stage 1: Dose Escalation (141 Days)||0
2361087|NCT01597193|5793789|P5|STARTED|Stage 1: Dose Escalation (141 Days)||0
2361088|NCT01597193|5793790|P4|STARTED|Stage 1: Dose Escalation (141 Days)||0
2361089|NCT01597193|5793791|P3|STARTED|Stage 1: Dose Escalation (141 Days)||0
2361090|NCT01597193|5793792|P2|STARTED|Stage 1: Dose Escalation (141 Days)||8
2361091|NCT01597193|5793793|P1|STARTED|Stage 1: Dose Escalation (141 Days)||7
2361092|NCT01597141|5793874|P2|NOT COMPLETED|Overall Study||0
2361093|NCT01597141|5793875|P1|NOT COMPLETED|Overall Study||0
2361094|NCT01597141|5793874|P2|COMPLETED|Overall Study||50
2361095|NCT01597141|5793875|P1|COMPLETED|Overall Study||50
2361096|NCT01597141|5793874|P2|STARTED|Overall Study||50
2361097|NCT01597141|5793875|P1|STARTED|Overall Study||50
2361098|NCT01597128|5793885|P2|NOT COMPLETED|Overall Study||0
2361099|NCT01597128|5793886|P1|NOT COMPLETED|Overall Study||0
2361100|NCT01597128|5793885|P2|COMPLETED|Overall Study||17
2361101|NCT01597128|5793886|P1|COMPLETED|Overall Study||18
2361102|NCT01597128|5793885|P2|STARTED|Overall Study||17
2361103|NCT01597128|5793886|P1|STARTED|Overall Study||18
2361104|NCT01597050|5793912|P2|NOT COMPLETED|Overall Study||0
2361105|NCT01597050|5793913|P1|NOT COMPLETED|Overall Study||1
2361106|NCT01597050|5793912|P2|COMPLETED|Overall Study||18
2361107|NCT01597050|5793913|P1|COMPLETED|Overall Study||35
2361108|NCT01597050|5793912|P2|STARTED|Overall Study||18
2361109|NCT01597050|5793913|P1|STARTED|Overall Study||36
2361110|NCT01596972|5793921|P2|NOT COMPLETED|Overall Study||14
2361111|NCT01596972|5793922|P1|NOT COMPLETED|Overall Study||1
2361112|NCT01596972|5793921|P2|COMPLETED|Overall Study||12
2361113|NCT01596972|5793922|P1|COMPLETED|Overall Study||24
2361114|NCT01596972|5793921|P2|STARTED|Overall Study||26
2361115|NCT01596972|5793922|P1|STARTED|Overall Study||25
2361116|NCT01596842|5793934|P2|NOT COMPLETED|Overall Study||0
2361117|NCT01596842|5793935|P1|NOT COMPLETED|Overall Study||2
2361118|NCT01596842|5793934|P2|COMPLETED|Overall Study||7
2361119|NCT01596842|5793935|P1|COMPLETED|Overall Study||8
2361120|NCT01596842|5793934|P2|STARTED|Overall Study||7
2361121|NCT01596842|5793935|P1|STARTED|Overall Study||10
2361122|NCT01596582|5793945|P2|NOT COMPLETED|Overall Study||7
2361123|NCT01596582|5793946|P1|NOT COMPLETED|Overall Study||4
2361124|NCT01596582|5793945|P2|COMPLETED|Overall Study||173
2361125|NCT01596582|5793946|P1|COMPLETED|Overall Study||168
2361126|NCT01596582|5793945|P2|STARTED|Overall Study||180
2361127|NCT01596582|5793946|P1|STARTED|Overall Study||172
2361128|NCT01596504|5793973|P3|NOT COMPLETED|Overall Study||1
2361129|NCT01596504|5793974|P2|NOT COMPLETED|Overall Study||3
2361130|NCT01596504|5793975|P1|NOT COMPLETED|Overall Study||2
2361131|NCT01596504|5793973|P3|COMPLETED|Overall Study||46
2361132|NCT01596504|5793974|P2|COMPLETED|Overall Study||44
2361133|NCT01596504|5793975|P1|COMPLETED|Overall Study||46
2361134|NCT01596504|5793973|P3|STARTED|Overall Study||47
2361135|NCT01596504|5793974|P2|STARTED|Overall Study||47
2361136|NCT01596504|5793975|P1|STARTED|Overall Study||48
2361137|NCT01596335|5794033|P2|NOT COMPLETED|Overall Study||9
2361138|NCT01596335|5794034|P1|NOT COMPLETED|Overall Study||5
2361139|NCT01596335|5794033|P2|COMPLETED|Overall Study||6
2361140|NCT01596335|5794034|P1|COMPLETED|Overall Study||11
2361141|NCT01596335|5794033|P2|STARTED|Overall Study||15
2361142|NCT01596335|5794034|P1|STARTED|Overall Study||16
2361143|NCT01596283|5794046|P2|NOT COMPLETED|Overall Study||0
2361144|NCT01596283|5794047|P1|NOT COMPLETED|Overall Study||0
2361145|NCT01596283|5794046|P2|COMPLETED|Overall Study||66
2361146|NCT01596283|5794047|P1|COMPLETED|Overall Study||69
2361147|NCT01596283|5794046|P2|STARTED|Overall Study||66
2361148|NCT01596283|5794047|P1|STARTED|Overall Study||69
2361149|NCT01596231|5794063|P2|NOT COMPLETED|Overall Study||0
2361150|NCT01596231|5794064|P1|NOT COMPLETED|Overall Study||0
2361151|NCT01596231|5794063|P2|COMPLETED|Overall Study||10
2361152|NCT01596231|5794064|P1|COMPLETED|Overall Study||10
2361153|NCT01596231|5794063|P2|STARTED|Overall Study||10
2361154|NCT01596231|5794064|P1|STARTED|Overall Study||10
2361155|NCT01596127|5794070|P1|NOT COMPLETED|Overall Study||1
2361156|NCT01596127|5794070|P1|COMPLETED|Overall Study||3
2361157|NCT01596127|5794070|P1|STARTED|Overall Study||4
2361158|NCT01596088|5794075|P1|NOT COMPLETED|Overall Study||0
2361159|NCT01596088|5794075|P1|COMPLETED|Overall Study||2
2361160|NCT01596088|5794075|P1|STARTED|Overall Study||2
2361161|NCT01596062|5794082|P3|NOT COMPLETED|Overall Study||3
2361162|NCT01596062|5794083|P2|NOT COMPLETED|Overall Study||0
2361163|NCT01596062|5794084|P1|NOT COMPLETED|Overall Study||1
2361164|NCT01596062|5794082|P3|COMPLETED|Overall Study||4
2361165|NCT01596062|5794083|P2|COMPLETED|Overall Study||6
2361166|NCT01596062|5794084|P1|COMPLETED|Overall Study||2
2361167|NCT01596062|5794082|P3|STARTED|Overall Study||7
2361168|NCT01596062|5794083|P2|STARTED|Overall Study||6
2361169|NCT01596062|5794084|P1|STARTED|Overall Study||3
2361170|NCT01595854|5794121|P5|NOT COMPLETED|Overall Study||0
2361171|NCT01595854|5794122|P4|NOT COMPLETED|Overall Study||0
2361172|NCT01595854|5794123|P3|NOT COMPLETED|Overall Study||0
2361173|NCT01595854|5794124|P2|NOT COMPLETED|Overall Study||0
2361174|NCT01595854|5794125|P1|NOT COMPLETED|Overall Study||0
2361175|NCT01595854|5794121|P5|COMPLETED|Overall Study||12
2361176|NCT01595854|5794122|P4|COMPLETED|Overall Study||4
2361177|NCT01595854|5794123|P3|COMPLETED|Overall Study||8
2361178|NCT01595854|5794124|P2|COMPLETED|Overall Study||4
2361179|NCT01595854|5794125|P1|COMPLETED|Overall Study||8
2361180|NCT01595854|5794121|P5|STARTED|Overall Study||12
2361181|NCT01595854|5794122|P4|STARTED|Overall Study||4
2361182|NCT01595854|5794123|P3|STARTED|Overall Study||8
2361183|NCT01595854|5794124|P2|STARTED|Overall Study||4
2361184|NCT01595854|5794125|P1|STARTED|Overall Study||8
2361185|NCT01595646|5794148|P3|NOT COMPLETED|Overall Study||0
2361186|NCT01595646|5794149|P2|NOT COMPLETED|Overall Study||0
2361187|NCT01595646|5794150|P1|NOT COMPLETED|Overall Study||1
2361188|NCT01595646|5794148|P3|COMPLETED|Overall Study||12
2361189|NCT01595646|5794149|P2|COMPLETED|Overall Study||12
2361190|NCT01595646|5794150|P1|COMPLETED|Overall Study||12
2361191|NCT01595646|5794148|P3|STARTED|Overall Study||12
2361192|NCT01595646|5794149|P2|STARTED|Overall Study||12
2361193|NCT01595646|5794150|P1|STARTED|Overall Study||13
2361194|NCT01595516|5794173|P3|NOT COMPLETED|Overall Study||0
2361195|NCT01595516|5794174|P2|NOT COMPLETED|Overall Study||0
2361196|NCT01595516|5794175|P1|NOT COMPLETED|Overall Study||0
2361197|NCT01595516|5794173|P3|COMPLETED|Overall Study||12
2361198|NCT01595516|5794174|P2|COMPLETED|Overall Study||16
2361199|NCT01595516|5794175|P1|COMPLETED|Overall Study||16
2361200|NCT01595516|5794173|P3|STARTED|Overall Study||12
2361201|NCT01595516|5794174|P2|STARTED|Overall Study||16
2361202|NCT01595516|5794175|P1|STARTED|Overall Study||16
2361203|NCT01595438|5794205|P2|NOT COMPLETED|Overall Study||41
2361204|NCT01595438|5794206|P1|NOT COMPLETED|Overall Study||43
2361205|NCT01595438|5794205|P2|COMPLETED|Overall Study||476
2361206|NCT01595438|5794206|P1|COMPLETED|Overall Study||473
2361207|NCT01595438|5794205|P2|STARTED|Overall Study||517
2361208|NCT01595438|5794206|P1|STARTED|Overall Study||516
2361209|NCT01595386|5794332|P2|NOT COMPLETED|Overall Study||0
2361210|NCT01595386|5794333|P1|NOT COMPLETED|Overall Study||0
2361211|NCT01595386|5794332|P2|COMPLETED|Overall Study||19
2361212|NCT01595386|5794333|P1|COMPLETED|Overall Study||21
2361213|NCT01595386|5794332|P2|STARTED|Overall Study||19
2361214|NCT01595386|5794333|P1|STARTED|Overall Study||21
2361215|NCT01595282|5794361|P2|NOT COMPLETED|Overall Study||0
2361216|NCT01595282|5794362|P1|NOT COMPLETED|Overall Study||0
2361217|NCT01595282|5794361|P2|COMPLETED|Overall Study||47
2361218|NCT01595282|5794362|P1|COMPLETED|Overall Study||47
2361219|NCT01595282|5794361|P2|STARTED|Overall Study||47
2361220|NCT01595282|5794362|P1|STARTED|Overall Study||47
2361221|NCT01595009|5794374|P4|NOT COMPLETED|Extension||11
2361222|NCT01595009|5794375|P3|NOT COMPLETED|Extension||4
2361223|NCT01595009|5794376|P2|NOT COMPLETED|Extension||0
2361224|NCT01595009|5794377|P1|NOT COMPLETED|Extension||0
2361225|NCT01595009|5794374|P4|COMPLETED|Extension||0
2361226|NCT01595009|5794375|P3|COMPLETED|Extension||0
2361227|NCT01595009|5794376|P2|COMPLETED|Extension||0
2361228|NCT01595009|5794377|P1|COMPLETED|Extension||0
2361229|NCT01595009|5794374|P4|STARTED|Extension||11
2361230|NCT01595009|5794375|P3|STARTED|Extension||4
2361231|NCT01595009|5794376|P2|STARTED|Extension||0
2361232|NCT01595009|5794377|P1|STARTED|Extension||0
2361233|NCT01595009|5794374|P4|NOT COMPLETED|Core||0
2361234|NCT01595009|5794375|P3|NOT COMPLETED|Core||0
2361235|NCT01595009|5794376|P2|NOT COMPLETED|Core||120
2361236|NCT01595009|5794377|P1|NOT COMPLETED|Core||126
2361237|NCT01595009|5794374|P4|COMPLETED|Core||0
2361238|NCT01595009|5794375|P3|COMPLETED|Core||0
2361239|NCT01595009|5794376|P2|COMPLETED|Core||0
2361240|NCT01595009|5794377|P1|COMPLETED|Core||0
2361241|NCT01595009|5794374|P4|STARTED|Core||0
2361242|NCT01595009|5794375|P3|STARTED|Core||0
2361243|NCT01595009|5794376|P2|STARTED|Core||120
2361244|NCT01595009|5794377|P1|STARTED|Core||126
2361245|NCT01594970|5794412|P3|NOT COMPLETED|Overall Study||66
2361246|NCT01594970|5794413|P2|NOT COMPLETED|Overall Study||82
2361247|NCT01594970|5794414|P1|NOT COMPLETED|Overall Study||75
2361248|NCT01594970|5794412|P3|COMPLETED|Overall Study||191
2361249|NCT01594970|5794413|P2|COMPLETED|Overall Study||166
2361250|NCT01594970|5794414|P1|COMPLETED|Overall Study||220
2361251|NCT01594970|5794412|P3|STARTED|Overall Study||257
2361252|NCT01594970|5794413|P2|STARTED|Overall Study||248
2361253|NCT01594970|5794414|P1|STARTED|Overall Study||295
2361254|NCT01594853|5794433|P2|NOT COMPLETED|Overall Study||3
2361255|NCT01594853|5794434|P1|NOT COMPLETED|Overall Study||2
2361256|NCT01594853|5794433|P2|COMPLETED|Overall Study||12
2361257|NCT01594853|5794434|P1|COMPLETED|Overall Study||14
2361258|NCT01594853|5794433|P2|STARTED|Overall Study||15
2361259|NCT01594853|5794434|P1|STARTED|Overall Study||16
2361260|NCT01594827|5794442|P2|NOT COMPLETED|Overall Study||0
2361261|NCT01594827|5794443|P1|NOT COMPLETED|Overall Study||4
2361262|NCT01594827|5794442|P2|COMPLETED|Overall Study||15
2361263|NCT01594827|5794443|P1|COMPLETED|Overall Study||10
2361264|NCT01594827|5794442|P2|STARTED|Overall Study||15
2361265|NCT01594827|5794443|P1|STARTED|Overall Study||14
2361266|NCT01594762|5794467|P2|NOT COMPLETED|Overall Study||10
2361267|NCT01594762|5794468|P1|NOT COMPLETED|Overall Study||11
2361268|NCT01594762|5794467|P2|COMPLETED|Overall Study||93
2361269|NCT01594762|5794468|P1|COMPLETED|Overall Study||86
2361270|NCT01594762|5794467|P2|STARTED|Overall Study||103
2361271|NCT01594762|5794468|P1|STARTED|Overall Study||97
2361272|NCT01594749|5794480|P2|NOT COMPLETED|Overall Study||18
2361273|NCT01594749|5794481|P1|NOT COMPLETED|Overall Study||22
2361274|NCT01594749|5794480|P2|COMPLETED|Overall Study||490
2361275|NCT01594749|5794481|P1|COMPLETED|Overall Study||485
2361276|NCT01594749|5794480|P2|Treated|Overall Study||498
2361277|NCT01594749|5794481|P1|Treated|Overall Study||503
2361278|NCT01594749|5794480|P2|STARTED|Overall Study||508
2361279|NCT01594749|5794481|P1|STARTED|Overall Study||507
2361280|NCT01594528|5794500|P3|NOT COMPLETED|Overall Study||0
2361281|NCT01594528|5794501|P2|NOT COMPLETED|Overall Study||0
2361282|NCT01594528|5794502|P1|NOT COMPLETED|Overall Study||0
2361283|NCT01594528|5794500|P3|COMPLETED|Overall Study||16
2361284|NCT01594528|5794501|P2|COMPLETED|Overall Study||17
2361285|NCT01594528|5794502|P1|COMPLETED|Overall Study||16
2361286|NCT01594528|5794500|P3|STARTED|Overall Study||16
2361287|NCT01594528|5794501|P2|STARTED|Overall Study||17
2361288|NCT01594528|5794502|P1|STARTED|Overall Study||16
2361289|NCT01594515|5794518|P10|NOT COMPLETED|Overall Study||0
2361290|NCT01594515|5794519|P9|NOT COMPLETED|Overall Study||0
2361291|NCT01594515|5794520|P8|NOT COMPLETED|Overall Study||0
2361292|NCT01594515|5794521|P7|NOT COMPLETED|Overall Study||0
2361293|NCT01594515|5794522|P6|NOT COMPLETED|Overall Study||0
2361294|NCT01594515|5794523|P5|NOT COMPLETED|Overall Study||0
2361295|NCT01594515|5794524|P4|NOT COMPLETED|Overall Study||0
2361296|NCT01594515|5794525|P3|NOT COMPLETED|Overall Study||0
2361297|NCT01594515|5794526|P2|NOT COMPLETED|Overall Study||0
2361298|NCT01594515|5794527|P1|NOT COMPLETED|Overall Study||0
2361299|NCT01594515|5794518|P10|COMPLETED|Overall Study||16
2361300|NCT01594515|5794519|P9|COMPLETED|Overall Study||6
2361301|NCT01594515|5794520|P8|COMPLETED|Overall Study||6
2361302|NCT01594515|5794521|P7|COMPLETED|Overall Study||6
2361303|NCT01594515|5794522|P6|COMPLETED|Overall Study||6
2361304|NCT01594515|5794523|P5|COMPLETED|Overall Study||6
2361305|NCT01594515|5794524|P4|COMPLETED|Overall Study||6
2361306|NCT01594515|5794525|P3|COMPLETED|Overall Study||6
2361307|NCT01594515|5794526|P2|COMPLETED|Overall Study||6
2361308|NCT01594515|5794527|P1|COMPLETED|Overall Study||6
2361309|NCT01594515|5794518|P10|STARTED|Overall Study||16
2361310|NCT01594515|5794519|P9|STARTED|Overall Study||6
2361311|NCT01594515|5794520|P8|STARTED|Overall Study||6
2361312|NCT01594515|5794521|P7|STARTED|Overall Study||6
2361313|NCT01594515|5794522|P6|STARTED|Overall Study||6
2361314|NCT01594515|5794523|P5|STARTED|Overall Study||6
2361315|NCT01594515|5794524|P4|STARTED|Overall Study||6
2361316|NCT01594515|5794525|P3|STARTED|Overall Study||6
2361317|NCT01594515|5794526|P2|STARTED|Overall Study||6
2361318|NCT01594515|5794527|P1|STARTED|Overall Study||6
2361319|NCT01594476|5794619|P2|NOT COMPLETED|Overall Study||3
2361320|NCT01594476|5794620|P1|NOT COMPLETED|Overall Study||1
2361321|NCT01594476|5794619|P2|COMPLETED|Overall Study||97
2361322|NCT01594476|5794620|P1|COMPLETED|Overall Study||100
2361323|NCT01594476|5794619|P2|Pregnant|Overall Study||5
2361324|NCT01594476|5794620|P1|Pregnant|Overall Study||2
2361325|NCT01594476|5794619|P2|IUD Expulsion|Overall Study||0
2361326|NCT01594476|5794620|P1|IUD Expulsion|Overall Study||2
2361327|NCT01594476|5794619|P2|IUD Removal|Overall Study||5
2361328|NCT01594476|5794620|P1|IUD Removal|Overall Study||3
2361329|NCT01594476|5794619|P2|Excluded After Allocation|Overall Study||3
2361330|NCT01594476|5794620|P1|Excluded After Allocation|Overall Study||1
2361331|NCT01594476|5794619|P2|Received Intervention|Overall Study||73
2361332|NCT01594476|5794620|P1|Received Intervention|Overall Study||66
2361333|NCT01594476|5794619|P2|STARTED|Overall Study||100
2361334|NCT01594476|5794620|P1|STARTED|Overall Study||101
2361335|NCT01594424|5794638|P1|NOT COMPLETED|Overall Study||2
2361336|NCT01594424|5794638|P1|COMPLETED|Overall Study||8
2361337|NCT01594424|5794638|P1|STARTED|Overall Study||10
2361338|NCT01594411|5794642|P1|NOT COMPLETED|Overall Study||2
2361339|NCT01594411|5794642|P1|COMPLETED|Overall Study||249
2361340|NCT01594411|5794642|P1|STARTED|Overall Study||251
2361341|NCT01594385|5794651|P2|NOT COMPLETED|Overall Study||0
2361342|NCT01594385|5794652|P1|NOT COMPLETED|Overall Study||0
2361343|NCT01594385|5794651|P2|COMPLETED|Overall Study||13
2361344|NCT01594385|5794652|P1|COMPLETED|Overall Study||17
2361345|NCT01594385|5794651|P2|STARTED|Overall Study||13
2361346|NCT01594385|5794652|P1|STARTED|Overall Study||17
2361347|NCT01594294|5794676|P2|NOT COMPLETED|Overall Study||4
2361348|NCT01594294|5794677|P1|NOT COMPLETED|Overall Study||3
2361349|NCT01594294|5794676|P2|COMPLETED|Overall Study||36
2361350|NCT01594294|5794677|P1|COMPLETED|Overall Study||36
2361351|NCT01594294|5794676|P2|STARTED|Overall Study||40
2361352|NCT01594294|5794677|P1|STARTED|Overall Study||39
2361353|NCT01594281|5794694|P3|NOT COMPLETED|Non-Interventional Follow Up Phase||2
2361354|NCT01594281|5794695|P2|NOT COMPLETED|Non-Interventional Follow Up Phase||2
2361355|NCT01594281|5794696|P1|NOT COMPLETED|Non-Interventional Follow Up Phase||3
2361356|NCT01594281|5794694|P3|COMPLETED|Non-Interventional Follow Up Phase||23
2361357|NCT01594281|5794695|P2|COMPLETED|Non-Interventional Follow Up Phase||19
2361358|NCT01594281|5794696|P1|COMPLETED|Non-Interventional Follow Up Phase||25
2361359|NCT01594281|5794694|P3|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||25
2361360|NCT01594281|5794695|P2|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||20
2361361|NCT01594281|5794696|P1|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||28
2361362|NCT01594281|5794694|P3|STARTED|Non-Interventional Follow Up Phase|3 patients exited after completing Core Phase and did not start the Follow-Up Phase|25
2361363|NCT01594281|5794695|P2|STARTED|Non-Interventional Follow Up Phase|5 patients exited after completing Core Phase and did not start the Follow-Up Phase|21
2361364|NCT01594281|5794696|P1|STARTED|Non-Interventional Follow Up Phase|1 patient exited after completing Core Phase and did not start the Follow-Up Phase|28
2361365|NCT01594281|5794694|P3|NOT COMPLETED|Interventional Core Phase||8
2361366|NCT01594281|5794695|P2|NOT COMPLETED|Interventional Core Phase||10
2361367|NCT01594281|5794696|P1|NOT COMPLETED|Interventional Core Phase||7
2361368|NCT01594281|5794694|P3|COMPLETED|Interventional Core Phase||28
2361369|NCT01594281|5794695|P2|COMPLETED|Interventional Core Phase||26
2361370|NCT01594281|5794696|P1|COMPLETED|Interventional Core Phase||29
2361371|NCT01594281|5794694|P3|Full Analysis Set (FAS)|Interventional Core Phase||36
2361372|NCT01594281|5794695|P2|Full Analysis Set (FAS)|Interventional Core Phase||35
2361373|NCT01594281|5794696|P1|Full Analysis Set (FAS)|Interventional Core Phase||35
2361374|NCT01594281|5794694|P3|STARTED|Interventional Core Phase||36
2361375|NCT01594281|5794695|P2|STARTED|Interventional Core Phase||36
2361376|NCT01594281|5794696|P1|STARTED|Interventional Core Phase||36
2361377|NCT01594125|5794736|P5|NOT COMPLETED|Overall Study||7
2361378|NCT01594125|5794737|P4|NOT COMPLETED|Overall Study||4
2361379|NCT01594125|5794738|P3|NOT COMPLETED|Overall Study||3
2361380|NCT01594125|5794739|P2|NOT COMPLETED|Overall Study||12
2361381|NCT01594125|5794740|P1|NOT COMPLETED|Overall Study||4
2361382|NCT01594125|5794736|P5|COMPLETED|Overall Study||0
2361383|NCT01594125|5794737|P4|COMPLETED|Overall Study||0
2361384|NCT01594125|5794738|P3|COMPLETED|Overall Study||0
2361385|NCT01594125|5794739|P2|COMPLETED|Overall Study||0
2361386|NCT01594125|5794740|P1|COMPLETED|Overall Study||0
2361387|NCT01594125|5794736|P5|STARTED|Overall Study||7
2361388|NCT01594125|5794737|P4|STARTED|Overall Study||4
2361389|NCT01594125|5794738|P3|STARTED|Overall Study||3
2361390|NCT01594125|5794739|P2|STARTED|Overall Study||12
2361391|NCT01594125|5794740|P1|STARTED|Overall Study||4
2361392|NCT01593852|5794774|P2|NOT COMPLETED|Overall Study||0
2361393|NCT01593852|5794775|P1|NOT COMPLETED|Overall Study||0
2361394|NCT01593852|5794774|P2|COMPLETED|Overall Study||68
2361395|NCT01593852|5794775|P1|COMPLETED|Overall Study||68
2361396|NCT01593852|5794774|P2|STARTED|Overall Study||68
2361397|NCT01593852|5794775|P1|STARTED|Overall Study||68
2361398|NCT01593787|5794800|P3|NOT COMPLETED|Overall Study||0
2361399|NCT01593787|5794801|P2|NOT COMPLETED|Overall Study||0
2361400|NCT01593787|5794802|P1|NOT COMPLETED|Overall Study||1
2361401|NCT01593787|5794800|P3|COMPLETED|Overall Study||18
2361402|NCT01593787|5794801|P2|COMPLETED|Overall Study||8
2361403|NCT01593787|5794802|P1|COMPLETED|Overall Study||5
2361404|NCT01593787|5794800|P3|STARTED|Overall Study||18
2361405|NCT01593787|5794801|P2|STARTED|Overall Study||8
2361406|NCT01593787|5794802|P1|STARTED|Overall Study||6
2361407|NCT01593722|5794842|P2|NOT COMPLETED|Overall Study||0
2361408|NCT01593722|5794843|P1|NOT COMPLETED|Overall Study||0
2361409|NCT01593722|5794842|P2|COMPLETED|Overall Study||6
2361410|NCT01593722|5794843|P1|COMPLETED|Overall Study||6
2361411|NCT01593722|5794842|P2|STARTED|Overall Study||6
2361412|NCT01593722|5794843|P1|STARTED|Overall Study||6
2361413|NCT01593670|5794857|P1|NOT COMPLETED|Overall Study||0
2361414|NCT01593670|5794857|P1|COMPLETED|Overall Study||9
2361415|NCT01593670|5794857|P1|STARTED|Overall Study||9
2361416|NCT01593592|5794867|P2|NOT COMPLETED|Overall Study||0
2361417|NCT01593592|5794868|P1|NOT COMPLETED|Overall Study||0
2361418|NCT01593592|5794867|P2|COMPLETED|Overall Study||35
2361419|NCT01593592|5794868|P1|COMPLETED|Overall Study||35
2361420|NCT01593592|5794867|P2|STARTED|Overall Study||35
2361421|NCT01593592|5794868|P1|STARTED|Overall Study||35
2361422|NCT01593254|5794880|P2|NOT COMPLETED|Follow-Up Period||11
2361423|NCT01593254|5794881|P1|NOT COMPLETED|Follow-Up Period||3
2361424|NCT01593254|5794880|P2|COMPLETED|Follow-Up Period||17
2361425|NCT01593254|5794881|P1|COMPLETED|Follow-Up Period||11
2361426|NCT01593254|5794880|P2|STARTED|Follow-Up Period||28
2361427|NCT01593254|5794881|P1|STARTED|Follow-Up Period||14
2361428|NCT01593254|5794880|P2|NOT COMPLETED|Treatment Period||31
2361429|NCT01593254|5794881|P1|NOT COMPLETED|Treatment Period||14
2361430|NCT01593254|5794880|P2|COMPLETED|Treatment Period||143
2361431|NCT01593254|5794881|P1|COMPLETED|Treatment Period||72
2361432|NCT01593254|5794880|P2|Crossed Over to Dasatinib|Treatment Period||0
2361433|NCT01593254|5794881|P1|Crossed Over to Dasatinib|Treatment Period||42
2361434|NCT01593254|5794880|P2|STARTED|Treatment Period||174
2361435|NCT01593254|5794881|P1|STARTED|Treatment Period||86
2361436|NCT01593215|5794890|P2|NOT COMPLETED|Overall Study||0
2361437|NCT01593215|5794891|P1|NOT COMPLETED|Overall Study||1
2361438|NCT01593215|5794890|P2|COMPLETED|Overall Study||25
2361439|NCT01593215|5794891|P1|COMPLETED|Overall Study||24
2361440|NCT01593215|5794890|P2|STARTED|Overall Study||25
2361441|NCT01593215|5794891|P1|STARTED|Overall Study||25
2361442|NCT01592864|5794899|P2|NOT COMPLETED|Overall Study||1
2361443|NCT01592864|5794900|P1|NOT COMPLETED|Overall Study||0
2361444|NCT01592864|5794899|P2|COMPLETED|Overall Study||57
2361445|NCT01592864|5794900|P1|COMPLETED|Overall Study||60
2361446|NCT01592864|5794899|P2|STARTED|Overall Study||58
2361447|NCT01592864|5794900|P1|STARTED|Overall Study||60
2361448|NCT01592851|5794914|P2|NOT COMPLETED|Overall Study||0
2361449|NCT01592851|5794915|P1|NOT COMPLETED|Overall Study||0
2361450|NCT01592851|5794914|P2|COMPLETED|Overall Study||57
2361451|NCT01592851|5794915|P1|COMPLETED|Overall Study||56
2361452|NCT01592851|5794914|P2|STARTED|Overall Study||57
2361453|NCT01592851|5794915|P1|STARTED|Overall Study||56
2361454|NCT01592799|5794931|P1|NOT COMPLETED|Overall Study||0
2361455|NCT01592799|5794931|P1|COMPLETED|Overall Study||501
2361456|NCT01592799|5794931|P1|STARTED|Overall Study||501
2361457|NCT01592786|5794961|P1|NOT COMPLETED|Overall Study||138
2361458|NCT01592786|5794961|P1|COMPLETED|Overall Study||765
2361459|NCT01592786|5794961|P1|STARTED|Overall Study|Participants in the Safety Population are being presented.|903
2361460|NCT01592773|5794965|P1|NOT COMPLETED|Overall Study||666
2361461|NCT01592773|5794965|P1|COMPLETED|Overall Study||81
2361462|NCT01592773|5794965|P1|STARTED|Overall Study|All enrolled patients received at least 1 dose of investigational product (Safety Population).|747
2361463|NCT01592760|5794972|P3|NOT COMPLETED|24-hour Follow-Up||2
2361464|NCT01592760|5794973|P2|NOT COMPLETED|24-hour Follow-Up||3
2361465|NCT01592760|5794974|P1|NOT COMPLETED|24-hour Follow-Up||4
2361466|NCT01592760|5794972|P3|COMPLETED|24-hour Follow-Up||43
2361467|NCT01592760|5794973|P2|COMPLETED|24-hour Follow-Up||87
2361468|NCT01592760|5794974|P1|COMPLETED|24-hour Follow-Up||86
2361469|NCT01592760|5794972|P3|STARTED|24-hour Follow-Up||45
2361470|NCT01592760|5794973|P2|STARTED|24-hour Follow-Up||90
2361471|NCT01592760|5794974|P1|STARTED|24-hour Follow-Up||90
2361472|NCT01592760|5794972|P3|NOT COMPLETED|Perioperative to Discharge||0
2361473|NCT01592760|5794973|P2|NOT COMPLETED|Perioperative to Discharge||0
2361474|NCT01592760|5794974|P1|NOT COMPLETED|Perioperative to Discharge||0
2361475|NCT01592760|5794972|P3|COMPLETED|Perioperative to Discharge||45
2361476|NCT01592760|5794973|P2|COMPLETED|Perioperative to Discharge||90
2361477|NCT01592760|5794974|P1|COMPLETED|Perioperative to Discharge||90
2361478|NCT01592760|5794972|P3|STARTED|Perioperative to Discharge||45
2361479|NCT01592760|5794973|P2|STARTED|Perioperative to Discharge||90
2361480|NCT01592760|5794974|P1|STARTED|Perioperative to Discharge||90
2361481|NCT01592747|5795018|P3|NOT COMPLETED|Overall Study||108
2361482|NCT01592747|5795019|P2|NOT COMPLETED|Overall Study||111
2361483|NCT01592747|5795020|P1|NOT COMPLETED|Overall Study||116
2361484|NCT01592747|5795018|P3|COMPLETED|Overall Study||50
2361485|NCT01592747|5795019|P2|COMPLETED|Overall Study||50
2361486|NCT01592747|5795020|P1|COMPLETED|Overall Study||44
2361487|NCT01592747|5795018|P3|STARTED|Overall Study|Based on Randomized Population|158
2361488|NCT01592747|5795019|P2|STARTED|Overall Study|Based on Randomized Population|161
2361489|NCT01592747|5795020|P1|STARTED|Overall Study|Based on Randomized Population|160
2361490|NCT01592708|5795063|P2|NOT COMPLETED|Overall Study||0
2361491|NCT01592708|5795064|P1|NOT COMPLETED|Overall Study||3
2361492|NCT01592708|5795063|P2|COMPLETED|Overall Study||137
2361493|NCT01592708|5795064|P1|COMPLETED|Overall Study||93
2361494|NCT01592708|5795063|P2|STARTED|Overall Study||137
2361495|NCT01592708|5795064|P1|STARTED|Overall Study||96
2361496|NCT01592695|5795080|P2|NOT COMPLETED|Overall Study||4
2361497|NCT01592695|5795081|P1|NOT COMPLETED|Overall Study||8
2361498|NCT01592695|5795080|P2|COMPLETED|Overall Study||28
2361499|NCT01592695|5795081|P1|COMPLETED|Overall Study||23
2361500|NCT01592695|5795080|P2|STARTED|Overall Study||32
2361501|NCT01592695|5795081|P1|STARTED|Overall Study||31
2361502|NCT01592500|5795103|P4|NOT COMPLETED|Overall Study||2
2361503|NCT01592500|5795104|P3|NOT COMPLETED|Overall Study||0
2361504|NCT01592500|5795105|P2|NOT COMPLETED|Overall Study||0
2361505|NCT01592500|5795106|P1|NOT COMPLETED|Overall Study||1
2361506|NCT01592500|5795103|P4|COMPLETED|Overall Study||11
2361507|NCT01592500|5795104|P3|COMPLETED|Overall Study||14
2361508|NCT01592500|5795105|P2|COMPLETED|Overall Study||15
2361509|NCT01592500|5795106|P1|COMPLETED|Overall Study||13
2361510|NCT01592500|5795103|P4|STARTED|Overall Study|Randomized Participants|13
2361511|NCT01592500|5795104|P3|STARTED|Overall Study||14
2361512|NCT01592500|5795105|P2|STARTED|Overall Study||15
2361513|NCT01592500|5795106|P1|STARTED|Overall Study|Randomized Participants|14
2361514|NCT01592435|5795128|P1|NOT COMPLETED|Overall Study||0
2361515|NCT01592435|5795128|P1|COMPLETED|Overall Study||76
2361516|NCT01592435|5795128|P1|STARTED|Overall Study||76
2361517|NCT01592409|5795136|P2|NOT COMPLETED|Overall Study||1
2361518|NCT01592409|5795137|P1|NOT COMPLETED|Overall Study||0
2361519|NCT01592409|5795136|P2|COMPLETED|Overall Study||31
2361520|NCT01592409|5795137|P1|COMPLETED|Overall Study||67
2361521|NCT01592409|5795136|P2|STARTED|Overall Study||32
2361522|NCT01592409|5795137|P1|STARTED|Overall Study||67
2361523|NCT01592396|5795145|P2|NOT COMPLETED|Overall Study||0
2361524|NCT01592396|5795146|P1|NOT COMPLETED|Overall Study||0
2361525|NCT01592396|5795145|P2|COMPLETED|Overall Study||10
2361526|NCT01592396|5795146|P1|COMPLETED|Overall Study||10
2361527|NCT01592396|5795145|P2|STARTED|Overall Study||10
2361528|NCT01592396|5795146|P1|STARTED|Overall Study||10
2361529|NCT01592383|5795161|P1|NOT COMPLETED|Overall Study||1
2361530|NCT01592383|5795161|P1|COMPLETED|Overall Study||1
2361531|NCT01592383|5795161|P1|STARTED|Overall Study||2
2361532|NCT01592344|5795172|P2|NOT COMPLETED|Overall Study||5
2361533|NCT01592344|5795173|P1|NOT COMPLETED|Overall Study||4
2361534|NCT01592344|5795172|P2|COMPLETED|Overall Study||44
2361535|NCT01592344|5795173|P1|COMPLETED|Overall Study||41
2361536|NCT01592344|5795172|P2|STARTED|Overall Study||49
2361537|NCT01592344|5795173|P1|STARTED|Overall Study||45
2361538|NCT01592292|5795187|P4|NOT COMPLETED|Overall Study||1
2361539|NCT01592292|5795188|P3|NOT COMPLETED|Overall Study||3
2361540|NCT01592292|5795189|P2|NOT COMPLETED|Overall Study||5
2361541|NCT01592292|5795190|P1|NOT COMPLETED|Overall Study||6
2361542|NCT01592292|5795187|P4|COMPLETED|Overall Study||10
2361543|NCT01592292|5795188|P3|COMPLETED|Overall Study||10
2361544|NCT01592292|5795189|P2|COMPLETED|Overall Study||15
2361545|NCT01592292|5795190|P1|COMPLETED|Overall Study|Participants who completed 12 months visit.|40
2361546|NCT01592292|5795187|P4|Standard Population Set (SPS)|Overall Study||7
2361547|NCT01592292|5795188|P3|Standard Population Set (SPS)|Overall Study||7
2361548|NCT01592292|5795189|P2|Standard Population Set (SPS)|Overall Study||10
2361549|NCT01592292|5795190|P1|Standard Population Set (SPS)|Overall Study|Excluding participants with change of administration drug or suspension of drug administration.|31
2361550|NCT01592292|5795187|P4|Intention to Treat (ITT) Set|Overall Study||8
2361551|NCT01592292|5795188|P3|Intention to Treat (ITT) Set|Overall Study||10
2361552|NCT01592292|5795189|P2|Intention to Treat (ITT) Set|Overall Study||13
2361553|NCT01592292|5795190|P1|Intention to Treat (ITT) Set|Overall Study|Excluding primary effect evaluation omission.|34
2361554|NCT01592292|5795187|P4|STARTED|Overall Study||11
2361555|NCT01592292|5795188|P3|STARTED|Overall Study||13
2361556|NCT01592292|5795189|P2|STARTED|Overall Study||20
2361557|NCT01592292|5795190|P1|STARTED|Overall Study||46
2361558|NCT01592240|5795229|P7|NOT COMPLETED|Overall Study||3
2361559|NCT01592240|5795230|P6|NOT COMPLETED|Overall Study||3
2361560|NCT01592240|5795231|P5|NOT COMPLETED|Overall Study||7
2361561|NCT01592240|5795232|P4|NOT COMPLETED|Overall Study||3
2361562|NCT01592240|5795233|P3|NOT COMPLETED|Overall Study||7
2361563|NCT01592240|5795234|P2|NOT COMPLETED|Overall Study||11
2361564|NCT01592240|5795235|P1|NOT COMPLETED|Overall Study||3
2361565|NCT01592240|5795229|P7|COMPLETED|Overall Study||48
2361566|NCT01592240|5795230|P6|COMPLETED|Overall Study||47
2361567|NCT01592240|5795231|P5|COMPLETED|Overall Study||44
2361568|NCT01592240|5795232|P4|COMPLETED|Overall Study||47
2361569|NCT01592240|5795233|P3|COMPLETED|Overall Study||45
2361570|NCT01592240|5795234|P2|COMPLETED|Overall Study||39
2361571|NCT01592240|5795235|P1|COMPLETED|Overall Study||47
2361572|NCT01592240|5795229|P7|STARTED|Overall Study||51
2361573|NCT01592240|5795230|P6|STARTED|Overall Study||50
2361574|NCT01592240|5795231|P5|STARTED|Overall Study||51
2361575|NCT01592240|5795232|P4|STARTED|Overall Study||50
2361576|NCT01592240|5795233|P3|STARTED|Overall Study||52
2361577|NCT01592240|5795234|P2|STARTED|Overall Study||50
2361578|NCT01592240|5795235|P1|STARTED|Overall Study||50
2361579|NCT01592071|5795415|P1|NOT COMPLETED|Overall Study||0
2361580|NCT01592071|5795415|P1|COMPLETED|Overall Study||120
2361581|NCT01592071|5795415|P1|STARTED|Overall Study||120
2361582|NCT01592045|5795428|P2|NOT COMPLETED|Overall Study||2
2361583|NCT01592045|5795429|P1|NOT COMPLETED|Overall Study||5
2361584|NCT01592045|5795428|P2|COMPLETED|Overall Study||12
2361585|NCT01592045|5795429|P1|COMPLETED|Overall Study||9
2361586|NCT01592045|5795428|P2|Completed Course 5|Overall Study||12
2361587|NCT01592045|5795429|P1|Completed Course 5|Overall Study||9
2361588|NCT01592045|5795428|P2|Completed Course 4|Overall Study||12
2361589|NCT01592045|5795429|P1|Completed Course 4|Overall Study||11
2361590|NCT01592045|5795428|P2|Completed Course 3|Overall Study||13
2361591|NCT01592045|5795429|P1|Completed Course 3|Overall Study||11
2361592|NCT01592045|5795428|P2|Completed Course 2|Overall Study||13
2361593|NCT01592045|5795429|P1|Completed Course 2|Overall Study||13
2361594|NCT01592045|5795428|P2|Completed Course 1|Overall Study||14
2361595|NCT01592045|5795429|P1|Completed Course 1|Overall Study||13
2361596|NCT01592045|5795428|P2|STARTED|Overall Study||14
2361597|NCT01592045|5795429|P1|STARTED|Overall Study||14
2361598|NCT01592006|5795437|P1|NOT COMPLETED|Overall Study||0
2361599|NCT01592006|5795437|P1|COMPLETED|Overall Study||3
2361600|NCT01592006|5795437|P1|STARTED|Overall Study||3
2361601|NCT01591954|5795442|P1|NOT COMPLETED|Overall Study||0
2361602|NCT01591954|5795442|P1|COMPLETED|Overall Study||1
2361603|NCT01591954|5795442|P1|STARTED|Overall Study||1
2361604|NCT01591863|5795447|P1|NOT COMPLETED|Overall Study||14
2361605|NCT01591863|5795447|P1|COMPLETED|Overall Study||24
2361606|NCT01591863|5795447|P1|STARTED|Overall Study||38
2361607|NCT01591837|5795459|P2|NOT COMPLETED|Overall Study||0
2361608|NCT01591837|5795460|P1|NOT COMPLETED|Overall Study||0
2361609|NCT01591837|5795459|P2|COMPLETED|Overall Study||60
2361610|NCT01591837|5795460|P1|COMPLETED|Overall Study||60
2361611|NCT01591837|5795459|P2|STARTED|Overall Study||60
2361612|NCT01591837|5795460|P1|STARTED|Overall Study||60
2361613|NCT01591746|5795476|P2|NOT COMPLETED|Overall Study||0
2361614|NCT01591746|5795477|P1|NOT COMPLETED|Overall Study||0
2361615|NCT01591746|5795476|P2|COMPLETED|Overall Study||63
2361616|NCT01591746|5795477|P1|COMPLETED|Overall Study||68
2361617|NCT01591746|5795476|P2|STARTED|Overall Study||63
2361618|NCT01591746|5795477|P1|STARTED|Overall Study||68
2361619|NCT01591733|5795493|P1|NOT COMPLETED|Overall Study||0
2361620|NCT01591733|5795493|P1|COMPLETED|Overall Study||48
2361621|NCT01591733|5795493|P1|STARTED|Overall Study||48
2361622|NCT01591681|5795504|P1|NOT COMPLETED|Overall Study||4
2361623|NCT01591681|5795504|P1|COMPLETED|Overall Study||45
2361624|NCT01591681|5795504|P1|STARTED|Overall Study||49
2361625|NCT01591616|5795530|P1|NOT COMPLETED|Overall Study||1
2361626|NCT01591616|5795530|P1|COMPLETED|Overall Study||15
2361627|NCT01591616|5795530|P1|STARTED|Overall Study||16
2361628|NCT01591499|5795671|P4|NOT COMPLETED|Second Intervention (up to 24 Days)||3
2361629|NCT01591499|5795672|P3|NOT COMPLETED|Second Intervention (up to 24 Days)||3
2361630|NCT01591499|5795673|P2|NOT COMPLETED|Second Intervention (up to 24 Days)||3
2361631|NCT01591499|5795674|P1|NOT COMPLETED|Second Intervention (up to 24 Days)||6
2361632|NCT01591499|5795671|P4|COMPLETED|Second Intervention (up to 24 Days)||34
2361633|NCT01591499|5795672|P3|COMPLETED|Second Intervention (up to 24 Days)||28
2361634|NCT01591499|5795673|P2|COMPLETED|Second Intervention (up to 24 Days)||34
2361635|NCT01591499|5795674|P1|COMPLETED|Second Intervention (up to 24 Days)||27
2361636|NCT01591499|5795671|P4|STARTED|Second Intervention (up to 24 Days)||37
2361637|NCT01591499|5795672|P3|STARTED|Second Intervention (up to 24 Days)||31
2361638|NCT01591499|5795673|P2|STARTED|Second Intervention (up to 24 Days)||37
2361639|NCT01591499|5795674|P1|STARTED|Second Intervention (up to 24 Days)||33
2361640|NCT01591499|5795671|P4|NOT COMPLETED|First Intervention (up to 24 Days)||0
2361641|NCT01591499|5795672|P3|NOT COMPLETED|First Intervention (up to 24 Days)||0
2361642|NCT01591499|5795673|P2|NOT COMPLETED|First Intervention (up to 24 Days)||0
2361643|NCT01591499|5795674|P1|NOT COMPLETED|First Intervention (up to 24 Days)||0
2361644|NCT01591499|5795671|P4|COMPLETED|First Intervention (up to 24 Days)||37
2361645|NCT01591499|5795672|P3|COMPLETED|First Intervention (up to 24 Days)||31
2361646|NCT01591499|5795673|P2|COMPLETED|First Intervention (up to 24 Days)||37
2361647|NCT01591499|5795674|P1|COMPLETED|First Intervention (up to 24 Days)||33
2361648|NCT01591499|5795671|P4|STARTED|First Intervention (up to 24 Days)||37
2361649|NCT01591499|5795672|P3|STARTED|First Intervention (up to 24 Days)||31
2361650|NCT01591499|5795673|P2|STARTED|First Intervention (up to 24 Days)||37
2361651|NCT01591499|5795674|P1|STARTED|First Intervention (up to 24 Days)||33
2361652|NCT01591499|5795671|P4|NOT COMPLETED|Baseline Visit||2
2361653|NCT01591499|5795672|P3|NOT COMPLETED|Baseline Visit||0
2361654|NCT01591499|5795673|P2|NOT COMPLETED|Baseline Visit||2
2361655|NCT01591499|5795674|P1|NOT COMPLETED|Baseline Visit||0
2361656|NCT01591499|5795671|P4|COMPLETED|Baseline Visit||37
2361657|NCT01591499|5795672|P3|COMPLETED|Baseline Visit||31
2361658|NCT01591499|5795673|P2|COMPLETED|Baseline Visit||37
2361659|NCT01591499|5795674|P1|COMPLETED|Baseline Visit||33
2361660|NCT01591499|5795671|P4|STARTED|Baseline Visit||39
2361661|NCT01591499|5795672|P3|STARTED|Baseline Visit||31
2361662|NCT01591499|5795673|P2|STARTED|Baseline Visit||39
2361663|NCT01591499|5795674|P1|STARTED|Baseline Visit||33
2361664|NCT01591460|5795740|P1|NOT COMPLETED|Overall Study||26
2361665|NCT01591460|5795740|P1|COMPLETED|Overall Study|The number who completed PEG-IFN, as scheduled according to response-guided treatment, is presented.|139
2361666|NCT01591460|5795740|P1|STARTED|Overall Study|Those with elevated (Week 12) or detectable (Week 24) virus discontinued due to the Futility Rule.|165
2361667|NCT01591408|5795822|P2|NOT COMPLETED|Overall Study||8
2361668|NCT01591408|5795823|P1|NOT COMPLETED|Overall Study||12
2361669|NCT01591408|5795822|P2|COMPLETED|Overall Study||24
2361670|NCT01591408|5795823|P1|COMPLETED|Overall Study||24
2361671|NCT01591408|5795822|P2|STARTED|Overall Study||32
2361672|NCT01591408|5795823|P1|STARTED|Overall Study||36
2361673|NCT01591382|5795831|P2|NOT COMPLETED|Overall Study||2
2361674|NCT01591382|5795832|P1|NOT COMPLETED|Overall Study||3
2361675|NCT01591382|5795831|P2|COMPLETED|Overall Study||30
2361676|NCT01591382|5795832|P1|COMPLETED|Overall Study||29
2361677|NCT01591382|5795831|P2|STARTED|Overall Study||32
2361678|NCT01591382|5795832|P1|STARTED|Overall Study||32
2361679|NCT01591317|5795849|P3|NOT COMPLETED|Overall Study||0
2361680|NCT01591317|5795850|P2|NOT COMPLETED|Overall Study||0
2361681|NCT01591317|5795851|P1|NOT COMPLETED|Overall Study||0
2361682|NCT01591317|5795849|P3|COMPLETED|Overall Study||10
2361683|NCT01591317|5795850|P2|COMPLETED|Overall Study||10
2361684|NCT01591317|5795851|P1|COMPLETED|Overall Study||10
2361685|NCT01591317|5795849|P3|STARTED|Overall Study||10
2361686|NCT01591317|5795850|P2|STARTED|Overall Study||10
2361687|NCT01591317|5795851|P1|STARTED|Overall Study||10
2361688|NCT01591096|5795877|P1|NOT COMPLETED|Overall Study||1
2361689|NCT01591096|5795877|P1|COMPLETED|Overall Study||0
2361690|NCT01591096|5795877|P1|STARTED|Overall Study||1
2361691|NCT01591044|5795886|P3|NOT COMPLETED|Overall Study||4
2361692|NCT01591044|5795887|P2|NOT COMPLETED|Overall Study||9
2361693|NCT01591044|5795888|P1|NOT COMPLETED|Overall Study||7
2361694|NCT01591044|5795886|P3|COMPLETED|Overall Study||96
2361695|NCT01591044|5795887|P2|COMPLETED|Overall Study||91
2361696|NCT01591044|5795888|P1|COMPLETED|Overall Study||94
2361697|NCT01591044|5795886|P3|STARTED|Overall Study||100
2361698|NCT01591044|5795887|P2|STARTED|Overall Study||100
2361699|NCT01591044|5795888|P1|STARTED|Overall Study||101
2361700|NCT01591018|5795898|P2|NOT COMPLETED|Overall Study||0
2361701|NCT01591018|5795899|P1|NOT COMPLETED|Overall Study||0
2361702|NCT01591018|5795898|P2|COMPLETED|Overall Study||60
2361703|NCT01591018|5795899|P1|COMPLETED|Overall Study||60
2361704|NCT01591018|5795898|P2|STARTED|Overall Study||60
2361705|NCT01591018|5795899|P1|STARTED|Overall Study||60
2361706|NCT01591005|5795913|P4|NOT COMPLETED|Overall Study||0
2361707|NCT01591005|5795914|P3|NOT COMPLETED|Overall Study||0
2361708|NCT01591005|5795915|P2|NOT COMPLETED|Overall Study||0
2361709|NCT01591005|5795916|P1|NOT COMPLETED|Overall Study||0
2361710|NCT01591005|5795913|P4|COMPLETED|Overall Study||68
2361711|NCT01591005|5795914|P3|COMPLETED|Overall Study||68
2361712|NCT01591005|5795915|P2|COMPLETED|Overall Study||53
2361713|NCT01591005|5795916|P1|COMPLETED|Overall Study||53
2361714|NCT01591005|5795913|P4|STARTED|Overall Study||68
2361715|NCT01591005|5795914|P3|STARTED|Overall Study||68
2361716|NCT01591005|5795915|P2|STARTED|Overall Study||53
2361717|NCT01591005|5795916|P1|STARTED|Overall Study||53
2361718|NCT01590979|5795952|P2|NOT COMPLETED|Overall Study||0
2361719|NCT01590979|5795953|P1|NOT COMPLETED|Overall Study||0
2361720|NCT01590979|5795952|P2|COMPLETED|Overall Study||27
2361721|NCT01590979|5795953|P1|COMPLETED|Overall Study||27
2361722|NCT01590979|5795952|P2|STARTED|Overall Study||27
2361723|NCT01590979|5795953|P1|STARTED|Overall Study||27
2361724|NCT01590888|5795962|P3|NOT COMPLETED|Overall Study||1
2361725|NCT01590888|5795963|P2|NOT COMPLETED|Overall Study||0
2361726|NCT01590888|5795964|P1|NOT COMPLETED|Overall Study||4
2361727|NCT01590888|5795962|P3|COMPLETED|Overall Study||34
2361728|NCT01590888|5795963|P2|COMPLETED|Overall Study||38
2361729|NCT01590888|5795964|P1|COMPLETED|Overall Study||32
2361730|NCT01590888|5795962|P3|STARTED|Overall Study||35
2361731|NCT01590888|5795963|P2|STARTED|Overall Study||38
2361732|NCT01590888|5795964|P1|STARTED|Overall Study||36
2361733|NCT01590875|5796010|P2|NOT COMPLETED|Overall Study||0
2361734|NCT01590875|5796011|P1|NOT COMPLETED|Overall Study||0
2361735|NCT01590875|5796010|P2|COMPLETED|Overall Study||10
2361736|NCT01590875|5796011|P1|COMPLETED|Overall Study||10
2361737|NCT01590875|5796010|P2|STARTED|Overall Study||10
2361738|NCT01590875|5796011|P1|STARTED|Overall Study||10
2361739|NCT01590810|5796024|P5|NOT COMPLETED|Overall Study||0
2361740|NCT01590810|5796025|P4|NOT COMPLETED|Overall Study||0
2361741|NCT01590810|5796026|P3|NOT COMPLETED|Overall Study||1
2361742|NCT01590810|5796027|P2|NOT COMPLETED|Overall Study||1
2361743|NCT01590810|5796028|P1|NOT COMPLETED|Overall Study||0
2361744|NCT01590810|5796024|P5|COMPLETED|Overall Study||2
2361745|NCT01590810|5796025|P4|COMPLETED|Overall Study||8
2361746|NCT01590810|5796026|P3|COMPLETED|Overall Study||7
2361747|NCT01590810|5796027|P2|COMPLETED|Overall Study||7
2361748|NCT01590810|5796028|P1|COMPLETED|Overall Study||8
2361749|NCT01590810|5796024|P5|STARTED|Overall Study||2
2361750|NCT01590810|5796025|P4|STARTED|Overall Study||8
2361751|NCT01590810|5796026|P3|STARTED|Overall Study||8
2361752|NCT01590810|5796027|P2|STARTED|Overall Study||8
2361753|NCT01590810|5796028|P1|STARTED|Overall Study||8
2361754|NCT01590797|5796173|P2|NOT COMPLETED|Overall Study||16
2361755|NCT01590797|5796174|P1|NOT COMPLETED|Overall Study||17
2361756|NCT01590797|5796173|P2|COMPLETED|Overall Study||217
2361757|NCT01590797|5796174|P1|COMPLETED|Overall Study||217
2361758|NCT01590797|5796173|P2|STARTED|Overall Study||233
2361759|NCT01590797|5796174|P1|STARTED|Overall Study||234
2361760|NCT01590771|5796190|P2|NOT COMPLETED|Overall Study||39
2361761|NCT01590771|5796191|P1|NOT COMPLETED|Overall Study||19
2361762|NCT01590771|5796190|P2|COMPLETED|Overall Study||210
2361763|NCT01590771|5796191|P1|COMPLETED|Overall Study||230
2361764|NCT01590771|5796190|P2|STARTED|Overall Study||249
2361765|NCT01590771|5796191|P1|STARTED|Overall Study||249
2361766|NCT01590758|5796219|P2|NOT COMPLETED|Overall Study||7
2361767|NCT01590758|5796220|P1|NOT COMPLETED|Overall Study||5
2361768|NCT01590758|5796219|P2|COMPLETED|Overall Study||97
2361769|NCT01590758|5796220|P1|COMPLETED|Overall Study||80
2361770|NCT01590758|5796219|P2|STARTED|Overall Study||104
2361771|NCT01590758|5796220|P1|STARTED|Overall Study||85
2361772|NCT01590563|5796230|P1|NOT COMPLETED|Overall Study||1
2361773|NCT01590563|5796230|P1|COMPLETED|Overall Study||14
2361774|NCT01590563|5796230|P1|STARTED|Overall Study||15
2361775|NCT01590550|5796236|P1|NOT COMPLETED|Overall Study||0
2361776|NCT01590550|5796236|P1|COMPLETED|Overall Study||18
2361777|NCT01590550|5796236|P1|STARTED|Overall Study||18
2361778|NCT01590433|5796244|P2|NOT COMPLETED|Overall Study||22
2361779|NCT01590433|5796245|P1|NOT COMPLETED|Overall Study||52
2361780|NCT01590433|5796244|P2|COMPLETED|Overall Study||33
2361781|NCT01590433|5796245|P1|COMPLETED|Overall Study||75
2361782|NCT01590433|5796244|P2|STARTED|Overall Study||55
2361783|NCT01590433|5796245|P1|STARTED|Overall Study||127
2361784|NCT01590394|5796251|P1|NOT COMPLETED|Overall Study||0
2361785|NCT01590394|5796251|P1|COMPLETED|Overall Study||3
2361786|NCT01590394|5796251|P1|STARTED|Overall Study||3
2361787|NCT01590264|5796255|P1|NOT COMPLETED|Overall Study||0
2361788|NCT01590264|5796255|P1|COMPLETED|Overall Study||5
2361789|NCT01590264|5796255|P1|STARTED|Overall Study||5
2361790|NCT01590238|5796260|P1|NOT COMPLETED|Overall Study||2
2361791|NCT01590238|5796260|P1|COMPLETED|Overall Study||13
2361792|NCT01590238|5796260|P1|STARTED|Overall Study||15
2361793|NCT01590212|5796267|P3|NOT COMPLETED|Overall Study||5
2361794|NCT01590212|5796268|P2|NOT COMPLETED|Overall Study||4
2361795|NCT01590212|5796269|P1|NOT COMPLETED|Overall Study||3
2361796|NCT01590212|5796267|P3|COMPLETED|Overall Study||9
2361797|NCT01590212|5796268|P2|COMPLETED|Overall Study||5
2361798|NCT01590212|5796269|P1|COMPLETED|Overall Study|Includes 2 contacted who failed contact at post-intervention data collection point|9
2361799|NCT01590212|5796267|P3|Post-intervention|Overall Study|failed contact=1|10
2361800|NCT01590212|5796268|P2|Post-intervention|Overall Study|failed contact=2; withdrew=1|6
2361801|NCT01590212|5796269|P1|Post-intervention|Overall Study|failed contact=3|7
2361802|NCT01590212|5796267|P3|Baseline (Pre-intervention)|Overall Study|failed contact=2|12
2361803|NCT01590212|5796268|P2|Baseline (Pre-intervention)|Overall Study||9
2361804|NCT01590212|5796269|P1|Baseline (Pre-intervention)|Overall Study|withdrew=2|10
2361805|NCT01590212|5796267|P3|STARTED|Overall Study||14
2361806|NCT01590212|5796268|P2|STARTED|Overall Study||9
2361807|NCT01590212|5796269|P1|STARTED|Overall Study||12
2361808|NCT01590017|5796286|P1|NOT COMPLETED|Overall Study||4
2361809|NCT01590017|5796286|P1|COMPLETED|Overall Study||37
2361810|NCT01590017|5796286|P1|STARTED|Overall Study||41
2361811|NCT01589978|5796291|P1|NOT COMPLETED|Overall Study||0
2361812|NCT01589978|5796291|P1|COMPLETED|Overall Study||2681
2361813|NCT01589978|5796291|P1|STARTED|Overall Study||2681
2361814|NCT01589926|5796317|P2|NOT COMPLETED|Overall Study||0
2361815|NCT01589926|5796318|P1|NOT COMPLETED|Overall Study||0
2361816|NCT01589926|5796317|P2|COMPLETED|Overall Study||0
2361817|NCT01589926|5796318|P1|COMPLETED|Overall Study||0
2361818|NCT01589926|5796317|P2|STARTED|Overall Study||0
2361819|NCT01589926|5796318|P1|STARTED|Overall Study||0
2361820|NCT01589822|5796339|P3|NOT COMPLETED|Overall Study||1
2361821|NCT01589822|5796340|P2|NOT COMPLETED|Overall Study||3
2361822|NCT01589822|5796341|P1|NOT COMPLETED|Overall Study||4
2361823|NCT01589822|5796339|P3|COMPLETED|Overall Study||40
2361824|NCT01589822|5796340|P2|COMPLETED|Overall Study||86
2361825|NCT01589822|5796341|P1|COMPLETED|Overall Study||80
2361826|NCT01589822|5796339|P3|STARTED|Overall Study||41
2361827|NCT01589822|5796340|P2|STARTED|Overall Study||89
2361828|NCT01589822|5796341|P1|STARTED|Overall Study||84
2361829|NCT01589770|5796360|P2|NOT COMPLETED|Overall Study||5
2361830|NCT01589770|5796361|P1|NOT COMPLETED|Overall Study||8
2361831|NCT01589770|5796360|P2|COMPLETED|Overall Study||56
2361832|NCT01589770|5796361|P1|COMPLETED|Overall Study||59
2361833|NCT01589770|5796360|P2|STARTED|Overall Study||61
2361834|NCT01589770|5796361|P1|STARTED|Overall Study||67
2361835|NCT01589653|5796371|P2|NOT COMPLETED|Overall Study||11
2361836|NCT01589653|5796372|P1|NOT COMPLETED|Overall Study||7
2361837|NCT01589653|5796371|P2|COMPLETED|Overall Study||68
2361838|NCT01589653|5796372|P1|COMPLETED|Overall Study||69
2361839|NCT01589653|5796371|P2|Exposed|Overall Study||78
2361840|NCT01589653|5796372|P1|Exposed|Overall Study||76
2361841|NCT01589653|5796371|P2|STARTED|Overall Study||79
2361842|NCT01589653|5796372|P1|STARTED|Overall Study||76
2361843|NCT01589601|5796388|P2|NOT COMPLETED|Overall Study||49
2361844|NCT01589601|5796389|P1|NOT COMPLETED|Overall Study||47
2361845|NCT01589601|5796388|P2|COMPLETED|Overall Study||26
2361846|NCT01589601|5796389|P1|COMPLETED|Overall Study||28
2361847|NCT01589601|5796388|P2|STARTED|Overall Study||75
2361848|NCT01589601|5796389|P1|STARTED|Overall Study||75
2361849|NCT01589510|5796407|P1|NOT COMPLETED|Overall Study||33
2361850|NCT01589510|5796407|P1|COMPLETED|Overall Study||386
2361851|NCT01589510|5796407|P1|STARTED|Overall Study||419
2361852|NCT01589497|5796422|P4|NOT COMPLETED|Overall Study||1
2361853|NCT01589497|5796423|P3|NOT COMPLETED|Overall Study||1
2361854|NCT01589497|5796424|P2|NOT COMPLETED|Overall Study||1
2361855|NCT01589497|5796425|P1|NOT COMPLETED|Overall Study||1
2361856|NCT01589497|5796422|P4|COMPLETED|Overall Study||17
2361857|NCT01589497|5796423|P3|COMPLETED|Overall Study||15
2361858|NCT01589497|5796424|P2|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|16
2361859|NCT01589497|5796425|P1|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|17
2361860|NCT01589497|5796422|P4|STARTED|Overall Study||18
2361861|NCT01589497|5796423|P3|STARTED|Overall Study||16
2361862|NCT01589497|5796424|P2|STARTED|Overall Study||17
2361863|NCT01589497|5796425|P1|STARTED|Overall Study||18
2361864|NCT01589484|5796526|P1|NOT COMPLETED|Overall Study||4
2361865|NCT01589484|5796526|P1|COMPLETED|Overall Study||100
2361866|NCT01589484|5796526|P1|STARTED|Overall Study||104
2361867|NCT01589445|5796531|P1|NOT COMPLETED|002 (Metformin)-3 Months||9
2361868|NCT01589445|5796531|P1|COMPLETED|002 (Metformin)-3 Months|61 patients completed the drug 002.9 patients dropped out.|61
2361869|NCT01589445|5796531|P1|STARTED|002 (Metformin)-3 Months|70 patients participated for trial of drug 002.|70
2361870|NCT01589445|5796531|P1|NOT COMPLETED|001 (Pioglitazone) -3 Months||7
2361871|NCT01589445|5796531|P1|COMPLETED|001 (Pioglitazone) -3 Months|dropped out 7 patients|70
2361872|NCT01589445|5796531|P1|STARTED|001 (Pioglitazone) -3 Months||77
2361873|NCT01589315|5796547|P1|NOT COMPLETED|Overall Study||1
2361874|NCT01589315|5796547|P1|COMPLETED|Overall Study||16
2361875|NCT01589315|5796547|P1|STARTED|Overall Study||17
2361876|NCT01589302|5796551|P1|NOT COMPLETED|Overall Study||2
2361877|NCT01589302|5796551|P1|COMPLETED|Overall Study||152
2361878|NCT01589302|5796551|P1|Non-Del17p Patients|Overall Study||76
2361879|NCT01589302|5796551|P1|Del17p Patients|Overall Study||76
2361880|NCT01589302|5796551|P1|STARTED|Overall Study||154
2361881|NCT01589237|5796574|P4|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
2361882|NCT01589237|5796575|P3|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
2361883|NCT01589237|5796576|P2|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||6
2361884|NCT01589237|5796577|P1|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||5
2361885|NCT01589237|5796574|P4|COMPLETED|Part B (Planned for 78 Week-terminated)||0
2361886|NCT01589237|5796575|P3|COMPLETED|Part B (Planned for 78 Week-terminated)||0
2361887|NCT01589237|5796576|P2|COMPLETED|Part B (Planned for 78 Week-terminated)||0
2361888|NCT01589237|5796577|P1|COMPLETED|Part B (Planned for 78 Week-terminated)||0
2361889|NCT01589237|5796574|P4|STARTED|Part B (Planned for 78 Week-terminated)||4
2361890|NCT01589237|5796575|P3|STARTED|Part B (Planned for 78 Week-terminated)||4
2361891|NCT01589237|5796576|P2|STARTED|Part B (Planned for 78 Week-terminated)||6
2361892|NCT01589237|5796577|P1|STARTED|Part B (Planned for 78 Week-terminated)||5
2361893|NCT01589237|5796574|P4|NOT COMPLETED|Part A (52 Weeks)||0
2361894|NCT01589237|5796575|P3|NOT COMPLETED|Part A (52 Weeks)||2
2361895|NCT01589237|5796576|P2|NOT COMPLETED|Part A (52 Weeks)||3
2361896|NCT01589237|5796577|P1|NOT COMPLETED|Part A (52 Weeks)||2
2361897|NCT01589237|5796574|P4|COMPLETED|Part A (52 Weeks)||5
2361898|NCT01589237|5796575|P3|COMPLETED|Part A (52 Weeks)||8
2361899|NCT01589237|5796576|P2|COMPLETED|Part A (52 Weeks)||9
2361900|NCT01589237|5796577|P1|COMPLETED|Part A (52 Weeks)||9
2361901|NCT01589237|5796574|P4|STARTED|Part A (52 Weeks)||5
2361902|NCT01589237|5796575|P3|STARTED|Part A (52 Weeks)||10
2361903|NCT01589237|5796576|P2|STARTED|Part A (52 Weeks)||12
2361904|NCT01589237|5796577|P1|STARTED|Part A (52 Weeks)|"Started = Full analysis set/safety set"|11
2361905|NCT01589094|5796623|P1|NOT COMPLETED|Overall Study||2
2361906|NCT01589094|5796623|P1|COMPLETED|Overall Study||49
2361907|NCT01589094|5796623|P1|STARTED|Overall Study||51
2361908|NCT01588990|5796630|P1|NOT COMPLETED|Phase B||16
2361909|NCT01588990|5796630|P1|COMPLETED|Phase B|A total of 37 participants had disease progression in Phase B and ended Phase B.|37
2361910|NCT01588990|5796630|P1|STARTED|Phase B|Of 58 participants who had documented disease progression in Phase A, 53 entered in Phase B.|53
2361911|NCT01588990|5796630|P1|NOT COMPLETED|Phase A||70
2361912|NCT01588990|5796630|P1|COMPLETED|Phase A|A total of 58 participants had disease progression in Phase A and ended Phase A.|58
2361913|NCT01588990|5796630|P1|STARTED|Phase A||128
2361914|NCT01588951|5796658|P3|NOT COMPLETED|Overall Study||1
2361915|NCT01588951|5796659|P2|NOT COMPLETED|Overall Study||0
2361916|NCT01588951|5796660|P1|NOT COMPLETED|Overall Study||0
2361917|NCT01588951|5796658|P3|COMPLETED|Overall Study||5
2361918|NCT01588951|5796659|P2|COMPLETED|Overall Study||2
2361919|NCT01588951|5796660|P1|COMPLETED|Overall Study||2
2361920|NCT01588951|5796658|P3|STARTED|Overall Study||6
2361921|NCT01588951|5796659|P2|STARTED|Overall Study||2
2361922|NCT01588951|5796660|P1|STARTED|Overall Study||2
2361923|NCT01588821|5796668|P1|NOT COMPLETED|Overall Study||0
2361924|NCT01588821|5796668|P1|COMPLETED|Overall Study||37
2361925|NCT01588821|5796668|P1|STARTED|Overall Study||37
2361926|NCT01588561|5796673|P2|NOT COMPLETED|Overall Study||0
2361927|NCT01588561|5796674|P1|NOT COMPLETED|Overall Study||0
2361928|NCT01588561|5796673|P2|COMPLETED|Overall Study||1
2361929|NCT01588561|5796674|P1|COMPLETED|Overall Study||14
2361930|NCT01588561|5796673|P2|Second Injection (Visit 2)|Overall Study||1
2361931|NCT01588561|5796674|P1|Second Injection (Visit 2)|Overall Study||14
2361932|NCT01588561|5796673|P2|Rest Period|Overall Study||1
2361933|NCT01588561|5796674|P1|Rest Period|Overall Study||14
2361934|NCT01588561|5796673|P2|First Injection (Visit 1)|Overall Study||1
2361935|NCT01588561|5796674|P1|First Injection (Visit 1)|Overall Study||14
2361936|NCT01588561|5796673|P2|STARTED|Overall Study||1
2361937|NCT01588561|5796674|P1|STARTED|Overall Study||14
2361938|NCT01588548|5796691|P6|NOT COMPLETED|Overall Study||6
2361939|NCT01588548|5796692|P5|NOT COMPLETED|Overall Study||6
2361940|NCT01588548|5796693|P4|NOT COMPLETED|Overall Study||7
2361941|NCT01588548|5796694|P3|NOT COMPLETED|Overall Study||6
2361942|NCT01588548|5796695|P2|NOT COMPLETED|Overall Study||7
2361943|NCT01588548|5796696|P1|NOT COMPLETED|Overall Study||3
2361944|NCT01588548|5796691|P6|COMPLETED|Overall Study||0
2361945|NCT01588548|5796692|P5|COMPLETED|Overall Study||0
2361946|NCT01588548|5796693|P4|COMPLETED|Overall Study||0
2361947|NCT01588548|5796694|P3|COMPLETED|Overall Study||0
2361948|NCT01588548|5796695|P2|COMPLETED|Overall Study||0
2361949|NCT01588548|5796696|P1|COMPLETED|Overall Study||0
2361950|NCT01588548|5796691|P6|Cycle 1 Day 21|Overall Study||3
2361951|NCT01588548|5796692|P5|Cycle 1 Day 21|Overall Study||3
2361952|NCT01588548|5796693|P4|Cycle 1 Day 21|Overall Study||5
2361953|NCT01588548|5796694|P3|Cycle 1 Day 21|Overall Study||2
2361954|NCT01588548|5796695|P2|Cycle 1 Day 21|Overall Study||5
2361955|NCT01588548|5796696|P1|Cycle 1 Day 21|Overall Study||3
2361956|NCT01588548|5796691|P6|STARTED|Overall Study||6
2361957|NCT01588548|5796692|P5|STARTED|Overall Study||6
2361958|NCT01588548|5796693|P4|STARTED|Overall Study||7
2361959|NCT01588548|5796694|P3|STARTED|Overall Study||6
2361960|NCT01588548|5796695|P2|STARTED|Overall Study||7
2361961|NCT01588548|5796696|P1|STARTED|Overall Study||3
2361962|NCT01588509|5796712|P2|NOT COMPLETED|Overall Study||0
2361963|NCT01588509|5796713|P1|NOT COMPLETED|Overall Study||1
2361964|NCT01588509|5796712|P2|COMPLETED|Overall Study||30
2361965|NCT01588509|5796713|P1|COMPLETED|Overall Study||29
2361966|NCT01588509|5796712|P2|Received Treatment|Overall Study||30
2361967|NCT01588509|5796713|P1|Received Treatment|Overall Study||30
2361968|NCT01588509|5796712|P2|STARTED|Overall Study||30
2361969|NCT01588509|5796713|P1|STARTED|Overall Study||30
2361970|NCT01588496|5796736|P3|NOT COMPLETED|Overall Study||0
2361971|NCT01588496|5796737|P2|NOT COMPLETED|Overall Study||1
2361972|NCT01588496|5796738|P1|NOT COMPLETED|Overall Study||0
2361973|NCT01588496|5796736|P3|COMPLETED|Overall Study||33
2361974|NCT01588496|5796737|P2|COMPLETED|Overall Study||16
2361975|NCT01588496|5796738|P1|COMPLETED|Overall Study||8
2361976|NCT01588496|5796736|P3|Received Treatment|Overall Study||33
2361977|NCT01588496|5796737|P2|Received Treatment|Overall Study||16
2361978|NCT01588496|5796738|P1|Received Treatment|Overall Study||8
2361979|NCT01588496|5796736|P3|STARTED|Overall Study||33
2361980|NCT01588496|5796737|P2|STARTED|Overall Study||17
2361981|NCT01588496|5796738|P1|STARTED|Overall Study||8
2361982|NCT01588470|5796763|P1|NOT COMPLETED|Overall Study||80
2361983|NCT01588470|5796763|P1|COMPLETED|Overall Study|Completed Dec. 2011|50
2361984|NCT01588470|5796763|P1|STARTED|Overall Study|First enrolled April 2007|130
2361985|NCT01588444|5796774|P2|NOT COMPLETED|Overall Study||0
2361986|NCT01588444|5796775|P1|NOT COMPLETED|Overall Study||0
2361987|NCT01588444|5796774|P2|COMPLETED|Overall Study||20
2361988|NCT01588444|5796775|P1|COMPLETED|Overall Study||20
2361989|NCT01588444|5796774|P2|STARTED|Overall Study||20
2361990|NCT01588444|5796775|P1|STARTED|Overall Study||20
2361991|NCT01588418|5796781|P2|NOT COMPLETED|Overall Study||0
2361992|NCT01588418|5796782|P1|NOT COMPLETED|Overall Study||0
2361993|NCT01588418|5796781|P2|COMPLETED|Overall Study||4
2361994|NCT01588418|5796782|P1|COMPLETED|Overall Study||11
2361995|NCT01588418|5796781|P2|STARTED|Overall Study||4
2361996|NCT01588418|5796782|P1|STARTED|Overall Study||11
2361997|NCT01588405|5796788|P1|NOT COMPLETED|Overall Study||2
2361998|NCT01588405|5796788|P1|COMPLETED|Overall Study||31
2361999|NCT01588405|5796788|P1|STARTED|Overall Study||33
2362000|NCT01588366|5796817|P6|NOT COMPLETED|Overall Study||2
2362001|NCT01588366|5796818|P5|NOT COMPLETED|Overall Study||0
2362002|NCT01588366|5796819|P4|NOT COMPLETED|Overall Study||1
2362003|NCT01588366|5796820|P3|NOT COMPLETED|Overall Study||0
2362004|NCT01588366|5796821|P2|NOT COMPLETED|Overall Study||1
2362005|NCT01588366|5796822|P1|NOT COMPLETED|Overall Study||0
2362006|NCT01588366|5796817|P6|COMPLETED|Overall Study||7
2362007|NCT01588366|5796818|P5|COMPLETED|Overall Study||3
2362008|NCT01588366|5796819|P4|COMPLETED|Overall Study||6
2362009|NCT01588366|5796820|P3|COMPLETED|Overall Study||2
2362010|NCT01588366|5796821|P2|COMPLETED|Overall Study||6
2362011|NCT01588366|5796822|P1|COMPLETED|Overall Study||2
2362012|NCT01588366|5796817|P6|Received at Least One Dose of Study Drug|Overall Study||9
2362013|NCT01588366|5796818|P5|Received at Least One Dose of Study Drug|Overall Study||3
2362014|NCT01588366|5796819|P4|Received at Least One Dose of Study Drug|Overall Study||7
2362015|NCT01588366|5796820|P3|Received at Least One Dose of Study Drug|Overall Study||2
2362016|NCT01588366|5796821|P2|Received at Least One Dose of Study Drug|Overall Study||7
2362017|NCT01588366|5796822|P1|Received at Least One Dose of Study Drug|Overall Study||2
2362018|NCT01588366|5796817|P6|STARTED|Overall Study||9
2362019|NCT01588366|5796818|P5|STARTED|Overall Study||3
2362020|NCT01588366|5796819|P4|STARTED|Overall Study||7
2362021|NCT01588366|5796820|P3|STARTED|Overall Study||2
2362022|NCT01588366|5796821|P2|STARTED|Overall Study||7
2362023|NCT01588366|5796822|P1|STARTED|Overall Study||2
2362024|NCT01588353|5796850|P3|NOT COMPLETED|Step3||2
2362025|NCT01588353|5796851|P2|NOT COMPLETED|Step3||0
2362026|NCT01588353|5796852|P1|NOT COMPLETED|Step3||0
2362027|NCT01588353|5796850|P3|COMPLETED|Step3||23
2362028|NCT01588353|5796851|P2|COMPLETED|Step3||0
2362029|NCT01588353|5796852|P1|COMPLETED|Step3||0
2362030|NCT01588353|5796850|P3|STARTED|Step3||25
2362031|NCT01588353|5796851|P2|STARTED|Step3||0
2362032|NCT01588353|5796852|P1|STARTED|Step3||0
2362033|NCT01588353|5796850|P3|NOT COMPLETED|Step2||0
2362034|NCT01588353|5796851|P2|NOT COMPLETED|Step2||1
2362035|NCT01588353|5796852|P1|NOT COMPLETED|Step2||0
2362036|NCT01588353|5796850|P3|COMPLETED|Step2||0
2362037|NCT01588353|5796851|P2|COMPLETED|Step2||70
2362038|NCT01588353|5796852|P1|COMPLETED|Step2||0
2362039|NCT01588353|5796850|P3|STARTED|Step2||0
2362040|NCT01588353|5796851|P2|STARTED|Step2||71
2362041|NCT01588353|5796852|P1|STARTED|Step2||0
2362042|NCT01588353|5796850|P3|NOT COMPLETED|Step1||0
2362043|NCT01588353|5796851|P2|NOT COMPLETED|Step1||0
2362044|NCT01588353|5796852|P1|NOT COMPLETED|Step1||0
2362045|NCT01588353|5796850|P3|COMPLETED|Step1||0
2362046|NCT01588353|5796851|P2|COMPLETED|Step1||0
2362047|NCT01588353|5796852|P1|COMPLETED|Step1||6
2362048|NCT01588353|5796850|P3|STARTED|Step1||0
2362049|NCT01588353|5796851|P2|STARTED|Step1||0
2362050|NCT01588353|5796852|P1|STARTED|Step1||6
2362051|NCT01588236|5796871|P3|NOT COMPLETED|Overall Study||25
2362052|NCT01588236|5796872|P2|NOT COMPLETED|Overall Study||28
2362053|NCT01588236|5796873|P1|NOT COMPLETED|Overall Study||16
2362054|NCT01588236|5796871|P3|COMPLETED|Overall Study||69
2362055|NCT01588236|5796872|P2|COMPLETED|Overall Study||66
2362056|NCT01588236|5796873|P1|COMPLETED|Overall Study||76
2362057|NCT01588236|5796871|P3|STARTED|Overall Study||94
2362058|NCT01588236|5796872|P2|STARTED|Overall Study||94
2362059|NCT01588236|5796873|P1|STARTED|Overall Study||92
2362060|NCT01588197|5796901|P2|NOT COMPLETED|Overall Study||1
2362061|NCT01588197|5796902|P1|NOT COMPLETED|Overall Study||1
2362062|NCT01588197|5796901|P2|COMPLETED|Overall Study||9
2362063|NCT01588197|5796902|P1|COMPLETED|Overall Study||9
2362064|NCT01588197|5796901|P2|STARTED|Overall Study||10
2362065|NCT01588197|5796902|P1|STARTED|Overall Study||10
2362066|NCT01588158|5796914|P2|NOT COMPLETED|Overall Study||0
2362067|NCT01588158|5796915|P1|NOT COMPLETED|Overall Study||0
2362068|NCT01588158|5796914|P2|COMPLETED|Overall Study||3
2362069|NCT01588158|5796915|P1|COMPLETED|Overall Study||4
2362070|NCT01588158|5796914|P2|STARTED|Overall Study||3
2362071|NCT01588158|5796915|P1|STARTED|Overall Study||4
2362072|NCT01588106|5796939|P2|NOT COMPLETED|Overall Study||4
2362073|NCT01588106|5796940|P1|NOT COMPLETED|Overall Study||5
2362074|NCT01588106|5796939|P2|COMPLETED|Overall Study||72
2362075|NCT01588106|5796940|P1|COMPLETED|Overall Study||73
2362076|NCT01588106|5796939|P2|STARTED|Overall Study||76
2362077|NCT01588106|5796940|P1|STARTED|Overall Study||78
2362078|NCT01587989|5796948|P3|NOT COMPLETED|Randomized Study Treatment||1
2362079|NCT01587989|5796949|P2|NOT COMPLETED|Randomized Study Treatment||2
2362080|NCT01587989|5796950|P1|NOT COMPLETED|Randomized Study Treatment||0
2362081|NCT01587989|5796948|P3|COMPLETED|Randomized Study Treatment||32
2362082|NCT01587989|5796949|P2|COMPLETED|Randomized Study Treatment||30
2362083|NCT01587989|5796950|P1|COMPLETED|Randomized Study Treatment||0
2362084|NCT01587989|5796948|P3|STARTED|Randomized Study Treatment||33
2362085|NCT01587989|5796949|P2|STARTED|Randomized Study Treatment||32
2362086|NCT01587989|5796950|P1|STARTED|Randomized Study Treatment||0
2362087|NCT01587989|5796948|P3|NOT COMPLETED|12-Week Open-Label Run-In Period||0
2362088|NCT01587989|5796949|P2|NOT COMPLETED|12-Week Open-Label Run-In Period||0
2362089|NCT01587989|5796950|P1|NOT COMPLETED|12-Week Open-Label Run-In Period||12
2362090|NCT01587989|5796948|P3|COMPLETED|12-Week Open-Label Run-In Period||0
2362091|NCT01587989|5796949|P2|COMPLETED|12-Week Open-Label Run-In Period||0
2362092|NCT01587989|5796950|P1|COMPLETED|12-Week Open-Label Run-In Period||65
2362093|NCT01587989|5796948|P3|STARTED|12-Week Open-Label Run-In Period||0
2362094|NCT01587989|5796949|P2|STARTED|12-Week Open-Label Run-In Period||0
2362095|NCT01587989|5796950|P1|STARTED|12-Week Open-Label Run-In Period||77
2362096|NCT01587963|5796974|P2|NOT COMPLETED|Overall Study||0
2362097|NCT01587963|5796975|P1|NOT COMPLETED|Overall Study||1
2362098|NCT01587963|5796974|P2|COMPLETED|Overall Study||4
2362099|NCT01587963|5796975|P1|COMPLETED|Overall Study||6
2362100|NCT01587963|5796974|P2|STARTED|Overall Study||4
2362101|NCT01587963|5796975|P1|STARTED|Overall Study||7
2362102|NCT01587950|5796981|P1|NOT COMPLETED|Period 3||0
2362103|NCT01587950|5796981|P1|COMPLETED|Period 3||12
2362104|NCT01587950|5796981|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 3||5
2362105|NCT01587950|5796981|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 3||3
2362106|NCT01587950|5796981|P1|Received 5% KNO3 Solution (2 Minutes)|Period 3||3
2362107|NCT01587950|5796981|P1|Received 5% KNO3 Solution (5 Minutes)|Period 3||5
2362108|NCT01587950|5796981|P1|Received Sterile Water (5 Minutes)|Period 3||5
2362109|NCT01587950|5796981|P1|Received 5% KNO3 Solution (10 Minutes)|Period 3||4
2362110|NCT01587950|5796981|P1|Received Sterile Water (2 Minutes)|Period 3||2
2362111|NCT01587950|5796981|P1|Received Sterile Water (10 Minutes)|Period 3||5
2362112|NCT01587950|5796981|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 3||4
2362113|NCT01587950|5796981|P1|STARTED|Period 3||12
2362114|NCT01587950|5796981|P1|NOT COMPLETED|Washout 2||0
2362115|NCT01587950|5796981|P1|COMPLETED|Washout 2||12
2362116|NCT01587950|5796981|P1|STARTED|Washout 2||12
2362117|NCT01587950|5796981|P1|NOT COMPLETED|Period 2||0
2362118|NCT01587950|5796981|P1|COMPLETED|Period 2||12
2362119|NCT01587950|5796981|P1|Received 5% KNO3 Solution (5 Minutes)|Period 2||2
2362120|NCT01587950|5796981|P1|Received Sterile Water (10 Minutes)|Period 2||2
2362121|NCT01587950|5796981|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 2||4
2362122|NCT01587950|5796981|P1|Received Sterile Water (5 Minutes)|Period 2||2
2362123|NCT01587950|5796981|P1|Received 5% KNO3 Solution (2 Minutes)|Period 2||6
2362124|NCT01587950|5796981|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 2||6
2362125|NCT01587950|5796981|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 2||2
2362126|NCT01587950|5796981|P1|Received 5% KNO3 Solution (10 Minutes)|Period 2||4
2362127|NCT01587950|5796981|P1|Received Sterile Water (2 Minutes)|Period 2||8
2362128|NCT01587950|5796981|P1|STARTED|Period 2||12
2362129|NCT01587950|5796981|P1|NOT COMPLETED|Washout 1||0
2362130|NCT01587950|5796981|P1|COMPLETED|Washout 1||12
2362131|NCT01587950|5796981|P1|STARTED|Washout 1||12
2362132|NCT01587950|5796981|P1|NOT COMPLETED|Period 1||0
2362133|NCT01587950|5796981|P1|COMPLETED|Period 1||12
2362134|NCT01587950|5796981|P1|Received Sterile Water (5 Minutes)|Period 1||5
2362135|NCT01587950|5796981|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 1||5
2362136|NCT01587950|5796981|P1|Received Sterile Water (10 Minutes)|Period 1||5
2362137|NCT01587950|5796981|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 1||3
2362138|NCT01587950|5796981|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 1||4
2362139|NCT01587950|5796981|P1|Received 5% KNO3 Solution (10 Minutes)|Period 1||4
2362140|NCT01587950|5796981|P1|Received Sterile Water (2 Minutes)|Period 1||2
2362141|NCT01587950|5796981|P1|Received 5% KNO3 Solution (2 Minutes)|Period 1||3
2362142|NCT01587950|5796981|P1|Received 5% KNO3 Solution (5 Minutes)|Period 1||5
2362143|NCT01587950|5796981|P1|STARTED|Period 1||12
2362144|NCT01587924|5797015|P4|NOT COMPLETED|Overall Study||1
2362145|NCT01587924|5797016|P3|NOT COMPLETED|Overall Study||4
2362146|NCT01587924|5797017|P2|NOT COMPLETED|Overall Study||4
2362147|NCT01587924|5797018|P1|NOT COMPLETED|Overall Study||4
2362148|NCT01587924|5797015|P4|COMPLETED|Overall Study||19
2362149|NCT01587924|5797016|P3|COMPLETED|Overall Study||17
2362150|NCT01587924|5797017|P2|COMPLETED|Overall Study||17
2362151|NCT01587924|5797018|P1|COMPLETED|Overall Study||17
2362152|NCT01587924|5797015|P4|STARTED|Overall Study||20
2362153|NCT01587924|5797016|P3|STARTED|Overall Study||21
2362154|NCT01587924|5797017|P2|STARTED|Overall Study||21
2362155|NCT01587924|5797018|P1|STARTED|Overall Study||21
2362156|NCT01587898|5797119|P4|NOT COMPLETED|Overall Study||2
2362157|NCT01587898|5797120|P3|NOT COMPLETED|Overall Study||2
2362158|NCT01587898|5797121|P2|NOT COMPLETED|Overall Study||5
2362159|NCT01587898|5797122|P1|NOT COMPLETED|Overall Study||4
2362160|NCT01587898|5797119|P4|COMPLETED|Overall Study||17
2362161|NCT01587898|5797120|P3|COMPLETED|Overall Study||16
2362162|NCT01587898|5797121|P2|COMPLETED|Overall Study||12
2362163|NCT01587898|5797122|P1|COMPLETED|Overall Study||14
2362164|NCT01587898|5797119|P4|STARTED|Overall Study||19
2362165|NCT01587898|5797120|P3|STARTED|Overall Study||18
2362166|NCT01587898|5797121|P2|STARTED|Overall Study||17
2362167|NCT01587898|5797122|P1|STARTED|Overall Study||18
2362168|NCT01587885|5797298|P2|NOT COMPLETED|Treatment Period 2||0
2362169|NCT01587885|5797299|P1|NOT COMPLETED|Treatment Period 2||0
2362170|NCT01587885|5797298|P2|COMPLETED|Treatment Period 2||19
2362171|NCT01587885|5797299|P1|COMPLETED|Treatment Period 2||26
2362172|NCT01587885|5797298|P2|STARTED|Treatment Period 2||19
2362173|NCT01587885|5797299|P1|STARTED|Treatment Period 2||26
2362174|NCT01587885|5797298|P2|NOT COMPLETED|Treatment Period 1||3
2362175|NCT01587885|5797299|P1|NOT COMPLETED|Treatment Period 1||0
2362176|NCT01587885|5797298|P2|COMPLETED|Treatment Period 1||19
2362177|NCT01587885|5797299|P1|COMPLETED|Treatment Period 1||26
2362178|NCT01587885|5797298|P2|STARTED|Treatment Period 1||22
2362179|NCT01587885|5797299|P1|STARTED|Treatment Period 1||26
2362180|NCT01587651|5797315|P3|NOT COMPLETED|Overall Study||1
2362181|NCT01587651|5797316|P2|NOT COMPLETED|Overall Study||3
2362182|NCT01587651|5797317|P1|NOT COMPLETED|Overall Study||0
2362183|NCT01587651|5797315|P3|COMPLETED|Overall Study||34
2362184|NCT01587651|5797316|P2|COMPLETED|Overall Study||38
2362185|NCT01587651|5797317|P1|COMPLETED|Overall Study||34
2362186|NCT01587651|5797315|P3|STARTED|Overall Study||35
2362187|NCT01587651|5797316|P2|STARTED|Overall Study||41
2362188|NCT01587651|5797317|P1|STARTED|Overall Study||34
2362189|NCT01587274|5797347|P3|NOT COMPLETED|Overall Study||3
2362190|NCT01587274|5797348|P2|NOT COMPLETED|Overall Study||5
2362191|NCT01587274|5797349|P1|NOT COMPLETED|Overall Study||4
2362192|NCT01587274|5797347|P3|COMPLETED|Overall Study||104
2362193|NCT01587274|5797348|P2|COMPLETED|Overall Study||103
2362194|NCT01587274|5797349|P1|COMPLETED|Overall Study||104
2362195|NCT01587274|5797347|P3|STARTED|Overall Study||107
2362196|NCT01587274|5797348|P2|STARTED|Overall Study||108
2362197|NCT01587274|5797349|P1|STARTED|Overall Study||108
2362198|NCT01587118|5797357|P1|NOT COMPLETED|Overall Study||7
2362199|NCT01587118|5797357|P1|COMPLETED|Overall Study||11
2362200|NCT01587118|5797357|P1|STARTED|Overall Study|31 signed consent and 18 were deemed eligible and initiated treatment with adjunctive asenapine.|18
2362201|NCT01587105|5797364|P2|NOT COMPLETED|Overall Study||43
2362202|NCT01587105|5797365|P1|NOT COMPLETED|Overall Study||6
2362203|NCT01587105|5797364|P2|COMPLETED|Overall Study||138
2362204|NCT01587105|5797365|P1|COMPLETED|Overall Study||144
2362205|NCT01587105|5797364|P2|STARTED|Overall Study||181
2362206|NCT01587105|5797365|P1|STARTED|Overall Study||150
2362207|NCT01587079|5797381|P1|NOT COMPLETED|Overall Study||39
2362208|NCT01587079|5797381|P1|COMPLETED|Overall Study||120
2362209|NCT01587079|5797381|P1|STARTED|Overall Study||159
2362210|NCT01587040|5797507|P4|NOT COMPLETED|Overall Study||4
2362211|NCT01587040|5797508|P3|NOT COMPLETED|Overall Study||37
2362212|NCT01587040|5797509|P2|NOT COMPLETED|Overall Study||3
2362213|NCT01587040|5797510|P1|NOT COMPLETED|Overall Study||17
2362214|NCT01587040|5797507|P4|COMPLETED|Overall Study||0
2362215|NCT01587040|5797508|P3|COMPLETED|Overall Study||0
2362216|NCT01587040|5797509|P2|COMPLETED|Overall Study||0
2362217|NCT01587040|5797510|P1|COMPLETED|Overall Study||0
2362218|NCT01587040|5797507|P4|STARTED|Overall Study||4
2362219|NCT01587040|5797508|P3|STARTED|Overall Study||37
2362220|NCT01587040|5797509|P2|STARTED|Overall Study||3
2362221|NCT01587040|5797510|P1|STARTED|Overall Study||17
2362222|NCT01587027|5797530|P2|NOT COMPLETED|Discharge (1 Day)||0
2362223|NCT01587027|5797531|P1|NOT COMPLETED|Discharge (1 Day)||0
2362224|NCT01587027|5797530|P2|COMPLETED|Discharge (1 Day)||8
2362225|NCT01587027|5797531|P1|COMPLETED|Discharge (1 Day)||8
2362226|NCT01587027|5797530|P2|STARTED|Discharge (1 Day)||8
2362227|NCT01587027|5797531|P1|STARTED|Discharge (1 Day)||8
2362228|NCT01587027|5797530|P2|NOT COMPLETED|Third Intervention (1 Day)||0
2362229|NCT01587027|5797531|P1|NOT COMPLETED|Third Intervention (1 Day)||0
2362230|NCT01587027|5797530|P2|COMPLETED|Third Intervention (1 Day)||8
2362231|NCT01587027|5797531|P1|COMPLETED|Third Intervention (1 Day)||8
2362232|NCT01587027|5797530|P2|STARTED|Third Intervention (1 Day)||8
2362233|NCT01587027|5797531|P1|STARTED|Third Intervention (1 Day)||8
2362234|NCT01587027|5797530|P2|NOT COMPLETED|Washout (1 Day)||0
2362235|NCT01587027|5797531|P1|NOT COMPLETED|Washout (1 Day)||0
2362236|NCT01587027|5797530|P2|COMPLETED|Washout (1 Day)||8
2362237|NCT01587027|5797531|P1|COMPLETED|Washout (1 Day)||8
2362238|NCT01587027|5797530|P2|STARTED|Washout (1 Day)||8
2362239|NCT01587027|5797531|P1|STARTED|Washout (1 Day)||8
2362240|NCT01587027|5797530|P2|NOT COMPLETED|Second Intervention (1 Day)||0
2362241|NCT01587027|5797531|P1|NOT COMPLETED|Second Intervention (1 Day)||0
2362242|NCT01587027|5797530|P2|COMPLETED|Second Intervention (1 Day)||8
2362243|NCT01587027|5797531|P1|COMPLETED|Second Intervention (1 Day)||8
2362244|NCT01587027|5797530|P2|STARTED|Second Intervention (1 Day)||8
2362245|NCT01587027|5797531|P1|STARTED|Second Intervention (1 Day)||8
2362246|NCT01587027|5797530|P2|NOT COMPLETED|Washout (1 Day)||0
2362247|NCT01587027|5797531|P1|NOT COMPLETED|Washout (1 Day)||0
2362248|NCT01587027|5797530|P2|COMPLETED|Washout (1 Day)||8
2362249|NCT01587027|5797531|P1|COMPLETED|Washout (1 Day)||8
2362250|NCT01587027|5797530|P2|STARTED|Washout (1 Day)||8
2362251|NCT01587027|5797531|P1|STARTED|Washout (1 Day)||8
2362252|NCT01587027|5797530|P2|NOT COMPLETED|First Intervention (1 Day)||0
2362253|NCT01587027|5797531|P1|NOT COMPLETED|First Intervention (1 Day)||0
2362254|NCT01587027|5797530|P2|COMPLETED|First Intervention (1 Day)||8
2362255|NCT01587027|5797531|P1|COMPLETED|First Intervention (1 Day)||8
2362256|NCT01587027|5797530|P2|STARTED|First Intervention (1 Day)||8
2362257|NCT01587027|5797531|P1|STARTED|First Intervention (1 Day)||8
2362258|NCT01587014|5797537|P1|NOT COMPLETED|Overall Study||2
2362259|NCT01587014|5797537|P1|COMPLETED|Overall Study||24
2362260|NCT01587014|5797537|P1|STARTED|Overall Study||26
2362261|NCT01587001|5797544|P2|NOT COMPLETED|Overall Study||1
2362262|NCT01587001|5797545|P1|NOT COMPLETED|Overall Study||6
2362263|NCT01587001|5797544|P2|COMPLETED|Overall Study||2
2362264|NCT01587001|5797545|P1|COMPLETED|Overall Study||8
2362265|NCT01587001|5797544|P2|STARTED|Overall Study||3
2362266|NCT01587001|5797545|P1|STARTED|Overall Study||14
2362267|NCT01586975|5797556|P3|NOT COMPLETED|Overall Study||0
2362268|NCT01586975|5797557|P2|NOT COMPLETED|Overall Study||0
2362269|NCT01586975|5797558|P1|NOT COMPLETED|Overall Study||0
2362270|NCT01586975|5797556|P3|COMPLETED|Overall Study||46
2362271|NCT01586975|5797557|P2|COMPLETED|Overall Study||32
2362272|NCT01586975|5797558|P1|COMPLETED|Overall Study||15
2362273|NCT01586975|5797556|P3|STARTED|Overall Study||46
2362274|NCT01586975|5797557|P2|STARTED|Overall Study||32
2362275|NCT01586975|5797558|P1|STARTED|Overall Study||15
2362276|NCT01586962|5797566|P1|NOT COMPLETED|Overall Study||0
2362277|NCT01586962|5797566|P1|COMPLETED|Overall Study||56
2362278|NCT01586962|5797566|P1|STARTED|Overall Study||56
2362279|NCT01586910|5797574|P2|NOT COMPLETED|Overall Study||71
2362280|NCT01586910|5797575|P1|NOT COMPLETED|Overall Study||15
2362281|NCT01586910|5797574|P2|COMPLETED|Overall Study||796
2362282|NCT01586910|5797575|P1|COMPLETED|Overall Study||864
2362283|NCT01586910|5797574|P2|STARTED|Overall Study||867
2362284|NCT01586910|5797575|P1|STARTED|Overall Study||879
2362285|NCT01586897|5797630|P2|NOT COMPLETED|Overall Study||0
2362286|NCT01586897|5797631|P1|NOT COMPLETED|Overall Study||0
2362287|NCT01586897|5797630|P2|COMPLETED|Overall Study||26
2362288|NCT01586897|5797631|P1|COMPLETED|Overall Study||26
2362289|NCT01586897|5797630|P2|STARTED|Overall Study||26
2362290|NCT01586897|5797631|P1|STARTED|Overall Study||26
2362291|NCT01586819|5797649|P2|NOT COMPLETED|Overall Study||0
2362292|NCT01586819|5797650|P1|NOT COMPLETED|Overall Study||1
2362293|NCT01586819|5797649|P2|COMPLETED|Overall Study||14
2362294|NCT01586819|5797650|P1|COMPLETED|Overall Study||11
2362295|NCT01586819|5797649|P2|STARTED|Overall Study||14
2362296|NCT01586819|5797650|P1|STARTED|Overall Study||12
2362297|NCT01586806|5797661|P3|NOT COMPLETED|Overall Study||2
2362298|NCT01586806|5797662|P2|NOT COMPLETED|Overall Study||4
2362299|NCT01586806|5797663|P1|NOT COMPLETED|Overall Study||3
2362300|NCT01586806|5797661|P3|COMPLETED|Overall Study||63
2362301|NCT01586806|5797662|P2|COMPLETED|Overall Study||61
2362302|NCT01586806|5797663|P1|COMPLETED|Overall Study||62
2362303|NCT01586806|5797661|P3|STARTED|Overall Study||65
2362304|NCT01586806|5797662|P2|STARTED|Overall Study||65
2362305|NCT01586806|5797663|P1|STARTED|Overall Study||65
2362306|NCT01586364|5797683|P1|NOT COMPLETED|Overall Study||117
2362307|NCT01586364|5797683|P1|COMPLETED|Overall Study||184
2362308|NCT01586364|5797683|P1|STARTED|Overall Study||301
2362309|NCT01586338|5797736|P1|NOT COMPLETED|Overall Study||8
2362310|NCT01586338|5797736|P1|COMPLETED|Overall Study||229
2362311|NCT01586338|5797736|P1|STARTED|Overall Study||237
2362312|NCT01586312|5797748|P2|NOT COMPLETED|Overall Study||0
2362313|NCT01586312|5797749|P1|NOT COMPLETED|Overall Study||0
2362314|NCT01586312|5797748|P2|COMPLETED|Overall Study||15
2362315|NCT01586312|5797749|P1|COMPLETED|Overall Study||15
2362316|NCT01586312|5797748|P2|STARTED|Overall Study||15
2362317|NCT01586312|5797749|P1|STARTED|Overall Study||15
2362318|NCT01586195|5797759|P1|NOT COMPLETED|Overall Study||26
2362319|NCT01586195|5797759|P1|COMPLETED|Overall Study||5
2362320|NCT01586195|5797759|P1|STARTED|Overall Study||31
2362321|NCT01586156|5797773|P3|NOT COMPLETED|Overall Study||0
2362322|NCT01586156|5797774|P2|NOT COMPLETED|Overall Study||1
2362323|NCT01586156|5797775|P1|NOT COMPLETED|Overall Study||0
2362324|NCT01586156|5797773|P3|COMPLETED|Overall Study||10
2362325|NCT01586156|5797774|P2|COMPLETED|Overall Study||9
2362326|NCT01586156|5797775|P1|COMPLETED|Overall Study||10
2362327|NCT01586156|5797773|P3|STARTED|Overall Study||10
2362328|NCT01586156|5797774|P2|STARTED|Overall Study||10
2362329|NCT01586156|5797775|P1|STARTED|Overall Study||10
2362330|NCT01586091|5797804|P3|NOT COMPLETED|Overall Study||0
2362331|NCT01586091|5797805|P2|NOT COMPLETED|Overall Study||0
2362332|NCT01586091|5797806|P1|NOT COMPLETED|Overall Study||0
2362333|NCT01586091|5797804|P3|COMPLETED|Overall Study||6
2362334|NCT01586091|5797805|P2|COMPLETED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
2362335|NCT01586091|5797806|P1|COMPLETED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
2362336|NCT01586091|5797804|P3|STARTED|Overall Study||6
2362337|NCT01586091|5797805|P2|STARTED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
2362338|NCT01586091|5797806|P1|STARTED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
2362339|NCT01586026|5797820|P3|NOT COMPLETED|Overall Study||0
2362340|NCT01586026|5797821|P2|NOT COMPLETED|Overall Study||0
2362341|NCT01586026|5797822|P1|NOT COMPLETED|Overall Study||0
2362342|NCT01586026|5797820|P3|COMPLETED|Overall Study||271
2362343|NCT01586026|5797821|P2|COMPLETED|Overall Study||414
2362344|NCT01586026|5797822|P1|COMPLETED|Overall Study||350
2362345|NCT01586026|5797820|P3|STARTED|Overall Study||271
2362346|NCT01586026|5797821|P2|STARTED|Overall Study||414
2362347|NCT01586026|5797822|P1|STARTED|Overall Study||350
2362348|NCT01585987|5797832|P2|NOT COMPLETED|Treated||49
2362349|NCT01585987|5797833|P1|NOT COMPLETED|Treated||54
2362350|NCT01585987|5797832|P2|COMPLETED|Treated||2
2362351|NCT01585987|5797833|P1|COMPLETED|Treated||3
2362352|NCT01585987|5797832|P2|STARTED|Treated||51
2362353|NCT01585987|5797833|P1|STARTED|Treated||57
2362354|NCT01585987|5797832|P2|NOT COMPLETED|Randomized||6
2362355|NCT01585987|5797833|P1|NOT COMPLETED|Randomized||0
2362356|NCT01585987|5797832|P2|COMPLETED|Randomized||51
2362357|NCT01585987|5797833|P1|COMPLETED|Randomized||57
2362358|NCT01585987|5797832|P2|STARTED|Randomized||57
2362359|NCT01585987|5797833|P1|STARTED|Randomized||57
2362360|NCT01585961|5797848|P1|NOT COMPLETED|Overall Study||33
2362361|NCT01585961|5797848|P1|COMPLETED|Overall Study||478
2362362|NCT01585961|5797848|P1|Safety|Overall Study|Patients ablated with study catheter|508
2362363|NCT01585961|5797848|P1|STARTED|Overall Study||511
2362364|NCT01585779|5797865|P2|NOT COMPLETED|Overall Study||7
2362365|NCT01585779|5797866|P1|NOT COMPLETED|Overall Study||10
2362366|NCT01585779|5797865|P2|COMPLETED|Overall Study||21
2362367|NCT01585779|5797866|P1|COMPLETED|Overall Study||26
2362368|NCT01585779|5797865|P2|STARTED|Overall Study||28
2362369|NCT01585779|5797866|P1|STARTED|Overall Study||36
2362370|NCT01585766|5797926|P6|NOT COMPLETED|Overall Study||0
2362371|NCT01585766|5797927|P5|NOT COMPLETED|Overall Study||0
2362372|NCT01585766|5797928|P4|NOT COMPLETED|Overall Study||0
2362373|NCT01585766|5797929|P3|NOT COMPLETED|Overall Study||2
2362374|NCT01585766|5797930|P2|NOT COMPLETED|Overall Study||2
2362375|NCT01585766|5797931|P1|NOT COMPLETED|Overall Study||0
2362376|NCT01585766|5797926|P6|COMPLETED|Overall Study||6
2362377|NCT01585766|5797927|P5|COMPLETED|Overall Study||3
2362378|NCT01585766|5797928|P4|COMPLETED|Overall Study||4
2362379|NCT01585766|5797929|P3|COMPLETED|Overall Study||1
2362380|NCT01585766|5797930|P2|COMPLETED|Overall Study||3
2362381|NCT01585766|5797931|P1|COMPLETED|Overall Study||7
2362382|NCT01585766|5797926|P6|STARTED|Overall Study||6
2362383|NCT01585766|5797927|P5|STARTED|Overall Study||3
2362384|NCT01585766|5797928|P4|STARTED|Overall Study||4
2362385|NCT01585766|5797929|P3|STARTED|Overall Study||3
2362386|NCT01585766|5797930|P2|STARTED|Overall Study||5
2362387|NCT01585766|5797931|P1|STARTED|Overall Study||7
2362388|NCT01585597|5798030|P1|NOT COMPLETED|Overall Study||0
2362389|NCT01585597|5798030|P1|COMPLETED|Overall Study||20
2362390|NCT01585597|5798030|P1|STARTED|Overall Study||20
2362391|NCT01585584|5798035|P1|NOT COMPLETED|Overall Study||4
2362392|NCT01585584|5798035|P1|COMPLETED|Overall Study||6
2362393|NCT01585584|5798035|P1|STARTED|Overall Study||10
2362394|NCT01585558|5798042|P3|NOT COMPLETED|Overall Study||15
2362395|NCT01585558|5798043|P2|NOT COMPLETED|Overall Study||12
2362396|NCT01585558|5798044|P1|NOT COMPLETED|Overall Study||13
2362397|NCT01585558|5798042|P3|COMPLETED|Overall Study||34
2362398|NCT01585558|5798043|P2|COMPLETED|Overall Study||57
2362399|NCT01585558|5798044|P1|COMPLETED|Overall Study||49
2362400|NCT01585558|5798042|P3|STARTED|Overall Study||49
2362401|NCT01585558|5798043|P2|STARTED|Overall Study||69
2362402|NCT01585558|5798044|P1|STARTED|Overall Study||62
2362403|NCT01585441|5798225|P2|NOT COMPLETED|Overall Study||0
2362404|NCT01585441|5798226|P1|NOT COMPLETED|Overall Study||0
2362405|NCT01585441|5798225|P2|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
2362406|NCT01585441|5798226|P1|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
2362407|NCT01585441|5798225|P2|Final Study Safety Visit|Overall Study|A final study visit was not required for the placebo participant who completed the study at Month 3.|2
2362408|NCT01585441|5798226|P1|Final Study Safety Visit|Overall Study||3
2362409|NCT01585441|5798225|P2|Received Finasteride at Month 3|Overall Study||2
2362410|NCT01585441|5798226|P1|Received Finasteride at Month 3|Overall Study||2
2362411|NCT01585441|5798225|P2|Month 3|Overall Study||3
2362412|NCT01585441|5798226|P1|Month 3|Overall Study|One participant was not evaluated at Month 3 but at the final visit due to study terminating early.|2
2362413|NCT01585441|5798225|P2|STARTED|Overall Study||3
2362414|NCT01585441|5798226|P1|STARTED|Overall Study||3
2362415|NCT01585428|5798278|P2|NOT COMPLETED|Overall Study||0
2362416|NCT01585428|5798279|P1|NOT COMPLETED|Overall Study||1
2362417|NCT01585428|5798278|P2|COMPLETED|Overall Study||11
2362418|NCT01585428|5798279|P1|COMPLETED|Overall Study||17
2362419|NCT01585428|5798278|P2|STARTED|Overall Study||11
2362420|NCT01585428|5798279|P1|STARTED|Overall Study||18
2362421|NCT01585324|5798287|P1|NOT COMPLETED|Overall Study||0
2362422|NCT01585324|5798287|P1|COMPLETED|Overall Study||30
2362423|NCT01585324|5798287|P1|STARTED|Overall Study||30
2362424|NCT01585298|5798303|P1|NOT COMPLETED|Overall Study||37
2362425|NCT01585298|5798303|P1|COMPLETED|Overall Study||6961
2362426|NCT01585298|5798303|P1|STARTED|Overall Study||6998
2362427|NCT01585272|5798311|P1|NOT COMPLETED|Overall Study||39
2362428|NCT01585272|5798311|P1|COMPLETED|Overall Study||82
2362429|NCT01585272|5798311|P1|Exelon Patch 10 cm2|Overall Study||96
2362430|NCT01585272|5798311|P1|Exelon Patch 5 cm2|Overall Study||114
2362431|NCT01585272|5798311|P1|Safety Set|Overall Study|Subjects received 3 mg bid Exelon caps for more than 4 weeks & used at least 1 dose of Exelon patch.|102
2362432|NCT01585272|5798311|P1|STARTED|Overall Study||121
2362433|NCT01585246|5798324|P5|NOT COMPLETED|Overall Study||2
2362434|NCT01585246|5798325|P4|NOT COMPLETED|Overall Study||4
2362435|NCT01585246|5798326|P3|NOT COMPLETED|Overall Study||4
2362436|NCT01585246|5798327|P2|NOT COMPLETED|Overall Study||1
2362437|NCT01585246|5798328|P1|NOT COMPLETED|Overall Study||0
2362438|NCT01585246|5798324|P5|COMPLETED|Overall Study||9
2362439|NCT01585246|5798325|P4|COMPLETED|Overall Study||6
2362440|NCT01585246|5798326|P3|COMPLETED|Overall Study||16
2362441|NCT01585246|5798327|P2|COMPLETED|Overall Study||3
2362442|NCT01585246|5798328|P1|COMPLETED|Overall Study||3
2362443|NCT01585246|5798324|P5|STARTED|Overall Study||11
2362444|NCT01585246|5798325|P4|STARTED|Overall Study||10
2362445|NCT01585246|5798326|P3|STARTED|Overall Study||20
2362446|NCT01585246|5798327|P2|STARTED|Overall Study||4
2362447|NCT01585246|5798328|P1|STARTED|Overall Study||3
2362448|NCT01585207|5798343|P1|NOT COMPLETED|Overall Study||0
2362449|NCT01585207|5798343|P1|COMPLETED|Overall Study||4
2362450|NCT01585207|5798343|P1|STARTED|Overall Study||4
2362451|NCT01585168|5798349|P4|NOT COMPLETED|Overall Study||1
2362452|NCT01585168|5798350|P3|NOT COMPLETED|Overall Study||1
2362453|NCT01585168|5798351|P2|NOT COMPLETED|Overall Study||1
2362454|NCT01585168|5798352|P1|NOT COMPLETED|Overall Study||3
2362455|NCT01585168|5798349|P4|COMPLETED|Overall Study||18
2362456|NCT01585168|5798350|P3|COMPLETED|Overall Study||15
2362457|NCT01585168|5798351|P2|COMPLETED|Overall Study||17
2362458|NCT01585168|5798352|P1|COMPLETED|Overall Study||15
2362459|NCT01585168|5798349|P4|STARTED|Overall Study||19
2362460|NCT01585168|5798350|P3|STARTED|Overall Study||16
2362461|NCT01585168|5798351|P2|STARTED|Overall Study||18
2362462|NCT01585168|5798352|P1|STARTED|Overall Study||18
2362463|NCT01585155|5798372|P1|NOT COMPLETED|Overall Study||5
2362464|NCT01585155|5798372|P1|COMPLETED|Overall Study||16
2362465|NCT01585155|5798372|P1|STARTED|Overall Study||21
2362466|NCT01585129|5798381|P2|NOT COMPLETED|Overall Study||0
2362467|NCT01585129|5798382|P1|NOT COMPLETED|Overall Study||0
2362468|NCT01585129|5798381|P2|COMPLETED|Overall Study||39
2362469|NCT01585129|5798382|P1|COMPLETED|Overall Study||41
2362470|NCT01585129|5798381|P2|STARTED|Overall Study||39
2362471|NCT01585129|5798382|P1|STARTED|Overall Study||41
2362472|NCT01585038|5798394|P2|NOT COMPLETED|Overall Study||2
2362473|NCT01585038|5798395|P1|NOT COMPLETED|Overall Study||2
2362474|NCT01585038|5798394|P2|COMPLETED|Overall Study||18
2362475|NCT01585038|5798395|P1|COMPLETED|Overall Study||18
2362476|NCT01585038|5798394|P2|STARTED|Overall Study||20
2362477|NCT01585038|5798395|P1|STARTED|Overall Study||20
2362478|NCT01585025|5798410|P3|NOT COMPLETED|Overall Study||4
2362479|NCT01585025|5798411|P2|NOT COMPLETED|Overall Study||3
2362480|NCT01585025|5798412|P1|NOT COMPLETED|Overall Study||0
2362481|NCT01585025|5798410|P3|COMPLETED|Overall Study||8
2362482|NCT01585025|5798411|P2|COMPLETED|Overall Study||10
2362483|NCT01585025|5798412|P1|COMPLETED|Overall Study||10
2362484|NCT01585025|5798410|P3|STARTED|Overall Study||12
2362485|NCT01585025|5798411|P2|STARTED|Overall Study||13
2362486|NCT01585025|5798412|P1|STARTED|Overall Study||10
2362487|NCT01584843|5798442|P6|NOT COMPLETED|Second Treatment Period||1
2362488|NCT01584843|5798443|P5|NOT COMPLETED|Second Treatment Period||0
2362489|NCT01584843|5798444|P4|NOT COMPLETED|Second Treatment Period||0
2362490|NCT01584843|5798445|P3|NOT COMPLETED|Second Treatment Period||0
2362491|NCT01584843|5798446|P2|NOT COMPLETED|Second Treatment Period||0
2362492|NCT01584843|5798447|P1|NOT COMPLETED|Second Treatment Period||0
2362493|NCT01584843|5798442|P6|COMPLETED|Second Treatment Period||0
2362494|NCT01584843|5798443|P5|COMPLETED|Second Treatment Period||3
2362495|NCT01584843|5798444|P4|COMPLETED|Second Treatment Period||6
2362496|NCT01584843|5798445|P3|COMPLETED|Second Treatment Period||2
2362497|NCT01584843|5798446|P2|COMPLETED|Second Treatment Period||1
2362498|NCT01584843|5798447|P1|COMPLETED|Second Treatment Period||2
2362499|NCT01584843|5798442|P6|STARTED|Second Treatment Period||1
2362500|NCT01584843|5798443|P5|STARTED|Second Treatment Period||3
2362501|NCT01584843|5798444|P4|STARTED|Second Treatment Period||6
2362502|NCT01584843|5798445|P3|STARTED|Second Treatment Period||2
2362503|NCT01584843|5798446|P2|STARTED|Second Treatment Period||1
2362504|NCT01584843|5798447|P1|STARTED|Second Treatment Period||2
2362505|NCT01584843|5798442|P6|NOT COMPLETED|First Treatment Period||2
2362506|NCT01584843|5798443|P5|NOT COMPLETED|First Treatment Period||0
2362507|NCT01584843|5798444|P4|NOT COMPLETED|First Treatment Period||0
2362508|NCT01584843|5798445|P3|NOT COMPLETED|First Treatment Period||1
2362509|NCT01584843|5798446|P2|NOT COMPLETED|First Treatment Period||0
2362510|NCT01584843|5798447|P1|NOT COMPLETED|First Treatment Period||0
2362511|NCT01584843|5798442|P6|COMPLETED|First Treatment Period||9
2362512|NCT01584843|5798443|P5|COMPLETED|First Treatment Period||10
2362513|NCT01584843|5798444|P4|COMPLETED|First Treatment Period||10
2362514|NCT01584843|5798445|P3|COMPLETED|First Treatment Period||2
2362515|NCT01584843|5798446|P2|COMPLETED|First Treatment Period||4
2362516|NCT01584843|5798447|P1|COMPLETED|First Treatment Period||3
2362517|NCT01584843|5798442|P6|STARTED|First Treatment Period||11
2362518|NCT01584843|5798443|P5|STARTED|First Treatment Period||10
2362519|NCT01584843|5798444|P4|STARTED|First Treatment Period||10
2362520|NCT01584843|5798445|P3|STARTED|First Treatment Period||3
2362521|NCT01584843|5798446|P2|STARTED|First Treatment Period||4
2362522|NCT01584843|5798447|P1|STARTED|First Treatment Period||3
2362523|NCT01584648|5798558|P2|NOT COMPLETED|Overall Study||212
2362524|NCT01584648|5798559|P1|NOT COMPLETED|Overall Study||211
2362525|NCT01584648|5798558|P2|COMPLETED|Overall Study||0
2362526|NCT01584648|5798559|P1|COMPLETED|Overall Study||0
2362527|NCT01584648|5798558|P2|Ongoing|Overall Study||147
2362528|NCT01584648|5798559|P1|Ongoing|Overall Study||154
2362529|NCT01584648|5798558|P2|STARTED|Overall Study||212
2362530|NCT01584648|5798559|P1|STARTED|Overall Study||211
2362531|NCT01584609|5798599|P2|NOT COMPLETED|Overall Study||4
2362532|NCT01584609|5798600|P1|NOT COMPLETED|Overall Study||12
2362533|NCT01584609|5798599|P2|COMPLETED|Overall Study||96
2362534|NCT01584609|5798600|P1|COMPLETED|Overall Study||86
2362535|NCT01584609|5798599|P2|STARTED|Overall Study||100
2362536|NCT01584609|5798600|P1|STARTED|Overall Study||98
2362537|NCT01584544|5798625|P5|NOT COMPLETED|Overall Study||0
2362538|NCT01584544|5798626|P4|NOT COMPLETED|Overall Study||0
2362539|NCT01584544|5798627|P3|NOT COMPLETED|Overall Study||0
2362540|NCT01584544|5798628|P2|NOT COMPLETED|Overall Study||0
2362541|NCT01584544|5798629|P1|NOT COMPLETED|Overall Study||0
2362542|NCT01584544|5798625|P5|COMPLETED|Overall Study||6
2362543|NCT01584544|5798626|P4|COMPLETED|Overall Study||3
2362544|NCT01584544|5798627|P3|COMPLETED|Overall Study||6
2362545|NCT01584544|5798628|P2|COMPLETED|Overall Study||6
2362546|NCT01584544|5798629|P1|COMPLETED|Overall Study||3
2362547|NCT01584544|5798625|P5|STARTED|Overall Study||6
2362548|NCT01584544|5798626|P4|STARTED|Overall Study||3
2362549|NCT01584544|5798627|P3|STARTED|Overall Study||6
2362550|NCT01584544|5798628|P2|STARTED|Overall Study||6
2362551|NCT01584544|5798629|P1|STARTED|Overall Study||3
2362552|NCT01584518|5798643|P2|NOT COMPLETED|Overall Study||0
2362553|NCT01584518|5798644|P1|NOT COMPLETED|Overall Study||0
2362554|NCT01584518|5798643|P2|COMPLETED|Overall Study||25
2362555|NCT01584518|5798644|P1|COMPLETED|Overall Study||25
2362556|NCT01584518|5798643|P2|STARTED|Overall Study||25
2362557|NCT01584518|5798644|P1|STARTED|Overall Study||25
2362558|NCT01584479|5798654|P4|NOT COMPLETED|Overall Study||0
2362559|NCT01584479|5798655|P3|NOT COMPLETED|Overall Study||0
2362560|NCT01584479|5798656|P2|NOT COMPLETED|Overall Study||0
2362561|NCT01584479|5798657|P1|NOT COMPLETED|Overall Study||0
2362562|NCT01584479|5798654|P4|COMPLETED|Overall Study||1847
2362563|NCT01584479|5798655|P3|COMPLETED|Overall Study||852
2362564|NCT01584479|5798656|P2|COMPLETED|Overall Study||1686
2362565|NCT01584479|5798657|P1|COMPLETED|Overall Study||732
2362566|NCT01584479|5798654|P4|STARTED|Overall Study||1847
2362567|NCT01584479|5798655|P3|STARTED|Overall Study||852
2362568|NCT01584479|5798656|P2|STARTED|Overall Study||1686
2362569|NCT01584479|5798657|P1|STARTED|Overall Study||732
2362570|NCT01584388|5798667|P1|NOT COMPLETED|Overall Study||0
2362571|NCT01584388|5798667|P1|COMPLETED|Overall Study||30
2362572|NCT01584388|5798667|P1|STARTED|Overall Study||30
2362573|NCT01584232|5798687|P2|NOT COMPLETED|Overall Study||3
2362574|NCT01584232|5798688|P1|NOT COMPLETED|Overall Study||8
2362575|NCT01584232|5798687|P2|COMPLETED|Overall Study||177
2362576|NCT01584232|5798688|P1|COMPLETED|Overall Study||173
2362577|NCT01584232|5798687|P2|Received at Least 1 Dose of Study Drug|Overall Study||180
2362578|NCT01584232|5798688|P1|Received at Least 1 Dose of Study Drug|Overall Study||181
2362579|NCT01584232|5798687|P2|STARTED|Overall Study||180
2362580|NCT01584232|5798688|P1|STARTED|Overall Study||181
2362581|NCT01584024|5798704|P1|NOT COMPLETED|Overall Study||13
2362582|NCT01584024|5798704|P1|COMPLETED|Overall Study||29
2362583|NCT01584024|5798704|P1|STARTED|Overall Study||42
2362584|NCT01583985|5798713|P2|NOT COMPLETED|Overall Study||3
2362585|NCT01583985|5798714|P1|NOT COMPLETED|Overall Study||3
2362586|NCT01583985|5798713|P2|COMPLETED|Overall Study||117
2362587|NCT01583985|5798714|P1|COMPLETED|Overall Study||117
2362588|NCT01583985|5798713|P2|Included in Primary Analysis|Overall Study||119
2362589|NCT01583985|5798714|P1|Included in Primary Analysis|Overall Study||119
2362590|NCT01583985|5798713|P2|STARTED|Overall Study||120
2362591|NCT01583985|5798714|P1|STARTED|Overall Study||120
2362592|NCT01583894|5798728|P1|NOT COMPLETED|Overall Study||15
2362593|NCT01583894|5798728|P1|COMPLETED|Overall Study||813
2362594|NCT01583894|5798728|P1|STARTED|Overall Study||828
2362595|NCT01583686|5798737|P5|NOT COMPLETED|Overall Study||0
2362596|NCT01583686|5798738|P4|NOT COMPLETED|Overall Study||0
2362597|NCT01583686|5798739|P3|NOT COMPLETED|Overall Study||0
2362598|NCT01583686|5798740|P2|NOT COMPLETED|Overall Study||0
2362599|NCT01583686|5798741|P1|NOT COMPLETED|Overall Study||0
2362600|NCT01583686|5798737|P5|COMPLETED|Overall Study||3
2362601|NCT01583686|5798738|P4|COMPLETED|Overall Study||3
2362602|NCT01583686|5798739|P3|COMPLETED|Overall Study||3
2362603|NCT01583686|5798740|P2|COMPLETED|Overall Study||3
2362604|NCT01583686|5798741|P1|COMPLETED|Overall Study||3
2362605|NCT01583686|5798737|P5|STARTED|Overall Study||3
2362606|NCT01583686|5798738|P4|STARTED|Overall Study||3
2362607|NCT01583686|5798739|P3|STARTED|Overall Study||3
2362608|NCT01583686|5798740|P2|STARTED|Overall Study||3
2362609|NCT01583686|5798741|P1|STARTED|Overall Study||3
2362610|NCT01583647|5798758|P2|NOT COMPLETED|Overall Study||0
2362611|NCT01583647|5798759|P1|NOT COMPLETED|Overall Study||0
2362612|NCT01583647|5798758|P2|COMPLETED|Overall Study||0
2362613|NCT01583647|5798759|P1|COMPLETED|Overall Study||10
2362614|NCT01583647|5798758|P2|STARTED|Overall Study|Study terminated prior to Panel B being conducted.|0
2362615|NCT01583647|5798759|P1|STARTED|Overall Study||10
2362616|NCT01583543|5798771|P1|NOT COMPLETED|Overall Study||0
2362617|NCT01583543|5798771|P1|COMPLETED|Overall Study||12
2362618|NCT01583543|5798771|P1|STARTED|Overall Study||12
2362619|NCT01583530|5798784|P6|NOT COMPLETED|Overall Study||3
2362620|NCT01583530|5798785|P5|NOT COMPLETED|Overall Study||5
2362621|NCT01583530|5798786|P4|NOT COMPLETED|Overall Study||1
2362622|NCT01583530|5798787|P3|NOT COMPLETED|Overall Study||0
2362623|NCT01583530|5798788|P2|NOT COMPLETED|Overall Study||3
2362624|NCT01583530|5798789|P1|NOT COMPLETED|Overall Study||0
2362625|NCT01583530|5798784|P6|COMPLETED|Overall Study||17
2362626|NCT01583530|5798785|P5|COMPLETED|Overall Study||15
2362627|NCT01583530|5798786|P4|COMPLETED|Overall Study||18
2362628|NCT01583530|5798787|P3|COMPLETED|Overall Study||20
2362629|NCT01583530|5798788|P2|COMPLETED|Overall Study||17
2362630|NCT01583530|5798789|P1|COMPLETED|Overall Study||19
2362631|NCT01583530|5798784|P6|STARTED|Overall Study||20
2362632|NCT01583530|5798785|P5|STARTED|Overall Study||20
2362633|NCT01583530|5798786|P4|STARTED|Overall Study||19
2362634|NCT01583530|5798787|P3|STARTED|Overall Study||20
2362635|NCT01583530|5798788|P2|STARTED|Overall Study||20
2362636|NCT01583530|5798789|P1|STARTED|Overall Study||19
2362637|NCT01583452|5798835|P2|NOT COMPLETED|Overall Study||0
2362638|NCT01583452|5798836|P1|NOT COMPLETED|Overall Study||0
2362639|NCT01583452|5798835|P2|COMPLETED|Overall Study||20
2362640|NCT01583452|5798836|P1|COMPLETED|Overall Study||21
2362641|NCT01583452|5798835|P2|STARTED|Overall Study||20
2362642|NCT01583452|5798836|P1|STARTED|Overall Study||21
2362643|NCT01583374|5798851|P9|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||10
2362644|NCT01583374|5798852|P8|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||9
2362645|NCT01583374|5798853|P7|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||18
2362646|NCT01583374|5798854|P6|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||17
2362647|NCT01583374|5798855|P5|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||31
2362648|NCT01583374|5798856|P4|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||13
2362649|NCT01583374|5798857|P3|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||20
2362650|NCT01583374|5798858|P2|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||26
2362651|NCT01583374|5798859|P1|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||0
2362652|NCT01583374|5798851|P9|COMPLETED|Long-Term Extension Phase Weeks 52-260||10
2362653|NCT01583374|5798852|P8|COMPLETED|Long-Term Extension Phase Weeks 52-260||12
2362654|NCT01583374|5798853|P7|COMPLETED|Long-Term Extension Phase Weeks 52-260||20
2362655|NCT01583374|5798854|P6|COMPLETED|Long-Term Extension Phase Weeks 52-260||22
2362656|NCT01583374|5798855|P5|COMPLETED|Long-Term Extension Phase Weeks 52-260||50
2362657|NCT01583374|5798856|P4|COMPLETED|Long-Term Extension Phase Weeks 52-260||22
2362658|NCT01583374|5798857|P3|COMPLETED|Long-Term Extension Phase Weeks 52-260||41
2362659|NCT01583374|5798858|P2|COMPLETED|Long-Term Extension Phase Weeks 52-260||40
2362660|NCT01583374|5798859|P1|COMPLETED|Long-Term Extension Phase Weeks 52-260||0
2362661|NCT01583374|5798851|P9|STARTED|Long-Term Extension Phase Weeks 52-260||20
2362662|NCT01583374|5798852|P8|STARTED|Long-Term Extension Phase Weeks 52-260||21
2362663|NCT01583374|5798853|P7|STARTED|Long-Term Extension Phase Weeks 52-260||38
2362664|NCT01583374|5798854|P6|STARTED|Long-Term Extension Phase Weeks 52-260||39
2362665|NCT01583374|5798855|P5|STARTED|Long-Term Extension Phase Weeks 52-260||81
2362666|NCT01583374|5798856|P4|STARTED|Long-Term Extension Phase Weeks 52-260||35
2362667|NCT01583374|5798857|P3|STARTED|Long-Term Extension Phase Weeks 52-260||61
2362668|NCT01583374|5798858|P2|STARTED|Long-Term Extension Phase Weeks 52-260||66
2362669|NCT01583374|5798859|P1|STARTED|Long-Term Extension Phase Weeks 52-260||0
2362670|NCT01583374|5798851|P9|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||2
2362671|NCT01583374|5798852|P8|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||3
2362672|NCT01583374|5798853|P7|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
2362673|NCT01583374|5798854|P6|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
2362674|NCT01583374|5798855|P5|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||6
2362675|NCT01583374|5798856|P4|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||6
2362676|NCT01583374|5798857|P3|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||4
2362677|NCT01583374|5798858|P2|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
2362678|NCT01583374|5798859|P1|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||0
2362679|NCT01583374|5798851|P9|COMPLETED|Extension Phase (Weeks 24 to 52)||21
2362680|NCT01583374|5798852|P8|COMPLETED|Extension Phase (Weeks 24 to 52)||22
2362681|NCT01583374|5798853|P7|COMPLETED|Extension Phase (Weeks 24 to 52)||43
2362682|NCT01583374|5798854|P6|COMPLETED|Extension Phase (Weeks 24 to 52)||43
2362683|NCT01583374|5798855|P5|COMPLETED|Extension Phase (Weeks 24 to 52)||85
2362684|NCT01583374|5798856|P4|COMPLETED|Extension Phase (Weeks 24 to 52)||41
2362685|NCT01583374|5798857|P3|COMPLETED|Extension Phase (Weeks 24 to 52)||61
2362686|NCT01583374|5798858|P2|COMPLETED|Extension Phase (Weeks 24 to 52)||69
2362687|NCT01583374|5798859|P1|COMPLETED|Extension Phase (Weeks 24 to 52)||0
2362688|NCT01583374|5798851|P9|STARTED|Extension Phase (Weeks 24 to 52)||23
2362689|NCT01583374|5798852|P8|STARTED|Extension Phase (Weeks 24 to 52)||25
2362690|NCT01583374|5798853|P7|STARTED|Extension Phase (Weeks 24 to 52)||48
2362691|NCT01583374|5798854|P6|STARTED|Extension Phase (Weeks 24 to 52)||48
2362692|NCT01583374|5798855|P5|STARTED|Extension Phase (Weeks 24 to 52)||91
2362693|NCT01583374|5798856|P4|STARTED|Extension Phase (Weeks 24 to 52)||47
2362694|NCT01583374|5798857|P3|STARTED|Extension Phase (Weeks 24 to 52)||65
2362695|NCT01583374|5798858|P2|STARTED|Extension Phase (Weeks 24 to 52)||74
2362696|NCT01583374|5798859|P1|STARTED|Extension Phase (Weeks 24 to 52)||0
2362697|NCT01583374|5798851|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
2362698|NCT01583374|5798852|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
2362699|NCT01583374|5798853|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
2362700|NCT01583374|5798854|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
2362701|NCT01583374|5798855|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
2362702|NCT01583374|5798856|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
2362703|NCT01583374|5798857|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||25
2362704|NCT01583374|5798858|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||16
2362705|NCT01583374|5798859|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||19
2362706|NCT01583374|5798851|P9|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
2362707|NCT01583374|5798852|P8|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
2362708|NCT01583374|5798853|P7|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
2362709|NCT01583374|5798854|P6|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
2362710|NCT01583374|5798855|P5|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
2362711|NCT01583374|5798856|P4|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
2362712|NCT01583374|5798857|P3|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|138
2362713|NCT01583374|5798858|P2|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|147
2362714|NCT01583374|5798859|P1|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|145
2362715|NCT01583374|5798851|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
2362716|NCT01583374|5798852|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
2362717|NCT01583374|5798853|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
2362718|NCT01583374|5798854|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
2362719|NCT01583374|5798855|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
2362720|NCT01583374|5798856|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
2362721|NCT01583374|5798857|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|One participant who escaped early did not complete Week 24|49
2362722|NCT01583374|5798858|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||49
2362723|NCT01583374|5798859|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|One participant who escaped early did not complete Week 24|51
2362724|NCT01583374|5798851|P9|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
2362725|NCT01583374|5798852|P8|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
2362726|NCT01583374|5798853|P7|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
2362727|NCT01583374|5798854|P6|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
2362728|NCT01583374|5798855|P5|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
2362729|NCT01583374|5798856|P4|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
2362730|NCT01583374|5798857|P3|Completed Week 16|Placebo-controlled Phase (Week 0-24)||144
2362731|NCT01583374|5798858|P2|Completed Week 16|Placebo-controlled Phase (Week 0-24)||151
2362732|NCT01583374|5798859|P1|Completed Week 16|Placebo-controlled Phase (Week 0-24)||150
2362733|NCT01583374|5798851|P9|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
2362734|NCT01583374|5798852|P8|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
2362735|NCT01583374|5798853|P7|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
2362736|NCT01583374|5798854|P6|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
2362737|NCT01583374|5798855|P5|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
2362738|NCT01583374|5798856|P4|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
2362739|NCT01583374|5798857|P3|Received Treatment|Placebo-controlled Phase (Week 0-24)||163
2362740|NCT01583374|5798858|P2|Received Treatment|Placebo-controlled Phase (Week 0-24)||163
2362741|NCT01583374|5798859|P1|Received Treatment|Placebo-controlled Phase (Week 0-24)||164
2362742|NCT01583374|5798851|P9|STARTED|Placebo-controlled Phase (Week 0-24)||0
2362743|NCT01583374|5798852|P8|STARTED|Placebo-controlled Phase (Week 0-24)||0
2362744|NCT01583374|5798853|P7|STARTED|Placebo-controlled Phase (Week 0-24)||0
2362745|NCT01583374|5798854|P6|STARTED|Placebo-controlled Phase (Week 0-24)||0
2362746|NCT01583374|5798855|P5|STARTED|Placebo-controlled Phase (Week 0-24)||0
2362747|NCT01583374|5798856|P4|STARTED|Placebo-controlled Phase (Week 0-24)||0
2362748|NCT01583374|5798857|P3|STARTED|Placebo-controlled Phase (Week 0-24)||163
2362749|NCT01583374|5798858|P2|STARTED|Placebo-controlled Phase (Week 0-24)||163
2362750|NCT01583374|5798859|P1|STARTED|Placebo-controlled Phase (Week 0-24)||164
2362751|NCT01583218|5798901|P2|NOT COMPLETED|Overall Study||283
2362752|NCT01583218|5798902|P1|NOT COMPLETED|Overall Study||289
2362753|NCT01583218|5798901|P2|COMPLETED|Overall Study||3471
2362754|NCT01583218|5798902|P1|COMPLETED|Overall Study||3470
2362755|NCT01583218|5798901|P2|STARTED|Overall Study||3754
2362756|NCT01583218|5798902|P1|STARTED|Overall Study||3759
2362757|NCT01583179|5798922|P2|NOT COMPLETED|Overall Study||2
2362758|NCT01583179|5798923|P1|NOT COMPLETED|Overall Study||1
2362759|NCT01583179|5798922|P2|COMPLETED|Overall Study||10
2362760|NCT01583179|5798923|P1|COMPLETED|Overall Study||13
2362761|NCT01583179|5798922|P2|STARTED|Overall Study||12
2362762|NCT01583179|5798923|P1|STARTED|Overall Study||14
2362763|NCT01583166|5798933|P2|NOT COMPLETED|Overall Study||6
2362764|NCT01583166|5798934|P1|NOT COMPLETED|Overall Study||4
2362765|NCT01583166|5798933|P2|COMPLETED|Overall Study||39
2362766|NCT01583166|5798934|P1|COMPLETED|Overall Study||41
2362767|NCT01583166|5798933|P2|STARTED|Overall Study||45
2362768|NCT01583166|5798934|P1|STARTED|Overall Study||45
2362769|NCT01583101|5798948|P2|NOT COMPLETED|Overall Study||0
2362770|NCT01583101|5798949|P1|NOT COMPLETED|Overall Study||0
2362771|NCT01583101|5798948|P2|COMPLETED|Overall Study||1161
2362772|NCT01583101|5798949|P1|COMPLETED|Overall Study||1076
2362773|NCT01583101|5798948|P2|STARTED|Overall Study||1161
2362774|NCT01583101|5798949|P1|STARTED|Overall Study||1076
2362775|NCT01582971|5798957|P2|NOT COMPLETED|Overall Study||37
2362776|NCT01582971|5798958|P1|NOT COMPLETED|Overall Study||39
2362777|NCT01582971|5798957|P2|COMPLETED|Overall Study||91
2362778|NCT01582971|5798958|P1|COMPLETED|Overall Study||89
2362779|NCT01582971|5798957|P2|STARTED|Overall Study||128
2362780|NCT01582971|5798958|P1|STARTED|Overall Study||128
2362781|NCT01582945|5798976|P1|NOT COMPLETED|Overall Study||2
2362782|NCT01582945|5798976|P1|COMPLETED|Overall Study||12
2362783|NCT01582945|5798976|P1|STARTED|Overall Study||14
2362784|NCT01582880|5798980|P1|NOT COMPLETED|Overall Study||0
2362785|NCT01582880|5798980|P1|COMPLETED|Overall Study||1
2362786|NCT01582880|5798980|P1|STARTED|Overall Study||1
2362787|NCT01582854|5798990|P2|NOT COMPLETED|Overall Study||34
2362788|NCT01582854|5798991|P1|NOT COMPLETED|Overall Study||36
2362789|NCT01582854|5798990|P2|COMPLETED|Overall Study||221
2362790|NCT01582854|5798991|P1|COMPLETED|Overall Study||212
2362791|NCT01582854|5798990|P2|STARTED|Overall Study||255
2362792|NCT01582854|5798991|P1|STARTED|Overall Study||248
2362793|NCT01582789|5799019|P2|NOT COMPLETED|Second Intervention (14 Days)||0
2362794|NCT01582789|5799020|P1|NOT COMPLETED|Second Intervention (14 Days)||1
2362795|NCT01582789|5799019|P2|COMPLETED|Second Intervention (14 Days)||27
2362796|NCT01582789|5799020|P1|COMPLETED|Second Intervention (14 Days)||33
2362797|NCT01582789|5799019|P2|STARTED|Second Intervention (14 Days)||27
2362798|NCT01582789|5799020|P1|STARTED|Second Intervention (14 Days)||34
2362799|NCT01582789|5799019|P2|NOT COMPLETED|First Intervention (14 Days)||0
2362800|NCT01582789|5799020|P1|NOT COMPLETED|First Intervention (14 Days)||0
2362801|NCT01582789|5799019|P2|COMPLETED|First Intervention (14 Days)||27
2362802|NCT01582789|5799020|P1|COMPLETED|First Intervention (14 Days)||34
2362803|NCT01582789|5799019|P2|STARTED|First Intervention (14 Days)||27
2362804|NCT01582789|5799020|P1|STARTED|First Intervention (14 Days)||34
2362805|NCT01582490|5799038|P2|NOT COMPLETED|Overall Study||1
2362806|NCT01582490|5799039|P1|NOT COMPLETED|Overall Study||1
2362807|NCT01582490|5799038|P2|COMPLETED|Overall Study||9
2362808|NCT01582490|5799039|P1|COMPLETED|Overall Study||8
2362809|NCT01582490|5799038|P2|STARTED|Overall Study||10
2362810|NCT01582490|5799039|P1|STARTED|Overall Study||9
2362811|NCT01582477|5799061|P2|NOT COMPLETED|Overall Study||0
2362812|NCT01582477|5799062|P1|NOT COMPLETED|Overall Study||0
2362813|NCT01582477|5799061|P2|COMPLETED|Overall Study||12
2362814|NCT01582477|5799062|P1|COMPLETED|Overall Study||12
2362815|NCT01582477|5799061|P2|STARTED|Overall Study||12
2362816|NCT01582477|5799062|P1|STARTED|Overall Study||12
2362817|NCT01582451|5799080|P2|NOT COMPLETED|Overall Study||20
2362818|NCT01582451|5799081|P1|NOT COMPLETED|Overall Study||32
2362819|NCT01582451|5799080|P2|COMPLETED|Overall Study||139
2362820|NCT01582451|5799081|P1|COMPLETED|Overall Study||275
2362821|NCT01582451|5799080|P2|Received at Least 1 Dose of Study Drug|Overall Study||159
2362822|NCT01582451|5799081|P1|Received at Least 1 Dose of Study Drug|Overall Study||305
2362823|NCT01582451|5799080|P2|STARTED|Overall Study||159
2362824|NCT01582451|5799081|P1|STARTED|Overall Study||307
2362825|NCT01582308|5799123|P10|NOT COMPLETED|Period 5||0
2362826|NCT01582308|5799124|P9|NOT COMPLETED|Period 5||0
2362827|NCT01582308|5799125|P8|NOT COMPLETED|Period 5||0
2362828|NCT01582308|5799126|P7|NOT COMPLETED|Period 5||0
2362829|NCT01582308|5799127|P6|NOT COMPLETED|Period 5||0
2362830|NCT01582308|5799128|P5|NOT COMPLETED|Period 5||0
2362831|NCT01582308|5799129|P4|NOT COMPLETED|Period 5||0
2362832|NCT01582308|5799130|P3|NOT COMPLETED|Period 5||0
2362833|NCT01582308|5799131|P2|NOT COMPLETED|Period 5||0
2362834|NCT01582308|5799132|P1|NOT COMPLETED|Period 5||0
2362835|NCT01582308|5799123|P10|COMPLETED|Period 5||1
2362836|NCT01582308|5799124|P9|COMPLETED|Period 5||2
2362837|NCT01582308|5799125|P8|COMPLETED|Period 5||2
2362838|NCT01582308|5799126|P7|COMPLETED|Period 5||2
2362839|NCT01582308|5799127|P6|COMPLETED|Period 5||1
2362840|NCT01582308|5799128|P5|COMPLETED|Period 5||2
2362841|NCT01582308|5799129|P4|COMPLETED|Period 5||2
2362842|NCT01582308|5799130|P3|COMPLETED|Period 5||2
2362843|NCT01582308|5799131|P2|COMPLETED|Period 5||2
2362844|NCT01582308|5799132|P1|COMPLETED|Period 5||1
2362845|NCT01582308|5799123|P10|STARTED|Period 5||1
2362846|NCT01582308|5799124|P9|STARTED|Period 5||2
2362847|NCT01582308|5799125|P8|STARTED|Period 5||2
2362848|NCT01582308|5799126|P7|STARTED|Period 5||2
2362849|NCT01582308|5799127|P6|STARTED|Period 5||1
2362850|NCT01582308|5799128|P5|STARTED|Period 5||2
2362851|NCT01582308|5799129|P4|STARTED|Period 5||2
2362852|NCT01582308|5799130|P3|STARTED|Period 5||2
2362853|NCT01582308|5799131|P2|STARTED|Period 5||2
2362854|NCT01582308|5799132|P1|STARTED|Period 5||1
2362855|NCT01582308|5799123|P10|NOT COMPLETED|10-day Washout Following Period 4||0
2362856|NCT01582308|5799124|P9|NOT COMPLETED|10-day Washout Following Period 4||0
2362857|NCT01582308|5799125|P8|NOT COMPLETED|10-day Washout Following Period 4||0
2362858|NCT01582308|5799126|P7|NOT COMPLETED|10-day Washout Following Period 4||0
2362859|NCT01582308|5799127|P6|NOT COMPLETED|10-day Washout Following Period 4||0
2362860|NCT01582308|5799128|P5|NOT COMPLETED|10-day Washout Following Period 4||0
2362861|NCT01582308|5799129|P4|NOT COMPLETED|10-day Washout Following Period 4||0
2362862|NCT01582308|5799130|P3|NOT COMPLETED|10-day Washout Following Period 4||0
2362863|NCT01582308|5799131|P2|NOT COMPLETED|10-day Washout Following Period 4||0
2362864|NCT01582308|5799132|P1|NOT COMPLETED|10-day Washout Following Period 4||0
2362865|NCT01582308|5799123|P10|COMPLETED|10-day Washout Following Period 4||1
2362866|NCT01582308|5799124|P9|COMPLETED|10-day Washout Following Period 4||2
2362867|NCT01582308|5799125|P8|COMPLETED|10-day Washout Following Period 4||2
2362868|NCT01582308|5799126|P7|COMPLETED|10-day Washout Following Period 4||2
2362869|NCT01582308|5799127|P6|COMPLETED|10-day Washout Following Period 4||1
2362870|NCT01582308|5799128|P5|COMPLETED|10-day Washout Following Period 4||2
2362871|NCT01582308|5799129|P4|COMPLETED|10-day Washout Following Period 4||2
2362872|NCT01582308|5799130|P3|COMPLETED|10-day Washout Following Period 4||2
2362873|NCT01582308|5799131|P2|COMPLETED|10-day Washout Following Period 4||2
2362874|NCT01582308|5799132|P1|COMPLETED|10-day Washout Following Period 4||1
2362875|NCT01582308|5799123|P10|STARTED|10-day Washout Following Period 4||1
2362876|NCT01582308|5799124|P9|STARTED|10-day Washout Following Period 4||2
2362877|NCT01582308|5799125|P8|STARTED|10-day Washout Following Period 4||2
2362878|NCT01582308|5799126|P7|STARTED|10-day Washout Following Period 4||2
2362879|NCT01582308|5799127|P6|STARTED|10-day Washout Following Period 4||1
2362880|NCT01582308|5799128|P5|STARTED|10-day Washout Following Period 4||2
2362881|NCT01582308|5799129|P4|STARTED|10-day Washout Following Period 4||2
2362882|NCT01582308|5799130|P3|STARTED|10-day Washout Following Period 4||2
2362883|NCT01582308|5799131|P2|STARTED|10-day Washout Following Period 4||2
2362884|NCT01582308|5799132|P1|STARTED|10-day Washout Following Period 4||1
2362885|NCT01582308|5799123|P10|NOT COMPLETED|Period 4||1
2362886|NCT01582308|5799124|P9|NOT COMPLETED|Period 4||0
2362887|NCT01582308|5799125|P8|NOT COMPLETED|Period 4||0
2362888|NCT01582308|5799126|P7|NOT COMPLETED|Period 4||0
2362889|NCT01582308|5799127|P6|NOT COMPLETED|Period 4||1
2362890|NCT01582308|5799128|P5|NOT COMPLETED|Period 4||0
2362891|NCT01582308|5799129|P4|NOT COMPLETED|Period 4||0
2362892|NCT01582308|5799130|P3|NOT COMPLETED|Period 4||0
2362893|NCT01582308|5799131|P2|NOT COMPLETED|Period 4||0
2362894|NCT01582308|5799132|P1|NOT COMPLETED|Period 4||1
2362895|NCT01582308|5799123|P10|COMPLETED|Period 4||1
2362896|NCT01582308|5799124|P9|COMPLETED|Period 4||2
2362897|NCT01582308|5799125|P8|COMPLETED|Period 4||2
2362898|NCT01582308|5799126|P7|COMPLETED|Period 4||2
2362899|NCT01582308|5799127|P6|COMPLETED|Period 4||1
2362900|NCT01582308|5799128|P5|COMPLETED|Period 4||2
2362901|NCT01582308|5799129|P4|COMPLETED|Period 4||2
2362902|NCT01582308|5799130|P3|COMPLETED|Period 4||2
2362903|NCT01582308|5799131|P2|COMPLETED|Period 4||2
2362904|NCT01582308|5799132|P1|COMPLETED|Period 4||1
2362905|NCT01582308|5799123|P10|STARTED|Period 4||2
2362906|NCT01582308|5799124|P9|STARTED|Period 4||2
2362907|NCT01582308|5799125|P8|STARTED|Period 4||2
2362908|NCT01582308|5799126|P7|STARTED|Period 4||2
2362909|NCT01582308|5799127|P6|STARTED|Period 4||2
2362910|NCT01582308|5799128|P5|STARTED|Period 4||2
2362911|NCT01582308|5799129|P4|STARTED|Period 4||2
2362912|NCT01582308|5799130|P3|STARTED|Period 4||2
2362913|NCT01582308|5799131|P2|STARTED|Period 4||2
2362914|NCT01582308|5799132|P1|STARTED|Period 4||2
2362915|NCT01582308|5799123|P10|NOT COMPLETED|10-day Washout Following Period 3||0
2362916|NCT01582308|5799124|P9|NOT COMPLETED|10-day Washout Following Period 3||0
2362917|NCT01582308|5799125|P8|NOT COMPLETED|10-day Washout Following Period 3||0
2362918|NCT01582308|5799126|P7|NOT COMPLETED|10-day Washout Following Period 3||0
2362919|NCT01582308|5799127|P6|NOT COMPLETED|10-day Washout Following Period 3||0
2362920|NCT01582308|5799128|P5|NOT COMPLETED|10-day Washout Following Period 3||0
2362921|NCT01582308|5799129|P4|NOT COMPLETED|10-day Washout Following Period 3||0
2362922|NCT01582308|5799130|P3|NOT COMPLETED|10-day Washout Following Period 3||0
2362923|NCT01582308|5799131|P2|NOT COMPLETED|10-day Washout Following Period 3||0
2362924|NCT01582308|5799132|P1|NOT COMPLETED|10-day Washout Following Period 3||0
2362925|NCT01582308|5799123|P10|COMPLETED|10-day Washout Following Period 3||2
2362926|NCT01582308|5799124|P9|COMPLETED|10-day Washout Following Period 3||2
2362927|NCT01582308|5799125|P8|COMPLETED|10-day Washout Following Period 3||2
2362928|NCT01582308|5799126|P7|COMPLETED|10-day Washout Following Period 3||2
2362929|NCT01582308|5799127|P6|COMPLETED|10-day Washout Following Period 3||2
2362930|NCT01582308|5799128|P5|COMPLETED|10-day Washout Following Period 3||2
2362931|NCT01582308|5799129|P4|COMPLETED|10-day Washout Following Period 3||2
2362932|NCT01582308|5799130|P3|COMPLETED|10-day Washout Following Period 3||2
2362933|NCT01582308|5799131|P2|COMPLETED|10-day Washout Following Period 3||2
2362934|NCT01582308|5799132|P1|COMPLETED|10-day Washout Following Period 3||2
2362935|NCT01582308|5799123|P10|STARTED|10-day Washout Following Period 3||2
2362936|NCT01582308|5799124|P9|STARTED|10-day Washout Following Period 3||2
2362937|NCT01582308|5799125|P8|STARTED|10-day Washout Following Period 3||2
2362938|NCT01582308|5799126|P7|STARTED|10-day Washout Following Period 3||2
2362939|NCT01582308|5799127|P6|STARTED|10-day Washout Following Period 3||2
2362940|NCT01582308|5799128|P5|STARTED|10-day Washout Following Period 3||2
2362941|NCT01582308|5799129|P4|STARTED|10-day Washout Following Period 3||2
2362942|NCT01582308|5799130|P3|STARTED|10-day Washout Following Period 3||2
2362943|NCT01582308|5799131|P2|STARTED|10-day Washout Following Period 3||2
2362944|NCT01582308|5799132|P1|STARTED|10-day Washout Following Period 3||2
2362945|NCT01582308|5799123|P10|NOT COMPLETED|Period 3||0
2362946|NCT01582308|5799124|P9|NOT COMPLETED|Period 3||0
2362947|NCT01582308|5799125|P8|NOT COMPLETED|Period 3||0
2362948|NCT01582308|5799126|P7|NOT COMPLETED|Period 3||0
2362949|NCT01582308|5799127|P6|NOT COMPLETED|Period 3||0
2362950|NCT01582308|5799128|P5|NOT COMPLETED|Period 3||0
2362951|NCT01582308|5799129|P4|NOT COMPLETED|Period 3||0
2362952|NCT01582308|5799130|P3|NOT COMPLETED|Period 3||0
2362953|NCT01582308|5799131|P2|NOT COMPLETED|Period 3||0
2362954|NCT01582308|5799132|P1|NOT COMPLETED|Period 3||0
2362955|NCT01582308|5799123|P10|COMPLETED|Period 3||2
2362956|NCT01582308|5799124|P9|COMPLETED|Period 3||2
2362957|NCT01582308|5799125|P8|COMPLETED|Period 3||2
2362958|NCT01582308|5799126|P7|COMPLETED|Period 3||2
2362959|NCT01582308|5799127|P6|COMPLETED|Period 3||2
2362960|NCT01582308|5799128|P5|COMPLETED|Period 3||2
2362961|NCT01582308|5799129|P4|COMPLETED|Period 3||2
2362962|NCT01582308|5799130|P3|COMPLETED|Period 3||2
2362963|NCT01582308|5799131|P2|COMPLETED|Period 3||2
2362964|NCT01582308|5799132|P1|COMPLETED|Period 3||2
2362965|NCT01582308|5799123|P10|STARTED|Period 3||2
2362966|NCT01582308|5799124|P9|STARTED|Period 3||2
2362967|NCT01582308|5799125|P8|STARTED|Period 3||2
2362968|NCT01582308|5799126|P7|STARTED|Period 3||2
2362969|NCT01582308|5799127|P6|STARTED|Period 3||2
2362970|NCT01582308|5799128|P5|STARTED|Period 3||2
2362971|NCT01582308|5799129|P4|STARTED|Period 3||2
2362972|NCT01582308|5799130|P3|STARTED|Period 3||2
2362973|NCT01582308|5799131|P2|STARTED|Period 3||2
2362974|NCT01582308|5799132|P1|STARTED|Period 3||2
2362975|NCT01582308|5799123|P10|NOT COMPLETED|10-day Washout Following Period 2||0
2362976|NCT01582308|5799124|P9|NOT COMPLETED|10-day Washout Following Period 2||0
2362977|NCT01582308|5799125|P8|NOT COMPLETED|10-day Washout Following Period 2||0
2362978|NCT01582308|5799126|P7|NOT COMPLETED|10-day Washout Following Period 2||0
2362979|NCT01582308|5799127|P6|NOT COMPLETED|10-day Washout Following Period 2||0
2362980|NCT01582308|5799128|P5|NOT COMPLETED|10-day Washout Following Period 2||0
2362981|NCT01582308|5799129|P4|NOT COMPLETED|10-day Washout Following Period 2||0
2362982|NCT01582308|5799130|P3|NOT COMPLETED|10-day Washout Following Period 2||0
2362983|NCT01582308|5799131|P2|NOT COMPLETED|10-day Washout Following Period 2||0
2362984|NCT01582308|5799132|P1|NOT COMPLETED|10-day Washout Following Period 2||0
2362985|NCT01582308|5799123|P10|COMPLETED|10-day Washout Following Period 2||2
2362986|NCT01582308|5799124|P9|COMPLETED|10-day Washout Following Period 2||2
2362987|NCT01582308|5799125|P8|COMPLETED|10-day Washout Following Period 2||2
2362988|NCT01582308|5799126|P7|COMPLETED|10-day Washout Following Period 2||2
2362989|NCT01582308|5799127|P6|COMPLETED|10-day Washout Following Period 2||2
2362990|NCT01582308|5799128|P5|COMPLETED|10-day Washout Following Period 2||2
2362991|NCT01582308|5799129|P4|COMPLETED|10-day Washout Following Period 2||2
2362992|NCT01582308|5799130|P3|COMPLETED|10-day Washout Following Period 2||2
2362993|NCT01582308|5799131|P2|COMPLETED|10-day Washout Following Period 2||2
2362994|NCT01582308|5799132|P1|COMPLETED|10-day Washout Following Period 2||2
2362995|NCT01582308|5799123|P10|STARTED|10-day Washout Following Period 2||2
2362996|NCT01582308|5799124|P9|STARTED|10-day Washout Following Period 2||2
2362997|NCT01582308|5799125|P8|STARTED|10-day Washout Following Period 2||2
2362998|NCT01582308|5799126|P7|STARTED|10-day Washout Following Period 2||2
2362999|NCT01582308|5799127|P6|STARTED|10-day Washout Following Period 2||2
2363000|NCT01582308|5799128|P5|STARTED|10-day Washout Following Period 2||2
2363001|NCT01582308|5799129|P4|STARTED|10-day Washout Following Period 2||2
2363002|NCT01582308|5799130|P3|STARTED|10-day Washout Following Period 2||2
2363003|NCT01582308|5799131|P2|STARTED|10-day Washout Following Period 2||2
2363004|NCT01582308|5799132|P1|STARTED|10-day Washout Following Period 2||2
2363005|NCT01582308|5799123|P10|NOT COMPLETED|Period 2||0
2363006|NCT01582308|5799124|P9|NOT COMPLETED|Period 2||0
2363007|NCT01582308|5799125|P8|NOT COMPLETED|Period 2||0
2363008|NCT01582308|5799126|P7|NOT COMPLETED|Period 2||0
2363009|NCT01582308|5799127|P6|NOT COMPLETED|Period 2||0
2363010|NCT01582308|5799128|P5|NOT COMPLETED|Period 2||0
2363011|NCT01582308|5799129|P4|NOT COMPLETED|Period 2||0
2363012|NCT01582308|5799130|P3|NOT COMPLETED|Period 2||0
2363013|NCT01582308|5799131|P2|NOT COMPLETED|Period 2||0
2363014|NCT01582308|5799132|P1|NOT COMPLETED|Period 2||0
2363015|NCT01582308|5799123|P10|COMPLETED|Period 2||2
2363016|NCT01582308|5799124|P9|COMPLETED|Period 2||2
2363017|NCT01582308|5799125|P8|COMPLETED|Period 2||2
2363018|NCT01582308|5799126|P7|COMPLETED|Period 2||2
2363019|NCT01582308|5799127|P6|COMPLETED|Period 2||2
2363020|NCT01582308|5799128|P5|COMPLETED|Period 2||2
2363021|NCT01582308|5799129|P4|COMPLETED|Period 2||2
2363022|NCT01582308|5799130|P3|COMPLETED|Period 2||2
2363023|NCT01582308|5799131|P2|COMPLETED|Period 2||2
2363024|NCT01582308|5799132|P1|COMPLETED|Period 2||2
2363025|NCT01582308|5799123|P10|STARTED|Period 2||2
2363026|NCT01582308|5799124|P9|STARTED|Period 2||2
2363027|NCT01582308|5799125|P8|STARTED|Period 2||2
2363028|NCT01582308|5799126|P7|STARTED|Period 2||2
2363029|NCT01582308|5799127|P6|STARTED|Period 2||2
2363030|NCT01582308|5799128|P5|STARTED|Period 2||2
2363031|NCT01582308|5799129|P4|STARTED|Period 2||2
2363032|NCT01582308|5799130|P3|STARTED|Period 2||2
2363033|NCT01582308|5799131|P2|STARTED|Period 2||2
2363034|NCT01582308|5799132|P1|STARTED|Period 2||2
2363035|NCT01582308|5799123|P10|NOT COMPLETED|10-day Washout Following Period 1||0
2363036|NCT01582308|5799124|P9|NOT COMPLETED|10-day Washout Following Period 1||0
2363037|NCT01582308|5799125|P8|NOT COMPLETED|10-day Washout Following Period 1||0
2363038|NCT01582308|5799126|P7|NOT COMPLETED|10-day Washout Following Period 1||0
2363039|NCT01582308|5799127|P6|NOT COMPLETED|10-day Washout Following Period 1||0
2363040|NCT01582308|5799128|P5|NOT COMPLETED|10-day Washout Following Period 1||1
2363041|NCT01582308|5799129|P4|NOT COMPLETED|10-day Washout Following Period 1||0
2363042|NCT01582308|5799130|P3|NOT COMPLETED|10-day Washout Following Period 1||0
2363043|NCT01582308|5799131|P2|NOT COMPLETED|10-day Washout Following Period 1||0
2363044|NCT01582308|5799132|P1|NOT COMPLETED|10-day Washout Following Period 1||0
2363045|NCT01582308|5799123|P10|COMPLETED|10-day Washout Following Period 1||2
2363046|NCT01582308|5799124|P9|COMPLETED|10-day Washout Following Period 1||2
2363047|NCT01582308|5799125|P8|COMPLETED|10-day Washout Following Period 1||2
2363048|NCT01582308|5799126|P7|COMPLETED|10-day Washout Following Period 1||2
2363049|NCT01582308|5799127|P6|COMPLETED|10-day Washout Following Period 1||2
2363050|NCT01582308|5799128|P5|COMPLETED|10-day Washout Following Period 1||2
2363051|NCT01582308|5799129|P4|COMPLETED|10-day Washout Following Period 1||2
2363052|NCT01582308|5799130|P3|COMPLETED|10-day Washout Following Period 1||2
2363053|NCT01582308|5799131|P2|COMPLETED|10-day Washout Following Period 1||2
2363054|NCT01582308|5799132|P1|COMPLETED|10-day Washout Following Period 1||2
2363055|NCT01582308|5799123|P10|STARTED|10-day Washout Following Period 1||2
2363056|NCT01582308|5799124|P9|STARTED|10-day Washout Following Period 1||2
2363057|NCT01582308|5799125|P8|STARTED|10-day Washout Following Period 1||2
2363058|NCT01582308|5799126|P7|STARTED|10-day Washout Following Period 1||2
2363059|NCT01582308|5799127|P6|STARTED|10-day Washout Following Period 1||2
2363060|NCT01582308|5799128|P5|STARTED|10-day Washout Following Period 1||3
2363061|NCT01582308|5799129|P4|STARTED|10-day Washout Following Period 1||2
2363062|NCT01582308|5799130|P3|STARTED|10-day Washout Following Period 1||2
2363063|NCT01582308|5799131|P2|STARTED|10-day Washout Following Period 1||2
2363064|NCT01582308|5799132|P1|STARTED|10-day Washout Following Period 1||2
2363065|NCT01582308|5799123|P10|NOT COMPLETED|Period 1||0
2363066|NCT01582308|5799124|P9|NOT COMPLETED|Period 1||0
2363067|NCT01582308|5799125|P8|NOT COMPLETED|Period 1||0
2363068|NCT01582308|5799126|P7|NOT COMPLETED|Period 1||1
2363069|NCT01582308|5799127|P6|NOT COMPLETED|Period 1||0
2363070|NCT01582308|5799128|P5|NOT COMPLETED|Period 1||0
2363071|NCT01582308|5799129|P4|NOT COMPLETED|Period 1||0
2363072|NCT01582308|5799130|P3|NOT COMPLETED|Period 1||0
2363073|NCT01582308|5799131|P2|NOT COMPLETED|Period 1||0
2363074|NCT01582308|5799132|P1|NOT COMPLETED|Period 1||0
2363075|NCT01582308|5799123|P10|COMPLETED|Period 1||2
2363076|NCT01582308|5799124|P9|COMPLETED|Period 1||2
2363077|NCT01582308|5799125|P8|COMPLETED|Period 1||2
2363078|NCT01582308|5799126|P7|COMPLETED|Period 1||2
2363079|NCT01582308|5799127|P6|COMPLETED|Period 1||2
2363080|NCT01582308|5799128|P5|COMPLETED|Period 1||3
2363081|NCT01582308|5799129|P4|COMPLETED|Period 1||2
2363082|NCT01582308|5799130|P3|COMPLETED|Period 1||2
2363083|NCT01582308|5799131|P2|COMPLETED|Period 1||2
2363084|NCT01582308|5799132|P1|COMPLETED|Period 1||2
2363085|NCT01582308|5799123|P10|STARTED|Period 1||2
2363086|NCT01582308|5799124|P9|STARTED|Period 1||2
2363087|NCT01582308|5799125|P8|STARTED|Period 1||2
2363088|NCT01582308|5799126|P7|STARTED|Period 1|Includes replacement for a participant who discontinued during period 1|3
2363089|NCT01582308|5799127|P6|STARTED|Period 1||2
2363090|NCT01582308|5799128|P5|STARTED|Period 1|Includes replacement for a participant who discontinued after period 1|3
2363091|NCT01582308|5799129|P4|STARTED|Period 1||2
2363092|NCT01582308|5799130|P3|STARTED|Period 1||2
2363093|NCT01582308|5799131|P2|STARTED|Period 1||2
2363094|NCT01582308|5799132|P1|STARTED|Period 1||2
2363095|NCT01582282|5799160|P3|NOT COMPLETED|Overall Study||0
2363096|NCT01582282|5799161|P2|NOT COMPLETED|Overall Study||2
2363097|NCT01582282|5799162|P1|NOT COMPLETED|Overall Study||2
2363098|NCT01582282|5799160|P3|COMPLETED|Overall Study||8
2363099|NCT01582282|5799161|P2|COMPLETED|Overall Study||12
2363100|NCT01582282|5799162|P1|COMPLETED|Overall Study||13
2363101|NCT01582282|5799160|P3|STARTED|Overall Study||8
2363102|NCT01582282|5799161|P2|STARTED|Overall Study||14
2363103|NCT01582282|5799162|P1|STARTED|Overall Study||15
2363104|NCT01582243|5799185|P1|NOT COMPLETED|Overall Study||3
2363105|NCT01582243|5799185|P1|COMPLETED|Overall Study||37
2363106|NCT01582243|5799185|P1|STARTED|Overall Study||40
2363107|NCT01582178|5799196|P2|NOT COMPLETED|Overall Study||5
2363108|NCT01582178|5799197|P1|NOT COMPLETED|Overall Study||6
2363109|NCT01582178|5799196|P2|COMPLETED|Overall Study||101
2363110|NCT01582178|5799197|P1|COMPLETED|Overall Study||100
2363111|NCT01582178|5799196|P2|STARTED|Overall Study||106
2363112|NCT01582178|5799197|P1|STARTED|Overall Study||106
2363113|NCT01582152|5799205|P2|NOT COMPLETED|Overall Study||6
2363114|NCT01582152|5799206|P1|NOT COMPLETED|Overall Study||6
2363115|NCT01582152|5799205|P2|COMPLETED|Overall Study||0
2363116|NCT01582152|5799206|P1|COMPLETED|Overall Study||0
2363117|NCT01582152|5799205|P2|STARTED|Overall Study||6
2363118|NCT01582152|5799206|P1|STARTED|Overall Study||6
2363119|NCT01582139|5799216|P2|NOT COMPLETED|Overall Study||0
2363120|NCT01582139|5799217|P1|NOT COMPLETED|Overall Study||0
2363121|NCT01582139|5799216|P2|COMPLETED|Overall Study||6
2363122|NCT01582139|5799217|P1|COMPLETED|Overall Study||6
2363123|NCT01582139|5799216|P2|STARTED|Overall Study||6
2363124|NCT01582139|5799217|P1|STARTED|Overall Study||6
2363125|NCT01582100|5799229|P1|NOT COMPLETED|Overall Study||2
2363126|NCT01582100|5799229|P1|COMPLETED|Overall Study||0
2363127|NCT01582100|5799229|P1|STARTED|Overall Study||2
2363128|NCT01582061|5799235|P2|NOT COMPLETED|Overall Study||36
2363129|NCT01582061|5799236|P1|NOT COMPLETED|Overall Study||28
2363130|NCT01582061|5799235|P2|COMPLETED|Overall Study||19
2363131|NCT01582061|5799236|P1|COMPLETED|Overall Study||21
2363132|NCT01582061|5799235|P2|STARTED|Overall Study||55
2363133|NCT01582061|5799236|P1|STARTED|Overall Study||49
2363134|NCT01582009|5799286|P1|NOT COMPLETED|Overall Study||2
2363135|NCT01582009|5799286|P1|COMPLETED|Overall Study||24
2363136|NCT01582009|5799286|P1|STARTED|Overall Study||26
2363137|NCT01581970|5799294|P1|NOT COMPLETED|Overall Study||0
2363138|NCT01581970|5799294|P1|COMPLETED|Overall Study||7
2363139|NCT01581970|5799294|P1|STARTED|Overall Study||7
2363140|NCT01581931|5799303|P2|NOT COMPLETED|Second Period||0
2363141|NCT01581931|5799304|P1|NOT COMPLETED|Second Period||0
2363142|NCT01581931|5799303|P2|COMPLETED|Second Period||15
2363143|NCT01581931|5799304|P1|COMPLETED|Second Period||16
2363144|NCT01581931|5799303|P2|STARTED|Second Period||15
2363145|NCT01581931|5799304|P1|STARTED|Second Period||16
2363146|NCT01581931|5799303|P2|NOT COMPLETED|Washout||1
2363147|NCT01581931|5799304|P1|NOT COMPLETED|Washout||0
2363148|NCT01581931|5799303|P2|COMPLETED|Washout||15
2363149|NCT01581931|5799304|P1|COMPLETED|Washout||16
2363150|NCT01581931|5799303|P2|STARTED|Washout||16
2363151|NCT01581931|5799304|P1|STARTED|Washout||16
2363152|NCT01581931|5799303|P2|NOT COMPLETED|First Period||0
2363153|NCT01581931|5799304|P1|NOT COMPLETED|First Period||0
2363154|NCT01581931|5799303|P2|COMPLETED|First Period||16
2363155|NCT01581931|5799304|P1|COMPLETED|First Period||16
2363156|NCT01581931|5799303|P2|STARTED|First Period||16
2363157|NCT01581931|5799304|P1|STARTED|First Period||16
2363158|NCT01581710|5799318|P2|NOT COMPLETED|Second Intervention (14days)||2
2363159|NCT01581710|5799319|P1|NOT COMPLETED|Second Intervention (14days)||0
2363160|NCT01581710|5799318|P2|COMPLETED|Second Intervention (14days)||12
2363161|NCT01581710|5799319|P1|COMPLETED|Second Intervention (14days)||18
2363162|NCT01581710|5799318|P2|STARTED|Second Intervention (14days)||14
2363163|NCT01581710|5799319|P1|STARTED|Second Intervention (14days)||18
2363164|NCT01581710|5799318|P2|NOT COMPLETED|Washout Period (14days)||0
2363165|NCT01581710|5799319|P1|NOT COMPLETED|Washout Period (14days)||0
2363166|NCT01581710|5799318|P2|COMPLETED|Washout Period (14days)||14
2363167|NCT01581710|5799319|P1|COMPLETED|Washout Period (14days)||18
2363168|NCT01581710|5799318|P2|STARTED|Washout Period (14days)||14
2363169|NCT01581710|5799319|P1|STARTED|Washout Period (14days)||18
2363170|NCT01581710|5799318|P2|NOT COMPLETED|First Intervention (14days)||0
2363171|NCT01581710|5799319|P1|NOT COMPLETED|First Intervention (14days)||0
2363172|NCT01581710|5799318|P2|COMPLETED|First Intervention (14days)||14
2363173|NCT01581710|5799319|P1|COMPLETED|First Intervention (14days)||18
2363174|NCT01581710|5799318|P2|STARTED|First Intervention (14days)||14
2363175|NCT01581710|5799319|P1|STARTED|First Intervention (14days)||18
2363176|NCT01581684|5799357|P10|NOT COMPLETED|Overall Study||0
2363177|NCT01581684|5799358|P9|NOT COMPLETED|Overall Study||1
2363178|NCT01581684|5799359|P8|NOT COMPLETED|Overall Study||0
2363179|NCT01581684|5799360|P7|NOT COMPLETED|Overall Study||0
2363180|NCT01581684|5799361|P6|NOT COMPLETED|Overall Study||0
2363181|NCT01581684|5799362|P5|NOT COMPLETED|Overall Study||0
2363182|NCT01581684|5799363|P4|NOT COMPLETED|Overall Study||0
2363183|NCT01581684|5799364|P3|NOT COMPLETED|Overall Study||0
2363184|NCT01581684|5799365|P2|NOT COMPLETED|Overall Study||0
2363185|NCT01581684|5799366|P1|NOT COMPLETED|Overall Study||0
2363186|NCT01581684|5799357|P10|COMPLETED|Overall Study||5
2363187|NCT01581684|5799358|P9|COMPLETED|Overall Study||0
2363188|NCT01581684|5799359|P8|COMPLETED|Overall Study||6
2363189|NCT01581684|5799360|P7|COMPLETED|Overall Study||6
2363190|NCT01581684|5799361|P6|COMPLETED|Overall Study||6
2363191|NCT01581684|5799362|P5|COMPLETED|Overall Study||6
2363192|NCT01581684|5799363|P4|COMPLETED|Overall Study||6
2363193|NCT01581684|5799364|P3|COMPLETED|Overall Study||6
2363194|NCT01581684|5799365|P2|COMPLETED|Overall Study||6
2363195|NCT01581684|5799366|P1|COMPLETED|Overall Study||14
2363196|NCT01581684|5799357|P10|STARTED|Overall Study||5
2363197|NCT01581684|5799358|P9|STARTED|Overall Study||1
2363198|NCT01581684|5799359|P8|STARTED|Overall Study||6
2363199|NCT01581684|5799360|P7|STARTED|Overall Study||6
2363200|NCT01581684|5799361|P6|STARTED|Overall Study||6
2363201|NCT01581684|5799362|P5|STARTED|Overall Study||6
2363202|NCT01581684|5799363|P4|STARTED|Overall Study||6
2363203|NCT01581684|5799364|P3|STARTED|Overall Study||6
2363204|NCT01581684|5799365|P2|STARTED|Overall Study||6
2363205|NCT01581684|5799366|P1|STARTED|Overall Study||14
2363206|NCT01581658|5799441|P4|NOT COMPLETED|Overall Study||0
2363207|NCT01581658|5799442|P3|NOT COMPLETED|Overall Study||0
2363208|NCT01581658|5799443|P2|NOT COMPLETED|Overall Study||0
2363209|NCT01581658|5799444|P1|NOT COMPLETED|Overall Study||0
2363210|NCT01581658|5799441|P4|COMPLETED|Overall Study||8
2363211|NCT01581658|5799442|P3|COMPLETED|Overall Study||8
2363212|NCT01581658|5799443|P2|COMPLETED|Overall Study||8
2363213|NCT01581658|5799444|P1|COMPLETED|Overall Study||8
2363214|NCT01581658|5799441|P4|STARTED|Overall Study||8
2363215|NCT01581658|5799442|P3|STARTED|Overall Study||8
2363216|NCT01581658|5799443|P2|STARTED|Overall Study||8
2363217|NCT01581658|5799444|P1|STARTED|Overall Study||8
2363218|NCT01581619|5799462|P1|NOT COMPLETED|Overall Study||2
2363219|NCT01581619|5799462|P1|COMPLETED|Overall Study||52
2363220|NCT01581619|5799462|P1|STARTED|Overall Study||54
2363221|NCT01581541|5799470|P11|NOT COMPLETED|Overall Study||0
2363222|NCT01581541|5799471|P10|NOT COMPLETED|Overall Study||0
2363223|NCT01581541|5799472|P9|NOT COMPLETED|Overall Study||0
2363224|NCT01581541|5799473|P8|NOT COMPLETED|Overall Study||0
2363225|NCT01581541|5799474|P7|NOT COMPLETED|Overall Study||0
2363226|NCT01581541|5799475|P6|NOT COMPLETED|Overall Study||0
2363227|NCT01581541|5799476|P5|NOT COMPLETED|Overall Study||0
2363228|NCT01581541|5799477|P4|NOT COMPLETED|Overall Study||0
2363229|NCT01581541|5799478|P3|NOT COMPLETED|Overall Study||0
2363230|NCT01581541|5799479|P2|NOT COMPLETED|Overall Study||0
2363231|NCT01581541|5799480|P1|NOT COMPLETED|Overall Study||0
2363232|NCT01581541|5799470|P11|COMPLETED|Overall Study||1
2363233|NCT01581541|5799471|P10|COMPLETED|Overall Study||3
2363234|NCT01581541|5799472|P9|COMPLETED|Overall Study||1
2363235|NCT01581541|5799473|P8|COMPLETED|Overall Study||2
2363236|NCT01581541|5799474|P7|COMPLETED|Overall Study||1
2363237|NCT01581541|5799475|P6|COMPLETED|Overall Study||3
2363238|NCT01581541|5799476|P5|COMPLETED|Overall Study||2
2363239|NCT01581541|5799477|P4|COMPLETED|Overall Study||1
2363240|NCT01581541|5799478|P3|COMPLETED|Overall Study||1
2363241|NCT01581541|5799479|P2|COMPLETED|Overall Study||1
2363242|NCT01581541|5799480|P1|COMPLETED|Overall Study||1
2363243|NCT01581541|5799470|P11|STARTED|Overall Study||1
2363244|NCT01581541|5799471|P10|STARTED|Overall Study||3
2363245|NCT01581541|5799472|P9|STARTED|Overall Study||1
2363246|NCT01581541|5799473|P8|STARTED|Overall Study||2
2363247|NCT01581541|5799474|P7|STARTED|Overall Study||1
2363248|NCT01581541|5799475|P6|STARTED|Overall Study||3
2363249|NCT01581541|5799476|P5|STARTED|Overall Study||2
2363250|NCT01581541|5799477|P4|STARTED|Overall Study||1
2363251|NCT01581541|5799478|P3|STARTED|Overall Study||1
2363252|NCT01581541|5799479|P2|STARTED|Overall Study||1
2363253|NCT01581541|5799480|P1|STARTED|Overall Study||1
2363254|NCT01581437|5799604|P1|NOT COMPLETED|Overall Study||0
2363255|NCT01581437|5799604|P1|COMPLETED|Overall Study||78
2363256|NCT01581437|5799604|P1|STARTED|Overall Study||78
2363257|NCT01581307|5799615|P1|NOT COMPLETED|Overall Study||1
2363258|NCT01581307|5799615|P1|COMPLETED|Overall Study||8
2363259|NCT01581307|5799615|P1|STARTED|Overall Study||9
2363260|NCT01581281|5799624|P3|NOT COMPLETED|Overall Study||12
2363261|NCT01581281|5799625|P2|NOT COMPLETED|Overall Study||6
2363262|NCT01581281|5799626|P1|NOT COMPLETED|Overall Study||15
2363263|NCT01581281|5799624|P3|COMPLETED|Overall Study||132
2363264|NCT01581281|5799625|P2|COMPLETED|Overall Study||66
2363265|NCT01581281|5799626|P1|COMPLETED|Overall Study||130
2363266|NCT01581281|5799624|P3|STARTED|Overall Study||144
2363267|NCT01581281|5799625|P2|STARTED|Overall Study||72
2363268|NCT01581281|5799626|P1|STARTED|Overall Study||145
2363269|NCT01581021|5799648|P2|NOT COMPLETED|Overall Study||11
2363270|NCT01581021|5799649|P1|NOT COMPLETED|Overall Study||10
2363271|NCT01581021|5799648|P2|COMPLETED|Overall Study||18
2363272|NCT01581021|5799649|P1|COMPLETED|Overall Study||19
2363273|NCT01581021|5799648|P2|STARTED|Overall Study||29
2363274|NCT01581021|5799649|P1|STARTED|Overall Study||29
2363275|NCT01581008|5799663|P2|NOT COMPLETED|Overall Study||6
2363276|NCT01581008|5799664|P1|NOT COMPLETED|Overall Study||1
2363277|NCT01581008|5799663|P2|COMPLETED|Overall Study||7
2363278|NCT01581008|5799664|P1|COMPLETED|Overall Study||16
2363279|NCT01581008|5799663|P2|STARTED|Overall Study||13
2363280|NCT01581008|5799664|P1|STARTED|Overall Study||17
2363281|NCT01580995|5799676|P2|NOT COMPLETED|Overall Study||2
2363282|NCT01580995|5799677|P1|NOT COMPLETED|Overall Study||2
2363283|NCT01580995|5799676|P2|COMPLETED|Overall Study||7
2363284|NCT01580995|5799677|P1|COMPLETED|Overall Study||8
2363285|NCT01580995|5799676|P2|STARTED|Overall Study||9
2363286|NCT01580995|5799677|P1|STARTED|Overall Study||10
2363287|NCT01580969|5799686|P3|NOT COMPLETED|Overall Study||0
2363288|NCT01580969|5799687|P2|NOT COMPLETED|Overall Study||0
2363289|NCT01580969|5799688|P1|NOT COMPLETED|Overall Study||3
2363290|NCT01580969|5799686|P3|COMPLETED|Overall Study||13
2363291|NCT01580969|5799687|P2|COMPLETED|Overall Study||3
2363292|NCT01580969|5799688|P1|COMPLETED|Overall Study||3
2363293|NCT01580969|5799686|P3|STARTED|Overall Study||13
2363294|NCT01580969|5799687|P2|STARTED|Overall Study||3
2363295|NCT01580969|5799688|P1|STARTED|Overall Study||6
2363296|NCT01580904|5799722|P2|NOT COMPLETED|Overall Study||7
2363297|NCT01580904|5799723|P1|NOT COMPLETED|Overall Study||4
2363298|NCT01580904|5799722|P2|COMPLETED|Overall Study||42
2363299|NCT01580904|5799723|P1|COMPLETED|Overall Study||47
2363300|NCT01580904|5799722|P2|STARTED|Overall Study||49
2363301|NCT01580904|5799723|P1|STARTED|Overall Study||51
2363302|NCT01580670|5799735|P1|NOT COMPLETED|Maintenance Period (Week 14 to 54)||2
2363303|NCT01580670|5799735|P1|COMPLETED|Maintenance Period (Week 14 to 54)||12
2363304|NCT01580670|5799735|P1|STARTED|Maintenance Period (Week 14 to 54)||14
2363305|NCT01580670|5799735|P1|NOT COMPLETED|Induction Period (Week 0 to 14)||0
2363306|NCT01580670|5799735|P1|COMPLETED|Induction Period (Week 0 to 14)||14
2363307|NCT01580670|5799735|P1|STARTED|Induction Period (Week 0 to 14)||14
2363308|NCT01580618|5799746|P2|NOT COMPLETED|Overall Study||0
2363309|NCT01580618|5799747|P1|NOT COMPLETED|Overall Study||1
2363310|NCT01580618|5799746|P2|COMPLETED|Overall Study||12
2363311|NCT01580618|5799747|P1|COMPLETED|Overall Study|One patient was switched from the normal saline to TNKase arm at attending physician request.|7
2363312|NCT01580618|5799746|P2|STARTED|Overall Study||12
2363313|NCT01580618|5799747|P1|STARTED|Overall Study||8
2363314|NCT01580592|5799763|P3|NOT COMPLETED|Overall Study||0
2363315|NCT01580592|5799764|P2|NOT COMPLETED|Overall Study||0
2363316|NCT01580592|5799765|P1|NOT COMPLETED|Overall Study||0
2363317|NCT01580592|5799763|P3|COMPLETED|Overall Study||12
2363318|NCT01580592|5799764|P2|COMPLETED|Overall Study||9
2363319|NCT01580592|5799765|P1|COMPLETED|Overall Study||10
2363320|NCT01580592|5799763|P3|STARTED|Overall Study||12
2363321|NCT01580592|5799764|P2|STARTED|Overall Study||9
2363322|NCT01580592|5799765|P1|STARTED|Overall Study||10
2363323|NCT01580488|5799776|P1|NOT COMPLETED|Overall Study||1
2363324|NCT01580488|5799776|P1|COMPLETED|Overall Study||23
2363325|NCT01580488|5799776|P1|STARTED|Overall Study||24
2363326|NCT01580423|5799820|P2|NOT COMPLETED|Second Intervention||0
2363327|NCT01580423|5799821|P1|NOT COMPLETED|Second Intervention||0
2363328|NCT01580423|5799820|P2|COMPLETED|Second Intervention||8
2363329|NCT01580423|5799821|P1|COMPLETED|Second Intervention||8
2363330|NCT01580423|5799820|P2|STARTED|Second Intervention||8
2363331|NCT01580423|5799821|P1|STARTED|Second Intervention||8
2363332|NCT01580423|5799820|P2|NOT COMPLETED|First Intervention||0
2363333|NCT01580423|5799821|P1|NOT COMPLETED|First Intervention||0
2363334|NCT01580423|5799820|P2|COMPLETED|First Intervention||8
2363335|NCT01580423|5799821|P1|COMPLETED|First Intervention||8
2363336|NCT01580423|5799820|P2|STARTED|First Intervention||8
2363337|NCT01580423|5799821|P1|STARTED|First Intervention||8
2363338|NCT01580410|5799833|P2|NOT COMPLETED|Overall Study||8
2363339|NCT01580410|5799834|P1|NOT COMPLETED|Overall Study||11
2363340|NCT01580410|5799833|P2|COMPLETED|Overall Study||60
2363341|NCT01580410|5799834|P1|COMPLETED|Overall Study||57
2363342|NCT01580410|5799833|P2|STARTED|Overall Study||68
2363343|NCT01580410|5799834|P1|STARTED|Overall Study||68
2363344|NCT01580306|5799850|P4|NOT COMPLETED|Overall Study||0
2363345|NCT01580306|5799851|P3|NOT COMPLETED|Overall Study||0
2363346|NCT01580306|5799852|P2|NOT COMPLETED|Overall Study||0
2363347|NCT01580306|5799853|P1|NOT COMPLETED|Overall Study||0
2363348|NCT01580306|5799850|P4|COMPLETED|Overall Study||8
2363349|NCT01580306|5799851|P3|COMPLETED|Overall Study||8
2363350|NCT01580306|5799852|P2|COMPLETED|Overall Study||8
2363351|NCT01580306|5799853|P1|COMPLETED|Overall Study||8
2363352|NCT01580306|5799850|P4|STARTED|Overall Study||8
2363353|NCT01580306|5799851|P3|STARTED|Overall Study||8
2363354|NCT01580306|5799852|P2|STARTED|Overall Study||8
2363355|NCT01580306|5799853|P1|STARTED|Overall Study||8
2363356|NCT01580293|5799882|P3|NOT COMPLETED|Part B||3
2363357|NCT01580293|5799883|P2|NOT COMPLETED|Part B||0
2363358|NCT01580293|5799884|P1|NOT COMPLETED|Part B||0
2363359|NCT01580293|5799882|P3|COMPLETED|Part B||16
2363360|NCT01580293|5799883|P2|COMPLETED|Part B||0
2363361|NCT01580293|5799884|P1|COMPLETED|Part B||0
2363362|NCT01580293|5799882|P3|Part B Ongoing|Part B||1
2363363|NCT01580293|5799883|P2|Part B Ongoing|Part B||0
2363364|NCT01580293|5799884|P1|Part B Ongoing|Part B||0
2363365|NCT01580293|5799882|P3|STARTED|Part B|11 participants were enrolled in Part B only, 8 participants switched from Part A to Part B.|19
2363366|NCT01580293|5799883|P2|STARTED|Part B|Time in Part A for 8 participants coming from Part A was not counted in part B.|0
2363367|NCT01580293|5799884|P1|STARTED|Part B|Time in Part A for 8 participants coming from Part A was not counted in part B.|0
2363368|NCT01580293|5799882|P3|NOT COMPLETED|Part A_Extension||0
2363369|NCT01580293|5799883|P2|NOT COMPLETED|Part A_Extension||75
2363370|NCT01580293|5799884|P1|NOT COMPLETED|Part A_Extension||9
2363371|NCT01580293|5799882|P3|COMPLETED|Part A_Extension||0
2363372|NCT01580293|5799883|P2|COMPLETED|Part A_Extension||32
2363373|NCT01580293|5799884|P1|COMPLETED|Part A_Extension||5
2363374|NCT01580293|5799882|P3|Extension Ongoing|Part A_Extension||0
2363375|NCT01580293|5799883|P2|Extension Ongoing|Part A_Extension||69
2363376|NCT01580293|5799884|P1|Extension Ongoing|Part A_Extension||9
2363377|NCT01580293|5799882|P3|STARTED|Part A_Extension|Participants in Part B were not counted for part A|0
2363378|NCT01580293|5799883|P2|STARTED|Part A_Extension|Not all participants from main trial entered extension or remained in the same arm.|107
2363379|NCT01580293|5799884|P1|STARTED|Part A_Extension|Not all participants from main trial entered extension or remained in the same arm.|14
2363380|NCT01580293|5799882|P3|NOT COMPLETED|Part A_Main Trial||0
2363381|NCT01580293|5799883|P2|NOT COMPLETED|Part A_Main Trial||6
2363382|NCT01580293|5799884|P1|NOT COMPLETED|Part A_Main Trial||2
2363383|NCT01580293|5799882|P3|COMPLETED|Part A_Main Trial||0
2363384|NCT01580293|5799883|P2|COMPLETED|Part A_Main Trial||108
2363385|NCT01580293|5799884|P1|COMPLETED|Part A_Main Trial||18
2363386|NCT01580293|5799882|P3|STARTED|Part A_Main Trial|Participants in Part B were not counted for Part A|0
2363387|NCT01580293|5799883|P2|STARTED|Part A_Main Trial||114
2363388|NCT01580293|5799884|P1|STARTED|Part A_Main Trial||20
2363389|NCT01580098|5799969|P3|NOT COMPLETED|Overall Study||3
2363390|NCT01580098|5799970|P2|NOT COMPLETED|Overall Study||13
2363391|NCT01580098|5799971|P1|NOT COMPLETED|Overall Study||15
2363392|NCT01580098|5799969|P3|COMPLETED|Overall Study|Due to high age and bad health conditions no patients finished (nursing)|0
2363393|NCT01580098|5799970|P2|COMPLETED|Overall Study||101
2363394|NCT01580098|5799971|P1|COMPLETED|Overall Study||61
2363395|NCT01580098|5799969|P3|STARTED|Overall Study||3
2363396|NCT01580098|5799970|P2|STARTED|Overall Study||114
2363397|NCT01580098|5799971|P1|STARTED|Overall Study||76
2363398|NCT01580072|5799994|P3|NOT COMPLETED|Overall Study||0
2363399|NCT01580072|5799995|P2|NOT COMPLETED|Overall Study||9
2363400|NCT01580072|5799996|P1|NOT COMPLETED|Overall Study||12
2363401|NCT01580072|5799994|P3|COMPLETED|Overall Study||0
2363402|NCT01580072|5799995|P2|COMPLETED|Overall Study||28
2363403|NCT01580072|5799996|P1|COMPLETED|Overall Study||16
2363404|NCT01580072|5799994|P3|STARTED|Overall Study||0
2363405|NCT01580072|5799995|P2|STARTED|Overall Study||37
2363406|NCT01580072|5799996|P1|STARTED|Overall Study||28
2363407|NCT01580020|5800024|P4|NOT COMPLETED|Overall Study||2
2363408|NCT01580020|5800025|P3|NOT COMPLETED|Overall Study||4
2363409|NCT01580020|5800026|P2|NOT COMPLETED|Overall Study||7
2363410|NCT01580020|5800027|P1|NOT COMPLETED|Overall Study||1
2363411|NCT01580020|5800024|P4|COMPLETED|Overall Study||20
2363412|NCT01580020|5800025|P3|COMPLETED|Overall Study||57
2363413|NCT01580020|5800026|P2|COMPLETED|Overall Study||33
2363414|NCT01580020|5800027|P1|COMPLETED|Overall Study||51
2363415|NCT01580020|5800024|P4|STARTED|Overall Study||22
2363416|NCT01580020|5800025|P3|STARTED|Overall Study||61
2363417|NCT01580020|5800026|P2|STARTED|Overall Study||40
2363418|NCT01580020|5800027|P1|STARTED|Overall Study||52
2363419|NCT01579916|5800071|P2|NOT COMPLETED|Overall Study||2
2363420|NCT01579916|5800072|P1|NOT COMPLETED|Overall Study||8
2363421|NCT01579916|5800071|P2|COMPLETED|Overall Study||59
2363422|NCT01579916|5800072|P1|COMPLETED|Overall Study||234
2363423|NCT01579916|5800071|P2|STARTED|Overall Study||61
2363424|NCT01579916|5800072|P1|STARTED|Overall Study||242
2363425|NCT01579812|5800098|P1|NOT COMPLETED|Overall Study||52
2363426|NCT01579812|5800098|P1|COMPLETED|Overall Study||38
2363427|NCT01579812|5800098|P1|STARTED|Overall Study||90
2363428|NCT01579747|5800108|P2|NOT COMPLETED|Overall Study||0
2363429|NCT01579747|5800109|P1|NOT COMPLETED|Overall Study||0
2363430|NCT01579747|5800108|P2|COMPLETED|Overall Study||12
2363431|NCT01579747|5800109|P1|COMPLETED|Overall Study||12
2363432|NCT01579747|5800108|P2|STARTED|Overall Study||12
2363433|NCT01579747|5800109|P1|STARTED|Overall Study||12
2363434|NCT01579669|5800119|P2|NOT COMPLETED|Overall Study||0
2363435|NCT01579669|5800120|P1|NOT COMPLETED|Overall Study||36
2363436|NCT01579669|5800119|P2|COMPLETED|Overall Study||41
2363437|NCT01579669|5800120|P1|COMPLETED|Overall Study||134
2363438|NCT01579669|5800119|P2|STARTED|Overall Study||41
2363439|NCT01579669|5800120|P1|STARTED|Overall Study||170
2363440|NCT01579578|5800132|P2|NOT COMPLETED|Overall Study||12
2363441|NCT01579578|5800133|P1|NOT COMPLETED|Overall Study||13
2363442|NCT01579578|5800132|P2|COMPLETED|Overall Study||0
2363443|NCT01579578|5800133|P1|COMPLETED|Overall Study||0
2363444|NCT01579578|5800132|P2|Ongoing|Overall Study||0
2363445|NCT01579578|5800133|P1|Ongoing|Overall Study||3
2363446|NCT01579578|5800132|P2|STARTED|Overall Study||12
2363447|NCT01579578|5800133|P1|STARTED|Overall Study||13
2363448|NCT01579565|5800145|P2|NOT COMPLETED|Treated||3
2363449|NCT01579565|5800146|P1|NOT COMPLETED|Treated||2
2363450|NCT01579565|5800145|P2|COMPLETED|Treated||201
2363451|NCT01579565|5800146|P1|COMPLETED|Treated||200
2363452|NCT01579565|5800145|P2|STARTED|Treated||204
2363453|NCT01579565|5800146|P1|STARTED|Treated||202
2363454|NCT01579565|5800145|P2|NOT COMPLETED|Randomized||5
2363455|NCT01579565|5800146|P1|NOT COMPLETED|Randomized||5
2363456|NCT01579565|5800145|P2|COMPLETED|Randomized||204
2363457|NCT01579565|5800146|P1|COMPLETED|Randomized||202
2363458|NCT01579565|5800145|P2|STARTED|Randomized||209
2363459|NCT01579565|5800146|P1|STARTED|Randomized||207
2363460|NCT01579513|5800176|P2|NOT COMPLETED|1 Year Neurodevelopmental Follow up||27
2363461|NCT01579513|5800177|P1|NOT COMPLETED|1 Year Neurodevelopmental Follow up||20
2363462|NCT01579513|5800176|P2|COMPLETED|1 Year Neurodevelopmental Follow up||68
2363463|NCT01579513|5800177|P1|COMPLETED|1 Year Neurodevelopmental Follow up||61
2363464|NCT01579513|5800176|P2|STARTED|1 Year Neurodevelopmental Follow up||95
2363465|NCT01579513|5800177|P1|STARTED|1 Year Neurodevelopmental Follow up||81
2363466|NCT01579513|5800176|P2|NOT COMPLETED|Primary Hospitalization||4
2363467|NCT01579513|5800177|P1|NOT COMPLETED|Primary Hospitalization||10
2363468|NCT01579513|5800176|P2|COMPLETED|Primary Hospitalization||95
2363469|NCT01579513|5800177|P1|COMPLETED|Primary Hospitalization||81
2363470|NCT01579513|5800176|P2|STARTED|Primary Hospitalization||99
2363471|NCT01579513|5800177|P1|STARTED|Primary Hospitalization||91
2363472|NCT01579474|5800197|P6|NOT COMPLETED|Overall Study||1
2363473|NCT01579474|5800198|P5|NOT COMPLETED|Overall Study||1
2363474|NCT01579474|5800199|P4|NOT COMPLETED|Overall Study||0
2363475|NCT01579474|5800200|P3|NOT COMPLETED|Overall Study||2
2363476|NCT01579474|5800201|P2|NOT COMPLETED|Overall Study||13
2363477|NCT01579474|5800202|P1|NOT COMPLETED|Overall Study||3
2363478|NCT01579474|5800197|P6|COMPLETED|Overall Study||1
2363479|NCT01579474|5800198|P5|COMPLETED|Overall Study||9
2363480|NCT01579474|5800199|P4|COMPLETED|Overall Study||3
2363481|NCT01579474|5800200|P3|COMPLETED|Overall Study||27
2363482|NCT01579474|5800201|P2|COMPLETED|Overall Study||30
2363483|NCT01579474|5800202|P1|COMPLETED|Overall Study||41
2363484|NCT01579474|5800197|P6|STARTED|Overall Study||2
2363485|NCT01579474|5800198|P5|STARTED|Overall Study||10
2363486|NCT01579474|5800199|P4|STARTED|Overall Study||3
2363487|NCT01579474|5800200|P3|STARTED|Overall Study||29
2363488|NCT01579474|5800201|P2|STARTED|Overall Study||43
2363489|NCT01579474|5800202|P1|STARTED|Overall Study||44
2363490|NCT01579318|5800276|P1|NOT COMPLETED|Overall Study||1
2363491|NCT01579318|5800276|P1|COMPLETED|Overall Study||1
2363492|NCT01579318|5800276|P1|STARTED|Overall Study||2
2363493|NCT01579305|5800289|P2|NOT COMPLETED|Overall Study||27
2363494|NCT01579305|5800290|P1|NOT COMPLETED|Overall Study||21
2363495|NCT01579305|5800289|P2|COMPLETED|Overall Study||115
2363496|NCT01579305|5800290|P1|COMPLETED|Overall Study||118
2363497|NCT01579305|5800289|P2|Continued After Treatment|Overall Study||141
2363498|NCT01579305|5800290|P1|Continued After Treatment|Overall Study||139
2363499|NCT01579305|5800289|P2|Discontinued Before Treatment|Overall Study||1
2363500|NCT01579305|5800290|P1|Discontinued Before Treatment|Overall Study||0
2363501|NCT01579305|5800289|P2|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|142
2363502|NCT01579305|5800290|P1|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|139
2363503|NCT01579214|5800298|P2|NOT COMPLETED|Overall Study||0
2363504|NCT01579214|5800299|P1|NOT COMPLETED|Overall Study||0
2363505|NCT01579214|5800298|P2|COMPLETED|Overall Study||138
2363506|NCT01579214|5800299|P1|COMPLETED|Overall Study||45
2363507|NCT01579214|5800298|P2|STARTED|Overall Study||138
2363508|NCT01579214|5800299|P1|STARTED|Overall Study||45
2363509|NCT01579084|5800317|P10|NOT COMPLETED|Overall Study||0
2363510|NCT01579084|5800318|P9|NOT COMPLETED|Overall Study||0
2363511|NCT01579084|5800319|P8|NOT COMPLETED|Overall Study||0
2363512|NCT01579084|5800320|P7|NOT COMPLETED|Overall Study||0
2363513|NCT01579084|5800321|P6|NOT COMPLETED|Overall Study||0
2363514|NCT01579084|5800322|P5|NOT COMPLETED|Overall Study||0
2363515|NCT01579084|5800323|P4|NOT COMPLETED|Overall Study||0
2363516|NCT01579084|5800324|P3|NOT COMPLETED|Overall Study||0
2363517|NCT01579084|5800325|P2|NOT COMPLETED|Overall Study||0
2363518|NCT01579084|5800326|P1|NOT COMPLETED|Overall Study||0
2363519|NCT01579084|5800317|P10|COMPLETED|Overall Study||4
2363520|NCT01579084|5800318|P9|COMPLETED|Overall Study||4
2363521|NCT01579084|5800319|P8|COMPLETED|Overall Study||4
2363522|NCT01579084|5800320|P7|COMPLETED|Overall Study||4
2363523|NCT01579084|5800321|P6|COMPLETED|Overall Study||8
2363524|NCT01579084|5800322|P5|COMPLETED|Overall Study||8
2363525|NCT01579084|5800323|P4|COMPLETED|Overall Study||8
2363526|NCT01579084|5800324|P3|COMPLETED|Overall Study||8
2363527|NCT01579084|5800325|P2|COMPLETED|Overall Study||8
2363528|NCT01579084|5800326|P1|COMPLETED|Overall Study||8
2363529|NCT01579084|5800317|P10|STARTED|Overall Study||4
2363530|NCT01579084|5800318|P9|STARTED|Overall Study||4
2363531|NCT01579084|5800319|P8|STARTED|Overall Study||4
2363532|NCT01579084|5800320|P7|STARTED|Overall Study||4
2363533|NCT01579084|5800321|P6|STARTED|Overall Study||8
2363534|NCT01579084|5800322|P5|STARTED|Overall Study||8
2363535|NCT01579084|5800323|P4|STARTED|Overall Study||8
2363536|NCT01579084|5800324|P3|STARTED|Overall Study||8
2363537|NCT01579084|5800325|P2|STARTED|Overall Study||8
2363538|NCT01579084|5800326|P1|STARTED|Overall Study||8
2363539|NCT01579045|5800354|P1|NOT COMPLETED|Overall Study||0
2363540|NCT01579045|5800354|P1|COMPLETED|Overall Study||24
2363541|NCT01579045|5800354|P1|STARTED|Overall Study||24
2363542|NCT01579006|5800371|P1|NOT COMPLETED|Overall Study||33
2363543|NCT01579006|5800371|P1|COMPLETED|Overall Study||151
2363544|NCT01579006|5800371|P1|STARTED|Overall Study||184
2363545|NCT01578993|5800410|P1|NOT COMPLETED|Overall Study||0
2363546|NCT01578993|5800410|P1|COMPLETED|Overall Study||101
2363547|NCT01578993|5800410|P1|STARTED|Overall Study||101
2363548|NCT01578980|5800414|P1|NOT COMPLETED|Overall Study||0
2363549|NCT01578980|5800414|P1|COMPLETED|Overall Study||20
2363550|NCT01578980|5800414|P1|STARTED|Overall Study||20
2363551|NCT01578967|5800419|P1|NOT COMPLETED|Overall Study||0
2363552|NCT01578967|5800419|P1|COMPLETED|Overall Study||41
2363553|NCT01578967|5800419|P1|STARTED|Overall Study||41
2363554|NCT01578850|5800430|P3|NOT COMPLETED|Period 2||14
2363555|NCT01578850|5800431|P2|NOT COMPLETED|Period 2||13
2363556|NCT01578850|5800432|P1|NOT COMPLETED|Period 2||0
2363557|NCT01578850|5800430|P3|COMPLETED|Period 2||162
2363558|NCT01578850|5800431|P2|COMPLETED|Period 2||154
2363559|NCT01578850|5800432|P1|COMPLETED|Period 2||0
2363560|NCT01578850|5800430|P3|STARTED|Period 2|One participants in PBO did not receive treatment.|176
2363561|NCT01578850|5800431|P2|STARTED|Period 2|Two participants in ETN did not receive treatment.|167
2363562|NCT01578850|5800432|P1|STARTED|Period 2||0
2363563|NCT01578850|5800430|P3|NOT COMPLETED|Period 1||0
2363564|NCT01578850|5800431|P2|NOT COMPLETED|Period 1||0
2363565|NCT01578850|5800432|P1|NOT COMPLETED|Period 1||37
2363566|NCT01578850|5800430|P3|COMPLETED|Period 1||0
2363567|NCT01578850|5800431|P2|COMPLETED|Period 1||0
2363568|NCT01578850|5800432|P1|COMPLETED|Period 1||452
2363569|NCT01578850|5800430|P3|STARTED|Period 1||0
2363570|NCT01578850|5800431|P2|STARTED|Period 1||0
2363571|NCT01578850|5800432|P1|STARTED|Period 1|491 participants were enrolled in open-label treatment but 2 did not receive study medication.|489
2363572|NCT01578785|5800484|P2|NOT COMPLETED|Overall Study||119
2363573|NCT01578785|5800485|P1|NOT COMPLETED|Overall Study||59
2363574|NCT01578785|5800484|P2|COMPLETED|Overall Study||0
2363575|NCT01578785|5800485|P1|COMPLETED|Overall Study||0
2363576|NCT01578785|5800484|P2|STARTED|Overall Study||119
2363577|NCT01578785|5800485|P1|STARTED|Overall Study||59
2363578|NCT01578772|5800497|P1|NOT COMPLETED|Overall Study||0
2363579|NCT01578772|5800497|P1|COMPLETED|Overall Study||17
2363580|NCT01578772|5800497|P1|STARTED|Overall Study||17
2363581|NCT01578707|5800506|P2|NOT COMPLETED|Overall Study||0
2363582|NCT01578707|5800507|P1|NOT COMPLETED|Overall Study||0
2363583|NCT01578707|5800506|P2|COMPLETED|Overall Study||195
2363584|NCT01578707|5800507|P1|COMPLETED|Overall Study||196
2363585|NCT01578707|5800506|P2|STARTED|Overall Study||195
2363586|NCT01578707|5800507|P1|STARTED|Overall Study||196
2363587|NCT01578577|5800526|P3|NOT COMPLETED|Overall Study||35
2363588|NCT01578577|5800527|P2|NOT COMPLETED|Overall Study||40
2363589|NCT01578577|5800528|P1|NOT COMPLETED|Overall Study||51
2363590|NCT01578577|5800526|P3|COMPLETED|Overall Study||278
2363591|NCT01578577|5800527|P2|COMPLETED|Overall Study||262
2363592|NCT01578577|5800528|P1|COMPLETED|Overall Study||254
2363593|NCT01578577|5800526|P3|STARTED|Overall Study||313
2363594|NCT01578577|5800527|P2|STARTED|Overall Study||302
2363595|NCT01578577|5800528|P1|STARTED|Overall Study||305
2363596|NCT01578551|5800550|P2|NOT COMPLETED|Overall Study||0
2363597|NCT01578551|5800551|P1|NOT COMPLETED|Overall Study||1
2363598|NCT01578551|5800550|P2|COMPLETED|Overall Study||6
2363599|NCT01578551|5800551|P1|COMPLETED|Overall Study||18
2363600|NCT01578551|5800550|P2|STARTED|Overall Study||6
2363601|NCT01578551|5800551|P1|STARTED|Overall Study||19
2363602|NCT01578499|5800563|P2|NOT COMPLETED|Overall Study||43
2363603|NCT01578499|5800564|P1|NOT COMPLETED|Overall Study||34
2363604|NCT01578499|5800563|P2|COMPLETED|Overall Study||22
2363605|NCT01578499|5800564|P1|COMPLETED|Overall Study||32
2363606|NCT01578499|5800563|P2|Intent to Treat Population: CD30+|Overall Study||64
2363607|NCT01578499|5800564|P1|Intent to Treat Population: CD30+|Overall Study||64
2363608|NCT01578499|5800563|P2|Safety Population: Treated|Overall Study||62
2363609|NCT01578499|5800564|P1|Safety Population: Treated|Overall Study||66
2363610|NCT01578499|5800563|P2|STARTED|Overall Study||65
2363611|NCT01578499|5800564|P1|STARTED|Overall Study||66
2363612|NCT01578486|5800598|P1|NOT COMPLETED|Overall Study||5
2363613|NCT01578486|5800598|P1|COMPLETED|Overall Study||8
2363614|NCT01578486|5800598|P1|STARTED|Overall Study||13
2363615|NCT01578330|5800609|P1|NOT COMPLETED|Overall Study||7
2363616|NCT01578330|5800609|P1|COMPLETED|Overall Study||35
2363617|NCT01578330|5800609|P1|Per Protocol Population|Overall Study||35
2363618|NCT01578330|5800609|P1|STARTED|Overall Study||42
2363619|NCT01578317|5800618|P2|NOT COMPLETED|Overall Study||1
2363620|NCT01578317|5800619|P1|NOT COMPLETED|Overall Study||0
2363621|NCT01578317|5800618|P2|COMPLETED|Overall Study||20
2363622|NCT01578317|5800619|P1|COMPLETED|Overall Study||22
2363623|NCT01578317|5800618|P2|Analysis Population|Overall Study||20
2363624|NCT01578317|5800619|P1|Analysis Population|Overall Study||22
2363625|NCT01578317|5800618|P2|STARTED|Overall Study||21
2363626|NCT01578317|5800619|P1|STARTED|Overall Study||22
2363627|NCT01578239|5800627|P2|NOT COMPLETED|Overall Study||25
2363628|NCT01578239|5800628|P1|NOT COMPLETED|Overall Study||22
2363629|NCT01578239|5800627|P2|COMPLETED|Overall Study||88
2363630|NCT01578239|5800628|P1|COMPLETED|Overall Study||94
2363631|NCT01578239|5800627|P2|STARTED|Overall Study||113
2363632|NCT01578239|5800628|P1|STARTED|Overall Study||116
2363633|NCT01578187|5800634|P1|NOT COMPLETED|Usability Phase||1
2363634|NCT01578187|5800634|P1|COMPLETED|Usability Phase||47
2363635|NCT01578187|5800634|P1|STARTED|Usability Phase||48
2363636|NCT01578187|5800634|P1|NOT COMPLETED|Label Comprehension Phase||0
2363637|NCT01578187|5800634|P1|COMPLETED|Label Comprehension Phase||63
2363638|NCT01578187|5800634|P1|STARTED|Label Comprehension Phase||63
2363639|NCT01578044|5800642|P2|NOT COMPLETED|Overall Study||0
2363640|NCT01578044|5800643|P1|NOT COMPLETED|Overall Study||0
2363641|NCT01578044|5800642|P2|COMPLETED|Overall Study||6
2363642|NCT01578044|5800643|P1|COMPLETED|Overall Study||6
2363643|NCT01578044|5800642|P2|STARTED|Overall Study||6
2363644|NCT01578044|5800643|P1|STARTED|Overall Study||6
2363645|NCT01578031|5800653|P4|NOT COMPLETED|Overall Study||0
2363646|NCT01578031|5800654|P3|NOT COMPLETED|Overall Study||0
2363647|NCT01578031|5800655|P2|NOT COMPLETED|Overall Study||34
2363648|NCT01578031|5800656|P1|NOT COMPLETED|Overall Study||62
2363649|NCT01578031|5800653|P4|COMPLETED|Overall Study|Only baseline data collected|30
2363650|NCT01578031|5800654|P3|COMPLETED|Overall Study|Only baseline data collected|12
2363651|NCT01578031|5800655|P2|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|35
2363652|NCT01578031|5800656|P1|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|67
2363653|NCT01578031|5800653|P4|STARTED|Overall Study||30
2363654|NCT01578031|5800654|P3|STARTED|Overall Study||12
2363655|NCT01578031|5800655|P2|STARTED|Overall Study||69
2363656|NCT01578031|5800656|P1|STARTED|Overall Study||129
2363657|NCT01577966|5800672|P1|NOT COMPLETED|Overall Study||0
2363658|NCT01577966|5800672|P1|COMPLETED|Overall Study||9
2363659|NCT01577966|5800672|P1|STARTED|Overall Study||9
2363660|NCT01577758|5800676|P8|NOT COMPLETED|mCRC Expansion Phase||25
2363661|NCT01577758|5800677|P7|NOT COMPLETED|mCRC Expansion Phase||0
2363662|NCT01577758|5800678|P6|NOT COMPLETED|mCRC Expansion Phase||0
2363663|NCT01577758|5800679|P5|NOT COMPLETED|mCRC Expansion Phase||0
2363664|NCT01577758|5800680|P4|NOT COMPLETED|mCRC Expansion Phase||0
2363665|NCT01577758|5800681|P3|NOT COMPLETED|mCRC Expansion Phase||0
2363666|NCT01577758|5800682|P2|NOT COMPLETED|mCRC Expansion Phase||0
2363667|NCT01577758|5800683|P1|NOT COMPLETED|mCRC Expansion Phase||0
2363668|NCT01577758|5800676|P8|COMPLETED|mCRC Expansion Phase||0
2363669|NCT01577758|5800677|P7|COMPLETED|mCRC Expansion Phase||0
2363670|NCT01577758|5800678|P6|COMPLETED|mCRC Expansion Phase||0
2363671|NCT01577758|5800679|P5|COMPLETED|mCRC Expansion Phase||0
2363672|NCT01577758|5800680|P4|COMPLETED|mCRC Expansion Phase||0
2363673|NCT01577758|5800681|P3|COMPLETED|mCRC Expansion Phase||0
2363674|NCT01577758|5800682|P2|COMPLETED|mCRC Expansion Phase||0
2363675|NCT01577758|5800683|P1|COMPLETED|mCRC Expansion Phase||0
2363676|NCT01577758|5800676|P8|STARTED|mCRC Expansion Phase||25
2363677|NCT01577758|5800677|P7|STARTED|mCRC Expansion Phase||0
2363678|NCT01577758|5800678|P6|STARTED|mCRC Expansion Phase||0
2363679|NCT01577758|5800679|P5|STARTED|mCRC Expansion Phase||0
2363680|NCT01577758|5800680|P4|STARTED|mCRC Expansion Phase||0
2363681|NCT01577758|5800681|P3|STARTED|mCRC Expansion Phase||0
2363682|NCT01577758|5800682|P2|STARTED|mCRC Expansion Phase||0
2363683|NCT01577758|5800683|P1|STARTED|mCRC Expansion Phase||0
2363684|NCT01577758|5800676|P8|NOT COMPLETED|Dose Escalation Phase||0
2363685|NCT01577758|5800677|P7|NOT COMPLETED|Dose Escalation Phase||1
2363686|NCT01577758|5800678|P6|NOT COMPLETED|Dose Escalation Phase||4
2363687|NCT01577758|5800679|P5|NOT COMPLETED|Dose Escalation Phase||6
2363688|NCT01577758|5800680|P4|NOT COMPLETED|Dose Escalation Phase||2
2363689|NCT01577758|5800681|P3|NOT COMPLETED|Dose Escalation Phase||2
2363690|NCT01577758|5800682|P2|NOT COMPLETED|Dose Escalation Phase||2
2363691|NCT01577758|5800683|P1|NOT COMPLETED|Dose Escalation Phase||2
2363692|NCT01577758|5800676|P8|COMPLETED|Dose Escalation Phase||0
2363693|NCT01577758|5800677|P7|COMPLETED|Dose Escalation Phase||0
2363694|NCT01577758|5800678|P6|COMPLETED|Dose Escalation Phase||0
2363695|NCT01577758|5800679|P5|COMPLETED|Dose Escalation Phase||0
2363696|NCT01577758|5800680|P4|COMPLETED|Dose Escalation Phase||0
2363697|NCT01577758|5800681|P3|COMPLETED|Dose Escalation Phase||0
2363698|NCT01577758|5800682|P2|COMPLETED|Dose Escalation Phase||0
2363699|NCT01577758|5800683|P1|COMPLETED|Dose Escalation Phase||0
2363700|NCT01577758|5800676|P8|STARTED|Dose Escalation Phase||0
2363701|NCT01577758|5800677|P7|STARTED|Dose Escalation Phase||1
2363702|NCT01577758|5800678|P6|STARTED|Dose Escalation Phase||4
2363703|NCT01577758|5800679|P5|STARTED|Dose Escalation Phase||6
2363704|NCT01577758|5800680|P4|STARTED|Dose Escalation Phase||2
2363705|NCT01577758|5800681|P3|STARTED|Dose Escalation Phase||2
2363706|NCT01577758|5800682|P2|STARTED|Dose Escalation Phase||2
2363707|NCT01577758|5800683|P1|STARTED|Dose Escalation Phase||2
2363708|NCT01577745|5800722|P6|NOT COMPLETED|Overall Study||4
2363709|NCT01577745|5800723|P5|NOT COMPLETED|Overall Study||5
2363710|NCT01577745|5800724|P4|NOT COMPLETED|Overall Study||6
2363711|NCT01577745|5800725|P3|NOT COMPLETED|Overall Study||2
2363712|NCT01577745|5800726|P2|NOT COMPLETED|Overall Study||3
2363713|NCT01577745|5800727|P1|NOT COMPLETED|Overall Study||3
2363714|NCT01577745|5800722|P6|COMPLETED|Overall Study||1
2363715|NCT01577745|5800723|P5|COMPLETED|Overall Study||0
2363716|NCT01577745|5800724|P4|COMPLETED|Overall Study||0
2363717|NCT01577745|5800725|P3|COMPLETED|Overall Study||1
2363718|NCT01577745|5800726|P2|COMPLETED|Overall Study||0
2363719|NCT01577745|5800727|P1|COMPLETED|Overall Study||0
2363720|NCT01577745|5800722|P6|STARTED|Overall Study||5
2363721|NCT01577745|5800723|P5|STARTED|Overall Study||5
2363722|NCT01577745|5800724|P4|STARTED|Overall Study||6
2363723|NCT01577745|5800725|P3|STARTED|Overall Study||3
2363724|NCT01577745|5800726|P2|STARTED|Overall Study||3
2363725|NCT01577745|5800727|P1|STARTED|Overall Study||3
2363726|NCT01577732|5800844|P1|NOT COMPLETED|Overall Study||0
2363727|NCT01577732|5800844|P1|COMPLETED|Overall Study||300
2363728|NCT01577732|5800844|P1|STARTED|Overall Study||300
2363729|NCT01577706|5800851|P3|NOT COMPLETED|Third Intervention (1 Day)||0
2363730|NCT01577706|5800852|P2|NOT COMPLETED|Third Intervention (1 Day)||0
2363731|NCT01577706|5800853|P1|NOT COMPLETED|Third Intervention (1 Day)||0
2363732|NCT01577706|5800851|P3|COMPLETED|Third Intervention (1 Day)||3
2363733|NCT01577706|5800852|P2|COMPLETED|Third Intervention (1 Day)||1
2363734|NCT01577706|5800853|P1|COMPLETED|Third Intervention (1 Day)||3
2363735|NCT01577706|5800851|P3|STARTED|Third Intervention (1 Day)||3
2363736|NCT01577706|5800852|P2|STARTED|Third Intervention (1 Day)||1
2363737|NCT01577706|5800853|P1|STARTED|Third Intervention (1 Day)||3
2363738|NCT01577706|5800851|P3|NOT COMPLETED|Washout (at Least 1 Week)||0
2363739|NCT01577706|5800852|P2|NOT COMPLETED|Washout (at Least 1 Week)||0
2363740|NCT01577706|5800853|P1|NOT COMPLETED|Washout (at Least 1 Week)||0
2363741|NCT01577706|5800851|P3|COMPLETED|Washout (at Least 1 Week)||3
2363742|NCT01577706|5800852|P2|COMPLETED|Washout (at Least 1 Week)||1
2363743|NCT01577706|5800853|P1|COMPLETED|Washout (at Least 1 Week)||3
2363744|NCT01577706|5800851|P3|STARTED|Washout (at Least 1 Week)||3
2363745|NCT01577706|5800852|P2|STARTED|Washout (at Least 1 Week)||1
2363746|NCT01577706|5800853|P1|STARTED|Washout (at Least 1 Week)||3
2363747|NCT01577706|5800851|P3|NOT COMPLETED|Second Intervention (1 Day)||0
2363748|NCT01577706|5800852|P2|NOT COMPLETED|Second Intervention (1 Day)||0
2363749|NCT01577706|5800853|P1|NOT COMPLETED|Second Intervention (1 Day)||0
2363750|NCT01577706|5800851|P3|COMPLETED|Second Intervention (1 Day)||3
2363751|NCT01577706|5800852|P2|COMPLETED|Second Intervention (1 Day)||1
2363752|NCT01577706|5800853|P1|COMPLETED|Second Intervention (1 Day)||3
2363753|NCT01577706|5800851|P3|STARTED|Second Intervention (1 Day)||3
2363754|NCT01577706|5800852|P2|STARTED|Second Intervention (1 Day)||1
2363755|NCT01577706|5800853|P1|STARTED|Second Intervention (1 Day)||3
2363756|NCT01577706|5800851|P3|NOT COMPLETED|Washout (at Least 1 Week)||0
2363757|NCT01577706|5800852|P2|NOT COMPLETED|Washout (at Least 1 Week)||0
2363758|NCT01577706|5800853|P1|NOT COMPLETED|Washout (at Least 1 Week)||0
2363759|NCT01577706|5800851|P3|COMPLETED|Washout (at Least 1 Week)||3
2363760|NCT01577706|5800852|P2|COMPLETED|Washout (at Least 1 Week)||1
2363761|NCT01577706|5800853|P1|COMPLETED|Washout (at Least 1 Week)||3
2363762|NCT01577706|5800851|P3|STARTED|Washout (at Least 1 Week)||3
2363763|NCT01577706|5800852|P2|STARTED|Washout (at Least 1 Week)||1
2363764|NCT01577706|5800853|P1|STARTED|Washout (at Least 1 Week)||3
2363765|NCT01577706|5800851|P3|NOT COMPLETED|First Intervention (1 Day)||0
2363766|NCT01577706|5800852|P2|NOT COMPLETED|First Intervention (1 Day)||0
2363767|NCT01577706|5800853|P1|NOT COMPLETED|First Intervention (1 Day)||0
2363768|NCT01577706|5800851|P3|COMPLETED|First Intervention (1 Day)||3
2363769|NCT01577706|5800852|P2|COMPLETED|First Intervention (1 Day)||1
2363770|NCT01577706|5800853|P1|COMPLETED|First Intervention (1 Day)||3
2363771|NCT01577706|5800851|P3|STARTED|First Intervention (1 Day)||3
2363772|NCT01577706|5800852|P2|STARTED|First Intervention (1 Day)||1
2363773|NCT01577706|5800853|P1|STARTED|First Intervention (1 Day)||3
2363774|NCT01577628|5800881|P3|NOT COMPLETED|Overall Study||2
2363775|NCT01577628|5800882|P2|NOT COMPLETED|Overall Study||0
2363776|NCT01577628|5800883|P1|NOT COMPLETED|Overall Study||0
2363777|NCT01577628|5800881|P3|COMPLETED|Overall Study||0
2363778|NCT01577628|5800882|P2|COMPLETED|Overall Study||0
2363779|NCT01577628|5800883|P1|COMPLETED|Overall Study||0
2363780|NCT01577628|5800881|P3|STARTED|Overall Study||2
2363781|NCT01577628|5800882|P2|STARTED|Overall Study||0
2363782|NCT01577628|5800883|P1|STARTED|Overall Study||0
2363783|NCT01577537|5800909|P2|NOT COMPLETED|Overall Study||7
2363784|NCT01577537|5800910|P1|NOT COMPLETED|Overall Study||8
2363785|NCT01577537|5800909|P2|COMPLETED|Overall Study||116
2363786|NCT01577537|5800910|P1|COMPLETED|Overall Study||120
2363787|NCT01577537|5800909|P2|STARTED|Overall Study||123
2363788|NCT01577537|5800910|P1|STARTED|Overall Study||128
2363789|NCT01577381|5800928|P4|NOT COMPLETED|Overall Study||2
2363790|NCT01577381|5800929|P3|NOT COMPLETED|Overall Study||3
2363791|NCT01577381|5800930|P2|NOT COMPLETED|Overall Study||3
2363792|NCT01577381|5800931|P1|NOT COMPLETED|Overall Study||2
2363793|NCT01577381|5800928|P4|COMPLETED|Overall Study||0
2363794|NCT01577381|5800929|P3|COMPLETED|Overall Study||0
2363795|NCT01577381|5800930|P2|COMPLETED|Overall Study||0
2363796|NCT01577381|5800931|P1|COMPLETED|Overall Study||0
2363797|NCT01577381|5800928|P4|STARTED|Overall Study||2
2363798|NCT01577381|5800929|P3|STARTED|Overall Study||3
2363799|NCT01577381|5800930|P2|STARTED|Overall Study||3
2363800|NCT01577381|5800931|P1|STARTED|Overall Study||2
2363801|NCT01577329|5801062|P2|NOT COMPLETED|Overall Study||0
2363802|NCT01577329|5801063|P1|NOT COMPLETED|Overall Study||3
2363803|NCT01577329|5801062|P2|COMPLETED|Overall Study||22
2363804|NCT01577329|5801063|P1|COMPLETED|Overall Study||16
2363805|NCT01577329|5801062|P2|STARTED|Overall Study||22
2363806|NCT01577329|5801063|P1|STARTED|Overall Study||19
2363807|NCT01577238|5801071|P2|NOT COMPLETED|Overall Study||12
2363808|NCT01577238|5801072|P1|NOT COMPLETED|Overall Study||10
2363809|NCT01577238|5801071|P2|COMPLETED|Overall Study||111
2363810|NCT01577238|5801072|P1|COMPLETED|Overall Study||117
2363811|NCT01577238|5801071|P2|STARTED|Overall Study||123
2363812|NCT01577238|5801072|P1|STARTED|Overall Study||127
2363813|NCT01577186|5801086|P1|NOT COMPLETED|Overall Study||130
2363814|NCT01577186|5801086|P1|COMPLETED|Overall Study||350
2363815|NCT01577186|5801086|P1|STARTED|Overall Study||480
2363816|NCT01577160|5801094|P1|NOT COMPLETED|Overall Study||98
2363817|NCT01577160|5801094|P1|COMPLETED|Overall Study||255
2363818|NCT01577160|5801094|P1|STARTED|Overall Study||353
2363819|NCT01577108|5801104|P2|NOT COMPLETED|Overall Study||6
2363820|NCT01577108|5801105|P1|NOT COMPLETED|Overall Study||5
2363821|NCT01577108|5801104|P2|COMPLETED|Overall Study||50
2363822|NCT01577108|5801105|P1|COMPLETED|Overall Study||49
2363823|NCT01577108|5801104|P2|STARTED|Overall Study||56
2363824|NCT01577108|5801105|P1|STARTED|Overall Study||54
2363825|NCT01576952|5801113|P2|NOT COMPLETED|Overall Study||55
2363826|NCT01576952|5801114|P1|NOT COMPLETED|Overall Study||41
2363827|NCT01576952|5801113|P2|COMPLETED|Overall Study||33
2363828|NCT01576952|5801114|P1|COMPLETED|Overall Study||139
2363829|NCT01576952|5801113|P2|mITT Population|Overall Study||85
2363830|NCT01576952|5801114|P1|mITT Population|Overall Study||168
2363831|NCT01576952|5801113|P2|Safety Population|Overall Study||85
2363832|NCT01576952|5801114|P1|Safety Population|Overall Study||169
2363833|NCT01576952|5801113|P2|STARTED|Overall Study||88
2363834|NCT01576952|5801114|P1|STARTED|Overall Study||180
2363835|NCT01576939|5801120|P1|NOT COMPLETED|Overall Study||0
2363836|NCT01576939|5801120|P1|COMPLETED|Overall Study||30
2363837|NCT01576939|5801120|P1|STARTED|Overall Study||30
2363838|NCT01576874|5801130|P2|NOT COMPLETED|Overall Study||0
2363839|NCT01576874|5801131|P1|NOT COMPLETED|Overall Study||0
2363840|NCT01576874|5801130|P2|COMPLETED|Overall Study||72
2363841|NCT01576874|5801131|P1|COMPLETED|Overall Study||72
2363842|NCT01576874|5801130|P2|STARTED|Overall Study||72
2363843|NCT01576874|5801131|P1|STARTED|Overall Study||72
2363844|NCT01576809|5801141|P1|NOT COMPLETED|Overall Study||0
2363845|NCT01576809|5801141|P1|COMPLETED|Overall Study||51
2363846|NCT01576809|5801141|P1|STARTED|Overall Study||51
2363847|NCT01576783|5801149|P2|NOT COMPLETED|Overall Study||17
2363848|NCT01576783|5801150|P1|NOT COMPLETED|Overall Study||20
2363849|NCT01576783|5801149|P2|COMPLETED|Overall Study||171
2363850|NCT01576783|5801150|P1|COMPLETED|Overall Study||169
2363851|NCT01576783|5801149|P2|STARTED|Overall Study||188
2363852|NCT01576783|5801150|P1|STARTED|Overall Study||189
2363853|NCT01576718|5801172|P7|NOT COMPLETED|Treatment Period||30
2363854|NCT01576718|5801173|P6|NOT COMPLETED|Treatment Period||48
2363855|NCT01576718|5801174|P5|NOT COMPLETED|Treatment Period||27
2363856|NCT01576718|5801175|P4|NOT COMPLETED|Treatment Period||31
2363857|NCT01576718|5801176|P3|NOT COMPLETED|Treatment Period||20
2363858|NCT01576718|5801177|P2|NOT COMPLETED|Treatment Period||25
2363859|NCT01576718|5801178|P1|NOT COMPLETED|Treatment Period||0
2363860|NCT01576718|5801172|P7|COMPLETED|Treatment Period||77
2363861|NCT01576718|5801173|P6|COMPLETED|Treatment Period||58
2363862|NCT01576718|5801174|P5|COMPLETED|Treatment Period||80
2363863|NCT01576718|5801175|P4|COMPLETED|Treatment Period||75
2363864|NCT01576718|5801176|P3|COMPLETED|Treatment Period||87
2363865|NCT01576718|5801177|P2|COMPLETED|Treatment Period||82
2363866|NCT01576718|5801178|P1|COMPLETED|Treatment Period||0
2363867|NCT01576718|5801172|P7|Efficacy Population (Full Analysis Set)|Treatment Period||103
2363868|NCT01576718|5801173|P6|Efficacy Population (Full Analysis Set)|Treatment Period||105
2363869|NCT01576718|5801174|P5|Efficacy Population (Full Analysis Set)|Treatment Period||107
2363870|NCT01576718|5801175|P4|Efficacy Population (Full Analysis Set)|Treatment Period||102
2363871|NCT01576718|5801176|P3|Efficacy Population (Full Analysis Set)|Treatment Period||106
2363872|NCT01576718|5801177|P2|Efficacy Population (Full Analysis Set)|Treatment Period||107
2363873|NCT01576718|5801178|P1|Efficacy Population (Full Analysis Set)|Treatment Period||0
2363874|NCT01576718|5801172|P7|Safety Population|Treatment Period||106
2363875|NCT01576718|5801173|P6|Safety Population|Treatment Period||106
2363876|NCT01576718|5801174|P5|Safety Population|Treatment Period||107
2363877|NCT01576718|5801175|P4|Safety Population|Treatment Period||106
2363878|NCT01576718|5801176|P3|Safety Population|Treatment Period||107
2363879|NCT01576718|5801177|P2|Safety Population|Treatment Period||107
2363880|NCT01576718|5801178|P1|Safety Population|Treatment Period||0
2363881|NCT01576718|5801172|P7|STARTED|Treatment Period||107
2363882|NCT01576718|5801173|P6|STARTED|Treatment Period||106
2363883|NCT01576718|5801174|P5|STARTED|Treatment Period||107
2363884|NCT01576718|5801175|P4|STARTED|Treatment Period||106
2363885|NCT01576718|5801176|P3|STARTED|Treatment Period||107
2363886|NCT01576718|5801177|P2|STARTED|Treatment Period||107
2363887|NCT01576718|5801178|P1|STARTED|Treatment Period||0
2363888|NCT01576718|5801172|P7|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
2363889|NCT01576718|5801173|P6|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
2363890|NCT01576718|5801174|P5|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
2363891|NCT01576718|5801175|P4|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
2363892|NCT01576718|5801176|P3|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
2363893|NCT01576718|5801177|P2|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
2363894|NCT01576718|5801178|P1|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||249
2363895|NCT01576718|5801172|P7|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
2363896|NCT01576718|5801173|P6|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
2363897|NCT01576718|5801174|P5|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
2363898|NCT01576718|5801175|P4|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
2363899|NCT01576718|5801176|P3|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
2363900|NCT01576718|5801177|P2|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
2363901|NCT01576718|5801178|P1|COMPLETED|Pre-Assignment Period (Run-In Placebo)|Participants randomized into the Treatment Period|640
2363902|NCT01576718|5801172|P7|STARTED|Pre-Assignment Period (Run-In Placebo)||0
2363903|NCT01576718|5801173|P6|STARTED|Pre-Assignment Period (Run-In Placebo)||0
2363904|NCT01576718|5801174|P5|STARTED|Pre-Assignment Period (Run-In Placebo)||0
2363905|NCT01576718|5801175|P4|STARTED|Pre-Assignment Period (Run-In Placebo)||0
2363906|NCT01576718|5801176|P3|STARTED|Pre-Assignment Period (Run-In Placebo)||0
2363907|NCT01576718|5801177|P2|STARTED|Pre-Assignment Period (Run-In Placebo)||0
2363908|NCT01576718|5801178|P1|STARTED|Pre-Assignment Period (Run-In Placebo)||889
2363909|NCT01576588|5801270|P1|NOT COMPLETED|Overall Study||2
2363910|NCT01576588|5801270|P1|COMPLETED|Overall Study||23
2363911|NCT01576588|5801270|P1|STARTED|Overall Study||25
2363912|NCT01576575|5801277|P1|NOT COMPLETED|Buprenorphine + Ketoconazole||0
2363913|NCT01576575|5801277|P1|COMPLETED|Buprenorphine + Ketoconazole||14
2363914|NCT01576575|5801277|P1|STARTED|Buprenorphine + Ketoconazole||14
2363915|NCT01576575|5801277|P1|NOT COMPLETED|Buprenorphine + Grapefruit||1
2363916|NCT01576575|5801277|P1|COMPLETED|Buprenorphine + Grapefruit||14
2363917|NCT01576575|5801277|P1|STARTED|Buprenorphine + Grapefruit||15
2363918|NCT01576575|5801277|P1|NOT COMPLETED|Buprenorphine + Rifampin||3
2363919|NCT01576575|5801277|P1|COMPLETED|Buprenorphine + Rifampin||15
2363920|NCT01576575|5801277|P1|STARTED|Buprenorphine + Rifampin||18
2363921|NCT01576575|5801277|P1|NOT COMPLETED|Buprenorphine Control||3
2363922|NCT01576575|5801277|P1|COMPLETED|Buprenorphine Control||18
2363923|NCT01576575|5801277|P1|STARTED|Buprenorphine Control||21
2363924|NCT01576549|5801287|P1|NOT COMPLETED|Overall Study||2
2363925|NCT01576549|5801287|P1|COMPLETED|Overall Study||0
2363926|NCT01576549|5801287|P1|Completed Post-Treatment Follow-Up|Overall Study|Each participant discontinued dosing and completed the Post-Treatment Follow-Up Period.|2
2363927|NCT01576549|5801287|P1|Received at Least 1 Dose of Study Drug|Overall Study||2
2363928|NCT01576549|5801287|P1|STARTED|Overall Study||2
2363929|NCT01576536|5801295|P1|NOT COMPLETED|Overall Study||0
2363930|NCT01576536|5801295|P1|COMPLETED|Overall Study||117
2363931|NCT01576536|5801295|P1|STARTED|Overall Study||117
2363932|NCT01576471|5801303|P2|NOT COMPLETED|Overall Study||9
2363933|NCT01576471|5801304|P1|NOT COMPLETED|Overall Study||8
2363934|NCT01576471|5801303|P2|COMPLETED|Overall Study||116
2363935|NCT01576471|5801304|P1|COMPLETED|Overall Study||117
2363936|NCT01576471|5801303|P2|STARTED|Overall Study||125
2363937|NCT01576471|5801304|P1|STARTED|Overall Study||125
2363938|NCT01576406|5801316|P6|NOT COMPLETED|Overall Study||12
2363939|NCT01576406|5801317|P5|NOT COMPLETED|Overall Study||8
2363940|NCT01576406|5801318|P4|NOT COMPLETED|Overall Study||9
2363941|NCT01576406|5801319|P3|NOT COMPLETED|Overall Study||16
2363942|NCT01576406|5801320|P2|NOT COMPLETED|Overall Study||8
2363943|NCT01576406|5801321|P1|NOT COMPLETED|Overall Study||6
2363944|NCT01576406|5801316|P6|COMPLETED|Overall Study||4
2363945|NCT01576406|5801317|P5|COMPLETED|Overall Study||8
2363946|NCT01576406|5801318|P4|COMPLETED|Overall Study||1
2363947|NCT01576406|5801319|P3|COMPLETED|Overall Study||4
2363948|NCT01576406|5801320|P2|COMPLETED|Overall Study||7
2363949|NCT01576406|5801321|P1|COMPLETED|Overall Study||5
2363950|NCT01576406|5801316|P6|STARTED|Overall Study||16
2363951|NCT01576406|5801317|P5|STARTED|Overall Study||16
2363952|NCT01576406|5801318|P4|STARTED|Overall Study||10
2363953|NCT01576406|5801319|P3|STARTED|Overall Study||20
2363954|NCT01576406|5801320|P2|STARTED|Overall Study||15
2363955|NCT01576406|5801321|P1|STARTED|Overall Study||11
2363956|NCT01576367|5801569|P1|NOT COMPLETED|Overall Study||3
2363957|NCT01576367|5801569|P1|COMPLETED|Overall Study||14
2363958|NCT01576367|5801569|P1|STARTED|Overall Study||17
2363959|NCT01576341|5801577|P1|NOT COMPLETED|Overall Study||93
2363960|NCT01576341|5801577|P1|COMPLETED|Overall Study||324
2363961|NCT01576341|5801577|P1|STARTED|Overall Study||417
2363962|NCT01576276|5801586|P2|NOT COMPLETED|Overall Study||11
2363963|NCT01576276|5801587|P1|NOT COMPLETED|Overall Study||8
2363964|NCT01576276|5801586|P2|COMPLETED|Overall Study||18
2363965|NCT01576276|5801587|P1|COMPLETED|Overall Study||14
2363966|NCT01576276|5801586|P2|STARTED|Overall Study||29
2363967|NCT01576276|5801587|P1|STARTED|Overall Study||22
2363968|NCT01576159|5801598|P4|NOT COMPLETED|Overall Study||1
2363969|NCT01576159|5801599|P3|NOT COMPLETED|Overall Study||1
2363970|NCT01576159|5801600|P2|NOT COMPLETED|Overall Study||1
2363971|NCT01576159|5801601|P1|NOT COMPLETED|Overall Study||1
2363972|NCT01576159|5801598|P4|COMPLETED|Overall Study||11
2363973|NCT01576159|5801599|P3|COMPLETED|Overall Study||11
2363974|NCT01576159|5801600|P2|COMPLETED|Overall Study||11
2363975|NCT01576159|5801601|P1|COMPLETED|Overall Study||11
2363976|NCT01576159|5801598|P4|STARTED|Overall Study||12
2363977|NCT01576159|5801599|P3|STARTED|Overall Study||12
2363978|NCT01576159|5801600|P2|STARTED|Overall Study||12
2363979|NCT01576159|5801601|P1|STARTED|Overall Study||12
2363980|NCT01576146|5801619|P1|NOT COMPLETED|Extension Period 2||17
2363981|NCT01576146|5801619|P1|COMPLETED|Extension Period 2||0
2363982|NCT01576146|5801619|P1|STARTED|Extension Period 2|Three participants who completed Extension Period 1 did not enroll in Period 2|17
2363983|NCT01576146|5801619|P1|NOT COMPLETED|Extension Period 1||10
2363984|NCT01576146|5801619|P1|COMPLETED|Extension Period 1||20
2363985|NCT01576146|5801619|P1|STARTED|Extension Period 1||30
2363986|NCT01576120|5801628|P2|NOT COMPLETED|Overall Study||0
2363987|NCT01576120|5801629|P1|NOT COMPLETED|Overall Study||0
2363988|NCT01576120|5801628|P2|COMPLETED|Overall Study||19
2363989|NCT01576120|5801629|P1|COMPLETED|Overall Study||21
2363990|NCT01576120|5801628|P2|STARTED|Overall Study||19
2363991|NCT01576120|5801629|P1|STARTED|Overall Study||21
2363992|NCT01576055|5801637|P2|NOT COMPLETED|Overall Study||6
2363993|NCT01576055|5801638|P1|NOT COMPLETED|Overall Study||19
2363994|NCT01576055|5801637|P2|COMPLETED|Overall Study||64
2363995|NCT01576055|5801638|P1|COMPLETED|Overall Study||178
2363996|NCT01576055|5801637|P2|STARTED|Overall Study||70
2363997|NCT01576055|5801638|P1|STARTED|Overall Study||197
2363998|NCT01576042|5801652|P2|NOT COMPLETED|Overall Study||0
2363999|NCT01576042|5801653|P1|NOT COMPLETED|Overall Study||2
2364000|NCT01576042|5801652|P2|COMPLETED|Overall Study||14
2364001|NCT01576042|5801653|P1|COMPLETED|Overall Study||11
2364002|NCT01576042|5801652|P2|Switched to the Other Arm|Overall Study||1
2364003|NCT01576042|5801653|P1|Switched to the Other Arm|Overall Study||5
2364004|NCT01576042|5801652|P2|STARTED|Overall Study||14
2364005|NCT01576042|5801653|P1|STARTED|Overall Study||13
2364006|NCT01575912|5801676|P3|NOT COMPLETED|Overall Study||0
2364007|NCT01575912|5801677|P2|NOT COMPLETED|Overall Study||0
2364008|NCT01575912|5801678|P1|NOT COMPLETED|Overall Study||0
2364009|NCT01575912|5801676|P3|COMPLETED|Overall Study||30
2364010|NCT01575912|5801677|P2|COMPLETED|Overall Study||32
2364011|NCT01575912|5801678|P1|COMPLETED|Overall Study||30
2364012|NCT01575912|5801676|P3|STARTED|Overall Study||30
2364013|NCT01575912|5801677|P2|STARTED|Overall Study||32
2364014|NCT01575912|5801678|P1|STARTED|Overall Study||30
2364015|NCT01575899|5801689|P3|NOT COMPLETED|Overall Study||2
2364016|NCT01575899|5801690|P2|NOT COMPLETED|Overall Study||5
2364017|NCT01575899|5801691|P1|NOT COMPLETED|Overall Study||5
2364018|NCT01575899|5801689|P3|COMPLETED|Overall Study||60
2364019|NCT01575899|5801690|P2|COMPLETED|Overall Study||68
2364020|NCT01575899|5801691|P1|COMPLETED|Overall Study||68
2364021|NCT01575899|5801689|P3|STARTED|Overall Study|Included patients still with Hp infection after previous therapy without levofloxacin and Augmentin.|62
2364022|NCT01575899|5801690|P2|STARTED|Overall Study||73
2364023|NCT01575899|5801691|P1|STARTED|Overall Study||73
2364024|NCT01575873|5801705|P4|NOT COMPLETED|Overall Study||67
2364025|NCT01575873|5801706|P3|NOT COMPLETED|Overall Study||74
2364026|NCT01575873|5801707|P2|NOT COMPLETED|Overall Study||36
2364027|NCT01575873|5801708|P1|NOT COMPLETED|Overall Study||28
2364028|NCT01575873|5801705|P4|COMPLETED|Overall Study||186
2364029|NCT01575873|5801706|P3|COMPLETED|Overall Study||178
2364030|NCT01575873|5801707|P2|COMPLETED|Overall Study||109
2364031|NCT01575873|5801708|P1|COMPLETED|Overall Study||117
2364032|NCT01575873|5801705|P4|Received Study Drug|Overall Study|Participants who received subcutaneous denosumab|251
2364033|NCT01575873|5801706|P3|Received Study Drug|Overall Study|Participants who received oral risedronate|246
2364034|NCT01575873|5801707|P2|Received Study Drug|Overall Study|Participants who received subcutaneous denosumab|142
2364035|NCT01575873|5801708|P1|Received Study Drug|Overall Study|Participants who received oral risedronate|140
2364036|NCT01575873|5801705|P4|STARTED|Overall Study||253
2364037|NCT01575873|5801706|P3|STARTED|Overall Study||252
2364038|NCT01575873|5801707|P2|STARTED|Overall Study||145
2364039|NCT01575873|5801708|P1|STARTED|Overall Study||145
2364040|NCT01575834|5801734|P2|NOT COMPLETED|Overall Study||738
2364041|NCT01575834|5801735|P1|NOT COMPLETED|Overall Study||699
2364042|NCT01575834|5801734|P2|COMPLETED|Overall Study|Completed 36-month study period|2851
2364043|NCT01575834|5801735|P1|COMPLETED|Overall Study|Completed 36-month study period|2892
2364044|NCT01575834|5801734|P2|Completed 24-month Study Period|Overall Study||2994
2364045|NCT01575834|5801735|P1|Completed 24-month Study Period|Overall Study||3032
2364046|NCT01575834|5801734|P2|Completed Double-blind Period|Overall Study||3185
2364047|NCT01575834|5801735|P1|Completed Double-blind Period|Overall Study||3205
2364048|NCT01575834|5801734|P2|Received Double-blind Treatment|Overall Study||3575
2364049|NCT01575834|5801735|P1|Received Double-blind Treatment|Overall Study|Six participants received a dose of romosozumab in error during the double-blind period.|3582
2364050|NCT01575834|5801734|P2|STARTED|Overall Study||3589
2364051|NCT01575834|5801735|P1|STARTED|Overall Study||3591
2364052|NCT01575808|5801787|P2|NOT COMPLETED|Overall Study||0
2364053|NCT01575808|5801788|P1|NOT COMPLETED|Overall Study||3
2364054|NCT01575808|5801787|P2|COMPLETED|Overall Study||68
2364055|NCT01575808|5801788|P1|COMPLETED|Overall Study|Study ongoing. All 103 assessed for primary invasiveness endpoints,100 for primary efficacy endpoint|100
2364056|NCT01575808|5801787|P2|STARTED|Overall Study||68
2364057|NCT01575808|5801788|P1|STARTED|Overall Study||103
2364058|NCT01575769|5801835|P1|NOT COMPLETED|Overall Study||41
2364059|NCT01575769|5801835|P1|COMPLETED|Overall Study||0
2364060|NCT01575769|5801835|P1|STARTED|Overall Study||41
2364061|NCT01575756|5801861|P2|NOT COMPLETED|Treatment Period 2||0
2364062|NCT01575756|5801862|P1|NOT COMPLETED|Treatment Period 2||0
2364063|NCT01575756|5801861|P2|COMPLETED|Treatment Period 2||11
2364064|NCT01575756|5801862|P1|COMPLETED|Treatment Period 2||11
2364065|NCT01575756|5801861|P2|STARTED|Treatment Period 2||11
2364066|NCT01575756|5801862|P1|STARTED|Treatment Period 2||11
2364067|NCT01575756|5801861|P2|NOT COMPLETED|Treatment Period 1||0
2364068|NCT01575756|5801862|P1|NOT COMPLETED|Treatment Period 1||0
2364069|NCT01575756|5801861|P2|COMPLETED|Treatment Period 1||11
2364070|NCT01575756|5801862|P1|COMPLETED|Treatment Period 1||11
2364071|NCT01575756|5801861|P2|STARTED|Treatment Period 1||11
2364072|NCT01575756|5801862|P1|STARTED|Treatment Period 1||11
2364073|NCT01575561|5801893|P1|NOT COMPLETED|Overall Study||39
2364074|NCT01575561|5801893|P1|COMPLETED|Overall Study||338
2364075|NCT01575561|5801893|P1|STARTED|Overall Study||377
2364076|NCT01575522|5801905|P1|NOT COMPLETED|Overall Study||0
2364077|NCT01575522|5801905|P1|COMPLETED|Overall Study||22
2364078|NCT01575522|5801905|P1|STARTED|Overall Study||22
2364079|NCT01575275|5801913|P1|NOT COMPLETED|Overall Study||0
2364080|NCT01575275|5801913|P1|COMPLETED|Overall Study||8
2364081|NCT01575275|5801913|P1|STARTED|Overall Study||8
2364082|NCT01575197|5801923|P3|NOT COMPLETED|Overall Study||6
2364083|NCT01575197|5801924|P2|NOT COMPLETED|Overall Study||9
2364084|NCT01575197|5801925|P1|NOT COMPLETED|Overall Study||3
2364085|NCT01575197|5801923|P3|COMPLETED|Overall Study||146
2364086|NCT01575197|5801924|P2|COMPLETED|Overall Study||143
2364087|NCT01575197|5801925|P1|COMPLETED|Overall Study||149
2364088|NCT01575197|5801923|P3|STARTED|Overall Study||152
2364089|NCT01575197|5801924|P2|STARTED|Overall Study||152
2364090|NCT01575197|5801925|P1|STARTED|Overall Study||152
2364091|NCT01575106|5801938|P1|NOT COMPLETED|Overall Study||14
2364092|NCT01575106|5801938|P1|COMPLETED|Overall Study||24
2364093|NCT01575106|5801938|P1|STARTED|Overall Study||38
2364094|NCT01575080|5801944|P1|NOT COMPLETED|Overall Study||0
2364095|NCT01575080|5801944|P1|COMPLETED|Overall Study||102
2364096|NCT01575080|5801944|P1|STARTED|Overall Study||102
2364097|NCT01575054|5801953|P2|NOT COMPLETED|Overall Study||26
2364098|NCT01575054|5801954|P1|NOT COMPLETED|Overall Study||29
2364099|NCT01575054|5801953|P2|COMPLETED|Overall Study||209
2364100|NCT01575054|5801954|P1|COMPLETED|Overall Study||204
2364101|NCT01575054|5801953|P2|STARTED|Overall Study||235
2364102|NCT01575054|5801954|P1|STARTED|Overall Study||233
2364103|NCT01575028|5801970|P2|NOT COMPLETED|Overall Study||1
2364104|NCT01575028|5801971|P1|NOT COMPLETED|Overall Study||0
2364105|NCT01575028|5801970|P2|COMPLETED|Overall Study||0
2364106|NCT01575028|5801971|P1|COMPLETED|Overall Study||2
2364107|NCT01575028|5801970|P2|STARTED|Overall Study||1
2364108|NCT01575028|5801971|P1|STARTED|Overall Study||2
2364109|NCT01574716|5801982|P5|NOT COMPLETED|Part 2||70
2364110|NCT01574716|5801983|P4|NOT COMPLETED|Part 2||137
2364111|NCT01574716|5801984|P3|NOT COMPLETED|Part 2||0
2364112|NCT01574716|5801985|P2|NOT COMPLETED|Part 2||0
2364113|NCT01574716|5801986|P1|NOT COMPLETED|Part 2||0
2364114|NCT01574716|5801982|P5|COMPLETED|Part 2||0
2364115|NCT01574716|5801983|P4|COMPLETED|Part 2||2
2364116|NCT01574716|5801984|P3|COMPLETED|Part 2||0
2364117|NCT01574716|5801985|P2|COMPLETED|Part 2||0
2364118|NCT01574716|5801986|P1|COMPLETED|Part 2||0
2364119|NCT01574716|5801982|P5|Treated Participants|Part 2||67
2364120|NCT01574716|5801983|P4|Treated Participants|Part 2||140
2364121|NCT01574716|5801984|P3|Treated Participants|Part 2||0
2364122|NCT01574716|5801985|P2|Treated Participants|Part 2||0
2364123|NCT01574716|5801986|P1|Treated Participants|Part 2||0
2364124|NCT01574716|5801982|P5|STARTED|Part 2||70
2364125|NCT01574716|5801983|P4|STARTED|Part 2||139
2364126|NCT01574716|5801984|P3|STARTED|Part 2||0
2364127|NCT01574716|5801985|P2|STARTED|Part 2||0
2364128|NCT01574716|5801986|P1|STARTED|Part 2||0
2364129|NCT01574716|5801982|P5|NOT COMPLETED|Part 1||0
2364130|NCT01574716|5801983|P4|NOT COMPLETED|Part 1||0
2364131|NCT01574716|5801984|P3|NOT COMPLETED|Part 1||9
2364132|NCT01574716|5801985|P2|NOT COMPLETED|Part 1||4
2364133|NCT01574716|5801986|P1|NOT COMPLETED|Part 1||3
2364134|NCT01574716|5801982|P5|COMPLETED|Part 1||0
2364135|NCT01574716|5801983|P4|COMPLETED|Part 1||0
2364136|NCT01574716|5801984|P3|COMPLETED|Part 1||0
2364137|NCT01574716|5801985|P2|COMPLETED|Part 1||0
2364138|NCT01574716|5801986|P1|COMPLETED|Part 1||0
2364139|NCT01574716|5801982|P5|STARTED|Part 1||0
2364140|NCT01574716|5801983|P4|STARTED|Part 1||0
2364141|NCT01574716|5801984|P3|STARTED|Part 1||9
2364142|NCT01574716|5801985|P2|STARTED|Part 1||4
2364143|NCT01574716|5801986|P1|STARTED|Part 1||3
2364144|NCT01574703|5802009|P4|NOT COMPLETED|Overall Study||114
2364145|NCT01574703|5802010|P3|NOT COMPLETED|Overall Study||105
2364146|NCT01574703|5802011|P2|NOT COMPLETED|Overall Study||112
2364147|NCT01574703|5802012|P1|NOT COMPLETED|Overall Study||125
2364148|NCT01574703|5802009|P4|COMPLETED|Overall Study||1007
2364149|NCT01574703|5802010|P3|COMPLETED|Overall Study||1011
2364150|NCT01574703|5802011|P2|COMPLETED|Overall Study||1054
2364151|NCT01574703|5802012|P1|COMPLETED|Overall Study||1067
2364152|NCT01574703|5802009|P4|STARTED|Overall Study||1121
2364153|NCT01574703|5802010|P3|STARTED|Overall Study||1116
2364154|NCT01574703|5802011|P2|STARTED|Overall Study||1166
2364155|NCT01574703|5802012|P1|STARTED|Overall Study||1192
2364156|NCT01574651|5802056|P2|NOT COMPLETED|Overall Study||52
2364157|NCT01574651|5802057|P1|NOT COMPLETED|Overall Study||61
2364158|NCT01574651|5802056|P2|COMPLETED|Overall Study||406
2364159|NCT01574651|5802057|P1|COMPLETED|Overall Study||415
2364160|NCT01574651|5802056|P2|Per Protocol Set (PPS)|Overall Study||374
2364161|NCT01574651|5802057|P1|Per Protocol Set (PPS)|Overall Study||373
2364162|NCT01574651|5802056|P2|Full Analysis Set (FAS)|Overall Study||458
2364163|NCT01574651|5802057|P1|Full Analysis Set (FAS)|Overall Study||476
2364164|NCT01574651|5802056|P2|STARTED|Overall Study||458
2364165|NCT01574651|5802057|P1|STARTED|Overall Study||476
2364166|NCT01574612|5802079|P1|NOT COMPLETED|Overall Study||8
2364167|NCT01574612|5802079|P1|COMPLETED|Overall Study||46
2364168|NCT01574612|5802079|P1|STARTED|Overall Study|patients who were identified as having the appropriate medical history of herpes labialis|54
2364169|NCT01574326|5802085|P2|NOT COMPLETED|Overall Study||19
2364170|NCT01574326|5802086|P1|NOT COMPLETED|Overall Study||16
2364171|NCT01574326|5802085|P2|COMPLETED|Overall Study||31
2364172|NCT01574326|5802086|P1|COMPLETED|Overall Study||35
2364173|NCT01574326|5802085|P2|Treated|Overall Study||49
2364174|NCT01574326|5802086|P1|Treated|Overall Study||51
2364175|NCT01574326|5802085|P2|STARTED|Overall Study||50
2364176|NCT01574326|5802086|P1|STARTED|Overall Study||51
2364177|NCT01574287|5802097|P1|NOT COMPLETED|Overall Study||0
2364178|NCT01574287|5802097|P1|COMPLETED|Overall Study||4
2364179|NCT01574287|5802097|P1|STARTED|Overall Study||4
2364180|NCT01574248|5802104|P2|NOT COMPLETED|Overall Study||0
2364181|NCT01574248|5802105|P1|NOT COMPLETED|Overall Study||3
2364182|NCT01574248|5802104|P2|COMPLETED|Overall Study||18
2364183|NCT01574248|5802105|P1|COMPLETED|Overall Study||12
2364184|NCT01574248|5802104|P2|STARTED|Overall Study||18
2364185|NCT01574248|5802105|P1|STARTED|Overall Study||15
2364186|NCT01574183|5802125|P2|NOT COMPLETED|Overall Study||18
2364187|NCT01574183|5802126|P1|NOT COMPLETED|Overall Study||27
2364188|NCT01574183|5802125|P2|COMPLETED|Overall Study||17
2364189|NCT01574183|5802126|P1|COMPLETED|Overall Study||14
2364190|NCT01574183|5802125|P2|STARTED|Overall Study||35
2364191|NCT01574183|5802126|P1|STARTED|Overall Study||41
2364192|NCT01574157|5802138|P2|NOT COMPLETED|Overall Study||8
2364193|NCT01574157|5802139|P1|NOT COMPLETED|Overall Study||4
2364194|NCT01574157|5802138|P2|COMPLETED|Overall Study||31
2364195|NCT01574157|5802139|P1|COMPLETED|Overall Study||31
2364196|NCT01574157|5802138|P2|Month 3|Overall Study||33
2364197|NCT01574157|5802139|P1|Month 3|Overall Study||31
2364198|NCT01574157|5802138|P2|STARTED|Overall Study||39
2364199|NCT01574157|5802139|P1|STARTED|Overall Study||35
2364200|NCT01574144|5802155|P1|NOT COMPLETED|Overall Study||0
2364201|NCT01574144|5802155|P1|COMPLETED|Overall Study||70
2364202|NCT01574144|5802155|P1|STARTED|Overall Study||70
2364203|NCT01574105|5802162|P2|NOT COMPLETED|Overall Study||0
2364204|NCT01574105|5802163|P1|NOT COMPLETED|Overall Study||0
2364205|NCT01574105|5802162|P2|COMPLETED|Overall Study||37
2364206|NCT01574105|5802163|P1|COMPLETED|Overall Study||29
2364207|NCT01574105|5802162|P2|STARTED|Overall Study||37
2364208|NCT01574105|5802163|P1|STARTED|Overall Study||29
2364209|NCT01574079|5802173|P2|NOT COMPLETED|Overall Study||2
2364210|NCT01574079|5802174|P1|NOT COMPLETED|Overall Study||1
2364211|NCT01574079|5802173|P2|COMPLETED|Overall Study||13
2364212|NCT01574079|5802174|P1|COMPLETED|Overall Study||17
2364213|NCT01574079|5802173|P2|STARTED|Overall Study||15
2364214|NCT01574079|5802174|P1|STARTED|Overall Study||18
2364215|NCT01573910|5802186|P2|NOT COMPLETED|Overall Study||17
2364216|NCT01573910|5802187|P1|NOT COMPLETED|Overall Study||20
2364217|NCT01573910|5802186|P2|COMPLETED|Overall Study||476
2364218|NCT01573910|5802187|P1|COMPLETED|Overall Study||469
2364219|NCT01573910|5802186|P2|STARTED|Overall Study||493
2364220|NCT01573910|5802187|P1|STARTED|Overall Study||489
2364221|NCT01573767|5802199|P4|NOT COMPLETED|Overall Study||24
2364222|NCT01573767|5802200|P3|NOT COMPLETED|Overall Study||14
2364223|NCT01573767|5802201|P2|NOT COMPLETED|Overall Study||21
2364224|NCT01573767|5802202|P1|NOT COMPLETED|Overall Study||22
2364225|NCT01573767|5802199|P4|COMPLETED|Overall Study||90
2364226|NCT01573767|5802200|P3|COMPLETED|Overall Study||99
2364227|NCT01573767|5802201|P2|COMPLETED|Overall Study||93
2364228|NCT01573767|5802202|P1|COMPLETED|Overall Study||93
2364229|NCT01573767|5802199|P4|STARTED|Overall Study||114
2364230|NCT01573767|5802200|P3|STARTED|Overall Study||113
2364231|NCT01573767|5802201|P2|STARTED|Overall Study||114
2364232|NCT01573767|5802202|P1|STARTED|Overall Study||115
2364233|NCT01573624|5802236|P7|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
2364234|NCT01573624|5802237|P6|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
2364235|NCT01573624|5802238|P5|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||2
2364236|NCT01573624|5802239|P4|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
2364237|NCT01573624|5802240|P3|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
2364238|NCT01573624|5802241|P2|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
2364239|NCT01573624|5802242|P1|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
2364240|NCT01573624|5802236|P7|COMPLETED|Period 6 : Follow-up Period (7 Days)||48
2364241|NCT01573624|5802237|P6|COMPLETED|Period 6 : Follow-up Period (7 Days)||38
2364242|NCT01573624|5802238|P5|COMPLETED|Period 6 : Follow-up Period (7 Days)||49
2364243|NCT01573624|5802239|P4|COMPLETED|Period 6 : Follow-up Period (7 Days)||53
2364244|NCT01573624|5802240|P3|COMPLETED|Period 6 : Follow-up Period (7 Days)||43
2364245|NCT01573624|5802241|P2|COMPLETED|Period 6 : Follow-up Period (7 Days)||47
2364246|NCT01573624|5802242|P1|COMPLETED|Period 6 : Follow-up Period (7 Days)||45
2364247|NCT01573624|5802236|P7|STARTED|Period 6 : Follow-up Period (7 Days)||48
2364248|NCT01573624|5802237|P6|STARTED|Period 6 : Follow-up Period (7 Days)||39
2364249|NCT01573624|5802238|P5|STARTED|Period 6 : Follow-up Period (7 Days)||51
2364250|NCT01573624|5802239|P4|STARTED|Period 6 : Follow-up Period (7 Days)||53
2364251|NCT01573624|5802240|P3|STARTED|Period 6 : Follow-up Period (7 Days)||43
2364252|NCT01573624|5802241|P2|STARTED|Period 6 : Follow-up Period (7 Days)||47
2364253|NCT01573624|5802242|P1|STARTED|Period 6 : Follow-up Period (7 Days)||46
2364254|NCT01573624|5802236|P7|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||4
2364255|NCT01573624|5802237|P6|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||2
2364256|NCT01573624|5802238|P5|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
2364257|NCT01573624|5802239|P4|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
2364258|NCT01573624|5802240|P3|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
2364259|NCT01573624|5802241|P2|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
2364260|NCT01573624|5802242|P1|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||3
2364261|NCT01573624|5802236|P7|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||48
2364262|NCT01573624|5802237|P6|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||39
2364263|NCT01573624|5802238|P5|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||51
2364264|NCT01573624|5802239|P4|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||53
2364265|NCT01573624|5802240|P3|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||43
2364266|NCT01573624|5802241|P2|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||47
2364267|NCT01573624|5802242|P1|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||46
2364268|NCT01573624|5802236|P7|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
2364269|NCT01573624|5802237|P6|STARTED|Period 5 : Treatment Period 3 (14 Days)||41
2364270|NCT01573624|5802238|P5|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
2364271|NCT01573624|5802239|P4|STARTED|Period 5 : Treatment Period 3 (14 Days)||53
2364272|NCT01573624|5802240|P3|STARTED|Period 5 : Treatment Period 3 (14 Days)||43
2364273|NCT01573624|5802241|P2|STARTED|Period 5 : Treatment Period 3 (14 Days)||48
2364274|NCT01573624|5802242|P1|STARTED|Period 5 : Treatment Period 3 (14 Days)||49
2364275|NCT01573624|5802236|P7|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||3
2364276|NCT01573624|5802237|P6|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
2364277|NCT01573624|5802238|P5|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
2364278|NCT01573624|5802239|P4|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
2364279|NCT01573624|5802240|P3|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
2364280|NCT01573624|5802241|P2|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||4
2364281|NCT01573624|5802242|P1|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
2364282|NCT01573624|5802236|P7|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
2364283|NCT01573624|5802237|P6|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||41
2364284|NCT01573624|5802238|P5|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
2364285|NCT01573624|5802239|P4|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||53
2364286|NCT01573624|5802240|P3|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||43
2364287|NCT01573624|5802241|P2|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||48
2364362|NCT01573442|5802298|P2|NOT COMPLETED|Overall Study||10
2364288|NCT01573624|5802242|P1|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||49
2364289|NCT01573624|5802236|P7|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
2364290|NCT01573624|5802237|P6|STARTED|Period 4 : Washout Period 2 (12-14 Days)||43
2364291|NCT01573624|5802238|P5|STARTED|Period 4 : Washout Period 2 (12-14 Days)||53
2364292|NCT01573624|5802239|P4|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
2364293|NCT01573624|5802240|P3|STARTED|Period 4 : Washout Period 2 (12-14 Days)||45
2364294|NCT01573624|5802241|P2|STARTED|Period 4 : Washout Period 2 (12-14 Days)||52
2364295|NCT01573624|5802242|P1|STARTED|Period 4 : Washout Period 2 (12-14 Days)||50
2364296|NCT01573624|5802236|P7|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||0
2364297|NCT01573624|5802237|P6|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||5
2364298|NCT01573624|5802238|P5|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
2364299|NCT01573624|5802239|P4|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||1
2364300|NCT01573624|5802240|P3|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
2364301|NCT01573624|5802241|P2|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||6
2364302|NCT01573624|5802242|P1|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||7
2364303|NCT01573624|5802236|P7|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
2364304|NCT01573624|5802237|P6|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||43
2364305|NCT01573624|5802238|P5|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||53
2364306|NCT01573624|5802239|P4|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
2364307|NCT01573624|5802240|P3|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||45
2364308|NCT01573624|5802241|P2|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||52
2364309|NCT01573624|5802242|P1|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||50
2364310|NCT01573624|5802236|P7|STARTED|Period 3 : Treatment Period 2 (14 Days)||55
2364311|NCT01573624|5802237|P6|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
2364312|NCT01573624|5802238|P5|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
2364313|NCT01573624|5802239|P4|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
2364314|NCT01573624|5802240|P3|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
2364315|NCT01573624|5802241|P2|STARTED|Period 3 : Treatment Period 2 (14 Days)||58
2364316|NCT01573624|5802242|P1|STARTED|Period 3 : Treatment Period 2 (14 Days)||57
2364317|NCT01573624|5802236|P7|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||2
2364318|NCT01573624|5802237|P6|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
2364319|NCT01573624|5802238|P5|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||0
2364320|NCT01573624|5802239|P4|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||5
2364321|NCT01573624|5802240|P3|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
2364322|NCT01573624|5802241|P2|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
2364323|NCT01573624|5802242|P1|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
2364324|NCT01573624|5802236|P7|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||55
2364325|NCT01573624|5802237|P6|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
2364326|NCT01573624|5802238|P5|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
2364327|NCT01573624|5802239|P4|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
2364328|NCT01573624|5802240|P3|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
2364329|NCT01573624|5802241|P2|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||58
2364330|NCT01573624|5802242|P1|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||57
2364331|NCT01573624|5802236|P7|STARTED|Period 2 : Washout Period 1 (12-14 Days)||57
2364332|NCT01573624|5802237|P6|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
2364333|NCT01573624|5802238|P5|STARTED|Period 2 : Washout Period 1 (12-14 Days)||56
2364334|NCT01573624|5802239|P4|STARTED|Period 2 : Washout Period 1 (12-14 Days)||61
2364335|NCT01573624|5802240|P3|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
2364336|NCT01573624|5802241|P2|STARTED|Period 2 : Washout Period 1 (12-14 Days)||59
2364337|NCT01573624|5802242|P1|STARTED|Period 2 : Washout Period 1 (12-14 Days)||58
2364338|NCT01573624|5802236|P7|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
2364339|NCT01573624|5802237|P6|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||4
2364340|NCT01573624|5802238|P5|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
2364341|NCT01573624|5802239|P4|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
2364342|NCT01573624|5802240|P3|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||9
2364343|NCT01573624|5802241|P2|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||3
2364344|NCT01573624|5802242|P1|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||6
2364345|NCT01573624|5802236|P7|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||57
2364346|NCT01573624|5802237|P6|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
2364347|NCT01573624|5802238|P5|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||56
2364348|NCT01573624|5802239|P4|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||61
2364349|NCT01573624|5802240|P3|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
2364350|NCT01573624|5802241|P2|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||59
2364351|NCT01573624|5802242|P1|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||58
2364352|NCT01573624|5802236|P7|STARTED|Period 1 : Treatment Period 1 (14 Days)||59
2364353|NCT01573624|5802237|P6|STARTED|Period 1 : Treatment Period 1 (14 Days)||55
2364354|NCT01573624|5802238|P5|STARTED|Period 1 : Treatment Period 1 (14 Days)||58
2364355|NCT01573624|5802239|P4|STARTED|Period 1 : Treatment Period 1 (14 Days)||63
2364356|NCT01573624|5802240|P3|STARTED|Period 1 : Treatment Period 1 (14 Days)||60
2364357|NCT01573624|5802241|P2|STARTED|Period 1 : Treatment Period 1 (14 Days)||62
2364358|NCT01573624|5802242|P1|STARTED|Period 1 : Treatment Period 1 (14 Days)||64
2364359|NCT01573533|5802289|P1|NOT COMPLETED|Overall Study||0
2364360|NCT01573533|5802289|P1|COMPLETED|Overall Study||9
2364361|NCT01573533|5802289|P1|STARTED|Overall Study||9
2364363|NCT01573442|5802299|P1|NOT COMPLETED|Overall Study||9
2364364|NCT01573442|5802298|P2|COMPLETED|Overall Study||104
2364365|NCT01573442|5802299|P1|COMPLETED|Overall Study||104
2364366|NCT01573442|5802298|P2|STARTED|Overall Study||114
2364367|NCT01573442|5802299|P1|STARTED|Overall Study||113
2364368|NCT01573325|5802335|P1|NOT COMPLETED|Overall Study||0
2364369|NCT01573325|5802335|P1|COMPLETED|Overall Study||50
2364370|NCT01573325|5802335|P1|STARTED|Overall Study||50
2364371|NCT01573273|5802344|P12|NOT COMPLETED|MRI 2||0
2364372|NCT01573273|5802345|P11|NOT COMPLETED|MRI 2||0
2364373|NCT01573273|5802346|P10|NOT COMPLETED|MRI 2||0
2364374|NCT01573273|5802347|P9|NOT COMPLETED|MRI 2||0
2364375|NCT01573273|5802348|P8|NOT COMPLETED|MRI 2||0
2364376|NCT01573273|5802349|P7|NOT COMPLETED|MRI 2||0
2364377|NCT01573273|5802350|P6|NOT COMPLETED|MRI 2||0
2364378|NCT01573273|5802351|P5|NOT COMPLETED|MRI 2||0
2364379|NCT01573273|5802352|P4|NOT COMPLETED|MRI 2||0
2364380|NCT01573273|5802353|P3|NOT COMPLETED|MRI 2||0
2364381|NCT01573273|5802354|P2|NOT COMPLETED|MRI 2||0
2364382|NCT01573273|5802355|P1|NOT COMPLETED|MRI 2||0
2364383|NCT01573273|5802344|P12|COMPLETED|MRI 2||28
2364384|NCT01573273|5802345|P11|COMPLETED|MRI 2||27
2364385|NCT01573273|5802346|P10|COMPLETED|MRI 2||0
2364386|NCT01573273|5802347|P9|COMPLETED|MRI 2||0
2364387|NCT01573273|5802348|P8|COMPLETED|MRI 2||0
2364388|NCT01573273|5802349|P7|COMPLETED|MRI 2||0
2364389|NCT01573273|5802350|P6|COMPLETED|MRI 2||18
2364390|NCT01573273|5802351|P5|COMPLETED|MRI 2||23
2364391|NCT01573273|5802352|P4|COMPLETED|MRI 2||0
2364392|NCT01573273|5802353|P3|COMPLETED|MRI 2||0
2364393|NCT01573273|5802354|P2|COMPLETED|MRI 2||0
2364394|NCT01573273|5802355|P1|COMPLETED|MRI 2||0
2364395|NCT01573273|5802344|P12|STARTED|MRI 2||28
2364396|NCT01573273|5802345|P11|STARTED|MRI 2||27
2364397|NCT01573273|5802346|P10|STARTED|MRI 2||0
2364398|NCT01573273|5802347|P9|STARTED|MRI 2||0
2364399|NCT01573273|5802348|P8|STARTED|MRI 2||0
2364400|NCT01573273|5802349|P7|STARTED|MRI 2||0
2364401|NCT01573273|5802350|P6|STARTED|MRI 2||18
2364402|NCT01573273|5802351|P5|STARTED|MRI 2||23
2364403|NCT01573273|5802352|P4|STARTED|MRI 2||0
2364404|NCT01573273|5802353|P3|STARTED|MRI 2||0
2364405|NCT01573273|5802354|P2|STARTED|MRI 2||0
2364406|NCT01573273|5802355|P1|STARTED|MRI 2||0
2364407|NCT01573273|5802344|P12|NOT COMPLETED|MRI 1||0
2364408|NCT01573273|5802345|P11|NOT COMPLETED|MRI 1||0
2364409|NCT01573273|5802346|P10|NOT COMPLETED|MRI 1||0
2364410|NCT01573273|5802347|P9|NOT COMPLETED|MRI 1||0
2364411|NCT01573273|5802348|P8|NOT COMPLETED|MRI 1||0
2364412|NCT01573273|5802349|P7|NOT COMPLETED|MRI 1||0
2364413|NCT01573273|5802350|P6|NOT COMPLETED|MRI 1||0
2364414|NCT01573273|5802351|P5|NOT COMPLETED|MRI 1||0
2364415|NCT01573273|5802352|P4|NOT COMPLETED|MRI 1||0
2364416|NCT01573273|5802353|P3|NOT COMPLETED|MRI 1||0
2364417|NCT01573273|5802354|P2|NOT COMPLETED|MRI 1||0
2364418|NCT01573273|5802355|P1|NOT COMPLETED|MRI 1||0
2364419|NCT01573273|5802344|P12|COMPLETED|MRI 1||0
2364420|NCT01573273|5802345|P11|COMPLETED|MRI 1||0
2364421|NCT01573273|5802346|P10|COMPLETED|MRI 1||29
2364422|NCT01573273|5802347|P9|COMPLETED|MRI 1||28
2364423|NCT01573273|5802348|P8|COMPLETED|MRI 1||0
2364424|NCT01573273|5802349|P7|COMPLETED|MRI 1||0
2364425|NCT01573273|5802350|P6|COMPLETED|MRI 1||0
2364426|NCT01573273|5802351|P5|COMPLETED|MRI 1||0
2364427|NCT01573273|5802352|P4|COMPLETED|MRI 1||23
2364428|NCT01573273|5802353|P3|COMPLETED|MRI 1||19
2364429|NCT01573273|5802354|P2|COMPLETED|MRI 1||0
2364430|NCT01573273|5802355|P1|COMPLETED|MRI 1||0
2364431|NCT01573273|5802344|P12|STARTED|MRI 1||0
2364432|NCT01573273|5802345|P11|STARTED|MRI 1||0
2364433|NCT01573273|5802346|P10|STARTED|MRI 1||29
2364434|NCT01573273|5802347|P9|STARTED|MRI 1||28
2364435|NCT01573273|5802348|P8|STARTED|MRI 1||0
2364436|NCT01573273|5802349|P7|STARTED|MRI 1||0
2364437|NCT01573273|5802350|P6|STARTED|MRI 1||0
2364438|NCT01573273|5802351|P5|STARTED|MRI 1||0
2364439|NCT01573273|5802352|P4|STARTED|MRI 1||23
2364440|NCT01573273|5802353|P3|STARTED|MRI 1||19
2364441|NCT01573273|5802354|P2|STARTED|MRI 1||0
2364442|NCT01573273|5802355|P1|STARTED|MRI 1||0
2364443|NCT01573273|5802344|P12|NOT COMPLETED|TSST : Trier Social Stress Task||0
2364444|NCT01573273|5802345|P11|NOT COMPLETED|TSST : Trier Social Stress Task||0
2364445|NCT01573273|5802346|P10|NOT COMPLETED|TSST : Trier Social Stress Task||0
2364446|NCT01573273|5802347|P9|NOT COMPLETED|TSST : Trier Social Stress Task||0
2364447|NCT01573273|5802348|P8|NOT COMPLETED|TSST : Trier Social Stress Task||0
2364448|NCT01573273|5802349|P7|NOT COMPLETED|TSST : Trier Social Stress Task||0
2364449|NCT01573273|5802350|P6|NOT COMPLETED|TSST : Trier Social Stress Task||0
2364450|NCT01573273|5802351|P5|NOT COMPLETED|TSST : Trier Social Stress Task||0
2364451|NCT01573273|5802352|P4|NOT COMPLETED|TSST : Trier Social Stress Task||0
2364452|NCT01573273|5802353|P3|NOT COMPLETED|TSST : Trier Social Stress Task||0
2364453|NCT01573273|5802354|P2|NOT COMPLETED|TSST : Trier Social Stress Task||0
2364454|NCT01573273|5802355|P1|NOT COMPLETED|TSST : Trier Social Stress Task||0
2364455|NCT01573273|5802344|P12|COMPLETED|TSST : Trier Social Stress Task||0
2364456|NCT01573273|5802345|P11|COMPLETED|TSST : Trier Social Stress Task||0
2364457|NCT01573273|5802346|P10|COMPLETED|TSST : Trier Social Stress Task||0
2364458|NCT01573273|5802347|P9|COMPLETED|TSST : Trier Social Stress Task||0
2364459|NCT01573273|5802348|P8|COMPLETED|TSST : Trier Social Stress Task||31
2364460|NCT01573273|5802349|P7|COMPLETED|TSST : Trier Social Stress Task||32
2364461|NCT01573273|5802350|P6|COMPLETED|TSST : Trier Social Stress Task||0
2364462|NCT01573273|5802351|P5|COMPLETED|TSST : Trier Social Stress Task||0
2364463|NCT01573273|5802352|P4|COMPLETED|TSST : Trier Social Stress Task||0
2364464|NCT01573273|5802353|P3|COMPLETED|TSST : Trier Social Stress Task||0
2364465|NCT01573273|5802354|P2|COMPLETED|TSST : Trier Social Stress Task||25
2364466|NCT01573273|5802355|P1|COMPLETED|TSST : Trier Social Stress Task||24
2364467|NCT01573273|5802344|P12|STARTED|TSST : Trier Social Stress Task||0
2364468|NCT01573273|5802345|P11|STARTED|TSST : Trier Social Stress Task||0
2364469|NCT01573273|5802346|P10|STARTED|TSST : Trier Social Stress Task||0
2364470|NCT01573273|5802347|P9|STARTED|TSST : Trier Social Stress Task||0
2364471|NCT01573273|5802348|P8|STARTED|TSST : Trier Social Stress Task||31
2364472|NCT01573273|5802349|P7|STARTED|TSST : Trier Social Stress Task||32
2364473|NCT01573273|5802350|P6|STARTED|TSST : Trier Social Stress Task||0
2364474|NCT01573273|5802351|P5|STARTED|TSST : Trier Social Stress Task||0
2364475|NCT01573273|5802352|P4|STARTED|TSST : Trier Social Stress Task||0
2364476|NCT01573273|5802353|P3|STARTED|TSST : Trier Social Stress Task||0
2364477|NCT01573273|5802354|P2|STARTED|TSST : Trier Social Stress Task||25
2364478|NCT01573273|5802355|P1|STARTED|TSST : Trier Social Stress Task||24
2364479|NCT01573260|5802395|P2|NOT COMPLETED|Overall Study||0
2364480|NCT01573260|5802396|P1|NOT COMPLETED|Overall Study||0
2364481|NCT01573260|5802395|P2|COMPLETED|Overall Study||15
2364482|NCT01573260|5802396|P1|COMPLETED|Overall Study||18
2364483|NCT01573260|5802395|P2|STARTED|Overall Study||15
2364484|NCT01573260|5802396|P1|STARTED|Overall Study||18
2364485|NCT01573000|5802430|P2|NOT COMPLETED|Long-Term Follow-Up||1
2364486|NCT01573000|5802431|P1|NOT COMPLETED|Long-Term Follow-Up||3
2364487|NCT01573000|5802430|P2|COMPLETED|Long-Term Follow-Up|One participant who received crossover treatment was lost to follow up.|4
2364488|NCT01573000|5802431|P1|COMPLETED|Long-Term Follow-Up||11
2364489|NCT01573000|5802430|P2|STARTED|Long-Term Follow-Up|5 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|5
2364490|NCT01573000|5802431|P1|STARTED|Long-Term Follow-Up|14 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|14
2364491|NCT01573000|5802430|P2|NOT COMPLETED|Crossover Phase||18
2364492|NCT01573000|5802431|P1|NOT COMPLETED|Crossover Phase||0
2364493|NCT01573000|5802430|P2|COMPLETED|Crossover Phase|This participant completed 2 years of follow up and enrolled in BEX104526.|1
2364494|NCT01573000|5802431|P1|COMPLETED|Crossover Phase||0
2364495|NCT01573000|5802430|P2|STARTED|Crossover Phase|19 of 36 par. randomized to receive Unlabeled TST crossed over to receive TST and Iodine I 131 TST.|19
2364496|NCT01573000|5802431|P1|STARTED|Crossover Phase||0
2364497|NCT01573000|5802430|P2|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
2364498|NCT01573000|5802431|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
2364499|NCT01573000|5802430|P2|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|1
2364500|NCT01573000|5802431|P1|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|7
2364501|NCT01573000|5802430|P2|STARTED|Dosimetric and Therapeutic Treatment||36
2364502|NCT01573000|5802431|P1|STARTED|Dosimetric and Therapeutic Treatment||42
2364503|NCT01572948|5802527|P2|NOT COMPLETED|Overall Study||1
2364504|NCT01572948|5802528|P1|NOT COMPLETED|Overall Study||1
2364505|NCT01572948|5802527|P2|COMPLETED|Overall Study||15
2364506|NCT01572948|5802528|P1|COMPLETED|Overall Study||10
2364507|NCT01572948|5802527|P2|STARTED|Overall Study||16
2364508|NCT01572948|5802528|P1|STARTED|Overall Study||11
2364509|NCT01572922|5802544|P1|NOT COMPLETED|Overall Study||3
2364510|NCT01572922|5802544|P1|COMPLETED|Overall Study||139
2364511|NCT01572922|5802544|P1|STARTED|Overall Study||142
2364512|NCT01572844|5802554|P2|NOT COMPLETED|Overall Study||1
2364513|NCT01572844|5802555|P1|NOT COMPLETED|Overall Study||1
2364514|NCT01572844|5802554|P2|COMPLETED|Overall Study||2
2364515|NCT01572844|5802555|P1|COMPLETED|Overall Study||2
2364516|NCT01572844|5802554|P2|STARTED|Overall Study||3
2364517|NCT01572844|5802555|P1|STARTED|Overall Study||3
2364518|NCT01572792|5802573|P5|NOT COMPLETED|Extension Study||32
2364519|NCT01572792|5802574|P4|NOT COMPLETED|Extension Study||29
2364520|NCT01572792|5802575|P3|NOT COMPLETED|Extension Study||26
2364521|NCT01572792|5802576|P2|NOT COMPLETED|Extension Study||29
2364522|NCT01572792|5802577|P1|NOT COMPLETED|Extension Study||25
2364523|NCT01572792|5802573|P5|COMPLETED|Extension Study||160
2364524|NCT01572792|5802574|P4|COMPLETED|Extension Study||165
2364525|NCT01572792|5802575|P3|COMPLETED|Extension Study||179
2364526|NCT01572792|5802576|P2|COMPLETED|Extension Study||155
2364527|NCT01572792|5802577|P1|COMPLETED|Extension Study||121
2364528|NCT01572792|5802573|P5|STARTED|Extension Study||192
2364529|NCT01572792|5802574|P4|STARTED|Extension Study||194
2364530|NCT01572792|5802575|P3|STARTED|Extension Study||205
2364531|NCT01572792|5802576|P2|STARTED|Extension Study||184
2364532|NCT01572792|5802577|P1|STARTED|Extension Study||146
2364533|NCT01572792|5802573|P5|NOT COMPLETED|Lead-in Study||69
2364534|NCT01572792|5802574|P4|NOT COMPLETED|Lead-in Study||72
2364535|NCT01572792|5802575|P3|NOT COMPLETED|Lead-in Study||62
2364536|NCT01572792|5802576|P2|NOT COMPLETED|Lead-in Study||66
2364537|NCT01572792|5802577|P1|NOT COMPLETED|Lead-in Study||101
2364538|NCT01572792|5802573|P5|COMPLETED|Lead-in Study||270
2364539|NCT01572792|5802574|P4|COMPLETED|Lead-in Study||268
2364540|NCT01572792|5802575|P3|COMPLETED|Lead-in Study||276
2364541|NCT01572792|5802576|P2|COMPLETED|Lead-in Study||272
2364542|NCT01572792|5802577|P1|COMPLETED|Lead-in Study||236
2364543|NCT01572792|5802573|P5|STARTED|Lead-in Study||339
2364544|NCT01572792|5802574|P4|STARTED|Lead-in Study||340
2364545|NCT01572792|5802575|P3|STARTED|Lead-in Study||338
2364546|NCT01572792|5802576|P2|STARTED|Lead-in Study||338
2364547|NCT01572792|5802577|P1|STARTED|Lead-in Study||337
2364548|NCT01572740|5802626|P2|NOT COMPLETED|Overall Study||5
2364549|NCT01572740|5802627|P1|NOT COMPLETED|Overall Study||6
2364550|NCT01572740|5802626|P2|COMPLETED|Overall Study||125
2364551|NCT01572740|5802627|P1|COMPLETED|Overall Study||121
2364552|NCT01572740|5802626|P2|STARTED|Overall Study||130
2364553|NCT01572740|5802627|P1|STARTED|Overall Study||127
2364554|NCT01572727|5802657|P2|NOT COMPLETED|Overall Study||209
2364555|NCT01572727|5802658|P1|NOT COMPLETED|Overall Study||207
2364556|NCT01572727|5802657|P2|COMPLETED|Overall Study||0
2364557|NCT01572727|5802658|P1|COMPLETED|Overall Study||0
2364558|NCT01572727|5802657|P2|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|201
2364559|NCT01572727|5802658|P1|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|202
2364560|NCT01572727|5802657|P2|STARTED|Overall Study||209
2364561|NCT01572727|5802658|P1|STARTED|Overall Study||207
2364562|NCT01572675|5802680|P2|NOT COMPLETED|Overall Study||223
2364563|NCT01572675|5802681|P1|NOT COMPLETED|Overall Study||237
2364564|NCT01572675|5802680|P2|COMPLETED|Overall Study||56
2364565|NCT01572675|5802681|P1|COMPLETED|Overall Study||31
2364566|NCT01572675|5802680|P2|STARTED|Overall Study||279
2364567|NCT01572675|5802681|P1|STARTED|Overall Study||268
2364568|NCT01572428|5802780|P2|NOT COMPLETED|Overall Study||1
2364569|NCT01572428|5802781|P1|NOT COMPLETED|Overall Study||3
2364570|NCT01572428|5802780|P2|COMPLETED|Overall Study||401
2364571|NCT01572428|5802781|P1|COMPLETED|Overall Study||399
2364572|NCT01572428|5802780|P2|STARTED|Overall Study||402
2364573|NCT01572428|5802781|P1|STARTED|Overall Study||402
2364574|NCT01572389|5802799|P2|NOT COMPLETED|Overall Study||21
2364575|NCT01572389|5802800|P1|NOT COMPLETED|Overall Study||46
2364576|NCT01572389|5802799|P2|COMPLETED|Overall Study||68
2364577|NCT01572389|5802800|P1|COMPLETED|Overall Study||90
2364578|NCT01572389|5802799|P2|STARTED|Overall Study||89
2364579|NCT01572389|5802800|P1|STARTED|Overall Study||136
2364580|NCT01572298|5802810|P2|NOT COMPLETED|Overall Study||1
2364581|NCT01572298|5802811|P1|NOT COMPLETED|Overall Study||2
2364582|NCT01572298|5802810|P2|COMPLETED|Overall Study||12
2364583|NCT01572298|5802811|P1|COMPLETED|Overall Study||12
2364584|NCT01572298|5802810|P2|STARTED|Overall Study||13
2364585|NCT01572298|5802811|P1|STARTED|Overall Study||14
2364586|NCT01572207|5802821|P2|NOT COMPLETED|Overall Study||3
2364587|NCT01572207|5802822|P1|NOT COMPLETED|Overall Study||2
2364588|NCT01572207|5802821|P2|COMPLETED|Overall Study||13
2364589|NCT01572207|5802822|P1|COMPLETED|Overall Study||12
2364590|NCT01572207|5802821|P2|STARTED|Overall Study||16
2364591|NCT01572207|5802822|P1|STARTED|Overall Study||14
2364592|NCT01571557|5802832|P1|NOT COMPLETED|Overall Study||0
2364593|NCT01571557|5802832|P1|COMPLETED|Overall Study||573
2364594|NCT01571557|5802832|P1|STARTED|Overall Study||573
2364595|NCT01571453|5802841|P2|NOT COMPLETED|Overall Study||62
2364596|NCT01571453|5802842|P1|NOT COMPLETED|Overall Study||38
2364597|NCT01571453|5802841|P2|COMPLETED|Overall Study||164
2364598|NCT01571453|5802842|P1|COMPLETED|Overall Study||173
2364599|NCT01571453|5802841|P2|STARTED|Overall Study||226
2364600|NCT01571453|5802842|P1|STARTED|Overall Study||211
2364601|NCT01571427|5802860|P2|NOT COMPLETED|Overall Study||0
2364602|NCT01571427|5802861|P1|NOT COMPLETED|Overall Study||0
2364603|NCT01571427|5802860|P2|COMPLETED|Overall Study||42
2364604|NCT01571427|5802861|P1|COMPLETED|Overall Study||41
2364605|NCT01571427|5802860|P2|STARTED|Overall Study||42
2364606|NCT01571427|5802861|P1|STARTED|Overall Study||41
2364607|NCT01571362|5802889|P3|NOT COMPLETED|Double-Blind Treatment Period||39
2364608|NCT01571362|5802890|P2|NOT COMPLETED|Double-Blind Treatment Period||53
2364609|NCT01571362|5802891|P1|NOT COMPLETED|Double-Blind Treatment Period||0
2364610|NCT01571362|5802889|P3|COMPLETED|Double-Blind Treatment Period||107
2364611|NCT01571362|5802890|P2|COMPLETED|Double-Blind Treatment Period||81
2364612|NCT01571362|5802891|P1|COMPLETED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
2364613|NCT01571362|5802889|P3|STARTED|Double-Blind Treatment Period||146
2364614|NCT01571362|5802890|P2|STARTED|Double-Blind Treatment Period||134
2364615|NCT01571362|5802891|P1|STARTED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
2364616|NCT01571362|5802889|P3|NOT COMPLETED|Open-Label Conversion + Titration Period||0
2364617|NCT01571362|5802890|P2|NOT COMPLETED|Open-Label Conversion + Titration Period||0
2364618|NCT01571362|5802891|P1|NOT COMPLETED|Open-Label Conversion + Titration Period||129
2364619|NCT01571362|5802889|P3|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
2364620|NCT01571362|5802890|P2|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
2364621|NCT01571362|5802891|P1|COMPLETED|Open-Label Conversion + Titration Period||281
2364622|NCT01571362|5802889|P3|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
2364623|NCT01571362|5802890|P2|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
2364624|NCT01571362|5802891|P1|STARTED|Open-Label Conversion + Titration Period||410
2364625|NCT01571284|5803061|P1|NOT COMPLETED|Overall Study||169
2364626|NCT01571284|5803061|P1|COMPLETED|Overall Study|403 participants with DP and 209 with adverse events were considered as completed.|612
2364627|NCT01571284|5803061|P1|Safety Population|Overall Study||779
2364628|NCT01571284|5803061|P1|STARTED|Overall Study||781
2364629|NCT01571232|5803084|P2|NOT COMPLETED|Overall Study||1
2364630|NCT01571232|5803085|P1|NOT COMPLETED|Overall Study||1
2364631|NCT01571232|5803084|P2|COMPLETED|Overall Study||9
2364632|NCT01571232|5803085|P1|COMPLETED|Overall Study||9
2364633|NCT01571232|5803084|P2|STARTED|Overall Study||10
2364634|NCT01571232|5803085|P1|STARTED|Overall Study||10
2364635|NCT01570868|5803097|P2|NOT COMPLETED|Overall Study||8
2364636|NCT01570868|5803098|P1|NOT COMPLETED|Overall Study||43
2364637|NCT01570868|5803097|P2|COMPLETED|Overall Study||0
2364638|NCT01570868|5803098|P1|COMPLETED|Overall Study||0
2364639|NCT01570868|5803097|P2|STARTED|Overall Study||8
2364640|NCT01570868|5803098|P1|STARTED|Overall Study||43
2364641|NCT01570751|5803110|P2|NOT COMPLETED|Period B (16 Weeks)||1
2364642|NCT01570751|5803111|P1|NOT COMPLETED|Period B (16 Weeks)||1
2364643|NCT01570751|5803110|P2|COMPLETED|Period B (16 Weeks)||66
2364644|NCT01570751|5803111|P1|COMPLETED|Period B (16 Weeks)||69
2364645|NCT01570751|5803110|P2|Exposed|Period B (16 Weeks)||67
2364646|NCT01570751|5803111|P1|Exposed|Period B (16 Weeks)||70
2364647|NCT01570751|5803110|P2|STARTED|Period B (16 Weeks)||67
2364648|NCT01570751|5803111|P1|STARTED|Period B (16 Weeks)||70
2364649|NCT01570751|5803110|P2|NOT COMPLETED|Period A (16 Weeks)||5
2364650|NCT01570751|5803111|P1|NOT COMPLETED|Period A (16 Weeks)||3
2364651|NCT01570751|5803110|P2|COMPLETED|Period A (16 Weeks)||67
2364652|NCT01570751|5803111|P1|COMPLETED|Period A (16 Weeks)||70
2364653|NCT01570751|5803110|P2|Exposed|Period A (16 Weeks)||72
2364654|NCT01570751|5803111|P1|Exposed|Period A (16 Weeks)||73
2364655|NCT01570751|5803110|P2|STARTED|Period A (16 Weeks)||72
2364656|NCT01570751|5803111|P1|STARTED|Period A (16 Weeks)||73
2364657|NCT01570686|5803129|P2|NOT COMPLETED|Overall Study||16
2364658|NCT01570686|5803130|P1|NOT COMPLETED|Overall Study||22
2364659|NCT01570686|5803129|P2|COMPLETED|Overall Study||278
2364660|NCT01570686|5803130|P1|COMPLETED|Overall Study||274
2364661|NCT01570686|5803129|P2|Safety and Full Analysis Set (FAS)|Overall Study||294
2364662|NCT01570686|5803130|P1|Safety and Full Analysis Set (FAS)|Overall Study|One patient was mis-randomized and never received study drug. Hence not included in Safety or FAS.|295
2364663|NCT01570686|5803129|P2|STARTED|Overall Study||294
2364664|NCT01570686|5803130|P1|STARTED|Overall Study||296
2364665|NCT01570634|5803156|P1|NOT COMPLETED|Overall Study||0
2364666|NCT01570634|5803156|P1|COMPLETED|Overall Study||2
2364667|NCT01570634|5803156|P1|STARTED|Overall Study||2
2364668|NCT01570491|5803166|P2|NOT COMPLETED|Overall Study||1
2364669|NCT01570491|5803167|P1|NOT COMPLETED|Overall Study||5
2364670|NCT01570491|5803166|P2|COMPLETED|Overall Study||18
2364671|NCT01570491|5803167|P1|COMPLETED|Overall Study||14
2364672|NCT01570491|5803166|P2|STARTED|Overall Study||19
2364673|NCT01570491|5803167|P1|STARTED|Overall Study||19
2364674|NCT01570387|5803183|P4|NOT COMPLETED|Overall Study||2
2364675|NCT01570387|5803184|P3|NOT COMPLETED|Overall Study||0
2364676|NCT01570387|5803185|P2|NOT COMPLETED|Overall Study||0
2364677|NCT01570387|5803186|P1|NOT COMPLETED|Overall Study||1
2364678|NCT01570387|5803183|P4|COMPLETED|Overall Study||10
2364679|NCT01570387|5803184|P3|COMPLETED|Overall Study||6
2364680|NCT01570387|5803185|P2|COMPLETED|Overall Study||3
2364681|NCT01570387|5803186|P1|COMPLETED|Overall Study||5
2364682|NCT01570387|5803183|P4|Response to Maximal Tolerated Dose|Overall Study||6
2364683|NCT01570387|5803184|P3|Response to Maximal Tolerated Dose|Overall Study||3
2364684|NCT01570387|5803185|P2|Response to Maximal Tolerated Dose|Overall Study||0
2364685|NCT01570387|5803186|P1|Response to Maximal Tolerated Dose|Overall Study||0
2364686|NCT01570387|5803183|P4|Dose Limiting Toxicity|Overall Study||12
2364687|NCT01570387|5803184|P3|Dose Limiting Toxicity|Overall Study||6
2364688|NCT01570387|5803185|P2|Dose Limiting Toxicity|Overall Study||0
2364689|NCT01570387|5803186|P1|Dose Limiting Toxicity|Overall Study||0
2364690|NCT01570387|5803183|P4|STARTED|Overall Study||12
2364691|NCT01570387|5803184|P3|STARTED|Overall Study||6
2364692|NCT01570387|5803185|P2|STARTED|Overall Study||3
2364693|NCT01570387|5803186|P1|STARTED|Overall Study||6
2364697|NCT01570309|5803212|P2|NOT COMPLETED|Overall Study||3
2364698|NCT01570309|5803213|P1|NOT COMPLETED|Overall Study||3
2364699|NCT01570309|5803212|P2|COMPLETED|Overall Study||45
2364700|NCT01570309|5803213|P1|COMPLETED|Overall Study||45
2364701|NCT01570309|5803212|P2|STARTED|Overall Study||48
2364702|NCT01570309|5803213|P1|STARTED|Overall Study||48
2364703|NCT01570283|5803230|P6|NOT COMPLETED|Cohort 3: Dose Level 3||2
2364704|NCT01570283|5803231|P5|NOT COMPLETED|Cohort 3: Dose Level 3||0
2364705|NCT01570283|5803232|P4|NOT COMPLETED|Cohort 3: Dose Level 3||0
2364706|NCT01570283|5803233|P3|NOT COMPLETED|Cohort 3: Dose Level 3||0
2364707|NCT01570283|5803234|P2|NOT COMPLETED|Cohort 3: Dose Level 3||0
2364708|NCT01570283|5803235|P1|NOT COMPLETED|Cohort 3: Dose Level 3||0
2364709|NCT01570283|5803230|P6|COMPLETED|Cohort 3: Dose Level 3||10
2364710|NCT01570283|5803231|P5|COMPLETED|Cohort 3: Dose Level 3||1
2364711|NCT01570283|5803232|P4|COMPLETED|Cohort 3: Dose Level 3||0
2364712|NCT01570283|5803233|P3|COMPLETED|Cohort 3: Dose Level 3||0
2364713|NCT01570283|5803234|P2|COMPLETED|Cohort 3: Dose Level 3||0
2364714|NCT01570283|5803235|P1|COMPLETED|Cohort 3: Dose Level 3||0
2364715|NCT01570283|5803230|P6|STARTED|Cohort 3: Dose Level 3||12
2364716|NCT01570283|5803231|P5|STARTED|Cohort 3: Dose Level 3||1
2364717|NCT01570283|5803232|P4|STARTED|Cohort 3: Dose Level 3||0
2364718|NCT01570283|5803233|P3|STARTED|Cohort 3: Dose Level 3||0
2364719|NCT01570283|5803234|P2|STARTED|Cohort 3: Dose Level 3||0
2364720|NCT01570283|5803235|P1|STARTED|Cohort 3: Dose Level 3||0
2364721|NCT01570283|5803230|P6|NOT COMPLETED|Cohort 2: Dose Level 2||0
2364722|NCT01570283|5803231|P5|NOT COMPLETED|Cohort 2: Dose Level 2||0
2364723|NCT01570283|5803232|P4|NOT COMPLETED|Cohort 2: Dose Level 2||1
2364724|NCT01570283|5803233|P3|NOT COMPLETED|Cohort 2: Dose Level 2||1
2364725|NCT01570283|5803234|P2|NOT COMPLETED|Cohort 2: Dose Level 2||0
2364726|NCT01570283|5803235|P1|NOT COMPLETED|Cohort 2: Dose Level 2||0
2364727|NCT01570283|5803230|P6|COMPLETED|Cohort 2: Dose Level 2||0
2364728|NCT01570283|5803231|P5|COMPLETED|Cohort 2: Dose Level 2||0
2364729|NCT01570283|5803232|P4|COMPLETED|Cohort 2: Dose Level 2||1
2364730|NCT01570283|5803233|P3|COMPLETED|Cohort 2: Dose Level 2||1
2364731|NCT01570283|5803234|P2|COMPLETED|Cohort 2: Dose Level 2||0
2364732|NCT01570283|5803235|P1|COMPLETED|Cohort 2: Dose Level 2||0
2364733|NCT01570283|5803230|P6|STARTED|Cohort 2: Dose Level 2||0
2364734|NCT01570283|5803231|P5|STARTED|Cohort 2: Dose Level 2||0
2364735|NCT01570283|5803232|P4|STARTED|Cohort 2: Dose Level 2||2
2364736|NCT01570283|5803233|P3|STARTED|Cohort 2: Dose Level 2||2
2364737|NCT01570283|5803234|P2|STARTED|Cohort 2: Dose Level 2||0
2364738|NCT01570283|5803235|P1|STARTED|Cohort 2: Dose Level 2||0
2364739|NCT01570283|5803230|P6|NOT COMPLETED|Cohort 1: Dose Level 1||0
2364740|NCT01570283|5803231|P5|NOT COMPLETED|Cohort 1: Dose Level 1||0
2364741|NCT01570283|5803232|P4|NOT COMPLETED|Cohort 1: Dose Level 1||0
2364742|NCT01570283|5803233|P3|NOT COMPLETED|Cohort 1: Dose Level 1||0
2364743|NCT01570283|5803234|P2|NOT COMPLETED|Cohort 1: Dose Level 1||2
2364744|NCT01570283|5803235|P1|NOT COMPLETED|Cohort 1: Dose Level 1||0
2364745|NCT01570283|5803230|P6|COMPLETED|Cohort 1: Dose Level 1||0
2364746|NCT01570283|5803231|P5|COMPLETED|Cohort 1: Dose Level 1||0
2364747|NCT01570283|5803232|P4|COMPLETED|Cohort 1: Dose Level 1||0
2364748|NCT01570283|5803233|P3|COMPLETED|Cohort 1: Dose Level 1||0
2364749|NCT01570283|5803234|P2|COMPLETED|Cohort 1: Dose Level 1||1
2364750|NCT01570283|5803235|P1|COMPLETED|Cohort 1: Dose Level 1||1
2364751|NCT01570283|5803230|P6|STARTED|Cohort 1: Dose Level 1||0
2364752|NCT01570283|5803231|P5|STARTED|Cohort 1: Dose Level 1||0
2364753|NCT01570283|5803232|P4|STARTED|Cohort 1: Dose Level 1||0
2364754|NCT01570283|5803233|P3|STARTED|Cohort 1: Dose Level 1||0
2364755|NCT01570283|5803234|P2|STARTED|Cohort 1: Dose Level 1||3
2364756|NCT01570283|5803235|P1|STARTED|Cohort 1: Dose Level 1||1
2364757|NCT01570244|5803252|P1|NOT COMPLETED|Microgynon+Faldaprevir||1
2364758|NCT01570244|5803252|P1|COMPLETED|Microgynon+Faldaprevir||15
2364759|NCT01570244|5803252|P1|STARTED|Microgynon+Faldaprevir||16
2364760|NCT01570244|5803252|P1|NOT COMPLETED|Microgynon||0
2364761|NCT01570244|5803252|P1|COMPLETED|Microgynon||16
2364762|NCT01570244|5803252|P1|STARTED|Microgynon||16
2364763|NCT01570192|5803274|P2|NOT COMPLETED|Overall Study||13
2364764|NCT01570192|5803275|P1|NOT COMPLETED|Overall Study||7
2364765|NCT01570192|5803274|P2|COMPLETED|Overall Study||17
2364766|NCT01570192|5803275|P1|COMPLETED|Overall Study||6
2364767|NCT01570192|5803274|P2|STARTED|Overall Study||30
2364768|NCT01570192|5803275|P1|STARTED|Overall Study||13
2364769|NCT01569841|5803313|P2|NOT COMPLETED|Period B (6 Weeks)||0
2364770|NCT01569841|5803314|P1|NOT COMPLETED|Period B (6 Weeks)||0
2364771|NCT01569841|5803313|P2|COMPLETED|Period B (6 Weeks)||11
2364772|NCT01569841|5803314|P1|COMPLETED|Period B (6 Weeks)||12
2364773|NCT01569841|5803313|P2|Exposed|Period B (6 Weeks)||11
2364774|NCT01569841|5803314|P1|Exposed|Period B (6 Weeks)||12
2364775|NCT01569841|5803313|P2|STARTED|Period B (6 Weeks)||11
2364776|NCT01569841|5803314|P1|STARTED|Period B (6 Weeks)||12
2364777|NCT01569841|5803313|P2|NOT COMPLETED|Period A (6 Weeks)||1
2364778|NCT01569841|5803314|P1|NOT COMPLETED|Period A (6 Weeks)||0
2364779|NCT01569841|5803313|P2|COMPLETED|Period A (6 Weeks)||11
2364780|NCT01569841|5803314|P1|COMPLETED|Period A (6 Weeks)||12
2364781|NCT01569841|5803313|P2|Exposed|Period A (6 Weeks)||12
2364782|NCT01569841|5803314|P1|Exposed|Period A (6 Weeks)||12
2364783|NCT01569841|5803313|P2|STARTED|Period A (6 Weeks)||12
2364784|NCT01569841|5803314|P1|STARTED|Period A (6 Weeks)||12
2364785|NCT01569828|5803332|P2|NOT COMPLETED|Overall Study||0
2364786|NCT01569828|5803333|P1|NOT COMPLETED|Overall Study||0
2364787|NCT01569828|5803332|P2|COMPLETED|Overall Study||6
2364788|NCT01569828|5803333|P1|COMPLETED|Overall Study||6
2364789|NCT01569828|5803332|P2|STARTED|Overall Study||6
2364790|NCT01569828|5803333|P1|STARTED|Overall Study||6
2364791|NCT01569815|5803355|P4|NOT COMPLETED|Overall Study||0
2364792|NCT01569815|5803356|P3|NOT COMPLETED|Overall Study||0
2364793|NCT01569815|5803357|P2|NOT COMPLETED|Overall Study||0
2364794|NCT01569815|5803358|P1|NOT COMPLETED|Overall Study||0
2364795|NCT01569815|5803355|P4|COMPLETED|Overall Study||8
2364796|NCT01569815|5803356|P3|COMPLETED|Overall Study||8
2364797|NCT01569815|5803357|P2|COMPLETED|Overall Study||8
2364798|NCT01569815|5803358|P1|COMPLETED|Overall Study||8
2364799|NCT01569815|5803355|P4|STARTED|Overall Study||8
2364800|NCT01569815|5803356|P3|STARTED|Overall Study||8
2364801|NCT01569815|5803357|P2|STARTED|Overall Study||8
2364802|NCT01569815|5803358|P1|STARTED|Overall Study||8
2364803|NCT01569763|5803403|P2|NOT COMPLETED|Overall Study||7
2364804|NCT01569763|5803404|P1|NOT COMPLETED|Overall Study||3
2364805|NCT01569763|5803403|P2|COMPLETED|Overall Study|Completed 12 Months of Follow-up|44
2364806|NCT01569763|5803404|P1|COMPLETED|Overall Study|Completed 12 Months of Follow-up|99
2364807|NCT01569763|5803403|P2|Treated|Overall Study||51
2364808|NCT01569763|5803404|P1|Treated|Overall Study||102
2364809|NCT01569763|5803403|P2|STARTED|Overall Study||51
2364810|NCT01569763|5803404|P1|STARTED|Overall Study||102
2364811|NCT01569737|5803414|P1|NOT COMPLETED|Overall Study||3
2364812|NCT01569737|5803414|P1|COMPLETED|Overall Study||95
2364813|NCT01569737|5803414|P1|STARTED|Overall Study||98
2364814|NCT01569607|5803420|P2|NOT COMPLETED|Overall Study||1
2364815|NCT01569607|5803421|P1|NOT COMPLETED|Overall Study||1
2364816|NCT01569607|5803420|P2|COMPLETED|Overall Study||10
2364817|NCT01569607|5803421|P1|COMPLETED|Overall Study||10
2364818|NCT01569607|5803420|P2|STARTED|Overall Study||11
2364819|NCT01569607|5803421|P1|STARTED|Overall Study||11
2364823|NCT01569568|5803449|P2|NOT COMPLETED|Overall Study||2
2364824|NCT01569568|5803450|P1|NOT COMPLETED|Overall Study||0
2364825|NCT01569568|5803449|P2|COMPLETED|Overall Study||27
2364826|NCT01569568|5803450|P1|COMPLETED|Overall Study||20
2364827|NCT01569568|5803449|P2|STARTED|Overall Study||29
2364828|NCT01569568|5803450|P1|STARTED|Overall Study||20
2364829|NCT01569529|5803464|P2|NOT COMPLETED|Overall Study||0
2364830|NCT01569529|5803465|P1|NOT COMPLETED|Overall Study||0
2364831|NCT01569529|5803464|P2|COMPLETED|Overall Study||394
2364832|NCT01569529|5803465|P1|COMPLETED|Overall Study||2676
2364833|NCT01569529|5803464|P2|STARTED|Overall Study||394
2364834|NCT01569529|5803465|P1|STARTED|Overall Study||2676
2364835|NCT01569464|5803473|P2|NOT COMPLETED|Overall Study||5
2364836|NCT01569464|5803474|P1|NOT COMPLETED|Overall Study||10
2364837|NCT01569464|5803473|P2|COMPLETED|Overall Study||44
2364838|NCT01569464|5803474|P1|COMPLETED|Overall Study||91
2364839|NCT01569464|5803473|P2|STARTED|Overall Study||49
2364840|NCT01569464|5803474|P1|STARTED|Overall Study||101
2364841|NCT01569451|5803512|P2|NOT COMPLETED|Overall Study||13
2364842|NCT01569451|5803513|P1|NOT COMPLETED|Overall Study||14
2364843|NCT01569451|5803512|P2|COMPLETED|Overall Study||14
2364844|NCT01569451|5803513|P1|COMPLETED|Overall Study||12
2364845|NCT01569451|5803512|P2|STARTED|Overall Study||27
2364846|NCT01569451|5803513|P1|STARTED|Overall Study||26
2364847|NCT01569438|5803541|P2|NOT COMPLETED|Overall Study||9
2364848|NCT01569438|5803542|P1|NOT COMPLETED|Overall Study||2
2364849|NCT01569438|5803541|P2|COMPLETED|Overall Study||27
2364850|NCT01569438|5803542|P1|COMPLETED|Overall Study||36
2364851|NCT01569438|5803541|P2|STARTED|Overall Study||36
2364852|NCT01569438|5803542|P1|STARTED|Overall Study||38
2364853|NCT01569295|5803556|P2|NOT COMPLETED|Overall Study||67
2364854|NCT01569295|5803557|P1|NOT COMPLETED|Overall Study||134
2364855|NCT01569295|5803556|P2|COMPLETED|Overall Study||142
2364856|NCT01569295|5803557|P1|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint (progressive disease or death)|73
2364857|NCT01569295|5803556|P2|STARTED|Overall Study||209
2364858|NCT01569295|5803557|P1|STARTED|Overall Study||207
2364859|NCT01569191|5803573|P2|NOT COMPLETED|Overall Study||0
2364860|NCT01569191|5803574|P1|NOT COMPLETED|Overall Study||0
2364861|NCT01569191|5803573|P2|COMPLETED|Overall Study||7
2364862|NCT01569191|5803574|P1|COMPLETED|Overall Study||11
2364863|NCT01569191|5803573|P2|STARTED|Overall Study||7
2364864|NCT01569191|5803574|P1|STARTED|Overall Study||11
2364865|NCT01569152|5803594|P3|NOT COMPLETED|Safety Extension, Period 3||55
2364866|NCT01569152|5803595|P2|NOT COMPLETED|Safety Extension, Period 3||0
2364867|NCT01569152|5803596|P1|NOT COMPLETED|Safety Extension, Period 3||0
2364868|NCT01569152|5803594|P3|COMPLETED|Safety Extension, Period 3||0
2364869|NCT01569152|5803595|P2|COMPLETED|Safety Extension, Period 3||0
2364870|NCT01569152|5803596|P1|COMPLETED|Safety Extension, Period 3||0
2364871|NCT01569152|5803594|P3|STARTED|Safety Extension, Period 3|Includes 29 completers and 26 early escapees from Base Study Phase IIa|55
2364872|NCT01569152|5803595|P2|STARTED|Safety Extension, Period 3||0
2364873|NCT01569152|5803596|P1|STARTED|Safety Extension, Period 3||0
2364874|NCT01569152|5803594|P3|NOT COMPLETED|Phase IIa, Period 1||0
2364875|NCT01569152|5803595|P2|NOT COMPLETED|Phase IIa, Period 1||32
2364876|NCT01569152|5803596|P1|NOT COMPLETED|Phase IIa, Period 1||21
2364877|NCT01569152|5803594|P3|COMPLETED|Phase IIa, Period 1||0
2364878|NCT01569152|5803595|P2|COMPLETED|Phase IIa, Period 1||9
2364879|NCT01569152|5803596|P1|COMPLETED|Phase IIa, Period 1||20
2364880|NCT01569152|5803594|P3|STARTED|Phase IIa, Period 1||0
2364881|NCT01569152|5803595|P2|STARTED|Phase IIa, Period 1||41
2364882|NCT01569152|5803596|P1|STARTED|Phase IIa, Period 1||41
2364883|NCT01569126|5803659|P6|NOT COMPLETED|Overall Study||0
2364884|NCT01569126|5803660|P5|NOT COMPLETED|Overall Study||0
2364885|NCT01569126|5803661|P4|NOT COMPLETED|Overall Study||0
2364886|NCT01569126|5803662|P3|NOT COMPLETED|Overall Study||0
2364887|NCT01569126|5803663|P2|NOT COMPLETED|Overall Study||0
2364888|NCT01569126|5803664|P1|NOT COMPLETED|Overall Study||0
2364889|NCT01569126|5803659|P6|COMPLETED|Overall Study||12
2364890|NCT01569126|5803660|P5|COMPLETED|Overall Study||12
2364891|NCT01569126|5803661|P4|COMPLETED|Overall Study||8
2364892|NCT01569126|5803662|P3|COMPLETED|Overall Study||8
2364893|NCT01569126|5803663|P2|COMPLETED|Overall Study||8
2364894|NCT01569126|5803664|P1|COMPLETED|Overall Study||8
2364895|NCT01569126|5803659|P6|Received at Least 1 Dose of Study Drug|Overall Study||12
2364896|NCT01569126|5803660|P5|Received at Least 1 Dose of Study Drug|Overall Study||12
2364897|NCT01569126|5803661|P4|Received at Least 1 Dose of Study Drug|Overall Study||8
2364898|NCT01569126|5803662|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
2364899|NCT01569126|5803663|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
2364900|NCT01569126|5803664|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
2364901|NCT01569126|5803659|P6|STARTED|Overall Study||12
2364902|NCT01569126|5803660|P5|STARTED|Overall Study||12
2364903|NCT01569126|5803661|P4|STARTED|Overall Study||8
2364904|NCT01569126|5803662|P3|STARTED|Overall Study||8
2364905|NCT01569126|5803663|P2|STARTED|Overall Study||8
2364906|NCT01569126|5803664|P1|STARTED|Overall Study||8
2364907|NCT01569087|5803702|P3|NOT COMPLETED|Overall Study||1
2364908|NCT01569087|5803703|P2|NOT COMPLETED|Overall Study||0
2364909|NCT01569087|5803704|P1|NOT COMPLETED|Overall Study||1
2364910|NCT01569087|5803702|P3|COMPLETED|Overall Study||18
2364911|NCT01569087|5803703|P2|COMPLETED|Overall Study||20
2364912|NCT01569087|5803704|P1|COMPLETED|Overall Study||20
2364913|NCT01569087|5803702|P3|STARTED|Overall Study||19
2364914|NCT01569087|5803703|P2|STARTED|Overall Study||20
2364915|NCT01569087|5803704|P1|STARTED|Overall Study||21
2364916|NCT01569074|5803732|P5|NOT COMPLETED|Overall Study||8
2364917|NCT01569074|5803733|P4|NOT COMPLETED|Overall Study||8
2364918|NCT01569074|5803734|P3|NOT COMPLETED|Overall Study||12
2364919|NCT01569074|5803735|P2|NOT COMPLETED|Overall Study||9
2364920|NCT01569074|5803736|P1|NOT COMPLETED|Overall Study||7
2364921|NCT01569074|5803732|P5|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
2364922|NCT01569074|5803733|P4|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
2364923|NCT01569074|5803734|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|21
2364924|NCT01569074|5803735|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
2364925|NCT01569074|5803736|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
2364926|NCT01569074|5803732|P5|Randomised But Did Not Receive Treatment|Overall Study||0
2364927|NCT01569074|5803733|P4|Randomised But Did Not Receive Treatment|Overall Study||0
2364928|NCT01569074|5803734|P3|Randomised But Did Not Receive Treatment|Overall Study||0
2364929|NCT01569074|5803735|P2|Randomised But Did Not Receive Treatment|Overall Study||0
2364930|NCT01569074|5803736|P1|Randomised But Did Not Receive Treatment|Overall Study||0
2364931|NCT01569074|5803732|P5|STARTED|Overall Study|Patients who received treatment|33
2364932|NCT01569074|5803733|P4|STARTED|Overall Study|Patients who received treatment|33
2364933|NCT01569074|5803734|P3|STARTED|Overall Study|Patients who received treatment|33
2364934|NCT01569074|5803735|P2|STARTED|Overall Study|Patients who received treatment|33
2364935|NCT01569074|5803736|P1|STARTED|Overall Study|Patients who received treatment|31
2364936|NCT01569022|5803792|P2|NOT COMPLETED|Second Intervention||2
2364937|NCT01569022|5803793|P1|NOT COMPLETED|Second Intervention||2
2364938|NCT01569022|5803792|P2|COMPLETED|Second Intervention||18
2364939|NCT01569022|5803793|P1|COMPLETED|Second Intervention||17
2364940|NCT01569022|5803792|P2|STARTED|Second Intervention||20
2364941|NCT01569022|5803793|P1|STARTED|Second Intervention||19
2364942|NCT01569022|5803792|P2|NOT COMPLETED|First Intervention||1
2364943|NCT01569022|5803793|P1|NOT COMPLETED|First Intervention||2
2364944|NCT01569022|5803792|P2|COMPLETED|First Intervention||20
2364945|NCT01569022|5803793|P1|COMPLETED|First Intervention||19
2364946|NCT01569022|5803792|P2|STARTED|First Intervention||21
2364947|NCT01569022|5803793|P1|STARTED|First Intervention||21
2364948|NCT01568905|5803808|P3|NOT COMPLETED|Overall Study||0
2364949|NCT01568905|5803809|P2|NOT COMPLETED|Overall Study||0
2364950|NCT01568905|5803810|P1|NOT COMPLETED|Overall Study||1
2364951|NCT01568905|5803808|P3|COMPLETED|Overall Study||12
2364952|NCT01568905|5803809|P2|COMPLETED|Overall Study||11
2364953|NCT01568905|5803810|P1|COMPLETED|Overall Study||12
2364954|NCT01568905|5803808|P3|STARTED|Overall Study||12
2364955|NCT01568905|5803809|P2|STARTED|Overall Study||11
2364956|NCT01568905|5803810|P1|STARTED|Overall Study||13
2364957|NCT01568892|5803829|P2|NOT COMPLETED|Open-label Phase||3
2364958|NCT01568892|5803830|P1|NOT COMPLETED|Open-label Phase||6
2364959|NCT01568892|5803829|P2|COMPLETED|Open-label Phase||13
2364960|NCT01568892|5803830|P1|COMPLETED|Open-label Phase||7
2364961|NCT01568892|5803829|P2|STARTED|Open-label Phase||16
2364962|NCT01568892|5803830|P1|STARTED|Open-label Phase|One participant completing the DB Phase withdrew on Day 8 and did not enter the Open-label Phase.|13
2364963|NCT01568892|5803829|P2|NOT COMPLETED|Double-blind Phase||0
2364964|NCT01568892|5803830|P1|NOT COMPLETED|Double-blind Phase||0
2364965|NCT01568892|5803829|P2|COMPLETED|Double-blind Phase||16
2364966|NCT01568892|5803830|P1|COMPLETED|Double-blind Phase||14
2364967|NCT01568892|5803829|P2|STARTED|Double-blind Phase||16
2364968|NCT01568892|5803830|P1|STARTED|Double-blind Phase||14
2364969|NCT01568866|5803900|P2|NOT COMPLETED|Overall Study||416
2364970|NCT01568866|5803901|P1|NOT COMPLETED|Overall Study||438
2364971|NCT01568866|5803900|P2|COMPLETED|Overall Study|Indicates participants still receiving treatment|48
2364972|NCT01568866|5803901|P1|COMPLETED|Overall Study|Indicates participants still receiving treatment|27
2364973|NCT01568866|5803900|P2|Received Treatment|Overall Study||463
2364974|NCT01568866|5803901|P1|Received Treatment|Overall Study||456
2364975|NCT01568866|5803900|P2|STARTED|Overall Study||464
2364976|NCT01568866|5803901|P1|STARTED|Overall Study||465
2364977|NCT01568827|5803923|P2|NOT COMPLETED|Intervention 2 (5 Days)||0
2364978|NCT01568827|5803924|P1|NOT COMPLETED|Intervention 2 (5 Days)||0
2364979|NCT01568827|5803923|P2|COMPLETED|Intervention 2 (5 Days)||5
2364980|NCT01568827|5803924|P1|COMPLETED|Intervention 2 (5 Days)||5
2364981|NCT01568827|5803923|P2|STARTED|Intervention 2 (5 Days)||5
2364982|NCT01568827|5803924|P1|STARTED|Intervention 2 (5 Days)||5
2364983|NCT01568827|5803923|P2|NOT COMPLETED|Washout (2 Days)||0
2364984|NCT01568827|5803924|P1|NOT COMPLETED|Washout (2 Days)||0
2364985|NCT01568827|5803923|P2|COMPLETED|Washout (2 Days)||5
2364986|NCT01568827|5803924|P1|COMPLETED|Washout (2 Days)||5
2364987|NCT01568827|5803923|P2|STARTED|Washout (2 Days)||5
2364988|NCT01568827|5803924|P1|STARTED|Washout (2 Days)||5
2364989|NCT01568827|5803923|P2|NOT COMPLETED|First Intervention (6 Days)||0
2364990|NCT01568827|5803924|P1|NOT COMPLETED|First Intervention (6 Days)||0
2364991|NCT01568827|5803923|P2|COMPLETED|First Intervention (6 Days)||5
2364992|NCT01568827|5803924|P1|COMPLETED|First Intervention (6 Days)||5
2364993|NCT01568827|5803923|P2|STARTED|First Intervention (6 Days)||5
2364994|NCT01568827|5803924|P1|STARTED|First Intervention (6 Days)||5
2364995|NCT01568593|5803932|P2|NOT COMPLETED|Overall Study||3
2364996|NCT01568593|5803933|P1|NOT COMPLETED|Overall Study||7
2364997|NCT01568593|5803932|P2|COMPLETED|Overall Study||42
2364998|NCT01568593|5803933|P1|COMPLETED|Overall Study||41
2364999|NCT01568593|5803932|P2|STARTED|Overall Study||45
2365000|NCT01568593|5803933|P1|STARTED|Overall Study||48
2365001|NCT01568528|5803942|P3|NOT COMPLETED|Overall Study||0
2365002|NCT01568528|5803943|P2|NOT COMPLETED|Overall Study||0
2365003|NCT01568528|5803944|P1|NOT COMPLETED|Overall Study||0
2365004|NCT01568528|5803942|P3|COMPLETED|Overall Study||9
2365005|NCT01568528|5803943|P2|COMPLETED|Overall Study||11
2365006|NCT01568528|5803944|P1|COMPLETED|Overall Study||19
2365007|NCT01568528|5803942|P3|STARTED|Overall Study||9
2365008|NCT01568528|5803943|P2|STARTED|Overall Study||11
2365009|NCT01568528|5803944|P1|STARTED|Overall Study||19
2365010|NCT01568424|5803964|P1|NOT COMPLETED|Overall Study||0
2365011|NCT01568424|5803964|P1|COMPLETED|Overall Study||25
2365012|NCT01568424|5803964|P1|STARTED|Overall Study||25
2365013|NCT01568112|5803978|P4|NOT COMPLETED|Overall Study||12
2365014|NCT01568112|5803979|P3|NOT COMPLETED|Overall Study||7
2365015|NCT01568112|5803980|P2|NOT COMPLETED|Overall Study||8
2365016|NCT01568112|5803981|P1|NOT COMPLETED|Overall Study||5
2365017|NCT01568112|5803978|P4|COMPLETED|Overall Study||30
2365018|NCT01568112|5803979|P3|COMPLETED|Overall Study||36
2365019|NCT01568112|5803980|P2|COMPLETED|Overall Study||36
2365020|NCT01568112|5803981|P1|COMPLETED|Overall Study||39
2365021|NCT01568112|5803978|P4|STARTED|Overall Study||42
2365022|NCT01568112|5803979|P3|STARTED|Overall Study||43
2365023|NCT01568112|5803980|P2|STARTED|Overall Study||44
2365024|NCT01568112|5803981|P1|STARTED|Overall Study||44
2365025|NCT01568073|5804104|P5|NOT COMPLETED|Overall Study||9
2365026|NCT01568073|5804105|P4|NOT COMPLETED|Overall Study||11
2365027|NCT01568073|5804106|P3|NOT COMPLETED|Overall Study||12
2365028|NCT01568073|5804107|P2|NOT COMPLETED|Overall Study||15
2365029|NCT01568073|5804108|P1|NOT COMPLETED|Overall Study||11
2365030|NCT01568073|5804104|P5|COMPLETED|Overall Study||107
2365031|NCT01568073|5804105|P4|COMPLETED|Overall Study||108
2365032|NCT01568073|5804106|P3|COMPLETED|Overall Study||110
2365033|NCT01568073|5804107|P2|COMPLETED|Overall Study||107
2365034|NCT01568073|5804108|P1|COMPLETED|Overall Study||110
2365035|NCT01568073|5804104|P5|STARTED|Overall Study||116
2365036|NCT01568073|5804105|P4|STARTED|Overall Study||119
2365037|NCT01568073|5804106|P3|STARTED|Overall Study||122
2365038|NCT01568073|5804107|P2|STARTED|Overall Study||122
2365039|NCT01568073|5804108|P1|STARTED|Overall Study||121
2365040|NCT01568047|5804139|P4|NOT COMPLETED|Overall Study||1
2365041|NCT01568047|5804140|P3|NOT COMPLETED|Overall Study||1
2365042|NCT01568047|5804141|P2|NOT COMPLETED|Overall Study||1
2365043|NCT01568047|5804142|P1|NOT COMPLETED|Overall Study||1
2365044|NCT01568047|5804139|P4|COMPLETED|Overall Study||9
2365045|NCT01568047|5804140|P3|COMPLETED|Overall Study||9
2365046|NCT01568047|5804141|P2|COMPLETED|Overall Study||9
2365047|NCT01568047|5804142|P1|COMPLETED|Overall Study||9
2365048|NCT01568047|5804139|P4|STARTED|Overall Study||10
2365049|NCT01568047|5804140|P3|STARTED|Overall Study||10
2365050|NCT01568047|5804141|P2|STARTED|Overall Study||10
2365051|NCT01568047|5804142|P1|STARTED|Overall Study||10
2365052|NCT01568034|5804160|P4|NOT COMPLETED|Overall Study||0
2365053|NCT01568034|5804161|P3|NOT COMPLETED|Overall Study||0
2365054|NCT01568034|5804162|P2|NOT COMPLETED|Overall Study||0
2365055|NCT01568034|5804163|P1|NOT COMPLETED|Overall Study||1
2365056|NCT01568034|5804160|P4|COMPLETED|Overall Study||3
2365057|NCT01568034|5804161|P3|COMPLETED|Overall Study||3
2365058|NCT01568034|5804162|P2|COMPLETED|Overall Study||2
2365059|NCT01568034|5804163|P1|COMPLETED|Overall Study||1
2365060|NCT01568034|5804160|P4|Placebo|Overall Study||3
2365061|NCT01568034|5804161|P3|Placebo|Overall Study||3
2365062|NCT01568034|5804162|P2|Placebo|Overall Study||2
2365063|NCT01568034|5804163|P1|Placebo|Overall Study||1
2365064|NCT01568034|5804160|P4|100 mg BIA 9-1067|Overall Study||3
2365065|NCT01568034|5804161|P3|100 mg BIA 9-1067|Overall Study||3
2365066|NCT01568034|5804162|P2|100 mg BIA 9-1067|Overall Study||2
2365067|NCT01568034|5804163|P1|100 mg BIA 9-1067|Overall Study||2
2365068|NCT01568034|5804160|P4|50 mg BIA 9-1067|Overall Study||3
2365069|NCT01568034|5804161|P3|50 mg BIA 9-1067|Overall Study||3
2365070|NCT01568034|5804162|P2|50 mg BIA 9-1067|Overall Study||2
2365071|NCT01568034|5804163|P1|50 mg BIA 9-1067|Overall Study||2
2365072|NCT01568034|5804160|P4|25 mg BIA 9-1067|Overall Study||3
2365073|NCT01568034|5804161|P3|25 mg BIA 9-1067|Overall Study||3
2365074|NCT01568034|5804162|P2|25 mg BIA 9-1067|Overall Study||2
2365075|NCT01568034|5804163|P1|25 mg BIA 9-1067|Overall Study||2
2365076|NCT01568034|5804160|P4|STARTED|Overall Study||3
2365077|NCT01568034|5804161|P3|STARTED|Overall Study||3
2365078|NCT01568034|5804162|P2|STARTED|Overall Study||2
2365079|NCT01568034|5804163|P1|STARTED|Overall Study||2
2365080|NCT01568021|5804181|P1|NOT COMPLETED|Overall Study||16
2365081|NCT01568021|5804181|P1|COMPLETED|Overall Study||83
2365082|NCT01568021|5804181|P1|STARTED|Overall Study||99
2365083|NCT01568008|5804187|P1|NOT COMPLETED|Overall Study||234
2365084|NCT01568008|5804187|P1|COMPLETED|Overall Study||699
2365085|NCT01568008|5804187|P1|STARTED|Overall Study||933
2365086|NCT01567943|5804198|P3|NOT COMPLETED|Overall Study||0
2365087|NCT01567943|5804199|P2|NOT COMPLETED|Overall Study||10
2365088|NCT01567943|5804200|P1|NOT COMPLETED|Overall Study||14
2365089|NCT01567943|5804198|P3|COMPLETED|Overall Study||44
2365090|NCT01567943|5804199|P2|COMPLETED|Overall Study||29
2365091|NCT01567943|5804200|P1|COMPLETED|Overall Study||26
2365092|NCT01567943|5804198|P3|STARTED|Overall Study||44
2365093|NCT01567943|5804199|P2|STARTED|Overall Study||39
2365094|NCT01567943|5804200|P1|STARTED|Overall Study||40
2365095|NCT01567891|5804208|P1|NOT COMPLETED|Overall Study||3
2365096|NCT01567891|5804208|P1|COMPLETED|Overall Study||6
2365097|NCT01567891|5804208|P1|Received T-cell|Overall Study||6
2365098|NCT01567891|5804208|P1|STARTED|Overall Study||9
2365099|NCT01567865|5804226|P4|NOT COMPLETED|Evaluated for Immunogenicity||30
2365100|NCT01567865|5804227|P3|NOT COMPLETED|Evaluated for Immunogenicity||19
2365101|NCT01567865|5804228|P2|NOT COMPLETED|Evaluated for Immunogenicity||25
2365102|NCT01567865|5804229|P1|NOT COMPLETED|Evaluated for Immunogenicity||17
2365103|NCT01567865|5804226|P4|COMPLETED|Evaluated for Immunogenicity||194
2365104|NCT01567865|5804227|P3|COMPLETED|Evaluated for Immunogenicity||192
2365105|NCT01567865|5804228|P2|COMPLETED|Evaluated for Immunogenicity||195
2365106|NCT01567865|5804229|P1|COMPLETED|Evaluated for Immunogenicity||146
2365107|NCT01567865|5804226|P4|STARTED|Evaluated for Immunogenicity||224
2365108|NCT01567865|5804227|P3|STARTED|Evaluated for Immunogenicity||211
2365109|NCT01567865|5804228|P2|STARTED|Evaluated for Immunogenicity||220
2365110|NCT01567865|5804229|P1|STARTED|Evaluated for Immunogenicity||163
2365111|NCT01567865|5804226|P4|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
2365112|NCT01567865|5804227|P3|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
2365113|NCT01567865|5804228|P2|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
2365114|NCT01567865|5804229|P1|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
2365115|NCT01567865|5804226|P4|COMPLETED|Enrolled and Vaccinated (Day 0)||224
2365116|NCT01567865|5804227|P3|COMPLETED|Enrolled and Vaccinated (Day 0)||211
2365117|NCT01567865|5804228|P2|COMPLETED|Enrolled and Vaccinated (Day 0)||220
2365118|NCT01567865|5804229|P1|COMPLETED|Enrolled and Vaccinated (Day 0)||163
2365119|NCT01567865|5804226|P4|STARTED|Enrolled and Vaccinated (Day 0)||224
2365120|NCT01567865|5804227|P3|STARTED|Enrolled and Vaccinated (Day 0)||211
2365121|NCT01567865|5804228|P2|STARTED|Enrolled and Vaccinated (Day 0)||220
2365122|NCT01567865|5804229|P1|STARTED|Enrolled and Vaccinated (Day 0)||163
2365123|NCT01567852|5804259|P2|NOT COMPLETED|Overall Study||7
2365124|NCT01567852|5804260|P1|NOT COMPLETED|Overall Study||4
2365125|NCT01567852|5804259|P2|COMPLETED|Overall Study||5
2365126|NCT01567852|5804260|P1|COMPLETED|Overall Study||4
2365127|NCT01567852|5804259|P2|STARTED|Overall Study||12
2365128|NCT01567852|5804260|P1|STARTED|Overall Study||8
2365129|NCT01567839|5804268|P1|NOT COMPLETED|Overall Study||0
2365130|NCT01567839|5804268|P1|COMPLETED|Overall Study||60
2365131|NCT01567839|5804268|P1|STARTED|Overall Study||60
2365132|NCT01567826|5804278|P2|NOT COMPLETED|Overall Study||2
2365133|NCT01567826|5804279|P1|NOT COMPLETED|Overall Study||3
2365134|NCT01567826|5804278|P2|COMPLETED|Overall Study||42
2365135|NCT01567826|5804279|P1|COMPLETED|Overall Study||40
2365136|NCT01567826|5804278|P2|STARTED|Overall Study||44
2365137|NCT01567826|5804279|P1|STARTED|Overall Study||43
2365138|NCT01567527|5804305|P5|NOT COMPLETED|Double-blind, Placebo-controlled Phase||95
2365139|NCT01567527|5804306|P4|NOT COMPLETED|Double-blind, Placebo-controlled Phase||69
2365140|NCT01567527|5804307|P3|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
2365141|NCT01567527|5804308|P2|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
2365142|NCT01567527|5804309|P1|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
2365143|NCT01567527|5804305|P5|COMPLETED|Double-blind, Placebo-controlled Phase||38
2365144|NCT01567527|5804306|P4|COMPLETED|Double-blind, Placebo-controlled Phase||64
2365145|NCT01567527|5804307|P3|COMPLETED|Double-blind, Placebo-controlled Phase||0
2365146|NCT01567527|5804308|P2|COMPLETED|Double-blind, Placebo-controlled Phase||0
2365147|NCT01567527|5804309|P1|COMPLETED|Double-blind, Placebo-controlled Phase||0
2365148|NCT01567527|5804305|P5|STARTED|Double-blind, Placebo-controlled Phase||133
2365149|NCT01567527|5804306|P4|STARTED|Double-blind, Placebo-controlled Phase||133
2365150|NCT01567527|5804307|P3|STARTED|Double-blind, Placebo-controlled Phase|Subjects were randomized to Aripiprazole IM Depot and placebo groups in this phase of the study|0
2365151|NCT01567527|5804308|P2|STARTED|Double-blind, Placebo-controlled Phase||0
2365152|NCT01567527|5804309|P1|STARTED|Double-blind, Placebo-controlled Phase||0
2365153|NCT01567527|5804305|P5|NOT COMPLETED|IM Depot Stabilization.||0
2365154|NCT01567527|5804306|P4|NOT COMPLETED|IM Depot Stabilization.||0
2365155|NCT01567527|5804307|P3|NOT COMPLETED|IM Depot Stabilization.||159
2365156|NCT01567527|5804308|P2|NOT COMPLETED|IM Depot Stabilization.||0
2365157|NCT01567527|5804309|P1|NOT COMPLETED|IM Depot Stabilization.||0
2365158|NCT01567527|5804305|P5|COMPLETED|IM Depot Stabilization.||0
2365159|NCT01567527|5804306|P4|COMPLETED|IM Depot Stabilization.||0
2365160|NCT01567527|5804307|P3|COMPLETED|IM Depot Stabilization.||266
2365161|NCT01567527|5804308|P2|COMPLETED|IM Depot Stabilization.||0
2365162|NCT01567527|5804309|P1|COMPLETED|IM Depot Stabilization.||0
2365163|NCT01567527|5804305|P5|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
2365164|NCT01567527|5804306|P4|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
2365165|NCT01567527|5804307|P3|STARTED|IM Depot Stabilization.||425
2365166|NCT01567527|5804308|P2|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
2365167|NCT01567527|5804309|P1|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
2365168|NCT01567527|5804305|P5|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
2365169|NCT01567527|5804306|P4|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
2365170|NCT01567527|5804307|P3|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
2365171|NCT01567527|5804308|P2|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||207
2365172|NCT01567527|5804309|P1|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
2365173|NCT01567527|5804305|P5|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
2365174|NCT01567527|5804306|P4|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
2365175|NCT01567527|5804307|P3|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
2365176|NCT01567527|5804308|P2|COMPLETED|Oral Aripiprazole Stabilization Phase.||425
2365177|NCT01567527|5804309|P1|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
2365178|NCT01567527|5804305|P5|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
2365179|NCT01567527|5804306|P4|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
2365180|NCT01567527|5804307|P3|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
2365181|NCT01567527|5804308|P2|STARTED|Oral Aripiprazole Stabilization Phase.|265 of the 632 subjects who started this phase entered the Oral Stabilization Phase directly.|632
2365182|NCT01567527|5804309|P1|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
2365183|NCT01567527|5804305|P5|NOT COMPLETED|Conversion Phase.||0
2365184|NCT01567527|5804306|P4|NOT COMPLETED|Conversion Phase.||0
2365185|NCT01567527|5804307|P3|NOT COMPLETED|Conversion Phase.||0
2365186|NCT01567527|5804308|P2|NOT COMPLETED|Conversion Phase.||0
2365187|NCT01567527|5804309|P1|NOT COMPLETED|Conversion Phase.||99
2365188|NCT01567527|5804305|P5|COMPLETED|Conversion Phase.||0
2365189|NCT01567527|5804306|P4|COMPLETED|Conversion Phase.||0
2365190|NCT01567527|5804307|P3|COMPLETED|Conversion Phase.||0
2365191|NCT01567527|5804308|P2|COMPLETED|Conversion Phase.||0
2365192|NCT01567527|5804309|P1|COMPLETED|Conversion Phase.||367
2365193|NCT01567527|5804305|P5|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
2365194|NCT01567527|5804306|P4|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
2365195|NCT01567527|5804307|P3|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
2365196|NCT01567527|5804308|P2|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
2365197|NCT01567527|5804309|P1|STARTED|Conversion Phase.||466
2365198|NCT01567462|5804326|P2|NOT COMPLETED|Overall Study||7
2365199|NCT01567462|5804327|P1|NOT COMPLETED|Overall Study||4
2365200|NCT01567462|5804326|P2|COMPLETED|Overall Study||38
2365201|NCT01567462|5804327|P1|COMPLETED|Overall Study||41
2365202|NCT01567462|5804326|P2|STARTED|Overall Study||45
2365203|NCT01567462|5804327|P1|STARTED|Overall Study||45
2365204|NCT01567371|5804339|P1|NOT COMPLETED|Overall Study||0
2365205|NCT01567371|5804339|P1|COMPLETED|Overall Study||30
2365206|NCT01567371|5804339|P1|STARTED|Overall Study||30
2365207|NCT01567306|5804350|P6|NOT COMPLETED|Overall Study||3
2365208|NCT01567306|5804351|P5|NOT COMPLETED|Overall Study||7
2365209|NCT01567306|5804352|P4|NOT COMPLETED|Overall Study||5
2365210|NCT01567306|5804353|P3|NOT COMPLETED|Overall Study||0
2365211|NCT01567306|5804354|P2|NOT COMPLETED|Overall Study||2
2365212|NCT01567306|5804355|P1|NOT COMPLETED|Overall Study||3
2365213|NCT01567306|5804350|P6|COMPLETED|Overall Study||23
2365214|NCT01567306|5804351|P5|COMPLETED|Overall Study||18
2365215|NCT01567306|5804352|P4|COMPLETED|Overall Study||19
2365216|NCT01567306|5804353|P3|COMPLETED|Overall Study||24
2365217|NCT01567306|5804354|P2|COMPLETED|Overall Study||23
2365218|NCT01567306|5804355|P1|COMPLETED|Overall Study||24
2365219|NCT01567306|5804350|P6|STARTED|Overall Study||26
2365220|NCT01567306|5804351|P5|STARTED|Overall Study||25
2365221|NCT01567306|5804352|P4|STARTED|Overall Study||24
2365222|NCT01567306|5804353|P3|STARTED|Overall Study||24
2365223|NCT01567306|5804354|P2|STARTED|Overall Study||25
2365224|NCT01567306|5804355|P1|STARTED|Overall Study||27
2365225|NCT01567163|5804369|P1|NOT COMPLETED|Overall Study||4
2365226|NCT01567163|5804369|P1|COMPLETED|Overall Study||18
2365227|NCT01567163|5804369|P1|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1, Day 1 and Cycle 2, Day 1 treatment with required assessments.|18
2365228|NCT01567163|5804369|P1|Received at Least 1 Dose of Study Drug|Overall Study||22
2365229|NCT01567163|5804369|P1|STARTED|Overall Study||22
2365230|NCT01567150|5804381|P2|NOT COMPLETED|Overall Study||2
2365231|NCT01567150|5804382|P1|NOT COMPLETED|Overall Study||2
2365232|NCT01567150|5804381|P2|COMPLETED|Overall Study||16
2365233|NCT01567150|5804382|P1|COMPLETED|Overall Study||19
2365234|NCT01567150|5804381|P2|STARTED|Overall Study||18
2365235|NCT01567150|5804382|P1|STARTED|Overall Study||21
2365236|NCT01567085|5804390|P1|NOT COMPLETED|Overall Study||20
2365237|NCT01567085|5804390|P1|COMPLETED|Overall Study||60
2365238|NCT01567085|5804390|P1|Received at Least 1 Dose of Study Drug|Overall Study||80
2365239|NCT01567085|5804390|P1|STARTED|Overall Study||80
2365240|NCT01567020|5804400|P4|NOT COMPLETED|Overall Study||1
2365241|NCT01567020|5804401|P3|NOT COMPLETED|Overall Study||2
2365242|NCT01567020|5804402|P2|NOT COMPLETED|Overall Study||5
2365243|NCT01567020|5804403|P1|NOT COMPLETED|Overall Study||7
2365244|NCT01567020|5804400|P4|COMPLETED|Overall Study||10
2365245|NCT01567020|5804401|P3|COMPLETED|Overall Study||18
2365246|NCT01567020|5804402|P2|COMPLETED|Overall Study||41
2365247|NCT01567020|5804403|P1|COMPLETED|Overall Study||21
2365248|NCT01567020|5804400|P4|STARTED|Overall Study||11
2365249|NCT01567020|5804401|P3|STARTED|Overall Study||20
2365250|NCT01567020|5804402|P2|STARTED|Overall Study||46
2365251|NCT01567020|5804403|P1|STARTED|Overall Study||28
2365252|NCT01566981|5804427|P2|NOT COMPLETED|Overall Study||8
2365253|NCT01566981|5804428|P1|NOT COMPLETED|Overall Study||5
2365254|NCT01566981|5804427|P2|COMPLETED|Overall Study||54
2365255|NCT01566981|5804428|P1|COMPLETED|Overall Study||53
2365256|NCT01566981|5804427|P2|STARTED|Overall Study||62
2365257|NCT01566981|5804428|P1|STARTED|Overall Study||58
2365258|NCT01566838|5804440|P2|NOT COMPLETED|Overall Study||0
2365259|NCT01566838|5804441|P1|NOT COMPLETED|Overall Study||3
2365260|NCT01566838|5804440|P2|COMPLETED|Overall Study||42
2365261|NCT01566838|5804441|P1|COMPLETED|Overall Study||38
2365262|NCT01566838|5804440|P2|STARTED|Overall Study||42
2365263|NCT01566838|5804441|P1|STARTED|Overall Study||41
2365264|NCT01566773|5804457|P1|NOT COMPLETED|Overall Study||30
2365265|NCT01566773|5804457|P1|COMPLETED|Overall Study||110
2365266|NCT01566773|5804457|P1|Spiriva® Handihaler®|Overall Study||62
2365267|NCT01566773|5804457|P1|Placebo MDI|Overall Study||62
2365268|NCT01566773|5804457|P1|GP MDI 0.6 µg BID|Overall Study||59
2365269|NCT01566773|5804457|P1|GP MDI 1.2 µg BID|Overall Study||57
2365270|NCT01566773|5804457|P1|GP MDI 2.4 µg BID|Overall Study||64
2365271|NCT01566773|5804457|P1|GP MDI 4.6 µg BID|Overall Study||62
2365272|NCT01566773|5804457|P1|GP MDI 9 µg BID|Overall Study||64
2365273|NCT01566773|5804457|P1|GP MDI 18 µg BID|Overall Study||64
2365274|NCT01566773|5804457|P1|STARTED|Overall Study||140
2365275|NCT01566721|5804666|P2|NOT COMPLETED|Overall Study||710
2365276|NCT01566721|5804667|P1|NOT COMPLETED|Overall Study||1867
2365277|NCT01566721|5804666|P2|COMPLETED|Overall Study||0
2365278|NCT01566721|5804667|P1|COMPLETED|Overall Study||0
2365279|NCT01566721|5804666|P2|Received Treatment|Overall Study||709
2365280|NCT01566721|5804667|P1|Received Treatment|Overall Study||1864
2365281|NCT01566721|5804666|P2|STARTED|Overall Study||710
2365282|NCT01566721|5804667|P1|STARTED|Overall Study||1867
2365283|NCT01566682|5804690|P1|NOT COMPLETED|Overall Study||46
2365284|NCT01566682|5804690|P1|COMPLETED|Overall Study||374
2365285|NCT01566682|5804690|P1|STARTED|Overall Study||420
2365286|NCT01566630|5804696|P2|NOT COMPLETED|Overall Study||0
2365287|NCT01566630|5804697|P1|NOT COMPLETED|Overall Study||0
2365288|NCT01566630|5804696|P2|COMPLETED|Overall Study||1
2365289|NCT01566630|5804697|P1|COMPLETED|Overall Study||2
2365290|NCT01566630|5804696|P2|STARTED|Overall Study||1
2365291|NCT01566630|5804697|P1|STARTED|Overall Study||2
2365292|NCT01566604|5804753|P2|NOT COMPLETED|Overall Study||11
2365293|NCT01566604|5804754|P1|NOT COMPLETED|Overall Study||24
2365294|NCT01566604|5804753|P2|COMPLETED|Overall Study||143
2365295|NCT01566604|5804754|P1|COMPLETED|Overall Study||282
2365296|NCT01566604|5804753|P2|FAS, Serial Spirometry Subgroup|Overall Study||58
2365297|NCT01566604|5804754|P1|FAS, Serial Spirometry Subgroup|Overall Study||134
2365298|NCT01566604|5804753|P2|Full Analysis Set (FAS)|Overall Study||154
2365299|NCT01566604|5804754|P1|Full Analysis Set (FAS)|Overall Study||305
2365300|NCT01566604|5804753|P2|Safety Set|Overall Study||154
2365301|NCT01566604|5804754|P1|Safety Set|Overall Study||305
2365302|NCT01566604|5804753|P2|STARTED|Overall Study||154
2365303|NCT01566604|5804754|P1|STARTED|Overall Study||306
2365304|NCT01566539|5804788|P9|NOT COMPLETED|Within Subject Group||0
2365305|NCT01566539|5804789|P8|NOT COMPLETED|Within Subject Group||0
2365306|NCT01566539|5804790|P7|NOT COMPLETED|Within Subject Group||0
2365307|NCT01566539|5804791|P6|NOT COMPLETED|Within Subject Group||0
2365308|NCT01566539|5804792|P5|NOT COMPLETED|Within Subject Group||0
2365309|NCT01566539|5804793|P4|NOT COMPLETED|Within Subject Group||3
2365310|NCT01566539|5804794|P3|NOT COMPLETED|Within Subject Group||0
2365311|NCT01566539|5804795|P2|NOT COMPLETED|Within Subject Group||0
2365312|NCT01566539|5804796|P1|NOT COMPLETED|Within Subject Group||0
2365313|NCT01566539|5804788|P9|COMPLETED|Within Subject Group||0
2365314|NCT01566539|5804789|P8|COMPLETED|Within Subject Group||0
2365315|NCT01566539|5804790|P7|COMPLETED|Within Subject Group||0
2365316|NCT01566539|5804791|P6|COMPLETED|Within Subject Group||0
2365317|NCT01566539|5804792|P5|COMPLETED|Within Subject Group||0
2365318|NCT01566539|5804793|P4|COMPLETED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|153
2365319|NCT01566539|5804794|P3|COMPLETED|Within Subject Group||0
2365320|NCT01566539|5804795|P2|COMPLETED|Within Subject Group||0
2365321|NCT01566539|5804796|P1|COMPLETED|Within Subject Group||0
2365322|NCT01566539|5804788|P9|STARTED|Within Subject Group||0
2365323|NCT01566539|5804789|P8|STARTED|Within Subject Group||0
2365324|NCT01566539|5804790|P7|STARTED|Within Subject Group||0
2365325|NCT01566539|5804791|P6|STARTED|Within Subject Group||0
2365326|NCT01566539|5804792|P5|STARTED|Within Subject Group||0
2365327|NCT01566539|5804793|P4|STARTED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|156
2365328|NCT01566539|5804794|P3|STARTED|Within Subject Group||0
2365329|NCT01566539|5804795|P2|STARTED|Within Subject Group||0
2365330|NCT01566539|5804796|P1|STARTED|Within Subject Group||0
2365331|NCT01566539|5804788|P9|NOT COMPLETED|Main Study Period||0
2365332|NCT01566539|5804789|P8|NOT COMPLETED|Main Study Period||0
2365333|NCT01566539|5804790|P7|NOT COMPLETED|Main Study Period||0
2365334|NCT01566539|5804791|P6|NOT COMPLETED|Main Study Period||3
2365335|NCT01566539|5804792|P5|NOT COMPLETED|Main Study Period||0
2365336|NCT01566539|5804793|P4|NOT COMPLETED|Main Study Period||0
2365337|NCT01566539|5804794|P3|NOT COMPLETED|Main Study Period||0
2365338|NCT01566539|5804795|P2|NOT COMPLETED|Main Study Period||0
2365339|NCT01566539|5804796|P1|NOT COMPLETED|Main Study Period||1
2365340|NCT01566539|5804788|P9|COMPLETED|Main Study Period||1
2365341|NCT01566539|5804789|P8|COMPLETED|Main Study Period||30
2365342|NCT01566539|5804790|P7|COMPLETED|Main Study Period||30
2365343|NCT01566539|5804791|P6|COMPLETED|Main Study Period||40
2365344|NCT01566539|5804792|P5|COMPLETED|Main Study Period||40
2365345|NCT01566539|5804793|P4|COMPLETED|Main Study Period||0
2365346|NCT01566539|5804794|P3|COMPLETED|Main Study Period||104
2365347|NCT01566539|5804795|P2|COMPLETED|Main Study Period||100
2365348|NCT01566539|5804796|P1|COMPLETED|Main Study Period||100
2365349|NCT01566539|5804788|P9|STARTED|Main Study Period||1
2365350|NCT01566539|5804789|P8|STARTED|Main Study Period||30
2365351|NCT01566539|5804790|P7|STARTED|Main Study Period||30
2365352|NCT01566539|5804791|P6|STARTED|Main Study Period||43
2365353|NCT01566539|5804792|P5|STARTED|Main Study Period||40
2365354|NCT01566539|5804793|P4|STARTED|Main Study Period||0
2365355|NCT01566539|5804794|P3|STARTED|Main Study Period||104
2365356|NCT01566539|5804795|P2|STARTED|Main Study Period||100
2365357|NCT01566539|5804796|P1|STARTED|Main Study Period||101
2365358|NCT01566526|5804849|P1|NOT COMPLETED|Overall Study||0
2365359|NCT01566526|5804849|P1|COMPLETED|Overall Study||26
2365360|NCT01566526|5804849|P1|STARTED|Overall Study||26
2365361|NCT01566500|5804859|P1|NOT COMPLETED|Overall Study||0
2365362|NCT01566500|5804859|P1|COMPLETED|Overall Study||140
2365363|NCT01566500|5804859|P1|STARTED|Overall Study||140
2365364|NCT01566461|5804865|P2|NOT COMPLETED|IN.PACT SFA II Phase||5
2365365|NCT01566461|5804866|P1|NOT COMPLETED|IN.PACT SFA II Phase||12
2365366|NCT01566461|5804865|P2|COMPLETED|IN.PACT SFA II Phase||55
2365367|NCT01566461|5804866|P1|COMPLETED|IN.PACT SFA II Phase||109
2365368|NCT01566461|5804865|P2|STARTED|IN.PACT SFA II Phase||60
2365369|NCT01566461|5804866|P1|STARTED|IN.PACT SFA II Phase||121
2365370|NCT01566461|5804865|P2|NOT COMPLETED|IN.PACT SFA I Phase||2
2365371|NCT01566461|5804866|P1|NOT COMPLETED|IN.PACT SFA I Phase||11
2365372|NCT01566461|5804865|P2|COMPLETED|IN.PACT SFA I Phase||49
2365373|NCT01566461|5804866|P1|COMPLETED|IN.PACT SFA I Phase||88
2365374|NCT01566461|5804865|P2|STARTED|IN.PACT SFA I Phase||51
2365375|NCT01566461|5804866|P1|STARTED|IN.PACT SFA I Phase||99
2365376|NCT01566435|5804910|P1|NOT COMPLETED|ACF Definitive Chemoradiation-cetuximab||0
2365377|NCT01566435|5804910|P1|COMPLETED|ACF Definitive Chemoradiation-cetuximab||2
2365378|NCT01566435|5804910|P1|STARTED|ACF Definitive Chemoradiation-cetuximab||2
2365379|NCT01566435|5804910|P1|NOT COMPLETED|ACF Definitive Chemoradiation-cisplatin||1
2365380|NCT01566435|5804910|P1|COMPLETED|ACF Definitive Chemoradiation-cisplatin||27
2365381|NCT01566435|5804910|P1|STARTED|ACF Definitive Chemoradiation-cisplatin||28
2365382|NCT01566435|5804910|P1|NOT COMPLETED|ACF Induction Therapy||0
2365383|NCT01566435|5804910|P1|COMPLETED|ACF Induction Therapy||30
2365384|NCT01566435|5804910|P1|STARTED|ACF Induction Therapy||30
2365385|NCT01566409|5804926|P2|NOT COMPLETED|Overall Study||5
2365386|NCT01566409|5804927|P1|NOT COMPLETED|Overall Study||2
2365387|NCT01566409|5804926|P2|COMPLETED|Overall Study||48
2365388|NCT01566409|5804927|P1|COMPLETED|Overall Study||47
2365389|NCT01566409|5804926|P2|STARTED|Overall Study||53
2365390|NCT01566409|5804927|P1|STARTED|Overall Study||49
2365391|NCT01566370|5804935|P2|NOT COMPLETED|Overall Study||1
2365392|NCT01566370|5804936|P1|NOT COMPLETED|Overall Study||2
2365393|NCT01566370|5804935|P2|COMPLETED|Overall Study||0
2365394|NCT01566370|5804936|P1|COMPLETED|Overall Study||0
2365395|NCT01566370|5804935|P2|STARTED|Overall Study||1
2365396|NCT01566370|5804936|P1|STARTED|Overall Study||2
2365397|NCT01566331|5804962|P2|NOT COMPLETED|Overall Study||0
2365398|NCT01566331|5804963|P1|NOT COMPLETED|Overall Study||0
2365399|NCT01566331|5804962|P2|COMPLETED|Overall Study||40
2365400|NCT01566331|5804963|P1|COMPLETED|Overall Study||40
2365401|NCT01566331|5804962|P2|STARTED|Overall Study||40
2365402|NCT01566331|5804963|P1|STARTED|Overall Study||40
2365403|NCT01566214|5804971|P2|NOT COMPLETED|Overall Study||0
2365404|NCT01566214|5804972|P1|NOT COMPLETED|Overall Study||3
2365405|NCT01566214|5804971|P2|COMPLETED|Overall Study||6
2365406|NCT01566214|5804972|P1|COMPLETED|Overall Study||3
2365407|NCT01566214|5804971|P2|STARTED|Overall Study||6
2365408|NCT01566214|5804972|P1|STARTED|Overall Study||6
2365409|NCT01566162|5805002|P1|NOT COMPLETED|Overall Study||36
2365410|NCT01566162|5805002|P1|COMPLETED|Overall Study||155
2365411|NCT01566162|5805002|P1|STARTED|Overall Study||191
2365412|NCT01566149|5805016|P2|NOT COMPLETED|Overall Study||2
2365413|NCT01566149|5805017|P1|NOT COMPLETED|Overall Study||3
2365414|NCT01566149|5805016|P2|COMPLETED|Overall Study||23
2365415|NCT01566149|5805017|P1|COMPLETED|Overall Study||21
2365416|NCT01566149|5805016|P2|STARTED|Overall Study||25
2365417|NCT01566149|5805017|P1|STARTED|Overall Study||24
2365418|NCT01566084|5805033|P2|NOT COMPLETED|Overall Study||0
2365419|NCT01566084|5805034|P1|NOT COMPLETED|Overall Study||0
2365420|NCT01566084|5805033|P2|COMPLETED|Overall Study||10
2365421|NCT01566084|5805034|P1|COMPLETED|Overall Study||7
2365422|NCT01566084|5805033|P2|STARTED|Overall Study||10
2365423|NCT01566084|5805034|P1|STARTED|Overall Study||7
2365424|NCT01565993|5805050|P2|NOT COMPLETED|Overall Study||3
2365425|NCT01565993|5805051|P1|NOT COMPLETED|Overall Study||0
2365426|NCT01565993|5805050|P2|COMPLETED|Overall Study||39
2365427|NCT01565993|5805051|P1|COMPLETED|Overall Study|A total of 105 polypectomies were performed on 98 patients|66
2365428|NCT01565993|5805050|P2|STARTED|Overall Study|3 patients were excluded for failing to meet the inclusion criteria|42
2365429|NCT01565993|5805051|P1|STARTED|Overall Study||66
2365430|NCT01565980|5805059|P2|NOT COMPLETED|Overall Study||4
2365431|NCT01565980|5805060|P1|NOT COMPLETED|Overall Study||4
2365432|NCT01565980|5805059|P2|COMPLETED|Overall Study||16
2365433|NCT01565980|5805060|P1|COMPLETED|Overall Study||16
2365434|NCT01565980|5805059|P2|STARTED|Overall Study|Three patients had started the intervention protocol at the time of study withdrawal.|20
2365435|NCT01565980|5805060|P1|STARTED|Overall Study||20
2365436|NCT01565941|5805080|P2|NOT COMPLETED|Overall Study||4
2365437|NCT01565941|5805081|P1|NOT COMPLETED|Overall Study||11
2365438|NCT01565941|5805080|P2|COMPLETED|Overall Study||349
2365439|NCT01565941|5805081|P1|COMPLETED|Overall Study||349
2365440|NCT01565941|5805080|P2|STARTED|Overall Study||353
2365441|NCT01565941|5805081|P1|STARTED|Overall Study||360
2365442|NCT01565928|5805123|P1|NOT COMPLETED|Overall Study||22
2365443|NCT01565928|5805123|P1|COMPLETED|Overall Study||0
2365444|NCT01565928|5805123|P1|STARTED|Overall Study||22
2365445|NCT01565902|5805140|P4|NOT COMPLETED|Overall Study||0
2365446|NCT01565902|5805141|P3|NOT COMPLETED|Overall Study||0
2365447|NCT01565902|5805142|P2|NOT COMPLETED|Overall Study||0
2365448|NCT01565902|5805143|P1|NOT COMPLETED|Overall Study||0
2365449|NCT01565902|5805140|P4|COMPLETED|Overall Study||16
2365450|NCT01565902|5805141|P3|COMPLETED|Overall Study||8
2365451|NCT01565902|5805142|P2|COMPLETED|Overall Study||8
2365452|NCT01565902|5805143|P1|COMPLETED|Overall Study||8
2365453|NCT01565902|5805140|P4|STARTED|Overall Study||16
2365454|NCT01565902|5805141|P3|STARTED|Overall Study||8
2365455|NCT01565902|5805142|P2|STARTED|Overall Study||8
2365456|NCT01565902|5805143|P1|STARTED|Overall Study||8
2365457|NCT01565889|5805177|P6|NOT COMPLETED|Part B||4
2365458|NCT01565889|5805178|P5|NOT COMPLETED|Part B||0
2365459|NCT01565889|5805179|P4|NOT COMPLETED|Part B||0
2365460|NCT01565889|5805180|P3|NOT COMPLETED|Part B||0
2365461|NCT01565889|5805181|P2|NOT COMPLETED|Part B||0
2365462|NCT01565889|5805182|P1|NOT COMPLETED|Part B||0
2365463|NCT01565889|5805177|P6|COMPLETED|Part B||19
2365464|NCT01565889|5805178|P5|COMPLETED|Part B||0
2365465|NCT01565889|5805179|P4|COMPLETED|Part B||0
2365466|NCT01565889|5805180|P3|COMPLETED|Part B||0
2365467|NCT01565889|5805181|P2|COMPLETED|Part B||0
2365468|NCT01565889|5805182|P1|COMPLETED|Part B||0
2365469|NCT01565889|5805177|P6|STARTED|Part B|9 participants in this group transferred from a Part A cohort, and 14 participants joined the study.|23
2365470|NCT01565889|5805178|P5|STARTED|Part B||0
2365471|NCT01565889|5805179|P4|STARTED|Part B||0
2365472|NCT01565889|5805180|P3|STARTED|Part B||0
2365473|NCT01565889|5805181|P2|STARTED|Part B||0
2365474|NCT01565889|5805182|P1|STARTED|Part B||0
2365475|NCT01565889|5805177|P6|NOT COMPLETED|Part A||0
2365476|NCT01565889|5805178|P5|NOT COMPLETED|Part A||0
2365477|NCT01565889|5805179|P4|NOT COMPLETED|Part A||0
2365478|NCT01565889|5805180|P3|NOT COMPLETED|Part A||0
2365479|NCT01565889|5805181|P2|NOT COMPLETED|Part A||0
2365480|NCT01565889|5805182|P1|NOT COMPLETED|Part A||1
2365481|NCT01565889|5805177|P6|COMPLETED|Part A||0
2365482|NCT01565889|5805178|P5|COMPLETED|Part A|1 participant from this group continued in the Part B: SOF+PEG+RBV group.|7
2365483|NCT01565889|5805179|P4|COMPLETED|Part A|2 participants from this group continued in the Part B: SOF+PEG+RBV group.|7
2365484|NCT01565889|5805180|P3|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|8
2365485|NCT01565889|5805181|P2|COMPLETED|Part A|No participants from this group continued in the Part B: SOF+PEG+RBV group.|4
2365486|NCT01565889|5805182|P1|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|11
2365487|NCT01565889|5805177|P6|STARTED|Part A||0
2365488|NCT01565889|5805178|P5|STARTED|Part A||7
2365489|NCT01565889|5805179|P4|STARTED|Part A||7
2365490|NCT01565889|5805180|P3|STARTED|Part A||8
2365491|NCT01565889|5805181|P2|STARTED|Part A||4
2365492|NCT01565889|5805182|P1|STARTED|Part A||12
2365493|NCT01565850|5805213|P2|NOT COMPLETED|Overall Study||8
2365494|NCT01565850|5805214|P1|NOT COMPLETED|Overall Study||20
2365495|NCT01565850|5805213|P2|COMPLETED|Overall Study||42
2365496|NCT01565850|5805214|P1|COMPLETED|Overall Study||83
2365497|NCT01565850|5805213|P2|STARTED|Overall Study||50
2365498|NCT01565850|5805214|P1|STARTED|Overall Study||103
2365499|NCT01565707|5805234|P4|NOT COMPLETED|Overall Study||5
2365500|NCT01565707|5805235|P3|NOT COMPLETED|Overall Study||3
2365501|NCT01565707|5805236|P2|NOT COMPLETED|Overall Study||8
2365502|NCT01565707|5805237|P1|NOT COMPLETED|Overall Study||9
2365503|NCT01565707|5805234|P4|COMPLETED|Overall Study||17
2365504|NCT01565707|5805235|P3|COMPLETED|Overall Study||16
2365505|NCT01565707|5805236|P2|COMPLETED|Overall Study||65
2365506|NCT01565707|5805237|P1|COMPLETED|Overall Study||66
2365507|NCT01565707|5805234|P4|Treated|Overall Study||22
2365508|NCT01565707|5805235|P3|Treated|Overall Study||19
2365509|NCT01565707|5805236|P2|Treated|Overall Study||73
2365510|NCT01565707|5805237|P1|Treated|Overall Study||73
2365511|NCT01565707|5805234|P4|STARTED|Overall Study||22
2365512|NCT01565707|5805235|P3|STARTED|Overall Study||19
2365513|NCT01565707|5805236|P2|STARTED|Overall Study||73
2365514|NCT01565707|5805237|P1|STARTED|Overall Study||75
2365515|NCT01565694|5805328|P1|NOT COMPLETED|Fixed-Dose Assessment Period||4
2365516|NCT01565694|5805328|P1|COMPLETED|Fixed-Dose Assessment Period||58
2365517|NCT01565694|5805328|P1|STARTED|Fixed-Dose Assessment Period||62
2365518|NCT01565694|5805328|P1|NOT COMPLETED|Dose-Titration Period||14
2365519|NCT01565694|5805328|P1|COMPLETED|Dose-Titration Period||62
2365520|NCT01565694|5805328|P1|STARTED|Dose-Titration Period||76
2365521|NCT01565668|5805349|P2|NOT COMPLETED|Overall Study||38
2365522|NCT01565668|5805350|P1|NOT COMPLETED|Overall Study||38
2365523|NCT01565668|5805349|P2|COMPLETED|Overall Study||0
2365524|NCT01565668|5805350|P1|COMPLETED|Overall Study||0
2365525|NCT01565668|5805349|P2|Completed Long-term Follow-up|Overall Study||0
2365526|NCT01565668|5805350|P1|Completed Long-term Follow-up|Overall Study||0
2365527|NCT01565668|5805349|P2|Started Long-term Follow-up|Overall Study||33
2365528|NCT01565668|5805350|P1|Started Long-term Follow-up|Overall Study||36
2365529|NCT01565668|5805349|P2|Completed 30-day Follow-up|Overall Study||5
2365530|NCT01565668|5805350|P1|Completed 30-day Follow-up|Overall Study||11
2365531|NCT01565668|5805349|P2|Started 30-day Follow-up|Overall Study||37
2365532|NCT01565668|5805350|P1|Started 30-day Follow-up|Overall Study||37
2365533|NCT01565668|5805349|P2|Completed Treatment Per Protocol|Overall Study||0
2365534|NCT01565668|5805350|P1|Completed Treatment Per Protocol|Overall Study||0
2365535|NCT01565668|5805349|P2|STARTED|Overall Study||38
2365536|NCT01565668|5805350|P1|STARTED|Overall Study||38
2365537|NCT01565642|5805374|P2|NOT COMPLETED|Overall Study||1
2365538|NCT01565642|5805375|P1|NOT COMPLETED|Overall Study||2
2365539|NCT01565642|5805374|P2|COMPLETED|Overall Study||150
2365540|NCT01565642|5805375|P1|COMPLETED|Overall Study||149
2365541|NCT01565642|5805374|P2|STARTED|Overall Study||151
2365542|NCT01565642|5805375|P1|STARTED|Overall Study||151
2365543|NCT01565616|5805397|P1|NOT COMPLETED|Overall Study||0
2365544|NCT01565616|5805397|P1|COMPLETED|Overall Study||22
2365545|NCT01565616|5805397|P1|Second Component: Related or Unrelated|Overall Study||17
2365546|NCT01565616|5805397|P1|First Component: 5 Related Donors|Overall Study||5
2365547|NCT01565616|5805397|P1|STARTED|Overall Study||22
2365548|NCT01565564|5805410|P2|NOT COMPLETED|Overall Study||1
2365549|NCT01565564|5805411|P1|NOT COMPLETED|Overall Study||5
2365550|NCT01565564|5805410|P2|COMPLETED|Overall Study||361
2365551|NCT01565564|5805411|P1|COMPLETED|Overall Study||339
2365552|NCT01565564|5805410|P2|STARTED|Overall Study||362
2365553|NCT01565564|5805411|P1|STARTED|Overall Study||344
2365554|NCT01565551|5805421|P2|NOT COMPLETED|Overall Study||0
2365555|NCT01565551|5805422|P1|NOT COMPLETED|Overall Study||0
2365556|NCT01565551|5805421|P2|COMPLETED|Overall Study||51
2365557|NCT01565551|5805422|P1|COMPLETED|Overall Study||586
2365558|NCT01565551|5805421|P2|6-Month Outcomes|Overall Study||30
2365559|NCT01565551|5805422|P1|6-Month Outcomes|Overall Study||412
2365560|NCT01565551|5805421|P2|Neuroimaging|Overall Study||25
2365561|NCT01565551|5805422|P1|Neuroimaging|Overall Study||233
2365562|NCT01565551|5805421|P2|Biospecimens/Biomarkers|Overall Study||22
2365563|NCT01565551|5805422|P1|Biospecimens/Biomarkers|Overall Study||479
2365564|NCT01565551|5805421|P2|Clinical/Demographics|Overall Study||51
2365565|NCT01565551|5805422|P1|Clinical/Demographics|Overall Study||586
2365566|NCT01565551|5805421|P2|STARTED|Overall Study||51
2365567|NCT01565551|5805422|P1|STARTED|Overall Study||586
2365568|NCT01565538|5805430|P2|NOT COMPLETED|Overall Study||0
2365569|NCT01565538|5805431|P1|NOT COMPLETED|Overall Study||0
2365570|NCT01565538|5805430|P2|COMPLETED|Overall Study||62
2365571|NCT01565538|5805431|P1|COMPLETED|Overall Study||61
2365572|NCT01565538|5805430|P2|STARTED|Overall Study||62
2365573|NCT01565538|5805431|P1|STARTED|Overall Study||61
2365574|NCT01565382|5805441|P2|NOT COMPLETED|Overall Study||0
2365575|NCT01565382|5805442|P1|NOT COMPLETED|Overall Study||0
2365576|NCT01565382|5805441|P2|COMPLETED|Overall Study||7
2365577|NCT01565382|5805442|P1|COMPLETED|Overall Study||40
2365578|NCT01565382|5805441|P2|STARTED|Overall Study||7
2365579|NCT01565382|5805442|P1|STARTED|Overall Study||40
2365580|NCT01565369|5805447|P1|NOT COMPLETED|Overall Study||0
2365581|NCT01565369|5805447|P1|COMPLETED|Overall Study||35
2365582|NCT01565369|5805447|P1|STARTED|Overall Study||35
2365583|NCT01565356|5805453|P1|NOT COMPLETED|Overall Study||0
2365584|NCT01565356|5805453|P1|COMPLETED|Overall Study||41
2365585|NCT01565356|5805453|P1|STARTED|Overall Study||41
2365586|NCT01565343|5805461|P3|NOT COMPLETED|Overall Study||0
2365587|NCT01565343|5805462|P2|NOT COMPLETED|Overall Study||0
2365588|NCT01565343|5805463|P1|NOT COMPLETED|Overall Study||1
2365589|NCT01565343|5805461|P3|COMPLETED|Overall Study||10
2365590|NCT01565343|5805462|P2|COMPLETED|Overall Study||4
2365591|NCT01565343|5805463|P1|COMPLETED|Overall Study||10
2365592|NCT01565343|5805461|P3|STARTED|Overall Study||10
2365593|NCT01565343|5805462|P2|STARTED|Overall Study||4
2365594|NCT01565343|5805463|P1|STARTED|Overall Study||11
2365595|NCT01565330|5805474|P4|NOT COMPLETED|Overall Study||0
2365596|NCT01565330|5805475|P3|NOT COMPLETED|Overall Study||0
2365597|NCT01565330|5805476|P2|NOT COMPLETED|Overall Study||0
2365598|NCT01565330|5805477|P1|NOT COMPLETED|Overall Study||0
2365599|NCT01565330|5805474|P4|COMPLETED|Overall Study||7
2365600|NCT01565330|5805475|P3|COMPLETED|Overall Study||4
2365601|NCT01565330|5805476|P2|COMPLETED|Overall Study||4
2365602|NCT01565330|5805477|P1|COMPLETED|Overall Study||5
2365603|NCT01565330|5805474|P4|STARTED|Overall Study||7
2365604|NCT01565330|5805475|P3|STARTED|Overall Study||4
2365605|NCT01565330|5805476|P2|STARTED|Overall Study||4
2365606|NCT01565330|5805477|P1|STARTED|Overall Study||5
2365607|NCT01565291|5805493|P2|NOT COMPLETED|Overall Study||0
2365608|NCT01565291|5805494|P1|NOT COMPLETED|Overall Study||1
2365609|NCT01565291|5805493|P2|COMPLETED|Overall Study||16
2365610|NCT01565291|5805494|P1|COMPLETED|Overall Study||15
2365611|NCT01565291|5805493|P2|STARTED|Overall Study||16
2365612|NCT01565291|5805494|P1|STARTED|Overall Study||16
2365613|NCT01565148|5805506|P4|NOT COMPLETED|Overall Study||13
2365614|NCT01565148|5805507|P3|NOT COMPLETED|Overall Study||7
2365615|NCT01565148|5805508|P2|NOT COMPLETED|Overall Study||15
2365616|NCT01565148|5805509|P1|NOT COMPLETED|Overall Study||15
2365617|NCT01565148|5805506|P4|COMPLETED|Overall Study||32
2365618|NCT01565148|5805507|P3|COMPLETED|Overall Study||40
2365619|NCT01565148|5805508|P2|COMPLETED|Overall Study||31
2365620|NCT01565148|5805509|P1|COMPLETED|Overall Study||32
2365621|NCT01565148|5805506|P4|STARTED|Overall Study||45
2365622|NCT01565148|5805507|P3|STARTED|Overall Study||47
2365623|NCT01565148|5805508|P2|STARTED|Overall Study||46
2365624|NCT01565148|5805509|P1|STARTED|Overall Study||47
2365625|NCT01565083|5805545|P2|NOT COMPLETED|Overall Study||39
2365626|NCT01565083|5805546|P1|NOT COMPLETED|Overall Study||33
2365627|NCT01565083|5805545|P2|COMPLETED|Overall Study||68
2365628|NCT01565083|5805546|P1|COMPLETED|Overall Study||73
2365629|NCT01565083|5805545|P2|STARTED|Overall Study||107
2365630|NCT01565083|5805546|P1|STARTED|Overall Study||106
2365631|NCT01564953|5805572|P1|NOT COMPLETED|Overall Study||0
2365632|NCT01564953|5805572|P1|COMPLETED|Overall Study||143
2365633|NCT01564953|5805572|P1|STARTED|Overall Study||143
2365634|NCT01564914|5805582|P2|NOT COMPLETED|Overall Study||0
2365635|NCT01564914|5805583|P1|NOT COMPLETED|Overall Study||0
2365636|NCT01564914|5805582|P2|COMPLETED|Overall Study||6
2365637|NCT01564914|5805583|P1|COMPLETED|Overall Study||16
2365638|NCT01564914|5805582|P2|STARTED|Overall Study||6
2365639|NCT01564914|5805583|P1|STARTED|Overall Study||16
2365640|NCT01564862|5805597|P3|NOT COMPLETED|Overall Study||30
2365641|NCT01564862|5805598|P2|NOT COMPLETED|Overall Study||34
2365642|NCT01564862|5805599|P1|NOT COMPLETED|Overall Study||30
2365643|NCT01564862|5805597|P3|COMPLETED|Overall Study||164
2365644|NCT01564862|5805598|P2|COMPLETED|Overall Study||176
2365645|NCT01564862|5805599|P1|COMPLETED|Overall Study||168
2365646|NCT01564862|5805597|P3|Received Treatment|Overall Study||191
2365647|NCT01564862|5805598|P2|Received Treatment|Overall Study||207
2365648|NCT01564862|5805599|P1|Received Treatment|Overall Study||196
2365649|NCT01564862|5805597|P3|STARTED|Overall Study||194
2365650|NCT01564862|5805598|P2|STARTED|Overall Study||210
2365651|NCT01564862|5805599|P1|STARTED|Overall Study||198
2365652|NCT01564784|5805650|P2|NOT COMPLETED|Overall Study||133
2365653|NCT01564784|5805651|P1|NOT COMPLETED|Overall Study||134
2365654|NCT01564784|5805650|P2|COMPLETED|Overall Study||10
2365655|NCT01564784|5805651|P1|COMPLETED|Overall Study||30
2365656|NCT01564784|5805650|P2|STARTED|Overall Study|Treated (162 randomized)|143
2365657|NCT01564784|5805651|P1|STARTED|Overall Study|Treated (164 randomized)|164
2365658|NCT01564758|5805678|P1|NOT COMPLETED|Overall Study||14
2365659|NCT01564758|5805678|P1|COMPLETED|Overall Study||85
2365660|NCT01564758|5805678|P1|STARTED|Overall Study||99
2365661|NCT01564732|5805685|P2|NOT COMPLETED|Overall Study||5
2365662|NCT01564732|5805686|P1|NOT COMPLETED|Overall Study||6
2365663|NCT01564732|5805685|P2|COMPLETED|Overall Study||0
2365664|NCT01564732|5805686|P1|COMPLETED|Overall Study||0
2365665|NCT01564732|5805685|P2|STARTED|Overall Study||5
2365666|NCT01564732|5805686|P1|STARTED|Overall Study||6
2365667|NCT01564706|5805702|P1|NOT COMPLETED|Overall Study||0
2365668|NCT01564706|5805702|P1|COMPLETED|Overall Study||9
2365669|NCT01564706|5805702|P1|STARTED|Overall Study||9
2365670|NCT01564693|5805709|P3|NOT COMPLETED|Overall Study||0
2365671|NCT01564693|5805710|P2|NOT COMPLETED|Overall Study||0
2365672|NCT01564693|5805711|P1|NOT COMPLETED|Overall Study||0
2365673|NCT01564693|5805709|P3|COMPLETED|Overall Study||2
2365674|NCT01564693|5805710|P2|COMPLETED|Overall Study||4
2365675|NCT01564693|5805711|P1|COMPLETED|Overall Study||9
2365676|NCT01564693|5805709|P3|STARTED|Overall Study|Only 2 patients were found necessary to give statistical relevance to the patients' results.|2
2365677|NCT01564693|5805710|P2|STARTED|Overall Study||4
2365678|NCT01564693|5805711|P1|STARTED|Overall Study|Originally we planned to study 4 patients. We expanded to 9 to improve consistency of the results.|9
2365679|NCT01564628|5805719|P3|NOT COMPLETED|Overall Study||2
2365680|NCT01564628|5805720|P2|NOT COMPLETED|Overall Study||2
2365681|NCT01564628|5805721|P1|NOT COMPLETED|Overall Study||4
2365682|NCT01564628|5805719|P3|COMPLETED|Overall Study||61
2365683|NCT01564628|5805720|P2|COMPLETED|Overall Study||56
2365684|NCT01564628|5805721|P1|COMPLETED|Overall Study||181
2365685|NCT01564628|5805719|P3|STARTED|Overall Study||63
2365686|NCT01564628|5805720|P2|STARTED|Overall Study||58
2365687|NCT01564628|5805721|P1|STARTED|Overall Study||185
2365688|NCT01564537|5805727|P2|NOT COMPLETED|Overall Study||6
2365689|NCT01564537|5805728|P1|NOT COMPLETED|Overall Study||6
2365690|NCT01564537|5805727|P2|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|356
2365691|NCT01564537|5805728|P1|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|354
2365692|NCT01564537|5805727|P2|Safety Population: Received Study Drug|Overall Study||360
2365693|NCT01564537|5805728|P1|Safety Population: Received Study Drug|Overall Study||360
2365694|NCT01564537|5805727|P2|STARTED|Overall Study||362
2365695|NCT01564537|5805728|P1|STARTED|Overall Study||360
2365696|NCT01564459|5805751|P3|NOT COMPLETED|Double-blind Treatment||1
2365697|NCT01564459|5805752|P2|NOT COMPLETED|Double-blind Treatment||0
2365698|NCT01564459|5805753|P1|NOT COMPLETED|Double-blind Treatment||0
2365699|NCT01564459|5805751|P3|COMPLETED|Double-blind Treatment||82
2365700|NCT01564459|5805752|P2|COMPLETED|Double-blind Treatment||87
2365701|NCT01564459|5805753|P1|COMPLETED|Double-blind Treatment||0
2365702|NCT01564459|5805751|P3|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|83
2365703|NCT01564459|5805752|P2|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|87
2365704|NCT01564459|5805753|P1|STARTED|Double-blind Treatment||0
2365705|NCT01564459|5805751|P3|NOT COMPLETED|Run-In||0
2365706|NCT01564459|5805752|P2|NOT COMPLETED|Run-In||0
2365707|NCT01564459|5805753|P1|NOT COMPLETED|Run-In||12
2365708|NCT01564459|5805751|P3|COMPLETED|Run-In||83
2365709|NCT01564459|5805752|P2|COMPLETED|Run-In||87
2365710|NCT01564459|5805753|P1|COMPLETED|Run-In||0
2365711|NCT01564459|5805751|P3|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|83
2365712|NCT01564459|5805752|P2|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|87
2365713|NCT01564459|5805753|P1|STARTED|Run-In||12
2365714|NCT01564407|5805777|P5|NOT COMPLETED|Overall Study||0
2365715|NCT01564407|5805778|P4|NOT COMPLETED|Overall Study||1
2365716|NCT01564407|5805779|P3|NOT COMPLETED|Overall Study||0
2365717|NCT01564407|5805780|P2|NOT COMPLETED|Overall Study||2
2365718|NCT01564407|5805781|P1|NOT COMPLETED|Overall Study||0
2365719|NCT01564407|5805777|P5|COMPLETED|Overall Study||0
2365720|NCT01564407|5805778|P4|COMPLETED|Overall Study||1
2365721|NCT01564407|5805779|P3|COMPLETED|Overall Study||4
2365722|NCT01564407|5805780|P2|COMPLETED|Overall Study||3
2365723|NCT01564407|5805781|P1|COMPLETED|Overall Study||4
2365724|NCT01564407|5805777|P5|STARTED|Overall Study||0
2365725|NCT01564407|5805778|P4|STARTED|Overall Study||2
2365726|NCT01564407|5805779|P3|STARTED|Overall Study||4
2365727|NCT01564407|5805780|P2|STARTED|Overall Study||5
2365728|NCT01564407|5805781|P1|STARTED|Overall Study||4
2365729|NCT01564394|5805822|P2|NOT COMPLETED|Overall Study||10
2365730|NCT01564394|5805823|P1|NOT COMPLETED|Overall Study||6
2365731|NCT01564394|5805822|P2|COMPLETED|Overall Study|Prostate cancer survivors n=13, family n=7.|20
2365732|NCT01564394|5805823|P1|COMPLETED|Overall Study|Prostate cancer survivors n=16, family n=8.|24
2365733|NCT01564394|5805822|P2|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
2365734|NCT01564394|5805823|P1|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
2365735|NCT01564277|5805837|P2|NOT COMPLETED|Overall Study||1
2365736|NCT01564277|5805838|P1|NOT COMPLETED|Overall Study||1
2365737|NCT01564277|5805837|P2|COMPLETED|Overall Study||11
2365738|NCT01564277|5805838|P1|COMPLETED|Overall Study||11
2365739|NCT01564277|5805837|P2|STARTED|Overall Study||12
2365740|NCT01564277|5805838|P1|STARTED|Overall Study||12
2365741|NCT01563978|5805856|P2|NOT COMPLETED|Overall Study||2
2365742|NCT01563978|5805857|P1|NOT COMPLETED|Overall Study||4
2365743|NCT01563978|5805856|P2|COMPLETED|Overall Study||65
2365744|NCT01563978|5805857|P1|COMPLETED|Overall Study||64
2365745|NCT01563978|5805856|P2|Randomised But Did Not Receive Treatment|Overall Study||0
2365746|NCT01563978|5805857|P1|Randomised But Did Not Receive Treatment|Overall Study||0
2365747|NCT01563978|5805856|P2|STARTED|Overall Study|Patients who received treatment.|67
2365748|NCT01563978|5805857|P1|STARTED|Overall Study|Patients who received treatment.|68
2365749|NCT01563913|5805883|P2|NOT COMPLETED|Overall Study||0
2365750|NCT01563913|5805884|P1|NOT COMPLETED|Overall Study||2
2365751|NCT01563913|5805883|P2|COMPLETED|Overall Study||15
2365752|NCT01563913|5805884|P1|COMPLETED|Overall Study||13
2365753|NCT01563913|5805883|P2|STARTED|Overall Study||15
2365754|NCT01563913|5805884|P1|STARTED|Overall Study||15
2365755|NCT01563536|5805896|P2|NOT COMPLETED|Overall Study||2
2365756|NCT01563536|5805897|P1|NOT COMPLETED|Overall Study||1
2365757|NCT01563536|5805896|P2|COMPLETED|Overall Study||4
2365758|NCT01563536|5805897|P1|COMPLETED|Overall Study||5
2365759|NCT01563536|5805896|P2|STARTED|Overall Study||6
2365760|NCT01563536|5805897|P1|STARTED|Overall Study||6
2365761|NCT01563406|5805929|P4|NOT COMPLETED|Overall Study||0
2365762|NCT01563406|5805930|P3|NOT COMPLETED|Overall Study||0
2365763|NCT01563406|5805931|P2|NOT COMPLETED|Overall Study||0
2365764|NCT01563406|5805932|P1|NOT COMPLETED|Overall Study||0
2365765|NCT01563406|5805929|P4|COMPLETED|Overall Study|112 hubs|29
2365766|NCT01563406|5805930|P3|COMPLETED|Overall Study|101 hubs|30
2365767|NCT01563406|5805931|P2|COMPLETED|Overall Study|102 hubs|30
2365768|NCT01563406|5805932|P1|COMPLETED|Overall Study|194 hubs|60
2365769|NCT01563406|5805929|P4|STARTED|Overall Study|112 hubs|29
2365770|NCT01563406|5805930|P3|STARTED|Overall Study|101 hubs|30
2365771|NCT01563406|5805931|P2|STARTED|Overall Study|102 hubs|30
2365772|NCT01563406|5805932|P1|STARTED|Overall Study|194 hubs|60
2365773|NCT01563198|5805950|P1|NOT COMPLETED|After Training||0
2365774|NCT01563198|5805950|P1|COMPLETED|After Training||47979
2365775|NCT01563198|5805950|P1|STARTED|After Training||47979
2365776|NCT01563198|5805950|P1|NOT COMPLETED|Baseline||0
2365777|NCT01563198|5805950|P1|COMPLETED|Baseline||49733
2365778|NCT01563198|5805950|P1|STARTED|Baseline||49733
2365779|NCT01563185|5805956|P1|NOT COMPLETED|Overall Study||2
2365780|NCT01563185|5805956|P1|COMPLETED|Overall Study||10
2365781|NCT01563185|5805956|P1|STARTED|Overall Study||12
2365782|NCT01563172|5805970|P1|NOT COMPLETED|Overall Study||13
2365783|NCT01563172|5805970|P1|COMPLETED|Overall Study||52
2365784|NCT01563172|5805970|P1|Control Dentifrice|Overall Study||60
2365785|NCT01563172|5805970|P1|Experimental Dentifrice 1.5g/ 45 Sec|Overall Study||58
2365786|NCT01563172|5805970|P1|Experimental Dentifrice 1.5g/ 2min|Overall Study||58
2365787|NCT01563172|5805970|P1|Experimental Dentifrice 0.5g/45 Sec|Overall Study||59
2365788|NCT01563172|5805970|P1|Experimental Dentifrice 0.5g/2 Min|Overall Study||59
2365789|NCT01563172|5805970|P1|STARTED|Overall Study||65
2365790|NCT01563081|5805999|P2|NOT COMPLETED|Overall Study||0
2365791|NCT01563081|5806000|P1|NOT COMPLETED|Overall Study||0
2365792|NCT01563081|5805999|P2|COMPLETED|Overall Study||30
2365793|NCT01563081|5806000|P1|COMPLETED|Overall Study||30
2365794|NCT01563081|5805999|P2|STARTED|Overall Study||30
2365795|NCT01563081|5806000|P1|STARTED|Overall Study||30
2365796|NCT01563055|5806013|P1|NOT COMPLETED|Overall Study||0
2365797|NCT01563055|5806013|P1|COMPLETED|Overall Study||10
2365798|NCT01563055|5806013|P1|STARTED|Overall Study||10
2365799|NCT01563029|5806076|P5|NOT COMPLETED|Overall Study||29
2365800|NCT01563029|5806077|P4|NOT COMPLETED|Overall Study||33
2365801|NCT01563029|5806078|P3|NOT COMPLETED|Overall Study||33
2365802|NCT01563029|5806079|P2|NOT COMPLETED|Overall Study||24
2365803|NCT01563029|5806080|P1|NOT COMPLETED|Overall Study||53
2365804|NCT01563029|5806076|P5|COMPLETED|Overall Study||89
2365805|NCT01563029|5806077|P4|COMPLETED|Overall Study||85
2365806|NCT01563029|5806078|P3|COMPLETED|Overall Study||87
2365807|NCT01563029|5806079|P2|COMPLETED|Overall Study||94
2365808|NCT01563029|5806080|P1|COMPLETED|Overall Study||66
2365809|NCT01563029|5806076|P5|STARTED|Overall Study||118
2365810|NCT01563029|5806077|P4|STARTED|Overall Study||118
2365811|NCT01563029|5806078|P3|STARTED|Overall Study||120
2365812|NCT01563029|5806079|P2|STARTED|Overall Study||118
2365813|NCT01563029|5806080|P1|STARTED|Overall Study||119
2365814|NCT01563003|5806130|P2|NOT COMPLETED|Overall Study||0
2365815|NCT01563003|5806131|P1|NOT COMPLETED|Overall Study||0
2365816|NCT01563003|5806130|P2|COMPLETED|Overall Study||15
2365817|NCT01563003|5806131|P1|COMPLETED|Overall Study||16
2365818|NCT01563003|5806130|P2|STARTED|Overall Study||15
2365819|NCT01563003|5806131|P1|STARTED|Overall Study||16
2365820|NCT01562886|5806141|P1|NOT COMPLETED|Overall Study||1
2365821|NCT01562886|5806141|P1|COMPLETED|Overall Study||13
2365822|NCT01562886|5806141|P1|STARTED|Overall Study||14
2365823|NCT01562873|5806146|P2|NOT COMPLETED|Overall Study||0
2365824|NCT01562873|5806147|P1|NOT COMPLETED|Overall Study||21
2365825|NCT01562873|5806146|P2|COMPLETED|Overall Study||0
2365826|NCT01562873|5806147|P1|COMPLETED|Overall Study||0
2365827|NCT01562873|5806146|P2|STARTED|Overall Study|The observed number of objective responses in Cohort A was not sufficient for Cohort B to open.|0
2365828|NCT01562873|5806147|P1|STARTED|Overall Study||21
2365829|NCT01562782|5806156|P2|NOT COMPLETED|Overall Study||5
2365830|NCT01562782|5806157|P1|NOT COMPLETED|Overall Study||4
2365831|NCT01562782|5806156|P2|COMPLETED|Overall Study||15
2365832|NCT01562782|5806157|P1|COMPLETED|Overall Study||15
2365833|NCT01562782|5806156|P2|STARTED|Overall Study||20
2365834|NCT01562782|5806157|P1|STARTED|Overall Study||19
2365835|NCT01562756|5806181|P1|NOT COMPLETED|Overall Study||0
2365836|NCT01562756|5806181|P1|COMPLETED|Overall Study||6
2365837|NCT01562756|5806181|P1|STARTED|Overall Study||6
2365838|NCT01562743|5806186|P1|NOT COMPLETED|Overall Study||52
2365839|NCT01562743|5806186|P1|COMPLETED|Overall Study||133
2365840|NCT01562743|5806186|P1|STARTED|Overall Study||185
2365841|NCT01562678|5806198|P2|NOT COMPLETED|Overall Study||2
2365842|NCT01562678|5806199|P1|NOT COMPLETED|Overall Study||6
2365843|NCT01562678|5806198|P2|COMPLETED|Overall Study||12
2365844|NCT01562678|5806199|P1|COMPLETED|Overall Study||8
2365845|NCT01562678|5806198|P2|STARTED|Overall Study||14
2365846|NCT01562678|5806199|P1|STARTED|Overall Study||14
2365847|NCT01562613|5806205|P1|NOT COMPLETED|Overall Study||4
2365848|NCT01562613|5806205|P1|COMPLETED|Overall Study||529
2365849|NCT01562613|5806205|P1|STARTED|Overall Study||533
2365850|NCT01562548|5806215|P4|NOT COMPLETED|Overall Study||0
2365851|NCT01562548|5806216|P3|NOT COMPLETED|Overall Study||1
2365852|NCT01562548|5806217|P2|NOT COMPLETED|Overall Study||0
2365853|NCT01562548|5806218|P1|NOT COMPLETED|Overall Study||0
2365854|NCT01562548|5806215|P4|COMPLETED|Overall Study||14
2365855|NCT01562548|5806216|P3|COMPLETED|Overall Study||24
2365856|NCT01562548|5806217|P2|COMPLETED|Overall Study||15
2365857|NCT01562548|5806218|P1|COMPLETED|Overall Study||25
2365858|NCT01562548|5806215|P4|STARTED|Overall Study||14
2365859|NCT01562548|5806216|P3|STARTED|Overall Study||25
2365860|NCT01562548|5806217|P2|STARTED|Overall Study||15
2365861|NCT01562548|5806218|P1|STARTED|Overall Study||25
2365862|NCT01562444|5806271|P3|NOT COMPLETED|Overall Study||7
2365863|NCT01562444|5806272|P2|NOT COMPLETED|Overall Study||2
2365864|NCT01562444|5806273|P1|NOT COMPLETED|Overall Study||5
2365865|NCT01562444|5806271|P3|COMPLETED|Overall Study||99
2365866|NCT01562444|5806272|P2|COMPLETED|Overall Study||49
2365867|NCT01562444|5806273|P1|COMPLETED|Overall Study||43
2365868|NCT01562444|5806271|P3|STARTED|Overall Study||106
2365869|NCT01562444|5806272|P2|STARTED|Overall Study||51
2365870|NCT01562444|5806273|P1|STARTED|Overall Study||48
2365871|NCT01562379|5806523|P5|NOT COMPLETED|Overall Study||40
2365872|NCT01562379|5806524|P4|NOT COMPLETED|Overall Study||57
2365873|NCT01562379|5806525|P3|NOT COMPLETED|Overall Study||62
2365874|NCT01562379|5806526|P2|NOT COMPLETED|Overall Study||97
2365875|NCT01562379|5806527|P1|NOT COMPLETED|Overall Study||126
2365876|NCT01562379|5806523|P5|COMPLETED|Overall Study||785
2365877|NCT01562379|5806524|P4|COMPLETED|Overall Study||786
2365878|NCT01562379|5806525|P3|COMPLETED|Overall Study||789
2365879|NCT01562379|5806526|P2|COMPLETED|Overall Study||1395
2365880|NCT01562379|5806527|P1|COMPLETED|Overall Study||1312
2365881|NCT01562379|5806523|P5|STARTED|Overall Study||825
2365882|NCT01562379|5806524|P4|STARTED|Overall Study||843
2365883|NCT01562379|5806525|P3|STARTED|Overall Study||851
2365884|NCT01562379|5806526|P2|STARTED|Overall Study||1492
2365885|NCT01562379|5806527|P1|STARTED|Overall Study||1438
2365886|NCT01562327|5806539|P1|NOT COMPLETED|Overall Study||8
2365887|NCT01562327|5806539|P1|COMPLETED|Overall Study||42
2365888|NCT01562327|5806539|P1|STARTED|Overall Study||50
2365889|NCT01562314|5806569|P2|NOT COMPLETED|Overall Study||8
2365890|NCT01562314|5806570|P1|NOT COMPLETED|Overall Study||13
2365891|NCT01562314|5806569|P2|COMPLETED|Overall Study||23
2365892|NCT01562314|5806570|P1|COMPLETED|Overall Study||16
2365893|NCT01562314|5806569|P2|Per Protocol (PP) Analysis Set|Overall Study||27
2365894|NCT01562314|5806570|P1|Per Protocol (PP) Analysis Set|Overall Study||17
2365895|NCT01562314|5806569|P2|Intent-to-Treat (ITT) Analysis Set|Overall Study||31
2365896|NCT01562314|5806570|P1|Intent-to-Treat (ITT) Analysis Set|Overall Study||29
2365897|NCT01562314|5806569|P2|Received at Least 1 Dose of Study Drug|Overall Study||31
2365898|NCT01562314|5806570|P1|Received at Least 1 Dose of Study Drug|Overall Study||29
2365899|NCT01562314|5806569|P2|STARTED|Overall Study||31
2365900|NCT01562314|5806570|P1|STARTED|Overall Study||29
2365901|NCT01562275|5806627|P13|NOT COMPLETED|Stage 2||5
2365902|NCT01562275|5806628|P12|NOT COMPLETED|Stage 2||14
2365903|NCT01562275|5806629|P11|NOT COMPLETED|Stage 2||0
2365904|NCT01562275|5806630|P10|NOT COMPLETED|Stage 2||0
2365905|NCT01562275|5806631|P9|NOT COMPLETED|Stage 2||0
2365906|NCT01562275|5806632|P8|NOT COMPLETED|Stage 2||0
2365907|NCT01562275|5806633|P7|NOT COMPLETED|Stage 2||0
2365908|NCT01562275|5806634|P6|NOT COMPLETED|Stage 2||0
2365909|NCT01562275|5806635|P5|NOT COMPLETED|Stage 2||0
2365910|NCT01562275|5806636|P4|NOT COMPLETED|Stage 2||0
2365911|NCT01562275|5806637|P3|NOT COMPLETED|Stage 2||0
2365912|NCT01562275|5806638|P2|NOT COMPLETED|Stage 2||0
2365913|NCT01562275|5806639|P1|NOT COMPLETED|Stage 2||0
2365914|NCT01562275|5806627|P13|COMPLETED|Stage 2||0
2365915|NCT01562275|5806628|P12|COMPLETED|Stage 2||0
2365916|NCT01562275|5806629|P11|COMPLETED|Stage 2||0
2365917|NCT01562275|5806630|P10|COMPLETED|Stage 2||0
2365918|NCT01562275|5806631|P9|COMPLETED|Stage 2||0
2365919|NCT01562275|5806632|P8|COMPLETED|Stage 2||0
2365920|NCT01562275|5806633|P7|COMPLETED|Stage 2||0
2365921|NCT01562275|5806634|P6|COMPLETED|Stage 2||0
2365922|NCT01562275|5806635|P5|COMPLETED|Stage 2||0
2365923|NCT01562275|5806636|P4|COMPLETED|Stage 2||0
2365924|NCT01562275|5806637|P3|COMPLETED|Stage 2||0
2365925|NCT01562275|5806638|P2|COMPLETED|Stage 2||0
2365926|NCT01562275|5806639|P1|COMPLETED|Stage 2||0
2365927|NCT01562275|5806627|P13|STARTED|Stage 2||5
2365928|NCT01562275|5806628|P12|STARTED|Stage 2||14
2365929|NCT01562275|5806629|P11|STARTED|Stage 2||0
2365930|NCT01562275|5806630|P10|STARTED|Stage 2||0
2365931|NCT01562275|5806631|P9|STARTED|Stage 2||0
2365932|NCT01562275|5806632|P8|STARTED|Stage 2||0
2365933|NCT01562275|5806633|P7|STARTED|Stage 2||0
2365934|NCT01562275|5806634|P6|STARTED|Stage 2||0
2365935|NCT01562275|5806635|P5|STARTED|Stage 2||0
2365936|NCT01562275|5806636|P4|STARTED|Stage 2||0
2365937|NCT01562275|5806637|P3|STARTED|Stage 2||0
2365938|NCT01562275|5806638|P2|STARTED|Stage 2||0
2365939|NCT01562275|5806639|P1|STARTED|Stage 2||0
2365940|NCT01562275|5806627|P13|NOT COMPLETED|Stage 1||0
2365941|NCT01562275|5806628|P12|NOT COMPLETED|Stage 1||0
2365942|NCT01562275|5806629|P11|NOT COMPLETED|Stage 1||3
2365943|NCT01562275|5806630|P10|NOT COMPLETED|Stage 1||7
2365944|NCT01562275|5806631|P9|NOT COMPLETED|Stage 1||3
2365945|NCT01562275|5806632|P8|NOT COMPLETED|Stage 1||7
2365946|NCT01562275|5806633|P7|NOT COMPLETED|Stage 1||3
2365947|NCT01562275|5806634|P6|NOT COMPLETED|Stage 1||4
2365948|NCT01562275|5806635|P5|NOT COMPLETED|Stage 1||4
2365949|NCT01562275|5806636|P4|NOT COMPLETED|Stage 1||4
2365950|NCT01562275|5806637|P3|NOT COMPLETED|Stage 1||3
2365951|NCT01562275|5806638|P2|NOT COMPLETED|Stage 1||7
2365952|NCT01562275|5806639|P1|NOT COMPLETED|Stage 1||3
2365953|NCT01562275|5806627|P13|COMPLETED|Stage 1||0
2365954|NCT01562275|5806628|P12|COMPLETED|Stage 1||0
2365955|NCT01562275|5806629|P11|COMPLETED|Stage 1||0
2365956|NCT01562275|5806630|P10|COMPLETED|Stage 1||0
2365957|NCT01562275|5806631|P9|COMPLETED|Stage 1||0
2365958|NCT01562275|5806632|P8|COMPLETED|Stage 1||0
2365959|NCT01562275|5806633|P7|COMPLETED|Stage 1||0
2365960|NCT01562275|5806634|P6|COMPLETED|Stage 1||0
2365961|NCT01562275|5806635|P5|COMPLETED|Stage 1||0
2365962|NCT01562275|5806636|P4|COMPLETED|Stage 1||0
2365963|NCT01562275|5806637|P3|COMPLETED|Stage 1||0
2365964|NCT01562275|5806638|P2|COMPLETED|Stage 1||0
2365965|NCT01562275|5806639|P1|COMPLETED|Stage 1||0
2365966|NCT01562275|5806627|P13|STARTED|Stage 1||0
2365967|NCT01562275|5806628|P12|STARTED|Stage 1||0
2365968|NCT01562275|5806629|P11|STARTED|Stage 1||3
2365969|NCT01562275|5806630|P10|STARTED|Stage 1||7
2365970|NCT01562275|5806631|P9|STARTED|Stage 1||3
2365971|NCT01562275|5806632|P8|STARTED|Stage 1||7
2365972|NCT01562275|5806633|P7|STARTED|Stage 1||3
2365973|NCT01562275|5806634|P6|STARTED|Stage 1||4
2365974|NCT01562275|5806635|P5|STARTED|Stage 1||4
2365975|NCT01562275|5806636|P4|STARTED|Stage 1||4
2365976|NCT01562275|5806637|P3|STARTED|Stage 1||3
2365977|NCT01562275|5806638|P2|STARTED|Stage 1||7
2365978|NCT01562275|5806639|P1|STARTED|Stage 1||3
2365979|NCT01562132|5806771|P2|NOT COMPLETED|Overall Study||0
2365980|NCT01562132|5806772|P1|NOT COMPLETED|Overall Study||0
2365981|NCT01562132|5806771|P2|COMPLETED|Overall Study||3
2365982|NCT01562132|5806772|P1|COMPLETED|Overall Study||3
2365983|NCT01562132|5806771|P2|STARTED|Overall Study||3
2365984|NCT01562132|5806772|P1|STARTED|Overall Study||3
2365985|NCT01562028|5806780|P2|NOT COMPLETED|Overall Study||2
2365986|NCT01562028|5806781|P1|NOT COMPLETED|Overall Study||3
2365987|NCT01562028|5806780|P2|COMPLETED|Overall Study||70
2365988|NCT01562028|5806781|P1|COMPLETED|Overall Study||34
2365989|NCT01562028|5806780|P2|STARTED|Overall Study||72
2365990|NCT01562028|5806781|P1|STARTED|Overall Study||37
2365991|NCT01561976|5806805|P6|NOT COMPLETED|Period 3||0
2365992|NCT01561976|5806806|P5|NOT COMPLETED|Period 3||0
2365993|NCT01561976|5806807|P4|NOT COMPLETED|Period 3||0
2365994|NCT01561976|5806808|P3|NOT COMPLETED|Period 3||0
2365995|NCT01561976|5806809|P2|NOT COMPLETED|Period 3||0
2365996|NCT01561976|5806810|P1|NOT COMPLETED|Period 3||0
2365997|NCT01561976|5806805|P6|COMPLETED|Period 3||4
2365998|NCT01561976|5806806|P5|COMPLETED|Period 3||5
2365999|NCT01561976|5806807|P4|COMPLETED|Period 3||4
2366000|NCT01561976|5806808|P3|COMPLETED|Period 3||3
2366001|NCT01561976|5806809|P2|COMPLETED|Period 3||5
2366002|NCT01561976|5806810|P1|COMPLETED|Period 3||4
2366003|NCT01561976|5806805|P6|STARTED|Period 3||4
2366004|NCT01561976|5806806|P5|STARTED|Period 3||5
2366005|NCT01561976|5806807|P4|STARTED|Period 3||4
2366006|NCT01561976|5806808|P3|STARTED|Period 3||3
2366007|NCT01561976|5806809|P2|STARTED|Period 3||5
2366008|NCT01561976|5806810|P1|STARTED|Period 3||4
2366009|NCT01561976|5806805|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
2366010|NCT01561976|5806806|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
2366011|NCT01561976|5806807|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
2366012|NCT01561976|5806808|P3|NOT COMPLETED|Washout Period 2 (7 Days)||1
2366013|NCT01561976|5806809|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
2366014|NCT01561976|5806810|P1|NOT COMPLETED|Washout Period 2 (7 Days)||1
2366015|NCT01561976|5806805|P6|COMPLETED|Washout Period 2 (7 Days)||4
2366016|NCT01561976|5806806|P5|COMPLETED|Washout Period 2 (7 Days)||5
2366017|NCT01561976|5806807|P4|COMPLETED|Washout Period 2 (7 Days)||4
2366018|NCT01561976|5806808|P3|COMPLETED|Washout Period 2 (7 Days)||3
2366019|NCT01561976|5806809|P2|COMPLETED|Washout Period 2 (7 Days)||5
2366020|NCT01561976|5806810|P1|COMPLETED|Washout Period 2 (7 Days)||4
2366021|NCT01561976|5806805|P6|STARTED|Washout Period 2 (7 Days)||4
2366022|NCT01561976|5806806|P5|STARTED|Washout Period 2 (7 Days)||5
2366023|NCT01561976|5806807|P4|STARTED|Washout Period 2 (7 Days)||4
2366024|NCT01561976|5806808|P3|STARTED|Washout Period 2 (7 Days)||4
2366025|NCT01561976|5806809|P2|STARTED|Washout Period 2 (7 Days)||5
2366026|NCT01561976|5806810|P1|STARTED|Washout Period 2 (7 Days)||5
2366027|NCT01561976|5806805|P6|NOT COMPLETED|Period 2||0
2366028|NCT01561976|5806806|P5|NOT COMPLETED|Period 2||0
2366029|NCT01561976|5806807|P4|NOT COMPLETED|Period 2||0
2366030|NCT01561976|5806808|P3|NOT COMPLETED|Period 2||0
2366031|NCT01561976|5806809|P2|NOT COMPLETED|Period 2||0
2366032|NCT01561976|5806810|P1|NOT COMPLETED|Period 2||0
2366033|NCT01561976|5806805|P6|COMPLETED|Period 2||4
2366034|NCT01561976|5806806|P5|COMPLETED|Period 2||5
2366035|NCT01561976|5806807|P4|COMPLETED|Period 2||4
2366036|NCT01561976|5806808|P3|COMPLETED|Period 2||4
2366037|NCT01561976|5806809|P2|COMPLETED|Period 2||5
2366038|NCT01561976|5806810|P1|COMPLETED|Period 2||5
2366039|NCT01561976|5806805|P6|STARTED|Period 2||4
2366040|NCT01561976|5806806|P5|STARTED|Period 2||5
2366041|NCT01561976|5806807|P4|STARTED|Period 2||4
2366042|NCT01561976|5806808|P3|STARTED|Period 2||4
2366043|NCT01561976|5806809|P2|STARTED|Period 2||5
2366044|NCT01561976|5806810|P1|STARTED|Period 2||5
2366045|NCT01561976|5806805|P6|NOT COMPLETED|Washout Period 1 (7 Days)||1
2366046|NCT01561976|5806806|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
2366047|NCT01561976|5806807|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
2366048|NCT01561976|5806808|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
2366049|NCT01561976|5806809|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
2366050|NCT01561976|5806810|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
2366051|NCT01561976|5806805|P6|COMPLETED|Washout Period 1 (7 Days)||4
2366052|NCT01561976|5806806|P5|COMPLETED|Washout Period 1 (7 Days)||5
2366053|NCT01561976|5806807|P4|COMPLETED|Washout Period 1 (7 Days)||4
2366054|NCT01561976|5806808|P3|COMPLETED|Washout Period 1 (7 Days)||4
2366055|NCT01561976|5806809|P2|COMPLETED|Washout Period 1 (7 Days)||5
2366056|NCT01561976|5806810|P1|COMPLETED|Washout Period 1 (7 Days)||5
2366057|NCT01561976|5806805|P6|STARTED|Washout Period 1 (7 Days)||5
2366058|NCT01561976|5806806|P5|STARTED|Washout Period 1 (7 Days)||5
2366059|NCT01561976|5806807|P4|STARTED|Washout Period 1 (7 Days)||5
2366060|NCT01561976|5806808|P3|STARTED|Washout Period 1 (7 Days)||4
2366061|NCT01561976|5806809|P2|STARTED|Washout Period 1 (7 Days)||5
2366062|NCT01561976|5806810|P1|STARTED|Washout Period 1 (7 Days)||5
2366063|NCT01561976|5806805|P6|NOT COMPLETED|Period 1||0
2366064|NCT01561976|5806806|P5|NOT COMPLETED|Period 1||0
2366065|NCT01561976|5806807|P4|NOT COMPLETED|Period 1||0
2366066|NCT01561976|5806808|P3|NOT COMPLETED|Period 1||1
2366067|NCT01561976|5806809|P2|NOT COMPLETED|Period 1||0
2366068|NCT01561976|5806810|P1|NOT COMPLETED|Period 1||0
2366069|NCT01561976|5806805|P6|COMPLETED|Period 1||5
2366070|NCT01561976|5806806|P5|COMPLETED|Period 1||5
2366071|NCT01561976|5806807|P4|COMPLETED|Period 1||5
2366072|NCT01561976|5806808|P3|COMPLETED|Period 1||4
2366073|NCT01561976|5806809|P2|COMPLETED|Period 1||5
2366074|NCT01561976|5806810|P1|COMPLETED|Period 1||5
2366075|NCT01561976|5806805|P6|STARTED|Period 1||5
2366076|NCT01561976|5806806|P5|STARTED|Period 1||5
2366077|NCT01561976|5806807|P4|STARTED|Period 1||5
2366078|NCT01561976|5806808|P3|STARTED|Period 1||5
2366079|NCT01561976|5806809|P2|STARTED|Period 1||5
2366080|NCT01561976|5806810|P1|STARTED|Period 1||5
2366081|NCT01561898|5806843|P4|NOT COMPLETED|Overall Study||20
2366082|NCT01561898|5806844|P3|NOT COMPLETED|Overall Study||44
2366083|NCT01561898|5806845|P2|NOT COMPLETED|Overall Study||41
2366084|NCT01561898|5806846|P1|NOT COMPLETED|Overall Study||2
2366085|NCT01561898|5806843|P4|COMPLETED|Overall Study||12
2366086|NCT01561898|5806844|P3|COMPLETED|Overall Study||53
2366087|NCT01561898|5806845|P2|COMPLETED|Overall Study||51
2366088|NCT01561898|5806846|P1|COMPLETED|Overall Study||5
2366089|NCT01561898|5806843|P4|STARTED|Overall Study||32
2366090|NCT01561898|5806844|P3|STARTED|Overall Study||97
2366091|NCT01561898|5806845|P2|STARTED|Overall Study||92
2366092|NCT01561898|5806846|P1|STARTED|Overall Study||7
2366093|NCT01561755|5806860|P2|NOT COMPLETED|Overall Study||1
2366094|NCT01561755|5806861|P1|NOT COMPLETED|Overall Study||0
2366095|NCT01561755|5806860|P2|COMPLETED|Overall Study||5
2366096|NCT01561755|5806861|P1|COMPLETED|Overall Study||6
2366097|NCT01561755|5806860|P2|STARTED|Overall Study||6
2366098|NCT01561755|5806861|P1|STARTED|Overall Study||6
2366099|NCT01561716|5806885|P6|NOT COMPLETED|Overall Study||0
2366100|NCT01561716|5806886|P5|NOT COMPLETED|Overall Study||0
2366101|NCT01561716|5806887|P4|NOT COMPLETED|Overall Study||0
2366102|NCT01561716|5806888|P3|NOT COMPLETED|Overall Study||0
2366103|NCT01561716|5806889|P2|NOT COMPLETED|Overall Study||0
2366104|NCT01561716|5806890|P1|NOT COMPLETED|Overall Study||0
2366105|NCT01561716|5806885|P6|COMPLETED|Overall Study||5
2366106|NCT01561716|5806886|P5|COMPLETED|Overall Study||5
2366107|NCT01561716|5806887|P4|COMPLETED|Overall Study||5
2366108|NCT01561716|5806888|P3|COMPLETED|Overall Study||5
2366109|NCT01561716|5806889|P2|COMPLETED|Overall Study||5
2366110|NCT01561716|5806890|P1|COMPLETED|Overall Study||5
2366111|NCT01561716|5806885|P6|STARTED|Overall Study||5
2366112|NCT01561716|5806886|P5|STARTED|Overall Study||5
2366113|NCT01561716|5806887|P4|STARTED|Overall Study||5
2366114|NCT01561716|5806888|P3|STARTED|Overall Study||5
2366115|NCT01561716|5806889|P2|STARTED|Overall Study||5
2366116|NCT01561716|5806890|P1|STARTED|Overall Study||5
2366117|NCT01561703|5806906|P2|NOT COMPLETED|Overall Study||6
2366118|NCT01561703|5806907|P1|NOT COMPLETED|Overall Study||8
2366119|NCT01561703|5806906|P2|COMPLETED|Overall Study||24
2366120|NCT01561703|5806907|P1|COMPLETED|Overall Study||20
2366121|NCT01561703|5806906|P2|STARTED|Overall Study||30
2366122|NCT01561703|5806907|P1|STARTED|Overall Study||28
2366123|NCT01561560|5806913|P2|NOT COMPLETED|Second Two Weeks of Wear||1
2366124|NCT01561560|5806914|P1|NOT COMPLETED|Second Two Weeks of Wear||0
2366125|NCT01561560|5806913|P2|COMPLETED|Second Two Weeks of Wear||58
2366126|NCT01561560|5806914|P1|COMPLETED|Second Two Weeks of Wear||60
2366127|NCT01561560|5806913|P2|STARTED|Second Two Weeks of Wear||59
2366128|NCT01561560|5806914|P1|STARTED|Second Two Weeks of Wear||60
2366129|NCT01561560|5806913|P2|NOT COMPLETED|First Two Weeks of Wear||2
2366130|NCT01561560|5806914|P1|NOT COMPLETED|First Two Weeks of Wear||0
2366131|NCT01561560|5806913|P2|COMPLETED|First Two Weeks of Wear||59
2366132|NCT01561560|5806914|P1|COMPLETED|First Two Weeks of Wear||60
2366133|NCT01561560|5806913|P2|STARTED|First Two Weeks of Wear||61
2366134|NCT01561560|5806914|P1|STARTED|First Two Weeks of Wear||60
2366135|NCT01561495|5806920|P1|NOT COMPLETED|Overall Study||0
2366136|NCT01561495|5806920|P1|COMPLETED|Overall Study||1
2366137|NCT01561495|5806920|P1|STARTED|Overall Study||1
2366138|NCT01561469|5806926|P2|NOT COMPLETED|Overall Study||0
2366139|NCT01561469|5806927|P1|NOT COMPLETED|Overall Study||0
2366140|NCT01561469|5806926|P2|COMPLETED|Overall Study||87
2366141|NCT01561469|5806927|P1|COMPLETED|Overall Study||101
2366142|NCT01561469|5806926|P2|STARTED|Overall Study||87
2366143|NCT01561469|5806927|P1|STARTED|Overall Study||101
2366144|NCT01561430|5806949|P4|NOT COMPLETED|Overall Study||13
2366145|NCT01561430|5806950|P3|NOT COMPLETED|Overall Study||17
2366146|NCT01561430|5806951|P2|NOT COMPLETED|Overall Study||15
2366147|NCT01561430|5806952|P1|NOT COMPLETED|Overall Study||1
2366148|NCT01561430|5806949|P4|COMPLETED|Overall Study||7
2366149|NCT01561430|5806950|P3|COMPLETED|Overall Study||1
2366150|NCT01561430|5806951|P2|COMPLETED|Overall Study||8
2366151|NCT01561430|5806952|P1|COMPLETED|Overall Study||8
2366152|NCT01561430|5806949|P4|Received at Least One Dose of Study Drug|Overall Study||20
2366153|NCT01561430|5806950|P3|Received at Least One Dose of Study Drug|Overall Study||18
2366154|NCT01561430|5806951|P2|Received at Least One Dose of Study Drug|Overall Study||23
2366155|NCT01561430|5806952|P1|Received at Least One Dose of Study Drug|Overall Study||9
2366156|NCT01561430|5806949|P4|STARTED|Overall Study||20
2366157|NCT01561430|5806950|P3|STARTED|Overall Study||18
2366158|NCT01561430|5806951|P2|STARTED|Overall Study||23
2366159|NCT01561430|5806952|P1|STARTED|Overall Study||9
2366160|NCT01561313|5806992|P2|NOT COMPLETED|Overall Study||0
2366161|NCT01561313|5806993|P1|NOT COMPLETED|Overall Study||2
2366162|NCT01561313|5806992|P2|COMPLETED|Overall Study||31
2366163|NCT01561313|5806993|P1|COMPLETED|Overall Study||31
2366164|NCT01561313|5806992|P2|STARTED|Overall Study||31
2366165|NCT01561313|5806993|P1|STARTED|Overall Study||33
2366166|NCT01561300|5807011|P2|NOT COMPLETED|Second Intervention||0
2366167|NCT01561300|5807012|P1|NOT COMPLETED|Second Intervention||0
2366168|NCT01561300|5807011|P2|COMPLETED|Second Intervention||15
2366169|NCT01561300|5807012|P1|COMPLETED|Second Intervention||14
2366170|NCT01561300|5807011|P2|STARTED|Second Intervention||15
2366171|NCT01561300|5807012|P1|STARTED|Second Intervention||14
2366172|NCT01561300|5807011|P2|NOT COMPLETED|Washout on Placebo||0
2366173|NCT01561300|5807012|P1|NOT COMPLETED|Washout on Placebo||0
2366174|NCT01561300|5807011|P2|COMPLETED|Washout on Placebo||15
2366175|NCT01561300|5807012|P1|COMPLETED|Washout on Placebo||14
2366176|NCT01561300|5807011|P2|STARTED|Washout on Placebo||15
2366177|NCT01561300|5807012|P1|STARTED|Washout on Placebo||14
2366178|NCT01561300|5807011|P2|NOT COMPLETED|First Intervention||0
2366179|NCT01561300|5807012|P1|NOT COMPLETED|First Intervention||0
2366180|NCT01561300|5807011|P2|COMPLETED|First Intervention||15
2366181|NCT01561300|5807012|P1|COMPLETED|First Intervention||14
2366182|NCT01561300|5807011|P2|STARTED|First Intervention||15
2366183|NCT01561300|5807012|P1|STARTED|First Intervention||14
2366184|NCT01561300|5807011|P2|NOT COMPLETED|Run in on Placebo||0
2366185|NCT01561300|5807012|P1|NOT COMPLETED|Run in on Placebo||1
2366186|NCT01561300|5807011|P2|COMPLETED|Run in on Placebo||15
2366187|NCT01561300|5807012|P1|COMPLETED|Run in on Placebo||14
2366188|NCT01561300|5807011|P2|STARTED|Run in on Placebo||15
2366189|NCT01561300|5807012|P1|STARTED|Run in on Placebo||15
2366190|NCT01561079|5807023|P1|NOT COMPLETED|Overall Study||78
2366191|NCT01561079|5807023|P1|COMPLETED|Overall Study||49
2366192|NCT01561079|5807023|P1|STARTED|Overall Study||127
2366193|NCT01561053|5807070|P4|NOT COMPLETED|Overall Study||23
2366194|NCT01561053|5807071|P3|NOT COMPLETED|Overall Study||21
2366195|NCT01561053|5807072|P2|NOT COMPLETED|Overall Study||36
2366196|NCT01561053|5807073|P1|NOT COMPLETED|Overall Study||35
2366197|NCT01561053|5807070|P4|COMPLETED|Overall Study||64
2366198|NCT01561053|5807071|P3|COMPLETED|Overall Study||61
2366199|NCT01561053|5807072|P2|COMPLETED|Overall Study||56
2366200|NCT01561053|5807073|P1|COMPLETED|Overall Study||51
2366201|NCT01561053|5807070|P4|Evaluable Subjects|Overall Study||80
2366202|NCT01561053|5807071|P3|Evaluable Subjects|Overall Study||78
2366203|NCT01561053|5807072|P2|Evaluable Subjects|Overall Study||86
2366204|NCT01561053|5807073|P1|Evaluable Subjects|Overall Study||78
2366205|NCT01561053|5807070|P4|Randomized Not Treated|Overall Study||7
2366206|NCT01561053|5807071|P3|Randomized Not Treated|Overall Study||4
2366207|NCT01561053|5807072|P2|Randomized Not Treated|Overall Study||6
2366208|NCT01561053|5807073|P1|Randomized Not Treated|Overall Study||8
2366209|NCT01561053|5807070|P4|Patients With Baseline MMSE:22-26|Overall Study||45
2366210|NCT01561053|5807071|P3|Patients With Baseline MMSE:22-26|Overall Study||35
2366211|NCT01561053|5807072|P2|Patients With Baseline MMSE:22-26|Overall Study||52
2366212|NCT01561053|5807073|P1|Patients With Baseline MMSE:22-26|Overall Study||39
2366213|NCT01561053|5807070|P4|Patients With Baseline MMSE:18-21|Overall Study||42
2366214|NCT01561053|5807071|P3|Patients With Baseline MMSE:18-21|Overall Study||47
2366215|NCT01561053|5807072|P2|Patients With Baseline MMSE:18-21|Overall Study||40
2366216|NCT01561053|5807073|P1|Patients With Baseline MMSE:18-21|Overall Study||47
2366217|NCT01561053|5807070|P4|STARTED|Overall Study||87
2366218|NCT01561053|5807071|P3|STARTED|Overall Study||82
2366219|NCT01561053|5807072|P2|STARTED|Overall Study||92
2366220|NCT01561053|5807073|P1|STARTED|Overall Study||86
2366221|NCT01560988|5807109|P2|NOT COMPLETED|Second Intervention (Six Weeks)||2
2366222|NCT01560988|5807110|P1|NOT COMPLETED|Second Intervention (Six Weeks)||2
2366223|NCT01560988|5807109|P2|COMPLETED|Second Intervention (Six Weeks)||22
2366224|NCT01560988|5807110|P1|COMPLETED|Second Intervention (Six Weeks)||18
2366225|NCT01560988|5807109|P2|STARTED|Second Intervention (Six Weeks)||24
2366226|NCT01560988|5807110|P1|STARTED|Second Intervention (Six Weeks)||20
2366227|NCT01560988|5807109|P2|NOT COMPLETED|Washout (Six Weeks)||2
2366228|NCT01560988|5807110|P1|NOT COMPLETED|Washout (Six Weeks)||2
2366229|NCT01560988|5807109|P2|COMPLETED|Washout (Six Weeks)||24
2366230|NCT01560988|5807110|P1|COMPLETED|Washout (Six Weeks)||20
2366231|NCT01560988|5807109|P2|STARTED|Washout (Six Weeks)||26
2366232|NCT01560988|5807110|P1|STARTED|Washout (Six Weeks)||22
2366233|NCT01560988|5807109|P2|NOT COMPLETED|First Intervention (Six Weeks)||4
2366234|NCT01560988|5807110|P1|NOT COMPLETED|First Intervention (Six Weeks)||10
2366235|NCT01560988|5807109|P2|COMPLETED|First Intervention (Six Weeks)||26
2366236|NCT01560988|5807110|P1|COMPLETED|First Intervention (Six Weeks)||22
2366237|NCT01560988|5807109|P2|STARTED|First Intervention (Six Weeks)||30
2366238|NCT01560988|5807110|P1|STARTED|First Intervention (Six Weeks)||32
2366239|NCT01560975|5807133|P1|NOT COMPLETED|Overall Study||0
2366240|NCT01560975|5807133|P1|COMPLETED|Overall Study||10
2366241|NCT01560975|5807133|P1|STARTED|Overall Study||10
2366242|NCT01560819|5807148|P2|NOT COMPLETED|Overall Study||0
2366243|NCT01560819|5807149|P1|NOT COMPLETED|Overall Study||1
2366244|NCT01560819|5807148|P2|COMPLETED|Overall Study||10
2366245|NCT01560819|5807149|P1|COMPLETED|Overall Study||9
2366246|NCT01560819|5807148|P2|STARTED|Overall Study||10
2366247|NCT01560819|5807149|P1|STARTED|Overall Study||10
2366248|NCT01560780|5807155|P2|NOT COMPLETED|Overall Study||12
2366249|NCT01560780|5807156|P1|NOT COMPLETED|Overall Study||13
2366250|NCT01560780|5807155|P2|COMPLETED|Overall Study||30
2366251|NCT01560780|5807156|P1|COMPLETED|Overall Study||29
2366252|NCT01560780|5807155|P2|Completed Study Drug for 12 Months|Overall Study||27
2366253|NCT01560780|5807156|P1|Completed Study Drug for 12 Months|Overall Study||27
2366254|NCT01560780|5807155|P2|Clinical Follow-Up at 12 Months|Overall Study||42
2366255|NCT01560780|5807156|P1|Clinical Follow-Up at 12 Months|Overall Study||42
2366256|NCT01560780|5807155|P2|STARTED|Overall Study||42
2366257|NCT01560780|5807156|P1|STARTED|Overall Study||42
2366258|NCT01560624|5807176|P2|NOT COMPLETED|Overall Study||189
2366259|NCT01560624|5807177|P1|NOT COMPLETED|Overall Study||198
2366260|NCT01560624|5807176|P2|COMPLETED|Overall Study||155
2366261|NCT01560624|5807177|P1|COMPLETED|Overall Study||148
2366262|NCT01560624|5807176|P2|Early Discontinuation From Treatment|Overall Study||56
2366263|NCT01560624|5807177|P1|Early Discontinuation From Treatment|Overall Study||107
2366264|NCT01560624|5807176|P2|Clinical Worsening Event|Overall Study||133
2366265|NCT01560624|5807177|P1|Clinical Worsening Event|Overall Study||91
2366266|NCT01560624|5807176|P2|STARTED|Overall Study||344
2366267|NCT01560624|5807177|P1|STARTED|Overall Study||346
2366268|NCT01560507|5807192|P3|NOT COMPLETED|Overall Study||2
2366269|NCT01560507|5807193|P2|NOT COMPLETED|Overall Study||2
2366270|NCT01560507|5807194|P1|NOT COMPLETED|Overall Study||4
2366271|NCT01560507|5807192|P3|COMPLETED|Overall Study||0
2366272|NCT01560507|5807193|P2|COMPLETED|Overall Study||0
2366273|NCT01560507|5807194|P1|COMPLETED|Overall Study||1
2366274|NCT01560507|5807192|P3|STARTED|Overall Study||2
2366275|NCT01560507|5807193|P2|STARTED|Overall Study||2
2366276|NCT01560507|5807194|P1|STARTED|Overall Study||5
2366277|NCT01560429|5807207|P2|NOT COMPLETED|Overall Study||6
2366278|NCT01560429|5807208|P1|NOT COMPLETED|Overall Study||3
2366279|NCT01560429|5807207|P2|COMPLETED|Overall Study||20
2366280|NCT01560429|5807208|P1|COMPLETED|Overall Study||23
2366281|NCT01560429|5807207|P2|STARTED|Overall Study||26
2366282|NCT01560429|5807208|P1|STARTED|Overall Study||26
2366283|NCT01560416|5807218|P2|NOT COMPLETED|Crossover Phase||0
2366284|NCT01560416|5807219|P1|NOT COMPLETED|Crossover Phase||0
2366285|NCT01560416|5807218|P2|COMPLETED|Crossover Phase||0
2366286|NCT01560416|5807219|P1|COMPLETED|Crossover Phase||7
2366287|NCT01560416|5807218|P2|STARTED|Crossover Phase||0
2366288|NCT01560416|5807219|P1|STARTED|Crossover Phase||7
2366289|NCT01560416|5807218|P2|NOT COMPLETED|Randomized Phase||0
2366290|NCT01560416|5807219|P1|NOT COMPLETED|Randomized Phase||7
2366291|NCT01560416|5807218|P2|COMPLETED|Randomized Phase||35
2366292|NCT01560416|5807219|P1|COMPLETED|Randomized Phase||8
2366293|NCT01560416|5807218|P2|STARTED|Randomized Phase||35
2366294|NCT01560416|5807219|P1|STARTED|Randomized Phase||15
2366295|NCT01560403|5807237|P2|NOT COMPLETED|Overall Study||1
2366296|NCT01560403|5807238|P1|NOT COMPLETED|Overall Study||0
2366297|NCT01560403|5807237|P2|COMPLETED|Overall Study||8
2366298|NCT01560403|5807238|P1|COMPLETED|Overall Study||5
2366299|NCT01560403|5807237|P2|STARTED|Overall Study||9
2366300|NCT01560403|5807238|P1|STARTED|Overall Study||5
2366301|NCT01560377|5807244|P1|NOT COMPLETED|Overall Study||0
2366302|NCT01560377|5807244|P1|COMPLETED|Overall Study||147
2366303|NCT01560377|5807244|P1|Eligible for Analysis|Overall Study||139
2366304|NCT01560377|5807244|P1|STARTED|Overall Study||147
2366305|NCT01560286|5807249|P1|NOT COMPLETED|Overall Study||0
2366306|NCT01560286|5807249|P1|COMPLETED|Overall Study||24
2366307|NCT01560286|5807249|P1|STARTED|Overall Study||24
2366308|NCT01560260|5807262|P1|NOT COMPLETED|Overall Study||0
2366309|NCT01560260|5807262|P1|COMPLETED|Overall Study||20
2366310|NCT01560260|5807262|P1|STARTED|Overall Study||20
2366311|NCT01560234|5807286|P8|NOT COMPLETED|Overall Study||2
2366312|NCT01560234|5807287|P7|NOT COMPLETED|Overall Study||0
2366313|NCT01560234|5807288|P6|NOT COMPLETED|Overall Study||2
2366314|NCT01560234|5807289|P5|NOT COMPLETED|Overall Study||0
2366315|NCT01560234|5807290|P4|NOT COMPLETED|Overall Study||0
2366316|NCT01560234|5807291|P3|NOT COMPLETED|Overall Study||1
2366317|NCT01560234|5807292|P2|NOT COMPLETED|Overall Study||0
2366318|NCT01560234|5807293|P1|NOT COMPLETED|Overall Study||3
2366319|NCT01560234|5807286|P8|COMPLETED|Overall Study||6
2366320|NCT01560234|5807287|P7|COMPLETED|Overall Study||4
2366321|NCT01560234|5807288|P6|COMPLETED|Overall Study||2
2366322|NCT01560234|5807289|P5|COMPLETED|Overall Study||4
2366323|NCT01560234|5807290|P4|COMPLETED|Overall Study||3
2366324|NCT01560234|5807291|P3|COMPLETED|Overall Study||3
2366325|NCT01560234|5807292|P2|COMPLETED|Overall Study||4
2366326|NCT01560234|5807293|P1|COMPLETED|Overall Study||13
2366327|NCT01560234|5807286|P8|STARTED|Overall Study||8
2366328|NCT01560234|5807287|P7|STARTED|Overall Study||4
2366329|NCT01560234|5807288|P6|STARTED|Overall Study||4
2366330|NCT01560234|5807289|P5|STARTED|Overall Study||4
2366331|NCT01560234|5807290|P4|STARTED|Overall Study||3
2366332|NCT01560234|5807291|P3|STARTED|Overall Study||4
2366333|NCT01560234|5807292|P2|STARTED|Overall Study||4
2366334|NCT01560234|5807293|P1|STARTED|Overall Study||16
2366335|NCT01560143|5807367|P1|NOT COMPLETED|Overall Study||0
2366336|NCT01560143|5807367|P1|COMPLETED|Overall Study||12
2366337|NCT01560143|5807367|P1|STARTED|Overall Study||12
2366338|NCT01559948|5807373|P2|NOT COMPLETED|Overall Study||0
2366339|NCT01559948|5807374|P1|NOT COMPLETED|Overall Study||0
2366340|NCT01559948|5807373|P2|COMPLETED|Overall Study||15
2366341|NCT01559948|5807374|P1|COMPLETED|Overall Study||15
2366342|NCT01559948|5807373|P2|STARTED|Overall Study||15
2366343|NCT01559948|5807374|P1|STARTED|Overall Study||15
2366344|NCT01559935|5807388|P1|NOT COMPLETED|Maintenance Phase||54
2366345|NCT01559935|5807388|P1|COMPLETED|Maintenance Phase||0
2366346|NCT01559935|5807388|P1|STARTED|Maintenance Phase||54
2366347|NCT01559935|5807388|P1|NOT COMPLETED|BiRD Phase||4
2366348|NCT01559935|5807388|P1|COMPLETED|BiRD Phase||54
2366349|NCT01559935|5807388|P1|STARTED|BiRD Phase||58
2366350|NCT01559935|5807388|P1|NOT COMPLETED|Car Phase||14
2366351|NCT01559935|5807388|P1|COMPLETED|Car Phase||58
2366352|NCT01559935|5807388|P1|STARTED|Car Phase||72
2366353|NCT01559922|5807398|P2|NOT COMPLETED|Overall Study||10
2366354|NCT01559922|5807399|P1|NOT COMPLETED|Overall Study||4
2366355|NCT01559922|5807398|P2|COMPLETED|Overall Study||87
2366356|NCT01559922|5807399|P1|COMPLETED|Overall Study||46
2366357|NCT01559922|5807398|P2|STARTED|Overall Study||97
2366358|NCT01559922|5807399|P1|STARTED|Overall Study||50
2366359|NCT01559857|5807407|P2|NOT COMPLETED|Overall Study||0
2366360|NCT01559857|5807408|P1|NOT COMPLETED|Overall Study||0
2366361|NCT01559857|5807407|P2|COMPLETED|Overall Study||18
2366362|NCT01559857|5807408|P1|COMPLETED|Overall Study||19
2366363|NCT01559857|5807407|P2|STARTED|Overall Study||18
2366364|NCT01559857|5807408|P1|STARTED|Overall Study||19
2366365|NCT01559844|5807424|P1|NOT COMPLETED|Overall Study||25
2366366|NCT01559844|5807424|P1|COMPLETED|Overall Study||36
2366367|NCT01559844|5807424|P1|STARTED|Overall Study||61
2366368|NCT01559675|5807437|P2|NOT COMPLETED|Overall Study||14
2366369|NCT01559675|5807438|P1|NOT COMPLETED|Overall Study||15
2366370|NCT01559675|5807437|P2|COMPLETED|Overall Study||49
2366371|NCT01559675|5807438|P1|COMPLETED|Overall Study||43
2366372|NCT01559675|5807437|P2|STARTED|Overall Study||63
2366373|NCT01559675|5807438|P1|STARTED|Overall Study||58
2366374|NCT01559649|5807446|P2|NOT COMPLETED|Overall Study||6
2366375|NCT01559649|5807447|P1|NOT COMPLETED|Overall Study||19
2366376|NCT01559649|5807446|P2|COMPLETED|Overall Study||9
2366377|NCT01559649|5807447|P1|COMPLETED|Overall Study|Screening not completed in 11, VFSS not completed in 2, 6 excluded from analysis. N=250 analyzed|250
2366378|NCT01559649|5807446|P2|STARTED|Overall Study|Started with 10 nurses. As an RN dropped out due to scheduling, etc, RN replaced with another RN|15
2366379|NCT01559649|5807447|P1|STARTED|Overall Study||269
2366380|NCT01559506|5807460|P2|NOT COMPLETED|Overall Study||3
2366381|NCT01559506|5807461|P1|NOT COMPLETED|Overall Study||0
2366382|NCT01559506|5807460|P2|COMPLETED|Overall Study||18
2366383|NCT01559506|5807461|P1|COMPLETED|Overall Study||20
2366384|NCT01559506|5807460|P2|STARTED|Overall Study||21
2366385|NCT01559506|5807461|P1|STARTED|Overall Study||20
2366386|NCT01559454|5807469|P2|NOT COMPLETED|Overall Study||6
2366387|NCT01559454|5807470|P1|NOT COMPLETED|Overall Study||3
2366388|NCT01559454|5807469|P2|COMPLETED|Overall Study||4
2366389|NCT01559454|5807470|P1|COMPLETED|Overall Study||6
2366390|NCT01559454|5807469|P2|STARTED|Overall Study||10
2366391|NCT01559454|5807470|P1|STARTED|Overall Study||9
2366392|NCT01559389|5807488|P2|NOT COMPLETED|Overall Study||20
2366393|NCT01559389|5807489|P1|NOT COMPLETED|Overall Study||20
2366394|NCT01559389|5807488|P2|COMPLETED|Overall Study||49
2366395|NCT01559389|5807489|P1|COMPLETED|Overall Study||49
2366396|NCT01559389|5807488|P2|STARTED|Overall Study||69
2366397|NCT01559389|5807489|P1|STARTED|Overall Study||69
2366398|NCT01559311|5807502|P3|NOT COMPLETED|Overall Study||8
2366399|NCT01559311|5807503|P2|NOT COMPLETED|Overall Study||6
2366400|NCT01559311|5807504|P1|NOT COMPLETED|Overall Study||3
2366401|NCT01559311|5807502|P3|COMPLETED|Overall Study|12-Month|26
2366402|NCT01559311|5807503|P2|COMPLETED|Overall Study|12-Month|28
2366403|NCT01559311|5807504|P1|COMPLETED|Overall Study|12-Month|27
2366404|NCT01559311|5807502|P3|6-Month|Overall Study||28
2366405|NCT01559311|5807503|P2|6-Month|Overall Study||33
2366406|NCT01559311|5807504|P1|6-Month|Overall Study||27
2366407|NCT01559311|5807502|P3|3-Month|Overall Study||29
2366408|NCT01559311|5807503|P2|3-Month|Overall Study||34
2366409|NCT01559311|5807504|P1|3-Month|Overall Study||27
2366410|NCT01559311|5807502|P3|1-Month|Overall Study||29
2366411|NCT01559311|5807503|P2|1-Month|Overall Study||34
2366412|NCT01559311|5807504|P1|1-Month|Overall Study||27
2366413|NCT01559311|5807502|P3|Implant|Overall Study||32
2366414|NCT01559311|5807503|P2|Implant|Overall Study||34
2366415|NCT01559311|5807504|P1|Implant|Overall Study||28
2366416|NCT01559311|5807502|P3|STARTED|Overall Study|Enrollment & Baseline|34
2366417|NCT01559311|5807503|P2|STARTED|Overall Study|Enrollment & Baseline|34
2366418|NCT01559311|5807504|P1|STARTED|Overall Study|Enrollment & Baseline|30
2366419|NCT01559129|5807517|P2|NOT COMPLETED|Open-label Extension Period||2
2366420|NCT01559129|5807518|P1|NOT COMPLETED|Open-label Extension Period||6
2366421|NCT01559129|5807517|P2|COMPLETED|Open-label Extension Period||0
2366422|NCT01559129|5807518|P1|COMPLETED|Open-label Extension Period||0
2366423|NCT01559129|5807517|P2|STARTED|Open-label Extension Period|Two participants elected not to enter the Extension Phase.|2
2366424|NCT01559129|5807518|P1|STARTED|Open-label Extension Period|One participant elected not to enter the Extension Phase.|6
2366425|NCT01559129|5807517|P2|NOT COMPLETED|Treatment Phase||7
2366426|NCT01559129|5807518|P1|NOT COMPLETED|Treatment Phase||5
2366427|NCT01559129|5807517|P2|COMPLETED|Treatment Phase||4
2366428|NCT01559129|5807518|P1|COMPLETED|Treatment Phase||7
2366429|NCT01559129|5807517|P2|Received Treatment|Treatment Phase||10
2366430|NCT01559129|5807518|P1|Received Treatment|Treatment Phase||12
2366431|NCT01559129|5807517|P2|STARTED|Treatment Phase||11
2366432|NCT01559129|5807518|P1|STARTED|Treatment Phase||12
2366433|NCT01559116|5807594|P1|NOT COMPLETED|Overall Study||26
2366434|NCT01559116|5807594|P1|COMPLETED|Overall Study|Completed all 4 treatment periods|193
2366435|NCT01559116|5807594|P1|STARTED|Overall Study|Randomised|219
2366436|NCT01559090|5807665|P3|NOT COMPLETED|Stage II||0
2366437|NCT01559090|5807666|P2|NOT COMPLETED|Stage II||0
2366438|NCT01559090|5807667|P1|NOT COMPLETED|Stage II||1
2366439|NCT01559090|5807665|P3|COMPLETED|Stage II||2
2366440|NCT01559090|5807666|P2|COMPLETED|Stage II||3
2366441|NCT01559090|5807667|P1|COMPLETED|Stage II||3
2366442|NCT01559090|5807665|P3|STARTED|Stage II|One subject who completed Stage I did not agree to participate in Stage II|2
2366443|NCT01559090|5807666|P2|STARTED|Stage II||3
2366444|NCT01559090|5807667|P1|STARTED|Stage II||4
2366445|NCT01559090|5807665|P3|NOT COMPLETED|Stage I||3
2366446|NCT01559090|5807666|P2|NOT COMPLETED|Stage I||2
2366447|NCT01559090|5807667|P1|NOT COMPLETED|Stage I||2
2366448|NCT01559090|5807665|P3|COMPLETED|Stage I||3
2366449|NCT01559090|5807666|P2|COMPLETED|Stage I||3
2366450|NCT01559090|5807667|P1|COMPLETED|Stage I||4
2366451|NCT01559090|5807665|P3|STARTED|Stage I||6
2366452|NCT01559090|5807666|P2|STARTED|Stage I||5
2366453|NCT01559090|5807667|P1|STARTED|Stage I||6
2366454|NCT01559064|5807687|P3|NOT COMPLETED|Overall Study||2
2366455|NCT01559064|5807688|P2|NOT COMPLETED|Overall Study||1
2366456|NCT01559064|5807689|P1|NOT COMPLETED|Overall Study||1
2366457|NCT01559064|5807687|P3|COMPLETED|Overall Study||57
2366458|NCT01559064|5807688|P2|COMPLETED|Overall Study||39
2366459|NCT01559064|5807689|P1|COMPLETED|Overall Study||15
2366460|NCT01559064|5807687|P3|STARTED|Overall Study||59
2366461|NCT01559064|5807688|P2|STARTED|Overall Study||40
2366462|NCT01559064|5807689|P1|STARTED|Overall Study||16
2366463|NCT01559012|5807699|P2|NOT COMPLETED|Overall Study||1
2366464|NCT01559012|5807700|P1|NOT COMPLETED|Overall Study||0
2366465|NCT01559012|5807699|P2|COMPLETED|Overall Study|Patient N. 2 withdrew from study for alleged side effects at day 1 of placebo cycle.|6
2366466|NCT01559012|5807700|P1|COMPLETED|Overall Study||6
2366467|NCT01559012|5807699|P2|STARTED|Overall Study|1 more patient added to randomization list to reach the pre-assignment number of treated patients|7
2366468|NCT01559012|5807700|P1|STARTED|Overall Study||6
2366469|NCT01558791|5807725|P2|NOT COMPLETED|Overall Study||0
2366470|NCT01558791|5807726|P1|NOT COMPLETED|Overall Study||0
2366471|NCT01558791|5807725|P2|COMPLETED|Overall Study||629
2366472|NCT01558791|5807726|P1|COMPLETED|Overall Study||607
2366473|NCT01558791|5807725|P2|STARTED|Overall Study||629
2366474|NCT01558791|5807726|P1|STARTED|Overall Study||607
2366475|NCT01558739|5807738|P1|NOT COMPLETED|Overall Study||17
2366476|NCT01558739|5807738|P1|COMPLETED|Overall Study||31
2366477|NCT01558739|5807738|P1|STARTED|Overall Study||48
2366478|NCT01558700|5807752|P2|NOT COMPLETED|Overall Study||0
2366479|NCT01558700|5807753|P1|NOT COMPLETED|Overall Study||0
2366480|NCT01558700|5807752|P2|COMPLETED|Overall Study||21
2366481|NCT01558700|5807753|P1|COMPLETED|Overall Study||19
2366482|NCT01558700|5807752|P2|STARTED|Overall Study||21
2366483|NCT01558700|5807753|P1|STARTED|Overall Study||19
2366484|NCT01558674|5807763|P2|NOT COMPLETED|Part 2||0
2366485|NCT01558674|5807764|P1|NOT COMPLETED|Part 2||0
2366486|NCT01558674|5807763|P2|COMPLETED|Part 2||0
2366487|NCT01558674|5807764|P1|COMPLETED|Part 2||0
2366488|NCT01558674|5807763|P2|STARTED|Part 2||0
2366489|NCT01558674|5807764|P1|STARTED|Part 2||0
2366490|NCT01558674|5807763|P2|NOT COMPLETED|Part 1||0
2366491|NCT01558674|5807764|P1|NOT COMPLETED|Part 1||11
2366492|NCT01558674|5807763|P2|COMPLETED|Part 1||0
2366493|NCT01558674|5807764|P1|COMPLETED|Part 1||0
2366494|NCT01558674|5807763|P2|STARTED|Part 1||0
2366495|NCT01558674|5807764|P1|STARTED|Part 1||11
2366496|NCT01558661|5807808|P1|NOT COMPLETED|Overall Study||0
2366497|NCT01558661|5807808|P1|COMPLETED|Overall Study||33
2366498|NCT01558661|5807808|P1|Second Stage|Overall Study||15
2366499|NCT01558661|5807808|P1|First Stage|Overall Study||18
2366500|NCT01558661|5807808|P1|STARTED|Overall Study||33
2366501|NCT01558635|5807815|P1|NOT COMPLETED|Overall Study||6
2366502|NCT01558635|5807815|P1|COMPLETED|Overall Study||11
2366503|NCT01558635|5807815|P1|6 Months Post-procedure|Overall Study||14
2366504|NCT01558635|5807815|P1|3 Months Post-procedure|Overall Study||14
2366505|NCT01558635|5807815|P1|Discharge /1 Month Post-procedure|Overall Study||15
2366506|NCT01558635|5807815|P1|Treated|Overall Study||17
2366507|NCT01558635|5807815|P1|STARTED|Overall Study||17
2366508|NCT01558596|5807832|P2|NOT COMPLETED|Overall Study||1
2366509|NCT01558596|5807833|P1|NOT COMPLETED|Overall Study||3
2366510|NCT01558596|5807832|P2|COMPLETED|Overall Study||100
2366511|NCT01558596|5807833|P1|COMPLETED|Overall Study||101
2366512|NCT01558596|5807832|P2|STARTED|Overall Study||101
2366513|NCT01558596|5807833|P1|STARTED|Overall Study||104
2366514|NCT01558492|5807839|P1|NOT COMPLETED|Overall Study||0
2366515|NCT01558492|5807839|P1|COMPLETED|Overall Study||3
2366516|NCT01558492|5807839|P1|STARTED|Overall Study||3
2366517|NCT01558297|5807848|P3|NOT COMPLETED|Overall Study||1
2366518|NCT01558297|5807849|P2|NOT COMPLETED|Overall Study||2
2366519|NCT01558297|5807850|P1|NOT COMPLETED|Overall Study||2
2366520|NCT01558297|5807848|P3|COMPLETED|Overall Study||29
2366521|NCT01558297|5807849|P2|COMPLETED|Overall Study||27
2366522|NCT01558297|5807850|P1|COMPLETED|Overall Study||28
2366523|NCT01558297|5807848|P3|STARTED|Overall Study||30
2366524|NCT01558297|5807849|P2|STARTED|Overall Study||29
2366525|NCT01558297|5807850|P1|STARTED|Overall Study||30
2366526|NCT01558271|5807867|P3|NOT COMPLETED|Overall Study||17
2366527|NCT01558271|5807868|P2|NOT COMPLETED|Overall Study||11
2366528|NCT01558271|5807869|P1|NOT COMPLETED|Overall Study||18
2366529|NCT01558271|5807867|P3|COMPLETED|Overall Study||124
2366530|NCT01558271|5807868|P2|COMPLETED|Overall Study||59
2366531|NCT01558271|5807869|P1|COMPLETED|Overall Study||263
2366532|NCT01558271|5807867|P3|Completed 26 Weeks|Overall Study||128
2366533|NCT01558271|5807868|P2|Completed 26 Weeks|Overall Study||63
2366534|NCT01558271|5807869|P1|Completed 26 Weeks|Overall Study||271
2366535|NCT01558271|5807867|P3|Received at Least 1 Dose of Study Drug|Overall Study||137
2366536|NCT01558271|5807868|P2|Received at Least 1 Dose of Study Drug|Overall Study||70
2366537|NCT01558271|5807869|P1|Received at Least 1 Dose of Study Drug|Overall Study||280
2366538|NCT01558271|5807867|P3|STARTED|Overall Study||141
2366539|NCT01558271|5807868|P2|STARTED|Overall Study||70
2366540|NCT01558271|5807869|P1|STARTED|Overall Study||281
2366541|NCT01558128|5807931|P1|NOT COMPLETED|Overall Study||0
2366542|NCT01558128|5807931|P1|COMPLETED|Overall Study||1
2366543|NCT01558128|5807931|P1|STARTED|Overall Study||1
2366544|NCT01558089|5807935|P1|NOT COMPLETED|Overall Study||13
2366545|NCT01558089|5807935|P1|COMPLETED|Overall Study||63
2366546|NCT01558089|5807935|P1|STARTED|Overall Study||76
2366547|NCT01558063|5807952|P6|NOT COMPLETED|Overall Study||0
2366548|NCT01558063|5807953|P5|NOT COMPLETED|Overall Study||0
2366549|NCT01558063|5807954|P4|NOT COMPLETED|Overall Study||0
2366550|NCT01558063|5807955|P3|NOT COMPLETED|Overall Study||0
2366551|NCT01558063|5807956|P2|NOT COMPLETED|Overall Study||0
2366552|NCT01558063|5807957|P1|NOT COMPLETED|Overall Study||0
2366553|NCT01558063|5807952|P6|COMPLETED|Overall Study||5
2366554|NCT01558063|5807953|P5|COMPLETED|Overall Study||9
2366555|NCT01558063|5807954|P4|COMPLETED|Overall Study||5
2366556|NCT01558063|5807955|P3|COMPLETED|Overall Study||8
2366557|NCT01558063|5807956|P2|COMPLETED|Overall Study||6
2366558|NCT01558063|5807957|P1|COMPLETED|Overall Study||5
2366559|NCT01558063|5807952|P6|STARTED|Overall Study||5
2366560|NCT01558063|5807953|P5|STARTED|Overall Study||9
2366561|NCT01558063|5807954|P4|STARTED|Overall Study||5
2366562|NCT01558063|5807955|P3|STARTED|Overall Study||8
2366563|NCT01558063|5807956|P2|STARTED|Overall Study||6
2366564|NCT01558063|5807957|P1|STARTED|Overall Study||5
2366565|NCT01557959|5807978|P1|NOT COMPLETED|Overall Study||0
2366566|NCT01557959|5807978|P1|COMPLETED|Overall Study||45
2366567|NCT01557959|5807978|P1|STARTED|Overall Study||45
2366568|NCT01557946|5807988|P2|NOT COMPLETED|Overall Study||0
2366569|NCT01557946|5807989|P1|NOT COMPLETED|Overall Study||3
2366570|NCT01557946|5807988|P2|COMPLETED|Overall Study|2 subjects with unusable imaging data.|12
2366571|NCT01557946|5807989|P1|COMPLETED|Overall Study|20 consented and scanned - 1 subject's data not used due to ongoing neurological condition.|17
2366572|NCT01557946|5807988|P2|STARTED|Overall Study||12
2366573|NCT01557946|5807989|P1|STARTED|Overall Study||20
2366574|NCT01557920|5807995|P2|NOT COMPLETED|Overall Study||3
2366575|NCT01557920|5807996|P1|NOT COMPLETED|Overall Study||3
2366576|NCT01557920|5807995|P2|COMPLETED|Overall Study||6
2366577|NCT01557920|5807996|P1|COMPLETED|Overall Study||6
2366578|NCT01557920|5807995|P2|STARTED|Overall Study||9
2366579|NCT01557920|5807996|P1|STARTED|Overall Study||9
2366580|NCT01557894|5808031|P2|NOT COMPLETED|Overall Study||5
2366581|NCT01557894|5808032|P1|NOT COMPLETED|Overall Study||3
2366582|NCT01557894|5808031|P2|COMPLETED|Overall Study||33
2366583|NCT01557894|5808032|P1|COMPLETED|Overall Study||35
2366584|NCT01557894|5808031|P2|STARTED|Overall Study||38
2366585|NCT01557894|5808032|P1|STARTED|Overall Study||38
2366589|NCT01557868|5808054|P2|NOT COMPLETED|Overall Study||30
2366590|NCT01557868|5808055|P1|NOT COMPLETED|Overall Study||27
2366591|NCT01557868|5808054|P2|COMPLETED|Overall Study||65
2366592|NCT01557868|5808055|P1|COMPLETED|Overall Study||76
2366593|NCT01557868|5808054|P2|STARTED|Overall Study||95
2366594|NCT01557868|5808055|P1|STARTED|Overall Study||103
2366595|NCT01557842|5808065|P2|NOT COMPLETED|Overall Study||6
2366596|NCT01557842|5808066|P1|NOT COMPLETED|Overall Study||9
2366597|NCT01557842|5808065|P2|COMPLETED|Overall Study||0
2366598|NCT01557842|5808066|P1|COMPLETED|Overall Study||0
2366599|NCT01557842|5808065|P2|STARTED|Overall Study||6
2366600|NCT01557842|5808066|P1|STARTED|Overall Study||9
2366601|NCT01557790|5808074|P1|NOT COMPLETED|Overall Study||1
2366602|NCT01557790|5808074|P1|COMPLETED|Overall Study||4
2366603|NCT01557790|5808074|P1|STARTED|Overall Study||5
2366604|NCT01557751|5808078|P1|NOT COMPLETED|Overall Study||3
2366605|NCT01557751|5808078|P1|COMPLETED|Overall Study||153
2366606|NCT01557751|5808078|P1|STARTED|Overall Study||156
2366607|NCT01557699|5808085|P3|NOT COMPLETED|Overall Study||0
2366608|NCT01557699|5808086|P2|NOT COMPLETED|Overall Study||0
2366609|NCT01557699|5808087|P1|NOT COMPLETED|Overall Study||0
2366610|NCT01557699|5808085|P3|COMPLETED|Overall Study||20
2366611|NCT01557699|5808086|P2|COMPLETED|Overall Study||20
2366612|NCT01557699|5808087|P1|COMPLETED|Overall Study||20
2366613|NCT01557699|5808085|P3|STARTED|Overall Study||20
2366614|NCT01557699|5808086|P2|STARTED|Overall Study||20
2366615|NCT01557699|5808087|P1|STARTED|Overall Study||20
2366616|NCT01557595|5808119|P1|NOT COMPLETED|Overall Study||8
2366617|NCT01557595|5808119|P1|COMPLETED|Overall Study||14
2366618|NCT01557595|5808119|P1|STARTED|Overall Study||22
2366619|NCT01557582|5808123|P1|NOT COMPLETED|Overall Study||6
2366620|NCT01557582|5808123|P1|COMPLETED|Overall Study||97
2366621|NCT01557582|5808123|P1|STARTED|Overall Study||103
2366622|NCT01557569|5808131|P2|NOT COMPLETED|Overall Study||7
2366623|NCT01557569|5808132|P1|NOT COMPLETED|Overall Study||5
2366624|NCT01557569|5808131|P2|COMPLETED|Overall Study||0
2366625|NCT01557569|5808132|P1|COMPLETED|Overall Study||1
2366626|NCT01557569|5808131|P2|Completed 2-wk Residential Stay|Overall Study||1
2366627|NCT01557569|5808132|P1|Completed 2-wk Residential Stay|Overall Study||3
2366628|NCT01557569|5808131|P2|STARTED|Overall Study|Those who received at least one dose of medication|7
2366629|NCT01557569|5808132|P1|STARTED|Overall Study|Those who received at least one dose of medication|6
2366630|NCT01557517|5808140|P2|NOT COMPLETED|Overall Study||4
2366631|NCT01557517|5808141|P1|NOT COMPLETED|Overall Study||2
2366632|NCT01557517|5808140|P2|COMPLETED|Overall Study||17
2366633|NCT01557517|5808141|P1|COMPLETED|Overall Study||17
2366634|NCT01557517|5808140|P2|STARTED|Overall Study||21
2366635|NCT01557517|5808141|P1|STARTED|Overall Study||19
2366636|NCT01557504|5808167|P2|NOT COMPLETED|Overall Study||0
2366637|NCT01557504|5808168|P1|NOT COMPLETED|Overall Study||1
2366638|NCT01557504|5808167|P2|COMPLETED|Overall Study||12
2366639|NCT01557504|5808168|P1|COMPLETED|Overall Study||12
2366640|NCT01557504|5808167|P2|STARTED|Overall Study||12
2366641|NCT01557504|5808168|P1|STARTED|Overall Study||13
2366642|NCT01557348|5808193|P2|NOT COMPLETED|Overall Study||90
2366643|NCT01557348|5808194|P1|NOT COMPLETED|Overall Study||80
2366644|NCT01557348|5808193|P2|COMPLETED|Overall Study||417
2366645|NCT01557348|5808194|P1|COMPLETED|Overall Study||524
2366646|NCT01557348|5808193|P2|Safety Population|Overall Study||507
2366647|NCT01557348|5808194|P1|Safety Population|Overall Study||604
2366648|NCT01557348|5808193|P2|STARTED|Overall Study||507
2366649|NCT01557348|5808194|P1|STARTED|Overall Study||604
2366650|NCT01557322|5808236|P2|NOT COMPLETED|Overall Study||0
2366651|NCT01557322|5808237|P1|NOT COMPLETED|Overall Study||0
2366652|NCT01557322|5808236|P2|COMPLETED|Overall Study||1543
2366653|NCT01557322|5808237|P1|COMPLETED|Overall Study||211
2366654|NCT01557322|5808236|P2|STARTED|Overall Study||1543
2366655|NCT01557322|5808237|P1|STARTED|Overall Study||211
2366656|NCT01557283|5808311|P1|NOT COMPLETED|Overall Study||44
2366657|NCT01557283|5808311|P1|COMPLETED|Overall Study||96
2366658|NCT01557283|5808311|P1|STARTED|Overall Study||140
2366659|NCT01557166|5808323|P2|NOT COMPLETED|Overall Study||37
2366660|NCT01557166|5808324|P1|NOT COMPLETED|Overall Study||46
2366661|NCT01557166|5808323|P2|COMPLETED|Overall Study||142
2366662|NCT01557166|5808324|P1|COMPLETED|Overall Study||134
2366663|NCT01557166|5808323|P2|Exposed|Overall Study||179
2366664|NCT01557166|5808324|P1|Exposed|Overall Study||176
2366665|NCT01557166|5808323|P2|STARTED|Overall Study||179
2366666|NCT01557166|5808324|P1|STARTED|Overall Study||180
2366667|NCT01556997|5808339|P3|NOT COMPLETED|Overall Study||32
2366668|NCT01556997|5808340|P2|NOT COMPLETED|Overall Study||28
2366669|NCT01556997|5808341|P1|NOT COMPLETED|Overall Study||26
2366670|NCT01556997|5808339|P3|COMPLETED|Overall Study||246
2366671|NCT01556997|5808340|P2|COMPLETED|Overall Study||252
2366672|NCT01556997|5808341|P1|COMPLETED|Overall Study||253
2366673|NCT01556997|5808339|P3|STARTED|Overall Study||278
2366674|NCT01556997|5808340|P2|STARTED|Overall Study||280
2366675|NCT01556997|5808341|P1|STARTED|Overall Study||279
2366676|NCT01556932|5808352|P2|NOT COMPLETED|Second Treament||0
2366677|NCT01556932|5808353|P1|NOT COMPLETED|Second Treament||0
2366678|NCT01556932|5808352|P2|COMPLETED|Second Treament||8
2366679|NCT01556932|5808353|P1|COMPLETED|Second Treament||12
2366680|NCT01556932|5808352|P2|Recieved|Second Treament||8
2366681|NCT01556932|5808353|P1|Recieved|Second Treament||12
2366682|NCT01556932|5808352|P2|STARTED|Second Treament||8
2366683|NCT01556932|5808353|P1|STARTED|Second Treament||12
2366684|NCT01556932|5808352|P2|NOT COMPLETED|Time Point 60 Minutes||1
2366685|NCT01556932|5808353|P1|NOT COMPLETED|Time Point 60 Minutes||1
2366686|NCT01556932|5808352|P2|COMPLETED|Time Point 60 Minutes||8
2366687|NCT01556932|5808353|P1|COMPLETED|Time Point 60 Minutes||12
2366688|NCT01556932|5808352|P2|Recieved|Time Point 60 Minutes||8
2366689|NCT01556932|5808353|P1|Recieved|Time Point 60 Minutes||12
2366690|NCT01556932|5808352|P2|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|9
2366691|NCT01556932|5808353|P1|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|13
2366692|NCT01556932|5808352|P2|NOT COMPLETED|Baseline First Treatment||0
2366693|NCT01556932|5808353|P1|NOT COMPLETED|Baseline First Treatment||0
2366694|NCT01556932|5808352|P2|COMPLETED|Baseline First Treatment||9
2366695|NCT01556932|5808353|P1|COMPLETED|Baseline First Treatment||13
2366696|NCT01556932|5808352|P2|Recieved|Baseline First Treatment||9
2366697|NCT01556932|5808353|P1|Recieved|Baseline First Treatment||13
2366698|NCT01556932|5808352|P2|STARTED|Baseline First Treatment||9
2366699|NCT01556932|5808353|P1|STARTED|Baseline First Treatment||13
2366700|NCT01556906|5808358|P1|NOT COMPLETED|Overall Study||0
2366701|NCT01556906|5808358|P1|COMPLETED|Overall Study||6
2366702|NCT01556906|5808358|P1|STARTED|Overall Study||6
2366703|NCT01556763|5808379|P3|NOT COMPLETED|Overall Study||0
2366704|NCT01556763|5808380|P2|NOT COMPLETED|Overall Study||1
2366705|NCT01556763|5808381|P1|NOT COMPLETED|Overall Study||0
2366706|NCT01556763|5808379|P3|COMPLETED|Overall Study||8
2366707|NCT01556763|5808380|P2|COMPLETED|Overall Study||8
2366708|NCT01556763|5808381|P1|COMPLETED|Overall Study||4
2366709|NCT01556763|5808379|P3|STARTED|Overall Study||8
2366710|NCT01556763|5808380|P2|STARTED|Overall Study||9
2366711|NCT01556763|5808381|P1|STARTED|Overall Study||4
2366712|NCT01556724|5808419|P2|NOT COMPLETED|Overall Study||0
2366713|NCT01556724|5808420|P1|NOT COMPLETED|Overall Study||0
2366714|NCT01556724|5808419|P2|COMPLETED|Overall Study||14
2366715|NCT01556724|5808420|P1|COMPLETED|Overall Study||16
2366716|NCT01556724|5808419|P2|STARTED|Overall Study||14
2366717|NCT01556724|5808420|P1|STARTED|Overall Study||16
2366718|NCT01556633|5808436|P2|NOT COMPLETED|Overall Study||0
2366719|NCT01556633|5808437|P1|NOT COMPLETED|Overall Study||0
2366720|NCT01556633|5808436|P2|COMPLETED|Overall Study||6
2366721|NCT01556633|5808437|P1|COMPLETED|Overall Study||10
2366722|NCT01556633|5808436|P2|STARTED|Overall Study||6
2366723|NCT01556633|5808437|P1|STARTED|Overall Study||10
2366724|NCT01556594|5808462|P3|NOT COMPLETED|Overall Study||0
2366725|NCT01556594|5808463|P2|NOT COMPLETED|Overall Study||0
2366726|NCT01556594|5808464|P1|NOT COMPLETED|Overall Study||0
2366727|NCT01556594|5808462|P3|COMPLETED|Overall Study||6
2366728|NCT01556594|5808463|P2|COMPLETED|Overall Study||2
2366729|NCT01556594|5808464|P1|COMPLETED|Overall Study||10
2366730|NCT01556594|5808462|P3|STARTED|Overall Study||6
2366731|NCT01556594|5808463|P2|STARTED|Overall Study||2
2366732|NCT01556594|5808464|P1|STARTED|Overall Study||10
2366733|NCT01556451|5808498|P1|NOT COMPLETED|Overall Study||0
2366734|NCT01556451|5808498|P1|COMPLETED|Overall Study||180
2366735|NCT01556451|5808498|P1|STARTED|Overall Study||180
2366736|NCT01556438|5808507|P2|NOT COMPLETED|Overall Study||11
2366737|NCT01556438|5808508|P1|NOT COMPLETED|Overall Study||4
2366738|NCT01556438|5808507|P2|COMPLETED|Overall Study||1
2366739|NCT01556438|5808508|P1|COMPLETED|Overall Study||0
2366740|NCT01556438|5808507|P2|Received BTZ SC|Overall Study||8
2366741|NCT01556438|5808508|P1|Received BTZ SC|Overall Study||0
2366742|NCT01556438|5808507|P2|Received BTZ IV|Overall Study||4
2366743|NCT01556438|5808508|P1|Received BTZ IV|Overall Study||4
2366744|NCT01556438|5808507|P2|Received at Least 1 Dose of Study Drug|Overall Study|300 mg tabalumab IV|12
2366745|NCT01556438|5808508|P1|Received at Least 1 Dose of Study Drug|Overall Study|100 mg tabalumab IV|4
2366746|NCT01556438|5808507|P2|STARTED|Overall Study||12
2366747|NCT01556438|5808508|P1|STARTED|Overall Study||4
2366748|NCT01556425|5808537|P4|NOT COMPLETED|Overall Study||0
2366749|NCT01556425|5808538|P3|NOT COMPLETED|Overall Study||0
2366750|NCT01556425|5808539|P2|NOT COMPLETED|Overall Study||0
2366751|NCT01556425|5808540|P1|NOT COMPLETED|Overall Study||0
2366752|NCT01556425|5808537|P4|COMPLETED|Overall Study||18
2366753|NCT01556425|5808538|P3|COMPLETED|Overall Study||18
2366754|NCT01556425|5808539|P2|COMPLETED|Overall Study||23
2366755|NCT01556425|5808540|P1|COMPLETED|Overall Study||25
2366756|NCT01556425|5808537|P4|STARTED|Overall Study||18
2366757|NCT01556425|5808538|P3|STARTED|Overall Study||18
2366758|NCT01556425|5808539|P2|STARTED|Overall Study||23
2366759|NCT01556425|5808540|P1|STARTED|Overall Study||25
2366760|NCT01556347|5808554|P1|NOT COMPLETED|Recovery Phase||0
2366761|NCT01556347|5808554|P1|COMPLETED|Recovery Phase||2
2366762|NCT01556347|5808554|P1|STARTED|Recovery Phase||2
2366763|NCT01556347|5808554|P1|NOT COMPLETED|Bortezomib Treatment Phase||0
2366764|NCT01556347|5808554|P1|COMPLETED|Bortezomib Treatment Phase||2
2366765|NCT01556347|5808554|P1|STARTED|Bortezomib Treatment Phase||2
2366766|NCT01556347|5808554|P1|NOT COMPLETED|Induction Immunotherapy||0
2366767|NCT01556347|5808554|P1|COMPLETED|Induction Immunotherapy||2
2366768|NCT01556347|5808554|P1|STARTED|Induction Immunotherapy||2
2366769|NCT01556204|5808584|P2|NOT COMPLETED|Overall Study||0
2366770|NCT01556204|5808585|P1|NOT COMPLETED|Overall Study||0
2366771|NCT01556204|5808584|P2|COMPLETED|Overall Study||38
2366772|NCT01556204|5808585|P1|COMPLETED|Overall Study||35
2366773|NCT01556204|5808584|P2|STARTED|Overall Study||38
2366774|NCT01556204|5808585|P1|STARTED|Overall Study||35
2366775|NCT01556165|5808595|P2|NOT COMPLETED|Overall Study||7
2366776|NCT01556165|5808596|P1|NOT COMPLETED|Overall Study||12
2366777|NCT01556165|5808595|P2|COMPLETED|Overall Study||58
2366778|NCT01556165|5808596|P1|COMPLETED|Overall Study||53
2366779|NCT01556165|5808595|P2|STARTED|Overall Study||65
2366780|NCT01556165|5808596|P1|STARTED|Overall Study||65
2366781|NCT01556100|5808608|P1|NOT COMPLETED|Overall Study||6
2366782|NCT01556100|5808608|P1|COMPLETED|Overall Study||34
2366783|NCT01556100|5808608|P1|STARTED|Overall Study||40
2366784|NCT01556061|5808615|P2|NOT COMPLETED|Overall Study||0
2366785|NCT01556061|5808616|P1|NOT COMPLETED|Overall Study||0
2366786|NCT01556061|5808615|P2|COMPLETED|Overall Study||25
2366787|NCT01556061|5808616|P1|COMPLETED|Overall Study||25
2366788|NCT01556061|5808615|P2|STARTED|Overall Study||25
2366789|NCT01556061|5808616|P1|STARTED|Overall Study||25
2366790|NCT01555983|5808626|P6|NOT COMPLETED|Overall Study||1
2366791|NCT01555983|5808627|P5|NOT COMPLETED|Overall Study||1
2366792|NCT01555983|5808628|P4|NOT COMPLETED|Overall Study||0
2366793|NCT01555983|5808629|P3|NOT COMPLETED|Overall Study||0
2366794|NCT01555983|5808630|P2|NOT COMPLETED|Overall Study||0
2366795|NCT01555983|5808631|P1|NOT COMPLETED|Overall Study||1
2366796|NCT01555983|5808626|P6|COMPLETED|Overall Study|One subject completed the 6.7%THC session, then dropped out.|6
2366797|NCT01555983|5808627|P5|COMPLETED|Overall Study|One subject complete 6.7%THC and placebo sessions, then dropped out|4
2366798|NCT01555983|5808628|P4|COMPLETED|Overall Study||7
2366799|NCT01555983|5808629|P3|COMPLETED|Overall Study||7
2366800|NCT01555983|5808630|P2|COMPLETED|Overall Study||7
2366801|NCT01555983|5808631|P1|COMPLETED|Overall Study|One subject only finished the placebo session, then dropped out of study|8
2366802|NCT01555983|5808626|P6|STARTED|Overall Study||7
2366803|NCT01555983|5808627|P5|STARTED|Overall Study||5
2366804|NCT01555983|5808628|P4|STARTED|Overall Study||7
2366805|NCT01555983|5808629|P3|STARTED|Overall Study||7
2366806|NCT01555983|5808630|P2|STARTED|Overall Study||7
2366807|NCT01555983|5808631|P1|STARTED|Overall Study||9
2366808|NCT01555931|5808641|P2|NOT COMPLETED|Overall Study||5
2366809|NCT01555931|5808642|P1|NOT COMPLETED|Overall Study||2
2366810|NCT01555931|5808641|P2|COMPLETED|Overall Study||13
2366811|NCT01555931|5808642|P1|COMPLETED|Overall Study||15
2366812|NCT01555931|5808641|P2|STARTED|Overall Study||18
2366813|NCT01555931|5808642|P1|STARTED|Overall Study||17
2366814|NCT01555762|5808650|P1|NOT COMPLETED|Overall Study||274
2366815|NCT01555762|5808650|P1|COMPLETED|Overall Study||128
2366816|NCT01555762|5808650|P1|Efficacy Population|Overall Study||358
2366817|NCT01555762|5808650|P1|Safety Population|Overall Study||383
2366818|NCT01555762|5808650|P1|STARTED|Overall Study||402
2366819|NCT01555567|5808664|P4|NOT COMPLETED|Return to Activity||1
2366820|NCT01555567|5808665|P3|NOT COMPLETED|Return to Activity||0
2366821|NCT01555567|5808666|P2|NOT COMPLETED|Return to Activity||2
2366822|NCT01555567|5808667|P1|NOT COMPLETED|Return to Activity||1
2366823|NCT01555567|5808664|P4|COMPLETED|Return to Activity||8
2366824|NCT01555567|5808665|P3|COMPLETED|Return to Activity||8
2366825|NCT01555567|5808666|P2|COMPLETED|Return to Activity||10
2366826|NCT01555567|5808667|P1|COMPLETED|Return to Activity||10
2366827|NCT01555567|5808664|P4|STARTED|Return to Activity||9
2366828|NCT01555567|5808665|P3|STARTED|Return to Activity||8
2366829|NCT01555567|5808666|P2|STARTED|Return to Activity||12
2366830|NCT01555567|5808667|P1|STARTED|Return to Activity||11
2366831|NCT01555567|5808664|P4|NOT COMPLETED|12 Week||0
2366832|NCT01555567|5808665|P3|NOT COMPLETED|12 Week||1
2366833|NCT01555567|5808666|P2|NOT COMPLETED|12 Week||1
2366834|NCT01555567|5808667|P1|NOT COMPLETED|12 Week||1
2366835|NCT01555567|5808664|P4|COMPLETED|12 Week||9
2366836|NCT01555567|5808665|P3|COMPLETED|12 Week||8
2366837|NCT01555567|5808666|P2|COMPLETED|12 Week||12
2366838|NCT01555567|5808667|P1|COMPLETED|12 Week||11
2366839|NCT01555567|5808664|P4|STARTED|12 Week||9
2366840|NCT01555567|5808665|P3|STARTED|12 Week||9
2366841|NCT01555567|5808666|P2|STARTED|12 Week||13
2366842|NCT01555567|5808667|P1|STARTED|12 Week||12
2366843|NCT01555541|5808681|P1|NOT COMPLETED|Autologous Transplantation||0
2366844|NCT01555541|5808681|P1|COMPLETED|Autologous Transplantation||12
2366845|NCT01555541|5808681|P1|STARTED|Autologous Transplantation||12
2366846|NCT01555541|5808681|P1|NOT COMPLETED|OVA Treatment||0
2366847|NCT01555541|5808681|P1|COMPLETED|OVA Treatment||19
2366848|NCT01555541|5808681|P1|STARTED|OVA Treatment||19
2366849|NCT01555541|5808681|P1|NOT COMPLETED|Salvage Response Assessment||0
2366850|NCT01555541|5808681|P1|COMPLETED|Salvage Response Assessment||19
2366851|NCT01555541|5808681|P1|STARTED|Salvage Response Assessment||19
2366852|NCT01555489|5808688|P1|NOT COMPLETED|Overall Study||0
2366853|NCT01555489|5808688|P1|COMPLETED|Overall Study||11
2366854|NCT01555489|5808688|P1|STARTED|Overall Study||11
2366855|NCT01555463|5808695|P2|NOT COMPLETED|Follow up||45
2366856|NCT01555463|5808696|P1|NOT COMPLETED|Follow up||38
2366857|NCT01555463|5808695|P2|COMPLETED|Follow up||394
2366858|NCT01555463|5808696|P1|COMPLETED|Follow up||409
2366859|NCT01555463|5808695|P2|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|439
2366860|NCT01555463|5808696|P1|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|447
2366861|NCT01555463|5808695|P2|NOT COMPLETED|Treatment||79
2366862|NCT01555463|5808696|P1|NOT COMPLETED|Treatment||64
2366863|NCT01555463|5808695|P2|COMPLETED|Treatment||399
2366864|NCT01555463|5808696|P1|COMPLETED|Treatment||419
2366865|NCT01555463|5808695|P2|STARTED|Treatment||478
2366866|NCT01555463|5808696|P1|STARTED|Treatment||483
2366867|NCT01555164|5808738|P2|NOT COMPLETED|Overall Study||35
2366868|NCT01555164|5808739|P1|NOT COMPLETED|Overall Study||40
2366869|NCT01555164|5808738|P2|COMPLETED|Overall Study||185
2366870|NCT01555164|5808739|P1|COMPLETED|Overall Study||182
2366871|NCT01555164|5808738|P2|STARTED|Overall Study||220
2366872|NCT01555164|5808739|P1|STARTED|Overall Study||222
2366873|NCT01555151|5808753|P4|NOT COMPLETED|Overall Study||10
2366874|NCT01555151|5808754|P3|NOT COMPLETED|Overall Study||6
2366875|NCT01555151|5808755|P2|NOT COMPLETED|Overall Study||8
2366876|NCT01555151|5808756|P1|NOT COMPLETED|Overall Study||13
2366877|NCT01555151|5808753|P4|COMPLETED|Overall Study||176
2366878|NCT01555151|5808754|P3|COMPLETED|Overall Study||178
2366879|NCT01555151|5808755|P2|COMPLETED|Overall Study||173
2366880|NCT01555151|5808756|P1|COMPLETED|Overall Study||175
2366881|NCT01555151|5808753|P4|Safety Set (SAF)|Overall Study||186
2366882|NCT01555151|5808754|P3|Safety Set (SAF)|Overall Study||183
2366883|NCT01555151|5808755|P2|Safety Set (SAF)|Overall Study||180
2366884|NCT01555151|5808756|P1|Safety Set (SAF)|Overall Study||186
2366885|NCT01555151|5808753|P4|STARTED|Overall Study||186
2366886|NCT01555151|5808754|P3|STARTED|Overall Study||184
2366887|NCT01555151|5808755|P2|STARTED|Overall Study||181
2366888|NCT01555151|5808756|P1|STARTED|Overall Study||188
2366889|NCT01555138|5808809|P2|NOT COMPLETED|Overall Study||38
2366890|NCT01555138|5808810|P1|NOT COMPLETED|Overall Study||47
2366891|NCT01555138|5808809|P2|COMPLETED|Overall Study||250
2366892|NCT01555138|5808810|P1|COMPLETED|Overall Study||246
2366893|NCT01555138|5808809|P2|STARTED|Overall Study||288
2366894|NCT01555138|5808810|P1|STARTED|Overall Study||293
2366895|NCT01555125|5808839|P5|NOT COMPLETED|Follow-Up Period||0
2366896|NCT01555125|5808840|P4|NOT COMPLETED|Follow-Up Period||1
2366897|NCT01555125|5808841|P3|NOT COMPLETED|Follow-Up Period||1
2366898|NCT01555125|5808842|P2|NOT COMPLETED|Follow-Up Period||1
2366899|NCT01555125|5808843|P1|NOT COMPLETED|Follow-Up Period||4
2366900|NCT01555125|5808839|P5|COMPLETED|Follow-Up Period||0
2366901|NCT01555125|5808840|P4|COMPLETED|Follow-Up Period||17
2366902|NCT01555125|5808841|P3|COMPLETED|Follow-Up Period||18
2366903|NCT01555125|5808842|P2|COMPLETED|Follow-Up Period||30
2366904|NCT01555125|5808843|P1|COMPLETED|Follow-Up Period||32
2366905|NCT01555125|5808839|P5|STARTED|Follow-Up Period||0
2366906|NCT01555125|5808840|P4|STARTED|Follow-Up Period||18
2366907|NCT01555125|5808841|P3|STARTED|Follow-Up Period||19
2366908|NCT01555125|5808842|P2|STARTED|Follow-Up Period||31
2366909|NCT01555125|5808843|P1|STARTED|Follow-Up Period||36
2366910|NCT01555125|5808839|P5|NOT COMPLETED|Extension||0
2366911|NCT01555125|5808840|P4|NOT COMPLETED|Extension||22
2366912|NCT01555125|5808841|P3|NOT COMPLETED|Extension||23
2366913|NCT01555125|5808842|P2|NOT COMPLETED|Extension||51
2366914|NCT01555125|5808843|P1|NOT COMPLETED|Extension||45
2366915|NCT01555125|5808839|P5|COMPLETED|Extension||0
2366916|NCT01555125|5808840|P4|COMPLETED|Extension||1
2366917|NCT01555125|5808841|P3|COMPLETED|Extension||0
2366918|NCT01555125|5808842|P2|COMPLETED|Extension||0
2366919|NCT01555125|5808843|P1|COMPLETED|Extension||1
2366920|NCT01555125|5808839|P5|STARTED|Extension||0
2366921|NCT01555125|5808840|P4|STARTED|Extension||23
2366922|NCT01555125|5808841|P3|STARTED|Extension||23
2366923|NCT01555125|5808842|P2|STARTED|Extension||51
2366924|NCT01555125|5808843|P1|STARTED|Extension||46
2366925|NCT01555125|5808839|P5|NOT COMPLETED|Maintenance Period||0
2366926|NCT01555125|5808840|P4|NOT COMPLETED|Maintenance Period||2
2366927|NCT01555125|5808841|P3|NOT COMPLETED|Maintenance Period||4
2366928|NCT01555125|5808842|P2|NOT COMPLETED|Maintenance Period||4
2366929|NCT01555125|5808843|P1|NOT COMPLETED|Maintenance Period||10
2366930|NCT01555125|5808839|P5|COMPLETED|Maintenance Period||0
2366931|NCT01555125|5808840|P4|COMPLETED|Maintenance Period||25
2366932|NCT01555125|5808841|P3|COMPLETED|Maintenance Period||25
2366933|NCT01555125|5808842|P2|COMPLETED|Maintenance Period||52
2366934|NCT01555125|5808843|P1|COMPLETED|Maintenance Period||48
2366935|NCT01555125|5808839|P5|STARTED|Maintenance Period||0
2366936|NCT01555125|5808840|P4|STARTED|Maintenance Period||27
2366937|NCT01555125|5808841|P3|STARTED|Maintenance Period||29
2366938|NCT01555125|5808842|P2|STARTED|Maintenance Period||56
2366939|NCT01555125|5808843|P1|STARTED|Maintenance Period||58
2366940|NCT01555125|5808839|P5|NOT COMPLETED|Induction Period||3
2366941|NCT01555125|5808840|P4|NOT COMPLETED|Induction Period||0
2366942|NCT01555125|5808841|P3|NOT COMPLETED|Induction Period||0
2366943|NCT01555125|5808842|P2|NOT COMPLETED|Induction Period||3
2366944|NCT01555125|5808843|P1|NOT COMPLETED|Induction Period||1
2366945|NCT01555125|5808839|P5|COMPLETED|Induction Period||56
2366946|NCT01555125|5808840|P4|COMPLETED|Induction Period||0
2366947|NCT01555125|5808841|P3|COMPLETED|Induction Period||0
2366948|NCT01555125|5808842|P2|COMPLETED|Induction Period||56
2366949|NCT01555125|5808843|P1|COMPLETED|Induction Period||58
2366950|NCT01555125|5808839|P5|STARTED|Induction Period||59
2366951|NCT01555125|5808840|P4|STARTED|Induction Period||0
2366952|NCT01555125|5808841|P3|STARTED|Induction Period||0
2366953|NCT01555125|5808842|P2|STARTED|Induction Period||59
2366954|NCT01555125|5808843|P1|STARTED|Induction Period||59
2366955|NCT01555073|5808936|P4|NOT COMPLETED|Overall Study||5
2366956|NCT01555073|5808937|P3|NOT COMPLETED|Overall Study||0
2366957|NCT01555073|5808938|P2|NOT COMPLETED|Overall Study||2
2366958|NCT01555073|5808939|P1|NOT COMPLETED|Overall Study||1
2366959|NCT01555073|5808936|P4|COMPLETED|Overall Study||1
2366960|NCT01555073|5808937|P3|COMPLETED|Overall Study||7
2366961|NCT01555073|5808938|P2|COMPLETED|Overall Study||1
2366962|NCT01555073|5808939|P1|COMPLETED|Overall Study||6
2366963|NCT01555073|5808936|P4|STARTED|Overall Study||6
2366964|NCT01555073|5808937|P3|STARTED|Overall Study||7
2366965|NCT01555073|5808938|P2|STARTED|Overall Study||3
2366966|NCT01555073|5808939|P1|STARTED|Overall Study||7
2366967|NCT01555021|5808955|P2|NOT COMPLETED|Overall Study||2
2366968|NCT01555021|5808956|P1|NOT COMPLETED|Overall Study||1
2366969|NCT01555021|5808955|P2|COMPLETED|Overall Study|None of the AGT subjects competed month 1, month 3, or month 6 follow up visits.|0
2366970|NCT01555021|5808956|P1|COMPLETED|Overall Study|One treatment as usual subject completed 1 month, 3 month, and 6 month follow up visits|1
2366971|NCT01555021|5808955|P2|STARTED|Overall Study||2
2366972|NCT01555021|5808956|P1|STARTED|Overall Study||2
2366973|NCT01554982|5808968|P1|NOT COMPLETED|Overall Study||43
2366974|NCT01554982|5808968|P1|COMPLETED|Overall Study||125
2366975|NCT01554982|5808968|P1|Received Drug|Overall Study||166
2366976|NCT01554982|5808968|P1|STARTED|Overall Study||168
2366977|NCT01554904|5808981|P1|NOT COMPLETED|Overall Study||4
2366978|NCT01554904|5808981|P1|COMPLETED|Overall Study||14
2366979|NCT01554904|5808981|P1|Home Sleep Study 2|Overall Study||14
2366980|NCT01554904|5808981|P1|Complete 6 Weeks of Facial Training|Overall Study|3 subjects withdrew during training|14
2366981|NCT01554904|5808981|P1|Start 6 Weeks of Facial Training|Overall Study|1 participant was found to have obstructive sleep apnea on the home sleep study #1|17
2366982|NCT01554904|5808981|P1|Home Sleep Study 1|Overall Study|After informed consent signed.|18
2366983|NCT01554904|5808981|P1|STARTED|Overall Study||18
2366984|NCT01554891|5808989|P3|NOT COMPLETED|Overall Study||2
2366985|NCT01554891|5808990|P2|NOT COMPLETED|Overall Study||5
2366986|NCT01554891|5808991|P1|NOT COMPLETED|Overall Study||7
2366987|NCT01554891|5808989|P3|COMPLETED|Overall Study||55
2366988|NCT01554891|5808990|P2|COMPLETED|Overall Study||115
2366989|NCT01554891|5808991|P1|COMPLETED|Overall Study||98
2366990|NCT01554891|5808989|P3|STARTED|Overall Study||57
2366991|NCT01554891|5808990|P2|STARTED|Overall Study||120
2366992|NCT01554891|5808991|P1|STARTED|Overall Study||105
2366993|NCT01554579|5809001|P2|NOT COMPLETED|Overall Study||27
2366994|NCT01554579|5809002|P1|NOT COMPLETED|Overall Study||10
2366995|NCT01554579|5809001|P2|COMPLETED|Overall Study||58
2366996|NCT01554579|5809002|P1|COMPLETED|Overall Study||76
2366997|NCT01554579|5809001|P2|STARTED|Overall Study||85
2366998|NCT01554579|5809002|P1|STARTED|Overall Study||86
2366999|NCT01554527|5809015|P3|NOT COMPLETED|Overall Study||8
2367000|NCT01554527|5809016|P2|NOT COMPLETED|Overall Study||0
2367001|NCT01554527|5809017|P1|NOT COMPLETED|Overall Study||1
2367002|NCT01554527|5809015|P3|COMPLETED|Overall Study||25
2367003|NCT01554527|5809016|P2|COMPLETED|Overall Study||38
2367004|NCT01554527|5809017|P1|COMPLETED|Overall Study||33
2367005|NCT01554527|5809015|P3|Completed as a Control|Overall Study||1
2367006|NCT01554527|5809016|P2|Completed as a Control|Overall Study||0
2367007|NCT01554527|5809017|P1|Completed as a Control|Overall Study||33
2367008|NCT01554527|5809015|P3|Initiated CPAP Treatment at Home|Overall Study||28
2367009|NCT01554527|5809016|P2|Initiated CPAP Treatment at Home|Overall Study||38
2367010|NCT01554527|5809017|P1|Initiated CPAP Treatment at Home|Overall Study||0
2367011|NCT01554527|5809015|P3|Had CPAP Titration|Overall Study||30
2367012|NCT01554527|5809016|P2|Had CPAP Titration|Overall Study||38
2367013|NCT01554527|5809017|P1|Had CPAP Titration|Overall Study|No control group members received CPAP (definitionally)|0
2367014|NCT01554527|5809015|P3|Crossed Over to Control|Overall Study||2
2367015|NCT01554527|5809016|P2|Crossed Over to Control|Overall Study||0
2367016|NCT01554527|5809017|P1|Crossed Over to Control|Overall Study||0
2367017|NCT01554527|5809015|P3|STARTED|Overall Study||33
2367018|NCT01554527|5809016|P2|STARTED|Overall Study||38
2367019|NCT01554527|5809017|P1|STARTED|Overall Study||34
2367020|NCT01554488|5809046|P2|NOT COMPLETED|Overall Study||3
2367021|NCT01554488|5809047|P1|NOT COMPLETED|Overall Study||1
2367022|NCT01554488|5809046|P2|COMPLETED|Overall Study||9
2367023|NCT01554488|5809047|P1|COMPLETED|Overall Study||12
2367024|NCT01554488|5809046|P2|STARTED|Overall Study||12
2367025|NCT01554488|5809047|P1|STARTED|Overall Study||13
2367026|NCT01554241|5809073|P4|NOT COMPLETED|Overall Study||1
2367027|NCT01554241|5809074|P3|NOT COMPLETED|Overall Study||4
2367028|NCT01554241|5809075|P2|NOT COMPLETED|Overall Study||1
2367029|NCT01554241|5809076|P1|NOT COMPLETED|Overall Study||3
2367030|NCT01554241|5809073|P4|COMPLETED|Overall Study||13
2367031|NCT01554241|5809074|P3|COMPLETED|Overall Study||20
2367032|NCT01554241|5809075|P2|COMPLETED|Overall Study||19
2367033|NCT01554241|5809076|P1|COMPLETED|Overall Study||20
2367034|NCT01554241|5809073|P4|STARTED|Overall Study||14
2367035|NCT01554241|5809074|P3|STARTED|Overall Study||24
2367036|NCT01554241|5809075|P2|STARTED|Overall Study||20
2367037|NCT01554241|5809076|P1|STARTED|Overall Study||23
2367038|NCT01554176|5809092|P5|NOT COMPLETED|Run-out Phase||0
2367039|NCT01554176|5809093|P4|NOT COMPLETED|Run-out Phase||1
2367040|NCT01554176|5809094|P3|NOT COMPLETED|Run-out Phase||0
2367041|NCT01554176|5809095|P2|NOT COMPLETED|Run-out Phase||0
2367042|NCT01554176|5809096|P1|NOT COMPLETED|Run-out Phase||0
2367043|NCT01554176|5809092|P5|COMPLETED|Run-out Phase||59
2367044|NCT01554176|5809093|P4|COMPLETED|Run-out Phase||27
2367045|NCT01554176|5809094|P3|COMPLETED|Run-out Phase||29
2367046|NCT01554176|5809095|P2|COMPLETED|Run-out Phase||0
2367047|NCT01554176|5809096|P1|COMPLETED|Run-out Phase||0
2367048|NCT01554176|5809092|P5|Treated|Run-out Phase||59
2367049|NCT01554176|5809093|P4|Treated|Run-out Phase||28
2367050|NCT01554176|5809094|P3|Treated|Run-out Phase||29
2367051|NCT01554176|5809095|P2|Treated|Run-out Phase||0
2367052|NCT01554176|5809096|P1|Treated|Run-out Phase||0
2367053|NCT01554176|5809092|P5|STARTED|Run-out Phase||59
2367054|NCT01554176|5809093|P4|STARTED|Run-out Phase||28
2367055|NCT01554176|5809094|P3|STARTED|Run-out Phase||29
2367056|NCT01554176|5809095|P2|STARTED|Run-out Phase||0
2367057|NCT01554176|5809096|P1|STARTED|Run-out Phase||0
2367058|NCT01554176|5809092|P5|NOT COMPLETED|Treatment Phase||0
2367059|NCT01554176|5809093|P4|NOT COMPLETED|Treatment Phase||0
2367060|NCT01554176|5809094|P3|NOT COMPLETED|Treatment Phase||0
2367061|NCT01554176|5809095|P2|NOT COMPLETED|Treatment Phase||5
2367062|NCT01554176|5809096|P1|NOT COMPLETED|Treatment Phase||8
2367063|NCT01554176|5809092|P5|COMPLETED|Treatment Phase||0
2367064|NCT01554176|5809093|P4|COMPLETED|Treatment Phase||0
2367065|NCT01554176|5809094|P3|COMPLETED|Treatment Phase||0
2367066|NCT01554176|5809095|P2|COMPLETED|Treatment Phase||59
2367067|NCT01554176|5809096|P1|COMPLETED|Treatment Phase||57
2367068|NCT01554176|5809092|P5|Treated|Treatment Phase||0
2367069|NCT01554176|5809093|P4|Treated|Treatment Phase||0
2367070|NCT01554176|5809094|P3|Treated|Treatment Phase||0
2367071|NCT01554176|5809095|P2|Treated|Treatment Phase||64
2367072|NCT01554176|5809096|P1|Treated|Treatment Phase||64
2367073|NCT01554176|5809092|P5|STARTED|Treatment Phase||0
2367074|NCT01554176|5809093|P4|STARTED|Treatment Phase||0
2367075|NCT01554176|5809094|P3|STARTED|Treatment Phase||0
2367076|NCT01554176|5809095|P2|STARTED|Treatment Phase||64
2367077|NCT01554176|5809096|P1|STARTED|Treatment Phase||65
2367078|NCT01554163|5809123|P2|NOT COMPLETED|Overall Study||10
2367079|NCT01554163|5809124|P1|NOT COMPLETED|Overall Study||8
2367080|NCT01554163|5809123|P2|COMPLETED|Overall Study||109
2367081|NCT01554163|5809124|P1|COMPLETED|Overall Study||112
2367082|NCT01554163|5809123|P2|Number Treated|Overall Study||119
2367083|NCT01554163|5809124|P1|Number Treated|Overall Study||119
2367084|NCT01554163|5809123|P2|STARTED|Overall Study||119
2367085|NCT01554163|5809124|P1|STARTED|Overall Study||120
2367086|NCT01553916|5809142|P1|NOT COMPLETED|Overall Study||3
2367087|NCT01553916|5809142|P1|COMPLETED|Overall Study||16
2367088|NCT01553916|5809142|P1|STARTED|Overall Study||19
2367089|NCT01553851|5809159|P1|NOT COMPLETED|Overall Study||3
2367090|NCT01553851|5809159|P1|COMPLETED|Overall Study||17
2367091|NCT01553851|5809159|P1|STARTED|Overall Study||20
2367092|NCT01553747|5809174|P3|NOT COMPLETED|Overall Study||109
2367093|NCT01553747|5809175|P2|NOT COMPLETED|Overall Study||119
2367094|NCT01553747|5809176|P1|NOT COMPLETED|Overall Study||131
2367095|NCT01553747|5809174|P3|COMPLETED|Overall Study||273
2367096|NCT01553747|5809175|P2|COMPLETED|Overall Study||264
2367097|NCT01553747|5809176|P1|COMPLETED|Overall Study||250
2367098|NCT01553747|5809174|P3|Participated in Blinded-Placebo Period|Overall Study||272
2367099|NCT01553747|5809175|P2|Participated in Blinded-Placebo Period|Overall Study||253
2367100|NCT01553747|5809176|P1|Participated in Blinded-Placebo Period|Overall Study||246
2367101|NCT01553747|5809174|P3|Attended Week 26 Visit|Overall Study||278
2367102|NCT01553747|5809175|P2|Attended Week 26 Visit|Overall Study||271
2367103|NCT01553747|5809176|P1|Attended Week 26 Visit|Overall Study||259
2367104|NCT01553747|5809174|P3|Attended Week 12 Visit|Overall Study||312
2367105|NCT01553747|5809175|P2|Attended Week 12 Visit|Overall Study||301
2367106|NCT01553747|5809176|P1|Attended Week 12 Visit|Overall Study||296
2367107|NCT01553747|5809174|P3|STARTED|Overall Study||382
2367108|NCT01553747|5809175|P2|STARTED|Overall Study||383
2367109|NCT01553747|5809176|P1|STARTED|Overall Study||381
2367110|NCT01553708|5809228|P2|NOT COMPLETED|Overall Study||0
2367111|NCT01553708|5809229|P1|NOT COMPLETED|Overall Study||0
2367112|NCT01553708|5809228|P2|COMPLETED|Overall Study||17
2367113|NCT01553708|5809229|P1|COMPLETED|Overall Study||17
2367114|NCT01553708|5809228|P2|STARTED|Overall Study||17
2367115|NCT01553708|5809229|P1|STARTED|Overall Study||17
2367116|NCT01553591|5809238|P3|NOT COMPLETED|Overall Study||158
2367117|NCT01553591|5809239|P2|NOT COMPLETED|Overall Study||169
2367118|NCT01553591|5809240|P1|NOT COMPLETED|Overall Study||172
2367119|NCT01553591|5809238|P3|COMPLETED|Overall Study||269
2367120|NCT01553591|5809239|P2|COMPLETED|Overall Study||257
2367121|NCT01553591|5809240|P1|COMPLETED|Overall Study||257
2367122|NCT01553591|5809238|P3|Attended Week 26 Visit|Overall Study||290
2367123|NCT01553591|5809239|P2|Attended Week 26 Visit|Overall Study||291
2367124|NCT01553591|5809240|P1|Attended Week 26 Visit|Overall Study||289
2367125|NCT01553591|5809238|P3|Attended Week 12 Visit|Overall Study||342
2367126|NCT01553591|5809239|P2|Attended Week 12 Visit|Overall Study||330
2367127|NCT01553591|5809240|P1|Attended Week 12 Visit|Overall Study||341
2367128|NCT01553591|5809238|P3|STARTED|Overall Study||427
2367129|NCT01553591|5809239|P2|STARTED|Overall Study||426
2367130|NCT01553591|5809240|P1|STARTED|Overall Study||429
2367131|NCT01553539|5809290|P1|NOT COMPLETED|Overall Study||0
2367132|NCT01553539|5809290|P1|COMPLETED|Overall Study||20
2367133|NCT01553539|5809290|P1|STARTED|Overall Study||20
2367134|NCT01553318|5809300|P2|NOT COMPLETED|Overall Study||2
2367135|NCT01553318|5809301|P1|NOT COMPLETED|Overall Study||3
2367136|NCT01553318|5809300|P2|COMPLETED|Overall Study||25
2367137|NCT01553318|5809301|P1|COMPLETED|Overall Study||21
2367138|NCT01553318|5809300|P2|STARTED|Overall Study||27
2367139|NCT01553318|5809301|P1|STARTED|Overall Study||24
2367140|NCT01553292|5809313|P1|NOT COMPLETED|Overall Study||0
2367141|NCT01553292|5809313|P1|COMPLETED|Overall Study||21
2367142|NCT01553292|5809313|P1|STARTED|Overall Study||21
2367143|NCT01553279|5809331|P2|NOT COMPLETED|Period 2: Toddler Vaccinations||7
2367144|NCT01553279|5809332|P1|NOT COMPLETED|Period 2: Toddler Vaccinations||3
2367145|NCT01553279|5809331|P2|COMPLETED|Period 2: Toddler Vaccinations||132
2367146|NCT01553279|5809332|P1|COMPLETED|Period 2: Toddler Vaccinations||134
2367147|NCT01553279|5809331|P2|STARTED|Period 2: Toddler Vaccinations||139
2367148|NCT01553279|5809332|P1|STARTED|Period 2: Toddler Vaccinations||137
2367149|NCT01553279|5809331|P2|NOT COMPLETED|Interim Period||2
2367150|NCT01553279|5809332|P1|NOT COMPLETED|Interim Period||3
2367151|NCT01553279|5809331|P2|COMPLETED|Interim Period||139
2367152|NCT01553279|5809332|P1|COMPLETED|Interim Period||137
2367153|NCT01553279|5809331|P2|STARTED|Interim Period||141
2367154|NCT01553279|5809332|P1|STARTED|Interim Period||140
2367155|NCT01553279|5809331|P2|NOT COMPLETED|Part 1 (Infant Vaccinations)||1
2367156|NCT01553279|5809332|P1|NOT COMPLETED|Part 1 (Infant Vaccinations)||2
2367157|NCT01553279|5809331|P2|COMPLETED|Part 1 (Infant Vaccinations)||141
2367158|NCT01553279|5809332|P1|COMPLETED|Part 1 (Infant Vaccinations)||140
2367159|NCT01553279|5809331|P2|STARTED|Part 1 (Infant Vaccinations)||142
2367160|NCT01553279|5809332|P1|STARTED|Part 1 (Infant Vaccinations)||142
2367161|NCT01553240|5809389|P1|NOT COMPLETED|Overall Study||0
2367162|NCT01553240|5809389|P1|COMPLETED|Overall Study||0
2367163|NCT01553240|5809389|P1|STARTED|Overall Study||0
2367164|NCT01553188|5809398|P4|NOT COMPLETED|Overall Study||0
2367165|NCT01553188|5809399|P3|NOT COMPLETED|Overall Study||2
2367166|NCT01553188|5809400|P2|NOT COMPLETED|Overall Study||1
2367167|NCT01553188|5809401|P1|NOT COMPLETED|Overall Study||1
2367168|NCT01553188|5809398|P4|COMPLETED|Overall Study||11
2367169|NCT01553188|5809399|P3|COMPLETED|Overall Study||14
2367170|NCT01553188|5809400|P2|COMPLETED|Overall Study||5
2367171|NCT01553188|5809401|P1|COMPLETED|Overall Study||2
2367172|NCT01553188|5809398|P4|STARTED|Overall Study||11
2367173|NCT01553188|5809399|P3|STARTED|Overall Study||16
2367174|NCT01553188|5809400|P2|STARTED|Overall Study||6
2367175|NCT01553188|5809401|P1|STARTED|Overall Study||3
2367176|NCT01553136|5809428|P2|NOT COMPLETED|Overall Study||22
2367177|NCT01553136|5809429|P1|NOT COMPLETED|Overall Study||16
2367178|NCT01553136|5809428|P2|COMPLETED|Overall Study||45
2367179|NCT01553136|5809429|P1|COMPLETED|Overall Study||48
2367180|NCT01553136|5809428|P2|Completed Treatment|Overall Study||52
2367181|NCT01553136|5809429|P1|Completed Treatment|Overall Study||55
2367182|NCT01553136|5809428|P2|STARTED|Overall Study||67
2367183|NCT01553136|5809429|P1|STARTED|Overall Study||64
2367184|NCT01553084|5809446|P3|NOT COMPLETED|Overall Study||35
2367185|NCT01553084|5809447|P2|NOT COMPLETED|Overall Study||13
2367186|NCT01553084|5809448|P1|NOT COMPLETED|Overall Study||15
2367187|NCT01553084|5809446|P3|COMPLETED|Overall Study||389
2367188|NCT01553084|5809447|P2|COMPLETED|Overall Study||408
2367189|NCT01553084|5809448|P1|COMPLETED|Overall Study||226
2367190|NCT01553084|5809446|P3|STARTED|Overall Study||424
2367191|NCT01553084|5809447|P2|STARTED|Overall Study||421
2367192|NCT01553084|5809448|P1|STARTED|Overall Study||241
2367193|NCT01553058|5809467|P3|NOT COMPLETED|Overall Study||3
2367194|NCT01553058|5809468|P2|NOT COMPLETED|Overall Study||1
2367195|NCT01553058|5809469|P1|NOT COMPLETED|Overall Study||1
2367196|NCT01553058|5809467|P3|COMPLETED|Overall Study||30
2367197|NCT01553058|5809468|P2|COMPLETED|Overall Study||30
2367198|NCT01553058|5809469|P1|COMPLETED|Overall Study||32
2367199|NCT01553058|5809467|P3|STARTED|Overall Study||33
2367200|NCT01553058|5809468|P2|STARTED|Overall Study||31
2367201|NCT01553058|5809469|P1|STARTED|Overall Study||33
2367202|NCT01552954|5809530|P2|NOT COMPLETED|Overall Study||6
2367203|NCT01552954|5809531|P1|NOT COMPLETED|Overall Study||5
2367204|NCT01552954|5809530|P2|COMPLETED|Overall Study||119
2367205|NCT01552954|5809531|P1|COMPLETED|Overall Study||126
2367206|NCT01552954|5809530|P2|STARTED|Overall Study||125
2367207|NCT01552954|5809531|P1|STARTED|Overall Study|A total of 13 patients were withdrawn from 269 patients. The remained 256 patients were randomized.|131
2367208|NCT01552928|5809547|P4|NOT COMPLETED|Period 4||0
2367209|NCT01552928|5809548|P3|NOT COMPLETED|Period 4||0
2367210|NCT01552928|5809549|P2|NOT COMPLETED|Period 4||0
2367211|NCT01552928|5809550|P1|NOT COMPLETED|Period 4||0
2367212|NCT01552928|5809547|P4|COMPLETED|Period 4||16
2367213|NCT01552928|5809548|P3|COMPLETED|Period 4||14
2367214|NCT01552928|5809549|P2|COMPLETED|Period 4||15
2367215|NCT01552928|5809550|P1|COMPLETED|Period 4||14
2367216|NCT01552928|5809547|P4|STARTED|Period 4||16
2367217|NCT01552928|5809548|P3|STARTED|Period 4||14
2367218|NCT01552928|5809549|P2|STARTED|Period 4||15
2367219|NCT01552928|5809550|P1|STARTED|Period 4||14
2367220|NCT01552928|5809547|P4|NOT COMPLETED|Period 3||0
2367221|NCT01552928|5809548|P3|NOT COMPLETED|Period 3||1
2367222|NCT01552928|5809549|P2|NOT COMPLETED|Period 3||0
2367223|NCT01552928|5809550|P1|NOT COMPLETED|Period 3||0
2367224|NCT01552928|5809547|P4|COMPLETED|Period 3||16
2367225|NCT01552928|5809548|P3|COMPLETED|Period 3||14
2367226|NCT01552928|5809549|P2|COMPLETED|Period 3||15
2367227|NCT01552928|5809550|P1|COMPLETED|Period 3||14
2367228|NCT01552928|5809547|P4|STARTED|Period 3||16
2367229|NCT01552928|5809548|P3|STARTED|Period 3||15
2367230|NCT01552928|5809549|P2|STARTED|Period 3||15
2367231|NCT01552928|5809550|P1|STARTED|Period 3||14
2367232|NCT01552928|5809547|P4|NOT COMPLETED|Period 2||0
2367233|NCT01552928|5809548|P3|NOT COMPLETED|Period 2||0
2367234|NCT01552928|5809549|P2|NOT COMPLETED|Period 2||0
2367235|NCT01552928|5809550|P1|NOT COMPLETED|Period 2||0
2367236|NCT01552928|5809547|P4|COMPLETED|Period 2||16
2367237|NCT01552928|5809548|P3|COMPLETED|Period 2||15
2367238|NCT01552928|5809549|P2|COMPLETED|Period 2||15
2367239|NCT01552928|5809550|P1|COMPLETED|Period 2||14
2367240|NCT01552928|5809547|P4|STARTED|Period 2||16
2367241|NCT01552928|5809548|P3|STARTED|Period 2||15
2367242|NCT01552928|5809549|P2|STARTED|Period 2||15
2367243|NCT01552928|5809550|P1|STARTED|Period 2||14
2367244|NCT01552928|5809547|P4|NOT COMPLETED|Period 1||0
2367245|NCT01552928|5809548|P3|NOT COMPLETED|Period 1||0
2367246|NCT01552928|5809549|P2|NOT COMPLETED|Period 1||0
2367247|NCT01552928|5809550|P1|NOT COMPLETED|Period 1||0
2367248|NCT01552928|5809547|P4|COMPLETED|Period 1||16
2367249|NCT01552928|5809548|P3|COMPLETED|Period 1||15
2367250|NCT01552928|5809549|P2|COMPLETED|Period 1||15
2367251|NCT01552928|5809550|P1|COMPLETED|Period 1||14
2367252|NCT01552928|5809547|P4|STARTED|Period 1||16
2367253|NCT01552928|5809548|P3|STARTED|Period 1||15
2367254|NCT01552928|5809549|P2|STARTED|Period 1||15
2367255|NCT01552928|5809550|P1|STARTED|Period 1||14
2367256|NCT01552915|5809597|P3|NOT COMPLETED|Overall Study||27
2367257|NCT01552915|5809598|P2|NOT COMPLETED|Overall Study||29
2367258|NCT01552915|5809599|P1|NOT COMPLETED|Overall Study||23
2367259|NCT01552915|5809597|P3|COMPLETED|Overall Study||157
2367260|NCT01552915|5809598|P2|COMPLETED|Overall Study||155
2367261|NCT01552915|5809599|P1|COMPLETED|Overall Study||68
2367262|NCT01552915|5809597|P3|STARTED|Overall Study|This population is from the Safety Set. One randomized subject was not dosed and was excluded.|184
2367263|NCT01552915|5809598|P2|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|184
2367264|NCT01552915|5809599|P1|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|91
2367265|NCT01552902|5809622|P3|NOT COMPLETED|Overall Study||33
2367266|NCT01552902|5809623|P2|NOT COMPLETED|Overall Study||37
2367267|NCT01552902|5809624|P1|NOT COMPLETED|Overall Study||13
2367268|NCT01552902|5809622|P3|COMPLETED|Overall Study||186
2367269|NCT01552902|5809623|P2|COMPLETED|Overall Study||181
2367270|NCT01552902|5809624|P1|COMPLETED|Overall Study||97
2367271|NCT01552902|5809622|P3|STARTED|Overall Study||219
2367272|NCT01552902|5809623|P2|STARTED|Overall Study||218
2367273|NCT01552902|5809624|P1|STARTED|Overall Study||110
2367274|NCT01552889|5809646|P2|NOT COMPLETED|Overall Study||5
2367275|NCT01552889|5809647|P1|NOT COMPLETED|Overall Study||11
2367276|NCT01552889|5809646|P2|COMPLETED|Overall Study||95
2367277|NCT01552889|5809647|P1|COMPLETED|Overall Study||90
2367278|NCT01552889|5809646|P2|STARTED|Overall Study||100
2367279|NCT01552889|5809647|P1|STARTED|Overall Study||101
2367280|NCT01552876|5809657|P2|NOT COMPLETED|Overall Study||0
2367281|NCT01552876|5809658|P1|NOT COMPLETED|Overall Study||0
2367282|NCT01552876|5809657|P2|COMPLETED|Overall Study||20
2367283|NCT01552876|5809658|P1|COMPLETED|Overall Study||20
2367284|NCT01552876|5809657|P2|STARTED|Overall Study||20
2367285|NCT01552876|5809658|P1|STARTED|Overall Study||20
2367286|NCT01552772|5809674|P1|NOT COMPLETED|Overall Study||4
2367287|NCT01552772|5809674|P1|COMPLETED|Overall Study|Participants who completed the Day 28 visit were defined as completers for the trial.|56
2367288|NCT01552772|5809674|P1|STARTED|Overall Study||60
2367289|NCT01552694|5809690|P2|NOT COMPLETED|Overall Study||2
2367290|NCT01552694|5809691|P1|NOT COMPLETED|Overall Study||0
2367291|NCT01552694|5809690|P2|COMPLETED|Overall Study||18
2367292|NCT01552694|5809691|P1|COMPLETED|Overall Study||18
2367293|NCT01552694|5809690|P2|STARTED|Overall Study||20
2367294|NCT01552694|5809691|P1|STARTED|Overall Study||18
2367295|NCT01552681|5809707|P2|NOT COMPLETED|Overall Study||1
2367296|NCT01552681|5809708|P1|NOT COMPLETED|Overall Study||5
2367297|NCT01552681|5809707|P2|COMPLETED|Overall Study||18
2367298|NCT01552681|5809708|P1|COMPLETED|Overall Study||28
2367299|NCT01552681|5809707|P2|STARTED|Overall Study||19
2367300|NCT01552681|5809708|P1|STARTED|Overall Study||33
2367301|NCT01552603|5809756|P1|NOT COMPLETED|Overall Study||1
2367302|NCT01552603|5809756|P1|COMPLETED|Overall Study||13
2367303|NCT01552603|5809756|P1|STARTED|Overall Study||14
2367304|NCT01552408|5809763|P2|NOT COMPLETED|Overall Study||2
2367305|NCT01552408|5809764|P1|NOT COMPLETED|Overall Study||4
2367306|NCT01552408|5809763|P2|COMPLETED|Overall Study||18
2367307|NCT01552408|5809764|P1|COMPLETED|Overall Study||16
2367308|NCT01552408|5809763|P2|STARTED|Overall Study||20
2367309|NCT01552408|5809764|P1|STARTED|Overall Study||20
2367310|NCT01552369|5809786|P2|NOT COMPLETED|Overall Study||9
2367311|NCT01552369|5809787|P1|NOT COMPLETED|Overall Study||8
2367312|NCT01552369|5809786|P2|COMPLETED|Overall Study||96
2367313|NCT01552369|5809787|P1|COMPLETED|Overall Study||92
2367314|NCT01552369|5809786|P2|Final Follow up|Overall Study||96
2367315|NCT01552369|5809787|P1|Final Follow up|Overall Study||92
2367316|NCT01552369|5809786|P2|One Year|Overall Study||105
2367317|NCT01552369|5809787|P1|One Year|Overall Study||100
2367318|NCT01552369|5809786|P2|STARTED|Overall Study||105
2367319|NCT01552369|5809787|P1|STARTED|Overall Study||100
2367320|NCT01552343|5809815|P2|NOT COMPLETED|Overall Study||0
2367321|NCT01552343|5809816|P1|NOT COMPLETED|Overall Study||0
2367322|NCT01552343|5809815|P2|COMPLETED|Overall Study||27
2367323|NCT01552343|5809816|P1|COMPLETED|Overall Study||29
2367324|NCT01552343|5809815|P2|STARTED|Overall Study||27
2367325|NCT01552343|5809816|P1|STARTED|Overall Study||29
2367326|NCT01552213|5809839|P2|NOT COMPLETED|Overall Study||8
2367327|NCT01552213|5809840|P1|NOT COMPLETED|Overall Study||13
2367328|NCT01552213|5809839|P2|COMPLETED|Overall Study||37
2367329|NCT01552213|5809840|P1|COMPLETED|Overall Study||37
2367330|NCT01552213|5809839|P2|Analyzed|Overall Study||41
2367331|NCT01552213|5809840|P1|Analyzed|Overall Study||42
2367332|NCT01552213|5809839|P2|STARTED|Overall Study||45
2367333|NCT01552213|5809840|P1|STARTED|Overall Study||50
2367334|NCT01552057|5809876|P2|NOT COMPLETED|Overall Study||48
2367335|NCT01552057|5809877|P1|NOT COMPLETED|Overall Study||30
2367336|NCT01552057|5809876|P2|COMPLETED|Overall Study||149
2367337|NCT01552057|5809877|P1|COMPLETED|Overall Study||166
2367338|NCT01552057|5809876|P2|Received at Least 1 Dose of Study Drug|Overall Study||196
2367339|NCT01552057|5809877|P1|Received at Least 1 Dose of Study Drug|Overall Study||194
2367340|NCT01552057|5809876|P2|STARTED|Overall Study||197
2367341|NCT01552057|5809877|P1|STARTED|Overall Study||196
2367342|NCT01551979|5809911|P2|NOT COMPLETED|Overall Study||2
2367343|NCT01551979|5809912|P1|NOT COMPLETED|Overall Study||2
2367344|NCT01551979|5809911|P2|COMPLETED|Overall Study||5
2367345|NCT01551979|5809912|P1|COMPLETED|Overall Study||8
2367346|NCT01551979|5809911|P2|1 Week Post Treatment|Overall Study||6
2367347|NCT01551979|5809912|P1|1 Week Post Treatment|Overall Study||10
2367348|NCT01551979|5809911|P2|Last Day of Treatment (After 5 Days)|Overall Study||7
2367349|NCT01551979|5809912|P1|Last Day of Treatment (After 5 Days)|Overall Study||10
2367350|NCT01551979|5809911|P2|STARTED|Overall Study||7
2367351|NCT01551979|5809912|P1|STARTED|Overall Study||10
2367352|NCT01551888|5809928|P2|NOT COMPLETED|Period 2||0
2367353|NCT01551888|5809929|P1|NOT COMPLETED|Period 2||0
2367354|NCT01551888|5809928|P2|COMPLETED|Period 2||12
2367355|NCT01551888|5809929|P1|COMPLETED|Period 2||12
2367356|NCT01551888|5809928|P2|STARTED|Period 2||12
2367357|NCT01551888|5809929|P1|STARTED|Period 2||12
2367358|NCT01551888|5809928|P2|NOT COMPLETED|Period 1||0
2367359|NCT01551888|5809929|P1|NOT COMPLETED|Period 1||0
2367360|NCT01551888|5809928|P2|COMPLETED|Period 1||12
2367361|NCT01551888|5809929|P1|COMPLETED|Period 1||12
2367362|NCT01551888|5809928|P2|STARTED|Period 1||12
2367363|NCT01551888|5809929|P1|STARTED|Period 1||12
2367364|NCT01551758|5809943|P2|NOT COMPLETED|Overall Study||105
2367365|NCT01551758|5809944|P1|NOT COMPLETED|Overall Study||94
2367366|NCT01551758|5809943|P2|COMPLETED|Overall Study||1291
2367367|NCT01551758|5809944|P1|COMPLETED|Overall Study||1309
2367368|NCT01551758|5809943|P2|STARTED|Overall Study||1396
2367369|NCT01551758|5809944|P1|STARTED|Overall Study||1403
2367370|NCT01551745|5809982|P1|NOT COMPLETED|Overall Study||3
2367462|NCT01551056|5810131|P2|NOT COMPLETED|Overall Study||0
2367371|NCT01551745|5809982|P1|COMPLETED|Overall Study|"Completed means subject had been given all manufactured doses"|2
2367372|NCT01551745|5809982|P1|STARTED|Overall Study||5
2367373|NCT01551693|5809991|P2|NOT COMPLETED|Overall Study||2
2367374|NCT01551693|5809992|P1|NOT COMPLETED|Overall Study||1
2367375|NCT01551693|5809991|P2|COMPLETED|Overall Study||0
2367376|NCT01551693|5809992|P1|COMPLETED|Overall Study||0
2367377|NCT01551693|5809991|P2|STARTED|Overall Study||2
2367378|NCT01551693|5809992|P1|STARTED|Overall Study||1
2367379|NCT01551550|5810004|P2|NOT COMPLETED|Overall Study||1
2367380|NCT01551550|5810005|P1|NOT COMPLETED|Overall Study||0
2367381|NCT01551550|5810004|P2|COMPLETED|Overall Study||40
2367382|NCT01551550|5810005|P1|COMPLETED|Overall Study||41
2367383|NCT01551550|5810004|P2|STARTED|Overall Study||41
2367384|NCT01551550|5810005|P1|STARTED|Overall Study||41
2367385|NCT01551420|5810013|P2|NOT COMPLETED|Home Use (Part B)||1
2367386|NCT01551420|5810014|P1|NOT COMPLETED|Home Use (Part B)||6
2367387|NCT01551420|5810013|P2|COMPLETED|Home Use (Part B)||7
2367388|NCT01551420|5810014|P1|COMPLETED|Home Use (Part B)||18
2367389|NCT01551420|5810013|P2|STARTED|Home Use (Part B)||8
2367390|NCT01551420|5810014|P1|STARTED|Home Use (Part B)||24
2367391|NCT01551420|5810013|P2|NOT COMPLETED|Screened for Part B Eligibility||3
2367392|NCT01551420|5810014|P1|NOT COMPLETED|Screened for Part B Eligibility||9
2367393|NCT01551420|5810013|P2|COMPLETED|Screened for Part B Eligibility||8
2367394|NCT01551420|5810014|P1|COMPLETED|Screened for Part B Eligibility||24
2367395|NCT01551420|5810013|P2|STARTED|Screened for Part B Eligibility||11
2367396|NCT01551420|5810014|P1|STARTED|Screened for Part B Eligibility||33
2367397|NCT01551420|5810013|P2|NOT COMPLETED|In-laboratory (Part A)||2
2367398|NCT01551420|5810014|P1|NOT COMPLETED|In-laboratory (Part A)||6
2367399|NCT01551420|5810013|P2|COMPLETED|In-laboratory (Part A)||11
2367400|NCT01551420|5810014|P1|COMPLETED|In-laboratory (Part A)||33
2367401|NCT01551420|5810013|P2|STARTED|In-laboratory (Part A)||13
2367402|NCT01551420|5810014|P1|STARTED|In-laboratory (Part A)||39
2367403|NCT01551355|5810044|P6|NOT COMPLETED|Overall Study||6
2367404|NCT01551355|5810045|P5|NOT COMPLETED|Overall Study||9
2367405|NCT01551355|5810046|P4|NOT COMPLETED|Overall Study||24
2367406|NCT01551355|5810047|P3|NOT COMPLETED|Overall Study||34
2367407|NCT01551355|5810048|P2|NOT COMPLETED|Overall Study||49
2367408|NCT01551355|5810049|P1|NOT COMPLETED|Overall Study||51
2367409|NCT01551355|5810044|P6|COMPLETED|Overall Study||65
2367410|NCT01551355|5810045|P5|COMPLETED|Overall Study||55
2367411|NCT01551355|5810046|P4|COMPLETED|Overall Study||411
2367412|NCT01551355|5810047|P3|COMPLETED|Overall Study||459
2367413|NCT01551355|5810048|P2|COMPLETED|Overall Study||545
2367414|NCT01551355|5810049|P1|COMPLETED|Overall Study||571
2367415|NCT01551355|5810044|P6|STARTED|Overall Study||71
2367416|NCT01551355|5810045|P5|STARTED|Overall Study||64
2367417|NCT01551355|5810046|P4|STARTED|Overall Study||435
2367418|NCT01551355|5810047|P3|STARTED|Overall Study||493
2367419|NCT01551355|5810048|P2|STARTED|Overall Study||594
2367420|NCT01551355|5810049|P1|STARTED|Overall Study||622
2367421|NCT01551303|5810063|P2|NOT COMPLETED|Overall Study||7
2367422|NCT01551303|5810064|P1|NOT COMPLETED|Overall Study||4
2367423|NCT01551303|5810063|P2|COMPLETED|Overall Study||15
2367424|NCT01551303|5810064|P1|COMPLETED|Overall Study||21
2367425|NCT01551303|5810063|P2|STARTED|Overall Study||22
2367426|NCT01551303|5810064|P1|STARTED|Overall Study||25
2367427|NCT01551212|5810072|P2|NOT COMPLETED|Overall Study||20
2367428|NCT01551212|5810073|P1|NOT COMPLETED|Overall Study||5
2367429|NCT01551212|5810072|P2|COMPLETED|Overall Study||148
2367430|NCT01551212|5810073|P1|COMPLETED|Overall Study||166
2367431|NCT01551212|5810072|P2|Per Protocol Set (PP)|Overall Study||101
2367432|NCT01551212|5810073|P1|Per Protocol Set (PP)|Overall Study||110
2367433|NCT01551212|5810072|P2|Safety Set|Overall Study||164
2367434|NCT01551212|5810073|P1|Safety Set|Overall Study||169
2367435|NCT01551212|5810072|P2|Full Anylsis Set (FAS)|Overall Study||164
2367436|NCT01551212|5810073|P1|Full Anylsis Set (FAS)|Overall Study||169
2367437|NCT01551212|5810072|P2|STARTED|Overall Study||168
2367438|NCT01551212|5810073|P1|STARTED|Overall Study||171
2367439|NCT01551199|5810091|P1|NOT COMPLETED|Overall Study||5
2367440|NCT01551199|5810091|P1|COMPLETED|Overall Study||2
2367441|NCT01551199|5810091|P1|STARTED|Overall Study||7
2367442|NCT01551186|5810099|P2|NOT COMPLETED|Overall Study||13
2367443|NCT01551186|5810100|P1|NOT COMPLETED|Overall Study||20
2367444|NCT01551186|5810099|P2|COMPLETED|Overall Study||40
2367445|NCT01551186|5810100|P1|COMPLETED|Overall Study||30
2367446|NCT01551186|5810099|P2|STARTED|Overall Study||53
2367447|NCT01551186|5810100|P1|STARTED|Overall Study||50
2367448|NCT01551173|5810108|P2|NOT COMPLETED|Overall Study||32
2367449|NCT01551173|5810109|P1|NOT COMPLETED|Overall Study||28
2367450|NCT01551173|5810108|P2|COMPLETED|Overall Study||186
2367451|NCT01551173|5810109|P1|COMPLETED|Overall Study||190
2367452|NCT01551173|5810108|P2|Full Analysis Set (FAS)|Overall Study||214
2367453|NCT01551173|5810109|P1|Full Analysis Set (FAS)|Overall Study|Patients took at least 1 dose of study drug & had at least 1 post-randomization efficacy parameter|210
2367454|NCT01551173|5810108|P2|STARTED|Overall Study||218
2367455|NCT01551173|5810109|P1|STARTED|Overall Study|"Started indicates randomized"|218
2367456|NCT01551095|5810120|P1|NOT COMPLETED|Overall Study||0
2367457|NCT01551095|5810120|P1|COMPLETED|Overall Study||7
2367458|NCT01551095|5810120|P1|STARTED|Overall Study||7
2367459|NCT01551082|5810125|P1|NOT COMPLETED|Overall Study||0
2367460|NCT01551082|5810125|P1|COMPLETED|Overall Study||12
2367461|NCT01551082|5810125|P1|STARTED|Overall Study||12
2367463|NCT01551056|5810132|P1|NOT COMPLETED|Overall Study||2
2367464|NCT01551056|5810131|P2|COMPLETED|Overall Study||45
2367465|NCT01551056|5810132|P1|COMPLETED|Overall Study||44
2367466|NCT01551056|5810131|P2|STARTED|Overall Study||45
2367467|NCT01551056|5810132|P1|STARTED|Overall Study||46
2367468|NCT01550965|5810186|P1|NOT COMPLETED|Overall Study||110
2367469|NCT01550965|5810186|P1|COMPLETED|Overall Study||353
2367470|NCT01550965|5810186|P1|STARTED|Overall Study||463
2367471|NCT01550952|5810205|P1|NOT COMPLETED|Overall Study||0
2367472|NCT01550952|5810205|P1|COMPLETED|Overall Study||10
2367473|NCT01550952|5810205|P1|STARTED|Overall Study||10
2367474|NCT01550809|5810215|P2|NOT COMPLETED|Overall Study||0
2367475|NCT01550809|5810216|P1|NOT COMPLETED|Overall Study||0
2367476|NCT01550809|5810215|P2|COMPLETED|Overall Study||6
2367477|NCT01550809|5810216|P1|COMPLETED|Overall Study||6
2367478|NCT01550809|5810215|P2|STARTED|Overall Study|Six patients started with the iBolus, the others with the tBolus, according to a crossover design.|6
2367479|NCT01550809|5810216|P1|STARTED|Overall Study|Six patients started with the tBolus, the others with the iBolus, according to a crossover design.|6
2367480|NCT01550757|5810230|P4|NOT COMPLETED|Overall Study||54
2367481|NCT01550757|5810231|P3|NOT COMPLETED|Overall Study||45
2367482|NCT01550757|5810232|P2|NOT COMPLETED|Overall Study||14
2367483|NCT01550757|5810233|P1|NOT COMPLETED|Overall Study||23
2367484|NCT01550757|5810230|P4|COMPLETED|Overall Study||90
2367485|NCT01550757|5810231|P3|COMPLETED|Overall Study||85
2367486|NCT01550757|5810232|P2|COMPLETED|Overall Study||38
2367487|NCT01550757|5810233|P1|COMPLETED|Overall Study||33
2367488|NCT01550757|5810230|P4|STARTED|Overall Study||144
2367489|NCT01550757|5810231|P3|STARTED|Overall Study||130
2367490|NCT01550757|5810232|P2|STARTED|Overall Study||52
2367491|NCT01550757|5810233|P1|STARTED|Overall Study||56
2367492|NCT01550744|5810243|P3|NOT COMPLETED|Double-Blind||67
2367493|NCT01550744|5810244|P2|NOT COMPLETED|Double-Blind||17
2367494|NCT01550744|5810245|P1|NOT COMPLETED|Double-Blind||0
2367495|NCT01550744|5810243|P3|COMPLETED|Double-Blind||235
2367496|NCT01550744|5810244|P2|COMPLETED|Double-Blind||59
2367497|NCT01550744|5810245|P1|COMPLETED|Double-Blind||0
2367498|NCT01550744|5810243|P3|STARTED|Double-Blind||302
2367499|NCT01550744|5810244|P2|STARTED|Double-Blind||76
2367500|NCT01550744|5810245|P1|STARTED|Double-Blind||0
2367501|NCT01550744|5810243|P3|NOT COMPLETED|Open-Label||0
2367502|NCT01550744|5810244|P2|NOT COMPLETED|Open-Label||0
2367503|NCT01550744|5810245|P1|NOT COMPLETED|Open-Label||100
2367504|NCT01550744|5810243|P3|COMPLETED|Open-Label||0
2367505|NCT01550744|5810244|P2|COMPLETED|Open-Label||0
2367506|NCT01550744|5810245|P1|COMPLETED|Open-Label||378
2367507|NCT01550744|5810243|P3|STARTED|Open-Label||0
2367508|NCT01550744|5810244|P2|STARTED|Open-Label||0
2367509|NCT01550744|5810245|P1|STARTED|Open-Label||478
2367510|NCT01550731|5810260|P2|NOT COMPLETED|Overall Study||0
2367511|NCT01550731|5810261|P1|NOT COMPLETED|Overall Study||0
2367512|NCT01550731|5810260|P2|COMPLETED|Overall Study||209
2367513|NCT01550731|5810261|P1|COMPLETED|Overall Study||205
2367514|NCT01550731|5810260|P2|STARTED|Overall Study||209
2367515|NCT01550731|5810261|P1|STARTED|Overall Study||205
2367516|NCT01550705|5810269|P1|NOT COMPLETED|Overall Study||1
2367517|NCT01550705|5810269|P1|COMPLETED|Overall Study||10
2367518|NCT01550705|5810269|P1|STARTED|Overall Study||11
2367519|NCT01550549|5810274|P1|NOT COMPLETED|Overall Study||0
2367520|NCT01550549|5810274|P1|COMPLETED|Overall Study||151
2367521|NCT01550549|5810274|P1|STARTED|Overall Study||151
2367522|NCT01550510|5810288|P2|NOT COMPLETED|Overall Study||0
2367523|NCT01550510|5810289|P1|NOT COMPLETED|Overall Study||0
2367524|NCT01550510|5810288|P2|COMPLETED|Overall Study||0
2367525|NCT01550510|5810289|P1|COMPLETED|Overall Study||4
2367526|NCT01550510|5810288|P2|STARTED|Overall Study||0
2367527|NCT01550510|5810289|P1|STARTED|Overall Study||4
2367528|NCT01550367|5810297|P1|NOT COMPLETED|Overall Study||0
2367529|NCT01550367|5810297|P1|COMPLETED|Overall Study||30
2367530|NCT01550367|5810297|P1|600 mg/d HCQ|Overall Study||17
2367531|NCT01550367|5810297|P1|1200 mg/d HCQ|Overall Study||13
2367532|NCT01550367|5810297|P1|STARTED|Overall Study||30
2367533|NCT01550302|5810324|P2|NOT COMPLETED|Overall Study||0
2367534|NCT01550302|5810325|P1|NOT COMPLETED|Overall Study||0
2367535|NCT01550302|5810324|P2|COMPLETED|Overall Study||5
2367536|NCT01550302|5810325|P1|COMPLETED|Overall Study||5
2367537|NCT01550302|5810324|P2|STARTED|Overall Study||5
2367538|NCT01550302|5810325|P1|STARTED|Overall Study||5
2367539|NCT01550289|5810345|P2|NOT COMPLETED|Overall Study||4
2367540|NCT01550289|5810346|P1|NOT COMPLETED|Overall Study||13
2367541|NCT01550289|5810345|P2|COMPLETED|Overall Study||57
2367542|NCT01550289|5810346|P1|COMPLETED|Overall Study||115
2367543|NCT01550289|5810345|P2|STARTED|Overall Study||61
2367544|NCT01550289|5810346|P1|STARTED|Overall Study||128
2367545|NCT01550224|5810378|P2|NOT COMPLETED|Overall Study||0
2367546|NCT01550224|5810379|P1|NOT COMPLETED|Overall Study||0
2367547|NCT01550224|5810378|P2|COMPLETED|Overall Study||20
2367548|NCT01550224|5810379|P1|COMPLETED|Overall Study||3
2367549|NCT01550224|5810378|P2|STARTED|Overall Study||20
2367550|NCT01550224|5810379|P1|STARTED|Overall Study||3
2367551|NCT01549977|5810403|P2|NOT COMPLETED|Overall Study||0
2367552|NCT01549977|5810404|P1|NOT COMPLETED|Overall Study||0
2367553|NCT01549977|5810403|P2|COMPLETED|Overall Study||0
2367554|NCT01549977|5810404|P1|COMPLETED|Overall Study||1
2367555|NCT01549977|5810403|P2|STARTED|Overall Study||0
2367556|NCT01549977|5810404|P1|STARTED|Overall Study||1
2367557|NCT01549964|5810422|P4|NOT COMPLETED|80-Week Extension Period||137
2367558|NCT01549964|5810423|P3|NOT COMPLETED|80-Week Extension Period||140
2367559|NCT01549964|5810424|P2|NOT COMPLETED|80-Week Extension Period||138
2367560|NCT01549964|5810425|P1|NOT COMPLETED|80-Week Extension Period||66
2367561|NCT01549964|5810422|P4|COMPLETED|80-Week Extension Period||0
2367562|NCT01549964|5810423|P3|COMPLETED|80-Week Extension Period||0
2367563|NCT01549964|5810424|P2|COMPLETED|80-Week Extension Period||0
2367564|NCT01549964|5810425|P1|COMPLETED|80-Week Extension Period||0
2367565|NCT01549964|5810422|P4|STARTED|80-Week Extension Period||137
2367566|NCT01549964|5810423|P3|STARTED|80-Week Extension Period||140
2367567|NCT01549964|5810424|P2|STARTED|80-Week Extension Period||138
2367568|NCT01549964|5810425|P1|STARTED|80-Week Extension Period||66
2367569|NCT01549964|5810422|P4|NOT COMPLETED|24-Week Treatment Period||121
2367570|NCT01549964|5810423|P3|NOT COMPLETED|24-Week Treatment Period||116
2367571|NCT01549964|5810424|P2|NOT COMPLETED|24-Week Treatment Period||111
2367572|NCT01549964|5810425|P1|NOT COMPLETED|24-Week Treatment Period||61
2367573|NCT01549964|5810422|P4|COMPLETED|24-Week Treatment Period||140
2367574|NCT01549964|5810423|P3|COMPLETED|24-Week Treatment Period||147
2367575|NCT01549964|5810424|P2|COMPLETED|24-Week Treatment Period||149
2367576|NCT01549964|5810425|P1|COMPLETED|24-Week Treatment Period||71
2367577|NCT01549964|5810422|P4|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
2367578|NCT01549964|5810423|P3|Safety Analysis Set=Received Treatment|24-Week Treatment Period||263
2367579|NCT01549964|5810424|P2|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
2367580|NCT01549964|5810425|P1|Safety Analysis Set=Received Treatment|24-Week Treatment Period||132
2367581|NCT01549964|5810422|P4|STARTED|24-Week Treatment Period||261
2367582|NCT01549964|5810423|P3|STARTED|24-Week Treatment Period||263
2367583|NCT01549964|5810424|P2|STARTED|24-Week Treatment Period||260
2367584|NCT01549964|5810425|P1|STARTED|24-Week Treatment Period||132
2367585|NCT01549951|5810443|P1|NOT COMPLETED|Overall Study||50
2367586|NCT01549951|5810443|P1|COMPLETED|Overall Study||0
2367587|NCT01549951|5810443|P1|Primary Reason Off Study Treatment|Overall Study||50
2367588|NCT01549951|5810443|P1|STARTED|Overall Study||50
2367589|NCT01549925|5810461|P2|NOT COMPLETED|Overall Study||0
2367590|NCT01549925|5810462|P1|NOT COMPLETED|Overall Study||0
2367591|NCT01549925|5810461|P2|COMPLETED|Overall Study||25
2367592|NCT01549925|5810462|P1|COMPLETED|Overall Study||25
2367593|NCT01549925|5810461|P2|STARTED|Overall Study||25
2367594|NCT01549925|5810462|P1|STARTED|Overall Study||25
2367595|NCT01549873|5810470|P2|NOT COMPLETED|Overall Study||1
2367596|NCT01549873|5810471|P1|NOT COMPLETED|Overall Study||0
2367597|NCT01549873|5810470|P2|COMPLETED|Overall Study||14
2367598|NCT01549873|5810471|P1|COMPLETED|Overall Study||15
2367599|NCT01549873|5810470|P2|STARTED|Overall Study||15
2367600|NCT01549873|5810471|P1|STARTED|Overall Study||15
2367601|NCT01549860|5810483|P2|NOT COMPLETED|Overall Study||1
2367602|NCT01549860|5810484|P1|NOT COMPLETED|Overall Study||2
2367603|NCT01549860|5810483|P2|COMPLETED|Overall Study||40
2367604|NCT01549860|5810484|P1|COMPLETED|Overall Study||38
2367605|NCT01549860|5810483|P2|STARTED|Overall Study||41
2367606|NCT01549860|5810484|P1|STARTED|Overall Study||40
2367607|NCT01549652|5810497|P4|NOT COMPLETED|Overall Study||11
2367608|NCT01549652|5810498|P3|NOT COMPLETED|Overall Study||17
2367609|NCT01549652|5810499|P2|NOT COMPLETED|Overall Study||12
2367610|NCT01549652|5810500|P1|NOT COMPLETED|Overall Study||12
2367611|NCT01549652|5810497|P4|COMPLETED|Overall Study||25
2367612|NCT01549652|5810498|P3|COMPLETED|Overall Study||23
2367613|NCT01549652|5810499|P2|COMPLETED|Overall Study||18
2367614|NCT01549652|5810500|P1|COMPLETED|Overall Study||15
2367615|NCT01549652|5810497|P4|STARTED|Overall Study||36
2367616|NCT01549652|5810498|P3|STARTED|Overall Study||40
2367617|NCT01549652|5810499|P2|STARTED|Overall Study||30
2367618|NCT01549652|5810500|P1|STARTED|Overall Study||27
2367619|NCT01549613|5810518|P2|NOT COMPLETED|Overall Study||11
2367620|NCT01549613|5810519|P1|NOT COMPLETED|Overall Study||11
2367621|NCT01549613|5810518|P2|COMPLETED|Overall Study||39
2367622|NCT01549613|5810519|P1|COMPLETED|Overall Study||39
2367623|NCT01549613|5810518|P2|STARTED|Overall Study||50
2367624|NCT01549613|5810519|P1|STARTED|Overall Study||50
2367625|NCT01549405|5810527|P2|NOT COMPLETED|Overall Study||0
2367626|NCT01549405|5810528|P1|NOT COMPLETED|Overall Study||0
2367627|NCT01549405|5810527|P2|COMPLETED|Overall Study||20
2367628|NCT01549405|5810528|P1|COMPLETED|Overall Study||20
2367629|NCT01549405|5810527|P2|STARTED|Overall Study||20
2367630|NCT01549405|5810528|P1|STARTED|Overall Study||20
2367631|NCT01549392|5810538|P2|NOT COMPLETED|Overall Study||0
2367632|NCT01549392|5810539|P1|NOT COMPLETED|Overall Study||1
2367633|NCT01549392|5810538|P2|COMPLETED|Overall Study||0
2367634|NCT01549392|5810539|P1|COMPLETED|Overall Study||2
2367635|NCT01549392|5810538|P2|STARTED|Overall Study||0
2367636|NCT01549392|5810539|P1|STARTED|Overall Study||3
2367637|NCT01549340|5810545|P1|NOT COMPLETED|Overall Study||8405
2367638|NCT01549340|5810545|P1|COMPLETED|Overall Study|Completed 5 years of AIT|385
2367639|NCT01549340|5810545|P1|Started AIT|Overall Study||3182
2367640|NCT01549340|5810545|P1|STARTED|Overall Study|Advised to receive AIT|8790
2367641|NCT01549275|5810558|P2|NOT COMPLETED|Overall Study||0
2367642|NCT01549275|5810559|P1|NOT COMPLETED|Overall Study||1
2367643|NCT01549275|5810558|P2|COMPLETED|Overall Study||29
2367644|NCT01549275|5810559|P1|COMPLETED|Overall Study||75
2367645|NCT01549275|5810558|P2|STARTED|Overall Study||29
2367646|NCT01549275|5810559|P1|STARTED|Overall Study||76
2367647|NCT01549223|5810571|P2|NOT COMPLETED|Overall Study||0
2367648|NCT01549223|5810572|P1|NOT COMPLETED|Overall Study||0
2367649|NCT01549223|5810571|P2|COMPLETED|Overall Study||30
2367650|NCT01549223|5810572|P1|COMPLETED|Overall Study||30
2367651|NCT01549223|5810571|P2|STARTED|Overall Study||30
2367652|NCT01549223|5810572|P1|STARTED|Overall Study||30
2367653|NCT01549041|5810582|P2|NOT COMPLETED|Overall Study||8
2367654|NCT01549041|5810583|P1|NOT COMPLETED|Overall Study||2
2367655|NCT01549041|5810582|P2|COMPLETED|Overall Study||10
2367656|NCT01549041|5810583|P1|COMPLETED|Overall Study||10
2367657|NCT01549041|5810582|P2|STARTED|Overall Study||18
2367658|NCT01549041|5810583|P1|STARTED|Overall Study||12
2367659|NCT01549002|5810593|P2|NOT COMPLETED|Overall Study||4
2367660|NCT01549002|5810594|P1|NOT COMPLETED|Overall Study||0
2367661|NCT01549002|5810593|P2|COMPLETED|Overall Study||6
2367662|NCT01549002|5810594|P1|COMPLETED|Overall Study||10
2367663|NCT01549002|5810593|P2|STARTED|Overall Study||10
2367664|NCT01549002|5810594|P1|STARTED|Overall Study||10
2367665|NCT01548885|5810604|P1|NOT COMPLETED|Overall Study||0
2367666|NCT01548885|5810604|P1|COMPLETED|Overall Study||146
2367667|NCT01548885|5810604|P1|STARTED|Overall Study||146
2367668|NCT01548833|5810609|P1|NOT COMPLETED|Overall Study||0
2367669|NCT01548833|5810609|P1|COMPLETED|Overall Study||39
2367670|NCT01548833|5810609|P1|STARTED|Overall Study||39
2367671|NCT01548742|5810619|P2|NOT COMPLETED|Overall Study||4
2367672|NCT01548742|5810620|P1|NOT COMPLETED|Overall Study||13
2367673|NCT01548742|5810619|P2|COMPLETED|Overall Study||54
2367674|NCT01548742|5810620|P1|COMPLETED|Overall Study||45
2367675|NCT01548742|5810619|P2|STARTED|Overall Study||58
2367676|NCT01548742|5810620|P1|STARTED|Overall Study||58
2367677|NCT01548690|5810638|P4|NOT COMPLETED|Overall Study||5
2367678|NCT01548690|5810639|P3|NOT COMPLETED|Overall Study||5
2367679|NCT01548690|5810640|P2|NOT COMPLETED|Overall Study||3
2367680|NCT01548690|5810641|P1|NOT COMPLETED|Overall Study||0
2367681|NCT01548690|5810638|P4|COMPLETED|Overall Study||10
2367682|NCT01548690|5810639|P3|COMPLETED|Overall Study||8
2367683|NCT01548690|5810640|P2|COMPLETED|Overall Study||7
2367684|NCT01548690|5810641|P1|COMPLETED|Overall Study||9
2367685|NCT01548690|5810638|P4|Evaluable (72 Hours on Infusion)|Overall Study||12
2367686|NCT01548690|5810639|P3|Evaluable (72 Hours on Infusion)|Overall Study||12
2367687|NCT01548690|5810640|P2|Evaluable (72 Hours on Infusion)|Overall Study||6
2367688|NCT01548690|5810641|P1|Evaluable (72 Hours on Infusion)|Overall Study||6
2367689|NCT01548690|5810638|P4|STARTED|Overall Study||15
2367690|NCT01548690|5810639|P3|STARTED|Overall Study||13
2367691|NCT01548690|5810640|P2|STARTED|Overall Study||10
2367692|NCT01548690|5810641|P1|STARTED|Overall Study||9
2367693|NCT01548651|5810669|P2|NOT COMPLETED|Overall Study||0
2367694|NCT01548651|5810670|P1|NOT COMPLETED|Overall Study||1
2367695|NCT01548651|5810669|P2|COMPLETED|Overall Study||4
2367696|NCT01548651|5810670|P1|COMPLETED|Overall Study||3
2367697|NCT01548651|5810669|P2|STARTED|Overall Study||4
2367698|NCT01548651|5810670|P1|STARTED|Overall Study||4
2367699|NCT01548638|5810680|P1|NOT COMPLETED|Overall Study||4
2367700|NCT01548638|5810680|P1|COMPLETED|Overall Study||9
2367701|NCT01548638|5810680|P1|STARTED|Overall Study||13
2367702|NCT01548573|5810690|P1|NOT COMPLETED|Overall Study||5
2367703|NCT01548573|5810690|P1|COMPLETED|Overall Study||14
2367704|NCT01548573|5810690|P1|STARTED|Overall Study||19
2367705|NCT01548417|5810699|P2|NOT COMPLETED|Overall Study||2
2367706|NCT01548417|5810700|P1|NOT COMPLETED|Overall Study||0
2367707|NCT01548417|5810699|P2|COMPLETED|Overall Study||26
2367708|NCT01548417|5810700|P1|COMPLETED|Overall Study||28
2367709|NCT01548417|5810699|P2|STARTED|Overall Study||28
2367710|NCT01548417|5810700|P1|STARTED|Overall Study||28
2367711|NCT01548404|5810710|P2|NOT COMPLETED|Overall Study||14
2367712|NCT01548404|5810711|P1|NOT COMPLETED|Overall Study||30
2367713|NCT01548404|5810710|P2|COMPLETED|Overall Study||41
2367714|NCT01548404|5810711|P1|COMPLETED|Overall Study||24
2367715|NCT01548404|5810710|P2|STARTED|Overall Study||55
2367716|NCT01548404|5810711|P1|STARTED|Overall Study||54
2367717|NCT01548339|5810735|P2|NOT COMPLETED|Overall Study||1
2367718|NCT01548339|5810736|P1|NOT COMPLETED|Overall Study||6
2367719|NCT01548339|5810735|P2|COMPLETED|Overall Study||41
2367720|NCT01548339|5810736|P1|COMPLETED|Overall Study||38
2367721|NCT01548339|5810735|P2|STARTED|Overall Study||42
2367722|NCT01548339|5810736|P1|STARTED|Overall Study||44
2367723|NCT01548287|5810750|P5|NOT COMPLETED|Randomized Period||0
2367724|NCT01548287|5810751|P4|NOT COMPLETED|Randomized Period||0
2367725|NCT01548287|5810752|P3|NOT COMPLETED|Randomized Period||7
2367726|NCT01548287|5810753|P2|NOT COMPLETED|Randomized Period||2
2367727|NCT01548287|5810754|P1|NOT COMPLETED|Randomized Period||0
2367728|NCT01548287|5810750|P5|COMPLETED|Randomized Period||0
2367729|NCT01548287|5810751|P4|COMPLETED|Randomized Period||20
2367730|NCT01548287|5810752|P3|COMPLETED|Randomized Period||13
2367731|NCT01548287|5810753|P2|COMPLETED|Randomized Period||20
2367732|NCT01548287|5810754|P1|COMPLETED|Randomized Period||19
2367733|NCT01548287|5810750|P5|STARTED|Randomized Period||0
2367734|NCT01548287|5810751|P4|STARTED|Randomized Period||20
2367735|NCT01548287|5810752|P3|STARTED|Randomized Period||20
2367736|NCT01548287|5810753|P2|STARTED|Randomized Period||22
2367737|NCT01548287|5810754|P1|STARTED|Randomized Period||19
2367738|NCT01548287|5810750|P5|NOT COMPLETED|Screening||83
2367739|NCT01548287|5810751|P4|NOT COMPLETED|Screening||0
2367740|NCT01548287|5810752|P3|NOT COMPLETED|Screening||0
2367741|NCT01548287|5810753|P2|NOT COMPLETED|Screening||0
2367742|NCT01548287|5810754|P1|NOT COMPLETED|Screening||0
2367743|NCT01548287|5810750|P5|COMPLETED|Screening||0
2367744|NCT01548287|5810751|P4|COMPLETED|Screening||20
2367745|NCT01548287|5810752|P3|COMPLETED|Screening||20
2367746|NCT01548287|5810753|P2|COMPLETED|Screening||22
2367747|NCT01548287|5810754|P1|COMPLETED|Screening||19
2367748|NCT01548287|5810750|P5|STARTED|Screening||83
2367749|NCT01548287|5810751|P4|STARTED|Screening||20
2367750|NCT01548287|5810752|P3|STARTED|Screening||20
2367751|NCT01548287|5810753|P2|STARTED|Screening||22
2367752|NCT01548287|5810754|P1|STARTED|Screening||19
2367753|NCT01548040|5810786|P2|NOT COMPLETED|Overall Study||10
2367754|NCT01548040|5810787|P1|NOT COMPLETED|Overall Study||13
2367755|NCT01548040|5810786|P2|COMPLETED|Overall Study||45
2367756|NCT01548040|5810787|P1|COMPLETED|Overall Study||43
2367757|NCT01548040|5810786|P2|STARTED|Overall Study||55
2367758|NCT01548040|5810787|P1|STARTED|Overall Study||56
2367759|NCT01547806|5810795|P1|NOT COMPLETED|Overall Study||0
2367760|NCT01547806|5810795|P1|COMPLETED|Overall Study||49
2367761|NCT01547806|5810795|P1|STARTED|Overall Study||49
2367762|NCT01547728|5810811|P1|NOT COMPLETED|Overall Study||41
2367763|NCT01547728|5810811|P1|COMPLETED|Overall Study||1
2367764|NCT01547728|5810811|P1|STARTED|Overall Study||42
2367765|NCT01547715|5810818|P3|NOT COMPLETED|Overall Study||0
2367766|NCT01547715|5810819|P2|NOT COMPLETED|Overall Study||0
2367767|NCT01547715|5810820|P1|NOT COMPLETED|Overall Study||0
2367768|NCT01547715|5810818|P3|COMPLETED|Overall Study||60
2367769|NCT01547715|5810819|P2|COMPLETED|Overall Study||60
2367770|NCT01547715|5810820|P1|COMPLETED|Overall Study||60
2367771|NCT01547715|5810818|P3|STARTED|Overall Study||60
2367772|NCT01547715|5810819|P2|STARTED|Overall Study||60
2367773|NCT01547715|5810820|P1|STARTED|Overall Study||60
2367774|NCT01547598|5810920|P2|NOT COMPLETED|Overall Study||5
2367775|NCT01547598|5810921|P1|NOT COMPLETED|Overall Study||6
2367776|NCT01547598|5810920|P2|COMPLETED|Overall Study||63
2367777|NCT01547598|5810921|P1|COMPLETED|Overall Study||61
2367778|NCT01547598|5810920|P2|STARTED|Overall Study||68
2367779|NCT01547598|5810921|P1|STARTED|Overall Study||67
2367780|NCT01547390|5810938|P2|NOT COMPLETED|Overall Study||10
2367781|NCT01547390|5810939|P1|NOT COMPLETED|Overall Study||13
2367782|NCT01547390|5810938|P2|COMPLETED|Overall Study||16
2367783|NCT01547390|5810939|P1|COMPLETED|Overall Study||14
2367784|NCT01547390|5810938|P2|STARTED|Overall Study||26
2367785|NCT01547390|5810939|P1|STARTED|Overall Study||27
2367786|NCT01547299|5810949|P2|NOT COMPLETED|Overall Study||2
2367787|NCT01547299|5810950|P1|NOT COMPLETED|Overall Study||2
2367788|NCT01547299|5810949|P2|COMPLETED|Overall Study||25
2367789|NCT01547299|5810950|P1|COMPLETED|Overall Study||23
2367790|NCT01547299|5810949|P2|STARTED|Overall Study||27
2367791|NCT01547299|5810950|P1|STARTED|Overall Study||25
2367792|NCT01547286|5811016|P1|NOT COMPLETED|Overall Study||2
2367793|NCT01547286|5811016|P1|COMPLETED|Overall Study||5
2367794|NCT01547286|5811016|P1|STARTED|Overall Study||7
2367795|NCT01547247|5811025|P2|NOT COMPLETED|Overall Study||6
2367796|NCT01547247|5811026|P1|NOT COMPLETED|Overall Study||6
2367797|NCT01547247|5811025|P2|COMPLETED|Overall Study||98
2367798|NCT01547247|5811026|P1|COMPLETED|Overall Study||98
2367799|NCT01547247|5811025|P2|STARTED|Overall Study||104
2367800|NCT01547247|5811026|P1|STARTED|Overall Study||104
2367801|NCT01547130|5811036|P2|NOT COMPLETED|Overall Study||5
2367802|NCT01547130|5811037|P1|NOT COMPLETED|Overall Study||9
2367803|NCT01547130|5811036|P2|COMPLETED|Overall Study||68
2367804|NCT01547130|5811037|P1|COMPLETED|Overall Study||65
2367805|NCT01547130|5811036|P2|STARTED|Overall Study||73
2367806|NCT01547130|5811037|P1|STARTED|Overall Study||74
2367807|NCT01547000|5811053|P2|NOT COMPLETED|Overall Study||0
2367808|NCT01547000|5811054|P1|NOT COMPLETED|Overall Study||0
2367809|NCT01547000|5811053|P2|COMPLETED|Overall Study||16
2367810|NCT01547000|5811054|P1|COMPLETED|Overall Study||18
2367811|NCT01547000|5811053|P2|STARTED|Overall Study||16
2367812|NCT01547000|5811054|P1|STARTED|Overall Study||18
2367813|NCT01546922|5811060|P2|NOT COMPLETED|Second Period of 10 Weeks||3
2367814|NCT01546922|5811061|P1|NOT COMPLETED|Second Period of 10 Weeks||3
2367815|NCT01546922|5811060|P2|COMPLETED|Second Period of 10 Weeks||25
2367816|NCT01546922|5811061|P1|COMPLETED|Second Period of 10 Weeks||22
2367817|NCT01546922|5811060|P2|STARTED|Second Period of 10 Weeks||28
2367818|NCT01546922|5811061|P1|STARTED|Second Period of 10 Weeks||25
2367819|NCT01546922|5811060|P2|NOT COMPLETED|First Period of 10 Weeks||2
2367820|NCT01546922|5811061|P1|NOT COMPLETED|First Period of 10 Weeks||5
2367821|NCT01546922|5811060|P2|COMPLETED|First Period of 10 Weeks||28
2367822|NCT01546922|5811061|P1|COMPLETED|First Period of 10 Weeks||25
2367823|NCT01546922|5811060|P2|STARTED|First Period of 10 Weeks||30
2367824|NCT01546922|5811061|P1|STARTED|First Period of 10 Weeks||30
2367825|NCT01546883|5811067|P1|NOT COMPLETED|Overall Study||12
2367826|NCT01546883|5811067|P1|COMPLETED|Overall Study||2
2367827|NCT01546883|5811067|P1|STARTED|Overall Study||14
2367828|NCT01546688|5811073|P2|NOT COMPLETED|Overall Study||5
2367829|NCT01546688|5811074|P1|NOT COMPLETED|Overall Study||3
2367830|NCT01546688|5811073|P2|COMPLETED|Overall Study||28
2367831|NCT01546688|5811074|P1|COMPLETED|Overall Study||15
2367832|NCT01546688|5811073|P2|STARTED|Overall Study||33
2367833|NCT01546688|5811074|P1|STARTED|Overall Study||18
2367834|NCT01546675|5811088|P2|NOT COMPLETED|Overall Study||0
2367835|NCT01546675|5811089|P1|NOT COMPLETED|Overall Study||0
2367836|NCT01546675|5811088|P2|COMPLETED|Overall Study||1
2367837|NCT01546675|5811089|P1|COMPLETED|Overall Study||1
2367838|NCT01546675|5811088|P2|STARTED|Overall Study||1
2367839|NCT01546675|5811089|P1|STARTED|Overall Study||1
2367840|NCT01546649|5811106|P2|NOT COMPLETED|Overall Study||9
2367841|NCT01546649|5811107|P1|NOT COMPLETED|Overall Study||8
2367842|NCT01546649|5811106|P2|COMPLETED|Overall Study||75
2367843|NCT01546649|5811107|P1|COMPLETED|Overall Study||75
2367844|NCT01546649|5811106|P2|STARTED|Overall Study||84
2367845|NCT01546649|5811107|P1|STARTED|Overall Study||83
2367846|NCT01546636|5811129|P2|NOT COMPLETED|Overall Study||0
2367847|NCT01546636|5811130|P1|NOT COMPLETED|Overall Study||0
2367848|NCT01546636|5811129|P2|COMPLETED|Overall Study||34
2367849|NCT01546636|5811130|P1|COMPLETED|Overall Study||36
2367850|NCT01546636|5811129|P2|STARTED|Overall Study||34
2367851|NCT01546636|5811130|P1|STARTED|Overall Study||36
2367852|NCT01546623|5811142|P2|NOT COMPLETED|Overall Study||6
2367853|NCT01546623|5811143|P1|NOT COMPLETED|Overall Study||6
2367854|NCT01546623|5811142|P2|COMPLETED|Overall Study||74
2367855|NCT01546623|5811143|P1|COMPLETED|Overall Study||76
2367856|NCT01546623|5811142|P2|Received Study Drug|Overall Study||79
2367857|NCT01546623|5811143|P1|Received Study Drug|Overall Study||81
2367858|NCT01546623|5811142|P2|STARTED|Overall Study||80
2367859|NCT01546623|5811143|P1|STARTED|Overall Study||82
2367860|NCT01546519|5811173|P4|NOT COMPLETED|Overall Study||6
2367861|NCT01546519|5811174|P3|NOT COMPLETED|Overall Study||8
2367862|NCT01546519|5811175|P2|NOT COMPLETED|Overall Study||8
2367863|NCT01546519|5811176|P1|NOT COMPLETED|Overall Study||9
2367864|NCT01546519|5811173|P4|COMPLETED|Overall Study||0
2367865|NCT01546519|5811174|P3|COMPLETED|Overall Study||0
2367866|NCT01546519|5811175|P2|COMPLETED|Overall Study||0
2367867|NCT01546519|5811176|P1|COMPLETED|Overall Study||0
2367868|NCT01546519|5811173|P4|Safety-Evaluable Participants|Overall Study||6
2367869|NCT01546519|5811174|P3|Safety-Evaluable Participants|Overall Study||8
2367870|NCT01546519|5811175|P2|Safety-Evaluable Participants|Overall Study||8
2367871|NCT01546519|5811176|P1|Safety-Evaluable Participants|Overall Study||9
2367872|NCT01546519|5811173|P4|STARTED|Overall Study||6
2367873|NCT01546519|5811174|P3|STARTED|Overall Study||8
2367874|NCT01546519|5811175|P2|STARTED|Overall Study||8
2367875|NCT01546519|5811176|P1|STARTED|Overall Study||9
2367876|NCT01546454|5811218|P1|NOT COMPLETED|Estrogen/Progesterone Replacement Cycle||0
2367877|NCT01546454|5811218|P1|COMPLETED|Estrogen/Progesterone Replacement Cycle||4
2367878|NCT01546454|5811218|P1|STARTED|Estrogen/Progesterone Replacement Cycle||4
2367879|NCT01546454|5811218|P1|NOT COMPLETED|Eligard Treatment||0
2367880|NCT01546454|5811218|P1|COMPLETED|Eligard Treatment||4
2367881|NCT01546454|5811218|P1|STARTED|Eligard Treatment||4
2367882|NCT01546454|5811218|P1|NOT COMPLETED|Oral Contraceptive Cycle||0
2367883|NCT01546454|5811218|P1|COMPLETED|Oral Contraceptive Cycle||4
2367884|NCT01546454|5811218|P1|STARTED|Oral Contraceptive Cycle||4
2367885|NCT01546454|5811218|P1|NOT COMPLETED|Natural Menstrual Cycle||0
2367886|NCT01546454|5811218|P1|COMPLETED|Natural Menstrual Cycle||4
2367887|NCT01546454|5811218|P1|STARTED|Natural Menstrual Cycle||4
2367888|NCT01546402|5811226|P2|NOT COMPLETED|Overall Study||0
2367889|NCT01546402|5811227|P1|NOT COMPLETED|Overall Study||0
2367890|NCT01546402|5811226|P2|COMPLETED|Overall Study||10
2367891|NCT01546402|5811227|P1|COMPLETED|Overall Study||10
2367892|NCT01546402|5811226|P2|STARTED|Overall Study||10
2367893|NCT01546402|5811227|P1|STARTED|Overall Study||10
2367894|NCT01546285|5811235|P1|NOT COMPLETED|Overall Study||0
2367895|NCT01546285|5811235|P1|COMPLETED|Overall Study||66
2367896|NCT01546285|5811235|P1|STARTED|Overall Study||66
2367897|NCT01546207|5811241|P1|NOT COMPLETED|Overall Study||1
2367898|NCT01546207|5811241|P1|COMPLETED|Overall Study||3
2367899|NCT01546207|5811241|P1|STARTED|Overall Study||4
2367900|NCT01546194|5811247|P2|NOT COMPLETED|Overall Study||35
2367901|NCT01546194|5811248|P1|NOT COMPLETED|Overall Study||36
2367902|NCT01546194|5811247|P2|COMPLETED|Overall Study||65
2367903|NCT01546194|5811248|P1|COMPLETED|Overall Study||64
2367904|NCT01546194|5811247|P2|STARTED|Overall Study||100
2367905|NCT01546194|5811248|P1|STARTED|Overall Study||100
2367906|NCT01546168|5811256|P2|NOT COMPLETED|Overall Study||0
2367907|NCT01546168|5811257|P1|NOT COMPLETED|Overall Study||4
2367908|NCT01546168|5811256|P2|COMPLETED|Overall Study||33
2367909|NCT01546168|5811257|P1|COMPLETED|Overall Study||51
2367910|NCT01546168|5811256|P2|STARTED|Overall Study||33
2367911|NCT01546168|5811257|P1|STARTED|Overall Study||55
2367912|NCT01546155|5811269|P1|NOT COMPLETED|Overall Study||3
2367913|NCT01546155|5811269|P1|COMPLETED|Overall Study||8
2367914|NCT01546155|5811269|P1|STARTED|Overall Study||11
2367915|NCT01546142|5811275|P2|NOT COMPLETED|Overall Study||34
2367916|NCT01546142|5811276|P1|NOT COMPLETED|Overall Study||44
2367917|NCT01546142|5811275|P2|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|224
2367918|NCT01546142|5811276|P1|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|214
2367919|NCT01546142|5811275|P2|Received Treatment|Overall Study||257
2367920|NCT01546142|5811276|P1|Received Treatment|Overall Study||257
2367921|NCT01546142|5811275|P2|STARTED|Overall Study||258
2367922|NCT01546142|5811276|P1|STARTED|Overall Study||258
2367923|NCT01546038|5811294|P9|NOT COMPLETED|Overall Study||44
2367924|NCT01546038|5811295|P8|NOT COMPLETED|Overall Study||88
2367925|NCT01546038|5811296|P7|NOT COMPLETED|Overall Study||71
2367926|NCT01546038|5811297|P6|NOT COMPLETED|Overall Study||6
2367927|NCT01546038|5811298|P5|NOT COMPLETED|Overall Study||16
2367928|NCT01546038|5811299|P4|NOT COMPLETED|Overall Study||3
2367929|NCT01546038|5811300|P3|NOT COMPLETED|Overall Study||4
2367930|NCT01546038|5811301|P2|NOT COMPLETED|Overall Study||6
2367931|NCT01546038|5811302|P1|NOT COMPLETED|Overall Study||17
2367932|NCT01546038|5811294|P9|COMPLETED|Overall Study||0
2367933|NCT01546038|5811295|P8|COMPLETED|Overall Study||0
2367934|NCT01546038|5811296|P7|COMPLETED|Overall Study||0
2367935|NCT01546038|5811297|P6|COMPLETED|Overall Study||0
2367936|NCT01546038|5811298|P5|COMPLETED|Overall Study||0
2367937|NCT01546038|5811299|P4|COMPLETED|Overall Study||0
2367938|NCT01546038|5811300|P3|COMPLETED|Overall Study||0
2367939|NCT01546038|5811301|P2|COMPLETED|Overall Study||0
2367940|NCT01546038|5811302|P1|COMPLETED|Overall Study||0
2367941|NCT01546038|5811294|P9|Received Treatment|Overall Study||41
2367942|NCT01546038|5811295|P8|Received Treatment|Overall Study||84
2367943|NCT01546038|5811296|P7|Received Treatment|Overall Study||69
2367944|NCT01546038|5811297|P6|Received Treatment|Overall Study||6
2367945|NCT01546038|5811298|P5|Received Treatment|Overall Study||16
2367946|NCT01546038|5811299|P4|Received Treatment|Overall Study||3
2367947|NCT01546038|5811300|P3|Received Treatment|Overall Study||4
2367948|NCT01546038|5811301|P2|Received Treatment|Overall Study||6
2367949|NCT01546038|5811302|P1|Received Treatment|Overall Study||17
2367950|NCT01546038|5811294|P9|STARTED|Overall Study||44
2367951|NCT01546038|5811295|P8|STARTED|Overall Study||88
2367952|NCT01546038|5811296|P7|STARTED|Overall Study||71
2367953|NCT01546038|5811297|P6|STARTED|Overall Study||6
2367954|NCT01546038|5811298|P5|STARTED|Overall Study||16
2367955|NCT01546038|5811299|P4|STARTED|Overall Study||3
2367956|NCT01546038|5811300|P3|STARTED|Overall Study||4
2367957|NCT01546038|5811301|P2|STARTED|Overall Study||6
2367958|NCT01546038|5811302|P1|STARTED|Overall Study||17
2367959|NCT01545843|5811465|P3|NOT COMPLETED|Overall Study||4
2367960|NCT01545843|5811466|P2|NOT COMPLETED|Overall Study||7
2367961|NCT01545843|5811467|P1|NOT COMPLETED|Overall Study||3
2367962|NCT01545843|5811465|P3|COMPLETED|Overall Study||21
2367963|NCT01545843|5811466|P2|COMPLETED|Overall Study||17
2367964|NCT01545843|5811467|P1|COMPLETED|Overall Study||16
2367965|NCT01545843|5811465|P3|STARTED|Overall Study||25
2367966|NCT01545843|5811466|P2|STARTED|Overall Study||24
2367967|NCT01545843|5811467|P1|STARTED|Overall Study||19
2367968|NCT01545817|5811496|P2|NOT COMPLETED|Everolimus||38
2367969|NCT01545817|5811497|P1|NOT COMPLETED|Everolimus||0
2367970|NCT01545817|5811496|P2|COMPLETED|Everolimus||0
2367971|NCT01545817|5811497|P1|COMPLETED|Everolimus||0
2367972|NCT01545817|5811496|P2|STARTED|Everolimus||38
2367973|NCT01545817|5811497|P1|STARTED|Everolimus||0
2367974|NCT01545817|5811496|P2|NOT COMPLETED|Pazopanib||0
2367975|NCT01545817|5811497|P1|NOT COMPLETED|Pazopanib||74
2367976|NCT01545817|5811496|P2|COMPLETED|Pazopanib||0
2367977|NCT01545817|5811497|P1|COMPLETED|Pazopanib||0
2367978|NCT01545817|5811496|P2|STARTED|Pazopanib||0
2367979|NCT01545817|5811497|P1|STARTED|Pazopanib||74
2367980|NCT01545765|5811508|P1|NOT COMPLETED|Overall Study||0
2367981|NCT01545765|5811508|P1|COMPLETED|Overall Study||31
2367982|NCT01545765|5811508|P1|STARTED|Overall Study||31
2367983|NCT01545700|5811525|P6|NOT COMPLETED|Overall Study||0
2367984|NCT01545700|5811526|P5|NOT COMPLETED|Overall Study||1
2367985|NCT01545700|5811527|P4|NOT COMPLETED|Overall Study||0
2367986|NCT01545700|5811528|P3|NOT COMPLETED|Overall Study||2
2367987|NCT01545700|5811529|P2|NOT COMPLETED|Overall Study||1
2367988|NCT01545700|5811530|P1|NOT COMPLETED|Overall Study||1
2367989|NCT01545700|5811525|P6|COMPLETED|Overall Study||33
2367990|NCT01545700|5811526|P5|COMPLETED|Overall Study||32
2367991|NCT01545700|5811527|P4|COMPLETED|Overall Study||34
2367992|NCT01545700|5811528|P3|COMPLETED|Overall Study||31
2367993|NCT01545700|5811529|P2|COMPLETED|Overall Study||32
2367994|NCT01545700|5811530|P1|COMPLETED|Overall Study||33
2367995|NCT01545700|5811525|P6|STARTED|Overall Study||33
2367996|NCT01545700|5811526|P5|STARTED|Overall Study||33
2367997|NCT01545700|5811527|P4|STARTED|Overall Study||34
2367998|NCT01545700|5811528|P3|STARTED|Overall Study||33
2367999|NCT01545700|5811529|P2|STARTED|Overall Study||33
2368000|NCT01545700|5811530|P1|STARTED|Overall Study||34
2368001|NCT01545648|5811564|P1|NOT COMPLETED|Overall Study||0
2368002|NCT01545648|5811564|P1|COMPLETED|Overall Study||4
2368003|NCT01545648|5811564|P1|6 Months of Treatment|Overall Study||4
2368004|NCT01545648|5811564|P1|STARTED|Overall Study||4
2368005|NCT01545583|5811579|P9|NOT COMPLETED|Overall Study||0
2368006|NCT01545583|5811580|P8|NOT COMPLETED|Overall Study||0
2368007|NCT01545583|5811581|P7|NOT COMPLETED|Overall Study||0
2368008|NCT01545583|5811582|P6|NOT COMPLETED|Overall Study||0
2368009|NCT01545583|5811583|P5|NOT COMPLETED|Overall Study||0
2368010|NCT01545583|5811584|P4|NOT COMPLETED|Overall Study||0
2368011|NCT01545583|5811585|P3|NOT COMPLETED|Overall Study||0
2368012|NCT01545583|5811586|P2|NOT COMPLETED|Overall Study||0
2368013|NCT01545583|5811587|P1|NOT COMPLETED|Overall Study||0
2368014|NCT01545583|5811579|P9|COMPLETED|Overall Study||6
2368015|NCT01545583|5811580|P8|COMPLETED|Overall Study||6
2368016|NCT01545583|5811581|P7|COMPLETED|Overall Study||6
2368017|NCT01545583|5811582|P6|COMPLETED|Overall Study||6
2368018|NCT01545583|5811583|P5|COMPLETED|Overall Study||6
2368019|NCT01545583|5811584|P4|COMPLETED|Overall Study||6
2368020|NCT01545583|5811585|P3|COMPLETED|Overall Study||6
2368021|NCT01545583|5811586|P2|COMPLETED|Overall Study||2
2368022|NCT01545583|5811587|P1|COMPLETED|Overall Study||12
2368023|NCT01545583|5811579|P9|Received at Least 1 Dose of Study Drug|Overall Study||6
2368024|NCT01545583|5811580|P8|Received at Least 1 Dose of Study Drug|Overall Study||6
2368025|NCT01545583|5811581|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
2368026|NCT01545583|5811582|P6|Received at Least 1 Dose of Study Drug|Overall Study||6
2368027|NCT01545583|5811583|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
2368028|NCT01545583|5811584|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
2368029|NCT01545583|5811585|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
2368030|NCT01545583|5811586|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
2368031|NCT01545583|5811587|P1|Received at Least 1 Dose of Study Drug|Overall Study||12
2368032|NCT01545583|5811579|P9|STARTED|Overall Study||6
2368033|NCT01545583|5811580|P8|STARTED|Overall Study||6
2368034|NCT01545583|5811581|P7|STARTED|Overall Study||6
2368035|NCT01545583|5811582|P6|STARTED|Overall Study||6
2368036|NCT01545583|5811583|P5|STARTED|Overall Study||6
2368037|NCT01545583|5811584|P4|STARTED|Overall Study||6
2368038|NCT01545583|5811585|P3|STARTED|Overall Study||6
2368039|NCT01545583|5811586|P2|STARTED|Overall Study||2
2368040|NCT01545583|5811587|P1|STARTED|Overall Study||12
2368041|NCT01545518|5811639|P1|NOT COMPLETED|Overall Study||0
2368042|NCT01545518|5811639|P1|COMPLETED|Overall Study||20
2368043|NCT01545518|5811639|P1|STARTED|Overall Study||20
2368044|NCT01545388|5811646|P3|NOT COMPLETED|Overall Study||8
2368045|NCT01545388|5811647|P2|NOT COMPLETED|Overall Study||11
2368046|NCT01545388|5811648|P1|NOT COMPLETED|Overall Study||8
2368047|NCT01545388|5811646|P3|COMPLETED|Overall Study||58
2368048|NCT01545388|5811647|P2|COMPLETED|Overall Study||122
2368049|NCT01545388|5811648|P1|COMPLETED|Overall Study||130
2368050|NCT01545388|5811646|P3|STARTED|Overall Study||66
2368051|NCT01545388|5811647|P2|STARTED|Overall Study||133
2368052|NCT01545388|5811648|P1|STARTED|Overall Study||138
2368053|NCT01545375|5811667|P2|NOT COMPLETED|Overall Study||90
2368054|NCT01545375|5811668|P1|NOT COMPLETED|Overall Study||97
2368055|NCT01545375|5811667|P2|COMPLETED|Overall Study||813
2368056|NCT01545375|5811668|P1|COMPLETED|Overall Study||803
2368057|NCT01545375|5811667|P2|STARTED|Overall Study||903
2368058|NCT01545375|5811668|P1|STARTED|Overall Study||900
2368059|NCT01545336|5811724|P2|NOT COMPLETED|Overall Study||0
2368060|NCT01545336|5811725|P1|NOT COMPLETED|Overall Study||0
2368061|NCT01545336|5811724|P2|COMPLETED|Overall Study||6
2368062|NCT01545336|5811725|P1|COMPLETED|Overall Study||12
2368063|NCT01545336|5811724|P2|STARTED|Overall Study||6
2368064|NCT01545336|5811725|P1|STARTED|Overall Study||12
2368065|NCT01545232|5811737|P2|NOT COMPLETED|Overall Study||0
2368066|NCT01545232|5811738|P1|NOT COMPLETED|Overall Study||0
2368067|NCT01545232|5811737|P2|COMPLETED|Overall Study||342
2368068|NCT01545232|5811738|P1|COMPLETED|Overall Study||338
2368069|NCT01545232|5811737|P2|STARTED|Overall Study||342
2368070|NCT01545232|5811738|P1|STARTED|Overall Study||338
2368071|NCT01545193|5811770|P2|NOT COMPLETED|Overall Study||1
2368072|NCT01545193|5811771|P1|NOT COMPLETED|Overall Study||0
2368073|NCT01545193|5811770|P2|COMPLETED|Overall Study||149
2368074|NCT01545193|5811771|P1|COMPLETED|Overall Study||150
2368075|NCT01545193|5811770|P2|STARTED|Overall Study||150
2368076|NCT01545193|5811771|P1|STARTED|Overall Study||150
2368077|NCT01545076|5811783|P5|NOT COMPLETED|IgPro10 Rescue Period||0
2368078|NCT01545076|5811784|P4|NOT COMPLETED|IgPro10 Rescue Period||0
2368079|NCT01545076|5811785|P3|NOT COMPLETED|IgPro10 Rescue Period||0
2368080|NCT01545076|5811786|P2|NOT COMPLETED|IgPro10 Rescue Period||0
2368081|NCT01545076|5811787|P1|NOT COMPLETED|IgPro10 Rescue Period||0
2368082|NCT01545076|5811783|P5|COMPLETED|IgPro10 Rescue Period||60
2368083|NCT01545076|5811784|P4|COMPLETED|IgPro10 Rescue Period||0
2368084|NCT01545076|5811785|P3|COMPLETED|IgPro10 Rescue Period||0
2368085|NCT01545076|5811786|P2|COMPLETED|IgPro10 Rescue Period||0
2368086|NCT01545076|5811787|P1|COMPLETED|IgPro10 Rescue Period||0
2368087|NCT01545076|5811783|P5|STARTED|IgPro10 Rescue Period||60
2368088|NCT01545076|5811784|P4|STARTED|IgPro10 Rescue Period||0
2368089|NCT01545076|5811785|P3|STARTED|IgPro10 Rescue Period||0
2368090|NCT01545076|5811786|P2|STARTED|IgPro10 Rescue Period||0
2368091|NCT01545076|5811787|P1|STARTED|IgPro10 Rescue Period||0
2368092|NCT01545076|5811783|P5|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||0
2368093|NCT01545076|5811784|P4|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||36
2368094|NCT01545076|5811785|P3|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||21
2368095|NCT01545076|5811786|P2|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||19
2368096|NCT01545076|5811787|P1|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||0
2368097|NCT01545076|5811783|P5|COMPLETED|IgPro20 Subcutaneous Treatment Period||0
2368098|NCT01545076|5811784|P4|COMPLETED|IgPro20 Subcutaneous Treatment Period||21
2368099|NCT01545076|5811785|P3|COMPLETED|IgPro20 Subcutaneous Treatment Period||36
2368100|NCT01545076|5811786|P2|COMPLETED|IgPro20 Subcutaneous Treatment Period||39
2368101|NCT01545076|5811787|P1|COMPLETED|IgPro20 Subcutaneous Treatment Period||0
2368102|NCT01545076|5811783|P5|STARTED|IgPro20 Subcutaneous Treatment Period||0
2368103|NCT01545076|5811784|P4|STARTED|IgPro20 Subcutaneous Treatment Period||57
2368104|NCT01545076|5811785|P3|STARTED|IgPro20 Subcutaneous Treatment Period||57
2368105|NCT01545076|5811786|P2|STARTED|IgPro20 Subcutaneous Treatment Period||58
2368106|NCT01545076|5811787|P1|STARTED|IgPro20 Subcutaneous Treatment Period||0
2368107|NCT01545076|5811783|P5|NOT COMPLETED|IgPro10 Restabilization Period||0
2368108|NCT01545076|5811784|P4|NOT COMPLETED|IgPro10 Restabilization Period||0
2368109|NCT01545076|5811785|P3|NOT COMPLETED|IgPro10 Restabilization Period||0
2368110|NCT01545076|5811786|P2|NOT COMPLETED|IgPro10 Restabilization Period||0
2368111|NCT01545076|5811787|P1|NOT COMPLETED|IgPro10 Restabilization Period||36
2368112|NCT01545076|5811783|P5|COMPLETED|IgPro10 Restabilization Period||0
2368113|NCT01545076|5811784|P4|COMPLETED|IgPro10 Restabilization Period||0
2368114|NCT01545076|5811785|P3|COMPLETED|IgPro10 Restabilization Period||0
2368115|NCT01545076|5811786|P2|COMPLETED|IgPro10 Restabilization Period||0
2368116|NCT01545076|5811787|P1|COMPLETED|IgPro10 Restabilization Period||172
2368117|NCT01545076|5811783|P5|STARTED|IgPro10 Restabilization Period||0
2368118|NCT01545076|5811784|P4|STARTED|IgPro10 Restabilization Period||0
2368119|NCT01545076|5811785|P3|STARTED|IgPro10 Restabilization Period||0
2368120|NCT01545076|5811786|P2|STARTED|IgPro10 Restabilization Period||0
2368121|NCT01545076|5811787|P1|STARTED|IgPro10 Restabilization Period||208
2368122|NCT01544998|5811837|P2|NOT COMPLETED|Second Intervention (3 Hours)||0
2368123|NCT01544998|5811838|P1|NOT COMPLETED|Second Intervention (3 Hours)||0
2368124|NCT01544998|5811837|P2|COMPLETED|Second Intervention (3 Hours)||15
2368125|NCT01544998|5811838|P1|COMPLETED|Second Intervention (3 Hours)||26
2368126|NCT01544998|5811837|P2|STARTED|Second Intervention (3 Hours)||15
2368127|NCT01544998|5811838|P1|STARTED|Second Intervention (3 Hours)||26
2368128|NCT01544998|5811837|P2|NOT COMPLETED|Washout (1 Week)||0
2368129|NCT01544998|5811838|P1|NOT COMPLETED|Washout (1 Week)||0
2368130|NCT01544998|5811837|P2|COMPLETED|Washout (1 Week)||15
2368131|NCT01544998|5811838|P1|COMPLETED|Washout (1 Week)||26
2368132|NCT01544998|5811837|P2|STARTED|Washout (1 Week)||15
2368133|NCT01544998|5811838|P1|STARTED|Washout (1 Week)||26
2368134|NCT01544998|5811837|P2|NOT COMPLETED|First Intervention (3 Hours)||0
2368135|NCT01544998|5811838|P1|NOT COMPLETED|First Intervention (3 Hours)||0
2368136|NCT01544998|5811837|P2|COMPLETED|First Intervention (3 Hours)||15
2368137|NCT01544998|5811838|P1|COMPLETED|First Intervention (3 Hours)||26
2368138|NCT01544998|5811837|P2|STARTED|First Intervention (3 Hours)||15
2368139|NCT01544998|5811838|P1|STARTED|First Intervention (3 Hours)||26
2368140|NCT01544920|5811858|P2|NOT COMPLETED|Overall Study||23
2368141|NCT01544920|5811859|P1|NOT COMPLETED|Overall Study||19
2368142|NCT01544920|5811858|P2|COMPLETED|Overall Study||346
2368143|NCT01544920|5811859|P1|COMPLETED|Overall Study||349
2368144|NCT01544920|5811858|P2|STARTED|Overall Study||369
2368145|NCT01544920|5811859|P1|STARTED|Overall Study||368
2368146|NCT01544595|5811873|P6|NOT COMPLETED|Status at Week 156||15
2368147|NCT01544595|5811874|P5|NOT COMPLETED|Status at Week 156||38
2368148|NCT01544595|5811875|P4|NOT COMPLETED|Status at Week 156||166
2368149|NCT01544595|5811876|P3|NOT COMPLETED|Status at Week 156||140
2368150|NCT01544595|5811877|P2|NOT COMPLETED|Status at Week 156||78
2368151|NCT01544595|5811878|P1|NOT COMPLETED|Status at Week 156||117
2368152|NCT01544595|5811873|P6|COMPLETED|Status at Week 156||38
2368153|NCT01544595|5811874|P5|COMPLETED|Status at Week 156||60
2368154|NCT01544595|5811875|P4|COMPLETED|Status at Week 156||15
2368155|NCT01544595|5811876|P3|COMPLETED|Status at Week 156||10
2368156|NCT01544595|5811877|P2|COMPLETED|Status at Week 156||285
2368157|NCT01544595|5811878|P1|COMPLETED|Status at Week 156||184
2368158|NCT01544595|5811873|P6|STARTED|Status at Week 156||53
2368159|NCT01544595|5811874|P5|STARTED|Status at Week 156||98
2368160|NCT01544595|5811875|P4|STARTED|Status at Week 156||181
2368161|NCT01544595|5811876|P3|STARTED|Status at Week 156||150
2368162|NCT01544595|5811877|P2|STARTED|Status at Week 156||363
2368163|NCT01544595|5811878|P1|STARTED|Status at Week 156||301
2368164|NCT01544595|5811873|P6|NOT COMPLETED|Status at Week 68||0
2368165|NCT01544595|5811874|P5|NOT COMPLETED|Status at Week 68||0
2368166|NCT01544595|5811875|P4|NOT COMPLETED|Status at Week 68||51
2368167|NCT01544595|5811876|P3|NOT COMPLETED|Status at Week 68||63
2368168|NCT01544595|5811877|P2|NOT COMPLETED|Status at Week 68||17
2368169|NCT01544595|5811878|P1|NOT COMPLETED|Status at Week 68||39
2368170|NCT01544595|5811873|P6|COMPLETED|Status at Week 68|These patients were not in the study arms at this time point.|0
2368171|NCT01544595|5811874|P5|COMPLETED|Status at Week 68|These patients were not in the study arms at this time point.|0
2368172|NCT01544595|5811875|P4|COMPLETED|Status at Week 68||130
2368173|NCT01544595|5811876|P3|COMPLETED|Status at Week 68||87
2368174|NCT01544595|5811877|P2|COMPLETED|Status at Week 68||346
2368175|NCT01544595|5811878|P1|COMPLETED|Status at Week 68||262
2368176|NCT01544595|5811873|P6|STARTED|Status at Week 68|These patients were not in the study arms at this time point.|0
2368177|NCT01544595|5811874|P5|STARTED|Status at Week 68|These patients were not in the study arms at this time point.|0
2368178|NCT01544595|5811875|P4|STARTED|Status at Week 68||181
2368179|NCT01544595|5811876|P3|STARTED|Status at Week 68||150
2368180|NCT01544595|5811877|P2|STARTED|Status at Week 68||363
2368181|NCT01544595|5811878|P1|STARTED|Status at Week 68||301
2368182|NCT01544582|5811954|P4|NOT COMPLETED|Analysis Population||39
2368183|NCT01544582|5811955|P3|NOT COMPLETED|Analysis Population||102
2368184|NCT01544582|5811956|P2|NOT COMPLETED|Analysis Population||118
2368185|NCT01544582|5811957|P1|NOT COMPLETED|Analysis Population||0
2368186|NCT01544582|5811954|P4|COMPLETED|Analysis Population||35
2368187|NCT01544582|5811955|P3|COMPLETED|Analysis Population||205
2368188|NCT01544582|5811956|P2|COMPLETED|Analysis Population||180
2368189|NCT01544582|5811957|P1|COMPLETED|Analysis Population||0
2368190|NCT01544582|5811954|P4|STARTED|Analysis Population||74
2368191|NCT01544582|5811955|P3|STARTED|Analysis Population||307
2368192|NCT01544582|5811956|P2|STARTED|Analysis Population||298
2368193|NCT01544582|5811957|P1|STARTED|Analysis Population|Analysis Population was grouped into Boceprevir+PR, Telaprevir+PR, or PR Alone|0
2368194|NCT01544582|5811954|P4|NOT COMPLETED|Screening/Eligibility||0
2368195|NCT01544582|5811955|P3|NOT COMPLETED|Screening/Eligibility||0
2368196|NCT01544582|5811956|P2|NOT COMPLETED|Screening/Eligibility||0
2368197|NCT01544582|5811957|P1|NOT COMPLETED|Screening/Eligibility||34
2368198|NCT01544582|5811954|P4|COMPLETED|Screening/Eligibility||0
2368199|NCT01544582|5811955|P3|COMPLETED|Screening/Eligibility||0
2368200|NCT01544582|5811956|P2|COMPLETED|Screening/Eligibility||0
2368201|NCT01544582|5811957|P1|COMPLETED|Screening/Eligibility|Completed means met criteria for Analysis Population|679
2368202|NCT01544582|5811954|P4|Analysis Population|Screening/Eligibility||0
2368203|NCT01544582|5811955|P3|Analysis Population|Screening/Eligibility||0
2368204|NCT01544582|5811956|P2|Analysis Population|Screening/Eligibility||0
2368205|NCT01544582|5811957|P1|Analysis Population|Screening/Eligibility||679
2368206|NCT01544582|5811954|P4|STARTED|Screening/Eligibility||0
2368207|NCT01544582|5811955|P3|STARTED|Screening/Eligibility||0
2368208|NCT01544582|5811956|P2|STARTED|Screening/Eligibility||0
2368209|NCT01544582|5811957|P1|STARTED|Screening/Eligibility||713
2368210|NCT01544491|5812017|P2|NOT COMPLETED|Overall Study||3
2368211|NCT01544491|5812018|P1|NOT COMPLETED|Overall Study||5
2368212|NCT01544491|5812017|P2|COMPLETED|Overall Study||51
2368213|NCT01544491|5812018|P1|COMPLETED|Overall Study||47
2368214|NCT01544491|5812017|P2|STARTED|Overall Study||54
2368215|NCT01544491|5812018|P1|STARTED|Overall Study||52
2368216|NCT01544478|5812044|P1|NOT COMPLETED|Overall Study||118
2368217|NCT01544478|5812044|P1|COMPLETED|Overall Study||912
2368218|NCT01544478|5812044|P1|Vaccination 3|Overall Study||1019
2368219|NCT01544478|5812044|P1|Vaccination 2|Overall Study||1026
2368220|NCT01544478|5812044|P1|Vaccination 1|Overall Study||1030
2368221|NCT01544478|5812044|P1|STARTED|Overall Study||1030
2368222|NCT01544361|5812053|P5|NOT COMPLETED|Overall Study||0
2368223|NCT01544361|5812054|P4|NOT COMPLETED|Overall Study||0
2368224|NCT01544361|5812055|P3|NOT COMPLETED|Overall Study||0
2368225|NCT01544361|5812056|P2|NOT COMPLETED|Overall Study||0
2368226|NCT01544361|5812057|P1|NOT COMPLETED|Overall Study||0
2368227|NCT01544361|5812053|P5|COMPLETED|Overall Study||6
2368228|NCT01544361|5812054|P4|COMPLETED|Overall Study||6
2368229|NCT01544361|5812055|P3|COMPLETED|Overall Study||6
2368230|NCT01544361|5812056|P2|COMPLETED|Overall Study||6
2368231|NCT01544361|5812057|P1|COMPLETED|Overall Study||8
2368232|NCT01544361|5812053|P5|STARTED|Overall Study||6
2368233|NCT01544361|5812054|P4|STARTED|Overall Study||6
2368234|NCT01544361|5812055|P3|STARTED|Overall Study||6
2368235|NCT01544361|5812056|P2|STARTED|Overall Study||6
2368236|NCT01544361|5812057|P1|STARTED|Overall Study||8
2368237|NCT01544348|5812087|P8|NOT COMPLETED|Overall Study||0
2368238|NCT01544348|5812088|P7|NOT COMPLETED|Overall Study||2
2368239|NCT01544348|5812089|P6|NOT COMPLETED|Overall Study||3
2368240|NCT01544348|5812090|P5|NOT COMPLETED|Overall Study||1
2368241|NCT01544348|5812091|P4|NOT COMPLETED|Overall Study||0
2368242|NCT01544348|5812092|P3|NOT COMPLETED|Overall Study||0
2368243|NCT01544348|5812093|P2|NOT COMPLETED|Overall Study||0
2368244|NCT01544348|5812094|P1|NOT COMPLETED|Overall Study||2
2368245|NCT01544348|5812087|P8|COMPLETED|Overall Study||8
2368246|NCT01544348|5812088|P7|COMPLETED|Overall Study||12
2368247|NCT01544348|5812089|P6|COMPLETED|Overall Study||16
2368248|NCT01544348|5812090|P5|COMPLETED|Overall Study||15
2368249|NCT01544348|5812091|P4|COMPLETED|Overall Study||3
2368250|NCT01544348|5812092|P3|COMPLETED|Overall Study||3
2368251|NCT01544348|5812093|P2|COMPLETED|Overall Study||6
2368252|NCT01544348|5812094|P1|COMPLETED|Overall Study||15
2368253|NCT01544348|5812087|P8|Treated|Overall Study||8
2368254|NCT01544348|5812088|P7|Treated|Overall Study||14
2368255|NCT01544348|5812089|P6|Treated|Overall Study||18
2368256|NCT01544348|5812090|P5|Treated|Overall Study||15
2368257|NCT01544348|5812091|P4|Treated|Overall Study||3
2368258|NCT01544348|5812092|P3|Treated|Overall Study||3
2368259|NCT01544348|5812093|P2|Treated|Overall Study||6
2368260|NCT01544348|5812094|P1|Treated|Overall Study||17
2368261|NCT01544348|5812087|P8|STARTED|Overall Study||8
2368262|NCT01544348|5812088|P7|STARTED|Overall Study||14
2368263|NCT01544348|5812089|P6|STARTED|Overall Study||19
2368264|NCT01544348|5812090|P5|STARTED|Overall Study||16
2368265|NCT01544348|5812091|P4|STARTED|Overall Study||3
2368266|NCT01544348|5812092|P3|STARTED|Overall Study||3
2368267|NCT01544348|5812093|P2|STARTED|Overall Study||6
2368268|NCT01544348|5812094|P1|STARTED|Overall Study||17
2368269|NCT01544309|5812136|P2|NOT COMPLETED|Overall Study||11
2368270|NCT01544309|5812137|P1|NOT COMPLETED|Overall Study||20
2368271|NCT01544309|5812136|P2|COMPLETED|Overall Study||514
2368272|NCT01544309|5812137|P1|COMPLETED|Overall Study||504
2368273|NCT01544309|5812136|P2|STARTED|Overall Study||525
2368274|NCT01544309|5812137|P1|STARTED|Overall Study||524
2368275|NCT01544179|5812175|P2|NOT COMPLETED|Overall Study||46
2368276|NCT01544179|5812176|P1|NOT COMPLETED|Overall Study||63
2368277|NCT01544179|5812175|P2|COMPLETED|Overall Study|Patients are ongoing in the study|86
2368278|NCT01544179|5812176|P1|COMPLETED|Overall Study|Patients are ongoing in the study|70
2368279|NCT01544179|5812175|P2|Did Not Receive Treatment|Overall Study||0
2368280|NCT01544179|5812176|P1|Did Not Receive Treatment|Overall Study||1
2368281|NCT01544179|5812175|P2|Received Treatment|Overall Study||132
2368282|NCT01544179|5812176|P1|Received Treatment|Overall Study||132
2368283|NCT01544179|5812175|P2|STARTED|Overall Study||132
2368284|NCT01544179|5812176|P1|STARTED|Overall Study||133
2368285|NCT01544166|5812204|P1|NOT COMPLETED|Overall Study||0
2368286|NCT01544166|5812204|P1|COMPLETED|Overall Study||44
2368287|NCT01544166|5812204|P1|STARTED|Overall Study||44
2368288|NCT01544153|5812269|P4|NOT COMPLETED|Overall Study||0
2368289|NCT01544153|5812270|P3|NOT COMPLETED|Overall Study||1
2368290|NCT01544153|5812271|P2|NOT COMPLETED|Overall Study||1
2368291|NCT01544153|5812272|P1|NOT COMPLETED|Overall Study||0
2368292|NCT01544153|5812269|P4|COMPLETED|Overall Study||1317
2368293|NCT01544153|5812270|P3|COMPLETED|Overall Study||1313
2368294|NCT01544153|5812271|P2|COMPLETED|Overall Study||1323
2368295|NCT01544153|5812272|P1|COMPLETED|Overall Study||1337
2368296|NCT01544153|5812269|P4|STARTED|Overall Study||1317
2368297|NCT01544153|5812270|P3|STARTED|Overall Study||1314
2368298|NCT01544153|5812271|P2|STARTED|Overall Study||1324
2368299|NCT01544153|5812272|P1|STARTED|Overall Study||1337
2368300|NCT01544127|5812289|P3|NOT COMPLETED|Overall Study||14
2368301|NCT01544127|5812290|P2|NOT COMPLETED|Overall Study||6
2368302|NCT01544127|5812291|P1|NOT COMPLETED|Overall Study||11
2368303|NCT01544127|5812289|P3|COMPLETED|Overall Study||52
2368304|NCT01544127|5812290|P2|COMPLETED|Overall Study||27
2368305|NCT01544127|5812291|P1|COMPLETED|Overall Study||22
2368306|NCT01544127|5812289|P3|STARTED|Overall Study||66
2368307|NCT01544127|5812290|P2|STARTED|Overall Study||33
2368308|NCT01544127|5812291|P1|STARTED|Overall Study||33
2368309|NCT01544114|5812311|P3|NOT COMPLETED|Overall Study||5
2368310|NCT01544114|5812312|P2|NOT COMPLETED|Overall Study||4
2368311|NCT01544114|5812313|P1|NOT COMPLETED|Overall Study||1
2368312|NCT01544114|5812311|P3|COMPLETED|Overall Study|completed study and received 6 months of study drug|17
2368313|NCT01544114|5812312|P2|COMPLETED|Overall Study|completed study and received 6 months of study drug|16
2368314|NCT01544114|5812313|P1|COMPLETED|Overall Study|completed study and received 6 months of study drug|3
2368315|NCT01544114|5812311|P3|STARTED|Overall Study||22
2368316|NCT01544114|5812312|P2|STARTED|Overall Study||20
2368317|NCT01544114|5812313|P1|STARTED|Overall Study||4
2368318|NCT01544088|5812344|P2|NOT COMPLETED|Overall Study||21
2368319|NCT01544088|5812345|P1|NOT COMPLETED|Overall Study||37
2368320|NCT01544088|5812344|P2|COMPLETED|Overall Study||79
2368321|NCT01544088|5812345|P1|COMPLETED|Overall Study||61
2368322|NCT01544088|5812344|P2|STARTED|Overall Study||100
2368323|NCT01544088|5812345|P1|STARTED|Overall Study||98
2368324|NCT01544062|5812359|P2|NOT COMPLETED|Overall Study||0
2368325|NCT01544062|5812360|P1|NOT COMPLETED|Overall Study||0
2368326|NCT01544062|5812359|P2|COMPLETED|Overall Study||35
2368327|NCT01544062|5812360|P1|COMPLETED|Overall Study||33
2368328|NCT01544062|5812359|P2|STARTED|Overall Study||35
2368329|NCT01544062|5812360|P1|STARTED|Overall Study||33
2368330|NCT01544023|5812406|P1|NOT COMPLETED|Overall Study||0
2368331|NCT01544023|5812406|P1|COMPLETED|Overall Study||207
2368332|NCT01544023|5812406|P1|STARTED|Overall Study|retrospective|207
2368333|NCT01543958|5812411|P1|NOT COMPLETED|Overall Study||4
2368334|NCT01543958|5812411|P1|COMPLETED|Overall Study||36
2368335|NCT01543958|5812411|P1|STARTED|Overall Study||40
2368336|NCT01543828|5812466|P2|NOT COMPLETED|Treatment 2||0
2368337|NCT01543828|5812467|P1|NOT COMPLETED|Treatment 2||1
2368338|NCT01543828|5812466|P2|COMPLETED|Treatment 2||19
2368339|NCT01543828|5812467|P1|COMPLETED|Treatment 2||19
2368340|NCT01543828|5812466|P2|STARTED|Treatment 2|1 participant completed treatment 1, had an adverse event, and did not receive treatment 2.|19
2368341|NCT01543828|5812467|P1|STARTED|Treatment 2||20
2368342|NCT01543828|5812466|P2|NOT COMPLETED|Treatment 1||0
2368343|NCT01543828|5812467|P1|NOT COMPLETED|Treatment 1||0
2368344|NCT01543828|5812466|P2|COMPLETED|Treatment 1||20
2368345|NCT01543828|5812467|P1|COMPLETED|Treatment 1||20
2368346|NCT01543828|5812466|P2|STARTED|Treatment 1||20
2368347|NCT01543828|5812467|P1|STARTED|Treatment 1||20
2368348|NCT01543776|5812477|P2|NOT COMPLETED|Overall Study||2
2368349|NCT01543776|5812478|P1|NOT COMPLETED|Overall Study||2
2368350|NCT01543776|5812477|P2|COMPLETED|Overall Study||34
2368351|NCT01543776|5812478|P1|COMPLETED|Overall Study||34
2368352|NCT01543776|5812477|P2|STARTED|Overall Study||36
2368353|NCT01543776|5812478|P1|STARTED|Overall Study||36
2368354|NCT01543685|5812497|P5|NOT COMPLETED|Overall Study||4
2368355|NCT01543685|5812498|P4|NOT COMPLETED|Overall Study||0
2368356|NCT01543685|5812499|P3|NOT COMPLETED|Overall Study||2
2368357|NCT01543685|5812500|P2|NOT COMPLETED|Overall Study||3
2368358|NCT01543685|5812501|P1|NOT COMPLETED|Overall Study||3
2368359|NCT01543685|5812497|P5|COMPLETED|Overall Study||90
2368360|NCT01543685|5812498|P4|COMPLETED|Overall Study||93
2368361|NCT01543685|5812499|P3|COMPLETED|Overall Study||89
2368362|NCT01543685|5812500|P2|COMPLETED|Overall Study||88
2368363|NCT01543685|5812501|P1|COMPLETED|Overall Study||90
2368364|NCT01543685|5812497|P5|STARTED|Overall Study||94
2368365|NCT01543685|5812498|P4|STARTED|Overall Study||93
2368366|NCT01543685|5812499|P3|STARTED|Overall Study||91
2368367|NCT01543685|5812500|P2|STARTED|Overall Study||91
2368368|NCT01543685|5812501|P1|STARTED|Overall Study||93
2368369|NCT01543607|5812548|P1|NOT COMPLETED|Overall Study||0
2368370|NCT01543607|5812548|P1|COMPLETED|Overall Study||1
2368371|NCT01543607|5812548|P1|STARTED|Overall Study||1
2368372|NCT01543581|5812554|P2|NOT COMPLETED|Overall Study||0
2368373|NCT01543581|5812555|P1|NOT COMPLETED|Overall Study||0
2368374|NCT01543581|5812554|P2|COMPLETED|Overall Study||0
2368375|NCT01543581|5812555|P1|COMPLETED|Overall Study||1
2368376|NCT01543581|5812554|P2|STARTED|Overall Study||0
2368377|NCT01543581|5812555|P1|STARTED|Overall Study||1
2368378|NCT01543568|5812561|P1|NOT COMPLETED|Overall Study||1
2368379|NCT01543568|5812561|P1|COMPLETED|Overall Study||45
2368380|NCT01543568|5812561|P1|STARTED|Overall Study||46
2368381|NCT01543503|5812573|P2|NOT COMPLETED|Overall Study||87
2368382|NCT01543503|5812574|P1|NOT COMPLETED|Overall Study||76
2368383|NCT01543503|5812573|P2|COMPLETED|Overall Study||711
2368384|NCT01543503|5812574|P1|COMPLETED|Overall Study||350
2368385|NCT01543503|5812573|P2|STARTED|Overall Study||798
2368386|NCT01543503|5812574|P1|STARTED|Overall Study||426
2368387|NCT01543204|5812618|P1|NOT COMPLETED|Overall Study||8
2368388|NCT01543204|5812618|P1|COMPLETED|Overall Study||56
2368389|NCT01543204|5812618|P1|STARTED|Overall Study||64
2368390|NCT01543178|5812665|P3|NOT COMPLETED|Double-blind Period||37
2368391|NCT01543178|5812666|P2|NOT COMPLETED|Double-blind Period||44
2368392|NCT01543178|5812667|P1|NOT COMPLETED|Double-blind Period||0
2368393|NCT01543178|5812665|P3|COMPLETED|Double-blind Period|283 completed 1st double-blind retreatment and 271 completed 2nd double-blind retreatment.|271
2368394|NCT01543178|5812666|P2|COMPLETED|Double-blind Period|295 completed 1st double-blind retreatment and 284 completed 2nd double-blind retreatment.|284
2368395|NCT01543178|5812667|P1|COMPLETED|Double-blind Period||0
2368396|NCT01543178|5812665|P3|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 308 randomized to placebo.|308
2368397|NCT01543178|5812666|P2|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 328 randomized to rifaximin.|328
2368398|NCT01543178|5812667|P1|STARTED|Double-blind Period|The open-label rifaximin arm/group is not applicable to the double-blind period.|0
2368399|NCT01543178|5812665|P3|NOT COMPLETED|Open-label Period||0
2368400|NCT01543178|5812666|P2|NOT COMPLETED|Open-label Period||0
2368401|NCT01543178|5812667|P1|NOT COMPLETED|Open-label Period||1947
2368402|NCT01543178|5812665|P3|COMPLETED|Open-label Period||0
2368403|NCT01543178|5812666|P2|COMPLETED|Open-label Period||0
2368404|NCT01543178|5812667|P1|COMPLETED|Open-label Period||636
2368405|NCT01543178|5812665|P3|STARTED|Open-label Period|The double-blind placebo arm/group is not applicable to the open-label period.|0
2368406|NCT01543178|5812666|P2|STARTED|Open-label Period|The double-blind rifaximin arm/group is not applicable to the open-label period.|0
2368407|NCT01543178|5812667|P1|STARTED|Open-label Period|2583 subjects entered the open-label period, but 4 received no rifaximin; 2579 received rifaximin.|2583
2368408|NCT01543074|5812678|P4|NOT COMPLETED|Overall Study||0
2368409|NCT01543074|5812679|P3|NOT COMPLETED|Overall Study||0
2368410|NCT01543074|5812680|P2|NOT COMPLETED|Overall Study||0
2368411|NCT01543074|5812681|P1|NOT COMPLETED|Overall Study||0
2368412|NCT01543074|5812678|P4|COMPLETED|Overall Study||6
2368413|NCT01543074|5812679|P3|COMPLETED|Overall Study||5
2368414|NCT01543074|5812680|P2|COMPLETED|Overall Study||7
2368415|NCT01543074|5812681|P1|COMPLETED|Overall Study||5
2368416|NCT01543074|5812678|P4|STARTED|Overall Study||6
2368417|NCT01543074|5812679|P3|STARTED|Overall Study||5
2368418|NCT01543074|5812680|P2|STARTED|Overall Study||7
2368419|NCT01543074|5812681|P1|STARTED|Overall Study||5
2368420|NCT01542957|5812701|P2|NOT COMPLETED|12-month Follow-up||13
2368421|NCT01542957|5812702|P1|NOT COMPLETED|12-month Follow-up||16
2368422|NCT01542957|5812701|P2|COMPLETED|12-month Follow-up||40
2368423|NCT01542957|5812702|P1|COMPLETED|12-month Follow-up||37
2368424|NCT01542957|5812701|P2|STARTED|12-month Follow-up||53
2368425|NCT01542957|5812702|P1|STARTED|12-month Follow-up||53
2368426|NCT01542957|5812701|P2|NOT COMPLETED|3-month Follow-up||8
2368427|NCT01542957|5812702|P1|NOT COMPLETED|3-month Follow-up||3
2368428|NCT01542957|5812701|P2|COMPLETED|3-month Follow-up||45
2368429|NCT01542957|5812702|P1|COMPLETED|3-month Follow-up||50
2368430|NCT01542957|5812701|P2|STARTED|3-month Follow-up||53
2368431|NCT01542957|5812702|P1|STARTED|3-month Follow-up||53
2368432|NCT01542957|5812701|P2|NOT COMPLETED|End of Therapy||10
2368433|NCT01542957|5812702|P1|NOT COMPLETED|End of Therapy||12
2368434|NCT01542957|5812701|P2|COMPLETED|End of Therapy||53
2368435|NCT01542957|5812702|P1|COMPLETED|End of Therapy||53
2368436|NCT01542957|5812701|P2|STARTED|End of Therapy||63
2368437|NCT01542957|5812702|P1|STARTED|End of Therapy||65
2368438|NCT01542788|5812714|P2|NOT COMPLETED|Overall Study||71
2368439|NCT01542788|5812715|P1|NOT COMPLETED|Overall Study||55
2368440|NCT01542788|5812714|P2|COMPLETED|Overall Study||0
2368441|NCT01542788|5812715|P1|COMPLETED|Overall Study||154
2368442|NCT01542788|5812714|P2|Randomized and Treated|Overall Study||71
2368443|NCT01542788|5812715|P1|Randomized and Treated|Overall Study||207
2368444|NCT01542788|5812714|P2|STARTED|Overall Study||71
2368445|NCT01542788|5812715|P1|STARTED|Overall Study||209
2368446|NCT01542684|5812731|P1|NOT COMPLETED|Overall Study||0
2368447|NCT01542684|5812731|P1|COMPLETED|Overall Study||8
2368448|NCT01542684|5812731|P1|STARTED|Overall Study||8
2368449|NCT01542645|5812737|P2|NOT COMPLETED|Overall Study||3
2368450|NCT01542645|5812738|P1|NOT COMPLETED|Overall Study||5
2368451|NCT01542645|5812737|P2|COMPLETED|Overall Study||79
2368452|NCT01542645|5812738|P1|COMPLETED|Overall Study||77
2368453|NCT01542645|5812737|P2|STARTED|Overall Study||82
2368454|NCT01542645|5812738|P1|STARTED|Overall Study||82
2368455|NCT01542632|5812762|P6|NOT COMPLETED|Overall Study||0
2368456|NCT01542632|5812763|P5|NOT COMPLETED|Overall Study||4
2368457|NCT01542632|5812764|P4|NOT COMPLETED|Overall Study||2
2368458|NCT01542632|5812765|P3|NOT COMPLETED|Overall Study||1
2368459|NCT01542632|5812766|P2|NOT COMPLETED|Overall Study||1
2368460|NCT01542632|5812767|P1|NOT COMPLETED|Overall Study||0
2368461|NCT01542632|5812762|P6|COMPLETED|Overall Study||24
2368462|NCT01542632|5812763|P5|COMPLETED|Overall Study||17
2368463|NCT01542632|5812764|P4|COMPLETED|Overall Study||19
2368464|NCT01542632|5812765|P3|COMPLETED|Overall Study||23
2368465|NCT01542632|5812766|P2|COMPLETED|Overall Study||24
2368466|NCT01542632|5812767|P1|COMPLETED|Overall Study||25
2368467|NCT01542632|5812762|P6|STARTED|Overall Study||24
2368468|NCT01542632|5812763|P5|STARTED|Overall Study||21
2368469|NCT01542632|5812764|P4|STARTED|Overall Study||21
2368470|NCT01542632|5812765|P3|STARTED|Overall Study||24
2368471|NCT01542632|5812766|P2|STARTED|Overall Study||25
2368472|NCT01542632|5812767|P1|STARTED|Overall Study||25
2368473|NCT01542541|5812813|P2|NOT COMPLETED|Overall Study||0
2368474|NCT01542541|5812814|P1|NOT COMPLETED|Overall Study||8
2368475|NCT01542541|5812813|P2|COMPLETED|Overall Study||30
2368476|NCT01542541|5812814|P1|COMPLETED|Overall Study||30
2368477|NCT01542541|5812813|P2|STARTED|Overall Study||30
2368478|NCT01542541|5812814|P1|STARTED|Overall Study||38
2368479|NCT01542528|5812824|P2|NOT COMPLETED|Overall Study||7
2368480|NCT01542528|5812825|P1|NOT COMPLETED|Overall Study||12
2368481|NCT01542528|5812824|P2|COMPLETED|Overall Study||49
2368482|NCT01542528|5812825|P1|COMPLETED|Overall Study||49
2368483|NCT01542528|5812824|P2|STARTED|Overall Study||56
2368484|NCT01542528|5812825|P1|STARTED|Overall Study||61
2368485|NCT01542502|5812833|P2|NOT COMPLETED|Overall Study||0
2368486|NCT01542502|5812834|P1|NOT COMPLETED|Overall Study||0
2368487|NCT01542502|5812833|P2|COMPLETED|Overall Study||6
2368488|NCT01542502|5812834|P1|COMPLETED|Overall Study||6
2368489|NCT01542502|5812833|P2|STARTED|Overall Study||6
2368490|NCT01542502|5812834|P1|STARTED|Overall Study||6
2368491|NCT01542398|5812844|P2|NOT COMPLETED|Overall Study||13
2368492|NCT01542398|5812845|P1|NOT COMPLETED|Overall Study||8
2368493|NCT01542398|5812844|P2|COMPLETED|Overall Study||67
2368494|NCT01542398|5812845|P1|COMPLETED|Overall Study||71
2368495|NCT01542398|5812844|P2|Post-Intervention Assessment|Overall Study||80
2368496|NCT01542398|5812845|P1|Post-Intervention Assessment|Overall Study||78
2368497|NCT01542398|5812844|P2|STARTED|Overall Study||80
2368498|NCT01542398|5812845|P1|STARTED|Overall Study||79
2368499|NCT01542372|5812853|P2|NOT COMPLETED|Overall Study||0
2368500|NCT01542372|5812854|P1|NOT COMPLETED|Overall Study||0
2368501|NCT01542372|5812853|P2|COMPLETED|Overall Study||11
2368502|NCT01542372|5812854|P1|COMPLETED|Overall Study||11
2368503|NCT01542372|5812853|P2|STARTED|Overall Study||11
2368504|NCT01542372|5812854|P1|STARTED|Overall Study||11
2368505|NCT01542307|5812869|P2|NOT COMPLETED|Overall Study||0
2368506|NCT01542307|5812870|P1|NOT COMPLETED|Overall Study||0
2368507|NCT01542307|5812869|P2|COMPLETED|Overall Study||22
2368508|NCT01542307|5812870|P1|COMPLETED|Overall Study||22
2368509|NCT01542307|5812869|P2|STARTED|Overall Study|Each subject inhaled Medical Air for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
2368510|NCT01542307|5812870|P1|STARTED|Overall Study|Each subject inhaled Oxygen for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
2368511|NCT01542255|5812890|P1|NOT COMPLETED|Overall Study||0
2368512|NCT01542255|5812890|P1|COMPLETED|Overall Study||7
2368513|NCT01542255|5812890|P1|Analyzed for Time to Progression|Overall Study||7
2368514|NCT01542255|5812890|P1|STARTED|Overall Study||7
2368515|NCT01542229|5812897|P2|NOT COMPLETED|Overall Study||36
2368516|NCT01542229|5812898|P1|NOT COMPLETED|Overall Study||23
2368517|NCT01542229|5812897|P2|COMPLETED|Overall Study||30
2368518|NCT01542229|5812898|P1|COMPLETED|Overall Study||45
2368519|NCT01542229|5812897|P2|STARTED|Overall Study||66
2368520|NCT01542229|5812898|P1|STARTED|Overall Study||68
2368521|NCT01542125|5812924|P2|NOT COMPLETED|Overall Study||0
2368522|NCT01542125|5812925|P1|NOT COMPLETED|Overall Study||0
2368523|NCT01542125|5812924|P2|COMPLETED|Overall Study||141
2368524|NCT01542125|5812925|P1|COMPLETED|Overall Study||140
2368525|NCT01542125|5812924|P2|STARTED|Overall Study||141
2368526|NCT01542125|5812925|P1|STARTED|Overall Study||140
2368527|NCT01542034|5812933|P2|NOT COMPLETED|Overall Study||23
2368528|NCT01542034|5812934|P1|NOT COMPLETED|Overall Study||30
2368529|NCT01542034|5812933|P2|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|227
2368530|NCT01542034|5812934|P1|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|226
2368531|NCT01542034|5812933|P2|Received Treatment|Overall Study||249
2368532|NCT01542034|5812934|P1|Received Treatment|Overall Study||256
2368533|NCT01542034|5812933|P2|STARTED|Overall Study||250
2368534|NCT01542034|5812934|P1|STARTED|Overall Study||256
2368535|NCT01541969|5812948|P2|NOT COMPLETED|Open Label Extension (12-36 Weeks)||13
2368536|NCT01541969|5812949|P1|NOT COMPLETED|Open Label Extension (12-36 Weeks)||11
2368537|NCT01541969|5812948|P2|COMPLETED|Open Label Extension (12-36 Weeks)||35
2368538|NCT01541969|5812949|P1|COMPLETED|Open Label Extension (12-36 Weeks)||33
2368539|NCT01541969|5812948|P2|STARTED|Open Label Extension (12-36 Weeks)||48
2368540|NCT01541969|5812949|P1|STARTED|Open Label Extension (12-36 Weeks)||44
2368541|NCT01541969|5812948|P2|NOT COMPLETED|Double-blind (0-12 Weeks)||2
2368542|NCT01541969|5812949|P1|NOT COMPLETED|Double-blind (0-12 Weeks)||6
2368543|NCT01541969|5812948|P2|COMPLETED|Double-blind (0-12 Weeks)||48
2368544|NCT01541969|5812949|P1|COMPLETED|Double-blind (0-12 Weeks)||44
2368545|NCT01541969|5812948|P2|STARTED|Double-blind (0-12 Weeks)||50
2368546|NCT01541969|5812949|P1|STARTED|Double-blind (0-12 Weeks)||50
2368547|NCT01541930|5812965|P1|NOT COMPLETED|Overall Study||1
2368548|NCT01541930|5812965|P1|COMPLETED|Overall Study||20
2368549|NCT01541930|5812965|P1|STARTED|Overall Study||21
2368550|NCT01541917|5812987|P2|NOT COMPLETED|Overall Study||9
2368551|NCT01541917|5812988|P1|NOT COMPLETED|Overall Study||15
2368552|NCT01541917|5812987|P2|COMPLETED|Overall Study||136
2368553|NCT01541917|5812988|P1|COMPLETED|Overall Study||129
2368554|NCT01541917|5812987|P2|STARTED|Overall Study||145
2368555|NCT01541917|5812988|P1|STARTED|Overall Study||144
2368556|NCT01541891|5813006|P2|NOT COMPLETED|Overall Study||1
2368557|NCT01541891|5813007|P1|NOT COMPLETED|Overall Study||1
2368558|NCT01541891|5813006|P2|COMPLETED|Overall Study||14
2368559|NCT01541891|5813007|P1|COMPLETED|Overall Study||14
2368560|NCT01541891|5813006|P2|STARTED|Overall Study||15
2368561|NCT01541891|5813007|P1|STARTED|Overall Study||15
2368562|NCT01541865|5813017|P1|NOT COMPLETED|Overall Study||22
2368563|NCT01541865|5813017|P1|COMPLETED|Overall Study||124
2368564|NCT01541865|5813017|P1|STARTED|Overall Study||146
2368565|NCT01541826|5813035|P3|NOT COMPLETED|Overall Study||0
2368566|NCT01541826|5813036|P2|NOT COMPLETED|Overall Study||3
2368567|NCT01541826|5813037|P1|NOT COMPLETED|Overall Study||4
2368568|NCT01541826|5813035|P3|COMPLETED|Overall Study||6
2368569|NCT01541826|5813036|P2|COMPLETED|Overall Study||25
2368570|NCT01541826|5813037|P1|COMPLETED|Overall Study||24
2368571|NCT01541826|5813035|P3|STARTED|Overall Study||6
2368572|NCT01541826|5813036|P2|STARTED|Overall Study||28
2368573|NCT01541826|5813037|P1|STARTED|Overall Study||28
2368574|NCT01541735|5813106|P2|NOT COMPLETED|Overall Study||0
2368575|NCT01541735|5813107|P1|NOT COMPLETED|Overall Study||0
2368576|NCT01541735|5813106|P2|COMPLETED|Overall Study||7
2368577|NCT01541735|5813107|P1|COMPLETED|Overall Study||7
2368578|NCT01541735|5813106|P2|STARTED|Overall Study||7
2368579|NCT01541735|5813107|P1|STARTED|Overall Study||7
2368580|NCT01541644|5813119|P1|NOT COMPLETED|Overall Study||3
2368581|NCT01541644|5813119|P1|COMPLETED|Overall Study||24
2368582|NCT01541644|5813119|P1|STARTED|Overall Study||27
2368583|NCT01541553|5813125|P2|NOT COMPLETED|Overall Study||14
2368584|NCT01541553|5813126|P1|NOT COMPLETED|Overall Study||12
2368585|NCT01541553|5813125|P2|COMPLETED|Overall Study||148
2368586|NCT01541553|5813126|P1|COMPLETED|Overall Study||155
2368587|NCT01541553|5813125|P2|STARTED|Overall Study||162
2368588|NCT01541553|5813126|P1|STARTED|Overall Study||167
2368589|NCT01541397|5813138|P2|NOT COMPLETED|Overall Study||2
2368590|NCT01541397|5813139|P1|NOT COMPLETED|Overall Study||4
2368591|NCT01541397|5813138|P2|COMPLETED|Overall Study||0
2368592|NCT01541397|5813139|P1|COMPLETED|Overall Study||0
2368593|NCT01541397|5813138|P2|STARTED|Overall Study||2
2368594|NCT01541397|5813139|P1|STARTED|Overall Study||4
2368595|NCT01541384|5813154|P3|NOT COMPLETED|Overall Study||2
2368596|NCT01541384|5813155|P2|NOT COMPLETED|Overall Study||1
2368597|NCT01541384|5813156|P1|NOT COMPLETED|Overall Study||0
2368598|NCT01541384|5813154|P3|COMPLETED|Overall Study||38
2368599|NCT01541384|5813155|P2|COMPLETED|Overall Study||39
2368600|NCT01541384|5813156|P1|COMPLETED|Overall Study||40
2368601|NCT01541384|5813154|P3|STARTED|Overall Study||40
2368602|NCT01541384|5813155|P2|STARTED|Overall Study||40
2368603|NCT01541384|5813156|P1|STARTED|Overall Study||40
2368604|NCT01541371|5813164|P1|NOT COMPLETED|Overall Study||77
2368605|NCT01541371|5813164|P1|COMPLETED|Overall Study||326
2368606|NCT01541371|5813164|P1|Full Analysis Set|Overall Study||394
2368607|NCT01541371|5813164|P1|STARTED|Overall Study||403
2368608|NCT01541358|5813187|P1|NOT COMPLETED|Overall Study||0
2368609|NCT01541358|5813187|P1|COMPLETED|Overall Study||2
2368610|NCT01541358|5813187|P1|STARTED|Overall Study||2
2368611|NCT01541254|5813193|P1|NOT COMPLETED|Overall Study||6
2368612|NCT01541254|5813193|P1|COMPLETED|Overall Study||30
2368613|NCT01541254|5813193|P1|STARTED|Overall Study||36
2368614|NCT01541215|5813200|P2|NOT COMPLETED|Overall Study||16
2368615|NCT01541215|5813201|P1|NOT COMPLETED|Overall Study||10
2368616|NCT01541215|5813200|P2|COMPLETED|Overall Study||53
2368617|NCT01541215|5813201|P1|COMPLETED|Overall Study||56
2368618|NCT01541215|5813200|P2|Exposed|Overall Study||68
2368619|NCT01541215|5813201|P1|Exposed|Overall Study||66
2368620|NCT01541215|5813200|P2|STARTED|Overall Study||69
2368621|NCT01541215|5813201|P1|STARTED|Overall Study||66
2368622|NCT01540981|5813339|P2|NOT COMPLETED|Overall Study||0
2368623|NCT01540981|5813340|P1|NOT COMPLETED|Overall Study||1
2368624|NCT01540981|5813339|P2|COMPLETED|Overall Study||6
2368625|NCT01540981|5813340|P1|COMPLETED|Overall Study||5
2368626|NCT01540981|5813339|P2|STARTED|Overall Study||6
2368627|NCT01540981|5813340|P1|STARTED|Overall Study||6
2368628|NCT01540851|5813350|P2|NOT COMPLETED|Overall Study||18
2368629|NCT01540851|5813351|P1|NOT COMPLETED|Overall Study||21
2368630|NCT01540851|5813350|P2|COMPLETED|Overall Study||136
2368631|NCT01540851|5813351|P1|COMPLETED|Overall Study||133
2368632|NCT01540851|5813350|P2|STARTED|Overall Study||154
2368633|NCT01540851|5813351|P1|STARTED|Overall Study||154
2368634|NCT01540838|5813363|P2|NOT COMPLETED|Overall Study||23
2368635|NCT01540838|5813364|P1|NOT COMPLETED|Overall Study||22
2368636|NCT01540838|5813363|P2|COMPLETED|Overall Study||164
2368637|NCT01540838|5813364|P1|COMPLETED|Overall Study||166
2368638|NCT01540838|5813363|P2|STARTED|Overall Study||187
2368639|NCT01540838|5813364|P1|STARTED|Overall Study||188
2368640|NCT01540825|5813397|P11|NOT COMPLETED|Overall Study||0
2368641|NCT01540825|5813398|P10|NOT COMPLETED|Overall Study||0
2368642|NCT01540825|5813399|P9|NOT COMPLETED|Overall Study||0
2368643|NCT01540825|5813400|P8|NOT COMPLETED|Overall Study||0
2368644|NCT01540825|5813401|P7|NOT COMPLETED|Overall Study||0
2368645|NCT01540825|5813402|P6|NOT COMPLETED|Overall Study||0
2368646|NCT01540825|5813403|P5|NOT COMPLETED|Overall Study||0
2368647|NCT01540825|5813404|P4|NOT COMPLETED|Overall Study||0
2368648|NCT01540825|5813405|P3|NOT COMPLETED|Overall Study||0
2368649|NCT01540825|5813406|P2|NOT COMPLETED|Overall Study||0
2368650|NCT01540825|5813407|P1|NOT COMPLETED|Overall Study||0
2368651|NCT01540825|5813397|P11|COMPLETED|Overall Study||6
2368652|NCT01540825|5813398|P10|COMPLETED|Overall Study||6
2368653|NCT01540825|5813399|P9|COMPLETED|Overall Study||6
2368654|NCT01540825|5813400|P8|COMPLETED|Overall Study||6
2368655|NCT01540825|5813401|P7|COMPLETED|Overall Study||6
2368656|NCT01540825|5813402|P6|COMPLETED|Overall Study||6
2368657|NCT01540825|5813403|P5|COMPLETED|Overall Study||6
2368658|NCT01540825|5813404|P4|COMPLETED|Overall Study||6
2368659|NCT01540825|5813405|P3|COMPLETED|Overall Study||6
2368660|NCT01540825|5813406|P2|COMPLETED|Overall Study||6
2368661|NCT01540825|5813407|P1|COMPLETED|Overall Study||20
2368662|NCT01540825|5813397|P11|STARTED|Overall Study||6
2368663|NCT01540825|5813398|P10|STARTED|Overall Study||6
2368664|NCT01540825|5813399|P9|STARTED|Overall Study||6
2368665|NCT01540825|5813400|P8|STARTED|Overall Study||6
2368666|NCT01540825|5813401|P7|STARTED|Overall Study||6
2368667|NCT01540825|5813402|P6|STARTED|Overall Study||6
2368668|NCT01540825|5813403|P5|STARTED|Overall Study||6
2368669|NCT01540825|5813404|P4|STARTED|Overall Study||6
2368670|NCT01540825|5813405|P3|STARTED|Overall Study||6
2368671|NCT01540825|5813406|P2|STARTED|Overall Study||6
2368672|NCT01540825|5813407|P1|STARTED|Overall Study||20
2368673|NCT01540773|5813503|P2|NOT COMPLETED|Second Intervention||0
2368674|NCT01540773|5813504|P1|NOT COMPLETED|Second Intervention||0
2368675|NCT01540773|5813503|P2|COMPLETED|Second Intervention||8
2368676|NCT01540773|5813504|P1|COMPLETED|Second Intervention||8
2368677|NCT01540773|5813503|P2|STARTED|Second Intervention||8
2368678|NCT01540773|5813504|P1|STARTED|Second Intervention||8
2368679|NCT01540773|5813503|P2|NOT COMPLETED|Wash Out Period of 1 Week||0
2368680|NCT01540773|5813504|P1|NOT COMPLETED|Wash Out Period of 1 Week||0
2368681|NCT01540773|5813503|P2|COMPLETED|Wash Out Period of 1 Week||8
2368682|NCT01540773|5813504|P1|COMPLETED|Wash Out Period of 1 Week||8
2368683|NCT01540773|5813503|P2|STARTED|Wash Out Period of 1 Week||8
2368684|NCT01540773|5813504|P1|STARTED|Wash Out Period of 1 Week||8
2368685|NCT01540773|5813503|P2|NOT COMPLETED|First Intervention||0
2368686|NCT01540773|5813504|P1|NOT COMPLETED|First Intervention||0
2368687|NCT01540773|5813503|P2|COMPLETED|First Intervention||8
2368688|NCT01540773|5813504|P1|COMPLETED|First Intervention||8
2368689|NCT01540773|5813503|P2|STARTED|First Intervention||8
2368690|NCT01540773|5813504|P1|STARTED|First Intervention||8
2368691|NCT01540565|5813514|P1|NOT COMPLETED|Overall Study||2
2368692|NCT01540565|5813514|P1|COMPLETED|Overall Study||50
2368693|NCT01540565|5813514|P1|STARTED|Overall Study||52
2368694|NCT01540513|5813524|P1|NOT COMPLETED|Overall Study||0
2368695|NCT01540513|5813524|P1|COMPLETED|Overall Study||12
2368696|NCT01540513|5813524|P1|STARTED|Overall Study||12
2368697|NCT01540487|5813533|P2|NOT COMPLETED|Overall Study||0
2368698|NCT01540487|5813534|P1|NOT COMPLETED|Overall Study||1
2368699|NCT01540487|5813533|P2|COMPLETED|Overall Study||24
2368700|NCT01540487|5813534|P1|COMPLETED|Overall Study||23
2368701|NCT01540487|5813533|P2|STARTED|Overall Study||24
2368702|NCT01540487|5813534|P1|STARTED|Overall Study||24
2368703|NCT01540409|5813570|P2|NOT COMPLETED|Overall Study||0
2368704|NCT01540409|5813571|P1|NOT COMPLETED|Overall Study||0
2368705|NCT01540409|5813570|P2|COMPLETED|Overall Study||6
2368706|NCT01540409|5813571|P1|COMPLETED|Overall Study||6
2368707|NCT01540409|5813570|P2|STARTED|Overall Study||6
2368708|NCT01540409|5813571|P1|STARTED|Overall Study||6
2368709|NCT01540370|5813580|P1|NOT COMPLETED|Overall Study||2
2368710|NCT01540370|5813580|P1|COMPLETED|Overall Study||100
2368711|NCT01540370|5813580|P1|STARTED|Overall Study||102
2368712|NCT01540266|5813591|P6|NOT COMPLETED|Overall Study||0
2368713|NCT01540266|5813592|P5|NOT COMPLETED|Overall Study||0
2368714|NCT01540266|5813593|P4|NOT COMPLETED|Overall Study||0
2368715|NCT01540266|5813594|P3|NOT COMPLETED|Overall Study||1
2368716|NCT01540266|5813595|P2|NOT COMPLETED|Overall Study||1
2368717|NCT01540266|5813596|P1|NOT COMPLETED|Overall Study||6
2368718|NCT01540266|5813591|P6|COMPLETED|Overall Study||19
2368719|NCT01540266|5813592|P5|COMPLETED|Overall Study||20
2368720|NCT01540266|5813593|P4|COMPLETED|Overall Study||38
2368721|NCT01540266|5813594|P3|COMPLETED|Overall Study||59
2368722|NCT01540266|5813595|P2|COMPLETED|Overall Study||41
2368723|NCT01540266|5813596|P1|COMPLETED|Overall Study||57
2368724|NCT01540266|5813591|P6|STARTED|Overall Study||19
2368725|NCT01540266|5813592|P5|STARTED|Overall Study||20
2368726|NCT01540266|5813593|P4|STARTED|Overall Study||38
2368727|NCT01540266|5813594|P3|STARTED|Overall Study||60
2368728|NCT01540266|5813595|P2|STARTED|Overall Study||42
2368729|NCT01540266|5813596|P1|STARTED|Overall Study||63
2368730|NCT01540162|5813612|P2|NOT COMPLETED|Overall Study||0
2368731|NCT01540162|5813613|P1|NOT COMPLETED|Overall Study||0
2368732|NCT01540162|5813612|P2|COMPLETED|Overall Study||32
2368733|NCT01540162|5813613|P1|COMPLETED|Overall Study||30
2368734|NCT01540162|5813612|P2|STARTED|Overall Study||32
2368735|NCT01540162|5813613|P1|STARTED|Overall Study||30
2368736|NCT01540045|5813623|P1|NOT COMPLETED|Overall Study||0
2368737|NCT01540045|5813623|P1|COMPLETED|Overall Study||40
2368738|NCT01540045|5813623|P1|STARTED|Overall Study||40
2368739|NCT01539980|5813662|P1|NOT COMPLETED|Overall Study||0
2368740|NCT01539980|5813662|P1|COMPLETED|Overall Study||30
2368741|NCT01539980|5813662|P1|STARTED|Overall Study||30
2368742|NCT01539811|5813672|P2|NOT COMPLETED|Overall Study||0
2368743|NCT01539811|5813673|P1|NOT COMPLETED|Overall Study||0
2368744|NCT01539811|5813672|P2|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
2368745|NCT01539811|5813673|P1|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
2368746|NCT01539811|5813672|P2|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
2368747|NCT01539811|5813673|P1|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
2368748|NCT01539759|5813681|P2|NOT COMPLETED|Overall Study||8
2368749|NCT01539759|5813682|P1|NOT COMPLETED|Overall Study||6
2368750|NCT01539759|5813681|P2|COMPLETED|Overall Study||48
2368751|NCT01539759|5813682|P1|COMPLETED|Overall Study||50
2368752|NCT01539759|5813681|P2|IUD in Place at 6 Months Posptartum|Overall Study||40
2368753|NCT01539759|5813682|P1|IUD in Place at 6 Months Posptartum|Overall Study||32
2368754|NCT01539759|5813681|P2|IUD Removal|Overall Study||7
2368755|NCT01539759|5813682|P1|IUD Removal|Overall Study||2
2368756|NCT01539759|5813681|P2|IUD Expulsion|Overall Study||4
2368757|NCT01539759|5813682|P1|IUD Expulsion|Overall Study||1
2368758|NCT01539759|5813681|P2|Had Successful IUD Placement|Overall Study||53
2368759|NCT01539759|5813682|P1|Had Successful IUD Placement|Overall Study||34
2368760|NCT01539759|5813681|P2|STARTED|Overall Study||56
2368761|NCT01539759|5813682|P1|STARTED|Overall Study||56
2368762|NCT01539642|5813694|P2|NOT COMPLETED|Overall Study||31
2368763|NCT01539642|5813695|P1|NOT COMPLETED|Overall Study||36
2368764|NCT01539642|5813694|P2|COMPLETED|Overall Study||27
2368765|NCT01539642|5813695|P1|COMPLETED|Overall Study||78
2368766|NCT01539642|5813694|P2|STARTED|Overall Study||58
2368767|NCT01539642|5813695|P1|STARTED|Overall Study||114
2368768|NCT01539590|5813703|P2|NOT COMPLETED|Overall Study||0
2368769|NCT01539590|5813704|P1|NOT COMPLETED|Overall Study||3
2368770|NCT01539590|5813703|P2|COMPLETED|Overall Study||2
2368771|NCT01539590|5813704|P1|COMPLETED|Overall Study||0
2368772|NCT01539590|5813703|P2|Complete Study Treatment|Overall Study||2
2368773|NCT01539590|5813704|P1|Complete Study Treatment|Overall Study||1
2368774|NCT01539590|5813703|P2|STARTED|Overall Study||2
2368775|NCT01539590|5813704|P1|STARTED|Overall Study||3
2368776|NCT01539538|5813712|P2|NOT COMPLETED|Overall Study||44
2368777|NCT01539538|5813713|P1|NOT COMPLETED|Overall Study||31
2368778|NCT01539538|5813712|P2|COMPLETED|Overall Study||136
2368779|NCT01539538|5813713|P1|COMPLETED|Overall Study||146
2368780|NCT01539538|5813712|P2|STARTED|Overall Study||180
2368781|NCT01539538|5813713|P1|STARTED|Overall Study||177
2368782|NCT01539525|5813722|P3|NOT COMPLETED|Overall Study||17
2368783|NCT01539525|5813723|P2|NOT COMPLETED|Overall Study||16
2368784|NCT01539525|5813724|P1|NOT COMPLETED|Overall Study||20
2368785|NCT01539525|5813722|P3|COMPLETED|Overall Study||134
2368786|NCT01539525|5813723|P2|COMPLETED|Overall Study||127
2368787|NCT01539525|5813724|P1|COMPLETED|Overall Study||125
2368788|NCT01539525|5813722|P3|STARTED|Overall Study||151
2368789|NCT01539525|5813723|P2|STARTED|Overall Study||143
2368790|NCT01539525|5813724|P1|STARTED|Overall Study||145
2368791|NCT01539512|5813743|P2|NOT COMPLETED|Overall Study||13
2368792|NCT01539512|5813744|P1|NOT COMPLETED|Overall Study||23
2368793|NCT01539512|5813743|P2|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|97
2368794|NCT01539512|5813744|P1|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|87
2368795|NCT01539512|5813743|P2|STARTED|Overall Study||110
2368796|NCT01539512|5813744|P1|STARTED|Overall Study||110
2368797|NCT01539317|5813760|P2|NOT COMPLETED|Overall Study||0
2368798|NCT01539317|5813761|P1|NOT COMPLETED|Overall Study||1
2368799|NCT01539317|5813760|P2|COMPLETED|Overall Study||25
2368800|NCT01539317|5813761|P1|COMPLETED|Overall Study||24
2368801|NCT01539317|5813760|P2|STARTED|Overall Study||25
2368802|NCT01539317|5813761|P1|STARTED|Overall Study||25
2368803|NCT01539291|5813779|P4|NOT COMPLETED|Study GS-US-312-0117||26
2368804|NCT01539291|5813780|P3|NOT COMPLETED|Study GS-US-312-0117||22
2368805|NCT01539291|5813781|P2|NOT COMPLETED|Study GS-US-312-0117||2
2368806|NCT01539291|5813782|P1|NOT COMPLETED|Study GS-US-312-0117||41
2368807|NCT01539291|5813779|P4|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|18
2368808|NCT01539291|5813780|P3|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|20
2368809|NCT01539291|5813781|P2|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|2
2368810|NCT01539291|5813782|P1|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|30
2368811|NCT01539291|5813779|P4|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|44
2368812|NCT01539291|5813780|P3|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|42
2368813|NCT01539291|5813781|P2|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|4
2368814|NCT01539291|5813782|P1|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|71
2368815|NCT01539291|5813779|P4|NOT COMPLETED|Study GS-US-312-0116||0
2368816|NCT01539291|5813780|P3|NOT COMPLETED|Study GS-US-312-0116||0
2368817|NCT01539291|5813781|P2|NOT COMPLETED|Study GS-US-312-0116||0
2368818|NCT01539291|5813782|P1|NOT COMPLETED|Study GS-US-312-0116||25
2368819|NCT01539291|5813779|P4|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|44
2368820|NCT01539291|5813780|P3|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|42
2368821|NCT01539291|5813781|P2|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|4
2368822|NCT01539291|5813782|P1|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|81
2368823|NCT01539291|5813779|P4|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|44
2368824|NCT01539291|5813780|P3|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|42
2368825|NCT01539291|5813781|P2|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|4
2368826|NCT01539291|5813782|P1|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|106
2368827|NCT01539239|5813854|P2|NOT COMPLETED|Overall Study||17
2368828|NCT01539239|5813855|P1|NOT COMPLETED|Overall Study||12
2368829|NCT01539239|5813854|P2|COMPLETED|Overall Study||170
2368830|NCT01539239|5813855|P1|COMPLETED|Overall Study||357
2368831|NCT01539239|5813854|P2|STARTED|Overall Study||187
2368832|NCT01539239|5813855|P1|STARTED|Overall Study||369
2368833|NCT01539135|5813865|P2|NOT COMPLETED|Overall Study||0
2368834|NCT01539135|5813866|P1|NOT COMPLETED|Overall Study||0
2368835|NCT01539135|5813865|P2|COMPLETED|Overall Study||37
2368836|NCT01539135|5813866|P1|COMPLETED|Overall Study||43
2368837|NCT01539135|5813865|P2|STARTED|Overall Study||37
2368838|NCT01539135|5813866|P1|STARTED|Overall Study||43
2368839|NCT01539083|5813878|P3|NOT COMPLETED|After Randomization (TP and VTP)||23
2368840|NCT01539083|5813879|P2|NOT COMPLETED|After Randomization (TP and VTP)||21
2368841|NCT01539083|5813880|P1|NOT COMPLETED|After Randomization (TP and VTP)||0
2368842|NCT01539083|5813878|P3|COMPLETED|After Randomization (TP and VTP)||80
2368843|NCT01539083|5813879|P2|COMPLETED|After Randomization (TP and VTP)||79
2368844|NCT01539083|5813880|P1|COMPLETED|After Randomization (TP and VTP)||0
2368845|NCT01539083|5813878|P3|Safety Population|After Randomization (TP and VTP)||103
2368846|NCT01539083|5813879|P2|Safety Population|After Randomization (TP and VTP)|One participant was randomized but not treated. Hence, was not included in safety population.|99
2368847|NCT01539083|5813880|P1|Safety Population|After Randomization (TP and VTP)||0
2368848|NCT01539083|5813878|P3|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidation treatment phase.|103
2368849|NCT01539083|5813879|P2|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidated treatment.|100
2368850|NCT01539083|5813880|P1|STARTED|After Randomization (TP and VTP)||0
2368851|NCT01539083|5813878|P3|NOT COMPLETED|Before Randomization (VCD Induction)||0
2368852|NCT01539083|5813879|P2|NOT COMPLETED|Before Randomization (VCD Induction)||0
2368853|NCT01539083|5813880|P1|NOT COMPLETED|Before Randomization (VCD Induction)||53
2368854|NCT01539083|5813878|P3|COMPLETED|Before Randomization (VCD Induction)||0
2368855|NCT01539083|5813879|P2|COMPLETED|Before Randomization (VCD Induction)||0
2368856|NCT01539083|5813880|P1|COMPLETED|Before Randomization (VCD Induction)||203
2368857|NCT01539083|5813878|P3|Treated|Before Randomization (VCD Induction)||0
2368858|NCT01539083|5813879|P2|Treated|Before Randomization (VCD Induction)||0
2368859|NCT01539083|5813880|P1|Treated|Before Randomization (VCD Induction)||254
2368860|NCT01539083|5813878|P3|STARTED|Before Randomization (VCD Induction)||0
2368861|NCT01539083|5813879|P2|STARTED|Before Randomization (VCD Induction)||0
2368862|NCT01539083|5813880|P1|STARTED|Before Randomization (VCD Induction)||256
2368863|NCT01539070|5813903|P2|NOT COMPLETED|Overall Study||39
2368864|NCT01539070|5813904|P1|NOT COMPLETED|Overall Study||59
2368865|NCT01539070|5813903|P2|COMPLETED|Overall Study||99
2368866|NCT01539070|5813904|P1|COMPLETED|Overall Study||109
2368867|NCT01539070|5813903|P2|STARTED|Overall Study||138
2368868|NCT01539070|5813904|P1|STARTED|Overall Study||168
2368869|NCT01538862|5813916|P1|NOT COMPLETED|Overall Study||0
2368870|NCT01538862|5813916|P1|COMPLETED|Overall Study||7
2368871|NCT01538862|5813916|P1|STARTED|Overall Study||7
2368872|NCT01538719|5813924|P2|NOT COMPLETED|Overall Study||0
2368873|NCT01538719|5813925|P1|NOT COMPLETED|Overall Study||2
2368874|NCT01538719|5813924|P2|COMPLETED|Overall Study||12
2368875|NCT01538719|5813925|P1|COMPLETED|Overall Study||5
2368876|NCT01538719|5813924|P2|STARTED|Overall Study||12
2368877|NCT01538719|5813925|P1|STARTED|Overall Study||7
2368878|NCT01538615|5813935|P2|NOT COMPLETED|Overall Study||12
2368879|NCT01538615|5813936|P1|NOT COMPLETED|Overall Study||22
2368880|NCT01538615|5813935|P2|COMPLETED|Overall Study||146
2368881|NCT01538615|5813936|P1|COMPLETED|Overall Study||140
2368882|NCT01538615|5813935|P2|STARTED|Overall Study||158
2368883|NCT01538615|5813936|P1|STARTED|Overall Study||162
2368884|NCT01538472|5813948|P1|NOT COMPLETED|Overall Study||4
2368885|NCT01538472|5813948|P1|COMPLETED|Overall Study||36
2368886|NCT01538472|5813948|P1|STARTED|Overall Study||40
2368887|NCT01538199|5813959|P4|NOT COMPLETED|Overall Study||2
2368888|NCT01538199|5813960|P3|NOT COMPLETED|Overall Study||1
2368889|NCT01538199|5813961|P2|NOT COMPLETED|Overall Study||3
2368890|NCT01538199|5813962|P1|NOT COMPLETED|Overall Study||2
2368891|NCT01538199|5813959|P4|COMPLETED|Overall Study|Completer excluded from analyses because determined to be not eligible at end of study.|1
2368892|NCT01538199|5813960|P3|COMPLETED|Overall Study|1 non-completer included in analyses because only missed follow up, completed all treatment visits.|3
2368893|NCT01538199|5813961|P2|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8
2368894|NCT01538199|5813962|P1|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8
2368895|NCT01538199|5813959|P4|STARTED|Overall Study||3
2368896|NCT01538199|5813960|P3|STARTED|Overall Study||4
2368897|NCT01538199|5813961|P2|STARTED|Overall Study||11
2368898|NCT01538199|5813962|P1|STARTED|Overall Study||10
2368899|NCT01537900|5813985|P1|NOT COMPLETED|Overall Study||0
2368900|NCT01537900|5813985|P1|COMPLETED|Overall Study||4
2368901|NCT01537900|5813985|P1|STARTED|Overall Study||4
2368902|NCT01537887|5813996|P6|NOT COMPLETED|Period 3||0
2368903|NCT01537887|5813997|P5|NOT COMPLETED|Period 3||0
2368904|NCT01537887|5813998|P4|NOT COMPLETED|Period 3||0
2368905|NCT01537887|5813999|P3|NOT COMPLETED|Period 3||1
2368906|NCT01537887|5814000|P2|NOT COMPLETED|Period 3||1
2368907|NCT01537887|5814001|P1|NOT COMPLETED|Period 3||0
2368908|NCT01537887|5813996|P6|COMPLETED|Period 3||11
2368909|NCT01537887|5813997|P5|COMPLETED|Period 3||11
2368910|NCT01537887|5813998|P4|COMPLETED|Period 3||12
2368911|NCT01537887|5813999|P3|COMPLETED|Period 3||10
2368912|NCT01537887|5814000|P2|COMPLETED|Period 3||10
2368913|NCT01537887|5814001|P1|COMPLETED|Period 3||12
2368914|NCT01537887|5813996|P6|STARTED|Period 3||11
2368915|NCT01537887|5813997|P5|STARTED|Period 3||11
2368916|NCT01537887|5813998|P4|STARTED|Period 3||12
2368917|NCT01537887|5813999|P3|STARTED|Period 3||11
2368918|NCT01537887|5814000|P2|STARTED|Period 3||11
2368919|NCT01537887|5814001|P1|STARTED|Period 3||12
2368920|NCT01537887|5813996|P6|NOT COMPLETED|Period 2||0
2368921|NCT01537887|5813997|P5|NOT COMPLETED|Period 2||0
2368922|NCT01537887|5813998|P4|NOT COMPLETED|Period 2||0
2368923|NCT01537887|5813999|P3|NOT COMPLETED|Period 2||0
2368924|NCT01537887|5814000|P2|NOT COMPLETED|Period 2||1
2368925|NCT01537887|5814001|P1|NOT COMPLETED|Period 2||0
2368926|NCT01537887|5813996|P6|COMPLETED|Period 2||11
2368927|NCT01537887|5813997|P5|COMPLETED|Period 2||11
2368928|NCT01537887|5813998|P4|COMPLETED|Period 2||12
2368929|NCT01537887|5813999|P3|COMPLETED|Period 2||11
2368930|NCT01537887|5814000|P2|COMPLETED|Period 2||11
2368931|NCT01537887|5814001|P1|COMPLETED|Period 2||12
2368932|NCT01537887|5813996|P6|STARTED|Period 2||11
2368933|NCT01537887|5813997|P5|STARTED|Period 2||11
2368934|NCT01537887|5813998|P4|STARTED|Period 2||12
2368935|NCT01537887|5813999|P3|STARTED|Period 2||11
2368936|NCT01537887|5814000|P2|STARTED|Period 2||12
2368937|NCT01537887|5814001|P1|STARTED|Period 2||12
2368938|NCT01537887|5813996|P6|NOT COMPLETED|Period 1||1
2368939|NCT01537887|5813997|P5|NOT COMPLETED|Period 1||1
2368940|NCT01537887|5813998|P4|NOT COMPLETED|Period 1||0
2368941|NCT01537887|5813999|P3|NOT COMPLETED|Period 1||1
2368942|NCT01537887|5814000|P2|NOT COMPLETED|Period 1||0
2368943|NCT01537887|5814001|P1|NOT COMPLETED|Period 1||0
2368944|NCT01537887|5813996|P6|COMPLETED|Period 1||11
2368945|NCT01537887|5813997|P5|COMPLETED|Period 1||11
2368946|NCT01537887|5813998|P4|COMPLETED|Period 1||12
2368947|NCT01537887|5813999|P3|COMPLETED|Period 1||11
2368948|NCT01537887|5814000|P2|COMPLETED|Period 1||12
2368949|NCT01537887|5814001|P1|COMPLETED|Period 1||12
2368950|NCT01537887|5813996|P6|Received at Least 1 Dose of Study Drug|Period 1||12
2368951|NCT01537887|5813997|P5|Received at Least 1 Dose of Study Drug|Period 1||12
2368952|NCT01537887|5813998|P4|Received at Least 1 Dose of Study Drug|Period 1||12
2368953|NCT01537887|5813999|P3|Received at Least 1 Dose of Study Drug|Period 1||11
2368954|NCT01537887|5814000|P2|Received at Least 1 Dose of Study Drug|Period 1||12
2368955|NCT01537887|5814001|P1|Received at Least 1 Dose of Study Drug|Period 1||12
2368956|NCT01537887|5813996|P6|STARTED|Period 1||12
2368957|NCT01537887|5813997|P5|STARTED|Period 1||12
2368958|NCT01537887|5813998|P4|STARTED|Period 1||12
2368959|NCT01537887|5813999|P3|STARTED|Period 1||12
2368960|NCT01537887|5814000|P2|STARTED|Period 1||12
2368961|NCT01537887|5814001|P1|STARTED|Period 1||12
2368962|NCT01537835|5814015|P3|NOT COMPLETED|Overall Study||0
2368963|NCT01537835|5814016|P2|NOT COMPLETED|Overall Study||0
2368964|NCT01537835|5814017|P1|NOT COMPLETED|Overall Study||0
2368965|NCT01537835|5814015|P3|COMPLETED|Overall Study||35
2368966|NCT01537835|5814016|P2|COMPLETED|Overall Study||37
2368967|NCT01537835|5814017|P1|COMPLETED|Overall Study||37
2368968|NCT01537835|5814015|P3|STARTED|Overall Study||35
2368969|NCT01537835|5814016|P2|STARTED|Overall Study||37
2368970|NCT01537835|5814017|P1|STARTED|Overall Study||37
2368971|NCT01537783|5814030|P2|NOT COMPLETED|Overall Study||2
2368972|NCT01537783|5814031|P1|NOT COMPLETED|Overall Study||11
2368973|NCT01537783|5814030|P2|COMPLETED|Overall Study||23
2368974|NCT01537783|5814031|P1|COMPLETED|Overall Study||14
2368975|NCT01537783|5814030|P2|STARTED|Overall Study||25
2368976|NCT01537783|5814031|P1|STARTED|Overall Study||25
2368977|NCT01537666|5814041|P4|NOT COMPLETED|Overall Study||0
2368978|NCT01537666|5814042|P3|NOT COMPLETED|Overall Study||0
2368979|NCT01537666|5814043|P2|NOT COMPLETED|Overall Study||0
2368980|NCT01537666|5814044|P1|NOT COMPLETED|Overall Study||0
2368981|NCT01537666|5814041|P4|COMPLETED|Overall Study|1 patient withdrew after a 32 mg dose and was replaced by a patient who only received an 80 mg dose.|7
2368982|NCT01537666|5814042|P3|COMPLETED|Overall Study||6
2368983|NCT01537666|5814043|P2|COMPLETED|Overall Study||6
2368984|NCT01537666|5814044|P1|COMPLETED|Overall Study||6
2368985|NCT01537666|5814041|P4|STARTED|Overall Study|5 of 7 patients received a 32 mg dose of AeroVanc followed by a dose of 80 mg at least 1 week later.|7
2368986|NCT01537666|5814042|P3|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
2368987|NCT01537666|5814043|P2|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
2368988|NCT01537666|5814044|P1|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
2368989|NCT01537549|5814082|P1|NOT COMPLETED|Overall Study||3
2368990|NCT01537549|5814082|P1|COMPLETED|Overall Study||8
2368991|NCT01537549|5814082|P1|STARTED|Overall Study||11
2368992|NCT01537432|5814090|P2|NOT COMPLETED|Overall Study||2
2368993|NCT01537432|5814091|P1|NOT COMPLETED|Overall Study||6
2368994|NCT01537432|5814090|P2|COMPLETED|Overall Study||10
2368995|NCT01537432|5814091|P1|COMPLETED|Overall Study||18
2368996|NCT01537432|5814090|P2|STARTED|Overall Study||12
2368997|NCT01537432|5814091|P1|STARTED|Overall Study||24
2368998|NCT01537419|5814101|P2|NOT COMPLETED|Overall Study||12
2368999|NCT01537419|5814102|P1|NOT COMPLETED|Overall Study||11
2369000|NCT01537419|5814101|P2|COMPLETED|Overall Study||54
2369001|NCT01537419|5814102|P1|COMPLETED|Overall Study||52
2369002|NCT01537419|5814101|P2|STARTED|Overall Study||66
2369003|NCT01537419|5814102|P1|STARTED|Overall Study||63
2369004|NCT01537393|5814114|P2|NOT COMPLETED|Overall Study||191
2369005|NCT01537393|5814115|P1|NOT COMPLETED|Overall Study||154
2369006|NCT01537393|5814114|P2|COMPLETED|Overall Study||507
2369007|NCT01537393|5814115|P1|COMPLETED|Overall Study||553
2369008|NCT01537393|5814114|P2|STARTED|Overall Study||698
2369009|NCT01537393|5814115|P1|STARTED|Overall Study||707
2369010|NCT01537367|5814126|P3|NOT COMPLETED|Overall Study||0
2369011|NCT01537367|5814127|P2|NOT COMPLETED|Overall Study||0
2369012|NCT01537367|5814128|P1|NOT COMPLETED|Overall Study||0
2369013|NCT01537367|5814126|P3|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|613
2369014|NCT01537367|5814127|P2|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|610
2369015|NCT01537367|5814128|P1|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|615
2369016|NCT01537367|5814126|P3|STARTED|Overall Study||613
2369017|NCT01537367|5814127|P2|STARTED|Overall Study||610
2369018|NCT01537367|5814128|P1|STARTED|Overall Study||615
2369019|NCT01537315|5814144|P2|NOT COMPLETED|Overall Study||0
2369020|NCT01537315|5814145|P1|NOT COMPLETED|Overall Study||0
2369021|NCT01537315|5814144|P2|COMPLETED|Overall Study||7
2369022|NCT01537315|5814145|P1|COMPLETED|Overall Study||1
2369023|NCT01537315|5814144|P2|STARTED|Overall Study||7
2369024|NCT01537315|5814145|P1|STARTED|Overall Study||1
2369025|NCT01537302|5814151|P1|NOT COMPLETED|Overall Study||2
2369026|NCT01537302|5814151|P1|COMPLETED|Overall Study||199
2369027|NCT01537302|5814151|P1|STARTED|Overall Study||201
2369028|NCT01537211|5814160|P2|NOT COMPLETED|Overall Study||1
2369029|NCT01537211|5814161|P1|NOT COMPLETED|Overall Study||0
2369030|NCT01537211|5814160|P2|COMPLETED|Overall Study||5
2369031|NCT01537211|5814161|P1|COMPLETED|Overall Study||4
2369032|NCT01537211|5814160|P2|STARTED|Overall Study||6
2369033|NCT01537211|5814161|P1|STARTED|Overall Study||4
2369034|NCT01537198|5814195|P1|NOT COMPLETED|Overall Study||154
2369035|NCT01537198|5814195|P1|COMPLETED|Overall Study||463
2369036|NCT01537198|5814195|P1|STARTED|Overall Study||617
2369037|NCT01537185|5814203|P4|NOT COMPLETED|Overall Study||2
2369038|NCT01537185|5814204|P3|NOT COMPLETED|Overall Study||6
2369039|NCT01537185|5814205|P2|NOT COMPLETED|Overall Study||6
2369040|NCT01537185|5814206|P1|NOT COMPLETED|Overall Study||3
2369041|NCT01537185|5814203|P4|COMPLETED|Overall Study||8
2369042|NCT01537185|5814204|P3|COMPLETED|Overall Study||4
2369043|NCT01537185|5814205|P2|COMPLETED|Overall Study||6
2369044|NCT01537185|5814206|P1|COMPLETED|Overall Study||7
2369045|NCT01537185|5814203|P4|STARTED|Overall Study||10
2369046|NCT01537185|5814204|P3|STARTED|Overall Study||10
2369047|NCT01537185|5814205|P2|STARTED|Overall Study||12
2369048|NCT01537185|5814206|P1|STARTED|Overall Study||10
2369049|NCT01537133|5814224|P4|NOT COMPLETED|Overall Study||0
2369050|NCT01537133|5814225|P3|NOT COMPLETED|Overall Study||0
2369051|NCT01537133|5814226|P2|NOT COMPLETED|Overall Study||0
2369052|NCT01537133|5814227|P1|NOT COMPLETED|Overall Study||3
2369053|NCT01537133|5814224|P4|COMPLETED|Overall Study||21
2369054|NCT01537133|5814225|P3|COMPLETED|Overall Study||21
2369055|NCT01537133|5814226|P2|COMPLETED|Overall Study||14
2369056|NCT01537133|5814227|P1|COMPLETED|Overall Study||25
2369057|NCT01537133|5814224|P4|STARTED|Overall Study||21
2369058|NCT01537133|5814225|P3|STARTED|Overall Study||21
2369059|NCT01537133|5814226|P2|STARTED|Overall Study||14
2369060|NCT01537133|5814227|P1|STARTED|Overall Study||28
2369061|NCT01537120|5814243|P1|NOT COMPLETED|12 Weeks Vildagliptin||0
2369062|NCT01537120|5814243|P1|COMPLETED|12 Weeks Vildagliptin||23
2369063|NCT01537120|5814243|P1|STARTED|12 Weeks Vildagliptin||23
2369064|NCT01537120|5814243|P1|NOT COMPLETED|3 Weeks Placebo||1
2369065|NCT01537120|5814243|P1|COMPLETED|3 Weeks Placebo||23
2369066|NCT01537120|5814243|P1|STARTED|3 Weeks Placebo||24
2369067|NCT01537120|5814243|P1|NOT COMPLETED|8 Weeks Washout||1
2369068|NCT01537120|5814243|P1|COMPLETED|8 Weeks Washout||24
2369069|NCT01537120|5814243|P1|STARTED|8 Weeks Washout||25
2369070|NCT01537120|5814243|P1|NOT COMPLETED|Enrolled||0
2369071|NCT01537120|5814243|P1|COMPLETED|Enrolled||25
2369072|NCT01537120|5814243|P1|STARTED|Enrolled||25
2369073|NCT01537081|5814256|P3|NOT COMPLETED|Overall Study||16
2369074|NCT01537081|5814257|P2|NOT COMPLETED|Overall Study||38
2369075|NCT01537081|5814258|P1|NOT COMPLETED|Overall Study||39
2369076|NCT01537081|5814256|P3|COMPLETED|Overall Study||547
2369077|NCT01537081|5814257|P2|COMPLETED|Overall Study||1086
2369078|NCT01537081|5814258|P1|COMPLETED|Overall Study||1084
2369079|NCT01537081|5814256|P3|Modified Intent to Treat Population|Overall Study||556
2369080|NCT01537081|5814257|P2|Modified Intent to Treat Population|Overall Study||1109
2369081|NCT01537081|5814258|P1|Modified Intent to Treat Population|Overall Study||1106
2369082|NCT01537081|5814256|P3|Safety Population|Overall Study||561
2369083|NCT01537081|5814257|P2|Safety Population|Overall Study||1122
2369084|NCT01537081|5814258|P1|Safety Population|Overall Study||1122
2369085|NCT01537081|5814256|P3|STARTED|Overall Study||563
2369086|NCT01537081|5814257|P2|STARTED|Overall Study||1124
2369087|NCT01537081|5814258|P1|STARTED|Overall Study||1123
2369088|NCT01537068|5814271|P2|NOT COMPLETED|Overall Study||3
2369089|NCT01537068|5814272|P1|NOT COMPLETED|Overall Study||4
2369090|NCT01537068|5814271|P2|COMPLETED|Overall Study||26
2369091|NCT01537068|5814272|P1|COMPLETED|Overall Study||26
2369092|NCT01537068|5814271|P2|STARTED|Overall Study||29
2369093|NCT01537068|5814272|P1|STARTED|Overall Study||30
2369094|NCT01537042|5814284|P2|NOT COMPLETED|Overall Study||5
2369095|NCT01537042|5814285|P1|NOT COMPLETED|Overall Study||0
2369096|NCT01537042|5814284|P2|COMPLETED|Overall Study||15
2369097|NCT01537042|5814285|P1|COMPLETED|Overall Study||10
2369098|NCT01537042|5814284|P2|STARTED|Overall Study||20
2369099|NCT01537042|5814285|P1|STARTED|Overall Study||10
2369100|NCT01537029|5814321|P1|NOT COMPLETED|Overall Study||0
2369101|NCT01537029|5814321|P1|COMPLETED|Overall Study||15
2369102|NCT01537029|5814321|P1|STARTED|Overall Study||15
2369103|NCT01536951|5814327|P9|NOT COMPLETED|Third Intervention||0
2369104|NCT01536951|5814328|P8|NOT COMPLETED|Third Intervention||0
2369105|NCT01536951|5814329|P7|NOT COMPLETED|Third Intervention||0
2369106|NCT01536951|5814330|P6|NOT COMPLETED|Third Intervention||0
2369107|NCT01536951|5814331|P5|NOT COMPLETED|Third Intervention||0
2369108|NCT01536951|5814332|P4|NOT COMPLETED|Third Intervention||0
2369109|NCT01536951|5814333|P3|NOT COMPLETED|Third Intervention||0
2369110|NCT01536951|5814334|P2|NOT COMPLETED|Third Intervention||0
2369111|NCT01536951|5814335|P1|NOT COMPLETED|Third Intervention||0
2369112|NCT01536951|5814327|P9|COMPLETED|Third Intervention||9
2369113|NCT01536951|5814328|P8|COMPLETED|Third Intervention||8
2369114|NCT01536951|5814329|P7|COMPLETED|Third Intervention||9
2369115|NCT01536951|5814330|P6|COMPLETED|Third Intervention||9
2369116|NCT01536951|5814331|P5|COMPLETED|Third Intervention||9
2369117|NCT01536951|5814332|P4|COMPLETED|Third Intervention||8
2369118|NCT01536951|5814333|P3|COMPLETED|Third Intervention||2
2369119|NCT01536951|5814334|P2|COMPLETED|Third Intervention||3
2369120|NCT01536951|5814335|P1|COMPLETED|Third Intervention||3
2369121|NCT01536951|5814327|P9|STARTED|Third Intervention||9
2369122|NCT01536951|5814328|P8|STARTED|Third Intervention||8
2369123|NCT01536951|5814329|P7|STARTED|Third Intervention||9
2369124|NCT01536951|5814330|P6|STARTED|Third Intervention||9
2369125|NCT01536951|5814331|P5|STARTED|Third Intervention||9
2369126|NCT01536951|5814332|P4|STARTED|Third Intervention||8
2369127|NCT01536951|5814333|P3|STARTED|Third Intervention||2
2369128|NCT01536951|5814334|P2|STARTED|Third Intervention||3
2369129|NCT01536951|5814335|P1|STARTED|Third Intervention||3
2369130|NCT01536951|5814327|P9|NOT COMPLETED|Second Intervention and Washout Period 2||0
2369131|NCT01536951|5814328|P8|NOT COMPLETED|Second Intervention and Washout Period 2||1
2369132|NCT01536951|5814329|P7|NOT COMPLETED|Second Intervention and Washout Period 2||0
2369133|NCT01536951|5814330|P6|NOT COMPLETED|Second Intervention and Washout Period 2||0
2369134|NCT01536951|5814331|P5|NOT COMPLETED|Second Intervention and Washout Period 2||0
2369135|NCT01536951|5814332|P4|NOT COMPLETED|Second Intervention and Washout Period 2||0
2369136|NCT01536951|5814333|P3|NOT COMPLETED|Second Intervention and Washout Period 2||0
2369137|NCT01536951|5814334|P2|NOT COMPLETED|Second Intervention and Washout Period 2||0
2369138|NCT01536951|5814335|P1|NOT COMPLETED|Second Intervention and Washout Period 2||0
2369139|NCT01536951|5814327|P9|COMPLETED|Second Intervention and Washout Period 2||9
2369140|NCT01536951|5814328|P8|COMPLETED|Second Intervention and Washout Period 2||8
2369141|NCT01536951|5814329|P7|COMPLETED|Second Intervention and Washout Period 2||9
2369142|NCT01536951|5814330|P6|COMPLETED|Second Intervention and Washout Period 2||9
2369143|NCT01536951|5814331|P5|COMPLETED|Second Intervention and Washout Period 2||9
2369144|NCT01536951|5814332|P4|COMPLETED|Second Intervention and Washout Period 2||8
2369145|NCT01536951|5814333|P3|COMPLETED|Second Intervention and Washout Period 2||2
2369146|NCT01536951|5814334|P2|COMPLETED|Second Intervention and Washout Period 2||3
2369147|NCT01536951|5814335|P1|COMPLETED|Second Intervention and Washout Period 2||3
2369148|NCT01536951|5814327|P9|STARTED|Second Intervention and Washout Period 2||9
2369149|NCT01536951|5814328|P8|STARTED|Second Intervention and Washout Period 2||9
2369150|NCT01536951|5814329|P7|STARTED|Second Intervention and Washout Period 2||9
2369151|NCT01536951|5814330|P6|STARTED|Second Intervention and Washout Period 2||9
2369152|NCT01536951|5814331|P5|STARTED|Second Intervention and Washout Period 2||9
2369153|NCT01536951|5814332|P4|STARTED|Second Intervention and Washout Period 2||8
2369154|NCT01536951|5814333|P3|STARTED|Second Intervention and Washout Period 2||2
2369155|NCT01536951|5814334|P2|STARTED|Second Intervention and Washout Period 2||3
2369156|NCT01536951|5814335|P1|STARTED|Second Intervention and Washout Period 2||3
2369157|NCT01536951|5814327|P9|NOT COMPLETED|First Intervention and Washout Period 1||0
2369158|NCT01536951|5814328|P8|NOT COMPLETED|First Intervention and Washout Period 1||0
2369159|NCT01536951|5814329|P7|NOT COMPLETED|First Intervention and Washout Period 1||0
2369160|NCT01536951|5814330|P6|NOT COMPLETED|First Intervention and Washout Period 1||0
2369161|NCT01536951|5814331|P5|NOT COMPLETED|First Intervention and Washout Period 1||0
2369162|NCT01536951|5814332|P4|NOT COMPLETED|First Intervention and Washout Period 1||0
2369163|NCT01536951|5814333|P3|NOT COMPLETED|First Intervention and Washout Period 1||1
2369164|NCT01536951|5814334|P2|NOT COMPLETED|First Intervention and Washout Period 1||0
2369165|NCT01536951|5814335|P1|NOT COMPLETED|First Intervention and Washout Period 1||0
2369166|NCT01536951|5814327|P9|COMPLETED|First Intervention and Washout Period 1||9
2369167|NCT01536951|5814328|P8|COMPLETED|First Intervention and Washout Period 1||9
2369168|NCT01536951|5814329|P7|COMPLETED|First Intervention and Washout Period 1||9
2369169|NCT01536951|5814330|P6|COMPLETED|First Intervention and Washout Period 1||9
2369170|NCT01536951|5814331|P5|COMPLETED|First Intervention and Washout Period 1||9
2369171|NCT01536951|5814332|P4|COMPLETED|First Intervention and Washout Period 1||8
2369172|NCT01536951|5814333|P3|COMPLETED|First Intervention and Washout Period 1||2
2369173|NCT01536951|5814334|P2|COMPLETED|First Intervention and Washout Period 1||3
2369174|NCT01536951|5814335|P1|COMPLETED|First Intervention and Washout Period 1||3
2369175|NCT01536951|5814327|P9|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
2369257|NCT01536860|5814393|P2|STARTED|First Intervention (1 Day)||4
2369176|NCT01536951|5814328|P8|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
2369177|NCT01536951|5814329|P7|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
2369178|NCT01536951|5814330|P6|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
2369179|NCT01536951|5814331|P5|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
2369180|NCT01536951|5814332|P4|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||8
2369181|NCT01536951|5814333|P3|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
2369182|NCT01536951|5814334|P2|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
2369183|NCT01536951|5814335|P1|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1|Across all reporting groups, study drug is LY3009104, moxifloxacin, or placebo.|3
2369184|NCT01536951|5814327|P9|STARTED|First Intervention and Washout Period 1||9
2369185|NCT01536951|5814328|P8|STARTED|First Intervention and Washout Period 1||9
2369186|NCT01536951|5814329|P7|STARTED|First Intervention and Washout Period 1||9
2369187|NCT01536951|5814330|P6|STARTED|First Intervention and Washout Period 1||9
2369188|NCT01536951|5814331|P5|STARTED|First Intervention and Washout Period 1||9
2369189|NCT01536951|5814332|P4|STARTED|First Intervention and Washout Period 1||8
2369190|NCT01536951|5814333|P3|STARTED|First Intervention and Washout Period 1||3
2369191|NCT01536951|5814334|P2|STARTED|First Intervention and Washout Period 1||3
2369192|NCT01536951|5814335|P1|STARTED|First Intervention and Washout Period 1||3
2369193|NCT01536938|5814365|P3|NOT COMPLETED|Overall Study||8
2369194|NCT01536938|5814366|P2|NOT COMPLETED|Overall Study||7
2369195|NCT01536938|5814367|P1|NOT COMPLETED|Overall Study||6
2369196|NCT01536938|5814365|P3|COMPLETED|Overall Study||93
2369197|NCT01536938|5814366|P2|COMPLETED|Overall Study||94
2369198|NCT01536938|5814367|P1|COMPLETED|Overall Study||94
2369199|NCT01536938|5814365|P3|STARTED|Overall Study||101
2369200|NCT01536938|5814366|P2|STARTED|Overall Study||101
2369201|NCT01536938|5814367|P1|STARTED|Overall Study||100
2369202|NCT01536886|5814379|P4|NOT COMPLETED|Overall Study||3
2369203|NCT01536886|5814380|P3|NOT COMPLETED|Overall Study||2
2369204|NCT01536886|5814381|P2|NOT COMPLETED|Overall Study||8
2369205|NCT01536886|5814382|P1|NOT COMPLETED|Overall Study||5
2369206|NCT01536886|5814379|P4|COMPLETED|Overall Study||48
2369207|NCT01536886|5814380|P3|COMPLETED|Overall Study||47
2369208|NCT01536886|5814381|P2|COMPLETED|Overall Study||127
2369209|NCT01536886|5814382|P1|COMPLETED|Overall Study||136
2369210|NCT01536886|5814379|P4|STARTED|Overall Study||51
2369211|NCT01536886|5814380|P3|STARTED|Overall Study||49
2369212|NCT01536886|5814381|P2|STARTED|Overall Study||135
2369213|NCT01536886|5814382|P1|STARTED|Overall Study||141
2369214|NCT01536860|5814392|P3|NOT COMPLETED|Third Intervention (1 Day)||0
2369215|NCT01536860|5814393|P2|NOT COMPLETED|Third Intervention (1 Day)||0
2369216|NCT01536860|5814394|P1|NOT COMPLETED|Third Intervention (1 Day)||0
2369217|NCT01536860|5814392|P3|COMPLETED|Third Intervention (1 Day)||4
2369218|NCT01536860|5814393|P2|COMPLETED|Third Intervention (1 Day)||4
2369219|NCT01536860|5814394|P1|COMPLETED|Third Intervention (1 Day)||3
2369220|NCT01536860|5814392|P3|STARTED|Third Intervention (1 Day)||4
2369221|NCT01536860|5814393|P2|STARTED|Third Intervention (1 Day)||4
2369222|NCT01536860|5814394|P1|STARTED|Third Intervention (1 Day)||3
2369223|NCT01536860|5814392|P3|NOT COMPLETED|Washout Period (3 Days)||0
2369224|NCT01536860|5814393|P2|NOT COMPLETED|Washout Period (3 Days)||0
2369225|NCT01536860|5814394|P1|NOT COMPLETED|Washout Period (3 Days)||1
2369226|NCT01536860|5814392|P3|COMPLETED|Washout Period (3 Days)||4
2369227|NCT01536860|5814393|P2|COMPLETED|Washout Period (3 Days)||4
2369228|NCT01536860|5814394|P1|COMPLETED|Washout Period (3 Days)||3
2369229|NCT01536860|5814392|P3|STARTED|Washout Period (3 Days)||4
2369230|NCT01536860|5814393|P2|STARTED|Washout Period (3 Days)||4
2369231|NCT01536860|5814394|P1|STARTED|Washout Period (3 Days)||4
2369232|NCT01536860|5814392|P3|NOT COMPLETED|Second Intervention (1 Day)||0
2369233|NCT01536860|5814393|P2|NOT COMPLETED|Second Intervention (1 Day)||0
2369234|NCT01536860|5814394|P1|NOT COMPLETED|Second Intervention (1 Day)||0
2369235|NCT01536860|5814392|P3|COMPLETED|Second Intervention (1 Day)||4
2369236|NCT01536860|5814393|P2|COMPLETED|Second Intervention (1 Day)||4
2369237|NCT01536860|5814394|P1|COMPLETED|Second Intervention (1 Day)||4
2369238|NCT01536860|5814392|P3|STARTED|Second Intervention (1 Day)||4
2369239|NCT01536860|5814393|P2|STARTED|Second Intervention (1 Day)||4
2369240|NCT01536860|5814394|P1|STARTED|Second Intervention (1 Day)||4
2369241|NCT01536860|5814392|P3|NOT COMPLETED|Washout Period (3 Days)||0
2369242|NCT01536860|5814393|P2|NOT COMPLETED|Washout Period (3 Days)||0
2369243|NCT01536860|5814394|P1|NOT COMPLETED|Washout Period (3 Days)||0
2369244|NCT01536860|5814392|P3|COMPLETED|Washout Period (3 Days)||4
2369245|NCT01536860|5814393|P2|COMPLETED|Washout Period (3 Days)||4
2369246|NCT01536860|5814394|P1|COMPLETED|Washout Period (3 Days)||4
2369247|NCT01536860|5814392|P3|STARTED|Washout Period (3 Days)||4
2369248|NCT01536860|5814393|P2|STARTED|Washout Period (3 Days)||4
2369249|NCT01536860|5814394|P1|STARTED|Washout Period (3 Days)||4
2369250|NCT01536860|5814392|P3|NOT COMPLETED|First Intervention (1 Day)||0
2369251|NCT01536860|5814393|P2|NOT COMPLETED|First Intervention (1 Day)||0
2369252|NCT01536860|5814394|P1|NOT COMPLETED|First Intervention (1 Day)||0
2369253|NCT01536860|5814392|P3|COMPLETED|First Intervention (1 Day)||4
2369254|NCT01536860|5814393|P2|COMPLETED|First Intervention (1 Day)||4
2369255|NCT01536860|5814394|P1|COMPLETED|First Intervention (1 Day)||4
2369256|NCT01536860|5814392|P3|STARTED|First Intervention (1 Day)||4
2369258|NCT01536860|5814394|P1|STARTED|First Intervention (1 Day)||4
2369259|NCT01536704|5814402|P4|NOT COMPLETED|Period 4||0
2369260|NCT01536704|5814403|P3|NOT COMPLETED|Period 4||0
2369261|NCT01536704|5814404|P2|NOT COMPLETED|Period 4||0
2369262|NCT01536704|5814405|P1|NOT COMPLETED|Period 4||0
2369263|NCT01536704|5814402|P4|COMPLETED|Period 4||10
2369264|NCT01536704|5814403|P3|COMPLETED|Period 4||10
2369265|NCT01536704|5814404|P2|COMPLETED|Period 4||11
2369266|NCT01536704|5814405|P1|COMPLETED|Period 4||12
2369267|NCT01536704|5814402|P4|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
2369268|NCT01536704|5814403|P3|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
2369269|NCT01536704|5814404|P2|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
2369270|NCT01536704|5814405|P1|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|12
2369271|NCT01536704|5814402|P4|NOT COMPLETED|Washout Period 3||0
2369272|NCT01536704|5814403|P3|NOT COMPLETED|Washout Period 3||1
2369273|NCT01536704|5814404|P2|NOT COMPLETED|Washout Period 3||0
2369274|NCT01536704|5814405|P1|NOT COMPLETED|Washout Period 3||0
2369275|NCT01536704|5814402|P4|COMPLETED|Washout Period 3||10
2369276|NCT01536704|5814403|P3|COMPLETED|Washout Period 3||11
2369277|NCT01536704|5814404|P2|COMPLETED|Washout Period 3||12
2369278|NCT01536704|5814405|P1|COMPLETED|Washout Period 3||10
2369279|NCT01536704|5814402|P4|STARTED|Washout Period 3||10
2369280|NCT01536704|5814403|P3|STARTED|Washout Period 3||12
2369281|NCT01536704|5814404|P2|STARTED|Washout Period 3||12
2369282|NCT01536704|5814405|P1|STARTED|Washout Period 3||10
2369283|NCT01536704|5814402|P4|NOT COMPLETED|Period 3||1
2369284|NCT01536704|5814403|P3|NOT COMPLETED|Period 3||0
2369285|NCT01536704|5814404|P2|NOT COMPLETED|Period 3||0
2369286|NCT01536704|5814405|P1|NOT COMPLETED|Period 3||0
2369287|NCT01536704|5814402|P4|COMPLETED|Period 3||10
2369288|NCT01536704|5814403|P3|COMPLETED|Period 3||12
2369289|NCT01536704|5814404|P2|COMPLETED|Period 3||12
2369290|NCT01536704|5814405|P1|COMPLETED|Period 3||10
2369291|NCT01536704|5814402|P4|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|11
2369292|NCT01536704|5814403|P3|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
2369293|NCT01536704|5814404|P2|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
2369294|NCT01536704|5814405|P1|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|10
2369295|NCT01536704|5814402|P4|NOT COMPLETED|Washout Period 2||1
2369296|NCT01536704|5814403|P3|NOT COMPLETED|Washout Period 2||0
2369297|NCT01536704|5814404|P2|NOT COMPLETED|Washout Period 2||0
2369298|NCT01536704|5814405|P1|NOT COMPLETED|Washout Period 2||1
2369299|NCT01536704|5814402|P4|COMPLETED|Washout Period 2||12
2369300|NCT01536704|5814403|P3|COMPLETED|Washout Period 2||10
2369301|NCT01536704|5814404|P2|COMPLETED|Washout Period 2||11
2369302|NCT01536704|5814405|P1|COMPLETED|Washout Period 2||12
2369303|NCT01536704|5814402|P4|STARTED|Washout Period 2||13
2369304|NCT01536704|5814403|P3|STARTED|Washout Period 2||10
2369305|NCT01536704|5814404|P2|STARTED|Washout Period 2||11
2369306|NCT01536704|5814405|P1|STARTED|Washout Period 2||13
2369307|NCT01536704|5814402|P4|NOT COMPLETED|Period 2||0
2369308|NCT01536704|5814403|P3|NOT COMPLETED|Period 2||0
2369309|NCT01536704|5814404|P2|NOT COMPLETED|Period 2||0
2369310|NCT01536704|5814405|P1|NOT COMPLETED|Period 2||0
2369311|NCT01536704|5814402|P4|COMPLETED|Period 2||13
2369312|NCT01536704|5814403|P3|COMPLETED|Period 2||10
2369313|NCT01536704|5814404|P2|COMPLETED|Period 2||11
2369314|NCT01536704|5814405|P1|COMPLETED|Period 2||13
2369315|NCT01536704|5814402|P4|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
2369316|NCT01536704|5814403|P3|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|10
2369317|NCT01536704|5814404|P2|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
2369318|NCT01536704|5814405|P1|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
2369319|NCT01536704|5814402|P4|NOT COMPLETED|Washout Period 1||0
2369320|NCT01536704|5814403|P3|NOT COMPLETED|Washout Period 1||0
2369321|NCT01536704|5814404|P2|NOT COMPLETED|Washout Period 1||2
2369322|NCT01536704|5814405|P1|NOT COMPLETED|Washout Period 1||1
2369323|NCT01536704|5814402|P4|COMPLETED|Washout Period 1||13
2369324|NCT01536704|5814403|P3|COMPLETED|Washout Period 1||13
2369325|NCT01536704|5814404|P2|COMPLETED|Washout Period 1||10
2369326|NCT01536704|5814405|P1|COMPLETED|Washout Period 1||11
2369327|NCT01536704|5814402|P4|STARTED|Washout Period 1||13
2369328|NCT01536704|5814403|P3|STARTED|Washout Period 1||13
2369329|NCT01536704|5814404|P2|STARTED|Washout Period 1||12
2369330|NCT01536704|5814405|P1|STARTED|Washout Period 1||12
2369331|NCT01536704|5814402|P4|NOT COMPLETED|Period 1||0
2369332|NCT01536704|5814403|P3|NOT COMPLETED|Period 1||0
2369333|NCT01536704|5814404|P2|NOT COMPLETED|Period 1||0
2369334|NCT01536704|5814405|P1|NOT COMPLETED|Period 1||0
2369335|NCT01536704|5814402|P4|COMPLETED|Period 1||13
2369336|NCT01536704|5814403|P3|COMPLETED|Period 1||13
2369337|NCT01536704|5814404|P2|COMPLETED|Period 1||12
2369338|NCT01536704|5814405|P1|COMPLETED|Period 1||12
2369339|NCT01536704|5814402|P4|STARTED|Period 1||13
2369340|NCT01536704|5814403|P3|STARTED|Period 1||13
2369341|NCT01536704|5814404|P2|STARTED|Period 1||12
2369342|NCT01536704|5814405|P1|STARTED|Period 1||12
2369343|NCT01536587|5814435|P1|NOT COMPLETED|Overall Study||2
2369344|NCT01536587|5814435|P1|COMPLETED|Overall Study||30
2369345|NCT01536587|5814435|P1|STARTED|Overall Study||32
2369346|NCT01536574|5814474|P2|NOT COMPLETED|Overall Study||7
2369347|NCT01536574|5814475|P1|NOT COMPLETED|Overall Study||6
2369348|NCT01536574|5814474|P2|COMPLETED|Overall Study||126
2369349|NCT01536574|5814475|P1|COMPLETED|Overall Study||156
2369350|NCT01536574|5814474|P2|STARTED|Overall Study||133
2369351|NCT01536574|5814475|P1|STARTED|Overall Study||162
2369352|NCT01536561|5814493|P1|NOT COMPLETED|Long-Term Follow-Up||0
2369353|NCT01536561|5814493|P1|COMPLETED|Long-Term Follow-Up||13
2369354|NCT01536561|5814493|P1|STARTED|Long-Term Follow-Up||13
2369355|NCT01536561|5814493|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||59
2369356|NCT01536561|5814493|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
2369357|NCT01536561|5814493|P1|STARTED|Dosimetric and Therapeutic Treatment||59
2369358|NCT01536535|5814533|P2|NOT COMPLETED|Overall Study||13
2369359|NCT01536535|5814534|P1|NOT COMPLETED|Overall Study||15
2369360|NCT01536535|5814533|P2|COMPLETED|Overall Study|Patients either completed week 52 visit or had early colectomy or had additional therapy.|237
2369361|NCT01536535|5814534|P1|COMPLETED|Overall Study|Patients either completed week 52 visit or had early colectomy or had additional therapy.|163
2369362|NCT01536535|5814533|P2|STARTED|Overall Study||250
2369363|NCT01536535|5814534|P1|STARTED|Overall Study||178
2369364|NCT01536496|5814546|P2|NOT COMPLETED|Overall Study||1
2369365|NCT01536496|5814547|P1|NOT COMPLETED|Overall Study||2
2369366|NCT01536496|5814546|P2|COMPLETED|Overall Study||56
2369367|NCT01536496|5814547|P1|COMPLETED|Overall Study||55
2369368|NCT01536496|5814546|P2|STARTED|Overall Study||57
2369369|NCT01536496|5814547|P1|STARTED|Overall Study||57
2369370|NCT01536418|5814583|P2|NOT COMPLETED|Overall Study||66
2369371|NCT01536418|5814584|P1|NOT COMPLETED|Overall Study||69
2369372|NCT01536418|5814583|P2|COMPLETED|Overall Study||60
2369373|NCT01536418|5814584|P1|COMPLETED|Overall Study||58
2369374|NCT01536418|5814583|P2|STARTED|Overall Study||126
2369375|NCT01536418|5814584|P1|STARTED|Overall Study||127
2369376|NCT01536405|5814604|P2|NOT COMPLETED|Visit 4 to Extended Study Follow-up||23
2369377|NCT01536405|5814605|P1|NOT COMPLETED|Visit 4 to Extended Study Follow-up||20
2369378|NCT01536405|5814604|P2|COMPLETED|Visit 4 to Extended Study Follow-up||595
2369379|NCT01536405|5814605|P1|COMPLETED|Visit 4 to Extended Study Follow-up||595
2369380|NCT01536405|5814604|P2|STARTED|Visit 4 to Extended Study Follow-up||618
2369381|NCT01536405|5814605|P1|STARTED|Visit 4 to Extended Study Follow-up||615
2369382|NCT01536405|5814604|P2|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||16
2369383|NCT01536405|5814605|P1|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||20
2369384|NCT01536405|5814604|P2|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||618
2369385|NCT01536405|5814605|P1|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||615
2369386|NCT01536405|5814604|P2|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||632
2369387|NCT01536405|5814605|P1|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||634
2369388|NCT01536405|5814604|P2|STARTED|Visit 3 (Vaccination 2) to Visit 4||634
2369389|NCT01536405|5814605|P1|STARTED|Visit 3 (Vaccination 2) to Visit 4||635
2369390|NCT01536405|5814604|P2|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||28
2369391|NCT01536405|5814605|P1|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||31
2369392|NCT01536405|5814604|P2|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||634
2369393|NCT01536405|5814605|P1|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||635
2369394|NCT01536405|5814604|P2|STARTED|Visit 2 to Visit 3 (Vaccination 2)||662
2369395|NCT01536405|5814605|P1|STARTED|Visit 2 to Visit 3 (Vaccination 2)||666
2369396|NCT01536405|5814604|P2|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||40
2369397|NCT01536405|5814605|P1|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||32
2369398|NCT01536405|5814604|P2|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||662
2369399|NCT01536405|5814605|P1|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||666
2369400|NCT01536405|5814604|P2|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||702
2369401|NCT01536405|5814605|P1|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||698
2369402|NCT01536405|5814604|P2|STARTED|Visit 1 (Vaccination 1) to Visit 2||702
2369403|NCT01536405|5814605|P1|STARTED|Visit 1 (Vaccination 1) to Visit 2||698
2369404|NCT01536405|5814604|P2|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||4
2369405|NCT01536405|5814605|P1|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||8
2369406|NCT01536405|5814604|P2|COMPLETED|Randomization to Visit 1 (Vaccination 1)||702
2369407|NCT01536405|5814605|P1|COMPLETED|Randomization to Visit 1 (Vaccination 1)||698
2369408|NCT01536405|5814604|P2|STARTED|Randomization to Visit 1 (Vaccination 1)||706
2369409|NCT01536405|5814605|P1|STARTED|Randomization to Visit 1 (Vaccination 1)||706
2369410|NCT01536379|5814643|P2|NOT COMPLETED|Overall Study||3
2369411|NCT01536379|5814644|P1|NOT COMPLETED|Overall Study||2
2369412|NCT01536379|5814643|P2|COMPLETED|Overall Study||9
2369413|NCT01536379|5814644|P1|COMPLETED|Overall Study||11
2369414|NCT01536379|5814643|P2|STARTED|Overall Study||12
2369415|NCT01536379|5814644|P1|STARTED|Overall Study||13
2369416|NCT01536366|5814720|P2|NOT COMPLETED|Overall Study||4
2369417|NCT01536366|5814721|P1|NOT COMPLETED|Overall Study||13
2369418|NCT01536366|5814720|P2|COMPLETED|Overall Study||9
2369419|NCT01536366|5814721|P1|COMPLETED|Overall Study||1
2369420|NCT01536366|5814720|P2|Follow-up|Overall Study||9
2369421|NCT01536366|5814721|P1|Follow-up|Overall Study||13
2369422|NCT01536366|5814720|P2|Repaglinide|Overall Study||13
2369423|NCT01536366|5814721|P1|Repaglinide|Overall Study||14
2369424|NCT01536366|5814720|P2|BIA 9-1067 + Repaglinide|Overall Study||10
2369425|NCT01536366|5814721|P1|BIA 9-1067 + Repaglinide|Overall Study||14
2369426|NCT01536366|5814720|P2|STARTED|Overall Study||13
2369427|NCT01536366|5814721|P1|STARTED|Overall Study||14
2369428|NCT01536262|5814736|P3|NOT COMPLETED|Overall Study||2
2369429|NCT01536262|5814737|P2|NOT COMPLETED|Overall Study||2
2369430|NCT01536262|5814738|P1|NOT COMPLETED|Overall Study||8
2369431|NCT01536262|5814736|P3|COMPLETED|Overall Study||39
2369432|NCT01536262|5814737|P2|COMPLETED|Overall Study||38
2369433|NCT01536262|5814738|P1|COMPLETED|Overall Study||33
2369434|NCT01536262|5814736|P3|STARTED|Overall Study||41
2369435|NCT01536262|5814737|P2|STARTED|Overall Study||40
2369436|NCT01536262|5814738|P1|STARTED|Overall Study||41
2369437|NCT01536197|5814754|P2|NOT COMPLETED|Overall Study||0
2369438|NCT01536197|5814755|P1|NOT COMPLETED|Overall Study||0
2369439|NCT01536197|5814754|P2|COMPLETED|Overall Study||10
2369440|NCT01536197|5814755|P1|COMPLETED|Overall Study||23
2369441|NCT01536197|5814754|P2|STARTED|Overall Study||10
2369442|NCT01536197|5814755|P1|STARTED|Overall Study||23
2369443|NCT01536184|5814765|P2|NOT COMPLETED|Overall Study||0
2369444|NCT01536184|5814766|P1|NOT COMPLETED|Overall Study||0
2369445|NCT01536184|5814765|P2|COMPLETED|Overall Study||4
2369446|NCT01536184|5814766|P1|COMPLETED|Overall Study||8
2369447|NCT01536184|5814765|P2|STARTED|Overall Study||4
2369448|NCT01536184|5814766|P1|STARTED|Overall Study||8
2369449|NCT01536171|5814780|P1|NOT COMPLETED|Overall Study||1
2369450|NCT01536171|5814780|P1|COMPLETED|Overall Study||21
2369451|NCT01536171|5814780|P1|STARTED|Overall Study||22
2369452|NCT01536145|5814785|P11|NOT COMPLETED|Overall Study||10
2369453|NCT01536145|5814786|P10|NOT COMPLETED|Overall Study||6
2369454|NCT01536145|5814787|P9|NOT COMPLETED|Overall Study||3
2369455|NCT01536145|5814788|P8|NOT COMPLETED|Overall Study||4
2369456|NCT01536145|5814789|P7|NOT COMPLETED|Overall Study||2
2369457|NCT01536145|5814790|P6|NOT COMPLETED|Overall Study||3
2369458|NCT01536145|5814791|P5|NOT COMPLETED|Overall Study||2
2369459|NCT01536145|5814792|P4|NOT COMPLETED|Overall Study||2
2369460|NCT01536145|5814793|P3|NOT COMPLETED|Overall Study||2
2369461|NCT01536145|5814794|P2|NOT COMPLETED|Overall Study||4
2369462|NCT01536145|5814795|P1|NOT COMPLETED|Overall Study||3
2369463|NCT01536145|5814785|P11|COMPLETED|Overall Study||0
2369464|NCT01536145|5814786|P10|COMPLETED|Overall Study||1
2369465|NCT01536145|5814787|P9|COMPLETED|Overall Study||0
2369466|NCT01536145|5814788|P8|COMPLETED|Overall Study||0
2369467|NCT01536145|5814789|P7|COMPLETED|Overall Study||1
2369468|NCT01536145|5814790|P6|COMPLETED|Overall Study||0
2369469|NCT01536145|5814791|P5|COMPLETED|Overall Study||2
2369470|NCT01536145|5814792|P4|COMPLETED|Overall Study||1
2369471|NCT01536145|5814793|P3|COMPLETED|Overall Study||1
2369472|NCT01536145|5814794|P2|COMPLETED|Overall Study||0
2369473|NCT01536145|5814795|P1|COMPLETED|Overall Study||0
2369474|NCT01536145|5814785|P11|STARTED|Overall Study||10
2369475|NCT01536145|5814786|P10|STARTED|Overall Study||7
2369476|NCT01536145|5814787|P9|STARTED|Overall Study||3
2369477|NCT01536145|5814788|P8|STARTED|Overall Study||4
2369478|NCT01536145|5814789|P7|STARTED|Overall Study||3
2369479|NCT01536145|5814790|P6|STARTED|Overall Study||3
2369480|NCT01536145|5814791|P5|STARTED|Overall Study||4
2369481|NCT01536145|5814792|P4|STARTED|Overall Study||3
2369482|NCT01536145|5814793|P3|STARTED|Overall Study||3
2369483|NCT01536145|5814794|P2|STARTED|Overall Study||4
2369484|NCT01536145|5814795|P1|STARTED|Overall Study||3
2369485|NCT01536119|5814902|P2|NOT COMPLETED|Overall Study||14
2369486|NCT01536119|5814903|P1|NOT COMPLETED|Overall Study||17
2369487|NCT01536119|5814902|P2|COMPLETED|Overall Study|105 mothers + 95 fathers = 200 participants 2 mothers + 12 fathers = 14 did not complete the study|200
2369488|NCT01536119|5814903|P1|COMPLETED|Overall Study|104 Mothers + 93 fathers = 197 participants 3 mothers + 14 fathers = 17 did not complete the study|197
2369489|NCT01536119|5814902|P2|STARTED|Overall Study|(107*2=214) (107 mothers and 107 fathers)|214
2369490|NCT01536119|5814903|P1|STARTED|Overall Study|(107*2= 214) (107 mothers and 107 fathers)|214
2369491|NCT01536093|5814929|P2|NOT COMPLETED|Overall Study||3
2369492|NCT01536093|5814930|P1|NOT COMPLETED|Overall Study||3
2369493|NCT01536093|5814929|P2|COMPLETED|Overall Study||21
2369494|NCT01536093|5814930|P1|COMPLETED|Overall Study||21
2369495|NCT01536093|5814929|P2|STARTED|Overall Study||24
2369496|NCT01536093|5814930|P1|STARTED|Overall Study||24
2369497|NCT01536067|5814946|P1|NOT COMPLETED|Overall Study||1
2369498|NCT01536067|5814946|P1|COMPLETED|Overall Study||2
2369499|NCT01536067|5814946|P1|STARTED|Overall Study||3
2369500|NCT01536015|5814959|P2|NOT COMPLETED|Overall Study||10
2369501|NCT01536015|5814960|P1|NOT COMPLETED|Overall Study||8
2369502|NCT01536015|5814959|P2|COMPLETED|Overall Study||3
2369503|NCT01536015|5814960|P1|COMPLETED|Overall Study||4
2369504|NCT01536015|5814959|P2|STARTED|Overall Study||13
2369505|NCT01536015|5814960|P1|STARTED|Overall Study||12
2369506|NCT01535976|5814978|P2|NOT COMPLETED|Overall Study||1
2369507|NCT01535976|5814979|P1|NOT COMPLETED|Overall Study||1
2369508|NCT01535976|5814978|P2|COMPLETED|Overall Study||26
2369509|NCT01535976|5814979|P1|COMPLETED|Overall Study||26
2369510|NCT01535976|5814978|P2|STARTED|Overall Study||27
2369511|NCT01535976|5814979|P1|STARTED|Overall Study||27
2369512|NCT01535937|5814987|P2|NOT COMPLETED|Overall Study||0
2369513|NCT01535937|5814988|P1|NOT COMPLETED|Overall Study||0
2369514|NCT01535937|5814987|P2|COMPLETED|Overall Study||28
2369515|NCT01535937|5814988|P1|COMPLETED|Overall Study||27
2369516|NCT01535937|5814987|P2|STARTED|Overall Study||28
2369517|NCT01535937|5814988|P1|STARTED|Overall Study||27
2369518|NCT01535807|5814998|P2|NOT COMPLETED|Overall Study||2
2369519|NCT01535807|5814999|P1|NOT COMPLETED|Overall Study||2
2369520|NCT01535807|5814998|P2|COMPLETED|Overall Study||20
2369521|NCT01535807|5814999|P1|COMPLETED|Overall Study||20
2369522|NCT01535807|5814998|P2|STARTED|Overall Study||22
2369523|NCT01535807|5814999|P1|STARTED|Overall Study||22
2369524|NCT01535729|5815005|P1|NOT COMPLETED|Overall Study||416
2369525|NCT01535729|5815005|P1|COMPLETED|Overall Study||49
2369526|NCT01535729|5815005|P1|Treated|Overall Study||385
2369527|NCT01535729|5815005|P1|STARTED|Overall Study||465
2369528|NCT01535664|5815032|P1|NOT COMPLETED|Overall Study||0
2369529|NCT01535664|5815032|P1|COMPLETED|Overall Study||20
2369530|NCT01535664|5815032|P1|STARTED|Overall Study||20
2369531|NCT01535638|5815046|P6|NOT COMPLETED|Treatment 3 (Single Dose)||0
2369532|NCT01535638|5815047|P5|NOT COMPLETED|Treatment 3 (Single Dose)||0
2369533|NCT01535638|5815048|P4|NOT COMPLETED|Treatment 3 (Single Dose)||1
2369534|NCT01535638|5815049|P3|NOT COMPLETED|Treatment 3 (Single Dose)||0
2369535|NCT01535638|5815050|P2|NOT COMPLETED|Treatment 3 (Single Dose)||0
2369536|NCT01535638|5815051|P1|NOT COMPLETED|Treatment 3 (Single Dose)||0
2369537|NCT01535638|5815046|P6|COMPLETED|Treatment 3 (Single Dose)||2
2369538|NCT01535638|5815047|P5|COMPLETED|Treatment 3 (Single Dose)||3
2369539|NCT01535638|5815048|P4|COMPLETED|Treatment 3 (Single Dose)||2
2369540|NCT01535638|5815049|P3|COMPLETED|Treatment 3 (Single Dose)||3
2369541|NCT01535638|5815050|P2|COMPLETED|Treatment 3 (Single Dose)||3
2369542|NCT01535638|5815051|P1|COMPLETED|Treatment 3 (Single Dose)||3
2369543|NCT01535638|5815046|P6|STARTED|Treatment 3 (Single Dose)||2
2369544|NCT01535638|5815047|P5|STARTED|Treatment 3 (Single Dose)||3
2369545|NCT01535638|5815048|P4|STARTED|Treatment 3 (Single Dose)||3
2369546|NCT01535638|5815049|P3|STARTED|Treatment 3 (Single Dose)||3
2369547|NCT01535638|5815050|P2|STARTED|Treatment 3 (Single Dose)||3
2369548|NCT01535638|5815051|P1|STARTED|Treatment 3 (Single Dose)||3
2369549|NCT01535638|5815046|P6|NOT COMPLETED|Treatment 2 (Single Dose)||0
2369550|NCT01535638|5815047|P5|NOT COMPLETED|Treatment 2 (Single Dose)||0
2369551|NCT01535638|5815048|P4|NOT COMPLETED|Treatment 2 (Single Dose)||0
2369552|NCT01535638|5815049|P3|NOT COMPLETED|Treatment 2 (Single Dose)||0
2369553|NCT01535638|5815050|P2|NOT COMPLETED|Treatment 2 (Single Dose)||0
2369554|NCT01535638|5815051|P1|NOT COMPLETED|Treatment 2 (Single Dose)||0
2369555|NCT01535638|5815046|P6|COMPLETED|Treatment 2 (Single Dose)||2
2369556|NCT01535638|5815047|P5|COMPLETED|Treatment 2 (Single Dose)||3
2369557|NCT01535638|5815048|P4|COMPLETED|Treatment 2 (Single Dose)||3
2369558|NCT01535638|5815049|P3|COMPLETED|Treatment 2 (Single Dose)||3
2369559|NCT01535638|5815050|P2|COMPLETED|Treatment 2 (Single Dose)||3
2369560|NCT01535638|5815051|P1|COMPLETED|Treatment 2 (Single Dose)||3
2369561|NCT01535638|5815046|P6|STARTED|Treatment 2 (Single Dose)||2
2369562|NCT01535638|5815047|P5|STARTED|Treatment 2 (Single Dose)||3
2369563|NCT01535638|5815048|P4|STARTED|Treatment 2 (Single Dose)||3
2369564|NCT01535638|5815049|P3|STARTED|Treatment 2 (Single Dose)||3
2369565|NCT01535638|5815050|P2|STARTED|Treatment 2 (Single Dose)||3
2369566|NCT01535638|5815051|P1|STARTED|Treatment 2 (Single Dose)||3
2369567|NCT01535638|5815046|P6|NOT COMPLETED|Treatment 1 (Single Dose)||1
2369568|NCT01535638|5815047|P5|NOT COMPLETED|Treatment 1 (Single Dose)||0
2369569|NCT01535638|5815048|P4|NOT COMPLETED|Treatment 1 (Single Dose)||0
2369570|NCT01535638|5815049|P3|NOT COMPLETED|Treatment 1 (Single Dose)||0
2369571|NCT01535638|5815050|P2|NOT COMPLETED|Treatment 1 (Single Dose)||0
2369572|NCT01535638|5815051|P1|NOT COMPLETED|Treatment 1 (Single Dose)||0
2369573|NCT01535638|5815046|P6|COMPLETED|Treatment 1 (Single Dose)||2
2369574|NCT01535638|5815047|P5|COMPLETED|Treatment 1 (Single Dose)||3
2369575|NCT01535638|5815048|P4|COMPLETED|Treatment 1 (Single Dose)||3
2369576|NCT01535638|5815049|P3|COMPLETED|Treatment 1 (Single Dose)||3
2369577|NCT01535638|5815050|P2|COMPLETED|Treatment 1 (Single Dose)||3
2369578|NCT01535638|5815051|P1|COMPLETED|Treatment 1 (Single Dose)||3
2369579|NCT01535638|5815046|P6|STARTED|Treatment 1 (Single Dose)||3
2369580|NCT01535638|5815047|P5|STARTED|Treatment 1 (Single Dose)||3
2369581|NCT01535638|5815048|P4|STARTED|Treatment 1 (Single Dose)||3
2369582|NCT01535638|5815049|P3|STARTED|Treatment 1 (Single Dose)||3
2369583|NCT01535638|5815050|P2|STARTED|Treatment 1 (Single Dose)||3
2369584|NCT01535638|5815051|P1|STARTED|Treatment 1 (Single Dose)||3
2369585|NCT01535599|5815065|P2|NOT COMPLETED|Overall Study||96
2369586|NCT01535599|5815066|P1|NOT COMPLETED|Overall Study||50
2369587|NCT01535599|5815065|P2|COMPLETED|Overall Study||250
2369588|NCT01535599|5815066|P1|COMPLETED|Overall Study||297
2369589|NCT01535599|5815065|P2|STARTED|Overall Study||346
2369590|NCT01535599|5815066|P1|STARTED|Overall Study||347
2369591|NCT01535560|5815078|P2|NOT COMPLETED|Overall Study||96
2369592|NCT01535560|5815079|P1|NOT COMPLETED|Overall Study||37
2369593|NCT01535560|5815078|P2|COMPLETED|Overall Study||179
2369594|NCT01535560|5815079|P1|COMPLETED|Overall Study||237
2369595|NCT01535560|5815078|P2|STARTED|Overall Study||275
2369596|NCT01535560|5815079|P1|STARTED|Overall Study||274
2369597|NCT01535443|5815089|P1|NOT COMPLETED|Overall Study||3
2369598|NCT01535443|5815089|P1|COMPLETED|Overall Study||32
2369599|NCT01535443|5815089|P1|STARTED|Overall Study||35
2369600|NCT01535365|5815106|P2|NOT COMPLETED|Overall Study||0
2369601|NCT01535365|5815107|P1|NOT COMPLETED|Overall Study||0
2369602|NCT01535365|5815106|P2|COMPLETED|Overall Study||29
2369603|NCT01535365|5815107|P1|COMPLETED|Overall Study||31
2369604|NCT01535365|5815106|P2|STARTED|Overall Study||29
2369605|NCT01535365|5815107|P1|STARTED|Overall Study||31
2369606|NCT01535326|5815118|P3|NOT COMPLETED|Overall Study||0
2369607|NCT01535326|5815119|P2|NOT COMPLETED|Overall Study||0
2369608|NCT01535326|5815120|P1|NOT COMPLETED|Overall Study||0
2369609|NCT01535326|5815118|P3|COMPLETED|Overall Study||90
2369610|NCT01535326|5815119|P2|COMPLETED|Overall Study||90
2369611|NCT01535326|5815120|P1|COMPLETED|Overall Study||90
2369612|NCT01535326|5815118|P3|STARTED|Overall Study||90
2369613|NCT01535326|5815119|P2|STARTED|Overall Study||90
2369614|NCT01535326|5815120|P1|STARTED|Overall Study||90
2369615|NCT01535287|5815139|P2|NOT COMPLETED|Overall Study||6
2369616|NCT01535287|5815140|P1|NOT COMPLETED|Overall Study||5
2369617|NCT01535287|5815139|P2|COMPLETED|Overall Study||64
2369618|NCT01535287|5815140|P1|COMPLETED|Overall Study||65
2369619|NCT01535287|5815139|P2|STARTED|Overall Study||70
2369620|NCT01535287|5815140|P1|STARTED|Overall Study||70
2369621|NCT01535261|5815156|P1|NOT COMPLETED|Overall Study||50
2369622|NCT01535261|5815156|P1|COMPLETED|Overall Study||307
2369623|NCT01535261|5815156|P1|STARTED|Overall Study||357
2369624|NCT01535235|5815169|P2|NOT COMPLETED|Overall Study||0
2369625|NCT01535235|5815170|P1|NOT COMPLETED|Overall Study||1
2369626|NCT01535235|5815169|P2|COMPLETED|Overall Study||15
2369627|NCT01535235|5815170|P1|COMPLETED|Overall Study||15
2369628|NCT01535235|5815169|P2|STARTED|Overall Study||15
2369629|NCT01535235|5815170|P1|STARTED|Overall Study||16
2369630|NCT01535222|5815184|P6|NOT COMPLETED|Overall Study||0
2369631|NCT01535222|5815185|P5|NOT COMPLETED|Overall Study||0
2369632|NCT01535222|5815186|P4|NOT COMPLETED|Overall Study||0
2369633|NCT01535222|5815187|P3|NOT COMPLETED|Overall Study||1
2369634|NCT01535222|5815188|P2|NOT COMPLETED|Overall Study||0
2369635|NCT01535222|5815189|P1|NOT COMPLETED|Overall Study||0
2369636|NCT01535222|5815184|P6|COMPLETED|Overall Study||8
2369637|NCT01535222|5815185|P5|COMPLETED|Overall Study||6
2369638|NCT01535222|5815186|P4|COMPLETED|Overall Study||6
2369639|NCT01535222|5815187|P3|COMPLETED|Overall Study||6
2369640|NCT01535222|5815188|P2|COMPLETED|Overall Study||3
2369641|NCT01535222|5815189|P1|COMPLETED|Overall Study||3
2369642|NCT01535222|5815184|P6|STARTED|Overall Study||8
2369643|NCT01535222|5815185|P5|STARTED|Overall Study||6
2369644|NCT01535222|5815186|P4|STARTED|Overall Study||6
2369645|NCT01535222|5815187|P3|STARTED|Overall Study|Patient randomized but did not meet inclusion/exclusion criteria and did not receive study drug|7
2369646|NCT01535222|5815188|P2|STARTED|Overall Study||3
2369647|NCT01535222|5815189|P1|STARTED|Overall Study||3
2369648|NCT01535118|5815209|P1|NOT COMPLETED|Overall Study||0
2369649|NCT01535118|5815209|P1|COMPLETED|Overall Study||2765
2369650|NCT01535118|5815209|P1|STARTED|Overall Study||2765
2369651|NCT01535053|5815220|P2|NOT COMPLETED|Overall Study||2
2369652|NCT01535053|5815221|P1|NOT COMPLETED|Overall Study||1
2369653|NCT01535053|5815220|P2|COMPLETED|Overall Study|treated for 3 cycles after hCG <5mIU/ml or until biologic,disease progression, unacceptable toxicity|26
2369654|NCT01535053|5815221|P1|COMPLETED|Overall Study|treated for 3 cycles after hCG <5mIU/ml or until biologic,disease progression, unacceptable toxicity|28
2369655|NCT01535053|5815220|P2|STARTED|Overall Study||28
2369656|NCT01535053|5815221|P1|STARTED|Overall Study||29
2369657|NCT01535040|5815239|P2|NOT COMPLETED|Overall Study||21
2369658|NCT01535040|5815240|P1|NOT COMPLETED|Overall Study||30
2369659|NCT01535040|5815239|P2|COMPLETED|Overall Study||44
2369660|NCT01535040|5815240|P1|COMPLETED|Overall Study||35
2369661|NCT01535040|5815239|P2|STARTED|Overall Study||65
2369662|NCT01535040|5815240|P1|STARTED|Overall Study||65
2369663|NCT01535014|5815256|P4|NOT COMPLETED|Overall Study||0
2369664|NCT01535014|5815257|P3|NOT COMPLETED|Overall Study||1
2369665|NCT01535014|5815258|P2|NOT COMPLETED|Overall Study||6
2369666|NCT01535014|5815259|P1|NOT COMPLETED|Overall Study||2
2369667|NCT01535014|5815256|P4|COMPLETED|Overall Study||33
2369668|NCT01535014|5815257|P3|COMPLETED|Overall Study||49
2369669|NCT01535014|5815258|P2|COMPLETED|Overall Study||194
2369670|NCT01535014|5815259|P1|COMPLETED|Overall Study||208
2369671|NCT01535014|5815256|P4|STARTED|Overall Study||33
2369672|NCT01535014|5815257|P3|STARTED|Overall Study||50
2369673|NCT01535014|5815258|P2|STARTED|Overall Study||200
2369674|NCT01535014|5815259|P1|STARTED|Overall Study||210
2369675|NCT01535001|5815293|P2|NOT COMPLETED|Overall Study||6
2369676|NCT01535001|5815294|P1|NOT COMPLETED|Overall Study||3
2369677|NCT01535001|5815293|P2|COMPLETED|Overall Study||44
2369678|NCT01535001|5815294|P1|COMPLETED|Overall Study||47
2369679|NCT01535001|5815293|P2|STARTED|Overall Study||50
2369680|NCT01535001|5815294|P1|STARTED|Overall Study||50
2369681|NCT01534975|5815320|P4|NOT COMPLETED|Overall Study||0
2369682|NCT01534975|5815321|P3|NOT COMPLETED|Overall Study||0
2369683|NCT01534975|5815322|P2|NOT COMPLETED|Overall Study||0
2369684|NCT01534975|5815323|P1|NOT COMPLETED|Overall Study||0
2369685|NCT01534975|5815320|P4|COMPLETED|Overall Study||84
2369686|NCT01534975|5815321|P3|COMPLETED|Overall Study||160
2369687|NCT01534975|5815322|P2|COMPLETED|Overall Study||133
2369688|NCT01534975|5815323|P1|COMPLETED|Overall Study||136
2369689|NCT01534975|5815320|P4|STARTED|Overall Study||84
2369690|NCT01534975|5815321|P3|STARTED|Overall Study||160
2369691|NCT01534975|5815322|P2|STARTED|Overall Study||133
2369692|NCT01534975|5815323|P1|STARTED|Overall Study||136
2369693|NCT01534962|5815337|P4|NOT COMPLETED|Overall Study||32
2369694|NCT01534962|5815338|P3|NOT COMPLETED|Overall Study||24
2369695|NCT01534962|5815339|P2|NOT COMPLETED|Overall Study||26
2369696|NCT01534962|5815340|P1|NOT COMPLETED|Overall Study||37
2369697|NCT01534962|5815337|P4|COMPLETED|Overall Study||24
2369698|NCT01534962|5815338|P3|COMPLETED|Overall Study||34
2369699|NCT01534962|5815339|P2|COMPLETED|Overall Study||34
2369700|NCT01534962|5815340|P1|COMPLETED|Overall Study||30
2369701|NCT01534962|5815337|P4|STARTED|Overall Study||56
2369702|NCT01534962|5815338|P3|STARTED|Overall Study||58
2369703|NCT01534962|5815339|P2|STARTED|Overall Study||60
2369704|NCT01534962|5815340|P1|STARTED|Overall Study||67
2369705|NCT01534910|5815372|P2|NOT COMPLETED|Overall Study||4
2369706|NCT01534910|5815373|P1|NOT COMPLETED|Overall Study||4
2369707|NCT01534910|5815372|P2|COMPLETED|Overall Study||28
2369708|NCT01534910|5815373|P1|COMPLETED|Overall Study||29
2369709|NCT01534910|5815372|P2|STARTED|Overall Study||32
2369710|NCT01534910|5815373|P1|STARTED|Overall Study||33
2369711|NCT01534897|5815381|P1|NOT COMPLETED|Overall Study||0
2369712|NCT01534897|5815381|P1|COMPLETED|Overall Study||10
2369713|NCT01534897|5815381|P1|Day 37 Iodine-131 Treatment|Overall Study||6
2369714|NCT01534897|5815381|P1|Day 25 Iodine-131 Scan|Overall Study||10
2369715|NCT01534897|5815381|P1|STARTED|Overall Study||10
2369716|NCT01534689|5815389|P1|NOT COMPLETED|Overall Study||0
2369717|NCT01534689|5815389|P1|COMPLETED|Overall Study||105
2369718|NCT01534689|5815389|P1|STARTED|Overall Study||105
2369719|NCT01534676|5815397|P2|NOT COMPLETED|Overall Study||1
2369720|NCT01534676|5815398|P1|NOT COMPLETED|Overall Study||2
2369721|NCT01534676|5815397|P2|COMPLETED|Overall Study||0
2369722|NCT01534676|5815398|P1|COMPLETED|Overall Study||0
2369723|NCT01534676|5815397|P2|STARTED|Overall Study||1
2369724|NCT01534676|5815398|P1|STARTED|Overall Study||2
2369725|NCT01534637|5815404|P1|NOT COMPLETED|Overall Study||9
2369726|NCT01534637|5815404|P1|COMPLETED|Overall Study||13
2369727|NCT01534637|5815404|P1|STARTED|Overall Study||22
2369728|NCT01534533|5815414|P4|NOT COMPLETED|Overall Study||4
2369729|NCT01534533|5815415|P3|NOT COMPLETED|Overall Study||8
2369730|NCT01534533|5815416|P2|NOT COMPLETED|Overall Study||3
2369731|NCT01534533|5815417|P1|NOT COMPLETED|Overall Study||8
2369732|NCT01534533|5815414|P4|COMPLETED|Overall Study||44
2369733|NCT01534533|5815415|P3|COMPLETED|Overall Study||40
2369734|NCT01534533|5815416|P2|COMPLETED|Overall Study||45
2369735|NCT01534533|5815417|P1|COMPLETED|Overall Study||40
2369736|NCT01534533|5815414|P4|STARTED|Overall Study||48
2369737|NCT01534533|5815415|P3|STARTED|Overall Study||48
2369738|NCT01534533|5815416|P2|STARTED|Overall Study||48
2369739|NCT01534533|5815417|P1|STARTED|Overall Study||48
2369740|NCT01534520|5815445|P2|NOT COMPLETED|Overall Study||1
2369741|NCT01534520|5815446|P1|NOT COMPLETED|Overall Study||0
2369742|NCT01534520|5815445|P2|COMPLETED|Overall Study|1 subject withdrew consent at time of uterine sound attempt due to intolerable pain|28
2369743|NCT01534520|5815446|P1|COMPLETED|Overall Study||30
2369744|NCT01534520|5815445|P2|STARTED|Overall Study||29
2369745|NCT01534520|5815446|P1|STARTED|Overall Study||30
2369746|NCT01534416|5815460|P2|NOT COMPLETED|Overall Study||0
2369747|NCT01534416|5815461|P1|NOT COMPLETED|Overall Study||0
2369748|NCT01534416|5815460|P2|COMPLETED|Overall Study||64
2369749|NCT01534416|5815461|P1|COMPLETED|Overall Study||68
2369750|NCT01534416|5815460|P2|STARTED|Overall Study||64
2369751|NCT01534416|5815461|P1|STARTED|Overall Study||68
2369752|NCT01534351|5815480|P3|NOT COMPLETED|Overall Study||0
2369753|NCT01534351|5815481|P2|NOT COMPLETED|Overall Study||0
2369754|NCT01534351|5815482|P1|NOT COMPLETED|Overall Study||1
2369755|NCT01534351|5815480|P3|COMPLETED|Overall Study||0
2369756|NCT01534351|5815481|P2|COMPLETED|Overall Study||0
2369757|NCT01534351|5815482|P1|COMPLETED|Overall Study||0
2369758|NCT01534351|5815480|P3|STARTED|Overall Study||0
2369759|NCT01534351|5815481|P2|STARTED|Overall Study||0
2369760|NCT01534351|5815482|P1|STARTED|Overall Study||1
2369761|NCT01534273|5815503|P7|NOT COMPLETED|Period 2||0
2369762|NCT01534273|5815504|P6|NOT COMPLETED|Period 2||0
2369763|NCT01534273|5815505|P5|NOT COMPLETED|Period 2||0
2369764|NCT01534273|5815506|P4|NOT COMPLETED|Period 2||0
2369765|NCT01534273|5815507|P3|NOT COMPLETED|Period 2||0
2369766|NCT01534273|5815508|P2|NOT COMPLETED|Period 2||0
2369767|NCT01534273|5815509|P1|NOT COMPLETED|Period 2||0
2369768|NCT01534273|5815503|P7|COMPLETED|Period 2||0
2369769|NCT01534273|5815504|P6|COMPLETED|Period 2||0
2369770|NCT01534273|5815505|P5|COMPLETED|Period 2||0
2369771|NCT01534273|5815506|P4|COMPLETED|Period 2||6
2369772|NCT01534273|5815507|P3|COMPLETED|Period 2||2
2369773|NCT01534273|5815508|P2|COMPLETED|Period 2||0
2369774|NCT01534273|5815509|P1|COMPLETED|Period 2||0
2369775|NCT01534273|5815503|P7|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
2369776|NCT01534273|5815504|P6|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
2369777|NCT01534273|5815505|P5|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
2369778|NCT01534273|5815506|P4|STARTED|Period 2||6
2369779|NCT01534273|5815507|P3|STARTED|Period 2||2
2369780|NCT01534273|5815508|P2|STARTED|Period 2|Participants in Cohort A participated in only 1 treatment period.|0
2369781|NCT01534273|5815509|P1|STARTED|Period 2|Participants in Cohort A participated in only 1 treatment period.|0
2369782|NCT01534273|5815503|P7|NOT COMPLETED|Period 1||0
2369783|NCT01534273|5815504|P6|NOT COMPLETED|Period 1||0
2369784|NCT01534273|5815505|P5|NOT COMPLETED|Period 1||0
2369785|NCT01534273|5815506|P4|NOT COMPLETED|Period 1||1
2369786|NCT01534273|5815507|P3|NOT COMPLETED|Period 1||0
2369787|NCT01534273|5815508|P2|NOT COMPLETED|Period 1||0
2369788|NCT01534273|5815509|P1|NOT COMPLETED|Period 1||0
2369789|NCT01534273|5815503|P7|COMPLETED|Period 1||6
2369790|NCT01534273|5815504|P6|COMPLETED|Period 1||3
2369791|NCT01534273|5815505|P5|COMPLETED|Period 1||3
2369792|NCT01534273|5815506|P4|COMPLETED|Period 1||6
2369793|NCT01534273|5815507|P3|COMPLETED|Period 1||2
2369794|NCT01534273|5815508|P2|COMPLETED|Period 1||6
2369795|NCT01534273|5815509|P1|COMPLETED|Period 1||3
2369796|NCT01534273|5815503|P7|Received at Least 1 Dose of Study Drug|Period 1||6
2369797|NCT01534273|5815504|P6|Received at Least 1 Dose of Study Drug|Period 1||3
2369798|NCT01534273|5815505|P5|Received at Least 1 Dose of Study Drug|Period 1||3
2369799|NCT01534273|5815506|P4|Received at Least 1 Dose of Study Drug|Period 1||7
2369800|NCT01534273|5815507|P3|Received at Least 1 Dose of Study Drug|Period 1||2
2369801|NCT01534273|5815508|P2|Received at Least 1 Dose of Study Drug|Period 1||6
2369802|NCT01534273|5815509|P1|Received at Least 1 Dose of Study Drug|Period 1||3
2369803|NCT01534273|5815503|P7|STARTED|Period 1||6
2369804|NCT01534273|5815504|P6|STARTED|Period 1||3
2369805|NCT01534273|5815505|P5|STARTED|Period 1||3
2369806|NCT01534273|5815506|P4|STARTED|Period 1||7
2369807|NCT01534273|5815507|P3|STARTED|Period 1||2
2369808|NCT01534273|5815508|P2|STARTED|Period 1||6
2369809|NCT01534273|5815509|P1|STARTED|Period 1||3
2369810|NCT01534260|5815536|P2|NOT COMPLETED|Overall Study||20
2369811|NCT01534260|5815537|P1|NOT COMPLETED|Overall Study||16
2369812|NCT01534260|5815536|P2|COMPLETED|Overall Study||0
2369813|NCT01534260|5815537|P1|COMPLETED|Overall Study||1
2369814|NCT01534260|5815536|P2|STARTED|Overall Study||20
2369815|NCT01534260|5815537|P1|STARTED|Overall Study||17
2369816|NCT01534208|5815547|P2|NOT COMPLETED|Overall Study||49
2369817|NCT01534208|5815548|P1|NOT COMPLETED|Overall Study||57
2369818|NCT01534208|5815547|P2|COMPLETED|Overall Study||234
2369819|NCT01534208|5815548|P1|COMPLETED|Overall Study||159
2369820|NCT01534208|5815547|P2|STARTED|Overall Study||283
2369821|NCT01534208|5815548|P1|STARTED|Overall Study||216
2369822|NCT01534195|5815566|P2|NOT COMPLETED|Overall Study||1
2369823|NCT01534195|5815567|P1|NOT COMPLETED|Overall Study||1
2369824|NCT01534195|5815566|P2|COMPLETED|Overall Study||5
2369825|NCT01534195|5815567|P1|COMPLETED|Overall Study||4
2369826|NCT01534195|5815566|P2|STARTED|Overall Study||6
2369827|NCT01534195|5815567|P1|STARTED|Overall Study||5
2369828|NCT01534182|5815581|P2|NOT COMPLETED|Overall Study||10
2369829|NCT01534182|5815582|P1|NOT COMPLETED|Overall Study||12
2369830|NCT01534182|5815581|P2|COMPLETED|Overall Study||58
2369831|NCT01534182|5815582|P1|COMPLETED|Overall Study||218
2369832|NCT01534182|5815581|P2|Full Analysis Set|Overall Study||62
2369833|NCT01534182|5815582|P1|Full Analysis Set|Overall Study||229
2369834|NCT01534182|5815581|P2|Safety Set|Overall Study||64
2369835|NCT01534182|5815582|P1|Safety Set|Overall Study||230
2369836|NCT01534182|5815581|P2|STARTED|Overall Study||68
2369837|NCT01534182|5815582|P1|STARTED|Overall Study||230
2369838|NCT01534143|5815597|P1|NOT COMPLETED|Overall Study||0
2369839|NCT01534143|5815597|P1|COMPLETED|Overall Study||1
2369840|NCT01534143|5815597|P1|STARTED|Overall Study||1
2369841|NCT01534078|5815613|P1|NOT COMPLETED|Overall Study||2
2369842|NCT01534078|5815613|P1|COMPLETED|Overall Study||32
2369843|NCT01534078|5815613|P1|STARTED|Overall Study||34
2369844|NCT01534052|5815620|P1|NOT COMPLETED|Overall Study||0
2369845|NCT01534052|5815620|P1|COMPLETED|Overall Study||52
2369846|NCT01534052|5815620|P1|Treatment Received|Overall Study||52
2369847|NCT01534052|5815620|P1|STARTED|Overall Study||52
2369848|NCT01534013|5815626|P2|NOT COMPLETED|Overall Study||0
2369849|NCT01534013|5815627|P1|NOT COMPLETED|Overall Study||2
2369850|NCT01534013|5815626|P2|COMPLETED|Overall Study||6
2369851|NCT01534013|5815627|P1|COMPLETED|Overall Study||6
2369852|NCT01534013|5815626|P2|STARTED|Overall Study||6
2369853|NCT01534013|5815627|P1|STARTED|Overall Study||8
2369854|NCT01533974|5815635|P2|NOT COMPLETED|Overall Study||50
2369855|NCT01533974|5815636|P1|NOT COMPLETED|Overall Study||51
2369856|NCT01533974|5815635|P2|COMPLETED|Overall Study||176
2369857|NCT01533974|5815636|P1|COMPLETED|Overall Study||173
2369858|NCT01533974|5815635|P2|STARTED|Overall Study||226
2369859|NCT01533974|5815636|P1|STARTED|Overall Study||224
2369860|NCT01533948|5815642|P1|NOT COMPLETED|Overall Study||0
2369861|NCT01533948|5815642|P1|COMPLETED|Overall Study||25
2369862|NCT01533948|5815642|P1|STARTED|Overall Study||25
2369863|NCT01533935|5815650|P5|NOT COMPLETED|Overall Study||8
2369864|NCT01533935|5815651|P4|NOT COMPLETED|Overall Study||7
2369865|NCT01533935|5815652|P3|NOT COMPLETED|Overall Study||8
2369866|NCT01533935|5815653|P2|NOT COMPLETED|Overall Study||13
2369867|NCT01533935|5815654|P1|NOT COMPLETED|Overall Study||6
2369868|NCT01533935|5815650|P5|COMPLETED|Overall Study|All treatment periods|50
2369869|NCT01533935|5815651|P4|COMPLETED|Overall Study|All treatment periods|52
2369870|NCT01533935|5815652|P3|COMPLETED|Overall Study|All treatment periods|50
2369871|NCT01533935|5815653|P2|COMPLETED|Overall Study|All treatment periods|45
2369872|NCT01533935|5815654|P1|COMPLETED|Overall Study|All treatment periods|52
2369873|NCT01533935|5815650|P5|Received Tio+Olo 5/5|Overall Study||55
2369874|NCT01533935|5815651|P4|Received Tio+Olo 5/5|Overall Study||54
2369875|NCT01533935|5815652|P3|Received Tio+Olo 5/5|Overall Study|One patient received Tio+Olo 5/5 instead of Tio+Olo 2.5/5 by mistake.|1
2369876|NCT01533935|5815653|P2|Received Tio+Olo 5/5|Overall Study||58
2369877|NCT01533935|5815654|P1|Received Tio+Olo 5/5|Overall Study||56
2369878|NCT01533935|5815650|P5|Received Tio+Olo 2.5/5|Overall Study||56
2369879|NCT01533935|5815651|P4|Received Tio+Olo 2.5/5|Overall Study||56
2369880|NCT01533935|5815652|P3|Received Tio+Olo 2.5/5|Overall Study||49
2369881|NCT01533935|5815653|P2|Received Tio+Olo 2.5/5|Overall Study||0
2369882|NCT01533935|5815654|P1|Received Tio+Olo 2.5/5|Overall Study||58
2369883|NCT01533935|5815650|P5|Received Tio 5|Overall Study||52
2369884|NCT01533935|5815651|P4|Received Tio 5|Overall Study||0
2369885|NCT01533935|5815652|P3|Received Tio 5|Overall Study||58
2369886|NCT01533935|5815653|P2|Received Tio 5|Overall Study||54
2369887|NCT01533935|5815654|P1|Received Tio 5|Overall Study||54
2369888|NCT01533935|5815650|P5|Received Olo 5|Overall Study||0
2369889|NCT01533935|5815651|P4|Received Olo 5|Overall Study||59
2369890|NCT01533935|5815652|P3|Received Olo 5|Overall Study||55
2369891|NCT01533935|5815653|P2|Received Olo 5|Overall Study||52
2369892|NCT01533935|5815654|P1|Received Olo 5|Overall Study||52
2369893|NCT01533935|5815650|P5|Received Placebo|Overall Study||58
2369894|NCT01533935|5815651|P4|Received Placebo|Overall Study||57
2369895|NCT01533935|5815652|P3|Received Placebo|Overall Study||52
2369896|NCT01533935|5815653|P2|Received Placebo|Overall Study||47
2369897|NCT01533935|5815654|P1|Received Placebo|Overall Study||0
2369898|NCT01533935|5815650|P5|STARTED|Overall Study||58
2369899|NCT01533935|5815651|P4|STARTED|Overall Study||59
2369900|NCT01533935|5815652|P3|STARTED|Overall Study||58
2369901|NCT01533935|5815653|P2|STARTED|Overall Study||58
2369902|NCT01533935|5815654|P1|STARTED|Overall Study||58
2369903|NCT01533922|5815681|P5|NOT COMPLETED|Overall Study||6
2369904|NCT01533922|5815682|P4|NOT COMPLETED|Overall Study||5
2369905|NCT01533922|5815683|P3|NOT COMPLETED|Overall Study||10
2369906|NCT01533922|5815684|P2|NOT COMPLETED|Overall Study||12
2369907|NCT01533922|5815685|P1|NOT COMPLETED|Overall Study||10
2369908|NCT01533922|5815681|P5|COMPLETED|Overall Study|Completed all treatment arms|53
2369909|NCT01533922|5815682|P4|COMPLETED|Overall Study|Completed all treatment arms|53
2369910|NCT01533922|5815683|P3|COMPLETED|Overall Study|Completed all treatment arms|50
2369911|NCT01533922|5815684|P2|COMPLETED|Overall Study|Completed all treatment arms|47
2369912|NCT01533922|5815685|P1|COMPLETED|Overall Study|Completed all treatment arms|49
2369913|NCT01533922|5815681|P5|Received Tio+Olo 5/5|Overall Study||56
2369914|NCT01533922|5815682|P4|Received Tio+Olo 5/5|Overall Study||53
2369915|NCT01533922|5815683|P3|Received Tio+Olo 5/5|Overall Study||0
2369916|NCT01533922|5815684|P2|Received Tio+Olo 5/5|Overall Study||59
2369917|NCT01533922|5815685|P1|Received Tio+Olo 5/5|Overall Study||58
2369918|NCT01533922|5815681|P5|Received Tio+Olo 2.5/5|Overall Study||56
2369919|NCT01533922|5815682|P4|Received Tio+Olo 2.5/5|Overall Study||55
2369920|NCT01533922|5815683|P3|Received Tio+Olo 2.5/5|Overall Study||52
2369921|NCT01533922|5815684|P2|Received Tio+Olo 2.5/5|Overall Study||0
2369922|NCT01533922|5815685|P1|Received Tio+Olo 2.5/5|Overall Study||59
2369923|NCT01533922|5815681|P5|Received Tio 5|Overall Study||54
2369924|NCT01533922|5815682|P4|Received Tio 5|Overall Study|One patient received Tio 5 instead of Olo 5 by mistake.|1
2369925|NCT01533922|5815683|P3|Received Tio 5|Overall Study||59
2369926|NCT01533922|5815684|P2|Received Tio 5|Overall Study||58
2369927|NCT01533922|5815685|P1|Received Tio 5|Overall Study||54
2369928|NCT01533922|5815681|P5|Received Olo 5|Overall Study||0
2369929|NCT01533922|5815682|P4|Received Olo 5|Overall Study||57
2369930|NCT01533922|5815683|P3|Received Olo 5|Overall Study||57
2369931|NCT01533922|5815684|P2|Received Olo 5|Overall Study||52
2369932|NCT01533922|5815685|P1|Received Olo 5|Overall Study||51
2369933|NCT01533922|5815681|P5|Received Placebo|Overall Study||59
2369934|NCT01533922|5815682|P4|Received Placebo|Overall Study||57
2369935|NCT01533922|5815683|P3|Received Placebo|Overall Study||57
2369936|NCT01533922|5815684|P2|Received Placebo|Overall Study||49
2369937|NCT01533922|5815685|P1|Received Placebo|Overall Study||0
2369938|NCT01533922|5815681|P5|STARTED|Overall Study||59
2369939|NCT01533922|5815682|P4|STARTED|Overall Study||58
2369940|NCT01533922|5815683|P3|STARTED|Overall Study||60
2369941|NCT01533922|5815684|P2|STARTED|Overall Study||59
2369942|NCT01533922|5815685|P1|STARTED|Overall Study||59
2369943|NCT01533753|5815714|P2|NOT COMPLETED|Overall Study||0
2369944|NCT01533753|5815715|P1|NOT COMPLETED|Overall Study||0
2369945|NCT01533753|5815714|P2|COMPLETED|Overall Study||3
2369946|NCT01533753|5815715|P1|COMPLETED|Overall Study||2
2369947|NCT01533753|5815714|P2|STARTED|Overall Study||3
2369948|NCT01533753|5815715|P1|STARTED|Overall Study||2
2369949|NCT01533688|5815730|P3|NOT COMPLETED|Overall Study||8
2369950|NCT01533688|5815731|P2|NOT COMPLETED|Overall Study||10
2369951|NCT01533688|5815732|P1|NOT COMPLETED|Overall Study||8
2369952|NCT01533688|5815730|P3|COMPLETED|Overall Study||63
2369953|NCT01533688|5815731|P2|COMPLETED|Overall Study||60
2369954|NCT01533688|5815732|P1|COMPLETED|Overall Study||63
2369955|NCT01533688|5815730|P3|STARTED|Overall Study||71
2369956|NCT01533688|5815731|P2|STARTED|Overall Study||70
2369957|NCT01533688|5815732|P1|STARTED|Overall Study||71
2369958|NCT01533597|5815745|P2|NOT COMPLETED|Overall Study||10
2369959|NCT01533597|5815746|P1|NOT COMPLETED|Overall Study||6
2369960|NCT01533597|5815745|P2|COMPLETED|Overall Study||25
2369961|NCT01533597|5815746|P1|COMPLETED|Overall Study||29
2369962|NCT01533597|5815745|P2|STARTED|Overall Study||35
2369963|NCT01533597|5815746|P1|STARTED|Overall Study||35
2369964|NCT01533493|5815764|P2|NOT COMPLETED|Overall Study||3
2369965|NCT01533493|5815765|P1|NOT COMPLETED|Overall Study||5
2369966|NCT01533493|5815764|P2|COMPLETED|Overall Study||11
2369967|NCT01533493|5815765|P1|COMPLETED|Overall Study||7
2369968|NCT01533493|5815764|P2|STARTED|Overall Study||14
2369969|NCT01533493|5815765|P1|STARTED|Overall Study||12
2369970|NCT01533428|5815773|P2|NOT COMPLETED|Overall Study||8
2369971|NCT01533428|5815774|P1|NOT COMPLETED|Overall Study||9
2369972|NCT01533428|5815773|P2|COMPLETED|Overall Study||175
2369973|NCT01533428|5815774|P1|COMPLETED|Overall Study||177
2369974|NCT01533428|5815773|P2|STARTED|Overall Study||183
2369975|NCT01533428|5815774|P1|STARTED|Overall Study||186
2369976|NCT01533259|5815814|P1|NOT COMPLETED|Overall Study||0
2369977|NCT01533259|5815814|P1|COMPLETED|Overall Study||48
2369978|NCT01533259|5815814|P1|STARTED|Overall Study||48
2369979|NCT01533246|5815820|P1|NOT COMPLETED|Overall Study||2
2369980|NCT01533246|5815820|P1|COMPLETED|Overall Study||15
2369981|NCT01533246|5815820|P1|STARTED|Overall Study||17
2369982|NCT01533181|5815831|P2|NOT COMPLETED|Overall Study||1
2369983|NCT01533181|5815832|P1|NOT COMPLETED|Overall Study||1
2369984|NCT01533181|5815831|P2|COMPLETED|Overall Study||28
2369985|NCT01533181|5815832|P1|COMPLETED|Overall Study||14
2369986|NCT01533181|5815831|P2|STARTED|Overall Study||29
2369987|NCT01533181|5815832|P1|STARTED|Overall Study||15
2369988|NCT01533116|5815848|P4|NOT COMPLETED|Overall Study||0
2369989|NCT01533116|5815849|P3|NOT COMPLETED|Overall Study||1
2369990|NCT01533116|5815850|P2|NOT COMPLETED|Overall Study||1
2369991|NCT01533116|5815851|P1|NOT COMPLETED|Overall Study||2
2369992|NCT01533116|5815848|P4|COMPLETED|Overall Study||12
2369993|NCT01533116|5815849|P3|COMPLETED|Overall Study||12
2369994|NCT01533116|5815850|P2|COMPLETED|Overall Study||12
2369995|NCT01533116|5815851|P1|COMPLETED|Overall Study||12
2369996|NCT01533116|5815848|P4|STARTED|Overall Study||12
2369997|NCT01533116|5815849|P3|STARTED|Overall Study||13
2369998|NCT01533116|5815850|P2|STARTED|Overall Study||13
2369999|NCT01533116|5815851|P1|STARTED|Overall Study||14
2370000|NCT01533077|5815881|P4|NOT COMPLETED|Overall Study||0
2370001|NCT01533077|5815882|P3|NOT COMPLETED|Overall Study||0
2370002|NCT01533077|5815883|P2|NOT COMPLETED|Overall Study||1
2370003|NCT01533077|5815884|P1|NOT COMPLETED|Overall Study||1
2370004|NCT01533077|5815881|P4|COMPLETED|Overall Study||4
2370005|NCT01533077|5815882|P3|COMPLETED|Overall Study||4
2370006|NCT01533077|5815883|P2|COMPLETED|Overall Study||4
2370007|NCT01533077|5815884|P1|COMPLETED|Overall Study||4
2370008|NCT01533077|5815881|P4|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
2370009|NCT01533077|5815882|P3|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
2370010|NCT01533077|5815883|P2|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
2370011|NCT01533077|5815884|P1|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
2370012|NCT01533077|5815881|P4|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
2370013|NCT01533077|5815882|P3|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
2370014|NCT01533077|5815883|P2|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
2370015|NCT01533077|5815884|P1|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
2370016|NCT01533077|5815881|P4|Sinemet® 100/25|Overall Study||4
2370017|NCT01533077|5815882|P3|Sinemet® 100/25|Overall Study||4
2370018|NCT01533077|5815883|P2|Sinemet® 100/25|Overall Study||5
2370019|NCT01533077|5815884|P1|Sinemet® 100/25|Overall Study||4
2370020|NCT01533077|5815881|P4|BIA 9-1067 50 mg|Overall Study||4
2370021|NCT01533077|5815882|P3|BIA 9-1067 50 mg|Overall Study||4
2370022|NCT01533077|5815883|P2|BIA 9-1067 50 mg|Overall Study||5
2370023|NCT01533077|5815884|P1|BIA 9-1067 50 mg|Overall Study||5
2370024|NCT01533077|5815881|P4|STARTED|Overall Study||4
2370025|NCT01533077|5815882|P3|STARTED|Overall Study||4
2370026|NCT01533077|5815883|P2|STARTED|Overall Study||5
2370027|NCT01533077|5815884|P1|STARTED|Overall Study||5
2370028|NCT01533038|5815940|P2|NOT COMPLETED|Overall Study||1
2370029|NCT01533038|5815941|P1|NOT COMPLETED|Overall Study||0
2370030|NCT01533038|5815940|P2|COMPLETED|Overall Study||34
2370031|NCT01533038|5815941|P1|COMPLETED|Overall Study||45
2370032|NCT01533038|5815940|P2|STARTED|Overall Study||35
2370033|NCT01533038|5815941|P1|STARTED|Overall Study||45
2370034|NCT01532999|5815949|P2|NOT COMPLETED|Overall Study||18
2370035|NCT01532999|5815950|P1|NOT COMPLETED|Overall Study||31
2370036|NCT01532999|5815949|P2|COMPLETED|Overall Study||77
2370037|NCT01532999|5815950|P1|COMPLETED|Overall Study||65
2370038|NCT01532999|5815949|P2|STARTED|Overall Study||95
2370039|NCT01532999|5815950|P1|STARTED|Overall Study||96
2370040|NCT01532986|5815974|P2|NOT COMPLETED|Overall Study||24
2370041|NCT01532986|5815975|P1|NOT COMPLETED|Overall Study||23
2370042|NCT01532986|5815974|P2|COMPLETED|Overall Study||138
2370043|NCT01532986|5815975|P1|COMPLETED|Overall Study||143
2370044|NCT01532986|5815974|P2|STARTED|Overall Study||162
2370045|NCT01532986|5815975|P1|STARTED|Overall Study||166
2370046|NCT01532973|5816008|P10|NOT COMPLETED|Part 3||0
2370047|NCT01532973|5816009|P9|NOT COMPLETED|Part 3||0
2370048|NCT01532973|5816010|P8|NOT COMPLETED|Part 3||0
2370049|NCT01532973|5816011|P7|NOT COMPLETED|Part 3||0
2370050|NCT01532973|5816012|P6|NOT COMPLETED|Part 3||0
2370051|NCT01532973|5816013|P5|NOT COMPLETED|Part 3||0
2370052|NCT01532973|5816014|P4|NOT COMPLETED|Part 3||0
2370053|NCT01532973|5816015|P3|NOT COMPLETED|Part 3||0
2370054|NCT01532973|5816016|P2|NOT COMPLETED|Part 3||0
2370055|NCT01532973|5816017|P1|NOT COMPLETED|Part 3||0
2370056|NCT01532973|5816008|P10|COMPLETED|Part 3||6
2370057|NCT01532973|5816009|P9|COMPLETED|Part 3||6
2370058|NCT01532973|5816010|P8|COMPLETED|Part 3||0
2370059|NCT01532973|5816011|P7|COMPLETED|Part 3||0
2370060|NCT01532973|5816012|P6|COMPLETED|Part 3||0
2370061|NCT01532973|5816013|P5|COMPLETED|Part 3||0
2370062|NCT01532973|5816014|P4|COMPLETED|Part 3||0
2370063|NCT01532973|5816015|P3|COMPLETED|Part 3||0
2370064|NCT01532973|5816016|P2|COMPLETED|Part 3||0
2370065|NCT01532973|5816017|P1|COMPLETED|Part 3||0
2370066|NCT01532973|5816008|P10|STARTED|Part 3||6
2370067|NCT01532973|5816009|P9|STARTED|Part 3||6
2370068|NCT01532973|5816010|P8|STARTED|Part 3||0
2370069|NCT01532973|5816011|P7|STARTED|Part 3||0
2370070|NCT01532973|5816012|P6|STARTED|Part 3||0
2370071|NCT01532973|5816013|P5|STARTED|Part 3||0
2370072|NCT01532973|5816014|P4|STARTED|Part 3||0
2370073|NCT01532973|5816015|P3|STARTED|Part 3||0
2370074|NCT01532973|5816016|P2|STARTED|Part 3||0
2370075|NCT01532973|5816017|P1|STARTED|Part 3||0
2370076|NCT01532973|5816008|P10|NOT COMPLETED|Part 2||0
2370077|NCT01532973|5816009|P9|NOT COMPLETED|Part 2||0
2370078|NCT01532973|5816010|P8|NOT COMPLETED|Part 2||0
2370079|NCT01532973|5816011|P7|NOT COMPLETED|Part 2||0
2370080|NCT01532973|5816012|P6|NOT COMPLETED|Part 2||0
2370081|NCT01532973|5816013|P5|NOT COMPLETED|Part 2||0
2370082|NCT01532973|5816014|P4|NOT COMPLETED|Part 2||0
2370083|NCT01532973|5816015|P3|NOT COMPLETED|Part 2||0
2370084|NCT01532973|5816016|P2|NOT COMPLETED|Part 2||0
2370085|NCT01532973|5816017|P1|NOT COMPLETED|Part 2||0
2370086|NCT01532973|5816008|P10|COMPLETED|Part 2||0
2370087|NCT01532973|5816009|P9|COMPLETED|Part 2||0
2370088|NCT01532973|5816010|P8|COMPLETED|Part 2||0
2370089|NCT01532973|5816011|P7|COMPLETED|Part 2||6
2370090|NCT01532973|5816012|P6|COMPLETED|Part 2||6
2370091|NCT01532973|5816013|P5|COMPLETED|Part 2||6
2370092|NCT01532973|5816014|P4|COMPLETED|Part 2||0
2370093|NCT01532973|5816015|P3|COMPLETED|Part 2||0
2370094|NCT01532973|5816016|P2|COMPLETED|Part 2||0
2370095|NCT01532973|5816017|P1|COMPLETED|Part 2||0
2370096|NCT01532973|5816008|P10|STARTED|Part 2||0
2370097|NCT01532973|5816009|P9|STARTED|Part 2||0
2370098|NCT01532973|5816010|P8|STARTED|Part 2|Planned panel not performed. No participants were enrolled.|0
2370099|NCT01532973|5816011|P7|STARTED|Part 2||6
2370100|NCT01532973|5816012|P6|STARTED|Part 2||6
2370101|NCT01532973|5816013|P5|STARTED|Part 2||6
2370102|NCT01532973|5816014|P4|STARTED|Part 2||0
2370103|NCT01532973|5816015|P3|STARTED|Part 2||0
2370104|NCT01532973|5816016|P2|STARTED|Part 2||0
2370105|NCT01532973|5816017|P1|STARTED|Part 2||0
2370106|NCT01532973|5816008|P10|NOT COMPLETED|Part 1||0
2370107|NCT01532973|5816009|P9|NOT COMPLETED|Part 1||0
2370108|NCT01532973|5816010|P8|NOT COMPLETED|Part 1||0
2370109|NCT01532973|5816011|P7|NOT COMPLETED|Part 1||0
2370110|NCT01532973|5816012|P6|NOT COMPLETED|Part 1||0
2370111|NCT01532973|5816013|P5|NOT COMPLETED|Part 1||0
2370112|NCT01532973|5816014|P4|NOT COMPLETED|Part 1||0
2370113|NCT01532973|5816015|P3|NOT COMPLETED|Part 1||0
2370114|NCT01532973|5816016|P2|NOT COMPLETED|Part 1||0
2370115|NCT01532973|5816017|P1|NOT COMPLETED|Part 1||0
2370116|NCT01532973|5816008|P10|COMPLETED|Part 1||0
2370117|NCT01532973|5816009|P9|COMPLETED|Part 1||0
2370118|NCT01532973|5816010|P8|COMPLETED|Part 1||0
2370119|NCT01532973|5816011|P7|COMPLETED|Part 1||0
2370120|NCT01532973|5816012|P6|COMPLETED|Part 1||0
2370121|NCT01532973|5816013|P5|COMPLETED|Part 1||0
2370122|NCT01532973|5816014|P4|COMPLETED|Part 1||0
2370123|NCT01532973|5816015|P3|COMPLETED|Part 1||6
2370124|NCT01532973|5816016|P2|COMPLETED|Part 1||6
2370125|NCT01532973|5816017|P1|COMPLETED|Part 1||6
2370126|NCT01532973|5816008|P10|STARTED|Part 1||0
2370127|NCT01532973|5816009|P9|STARTED|Part 1||0
2370128|NCT01532973|5816010|P8|STARTED|Part 1||0
2370129|NCT01532973|5816011|P7|STARTED|Part 1||0
2370130|NCT01532973|5816012|P6|STARTED|Part 1||0
2370131|NCT01532973|5816013|P5|STARTED|Part 1||0
2370132|NCT01532973|5816014|P4|STARTED|Part 1|Planned panel not performed. No participants were enrolled.|0
2370133|NCT01532973|5816015|P3|STARTED|Part 1||6
2370134|NCT01532973|5816016|P2|STARTED|Part 1||6
2370135|NCT01532973|5816017|P1|STARTED|Part 1||6
2370136|NCT01532934|5816059|P2|NOT COMPLETED|Overall Study||13
2370137|NCT01532934|5816060|P1|NOT COMPLETED|Overall Study||14
2370138|NCT01532934|5816059|P2|COMPLETED|Overall Study||39
2370139|NCT01532934|5816060|P1|COMPLETED|Overall Study||39
2370140|NCT01532934|5816059|P2|STARTED|Overall Study||52
2370141|NCT01532934|5816060|P1|STARTED|Overall Study||53
2370142|NCT01532921|5816070|P1|NOT COMPLETED|Overall Study||16
2370143|NCT01532921|5816070|P1|COMPLETED|Overall Study||69
2370144|NCT01532921|5816070|P1|6 Months Follow Up|Overall Study||68
2370145|NCT01532921|5816070|P1|Discharge|Overall Study||75
2370146|NCT01532921|5816070|P1|Implantation Procedure|Overall Study||76
2370147|NCT01532921|5816070|P1|STARTED|Overall Study||85
2370148|NCT01532869|5816092|P2|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||3
2370149|NCT01532869|5816093|P1|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||7
2370150|NCT01532869|5816092|P2|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|27
2370151|NCT01532869|5816093|P1|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|24
2370152|NCT01532869|5816092|P2|STARTED|Open-label Period (Week 48 to Week 96)||30
2370153|NCT01532869|5816093|P1|STARTED|Open-label Period (Week 48 to Week 96)|Two participants did not start the open label extension period.|31
2370154|NCT01532869|5816092|P2|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||13
2370155|NCT01532869|5816093|P1|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||11
2370156|NCT01532869|5816092|P2|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|30
2370157|NCT01532869|5816093|P1|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|33
2370158|NCT01532869|5816092|P2|STARTED|Blinded-Treatment Period (Up to Week 48)||43
2370159|NCT01532869|5816093|P1|STARTED|Blinded-Treatment Period (Up to Week 48)||44
2370160|NCT01532869|5816092|P2|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
2370161|NCT01532869|5816093|P1|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
2370254|NCT01532089|5816305|P2|NOT COMPLETED|Overall Study||0
2370255|NCT01532089|5816306|P1|NOT COMPLETED|Overall Study||0
2370162|NCT01532869|5816092|P2|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|35
2370163|NCT01532869|5816093|P1|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|36
2370164|NCT01532869|5816092|P2|STARTED|Blinded-Treatment Period (Up to Week 24)||43
2370165|NCT01532869|5816093|P1|STARTED|Blinded-Treatment Period (Up to Week 24)||44
2370166|NCT01532830|5816130|P1|NOT COMPLETED|Overall Study||4
2370167|NCT01532830|5816130|P1|COMPLETED|Overall Study||26
2370168|NCT01532830|5816130|P1|STARTED|Overall Study||30
2370169|NCT01532817|5816139|P1|NOT COMPLETED|Overall Study||0
2370170|NCT01532817|5816139|P1|COMPLETED|Overall Study||30
2370171|NCT01532817|5816139|P1|STARTED|Overall Study||30
2370172|NCT01532700|5816143|P1|NOT COMPLETED|Overall Study||0
2370173|NCT01532700|5816143|P1|COMPLETED|Overall Study||28
2370174|NCT01532700|5816143|P1|STARTED|Overall Study||28
2370175|NCT01532648|5816152|P2|NOT COMPLETED|Overall Study||17
2370176|NCT01532648|5816153|P1|NOT COMPLETED|Overall Study||36
2370177|NCT01532648|5816152|P2|COMPLETED|Overall Study||238
2370178|NCT01532648|5816153|P1|COMPLETED|Overall Study||219
2370179|NCT01532648|5816152|P2|Intent-To-Treat Population|Overall Study||228
2370180|NCT01532648|5816153|P1|Intent-To-Treat Population|Overall Study||230
2370181|NCT01532648|5816152|P2|Safety Population|Overall Study||255
2370182|NCT01532648|5816153|P1|Safety Population|Overall Study||255
2370183|NCT01532648|5816152|P2|STARTED|Overall Study||255
2370184|NCT01532648|5816153|P1|STARTED|Overall Study||255
2370185|NCT01532635|5816171|P1|NOT COMPLETED|Overall Study||0
2370186|NCT01532635|5816171|P1|COMPLETED|Overall Study||4
2370187|NCT01532635|5816171|P1|STARTED|Overall Study||4
2370188|NCT01532570|5816187|P4|NOT COMPLETED|Overall Study||0
2370189|NCT01532570|5816188|P3|NOT COMPLETED|Overall Study||0
2370190|NCT01532570|5816189|P2|NOT COMPLETED|Overall Study||1
2370191|NCT01532570|5816190|P1|NOT COMPLETED|Overall Study||1
2370192|NCT01532570|5816187|P4|COMPLETED|Overall Study||4
2370193|NCT01532570|5816188|P3|COMPLETED|Overall Study||1
2370194|NCT01532570|5816189|P2|COMPLETED|Overall Study||1
2370195|NCT01532570|5816190|P1|COMPLETED|Overall Study||10
2370196|NCT01532570|5816187|P4|STARTED|Overall Study||4
2370197|NCT01532570|5816188|P3|STARTED|Overall Study||1
2370198|NCT01532570|5816189|P2|STARTED|Overall Study||2
2370199|NCT01532570|5816190|P1|STARTED|Overall Study||11
2370200|NCT01532453|5816223|P2|NOT COMPLETED|Overall Study||70
2370201|NCT01532453|5816224|P1|NOT COMPLETED|Overall Study||27
2370202|NCT01532453|5816223|P2|COMPLETED|Overall Study||90
2370203|NCT01532453|5816224|P1|COMPLETED|Overall Study||54
2370204|NCT01532453|5816223|P2|STARTED|Overall Study||160
2370205|NCT01532453|5816224|P1|STARTED|Overall Study||81
2370206|NCT01532414|5816235|P3|NOT COMPLETED|Overall Study||3
2370207|NCT01532414|5816236|P2|NOT COMPLETED|Overall Study||2
2370208|NCT01532414|5816237|P1|NOT COMPLETED|Overall Study||7
2370209|NCT01532414|5816235|P3|COMPLETED|Overall Study||35
2370210|NCT01532414|5816236|P2|COMPLETED|Overall Study||19
2370211|NCT01532414|5816237|P1|COMPLETED|Overall Study||85
2370212|NCT01532414|5816235|P3|STARTED|Overall Study||38
2370213|NCT01532414|5816236|P2|STARTED|Overall Study|Up-titrated at 6 weeks from a starting dose of 12.5 mg due to morning testosterone <300 ng/dL|21
2370214|NCT01532414|5816237|P1|STARTED|Overall Study||92
2370215|NCT01532362|5816247|P2|NOT COMPLETED|Overall Study||0
2370216|NCT01532362|5816248|P1|NOT COMPLETED|Overall Study||0
2370217|NCT01532362|5816247|P2|COMPLETED|Overall Study||0
2370218|NCT01532362|5816248|P1|COMPLETED|Overall Study||1
2370219|NCT01532362|5816247|P2|STARTED|Overall Study||0
2370220|NCT01532362|5816248|P1|STARTED|Overall Study||1
2370221|NCT01532349|5816256|P2|NOT COMPLETED|Overall Study||5
2370222|NCT01532349|5816257|P1|NOT COMPLETED|Overall Study||2
2370223|NCT01532349|5816256|P2|COMPLETED|Overall Study||12
2370224|NCT01532349|5816257|P1|COMPLETED|Overall Study||15
2370225|NCT01532349|5816256|P2|STARTED|Overall Study||17
2370226|NCT01532349|5816257|P1|STARTED|Overall Study||17
2370227|NCT01532141|5816266|P3|NOT COMPLETED|Overall Study||0
2370228|NCT01532141|5816267|P2|NOT COMPLETED|Overall Study||0
2370229|NCT01532141|5816268|P1|NOT COMPLETED|Overall Study||1
2370230|NCT01532141|5816266|P3|COMPLETED|Overall Study||8
2370231|NCT01532141|5816267|P2|COMPLETED|Overall Study||8
2370232|NCT01532141|5816268|P1|COMPLETED|Overall Study||8
2370233|NCT01532141|5816266|P3|Period 3|Overall Study||8
2370234|NCT01532141|5816267|P2|Period 3|Overall Study||8
2370235|NCT01532141|5816268|P1|Period 3|Overall Study||8
2370236|NCT01532141|5816266|P3|Period 2|Overall Study||8
2370237|NCT01532141|5816267|P2|Period 2|Overall Study||8
2370238|NCT01532141|5816268|P1|Period 2|Overall Study||8
2370239|NCT01532141|5816266|P3|Period 1|Overall Study||8
2370240|NCT01532141|5816267|P2|Period 1|Overall Study||8
2370241|NCT01532141|5816268|P1|Period 1|Overall Study||9
2370242|NCT01532141|5816266|P3|STARTED|Overall Study||8
2370243|NCT01532141|5816267|P2|STARTED|Overall Study||8
2370244|NCT01532141|5816268|P1|STARTED|Overall Study||9
2370245|NCT01532128|5816286|P3|NOT COMPLETED|Overall Study||0
2370246|NCT01532128|5816287|P2|NOT COMPLETED|Overall Study||0
2370247|NCT01532128|5816288|P1|NOT COMPLETED|Overall Study||0
2370248|NCT01532128|5816286|P3|COMPLETED|Overall Study||8
2370249|NCT01532128|5816287|P2|COMPLETED|Overall Study||8
2370250|NCT01532128|5816288|P1|COMPLETED|Overall Study||8
2370251|NCT01532128|5816286|P3|STARTED|Overall Study||8
2370252|NCT01532128|5816287|P2|STARTED|Overall Study||8
2370253|NCT01532128|5816288|P1|STARTED|Overall Study||8
2370256|NCT01532089|5816305|P2|COMPLETED|Overall Study||43
2370257|NCT01532089|5816306|P1|COMPLETED|Overall Study||45
2370258|NCT01532089|5816305|P2|STARTED|Overall Study||43
2370259|NCT01532089|5816306|P1|STARTED|Overall Study||45
2370260|NCT01531998|5816320|P1|NOT COMPLETED|Overall Study||3
2370261|NCT01531998|5816320|P1|COMPLETED|Overall Study||8
2370262|NCT01531998|5816320|P1|STARTED|Overall Study||11
2370263|NCT01531894|5816325|P1|NOT COMPLETED|Overall Study||9
2370264|NCT01531894|5816325|P1|COMPLETED|Overall Study||2
2370265|NCT01531894|5816325|P1|STARTED|Overall Study||11
2370266|NCT01531725|5816329|P1|NOT COMPLETED|Overall Study||5
2370267|NCT01531725|5816329|P1|COMPLETED|Overall Study||197
2370268|NCT01531725|5816329|P1|STARTED|Overall Study|5 patients with protocol violation were excluded.|202
2370269|NCT01531673|5816347|P13|NOT COMPLETED|Overall Study||0
2370270|NCT01531673|5816348|P12|NOT COMPLETED|Overall Study||0
2370271|NCT01531673|5816349|P11|NOT COMPLETED|Overall Study||0
2370272|NCT01531673|5816350|P10|NOT COMPLETED|Overall Study||1
2370273|NCT01531673|5816351|P9|NOT COMPLETED|Overall Study||0
2370274|NCT01531673|5816352|P8|NOT COMPLETED|Overall Study||0
2370275|NCT01531673|5816353|P7|NOT COMPLETED|Overall Study||0
2370276|NCT01531673|5816354|P6|NOT COMPLETED|Overall Study||1
2370277|NCT01531673|5816355|P5|NOT COMPLETED|Overall Study||1
2370278|NCT01531673|5816356|P4|NOT COMPLETED|Overall Study||1
2370279|NCT01531673|5816357|P3|NOT COMPLETED|Overall Study||0
2370280|NCT01531673|5816358|P2|NOT COMPLETED|Overall Study||1
2370281|NCT01531673|5816359|P1|NOT COMPLETED|Overall Study||0
2370282|NCT01531673|5816347|P13|COMPLETED|Overall Study||14
2370283|NCT01531673|5816348|P12|COMPLETED|Overall Study||4
2370284|NCT01531673|5816349|P11|COMPLETED|Overall Study||16
2370285|NCT01531673|5816350|P10|COMPLETED|Overall Study||18
2370286|NCT01531673|5816351|P9|COMPLETED|Overall Study||17
2370287|NCT01531673|5816352|P8|COMPLETED|Overall Study||9
2370288|NCT01531673|5816353|P7|COMPLETED|Overall Study||17
2370289|NCT01531673|5816354|P6|COMPLETED|Overall Study||18
2370290|NCT01531673|5816355|P5|COMPLETED|Overall Study||7
2370291|NCT01531673|5816356|P4|COMPLETED|Overall Study||17
2370292|NCT01531673|5816357|P3|COMPLETED|Overall Study||8
2370293|NCT01531673|5816358|P2|COMPLETED|Overall Study||7
2370294|NCT01531673|5816359|P1|COMPLETED|Overall Study||33
2370295|NCT01531673|5816347|P13|STARTED|Overall Study||14
2370296|NCT01531673|5816348|P12|STARTED|Overall Study||4
2370297|NCT01531673|5816349|P11|STARTED|Overall Study||16
2370298|NCT01531673|5816350|P10|STARTED|Overall Study||19
2370299|NCT01531673|5816351|P9|STARTED|Overall Study||17
2370300|NCT01531673|5816352|P8|STARTED|Overall Study||9
2370301|NCT01531673|5816353|P7|STARTED|Overall Study||17
2370302|NCT01531673|5816354|P6|STARTED|Overall Study||19
2370303|NCT01531673|5816355|P5|STARTED|Overall Study||8
2370304|NCT01531673|5816356|P4|STARTED|Overall Study||18
2370305|NCT01531673|5816357|P3|STARTED|Overall Study||8
2370306|NCT01531673|5816358|P2|STARTED|Overall Study||8
2370307|NCT01531673|5816359|P1|STARTED|Overall Study||33
2370308|NCT01531387|5816470|P2|NOT COMPLETED|Overall Study||11
2370309|NCT01531387|5816471|P1|NOT COMPLETED|Overall Study||11
2370310|NCT01531387|5816470|P2|COMPLETED|Overall Study||0
2370311|NCT01531387|5816471|P1|COMPLETED|Overall Study||0
2370312|NCT01531387|5816470|P2|STARTED|Overall Study||11
2370313|NCT01531387|5816471|P1|STARTED|Overall Study||11
2370314|NCT01531374|5816488|P3|NOT COMPLETED|Overall Study||283
2370315|NCT01531374|5816489|P2|NOT COMPLETED|Overall Study||142
2370316|NCT01531374|5816490|P1|NOT COMPLETED|Overall Study||364
2370317|NCT01531374|5816488|P3|COMPLETED|Overall Study||836
2370318|NCT01531374|5816489|P2|COMPLETED|Overall Study||231
2370319|NCT01531374|5816490|P1|COMPLETED|Overall Study||921
2370320|NCT01531374|5816488|P3|STARTED|Overall Study||1119
2370321|NCT01531374|5816489|P2|STARTED|Overall Study||373
2370322|NCT01531374|5816490|P1|STARTED|Overall Study||1285
2370323|NCT01531335|5816554|P2|NOT COMPLETED|Overall Study||0
2370324|NCT01531335|5816555|P1|NOT COMPLETED|Overall Study||0
2370325|NCT01531335|5816554|P2|COMPLETED|Overall Study||40
2370326|NCT01531335|5816555|P1|COMPLETED|Overall Study||40
2370327|NCT01531335|5816554|P2|STARTED|Overall Study||40
2370328|NCT01531335|5816555|P1|STARTED|Overall Study||40
2370329|NCT01531205|5816563|P1|NOT COMPLETED|Overall Study||1
2370330|NCT01531205|5816563|P1|COMPLETED|Overall Study||1
2370331|NCT01531205|5816563|P1|STARTED|Overall Study||2
2370332|NCT01531153|5816575|P3|NOT COMPLETED|Overall Study||15
2370333|NCT01531153|5816576|P2|NOT COMPLETED|Overall Study||9
2370334|NCT01531153|5816577|P1|NOT COMPLETED|Overall Study||10
2370335|NCT01531153|5816575|P3|COMPLETED|Overall Study||15
2370336|NCT01531153|5816576|P2|COMPLETED|Overall Study||22
2370337|NCT01531153|5816577|P1|COMPLETED|Overall Study||22
2370338|NCT01531153|5816575|P3|STARTED|Overall Study||30
2370339|NCT01531153|5816576|P2|STARTED|Overall Study||31
2370340|NCT01531153|5816577|P1|STARTED|Overall Study||32
2370341|NCT01530997|5816633|P1|NOT COMPLETED|Overall Study||2
2370342|NCT01530997|5816633|P1|COMPLETED|Overall Study||43
2370343|NCT01530997|5816633|P1|STARTED|Overall Study||45
2370344|NCT01530880|5816653|P1|NOT COMPLETED|Overall Study||0
2370345|NCT01530880|5816653|P1|COMPLETED|Overall Study||35
2370346|NCT01530880|5816653|P1|STARTED|Overall Study||35
2370347|NCT01530477|5816667|P3|NOT COMPLETED|Overall Study||0
2370348|NCT01530477|5816668|P2|NOT COMPLETED|Overall Study||0
2370349|NCT01530477|5816669|P1|NOT COMPLETED|Overall Study||0
2370350|NCT01530477|5816667|P3|COMPLETED|Overall Study|53 subjects completed the imaging in both the Skeletal and Body Composition cohorts.|53
2370351|NCT01530477|5816668|P2|COMPLETED|Overall Study|12 subjects completed imaging in the Body Composition cohort only.|12
2370352|NCT01530477|5816669|P1|COMPLETED|Overall Study|17 subjects completed imaging in the Skeletal cohort only.|17
2370353|NCT01530477|5816667|P3|STARTED|Overall Study|53 subjects consented to both the Skeletal and body Composition cohorts.|53
2370354|NCT01530477|5816668|P2|STARTED|Overall Study|12 subjects consented to the Body Composition cohort only.|12
2370355|NCT01530477|5816669|P1|STARTED|Overall Study|17 subjects consented to the Skeletal cohort only.|17
2370356|NCT01530464|5816677|P2|NOT COMPLETED|Washout (24h)||1
2370357|NCT01530464|5816678|P1|NOT COMPLETED|Washout (24h)||0
2370358|NCT01530464|5816677|P2|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|7
2370359|NCT01530464|5816678|P1|COMPLETED|Washout (24h)||9
2370360|NCT01530464|5816677|P2|STARTED|Washout (24h)||8
2370361|NCT01530464|5816678|P1|STARTED|Washout (24h)||9
2370362|NCT01530464|5816677|P2|NOT COMPLETED|Third Intervention (24h)||0
2370363|NCT01530464|5816678|P1|NOT COMPLETED|Third Intervention (24h)||0
2370364|NCT01530464|5816677|P2|COMPLETED|Third Intervention (24h)||8
2370365|NCT01530464|5816678|P1|COMPLETED|Third Intervention (24h)||9
2370366|NCT01530464|5816677|P2|STARTED|Third Intervention (24h)||8
2370367|NCT01530464|5816678|P1|STARTED|Third Intervention (24h)||9
2370368|NCT01530464|5816677|P2|NOT COMPLETED|Washout (24h)||0
2370369|NCT01530464|5816678|P1|NOT COMPLETED|Washout (24h)||1
2370370|NCT01530464|5816677|P2|COMPLETED|Washout (24h)||8
2370371|NCT01530464|5816678|P1|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|9
2370372|NCT01530464|5816677|P2|STARTED|Washout (24h)||8
2370373|NCT01530464|5816678|P1|STARTED|Washout (24h)||10
2370374|NCT01530464|5816677|P2|NOT COMPLETED|Second Intervention (24h)||0
2370375|NCT01530464|5816678|P1|NOT COMPLETED|Second Intervention (24h)||0
2370376|NCT01530464|5816677|P2|COMPLETED|Second Intervention (24h)||8
2370377|NCT01530464|5816678|P1|COMPLETED|Second Intervention (24h)||10
2370378|NCT01530464|5816677|P2|STARTED|Second Intervention (24h)||8
2370379|NCT01530464|5816678|P1|STARTED|Second Intervention (24h)||10
2370380|NCT01530464|5816677|P2|NOT COMPLETED|Washout (24h)||0
2370381|NCT01530464|5816678|P1|NOT COMPLETED|Washout (24h)||0
2370382|NCT01530464|5816677|P2|COMPLETED|Washout (24h)||8
2370383|NCT01530464|5816678|P1|COMPLETED|Washout (24h)||10
2370384|NCT01530464|5816677|P2|STARTED|Washout (24h)||8
2370385|NCT01530464|5816678|P1|STARTED|Washout (24h)||10
2370386|NCT01530464|5816677|P2|NOT COMPLETED|First Intervention (24h)||0
2370387|NCT01530464|5816678|P1|NOT COMPLETED|First Intervention (24h)||0
2370388|NCT01530464|5816677|P2|COMPLETED|First Intervention (24h)||8
2370389|NCT01530464|5816678|P1|COMPLETED|First Intervention (24h)||10
2370390|NCT01530464|5816677|P2|STARTED|First Intervention (24h)||8
2370391|NCT01530464|5816678|P1|STARTED|First Intervention (24h)||10
2370392|NCT01530399|5816711|P6|NOT COMPLETED|Overall Study||1
2370393|NCT01530399|5816712|P5|NOT COMPLETED|Overall Study||0
2370394|NCT01530399|5816713|P4|NOT COMPLETED|Overall Study||0
2370395|NCT01530399|5816714|P3|NOT COMPLETED|Overall Study||1
2370396|NCT01530399|5816715|P2|NOT COMPLETED|Overall Study||2
2370397|NCT01530399|5816716|P1|NOT COMPLETED|Overall Study||1
2370398|NCT01530399|5816711|P6|COMPLETED|Overall Study||6
2370399|NCT01530399|5816712|P5|COMPLETED|Overall Study||6
2370400|NCT01530399|5816713|P4|COMPLETED|Overall Study||10
2370401|NCT01530399|5816714|P3|COMPLETED|Overall Study||7
2370402|NCT01530399|5816715|P2|COMPLETED|Overall Study||8
2370403|NCT01530399|5816716|P1|COMPLETED|Overall Study||7
2370404|NCT01530399|5816711|P6|STARTED|Overall Study||7
2370405|NCT01530399|5816712|P5|STARTED|Overall Study||6
2370406|NCT01530399|5816713|P4|STARTED|Overall Study||10
2370407|NCT01530399|5816714|P3|STARTED|Overall Study||8
2370408|NCT01530399|5816715|P2|STARTED|Overall Study||10
2370409|NCT01530399|5816716|P1|STARTED|Overall Study||8
2370410|NCT01530334|5816730|P1|NOT COMPLETED|Overall Study||51
2370411|NCT01530334|5816730|P1|COMPLETED|Overall Study||10
2370412|NCT01530334|5816730|P1|STARTED|Overall Study||61
2370413|NCT01530243|5816743|P4|NOT COMPLETED|Overall Study||2
2370414|NCT01530243|5816744|P3|NOT COMPLETED|Overall Study||3
2370415|NCT01530243|5816745|P2|NOT COMPLETED|Overall Study||3
2370416|NCT01530243|5816746|P1|NOT COMPLETED|Overall Study||2
2370417|NCT01530243|5816743|P4|COMPLETED|Overall Study||24
2370418|NCT01530243|5816744|P3|COMPLETED|Overall Study||23
2370419|NCT01530243|5816745|P2|COMPLETED|Overall Study||23
2370420|NCT01530243|5816746|P1|COMPLETED|Overall Study||24
2370421|NCT01530243|5816743|P4|STARTED|Overall Study||26
2370422|NCT01530243|5816744|P3|STARTED|Overall Study||26
2370423|NCT01530243|5816745|P2|STARTED|Overall Study||26
2370424|NCT01530243|5816746|P1|STARTED|Overall Study||26
2370425|NCT01530178|5816766|P2|NOT COMPLETED|Overall Study||0
2370426|NCT01530178|5816767|P1|NOT COMPLETED|Overall Study||0
2370427|NCT01530178|5816766|P2|COMPLETED|Overall Study||6
2370428|NCT01530178|5816767|P1|COMPLETED|Overall Study||2
2370429|NCT01530178|5816766|P2|STARTED|Overall Study||6
2370430|NCT01530178|5816767|P1|STARTED|Overall Study||2
2370431|NCT01530087|5816777|P1|NOT COMPLETED|Overall Study||2
2370432|NCT01530087|5816777|P1|COMPLETED|Overall Study||1
2370433|NCT01530087|5816777|P1|STARTED|Overall Study||3
2370434|NCT01529827|5816782|P1|NOT COMPLETED|Overall Study||0
2370435|NCT01529827|5816782|P1|COMPLETED|Overall Study||94
2370436|NCT01529827|5816782|P1|STARTED|Overall Study||94
2370437|NCT01529749|5816793|P4|NOT COMPLETED|Overall Study||2
2370438|NCT01529749|5816794|P3|NOT COMPLETED|Overall Study||2
2370439|NCT01529749|5816795|P2|NOT COMPLETED|Overall Study||2
2370440|NCT01529749|5816796|P1|NOT COMPLETED|Overall Study||0
2370441|NCT01529749|5816793|P4|COMPLETED|Overall Study||10
2370442|NCT01529749|5816794|P3|COMPLETED|Overall Study||10
2370443|NCT01529749|5816795|P2|COMPLETED|Overall Study||10
2370444|NCT01529749|5816796|P1|COMPLETED|Overall Study||12
2370445|NCT01529749|5816793|P4|STARTED|Overall Study||12
2370446|NCT01529749|5816794|P3|STARTED|Overall Study||12
2370447|NCT01529749|5816795|P2|STARTED|Overall Study||12
2370448|NCT01529749|5816796|P1|STARTED|Overall Study||12
2370449|NCT01529645|5816880|P10|NOT COMPLETED|Overall Study||0
2370450|NCT01529645|5816881|P9|NOT COMPLETED|Overall Study||1
2370451|NCT01529645|5816882|P8|NOT COMPLETED|Overall Study||0
2370452|NCT01529645|5816883|P7|NOT COMPLETED|Overall Study||2
2370453|NCT01529645|5816884|P6|NOT COMPLETED|Overall Study||1
2370454|NCT01529645|5816885|P5|NOT COMPLETED|Overall Study||2
2370455|NCT01529645|5816886|P4|NOT COMPLETED|Overall Study||2
2370456|NCT01529645|5816887|P3|NOT COMPLETED|Overall Study||2
2370457|NCT01529645|5816888|P2|NOT COMPLETED|Overall Study||1
2370458|NCT01529645|5816889|P1|NOT COMPLETED|Overall Study||2
2370459|NCT01529645|5816880|P10|COMPLETED|Overall Study||42
2370460|NCT01529645|5816881|P9|COMPLETED|Overall Study||41
2370461|NCT01529645|5816882|P8|COMPLETED|Overall Study||42
2370462|NCT01529645|5816883|P7|COMPLETED|Overall Study||40
2370463|NCT01529645|5816884|P6|COMPLETED|Overall Study||41
2370464|NCT01529645|5816885|P5|COMPLETED|Overall Study||40
2370465|NCT01529645|5816886|P4|COMPLETED|Overall Study||40
2370466|NCT01529645|5816887|P3|COMPLETED|Overall Study||40
2370467|NCT01529645|5816888|P2|COMPLETED|Overall Study||41
2370468|NCT01529645|5816889|P1|COMPLETED|Overall Study||40
2370469|NCT01529645|5816880|P10|STARTED|Overall Study||42
2370470|NCT01529645|5816881|P9|STARTED|Overall Study||42
2370471|NCT01529645|5816882|P8|STARTED|Overall Study||42
2370472|NCT01529645|5816883|P7|STARTED|Overall Study||42
2370473|NCT01529645|5816884|P6|STARTED|Overall Study||42
2370474|NCT01529645|5816885|P5|STARTED|Overall Study||42
2370475|NCT01529645|5816886|P4|STARTED|Overall Study||42
2370476|NCT01529645|5816887|P3|STARTED|Overall Study||42
2370477|NCT01529645|5816888|P2|STARTED|Overall Study||42
2370478|NCT01529645|5816889|P1|STARTED|Overall Study||42
2370479|NCT01529632|5816987|P2|NOT COMPLETED|Overall Study||3
2370480|NCT01529632|5816988|P1|NOT COMPLETED|Overall Study||3
2370481|NCT01529632|5816987|P2|COMPLETED|Overall Study||100
2370482|NCT01529632|5816988|P1|COMPLETED|Overall Study||87
2370483|NCT01529632|5816987|P2|STARTED|Overall Study||103
2370484|NCT01529632|5816988|P1|STARTED|Overall Study||90
2370485|NCT01529515|5817008|P4|NOT COMPLETED|DOUBLE BLIND PHASE||12
2370486|NCT01529515|5817009|P3|NOT COMPLETED|DOUBLE BLIND PHASE||23
2370487|NCT01529515|5817010|P2|NOT COMPLETED|DOUBLE BLIND PHASE||0
2370488|NCT01529515|5817011|P1|NOT COMPLETED|DOUBLE BLIND PHASE||0
2370489|NCT01529515|5817008|P4|COMPLETED|DOUBLE BLIND PHASE||148
2370490|NCT01529515|5817009|P3|COMPLETED|DOUBLE BLIND PHASE||122
2370491|NCT01529515|5817010|P2|COMPLETED|DOUBLE BLIND PHASE||0
2370492|NCT01529515|5817011|P1|COMPLETED|DOUBLE BLIND PHASE||0
2370493|NCT01529515|5817008|P4|STARTED|DOUBLE BLIND PHASE||160
2370494|NCT01529515|5817009|P3|STARTED|DOUBLE BLIND PHASE||145
2370495|NCT01529515|5817010|P2|STARTED|DOUBLE BLIND PHASE||0
2370496|NCT01529515|5817011|P1|STARTED|DOUBLE BLIND PHASE||0
2370497|NCT01529515|5817008|P4|NOT COMPLETED|MAINTENANCE PHASE||0
2370498|NCT01529515|5817009|P3|NOT COMPLETED|MAINTENANCE PHASE||0
2370499|NCT01529515|5817010|P2|NOT COMPLETED|MAINTENANCE PHASE||74
2370500|NCT01529515|5817011|P1|NOT COMPLETED|MAINTENANCE PHASE||0
2370501|NCT01529515|5817008|P4|COMPLETED|MAINTENANCE PHASE||0
2370502|NCT01529515|5817009|P3|COMPLETED|MAINTENANCE PHASE||0
2370503|NCT01529515|5817010|P2|COMPLETED|MAINTENANCE PHASE||305
2370504|NCT01529515|5817011|P1|COMPLETED|MAINTENANCE PHASE||0
2370505|NCT01529515|5817008|P4|STARTED|MAINTENANCE PHASE||0
2370506|NCT01529515|5817009|P3|STARTED|MAINTENANCE PHASE||0
2370507|NCT01529515|5817010|P2|STARTED|MAINTENANCE PHASE||379
2370508|NCT01529515|5817011|P1|STARTED|MAINTENANCE PHASE||0
2370509|NCT01529515|5817008|P4|NOT COMPLETED|TRANSITION PHASE||0
2370510|NCT01529515|5817009|P3|NOT COMPLETED|TRANSITION PHASE||0
2370511|NCT01529515|5817010|P2|NOT COMPLETED|TRANSITION PHASE||0
2370512|NCT01529515|5817011|P1|NOT COMPLETED|TRANSITION PHASE||127
2370513|NCT01529515|5817008|P4|COMPLETED|TRANSITION PHASE||0
2370514|NCT01529515|5817009|P3|COMPLETED|TRANSITION PHASE||0
2370515|NCT01529515|5817010|P2|COMPLETED|TRANSITION PHASE||0
2370516|NCT01529515|5817011|P1|COMPLETED|TRANSITION PHASE||379
2370517|NCT01529515|5817008|P4|STARTED|TRANSITION PHASE||0
2370518|NCT01529515|5817009|P3|STARTED|TRANSITION PHASE||0
2370519|NCT01529515|5817010|P2|STARTED|TRANSITION PHASE||0
2370520|NCT01529515|5817011|P1|STARTED|TRANSITION PHASE||506
2370521|NCT01529502|5817030|P6|NOT COMPLETED|Overall Study||0
2370522|NCT01529502|5817031|P5|NOT COMPLETED|Overall Study||0
2370523|NCT01529502|5817032|P4|NOT COMPLETED|Overall Study||2
2370524|NCT01529502|5817033|P3|NOT COMPLETED|Overall Study||0
2370525|NCT01529502|5817034|P2|NOT COMPLETED|Overall Study||0
2370526|NCT01529502|5817035|P1|NOT COMPLETED|Overall Study||0
2370527|NCT01529502|5817030|P6|COMPLETED|Overall Study||2
2370528|NCT01529502|5817031|P5|COMPLETED|Overall Study||2
2370529|NCT01529502|5817032|P4|COMPLETED|Overall Study||1
2370530|NCT01529502|5817033|P3|COMPLETED|Overall Study||2
2370531|NCT01529502|5817034|P2|COMPLETED|Overall Study||3
2370532|NCT01529502|5817035|P1|COMPLETED|Overall Study||2
2370533|NCT01529502|5817030|P6|STARTED|Overall Study||2
2370534|NCT01529502|5817031|P5|STARTED|Overall Study||2
2370535|NCT01529502|5817032|P4|STARTED|Overall Study||3
2370536|NCT01529502|5817033|P3|STARTED|Overall Study||2
2370537|NCT01529502|5817034|P2|STARTED|Overall Study||3
2370538|NCT01529502|5817035|P1|STARTED|Overall Study||2
2370539|NCT01529450|5817048|P2|NOT COMPLETED|Overall Study||2
2370540|NCT01529450|5817049|P1|NOT COMPLETED|Overall Study||0
2370541|NCT01529450|5817048|P2|COMPLETED|Overall Study||6
2370542|NCT01529450|5817049|P1|COMPLETED|Overall Study||3
2370543|NCT01529450|5817048|P2|STARTED|Overall Study||8
2370544|NCT01529450|5817049|P1|STARTED|Overall Study||3
2370545|NCT01529385|5817058|P2|NOT COMPLETED|Overall Study||1
2370546|NCT01529385|5817059|P1|NOT COMPLETED|Overall Study||2
2370547|NCT01529385|5817058|P2|COMPLETED|Overall Study||39
2370548|NCT01529385|5817059|P1|COMPLETED|Overall Study||38
2370549|NCT01529385|5817058|P2|Received Intervention|Overall Study||40
2370550|NCT01529385|5817059|P1|Received Intervention|Overall Study|1 participant failed to show up to treatment allocation visit and was subsequently lost to follow up|39
2370551|NCT01529385|5817058|P2|STARTED|Overall Study||40
2370552|NCT01529385|5817059|P1|STARTED|Overall Study||40
2370553|NCT01529346|5817088|P5|NOT COMPLETED|Overall Study||0
2370554|NCT01529346|5817089|P4|NOT COMPLETED|Overall Study||0
2370555|NCT01529346|5817090|P3|NOT COMPLETED|Overall Study||2
2370556|NCT01529346|5817091|P2|NOT COMPLETED|Overall Study||1
2370557|NCT01529346|5817092|P1|NOT COMPLETED|Overall Study||2
2370558|NCT01529346|5817088|P5|COMPLETED|Overall Study||36
2370559|NCT01529346|5817089|P4|COMPLETED|Overall Study||36
2370560|NCT01529346|5817090|P3|COMPLETED|Overall Study||52
2370561|NCT01529346|5817091|P2|COMPLETED|Overall Study||53
2370562|NCT01529346|5817092|P1|COMPLETED|Overall Study||53
2370563|NCT01529346|5817088|P5|STARTED|Overall Study||36
2370564|NCT01529346|5817089|P4|STARTED|Overall Study||36
2370565|NCT01529346|5817090|P3|STARTED|Overall Study||54
2370566|NCT01529346|5817091|P2|STARTED|Overall Study||54
2370567|NCT01529346|5817092|P1|STARTED|Overall Study||55
2370568|NCT01529268|5817180|P2|NOT COMPLETED|Overall Study||3
2370569|NCT01529268|5817181|P1|NOT COMPLETED|Overall Study||12
2370570|NCT01529268|5817180|P2|COMPLETED|Overall Study||78
2370571|NCT01529268|5817181|P1|COMPLETED|Overall Study||76
2370572|NCT01529268|5817180|P2|Completed 52-week Biopsy|Overall Study||75
2370573|NCT01529268|5817181|P1|Completed 52-week Biopsy|Overall Study||71
2370574|NCT01529268|5817180|P2|STARTED|Overall Study||81
2370575|NCT01529268|5817181|P1|STARTED|Overall Study||88
2370576|NCT01529203|5817235|P1|NOT COMPLETED|Overall Study||3
2370577|NCT01529203|5817235|P1|COMPLETED|Overall Study||57
2370578|NCT01529203|5817235|P1|STARTED|Overall Study||60
2370579|NCT01529112|5817243|P2|NOT COMPLETED|Overall Study||41
2370580|NCT01529112|5817244|P1|NOT COMPLETED|Overall Study||69
2370581|NCT01529112|5817243|P2|COMPLETED|Overall Study|Discontinued treatment-continued follow-up=5 (data cut-off date 21 January 2014)|5
2370582|NCT01529112|5817244|P1|COMPLETED|Overall Study|On treatment=2, Discontinued treatment-continued follow-up=18 (data cut-off date 21 January 2014)|20
2370583|NCT01529112|5817243|P2|STARTED|Overall Study||46
2370584|NCT01529112|5817244|P1|STARTED|Overall Study||89
2370585|NCT01529060|5817271|P2|NOT COMPLETED|Overall Study||0
2370586|NCT01529060|5817272|P1|NOT COMPLETED|Overall Study||0
2370587|NCT01529060|5817271|P2|COMPLETED|Overall Study||10
2370588|NCT01529060|5817272|P1|COMPLETED|Overall Study||10
2370589|NCT01529060|5817271|P2|STARTED|Overall Study||10
2370590|NCT01529060|5817272|P1|STARTED|Overall Study||10
2370591|NCT01529034|5817280|P1|NOT COMPLETED|Overall Study||174
2370592|NCT01529034|5817280|P1|COMPLETED|Overall Study|Completed under initial protocol duration of 2 years; amended protocol open-ended duration|1
2370593|NCT01529034|5817280|P1|Exposed|Overall Study|Treated at least 1 seizure cluster with USL261|161
2370594|NCT01529034|5817280|P1|STARTED|Overall Study|Completed Study P261-401 and rolled over to Study P261-402|175
2370595|NCT01528969|5817295|P2|NOT COMPLETED|Overall Study||0
2370596|NCT01528969|5817296|P1|NOT COMPLETED|Overall Study||2
2370597|NCT01528969|5817295|P2|COMPLETED|Overall Study||38
2370598|NCT01528969|5817296|P1|COMPLETED|Overall Study||35
2370599|NCT01528969|5817295|P2|STARTED|Overall Study||38
2370600|NCT01528969|5817296|P1|STARTED|Overall Study||37
2370601|NCT01528891|5817304|P2|NOT COMPLETED|Overall Study||0
2370602|NCT01528891|5817305|P1|NOT COMPLETED|Overall Study||0
2370603|NCT01528891|5817304|P2|COMPLETED|Overall Study||200
2370604|NCT01528891|5817305|P1|COMPLETED|Overall Study||200
2370605|NCT01528891|5817304|P2|STARTED|Overall Study||200
2370606|NCT01528891|5817305|P1|STARTED|Overall Study||200
2370607|NCT01528878|5817317|P1|NOT COMPLETED|Overall Study||0
2370608|NCT01528878|5817317|P1|COMPLETED|Overall Study||30
2370609|NCT01528878|5817317|P1|STARTED|Overall Study||30
2370610|NCT01528787|5817329|P4|NOT COMPLETED|Overall Study||1
2370611|NCT01528787|5817330|P3|NOT COMPLETED|Overall Study||1
2370612|NCT01528787|5817331|P2|NOT COMPLETED|Overall Study||0
2370613|NCT01528787|5817332|P1|NOT COMPLETED|Overall Study||0
2370614|NCT01528787|5817329|P4|COMPLETED|Overall Study||22
2370615|NCT01528787|5817330|P3|COMPLETED|Overall Study||18
2370616|NCT01528787|5817331|P2|COMPLETED|Overall Study||21
2370617|NCT01528787|5817332|P1|COMPLETED|Overall Study||22
2370618|NCT01528787|5817329|P4|STARTED|Overall Study||23
2370619|NCT01528787|5817330|P3|STARTED|Overall Study||19
2370620|NCT01528787|5817331|P2|STARTED|Overall Study||21
2370621|NCT01528787|5817332|P1|STARTED|Overall Study||22
2370622|NCT01528735|5817344|P2|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||0
2370623|NCT01528735|5817345|P1|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||1
2370624|NCT01528735|5817344|P2|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||12
2370625|NCT01528735|5817345|P1|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||10
2370626|NCT01528735|5817344|P2|STARTED|Treatment Period 2: Faldap/PegIFN/RBV|One patient was treated with only PegIFN/RBV, as faldaprevir was discontinued due to adverse events|12
2370627|NCT01528735|5817345|P1|STARTED|Treatment Period 2: Faldap/PegIFN/RBV||11
2370628|NCT01528735|5817344|P2|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
2370629|NCT01528735|5817345|P1|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
2370630|NCT01528735|5817344|P2|COMPLETED|Treatment Period 1: Faldap/Del/RBV||12
2370631|NCT01528735|5817345|P1|COMPLETED|Treatment Period 1: Faldap/Del/RBV||11
2370632|NCT01528735|5817344|P2|STARTED|Treatment Period 1: Faldap/Del/RBV||13
2370633|NCT01528735|5817345|P1|STARTED|Treatment Period 1: Faldap/Del/RBV||12
2370634|NCT01528709|5817447|P2|NOT COMPLETED|Overall Study||15
2370635|NCT01528709|5817448|P1|NOT COMPLETED|Overall Study||13
2370636|NCT01528709|5817447|P2|COMPLETED|Overall Study||72
2370637|NCT01528709|5817448|P1|COMPLETED|Overall Study||73
2370638|NCT01528709|5817447|P2|STARTED|Overall Study||87
2370639|NCT01528709|5817448|P1|STARTED|Overall Study||86
2370640|NCT01528696|5817458|P2|NOT COMPLETED|Overall Study||19
2370641|NCT01528696|5817459|P1|NOT COMPLETED|Overall Study||18
2370642|NCT01528696|5817458|P2|COMPLETED|Overall Study||0
2370643|NCT01528696|5817459|P1|COMPLETED|Overall Study||0
2370644|NCT01528696|5817458|P2|Hospital Stay (2-5 Days)|Overall Study||19
2370645|NCT01528696|5817459|P1|Hospital Stay (2-5 Days)|Overall Study||18
2370646|NCT01528696|5817458|P2|STARTED|Overall Study||19
2370647|NCT01528696|5817459|P1|STARTED|Overall Study||18
2370648|NCT01528605|5817475|P6|NOT COMPLETED|Overall Study||0
2370649|NCT01528605|5817476|P5|NOT COMPLETED|Overall Study||0
2370650|NCT01528605|5817477|P4|NOT COMPLETED|Overall Study||1
2370651|NCT01528605|5817478|P3|NOT COMPLETED|Overall Study||1
2370652|NCT01528605|5817479|P2|NOT COMPLETED|Overall Study||0
2370653|NCT01528605|5817480|P1|NOT COMPLETED|Overall Study||2
2370654|NCT01528605|5817475|P6|COMPLETED|Overall Study||28
2370655|NCT01528605|5817476|P5|COMPLETED|Overall Study||28
2370656|NCT01528605|5817477|P4|COMPLETED|Overall Study||27
2370657|NCT01528605|5817478|P3|COMPLETED|Overall Study||27
2370658|NCT01528605|5817479|P2|COMPLETED|Overall Study||28
2370659|NCT01528605|5817480|P1|COMPLETED|Overall Study||26
2370660|NCT01528605|5817475|P6|STARTED|Overall Study||28
2370661|NCT01528605|5817476|P5|STARTED|Overall Study||28
2370662|NCT01528605|5817477|P4|STARTED|Overall Study||28
2370663|NCT01528605|5817478|P3|STARTED|Overall Study||28
2370664|NCT01528605|5817479|P2|STARTED|Overall Study||28
2370665|NCT01528605|5817480|P1|STARTED|Overall Study||28
2370666|NCT01528592|5817504|P1|NOT COMPLETED|Overall Study||0
2370667|NCT01528592|5817504|P1|COMPLETED|Overall Study||18
2370668|NCT01528592|5817504|P1|STARTED|Overall Study||18
2370669|NCT01528345|5817510|P2|NOT COMPLETED|Overall Study||50
2370670|NCT01528345|5817511|P1|NOT COMPLETED|Overall Study||47
2370671|NCT01528345|5817510|P2|COMPLETED|Overall Study||0
2370672|NCT01528345|5817511|P1|COMPLETED|Overall Study||0
2370673|NCT01528345|5817510|P2|STARTED|Overall Study||50
2370674|NCT01528345|5817511|P1|STARTED|Overall Study||47
2370675|NCT01528332|5817529|P2|NOT COMPLETED|Overall Study||2
2370676|NCT01528332|5817530|P1|NOT COMPLETED|Overall Study||4
2370677|NCT01528332|5817529|P2|COMPLETED|Overall Study||84
2370678|NCT01528332|5817530|P1|COMPLETED|Overall Study||81
2370679|NCT01528332|5817529|P2|STARTED|Overall Study||86
2370680|NCT01528332|5817530|P1|STARTED|Overall Study||85
2370681|NCT01528319|5817536|P1|NOT COMPLETED|Overall Study||1
2370682|NCT01528319|5817536|P1|COMPLETED|Overall Study||23
2370683|NCT01528319|5817536|P1|12 Weeks After Surgery|Overall Study||24
2370684|NCT01528319|5817536|P1|STARTED|Overall Study||24
2370685|NCT01528293|5817547|P2|NOT COMPLETED|Overall Study||0
2370686|NCT01528293|5817548|P1|NOT COMPLETED|Overall Study||1
2370687|NCT01528293|5817547|P2|COMPLETED|Overall Study||1
2370688|NCT01528293|5817548|P1|COMPLETED|Overall Study||0
2370689|NCT01528293|5817547|P2|STARTED|Overall Study||1
2370690|NCT01528293|5817548|P1|STARTED|Overall Study||1
2370691|NCT01528228|5817562|P2|NOT COMPLETED|Overall Study||1
2370692|NCT01528228|5817563|P1|NOT COMPLETED|Overall Study||1
2370693|NCT01528228|5817562|P2|COMPLETED|Overall Study||9
2370694|NCT01528228|5817563|P1|COMPLETED|Overall Study||9
2370695|NCT01528228|5817562|P2|STARTED|Overall Study||10
2370696|NCT01528228|5817563|P1|STARTED|Overall Study||10
2370697|NCT01528215|5817571|P2|NOT COMPLETED|Overall Study||1
2370698|NCT01528215|5817572|P1|NOT COMPLETED|Overall Study||4
2370699|NCT01528215|5817571|P2|COMPLETED|Overall Study||60
2370700|NCT01528215|5817572|P1|COMPLETED|Overall Study||55
2370701|NCT01528215|5817571|P2|STARTED|Overall Study||61
2370702|NCT01528215|5817572|P1|STARTED|Overall Study||59
2370703|NCT01528150|5817578|P1|NOT COMPLETED|Overall Study||44
2370704|NCT01528150|5817578|P1|COMPLETED|Overall Study||422
2370705|NCT01528150|5817578|P1|STARTED|Overall Study||466
2370706|NCT01528124|5817589|P7|NOT COMPLETED|Overall Study||0
2370707|NCT01528124|5817590|P6|NOT COMPLETED|Overall Study||0
2370708|NCT01528124|5817591|P5|NOT COMPLETED|Overall Study||0
2370709|NCT01528124|5817592|P4|NOT COMPLETED|Overall Study||0
2370710|NCT01528124|5817593|P3|NOT COMPLETED|Overall Study||0
2370711|NCT01528124|5817594|P2|NOT COMPLETED|Overall Study||0
2370712|NCT01528124|5817595|P1|NOT COMPLETED|Overall Study||0
2370713|NCT01528124|5817589|P7|COMPLETED|Overall Study||6
2370714|NCT01528124|5817590|P6|COMPLETED|Overall Study||6
2370715|NCT01528124|5817591|P5|COMPLETED|Overall Study||5
2370716|NCT01528124|5817592|P4|COMPLETED|Overall Study||6
2370717|NCT01528124|5817593|P3|COMPLETED|Overall Study||6
2370718|NCT01528124|5817594|P2|COMPLETED|Overall Study||6
2370719|NCT01528124|5817595|P1|COMPLETED|Overall Study||6
2370720|NCT01528124|5817589|P7|Received Study Drug|Overall Study||6
2370721|NCT01528124|5817590|P6|Received Study Drug|Overall Study||6
2370722|NCT01528124|5817591|P5|Received Study Drug|Overall Study||5
2370723|NCT01528124|5817592|P4|Received Study Drug|Overall Study||6
2370724|NCT01528124|5817593|P3|Received Study Drug|Overall Study||6
2370725|NCT01528124|5817594|P2|Received Study Drug|Overall Study||6
2370726|NCT01528124|5817595|P1|Received Study Drug|Overall Study||6
2370727|NCT01528124|5817589|P7|STARTED|Overall Study||6
2370728|NCT01528124|5817590|P6|STARTED|Overall Study||6
2370729|NCT01528124|5817591|P5|STARTED|Overall Study||5
2370730|NCT01528124|5817592|P4|STARTED|Overall Study||6
2370731|NCT01528124|5817593|P3|STARTED|Overall Study||6
2370732|NCT01528124|5817594|P2|STARTED|Overall Study||6
2370733|NCT01528124|5817595|P1|STARTED|Overall Study||6
2370734|NCT01528072|5817629|P1|NOT COMPLETED|Overall Study||74
2370735|NCT01528072|5817629|P1|COMPLETED|Overall Study||66
2370736|NCT01528072|5817629|P1|STARTED|Overall Study||140
2370737|NCT01527942|5817635|P2|NOT COMPLETED|Overall Study||0
2370738|NCT01527942|5817636|P1|NOT COMPLETED|Overall Study||0
2370739|NCT01527942|5817635|P2|COMPLETED|Overall Study||18
2370740|NCT01527942|5817636|P1|COMPLETED|Overall Study||16
2370741|NCT01527942|5817635|P2|STARTED|Overall Study||18
2370742|NCT01527942|5817636|P1|STARTED|Overall Study||16
2370743|NCT01527682|5817646|P1|NOT COMPLETED|Overall Study||8
2370744|NCT01527682|5817646|P1|COMPLETED|Overall Study||29
2370745|NCT01527682|5817646|P1|STARTED|Overall Study||37
2370746|NCT01527513|5817654|P2|NOT COMPLETED|Eligible for 1-Year Open Label Period||17
2370747|NCT01527513|5817655|P1|NOT COMPLETED|Eligible for 1-Year Open Label Period||0
2370748|NCT01527513|5817654|P2|COMPLETED|Eligible for 1-Year Open Label Period||95
2370749|NCT01527513|5817655|P1|COMPLETED|Eligible for 1-Year Open Label Period||0
2370750|NCT01527513|5817654|P2|STARTED|Eligible for 1-Year Open Label Period|Participants that were eligible to participate in for 1-Year Open Label Period - Part II|112
2370751|NCT01527513|5817655|P1|STARTED|Eligible for 1-Year Open Label Period||0
2370752|NCT01527513|5817654|P2|NOT COMPLETED|Double Blind Period (DB) - Part I||8
2370753|NCT01527513|5817655|P1|NOT COMPLETED|Double Blind Period (DB) - Part I||3
2370754|NCT01527513|5817654|P2|COMPLETED|Double Blind Period (DB) - Part I||75
2370755|NCT01527513|5817655|P1|COMPLETED|Double Blind Period (DB) - Part I||37
2370756|NCT01527513|5817654|P2|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||66
2370757|NCT01527513|5817655|P1|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||36
2370758|NCT01527513|5817654|P2|Efficacy PP Population|Double Blind Period (DB) - Part I||67
2370759|NCT01527513|5817655|P1|Efficacy PP Population|Double Blind Period (DB) - Part I||37
2370760|NCT01527513|5817654|P2|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||75
2370761|NCT01527513|5817655|P1|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||37
2370762|NCT01527513|5817654|P2|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||75
2370763|NCT01527513|5817655|P1|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||37
2370764|NCT01527513|5817654|P2|Entered Maintenance Period|Double Blind Period (DB) - Part I||76
2370765|NCT01527513|5817655|P1|Entered Maintenance Period|Double Blind Period (DB) - Part I||40
2370766|NCT01527513|5817654|P2|Safety Population|Double Blind Period (DB) - Part I||83
2370767|NCT01527513|5817655|P1|Safety Population|Double Blind Period (DB) - Part I||40
2370768|NCT01527513|5817654|P2|Randomized|Double Blind Period (DB) - Part I||83
2370769|NCT01527513|5817655|P1|Randomized|Double Blind Period (DB) - Part I||40
2370770|NCT01527513|5817654|P2|STARTED|Double Blind Period (DB) - Part I||83
2370771|NCT01527513|5817655|P1|STARTED|Double Blind Period (DB) - Part I||40
2370772|NCT01527500|5817669|P2|NOT COMPLETED|Part B||0
2370773|NCT01527500|5817670|P1|NOT COMPLETED|Part B||1
2370774|NCT01527500|5817669|P2|COMPLETED|Part B||1
2370775|NCT01527500|5817670|P1|COMPLETED|Part B||6
2370776|NCT01527500|5817669|P2|STARTED|Part B||1
2370777|NCT01527500|5817670|P1|STARTED|Part B||7
2370778|NCT01527500|5817669|P2|NOT COMPLETED|Part A||13
2370779|NCT01527500|5817670|P1|NOT COMPLETED|Part A||30
2370780|NCT01527500|5817669|P2|COMPLETED|Part A||38
2370781|NCT01527500|5817670|P1|COMPLETED|Part A||69
2370782|NCT01527500|5817669|P2|STARTED|Part A||51
2370783|NCT01527500|5817670|P1|STARTED|Part A||99
2370784|NCT01527487|5817700|P2|NOT COMPLETED|Overall Study||7
2370785|NCT01527487|5817701|P1|NOT COMPLETED|Overall Study||8
2370786|NCT01527487|5817700|P2|COMPLETED|Overall Study||15
2370787|NCT01527487|5817701|P1|COMPLETED|Overall Study|Patients who completed 6 cycles plus surgery.|46
2370788|NCT01527487|5817700|P2|STARTED|Overall Study||22
2370789|NCT01527487|5817701|P1|STARTED|Overall Study|Includes 10 patients from safety lead-in.|54
2370790|NCT01527383|5817715|P2|NOT COMPLETED|Overall Study||4
2370791|NCT01527383|5817716|P1|NOT COMPLETED|Overall Study||15
2370792|NCT01527383|5817715|P2|COMPLETED|Overall Study||58
2370793|NCT01527383|5817716|P1|COMPLETED|Overall Study||277
2370794|NCT01527383|5817715|P2|Vaccination 4 (~Day 90)|Overall Study||58
2370795|NCT01527383|5817716|P1|Vaccination 4 (~Day 90)|Overall Study||277
2370796|NCT01527383|5817715|P2|Vaccination 3 (~Day 60)|Overall Study||58
2370797|NCT01527383|5817716|P1|Vaccination 3 (~Day 60)|Overall Study||278
2370798|NCT01527383|5817715|P2|Vaccination 2 (~Day 30)|Overall Study||61
2370799|NCT01527383|5817716|P1|Vaccination 2 (~Day 30)|Overall Study||283
2370800|NCT01527383|5817715|P2|Vaccination 1 (Day 1)|Overall Study||62
2370801|NCT01527383|5817716|P1|Vaccination 1 (Day 1)|Overall Study||291
2370802|NCT01527383|5817715|P2|STARTED|Overall Study||62
2370803|NCT01527383|5817716|P1|STARTED|Overall Study||292
2370804|NCT01527370|5817730|P1|NOT COMPLETED|Overall Study||6
2370805|NCT01527370|5817730|P1|COMPLETED|Overall Study||244
2370806|NCT01527370|5817730|P1|STARTED|Overall Study||250
2370807|NCT01527357|5817738|P2|NOT COMPLETED|Overall Study||9
2370808|NCT01527357|5817739|P1|NOT COMPLETED|Overall Study||17
2370809|NCT01527357|5817738|P2|COMPLETED|Overall Study||230
2370810|NCT01527357|5817739|P1|COMPLETED|Overall Study||465
2370811|NCT01527357|5817738|P2|Efficacy Population|Overall Study||239
2370812|NCT01527357|5817739|P1|Efficacy Population|Overall Study|Two participants did not receive study treatment.|480
2370813|NCT01527357|5817738|P2|STARTED|Overall Study||239
2370814|NCT01527357|5817739|P1|STARTED|Overall Study||482
2370815|NCT01527292|5817761|P2|NOT COMPLETED|Overall Study||3
2370816|NCT01527292|5817762|P1|NOT COMPLETED|Overall Study||0
2370817|NCT01527292|5817761|P2|COMPLETED|Overall Study||0
2370818|NCT01527292|5817762|P1|COMPLETED|Overall Study||0
2370819|NCT01527292|5817761|P2|STARTED|Overall Study||3
2370820|NCT01527292|5817762|P1|STARTED|Overall Study||0
2370821|NCT01527162|5817778|P2|NOT COMPLETED|Overall Study||0
2370822|NCT01527162|5817779|P1|NOT COMPLETED|Overall Study||0
2370823|NCT01527162|5817778|P2|COMPLETED|Overall Study||5
2370824|NCT01527162|5817779|P1|COMPLETED|Overall Study||6
2370825|NCT01527162|5817778|P2|STARTED|Overall Study||5
2370826|NCT01527162|5817779|P1|STARTED|Overall Study||6
2370827|NCT01527110|5817789|P1|NOT COMPLETED|Overall Study||1
2370828|NCT01527110|5817789|P1|COMPLETED|Overall Study||20
2370829|NCT01527110|5817789|P1|STARTED|Overall Study||21
2370830|NCT01527045|5817837|P3|NOT COMPLETED|Overall Study||0
2370831|NCT01527045|5817838|P2|NOT COMPLETED|Overall Study||0
2370832|NCT01527045|5817839|P1|NOT COMPLETED|Overall Study||1
2370833|NCT01527045|5817837|P3|COMPLETED|Overall Study||12
2370834|NCT01527045|5817838|P2|COMPLETED|Overall Study||5
2370835|NCT01527045|5817839|P1|COMPLETED|Overall Study||29
2370836|NCT01527045|5817837|P3|STARTED|Overall Study||12
2370837|NCT01527045|5817838|P2|STARTED|Overall Study||5
2370838|NCT01527045|5817839|P1|STARTED|Overall Study||30
2370839|NCT01527006|5817870|P2|NOT COMPLETED|Extension Phase||8
2370840|NCT01527006|5817871|P1|NOT COMPLETED|Extension Phase||6
2370841|NCT01527006|5817870|P2|COMPLETED|Extension Phase||14
2370842|NCT01527006|5817871|P1|COMPLETED|Extension Phase||13
2370843|NCT01527006|5817870|P2|STARTED|Extension Phase||22
2370844|NCT01527006|5817871|P1|STARTED|Extension Phase|Of the 20 subjects who completed the Core Study, 19 subjects continued into the Extension Phase.|19
2370845|NCT01527006|5817870|P2|NOT COMPLETED|Core Study||6
2370846|NCT01527006|5817871|P1|NOT COMPLETED|Core Study||2
2370847|NCT01527006|5817870|P2|COMPLETED|Core Study||22
2370848|NCT01527006|5817871|P1|COMPLETED|Core Study||20
2370849|NCT01527006|5817870|P2|STARTED|Core Study||28
2370850|NCT01527006|5817871|P1|STARTED|Core Study||22
2370851|NCT01526928|5817927|P6|NOT COMPLETED|Overall Study||6
2370852|NCT01526928|5817928|P5|NOT COMPLETED|Overall Study||95
2370853|NCT01526928|5817929|P4|NOT COMPLETED|Overall Study||245
2370854|NCT01526928|5817930|P3|NOT COMPLETED|Overall Study||209
2370855|NCT01526928|5817931|P2|NOT COMPLETED|Overall Study||19
2370856|NCT01526928|5817932|P1|NOT COMPLETED|Overall Study||38
2370857|NCT01526928|5817927|P6|COMPLETED|Overall Study||0
2370858|NCT01526928|5817928|P5|COMPLETED|Overall Study||0
2370859|NCT01526928|5817929|P4|COMPLETED|Overall Study||0
2370860|NCT01526928|5817930|P3|COMPLETED|Overall Study||0
2370861|NCT01526928|5817931|P2|COMPLETED|Overall Study||0
2370862|NCT01526928|5817932|P1|COMPLETED|Overall Study||0
2370863|NCT01526928|5817927|P6|Started Phase 2|Overall Study||0
2370864|NCT01526928|5817928|P5|Started Phase 2|Overall Study||82
2370865|NCT01526928|5817929|P4|Started Phase 2|Overall Study||228
2370866|NCT01526928|5817930|P3|Started Phase 2|Overall Study||191
2370867|NCT01526928|5817931|P2|Started Phase 2|Overall Study||0
2370868|NCT01526928|5817932|P1|Started Phase 2|Overall Study||0
2370869|NCT01526928|5817927|P6|Started Phase 1|Overall Study||6
2370870|NCT01526928|5817928|P5|Started Phase 1|Overall Study||13
2370871|NCT01526928|5817929|P4|Started Phase 1|Overall Study||17
2370872|NCT01526928|5817930|P3|Started Phase 1|Overall Study||18
2370873|NCT01526928|5817931|P2|Started Phase 1|Overall Study||19
2370874|NCT01526928|5817932|P1|Started Phase 1|Overall Study||38
2370875|NCT01526928|5817927|P6|STARTED|Overall Study||6
2370876|NCT01526928|5817928|P5|STARTED|Overall Study||95
2370877|NCT01526928|5817929|P4|STARTED|Overall Study||245
2370878|NCT01526928|5817930|P3|STARTED|Overall Study||209
2370879|NCT01526928|5817931|P2|STARTED|Overall Study||19
2370880|NCT01526928|5817932|P1|STARTED|Overall Study||38
2370881|NCT01526902|5818051|P2|NOT COMPLETED|Overall Study||0
2370882|NCT01526902|5818052|P1|NOT COMPLETED|Overall Study||0
2370883|NCT01526902|5818051|P2|COMPLETED|Overall Study||24
2370884|NCT01526902|5818052|P1|COMPLETED|Overall Study||25
2370885|NCT01526902|5818051|P2|STARTED|Overall Study||24
2370886|NCT01526902|5818052|P1|STARTED|Overall Study||25
2370887|NCT01526889|5818070|P2|NOT COMPLETED|Treatment Extension Period||0
2370888|NCT01526889|5818071|P1|NOT COMPLETED|Treatment Extension Period||1
2370889|NCT01526889|5818070|P2|COMPLETED|Treatment Extension Period||0
2370890|NCT01526889|5818071|P1|COMPLETED|Treatment Extension Period||4
2370891|NCT01526889|5818070|P2|STARTED|Treatment Extension Period||0
2370892|NCT01526889|5818071|P1|STARTED|Treatment Extension Period||5
2370893|NCT01526889|5818070|P2|NOT COMPLETED|Treatment Period||0
2370894|NCT01526889|5818071|P1|NOT COMPLETED|Treatment Period||2
2370895|NCT01526889|5818070|P2|COMPLETED|Treatment Period||7
2370896|NCT01526889|5818071|P1|COMPLETED|Treatment Period||16
2370897|NCT01526889|5818070|P2|STARTED|Treatment Period||7
2370898|NCT01526889|5818071|P1|STARTED|Treatment Period||18
2370899|NCT01526785|5818092|P1|NOT COMPLETED|Overall Study||13
2370900|NCT01526785|5818092|P1|COMPLETED|Overall Study||100
2370901|NCT01526785|5818092|P1|STARTED|Overall Study||113
2370902|NCT01526733|5818102|P2|NOT COMPLETED|Phase 2||0
2370903|NCT01526733|5818103|P1|NOT COMPLETED|Phase 2||0
2370904|NCT01526733|5818102|P2|COMPLETED|Phase 2||12
2370905|NCT01526733|5818103|P1|COMPLETED|Phase 2||10
2370906|NCT01526733|5818102|P2|STARTED|Phase 2||12
2370907|NCT01526733|5818103|P1|STARTED|Phase 2||10
2370908|NCT01526733|5818102|P2|NOT COMPLETED|Washout Period of 5 to 21 Days||0
2370909|NCT01526733|5818103|P1|NOT COMPLETED|Washout Period of 5 to 21 Days||0
2370910|NCT01526733|5818102|P2|COMPLETED|Washout Period of 5 to 21 Days||12
2370911|NCT01526733|5818103|P1|COMPLETED|Washout Period of 5 to 21 Days||10
2370912|NCT01526733|5818102|P2|STARTED|Washout Period of 5 to 21 Days||12
2370913|NCT01526733|5818103|P1|STARTED|Washout Period of 5 to 21 Days||10
2370914|NCT01526733|5818102|P2|NOT COMPLETED|Phase 1||1
2370915|NCT01526733|5818103|P1|NOT COMPLETED|Phase 1||2
2370916|NCT01526733|5818102|P2|COMPLETED|Phase 1||12
2370917|NCT01526733|5818103|P1|COMPLETED|Phase 1||10
2370918|NCT01526733|5818102|P2|Received at Least 1 Dose of Study Drug|Phase 1||13
2370919|NCT01526733|5818103|P1|Received at Least 1 Dose of Study Drug|Phase 1||12
2370920|NCT01526733|5818102|P2|STARTED|Phase 1|One participant discontinued after receiving insulin-sham and before receiving insulin-rHuPH20.|13
2370921|NCT01526733|5818103|P1|STARTED|Phase 1||12
2370922|NCT01526629|5818121|P1|NOT COMPLETED|Overall Study||46
2370923|NCT01526629|5818121|P1|COMPLETED|Overall Study||308
2370924|NCT01526629|5818121|P1|STARTED|Overall Study||354
2370925|NCT01526577|5818130|P5|NOT COMPLETED|Overall Study||2
2370926|NCT01526577|5818131|P4|NOT COMPLETED|Overall Study||1
2370927|NCT01526577|5818132|P3|NOT COMPLETED|Overall Study||1
2370928|NCT01526577|5818133|P2|NOT COMPLETED|Overall Study||0
2370929|NCT01526577|5818134|P1|NOT COMPLETED|Overall Study||1
2370930|NCT01526577|5818130|P5|COMPLETED|Overall Study||8
2370931|NCT01526577|5818131|P4|COMPLETED|Overall Study||8
2370932|NCT01526577|5818132|P3|COMPLETED|Overall Study||32
2370933|NCT01526577|5818133|P2|COMPLETED|Overall Study||12
2370934|NCT01526577|5818134|P1|COMPLETED|Overall Study||48
2370935|NCT01526577|5818130|P5|STARTED|Overall Study|2 more subjects were enrolled as the substitutes for 2 withdrawn subjects before the administration.|10
2370936|NCT01526577|5818131|P4|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|9
2370937|NCT01526577|5818132|P3|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|33
2370938|NCT01526577|5818133|P2|STARTED|Overall Study||12
2370939|NCT01526577|5818134|P1|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|49
2370940|NCT01526551|5818142|P1|NOT COMPLETED|Overall Study||424
2370941|NCT01526551|5818142|P1|COMPLETED|Overall Study||511
2370942|NCT01526551|5818142|P1|STARTED|Overall Study||935
2370943|NCT01526538|5818149|P2|NOT COMPLETED|Overall Study||4
2370944|NCT01526538|5818150|P1|NOT COMPLETED|Overall Study||9
2370945|NCT01526538|5818149|P2|COMPLETED|Overall Study||18
2370946|NCT01526538|5818150|P1|COMPLETED|Overall Study||21
2370947|NCT01526538|5818149|P2|STARTED|Overall Study||22
2370948|NCT01526538|5818150|P1|STARTED|Overall Study||30
2370949|NCT01526343|5818160|P1|NOT COMPLETED|Overall Study||0
2370950|NCT01526343|5818160|P1|COMPLETED|Overall Study||47
2370951|NCT01526343|5818160|P1|STARTED|Overall Study||47
2370952|NCT01526213|5818171|P6|NOT COMPLETED|Period 3 (5 Days)||0
2370953|NCT01526213|5818172|P5|NOT COMPLETED|Period 3 (5 Days)||0
2370954|NCT01526213|5818173|P4|NOT COMPLETED|Period 3 (5 Days)||0
2370955|NCT01526213|5818174|P3|NOT COMPLETED|Period 3 (5 Days)||0
2370956|NCT01526213|5818175|P2|NOT COMPLETED|Period 3 (5 Days)||0
2370957|NCT01526213|5818176|P1|NOT COMPLETED|Period 3 (5 Days)||0
2370958|NCT01526213|5818171|P6|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
2370959|NCT01526213|5818172|P5|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
2370960|NCT01526213|5818173|P4|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
2370961|NCT01526213|5818174|P3|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
2370962|NCT01526213|5818175|P2|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
2370963|NCT01526213|5818176|P1|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
2370964|NCT01526213|5818171|P6|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
2370965|NCT01526213|5818172|P5|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
2370966|NCT01526213|5818173|P4|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
2370967|NCT01526213|5818174|P3|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
2370968|NCT01526213|5818175|P2|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
2370969|NCT01526213|5818176|P1|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
2370970|NCT01526213|5818171|P6|NOT COMPLETED|Washout 2 (10 Days)||0
2370971|NCT01526213|5818172|P5|NOT COMPLETED|Washout 2 (10 Days)||0
2370972|NCT01526213|5818173|P4|NOT COMPLETED|Washout 2 (10 Days)||0
2370973|NCT01526213|5818174|P3|NOT COMPLETED|Washout 2 (10 Days)||0
2370974|NCT01526213|5818175|P2|NOT COMPLETED|Washout 2 (10 Days)||0
2370975|NCT01526213|5818176|P1|NOT COMPLETED|Washout 2 (10 Days)||0
2370976|NCT01526213|5818171|P6|COMPLETED|Washout 2 (10 Days)||3
2370977|NCT01526213|5818172|P5|COMPLETED|Washout 2 (10 Days)||3
2370978|NCT01526213|5818173|P4|COMPLETED|Washout 2 (10 Days)||3
2370979|NCT01526213|5818174|P3|COMPLETED|Washout 2 (10 Days)||3
2370980|NCT01526213|5818175|P2|COMPLETED|Washout 2 (10 Days)||3
2370981|NCT01526213|5818176|P1|COMPLETED|Washout 2 (10 Days)||3
2370982|NCT01526213|5818171|P6|STARTED|Washout 2 (10 Days)||3
2370983|NCT01526213|5818172|P5|STARTED|Washout 2 (10 Days)||3
2370984|NCT01526213|5818173|P4|STARTED|Washout 2 (10 Days)||3
2370985|NCT01526213|5818174|P3|STARTED|Washout 2 (10 Days)||3
2370986|NCT01526213|5818175|P2|STARTED|Washout 2 (10 Days)||3
2370987|NCT01526213|5818176|P1|STARTED|Washout 2 (10 Days)||3
2370988|NCT01526213|5818171|P6|NOT COMPLETED|Period 2 (5 Days)||0
2370989|NCT01526213|5818172|P5|NOT COMPLETED|Period 2 (5 Days)||0
2370990|NCT01526213|5818173|P4|NOT COMPLETED|Period 2 (5 Days)||0
2370991|NCT01526213|5818174|P3|NOT COMPLETED|Period 2 (5 Days)||0
2370992|NCT01526213|5818175|P2|NOT COMPLETED|Period 2 (5 Days)||0
2370993|NCT01526213|5818176|P1|NOT COMPLETED|Period 2 (5 Days)||0
2370994|NCT01526213|5818171|P6|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
2370995|NCT01526213|5818172|P5|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
2370996|NCT01526213|5818173|P4|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
2370997|NCT01526213|5818174|P3|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
2370998|NCT01526213|5818175|P2|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
2370999|NCT01526213|5818176|P1|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
2371000|NCT01526213|5818171|P6|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
2371001|NCT01526213|5818172|P5|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
2371002|NCT01526213|5818173|P4|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
2371003|NCT01526213|5818174|P3|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
2371004|NCT01526213|5818175|P2|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
2371005|NCT01526213|5818176|P1|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
2371006|NCT01526213|5818171|P6|NOT COMPLETED|Washout 1 (10 Days)||0
2371007|NCT01526213|5818172|P5|NOT COMPLETED|Washout 1 (10 Days)||0
2371008|NCT01526213|5818173|P4|NOT COMPLETED|Washout 1 (10 Days)||0
2371009|NCT01526213|5818174|P3|NOT COMPLETED|Washout 1 (10 Days)||0
2371010|NCT01526213|5818175|P2|NOT COMPLETED|Washout 1 (10 Days)||0
2371011|NCT01526213|5818176|P1|NOT COMPLETED|Washout 1 (10 Days)||0
2371012|NCT01526213|5818171|P6|COMPLETED|Washout 1 (10 Days)||3
2371013|NCT01526213|5818172|P5|COMPLETED|Washout 1 (10 Days)||3
2371014|NCT01526213|5818173|P4|COMPLETED|Washout 1 (10 Days)||3
2371015|NCT01526213|5818174|P3|COMPLETED|Washout 1 (10 Days)||3
2371016|NCT01526213|5818175|P2|COMPLETED|Washout 1 (10 Days)||3
2371017|NCT01526213|5818176|P1|COMPLETED|Washout 1 (10 Days)||3
2371018|NCT01526213|5818171|P6|STARTED|Washout 1 (10 Days)||3
2371019|NCT01526213|5818172|P5|STARTED|Washout 1 (10 Days)||3
2371020|NCT01526213|5818173|P4|STARTED|Washout 1 (10 Days)||3
2371021|NCT01526213|5818174|P3|STARTED|Washout 1 (10 Days)||3
2371022|NCT01526213|5818175|P2|STARTED|Washout 1 (10 Days)||3
2371023|NCT01526213|5818176|P1|STARTED|Washout 1 (10 Days)||3
2371024|NCT01526213|5818171|P6|NOT COMPLETED|Period 1 (5 Days)||0
2371025|NCT01526213|5818172|P5|NOT COMPLETED|Period 1 (5 Days)||0
2371026|NCT01526213|5818173|P4|NOT COMPLETED|Period 1 (5 Days)||0
2371027|NCT01526213|5818174|P3|NOT COMPLETED|Period 1 (5 Days)||0
2371028|NCT01526213|5818175|P2|NOT COMPLETED|Period 1 (5 Days)||0
2371029|NCT01526213|5818176|P1|NOT COMPLETED|Period 1 (5 Days)||0
2371030|NCT01526213|5818171|P6|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
2371031|NCT01526213|5818172|P5|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
2371032|NCT01526213|5818173|P4|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
2371033|NCT01526213|5818174|P3|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
2371034|NCT01526213|5818175|P2|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
2371035|NCT01526213|5818176|P1|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
2371036|NCT01526213|5818171|P6|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to (and completed) one of six sequences.|3
2371037|NCT01526213|5818172|P5|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
2371038|NCT01526213|5818173|P4|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
2371039|NCT01526213|5818174|P3|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
2371040|NCT01526213|5818175|P2|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
2371041|NCT01526213|5818176|P1|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
2371042|NCT01526148|5818189|P2|NOT COMPLETED|Overall Study||13
2371043|NCT01526148|5818190|P1|NOT COMPLETED|Overall Study||14
2371044|NCT01526148|5818189|P2|COMPLETED|Overall Study||11
2371045|NCT01526148|5818190|P1|COMPLETED|Overall Study||4
2371046|NCT01526148|5818189|P2|STARTED|Overall Study||24
2371047|NCT01526148|5818190|P1|STARTED|Overall Study||18
2371048|NCT01526057|5818201|P3|NOT COMPLETED|Overall Study||6
2371049|NCT01526057|5818202|P2|NOT COMPLETED|Overall Study||3
2371050|NCT01526057|5818203|P1|NOT COMPLETED|Overall Study||9
2371051|NCT01526057|5818201|P3|COMPLETED|Overall Study||67
2371052|NCT01526057|5818202|P2|COMPLETED|Overall Study||71
2371053|NCT01526057|5818203|P1|COMPLETED|Overall Study||64
2371054|NCT01526057|5818201|P3|STARTED|Overall Study||73
2371055|NCT01526057|5818202|P2|STARTED|Overall Study||74
2371056|NCT01526057|5818203|P1|STARTED|Overall Study||73
2371057|NCT01525927|5818288|P1|NOT COMPLETED|Overall Study||0
2371058|NCT01525927|5818288|P1|COMPLETED|Overall Study||0
2371059|NCT01525927|5818288|P1|STARTED|Overall Study||0
2371060|NCT01525875|5818302|P2|NOT COMPLETED|Open-label Period||2
2371061|NCT01525875|5818303|P1|NOT COMPLETED|Open-label Period||0
2371062|NCT01525875|5818302|P2|COMPLETED|Open-label Period||18
2371063|NCT01525875|5818303|P1|COMPLETED|Open-label Period||21
2371064|NCT01525875|5818302|P2|STARTED|Open-label Period||20
2371065|NCT01525875|5818303|P1|STARTED|Open-label Period||21
2371066|NCT01525875|5818302|P2|NOT COMPLETED|Placebo-controlled Period||2
2371067|NCT01525875|5818303|P1|NOT COMPLETED|Placebo-controlled Period||1
2371068|NCT01525875|5818302|P2|COMPLETED|Placebo-controlled Period||20
2371069|NCT01525875|5818303|P1|COMPLETED|Placebo-controlled Period||21
2371070|NCT01525875|5818302|P2|STARTED|Placebo-controlled Period||22
2371071|NCT01525875|5818303|P1|STARTED|Placebo-controlled Period||22
2371072|NCT01525849|5818319|P2|NOT COMPLETED|Overall Study||16
2371073|NCT01525849|5818320|P1|NOT COMPLETED|Overall Study||5
2371074|NCT01525849|5818319|P2|COMPLETED|Overall Study||59
2371075|NCT01525849|5818320|P1|COMPLETED|Overall Study||71
2371076|NCT01525849|5818319|P2|6-Months|Overall Study||60
2371077|NCT01525849|5818320|P1|6-Months|Overall Study||73
2371078|NCT01525849|5818319|P2|Treated|Overall Study|14 withdrew before treatment: 8 didn't want FESS, 1 too busy, 2 medical issues, 3 excl. criteria.|61
2371079|NCT01525849|5818320|P1|Treated|Overall Study|2 withdrew before treatment: 1 didn't want balloon dilation, 1 unrelated medical issue.|74
2371080|NCT01525849|5818319|P2|STARTED|Overall Study||75
2371081|NCT01525849|5818320|P1|STARTED|Overall Study||76
2371082|NCT01525745|5818336|P2|NOT COMPLETED|Overall Study||1
2371083|NCT01525745|5818337|P1|NOT COMPLETED|Overall Study||1
2371084|NCT01525745|5818336|P2|COMPLETED|Overall Study||1
2371085|NCT01525745|5818337|P1|COMPLETED|Overall Study||3
2371086|NCT01525745|5818336|P2|STARTED|Overall Study||2
2371087|NCT01525745|5818337|P1|STARTED|Overall Study||4
2371088|NCT01525667|5818354|P3|NOT COMPLETED|Overall Study||0
2371089|NCT01525667|5818355|P2|NOT COMPLETED|Overall Study||0
2371090|NCT01525667|5818356|P1|NOT COMPLETED|Overall Study||0
2371091|NCT01525667|5818354|P3|COMPLETED|Overall Study||7
2371092|NCT01525667|5818355|P2|COMPLETED|Overall Study||6
2371093|NCT01525667|5818356|P1|COMPLETED|Overall Study||7
2371094|NCT01525667|5818354|P3|STARTED|Overall Study||7
2371095|NCT01525667|5818355|P2|STARTED|Overall Study||6
2371096|NCT01525667|5818356|P1|STARTED|Overall Study||7
2371097|NCT01525641|5818376|P1|NOT COMPLETED|Overall Study||180
2371098|NCT01525641|5818376|P1|COMPLETED|Overall Study||435
2371099|NCT01525641|5818376|P1|STARTED|Overall Study||615
2371100|NCT01525628|5818390|P5|NOT COMPLETED|Overall Study||3
2371101|NCT01525628|5818391|P4|NOT COMPLETED|Overall Study||4
2371102|NCT01525628|5818392|P3|NOT COMPLETED|Overall Study||5
2371103|NCT01525628|5818393|P2|NOT COMPLETED|Overall Study||5
2371104|NCT01525628|5818394|P1|NOT COMPLETED|Overall Study||2
2371105|NCT01525628|5818390|P5|COMPLETED|Overall Study||4
2371106|NCT01525628|5818391|P4|COMPLETED|Overall Study||10
2371107|NCT01525628|5818392|P3|COMPLETED|Overall Study||11
2371108|NCT01525628|5818393|P2|COMPLETED|Overall Study||14
2371109|NCT01525628|5818394|P1|COMPLETED|Overall Study||14
2371110|NCT01525628|5818390|P5|STARTED|Overall Study||7
2371111|NCT01525628|5818391|P4|STARTED|Overall Study||14
2371112|NCT01525628|5818392|P3|STARTED|Overall Study||16
2371113|NCT01525628|5818393|P2|STARTED|Overall Study||19
2371114|NCT01525628|5818394|P1|STARTED|Overall Study||16
2371115|NCT01525615|5818461|P3|NOT COMPLETED|Overall Study||6
2371116|NCT01525615|5818462|P2|NOT COMPLETED|Overall Study||7
2371117|NCT01525615|5818463|P1|NOT COMPLETED|Overall Study||14
2371118|NCT01525615|5818461|P3|COMPLETED|Overall Study||133
2371119|NCT01525615|5818462|P2|COMPLETED|Overall Study||126
2371120|NCT01525615|5818463|P1|COMPLETED|Overall Study||118
2371121|NCT01525615|5818461|P3|STARTED|Overall Study||139
2371122|NCT01525615|5818462|P2|STARTED|Overall Study||133
2371123|NCT01525615|5818463|P1|STARTED|Overall Study||132
2371124|NCT01525563|5818507|P1|NOT COMPLETED|Overall Study||212
2371125|NCT01525563|5818507|P1|COMPLETED|Overall Study|6 Months Follow-up|788
2371126|NCT01525563|5818507|P1|3 Months Follow-up|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|838
2371127|NCT01525563|5818507|P1|End of Treatment|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|910
2371128|NCT01525563|5818507|P1|STARTED|Overall Study||1000
2371129|NCT01525550|5818519|P2|NOT COMPLETED|Overall Study||45
2371130|NCT01525550|5818520|P1|NOT COMPLETED|Overall Study||61
2371131|NCT01525550|5818519|P2|COMPLETED|Overall Study||0
2371132|NCT01525550|5818520|P1|COMPLETED|Overall Study||0
2371133|NCT01525550|5818519|P2|STARTED|Overall Study||45
2371134|NCT01525550|5818520|P1|STARTED|Overall Study||61
2371135|NCT01525420|5818582|P2|NOT COMPLETED|Overall Study||24
2371136|NCT01525420|5818583|P1|NOT COMPLETED|Overall Study||16
2371137|NCT01525420|5818582|P2|COMPLETED|Overall Study||38
2371138|NCT01525420|5818583|P1|COMPLETED|Overall Study||43
2371139|NCT01525420|5818582|P2|STARTED|Overall Study||62
2371140|NCT01525420|5818583|P1|STARTED|Overall Study||59
2371141|NCT01525407|5818591|P2|NOT COMPLETED|Overall Study||4
2371142|NCT01525407|5818592|P1|NOT COMPLETED|Overall Study||3
2371143|NCT01525407|5818591|P2|COMPLETED|Overall Study||38
2371144|NCT01525407|5818592|P1|COMPLETED|Overall Study||38
2371145|NCT01525407|5818591|P2|STARTED|Overall Study||42
2371146|NCT01525407|5818592|P1|STARTED|Overall Study||41
2371147|NCT01525329|5818608|P2|NOT COMPLETED|Overall Study||0
2371148|NCT01525329|5818609|P1|NOT COMPLETED|Overall Study||0
2371149|NCT01525329|5818608|P2|COMPLETED|Overall Study||14
2371150|NCT01525329|5818609|P1|COMPLETED|Overall Study||4
2371151|NCT01525329|5818608|P2|STARTED|Overall Study||14
2371152|NCT01525329|5818609|P1|STARTED|Overall Study||4
2371153|NCT01525238|5818624|P3|NOT COMPLETED|Overall Study||0
2371154|NCT01525238|5818625|P2|NOT COMPLETED|Overall Study||0
2371155|NCT01525238|5818626|P1|NOT COMPLETED|Overall Study||1
2371156|NCT01525238|5818624|P3|COMPLETED|Overall Study||8
2371157|NCT01525238|5818625|P2|COMPLETED|Overall Study||8
2371158|NCT01525238|5818626|P1|COMPLETED|Overall Study||7
2371159|NCT01525238|5818624|P3|STARTED|Overall Study||8
2371160|NCT01525238|5818625|P2|STARTED|Overall Study||8
2371161|NCT01525238|5818626|P1|STARTED|Overall Study||8
2371162|NCT01525225|5818691|P1|NOT COMPLETED|Treated||0
2371163|NCT01525225|5818691|P1|COMPLETED|Treated||2
2371164|NCT01525225|5818691|P1|STARTED|Treated||2
2371165|NCT01525225|5818691|P1|NOT COMPLETED|Enrollment||2
2371166|NCT01525225|5818691|P1|COMPLETED|Enrollment||2
2371167|NCT01525225|5818691|P1|STARTED|Enrollment||4
2371168|NCT01525173|5818698|P2|NOT COMPLETED|Overall Study||5
2371169|NCT01525173|5818699|P1|NOT COMPLETED|Overall Study||7
2371170|NCT01525173|5818698|P2|COMPLETED|Overall Study||62
2371171|NCT01525173|5818699|P1|COMPLETED|Overall Study||63
2371172|NCT01525173|5818698|P2|STARTED|Overall Study||67
2371173|NCT01525173|5818699|P1|STARTED|Overall Study||70
2371174|NCT01524991|5818705|P1|NOT COMPLETED|Overall Study||34
2371175|NCT01524991|5818705|P1|COMPLETED|Overall Study||2
2371176|NCT01524991|5818705|P1|STARTED|Overall Study||36
2371177|NCT01524978|5818723|P11|NOT COMPLETED|Overall Study||28
2371178|NCT01524978|5818724|P10|NOT COMPLETED|Overall Study||9
2371179|NCT01524978|5818725|P9|NOT COMPLETED|Overall Study||12
2371180|NCT01524978|5818726|P8|NOT COMPLETED|Overall Study||12
2371181|NCT01524978|5818727|P7|NOT COMPLETED|Overall Study||26
2371182|NCT01524978|5818728|P6|NOT COMPLETED|Overall Study||9
2371183|NCT01524978|5818729|P5|NOT COMPLETED|Overall Study||9
2371184|NCT01524978|5818730|P4|NOT COMPLETED|Overall Study||27
2371185|NCT01524978|5818731|P3|NOT COMPLETED|Overall Study||10
2371186|NCT01524978|5818732|P2|NOT COMPLETED|Overall Study||4
2371187|NCT01524978|5818733|P1|NOT COMPLETED|Overall Study||62
2371188|NCT01524978|5818723|P11|COMPLETED|Overall Study||0
2371189|NCT01524978|5818724|P10|COMPLETED|Overall Study||0
2371190|NCT01524978|5818725|P9|COMPLETED|Overall Study||0
2371191|NCT01524978|5818726|P8|COMPLETED|Overall Study||0
2371192|NCT01524978|5818727|P7|COMPLETED|Overall Study||0
2371193|NCT01524978|5818728|P6|COMPLETED|Overall Study||0
2371194|NCT01524978|5818729|P5|COMPLETED|Overall Study||0
2371195|NCT01524978|5818730|P4|COMPLETED|Overall Study||0
2371196|NCT01524978|5818731|P3|COMPLETED|Overall Study||0
2371197|NCT01524978|5818732|P2|COMPLETED|Overall Study||0
2371198|NCT01524978|5818733|P1|COMPLETED|Overall Study||0
2371199|NCT01524978|5818723|P11|STARTED|Overall Study||28
2371200|NCT01524978|5818724|P10|STARTED|Overall Study||9
2371201|NCT01524978|5818725|P9|STARTED|Overall Study||12
2371202|NCT01524978|5818726|P8|STARTED|Overall Study||12
2371203|NCT01524978|5818727|P7|STARTED|Overall Study||26
2371204|NCT01524978|5818728|P6|STARTED|Overall Study||9
2371205|NCT01524978|5818729|P5|STARTED|Overall Study||9
2371206|NCT01524978|5818730|P4|STARTED|Overall Study||27
2371207|NCT01524978|5818731|P3|STARTED|Overall Study||10
2371208|NCT01524978|5818732|P2|STARTED|Overall Study||4
2371209|NCT01524978|5818733|P1|STARTED|Overall Study||62
2371210|NCT01524913|5818861|P3|NOT COMPLETED|Overall Study||0
2371211|NCT01524913|5818862|P2|NOT COMPLETED|Overall Study||0
2371212|NCT01524913|5818863|P1|NOT COMPLETED|Overall Study||4
2371213|NCT01524913|5818861|P3|COMPLETED|Overall Study||31
2371214|NCT01524913|5818862|P2|COMPLETED|Overall Study||36
2371215|NCT01524913|5818863|P1|COMPLETED|Overall Study||31
2371216|NCT01524913|5818861|P3|STARTED|Overall Study||31
2371217|NCT01524913|5818862|P2|STARTED|Overall Study||36
2371218|NCT01524913|5818863|P1|STARTED|Overall Study||35
2371219|NCT01524900|5818885|P5|NOT COMPLETED|Overall Study||0
2371220|NCT01524900|5818886|P4|NOT COMPLETED|Overall Study||1
2371221|NCT01524900|5818887|P3|NOT COMPLETED|Overall Study||1
2371222|NCT01524900|5818888|P2|NOT COMPLETED|Overall Study||14
2371223|NCT01524900|5818889|P1|NOT COMPLETED|Overall Study||6
2371224|NCT01524900|5818885|P5|COMPLETED|Overall Study||40
2371225|NCT01524900|5818886|P4|COMPLETED|Overall Study||21
2371226|NCT01524900|5818887|P3|COMPLETED|Overall Study||29
2371227|NCT01524900|5818888|P2|COMPLETED|Overall Study||232
2371228|NCT01524900|5818889|P1|COMPLETED|Overall Study||43
2371229|NCT01524900|5818885|P5|STARTED|Overall Study||40
2371230|NCT01524900|5818886|P4|STARTED|Overall Study||22
2371231|NCT01524900|5818887|P3|STARTED|Overall Study||30
2371232|NCT01524900|5818888|P2|STARTED|Overall Study||246
2371233|NCT01524900|5818889|P1|STARTED|Overall Study||49
2371234|NCT01524887|5818934|P3|NOT COMPLETED|Overall Study||86
2371235|NCT01524887|5818935|P2|NOT COMPLETED|Overall Study||90
2371236|NCT01524887|5818936|P1|NOT COMPLETED|Overall Study||85
2371237|NCT01524887|5818934|P3|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
2371238|NCT01524887|5818935|P2|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
2371239|NCT01524887|5818936|P1|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
2371240|NCT01524887|5818934|P3|Received Treatment|Overall Study||83
2371241|NCT01524887|5818935|P2|Received Treatment|Overall Study||85
2371242|NCT01524887|5818936|P1|Received Treatment|Overall Study||83
2371243|NCT01524887|5818934|P3|STARTED|Overall Study||86
2371244|NCT01524887|5818935|P2|STARTED|Overall Study||90
2371245|NCT01524887|5818936|P1|STARTED|Overall Study||85
2371246|NCT01524796|5818980|P1|NOT COMPLETED|Overall Study||28
2371247|NCT01524796|5818980|P1|COMPLETED|Overall Study||100
2371248|NCT01524796|5818980|P1|STARTED|Overall Study||128
2371249|NCT01524783|5818995|P2|NOT COMPLETED|Randomized and Treated||84
2371250|NCT01524783|5818996|P1|NOT COMPLETED|Randomized and Treated||155
2371251|NCT01524783|5818995|P2|COMPLETED|Randomized and Treated|Completed = Patients with ongoing treatment at the time of data cut-off of 28-Nov-2014.|13
2371252|NCT01524783|5818996|P1|COMPLETED|Randomized and Treated|Completed = Patients with ongoing treatment at the time of data cut-off of 28-Nov-2014.|48
2371253|NCT01524783|5818995|P2|STARTED|Randomized and Treated||97
2371254|NCT01524783|5818996|P1|STARTED|Randomized and Treated||203
2371255|NCT01524783|5818995|P2|NOT COMPLETED|Randomized But Not Treated||0
2371256|NCT01524783|5818996|P1|NOT COMPLETED|Randomized But Not Treated||2
2371257|NCT01524783|5818995|P2|COMPLETED|Randomized But Not Treated|Completed = Participants randomized and treated with study drug|97
2371258|NCT01524783|5818996|P1|COMPLETED|Randomized But Not Treated|Completed = Participants randomized and treated with study drug|203
2371259|NCT01524783|5818995|P2|STARTED|Randomized But Not Treated||97
2371260|NCT01524783|5818996|P1|STARTED|Randomized But Not Treated||205
2371261|NCT01524770|5819004|P2|NOT COMPLETED|Second Intervention||0
2371262|NCT01524770|5819005|P1|NOT COMPLETED|Second Intervention||0
2371263|NCT01524770|5819004|P2|COMPLETED|Second Intervention||23
2371264|NCT01524770|5819005|P1|COMPLETED|Second Intervention||23
2371265|NCT01524770|5819004|P2|STARTED|Second Intervention||23
2371266|NCT01524770|5819005|P1|STARTED|Second Intervention||23
2371267|NCT01524770|5819004|P2|NOT COMPLETED|Washout Period of at Least 28 Days||0
2371268|NCT01524770|5819005|P1|NOT COMPLETED|Washout Period of at Least 28 Days||0
2371269|NCT01524770|5819004|P2|COMPLETED|Washout Period of at Least 28 Days||23
2371270|NCT01524770|5819005|P1|COMPLETED|Washout Period of at Least 28 Days||23
2371271|NCT01524770|5819004|P2|STARTED|Washout Period of at Least 28 Days||23
2371272|NCT01524770|5819005|P1|STARTED|Washout Period of at Least 28 Days||23
2371273|NCT01524770|5819004|P2|NOT COMPLETED|First Intervention||1
2371274|NCT01524770|5819005|P1|NOT COMPLETED|First Intervention||3
2371275|NCT01524770|5819004|P2|COMPLETED|First Intervention||23
2371276|NCT01524770|5819005|P1|COMPLETED|First Intervention||23
2371277|NCT01524770|5819004|P2|Received at Least 1 Dose of Study Drug|First Intervention||24
2371278|NCT01524770|5819005|P1|Received at Least 1 Dose of Study Drug|First Intervention||26
2371279|NCT01524770|5819004|P2|STARTED|First Intervention||24
2371280|NCT01524770|5819005|P1|STARTED|First Intervention||26
2371281|NCT01524692|5819015|P1|NOT COMPLETED|Overall Study||3
2371282|NCT01524692|5819015|P1|COMPLETED|Overall Study||32
2371283|NCT01524692|5819015|P1|STARTED|Overall Study||35
2371290|NCT01524627|5819038|P2|NOT COMPLETED|Overall Study||2
2371291|NCT01524627|5819039|P1|NOT COMPLETED|Overall Study||1
2371292|NCT01524627|5819038|P2|COMPLETED|Overall Study||19
2371293|NCT01524627|5819039|P1|COMPLETED|Overall Study||21
2371294|NCT01524627|5819038|P2|STARTED|Overall Study||21
2371295|NCT01524627|5819039|P1|STARTED|Overall Study||22
2371296|NCT01524302|5819047|P2|NOT COMPLETED|Overall Study||0
2371297|NCT01524302|5819048|P1|NOT COMPLETED|Overall Study||0
2371298|NCT01524302|5819047|P2|COMPLETED|Overall Study||6
2371299|NCT01524302|5819048|P1|COMPLETED|Overall Study||6
2371300|NCT01524302|5819047|P2|STARTED|Overall Study||6
2371301|NCT01524302|5819048|P1|STARTED|Overall Study||6
2371302|NCT01524289|5819066|P2|NOT COMPLETED|Overall Study||14
2371303|NCT01524289|5819067|P1|NOT COMPLETED|Overall Study||30
2371304|NCT01524289|5819066|P2|COMPLETED|Overall Study||88
2371305|NCT01524289|5819067|P1|COMPLETED|Overall Study||174
2371306|NCT01524289|5819066|P2|Treated|Overall Study||102
2371307|NCT01524289|5819067|P1|Treated|Overall Study||203
2371308|NCT01524289|5819066|P2|STARTED|Overall Study||102
2371309|NCT01524289|5819067|P1|STARTED|Overall Study||204
2371310|NCT01524224|5819125|P8|NOT COMPLETED|Overall Study||6
2371311|NCT01524224|5819126|P7|NOT COMPLETED|Overall Study||3
2371312|NCT01524224|5819127|P6|NOT COMPLETED|Overall Study||2
2371313|NCT01524224|5819128|P5|NOT COMPLETED|Overall Study||4
2371314|NCT01524224|5819129|P4|NOT COMPLETED|Overall Study||2
2371315|NCT01524224|5819130|P3|NOT COMPLETED|Overall Study||2
2371316|NCT01524224|5819131|P2|NOT COMPLETED|Overall Study||1
2371317|NCT01524224|5819132|P1|NOT COMPLETED|Overall Study||3
2371318|NCT01524224|5819125|P8|COMPLETED|Overall Study||0
2371319|NCT01524224|5819126|P7|COMPLETED|Overall Study||0
2371320|NCT01524224|5819127|P6|COMPLETED|Overall Study||1
2371321|NCT01524224|5819128|P5|COMPLETED|Overall Study||0
2371322|NCT01524224|5819129|P4|COMPLETED|Overall Study||1
2371323|NCT01524224|5819130|P3|COMPLETED|Overall Study||1
2371324|NCT01524224|5819131|P2|COMPLETED|Overall Study||2
2371325|NCT01524224|5819132|P1|COMPLETED|Overall Study||1
2371326|NCT01524224|5819125|P8|Received at Least One Dose of Study Drug|Overall Study||6
2371327|NCT01524224|5819126|P7|Received at Least One Dose of Study Drug|Overall Study||3
2371328|NCT01524224|5819127|P6|Received at Least One Dose of Study Drug|Overall Study||3
2371329|NCT01524224|5819128|P5|Received at Least One Dose of Study Drug|Overall Study||4
2371330|NCT01524224|5819129|P4|Received at Least One Dose of Study Drug|Overall Study||3
2371331|NCT01524224|5819130|P3|Received at Least One Dose of Study Drug|Overall Study||3
2371332|NCT01524224|5819131|P2|Received at Least One Dose of Study Drug|Overall Study||3
2371333|NCT01524224|5819132|P1|Received at Least One Dose of Study Drug|Overall Study||4
2371334|NCT01524224|5819125|P8|STARTED|Overall Study||6
2371335|NCT01524224|5819126|P7|STARTED|Overall Study||3
2371336|NCT01524224|5819127|P6|STARTED|Overall Study||3
2371337|NCT01524224|5819128|P5|STARTED|Overall Study||4
2371338|NCT01524224|5819129|P4|STARTED|Overall Study||3
2371339|NCT01524224|5819130|P3|STARTED|Overall Study||3
2371340|NCT01524224|5819131|P2|STARTED|Overall Study||3
2371341|NCT01524224|5819132|P1|STARTED|Overall Study||4
2371342|NCT01524198|5819168|P2|NOT COMPLETED|Overall Study||16
2371343|NCT01524198|5819169|P1|NOT COMPLETED|Overall Study||23
2371344|NCT01524198|5819168|P2|COMPLETED|Overall Study||458
2371345|NCT01524198|5819169|P1|COMPLETED|Overall Study||448
2371346|NCT01524198|5819168|P2|STARTED|Overall Study||474
2371347|NCT01524198|5819169|P1|STARTED|Overall Study||471
2371348|NCT01524133|5819180|P3|NOT COMPLETED|Overall Study 52 Weeks||27
2371349|NCT01524133|5819181|P2|NOT COMPLETED|Overall Study 52 Weeks||20
2371350|NCT01524133|5819182|P1|NOT COMPLETED|Overall Study 52 Weeks||21
2371351|NCT01524133|5819180|P3|COMPLETED|Overall Study 52 Weeks||40
2371352|NCT01524133|5819181|P2|COMPLETED|Overall Study 52 Weeks||49
2371353|NCT01524133|5819182|P1|COMPLETED|Overall Study 52 Weeks||50
2371354|NCT01524133|5819180|P3|STARTED|Overall Study 52 Weeks||67
2371355|NCT01524133|5819181|P2|STARTED|Overall Study 52 Weeks||69
2371356|NCT01524133|5819182|P1|STARTED|Overall Study 52 Weeks||71
2371357|NCT01524133|5819180|P3|NOT COMPLETED|Treatment Phase||36
2371358|NCT01524133|5819181|P2|NOT COMPLETED|Treatment Phase||32
2371359|NCT01524133|5819182|P1|NOT COMPLETED|Treatment Phase||19
2371360|NCT01524133|5819180|P3|COMPLETED|Treatment Phase|Completed both assigned treatments|31
2371361|NCT01524133|5819181|P2|COMPLETED|Treatment Phase|Completed Both Assigned Treatments|37
2371362|NCT01524133|5819182|P1|COMPLETED|Treatment Phase|Completed Both Assigned treatment|52
2371363|NCT01524133|5819180|P3|STARTED|Treatment Phase||67
2371364|NCT01524133|5819181|P2|STARTED|Treatment Phase||69
2371365|NCT01524133|5819182|P1|STARTED|Treatment Phase||71
2371366|NCT01523964|5819197|P4|NOT COMPLETED|Overall Study||0
2371367|NCT01523964|5819198|P3|NOT COMPLETED|Overall Study||0
2371368|NCT01523964|5819199|P2|NOT COMPLETED|Overall Study||0
2371369|NCT01523964|5819200|P1|NOT COMPLETED|Overall Study||0
2371370|NCT01523964|5819197|P4|COMPLETED|Overall Study||15
2371371|NCT01523964|5819198|P3|COMPLETED|Overall Study||16
2371372|NCT01523964|5819199|P2|COMPLETED|Overall Study||30
2371373|NCT01523964|5819200|P1|COMPLETED|Overall Study||31
2371374|NCT01523964|5819197|P4|STARTED|Overall Study||15
2371375|NCT01523964|5819198|P3|STARTED|Overall Study||16
2371376|NCT01523964|5819199|P2|STARTED|Overall Study||30
2371377|NCT01523964|5819200|P1|STARTED|Overall Study||31
2371378|NCT01523899|5819212|P2|NOT COMPLETED|Overall Study||0
2371379|NCT01523899|5819213|P1|NOT COMPLETED|Overall Study||0
2371380|NCT01523899|5819212|P2|COMPLETED|Overall Study||126
2371381|NCT01523899|5819213|P1|COMPLETED|Overall Study||126
2371382|NCT01523899|5819212|P2|STARTED|Overall Study||126
2371383|NCT01523899|5819213|P1|STARTED|Overall Study||126
2371384|NCT01523886|5819225|P2|NOT COMPLETED|Overall Study||1
2371385|NCT01523886|5819226|P1|NOT COMPLETED|Overall Study||0
2371386|NCT01523886|5819225|P2|COMPLETED|Overall Study||23
2371387|NCT01523886|5819226|P1|COMPLETED|Overall Study||25
2371388|NCT01523886|5819225|P2|STARTED|Overall Study||24
2371389|NCT01523886|5819226|P1|STARTED|Overall Study||25
2371390|NCT01523873|5819232|P1|NOT COMPLETED|Overall Study||422
2371391|NCT01523873|5819232|P1|COMPLETED|Overall Study||35499
2371392|NCT01523873|5819232|P1|Administered With Dotarem|Overall Study||35474
2371393|NCT01523873|5819232|P1|STARTED|Overall Study||35921
2371394|NCT01523834|5819239|P1|NOT COMPLETED|Overall Study||31
2371395|NCT01523834|5819239|P1|COMPLETED|Overall Study||4
2371396|NCT01523834|5819239|P1|Maintenance Phase|Overall Study|Started Maintenance Phase|6
2371397|NCT01523834|5819239|P1|Consolidation Phase|Overall Study|Started Consolidation Phase|7
2371398|NCT01523834|5819239|P1|STARTED|Overall Study|Started Induction Phase|35
2371399|NCT01523821|5819250|P3|NOT COMPLETED|Overall Study||0
2371400|NCT01523821|5819251|P2|NOT COMPLETED|Overall Study||0
2371401|NCT01523821|5819252|P1|NOT COMPLETED|Overall Study||0
2371402|NCT01523821|5819250|P3|COMPLETED|Overall Study||6
2371403|NCT01523821|5819251|P2|COMPLETED|Overall Study||6
2371404|NCT01523821|5819252|P1|COMPLETED|Overall Study||8
2371405|NCT01523821|5819250|P3|STARTED|Overall Study||6
2371406|NCT01523821|5819251|P2|STARTED|Overall Study||6
2371407|NCT01523821|5819252|P1|STARTED|Overall Study||8
2371408|NCT01523782|5819278|P3|NOT COMPLETED|Overall Study||5
2371409|NCT01523782|5819279|P2|NOT COMPLETED|Overall Study||0
2371410|NCT01523782|5819280|P1|NOT COMPLETED|Overall Study||1
2371411|NCT01523782|5819278|P3|COMPLETED|Overall Study||9
2371412|NCT01523782|5819279|P2|COMPLETED|Overall Study||13
2371413|NCT01523782|5819280|P1|COMPLETED|Overall Study||2
2371414|NCT01523782|5819278|P3|STARTED|Overall Study||14
2371415|NCT01523782|5819279|P2|STARTED|Overall Study||13
2371416|NCT01523782|5819280|P1|STARTED|Overall Study||3
2371417|NCT01523756|5819327|P2|NOT COMPLETED|Test Period 2||1
2371418|NCT01523756|5819328|P1|NOT COMPLETED|Test Period 2||0
2371419|NCT01523756|5819327|P2|COMPLETED|Test Period 2||7
2371420|NCT01523756|5819328|P1|COMPLETED|Test Period 2||10
2371421|NCT01523756|5819327|P2|STARTED|Test Period 2||8
2371422|NCT01523756|5819328|P1|STARTED|Test Period 2||10
2371423|NCT01523756|5819327|P2|NOT COMPLETED|Test Period 1||0
2371424|NCT01523756|5819328|P1|NOT COMPLETED|Test Period 1||1
2371425|NCT01523756|5819327|P2|COMPLETED|Test Period 1||8
2371426|NCT01523756|5819328|P1|COMPLETED|Test Period 1||10
2371427|NCT01523756|5819327|P2|STARTED|Test Period 1||8
2371428|NCT01523756|5819328|P1|STARTED|Test Period 1||11
2371429|NCT01523756|5819327|P2|NOT COMPLETED|Baseline Period||1
2371430|NCT01523756|5819328|P1|NOT COMPLETED|Baseline Period||0
2371431|NCT01523756|5819327|P2|COMPLETED|Baseline Period||8
2371432|NCT01523756|5819328|P1|COMPLETED|Baseline Period||11
2371433|NCT01523756|5819327|P2|STARTED|Baseline Period||9
2371434|NCT01523756|5819328|P1|STARTED|Baseline Period||11
2371435|NCT01523743|5819336|P2|NOT COMPLETED|Period 2||2
2371436|NCT01523743|5819337|P1|NOT COMPLETED|Period 2||1
2371437|NCT01523743|5819336|P2|COMPLETED|Period 2||58
2371438|NCT01523743|5819337|P1|COMPLETED|Period 2||52
2371439|NCT01523743|5819336|P2|STARTED|Period 2||60
2371440|NCT01523743|5819337|P1|STARTED|Period 2||53
2371441|NCT01523743|5819336|P2|NOT COMPLETED|Period 1||2
2371442|NCT01523743|5819337|P1|NOT COMPLETED|Period 1||10
2371443|NCT01523743|5819336|P2|COMPLETED|Period 1||60
2371444|NCT01523743|5819337|P1|COMPLETED|Period 1||53
2371445|NCT01523743|5819336|P2|STARTED|Period 1||62
2371446|NCT01523743|5819337|P1|STARTED|Period 1||63
2371447|NCT01523613|5819346|P3|NOT COMPLETED|Overall Study||12
2371448|NCT01523613|5819347|P2|NOT COMPLETED|Overall Study||5
2371449|NCT01523613|5819348|P1|NOT COMPLETED|Overall Study||7
2371450|NCT01523613|5819346|P3|COMPLETED|Overall Study|- 42 paired restorations (21R and 21F)|21
2371451|NCT01523613|5819347|P2|COMPLETED|Overall Study|- 25 single restorations (25F)|25
2371452|NCT01523613|5819348|P1|COMPLETED|Overall Study|- 23 single restorations (23R)|23
2371453|NCT01523613|5819346|P3|STARTED|Overall Study|- 66 paired restorations (33R + 33F)|33
2371454|NCT01523613|5819347|P2|STARTED|Overall Study|- 30 single restorations (30 F)|30
2371455|NCT01523613|5819348|P1|STARTED|Overall Study|- 30 single restorations (30 R)|30
2371456|NCT01523587|5819360|P2|NOT COMPLETED|Overall Study||397
2371457|NCT01523587|5819361|P1|NOT COMPLETED|Overall Study||398
2371458|NCT01523587|5819360|P2|COMPLETED|Overall Study||0
2371459|NCT01523587|5819361|P1|COMPLETED|Overall Study||0
2371460|NCT01523587|5819360|P2|Treated|Overall Study||395
2371461|NCT01523587|5819361|P1|Treated|Overall Study||392
2371462|NCT01523587|5819360|P2|STARTED|Overall Study||397
2371463|NCT01523587|5819361|P1|STARTED|Overall Study||398
2371464|NCT01523496|5819385|P4|NOT COMPLETED|Overall Study||3
2371465|NCT01523496|5819386|P3|NOT COMPLETED|Overall Study||12
2371466|NCT01523496|5819387|P2|NOT COMPLETED|Overall Study||4
2371467|NCT01523496|5819388|P1|NOT COMPLETED|Overall Study||10
2371468|NCT01523496|5819385|P4|COMPLETED|Overall Study||27
2371469|NCT01523496|5819386|P3|COMPLETED|Overall Study||46
2371470|NCT01523496|5819387|P2|COMPLETED|Overall Study||32
2371471|NCT01523496|5819388|P1|COMPLETED|Overall Study||56
2371472|NCT01523496|5819385|P4|STARTED|Overall Study||30
2371473|NCT01523496|5819386|P3|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|58
2371474|NCT01523496|5819387|P2|STARTED|Overall Study||36
2371475|NCT01523496|5819388|P1|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|66
2371476|NCT01523457|5819404|P2|NOT COMPLETED|Overall Study||2
2371477|NCT01523457|5819405|P1|NOT COMPLETED|Overall Study||7
2371478|NCT01523457|5819404|P2|COMPLETED|Overall Study||29
2371479|NCT01523457|5819405|P1|COMPLETED|Overall Study||37
2371480|NCT01523457|5819404|P2|STARTED|Overall Study||31
2371481|NCT01523457|5819405|P1|STARTED|Overall Study||44
2371482|NCT01523392|5819423|P2|NOT COMPLETED|Treatment Period 2||0
2371483|NCT01523392|5819424|P1|NOT COMPLETED|Treatment Period 2||0
2371484|NCT01523392|5819423|P2|COMPLETED|Treatment Period 2||14
2371485|NCT01523392|5819424|P1|COMPLETED|Treatment Period 2||17
2371486|NCT01523392|5819423|P2|STARTED|Treatment Period 2||14
2371487|NCT01523392|5819424|P1|STARTED|Treatment Period 2||17
2371488|NCT01523392|5819423|P2|NOT COMPLETED|Washout Period - 10 to 14 Days||0
2371489|NCT01523392|5819424|P1|NOT COMPLETED|Washout Period - 10 to 14 Days||1
2371490|NCT01523392|5819423|P2|COMPLETED|Washout Period - 10 to 14 Days||14
2371491|NCT01523392|5819424|P1|COMPLETED|Washout Period - 10 to 14 Days||17
2371492|NCT01523392|5819423|P2|STARTED|Washout Period - 10 to 14 Days||14
2371493|NCT01523392|5819424|P1|STARTED|Washout Period - 10 to 14 Days|1 patient did not complete 7-9 days of Period 1 treatment but continued in the Washout and Period 2|18
2371494|NCT01523392|5819423|P2|NOT COMPLETED|Treatment Period 1||0
2371495|NCT01523392|5819424|P1|NOT COMPLETED|Treatment Period 1||3
2371496|NCT01523392|5819423|P2|COMPLETED|Treatment Period 1||14
2371497|NCT01523392|5819424|P1|COMPLETED|Treatment Period 1||17
2371498|NCT01523392|5819423|P2|STARTED|Treatment Period 1||14
2371499|NCT01523392|5819424|P1|STARTED|Treatment Period 1||20
2371500|NCT01523366|5819440|P2|NOT COMPLETED|Treatment Period 2||0
2371501|NCT01523366|5819441|P1|NOT COMPLETED|Treatment Period 2||1
2371502|NCT01523366|5819440|P2|COMPLETED|Treatment Period 2||20
2371503|NCT01523366|5819441|P1|COMPLETED|Treatment Period 2||18
2371504|NCT01523366|5819440|P2|STARTED|Treatment Period 2||20
2371505|NCT01523366|5819441|P1|STARTED|Treatment Period 2||19
2371506|NCT01523366|5819440|P2|NOT COMPLETED|Washout Period - 10-14 Days||0
2371507|NCT01523366|5819441|P1|NOT COMPLETED|Washout Period - 10-14 Days||0
2371508|NCT01523366|5819440|P2|COMPLETED|Washout Period - 10-14 Days||20
2371509|NCT01523366|5819441|P1|COMPLETED|Washout Period - 10-14 Days||19
2371510|NCT01523366|5819440|P2|STARTED|Washout Period - 10-14 Days||20
2371511|NCT01523366|5819441|P1|STARTED|Washout Period - 10-14 Days||19
2371512|NCT01523366|5819440|P2|NOT COMPLETED|Treatment Period 1||0
2371513|NCT01523366|5819441|P1|NOT COMPLETED|Treatment Period 1||1
2371514|NCT01523366|5819440|P2|COMPLETED|Treatment Period 1||20
2371515|NCT01523366|5819441|P1|COMPLETED|Treatment Period 1||19
2371516|NCT01523366|5819440|P2|STARTED|Treatment Period 1||20
2371517|NCT01523366|5819441|P1|STARTED|Treatment Period 1||20
2371518|NCT01523301|5819457|P2|NOT COMPLETED|Overall Study||32
2371519|NCT01523301|5819458|P1|NOT COMPLETED|Overall Study||35
2371520|NCT01523301|5819457|P2|COMPLETED|Overall Study||164
2371521|NCT01523301|5819458|P1|COMPLETED|Overall Study||149
2371522|NCT01523301|5819457|P2|STARTED|Overall Study||196
2371523|NCT01523301|5819458|P1|STARTED|Overall Study||184
2371524|NCT01523275|5819478|P2|NOT COMPLETED|Overall Study||2
2371525|NCT01523275|5819479|P1|NOT COMPLETED|Overall Study||2
2371526|NCT01523275|5819478|P2|COMPLETED|Overall Study||7
2371527|NCT01523275|5819479|P1|COMPLETED|Overall Study||4
2371528|NCT01523275|5819478|P2|STARTED|Overall Study||9
2371529|NCT01523275|5819479|P1|STARTED|Overall Study||6
2371530|NCT01522976|5819492|P3|NOT COMPLETED|Overall Study||93
2371531|NCT01522976|5819493|P2|NOT COMPLETED|Overall Study||92
2371532|NCT01522976|5819494|P1|NOT COMPLETED|Overall Study||97
2371533|NCT01522976|5819492|P3|COMPLETED|Overall Study||0
2371534|NCT01522976|5819493|P2|COMPLETED|Overall Study||0
2371535|NCT01522976|5819494|P1|COMPLETED|Overall Study||0
2371536|NCT01522976|5819492|P3|STARTED|Overall Study||93
2371537|NCT01522976|5819493|P2|STARTED|Overall Study||92
2371538|NCT01522976|5819494|P1|STARTED|Overall Study||97
2371539|NCT01522963|5819521|P4|NOT COMPLETED|Overall Study||6
2371540|NCT01522963|5819522|P3|NOT COMPLETED|Overall Study||3
2371541|NCT01522963|5819523|P2|NOT COMPLETED|Overall Study||3
2371542|NCT01522963|5819524|P1|NOT COMPLETED|Overall Study||2
2371543|NCT01522963|5819521|P4|COMPLETED|Overall Study||18
2371544|NCT01522963|5819522|P3|COMPLETED|Overall Study||22
2371545|NCT01522963|5819523|P2|COMPLETED|Overall Study||22
2371546|NCT01522963|5819524|P1|COMPLETED|Overall Study||22
2371547|NCT01522963|5819521|P4|STARTED|Overall Study||24
2371548|NCT01522963|5819522|P3|STARTED|Overall Study||25
2371549|NCT01522963|5819523|P2|STARTED|Overall Study||25
2371550|NCT01522963|5819524|P1|STARTED|Overall Study||24
2371551|NCT01522950|5819539|P3|NOT COMPLETED|Overall Study||5
2371552|NCT01522950|5819540|P2|NOT COMPLETED|Overall Study||5
2371553|NCT01522950|5819541|P1|NOT COMPLETED|Overall Study||6
2371554|NCT01522950|5819539|P3|COMPLETED|Overall Study||22
2371555|NCT01522950|5819540|P2|COMPLETED|Overall Study||18
2371556|NCT01522950|5819541|P1|COMPLETED|Overall Study||20
2371557|NCT01522950|5819539|P3|STARTED|Overall Study||27
2371558|NCT01522950|5819540|P2|STARTED|Overall Study||23
2371559|NCT01522950|5819541|P1|STARTED|Overall Study||26
2371560|NCT01522937|5819558|P1|NOT COMPLETED|Overall Study||0
2371561|NCT01522937|5819558|P1|COMPLETED|Overall Study||146
2371562|NCT01522937|5819558|P1|STARTED|Overall Study||146
2371563|NCT01522924|5819568|P2|NOT COMPLETED|Overall Study||0
2371564|NCT01522924|5819569|P1|NOT COMPLETED|Overall Study||0
2371565|NCT01522924|5819568|P2|COMPLETED|Overall Study|There were 52 dental students who completed the second survey after the lecture.|52
2371566|NCT01522924|5819569|P1|COMPLETED|Overall Study|There were 42 dental students who completed the second survey after the intervention.|42
2371567|NCT01522924|5819568|P2|STARTED|Overall Study|There were 52 dental students in the control group.|52
2371568|NCT01522924|5819569|P1|STARTED|Overall Study|There were 42 dental students in the intervention group.|42
2371569|NCT01522755|5819587|P1|NOT COMPLETED|Overall Study||0
2371570|NCT01522755|5819587|P1|COMPLETED|Overall Study||409
2371571|NCT01522755|5819587|P1|STARTED|Overall Study||409
2371572|NCT01522703|5819597|P2|NOT COMPLETED|Overall Study||6
2371573|NCT01522703|5819598|P1|NOT COMPLETED|Overall Study||5
2371574|NCT01522703|5819597|P2|COMPLETED|Overall Study||20
2371575|NCT01522703|5819598|P1|COMPLETED|Overall Study||20
2371576|NCT01522703|5819597|P2|STARTED|Overall Study||26
2371577|NCT01522703|5819598|P1|STARTED|Overall Study||25
2371578|NCT01522456|5819604|P1|NOT COMPLETED|Overall Study||8
2371579|NCT01522456|5819604|P1|COMPLETED|Overall Study||65
2371580|NCT01522456|5819604|P1|STARTED|Overall Study||73
2371581|NCT01522443|5819667|P2|NOT COMPLETED|Overall Study||55
2371582|NCT01522443|5819668|P1|NOT COMPLETED|Overall Study||53
2371583|NCT01522443|5819667|P2|COMPLETED|Overall Study||3
2371584|NCT01522443|5819668|P1|COMPLETED|Overall Study||8
2371585|NCT01522443|5819667|P2|STARTED|Overall Study||58
2371586|NCT01522443|5819668|P1|STARTED|Overall Study||61
2371587|NCT01522404|5819680|P2|NOT COMPLETED|Second Intervention (up to Week 58)||0
2371588|NCT01522404|5819681|P1|NOT COMPLETED|Second Intervention (up to Week 58)||1
2371589|NCT01522404|5819680|P2|COMPLETED|Second Intervention (up to Week 58)||19
2371590|NCT01522404|5819681|P1|COMPLETED|Second Intervention (up to Week 58)||17
2371591|NCT01522404|5819680|P2|STARTED|Second Intervention (up to Week 58)||19
2371592|NCT01522404|5819681|P1|STARTED|Second Intervention (up to Week 58)||18
2371593|NCT01522404|5819680|P2|NOT COMPLETED|First Intervention (up to Week 29)||0
2371594|NCT01522404|5819681|P1|NOT COMPLETED|First Intervention (up to Week 29)||2
2371595|NCT01522404|5819680|P2|COMPLETED|First Intervention (up to Week 29)||19
2371596|NCT01522404|5819681|P1|COMPLETED|First Intervention (up to Week 29)||18
2371597|NCT01522404|5819680|P2|STARTED|First Intervention (up to Week 29)||19
2371598|NCT01522404|5819681|P1|STARTED|First Intervention (up to Week 29)||20
2371599|NCT01522391|5819699|P2|NOT COMPLETED|Overall Study||1
2371600|NCT01522391|5819700|P1|NOT COMPLETED|Overall Study||1
2371601|NCT01522391|5819699|P2|COMPLETED|Overall Study||20
2371602|NCT01522391|5819700|P1|COMPLETED|Overall Study||19
2371603|NCT01522391|5819699|P2|STARTED|Overall Study||21
2371604|NCT01522391|5819700|P1|STARTED|Overall Study||20
2371605|NCT01522339|5819760|P1|NOT COMPLETED|Overall Study||0
2371606|NCT01522339|5819760|P1|COMPLETED|Overall Study||15
2371607|NCT01522339|5819760|P1|STARTED|Overall Study||15
2371608|NCT01522248|5819767|P2|NOT COMPLETED|Overall Study||0
2371609|NCT01522248|5819768|P1|NOT COMPLETED|Overall Study||1
2371610|NCT01522248|5819767|P2|COMPLETED|Overall Study||10
2371611|NCT01522248|5819768|P1|COMPLETED|Overall Study||9
2371612|NCT01522248|5819767|P2|STARTED|Overall Study||10
2371613|NCT01522248|5819768|P1|STARTED|Overall Study||10
2371614|NCT01522235|5819783|P2|NOT COMPLETED|Overall Study||1
2371615|NCT01522235|5819784|P1|NOT COMPLETED|Overall Study||1
2371616|NCT01522235|5819783|P2|COMPLETED|Overall Study||2
2371617|NCT01522235|5819784|P1|COMPLETED|Overall Study||2
2371618|NCT01522235|5819783|P2|Randomized|Overall Study||3
2371619|NCT01522235|5819784|P1|Randomized|Overall Study||2
2371620|NCT01522235|5819783|P2|STARTED|Overall Study||3
2371621|NCT01522235|5819784|P1|STARTED|Overall Study||3
2371622|NCT01522131|5819802|P2|NOT COMPLETED|Overall Study||0
2371623|NCT01522131|5819803|P1|NOT COMPLETED|Overall Study||2
2371624|NCT01522131|5819802|P2|COMPLETED|Overall Study||17
2371625|NCT01522131|5819803|P1|COMPLETED|Overall Study||14
2371626|NCT01522131|5819802|P2|STARTED|Overall Study||17
2371627|NCT01522131|5819803|P1|STARTED|Overall Study||16
2371628|NCT01521949|5819811|P1|NOT COMPLETED|Overall Study||0
2371629|NCT01521949|5819811|P1|COMPLETED|Overall Study||21
2371630|NCT01521949|5819811|P1|STARTED|Overall Study||21
2371631|NCT01521923|5819820|P4|NOT COMPLETED|Overall Study||13
2371632|NCT01521923|5819821|P3|NOT COMPLETED|Overall Study||15
2371633|NCT01521923|5819822|P2|NOT COMPLETED|Overall Study||9
2371634|NCT01521923|5819823|P1|NOT COMPLETED|Overall Study||7
2371635|NCT01521923|5819820|P4|COMPLETED|Overall Study||70
2371636|NCT01521923|5819821|P3|COMPLETED|Overall Study||112
2371637|NCT01521923|5819822|P2|COMPLETED|Overall Study||72
2371638|NCT01521923|5819823|P1|COMPLETED|Overall Study||59
2371639|NCT01521923|5819820|P4|STARTED|Overall Study||83
2371640|NCT01521923|5819821|P3|STARTED|Overall Study||127
2371641|NCT01521923|5819822|P2|STARTED|Overall Study||81
2371642|NCT01521923|5819823|P1|STARTED|Overall Study||66
2371643|NCT01521897|5819943|P1|NOT COMPLETED|Overall Study||23
2371644|NCT01521897|5819943|P1|COMPLETED|Overall Study||1120
2371645|NCT01521897|5819943|P1|STARTED|Overall Study||1143
2371646|NCT01521884|5819955|P1|NOT COMPLETED|Overall Study||27
2371647|NCT01521884|5819955|P1|COMPLETED|Overall Study||35
2371648|NCT01521884|5819955|P1|STARTED|Overall Study||62
2371649|NCT01521871|5819974|P2|NOT COMPLETED|Overall Study||0
2371650|NCT01521871|5819975|P1|NOT COMPLETED|Overall Study||0
2371651|NCT01521871|5819974|P2|COMPLETED|Overall Study||32
2371652|NCT01521871|5819975|P1|COMPLETED|Overall Study||32
2371653|NCT01521871|5819974|P2|STARTED|Overall Study||32
2371654|NCT01521871|5819975|P1|STARTED|Overall Study||32
2371655|NCT01521845|5820015|P2|NOT COMPLETED|Overall Study||5
2371656|NCT01521845|5820016|P1|NOT COMPLETED|Overall Study||9
2371657|NCT01521845|5820015|P2|COMPLETED|Overall Study||47
2371658|NCT01521845|5820016|P1|COMPLETED|Overall Study||43
2371659|NCT01521845|5820015|P2|STARTED|Overall Study||52
2371660|NCT01521845|5820016|P1|STARTED|Overall Study||52
2371661|NCT01521780|5820026|P3|NOT COMPLETED|Overall Study||0
2371662|NCT01521780|5820027|P2|NOT COMPLETED|Overall Study||0
2371663|NCT01521780|5820028|P1|NOT COMPLETED|Overall Study||0
2371664|NCT01521780|5820026|P3|COMPLETED|Overall Study||2
2371665|NCT01521780|5820027|P2|COMPLETED|Overall Study||1
2371666|NCT01521780|5820028|P1|COMPLETED|Overall Study||9
2371667|NCT01521780|5820026|P3|STARTED|Overall Study||2
2371668|NCT01521780|5820027|P2|STARTED|Overall Study||1
2371669|NCT01521780|5820028|P1|STARTED|Overall Study||9
2371670|NCT01521559|5820052|P2|NOT COMPLETED|Overall Study||18
2371671|NCT01521559|5820053|P1|NOT COMPLETED|Overall Study||15
2371672|NCT01521559|5820052|P2|COMPLETED|Overall Study||73
2371673|NCT01521559|5820053|P1|COMPLETED|Overall Study||77
2371674|NCT01521559|5820052|P2|Completed Week 52|Overall Study||73
2371675|NCT01521559|5820053|P1|Completed Week 52|Overall Study||77
2371676|NCT01521559|5820052|P2|Completed Week 24|Overall Study||85
2371677|NCT01521559|5820053|P1|Completed Week 24|Overall Study||83
2371678|NCT01521559|5820052|P2|STARTED|Overall Study||91
2371679|NCT01521559|5820053|P1|STARTED|Overall Study||92
2371680|NCT01521546|5820067|P2|NOT COMPLETED|Overall Study||0
2371681|NCT01521546|5820068|P1|NOT COMPLETED|Overall Study||2
2371682|NCT01521546|5820067|P2|COMPLETED|Overall Study||20
2371683|NCT01521546|5820068|P1|COMPLETED|Overall Study||20
2371684|NCT01521546|5820067|P2|STARTED|Overall Study||20
2371685|NCT01521546|5820068|P1|STARTED|Overall Study||22
2371686|NCT01521507|5820076|P2|NOT COMPLETED|Stage 2: Observational Design||2
2371687|NCT01521507|5820077|P1|NOT COMPLETED|Stage 2: Observational Design||4
2371688|NCT01521507|5820076|P2|COMPLETED|Stage 2: Observational Design||92
2371689|NCT01521507|5820077|P1|COMPLETED|Stage 2: Observational Design||94
2371690|NCT01521507|5820076|P2|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||1
2371691|NCT01521507|5820077|P1|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||2
2371692|NCT01521507|5820076|P2|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||9
2371693|NCT01521507|5820077|P1|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||11
2371694|NCT01521507|5820076|P2|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||82
2371695|NCT01521507|5820077|P1|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||81
2371696|NCT01521507|5820076|P2|Received Crossover LipiFlow Tx|Stage 2: Observational Design||93
2371697|NCT01521507|5820077|P1|Received Crossover LipiFlow Tx|Stage 2: Observational Design||0
2371698|NCT01521507|5820076|P2|STARTED|Stage 2: Observational Design||94
2371699|NCT01521507|5820077|P1|STARTED|Stage 2: Observational Design||98
2371700|NCT01521507|5820076|P2|NOT COMPLETED|Stage 1: Randomized Design||5
2371701|NCT01521507|5820077|P1|NOT COMPLETED|Stage 1: Randomized Design||3
2371702|NCT01521507|5820076|P2|COMPLETED|Stage 1: Randomized Design||94
2371703|NCT01521507|5820077|P1|COMPLETED|Stage 1: Randomized Design||98
2371704|NCT01521507|5820076|P2|Received Initial Treatment (Tx)|Stage 1: Randomized Design||98
2371705|NCT01521507|5820077|P1|Received Initial Treatment (Tx)|Stage 1: Randomized Design||99
2371706|NCT01521507|5820076|P2|STARTED|Stage 1: Randomized Design||99
2371707|NCT01521507|5820077|P1|STARTED|Stage 1: Randomized Design||101
2371708|NCT01521494|5820099|P5|NOT COMPLETED|Overall Study||7
2371709|NCT01521494|5820100|P4|NOT COMPLETED|Overall Study||21
2371710|NCT01521494|5820101|P3|NOT COMPLETED|Overall Study||12
2371711|NCT01521494|5820102|P2|NOT COMPLETED|Overall Study||5
2371712|NCT01521494|5820103|P1|NOT COMPLETED|Overall Study||2
2371713|NCT01521494|5820099|P5|COMPLETED|Overall Study||30
2371714|NCT01521494|5820100|P4|COMPLETED|Overall Study||15
2371715|NCT01521494|5820101|P3|COMPLETED|Overall Study||23
2371716|NCT01521494|5820102|P2|COMPLETED|Overall Study||31
2371717|NCT01521494|5820103|P1|COMPLETED|Overall Study||37
2371718|NCT01521494|5820099|P5|STARTED|Overall Study||37
2371719|NCT01521494|5820100|P4|STARTED|Overall Study||36
2371720|NCT01521494|5820101|P3|STARTED|Overall Study||35
2371721|NCT01521494|5820102|P2|STARTED|Overall Study||36
2371722|NCT01521494|5820103|P1|STARTED|Overall Study||39
2371723|NCT01521364|5820125|P1|NOT COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||1
2371724|NCT01521364|5820125|P1|COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||5
2371725|NCT01521364|5820125|P1|STARTED|Linezolid + 500mg Claritromycin (wk 4&5)||6
2371726|NCT01521364|5820125|P1|NOT COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||1
2371727|NCT01521364|5820125|P1|COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||6
2371728|NCT01521364|5820125|P1|STARTED|Linezolid + 250mg Claritromycin (wk 2&3)||7
2371729|NCT01521364|5820125|P1|NOT COMPLETED|Linezolid Without Clarithromycin (1 wk)||0
2371730|NCT01521364|5820125|P1|COMPLETED|Linezolid Without Clarithromycin (1 wk)||7
2371731|NCT01521364|5820125|P1|STARTED|Linezolid Without Clarithromycin (1 wk)||7
2371732|NCT01521260|5820138|P2|NOT COMPLETED|Overall Study||0
2371733|NCT01521260|5820139|P1|NOT COMPLETED|Overall Study||0
2371734|NCT01521260|5820138|P2|COMPLETED|Overall Study||15
2371735|NCT01521260|5820139|P1|COMPLETED|Overall Study||15
2371736|NCT01521260|5820138|P2|STARTED|Overall Study||15
2371737|NCT01521260|5820139|P1|STARTED|Overall Study||15
2371738|NCT01521143|5820149|P4|NOT COMPLETED|Overall Study||7
2371739|NCT01521143|5820150|P3|NOT COMPLETED|Overall Study||8
2371740|NCT01521143|5820151|P2|NOT COMPLETED|Overall Study||26
2371741|NCT01521143|5820152|P1|NOT COMPLETED|Overall Study||29
2371742|NCT01521143|5820149|P4|COMPLETED|Overall Study||0
2371743|NCT01521143|5820150|P3|COMPLETED|Overall Study||0
2371744|NCT01521143|5820151|P2|COMPLETED|Overall Study||10
2371745|NCT01521143|5820152|P1|COMPLETED|Overall Study||11
2371746|NCT01521143|5820149|P4|Received Treatment|Overall Study||4
2371747|NCT01521143|5820150|P3|Received Treatment|Overall Study||3
2371748|NCT01521143|5820151|P2|Received Treatment|Overall Study||20
2371749|NCT01521143|5820152|P1|Received Treatment|Overall Study||20
2371750|NCT01521143|5820149|P4|STARTED|Overall Study||7
2371751|NCT01521143|5820150|P3|STARTED|Overall Study||8
2371752|NCT01521143|5820151|P2|STARTED|Overall Study||36
2371753|NCT01521143|5820152|P1|STARTED|Overall Study||40
2371754|NCT01521026|5820184|P2|NOT COMPLETED|Overall Study||3
2371755|NCT01521026|5820185|P1|NOT COMPLETED|Overall Study||15
2371756|NCT01521026|5820184|P2|COMPLETED|Overall Study||28
2371757|NCT01521026|5820185|P1|COMPLETED|Overall Study||23
2371758|NCT01521026|5820184|P2|STARTED|Overall Study||31
2371759|NCT01521026|5820185|P1|STARTED|Overall Study||38
2371760|NCT01520987|5820201|P8|NOT COMPLETED|Overall Study||0
2371761|NCT01520987|5820202|P7|NOT COMPLETED|Overall Study||0
2371762|NCT01520987|5820203|P6|NOT COMPLETED|Overall Study||1
2371763|NCT01520987|5820204|P5|NOT COMPLETED|Overall Study||0
2371764|NCT01520987|5820205|P4|NOT COMPLETED|Overall Study||0
2371765|NCT01520987|5820206|P3|NOT COMPLETED|Overall Study||0
2371766|NCT01520987|5820207|P2|NOT COMPLETED|Overall Study||0
2371767|NCT01520987|5820208|P1|NOT COMPLETED|Overall Study||1
2371768|NCT01520987|5820201|P8|COMPLETED|Overall Study||14
2371769|NCT01520987|5820202|P7|COMPLETED|Overall Study||12
2371770|NCT01520987|5820203|P6|COMPLETED|Overall Study||13
2371771|NCT01520987|5820204|P5|COMPLETED|Overall Study||14
2371772|NCT01520987|5820205|P4|COMPLETED|Overall Study||15
2371773|NCT01520987|5820206|P3|COMPLETED|Overall Study||11
2371774|NCT01520987|5820207|P2|COMPLETED|Overall Study||12
2371775|NCT01520987|5820208|P1|COMPLETED|Overall Study||12
2371776|NCT01520987|5820201|P8|Dosed|Overall Study||14
2371777|NCT01520987|5820202|P7|Dosed|Overall Study||12
2371778|NCT01520987|5820203|P6|Dosed|Overall Study||14
2371779|NCT01520987|5820204|P5|Dosed|Overall Study||14
2371780|NCT01520987|5820205|P4|Dosed|Overall Study||15
2371781|NCT01520987|5820206|P3|Dosed|Overall Study||11
2371782|NCT01520987|5820207|P2|Dosed|Overall Study||12
2371783|NCT01520987|5820208|P1|Dosed|Overall Study||13
2371784|NCT01520987|5820201|P8|STARTED|Overall Study||14
2371785|NCT01520987|5820202|P7|STARTED|Overall Study||12
2371786|NCT01520987|5820203|P6|STARTED|Overall Study||14
2371787|NCT01520987|5820204|P5|STARTED|Overall Study||14
2371788|NCT01520987|5820205|P4|STARTED|Overall Study||15
2371789|NCT01520987|5820206|P3|STARTED|Overall Study||11
2371790|NCT01520987|5820207|P2|STARTED|Overall Study||12
2371791|NCT01520987|5820208|P1|STARTED|Overall Study||13
2371792|NCT01520922|5820268|P2|NOT COMPLETED|Survival Follow-up||0
2371793|NCT01520922|5820269|P1|NOT COMPLETED|Survival Follow-up||1
2371794|NCT01520922|5820268|P2|COMPLETED|Survival Follow-up||40
2371795|NCT01520922|5820269|P1|COMPLETED|Survival Follow-up||20
2371796|NCT01520922|5820268|P2|STARTED|Survival Follow-up||40
2371797|NCT01520922|5820269|P1|STARTED|Survival Follow-up||21
2371798|NCT01520922|5820268|P2|NOT COMPLETED|Follow up||1
2371799|NCT01520922|5820269|P1|NOT COMPLETED|Follow up||0
2371800|NCT01520922|5820268|P2|COMPLETED|Follow up||44
2371801|NCT01520922|5820269|P1|COMPLETED|Follow up||44
2371802|NCT01520922|5820268|P2|STARTED|Follow up||45
2371803|NCT01520922|5820269|P1|STARTED|Follow up||44
2371804|NCT01520922|5820268|P2|NOT COMPLETED|Treatment Phase||8
2371805|NCT01520922|5820269|P1|NOT COMPLETED|Treatment Phase||5
2371806|NCT01520922|5820268|P2|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|45
2371807|NCT01520922|5820269|P1|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|39
2371808|NCT01520922|5820268|P2|STARTED|Treatment Phase||53
2371809|NCT01520922|5820269|P1|STARTED|Treatment Phase||44
2371810|NCT01520909|5820331|P3|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||7
2371811|NCT01520909|5820332|P2|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
2371812|NCT01520909|5820333|P1|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
2371813|NCT01520909|5820331|P3|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||80
2371814|NCT01520909|5820332|P2|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
2371815|NCT01520909|5820333|P1|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
2371816|NCT01520909|5820331|P3|STARTED|Part 2 (Open-Label Period)-Eltrombopag|Two participants that completed Part 1 did not start Part 2 because of lack of efficacy.|87
2371817|NCT01520909|5820332|P2|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
2371818|NCT01520909|5820333|P1|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
2371819|NCT01520909|5820331|P3|NOT COMPLETED|Part 1 (Randomized Period)||0
2371820|NCT01520909|5820332|P2|NOT COMPLETED|Part 1 (Randomized Period)||2
2371821|NCT01520909|5820333|P1|NOT COMPLETED|Part 1 (Randomized Period)||1
2371822|NCT01520909|5820331|P3|COMPLETED|Part 1 (Randomized Period)||0
2371823|NCT01520909|5820332|P2|COMPLETED|Part 1 (Randomized Period)||61
2371824|NCT01520909|5820333|P1|COMPLETED|Part 1 (Randomized Period)||28
2371825|NCT01520909|5820331|P3|STARTED|Part 1 (Randomized Period)||0
2371826|NCT01520909|5820332|P2|STARTED|Part 1 (Randomized Period)||63
2371827|NCT01520909|5820333|P1|STARTED|Part 1 (Randomized Period)||29
2371828|NCT01520727|5820404|P9|NOT COMPLETED|Overall Study||0
2371829|NCT01520727|5820405|P8|NOT COMPLETED|Overall Study||0
2371830|NCT01520727|5820406|P7|NOT COMPLETED|Overall Study||0
2371831|NCT01520727|5820407|P6|NOT COMPLETED|Overall Study||0
2371832|NCT01520727|5820408|P5|NOT COMPLETED|Overall Study||0
2371833|NCT01520727|5820409|P4|NOT COMPLETED|Overall Study||0
2371834|NCT01520727|5820410|P3|NOT COMPLETED|Overall Study||0
2371835|NCT01520727|5820411|P2|NOT COMPLETED|Overall Study||0
2371836|NCT01520727|5820412|P1|NOT COMPLETED|Overall Study||0
2371837|NCT01520727|5820404|P9|COMPLETED|Overall Study||16
2371838|NCT01520727|5820405|P8|COMPLETED|Overall Study||6
2371839|NCT01520727|5820406|P7|COMPLETED|Overall Study||6
2371840|NCT01520727|5820407|P6|COMPLETED|Overall Study||6
2371841|NCT01520727|5820408|P5|COMPLETED|Overall Study||6
2371842|NCT01520727|5820409|P4|COMPLETED|Overall Study||6
2371843|NCT01520727|5820410|P3|COMPLETED|Overall Study||6
2371844|NCT01520727|5820411|P2|COMPLETED|Overall Study||6
2371845|NCT01520727|5820412|P1|COMPLETED|Overall Study||6
2371846|NCT01520727|5820404|P9|STARTED|Overall Study||16
2371847|NCT01520727|5820405|P8|STARTED|Overall Study||6
2371848|NCT01520727|5820406|P7|STARTED|Overall Study||6
2371849|NCT01520727|5820407|P6|STARTED|Overall Study||6
2371850|NCT01520727|5820408|P5|STARTED|Overall Study||6
2371851|NCT01520727|5820409|P4|STARTED|Overall Study||6
2371852|NCT01520727|5820410|P3|STARTED|Overall Study||6
2371853|NCT01520727|5820411|P2|STARTED|Overall Study||6
2371854|NCT01520727|5820412|P1|STARTED|Overall Study||6
2371855|NCT01520714|5820450|P2|NOT COMPLETED|Overall Study||6
2371856|NCT01520714|5820451|P1|NOT COMPLETED|Overall Study||0
2371857|NCT01520714|5820450|P2|COMPLETED|Overall Study||5
2371858|NCT01520714|5820451|P1|COMPLETED|Overall Study||0
2371859|NCT01520714|5820450|P2|STARTED|Overall Study||11
2371860|NCT01520714|5820451|P1|STARTED|Overall Study||0
2371861|NCT01520558|5820460|P3|NOT COMPLETED|Overall Study||3
2371862|NCT01520558|5820461|P2|NOT COMPLETED|Overall Study||2
2371863|NCT01520558|5820462|P1|NOT COMPLETED|Overall Study||2
2371864|NCT01520558|5820460|P3|COMPLETED|Overall Study||3
2371865|NCT01520558|5820461|P2|COMPLETED|Overall Study||1
2371866|NCT01520558|5820462|P1|COMPLETED|Overall Study||1
2371867|NCT01520558|5820460|P3|STARTED|Overall Study||6
2371868|NCT01520558|5820461|P2|STARTED|Overall Study||3
2371869|NCT01520558|5820462|P1|STARTED|Overall Study||3
2371870|NCT01520532|5820470|P1|NOT COMPLETED|Overall Study||0
2371871|NCT01520532|5820470|P1|COMPLETED|Overall Study||60
2371872|NCT01520532|5820470|P1|STARTED|Overall Study|Subjects who underwent an ablation and had post-procedure MRI|60
2371873|NCT01520519|5820476|P1|NOT COMPLETED|Overall Study||0
2371874|NCT01520519|5820476|P1|COMPLETED|Overall Study||40
2371875|NCT01520519|5820476|P1|STARTED|Overall Study||40
2371876|NCT01520506|5820481|P1|NOT COMPLETED|Overall Study||6
2371877|NCT01520506|5820481|P1|COMPLETED|Overall Study||44
2371878|NCT01520506|5820481|P1|STARTED|Overall Study||50
2371879|NCT01520454|5820491|P4|NOT COMPLETED|Overall Study||0
2371880|NCT01520454|5820492|P3|NOT COMPLETED|Overall Study||0
2371881|NCT01520454|5820493|P2|NOT COMPLETED|Overall Study||0
2371882|NCT01520454|5820494|P1|NOT COMPLETED|Overall Study||0
2371883|NCT01520454|5820491|P4|COMPLETED|Overall Study||6
2371884|NCT01520454|5820492|P3|COMPLETED|Overall Study||5
2371885|NCT01520454|5820493|P2|COMPLETED|Overall Study||6
2371886|NCT01520454|5820494|P1|COMPLETED|Overall Study||9
2371887|NCT01520454|5820491|P4|STARTED|Overall Study||6
2371888|NCT01520454|5820492|P3|STARTED|Overall Study||5
2371889|NCT01520454|5820493|P2|STARTED|Overall Study||6
2371890|NCT01520454|5820494|P1|STARTED|Overall Study||9
2371891|NCT01520402|5820536|P1|NOT COMPLETED|Overall Study||5
2371892|NCT01520402|5820536|P1|COMPLETED|Overall Study||30
2371893|NCT01520402|5820536|P1|STARTED|Overall Study||35
2371894|NCT01520363|5820549|P2|NOT COMPLETED|Overall Study||0
2371895|NCT01520363|5820550|P1|NOT COMPLETED|Overall Study||2
2371896|NCT01520363|5820549|P2|COMPLETED|Overall Study||26
2371897|NCT01520363|5820550|P1|COMPLETED|Overall Study||24
2371898|NCT01520363|5820549|P2|STARTED|Overall Study||26
2371899|NCT01520363|5820550|P1|STARTED|Overall Study||26
2371900|NCT01520324|5820624|P1|NOT COMPLETED|Overall Study||1
2371901|NCT01520324|5820624|P1|COMPLETED|Overall Study||52
2371902|NCT01520324|5820624|P1|STARTED|Overall Study||53
2371903|NCT01520207|5820637|P2|NOT COMPLETED|Overall Study||0
2371904|NCT01520207|5820638|P1|NOT COMPLETED|Overall Study||2
2371905|NCT01520207|5820637|P2|COMPLETED|Overall Study||25
2371906|NCT01520207|5820638|P1|COMPLETED|Overall Study||25
2371907|NCT01520207|5820637|P2|STARTED|Overall Study||25
2371908|NCT01520207|5820638|P1|STARTED|Overall Study||27
2371909|NCT01520038|5820644|P1|NOT COMPLETED|Overall Study||1
2371910|NCT01520038|5820644|P1|COMPLETED|Overall Study||1
2371911|NCT01520038|5820644|P1|STARTED|Overall Study||2
2371912|NCT01519960|5820653|P3|NOT COMPLETED|Overall Study||10
2371913|NCT01519960|5820654|P2|NOT COMPLETED|Overall Study||50
2371914|NCT01519960|5820655|P1|NOT COMPLETED|Overall Study||101
2371915|NCT01519960|5820653|P3|COMPLETED|Overall Study||0
2371916|NCT01519960|5820654|P2|COMPLETED|Overall Study||0
2371917|NCT01519960|5820655|P1|COMPLETED|Overall Study||0
2371918|NCT01519960|5820653|P3|Completed FU Week 24|Overall Study||10
2371919|NCT01519960|5820654|P2|Completed FU Week 24|Overall Study||15
2371920|NCT01519960|5820655|P1|Completed FU Week 24|Overall Study||101
2371921|NCT01519960|5820653|P3|Completed Follow-Up (FU) Week 12|Overall Study||10
2371922|NCT01519960|5820654|P2|Completed Follow-Up (FU) Week 12|Overall Study||26
2371923|NCT01519960|5820655|P1|Completed Follow-Up (FU) Week 12|Overall Study||101
2371924|NCT01519960|5820653|P3|Completed Week 48|Overall Study||10
2371925|NCT01519960|5820654|P2|Completed Week 48|Overall Study||47
2371926|NCT01519960|5820655|P1|Completed Week 48|Overall Study||99
2371927|NCT01519960|5820653|P3|STARTED|Overall Study||10
2371928|NCT01519960|5820654|P2|STARTED|Overall Study||50
2371929|NCT01519960|5820655|P1|STARTED|Overall Study||101
2371930|NCT01519947|5820765|P4|NOT COMPLETED|Overall Study||8
2371931|NCT01519947|5820766|P3|NOT COMPLETED|Overall Study||7
2371932|NCT01519947|5820767|P2|NOT COMPLETED|Overall Study||4
2371933|NCT01519947|5820768|P1|NOT COMPLETED|Overall Study||2
2371934|NCT01519947|5820765|P4|COMPLETED|Overall Study||34
2371935|NCT01519947|5820766|P3|COMPLETED|Overall Study||8
2371936|NCT01519947|5820767|P2|COMPLETED|Overall Study||7
2371937|NCT01519947|5820768|P1|COMPLETED|Overall Study||17
2371938|NCT01519947|5820765|P4|STARTED|Overall Study||42
2371939|NCT01519947|5820766|P3|STARTED|Overall Study||15
2371940|NCT01519947|5820767|P2|STARTED|Overall Study||11
2371941|NCT01519947|5820768|P1|STARTED|Overall Study||19
2371942|NCT01519934|5820798|P1|NOT COMPLETED|Overall Study||3
2371943|NCT01519934|5820798|P1|COMPLETED|Overall Study||45
2371944|NCT01519934|5820798|P1|STARTED|Overall Study||48
2371945|NCT01519921|5820807|P2|NOT COMPLETED|Overall Study||15
2371946|NCT01519921|5820808|P1|NOT COMPLETED|Overall Study||21
2371947|NCT01519921|5820807|P2|COMPLETED|Overall Study||49
2371948|NCT01519921|5820808|P1|COMPLETED|Overall Study||65
2371949|NCT01519921|5820807|P2|STARTED|Overall Study||64
2371950|NCT01519921|5820808|P1|STARTED|Overall Study||86
2371951|NCT01519882|5820832|P2|NOT COMPLETED|Overall Study||0
2371952|NCT01519882|5820833|P1|NOT COMPLETED|Overall Study||0
2371953|NCT01519882|5820832|P2|COMPLETED|Overall Study||0
2371954|NCT01519882|5820833|P1|COMPLETED|Overall Study||1
2371955|NCT01519882|5820832|P2|STARTED|Overall Study||0
2371956|NCT01519882|5820833|P1|STARTED|Overall Study||1
2371957|NCT01519817|5820857|P4|NOT COMPLETED|Overall Study||1
2371958|NCT01519817|5820858|P3|NOT COMPLETED|Overall Study||0
2371959|NCT01519817|5820859|P2|NOT COMPLETED|Overall Study||0
2371960|NCT01519817|5820860|P1|NOT COMPLETED|Overall Study||1
2371961|NCT01519817|5820857|P4|COMPLETED|Overall Study||10
2371962|NCT01519817|5820858|P3|COMPLETED|Overall Study||16
2371963|NCT01519817|5820859|P2|COMPLETED|Overall Study||3
2371964|NCT01519817|5820860|P1|COMPLETED|Overall Study||3
2371965|NCT01519817|5820857|P4|STARTED|Overall Study||11
2371966|NCT01519817|5820858|P3|STARTED|Overall Study||16
2371967|NCT01519817|5820859|P2|STARTED|Overall Study||3
2371968|NCT01519817|5820860|P1|STARTED|Overall Study||4
2371969|NCT01519791|5820900|P2|NOT COMPLETED|Overall Study||368
2371970|NCT01519791|5820901|P1|NOT COMPLETED|Overall Study||152
2371971|NCT01519791|5820900|P2|COMPLETED|Overall Study||292
2371972|NCT01519791|5820901|P1|COMPLETED|Overall Study||67
2371973|NCT01519791|5820900|P2|Completed Week 52|Overall Study||500
2371974|NCT01519791|5820901|P1|Completed Week 52|Overall Study||143
2371975|NCT01519791|5820900|P2|STARTED|Overall Study||660
2371976|NCT01519791|5820901|P1|STARTED|Overall Study||219
2371977|NCT01519778|5820965|P1|NOT COMPLETED|Overall Study||14
2371978|NCT01519778|5820965|P1|COMPLETED|Overall Study||186
2371979|NCT01519778|5820965|P1|STARTED|Overall Study||200
2371980|NCT01519765|5820971|P2|NOT COMPLETED|Overall Study||2
2371981|NCT01519765|5820972|P1|NOT COMPLETED|Overall Study||3
2371982|NCT01519765|5820971|P2|COMPLETED|Overall Study||34
2371983|NCT01519765|5820972|P1|COMPLETED|Overall Study||34
2371984|NCT01519765|5820971|P2|STARTED|Overall Study||36
2371985|NCT01519765|5820972|P1|STARTED|Overall Study||37
2371986|NCT01519713|5821021|P3|NOT COMPLETED|Overall Study||0
2371987|NCT01519713|5821022|P2|NOT COMPLETED|Overall Study||0
2371988|NCT01519713|5821023|P1|NOT COMPLETED|Overall Study||0
2371989|NCT01519713|5821021|P3|COMPLETED|Overall Study||4
2371990|NCT01519713|5821022|P2|COMPLETED|Overall Study||2
2371991|NCT01519713|5821023|P1|COMPLETED|Overall Study||194
2371992|NCT01519713|5821021|P3|STARTED|Overall Study||4
2371993|NCT01519713|5821022|P2|STARTED|Overall Study||2
2371994|NCT01519713|5821023|P1|STARTED|Overall Study||194
2371995|NCT01519700|5821050|P4|NOT COMPLETED|Overall Study||7
2371996|NCT01519700|5821051|P3|NOT COMPLETED|Overall Study||7
2371997|NCT01519700|5821052|P2|NOT COMPLETED|Overall Study||6
2371998|NCT01519700|5821053|P1|NOT COMPLETED|Overall Study||9
2371999|NCT01519700|5821050|P4|COMPLETED|Overall Study||47
2372000|NCT01519700|5821051|P3|COMPLETED|Overall Study||48
2372001|NCT01519700|5821052|P2|COMPLETED|Overall Study||49
2372002|NCT01519700|5821053|P1|COMPLETED|Overall Study||45
2372003|NCT01519700|5821050|P4|Treated Cycle 6 Neupogen|Overall Study||49
2372004|NCT01519700|5821051|P3|Treated Cycle 6 Neupogen|Overall Study||0
2372005|NCT01519700|5821052|P2|Treated Cycle 6 Neupogen|Overall Study||49
2372006|NCT01519700|5821053|P1|Treated Cycle 6 Neupogen|Overall Study||0
2372007|NCT01519700|5821050|P4|Treated Cycle 6 EP2006|Overall Study||0
2372008|NCT01519700|5821051|P3|Treated Cycle 6 EP2006|Overall Study||48
2372009|NCT01519700|5821052|P2|Treated Cycle 6 EP2006|Overall Study||0
2372010|NCT01519700|5821053|P1|Treated Cycle 6 EP2006|Overall Study||45
2372011|NCT01519700|5821050|P4|Treated Cycle 5 Neupogen|Overall Study||50
2372012|NCT01519700|5821051|P3|Treated Cycle 5 Neupogen|Overall Study||48
2372013|NCT01519700|5821052|P2|Treated Cycle 5 Neupogen|Overall Study||0
2372014|NCT01519700|5821053|P1|Treated Cycle 5 Neupogen|Overall Study||0
2372015|NCT01519700|5821050|P4|Treated Cycle 5 EP2006|Overall Study||0
2372016|NCT01519700|5821051|P3|Treated Cycle 5 EP2006|Overall Study||0
2372017|NCT01519700|5821052|P2|Treated Cycle 5 EP2006|Overall Study||49
2372018|NCT01519700|5821053|P1|Treated Cycle 5 EP2006|Overall Study||46
2372019|NCT01519700|5821050|P4|Treated Cycle 4 Neupogen|Overall Study||50
2372020|NCT01519700|5821051|P3|Treated Cycle 4 Neupogen|Overall Study||0
2372021|NCT01519700|5821052|P2|Treated Cycle 4 Neupogen|Overall Study||51
2372022|NCT01519700|5821053|P1|Treated Cycle 4 Neupogen|Overall Study||0
2372023|NCT01519700|5821050|P4|Treated Cycle 4 EP2006|Overall Study||0
2372024|NCT01519700|5821051|P3|Treated Cycle 4 EP2006|Overall Study||50
2372025|NCT01519700|5821052|P2|Treated Cycle 4 EP2006|Overall Study||0
2372026|NCT01519700|5821053|P1|Treated Cycle 4 EP2006|Overall Study||51
2372027|NCT01519700|5821050|P4|Treated Cycle 3 Neupogen|Overall Study||51
2372028|NCT01519700|5821051|P3|Treated Cycle 3 Neupogen|Overall Study||54
2372029|NCT01519700|5821052|P2|Treated Cycle 3 Neupogen|Overall Study||0
2372030|NCT01519700|5821053|P1|Treated Cycle 3 Neupogen|Overall Study||0
2372031|NCT01519700|5821050|P4|Treated Cycle 3 EP2006|Overall Study||0
2372032|NCT01519700|5821051|P3|Treated Cycle 3 EP2006|Overall Study||0
2372033|NCT01519700|5821052|P2|Treated Cycle 3 EP2006|Overall Study||51
2372034|NCT01519700|5821053|P1|Treated Cycle 3 EP2006|Overall Study||51
2372035|NCT01519700|5821050|P4|Treated Cycle 2 Neupogen|Overall Study||51
2372036|NCT01519700|5821051|P3|Treated Cycle 2 Neupogen|Overall Study||0
2372037|NCT01519700|5821052|P2|Treated Cycle 2 Neupogen|Overall Study||52
2372038|NCT01519700|5821053|P1|Treated Cycle 2 Neupogen|Overall Study||0
2372039|NCT01519700|5821050|P4|Treated Cycle 2 EP2006|Overall Study||0
2372040|NCT01519700|5821051|P3|Treated Cycle 2 EP2006|Overall Study||55
2372041|NCT01519700|5821052|P2|Treated Cycle 2 EP2006|Overall Study||0
2372042|NCT01519700|5821053|P1|Treated Cycle 2 EP2006|Overall Study||52
2372043|NCT01519700|5821050|P4|Treated Cycle 1 Neupogen|Overall Study||52
2372044|NCT01519700|5821051|P3|Treated Cycle 1 Neupogen|Overall Study||55
2372045|NCT01519700|5821052|P2|Treated Cycle 1 Neupogen|Overall Study||0
2372046|NCT01519700|5821053|P1|Treated Cycle 1 Neupogen|Overall Study||0
2372047|NCT01519700|5821050|P4|Treated Cycle 1 EP2006|Overall Study||0
2372048|NCT01519700|5821051|P3|Treated Cycle 1 EP2006|Overall Study||0
2372049|NCT01519700|5821052|P2|Treated Cycle 1 EP2006|Overall Study||54
2372050|NCT01519700|5821053|P1|Treated Cycle 1 EP2006|Overall Study||53
2372051|NCT01519700|5821050|P4|STARTED|Overall Study||54
2372052|NCT01519700|5821051|P3|STARTED|Overall Study||55
2372053|NCT01519700|5821052|P2|STARTED|Overall Study||55
2372054|NCT01519700|5821053|P1|STARTED|Overall Study||54
2372055|NCT01519674|5821088|P3|NOT COMPLETED|Overall Study||12
2372056|NCT01519674|5821089|P2|NOT COMPLETED|Overall Study||13
2372057|NCT01519674|5821090|P1|NOT COMPLETED|Overall Study||21
2372058|NCT01519674|5821088|P3|COMPLETED|Overall Study||181
2372059|NCT01519674|5821089|P2|COMPLETED|Overall Study||182
2372060|NCT01519674|5821090|P1|COMPLETED|Overall Study||173
2372061|NCT01519674|5821088|P3|Exposed|Overall Study||190
2372062|NCT01519674|5821089|P2|Exposed|Overall Study||193
2372063|NCT01519674|5821090|P1|Exposed|Overall Study||192
2372064|NCT01519674|5821088|P3|STARTED|Overall Study||193
2372065|NCT01519674|5821089|P2|STARTED|Overall Study||195
2372066|NCT01519674|5821090|P1|STARTED|Overall Study||194
2372067|NCT01519661|5821128|P1|NOT COMPLETED|Overall Study||61
2372068|NCT01519661|5821128|P1|COMPLETED|Overall Study||96
2372069|NCT01519661|5821128|P1|STARTED|Overall Study||157
2372070|NCT01519648|5821145|P2|NOT COMPLETED|Overall Study||0
2372071|NCT01519648|5821146|P1|NOT COMPLETED|Overall Study||0
2372072|NCT01519648|5821145|P2|COMPLETED|Overall Study||306
2372073|NCT01519648|5821146|P1|COMPLETED|Overall Study||502
2372074|NCT01519648|5821145|P2|STARTED|Overall Study||306
2372075|NCT01519648|5821146|P1|STARTED|Overall Study||502
2372076|NCT01519635|5821154|P2|NOT COMPLETED|Overall Study||3
2372077|NCT01519635|5821155|P1|NOT COMPLETED|Overall Study||1
2372078|NCT01519635|5821154|P2|COMPLETED|Overall Study||9
2372079|NCT01519635|5821155|P1|COMPLETED|Overall Study||11
2372080|NCT01519635|5821154|P2|STARTED|Overall Study||12
2372081|NCT01519635|5821155|P1|STARTED|Overall Study||12
2372082|NCT01519570|5821163|P2|NOT COMPLETED|Overall Study||0
2372083|NCT01519570|5821164|P1|NOT COMPLETED|Overall Study||0
2372084|NCT01519570|5821163|P2|COMPLETED|Overall Study||2089
2372085|NCT01519570|5821164|P1|COMPLETED|Overall Study||500
2372086|NCT01519570|5821163|P2|STARTED|Overall Study||2089
2372087|NCT01519570|5821164|P1|STARTED|Overall Study||500
2372088|NCT01519518|5821172|P2|NOT COMPLETED|Overall Study||10
2372089|NCT01519518|5821173|P1|NOT COMPLETED|Overall Study||7
2372090|NCT01519518|5821172|P2|COMPLETED|Overall Study||905
2372091|NCT01519518|5821173|P1|COMPLETED|Overall Study||907
2372092|NCT01519518|5821172|P2|STARTED|Overall Study||915
2372093|NCT01519518|5821173|P1|STARTED|Overall Study||914
2372094|NCT01519466|5821187|P2|NOT COMPLETED|Overall Study||0
2372095|NCT01519466|5821188|P1|NOT COMPLETED|Overall Study||0
2372096|NCT01519466|5821187|P2|COMPLETED|Overall Study||16
2372097|NCT01519466|5821188|P1|COMPLETED|Overall Study||33
2372098|NCT01519466|5821187|P2|STARTED|Overall Study||16
2372099|NCT01519466|5821188|P1|STARTED|Overall Study||33
2372100|NCT01519427|5821198|P1|NOT COMPLETED|Overall Study||2
2372101|NCT01519427|5821198|P1|COMPLETED|Overall Study||0
2372102|NCT01519427|5821198|P1|STARTED|Overall Study||2
2372103|NCT01519414|5821207|P3|NOT COMPLETED|Post Cross-over||0
2372104|NCT01519414|5821208|P2|NOT COMPLETED|Post Cross-over||0
2372105|NCT01519414|5821209|P1|NOT COMPLETED|Post Cross-over||0
2372106|NCT01519414|5821207|P3|COMPLETED|Post Cross-over||12
2372107|NCT01519414|5821208|P2|COMPLETED|Post Cross-over||14
2372108|NCT01519414|5821209|P1|COMPLETED|Post Cross-over||52
2372109|NCT01519414|5821207|P3|STARTED|Post Cross-over||12
2372110|NCT01519414|5821208|P2|STARTED|Post Cross-over||14
2372111|NCT01519414|5821209|P1|STARTED|Post Cross-over||52
2372112|NCT01519414|5821207|P3|NOT COMPLETED|Pre Cross-over||0
2372113|NCT01519414|5821208|P2|NOT COMPLETED|Pre Cross-over||0
2372114|NCT01519414|5821209|P1|NOT COMPLETED|Pre Cross-over||0
2372115|NCT01519414|5821207|P3|COMPLETED|Pre Cross-over||0
2372116|NCT01519414|5821208|P2|COMPLETED|Pre Cross-over||26
2372117|NCT01519414|5821209|P1|COMPLETED|Pre Cross-over||52
2372118|NCT01519414|5821207|P3|STARTED|Pre Cross-over||0
2372119|NCT01519414|5821208|P2|STARTED|Pre Cross-over||26
2372120|NCT01519414|5821209|P1|STARTED|Pre Cross-over||52
2372121|NCT01519323|5821230|P2|NOT COMPLETED|Overall Study||3
2372122|NCT01519323|5821231|P1|NOT COMPLETED|Overall Study||3
2372123|NCT01519323|5821230|P2|COMPLETED|Overall Study||0
2372124|NCT01519323|5821231|P1|COMPLETED|Overall Study||0
2372125|NCT01519323|5821230|P2|STARTED|Overall Study||3
2372126|NCT01519323|5821231|P1|STARTED|Overall Study||3
2372127|NCT01519284|5821247|P5|NOT COMPLETED|Overall Study||0
2372128|NCT01519284|5821248|P4|NOT COMPLETED|Overall Study||0
2372129|NCT01519284|5821249|P3|NOT COMPLETED|Overall Study||2
2372130|NCT01519284|5821250|P2|NOT COMPLETED|Overall Study||0
2372131|NCT01519284|5821251|P1|NOT COMPLETED|Overall Study||0
2372132|NCT01519284|5821247|P5|COMPLETED|Overall Study||16
2372133|NCT01519284|5821248|P4|COMPLETED|Overall Study||16
2372134|NCT01519284|5821249|P3|COMPLETED|Overall Study||16
2372135|NCT01519284|5821250|P2|COMPLETED|Overall Study||16
2372136|NCT01519284|5821251|P1|COMPLETED|Overall Study||16
2372137|NCT01519284|5821247|P5|STARTED|Overall Study||16
2372138|NCT01519284|5821248|P4|STARTED|Overall Study||16
2372139|NCT01519284|5821249|P3|STARTED|Overall Study||18
2372140|NCT01519284|5821250|P2|STARTED|Overall Study||16
2372141|NCT01519284|5821251|P1|STARTED|Overall Study||16
2372142|NCT01519271|5821280|P2|NOT COMPLETED|Phase 2||0
2372143|NCT01519271|5821281|P1|NOT COMPLETED|Phase 2||0
2372144|NCT01519271|5821280|P2|COMPLETED|Phase 2||14
2372145|NCT01519271|5821281|P1|COMPLETED|Phase 2||12
2372146|NCT01519271|5821280|P2|STARTED|Phase 2||14
2372147|NCT01519271|5821281|P1|STARTED|Phase 2|2 participants discontinued after Phase 1|12
2372148|NCT01519271|5821280|P2|NOT COMPLETED|Phase 1||1
2372149|NCT01519271|5821281|P1|NOT COMPLETED|Phase 1||0
2372150|NCT01519271|5821280|P2|COMPLETED|Phase 1|1 participant discontinued participation in the middle of phase 1.|13
2372151|NCT01519271|5821281|P1|COMPLETED|Phase 1||14
2372152|NCT01519271|5821280|P2|STARTED|Phase 1||14
2372153|NCT01519271|5821281|P1|STARTED|Phase 1||14
2372154|NCT01519245|5821291|P2|NOT COMPLETED|Overall Study||2
2372155|NCT01519245|5821292|P1|NOT COMPLETED|Overall Study||1
2372156|NCT01519245|5821291|P2|COMPLETED|Overall Study||18
2372157|NCT01519245|5821292|P1|COMPLETED|Overall Study||23
2372158|NCT01519245|5821291|P2|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|2
2372159|NCT01519245|5821292|P1|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|6
2372160|NCT01519245|5821291|P2|Received Pre-pump IV TXA|Overall Study|All patients meeting inclusion criteria received appropriate dosing, as per protocol.|18
2372161|NCT01519245|5821292|P1|Received Pre-pump IV TXA|Overall Study|Two patients included in in the final analysis did not receive pre-pump IV TXA.|21
2372162|NCT01519245|5821291|P2|STARTED|Overall Study||20
2372163|NCT01519245|5821292|P1|STARTED|Overall Study||24
2372164|NCT01519206|5821304|P1|NOT COMPLETED|Overall Study||5
2372165|NCT01519206|5821304|P1|COMPLETED|Overall Study||27
2372166|NCT01519206|5821304|P1|STARTED|Overall Study||32
2372167|NCT01519167|5821318|P2|NOT COMPLETED|Overall Study||8
2372168|NCT01519167|5821319|P1|NOT COMPLETED|Overall Study||0
2372169|NCT01519167|5821318|P2|COMPLETED|Overall Study||81
2372170|NCT01519167|5821319|P1|COMPLETED|Overall Study||1
2372171|NCT01519167|5821318|P2|STARTED|Overall Study||89
2372172|NCT01519167|5821319|P1|STARTED|Overall Study||1
2372173|NCT01519089|5821345|P2|NOT COMPLETED|Overall Study||15
2372174|NCT01519089|5821346|P1|NOT COMPLETED|Overall Study||7
2372175|NCT01519089|5821345|P2|COMPLETED|Overall Study||33
2372176|NCT01519089|5821346|P1|COMPLETED|Overall Study||40
2372177|NCT01519089|5821345|P2|Received Treatment|Overall Study||47
2372178|NCT01519089|5821346|P1|Received Treatment|Overall Study||47
2372179|NCT01519089|5821345|P2|STARTED|Overall Study||48
2372180|NCT01519089|5821346|P1|STARTED|Overall Study||47
2372181|NCT01519063|5821467|P2|NOT COMPLETED|Overall Study||5
2372182|NCT01519063|5821468|P1|NOT COMPLETED|Overall Study||7
2372183|NCT01519063|5821467|P2|COMPLETED|Overall Study||25
2372184|NCT01519063|5821468|P1|COMPLETED|Overall Study||19
2372185|NCT01519063|5821467|P2|STARTED|Overall Study||30
2372186|NCT01519063|5821468|P1|STARTED|Overall Study||26
2372187|NCT01518946|5821488|P3|NOT COMPLETED|Randomized Phase (Second Intervention)||0
2372188|NCT01518946|5821489|P2|NOT COMPLETED|Randomized Phase (Second Intervention)||0
2372189|NCT01518946|5821490|P1|NOT COMPLETED|Randomized Phase (Second Intervention)||0
2372190|NCT01518946|5821488|P3|COMPLETED|Randomized Phase (Second Intervention)||10
2372191|NCT01518946|5821489|P2|COMPLETED|Randomized Phase (Second Intervention)||9
2372192|NCT01518946|5821490|P1|COMPLETED|Randomized Phase (Second Intervention)||0
2372193|NCT01518946|5821488|P3|STARTED|Randomized Phase (Second Intervention)||10
2372194|NCT01518946|5821489|P2|STARTED|Randomized Phase (Second Intervention)||9
2372195|NCT01518946|5821490|P1|STARTED|Randomized Phase (Second Intervention)||0
2372196|NCT01518946|5821488|P3|NOT COMPLETED|Randomized Phase (First Intervention)||0
2372197|NCT01518946|5821489|P2|NOT COMPLETED|Randomized Phase (First Intervention)||1
2372198|NCT01518946|5821490|P1|NOT COMPLETED|Randomized Phase (First Intervention)||0
2372199|NCT01518946|5821488|P3|COMPLETED|Randomized Phase (First Intervention)||10
2372200|NCT01518946|5821489|P2|COMPLETED|Randomized Phase (First Intervention)||9
2372201|NCT01518946|5821490|P1|COMPLETED|Randomized Phase (First Intervention)||0
2372202|NCT01518946|5821488|P3|STARTED|Randomized Phase (First Intervention)||10
2372203|NCT01518946|5821489|P2|STARTED|Randomized Phase (First Intervention)||10
2372204|NCT01518946|5821490|P1|STARTED|Randomized Phase (First Intervention)||0
2372205|NCT01518946|5821488|P3|NOT COMPLETED|Open-label Phase||0
2372206|NCT01518946|5821489|P2|NOT COMPLETED|Open-label Phase||0
2372207|NCT01518946|5821490|P1|NOT COMPLETED|Open-label Phase||4
2372208|NCT01518946|5821488|P3|COMPLETED|Open-label Phase||0
2372209|NCT01518946|5821489|P2|COMPLETED|Open-label Phase||0
2372210|NCT01518946|5821490|P1|COMPLETED|Open-label Phase||20
2372211|NCT01518946|5821488|P3|STARTED|Open-label Phase||0
2372212|NCT01518946|5821489|P2|STARTED|Open-label Phase||0
2372213|NCT01518946|5821490|P1|STARTED|Open-label Phase||24
2372214|NCT01518530|5821497|P1|NOT COMPLETED|Post-Treatment Follow-up||0
2372215|NCT01518530|5821497|P1|COMPLETED|Post-Treatment Follow-up||9
2372216|NCT01518530|5821497|P1|STARTED|Post-Treatment Follow-up||9
2372217|NCT01518530|5821497|P1|NOT COMPLETED|Active Treatment Period||1
2372218|NCT01518530|5821497|P1|COMPLETED|Active Treatment Period||9
2372219|NCT01518530|5821497|P1|STARTED|Active Treatment Period||10
2372220|NCT01518374|5821501|P1|NOT COMPLETED|Overall Study||7
2372221|NCT01518374|5821501|P1|COMPLETED|Overall Study||1761
2372222|NCT01518374|5821501|P1|STARTED|Overall Study||1768
2372223|NCT01518322|5821505|P1|NOT COMPLETED|Overall Study||13
2372224|NCT01518322|5821505|P1|COMPLETED|Overall Study||222
2372225|NCT01518322|5821505|P1|STARTED|Overall Study||235
2372226|NCT01518270|5821518|P1|NOT COMPLETED|Overall Study||0
2372227|NCT01518270|5821518|P1|COMPLETED|Overall Study||179
2372228|NCT01518270|5821518|P1|STARTED|Overall Study||179
2372229|NCT01518257|5821526|P2|NOT COMPLETED|Overall Study||0
2372230|NCT01518257|5821527|P1|NOT COMPLETED|Overall Study||2
2372231|NCT01518257|5821526|P2|COMPLETED|Overall Study||60
2372232|NCT01518257|5821527|P1|COMPLETED|Overall Study||59
2372233|NCT01518257|5821526|P2|STARTED|Overall Study||60
2372234|NCT01518257|5821527|P1|STARTED|Overall Study||61
2372235|NCT01518244|5821549|P1|NOT COMPLETED|Overall Study||3
2372236|NCT01518244|5821549|P1|COMPLETED|Overall Study||47
2372237|NCT01518244|5821549|P1|STARTED|Overall Study||50
2372238|NCT01518192|5821557|P3|NOT COMPLETED|Overall Study||35
2372239|NCT01518192|5821558|P2|NOT COMPLETED|Overall Study||26
2372240|NCT01518192|5821559|P1|NOT COMPLETED|Overall Study||29
2372241|NCT01518192|5821557|P3|COMPLETED|Overall Study||224
2372242|NCT01518192|5821558|P2|COMPLETED|Overall Study||114
2372243|NCT01518192|5821559|P1|COMPLETED|Overall Study||116
2372244|NCT01518192|5821557|P3|STARTED|Overall Study||259
2372245|NCT01518192|5821558|P2|STARTED|Overall Study||140
2372246|NCT01518192|5821559|P1|STARTED|Overall Study||145
2372247|NCT01518153|5821580|P3|NOT COMPLETED|Donor Lymphocyte Infusion||1
2372248|NCT01518153|5821581|P2|NOT COMPLETED|Donor Lymphocyte Infusion||2
2372249|NCT01518153|5821582|P1|NOT COMPLETED|Donor Lymphocyte Infusion||0
2372250|NCT01518153|5821580|P3|COMPLETED|Donor Lymphocyte Infusion||3
2372251|NCT01518153|5821581|P2|COMPLETED|Donor Lymphocyte Infusion||1
2372252|NCT01518153|5821582|P1|COMPLETED|Donor Lymphocyte Infusion||0
2372253|NCT01518153|5821580|P3|STARTED|Donor Lymphocyte Infusion||4
2372254|NCT01518153|5821581|P2|STARTED|Donor Lymphocyte Infusion||3
2372255|NCT01518153|5821582|P1|STARTED|Donor Lymphocyte Infusion||0
2372256|NCT01518153|5821580|P3|NOT COMPLETED|Stem Cell Transplant||0
2372257|NCT01518153|5821581|P2|NOT COMPLETED|Stem Cell Transplant||0
2372258|NCT01518153|5821582|P1|NOT COMPLETED|Stem Cell Transplant||9
2372259|NCT01518153|5821580|P3|COMPLETED|Stem Cell Transplant||0
2372260|NCT01518153|5821581|P2|COMPLETED|Stem Cell Transplant||0
2372261|NCT01518153|5821582|P1|COMPLETED|Stem Cell Transplant||7
2372262|NCT01518153|5821580|P3|STARTED|Stem Cell Transplant||0
2372263|NCT01518153|5821581|P2|STARTED|Stem Cell Transplant||0
2372264|NCT01518153|5821582|P1|STARTED|Stem Cell Transplant||16
2372265|NCT01517984|5821593|P4|NOT COMPLETED|Overall Study||1
2372266|NCT01517984|5821594|P3|NOT COMPLETED|Overall Study||4
2372267|NCT01517984|5821595|P2|NOT COMPLETED|Overall Study||23
2372268|NCT01517984|5821596|P1|NOT COMPLETED|Overall Study||5
2372269|NCT01517984|5821593|P4|COMPLETED|Overall Study||6
2372270|NCT01517984|5821594|P3|COMPLETED|Overall Study||10
2372271|NCT01517984|5821595|P2|COMPLETED|Overall Study||3
2372272|NCT01517984|5821596|P1|COMPLETED|Overall Study||0
2372273|NCT01517984|5821593|P4|STARTED|Overall Study||7
2372274|NCT01517984|5821594|P3|STARTED|Overall Study||14
2372275|NCT01517984|5821595|P2|STARTED|Overall Study||26
2372276|NCT01517984|5821596|P1|STARTED|Overall Study||5
2372277|NCT01517893|5821622|P2|NOT COMPLETED|Overall Study||0
2372278|NCT01517893|5821623|P1|NOT COMPLETED|Overall Study||3
2372279|NCT01517893|5821622|P2|COMPLETED|Overall Study||7
2372280|NCT01517893|5821623|P1|COMPLETED|Overall Study||5
2372281|NCT01517893|5821622|P2|STARTED|Overall Study||7
2372282|NCT01517893|5821623|P1|STARTED|Overall Study||8
2372283|NCT01517867|5821645|P2|NOT COMPLETED|Overall Study||65
2372284|NCT01517867|5821646|P1|NOT COMPLETED|Overall Study||63
2372285|NCT01517867|5821645|P2|COMPLETED|Overall Study||15
2372286|NCT01517867|5821646|P1|COMPLETED|Overall Study||18
2372287|NCT01517867|5821645|P2|STARTED|Overall Study||80
2372288|NCT01517867|5821646|P1|STARTED|Overall Study||81
2372289|NCT01517763|5821657|P3|NOT COMPLETED|Overall Study||0
2372290|NCT01517763|5821658|P2|NOT COMPLETED|Overall Study||0
2372291|NCT01517763|5821659|P1|NOT COMPLETED|Overall Study||0
2372292|NCT01517763|5821657|P3|COMPLETED|Overall Study||0
2372293|NCT01517763|5821658|P2|COMPLETED|Overall Study||0
2372294|NCT01517763|5821659|P1|COMPLETED|Overall Study||0
2372295|NCT01517763|5821657|P3|STARTED|Overall Study||0
2372296|NCT01517763|5821658|P2|STARTED|Overall Study||0
2372297|NCT01517763|5821659|P1|STARTED|Overall Study||0
2372298|NCT01517750|5821674|P4|NOT COMPLETED|Overall Study||1
2372299|NCT01517750|5821675|P3|NOT COMPLETED|Overall Study||4
2372300|NCT01517750|5821676|P2|NOT COMPLETED|Overall Study||2
2372301|NCT01517750|5821677|P1|NOT COMPLETED|Overall Study||1
2372302|NCT01517750|5821674|P4|COMPLETED|Overall Study||18
2372303|NCT01517750|5821675|P3|COMPLETED|Overall Study||17
2372304|NCT01517750|5821676|P2|COMPLETED|Overall Study||17
2372305|NCT01517750|5821677|P1|COMPLETED|Overall Study||20
2372306|NCT01517750|5821674|P4|STARTED|Overall Study||19
2372307|NCT01517750|5821675|P3|STARTED|Overall Study||21
2372308|NCT01517750|5821676|P2|STARTED|Overall Study||19
2372309|NCT01517750|5821677|P1|STARTED|Overall Study||21
2372310|NCT01517529|5821707|P1|NOT COMPLETED|Overall Study||0
2372311|NCT01517529|5821707|P1|COMPLETED|Overall Study||10
2372312|NCT01517529|5821707|P1|STARTED|Overall Study||10
2372313|NCT01517412|5821714|P2|NOT COMPLETED|Overall Study||24
2372314|NCT01517412|5821715|P1|NOT COMPLETED|Overall Study||36
2372315|NCT01517412|5821714|P2|COMPLETED|Overall Study||202
2372316|NCT01517412|5821715|P1|COMPLETED|Overall Study||189
2372317|NCT01517412|5821714|P2|STARTED|Overall Study||226
2372318|NCT01517412|5821715|P1|STARTED|Overall Study||225
2372319|NCT01517373|5821744|P6|NOT COMPLETED|Treatment Period||7
2372320|NCT01517373|5821745|P5|NOT COMPLETED|Treatment Period||6
2372321|NCT01517373|5821746|P4|NOT COMPLETED|Treatment Period||7
2372322|NCT01517373|5821747|P3|NOT COMPLETED|Treatment Period||6
2372323|NCT01517373|5821748|P2|NOT COMPLETED|Treatment Period||4
2372324|NCT01517373|5821749|P1|NOT COMPLETED|Treatment Period||0
2372325|NCT01517373|5821744|P6|COMPLETED|Treatment Period||54
2372326|NCT01517373|5821745|P5|COMPLETED|Treatment Period||55
2372327|NCT01517373|5821746|P4|COMPLETED|Treatment Period||54
2372328|NCT01517373|5821747|P3|COMPLETED|Treatment Period||54
2372329|NCT01517373|5821748|P2|COMPLETED|Treatment Period||57
2372330|NCT01517373|5821749|P1|COMPLETED|Treatment Period||0
2372331|NCT01517373|5821744|P6|STARTED|Treatment Period||61
2372332|NCT01517373|5821745|P5|STARTED|Treatment Period||61
2372333|NCT01517373|5821746|P4|STARTED|Treatment Period||61
2372334|NCT01517373|5821747|P3|STARTED|Treatment Period||60
2372335|NCT01517373|5821748|P2|STARTED|Treatment Period||61
2372336|NCT01517373|5821749|P1|STARTED|Treatment Period||0
2372337|NCT01517373|5821744|P6|NOT COMPLETED|Run-in Period||0
2372338|NCT01517373|5821745|P5|NOT COMPLETED|Run-in Period||0
2372339|NCT01517373|5821746|P4|NOT COMPLETED|Run-in Period||0
2372340|NCT01517373|5821747|P3|NOT COMPLETED|Run-in Period||0
2372341|NCT01517373|5821748|P2|NOT COMPLETED|Run-in Period||0
2372342|NCT01517373|5821749|P1|NOT COMPLETED|Run-in Period||57
2372343|NCT01517373|5821744|P6|COMPLETED|Run-in Period||0
2372344|NCT01517373|5821745|P5|COMPLETED|Run-in Period||0
2372345|NCT01517373|5821746|P4|COMPLETED|Run-in Period||0
2372346|NCT01517373|5821747|P3|COMPLETED|Run-in Period||0
2372347|NCT01517373|5821748|P2|COMPLETED|Run-in Period||0
2372348|NCT01517373|5821749|P1|COMPLETED|Run-in Period||304
2372349|NCT01517373|5821744|P6|STARTED|Run-in Period||0
2372350|NCT01517373|5821745|P5|STARTED|Run-in Period||0
2372351|NCT01517373|5821746|P4|STARTED|Run-in Period||0
2372352|NCT01517373|5821747|P3|STARTED|Run-in Period||0
2372353|NCT01517373|5821748|P2|STARTED|Run-in Period||0
2372354|NCT01517373|5821749|P1|STARTED|Run-in Period||361
2372355|NCT01517295|5821819|P2|NOT COMPLETED|Overall Study||0
2372356|NCT01517295|5821820|P1|NOT COMPLETED|Overall Study||1
2372357|NCT01517295|5821819|P2|COMPLETED|Overall Study||14
2372358|NCT01517295|5821820|P1|COMPLETED|Overall Study||15
2372359|NCT01517295|5821819|P2|STARTED|Overall Study||14
2372360|NCT01517295|5821820|P1|STARTED|Overall Study||16
2372361|NCT01517282|5821834|P4|NOT COMPLETED|Overall Study||1
2372362|NCT01517282|5821835|P3|NOT COMPLETED|Overall Study||1
2372363|NCT01517282|5821836|P2|NOT COMPLETED|Overall Study||1
2372364|NCT01517282|5821837|P1|NOT COMPLETED|Overall Study||1
2372365|NCT01517282|5821834|P4|COMPLETED|Overall Study||5
2372366|NCT01517282|5821835|P3|COMPLETED|Overall Study||8
2372367|NCT01517282|5821836|P2|COMPLETED|Overall Study||7
2372368|NCT01517282|5821837|P1|COMPLETED|Overall Study||8
2372369|NCT01517282|5821834|P4|STARTED|Overall Study||6
2372370|NCT01517282|5821835|P3|STARTED|Overall Study|1 patient completed the trial, but received only 4 doses of medication and 2 MRIs due to pregnancy|9
2372371|NCT01517282|5821836|P2|STARTED|Overall Study||8
2372372|NCT01517282|5821837|P1|STARTED|Overall Study|One patient was randomized but did not receive study medication based on the investigator's decision|9
2372373|NCT01517178|5821871|P2|NOT COMPLETED|Period 2||2
2372374|NCT01517178|5821872|P1|NOT COMPLETED|Period 2||6
2372375|NCT01517178|5821871|P2|COMPLETED|Period 2||4
2372376|NCT01517178|5821872|P1|COMPLETED|Period 2||5
2372377|NCT01517178|5821871|P2|STARTED|Period 2||6
2372378|NCT01517178|5821872|P1|STARTED|Period 2|One subject discontinued during run-in and did not start period 2.|11
2372379|NCT01517178|5821871|P2|NOT COMPLETED|Period 1||5
2372380|NCT01517178|5821872|P1|NOT COMPLETED|Period 1||4
2372381|NCT01517178|5821871|P2|COMPLETED|Period 1||6
2372382|NCT01517178|5821872|P1|COMPLETED|Period 1||12
2372383|NCT01517178|5821871|P2|STARTED|Period 1||11
2372384|NCT01517178|5821872|P1|STARTED|Period 1|One subject (who discontinued due to an adverse event) actually used New ostomy base plate.|16
2372385|NCT01517074|5821878|P1|NOT COMPLETED|Overall Study||0
2372386|NCT01517074|5821878|P1|COMPLETED|Overall Study||5
2372387|NCT01517074|5821878|P1|STARTED|Overall Study||5
2372388|NCT01516970|5821891|P2|NOT COMPLETED|Overall Study||21
2372389|NCT01516970|5821892|P1|NOT COMPLETED|Overall Study||18
2372390|NCT01516970|5821891|P2|COMPLETED|Overall Study||132
2372391|NCT01516970|5821892|P1|COMPLETED|Overall Study||141
2372392|NCT01516970|5821891|P2|STARTED|Overall Study||153
2372393|NCT01516970|5821892|P1|STARTED|Overall Study||159
2372394|NCT01516892|5821904|P1|NOT COMPLETED|Overall Study||343
2372395|NCT01516892|5821904|P1|COMPLETED|Overall Study||373
2372396|NCT01516892|5821904|P1|STARTED|Overall Study||716
2372397|NCT01516879|5821912|P2|NOT COMPLETED|Overall Study||34
2372398|NCT01516879|5821913|P1|NOT COMPLETED|Overall Study||16
2372399|NCT01516879|5821912|P2|COMPLETED|Overall Study||568
2372400|NCT01516879|5821913|P1|COMPLETED|Overall Study||287
2372401|NCT01516879|5821912|P2|Received Treatment|Overall Study||599
2372402|NCT01516879|5821913|P1|Received Treatment|Overall Study||302
2372403|NCT01516879|5821912|P2|STARTED|Overall Study||602
2372404|NCT01516879|5821913|P1|STARTED|Overall Study||303
2372405|NCT01516749|5821947|P1|NOT COMPLETED|Follow-up Off Therapy||1
2372406|NCT01516749|5821947|P1|COMPLETED|Follow-up Off Therapy||4
2372407|NCT01516749|5821947|P1|STARTED|Follow-up Off Therapy||5
2372408|NCT01516749|5821947|P1|NOT COMPLETED|Active Therapy||1
2372409|NCT01516749|5821947|P1|COMPLETED|Active Therapy||5
2372410|NCT01516749|5821947|P1|STARTED|Active Therapy||6
2372411|NCT01516736|5821956|P2|NOT COMPLETED|Overall Study||13
2372412|NCT01516736|5821957|P1|NOT COMPLETED|Overall Study||20
2372413|NCT01516736|5821956|P2|COMPLETED|Overall Study||140
2372414|NCT01516736|5821957|P1|COMPLETED|Overall Study||135
2372415|NCT01516736|5821956|P2|STARTED|Overall Study||153
2372416|NCT01516736|5821957|P1|STARTED|Overall Study||155
2372417|NCT01516684|5821979|P2|NOT COMPLETED|Overall Study||0
2372418|NCT01516684|5821980|P1|NOT COMPLETED|Overall Study||0
2372419|NCT01516684|5821979|P2|COMPLETED|Overall Study|"Overall number of units (trials) completed was 152~Trials were randomized for each arm, not participants"|0
2372420|NCT01516684|5821980|P1|COMPLETED|Overall Study|Trials were randomized for each arm, not participants|0
2372421|NCT01516684|5821979|P2|STARTED|Overall Study|"Overall number of units (trials) was used for measuring results with 170 trials.~Trials were randomized for each arm, not participants"|0
2372422|NCT01516684|5821980|P1|STARTED|Overall Study|"Overall number of units (trials) was used for measuring results with 170 trials.~Trials were randomized for each arm, not participants"|0
2372423|NCT01516632|5821996|P2|NOT COMPLETED|Overall Study||15
2372424|NCT01516632|5821997|P1|NOT COMPLETED|Overall Study||24
2372425|NCT01516632|5821996|P2|COMPLETED|Overall Study||48
2372426|NCT01516632|5821997|P1|COMPLETED|Overall Study||77
2372427|NCT01516632|5821996|P2|STARTED|Overall Study||63
2372428|NCT01516632|5821997|P1|STARTED|Overall Study||101
2372429|NCT01516437|5822011|P4|NOT COMPLETED|Overall Study||1
2372430|NCT01516437|5822012|P3|NOT COMPLETED|Overall Study||1
2372431|NCT01516437|5822013|P2|NOT COMPLETED|Overall Study||0
2372432|NCT01516437|5822014|P1|NOT COMPLETED|Overall Study||0
2372433|NCT01516437|5822011|P4|COMPLETED|Overall Study||6
2372434|NCT01516437|5822012|P3|COMPLETED|Overall Study||14
2372435|NCT01516437|5822013|P2|COMPLETED|Overall Study||24
2372436|NCT01516437|5822014|P1|COMPLETED|Overall Study||24
2372437|NCT01516437|5822011|P4|STARTED|Overall Study||7
2372438|NCT01516437|5822012|P3|STARTED|Overall Study||15
2372439|NCT01516437|5822013|P2|STARTED|Overall Study||24
2372440|NCT01516437|5822014|P1|STARTED|Overall Study||24
2372441|NCT01516424|5822070|P2|NOT COMPLETED|Overall Study||22
2372442|NCT01516424|5822071|P1|NOT COMPLETED|Overall Study||35
2372443|NCT01516424|5822070|P2|COMPLETED|Overall Study||114
2372444|NCT01516424|5822071|P1|COMPLETED|Overall Study||96
2372445|NCT01516424|5822070|P2|STARTED|Overall Study|the patient number of randomization for Risperidone Group|136
2372446|NCT01516424|5822071|P1|STARTED|Overall Study|the patient number of randomization for Blonanserin Group|131
2372447|NCT01516268|5822079|P2|NOT COMPLETED|Overall Study||0
2372448|NCT01516268|5822080|P1|NOT COMPLETED|Overall Study||0
2372449|NCT01516268|5822079|P2|COMPLETED|Overall Study||25
2372450|NCT01516268|5822080|P1|COMPLETED|Overall Study||25
2372451|NCT01516268|5822079|P2|STARTED|Overall Study||25
2372452|NCT01516268|5822080|P1|STARTED|Overall Study||25
2372453|NCT01516034|5822086|P1|NOT COMPLETED|Overall Study||8
2372454|NCT01516034|5822086|P1|COMPLETED|Overall Study||0
2372455|NCT01516034|5822086|P1|STARTED|Overall Study||8
2372456|NCT01516008|5822093|P3|NOT COMPLETED|Overall Study||18
2372457|NCT01516008|5822094|P2|NOT COMPLETED|Overall Study||16
2372458|NCT01516008|5822095|P1|NOT COMPLETED|Overall Study||45
2372459|NCT01516008|5822093|P3|COMPLETED|Overall Study||99
2372460|NCT01516008|5822094|P2|COMPLETED|Overall Study||105
2372461|NCT01516008|5822095|P1|COMPLETED|Overall Study||69
2372462|NCT01516008|5822093|P3|STARTED|Overall Study||117
2372463|NCT01516008|5822094|P2|STARTED|Overall Study||121
2372464|NCT01516008|5822095|P1|STARTED|Overall Study||114
2372465|NCT01515995|5822129|P2|NOT COMPLETED|Overall Study||4
2372466|NCT01515995|5822130|P1|NOT COMPLETED|Overall Study||3
2372467|NCT01515995|5822129|P2|COMPLETED|Overall Study||21
2372468|NCT01515995|5822130|P1|COMPLETED|Overall Study||22
2372469|NCT01515995|5822129|P2|STARTED|Overall Study||25
2372470|NCT01515995|5822130|P1|STARTED|Overall Study||25
2372471|NCT01515956|5822136|P1|NOT COMPLETED|Overall Study||0
2372472|NCT01515956|5822136|P1|COMPLETED|Overall Study||15
2372473|NCT01515956|5822136|P1|STARTED|Overall Study||15
2372474|NCT01515943|5822145|P3|NOT COMPLETED|Overall Study||13
2372475|NCT01515943|5822146|P2|NOT COMPLETED|Overall Study||16
2372476|NCT01515943|5822147|P1|NOT COMPLETED|Overall Study||6
2372477|NCT01515943|5822145|P3|COMPLETED|Overall Study||31
2372478|NCT01515943|5822146|P2|COMPLETED|Overall Study||69
2372479|NCT01515943|5822147|P1|COMPLETED|Overall Study||69
2372480|NCT01515943|5822145|P3|STARTED|Overall Study||44
2372481|NCT01515943|5822146|P2|STARTED|Overall Study||85
2372482|NCT01515943|5822147|P1|STARTED|Overall Study||75
2372483|NCT01515891|5822193|P1|NOT COMPLETED|Overall Study||0
2372484|NCT01515891|5822193|P1|COMPLETED|Overall Study||4
2372485|NCT01515891|5822193|P1|STARTED|Overall Study||4
2372486|NCT01515865|5822200|P3|NOT COMPLETED|Part C (Randomized)||0
2372487|NCT01515865|5822201|P2|NOT COMPLETED|Part C (Randomized)||0
2372488|NCT01515865|5822202|P1|NOT COMPLETED|Part C (Randomized)||0
2372489|NCT01515865|5822200|P3|COMPLETED|Part C (Randomized)||34
2372490|NCT01515865|5822201|P2|COMPLETED|Part C (Randomized)||33
2372491|NCT01515865|5822202|P1|COMPLETED|Part C (Randomized)||0
2372492|NCT01515865|5822200|P3|STARTED|Part C (Randomized)||34
2372493|NCT01515865|5822201|P2|STARTED|Part C (Randomized)|A total of two subjects from Part B did not meet the criteria required to be enrolled into Part C.|33
2372494|NCT01515865|5822202|P1|STARTED|Part C (Randomized)||0
2372495|NCT01515865|5822200|P3|NOT COMPLETED|Part B (Open-label)||0
2372496|NCT01515865|5822201|P2|NOT COMPLETED|Part B (Open-label)||0
2372497|NCT01515865|5822202|P1|NOT COMPLETED|Part B (Open-label)||2
2372498|NCT01515865|5822200|P3|COMPLETED|Part B (Open-label)||0
2372499|NCT01515865|5822201|P2|COMPLETED|Part B (Open-label)||0
2372500|NCT01515865|5822202|P1|COMPLETED|Part B (Open-label)||69
2372501|NCT01515865|5822200|P3|STARTED|Part B (Open-label)||0
2372502|NCT01515865|5822201|P2|STARTED|Part B (Open-label)||0
2372503|NCT01515865|5822202|P1|STARTED|Part B (Open-label)|Twenty-four subjects from Part A did not meet the criteria required to be enrolled into Part B.|71
2372504|NCT01515865|5822200|P3|NOT COMPLETED|Part A (Open-label)||0
2372505|NCT01515865|5822201|P2|NOT COMPLETED|Part A (Open-label)||0
2372506|NCT01515865|5822202|P1|NOT COMPLETED|Part A (Open-label)||3
2372507|NCT01515865|5822200|P3|COMPLETED|Part A (Open-label)||0
2372508|NCT01515865|5822201|P2|COMPLETED|Part A (Open-label)||0
2372509|NCT01515865|5822202|P1|COMPLETED|Part A (Open-label)||95
2372510|NCT01515865|5822200|P3|STARTED|Part A (Open-label)||0
2372511|NCT01515865|5822201|P2|STARTED|Part A (Open-label)||0
2372512|NCT01515865|5822202|P1|STARTED|Part A (Open-label)||98
2372513|NCT01515696|5822212|P2|NOT COMPLETED|Overall Study||10
2372514|NCT01515696|5822213|P1|NOT COMPLETED|Overall Study||8
2372515|NCT01515696|5822212|P2|COMPLETED|Overall Study||39
2372516|NCT01515696|5822213|P1|COMPLETED|Overall Study||39
2372517|NCT01515696|5822212|P2|STARTED|Overall Study||49
2372518|NCT01515696|5822213|P1|STARTED|Overall Study||47
2372519|NCT01515657|5822223|P3|NOT COMPLETED|Third Intervention||0
2372520|NCT01515657|5822224|P2|NOT COMPLETED|Third Intervention||0
2372521|NCT01515657|5822225|P1|NOT COMPLETED|Third Intervention||1
2372522|NCT01515657|5822223|P3|COMPLETED|Third Intervention||13
2372523|NCT01515657|5822224|P2|COMPLETED|Third Intervention||11
2372524|NCT01515657|5822225|P1|COMPLETED|Third Intervention||13
2372525|NCT01515657|5822223|P3|STARTED|Third Intervention||13
2372526|NCT01515657|5822224|P2|STARTED|Third Intervention||11
2372527|NCT01515657|5822225|P1|STARTED|Third Intervention||14
2372528|NCT01515657|5822223|P3|NOT COMPLETED|Second Intervention||0
2372529|NCT01515657|5822224|P2|NOT COMPLETED|Second Intervention||1
2372530|NCT01515657|5822225|P1|NOT COMPLETED|Second Intervention||0
2372531|NCT01515657|5822223|P3|COMPLETED|Second Intervention||13
2372532|NCT01515657|5822224|P2|COMPLETED|Second Intervention||11
2372533|NCT01515657|5822225|P1|COMPLETED|Second Intervention||14
2372534|NCT01515657|5822223|P3|STARTED|Second Intervention||13
2372535|NCT01515657|5822224|P2|STARTED|Second Intervention||12
2372536|NCT01515657|5822225|P1|STARTED|Second Intervention||14
2372537|NCT01515657|5822223|P3|NOT COMPLETED|First Intervention||0
2372538|NCT01515657|5822224|P2|NOT COMPLETED|First Intervention||1
2372539|NCT01515657|5822225|P1|NOT COMPLETED|First Intervention||0
2372540|NCT01515657|5822223|P3|COMPLETED|First Intervention||13
2372541|NCT01515657|5822224|P2|COMPLETED|First Intervention||12
2372542|NCT01515657|5822225|P1|COMPLETED|First Intervention||14
2372543|NCT01515657|5822223|P3|STARTED|First Intervention||13
2372544|NCT01515657|5822224|P2|STARTED|First Intervention||13
2372545|NCT01515657|5822225|P1|STARTED|First Intervention||14
2372546|NCT01515566|5822235|P2|NOT COMPLETED|Overall Study||0
2372547|NCT01515566|5822236|P1|NOT COMPLETED|Overall Study||0
2372548|NCT01515566|5822235|P2|COMPLETED|Overall Study||10
2372549|NCT01515566|5822236|P1|COMPLETED|Overall Study||10
2372550|NCT01515566|5822235|P2|STARTED|Overall Study||10
2372551|NCT01515566|5822236|P1|STARTED|Overall Study||10
2372552|NCT01515540|5822248|P2|NOT COMPLETED|Overall Study||3
2372553|NCT01515540|5822249|P1|NOT COMPLETED|Overall Study||5
2372554|NCT01515540|5822248|P2|COMPLETED|Overall Study||15
2372555|NCT01515540|5822249|P1|COMPLETED|Overall Study||15
2372556|NCT01515540|5822248|P2|STARTED|Overall Study||18
2372557|NCT01515540|5822249|P1|STARTED|Overall Study||20
2372558|NCT01515488|5822257|P2|NOT COMPLETED|Overall Study||0
2372559|NCT01515488|5822258|P1|NOT COMPLETED|Overall Study||0
2372560|NCT01515488|5822257|P2|COMPLETED|Overall Study||200
2372561|NCT01515488|5822258|P1|COMPLETED|Overall Study||200
2372562|NCT01515488|5822257|P2|STARTED|Overall Study||200
2372563|NCT01515488|5822258|P1|STARTED|Overall Study||200
2372564|NCT01515475|5822272|P4|NOT COMPLETED|Overall Study||12
2372565|NCT01515475|5822273|P3|NOT COMPLETED|Overall Study||12
2372566|NCT01515475|5822274|P2|NOT COMPLETED|Overall Study||15
2372567|NCT01515475|5822275|P1|NOT COMPLETED|Overall Study||20
2372568|NCT01515475|5822272|P4|COMPLETED|Overall Study||53
2372569|NCT01515475|5822273|P3|COMPLETED|Overall Study||53
2372570|NCT01515475|5822274|P2|COMPLETED|Overall Study||43
2372571|NCT01515475|5822275|P1|COMPLETED|Overall Study||41
2372572|NCT01515475|5822272|P4|STARTED|Overall Study||65
2372573|NCT01515475|5822273|P3|STARTED|Overall Study||65
2372574|NCT01515475|5822274|P2|STARTED|Overall Study||58
2372575|NCT01515475|5822275|P1|STARTED|Overall Study||61
2372576|NCT01515423|5822349|P3|NOT COMPLETED|DOUBLE BLIND||92
2372577|NCT01515423|5822350|P2|NOT COMPLETED|DOUBLE BLIND||82
2372578|NCT01515423|5822351|P1|NOT COMPLETED|DOUBLE BLIND||0
2372579|NCT01515423|5822349|P3|COMPLETED|DOUBLE BLIND||420
2372580|NCT01515423|5822350|P2|COMPLETED|DOUBLE BLIND||422
2372581|NCT01515423|5822351|P1|COMPLETED|DOUBLE BLIND||0
2372582|NCT01515423|5822349|P3|STARTED|DOUBLE BLIND||512
2372583|NCT01515423|5822350|P2|STARTED|DOUBLE BLIND||504
2372584|NCT01515423|5822351|P1|STARTED|DOUBLE BLIND||0
2372585|NCT01515423|5822349|P3|NOT COMPLETED|Open Label Phase||0
2372586|NCT01515423|5822350|P2|NOT COMPLETED|Open Label Phase||0
2372587|NCT01515423|5822351|P1|NOT COMPLETED|Open Label Phase||413
2372588|NCT01515423|5822349|P3|COMPLETED|Open Label Phase||0
2372589|NCT01515423|5822350|P2|COMPLETED|Open Label Phase||0
2372590|NCT01515423|5822351|P1|COMPLETED|Open Label Phase||1016
2372591|NCT01515423|5822349|P3|STARTED|Open Label Phase||0
2372592|NCT01515423|5822350|P2|STARTED|Open Label Phase||0
2372593|NCT01515423|5822351|P1|STARTED|Open Label Phase||1429
2372594|NCT01515410|5822370|P2|NOT COMPLETED|Overall Study||0
2372595|NCT01515410|5822371|P1|NOT COMPLETED|Overall Study||0
2372596|NCT01515410|5822370|P2|COMPLETED|Overall Study||15
2372597|NCT01515410|5822371|P1|COMPLETED|Overall Study||19
2372598|NCT01515410|5822370|P2|STARTED|Overall Study||15
2372599|NCT01515410|5822371|P1|STARTED|Overall Study||19
2372600|NCT01515345|5822379|P2|NOT COMPLETED|Overall Study||0
2372601|NCT01515345|5822380|P1|NOT COMPLETED|Overall Study||1
2372602|NCT01515345|5822379|P2|COMPLETED|Overall Study||343
2372603|NCT01515345|5822380|P1|COMPLETED|Overall Study||664
2372604|NCT01515345|5822379|P2|STARTED|Overall Study||343
2372605|NCT01515345|5822380|P1|STARTED|Overall Study||665
2372606|NCT01515306|5822392|P2|NOT COMPLETED|Overall Study||14
2372607|NCT01515306|5822393|P1|NOT COMPLETED|Overall Study||12
2372608|NCT01515306|5822392|P2|COMPLETED|Overall Study||2
2372609|NCT01515306|5822393|P1|COMPLETED|Overall Study|Completed the required treatment in Cycle 1 Day 1 and Cycle 2 Day 1 and assessment.|12
2372610|NCT01515306|5822392|P2|Drug-Drug Interaction Population|Overall Study|Drug-drug interaction was only assessed in Part A.|0
2372611|NCT01515306|5822393|P1|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1 Day 1 and Cycle 2 Day 1 treatment.|21
2372612|NCT01515306|5822392|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
2372613|NCT01515306|5822393|P1|Received at Least 1 Dose of Study Drug|Overall Study||24
2372614|NCT01515306|5822392|P2|STARTED|Overall Study||16
2372615|NCT01515306|5822393|P1|STARTED|Overall Study||24
2372616|NCT01515189|5822406|P2|NOT COMPLETED|First Re-Induction Phase||15
2372617|NCT01515189|5822407|P1|NOT COMPLETED|First Re-Induction Phase||14
2372618|NCT01515189|5822406|P2|COMPLETED|First Re-Induction Phase||17
2372619|NCT01515189|5822407|P1|COMPLETED|First Re-Induction Phase||9
2372620|NCT01515189|5822406|P2|STARTED|First Re-Induction Phase||32
2372621|NCT01515189|5822407|P1|STARTED|First Re-Induction Phase||23
2372622|NCT01515189|5822406|P2|NOT COMPLETED|Induction||232
2372623|NCT01515189|5822407|P1|NOT COMPLETED|Induction||237
2372624|NCT01515189|5822406|P2|COMPLETED|Induction||130
2372625|NCT01515189|5822407|P1|COMPLETED|Induction||128
2372626|NCT01515189|5822406|P2|STARTED|Induction||362
2372627|NCT01515189|5822407|P1|STARTED|Induction|Includes 1 subject who was randomized but not treated due to an Adverse Event before treatment|365
2372628|NCT01515176|5822429|P2|NOT COMPLETED|Overall Study||0
2372629|NCT01515176|5822430|P1|NOT COMPLETED|Overall Study||0
2372630|NCT01515176|5822429|P2|COMPLETED|Overall Study||32
2372631|NCT01515176|5822430|P1|COMPLETED|Overall Study||4
2372632|NCT01515176|5822429|P2|STARTED|Overall Study||32
2372633|NCT01515176|5822430|P1|STARTED|Overall Study||4
2372634|NCT01515072|5822444|P2|NOT COMPLETED|Overall Study||0
2372635|NCT01515072|5822445|P1|NOT COMPLETED|Overall Study||0
2372636|NCT01515072|5822444|P2|COMPLETED|Overall Study|There were 513 total organs transplanted and 235 kidneys transplanted in the RIPC group|155
2372637|NCT01515072|5822445|P1|COMPLETED|Overall Study|There were 566 total organs transplanted and 248 kidneys transplanted in the No RIPC group.|166
2372638|NCT01515072|5822444|P2|STARTED|Overall Study||155
2372639|NCT01515072|5822445|P1|STARTED|Overall Study||166
2372640|NCT01515046|5822485|P1|NOT COMPLETED|Overall Study||0
2372641|NCT01515046|5822485|P1|COMPLETED|Overall Study||1
2372642|NCT01515046|5822485|P1|STARTED|Overall Study||1
2372643|NCT01514864|5822495|P2|NOT COMPLETED|Overall Study||5
2372644|NCT01514864|5822496|P1|NOT COMPLETED|Overall Study||9
2372645|NCT01514864|5822495|P2|COMPLETED|Overall Study||0
2372646|NCT01514864|5822496|P1|COMPLETED|Overall Study|Study was terminated; no patients completed study treatment|0
2372647|NCT01514864|5822495|P2|STARTED|Overall Study||5
2372648|NCT01514864|5822496|P1|STARTED|Overall Study||9
2372649|NCT01514786|5822514|P2|NOT COMPLETED|Overall Study||0
2372650|NCT01514786|5822515|P1|NOT COMPLETED|Overall Study||0
2372651|NCT01514786|5822514|P2|COMPLETED|Overall Study||284
2372652|NCT01514786|5822515|P1|COMPLETED|Overall Study||286
2372653|NCT01514786|5822514|P2|STARTED|Overall Study||284
2372654|NCT01514786|5822515|P1|STARTED|Overall Study||286
2372655|NCT01514760|5822521|P1|NOT COMPLETED|Overall Study||2
2372656|NCT01514760|5822521|P1|COMPLETED|Overall Study||20
2372657|NCT01514760|5822521|P1|STARTED|Overall Study||22
2372658|NCT01514734|5822528|P1|NOT COMPLETED|Overall Study||0
2372659|NCT01514734|5822528|P1|COMPLETED|Overall Study||9
2372660|NCT01514734|5822528|P1|STARTED|Overall Study||9
2372661|NCT01514682|5822534|P2|NOT COMPLETED|Overall Study||6
2372662|NCT01514682|5822535|P1|NOT COMPLETED|Overall Study||6
2372663|NCT01514682|5822534|P2|COMPLETED|Overall Study||14
2372664|NCT01514682|5822535|P1|COMPLETED|Overall Study||13
2372665|NCT01514682|5822534|P2|STARTED|Overall Study||20
2372666|NCT01514682|5822535|P1|STARTED|Overall Study||19
2372667|NCT01514630|5822551|P1|NOT COMPLETED|Overall Study||3
2372668|NCT01514630|5822551|P1|COMPLETED|Overall Study||11
2372669|NCT01514630|5822551|P1|STARTED|Overall Study||14
2372670|NCT01514513|5822557|P2|NOT COMPLETED|Overall Study||1
2372671|NCT01514513|5822558|P1|NOT COMPLETED|Overall Study||1
2372672|NCT01514513|5822557|P2|COMPLETED|Overall Study||20
2372673|NCT01514513|5822558|P1|COMPLETED|Overall Study||20
2372674|NCT01514513|5822557|P2|STARTED|Overall Study||21
2372675|NCT01514513|5822558|P1|STARTED|Overall Study||21
2372676|NCT01514461|5822569|P3|NOT COMPLETED|Overall Study||4
2372677|NCT01514461|5822570|P2|NOT COMPLETED|Overall Study||3
2372678|NCT01514461|5822571|P1|NOT COMPLETED|Overall Study||5
2372679|NCT01514461|5822569|P3|COMPLETED|Overall Study||11
2372680|NCT01514461|5822570|P2|COMPLETED|Overall Study||12
2372681|NCT01514461|5822571|P1|COMPLETED|Overall Study||10
2372682|NCT01514461|5822569|P3|STARTED|Overall Study||15
2372683|NCT01514461|5822570|P2|STARTED|Overall Study||15
2372684|NCT01514461|5822571|P1|STARTED|Overall Study||15
2372685|NCT01514448|5822610|P2|NOT COMPLETED|Overall Study||8
2372686|NCT01514448|5822611|P1|NOT COMPLETED|Overall Study||12
2372687|NCT01514448|5822610|P2|COMPLETED|Overall Study||5
2372688|NCT01514448|5822611|P1|COMPLETED|Overall Study||4
2372689|NCT01514448|5822610|P2|Full Analysis Set (FAS)|Overall Study||13
2372690|NCT01514448|5822611|P1|Full Analysis Set (FAS)|Overall Study||12
2372691|NCT01514448|5822610|P2|STARTED|Overall Study||13
2372692|NCT01514448|5822611|P1|STARTED|Overall Study||16
2372693|NCT01514422|5822626|P1|NOT COMPLETED|Overall Study||1
2372694|NCT01514422|5822626|P1|COMPLETED|Overall Study||19
2372695|NCT01514422|5822626|P1|STARTED|Overall Study||20
2372696|NCT01514396|5822632|P1|NOT COMPLETED|Overall Study||0
2372697|NCT01514396|5822632|P1|COMPLETED|Overall Study||8
2372698|NCT01514396|5822632|P1|STARTED|Overall Study||8
2372699|NCT01514383|5822637|P1|NOT COMPLETED|Overall Study||0
2372700|NCT01514383|5822637|P1|COMPLETED|Overall Study||34
2372701|NCT01514383|5822637|P1|STARTED|Overall Study||34
2372702|NCT01514370|5822644|P2|NOT COMPLETED|Overall Study||16
2372703|NCT01514370|5822645|P1|NOT COMPLETED|Overall Study||11
2372704|NCT01514370|5822644|P2|COMPLETED|Overall Study||24
2372705|NCT01514370|5822645|P1|COMPLETED|Overall Study||29
2372706|NCT01514370|5822644|P2|Safety Population|Overall Study|The Safety population consisted all randomized subjects who received at least 1 dose of study drug.|40
2372707|NCT01514370|5822645|P1|Safety Population|Overall Study|The Safety population consisted all randomized subjects who received at least 1 dose of study drug.|38
2372708|NCT01514370|5822644|P2|STARTED|Overall Study||40
2372709|NCT01514370|5822645|P1|STARTED|Overall Study||40
2372710|NCT01514357|5822691|P2|NOT COMPLETED|Overall Study||0
2372711|NCT01514357|5822692|P1|NOT COMPLETED|Overall Study||4
2372712|NCT01514357|5822691|P2|COMPLETED|Overall Study||0
2372713|NCT01514357|5822692|P1|COMPLETED|Overall Study||8
2372714|NCT01514357|5822691|P2|STARTED|Overall Study||0
2372715|NCT01514357|5822692|P1|STARTED|Overall Study||12
2372716|NCT01514318|5822698|P1|NOT COMPLETED|Overall Study||0
2372717|NCT01514318|5822698|P1|COMPLETED|Overall Study||8
2372718|NCT01514318|5822698|P1|STARTED|Overall Study||8
2372719|NCT01514292|5822704|P1|NOT COMPLETED|Overall Study||0
2372720|NCT01514292|5822704|P1|COMPLETED|Overall Study||72
2372721|NCT01514292|5822704|P1|STARTED|Overall Study||72
2372722|NCT01514240|5822710|P2|NOT COMPLETED|Overall Study||11
2372723|NCT01514240|5822711|P1|NOT COMPLETED|Overall Study||6
2372724|NCT01514240|5822710|P2|COMPLETED|Overall Study||45
2372725|NCT01514240|5822711|P1|COMPLETED|Overall Study||50
2372726|NCT01514240|5822710|P2|STARTED|Overall Study||56
2372727|NCT01514240|5822711|P1|STARTED|Overall Study||56
2372728|NCT01514201|5822789|P4|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||33
2372729|NCT01514201|5822790|P3|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
2372730|NCT01514201|5822791|P2|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
2372731|NCT01514201|5822792|P1|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
2372732|NCT01514201|5822789|P4|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||2
2372733|NCT01514201|5822790|P3|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
2372734|NCT01514201|5822791|P2|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
2372735|NCT01514201|5822792|P1|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
2372736|NCT01514201|5822789|P4|STARTED|PHASE II: Maintenance With Veliparib/TMZ||35
2372737|NCT01514201|5822790|P3|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
2372738|NCT01514201|5822791|P2|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
2372739|NCT01514201|5822792|P1|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
2372740|NCT01514201|5822789|P4|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||12
2372741|NCT01514201|5822790|P3|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
2372742|NCT01514201|5822791|P2|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
2372743|NCT01514201|5822792|P1|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
2372744|NCT01514201|5822789|P4|COMPLETED|PHASE II: Veliparib + Radiation Therapy||35
2372745|NCT01514201|5822790|P3|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
2372746|NCT01514201|5822791|P2|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
2372747|NCT01514201|5822792|P1|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
2372748|NCT01514201|5822789|P4|STARTED|PHASE II: Veliparib + Radiation Therapy||47
2372749|NCT01514201|5822790|P3|STARTED|PHASE II: Veliparib + Radiation Therapy||0
2372750|NCT01514201|5822791|P2|STARTED|PHASE II: Veliparib + Radiation Therapy||0
2372751|NCT01514201|5822792|P1|STARTED|PHASE II: Veliparib + Radiation Therapy||0
2372752|NCT01514201|5822789|P4|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
2372753|NCT01514201|5822790|P3|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||6
2372754|NCT01514201|5822791|P2|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||6
2372755|NCT01514201|5822792|P1|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||5
2372756|NCT01514201|5822789|P4|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
2372757|NCT01514201|5822790|P3|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
2372758|NCT01514201|5822791|P2|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
2372759|NCT01514201|5822792|P1|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
2372760|NCT01514201|5822789|P4|STARTED|PHASE I: Maintenance With Veliparib/TMZ||0
2372761|NCT01514201|5822790|P3|STARTED|PHASE I: Maintenance With Veliparib/TMZ||6
2372762|NCT01514201|5822791|P2|STARTED|PHASE I: Maintenance With Veliparib/TMZ||6
2372849|NCT01514136|5822897|P1|NOT COMPLETED|Test Period 2; Test B*||0
2372763|NCT01514201|5822792|P1|STARTED|PHASE I: Maintenance With Veliparib/TMZ||5
2372764|NCT01514201|5822789|P4|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
2372765|NCT01514201|5822790|P3|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
2372766|NCT01514201|5822791|P2|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
2372767|NCT01514201|5822792|P1|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||1
2372768|NCT01514201|5822789|P4|COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
2372769|NCT01514201|5822790|P3|COMPLETED|PHASE I: Veliparib + Radiation Therapy||6
2372770|NCT01514201|5822791|P2|COMPLETED|PHASE I: Veliparib + Radiation Therapy||6
2372771|NCT01514201|5822792|P1|COMPLETED|PHASE I: Veliparib + Radiation Therapy||5
2372772|NCT01514201|5822789|P4|STARTED|PHASE I: Veliparib + Radiation Therapy||0
2372773|NCT01514201|5822790|P3|STARTED|PHASE I: Veliparib + Radiation Therapy||6
2372774|NCT01514201|5822791|P2|STARTED|PHASE I: Veliparib + Radiation Therapy||6
2372775|NCT01514201|5822792|P1|STARTED|PHASE I: Veliparib + Radiation Therapy||6
2372776|NCT01514162|5822851|P1|NOT COMPLETED|Overall Study||85
2372777|NCT01514162|5822851|P1|COMPLETED|Overall Study||160
2372778|NCT01514162|5822851|P1|STARTED|Overall Study||245
2372779|NCT01514149|5822862|P5|NOT COMPLETED|Overall Study||1
2372780|NCT01514149|5822863|P4|NOT COMPLETED|Overall Study||1
2372781|NCT01514149|5822864|P3|NOT COMPLETED|Overall Study||3
2372782|NCT01514149|5822865|P2|NOT COMPLETED|Overall Study||1
2372783|NCT01514149|5822866|P1|NOT COMPLETED|Overall Study||3
2372784|NCT01514149|5822862|P5|COMPLETED|Overall Study||14
2372785|NCT01514149|5822863|P4|COMPLETED|Overall Study||13
2372786|NCT01514149|5822864|P3|COMPLETED|Overall Study||11
2372787|NCT01514149|5822865|P2|COMPLETED|Overall Study||14
2372788|NCT01514149|5822866|P1|COMPLETED|Overall Study||12
2372789|NCT01514149|5822862|P5|STARTED|Overall Study||15
2372790|NCT01514149|5822863|P4|STARTED|Overall Study||14
2372791|NCT01514149|5822864|P3|STARTED|Overall Study||14
2372792|NCT01514149|5822865|P2|STARTED|Overall Study||15
2372793|NCT01514149|5822866|P1|STARTED|Overall Study||15
2372794|NCT01514136|5822890|P8|NOT COMPLETED|Test Period; Test D*||0
2372795|NCT01514136|5822891|P7|NOT COMPLETED|Test Period; Test D*||0
2372796|NCT01514136|5822892|P6|NOT COMPLETED|Test Period; Test D*||0
2372797|NCT01514136|5822893|P5|NOT COMPLETED|Test Period; Test D*||0
2372798|NCT01514136|5822894|P4|NOT COMPLETED|Test Period; Test D*||0
2372799|NCT01514136|5822895|P3|NOT COMPLETED|Test Period; Test D*||0
2372800|NCT01514136|5822896|P2|NOT COMPLETED|Test Period; Test D*||0
2372801|NCT01514136|5822897|P1|NOT COMPLETED|Test Period; Test D*||0
2372802|NCT01514136|5822890|P8|COMPLETED|Test Period; Test D*||23
2372803|NCT01514136|5822891|P7|COMPLETED|Test Period; Test D*||0
2372804|NCT01514136|5822892|P6|COMPLETED|Test Period; Test D*||0
2372805|NCT01514136|5822893|P5|COMPLETED|Test Period; Test D*||0
2372806|NCT01514136|5822894|P4|COMPLETED|Test Period; Test D*||0
2372807|NCT01514136|5822895|P3|COMPLETED|Test Period; Test D*||0
2372808|NCT01514136|5822896|P2|COMPLETED|Test Period; Test D*||0
2372809|NCT01514136|5822897|P1|COMPLETED|Test Period; Test D*||0
2372810|NCT01514136|5822890|P8|STARTED|Test Period; Test D*||23
2372811|NCT01514136|5822891|P7|STARTED|Test Period; Test D*||0
2372812|NCT01514136|5822892|P6|STARTED|Test Period; Test D*||0
2372813|NCT01514136|5822893|P5|STARTED|Test Period; Test D*||0
2372814|NCT01514136|5822894|P4|STARTED|Test Period; Test D*||0
2372815|NCT01514136|5822895|P3|STARTED|Test Period; Test D*||0
2372816|NCT01514136|5822896|P2|STARTED|Test Period; Test D*||0
2372817|NCT01514136|5822897|P1|STARTED|Test Period; Test D*||0
2372818|NCT01514136|5822890|P8|NOT COMPLETED|Test Period 2; Test C*||0
2372819|NCT01514136|5822891|P7|NOT COMPLETED|Test Period 2; Test C*||3
2372820|NCT01514136|5822892|P6|NOT COMPLETED|Test Period 2; Test C*||0
2372821|NCT01514136|5822893|P5|NOT COMPLETED|Test Period 2; Test C*||0
2372822|NCT01514136|5822894|P4|NOT COMPLETED|Test Period 2; Test C*||0
2372823|NCT01514136|5822895|P3|NOT COMPLETED|Test Period 2; Test C*||0
2372824|NCT01514136|5822896|P2|NOT COMPLETED|Test Period 2; Test C*||0
2372825|NCT01514136|5822897|P1|NOT COMPLETED|Test Period 2; Test C*||0
2372826|NCT01514136|5822890|P8|COMPLETED|Test Period 2; Test C*||0
2372827|NCT01514136|5822891|P7|COMPLETED|Test Period 2; Test C*||23
2372828|NCT01514136|5822892|P6|COMPLETED|Test Period 2; Test C*||0
2372829|NCT01514136|5822893|P5|COMPLETED|Test Period 2; Test C*||0
2372830|NCT01514136|5822894|P4|COMPLETED|Test Period 2; Test C*||0
2372831|NCT01514136|5822895|P3|COMPLETED|Test Period 2; Test C*||0
2372832|NCT01514136|5822896|P2|COMPLETED|Test Period 2; Test C*||0
2372833|NCT01514136|5822897|P1|COMPLETED|Test Period 2; Test C*||0
2372834|NCT01514136|5822890|P8|STARTED|Test Period 2; Test C*||0
2372835|NCT01514136|5822891|P7|STARTED|Test Period 2; Test C*||26
2372836|NCT01514136|5822892|P6|STARTED|Test Period 2; Test C*||0
2372837|NCT01514136|5822893|P5|STARTED|Test Period 2; Test C*||0
2372838|NCT01514136|5822894|P4|STARTED|Test Period 2; Test C*||0
2372839|NCT01514136|5822895|P3|STARTED|Test Period 2; Test C*||0
2372840|NCT01514136|5822896|P2|STARTED|Test Period 2; Test C*||0
2372841|NCT01514136|5822897|P1|STARTED|Test Period 2; Test C*||0
2372842|NCT01514136|5822890|P8|NOT COMPLETED|Test Period 2; Test B*||0
2372843|NCT01514136|5822891|P7|NOT COMPLETED|Test Period 2; Test B*||0
2372844|NCT01514136|5822892|P6|NOT COMPLETED|Test Period 2; Test B*||2
2372845|NCT01514136|5822893|P5|NOT COMPLETED|Test Period 2; Test B*||0
2372846|NCT01514136|5822894|P4|NOT COMPLETED|Test Period 2; Test B*||0
2372847|NCT01514136|5822895|P3|NOT COMPLETED|Test Period 2; Test B*||0
2372848|NCT01514136|5822896|P2|NOT COMPLETED|Test Period 2; Test B*||0
2372850|NCT01514136|5822890|P8|COMPLETED|Test Period 2; Test B*||0
2372851|NCT01514136|5822891|P7|COMPLETED|Test Period 2; Test B*||0
2372852|NCT01514136|5822892|P6|COMPLETED|Test Period 2; Test B*||26
2372853|NCT01514136|5822893|P5|COMPLETED|Test Period 2; Test B*||0
2372854|NCT01514136|5822894|P4|COMPLETED|Test Period 2; Test B*||0
2372855|NCT01514136|5822895|P3|COMPLETED|Test Period 2; Test B*||0
2372856|NCT01514136|5822896|P2|COMPLETED|Test Period 2; Test B*||0
2372857|NCT01514136|5822897|P1|COMPLETED|Test Period 2; Test B*||0
2372858|NCT01514136|5822890|P8|STARTED|Test Period 2; Test B*||0
2372859|NCT01514136|5822891|P7|STARTED|Test Period 2; Test B*||0
2372860|NCT01514136|5822892|P6|STARTED|Test Period 2; Test B*|Two subjects did not test test A*, but had a break and continued again on Test B*|28
2372861|NCT01514136|5822893|P5|STARTED|Test Period 2; Test B*||0
2372862|NCT01514136|5822894|P4|STARTED|Test Period 2; Test B*||0
2372863|NCT01514136|5822895|P3|STARTED|Test Period 2; Test B*||0
2372864|NCT01514136|5822896|P2|STARTED|Test Period 2; Test B*||0
2372865|NCT01514136|5822897|P1|STARTED|Test Period 2; Test B*||0
2372866|NCT01514136|5822890|P8|NOT COMPLETED|Test Period 2; Test A*||0
2372867|NCT01514136|5822891|P7|NOT COMPLETED|Test Period 2; Test A*||0
2372868|NCT01514136|5822892|P6|NOT COMPLETED|Test Period 2; Test A*||0
2372869|NCT01514136|5822893|P5|NOT COMPLETED|Test Period 2; Test A*||2
2372870|NCT01514136|5822894|P4|NOT COMPLETED|Test Period 2; Test A*||0
2372871|NCT01514136|5822895|P3|NOT COMPLETED|Test Period 2; Test A*||0
2372872|NCT01514136|5822896|P2|NOT COMPLETED|Test Period 2; Test A*||0
2372873|NCT01514136|5822897|P1|NOT COMPLETED|Test Period 2; Test A*||0
2372874|NCT01514136|5822890|P8|COMPLETED|Test Period 2; Test A*||0
2372875|NCT01514136|5822891|P7|COMPLETED|Test Period 2; Test A*||0
2372876|NCT01514136|5822892|P6|COMPLETED|Test Period 2; Test A*||0
2372877|NCT01514136|5822893|P5|COMPLETED|Test Period 2; Test A*||26
2372878|NCT01514136|5822894|P4|COMPLETED|Test Period 2; Test A*||0
2372879|NCT01514136|5822895|P3|COMPLETED|Test Period 2; Test A*||0
2372880|NCT01514136|5822896|P2|COMPLETED|Test Period 2; Test A*||0
2372881|NCT01514136|5822897|P1|COMPLETED|Test Period 2; Test A*||0
2372882|NCT01514136|5822890|P8|STARTED|Test Period 2; Test A*||0
2372883|NCT01514136|5822891|P7|STARTED|Test Period 2; Test A*||0
2372884|NCT01514136|5822892|P6|STARTED|Test Period 2; Test A*||0
2372885|NCT01514136|5822893|P5|STARTED|Test Period 2; Test A*|4 new subjects were included in the investigation|28
2372886|NCT01514136|5822894|P4|STARTED|Test Period 2; Test A*||0
2372887|NCT01514136|5822895|P3|STARTED|Test Period 2; Test A*||0
2372888|NCT01514136|5822896|P2|STARTED|Test Period 2; Test A*||0
2372889|NCT01514136|5822897|P1|STARTED|Test Period 2; Test A*||0
2372890|NCT01514136|5822890|P8|NOT COMPLETED|Test Period 1; Test D||0
2372891|NCT01514136|5822891|P7|NOT COMPLETED|Test Period 1; Test D||0
2372892|NCT01514136|5822892|P6|NOT COMPLETED|Test Period 1; Test D||0
2372893|NCT01514136|5822893|P5|NOT COMPLETED|Test Period 1; Test D||0
2372894|NCT01514136|5822894|P4|NOT COMPLETED|Test Period 1; Test D||2
2372895|NCT01514136|5822895|P3|NOT COMPLETED|Test Period 1; Test D||0
2372896|NCT01514136|5822896|P2|NOT COMPLETED|Test Period 1; Test D||0
2372897|NCT01514136|5822897|P1|NOT COMPLETED|Test Period 1; Test D||0
2372898|NCT01514136|5822890|P8|COMPLETED|Test Period 1; Test D||0
2372899|NCT01514136|5822891|P7|COMPLETED|Test Period 1; Test D||0
2372900|NCT01514136|5822892|P6|COMPLETED|Test Period 1; Test D||0
2372901|NCT01514136|5822893|P5|COMPLETED|Test Period 1; Test D||0
2372902|NCT01514136|5822894|P4|COMPLETED|Test Period 1; Test D||24
2372903|NCT01514136|5822895|P3|COMPLETED|Test Period 1; Test D||0
2372904|NCT01514136|5822896|P2|COMPLETED|Test Period 1; Test D||0
2372905|NCT01514136|5822897|P1|COMPLETED|Test Period 1; Test D||0
2372906|NCT01514136|5822890|P8|STARTED|Test Period 1; Test D||0
2372907|NCT01514136|5822891|P7|STARTED|Test Period 1; Test D||0
2372908|NCT01514136|5822892|P6|STARTED|Test Period 1; Test D||0
2372909|NCT01514136|5822893|P5|STARTED|Test Period 1; Test D||0
2372910|NCT01514136|5822894|P4|STARTED|Test Period 1; Test D|The two subject that were on holiday after test A re-entered the investigation|26
2372911|NCT01514136|5822895|P3|STARTED|Test Period 1; Test D||0
2372912|NCT01514136|5822896|P2|STARTED|Test Period 1; Test D||0
2372913|NCT01514136|5822897|P1|STARTED|Test Period 1; Test D||0
2372914|NCT01514136|5822890|P8|NOT COMPLETED|Test Period 1; Test C||0
2372915|NCT01514136|5822891|P7|NOT COMPLETED|Test Period 1; Test C||0
2372916|NCT01514136|5822892|P6|NOT COMPLETED|Test Period 1; Test C||0
2372917|NCT01514136|5822893|P5|NOT COMPLETED|Test Period 1; Test C||0
2372918|NCT01514136|5822894|P4|NOT COMPLETED|Test Period 1; Test C||0
2372919|NCT01514136|5822895|P3|NOT COMPLETED|Test Period 1; Test C||0
2372920|NCT01514136|5822896|P2|NOT COMPLETED|Test Period 1; Test C||0
2372921|NCT01514136|5822897|P1|NOT COMPLETED|Test Period 1; Test C||0
2372922|NCT01514136|5822890|P8|COMPLETED|Test Period 1; Test C||0
2372923|NCT01514136|5822891|P7|COMPLETED|Test Period 1; Test C||0
2372924|NCT01514136|5822892|P6|COMPLETED|Test Period 1; Test C||0
2372925|NCT01514136|5822893|P5|COMPLETED|Test Period 1; Test C||0
2372926|NCT01514136|5822894|P4|COMPLETED|Test Period 1; Test C||0
2372927|NCT01514136|5822895|P3|COMPLETED|Test Period 1; Test C||24
2372928|NCT01514136|5822896|P2|COMPLETED|Test Period 1; Test C||0
2372929|NCT01514136|5822897|P1|COMPLETED|Test Period 1; Test C||0
2372930|NCT01514136|5822890|P8|STARTED|Test Period 1; Test C||0
2372931|NCT01514136|5822891|P7|STARTED|Test Period 1; Test C||0
2372932|NCT01514136|5822892|P6|STARTED|Test Period 1; Test C||0
2372933|NCT01514136|5822893|P5|STARTED|Test Period 1; Test C||0
2372934|NCT01514136|5822894|P4|STARTED|Test Period 1; Test C||0
2372935|NCT01514136|5822895|P3|STARTED|Test Period 1; Test C|1 new subject was included in the investigation|24
2372936|NCT01514136|5822896|P2|STARTED|Test Period 1; Test C||0
2372937|NCT01514136|5822897|P1|STARTED|Test Period 1; Test C||0
2372938|NCT01514136|5822890|P8|NOT COMPLETED|Test Period 1; Test B||0
2372939|NCT01514136|5822891|P7|NOT COMPLETED|Test Period 1; Test B||0
2372940|NCT01514136|5822892|P6|NOT COMPLETED|Test Period 1; Test B||0
2372941|NCT01514136|5822893|P5|NOT COMPLETED|Test Period 1; Test B||0
2372942|NCT01514136|5822894|P4|NOT COMPLETED|Test Period 1; Test B||0
2372943|NCT01514136|5822895|P3|NOT COMPLETED|Test Period 1; Test B||0
2372944|NCT01514136|5822896|P2|NOT COMPLETED|Test Period 1; Test B||1
2372945|NCT01514136|5822897|P1|NOT COMPLETED|Test Period 1; Test B||0
2372946|NCT01514136|5822890|P8|COMPLETED|Test Period 1; Test B||0
2372947|NCT01514136|5822891|P7|COMPLETED|Test Period 1; Test B||0
2372948|NCT01514136|5822892|P6|COMPLETED|Test Period 1; Test B||0
2372949|NCT01514136|5822893|P5|COMPLETED|Test Period 1; Test B||0
2372950|NCT01514136|5822894|P4|COMPLETED|Test Period 1; Test B||0
2372951|NCT01514136|5822895|P3|COMPLETED|Test Period 1; Test B||0
2372952|NCT01514136|5822896|P2|COMPLETED|Test Period 1; Test B||23
2372953|NCT01514136|5822897|P1|COMPLETED|Test Period 1; Test B||0
2372954|NCT01514136|5822890|P8|STARTED|Test Period 1; Test B||0
2372955|NCT01514136|5822891|P7|STARTED|Test Period 1; Test B||0
2372956|NCT01514136|5822892|P6|STARTED|Test Period 1; Test B||0
2372957|NCT01514136|5822893|P5|STARTED|Test Period 1; Test B||0
2372958|NCT01514136|5822894|P4|STARTED|Test Period 1; Test B||0
2372959|NCT01514136|5822895|P3|STARTED|Test Period 1; Test B||0
2372960|NCT01514136|5822896|P2|STARTED|Test Period 1; Test B|2 new subjects were entered the investigation|24
2372961|NCT01514136|5822897|P1|STARTED|Test Period 1; Test B||0
2372962|NCT01514136|5822890|P8|NOT COMPLETED|Test Period 1; Test A||0
2372963|NCT01514136|5822891|P7|NOT COMPLETED|Test Period 1; Test A||0
2372964|NCT01514136|5822892|P6|NOT COMPLETED|Test Period 1; Test A||0
2372965|NCT01514136|5822893|P5|NOT COMPLETED|Test Period 1; Test A||0
2372966|NCT01514136|5822894|P4|NOT COMPLETED|Test Period 1; Test A||0
2372967|NCT01514136|5822895|P3|NOT COMPLETED|Test Period 1; Test A||0
2372968|NCT01514136|5822896|P2|NOT COMPLETED|Test Period 1; Test A||0
2372969|NCT01514136|5822897|P1|NOT COMPLETED|Test Period 1; Test A||3
2372970|NCT01514136|5822890|P8|COMPLETED|Test Period 1; Test A||0
2372971|NCT01514136|5822891|P7|COMPLETED|Test Period 1; Test A||0
2372972|NCT01514136|5822892|P6|COMPLETED|Test Period 1; Test A||0
2372973|NCT01514136|5822893|P5|COMPLETED|Test Period 1; Test A||0
2372974|NCT01514136|5822894|P4|COMPLETED|Test Period 1; Test A||0
2372975|NCT01514136|5822895|P3|COMPLETED|Test Period 1; Test A||0
2372976|NCT01514136|5822896|P2|COMPLETED|Test Period 1; Test A||0
2372977|NCT01514136|5822897|P1|COMPLETED|Test Period 1; Test A||22
2372978|NCT01514136|5822890|P8|STARTED|Test Period 1; Test A||0
2372979|NCT01514136|5822891|P7|STARTED|Test Period 1; Test A||0
2372980|NCT01514136|5822892|P6|STARTED|Test Period 1; Test A||0
2372981|NCT01514136|5822893|P5|STARTED|Test Period 1; Test A||0
2372982|NCT01514136|5822894|P4|STARTED|Test Period 1; Test A||0
2372983|NCT01514136|5822895|P3|STARTED|Test Period 1; Test A||0
2372984|NCT01514136|5822896|P2|STARTED|Test Period 1; Test A||0
2372985|NCT01514136|5822897|P1|STARTED|Test Period 1; Test A|26 subjects tested Test A|25
2372986|NCT01513902|5822926|P3|NOT COMPLETED|Overall Study||0
2372987|NCT01513902|5822927|P2|NOT COMPLETED|Overall Study||0
2372988|NCT01513902|5822928|P1|NOT COMPLETED|Overall Study||0
2372989|NCT01513902|5822926|P3|COMPLETED|Overall Study||9
2372990|NCT01513902|5822927|P2|COMPLETED|Overall Study||9
2372991|NCT01513902|5822928|P1|COMPLETED|Overall Study||8
2372992|NCT01513902|5822926|P3|STARTED|Overall Study||9
2372993|NCT01513902|5822927|P2|STARTED|Overall Study||9
2372994|NCT01513902|5822928|P1|STARTED|Overall Study||8
2372995|NCT01513759|5822963|P1|NOT COMPLETED|Overall Study||5
2372996|NCT01513759|5822963|P1|COMPLETED|Overall Study||145
2372997|NCT01513759|5822963|P1|At Least One Device Successfully Placed|Overall Study||149
2372998|NCT01513759|5822963|P1|STARTED|Overall Study||150
2372999|NCT01513590|5822974|P2|NOT COMPLETED|Overall Study||13
2373000|NCT01513590|5822975|P1|NOT COMPLETED|Overall Study||10
2373001|NCT01513590|5822974|P2|COMPLETED|Overall Study||184
2373002|NCT01513590|5822975|P1|COMPLETED|Overall Study||187
2373003|NCT01513590|5822974|P2|Exposed|Overall Study|"Two (2) subjects were withdrawn prior to exposure due to withdrawal of consent"|195
2373004|NCT01513590|5822975|P1|Exposed|Overall Study|One (1) subject was withdrawn prior to exposure due to “non fulfilment of inclusion criteria”|196
2373005|NCT01513590|5822974|P2|STARTED|Overall Study||197
2373006|NCT01513590|5822975|P1|STARTED|Overall Study||197
2373007|NCT01513551|5822996|P3|NOT COMPLETED|Overall Study||5
2373008|NCT01513551|5822997|P2|NOT COMPLETED|Overall Study||6
2373009|NCT01513551|5822998|P1|NOT COMPLETED|Overall Study||4
2373010|NCT01513551|5822996|P3|COMPLETED|Overall Study||226
2373011|NCT01513551|5822997|P2|COMPLETED|Overall Study||225
2373012|NCT01513551|5822998|P1|COMPLETED|Overall Study||226
2373013|NCT01513551|5822996|P3|Vaccinated|Overall Study||230
2373014|NCT01513551|5822997|P2|Vaccinated|Overall Study||231
2373015|NCT01513551|5822998|P1|Vaccinated|Overall Study||230
2373016|NCT01513551|5822996|P3|STARTED|Overall Study||231
2373017|NCT01513551|5822997|P2|STARTED|Overall Study||231
2373018|NCT01513551|5822998|P1|STARTED|Overall Study||230
2373019|NCT01513538|5823024|P1|NOT COMPLETED|Overall Study||5
2373020|NCT01513538|5823024|P1|COMPLETED|Overall Study||573
2373021|NCT01513538|5823024|P1|STARTED|Overall Study||578
2373022|NCT01513473|5823030|P2|NOT COMPLETED|Extension Trial (26 Weeks)||6
2373023|NCT01513473|5823031|P1|NOT COMPLETED|Extension Trial (26 Weeks)||1
2373024|NCT01513473|5823030|P2|COMPLETED|Extension Trial (26 Weeks)||122
2373025|NCT01513473|5823031|P1|COMPLETED|Extension Trial (26 Weeks)||151
2373026|NCT01513473|5823030|P2|STARTED|Extension Trial (26 Weeks)|37 subjects did not consent to participate in the extension trial.|128
2373027|NCT01513473|5823031|P1|STARTED|Extension Trial (26 Weeks)|18 subjects did not consent to participate in the extension trial.|152
2373028|NCT01513473|5823030|P2|NOT COMPLETED|Main Trial (26 Weeks)||11
2373029|NCT01513473|5823031|P1|NOT COMPLETED|Main Trial (26 Weeks)||4
2373030|NCT01513473|5823030|P2|COMPLETED|Main Trial (26 Weeks)||165
2373031|NCT01513473|5823031|P1|COMPLETED|Main Trial (26 Weeks)||170
2373032|NCT01513473|5823030|P2|Exposed|Main Trial (26 Weeks)||175
2373033|NCT01513473|5823031|P1|Exposed|Main Trial (26 Weeks)||174
2373034|NCT01513473|5823030|P2|STARTED|Main Trial (26 Weeks)|1 subject was randomised but withdrew before the drug exposure.|176
2373035|NCT01513473|5823031|P1|STARTED|Main Trial (26 Weeks)||174
2373036|NCT01513460|5823058|P3|NOT COMPLETED|Overall Study||56
2373037|NCT01513460|5823059|P2|NOT COMPLETED|Overall Study||32
2373038|NCT01513460|5823060|P1|NOT COMPLETED|Overall Study||29
2373039|NCT01513460|5823058|P3|COMPLETED|Overall Study||201
2373040|NCT01513460|5823059|P2|COMPLETED|Overall Study||226
2373041|NCT01513460|5823060|P1|COMPLETED|Overall Study||229
2373042|NCT01513460|5823058|P3|Per-protocol Set|Overall Study||166
2373043|NCT01513460|5823059|P2|Per-protocol Set|Overall Study||186
2373044|NCT01513460|5823060|P1|Per-protocol Set|Overall Study||196
2373045|NCT01513460|5823058|P3|Full Analysis Set|Overall Study||257
2373046|NCT01513460|5823059|P2|Full Analysis Set|Overall Study||258
2373047|NCT01513460|5823060|P1|Full Analysis Set|Overall Study||257
2373048|NCT01513460|5823058|P3|STARTED|Overall Study||257
2373049|NCT01513460|5823059|P2|STARTED|Overall Study||258
2373050|NCT01513460|5823060|P1|STARTED|Overall Study||258
2373051|NCT01513447|5823086|P2|NOT COMPLETED|Overall Study||0
2373052|NCT01513447|5823087|P1|NOT COMPLETED|Overall Study||0
2373053|NCT01513447|5823086|P2|COMPLETED|Overall Study||5
2373054|NCT01513447|5823087|P1|COMPLETED|Overall Study||3
2373055|NCT01513447|5823086|P2|STARTED|Overall Study||5
2373056|NCT01513447|5823087|P1|STARTED|Overall Study||3
2373057|NCT01513330|5823095|P2|NOT COMPLETED|Standard Care First,||4
2373058|NCT01513330|5823096|P1|NOT COMPLETED|Standard Care First,||4
2373059|NCT01513330|5823095|P2|COMPLETED|Standard Care First,||52
2373060|NCT01513330|5823096|P1|COMPLETED|Standard Care First,||56
2373061|NCT01513330|5823095|P2|STARTED|Standard Care First,||56
2373062|NCT01513330|5823096|P1|STARTED|Standard Care First,||60
2373063|NCT01513330|5823095|P2|NOT COMPLETED|SenSura Mio First,||2
2373064|NCT01513330|5823096|P1|NOT COMPLETED|SenSura Mio First,||4
2373065|NCT01513330|5823095|P2|COMPLETED|SenSura Mio First,||56
2373066|NCT01513330|5823096|P1|COMPLETED|SenSura Mio First,||60
2373067|NCT01513330|5823095|P2|STARTED|SenSura Mio First,||58
2373068|NCT01513330|5823096|P1|STARTED|SenSura Mio First,||64
2373069|NCT01513317|5823104|P2|NOT COMPLETED|Overall Study||24
2373070|NCT01513317|5823105|P1|NOT COMPLETED|Overall Study||34
2373071|NCT01513317|5823104|P2|COMPLETED|Overall Study||2
2373072|NCT01513317|5823105|P1|COMPLETED|Overall Study||16
2373073|NCT01513317|5823104|P2|STARTED|Overall Study||26
2373074|NCT01513317|5823105|P1|STARTED|Overall Study||50
2373075|NCT01513291|5823123|P5|NOT COMPLETED|Run-out Period||0
2373076|NCT01513291|5823124|P4|NOT COMPLETED|Run-out Period||2
2373077|NCT01513291|5823125|P3|NOT COMPLETED|Run-out Period||0
2373078|NCT01513291|5823126|P2|NOT COMPLETED|Run-out Period||0
2373079|NCT01513291|5823127|P1|NOT COMPLETED|Run-out Period||0
2373080|NCT01513291|5823123|P5|COMPLETED|Run-out Period||101
2373081|NCT01513291|5823124|P4|COMPLETED|Run-out Period||45
2373082|NCT01513291|5823125|P3|COMPLETED|Run-out Period||50
2373083|NCT01513291|5823126|P2|COMPLETED|Run-out Period||0
2373084|NCT01513291|5823127|P1|COMPLETED|Run-out Period||0
2373085|NCT01513291|5823123|P5|STARTED|Run-out Period|These participants were completers from the Treatment Period: Placebo group|101
2373086|NCT01513291|5823124|P4|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|47
2373087|NCT01513291|5823125|P3|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|50
2373088|NCT01513291|5823126|P2|STARTED|Run-out Period||0
2373089|NCT01513291|5823127|P1|STARTED|Run-out Period||0
2373090|NCT01513291|5823123|P5|NOT COMPLETED|Treatment Period||0
2373091|NCT01513291|5823124|P4|NOT COMPLETED|Treatment Period||0
2373092|NCT01513291|5823125|P3|NOT COMPLETED|Treatment Period||0
2373093|NCT01513291|5823126|P2|NOT COMPLETED|Treatment Period||16
2373094|NCT01513291|5823127|P1|NOT COMPLETED|Treatment Period||23
2373095|NCT01513291|5823123|P5|COMPLETED|Treatment Period||0
2373096|NCT01513291|5823124|P4|COMPLETED|Treatment Period||0
2373097|NCT01513291|5823125|P3|COMPLETED|Treatment Period||0
2373098|NCT01513291|5823126|P2|COMPLETED|Treatment Period||101
2373099|NCT01513291|5823127|P1|COMPLETED|Treatment Period||97
2373100|NCT01513291|5823123|P5|Treated|Treatment Period||0
2373101|NCT01513291|5823124|P4|Treated|Treatment Period||0
2373102|NCT01513291|5823125|P3|Treated|Treatment Period||0
2373103|NCT01513291|5823126|P2|Treated|Treatment Period||115
2373104|NCT01513291|5823127|P1|Treated|Treatment Period||120
2373105|NCT01513291|5823123|P5|STARTED|Treatment Period||0
2373106|NCT01513291|5823124|P4|STARTED|Treatment Period||0
2373107|NCT01513291|5823125|P3|STARTED|Treatment Period||0
2373108|NCT01513291|5823126|P2|STARTED|Treatment Period||117
2373109|NCT01513291|5823127|P1|STARTED|Treatment Period||120
2373110|NCT01513239|5823155|P6|NOT COMPLETED|Period 2: 9 Month Extension Phase||5
2373111|NCT01513239|5823156|P5|NOT COMPLETED|Period 2: 9 Month Extension Phase||10
2373112|NCT01513239|5823157|P4|NOT COMPLETED|Period 2: 9 Month Extension Phase||10
2373113|NCT01513239|5823158|P3|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
2373114|NCT01513239|5823159|P2|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
2373115|NCT01513239|5823160|P1|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
2373116|NCT01513239|5823155|P6|COMPLETED|Period 2: 9 Month Extension Phase||78
2373117|NCT01513239|5823156|P5|COMPLETED|Period 2: 9 Month Extension Phase||90
2373118|NCT01513239|5823157|P4|COMPLETED|Period 2: 9 Month Extension Phase||102
2373119|NCT01513239|5823158|P3|COMPLETED|Period 2: 9 Month Extension Phase||0
2373120|NCT01513239|5823159|P2|COMPLETED|Period 2: 9 Month Extension Phase||0
2373121|NCT01513239|5823160|P1|COMPLETED|Period 2: 9 Month Extension Phase||0
2373122|NCT01513239|5823155|P6|STARTED|Period 2: 9 Month Extension Phase||83
2373123|NCT01513239|5823156|P5|STARTED|Period 2: 9 Month Extension Phase||100
2373124|NCT01513239|5823157|P4|STARTED|Period 2: 9 Month Extension Phase||112
2373125|NCT01513239|5823158|P3|STARTED|Period 2: 9 Month Extension Phase||0
2373126|NCT01513239|5823159|P2|STARTED|Period 2: 9 Month Extension Phase||0
2373127|NCT01513239|5823160|P1|STARTED|Period 2: 9 Month Extension Phase||0
2373128|NCT01513239|5823155|P6|NOT COMPLETED|Period 1: Main Phase||0
2373129|NCT01513239|5823156|P5|NOT COMPLETED|Period 1: Main Phase||0
2373130|NCT01513239|5823157|P4|NOT COMPLETED|Period 1: Main Phase||0
2373131|NCT01513239|5823158|P3|NOT COMPLETED|Period 1: Main Phase||88
2373132|NCT01513239|5823159|P2|NOT COMPLETED|Period 1: Main Phase||70
2373133|NCT01513239|5823160|P1|NOT COMPLETED|Period 1: Main Phase||75
2373134|NCT01513239|5823155|P6|COMPLETED|Period 1: Main Phase||0
2373135|NCT01513239|5823156|P5|COMPLETED|Period 1: Main Phase||0
2373136|NCT01513239|5823157|P4|COMPLETED|Period 1: Main Phase||0
2373137|NCT01513239|5823158|P3|COMPLETED|Period 1: Main Phase||311
2373138|NCT01513239|5823159|P2|COMPLETED|Period 1: Main Phase||337
2373139|NCT01513239|5823160|P1|COMPLETED|Period 1: Main Phase||322
2373140|NCT01513239|5823155|P6|All Participants as Treated|Period 1: Main Phase||0
2373141|NCT01513239|5823156|P5|All Participants as Treated|Period 1: Main Phase||0
2373142|NCT01513239|5823157|P4|All Participants as Treated|Period 1: Main Phase||0
2373143|NCT01513239|5823158|P3|All Participants as Treated|Period 1: Main Phase|Treatment actually received|381
2373144|NCT01513239|5823159|P2|All Participants as Treated|Period 1: Main Phase|Treatment actually received|396
2373145|NCT01513239|5823160|P1|All Participants as Treated|Period 1: Main Phase|One participant randomized to receive MK-3415A (MK-3415 plus MK-6072) received only MK-3415|390
2373146|NCT01513239|5823155|P6|Treated|Period 1: Main Phase||0
2373147|NCT01513239|5823156|P5|Treated|Period 1: Main Phase||0
2373148|NCT01513239|5823157|P4|Treated|Period 1: Main Phase||0
2373149|NCT01513239|5823158|P3|Treated|Period 1: Main Phase|Treated participants|381
2373150|NCT01513239|5823159|P2|Treated|Period 1: Main Phase|Treated participants|396
2373151|NCT01513239|5823160|P1|Treated|Period 1: Main Phase|Treated participants|391
2373152|NCT01513239|5823155|P6|STARTED|Period 1: Main Phase||0
2373153|NCT01513239|5823156|P5|STARTED|Period 1: Main Phase||0
2373154|NCT01513239|5823157|P4|STARTED|Period 1: Main Phase||0
2373155|NCT01513239|5823158|P3|STARTED|Period 1: Main Phase|Randomized participants|399
2373156|NCT01513239|5823159|P2|STARTED|Period 1: Main Phase|Randomized participants|407
2373157|NCT01513239|5823160|P1|STARTED|Period 1: Main Phase|Randomized participants|397
2373158|NCT01513148|5823213|P2|NOT COMPLETED|Overall Study||2
2373159|NCT01513148|5823214|P1|NOT COMPLETED|Overall Study||2
2373160|NCT01513148|5823213|P2|COMPLETED|Overall Study||14
2373161|NCT01513148|5823214|P1|COMPLETED|Overall Study||14
2373162|NCT01513148|5823213|P2|STARTED|Overall Study||16
2373163|NCT01513148|5823214|P1|STARTED|Overall Study||16
2373164|NCT01513122|5823262|P2|NOT COMPLETED|Overall Study||3
2373165|NCT01513122|5823263|P1|NOT COMPLETED|Overall Study||11
2373166|NCT01513122|5823262|P2|COMPLETED|Overall Study||105
2373167|NCT01513122|5823263|P1|COMPLETED|Overall Study||91
2373168|NCT01513122|5823262|P2|STARTED|Overall Study||108
2373169|NCT01513122|5823263|P1|STARTED|Overall Study||102
2373170|NCT01512979|5823281|P2|NOT COMPLETED|Overall Study||22
2373171|NCT01512979|5823282|P1|NOT COMPLETED|Overall Study||19
2373172|NCT01512979|5823281|P2|COMPLETED|Overall Study||135
2373173|NCT01512979|5823282|P1|COMPLETED|Overall Study||140
2373174|NCT01512979|5823281|P2|STARTED|Overall Study|Randomised and treated|157
2373175|NCT01512979|5823282|P1|STARTED|Overall Study|Randomised and treated|159
2373176|NCT01512849|5823302|P4|NOT COMPLETED|Crossover Period 2||0
2373177|NCT01512849|5823303|P3|NOT COMPLETED|Crossover Period 2||0
2373178|NCT01512849|5823304|P2|NOT COMPLETED|Crossover Period 2||0
2373179|NCT01512849|5823305|P1|NOT COMPLETED|Crossover Period 2||0
2373180|NCT01512849|5823302|P4|COMPLETED|Crossover Period 2||6
2373181|NCT01512849|5823303|P3|COMPLETED|Crossover Period 2||6
2373182|NCT01512849|5823304|P2|COMPLETED|Crossover Period 2||6
2373183|NCT01512849|5823305|P1|COMPLETED|Crossover Period 2||6
2373184|NCT01512849|5823302|P4|STARTED|Crossover Period 2||6
2373185|NCT01512849|5823303|P3|STARTED|Crossover Period 2||6
2373186|NCT01512849|5823304|P2|STARTED|Crossover Period 2||6
2373187|NCT01512849|5823305|P1|STARTED|Crossover Period 2||6
2373188|NCT01512849|5823302|P4|NOT COMPLETED|Crossover Period 1||0
2373189|NCT01512849|5823303|P3|NOT COMPLETED|Crossover Period 1||0
2373190|NCT01512849|5823304|P2|NOT COMPLETED|Crossover Period 1||0
2373191|NCT01512849|5823305|P1|NOT COMPLETED|Crossover Period 1||0
2373192|NCT01512849|5823302|P4|COMPLETED|Crossover Period 1||6
2373193|NCT01512849|5823303|P3|COMPLETED|Crossover Period 1||6
2373194|NCT01512849|5823304|P2|COMPLETED|Crossover Period 1||6
2373195|NCT01512849|5823305|P1|COMPLETED|Crossover Period 1||6
2373196|NCT01512849|5823302|P4|STARTED|Crossover Period 1||6
2373197|NCT01512849|5823303|P3|STARTED|Crossover Period 1||6
2373198|NCT01512849|5823304|P2|STARTED|Crossover Period 1||6
2373199|NCT01512849|5823305|P1|STARTED|Crossover Period 1||6
2373200|NCT01512797|5823329|P2|NOT COMPLETED|Overall Study||0
2373201|NCT01512797|5823330|P1|NOT COMPLETED|Overall Study||0
2373202|NCT01512797|5823329|P2|COMPLETED|Overall Study||16
2373203|NCT01512797|5823330|P1|COMPLETED|Overall Study||16
2373204|NCT01512797|5823329|P2|STARTED|Overall Study||16
2373205|NCT01512797|5823330|P1|STARTED|Overall Study||16
2373206|NCT01512758|5823346|P2|NOT COMPLETED|Overall Study||0
2373207|NCT01512758|5823347|P1|NOT COMPLETED|Overall Study||0
2373208|NCT01512758|5823346|P2|COMPLETED|Overall Study||6
2373209|NCT01512758|5823347|P1|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK assessment.|30
2373210|NCT01512758|5823346|P2|STARTED|Overall Study||6
2373211|NCT01512758|5823347|P1|STARTED|Overall Study||30
2373212|NCT01512745|5823382|P2|NOT COMPLETED|Overall Study||20
2373213|NCT01512745|5823383|P1|NOT COMPLETED|Overall Study||40
2373214|NCT01512745|5823382|P2|COMPLETED|Overall Study||71
2373215|NCT01512745|5823383|P1|COMPLETED|Overall Study||136
2373216|NCT01512745|5823382|P2|STARTED|Overall Study||91
2373217|NCT01512745|5823383|P1|STARTED|Overall Study||176
2373218|NCT01512693|5823399|P2|NOT COMPLETED|Overall Study||1
2373219|NCT01512693|5823400|P1|NOT COMPLETED|Overall Study||0
2373220|NCT01512693|5823399|P2|COMPLETED|Overall Study||8
2373221|NCT01512693|5823400|P1|COMPLETED|Overall Study||8
2373222|NCT01512693|5823399|P2|STARTED|Overall Study||9
2373223|NCT01512693|5823400|P1|STARTED|Overall Study||8
2373224|NCT01512667|5823414|P2|NOT COMPLETED|Overall Study||0
2373225|NCT01512667|5823415|P1|NOT COMPLETED|Overall Study||0
2373226|NCT01512667|5823414|P2|COMPLETED|Overall Study||12
2373227|NCT01512667|5823415|P1|COMPLETED|Overall Study||13
2373228|NCT01512667|5823414|P2|Unmatched Participants|Overall Study||0
2373229|NCT01512667|5823415|P1|Unmatched Participants|Overall Study|Participant was not matched to a healthy control participant.|1
2373230|NCT01512667|5823414|P2|Matched Participants|Overall Study||12
2373231|NCT01512667|5823415|P1|Matched Participants|Overall Study||12
2373232|NCT01512667|5823414|P2|STARTED|Overall Study||12
2373233|NCT01512667|5823415|P1|STARTED|Overall Study||13
2373234|NCT01512446|5823429|P2|NOT COMPLETED|Overall Study||215
2373235|NCT01512446|5823430|P1|NOT COMPLETED|Overall Study||221
2373236|NCT01512446|5823429|P2|COMPLETED|Overall Study||0
2373237|NCT01512446|5823430|P1|COMPLETED|Overall Study||0
2373238|NCT01512446|5823429|P2|Safety Analysis Set|Overall Study||188
2373239|NCT01512446|5823430|P1|Safety Analysis Set|Overall Study||197
2373240|NCT01512446|5823429|P2|STARTED|Overall Study||215
2373241|NCT01512446|5823430|P1|STARTED|Overall Study||221
2373242|NCT01512368|5823440|P1|NOT COMPLETED|Overall Study||3
2373243|NCT01512368|5823440|P1|COMPLETED|Overall Study||60
2373244|NCT01512368|5823440|P1|STARTED|Overall Study||63
2373245|NCT01512264|5823453|P4|NOT COMPLETED|Overall Study||1
2373246|NCT01512264|5823454|P3|NOT COMPLETED|Overall Study||0
2373247|NCT01512264|5823455|P2|NOT COMPLETED|Overall Study||0
2373248|NCT01512264|5823456|P1|NOT COMPLETED|Overall Study||0
2373249|NCT01512264|5823453|P4|COMPLETED|Overall Study||6
2373250|NCT01512264|5823454|P3|COMPLETED|Overall Study||7
2373251|NCT01512264|5823455|P2|COMPLETED|Overall Study||7
2373252|NCT01512264|5823456|P1|COMPLETED|Overall Study||7
2373253|NCT01512264|5823453|P4|STARTED|Overall Study||7
2373254|NCT01512264|5823454|P3|STARTED|Overall Study||7
2373255|NCT01512264|5823455|P2|STARTED|Overall Study||7
2373256|NCT01512264|5823456|P1|STARTED|Overall Study||7
2373257|NCT01512251|5823548|P2|NOT COMPLETED|Phase II||0
2373258|NCT01512251|5823549|P1|NOT COMPLETED|Phase II||0
2373259|NCT01512251|5823548|P2|COMPLETED|Phase II||0
2373260|NCT01512251|5823549|P1|COMPLETED|Phase II||0
2373261|NCT01512251|5823548|P2|STARTED|Phase II||0
2373262|NCT01512251|5823549|P1|STARTED|Phase II||0
2373263|NCT01512251|5823548|P2|NOT COMPLETED|Phase I, Dose 4||0
2373264|NCT01512251|5823549|P1|NOT COMPLETED|Phase I, Dose 4||0
2373265|NCT01512251|5823548|P2|COMPLETED|Phase I, Dose 4||0
2373266|NCT01512251|5823549|P1|COMPLETED|Phase I, Dose 4||0
2373267|NCT01512251|5823548|P2|STARTED|Phase I, Dose 4||0
2373268|NCT01512251|5823549|P1|STARTED|Phase I, Dose 4||0
2373269|NCT01512251|5823548|P2|NOT COMPLETED|Phase I, Dose 3||0
2373270|NCT01512251|5823549|P1|NOT COMPLETED|Phase I, Dose 3||0
2373271|NCT01512251|5823548|P2|COMPLETED|Phase I, Dose 3||0
2373272|NCT01512251|5823549|P1|COMPLETED|Phase I, Dose 3||0
2373273|NCT01512251|5823548|P2|STARTED|Phase I, Dose 3||0
2373274|NCT01512251|5823549|P1|STARTED|Phase I, Dose 3||0
2373275|NCT01512251|5823548|P2|NOT COMPLETED|Phase I, Dose 2||0
2373276|NCT01512251|5823549|P1|NOT COMPLETED|Phase I, Dose 2||0
2373277|NCT01512251|5823548|P2|COMPLETED|Phase I, Dose 2||0
2373278|NCT01512251|5823549|P1|COMPLETED|Phase I, Dose 2||0
2373279|NCT01512251|5823548|P2|STARTED|Phase I, Dose 2||0
2373280|NCT01512251|5823549|P1|STARTED|Phase I, Dose 2||0
2373281|NCT01512251|5823548|P2|NOT COMPLETED|Phase I, Dose 1||5
2373282|NCT01512251|5823549|P1|NOT COMPLETED|Phase I, Dose 1||3
2373283|NCT01512251|5823548|P2|COMPLETED|Phase I, Dose 1||0
2373284|NCT01512251|5823549|P1|COMPLETED|Phase I, Dose 1||0
2373285|NCT01512251|5823548|P2|STARTED|Phase I, Dose 1||5
2373286|NCT01512251|5823549|P1|STARTED|Phase I, Dose 1||3
2373287|NCT01512251|5823548|P2|NOT COMPLETED|Dose Level -1||0
2373288|NCT01512251|5823549|P1|NOT COMPLETED|Dose Level -1||0
2373289|NCT01512251|5823548|P2|COMPLETED|Dose Level -1||5
2373290|NCT01512251|5823549|P1|COMPLETED|Dose Level -1||3
2373291|NCT01512251|5823548|P2|STARTED|Dose Level -1||5
2373292|NCT01512251|5823549|P1|STARTED|Dose Level -1||3
2373293|NCT01512225|5823570|P2|NOT COMPLETED|Overall Study||0
2373294|NCT01512225|5823571|P1|NOT COMPLETED|Overall Study||0
2373295|NCT01512225|5823570|P2|COMPLETED|Overall Study||45
2373296|NCT01512225|5823571|P1|COMPLETED|Overall Study||45
2373297|NCT01512225|5823570|P2|Provided Day 14 Volume|Overall Study||40
2373298|NCT01512225|5823571|P1|Provided Day 14 Volume|Overall Study||45
2373299|NCT01512225|5823570|P2|STARTED|Overall Study||45
2373300|NCT01512225|5823571|P1|STARTED|Overall Study||45
2373301|NCT01512160|5823595|P4|NOT COMPLETED|Overall Study||1
2373302|NCT01512160|5823596|P3|NOT COMPLETED|Overall Study||0
2373303|NCT01512160|5823597|P2|NOT COMPLETED|Overall Study||0
2373304|NCT01512160|5823598|P1|NOT COMPLETED|Overall Study||2
2373305|NCT01512160|5823595|P4|COMPLETED|Overall Study||22
2373306|NCT01512160|5823596|P3|COMPLETED|Overall Study||22
2373307|NCT01512160|5823597|P2|COMPLETED|Overall Study||23
2373308|NCT01512160|5823598|P1|COMPLETED|Overall Study||20
2373309|NCT01512160|5823595|P4|STARTED|Overall Study||23
2373310|NCT01512160|5823596|P3|STARTED|Overall Study||22
2373311|NCT01512160|5823597|P2|STARTED|Overall Study||23
2373312|NCT01512160|5823598|P1|STARTED|Overall Study||22
2373313|NCT01512108|5823690|P2|NOT COMPLETED|Overall Study||9
2373314|NCT01512108|5823691|P1|NOT COMPLETED|Overall Study||22
2373315|NCT01512108|5823690|P2|COMPLETED|Overall Study||111
2373316|NCT01512108|5823691|P1|COMPLETED|Overall Study||221
2373317|NCT01512108|5823690|P2|Exposed|Overall Study||120
2373318|NCT01512108|5823691|P1|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|240
2373319|NCT01512108|5823690|P2|STARTED|Overall Study||120
2373320|NCT01512108|5823691|P1|STARTED|Overall Study||243
2373321|NCT01511978|5823705|P2|NOT COMPLETED|Overall Study||0
2373322|NCT01511978|5823706|P1|NOT COMPLETED|Overall Study||0
2373323|NCT01511978|5823705|P2|COMPLETED|Overall Study||18
2373324|NCT01511978|5823706|P1|COMPLETED|Overall Study||14
2373325|NCT01511978|5823705|P2|STARTED|Overall Study||18
2373326|NCT01511978|5823706|P1|STARTED|Overall Study||14
2373327|NCT01511939|5823717|P3|NOT COMPLETED|Overall Study||0
2373328|NCT01511939|5823718|P2|NOT COMPLETED|Overall Study||1
2373329|NCT01511939|5823719|P1|NOT COMPLETED|Overall Study||2
2373330|NCT01511939|5823717|P3|COMPLETED|Overall Study||8
2373331|NCT01511939|5823718|P2|COMPLETED|Overall Study||4
2373332|NCT01511939|5823719|P1|COMPLETED|Overall Study||7
2373333|NCT01511939|5823717|P3|STARTED|Overall Study||8
2373334|NCT01511939|5823718|P2|STARTED|Overall Study|Includes one patient who was also taking aspirin.|5
2373335|NCT01511939|5823719|P1|STARTED|Overall Study|Includes 1 subject who was also taking aspirin.|9
2373336|NCT01511809|5823738|P2|NOT COMPLETED|Overall Study||7
2373337|NCT01511809|5823739|P1|NOT COMPLETED|Overall Study||7
2373338|NCT01511809|5823738|P2|COMPLETED|Overall Study||52
2373339|NCT01511809|5823739|P1|COMPLETED|Overall Study||51
2373340|NCT01511809|5823738|P2|STARTED|Overall Study||59
2373341|NCT01511809|5823739|P1|STARTED|Overall Study||58
2373342|NCT01511536|5823748|P3|NOT COMPLETED|Phase 2||9
2373343|NCT01511536|5823749|P2|NOT COMPLETED|Phase 2||0
2373344|NCT01511536|5823750|P1|NOT COMPLETED|Phase 2||0
2373345|NCT01511536|5823748|P3|COMPLETED|Phase 2|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|18
2373346|NCT01511536|5823749|P2|COMPLETED|Phase 2||0
2373347|NCT01511536|5823750|P1|COMPLETED|Phase 2||0
2373348|NCT01511536|5823748|P3|STARTED|Phase 2||27
2373349|NCT01511536|5823749|P2|STARTED|Phase 2||0
2373350|NCT01511536|5823750|P1|STARTED|Phase 2||0
2373351|NCT01511536|5823748|P3|NOT COMPLETED|Phase 1||0
2373352|NCT01511536|5823749|P2|NOT COMPLETED|Phase 1||1
2373353|NCT01511536|5823750|P1|NOT COMPLETED|Phase 1||0
2373354|NCT01511536|5823748|P3|COMPLETED|Phase 1||0
2373355|NCT01511536|5823749|P2|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|6
2373356|NCT01511536|5823750|P1|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|3
2373357|NCT01511536|5823748|P3|STARTED|Phase 1|Phase 1 and phase 2 are separate populations.|0
2373358|NCT01511536|5823749|P2|STARTED|Phase 1||7
2373359|NCT01511536|5823750|P1|STARTED|Phase 1||3
2373360|NCT01511445|5823772|P2|NOT COMPLETED|Overall Study||4
2373361|NCT01511445|5823773|P1|NOT COMPLETED|Overall Study||5
2373362|NCT01511445|5823772|P2|COMPLETED|Overall Study|Data analysis was completed in February, 2016|47
2373363|NCT01511445|5823773|P1|COMPLETED|Overall Study|Data analysis was completed in February, 2016|48
2373364|NCT01511445|5823772|P2|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|47
2373365|NCT01511445|5823773|P1|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|48
2373366|NCT01511445|5823772|P2|Primary Completion October, 2014|Overall Study|3 protocol violations. 1 lost to follow-up.|47
2373367|NCT01511445|5823773|P1|Primary Completion October, 2014|Overall Study|1 was excluded Bechterew's disease. 1 protocol violation. 3 were lost to follow-up.|48
2373368|NCT01511445|5823772|P2|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|51
2373369|NCT01511445|5823773|P1|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|53
2373370|NCT01511445|5823772|P2|STARTED|Overall Study|Patient enrollment started in December, 2011.|51
2373371|NCT01511445|5823773|P1|STARTED|Overall Study|Patient enrollment started in December, 2011.|53
2373372|NCT01511419|5823783|P2|NOT COMPLETED|Dose 2||0
2373373|NCT01511419|5823784|P1|NOT COMPLETED|Dose 2||1
2373374|NCT01511419|5823783|P2|COMPLETED|Dose 2||10
2373375|NCT01511419|5823784|P1|COMPLETED|Dose 2||29
2373376|NCT01511419|5823783|P2|STARTED|Dose 2||10
2373377|NCT01511419|5823784|P1|STARTED|Dose 2||30
2373378|NCT01511419|5823783|P2|NOT COMPLETED|Dose 1||0
2373379|NCT01511419|5823784|P1|NOT COMPLETED|Dose 1||0
2373380|NCT01511419|5823783|P2|COMPLETED|Dose 1||10
2373381|NCT01511419|5823784|P1|COMPLETED|Dose 1||30
2373382|NCT01511419|5823783|P2|STARTED|Dose 1||10
2373383|NCT01511419|5823784|P1|STARTED|Dose 1||30
2373384|NCT01511315|5823876|P1|NOT COMPLETED|Overall Study||4
2373385|NCT01511315|5823876|P1|COMPLETED|Overall Study||32
2373386|NCT01511315|5823876|P1|STARTED|Overall Study||36
2373387|NCT01511250|5823896|P10|NOT COMPLETED|Overall Study||5
2373388|NCT01511250|5823897|P9|NOT COMPLETED|Overall Study||14
2373389|NCT01511250|5823898|P8|NOT COMPLETED|Overall Study||4
2373390|NCT01511250|5823899|P7|NOT COMPLETED|Overall Study||2
2373391|NCT01511250|5823900|P6|NOT COMPLETED|Overall Study||0
2373392|NCT01511250|5823901|P5|NOT COMPLETED|Overall Study||0
2373393|NCT01511250|5823902|P4|NOT COMPLETED|Overall Study||3
2373394|NCT01511250|5823903|P3|NOT COMPLETED|Overall Study||4
2373395|NCT01511250|5823904|P2|NOT COMPLETED|Overall Study||5
2373396|NCT01511250|5823905|P1|NOT COMPLETED|Overall Study||9
2373397|NCT01511250|5823896|P10|COMPLETED|Overall Study||48
2373398|NCT01511250|5823897|P9|COMPLETED|Overall Study||145
2373399|NCT01511250|5823898|P8|COMPLETED|Overall Study||9
2373400|NCT01511250|5823899|P7|COMPLETED|Overall Study||21
2373401|NCT01511250|5823900|P6|COMPLETED|Overall Study||17
2373402|NCT01511250|5823901|P5|COMPLETED|Overall Study||21
2373403|NCT01511250|5823902|P4|COMPLETED|Overall Study||11
2373404|NCT01511250|5823903|P3|COMPLETED|Overall Study||18
2373405|NCT01511250|5823904|P2|COMPLETED|Overall Study||9
2373406|NCT01511250|5823905|P1|COMPLETED|Overall Study||15
2373407|NCT01511250|5823896|P10|STARTED|Overall Study||53
2373408|NCT01511250|5823897|P9|STARTED|Overall Study||159
2373409|NCT01511250|5823898|P8|STARTED|Overall Study||13
2373410|NCT01511250|5823899|P7|STARTED|Overall Study||23
2373411|NCT01511250|5823900|P6|STARTED|Overall Study||17
2373412|NCT01511250|5823901|P5|STARTED|Overall Study||21
2373413|NCT01511250|5823902|P4|STARTED|Overall Study||14
2373414|NCT01511250|5823903|P3|STARTED|Overall Study||22
2373415|NCT01511250|5823904|P2|STARTED|Overall Study||14
2373416|NCT01511250|5823905|P1|STARTED|Overall Study||24
2373417|NCT01511107|5824053|P2|NOT COMPLETED|Overall Study||41
2373418|NCT01511107|5824054|P1|NOT COMPLETED|Overall Study||22
2373419|NCT01511107|5824053|P2|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|219
2373420|NCT01511107|5824054|P1|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|238
2373421|NCT01511107|5824053|P2|STARTED|Overall Study|Randomized to the treatment group.|260
2373422|NCT01511107|5824054|P1|STARTED|Overall Study|Randomized to the treatment group.|260
2373423|NCT01511081|5824104|P2|NOT COMPLETED|Overall Study||0
2373424|NCT01511081|5824105|P1|NOT COMPLETED|Overall Study||0
2373425|NCT01511081|5824104|P2|COMPLETED|Overall Study||9
2373426|NCT01511081|5824105|P1|COMPLETED|Overall Study||8
2373427|NCT01511081|5824104|P2|STARTED|Overall Study||9
2373428|NCT01511081|5824105|P1|STARTED|Overall Study||8
2373429|NCT01511016|5824115|P2|NOT COMPLETED|Overall Study||2
2373430|NCT01511016|5824116|P1|NOT COMPLETED|Overall Study||2
2373431|NCT01511016|5824115|P2|COMPLETED|Overall Study||7
2373432|NCT01511016|5824116|P1|COMPLETED|Overall Study||6
2373433|NCT01511016|5824115|P2|STARTED|Overall Study||9
2373434|NCT01511016|5824116|P1|STARTED|Overall Study||8
2373435|NCT01510912|5824132|P1|NOT COMPLETED|Overall Study||242
2373436|NCT01510912|5824132|P1|COMPLETED|Overall Study||360
2373437|NCT01510912|5824132|P1|STARTED|Overall Study||602
2373438|NCT01510834|5824138|P1|NOT COMPLETED|Overall Study||33
2373439|NCT01510834|5824138|P1|COMPLETED|Overall Study||57
2373440|NCT01510834|5824138|P1|STARTED|Overall Study||90
2373441|NCT01510769|5824148|P3|NOT COMPLETED|Overall Study||22
2373442|NCT01510769|5824149|P2|NOT COMPLETED|Overall Study||25
2373443|NCT01510769|5824150|P1|NOT COMPLETED|Overall Study||27
2373444|NCT01510769|5824148|P3|COMPLETED|Overall Study||87
2373445|NCT01510769|5824149|P2|COMPLETED|Overall Study||84
2373446|NCT01510769|5824150|P1|COMPLETED|Overall Study||79
2373447|NCT01510769|5824148|P3|STARTED|Overall Study||109
2373448|NCT01510769|5824149|P2|STARTED|Overall Study||109
2373449|NCT01510769|5824150|P1|STARTED|Overall Study||106
2373450|NCT01510756|5824167|P1|NOT COMPLETED|Overall Study||4
2373451|NCT01510756|5824167|P1|COMPLETED|Overall Study||0
2373452|NCT01510756|5824167|P1|STARTED|Overall Study||4
2373453|NCT01510717|5824175|P2|NOT COMPLETED|Overall Study||5
2373454|NCT01510717|5824176|P1|NOT COMPLETED|Overall Study||2
2373455|NCT01510717|5824175|P2|COMPLETED|Overall Study||160
2373456|NCT01510717|5824176|P1|COMPLETED|Overall Study||153
2373457|NCT01510717|5824175|P2|STARTED|Overall Study||165
2373458|NCT01510717|5824176|P1|STARTED|Overall Study||155
2373459|NCT01510704|5824204|P4|NOT COMPLETED|Overall Study||0
2373460|NCT01510704|5824205|P3|NOT COMPLETED|Overall Study||0
2373461|NCT01510704|5824206|P2|NOT COMPLETED|Overall Study||0
2373462|NCT01510704|5824207|P1|NOT COMPLETED|Overall Study||0
2373463|NCT01510704|5824204|P4|COMPLETED|Overall Study||53
2373464|NCT01510704|5824205|P3|COMPLETED|Overall Study||50
2373465|NCT01510704|5824206|P2|COMPLETED|Overall Study||58
2373466|NCT01510704|5824207|P1|COMPLETED|Overall Study||54
2373467|NCT01510704|5824204|P4|STARTED|Overall Study||53
2373468|NCT01510704|5824205|P3|STARTED|Overall Study||50
2373469|NCT01510704|5824206|P2|STARTED|Overall Study||58
2373470|NCT01510704|5824207|P1|STARTED|Overall Study||54
2373471|NCT01510652|5824219|P2|NOT COMPLETED|Overall Study||67
2373472|NCT01510652|5824220|P1|NOT COMPLETED|Overall Study||92
2373473|NCT01510652|5824219|P2|COMPLETED|Overall Study||288
2373474|NCT01510652|5824220|P1|COMPLETED|Overall Study||627
2373475|NCT01510652|5824219|P2|Baseline|Overall Study||348
2373476|NCT01510652|5824220|P1|Baseline|Overall Study||718
2373477|NCT01510652|5824219|P2|STARTED|Overall Study||355
2373478|NCT01510652|5824220|P1|STARTED|Overall Study||719
2373479|NCT01510457|5824232|P2|NOT COMPLETED|Overall Study||3
2373480|NCT01510457|5824233|P1|NOT COMPLETED|Overall Study||5
2373481|NCT01510457|5824232|P2|COMPLETED|Overall Study||26
2373482|NCT01510457|5824233|P1|COMPLETED|Overall Study||12
2373483|NCT01510457|5824232|P2|STARTED|Overall Study||29
2373484|NCT01510457|5824233|P1|STARTED|Overall Study||17
2373485|NCT01510379|5824253|P2|NOT COMPLETED|Overall Study||0
2373486|NCT01510379|5824254|P1|NOT COMPLETED|Overall Study||0
2373487|NCT01510379|5824253|P2|COMPLETED|Overall Study||51
2373488|NCT01510379|5824254|P1|COMPLETED|Overall Study||49
2373489|NCT01510379|5824253|P2|STARTED|Overall Study||51
2373490|NCT01510379|5824254|P1|STARTED|Overall Study||49
2373491|NCT01510327|5824262|P1|NOT COMPLETED|Overall Study||0
2373492|NCT01510327|5824262|P1|COMPLETED|Overall Study||22
2373493|NCT01510327|5824262|P1|STARTED|Overall Study||22
2373494|NCT01510158|5824296|P3|NOT COMPLETED|Overall Study||50
2373495|NCT01510158|5824297|P2|NOT COMPLETED|Overall Study||53
2373496|NCT01510158|5824298|P1|NOT COMPLETED|Overall Study||51
2373497|NCT01510158|5824296|P3|COMPLETED|Overall Study||152
2373498|NCT01510158|5824297|P2|COMPLETED|Overall Study||150
2373499|NCT01510158|5824298|P1|COMPLETED|Overall Study||151
2373500|NCT01510158|5824296|P3|STARTED|Overall Study||202
2373501|NCT01510158|5824297|P2|STARTED|Overall Study||203
2373502|NCT01510158|5824298|P1|STARTED|Overall Study||202
2373503|NCT01510145|5824312|P1|NOT COMPLETED|Overall Study||18
2373504|NCT01510145|5824312|P1|COMPLETED|Overall Study||173
2373505|NCT01510145|5824312|P1|STARTED|Overall Study||191
2373506|NCT01510028|5824321|P4|NOT COMPLETED|Overall Study||0
2373507|NCT01510028|5824322|P3|NOT COMPLETED|Overall Study||0
2373508|NCT01510028|5824323|P2|NOT COMPLETED|Overall Study||0
2373509|NCT01510028|5824324|P1|NOT COMPLETED|Overall Study||1
2373510|NCT01510028|5824321|P4|COMPLETED|Overall Study||6
2373511|NCT01510028|5824322|P3|COMPLETED|Overall Study||6
2373512|NCT01510028|5824323|P2|COMPLETED|Overall Study||6
2373513|NCT01510028|5824324|P1|COMPLETED|Overall Study||5
2373514|NCT01510028|5824321|P4|STARTED|Overall Study||6
2373515|NCT01510028|5824322|P3|STARTED|Overall Study||6
2373516|NCT01510028|5824323|P2|STARTED|Overall Study||6
2373517|NCT01510028|5824324|P1|STARTED|Overall Study||6
2373518|NCT01509950|5824440|P3|NOT COMPLETED|Overall Study||0
2373519|NCT01509950|5824441|P2|NOT COMPLETED|Overall Study||0
2373520|NCT01509950|5824442|P1|NOT COMPLETED|Overall Study||0
2373521|NCT01509950|5824440|P3|COMPLETED|Overall Study||0
2373522|NCT01509950|5824441|P2|COMPLETED|Overall Study||8
2373523|NCT01509950|5824442|P1|COMPLETED|Overall Study||7
2373524|NCT01509950|5824440|P3|STARTED|Overall Study||0
2373525|NCT01509950|5824441|P2|STARTED|Overall Study||8
2373526|NCT01509950|5824442|P1|STARTED|Overall Study||7
2373527|NCT01509872|5824470|P2|NOT COMPLETED|Overall Study||0
2373528|NCT01509872|5824471|P1|NOT COMPLETED|Overall Study||1
2373529|NCT01509872|5824470|P2|COMPLETED|Overall Study||24
2373530|NCT01509872|5824471|P1|COMPLETED|Overall Study||25
2373531|NCT01509872|5824470|P2|Post-Intervention Assessment|Overall Study||24
2373532|NCT01509872|5824471|P1|Post-Intervention Assessment|Overall Study||26
2373533|NCT01509872|5824470|P2|STARTED|Overall Study||24
2373534|NCT01509872|5824471|P1|STARTED|Overall Study||26
2373535|NCT01509807|5824485|P2|NOT COMPLETED|Overall Study||1
2373536|NCT01509807|5824486|P1|NOT COMPLETED|Overall Study||1
2373537|NCT01509807|5824485|P2|COMPLETED|Overall Study||16
2373538|NCT01509807|5824486|P1|COMPLETED|Overall Study||15
2373539|NCT01509807|5824485|P2|STARTED|Overall Study||17
2373540|NCT01509807|5824486|P1|STARTED|Overall Study||16
2373541|NCT01509677|5824512|P2|NOT COMPLETED|Overall Study||6
2373542|NCT01509677|5824513|P1|NOT COMPLETED|Overall Study||3
2373543|NCT01509677|5824512|P2|COMPLETED|Overall Study||73
2373544|NCT01509677|5824513|P1|COMPLETED|Overall Study||76
2373545|NCT01509677|5824512|P2|STARTED|Overall Study||79
2373546|NCT01509677|5824513|P1|STARTED|Overall Study||79
2373547|NCT01509664|5824585|P2|NOT COMPLETED|Overall Study||21
2373548|NCT01509664|5824586|P1|NOT COMPLETED|Overall Study||15
2373549|NCT01509664|5824585|P2|COMPLETED|Overall Study||28
2373550|NCT01509664|5824586|P1|COMPLETED|Overall Study||34
2373551|NCT01509664|5824585|P2|T3 Follow-up|Overall Study||33
2373552|NCT01509664|5824586|P1|T3 Follow-up|Overall Study||40
2373553|NCT01509664|5824585|P2|T2 Follow-up|Overall Study||38
2373554|NCT01509664|5824586|P1|T2 Follow-up|Overall Study||45
2373555|NCT01509664|5824585|P2|STARTED|Overall Study||49
2373556|NCT01509664|5824586|P1|STARTED|Overall Study||49
2373557|NCT01509638|5824594|P2|NOT COMPLETED|Overall Study||2
2373558|NCT01509638|5824595|P1|NOT COMPLETED|Overall Study||3
2373559|NCT01509638|5824594|P2|COMPLETED|Overall Study||24
2373560|NCT01509638|5824595|P1|COMPLETED|Overall Study||20
2373561|NCT01509638|5824594|P2|STARTED|Overall Study||26
2373562|NCT01509638|5824595|P1|STARTED|Overall Study||23
2373563|NCT01509625|5824619|P1|NOT COMPLETED|Overall Study||9
2373564|NCT01509625|5824619|P1|COMPLETED|Overall Study||263
2373565|NCT01509625|5824619|P1|STARTED|Overall Study||272
2373566|NCT01509586|5824637|P2|NOT COMPLETED|Overall Study||0
2373567|NCT01509586|5824638|P1|NOT COMPLETED|Overall Study||0
2373568|NCT01509586|5824637|P2|COMPLETED|Overall Study|final intent to treat sample|610
2373569|NCT01509586|5824638|P1|COMPLETED|Overall Study|final intent to treat sample|626
2373570|NCT01509586|5824637|P2|Week 58 (Month 12)|Overall Study||499
2373571|NCT01509586|5824638|P1|Week 58 (Month 12)|Overall Study||492
2373572|NCT01509586|5824637|P2|Week 46|Overall Study||494
2373573|NCT01509586|5824638|P1|Week 46|Overall Study||483
2373574|NCT01509586|5824637|P2|Week 32 (Month 6)|Overall Study||523
2373575|NCT01509586|5824638|P1|Week 32 (Month 6)|Overall Study||504
2373576|NCT01509586|5824637|P2|Week18|Overall Study||555
2373577|NCT01509586|5824638|P1|Week18|Overall Study||529
2373578|NCT01509586|5824637|P2|Week 14|Overall Study||566
2373579|NCT01509586|5824638|P1|Week 14|Overall Study||528
2373580|NCT01509586|5824637|P2|Week 10|Overall Study||574
2373581|NCT01509586|5824638|P1|Week 10|Overall Study||537
2373582|NCT01509586|5824637|P2|Week 6|Overall Study||585
2373583|NCT01509586|5824638|P1|Week 6|Overall Study||551
2373584|NCT01509586|5824637|P2|Week 3|Overall Study||585
2373585|NCT01509586|5824638|P1|Week 3|Overall Study||574
2373586|NCT01509586|5824637|P2|STARTED|Overall Study|Week 0|610
2373587|NCT01509586|5824638|P1|STARTED|Overall Study|Week 0|626
2373588|NCT01509547|5824646|P2|NOT COMPLETED|Overall Study||39
2373589|NCT01509547|5824647|P1|NOT COMPLETED|Overall Study||35
2373590|NCT01509547|5824646|P2|COMPLETED|Overall Study||41
2373591|NCT01509547|5824647|P1|COMPLETED|Overall Study||42
2373592|NCT01509547|5824646|P2|STARTED|Overall Study||80
2373593|NCT01509547|5824647|P1|STARTED|Overall Study||77
2373594|NCT01509404|5824665|P2|NOT COMPLETED|Overall Study||0
2373595|NCT01509404|5824666|P1|NOT COMPLETED|Overall Study||0
2373596|NCT01509404|5824665|P2|COMPLETED|Overall Study||20
2373597|NCT01509404|5824666|P1|COMPLETED|Overall Study||20
2373598|NCT01509404|5824665|P2|STARTED|Overall Study||20
2373599|NCT01509404|5824666|P1|STARTED|Overall Study||20
2373600|NCT01509183|5824688|P2|NOT COMPLETED|Overall Study||111
2373601|NCT01509183|5824689|P1|NOT COMPLETED|Overall Study||109
2373602|NCT01509183|5824688|P2|COMPLETED|Overall Study||134
2373603|NCT01509183|5824689|P1|COMPLETED|Overall Study||141
2373604|NCT01509183|5824688|P2|STARTED|Overall Study||245
2373605|NCT01509183|5824689|P1|STARTED|Overall Study||250
2373606|NCT01509105|5824697|P1|NOT COMPLETED|Overall Study||0
2373607|NCT01509105|5824697|P1|COMPLETED|Overall Study||649
2373608|NCT01509105|5824697|P1|STARTED|Overall Study||649
2373609|NCT01509079|5824714|P2|NOT COMPLETED|Overall Study||3
2373610|NCT01509079|5824715|P1|NOT COMPLETED|Overall Study||0
2373611|NCT01509079|5824714|P2|COMPLETED|Overall Study||56
2373612|NCT01509079|5824715|P1|COMPLETED|Overall Study||57
2373613|NCT01509079|5824714|P2|STARTED|Overall Study||59
2373614|NCT01509079|5824715|P1|STARTED|Overall Study||57
2373615|NCT01509053|5824735|P1|NOT COMPLETED|Aripiprazole IM Depot Extension Phase(C)||3
2373616|NCT01509053|5824735|P1|COMPLETED|Aripiprazole IM Depot Extension Phase(C)||0
2373617|NCT01509053|5824735|P1|STARTED|Aripiprazole IM Depot Extension Phase(C)||3
2373618|NCT01509053|5824735|P1|NOT COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||16
2373619|NCT01509053|5824735|P1|COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||3
2373620|NCT01509053|5824735|P1|STARTED|Aripiprazole IM Depot Treatment Phase(B)|Includes 8 patients from Phase A + 11 patients who entered directly into Phase B.|19
2373621|NCT01509053|5824735|P1|NOT COMPLETED|Oral Aripirazole (Phase A)||11
2373622|NCT01509053|5824735|P1|COMPLETED|Oral Aripirazole (Phase A)||8
2373623|NCT01509053|5824735|P1|STARTED|Oral Aripirazole (Phase A)||19
2373624|NCT01509040|5824749|P3|NOT COMPLETED|Overall Study||0
2373625|NCT01509040|5824750|P2|NOT COMPLETED|Overall Study||1
2373626|NCT01509040|5824751|P1|NOT COMPLETED|Overall Study||0
2373627|NCT01509040|5824749|P3|COMPLETED|Overall Study||0
2373628|NCT01509040|5824750|P2|COMPLETED|Overall Study||1
2373629|NCT01509040|5824751|P1|COMPLETED|Overall Study||0
2373630|NCT01509040|5824749|P3|STARTED|Overall Study||0
2373631|NCT01509040|5824750|P2|STARTED|Overall Study||2
2373632|NCT01509040|5824751|P1|STARTED|Overall Study||0
2373633|NCT01508936|5824797|P2|NOT COMPLETED|Overall Study||79
2373634|NCT01508936|5824798|P1|NOT COMPLETED|Overall Study||23
2373635|NCT01508936|5824797|P2|COMPLETED|Overall Study||330
2373636|NCT01508936|5824798|P1|COMPLETED|Overall Study||79
2373637|NCT01508936|5824797|P2|FEV1 Subpopulation Analysis Set|Overall Study||346
2373638|NCT01508936|5824798|P1|FEV1 Subpopulation Analysis Set|Overall Study||91
2373639|NCT01508936|5824797|P2|Full Analysis Set|Overall Study||395
2373640|NCT01508936|5824798|P1|Full Analysis Set|Overall Study||97
2373641|NCT01508936|5824797|P2|Safety Analysis Set|Overall Study||395
2373642|NCT01508936|5824798|P1|Safety Analysis Set|Overall Study||97
2373643|NCT01508936|5824797|P2|Randomized, Not Treated|Overall Study||3
2373644|NCT01508936|5824798|P1|Randomized, Not Treated|Overall Study||1
2373645|NCT01508936|5824797|P2|Randomized|Overall Study||398
2373646|NCT01508936|5824798|P1|Randomized|Overall Study||98
2373647|NCT01508936|5824797|P2|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|11
2373648|NCT01508936|5824798|P1|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|4
2373649|NCT01508936|5824797|P2|STARTED|Overall Study||409
2373650|NCT01508936|5824798|P1|STARTED|Overall Study||102
2373651|NCT01508910|5824837|P4|NOT COMPLETED|Treatment||3
2373652|NCT01508910|5824838|P3|NOT COMPLETED|Treatment||10
2373653|NCT01508910|5824839|P2|NOT COMPLETED|Treatment||4
2373654|NCT01508910|5824840|P1|NOT COMPLETED|Treatment||2
2373655|NCT01508910|5824837|P4|COMPLETED|Treatment||3
2373656|NCT01508910|5824838|P3|COMPLETED|Treatment||18
2373657|NCT01508910|5824839|P2|COMPLETED|Treatment||24
2373658|NCT01508910|5824840|P1|COMPLETED|Treatment||48
2373659|NCT01508910|5824837|P4|STARTED|Treatment|3 moved from Treatment (Tx) to Active Control (AC) Arm; 6 in Not injected Arm(4 from Tx ; 2 from AC)|6
2373660|NCT01508910|5824838|P3|STARTED|Treatment||28
2373661|NCT01508910|5824839|P2|STARTED|Treatment||28
2373662|NCT01508910|5824840|P1|STARTED|Treatment||50
2373663|NCT01508910|5824837|P4|NOT COMPLETED|Randomization||0
2373664|NCT01508910|5824838|P3|NOT COMPLETED|Randomization||0
2373665|NCT01508910|5824839|P2|NOT COMPLETED|Randomization||0
2373666|NCT01508910|5824840|P1|NOT COMPLETED|Randomization||0
2373667|NCT01508910|5824837|P4|COMPLETED|Randomization||0
2373668|NCT01508910|5824838|P3|COMPLETED|Randomization||28
2373669|NCT01508910|5824839|P2|COMPLETED|Randomization||27
2373670|NCT01508910|5824840|P1|COMPLETED|Randomization||57
2373671|NCT01508910|5824837|P4|STARTED|Randomization|Participants not randomized into Not Injected arm, but some were re-assigned here during treatment.|0
2373672|NCT01508910|5824838|P3|STARTED|Randomization||28
2373673|NCT01508910|5824839|P2|STARTED|Randomization||27
2373674|NCT01508910|5824840|P1|STARTED|Randomization||57
2373675|NCT01508832|5824864|P2|NOT COMPLETED|Overall Study||0
2373676|NCT01508832|5824865|P1|NOT COMPLETED|Overall Study||0
2373677|NCT01508832|5824864|P2|COMPLETED|Overall Study||6
2373678|NCT01508832|5824865|P1|COMPLETED|Overall Study||6
2373679|NCT01508832|5824864|P2|STARTED|Overall Study||6
2373680|NCT01508832|5824865|P1|STARTED|Overall Study||6
2373681|NCT01508702|5824873|P2|NOT COMPLETED|Overall Study||13
2373682|NCT01508702|5824874|P1|NOT COMPLETED|Overall Study||23
2373683|NCT01508702|5824873|P2|COMPLETED|Overall Study||94
2373684|NCT01508702|5824874|P1|COMPLETED|Overall Study||84
2373685|NCT01508702|5824873|P2|STARTED|Overall Study||107
2373686|NCT01508702|5824874|P1|STARTED|Overall Study||107
2373687|NCT01508676|5824882|P2|NOT COMPLETED|Phase II (2 Weeks)||1
2373688|NCT01508676|5824883|P1|NOT COMPLETED|Phase II (2 Weeks)||1
2373689|NCT01508676|5824882|P2|COMPLETED|Phase II (2 Weeks)||13
2373690|NCT01508676|5824883|P1|COMPLETED|Phase II (2 Weeks)||15
2373691|NCT01508676|5824882|P2|STARTED|Phase II (2 Weeks)||14
2373692|NCT01508676|5824883|P1|STARTED|Phase II (2 Weeks)||16
2373693|NCT01508676|5824882|P2|NOT COMPLETED|Washout Period (1 Week)||0
2373694|NCT01508676|5824883|P1|NOT COMPLETED|Washout Period (1 Week)||0
2373695|NCT01508676|5824882|P2|COMPLETED|Washout Period (1 Week)||14
2373696|NCT01508676|5824883|P1|COMPLETED|Washout Period (1 Week)||16
2373697|NCT01508676|5824882|P2|STARTED|Washout Period (1 Week)||14
2373698|NCT01508676|5824883|P1|STARTED|Washout Period (1 Week)||16
2373699|NCT01508676|5824882|P2|NOT COMPLETED|Phase I (2 Weeks)||3
2373700|NCT01508676|5824883|P1|NOT COMPLETED|Phase I (2 Weeks)||2
2373701|NCT01508676|5824882|P2|COMPLETED|Phase I (2 Weeks)||14
2373702|NCT01508676|5824883|P1|COMPLETED|Phase I (2 Weeks)||16
2373703|NCT01508676|5824882|P2|STARTED|Phase I (2 Weeks)||17
2373704|NCT01508676|5824883|P1|STARTED|Phase I (2 Weeks)||18
2373705|NCT01508650|5824895|P2|NOT COMPLETED|Overall Study||3
2373706|NCT01508650|5824896|P1|NOT COMPLETED|Overall Study||0
2373707|NCT01508650|5824895|P2|COMPLETED|Overall Study||12
2373708|NCT01508650|5824896|P1|COMPLETED|Overall Study||12
2373709|NCT01508650|5824895|P2|STARTED|Overall Study||15
2373710|NCT01508650|5824896|P1|STARTED|Overall Study||12
2373711|NCT01508455|5824904|P1|NOT COMPLETED|Overall Study||0
2373712|NCT01508455|5824904|P1|COMPLETED|Overall Study||6
2373713|NCT01508455|5824904|P1|STARTED|Overall Study||6
2373714|NCT01508325|5824915|P2|NOT COMPLETED|Overall Study||21
2373715|NCT01508325|5824916|P1|NOT COMPLETED|Overall Study||18
2373716|NCT01508325|5824915|P2|COMPLETED|Overall Study||72
2373717|NCT01508325|5824916|P1|COMPLETED|Overall Study||75
2373718|NCT01508325|5824915|P2|STARTED|Overall Study||93
2373719|NCT01508325|5824916|P1|STARTED|Overall Study||93
2373720|NCT01508169|5824946|P2|NOT COMPLETED|Overall Study||2
2373721|NCT01508169|5824947|P1|NOT COMPLETED|Overall Study||3
2373722|NCT01508169|5824946|P2|COMPLETED|Overall Study||45
2373723|NCT01508169|5824947|P1|COMPLETED|Overall Study||44
2373724|NCT01508169|5824946|P2|STARTED|Overall Study||47
2373725|NCT01508169|5824947|P1|STARTED|Overall Study||47
2373726|NCT01508130|5824961|P2|NOT COMPLETED|Overall Study||69
2373727|NCT01508130|5824962|P1|NOT COMPLETED|Overall Study||227
2373728|NCT01508130|5824961|P2|COMPLETED|Overall Study||73
2373729|NCT01508130|5824962|P1|COMPLETED|Overall Study||266
2373730|NCT01508130|5824961|P2|mTRT|Overall Study||142
2373731|NCT01508130|5824962|P1|mTRT|Overall Study||493
2373732|NCT01508130|5824961|P2|STARTED|Overall Study||142
2373733|NCT01508130|5824962|P1|STARTED|Overall Study||493
2373734|NCT01508117|5825004|P1|NOT COMPLETED|Overall Study||0
2373735|NCT01508117|5825004|P1|COMPLETED|Overall Study||1
2373736|NCT01508117|5825004|P1|STARTED|Overall Study||1
2373737|NCT01508052|5825010|P2|NOT COMPLETED|Overall Study||0
2373738|NCT01508052|5825011|P1|NOT COMPLETED|Overall Study||0
2373739|NCT01508052|5825010|P2|COMPLETED|Overall Study||20
2373740|NCT01508052|5825011|P1|COMPLETED|Overall Study||20
2373741|NCT01508052|5825010|P2|STARTED|Overall Study||20
2373742|NCT01508052|5825011|P1|STARTED|Overall Study||20
2373743|NCT01508013|5825019|P2|NOT COMPLETED|Overall Study||23
2373744|NCT01508013|5825020|P1|NOT COMPLETED|Overall Study||32
2373745|NCT01508013|5825019|P2|COMPLETED|Overall Study||206
2373746|NCT01508013|5825020|P1|COMPLETED|Overall Study||182
2373747|NCT01508013|5825019|P2|STARTED|Overall Study||229
2373748|NCT01508013|5825020|P1|STARTED|Overall Study||214
2373749|NCT01507896|5825030|P1|NOT COMPLETED|Overall Study||2
2373750|NCT01507896|5825030|P1|COMPLETED|Overall Study|28 unique participants had 38 surgeries (participants could have multiple surgeries).|28
2373751|NCT01507896|5825030|P1|STARTED|Overall Study|30 unique participants had 40 surgeries planned (participants could have multiple surgeries).|30
2373752|NCT01507831|5825073|P2|NOT COMPLETED|Overall Study||440
2373753|NCT01507831|5825074|P1|NOT COMPLETED|Overall Study||193
2373754|NCT01507831|5825073|P2|COMPLETED|Overall Study||1113
2373755|NCT01507831|5825074|P1|COMPLETED|Overall Study||595
2373756|NCT01507831|5825073|P2|Treated|Overall Study||1550
2373757|NCT01507831|5825074|P1|Treated|Overall Study||788
2373758|NCT01507831|5825073|P2|STARTED|Overall Study|Randomized|1553
2373759|NCT01507831|5825074|P1|STARTED|Overall Study|Randomized|788
2373760|NCT01507779|5825144|P2|NOT COMPLETED|Overall Study||0
2373761|NCT01507779|5825145|P1|NOT COMPLETED|Overall Study||0
2373762|NCT01507779|5825144|P2|COMPLETED|Overall Study||25
2373763|NCT01507779|5825145|P1|COMPLETED|Overall Study||23
2373764|NCT01507779|5825144|P2|STARTED|Overall Study||25
2373765|NCT01507779|5825145|P1|STARTED|Overall Study||23
2373766|NCT01507688|5825185|P2|NOT COMPLETED|6 Month to 12 Month Assessment||3
2373767|NCT01507688|5825186|P1|NOT COMPLETED|6 Month to 12 Month Assessment||5
2373768|NCT01507688|5825185|P2|COMPLETED|6 Month to 12 Month Assessment||116
2373769|NCT01507688|5825186|P1|COMPLETED|6 Month to 12 Month Assessment||108
2373770|NCT01507688|5825185|P2|STARTED|6 Month to 12 Month Assessment||119
2373771|NCT01507688|5825186|P1|STARTED|6 Month to 12 Month Assessment||113
2373772|NCT01507688|5825185|P2|NOT COMPLETED|Baseline to 6 Month Assessment||10
2373773|NCT01507688|5825186|P1|NOT COMPLETED|Baseline to 6 Month Assessment||16
2373774|NCT01507688|5825185|P2|COMPLETED|Baseline to 6 Month Assessment||119
2373775|NCT01507688|5825186|P1|COMPLETED|Baseline to 6 Month Assessment||113
2373776|NCT01507688|5825185|P2|STARTED|Baseline to 6 Month Assessment||129
2373777|NCT01507688|5825186|P1|STARTED|Baseline to 6 Month Assessment||129
2373778|NCT01507662|5825194|P2|NOT COMPLETED|Overall Study||831
2373779|NCT01507662|5825195|P1|NOT COMPLETED|Overall Study||816
2373780|NCT01507662|5825194|P2|COMPLETED|Overall Study||3020
2373781|NCT01507662|5825195|P1|COMPLETED|Overall Study||3082
2373782|NCT01507662|5825194|P2|STARTED|Overall Study||3851
2373783|NCT01507662|5825195|P1|STARTED|Overall Study||3898
2373784|NCT01507584|5825201|P1|NOT COMPLETED|Overall Study||0
2373785|NCT01507584|5825201|P1|COMPLETED|Overall Study||0
2373786|NCT01507584|5825201|P1|STARTED|Overall Study||0
2373787|NCT01507493|5825209|P2|NOT COMPLETED|Overall Study||0
2373788|NCT01507493|5825210|P1|NOT COMPLETED|Overall Study||0
2373789|NCT01507493|5825209|P2|COMPLETED|Overall Study||178
2373790|NCT01507493|5825210|P1|COMPLETED|Overall Study||22
2373791|NCT01507493|5825209|P2|STARTED|Overall Study||178
2373792|NCT01507493|5825210|P1|STARTED|Overall Study||22
2373793|NCT01507298|5825226|P2|NOT COMPLETED|Overall Study||6
2373794|NCT01507298|5825227|P1|NOT COMPLETED|Overall Study||0
2373795|NCT01507298|5825226|P2|COMPLETED|Overall Study||14
2373796|NCT01507298|5825227|P1|COMPLETED|Overall Study||1
2373797|NCT01507298|5825226|P2|STARTED|Overall Study||20
2373798|NCT01507298|5825227|P1|STARTED|Overall Study||1
2373799|NCT01507246|5825237|P2|NOT COMPLETED|Overall Study||1
2373800|NCT01507246|5825238|P1|NOT COMPLETED|Overall Study||2
2373801|NCT01507246|5825237|P2|COMPLETED|Overall Study||21
2373802|NCT01507246|5825238|P1|COMPLETED|Overall Study||18
2373803|NCT01507246|5825237|P2|STARTED|Overall Study||22
2373804|NCT01507246|5825238|P1|STARTED|Overall Study||20
2373805|NCT01507233|5825252|P2|NOT COMPLETED|Overall Study||0
2373806|NCT01507233|5825253|P1|NOT COMPLETED|Overall Study||0
2373807|NCT01507233|5825252|P2|COMPLETED|Overall Study||0
2373808|NCT01507233|5825253|P1|COMPLETED|Overall Study||5
2373809|NCT01507233|5825252|P2|STARTED|Overall Study||0
2373810|NCT01507233|5825253|P1|STARTED|Overall Study||5
2373811|NCT01507220|5825265|P2|NOT COMPLETED|Overall Study||0
2373812|NCT01507220|5825266|P1|NOT COMPLETED|Overall Study||0
2373813|NCT01507220|5825265|P2|COMPLETED|Overall Study||0
2373814|NCT01507220|5825266|P1|COMPLETED|Overall Study||2
2373815|NCT01507220|5825265|P2|STARTED|Overall Study||0
2373816|NCT01507220|5825266|P1|STARTED|Overall Study||2
2373817|NCT01507181|5825280|P2|NOT COMPLETED|Overall Study||0
2373818|NCT01507181|5825281|P1|NOT COMPLETED|Overall Study||0
2373819|NCT01507181|5825280|P2|COMPLETED|Overall Study||12
2373820|NCT01507181|5825281|P1|COMPLETED|Overall Study||12
2373821|NCT01507181|5825280|P2|STARTED|Overall Study||12
2373822|NCT01507181|5825281|P1|STARTED|Overall Study||12
2373823|NCT01507155|5825301|P2|NOT COMPLETED|Overall Study||0
2373824|NCT01507155|5825302|P1|NOT COMPLETED|Overall Study||0
2373825|NCT01507155|5825301|P2|COMPLETED|Overall Study||60
2373826|NCT01507155|5825302|P1|COMPLETED|Overall Study||625
2373827|NCT01507155|5825301|P2|STARTED|Overall Study||60
2373828|NCT01507155|5825302|P1|STARTED|Overall Study||625
2373829|NCT01507103|5825311|P3|NOT COMPLETED|Overall Study||0
2373830|NCT01507103|5825312|P2|NOT COMPLETED|Overall Study||0
2373831|NCT01507103|5825313|P1|NOT COMPLETED|Overall Study||0
2373832|NCT01507103|5825311|P3|COMPLETED|Overall Study||42
2373833|NCT01507103|5825312|P2|COMPLETED|Overall Study||41
2373834|NCT01507103|5825313|P1|COMPLETED|Overall Study||41
2373835|NCT01507103|5825311|P3|STARTED|Overall Study||42
2373836|NCT01507103|5825312|P2|STARTED|Overall Study||41
2373837|NCT01507103|5825313|P1|STARTED|Overall Study||41
2373838|NCT01507090|5825336|P1|NOT COMPLETED|Overall Study||18
2373839|NCT01507090|5825336|P1|COMPLETED|Overall Study||624
2373840|NCT01507090|5825336|P1|STARTED|Overall Study||642
2373841|NCT01507051|5825375|P4|NOT COMPLETED|Overall Study||7
2373842|NCT01507051|5825376|P3|NOT COMPLETED|Overall Study||1
2373843|NCT01507051|5825377|P2|NOT COMPLETED|Overall Study||3
2373844|NCT01507051|5825378|P1|NOT COMPLETED|Overall Study||2
2373845|NCT01507051|5825375|P4|COMPLETED|Overall Study||0
2373846|NCT01507051|5825376|P3|COMPLETED|Overall Study||28
2373847|NCT01507051|5825377|P2|COMPLETED|Overall Study||28
2373848|NCT01507051|5825378|P1|COMPLETED|Overall Study||27
2373849|NCT01507051|5825375|P4|Received Placebo or Rivaroxaban|Overall Study||0
2373850|NCT01507051|5825376|P3|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG3|28
2373851|NCT01507051|5825377|P2|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG2 and in RG4|28
2373852|NCT01507051|5825378|P1|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG1 and in RG4 (RG = Reporting Group for Safety Data)|28
2373853|NCT01507051|5825375|P4|Warfarin run-in Phase|Overall Study|Safety Population: in RG4|7
2373854|NCT01507051|5825376|P3|Warfarin run-in Phase|Overall Study||0
2373855|NCT01507051|5825377|P2|Warfarin run-in Phase|Overall Study||28
2373856|NCT01507051|5825378|P1|Warfarin run-in Phase|Overall Study||28
2373857|NCT01507051|5825375|P4|STARTED|Overall Study||7
2373858|NCT01507051|5825376|P3|STARTED|Overall Study||29
2373859|NCT01507051|5825377|P2|STARTED|Overall Study||31
2373860|NCT01507051|5825378|P1|STARTED|Overall Study||29
2373861|NCT01506960|5825496|P1|NOT COMPLETED|Overall Study||47
2373862|NCT01506960|5825496|P1|COMPLETED|Overall Study||17
2373863|NCT01506960|5825496|P1|STARTED|Overall Study||64
2373864|NCT01506947|5825502|P1|NOT COMPLETED|Overall Study||16
2373865|NCT01506947|5825502|P1|COMPLETED|Overall Study||49
2373866|NCT01506947|5825502|P1|STARTED|Overall Study||65
2373867|NCT01506908|5825520|P2|NOT COMPLETED|Overall Study||0
2373868|NCT01506908|5825521|P1|NOT COMPLETED|Overall Study||1
2373869|NCT01506908|5825520|P2|COMPLETED|Overall Study||161
2373870|NCT01506908|5825521|P1|COMPLETED|Overall Study||161
2373871|NCT01506908|5825520|P2|STARTED|Overall Study||161
2373872|NCT01506908|5825521|P1|STARTED|Overall Study||162
2373873|NCT01506882|5825539|P2|NOT COMPLETED|Overall Study||7
2373874|NCT01506882|5825540|P1|NOT COMPLETED|Overall Study||22
2373875|NCT01506882|5825539|P2|COMPLETED|Overall Study||3
2373876|NCT01506882|5825540|P1|COMPLETED|Overall Study||39
2373877|NCT01506882|5825539|P2|STARTED|Overall Study||10
2373878|NCT01506882|5825540|P1|STARTED|Overall Study||61
2373879|NCT01506726|5825554|P2|NOT COMPLETED|Overall Study||2
2373880|NCT01506726|5825555|P1|NOT COMPLETED|Overall Study||1
2373881|NCT01506726|5825554|P2|COMPLETED|Overall Study||3
2373882|NCT01506726|5825555|P1|COMPLETED|Overall Study||5
2373883|NCT01506726|5825554|P2|STARTED|Overall Study||5
2373884|NCT01506726|5825555|P1|STARTED|Overall Study||6
2373885|NCT01506596|5825595|P1|NOT COMPLETED|Overall Study||1
2373886|NCT01506596|5825595|P1|COMPLETED|Overall Study|One enrolled patient had ineligible pathology after starting treatment; was removed from treatment.|41
2373887|NCT01506596|5825595|P1|STARTED|Overall Study||42
2373888|NCT01506479|5825606|P3|NOT COMPLETED|Overall Study||3
2373889|NCT01506479|5825607|P2|NOT COMPLETED|Overall Study||5
2373890|NCT01506479|5825608|P1|NOT COMPLETED|Overall Study||3
2373891|NCT01506479|5825606|P3|COMPLETED|Overall Study||42
2373892|NCT01506479|5825607|P2|COMPLETED|Overall Study||38
2373893|NCT01506479|5825608|P1|COMPLETED|Overall Study||37
2373894|NCT01506479|5825606|P3|STARTED|Overall Study||45
2373895|NCT01506479|5825607|P2|STARTED|Overall Study||43
2373896|NCT01506479|5825608|P1|STARTED|Overall Study||40
2373897|NCT01506453|5825622|P2|NOT COMPLETED|Overall Study||2
2373898|NCT01506453|5825623|P1|NOT COMPLETED|Overall Study||0
2373899|NCT01506453|5825622|P2|COMPLETED|Overall Study||24
2373900|NCT01506453|5825623|P1|COMPLETED|Overall Study||25
2373901|NCT01506453|5825622|P2|STARTED|Overall Study||26
2373902|NCT01506453|5825623|P1|STARTED|Overall Study||25
2373903|NCT01506362|5825633|P1|NOT COMPLETED|Overall Study||6
2373904|NCT01506362|5825633|P1|COMPLETED|Overall Study||16
2373905|NCT01506362|5825633|P1|STARTED|Overall Study||22
2373906|NCT01506323|5825639|P2|NOT COMPLETED|Overall Study||13
2373907|NCT01506323|5825640|P1|NOT COMPLETED|Overall Study||24
2373908|NCT01506323|5825639|P2|COMPLETED|Overall Study||71
2373909|NCT01506323|5825640|P1|COMPLETED|Overall Study||65
2373910|NCT01506323|5825639|P2|Post-treatment Completed CAPS|Overall Study||72
2373911|NCT01506323|5825640|P1|Post-treatment Completed CAPS|Overall Study||68
2373912|NCT01506323|5825639|P2|Post-treatment Completers|Overall Study||72
2373913|NCT01506323|5825640|P1|Post-treatment Completers|Overall Study||69
2373914|NCT01506323|5825639|P2|STARTED|Overall Study||84
2373915|NCT01506323|5825640|P1|STARTED|Overall Study||89
2373916|NCT01506271|5825669|P3|NOT COMPLETED|Overall Study||3
2373917|NCT01506271|5825670|P2|NOT COMPLETED|Overall Study||7
2373918|NCT01506271|5825671|P1|NOT COMPLETED|Overall Study||4
2373919|NCT01506271|5825669|P3|COMPLETED|Overall Study||114
2373920|NCT01506271|5825670|P2|COMPLETED|Overall Study||109
2373921|NCT01506271|5825671|P1|COMPLETED|Overall Study||114
2373922|NCT01506271|5825669|P3|Treated|Overall Study||114
2373923|NCT01506271|5825670|P2|Treated|Overall Study||116
2373924|NCT01506271|5825671|P1|Treated|Overall Study||117
2373925|NCT01506271|5825669|P3|STARTED|Overall Study||117
2373926|NCT01506271|5825670|P2|STARTED|Overall Study||116
2373927|NCT01506271|5825671|P1|STARTED|Overall Study||118
2373928|NCT01506193|5825733|P3|NOT COMPLETED|Overall Study||14
2373929|NCT01506193|5825734|P2|NOT COMPLETED|Overall Study||4
2373930|NCT01506193|5825735|P1|NOT COMPLETED|Overall Study||14
2373931|NCT01506193|5825733|P3|COMPLETED|Overall Study||168
2373932|NCT01506193|5825734|P2|COMPLETED|Overall Study||179
2373933|NCT01506193|5825735|P1|COMPLETED|Overall Study||337
2373934|NCT01506193|5825733|P3|STARTED|Overall Study||182
2373935|NCT01506193|5825734|P2|STARTED|Overall Study||183
2373936|NCT01506193|5825735|P1|STARTED|Overall Study||351
2373937|NCT01505933|5825768|P2|NOT COMPLETED|Overall Study||0
2373938|NCT01505933|5825769|P1|NOT COMPLETED|Overall Study||0
2373939|NCT01505933|5825768|P2|COMPLETED|Overall Study||14
2373940|NCT01505933|5825769|P1|COMPLETED|Overall Study||10
2373941|NCT01505933|5825768|P2|STARTED|Overall Study||14
2373942|NCT01505933|5825769|P1|STARTED|Overall Study||10
2373943|NCT01505881|5825781|P2|NOT COMPLETED|Overall Study||1
2373944|NCT01505881|5825782|P1|NOT COMPLETED|Overall Study||4
2373945|NCT01505881|5825781|P2|COMPLETED|Overall Study||58
2373946|NCT01505881|5825782|P1|COMPLETED|Overall Study||95
2373947|NCT01505881|5825781|P2|STARTED|Overall Study||59
2373948|NCT01505881|5825782|P1|STARTED|Overall Study||99
2373949|NCT01505764|5825796|P2|NOT COMPLETED|Overall Study||1
2373950|NCT01505764|5825797|P1|NOT COMPLETED|Overall Study||3
2373951|NCT01505764|5825796|P2|COMPLETED|Overall Study||2
2373952|NCT01505764|5825797|P1|COMPLETED|Overall Study||3
2373953|NCT01505764|5825796|P2|STARTED|Overall Study||3
2373954|NCT01505764|5825797|P1|STARTED|Overall Study||6
2373955|NCT01505673|5825827|P2|NOT COMPLETED|Overall Study||2
2373956|NCT01505673|5825828|P1|NOT COMPLETED|Overall Study||3
2373957|NCT01505673|5825827|P2|COMPLETED|Overall Study||34
2373958|NCT01505673|5825828|P1|COMPLETED|Overall Study||32
2373959|NCT01505673|5825827|P2|STARTED|Overall Study||36
2373960|NCT01505673|5825828|P1|STARTED|Overall Study||35
2373961|NCT01505647|5825888|P2|NOT COMPLETED|Day 43 Through Day 182 Follow-up||3
2373962|NCT01505647|5825889|P1|NOT COMPLETED|Day 43 Through Day 182 Follow-up||1
2373963|NCT01505647|5825888|P2|COMPLETED|Day 43 Through Day 182 Follow-up||163
2373964|NCT01505647|5825889|P1|COMPLETED|Day 43 Through Day 182 Follow-up||328
2373965|NCT01505647|5825888|P2|STARTED|Day 43 Through Day 182 Follow-up||166
2373966|NCT01505647|5825889|P1|STARTED|Day 43 Through Day 182 Follow-up||329
2373967|NCT01505647|5825888|P2|NOT COMPLETED|Day 1 Through Day 42 Follow-up||0
2373968|NCT01505647|5825889|P1|NOT COMPLETED|Day 1 Through Day 42 Follow-up||3
2373969|NCT01505647|5825888|P2|COMPLETED|Day 1 Through Day 42 Follow-up||166
2373970|NCT01505647|5825889|P1|COMPLETED|Day 1 Through Day 42 Follow-up||329
2373971|NCT01505647|5825888|P2|Vaccinated|Day 1 Through Day 42 Follow-up||166
2373972|NCT01505647|5825889|P1|Vaccinated|Day 1 Through Day 42 Follow-up||331
2373973|NCT01505647|5825888|P2|STARTED|Day 1 Through Day 42 Follow-up||166
2373974|NCT01505647|5825889|P1|STARTED|Day 1 Through Day 42 Follow-up||332
2373975|NCT01505634|5825906|P3|NOT COMPLETED|Overall Study||6
2373976|NCT01505634|5825907|P2|NOT COMPLETED|Overall Study||10
2373977|NCT01505634|5825908|P1|NOT COMPLETED|Overall Study||9
2373978|NCT01505634|5825906|P3|COMPLETED|Overall Study||94
2373979|NCT01505634|5825907|P2|COMPLETED|Overall Study||91
2373980|NCT01505634|5825908|P1|COMPLETED|Overall Study||92
2373981|NCT01505634|5825906|P3|Treated|Overall Study||100
2373982|NCT01505634|5825907|P2|Treated|Overall Study||99
2373983|NCT01505634|5825908|P1|Treated|Overall Study||99
2373984|NCT01505634|5825906|P3|STARTED|Overall Study||100
2373985|NCT01505634|5825907|P2|STARTED|Overall Study||101
2373986|NCT01505634|5825908|P1|STARTED|Overall Study||101
2373987|NCT01505608|5825963|P2|NOT COMPLETED|Phase II||2
2373988|NCT01505608|5825964|P1|NOT COMPLETED|Phase II||2
2373989|NCT01505608|5825963|P2|COMPLETED|Phase II||2
2373990|NCT01505608|5825964|P1|COMPLETED|Phase II||0
2373991|NCT01505608|5825963|P2|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|4
2373992|NCT01505608|5825964|P1|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|2
2373993|NCT01505608|5825963|P2|NOT COMPLETED|Phase I||6
2373994|NCT01505608|5825964|P1|NOT COMPLETED|Phase I||0
2373995|NCT01505608|5825963|P2|COMPLETED|Phase I||2
2373996|NCT01505608|5825964|P1|COMPLETED|Phase I||0
2373997|NCT01505608|5825963|P2|STARTED|Phase I||8
2373998|NCT01505608|5825964|P1|STARTED|Phase I|Randomization to Arm A began in Phase 2. All patients in Phase I were enrolled to receive TPI 287.|0
2373999|NCT01505530|5825983|P3|NOT COMPLETED|Overall Study||41
2374000|NCT01505530|5825984|P2|NOT COMPLETED|Overall Study||43
2374001|NCT01505530|5825985|P1|NOT COMPLETED|Overall Study||41
2374002|NCT01505530|5825983|P3|COMPLETED|Overall Study||0
2374003|NCT01505530|5825984|P2|COMPLETED|Overall Study||0
2374004|NCT01505530|5825985|P1|COMPLETED|Overall Study||0
2374005|NCT01505530|5825983|P3|Completed One Cycle of Study Drug|Overall Study||31
2374006|NCT01505530|5825984|P2|Completed One Cycle of Study Drug|Overall Study||27
2374007|NCT01505530|5825985|P1|Completed One Cycle of Study Drug|Overall Study||29
2374008|NCT01505530|5825983|P3|Received At Least One Dose of Study Drug|Overall Study||41
2374009|NCT01505530|5825984|P2|Received At Least One Dose of Study Drug|Overall Study||42
2374010|NCT01505530|5825985|P1|Received At Least One Dose of Study Drug|Overall Study||41
2374011|NCT01505530|5825983|P3|STARTED|Overall Study||41
2374012|NCT01505530|5825984|P2|STARTED|Overall Study||43
2374013|NCT01505530|5825985|P1|STARTED|Overall Study||41
2374014|NCT01505491|5826029|P3|NOT COMPLETED|Overall Study||5
2374015|NCT01505491|5826030|P2|NOT COMPLETED|Overall Study||1
2374016|NCT01505491|5826031|P1|NOT COMPLETED|Overall Study||2
2374017|NCT01505491|5826029|P3|COMPLETED|Overall Study||59
2374018|NCT01505491|5826030|P2|COMPLETED|Overall Study||61
2374019|NCT01505491|5826031|P1|COMPLETED|Overall Study||65
2374020|NCT01505491|5826029|P3|STARTED|Overall Study||64
2374021|NCT01505491|5826030|P2|STARTED|Overall Study||62
2374022|NCT01505491|5826031|P1|STARTED|Overall Study||67
2374023|NCT01505465|5826053|P2|NOT COMPLETED|Overall Study||7
2374024|NCT01505465|5826054|P1|NOT COMPLETED|Overall Study||6
2374025|NCT01505465|5826053|P2|COMPLETED|Overall Study||18
2374026|NCT01505465|5826054|P1|COMPLETED|Overall Study||19
2374027|NCT01505465|5826053|P2|STARTED|Overall Study||25
2374028|NCT01505465|5826054|P1|STARTED|Overall Study||25
2374029|NCT01505387|5826070|P2|NOT COMPLETED|Overall Study||1
2374030|NCT01505387|5826071|P1|NOT COMPLETED|Overall Study||2
2374031|NCT01505387|5826070|P2|COMPLETED|Overall Study||24
2374032|NCT01505387|5826071|P1|COMPLETED|Overall Study|1 subject not included in intention to treat population as violated inclusion criteria|23
2374033|NCT01505387|5826070|P2|Treated|Overall Study||24
2374034|NCT01505387|5826071|P1|Treated|Overall Study||24
2374035|NCT01505387|5826070|P2|STARTED|Overall Study||25
2374036|NCT01505387|5826071|P1|STARTED|Overall Study||25
2374037|NCT01505374|5826077|P2|NOT COMPLETED|Overall Study||0
2374038|NCT01505374|5826078|P1|NOT COMPLETED|Overall Study||1
2374039|NCT01505374|5826077|P2|COMPLETED|Overall Study||30
2374040|NCT01505374|5826078|P1|COMPLETED|Overall Study||29
2374041|NCT01505374|5826077|P2|STARTED|Overall Study||30
2374042|NCT01505374|5826078|P1|STARTED|Overall Study||30
2374043|NCT01505179|5826094|P2|NOT COMPLETED|Overall Study||0
2374044|NCT01505179|5826095|P1|NOT COMPLETED|Overall Study||0
2374045|NCT01505179|5826094|P2|COMPLETED|Overall Study||4
2374046|NCT01505179|5826095|P1|COMPLETED|Overall Study||6
2374047|NCT01505179|5826094|P2|STARTED|Overall Study||4
2374048|NCT01505179|5826095|P1|STARTED|Overall Study||6
2374049|NCT01505166|5826110|P3|NOT COMPLETED|Overall Study||0
2374050|NCT01505166|5826111|P2|NOT COMPLETED|Overall Study||0
2374051|NCT01505166|5826112|P1|NOT COMPLETED|Overall Study||0
2374052|NCT01505166|5826110|P3|COMPLETED|Overall Study||0
2374053|NCT01505166|5826111|P2|COMPLETED|Overall Study||0
2374054|NCT01505166|5826112|P1|COMPLETED|Overall Study|"Completed means subject had successful Vigil manufacturing and had been given all the doses."|3
2374055|NCT01505166|5826110|P3|STARTED|Overall Study||0
2374056|NCT01505166|5826111|P2|STARTED|Overall Study||0
2374057|NCT01505166|5826112|P1|STARTED|Overall Study||3
2374058|NCT01505114|5826128|P4|NOT COMPLETED|Overall Study||23
2374059|NCT01505114|5826129|P3|NOT COMPLETED|Overall Study||18
2374060|NCT01505114|5826130|P2|NOT COMPLETED|Overall Study||13
2374061|NCT01505114|5826131|P1|NOT COMPLETED|Overall Study||25
2374062|NCT01505114|5826128|P4|COMPLETED|Overall Study||128
2374063|NCT01505114|5826129|P3|COMPLETED|Overall Study||129
2374064|NCT01505114|5826130|P2|COMPLETED|Overall Study||135
2374065|NCT01505114|5826131|P1|COMPLETED|Overall Study||123
2374066|NCT01505114|5826128|P4|STARTED|Overall Study||151
2374067|NCT01505114|5826129|P3|STARTED|Overall Study||147
2374068|NCT01505114|5826130|P2|STARTED|Overall Study||148
2374069|NCT01505114|5826131|P1|STARTED|Overall Study||148
2374070|NCT01504997|5826141|P1|NOT COMPLETED|Overall Study||0
2374071|NCT01504997|5826141|P1|COMPLETED|Overall Study||18
2374072|NCT01504997|5826141|P1|STARTED|Overall Study||18
2374073|NCT01504971|5826145|P1|NOT COMPLETED|Overall Study||13
2374074|NCT01504971|5826145|P1|COMPLETED|Overall Study||82
2374075|NCT01504971|5826145|P1|STARTED|Overall Study||95
2374076|NCT01504958|5826156|P3|NOT COMPLETED|Overall Study||0
2374077|NCT01504958|5826157|P2|NOT COMPLETED|Overall Study||0
2374078|NCT01504958|5826158|P1|NOT COMPLETED|Overall Study||0
2374079|NCT01504958|5826156|P3|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
2374080|NCT01504958|5826157|P2|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
2374081|NCT01504958|5826158|P1|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|10
2374082|NCT01504958|5826156|P3|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
2374083|NCT01504958|5826157|P2|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
2374084|NCT01504958|5826158|P1|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|10
2374085|NCT01504867|5826174|P2|NOT COMPLETED|Overall Study||3
2374086|NCT01504867|5826175|P1|NOT COMPLETED|Overall Study||7
2374087|NCT01504867|5826174|P2|COMPLETED|Overall Study||195
2374088|NCT01504867|5826175|P1|COMPLETED|Overall Study||195
2374089|NCT01504867|5826174|P2|STARTED|Overall Study||198
2374090|NCT01504867|5826175|P1|STARTED|Overall Study||202
2374091|NCT01504854|5826195|P2|NOT COMPLETED|Overall Study||7
2374092|NCT01504854|5826196|P1|NOT COMPLETED|Overall Study||8
2374093|NCT01504854|5826195|P2|COMPLETED|Overall Study||48
2374094|NCT01504854|5826196|P1|COMPLETED|Overall Study||56
2374095|NCT01504854|5826195|P2|STARTED|Overall Study||55
2374096|NCT01504854|5826196|P1|STARTED|Overall Study||64
2374097|NCT01504841|5826213|P3|NOT COMPLETED|Overall Study||0
2374098|NCT01504841|5826214|P2|NOT COMPLETED|Overall Study||4
2374099|NCT01504841|5826215|P1|NOT COMPLETED|Overall Study||16
2374100|NCT01504841|5826213|P3|COMPLETED|Overall Study||0
2374101|NCT01504841|5826214|P2|COMPLETED|Overall Study||2
2374102|NCT01504841|5826215|P1|COMPLETED|Overall Study||4
2374103|NCT01504841|5826213|P3|STARTED|Overall Study|No enrollments occurred into Cohort 3 during the study.|0
2374104|NCT01504841|5826214|P2|STARTED|Overall Study||6
2374105|NCT01504841|5826215|P1|STARTED|Overall Study||20
2374106|NCT01504204|5826250|P2|NOT COMPLETED|Overall Study||1
2374107|NCT01504204|5826251|P1|NOT COMPLETED|Overall Study||1
2374108|NCT01504204|5826250|P2|COMPLETED|Overall Study||9
2374109|NCT01504204|5826251|P1|COMPLETED|Overall Study||9
2374110|NCT01504204|5826250|P2|STARTED|Overall Study||10
2374111|NCT01504204|5826251|P1|STARTED|Overall Study||10
2374112|NCT01503749|5826264|P3|NOT COMPLETED|Overall Study||0
2374113|NCT01503749|5826265|P2|NOT COMPLETED|Overall Study||0
2374114|NCT01503749|5826266|P1|NOT COMPLETED|Overall Study||0
2374115|NCT01503749|5826264|P3|COMPLETED|Overall Study||3
2374116|NCT01503749|5826265|P2|COMPLETED|Overall Study||3
2374117|NCT01503749|5826266|P1|COMPLETED|Overall Study||3
2374118|NCT01503749|5826264|P3|STARTED|Overall Study||3
2374119|NCT01503749|5826265|P2|STARTED|Overall Study||3
2374120|NCT01503749|5826266|P1|STARTED|Overall Study||3
2374121|NCT01503333|5826279|P2|NOT COMPLETED|Overall Study||305
2374122|NCT01503333|5826280|P1|NOT COMPLETED|Overall Study||340
2374123|NCT01503333|5826279|P2|COMPLETED|Overall Study||461
2374124|NCT01503333|5826280|P1|COMPLETED|Overall Study||437
2374125|NCT01503333|5826279|P2|Completed Post-intervention|Overall Study||706
2374126|NCT01503333|5826280|P1|Completed Post-intervention|Overall Study||680
2374127|NCT01503333|5826279|P2|Completed Baseline|Overall Study||753
2374128|NCT01503333|5826280|P1|Completed Baseline|Overall Study||766
2374129|NCT01503333|5826279|P2|STARTED|Overall Study||766
2374130|NCT01503333|5826280|P1|STARTED|Overall Study||777
2374131|NCT01503164|5826308|P2|NOT COMPLETED|Overall Study||1
2374132|NCT01503164|5826309|P1|NOT COMPLETED|Overall Study||2
2374133|NCT01503164|5826308|P2|COMPLETED|Overall Study||55
2374134|NCT01503164|5826309|P1|COMPLETED|Overall Study||53
2374135|NCT01503164|5826308|P2|STARTED|Overall Study||56
2374136|NCT01503164|5826309|P1|STARTED|Overall Study||55
2374137|NCT01503021|5826339|P2|NOT COMPLETED|Overall Study||26
2374138|NCT01503021|5826340|P1|NOT COMPLETED|Overall Study||27
2374139|NCT01503021|5826339|P2|COMPLETED|Overall Study||332
2374140|NCT01503021|5826340|P1|COMPLETED|Overall Study||333
2374141|NCT01503021|5826339|P2|Completed Treatment|Overall Study|One patient completed the treatment period but discontinued prior to completing the follow-up visit.|333
2374142|NCT01503021|5826340|P1|Completed Treatment|Overall Study||333
2374143|NCT01503021|5826339|P2|Dosed|Overall Study||352
2374144|NCT01503021|5826340|P1|Dosed|Overall Study||351
2374145|NCT01503021|5826339|P2|STARTED|Overall Study||358
2374146|NCT01503021|5826340|P1|STARTED|Overall Study||360
2374147|NCT01502956|5826389|P2|NOT COMPLETED|Overall Study||26
2374148|NCT01502956|5826390|P1|NOT COMPLETED|Overall Study||24
2374149|NCT01502956|5826389|P2|COMPLETED|Overall Study||168
2374150|NCT01502956|5826390|P1|COMPLETED|Overall Study||168
2374151|NCT01502956|5826389|P2|STARTED|Overall Study||194
2374152|NCT01502956|5826390|P1|STARTED|Overall Study||192
2374153|NCT01502787|5826414|P2|NOT COMPLETED|Overall Study||0
2374154|NCT01502787|5826415|P1|NOT COMPLETED|Overall Study||0
2374155|NCT01502787|5826414|P2|COMPLETED|Overall Study||10
2374156|NCT01502787|5826415|P1|COMPLETED|Overall Study||11
2374157|NCT01502787|5826414|P2|STARTED|Overall Study||10
2374158|NCT01502787|5826415|P1|STARTED|Overall Study||11
2374159|NCT01502761|5826429|P4|NOT COMPLETED|Overall Study||0
2374160|NCT01502761|5826430|P3|NOT COMPLETED|Overall Study||0
2374161|NCT01502761|5826431|P2|NOT COMPLETED|Overall Study||0
2374162|NCT01502761|5826432|P1|NOT COMPLETED|Overall Study||0
2374163|NCT01502761|5826429|P4|COMPLETED|Overall Study||0
2374164|NCT01502761|5826430|P3|COMPLETED|Overall Study||0
2374165|NCT01502761|5826431|P2|COMPLETED|Overall Study||0
2374166|NCT01502761|5826432|P1|COMPLETED|Overall Study||4
2374167|NCT01502761|5826429|P4|STARTED|Overall Study||0
2374168|NCT01502761|5826430|P3|STARTED|Overall Study||0
2374169|NCT01502761|5826431|P2|STARTED|Overall Study||0
2374170|NCT01502761|5826432|P1|STARTED|Overall Study||4
2374171|NCT01502709|5826448|P2|NOT COMPLETED|Overall Study||0
2374172|NCT01502709|5826449|P1|NOT COMPLETED|Overall Study||4
2374173|NCT01502709|5826448|P2|COMPLETED|Overall Study||0
2374174|NCT01502709|5826449|P1|COMPLETED|Overall Study||1
2374175|NCT01502709|5826448|P2|STARTED|Overall Study||0
2374176|NCT01502709|5826449|P1|STARTED|Overall Study||5
2374177|NCT01502644|5826462|P4|NOT COMPLETED|Assigned to NA Groups||8
2374178|NCT01502644|5826463|P3|NOT COMPLETED|Assigned to NA Groups||3
2374179|NCT01502644|5826464|P2|NOT COMPLETED|Assigned to NA Groups||6
2374180|NCT01502644|5826465|P1|NOT COMPLETED|Assigned to NA Groups||0
2374181|NCT01502644|5826462|P4|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
2374182|NCT01502644|5826463|P3|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|7
2374183|NCT01502644|5826464|P2|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
2374184|NCT01502644|5826465|P1|COMPLETED|Assigned to NA Groups||0
2374185|NCT01502644|5826462|P4|STARTED|Assigned to NA Groups||32
2374186|NCT01502644|5826463|P3|STARTED|Assigned to NA Groups||10
2374187|NCT01502644|5826464|P2|STARTED|Assigned to NA Groups||30
2374188|NCT01502644|5826465|P1|STARTED|Assigned to NA Groups||0
2374189|NCT01502644|5826462|P4|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
2374190|NCT01502644|5826463|P3|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
2374191|NCT01502644|5826464|P2|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
2374192|NCT01502644|5826465|P1|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||9
2374193|NCT01502644|5826462|P4|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
2374194|NCT01502644|5826463|P3|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
2374195|NCT01502644|5826464|P2|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
2374196|NCT01502644|5826465|P1|COMPLETED|Enrolled at Visit 1 After Pre-screening|Participants who completed Visit 1 were assigned to 1 of the 3 NA groups for remainder of the trial|72
2374197|NCT01502644|5826462|P4|STARTED|Enrolled at Visit 1 After Pre-screening||0
2374198|NCT01502644|5826463|P3|STARTED|Enrolled at Visit 1 After Pre-screening||0
2374199|NCT01502644|5826464|P2|STARTED|Enrolled at Visit 1 After Pre-screening||0
2374200|NCT01502644|5826465|P1|STARTED|Enrolled at Visit 1 After Pre-screening||81
2374201|NCT01502423|5826475|P2|NOT COMPLETED|Overall Study||1
2374202|NCT01502423|5826476|P1|NOT COMPLETED|Overall Study||0
2374203|NCT01502423|5826475|P2|COMPLETED|Overall Study||29
2374204|NCT01502423|5826476|P1|COMPLETED|Overall Study||31
2374205|NCT01502423|5826475|P2|STARTED|Overall Study||30
2374206|NCT01502423|5826476|P1|STARTED|Overall Study||31
2374207|NCT01502410|5826498|P4|NOT COMPLETED|Overall Study||0
2374208|NCT01502410|5826499|P3|NOT COMPLETED|Overall Study||0
2374209|NCT01502410|5826500|P2|NOT COMPLETED|Overall Study||10
2374210|NCT01502410|5826501|P1|NOT COMPLETED|Overall Study||10
2374211|NCT01502410|5826498|P4|COMPLETED|Overall Study||0
2374212|NCT01502410|5826499|P3|COMPLETED|Overall Study||0
2374213|NCT01502410|5826500|P2|COMPLETED|Overall Study||0
2374214|NCT01502410|5826501|P1|COMPLETED|Overall Study||0
2374215|NCT01502410|5826498|P4|STARTED|Overall Study||0
2374216|NCT01502410|5826499|P3|STARTED|Overall Study||0
2374217|NCT01502410|5826500|P2|STARTED|Overall Study||10
2374218|NCT01502410|5826501|P1|STARTED|Overall Study||10
2374219|NCT01502371|5826519|P5|NOT COMPLETED|Overall Study||52
2374220|NCT01502371|5826520|P4|NOT COMPLETED|Overall Study||37
2374221|NCT01502371|5826521|P3|NOT COMPLETED|Overall Study||25
2374222|NCT01502371|5826522|P2|NOT COMPLETED|Overall Study||32
2374223|NCT01502371|5826523|P1|NOT COMPLETED|Overall Study||41
2374224|NCT01502371|5826519|P5|COMPLETED|Overall Study||60
2374225|NCT01502371|5826520|P4|COMPLETED|Overall Study||88
2374226|NCT01502371|5826521|P3|COMPLETED|Overall Study||83
2374227|NCT01502371|5826522|P2|COMPLETED|Overall Study||81
2374228|NCT01502371|5826523|P1|COMPLETED|Overall Study||79
2374229|NCT01502371|5826519|P5|STARTED|Overall Study||112
2374230|NCT01502371|5826520|P4|STARTED|Overall Study||125
2374231|NCT01502371|5826521|P3|STARTED|Overall Study||108
2374232|NCT01502371|5826522|P2|STARTED|Overall Study||113
2374233|NCT01502371|5826523|P1|STARTED|Overall Study||120
2374234|NCT01502332|5826548|P2|NOT COMPLETED|Overall Study||0
2374235|NCT01502332|5826549|P1|NOT COMPLETED|Overall Study||0
2374236|NCT01502332|5826548|P2|COMPLETED|Overall Study||163
2374237|NCT01502332|5826549|P1|COMPLETED|Overall Study||157
2374238|NCT01502332|5826548|P2|STARTED|Overall Study||163
2374239|NCT01502332|5826549|P1|STARTED|Overall Study||157
2374240|NCT01502306|5826566|P3|NOT COMPLETED|Overall Study||0
2374241|NCT01502306|5826567|P2|NOT COMPLETED|Overall Study||0
2374242|NCT01502306|5826568|P1|NOT COMPLETED|Overall Study||0
2374243|NCT01502306|5826566|P3|COMPLETED|Overall Study||1407
2374244|NCT01502306|5826567|P2|COMPLETED|Overall Study||1405
2374245|NCT01502306|5826568|P1|COMPLETED|Overall Study||1004
2374246|NCT01502306|5826566|P3|STARTED|Overall Study||1407
2374247|NCT01502306|5826567|P2|STARTED|Overall Study||1405
2374248|NCT01502306|5826568|P1|STARTED|Overall Study||1004
2374249|NCT01502293|5826588|P3|NOT COMPLETED|Overall Study||4
2374250|NCT01502293|5826589|P2|NOT COMPLETED|Overall Study||17
2374251|NCT01502293|5826590|P1|NOT COMPLETED|Overall Study||25
2374252|NCT01502293|5826588|P3|COMPLETED|Overall Study||0
2374253|NCT01502293|5826589|P2|COMPLETED|Overall Study||0
2374254|NCT01502293|5826590|P1|COMPLETED|Overall Study||5
2374255|NCT01502293|5826588|P3|STARTED|Overall Study||4
2374256|NCT01502293|5826589|P2|STARTED|Overall Study||17
2374257|NCT01502293|5826590|P1|STARTED|Overall Study||30
2374258|NCT01502228|5826619|P1|NOT COMPLETED|Overall Study||1
2374259|NCT01502228|5826619|P1|COMPLETED|Overall Study||13
2374260|NCT01502228|5826619|P1|STARTED|Overall Study||14
2374261|NCT01502033|5826624|P1|NOT COMPLETED|Overall Study||3
2374262|NCT01502033|5826624|P1|COMPLETED|Overall Study|Milestone (10 participants) met|7
2374263|NCT01502033|5826624|P1|STARTED|Overall Study|Milestone (10 participants) met.|10
2374264|NCT01501955|5826632|P2|NOT COMPLETED|Overall Study||3
2374265|NCT01501955|5826633|P1|NOT COMPLETED|Overall Study||2
2374266|NCT01501955|5826632|P2|COMPLETED|Overall Study||6
2374267|NCT01501955|5826633|P1|COMPLETED|Overall Study||9
2374268|NCT01501955|5826632|P2|2 Years Postop|Overall Study|1 patient terminated due to stem revision|6
2374269|NCT01501955|5826633|P1|2 Years Postop|Overall Study||9
2374270|NCT01501955|5826632|P2|1 Year Postop|Overall Study|2 patients terminated due to stem revision|7
2374271|NCT01501955|5826633|P1|1 Year Postop|Overall Study|1 patient terminated due to stem revision|9
2374272|NCT01501955|5826632|P2|6 Weeks Postop|Overall Study||9
2374273|NCT01501955|5826633|P1|6 Weeks Postop|Overall Study|1 patient withdrew on own request|10
2374274|NCT01501955|5826632|P2|Surgery|Overall Study||9
2374275|NCT01501955|5826633|P1|Surgery|Overall Study||11
2374276|NCT01501955|5826632|P2|STARTED|Overall Study||9
2374277|NCT01501955|5826633|P1|STARTED|Overall Study||11
2374278|NCT01501929|5826675|P2|NOT COMPLETED|Second Intervention||0
2374279|NCT01501929|5826676|P1|NOT COMPLETED|Second Intervention||0
2374280|NCT01501929|5826675|P2|COMPLETED|Second Intervention||17
2374281|NCT01501929|5826676|P1|COMPLETED|Second Intervention||8
2374282|NCT01501929|5826675|P2|STARTED|Second Intervention||17
2374283|NCT01501929|5826676|P1|STARTED|Second Intervention||8
2374284|NCT01501929|5826675|P2|NOT COMPLETED|First Intervention||0
2374285|NCT01501929|5826676|P1|NOT COMPLETED|First Intervention||0
2374286|NCT01501929|5826675|P2|COMPLETED|First Intervention||17
2374287|NCT01501929|5826676|P1|COMPLETED|First Intervention||8
2374288|NCT01501929|5826675|P2|STARTED|First Intervention||17
2374289|NCT01501929|5826676|P1|STARTED|First Intervention||8
2374290|NCT01501162|5826686|P2|NOT COMPLETED|Overall Study||5
2374291|NCT01501162|5826687|P1|NOT COMPLETED|Overall Study||8
2374292|NCT01501162|5826686|P2|COMPLETED|Overall Study||60
2374293|NCT01501162|5826687|P1|COMPLETED|Overall Study||57
2374294|NCT01501162|5826686|P2|STARTED|Overall Study||65
2374295|NCT01501162|5826687|P1|STARTED|Overall Study||65
2374296|NCT01501110|5826697|P2|NOT COMPLETED|Overall Study||1
2374297|NCT01501110|5826698|P1|NOT COMPLETED|Overall Study||0
2374298|NCT01501110|5826697|P2|COMPLETED|Overall Study||33
2374299|NCT01501110|5826698|P1|COMPLETED|Overall Study||34
2374300|NCT01501110|5826697|P2|STARTED|Overall Study||34
2374301|NCT01501110|5826698|P1|STARTED|Overall Study||34
2374302|NCT01500772|5826704|P1|NOT COMPLETED|Overall Study||6
2374303|NCT01500772|5826704|P1|COMPLETED|Overall Study||0
2374304|NCT01500772|5826704|P1|STARTED|Overall Study||6
2374305|NCT01500746|5826713|P2|NOT COMPLETED|Overall Study||0
2374306|NCT01500746|5826714|P1|NOT COMPLETED|Overall Study||0
2374307|NCT01500746|5826713|P2|COMPLETED|Overall Study||4
2374308|NCT01500746|5826714|P1|COMPLETED|Overall Study||4
2374309|NCT01500746|5826713|P2|STARTED|Overall Study||4
2374310|NCT01500746|5826714|P1|STARTED|Overall Study||4
2374311|NCT01500733|5826722|P2|NOT COMPLETED|Overall Study||3
2374312|NCT01500733|5826723|P1|NOT COMPLETED|Overall Study||2
2374313|NCT01500733|5826722|P2|COMPLETED|Overall Study||48
2374314|NCT01500733|5826723|P1|COMPLETED|Overall Study||33
2374315|NCT01500733|5826722|P2|STARTED|Overall Study||51
2374316|NCT01500733|5826723|P1|STARTED|Overall Study||35
2374317|NCT01500720|5826731|P2|NOT COMPLETED|Overall Study||9
2374318|NCT01500720|5826732|P1|NOT COMPLETED|Overall Study||5
2374319|NCT01500720|5826731|P2|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|80
2374320|NCT01500720|5826732|P1|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|85
2374321|NCT01500720|5826731|P2|Treated|Overall Study||88
2374322|NCT01500720|5826732|P1|Treated|Overall Study||89
2374323|NCT01500720|5826731|P2|STARTED|Overall Study|Randomized|89
2374324|NCT01500720|5826732|P1|STARTED|Overall Study|Randomized|90
2374325|NCT01500694|5826746|P2|NOT COMPLETED|Overall Study||29
2374326|NCT01500694|5826747|P1|NOT COMPLETED|Overall Study||52
2374327|NCT01500694|5826746|P2|COMPLETED|Overall Study||54
2374328|NCT01500694|5826747|P1|COMPLETED|Overall Study||79
2374329|NCT01500694|5826746|P2|STARTED|Overall Study|Participants who received treatment were reported as Started.|83
2374330|NCT01500694|5826747|P1|STARTED|Overall Study||131
2374331|NCT01500629|5826773|P2|NOT COMPLETED|Period 2 (Single Dose)||0
2374332|NCT01500629|5826774|P1|NOT COMPLETED|Period 2 (Single Dose)||0
2374333|NCT01500629|5826773|P2|COMPLETED|Period 2 (Single Dose)||10
2374334|NCT01500629|5826774|P1|COMPLETED|Period 2 (Single Dose)||10
2374335|NCT01500629|5826773|P2|STARTED|Period 2 (Single Dose)||10
2374336|NCT01500629|5826774|P1|STARTED|Period 2 (Single Dose)||10
2374337|NCT01500629|5826773|P2|NOT COMPLETED|Washout Period of 14 to 30 Days||0
2374338|NCT01500629|5826774|P1|NOT COMPLETED|Washout Period of 14 to 30 Days||1
2374339|NCT01500629|5826773|P2|COMPLETED|Washout Period of 14 to 30 Days||10
2374340|NCT01500629|5826774|P1|COMPLETED|Washout Period of 14 to 30 Days||10
2374341|NCT01500629|5826773|P2|STARTED|Washout Period of 14 to 30 Days||10
2374342|NCT01500629|5826774|P1|STARTED|Washout Period of 14 to 30 Days||11
2374343|NCT01500629|5826773|P2|NOT COMPLETED|Period 1 (Single Dose)||0
2374344|NCT01500629|5826774|P1|NOT COMPLETED|Period 1 (Single Dose)||0
2374345|NCT01500629|5826773|P2|COMPLETED|Period 1 (Single Dose)||10
2374346|NCT01500629|5826774|P1|COMPLETED|Period 1 (Single Dose)||11
2374347|NCT01500629|5826773|P2|STARTED|Period 1 (Single Dose)||10
2374348|NCT01500629|5826774|P1|STARTED|Period 1 (Single Dose)||11
2374349|NCT01500434|5826858|P1|NOT COMPLETED|Overall Study||7
2374350|NCT01500434|5826858|P1|COMPLETED|Overall Study||95
2374351|NCT01500434|5826858|P1|STARTED|Overall Study||102
2374352|NCT01500382|5826891|P4|NOT COMPLETED|Treatment Period 2||0
2374353|NCT01500382|5826892|P3|NOT COMPLETED|Treatment Period 2||0
2374354|NCT01500382|5826893|P2|NOT COMPLETED|Treatment Period 2||0
2374355|NCT01500382|5826894|P1|NOT COMPLETED|Treatment Period 2||0
2374356|NCT01500382|5826891|P4|COMPLETED|Treatment Period 2||1
2374357|NCT01500382|5826892|P3|COMPLETED|Treatment Period 2||0
2374358|NCT01500382|5826893|P2|COMPLETED|Treatment Period 2||1
2374359|NCT01500382|5826894|P1|COMPLETED|Treatment Period 2||1
2374360|NCT01500382|5826891|P4|STARTED|Treatment Period 2||1
2374361|NCT01500382|5826892|P3|STARTED|Treatment Period 2||0
2374362|NCT01500382|5826893|P2|STARTED|Treatment Period 2||1
2374363|NCT01500382|5826894|P1|STARTED|Treatment Period 2||1
2374364|NCT01500382|5826891|P4|NOT COMPLETED|Washout Period||0
2374365|NCT01500382|5826892|P3|NOT COMPLETED|Washout Period||1
2374366|NCT01500382|5826893|P2|NOT COMPLETED|Washout Period||0
2374367|NCT01500382|5826894|P1|NOT COMPLETED|Washout Period||0
2374368|NCT01500382|5826891|P4|COMPLETED|Washout Period||1
2374369|NCT01500382|5826892|P3|COMPLETED|Washout Period||0
2374370|NCT01500382|5826893|P2|COMPLETED|Washout Period||1
2374371|NCT01500382|5826894|P1|COMPLETED|Washout Period||1
2374372|NCT01500382|5826891|P4|STARTED|Washout Period||1
2374373|NCT01500382|5826892|P3|STARTED|Washout Period||1
2374374|NCT01500382|5826893|P2|STARTED|Washout Period||1
2374375|NCT01500382|5826894|P1|STARTED|Washout Period||1
2374376|NCT01500382|5826891|P4|NOT COMPLETED|Treatment Period 1||0
2374377|NCT01500382|5826892|P3|NOT COMPLETED|Treatment Period 1||0
2374378|NCT01500382|5826893|P2|NOT COMPLETED|Treatment Period 1||0
2374379|NCT01500382|5826894|P1|NOT COMPLETED|Treatment Period 1||0
2374380|NCT01500382|5826891|P4|COMPLETED|Treatment Period 1||1
2374381|NCT01500382|5826892|P3|COMPLETED|Treatment Period 1||1
2374382|NCT01500382|5826893|P2|COMPLETED|Treatment Period 1||1
2374383|NCT01500382|5826894|P1|COMPLETED|Treatment Period 1||1
2374384|NCT01500382|5826891|P4|STARTED|Treatment Period 1||1
2374385|NCT01500382|5826892|P3|STARTED|Treatment Period 1||1
2374386|NCT01500382|5826893|P2|STARTED|Treatment Period 1||1
2374387|NCT01500382|5826894|P1|STARTED|Treatment Period 1||1
2374388|NCT01500317|5826919|P3|NOT COMPLETED|Overall Study||0
2374389|NCT01500317|5826920|P2|NOT COMPLETED|Overall Study||2
2374390|NCT01500317|5826921|P1|NOT COMPLETED|Overall Study||3
2374391|NCT01500317|5826919|P3|COMPLETED|Overall Study||13
2374392|NCT01500317|5826920|P2|COMPLETED|Overall Study||10
2374393|NCT01500317|5826921|P1|COMPLETED|Overall Study||10
2374394|NCT01500317|5826919|P3|STARTED|Overall Study||13
2374395|NCT01500317|5826920|P2|STARTED|Overall Study||12
2374396|NCT01500317|5826921|P1|STARTED|Overall Study||13
2374397|NCT01500278|5826943|P2|NOT COMPLETED|Week 13 - Week 104||126
2374398|NCT01500278|5826944|P1|NOT COMPLETED|Week 13 - Week 104||139
2374399|NCT01500278|5826943|P2|COMPLETED|Week 13 - Week 104||302
2374400|NCT01500278|5826944|P1|COMPLETED|Week 13 - Week 104||287
2374401|NCT01500278|5826943|P2|STARTED|Week 13 - Week 104||428
2374402|NCT01500278|5826944|P1|STARTED|Week 13 - Week 104||426
2374403|NCT01500278|5826943|P2|NOT COMPLETED|Week 0 - Week 12||30
2374404|NCT01500278|5826944|P1|NOT COMPLETED|Week 0 - Week 12||31
2374405|NCT01500278|5826943|P2|COMPLETED|Week 0 - Week 12||428
2374406|NCT01500278|5826944|P1|COMPLETED|Week 0 - Week 12||426
2374407|NCT01500278|5826943|P2|STARTED|Week 0 - Week 12||458
2374408|NCT01500278|5826944|P1|STARTED|Week 0 - Week 12||457
2374409|NCT01500252|5826968|P2|NOT COMPLETED|Overall Study||6
2374410|NCT01500252|5826969|P1|NOT COMPLETED|Overall Study||9
2374411|NCT01500252|5826968|P2|COMPLETED|Overall Study|2 participant deceased by 5 years; no further deaths between 5 & 10 years for a total of 2 deaths|11
2374412|NCT01500252|5826969|P1|COMPLETED|Overall Study|2 participants died within 5 years; 2 participants died between 5 & 10 years for a total of 4 deaths|12
2374413|NCT01500252|5826968|P2|Ten Years|Overall Study||11
2374414|NCT01500252|5826969|P1|Ten Years|Overall Study||12
2374415|NCT01500252|5826968|P2|Five Years|Overall Study||13
2374416|NCT01500252|5826969|P1|Five Years|Overall Study||17
2374417|NCT01500252|5826968|P2|One Years|Overall Study||16
2374418|NCT01500252|5826969|P1|One Years|Overall Study||20
2374419|NCT01500252|5826968|P2|STARTED|Overall Study||17
2374420|NCT01500252|5826969|P1|STARTED|Overall Study||21
2374421|NCT01500226|5826995|P2|NOT COMPLETED|Overall Study||494
2374422|NCT01500226|5826996|P1|NOT COMPLETED|Overall Study||499
2374423|NCT01500226|5826995|P2|COMPLETED|Overall Study||191
2374424|NCT01500226|5826996|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|185
2374425|NCT01500226|5826995|P2|STARTED|Overall Study||685
2374426|NCT01500226|5826996|P1|STARTED|Overall Study|Number of randomized patients|684
2374427|NCT01500213|5827008|P2|NOT COMPLETED|Overall Study||224
2374428|NCT01500213|5827009|P1|NOT COMPLETED|Overall Study||217
2374429|NCT01500213|5827008|P2|COMPLETED|Overall Study||53
2374430|NCT01500213|5827009|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|61
2374431|NCT01500213|5827008|P2|STARTED|Overall Study||277
2374432|NCT01500213|5827009|P1|STARTED|Overall Study|Number of randomized patients|278
2374433|NCT01500200|5827022|P6|NOT COMPLETED|Stage 2||4
2374434|NCT01500200|5827023|P5|NOT COMPLETED|Stage 2||5
2374435|NCT01500200|5827024|P4|NOT COMPLETED|Stage 2||0
2374436|NCT01500200|5827025|P3|NOT COMPLETED|Stage 2||0
2374437|NCT01500200|5827026|P2|NOT COMPLETED|Stage 2||0
2374438|NCT01500200|5827027|P1|NOT COMPLETED|Stage 2||0
2374439|NCT01500200|5827022|P6|COMPLETED|Stage 2||18
2374440|NCT01500200|5827023|P5|COMPLETED|Stage 2||18
2374441|NCT01500200|5827024|P4|COMPLETED|Stage 2||20
2374442|NCT01500200|5827025|P3|COMPLETED|Stage 2||0
2374443|NCT01500200|5827026|P2|COMPLETED|Stage 2||0
2374444|NCT01500200|5827027|P1|COMPLETED|Stage 2||0
2374445|NCT01500200|5827022|P6|STARTED|Stage 2||22
2374446|NCT01500200|5827023|P5|STARTED|Stage 2||23
2374447|NCT01500200|5827024|P4|STARTED|Stage 2||20
2374448|NCT01500200|5827025|P3|STARTED|Stage 2||0
2374449|NCT01500200|5827026|P2|STARTED|Stage 2||0
2374450|NCT01500200|5827027|P1|STARTED|Stage 2||0
2374451|NCT01500200|5827022|P6|NOT COMPLETED|Stage 1||0
2374452|NCT01500200|5827023|P5|NOT COMPLETED|Stage 1||0
2374453|NCT01500200|5827024|P4|NOT COMPLETED|Stage 1||0
2374454|NCT01500200|5827025|P3|NOT COMPLETED|Stage 1||6
2374455|NCT01500200|5827026|P2|NOT COMPLETED|Stage 1||6
2374456|NCT01500200|5827027|P1|NOT COMPLETED|Stage 1||8
2374457|NCT01500200|5827022|P6|COMPLETED|Stage 1||0
2374458|NCT01500200|5827023|P5|COMPLETED|Stage 1||0
2374459|NCT01500200|5827024|P4|COMPLETED|Stage 1||0
2374460|NCT01500200|5827025|P3|COMPLETED|Stage 1||13
2374461|NCT01500200|5827026|P2|COMPLETED|Stage 1||18
2374462|NCT01500200|5827027|P1|COMPLETED|Stage 1||90
2374463|NCT01500200|5827022|P6|STARTED|Stage 1||0
2374464|NCT01500200|5827023|P5|STARTED|Stage 1||0
2374465|NCT01500200|5827024|P4|STARTED|Stage 1||0
2374466|NCT01500200|5827025|P3|STARTED|Stage 1||19
2374467|NCT01500200|5827026|P2|STARTED|Stage 1||24
2374468|NCT01500200|5827027|P1|STARTED|Stage 1||98
2374469|NCT01500187|5827061|P2|NOT COMPLETED|Overall Study||0
2374470|NCT01500187|5827062|P1|NOT COMPLETED|Overall Study||6
2374471|NCT01500187|5827061|P2|COMPLETED|Overall Study||15
2374472|NCT01500187|5827062|P1|COMPLETED|Overall Study||17
2374473|NCT01500187|5827061|P2|STARTED|Overall Study||15
2374474|NCT01500187|5827062|P1|STARTED|Overall Study||23
2374475|NCT01500135|5827070|P2|NOT COMPLETED|Overall Study||11
2374476|NCT01500135|5827071|P1|NOT COMPLETED|Overall Study||17
2374477|NCT01500135|5827070|P2|COMPLETED|Overall Study||39
2374478|NCT01500135|5827071|P1|COMPLETED|Overall Study||83
2374479|NCT01500135|5827070|P2|STARTED|Overall Study||50
2374480|NCT01500135|5827071|P1|STARTED|Overall Study||100
2374481|NCT01500109|5827084|P3|NOT COMPLETED|Overall Study||0
2374482|NCT01500109|5827085|P2|NOT COMPLETED|Overall Study||0
2374483|NCT01500109|5827086|P1|NOT COMPLETED|Overall Study||0
2374484|NCT01500109|5827084|P3|COMPLETED|Overall Study||16
2374485|NCT01500109|5827085|P2|COMPLETED|Overall Study||14
2374486|NCT01500109|5827086|P1|COMPLETED|Overall Study||15
2374487|NCT01500109|5827084|P3|STARTED|Overall Study||16
2374488|NCT01500109|5827085|P2|STARTED|Overall Study||14
2374489|NCT01500109|5827086|P1|STARTED|Overall Study||15
2374490|NCT01500096|5827098|P4|NOT COMPLETED|Overall Study||2
2374491|NCT01500096|5827099|P3|NOT COMPLETED|Overall Study||0
2374492|NCT01500096|5827100|P2|NOT COMPLETED|Overall Study||0
2374493|NCT01500096|5827101|P1|NOT COMPLETED|Overall Study||1
2374494|NCT01500096|5827098|P4|COMPLETED|Overall Study||14
2374495|NCT01500096|5827099|P3|COMPLETED|Overall Study||31
2374496|NCT01500096|5827100|P2|COMPLETED|Overall Study||17
2374497|NCT01500096|5827101|P1|COMPLETED|Overall Study||31
2374498|NCT01500096|5827098|P4|STARTED|Overall Study||16
2374499|NCT01500096|5827099|P3|STARTED|Overall Study||31
2374500|NCT01500096|5827100|P2|STARTED|Overall Study||17
2374501|NCT01500096|5827101|P1|STARTED|Overall Study||32
2374502|NCT01500083|5827157|P2|NOT COMPLETED|Overall Study||43
2374503|NCT01500083|5827158|P1|NOT COMPLETED|Overall Study||12
2374504|NCT01500083|5827157|P2|COMPLETED|Overall Study||31
2374505|NCT01500083|5827158|P1|COMPLETED|Overall Study||4
2374506|NCT01500083|5827157|P2|STARTED|Overall Study||74
2374507|NCT01500083|5827158|P1|STARTED|Overall Study||16
2374508|NCT01500057|5827166|P2|NOT COMPLETED|Overall Study||4
2374509|NCT01500057|5827167|P1|NOT COMPLETED|Overall Study||6
2374510|NCT01500057|5827166|P2|COMPLETED|Overall Study||31
2374511|NCT01500057|5827167|P1|COMPLETED|Overall Study||25
2374512|NCT01500057|5827166|P2|STARTED|Overall Study||35
2374513|NCT01500057|5827167|P1|STARTED|Overall Study||31
2374514|NCT01500031|5827177|P1|NOT COMPLETED|Overall Study||5
2374515|NCT01500031|5827177|P1|COMPLETED|Overall Study||87
2374516|NCT01500031|5827177|P1|STARTED|Overall Study||92
2374517|NCT01499862|5827192|P1|NOT COMPLETED|Overall Study||0
2374518|NCT01499862|5827192|P1|COMPLETED|Overall Study||3
2374519|NCT01499862|5827192|P1|STARTED|Overall Study||3
2374520|NCT01499849|5827212|P2|NOT COMPLETED|Overall Study||226
2374521|NCT01499849|5827213|P1|NOT COMPLETED|Overall Study||224
2374522|NCT01499849|5827212|P2|COMPLETED|Overall Study||40
2374523|NCT01499849|5827213|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|42
2374524|NCT01499849|5827212|P2|STARTED|Overall Study||266
2374525|NCT01499849|5827213|P1|STARTED|Overall Study|Number of randomized patients|266
2374526|NCT01499810|5827223|P1|NOT COMPLETED|Overall Study||12
2374527|NCT01499810|5827223|P1|COMPLETED|Overall Study||41
2374528|NCT01499810|5827223|P1|STARTED|Overall Study||53
2374529|NCT01499667|5827273|P3|NOT COMPLETED|Overall Study||10
2374530|NCT01499667|5827274|P2|NOT COMPLETED|Overall Study||11
2374531|NCT01499667|5827275|P1|NOT COMPLETED|Overall Study||9
2374532|NCT01499667|5827273|P3|COMPLETED|Overall Study||40
2374533|NCT01499667|5827274|P2|COMPLETED|Overall Study||31
2374534|NCT01499667|5827275|P1|COMPLETED|Overall Study||41
2374535|NCT01499667|5827273|P3|Modified Full Analysis Set|Overall Study||39
2374536|NCT01499667|5827274|P2|Modified Full Analysis Set|Overall Study||29
2374537|NCT01499667|5827275|P1|Modified Full Analysis Set|Overall Study|mFAS included all FAS patients who completed 8 wks of fingolimod treatment with MRI scan|41
2374538|NCT01499667|5827273|P3|Full Analysis Set (FAS)|Overall Study||50
2374539|NCT01499667|5827274|P2|Full Analysis Set (FAS)|Overall Study||42
2374540|NCT01499667|5827275|P1|Full Analysis Set (FAS)|Overall Study|One randomized patient did not receive natalizumub at screening, which was a requirement for FAS.|49
2374541|NCT01499667|5827273|P3|STARTED|Overall Study||50
2374542|NCT01499667|5827274|P2|STARTED|Overall Study||42
2374543|NCT01499667|5827275|P1|STARTED|Overall Study|Started” indicates randomized as well as safety population.|50
2374544|NCT01499654|5827304|P1|NOT COMPLETED|Overall Study||0
2374545|NCT01499654|5827304|P1|COMPLETED|Overall Study||64
2374546|NCT01499654|5827304|P1|STARTED|Overall Study||64
2374547|NCT01499576|5827323|P1|NOT COMPLETED|Overall Study||21
2374548|NCT01499576|5827323|P1|COMPLETED|Overall Study||105
2374549|NCT01499576|5827323|P1|STARTED|Overall Study||126
2374550|NCT01499511|5827331|P2|NOT COMPLETED|Overall Study||0
2374551|NCT01499511|5827332|P1|NOT COMPLETED|Overall Study||1
2374552|NCT01499511|5827331|P2|COMPLETED|Overall Study||833
2374553|NCT01499511|5827332|P1|COMPLETED|Overall Study||884
2374554|NCT01499511|5827331|P2|STARTED|Overall Study||833
2374555|NCT01499511|5827332|P1|STARTED|Overall Study||885
2374556|NCT01499498|5827349|P1|NOT COMPLETED|Overall Study||0
2374557|NCT01499498|5827349|P1|COMPLETED|Overall Study||13
2374558|NCT01499498|5827349|P1|STARTED|Overall Study||13
2374559|NCT01499355|5827357|P4|NOT COMPLETED|Double-Blind Period||23
2374560|NCT01499355|5827358|P3|NOT COMPLETED|Double-Blind Period||25
2374561|NCT01499355|5827359|P2|NOT COMPLETED|Double-Blind Period||23
2374562|NCT01499355|5827360|P1|NOT COMPLETED|Double-Blind Period||0
2374563|NCT01499355|5827357|P4|COMPLETED|Double-Blind Period||39
2374564|NCT01499355|5827358|P3|COMPLETED|Double-Blind Period||38
2374565|NCT01499355|5827359|P2|COMPLETED|Double-Blind Period||40
2374566|NCT01499355|5827360|P1|COMPLETED|Double-Blind Period||0
2374567|NCT01499355|5827357|P4|STARTED|Double-Blind Period||62
2374568|NCT01499355|5827358|P3|STARTED|Double-Blind Period||63
2374569|NCT01499355|5827359|P2|STARTED|Double-Blind Period||63
2374570|NCT01499355|5827360|P1|STARTED|Double-Blind Period||0
2374571|NCT01499355|5827357|P4|NOT COMPLETED|Run-In Period||0
2374572|NCT01499355|5827358|P3|NOT COMPLETED|Run-In Period||0
2374573|NCT01499355|5827359|P2|NOT COMPLETED|Run-In Period||0
2374574|NCT01499355|5827360|P1|NOT COMPLETED|Run-In Period||31
2374575|NCT01499355|5827357|P4|COMPLETED|Run-In Period||0
2374576|NCT01499355|5827358|P3|COMPLETED|Run-In Period||0
2374577|NCT01499355|5827359|P2|COMPLETED|Run-In Period||0
2374578|NCT01499355|5827360|P1|COMPLETED|Run-In Period||245
2374579|NCT01499355|5827357|P4|STARTED|Run-In Period||0
2374580|NCT01499355|5827358|P3|STARTED|Run-In Period||0
2374581|NCT01499355|5827359|P2|STARTED|Run-In Period||0
2374582|NCT01499355|5827360|P1|STARTED|Run-In Period||276
2374583|NCT01499303|5827393|P2|NOT COMPLETED|Overall Study||7
2374584|NCT01499303|5827394|P1|NOT COMPLETED|Overall Study||3
2374585|NCT01499303|5827393|P2|COMPLETED|Overall Study||40
2374586|NCT01499303|5827394|P1|COMPLETED|Overall Study||18
2374587|NCT01499303|5827393|P2|STARTED|Overall Study||47
2374588|NCT01499303|5827394|P1|STARTED|Overall Study||21
2374589|NCT01499290|5827402|P2|NOT COMPLETED|Overall Study||35
2374590|NCT01499290|5827403|P1|NOT COMPLETED|Overall Study||55
2374591|NCT01499290|5827402|P2|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|494
2374592|NCT01499290|5827403|P1|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|474
2374593|NCT01499290|5827402|P2|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
2374594|NCT01499290|5827403|P1|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
2374595|NCT01499277|5827453|P2|NOT COMPLETED|Overall Study||32
2374596|NCT01499277|5827454|P1|NOT COMPLETED|Overall Study||47
2374597|NCT01499277|5827453|P2|COMPLETED|Overall Study||223
2374598|NCT01499277|5827454|P1|COMPLETED|Overall Study||459
2374599|NCT01499277|5827453|P2|STARTED|Overall Study||255
2374600|NCT01499277|5827454|P1|STARTED|Overall Study||506
2374601|NCT01499199|5827476|P1|NOT COMPLETED|Overall Study||2
2374602|NCT01499199|5827476|P1|COMPLETED|Overall Study||11
2374603|NCT01499199|5827476|P1|STARTED|Overall Study||13
2374604|NCT01499173|5827495|P1|NOT COMPLETED|Overall Study||37
2374605|NCT01499173|5827495|P1|COMPLETED|Overall Study||64
2374606|NCT01499173|5827495|P1|STARTED|Overall Study||101
2374607|NCT01499160|5827505|P1|NOT COMPLETED|Overall Study||2
2374608|NCT01499160|5827505|P1|COMPLETED|Overall Study|"1 pt-withdrew consent~1pt-had cardiac toxicity"|5
2374609|NCT01499160|5827505|P1|STARTED|Overall Study||7
2374610|NCT01499147|5827512|P2|NOT COMPLETED|Overall Study||5
2374611|NCT01499147|5827513|P1|NOT COMPLETED|Overall Study||15
2374612|NCT01499147|5827512|P2|COMPLETED|Overall Study||12
2374613|NCT01499147|5827513|P1|COMPLETED|Overall Study||18
2374614|NCT01499147|5827512|P2|STARTED|Overall Study||17
2374615|NCT01499147|5827513|P1|STARTED|Overall Study||33
2374616|NCT01499134|5827528|P2|NOT COMPLETED|Overall Study||1
2374617|NCT01499134|5827529|P1|NOT COMPLETED|Overall Study||0
2374618|NCT01499134|5827528|P2|COMPLETED|Overall Study||7
2374619|NCT01499134|5827529|P1|COMPLETED|Overall Study||9
2374620|NCT01499134|5827528|P2|STARTED|Overall Study||8
2374621|NCT01499134|5827529|P1|STARTED|Overall Study||9
2374622|NCT01499095|5827551|P2|NOT COMPLETED|Overall Study||93
2374623|NCT01499095|5827552|P1|NOT COMPLETED|Overall Study||89
2374624|NCT01499095|5827551|P2|COMPLETED|Overall Study||314
2374625|NCT01499095|5827552|P1|COMPLETED|Overall Study||315
2374626|NCT01499095|5827551|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|405
2374627|NCT01499095|5827552|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|403
2374628|NCT01499095|5827551|P2|Participated in Substudy|Overall Study||0
2374629|NCT01499095|5827552|P1|Participated in Substudy|Overall Study|45 participants received adaptable dosing regimen and 44 participants received fixed dosing regimen|89
2374630|NCT01499095|5827551|P2|Treated|Overall Study||406
2374631|NCT01499095|5827552|P1|Treated|Overall Study||403
2374632|NCT01499095|5827551|P2|STARTED|Overall Study||407
2374633|NCT01499095|5827552|P1|STARTED|Overall Study||404
2374634|NCT01499082|5827582|P2|NOT COMPLETED|Overall Study||48
2374635|NCT01499082|5827583|P1|NOT COMPLETED|Overall Study||45
2374636|NCT01499082|5827582|P2|COMPLETED|Overall Study||355
2374637|NCT01499082|5827583|P1|COMPLETED|Overall Study||359
2374638|NCT01499082|5827582|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|400
2374639|NCT01499082|5827583|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|404
2374640|NCT01499082|5827582|P2|Participated in Substudy|Overall Study||0
2374641|NCT01499082|5827583|P1|Participated in Substudy|Overall Study|56 participants received adaptable dosing regimen and 53 participants received fixed dosing regimen|109
2374642|NCT01499082|5827582|P2|Treated|Overall Study||402
2374643|NCT01499082|5827583|P1|Treated|Overall Study||404
2374644|NCT01499082|5827582|P2|STARTED|Overall Study||403
2374645|NCT01499082|5827583|P1|STARTED|Overall Study||404
2374646|NCT01499043|5827611|P1|NOT COMPLETED|Overall Study||6
2374647|NCT01499043|5827611|P1|COMPLETED|Overall Study||0
2374648|NCT01499043|5827611|P1|STARTED|Overall Study||6
2374649|NCT01498991|5827621|P1|NOT COMPLETED|Overall Study||0
2374650|NCT01498991|5827621|P1|COMPLETED|Overall Study||2
2374651|NCT01498991|5827621|P1|STARTED|Overall Study||2
2374652|NCT01498978|5827632|P1|NOT COMPLETED|Overall Study||2
2374653|NCT01498978|5827632|P1|COMPLETED|Overall Study||8
2374654|NCT01498978|5827632|P1|STARTED|Overall Study||10
2374655|NCT01498952|5827654|P5|NOT COMPLETED|Overall Study||0
2374656|NCT01498952|5827655|P4|NOT COMPLETED|Overall Study||0
2374657|NCT01498952|5827656|P3|NOT COMPLETED|Overall Study||0
2374658|NCT01498952|5827657|P2|NOT COMPLETED|Overall Study||2
2374659|NCT01498952|5827658|P1|NOT COMPLETED|Overall Study||2
2374660|NCT01498952|5827654|P5|COMPLETED|Overall Study||0
2374661|NCT01498952|5827655|P4|COMPLETED|Overall Study||0
2374662|NCT01498952|5827656|P3|COMPLETED|Overall Study||0
2374663|NCT01498952|5827657|P2|COMPLETED|Overall Study||1
2374664|NCT01498952|5827658|P1|COMPLETED|Overall Study||1
2374665|NCT01498952|5827654|P5|STARTED|Overall Study||0
2374666|NCT01498952|5827655|P4|STARTED|Overall Study||0
2374667|NCT01498952|5827656|P3|STARTED|Overall Study||0
2374668|NCT01498952|5827657|P2|STARTED|Overall Study||3
2374669|NCT01498952|5827658|P1|STARTED|Overall Study||3
2374670|NCT01498887|5827700|P2|NOT COMPLETED|Overall Study||11
2374671|NCT01498887|5827701|P1|NOT COMPLETED|Overall Study||16
2374672|NCT01498887|5827700|P2|COMPLETED|Overall Study||136
2374673|NCT01498887|5827701|P1|COMPLETED|Overall Study||184
2374674|NCT01498887|5827700|P2|Intent-to-treat|Overall Study||135
2374675|NCT01498887|5827701|P1|Intent-to-treat|Overall Study||185
2374676|NCT01498887|5827700|P2|Safety Set|Overall Study||147
2374677|NCT01498887|5827701|P1|Safety Set|Overall Study||200
2374678|NCT01498887|5827700|P2|STARTED|Overall Study||147
2374679|NCT01498887|5827701|P1|STARTED|Overall Study||200
2374680|NCT01498822|5827722|P2|NOT COMPLETED|Overall Study||56
2374681|NCT01498822|5827723|P1|NOT COMPLETED|Overall Study||54
2374682|NCT01498822|5827722|P2|COMPLETED|Overall Study||122
2374683|NCT01498822|5827723|P1|COMPLETED|Overall Study||121
2374684|NCT01498822|5827722|P2|STARTED|Overall Study||178
2374685|NCT01498822|5827723|P1|STARTED|Overall Study||175
2374686|NCT01498744|5827737|P2|NOT COMPLETED|Overall Study||0
2374687|NCT01498744|5827738|P1|NOT COMPLETED|Overall Study||0
2374688|NCT01498744|5827737|P2|COMPLETED|Overall Study||31
2374689|NCT01498744|5827738|P1|COMPLETED|Overall Study||22
2374690|NCT01498744|5827737|P2|STARTED|Overall Study||31
2374691|NCT01498744|5827738|P1|STARTED|Overall Study||22
2374692|NCT01498692|5827750|P1|NOT COMPLETED|Overall Study||8
2374693|NCT01498692|5827750|P1|COMPLETED|Overall Study||86
2374694|NCT01498692|5827750|P1|STARTED|Overall Study||94
2374695|NCT01498679|5827781|P2|NOT COMPLETED|Overall Study||22
2374696|NCT01498679|5827782|P1|NOT COMPLETED|Overall Study||89
2374697|NCT01498679|5827781|P2|COMPLETED|Overall Study||131
2374698|NCT01498679|5827782|P1|COMPLETED|Overall Study||65
2374699|NCT01498679|5827781|P2|STARTED|Overall Study||153
2374700|NCT01498679|5827782|P1|STARTED|Overall Study||154
2374701|NCT01498653|5827798|P2|NOT COMPLETED|Overall Study||35
2374702|NCT01498653|5827799|P1|NOT COMPLETED|Overall Study||19
2374703|NCT01498653|5827798|P2|COMPLETED|Overall Study||119
2374704|NCT01498653|5827799|P1|COMPLETED|Overall Study||136
2374705|NCT01498653|5827798|P2|STARTED|Overall Study||154
2374706|NCT01498653|5827799|P1|STARTED|Overall Study||155
2374707|NCT01498640|5827813|P1|NOT COMPLETED|Overall Study||5
2374708|NCT01498640|5827813|P1|COMPLETED|Overall Study||47
2374709|NCT01498640|5827813|P1|STARTED|Overall Study||52
2374710|NCT01498601|5827829|P2|NOT COMPLETED|Overall Study||0
2374711|NCT01498601|5827830|P1|NOT COMPLETED|Overall Study||0
2374712|NCT01498601|5827829|P2|COMPLETED|Overall Study||32
2374713|NCT01498601|5827830|P1|COMPLETED|Overall Study||51
2374714|NCT01498601|5827829|P2|STARTED|Overall Study||32
2374715|NCT01498601|5827830|P1|STARTED|Overall Study||51
2374716|NCT01498588|5827836|P1|NOT COMPLETED|Overall Study||0
2374717|NCT01498588|5827836|P1|COMPLETED|Overall Study||7
2374718|NCT01498588|5827836|P1|STARTED|Overall Study||7
2374719|NCT01498575|5827843|P2|NOT COMPLETED|On the Road Driving Assessment (ODA)||24
2374720|NCT01498575|5827844|P1|NOT COMPLETED|On the Road Driving Assessment (ODA)||42
2374721|NCT01498575|5827843|P2|COMPLETED|On the Road Driving Assessment (ODA)||65
2374722|NCT01498575|5827844|P1|COMPLETED|On the Road Driving Assessment (ODA)||86
2374723|NCT01498575|5827843|P2|STARTED|On the Road Driving Assessment (ODA)||89
2374724|NCT01498575|5827844|P1|STARTED|On the Road Driving Assessment (ODA)||128
2374725|NCT01498575|5827843|P2|NOT COMPLETED|Overall Sample||14
2374726|NCT01498575|5827844|P1|NOT COMPLETED|Overall Sample||60
2374727|NCT01498575|5827843|P2|COMPLETED|Overall Sample||400
2374728|NCT01498575|5827844|P1|COMPLETED|Overall Sample||550
2374729|NCT01498575|5827843|P2|STARTED|Overall Sample||414
2374730|NCT01498575|5827844|P1|STARTED|Overall Sample||610
2374731|NCT01498549|5827850|P1|NOT COMPLETED|Overall Study||4
2374732|NCT01498549|5827850|P1|COMPLETED|Overall Study||35
2374733|NCT01498549|5827850|P1|Sugar Pill 0 mg|Overall Study||36
2374734|NCT01498549|5827850|P1|Atomoxetine 80 mg|Overall Study||37
2374735|NCT01498549|5827850|P1|Atomoxetine 40 mg|Overall Study||39
2374736|NCT01498549|5827850|P1|STARTED|Overall Study||39
2374737|NCT01498458|5827861|P1|NOT COMPLETED|Overall Study||7
2374738|NCT01498458|5827861|P1|COMPLETED|Overall Study|only 1 patient was in the study at the end. 7 left due to Adverse Events or Investigators Decision.|1
2374739|NCT01498458|5827861|P1|STARTED|Overall Study|9 patients took part in the study of which 8 received pazopanib.|8
2374740|NCT01498419|5827874|P4|NOT COMPLETED|Overall Study||19
2374741|NCT01498419|5827875|P3|NOT COMPLETED|Overall Study||18
2374742|NCT01498419|5827876|P2|NOT COMPLETED|Overall Study||23
2374743|NCT01498419|5827877|P1|NOT COMPLETED|Overall Study||18
2374744|NCT01498419|5827874|P4|COMPLETED|Overall Study||7
2374745|NCT01498419|5827875|P3|COMPLETED|Overall Study||41
2374746|NCT01498419|5827876|P2|COMPLETED|Overall Study||39
2374747|NCT01498419|5827877|P1|COMPLETED|Overall Study||42
2374748|NCT01498419|5827874|P4|STARTED|Overall Study||26
2374749|NCT01498419|5827875|P3|STARTED|Overall Study||59
2374750|NCT01498419|5827876|P2|STARTED|Overall Study||62
2374751|NCT01498419|5827877|P1|STARTED|Overall Study||60
2374752|NCT01498289|5827913|P2|NOT COMPLETED|Overall Study||104
2374753|NCT01498289|5827914|P1|NOT COMPLETED|Overall Study||98
2374754|NCT01498289|5827913|P2|COMPLETED|Overall Study||0
2374755|NCT01498289|5827914|P1|COMPLETED|Overall Study||0
2374756|NCT01498289|5827913|P2|Participants Assessed for AEs|Overall Study||98
2374757|NCT01498289|5827914|P1|Participants Assessed for AEs|Overall Study||91
2374758|NCT01498289|5827913|P2|STARTED|Overall Study||104
2374759|NCT01498289|5827914|P1|STARTED|Overall Study||98
2374760|NCT01498185|5827935|P5|NOT COMPLETED|Overall Study||3
2374761|NCT01498185|5827936|P4|NOT COMPLETED|Overall Study||3
2374762|NCT01498185|5827937|P3|NOT COMPLETED|Overall Study||0
2374763|NCT01498185|5827938|P2|NOT COMPLETED|Overall Study||1
2374764|NCT01498185|5827939|P1|NOT COMPLETED|Overall Study||1
2374765|NCT01498185|5827935|P5|COMPLETED|Overall Study||12
2374766|NCT01498185|5827936|P4|COMPLETED|Overall Study||11
2374767|NCT01498185|5827937|P3|COMPLETED|Overall Study||15
2374768|NCT01498185|5827938|P2|COMPLETED|Overall Study||12
2374769|NCT01498185|5827939|P1|COMPLETED|Overall Study||12
2374770|NCT01498185|5827935|P5|STARTED|Overall Study||15
2374771|NCT01498185|5827936|P4|STARTED|Overall Study||14
2374772|NCT01498185|5827937|P3|STARTED|Overall Study||15
2374773|NCT01498185|5827938|P2|STARTED|Overall Study||13
2374774|NCT01498185|5827939|P1|STARTED|Overall Study||13
2374775|NCT01498120|5827979|P1|NOT COMPLETED|Overall Study||13
2374776|NCT01498120|5827979|P1|COMPLETED|Overall Study||1
2374777|NCT01498120|5827979|P1|STARTED|Overall Study||14
2374778|NCT01498068|5827986|P2|NOT COMPLETED|Overall Study||1
2374779|NCT01498068|5827987|P1|NOT COMPLETED|Overall Study||1
2374780|NCT01498068|5827986|P2|COMPLETED|Overall Study||19
2374781|NCT01498068|5827987|P1|COMPLETED|Overall Study||15
2374782|NCT01498068|5827986|P2|STARTED|Overall Study||20
2374783|NCT01498068|5827987|P1|STARTED|Overall Study||16
2374784|NCT01497938|5828005|P2|NOT COMPLETED|Overall Study||2
2374785|NCT01497938|5828006|P1|NOT COMPLETED|Overall Study||5
2374786|NCT01497938|5828005|P2|COMPLETED|Overall Study||124
2374787|NCT01497938|5828006|P1|COMPLETED|Overall Study||116
2374788|NCT01497938|5828005|P2|STARTED|Overall Study||126
2374789|NCT01497938|5828006|P1|STARTED|Overall Study||121
2374790|NCT01497899|5828018|P4|NOT COMPLETED|Open-Label Extension Phase||5
2374791|NCT01497899|5828019|P3|NOT COMPLETED|Open-Label Extension Phase||9
2374792|NCT01497899|5828020|P2|NOT COMPLETED|Open-Label Extension Phase||7
2374793|NCT01497899|5828021|P1|NOT COMPLETED|Open-Label Extension Phase||19
2374794|NCT01497899|5828018|P4|COMPLETED|Open-Label Extension Phase||33
2374795|NCT01497899|5828019|P3|COMPLETED|Open-Label Extension Phase||61
2374796|NCT01497899|5828020|P2|COMPLETED|Open-Label Extension Phase||46
2374797|NCT01497899|5828021|P1|COMPLETED|Open-Label Extension Phase||86
2374798|NCT01497899|5828018|P4|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|38
2374799|NCT01497899|5828019|P3|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|70
2374800|NCT01497899|5828020|P2|STARTED|Open-Label Extension Phase||53
2374801|NCT01497899|5828021|P1|STARTED|Open-Label Extension Phase|2 participants completed the Double-Blind Phase, but did not continue in the Open-Label Extension.|105
2374802|NCT01497899|5828018|P4|NOT COMPLETED|Double-Blind Phase||0
2374803|NCT01497899|5828019|P3|NOT COMPLETED|Double-Blind Phase||0
2374804|NCT01497899|5828020|P2|NOT COMPLETED|Double-Blind Phase||5
2374805|NCT01497899|5828021|P1|NOT COMPLETED|Double-Blind Phase||6
2374806|NCT01497899|5828018|P4|COMPLETED|Double-Blind Phase||0
2374807|NCT01497899|5828019|P3|COMPLETED|Double-Blind Phase||0
2374808|NCT01497899|5828020|P2|COMPLETED|Double-Blind Phase||53
2374809|NCT01497899|5828021|P1|COMPLETED|Double-Blind Phase||107
2374810|NCT01497899|5828018|P4|STARTED|Double-Blind Phase||0
2374811|NCT01497899|5828019|P3|STARTED|Double-Blind Phase||0
2374812|NCT01497899|5828020|P2|STARTED|Double-Blind Phase||58
2374813|NCT01497899|5828021|P1|STARTED|Double-Blind Phase||113
2374814|NCT01497860|5828034|P1|NOT COMPLETED|Overall Study||0
2374815|NCT01497860|5828034|P1|COMPLETED|Overall Study||12
2374816|NCT01497860|5828034|P1|STARTED|Overall Study||12
2374820|NCT01497665|5828043|P1|NOT COMPLETED|Overall Study||0
2374821|NCT01497665|5828043|P1|COMPLETED|Overall Study||16
2374822|NCT01497665|5828043|P1|Completed Effifcacy Assessment|Overall Study|Number of patients who completed efficacy assessment with CNS lesions per Overall RECIST 1.1.|10
2374823|NCT01497665|5828043|P1|STARTED|Overall Study||16
2374824|NCT01497613|5828053|P2|NOT COMPLETED|Overall Study||19
2374825|NCT01497613|5828054|P1|NOT COMPLETED|Overall Study||37
2374826|NCT01497613|5828053|P2|COMPLETED|Overall Study||131
2374827|NCT01497613|5828054|P1|COMPLETED|Overall Study||113
2374828|NCT01497613|5828053|P2|STARTED|Overall Study||150
2374829|NCT01497613|5828054|P1|STARTED|Overall Study||150
2374830|NCT01497366|5828092|P2|NOT COMPLETED|Overall Study||88
2374831|NCT01497366|5828093|P1|NOT COMPLETED|Overall Study||39
2374832|NCT01497366|5828092|P2|COMPLETED|Overall Study||176
2374833|NCT01497366|5828093|P1|COMPLETED|Overall Study||224
2374834|NCT01497366|5828092|P2|Randomized But Not Treated|Overall Study||21
2374835|NCT01497366|5828093|P1|Randomized But Not Treated|Overall Study||7
2374836|NCT01497366|5828092|P2|STARTED|Overall Study||264
2374837|NCT01497366|5828093|P1|STARTED|Overall Study||263
2374838|NCT01497275|5828111|P1|NOT COMPLETED|Overall Study||2
2374839|NCT01497275|5828111|P1|COMPLETED|Overall Study||3
2374840|NCT01497275|5828111|P1|STARTED|Overall Study||5
2374841|NCT01497262|5828118|P1|NOT COMPLETED|Overall Study||11
2374842|NCT01497262|5828118|P1|COMPLETED|Overall Study||151
2374843|NCT01497262|5828118|P1|STARTED|Overall Study||162
2374844|NCT01497197|5828125|P2|NOT COMPLETED|Overall Study||15
2374845|NCT01497197|5828126|P1|NOT COMPLETED|Overall Study||17
2374846|NCT01497197|5828125|P2|COMPLETED|Overall Study||70
2374847|NCT01497197|5828126|P1|COMPLETED|Overall Study||72
2374848|NCT01497197|5828125|P2|STARTED|Overall Study||85
2374849|NCT01497197|5828126|P1|STARTED|Overall Study||89
2374850|NCT01497171|5828154|P2|NOT COMPLETED|Overall Study||0
2374851|NCT01497171|5828155|P1|NOT COMPLETED|Overall Study||0
2374852|NCT01497171|5828154|P2|COMPLETED|Overall Study||3
2374853|NCT01497171|5828155|P1|COMPLETED|Overall Study||2
2374854|NCT01497171|5828154|P2|STARTED|Overall Study||3
2374855|NCT01497171|5828155|P1|STARTED|Overall Study||2
2374856|NCT01497067|5828161|P1|NOT COMPLETED|Overall Study||82
2374857|NCT01497067|5828161|P1|COMPLETED|Overall Study||575
2374858|NCT01497067|5828161|P1|STARTED|Overall Study||657
2374859|NCT01496846|5828172|P6|NOT COMPLETED|Supplemental Buccal Infiltration||0
2374860|NCT01496846|5828173|P5|NOT COMPLETED|Supplemental Buccal Infiltration||0
2374861|NCT01496846|5828174|P4|NOT COMPLETED|Supplemental Buccal Infiltration||0
2374862|NCT01496846|5828175|P3|NOT COMPLETED|Supplemental Buccal Infiltration||0
2374863|NCT01496846|5828176|P2|NOT COMPLETED|Supplemental Buccal Infiltration||0
2374864|NCT01496846|5828177|P1|NOT COMPLETED|Supplemental Buccal Infiltration||0
2374865|NCT01496846|5828172|P6|COMPLETED|Supplemental Buccal Infiltration||38
2374866|NCT01496846|5828173|P5|COMPLETED|Supplemental Buccal Infiltration||35
2374867|NCT01496846|5828174|P4|COMPLETED|Supplemental Buccal Infiltration||40
2374868|NCT01496846|5828175|P3|COMPLETED|Supplemental Buccal Infiltration||36
2374869|NCT01496846|5828176|P2|COMPLETED|Supplemental Buccal Infiltration||0
2374870|NCT01496846|5828177|P1|COMPLETED|Supplemental Buccal Infiltration||0
2374871|NCT01496846|5828172|P6|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|38
2374872|NCT01496846|5828173|P5|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|35
2374873|NCT01496846|5828174|P4|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|40
2374874|NCT01496846|5828175|P3|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|36
2374875|NCT01496846|5828176|P2|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
2374876|NCT01496846|5828177|P1|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
2374877|NCT01496846|5828172|P6|NOT COMPLETED|IANB Articaine (All Participants)||0
2374878|NCT01496846|5828173|P5|NOT COMPLETED|IANB Articaine (All Participants)||0
2374879|NCT01496846|5828174|P4|NOT COMPLETED|IANB Articaine (All Participants)||0
2374880|NCT01496846|5828175|P3|NOT COMPLETED|IANB Articaine (All Participants)||0
2374881|NCT01496846|5828176|P2|NOT COMPLETED|IANB Articaine (All Participants)||1
2374882|NCT01496846|5828177|P1|NOT COMPLETED|IANB Articaine (All Participants)||1
2374883|NCT01496846|5828172|P6|COMPLETED|IANB Articaine (All Participants)||38
2374884|NCT01496846|5828173|P5|COMPLETED|IANB Articaine (All Participants)||35
2374885|NCT01496846|5828174|P4|COMPLETED|IANB Articaine (All Participants)||40
2374886|NCT01496846|5828175|P3|COMPLETED|IANB Articaine (All Participants)||36
2374887|NCT01496846|5828176|P2|COMPLETED|IANB Articaine (All Participants)||23
2374888|NCT01496846|5828177|P1|COMPLETED|IANB Articaine (All Participants)||27
2374889|NCT01496846|5828172|P6|STARTED|IANB Articaine (All Participants)||38
2374890|NCT01496846|5828173|P5|STARTED|IANB Articaine (All Participants)||35
2374891|NCT01496846|5828174|P4|STARTED|IANB Articaine (All Participants)||40
2374892|NCT01496846|5828175|P3|STARTED|IANB Articaine (All Participants)||36
2374893|NCT01496846|5828176|P2|STARTED|IANB Articaine (All Participants)||24
2374894|NCT01496846|5828177|P1|STARTED|IANB Articaine (All Participants)||28
2374895|NCT01496807|5828188|P1|NOT COMPLETED|Overall Study||30
2374896|NCT01496807|5828188|P1|COMPLETED|Overall Study||1
2374897|NCT01496807|5828188|P1|STARTED|Overall Study||31
2374898|NCT01496469|5828200|P2|NOT COMPLETED|Overall Study||8
2374899|NCT01496469|5828201|P1|NOT COMPLETED|Overall Study||10
2374900|NCT01496469|5828200|P2|COMPLETED|Overall Study||53
2374901|NCT01496469|5828201|P1|COMPLETED|Overall Study||50
2374902|NCT01496469|5828200|P2|STARTED|Overall Study||61
2374903|NCT01496469|5828201|P1|STARTED|Overall Study||60
2374904|NCT01496456|5828211|P1|NOT COMPLETED|Overall Study||8
2374905|NCT01496456|5828211|P1|COMPLETED|Overall Study||9
2374906|NCT01496456|5828211|P1|3-yr Final Recall|Overall Study||9
2374907|NCT01496456|5828211|P1|2-yr Recall|Overall Study||10
2374908|NCT01496456|5828211|P1|1-yr Recall|Overall Study||12
2374909|NCT01496456|5828211|P1|Baseline|Overall Study|Baseline group started with 16 patients.|16
2374910|NCT01496456|5828211|P1|STARTED|Overall Study||17
2374911|NCT01496430|5828224|P3|NOT COMPLETED|Overall Study||10
2374912|NCT01496430|5828225|P2|NOT COMPLETED|Overall Study||5
2374913|NCT01496430|5828226|P1|NOT COMPLETED|Overall Study||6
2374914|NCT01496430|5828224|P3|COMPLETED|Overall Study||25
2374915|NCT01496430|5828225|P2|COMPLETED|Overall Study||30
2374916|NCT01496430|5828226|P1|COMPLETED|Overall Study||29
2374917|NCT01496430|5828224|P3|STARTED|Overall Study||35
2374918|NCT01496430|5828225|P2|STARTED|Overall Study||35
2374919|NCT01496430|5828226|P1|STARTED|Overall Study||35
2374920|NCT01496352|5828302|P2|NOT COMPLETED|Overall Study||0
2374921|NCT01496352|5828303|P1|NOT COMPLETED|Overall Study||0
2374922|NCT01496352|5828302|P2|COMPLETED|Overall Study||6
2374923|NCT01496352|5828303|P1|COMPLETED|Overall Study||24
2374924|NCT01496352|5828302|P2|STARTED|Overall Study||6
2374925|NCT01496352|5828303|P1|STARTED|Overall Study||24
2374926|NCT01496313|5828321|P2|NOT COMPLETED|Overall Study||15
2374927|NCT01496313|5828322|P1|NOT COMPLETED|Overall Study||5
2374928|NCT01496313|5828321|P2|COMPLETED|Overall Study||26
2374929|NCT01496313|5828322|P1|COMPLETED|Overall Study||35
2374930|NCT01496313|5828321|P2|STARTED|Overall Study||41
2374931|NCT01496313|5828322|P1|STARTED|Overall Study||40
2374932|NCT01496287|5828338|P1|NOT COMPLETED|Overall Study||6
2374933|NCT01496287|5828338|P1|COMPLETED|Overall Study||64
2374934|NCT01496287|5828338|P1|STARTED|Overall Study||70
2374935|NCT01496274|5828348|P2|NOT COMPLETED|Overall Study||5
2374936|NCT01496274|5828349|P1|NOT COMPLETED|Overall Study||3
2374937|NCT01496274|5828348|P2|COMPLETED|Overall Study||18
2374938|NCT01496274|5828349|P1|COMPLETED|Overall Study||37
2374939|NCT01496274|5828348|P2|STARTED|Overall Study||23
2374940|NCT01496274|5828349|P1|STARTED|Overall Study||40
2374941|NCT01496248|5828381|P1|NOT COMPLETED|Overall Study||10
2374942|NCT01496248|5828381|P1|COMPLETED|Overall Study||25
2374943|NCT01496248|5828381|P1|STARTED|Overall Study||35
2374944|NCT01496183|5828394|P2|NOT COMPLETED|Overall Study||2
2374945|NCT01496183|5828395|P1|NOT COMPLETED|Overall Study||3
2374946|NCT01496183|5828394|P2|COMPLETED|Overall Study||13
2374947|NCT01496183|5828395|P1|COMPLETED|Overall Study||6
2374948|NCT01496183|5828394|P2|STARTED|Overall Study||15
2374949|NCT01496183|5828395|P1|STARTED|Overall Study||9
2374950|NCT01496157|5828425|P1|NOT COMPLETED|Overall Study||0
2374951|NCT01496157|5828425|P1|COMPLETED|Overall Study||13
2374952|NCT01496157|5828425|P1|STARTED|Overall Study||13
2374953|NCT01496131|5828432|P2|NOT COMPLETED|Overall Study||0
2374954|NCT01496131|5828433|P1|NOT COMPLETED|Overall Study||0
2374955|NCT01496131|5828432|P2|COMPLETED|Overall Study||14
2374956|NCT01496131|5828433|P1|COMPLETED|Overall Study||14
2374957|NCT01496131|5828432|P2|STARTED|Overall Study||14
2374958|NCT01496131|5828433|P1|STARTED|Overall Study||14
2374959|NCT01496066|5828447|P2|NOT COMPLETED|Overall Study||9
2374960|NCT01496066|5828448|P1|NOT COMPLETED|Overall Study||12
2374961|NCT01496066|5828447|P2|COMPLETED|Overall Study||188
2374962|NCT01496066|5828448|P1|COMPLETED|Overall Study||391
2374963|NCT01496066|5828447|P2|STARTED|Overall Study||197
2374964|NCT01496066|5828448|P1|STARTED|Overall Study||403
2374965|NCT01495988|5828471|P4|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
2374966|NCT01495988|5828472|P3|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
2374967|NCT01495988|5828473|P2|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
2374968|NCT01495988|5828474|P1|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
2374969|NCT01495988|5828471|P4|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
2374970|NCT01495988|5828472|P3|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
2374971|NCT01495988|5828473|P2|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||2
2374972|NCT01495988|5828474|P1|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
2374973|NCT01495988|5828471|P4|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
2374974|NCT01495988|5828472|P3|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
2374975|NCT01495988|5828473|P2|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||2
2374976|NCT01495988|5828474|P1|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
2374977|NCT01495988|5828471|P4|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
2374978|NCT01495988|5828472|P3|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
2374979|NCT01495988|5828473|P2|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
2374980|NCT01495988|5828474|P1|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
2374981|NCT01495988|5828471|P4|COMPLETED|Vem +/- Bev (Protocol v2.0)||3
2374982|NCT01495988|5828472|P3|COMPLETED|Vem +/- Bev (Protocol v2.0)||5
2374983|NCT01495988|5828473|P2|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
2374984|NCT01495988|5828474|P1|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
2374985|NCT01495988|5828471|P4|STARTED|Vem +/- Bev (Protocol v2.0)||3
2374986|NCT01495988|5828472|P3|STARTED|Vem +/- Bev (Protocol v2.0)||5
2374987|NCT01495988|5828473|P2|STARTED|Vem +/- Bev (Protocol v2.0)||0
2374988|NCT01495988|5828474|P1|STARTED|Vem +/- Bev (Protocol v2.0)||0
2374989|NCT01495975|5828510|P2|NOT COMPLETED|Overall Study||0
2374990|NCT01495975|5828511|P1|NOT COMPLETED|Overall Study||1
2374991|NCT01495975|5828510|P2|COMPLETED|Overall Study||14
2374992|NCT01495975|5828511|P1|COMPLETED|Overall Study||14
2374993|NCT01495975|5828510|P2|STARTED|Overall Study||14
2374994|NCT01495975|5828511|P1|STARTED|Overall Study||15
2374995|NCT01495923|5828519|P2|NOT COMPLETED|Overall Study||0
2374996|NCT01495923|5828520|P1|NOT COMPLETED|Overall Study||0
2374997|NCT01495923|5828519|P2|COMPLETED|Overall Study||72
2374998|NCT01495923|5828520|P1|COMPLETED|Overall Study||73
2374999|NCT01495923|5828519|P2|STARTED|Overall Study||72
2375000|NCT01495923|5828520|P1|STARTED|Overall Study||73
2375001|NCT01495858|5828553|P3|NOT COMPLETED|Overall Study||0
2375002|NCT01495858|5828554|P2|NOT COMPLETED|Overall Study||0
2375003|NCT01495858|5828555|P1|NOT COMPLETED|Overall Study||0
2375004|NCT01495858|5828553|P3|COMPLETED|Overall Study||54
2375005|NCT01495858|5828554|P2|COMPLETED|Overall Study||106
2375006|NCT01495858|5828555|P1|COMPLETED|Overall Study||107
2375007|NCT01495858|5828553|P3|STARTED|Overall Study||54
2375008|NCT01495858|5828554|P2|STARTED|Overall Study||106
2375009|NCT01495858|5828555|P1|STARTED|Overall Study||107
2375010|NCT01495793|5828635|P1|NOT COMPLETED|Overall Study||2
2375011|NCT01495793|5828635|P1|COMPLETED|Overall Study||22
2375012|NCT01495793|5828635|P1|STARTED|Overall Study||24
2375013|NCT01495702|5828648|P2|NOT COMPLETED|Extension Phase||0
2375014|NCT01495702|5828649|P1|NOT COMPLETED|Extension Phase||0
2375015|NCT01495702|5828648|P2|COMPLETED|Extension Phase||2
2375016|NCT01495702|5828649|P1|COMPLETED|Extension Phase||26
2375017|NCT01495702|5828648|P2|STARTED|Extension Phase||2
2375018|NCT01495702|5828649|P1|STARTED|Extension Phase||26
2375019|NCT01495702|5828648|P2|NOT COMPLETED|Randomized Phase||28
2375020|NCT01495702|5828649|P1|NOT COMPLETED|Randomized Phase||26
2375021|NCT01495702|5828648|P2|COMPLETED|Randomized Phase||119
2375022|NCT01495702|5828649|P1|COMPLETED|Randomized Phase||266
2375023|NCT01495702|5828648|P2|STARTED|Randomized Phase||147
2375024|NCT01495702|5828649|P1|STARTED|Randomized Phase||292
2375025|NCT01495689|5828664|P2|NOT COMPLETED|Overall Study||7
2375026|NCT01495689|5828665|P1|NOT COMPLETED|Overall Study||10
2375027|NCT01495689|5828664|P2|COMPLETED|Overall Study||16
2375028|NCT01495689|5828665|P1|COMPLETED|Overall Study||16
2375029|NCT01495689|5828664|P2|STARTED|Overall Study||23
2375030|NCT01495689|5828665|P1|STARTED|Overall Study||26
2375031|NCT01495585|5828674|P3|NOT COMPLETED|Overall Study||0
2375032|NCT01495585|5828675|P2|NOT COMPLETED|Overall Study||0
2375033|NCT01495585|5828676|P1|NOT COMPLETED|Overall Study||0
2375034|NCT01495585|5828674|P3|COMPLETED|Overall Study||4
2375035|NCT01495585|5828675|P2|COMPLETED|Overall Study||6
2375036|NCT01495585|5828676|P1|COMPLETED|Overall Study||4
2375037|NCT01495585|5828674|P3|Open Label Lonafarnib 200 mg|Overall Study||0
2375038|NCT01495585|5828675|P2|Open Label Lonafarnib 200 mg|Overall Study||0
2375039|NCT01495585|5828676|P1|Open Label Lonafarnib 200 mg|Overall Study||2
2375040|NCT01495585|5828674|P3|STARTED|Overall Study||4
2375041|NCT01495585|5828675|P2|STARTED|Overall Study||6
2375042|NCT01495585|5828676|P1|STARTED|Overall Study||4
2375043|NCT01495572|5828689|P2|NOT COMPLETED|Overall Study||0
2375044|NCT01495572|5828690|P1|NOT COMPLETED|Overall Study||0
2375045|NCT01495572|5828689|P2|COMPLETED|Overall Study||5
2375046|NCT01495572|5828690|P1|COMPLETED|Overall Study||0
2375047|NCT01495572|5828689|P2|STARTED|Overall Study||5
2375048|NCT01495572|5828690|P1|STARTED|Overall Study||0
2375049|NCT01495481|5828698|P1|NOT COMPLETED|Dexmedetomidine||0
2375050|NCT01495481|5828698|P1|COMPLETED|Dexmedetomidine||22
2375051|NCT01495481|5828698|P1|STARTED|Dexmedetomidine||22
2375052|NCT01495481|5828698|P1|NOT COMPLETED|Washout||0
2375053|NCT01495481|5828698|P1|COMPLETED|Washout||22
2375054|NCT01495481|5828698|P1|STARTED|Washout||22
2375055|NCT01495481|5828698|P1|NOT COMPLETED|Adenosine||0
2375056|NCT01495481|5828698|P1|COMPLETED|Adenosine||22
2375057|NCT01495481|5828698|P1|STARTED|Adenosine|Patients first received adenosine and then dexmedetomidine.|22
2375058|NCT01495286|5828710|P1|NOT COMPLETED|Overall Study||0
2375059|NCT01495286|5828710|P1|COMPLETED|Overall Study||30
2375060|NCT01495286|5828710|P1|STARTED|Overall Study||30
2375061|NCT01495221|5828718|P1|NOT COMPLETED|Overall Study||0
2375062|NCT01495221|5828718|P1|COMPLETED|Overall Study|Last patient enrolled May 2012.|9
2375063|NCT01495221|5828718|P1|STARTED|Overall Study|First Patient enrolled December 2011.|9
2375064|NCT01495000|5828727|P2|NOT COMPLETED|Overall Study||12
2375065|NCT01495000|5828728|P1|NOT COMPLETED|Overall Study||13
2375066|NCT01495000|5828727|P2|COMPLETED|Overall Study||114
2375067|NCT01495000|5828728|P1|COMPLETED|Overall Study||111
2375068|NCT01495000|5828727|P2|STARTED|Overall Study||126
2375069|NCT01495000|5828728|P1|STARTED|Overall Study||124
2375070|NCT01494987|5828770|P2|NOT COMPLETED|Overall Study||28
2375071|NCT01494987|5828771|P1|NOT COMPLETED|Overall Study||28
2375072|NCT01494987|5828770|P2|COMPLETED|Overall Study||187
2375073|NCT01494987|5828771|P1|COMPLETED|Overall Study||188
2375074|NCT01494987|5828770|P2|STARTED|Overall Study||215
2375075|NCT01494987|5828771|P1|STARTED|Overall Study||216
2375076|NCT01494818|5828785|P2|NOT COMPLETED|Overall Study||2
2375077|NCT01494818|5828786|P1|NOT COMPLETED|Overall Study||2
2375078|NCT01494818|5828785|P2|COMPLETED|Overall Study||37
2375079|NCT01494818|5828786|P1|COMPLETED|Overall Study||37
2375080|NCT01494818|5828785|P2|STARTED|Overall Study||39
2375081|NCT01494818|5828786|P1|STARTED|Overall Study||39
2375082|NCT01494753|5828808|P2|NOT COMPLETED|Day42-Day84||0
2375083|NCT01494753|5828809|P1|NOT COMPLETED|Day42-Day84||0
2375084|NCT01494753|5828808|P2|COMPLETED|Day42-Day84||15
2375085|NCT01494753|5828809|P1|COMPLETED|Day42-Day84||15
2375086|NCT01494753|5828808|P2|STARTED|Day42-Day84||15
2375087|NCT01494753|5828809|P1|STARTED|Day42-Day84||15
2375088|NCT01494753|5828808|P2|NOT COMPLETED|Day0-Day42||0
2375089|NCT01494753|5828809|P1|NOT COMPLETED|Day0-Day42||0
2375090|NCT01494753|5828808|P2|COMPLETED|Day0-Day42||15
2375091|NCT01494753|5828809|P1|COMPLETED|Day0-Day42||15
2375092|NCT01494753|5828808|P2|STARTED|Day0-Day42||15
2375093|NCT01494753|5828809|P1|STARTED|Day0-Day42||15
2375094|NCT01494649|5828817|P2|NOT COMPLETED|Overall Study||1
2375095|NCT01494649|5828818|P1|NOT COMPLETED|Overall Study||0
2375096|NCT01494649|5828817|P2|COMPLETED|Overall Study||58
2375097|NCT01494649|5828818|P1|COMPLETED|Overall Study||59
2375098|NCT01494649|5828817|P2|STARTED|Overall Study||59
2375099|NCT01494649|5828818|P1|STARTED|Overall Study||59
2375100|NCT01494610|5828834|P2|NOT COMPLETED|Period 4||0
2375101|NCT01494610|5828835|P1|NOT COMPLETED|Period 4||1
2375102|NCT01494610|5828834|P2|COMPLETED|Period 4||28
2375103|NCT01494610|5828835|P1|COMPLETED|Period 4||27
2375104|NCT01494610|5828834|P2|STARTED|Period 4||28
2375105|NCT01494610|5828835|P1|STARTED|Period 4||28
2375106|NCT01494610|5828834|P2|NOT COMPLETED|Period 3||0
2375107|NCT01494610|5828835|P1|NOT COMPLETED|Period 3||2
2375108|NCT01494610|5828834|P2|COMPLETED|Period 3||28
2375109|NCT01494610|5828835|P1|COMPLETED|Period 3||28
2375110|NCT01494610|5828834|P2|STARTED|Period 3||28
2375111|NCT01494610|5828835|P1|STARTED|Period 3||30
2375112|NCT01494610|5828834|P2|NOT COMPLETED|Period 2||0
2375113|NCT01494610|5828835|P1|NOT COMPLETED|Period 2||0
2375114|NCT01494610|5828834|P2|COMPLETED|Period 2||28
2375115|NCT01494610|5828835|P1|COMPLETED|Period 2||30
2375116|NCT01494610|5828834|P2|STARTED|Period 2||28
2375117|NCT01494610|5828835|P1|STARTED|Period 2||30
2375118|NCT01494610|5828834|P2|NOT COMPLETED|Period 1||1
2375119|NCT01494610|5828835|P1|NOT COMPLETED|Period 1||1
2375120|NCT01494610|5828834|P2|COMPLETED|Period 1||28
2375121|NCT01494610|5828835|P1|COMPLETED|Period 1||30
2375122|NCT01494610|5828834|P2|STARTED|Period 1||29
2375123|NCT01494610|5828835|P1|STARTED|Period 1||31
2375124|NCT01494584|5828903|P1|NOT COMPLETED|Overall Study||1
2375125|NCT01494584|5828903|P1|COMPLETED|Overall Study||4
2375126|NCT01494584|5828903|P1|STARTED|Overall Study||5
2375127|NCT01494545|5828992|P1|NOT COMPLETED|Overall Study||10
2375128|NCT01494545|5828992|P1|COMPLETED|Overall Study||92
2375129|NCT01494545|5828992|P1|STARTED|Overall Study||102
2375130|NCT01494532|5829035|P6|NOT COMPLETED|Overall Study||0
2375131|NCT01494532|5829036|P5|NOT COMPLETED|Overall Study||12
2375132|NCT01494532|5829037|P4|NOT COMPLETED|Overall Study||15
2375133|NCT01494532|5829038|P3|NOT COMPLETED|Overall Study||17
2375134|NCT01494532|5829039|P2|NOT COMPLETED|Overall Study||4
2375135|NCT01494532|5829040|P1|NOT COMPLETED|Overall Study||10
2375136|NCT01494532|5829035|P6|COMPLETED|Overall Study||25
2375137|NCT01494532|5829036|P5|COMPLETED|Overall Study||64
2375138|NCT01494532|5829037|P4|COMPLETED|Overall Study||60
2375139|NCT01494532|5829038|P3|COMPLETED|Overall Study||59
2375140|NCT01494532|5829039|P2|COMPLETED|Overall Study||21
2375141|NCT01494532|5829040|P1|COMPLETED|Overall Study||65
2375142|NCT01494532|5829035|P6|STARTED|Overall Study||25
2375143|NCT01494532|5829036|P5|STARTED|Overall Study||76
2375144|NCT01494532|5829037|P4|STARTED|Overall Study||75
2375145|NCT01494532|5829038|P3|STARTED|Overall Study||76
2375146|NCT01494532|5829039|P2|STARTED|Overall Study||25
2375147|NCT01494532|5829040|P1|STARTED|Overall Study||75
2375148|NCT01494506|5829195|P3|NOT COMPLETED|Overall Study||103
2375149|NCT01494506|5829196|P2|NOT COMPLETED|Overall Study||143
2375150|NCT01494506|5829197|P1|NOT COMPLETED|Overall Study||148
2375151|NCT01494506|5829195|P3|COMPLETED|Overall Study||14
2375152|NCT01494506|5829196|P2|COMPLETED|Overall Study||6
2375153|NCT01494506|5829197|P1|COMPLETED|Overall Study|Completed = Subjects remaining on treatment at the time of the primary analysis data cut off.|3
2375154|NCT01494506|5829195|P3|Treated Population|Overall Study|2 randomized Arm C patients did not receive study drug. 1 patient each in A and B received Arm C.|117
2375155|NCT01494506|5829196|P2|Treated Population|Overall Study||134
2375156|NCT01494506|5829197|P1|Treated Population|Overall Study|Treated population: Patients who received at least 1 dose of study drug.|147
2375157|NCT01494506|5829195|P3|STARTED|Overall Study||117
2375158|NCT01494506|5829196|P2|STARTED|Overall Study||149
2375159|NCT01494506|5829197|P1|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|151
2375160|NCT01494467|5829234|P2|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
2375161|NCT01494467|5829235|P1|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
2375162|NCT01494467|5829234|P2|COMPLETED|Part C Safety Follow up (4 Weeks)||159
2375163|NCT01494467|5829235|P1|COMPLETED|Part C Safety Follow up (4 Weeks)||353
2375164|NCT01494467|5829234|P2|STARTED|Part C Safety Follow up (4 Weeks)||159
2375165|NCT01494467|5829235|P1|STARTED|Part C Safety Follow up (4 Weeks)||353
2375166|NCT01494467|5829234|P2|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||49
2375167|NCT01494467|5829235|P1|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||75
2375168|NCT01494467|5829234|P2|COMPLETED|Part B Long Term Active Control 40 Weeks||159
2375169|NCT01494467|5829235|P1|COMPLETED|Part B Long Term Active Control 40 Weeks||353
2375170|NCT01494467|5829234|P2|STARTED|Part B Long Term Active Control 40 Weeks||208
2375171|NCT01494467|5829235|P1|STARTED|Part B Long Term Active Control 40 Weeks|429 completed Part A. Subsequently, one subject discontinued so only 428 entered Part B|428
2375172|NCT01494467|5829234|P2|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||21
2375173|NCT01494467|5829235|P1|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||30
2375174|NCT01494467|5829234|P2|COMPLETED|Part A Vehicle Control (12 Weeks)||208
2375175|NCT01494467|5829235|P1|COMPLETED|Part A Vehicle Control (12 Weeks)||429
2375176|NCT01494467|5829234|P2|STARTED|Part A Vehicle Control (12 Weeks)||229
2375177|NCT01494467|5829235|P1|STARTED|Part A Vehicle Control (12 Weeks)||459
2375178|NCT01494350|5829251|P1|NOT COMPLETED|Overall Study||1
2375179|NCT01494350|5829251|P1|COMPLETED|Overall Study||49
2375180|NCT01494350|5829251|P1|STARTED|Overall Study||50
2375181|NCT01494298|5829261|P2|NOT COMPLETED|Overall Study||8
2375182|NCT01494298|5829262|P1|NOT COMPLETED|Overall Study||2
2375183|NCT01494298|5829261|P2|COMPLETED|Overall Study||47
2375184|NCT01494298|5829262|P1|COMPLETED|Overall Study||54
2375185|NCT01494298|5829261|P2|STARTED|Overall Study||55
2375186|NCT01494298|5829262|P1|STARTED|Overall Study||56
2375187|NCT01494038|5829274|P2|NOT COMPLETED|Overall Study||83
2375188|NCT01494038|5829275|P1|NOT COMPLETED|Overall Study||88
2375189|NCT01494038|5829274|P2|COMPLETED|Overall Study||396
2375190|NCT01494038|5829275|P1|COMPLETED|Overall Study||389
2375191|NCT01494038|5829274|P2|STARTED|Overall Study||479
2375192|NCT01494038|5829275|P1|STARTED|Overall Study||477
2375193|NCT01493960|5829363|P2|NOT COMPLETED|Overall Study||18
2375194|NCT01493960|5829364|P1|NOT COMPLETED|Overall Study||32
2375195|NCT01493960|5829363|P2|COMPLETED|Overall Study||26
2375196|NCT01493960|5829364|P1|COMPLETED|Overall Study||55
2375197|NCT01493960|5829363|P2|Received Study Drug|Overall Study||43
2375198|NCT01493960|5829364|P1|Received Study Drug|Overall Study||87
2375199|NCT01493960|5829363|P2|STARTED|Overall Study||44
2375200|NCT01493960|5829364|P1|STARTED|Overall Study||87
2375201|NCT01493947|5829384|P2|NOT COMPLETED|Period B Extension Period||32
2375202|NCT01493947|5829385|P1|NOT COMPLETED|Period B Extension Period||33
2375203|NCT01493947|5829384|P2|COMPLETED|Period B Extension Period||326
2375204|NCT01493947|5829385|P1|COMPLETED|Period B Extension Period||366
2375205|NCT01493947|5829384|P2|STARTED|Period B Extension Period|358 / 456 subjects were eligible to enter in Period B (i.e IGA =0 or 1 at end of Period A).|358
2375206|NCT01493947|5829385|P1|STARTED|Period B Extension Period|Only 399 /446 subjects were eligible to enter in Period B (i.e IGA=0 or1 at end of Period A).|399
2375207|NCT01493947|5829384|P2|NOT COMPLETED|Period A Efficacy and Safety Data||28
2375208|NCT01493947|5829385|P1|NOT COMPLETED|Period A Efficacy and Safety Data||32
2375209|NCT01493947|5829384|P2|COMPLETED|Period A Efficacy and Safety Data||456
2375210|NCT01493947|5829385|P1|COMPLETED|Period A Efficacy and Safety Data||446
2375211|NCT01493947|5829384|P2|STARTED|Period A Efficacy and Safety Data||484
2375212|NCT01493947|5829385|P1|STARTED|Period A Efficacy and Safety Data||478
2375213|NCT01493778|5829395|P1|NOT COMPLETED|Overall Study||8
2375214|NCT01493778|5829395|P1|COMPLETED|Overall Study||52
2375215|NCT01493778|5829395|P1|STARTED|Overall Study||60
2375216|NCT01493687|5829457|P2|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||1
2375217|NCT01493687|5829458|P1|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
2375218|NCT01493687|5829457|P2|COMPLETED|Part C Safety Follow up (4 Weeks)||174
2375219|NCT01493687|5829458|P1|COMPLETED|Part C Safety Follow up (4 Weeks)||350
2375220|NCT01493687|5829457|P2|STARTED|Part C Safety Follow up (4 Weeks)||175
2375221|NCT01493687|5829458|P1|STARTED|Part C Safety Follow up (4 Weeks)|351 completed Part B. Then 1 discontinued (subject request) prior to Part C.|350
2375222|NCT01493687|5829457|P2|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||35
2375223|NCT01493687|5829458|P1|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||61
2375224|NCT01493687|5829457|P2|COMPLETED|Part B Long Term Active Control 40 Weeks||175
2375225|NCT01493687|5829458|P1|COMPLETED|Part B Long Term Active Control 40 Weeks||351
2375226|NCT01493687|5829457|P2|STARTED|Part B Long Term Active Control 40 Weeks||210
2375227|NCT01493687|5829458|P1|STARTED|Part B Long Term Active Control 40 Weeks|414 completed Part A. Then 2 discontinued (lack of efficacy, subject request) prior to Part B.|412
2375228|NCT01493687|5829457|P2|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||22
2375229|NCT01493687|5829458|P1|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||37
2375230|NCT01493687|5829457|P2|COMPLETED|Part A Vehicle Control (12 Weeks)||210
2375231|NCT01493687|5829458|P1|COMPLETED|Part A Vehicle Control (12 Weeks)||414
2375232|NCT01493687|5829457|P2|STARTED|Part A Vehicle Control (12 Weeks)||232
2375233|NCT01493687|5829458|P1|STARTED|Part A Vehicle Control (12 Weeks)||451
2375234|NCT01493557|5829477|P3|NOT COMPLETED|Adding the Second Strategy||0
2375235|NCT01493557|5829478|P2|NOT COMPLETED|Adding the Second Strategy||4
2375236|NCT01493557|5829479|P1|NOT COMPLETED|Adding the Second Strategy||2
2375237|NCT01493557|5829477|P3|COMPLETED|Adding the Second Strategy||0
2375238|NCT01493557|5829478|P2|COMPLETED|Adding the Second Strategy||11
2375239|NCT01493557|5829479|P1|COMPLETED|Adding the Second Strategy||12
2375240|NCT01493557|5829477|P3|STARTED|Adding the Second Strategy||0
2375241|NCT01493557|5829478|P2|STARTED|Adding the Second Strategy||15
2375242|NCT01493557|5829479|P1|STARTED|Adding the Second Strategy||14
2375243|NCT01493557|5829477|P3|NOT COMPLETED|Randomized to Management Strategies||0
2375244|NCT01493557|5829478|P2|NOT COMPLETED|Randomized to Management Strategies||11
2375245|NCT01493557|5829479|P1|NOT COMPLETED|Randomized to Management Strategies||15
2375246|NCT01493557|5829477|P3|COMPLETED|Randomized to Management Strategies||0
2375247|NCT01493557|5829478|P2|COMPLETED|Randomized to Management Strategies||47
2375248|NCT01493557|5829479|P1|COMPLETED|Randomized to Management Strategies||44
2375249|NCT01493557|5829477|P3|STARTED|Randomized to Management Strategies||0
2375250|NCT01493557|5829478|P2|STARTED|Randomized to Management Strategies||58
2375251|NCT01493557|5829479|P1|STARTED|Randomized to Management Strategies||59
2375252|NCT01493557|5829477|P3|NOT COMPLETED|Not Randomized to Management Strategies||134
2375253|NCT01493557|5829478|P2|NOT COMPLETED|Not Randomized to Management Strategies||0
2375254|NCT01493557|5829479|P1|NOT COMPLETED|Not Randomized to Management Strategies||0
2375255|NCT01493557|5829477|P3|COMPLETED|Not Randomized to Management Strategies||816
2375256|NCT01493557|5829478|P2|COMPLETED|Not Randomized to Management Strategies||0
2375257|NCT01493557|5829479|P1|COMPLETED|Not Randomized to Management Strategies||0
2375258|NCT01493557|5829477|P3|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies|26 patients completed (GIS resolved ) and 4 patients completed (GIS not resolved ) the trial.|48
2375259|NCT01493557|5829478|P2|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
2375260|NCT01493557|5829479|P1|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
2375351|NCT01492400|5829764|P1|NOT COMPLETED|Overall Study||16
2375261|NCT01493557|5829477|P3|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies|32 patients completed the trial.|48
2375262|NCT01493557|5829478|P2|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
2375263|NCT01493557|5829479|P1|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
2375264|NCT01493557|5829477|P3|Without Experiencing GIS|Not Randomized to Management Strategies|754 patients completed the trial.|854
2375265|NCT01493557|5829478|P2|Without Experiencing GIS|Not Randomized to Management Strategies||0
2375266|NCT01493557|5829479|P1|Without Experiencing GIS|Not Randomized to Management Strategies||0
2375267|NCT01493557|5829477|P3|STARTED|Not Randomized to Management Strategies||950
2375268|NCT01493557|5829478|P2|STARTED|Not Randomized to Management Strategies||0
2375269|NCT01493557|5829479|P1|STARTED|Not Randomized to Management Strategies||0
2375270|NCT01493531|5829507|P3|NOT COMPLETED|Overall Study||48
2375271|NCT01493531|5829508|P2|NOT COMPLETED|Overall Study||50
2375272|NCT01493531|5829509|P1|NOT COMPLETED|Overall Study||41
2375273|NCT01493531|5829507|P3|COMPLETED|Overall Study||158
2375274|NCT01493531|5829508|P2|COMPLETED|Overall Study||150
2375275|NCT01493531|5829509|P1|COMPLETED|Overall Study||163
2375276|NCT01493531|5829507|P3|STARTED|Overall Study||206
2375277|NCT01493531|5829508|P2|STARTED|Overall Study||200
2375278|NCT01493531|5829509|P1|STARTED|Overall Study||204
2375279|NCT01493427|5829523|P1|NOT COMPLETED|Overall Study||20
2375280|NCT01493427|5829523|P1|COMPLETED|Overall Study||179
2375281|NCT01493427|5829523|P1|STARTED|Overall Study||199
2375282|NCT01493414|5829528|P1|NOT COMPLETED|Overall Study||950
2375283|NCT01493414|5829528|P1|COMPLETED|Overall Study||1283
2375284|NCT01493414|5829528|P1|STARTED|Overall Study||2233
2375285|NCT01493284|5829541|P1|NOT COMPLETED|Overall Study||61
2375286|NCT01493284|5829541|P1|COMPLETED|Overall Study||161
2375287|NCT01493284|5829541|P1|STARTED|Overall Study||222
2375288|NCT01493180|5829550|P2|NOT COMPLETED|Overall Study||2
2375289|NCT01493180|5829551|P1|NOT COMPLETED|Overall Study||3
2375290|NCT01493180|5829550|P2|COMPLETED|Overall Study||49
2375291|NCT01493180|5829551|P1|COMPLETED|Overall Study||48
2375292|NCT01493180|5829550|P2|STARTED|Overall Study||51
2375293|NCT01493180|5829551|P1|STARTED|Overall Study||51
2375294|NCT01493167|5829557|P1|NOT COMPLETED|Overall Study||0
2375295|NCT01493167|5829557|P1|COMPLETED|Overall Study||97
2375296|NCT01493167|5829557|P1|STARTED|Overall Study||97
2375297|NCT01493089|5829563|P2|NOT COMPLETED|Overall Study||3
2375298|NCT01493089|5829564|P1|NOT COMPLETED|Overall Study||3
2375299|NCT01493089|5829563|P2|COMPLETED|Overall Study||114
2375300|NCT01493089|5829564|P1|COMPLETED|Overall Study||119
2375301|NCT01493089|5829563|P2|STARTED|Overall Study||117
2375302|NCT01493089|5829564|P1|STARTED|Overall Study||122
2375303|NCT01493024|5829584|P4|NOT COMPLETED|Overall Study||0
2375304|NCT01493024|5829585|P3|NOT COMPLETED|Overall Study||0
2375305|NCT01493024|5829586|P2|NOT COMPLETED|Overall Study||0
2375306|NCT01493024|5829587|P1|NOT COMPLETED|Overall Study||0
2375307|NCT01493024|5829584|P4|COMPLETED|Overall Study||24
2375308|NCT01493024|5829585|P3|COMPLETED|Overall Study||24
2375309|NCT01493024|5829586|P2|COMPLETED|Overall Study||12
2375310|NCT01493024|5829587|P1|COMPLETED|Overall Study||30
2375311|NCT01493024|5829584|P4|STARTED|Overall Study||24
2375312|NCT01493024|5829585|P3|STARTED|Overall Study||24
2375313|NCT01493024|5829586|P2|STARTED|Overall Study||12
2375314|NCT01493024|5829587|P1|STARTED|Overall Study||30
2375315|NCT01492686|5829663|P2|NOT COMPLETED|Open-label Phase||18
2375316|NCT01492686|5829664|P1|NOT COMPLETED|Open-label Phase||12
2375317|NCT01492686|5829663|P2|COMPLETED|Open-label Phase||40
2375318|NCT01492686|5829664|P1|COMPLETED|Open-label Phase||53
2375319|NCT01492686|5829663|P2|STARTED|Open-label Phase||58
2375320|NCT01492686|5829664|P1|STARTED|Open-label Phase||65
2375321|NCT01492686|5829663|P2|NOT COMPLETED|Double-blind Phase||8
2375322|NCT01492686|5829664|P1|NOT COMPLETED|Double-blind Phase||2
2375323|NCT01492686|5829663|P2|COMPLETED|Double-blind Phase||60
2375324|NCT01492686|5829664|P1|COMPLETED|Double-blind Phase||67
2375325|NCT01492686|5829663|P2|STARTED|Double-blind Phase||68
2375326|NCT01492686|5829664|P1|STARTED|Double-blind Phase||69
2375327|NCT01492673|5829688|P1|NOT COMPLETED|Overall Study||0
2375328|NCT01492673|5829688|P1|COMPLETED|Overall Study||9
2375329|NCT01492673|5829688|P1|STARTED|Overall Study||9
2375330|NCT01492439|5829695|P2|NOT COMPLETED|Overall Study||9
2375331|NCT01492439|5829696|P1|NOT COMPLETED|Overall Study||4
2375332|NCT01492439|5829695|P2|COMPLETED|Overall Study||9
2375333|NCT01492439|5829696|P1|COMPLETED|Overall Study||15
2375334|NCT01492439|5829695|P2|Post-intervention|Overall Study||13
2375335|NCT01492439|5829696|P1|Post-intervention|Overall Study||18
2375336|NCT01492439|5829695|P2|STARTED|Overall Study||18
2375337|NCT01492439|5829696|P1|STARTED|Overall Study||19
2375338|NCT01492426|5829744|P2|NOT COMPLETED|Follow-Up||10
2375339|NCT01492426|5829745|P1|NOT COMPLETED|Follow-Up||25
2375340|NCT01492426|5829744|P2|COMPLETED|Follow-Up||181
2375341|NCT01492426|5829745|P1|COMPLETED|Follow-Up||359
2375342|NCT01492426|5829744|P2|STARTED|Follow-Up|This total number includes 160 who completed treatment plus 31 who rejoined for follow-up.|191
2375343|NCT01492426|5829745|P1|STARTED|Follow-Up|This total number includes 319 who completed treatment plus 65 who rejoined for follow-up.|384
2375344|NCT01492426|5829744|P2|NOT COMPLETED|Treatment||40
2375345|NCT01492426|5829745|P1|NOT COMPLETED|Treatment||83
2375346|NCT01492426|5829744|P2|COMPLETED|Treatment||160
2375347|NCT01492426|5829745|P1|COMPLETED|Treatment||319
2375348|NCT01492426|5829744|P2|STARTED|Treatment||200
2375349|NCT01492426|5829745|P1|STARTED|Treatment||402
2375350|NCT01492400|5829763|P2|NOT COMPLETED|Overall Study||16
2375352|NCT01492400|5829763|P2|COMPLETED|Overall Study||166
2375353|NCT01492400|5829764|P1|COMPLETED|Overall Study||165
2375354|NCT01492400|5829763|P2|STARTED|Overall Study||182
2375355|NCT01492400|5829764|P1|STARTED|Overall Study||181
2375356|NCT01492309|5829776|P2|NOT COMPLETED|Overall Study||0
2375357|NCT01492309|5829777|P1|NOT COMPLETED|Overall Study||0
2375358|NCT01492309|5829776|P2|COMPLETED|Overall Study||11
2375359|NCT01492309|5829777|P1|COMPLETED|Overall Study||11
2375360|NCT01492309|5829776|P2|STARTED|Overall Study||11
2375361|NCT01492309|5829777|P1|STARTED|Overall Study||11
2375362|NCT01492088|5829788|P3|NOT COMPLETED|Overall Study||14
2375363|NCT01492088|5829789|P2|NOT COMPLETED|Overall Study||14
2375364|NCT01492088|5829790|P1|NOT COMPLETED|Overall Study||3
2375365|NCT01492088|5829788|P3|COMPLETED|Overall Study||3
2375366|NCT01492088|5829789|P2|COMPLETED|Overall Study||2
2375367|NCT01492088|5829790|P1|COMPLETED|Overall Study||0
2375368|NCT01492088|5829788|P3|STARTED|Overall Study||17
2375369|NCT01492088|5829789|P2|STARTED|Overall Study||16
2375370|NCT01492088|5829790|P1|STARTED|Overall Study||3
2375371|NCT01491984|5829850|P2|NOT COMPLETED|Overall Study||1
2375372|NCT01491984|5829851|P1|NOT COMPLETED|Overall Study||2
2375373|NCT01491984|5829850|P2|COMPLETED|Overall Study||44
2375374|NCT01491984|5829851|P1|COMPLETED|Overall Study||47
2375375|NCT01491984|5829850|P2|STARTED|Overall Study||45
2375376|NCT01491984|5829851|P1|STARTED|Overall Study||49
2375377|NCT01491958|5829859|P2|NOT COMPLETED|Overall Study||0
2375378|NCT01491958|5829860|P1|NOT COMPLETED|Overall Study||0
2375379|NCT01491958|5829859|P2|COMPLETED|Overall Study||40
2375380|NCT01491958|5829860|P1|COMPLETED|Overall Study||40
2375381|NCT01491958|5829859|P2|STARTED|Overall Study||40
2375382|NCT01491958|5829860|P1|STARTED|Overall Study||40
2375383|NCT01491919|5829871|P3|NOT COMPLETED|Overall Study||1
2375384|NCT01491919|5829872|P2|NOT COMPLETED|Overall Study||2
2375385|NCT01491919|5829873|P1|NOT COMPLETED|Overall Study||1
2375386|NCT01491919|5829871|P3|COMPLETED|Overall Study||2
2375387|NCT01491919|5829872|P2|COMPLETED|Overall Study||8
2375388|NCT01491919|5829873|P1|COMPLETED|Overall Study||12
2375389|NCT01491919|5829871|P3|STARTED|Overall Study||3
2375390|NCT01491919|5829872|P2|STARTED|Overall Study||10
2375391|NCT01491919|5829873|P1|STARTED|Overall Study||13
2375392|NCT01491893|5829919|P10|NOT COMPLETED|Overall Study||0
2375393|NCT01491893|5829920|P9|NOT COMPLETED|Overall Study||0
2375394|NCT01491893|5829921|P8|NOT COMPLETED|Overall Study||0
2375395|NCT01491893|5829922|P7|NOT COMPLETED|Overall Study||0
2375396|NCT01491893|5829923|P6|NOT COMPLETED|Overall Study||0
2375397|NCT01491893|5829924|P5|NOT COMPLETED|Overall Study||0
2375398|NCT01491893|5829925|P4|NOT COMPLETED|Overall Study||0
2375399|NCT01491893|5829926|P3|NOT COMPLETED|Overall Study||0
2375400|NCT01491893|5829927|P2|NOT COMPLETED|Overall Study||0
2375401|NCT01491893|5829928|P1|NOT COMPLETED|Overall Study||0
2375402|NCT01491893|5829919|P10|COMPLETED|Overall Study||7
2375403|NCT01491893|5829920|P9|COMPLETED|Overall Study||15
2375404|NCT01491893|5829921|P8|COMPLETED|Overall Study||24
2375405|NCT01491893|5829922|P7|COMPLETED|Overall Study||6
2375406|NCT01491893|5829923|P6|COMPLETED|Overall Study||1
2375407|NCT01491893|5829924|P5|COMPLETED|Overall Study||4
2375408|NCT01491893|5829925|P4|COMPLETED|Overall Study||1
2375409|NCT01491893|5829926|P3|COMPLETED|Overall Study||1
2375410|NCT01491893|5829927|P2|COMPLETED|Overall Study||1
2375411|NCT01491893|5829928|P1|COMPLETED|Overall Study||1
2375412|NCT01491893|5829919|P10|STARTED|Overall Study||7
2375413|NCT01491893|5829920|P9|STARTED|Overall Study||15
2375414|NCT01491893|5829921|P8|STARTED|Overall Study||24
2375415|NCT01491893|5829922|P7|STARTED|Overall Study||6
2375416|NCT01491893|5829923|P6|STARTED|Overall Study||1
2375417|NCT01491893|5829924|P5|STARTED|Overall Study||4
2375418|NCT01491893|5829925|P4|STARTED|Overall Study||1
2375419|NCT01491893|5829926|P3|STARTED|Overall Study||1
2375420|NCT01491893|5829927|P2|STARTED|Overall Study||1
2375421|NCT01491893|5829928|P1|STARTED|Overall Study||1
2375422|NCT01491854|5829944|P1|NOT COMPLETED|Overall Study||130
2375423|NCT01491854|5829944|P1|COMPLETED|Overall Study||0
2375424|NCT01491854|5829944|P1|STARTED|Overall Study||130
2375425|NCT01491841|5829955|P1|NOT COMPLETED|Overall Study||11
2375426|NCT01491841|5829955|P1|COMPLETED|Overall Study||22
2375427|NCT01491841|5829955|P1|STARTED|Overall Study||33
2375428|NCT01491802|5829969|P2|NOT COMPLETED|Overall Study||2
2375429|NCT01491802|5829970|P1|NOT COMPLETED|Overall Study||1
2375430|NCT01491802|5829969|P2|COMPLETED|Overall Study||6
2375431|NCT01491802|5829970|P1|COMPLETED|Overall Study||8
2375432|NCT01491802|5829969|P2|STARTED|Overall Study||8
2375433|NCT01491802|5829970|P1|STARTED|Overall Study||9
2375434|NCT01491737|5829997|P2|NOT COMPLETED|Overall Study||50
2375435|NCT01491737|5829998|P1|NOT COMPLETED|Overall Study||49
2375436|NCT01491737|5829997|P2|COMPLETED|Overall Study||79
2375437|NCT01491737|5829998|P1|COMPLETED|Overall Study||80
2375438|NCT01491737|5829997|P2|STARTED|Overall Study||129
2375439|NCT01491737|5829998|P1|STARTED|Overall Study||129
2375440|NCT01491672|5830021|P3|NOT COMPLETED|Overall Study||11
2375441|NCT01491672|5830022|P2|NOT COMPLETED|Overall Study||60
2375442|NCT01491672|5830023|P1|NOT COMPLETED|Overall Study||56
2375443|NCT01491672|5830021|P3|COMPLETED|Overall Study||3
2375444|NCT01491672|5830022|P2|COMPLETED|Overall Study||2
2375445|NCT01491672|5830023|P1|COMPLETED|Overall Study||2
2375446|NCT01491672|5830021|P3|Safety Set|Overall Study||14
2375447|NCT01491672|5830022|P2|Safety Set|Overall Study||61
2375448|NCT01491672|5830023|P1|Safety Set|Overall Study||58
2375449|NCT01491672|5830021|P3|STARTED|Overall Study||14
2375450|NCT01491672|5830022|P2|STARTED|Overall Study|1 participant died prior to treatment initiation.|62
2375451|NCT01491672|5830023|P1|STARTED|Overall Study||58
2375452|NCT01491633|5830048|P1|NOT COMPLETED|Overall Study||5
2375453|NCT01491633|5830048|P1|COMPLETED|Overall Study||0
2375454|NCT01491633|5830048|P1|STARTED|Overall Study||5
2375455|NCT01491607|5830060|P1|NOT COMPLETED|Overall Study||10
2375456|NCT01491607|5830060|P1|COMPLETED|Overall Study||190
2375457|NCT01491607|5830060|P1|STARTED|Overall Study||200
2375458|NCT01491490|5830158|P2|NOT COMPLETED|Overall Study||0
2375459|NCT01491490|5830159|P1|NOT COMPLETED|Overall Study||0
2375460|NCT01491490|5830158|P2|COMPLETED|Overall Study||1
2375461|NCT01491490|5830159|P1|COMPLETED|Overall Study||1
2375462|NCT01491490|5830158|P2|STARTED|Overall Study||1
2375463|NCT01491490|5830159|P1|STARTED|Overall Study||1
2375464|NCT01491178|5830165|P1|NOT COMPLETED|Overall Study||2794
2375465|NCT01491178|5830165|P1|COMPLETED|Overall Study|Completed is defined as 104 weeks follow-up after enrollment.|3649
2375466|NCT01491178|5830165|P1|STARTED|Overall Study|Started are the enrolled subjects who followed registration rule and for who eCRF was collected.|6443
2375467|NCT01491113|5830175|P5|NOT COMPLETED|Overall Study||0
2375468|NCT01491113|5830176|P4|NOT COMPLETED|Overall Study||0
2375469|NCT01491113|5830177|P3|NOT COMPLETED|Overall Study||0
2375470|NCT01491113|5830178|P2|NOT COMPLETED|Overall Study||0
2375471|NCT01491113|5830179|P1|NOT COMPLETED|Overall Study||0
2375472|NCT01491113|5830175|P5|COMPLETED|Overall Study||6
2375473|NCT01491113|5830176|P4|COMPLETED|Overall Study||6
2375474|NCT01491113|5830177|P3|COMPLETED|Overall Study||6
2375475|NCT01491113|5830178|P2|COMPLETED|Overall Study||6
2375476|NCT01491113|5830179|P1|COMPLETED|Overall Study||6
2375477|NCT01491113|5830175|P5|STARTED|Overall Study||6
2375478|NCT01491113|5830176|P4|STARTED|Overall Study||6
2375479|NCT01491113|5830177|P3|STARTED|Overall Study||6
2375480|NCT01491113|5830178|P2|STARTED|Overall Study||6
2375481|NCT01491113|5830179|P1|STARTED|Overall Study||6
2375482|NCT01491035|5830274|P8|NOT COMPLETED|Overall Study||0
2375483|NCT01491035|5830275|P7|NOT COMPLETED|Overall Study||0
2375484|NCT01491035|5830276|P6|NOT COMPLETED|Overall Study||0
2375485|NCT01491035|5830277|P5|NOT COMPLETED|Overall Study||1
2375486|NCT01491035|5830278|P4|NOT COMPLETED|Overall Study||0
2375487|NCT01491035|5830279|P3|NOT COMPLETED|Overall Study||0
2375488|NCT01491035|5830280|P2|NOT COMPLETED|Overall Study||0
2375489|NCT01491035|5830281|P1|NOT COMPLETED|Overall Study||0
2375490|NCT01491035|5830274|P8|COMPLETED|Overall Study||6
2375491|NCT01491035|5830275|P7|COMPLETED|Overall Study||6
2375492|NCT01491035|5830276|P6|COMPLETED|Overall Study||6
2375493|NCT01491035|5830277|P5|COMPLETED|Overall Study||5
2375494|NCT01491035|5830278|P4|COMPLETED|Overall Study||6
2375495|NCT01491035|5830279|P3|COMPLETED|Overall Study||6
2375496|NCT01491035|5830280|P2|COMPLETED|Overall Study||6
2375497|NCT01491035|5830281|P1|COMPLETED|Overall Study||6
2375498|NCT01491035|5830274|P8|STARTED|Overall Study||6
2375499|NCT01491035|5830275|P7|STARTED|Overall Study||6
2375500|NCT01491035|5830276|P6|STARTED|Overall Study||6
2375501|NCT01491035|5830277|P5|STARTED|Overall Study||6
2375502|NCT01491035|5830278|P4|STARTED|Overall Study||6
2375503|NCT01491035|5830279|P3|STARTED|Overall Study||6
2375504|NCT01491035|5830280|P2|STARTED|Overall Study||6
2375505|NCT01491035|5830281|P1|STARTED|Overall Study||6
2375506|NCT01491022|5830349|P2|NOT COMPLETED|Intervention 2||0
2375507|NCT01491022|5830350|P1|NOT COMPLETED|Intervention 2||1
2375508|NCT01491022|5830349|P2|COMPLETED|Intervention 2||11
2375509|NCT01491022|5830350|P1|COMPLETED|Intervention 2||8
2375510|NCT01491022|5830349|P2|STARTED|Intervention 2||11
2375511|NCT01491022|5830350|P1|STARTED|Intervention 2||9
2375512|NCT01491022|5830349|P2|NOT COMPLETED|2 Week Washout||0
2375513|NCT01491022|5830350|P1|NOT COMPLETED|2 Week Washout||0
2375514|NCT01491022|5830349|P2|COMPLETED|2 Week Washout||11
2375515|NCT01491022|5830350|P1|COMPLETED|2 Week Washout||9
2375516|NCT01491022|5830349|P2|STARTED|2 Week Washout||11
2375517|NCT01491022|5830350|P1|STARTED|2 Week Washout||9
2375518|NCT01491022|5830349|P2|NOT COMPLETED|Intervention 1||1
2375519|NCT01491022|5830350|P1|NOT COMPLETED|Intervention 1||1
2375520|NCT01491022|5830349|P2|COMPLETED|Intervention 1||11
2375521|NCT01491022|5830350|P1|COMPLETED|Intervention 1||9
2375522|NCT01491022|5830349|P2|STARTED|Intervention 1||12
2375523|NCT01491022|5830350|P1|STARTED|Intervention 1||10
2375524|NCT01490931|5830366|P1|NOT COMPLETED|Overall Study||0
2375525|NCT01490931|5830366|P1|COMPLETED|Overall Study||25
2375526|NCT01490931|5830366|P1|STARTED|Overall Study||25
2375530|NCT01490866|5830387|P1|NOT COMPLETED|Axitinib Maintenance Therapy||49
2375531|NCT01490866|5830387|P1|COMPLETED|Axitinib Maintenance Therapy|No protocol defined endpoint to Axitinib maintenance treatment.|0
2375532|NCT01490866|5830387|P1|STARTED|Axitinib Maintenance Therapy||49
2375533|NCT01490866|5830387|P1|NOT COMPLETED|FOLFOX/Bevacizumab Treatment||21
2375534|NCT01490866|5830387|P1|COMPLETED|FOLFOX/Bevacizumab Treatment||49
2375535|NCT01490866|5830387|P1|STARTED|FOLFOX/Bevacizumab Treatment||70
2375536|NCT01490840|5830398|P2|NOT COMPLETED|Phase 2||6
2375537|NCT01490840|5830399|P1|NOT COMPLETED|Phase 2||6
2375538|NCT01490840|5830398|P2|COMPLETED|Phase 2||68
2375539|NCT01490840|5830399|P1|COMPLETED|Phase 2||75
2375826|NCT01490632|5830486|P17|STARTED|Part A: Initial Treatment Period||0
2375540|NCT01490840|5830398|P2|STARTED|Phase 2|4 participants discontinued between phase 1 and phase 2|74
2375541|NCT01490840|5830399|P1|STARTED|Phase 2|3 participants discontinued between phase 1 and phase 2|81
2375542|NCT01490840|5830398|P2|NOT COMPLETED|Phase 1||6
2375543|NCT01490840|5830399|P1|NOT COMPLETED|Phase 1||10
2375544|NCT01490840|5830398|P2|COMPLETED|Phase 1||78
2375545|NCT01490840|5830399|P1|COMPLETED|Phase 1||84
2375546|NCT01490840|5830398|P2|Modified Full Analysis Set|Phase 1||83
2375547|NCT01490840|5830399|P1|Modified Full Analysis Set|Phase 1||56
2375548|NCT01490840|5830398|P2|STARTED|Phase 1||84
2375549|NCT01490840|5830399|P1|STARTED|Phase 1||94
2375550|NCT01490814|5830423|P2|NOT COMPLETED|Overall Study||8
2375551|NCT01490814|5830424|P1|NOT COMPLETED|Overall Study||4
2375552|NCT01490814|5830423|P2|COMPLETED|Overall Study|376 received ablation|376
2375553|NCT01490814|5830424|P1|COMPLETED|Overall Study|374 received ablation|374
2375554|NCT01490814|5830423|P2|STARTED|Overall Study|384 subjects randomized to radiofrequency arm|384
2375555|NCT01490814|5830424|P1|STARTED|Overall Study|378 subjects randomized to Cryoballoon arm|378
2375556|NCT01490788|5830444|P6|NOT COMPLETED|Overall Study||0
2375557|NCT01490788|5830445|P5|NOT COMPLETED|Overall Study||0
2375558|NCT01490788|5830446|P4|NOT COMPLETED|Overall Study||0
2375559|NCT01490788|5830447|P3|NOT COMPLETED|Overall Study||0
2375560|NCT01490788|5830448|P2|NOT COMPLETED|Overall Study||0
2375561|NCT01490788|5830449|P1|NOT COMPLETED|Overall Study||1
2375562|NCT01490788|5830444|P6|COMPLETED|Overall Study||5
2375563|NCT01490788|5830445|P5|COMPLETED|Overall Study||5
2375564|NCT01490788|5830446|P4|COMPLETED|Overall Study||5
2375565|NCT01490788|5830447|P3|COMPLETED|Overall Study||5
2375566|NCT01490788|5830448|P2|COMPLETED|Overall Study||5
2375567|NCT01490788|5830449|P1|COMPLETED|Overall Study||4
2375568|NCT01490788|5830444|P6|STARTED|Overall Study||5
2375569|NCT01490788|5830445|P5|STARTED|Overall Study||5
2375570|NCT01490788|5830446|P4|STARTED|Overall Study||5
2375571|NCT01490788|5830447|P3|STARTED|Overall Study||5
2375572|NCT01490788|5830448|P2|STARTED|Overall Study||5
2375573|NCT01490788|5830449|P1|STARTED|Overall Study||5
2375574|NCT01490697|5830462|P2|NOT COMPLETED|Overall Study||2
2375575|NCT01490697|5830463|P1|NOT COMPLETED|Overall Study||1
2375576|NCT01490697|5830462|P2|COMPLETED|Overall Study||16
2375577|NCT01490697|5830463|P1|COMPLETED|Overall Study||15
2375578|NCT01490697|5830462|P2|STARTED|Overall Study||18
2375579|NCT01490697|5830463|P1|STARTED|Overall Study||16
2375580|NCT01490684|5830471|P1|NOT COMPLETED|Overall Study||0
2375581|NCT01490684|5830471|P1|COMPLETED|Overall Study||162
2375582|NCT01490684|5830471|P1|STARTED|Overall Study||162
2375583|NCT01490632|5830483|P20|NOT COMPLETED|Part D: Re-Treatment Period||7
2375584|NCT01490632|5830484|P19|NOT COMPLETED|Part D: Re-Treatment Period||7
2375585|NCT01490632|5830485|P18|NOT COMPLETED|Part D: Re-Treatment Period||5
2375586|NCT01490632|5830486|P17|NOT COMPLETED|Part D: Re-Treatment Period||0
2375587|NCT01490632|5830487|P16|NOT COMPLETED|Part D: Re-Treatment Period||0
2375588|NCT01490632|5830488|P15|NOT COMPLETED|Part D: Re-Treatment Period||0
2375589|NCT01490632|5830489|P14|NOT COMPLETED|Part D: Re-Treatment Period||0
2375590|NCT01490632|5830490|P13|NOT COMPLETED|Part D: Re-Treatment Period||0
2375591|NCT01490632|5830491|P12|NOT COMPLETED|Part D: Re-Treatment Period||0
2375592|NCT01490632|5830492|P11|NOT COMPLETED|Part D: Re-Treatment Period||0
2375593|NCT01490632|5830493|P10|NOT COMPLETED|Part D: Re-Treatment Period||0
2375594|NCT01490632|5830494|P9|NOT COMPLETED|Part D: Re-Treatment Period||0
2375595|NCT01490632|5830495|P8|NOT COMPLETED|Part D: Re-Treatment Period||0
2375596|NCT01490632|5830496|P7|NOT COMPLETED|Part D: Re-Treatment Period||0
2375597|NCT01490632|5830497|P6|NOT COMPLETED|Part D: Re-Treatment Period||0
2375598|NCT01490632|5830498|P5|NOT COMPLETED|Part D: Re-Treatment Period||0
2375599|NCT01490632|5830499|P4|NOT COMPLETED|Part D: Re-Treatment Period||0
2375600|NCT01490632|5830500|P3|NOT COMPLETED|Part D: Re-Treatment Period||0
2375601|NCT01490632|5830501|P2|NOT COMPLETED|Part D: Re-Treatment Period||0
2375602|NCT01490632|5830502|P1|NOT COMPLETED|Part D: Re-Treatment Period||0
2375603|NCT01490632|5830483|P20|COMPLETED|Part D: Re-Treatment Period||30
2375604|NCT01490632|5830484|P19|COMPLETED|Part D: Re-Treatment Period||12
2375605|NCT01490632|5830485|P18|COMPLETED|Part D: Re-Treatment Period||8
2375606|NCT01490632|5830486|P17|COMPLETED|Part D: Re-Treatment Period||3
2375607|NCT01490632|5830487|P16|COMPLETED|Part D: Re-Treatment Period||0
2375608|NCT01490632|5830488|P15|COMPLETED|Part D: Re-Treatment Period||0
2375609|NCT01490632|5830489|P14|COMPLETED|Part D: Re-Treatment Period||0
2375610|NCT01490632|5830490|P13|COMPLETED|Part D: Re-Treatment Period||0
2375611|NCT01490632|5830491|P12|COMPLETED|Part D: Re-Treatment Period||0
2375612|NCT01490632|5830492|P11|COMPLETED|Part D: Re-Treatment Period||0
2375613|NCT01490632|5830493|P10|COMPLETED|Part D: Re-Treatment Period||0
2375614|NCT01490632|5830494|P9|COMPLETED|Part D: Re-Treatment Period||0
2375615|NCT01490632|5830495|P8|COMPLETED|Part D: Re-Treatment Period||0
2375616|NCT01490632|5830496|P7|COMPLETED|Part D: Re-Treatment Period||0
2375617|NCT01490632|5830497|P6|COMPLETED|Part D: Re-Treatment Period||0
2375618|NCT01490632|5830498|P5|COMPLETED|Part D: Re-Treatment Period||0
2375619|NCT01490632|5830499|P4|COMPLETED|Part D: Re-Treatment Period||0
2375620|NCT01490632|5830500|P3|COMPLETED|Part D: Re-Treatment Period||0
2375621|NCT01490632|5830501|P2|COMPLETED|Part D: Re-Treatment Period||0
2375622|NCT01490632|5830502|P1|COMPLETED|Part D: Re-Treatment Period||0
2375623|NCT01490632|5830483|P20|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 10 mg.|37
2375827|NCT01490632|5830487|P16|STARTED|Part A: Initial Treatment Period||0
2375624|NCT01490632|5830484|P19|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 8 mg.|19
2375625|NCT01490632|5830485|P18|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 4 mg.|13
2375626|NCT01490632|5830486|P17|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 2 mg.|3
2375627|NCT01490632|5830487|P16|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|0
2375628|NCT01490632|5830488|P15|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|0
2375629|NCT01490632|5830489|P14|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|0
2375630|NCT01490632|5830490|P13|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|0
2375631|NCT01490632|5830491|P12|STARTED|Part D: Re-Treatment Period||0
2375632|NCT01490632|5830492|P11|STARTED|Part D: Re-Treatment Period||0
2375633|NCT01490632|5830493|P10|STARTED|Part D: Re-Treatment Period||0
2375634|NCT01490632|5830494|P9|STARTED|Part D: Re-Treatment Period||0
2375635|NCT01490632|5830495|P8|STARTED|Part D: Re-Treatment Period||0
2375636|NCT01490632|5830496|P7|STARTED|Part D: Re-Treatment Period||0
2375637|NCT01490632|5830497|P6|STARTED|Part D: Re-Treatment Period||0
2375638|NCT01490632|5830498|P5|STARTED|Part D: Re-Treatment Period||0
2375639|NCT01490632|5830499|P4|STARTED|Part D: Re-Treatment Period||0
2375640|NCT01490632|5830500|P3|STARTED|Part D: Re-Treatment Period||0
2375641|NCT01490632|5830501|P2|STARTED|Part D: Re-Treatment Period||0
2375642|NCT01490632|5830502|P1|STARTED|Part D: Re-Treatment Period||0
2375643|NCT01490632|5830483|P20|NOT COMPLETED|Part C: Washout or Step-Down Period||0
2375644|NCT01490632|5830484|P19|NOT COMPLETED|Part C: Washout or Step-Down Period||0
2375645|NCT01490632|5830485|P18|NOT COMPLETED|Part C: Washout or Step-Down Period||0
2375646|NCT01490632|5830486|P17|NOT COMPLETED|Part C: Washout or Step-Down Period||0
2375647|NCT01490632|5830487|P16|NOT COMPLETED|Part C: Washout or Step-Down Period||37
2375648|NCT01490632|5830488|P15|NOT COMPLETED|Part C: Washout or Step-Down Period||18
2375649|NCT01490632|5830489|P14|NOT COMPLETED|Part C: Washout or Step-Down Period||10
2375650|NCT01490632|5830490|P13|NOT COMPLETED|Part C: Washout or Step-Down Period||5
2375651|NCT01490632|5830491|P12|NOT COMPLETED|Part C: Washout or Step-Down Period||0
2375652|NCT01490632|5830492|P11|NOT COMPLETED|Part C: Washout or Step-Down Period||0
2375653|NCT01490632|5830493|P10|NOT COMPLETED|Part C: Washout or Step-Down Period||0
2375654|NCT01490632|5830494|P9|NOT COMPLETED|Part C: Washout or Step-Down Period||0
2375655|NCT01490632|5830495|P8|NOT COMPLETED|Part C: Washout or Step-Down Period||0
2375656|NCT01490632|5830496|P7|NOT COMPLETED|Part C: Washout or Step-Down Period||0
2375657|NCT01490632|5830497|P6|NOT COMPLETED|Part C: Washout or Step-Down Period||0
2375658|NCT01490632|5830498|P5|NOT COMPLETED|Part C: Washout or Step-Down Period||0
2375659|NCT01490632|5830499|P4|NOT COMPLETED|Part C: Washout or Step-Down Period||0
2375660|NCT01490632|5830500|P3|NOT COMPLETED|Part C: Washout or Step-Down Period||0
2375661|NCT01490632|5830501|P2|NOT COMPLETED|Part C: Washout or Step-Down Period||0
2375662|NCT01490632|5830502|P1|NOT COMPLETED|Part C: Washout or Step-Down Period||0
2375663|NCT01490632|5830483|P20|COMPLETED|Part C: Washout or Step-Down Period||0
2375664|NCT01490632|5830484|P19|COMPLETED|Part C: Washout or Step-Down Period||0
2375665|NCT01490632|5830485|P18|COMPLETED|Part C: Washout or Step-Down Period||0
2375666|NCT01490632|5830486|P17|COMPLETED|Part C: Washout or Step-Down Period||0
2375667|NCT01490632|5830487|P16|COMPLETED|Part C: Washout or Step-Down Period||18
2375668|NCT01490632|5830488|P15|COMPLETED|Part C: Washout or Step-Down Period||37
2375669|NCT01490632|5830489|P14|COMPLETED|Part C: Washout or Step-Down Period||6
2375670|NCT01490632|5830490|P13|COMPLETED|Part C: Washout or Step-Down Period||10
2375671|NCT01490632|5830491|P12|COMPLETED|Part C: Washout or Step-Down Period||0
2375672|NCT01490632|5830492|P11|COMPLETED|Part C: Washout or Step-Down Period||0
2375673|NCT01490632|5830493|P10|COMPLETED|Part C: Washout or Step-Down Period||0
2375674|NCT01490632|5830494|P9|COMPLETED|Part C: Washout or Step-Down Period||0
2375675|NCT01490632|5830495|P8|COMPLETED|Part C: Washout or Step-Down Period||0
2375676|NCT01490632|5830496|P7|COMPLETED|Part C: Washout or Step-Down Period||0
2375677|NCT01490632|5830497|P6|COMPLETED|Part C: Washout or Step-Down Period||0
2375678|NCT01490632|5830498|P5|COMPLETED|Part C: Washout or Step-Down Period||0
2375679|NCT01490632|5830499|P4|COMPLETED|Part C: Washout or Step-Down Period||0
2375680|NCT01490632|5830500|P3|COMPLETED|Part C: Washout or Step-Down Period||0
2375681|NCT01490632|5830501|P2|COMPLETED|Part C: Washout or Step-Down Period||0
2375682|NCT01490632|5830502|P1|COMPLETED|Part C: Washout or Step-Down Period||0
2375683|NCT01490632|5830483|P20|STARTED|Part C: Washout or Step-Down Period||0
2375684|NCT01490632|5830484|P19|STARTED|Part C: Washout or Step-Down Period||0
2375685|NCT01490632|5830485|P18|STARTED|Part C: Washout or Step-Down Period||0
2375686|NCT01490632|5830486|P17|STARTED|Part C: Washout or Step-Down Period||0
2375687|NCT01490632|5830487|P16|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|55
2375688|NCT01490632|5830488|P15|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|55
2375689|NCT01490632|5830489|P14|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|16
2375690|NCT01490632|5830490|P13|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|15
2375691|NCT01490632|5830491|P12|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to Placebo remained on Placebo.|0
2375692|NCT01490632|5830492|P11|STARTED|Part C: Washout or Step-Down Period|Part A 10 mg non-responders were discontinued from the study.|0
2375693|NCT01490632|5830493|P10|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|0
2375694|NCT01490632|5830494|P9|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|0
2375695|NCT01490632|5830495|P8|STARTED|Part C: Washout or Step-Down Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|0
2375696|NCT01490632|5830496|P7|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|0
2375697|NCT01490632|5830497|P6|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|0
2375698|NCT01490632|5830498|P5|STARTED|Part C: Washout or Step-Down Period|One participant completed Part B but discontinued without receiving a Part C treatment assignment.|0
2375699|NCT01490632|5830499|P4|STARTED|Part C: Washout or Step-Down Period||0
2375700|NCT01490632|5830500|P3|STARTED|Part C: Washout or Step-Down Period||0
2375701|NCT01490632|5830501|P2|STARTED|Part C: Washout or Step-Down Period||0
2375702|NCT01490632|5830502|P1|STARTED|Part C: Washout or Step-Down Period||0
2375703|NCT01490632|5830483|P20|NOT COMPLETED|Part B: Extension or Step-Up Period||0
2375704|NCT01490632|5830484|P19|NOT COMPLETED|Part B: Extension or Step-Up Period||0
2375705|NCT01490632|5830485|P18|NOT COMPLETED|Part B: Extension or Step-Up Period||0
2375706|NCT01490632|5830486|P17|NOT COMPLETED|Part B: Extension or Step-Up Period||0
2375707|NCT01490632|5830487|P16|NOT COMPLETED|Part B: Extension or Step-Up Period||0
2375708|NCT01490632|5830488|P15|NOT COMPLETED|Part B: Extension or Step-Up Period||0
2375709|NCT01490632|5830489|P14|NOT COMPLETED|Part B: Extension or Step-Up Period||0
2375710|NCT01490632|5830490|P13|NOT COMPLETED|Part B: Extension or Step-Up Period||0
2375711|NCT01490632|5830491|P12|NOT COMPLETED|Part B: Extension or Step-Up Period||8
2375712|NCT01490632|5830492|P11|NOT COMPLETED|Part B: Extension or Step-Up Period||21
2375713|NCT01490632|5830493|P10|NOT COMPLETED|Part B: Extension or Step-Up Period||25
2375714|NCT01490632|5830494|P9|NOT COMPLETED|Part B: Extension or Step-Up Period||10
2375715|NCT01490632|5830495|P8|NOT COMPLETED|Part B: Extension or Step-Up Period||6
2375716|NCT01490632|5830496|P7|NOT COMPLETED|Part B: Extension or Step-Up Period||13
2375717|NCT01490632|5830497|P6|NOT COMPLETED|Part B: Extension or Step-Up Period||4
2375718|NCT01490632|5830498|P5|NOT COMPLETED|Part B: Extension or Step-Up Period||0
2375719|NCT01490632|5830499|P4|NOT COMPLETED|Part B: Extension or Step-Up Period||0
2375720|NCT01490632|5830500|P3|NOT COMPLETED|Part B: Extension or Step-Up Period||0
2375721|NCT01490632|5830501|P2|NOT COMPLETED|Part B: Extension or Step-Up Period||0
2375722|NCT01490632|5830502|P1|NOT COMPLETED|Part B: Extension or Step-Up Period||0
2375723|NCT01490632|5830483|P20|COMPLETED|Part B: Extension or Step-Up Period||0
2375724|NCT01490632|5830484|P19|COMPLETED|Part B: Extension or Step-Up Period||0
2375725|NCT01490632|5830485|P18|COMPLETED|Part B: Extension or Step-Up Period||0
2375726|NCT01490632|5830486|P17|COMPLETED|Part B: Extension or Step-Up Period||0
2375727|NCT01490632|5830487|P16|COMPLETED|Part B: Extension or Step-Up Period||0
2375728|NCT01490632|5830488|P15|COMPLETED|Part B: Extension or Step-Up Period||0
2375729|NCT01490632|5830489|P14|COMPLETED|Part B: Extension or Step-Up Period||0
2375730|NCT01490632|5830490|P13|COMPLETED|Part B: Extension or Step-Up Period||0
2375731|NCT01490632|5830491|P12|COMPLETED|Part B: Extension or Step-Up Period||0
2375732|NCT01490632|5830492|P11|COMPLETED|Part B: Extension or Step-Up Period||22
2375733|NCT01490632|5830493|P10|COMPLETED|Part B: Extension or Step-Up Period||25
2375734|NCT01490632|5830494|P9|COMPLETED|Part B: Extension or Step-Up Period||6
2375735|NCT01490632|5830495|P8|COMPLETED|Part B: Extension or Step-Up Period||13
2375736|NCT01490632|5830496|P7|COMPLETED|Part B: Extension or Step-Up Period||51
2375737|NCT01490632|5830497|P6|COMPLETED|Part B: Extension or Step-Up Period||25
2375738|NCT01490632|5830498|P5|COMPLETED|Part B: Extension or Step-Up Period||0
2375739|NCT01490632|5830499|P4|COMPLETED|Part B: Extension or Step-Up Period||0
2375740|NCT01490632|5830500|P3|COMPLETED|Part B: Extension or Step-Up Period||0
2375741|NCT01490632|5830501|P2|COMPLETED|Part B: Extension or Step-Up Period||0
2375742|NCT01490632|5830502|P1|COMPLETED|Part B: Extension or Step-Up Period||0
2375743|NCT01490632|5830483|P20|STARTED|Part B: Extension or Step-Up Period||0
2375744|NCT01490632|5830484|P19|STARTED|Part B: Extension or Step-Up Period||0
2375745|NCT01490632|5830485|P18|STARTED|Part B: Extension or Step-Up Period||0
2375746|NCT01490632|5830486|P17|STARTED|Part B: Extension or Step-Up Period||0
2375747|NCT01490632|5830487|P16|STARTED|Part B: Extension or Step-Up Period||0
2375748|NCT01490632|5830488|P15|STARTED|Part B: Extension or Step-Up Period||0
2375749|NCT01490632|5830489|P14|STARTED|Part B: Extension or Step-Up Period||0
2375750|NCT01490632|5830490|P13|STARTED|Part B: Extension or Step-Up Period||0
2375751|NCT01490632|5830491|P12|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to Placebo remained on Placebo.|8
2375752|NCT01490632|5830492|P11|STARTED|Part B: Extension or Step-Up Period|Part A 10 mg non-responders were discontinued from the study.|43
2375753|NCT01490632|5830493|P10|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|50
2375754|NCT01490632|5830494|P9|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|16
2375755|NCT01490632|5830495|P8|STARTED|Part B: Extension or Step-Up Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|19
2375756|NCT01490632|5830496|P7|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|64
2375757|NCT01490632|5830497|P6|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|29
2375758|NCT01490632|5830498|P5|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
2375759|NCT01490632|5830499|P4|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
2375760|NCT01490632|5830500|P3|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
2375761|NCT01490632|5830501|P2|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
2375762|NCT01490632|5830502|P1|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
2375763|NCT01490632|5830483|P20|NOT COMPLETED|Part A: Initial Treatment Period||0
2375764|NCT01490632|5830484|P19|NOT COMPLETED|Part A: Initial Treatment Period||0
2375765|NCT01490632|5830485|P18|NOT COMPLETED|Part A: Initial Treatment Period||0
2375766|NCT01490632|5830486|P17|NOT COMPLETED|Part A: Initial Treatment Period||0
2375767|NCT01490632|5830487|P16|NOT COMPLETED|Part A: Initial Treatment Period||0
2375768|NCT01490632|5830488|P15|NOT COMPLETED|Part A: Initial Treatment Period||0
2375769|NCT01490632|5830489|P14|NOT COMPLETED|Part A: Initial Treatment Period||0
2375770|NCT01490632|5830490|P13|NOT COMPLETED|Part A: Initial Treatment Period||0
2375771|NCT01490632|5830491|P12|NOT COMPLETED|Part A: Initial Treatment Period||0
2375772|NCT01490632|5830492|P11|NOT COMPLETED|Part A: Initial Treatment Period||0
2375773|NCT01490632|5830493|P10|NOT COMPLETED|Part A: Initial Treatment Period||0
2375774|NCT01490632|5830494|P9|NOT COMPLETED|Part A: Initial Treatment Period||0
2375775|NCT01490632|5830495|P8|NOT COMPLETED|Part A: Initial Treatment Period||0
2375776|NCT01490632|5830496|P7|NOT COMPLETED|Part A: Initial Treatment Period||0
2375777|NCT01490632|5830497|P6|NOT COMPLETED|Part A: Initial Treatment Period||0
2375778|NCT01490632|5830498|P5|NOT COMPLETED|Part A: Initial Treatment Period||17
2375779|NCT01490632|5830499|P4|NOT COMPLETED|Part A: Initial Treatment Period||9
2375780|NCT01490632|5830500|P3|NOT COMPLETED|Part A: Initial Treatment Period||5
2375781|NCT01490632|5830501|P2|NOT COMPLETED|Part A: Initial Treatment Period||4
2375782|NCT01490632|5830502|P1|NOT COMPLETED|Part A: Initial Treatment Period||7
2375783|NCT01490632|5830483|P20|COMPLETED|Part A: Initial Treatment Period||0
2375784|NCT01490632|5830484|P19|COMPLETED|Part A: Initial Treatment Period||0
2375785|NCT01490632|5830485|P18|COMPLETED|Part A: Initial Treatment Period||0
2375786|NCT01490632|5830486|P17|COMPLETED|Part A: Initial Treatment Period||0
2375787|NCT01490632|5830487|P16|COMPLETED|Part A: Initial Treatment Period||0
2375788|NCT01490632|5830488|P15|COMPLETED|Part A: Initial Treatment Period||0
2375789|NCT01490632|5830489|P14|COMPLETED|Part A: Initial Treatment Period||0
2375790|NCT01490632|5830490|P13|COMPLETED|Part A: Initial Treatment Period||0
2375791|NCT01490632|5830491|P12|COMPLETED|Part A: Initial Treatment Period||0
2375792|NCT01490632|5830492|P11|COMPLETED|Part A: Initial Treatment Period||0
2375793|NCT01490632|5830493|P10|COMPLETED|Part A: Initial Treatment Period||0
2375794|NCT01490632|5830494|P9|COMPLETED|Part A: Initial Treatment Period||0
2375795|NCT01490632|5830495|P8|COMPLETED|Part A: Initial Treatment Period||0
2375796|NCT01490632|5830496|P7|COMPLETED|Part A: Initial Treatment Period||0
2375797|NCT01490632|5830497|P6|COMPLETED|Part A: Initial Treatment Period||0
2375798|NCT01490632|5830498|P5|COMPLETED|Part A: Initial Treatment Period|Includes participants who completed Part A, but discontinued per protocol using Part A PASI score.|52
2375799|NCT01490632|5830499|P4|COMPLETED|Part A: Initial Treatment Period||55
2375800|NCT01490632|5830500|P3|COMPLETED|Part A: Initial Treatment Period||67
2375801|NCT01490632|5830501|P2|COMPLETED|Part A: Initial Treatment Period||28
2375802|NCT01490632|5830502|P1|COMPLETED|Part A: Initial Treatment Period||27
2375803|NCT01490632|5830483|P20|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
2375804|NCT01490632|5830484|P19|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
2375805|NCT01490632|5830485|P18|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
2375806|NCT01490632|5830486|P17|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
2375807|NCT01490632|5830487|P16|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
2375808|NCT01490632|5830488|P15|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
2375809|NCT01490632|5830489|P14|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
2375810|NCT01490632|5830490|P13|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
2375811|NCT01490632|5830491|P12|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
2375812|NCT01490632|5830492|P11|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
2375813|NCT01490632|5830493|P10|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
2375814|NCT01490632|5830494|P9|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
2375815|NCT01490632|5830495|P8|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
2375816|NCT01490632|5830496|P7|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
2375817|NCT01490632|5830497|P6|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
2375818|NCT01490632|5830498|P5|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||69
2375819|NCT01490632|5830499|P4|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||64
2375820|NCT01490632|5830500|P3|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||72
2375821|NCT01490632|5830501|P2|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||32
2375822|NCT01490632|5830502|P1|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||34
2375823|NCT01490632|5830483|P20|STARTED|Part A: Initial Treatment Period||0
2375824|NCT01490632|5830484|P19|STARTED|Part A: Initial Treatment Period||0
2375825|NCT01490632|5830485|P18|STARTED|Part A: Initial Treatment Period||0
2375828|NCT01490632|5830488|P15|STARTED|Part A: Initial Treatment Period||0
2375829|NCT01490632|5830489|P14|STARTED|Part A: Initial Treatment Period||0
2375830|NCT01490632|5830490|P13|STARTED|Part A: Initial Treatment Period||0
2375831|NCT01490632|5830491|P12|STARTED|Part A: Initial Treatment Period||0
2375832|NCT01490632|5830492|P11|STARTED|Part A: Initial Treatment Period||0
2375833|NCT01490632|5830493|P10|STARTED|Part A: Initial Treatment Period||0
2375834|NCT01490632|5830494|P9|STARTED|Part A: Initial Treatment Period||0
2375835|NCT01490632|5830495|P8|STARTED|Part A: Initial Treatment Period||0
2375836|NCT01490632|5830496|P7|STARTED|Part A: Initial Treatment Period||0
2375837|NCT01490632|5830497|P6|STARTED|Part A: Initial Treatment Period||0
2375838|NCT01490632|5830498|P5|STARTED|Part A: Initial Treatment Period||69
2375839|NCT01490632|5830499|P4|STARTED|Part A: Initial Treatment Period||64
2375840|NCT01490632|5830500|P3|STARTED|Part A: Initial Treatment Period||72
2375841|NCT01490632|5830501|P2|STARTED|Part A: Initial Treatment Period||32
2375842|NCT01490632|5830502|P1|STARTED|Part A: Initial Treatment Period||34
2375843|NCT01490580|5830632|P2|NOT COMPLETED|Overall Study||2
2375844|NCT01490580|5830633|P1|NOT COMPLETED|Overall Study||0
2375845|NCT01490580|5830632|P2|COMPLETED|Overall Study||89
2375846|NCT01490580|5830633|P1|COMPLETED|Overall Study||82
2375847|NCT01490580|5830632|P2|STARTED|Overall Study||91
2375848|NCT01490580|5830633|P1|STARTED|Overall Study||82
2375849|NCT01490359|5830655|P2|NOT COMPLETED|Overall Study||17
2375850|NCT01490359|5830656|P1|NOT COMPLETED|Overall Study||24
2375851|NCT01490359|5830655|P2|COMPLETED|Overall Study||555
2375852|NCT01490359|5830656|P1|COMPLETED|Overall Study||585
2375853|NCT01490359|5830655|P2|Followed-up at 12 mo|Overall Study||537
2375854|NCT01490359|5830656|P1|Followed-up at 12 mo|Overall Study||569
2375855|NCT01490359|5830655|P2|Followed-up at 6 mo|Overall Study||535
2375856|NCT01490359|5830656|P1|Followed-up at 6 mo|Overall Study||558
2375857|NCT01490359|5830655|P2|STARTED|Overall Study||572
2375858|NCT01490359|5830656|P1|STARTED|Overall Study||609
2375859|NCT01490294|5830680|P4|NOT COMPLETED|Overall Study||1
2375860|NCT01490294|5830681|P3|NOT COMPLETED|Overall Study||1
2375861|NCT01490294|5830682|P2|NOT COMPLETED|Overall Study||0
2375862|NCT01490294|5830683|P1|NOT COMPLETED|Overall Study||5
2375863|NCT01490294|5830680|P4|COMPLETED|Overall Study||54
2375864|NCT01490294|5830681|P3|COMPLETED|Overall Study||58
2375865|NCT01490294|5830682|P2|COMPLETED|Overall Study||60
2375866|NCT01490294|5830683|P1|COMPLETED|Overall Study||53
2375867|NCT01490294|5830680|P4|Participant Received Treatment|Overall Study||54
2375868|NCT01490294|5830681|P3|Participant Received Treatment|Overall Study||58
2375869|NCT01490294|5830682|P2|Participant Received Treatment|Overall Study||60
2375870|NCT01490294|5830683|P1|Participant Received Treatment|Overall Study||54
2375871|NCT01490294|5830680|P4|STARTED|Overall Study||55
2375872|NCT01490294|5830681|P3|STARTED|Overall Study||59
2375873|NCT01490294|5830682|P2|STARTED|Overall Study||60
2375874|NCT01490294|5830683|P1|STARTED|Overall Study||58
2375875|NCT01490190|5830917|P1|NOT COMPLETED|Overall Study||48
2375876|NCT01490190|5830917|P1|COMPLETED|Overall Study||204
2375877|NCT01490190|5830917|P1|STARTED|Overall Study||252
2375878|NCT01490151|5830938|P1|NOT COMPLETED|Overall Study||0
2375879|NCT01490151|5830938|P1|COMPLETED|Overall Study||22
2375880|NCT01490151|5830938|P1|STARTED|Overall Study||22
2375881|NCT01490125|5830944|P6|NOT COMPLETED|Period III||0
2375882|NCT01490125|5830945|P5|NOT COMPLETED|Period III||1
2375883|NCT01490125|5830946|P4|NOT COMPLETED|Period III||2
2375884|NCT01490125|5830947|P3|NOT COMPLETED|Period III||0
2375885|NCT01490125|5830948|P2|NOT COMPLETED|Period III||1
2375886|NCT01490125|5830949|P1|NOT COMPLETED|Period III||3
2375887|NCT01490125|5830944|P6|COMPLETED|Period III||35
2375888|NCT01490125|5830945|P5|COMPLETED|Period III||31
2375889|NCT01490125|5830946|P4|COMPLETED|Period III||28
2375890|NCT01490125|5830947|P3|COMPLETED|Period III||34
2375891|NCT01490125|5830948|P2|COMPLETED|Period III||32
2375892|NCT01490125|5830949|P1|COMPLETED|Period III||31
2375893|NCT01490125|5830944|P6|STARTED|Period III||35
2375894|NCT01490125|5830945|P5|STARTED|Period III||32
2375895|NCT01490125|5830946|P4|STARTED|Period III||30
2375896|NCT01490125|5830947|P3|STARTED|Period III||34
2375897|NCT01490125|5830948|P2|STARTED|Period III||33
2375898|NCT01490125|5830949|P1|STARTED|Period III||34
2375899|NCT01490125|5830944|P6|NOT COMPLETED|Period II||2
2375900|NCT01490125|5830945|P5|NOT COMPLETED|Period II||4
2375901|NCT01490125|5830946|P4|NOT COMPLETED|Period II||3
2375902|NCT01490125|5830947|P3|NOT COMPLETED|Period II||3
2375903|NCT01490125|5830948|P2|NOT COMPLETED|Period II||4
2375904|NCT01490125|5830949|P1|NOT COMPLETED|Period II||3
2375905|NCT01490125|5830944|P6|COMPLETED|Period II||35
2375906|NCT01490125|5830945|P5|COMPLETED|Period II||32
2375907|NCT01490125|5830946|P4|COMPLETED|Period II||30
2375908|NCT01490125|5830947|P3|COMPLETED|Period II||34
2375909|NCT01490125|5830948|P2|COMPLETED|Period II||33
2375910|NCT01490125|5830949|P1|COMPLETED|Period II||34
2375911|NCT01490125|5830944|P6|STARTED|Period II||37
2375912|NCT01490125|5830945|P5|STARTED|Period II||36
2375913|NCT01490125|5830946|P4|STARTED|Period II||33
2375914|NCT01490125|5830947|P3|STARTED|Period II||37
2375915|NCT01490125|5830948|P2|STARTED|Period II||37
2375916|NCT01490125|5830949|P1|STARTED|Period II||37
2375917|NCT01490125|5830944|P6|NOT COMPLETED|Period I||5
2375918|NCT01490125|5830945|P5|NOT COMPLETED|Period I||4
2375919|NCT01490125|5830946|P4|NOT COMPLETED|Period I||5
2375920|NCT01490125|5830947|P3|NOT COMPLETED|Period I||4
2375921|NCT01490125|5830948|P2|NOT COMPLETED|Period I||5
2375922|NCT01490125|5830949|P1|NOT COMPLETED|Period I||6
2375923|NCT01490125|5830944|P6|COMPLETED|Period I||37
2375924|NCT01490125|5830945|P5|COMPLETED|Period I||36
2375925|NCT01490125|5830946|P4|COMPLETED|Period I||33
2375926|NCT01490125|5830947|P3|COMPLETED|Period I||37
2375927|NCT01490125|5830948|P2|COMPLETED|Period I||37
2375928|NCT01490125|5830949|P1|COMPLETED|Period I||37
2375929|NCT01490125|5830944|P6|STARTED|Period I||42
2375930|NCT01490125|5830945|P5|STARTED|Period I||40
2375931|NCT01490125|5830946|P4|STARTED|Period I||38
2375932|NCT01490125|5830947|P3|STARTED|Period I||41
2375933|NCT01490125|5830948|P2|STARTED|Period I||42
2375934|NCT01490125|5830949|P1|STARTED|Period I||43
2375935|NCT01490086|5830977|P5|NOT COMPLETED|Overall Study||11
2375936|NCT01490086|5830978|P4|NOT COMPLETED|Overall Study||7
2375937|NCT01490086|5830979|P3|NOT COMPLETED|Overall Study||7
2375938|NCT01490086|5830980|P2|NOT COMPLETED|Overall Study||15
2375939|NCT01490086|5830981|P1|NOT COMPLETED|Overall Study||8
2375940|NCT01490086|5830977|P5|COMPLETED|Overall Study||28
2375941|NCT01490086|5830978|P4|COMPLETED|Overall Study||13
2375942|NCT01490086|5830979|P3|COMPLETED|Overall Study||51
2375943|NCT01490086|5830980|P2|COMPLETED|Overall Study||44
2375944|NCT01490086|5830981|P1|COMPLETED|Overall Study||50
2375945|NCT01490086|5830977|P5|STARTED|Overall Study||39
2375946|NCT01490086|5830978|P4|STARTED|Overall Study||20
2375947|NCT01490086|5830979|P3|STARTED|Overall Study||58
2375948|NCT01490086|5830980|P2|STARTED|Overall Study||59
2375949|NCT01490086|5830981|P1|STARTED|Overall Study||58
2375950|NCT01490073|5831015|P2|NOT COMPLETED|Overall Study||0
2375951|NCT01490073|5831016|P1|NOT COMPLETED|Overall Study||0
2375952|NCT01490073|5831015|P2|COMPLETED|Overall Study||12
2375953|NCT01490073|5831016|P1|COMPLETED|Overall Study||12
2375954|NCT01490073|5831015|P2|STARTED|Overall Study||12
2375955|NCT01490073|5831016|P1|STARTED|Overall Study||12
2375956|NCT01490060|5831026|P4|NOT COMPLETED|Cycle 2||0
2375957|NCT01490060|5831027|P3|NOT COMPLETED|Cycle 2||1
2375958|NCT01490060|5831028|P2|NOT COMPLETED|Cycle 2||1
2375959|NCT01490060|5831029|P1|NOT COMPLETED|Cycle 2||2
2375960|NCT01490060|5831026|P4|COMPLETED|Cycle 2||8
2375961|NCT01490060|5831027|P3|COMPLETED|Cycle 2||8
2375962|NCT01490060|5831028|P2|COMPLETED|Cycle 2||11
2375963|NCT01490060|5831029|P1|COMPLETED|Cycle 2||9
2375964|NCT01490060|5831026|P4|STARTED|Cycle 2||8
2375965|NCT01490060|5831027|P3|STARTED|Cycle 2||9
2375966|NCT01490060|5831028|P2|STARTED|Cycle 2||12
2375967|NCT01490060|5831029|P1|STARTED|Cycle 2||11
2375968|NCT01490060|5831026|P4|NOT COMPLETED|Cycle 1||3
2375969|NCT01490060|5831027|P3|NOT COMPLETED|Cycle 1||3
2375970|NCT01490060|5831028|P2|NOT COMPLETED|Cycle 1||1
2375971|NCT01490060|5831029|P1|NOT COMPLETED|Cycle 1||0
2375972|NCT01490060|5831026|P4|COMPLETED|Cycle 1||8
2375973|NCT01490060|5831027|P3|COMPLETED|Cycle 1||9
2375974|NCT01490060|5831028|P2|COMPLETED|Cycle 1||12
2375975|NCT01490060|5831029|P1|COMPLETED|Cycle 1||11
2375976|NCT01490060|5831026|P4|STARTED|Cycle 1||11
2375977|NCT01490060|5831027|P3|STARTED|Cycle 1||12
2375978|NCT01490060|5831028|P2|STARTED|Cycle 1||13
2375979|NCT01490060|5831029|P1|STARTED|Cycle 1||11
2375980|NCT01489969|5831040|P3|NOT COMPLETED|Overall Study||1
2375981|NCT01489969|5831041|P2|NOT COMPLETED|Overall Study||4
2375982|NCT01489969|5831042|P1|NOT COMPLETED|Overall Study||5
2375983|NCT01489969|5831040|P3|COMPLETED|Overall Study||44
2375984|NCT01489969|5831041|P2|COMPLETED|Overall Study||43
2375985|NCT01489969|5831042|P1|COMPLETED|Overall Study||40
2375986|NCT01489969|5831040|P3|STARTED|Overall Study||45
2375987|NCT01489969|5831041|P2|STARTED|Overall Study||47
2375988|NCT01489969|5831042|P1|STARTED|Overall Study||45
2375989|NCT01489956|5831058|P3|NOT COMPLETED|Overall Study||1
2375990|NCT01489956|5831059|P2|NOT COMPLETED|Overall Study||0
2375991|NCT01489956|5831060|P1|NOT COMPLETED|Overall Study||1
2375992|NCT01489956|5831058|P3|COMPLETED|Overall Study||5
2375993|NCT01489956|5831059|P2|COMPLETED|Overall Study||0
2375994|NCT01489956|5831060|P1|COMPLETED|Overall Study||12
2375995|NCT01489956|5831058|P3|STARTED|Overall Study|These 6 subjects had Immucothel alone since Montanide was not needed for the 10 participants dosed.|6
2375996|NCT01489956|5831059|P2|STARTED|Overall Study|Nine of the 10 participants receiving Immucothel alone had a response, so Montanide was not used.|0
2375997|NCT01489956|5831060|P1|STARTED|Overall Study|Ten of the 13 participants were considered evaluable.|13
2375998|NCT01489891|5831097|P2|NOT COMPLETED|Overall Study||0
2375999|NCT01489891|5831098|P1|NOT COMPLETED|Overall Study||1
2376000|NCT01489891|5831097|P2|COMPLETED|Overall Study||60
2376001|NCT01489891|5831098|P1|COMPLETED|Overall Study||59
2376002|NCT01489891|5831097|P2|STARTED|Overall Study||60
2376003|NCT01489891|5831098|P1|STARTED|Overall Study||60
2376004|NCT01489826|5831119|P9|NOT COMPLETED|Overall Study||0
2376005|NCT01489826|5831120|P8|NOT COMPLETED|Overall Study||0
2376006|NCT01489826|5831121|P7|NOT COMPLETED|Overall Study||0
2376007|NCT01489826|5831122|P6|NOT COMPLETED|Overall Study||0
2376008|NCT01489826|5831123|P5|NOT COMPLETED|Overall Study||0
2376009|NCT01489826|5831124|P4|NOT COMPLETED|Overall Study||0
2376010|NCT01489826|5831125|P3|NOT COMPLETED|Overall Study||0
2376011|NCT01489826|5831126|P2|NOT COMPLETED|Overall Study||0
2376012|NCT01489826|5831127|P1|NOT COMPLETED|Overall Study||0
2376013|NCT01489826|5831119|P9|COMPLETED|Overall Study||6
2376014|NCT01489826|5831120|P8|COMPLETED|Overall Study||3
2376015|NCT01489826|5831121|P7|COMPLETED|Overall Study||9
2376016|NCT01489826|5831122|P6|COMPLETED|Overall Study||3
2376017|NCT01489826|5831123|P5|COMPLETED|Overall Study||3
2376018|NCT01489826|5831124|P4|COMPLETED|Overall Study||7
2376019|NCT01489826|5831125|P3|COMPLETED|Overall Study||3
2376020|NCT01489826|5831126|P2|COMPLETED|Overall Study||3
2376021|NCT01489826|5831127|P1|COMPLETED|Overall Study||3
2376022|NCT01489826|5831119|P9|STARTED|Overall Study||6
2376023|NCT01489826|5831120|P8|STARTED|Overall Study||3
2376024|NCT01489826|5831121|P7|STARTED|Overall Study||9
2376025|NCT01489826|5831122|P6|STARTED|Overall Study||3
2376026|NCT01489826|5831123|P5|STARTED|Overall Study||3
2376027|NCT01489826|5831124|P4|STARTED|Overall Study||7
2376028|NCT01489826|5831125|P3|STARTED|Overall Study||3
2376029|NCT01489826|5831126|P2|STARTED|Overall Study||3
2376030|NCT01489826|5831127|P1|STARTED|Overall Study||3
2376031|NCT01489670|5831224|P1|NOT COMPLETED|Overall Study||53
2376032|NCT01489670|5831224|P1|COMPLETED|Overall Study||334
2376033|NCT01489670|5831224|P1|STARTED|Overall Study||387
2376034|NCT01489579|5831236|P2|NOT COMPLETED|Overall Study||7
2376035|NCT01489579|5831237|P1|NOT COMPLETED|Overall Study||9
2376036|NCT01489579|5831236|P2|COMPLETED|Overall Study||57
2376037|NCT01489579|5831237|P1|COMPLETED|Overall Study||47
2376038|NCT01489579|5831236|P2|STARTED|Overall Study||64
2376039|NCT01489579|5831237|P1|STARTED|Overall Study||56
2376040|NCT01489527|5831253|P2|NOT COMPLETED|Overall Study||26
2376041|NCT01489527|5831254|P1|NOT COMPLETED|Overall Study||22
2376042|NCT01489527|5831253|P2|COMPLETED|Overall Study||175
2376043|NCT01489527|5831254|P1|COMPLETED|Overall Study||183
2376044|NCT01489527|5831253|P2|STARTED|Overall Study||201
2376045|NCT01489527|5831254|P1|STARTED|Overall Study||205
2376046|NCT01489358|5831271|P3|NOT COMPLETED|Overall Study||2
2376047|NCT01489358|5831272|P2|NOT COMPLETED|Overall Study||0
2376048|NCT01489358|5831273|P1|NOT COMPLETED|Overall Study||0
2376049|NCT01489358|5831271|P3|COMPLETED|Overall Study||8
2376050|NCT01489358|5831272|P2|COMPLETED|Overall Study||10
2376051|NCT01489358|5831273|P1|COMPLETED|Overall Study||5
2376052|NCT01489358|5831271|P3|STARTED|Overall Study||10
2376053|NCT01489358|5831272|P2|STARTED|Overall Study||10
2376054|NCT01489358|5831273|P1|STARTED|Overall Study||5
2376055|NCT01489254|5831323|P4|NOT COMPLETED|Open-label Extension Part||58
2376056|NCT01489254|5831324|P3|NOT COMPLETED|Open-label Extension Part||0
2376057|NCT01489254|5831325|P2|NOT COMPLETED|Open-label Extension Part||0
2376058|NCT01489254|5831326|P1|NOT COMPLETED|Open-label Extension Part||0
2376059|NCT01489254|5831323|P4|COMPLETED|Open-label Extension Part||670
2376060|NCT01489254|5831324|P3|COMPLETED|Open-label Extension Part||0
2376061|NCT01489254|5831325|P2|COMPLETED|Open-label Extension Part||0
2376062|NCT01489254|5831326|P1|COMPLETED|Open-label Extension Part||0
2376063|NCT01489254|5831323|P4|STARTED|Open-label Extension Part|735 completed the DB part, 729 were eligible to continue in the OL part, 1 opted not to continue|728
2376064|NCT01489254|5831324|P3|STARTED|Open-label Extension Part||0
2376065|NCT01489254|5831325|P2|STARTED|Open-label Extension Part||0
2376066|NCT01489254|5831326|P1|STARTED|Open-label Extension Part||0
2376067|NCT01489254|5831323|P4|NOT COMPLETED|Double-blind Part||0
2376068|NCT01489254|5831324|P3|NOT COMPLETED|Double-blind Part||3
2376069|NCT01489254|5831325|P2|NOT COMPLETED|Double-blind Part||33
2376070|NCT01489254|5831326|P1|NOT COMPLETED|Double-blind Part||25
2376071|NCT01489254|5831323|P4|COMPLETED|Double-blind Part||0
2376072|NCT01489254|5831324|P3|COMPLETED|Double-blind Part||81
2376073|NCT01489254|5831325|P2|COMPLETED|Double-blind Part||324
2376074|NCT01489254|5831326|P1|COMPLETED|Double-blind Part||330
2376075|NCT01489254|5831323|P4|STARTED|Double-blind Part||0
2376076|NCT01489254|5831324|P3|STARTED|Double-blind Part||84
2376077|NCT01489254|5831325|P2|STARTED|Double-blind Part||357
2376078|NCT01489254|5831326|P1|STARTED|Double-blind Part||355
2376079|NCT01489189|5831337|P2|NOT COMPLETED|Overall Study||35
2376080|NCT01489189|5831338|P1|NOT COMPLETED|Overall Study||31
2376081|NCT01489189|5831337|P2|COMPLETED|Overall Study|Number of Eyes|168
2376082|NCT01489189|5831338|P1|COMPLETED|Overall Study|Number of Eyes|160
2376083|NCT01489189|5831337|P2|STARTED|Overall Study|Number of Eyes|203
2376084|NCT01489189|5831338|P1|STARTED|Overall Study|Number of Eyes|191
2376085|NCT01489111|5831363|P1|NOT COMPLETED|Overall Study||1
2376086|NCT01489111|5831363|P1|COMPLETED|Overall Study||35
2376087|NCT01489111|5831363|P1|STARTED|Overall Study||36
2376088|NCT01489020|5831384|P6|NOT COMPLETED|Overall Study||0
2376089|NCT01489020|5831385|P5|NOT COMPLETED|Overall Study||6
2376090|NCT01489020|5831386|P4|NOT COMPLETED|Overall Study||0
2376091|NCT01489020|5831387|P3|NOT COMPLETED|Overall Study||3
2376092|NCT01489020|5831388|P2|NOT COMPLETED|Overall Study||0
2376093|NCT01489020|5831389|P1|NOT COMPLETED|Overall Study||1
2376094|NCT01489020|5831384|P6|COMPLETED|Overall Study||4
2376095|NCT01489020|5831385|P5|COMPLETED|Overall Study||6
2376096|NCT01489020|5831386|P4|COMPLETED|Overall Study||4
2376097|NCT01489020|5831387|P3|COMPLETED|Overall Study||9
2376098|NCT01489020|5831388|P2|COMPLETED|Overall Study||4
2376099|NCT01489020|5831389|P1|COMPLETED|Overall Study||11
2376100|NCT01489020|5831384|P6|STARTED|Overall Study||4
2376101|NCT01489020|5831385|P5|STARTED|Overall Study||12
2376102|NCT01489020|5831386|P4|STARTED|Overall Study||4
2376103|NCT01489020|5831387|P3|STARTED|Overall Study||12
2376104|NCT01489020|5831388|P2|STARTED|Overall Study||4
2376105|NCT01489020|5831389|P1|STARTED|Overall Study||12
2376106|NCT01488994|5831423|P2|NOT COMPLETED|Overall Study||1
2376107|NCT01488994|5831424|P1|NOT COMPLETED|Overall Study||0
2376108|NCT01488994|5831423|P2|COMPLETED|Overall Study||11
2376109|NCT01488994|5831424|P1|COMPLETED|Overall Study||11
2376110|NCT01488994|5831423|P2|STARTED|Overall Study||12
2376111|NCT01488994|5831424|P1|STARTED|Overall Study||11
2376112|NCT01488890|5831515|P4|NOT COMPLETED|Overall Study||5
2376113|NCT01488890|5831516|P3|NOT COMPLETED|Overall Study||35
2376114|NCT01488890|5831517|P2|NOT COMPLETED|Overall Study||20
2376115|NCT01488890|5831518|P1|NOT COMPLETED|Overall Study||32
2376116|NCT01488890|5831515|P4|COMPLETED|Overall Study||25
2376117|NCT01488890|5831516|P3|COMPLETED|Overall Study||85
2376118|NCT01488890|5831517|P2|COMPLETED|Overall Study||100
2376119|NCT01488890|5831518|P1|COMPLETED|Overall Study||88
2376120|NCT01488890|5831515|P4|Treated|Overall Study||30
2376121|NCT01488890|5831516|P3|Treated|Overall Study||119
2376122|NCT01488890|5831517|P2|Treated|Overall Study||120
2376123|NCT01488890|5831518|P1|Treated|Overall Study||120
2376124|NCT01488890|5831515|P4|STARTED|Overall Study||30
2376125|NCT01488890|5831516|P3|STARTED|Overall Study||120
2376126|NCT01488890|5831517|P2|STARTED|Overall Study||120
2376127|NCT01488890|5831518|P1|STARTED|Overall Study||120
2376128|NCT01488877|5831556|P3|NOT COMPLETED|Re-randomization||0
2376129|NCT01488877|5831557|P2|NOT COMPLETED|Re-randomization||0
2376130|NCT01488877|5831558|P1|NOT COMPLETED|Re-randomization||0
2376131|NCT01488877|5831556|P3|COMPLETED|Re-randomization||3
2376132|NCT01488877|5831557|P2|COMPLETED|Re-randomization||0
2376133|NCT01488877|5831558|P1|COMPLETED|Re-randomization||0
2376134|NCT01488877|5831556|P3|STARTED|Re-randomization|Three participants were re-randomized from PF-03882845 3 mg arm.|3
2376135|NCT01488877|5831557|P2|STARTED|Re-randomization||0
2376136|NCT01488877|5831558|P1|STARTED|Re-randomization||0
2376137|NCT01488877|5831556|P3|NOT COMPLETED|Initial Randomization||0
2376138|NCT01488877|5831557|P2|NOT COMPLETED|Initial Randomization||0
2376139|NCT01488877|5831558|P1|NOT COMPLETED|Initial Randomization||0
2376140|NCT01488877|5831556|P3|COMPLETED|Initial Randomization||0
2376141|NCT01488877|5831557|P2|COMPLETED|Initial Randomization||5
2376142|NCT01488877|5831558|P1|COMPLETED|Initial Randomization||1
2376143|NCT01488877|5831556|P3|STARTED|Initial Randomization||0
2376144|NCT01488877|5831557|P2|STARTED|Initial Randomization||5
2376145|NCT01488877|5831558|P1|STARTED|Initial Randomization||1
2376146|NCT01488708|5831575|P2|NOT COMPLETED|Overall Study||578
2376147|NCT01488708|5831576|P1|NOT COMPLETED|Overall Study||940
2376148|NCT01488708|5831575|P2|COMPLETED|Overall Study||0
2376149|NCT01488708|5831576|P1|COMPLETED|Overall Study||0
2376150|NCT01488708|5831575|P2|Participated in Follow Up|Overall Study||526
2376151|NCT01488708|5831576|P1|Participated in Follow Up|Overall Study||810
2376152|NCT01488708|5831575|P2|Received at Least 1 Dose of Study Drug|Overall Study||578
2376153|NCT01488708|5831576|P1|Received at Least 1 Dose of Study Drug|Overall Study||937
2376154|NCT01488708|5831575|P2|STARTED|Overall Study||578
2376155|NCT01488708|5831576|P1|STARTED|Overall Study||940
2376156|NCT01488578|5831596|P1|NOT COMPLETED|Overall Study||1836
2376157|NCT01488578|5831596|P1|COMPLETED|Overall Study||9321
2376158|NCT01488578|5831596|P1|STARTED|Overall Study||11157
2376159|NCT01488487|5831630|P1|NOT COMPLETED|Overall Study||9
2376160|NCT01488487|5831630|P1|COMPLETED|Overall Study||15
2376161|NCT01488487|5831630|P1|Received Treatment|Overall Study||24
2376162|NCT01488487|5831630|P1|STARTED|Overall Study||24
2376163|NCT01488448|5831639|P2|NOT COMPLETED|Overall Study||17
2376164|NCT01488448|5831640|P1|NOT COMPLETED|Overall Study||20
2376165|NCT01488448|5831639|P2|COMPLETED|Overall Study||97
2376166|NCT01488448|5831640|P1|COMPLETED|Overall Study||93
2376167|NCT01488448|5831639|P2|STARTED|Overall Study||114
2376168|NCT01488448|5831640|P1|STARTED|Overall Study||113
2376169|NCT01488409|5831664|P2|NOT COMPLETED|Overall Study||4
2376170|NCT01488409|5831665|P1|NOT COMPLETED|Overall Study||4
2376171|NCT01488409|5831664|P2|COMPLETED|Overall Study||15
2376172|NCT01488409|5831665|P1|COMPLETED|Overall Study||16
2376173|NCT01488409|5831664|P2|STARTED|Overall Study||19
2376174|NCT01488409|5831665|P1|STARTED|Overall Study||20
2376175|NCT01488370|5831682|P3|NOT COMPLETED|Overall Study||1
2376176|NCT01488370|5831683|P2|NOT COMPLETED|Overall Study||1
2376177|NCT01488370|5831684|P1|NOT COMPLETED|Overall Study||0
2376178|NCT01488370|5831682|P3|COMPLETED|Overall Study||19
2376179|NCT01488370|5831683|P2|COMPLETED|Overall Study||22
2376180|NCT01488370|5831684|P1|COMPLETED|Overall Study||22
2376181|NCT01488370|5831682|P3|STARTED|Overall Study||20
2376182|NCT01488370|5831683|P2|STARTED|Overall Study||23
2376183|NCT01488370|5831684|P1|STARTED|Overall Study||22
2376184|NCT01488318|5831704|P1|NOT COMPLETED|Overall Study||0
2376185|NCT01488318|5831704|P1|COMPLETED|Overall Study||14
2376186|NCT01488318|5831704|P1|STARTED|Overall Study||14
2376187|NCT01488279|5831713|P2|NOT COMPLETED|Overall Study||0
2376188|NCT01488279|5831714|P1|NOT COMPLETED|Overall Study||0
2376189|NCT01488279|5831713|P2|COMPLETED|Overall Study||5
2376190|NCT01488279|5831714|P1|COMPLETED|Overall Study||5
2376191|NCT01488279|5831713|P2|STARTED|Overall Study||5
2376192|NCT01488279|5831714|P1|STARTED|Overall Study||5
2376193|NCT01488188|5831730|P2|NOT COMPLETED|Overall Study||0
2376194|NCT01488188|5831731|P1|NOT COMPLETED|Overall Study||0
2376195|NCT01488188|5831730|P2|COMPLETED|Overall Study||20
2376196|NCT01488188|5831731|P1|COMPLETED|Overall Study||20
2376197|NCT01488188|5831730|P2|STARTED|Overall Study||20
2376198|NCT01488188|5831731|P1|STARTED|Overall Study||20
2376199|NCT01488097|5831743|P1|NOT COMPLETED|Overall Study||1
2376200|NCT01488097|5831743|P1|COMPLETED|Overall Study||7
2376201|NCT01488097|5831743|P1|Received Study Drug in Extension Study|Overall Study||8
2376202|NCT01488097|5831743|P1|STARTED|Overall Study||8
2376203|NCT01488071|5831756|P2|NOT COMPLETED|Overall Study||63
2376204|NCT01488071|5831757|P1|NOT COMPLETED|Overall Study||53
2376205|NCT01488071|5831756|P2|COMPLETED|Overall Study||179
2376206|NCT01488071|5831757|P1|COMPLETED|Overall Study||200
2376207|NCT01488071|5831756|P2|STARTED|Overall Study|APTS|242
2376208|NCT01488071|5831757|P1|STARTED|Overall Study|all-patients-treated set (APTS)|253
2376209|NCT01488019|5831791|P2|NOT COMPLETED|Overall Study||304
2376210|NCT01488019|5831792|P1|NOT COMPLETED|Overall Study||247
2376211|NCT01488019|5831791|P2|COMPLETED|Overall Study||226
2376212|NCT01488019|5831792|P1|COMPLETED|Overall Study||294
2376213|NCT01488019|5831791|P2|STARTED|Overall Study||530
2376214|NCT01488019|5831792|P1|STARTED|Overall Study||541
2376215|NCT01487954|5831826|P2|NOT COMPLETED|Overall Study||0
2376216|NCT01487954|5831827|P1|NOT COMPLETED|Overall Study||0
2376217|NCT01487954|5831826|P2|COMPLETED|Overall Study||16
2376218|NCT01487954|5831827|P1|COMPLETED|Overall Study||29
2376219|NCT01487954|5831826|P2|Safety lead-in|Overall Study|Only the first 10 patients in the alkaline group were analyzed, as that was the experimental group.|0
2376220|NCT01487954|5831827|P1|Safety lead-in|Overall Study||10
2376221|NCT01487954|5831826|P2|STARTED|Overall Study||16
2376222|NCT01487954|5831827|P1|STARTED|Overall Study||29
2376223|NCT01487863|5831837|P2|NOT COMPLETED|Overall Study||19
2376224|NCT01487863|5831838|P1|NOT COMPLETED|Overall Study||19
2376225|NCT01487863|5831837|P2|COMPLETED|Overall Study||15
2376226|NCT01487863|5831838|P1|COMPLETED|Overall Study||16
2376227|NCT01487863|5831837|P2|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||34
2376228|NCT01487863|5831838|P1|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||35
2376229|NCT01487863|5831837|P2|Subjects Randomized (Efficacy Analysis)|Overall Study||34
2376230|NCT01487863|5831838|P1|Subjects Randomized (Efficacy Analysis)|Overall Study||35
2376231|NCT01487863|5831837|P2|STARTED|Overall Study||34
2376232|NCT01487863|5831838|P1|STARTED|Overall Study||35
2376233|NCT01487668|5831846|P2|NOT COMPLETED|Overall Study||17
2376234|NCT01487668|5831847|P1|NOT COMPLETED|Overall Study||25
2376235|NCT01487668|5831846|P2|COMPLETED|Overall Study||124
2376236|NCT01487668|5831847|P1|COMPLETED|Overall Study||121
2376237|NCT01487668|5831846|P2|STARTED|Overall Study||141
2376238|NCT01487668|5831847|P1|STARTED|Overall Study||146
2376239|NCT01487577|5831855|P1|NOT COMPLETED|Overall Study||1
2376240|NCT01487577|5831855|P1|COMPLETED|Overall Study|One participant became ineligible after signing consent, but before receiving protocol therapy.|18
2376241|NCT01487577|5831855|P1|STARTED|Overall Study||19
2376242|NCT01487525|5831869|P2|NOT COMPLETED|Overall Study||1
2376243|NCT01487525|5831870|P1|NOT COMPLETED|Overall Study||0
2376244|NCT01487525|5831869|P2|COMPLETED|Overall Study||19
2376245|NCT01487525|5831870|P1|COMPLETED|Overall Study||22
2376246|NCT01487525|5831869|P2|STARTED|Overall Study||20
2376247|NCT01487525|5831870|P1|STARTED|Overall Study||22
2376248|NCT01487499|5831880|P1|NOT COMPLETED|Overall Study||0
2376249|NCT01487499|5831880|P1|COMPLETED|Overall Study||4
2376250|NCT01487499|5831880|P1|STARTED|Overall Study||4
2376251|NCT01487265|5831886|P1|NOT COMPLETED|Overall Study||37
2376252|NCT01487265|5831886|P1|COMPLETED|Overall Study||0
2376253|NCT01487265|5831886|P1|STARTED|Overall Study||37
2376254|NCT01487200|5831898|P4|NOT COMPLETED|Overall Study||0
2376255|NCT01487200|5831899|P3|NOT COMPLETED|Overall Study||0
2376256|NCT01487200|5831900|P2|NOT COMPLETED|Overall Study||1
2376257|NCT01487200|5831901|P1|NOT COMPLETED|Overall Study||0
2376258|NCT01487200|5831898|P4|COMPLETED|Overall Study||5
2376259|NCT01487200|5831899|P3|COMPLETED|Overall Study||7
2376260|NCT01487200|5831900|P2|COMPLETED|Overall Study||6
2376261|NCT01487200|5831901|P1|COMPLETED|Overall Study||5
2376262|NCT01487200|5831898|P4|STARTED|Overall Study||5
2376263|NCT01487200|5831899|P3|STARTED|Overall Study||7
2376264|NCT01487200|5831900|P2|STARTED|Overall Study||7
2376265|NCT01487200|5831901|P1|STARTED|Overall Study||5
2376266|NCT01487161|5831931|P4|NOT COMPLETED|Overall Study||2
2376267|NCT01487161|5831932|P3|NOT COMPLETED|Overall Study||1
2376268|NCT01487161|5831933|P2|NOT COMPLETED|Overall Study||2
2376269|NCT01487161|5831934|P1|NOT COMPLETED|Overall Study||2
2376270|NCT01487161|5831931|P4|COMPLETED|Overall Study||50
2376271|NCT01487161|5831932|P3|COMPLETED|Overall Study||59
2376272|NCT01487161|5831933|P2|COMPLETED|Overall Study||57
2376273|NCT01487161|5831934|P1|COMPLETED|Overall Study||56
2376274|NCT01487161|5831931|P4|STARTED|Overall Study||52
2376275|NCT01487161|5831932|P3|STARTED|Overall Study||60
2376276|NCT01487161|5831933|P2|STARTED|Overall Study||59
2376277|NCT01487161|5831934|P1|STARTED|Overall Study||58
2376278|NCT01486966|5831999|P2|NOT COMPLETED|Overall Study||2
2376279|NCT01486966|5832000|P1|NOT COMPLETED|Overall Study||0
2376280|NCT01486966|5831999|P2|COMPLETED|Overall Study||27
2376281|NCT01486966|5832000|P1|COMPLETED|Overall Study||29
2376282|NCT01486966|5831999|P2|STARTED|Overall Study||29
2376283|NCT01486966|5832000|P1|STARTED|Overall Study||29
2376284|NCT01486927|5832024|P1|NOT COMPLETED|Overall Study||13
2376285|NCT01486927|5832024|P1|COMPLETED|Overall Study||161
2376286|NCT01486927|5832024|P1|STARTED|Overall Study||174
2376287|NCT01486810|5832055|P1|NOT COMPLETED|Overall Study||8
2376288|NCT01486810|5832055|P1|COMPLETED|Overall Study||9
2376289|NCT01486810|5832055|P1|STARTED|Overall Study||17
2376290|NCT01486758|5832062|P2|NOT COMPLETED|Overall Study||1
2376291|NCT01486758|5832063|P1|NOT COMPLETED|Overall Study||0
2376292|NCT01486758|5832062|P2|COMPLETED|Overall Study||19
2376293|NCT01486758|5832063|P1|COMPLETED|Overall Study||20
2376294|NCT01486758|5832062|P2|STARTED|Overall Study||20
2376295|NCT01486758|5832063|P1|STARTED|Overall Study||20
2376296|NCT01486615|5832087|P4|NOT COMPLETED|Overall Study||2
2376297|NCT01486615|5832088|P3|NOT COMPLETED|Overall Study||2
2376298|NCT01486615|5832089|P2|NOT COMPLETED|Overall Study||1
2376299|NCT01486615|5832090|P1|NOT COMPLETED|Overall Study||0
2376300|NCT01486615|5832087|P4|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
2376301|NCT01486615|5832088|P3|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
2376302|NCT01486615|5832089|P2|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|19
2376303|NCT01486615|5832090|P1|COMPLETED|Overall Study||20
2376304|NCT01486615|5832087|P4|STARTED|Overall Study||20
2376305|NCT01486615|5832088|P3|STARTED|Overall Study||20
2376306|NCT01486615|5832089|P2|STARTED|Overall Study||20
2376307|NCT01486615|5832090|P1|STARTED|Overall Study||20
2376308|NCT01486446|5832130|P2|NOT COMPLETED|Overall Study||0
2376309|NCT01486446|5832131|P1|NOT COMPLETED|Overall Study||1
2376310|NCT01486446|5832130|P2|COMPLETED|Overall Study||1
2376311|NCT01486446|5832131|P1|COMPLETED|Overall Study||6
2376312|NCT01486446|5832130|P2|STARTED|Overall Study||1
2376313|NCT01486446|5832131|P1|STARTED|Overall Study||7
2376314|NCT01486316|5832154|P4|NOT COMPLETED|Overall Study||2
2376315|NCT01486316|5832155|P3|NOT COMPLETED|Overall Study||5
2376316|NCT01486316|5832156|P2|NOT COMPLETED|Overall Study||3
2376317|NCT01486316|5832157|P1|NOT COMPLETED|Overall Study||4
2376318|NCT01486316|5832154|P4|COMPLETED|Overall Study||0
2376319|NCT01486316|5832155|P3|COMPLETED|Overall Study||0
2376320|NCT01486316|5832156|P2|COMPLETED|Overall Study||7
2376321|NCT01486316|5832157|P1|COMPLETED|Overall Study||3
2376322|NCT01486316|5832154|P4|STARTED|Overall Study|Exited prior to 6 month visit|2
2376323|NCT01486316|5832155|P3|STARTED|Overall Study|Exited prior to implant|5
2376324|NCT01486316|5832156|P2|STARTED|Overall Study|prior to study closure, 24 subjects were enrolled with 10 being randomized to HFRS Guided Arm|10
2376325|NCT01486316|5832157|P1|STARTED|Overall Study|prior to study closure, 24 subjects were enrolled 7 subjects randomized to Control Arm|7
2376326|NCT01486264|5832169|P2|NOT COMPLETED|Overall Study||47
2376327|NCT01486264|5832170|P1|NOT COMPLETED|Overall Study||29
2376328|NCT01486264|5832169|P2|COMPLETED|Overall Study||94
2376329|NCT01486264|5832170|P1|COMPLETED|Overall Study||113
2376330|NCT01486264|5832169|P2|Treated|Overall Study||140
2376331|NCT01486264|5832170|P1|Treated|Overall Study||142
2376332|NCT01486264|5832169|P2|STARTED|Overall Study||141
2376333|NCT01486264|5832170|P1|STARTED|Overall Study||142
2376334|NCT01486238|5832202|P2|NOT COMPLETED|Overall Study||6
2376335|NCT01486238|5832203|P1|NOT COMPLETED|Overall Study||2
2376336|NCT01486238|5832202|P2|COMPLETED|Overall Study||43
2376337|NCT01486238|5832203|P1|COMPLETED|Overall Study||21
2376338|NCT01486238|5832202|P2|STARTED|Overall Study||49
2376339|NCT01486238|5832203|P1|STARTED|Overall Study||23
2376340|NCT01486199|5832211|P2|NOT COMPLETED|Study Day at t= 2 Years||0
2376341|NCT01486199|5832212|P1|NOT COMPLETED|Study Day at t= 2 Years||0
2376342|NCT01486199|5832211|P2|COMPLETED|Study Day at t= 2 Years||0
2376343|NCT01486199|5832212|P1|COMPLETED|Study Day at t= 2 Years||9
2376344|NCT01486199|5832211|P2|STARTED|Study Day at t= 2 Years||0
2376345|NCT01486199|5832212|P1|STARTED|Study Day at t= 2 Years||9
2376346|NCT01486199|5832211|P2|NOT COMPLETED|Two Year Period Between Study Days||0
2376347|NCT01486199|5832212|P1|NOT COMPLETED|Two Year Period Between Study Days||1
2376348|NCT01486199|5832211|P2|COMPLETED|Two Year Period Between Study Days||0
2376349|NCT01486199|5832212|P1|COMPLETED|Two Year Period Between Study Days||9
2376350|NCT01486199|5832211|P2|STARTED|Two Year Period Between Study Days||0
2376351|NCT01486199|5832212|P1|STARTED|Two Year Period Between Study Days||10
2376352|NCT01486199|5832211|P2|NOT COMPLETED|Baseline Study Day||1
2376353|NCT01486199|5832212|P1|NOT COMPLETED|Baseline Study Day||0
2376354|NCT01486199|5832211|P2|COMPLETED|Baseline Study Day||9
2376355|NCT01486199|5832212|P1|COMPLETED|Baseline Study Day||10
2376356|NCT01486199|5832211|P2|STARTED|Baseline Study Day||10
2376357|NCT01486199|5832212|P1|STARTED|Baseline Study Day||10
2376358|NCT01486043|5832224|P1|NOT COMPLETED|Overall Study||2
2376359|NCT01486043|5832224|P1|COMPLETED|Overall Study|Study terminated due to insufficient recruitment|2
2376360|NCT01486043|5832224|P1|STARTED|Overall Study||4
2376361|NCT01485991|5832232|P2|NOT COMPLETED|Overall Study||36
2376362|NCT01485991|5832233|P1|NOT COMPLETED|Overall Study||32
2376363|NCT01485991|5832232|P2|COMPLETED|Overall Study||350
2376364|NCT01485991|5832233|P1|COMPLETED|Overall Study||353
2376365|NCT01485991|5832232|P2|Treated|Overall Study||384
2376366|NCT01485991|5832233|P1|Treated|Overall Study||379
2376367|NCT01485991|5832232|P2|STARTED|Overall Study||386
2376368|NCT01485991|5832233|P1|STARTED|Overall Study||385
2376369|NCT01485887|5832243|P1|NOT COMPLETED|Overall Study||12
2376370|NCT01485887|5832243|P1|COMPLETED|Overall Study||38
2376371|NCT01485887|5832243|P1|STARTED|Overall Study||50
2376372|NCT01485796|5832255|P1|NOT COMPLETED|Overall Trial (Incl. Safety Follow-up)||12
2376373|NCT01485796|5832255|P1|COMPLETED|Overall Trial (Incl. Safety Follow-up)|1 subject who completed Epoch 2 + 24 subjects who completed the safety follow-up|25
2376374|NCT01485796|5832255|P1|Completed Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||24
2376375|NCT01485796|5832255|P1|Switch to Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||26
2376376|NCT01485796|5832255|P1|Completed Epoch 2|Overall Trial (Incl. Safety Follow-up)||1
2376377|NCT01485796|5832255|P1|Treated in Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
2376378|NCT01485796|5832255|P1|Started Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
2376379|NCT01485796|5832255|P1|Completed Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||36
2376380|NCT01485796|5832255|P1|Treated in Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||37
2376381|NCT01485796|5832255|P1|STARTED|Overall Trial (Incl. Safety Follow-up)||37
2376382|NCT01485796|5832255|P1|NOT COMPLETED|Period 2: Epoch 2||35
2376383|NCT01485796|5832255|P1|COMPLETED|Period 2: Epoch 2||1
2376384|NCT01485796|5832255|P1|Treated in Epoch 2|Period 2: Epoch 2||36
2376385|NCT01485796|5832255|P1|STARTED|Period 2: Epoch 2||36
2376386|NCT01485796|5832255|P1|NOT COMPLETED|Period 1: Epoch 1 (Ramp-up)||1
2376387|NCT01485796|5832255|P1|COMPLETED|Period 1: Epoch 1 (Ramp-up)||36
2376388|NCT01485796|5832255|P1|Treated in Epoch 1|Period 1: Epoch 1 (Ramp-up)||37
2376389|NCT01485796|5832255|P1|STARTED|Period 1: Epoch 1 (Ramp-up)||37
2376390|NCT01485640|5832277|P1|NOT COMPLETED|Overall Study||122
2376391|NCT01485640|5832277|P1|COMPLETED|Overall Study||40
2376392|NCT01485640|5832277|P1|STARTED|Overall Study||162
2376393|NCT01485627|5832284|P2|NOT COMPLETED|Overall Study||57
2376394|NCT01485627|5832285|P1|NOT COMPLETED|Overall Study||66
2376395|NCT01485627|5832284|P2|COMPLETED|Overall Study|135 patients and 49 caregivers|184
2376396|NCT01485627|5832285|P1|COMPLETED|Overall Study|130 patients and 48 caregivers|178
2376397|NCT01485627|5832284|P2|Bereaved Caregivers: 7 Month Completed|Overall Study||49
2376398|NCT01485627|5832285|P1|Bereaved Caregivers: 7 Month Completed|Overall Study||48
2376399|NCT01485627|5832284|P2|Bereaved Caregivers: 2 Month Completed|Overall Study||52
2376400|NCT01485627|5832285|P1|Bereaved Caregivers: 2 Month Completed|Overall Study||49
2376401|NCT01485627|5832284|P2|Bereaved Caregivers: 1 Month|Overall Study||51
2376402|NCT01485627|5832285|P1|Bereaved Caregivers: 1 Month|Overall Study||51
2376403|NCT01485627|5832284|P2|Bereaved Caregivers: Total|Overall Study||64
2376404|NCT01485627|5832285|P1|Bereaved Caregivers: Total|Overall Study||63
2376405|NCT01485627|5832284|P2|Allocated Caregivers: Total|Overall Study||99
2376406|NCT01485627|5832285|P1|Allocated Caregivers: Total|Overall Study||105
2376407|NCT01485627|5832284|P2|STARTED|Overall Study|142 patients and 99 caregivers|241
2376408|NCT01485627|5832285|P1|STARTED|Overall Study|139 patients and 105 caregivers|244
2376409|NCT01485536|5832303|P1|NOT COMPLETED|Overall Study||4
2376410|NCT01485536|5832303|P1|COMPLETED|Overall Study||17
2376411|NCT01485536|5832303|P1|STARTED|Overall Study||21
2376412|NCT01485393|5832308|P2|NOT COMPLETED|Overall Study||0
2376413|NCT01485393|5832309|P1|NOT COMPLETED|Overall Study||0
2376414|NCT01485393|5832308|P2|COMPLETED|Overall Study||5
2376415|NCT01485393|5832309|P1|COMPLETED|Overall Study||5
2376416|NCT01485393|5832308|P2|STARTED|Overall Study||5
2376417|NCT01485393|5832309|P1|STARTED|Overall Study||5
2376418|NCT01485380|5832317|P1|NOT COMPLETED|Overall Study||3
2376419|NCT01485380|5832317|P1|COMPLETED|Overall Study||17
2376420|NCT01485380|5832317|P1|STARTED|Overall Study||20
2376421|NCT01485354|5832321|P1|NOT COMPLETED|Overall Study||5
2376422|NCT01485354|5832321|P1|COMPLETED|Overall Study||12
2376423|NCT01485354|5832321|P1|STARTED|Overall Study||17
2376424|NCT01485172|5832335|P6|NOT COMPLETED|Overall Study||4
2376425|NCT01485172|5832336|P5|NOT COMPLETED|Overall Study||5
2376426|NCT01485172|5832337|P4|NOT COMPLETED|Overall Study||8
2376427|NCT01485172|5832338|P3|NOT COMPLETED|Overall Study||7
2376428|NCT01485172|5832339|P2|NOT COMPLETED|Overall Study||1
2376429|NCT01485172|5832340|P1|NOT COMPLETED|Overall Study||7
2376430|NCT01485172|5832335|P6|COMPLETED|Overall Study||9
2376431|NCT01485172|5832336|P5|COMPLETED|Overall Study||34
2376432|NCT01485172|5832337|P4|COMPLETED|Overall Study||32
2376433|NCT01485172|5832338|P3|COMPLETED|Overall Study||34
2376434|NCT01485172|5832339|P2|COMPLETED|Overall Study||12
2376435|NCT01485172|5832340|P1|COMPLETED|Overall Study||33
2376436|NCT01485172|5832335|P6|STARTED|Overall Study||13
2376437|NCT01485172|5832336|P5|STARTED|Overall Study||39
2376438|NCT01485172|5832337|P4|STARTED|Overall Study||40
2376439|NCT01485172|5832338|P3|STARTED|Overall Study||41
2376440|NCT01485172|5832339|P2|STARTED|Overall Study||13
2376441|NCT01485172|5832340|P1|STARTED|Overall Study||40
2376442|NCT01485120|5832414|P1|NOT COMPLETED|Overall Study||2
2376443|NCT01485120|5832414|P1|COMPLETED|Overall Study||32
2376444|NCT01485120|5832414|P1|STARTED|Overall Study||34
2376445|NCT01485094|5832422|P3|NOT COMPLETED|Overall Study||1
2376446|NCT01485094|5832423|P2|NOT COMPLETED|Overall Study||2
2376447|NCT01485094|5832424|P1|NOT COMPLETED|Overall Study||3
2376448|NCT01485094|5832422|P3|COMPLETED|Overall Study||18
2376449|NCT01485094|5832423|P2|COMPLETED|Overall Study||18
2376450|NCT01485094|5832424|P1|COMPLETED|Overall Study||17
2376451|NCT01485094|5832422|P3|STARTED|Overall Study||19
2376452|NCT01485094|5832423|P2|STARTED|Overall Study||20
2376453|NCT01485094|5832424|P1|STARTED|Overall Study||20
2376454|NCT01485055|5832465|P1|NOT COMPLETED|Overall Study||0
2376455|NCT01485055|5832465|P1|COMPLETED|Overall Study||11
2376456|NCT01485055|5832465|P1|STARTED|Overall Study||11
2376457|NCT01484977|5832469|P1|NOT COMPLETED|Overall Study||27
2376458|NCT01484977|5832469|P1|COMPLETED|Overall Study||93
2376459|NCT01484977|5832469|P1|STARTED|Overall Study||120
2376460|NCT01484951|5832473|P1|NOT COMPLETED|Overall Study||5
2376461|NCT01484951|5832473|P1|COMPLETED|Overall Study||69
2376462|NCT01484951|5832473|P1|STARTED|Overall Study||74
2376463|NCT01484938|5832478|P1|NOT COMPLETED|Overall Study||4
2376464|NCT01484938|5832478|P1|COMPLETED|Overall Study||171
2376465|NCT01484938|5832478|P1|STARTED|Overall Study||175
2376466|NCT01484912|5832485|P2|NOT COMPLETED|Overall Study||1
2376467|NCT01484912|5832486|P1|NOT COMPLETED|Overall Study||1
2376468|NCT01484912|5832485|P2|COMPLETED|Overall Study||39
2376469|NCT01484912|5832486|P1|COMPLETED|Overall Study||38
2376470|NCT01484912|5832485|P2|STARTED|Overall Study||40
2376471|NCT01484912|5832486|P1|STARTED|Overall Study||39
2376472|NCT01484873|5832496|P1|NOT COMPLETED|Overall Study||2
2376473|NCT01484873|5832496|P1|COMPLETED|Overall Study||8
2376474|NCT01484873|5832496|P1|STARTED|Overall Study||10
2376475|NCT01484834|5832508|P4|NOT COMPLETED|Overall Study||4
2376476|NCT01484834|5832509|P3|NOT COMPLETED|Overall Study||1
2376477|NCT01484834|5832510|P2|NOT COMPLETED|Overall Study||8
2376478|NCT01484834|5832511|P1|NOT COMPLETED|Overall Study||5
2376479|NCT01484834|5832508|P4|COMPLETED|Overall Study||20
2376480|NCT01484834|5832509|P3|COMPLETED|Overall Study||38
2376481|NCT01484834|5832510|P2|COMPLETED|Overall Study||54
2376482|NCT01484834|5832511|P1|COMPLETED|Overall Study||60
2376483|NCT01484834|5832508|P4|STARTED|Overall Study||24
2376484|NCT01484834|5832509|P3|STARTED|Overall Study||39
2376485|NCT01484834|5832510|P2|STARTED|Overall Study||62
2376486|NCT01484834|5832511|P1|STARTED|Overall Study||65
2376487|NCT01484652|5832539|P2|NOT COMPLETED|Overall Study||21
2376488|NCT01484652|5832540|P1|NOT COMPLETED|Overall Study||15
2376489|NCT01484652|5832539|P2|COMPLETED|Overall Study||142
2376490|NCT01484652|5832540|P1|COMPLETED|Overall Study||151
2376491|NCT01484652|5832539|P2|STARTED|Overall Study||163
2376492|NCT01484652|5832540|P1|STARTED|Overall Study||166
2376493|NCT01484626|5832546|P1|NOT COMPLETED|Overall Study||0
2376494|NCT01484626|5832546|P1|COMPLETED|Overall Study||3
2376495|NCT01484626|5832546|P1|STARTED|Overall Study||3
2376496|NCT01484561|5832552|P2|NOT COMPLETED|Overall Study||6
2376497|NCT01484561|5832553|P1|NOT COMPLETED|Overall Study||9
2376498|NCT01484561|5832552|P2|COMPLETED|Overall Study||45
2376499|NCT01484561|5832553|P1|COMPLETED|Overall Study||88
2376500|NCT01484561|5832552|P2|STARTED|Overall Study||51
2376501|NCT01484561|5832553|P1|STARTED|Overall Study||97
2376502|NCT01484496|5832643|P4|NOT COMPLETED|Period 2||22
2376503|NCT01484496|5832644|P3|NOT COMPLETED|Period 2||15
2376504|NCT01484496|5832645|P2|NOT COMPLETED|Period 2||0
2376505|NCT01484496|5832646|P1|NOT COMPLETED|Period 2||0
2376506|NCT01484496|5832643|P4|COMPLETED|Period 2||434
2376507|NCT01484496|5832644|P3|COMPLETED|Period 2||191
2376508|NCT01484496|5832645|P2|COMPLETED|Period 2||0
2376509|NCT01484496|5832646|P1|COMPLETED|Period 2||0
2376510|NCT01484496|5832643|P4|STARTED|Period 2||456
2376511|NCT01484496|5832644|P3|STARTED|Period 2||206
2376512|NCT01484496|5832645|P2|STARTED|Period 2||0
2376513|NCT01484496|5832646|P1|STARTED|Period 2||0
2376514|NCT01484496|5832643|P4|NOT COMPLETED|Period 1||0
2376515|NCT01484496|5832644|P3|NOT COMPLETED|Period 1||0
2376516|NCT01484496|5832645|P2|NOT COMPLETED|Period 1||93
2376517|NCT01484496|5832646|P1|NOT COMPLETED|Period 1||66
2376518|NCT01484496|5832643|P4|COMPLETED|Period 1||0
2376519|NCT01484496|5832644|P3|COMPLETED|Period 1||0
2376520|NCT01484496|5832645|P2|COMPLETED|Period 1||463
2376521|NCT01484496|5832646|P1|COMPLETED|Period 1||214
2376522|NCT01484496|5832643|P4|STARTED|Period 1||0
2376523|NCT01484496|5832644|P3|STARTED|Period 1||0
2376524|NCT01484496|5832645|P2|STARTED|Period 1||556
2376525|NCT01484496|5832646|P1|STARTED|Period 1||280
2376526|NCT01484431|5832661|P3|NOT COMPLETED|Period 2||2
2376527|NCT01484431|5832662|P2|NOT COMPLETED|Period 2||1
2376528|NCT01484431|5832663|P1|NOT COMPLETED|Period 2||1
2376529|NCT01484431|5832661|P3|COMPLETED|Period 2||4
2376530|NCT01484431|5832662|P2|COMPLETED|Period 2||5
2376531|NCT01484431|5832663|P1|COMPLETED|Period 2||5
2376532|NCT01484431|5832661|P3|Received 40 mg|Period 2||1
2376533|NCT01484431|5832662|P2|Received 40 mg|Period 2||0
2376534|NCT01484431|5832663|P1|Received 40 mg|Period 2||0
2376535|NCT01484431|5832661|P3|Received 20 mg|Period 2||4
2376536|NCT01484431|5832662|P2|Received 20 mg|Period 2||1
2376537|NCT01484431|5832663|P1|Received 20 mg|Period 2||3
2376538|NCT01484431|5832661|P3|Received 15 mg|Period 2||1
2376539|NCT01484431|5832662|P2|Received 15 mg|Period 2||2
2376540|NCT01484431|5832663|P1|Received 15 mg|Period 2||1
2376541|NCT01484431|5832661|P3|Received 10 mg|Period 2||0
2376542|NCT01484431|5832662|P2|Received 10 mg|Period 2||1
2376543|NCT01484431|5832663|P1|Received 10 mg|Period 2||0
2376544|NCT01484431|5832661|P3|Received 8 mg|Period 2||0
2376545|NCT01484431|5832662|P2|Received 8 mg|Period 2||0
2376546|NCT01484431|5832663|P1|Received 8 mg|Period 2||1
2376547|NCT01484431|5832661|P3|Received 7.5 mg|Period 2||0
2376548|NCT01484431|5832662|P2|Received 7.5 mg|Period 2||2
2376549|NCT01484431|5832663|P1|Received 7.5 mg|Period 2||0
2376550|NCT01484431|5832661|P3|Received 7 mg|Period 2||0
2376551|NCT01484431|5832662|P2|Received 7 mg|Period 2||0
2376552|NCT01484431|5832663|P1|Received 7 mg|Period 2||1
2376553|NCT01484431|5832661|P3|STARTED|Period 2||6
2376554|NCT01484431|5832662|P2|STARTED|Period 2||6
2376555|NCT01484431|5832663|P1|STARTED|Period 2||6
2376556|NCT01484431|5832661|P3|NOT COMPLETED|Period 1: High Dose||0
2376557|NCT01484431|5832662|P2|NOT COMPLETED|Period 1: High Dose||1
2376558|NCT01484431|5832663|P1|NOT COMPLETED|Period 1: High Dose||0
2376559|NCT01484431|5832661|P3|COMPLETED|Period 1: High Dose||6
2376560|NCT01484431|5832662|P2|COMPLETED|Period 1: High Dose||6
2376561|NCT01484431|5832663|P1|COMPLETED|Period 1: High Dose||6
2376562|NCT01484431|5832661|P3|Received 40 mg|Period 1: High Dose||5
2376563|NCT01484431|5832662|P2|Received 40 mg|Period 1: High Dose||0
2376564|NCT01484431|5832663|P1|Received 40 mg|Period 1: High Dose||0
2376565|NCT01484431|5832661|P3|Received 20 mg|Period 1: High Dose||1
2376566|NCT01484431|5832662|P2|Received 20 mg|Period 1: High Dose||5
2376567|NCT01484431|5832663|P1|Received 20 mg|Period 1: High Dose||3
2376568|NCT01484431|5832661|P3|Received 15 mg|Period 1: High Dose||0
2376569|NCT01484431|5832662|P2|Received 15 mg|Period 1: High Dose||1
2376570|NCT01484431|5832663|P1|Received 15 mg|Period 1: High Dose||1
2376571|NCT01484431|5832661|P3|Received 10 mg|Period 1: High Dose||0
2376572|NCT01484431|5832662|P2|Received 10 mg|Period 1: High Dose||1
2376573|NCT01484431|5832663|P1|Received 10 mg|Period 1: High Dose||1
2376574|NCT01484431|5832661|P3|Received 8 mg|Period 1: High Dose||0
2376575|NCT01484431|5832662|P2|Received 8 mg|Period 1: High Dose||0
2376576|NCT01484431|5832663|P1|Received 8 mg|Period 1: High Dose||1
2376577|NCT01484431|5832661|P3|STARTED|Period 1: High Dose||6
2376578|NCT01484431|5832662|P2|STARTED|Period 1: High Dose||7
2376579|NCT01484431|5832663|P1|STARTED|Period 1: High Dose||6
2376580|NCT01484431|5832661|P3|NOT COMPLETED|Period 1: Low Dose||0
2376581|NCT01484431|5832662|P2|NOT COMPLETED|Period 1: Low Dose||0
2376582|NCT01484431|5832663|P1|NOT COMPLETED|Period 1: Low Dose||0
2376583|NCT01484431|5832661|P3|COMPLETED|Period 1: Low Dose||6
2376584|NCT01484431|5832662|P2|COMPLETED|Period 1: Low Dose||7
2376585|NCT01484431|5832663|P1|COMPLETED|Period 1: Low Dose||6
2376586|NCT01484431|5832661|P3|Received 10 mg|Period 1: Low Dose||6
2376587|NCT01484431|5832662|P2|Received 10 mg|Period 1: Low Dose||0
2376588|NCT01484431|5832663|P1|Received 10 mg|Period 1: Low Dose||0
2376589|NCT01484431|5832661|P3|Received 5 mg|Period 1: Low Dose||0
2376590|NCT01484431|5832662|P2|Received 5 mg|Period 1: Low Dose||7
2376591|NCT01484431|5832663|P1|Received 5 mg|Period 1: Low Dose||0
2376592|NCT01484431|5832661|P3|Received 4 mg|Period 1: Low Dose||0
2376593|NCT01484431|5832662|P2|Received 4 mg|Period 1: Low Dose||0
2376594|NCT01484431|5832663|P1|Received 4 mg|Period 1: Low Dose||5
2376595|NCT01484431|5832661|P3|Received 2 mg|Period 1: Low Dose||0
2376596|NCT01484431|5832662|P2|Received 2 mg|Period 1: Low Dose||0
2376597|NCT01484431|5832663|P1|Received 2 mg|Period 1: Low Dose||1
2376598|NCT01484431|5832661|P3|STARTED|Period 1: Low Dose||6
2376599|NCT01484431|5832662|P2|STARTED|Period 1: Low Dose||7
2376600|NCT01484431|5832663|P1|STARTED|Period 1: Low Dose||6
2376601|NCT01484340|5832680|P2|NOT COMPLETED|Overall Study||0
2376602|NCT01484340|5832681|P1|NOT COMPLETED|Overall Study||0
2376603|NCT01484340|5832680|P2|COMPLETED|Overall Study||279
2376604|NCT01484340|5832681|P1|COMPLETED|Overall Study||281
2376605|NCT01484340|5832680|P2|STARTED|Overall Study||279
2376606|NCT01484340|5832681|P1|STARTED|Overall Study||281
2376607|NCT01484314|5832693|P1|NOT COMPLETED|Overall Study||0
2376608|NCT01484314|5832693|P1|COMPLETED|Overall Study||1
2376609|NCT01484314|5832693|P1|STARTED|Overall Study||1
2376610|NCT01484275|5832701|P2|NOT COMPLETED|Overall Study||42
2376611|NCT01484275|5832702|P1|NOT COMPLETED|Overall Study||43
2376612|NCT01484275|5832701|P2|COMPLETED|Overall Study||0
2376613|NCT01484275|5832702|P1|COMPLETED|Overall Study||0
2376614|NCT01484275|5832701|P2|STARTED|Overall Study||42
2376615|NCT01484275|5832702|P1|STARTED|Overall Study||43
2376616|NCT01484197|5832724|P4|NOT COMPLETED|Treatment Period 4||0
2376617|NCT01484197|5832725|P3|NOT COMPLETED|Treatment Period 4||0
2376618|NCT01484197|5832726|P2|NOT COMPLETED|Treatment Period 4||0
2376619|NCT01484197|5832727|P1|NOT COMPLETED|Treatment Period 4||0
2376620|NCT01484197|5832724|P4|COMPLETED|Treatment Period 4||6
2376621|NCT01484197|5832725|P3|COMPLETED|Treatment Period 4||9
2376622|NCT01484197|5832726|P2|COMPLETED|Treatment Period 4||8
2376623|NCT01484197|5832727|P1|COMPLETED|Treatment Period 4||7
2376624|NCT01484197|5832724|P4|STARTED|Treatment Period 4|2 patients completed Period 3 but did not enter Period 4 due to a Protocol deviation and an AE.|6
2376625|NCT01484197|5832725|P3|STARTED|Treatment Period 4||9
2376626|NCT01484197|5832726|P2|STARTED|Treatment Period 4||8
2376627|NCT01484197|5832727|P1|STARTED|Treatment Period 4||7
2376628|NCT01484197|5832724|P4|NOT COMPLETED|Treatment Period 3||0
2376629|NCT01484197|5832725|P3|NOT COMPLETED|Treatment Period 3||0
2376630|NCT01484197|5832726|P2|NOT COMPLETED|Treatment Period 3||0
2376631|NCT01484197|5832727|P1|NOT COMPLETED|Treatment Period 3||0
2376632|NCT01484197|5832724|P4|COMPLETED|Treatment Period 3||8
2376633|NCT01484197|5832725|P3|COMPLETED|Treatment Period 3||9
2376634|NCT01484197|5832726|P2|COMPLETED|Treatment Period 3||8
2376635|NCT01484197|5832727|P1|COMPLETED|Treatment Period 3||7
2376636|NCT01484197|5832724|P4|STARTED|Treatment Period 3||8
2376637|NCT01484197|5832725|P3|STARTED|Treatment Period 3||9
2376638|NCT01484197|5832726|P2|STARTED|Treatment Period 3||8
2376639|NCT01484197|5832727|P1|STARTED|Treatment Period 3||7
2376640|NCT01484197|5832724|P4|NOT COMPLETED|Treatment Period 2||1
2376641|NCT01484197|5832725|P3|NOT COMPLETED|Treatment Period 2||0
2376642|NCT01484197|5832726|P2|NOT COMPLETED|Treatment Period 2||0
2376643|NCT01484197|5832727|P1|NOT COMPLETED|Treatment Period 2||0
2376644|NCT01484197|5832724|P4|COMPLETED|Treatment Period 2||8
2376645|NCT01484197|5832725|P3|COMPLETED|Treatment Period 2||9
2376646|NCT01484197|5832726|P2|COMPLETED|Treatment Period 2||8
2376647|NCT01484197|5832727|P1|COMPLETED|Treatment Period 2||7
2376648|NCT01484197|5832724|P4|STARTED|Treatment Period 2||9
2376649|NCT01484197|5832725|P3|STARTED|Treatment Period 2||9
2376650|NCT01484197|5832726|P2|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to an Adverse event (AE).|8
2376651|NCT01484197|5832727|P1|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to a Protocol deviation.|7
2376652|NCT01484197|5832724|P4|NOT COMPLETED|Treatment Period 1||0
2376653|NCT01484197|5832725|P3|NOT COMPLETED|Treatment Period 1||0
2376654|NCT01484197|5832726|P2|NOT COMPLETED|Treatment Period 1||0
2376655|NCT01484197|5832727|P1|NOT COMPLETED|Treatment Period 1||1
2376656|NCT01484197|5832724|P4|COMPLETED|Treatment Period 1||9
2376657|NCT01484197|5832725|P3|COMPLETED|Treatment Period 1||9
2376658|NCT01484197|5832726|P2|COMPLETED|Treatment Period 1||9
2376659|NCT01484197|5832727|P1|COMPLETED|Treatment Period 1||8
2376660|NCT01484197|5832724|P4|STARTED|Treatment Period 1||9
2376661|NCT01484197|5832725|P3|STARTED|Treatment Period 1||9
2376662|NCT01484197|5832726|P2|STARTED|Treatment Period 1||9
2376663|NCT01484197|5832727|P1|STARTED|Treatment Period 1||9
2376664|NCT01484132|5832810|P1|NOT COMPLETED|Overall Study||22
2376665|NCT01484132|5832810|P1|COMPLETED|Overall Study|91 subjects had at least one pre-treatment and at least one post-treatment urine sample.|91
2376666|NCT01484132|5832810|P1|Pre-treatment Urine Sample|Overall Study|Urine samples were collected twice pre-treatment. 101 subjects completed at least one urine sample.|101
2376667|NCT01484132|5832810|P1|STARTED|Overall Study||113
2376668|NCT01484054|5832818|P2|NOT COMPLETED|Period 2||0
2376669|NCT01484054|5832819|P1|NOT COMPLETED|Period 2||0
2376670|NCT01484054|5832818|P2|COMPLETED|Period 2||49
2376671|NCT01484054|5832819|P1|COMPLETED|Period 2||50
2376672|NCT01484054|5832818|P2|STARTED|Period 2||49
2376673|NCT01484054|5832819|P1|STARTED|Period 2||50
2376674|NCT01484054|5832818|P2|NOT COMPLETED|Period 1||1
2376675|NCT01484054|5832819|P1|NOT COMPLETED|Period 1||0
2376676|NCT01484054|5832818|P2|COMPLETED|Period 1||49
2376677|NCT01484054|5832819|P1|COMPLETED|Period 1||50
2376678|NCT01484054|5832818|P2|STARTED|Period 1||50
2376679|NCT01484054|5832819|P1|STARTED|Period 1||50
2376680|NCT01484041|5832829|P1|NOT COMPLETED|Overall Study||0
2376681|NCT01484041|5832829|P1|COMPLETED|Overall Study||12
2376682|NCT01484041|5832829|P1|STARTED|Overall Study||12
2376683|NCT01484028|5832837|P4|NOT COMPLETED|Period 2||0
2376684|NCT01484028|5832838|P3|NOT COMPLETED|Period 2||0
2376685|NCT01484028|5832839|P2|NOT COMPLETED|Period 2||0
2376686|NCT01484028|5832840|P1|NOT COMPLETED|Period 2||0
2376687|NCT01484028|5832837|P4|COMPLETED|Period 2||66
2376688|NCT01484028|5832838|P3|COMPLETED|Period 2||64
2376689|NCT01484028|5832839|P2|COMPLETED|Period 2||67
2376690|NCT01484028|5832840|P1|COMPLETED|Period 2||66
2376691|NCT01484028|5832837|P4|STARTED|Period 2||66
2376692|NCT01484028|5832838|P3|STARTED|Period 2||64
2376693|NCT01484028|5832839|P2|STARTED|Period 2||67
2376694|NCT01484028|5832840|P1|STARTED|Period 2||66
2376695|NCT01484028|5832837|P4|NOT COMPLETED|Period 1||1
2376696|NCT01484028|5832838|P3|NOT COMPLETED|Period 1||0
2376697|NCT01484028|5832839|P2|NOT COMPLETED|Period 1||3
2376698|NCT01484028|5832840|P1|NOT COMPLETED|Period 1||0
2376699|NCT01484028|5832837|P4|COMPLETED|Period 1||66
2376700|NCT01484028|5832838|P3|COMPLETED|Period 1||64
2376701|NCT01484028|5832839|P2|COMPLETED|Period 1||67
2376702|NCT01484028|5832840|P1|COMPLETED|Period 1||66
2376703|NCT01484028|5832837|P4|STARTED|Period 1||67
2376704|NCT01484028|5832838|P3|STARTED|Period 1||64
2376705|NCT01484028|5832839|P2|STARTED|Period 1||70
2376706|NCT01484028|5832840|P1|STARTED|Period 1||66
2376707|NCT01483963|5832855|P5|NOT COMPLETED|Overall Study||0
2376708|NCT01483963|5832856|P4|NOT COMPLETED|Overall Study||0
2376709|NCT01483963|5832857|P3|NOT COMPLETED|Overall Study||0
2376710|NCT01483963|5832858|P2|NOT COMPLETED|Overall Study||0
2376711|NCT01483963|5832859|P1|NOT COMPLETED|Overall Study||0
2376712|NCT01483963|5832855|P5|COMPLETED|Overall Study||10
2376713|NCT01483963|5832856|P4|COMPLETED|Overall Study||10
2376714|NCT01483963|5832857|P3|COMPLETED|Overall Study||10
2376715|NCT01483963|5832858|P2|COMPLETED|Overall Study||10
2376716|NCT01483963|5832859|P1|COMPLETED|Overall Study||10
2376717|NCT01483963|5832855|P5|STARTED|Overall Study||10
2376718|NCT01483963|5832856|P4|STARTED|Overall Study||10
2376719|NCT01483963|5832857|P3|STARTED|Overall Study||10
2376720|NCT01483963|5832858|P2|STARTED|Overall Study||10
2376721|NCT01483963|5832859|P1|STARTED|Overall Study||10
2376722|NCT01483937|5832933|P2|NOT COMPLETED|Overall Study||3
2376723|NCT01483937|5832934|P1|NOT COMPLETED|Overall Study||4
2376724|NCT01483937|5832933|P2|COMPLETED|Overall Study||14
2376725|NCT01483937|5832934|P1|COMPLETED|Overall Study||11
2376726|NCT01483937|5832933|P2|STARTED|Overall Study||17
2376727|NCT01483937|5832934|P1|STARTED|Overall Study||15
2376728|NCT01483924|5832961|P5|NOT COMPLETED|Overall Study||2
2376729|NCT01483924|5832962|P4|NOT COMPLETED|Overall Study||4
2376730|NCT01483924|5832963|P3|NOT COMPLETED|Overall Study||1
2376731|NCT01483924|5832964|P2|NOT COMPLETED|Overall Study||0
2376732|NCT01483924|5832965|P1|NOT COMPLETED|Overall Study||2
2376733|NCT01483924|5832961|P5|COMPLETED|Overall Study||10
2376734|NCT01483924|5832962|P4|COMPLETED|Overall Study||8
2376735|NCT01483924|5832963|P3|COMPLETED|Overall Study||11
2376736|NCT01483924|5832964|P2|COMPLETED|Overall Study||12
2376737|NCT01483924|5832965|P1|COMPLETED|Overall Study||10
2376738|NCT01483924|5832961|P5|STARTED|Overall Study||12
2376739|NCT01483924|5832962|P4|STARTED|Overall Study||12
2376740|NCT01483924|5832963|P3|STARTED|Overall Study||12
2376741|NCT01483924|5832964|P2|STARTED|Overall Study||12
2376742|NCT01483924|5832965|P1|STARTED|Overall Study||12
2376743|NCT01483872|5833013|P2|NOT COMPLETED|Overall Study||0
2376744|NCT01483872|5833014|P1|NOT COMPLETED|Overall Study||0
2376745|NCT01483872|5833013|P2|COMPLETED|Overall Study||1
2376746|NCT01483872|5833014|P1|COMPLETED|Overall Study||0
2376747|NCT01483872|5833013|P2|STARTED|Overall Study||1
2376748|NCT01483872|5833014|P1|STARTED|Overall Study||0
2376749|NCT01483820|5833018|P1|NOT COMPLETED|Overall Study||8
2376750|NCT01483820|5833018|P1|COMPLETED|Overall Study||0
2376751|NCT01483820|5833018|P1|STARTED|Overall Study||8
2376752|NCT01483807|5833027|P2|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
2376753|NCT01483807|5833028|P1|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
2376754|NCT01483807|5833027|P2|COMPLETED|Second Treatment Phase (7 Weeks)||10
2376755|NCT01483807|5833028|P1|COMPLETED|Second Treatment Phase (7 Weeks)||10
2376756|NCT01483807|5833027|P2|STARTED|Second Treatment Phase (7 Weeks)||10
2376757|NCT01483807|5833028|P1|STARTED|Second Treatment Phase (7 Weeks)||10
2376758|NCT01483807|5833027|P2|NOT COMPLETED|Washout (2 Weeks)||0
2376759|NCT01483807|5833028|P1|NOT COMPLETED|Washout (2 Weeks)||0
2376760|NCT01483807|5833027|P2|COMPLETED|Washout (2 Weeks)||10
2376761|NCT01483807|5833028|P1|COMPLETED|Washout (2 Weeks)||10
2376762|NCT01483807|5833027|P2|STARTED|Washout (2 Weeks)||10
2376763|NCT01483807|5833028|P1|STARTED|Washout (2 Weeks)||10
2376764|NCT01483807|5833027|P2|NOT COMPLETED|First Treatment Phase (7 Weeks)||0
2376765|NCT01483807|5833028|P1|NOT COMPLETED|First Treatment Phase (7 Weeks)||0
2376766|NCT01483807|5833027|P2|COMPLETED|First Treatment Phase (7 Weeks)||10
2376767|NCT01483807|5833028|P1|COMPLETED|First Treatment Phase (7 Weeks)||10
2376768|NCT01483807|5833027|P2|STARTED|First Treatment Phase (7 Weeks)||10
2376769|NCT01483807|5833028|P1|STARTED|First Treatment Phase (7 Weeks)||10
2376770|NCT01483651|5833039|P6|NOT COMPLETED|Overall Study||1
2376771|NCT01483651|5833040|P5|NOT COMPLETED|Overall Study||0
2376772|NCT01483651|5833041|P4|NOT COMPLETED|Overall Study||0
2376773|NCT01483651|5833042|P3|NOT COMPLETED|Overall Study||1
2376774|NCT01483651|5833043|P2|NOT COMPLETED|Overall Study||1
2376775|NCT01483651|5833044|P1|NOT COMPLETED|Overall Study||0
2376776|NCT01483651|5833039|P6|COMPLETED|Overall Study||1
2376777|NCT01483651|5833040|P5|COMPLETED|Overall Study||2
2376778|NCT01483651|5833041|P4|COMPLETED|Overall Study||1
2376779|NCT01483651|5833042|P3|COMPLETED|Overall Study||1
2376780|NCT01483651|5833043|P2|COMPLETED|Overall Study||2
2376781|NCT01483651|5833044|P1|COMPLETED|Overall Study||1
2376782|NCT01483651|5833039|P6|STARTED|Overall Study||2
2376783|NCT01483651|5833040|P5|STARTED|Overall Study||2
2376784|NCT01483651|5833041|P4|STARTED|Overall Study||1
2376785|NCT01483651|5833042|P3|STARTED|Overall Study||2
2376786|NCT01483651|5833043|P2|STARTED|Overall Study||3
2376787|NCT01483651|5833044|P1|STARTED|Overall Study||1
2376788|NCT01483625|5833054|P2|NOT COMPLETED|Overall Study||2
2376789|NCT01483625|5833055|P1|NOT COMPLETED|Overall Study||4
2376790|NCT01483625|5833054|P2|COMPLETED|Overall Study||66
2376791|NCT01483625|5833055|P1|COMPLETED|Overall Study||68
2376792|NCT01483625|5833054|P2|STARTED|Overall Study||68
2376793|NCT01483625|5833055|P1|STARTED|Overall Study||72
2376794|NCT01483599|5833078|P14|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||7
2376795|NCT01483599|5833079|P13|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||3
2376796|NCT01483599|5833080|P12|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||1
2376797|NCT01483599|5833081|P11|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
2376798|NCT01483599|5833082|P10|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||4
2376799|NCT01483599|5833083|P9|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||9
2376800|NCT01483599|5833084|P8|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
2376801|NCT01483599|5833085|P7|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
2376802|NCT01483599|5833086|P6|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
2376803|NCT01483599|5833087|P5|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
2376804|NCT01483599|5833088|P4|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
2376805|NCT01483599|5833089|P3|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
2376806|NCT01483599|5833090|P2|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
2376807|NCT01483599|5833091|P1|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
2376808|NCT01483599|5833078|P14|COMPLETED|After Controlled Period(Week 16-Week 40)||32
2376809|NCT01483599|5833079|P13|COMPLETED|After Controlled Period(Week 16-Week 40)||35
2376810|NCT01483599|5833080|P12|COMPLETED|After Controlled Period(Week 16-Week 40)||39
2376811|NCT01483599|5833081|P11|COMPLETED|After Controlled Period(Week 16-Week 40)||37
2376812|NCT01483599|5833082|P10|COMPLETED|After Controlled Period(Week 16-Week 40)||37
2376813|NCT01483599|5833083|P9|COMPLETED|After Controlled Period(Week 16-Week 40)||29
2376814|NCT01483599|5833084|P8|COMPLETED|After Controlled Period(Week 16-Week 40)||37
2376815|NCT01483599|5833085|P7|COMPLETED|After Controlled Period(Week 16-Week 40)||0
2376816|NCT01483599|5833086|P6|COMPLETED|After Controlled Period(Week 16-Week 40)||0
2376817|NCT01483599|5833087|P5|COMPLETED|After Controlled Period(Week 16-Week 40)||0
2376818|NCT01483599|5833088|P4|COMPLETED|After Controlled Period(Week 16-Week 40)||0
2376819|NCT01483599|5833089|P3|COMPLETED|After Controlled Period(Week 16-Week 40)||0
2376820|NCT01483599|5833090|P2|COMPLETED|After Controlled Period(Week 16-Week 40)||0
2376821|NCT01483599|5833091|P1|COMPLETED|After Controlled Period(Week 16-Week 40)||0
2376822|NCT01483599|5833078|P14|STARTED|After Controlled Period(Week 16-Week 40)||39
2376823|NCT01483599|5833079|P13|STARTED|After Controlled Period(Week 16-Week 40)||38
2376824|NCT01483599|5833080|P12|STARTED|After Controlled Period(Week 16-Week 40)||40
2376825|NCT01483599|5833081|P11|STARTED|After Controlled Period(Week 16-Week 40)||39
2376826|NCT01483599|5833082|P10|STARTED|After Controlled Period(Week 16-Week 40)||41
2376827|NCT01483599|5833083|P9|STARTED|After Controlled Period(Week 16-Week 40)||38
2376828|NCT01483599|5833084|P8|STARTED|After Controlled Period(Week 16-Week 40)||39
2376829|NCT01483599|5833085|P7|STARTED|After Controlled Period(Week 16-Week 40)||0
2376830|NCT01483599|5833086|P6|STARTED|After Controlled Period(Week 16-Week 40)||0
2376831|NCT01483599|5833087|P5|STARTED|After Controlled Period(Week 16-Week 40)||0
2376832|NCT01483599|5833088|P4|STARTED|After Controlled Period(Week 16-Week 40)||0
2376833|NCT01483599|5833089|P3|STARTED|After Controlled Period(Week 16-Week 40)||0
2376834|NCT01483599|5833090|P2|STARTED|After Controlled Period(Week 16-Week 40)||0
2376835|NCT01483599|5833091|P1|STARTED|After Controlled Period(Week 16-Week 40)||0
2376836|NCT01483599|5833078|P14|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
2376837|NCT01483599|5833079|P13|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
2376838|NCT01483599|5833080|P12|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
2376839|NCT01483599|5833081|P11|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
2376840|NCT01483599|5833082|P10|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
2376841|NCT01483599|5833083|P9|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
2376842|NCT01483599|5833084|P8|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
2376843|NCT01483599|5833085|P7|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
2376844|NCT01483599|5833086|P6|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
2376845|NCT01483599|5833087|P5|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||2
2376846|NCT01483599|5833088|P4|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
2376847|NCT01483599|5833089|P3|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
2376848|NCT01483599|5833090|P2|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
2376849|NCT01483599|5833091|P1|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
2376850|NCT01483599|5833078|P14|COMPLETED|Controlled Period (CP) (up to Week 16)||0
2376851|NCT01483599|5833079|P13|COMPLETED|Controlled Period (CP) (up to Week 16)||0
2376852|NCT01483599|5833080|P12|COMPLETED|Controlled Period (CP) (up to Week 16)||0
2376853|NCT01483599|5833081|P11|COMPLETED|Controlled Period (CP) (up to Week 16)||0
2376854|NCT01483599|5833082|P10|COMPLETED|Controlled Period (CP) (up to Week 16)||0
2376855|NCT01483599|5833083|P9|COMPLETED|Controlled Period (CP) (up to Week 16)||0
2376856|NCT01483599|5833084|P8|COMPLETED|Controlled Period (CP) (up to Week 16)||0
2376857|NCT01483599|5833085|P7|COMPLETED|Controlled Period (CP) (up to Week 16)||39
2376858|NCT01483599|5833086|P6|COMPLETED|Controlled Period (CP) (up to Week 16)||38
2376859|NCT01483599|5833087|P5|COMPLETED|Controlled Period (CP) (up to Week 16)||40
2376860|NCT01483599|5833088|P4|COMPLETED|Controlled Period (CP) (up to Week 16)||39
2376861|NCT01483599|5833089|P3|COMPLETED|Controlled Period (CP) (up to Week 16)||41
2376862|NCT01483599|5833090|P2|COMPLETED|Controlled Period (CP) (up to Week 16)||38
2376863|NCT01483599|5833091|P1|COMPLETED|Controlled Period (CP) (up to Week 16)||39
2376864|NCT01483599|5833078|P14|Treated|Controlled Period (CP) (up to Week 16)||0
2376865|NCT01483599|5833079|P13|Treated|Controlled Period (CP) (up to Week 16)||0
2376866|NCT01483599|5833080|P12|Treated|Controlled Period (CP) (up to Week 16)||0
2376867|NCT01483599|5833081|P11|Treated|Controlled Period (CP) (up to Week 16)||0
2376868|NCT01483599|5833082|P10|Treated|Controlled Period (CP) (up to Week 16)||0
2376869|NCT01483599|5833083|P9|Treated|Controlled Period (CP) (up to Week 16)||0
2376870|NCT01483599|5833084|P8|Treated|Controlled Period (CP) (up to Week 16)||0
2376871|NCT01483599|5833085|P7|Treated|Controlled Period (CP) (up to Week 16)||43
2376872|NCT01483599|5833086|P6|Treated|Controlled Period (CP) (up to Week 16)||41
2376873|NCT01483599|5833087|P5|Treated|Controlled Period (CP) (up to Week 16)||42
2376874|NCT01483599|5833088|P4|Treated|Controlled Period (CP) (up to Week 16)||42
2376875|NCT01483599|5833089|P3|Treated|Controlled Period (CP) (up to Week 16)||41
2376876|NCT01483599|5833090|P2|Treated|Controlled Period (CP) (up to Week 16)||41
2376877|NCT01483599|5833091|P1|Treated|Controlled Period (CP) (up to Week 16)||42
2376878|NCT01483599|5833078|P14|STARTED|Controlled Period (CP) (up to Week 16)||0
2376879|NCT01483599|5833079|P13|STARTED|Controlled Period (CP) (up to Week 16)||0
2376880|NCT01483599|5833080|P12|STARTED|Controlled Period (CP) (up to Week 16)||0
2376881|NCT01483599|5833081|P11|STARTED|Controlled Period (CP) (up to Week 16)||0
2376882|NCT01483599|5833082|P10|STARTED|Controlled Period (CP) (up to Week 16)||0
2376883|NCT01483599|5833083|P9|STARTED|Controlled Period (CP) (up to Week 16)||0
2376884|NCT01483599|5833084|P8|STARTED|Controlled Period (CP) (up to Week 16)||0
2376885|NCT01483599|5833085|P7|STARTED|Controlled Period (CP) (up to Week 16)||43
2376886|NCT01483599|5833086|P6|STARTED|Controlled Period (CP) (up to Week 16)||42
2376887|NCT01483599|5833087|P5|STARTED|Controlled Period (CP) (up to Week 16)||42
2376888|NCT01483599|5833088|P4|STARTED|Controlled Period (CP) (up to Week 16)||42
2376889|NCT01483599|5833089|P3|STARTED|Controlled Period (CP) (up to Week 16)||41
2376890|NCT01483599|5833090|P2|STARTED|Controlled Period (CP) (up to Week 16)||41
2376891|NCT01483599|5833091|P1|STARTED|Controlled Period (CP) (up to Week 16)||42
2376892|NCT01483560|5833142|P2|NOT COMPLETED|Overall Study||15
2376893|NCT01483560|5833143|P1|NOT COMPLETED|Overall Study||26
2376894|NCT01483560|5833142|P2|COMPLETED|Overall Study||194
2376895|NCT01483560|5833143|P1|COMPLETED|Overall Study||193
2376896|NCT01483560|5833142|P2|STARTED|Overall Study||209
2376897|NCT01483560|5833143|P1|STARTED|Overall Study||219
2376898|NCT01483378|5833163|P2|NOT COMPLETED|Overall Study||0
2376899|NCT01483378|5833164|P1|NOT COMPLETED|Overall Study||0
2376900|NCT01483378|5833163|P2|COMPLETED|Overall Study||66
2376901|NCT01483378|5833164|P1|COMPLETED|Overall Study||100
2376902|NCT01483378|5833163|P2|STARTED|Overall Study||66
2376903|NCT01483378|5833164|P1|STARTED|Overall Study||100
2376904|NCT01483352|5833170|P1|NOT COMPLETED|Overall Study||0
2376905|NCT01483352|5833170|P1|COMPLETED|Overall Study||12
2376906|NCT01483352|5833170|P1|STARTED|Overall Study||12
2376907|NCT01483209|5833189|P1|NOT COMPLETED|Overall Study||1
2376908|NCT01483209|5833189|P1|COMPLETED|Overall Study||1
2376909|NCT01483209|5833189|P1|STARTED|Overall Study||2
2376910|NCT01483183|5833204|P10|NOT COMPLETED|Overall Study||1
2376911|NCT01483183|5833205|P9|NOT COMPLETED|Overall Study||0
2376912|NCT01483183|5833206|P8|NOT COMPLETED|Overall Study||0
2376913|NCT01483183|5833207|P7|NOT COMPLETED|Overall Study||2
2376914|NCT01483183|5833208|P6|NOT COMPLETED|Overall Study||0
2376915|NCT01483183|5833209|P5|NOT COMPLETED|Overall Study||0
2376916|NCT01483183|5833210|P4|NOT COMPLETED|Overall Study||0
2376917|NCT01483183|5833211|P3|NOT COMPLETED|Overall Study||0
2376918|NCT01483183|5833212|P2|NOT COMPLETED|Overall Study||0
2376919|NCT01483183|5833213|P1|NOT COMPLETED|Overall Study||0
2376920|NCT01483183|5833204|P10|COMPLETED|Overall Study||4
2376921|NCT01483183|5833205|P9|COMPLETED|Overall Study||4
2376922|NCT01483183|5833206|P8|COMPLETED|Overall Study||4
2376923|NCT01483183|5833207|P7|COMPLETED|Overall Study||4
2376924|NCT01483183|5833208|P6|COMPLETED|Overall Study||4
2376925|NCT01483183|5833209|P5|COMPLETED|Overall Study||4
2376926|NCT01483183|5833210|P4|COMPLETED|Overall Study||3
2376927|NCT01483183|5833211|P3|COMPLETED|Overall Study||5
2376928|NCT01483183|5833212|P2|COMPLETED|Overall Study||1
2376929|NCT01483183|5833213|P1|COMPLETED|Overall Study||4
2376930|NCT01483183|5833204|P10|STARTED|Overall Study||5
2376931|NCT01483183|5833205|P9|STARTED|Overall Study||4
2376932|NCT01483183|5833206|P8|STARTED|Overall Study||4
2376933|NCT01483183|5833207|P7|STARTED|Overall Study||6
2376934|NCT01483183|5833208|P6|STARTED|Overall Study||4
2376935|NCT01483183|5833209|P5|STARTED|Overall Study||4
2376936|NCT01483183|5833210|P4|STARTED|Overall Study||3
2376937|NCT01483183|5833211|P3|STARTED|Overall Study||5
2376938|NCT01483183|5833212|P2|STARTED|Overall Study||1
2376939|NCT01483183|5833213|P1|STARTED|Overall Study||4
2376940|NCT01483118|5833283|P2|NOT COMPLETED|Overall Study||16
2376941|NCT01483118|5833284|P1|NOT COMPLETED|Overall Study||12
2376942|NCT01483118|5833283|P2|COMPLETED|Overall Study||6
2376943|NCT01483118|5833284|P1|COMPLETED|Overall Study||11
2376944|NCT01483118|5833283|P2|Completed 3 Months|Overall Study||11
2376945|NCT01483118|5833284|P1|Completed 3 Months|Overall Study||15
2376946|NCT01483118|5833283|P2|STARTED|Overall Study||22
2376947|NCT01483118|5833284|P1|STARTED|Overall Study||23
2376948|NCT01482962|5833296|P2|NOT COMPLETED|Overall Study||133
2376949|NCT01482962|5833297|P1|NOT COMPLETED|Overall Study||138
2376950|NCT01482962|5833296|P2|COMPLETED|Overall Study||0
2376951|NCT01482962|5833297|P1|COMPLETED|Overall Study||0
2376952|NCT01482962|5833296|P2|Safety Population: Received Study Drug|Overall Study||127
2376953|NCT01482962|5833297|P1|Safety Population: Received Study Drug|Overall Study||137
2376954|NCT01482962|5833296|P2|STARTED|Overall Study||133
2376955|NCT01482962|5833297|P1|STARTED|Overall Study||138
2376956|NCT01482910|5833330|P2|NOT COMPLETED|Overall Study||9
2376957|NCT01482910|5833331|P1|NOT COMPLETED|Overall Study||15
2376958|NCT01482910|5833330|P2|COMPLETED|Overall Study||67
2376959|NCT01482910|5833331|P1|COMPLETED|Overall Study||213
2376960|NCT01482910|5833330|P2|Completed Week 28|Overall Study||71
2376961|NCT01482910|5833331|P1|Completed Week 28|Overall Study||216
2376962|NCT01482910|5833330|P2|STARTED|Overall Study||76
2376963|NCT01482910|5833331|P1|STARTED|Overall Study||228
2376964|NCT01482884|5833343|P2|NOT COMPLETED|Overall Study||18
2376965|NCT01482884|5833344|P1|NOT COMPLETED|Overall Study||13
2376966|NCT01482884|5833343|P2|COMPLETED|Overall Study||37
2376967|NCT01482884|5833344|P1|COMPLETED|Overall Study||43
2376968|NCT01482884|5833343|P2|STARTED|Overall Study||55
2376969|NCT01482884|5833344|P1|STARTED|Overall Study|One participant did not receive study treatment|56
2376970|NCT01482819|5833370|P1|NOT COMPLETED|Overall Study||2
2376971|NCT01482819|5833370|P1|COMPLETED|Overall Study||19
2376972|NCT01482819|5833370|P1|STARTED|Overall Study||21
2376973|NCT01482767|5833390|P2|NOT COMPLETED|Overall Study||49
2376974|NCT01482767|5833391|P1|NOT COMPLETED|Overall Study||54
2376975|NCT01482767|5833390|P2|COMPLETED|Overall Study||78
2376976|NCT01482767|5833391|P1|COMPLETED|Overall Study||81
2376977|NCT01482767|5833390|P2|STARTED|Overall Study||127
2376978|NCT01482767|5833391|P1|STARTED|Overall Study||135
2376979|NCT01482429|5833413|P2|NOT COMPLETED|Protocol||0
2376980|NCT01482429|5833414|P1|NOT COMPLETED|Protocol||275
2376981|NCT01482429|5833413|P2|COMPLETED|Protocol||0
2376982|NCT01482429|5833414|P1|COMPLETED|Protocol||139
2376983|NCT01482429|5833413|P2|STARTED|Protocol||0
2376984|NCT01482429|5833414|P1|STARTED|Protocol||414
2376985|NCT01482429|5833413|P2|NOT COMPLETED|Care Usual||173
2376986|NCT01482429|5833414|P1|NOT COMPLETED|Care Usual||0
2376987|NCT01482429|5833413|P2|COMPLETED|Care Usual||96
2376988|NCT01482429|5833414|P1|COMPLETED|Care Usual||0
2376989|NCT01482429|5833413|P2|STARTED|Care Usual||269
2376990|NCT01482429|5833414|P1|STARTED|Care Usual||0
2376991|NCT01482351|5833424|P1|NOT COMPLETED|Overall Study||14
2376992|NCT01482351|5833424|P1|COMPLETED|Overall Study||54
2376993|NCT01482351|5833424|P1|12 Months|Overall Study||54
2376994|NCT01482351|5833424|P1|6 Months|Overall Study|14 dropped out|54
2376995|NCT01482351|5833424|P1|STARTED|Overall Study||68
2376996|NCT01482325|5833446|P1|NOT COMPLETED|Overall Study||0
2376997|NCT01482325|5833446|P1|COMPLETED|Overall Study||31
2376998|NCT01482325|5833446|P1|STARTED|Overall Study||31
2376999|NCT01482312|5833450|P3|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
2377000|NCT01482312|5833451|P2|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
2377001|NCT01482312|5833452|P1|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
2377002|NCT01482312|5833450|P3|COMPLETED|Period 3, 90 Minutes of Wear||9
2377003|NCT01482312|5833451|P2|COMPLETED|Period 3, 90 Minutes of Wear||9
2377004|NCT01482312|5833452|P1|COMPLETED|Period 3, 90 Minutes of Wear||8
2377005|NCT01482312|5833450|P3|STARTED|Period 3, 90 Minutes of Wear||9
2377006|NCT01482312|5833451|P2|STARTED|Period 3, 90 Minutes of Wear||9
2377007|NCT01482312|5833452|P1|STARTED|Period 3, 90 Minutes of Wear||8
2377008|NCT01482312|5833450|P3|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
2377009|NCT01482312|5833451|P2|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
2377010|NCT01482312|5833452|P1|NOT COMPLETED|Period 2, 90 Minutes of Wear||1
2377011|NCT01482312|5833450|P3|COMPLETED|Period 2, 90 Minutes of Wear||9
2377012|NCT01482312|5833451|P2|COMPLETED|Period 2, 90 Minutes of Wear||9
2377013|NCT01482312|5833452|P1|COMPLETED|Period 2, 90 Minutes of Wear||8
2377014|NCT01482312|5833450|P3|STARTED|Period 2, 90 Minutes of Wear|One participant discontinued between Period 1 and Period 2|9
2377015|NCT01482312|5833451|P2|STARTED|Period 2, 90 Minutes of Wear||9
2377016|NCT01482312|5833452|P1|STARTED|Period 2, 90 Minutes of Wear||9
2377017|NCT01482312|5833450|P3|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
2377018|NCT01482312|5833451|P2|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
2377019|NCT01482312|5833452|P1|NOT COMPLETED|Period 1, 90 Minutes of Wear||1
2377020|NCT01482312|5833450|P3|COMPLETED|Period 1, 90 Minutes of Wear||10
2377021|NCT01482312|5833451|P2|COMPLETED|Period 1, 90 Minutes of Wear||9
2377022|NCT01482312|5833452|P1|COMPLETED|Period 1, 90 Minutes of Wear||9
2377023|NCT01482312|5833450|P3|STARTED|Period 1, 90 Minutes of Wear||10
2377024|NCT01482312|5833451|P2|STARTED|Period 1, 90 Minutes of Wear||9
2377025|NCT01482312|5833452|P1|STARTED|Period 1, 90 Minutes of Wear||10
2377026|NCT01482221|5833466|P3|NOT COMPLETED|Overall Study||23
2377027|NCT01482221|5833467|P2|NOT COMPLETED|Overall Study||20
2377028|NCT01482221|5833468|P1|NOT COMPLETED|Overall Study||21
2377029|NCT01482221|5833466|P3|COMPLETED|Overall Study||77
2377030|NCT01482221|5833467|P2|COMPLETED|Overall Study||81
2377031|NCT01482221|5833468|P1|COMPLETED|Overall Study||80
2377032|NCT01482221|5833466|P3|STARTED|Overall Study||100
2377033|NCT01482221|5833467|P2|STARTED|Overall Study||101
2377034|NCT01482221|5833468|P1|STARTED|Overall Study||101
2377035|NCT01482169|5833509|P1|NOT COMPLETED|Overall Study||2
2377036|NCT01482169|5833509|P1|COMPLETED|Overall Study||46
2377037|NCT01482169|5833509|P1|STARTED|Overall Study||48
2377038|NCT01482091|5833518|P2|NOT COMPLETED|Overall Study||0
2377039|NCT01482091|5833519|P1|NOT COMPLETED|Overall Study||0
2377040|NCT01482091|5833518|P2|COMPLETED|Overall Study||24
2377041|NCT01482091|5833519|P1|COMPLETED|Overall Study||25
2377042|NCT01482091|5833518|P2|STARTED|Overall Study||24
2377043|NCT01482091|5833519|P1|STARTED|Overall Study||25
2377044|NCT01482065|5833551|P2|NOT COMPLETED|Overall Study||1
2377045|NCT01482065|5833552|P1|NOT COMPLETED|Overall Study||0
2377046|NCT01482065|5833551|P2|COMPLETED|Overall Study||4
2377047|NCT01482065|5833552|P1|COMPLETED|Overall Study||4
2377048|NCT01482065|5833551|P2|STARTED|Overall Study||5
2377049|NCT01482065|5833552|P1|STARTED|Overall Study||4
2377050|NCT01481935|5833566|P2|NOT COMPLETED|Overall Study||0
2377051|NCT01481935|5833567|P1|NOT COMPLETED|Overall Study||0
2377052|NCT01481935|5833566|P2|COMPLETED|Overall Study||93
2377053|NCT01481935|5833567|P1|COMPLETED|Overall Study||97
2377054|NCT01481935|5833566|P2|STARTED|Overall Study||93
2377055|NCT01481935|5833567|P1|STARTED|Overall Study||97
2377056|NCT01481896|5833573|P1|NOT COMPLETED|Overall Study||12
2377057|NCT01481896|5833573|P1|COMPLETED|Overall Study|The 114 participants includes 5 participants with bilateral hip replacements for a total of 119 THAs|114
2377058|NCT01481896|5833573|P1|Min 4.75 yr Follow-up, Revised or Dead|Overall Study|114 participants with 119 THAs had at least 4.75 year follow-up or were known revised or deceased|114
2377059|NCT01481896|5833573|P1|STARTED|Overall Study|The 126 participants includes 5 participants with bilateral hip replacements for a total of 131 THAs|126
2377060|NCT01481779|5833589|P2|NOT COMPLETED|Overall Study||28
2377061|NCT01481779|5833590|P1|NOT COMPLETED|Overall Study||70
2377062|NCT01481779|5833589|P2|COMPLETED|Overall Study||132
2377063|NCT01481779|5833590|P1|COMPLETED|Overall Study||225
2377064|NCT01481779|5833589|P2|Received at Least 1 Dose of Study Drug|Overall Study||159
2377065|NCT01481779|5833590|P1|Received at Least 1 Dose of Study Drug|Overall Study||294
2377066|NCT01481779|5833589|P2|STARTED|Overall Study||160
2377067|NCT01481779|5833590|P1|STARTED|Overall Study||295
2377068|NCT01481740|5833638|P2|NOT COMPLETED|Overall Study||7
2377069|NCT01481740|5833639|P1|NOT COMPLETED|Overall Study||11
2377070|NCT01481740|5833638|P2|COMPLETED|Overall Study||81
2377071|NCT01481740|5833639|P1|COMPLETED|Overall Study||79
2377072|NCT01481740|5833638|P2|STARTED|Overall Study||88
2377073|NCT01481740|5833639|P1|STARTED|Overall Study||90
2377074|NCT01481558|5833657|P2|NOT COMPLETED|Overall Study||0
2377075|NCT01481558|5833658|P1|NOT COMPLETED|Overall Study||0
2377076|NCT01481558|5833657|P2|COMPLETED|Overall Study||20
2377077|NCT01481558|5833658|P1|COMPLETED|Overall Study||20
2377078|NCT01481558|5833657|P2|STARTED|Overall Study||20
2377079|NCT01481558|5833658|P1|STARTED|Overall Study||20
2377080|NCT01481376|5833664|P1|NOT COMPLETED|Overall Study||31
2377081|NCT01481376|5833664|P1|COMPLETED|Overall Study||169
2377082|NCT01481376|5833664|P1|STARTED|Overall Study||200
2377083|NCT01481324|5833675|P3|NOT COMPLETED|Overall Study||2
2377084|NCT01481324|5833676|P2|NOT COMPLETED|Overall Study||2
2377085|NCT01481324|5833677|P1|NOT COMPLETED|Overall Study||0
2377086|NCT01481324|5833675|P3|COMPLETED|Overall Study||20
2377087|NCT01481324|5833676|P2|COMPLETED|Overall Study||22
2377088|NCT01481324|5833677|P1|COMPLETED|Overall Study||21
2377089|NCT01481324|5833675|P3|Month 3-Wear Rate Data|Overall Study||6
2377090|NCT01481324|5833676|P2|Month 3-Wear Rate Data|Overall Study||11
2377091|NCT01481324|5833677|P1|Month 3-Wear Rate Data|Overall Study||7
2377092|NCT01481324|5833675|P3|Month 2-Wear Rate Data|Overall Study||7
2377093|NCT01481324|5833676|P2|Month 2-Wear Rate Data|Overall Study||13
2377094|NCT01481324|5833677|P1|Month 2-Wear Rate Data|Overall Study||9
2377095|NCT01481324|5833675|P3|Month 1-Wear Rate Data|Overall Study||8
2377096|NCT01481324|5833676|P2|Month 1-Wear Rate Data|Overall Study||16
2377097|NCT01481324|5833677|P1|Month 1-Wear Rate Data|Overall Study||15
2377098|NCT01481324|5833675|P3|STARTED|Overall Study||22
2377099|NCT01481324|5833676|P2|STARTED|Overall Study||24
2377100|NCT01481324|5833677|P1|STARTED|Overall Study||21
2377101|NCT01481129|5833685|P1|NOT COMPLETED|Overall Study||0
2377102|NCT01481129|5833685|P1|COMPLETED|Overall Study||22
2377103|NCT01481129|5833685|P1|STARTED|Overall Study||22
2377104|NCT01481116|5833696|P3|NOT COMPLETED|Overall Study||813
2377105|NCT01481116|5833697|P2|NOT COMPLETED|Overall Study||817
2377106|NCT01481116|5833698|P1|NOT COMPLETED|Overall Study||824
2377107|NCT01481116|5833696|P3|COMPLETED|Overall Study||0
2377108|NCT01481116|5833697|P2|COMPLETED|Overall Study||0
2377109|NCT01481116|5833698|P1|COMPLETED|Overall Study||0
2377110|NCT01481116|5833696|P3|Treated|Overall Study||813
2377111|NCT01481116|5833697|P2|Treated|Overall Study||816
2377112|NCT01481116|5833698|P1|Treated|Overall Study||822
2377113|NCT01481116|5833696|P3|STARTED|Overall Study||813
2377114|NCT01481116|5833697|P2|STARTED|Overall Study||817
2377115|NCT01481116|5833698|P1|STARTED|Overall Study||824
2377116|NCT01480843|5833724|P1|NOT COMPLETED|Overall Study||5
2377117|NCT01480843|5833724|P1|COMPLETED|Overall Study||60
2377118|NCT01480843|5833724|P1|STARTED|Overall Study||65
2377119|NCT01480674|5833729|P1|NOT COMPLETED|Overall Study||35
2377120|NCT01480674|5833729|P1|COMPLETED|Overall Study||125
2377121|NCT01480674|5833729|P1|Analysed Set|Overall Study||128
2377122|NCT01480674|5833729|P1|Safety Set|Overall Study||154
2377123|NCT01480674|5833729|P1|STARTED|Overall Study||160
2377124|NCT01480596|5833743|P2|NOT COMPLETED|Overall Study||2
2377125|NCT01480596|5833744|P1|NOT COMPLETED|Overall Study||5
2377126|NCT01480596|5833743|P2|COMPLETED|Overall Study||16
2377127|NCT01480596|5833744|P1|COMPLETED|Overall Study||17
2377128|NCT01480596|5833743|P2|STARTED|Overall Study||18
2377129|NCT01480596|5833744|P1|STARTED|Overall Study||22
2377130|NCT01480297|5833786|P1|NOT COMPLETED|Overall Study||0
2377131|NCT01480297|5833786|P1|COMPLETED|Overall Study||8
2377132|NCT01480297|5833786|P1|STARTED|Overall Study||8
2377133|NCT01480284|5833792|P2|NOT COMPLETED|Overall Study||0
2377134|NCT01480284|5833793|P1|NOT COMPLETED|Overall Study||8
2377135|NCT01480284|5833792|P2|COMPLETED|Overall Study||56
2377136|NCT01480284|5833793|P1|COMPLETED|Overall Study||102
2377137|NCT01480284|5833792|P2|STARTED|Overall Study||56
2377138|NCT01480284|5833793|P1|STARTED|Overall Study||110
2377139|NCT01480258|5833823|P2|NOT COMPLETED|Toddler Dose||0
2377140|NCT01480258|5833824|P1|NOT COMPLETED|Toddler Dose||0
2377141|NCT01480258|5833823|P2|COMPLETED|Toddler Dose||642
2377142|NCT01480258|5833824|P1|COMPLETED|Toddler Dose||639
2377143|NCT01480258|5833823|P2|STARTED|Toddler Dose||642
2377144|NCT01480258|5833824|P1|STARTED|Toddler Dose||639
2377145|NCT01480258|5833823|P2|NOT COMPLETED|Interim Period||9
2377146|NCT01480258|5833824|P1|NOT COMPLETED|Interim Period||10
2377147|NCT01480258|5833823|P2|COMPLETED|Interim Period||642
2377148|NCT01480258|5833824|P1|COMPLETED|Interim Period||639
2377149|NCT01480258|5833823|P2|STARTED|Interim Period||651
2377150|NCT01480258|5833824|P1|STARTED|Interim Period||649
2377151|NCT01480258|5833823|P2|NOT COMPLETED|Infant Series||8
2377152|NCT01480258|5833824|P1|NOT COMPLETED|Infant Series||7
2377153|NCT01480258|5833823|P2|COMPLETED|Infant Series||651
2377154|NCT01480258|5833824|P1|COMPLETED|Infant Series||649
2377155|NCT01480258|5833823|P2|Vaccinated|Infant Series||659
2377156|NCT01480258|5833824|P1|Vaccinated|Infant Series||653
2377157|NCT01480258|5833823|P2|STARTED|Infant Series||659
2377158|NCT01480258|5833824|P1|STARTED|Infant Series||656
2377159|NCT01480232|5833850|P4|NOT COMPLETED|Overall Study||19
2377160|NCT01480232|5833851|P3|NOT COMPLETED|Overall Study||17
2377161|NCT01480232|5833852|P2|NOT COMPLETED|Overall Study||22
2377162|NCT01480232|5833853|P1|NOT COMPLETED|Overall Study||18
2377163|NCT01480232|5833850|P4|COMPLETED|Overall Study||22
2377164|NCT01480232|5833851|P3|COMPLETED|Overall Study||21
2377165|NCT01480232|5833852|P2|COMPLETED|Overall Study||19
2377166|NCT01480232|5833853|P1|COMPLETED|Overall Study||22
2377167|NCT01480232|5833850|P4|STARTED|Overall Study||41
2377168|NCT01480232|5833851|P3|STARTED|Overall Study||38
2377169|NCT01480232|5833852|P2|STARTED|Overall Study||41
2377170|NCT01480232|5833853|P1|STARTED|Overall Study||40
2377171|NCT01480219|5833881|P2|NOT COMPLETED|Overall Study||0
2377172|NCT01480219|5833882|P1|NOT COMPLETED|Overall Study||0
2377173|NCT01480219|5833881|P2|COMPLETED|Overall Study||142
2377174|NCT01480219|5833882|P1|COMPLETED|Overall Study||325
2377175|NCT01480219|5833881|P2|STARTED|Overall Study||142
2377176|NCT01480219|5833882|P1|STARTED|Overall Study||325
2377177|NCT01480089|5833890|P2|NOT COMPLETED|Overall Study||0
2377178|NCT01480089|5833891|P1|NOT COMPLETED|Overall Study||0
2377179|NCT01480089|5833890|P2|COMPLETED|Overall Study||30
2377180|NCT01480089|5833891|P1|COMPLETED|Overall Study||25
2377181|NCT01480089|5833890|P2|STARTED|Overall Study||30
2377182|NCT01480089|5833891|P1|STARTED|Overall Study||25
2377183|NCT01480076|5833901|P1|NOT COMPLETED|Overall Study||290
2377184|NCT01480076|5833901|P1|COMPLETED|Overall Study||611
2377185|NCT01480076|5833901|P1|Intent to Treat Population|Overall Study|Received ≥1 dose of study drug & provided ≥1 efficacy assessment at Baseline & the 3-month visit.|835
2377186|NCT01480076|5833901|P1|STARTED|Overall Study|enrolled and started run-in treatment|901
2377187|NCT01479985|5834022|P2|NOT COMPLETED|Overall Study||0
2377188|NCT01479985|5834023|P1|NOT COMPLETED|Overall Study||0
2377189|NCT01479985|5834022|P2|COMPLETED|Overall Study||80
2377190|NCT01479985|5834023|P1|COMPLETED|Overall Study||161
2377191|NCT01479985|5834022|P2|STARTED|Overall Study||80
2377192|NCT01479985|5834023|P1|STARTED|Overall Study||161
2377193|NCT01479868|5834031|P1|NOT COMPLETED|Overall Study||9
2377194|NCT01479868|5834031|P1|COMPLETED|Overall Study||97
2377195|NCT01479868|5834031|P1|STARTED|Overall Study|Restricted to subject who received at least one dose of treatment (TMC435/RBV/PegIFN).|106
2377196|NCT01479777|5834046|P1|NOT COMPLETED|Overall Study||2
2377197|NCT01479777|5834046|P1|COMPLETED|Overall Study||10
2377198|NCT01479777|5834046|P1|STARTED|Overall Study||12
2377199|NCT01479764|5834058|P2|NOT COMPLETED|Treated||2
2377200|NCT01479764|5834059|P1|NOT COMPLETED|Treated||0
2377201|NCT01479764|5834058|P2|COMPLETED|Treated||75
2377202|NCT01479764|5834059|P1|COMPLETED|Treated||74
2377203|NCT01479764|5834058|P2|STARTED|Treated||77
2377204|NCT01479764|5834059|P1|STARTED|Treated||74
2377205|NCT01479764|5834058|P2|NOT COMPLETED|Randomized||1
2377206|NCT01479764|5834059|P1|NOT COMPLETED|Randomized||2
2377207|NCT01479764|5834058|P2|COMPLETED|Randomized|1 randomized participant did not receive study drug|77
2377208|NCT01479764|5834059|P1|COMPLETED|Randomized|2 randomized participants did not receive study drug|74
2377209|NCT01479764|5834058|P2|STARTED|Randomized||78
2377210|NCT01479764|5834059|P1|STARTED|Randomized||76
2377211|NCT01479725|5834069|P2|NOT COMPLETED|Overall Study||1
2377212|NCT01479725|5834070|P1|NOT COMPLETED|Overall Study||2
2377213|NCT01479725|5834069|P2|COMPLETED|Overall Study||1
2377214|NCT01479725|5834070|P1|COMPLETED|Overall Study||4
2377215|NCT01479725|5834069|P2|STARTED|Overall Study||2
2377216|NCT01479725|5834070|P1|STARTED|Overall Study||6
2377217|NCT01479621|5834082|P7|NOT COMPLETED|Treatment Period||20
2377218|NCT01479621|5834083|P6|NOT COMPLETED|Treatment Period||41
2377219|NCT01479621|5834084|P5|NOT COMPLETED|Treatment Period||21
2377220|NCT01479621|5834085|P4|NOT COMPLETED|Treatment Period||12
2377221|NCT01479621|5834086|P3|NOT COMPLETED|Treatment Period||21
2377222|NCT01479621|5834087|P2|NOT COMPLETED|Treatment Period||24
2377223|NCT01479621|5834088|P1|NOT COMPLETED|Treatment Period||0
2377224|NCT01479621|5834082|P7|COMPLETED|Treatment Period||84
2377225|NCT01479621|5834083|P6|COMPLETED|Treatment Period||63
2377226|NCT01479621|5834084|P5|COMPLETED|Treatment Period||82
2377227|NCT01479621|5834085|P4|COMPLETED|Treatment Period||92
2377228|NCT01479621|5834086|P3|COMPLETED|Treatment Period||83
2377229|NCT01479621|5834087|P2|COMPLETED|Treatment Period||79
2377230|NCT01479621|5834088|P1|COMPLETED|Treatment Period||0
2377231|NCT01479621|5834082|P7|Full Analysis Set|Treatment Period||102
2377232|NCT01479621|5834083|P6|Full Analysis Set|Treatment Period||102
2377233|NCT01479621|5834084|P5|Full Analysis Set|Treatment Period||102
2377234|NCT01479621|5834085|P4|Full Analysis Set|Treatment Period||102
2377235|NCT01479621|5834086|P3|Full Analysis Set|Treatment Period||101
2377236|NCT01479621|5834087|P2|Full Analysis Set|Treatment Period||102
2377237|NCT01479621|5834088|P1|Full Analysis Set|Treatment Period||0
2377238|NCT01479621|5834082|P7|Safety Population|Treatment Period||104
2377239|NCT01479621|5834083|P6|Safety Population|Treatment Period||104
2377240|NCT01479621|5834084|P5|Safety Population|Treatment Period||103
2377241|NCT01479621|5834085|P4|Safety Population|Treatment Period||104
2377242|NCT01479621|5834086|P3|Safety Population|Treatment Period||104
2377243|NCT01479621|5834087|P2|Safety Population|Treatment Period||103
2377244|NCT01479621|5834088|P1|Safety Population|Treatment Period||0
2377245|NCT01479621|5834082|P7|STARTED|Treatment Period||104
2377246|NCT01479621|5834083|P6|STARTED|Treatment Period||104
2377247|NCT01479621|5834084|P5|STARTED|Treatment Period||103
2377248|NCT01479621|5834085|P4|STARTED|Treatment Period||104
2377249|NCT01479621|5834086|P3|STARTED|Treatment Period||104
2377250|NCT01479621|5834087|P2|STARTED|Treatment Period||103
2377251|NCT01479621|5834088|P1|STARTED|Treatment Period||0
2377252|NCT01479621|5834082|P7|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
2377253|NCT01479621|5834083|P6|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
2377254|NCT01479621|5834084|P5|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
2377255|NCT01479621|5834085|P4|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
2377256|NCT01479621|5834086|P3|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
2377257|NCT01479621|5834087|P2|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
2377258|NCT01479621|5834088|P1|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||287
2377259|NCT01479621|5834082|P7|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
2377260|NCT01479621|5834083|P6|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
2377261|NCT01479621|5834084|P5|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
2377262|NCT01479621|5834085|P4|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
2377263|NCT01479621|5834086|P3|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
2377264|NCT01479621|5834087|P2|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
2377265|NCT01479621|5834088|P1|COMPLETED|Pre-Assignment Period (Run-In Placebo)||622
2377266|NCT01479621|5834082|P7|STARTED|Pre-Assignment Period (Run-In Placebo)||0
2377267|NCT01479621|5834083|P6|STARTED|Pre-Assignment Period (Run-In Placebo)||0
2377268|NCT01479621|5834084|P5|STARTED|Pre-Assignment Period (Run-In Placebo)||0
2377269|NCT01479621|5834085|P4|STARTED|Pre-Assignment Period (Run-In Placebo)||0
2377270|NCT01479621|5834086|P3|STARTED|Pre-Assignment Period (Run-In Placebo)||0
2377271|NCT01479621|5834087|P2|STARTED|Pre-Assignment Period (Run-In Placebo)||0
2377272|NCT01479621|5834088|P1|STARTED|Pre-Assignment Period (Run-In Placebo)||909
2377273|NCT01479595|5834176|P2|NOT COMPLETED|Overall Study||2
2377274|NCT01479595|5834177|P1|NOT COMPLETED|Overall Study||2
2377275|NCT01479595|5834176|P2|COMPLETED|Overall Study||19
2377276|NCT01479595|5834177|P1|COMPLETED|Overall Study||42
2377277|NCT01479595|5834176|P2|Per Protocol Analysis Set|Overall Study||20
2377278|NCT01479595|5834177|P1|Per Protocol Analysis Set|Overall Study||41
2377279|NCT01479595|5834176|P2|PK Analysis Set|Overall Study||0
2377280|NCT01479595|5834177|P1|PK Analysis Set|Overall Study||42
2377281|NCT01479595|5834176|P2|STARTED|Overall Study||21
2377282|NCT01479595|5834177|P1|STARTED|Overall Study||44
2377283|NCT01479543|5834204|P5|NOT COMPLETED|Overall Study||1
2377284|NCT01479543|5834205|P4|NOT COMPLETED|Overall Study||0
2377285|NCT01479543|5834206|P3|NOT COMPLETED|Overall Study||1
2377286|NCT01479543|5834207|P2|NOT COMPLETED|Overall Study||0
2377287|NCT01479543|5834208|P1|NOT COMPLETED|Overall Study||1
2377288|NCT01479543|5834204|P5|COMPLETED|Overall Study||20
2377289|NCT01479543|5834205|P4|COMPLETED|Overall Study||20
2377290|NCT01479543|5834206|P3|COMPLETED|Overall Study||20
2377291|NCT01479543|5834207|P2|COMPLETED|Overall Study||20
2377292|NCT01479543|5834208|P1|COMPLETED|Overall Study||20
2377293|NCT01479543|5834204|P5|STARTED|Overall Study||21
2377294|NCT01479543|5834205|P4|STARTED|Overall Study||20
2377295|NCT01479543|5834206|P3|STARTED|Overall Study||21
2377296|NCT01479543|5834207|P2|STARTED|Overall Study||20
2377297|NCT01479543|5834208|P1|STARTED|Overall Study||21
2377298|NCT01479530|5834222|P2|NOT COMPLETED|Overall Study||12
2377299|NCT01479530|5834223|P1|NOT COMPLETED|Overall Study||10
2377300|NCT01479530|5834222|P2|COMPLETED|Overall Study||151
2377301|NCT01479530|5834223|P1|COMPLETED|Overall Study||148
2377302|NCT01479530|5834222|P2|STARTED|Overall Study||163
2377303|NCT01479530|5834223|P1|STARTED|Overall Study||158
2377304|NCT01479517|5834238|P3|NOT COMPLETED|Overall Study||0
2377305|NCT01479517|5834239|P2|NOT COMPLETED|Overall Study||0
2377306|NCT01479517|5834240|P1|NOT COMPLETED|Overall Study||0
2377307|NCT01479517|5834238|P3|COMPLETED|Overall Study||10
2377308|NCT01479517|5834239|P2|COMPLETED|Overall Study||10
2377309|NCT01479517|5834240|P1|COMPLETED|Overall Study||10
2377310|NCT01479517|5834238|P3|STARTED|Overall Study||10
2377311|NCT01479517|5834239|P2|STARTED|Overall Study||10
2377312|NCT01479517|5834240|P1|STARTED|Overall Study||10
2377313|NCT01479478|5834259|P2|NOT COMPLETED|Overall Study||0
2377314|NCT01479478|5834260|P1|NOT COMPLETED|Overall Study||0
2377315|NCT01479478|5834259|P2|COMPLETED|Overall Study||126
2377316|NCT01479478|5834260|P1|COMPLETED|Overall Study||125
2377317|NCT01479478|5834259|P2|STARTED|Overall Study||126
2377318|NCT01479478|5834260|P1|STARTED|Overall Study||125
2377319|NCT01479465|5834304|P4|NOT COMPLETED|Overall Study||85
2377320|NCT01479465|5834305|P3|NOT COMPLETED|Overall Study||86
2377321|NCT01479465|5834306|P2|NOT COMPLETED|Overall Study||84
2377322|NCT01479465|5834307|P1|NOT COMPLETED|Overall Study||11
2377323|NCT01479465|5834304|P4|COMPLETED|Overall Study||0
2377324|NCT01479465|5834305|P3|COMPLETED|Overall Study||0
2377325|NCT01479465|5834306|P2|COMPLETED|Overall Study||0
2377326|NCT01479465|5834307|P1|COMPLETED|Overall Study||0
2377327|NCT01479465|5834304|P4|STARTED|Overall Study||85
2377328|NCT01479465|5834305|P3|STARTED|Overall Study||86
2377329|NCT01479465|5834306|P2|STARTED|Overall Study||84
2377330|NCT01479465|5834307|P1|STARTED|Overall Study||11
2377331|NCT01479426|5834327|P2|NOT COMPLETED|Overall Study||3
2377332|NCT01479426|5834328|P1|NOT COMPLETED|Overall Study||4
2377333|NCT01479426|5834327|P2|COMPLETED|Overall Study||37
2377334|NCT01479426|5834328|P1|COMPLETED|Overall Study||36
2377335|NCT01479426|5834327|P2|STARTED|Overall Study||40
2377336|NCT01479426|5834328|P1|STARTED|Overall Study||40
2377337|NCT01479374|5834343|P3|NOT COMPLETED|Overall Study||5
2377338|NCT01479374|5834344|P2|NOT COMPLETED|Overall Study||8
2377339|NCT01479374|5834345|P1|NOT COMPLETED|Overall Study||3
2377340|NCT01479374|5834343|P3|COMPLETED|Overall Study||63
2377341|NCT01479374|5834344|P2|COMPLETED|Overall Study||60
2377342|NCT01479374|5834345|P1|COMPLETED|Overall Study||63
2377343|NCT01479374|5834343|P3|STARTED|Overall Study||68
2377344|NCT01479374|5834344|P2|STARTED|Overall Study||68
2377345|NCT01479374|5834345|P1|STARTED|Overall Study||66
2377346|NCT01479270|5834373|P2|NOT COMPLETED|Overall Study||0
2377347|NCT01479270|5834374|P1|NOT COMPLETED|Overall Study||0
2377348|NCT01479270|5834373|P2|COMPLETED|Overall Study||28
2377349|NCT01479270|5834374|P1|COMPLETED|Overall Study||28
2377350|NCT01479270|5834373|P2|STARTED|Overall Study||28
2377351|NCT01479270|5834374|P1|STARTED|Overall Study||28
2377352|NCT01479127|5834386|P1|NOT COMPLETED|Overall Study||3
2377353|NCT01479127|5834386|P1|COMPLETED|Overall Study||5
2377354|NCT01479127|5834386|P1|Started LCIG|Overall Study||6
2377355|NCT01479127|5834386|P1|STARTED|Overall Study|started oral study drug (full safety sample)|8
2377356|NCT01479010|5834420|P1|NOT COMPLETED|Overall Study||1
2377357|NCT01479010|5834420|P1|COMPLETED|Overall Study||1
2377358|NCT01479010|5834420|P1|STARTED|Overall Study||2
2377359|NCT01478971|5834431|P1|NOT COMPLETED|Peginesatide Treatment Period||14
2377360|NCT01478971|5834431|P1|COMPLETED|Peginesatide Treatment Period||143
2377361|NCT01478971|5834431|P1|STARTED|Peginesatide Treatment Period|2 participants terminated the study before transitioning to peginesatide for unknown reasons|157
2377362|NCT01478971|5834431|P1|NOT COMPLETED|Standard of Care Period||25
2377363|NCT01478971|5834431|P1|COMPLETED|Standard of Care Period||159
2377364|NCT01478971|5834431|P1|Received Treatment|Standard of Care Period||178
2377365|NCT01478971|5834431|P1|STARTED|Standard of Care Period||184
2377366|NCT01478958|5834448|P3|NOT COMPLETED|Overall Study||3
2377367|NCT01478958|5834449|P2|NOT COMPLETED|Overall Study||2
2377368|NCT01478958|5834450|P1|NOT COMPLETED|Overall Study||2
2377369|NCT01478958|5834448|P3|COMPLETED|Overall Study||66
2377370|NCT01478958|5834449|P2|COMPLETED|Overall Study||64
2377371|NCT01478958|5834450|P1|COMPLETED|Overall Study||65
2377372|NCT01478958|5834448|P3|STARTED|Overall Study||69
2377373|NCT01478958|5834449|P2|STARTED|Overall Study||66
2377374|NCT01478958|5834450|P1|STARTED|Overall Study||67
2377375|NCT01478854|5834458|P1|NOT COMPLETED|Overall Study||0
2377376|NCT01478854|5834458|P1|COMPLETED|Overall Study||30
2377377|NCT01478854|5834458|P1|STARTED|Overall Study||30
2377378|NCT01478828|5834470|P1|NOT COMPLETED|Overall Study||1
2377379|NCT01478828|5834470|P1|COMPLETED|Overall Study||1
2377380|NCT01478828|5834470|P1|STARTED|Overall Study||2
2377381|NCT01478620|5834481|P1|NOT COMPLETED|Overall Study||6
2377382|NCT01478620|5834481|P1|COMPLETED|Overall Study||119
2377383|NCT01478620|5834481|P1|STARTED|Overall Study||125
2377384|NCT01478594|5834487|P2|NOT COMPLETED|Overall Study||28
2377385|NCT01478594|5834488|P1|NOT COMPLETED|Overall Study||65
2377386|NCT01478594|5834487|P2|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|60
2377387|NCT01478594|5834488|P1|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|112
2377388|NCT01478594|5834487|P2|Treated|Overall Study||87
2377389|NCT01478594|5834488|P1|Treated|Overall Study||177
2377390|NCT01478594|5834487|P2|STARTED|Overall Study||88
2377391|NCT01478594|5834488|P1|STARTED|Overall Study||177
2377392|NCT01478581|5834564|P4|NOT COMPLETED|Overall Study||0
2377393|NCT01478581|5834565|P3|NOT COMPLETED|Overall Study||0
2377394|NCT01478581|5834566|P2|NOT COMPLETED|Overall Study||0
2377395|NCT01478581|5834567|P1|NOT COMPLETED|Overall Study||0
2377396|NCT01478581|5834564|P4|COMPLETED|Overall Study||43
2377397|NCT01478581|5834565|P3|COMPLETED|Overall Study||18
2377398|NCT01478581|5834566|P2|COMPLETED|Overall Study||18
2377399|NCT01478581|5834567|P1|COMPLETED|Overall Study||13
2377400|NCT01478581|5834564|P4|STARTED|Overall Study|Simon 2-stage design - cohort 4 expansion per stage 1 data (≥3 Clinical Benefit Responders observed|43
2377401|NCT01478581|5834565|P3|STARTED|Overall Study||18
2377402|NCT01478581|5834566|P2|STARTED|Overall Study||18
2377403|NCT01478581|5834567|P1|STARTED|Overall Study||13
2377404|NCT01478373|5834617|P1|NOT COMPLETED|Survival Phase||38
2377405|NCT01478373|5834617|P1|COMPLETED|Survival Phase||0
2377406|NCT01478373|5834617|P1|STARTED|Survival Phase||38
2377407|NCT01478373|5834617|P1|NOT COMPLETED|Treatment Phase||1
2377408|NCT01478373|5834617|P1|COMPLETED|Treatment Phase||38
2377409|NCT01478373|5834617|P1|STARTED|Treatment Phase||39
2377410|NCT01478360|5834630|P2|NOT COMPLETED|Overall Study||3
2377411|NCT01478360|5834631|P1|NOT COMPLETED|Overall Study||2
2377412|NCT01478360|5834630|P2|COMPLETED|Overall Study||12
2377413|NCT01478360|5834631|P1|COMPLETED|Overall Study||29
2377414|NCT01478360|5834630|P2|PK (Pharmacokinetics) Analysis Set|Overall Study||0
2377415|NCT01478360|5834631|P1|PK (Pharmacokinetics) Analysis Set|Overall Study|Serum samples were collected during the study and analyzed only for the AIN457 group|31
2377416|NCT01478360|5834630|P2|PD (Pharmacodynamic) Analysis Set|Overall Study||15
2377417|NCT01478360|5834631|P1|PD (Pharmacodynamic) Analysis Set|Overall Study||31
2377418|NCT01478360|5834630|P2|STARTED|Overall Study||15
2377419|NCT01478360|5834631|P1|STARTED|Overall Study||31
2377420|NCT01478347|5834637|P1|NOT COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||8
2377421|NCT01478347|5834637|P1|COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||4
2377422|NCT01478347|5834637|P1|STARTED|Visit 4-Visit 7 (Day 151-331) - Part II||12
2377423|NCT01478347|5834637|P1|NOT COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||1
2377424|NCT01478347|5834637|P1|COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||17
2377425|NCT01478347|5834637|P1|STARTED|Visit 1-Visit 3 (Day 0-91) - Part I||18
2377426|NCT01478256|5834644|P2|NOT COMPLETED|Overall Study||0
2377427|NCT01478256|5834645|P1|NOT COMPLETED|Overall Study||0
2377428|NCT01478256|5834644|P2|COMPLETED|Overall Study||15
2377429|NCT01478256|5834645|P1|COMPLETED|Overall Study||15
2377430|NCT01478256|5834644|P2|STARTED|Overall Study||15
2377431|NCT01478256|5834645|P1|STARTED|Overall Study||15
2377432|NCT01478113|5834655|P2|NOT COMPLETED|Overall Study||1
2377433|NCT01478113|5834656|P1|NOT COMPLETED|Overall Study||1
2377434|NCT01478113|5834655|P2|COMPLETED|Overall Study||1
2377435|NCT01478113|5834656|P1|COMPLETED|Overall Study||1
2377436|NCT01478113|5834655|P2|STARTED|Overall Study||2
2377437|NCT01478113|5834656|P1|STARTED|Overall Study||2
2377438|NCT01478087|5834674|P1|NOT COMPLETED|Overall Study||1
2377439|NCT01478087|5834674|P1|COMPLETED|Overall Study||2
2377440|NCT01478087|5834674|P1|STARTED|Overall Study||3
2377441|NCT01478048|5834681|P2|NOT COMPLETED|Overall Study||75
2377442|NCT01478048|5834682|P1|NOT COMPLETED|Overall Study||77
2377443|NCT01478048|5834681|P2|COMPLETED|Overall Study||0
2377444|NCT01478048|5834682|P1|COMPLETED|Overall Study||0
2377445|NCT01478048|5834681|P2|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|74
2377446|NCT01478048|5834682|P1|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|76
2377447|NCT01478048|5834681|P2|STARTED|Overall Study||75
2377448|NCT01478048|5834682|P1|STARTED|Overall Study||77
2377449|NCT01478009|5834700|P2|NOT COMPLETED|Overall Study||1
2377450|NCT01478009|5834701|P1|NOT COMPLETED|Overall Study||1
2377451|NCT01478009|5834700|P2|COMPLETED|Overall Study||49
2377452|NCT01478009|5834701|P1|COMPLETED|Overall Study||49
2377453|NCT01478009|5834700|P2|STARTED|Overall Study||50
2377454|NCT01478009|5834701|P1|STARTED|Overall Study||50
2377455|NCT01477892|5834711|P2|NOT COMPLETED|Overall Study||2
2377456|NCT01477892|5834712|P1|NOT COMPLETED|Overall Study||0
2377457|NCT01477892|5834711|P2|COMPLETED|Overall Study||5
2377458|NCT01477892|5834712|P1|COMPLETED|Overall Study||7
2377459|NCT01477892|5834711|P2|STARTED|Overall Study||7
2377460|NCT01477892|5834712|P1|STARTED|Overall Study||7
2377461|NCT01477853|5834723|P3|NOT COMPLETED|Phase B||11
2377462|NCT01477853|5834724|P2|NOT COMPLETED|Phase B||11
2377463|NCT01477853|5834725|P1|NOT COMPLETED|Phase B||12
2377464|NCT01477853|5834723|P3|COMPLETED|Phase B||0
2377465|NCT01477853|5834724|P2|COMPLETED|Phase B||0
2377466|NCT01477853|5834725|P1|COMPLETED|Phase B||0
2377467|NCT01477853|5834723|P3|STARTED|Phase B||11
2377468|NCT01477853|5834724|P2|STARTED|Phase B||11
2377469|NCT01477853|5834725|P1|STARTED|Phase B||12
2377470|NCT01477853|5834723|P3|NOT COMPLETED|Phase A||44
2377471|NCT01477853|5834724|P2|NOT COMPLETED|Phase A||45
2377472|NCT01477853|5834725|P1|NOT COMPLETED|Phase A||43
2377473|NCT01477853|5834723|P3|COMPLETED|Phase A||11
2377474|NCT01477853|5834724|P2|COMPLETED|Phase A||11
2377475|NCT01477853|5834725|P1|COMPLETED|Phase A||12
2377476|NCT01477853|5834723|P3|STARTED|Phase A||55
2377477|NCT01477853|5834724|P2|STARTED|Phase A||56
2377478|NCT01477853|5834725|P1|STARTED|Phase A||55
2377479|NCT01477762|5834767|P4|NOT COMPLETED|Overall Study||2
2377480|NCT01477762|5834768|P3|NOT COMPLETED|Overall Study||4
2377481|NCT01477762|5834769|P2|NOT COMPLETED|Overall Study||13
2377482|NCT01477762|5834770|P1|NOT COMPLETED|Overall Study||9
2377483|NCT01477762|5834767|P4|COMPLETED|Overall Study||11
2377484|NCT01477762|5834768|P3|COMPLETED|Overall Study||16
2377485|NCT01477762|5834769|P2|COMPLETED|Overall Study||20
2377486|NCT01477762|5834770|P1|COMPLETED|Overall Study||16
2377487|NCT01477762|5834767|P4|STARTED|Overall Study||13
2377488|NCT01477762|5834768|P3|STARTED|Overall Study||20
2377489|NCT01477762|5834769|P2|STARTED|Overall Study||33
2377490|NCT01477762|5834770|P1|STARTED|Overall Study||25
2377491|NCT01477749|5834792|P1|NOT COMPLETED|Overall Study||4
2377492|NCT01477749|5834792|P1|COMPLETED|Overall Study||43
2377493|NCT01477749|5834792|P1|STARTED|Overall Study||47
2377494|NCT01477710|5834799|P1|NOT COMPLETED|Overall Study||0
2377495|NCT01477710|5834799|P1|COMPLETED|Overall Study||30
2377496|NCT01477710|5834799|P1|STARTED|Overall Study||30
2377497|NCT01477567|5834814|P7|NOT COMPLETED|Overall Study||0
2377498|NCT01477567|5834815|P6|NOT COMPLETED|Overall Study||0
2377499|NCT01477567|5834816|P5|NOT COMPLETED|Overall Study||0
2377500|NCT01477567|5834817|P4|NOT COMPLETED|Overall Study||0
2377501|NCT01477567|5834818|P3|NOT COMPLETED|Overall Study||0
2377502|NCT01477567|5834819|P2|NOT COMPLETED|Overall Study||0
2377503|NCT01477567|5834820|P1|NOT COMPLETED|Overall Study||0
2377504|NCT01477567|5834814|P7|COMPLETED|Overall Study||6
2377505|NCT01477567|5834815|P6|COMPLETED|Overall Study||5
2377506|NCT01477567|5834816|P5|COMPLETED|Overall Study||6
2377507|NCT01477567|5834817|P4|COMPLETED|Overall Study||6
2377508|NCT01477567|5834818|P3|COMPLETED|Overall Study||6
2377509|NCT01477567|5834819|P2|COMPLETED|Overall Study||6
2377510|NCT01477567|5834820|P1|COMPLETED|Overall Study||5
2377511|NCT01477567|5834814|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
2377512|NCT01477567|5834815|P6|Received at Least 1 Dose of Study Drug|Overall Study||5
2377513|NCT01477567|5834816|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
2377514|NCT01477567|5834817|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
2377515|NCT01477567|5834818|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
2377516|NCT01477567|5834819|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
2377517|NCT01477567|5834820|P1|Received at Least 1 Dose of Study Drug|Overall Study||5
2377518|NCT01477567|5834814|P7|STARTED|Overall Study||6
2377519|NCT01477567|5834815|P6|STARTED|Overall Study||5
2377520|NCT01477567|5834816|P5|STARTED|Overall Study||6
2377521|NCT01477567|5834817|P4|STARTED|Overall Study||6
2377522|NCT01477567|5834818|P3|STARTED|Overall Study||6
2377523|NCT01477567|5834819|P2|STARTED|Overall Study||6
2377524|NCT01477567|5834820|P1|STARTED|Overall Study||5
2377525|NCT01477463|5834876|P2|NOT COMPLETED|Overall Study||0
2377526|NCT01477463|5834877|P1|NOT COMPLETED|Overall Study||0
2377527|NCT01477463|5834876|P2|COMPLETED|Overall Study||6
2377528|NCT01477463|5834877|P1|COMPLETED|Overall Study||18
2377529|NCT01477463|5834876|P2|STARTED|Overall Study||6
2377530|NCT01477463|5834877|P1|STARTED|Overall Study||18
2377531|NCT01477450|5834890|P3|NOT COMPLETED|Overall Study||0
2377532|NCT01477450|5834891|P2|NOT COMPLETED|Overall Study||0
2377533|NCT01477450|5834892|P1|NOT COMPLETED|Overall Study||0
2377534|NCT01477450|5834890|P3|COMPLETED|Overall Study||10
2377535|NCT01477450|5834891|P2|COMPLETED|Overall Study||10
2377536|NCT01477450|5834892|P1|COMPLETED|Overall Study||10
2377537|NCT01477450|5834890|P3|STARTED|Overall Study||10
2377538|NCT01477450|5834891|P2|STARTED|Overall Study||10
2377539|NCT01477450|5834892|P1|STARTED|Overall Study||10
2377540|NCT01477333|5834900|P1|NOT COMPLETED|Overall Study||3
2377541|NCT01477333|5834900|P1|COMPLETED|Overall Study||15
2377542|NCT01477333|5834900|P1|STARTED|Overall Study||18
2377543|NCT01477320|5834918|P2|NOT COMPLETED|Overall Study||15
2377544|NCT01477320|5834919|P1|NOT COMPLETED|Overall Study||7
2377545|NCT01477320|5834918|P2|COMPLETED|Overall Study||47
2377546|NCT01477320|5834919|P1|COMPLETED|Overall Study||55
2377547|NCT01477320|5834918|P2|STARTED|Overall Study||62
2377548|NCT01477320|5834919|P1|STARTED|Overall Study||62
2377549|NCT01477177|5834927|P1|NOT COMPLETED|Overall Study||0
2377550|NCT01477177|5834927|P1|COMPLETED|Overall Study||4
2377551|NCT01477177|5834927|P1|STARTED|Overall Study||4
2377552|NCT01476748|5834938|P3|NOT COMPLETED|Overall Study||0
2377553|NCT01476748|5834939|P2|NOT COMPLETED|Overall Study||0
2377554|NCT01476748|5834940|P1|NOT COMPLETED|Overall Study||0
2377555|NCT01476748|5834938|P3|COMPLETED|Overall Study||5
2377556|NCT01476748|5834939|P2|COMPLETED|Overall Study||5
2377557|NCT01476748|5834940|P1|COMPLETED|Overall Study||5
2377558|NCT01476748|5834938|P3|STARTED|Overall Study||5
2377559|NCT01476748|5834939|P2|STARTED|Overall Study||5
2377560|NCT01476748|5834940|P1|STARTED|Overall Study||5
2377561|NCT01476722|5834951|P1|NOT COMPLETED|Overall Study||1
2377562|NCT01476722|5834951|P1|COMPLETED|Overall Study||124
2377563|NCT01476722|5834951|P1|STARTED|Overall Study||125
2377564|NCT01476696|5834958|P3|NOT COMPLETED|Overall Study||0
2377565|NCT01476696|5834959|P2|NOT COMPLETED|Overall Study||1
2377566|NCT01476696|5834960|P1|NOT COMPLETED|Overall Study||3
2377567|NCT01476696|5834958|P3|COMPLETED|Overall Study||9
2377568|NCT01476696|5834959|P2|COMPLETED|Overall Study||8
2377569|NCT01476696|5834960|P1|COMPLETED|Overall Study||12
2377570|NCT01476696|5834958|P3|Received at Least 1 Dose of Study Drug|Overall Study||9
2377571|NCT01476696|5834959|P2|Received at Least 1 Dose of Study Drug|Overall Study||9
2377572|NCT01476696|5834960|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
2377573|NCT01476696|5834958|P3|STARTED|Overall Study||9
2377574|NCT01476696|5834959|P2|STARTED|Overall Study||9
2377575|NCT01476696|5834960|P1|STARTED|Overall Study||15
2377576|NCT01476644|5834974|P1|NOT COMPLETED|Overall Study||39
2377577|NCT01476644|5834974|P1|COMPLETED|Overall Study||122
2377578|NCT01476644|5834974|P1|STARTED|Overall Study||161
2377579|NCT01476475|5834981|P2|NOT COMPLETED|Overall Study||3
2377580|NCT01476475|5834982|P1|NOT COMPLETED|Overall Study||11
2377581|NCT01476475|5834981|P2|COMPLETED|Overall Study||159
2377582|NCT01476475|5834982|P1|COMPLETED|Overall Study||150
2377583|NCT01476475|5834981|P2|STARTED|Overall Study||162
2377584|NCT01476475|5834982|P1|STARTED|Overall Study||161
2377585|NCT01476449|5835016|P2|NOT COMPLETED|Overall Study||2
2377586|NCT01476449|5835017|P1|NOT COMPLETED|Overall Study||2
2377587|NCT01476449|5835016|P2|COMPLETED|Overall Study||8
2377588|NCT01476449|5835017|P1|COMPLETED|Overall Study||8
2377589|NCT01476449|5835016|P2|STARTED|Overall Study||10
2377590|NCT01476449|5835017|P1|STARTED|Overall Study||10
2377591|NCT01476345|5835031|P2|NOT COMPLETED|Period 4||0
2377592|NCT01476345|5835032|P1|NOT COMPLETED|Period 4||0
2377593|NCT01476345|5835031|P2|COMPLETED|Period 4||39
2377594|NCT01476345|5835032|P1|COMPLETED|Period 4||39
2377595|NCT01476345|5835031|P2|STARTED|Period 4||39
2377596|NCT01476345|5835032|P1|STARTED|Period 4||39
2377597|NCT01476345|5835031|P2|NOT COMPLETED|Period 3||0
2377598|NCT01476345|5835032|P1|NOT COMPLETED|Period 3||0
2377599|NCT01476345|5835031|P2|COMPLETED|Period 3||39
2377600|NCT01476345|5835032|P1|COMPLETED|Period 3||39
2377601|NCT01476345|5835031|P2|STARTED|Period 3||39
2377602|NCT01476345|5835032|P1|STARTED|Period 3||39
2377603|NCT01476345|5835031|P2|NOT COMPLETED|Period 2||0
2377604|NCT01476345|5835032|P1|NOT COMPLETED|Period 2||0
2377605|NCT01476345|5835031|P2|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
2377606|NCT01476345|5835032|P1|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
2377607|NCT01476345|5835031|P2|STARTED|Period 2||40
2377608|NCT01476345|5835032|P1|STARTED|Period 2||40
2377609|NCT01476345|5835031|P2|NOT COMPLETED|Period 1||0
2377610|NCT01476345|5835032|P1|NOT COMPLETED|Period 1||0
2377611|NCT01476345|5835031|P2|COMPLETED|Period 1||40
2377612|NCT01476345|5835032|P1|COMPLETED|Period 1||40
2377613|NCT01476345|5835031|P2|Received at Least 1 Dose of Study Drug|Period 1||40
2377614|NCT01476345|5835032|P1|Received at Least 1 Dose of Study Drug|Period 1||40
2377615|NCT01476345|5835031|P2|STARTED|Period 1||40
2377616|NCT01476345|5835032|P1|STARTED|Period 1||40
2377617|NCT01476267|5835044|P1|NOT COMPLETED|Overall Study||0
2377618|NCT01476267|5835044|P1|COMPLETED|Overall Study||6
2377619|NCT01476267|5835044|P1|STARTED|Overall Study||6
2377620|NCT01476202|5835052|P3|NOT COMPLETED|Overall Study||0
2377621|NCT01476202|5835053|P2|NOT COMPLETED|Overall Study||0
2377622|NCT01476202|5835054|P1|NOT COMPLETED|Overall Study||0
2377623|NCT01476202|5835052|P3|COMPLETED|Overall Study||40
2377624|NCT01476202|5835053|P2|COMPLETED|Overall Study||40
2377625|NCT01476202|5835054|P1|COMPLETED|Overall Study||40
2377626|NCT01476202|5835052|P3|STARTED|Overall Study||40
2377627|NCT01476202|5835053|P2|STARTED|Overall Study||40
2377628|NCT01476202|5835054|P1|STARTED|Overall Study||40
2377629|NCT01475955|5835070|P5|NOT COMPLETED|Overall Study||0
2377630|NCT01475955|5835071|P4|NOT COMPLETED|Overall Study||0
2377631|NCT01475955|5835072|P3|NOT COMPLETED|Overall Study||3
2377632|NCT01475955|5835073|P2|NOT COMPLETED|Overall Study||0
2377633|NCT01475955|5835074|P1|NOT COMPLETED|Overall Study||1
2377634|NCT01475955|5835070|P5|COMPLETED|Overall Study||46
2377635|NCT01475955|5835071|P4|COMPLETED|Overall Study||46
2377636|NCT01475955|5835072|P3|COMPLETED|Overall Study||44
2377637|NCT01475955|5835073|P2|COMPLETED|Overall Study||48
2377638|NCT01475955|5835074|P1|COMPLETED|Overall Study||47
2377639|NCT01475955|5835070|P5|STARTED|Overall Study||46
2377640|NCT01475955|5835071|P4|STARTED|Overall Study||46
2377641|NCT01475955|5835072|P3|STARTED|Overall Study||47
2377642|NCT01475955|5835073|P2|STARTED|Overall Study||48
2377643|NCT01475955|5835074|P1|STARTED|Overall Study||48
2377644|NCT01475851|5835433|P2|NOT COMPLETED|Overall Study||0
2377645|NCT01475851|5835434|P1|NOT COMPLETED|Overall Study||1
2377646|NCT01475851|5835433|P2|COMPLETED|Overall Study||21
2377647|NCT01475851|5835434|P1|COMPLETED|Overall Study||12
2377648|NCT01475851|5835433|P2|STARTED|Overall Study||21
2377649|NCT01475851|5835434|P1|STARTED|Overall Study||13
2377650|NCT01475838|5835462|P2|NOT COMPLETED|Extension Phase||0
2377651|NCT01475838|5835463|P1|NOT COMPLETED|Extension Phase||1
2377652|NCT01475838|5835462|P2|COMPLETED|Extension Phase||20
2377653|NCT01475838|5835463|P1|COMPLETED|Extension Phase||41
2377654|NCT01475838|5835462|P2|STARTED|Extension Phase||20
2377655|NCT01475838|5835463|P1|STARTED|Extension Phase||42
2377656|NCT01475838|5835462|P2|NOT COMPLETED|Randomized Phase||36
2377657|NCT01475838|5835463|P1|NOT COMPLETED|Randomized Phase||30
2377658|NCT01475838|5835462|P2|COMPLETED|Randomized Phase||109
2377659|NCT01475838|5835463|P1|COMPLETED|Randomized Phase||263
2377660|NCT01475838|5835462|P2|STARTED|Randomized Phase||145
2377661|NCT01475838|5835463|P1|STARTED|Randomized Phase||293
2377662|NCT01475825|5835480|P4|NOT COMPLETED|Overall Study||30
2377663|NCT01475825|5835481|P3|NOT COMPLETED|Overall Study||64
2377664|NCT01475825|5835482|P2|NOT COMPLETED|Overall Study||32
2377665|NCT01475825|5835483|P1|NOT COMPLETED|Overall Study||67
2377666|NCT01475825|5835480|P4|COMPLETED|Overall Study||22
2377667|NCT01475825|5835481|P3|COMPLETED|Overall Study||38
2377668|NCT01475825|5835482|P2|COMPLETED|Overall Study||19
2377669|NCT01475825|5835483|P1|COMPLETED|Overall Study||37
2377670|NCT01475825|5835480|P4|Completed Open-Label Continuation|Overall Study||22
2377671|NCT01475825|5835481|P3|Completed Open-Label Continuation|Overall Study||38
2377672|NCT01475825|5835482|P2|Completed Open-Label Continuation|Overall Study||19
2377673|NCT01475825|5835483|P1|Completed Open-Label Continuation|Overall Study||37
2377674|NCT01475825|5835480|P4|Entered Open-Label Continuation|Overall Study||29
2377675|NCT01475825|5835481|P3|Entered Open-Label Continuation|Overall Study||44
2377676|NCT01475825|5835482|P2|Entered Open-Label Continuation|Overall Study||31
2377677|NCT01475825|5835483|P1|Entered Open-Label Continuation|Overall Study||45
2377678|NCT01475825|5835480|P4|Completed Blinded Treatment Period|Overall Study||40
2377679|NCT01475825|5835481|P3|Completed Blinded Treatment Period|Overall Study||59
2377680|NCT01475825|5835482|P2|Completed Blinded Treatment Period|Overall Study||42
2377681|NCT01475825|5835483|P1|Completed Blinded Treatment Period|Overall Study||60
2377682|NCT01475825|5835480|P4|Randomized and Treated|Overall Study||52
2377683|NCT01475825|5835481|P3|Randomized and Treated|Overall Study||102
2377684|NCT01475825|5835482|P2|Randomized and Treated|Overall Study||51
2377685|NCT01475825|5835483|P1|Randomized and Treated|Overall Study||104
2377686|NCT01475825|5835480|P4|STARTED|Overall Study||52
2377687|NCT01475825|5835481|P3|STARTED|Overall Study||102
2377688|NCT01475825|5835482|P2|STARTED|Overall Study||51
2377689|NCT01475825|5835483|P1|STARTED|Overall Study||104
2377690|NCT01475734|5835515|P2|NOT COMPLETED|Overall Study||1
2377691|NCT01475734|5835516|P1|NOT COMPLETED|Overall Study||2
2377692|NCT01475734|5835515|P2|COMPLETED|Overall Study||21
2377693|NCT01475734|5835516|P1|COMPLETED|Overall Study||20
2377694|NCT01475734|5835515|P2|STARTED|Overall Study||22
2377695|NCT01475734|5835516|P1|STARTED|Overall Study||22
2377696|NCT01475721|5835544|P2|NOT COMPLETED|Overall Study||14
2377697|NCT01475721|5835545|P1|NOT COMPLETED|Overall Study||11
2377698|NCT01475721|5835544|P2|COMPLETED|Overall Study||5831
2377699|NCT01475721|5835545|P1|COMPLETED|Overall Study||5823
2377700|NCT01475721|5835544|P2|STARTED|Overall Study||5845
2377701|NCT01475721|5835545|P1|STARTED|Overall Study||5834
2377702|NCT01475643|5835561|P2|NOT COMPLETED|Overall Study||10
2377703|NCT01475643|5835562|P1|NOT COMPLETED|Overall Study||14
2377704|NCT01475643|5835561|P2|COMPLETED|Overall Study||43
2377705|NCT01475643|5835562|P1|COMPLETED|Overall Study||40
2377706|NCT01475643|5835561|P2|STARTED|Overall Study|52 included in Intent-to-treat (ITT) population, due to no post-treatment assessment.|53
2377707|NCT01475643|5835562|P1|STARTED|Overall Study|53 included in Intent-to-treat (ITT) population, due to no post-treatment assessment.|54
2377708|NCT01475513|5835572|P2|NOT COMPLETED|Overall Study||10
2377709|NCT01475513|5835573|P1|NOT COMPLETED|Overall Study||3
2377710|NCT01475513|5835572|P2|COMPLETED|Overall Study||16
2377711|NCT01475513|5835573|P1|COMPLETED|Overall Study||17
2377712|NCT01475513|5835572|P2|STARTED|Overall Study||26
2377713|NCT01475513|5835573|P1|STARTED|Overall Study||20
2377714|NCT01475487|5835611|P2|NOT COMPLETED|Overall Study||1
2377715|NCT01475487|5835612|P1|NOT COMPLETED|Overall Study||2
2377716|NCT01475487|5835611|P2|COMPLETED|Overall Study||24
2377717|NCT01475487|5835612|P1|COMPLETED|Overall Study||23
2377718|NCT01475487|5835611|P2|STARTED|Overall Study||25
2377719|NCT01475487|5835612|P1|STARTED|Overall Study||25
2377720|NCT01475474|5835624|P1|NOT COMPLETED|Return to Baseline Period - 4 Weeks||2
2377721|NCT01475474|5835624|P1|COMPLETED|Return to Baseline Period - 4 Weeks||71
2377722|NCT01475474|5835624|P1|STARTED|Return to Baseline Period - 4 Weeks||73
2377723|NCT01475474|5835624|P1|NOT COMPLETED|Treatment Period - 12 Weeks||18
2377724|NCT01475474|5835624|P1|COMPLETED|Treatment Period - 12 Weeks||73
2377725|NCT01475474|5835624|P1|STARTED|Treatment Period - 12 Weeks||91
2377726|NCT01475474|5835624|P1|NOT COMPLETED|Baseline Period - 4 Weeks||6
2377727|NCT01475474|5835624|P1|COMPLETED|Baseline Period - 4 Weeks||91
2377728|NCT01475474|5835624|P1|STARTED|Baseline Period - 4 Weeks||97
2377729|NCT01475461|5835635|P7|NOT COMPLETED|Treatment Period||2
2377730|NCT01475461|5835636|P6|NOT COMPLETED|Treatment Period||5
2377731|NCT01475461|5835637|P5|NOT COMPLETED|Treatment Period||4
2377732|NCT01475461|5835638|P4|NOT COMPLETED|Treatment Period||8
2377733|NCT01475461|5835639|P3|NOT COMPLETED|Treatment Period||4
2377734|NCT01475461|5835640|P2|NOT COMPLETED|Treatment Period||9
2377735|NCT01475461|5835641|P1|NOT COMPLETED|Treatment Period||0
2377736|NCT01475461|5835635|P7|COMPLETED|Treatment Period||53
2377737|NCT01475461|5835636|P6|COMPLETED|Treatment Period||51
2377738|NCT01475461|5835637|P5|COMPLETED|Treatment Period||52
2377739|NCT01475461|5835638|P4|COMPLETED|Treatment Period||46
2377740|NCT01475461|5835639|P3|COMPLETED|Treatment Period||53
2377741|NCT01475461|5835640|P2|COMPLETED|Treatment Period||48
2377742|NCT01475461|5835641|P1|COMPLETED|Treatment Period||0
2377743|NCT01475461|5835635|P7|STARTED|Treatment Period||55
2377744|NCT01475461|5835636|P6|STARTED|Treatment Period||56
2377745|NCT01475461|5835637|P5|STARTED|Treatment Period||56
2377746|NCT01475461|5835638|P4|STARTED|Treatment Period||54
2377747|NCT01475461|5835639|P3|STARTED|Treatment Period||57
2377748|NCT01475461|5835640|P2|STARTED|Treatment Period||57
2377749|NCT01475461|5835641|P1|STARTED|Treatment Period||0
2377750|NCT01475461|5835635|P7|NOT COMPLETED|Run-in Period||0
2377751|NCT01475461|5835636|P6|NOT COMPLETED|Run-in Period||0
2377752|NCT01475461|5835637|P5|NOT COMPLETED|Run-in Period||0
2377753|NCT01475461|5835638|P4|NOT COMPLETED|Run-in Period||0
2377754|NCT01475461|5835639|P3|NOT COMPLETED|Run-in Period||0
2377755|NCT01475461|5835640|P2|NOT COMPLETED|Run-in Period||0
2377756|NCT01475461|5835641|P1|NOT COMPLETED|Run-in Period||41
2377757|NCT01475461|5835635|P7|COMPLETED|Run-in Period||0
2377758|NCT01475461|5835636|P6|COMPLETED|Run-in Period||0
2377759|NCT01475461|5835637|P5|COMPLETED|Run-in Period||0
2377760|NCT01475461|5835638|P4|COMPLETED|Run-in Period||0
2377761|NCT01475461|5835639|P3|COMPLETED|Run-in Period||0
2377762|NCT01475461|5835640|P2|COMPLETED|Run-in Period||0
2377763|NCT01475461|5835641|P1|COMPLETED|Run-in Period||335
2377764|NCT01475461|5835635|P7|STARTED|Run-in Period||0
2377765|NCT01475461|5835636|P6|STARTED|Run-in Period||0
2377766|NCT01475461|5835637|P5|STARTED|Run-in Period||0
2377767|NCT01475461|5835638|P4|STARTED|Run-in Period||0
2377768|NCT01475461|5835639|P3|STARTED|Run-in Period||0
2377769|NCT01475461|5835640|P2|STARTED|Run-in Period||0
2377770|NCT01475461|5835641|P1|STARTED|Run-in Period||376
2377771|NCT01475331|5835721|P2|NOT COMPLETED|Overall Study||2
2377772|NCT01475331|5835722|P1|NOT COMPLETED|Overall Study||5
2377773|NCT01475331|5835721|P2|COMPLETED|Overall Study||21
2377774|NCT01475331|5835722|P1|COMPLETED|Overall Study||18
2377775|NCT01475331|5835721|P2|STARTED|Overall Study||23
2377776|NCT01475331|5835722|P1|STARTED|Overall Study||23
2377777|NCT01475305|5835730|P2|NOT COMPLETED|Overall Study||0
2377778|NCT01475305|5835731|P1|NOT COMPLETED|Overall Study||0
2377779|NCT01475305|5835730|P2|COMPLETED|Overall Study||3
2377780|NCT01475305|5835731|P1|COMPLETED|Overall Study||4
2377781|NCT01475305|5835730|P2|End of Quarantine, Day 15|Overall Study||3
2377782|NCT01475305|5835731|P1|End of Quarantine, Day 15|Overall Study||4
2377783|NCT01475305|5835730|P2|STARTED|Overall Study||3
2377784|NCT01475305|5835731|P1|STARTED|Overall Study||4
2377785|NCT01475253|5835774|P4|NOT COMPLETED|Open Label Extension||0
2377786|NCT01475253|5835775|P3|NOT COMPLETED|Open Label Extension||0
2377787|NCT01475253|5835776|P2|NOT COMPLETED|Open Label Extension||0
2377788|NCT01475253|5835777|P1|NOT COMPLETED|Open Label Extension||0
2377789|NCT01475253|5835774|P4|COMPLETED|Open Label Extension||56
2377790|NCT01475253|5835775|P3|COMPLETED|Open Label Extension||0
2377791|NCT01475253|5835776|P2|COMPLETED|Open Label Extension||0
2377792|NCT01475253|5835777|P1|COMPLETED|Open Label Extension||0
2377793|NCT01475253|5835774|P4|STARTED|Open Label Extension||56
2377794|NCT01475253|5835775|P3|STARTED|Open Label Extension||0
2377795|NCT01475253|5835776|P2|STARTED|Open Label Extension||0
2377796|NCT01475253|5835777|P1|STARTED|Open Label Extension||0
2377797|NCT01475253|5835774|P4|NOT COMPLETED|Randomized, Blinded Study||0
2377798|NCT01475253|5835775|P3|NOT COMPLETED|Randomized, Blinded Study||0
2377799|NCT01475253|5835776|P2|NOT COMPLETED|Randomized, Blinded Study||1
2377800|NCT01475253|5835777|P1|NOT COMPLETED|Randomized, Blinded Study||2
2377801|NCT01475253|5835774|P4|COMPLETED|Randomized, Blinded Study||0
2377802|NCT01475253|5835775|P3|COMPLETED|Randomized, Blinded Study||11
2377803|NCT01475253|5835776|P2|COMPLETED|Randomized, Blinded Study||45
2377804|NCT01475253|5835777|P1|COMPLETED|Randomized, Blinded Study||45
2377805|NCT01475253|5835774|P4|STARTED|Randomized, Blinded Study||0
2377806|NCT01475253|5835775|P3|STARTED|Randomized, Blinded Study||11
2377807|NCT01475253|5835776|P2|STARTED|Randomized, Blinded Study||46
2377808|NCT01475253|5835777|P1|STARTED|Randomized, Blinded Study||47
2377809|NCT01475214|5835806|P3|NOT COMPLETED|Overall Study||2
2377810|NCT01475214|5835807|P2|NOT COMPLETED|Overall Study||4
2377811|NCT01475214|5835808|P1|NOT COMPLETED|Overall Study||5
2377812|NCT01475214|5835806|P3|COMPLETED|Overall Study||79
2377813|NCT01475214|5835807|P2|COMPLETED|Overall Study||75
2377814|NCT01475214|5835808|P1|COMPLETED|Overall Study||79
2377815|NCT01475214|5835806|P3|STARTED|Overall Study||81
2377816|NCT01475214|5835807|P2|STARTED|Overall Study||79
2377817|NCT01475214|5835808|P1|STARTED|Overall Study||84
2377818|NCT01475175|5835819|P1|NOT COMPLETED|Overall Study||0
2377819|NCT01475175|5835819|P1|COMPLETED|Overall Study||12
2377820|NCT01475175|5835819|P1|STARTED|Overall Study||12
2377824|NCT01475097|5835844|P2|NOT COMPLETED|Overall Study||1
2377825|NCT01475097|5835845|P1|NOT COMPLETED|Overall Study||1
2377826|NCT01475097|5835844|P2|COMPLETED|Overall Study||126
2377827|NCT01475097|5835845|P1|COMPLETED|Overall Study||127
2377828|NCT01475097|5835844|P2|STARTED|Overall Study||127
2377829|NCT01475097|5835845|P1|STARTED|Overall Study||128
2377830|NCT01475071|5835853|P1|NOT COMPLETED|Overall Study||8
2377831|NCT01475071|5835853|P1|COMPLETED|Overall Study||92
2377832|NCT01475071|5835853|P1|STARTED|Overall Study||100
2377833|NCT01474993|5835863|P2|NOT COMPLETED|Overall Study||3
2377834|NCT01474993|5835864|P1|NOT COMPLETED|Overall Study||1
2377835|NCT01474993|5835863|P2|COMPLETED|Overall Study||26
2377836|NCT01474993|5835864|P1|COMPLETED|Overall Study||14
2377837|NCT01474993|5835863|P2|STARTED|Overall Study||29
2377838|NCT01474993|5835864|P1|STARTED|Overall Study||15
2377839|NCT01474915|5835894|P2|NOT COMPLETED|Overall Study||10
2377840|NCT01474915|5835895|P1|NOT COMPLETED|Overall Study||10
2377841|NCT01474915|5835894|P2|COMPLETED|Overall Study||51
2377842|NCT01474915|5835895|P1|COMPLETED|Overall Study||50
2377843|NCT01474915|5835894|P2|STARTED|Overall Study||61
2377844|NCT01474915|5835895|P1|STARTED|Overall Study||60
2377845|NCT01474876|5835906|P3|NOT COMPLETED|Overall Study||0
2377846|NCT01474876|5835907|P2|NOT COMPLETED|Overall Study||23
2377847|NCT01474876|5835908|P1|NOT COMPLETED|Overall Study||66
2377848|NCT01474876|5835906|P3|COMPLETED|Overall Study||1
2377849|NCT01474876|5835907|P2|COMPLETED|Overall Study||128
2377850|NCT01474876|5835908|P1|COMPLETED|Overall Study||337
2377851|NCT01474876|5835906|P3|STARTED|Overall Study||1
2377852|NCT01474876|5835907|P2|STARTED|Overall Study||151
2377853|NCT01474876|5835908|P1|STARTED|Overall Study||403
2377854|NCT01474863|5835942|P3|NOT COMPLETED|Overall Study||0
2377855|NCT01474863|5835943|P2|NOT COMPLETED|Overall Study||0
2377856|NCT01474863|5835944|P1|NOT COMPLETED|Overall Study||0
2377857|NCT01474863|5835942|P3|COMPLETED|Overall Study||24
2377858|NCT01474863|5835943|P2|COMPLETED|Overall Study||22
2377859|NCT01474863|5835944|P1|COMPLETED|Overall Study||26
2377860|NCT01474863|5835942|P3|STARTED|Overall Study||24
2377861|NCT01474863|5835943|P2|STARTED|Overall Study||22
2377862|NCT01474863|5835944|P1|STARTED|Overall Study||26
2377863|NCT01474772|5835954|P2|NOT COMPLETED|Follow-up||1
2377864|NCT01474772|5835955|P1|NOT COMPLETED|Follow-up||0
2377865|NCT01474772|5835954|P2|COMPLETED|Follow-up||86
2377866|NCT01474772|5835955|P1|COMPLETED|Follow-up||77
2377867|NCT01474772|5835954|P2|STARTED|Follow-up||87
2377868|NCT01474772|5835955|P1|STARTED|Follow-up||77
2377869|NCT01474772|5835954|P2|NOT COMPLETED|Period 2||10
2377870|NCT01474772|5835955|P1|NOT COMPLETED|Period 2||9
2377871|NCT01474772|5835954|P2|COMPLETED|Period 2||87
2377872|NCT01474772|5835955|P1|COMPLETED|Period 2||77
2377873|NCT01474772|5835954|P2|STARTED|Period 2||97
2377874|NCT01474772|5835955|P1|STARTED|Period 2||86
2377875|NCT01474772|5835954|P2|NOT COMPLETED|Washout||2
2377876|NCT01474772|5835955|P1|NOT COMPLETED|Washout||3
2377877|NCT01474772|5835954|P2|COMPLETED|Washout||97
2377878|NCT01474772|5835955|P1|COMPLETED|Washout||86
2377879|NCT01474772|5835954|P2|STARTED|Washout||99
2377880|NCT01474772|5835955|P1|STARTED|Washout||89
2377881|NCT01474772|5835954|P2|NOT COMPLETED|Period 1||3
2377882|NCT01474772|5835955|P1|NOT COMPLETED|Period 1||12
2377883|NCT01474772|5835954|P2|COMPLETED|Period 1||99
2377884|NCT01474772|5835955|P1|COMPLETED|Period 1||89
2377885|NCT01474772|5835954|P2|STARTED|Period 1|STARTED=treated|102
2377886|NCT01474772|5835955|P1|STARTED|Period 1|STARTED=treated. In Period 1 a participant discontinued due to an AE and later died due to the AE.|101
2377887|NCT01474746|5836005|P2|NOT COMPLETED|Overall Study||2
2377888|NCT01474746|5836006|P1|NOT COMPLETED|Overall Study||3
2377889|NCT01474746|5836005|P2|COMPLETED|Overall Study||25
2377890|NCT01474746|5836006|P1|COMPLETED|Overall Study||27
2377891|NCT01474746|5836005|P2|STARTED|Overall Study||27
2377892|NCT01474746|5836006|P1|STARTED|Overall Study||30
2377893|NCT01474681|5836070|P4|NOT COMPLETED|Overall Study||6
2377894|NCT01474681|5836071|P3|NOT COMPLETED|Overall Study||2
2377895|NCT01474681|5836072|P2|NOT COMPLETED|Overall Study||3
2377896|NCT01474681|5836073|P1|NOT COMPLETED|Overall Study||0
2377897|NCT01474681|5836070|P4|COMPLETED|Overall Study||9
2377898|NCT01474681|5836071|P3|COMPLETED|Overall Study||1
2377899|NCT01474681|5836072|P2|COMPLETED|Overall Study||5
2377900|NCT01474681|5836073|P1|COMPLETED|Overall Study||1
2377901|NCT01474681|5836070|P4|STARTED|Overall Study||15
2377902|NCT01474681|5836071|P3|STARTED|Overall Study||3
2377903|NCT01474681|5836072|P2|STARTED|Overall Study||8
2377904|NCT01474681|5836073|P1|STARTED|Overall Study||1
2377905|NCT01474590|5836117|P2|NOT COMPLETED|Overall Study||17
2377906|NCT01474590|5836118|P1|NOT COMPLETED|Overall Study||28
2377907|NCT01474590|5836117|P2|COMPLETED|Overall Study||116
2377908|NCT01474590|5836118|P1|COMPLETED|Overall Study||105
2377909|NCT01474590|5836117|P2|STARTED|Overall Study||133
2377910|NCT01474590|5836118|P1|STARTED|Overall Study||133
2377911|NCT01474551|5836124|P1|NOT COMPLETED|Overall Study||1
2377912|NCT01474551|5836124|P1|COMPLETED|Overall Study||1
2377913|NCT01474551|5836124|P1|STARTED|Overall Study||2
2377914|NCT01474538|5836130|P2|NOT COMPLETED|Treatment Period 2||2
2377915|NCT01474538|5836131|P1|NOT COMPLETED|Treatment Period 2||6
2377916|NCT01474538|5836130|P2|COMPLETED|Treatment Period 2||56
2377917|NCT01474538|5836131|P1|COMPLETED|Treatment Period 2||51
2377918|NCT01474538|5836130|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||58
2377919|NCT01474538|5836131|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||57
2377920|NCT01474538|5836130|P2|STARTED|Treatment Period 2||58
2377921|NCT01474538|5836131|P1|STARTED|Treatment Period 2||57
2377922|NCT01474538|5836130|P2|NOT COMPLETED|Treatment Period 1||4
2377923|NCT01474538|5836131|P1|NOT COMPLETED|Treatment Period 1||3
2377924|NCT01474538|5836130|P2|COMPLETED|Treatment Period 1||58
2377925|NCT01474538|5836131|P1|COMPLETED|Treatment Period 1||57
2377926|NCT01474538|5836130|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||62
2377927|NCT01474538|5836131|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||60
2377928|NCT01474538|5836130|P2|STARTED|Treatment Period 1||62
2377929|NCT01474538|5836131|P1|STARTED|Treatment Period 1||60
2377930|NCT01474512|5836148|P18|NOT COMPLETED|Post-Treatment Follow-Up||46
2377931|NCT01474512|5836149|P17|NOT COMPLETED|Post-Treatment Follow-Up||156
2377932|NCT01474512|5836150|P16|NOT COMPLETED|Post-Treatment Follow-Up||8
2377933|NCT01474512|5836151|P15|NOT COMPLETED|Post-Treatment Follow-Up||18
2377934|NCT01474512|5836152|P14|NOT COMPLETED|Post-Treatment Follow-Up||0
2377935|NCT01474512|5836153|P13|NOT COMPLETED|Post-Treatment Follow-Up||0
2377936|NCT01474512|5836154|P12|NOT COMPLETED|Post-Treatment Follow-Up||0
2377937|NCT01474512|5836155|P11|NOT COMPLETED|Post-Treatment Follow-Up||0
2377938|NCT01474512|5836156|P10|NOT COMPLETED|Post-Treatment Follow-Up||0
2377939|NCT01474512|5836157|P9|NOT COMPLETED|Post-Treatment Follow-Up||0
2377940|NCT01474512|5836158|P8|NOT COMPLETED|Post-Treatment Follow-Up||0
2377941|NCT01474512|5836159|P7|NOT COMPLETED|Post-Treatment Follow-Up||0
2377942|NCT01474512|5836160|P6|NOT COMPLETED|Post-Treatment Follow-Up||0
2377943|NCT01474512|5836161|P5|NOT COMPLETED|Post-Treatment Follow-Up||0
2377944|NCT01474512|5836162|P4|NOT COMPLETED|Post-Treatment Follow-Up||0
2377945|NCT01474512|5836163|P3|NOT COMPLETED|Post-Treatment Follow-Up||0
2377946|NCT01474512|5836164|P2|NOT COMPLETED|Post-Treatment Follow-Up||0
2377947|NCT01474512|5836165|P1|NOT COMPLETED|Post-Treatment Follow-Up||0
2377948|NCT01474512|5836148|P18|COMPLETED|Post-Treatment Follow-Up||239
2377949|NCT01474512|5836149|P17|COMPLETED|Post-Treatment Follow-Up||544
2377950|NCT01474512|5836150|P16|COMPLETED|Post-Treatment Follow-Up||17
2377951|NCT01474512|5836151|P15|COMPLETED|Post-Treatment Follow-Up||0
2377952|NCT01474512|5836152|P14|COMPLETED|Post-Treatment Follow-Up||0
2377953|NCT01474512|5836153|P13|COMPLETED|Post-Treatment Follow-Up||0
2377954|NCT01474512|5836154|P12|COMPLETED|Post-Treatment Follow-Up||0
2377955|NCT01474512|5836155|P11|COMPLETED|Post-Treatment Follow-Up||0
2377956|NCT01474512|5836156|P10|COMPLETED|Post-Treatment Follow-Up||0
2377957|NCT01474512|5836157|P9|COMPLETED|Post-Treatment Follow-Up||0
2377958|NCT01474512|5836158|P8|COMPLETED|Post-Treatment Follow-Up||0
2377959|NCT01474512|5836159|P7|COMPLETED|Post-Treatment Follow-Up||0
2377960|NCT01474512|5836160|P6|COMPLETED|Post-Treatment Follow-Up||0
2377961|NCT01474512|5836161|P5|COMPLETED|Post-Treatment Follow-Up||0
2377962|NCT01474512|5836162|P4|COMPLETED|Post-Treatment Follow-Up||0
2377963|NCT01474512|5836163|P3|COMPLETED|Post-Treatment Follow-Up||0
2377964|NCT01474512|5836164|P2|COMPLETED|Post-Treatment Follow-Up||0
2377965|NCT01474512|5836165|P1|COMPLETED|Post-Treatment Follow-Up||0
2377966|NCT01474512|5836148|P18|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|285
2377967|NCT01474512|5836149|P17|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|700
2377968|NCT01474512|5836150|P16|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|25
2377969|NCT01474512|5836151|P15|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|18
2377970|NCT01474512|5836152|P14|STARTED|Post-Treatment Follow-Up||0
2377971|NCT01474512|5836153|P13|STARTED|Post-Treatment Follow-Up||0
2377972|NCT01474512|5836154|P12|STARTED|Post-Treatment Follow-Up||0
2377973|NCT01474512|5836155|P11|STARTED|Post-Treatment Follow-Up||0
2377974|NCT01474512|5836156|P10|STARTED|Post-Treatment Follow-Up||0
2377975|NCT01474512|5836157|P9|STARTED|Post-Treatment Follow-Up||0
2377976|NCT01474512|5836158|P8|STARTED|Post-Treatment Follow-Up||0
2377977|NCT01474512|5836159|P7|STARTED|Post-Treatment Follow-Up||0
2377978|NCT01474512|5836160|P6|STARTED|Post-Treatment Follow-Up||0
2377979|NCT01474512|5836161|P5|STARTED|Post-Treatment Follow-Up||0
2377980|NCT01474512|5836162|P4|STARTED|Post-Treatment Follow-Up||0
2377981|NCT01474512|5836163|P3|STARTED|Post-Treatment Follow-Up||0
2377982|NCT01474512|5836164|P2|STARTED|Post-Treatment Follow-Up||0
2377983|NCT01474512|5836165|P1|STARTED|Post-Treatment Follow-Up||0
2377984|NCT01474512|5836148|P18|NOT COMPLETED|Long-Term Extension Period||0
2377985|NCT01474512|5836149|P17|NOT COMPLETED|Long-Term Extension Period||0
2377986|NCT01474512|5836150|P16|NOT COMPLETED|Long-Term Extension Period||0
2377987|NCT01474512|5836151|P15|NOT COMPLETED|Long-Term Extension Period||0
2377988|NCT01474512|5836152|P14|NOT COMPLETED|Long-Term Extension Period||220
2377989|NCT01474512|5836153|P13|NOT COMPLETED|Long-Term Extension Period||218
2377990|NCT01474512|5836154|P12|NOT COMPLETED|Long-Term Extension Period||26
2377991|NCT01474512|5836155|P11|NOT COMPLETED|Long-Term Extension Period||0
2377992|NCT01474512|5836156|P10|NOT COMPLETED|Long-Term Extension Period||0
2377993|NCT01474512|5836157|P9|NOT COMPLETED|Long-Term Extension Period||0
2377994|NCT01474512|5836158|P8|NOT COMPLETED|Long-Term Extension Period||0
2377995|NCT01474512|5836159|P7|NOT COMPLETED|Long-Term Extension Period||0
2377996|NCT01474512|5836160|P6|NOT COMPLETED|Long-Term Extension Period||0
2377997|NCT01474512|5836161|P5|NOT COMPLETED|Long-Term Extension Period||0
2377998|NCT01474512|5836162|P4|NOT COMPLETED|Long-Term Extension Period||0
2377999|NCT01474512|5836163|P3|NOT COMPLETED|Long-Term Extension Period||0
2378000|NCT01474512|5836164|P2|NOT COMPLETED|Long-Term Extension Period||0
2378001|NCT01474512|5836165|P1|NOT COMPLETED|Long-Term Extension Period||0
2378002|NCT01474512|5836148|P18|COMPLETED|Long-Term Extension Period||0
2378003|NCT01474512|5836149|P17|COMPLETED|Long-Term Extension Period||0
2378004|NCT01474512|5836150|P16|COMPLETED|Long-Term Extension Period||0
2378005|NCT01474512|5836151|P15|COMPLETED|Long-Term Extension Period||0
2378006|NCT01474512|5836152|P14|COMPLETED|Long-Term Extension Period||855
2378007|NCT01474512|5836153|P13|COMPLETED|Long-Term Extension Period||836
2378008|NCT01474512|5836154|P12|COMPLETED|Long-Term Extension Period||0
2378009|NCT01474512|5836155|P11|COMPLETED|Long-Term Extension Period||0
2378010|NCT01474512|5836156|P10|COMPLETED|Long-Term Extension Period||0
2378011|NCT01474512|5836157|P9|COMPLETED|Long-Term Extension Period||0
2378012|NCT01474512|5836158|P8|COMPLETED|Long-Term Extension Period||0
2378013|NCT01474512|5836159|P7|COMPLETED|Long-Term Extension Period||0
2378014|NCT01474512|5836160|P6|COMPLETED|Long-Term Extension Period||0
2378015|NCT01474512|5836161|P5|COMPLETED|Long-Term Extension Period||0
2378016|NCT01474512|5836162|P4|COMPLETED|Long-Term Extension Period||0
2378017|NCT01474512|5836163|P3|COMPLETED|Long-Term Extension Period||0
2378018|NCT01474512|5836164|P2|COMPLETED|Long-Term Extension Period||0
2378019|NCT01474512|5836165|P1|COMPLETED|Long-Term Extension Period||0
2378020|NCT01474512|5836148|P18|STARTED|Long-Term Extension Period||0
2378021|NCT01474512|5836149|P17|STARTED|Long-Term Extension Period||0
2378022|NCT01474512|5836150|P16|STARTED|Long-Term Extension Period||0
2378023|NCT01474512|5836151|P15|STARTED|Long-Term Extension Period||0
2378024|NCT01474512|5836152|P14|STARTED|Long-Term Extension Period|Participants received Ixe in all dosing regimens, including participants who switched PBO to Ixe.|1075
2378025|NCT01474512|5836153|P13|STARTED|Long-Term Extension Period|Participants received Ixe alone at the start of long-term extension.|1054
2378026|NCT01474512|5836154|P12|STARTED|Long-Term Extension Period|9 participants did not start the long-term extension period.|26
2378027|NCT01474512|5836155|P11|STARTED|Long-Term Extension Period||0
2378028|NCT01474512|5836156|P10|STARTED|Long-Term Extension Period||0
2378029|NCT01474512|5836157|P9|STARTED|Long-Term Extension Period||0
2378030|NCT01474512|5836158|P8|STARTED|Long-Term Extension Period||0
2378031|NCT01474512|5836159|P7|STARTED|Long-Term Extension Period||0
2378032|NCT01474512|5836160|P6|STARTED|Long-Term Extension Period||0
2378033|NCT01474512|5836161|P5|STARTED|Long-Term Extension Period||0
2378034|NCT01474512|5836162|P4|STARTED|Long-Term Extension Period||0
2378035|NCT01474512|5836163|P3|STARTED|Long-Term Extension Period||0
2378036|NCT01474512|5836164|P2|STARTED|Long-Term Extension Period||0
2378037|NCT01474512|5836165|P1|STARTED|Long-Term Extension Period||0
2378038|NCT01474512|5836148|P18|NOT COMPLETED|Maintenance Period||0
2378039|NCT01474512|5836149|P17|NOT COMPLETED|Maintenance Period||0
2378040|NCT01474512|5836150|P16|NOT COMPLETED|Maintenance Period||0
2378041|NCT01474512|5836151|P15|NOT COMPLETED|Maintenance Period||0
2378042|NCT01474512|5836152|P14|NOT COMPLETED|Maintenance Period||0
2378043|NCT01474512|5836153|P13|NOT COMPLETED|Maintenance Period||0
2378044|NCT01474512|5836154|P12|NOT COMPLETED|Maintenance Period||0
2378045|NCT01474512|5836155|P11|NOT COMPLETED|Maintenance Period||0
2378046|NCT01474512|5836156|P10|NOT COMPLETED|Maintenance Period||18
2378047|NCT01474512|5836157|P9|NOT COMPLETED|Maintenance Period||16
2378048|NCT01474512|5836158|P8|NOT COMPLETED|Maintenance Period||41
2378049|NCT01474512|5836159|P7|NOT COMPLETED|Maintenance Period||10
2378050|NCT01474512|5836160|P6|NOT COMPLETED|Maintenance Period||52
2378051|NCT01474512|5836161|P5|NOT COMPLETED|Maintenance Period||119
2378052|NCT01474512|5836162|P4|NOT COMPLETED|Maintenance Period||202
2378053|NCT01474512|5836163|P3|NOT COMPLETED|Maintenance Period||0
2378054|NCT01474512|5836164|P2|NOT COMPLETED|Maintenance Period||0
2378055|NCT01474512|5836165|P1|NOT COMPLETED|Maintenance Period||0
2378056|NCT01474512|5836148|P18|COMPLETED|Maintenance Period||0
2378057|NCT01474512|5836149|P17|COMPLETED|Maintenance Period||0
2378058|NCT01474512|5836150|P16|COMPLETED|Maintenance Period||0
2378059|NCT01474512|5836151|P15|COMPLETED|Maintenance Period||0
2378060|NCT01474512|5836152|P14|COMPLETED|Maintenance Period||0
2378061|NCT01474512|5836153|P13|COMPLETED|Maintenance Period||0
2378062|NCT01474512|5836154|P12|COMPLETED|Maintenance Period||0
2378063|NCT01474512|5836155|P11|COMPLETED|Maintenance Period||0
2378064|NCT01474512|5836156|P10|COMPLETED|Maintenance Period||44
2378065|NCT01474512|5836157|P9|COMPLETED|Maintenance Period||62
2378066|NCT01474512|5836158|P8|COMPLETED|Maintenance Period||350
2378067|NCT01474512|5836159|P7|COMPLETED|Maintenance Period||6
2378068|NCT01474512|5836160|P6|COMPLETED|Maintenance Period||177
2378069|NCT01474512|5836161|P5|COMPLETED|Maintenance Period||108
2378070|NCT01474512|5836162|P4|COMPLETED|Maintenance Period||24
2378071|NCT01474512|5836163|P3|COMPLETED|Maintenance Period||0
2378072|NCT01474512|5836164|P2|COMPLETED|Maintenance Period||0
2378073|NCT01474512|5836165|P1|COMPLETED|Maintenance Period||0
2378074|NCT01474512|5836148|P18|Relapsed Population Completers|Maintenance Period||0
2378075|NCT01474512|5836149|P17|Relapsed Population Completers|Maintenance Period||0
2378076|NCT01474512|5836150|P16|Relapsed Population Completers|Maintenance Period||0
2378077|NCT01474512|5836151|P15|Relapsed Population Completers|Maintenance Period||0
2378078|NCT01474512|5836152|P14|Relapsed Population Completers|Maintenance Period||0
2378079|NCT01474512|5836153|P13|Relapsed Population Completers|Maintenance Period||0
2378080|NCT01474512|5836154|P12|Relapsed Population Completers|Maintenance Period||0
2378081|NCT01474512|5836155|P11|Relapsed Population Completers|Maintenance Period||321
2378082|NCT01474512|5836156|P10|Relapsed Population Completers|Maintenance Period||0
2378083|NCT01474512|5836157|P9|Relapsed Population Completers|Maintenance Period||0
2378084|NCT01474512|5836158|P8|Relapsed Population Completers|Maintenance Period||0
2378085|NCT01474512|5836159|P7|Relapsed Population Completers|Maintenance Period||0
2378086|NCT01474512|5836160|P6|Relapsed Population Completers|Maintenance Period||0
2378087|NCT01474512|5836161|P5|Relapsed Population Completers|Maintenance Period||0
2378088|NCT01474512|5836162|P4|Relapsed Population Completers|Maintenance Period||0
2378089|NCT01474512|5836163|P3|Relapsed Population Completers|Maintenance Period||0
2378090|NCT01474512|5836164|P2|Relapsed Population Completers|Maintenance Period||0
2378091|NCT01474512|5836165|P1|Relapsed Population Completers|Maintenance Period||0
2378092|NCT01474512|5836148|P18|Relapsed Population Received Drug|Maintenance Period||0
2378093|NCT01474512|5836149|P17|Relapsed Population Received Drug|Maintenance Period||0
2378094|NCT01474512|5836150|P16|Relapsed Population Received Drug|Maintenance Period||0
2378095|NCT01474512|5836151|P15|Relapsed Population Received Drug|Maintenance Period||0
2378096|NCT01474512|5836152|P14|Relapsed Population Received Drug|Maintenance Period||0
2378097|NCT01474512|5836153|P13|Relapsed Population Received Drug|Maintenance Period||0
2378098|NCT01474512|5836154|P12|Relapsed Population Received Drug|Maintenance Period||0
2378099|NCT01474512|5836155|P11|Relapsed Population Received Drug|Maintenance Period||348
2378100|NCT01474512|5836156|P10|Relapsed Population Received Drug|Maintenance Period||0
2378101|NCT01474512|5836157|P9|Relapsed Population Received Drug|Maintenance Period||0
2378102|NCT01474512|5836158|P8|Relapsed Population Received Drug|Maintenance Period||0
2378103|NCT01474512|5836159|P7|Relapsed Population Received Drug|Maintenance Period||0
2378104|NCT01474512|5836160|P6|Relapsed Population Received Drug|Maintenance Period||0
2378105|NCT01474512|5836161|P5|Relapsed Population Received Drug|Maintenance Period||0
2378106|NCT01474512|5836162|P4|Relapsed Population Received Drug|Maintenance Period||0
2378107|NCT01474512|5836163|P3|Relapsed Population Received Drug|Maintenance Period||0
2378108|NCT01474512|5836164|P2|Relapsed Population Received Drug|Maintenance Period||0
2378109|NCT01474512|5836165|P1|Relapsed Population Received Drug|Maintenance Period||0
2378110|NCT01474512|5836148|P18|Received Study Drug|Maintenance Period||0
2378111|NCT01474512|5836149|P17|Received Study Drug|Maintenance Period||0
2378112|NCT01474512|5836150|P16|Received Study Drug|Maintenance Period||0
2378113|NCT01474512|5836151|P15|Received Study Drug|Maintenance Period||0
2378114|NCT01474512|5836152|P14|Received Study Drug|Maintenance Period||0
2378115|NCT01474512|5836153|P13|Received Study Drug|Maintenance Period||0
2378116|NCT01474512|5836154|P12|Received Study Drug|Maintenance Period||0
2378117|NCT01474512|5836155|P11|Received Study Drug|Maintenance Period||0
2378118|NCT01474512|5836156|P10|Received Study Drug|Maintenance Period||62
2378119|NCT01474512|5836157|P9|Received Study Drug|Maintenance Period||78
2378120|NCT01474512|5836158|P8|Received Study Drug|Maintenance Period||391
2378121|NCT01474512|5836159|P7|Received Study Drug|Maintenance Period||16
2378122|NCT01474512|5836160|P6|Received Study Drug|Maintenance Period||229
2378123|NCT01474512|5836161|P5|Received Study Drug|Maintenance Period||227
2378124|NCT01474512|5836162|P4|Received Study Drug|Maintenance Period||226
2378125|NCT01474512|5836163|P3|Received Study Drug|Maintenance Period||0
2378126|NCT01474512|5836164|P2|Received Study Drug|Maintenance Period||0
2378127|NCT01474512|5836165|P1|Received Study Drug|Maintenance Period||0
2378128|NCT01474512|5836148|P18|STARTED|Maintenance Period||0
2378129|NCT01474512|5836149|P17|STARTED|Maintenance Period||0
2378130|NCT01474512|5836150|P16|STARTED|Maintenance Period||0
2378131|NCT01474512|5836151|P15|STARTED|Maintenance Period||0
2378132|NCT01474512|5836152|P14|STARTED|Maintenance Period||0
2378133|NCT01474512|5836153|P13|STARTED|Maintenance Period||0
2378134|NCT01474512|5836154|P12|STARTED|Maintenance Period||0
2378135|NCT01474512|5836155|P11|STARTED|Maintenance Period||0
2378136|NCT01474512|5836156|P10|STARTED|Maintenance Period||62
2378137|NCT01474512|5836157|P9|STARTED|Maintenance Period||78
2378138|NCT01474512|5836158|P8|STARTED|Maintenance Period||391
2378139|NCT01474512|5836159|P7|STARTED|Maintenance Period||16
2378140|NCT01474512|5836160|P6|STARTED|Maintenance Period||229
2378141|NCT01474512|5836161|P5|STARTED|Maintenance Period|One participant withdrew end of Induction but re-randomized and treated with maintenance dose ixe.|227
2378142|NCT01474512|5836162|P4|STARTED|Maintenance Period||226
2378143|NCT01474512|5836163|P3|STARTED|Maintenance Period||0
2378144|NCT01474512|5836164|P2|STARTED|Maintenance Period||0
2378145|NCT01474512|5836165|P1|STARTED|Maintenance Period||0
2378146|NCT01474512|5836148|P18|NOT COMPLETED|Induction Period||0
2378147|NCT01474512|5836149|P17|NOT COMPLETED|Induction Period||0
2378148|NCT01474512|5836150|P16|NOT COMPLETED|Induction Period||0
2378149|NCT01474512|5836151|P15|NOT COMPLETED|Induction Period||0
2378150|NCT01474512|5836152|P14|NOT COMPLETED|Induction Period||0
2378151|NCT01474512|5836153|P13|NOT COMPLETED|Induction Period||0
2378152|NCT01474512|5836154|P12|NOT COMPLETED|Induction Period||0
2378153|NCT01474512|5836155|P11|NOT COMPLETED|Induction Period||0
2378154|NCT01474512|5836156|P10|NOT COMPLETED|Induction Period||0
2378155|NCT01474512|5836157|P9|NOT COMPLETED|Induction Period||0
2378156|NCT01474512|5836158|P8|NOT COMPLETED|Induction Period||0
2378157|NCT01474512|5836159|P7|NOT COMPLETED|Induction Period||0
2378158|NCT01474512|5836160|P6|NOT COMPLETED|Induction Period||0
2378159|NCT01474512|5836161|P5|NOT COMPLETED|Induction Period||0
2378160|NCT01474512|5836162|P4|NOT COMPLETED|Induction Period||0
2378161|NCT01474512|5836163|P3|NOT COMPLETED|Induction Period||18
2378162|NCT01474512|5836164|P2|NOT COMPLETED|Induction Period||24
2378163|NCT01474512|5836165|P1|NOT COMPLETED|Induction Period||24
2378164|NCT01474512|5836148|P18|COMPLETED|Induction Period||0
2378165|NCT01474512|5836149|P17|COMPLETED|Induction Period||0
2378166|NCT01474512|5836150|P16|COMPLETED|Induction Period||0
2378167|NCT01474512|5836151|P15|COMPLETED|Induction Period||0
2378168|NCT01474512|5836152|P14|COMPLETED|Induction Period||0
2378169|NCT01474512|5836153|P13|COMPLETED|Induction Period||0
2378170|NCT01474512|5836154|P12|COMPLETED|Induction Period||0
2378171|NCT01474512|5836155|P11|COMPLETED|Induction Period||0
2378172|NCT01474512|5836156|P10|COMPLETED|Induction Period||0
2378173|NCT01474512|5836157|P9|COMPLETED|Induction Period||0
2378174|NCT01474512|5836158|P8|COMPLETED|Induction Period||0
2378175|NCT01474512|5836159|P7|COMPLETED|Induction Period||0
2378176|NCT01474512|5836160|P6|COMPLETED|Induction Period||0
2378177|NCT01474512|5836161|P5|COMPLETED|Induction Period||0
2378178|NCT01474512|5836162|P4|COMPLETED|Induction Period||0
2378179|NCT01474512|5836163|P3|COMPLETED|Induction Period||415
2378180|NCT01474512|5836164|P2|COMPLETED|Induction Period||408
2378181|NCT01474512|5836165|P1|COMPLETED|Induction Period||407
2378182|NCT01474512|5836148|P18|Received Study Drug|Induction Period||0
2378183|NCT01474512|5836149|P17|Received Study Drug|Induction Period||0
2378184|NCT01474512|5836150|P16|Received Study Drug|Induction Period||0
2378185|NCT01474512|5836151|P15|Received Study Drug|Induction Period||0
2378186|NCT01474512|5836152|P14|Received Study Drug|Induction Period||0
2378187|NCT01474512|5836153|P13|Received Study Drug|Induction Period||0
2378188|NCT01474512|5836154|P12|Received Study Drug|Induction Period||0
2378189|NCT01474512|5836155|P11|Received Study Drug|Induction Period||0
2378190|NCT01474512|5836156|P10|Received Study Drug|Induction Period||0
2378191|NCT01474512|5836157|P9|Received Study Drug|Induction Period||0
2378192|NCT01474512|5836158|P8|Received Study Drug|Induction Period||0
2378193|NCT01474512|5836159|P7|Received Study Drug|Induction Period||0
2378194|NCT01474512|5836160|P6|Received Study Drug|Induction Period||0
2378195|NCT01474512|5836161|P5|Received Study Drug|Induction Period||0
2378196|NCT01474512|5836162|P4|Received Study Drug|Induction Period||0
2378197|NCT01474512|5836163|P3|Received Study Drug|Induction Period||433
2378198|NCT01474512|5836164|P2|Received Study Drug|Induction Period||432
2378199|NCT01474512|5836165|P1|Received Study Drug|Induction Period||431
2378200|NCT01474512|5836148|P18|STARTED|Induction Period||0
2378201|NCT01474512|5836149|P17|STARTED|Induction Period||0
2378202|NCT01474512|5836150|P16|STARTED|Induction Period||0
2378203|NCT01474512|5836151|P15|STARTED|Induction Period||0
2378204|NCT01474512|5836152|P14|STARTED|Induction Period||0
2378205|NCT01474512|5836153|P13|STARTED|Induction Period||0
2378206|NCT01474512|5836154|P12|STARTED|Induction Period||0
2378207|NCT01474512|5836155|P11|STARTED|Induction Period||0
2378208|NCT01474512|5836156|P10|STARTED|Induction Period||0
2378209|NCT01474512|5836157|P9|STARTED|Induction Period||0
2378210|NCT01474512|5836158|P8|STARTED|Induction Period||0
2378211|NCT01474512|5836159|P7|STARTED|Induction Period||0
2378212|NCT01474512|5836160|P6|STARTED|Induction Period||0
2378213|NCT01474512|5836161|P5|STARTED|Induction Period||0
2378214|NCT01474512|5836162|P4|STARTED|Induction Period||0
2378215|NCT01474512|5836163|P3|STARTED|Induction Period||433
2378216|NCT01474512|5836164|P2|STARTED|Induction Period||432
2378217|NCT01474512|5836165|P1|STARTED|Induction Period||431
2378218|NCT01474434|5836241|P4|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
2378219|NCT01474434|5836242|P3|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
2378220|NCT01474434|5836243|P2|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
2378221|NCT01474434|5836244|P1|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
2378222|NCT01474434|5836241|P4|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||11
2378223|NCT01474434|5836242|P3|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||10
2378224|NCT01474434|5836243|P2|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||9
2378225|NCT01474434|5836244|P1|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||7
2378226|NCT01474434|5836241|P4|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||11
2378227|NCT01474434|5836242|P3|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||10
2378228|NCT01474434|5836243|P2|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||9
2378229|NCT01474434|5836244|P1|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||7
2378230|NCT01474434|5836241|P4|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||2
2378231|NCT01474434|5836242|P3|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
2378232|NCT01474434|5836243|P2|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||0
2378233|NCT01474434|5836244|P1|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
2378234|NCT01474434|5836241|P4|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||11
2378235|NCT01474434|5836242|P3|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||10
2378236|NCT01474434|5836243|P2|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||9
2378237|NCT01474434|5836244|P1|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||7
2378238|NCT01474434|5836241|P4|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||13
2378239|NCT01474434|5836242|P3|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||11
2378240|NCT01474434|5836243|P2|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||9
2378241|NCT01474434|5836244|P1|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||8
2378242|NCT01474317|5836286|P1|NOT COMPLETED|Overall Study||2
2378243|NCT01474317|5836286|P1|COMPLETED|Overall Study||224
2378244|NCT01474317|5836286|P1|STARTED|Overall Study||226
2378245|NCT01474291|5836295|P1|NOT COMPLETED|Overall Study||220
2378246|NCT01474291|5836295|P1|COMPLETED|Overall Study||383
2378247|NCT01474291|5836295|P1|Evaluable for Efficacy|Overall Study|Received tocilizumab infusion and met all inclusion/exclusion criteria|577
2378248|NCT01474291|5836295|P1|STARTED|Overall Study||603
2378249|NCT01474239|5836339|P2|NOT COMPLETED|Overall Study||32
2378250|NCT01474239|5836340|P1|NOT COMPLETED|Overall Study||59
2378251|NCT01474239|5836339|P2|COMPLETED|Overall Study||0
2378252|NCT01474239|5836340|P1|COMPLETED|Overall Study||0
2378253|NCT01474239|5836339|P2|STARTED|Overall Study||32
2378254|NCT01474239|5836340|P1|STARTED|Overall Study||59
2378255|NCT01474213|5836378|P2|NOT COMPLETED|Overall Study||0
2378256|NCT01474213|5836379|P1|NOT COMPLETED|Overall Study||0
2378257|NCT01474213|5836378|P2|COMPLETED|Overall Study||20
2378258|NCT01474213|5836379|P1|COMPLETED|Overall Study||20
2378259|NCT01474213|5836378|P2|STARTED|Overall Study||20
2378260|NCT01474213|5836379|P1|STARTED|Overall Study||20
2378261|NCT01474200|5836403|P2|NOT COMPLETED|Overall Study||30
2378262|NCT01474200|5836404|P1|NOT COMPLETED|Overall Study||29
2378263|NCT01474200|5836403|P2|COMPLETED|Overall Study||84
2378264|NCT01474200|5836404|P1|COMPLETED|Overall Study||81
2378265|NCT01474200|5836403|P2|STARTED|Overall Study||114
2378266|NCT01474200|5836404|P1|STARTED|Overall Study||110
2378267|NCT01474122|5836457|P3|NOT COMPLETED|Period 2: Week 16 to End of Study||15
2378268|NCT01474122|5836458|P2|NOT COMPLETED|Period 2: Week 16 to End of Study||13
2378269|NCT01474122|5836459|P1|NOT COMPLETED|Period 2: Week 16 to End of Study||17
2378270|NCT01474122|5836457|P3|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
2378271|NCT01474122|5836458|P2|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
2378272|NCT01474122|5836459|P1|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|70
2378273|NCT01474122|5836457|P3|STARTED|Period 2: Week 16 to End of Study||88
2378274|NCT01474122|5836458|P2|STARTED|Period 2: Week 16 to End of Study||86
2378275|NCT01474122|5836459|P1|STARTED|Period 2: Week 16 to End of Study||87
2378276|NCT01474122|5836457|P3|NOT COMPLETED|Period 1: Baseline to Week 16||1
2378277|NCT01474122|5836458|P2|NOT COMPLETED|Period 1: Baseline to Week 16||2
2378278|NCT01474122|5836459|P1|NOT COMPLETED|Period 1: Baseline to Week 16||1
2378279|NCT01474122|5836457|P3|COMPLETED|Period 1: Baseline to Week 16||88
2378280|NCT01474122|5836458|P2|COMPLETED|Period 1: Baseline to Week 16||86
2378281|NCT01474122|5836459|P1|COMPLETED|Period 1: Baseline to Week 16||87
2378282|NCT01474122|5836457|P3|STARTED|Period 1: Baseline to Week 16||89
2378283|NCT01474122|5836458|P2|STARTED|Period 1: Baseline to Week 16|One patient was randomised but did not receive study treatment|88
2378284|NCT01474122|5836459|P1|STARTED|Period 1: Baseline to Week 16||88
2378285|NCT01474109|5836485|P3|NOT COMPLETED|Period 2: Week 16 to End of Study||12
2378286|NCT01474109|5836486|P2|NOT COMPLETED|Period 2: Week 16 to End of Study||18
2378287|NCT01474109|5836487|P1|NOT COMPLETED|Period 2: Week 16 to End of Study||18
2378288|NCT01474109|5836485|P3|COMPLETED|Period 2: Week 16 to End of Study||83
2378289|NCT01474109|5836486|P2|COMPLETED|Period 2: Week 16 to End of Study||73
2378290|NCT01474109|5836487|P1|COMPLETED|Period 2: Week 16 to End of Study||70
2378291|NCT01474109|5836485|P3|STARTED|Period 2: Week 16 to End of Study||95
2378292|NCT01474109|5836486|P2|STARTED|Period 2: Week 16 to End of Study||91
2378293|NCT01474109|5836487|P1|STARTED|Period 2: Week 16 to End of Study||88
2378294|NCT01474109|5836485|P3|NOT COMPLETED|Period 1: Baseline to Week 16||2
2378295|NCT01474109|5836486|P2|NOT COMPLETED|Period 1: Baseline to Week 16||6
2378296|NCT01474109|5836487|P1|NOT COMPLETED|Period 1: Baseline to Week 16||7
2378297|NCT01474109|5836485|P3|COMPLETED|Period 1: Baseline to Week 16||95
2378298|NCT01474109|5836486|P2|COMPLETED|Period 1: Baseline to Week 16||91
2378299|NCT01474109|5836487|P1|COMPLETED|Period 1: Baseline to Week 16||88
2378300|NCT01474109|5836485|P3|STARTED|Period 1: Baseline to Week 16||97
2378301|NCT01474109|5836486|P2|STARTED|Period 1: Baseline to Week 16||97
2378302|NCT01474109|5836487|P1|STARTED|Period 1: Baseline to Week 16||95
2378303|NCT01474018|5836512|P2|NOT COMPLETED|Overall Study||3
2378304|NCT01474018|5836513|P1|NOT COMPLETED|Overall Study||0
2378305|NCT01474018|5836512|P2|COMPLETED|Overall Study||7
2378306|NCT01474018|5836513|P1|COMPLETED|Overall Study|Writing paper|5
2378307|NCT01474018|5836512|P2|STARTED|Overall Study||10
2378308|NCT01474018|5836513|P1|STARTED|Overall Study||5
2378309|NCT01473992|5836523|P3|NOT COMPLETED|Overall Study||0
2378310|NCT01473992|5836524|P2|NOT COMPLETED|Overall Study||0
2378311|NCT01473992|5836525|P1|NOT COMPLETED|Overall Study||0
2378312|NCT01473992|5836523|P3|COMPLETED|Overall Study||5
2378313|NCT01473992|5836524|P2|COMPLETED|Overall Study||10
2378314|NCT01473992|5836525|P1|COMPLETED|Overall Study||10
2378315|NCT01473992|5836523|P3|STARTED|Overall Study||5
2378316|NCT01473992|5836524|P2|STARTED|Overall Study||10
2378317|NCT01473992|5836525|P1|STARTED|Overall Study||10
2378318|NCT01473953|5836545|P5|NOT COMPLETED|Overall Study||0
2378319|NCT01473953|5836546|P4|NOT COMPLETED|Overall Study||0
2378320|NCT01473953|5836547|P3|NOT COMPLETED|Overall Study||0
2378321|NCT01473953|5836548|P2|NOT COMPLETED|Overall Study||0
2378322|NCT01473953|5836549|P1|NOT COMPLETED|Overall Study||1
2378323|NCT01473953|5836545|P5|COMPLETED|Overall Study||8
2378324|NCT01473953|5836546|P4|COMPLETED|Overall Study||5
2378325|NCT01473953|5836547|P3|COMPLETED|Overall Study||6
2378326|NCT01473953|5836548|P2|COMPLETED|Overall Study||6
2378327|NCT01473953|5836549|P1|COMPLETED|Overall Study||5
2378328|NCT01473953|5836545|P5|STARTED|Overall Study||8
2378329|NCT01473953|5836546|P4|STARTED|Overall Study||5
2378330|NCT01473953|5836547|P3|STARTED|Overall Study||6
2378331|NCT01473953|5836548|P2|STARTED|Overall Study||6
2378332|NCT01473953|5836549|P1|STARTED|Overall Study||6
2378333|NCT01473836|5836591|P1|NOT COMPLETED|Overall Study||6
2378334|NCT01473836|5836591|P1|COMPLETED|Overall Study||32
2378335|NCT01473836|5836591|P1|STARTED|Overall Study||38
2378336|NCT01473758|5836602|P4|NOT COMPLETED|Cycle 2||0
2378337|NCT01473758|5836603|P3|NOT COMPLETED|Cycle 2||5
2378338|NCT01473758|5836604|P2|NOT COMPLETED|Cycle 2||0
2378339|NCT01473758|5836605|P1|NOT COMPLETED|Cycle 2||0
2378340|NCT01473758|5836602|P4|COMPLETED|Cycle 2||4
2378341|NCT01473758|5836603|P3|COMPLETED|Cycle 2||5
2378342|NCT01473758|5836604|P2|COMPLETED|Cycle 2||0
2378343|NCT01473758|5836605|P1|COMPLETED|Cycle 2||0
2378344|NCT01473758|5836602|P4|STARTED|Cycle 2||4
2378345|NCT01473758|5836603|P3|STARTED|Cycle 2||10
2378346|NCT01473758|5836604|P2|STARTED|Cycle 2||0
2378347|NCT01473758|5836605|P1|STARTED|Cycle 2||0
2378348|NCT01473758|5836602|P4|NOT COMPLETED|Cycle 1||0
2378349|NCT01473758|5836603|P3|NOT COMPLETED|Cycle 1||0
2378350|NCT01473758|5836604|P2|NOT COMPLETED|Cycle 1||3
2378351|NCT01473758|5836605|P1|NOT COMPLETED|Cycle 1||11
2378352|NCT01473758|5836602|P4|COMPLETED|Cycle 1||0
2378353|NCT01473758|5836603|P3|COMPLETED|Cycle 1||0
2378354|NCT01473758|5836604|P2|COMPLETED|Cycle 1||40
2378355|NCT01473758|5836605|P1|COMPLETED|Cycle 1||27
2378356|NCT01473758|5836602|P4|STARTED|Cycle 1||0
2378357|NCT01473758|5836603|P3|STARTED|Cycle 1||0
2378358|NCT01473758|5836604|P2|STARTED|Cycle 1||43
2378359|NCT01473758|5836605|P1|STARTED|Cycle 1||38
2378360|NCT01473745|5836729|P2|NOT COMPLETED|Overall Study||0
2378361|NCT01473745|5836730|P1|NOT COMPLETED|Overall Study||0
2378362|NCT01473745|5836729|P2|COMPLETED|Overall Study||24
2378363|NCT01473745|5836730|P1|COMPLETED|Overall Study||24
2378364|NCT01473745|5836729|P2|STARTED|Overall Study||24
2378365|NCT01473745|5836730|P1|STARTED|Overall Study||24
2378366|NCT01473732|5836742|P2|NOT COMPLETED|Overall Study||0
2378367|NCT01473732|5836743|P1|NOT COMPLETED|Overall Study||2
2378368|NCT01473732|5836742|P2|COMPLETED|Overall Study||0
2378369|NCT01473732|5836743|P1|COMPLETED|Overall Study||0
2378370|NCT01473732|5836742|P2|STARTED|Overall Study||0
2378371|NCT01473732|5836743|P1|STARTED|Overall Study||2
2378372|NCT01473602|5836751|P2|NOT COMPLETED|Overall Study||8
2378373|NCT01473602|5836752|P1|NOT COMPLETED|Overall Study||8
2378374|NCT01473602|5836751|P2|COMPLETED|Overall Study||13
2378375|NCT01473602|5836752|P1|COMPLETED|Overall Study||10
2378376|NCT01473602|5836751|P2|Completed 12 Months|Overall Study||13
2378377|NCT01473602|5836752|P1|Completed 12 Months|Overall Study||10
2378378|NCT01473602|5836751|P2|Completed 6 Months|Overall Study||15
2378379|NCT01473602|5836752|P1|Completed 6 Months|Overall Study||12
2378380|NCT01473602|5836751|P2|Received at Least 1 Dose of Study Drug|Overall Study||20
2378381|NCT01473602|5836752|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
2378382|NCT01473602|5836751|P2|STARTED|Overall Study||21
2378383|NCT01473602|5836752|P1|STARTED|Overall Study||18
2378384|NCT01473589|5836788|P2|NOT COMPLETED|Overall Study||16
2378385|NCT01473589|5836789|P1|NOT COMPLETED|Overall Study||11
2378386|NCT01473589|5836788|P2|COMPLETED|Overall Study||46
2378387|NCT01473589|5836789|P1|COMPLETED|Overall Study||49
2378388|NCT01473589|5836788|P2|Completed 12 Months|Overall Study||48
2378389|NCT01473589|5836789|P1|Completed 12 Months|Overall Study||49
2378390|NCT01473589|5836788|P2|Completed 6 Months|Overall Study||54
2378391|NCT01473589|5836789|P1|Completed 6 Months|Overall Study||51
2378392|NCT01473589|5836788|P2|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|61
2378393|NCT01473589|5836789|P1|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|60
2378394|NCT01473589|5836788|P2|STARTED|Overall Study||62
2378395|NCT01473589|5836789|P1|STARTED|Overall Study||60
2378396|NCT01473563|5836823|P1|NOT COMPLETED|Overall Study||1
2378397|NCT01473563|5836823|P1|COMPLETED|Overall Study||51
2378398|NCT01473563|5836823|P1|Received at Least 1 Dose of Study Drug|Overall Study||52
2378399|NCT01473563|5836823|P1|STARTED|Overall Study||52
2378400|NCT01473524|5836845|P3|NOT COMPLETED|Overall Study||3
2378401|NCT01473524|5836846|P2|NOT COMPLETED|Overall Study||9
2378402|NCT01473524|5836847|P1|NOT COMPLETED|Overall Study||7
2378403|NCT01473524|5836845|P3|COMPLETED|Overall Study||70
2378404|NCT01473524|5836846|P2|COMPLETED|Overall Study||64
2378405|NCT01473524|5836847|P1|COMPLETED|Overall Study||64
2378406|NCT01473524|5836845|P3|STARTED|Overall Study||73
2378407|NCT01473524|5836846|P2|STARTED|Overall Study||73
2378408|NCT01473524|5836847|P1|STARTED|Overall Study||71
2378409|NCT01473420|5836880|P2|NOT COMPLETED|Maintenance Period (16 Weeks)||17
2378410|NCT01473420|5836881|P1|NOT COMPLETED|Maintenance Period (16 Weeks)||18
2378411|NCT01473420|5836880|P2|COMPLETED|Maintenance Period (16 Weeks)||105
2378412|NCT01473420|5836881|P1|COMPLETED|Maintenance Period (16 Weeks)||106
2378413|NCT01473420|5836880|P2|STARTED|Maintenance Period (16 Weeks)||122
2378414|NCT01473420|5836881|P1|STARTED|Maintenance Period (16 Weeks)||124
2378415|NCT01473420|5836880|P2|NOT COMPLETED|Titration Period (18 Weeks)||38
2378416|NCT01473420|5836881|P1|NOT COMPLETED|Titration Period (18 Weeks)||36
2378417|NCT01473420|5836880|P2|COMPLETED|Titration Period (18 Weeks)||122
2378418|NCT01473420|5836881|P1|COMPLETED|Titration Period (18 Weeks)||124
2378419|NCT01473420|5836880|P2|Treated|Titration Period (18 Weeks)||86
2378420|NCT01473420|5836881|P1|Treated|Titration Period (18 Weeks)||80
2378421|NCT01473420|5836880|P2|STARTED|Titration Period (18 Weeks)||160
2378422|NCT01473420|5836881|P1|STARTED|Titration Period (18 Weeks)||160
2378423|NCT01473407|5836965|P2|NOT COMPLETED|Overall Study||47
2378424|NCT01473407|5836966|P1|NOT COMPLETED|Overall Study||54
2378425|NCT01473407|5836965|P2|COMPLETED|Overall Study||259
2378426|NCT01473407|5836966|P1|COMPLETED|Overall Study||252
2378427|NCT01473407|5836965|P2|STARTED|Overall Study||306
2378428|NCT01473407|5836966|P1|STARTED|Overall Study||306
2378429|NCT01473394|5837020|P2|NOT COMPLETED|Overall Study||43
2378430|NCT01473394|5837021|P1|NOT COMPLETED|Overall Study||45
2378431|NCT01473394|5837020|P2|COMPLETED|Overall Study||212
2378432|NCT01473394|5837021|P1|COMPLETED|Overall Study||208
2378433|NCT01473394|5837020|P2|STARTED|Overall Study||255
2378434|NCT01473394|5837021|P1|STARTED|Overall Study||253
2378435|NCT01473381|5837035|P4|NOT COMPLETED|Overall Study||89
2378436|NCT01473381|5837036|P3|NOT COMPLETED|Overall Study||102
2378437|NCT01473381|5837037|P2|NOT COMPLETED|Overall Study||93
2378438|NCT01473381|5837038|P1|NOT COMPLETED|Overall Study||80
2378439|NCT01473381|5837035|P4|COMPLETED|Overall Study||200
2378440|NCT01473381|5837036|P3|COMPLETED|Overall Study||189
2378441|NCT01473381|5837037|P2|COMPLETED|Overall Study||199
2378442|NCT01473381|5837038|P1|COMPLETED|Overall Study||210
2378443|NCT01473381|5837035|P4|Safety Population|Overall Study||282
2378444|NCT01473381|5837036|P3|Safety Population|Overall Study||287
2378445|NCT01473381|5837037|P2|Safety Population|Overall Study||288
2378446|NCT01473381|5837038|P1|Safety Population|Overall Study||281
2378447|NCT01473381|5837035|P4|STARTED|Overall Study||289
2378448|NCT01473381|5837036|P3|STARTED|Overall Study||291
2378449|NCT01473381|5837037|P2|STARTED|Overall Study||292
2378450|NCT01473381|5837038|P1|STARTED|Overall Study||290
2378451|NCT01473368|5837060|P4|NOT COMPLETED|Overall Study||0
2378452|NCT01473368|5837061|P3|NOT COMPLETED|Overall Study||3
2378453|NCT01473368|5837062|P2|NOT COMPLETED|Overall Study||0
2378454|NCT01473368|5837063|P1|NOT COMPLETED|Overall Study||1
2378455|NCT01473368|5837060|P4|COMPLETED|Overall Study||12
2378456|NCT01473368|5837061|P3|COMPLETED|Overall Study||12
2378457|NCT01473368|5837062|P2|COMPLETED|Overall Study||12
2378458|NCT01473368|5837063|P1|COMPLETED|Overall Study||13
2378459|NCT01473368|5837060|P4|STARTED|Overall Study||12
2378460|NCT01473368|5837061|P3|STARTED|Overall Study||15
2378461|NCT01473368|5837062|P2|STARTED|Overall Study||12
2378462|NCT01473368|5837063|P1|STARTED|Overall Study||14
2378463|NCT01473355|5837100|P1|NOT COMPLETED|Overall Study||6
2378464|NCT01473355|5837100|P1|COMPLETED|Overall Study||39
2378465|NCT01473355|5837100|P1|STARTED|Overall Study||45
2378466|NCT01473160|5837109|P1|NOT COMPLETED|Overall Study||0
2378467|NCT01473160|5837109|P1|COMPLETED|Overall Study||9
2378468|NCT01473160|5837109|P1|STARTED|Overall Study||9
2378469|NCT01472965|5837129|P2|NOT COMPLETED|Overall Study||0
2378470|NCT01472965|5837130|P1|NOT COMPLETED|Overall Study||1
2378471|NCT01472965|5837129|P2|COMPLETED|Overall Study||46
2378472|NCT01472965|5837130|P1|COMPLETED|Overall Study||48
2378473|NCT01472965|5837129|P2|STARTED|Overall Study||46
2378474|NCT01472965|5837130|P1|STARTED|Overall Study||49
2378475|NCT01472939|5837150|P4|NOT COMPLETED|Overall Study||20
2378476|NCT01472939|5837151|P3|NOT COMPLETED|Overall Study||11
2378477|NCT01472939|5837152|P2|NOT COMPLETED|Overall Study||14
2378478|NCT01472939|5837153|P1|NOT COMPLETED|Overall Study||20
2378479|NCT01472939|5837150|P4|COMPLETED|Overall Study||99
2378480|NCT01472939|5837151|P3|COMPLETED|Overall Study||108
2378481|NCT01472939|5837152|P2|COMPLETED|Overall Study||105
2378482|NCT01472939|5837153|P1|COMPLETED|Overall Study||103
2378483|NCT01472939|5837150|P4|STARTED|Overall Study||119
2378484|NCT01472939|5837151|P3|STARTED|Overall Study||119
2378485|NCT01472939|5837152|P2|STARTED|Overall Study||119
2378486|NCT01472939|5837153|P1|STARTED|Overall Study||123
2378487|NCT01472874|5837180|P1|NOT COMPLETED|Overall Study||0
2378488|NCT01472874|5837180|P1|COMPLETED|Overall Study||8
2378489|NCT01472874|5837180|P1|STARTED|Overall Study||8
2378490|NCT01472835|5837197|P2|NOT COMPLETED|Overall Study||0
2378491|NCT01472835|5837198|P1|NOT COMPLETED|Overall Study||2
2378492|NCT01472835|5837197|P2|COMPLETED|Overall Study||36
2378493|NCT01472835|5837198|P1|COMPLETED|Overall Study||35
2378494|NCT01472835|5837197|P2|STARTED|Overall Study||36
2378495|NCT01472835|5837198|P1|STARTED|Overall Study||37
2378496|NCT01472822|5837214|P2|NOT COMPLETED|Overall Study||2
2378497|NCT01472822|5837215|P1|NOT COMPLETED|Overall Study||2
2378498|NCT01472822|5837214|P2|COMPLETED|Overall Study||28
2378499|NCT01472822|5837215|P1|COMPLETED|Overall Study||28
2378500|NCT01472822|5837214|P2|STARTED|Overall Study||30
2378501|NCT01472822|5837215|P1|STARTED|Overall Study||30
2378502|NCT01472718|5837231|P2|NOT COMPLETED|Overall Study||7
2378503|NCT01472718|5837232|P1|NOT COMPLETED|Overall Study||6
2378504|NCT01472718|5837231|P2|COMPLETED|Overall Study||97
2378505|NCT01472718|5837232|P1|COMPLETED|Overall Study||98
2378506|NCT01472718|5837231|P2|STARTED|Overall Study||104
2378507|NCT01472718|5837232|P1|STARTED|Overall Study||104
2378508|NCT01472692|5837242|P2|NOT COMPLETED|Overall Study||0
2378509|NCT01472692|5837243|P1|NOT COMPLETED|Overall Study||0
2378510|NCT01472692|5837242|P2|COMPLETED|Overall Study||0
2378511|NCT01472692|5837243|P1|COMPLETED|Overall Study||0
2378512|NCT01472692|5837242|P2|STARTED|Overall Study||0
2378513|NCT01472692|5837243|P1|STARTED|Overall Study||0
2378514|NCT01472562|5837251|P1|NOT COMPLETED|Maintenance Phase (Week 49 to PD)||23
2378515|NCT01472562|5837251|P1|COMPLETED|Maintenance Phase (Week 49 to PD)||4
2378516|NCT01472562|5837251|P1|STARTED|Maintenance Phase (Week 49 to PD)||27
2378517|NCT01472562|5837251|P1|NOT COMPLETED|Induction Phase (Week 1- 48)||11
2378518|NCT01472562|5837251|P1|COMPLETED|Induction Phase (Week 1- 48)||27
2378519|NCT01472562|5837251|P1|STARTED|Induction Phase (Week 1- 48)||38
2378520|NCT01472549|5837258|P2|NOT COMPLETED|Overall Study||0
2378521|NCT01472549|5837259|P1|NOT COMPLETED|Overall Study||0
2378522|NCT01472549|5837258|P2|COMPLETED|Overall Study||575
2378523|NCT01472549|5837259|P1|COMPLETED|Overall Study||572
2378524|NCT01472549|5837258|P2|STARTED|Overall Study||575
2378525|NCT01472549|5837259|P1|STARTED|Overall Study||572
2378526|NCT01472445|5837281|P2|NOT COMPLETED|Overall Study||0
2378527|NCT01472445|5837282|P1|NOT COMPLETED|Overall Study||0
2378528|NCT01472445|5837281|P2|COMPLETED|Overall Study||16
2378529|NCT01472445|5837282|P1|COMPLETED|Overall Study||25
2378530|NCT01472445|5837281|P2|STARTED|Overall Study||16
2378531|NCT01472445|5837282|P1|STARTED|Overall Study||25
2378532|NCT01472432|5837306|P2|NOT COMPLETED|Overall Study||0
2378533|NCT01472432|5837307|P1|NOT COMPLETED|Overall Study||0
2378534|NCT01472432|5837306|P2|COMPLETED|Overall Study||53
2378535|NCT01472432|5837307|P1|COMPLETED|Overall Study||53
2378536|NCT01472432|5837306|P2|Ulcer Reduction|Overall Study||33
2378537|NCT01472432|5837307|P1|Ulcer Reduction|Overall Study||13
2378538|NCT01472432|5837306|P2|STARTED|Overall Study||53
2378539|NCT01472432|5837307|P1|STARTED|Overall Study||53
2378540|NCT01472380|5837323|P1|NOT COMPLETED|Efavirenz and FFA||0
2378541|NCT01472380|5837323|P1|COMPLETED|Efavirenz and FFA||28
2378542|NCT01472380|5837323|P1|STARTED|Efavirenz and FFA||28
2378543|NCT01472380|5837323|P1|NOT COMPLETED|1 Day Period Between Dosing||1
2378544|NCT01472380|5837323|P1|COMPLETED|1 Day Period Between Dosing||28
2378545|NCT01472380|5837323|P1|STARTED|1 Day Period Between Dosing||29
2378546|NCT01472380|5837323|P1|NOT COMPLETED|Fenofibric Acid (FFA) Alone||0
2378547|NCT01472380|5837323|P1|COMPLETED|Fenofibric Acid (FFA) Alone||29
2378548|NCT01472380|5837323|P1|STARTED|Fenofibric Acid (FFA) Alone||29
2378549|NCT01472380|5837323|P1|NOT COMPLETED|Efavirenz Alone||1
2378550|NCT01472380|5837323|P1|COMPLETED|Efavirenz Alone||29
2378551|NCT01472380|5837323|P1|STARTED|Efavirenz Alone||30
2378552|NCT01472341|5837334|P1|NOT COMPLETED|Overall Study||272
2378553|NCT01472341|5837334|P1|COMPLETED|Overall Study||235
2378554|NCT01472341|5837334|P1|STARTED|Overall Study||507
2378555|NCT01472289|5837340|P1|NOT COMPLETED|Overall Study||2
2378556|NCT01472289|5837340|P1|COMPLETED|Overall Study||15
2378557|NCT01472289|5837340|P1|STARTED|Overall Study||17
2378558|NCT01472185|5837352|P2|NOT COMPLETED|Overall Study||34
2378559|NCT01472185|5837353|P1|NOT COMPLETED|Overall Study||34
2378560|NCT01472185|5837352|P2|COMPLETED|Overall Study||199
2378561|NCT01472185|5837353|P1|COMPLETED|Overall Study||198
2378562|NCT01472185|5837352|P2|STARTED|Overall Study||233
2378563|NCT01472185|5837353|P1|STARTED|Overall Study||232
2378564|NCT01472081|5837373|P6|NOT COMPLETED|Overall Study||6
2378565|NCT01472081|5837374|P5|NOT COMPLETED|Overall Study||47
2378566|NCT01472081|5837375|P4|NOT COMPLETED|Overall Study||46
2378567|NCT01472081|5837376|P3|NOT COMPLETED|Overall Study||20
2378568|NCT01472081|5837377|P2|NOT COMPLETED|Overall Study||26
2378569|NCT01472081|5837378|P1|NOT COMPLETED|Overall Study||7
2378570|NCT01472081|5837373|P6|COMPLETED|Overall Study||0
2378571|NCT01472081|5837374|P5|COMPLETED|Overall Study||0
2378572|NCT01472081|5837375|P4|COMPLETED|Overall Study||1
2378573|NCT01472081|5837376|P3|COMPLETED|Overall Study||0
2378574|NCT01472081|5837377|P2|COMPLETED|Overall Study||0
2378575|NCT01472081|5837378|P1|COMPLETED|Overall Study||0
2378576|NCT01472081|5837373|P6|STARTED|Overall Study||6
2378577|NCT01472081|5837374|P5|STARTED|Overall Study||47
2378578|NCT01472081|5837375|P4|STARTED|Overall Study||47
2378579|NCT01472081|5837376|P3|STARTED|Overall Study||20
2378580|NCT01472081|5837377|P2|STARTED|Overall Study||26
2378581|NCT01472081|5837378|P1|STARTED|Overall Study||7
2378582|NCT01471782|5837427|P6|NOT COMPLETED|Overall Study||41
2378583|NCT01471782|5837428|P5|NOT COMPLETED|Overall Study||26
2378584|NCT01471782|5837429|P4|NOT COMPLETED|Overall Study||5
2378585|NCT01471782|5837430|P3|NOT COMPLETED|Overall Study||5
2378586|NCT01471782|5837431|P2|NOT COMPLETED|Overall Study||6
2378587|NCT01471782|5837432|P1|NOT COMPLETED|Overall Study||5
2378588|NCT01471782|5837427|P6|COMPLETED|Overall Study|Completed 5 cycles|3
2378589|NCT01471782|5837428|P5|COMPLETED|Overall Study|Completed 5 cycles|0
2378590|NCT01471782|5837429|P4|COMPLETED|Overall Study|Completed 5 cycles|1
2378591|NCT01471782|5837430|P3|COMPLETED|Overall Study|Completed 5 cycles|0
2378592|NCT01471782|5837431|P2|COMPLETED|Overall Study|Completed 5 cycles|1
2378593|NCT01471782|5837432|P1|COMPLETED|Overall Study|Completed 5 cycles|0
2378594|NCT01471782|5837427|P6|STARTED|Overall Study||44
2378595|NCT01471782|5837428|P5|STARTED|Overall Study||26
2378596|NCT01471782|5837429|P4|STARTED|Overall Study||6
2378597|NCT01471782|5837430|P3|STARTED|Overall Study||5
2378598|NCT01471782|5837431|P2|STARTED|Overall Study||7
2378599|NCT01471782|5837432|P1|STARTED|Overall Study||5
2378600|NCT01471691|5837486|P2|NOT COMPLETED|Overall Study||1
2378601|NCT01471691|5837487|P1|NOT COMPLETED|Overall Study||0
2378602|NCT01471691|5837486|P2|COMPLETED|Overall Study||5
2378603|NCT01471691|5837487|P1|COMPLETED|Overall Study||8
2378604|NCT01471691|5837486|P2|STARTED|Overall Study||6
2378605|NCT01471691|5837487|P1|STARTED|Overall Study||8
2378606|NCT01471379|5837496|P3|NOT COMPLETED|Overall Study||0
2378607|NCT01471379|5837497|P2|NOT COMPLETED|Overall Study||1
2378608|NCT01471379|5837498|P1|NOT COMPLETED|Overall Study||1
2378609|NCT01471379|5837496|P3|COMPLETED|Overall Study||0
2378610|NCT01471379|5837497|P2|COMPLETED|Overall Study||0
2378611|NCT01471379|5837498|P1|COMPLETED|Overall Study||0
2378612|NCT01471379|5837496|P3|STARTED|Overall Study||0
2378613|NCT01471379|5837497|P2|STARTED|Overall Study||1
2378614|NCT01471379|5837498|P1|STARTED|Overall Study||1
2378615|NCT01471353|5837518|P1|NOT COMPLETED|Overall Study||3
2378616|NCT01471353|5837518|P1|COMPLETED|Overall Study||39
2378617|NCT01471353|5837518|P1|STARTED|Overall Study||42
2378618|NCT01471340|5837529|P2|NOT COMPLETED|Overall Study||6
2378619|NCT01471340|5837530|P1|NOT COMPLETED|Overall Study||6
2378620|NCT01471340|5837529|P2|COMPLETED|Overall Study||5855
2378621|NCT01471340|5837530|P1|COMPLETED|Overall Study||5862
2378715|NCT01470651|5837685|P1|STARTED|Overall Study||13
2378622|NCT01471340|5837529|P2|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5861
2378623|NCT01471340|5837530|P1|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5868
2378624|NCT01471639|5837540|P1|NOT COMPLETED|Overall Study||0
2378625|NCT01471639|5837540|P1|COMPLETED|Overall Study||37
2378626|NCT01471639|5837540|P1|STARTED|Overall Study||37
2378627|NCT01471626|5837545|P1|NOT COMPLETED|Overall Study||0
2378628|NCT01471626|5837545|P1|COMPLETED|Overall Study||21
2378629|NCT01471626|5837545|P1|STARTED|Overall Study||21
2378630|NCT01471574|5837553|P4|NOT COMPLETED|Follow-up Period||3
2378631|NCT01471574|5837554|P3|NOT COMPLETED|Follow-up Period||7
2378632|NCT01471574|5837555|P2|NOT COMPLETED|Follow-up Period||2
2378633|NCT01471574|5837556|P1|NOT COMPLETED|Follow-up Period||7
2378634|NCT01471574|5837553|P4|COMPLETED|Follow-up Period||21
2378635|NCT01471574|5837554|P3|COMPLETED|Follow-up Period||95
2378636|NCT01471574|5837555|P2|COMPLETED|Follow-up Period||32
2378637|NCT01471574|5837556|P1|COMPLETED|Follow-up Period||114
2378638|NCT01471574|5837553|P4|STARTED|Follow-up Period||24
2378639|NCT01471574|5837554|P3|STARTED|Follow-up Period||102
2378640|NCT01471574|5837555|P2|STARTED|Follow-up Period||34
2378641|NCT01471574|5837556|P1|STARTED|Follow-up Period||121
2378642|NCT01471574|5837553|P4|NOT COMPLETED|Treatment Period||3
2378643|NCT01471574|5837554|P3|NOT COMPLETED|Treatment Period||24
2378644|NCT01471574|5837555|P2|NOT COMPLETED|Treatment Period||10
2378645|NCT01471574|5837556|P1|NOT COMPLETED|Treatment Period||31
2378646|NCT01471574|5837553|P4|COMPLETED|Treatment Period||21
2378647|NCT01471574|5837554|P3|COMPLETED|Treatment Period||82
2378648|NCT01471574|5837555|P2|COMPLETED|Treatment Period||29
2378649|NCT01471574|5837556|P1|COMPLETED|Treatment Period||101
2378650|NCT01471574|5837553|P4|STARTED|Treatment Period||24
2378651|NCT01471574|5837554|P3|STARTED|Treatment Period||106
2378652|NCT01471574|5837555|P2|STARTED|Treatment Period||39
2378653|NCT01471574|5837556|P1|STARTED|Treatment Period||132
2378654|NCT01471197|5837587|P2|NOT COMPLETED|Overall Study||2
2378655|NCT01471197|5837588|P1|NOT COMPLETED|Overall Study||6
2378656|NCT01471197|5837587|P2|COMPLETED|Overall Study||0
2378657|NCT01471197|5837588|P1|COMPLETED|Overall Study||0
2378658|NCT01471197|5837587|P2|STARTED|Overall Study||2
2378659|NCT01471197|5837588|P1|STARTED|Overall Study||6
2378660|NCT01471171|5837598|P2|NOT COMPLETED|Treatment Period 2||0
2378661|NCT01471171|5837599|P1|NOT COMPLETED|Treatment Period 2||1
2378662|NCT01471171|5837598|P2|COMPLETED|Treatment Period 2||54
2378663|NCT01471171|5837599|P1|COMPLETED|Treatment Period 2||52
2378664|NCT01471171|5837598|P2|STARTED|Treatment Period 2||54
2378665|NCT01471171|5837599|P1|STARTED|Treatment Period 2||53
2378666|NCT01471171|5837598|P2|NOT COMPLETED|Treatment Period 1||1
2378667|NCT01471171|5837599|P1|NOT COMPLETED|Treatment Period 1||4
2378668|NCT01471171|5837598|P2|COMPLETED|Treatment Period 1||54
2378669|NCT01471171|5837599|P1|COMPLETED|Treatment Period 1||53
2378670|NCT01471171|5837598|P2|STARTED|Treatment Period 1||55
2378671|NCT01471171|5837599|P1|STARTED|Treatment Period 1||57
2378672|NCT01471054|5837611|P2|NOT COMPLETED|Overall Study||0
2378673|NCT01471054|5837612|P1|NOT COMPLETED|Overall Study||4
2378674|NCT01471054|5837611|P2|COMPLETED|Overall Study||1
2378675|NCT01471054|5837612|P1|COMPLETED|Overall Study||1
2378676|NCT01471054|5837611|P2|STARTED|Overall Study||1
2378677|NCT01471054|5837612|P1|STARTED|Overall Study||5
2378678|NCT01471041|5837628|P1|NOT COMPLETED|Overall Study||7
2378679|NCT01471041|5837628|P1|COMPLETED|Overall Study||47
2378680|NCT01471041|5837628|P1|STARTED|Overall Study||54
2378681|NCT01471028|5837635|P2|NOT COMPLETED|VTI-208E||12
2378682|NCT01471028|5837636|P1|NOT COMPLETED|VTI-208E||8
2378683|NCT01471028|5837635|P2|COMPLETED|VTI-208E||51
2378684|NCT01471028|5837636|P1|COMPLETED|VTI-208E||48
2378685|NCT01471028|5837635|P2|Database Lock, 31 July 2015|VTI-208E||63
2378686|NCT01471028|5837636|P1|Database Lock, 31 July 2015|VTI-208E||56
2378687|NCT01471028|5837635|P2|STARTED|VTI-208E||63
2378688|NCT01471028|5837636|P1|STARTED|VTI-208E||56
2378689|NCT01471028|5837635|P2|NOT COMPLETED|VTI-208||44
2378690|NCT01471028|5837636|P1|NOT COMPLETED|VTI-208||40
2378691|NCT01471028|5837635|P2|COMPLETED|VTI-208||63
2378692|NCT01471028|5837636|P1|COMPLETED|VTI-208||56
2378693|NCT01471028|5837635|P2|STARTED|VTI-208||107
2378694|NCT01471028|5837636|P1|STARTED|VTI-208||96
2378695|NCT01471015|5837651|P3|NOT COMPLETED|Overall Study||1
2378696|NCT01471015|5837652|P2|NOT COMPLETED|Overall Study||1
2378697|NCT01471015|5837653|P1|NOT COMPLETED|Overall Study||0
2378698|NCT01471015|5837651|P3|COMPLETED|Overall Study||9
2378699|NCT01471015|5837652|P2|COMPLETED|Overall Study||9
2378700|NCT01471015|5837653|P1|COMPLETED|Overall Study||10
2378701|NCT01471015|5837651|P3|STARTED|Overall Study||10
2378702|NCT01471015|5837652|P2|STARTED|Overall Study||10
2378703|NCT01471015|5837653|P1|STARTED|Overall Study||10
2378704|NCT01470859|5837667|P2|NOT COMPLETED|Overall Study||0
2378705|NCT01470859|5837668|P1|NOT COMPLETED|Overall Study||1
2378706|NCT01470859|5837667|P2|COMPLETED|Overall Study||15
2378707|NCT01470859|5837668|P1|COMPLETED|Overall Study||14
2378708|NCT01470859|5837667|P2|STARTED|Overall Study||15
2378709|NCT01470859|5837668|P1|STARTED|Overall Study||15
2378710|NCT01470651|5837684|P2|NOT COMPLETED|Overall Study||3
2378711|NCT01470651|5837685|P1|NOT COMPLETED|Overall Study||7
2378712|NCT01470651|5837684|P2|COMPLETED|Overall Study||10
2378713|NCT01470651|5837685|P1|COMPLETED|Overall Study||6
2378714|NCT01470651|5837684|P2|STARTED|Overall Study||13
2378716|NCT01470599|5837695|P2|NOT COMPLETED|Overall Study||43
2378717|NCT01470599|5837696|P1|NOT COMPLETED|Overall Study||19
2378718|NCT01470599|5837695|P2|COMPLETED|Overall Study||45
2378719|NCT01470599|5837696|P1|COMPLETED|Overall Study||43
2378720|NCT01470599|5837695|P2|STARTED|Overall Study||88
2378721|NCT01470599|5837696|P1|STARTED|Overall Study||62
2378722|NCT01470469|5837760|P2|NOT COMPLETED|Overall Study||24
2378723|NCT01470469|5837761|P1|NOT COMPLETED|Overall Study||10
2378724|NCT01470469|5837760|P2|COMPLETED|Overall Study||38
2378725|NCT01470469|5837761|P1|COMPLETED|Overall Study||11
2378726|NCT01470469|5837760|P2|STARTED|Overall Study||62
2378727|NCT01470469|5837761|P1|STARTED|Overall Study||21
2378728|NCT01470417|5837781|P2|NOT COMPLETED|Overall Study||2
2378729|NCT01470417|5837782|P1|NOT COMPLETED|Overall Study||0
2378730|NCT01470417|5837781|P2|COMPLETED|Overall Study||5
2378731|NCT01470417|5837782|P1|COMPLETED|Overall Study||3
2378732|NCT01470417|5837781|P2|STARTED|Overall Study||7
2378733|NCT01470417|5837782|P1|STARTED|Overall Study||3
2378734|NCT01470326|5837794|P1|NOT COMPLETED|Overall Study||153
2378735|NCT01470326|5837794|P1|COMPLETED|Overall Study||3034
2378736|NCT01470326|5837794|P1|STARTED|Overall Study||3187
2378737|NCT01470248|5837805|P1|NOT COMPLETED|Overall Study||1
2378738|NCT01470248|5837805|P1|COMPLETED|Overall Study||19
2378739|NCT01470248|5837805|P1|STARTED|Overall Study||20
2378740|NCT01470196|5837812|P1|NOT COMPLETED|Overall Study||0
2378741|NCT01470196|5837812|P1|COMPLETED|Overall Study||31
2378742|NCT01470196|5837812|P1|STARTED|Overall Study||31
2378743|NCT01470170|5837825|P5|NOT COMPLETED|Overall Study||0
2378744|NCT01470170|5837826|P4|NOT COMPLETED|Overall Study||0
2378745|NCT01470170|5837827|P3|NOT COMPLETED|Overall Study||0
2378746|NCT01470170|5837828|P2|NOT COMPLETED|Overall Study||0
2378747|NCT01470170|5837829|P1|NOT COMPLETED|Overall Study||0
2378748|NCT01470170|5837825|P5|COMPLETED|Overall Study||34
2378749|NCT01470170|5837826|P4|COMPLETED|Overall Study||36
2378750|NCT01470170|5837827|P3|COMPLETED|Overall Study||34
2378751|NCT01470170|5837828|P2|COMPLETED|Overall Study||35
2378752|NCT01470170|5837829|P1|COMPLETED|Overall Study||34
2378753|NCT01470170|5837825|P5|STARTED|Overall Study||34
2378754|NCT01470170|5837826|P4|STARTED|Overall Study||36
2378755|NCT01470170|5837827|P3|STARTED|Overall Study||34
2378756|NCT01470170|5837828|P2|STARTED|Overall Study||35
2378757|NCT01470170|5837829|P1|STARTED|Overall Study||34
2378758|NCT01470144|5837861|P1|NOT COMPLETED|Overall Study||10
2378759|NCT01470144|5837861|P1|COMPLETED|Overall Study|"Completed corresponds to subjects switching to commercial EFI upon market approval/reimbursement"|31
2378760|NCT01470144|5837861|P1|STARTED|Overall Study||41
2378761|NCT01470118|5837869|P3|NOT COMPLETED|Overall Study||2
2378762|NCT01470118|5837870|P2|NOT COMPLETED|Overall Study||5
2378763|NCT01470118|5837871|P1|NOT COMPLETED|Overall Study||5
2378764|NCT01470118|5837869|P3|COMPLETED|Overall Study||39
2378765|NCT01470118|5837870|P2|COMPLETED|Overall Study||38
2378766|NCT01470118|5837871|P1|COMPLETED|Overall Study||38
2378767|NCT01470118|5837869|P3|STARTED|Overall Study||41
2378768|NCT01470118|5837870|P2|STARTED|Overall Study||43
2378769|NCT01470118|5837871|P1|STARTED|Overall Study||43
2378770|NCT01470027|5837906|P3|NOT COMPLETED|Overall Study||1
2378771|NCT01470027|5837907|P2|NOT COMPLETED|Overall Study||1
2378772|NCT01470027|5837908|P1|NOT COMPLETED|Overall Study||1
2378773|NCT01470027|5837906|P3|COMPLETED|Overall Study||15
2378774|NCT01470027|5837907|P2|COMPLETED|Overall Study||14
2378775|NCT01470027|5837908|P1|COMPLETED|Overall Study||15
2378776|NCT01470027|5837906|P3|STARTED|Overall Study||16
2378777|NCT01470027|5837907|P2|STARTED|Overall Study||15
2378778|NCT01470027|5837908|P1|STARTED|Overall Study||16
2378779|NCT01470001|5837966|P2|NOT COMPLETED|Overall Study||2
2378780|NCT01470001|5837967|P1|NOT COMPLETED|Overall Study||5
2378781|NCT01470001|5837966|P2|COMPLETED|Overall Study||58
2378782|NCT01470001|5837967|P1|COMPLETED|Overall Study||53
2378783|NCT01470001|5837966|P2|STARTED|Overall Study||60
2378784|NCT01470001|5837967|P1|STARTED|Overall Study||58
2378785|NCT01469819|5837977|P1|NOT COMPLETED|Overall Study||8
2378786|NCT01469819|5837977|P1|COMPLETED|Overall Study||29
2378787|NCT01469819|5837977|P1|STARTED|Overall Study||37
2378788|NCT01469767|5837987|P1|NOT COMPLETED|Overall Study||0
2378789|NCT01469767|5837987|P1|COMPLETED|Overall Study||10
2378790|NCT01469767|5837987|P1|STARTED|Overall Study||10
2378791|NCT01469715|5837995|P1|NOT COMPLETED|Overall Study||0
2378792|NCT01469715|5837995|P1|COMPLETED|Overall Study||16
2378793|NCT01469715|5837995|P1|STARTED|Overall Study||16
2378794|NCT01469637|5838001|P2|NOT COMPLETED|Second Intervention||0
2378795|NCT01469637|5838002|P1|NOT COMPLETED|Second Intervention||1
2378796|NCT01469637|5838001|P2|COMPLETED|Second Intervention||21
2378797|NCT01469637|5838002|P1|COMPLETED|Second Intervention||21
2378798|NCT01469637|5838001|P2|STARTED|Second Intervention||21
2378799|NCT01469637|5838002|P1|STARTED|Second Intervention||22
2378800|NCT01469637|5838001|P2|NOT COMPLETED|First Intervention||1
2378801|NCT01469637|5838002|P1|NOT COMPLETED|First Intervention||0
2378802|NCT01469637|5838001|P2|COMPLETED|First Intervention||21
2378803|NCT01469637|5838002|P1|COMPLETED|First Intervention||22
2378804|NCT01469637|5838001|P2|STARTED|First Intervention||22
2378805|NCT01469637|5838002|P1|STARTED|First Intervention||22
2378806|NCT01469546|5838010|P1|NOT COMPLETED|Dose Escalation to 10 mg||0
2378807|NCT01469546|5838010|P1|COMPLETED|Dose Escalation to 10 mg||19
2378808|NCT01469546|5838010|P1|STARTED|Dose Escalation to 10 mg||19
2378809|NCT01469546|5838010|P1|NOT COMPLETED|Received 5 mg Dose||23
2378810|NCT01469546|5838010|P1|COMPLETED|Received 5 mg Dose||19
2378811|NCT01469546|5838010|P1|Completed First Cycle|Received 5 mg Dose||30
2378812|NCT01469546|5838010|P1|STARTED|Received 5 mg Dose||42
2378813|NCT01469377|5838020|P3|NOT COMPLETED|Overall Study||66
2378814|NCT01469377|5838021|P2|NOT COMPLETED|Overall Study||48
2378815|NCT01469377|5838022|P1|NOT COMPLETED|Overall Study||35
2378816|NCT01469377|5838020|P3|COMPLETED|Overall Study||210
2378817|NCT01469377|5838021|P2|COMPLETED|Overall Study||226
2378818|NCT01469377|5838022|P1|COMPLETED|Overall Study||234
2378819|NCT01469377|5838020|P3|STARTED|Overall Study||276
2378820|NCT01469377|5838021|P2|STARTED|Overall Study||274
2378821|NCT01469377|5838022|P1|STARTED|Overall Study||269
2378822|NCT01469364|5838033|P1|NOT COMPLETED|Overall Study||2
2378823|NCT01469364|5838033|P1|COMPLETED|Overall Study||28
2378824|NCT01469364|5838033|P1|STARTED|Overall Study||30
2378825|NCT01469234|5838051|P3|NOT COMPLETED|Overall Study||0
2378826|NCT01469234|5838052|P2|NOT COMPLETED|Overall Study||0
2378827|NCT01469234|5838053|P1|NOT COMPLETED|Overall Study||0
2378828|NCT01469234|5838051|P3|COMPLETED|Overall Study||85
2378829|NCT01469234|5838052|P2|COMPLETED|Overall Study||85
2378830|NCT01469234|5838053|P1|COMPLETED|Overall Study||85
2378831|NCT01469234|5838051|P3|STARTED|Overall Study||85
2378832|NCT01469234|5838052|P2|STARTED|Overall Study||85
2378833|NCT01469234|5838053|P1|STARTED|Overall Study||85
2378834|NCT01469221|5838084|P3|NOT COMPLETED|Double Blind Phase||0
2378835|NCT01469221|5838085|P2|NOT COMPLETED|Double Blind Phase||17
2378836|NCT01469221|5838086|P1|NOT COMPLETED|Double Blind Phase||14
2378837|NCT01469221|5838084|P3|COMPLETED|Double Blind Phase||0
2378838|NCT01469221|5838085|P2|COMPLETED|Double Blind Phase||0
2378839|NCT01469221|5838086|P1|COMPLETED|Double Blind Phase||0
2378840|NCT01469221|5838084|P3|STARTED|Double Blind Phase||0
2378841|NCT01469221|5838085|P2|STARTED|Double Blind Phase||17
2378842|NCT01469221|5838086|P1|STARTED|Double Blind Phase||14
2378843|NCT01469221|5838084|P3|NOT COMPLETED|Open Label Phase||3
2378844|NCT01469221|5838085|P2|NOT COMPLETED|Open Label Phase||0
2378845|NCT01469221|5838086|P1|NOT COMPLETED|Open Label Phase||0
2378846|NCT01469221|5838084|P3|COMPLETED|Open Label Phase||44
2378847|NCT01469221|5838085|P2|COMPLETED|Open Label Phase||0
2378848|NCT01469221|5838086|P1|COMPLETED|Open Label Phase||0
2378849|NCT01469221|5838084|P3|STARTED|Open Label Phase||47
2378850|NCT01469221|5838085|P2|STARTED|Open Label Phase||0
2378851|NCT01469221|5838086|P1|STARTED|Open Label Phase||0
2378852|NCT01469182|5838097|P2|NOT COMPLETED|Overall Study||6
2378853|NCT01469182|5838098|P1|NOT COMPLETED|Overall Study||35
2378854|NCT01469182|5838097|P2|COMPLETED|Overall Study||298
2378855|NCT01469182|5838098|P1|COMPLETED|Overall Study||575
2378856|NCT01469182|5838097|P2|Treated|Overall Study||304
2378857|NCT01469182|5838098|P1|Treated|Overall Study||609
2378858|NCT01469182|5838097|P2|STARTED|Overall Study||304
2378859|NCT01469182|5838098|P1|STARTED|Overall Study||610
2378860|NCT01469065|5838125|P5|NOT COMPLETED|Overall Study||1
2378861|NCT01469065|5838126|P4|NOT COMPLETED|Overall Study||0
2378862|NCT01469065|5838127|P3|NOT COMPLETED|Overall Study||0
2378863|NCT01469065|5838128|P2|NOT COMPLETED|Overall Study||1
2378864|NCT01469065|5838129|P1|NOT COMPLETED|Overall Study||0
2378865|NCT01469065|5838125|P5|COMPLETED|Overall Study||16
2378866|NCT01469065|5838126|P4|COMPLETED|Overall Study||16
2378867|NCT01469065|5838127|P3|COMPLETED|Overall Study||16
2378868|NCT01469065|5838128|P2|COMPLETED|Overall Study||16
2378869|NCT01469065|5838129|P1|COMPLETED|Overall Study||16
2378870|NCT01469065|5838125|P5|STARTED|Overall Study||17
2378871|NCT01469065|5838126|P4|STARTED|Overall Study||16
2378872|NCT01469065|5838127|P3|STARTED|Overall Study||16
2378873|NCT01469065|5838128|P2|STARTED|Overall Study||17
2378874|NCT01469065|5838129|P1|STARTED|Overall Study||16
2378875|NCT01469052|5838225|P6|NOT COMPLETED|Overall Study||6
2378876|NCT01469052|5838226|P5|NOT COMPLETED|Overall Study||8
2378877|NCT01469052|5838227|P4|NOT COMPLETED|Overall Study||5
2378878|NCT01469052|5838228|P3|NOT COMPLETED|Overall Study||6
2378879|NCT01469052|5838229|P2|NOT COMPLETED|Overall Study||4
2378880|NCT01469052|5838230|P1|NOT COMPLETED|Overall Study||6
2378881|NCT01469052|5838225|P6|COMPLETED|Overall Study||0
2378882|NCT01469052|5838226|P5|COMPLETED|Overall Study||0
2378883|NCT01469052|5838227|P4|COMPLETED|Overall Study||1
2378884|NCT01469052|5838228|P3|COMPLETED|Overall Study||0
2378885|NCT01469052|5838229|P2|COMPLETED|Overall Study||0
2378886|NCT01469052|5838230|P1|COMPLETED|Overall Study||0
2378887|NCT01469052|5838225|P6|STARTED|Overall Study||6
2378888|NCT01469052|5838226|P5|STARTED|Overall Study||8
2378889|NCT01469052|5838227|P4|STARTED|Overall Study||6
2378890|NCT01469052|5838228|P3|STARTED|Overall Study||6
2378891|NCT01469052|5838229|P2|STARTED|Overall Study||4
2378892|NCT01469052|5838230|P1|STARTED|Overall Study||6
2378893|NCT01469039|5838277|P3|NOT COMPLETED|Overall Study||113
2378894|NCT01469039|5838278|P2|NOT COMPLETED|Overall Study||73
2378895|NCT01469039|5838279|P1|NOT COMPLETED|Overall Study||77
2378896|NCT01469039|5838277|P3|COMPLETED|Overall Study||95
2378897|NCT01469039|5838278|P2|COMPLETED|Overall Study||135
2378898|NCT01469039|5838279|P1|COMPLETED|Overall Study||130
2378899|NCT01469039|5838277|P3|STARTED|Overall Study||208
2378900|NCT01469039|5838278|P2|STARTED|Overall Study||208
2378901|NCT01469039|5838279|P1|STARTED|Overall Study||207
2378902|NCT01469013|5838295|P13|NOT COMPLETED|Part B (Extension Period)||6
2378903|NCT01469013|5838296|P12|NOT COMPLETED|Part B (Extension Period)||6
2378904|NCT01469013|5838297|P11|NOT COMPLETED|Part B (Extension Period)||2
2378905|NCT01469013|5838298|P10|NOT COMPLETED|Part B (Extension Period)||3
2378906|NCT01469013|5838299|P9|NOT COMPLETED|Part B (Extension Period)||4
2378907|NCT01469013|5838300|P8|NOT COMPLETED|Part B (Extension Period)||5
2378908|NCT01469013|5838301|P7|NOT COMPLETED|Part B (Extension Period)||5
2378909|NCT01469013|5838302|P6|NOT COMPLETED|Part B (Extension Period)||2
2378910|NCT01469013|5838303|P5|NOT COMPLETED|Part B (Extension Period)||0
2378911|NCT01469013|5838304|P4|NOT COMPLETED|Part B (Extension Period)||0
2378912|NCT01469013|5838305|P3|NOT COMPLETED|Part B (Extension Period)||0
2378913|NCT01469013|5838306|P2|NOT COMPLETED|Part B (Extension Period)||0
2378914|NCT01469013|5838307|P1|NOT COMPLETED|Part B (Extension Period)||0
2378915|NCT01469013|5838295|P13|COMPLETED|Part B (Extension Period)||18
2378916|NCT01469013|5838296|P12|COMPLETED|Part B (Extension Period)||18
2378917|NCT01469013|5838297|P11|COMPLETED|Part B (Extension Period)||10
2378918|NCT01469013|5838298|P10|COMPLETED|Part B (Extension Period)||8
2378919|NCT01469013|5838299|P9|COMPLETED|Part B (Extension Period)||20
2378920|NCT01469013|5838300|P8|COMPLETED|Part B (Extension Period)||18
2378921|NCT01469013|5838301|P7|COMPLETED|Part B (Extension Period)||7
2378922|NCT01469013|5838302|P6|COMPLETED|Part B (Extension Period)||10
2378923|NCT01469013|5838303|P5|COMPLETED|Part B (Extension Period)||0
2378924|NCT01469013|5838304|P4|COMPLETED|Part B (Extension Period)||0
2378925|NCT01469013|5838305|P3|COMPLETED|Part B (Extension Period)||0
2378926|NCT01469013|5838306|P2|COMPLETED|Part B (Extension Period)||0
2378927|NCT01469013|5838307|P1|COMPLETED|Part B (Extension Period)||0
2378928|NCT01469013|5838295|P13|Received at Least 1 Dose of Study Drug|Part B (Extension Period)|1 participant discontinued prior to receiving study drug|23
2378929|NCT01469013|5838296|P12|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||24
2378930|NCT01469013|5838297|P11|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
2378931|NCT01469013|5838298|P10|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||11
2378932|NCT01469013|5838299|P9|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||24
2378933|NCT01469013|5838300|P8|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||23
2378934|NCT01469013|5838301|P7|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
2378935|NCT01469013|5838302|P6|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
2378936|NCT01469013|5838303|P5|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
2378937|NCT01469013|5838304|P4|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
2378938|NCT01469013|5838305|P3|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
2378939|NCT01469013|5838306|P2|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
2378940|NCT01469013|5838307|P1|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
2378941|NCT01469013|5838295|P13|STARTED|Part B (Extension Period)||24
2378942|NCT01469013|5838296|P12|STARTED|Part B (Extension Period)||24
2378943|NCT01469013|5838297|P11|STARTED|Part B (Extension Period)||12
2378944|NCT01469013|5838298|P10|STARTED|Part B (Extension Period)||11
2378945|NCT01469013|5838299|P9|STARTED|Part B (Extension Period)||24
2378946|NCT01469013|5838300|P8|STARTED|Part B (Extension Period)||23
2378947|NCT01469013|5838301|P7|STARTED|Part B (Extension Period)||12
2378948|NCT01469013|5838302|P6|STARTED|Part B (Extension Period)||12
2378949|NCT01469013|5838303|P5|STARTED|Part B (Extension Period)||0
2378950|NCT01469013|5838304|P4|STARTED|Part B (Extension Period)||0
2378951|NCT01469013|5838305|P3|STARTED|Part B (Extension Period)||0
2378952|NCT01469013|5838306|P2|STARTED|Part B (Extension Period)||0
2378953|NCT01469013|5838307|P1|STARTED|Part B (Extension Period)||0
2378954|NCT01469013|5838295|P13|NOT COMPLETED|Part A (Treatment Period)||0
2378955|NCT01469013|5838296|P12|NOT COMPLETED|Part A (Treatment Period)||0
2378956|NCT01469013|5838297|P11|NOT COMPLETED|Part A (Treatment Period)||0
2378957|NCT01469013|5838298|P10|NOT COMPLETED|Part A (Treatment Period)||0
2378958|NCT01469013|5838299|P9|NOT COMPLETED|Part A (Treatment Period)||0
2378959|NCT01469013|5838300|P8|NOT COMPLETED|Part A (Treatment Period)||0
2378960|NCT01469013|5838301|P7|NOT COMPLETED|Part A (Treatment Period)||0
2378961|NCT01469013|5838302|P6|NOT COMPLETED|Part A (Treatment Period)||0
2378962|NCT01469013|5838303|P5|NOT COMPLETED|Part A (Treatment Period)||1
2378963|NCT01469013|5838304|P4|NOT COMPLETED|Part A (Treatment Period)||0
2378964|NCT01469013|5838305|P3|NOT COMPLETED|Part A (Treatment Period)||1
2378965|NCT01469013|5838306|P2|NOT COMPLETED|Part A (Treatment Period)||0
2378966|NCT01469013|5838307|P1|NOT COMPLETED|Part A (Treatment Period)||1
2378967|NCT01469013|5838295|P13|COMPLETED|Part A (Treatment Period)||0
2378968|NCT01469013|5838296|P12|COMPLETED|Part A (Treatment Period)||0
2378969|NCT01469013|5838297|P11|COMPLETED|Part A (Treatment Period)||0
2378970|NCT01469013|5838298|P10|COMPLETED|Part A (Treatment Period)||0
2378971|NCT01469013|5838299|P9|COMPLETED|Part A (Treatment Period)||0
2378972|NCT01469013|5838300|P8|COMPLETED|Part A (Treatment Period)||0
2378973|NCT01469013|5838301|P7|COMPLETED|Part A (Treatment Period)||0
2378974|NCT01469013|5838302|P6|COMPLETED|Part A (Treatment Period)||0
2378975|NCT01469013|5838303|P5|COMPLETED|Part A (Treatment Period)||48
2378976|NCT01469013|5838304|P4|COMPLETED|Part A (Treatment Period)||24
2378977|NCT01469013|5838305|P3|COMPLETED|Part A (Treatment Period)||23
2378978|NCT01469013|5838306|P2|COMPLETED|Part A (Treatment Period)||24
2378979|NCT01469013|5838307|P1|COMPLETED|Part A (Treatment Period)||23
2378980|NCT01469013|5838295|P13|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
2378981|NCT01469013|5838296|P12|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
2378982|NCT01469013|5838297|P11|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
2378983|NCT01469013|5838298|P10|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
2378984|NCT01469013|5838299|P9|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
2378985|NCT01469013|5838300|P8|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
2378986|NCT01469013|5838301|P7|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
2378987|NCT01469013|5838302|P6|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
2378988|NCT01469013|5838303|P5|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||49
2378989|NCT01469013|5838304|P4|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
2378990|NCT01469013|5838305|P3|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
2378991|NCT01469013|5838306|P2|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
2378992|NCT01469013|5838307|P1|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
2378993|NCT01469013|5838295|P13|STARTED|Part A (Treatment Period)||0
2378994|NCT01469013|5838296|P12|STARTED|Part A (Treatment Period)||0
2378995|NCT01469013|5838297|P11|STARTED|Part A (Treatment Period)||0
2378996|NCT01469013|5838298|P10|STARTED|Part A (Treatment Period)||0
2378997|NCT01469013|5838299|P9|STARTED|Part A (Treatment Period)||0
2378998|NCT01469013|5838300|P8|STARTED|Part A (Treatment Period)||0
2378999|NCT01469013|5838301|P7|STARTED|Part A (Treatment Period)||0
2379000|NCT01469013|5838302|P6|STARTED|Part A (Treatment Period)||0
2379001|NCT01469013|5838303|P5|STARTED|Part A (Treatment Period)||49
2379002|NCT01469013|5838304|P4|STARTED|Part A (Treatment Period)||24
2379003|NCT01469013|5838305|P3|STARTED|Part A (Treatment Period)||24
2379004|NCT01469013|5838306|P2|STARTED|Part A (Treatment Period)||24
2379005|NCT01469013|5838307|P1|STARTED|Part A (Treatment Period)||24
2379006|NCT01469000|5838392|P2|NOT COMPLETED|Overall Study||4
2379007|NCT01469000|5838393|P1|NOT COMPLETED|Overall Study||20
2379008|NCT01469000|5838392|P2|COMPLETED|Overall Study||62
2379009|NCT01469000|5838393|P1|COMPLETED|Overall Study||109
2379010|NCT01469000|5838392|P2|Received at Least 1 Dose of Study Drug|Overall Study||65
2379011|NCT01469000|5838393|P1|Received at Least 1 Dose of Study Drug|Overall Study||126
2379012|NCT01469000|5838392|P2|STARTED|Overall Study||66
2379013|NCT01469000|5838393|P1|STARTED|Overall Study||129
2379014|NCT01468987|5838413|P2|NOT COMPLETED|Overall Study||60
2379015|NCT01468987|5838414|P1|NOT COMPLETED|Overall Study||71
2379016|NCT01468987|5838413|P2|COMPLETED|Overall Study||618
2379017|NCT01468987|5838414|P1|COMPLETED|Overall Study||620
2379018|NCT01468987|5838413|P2|Received at Least 1 Dose of Study Drug|Overall Study||677
2379019|NCT01468987|5838414|P1|Received at Least 1 Dose of Study Drug|Overall Study||691
2379020|NCT01468987|5838413|P2|STARTED|Overall Study||678
2379021|NCT01468987|5838414|P1|STARTED|Overall Study||691
2379022|NCT01468974|5838458|P1|NOT COMPLETED|3 Years Follow-up||6
2379023|NCT01468974|5838458|P1|COMPLETED|3 Years Follow-up||26
2379024|NCT01468974|5838458|P1|STARTED|3 Years Follow-up||32
2379025|NCT01468974|5838458|P1|NOT COMPLETED|2 Years Follow-up||2
2379026|NCT01468974|5838458|P1|COMPLETED|2 Years Follow-up||32
2379027|NCT01468974|5838458|P1|STARTED|2 Years Follow-up||34
2379028|NCT01468974|5838458|P1|NOT COMPLETED|1 Year Follow-up||0
2379029|NCT01468974|5838458|P1|COMPLETED|1 Year Follow-up||34
2379030|NCT01468974|5838458|P1|STARTED|1 Year Follow-up||34
2379031|NCT01468974|5838458|P1|NOT COMPLETED|6 Months Follow-up||0
2379032|NCT01468974|5838458|P1|COMPLETED|6 Months Follow-up||34
2379033|NCT01468974|5838458|P1|STARTED|6 Months Follow-up||34
2379034|NCT01468974|5838458|P1|NOT COMPLETED|1 Month Follow-up||1
2379035|NCT01468974|5838458|P1|COMPLETED|1 Month Follow-up||34
2379036|NCT01468974|5838458|P1|STARTED|1 Month Follow-up|Intent-to-treat (ITT) population|35
2379037|NCT01468909|5838591|P2|NOT COMPLETED|Overall Study||2
2379038|NCT01468909|5838592|P1|NOT COMPLETED|Overall Study||2
2379039|NCT01468909|5838591|P2|COMPLETED|Overall Study||52
2379040|NCT01468909|5838592|P1|COMPLETED|Overall Study||50
2379041|NCT01468909|5838591|P2|STARTED|Overall Study||54
2379042|NCT01468909|5838592|P1|STARTED|Overall Study||52
2379043|NCT01468896|5838608|P2|NOT COMPLETED|Overall Study||0
2379044|NCT01468896|5838609|P1|NOT COMPLETED|Overall Study||0
2379045|NCT01468896|5838608|P2|COMPLETED|Overall Study||17
2379046|NCT01468896|5838609|P1|COMPLETED|Overall Study||6
2379047|NCT01468896|5838608|P2|STARTED|Overall Study||17
2379048|NCT01468896|5838609|P1|STARTED|Overall Study||6
2379049|NCT01468818|5838625|P1|NOT COMPLETED|Overall Study||2
2379050|NCT01468818|5838625|P1|COMPLETED|Overall Study||16
2379051|NCT01468818|5838625|P1|STARTED|Overall Study||18
2379052|NCT01468675|5838632|P2|NOT COMPLETED|Overall Study||1372
2379053|NCT01468675|5838633|P1|NOT COMPLETED|Overall Study||1000
2379054|NCT01468675|5838632|P2|COMPLETED|Overall Study||2004
2379055|NCT01468675|5838633|P1|COMPLETED|Overall Study||1699
2379056|NCT01468675|5838632|P2|STARTED|Overall Study||3376
2379057|NCT01468675|5838633|P1|STARTED|Overall Study||2699
2379058|NCT01468584|5838639|P1|NOT COMPLETED|Overall Study||0
2379059|NCT01468584|5838639|P1|COMPLETED|Overall Study||10
2379060|NCT01468584|5838639|P1|STARTED|Overall Study||10
2379061|NCT01468558|5838643|P1|NOT COMPLETED|Overall Study||2
2379062|NCT01468558|5838643|P1|COMPLETED|Overall Study||22
2379063|NCT01468558|5838643|P1|STARTED|Overall Study||24
2379064|NCT01468350|5838658|P4|NOT COMPLETED|(PART B) Day 1, Day 15||0
2379065|NCT01468350|5838659|P3|NOT COMPLETED|(PART B) Day 1, Day 15||0
2379066|NCT01468350|5838660|P2|NOT COMPLETED|(PART B) Day 1, Day 15||0
2379067|NCT01468350|5838661|P1|NOT COMPLETED|(PART B) Day 1, Day 15||0
2379068|NCT01468350|5838658|P4|COMPLETED|(PART B) Day 1, Day 15||12
2379069|NCT01468350|5838659|P3|COMPLETED|(PART B) Day 1, Day 15||12
2379070|NCT01468350|5838660|P2|COMPLETED|(PART B) Day 1, Day 15||0
2379071|NCT01468350|5838661|P1|COMPLETED|(PART B) Day 1, Day 15||0
2379072|NCT01468350|5838658|P4|STARTED|(PART B) Day 1, Day 15||12
2379073|NCT01468350|5838659|P3|STARTED|(PART B) Day 1, Day 15||12
2379074|NCT01468350|5838660|P2|STARTED|(PART B) Day 1, Day 15||0
2379075|NCT01468350|5838661|P1|STARTED|(PART B) Day 1, Day 15||0
2379076|NCT01468350|5838658|P4|NOT COMPLETED|(PART A) Day 1, Day 3||0
2379077|NCT01468350|5838659|P3|NOT COMPLETED|(PART A) Day 1, Day 3||0
2379078|NCT01468350|5838660|P2|NOT COMPLETED|(PART A) Day 1, Day 3||0
2379079|NCT01468350|5838661|P1|NOT COMPLETED|(PART A) Day 1, Day 3||0
2379080|NCT01468350|5838658|P4|COMPLETED|(PART A) Day 1, Day 3||0
2379081|NCT01468350|5838659|P3|COMPLETED|(PART A) Day 1, Day 3||0
2379082|NCT01468350|5838660|P2|COMPLETED|(PART A) Day 1, Day 3||5
2379083|NCT01468350|5838661|P1|COMPLETED|(PART A) Day 1, Day 3||6
2379084|NCT01468350|5838658|P4|STARTED|(PART A) Day 1, Day 3||0
2379085|NCT01468350|5838659|P3|STARTED|(PART A) Day 1, Day 3||0
2379086|NCT01468350|5838660|P2|STARTED|(PART A) Day 1, Day 3||5
2379087|NCT01468350|5838661|P1|STARTED|(PART A) Day 1, Day 3||6
2379088|NCT01468337|5838671|P1|NOT COMPLETED|Overall Study||0
2379089|NCT01468337|5838671|P1|COMPLETED|Overall Study||5
2379090|NCT01468337|5838671|P1|Week 48|Overall Study|Two participants did not have a Week 48 visit but completed the study.|3
2379091|NCT01468337|5838671|P1|Received Interferon Gamma-1b After Wk 8|Overall Study|Two participants had 2 Interferon gamma-1b dosing cycles after Wk 8|4
2379092|NCT01468337|5838671|P1|Received Interferon Gamma-1b at Week 4|Overall Study|One participant received additional Interferon gamma-1b dosing at Week 4 and after Week 8|2
2379093|NCT01468337|5838671|P1|Week 2|Overall Study||5
2379094|NCT01468337|5838671|P1|STARTED|Overall Study||5
2379095|NCT01468311|5838683|P1|NOT COMPLETED|Overall Study||2
2379096|NCT01468311|5838683|P1|COMPLETED|Overall Study||4
2379097|NCT01468311|5838683|P1|STARTED|Overall Study||6
2379098|NCT01468233|5838695|P6|NOT COMPLETED|Treatment Period 2||23
2379099|NCT01468233|5838696|P5|NOT COMPLETED|Treatment Period 2||28
2379100|NCT01468233|5838697|P4|NOT COMPLETED|Treatment Period 2||28
2379101|NCT01468233|5838698|P3|NOT COMPLETED|Treatment Period 2||111
2379102|NCT01468233|5838699|P2|NOT COMPLETED|Treatment Period 2||0
2379103|NCT01468233|5838700|P1|NOT COMPLETED|Treatment Period 2||0
2379104|NCT01468233|5838695|P6|COMPLETED|Treatment Period 2||28
2379105|NCT01468233|5838696|P5|COMPLETED|Treatment Period 2||25
2379106|NCT01468233|5838697|P4|COMPLETED|Treatment Period 2||23
2379107|NCT01468233|5838698|P3|COMPLETED|Treatment Period 2||40
2379108|NCT01468233|5838699|P2|COMPLETED|Treatment Period 2||0
2379109|NCT01468233|5838700|P1|COMPLETED|Treatment Period 2||0
2379110|NCT01468233|5838695|P6|STARTED|Treatment Period 2||51
2379111|NCT01468233|5838696|P5|STARTED|Treatment Period 2||53
2379112|NCT01468233|5838697|P4|STARTED|Treatment Period 2||51
2379113|NCT01468233|5838698|P3|STARTED|Treatment Period 2||151
2379114|NCT01468233|5838699|P2|STARTED|Treatment Period 2||0
2379115|NCT01468233|5838700|P1|STARTED|Treatment Period 2||0
2379116|NCT01468233|5838695|P6|NOT COMPLETED|Treatment Period 1||0
2379117|NCT01468233|5838696|P5|NOT COMPLETED|Treatment Period 1||0
2379118|NCT01468233|5838697|P4|NOT COMPLETED|Treatment Period 1||0
2379119|NCT01468233|5838698|P3|NOT COMPLETED|Treatment Period 1||0
2379120|NCT01468233|5838699|P2|NOT COMPLETED|Treatment Period 1||8
2379121|NCT01468233|5838700|P1|NOT COMPLETED|Treatment Period 1||12
2379122|NCT01468233|5838695|P6|COMPLETED|Treatment Period 1||0
2379123|NCT01468233|5838696|P5|COMPLETED|Treatment Period 1||0
2379124|NCT01468233|5838697|P4|COMPLETED|Treatment Period 1||0
2379125|NCT01468233|5838698|P3|COMPLETED|Treatment Period 1||0
2379126|NCT01468233|5838699|P2|COMPLETED|Treatment Period 1||155
2379127|NCT01468233|5838700|P1|COMPLETED|Treatment Period 1||151
2379128|NCT01468233|5838695|P6|STARTED|Treatment Period 1||0
2379129|NCT01468233|5838696|P5|STARTED|Treatment Period 1||0
2379130|NCT01468233|5838697|P4|STARTED|Treatment Period 1||0
2379131|NCT01468233|5838698|P3|STARTED|Treatment Period 1||0
2379132|NCT01468233|5838699|P2|STARTED|Treatment Period 1||163
2379133|NCT01468233|5838700|P1|STARTED|Treatment Period 1||163
2379134|NCT01468207|5838722|P6|NOT COMPLETED|Treatment Period 2||20
2379135|NCT01468207|5838723|P5|NOT COMPLETED|Treatment Period 2||21
2379136|NCT01468207|5838724|P4|NOT COMPLETED|Treatment Period 2||27
2379137|NCT01468207|5838725|P3|NOT COMPLETED|Treatment Period 2||52
2379138|NCT01468207|5838726|P2|NOT COMPLETED|Treatment Period 2||0
2379139|NCT01468207|5838727|P1|NOT COMPLETED|Treatment Period 2||0
2379140|NCT01468207|5838722|P6|COMPLETED|Treatment Period 2||28
2379141|NCT01468207|5838723|P5|COMPLETED|Treatment Period 2||27
2379142|NCT01468207|5838724|P4|COMPLETED|Treatment Period 2||22
2379143|NCT01468207|5838725|P3|COMPLETED|Treatment Period 2||93
2379144|NCT01468207|5838726|P2|COMPLETED|Treatment Period 2||0
2379145|NCT01468207|5838727|P1|COMPLETED|Treatment Period 2||0
2379146|NCT01468207|5838722|P6|STARTED|Treatment Period 2||48
2379147|NCT01468207|5838723|P5|STARTED|Treatment Period 2||48
2379148|NCT01468207|5838724|P4|STARTED|Treatment Period 2||49
2379149|NCT01468207|5838725|P3|STARTED|Treatment Period 2||145
2379150|NCT01468207|5838726|P2|STARTED|Treatment Period 2||0
2379151|NCT01468207|5838727|P1|STARTED|Treatment Period 2||0
2379152|NCT01468207|5838722|P6|NOT COMPLETED|Treatment Period 1||0
2379153|NCT01468207|5838723|P5|NOT COMPLETED|Treatment Period 1||0
2379154|NCT01468207|5838724|P4|NOT COMPLETED|Treatment Period 1||0
2379155|NCT01468207|5838725|P3|NOT COMPLETED|Treatment Period 1||0
2379156|NCT01468207|5838726|P2|NOT COMPLETED|Treatment Period 1||8
2379157|NCT01468207|5838727|P1|NOT COMPLETED|Treatment Period 1||9
2379158|NCT01468207|5838722|P6|COMPLETED|Treatment Period 1||0
2379159|NCT01468207|5838723|P5|COMPLETED|Treatment Period 1||0
2379160|NCT01468207|5838724|P4|COMPLETED|Treatment Period 1||0
2379161|NCT01468207|5838725|P3|COMPLETED|Treatment Period 1||0
2379162|NCT01468207|5838726|P2|COMPLETED|Treatment Period 1||145
2379163|NCT01468207|5838727|P1|COMPLETED|Treatment Period 1||145
2379164|NCT01468207|5838722|P6|Received Study Drug|Treatment Period 1||0
2379165|NCT01468207|5838723|P5|Received Study Drug|Treatment Period 1||0
2379166|NCT01468207|5838724|P4|Received Study Drug|Treatment Period 1||0
2379167|NCT01468207|5838725|P3|Received Study Drug|Treatment Period 1||0
2379168|NCT01468207|5838726|P2|Received Study Drug|Treatment Period 1||153
2379169|NCT01468207|5838727|P1|Received Study Drug|Treatment Period 1||152
2379170|NCT01468207|5838722|P6|STARTED|Treatment Period 1||0
2379171|NCT01468207|5838723|P5|STARTED|Treatment Period 1||0
2379172|NCT01468207|5838724|P4|STARTED|Treatment Period 1||0
2379173|NCT01468207|5838725|P3|STARTED|Treatment Period 1||0
2379174|NCT01468207|5838726|P2|STARTED|Treatment Period 1||153
2379175|NCT01468207|5838727|P1|STARTED|Treatment Period 1||154
2379176|NCT01468181|5838752|P5|NOT COMPLETED|Overall Study||5
2379177|NCT01468181|5838753|P4|NOT COMPLETED|Overall Study||3
2379178|NCT01468181|5838754|P3|NOT COMPLETED|Overall Study||8
2379179|NCT01468181|5838755|P2|NOT COMPLETED|Overall Study||2
2379180|NCT01468181|5838756|P1|NOT COMPLETED|Overall Study||10
2379181|NCT01468181|5838752|P5|COMPLETED|Overall Study||66
2379182|NCT01468181|5838753|P4|COMPLETED|Overall Study||63
2379183|NCT01468181|5838754|P3|COMPLETED|Overall Study||57
2379184|NCT01468181|5838755|P2|COMPLETED|Overall Study||59
2379185|NCT01468181|5838756|P1|COMPLETED|Overall Study||121
2379186|NCT01468181|5838752|P5|Received at Least 1 Dose of Study Drug|Overall Study||71
2379187|NCT01468181|5838753|P4|Received at Least 1 Dose of Study Drug|Overall Study||66
2379188|NCT01468181|5838754|P3|Received at Least 1 Dose of Study Drug|Overall Study||65
2379189|NCT01468181|5838755|P2|Received at Least 1 Dose of Study Drug|Overall Study||61
2379190|NCT01468181|5838756|P1|Received at Least 1 Dose of Study Drug|Overall Study||131
2379191|NCT01468181|5838752|P5|STARTED|Overall Study||71
2379192|NCT01468181|5838753|P4|STARTED|Overall Study||66
2379193|NCT01468181|5838754|P3|STARTED|Overall Study||65
2379194|NCT01468181|5838755|P2|STARTED|Overall Study||61
2379195|NCT01468181|5838756|P1|STARTED|Overall Study||131
2379196|NCT01468077|5838805|P2|NOT COMPLETED|Overall Study||3
2379197|NCT01468077|5838806|P1|NOT COMPLETED|Overall Study||4
2379198|NCT01468077|5838805|P2|COMPLETED|Overall Study||22
2379199|NCT01468077|5838806|P1|COMPLETED|Overall Study||18
2379200|NCT01468077|5838805|P2|STARTED|Overall Study||25
2379201|NCT01468077|5838806|P1|STARTED|Overall Study||22
2379202|NCT01468012|5838845|P3|NOT COMPLETED|Overall Study||4
2379203|NCT01468012|5838846|P2|NOT COMPLETED|Overall Study||1
2379204|NCT01468012|5838847|P1|NOT COMPLETED|Overall Study||2
2379205|NCT01468012|5838845|P3|COMPLETED|Overall Study||0
2379206|NCT01468012|5838846|P2|COMPLETED|Overall Study||9
2379207|NCT01468012|5838847|P1|COMPLETED|Overall Study||7
2379208|NCT01468012|5838845|P3|STARTED|Overall Study||4
2379209|NCT01468012|5838846|P2|STARTED|Overall Study||10
2379210|NCT01468012|5838847|P1|STARTED|Overall Study||9
2379211|NCT01467999|5838858|P1|NOT COMPLETED|Overall Study||13
2379212|NCT01467999|5838858|P1|COMPLETED|Overall Study||9
2379213|NCT01467999|5838858|P1|STARTED|Overall Study||22
2379214|NCT01467960|5838868|P6|NOT COMPLETED|Overall Study||30
2379215|NCT01467960|5838869|P5|NOT COMPLETED|Overall Study||30
2379216|NCT01467960|5838870|P4|NOT COMPLETED|Overall Study||30
2379217|NCT01467960|5838871|P3|NOT COMPLETED|Overall Study||0
2379218|NCT01467960|5838872|P2|NOT COMPLETED|Overall Study||0
2379219|NCT01467960|5838873|P1|NOT COMPLETED|Overall Study||0
2379220|NCT01467960|5838868|P6|COMPLETED|Overall Study||0
2379221|NCT01467960|5838869|P5|COMPLETED|Overall Study||0
2379222|NCT01467960|5838870|P4|COMPLETED|Overall Study||0
2379223|NCT01467960|5838871|P3|COMPLETED|Overall Study||30
2379224|NCT01467960|5838872|P2|COMPLETED|Overall Study||30
2379225|NCT01467960|5838873|P1|COMPLETED|Overall Study||30
2379226|NCT01467960|5838868|P6|STARTED|Overall Study||30
2379227|NCT01467960|5838869|P5|STARTED|Overall Study||30
2379228|NCT01467960|5838870|P4|STARTED|Overall Study||30
2379229|NCT01467960|5838871|P3|STARTED|Overall Study||30
2379230|NCT01467960|5838872|P2|STARTED|Overall Study||30
2379231|NCT01467960|5838873|P1|STARTED|Overall Study||30
2379232|NCT01467947|5838887|P1|NOT COMPLETED|Overall Study||0
2379233|NCT01467947|5838887|P1|COMPLETED|Overall Study||46
2379234|NCT01467947|5838887|P1|STARTED|Overall Study||46
2379235|NCT01467934|5838895|P3|NOT COMPLETED|Overall Study||0
2379236|NCT01467934|5838896|P2|NOT COMPLETED|Overall Study||0
2379237|NCT01467934|5838897|P1|NOT COMPLETED|Overall Study||0
2379238|NCT01467934|5838895|P3|COMPLETED|Overall Study||110
2379239|NCT01467934|5838896|P2|COMPLETED|Overall Study||212
2379240|NCT01467934|5838897|P1|COMPLETED|Overall Study||208
2379241|NCT01467934|5838895|P3|STARTED|Overall Study||110
2379242|NCT01467934|5838896|P2|STARTED|Overall Study||212
2379243|NCT01467934|5838897|P1|STARTED|Overall Study||208
2379244|NCT01467882|5838905|P1|NOT COMPLETED|Overall Study||0
2379245|NCT01467882|5838905|P1|COMPLETED|Overall Study||44
2379246|NCT01467882|5838905|P1|STARTED|Overall Study||44
2379247|NCT01467713|5838932|P4|NOT COMPLETED|Overall Study||109
2379248|NCT01467713|5838933|P3|NOT COMPLETED|Overall Study||102
2379249|NCT01467713|5838934|P2|NOT COMPLETED|Overall Study||104
2379250|NCT01467713|5838935|P1|NOT COMPLETED|Overall Study||102
2379251|NCT01467713|5838932|P4|COMPLETED|Overall Study||45
2379252|NCT01467713|5838933|P3|COMPLETED|Overall Study||58
2379253|NCT01467713|5838934|P2|COMPLETED|Overall Study||60
2379254|NCT01467713|5838935|P1|COMPLETED|Overall Study||62
2379255|NCT01467713|5838932|P4|Safety Analysis Set: Received Treatment|Overall Study||154
2379256|NCT01467713|5838933|P3|Safety Analysis Set: Received Treatment|Overall Study||159
2379257|NCT01467713|5838934|P2|Safety Analysis Set: Received Treatment|Overall Study||164
2379258|NCT01467713|5838935|P1|Safety Analysis Set: Received Treatment|Overall Study||163
2379259|NCT01467713|5838932|P4|STARTED|Overall Study||154
2379260|NCT01467713|5838933|P3|STARTED|Overall Study||160
2379261|NCT01467713|5838934|P2|STARTED|Overall Study||164
2379262|NCT01467713|5838935|P1|STARTED|Overall Study||164
2379263|NCT01467700|5838989|P4|NOT COMPLETED|Overall Study||27
2379264|NCT01467700|5838990|P3|NOT COMPLETED|Overall Study||27
2379265|NCT01467700|5838991|P2|NOT COMPLETED|Overall Study||28
2379266|NCT01467700|5838992|P1|NOT COMPLETED|Overall Study||29
2379267|NCT01467700|5838989|P4|COMPLETED|Overall Study||96
2379268|NCT01467700|5838990|P3|COMPLETED|Overall Study||97
2379269|NCT01467700|5838991|P2|COMPLETED|Overall Study||100
2379270|NCT01467700|5838992|P1|COMPLETED|Overall Study||86
2379271|NCT01467700|5838989|P4|Safety Set - Received Treatment|Overall Study||123
2379272|NCT01467700|5838990|P3|Safety Set - Received Treatment|Overall Study||124
2379273|NCT01467700|5838991|P2|Safety Set - Received Treatment|Overall Study||127
2379274|NCT01467700|5838992|P1|Safety Set - Received Treatment|Overall Study||115
2379275|NCT01467700|5838989|P4|STARTED|Overall Study||123
2379276|NCT01467700|5838990|P3|STARTED|Overall Study||124
2379277|NCT01467700|5838991|P2|STARTED|Overall Study||128
2379278|NCT01467700|5838992|P1|STARTED|Overall Study||115
2379279|NCT01467661|5839034|P1|NOT COMPLETED|Overall Study||21
2379280|NCT01467661|5839034|P1|COMPLETED|Overall Study||32
2379281|NCT01467661|5839034|P1|Started Post Marketing Trial|Overall Study||33
2379282|NCT01467661|5839034|P1|Started SPD422-309 (NCT01467661)|Overall Study||41
2379283|NCT01467661|5839034|P1|Completed SPD422-308 (NCT01214915)|Overall Study||42
2379284|NCT01467661|5839034|P1|STARTED|Overall Study||53
2379285|NCT01467583|5839054|P3|NOT COMPLETED|Overall Study||2
2379286|NCT01467583|5839055|P2|NOT COMPLETED|Overall Study||1
2379287|NCT01467583|5839056|P1|NOT COMPLETED|Overall Study||2
2379288|NCT01467583|5839054|P3|COMPLETED|Overall Study||10
2379289|NCT01467583|5839055|P2|COMPLETED|Overall Study|Death unrelated to study drug on day #3. Data to that point is included in the results|3
2379290|NCT01467583|5839056|P1|COMPLETED|Overall Study|Both patients completed > 1 dose and so their data was included in the results.|14
2379291|NCT01467583|5839054|P3|STARTED|Overall Study||12
2379292|NCT01467583|5839055|P2|STARTED|Overall Study||4
2379293|NCT01467583|5839056|P1|STARTED|Overall Study||16
2379294|NCT01467570|5839069|P2|NOT COMPLETED|Overall Study||9
2379295|NCT01467570|5839070|P1|NOT COMPLETED|Overall Study||8
2379296|NCT01467570|5839069|P2|COMPLETED|Overall Study||63
2379297|NCT01467570|5839070|P1|COMPLETED|Overall Study||67
2379298|NCT01467570|5839069|P2|STARTED|Overall Study||72
2379299|NCT01467570|5839070|P1|STARTED|Overall Study||75
2379300|NCT01467557|5839096|P2|NOT COMPLETED|Overall Study||107
2379301|NCT01467557|5839097|P1|NOT COMPLETED|Overall Study||99
2379302|NCT01467557|5839096|P2|COMPLETED|Overall Study||463
2379303|NCT01467557|5839097|P1|COMPLETED|Overall Study||502
2379304|NCT01467557|5839096|P2|12 Month Survey Completed|Overall Study||463
2379305|NCT01467557|5839097|P1|12 Month Survey Completed|Overall Study||502
2379306|NCT01467557|5839096|P2|4 Month Survey Completed|Overall Study||493
2379307|NCT01467557|5839097|P1|4 Month Survey Completed|Overall Study||533
2379308|NCT01467557|5839096|P2|2 Week Survey Completed|Overall Study||522
2379309|NCT01467557|5839097|P1|2 Week Survey Completed|Overall Study||551
2379310|NCT01467557|5839096|P2|STARTED|Overall Study||570
2379311|NCT01467557|5839097|P1|STARTED|Overall Study||601
2379312|NCT01467505|5839107|P2|NOT COMPLETED|Overall Study||3
2379313|NCT01467505|5839108|P1|NOT COMPLETED|Overall Study||33
2379314|NCT01467505|5839107|P2|COMPLETED|Overall Study||7
2379315|NCT01467505|5839108|P1|COMPLETED|Overall Study||18
2379316|NCT01467505|5839107|P2|STARTED|Overall Study||10
2379317|NCT01467505|5839108|P1|STARTED|Overall Study||51
2379318|NCT01467492|5839140|P2|NOT COMPLETED|Overall Study||13
2379319|NCT01467492|5839141|P1|NOT COMPLETED|Overall Study||22
2379320|NCT01467492|5839140|P2|COMPLETED|Overall Study||25
2379321|NCT01467492|5839141|P1|COMPLETED|Overall Study||61
2379322|NCT01467492|5839140|P2|STARTED|Overall Study||38
2379323|NCT01467492|5839141|P1|STARTED|Overall Study||83
2379324|NCT01467479|5839165|P3|NOT COMPLETED|Overall Study||16
2379325|NCT01467479|5839166|P2|NOT COMPLETED|Overall Study||17
2379326|NCT01467479|5839167|P1|NOT COMPLETED|Overall Study||9
2379327|NCT01467479|5839165|P3|COMPLETED|Overall Study||45
2379328|NCT01467479|5839166|P2|COMPLETED|Overall Study||52
2379329|NCT01467479|5839167|P1|COMPLETED|Overall Study||46
2379330|NCT01467479|5839165|P3|Treated|Overall Study||59
2379331|NCT01467479|5839166|P2|Treated|Overall Study||69
2379332|NCT01467479|5839167|P1|Treated|Overall Study||54
2379333|NCT01467479|5839165|P3|STARTED|Overall Study||61
2379334|NCT01467479|5839166|P2|STARTED|Overall Study||69
2379335|NCT01467479|5839167|P1|STARTED|Overall Study||55
2379336|NCT01467466|5839198|P4|NOT COMPLETED|Overall Study||88
2379337|NCT01467466|5839199|P3|NOT COMPLETED|Overall Study||104
2379338|NCT01467466|5839200|P2|NOT COMPLETED|Overall Study||104
2379339|NCT01467466|5839201|P1|NOT COMPLETED|Overall Study||109
2379340|NCT01467466|5839198|P4|COMPLETED|Overall Study||1203
2379341|NCT01467466|5839199|P3|COMPLETED|Overall Study||1190
2379342|NCT01467466|5839200|P2|COMPLETED|Overall Study||1188
2379343|NCT01467466|5839201|P1|COMPLETED|Overall Study||1191
2379344|NCT01467466|5839198|P4|STARTED|Overall Study||1291
2379345|NCT01467466|5839199|P3|STARTED|Overall Study||1294
2379346|NCT01467466|5839200|P2|STARTED|Overall Study||1292
2379347|NCT01467466|5839201|P1|STARTED|Overall Study||1300
2379356|NCT01467271|5839232|P1|NOT COMPLETED|Overall Study||202
2379357|NCT01467271|5839232|P1|COMPLETED|Overall Study||338
2379358|NCT01467271|5839232|P1|STARTED|Overall Study||540
2379359|NCT01467076|5839239|P3|NOT COMPLETED|Overall Study||0
2379360|NCT01467076|5839240|P2|NOT COMPLETED|Overall Study||0
2379361|NCT01467076|5839241|P1|NOT COMPLETED|Overall Study||1
2379362|NCT01467076|5839239|P3|COMPLETED|Overall Study||2
2379363|NCT01467076|5839240|P2|COMPLETED|Overall Study||2
2379364|NCT01467076|5839241|P1|COMPLETED|Overall Study||2
2379365|NCT01467076|5839239|P3|STARTED|Overall Study||2
2379366|NCT01467076|5839240|P2|STARTED|Overall Study||2
2379367|NCT01467076|5839241|P1|STARTED|Overall Study||3
2379368|NCT01467037|5839278|P1|NOT COMPLETED|Overall Study||0
2379369|NCT01467037|5839278|P1|COMPLETED|Overall Study||374
2379370|NCT01467037|5839278|P1|STARTED|Overall Study||374
2379371|NCT01466985|5839288|P3|NOT COMPLETED|Overall Study||0
2379372|NCT01466985|5839289|P2|NOT COMPLETED|Overall Study||0
2379373|NCT01466985|5839290|P1|NOT COMPLETED|Overall Study||0
2379374|NCT01466985|5839288|P3|COMPLETED|Overall Study||6
2379375|NCT01466985|5839289|P2|COMPLETED|Overall Study||6
2379376|NCT01466985|5839290|P1|COMPLETED|Overall Study||6
2379377|NCT01466985|5839288|P3|STARTED|Overall Study||6
2379378|NCT01466985|5839289|P2|STARTED|Overall Study||6
2379379|NCT01466985|5839290|P1|STARTED|Overall Study||6
2379380|NCT01466881|5839307|P1|NOT COMPLETED|Overall Study||40
2379381|NCT01466881|5839307|P1|COMPLETED|Overall Study||2
2379382|NCT01466881|5839307|P1|Eligible and Treated|Overall Study||37
2379383|NCT01466881|5839307|P1|STARTED|Overall Study||42
2379384|NCT01466790|5839324|P8|NOT COMPLETED|Overall Study||1
2379385|NCT01466790|5839325|P7|NOT COMPLETED|Overall Study||1
2379386|NCT01466790|5839326|P6|NOT COMPLETED|Overall Study||0
2379387|NCT01466790|5839327|P5|NOT COMPLETED|Overall Study||3
2379388|NCT01466790|5839328|P4|NOT COMPLETED|Overall Study||0
2379389|NCT01466790|5839329|P3|NOT COMPLETED|Overall Study||0
2379390|NCT01466790|5839330|P2|NOT COMPLETED|Overall Study||1
2379391|NCT01466790|5839331|P1|NOT COMPLETED|Overall Study||4
2379392|NCT01466790|5839324|P8|COMPLETED|Overall Study||13
2379393|NCT01466790|5839325|P7|COMPLETED|Overall Study||26
2379394|NCT01466790|5839326|P6|COMPLETED|Overall Study||16
2379395|NCT01466790|5839327|P5|COMPLETED|Overall Study||27
2379396|NCT01466790|5839328|P4|COMPLETED|Overall Study||14
2379397|NCT01466790|5839329|P3|COMPLETED|Overall Study||27
2379398|NCT01466790|5839330|P2|COMPLETED|Overall Study||14
2379399|NCT01466790|5839331|P1|COMPLETED|Overall Study||20
2379400|NCT01466790|5839324|P8|STARTED|Overall Study||14
2379401|NCT01466790|5839325|P7|STARTED|Overall Study||27
2379402|NCT01466790|5839326|P6|STARTED|Overall Study||16
2379403|NCT01466790|5839327|P5|STARTED|Overall Study||30
2379404|NCT01466790|5839328|P4|STARTED|Overall Study||14
2379405|NCT01466790|5839329|P3|STARTED|Overall Study||27
2379406|NCT01466790|5839330|P2|STARTED|Overall Study||15
2379407|NCT01466790|5839331|P1|STARTED|Overall Study|Not including 1 participant who was randomized to this group, but never received treatment.|24
2379408|NCT01466764|5839395|P2|NOT COMPLETED|Overall Study||0
2379409|NCT01466764|5839396|P1|NOT COMPLETED|Overall Study||0
2379410|NCT01466764|5839395|P2|COMPLETED|Overall Study||5
2379411|NCT01466764|5839396|P1|COMPLETED|Overall Study||5
2379412|NCT01466764|5839395|P2|STARTED|Overall Study||5
2379413|NCT01466764|5839396|P1|STARTED|Overall Study||5
2379414|NCT01466751|5839416|P2|NOT COMPLETED|Overall Study||0
2379415|NCT01466751|5839417|P1|NOT COMPLETED|Overall Study||1
2379416|NCT01466751|5839416|P2|COMPLETED|Overall Study||14
2379417|NCT01466751|5839417|P1|COMPLETED|Overall Study||13
2379418|NCT01466751|5839416|P2|STARTED|Overall Study||14
2379419|NCT01466751|5839417|P1|STARTED|Overall Study||14
2379420|NCT01466673|5839427|P2|NOT COMPLETED|Overall Study||6
2379421|NCT01466673|5839428|P1|NOT COMPLETED|Overall Study||7
2379422|NCT01466673|5839427|P2|COMPLETED|Overall Study||95
2379423|NCT01466673|5839428|P1|COMPLETED|Overall Study||93
2379424|NCT01466673|5839427|P2|STARTED|Overall Study||101
2379425|NCT01466673|5839428|P1|STARTED|Overall Study||100
2379426|NCT01466660|5839454|P2|NOT COMPLETED|Overall Study||151
2379427|NCT01466660|5839455|P1|NOT COMPLETED|Overall Study||146
2379428|NCT01466660|5839454|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date, 08 April 2016|8
2379429|NCT01466660|5839455|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date, 08 April 2016|14
2379430|NCT01466660|5839454|P2|STARTED|Overall Study||159
2379431|NCT01466660|5839455|P1|STARTED|Overall Study||160
2379432|NCT01466595|5839481|P2|NOT COMPLETED|Overall Study||1
2379433|NCT01466595|5839482|P1|NOT COMPLETED|Overall Study||0
2379434|NCT01466595|5839481|P2|COMPLETED|Overall Study||23
2379435|NCT01466595|5839482|P1|COMPLETED|Overall Study||49
2379436|NCT01466595|5839481|P2|STARTED|Overall Study||24
2379437|NCT01466595|5839482|P1|STARTED|Overall Study||49
2379438|NCT01466491|5839576|P4|NOT COMPLETED|Overall Study||0
2379439|NCT01466491|5839577|P3|NOT COMPLETED|Overall Study||3
2379440|NCT01466491|5839578|P2|NOT COMPLETED|Overall Study||3
2379441|NCT01466491|5839579|P1|NOT COMPLETED|Overall Study||0
2379442|NCT01466491|5839576|P4|COMPLETED|Overall Study||83
2379443|NCT01466491|5839577|P3|COMPLETED|Overall Study||80
2379444|NCT01466491|5839578|P2|COMPLETED|Overall Study||80
2379445|NCT01466491|5839579|P1|COMPLETED|Overall Study||83
2379446|NCT01466491|5839576|P4|STARTED|Overall Study||83
2379447|NCT01466491|5839577|P3|STARTED|Overall Study||83
2379448|NCT01466491|5839578|P2|STARTED|Overall Study||83
2379449|NCT01466491|5839579|P1|STARTED|Overall Study||83
2379450|NCT01466387|5839599|P6|NOT COMPLETED|Overall Study||1
2379451|NCT01466387|5839600|P5|NOT COMPLETED|Overall Study||0
2379452|NCT01466387|5839601|P4|NOT COMPLETED|Overall Study||2
2379453|NCT01466387|5839602|P3|NOT COMPLETED|Overall Study||1
2379454|NCT01466387|5839603|P2|NOT COMPLETED|Overall Study||0
2379455|NCT01466387|5839604|P1|NOT COMPLETED|Overall Study||1
2379456|NCT01466387|5839599|P6|COMPLETED|Overall Study||99
2379457|NCT01466387|5839600|P5|COMPLETED|Overall Study||51
2379458|NCT01466387|5839601|P4|COMPLETED|Overall Study||99
2379459|NCT01466387|5839602|P3|COMPLETED|Overall Study||98
2379460|NCT01466387|5839603|P2|COMPLETED|Overall Study||100
2379461|NCT01466387|5839604|P1|COMPLETED|Overall Study||100
2379462|NCT01466387|5839599|P6|STARTED|Overall Study||100
2379463|NCT01466387|5839600|P5|STARTED|Overall Study||51
2379464|NCT01466387|5839601|P4|STARTED|Overall Study||101
2379465|NCT01466387|5839602|P3|STARTED|Overall Study||99
2379466|NCT01466387|5839603|P2|STARTED|Overall Study||100
2379467|NCT01466387|5839604|P1|STARTED|Overall Study||101
2379468|NCT01466361|5839646|P4|NOT COMPLETED|Overall Study||0
2379469|NCT01466361|5839647|P3|NOT COMPLETED|Overall Study||0
2379470|NCT01466361|5839648|P2|NOT COMPLETED|Overall Study||0
2379471|NCT01466361|5839649|P1|NOT COMPLETED|Overall Study||0
2379472|NCT01466361|5839646|P4|COMPLETED|Overall Study||41
2379473|NCT01466361|5839647|P3|COMPLETED|Overall Study||60
2379474|NCT01466361|5839648|P2|COMPLETED|Overall Study||34
2379475|NCT01466361|5839649|P1|COMPLETED|Overall Study||52
2379476|NCT01466361|5839646|P4|STARTED|Overall Study||41
2379477|NCT01466361|5839647|P3|STARTED|Overall Study||60
2379478|NCT01466361|5839648|P2|STARTED|Overall Study||34
2379479|NCT01466361|5839649|P1|STARTED|Overall Study||52
2379480|NCT01466348|5839665|P2|NOT COMPLETED|Period II - Second Intervention||0
2379481|NCT01466348|5839666|P1|NOT COMPLETED|Period II - Second Intervention||0
2379482|NCT01466348|5839665|P2|COMPLETED|Period II - Second Intervention||36
2379483|NCT01466348|5839666|P1|COMPLETED|Period II - Second Intervention||35
2379484|NCT01466348|5839665|P2|STARTED|Period II - Second Intervention||36
2379485|NCT01466348|5839666|P1|STARTED|Period II - Second Intervention||35
2379486|NCT01466348|5839665|P2|NOT COMPLETED|Period I - First Intervention||1
2379487|NCT01466348|5839666|P1|NOT COMPLETED|Period I - First Intervention||0
2379488|NCT01466348|5839665|P2|COMPLETED|Period I - First Intervention||35
2379489|NCT01466348|5839666|P1|COMPLETED|Period I - First Intervention||36
2379490|NCT01466348|5839665|P2|Intent To Treat (ITT) Population|Period I - First Intervention|1 participant withdrew prior receiving the treatment|35
2379491|NCT01466348|5839666|P1|Intent To Treat (ITT) Population|Period I - First Intervention||36
2379492|NCT01466348|5839665|P2|STARTED|Period I - First Intervention||36
2379493|NCT01466348|5839666|P1|STARTED|Period I - First Intervention||36
2379494|NCT01466270|5839694|P2|NOT COMPLETED|Overall Study||6
2379495|NCT01466270|5839695|P1|NOT COMPLETED|Overall Study||12
2379496|NCT01466270|5839694|P2|COMPLETED|Overall Study||25
2379497|NCT01466270|5839695|P1|COMPLETED|Overall Study||19
2379498|NCT01466270|5839694|P2|STARTED|Overall Study||31
2379499|NCT01466270|5839695|P1|STARTED|Overall Study||31
2379500|NCT01466192|5839707|P1|NOT COMPLETED|Overall Study||4
2379501|NCT01466192|5839707|P1|COMPLETED|Overall Study||104
2379502|NCT01466192|5839707|P1|STARTED|Overall Study||108
2379503|NCT01466179|5839711|P1|NOT COMPLETED|Overall Study||179
2379504|NCT01466179|5839711|P1|COMPLETED|Overall Study|Completed 5 cycles of treatment; Data as of the time of the data cut-off date (10 October 2013).|10
2379505|NCT01466179|5839711|P1|STARTED|Overall Study|Participants enrolled during the first 3 stages of the study|189
2379506|NCT01466166|5839731|P1|NOT COMPLETED|Overall Study||163
2379507|NCT01466166|5839731|P1|COMPLETED|Overall Study||25
2379508|NCT01466166|5839731|P1|Completed 24 Weeks of Treatment|Overall Study||55
2379509|NCT01466166|5839731|P1|Received Treatment|Overall Study||188
2379510|NCT01466166|5839731|P1|STARTED|Overall Study||188
2379511|NCT01466153|5839745|P3|NOT COMPLETED|Overall Study||25
2379512|NCT01466153|5839746|P2|NOT COMPLETED|Overall Study||24
2379513|NCT01466153|5839747|P1|NOT COMPLETED|Overall Study||29
2379514|NCT01466153|5839745|P3|COMPLETED|Overall Study||36
2379515|NCT01466153|5839746|P2|COMPLETED|Overall Study||12
2379516|NCT01466153|5839747|P1|COMPLETED|Overall Study||33
2379517|NCT01466153|5839745|P3|STARTED|Overall Study||61
2379518|NCT01466153|5839746|P2|STARTED|Overall Study||36
2379519|NCT01466153|5839747|P1|STARTED|Overall Study||62
2379520|NCT01466127|5839788|P2|NOT COMPLETED|Overall Study||16
2379521|NCT01466127|5839789|P1|NOT COMPLETED|Overall Study||14
2379522|NCT01466127|5839788|P2|COMPLETED|Overall Study||14
2379523|NCT01466127|5839789|P1|COMPLETED|Overall Study||16
2379524|NCT01466127|5839788|P2|STARTED|Overall Study||30
2379525|NCT01466127|5839789|P1|STARTED|Overall Study||30
2379526|NCT01466075|5839795|P1|NOT COMPLETED|Overall Study||0
2379527|NCT01466075|5839795|P1|COMPLETED|Overall Study||207
2379528|NCT01466075|5839795|P1|STARTED|Overall Study||207
2379529|NCT01466062|5839802|P1|NOT COMPLETED|Overall Study||2
2379530|NCT01466062|5839802|P1|COMPLETED|Overall Study||26
2379531|NCT01466062|5839802|P1|STARTED|Overall Study||28
2379532|NCT01465997|5839825|P2|NOT COMPLETED|Overall Study||89
2379533|NCT01465997|5839826|P1|NOT COMPLETED|Overall Study||68
2379534|NCT01465997|5839825|P2|COMPLETED|Overall Study||180
2379535|NCT01465997|5839826|P1|COMPLETED|Overall Study||211
2379536|NCT01465997|5839825|P2|STARTED|Overall Study||269
2379537|NCT01465997|5839826|P1|STARTED|Overall Study||279
2379538|NCT01465958|5839836|P2|NOT COMPLETED|Subcutaneous (SC) Phase||1
2379539|NCT01465958|5839837|P1|NOT COMPLETED|Subcutaneous (SC) Phase||0
2379540|NCT01465958|5839836|P2|COMPLETED|Subcutaneous (SC) Phase||10
2379541|NCT01465958|5839837|P1|COMPLETED|Subcutaneous (SC) Phase||0
2379542|NCT01465958|5839836|P2|STARTED|Subcutaneous (SC) Phase|Eleven subjects completed the IV phase and entered the SC phase.|11
2379543|NCT01465958|5839837|P1|STARTED|Subcutaneous (SC) Phase|After completing the intravenous (IV) phase, subjects entered the subcutaneous (SC) phase.|0
2379544|NCT01465958|5839836|P2|NOT COMPLETED|Intravenous (IV) Phase||0
2379545|NCT01465958|5839837|P1|NOT COMPLETED|Intravenous (IV) Phase||0
2379546|NCT01465958|5839836|P2|COMPLETED|Intravenous (IV) Phase||0
2379547|NCT01465958|5839837|P1|COMPLETED|Intravenous (IV) Phase||11
2379548|NCT01465958|5839836|P2|STARTED|Intravenous (IV) Phase||0
2379549|NCT01465958|5839837|P1|STARTED|Intravenous (IV) Phase|One subject entered the IV phase directly.|11
2379550|NCT01465958|5839836|P2|NOT COMPLETED|Run-in Phase||0
2379551|NCT01465958|5839837|P1|NOT COMPLETED|Run-in Phase||1
2379552|NCT01465958|5839836|P2|COMPLETED|Run-in Phase||0
2379553|NCT01465958|5839837|P1|COMPLETED|Run-in Phase||10
2379554|NCT01465958|5839836|P2|STARTED|Run-in Phase||0
2379555|NCT01465958|5839837|P1|STARTED|Run-in Phase||11
2379556|NCT01465802|5839850|P5|NOT COMPLETED|Overall Study||12
2379557|NCT01465802|5839851|P4|NOT COMPLETED|Overall Study||29
2379558|NCT01465802|5839852|P3|NOT COMPLETED|Overall Study||0
2379559|NCT01465802|5839853|P2|NOT COMPLETED|Overall Study||24
2379560|NCT01465802|5839854|P1|NOT COMPLETED|Overall Study||33
2379561|NCT01465802|5839850|P5|COMPLETED|Overall Study||13
2379562|NCT01465802|5839851|P4|COMPLETED|Overall Study||38
2379563|NCT01465802|5839852|P3|COMPLETED|Overall Study||7
2379564|NCT01465802|5839853|P2|COMPLETED|Overall Study||42
2379565|NCT01465802|5839854|P1|COMPLETED|Overall Study||33
2379566|NCT01465802|5839850|P5|STARTED|Overall Study||25
2379567|NCT01465802|5839851|P4|STARTED|Overall Study|An additional 5 participants were enrolled in Cohort II but not treated.|67
2379568|NCT01465802|5839852|P3|STARTED|Overall Study||7
2379569|NCT01465802|5839853|P2|STARTED|Overall Study||66
2379570|NCT01465802|5839854|P1|STARTED|Overall Study||66
2379571|NCT01465763|5839906|P3|NOT COMPLETED|Overall Study||4
2379572|NCT01465763|5839907|P2|NOT COMPLETED|Overall Study||1
2379573|NCT01465763|5839908|P1|NOT COMPLETED|Overall Study||31
2379574|NCT01465763|5839906|P3|COMPLETED|Overall Study||118
2379575|NCT01465763|5839907|P2|COMPLETED|Overall Study||15
2379576|NCT01465763|5839908|P1|COMPLETED|Overall Study||445
2379577|NCT01465763|5839906|P3|STARTED|Overall Study||122
2379578|NCT01465763|5839907|P2|STARTED|Overall Study||16
2379579|NCT01465763|5839908|P1|STARTED|Overall Study||476
2379580|NCT01465464|5839935|P2|NOT COMPLETED|Overall Study||444
2379581|NCT01465464|5839936|P1|NOT COMPLETED|Overall Study||444
2379582|NCT01465464|5839935|P2|COMPLETED|Overall Study||0
2379583|NCT01465464|5839936|P1|COMPLETED|Overall Study||0
2379584|NCT01465464|5839935|P2|STARTED|Overall Study||444
2379585|NCT01465464|5839936|P1|STARTED|Overall Study||444
2379586|NCT01465412|5839948|P4|NOT COMPLETED|Overall Study||0
2379587|NCT01465412|5839949|P3|NOT COMPLETED|Overall Study||0
2379588|NCT01465412|5839950|P2|NOT COMPLETED|Overall Study||0
2379589|NCT01465412|5839951|P1|NOT COMPLETED|Overall Study||0
2379590|NCT01465412|5839948|P4|COMPLETED|Overall Study||9
2379591|NCT01465412|5839949|P3|COMPLETED|Overall Study||9
2379592|NCT01465412|5839950|P2|COMPLETED|Overall Study||12
2379593|NCT01465412|5839951|P1|COMPLETED|Overall Study||12
2379594|NCT01465412|5839948|P4|STARTED|Overall Study||9
2379595|NCT01465412|5839949|P3|STARTED|Overall Study||9
2379596|NCT01465412|5839950|P2|STARTED|Overall Study||12
2379597|NCT01465412|5839951|P1|STARTED|Overall Study||12
2379598|NCT01465386|5839989|P1|NOT COMPLETED|Overall Study||4
2379599|NCT01465386|5839989|P1|COMPLETED|Overall Study||2
2379600|NCT01465386|5839989|P1|STARTED|Overall Study||6
2379601|NCT01465347|5839993|P2|NOT COMPLETED|Overall Study||3
2379602|NCT01465347|5839994|P1|NOT COMPLETED|Overall Study||1
2379603|NCT01465347|5839993|P2|COMPLETED|Overall Study||53
2379604|NCT01465347|5839994|P1|COMPLETED|Overall Study||2
2379605|NCT01465347|5839993|P2|STARTED|Overall Study||56
2379606|NCT01465347|5839994|P1|STARTED|Overall Study||3
2379607|NCT01465334|5840006|P2|NOT COMPLETED|Overall Study||6
2379608|NCT01465334|5840007|P1|NOT COMPLETED|Overall Study||2
2379609|NCT01465334|5840006|P2|COMPLETED|Overall Study||9
2379610|NCT01465334|5840007|P1|COMPLETED|Overall Study||13
2379611|NCT01465334|5840006|P2|Eligible for Allogeneic Transplant|Overall Study||9
2379612|NCT01465334|5840007|P1|Eligible for Allogeneic Transplant|Overall Study||9
2379613|NCT01465334|5840006|P2|Complete Part B Induction|Overall Study||15
2379614|NCT01465334|5840007|P1|Complete Part B Induction|Overall Study||7
2379615|NCT01465334|5840006|P2|Complete Part A Induction|Overall Study||15
2379616|NCT01465334|5840007|P1|Complete Part A Induction|Overall Study||12
2379617|NCT01465334|5840006|P2|STARTED|Overall Study||15
2379618|NCT01465334|5840007|P1|STARTED|Overall Study||15
2379619|NCT01465230|5840033|P1|NOT COMPLETED|Overall Study||2
2379620|NCT01465230|5840033|P1|COMPLETED|Overall Study||0
2379621|NCT01465230|5840033|P1|STARTED|Overall Study||2
2379622|NCT01465178|5840039|P2|NOT COMPLETED|Overall Study||0
2379623|NCT01465178|5840040|P1|NOT COMPLETED|Overall Study||1
2379624|NCT01465178|5840039|P2|COMPLETED|Overall Study||31
2379625|NCT01465178|5840040|P1|COMPLETED|Overall Study||30
2379626|NCT01465178|5840039|P2|STARTED|Overall Study||31
2379627|NCT01465178|5840040|P1|STARTED|Overall Study||31
2379628|NCT01465048|5840051|P3|NOT COMPLETED|Overall Study||0
2379629|NCT01465048|5840052|P2|NOT COMPLETED|Overall Study||0
2379630|NCT01465048|5840053|P1|NOT COMPLETED|Overall Study||0
2379631|NCT01465048|5840051|P3|COMPLETED|Overall Study||6
2379632|NCT01465048|5840052|P2|COMPLETED|Overall Study||6
2379633|NCT01465048|5840053|P1|COMPLETED|Overall Study||6
2379634|NCT01465048|5840051|P3|STARTED|Overall Study||6
2379635|NCT01465048|5840052|P2|STARTED|Overall Study||6
2379636|NCT01465048|5840053|P1|STARTED|Overall Study||6
2379637|NCT01465022|5840064|P3|NOT COMPLETED|Overall Study||70
2379638|NCT01465022|5840065|P2|NOT COMPLETED|Overall Study||23
2379639|NCT01465022|5840066|P1|NOT COMPLETED|Overall Study||23
2379640|NCT01465022|5840064|P3|COMPLETED|Overall Study||0
2379641|NCT01465022|5840065|P2|COMPLETED|Overall Study||40
2379642|NCT01465022|5840066|P1|COMPLETED|Overall Study||41
2379643|NCT01465022|5840064|P3|STARTED|Overall Study||70
2379644|NCT01465022|5840065|P2|STARTED|Overall Study||63
2379645|NCT01465022|5840066|P1|STARTED|Overall Study||64
2379646|NCT01464996|5840080|P1|NOT COMPLETED|Overall Study||0
2379647|NCT01464996|5840080|P1|COMPLETED|Overall Study||24
2379648|NCT01464996|5840080|P1|OptiBond FL|Overall Study||24
2379649|NCT01464996|5840080|P1|OptiBond XTR|Overall Study||23
2379650|NCT01464996|5840080|P1|STARTED|Overall Study||24
2379651|NCT01464931|5840100|P2|NOT COMPLETED|Overall Study||0
2379652|NCT01464931|5840101|P1|NOT COMPLETED|Overall Study||1
2379653|NCT01464931|5840100|P2|COMPLETED|Overall Study||16
2379654|NCT01464931|5840101|P1|COMPLETED|Overall Study||15
2379655|NCT01464931|5840100|P2|STARTED|Overall Study||16
2379656|NCT01464931|5840101|P1|STARTED|Overall Study||16
2379657|NCT01464879|5840138|P1|NOT COMPLETED|Overall Study||2
2379658|NCT01464879|5840138|P1|COMPLETED|Overall Study||18
2379659|NCT01464879|5840138|P1|Applicator Application (3.75 mL)|Overall Study||18
2379660|NCT01464879|5840138|P1|Applicator Application (2.50 mL)|Overall Study|One subject discontinued due to physician's decision.|18
2379661|NCT01464879|5840138|P1|Applicator Application (1.25 mL)|Overall Study|One subject discontinued due to non-compliance.|19
2379662|NCT01464879|5840138|P1|Washout Period|Overall Study||20
2379663|NCT01464879|5840138|P1|Hand Application (2.50 mL)|Overall Study||20
2379664|NCT01464879|5840138|P1|STARTED|Overall Study||20
2379665|NCT01464840|5840175|P3|NOT COMPLETED|Overall Study||0
2379666|NCT01464840|5840176|P2|NOT COMPLETED|Overall Study||0
2379667|NCT01464840|5840177|P1|NOT COMPLETED|Overall Study||0
2379668|NCT01464840|5840175|P3|COMPLETED|Overall Study||10
2379669|NCT01464840|5840176|P2|COMPLETED|Overall Study||10
2379670|NCT01464840|5840177|P1|COMPLETED|Overall Study||10
2379671|NCT01464840|5840175|P3|STARTED|Overall Study||10
2379672|NCT01464840|5840176|P2|STARTED|Overall Study||10
2379673|NCT01464840|5840177|P1|STARTED|Overall Study||10
2379674|NCT01464827|5840199|P14|NOT COMPLETED|Overall Study||3
2379675|NCT01464827|5840200|P13|NOT COMPLETED|Overall Study||2
2379676|NCT01464827|5840201|P12|NOT COMPLETED|Overall Study||2
2379677|NCT01464827|5840202|P11|NOT COMPLETED|Overall Study||2
2379678|NCT01464827|5840203|P10|NOT COMPLETED|Overall Study||3
2379679|NCT01464827|5840204|P9|NOT COMPLETED|Overall Study||3
2379680|NCT01464827|5840205|P8|NOT COMPLETED|Overall Study||3
2379681|NCT01464827|5840206|P7|NOT COMPLETED|Overall Study||4
2379682|NCT01464827|5840207|P6|NOT COMPLETED|Overall Study||1
2379683|NCT01464827|5840208|P5|NOT COMPLETED|Overall Study||8
2379684|NCT01464827|5840209|P4|NOT COMPLETED|Overall Study||4
2379685|NCT01464827|5840210|P3|NOT COMPLETED|Overall Study||0
2379686|NCT01464827|5840211|P2|NOT COMPLETED|Overall Study||7
2379687|NCT01464827|5840212|P1|NOT COMPLETED|Overall Study||3
2379688|NCT01464827|5840199|P14|COMPLETED|Overall Study||19
2379689|NCT01464827|5840200|P13|COMPLETED|Overall Study||21
2379690|NCT01464827|5840201|P12|COMPLETED|Overall Study||21
2379691|NCT01464827|5840202|P11|COMPLETED|Overall Study||21
2379692|NCT01464827|5840203|P10|COMPLETED|Overall Study||44
2379693|NCT01464827|5840204|P9|COMPLETED|Overall Study||37
2379694|NCT01464827|5840205|P8|COMPLETED|Overall Study||37
2379695|NCT01464827|5840206|P7|COMPLETED|Overall Study||37
2379696|NCT01464827|5840207|P6|COMPLETED|Overall Study||38
2379697|NCT01464827|5840208|P5|COMPLETED|Overall Study||72
2379698|NCT01464827|5840209|P4|COMPLETED|Overall Study||36
2379699|NCT01464827|5840210|P3|COMPLETED|Overall Study||39
2379700|NCT01464827|5840211|P2|COMPLETED|Overall Study||36
2379701|NCT01464827|5840212|P1|COMPLETED|Overall Study||77
2379702|NCT01464827|5840199|P14|Treated|Overall Study||20
2379703|NCT01464827|5840200|P13|Treated|Overall Study||23
2379704|NCT01464827|5840201|P12|Treated|Overall Study||22
2379705|NCT01464827|5840202|P11|Treated|Overall Study||23
2379706|NCT01464827|5840203|P10|Treated|Overall Study||45
2379707|NCT01464827|5840204|P9|Treated|Overall Study||40
2379708|NCT01464827|5840205|P8|Treated|Overall Study||40
2379709|NCT01464827|5840206|P7|Treated|Overall Study||40
2379710|NCT01464827|5840207|P6|Treated|Overall Study||39
2379711|NCT01464827|5840208|P5|Treated|Overall Study||79
2379712|NCT01464827|5840209|P4|Treated|Overall Study||40
2379713|NCT01464827|5840210|P3|Treated|Overall Study||39
2379714|NCT01464827|5840211|P2|Treated|Overall Study||41
2379715|NCT01464827|5840212|P1|Treated|Overall Study||80
2379716|NCT01464827|5840199|P14|STARTED|Overall Study||22
2379717|NCT01464827|5840200|P13|STARTED|Overall Study||23
2379718|NCT01464827|5840201|P12|STARTED|Overall Study||23
2379719|NCT01464827|5840202|P11|STARTED|Overall Study||23
2379720|NCT01464827|5840203|P10|STARTED|Overall Study||47
2379721|NCT01464827|5840204|P9|STARTED|Overall Study||40
2379722|NCT01464827|5840205|P8|STARTED|Overall Study||40
2379723|NCT01464827|5840206|P7|STARTED|Overall Study||41
2379724|NCT01464827|5840207|P6|STARTED|Overall Study||39
2379725|NCT01464827|5840208|P5|STARTED|Overall Study||80
2379726|NCT01464827|5840209|P4|STARTED|Overall Study||40
2379727|NCT01464827|5840210|P3|STARTED|Overall Study||39
2379728|NCT01464827|5840211|P2|STARTED|Overall Study||43
2379729|NCT01464827|5840212|P1|STARTED|Overall Study||80
2379730|NCT01464788|5840259|P3|NOT COMPLETED|Overall Study||0
2379731|NCT01464788|5840260|P2|NOT COMPLETED|Overall Study||2
2379732|NCT01464788|5840261|P1|NOT COMPLETED|Overall Study||0
2379733|NCT01464788|5840259|P3|COMPLETED|Overall Study||29
2379734|NCT01464788|5840260|P2|COMPLETED|Overall Study||29
2379735|NCT01464788|5840261|P1|COMPLETED|Overall Study||30
2379736|NCT01464788|5840259|P3|STARTED|Overall Study||29
2379737|NCT01464788|5840260|P2|STARTED|Overall Study||31
2379738|NCT01464788|5840261|P1|STARTED|Overall Study||30
2379739|NCT01464723|5840272|P1|NOT COMPLETED|Overall Study||0
2379740|NCT01464723|5840272|P1|COMPLETED|Overall Study||0
2379741|NCT01464723|5840272|P1|STARTED|Overall Study||0
2379742|NCT01464697|5840281|P2|NOT COMPLETED|Overall Study||10
2379743|NCT01464697|5840282|P1|NOT COMPLETED|Overall Study||3
2379744|NCT01464697|5840281|P2|COMPLETED|Overall Study||86
2379745|NCT01464697|5840282|P1|COMPLETED|Overall Study||90
2379746|NCT01464697|5840281|P2|STARTED|Overall Study||96
2379747|NCT01464697|5840282|P1|STARTED|Overall Study||93
2379748|NCT01464619|5840336|P2|NOT COMPLETED|Overall Study||4
2379749|NCT01464619|5840337|P1|NOT COMPLETED|Overall Study||3
2379750|NCT01464619|5840336|P2|COMPLETED|Overall Study||25
2379751|NCT01464619|5840337|P1|COMPLETED|Overall Study||29
2379752|NCT01464619|5840336|P2|STARTED|Overall Study||29
2379753|NCT01464619|5840337|P1|STARTED|Overall Study||32
2379754|NCT01464424|5840357|P2|NOT COMPLETED|Period 2, Second 6 Weeks||0
2379755|NCT01464424|5840358|P1|NOT COMPLETED|Period 2, Second 6 Weeks||0
2379756|NCT01464424|5840357|P2|COMPLETED|Period 2, Second 6 Weeks||41
2379757|NCT01464424|5840358|P1|COMPLETED|Period 2, Second 6 Weeks||42
2379758|NCT01464424|5840357|P2|STARTED|Period 2, Second 6 Weeks||41
2379759|NCT01464424|5840358|P1|STARTED|Period 2, Second 6 Weeks||42
2379760|NCT01464424|5840357|P2|NOT COMPLETED|Period 1, First 6 Weeks||1
2379761|NCT01464424|5840358|P1|NOT COMPLETED|Period 1, First 6 Weeks||0
2379762|NCT01464424|5840357|P2|COMPLETED|Period 1, First 6 Weeks||41
2379763|NCT01464424|5840358|P1|COMPLETED|Period 1, First 6 Weeks||42
2379764|NCT01464424|5840357|P2|STARTED|Period 1, First 6 Weeks||42
2379765|NCT01464424|5840358|P1|STARTED|Period 1, First 6 Weeks||42
2379766|NCT01464359|5840366|P1|NOT COMPLETED|Overall Study||0
2379767|NCT01464359|5840366|P1|COMPLETED|Overall Study||3
2379768|NCT01464359|5840366|P1|STARTED|Overall Study||3
2379769|NCT01464346|5840378|P3|NOT COMPLETED|Overall Study||1
2379770|NCT01464346|5840379|P2|NOT COMPLETED|Overall Study||0
2379771|NCT01464346|5840380|P1|NOT COMPLETED|Overall Study||0
2379772|NCT01464346|5840378|P3|COMPLETED|Overall Study||28
2379773|NCT01464346|5840379|P2|COMPLETED|Overall Study||32
2379774|NCT01464346|5840380|P1|COMPLETED|Overall Study||29
2379775|NCT01464346|5840378|P3|STARTED|Overall Study||29
2379776|NCT01464346|5840379|P2|STARTED|Overall Study||32
2379777|NCT01464346|5840380|P1|STARTED|Overall Study||29
2379778|NCT01464333|5840389|P1|NOT COMPLETED|Overall Study||163
2379779|NCT01464333|5840389|P1|COMPLETED|Overall Study||226
2379780|NCT01464333|5840389|P1|STARTED|Overall Study||389
2379781|NCT01464307|5840402|P2|NOT COMPLETED|Open-Label Extension Period||0
2379782|NCT01464307|5840403|P1|NOT COMPLETED|Open-Label Extension Period||51
2379783|NCT01464307|5840402|P2|COMPLETED|Open-Label Extension Period||0
2379784|NCT01464307|5840403|P1|COMPLETED|Open-Label Extension Period||218
2379785|NCT01464307|5840402|P2|Treated|Open-Label Extension Period||0
2379786|NCT01464307|5840403|P1|Treated|Open-Label Extension Period||269
2379787|NCT01464307|5840402|P2|STARTED|Open-Label Extension Period||0
2379788|NCT01464307|5840403|P1|STARTED|Open-Label Extension Period||269
2379789|NCT01464307|5840402|P2|NOT COMPLETED|Main Period||5
2379790|NCT01464307|5840403|P1|NOT COMPLETED|Main Period||15
2379791|NCT01464307|5840402|P2|COMPLETED|Main Period||140
2379792|NCT01464307|5840403|P1|COMPLETED|Main Period||129
2379793|NCT01464307|5840402|P2|Treated|Main Period||145
2379794|NCT01464307|5840403|P1|Treated|Main Period||144
2379795|NCT01464307|5840402|P2|STARTED|Main Period||145
2379796|NCT01464307|5840403|P1|STARTED|Main Period||144
2379797|NCT01464255|5840418|P2|NOT COMPLETED|Overall Study||1
2379798|NCT01464255|5840419|P1|NOT COMPLETED|Overall Study||0
2379799|NCT01464255|5840418|P2|COMPLETED|Overall Study||24
2379800|NCT01464255|5840419|P1|COMPLETED|Overall Study||25
2379801|NCT01464255|5840418|P2|STARTED|Overall Study||25
2379802|NCT01464255|5840419|P1|STARTED|Overall Study||25
2379803|NCT01464229|5840444|P2|NOT COMPLETED|Overall Study||2
2379804|NCT01464229|5840445|P1|NOT COMPLETED|Overall Study||5
2379805|NCT01464229|5840444|P2|COMPLETED|Overall Study||8
2379806|NCT01464229|5840445|P1|COMPLETED|Overall Study||5
2379807|NCT01464229|5840444|P2|STARTED|Overall Study||10
2379808|NCT01464229|5840445|P1|STARTED|Overall Study||10
2379809|NCT01464190|5840453|P2|NOT COMPLETED|Overall Study||41
2379810|NCT01464190|5840454|P1|NOT COMPLETED|Overall Study||69
2379811|NCT01464190|5840453|P2|COMPLETED|Overall Study||227
2379812|NCT01464190|5840454|P1|COMPLETED|Overall Study||322
2379813|NCT01464190|5840453|P2|STARTED|Overall Study||268
2379814|NCT01464190|5840454|P1|STARTED|Overall Study||391
2379815|NCT01464021|5840464|P1|NOT COMPLETED|Overall Study||26
2379816|NCT01464021|5840464|P1|COMPLETED|Overall Study||0
2379817|NCT01464021|5840464|P1|STARTED|Overall Study||26
2379818|NCT01463982|5840480|P4|NOT COMPLETED|Overall Study||0
2379819|NCT01463982|5840481|P3|NOT COMPLETED|Overall Study||2
2379820|NCT01463982|5840482|P2|NOT COMPLETED|Overall Study||1
2379821|NCT01463982|5840483|P1|NOT COMPLETED|Overall Study||0
2379822|NCT01463982|5840480|P4|COMPLETED|Overall Study||6
2379823|NCT01463982|5840481|P3|COMPLETED|Overall Study||2
2379824|NCT01463982|5840482|P2|COMPLETED|Overall Study||7
2379825|NCT01463982|5840483|P1|COMPLETED|Overall Study||3
2379826|NCT01463982|5840480|P4|STARTED|Overall Study||6
2379827|NCT01463982|5840481|P3|STARTED|Overall Study||4
2379828|NCT01463982|5840482|P2|STARTED|Overall Study||8
2379829|NCT01463982|5840483|P1|STARTED|Overall Study||3
2379830|NCT01463878|5840499|P2|NOT COMPLETED|Overall Study||2
2379831|NCT01463878|5840500|P1|NOT COMPLETED|Overall Study||2
2379832|NCT01463878|5840499|P2|COMPLETED|Overall Study||7
2379833|NCT01463878|5840500|P1|COMPLETED|Overall Study||7
2379834|NCT01463878|5840499|P2|STARTED|Overall Study||9
2379835|NCT01463878|5840500|P1|STARTED|Overall Study||9
2379836|NCT01463696|5840514|P8|NOT COMPLETED|Overall Study||4
2379837|NCT01463696|5840515|P7|NOT COMPLETED|Overall Study||10
2379838|NCT01463696|5840516|P6|NOT COMPLETED|Overall Study||3
2379839|NCT01463696|5840517|P5|NOT COMPLETED|Overall Study||1
2379840|NCT01463696|5840518|P4|NOT COMPLETED|Overall Study||4
2379841|NCT01463696|5840519|P3|NOT COMPLETED|Overall Study||1
2379842|NCT01463696|5840520|P2|NOT COMPLETED|Overall Study||2
2379843|NCT01463696|5840521|P1|NOT COMPLETED|Overall Study||0
2379844|NCT01463696|5840514|P8|COMPLETED|Overall Study||2
2379845|NCT01463696|5840515|P7|COMPLETED|Overall Study||6
2379846|NCT01463696|5840516|P6|COMPLETED|Overall Study||3
2379847|NCT01463696|5840517|P5|COMPLETED|Overall Study||2
2379848|NCT01463696|5840518|P4|COMPLETED|Overall Study||3
2379849|NCT01463696|5840519|P3|COMPLETED|Overall Study||2
2379850|NCT01463696|5840520|P2|COMPLETED|Overall Study||4
2379851|NCT01463696|5840521|P1|COMPLETED|Overall Study||1
2379852|NCT01463696|5840514|P8|Treated|Overall Study||6
2379853|NCT01463696|5840515|P7|Treated|Overall Study||15
2379854|NCT01463696|5840516|P6|Treated|Overall Study||6
2379855|NCT01463696|5840517|P5|Treated|Overall Study||3
2379856|NCT01463696|5840518|P4|Treated|Overall Study||7
2379857|NCT01463696|5840519|P3|Treated|Overall Study||3
2379858|NCT01463696|5840520|P2|Treated|Overall Study||6
2379859|NCT01463696|5840521|P1|Treated|Overall Study||1
2379860|NCT01463696|5840514|P8|STARTED|Overall Study||6
2379861|NCT01463696|5840515|P7|STARTED|Overall Study||16
2379862|NCT01463696|5840516|P6|STARTED|Overall Study||6
2379863|NCT01463696|5840517|P5|STARTED|Overall Study||3
2379864|NCT01463696|5840518|P4|STARTED|Overall Study||7
2379865|NCT01463696|5840519|P3|STARTED|Overall Study||3
2379866|NCT01463696|5840520|P2|STARTED|Overall Study||6
2379867|NCT01463696|5840521|P1|STARTED|Overall Study||1
2379868|NCT01463683|5840574|P3|NOT COMPLETED|Overall Study||11
2379869|NCT01463683|5840575|P2|NOT COMPLETED|Overall Study||31
2379870|NCT01463683|5840576|P1|NOT COMPLETED|Overall Study||19
2379871|NCT01463683|5840574|P3|COMPLETED|Overall Study||93
2379872|NCT01463683|5840575|P2|COMPLETED|Overall Study||278
2379873|NCT01463683|5840576|P1|COMPLETED|Overall Study||290
2379874|NCT01463683|5840574|P3|Received Vaccination 3 (Month 6)|Overall Study||93
2379875|NCT01463683|5840575|P2|Received Vaccination 3 (Month 6)|Overall Study||281
2379876|NCT01463683|5840576|P1|Received Vaccination 3 (Month 6)|Overall Study||290
2379877|NCT01463683|5840574|P3|Received Vaccination 2 (Month 1)|Overall Study||103
2379878|NCT01463683|5840575|P2|Received Vaccination 2 (Month 1)|Overall Study||300
2379879|NCT01463683|5840576|P1|Received Vaccination 2 (Month 1)|Overall Study||302
2379880|NCT01463683|5840574|P3|Received Vaccination 1 (Day 1)|Overall Study||104
2379881|NCT01463683|5840575|P2|Received Vaccination 1 (Day 1)|Overall Study||308
2379882|NCT01463683|5840576|P1|Received Vaccination 1 (Day 1)|Overall Study||309
2379883|NCT01463683|5840574|P3|STARTED|Overall Study||104
2379884|NCT01463683|5840575|P2|STARTED|Overall Study||309
2379885|NCT01463683|5840576|P1|STARTED|Overall Study||309
2379886|NCT01463631|5840593|P4|NOT COMPLETED|Overall Study||6
2379887|NCT01463631|5840594|P3|NOT COMPLETED|Overall Study||1
2379888|NCT01463631|5840595|P2|NOT COMPLETED|Overall Study||0
2379889|NCT01463631|5840596|P1|NOT COMPLETED|Overall Study||0
2379890|NCT01463631|5840593|P4|COMPLETED|Overall Study||9
2379891|NCT01463631|5840594|P3|COMPLETED|Overall Study||4
2379892|NCT01463631|5840595|P2|COMPLETED|Overall Study||4
2379893|NCT01463631|5840596|P1|COMPLETED|Overall Study||3
2379894|NCT01463631|5840593|P4|Received at Least One Dose of Study Drug|Overall Study||15
2379895|NCT01463631|5840594|P3|Received at Least One Dose of Study Drug|Overall Study||5
2379896|NCT01463631|5840595|P2|Received at Least One Dose of Study Drug|Overall Study||4
2379897|NCT01463631|5840596|P1|Received at Least One Dose of Study Drug|Overall Study||3
2379898|NCT01463631|5840593|P4|STARTED|Overall Study||15
2379899|NCT01463631|5840594|P3|STARTED|Overall Study||5
2379900|NCT01463631|5840595|P2|STARTED|Overall Study||4
2379901|NCT01463631|5840596|P1|STARTED|Overall Study||3
2379902|NCT01463527|5840618|P2|NOT COMPLETED|Overall Study||7
2379903|NCT01463527|5840619|P1|NOT COMPLETED|Overall Study||6
2379904|NCT01463527|5840618|P2|COMPLETED|Overall Study||77
2379905|NCT01463527|5840619|P1|COMPLETED|Overall Study||77
2379906|NCT01463527|5840618|P2|STARTED|Overall Study||84
2379907|NCT01463527|5840619|P1|STARTED|Overall Study||83
2379908|NCT01463384|5840627|P1|NOT COMPLETED|Overall Study||0
2379909|NCT01463384|5840627|P1|COMPLETED|Overall Study||13
2379910|NCT01463384|5840627|P1|STARTED|Overall Study||13
2379920|NCT01463293|5840715|P3|NOT COMPLETED|Overall Study||12
2379921|NCT01463293|5840716|P2|NOT COMPLETED|Overall Study||16
2379922|NCT01463293|5840717|P1|NOT COMPLETED|Overall Study||6
2379923|NCT01463293|5840715|P3|COMPLETED|Overall Study||59
2379924|NCT01463293|5840716|P2|COMPLETED|Overall Study||63
2379925|NCT01463293|5840717|P1|COMPLETED|Overall Study||68
2379926|NCT01463293|5840715|P3|STARTED|Overall Study||71
2379927|NCT01463293|5840716|P2|STARTED|Overall Study||79
2379928|NCT01463293|5840717|P1|STARTED|Overall Study||74
2379929|NCT01463202|5840727|P2|NOT COMPLETED|Overall Study||0
2379930|NCT01463202|5840728|P1|NOT COMPLETED|Overall Study||0
2379931|NCT01463202|5840727|P2|COMPLETED|Overall Study||78
2379932|NCT01463202|5840728|P1|COMPLETED|Overall Study||79
2379933|NCT01463202|5840727|P2|STARTED|Overall Study||78
2379934|NCT01463202|5840728|P1|STARTED|Overall Study||79
2379935|NCT01463111|5840740|P1|NOT COMPLETED|Overall Study||9
2379936|NCT01463111|5840740|P1|COMPLETED|Overall Study||17
2379937|NCT01463111|5840740|P1|STARTED|Overall Study||26
2379938|NCT01463098|5840762|P14|NOT COMPLETED|Part B (11 Days)||0
2379939|NCT01463098|5840763|P13|NOT COMPLETED|Part B (11 Days)||0
2379940|NCT01463098|5840764|P12|NOT COMPLETED|Part B (11 Days)||1
2379941|NCT01463098|5840765|P11|NOT COMPLETED|Part B (11 Days)||0
2379942|NCT01463098|5840766|P10|NOT COMPLETED|Part B (11 Days)||0
2379943|NCT01463098|5840767|P9|NOT COMPLETED|Part B (11 Days)||0
2379944|NCT01463098|5840768|P8|NOT COMPLETED|Part B (11 Days)||0
2379945|NCT01463098|5840769|P7|NOT COMPLETED|Part B (11 Days)||0
2379946|NCT01463098|5840770|P6|NOT COMPLETED|Part B (11 Days)||0
2379947|NCT01463098|5840771|P5|NOT COMPLETED|Part B (11 Days)||0
2379948|NCT01463098|5840772|P4|NOT COMPLETED|Part B (11 Days)||0
2379949|NCT01463098|5840773|P3|NOT COMPLETED|Part B (11 Days)||0
2379950|NCT01463098|5840774|P2|NOT COMPLETED|Part B (11 Days)||0
2379951|NCT01463098|5840775|P1|NOT COMPLETED|Part B (11 Days)||0
2379952|NCT01463098|5840762|P14|COMPLETED|Part B (11 Days)||12
2379953|NCT01463098|5840763|P13|COMPLETED|Part B (11 Days)||10
2379954|NCT01463098|5840764|P12|COMPLETED|Part B (11 Days)||12
2379955|NCT01463098|5840765|P11|COMPLETED|Part B (11 Days)||11
2379956|NCT01463098|5840766|P10|COMPLETED|Part B (11 Days)||12
2379957|NCT01463098|5840767|P9|COMPLETED|Part B (11 Days)||0
2379958|NCT01463098|5840768|P8|COMPLETED|Part B (11 Days)||0
2379959|NCT01463098|5840769|P7|COMPLETED|Part B (11 Days)||0
2379960|NCT01463098|5840770|P6|COMPLETED|Part B (11 Days)||0
2379961|NCT01463098|5840771|P5|COMPLETED|Part B (11 Days)||0
2379962|NCT01463098|5840772|P4|COMPLETED|Part B (11 Days)||0
2379963|NCT01463098|5840773|P3|COMPLETED|Part B (11 Days)||0
2379964|NCT01463098|5840774|P2|COMPLETED|Part B (11 Days)||0
2379965|NCT01463098|5840775|P1|COMPLETED|Part B (11 Days)||0
2379966|NCT01463098|5840762|P14|STARTED|Part B (11 Days)||12
2379967|NCT01463098|5840763|P13|STARTED|Part B (11 Days)||10
2379968|NCT01463098|5840764|P12|STARTED|Part B (11 Days)||13
2379969|NCT01463098|5840765|P11|STARTED|Part B (11 Days)||11
2379970|NCT01463098|5840766|P10|STARTED|Part B (11 Days)||12
2379971|NCT01463098|5840767|P9|STARTED|Part B (11 Days)||0
2379972|NCT01463098|5840768|P8|STARTED|Part B (11 Days)||0
2379973|NCT01463098|5840769|P7|STARTED|Part B (11 Days)||0
2379974|NCT01463098|5840770|P6|STARTED|Part B (11 Days)||0
2379975|NCT01463098|5840771|P5|STARTED|Part B (11 Days)||0
2379976|NCT01463098|5840772|P4|STARTED|Part B (11 Days)||0
2379977|NCT01463098|5840773|P3|STARTED|Part B (11 Days)||0
2379978|NCT01463098|5840774|P2|STARTED|Part B (11 Days)||0
2379979|NCT01463098|5840775|P1|STARTED|Part B (11 Days)||0
2379980|NCT01463098|5840762|P14|NOT COMPLETED|Part A (11 Days)||0
2379981|NCT01463098|5840763|P13|NOT COMPLETED|Part A (11 Days)||0
2379982|NCT01463098|5840764|P12|NOT COMPLETED|Part A (11 Days)||0
2379983|NCT01463098|5840765|P11|NOT COMPLETED|Part A (11 Days)||0
2379984|NCT01463098|5840766|P10|NOT COMPLETED|Part A (11 Days)||0
2379985|NCT01463098|5840767|P9|NOT COMPLETED|Part A (11 Days)||1
2379986|NCT01463098|5840768|P8|NOT COMPLETED|Part A (11 Days)||0
2379987|NCT01463098|5840769|P7|NOT COMPLETED|Part A (11 Days)||0
2379988|NCT01463098|5840770|P6|NOT COMPLETED|Part A (11 Days)||0
2379989|NCT01463098|5840771|P5|NOT COMPLETED|Part A (11 Days)||1
2379990|NCT01463098|5840772|P4|NOT COMPLETED|Part A (11 Days)||0
2379991|NCT01463098|5840773|P3|NOT COMPLETED|Part A (11 Days)||0
2379992|NCT01463098|5840774|P2|NOT COMPLETED|Part A (11 Days)||0
2379993|NCT01463098|5840775|P1|NOT COMPLETED|Part A (11 Days)||2
2379994|NCT01463098|5840762|P14|COMPLETED|Part A (11 Days)||0
2379995|NCT01463098|5840763|P13|COMPLETED|Part A (11 Days)||0
2379996|NCT01463098|5840764|P12|COMPLETED|Part A (11 Days)||0
2379997|NCT01463098|5840765|P11|COMPLETED|Part A (11 Days)||0
2379998|NCT01463098|5840766|P10|COMPLETED|Part A (11 Days)||0
2379999|NCT01463098|5840767|P9|COMPLETED|Part A (11 Days)||5
2380000|NCT01463098|5840768|P8|COMPLETED|Part A (11 Days)||6
2380001|NCT01463098|5840769|P7|COMPLETED|Part A (11 Days)||6
2380002|NCT01463098|5840770|P6|COMPLETED|Part A (11 Days)||6
2380003|NCT01463098|5840771|P5|COMPLETED|Part A (11 Days)||5
2380004|NCT01463098|5840772|P4|COMPLETED|Part A (11 Days)||6
2380005|NCT01463098|5840773|P3|COMPLETED|Part A (11 Days)||6
2380006|NCT01463098|5840774|P2|COMPLETED|Part A (11 Days)||6
2380007|NCT01463098|5840775|P1|COMPLETED|Part A (11 Days)||14
2380008|NCT01463098|5840762|P14|STARTED|Part A (11 Days)||0
2380009|NCT01463098|5840763|P13|STARTED|Part A (11 Days)||0
2380010|NCT01463098|5840764|P12|STARTED|Part A (11 Days)||0
2380011|NCT01463098|5840765|P11|STARTED|Part A (11 Days)||0
2380012|NCT01463098|5840766|P10|STARTED|Part A (11 Days)||0
2380013|NCT01463098|5840767|P9|STARTED|Part A (11 Days)||6
2380014|NCT01463098|5840768|P8|STARTED|Part A (11 Days)||6
2380015|NCT01463098|5840769|P7|STARTED|Part A (11 Days)||6
2380016|NCT01463098|5840770|P6|STARTED|Part A (11 Days)||6
2380017|NCT01463098|5840771|P5|STARTED|Part A (11 Days)||6
2380018|NCT01463098|5840772|P4|STARTED|Part A (11 Days)||6
2380019|NCT01463098|5840773|P3|STARTED|Part A (11 Days)||6
2380020|NCT01463098|5840774|P2|STARTED|Part A (11 Days)||6
2380021|NCT01463098|5840775|P1|STARTED|Part A (11 Days)||16
2380022|NCT01463033|5841098|P2|NOT COMPLETED|Overall Study||6
2380023|NCT01463033|5841099|P1|NOT COMPLETED|Overall Study||7
2380024|NCT01463033|5841098|P2|COMPLETED|Overall Study|2 deaths, 4 lost to follow up|54
2380025|NCT01463033|5841099|P1|COMPLETED|Overall Study|3 deaths, 4 lost to follow up|59
2380026|NCT01463033|5841098|P2|STARTED|Overall Study||60
2380027|NCT01463033|5841099|P1|STARTED|Overall Study||66
2380028|NCT01463007|5841106|P1|NOT COMPLETED|Overall Study||1
2380029|NCT01463007|5841106|P1|COMPLETED|Overall Study||40
2380030|NCT01463007|5841106|P1|STARTED|Overall Study||41
2380031|NCT01462942|5841117|P5|NOT COMPLETED|Overall Study||45
2380032|NCT01462942|5841118|P4|NOT COMPLETED|Overall Study||50
2380033|NCT01462942|5841119|P3|NOT COMPLETED|Overall Study||40
2380034|NCT01462942|5841120|P2|NOT COMPLETED|Overall Study||34
2380035|NCT01462942|5841121|P1|NOT COMPLETED|Overall Study||34
2380036|NCT01462942|5841117|P5|COMPLETED|Overall Study||339
2380037|NCT01462942|5841118|P4|COMPLETED|Overall Study||335
2380038|NCT01462942|5841119|P3|COMPLETED|Overall Study||341
2380039|NCT01462942|5841120|P2|COMPLETED|Overall Study||351
2380040|NCT01462942|5841121|P1|COMPLETED|Overall Study||160
2380041|NCT01462942|5841117|P5|STARTED|Overall Study||384
2380042|NCT01462942|5841118|P4|STARTED|Overall Study||385
2380043|NCT01462942|5841119|P3|STARTED|Overall Study||381
2380044|NCT01462942|5841120|P2|STARTED|Overall Study||385
2380045|NCT01462942|5841121|P1|STARTED|Overall Study||194
2380046|NCT01462929|5841151|P3|NOT COMPLETED|Overall Study||5
2380047|NCT01462929|5841152|P2|NOT COMPLETED|Overall Study||4
2380048|NCT01462929|5841153|P1|NOT COMPLETED|Overall Study||5
2380049|NCT01462929|5841151|P3|COMPLETED|Overall Study||80
2380050|NCT01462929|5841152|P2|COMPLETED|Overall Study||154
2380051|NCT01462929|5841153|P1|COMPLETED|Overall Study||166
2380052|NCT01462929|5841151|P3|STARTED|Overall Study||85
2380053|NCT01462929|5841152|P2|STARTED|Overall Study||158
2380054|NCT01462929|5841153|P1|STARTED|Overall Study||171
2380055|NCT01462877|5841164|P1|NOT COMPLETED|Overall Study||71
2380056|NCT01462877|5841164|P1|COMPLETED|Overall Study||435
2380057|NCT01462877|5841164|P1|Per-protocol Set|Overall Study||364
2380058|NCT01462877|5841164|P1|Full Analysis Set|Overall Study||468
2380059|NCT01462877|5841164|P1|Safety Set|Overall Study||492
2380060|NCT01462877|5841164|P1|STARTED|Overall Study||506
2380061|NCT01462812|5841180|P2|NOT COMPLETED|Overall Study||1
2380062|NCT01462812|5841181|P1|NOT COMPLETED|Overall Study||0
2380063|NCT01462812|5841180|P2|COMPLETED|Overall Study||111
2380064|NCT01462812|5841181|P1|COMPLETED|Overall Study||111
2380065|NCT01462812|5841180|P2|STARTED|Overall Study||112
2380066|NCT01462812|5841181|P1|STARTED|Overall Study||111
2380067|NCT01462773|5841187|P1|NOT COMPLETED|Overall Study||0
2380068|NCT01462773|5841187|P1|COMPLETED|Overall Study||16
2380069|NCT01462773|5841187|P1|STARTED|Overall Study||16
2380070|NCT01462695|5841194|P2|NOT COMPLETED|Overall Study||13
2380071|NCT01462695|5841195|P1|NOT COMPLETED|Overall Study||17
2380072|NCT01462695|5841194|P2|COMPLETED|Overall Study||0
2380073|NCT01462695|5841195|P1|COMPLETED|Overall Study||0
2380074|NCT01462695|5841194|P2|STARTED|Overall Study||13
2380075|NCT01462695|5841195|P1|STARTED|Overall Study||17
2380076|NCT01462565|5841201|P1|NOT COMPLETED|Overall Study||0
2380077|NCT01462565|5841201|P1|COMPLETED|Overall Study||16
2380078|NCT01462565|5841201|P1|STARTED|Overall Study||16
2380079|NCT01462435|5841223|P4|NOT COMPLETED|Overall Study||5
2380080|NCT01462435|5841224|P3|NOT COMPLETED|Overall Study||1
2380081|NCT01462435|5841225|P2|NOT COMPLETED|Overall Study||0
2380082|NCT01462435|5841226|P1|NOT COMPLETED|Overall Study||1
2380083|NCT01462435|5841223|P4|COMPLETED|Overall Study||101
2380084|NCT01462435|5841224|P3|COMPLETED|Overall Study||106
2380085|NCT01462435|5841225|P2|COMPLETED|Overall Study||109
2380086|NCT01462435|5841226|P1|COMPLETED|Overall Study||105
2380087|NCT01462435|5841223|P4|STARTED|Overall Study||106
2380088|NCT01462435|5841224|P3|STARTED|Overall Study||107
2380089|NCT01462435|5841225|P2|STARTED|Overall Study||109
2380090|NCT01462435|5841226|P1|STARTED|Overall Study||106
2380091|NCT01462370|5841264|P2|NOT COMPLETED|Overall Study||5
2380092|NCT01462370|5841265|P1|NOT COMPLETED|Overall Study||1
2380093|NCT01462370|5841264|P2|COMPLETED|Overall Study||65
2380094|NCT01462370|5841265|P1|COMPLETED|Overall Study||68
2380095|NCT01462370|5841264|P2|STARTED|Overall Study||70
2380096|NCT01462370|5841265|P1|STARTED|Overall Study||69
2380097|NCT01462357|5841300|P3|NOT COMPLETED|Overall Study||12
2380098|NCT01462357|5841301|P2|NOT COMPLETED|Overall Study||19
2380099|NCT01462357|5841302|P1|NOT COMPLETED|Overall Study||8
2380100|NCT01462357|5841300|P3|COMPLETED|Overall Study||346
2380101|NCT01462357|5841301|P2|COMPLETED|Overall Study||339
2380102|NCT01462357|5841302|P1|COMPLETED|Overall Study||351
2380103|NCT01462357|5841300|P3|STARTED|Overall Study||358
2380104|NCT01462357|5841301|P2|STARTED|Overall Study||358
2380105|NCT01462357|5841302|P1|STARTED|Overall Study||359
2380106|NCT01462344|5841375|P2|NOT COMPLETED|Overall Study||350
2380107|NCT01462344|5841376|P1|NOT COMPLETED|Overall Study||383
2380108|NCT01462344|5841375|P2|COMPLETED|Overall Study||2751
2380109|NCT01462344|5841376|P1|COMPLETED|Overall Study||2724
2380110|NCT01462344|5841375|P2|STARTED|Overall Study||3101
2380111|NCT01462344|5841376|P1|STARTED|Overall Study||3107
2380112|NCT01462318|5841398|P3|NOT COMPLETED|Extension Phase||45
2380113|NCT01462318|5841399|P2|NOT COMPLETED|Extension Phase||0
2380114|NCT01462318|5841400|P1|NOT COMPLETED|Extension Phase||0
2380115|NCT01462318|5841398|P3|COMPLETED|Extension Phase||70
2380116|NCT01462318|5841399|P2|COMPLETED|Extension Phase||0
2380117|NCT01462318|5841400|P1|COMPLETED|Extension Phase||0
2380118|NCT01462318|5841398|P3|STARTED|Extension Phase|10 participants from the Main Study did not enter the Extension Phase.|115
2380119|NCT01462318|5841399|P2|STARTED|Extension Phase|20 participants from the TP-DI Study entered the Extension Phase|0
2380120|NCT01462318|5841400|P1|STARTED|Extension Phase|95 participants from the Main Study entered the Extension Phase|0
2380121|NCT01462318|5841398|P3|NOT COMPLETED|Main Study / TP-DI Study||0
2380122|NCT01462318|5841399|P2|NOT COMPLETED|Main Study / TP-DI Study||0
2380123|NCT01462318|5841400|P1|NOT COMPLETED|Main Study / TP-DI Study||8
2380124|NCT01462318|5841398|P3|COMPLETED|Main Study / TP-DI Study||0
2380125|NCT01462318|5841399|P2|COMPLETED|Main Study / TP-DI Study||20
2380126|NCT01462318|5841400|P1|COMPLETED|Main Study / TP-DI Study||105
2380127|NCT01462318|5841398|P3|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
2380128|NCT01462318|5841399|P2|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
2380129|NCT01462318|5841400|P1|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||26
2380130|NCT01462318|5841398|P3|STARTED|Main Study / TP-DI Study||0
2380131|NCT01462318|5841399|P2|STARTED|Main Study / TP-DI Study||20
2380132|NCT01462318|5841400|P1|STARTED|Main Study / TP-DI Study||113
2380133|NCT01462305|5841419|P2|NOT COMPLETED|Overall Study||4
2380134|NCT01462305|5841420|P1|NOT COMPLETED|Overall Study||2
2380135|NCT01462305|5841419|P2|COMPLETED|Overall Study||13
2380136|NCT01462305|5841420|P1|COMPLETED|Overall Study||16
2380137|NCT01462305|5841419|P2|STARTED|Overall Study||17
2380138|NCT01462305|5841420|P1|STARTED|Overall Study||18
2380139|NCT01462292|5841433|P3|NOT COMPLETED|Overall Study||0
2380140|NCT01462292|5841434|P2|NOT COMPLETED|Overall Study||0
2380141|NCT01462292|5841435|P1|NOT COMPLETED|Overall Study||0
2380142|NCT01462292|5841433|P3|COMPLETED|Overall Study||18
2380143|NCT01462292|5841434|P2|COMPLETED|Overall Study||17
2380144|NCT01462292|5841435|P1|COMPLETED|Overall Study||16
2380145|NCT01462292|5841433|P3|STARTED|Overall Study||18
2380146|NCT01462292|5841434|P2|STARTED|Overall Study||17
2380147|NCT01462292|5841435|P1|STARTED|Overall Study||16
2380148|NCT01462279|5841494|P1|NOT COMPLETED|Overall Study||3
2380149|NCT01462279|5841494|P1|COMPLETED|Overall Study||17
2380150|NCT01462279|5841494|P1|STARTED|Overall Study||20
2380151|NCT01462266|5841501|P2|NOT COMPLETED|Overall Study||27
2380152|NCT01462266|5841502|P1|NOT COMPLETED|Overall Study||35
2380153|NCT01462266|5841501|P2|COMPLETED|Overall Study||303
2380154|NCT01462266|5841502|P1|COMPLETED|Overall Study||295
2380155|NCT01462266|5841501|P2|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
2380156|NCT01462266|5841502|P1|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
2380157|NCT01462266|5841501|P2|STARTED|Overall Study||330
2380158|NCT01462266|5841502|P1|STARTED|Overall Study||330
2380159|NCT01462253|5841516|P1|NOT COMPLETED|Overall Study||8
2380160|NCT01462253|5841516|P1|COMPLETED|Overall Study||27
2380161|NCT01462253|5841516|P1|STARTED|Overall Study||35
2380162|NCT01462227|5841527|P4|NOT COMPLETED|Second Assignment||0
2380163|NCT01462227|5841528|P3|NOT COMPLETED|Second Assignment||1
2380164|NCT01462227|5841529|P2|NOT COMPLETED|Second Assignment||1
2380165|NCT01462227|5841530|P1|NOT COMPLETED|Second Assignment||1
2380166|NCT01462227|5841527|P4|COMPLETED|Second Assignment||5
2380167|NCT01462227|5841528|P3|COMPLETED|Second Assignment||5
2380168|NCT01462227|5841529|P2|COMPLETED|Second Assignment||1
2380169|NCT01462227|5841530|P1|COMPLETED|Second Assignment||3
2380170|NCT01462227|5841527|P4|STARTED|Second Assignment||5
2380171|NCT01462227|5841528|P3|STARTED|Second Assignment||6
2380172|NCT01462227|5841529|P2|STARTED|Second Assignment||2
2380173|NCT01462227|5841530|P1|STARTED|Second Assignment||4
2380174|NCT01462227|5841527|P4|NOT COMPLETED|First Assignment||0
2380175|NCT01462227|5841528|P3|NOT COMPLETED|First Assignment||0
2380176|NCT01462227|5841529|P2|NOT COMPLETED|First Assignment||0
2380177|NCT01462227|5841530|P1|NOT COMPLETED|First Assignment||0
2380178|NCT01462227|5841527|P4|COMPLETED|First Assignment||5
2380179|NCT01462227|5841528|P3|COMPLETED|First Assignment||6
2380180|NCT01462227|5841529|P2|COMPLETED|First Assignment||2
2380181|NCT01462227|5841530|P1|COMPLETED|First Assignment||4
2380182|NCT01462227|5841527|P4|STARTED|First Assignment||5
2380183|NCT01462227|5841528|P3|STARTED|First Assignment||6
2380184|NCT01462227|5841529|P2|STARTED|First Assignment||2
2380185|NCT01462227|5841530|P1|STARTED|First Assignment||4
2380186|NCT01462162|5841548|P1|NOT COMPLETED|Overall Study||12
2380187|NCT01462162|5841548|P1|COMPLETED|Overall Study||108
2380188|NCT01462162|5841548|P1|STARTED|Overall Study||120
2380189|NCT01462084|5841573|P2|NOT COMPLETED|Overall Study||1
2380190|NCT01462084|5841574|P1|NOT COMPLETED|Overall Study||2
2380191|NCT01462084|5841573|P2|COMPLETED|Overall Study||9
2380192|NCT01462084|5841574|P1|COMPLETED|Overall Study||9
2380193|NCT01462084|5841573|P2|Included for Analysis|Overall Study||9
2380194|NCT01462084|5841574|P1|Included for Analysis|Overall Study||9
2380195|NCT01462084|5841573|P2|STARTED|Overall Study||10
2380196|NCT01462084|5841574|P1|STARTED|Overall Study||11
2380197|NCT01462045|5841585|P3|NOT COMPLETED|Overall Study||0
2380198|NCT01462045|5841586|P2|NOT COMPLETED|Overall Study||1
2380199|NCT01462045|5841587|P1|NOT COMPLETED|Overall Study||0
2380200|NCT01462045|5841585|P3|COMPLETED|Overall Study||7
2380201|NCT01462045|5841586|P2|COMPLETED|Overall Study||10
2380202|NCT01462045|5841587|P1|COMPLETED|Overall Study||11
2380203|NCT01462045|5841585|P3|STARTED|Overall Study||7
2380204|NCT01462045|5841586|P2|STARTED|Overall Study||11
2380205|NCT01462045|5841587|P1|STARTED|Overall Study||11
2380206|NCT01461993|5841601|P3|NOT COMPLETED|Overall Study||64
2380207|NCT01461993|5841602|P2|NOT COMPLETED|Overall Study||157
2380208|NCT01461993|5841603|P1|NOT COMPLETED|Overall Study||151
2380209|NCT01461993|5841601|P3|COMPLETED|Overall Study||438
2380210|NCT01461993|5841602|P2|COMPLETED|Overall Study||841
2380211|NCT01461993|5841603|P1|COMPLETED|Overall Study||848
2380212|NCT01461993|5841601|P3|STARTED|Overall Study||502
2380213|NCT01461993|5841602|P2|STARTED|Overall Study||998
2380214|NCT01461993|5841603|P1|STARTED|Overall Study||999
2380215|NCT01461980|5841628|P3|NOT COMPLETED|Overall Study||165
2380216|NCT01461980|5841629|P2|NOT COMPLETED|Overall Study||145
2380217|NCT01461980|5841630|P1|NOT COMPLETED|Overall Study||166
2380218|NCT01461980|5841628|P3|COMPLETED|Overall Study||717
2380219|NCT01461980|5841629|P2|COMPLETED|Overall Study||733
2380220|NCT01461980|5841630|P1|COMPLETED|Overall Study||722
2380221|NCT01461980|5841628|P3|Vaccination 3|Overall Study||748
2380222|NCT01461980|5841629|P2|Vaccination 3|Overall Study||777
2380223|NCT01461980|5841630|P1|Vaccination 3|Overall Study||757
2380224|NCT01461980|5841628|P3|Vaccination 2|Overall Study||799
2380225|NCT01461980|5841629|P2|Vaccination 2|Overall Study||819
2380226|NCT01461980|5841630|P1|Vaccination 2|Overall Study||802
2380227|NCT01461980|5841628|P3|Vaccination 1|Overall Study||875
2380228|NCT01461980|5841629|P2|Vaccination 1|Overall Study||870
2380229|NCT01461980|5841630|P1|Vaccination 1|Overall Study||884
2380230|NCT01461980|5841628|P3|STARTED|Overall Study||882
2380231|NCT01461980|5841629|P2|STARTED|Overall Study||878
2380232|NCT01461980|5841630|P1|STARTED|Overall Study||888
2380233|NCT01461928|5841660|P3|NOT COMPLETED|Maintenance II (15 Months)||27
2380234|NCT01461928|5841661|P2|NOT COMPLETED|Maintenance II (15 Months)||23
2380235|NCT01461928|5841662|P1|NOT COMPLETED|Maintenance II (15 Months)||0
2380236|NCT01461928|5841660|P3|COMPLETED|Maintenance II (15 Months)||111
2380237|NCT01461928|5841661|P2|COMPLETED|Maintenance II (15 Months)|6 participants did not receive treatment|115
2380238|NCT01461928|5841662|P1|COMPLETED|Maintenance II (15 Months)||0
2380239|NCT01461928|5841660|P3|STARTED|Maintenance II (15 Months)||138
2380240|NCT01461928|5841661|P2|STARTED|Maintenance II (15 Months)||138
2380241|NCT01461928|5841662|P1|STARTED|Maintenance II (15 Months)||0
2380242|NCT01461928|5841660|P3|NOT COMPLETED|Maintenance I (24 Months)||0
2380243|NCT01461928|5841661|P2|NOT COMPLETED|Maintenance I (24 Months)||0
2380244|NCT01461928|5841662|P1|NOT COMPLETED|Maintenance I (24 Months)||218
2380245|NCT01461928|5841660|P3|COMPLETED|Maintenance I (24 Months)||0
2380246|NCT01461928|5841661|P2|COMPLETED|Maintenance I (24 Months)||0
2380247|NCT01461928|5841662|P1|COMPLETED|Maintenance I (24 Months)|Responders during 2 yrs Maint I treatment|276
2380248|NCT01461928|5841660|P3|STARTED|Maintenance I (24 Months)||0
2380249|NCT01461928|5841661|P2|STARTED|Maintenance I (24 Months)||0
2380250|NCT01461928|5841662|P1|STARTED|Maintenance I (24 Months)||494
2380251|NCT01461928|5841660|P3|NOT COMPLETED|Induction (up to 8 Months)||0
2380252|NCT01461928|5841661|P2|NOT COMPLETED|Induction (up to 8 Months)||0
2380253|NCT01461928|5841662|P1|NOT COMPLETED|Induction (up to 8 Months)||198
2380254|NCT01461928|5841660|P3|COMPLETED|Induction (up to 8 Months)||0
2380255|NCT01461928|5841661|P2|COMPLETED|Induction (up to 8 Months)||0
2380256|NCT01461928|5841662|P1|COMPLETED|Induction (up to 8 Months)||494
2380257|NCT01461928|5841660|P3|STARTED|Induction (up to 8 Months)||0
2380258|NCT01461928|5841661|P2|STARTED|Induction (up to 8 Months)||0
2380259|NCT01461928|5841662|P1|STARTED|Induction (up to 8 Months)||692
2380260|NCT01461863|5841683|P2|NOT COMPLETED|Overall Study||0
2380261|NCT01461863|5841684|P1|NOT COMPLETED|Overall Study||0
2380262|NCT01461863|5841683|P2|COMPLETED|Overall Study||48
2380263|NCT01461863|5841684|P1|COMPLETED|Overall Study||48
2380264|NCT01461863|5841683|P2|STARTED|Overall Study||48
2380265|NCT01461863|5841684|P1|STARTED|Overall Study||48
2380266|NCT01461824|5841695|P3|NOT COMPLETED|Overall Study||3
2380267|NCT01461824|5841696|P2|NOT COMPLETED|Overall Study||4
2380268|NCT01461824|5841697|P1|NOT COMPLETED|Overall Study||2
2380269|NCT01461824|5841695|P3|COMPLETED|Overall Study||8
2380270|NCT01461824|5841696|P2|COMPLETED|Overall Study||7
2380271|NCT01461824|5841697|P1|COMPLETED|Overall Study||10
2380272|NCT01461824|5841695|P3|STARTED|Overall Study||11
2380273|NCT01461824|5841696|P2|STARTED|Overall Study||11
2380274|NCT01461824|5841697|P1|STARTED|Overall Study||12
2380275|NCT01461811|5841713|P2|NOT COMPLETED|Overall Study||3
2380276|NCT01461811|5841714|P1|NOT COMPLETED|Overall Study||4
2380277|NCT01461811|5841713|P2|COMPLETED|Overall Study||46
2380278|NCT01461811|5841714|P1|COMPLETED|Overall Study||91
2380279|NCT01461811|5841713|P2|STARTED|Overall Study||49
2380280|NCT01461811|5841714|P1|STARTED|Overall Study||95
2380281|NCT01461733|5841744|P2|NOT COMPLETED|Overall Study||4
2380282|NCT01461733|5841745|P1|NOT COMPLETED|Overall Study||4
2380283|NCT01461733|5841744|P2|COMPLETED|Overall Study||8
2380284|NCT01461733|5841745|P1|COMPLETED|Overall Study||8
2380285|NCT01461733|5841744|P2|STARTED|Overall Study||12
2380286|NCT01461733|5841745|P1|STARTED|Overall Study||12
2380287|NCT01461707|5841753|P2|NOT COMPLETED|Overall Study||0
2380288|NCT01461707|5841754|P1|NOT COMPLETED|Overall Study||1
2380289|NCT01461707|5841753|P2|COMPLETED|Overall Study||15
2380290|NCT01461707|5841754|P1|COMPLETED|Overall Study||14
2380291|NCT01461707|5841753|P2|STARTED|Overall Study||15
2380292|NCT01461707|5841754|P1|STARTED|Overall Study||15
2380293|NCT01461668|5841764|P2|NOT COMPLETED|Overall Study||1
2380294|NCT01461668|5841765|P1|NOT COMPLETED|Overall Study||2
2380295|NCT01461668|5841764|P2|COMPLETED|Overall Study||25
2380296|NCT01461668|5841765|P1|COMPLETED|Overall Study||25
2380297|NCT01461668|5841764|P2|STARTED|Overall Study||26
2380298|NCT01461668|5841765|P1|STARTED|Overall Study||27
2380299|NCT01461655|5841771|P1|NOT COMPLETED|Overall Study||0
2380300|NCT01461655|5841771|P1|COMPLETED|Overall Study||40
2380301|NCT01461655|5841771|P1|STARTED|Overall Study||40
2380302|NCT01461551|5841791|P3|NOT COMPLETED|Overall Study||2
2380303|NCT01461551|5841792|P2|NOT COMPLETED|Overall Study||1
2380304|NCT01461551|5841793|P1|NOT COMPLETED|Overall Study||2
2380305|NCT01461551|5841791|P3|COMPLETED|Overall Study||33
2380306|NCT01461551|5841792|P2|COMPLETED|Overall Study||34
2380307|NCT01461551|5841793|P1|COMPLETED|Overall Study||33
2380308|NCT01461551|5841791|P3|STARTED|Overall Study||35
2380309|NCT01461551|5841792|P2|STARTED|Overall Study||35
2380310|NCT01461551|5841793|P1|STARTED|Overall Study||35
2380311|NCT01461538|5841804|P3|NOT COMPLETED|Overall Study||2
2380312|NCT01461538|5841805|P2|NOT COMPLETED|Overall Study||8
2380313|NCT01461538|5841806|P1|NOT COMPLETED|Overall Study||18
2380314|NCT01461538|5841804|P3|COMPLETED|Overall Study||7
2380315|NCT01461538|5841805|P2|COMPLETED|Overall Study||20
2380316|NCT01461538|5841806|P1|COMPLETED|Overall Study||28
2380317|NCT01461538|5841804|P3|STARTED|Overall Study||9
2380318|NCT01461538|5841805|P2|STARTED|Overall Study||28
2380319|NCT01461538|5841806|P1|STARTED|Overall Study||46
2380320|NCT01461499|5841844|P2|NOT COMPLETED|Overall Study||4
2380321|NCT01461499|5841845|P1|NOT COMPLETED|Overall Study||8
2380322|NCT01461499|5841844|P2|COMPLETED|Overall Study||114
2380323|NCT01461499|5841845|P1|COMPLETED|Overall Study||111
2380324|NCT01461499|5841844|P2|STARTED|Overall Study||118
2380325|NCT01461499|5841845|P1|STARTED|Overall Study||119
2380326|NCT01461473|5841855|P2|NOT COMPLETED|Overall Study||4
2380327|NCT01461473|5841856|P1|NOT COMPLETED|Overall Study||5
2380328|NCT01461473|5841855|P2|COMPLETED|Overall Study||55
2380329|NCT01461473|5841856|P1|COMPLETED|Overall Study||67
2380330|NCT01461473|5841855|P2|STARTED|Overall Study||59
2380331|NCT01461473|5841856|P1|STARTED|Overall Study||72
2380332|NCT01461369|5841875|P3|NOT COMPLETED|Overall Study||17
2380333|NCT01461369|5841876|P2|NOT COMPLETED|Overall Study||17
2380334|NCT01461369|5841877|P1|NOT COMPLETED|Overall Study||13
2380335|NCT01461369|5841875|P3|COMPLETED|Overall Study||86
2380336|NCT01461369|5841876|P2|COMPLETED|Overall Study||81
2380337|NCT01461369|5841877|P1|COMPLETED|Overall Study||91
2380338|NCT01461369|5841875|P3|STARTED|Overall Study||103
2380339|NCT01461369|5841876|P2|STARTED|Overall Study||98
2380340|NCT01461369|5841877|P1|STARTED|Overall Study||104
2380341|NCT01461096|5841902|P2|NOT COMPLETED|Overall Study||61
2380342|NCT01461096|5841903|P1|NOT COMPLETED|Overall Study||62
2380343|NCT01461096|5841902|P2|COMPLETED|Overall Study||226
2380344|NCT01461096|5841903|P1|COMPLETED|Overall Study||226
2380345|NCT01461096|5841902|P2|Did Not Start Treatment|Overall Study|Randomized but never started treatment and was discontinued from the study|1
2380346|NCT01461096|5841903|P1|Did Not Start Treatment|Overall Study||0
2380347|NCT01461096|5841902|P2|STARTED|Overall Study||287
2380348|NCT01461096|5841903|P1|STARTED|Overall Study||288
2380349|NCT01461057|5841919|P2|NOT COMPLETED|Overall Study||15
2380350|NCT01461057|5841920|P1|NOT COMPLETED|Overall Study||15
2380351|NCT01461057|5841919|P2|COMPLETED|Overall Study||0
2380352|NCT01461057|5841920|P1|COMPLETED|Overall Study||0
2380353|NCT01461057|5841919|P2|STARTED|Overall Study||15
2380354|NCT01461057|5841920|P1|STARTED|Overall Study||15
2380355|NCT01461044|5841930|P2|NOT COMPLETED|Overall Study||40
2380356|NCT01461044|5841931|P1|NOT COMPLETED|Overall Study||70
2380357|NCT01461044|5841930|P2|COMPLETED|Overall Study||37
2380358|NCT01461044|5841931|P1|COMPLETED|Overall Study||80
2380359|NCT01461044|5841930|P2|Participants Alive at Inclusion|Overall Study||58
2380360|NCT01461044|5841931|P1|Participants Alive at Inclusion|Overall Study||127
2380361|NCT01461044|5841930|P2|STARTED|Overall Study||77
2380362|NCT01461044|5841931|P1|STARTED|Overall Study||150
2380366|NCT01460940|5842013|P1|NOT COMPLETED|Overall Study||0
2380367|NCT01460940|5842013|P1|COMPLETED|Overall Study||24
2380368|NCT01460940|5842013|P1|STARTED|Overall Study||24
2380369|NCT01460927|5842019|P1|NOT COMPLETED|Overall Study||0
2380370|NCT01460927|5842019|P1|COMPLETED|Overall Study||25
2380371|NCT01460927|5842019|P1|STARTED|Overall Study||25
2380372|NCT01460901|5842027|P1|NOT COMPLETED|Overall Study||2
2380373|NCT01460901|5842027|P1|COMPLETED|Overall Study|Follow-up completed|3
2380374|NCT01460901|5842027|P1|tV-CTL Infusion|Overall Study||3
2380375|NCT01460901|5842027|P1|STARTED|Overall Study|First enrollment|5
2380376|NCT01460875|5842035|P1|NOT COMPLETED|Overall Study||0
2380377|NCT01460875|5842035|P1|COMPLETED|Overall Study||34
2380378|NCT01460875|5842035|P1|STARTED|Overall Study||34
2380379|NCT01460732|5842046|P1|NOT COMPLETED|Overall Study||0
2380380|NCT01460732|5842046|P1|COMPLETED|Overall Study||81
2380381|NCT01460732|5842046|P1|STARTED|Overall Study||81
2380382|NCT01460719|5842059|P1|NOT COMPLETED|Overall Study||2
2380383|NCT01460719|5842059|P1|COMPLETED|Overall Study||78
2380384|NCT01460719|5842059|P1|Vaccination 4 (~Day 90)|Overall Study||78
2380385|NCT01460719|5842059|P1|Vaccination 3 (~Day 60)|Overall Study||78
2380386|NCT01460719|5842059|P1|Vaccination 2 (~Day 30)|Overall Study||78
2380387|NCT01460719|5842059|P1|Vaccination 1 (Day 1)|Overall Study||80
2380388|NCT01460719|5842059|P1|STARTED|Overall Study||80
2380389|NCT01460628|5842069|P1|NOT COMPLETED|Overall Study||5
2380390|NCT01460628|5842069|P1|COMPLETED|Overall Study||20
2380391|NCT01460628|5842069|P1|STARTED|Overall Study||25
2380392|NCT01460446|5842081|P2|NOT COMPLETED|Overall Study||20
2380393|NCT01460446|5842082|P1|NOT COMPLETED|Overall Study||5
2380394|NCT01460446|5842081|P2|COMPLETED|Overall Study||93
2380395|NCT01460446|5842082|P1|COMPLETED|Overall Study||100
2380396|NCT01460446|5842081|P2|STARTED|Overall Study||113
2380397|NCT01460446|5842082|P1|STARTED|Overall Study||105
2380398|NCT01460407|5842109|P2|NOT COMPLETED|Period 2: Day 6 to Day 14||1
2380399|NCT01460407|5842110|P1|NOT COMPLETED|Period 2: Day 6 to Day 14||0
2380400|NCT01460407|5842109|P2|COMPLETED|Period 2: Day 6 to Day 14||13
2380401|NCT01460407|5842110|P1|COMPLETED|Period 2: Day 6 to Day 14||0
2380402|NCT01460407|5842109|P2|STARTED|Period 2: Day 6 to Day 14||14
2380403|NCT01460407|5842110|P1|STARTED|Period 2: Day 6 to Day 14||0
2380404|NCT01460407|5842109|P2|NOT COMPLETED|Period 1: Day 1 to Day 5||0
2380405|NCT01460407|5842110|P1|NOT COMPLETED|Period 1: Day 1 to Day 5||0
2380406|NCT01460407|5842109|P2|COMPLETED|Period 1: Day 1 to Day 5||0
2380407|NCT01460407|5842110|P1|COMPLETED|Period 1: Day 1 to Day 5||14
2380408|NCT01460407|5842109|P2|STARTED|Period 1: Day 1 to Day 5||0
2380409|NCT01460407|5842110|P1|STARTED|Period 1: Day 1 to Day 5||14
2380410|NCT01460381|5842123|P2|NOT COMPLETED|Period 2 (Days 8-15)||0
2380411|NCT01460381|5842124|P1|NOT COMPLETED|Period 2 (Days 8-15)||1
2380412|NCT01460381|5842123|P2|COMPLETED|Period 2 (Days 8-15)|CYP2C19 extensive metabolizers did not participate in Period 2|0
2380413|NCT01460381|5842124|P1|COMPLETED|Period 2 (Days 8-15)|One participant was lost to follow-up after completing Period 2 and did not complete the study.|6
2380414|NCT01460381|5842123|P2|STARTED|Period 2 (Days 8-15)|CYP2C19 extensive metabolizers did not participate in Period 2.|0
2380415|NCT01460381|5842124|P1|STARTED|Period 2 (Days 8-15)||7
2380416|NCT01460381|5842123|P2|NOT COMPLETED|Period 1 (Days 1-7)||0
2380417|NCT01460381|5842124|P1|NOT COMPLETED|Period 1 (Days 1-7)||0
2380418|NCT01460381|5842123|P2|COMPLETED|Period 1 (Days 1-7)||11
2380419|NCT01460381|5842124|P1|COMPLETED|Period 1 (Days 1-7)||7
2380420|NCT01460381|5842123|P2|Received at Least 1 Dose of Study Drug|Period 1 (Days 1-7)||11
2380421|NCT01460381|5842124|P1|Received at Least 1 Dose of Study Drug|Period 1 (Days 1-7)||7
2380422|NCT01460381|5842123|P2|STARTED|Period 1 (Days 1-7)||11
2380423|NCT01460381|5842124|P1|STARTED|Period 1 (Days 1-7)||7
2380424|NCT01460368|5842140|P7|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
2380425|NCT01460368|5842141|P6|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
2380426|NCT01460368|5842142|P5|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
2380427|NCT01460368|5842143|P4|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
2380428|NCT01460368|5842144|P3|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
2380429|NCT01460368|5842145|P2|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
2380430|NCT01460368|5842146|P1|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
2380431|NCT01460368|5842140|P7|COMPLETED|Part B: Third Interventions (Period 3)||9
2380432|NCT01460368|5842141|P6|COMPLETED|Part B: Third Interventions (Period 3)||9
2380433|NCT01460368|5842142|P5|COMPLETED|Part B: Third Interventions (Period 3)||9
2380434|NCT01460368|5842143|P4|COMPLETED|Part B: Third Interventions (Period 3)||9
2380435|NCT01460368|5842144|P3|COMPLETED|Part B: Third Interventions (Period 3)||8
2380436|NCT01460368|5842145|P2|COMPLETED|Part B: Third Interventions (Period 3)||8
2380437|NCT01460368|5842146|P1|COMPLETED|Part B: Third Interventions (Period 3)||0
2380438|NCT01460368|5842140|P7|STARTED|Part B: Third Interventions (Period 3)||9
2380439|NCT01460368|5842141|P6|STARTED|Part B: Third Interventions (Period 3)||10
2380440|NCT01460368|5842142|P5|STARTED|Part B: Third Interventions (Period 3)||9
2380441|NCT01460368|5842143|P4|STARTED|Part B: Third Interventions (Period 3)||10
2380442|NCT01460368|5842144|P3|STARTED|Part B: Third Interventions (Period 3)||9
2380443|NCT01460368|5842145|P2|STARTED|Part B: Third Interventions (Period 3)||8
2380444|NCT01460368|5842146|P1|STARTED|Part B: Third Interventions (Period 3)||0
2380445|NCT01460368|5842140|P7|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
2380446|NCT01460368|5842141|P6|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
2380447|NCT01460368|5842142|P5|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
2380448|NCT01460368|5842143|P4|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
2380449|NCT01460368|5842144|P3|NOT COMPLETED|Part B: Washout (up to 15 Days)||1
2380450|NCT01460368|5842145|P2|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
2380451|NCT01460368|5842146|P1|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
2380452|NCT01460368|5842140|P7|COMPLETED|Part B: Washout (up to 15 Days)||9
2380453|NCT01460368|5842141|P6|COMPLETED|Part B: Washout (up to 15 Days)||10
2380454|NCT01460368|5842142|P5|COMPLETED|Part B: Washout (up to 15 Days)||9
2380455|NCT01460368|5842143|P4|COMPLETED|Part B: Washout (up to 15 Days)||10
2380456|NCT01460368|5842144|P3|COMPLETED|Part B: Washout (up to 15 Days)||9
2380457|NCT01460368|5842145|P2|COMPLETED|Part B: Washout (up to 15 Days)||8
2380458|NCT01460368|5842146|P1|COMPLETED|Part B: Washout (up to 15 Days)||0
2380459|NCT01460368|5842140|P7|STARTED|Part B: Washout (up to 15 Days)||9
2380460|NCT01460368|5842141|P6|STARTED|Part B: Washout (up to 15 Days)||10
2380461|NCT01460368|5842142|P5|STARTED|Part B: Washout (up to 15 Days)||9
2380462|NCT01460368|5842143|P4|STARTED|Part B: Washout (up to 15 Days)||10
2380463|NCT01460368|5842144|P3|STARTED|Part B: Washout (up to 15 Days)||10
2380464|NCT01460368|5842145|P2|STARTED|Part B: Washout (up to 15 Days)||8
2380465|NCT01460368|5842146|P1|STARTED|Part B: Washout (up to 15 Days)||0
2380466|NCT01460368|5842140|P7|NOT COMPLETED|Part B: Second Intervention (Period 2)||1
2380467|NCT01460368|5842141|P6|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
2380468|NCT01460368|5842142|P5|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
2380469|NCT01460368|5842143|P4|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
2380470|NCT01460368|5842144|P3|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
2380471|NCT01460368|5842145|P2|NOT COMPLETED|Part B: Second Intervention (Period 2)||2
2380472|NCT01460368|5842146|P1|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
2380473|NCT01460368|5842140|P7|COMPLETED|Part B: Second Intervention (Period 2)||9
2380474|NCT01460368|5842141|P6|COMPLETED|Part B: Second Intervention (Period 2)||10
2380475|NCT01460368|5842142|P5|COMPLETED|Part B: Second Intervention (Period 2)||9
2380476|NCT01460368|5842143|P4|COMPLETED|Part B: Second Intervention (Period 2)||10
2380477|NCT01460368|5842144|P3|COMPLETED|Part B: Second Intervention (Period 2)||10
2380478|NCT01460368|5842145|P2|COMPLETED|Part B: Second Intervention (Period 2)||8
2380479|NCT01460368|5842146|P1|COMPLETED|Part B: Second Intervention (Period 2)||0
2380480|NCT01460368|5842140|P7|STARTED|Part B: Second Intervention (Period 2)||10
2380481|NCT01460368|5842141|P6|STARTED|Part B: Second Intervention (Period 2)||10
2380482|NCT01460368|5842142|P5|STARTED|Part B: Second Intervention (Period 2)||9
2380483|NCT01460368|5842143|P4|STARTED|Part B: Second Intervention (Period 2)||10
2380484|NCT01460368|5842144|P3|STARTED|Part B: Second Intervention (Period 2)||10
2380485|NCT01460368|5842145|P2|STARTED|Part B: Second Intervention (Period 2)||10
2380486|NCT01460368|5842146|P1|STARTED|Part B: Second Intervention (Period 2)||0
2380487|NCT01460368|5842140|P7|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
2380488|NCT01460368|5842141|P6|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
2380489|NCT01460368|5842142|P5|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
2380490|NCT01460368|5842143|P4|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
2380491|NCT01460368|5842144|P3|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
2380492|NCT01460368|5842145|P2|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
2380493|NCT01460368|5842146|P1|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
2380494|NCT01460368|5842140|P7|COMPLETED|Part B: Washout (up to 15 Days)||10
2380495|NCT01460368|5842141|P6|COMPLETED|Part B: Washout (up to 15 Days)||10
2380496|NCT01460368|5842142|P5|COMPLETED|Part B: Washout (up to 15 Days)||9
2380497|NCT01460368|5842143|P4|COMPLETED|Part B: Washout (up to 15 Days)||10
2380498|NCT01460368|5842144|P3|COMPLETED|Part B: Washout (up to 15 Days)||10
2380499|NCT01460368|5842145|P2|COMPLETED|Part B: Washout (up to 15 Days)||10
2380500|NCT01460368|5842146|P1|COMPLETED|Part B: Washout (up to 15 Days)||0
2380501|NCT01460368|5842140|P7|STARTED|Part B: Washout (up to 15 Days)||10
2380502|NCT01460368|5842141|P6|STARTED|Part B: Washout (up to 15 Days)||10
2380503|NCT01460368|5842142|P5|STARTED|Part B: Washout (up to 15 Days)||9
2380504|NCT01460368|5842143|P4|STARTED|Part B: Washout (up to 15 Days)||10
2380505|NCT01460368|5842144|P3|STARTED|Part B: Washout (up to 15 Days)||10
2380506|NCT01460368|5842145|P2|STARTED|Part B: Washout (up to 15 Days)||10
2380507|NCT01460368|5842146|P1|STARTED|Part B: Washout (up to 15 Days)||0
2380508|NCT01460368|5842140|P7|NOT COMPLETED|Part B: First Intervention (Period 1)||0
2380509|NCT01460368|5842141|P6|NOT COMPLETED|Part B: First Intervention (Period 1)||0
2380510|NCT01460368|5842142|P5|NOT COMPLETED|Part B: First Intervention (Period 1)||1
2380511|NCT01460368|5842143|P4|NOT COMPLETED|Part B: First Intervention (Period 1)||0
2380512|NCT01460368|5842144|P3|NOT COMPLETED|Part B: First Intervention (Period 1)||0
2380513|NCT01460368|5842145|P2|NOT COMPLETED|Part B: First Intervention (Period 1)||0
2380514|NCT01460368|5842146|P1|NOT COMPLETED|Part B: First Intervention (Period 1)||0
2380515|NCT01460368|5842140|P7|COMPLETED|Part B: First Intervention (Period 1)||10
2380516|NCT01460368|5842141|P6|COMPLETED|Part B: First Intervention (Period 1)||10
2380517|NCT01460368|5842142|P5|COMPLETED|Part B: First Intervention (Period 1)||9
2380518|NCT01460368|5842143|P4|COMPLETED|Part B: First Intervention (Period 1)||10
2380519|NCT01460368|5842144|P3|COMPLETED|Part B: First Intervention (Period 1)||10
2380520|NCT01460368|5842145|P2|COMPLETED|Part B: First Intervention (Period 1)||10
2380521|NCT01460368|5842146|P1|COMPLETED|Part B: First Intervention (Period 1)||0
2380522|NCT01460368|5842140|P7|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
2380523|NCT01460368|5842141|P6|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
2380524|NCT01460368|5842142|P5|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
2380525|NCT01460368|5842143|P4|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
2380526|NCT01460368|5842144|P3|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
2380527|NCT01460368|5842145|P2|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
2380528|NCT01460368|5842146|P1|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||0
2380529|NCT01460368|5842140|P7|STARTED|Part B: First Intervention (Period 1)||10
2380530|NCT01460368|5842141|P6|STARTED|Part B: First Intervention (Period 1)||10
2380531|NCT01460368|5842142|P5|STARTED|Part B: First Intervention (Period 1)||10
2380532|NCT01460368|5842143|P4|STARTED|Part B: First Intervention (Period 1)||10
2380533|NCT01460368|5842144|P3|STARTED|Part B: First Intervention (Period 1)||10
2380534|NCT01460368|5842145|P2|STARTED|Part B: First Intervention (Period 1)||10
2380535|NCT01460368|5842146|P1|STARTED|Part B: First Intervention (Period 1)||0
2380536|NCT01460368|5842140|P7|NOT COMPLETED|Part A||0
2380537|NCT01460368|5842141|P6|NOT COMPLETED|Part A||0
2380538|NCT01460368|5842142|P5|NOT COMPLETED|Part A||0
2380539|NCT01460368|5842143|P4|NOT COMPLETED|Part A||0
2380540|NCT01460368|5842144|P3|NOT COMPLETED|Part A||0
2380541|NCT01460368|5842145|P2|NOT COMPLETED|Part A||0
2380542|NCT01460368|5842146|P1|NOT COMPLETED|Part A||0
2380543|NCT01460368|5842140|P7|COMPLETED|Part A||0
2380544|NCT01460368|5842141|P6|COMPLETED|Part A||0
2380545|NCT01460368|5842142|P5|COMPLETED|Part A||0
2380546|NCT01460368|5842143|P4|COMPLETED|Part A||0
2380547|NCT01460368|5842144|P3|COMPLETED|Part A||0
2380548|NCT01460368|5842145|P2|COMPLETED|Part A||0
2380549|NCT01460368|5842146|P1|COMPLETED|Part A||7
2380550|NCT01460368|5842140|P7|Received at Least One Dose of Study Drug|Part A||0
2380551|NCT01460368|5842141|P6|Received at Least One Dose of Study Drug|Part A||0
2380552|NCT01460368|5842142|P5|Received at Least One Dose of Study Drug|Part A||0
2380553|NCT01460368|5842143|P4|Received at Least One Dose of Study Drug|Part A||0
2380554|NCT01460368|5842144|P3|Received at Least One Dose of Study Drug|Part A||0
2380555|NCT01460368|5842145|P2|Received at Least One Dose of Study Drug|Part A||0
2380556|NCT01460368|5842146|P1|Received at Least One Dose of Study Drug|Part A||7
2380557|NCT01460368|5842140|P7|STARTED|Part A||0
2380558|NCT01460368|5842141|P6|STARTED|Part A||0
2380559|NCT01460368|5842142|P5|STARTED|Part A||0
2380560|NCT01460368|5842143|P4|STARTED|Part A||0
2380561|NCT01460368|5842144|P3|STARTED|Part A||0
2380562|NCT01460368|5842145|P2|STARTED|Part A||0
2380563|NCT01460368|5842146|P1|STARTED|Part A||7
2380564|NCT01460342|5842158|P2|NOT COMPLETED|Overall Study||14
2380565|NCT01460342|5842159|P1|NOT COMPLETED|Overall Study||11
2380566|NCT01460342|5842158|P2|COMPLETED|Overall Study||292
2380567|NCT01460342|5842159|P1|COMPLETED|Overall Study||293
2380568|NCT01460342|5842158|P2|Received at Least 1 Dose of Study Drug|Overall Study||306
2380569|NCT01460342|5842159|P1|Received at Least 1 Dose of Study Drug|Overall Study||304
2380570|NCT01460342|5842158|P2|STARTED|Overall Study||306
2380571|NCT01460342|5842159|P1|STARTED|Overall Study||304
2380572|NCT01460303|5842181|P2|NOT COMPLETED|Overall Study||0
2380573|NCT01460303|5842182|P1|NOT COMPLETED|Overall Study||0
2380574|NCT01460303|5842181|P2|COMPLETED|Overall Study||24
2380575|NCT01460303|5842182|P1|COMPLETED|Overall Study||25
2380576|NCT01460303|5842181|P2|STARTED|Overall Study||24
2380577|NCT01460303|5842182|P1|STARTED|Overall Study||25
2380578|NCT01460290|5842190|P1|NOT COMPLETED|Overall Study||4
2380579|NCT01460290|5842190|P1|COMPLETED|Overall Study||11
2380580|NCT01460290|5842190|P1|STARTED|Overall Study||15
2380581|NCT01460225|5842210|P1|NOT COMPLETED|Overall Study||0
2380582|NCT01460225|5842210|P1|COMPLETED|Overall Study|November 2010|19
2380583|NCT01460225|5842210|P1|STARTED|Overall Study|January 2009.|19
2380596|NCT01459913|5842259|P4|NOT COMPLETED|Overall Study||33
2380597|NCT01459913|5842260|P3|NOT COMPLETED|Overall Study||13
2380598|NCT01459913|5842261|P2|NOT COMPLETED|Overall Study||20
2380599|NCT01459913|5842262|P1|NOT COMPLETED|Overall Study||41
2380600|NCT01459913|5842259|P4|COMPLETED|Overall Study||29
2380601|NCT01459913|5842260|P3|COMPLETED|Overall Study||6
2380602|NCT01459913|5842261|P2|COMPLETED|Overall Study||32
2380603|NCT01459913|5842262|P1|COMPLETED|Overall Study||65
2380604|NCT01459913|5842259|P4|STARTED|Overall Study||62
2380605|NCT01459913|5842260|P3|STARTED|Overall Study||19
2380606|NCT01459913|5842261|P2|STARTED|Overall Study||52
2380607|NCT01459913|5842262|P1|STARTED|Overall Study||106
2380608|NCT01459796|5842293|P2|NOT COMPLETED|Overall Study||126
2380609|NCT01459796|5842294|P1|NOT COMPLETED|Overall Study||94
2380610|NCT01459796|5842293|P2|COMPLETED|Overall Study||0
2380611|NCT01459796|5842294|P1|COMPLETED|Overall Study||0
2380612|NCT01459796|5842293|P2|STARTED|Overall Study||126
2380613|NCT01459796|5842294|P1|STARTED|Overall Study||94
2380614|NCT01459783|5842312|P2|NOT COMPLETED|6 Months to 12 Months||30
2380615|NCT01459783|5842313|P1|NOT COMPLETED|6 Months to 12 Months||19
2380616|NCT01459783|5842312|P2|COMPLETED|6 Months to 12 Months||23
2380617|NCT01459783|5842313|P1|COMPLETED|6 Months to 12 Months||20
2380618|NCT01459783|5842312|P2|STARTED|6 Months to 12 Months||53
2380619|NCT01459783|5842313|P1|STARTED|6 Months to 12 Months||39
2380620|NCT01459783|5842312|P2|NOT COMPLETED|Baseline to 6 Months||20
2380621|NCT01459783|5842313|P1|NOT COMPLETED|Baseline to 6 Months||32
2380622|NCT01459783|5842312|P2|COMPLETED|Baseline to 6 Months||53
2380623|NCT01459783|5842313|P1|COMPLETED|Baseline to 6 Months||39
2380624|NCT01459783|5842312|P2|STARTED|Baseline to 6 Months||73
2380625|NCT01459783|5842313|P1|STARTED|Baseline to 6 Months||71
2380626|NCT01459718|5842321|P1|NOT COMPLETED|Overall Study||3
2380627|NCT01459718|5842321|P1|COMPLETED|Overall Study||10
2380628|NCT01459718|5842321|P1|Safety Analysis Set|Overall Study||13
2380629|NCT01459718|5842321|P1|STARTED|Overall Study||13
2380630|NCT01459705|5842335|P3|NOT COMPLETED|Overall Study||7
2380631|NCT01459705|5842336|P2|NOT COMPLETED|Overall Study||24
2380632|NCT01459705|5842337|P1|NOT COMPLETED|Overall Study||22
2380633|NCT01459705|5842335|P3|COMPLETED|Overall Study||47
2380634|NCT01459705|5842336|P2|COMPLETED|Overall Study||30
2380635|NCT01459705|5842337|P1|COMPLETED|Overall Study||32
2380636|NCT01459705|5842335|P3|STARTED|Overall Study||54
2380637|NCT01459705|5842336|P2|STARTED|Overall Study||54
2380638|NCT01459705|5842337|P1|STARTED|Overall Study||54
2380639|NCT01459653|5842355|P1|NOT COMPLETED|Overall Study||668
2380640|NCT01459653|5842355|P1|COMPLETED|Overall Study||828
2380641|NCT01459653|5842355|P1|STARTED|Overall Study||1496
2380642|NCT01459614|5842503|P2|NOT COMPLETED|Overall Study||0
2380643|NCT01459614|5842504|P1|NOT COMPLETED|Overall Study||1
2380644|NCT01459614|5842503|P2|COMPLETED|Overall Study||10
2380645|NCT01459614|5842504|P1|COMPLETED|Overall Study||28
2380646|NCT01459614|5842503|P2|STARTED|Overall Study||10
2380647|NCT01459614|5842504|P1|STARTED|Overall Study||29
2380648|NCT01459588|5842514|P4|NOT COMPLETED|Overall Study||1
2380649|NCT01459588|5842515|P3|NOT COMPLETED|Overall Study||1
2380650|NCT01459588|5842516|P2|NOT COMPLETED|Overall Study||2
2380651|NCT01459588|5842517|P1|NOT COMPLETED|Overall Study||1
2380652|NCT01459588|5842514|P4|COMPLETED|Overall Study||55
2380653|NCT01459588|5842515|P3|COMPLETED|Overall Study||102
2380654|NCT01459588|5842516|P2|COMPLETED|Overall Study||49
2380655|NCT01459588|5842517|P1|COMPLETED|Overall Study||104
2380656|NCT01459588|5842514|P4|STARTED|Overall Study||56
2380657|NCT01459588|5842515|P3|STARTED|Overall Study||103
2380658|NCT01459588|5842516|P2|STARTED|Overall Study||51
2380659|NCT01459588|5842517|P1|STARTED|Overall Study||105
2380660|NCT01459068|5842545|P2|NOT COMPLETED|Overall Study||34
2380661|NCT01459068|5842546|P1|NOT COMPLETED|Overall Study||39
2380662|NCT01459068|5842545|P2|COMPLETED|Overall Study||148
2380663|NCT01459068|5842546|P1|COMPLETED|Overall Study||126
2380664|NCT01459068|5842545|P2|STARTED|Overall Study||182
2380665|NCT01459068|5842546|P1|STARTED|Overall Study||165
2380666|NCT01459016|5842562|P1|NOT COMPLETED|Overall Study||15
2380667|NCT01459016|5842562|P1|COMPLETED|Overall Study||41
2380668|NCT01459016|5842562|P1|STARTED|Overall Study||56
2380669|NCT01458990|5842578|P2|NOT COMPLETED|Overall Study||0
2380670|NCT01458990|5842579|P1|NOT COMPLETED|Overall Study||0
2380671|NCT01458990|5842578|P2|COMPLETED|Overall Study||15
2380672|NCT01458990|5842579|P1|COMPLETED|Overall Study||45
2380673|NCT01458990|5842578|P2|STARTED|Overall Study||15
2380674|NCT01458990|5842579|P1|STARTED|Overall Study||45
2380675|NCT01458951|5842590|P3|NOT COMPLETED|Overall Study||15
2380676|NCT01458951|5842591|P2|NOT COMPLETED|Overall Study||1
2380677|NCT01458951|5842592|P1|NOT COMPLETED|Overall Study||32
2380678|NCT01458951|5842590|P3|COMPLETED|Overall Study||97
2380679|NCT01458951|5842591|P2|COMPLETED|Overall Study||5
2380680|NCT01458951|5842592|P1|COMPLETED|Overall Study||397
2380681|NCT01458951|5842590|P3|STARTED|Overall Study||112
2380682|NCT01458951|5842591|P2|STARTED|Overall Study||6
2380683|NCT01458951|5842592|P1|STARTED|Overall Study||429
2380684|NCT01458639|5842617|P1|NOT COMPLETED|Overall Study||6
2380685|NCT01458639|5842617|P1|COMPLETED|Overall Study||12
2380686|NCT01458639|5842617|P1|STARTED|Overall Study||18
2380687|NCT01458587|5842629|P2|NOT COMPLETED|Overall Study||0
2380688|NCT01458587|5842630|P1|NOT COMPLETED|Overall Study||1
2380689|NCT01458587|5842629|P2|COMPLETED|Overall Study||35
2380690|NCT01458587|5842630|P1|COMPLETED|Overall Study||34
2380691|NCT01458587|5842629|P2|STARTED|Overall Study||35
2380692|NCT01458587|5842630|P1|STARTED|Overall Study||35
2380693|NCT01458574|5842793|P3|NOT COMPLETED|Overall Study||145
2380694|NCT01458574|5842794|P2|NOT COMPLETED|Overall Study||71
2380695|NCT01458574|5842795|P1|NOT COMPLETED|Overall Study||87
2380696|NCT01458574|5842793|P3|COMPLETED|Overall Study||53
2380697|NCT01458574|5842794|P2|COMPLETED|Overall Study||126
2380698|NCT01458574|5842795|P1|COMPLETED|Overall Study||111
2380699|NCT01458574|5842793|P3|Treated|Overall Study||198
2380700|NCT01458574|5842794|P2|Treated|Overall Study||196
2380701|NCT01458574|5842795|P1|Treated|Overall Study||198
2380702|NCT01458574|5842793|P3|STARTED|Overall Study||198
2380703|NCT01458574|5842794|P2|STARTED|Overall Study||197
2380704|NCT01458574|5842795|P1|STARTED|Overall Study||198
2380705|NCT01458561|5842880|P2|NOT COMPLETED|Overall Study||0
2380706|NCT01458561|5842881|P1|NOT COMPLETED|Overall Study||0
2380707|NCT01458561|5842880|P2|COMPLETED|Overall Study||1
2380708|NCT01458561|5842881|P1|COMPLETED|Overall Study||0
2380709|NCT01458561|5842880|P2|STARTED|Overall Study||1
2380710|NCT01458561|5842881|P1|STARTED|Overall Study||0
2380711|NCT01458535|5842925|P6|NOT COMPLETED|Overall Study||4
2380712|NCT01458535|5842926|P5|NOT COMPLETED|Overall Study||4
2380713|NCT01458535|5842927|P4|NOT COMPLETED|Overall Study||4
2380714|NCT01458535|5842928|P3|NOT COMPLETED|Overall Study||2
2380715|NCT01458535|5842929|P2|NOT COMPLETED|Overall Study||2
2380716|NCT01458535|5842930|P1|NOT COMPLETED|Overall Study||0
2380717|NCT01458535|5842925|P6|COMPLETED|Overall Study||7
2380718|NCT01458535|5842926|P5|COMPLETED|Overall Study||6
2380719|NCT01458535|5842927|P4|COMPLETED|Overall Study||6
2380720|NCT01458535|5842928|P3|COMPLETED|Overall Study||8
2380721|NCT01458535|5842929|P2|COMPLETED|Overall Study||8
2380722|NCT01458535|5842930|P1|COMPLETED|Overall Study||10
2380723|NCT01458535|5842925|P6|STARTED|Overall Study||11
2380724|NCT01458535|5842926|P5|STARTED|Overall Study||10
2380725|NCT01458535|5842927|P4|STARTED|Overall Study||10
2380726|NCT01458535|5842928|P3|STARTED|Overall Study||10
2380727|NCT01458535|5842929|P2|STARTED|Overall Study||10
2380728|NCT01458535|5842930|P1|STARTED|Overall Study||10
2380729|NCT01458522|5842982|P2|NOT COMPLETED|Overall Study||11
2380730|NCT01458522|5842983|P1|NOT COMPLETED|Overall Study||3
2380731|NCT01458522|5842982|P2|COMPLETED|Overall Study||26
2380732|NCT01458522|5842983|P1|COMPLETED|Overall Study||34
2380733|NCT01458522|5842982|P2|Crossover to Second Drug|Overall Study||10
2380734|NCT01458522|5842983|P1|Crossover to Second Drug|Overall Study||15
2380735|NCT01458522|5842982|P2|Received First Drug|Overall Study||35
2380736|NCT01458522|5842983|P1|Received First Drug|Overall Study||35
2380737|NCT01458522|5842982|P2|STARTED|Overall Study||37
2380738|NCT01458522|5842983|P1|STARTED|Overall Study||37
2380739|NCT01458392|5843012|P3|NOT COMPLETED|Overall Study||31
2380740|NCT01458392|5843013|P2|NOT COMPLETED|Overall Study||13
2380741|NCT01458392|5843014|P1|NOT COMPLETED|Overall Study||2
2380742|NCT01458392|5843012|P3|COMPLETED|Overall Study||0
2380743|NCT01458392|5843013|P2|COMPLETED|Overall Study||0
2380744|NCT01458392|5843014|P1|COMPLETED|Overall Study||0
2380745|NCT01458392|5843012|P3|STARTED|Overall Study||31
2380746|NCT01458392|5843013|P2|STARTED|Overall Study||13
2380747|NCT01458392|5843014|P1|STARTED|Overall Study||2
2380748|NCT01458288|5843034|P1|NOT COMPLETED|Overall Study||0
2380749|NCT01458288|5843034|P1|COMPLETED|Overall Study||12
2380750|NCT01458288|5843034|P1|STARTED|Overall Study||12
2380751|NCT01458275|5843046|P3|NOT COMPLETED|Overall Study||9
2380752|NCT01458275|5843047|P2|NOT COMPLETED|Overall Study||13
2380753|NCT01458275|5843048|P1|NOT COMPLETED|Overall Study||14
2380754|NCT01458275|5843046|P3|COMPLETED|Overall Study||273
2380755|NCT01458275|5843047|P2|COMPLETED|Overall Study||269
2380756|NCT01458275|5843048|P1|COMPLETED|Overall Study||269
2380757|NCT01458275|5843046|P3|STARTED|Overall Study||282
2380758|NCT01458275|5843047|P2|STARTED|Overall Study||282
2380759|NCT01458275|5843048|P1|STARTED|Overall Study||283
2380760|NCT01458249|5843090|P1|NOT COMPLETED|Overall Study||8
2380761|NCT01458249|5843090|P1|COMPLETED|Overall Study||44
2380762|NCT01458249|5843090|P1|Participants Treated|Overall Study||51
2380763|NCT01458249|5843090|P1|STARTED|Overall Study||52
2380764|NCT01458210|5843109|P1|NOT COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||3
2380765|NCT01458210|5843109|P1|COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||15
2380766|NCT01458210|5843109|P1|STARTED|Ortho-Cyclen + Dulaglutide (Period 2)|1 participant received Ortho-Cyclen, discontinued due to Adverse Event before receiving Dulaglutide.|18
2380767|NCT01458210|5843109|P1|NOT COMPLETED|Ortho-Cyclen Alone (Period 1)||4
2380768|NCT01458210|5843109|P1|COMPLETED|Ortho-Cyclen Alone (Period 1)||18
2380769|NCT01458210|5843109|P1|STARTED|Ortho-Cyclen Alone (Period 1)||22
2380770|NCT01458210|5843109|P1|NOT COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||0
2380771|NCT01458210|5843109|P1|COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||22
2380772|NCT01458210|5843109|P1|Received at Least One Dose of Study Drug|Lead-in (1st Course of Ortho-Cyclen)||22
2380773|NCT01458210|5843109|P1|STARTED|Lead-in (1st Course of Ortho-Cyclen)||22
2380774|NCT01458171|5843126|P1|NOT COMPLETED|Overall Study||1
2380775|NCT01458171|5843126|P1|COMPLETED|Overall Study||22
2380776|NCT01458171|5843126|P1|STARTED|Overall Study||23
2380777|NCT01458132|5843149|P2|NOT COMPLETED|Overall Study||3
2380778|NCT01458132|5843150|P1|NOT COMPLETED|Overall Study||15
2380779|NCT01458132|5843149|P2|COMPLETED|Overall Study||1
2380780|NCT01458132|5843150|P1|COMPLETED|Overall Study||0
2380781|NCT01458132|5843149|P2|STARTED|Overall Study||4
2380782|NCT01458132|5843150|P1|STARTED|Overall Study||15
2380783|NCT01458119|5843158|P1|NOT COMPLETED|Overall Study||20
2380784|NCT01458119|5843158|P1|COMPLETED|Overall Study||65
2380785|NCT01458119|5843158|P1|ITT-Amenable Population|Overall Study||68
2380786|NCT01458119|5843158|P1|Intent to Treat (ITT) Population|Overall Study||85
2380787|NCT01458119|5843158|P1|Safety Population|Overall Study||85
2380788|NCT01458119|5843158|P1|Received at Least 1 Dose of Study Drug|Overall Study||85
2380789|NCT01458119|5843158|P1|STARTED|Overall Study||85
2380790|NCT01458106|5843165|P2|NOT COMPLETED|Overall Study||1
2380791|NCT01458106|5843166|P1|NOT COMPLETED|Overall Study||3
2380792|NCT01458106|5843165|P2|COMPLETED|Overall Study||34
2380793|NCT01458106|5843166|P1|COMPLETED|Overall Study||33
2380794|NCT01458106|5843165|P2|Non-PK Subgroup|Overall Study||0
2380795|NCT01458106|5843166|P1|Non-PK Subgroup|Overall Study||11
2380796|NCT01458106|5843165|P2|PK Subgroup|Overall Study||35
2380797|NCT01458106|5843166|P1|PK Subgroup|Overall Study||25
2380798|NCT01458106|5843165|P2|STARTED|Overall Study||35
2380799|NCT01458106|5843166|P1|STARTED|Overall Study||36
2380800|NCT01457950|5843243|P4|NOT COMPLETED|Open-Label Phase||2
2380801|NCT01457950|5843244|P3|NOT COMPLETED|Open-Label Phase||2
2380802|NCT01457950|5843245|P2|NOT COMPLETED|Open-Label Phase||0
2380803|NCT01457950|5843246|P1|NOT COMPLETED|Open-Label Phase||0
2380804|NCT01457950|5843243|P4|COMPLETED|Open-Label Phase||61
2380805|NCT01457950|5843244|P3|COMPLETED|Open-Label Phase||58
2380806|NCT01457950|5843245|P2|COMPLETED|Open-Label Phase||0
2380807|NCT01457950|5843246|P1|COMPLETED|Open-Label Phase||0
2380808|NCT01457950|5843243|P4|STARTED|Open-Label Phase||63
2380809|NCT01457950|5843244|P3|STARTED|Open-Label Phase||60
2380810|NCT01457950|5843245|P2|STARTED|Open-Label Phase||0
2380811|NCT01457950|5843246|P1|STARTED|Open-Label Phase||0
2380812|NCT01457950|5843243|P4|NOT COMPLETED|Double-Blind Phase||0
2380813|NCT01457950|5843244|P3|NOT COMPLETED|Double-Blind Phase||0
2380814|NCT01457950|5843245|P2|NOT COMPLETED|Double-Blind Phase||3
2380815|NCT01457950|5843246|P1|NOT COMPLETED|Double-Blind Phase||9
2380816|NCT01457950|5843243|P4|COMPLETED|Double-Blind Phase||0
2380817|NCT01457950|5843244|P3|COMPLETED|Double-Blind Phase||0
2380818|NCT01457950|5843245|P2|COMPLETED|Double-Blind Phase|“Completed” refers to par. that did not have a withdraw reason at the 6 month visit.|63
2380819|NCT01457950|5843246|P1|COMPLETED|Double-Blind Phase|“Completed” refers to par. that did not have a withdraw reason at the 6 month visit.|60
2380820|NCT01457950|5843243|P4|Completed the 6 Month Assessment|Double-Blind Phase||0
2380821|NCT01457950|5843244|P3|Completed the 6 Month Assessment|Double-Blind Phase||0
2380822|NCT01457950|5843245|P2|Completed the 6 Month Assessment|Double-Blind Phase|“Completed 6 month assessment” refers to par. that completed at least one 6 month assessment.|64
2380823|NCT01457950|5843246|P1|Completed the 6 Month Assessment|Double-Blind Phase|“Completed 6 month assessment” refers to par. that completed at least one 6 month assessment.|62
2380824|NCT01457950|5843243|P4|STARTED|Double-Blind Phase||0
2380825|NCT01457950|5843244|P3|STARTED|Double-Blind Phase||0
2380826|NCT01457950|5843245|P2|STARTED|Double-Blind Phase||66
2380827|NCT01457950|5843246|P1|STARTED|Double-Blind Phase||69
2380828|NCT01457924|5843325|P5|NOT COMPLETED|Individualized FUP (Weeks 48+)||6
2380829|NCT01457924|5843326|P4|NOT COMPLETED|Individualized FUP (Weeks 48+)||5
2380830|NCT01457924|5843327|P3|NOT COMPLETED|Individualized FUP (Weeks 48+)||4
2380831|NCT01457924|5843328|P2|NOT COMPLETED|Individualized FUP (Weeks 48+)||4
2380832|NCT01457924|5843329|P1|NOT COMPLETED|Individualized FUP (Weeks 48+)||5
2380833|NCT01457924|5843325|P5|COMPLETED|Individualized FUP (Weeks 48+)||36
2380834|NCT01457924|5843326|P4|COMPLETED|Individualized FUP (Weeks 48+)||15
2380835|NCT01457924|5843327|P3|COMPLETED|Individualized FUP (Weeks 48+)||12
2380836|NCT01457924|5843328|P2|COMPLETED|Individualized FUP (Weeks 48+)||14
2380837|NCT01457924|5843329|P1|COMPLETED|Individualized FUP (Weeks 48+)||11
2380838|NCT01457924|5843325|P5|STARTED|Individualized FUP (Weeks 48+)||42
2380839|NCT01457924|5843326|P4|STARTED|Individualized FUP (Weeks 48+)||20
2380840|NCT01457924|5843327|P3|STARTED|Individualized FUP (Weeks 48+)||16
2380841|NCT01457924|5843328|P2|STARTED|Individualized FUP (Weeks 48+)||18
2380842|NCT01457924|5843329|P1|STARTED|Individualized FUP (Weeks 48+)||16
2380843|NCT01457924|5843325|P5|NOT COMPLETED|FUP (Weeks 24-48)||2
2380844|NCT01457924|5843326|P4|NOT COMPLETED|FUP (Weeks 24-48)||1
2380845|NCT01457924|5843327|P3|NOT COMPLETED|FUP (Weeks 24-48)||2
2380846|NCT01457924|5843328|P2|NOT COMPLETED|FUP (Weeks 24-48)||1
2380847|NCT01457924|5843329|P1|NOT COMPLETED|FUP (Weeks 24-48)||3
2380848|NCT01457924|5843325|P5|COMPLETED|FUP (Weeks 24-48)||57
2380849|NCT01457924|5843326|P4|COMPLETED|FUP (Weeks 24-48)||32
2380850|NCT01457924|5843327|P3|COMPLETED|FUP (Weeks 24-48)||30
2380851|NCT01457924|5843328|P2|COMPLETED|FUP (Weeks 24-48)||30
2380852|NCT01457924|5843329|P1|COMPLETED|FUP (Weeks 24-48)||63
2380853|NCT01457924|5843325|P5|STARTED|FUP (Weeks 24-48)||59
2380854|NCT01457924|5843326|P4|STARTED|FUP (Weeks 24-48)||33
2380855|NCT01457924|5843327|P3|STARTED|FUP (Weeks 24-48)||32
2380856|NCT01457924|5843328|P2|STARTED|FUP (Weeks 24-48)||31
2380857|NCT01457924|5843329|P1|STARTED|FUP (Weeks 24-48)||66
2380858|NCT01457924|5843325|P5|NOT COMPLETED|Treatment Phase (Weeks 0-24)||6
2380859|NCT01457924|5843326|P4|NOT COMPLETED|Treatment Phase (Weeks 0-24)||1
2380860|NCT01457924|5843327|P3|NOT COMPLETED|Treatment Phase (Weeks 0-24)||2
2380861|NCT01457924|5843328|P2|NOT COMPLETED|Treatment Phase (Weeks 0-24)||5
2380862|NCT01457924|5843329|P1|NOT COMPLETED|Treatment Phase (Weeks 0-24)||3
2380863|NCT01457924|5843325|P5|COMPLETED|Treatment Phase (Weeks 0-24)||58
2380864|NCT01457924|5843326|P4|COMPLETED|Treatment Phase (Weeks 0-24)||33
2380865|NCT01457924|5843327|P3|COMPLETED|Treatment Phase (Weeks 0-24)||30
2380866|NCT01457924|5843328|P2|COMPLETED|Treatment Phase (Weeks 0-24)||29
2380867|NCT01457924|5843329|P1|COMPLETED|Treatment Phase (Weeks 0-24)||64
2380868|NCT01457924|5843325|P5|Completed to Week 12|Treatment Phase (Weeks 0-24)||60
2380869|NCT01457924|5843326|P4|Completed to Week 12|Treatment Phase (Weeks 0-24)||33
2380870|NCT01457924|5843327|P3|Completed to Week 12|Treatment Phase (Weeks 0-24)||30
2380871|NCT01457924|5843328|P2|Completed to Week 12|Treatment Phase (Weeks 0-24)||31
2380872|NCT01457924|5843329|P1|Completed to Week 12|Treatment Phase (Weeks 0-24)||65
2380873|NCT01457924|5843325|P5|STARTED|Treatment Phase (Weeks 0-24)||64
2380874|NCT01457924|5843326|P4|STARTED|Treatment Phase (Weeks 0-24)||34
2380875|NCT01457924|5843327|P3|STARTED|Treatment Phase (Weeks 0-24)||32
2380876|NCT01457924|5843328|P2|STARTED|Treatment Phase (Weeks 0-24)||34
2380877|NCT01457924|5843329|P1|STARTED|Treatment Phase (Weeks 0-24)||67
2380878|NCT01457885|5843391|P1|NOT COMPLETED|Overall Study||0
2380879|NCT01457885|5843391|P1|COMPLETED|Overall Study||74
2380880|NCT01457885|5843391|P1|STARTED|Overall Study||74
2380881|NCT01457846|5843399|P2|NOT COMPLETED|Overall Study||30
2380882|NCT01457846|5843400|P1|NOT COMPLETED|Overall Study||41
2380883|NCT01457846|5843399|P2|COMPLETED|Overall Study||0
2380884|NCT01457846|5843400|P1|COMPLETED|Overall Study||0
2380885|NCT01457846|5843399|P2|Ongoing Treatment at Data Cut-off|Overall Study||1
2380886|NCT01457846|5843400|P1|Ongoing Treatment at Data Cut-off|Overall Study||1
2380887|NCT01457846|5843399|P2|Did Not Receive Treatment|Overall Study||3
2380888|NCT01457846|5843400|P1|Did Not Receive Treatment|Overall Study||1
2380889|NCT01457846|5843399|P2|Received Treatment|Overall Study||27
2380890|NCT01457846|5843400|P1|Received Treatment|Overall Study||40
2380891|NCT01457846|5843399|P2|STARTED|Overall Study||30
2380892|NCT01457846|5843400|P1|STARTED|Overall Study||41
2380893|NCT01457703|5843416|P2|NOT COMPLETED|Overall Study||11
2380894|NCT01457703|5843417|P1|NOT COMPLETED|Overall Study||6
2380895|NCT01457703|5843416|P2|COMPLETED|Overall Study||22
2380896|NCT01457703|5843417|P1|COMPLETED|Overall Study||23
2380897|NCT01457703|5843416|P2|STARTED|Overall Study||33
2380898|NCT01457703|5843417|P1|STARTED|Overall Study||29
2380899|NCT01457573|5843431|P1|NOT COMPLETED|Overall Study||0
2380900|NCT01457573|5843431|P1|COMPLETED|Overall Study||10
2380901|NCT01457573|5843431|P1|STARTED|Overall Study||10
2380902|NCT01457521|5843447|P2|NOT COMPLETED|Overall Study||10
2380903|NCT01457521|5843448|P1|NOT COMPLETED|Overall Study||12
2380904|NCT01457521|5843447|P2|COMPLETED|Overall Study||117
2380905|NCT01457521|5843448|P1|COMPLETED|Overall Study||111
2380906|NCT01457521|5843447|P2|STARTED|Overall Study||127
2380907|NCT01457521|5843448|P1|STARTED|Overall Study||123
2380908|NCT01457430|5843454|P1|NOT COMPLETED|Overall Study||0
2380909|NCT01457430|5843454|P1|COMPLETED|Overall Study||19
2380910|NCT01457430|5843454|P1|STARTED|Overall Study||19
2380911|NCT01457417|5843466|P5|NOT COMPLETED|Overall Study||0
2380912|NCT01457417|5843467|P4|NOT COMPLETED|Overall Study||0
2380913|NCT01457417|5843468|P3|NOT COMPLETED|Overall Study||0
2380914|NCT01457417|5843469|P2|NOT COMPLETED|Overall Study||0
2380915|NCT01457417|5843470|P1|NOT COMPLETED|Overall Study||0
2380916|NCT01457417|5843466|P5|COMPLETED|Overall Study||19
2380917|NCT01457417|5843467|P4|COMPLETED|Overall Study||3
2380918|NCT01457417|5843468|P3|COMPLETED|Overall Study||4
2380919|NCT01457417|5843469|P2|COMPLETED|Overall Study||3
2380920|NCT01457417|5843470|P1|COMPLETED|Overall Study||3
2380921|NCT01457417|5843466|P5|STARTED|Overall Study||19
2380922|NCT01457417|5843467|P4|STARTED|Overall Study||3
2380923|NCT01457417|5843468|P3|STARTED|Overall Study||4
2380924|NCT01457417|5843469|P2|STARTED|Overall Study||3
2380925|NCT01457417|5843470|P1|STARTED|Overall Study||3
2380926|NCT01457352|5843528|P2|NOT COMPLETED|Period 3||5
2380927|NCT01457352|5843529|P1|NOT COMPLETED|Period 3||1
2380928|NCT01457352|5843528|P2|COMPLETED|Period 3||144
2380929|NCT01457352|5843529|P1|COMPLETED|Period 3||146
2380930|NCT01457352|5843528|P2|Randomization|Period 3||149
2380931|NCT01457352|5843529|P1|Randomization|Period 3||147
2380932|NCT01457352|5843528|P2|STARTED|Period 3||149
2380933|NCT01457352|5843529|P1|STARTED|Period 3||147
2380934|NCT01457352|5843528|P2|NOT COMPLETED|Period 2||0
2380935|NCT01457352|5843529|P1|NOT COMPLETED|Period 2||80
2380936|NCT01457352|5843528|P2|COMPLETED|Period 2||0
2380937|NCT01457352|5843529|P1|COMPLETED|Period 2||296
2380938|NCT01457352|5843528|P2|STARTED|Period 2||0
2380939|NCT01457352|5843529|P1|STARTED|Period 2||376
2380940|NCT01457352|5843528|P2|NOT COMPLETED|Period 1||0
2380941|NCT01457352|5843529|P1|NOT COMPLETED|Period 1||16
2380942|NCT01457352|5843528|P2|COMPLETED|Period 1||0
2380943|NCT01457352|5843529|P1|COMPLETED|Period 1||376
2380944|NCT01457352|5843528|P2|STARTED|Period 1||0
2380945|NCT01457352|5843529|P1|STARTED|Period 1||392
2380946|NCT01457339|5843541|P2|NOT COMPLETED|Period 6 (250 mg)||1
2380947|NCT01457339|5843542|P1|NOT COMPLETED|Period 6 (250 mg)||1
2380948|NCT01457339|5843541|P2|COMPLETED|Period 6 (250 mg)||21
2380949|NCT01457339|5843542|P1|COMPLETED|Period 6 (250 mg)||6
2380950|NCT01457339|5843541|P2|STARTED|Period 6 (250 mg)||22
2380951|NCT01457339|5843542|P1|STARTED|Period 6 (250 mg)||7
2380952|NCT01457339|5843541|P2|NOT COMPLETED|Period 5 (200 mg)||1
2380953|NCT01457339|5843542|P1|NOT COMPLETED|Period 5 (200 mg)||0
2380954|NCT01457339|5843541|P2|COMPLETED|Period 5 (200 mg)||22
2380955|NCT01457339|5843542|P1|COMPLETED|Period 5 (200 mg)||7
2380956|NCT01457339|5843541|P2|STARTED|Period 5 (200 mg)||23
2380957|NCT01457339|5843542|P1|STARTED|Period 5 (200 mg)||7
2380958|NCT01457339|5843541|P2|NOT COMPLETED|Period 4 (150 mg)||0
2380959|NCT01457339|5843542|P1|NOT COMPLETED|Period 4 (150 mg)||0
2380960|NCT01457339|5843541|P2|COMPLETED|Period 4 (150 mg)||23
2380961|NCT01457339|5843542|P1|COMPLETED|Period 4 (150 mg)||7
2380962|NCT01457339|5843541|P2|STARTED|Period 4 (150 mg)||23
2380963|NCT01457339|5843542|P1|STARTED|Period 4 (150 mg)||7
2380964|NCT01457339|5843541|P2|NOT COMPLETED|Period 3 (100 mg)||1
2380965|NCT01457339|5843542|P1|NOT COMPLETED|Period 3 (100 mg)||0
2380966|NCT01457339|5843541|P2|COMPLETED|Period 3 (100 mg)||23
2380967|NCT01457339|5843542|P1|COMPLETED|Period 3 (100 mg)||7
2380968|NCT01457339|5843541|P2|STARTED|Period 3 (100 mg)||24
2380969|NCT01457339|5843542|P1|STARTED|Period 3 (100 mg)||7
2380970|NCT01457339|5843541|P2|NOT COMPLETED|Period 2 (70 mg)||0
2380971|NCT01457339|5843542|P1|NOT COMPLETED|Period 2 (70 mg)||0
2380972|NCT01457339|5843541|P2|COMPLETED|Period 2 (70 mg)||24
2380973|NCT01457339|5843542|P1|COMPLETED|Period 2 (70 mg)||7
2380974|NCT01457339|5843541|P2|STARTED|Period 2 (70 mg)||24
2380975|NCT01457339|5843542|P1|STARTED|Period 2 (70 mg)||7
2380976|NCT01457339|5843541|P2|NOT COMPLETED|Period 1 (50 mg)||0
2380977|NCT01457339|5843542|P1|NOT COMPLETED|Period 1 (50 mg)||0
2380978|NCT01457339|5843541|P2|COMPLETED|Period 1 (50 mg)||24
2380979|NCT01457339|5843542|P1|COMPLETED|Period 1 (50 mg)||7
2380980|NCT01457339|5843541|P2|STARTED|Period 1 (50 mg)||24
2380981|NCT01457339|5843542|P1|STARTED|Period 1 (50 mg)||7
2380982|NCT01457196|5843708|P1|NOT COMPLETED|Overall Study||0
2380983|NCT01457196|5843708|P1|COMPLETED|Overall Study||2074
2380984|NCT01457196|5843708|P1|STARTED|Overall Study||2074
2380985|NCT01457053|5843714|P2|NOT COMPLETED|Overall Study||1
2380986|NCT01457053|5843715|P1|NOT COMPLETED|Overall Study||1
2380987|NCT01457053|5843714|P2|COMPLETED|Overall Study||1
2380988|NCT01457053|5843715|P1|COMPLETED|Overall Study||1
2380989|NCT01457053|5843714|P2|STARTED|Overall Study||2
2380990|NCT01457053|5843715|P1|STARTED|Overall Study||2
2380991|NCT01457014|5843721|P4|NOT COMPLETED|Fourth Night||0
2380992|NCT01457014|5843722|P3|NOT COMPLETED|Fourth Night||0
2380993|NCT01457014|5843723|P2|NOT COMPLETED|Fourth Night||0
2380994|NCT01457014|5843724|P1|NOT COMPLETED|Fourth Night||0
2380995|NCT01457014|5843721|P4|COMPLETED|Fourth Night||11
2380996|NCT01457014|5843722|P3|COMPLETED|Fourth Night||12
2380997|NCT01457014|5843723|P2|COMPLETED|Fourth Night||11
2380998|NCT01457014|5843724|P1|COMPLETED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
2380999|NCT01457014|5843721|P4|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
2381000|NCT01457014|5843722|P3|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
2381001|NCT01457014|5843723|P2|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
2381002|NCT01457014|5843724|P1|STARTED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
2381003|NCT01457014|5843721|P4|NOT COMPLETED|Third Night||0
2381004|NCT01457014|5843722|P3|NOT COMPLETED|Third Night||0
2381005|NCT01457014|5843723|P2|NOT COMPLETED|Third Night||0
2381006|NCT01457014|5843724|P1|NOT COMPLETED|Third Night||0
2381007|NCT01457014|5843721|P4|COMPLETED|Third Night||12
2381008|NCT01457014|5843722|P3|COMPLETED|Third Night||11
2381009|NCT01457014|5843723|P2|COMPLETED|Third Night||11
2381010|NCT01457014|5843724|P1|COMPLETED|Third Night|The Diagnostic PSG was only completed on the First night|0
2381011|NCT01457014|5843721|P4|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
2381012|NCT01457014|5843722|P3|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
2381013|NCT01457014|5843723|P2|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
2381014|NCT01457014|5843724|P1|STARTED|Third Night|The Diagnostic PSG was only completed on the First night|0
2381015|NCT01457014|5843721|P4|NOT COMPLETED|Second Night||0
2381016|NCT01457014|5843722|P3|NOT COMPLETED|Second Night||0
2381017|NCT01457014|5843723|P2|NOT COMPLETED|Second Night||0
2381018|NCT01457014|5843724|P1|NOT COMPLETED|Second Night||0
2381019|NCT01457014|5843721|P4|COMPLETED|Second Night||11
2381020|NCT01457014|5843722|P3|COMPLETED|Second Night||11
2381021|NCT01457014|5843723|P2|COMPLETED|Second Night||12
2381022|NCT01457014|5843724|P1|COMPLETED|Second Night|The Diagnostic PSG was only completed on the First night|0
2381023|NCT01457014|5843721|P4|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
2381024|NCT01457014|5843722|P3|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
2381025|NCT01457014|5843723|P2|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
2381026|NCT01457014|5843724|P1|STARTED|Second Night|The Diagnostic PSG was only completed on the First night|0
2381027|NCT01457014|5843721|P4|NOT COMPLETED|First Night||0
2381028|NCT01457014|5843722|P3|NOT COMPLETED|First Night||0
2381029|NCT01457014|5843723|P2|NOT COMPLETED|First Night||0
2381030|NCT01457014|5843724|P1|NOT COMPLETED|First Night||40
2381031|NCT01457014|5843721|P4|COMPLETED|First Night||0
2381032|NCT01457014|5843722|P3|COMPLETED|First Night||0
2381033|NCT01457014|5843723|P2|COMPLETED|First Night||0
2381034|NCT01457014|5843724|P1|COMPLETED|First Night||34
2381035|NCT01457014|5843721|P4|STARTED|First Night||0
2381036|NCT01457014|5843722|P3|STARTED|First Night||0
2381037|NCT01457014|5843723|P2|STARTED|First Night||0
2381038|NCT01457014|5843724|P1|STARTED|First Night||74
2381039|NCT01456962|5843741|P2|NOT COMPLETED|Overall Study||1
2381040|NCT01456962|5843742|P1|NOT COMPLETED|Overall Study||2
2381041|NCT01456962|5843741|P2|COMPLETED|Overall Study||19
2381042|NCT01456962|5843742|P1|COMPLETED|Overall Study||14
2381043|NCT01456962|5843741|P2|STARTED|Overall Study||20
2381044|NCT01456962|5843742|P1|STARTED|Overall Study||16
2381045|NCT01456949|5843748|P1|NOT COMPLETED|Study Cryoablation Procedure & Follow-up||62
2381046|NCT01456949|5843748|P1|COMPLETED|Study Cryoablation Procedure & Follow-up|5 subjects completed at least 36 months of follow-up but did not complete a 36 month follow-up visit|303
2381047|NCT01456949|5843748|P1|36-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|298
2381048|NCT01456949|5843748|P1|24-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|309
2381049|NCT01456949|5843748|P1|12-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|325
2381050|NCT01456949|5843748|P1|6-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|342
2381051|NCT01456949|5843748|P1|3-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of 354 subjects who were treated and met all I/E criteria (mITT group).|344
2381052|NCT01456949|5843748|P1|STARTED|Study Cryoablation Procedure & Follow-up||365
2381053|NCT01456949|5843748|P1|NOT COMPLETED|Enrollment||37
2381143|NCT01456052|5844051|P3|COMPLETED|Overall Study||19
2381054|NCT01456949|5843748|P1|COMPLETED|Enrollment|6 rollover subjects not included in final analysis. 359 treated; 354 treated & met all I/E criteria.|365
2381055|NCT01456949|5843748|P1|Modified Intent to Treat Group (mITT)|Enrollment||354
2381056|NCT01456949|5843748|P1|Treated|Enrollment||359
2381057|NCT01456949|5843748|P1|STARTED|Enrollment||402
2381058|NCT01456936|5843759|P4|NOT COMPLETED|Overall Study||483
2381059|NCT01456936|5843760|P3|NOT COMPLETED|Overall Study||481
2381060|NCT01456936|5843761|P2|NOT COMPLETED|Overall Study||448
2381061|NCT01456936|5843762|P1|NOT COMPLETED|Overall Study||439
2381062|NCT01456936|5843759|P4|COMPLETED|Overall Study||1552
2381063|NCT01456936|5843760|P3|COMPLETED|Overall Study||1557
2381064|NCT01456936|5843761|P2|COMPLETED|Overall Study||1586
2381065|NCT01456936|5843762|P1|COMPLETED|Overall Study||1598
2381066|NCT01456936|5843759|P4|Randomized and Treated|Overall Study||2014
2381067|NCT01456936|5843760|P3|Randomized and Treated|Overall Study||2022
2381068|NCT01456936|5843761|P2|Randomized and Treated|Overall Study||2006
2381069|NCT01456936|5843762|P1|Randomized and Treated|Overall Study||2016
2381070|NCT01456936|5843759|P4|STARTED|Overall Study||2035
2381071|NCT01456936|5843760|P3|STARTED|Overall Study||2038
2381072|NCT01456936|5843761|P2|STARTED|Overall Study||2034
2381073|NCT01456936|5843762|P1|STARTED|Overall Study||2037
2381074|NCT01456897|5843870|P2|NOT COMPLETED|Overall Study||57
2381075|NCT01456897|5843871|P1|NOT COMPLETED|Overall Study||75
2381076|NCT01456897|5843870|P2|COMPLETED|Overall Study||41
2381077|NCT01456897|5843871|P1|COMPLETED|Overall Study||109
2381078|NCT01456897|5843870|P2|STARTED|Overall Study||98
2381079|NCT01456897|5843871|P1|STARTED|Overall Study||184
2381080|NCT01456780|5843890|P3|NOT COMPLETED|Overall Study||0
2381081|NCT01456780|5843891|P2|NOT COMPLETED|Overall Study||3
2381082|NCT01456780|5843892|P1|NOT COMPLETED|Overall Study||3
2381083|NCT01456780|5843890|P3|COMPLETED|Overall Study||20
2381084|NCT01456780|5843891|P2|COMPLETED|Overall Study||17
2381085|NCT01456780|5843892|P1|COMPLETED|Overall Study||17
2381086|NCT01456780|5843890|P3|STARTED|Overall Study||20
2381087|NCT01456780|5843891|P2|STARTED|Overall Study||20
2381088|NCT01456780|5843892|P1|STARTED|Overall Study||20
2381089|NCT01456494|5843911|P2|NOT COMPLETED|Follow-Up Visit (Post 30-day Discharge)||6
2381090|NCT01456494|5843912|P1|NOT COMPLETED|Follow-Up Visit (Post 30-day Discharge)||5
2381091|NCT01456494|5843911|P2|COMPLETED|Follow-Up Visit (Post 30-day Discharge)||20
2381092|NCT01456494|5843912|P1|COMPLETED|Follow-Up Visit (Post 30-day Discharge)||19
2381093|NCT01456494|5843911|P2|STARTED|Follow-Up Visit (Post 30-day Discharge)||26
2381094|NCT01456494|5843912|P1|STARTED|Follow-Up Visit (Post 30-day Discharge)||24
2381095|NCT01456494|5843911|P2|NOT COMPLETED|Initial Inpatient Visit||0
2381096|NCT01456494|5843912|P1|NOT COMPLETED|Initial Inpatient Visit||0
2381097|NCT01456494|5843911|P2|COMPLETED|Initial Inpatient Visit||26
2381098|NCT01456494|5843912|P1|COMPLETED|Initial Inpatient Visit||24
2381099|NCT01456494|5843911|P2|STARTED|Initial Inpatient Visit||26
2381100|NCT01456494|5843912|P1|STARTED|Initial Inpatient Visit||24
2381101|NCT01456299|5843929|P3|NOT COMPLETED|Overall Study||1
2381102|NCT01456299|5843930|P2|NOT COMPLETED|Overall Study||1
2381103|NCT01456299|5843931|P1|NOT COMPLETED|Overall Study||0
2381104|NCT01456299|5843929|P3|COMPLETED|Overall Study||33
2381105|NCT01456299|5843930|P2|COMPLETED|Overall Study||33
2381106|NCT01456299|5843931|P1|COMPLETED|Overall Study||34
2381107|NCT01456299|5843929|P3|STARTED|Overall Study||34
2381108|NCT01456299|5843930|P2|STARTED|Overall Study||34
2381109|NCT01456299|5843931|P1|STARTED|Overall Study||34
2381110|NCT01456221|5843941|P2|NOT COMPLETED|Overall Study||57
2381111|NCT01456221|5843942|P1|NOT COMPLETED|Overall Study||64
2381112|NCT01456221|5843941|P2|COMPLETED|Overall Study||126
2381113|NCT01456221|5843942|P1|COMPLETED|Overall Study||119
2381114|NCT01456221|5843941|P2|STARTED|Overall Study||183
2381115|NCT01456221|5843942|P1|STARTED|Overall Study||183
2381116|NCT01456195|5843957|P3|NOT COMPLETED|Overall Study||14
2381117|NCT01456195|5843958|P2|NOT COMPLETED|Overall Study||10
2381118|NCT01456195|5843959|P1|NOT COMPLETED|Overall Study||11
2381119|NCT01456195|5843957|P3|COMPLETED|Overall Study||127
2381120|NCT01456195|5843958|P2|COMPLETED|Overall Study||127
2381121|NCT01456195|5843959|P1|COMPLETED|Overall Study||132
2381122|NCT01456195|5843957|P3|STARTED|Overall Study||141
2381123|NCT01456195|5843958|P2|STARTED|Overall Study||137
2381124|NCT01456195|5843959|P1|STARTED|Overall Study||143
2381125|NCT01456169|5843979|P3|NOT COMPLETED|Overall Study||12
2381126|NCT01456169|5843980|P2|NOT COMPLETED|Overall Study||5
2381127|NCT01456169|5843981|P1|NOT COMPLETED|Overall Study||10
2381128|NCT01456169|5843979|P3|COMPLETED|Overall Study||123
2381129|NCT01456169|5843980|P2|COMPLETED|Overall Study||122
2381130|NCT01456169|5843981|P1|COMPLETED|Overall Study||123
2381131|NCT01456169|5843979|P3|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|135
2381132|NCT01456169|5843980|P2|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|127
2381133|NCT01456169|5843981|P1|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|133
2381134|NCT01456143|5844032|P1|NOT COMPLETED|Overall Study||0
2381135|NCT01456143|5844032|P1|COMPLETED|Overall Study||33
2381136|NCT01456143|5844032|P1|STARTED|Overall Study||33
2381137|NCT01456130|5844041|P1|NOT COMPLETED|Overall Study||10
2381138|NCT01456130|5844041|P1|COMPLETED|Overall Study||57
2381139|NCT01456130|5844041|P1|STARTED|Overall Study||67
2381140|NCT01456052|5844051|P3|NOT COMPLETED|Overall Study||5
2381141|NCT01456052|5844052|P2|NOT COMPLETED|Overall Study||5
2381142|NCT01456052|5844053|P1|NOT COMPLETED|Overall Study||2
2381144|NCT01456052|5844052|P2|COMPLETED|Overall Study||20
2381145|NCT01456052|5844053|P1|COMPLETED|Overall Study||8
2381146|NCT01456052|5844051|P3|STARTED|Overall Study||24
2381147|NCT01456052|5844052|P2|STARTED|Overall Study|One subject did not receive any study drug. That subject is not included in the safety population.|25
2381148|NCT01456052|5844053|P1|STARTED|Overall Study||10
2381149|NCT01456039|5844073|P3|NOT COMPLETED|Phase 2 (Second Step)||33
2381150|NCT01456039|5844074|P2|NOT COMPLETED|Phase 2 (Second Step)||0
2381151|NCT01456039|5844075|P1|NOT COMPLETED|Phase 2 (Second Step)||0
2381152|NCT01456039|5844073|P3|COMPLETED|Phase 2 (Second Step)||7
2381153|NCT01456039|5844074|P2|COMPLETED|Phase 2 (Second Step)||0
2381154|NCT01456039|5844075|P1|COMPLETED|Phase 2 (Second Step)||0
2381155|NCT01456039|5844073|P3|STARTED|Phase 2 (Second Step)||40
2381156|NCT01456039|5844074|P2|STARTED|Phase 2 (Second Step)||0
2381157|NCT01456039|5844075|P1|STARTED|Phase 2 (Second Step)||0
2381158|NCT01456039|5844073|P3|NOT COMPLETED|Phase 1 (First Step)||0
2381159|NCT01456039|5844074|P2|NOT COMPLETED|Phase 1 (First Step)||7
2381160|NCT01456039|5844075|P1|NOT COMPLETED|Phase 1 (First Step)||2
2381161|NCT01456039|5844073|P3|COMPLETED|Phase 1 (First Step)||0
2381162|NCT01456039|5844074|P2|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
2381163|NCT01456039|5844075|P1|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
2381164|NCT01456039|5844073|P3|STARTED|Phase 1 (First Step)||0
2381165|NCT01456039|5844074|P2|STARTED|Phase 1 (First Step)||8
2381166|NCT01456039|5844075|P1|STARTED|Phase 1 (First Step)||3
2381167|NCT01456000|5844147|P2|NOT COMPLETED|Overall Study||3
2381168|NCT01456000|5844148|P1|NOT COMPLETED|Overall Study||8
2381169|NCT01456000|5844147|P2|COMPLETED|Overall Study||172
2381170|NCT01456000|5844148|P1|COMPLETED|Overall Study||170
2381171|NCT01456000|5844147|P2|STARTED|Overall Study||175
2381172|NCT01456000|5844148|P1|STARTED|Overall Study||178
2381173|NCT01455545|5844154|P2|NOT COMPLETED|Overall Study||0
2381174|NCT01455545|5844155|P1|NOT COMPLETED|Overall Study||0
2381175|NCT01455545|5844154|P2|COMPLETED|Overall Study||45
2381176|NCT01455545|5844155|P1|COMPLETED|Overall Study||55
2381177|NCT01455545|5844154|P2|STARTED|Overall Study||45
2381178|NCT01455545|5844155|P1|STARTED|Overall Study||55
2381179|NCT01455519|5844185|P2|NOT COMPLETED|Overall Study||5
2381180|NCT01455519|5844186|P1|NOT COMPLETED|Overall Study||4
2381181|NCT01455519|5844185|P2|COMPLETED|Overall Study||18
2381182|NCT01455519|5844186|P1|COMPLETED|Overall Study||8
2381183|NCT01455519|5844185|P2|STARTED|Overall Study||23
2381184|NCT01455519|5844186|P1|STARTED|Overall Study||12
2381185|NCT01455428|5844218|P2|NOT COMPLETED|Overall Study||18
2381186|NCT01455428|5844219|P1|NOT COMPLETED|Overall Study||14
2381187|NCT01455428|5844218|P2|COMPLETED|Overall Study||92
2381188|NCT01455428|5844219|P1|COMPLETED|Overall Study||98
2381189|NCT01455428|5844218|P2|Treated|Overall Study||109
2381190|NCT01455428|5844219|P1|Treated|Overall Study||111
2381191|NCT01455428|5844218|P2|STARTED|Overall Study||110
2381192|NCT01455428|5844219|P1|STARTED|Overall Study||112
2381193|NCT01455415|5844275|P2|NOT COMPLETED|Follow-up||2
2381194|NCT01455415|5844276|P1|NOT COMPLETED|Follow-up||3
2381195|NCT01455415|5844275|P2|COMPLETED|Follow-up||104
2381196|NCT01455415|5844276|P1|COMPLETED|Follow-up||111
2381197|NCT01455415|5844275|P2|STARTED|Follow-up||106
2381198|NCT01455415|5844276|P1|STARTED|Follow-up||114
2381199|NCT01455415|5844275|P2|NOT COMPLETED|Period 2||10
2381200|NCT01455415|5844276|P1|NOT COMPLETED|Period 2||13
2381201|NCT01455415|5844275|P2|COMPLETED|Period 2||106
2381202|NCT01455415|5844276|P1|COMPLETED|Period 2||114
2381203|NCT01455415|5844275|P2|STARTED|Period 2||116
2381204|NCT01455415|5844276|P1|STARTED|Period 2||127
2381205|NCT01455415|5844275|P2|NOT COMPLETED|Washout||7
2381206|NCT01455415|5844276|P1|NOT COMPLETED|Washout||8
2381207|NCT01455415|5844275|P2|COMPLETED|Washout||116
2381208|NCT01455415|5844276|P1|COMPLETED|Washout||127
2381209|NCT01455415|5844275|P2|STARTED|Washout||123
2381210|NCT01455415|5844276|P1|STARTED|Washout||135
2381211|NCT01455415|5844275|P2|NOT COMPLETED|Period 1||24
2381212|NCT01455415|5844276|P1|NOT COMPLETED|Period 1||19
2381213|NCT01455415|5844275|P2|COMPLETED|Period 1||123
2381214|NCT01455415|5844276|P1|COMPLETED|Period 1||135
2381215|NCT01455415|5844275|P2|STARTED|Period 1|Started=Treated|147
2381216|NCT01455415|5844276|P1|STARTED|Period 1|Started=Treated|154
2381217|NCT01455220|5844326|P1|NOT COMPLETED|Overall Study||30
2381218|NCT01455220|5844326|P1|COMPLETED|Overall Study||15
2381219|NCT01455220|5844326|P1|STARTED|Overall Study||45
2381220|NCT01455194|5844336|P4|NOT COMPLETED|Overall Study||28
2381221|NCT01455194|5844337|P3|NOT COMPLETED|Overall Study||30
2381222|NCT01455194|5844338|P2|NOT COMPLETED|Overall Study||31
2381223|NCT01455194|5844339|P1|NOT COMPLETED|Overall Study||153
2381224|NCT01455194|5844336|P4|COMPLETED|Overall Study||97
2381225|NCT01455194|5844337|P3|COMPLETED|Overall Study||92
2381226|NCT01455194|5844338|P2|COMPLETED|Overall Study||89
2381227|NCT01455194|5844339|P1|COMPLETED|Overall Study||0
2381228|NCT01455194|5844336|P4|STARTED|Overall Study||125
2381229|NCT01455194|5844337|P3|STARTED|Overall Study||122
2381230|NCT01455194|5844338|P2|STARTED|Overall Study||120
2381231|NCT01455194|5844339|P1|STARTED|Overall Study||153
2381232|NCT01455181|5844388|P1|NOT COMPLETED|Overall Study||0
2381233|NCT01455181|5844388|P1|COMPLETED|Overall Study||24
2381234|NCT01455181|5844388|P1|STARTED|Overall Study||24
2381235|NCT01455064|5844396|P1|NOT COMPLETED|Overall Study||1
2381236|NCT01455064|5844396|P1|COMPLETED|Overall Study||30
2381237|NCT01455064|5844396|P1|STARTED|Overall Study||31
2381238|NCT01455012|5844402|P2|NOT COMPLETED|Overall Study||4
2381239|NCT01455012|5844403|P1|NOT COMPLETED|Overall Study||11
2381240|NCT01455012|5844402|P2|COMPLETED|Overall Study||36
2381241|NCT01455012|5844403|P1|COMPLETED|Overall Study||30
2381242|NCT01455012|5844402|P2|STARTED|Overall Study||40
2381243|NCT01455012|5844403|P1|STARTED|Overall Study||41
2381244|NCT01454947|5844443|P8|NOT COMPLETED|Overall Study||5
2381245|NCT01454947|5844444|P7|NOT COMPLETED|Overall Study||1
2381246|NCT01454947|5844445|P6|NOT COMPLETED|Overall Study||3
2381247|NCT01454947|5844446|P5|NOT COMPLETED|Overall Study||1
2381248|NCT01454947|5844447|P4|NOT COMPLETED|Overall Study||1
2381249|NCT01454947|5844448|P3|NOT COMPLETED|Overall Study||3
2381250|NCT01454947|5844449|P2|NOT COMPLETED|Overall Study||4
2381251|NCT01454947|5844450|P1|NOT COMPLETED|Overall Study||3
2381252|NCT01454947|5844443|P8|COMPLETED|Overall Study||23
2381253|NCT01454947|5844444|P7|COMPLETED|Overall Study||26
2381254|NCT01454947|5844445|P6|COMPLETED|Overall Study||32
2381255|NCT01454947|5844446|P5|COMPLETED|Overall Study||33
2381256|NCT01454947|5844447|P4|COMPLETED|Overall Study||19
2381257|NCT01454947|5844448|P3|COMPLETED|Overall Study||32
2381258|NCT01454947|5844449|P2|COMPLETED|Overall Study||38
2381259|NCT01454947|5844450|P1|COMPLETED|Overall Study||24
2381260|NCT01454947|5844443|P8|STARTED|Overall Study||28
2381261|NCT01454947|5844444|P7|STARTED|Overall Study||27
2381262|NCT01454947|5844445|P6|STARTED|Overall Study||35
2381263|NCT01454947|5844446|P5|STARTED|Overall Study||34
2381264|NCT01454947|5844447|P4|STARTED|Overall Study||20
2381265|NCT01454947|5844448|P3|STARTED|Overall Study||35
2381266|NCT01454947|5844449|P2|STARTED|Overall Study||42
2381267|NCT01454947|5844450|P1|STARTED|Overall Study||27
2381268|NCT01454934|5844470|P2|NOT COMPLETED|Overall Study||270
2381269|NCT01454934|5844471|P1|NOT COMPLETED|Overall Study||270
2381270|NCT01454934|5844470|P2|COMPLETED|Overall Study||0
2381271|NCT01454934|5844471|P1|COMPLETED|Overall Study||0
2381272|NCT01454934|5844470|P2|STARTED|Overall Study||270
2381273|NCT01454934|5844471|P1|STARTED|Overall Study||270
2381274|NCT01454830|5844483|P2|NOT COMPLETED|Overall Study||27
2381275|NCT01454830|5844484|P1|NOT COMPLETED|Overall Study||31
2381276|NCT01454830|5844483|P2|COMPLETED|Overall Study||30
2381277|NCT01454830|5844484|P1|COMPLETED|Overall Study||30
2381278|NCT01454830|5844483|P2|STARTED|Overall Study||57
2381279|NCT01454830|5844484|P1|STARTED|Overall Study||61
2381280|NCT01454791|5844504|P2|NOT COMPLETED|Overall Study||0
2381281|NCT01454791|5844505|P1|NOT COMPLETED|Overall Study||0
2381282|NCT01454791|5844504|P2|COMPLETED|Overall Study|20 subjects started with placebo, then switched to Diclofenac|20
2381283|NCT01454791|5844505|P1|COMPLETED|Overall Study|20 subjects started with Diclofenac, then switched to placebo|20
2381284|NCT01454791|5844504|P2|STARTED|Overall Study||20
2381285|NCT01454791|5844505|P1|STARTED|Overall Study||20
2381286|NCT01454778|5844515|P1|NOT COMPLETED|Overall Study||3
2381287|NCT01454778|5844515|P1|COMPLETED|Overall Study||47
2381288|NCT01454778|5844515|P1|STARTED|Overall Study||50
2381289|NCT01454739|5844526|P2|NOT COMPLETED|Overall Study||21
2381290|NCT01454739|5844527|P1|NOT COMPLETED|Overall Study||7
2381291|NCT01454739|5844526|P2|COMPLETED|Overall Study||158
2381292|NCT01454739|5844527|P1|COMPLETED|Overall Study||54
2381293|NCT01454739|5844526|P2|Surgery Subgroup|Overall Study||26
2381294|NCT01454739|5844527|P1|Surgery Subgroup|Overall Study||2
2381295|NCT01454739|5844526|P2|Episodic|Overall Study||13
2381296|NCT01454739|5844527|P1|Episodic|Overall Study||0
2381297|NCT01454739|5844526|P2|Personalized Prophylaxis|Overall Study||23
2381298|NCT01454739|5844527|P1|Personalized Prophylaxis|Overall Study||3
2381299|NCT01454739|5844526|P2|Weekly Prophylaxis|Overall Study||34
2381300|NCT01454739|5844527|P1|Weekly Prophylaxis|Overall Study||0
2381301|NCT01454739|5844526|P2|Tailored Prophylaxis|Overall Study||131
2381302|NCT01454739|5844527|P1|Tailored Prophylaxis|Overall Study||59
2381303|NCT01454739|5844526|P2|STARTED|Overall Study||179
2381304|NCT01454739|5844527|P1|STARTED|Overall Study|30 participants in <6 Years Old Age Cohort and 31 participants in 6 to <12 Years Old Age Cohort.|61
2381305|NCT01454726|5844556|P2|NOT COMPLETED|Overall Study||1
2381306|NCT01454726|5844557|P1|NOT COMPLETED|Overall Study||0
2381307|NCT01454726|5844556|P2|COMPLETED|Overall Study||10
2381308|NCT01454726|5844557|P1|COMPLETED|Overall Study||16
2381309|NCT01454726|5844556|P2|STARTED|Overall Study||11
2381310|NCT01454726|5844557|P1|STARTED|Overall Study||16
2381311|NCT01454596|5844575|P12|NOT COMPLETED|Overall Study||0
2381312|NCT01454596|5844576|P11|NOT COMPLETED|Overall Study||1
2381313|NCT01454596|5844577|P10|NOT COMPLETED|Overall Study||1
2381314|NCT01454596|5844578|P9|NOT COMPLETED|Overall Study||0
2381315|NCT01454596|5844579|P8|NOT COMPLETED|Overall Study||0
2381316|NCT01454596|5844580|P7|NOT COMPLETED|Overall Study||0
2381317|NCT01454596|5844581|P6|NOT COMPLETED|Overall Study||0
2381318|NCT01454596|5844582|P5|NOT COMPLETED|Overall Study||0
2381319|NCT01454596|5844583|P4|NOT COMPLETED|Overall Study||0
2381320|NCT01454596|5844584|P3|NOT COMPLETED|Overall Study||0
2381321|NCT01454596|5844585|P2|NOT COMPLETED|Overall Study||0
2381322|NCT01454596|5844586|P1|NOT COMPLETED|Overall Study||0
2381323|NCT01454596|5844575|P12|COMPLETED|Overall Study||1
2381324|NCT01454596|5844576|P11|COMPLETED|Overall Study||0
2381325|NCT01454596|5844577|P10|COMPLETED|Overall Study||2
2381326|NCT01454596|5844578|P9|COMPLETED|Overall Study||3
2381327|NCT01454596|5844579|P8|COMPLETED|Overall Study||3
2381328|NCT01454596|5844580|P7|COMPLETED|Overall Study||1
2381329|NCT01454596|5844581|P6|COMPLETED|Overall Study||1
2381330|NCT01454596|5844582|P5|COMPLETED|Overall Study||1
2381331|NCT01454596|5844583|P4|COMPLETED|Overall Study||1
2381332|NCT01454596|5844584|P3|COMPLETED|Overall Study||1
2381333|NCT01454596|5844585|P2|COMPLETED|Overall Study||1
2381334|NCT01454596|5844586|P1|COMPLETED|Overall Study||1
2381335|NCT01454596|5844575|P12|STARTED|Overall Study||1
2381336|NCT01454596|5844576|P11|STARTED|Overall Study||1
2381337|NCT01454596|5844577|P10|STARTED|Overall Study||3
2381338|NCT01454596|5844578|P9|STARTED|Overall Study||3
2381339|NCT01454596|5844579|P8|STARTED|Overall Study||3
2381340|NCT01454596|5844580|P7|STARTED|Overall Study||1
2381341|NCT01454596|5844581|P6|STARTED|Overall Study||1
2381342|NCT01454596|5844582|P5|STARTED|Overall Study||1
2381343|NCT01454596|5844583|P4|STARTED|Overall Study||1
2381344|NCT01454596|5844584|P3|STARTED|Overall Study||1
2381345|NCT01454596|5844585|P2|STARTED|Overall Study||1
2381346|NCT01454596|5844586|P1|STARTED|Overall Study||1
2381347|NCT01454583|5844663|P3|NOT COMPLETED|3rd Year||297
2381348|NCT01454583|5844664|P2|NOT COMPLETED|3rd Year||512
2381349|NCT01454583|5844665|P1|NOT COMPLETED|3rd Year||1959
2381350|NCT01454583|5844663|P3|COMPLETED|3rd Year||285
2381351|NCT01454583|5844664|P2|COMPLETED|3rd Year||470
2381352|NCT01454583|5844665|P1|COMPLETED|3rd Year||1832
2381353|NCT01454583|5844663|P3|STARTED|3rd Year||582
2381354|NCT01454583|5844664|P2|STARTED|3rd Year||982
2381355|NCT01454583|5844665|P1|STARTED|3rd Year||3791
2381356|NCT01454583|5844663|P3|NOT COMPLETED|2nd Year||737
2381357|NCT01454583|5844664|P2|NOT COMPLETED|2nd Year||1049
2381358|NCT01454583|5844665|P1|NOT COMPLETED|2nd Year||3965
2381359|NCT01454583|5844663|P3|COMPLETED|2nd Year||1376
2381360|NCT01454583|5844664|P2|COMPLETED|2nd Year||1647
2381361|NCT01454583|5844665|P1|COMPLETED|2nd Year||6212
2381362|NCT01454583|5844663|P3|STARTED|2nd Year||2113
2381363|NCT01454583|5844664|P2|STARTED|2nd Year||2696
2381364|NCT01454583|5844665|P1|STARTED|2nd Year||10177
2381365|NCT01454583|5844663|P3|NOT COMPLETED|1st Year||180
2381366|NCT01454583|5844664|P2|NOT COMPLETED|1st Year||318
2381367|NCT01454583|5844665|P1|NOT COMPLETED|1st Year||1057
2381368|NCT01454583|5844663|P3|COMPLETED|1st Year||1933
2381369|NCT01454583|5844664|P2|COMPLETED|1st Year||2378
2381370|NCT01454583|5844665|P1|COMPLETED|1st Year||9120
2381371|NCT01454583|5844663|P3|STARTED|1st Year||2113
2381372|NCT01454583|5844664|P2|STARTED|1st Year||2696
2381373|NCT01454583|5844665|P1|STARTED|1st Year|From initially 15337 pat. 351 withdrawed from the registry, 14986 pat. were assigned to the groups.|10177
2381374|NCT01454531|5844733|P1|NOT COMPLETED|Overall Study||23
2381375|NCT01454531|5844733|P1|COMPLETED|Overall Study||173
2381376|NCT01454531|5844733|P1|Subjects Treated|Overall Study||192
2381377|NCT01454531|5844733|P1|STARTED|Overall Study||196
2381378|NCT01454505|5844745|P4|NOT COMPLETED|Overall Study||0
2381379|NCT01454505|5844746|P3|NOT COMPLETED|Overall Study||0
2381380|NCT01454505|5844747|P2|NOT COMPLETED|Overall Study||0
2381381|NCT01454505|5844748|P1|NOT COMPLETED|Overall Study||0
2381382|NCT01454505|5844745|P4|COMPLETED|Overall Study||20
2381383|NCT01454505|5844746|P3|COMPLETED|Overall Study||40
2381384|NCT01454505|5844747|P2|COMPLETED|Overall Study||15
2381385|NCT01454505|5844748|P1|COMPLETED|Overall Study||35
2381386|NCT01454505|5844745|P4|STARTED|Overall Study||20
2381387|NCT01454505|5844746|P3|STARTED|Overall Study||40
2381388|NCT01454505|5844747|P2|STARTED|Overall Study||15
2381389|NCT01454505|5844748|P1|STARTED|Overall Study||35
2381390|NCT01454414|5844762|P2|NOT COMPLETED|Overall Study||16
2381391|NCT01454414|5844763|P1|NOT COMPLETED|Overall Study||13
2381392|NCT01454414|5844762|P2|COMPLETED|Overall Study||64
2381393|NCT01454414|5844763|P1|COMPLETED|Overall Study||66
2381394|NCT01454414|5844762|P2|Baseline: Subjects That Sent Uniforms|Overall Study||66
2381395|NCT01454414|5844763|P1|Baseline: Subjects That Sent Uniforms|Overall Study||67
2381396|NCT01454414|5844762|P2|STARTED|Overall Study||80
2381397|NCT01454414|5844763|P1|STARTED|Overall Study||79
2381398|NCT01454401|5844769|P1|NOT COMPLETED|Overall Study||5
2381399|NCT01454401|5844769|P1|COMPLETED|Overall Study|Per Protocol (PP)|39
2381400|NCT01454401|5844769|P1|STARTED|Overall Study|ITT|44
2381401|NCT01454362|5844776|P2|NOT COMPLETED|Overall Study||0
2381402|NCT01454362|5844777|P1|NOT COMPLETED|Overall Study||0
2381403|NCT01454362|5844776|P2|COMPLETED|Overall Study||23
2381404|NCT01454362|5844777|P1|COMPLETED|Overall Study||28
2381405|NCT01454362|5844776|P2|STARTED|Overall Study||23
2381406|NCT01454362|5844777|P1|STARTED|Overall Study||28
2381407|NCT01454284|5844793|P2|NOT COMPLETED|Overall Study||73
2381408|NCT01454284|5844794|P1|NOT COMPLETED|Overall Study||116
2381409|NCT01454284|5844793|P2|COMPLETED|Overall Study||377
2381410|NCT01454284|5844794|P1|COMPLETED|Overall Study||548
2381411|NCT01454284|5844793|P2|Received at Least 1 Dose of Study Drug|Overall Study||449
2381412|NCT01454284|5844794|P1|Received at Least 1 Dose of Study Drug|Overall Study||663
2381413|NCT01454284|5844793|P2|STARTED|Overall Study||450
2381414|NCT01454284|5844794|P1|STARTED|Overall Study||664
2381415|NCT01454258|5844842|P1|NOT COMPLETED|Overall Study||997
2381416|NCT01454258|5844842|P1|COMPLETED|Overall Study||9103
2381417|NCT01454258|5844842|P1|STARTED|Overall Study||10100
2381418|NCT01454102|5844864|P16|NOT COMPLETED|Overall Study||1
2381419|NCT01454102|5844865|P15|NOT COMPLETED|Overall Study||3
2381420|NCT01454102|5844866|P14|NOT COMPLETED|Overall Study||4
2381421|NCT01454102|5844867|P13|NOT COMPLETED|Overall Study||7
2381422|NCT01454102|5844868|P12|NOT COMPLETED|Overall Study||4
2381423|NCT01454102|5844869|P11|NOT COMPLETED|Overall Study||0
2381424|NCT01454102|5844870|P10|NOT COMPLETED|Overall Study||0
2381425|NCT01454102|5844871|P9|NOT COMPLETED|Overall Study||1
2381426|NCT01454102|5844872|P8|NOT COMPLETED|Overall Study||0
2381427|NCT01454102|5844873|P7|NOT COMPLETED|Overall Study||2
2381428|NCT01454102|5844874|P6|NOT COMPLETED|Overall Study||3
2381429|NCT01454102|5844875|P5|NOT COMPLETED|Overall Study||3
2381430|NCT01454102|5844876|P4|NOT COMPLETED|Overall Study||0
2381431|NCT01454102|5844877|P3|NOT COMPLETED|Overall Study||0
2381432|NCT01454102|5844878|P2|NOT COMPLETED|Overall Study||0
2381433|NCT01454102|5844879|P1|NOT COMPLETED|Overall Study||0
2381434|NCT01454102|5844864|P16|COMPLETED|Overall Study||13
2381435|NCT01454102|5844865|P15|COMPLETED|Overall Study||36
2381436|NCT01454102|5844866|P14|COMPLETED|Overall Study||34
2381437|NCT01454102|5844867|P13|COMPLETED|Overall Study||33
2381438|NCT01454102|5844868|P12|COMPLETED|Overall Study||27
2381439|NCT01454102|5844869|P11|COMPLETED|Overall Study||12
2381440|NCT01454102|5844870|P10|COMPLETED|Overall Study||13
2381441|NCT01454102|5844871|P9|COMPLETED|Overall Study||12
2381442|NCT01454102|5844872|P8|COMPLETED|Overall Study||25
2381443|NCT01454102|5844873|P7|COMPLETED|Overall Study||22
2381444|NCT01454102|5844874|P6|COMPLETED|Overall Study||49
2381445|NCT01454102|5844875|P5|COMPLETED|Overall Study||18
2381446|NCT01454102|5844876|P4|COMPLETED|Overall Study||12
2381447|NCT01454102|5844877|P3|COMPLETED|Overall Study||15
2381448|NCT01454102|5844878|P2|COMPLETED|Overall Study||15
2381449|NCT01454102|5844879|P1|COMPLETED|Overall Study||12
2381450|NCT01454102|5844864|P16|STARTED|Overall Study||14
2381451|NCT01454102|5844865|P15|STARTED|Overall Study||39
2381452|NCT01454102|5844866|P14|STARTED|Overall Study||38
2381453|NCT01454102|5844867|P13|STARTED|Overall Study||40
2381454|NCT01454102|5844868|P12|STARTED|Overall Study||31
2381455|NCT01454102|5844869|P11|STARTED|Overall Study||12
2381456|NCT01454102|5844870|P10|STARTED|Overall Study||13
2381457|NCT01454102|5844871|P9|STARTED|Overall Study||13
2381458|NCT01454102|5844872|P8|STARTED|Overall Study||25
2381459|NCT01454102|5844873|P7|STARTED|Overall Study||24
2381460|NCT01454102|5844874|P6|STARTED|Overall Study||52
2381461|NCT01454102|5844875|P5|STARTED|Overall Study||21
2381462|NCT01454102|5844876|P4|STARTED|Overall Study||12
2381463|NCT01454102|5844877|P3|STARTED|Overall Study||15
2381464|NCT01454102|5844878|P2|STARTED|Overall Study||15
2381465|NCT01454102|5844879|P1|STARTED|Overall Study||12
2381466|NCT01454076|5844999|P5|NOT COMPLETED|Overall Study||6
2381467|NCT01454076|5845000|P4|NOT COMPLETED|Overall Study||2
2381468|NCT01454076|5845001|P3|NOT COMPLETED|Overall Study||9
2381469|NCT01454076|5845002|P2|NOT COMPLETED|Overall Study||6
2381470|NCT01454076|5845003|P1|NOT COMPLETED|Overall Study||13
2381471|NCT01454076|5844999|P5|COMPLETED|Overall Study||15
2381472|NCT01454076|5845000|P4|COMPLETED|Overall Study||16
2381473|NCT01454076|5845001|P3|COMPLETED|Overall Study||15
2381474|NCT01454076|5845002|P2|COMPLETED|Overall Study||14
2381475|NCT01454076|5845003|P1|COMPLETED|Overall Study||16
2381476|NCT01454076|5844999|P5|STARTED|Overall Study||21
2381477|NCT01454076|5845000|P4|STARTED|Overall Study||18
2381478|NCT01454076|5845001|P3|STARTED|Overall Study||24
2381479|NCT01454076|5845002|P2|STARTED|Overall Study||20
2381480|NCT01454076|5845003|P1|STARTED|Overall Study||29
2381481|NCT01454063|5845056|P2|NOT COMPLETED|Treated||0
2381482|NCT01454063|5845057|P1|NOT COMPLETED|Treated||2
2381483|NCT01454063|5845056|P2|COMPLETED|Treated||201
2381484|NCT01454063|5845057|P1|COMPLETED|Treated||199
2381485|NCT01454063|5845056|P2|STARTED|Treated||201
2381486|NCT01454063|5845057|P1|STARTED|Treated||201
2381487|NCT01454063|5845056|P2|NOT COMPLETED|Randomized||2
2381488|NCT01454063|5845057|P1|NOT COMPLETED|Randomized||1
2381489|NCT01454063|5845056|P2|COMPLETED|Randomized||201
2381490|NCT01454063|5845057|P1|COMPLETED|Randomized||201
2381491|NCT01454063|5845056|P2|STARTED|Randomized||203
2381492|NCT01454063|5845057|P1|STARTED|Randomized||202
2381493|NCT01453998|5845078|P3|NOT COMPLETED|After Protocol Amendment 2.||0
2381494|NCT01453998|5845079|P2|NOT COMPLETED|After Protocol Amendment 2.||0
2381495|NCT01453998|5845080|P1|NOT COMPLETED|After Protocol Amendment 2.||1
2381496|NCT01453998|5845078|P3|COMPLETED|After Protocol Amendment 2.||183
2381497|NCT01453998|5845079|P2|COMPLETED|After Protocol Amendment 2.||99
2381498|NCT01453998|5845080|P1|COMPLETED|After Protocol Amendment 2.||102
2381499|NCT01453998|5845078|P3|STARTED|After Protocol Amendment 2.||183
2381500|NCT01453998|5845079|P2|STARTED|After Protocol Amendment 2.||99
2381501|NCT01453998|5845080|P1|STARTED|After Protocol Amendment 2.||103
2381502|NCT01453998|5845078|P3|NOT COMPLETED|Before Protocol Amendment 2||0
2381503|NCT01453998|5845079|P2|NOT COMPLETED|Before Protocol Amendment 2||0
2381504|NCT01453998|5845080|P1|NOT COMPLETED|Before Protocol Amendment 2||0
2381505|NCT01453998|5845078|P3|COMPLETED|Before Protocol Amendment 2||99
2381506|NCT01453998|5845079|P2|COMPLETED|Before Protocol Amendment 2||88
2381507|NCT01453998|5845080|P1|COMPLETED|Before Protocol Amendment 2||85
2381508|NCT01453998|5845078|P3|STARTED|Before Protocol Amendment 2||99
2381509|NCT01453998|5845079|P2|STARTED|Before Protocol Amendment 2||88
2381510|NCT01453998|5845080|P1|STARTED|Before Protocol Amendment 2||85
2381511|NCT01453946|5845145|P1|NOT COMPLETED|Overall Study||9
2381512|NCT01453946|5845145|P1|COMPLETED|Overall Study||41
2381513|NCT01453946|5845145|P1|STARTED|Overall Study||50
2381514|NCT01453894|5845153|P2|NOT COMPLETED|Overall Study||0
2381515|NCT01453894|5845154|P1|NOT COMPLETED|Overall Study||0
2381516|NCT01453894|5845153|P2|COMPLETED|Overall Study||225
2381517|NCT01453894|5845154|P1|COMPLETED|Overall Study||225
2381518|NCT01453894|5845153|P2|STARTED|Overall Study||225
2381519|NCT01453894|5845154|P1|STARTED|Overall Study||225
2381520|NCT01453855|5845162|P2|NOT COMPLETED|Overall Study||14
2381521|NCT01453855|5845163|P1|NOT COMPLETED|Overall Study||10
2381522|NCT01453855|5845162|P2|COMPLETED|Overall Study||408
2381523|NCT01453855|5845163|P1|COMPLETED|Overall Study||432
2381524|NCT01453855|5845162|P2|STARTED|Overall Study||422
2381525|NCT01453855|5845163|P1|STARTED|Overall Study||442
2381526|NCT01453725|5845171|P2|NOT COMPLETED|Overall Study||11
2381527|NCT01453725|5845172|P1|NOT COMPLETED|Overall Study||13
2381528|NCT01453725|5845171|P2|COMPLETED|Overall Study||89
2381529|NCT01453725|5845172|P1|COMPLETED|Overall Study||85
2381530|NCT01453725|5845171|P2|STARTED|Overall Study||100
2381531|NCT01453725|5845172|P1|STARTED|Overall Study||98
2381532|NCT01453595|5845195|P3|NOT COMPLETED|Overall Study||2
2381533|NCT01453595|5845196|P2|NOT COMPLETED|Overall Study||1
2381534|NCT01453595|5845197|P1|NOT COMPLETED|Overall Study||2
2381535|NCT01453595|5845195|P3|COMPLETED|Overall Study||0
2381536|NCT01453595|5845196|P2|COMPLETED|Overall Study||5
2381537|NCT01453595|5845197|P1|COMPLETED|Overall Study||0
2381538|NCT01453595|5845195|P3|STARTED|Overall Study||2
2381539|NCT01453595|5845196|P2|STARTED|Overall Study||6
2381540|NCT01453595|5845197|P1|STARTED|Overall Study||2
2381541|NCT01453569|5845206|P3|NOT COMPLETED|Overall Study||7
2381542|NCT01453569|5845207|P2|NOT COMPLETED|Overall Study||14
2381543|NCT01453569|5845208|P1|NOT COMPLETED|Overall Study||11
2381544|NCT01453569|5845206|P3|COMPLETED|Overall Study||78
2381545|NCT01453569|5845207|P2|COMPLETED|Overall Study||70
2381546|NCT01453569|5845208|P1|COMPLETED|Overall Study||75
2381547|NCT01453569|5845206|P3|STARTED|Overall Study||85
2381548|NCT01453569|5845207|P2|STARTED|Overall Study||84
2381549|NCT01453569|5845208|P1|STARTED|Overall Study||86
2381550|NCT01453413|5845225|P1|NOT COMPLETED|Overall Study||0
2381551|NCT01453413|5845225|P1|COMPLETED|Overall Study||297
2381552|NCT01453413|5845225|P1|STARTED|Overall Study||297
2381553|NCT01453387|5845232|P2|NOT COMPLETED|Overall Study||0
2381554|NCT01453387|5845233|P1|NOT COMPLETED|Overall Study||0
2381555|NCT01453387|5845232|P2|COMPLETED|Overall Study||7
2381556|NCT01453387|5845233|P1|COMPLETED|Overall Study||21
2381557|NCT01453387|5845232|P2|STARTED|Overall Study||7
2381558|NCT01453387|5845233|P1|STARTED|Overall Study||21
2381559|NCT01453374|5845316|P1|NOT COMPLETED|Overall Study||18
2381560|NCT01453374|5845316|P1|COMPLETED|Overall Study|Defined as receiving 7 injections and 2 follow-up visits.|9
2381561|NCT01453374|5845316|P1|STARTED|Overall Study||27
2381562|NCT01453361|5845332|P1|NOT COMPLETED|Overall Study||16
2381563|NCT01453361|5845332|P1|COMPLETED|Overall Study||2
2381564|NCT01453361|5845332|P1|STARTED|Overall Study||18
2381565|NCT01453348|5845340|P3|NOT COMPLETED|Overall Study||1
2381566|NCT01453348|5845341|P2|NOT COMPLETED|Overall Study||1
2381567|NCT01453348|5845342|P1|NOT COMPLETED|Overall Study||1
2381568|NCT01453348|5845340|P3|COMPLETED|Overall Study||83
2381569|NCT01453348|5845341|P2|COMPLETED|Overall Study||83
2381570|NCT01453348|5845342|P1|COMPLETED|Overall Study||83
2381571|NCT01453348|5845340|P3|STARTED|Overall Study||84
2381572|NCT01453348|5845341|P2|STARTED|Overall Study||84
2381573|NCT01453348|5845342|P1|STARTED|Overall Study||84
2381574|NCT01453296|5845358|P2|NOT COMPLETED|Treatment Period 2||0
2381575|NCT01453296|5845359|P1|NOT COMPLETED|Treatment Period 2||2
2381576|NCT01453296|5845358|P2|COMPLETED|Treatment Period 2||13
2381577|NCT01453296|5845359|P1|COMPLETED|Treatment Period 2||11
2381578|NCT01453296|5845358|P2|STARTED|Treatment Period 2||13
2381579|NCT01453296|5845359|P1|STARTED|Treatment Period 2||13
2381580|NCT01453296|5845358|P2|NOT COMPLETED|Washout Period||0
2381581|NCT01453296|5845359|P1|NOT COMPLETED|Washout Period||0
2381582|NCT01453296|5845358|P2|COMPLETED|Washout Period||13
2381583|NCT01453296|5845359|P1|COMPLETED|Washout Period||13
2381584|NCT01453296|5845358|P2|STARTED|Washout Period||13
2381585|NCT01453296|5845359|P1|STARTED|Washout Period||13
2381586|NCT01453296|5845358|P2|NOT COMPLETED|Treatment Period 1||1
2381587|NCT01453296|5845359|P1|NOT COMPLETED|Treatment Period 1||1
2381588|NCT01453296|5845358|P2|COMPLETED|Treatment Period 1||13
2381589|NCT01453296|5845359|P1|COMPLETED|Treatment Period 1||13
2381590|NCT01453296|5845358|P2|STARTED|Treatment Period 1||14
2381591|NCT01453296|5845359|P1|STARTED|Treatment Period 1||14
2381592|NCT01453205|5845426|P3|NOT COMPLETED|Overall Study||54
2381593|NCT01453205|5845427|P2|NOT COMPLETED|Overall Study||52
2381594|NCT01453205|5845428|P1|NOT COMPLETED|Overall Study||80
2381595|NCT01453205|5845426|P3|COMPLETED|Overall Study||1
2381596|NCT01453205|5845427|P2|COMPLETED|Overall Study||0
2381597|NCT01453205|5845428|P1|COMPLETED|Overall Study||0
2381598|NCT01453205|5845426|P3|STARTED|Overall Study||55
2381599|NCT01453205|5845427|P2|STARTED|Overall Study||52
2381600|NCT01453205|5845428|P1|STARTED|Overall Study||80
2381601|NCT01453166|5845479|P3|NOT COMPLETED|Overall Study||1
2381602|NCT01453166|5845480|P2|NOT COMPLETED|Overall Study||2
2381603|NCT01453166|5845481|P1|NOT COMPLETED|Overall Study||2
2381604|NCT01453166|5845479|P3|COMPLETED|Overall Study||38
2381605|NCT01453166|5845480|P2|COMPLETED|Overall Study||39
2381606|NCT01453166|5845481|P1|COMPLETED|Overall Study||40
2381607|NCT01453166|5845479|P3|STARTED|Overall Study||39
2381608|NCT01453166|5845480|P2|STARTED|Overall Study||41
2381609|NCT01453166|5845481|P1|STARTED|Overall Study||42
2381610|NCT01453153|5845504|P3|NOT COMPLETED|Overall Study||20
2381611|NCT01453153|5845505|P2|NOT COMPLETED|Overall Study||4
2381612|NCT01453153|5845506|P1|NOT COMPLETED|Overall Study||4
2381613|NCT01453153|5845504|P3|COMPLETED|Overall Study||0
2381614|NCT01453153|5845505|P2|COMPLETED|Overall Study||0
2381615|NCT01453153|5845506|P1|COMPLETED|Overall Study||0
2381616|NCT01453153|5845504|P3|STARTED|Overall Study||20
2381617|NCT01453153|5845505|P2|STARTED|Overall Study||4
2381618|NCT01453153|5845506|P1|STARTED|Overall Study||4
2381619|NCT01453075|5845579|P2|NOT COMPLETED|Overall Study||1
2381620|NCT01453075|5845580|P1|NOT COMPLETED|Overall Study||5
2381621|NCT01453075|5845579|P2|COMPLETED|Overall Study||14
2381622|NCT01453075|5845580|P1|COMPLETED|Overall Study||11
2381623|NCT01453075|5845579|P2|STARTED|Overall Study||15
2381624|NCT01453075|5845580|P1|STARTED|Overall Study||16
2381625|NCT01453049|5845588|P2|NOT COMPLETED|Overall Study||42
2381626|NCT01453049|5845589|P1|NOT COMPLETED|Overall Study||41
2381627|NCT01453049|5845588|P2|COMPLETED|Overall Study||2
2381628|NCT01453049|5845589|P1|COMPLETED|Overall Study||1
2381629|NCT01453049|5845588|P2|STARTED|Overall Study||44
2381630|NCT01453049|5845589|P1|STARTED|Overall Study||42
2381631|NCT01453036|5845662|P3|NOT COMPLETED|Overall Study||31
2381632|NCT01453036|5845663|P2|NOT COMPLETED|Overall Study||115
2381633|NCT01453036|5845664|P1|NOT COMPLETED|Overall Study||26
2381634|NCT01453036|5845662|P3|COMPLETED|Overall Study||277
2381635|NCT01453036|5845663|P2|COMPLETED|Overall Study||193
2381636|NCT01453036|5845664|P1|COMPLETED|Overall Study||282
2381637|NCT01453036|5845662|P3|STARTED|Overall Study||308
2381638|NCT01453036|5845663|P2|STARTED|Overall Study||308
2381639|NCT01453036|5845664|P1|STARTED|Overall Study||308
2381640|NCT01453023|5845672|P2|NOT COMPLETED|Treatment Period 2||1
2381641|NCT01453023|5845673|P1|NOT COMPLETED|Treatment Period 2||0
2381642|NCT01453023|5845672|P2|COMPLETED|Treatment Period 2||11
2381643|NCT01453023|5845673|P1|COMPLETED|Treatment Period 2||12
2381644|NCT01453023|5845672|P2|STARTED|Treatment Period 2||12
2381645|NCT01453023|5845673|P1|STARTED|Treatment Period 2||12
2381646|NCT01453023|5845672|P2|NOT COMPLETED|Washout Period||0
2381647|NCT01453023|5845673|P1|NOT COMPLETED|Washout Period||0
2381648|NCT01453023|5845672|P2|COMPLETED|Washout Period||12
2381649|NCT01453023|5845673|P1|COMPLETED|Washout Period||12
2381650|NCT01453023|5845672|P2|STARTED|Washout Period||12
2381651|NCT01453023|5845673|P1|STARTED|Washout Period||12
2381652|NCT01453023|5845672|P2|NOT COMPLETED|Treatment Period (TP) 1||1
2381653|NCT01453023|5845673|P1|NOT COMPLETED|Treatment Period (TP) 1||1
2381654|NCT01453023|5845672|P2|COMPLETED|Treatment Period (TP) 1||12
2381655|NCT01453023|5845673|P1|COMPLETED|Treatment Period (TP) 1||12
2381656|NCT01453023|5845672|P2|STARTED|Treatment Period (TP) 1||13
2381657|NCT01453023|5845673|P1|STARTED|Treatment Period (TP) 1||13
2381658|NCT01452854|5845741|P1|NOT COMPLETED|Overall Study||0
2381659|NCT01452854|5845741|P1|COMPLETED|Overall Study||2
2381660|NCT01452854|5845741|P1|STARTED|Overall Study||2
2381661|NCT01452529|5845747|P3|NOT COMPLETED|Double-blind (DB) Period||82
2381662|NCT01452529|5845748|P2|NOT COMPLETED|Double-blind (DB) Period||67
2381663|NCT01452529|5845749|P1|NOT COMPLETED|Double-blind (DB) Period||0
2381664|NCT01452529|5845747|P3|COMPLETED|Double-blind (DB) Period||210
2381665|NCT01452529|5845748|P2|COMPLETED|Double-blind (DB) Period|4 subjects who did not receive DB medication were still counted as discontinued in the DB period|229
2381666|NCT01452529|5845749|P1|COMPLETED|Double-blind (DB) Period||0
2381667|NCT01452529|5845747|P3|STARTED|Double-blind (DB) Period||292
2381668|NCT01452529|5845748|P2|STARTED|Double-blind (DB) Period|Four subjects were randomized but did not receive DB medication|296
2381669|NCT01452529|5845749|P1|STARTED|Double-blind (DB) Period||0
2381670|NCT01452529|5845747|P3|NOT COMPLETED|Run-in Period||0
2381671|NCT01452529|5845748|P2|NOT COMPLETED|Run-in Period||0
2381672|NCT01452529|5845749|P1|NOT COMPLETED|Run-in Period||313
2381673|NCT01452529|5845747|P3|COMPLETED|Run-in Period||0
2381674|NCT01452529|5845748|P2|COMPLETED|Run-in Period||0
2381675|NCT01452529|5845749|P1|COMPLETED|Run-in Period||592
2381676|NCT01452529|5845747|P3|STARTED|Run-in Period||0
2381677|NCT01452529|5845748|P2|STARTED|Run-in Period||0
2381678|NCT01452529|5845749|P1|STARTED|Run-in Period||905
2381679|NCT01452425|5845764|P1|NOT COMPLETED|Overall Study||0
2381680|NCT01452425|5845764|P1|COMPLETED|Overall Study||10
2381681|NCT01452425|5845764|P1|STARTED|Overall Study||10
2381682|NCT01452412|5845771|P2|NOT COMPLETED|Overall Study||17
2381683|NCT01452412|5845772|P1|NOT COMPLETED|Overall Study||28
2381684|NCT01452412|5845771|P2|COMPLETED|Overall Study||58
2381685|NCT01452412|5845772|P1|COMPLETED|Overall Study||46
2381686|NCT01452412|5845771|P2|STARTED|Overall Study||75
2381687|NCT01452412|5845772|P1|STARTED|Overall Study||74
2381688|NCT01452347|5845788|P2|NOT COMPLETED|Overall Study||7
2381689|NCT01452347|5845789|P1|NOT COMPLETED|Overall Study||17
2381690|NCT01452347|5845788|P2|COMPLETED|Overall Study||77
2381691|NCT01452347|5845789|P1|COMPLETED|Overall Study||151
2381692|NCT01452347|5845788|P2|STARTED|Overall Study||84
2381693|NCT01452347|5845789|P1|STARTED|Overall Study||168
2381694|NCT01452269|5845807|P2|NOT COMPLETED|Overall Study||5
2381695|NCT01452269|5845808|P1|NOT COMPLETED|Overall Study||1
2381696|NCT01452269|5845807|P2|COMPLETED|Overall Study||51
2381697|NCT01452269|5845808|P1|COMPLETED|Overall Study||47
2381698|NCT01452269|5845807|P2|STARTED|Overall Study||56
2381699|NCT01452269|5845808|P1|STARTED|Overall Study||48
2381700|NCT01452191|5845821|P3|NOT COMPLETED|Overall Study||112
2381701|NCT01452191|5845822|P2|NOT COMPLETED|Overall Study||117
2381702|NCT01452191|5845823|P1|NOT COMPLETED|Overall Study||132
2381703|NCT01452191|5845821|P3|COMPLETED|Overall Study||258
2381704|NCT01452191|5845822|P2|COMPLETED|Overall Study||252
2381705|NCT01452191|5845823|P1|COMPLETED|Overall Study||241
2381706|NCT01452191|5845821|P3|STARTED|Overall Study||370
2381707|NCT01452191|5845822|P2|STARTED|Overall Study||369
2381708|NCT01452191|5845823|P1|STARTED|Overall Study||373
2381709|NCT01452152|5845849|P3|NOT COMPLETED|Overall Study||4
2381710|NCT01452152|5845850|P2|NOT COMPLETED|Overall Study||0
2381711|NCT01452152|5845851|P1|NOT COMPLETED|Overall Study||5
2381712|NCT01452152|5845849|P3|COMPLETED|Overall Study||0
2381713|NCT01452152|5845850|P2|COMPLETED|Overall Study||0
2381714|NCT01452152|5845851|P1|COMPLETED|Overall Study||0
2381715|NCT01452152|5845849|P3|STARTED|Overall Study||4
2381716|NCT01452152|5845850|P2|STARTED|Overall Study||0
2381717|NCT01452152|5845851|P1|STARTED|Overall Study||5
2381718|NCT01452126|5845874|P1|NOT COMPLETED|Overall Study||0
2381719|NCT01452126|5845874|P1|COMPLETED|Overall Study||49
2381720|NCT01452126|5845874|P1|STARTED|Overall Study||49
2381721|NCT01451996|5845886|P4|NOT COMPLETED|Overall Study||0
2381722|NCT01451996|5845887|P3|NOT COMPLETED|Overall Study||0
2381723|NCT01451996|5845888|P2|NOT COMPLETED|Overall Study||0
2381724|NCT01451996|5845889|P1|NOT COMPLETED|Overall Study||0
2381725|NCT01451996|5845886|P4|COMPLETED|Overall Study||85
2381726|NCT01451996|5845887|P3|COMPLETED|Overall Study||85
2381727|NCT01451996|5845888|P2|COMPLETED|Overall Study||87
2381728|NCT01451996|5845889|P1|COMPLETED|Overall Study||83
2381729|NCT01451996|5845886|P4|STARTED|Overall Study||85
2381730|NCT01451996|5845887|P3|STARTED|Overall Study||85
2381731|NCT01451996|5845888|P2|STARTED|Overall Study||87
2381732|NCT01451996|5845889|P1|STARTED|Overall Study||83
2381733|NCT01451983|5845907|P4|NOT COMPLETED|Overall Study||0
2381734|NCT01451983|5845908|P3|NOT COMPLETED|Overall Study||0
2381735|NCT01451983|5845909|P2|NOT COMPLETED|Overall Study||0
2381736|NCT01451983|5845910|P1|NOT COMPLETED|Overall Study||0
2381737|NCT01451983|5845907|P4|COMPLETED|Overall Study||24
2381738|NCT01451983|5845908|P3|COMPLETED|Overall Study||61
2381739|NCT01451983|5845909|P2|COMPLETED|Overall Study||27
2381740|NCT01451983|5845910|P1|COMPLETED|Overall Study||26
2381741|NCT01451983|5845907|P4|STARTED|Overall Study||24
2381742|NCT01451983|5845908|P3|STARTED|Overall Study||61
2381743|NCT01451983|5845909|P2|STARTED|Overall Study||27
2381744|NCT01451983|5845910|P1|STARTED|Overall Study||26
2381745|NCT01451931|5845923|P3|NOT COMPLETED|Overall Study||43
2381746|NCT01451931|5845924|P2|NOT COMPLETED|Overall Study||58
2381747|NCT01451931|5845925|P1|NOT COMPLETED|Overall Study||33
2381748|NCT01451931|5845923|P3|COMPLETED|Overall Study||923
2381749|NCT01451931|5845924|P2|COMPLETED|Overall Study||843
2381750|NCT01451931|5845925|P1|COMPLETED|Overall Study||876
2381751|NCT01451931|5845923|P3|6-month Follow up|Overall Study||923
2381752|NCT01451931|5845924|P2|6-month Follow up|Overall Study||843
2381753|NCT01451931|5845925|P1|6-month Follow up|Overall Study||876
2381754|NCT01451931|5845923|P3|Baseline Data Collection|Overall Study||958
2381755|NCT01451931|5845924|P2|Baseline Data Collection|Overall Study||893
2381756|NCT01451931|5845925|P1|Baseline Data Collection|Overall Study||908
2381757|NCT01451931|5845923|P3|STARTED|Overall Study||966
2381758|NCT01451931|5845924|P2|STARTED|Overall Study||901
2381759|NCT01451931|5845925|P1|STARTED|Overall Study||909
2381760|NCT01451827|5845949|P4|NOT COMPLETED|Overall Study||4
2381761|NCT01451827|5845950|P3|NOT COMPLETED|Overall Study||2
2381762|NCT01451827|5845951|P2|NOT COMPLETED|Overall Study||5
2381763|NCT01451827|5845952|P1|NOT COMPLETED|Overall Study||3
2381764|NCT01451827|5845949|P4|COMPLETED|Overall Study||39
2381765|NCT01451827|5845950|P3|COMPLETED|Overall Study||42
2381766|NCT01451827|5845951|P2|COMPLETED|Overall Study||40
2381767|NCT01451827|5845952|P1|COMPLETED|Overall Study||42
2381768|NCT01451827|5845949|P4|STARTED|Overall Study||43
2381769|NCT01451827|5845950|P3|STARTED|Overall Study||44
2381770|NCT01451827|5845951|P2|STARTED|Overall Study||45
2381771|NCT01451827|5845952|P1|STARTED|Overall Study||45
2381772|NCT01451814|5845972|P2|NOT COMPLETED|Overall Study||5
2381773|NCT01451814|5845973|P1|NOT COMPLETED|Overall Study||6
2381774|NCT01451814|5845972|P2|COMPLETED|Overall Study||26
2381775|NCT01451814|5845973|P1|COMPLETED|Overall Study||29
2381776|NCT01451814|5845972|P2|Attended a Session|Overall Study||31
2381777|NCT01451814|5845973|P1|Attended a Session|Overall Study||35
2381778|NCT01451814|5845972|P2|STARTED|Overall Study||31
2381779|NCT01451814|5845973|P1|STARTED|Overall Study||35
2381780|NCT01451775|5845983|P6|NOT COMPLETED|Overall Study||0
2381781|NCT01451775|5845984|P5|NOT COMPLETED|Overall Study||0
2381782|NCT01451775|5845985|P4|NOT COMPLETED|Overall Study||0
2381783|NCT01451775|5845986|P3|NOT COMPLETED|Overall Study||0
2381784|NCT01451775|5845987|P2|NOT COMPLETED|Overall Study||0
2381785|NCT01451775|5845988|P1|NOT COMPLETED|Overall Study||0
2381786|NCT01451775|5845983|P6|COMPLETED|Overall Study||3
2381787|NCT01451775|5845984|P5|COMPLETED|Overall Study||3
2381788|NCT01451775|5845985|P4|COMPLETED|Overall Study||3
2381789|NCT01451775|5845986|P3|COMPLETED|Overall Study||3
2381790|NCT01451775|5845987|P2|COMPLETED|Overall Study||3
2381791|NCT01451775|5845988|P1|COMPLETED|Overall Study||3
2381792|NCT01451775|5845983|P6|STARTED|Overall Study||3
2381793|NCT01451775|5845984|P5|STARTED|Overall Study||3
2381794|NCT01451775|5845985|P4|STARTED|Overall Study||3
2381795|NCT01451775|5845986|P3|STARTED|Overall Study||3
2381796|NCT01451775|5845987|P2|STARTED|Overall Study||3
2381797|NCT01451775|5845988|P1|STARTED|Overall Study||3
2381798|NCT01451762|5846005|P3|NOT COMPLETED|Overall Study||6
2381799|NCT01451762|5846006|P2|NOT COMPLETED|Overall Study||6
2381800|NCT01451762|5846007|P1|NOT COMPLETED|Overall Study||3
2381801|NCT01451762|5846005|P3|COMPLETED|Overall Study||24
2381802|NCT01451762|5846006|P2|COMPLETED|Overall Study||24
2381803|NCT01451762|5846007|P1|COMPLETED|Overall Study||27
2381804|NCT01451762|5846005|P3|STARTED|Overall Study||30
2381805|NCT01451762|5846006|P2|STARTED|Overall Study||30
2381806|NCT01451762|5846007|P1|STARTED|Overall Study||30
2381807|NCT01451749|5846017|P2|NOT COMPLETED|Overall Study||14
2381808|NCT01451749|5846018|P1|NOT COMPLETED|Overall Study||32
2381809|NCT01451749|5846017|P2|COMPLETED|Overall Study||94
2381810|NCT01451749|5846018|P1|COMPLETED|Overall Study||184
2381811|NCT01451749|5846017|P2|STARTED|Overall Study||108
2381812|NCT01451749|5846018|P1|STARTED|Overall Study||216
2381813|NCT01451723|5846030|P2|NOT COMPLETED|Overall Study||5
2381814|NCT01451723|5846031|P1|NOT COMPLETED|Overall Study||6
2381815|NCT01451723|5846030|P2|COMPLETED|Overall Study||0
2381816|NCT01451723|5846031|P1|COMPLETED|Overall Study||0
2381817|NCT01451723|5846030|P2|STARTED|Overall Study||5
2381818|NCT01451723|5846031|P1|STARTED|Overall Study||6
2381819|NCT01451645|5846041|P2|NOT COMPLETED|Overall Study||8
2381820|NCT01451645|5846042|P1|NOT COMPLETED|Overall Study||9
2381821|NCT01451645|5846041|P2|COMPLETED|Overall Study||33
2381822|NCT01451645|5846042|P1|COMPLETED|Overall Study||32
2381823|NCT01451645|5846041|P2|STARTED|Overall Study||41
2381824|NCT01451645|5846042|P1|STARTED|Overall Study||41
2381825|NCT01451632|5846056|P10|NOT COMPLETED|Overall Study||0
2381826|NCT01451632|5846057|P9|NOT COMPLETED|Overall Study||0
2381827|NCT01451632|5846058|P8|NOT COMPLETED|Overall Study||0
2381828|NCT01451632|5846059|P7|NOT COMPLETED|Overall Study||0
2381829|NCT01451632|5846060|P6|NOT COMPLETED|Overall Study||0
2381830|NCT01451632|5846061|P5|NOT COMPLETED|Overall Study||0
2381831|NCT01451632|5846062|P4|NOT COMPLETED|Overall Study||0
2381832|NCT01451632|5846063|P3|NOT COMPLETED|Overall Study||0
2381833|NCT01451632|5846064|P2|NOT COMPLETED|Overall Study||0
2381834|NCT01451632|5846065|P1|NOT COMPLETED|Overall Study||0
2381835|NCT01451632|5846056|P10|COMPLETED|Overall Study||4
2381836|NCT01451632|5846057|P9|COMPLETED|Overall Study||4
2381837|NCT01451632|5846058|P8|COMPLETED|Overall Study||6
2381838|NCT01451632|5846059|P7|COMPLETED|Overall Study||8
2381839|NCT01451632|5846060|P6|COMPLETED|Overall Study||4
2381840|NCT01451632|5846061|P5|COMPLETED|Overall Study||4
2381841|NCT01451632|5846062|P4|COMPLETED|Overall Study||3
2381842|NCT01451632|5846063|P3|COMPLETED|Overall Study||3
2381843|NCT01451632|5846064|P2|COMPLETED|Overall Study||4
2381844|NCT01451632|5846065|P1|COMPLETED|Overall Study||8
2381845|NCT01451632|5846056|P10|STARTED|Overall Study||4
2381846|NCT01451632|5846057|P9|STARTED|Overall Study||4
2381847|NCT01451632|5846058|P8|STARTED|Overall Study||6
2381848|NCT01451632|5846059|P7|STARTED|Overall Study||8
2381849|NCT01451632|5846060|P6|STARTED|Overall Study||4
2381850|NCT01451632|5846061|P5|STARTED|Overall Study||4
2381851|NCT01451632|5846062|P4|STARTED|Overall Study||3
2381852|NCT01451632|5846063|P3|STARTED|Overall Study||3
2381853|NCT01451632|5846064|P2|STARTED|Overall Study||4
2381854|NCT01451632|5846065|P1|STARTED|Overall Study||8
2381855|NCT01451606|5846113|P2|NOT COMPLETED|Overall Study||3
2381856|NCT01451606|5846114|P1|NOT COMPLETED|Overall Study||4
2381857|NCT01451606|5846113|P2|COMPLETED|Overall Study||15
2381858|NCT01451606|5846114|P1|COMPLETED|Overall Study||12
2381859|NCT01451606|5846113|P2|STARTED|Overall Study||18
2381860|NCT01451606|5846114|P1|STARTED|Overall Study||16
2381861|NCT01451554|5846124|P2|NOT COMPLETED|Overall Study||9
2381862|NCT01451554|5846125|P1|NOT COMPLETED|Overall Study||14
2381863|NCT01451554|5846124|P2|COMPLETED|Overall Study||23
2381864|NCT01451554|5846125|P1|COMPLETED|Overall Study||19
2381865|NCT01451554|5846124|P2|STARTED|Overall Study||32
2381866|NCT01451554|5846125|P1|STARTED|Overall Study||33
2381867|NCT01451541|5846136|P3|NOT COMPLETED|Overall Study||27
2381868|NCT01451541|5846137|P2|NOT COMPLETED|Overall Study||25
2381869|NCT01451541|5846138|P1|NOT COMPLETED|Overall Study||36
2381870|NCT01451541|5846136|P3|COMPLETED|Overall Study||254
2381871|NCT01451541|5846137|P2|COMPLETED|Overall Study||257
2381872|NCT01451541|5846138|P1|COMPLETED|Overall Study||247
2381873|NCT01451541|5846136|P3|STARTED|Overall Study|283 randomized. ITT = 281 (2 subjects discontinued prior to study medication).|281
2381874|NCT01451541|5846137|P2|STARTED|Overall Study||282
2381875|NCT01451541|5846138|P1|STARTED|Overall Study||283
2381876|NCT01451463|5846178|P1|NOT COMPLETED|Overall Study||0
2381877|NCT01451463|5846178|P1|COMPLETED|Overall Study||11
2381878|NCT01451463|5846178|P1|STARTED|Overall Study||11
2381879|NCT01451437|5846196|P9|NOT COMPLETED|Overall Study||4
2381880|NCT01451437|5846197|P8|NOT COMPLETED|Overall Study||3
2381881|NCT01451437|5846198|P7|NOT COMPLETED|Overall Study||6
2381882|NCT01451437|5846199|P6|NOT COMPLETED|Overall Study||3
2381883|NCT01451437|5846200|P5|NOT COMPLETED|Overall Study||4
2381884|NCT01451437|5846201|P4|NOT COMPLETED|Overall Study||1
2381885|NCT01451437|5846202|P3|NOT COMPLETED|Overall Study||3
2381886|NCT01451437|5846203|P2|NOT COMPLETED|Overall Study||1
2381887|NCT01451437|5846204|P1|NOT COMPLETED|Overall Study||1
2381888|NCT01451437|5846196|P9|COMPLETED|Overall Study||0
2381889|NCT01451437|5846197|P8|COMPLETED|Overall Study||0
2381890|NCT01451437|5846198|P7|COMPLETED|Overall Study||0
2381891|NCT01451437|5846199|P6|COMPLETED|Overall Study||0
2381892|NCT01451437|5846200|P5|COMPLETED|Overall Study||0
2381893|NCT01451437|5846201|P4|COMPLETED|Overall Study||0
2381894|NCT01451437|5846202|P3|COMPLETED|Overall Study||0
2381895|NCT01451437|5846203|P2|COMPLETED|Overall Study||0
2381896|NCT01451437|5846204|P1|COMPLETED|Overall Study||0
2381897|NCT01451437|5846196|P9|STARTED|Overall Study||4
2381898|NCT01451437|5846197|P8|STARTED|Overall Study||3
2381899|NCT01451437|5846198|P7|STARTED|Overall Study||6
2381900|NCT01451437|5846199|P6|STARTED|Overall Study||3
2381901|NCT01451437|5846200|P5|STARTED|Overall Study||4
2381902|NCT01451437|5846201|P4|STARTED|Overall Study||1
2381903|NCT01451437|5846202|P3|STARTED|Overall Study||3
2381904|NCT01451437|5846203|P2|STARTED|Overall Study||1
2381905|NCT01451437|5846204|P1|STARTED|Overall Study||1
2381906|NCT01451424|5846336|P4|NOT COMPLETED|Overall Study||5
2381907|NCT01451424|5846337|P3|NOT COMPLETED|Overall Study||1
2381908|NCT01451424|5846338|P2|NOT COMPLETED|Overall Study||2
2381909|NCT01451424|5846339|P1|NOT COMPLETED|Overall Study||1
2381910|NCT01451424|5846336|P4|COMPLETED|Overall Study||5
2381911|NCT01451424|5846337|P3|COMPLETED|Overall Study||11
2381912|NCT01451424|5846338|P2|COMPLETED|Overall Study||7
2381913|NCT01451424|5846339|P1|COMPLETED|Overall Study||8
2381914|NCT01451424|5846336|P4|STARTED|Overall Study||10
2381915|NCT01451424|5846337|P3|STARTED|Overall Study||12
2381916|NCT01451424|5846338|P2|STARTED|Overall Study||9
2381917|NCT01451424|5846339|P1|STARTED|Overall Study||9
2381918|NCT01451411|5846372|P2|NOT COMPLETED|Overall Study||0
2381919|NCT01451411|5846373|P1|NOT COMPLETED|Overall Study||0
2381920|NCT01451411|5846372|P2|COMPLETED|Overall Study||1
2381921|NCT01451411|5846373|P1|COMPLETED|Overall Study||3
2381922|NCT01451411|5846372|P2|STARTED|Overall Study||1
2381923|NCT01451411|5846373|P1|STARTED|Overall Study||3
2381924|NCT01451398|5846397|P2|NOT COMPLETED|Overall Study||37
2381925|NCT01451398|5846398|P1|NOT COMPLETED|Overall Study||27
2381926|NCT01451398|5846397|P2|COMPLETED|Overall Study||139
2381927|NCT01451398|5846398|P1|COMPLETED|Overall Study||150
2381928|NCT01451398|5846397|P2|STARTED|Overall Study||176
2381929|NCT01451398|5846398|P1|STARTED|Overall Study||177
2381930|NCT01451372|5846430|P1|NOT COMPLETED|Overall Study||0
2381931|NCT01451372|5846430|P1|COMPLETED|Overall Study||69
2381932|NCT01451372|5846430|P1|STARTED|Overall Study||69
2381933|NCT01451203|5846437|P2|NOT COMPLETED|Post-treatment Period||34
2381934|NCT01451203|5846438|P1|NOT COMPLETED|Post-treatment Period||14
2381935|NCT01451203|5846437|P2|COMPLETED|Post-treatment Period||74
2381936|NCT01451203|5846438|P1|COMPLETED|Post-treatment Period||57
2381937|NCT01451203|5846437|P2|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|28
2381938|NCT01451203|5846438|P1|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|12
2381939|NCT01451203|5846437|P2|STARTED|Post-treatment Period|Three participants received rescue treatment and did not enter this period.|108
2381940|NCT01451203|5846438|P1|STARTED|Post-treatment Period|Two participants received rescue treatment and did not enter this period.|71
2381941|NCT01451203|5846437|P2|NOT COMPLETED|Double-blind Treatment Period||50
2381942|NCT01451203|5846438|P1|NOT COMPLETED|Double-blind Treatment Period||85
2381943|NCT01451203|5846437|P2|COMPLETED|Double-blind Treatment Period||111
2381944|NCT01451203|5846438|P1|COMPLETED|Double-blind Treatment Period||73
2381945|NCT01451203|5846437|P2|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|36
2381946|NCT01451203|5846438|P1|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|70
2381947|NCT01451203|5846437|P2|Received Treatment|Double-blind Treatment Period||159
2381948|NCT01451203|5846438|P1|Received Treatment|Double-blind Treatment Period||157
2381949|NCT01451203|5846437|P2|STARTED|Double-blind Treatment Period||161
2381950|NCT01451203|5846438|P1|STARTED|Double-blind Treatment Period||158
2381951|NCT01451164|5846456|P4|NOT COMPLETED|Overall Study||46
2381952|NCT01451164|5846457|P3|NOT COMPLETED|Overall Study||45
2381953|NCT01451164|5846458|P2|NOT COMPLETED|Overall Study||34
2381954|NCT01451164|5846459|P1|NOT COMPLETED|Overall Study||43
2381955|NCT01451164|5846456|P4|COMPLETED|Overall Study||70
2381956|NCT01451164|5846457|P3|COMPLETED|Overall Study||68
2381957|NCT01451164|5846458|P2|COMPLETED|Overall Study||81
2381958|NCT01451164|5846459|P1|COMPLETED|Overall Study||72
2381959|NCT01451164|5846456|P4|STARTED|Overall Study||116
2381960|NCT01451164|5846457|P3|STARTED|Overall Study||113
2381961|NCT01451164|5846458|P2|STARTED|Overall Study||115
2381962|NCT01451164|5846459|P1|STARTED|Overall Study||115
2381963|NCT01450943|5846488|P3|NOT COMPLETED|Overall Study||6
2381964|NCT01450943|5846489|P2|NOT COMPLETED|Overall Study||7
2381965|NCT01450943|5846490|P1|NOT COMPLETED|Overall Study||2
2381966|NCT01450943|5846488|P3|COMPLETED|Overall Study||42
2381967|NCT01450943|5846489|P2|COMPLETED|Overall Study||35
2381968|NCT01450943|5846490|P1|COMPLETED|Overall Study||26
2381969|NCT01450943|5846488|P3|STARTED|Overall Study||48
2381970|NCT01450943|5846489|P2|STARTED|Overall Study||42
2381971|NCT01450943|5846490|P1|STARTED|Overall Study||28
2381972|NCT01450826|5846506|P2|NOT COMPLETED|Overall Study||0
2381973|NCT01450826|5846507|P1|NOT COMPLETED|Overall Study||0
2381974|NCT01450826|5846506|P2|COMPLETED|Overall Study||66
2381975|NCT01450826|5846507|P1|COMPLETED|Overall Study||70
2381976|NCT01450826|5846506|P2|STARTED|Overall Study||66
2381977|NCT01450826|5846507|P1|STARTED|Overall Study||70
2381978|NCT01450813|5846523|P4|NOT COMPLETED|Overall Study||3
2381979|NCT01450813|5846524|P3|NOT COMPLETED|Overall Study||0
2381980|NCT01450813|5846525|P2|NOT COMPLETED|Overall Study||1
2381981|NCT01450813|5846526|P1|NOT COMPLETED|Overall Study||1
2381982|NCT01450813|5846523|P4|COMPLETED|Overall Study||17
2381983|NCT01450813|5846524|P3|COMPLETED|Overall Study||20
2381984|NCT01450813|5846525|P2|COMPLETED|Overall Study||19
2381985|NCT01450813|5846526|P1|COMPLETED|Overall Study||19
2381986|NCT01450813|5846523|P4|STARTED|Overall Study||20
2381987|NCT01450813|5846524|P3|STARTED|Overall Study||20
2381988|NCT01450813|5846525|P2|STARTED|Overall Study||20
2381989|NCT01450813|5846526|P1|STARTED|Overall Study||20
2381990|NCT01450800|5846540|P2|NOT COMPLETED|Overall Study||3
2381991|NCT01450800|5846541|P1|NOT COMPLETED|Overall Study||1
2381992|NCT01450800|5846540|P2|COMPLETED|Overall Study||78
2381993|NCT01450800|5846541|P1|COMPLETED|Overall Study||81
2381994|NCT01450800|5846540|P2|STARTED|Overall Study|81 participants were randomized to placebo|81
2381995|NCT01450800|5846541|P1|STARTED|Overall Study|82 participants were randomized to nitrofurantoin|82
2381996|NCT01450787|5846557|P2|NOT COMPLETED|Overall Study||0
2381997|NCT01450787|5846558|P1|NOT COMPLETED|Overall Study||0
2381998|NCT01450787|5846557|P2|COMPLETED|Overall Study||25
2381999|NCT01450787|5846558|P1|COMPLETED|Overall Study||38
2382000|NCT01450787|5846557|P2|STARTED|Overall Study||25
2382001|NCT01450787|5846558|P1|STARTED|Overall Study||38
2382002|NCT01450761|5846576|P2|NOT COMPLETED|Treatment With Blinded Study Therapy||476
2382003|NCT01450761|5846577|P1|NOT COMPLETED|Treatment With Blinded Study Therapy||478
2382004|NCT01450761|5846576|P2|COMPLETED|Treatment With Blinded Study Therapy||0
2382005|NCT01450761|5846577|P1|COMPLETED|Treatment With Blinded Study Therapy||0
2382006|NCT01450761|5846576|P2|STARTED|Treatment With Blinded Study Therapy||476
2382007|NCT01450761|5846577|P1|STARTED|Treatment With Blinded Study Therapy||478
2382008|NCT01450761|5846576|P2|NOT COMPLETED|Lead-in Chemotherapy||85
2382009|NCT01450761|5846577|P1|NOT COMPLETED|Lead-in Chemotherapy||84
2382010|NCT01450761|5846576|P2|COMPLETED|Lead-in Chemotherapy||476
2382011|NCT01450761|5846577|P1|COMPLETED|Lead-in Chemotherapy||478
2382012|NCT01450761|5846576|P2|STARTED|Lead-in Chemotherapy||561
2382013|NCT01450761|5846577|P1|STARTED|Lead-in Chemotherapy||562
2382014|NCT01450761|5846576|P2|NOT COMPLETED|Randomization||5
2382015|NCT01450761|5846577|P1|NOT COMPLETED|Randomization||4
2382016|NCT01450761|5846576|P2|COMPLETED|Randomization||561
2382017|NCT01450761|5846577|P1|COMPLETED|Randomization||562
2382018|NCT01450761|5846576|P2|STARTED|Randomization||566
2382019|NCT01450761|5846577|P1|STARTED|Randomization||566
2382020|NCT01450696|5846589|P2|NOT COMPLETED|Overall Study||148
2382021|NCT01450696|5846590|P1|NOT COMPLETED|Overall Study||148
2382022|NCT01450696|5846589|P2|COMPLETED|Overall Study||0
2382023|NCT01450696|5846590|P1|COMPLETED|Overall Study||0
2382024|NCT01450696|5846589|P2|Treated (Safety Population)|Overall Study||147
2382025|NCT01450696|5846590|P1|Treated (Safety Population)|Overall Study||147
2382026|NCT01450696|5846589|P2|STARTED|Overall Study||148
2382027|NCT01450696|5846590|P1|STARTED|Overall Study||148
2382028|NCT01450683|5846612|P1|NOT COMPLETED|Overall Study||2
2382029|NCT01450683|5846612|P1|COMPLETED|Overall Study||2
2382030|NCT01450683|5846612|P1|STARTED|Overall Study||4
2382031|NCT01450631|5846618|P2|NOT COMPLETED|Overall Study||4
2382032|NCT01450631|5846619|P1|NOT COMPLETED|Overall Study||3
2382033|NCT01450631|5846618|P2|COMPLETED|Overall Study||42
2382034|NCT01450631|5846619|P1|COMPLETED|Overall Study||43
2382035|NCT01450631|5846618|P2|STARTED|Overall Study||46
2382036|NCT01450631|5846619|P1|STARTED|Overall Study||46
2382037|NCT01450397|5846627|P1|NOT COMPLETED|Overall Study||0
2382038|NCT01450397|5846627|P1|COMPLETED|Overall Study||5
2382039|NCT01450397|5846627|P1|STARTED|Overall Study||5
2382040|NCT01450319|5846631|P1|NOT COMPLETED|Overall Study||0
2382041|NCT01450319|5846631|P1|COMPLETED|Overall Study||70
2382042|NCT01450319|5846631|P1|STARTED|Overall Study||70
2382043|NCT01450306|5846644|P2|NOT COMPLETED|Overall Study||0
2382044|NCT01450306|5846645|P1|NOT COMPLETED|Overall Study||0
2382045|NCT01450306|5846644|P2|COMPLETED|Overall Study||10
2382046|NCT01450306|5846645|P1|COMPLETED|Overall Study||10
2382047|NCT01450306|5846644|P2|STARTED|Overall Study||10
2382048|NCT01450306|5846645|P1|STARTED|Overall Study||10
2382049|NCT01450189|5846658|P3|NOT COMPLETED|Overall Study||0
2382050|NCT01450189|5846659|P2|NOT COMPLETED|Overall Study||0
2382051|NCT01450189|5846660|P1|NOT COMPLETED|Overall Study||0
2382052|NCT01450189|5846658|P3|COMPLETED|Overall Study||19
2382053|NCT01450189|5846659|P2|COMPLETED|Overall Study||18
2382054|NCT01450189|5846660|P1|COMPLETED|Overall Study||9
2382055|NCT01450189|5846658|P3|STARTED|Overall Study||19
2382056|NCT01450189|5846659|P2|STARTED|Overall Study||18
2382057|NCT01450189|5846660|P1|STARTED|Overall Study||9
2382058|NCT01450137|5846749|P2|NOT COMPLETED|Week 12 to Study End||2
2382059|NCT01450137|5846750|P1|NOT COMPLETED|Week 12 to Study End||0
2382060|NCT01450137|5846749|P2|COMPLETED|Week 12 to Study End||5
2382061|NCT01450137|5846750|P1|COMPLETED|Week 12 to Study End||18
2382062|NCT01450137|5846749|P2|STARTED|Week 12 to Study End||7
2382063|NCT01450137|5846750|P1|STARTED|Week 12 to Study End||18
2382064|NCT01450137|5846749|P2|NOT COMPLETED|Up to Week 12||3
2382065|NCT01450137|5846750|P1|NOT COMPLETED|Up to Week 12||2
2382066|NCT01450137|5846749|P2|COMPLETED|Up to Week 12||7
2382067|NCT01450137|5846750|P1|COMPLETED|Up to Week 12||18
2382068|NCT01450137|5846749|P2|STARTED|Up to Week 12||10
2382069|NCT01450137|5846750|P1|STARTED|Up to Week 12||20
2382070|NCT01450098|5846764|P2|NOT COMPLETED|Period 3||3
2382071|NCT01450098|5846765|P1|NOT COMPLETED|Period 3||0
2382072|NCT01450098|5846764|P2|COMPLETED|Period 3||28
2382073|NCT01450098|5846765|P1|COMPLETED|Period 3||8
2382074|NCT01450098|5846764|P2|Received at Least 1 Dose of Study Drug|Period 3||30
2382075|NCT01450098|5846765|P1|Received at Least 1 Dose of Study Drug|Period 3||8
2382076|NCT01450098|5846764|P2|STARTED|Period 3||31
2382077|NCT01450098|5846765|P1|STARTED|Period 3||8
2382078|NCT01450098|5846764|P2|NOT COMPLETED|Washout of at Least 14 Days||0
2382079|NCT01450098|5846765|P1|NOT COMPLETED|Washout of at Least 14 Days||0
2382080|NCT01450098|5846764|P2|COMPLETED|Washout of at Least 14 Days||31
2382081|NCT01450098|5846765|P1|COMPLETED|Washout of at Least 14 Days||8
2382082|NCT01450098|5846764|P2|STARTED|Washout of at Least 14 Days||31
2382083|NCT01450098|5846765|P1|STARTED|Washout of at Least 14 Days||8
2382084|NCT01450098|5846764|P2|NOT COMPLETED|Period 2||0
2382085|NCT01450098|5846765|P1|NOT COMPLETED|Period 2||0
2382086|NCT01450098|5846764|P2|COMPLETED|Period 2||31
2382087|NCT01450098|5846765|P1|COMPLETED|Period 2||8
2382088|NCT01450098|5846764|P2|Received at Least 1 Dose of Study Drug|Period 2||31
2382089|NCT01450098|5846765|P1|Received at Least 1 Dose of Study Drug|Period 2||8
2382090|NCT01450098|5846764|P2|STARTED|Period 2||31
2382091|NCT01450098|5846765|P1|STARTED|Period 2||8
2382092|NCT01450098|5846764|P2|NOT COMPLETED|Washout Period of at Least 14 Days||0
2382093|NCT01450098|5846765|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
2382094|NCT01450098|5846764|P2|COMPLETED|Washout Period of at Least 14 Days||31
2382095|NCT01450098|5846765|P1|COMPLETED|Washout Period of at Least 14 Days||8
2382096|NCT01450098|5846764|P2|STARTED|Washout Period of at Least 14 Days||31
2382097|NCT01450098|5846765|P1|STARTED|Washout Period of at Least 14 Days||8
2382098|NCT01450098|5846764|P2|NOT COMPLETED|Period 1||0
2382099|NCT01450098|5846765|P1|NOT COMPLETED|Period 1||0
2382100|NCT01450098|5846764|P2|COMPLETED|Period 1||31
2382101|NCT01450098|5846765|P1|COMPLETED|Period 1||8
2382102|NCT01450098|5846764|P2|Received at Least 1 Dose of Study Drug|Period 1||31
2382103|NCT01450098|5846765|P1|Received at Least 1 Dose of Study Drug|Period 1||8
2382104|NCT01450098|5846764|P2|STARTED|Period 1||31
2382105|NCT01450098|5846765|P1|STARTED|Period 1||8
2382106|NCT01450007|5846784|P3|NOT COMPLETED|Overall Study||3
2382107|NCT01450007|5846785|P2|NOT COMPLETED|Overall Study||5
2382108|NCT01450007|5846786|P1|NOT COMPLETED|Overall Study||2
2382109|NCT01450007|5846784|P3|COMPLETED|Overall Study||41
2382110|NCT01450007|5846785|P2|COMPLETED|Overall Study||37
2382111|NCT01450007|5846786|P1|COMPLETED|Overall Study||42
2382112|NCT01450007|5846784|P3|STARTED|Overall Study||44
2382113|NCT01450007|5846785|P2|STARTED|Overall Study||42
2382114|NCT01450007|5846786|P1|STARTED|Overall Study||44
2382115|NCT01449955|5846805|P2|NOT COMPLETED|Overall Study||2
2382116|NCT01449955|5846806|P1|NOT COMPLETED|Overall Study||1
2382117|NCT01449955|5846805|P2|COMPLETED|Overall Study||24
2382118|NCT01449955|5846806|P1|COMPLETED|Overall Study||27
2382119|NCT01449955|5846805|P2|STARTED|Overall Study||26
2382120|NCT01449955|5846806|P1|STARTED|Overall Study||28
2382121|NCT01449929|5846834|P3|NOT COMPLETED|Extension Phase Approximately 3 Years||8
2382122|NCT01449929|5846835|P2|NOT COMPLETED|Extension Phase Approximately 3 Years||0
2382123|NCT01449929|5846836|P1|NOT COMPLETED|Extension Phase Approximately 3 Years||0
2382124|NCT01449929|5846834|P3|COMPLETED|Extension Phase Approximately 3 Years||115
2382125|NCT01449929|5846835|P2|COMPLETED|Extension Phase Approximately 3 Years||0
2382126|NCT01449929|5846836|P1|COMPLETED|Extension Phase Approximately 3 Years||0
2382127|NCT01449929|5846834|P3|STARTED|Extension Phase Approximately 3 Years||123
2382128|NCT01449929|5846835|P2|STARTED|Extension Phase Approximately 3 Years||0
2382129|NCT01449929|5846836|P1|STARTED|Extension Phase Approximately 3 Years||0
2382130|NCT01449929|5846834|P3|NOT COMPLETED|Randomization Phase 96 Week||0
2382131|NCT01449929|5846835|P2|NOT COMPLETED|Randomization Phase 96 Week||53
2382132|NCT01449929|5846836|P1|NOT COMPLETED|Randomization Phase 96 Week||33
2382133|NCT01449929|5846834|P3|COMPLETED|Randomization Phase 96 Week||0
2382134|NCT01449929|5846835|P2|COMPLETED|Randomization Phase 96 Week||189
2382135|NCT01449929|5846836|P1|COMPLETED|Randomization Phase 96 Week||209
2382136|NCT01449929|5846834|P3|STARTED|Randomization Phase 96 Week||0
2382137|NCT01449929|5846835|P2|STARTED|Randomization Phase 96 Week||242
2382138|NCT01449929|5846836|P1|STARTED|Randomization Phase 96 Week||242
2382139|NCT01449864|5846873|P1|NOT COMPLETED|Overall Study||5
2382140|NCT01449864|5846873|P1|COMPLETED|Overall Study||17
2382141|NCT01449864|5846873|P1|STARTED|Overall Study||22
2382142|NCT01449812|5846881|P3|NOT COMPLETED|Overall Study||1
2382143|NCT01449812|5846882|P2|NOT COMPLETED|Overall Study||0
2382144|NCT01449812|5846883|P1|NOT COMPLETED|Overall Study||2
2382145|NCT01449812|5846881|P3|COMPLETED|Overall Study||279
2382146|NCT01449812|5846882|P2|COMPLETED|Overall Study||273
2382147|NCT01449812|5846883|P1|COMPLETED|Overall Study||270
2382148|NCT01449812|5846881|P3|STARTED|Overall Study||280
2382149|NCT01449812|5846882|P2|STARTED|Overall Study||273
2382150|NCT01449812|5846883|P1|STARTED|Overall Study||272
2382151|NCT01449747|5846977|P2|NOT COMPLETED|Overall Study||0
2382152|NCT01449747|5846978|P1|NOT COMPLETED|Overall Study||0
2382153|NCT01449747|5846977|P2|COMPLETED|Overall Study||12
2382154|NCT01449747|5846978|P1|COMPLETED|Overall Study||12
2382155|NCT01449747|5846977|P2|STARTED|Overall Study||12
2382156|NCT01449747|5846978|P1|STARTED|Overall Study||12
2382157|NCT01449734|5846992|P1|NOT COMPLETED|Overall Study||0
2382158|NCT01449734|5846992|P1|COMPLETED|Overall Study||215
2382159|NCT01449734|5846992|P1|STARTED|Overall Study||215
2382160|NCT01449721|5846998|P2|NOT COMPLETED|Overall Study||2
2382161|NCT01449721|5846999|P1|NOT COMPLETED|Overall Study||0
2382162|NCT01449721|5846998|P2|COMPLETED|Overall Study||28
2382163|NCT01449721|5846999|P1|COMPLETED|Overall Study||112
2382164|NCT01449721|5846998|P2|STARTED|Overall Study||30
2382165|NCT01449721|5846999|P1|STARTED|Overall Study||112
2382166|NCT01449708|5847011|P2|NOT COMPLETED|Overall Study||3
2382167|NCT01449708|5847012|P1|NOT COMPLETED|Overall Study||2
2382168|NCT01449708|5847011|P2|COMPLETED|Overall Study||60
2382169|NCT01449708|5847012|P1|COMPLETED|Overall Study||59
2382170|NCT01449708|5847011|P2|STARTED|Overall Study||63
2382171|NCT01449708|5847012|P1|STARTED|Overall Study||61
2382172|NCT01449682|5847023|P2|NOT COMPLETED|Overall Study||1
2382173|NCT01449682|5847024|P1|NOT COMPLETED|Overall Study||1
2382174|NCT01449682|5847023|P2|COMPLETED|Overall Study||4
2382175|NCT01449682|5847024|P1|COMPLETED|Overall Study||4
2382176|NCT01449682|5847023|P2|STARTED|Overall Study||5
2382177|NCT01449682|5847024|P1|STARTED|Overall Study||5
2382178|NCT01449630|5847045|P9|NOT COMPLETED|Period 3||0
2382179|NCT01449630|5847046|P8|NOT COMPLETED|Period 3||0
2382180|NCT01449630|5847047|P7|NOT COMPLETED|Period 3||0
2382181|NCT01449630|5847048|P6|NOT COMPLETED|Period 3||0
2382182|NCT01449630|5847049|P5|NOT COMPLETED|Period 3||0
2382183|NCT01449630|5847050|P4|NOT COMPLETED|Period 3||0
2382184|NCT01449630|5847051|P3|NOT COMPLETED|Period 3||0
2382185|NCT01449630|5847052|P2|NOT COMPLETED|Period 3||0
2382186|NCT01449630|5847053|P1|NOT COMPLETED|Period 3||0
2382187|NCT01449630|5847045|P9|COMPLETED|Period 3||2
2382188|NCT01449630|5847046|P8|COMPLETED|Period 3||6
2382189|NCT01449630|5847047|P7|COMPLETED|Period 3||1
2382190|NCT01449630|5847048|P6|COMPLETED|Period 3||1
2382191|NCT01449630|5847049|P5|COMPLETED|Period 3||5
2382192|NCT01449630|5847050|P4|COMPLETED|Period 3||1
2382193|NCT01449630|5847051|P3|COMPLETED|Period 3||2
2382194|NCT01449630|5847052|P2|COMPLETED|Period 3||6
2382195|NCT01449630|5847053|P1|COMPLETED|Period 3||1
2382196|NCT01449630|5847045|P9|STARTED|Period 3||2
2382197|NCT01449630|5847046|P8|STARTED|Period 3||6
2382198|NCT01449630|5847047|P7|STARTED|Period 3||1
2382199|NCT01449630|5847048|P6|STARTED|Period 3||1
2382200|NCT01449630|5847049|P5|STARTED|Period 3||5
2382201|NCT01449630|5847050|P4|STARTED|Period 3||1
2382202|NCT01449630|5847051|P3|STARTED|Period 3||2
2382203|NCT01449630|5847052|P2|STARTED|Period 3||6
2382204|NCT01449630|5847053|P1|STARTED|Period 3||1
2382205|NCT01449630|5847045|P9|NOT COMPLETED|Period 2||0
2382206|NCT01449630|5847046|P8|NOT COMPLETED|Period 2||0
2382207|NCT01449630|5847047|P7|NOT COMPLETED|Period 2||1
2382208|NCT01449630|5847048|P6|NOT COMPLETED|Period 2||0
2382209|NCT01449630|5847049|P5|NOT COMPLETED|Period 2||0
2382210|NCT01449630|5847050|P4|NOT COMPLETED|Period 2||0
2382211|NCT01449630|5847051|P3|NOT COMPLETED|Period 2||0
2382212|NCT01449630|5847052|P2|NOT COMPLETED|Period 2||0
2382213|NCT01449630|5847053|P1|NOT COMPLETED|Period 2||0
2382214|NCT01449630|5847045|P9|COMPLETED|Period 2||2
2382215|NCT01449630|5847046|P8|COMPLETED|Period 2||6
2382216|NCT01449630|5847047|P7|COMPLETED|Period 2||1
2382217|NCT01449630|5847048|P6|COMPLETED|Period 2||1
2382218|NCT01449630|5847049|P5|COMPLETED|Period 2||5
2382219|NCT01449630|5847050|P4|COMPLETED|Period 2||1
2382220|NCT01449630|5847051|P3|COMPLETED|Period 2||2
2382221|NCT01449630|5847052|P2|COMPLETED|Period 2||6
2382222|NCT01449630|5847053|P1|COMPLETED|Period 2||1
2382223|NCT01449630|5847045|P9|STARTED|Period 2||2
2382224|NCT01449630|5847046|P8|STARTED|Period 2||6
2382225|NCT01449630|5847047|P7|STARTED|Period 2||2
2382226|NCT01449630|5847048|P6|STARTED|Period 2||1
2382227|NCT01449630|5847049|P5|STARTED|Period 2||5
2382228|NCT01449630|5847050|P4|STARTED|Period 2||1
2382229|NCT01449630|5847051|P3|STARTED|Period 2||2
2382230|NCT01449630|5847052|P2|STARTED|Period 2||6
2382231|NCT01449630|5847053|P1|STARTED|Period 2||1
2382232|NCT01449630|5847045|P9|NOT COMPLETED|Period 1||0
2382233|NCT01449630|5847046|P8|NOT COMPLETED|Period 1||0
2382234|NCT01449630|5847047|P7|NOT COMPLETED|Period 1||0
2382235|NCT01449630|5847048|P6|NOT COMPLETED|Period 1||1
2382236|NCT01449630|5847049|P5|NOT COMPLETED|Period 1||0
2382237|NCT01449630|5847050|P4|NOT COMPLETED|Period 1||1
2382238|NCT01449630|5847051|P3|NOT COMPLETED|Period 1||0
2382239|NCT01449630|5847052|P2|NOT COMPLETED|Period 1||0
2382240|NCT01449630|5847053|P1|NOT COMPLETED|Period 1||1
2382241|NCT01449630|5847045|P9|COMPLETED|Period 1||2
2382242|NCT01449630|5847046|P8|COMPLETED|Period 1||6
2382243|NCT01449630|5847047|P7|COMPLETED|Period 1||2
2382244|NCT01449630|5847048|P6|COMPLETED|Period 1||1
2382245|NCT01449630|5847049|P5|COMPLETED|Period 1||5
2382246|NCT01449630|5847050|P4|COMPLETED|Period 1||1
2382247|NCT01449630|5847051|P3|COMPLETED|Period 1||2
2382248|NCT01449630|5847052|P2|COMPLETED|Period 1||6
2382249|NCT01449630|5847053|P1|COMPLETED|Period 1||1
2382250|NCT01449630|5847045|P9|Received at Least 1 Dose|Period 1||2
2382251|NCT01449630|5847046|P8|Received at Least 1 Dose|Period 1||6
2382252|NCT01449630|5847047|P7|Received at Least 1 Dose|Period 1||2
2382253|NCT01449630|5847048|P6|Received at Least 1 Dose|Period 1||1
2382254|NCT01449630|5847049|P5|Received at Least 1 Dose|Period 1||5
2382255|NCT01449630|5847050|P4|Received at Least 1 Dose|Period 1||2
2382256|NCT01449630|5847051|P3|Received at Least 1 Dose|Period 1||2
2382257|NCT01449630|5847052|P2|Received at Least 1 Dose|Period 1||6
2382258|NCT01449630|5847053|P1|Received at Least 1 Dose|Period 1||2
2382259|NCT01449630|5847045|P9|STARTED|Period 1||2
2382260|NCT01449630|5847046|P8|STARTED|Period 1||6
2382261|NCT01449630|5847047|P7|STARTED|Period 1||2
2382262|NCT01449630|5847048|P6|STARTED|Period 1||2
2382263|NCT01449630|5847049|P5|STARTED|Period 1||5
2382264|NCT01449630|5847050|P4|STARTED|Period 1||2
2382265|NCT01449630|5847051|P3|STARTED|Period 1||2
2382266|NCT01449630|5847052|P2|STARTED|Period 1||6
2382267|NCT01449630|5847053|P1|STARTED|Period 1||2
2382268|NCT01449539|5847123|P1|NOT COMPLETED|Overall Study||4
2382269|NCT01449539|5847123|P1|COMPLETED|Overall Study||4
2382270|NCT01449539|5847123|P1|STARTED|Overall Study||8
2382271|NCT01449526|5847129|P2|NOT COMPLETED|Overall Study||6
2382272|NCT01449526|5847130|P1|NOT COMPLETED|Overall Study||2
2382273|NCT01449526|5847129|P2|COMPLETED|Overall Study||77
2382274|NCT01449526|5847130|P1|COMPLETED|Overall Study||81
2382275|NCT01449526|5847129|P2|STARTED|Overall Study||83
2382276|NCT01449526|5847130|P1|STARTED|Overall Study||83
2382277|NCT01449513|5847140|P2|NOT COMPLETED|Overall Study||0
2382278|NCT01449513|5847141|P1|NOT COMPLETED|Overall Study||0
2382279|NCT01449513|5847140|P2|COMPLETED|Overall Study||8
2382280|NCT01449513|5847141|P1|COMPLETED|Overall Study||16
2382281|NCT01449513|5847140|P2|STARTED|Overall Study||8
2382282|NCT01449513|5847141|P1|STARTED|Overall Study||16
2382283|NCT01449461|5847199|P6|NOT COMPLETED|Overall Study||15
2382284|NCT01449461|5847200|P5|NOT COMPLETED|Overall Study||48
2382285|NCT01449461|5847201|P4|NOT COMPLETED|Overall Study||32
2382286|NCT01449461|5847202|P3|NOT COMPLETED|Overall Study||18
2382287|NCT01449461|5847203|P2|NOT COMPLETED|Overall Study||18
2382288|NCT01449461|5847204|P1|NOT COMPLETED|Overall Study||6
2382289|NCT01449461|5847199|P6|COMPLETED|Overall Study||0
2382290|NCT01449461|5847200|P5|COMPLETED|Overall Study||0
2382291|NCT01449461|5847201|P4|COMPLETED|Overall Study||0
2382292|NCT01449461|5847202|P3|COMPLETED|Overall Study||0
2382293|NCT01449461|5847203|P2|COMPLETED|Overall Study||0
2382294|NCT01449461|5847204|P1|COMPLETED|Overall Study||0
2382295|NCT01449461|5847199|P6|STARTED|Overall Study||15
2382296|NCT01449461|5847200|P5|STARTED|Overall Study||48
2382297|NCT01449461|5847201|P4|STARTED|Overall Study||32
2382298|NCT01449461|5847202|P3|STARTED|Overall Study||18
2382299|NCT01449461|5847203|P2|STARTED|Overall Study||18
2382300|NCT01449461|5847204|P1|STARTED|Overall Study||6
2382301|NCT01449370|5847341|P25|NOT COMPLETED|Overall Study||8
2382302|NCT01449370|5847342|P24|NOT COMPLETED|Overall Study||10
2382303|NCT01449370|5847343|P23|NOT COMPLETED|Overall Study||4
2382304|NCT01449370|5847344|P22|NOT COMPLETED|Overall Study||4
2382305|NCT01449370|5847345|P21|NOT COMPLETED|Overall Study||6
2382306|NCT01449370|5847346|P20|NOT COMPLETED|Overall Study||3
2382307|NCT01449370|5847347|P19|NOT COMPLETED|Overall Study||3
2382308|NCT01449370|5847348|P18|NOT COMPLETED|Overall Study||3
2382309|NCT01449370|5847349|P17|NOT COMPLETED|Overall Study||7
2382310|NCT01449370|5847350|P16|NOT COMPLETED|Overall Study||3
2382311|NCT01449370|5847351|P15|NOT COMPLETED|Overall Study||3
2382312|NCT01449370|5847352|P14|NOT COMPLETED|Overall Study||11
2382313|NCT01449370|5847353|P13|NOT COMPLETED|Overall Study||3
2382314|NCT01449370|5847354|P12|NOT COMPLETED|Overall Study||3
2382315|NCT01449370|5847355|P11|NOT COMPLETED|Overall Study||3
2382316|NCT01449370|5847356|P10|NOT COMPLETED|Overall Study||3
2382317|NCT01449370|5847357|P9|NOT COMPLETED|Overall Study||12
2382318|NCT01449370|5847358|P8|NOT COMPLETED|Overall Study||3
2382319|NCT01449370|5847359|P7|NOT COMPLETED|Overall Study||3
2382320|NCT01449370|5847360|P6|NOT COMPLETED|Overall Study||3
2382321|NCT01449370|5847361|P5|NOT COMPLETED|Overall Study||3
2382322|NCT01449370|5847362|P4|NOT COMPLETED|Overall Study||4
2382323|NCT01449370|5847363|P3|NOT COMPLETED|Overall Study||8
2382324|NCT01449370|5847364|P2|NOT COMPLETED|Overall Study||6
2382325|NCT01449370|5847365|P1|NOT COMPLETED|Overall Study||6
2382326|NCT01449370|5847341|P25|COMPLETED|Overall Study||0
2382327|NCT01449370|5847342|P24|COMPLETED|Overall Study||0
2382328|NCT01449370|5847343|P23|COMPLETED|Overall Study||0
2382329|NCT01449370|5847344|P22|COMPLETED|Overall Study||0
2382330|NCT01449370|5847345|P21|COMPLETED|Overall Study||0
2382331|NCT01449370|5847346|P20|COMPLETED|Overall Study||0
2382332|NCT01449370|5847347|P19|COMPLETED|Overall Study||0
2382333|NCT01449370|5847348|P18|COMPLETED|Overall Study||0
2382334|NCT01449370|5847349|P17|COMPLETED|Overall Study||0
2382335|NCT01449370|5847350|P16|COMPLETED|Overall Study||0
2382336|NCT01449370|5847351|P15|COMPLETED|Overall Study||0
2382337|NCT01449370|5847352|P14|COMPLETED|Overall Study||0
2382338|NCT01449370|5847353|P13|COMPLETED|Overall Study||0
2382339|NCT01449370|5847354|P12|COMPLETED|Overall Study||0
2382340|NCT01449370|5847355|P11|COMPLETED|Overall Study||0
2382341|NCT01449370|5847356|P10|COMPLETED|Overall Study||0
2382342|NCT01449370|5847357|P9|COMPLETED|Overall Study||0
2382343|NCT01449370|5847358|P8|COMPLETED|Overall Study||0
2382344|NCT01449370|5847359|P7|COMPLETED|Overall Study||0
2382345|NCT01449370|5847360|P6|COMPLETED|Overall Study||0
2382346|NCT01449370|5847361|P5|COMPLETED|Overall Study||0
2382347|NCT01449370|5847362|P4|COMPLETED|Overall Study||0
2382348|NCT01449370|5847363|P3|COMPLETED|Overall Study||0
2382349|NCT01449370|5847364|P2|COMPLETED|Overall Study||0
2382350|NCT01449370|5847365|P1|COMPLETED|Overall Study||0
2382351|NCT01449370|5847341|P25|STARTED|Overall Study||8
2382352|NCT01449370|5847342|P24|STARTED|Overall Study||10
2382353|NCT01449370|5847343|P23|STARTED|Overall Study||4
2382354|NCT01449370|5847344|P22|STARTED|Overall Study||4
2382355|NCT01449370|5847345|P21|STARTED|Overall Study||6
2382356|NCT01449370|5847346|P20|STARTED|Overall Study||3
2382357|NCT01449370|5847347|P19|STARTED|Overall Study||3
2382358|NCT01449370|5847348|P18|STARTED|Overall Study||3
2382359|NCT01449370|5847349|P17|STARTED|Overall Study||7
2382360|NCT01449370|5847350|P16|STARTED|Overall Study||3
2382361|NCT01449370|5847351|P15|STARTED|Overall Study||3
2382362|NCT01449370|5847352|P14|STARTED|Overall Study||11
2382363|NCT01449370|5847353|P13|STARTED|Overall Study||3
2382364|NCT01449370|5847354|P12|STARTED|Overall Study||3
2382365|NCT01449370|5847355|P11|STARTED|Overall Study||3
2382366|NCT01449370|5847356|P10|STARTED|Overall Study||3
2382367|NCT01449370|5847357|P9|STARTED|Overall Study||12
2382368|NCT01449370|5847358|P8|STARTED|Overall Study||3
2382369|NCT01449370|5847359|P7|STARTED|Overall Study||3
2382370|NCT01449370|5847360|P6|STARTED|Overall Study||3
2382371|NCT01449370|5847361|P5|STARTED|Overall Study||3
2382372|NCT01449370|5847362|P4|STARTED|Overall Study||4
2382373|NCT01449370|5847363|P3|STARTED|Overall Study||8
2382374|NCT01449370|5847364|P2|STARTED|Overall Study||6
2382375|NCT01449370|5847365|P1|STARTED|Overall Study||6
2382376|NCT01449305|5847738|P1|NOT COMPLETED|Overall Study||2
2382377|NCT01449305|5847738|P1|COMPLETED|Overall Study||42
2382378|NCT01449305|5847738|P1|STARTED|Overall Study||44
2382379|NCT01449279|5847743|P1|NOT COMPLETED|Overall Study||7
2382380|NCT01449279|5847743|P1|COMPLETED|Overall Study||15
2382381|NCT01449279|5847743|P1|STARTED|Overall Study||22
2382382|NCT01449266|5847754|P1|NOT COMPLETED|Overall Study||0
2382383|NCT01449266|5847754|P1|COMPLETED|Overall Study||10
2382384|NCT01449266|5847754|P1|STARTED|Overall Study||10
2382385|NCT01449240|5847761|P1|NOT COMPLETED|Overall Study||0
2382386|NCT01449240|5847761|P1|COMPLETED|Overall Study||10
2382387|NCT01449240|5847761|P1|STARTED|Overall Study||10
2382388|NCT01449006|5847768|P2|NOT COMPLETED|Overall Study||0
2382389|NCT01449006|5847769|P1|NOT COMPLETED|Overall Study||3
2382390|NCT01449006|5847768|P2|COMPLETED|Overall Study||9
2382391|NCT01449006|5847769|P1|COMPLETED|Overall Study||5
2382392|NCT01449006|5847768|P2|STARTED|Overall Study||9
2382393|NCT01449006|5847769|P1|STARTED|Overall Study||8
2382394|NCT01448850|5847783|P2|NOT COMPLETED|Overall Study||40
2382395|NCT01448850|5847784|P1|NOT COMPLETED|Overall Study||34
2382396|NCT01448850|5847783|P2|COMPLETED|Overall Study||120
2382397|NCT01448850|5847784|P1|COMPLETED|Overall Study||130
2382398|NCT01448850|5847783|P2|STARTED|Overall Study||160
2382399|NCT01448850|5847784|P1|STARTED|Overall Study||164
2382400|NCT01448824|5847815|P8|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||3
2382401|NCT01448824|5847816|P7|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
2382402|NCT01448824|5847817|P6|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
2382403|NCT01448824|5847818|P5|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
2382404|NCT01448824|5847819|P4|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
2382405|NCT01448824|5847820|P3|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
2382406|NCT01448824|5847821|P2|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
2382407|NCT01448824|5847822|P1|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
2382408|NCT01448824|5847815|P8|COMPLETED|Part 2 Period 2: Drug-drug Interaction||8
2382409|NCT01448824|5847816|P7|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
2382410|NCT01448824|5847817|P6|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
2382411|NCT01448824|5847818|P5|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
2382412|NCT01448824|5847819|P4|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
2382413|NCT01448824|5847820|P3|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
2382414|NCT01448824|5847821|P2|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
2382415|NCT01448824|5847822|P1|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
2382416|NCT01448824|5847815|P8|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||10
2382417|NCT01448824|5847816|P7|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
2382418|NCT01448824|5847817|P6|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
2382419|NCT01448824|5847818|P5|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
2382420|NCT01448824|5847819|P4|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
2382421|NCT01448824|5847820|P3|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
2382422|NCT01448824|5847821|P2|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
2382423|NCT01448824|5847822|P1|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
2382424|NCT01448824|5847815|P8|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||11
2382425|NCT01448824|5847816|P7|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
2382426|NCT01448824|5847817|P6|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
2382427|NCT01448824|5847818|P5|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
2382428|NCT01448824|5847819|P4|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
2382429|NCT01448824|5847820|P3|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
2382430|NCT01448824|5847821|P2|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
2382431|NCT01448824|5847822|P1|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
2382432|NCT01448824|5847815|P8|STARTED|Part 2 Period 2: Drug-drug Interaction||11
2382433|NCT01448824|5847816|P7|STARTED|Part 2 Period 2: Drug-drug Interaction||0
2382434|NCT01448824|5847817|P6|STARTED|Part 2 Period 2: Drug-drug Interaction||0
2382435|NCT01448824|5847818|P5|STARTED|Part 2 Period 2: Drug-drug Interaction||0
2382436|NCT01448824|5847819|P4|STARTED|Part 2 Period 2: Drug-drug Interaction||0
2382437|NCT01448824|5847820|P3|STARTED|Part 2 Period 2: Drug-drug Interaction||0
2382438|NCT01448824|5847821|P2|STARTED|Part 2 Period 2: Drug-drug Interaction||0
2382439|NCT01448824|5847822|P1|STARTED|Part 2 Period 2: Drug-drug Interaction||0
2382440|NCT01448824|5847815|P8|NOT COMPLETED|Part 2: Washout Period||0
2382441|NCT01448824|5847816|P7|NOT COMPLETED|Part 2: Washout Period||0
2382442|NCT01448824|5847817|P6|NOT COMPLETED|Part 2: Washout Period||0
2382443|NCT01448824|5847818|P5|NOT COMPLETED|Part 2: Washout Period||0
2382444|NCT01448824|5847819|P4|NOT COMPLETED|Part 2: Washout Period||0
2382445|NCT01448824|5847820|P3|NOT COMPLETED|Part 2: Washout Period||0
2382446|NCT01448824|5847821|P2|NOT COMPLETED|Part 2: Washout Period||0
2382447|NCT01448824|5847822|P1|NOT COMPLETED|Part 2: Washout Period||0
2382448|NCT01448824|5847815|P8|COMPLETED|Part 2: Washout Period||11
2382449|NCT01448824|5847816|P7|COMPLETED|Part 2: Washout Period||0
2382450|NCT01448824|5847817|P6|COMPLETED|Part 2: Washout Period||0
2382451|NCT01448824|5847818|P5|COMPLETED|Part 2: Washout Period||0
2382452|NCT01448824|5847819|P4|COMPLETED|Part 2: Washout Period||0
2382453|NCT01448824|5847820|P3|COMPLETED|Part 2: Washout Period||0
2382454|NCT01448824|5847821|P2|COMPLETED|Part 2: Washout Period||0
2382455|NCT01448824|5847822|P1|COMPLETED|Part 2: Washout Period||0
2382456|NCT01448824|5847815|P8|STARTED|Part 2: Washout Period||11
2382457|NCT01448824|5847816|P7|STARTED|Part 2: Washout Period||0
2382458|NCT01448824|5847817|P6|STARTED|Part 2: Washout Period||0
2382459|NCT01448824|5847818|P5|STARTED|Part 2: Washout Period||0
2382460|NCT01448824|5847819|P4|STARTED|Part 2: Washout Period||0
2382461|NCT01448824|5847820|P3|STARTED|Part 2: Washout Period||0
2382462|NCT01448824|5847821|P2|STARTED|Part 2: Washout Period||0
2382463|NCT01448824|5847822|P1|STARTED|Part 2: Washout Period||0
2382464|NCT01448824|5847815|P8|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||1
2382465|NCT01448824|5847816|P7|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
2382466|NCT01448824|5847817|P6|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
2382467|NCT01448824|5847818|P5|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
2382468|NCT01448824|5847819|P4|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
2382469|NCT01448824|5847820|P3|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
2382470|NCT01448824|5847821|P2|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
2382471|NCT01448824|5847822|P1|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
2382472|NCT01448824|5847815|P8|COMPLETED|Part 2 Period 1: Drug-drug Interaction||11
2382473|NCT01448824|5847816|P7|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
2382474|NCT01448824|5847817|P6|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
2382475|NCT01448824|5847818|P5|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
2382476|NCT01448824|5847819|P4|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
2382477|NCT01448824|5847820|P3|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
2382478|NCT01448824|5847821|P2|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
2382479|NCT01448824|5847822|P1|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
2382480|NCT01448824|5847815|P8|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||12
2382481|NCT01448824|5847816|P7|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
2382482|NCT01448824|5847817|P6|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
2382483|NCT01448824|5847818|P5|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
2382484|NCT01448824|5847819|P4|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
2382485|NCT01448824|5847820|P3|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
2382486|NCT01448824|5847821|P2|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
2382487|NCT01448824|5847822|P1|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
2382488|NCT01448824|5847815|P8|STARTED|Part 2 Period 1: Drug-drug Interaction||12
2382489|NCT01448824|5847816|P7|STARTED|Part 2 Period 1: Drug-drug Interaction||0
2382490|NCT01448824|5847817|P6|STARTED|Part 2 Period 1: Drug-drug Interaction||0
2382491|NCT01448824|5847818|P5|STARTED|Part 2 Period 1: Drug-drug Interaction||0
2382492|NCT01448824|5847819|P4|STARTED|Part 2 Period 1: Drug-drug Interaction||0
2382493|NCT01448824|5847820|P3|STARTED|Part 2 Period 1: Drug-drug Interaction||0
2382494|NCT01448824|5847821|P2|STARTED|Part 2 Period 1: Drug-drug Interaction||0
2382495|NCT01448824|5847822|P1|STARTED|Part 2 Period 1: Drug-drug Interaction||0
2382496|NCT01448824|5847815|P8|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
2382497|NCT01448824|5847816|P7|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
2382498|NCT01448824|5847817|P6|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
2382499|NCT01448824|5847818|P5|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
2382500|NCT01448824|5847819|P4|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
2382501|NCT01448824|5847820|P3|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
2382502|NCT01448824|5847821|P2|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
2382503|NCT01448824|5847822|P1|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
2382504|NCT01448824|5847815|P8|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
2382505|NCT01448824|5847816|P7|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
2382506|NCT01448824|5847817|P6|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
2382507|NCT01448824|5847818|P5|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
2382508|NCT01448824|5847819|P4|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
2382509|NCT01448824|5847820|P3|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||4
2382510|NCT01448824|5847821|P2|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||4
2382511|NCT01448824|5847822|P1|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||11
2382512|NCT01448824|5847815|P8|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
2382513|NCT01448824|5847816|P7|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
2382514|NCT01448824|5847817|P6|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
2382515|NCT01448824|5847818|P5|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
2382516|NCT01448824|5847819|P4|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
2382517|NCT01448824|5847820|P3|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||4
2382518|NCT01448824|5847821|P2|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||4
2382519|NCT01448824|5847822|P1|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||11
2382520|NCT01448824|5847815|P8|STARTED|Part 1 Period 2: Multiple Ascending Dose||0
2382521|NCT01448824|5847816|P7|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort D participated in Period 1 only.|0
2382522|NCT01448824|5847817|P6|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort C participated in Period 1 only.|0
2382523|NCT01448824|5847818|P5|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort B participated in Period 1 only.|0
2382524|NCT01448824|5847819|P4|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohorts B through D participated in Period 1 only.|0
2382525|NCT01448824|5847820|P3|STARTED|Part 1 Period 2: Multiple Ascending Dose||4
2382526|NCT01448824|5847821|P2|STARTED|Part 1 Period 2: Multiple Ascending Dose||4
2382527|NCT01448824|5847822|P1|STARTED|Part 1 Period 2: Multiple Ascending Dose||11
2382528|NCT01448824|5847815|P8|NOT COMPLETED|Part 1: Washout Period||0
2382529|NCT01448824|5847816|P7|NOT COMPLETED|Part 1: Washout Period||0
2382530|NCT01448824|5847817|P6|NOT COMPLETED|Part 1: Washout Period||0
2382531|NCT01448824|5847818|P5|NOT COMPLETED|Part 1: Washout Period||0
2382532|NCT01448824|5847819|P4|NOT COMPLETED|Part 1: Washout Period||0
2382533|NCT01448824|5847820|P3|NOT COMPLETED|Part 1: Washout Period||0
2382534|NCT01448824|5847821|P2|NOT COMPLETED|Part 1: Washout Period||0
2382535|NCT01448824|5847822|P1|NOT COMPLETED|Part 1: Washout Period||1
2382536|NCT01448824|5847815|P8|COMPLETED|Part 1: Washout Period||0
2382537|NCT01448824|5847816|P7|COMPLETED|Part 1: Washout Period||0
2382538|NCT01448824|5847817|P6|COMPLETED|Part 1: Washout Period||0
2382539|NCT01448824|5847818|P5|COMPLETED|Part 1: Washout Period||0
2382540|NCT01448824|5847819|P4|COMPLETED|Part 1: Washout Period||0
2382541|NCT01448824|5847820|P3|COMPLETED|Part 1: Washout Period||4
2382542|NCT01448824|5847821|P2|COMPLETED|Part 1: Washout Period||4
2382543|NCT01448824|5847822|P1|COMPLETED|Part 1: Washout Period||11
2382544|NCT01448824|5847815|P8|STARTED|Part 1: Washout Period||0
2382545|NCT01448824|5847816|P7|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort D participated in Period 1 only.|0
2382546|NCT01448824|5847817|P6|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort C participated in Period 1 only.|0
2382547|NCT01448824|5847818|P5|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort B participated in Period 1 only.|0
2382548|NCT01448824|5847819|P4|STARTED|Part 1: Washout Period|Participants in Part 1 Cohorts B through D participated in Period 1 only.|0
2382549|NCT01448824|5847820|P3|STARTED|Part 1: Washout Period||4
2382550|NCT01448824|5847821|P2|STARTED|Part 1: Washout Period||4
2382551|NCT01448824|5847822|P1|STARTED|Part 1: Washout Period||12
2382552|NCT01448824|5847815|P8|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
2382553|NCT01448824|5847816|P7|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||1
2382554|NCT01448824|5847817|P6|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||2
2382555|NCT01448824|5847818|P5|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||2
2382556|NCT01448824|5847819|P4|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||1
2382557|NCT01448824|5847820|P3|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
2382558|NCT01448824|5847821|P2|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
2382559|NCT01448824|5847822|P1|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
2382560|NCT01448824|5847815|P8|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
2382561|NCT01448824|5847816|P7|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||11
2382562|NCT01448824|5847817|P6|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||10
2382563|NCT01448824|5847818|P5|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||14
2382564|NCT01448824|5847819|P4|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||9
2382565|NCT01448824|5847820|P3|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||4
2382566|NCT01448824|5847821|P2|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||4
2382567|NCT01448824|5847822|P1|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||12
2382568|NCT01448824|5847815|P8|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||0
2382569|NCT01448824|5847816|P7|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
2382570|NCT01448824|5847817|P6|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
2382571|NCT01448824|5847818|P5|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||16
2382572|NCT01448824|5847819|P4|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||10
2382573|NCT01448824|5847820|P3|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||4
2382574|NCT01448824|5847821|P2|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||4
2382575|NCT01448824|5847822|P1|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
2382576|NCT01448824|5847815|P8|STARTED|Part 1 Period 1: Multiple Ascending Dose||0
2382577|NCT01448824|5847816|P7|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
2382578|NCT01448824|5847817|P6|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
2382579|NCT01448824|5847818|P5|STARTED|Part 1 Period 1: Multiple Ascending Dose||16
2382580|NCT01448824|5847819|P4|STARTED|Part 1 Period 1: Multiple Ascending Dose||10
2382581|NCT01448824|5847820|P3|STARTED|Part 1 Period 1: Multiple Ascending Dose||4
2382582|NCT01448824|5847821|P2|STARTED|Part 1 Period 1: Multiple Ascending Dose||4
2382583|NCT01448824|5847822|P1|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
2382584|NCT01448707|5847873|P2|NOT COMPLETED|Overall Study||18
2382585|NCT01448707|5847874|P1|NOT COMPLETED|Overall Study||18
2382586|NCT01448707|5847873|P2|COMPLETED|Overall Study||118
2382587|NCT01448707|5847874|P1|COMPLETED|Overall Study||119
2382588|NCT01448707|5847873|P2|STARTED|Overall Study||136
2382589|NCT01448707|5847874|P1|STARTED|Overall Study||137
2382590|NCT01448616|5847895|P4|NOT COMPLETED|Study Drug (Treatment Phase)||4
2382591|NCT01448616|5847896|P3|NOT COMPLETED|Study Drug (Treatment Phase)||4
2382592|NCT01448616|5847897|P2|NOT COMPLETED|Study Drug (Treatment Phase)||2
2382593|NCT01448616|5847898|P1|NOT COMPLETED|Study Drug (Treatment Phase)||0
2382594|NCT01448616|5847895|P4|COMPLETED|Study Drug (Treatment Phase)||9
2382595|NCT01448616|5847896|P3|COMPLETED|Study Drug (Treatment Phase)||23
2382596|NCT01448616|5847897|P2|COMPLETED|Study Drug (Treatment Phase)||22
2382597|NCT01448616|5847898|P1|COMPLETED|Study Drug (Treatment Phase)||0
2382598|NCT01448616|5847895|P4|STARTED|Study Drug (Treatment Phase)||13
2382599|NCT01448616|5847896|P3|STARTED|Study Drug (Treatment Phase)||27
2382600|NCT01448616|5847897|P2|STARTED|Study Drug (Treatment Phase)||24
2382601|NCT01448616|5847898|P1|STARTED|Study Drug (Treatment Phase)|All qualifying participants from this group moved to treatment group.|0
2382602|NCT01448616|5847895|P4|NOT COMPLETED|Lead-In (Observational Phase)||0
2382603|NCT01448616|5847896|P3|NOT COMPLETED|Lead-In (Observational Phase)||0
2382604|NCT01448616|5847897|P2|NOT COMPLETED|Lead-In (Observational Phase)||0
2382605|NCT01448616|5847898|P1|NOT COMPLETED|Lead-In (Observational Phase)||9
2382606|NCT01448616|5847895|P4|COMPLETED|Lead-In (Observational Phase)||0
2382607|NCT01448616|5847896|P3|COMPLETED|Lead-In (Observational Phase)||0
2382608|NCT01448616|5847897|P2|COMPLETED|Lead-In (Observational Phase)|completed >90% of sample collection to qualify for randomization for next phase|0
2382609|NCT01448616|5847898|P1|COMPLETED|Lead-In (Observational Phase)|Participants who swabbed >90% completed this phase and were randomized to treatment 2:2:1.|64
2382610|NCT01448616|5847895|P4|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
2382611|NCT01448616|5847896|P3|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
2382612|NCT01448616|5847897|P2|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
2382613|NCT01448616|5847898|P1|STARTED|Lead-In (Observational Phase)||73
2382614|NCT01448525|5847918|P2|NOT COMPLETED|Overall Study||2
2382615|NCT01448525|5847919|P1|NOT COMPLETED|Overall Study||1
2382616|NCT01448525|5847918|P2|COMPLETED|Overall Study||42
2382617|NCT01448525|5847919|P1|COMPLETED|Overall Study||43
2382618|NCT01448525|5847918|P2|STARTED|Overall Study||44
2382619|NCT01448525|5847919|P1|STARTED|Overall Study||44
2382620|NCT01448486|5847929|P2|NOT COMPLETED|Overall Study||0
2382621|NCT01448486|5847930|P1|NOT COMPLETED|Overall Study||0
2382622|NCT01448486|5847929|P2|COMPLETED|Overall Study||3
2382623|NCT01448486|5847930|P1|COMPLETED|Overall Study||3
2382624|NCT01448486|5847929|P2|STARTED|Overall Study||3
2382625|NCT01448486|5847930|P1|STARTED|Overall Study||3
2382626|NCT01448356|5847938|P1|NOT COMPLETED|Overall Study||0
2382627|NCT01448356|5847938|P1|COMPLETED|Overall Study|cross-over|10
2382628|NCT01448356|5847938|P1|STARTED|Overall Study||10
2382629|NCT01448213|5847945|P2|NOT COMPLETED|Overall Study||22
2382630|NCT01448213|5847946|P1|NOT COMPLETED|Overall Study||17
2382631|NCT01448213|5847945|P2|COMPLETED|Overall Study||112
2382632|NCT01448213|5847946|P1|COMPLETED|Overall Study||113
2382633|NCT01448213|5847945|P2|STARTED|Overall Study||134
2382634|NCT01448213|5847946|P1|STARTED|Overall Study||130
2382635|NCT01448057|5847956|P2|NOT COMPLETED|Overall Study||4
2382636|NCT01448057|5847957|P1|NOT COMPLETED|Overall Study||8
2382637|NCT01448057|5847956|P2|COMPLETED|Overall Study||167
2382638|NCT01448057|5847957|P1|COMPLETED|Overall Study||162
2382639|NCT01448057|5847956|P2|STARTED|Overall Study||171
2382640|NCT01448057|5847957|P1|STARTED|Overall Study||170
2382641|NCT01448044|5847967|P2|NOT COMPLETED|Follow Up Period||14
2382642|NCT01448044|5847968|P1|NOT COMPLETED|Follow Up Period||12
2382643|NCT01448044|5847967|P2|COMPLETED|Follow Up Period||26
2382644|NCT01448044|5847968|P1|COMPLETED|Follow Up Period||65
2382645|NCT01448044|5847967|P2|STARTED|Follow Up Period|Out of 42 participants who entered the treatment period, 40 continued in the follow-up period.|40
2382646|NCT01448044|5847968|P1|STARTED|Follow Up Period|Out of 82 participants who entered the treatment period, 77 continued in the follow-up period.|77
2382647|NCT01448044|5847967|P2|NOT COMPLETED|Treatment Period||16
2382648|NCT01448044|5847968|P1|NOT COMPLETED|Treatment Period||23
2382649|NCT01448044|5847967|P2|COMPLETED|Treatment Period||26
2382650|NCT01448044|5847968|P1|COMPLETED|Treatment Period||59
2382651|NCT01448044|5847967|P2|STARTED|Treatment Period||42
2382652|NCT01448044|5847968|P1|STARTED|Treatment Period||82
2382653|NCT01447927|5847984|P2|NOT COMPLETED|Overall Study||3
2382654|NCT01447927|5847985|P1|NOT COMPLETED|Overall Study||5
2382655|NCT01447927|5847984|P2|COMPLETED|Overall Study||33
2382656|NCT01447927|5847985|P1|COMPLETED|Overall Study||33
2382657|NCT01447927|5847984|P2|STARTED|Overall Study||36
2382658|NCT01447927|5847985|P1|STARTED|Overall Study||38
2382659|NCT01447914|5847993|P1|NOT COMPLETED|Overall Study||0
2382660|NCT01447914|5847993|P1|COMPLETED|Overall Study||16
2382661|NCT01447914|5847993|P1|STARTED|Overall Study||16
2382662|NCT01447849|5848006|P4|NOT COMPLETED|Second Intervention||0
2382663|NCT01447849|5848007|P3|NOT COMPLETED|Second Intervention||0
2382664|NCT01447849|5848008|P2|NOT COMPLETED|Second Intervention||0
2382665|NCT01447849|5848009|P1|NOT COMPLETED|Second Intervention||0
2382666|NCT01447849|5848006|P4|COMPLETED|Second Intervention||10
2382667|NCT01447849|5848007|P3|COMPLETED|Second Intervention||10
2382668|NCT01447849|5848008|P2|COMPLETED|Second Intervention||10
2382669|NCT01447849|5848009|P1|COMPLETED|Second Intervention||10
2382670|NCT01447849|5848006|P4|STARTED|Second Intervention||10
2382671|NCT01447849|5848007|P3|STARTED|Second Intervention||10
2382672|NCT01447849|5848008|P2|STARTED|Second Intervention||10
2382673|NCT01447849|5848009|P1|STARTED|Second Intervention||10
2382674|NCT01447849|5848006|P4|NOT COMPLETED|Washout Period for 1 Week||0
2382675|NCT01447849|5848007|P3|NOT COMPLETED|Washout Period for 1 Week||0
2382676|NCT01447849|5848008|P2|NOT COMPLETED|Washout Period for 1 Week||0
2382677|NCT01447849|5848009|P1|NOT COMPLETED|Washout Period for 1 Week||0
2382678|NCT01447849|5848006|P4|COMPLETED|Washout Period for 1 Week||10
2382679|NCT01447849|5848007|P3|COMPLETED|Washout Period for 1 Week||10
2382680|NCT01447849|5848008|P2|COMPLETED|Washout Period for 1 Week||10
2382681|NCT01447849|5848009|P1|COMPLETED|Washout Period for 1 Week||10
2382682|NCT01447849|5848006|P4|STARTED|Washout Period for 1 Week||10
2382683|NCT01447849|5848007|P3|STARTED|Washout Period for 1 Week||10
2382684|NCT01447849|5848008|P2|STARTED|Washout Period for 1 Week||10
2382685|NCT01447849|5848009|P1|STARTED|Washout Period for 1 Week||10
2382686|NCT01447849|5848006|P4|NOT COMPLETED|First Intervention||0
2382687|NCT01447849|5848007|P3|NOT COMPLETED|First Intervention||0
2382688|NCT01447849|5848008|P2|NOT COMPLETED|First Intervention||0
2382689|NCT01447849|5848009|P1|NOT COMPLETED|First Intervention||0
2382690|NCT01447849|5848006|P4|COMPLETED|First Intervention||10
2382691|NCT01447849|5848007|P3|COMPLETED|First Intervention||10
2382692|NCT01447849|5848008|P2|COMPLETED|First Intervention||10
2382693|NCT01447849|5848009|P1|COMPLETED|First Intervention||10
2382694|NCT01447849|5848006|P4|STARTED|First Intervention||10
2382695|NCT01447849|5848007|P3|STARTED|First Intervention||10
2382696|NCT01447849|5848008|P2|STARTED|First Intervention||10
2382697|NCT01447849|5848009|P1|STARTED|First Intervention||10
2382698|NCT01447719|5848019|P1|NOT COMPLETED|Overall Study||93
2382699|NCT01447719|5848019|P1|COMPLETED|Overall Study||59
2382700|NCT01447719|5848019|P1|Deceased <2 Years After AV-45 Scan|Overall Study||66
2382701|NCT01447719|5848019|P1|Valid AV-45 Scan Acquired|Overall Study||147
2382702|NCT01447719|5848019|P1|STARTED|Overall Study||152
2382703|NCT01447706|5848032|P2|NOT COMPLETED|Overall Study||3
2382704|NCT01447706|5848033|P1|NOT COMPLETED|Overall Study||0
2382705|NCT01447706|5848032|P2|COMPLETED|Overall Study||80
2382706|NCT01447706|5848033|P1|COMPLETED|Overall Study||140
2382707|NCT01447706|5848032|P2|STARTED|Overall Study|3 patients enrolled but not dosed|83
2382708|NCT01447706|5848033|P1|STARTED|Overall Study||140
2382709|NCT01447576|5848045|P1|NOT COMPLETED|Overall Study||476
2382710|NCT01447576|5848045|P1|COMPLETED|Overall Study||560
2382711|NCT01447576|5848045|P1|STARTED|Overall Study||1036
2382712|NCT01447511|5848056|P5|NOT COMPLETED|Rifampin Period||0
2382713|NCT01447511|5848057|P4|NOT COMPLETED|Rifampin Period||1
2382714|NCT01447511|5848058|P3|NOT COMPLETED|Rifampin Period||0
2382715|NCT01447511|5848059|P2|NOT COMPLETED|Rifampin Period||0
2382716|NCT01447511|5848060|P1|NOT COMPLETED|Rifampin Period||0
2382717|NCT01447511|5848056|P5|COMPLETED|Rifampin Period||4
2382718|NCT01447511|5848057|P4|COMPLETED|Rifampin Period||2
2382719|NCT01447511|5848058|P3|COMPLETED|Rifampin Period||8
2382720|NCT01447511|5848059|P2|COMPLETED|Rifampin Period||5
2382721|NCT01447511|5848060|P1|COMPLETED|Rifampin Period||8
2382722|NCT01447511|5848056|P5|STARTED|Rifampin Period||4
2382723|NCT01447511|5848057|P4|STARTED|Rifampin Period||3
2382724|NCT01447511|5848058|P3|STARTED|Rifampin Period||8
2382725|NCT01447511|5848059|P2|STARTED|Rifampin Period||5
2382726|NCT01447511|5848060|P1|STARTED|Rifampin Period||8
2382727|NCT01447511|5848056|P5|NOT COMPLETED|Fluconazole Period||0
2382728|NCT01447511|5848057|P4|NOT COMPLETED|Fluconazole Period||0
2382729|NCT01447511|5848058|P3|NOT COMPLETED|Fluconazole Period||1
2382730|NCT01447511|5848059|P2|NOT COMPLETED|Fluconazole Period||0
2382731|NCT01447511|5848060|P1|NOT COMPLETED|Fluconazole Period||0
2382732|NCT01447511|5848056|P5|COMPLETED|Fluconazole Period||4
2382733|NCT01447511|5848057|P4|COMPLETED|Fluconazole Period||3
2382734|NCT01447511|5848058|P3|COMPLETED|Fluconazole Period||8
2382735|NCT01447511|5848059|P2|COMPLETED|Fluconazole Period||0
2382736|NCT01447511|5848060|P1|COMPLETED|Fluconazole Period||8
2382737|NCT01447511|5848056|P5|STARTED|Fluconazole Period||4
2382738|NCT01447511|5848057|P4|STARTED|Fluconazole Period||3
2382739|NCT01447511|5848058|P3|STARTED|Fluconazole Period||9
2382740|NCT01447511|5848059|P2|STARTED|Fluconazole Period||0
2382741|NCT01447511|5848060|P1|STARTED|Fluconazole Period||8
2382742|NCT01447511|5848056|P5|NOT COMPLETED|Control Period||0
2382743|NCT01447511|5848057|P4|NOT COMPLETED|Control Period||0
2382744|NCT01447511|5848058|P3|NOT COMPLETED|Control Period||0
2382745|NCT01447511|5848059|P2|NOT COMPLETED|Control Period||0
2382746|NCT01447511|5848060|P1|NOT COMPLETED|Control Period||0
2382747|NCT01447511|5848056|P5|COMPLETED|Control Period||4
2382748|NCT01447511|5848057|P4|COMPLETED|Control Period||3
2382749|NCT01447511|5848058|P3|COMPLETED|Control Period||9
2382750|NCT01447511|5848059|P2|COMPLETED|Control Period||5
2382751|NCT01447511|5848060|P1|COMPLETED|Control Period||8
2382752|NCT01447511|5848056|P5|STARTED|Control Period||4
2382753|NCT01447511|5848057|P4|STARTED|Control Period||3
2382754|NCT01447511|5848058|P3|STARTED|Control Period||9
2382755|NCT01447511|5848059|P2|STARTED|Control Period||5
2382756|NCT01447511|5848060|P1|STARTED|Control Period||8
2382757|NCT01447446|5848078|P6|NOT COMPLETED|Overall Study||32
2382758|NCT01447446|5848079|P5|NOT COMPLETED|Overall Study||211
2382759|NCT01447446|5848080|P4|NOT COMPLETED|Overall Study||33
2382760|NCT01447446|5848081|P3|NOT COMPLETED|Overall Study||100
2382761|NCT01447446|5848082|P2|NOT COMPLETED|Overall Study||165
2382762|NCT01447446|5848083|P1|NOT COMPLETED|Overall Study||722
2382763|NCT01447446|5848078|P6|COMPLETED|Overall Study||54
2382764|NCT01447446|5848079|P5|COMPLETED|Overall Study||610
2382765|NCT01447446|5848080|P4|COMPLETED|Overall Study||60
2382766|NCT01447446|5848081|P3|COMPLETED|Overall Study||192
2382767|NCT01447446|5848082|P2|COMPLETED|Overall Study|Insuff.=Insufficient VR= Virological response TRT.=Treatment SVR= Sustained Virological Response|331
2382768|NCT01447446|5848083|P1|COMPLETED|Overall Study|Completed means the participants who completed the 24- weeks of follow-up period.|1590
2382769|NCT01447446|5848078|P6|STARTED|Overall Study||86
2382770|NCT01447446|5848079|P5|STARTED|Overall Study||821
2382771|NCT01447446|5848080|P4|STARTED|Overall Study||93
2382772|NCT01447446|5848081|P3|STARTED|Overall Study||292
2382773|NCT01447446|5848082|P2|STARTED|Overall Study||496
2382774|NCT01447446|5848083|P1|STARTED|Overall Study|Started means participants who started treatment and included in core population.|2312
2382775|NCT01447433|5848173|P2|NOT COMPLETED|Overall Study||6
2382776|NCT01447433|5848174|P1|NOT COMPLETED|Overall Study||4
2382777|NCT01447433|5848173|P2|COMPLETED|Overall Study||21
2382778|NCT01447433|5848174|P1|COMPLETED|Overall Study||22
2382779|NCT01447433|5848173|P2|STARTED|Overall Study||27
2382780|NCT01447433|5848174|P1|STARTED|Overall Study||26
2382781|NCT01447420|5848201|P3|NOT COMPLETED|Overall Study||10
2382782|NCT01447420|5848202|P2|NOT COMPLETED|Overall Study||27
2382783|NCT01447420|5848203|P1|NOT COMPLETED|Overall Study||10
2382784|NCT01447420|5848201|P3|COMPLETED|Overall Study||8
2382785|NCT01447420|5848202|P2|COMPLETED|Overall Study||45
2382786|NCT01447420|5848203|P1|COMPLETED|Overall Study||29
2382787|NCT01447420|5848201|P3|STARTED|Overall Study||18
2382788|NCT01447420|5848202|P2|STARTED|Overall Study||72
2382789|NCT01447420|5848203|P1|STARTED|Overall Study||39
2382790|NCT01447225|5848223|P10|NOT COMPLETED|Overall Study||0
2382791|NCT01447225|5848224|P9|NOT COMPLETED|Overall Study||0
2382792|NCT01447225|5848225|P8|NOT COMPLETED|Overall Study||0
2382793|NCT01447225|5848226|P7|NOT COMPLETED|Overall Study||0
2382794|NCT01447225|5848227|P6|NOT COMPLETED|Overall Study||0
2382795|NCT01447225|5848228|P5|NOT COMPLETED|Overall Study||0
2382796|NCT01447225|5848229|P4|NOT COMPLETED|Overall Study||0
2382797|NCT01447225|5848230|P3|NOT COMPLETED|Overall Study||0
2382798|NCT01447225|5848231|P2|NOT COMPLETED|Overall Study||0
2382799|NCT01447225|5848232|P1|NOT COMPLETED|Overall Study||0
2382800|NCT01447225|5848223|P10|COMPLETED|Overall Study||4
2382801|NCT01447225|5848224|P9|COMPLETED|Overall Study||3
2382802|NCT01447225|5848225|P8|COMPLETED|Overall Study||4
2382803|NCT01447225|5848226|P7|COMPLETED|Overall Study||7
2382804|NCT01447225|5848227|P6|COMPLETED|Overall Study||3
2382805|NCT01447225|5848228|P5|COMPLETED|Overall Study||3
2382806|NCT01447225|5848229|P4|COMPLETED|Overall Study||3
2382807|NCT01447225|5848230|P3|COMPLETED|Overall Study||5
2382808|NCT01447225|5848231|P2|COMPLETED|Overall Study||8
2382809|NCT01447225|5848232|P1|COMPLETED|Overall Study||3
2382810|NCT01447225|5848223|P10|STARTED|Overall Study||4
2382811|NCT01447225|5848224|P9|STARTED|Overall Study||3
2382812|NCT01447225|5848225|P8|STARTED|Overall Study||4
2382813|NCT01447225|5848226|P7|STARTED|Overall Study||7
2382814|NCT01447225|5848227|P6|STARTED|Overall Study||3
2382815|NCT01447225|5848228|P5|STARTED|Overall Study||3
2382816|NCT01447225|5848229|P4|STARTED|Overall Study||3
2382817|NCT01447225|5848230|P3|STARTED|Overall Study||5
2382818|NCT01447225|5848231|P2|STARTED|Overall Study||8
2382819|NCT01447225|5848232|P1|STARTED|Overall Study||3
2382820|NCT01447121|5848302|P1|NOT COMPLETED|Overall Study||0
2382821|NCT01447121|5848302|P1|COMPLETED|Overall Study||118
2382822|NCT01447121|5848302|P1|STARTED|Overall Study||118
2382823|NCT01447017|5848309|P2|NOT COMPLETED|Overall Study||10
2382824|NCT01447017|5848310|P1|NOT COMPLETED|Overall Study||10
2382825|NCT01447017|5848309|P2|COMPLETED|Overall Study|In safety analysis: 24. In efficacy analyses: 24 in full analysis set, and 22 in per-protocol set.|14
2382826|NCT01447017|5848310|P1|COMPLETED|Overall Study|In safety analysis: 42. In efficacy analyses: 40 in full analysis set, and 39 in per-protocol set.|35
2382827|NCT01447017|5848309|P2|Performed Visit 2|Overall Study||24
2382828|NCT01447017|5848310|P1|Performed Visit 2|Overall Study||43
2382829|NCT01447017|5848309|P2|STARTED|Overall Study||24
2382830|NCT01447017|5848310|P1|STARTED|Overall Study||45
2382831|NCT01446874|5848319|P3|NOT COMPLETED|Overall Study||18
2382832|NCT01446874|5848320|P2|NOT COMPLETED|Overall Study||4
2382833|NCT01446874|5848321|P1|NOT COMPLETED|Overall Study||2
2382834|NCT01446874|5848319|P3|COMPLETED|Overall Study||62
2382835|NCT01446874|5848320|P2|COMPLETED|Overall Study||46
2382836|NCT01446874|5848321|P1|COMPLETED|Overall Study||18
2382837|NCT01446874|5848319|P3|STARTED|Overall Study||80
2382838|NCT01446874|5848320|P2|STARTED|Overall Study||50
2382839|NCT01446874|5848321|P1|STARTED|Overall Study||20
2382840|NCT01446809|5848349|P3|NOT COMPLETED|Overall Study||2
2382841|NCT01446809|5848350|P2|NOT COMPLETED|Overall Study||0
2382842|NCT01446809|5848351|P1|NOT COMPLETED|Overall Study||0
2382843|NCT01446809|5848349|P3|COMPLETED|Overall Study||0
2382844|NCT01446809|5848350|P2|COMPLETED|Overall Study||7
2382845|NCT01446809|5848351|P1|COMPLETED|Overall Study||14
2382846|NCT01446809|5848349|P3|STARTED|Overall Study||2
2382847|NCT01446809|5848350|P2|STARTED|Overall Study||7
2382848|NCT01446809|5848351|P1|STARTED|Overall Study||14
2382849|NCT01446796|5848364|P2|NOT COMPLETED|Overall Study||0
2382850|NCT01446796|5848365|P1|NOT COMPLETED|Overall Study||1
2382851|NCT01446796|5848364|P2|COMPLETED|Overall Study|Study terminated early|0
2382852|NCT01446796|5848365|P1|COMPLETED|Overall Study|"Study terminated early~One subject of three withdrew prior to randomization and did not start"|2
2382853|NCT01446796|5848364|P2|STARTED|Overall Study||0
2382854|NCT01446796|5848365|P1|STARTED|Overall Study||3
2382855|NCT01446705|5848379|P2|NOT COMPLETED|Overall Study||0
2382856|NCT01446705|5848380|P1|NOT COMPLETED|Overall Study||0
2382857|NCT01446705|5848379|P2|COMPLETED|Overall Study||6627
2382858|NCT01446705|5848380|P1|COMPLETED|Overall Study||50446
2382859|NCT01446705|5848379|P2|STARTED|Overall Study||6627
2382860|NCT01446705|5848380|P1|STARTED|Overall Study||50446
2382861|NCT01446666|5848396|P1|NOT COMPLETED|Overall Study||81
2382862|NCT01446666|5848396|P1|COMPLETED|Overall Study||326
2382863|NCT01446666|5848396|P1|STARTED|Overall Study|Among the 423 participants who consented, 15 withdrew the consent and one died.|407
2382864|NCT01446419|5848411|P2|NOT COMPLETED|Overall Study||1
2382865|NCT01446419|5848412|P1|NOT COMPLETED|Overall Study||5
2382866|NCT01446419|5848411|P2|COMPLETED|Overall Study||77
2382867|NCT01446419|5848412|P1|COMPLETED|Overall Study||142
2382868|NCT01446419|5848411|P2|12 Month Follow-up|Overall Study||77
2382869|NCT01446419|5848412|P1|12 Month Follow-up|Overall Study||142
2382870|NCT01446419|5848411|P2|6 Month Follow-up|Overall Study||77
2382871|NCT01446419|5848412|P1|6 Month Follow-up|Overall Study||144
2382872|NCT01446419|5848411|P2|3 Month Follow-up|Overall Study||77
2382873|NCT01446419|5848412|P1|3 Month Follow-up|Overall Study||146
2382874|NCT01446419|5848411|P2|STARTED|Overall Study||78
2382875|NCT01446419|5848412|P1|STARTED|Overall Study||147
2382876|NCT01446289|5848426|P4|NOT COMPLETED|Overall Study||0
2382877|NCT01446289|5848427|P3|NOT COMPLETED|Overall Study||1
2382878|NCT01446289|5848428|P2|NOT COMPLETED|Overall Study||0
2382879|NCT01446289|5848429|P1|NOT COMPLETED|Overall Study||1
2382880|NCT01446289|5848426|P4|COMPLETED|Overall Study||35
2382881|NCT01446289|5848427|P3|COMPLETED|Overall Study||50
2382882|NCT01446289|5848428|P2|COMPLETED|Overall Study||35
2382883|NCT01446289|5848429|P1|COMPLETED|Overall Study||50
2382884|NCT01446289|5848426|P4|STARTED|Overall Study||35
2382885|NCT01446289|5848427|P3|STARTED|Overall Study||51
2382886|NCT01446289|5848428|P2|STARTED|Overall Study||35
2382887|NCT01446289|5848429|P1|STARTED|Overall Study||51
2382888|NCT01446250|5848457|P4|NOT COMPLETED|Follow-up||6
2382889|NCT01446250|5848458|P3|NOT COMPLETED|Follow-up||0
2382890|NCT01446250|5848459|P2|NOT COMPLETED|Follow-up||0
2382891|NCT01446250|5848460|P1|NOT COMPLETED|Follow-up||0
2382892|NCT01446250|5848457|P4|COMPLETED|Follow-up||0
2382893|NCT01446250|5848458|P3|COMPLETED|Follow-up||0
2382894|NCT01446250|5848459|P2|COMPLETED|Follow-up||0
2382895|NCT01446250|5848460|P1|COMPLETED|Follow-up||0
2382896|NCT01446250|5848457|P4|STARTED|Follow-up||6
2382897|NCT01446250|5848458|P3|STARTED|Follow-up||0
2382898|NCT01446250|5848459|P2|STARTED|Follow-up||0
2382899|NCT01446250|5848460|P1|STARTED|Follow-up||0
2382900|NCT01446250|5848457|P4|NOT COMPLETED|Treatment Period 2||0
2382901|NCT01446250|5848458|P3|NOT COMPLETED|Treatment Period 2||0
2382902|NCT01446250|5848459|P2|NOT COMPLETED|Treatment Period 2||1
2382903|NCT01446250|5848460|P1|NOT COMPLETED|Treatment Period 2||0
2382904|NCT01446250|5848457|P4|COMPLETED|Treatment Period 2||0
2382905|NCT01446250|5848458|P3|COMPLETED|Treatment Period 2||0
2382906|NCT01446250|5848459|P2|COMPLETED|Treatment Period 2||6
2382907|NCT01446250|5848460|P1|COMPLETED|Treatment Period 2||0
2382908|NCT01446250|5848457|P4|STARTED|Treatment Period 2||0
2382909|NCT01446250|5848458|P3|STARTED|Treatment Period 2||0
2382910|NCT01446250|5848459|P2|STARTED|Treatment Period 2||7
2382911|NCT01446250|5848460|P1|STARTED|Treatment Period 2||0
2382912|NCT01446250|5848457|P4|NOT COMPLETED|Clinical Hold||0
2382913|NCT01446250|5848458|P3|NOT COMPLETED|Clinical Hold||0
2382914|NCT01446250|5848459|P2|NOT COMPLETED|Clinical Hold||0
2382915|NCT01446250|5848460|P1|NOT COMPLETED|Clinical Hold||0
2382916|NCT01446250|5848457|P4|COMPLETED|Clinical Hold||0
2382917|NCT01446250|5848458|P3|COMPLETED|Clinical Hold||5
2382918|NCT01446250|5848459|P2|COMPLETED|Clinical Hold||2
2382919|NCT01446250|5848460|P1|COMPLETED|Clinical Hold||0
2382920|NCT01446250|5848457|P4|STARTED|Clinical Hold||0
2382921|NCT01446250|5848458|P3|STARTED|Clinical Hold||5
2382922|NCT01446250|5848459|P2|STARTED|Clinical Hold||2
2382923|NCT01446250|5848460|P1|STARTED|Clinical Hold||0
2382924|NCT01446250|5848457|P4|NOT COMPLETED|Treatment Period 1||0
2382925|NCT01446250|5848458|P3|NOT COMPLETED|Treatment Period 1||0
2382926|NCT01446250|5848459|P2|NOT COMPLETED|Treatment Period 1||1
2382927|NCT01446250|5848460|P1|NOT COMPLETED|Treatment Period 1||0
2382928|NCT01446250|5848457|P4|COMPLETED|Treatment Period 1||0
2382929|NCT01446250|5848458|P3|COMPLETED|Treatment Period 1||0
2382930|NCT01446250|5848459|P2|COMPLETED|Treatment Period 1||2
2382931|NCT01446250|5848460|P1|COMPLETED|Treatment Period 1||5
2382932|NCT01446250|5848457|P4|STARTED|Treatment Period 1||0
2382933|NCT01446250|5848458|P3|STARTED|Treatment Period 1||0
2382934|NCT01446250|5848459|P2|STARTED|Treatment Period 1||3
2382935|NCT01446250|5848460|P1|STARTED|Treatment Period 1||5
2382936|NCT01446237|5848472|P1|NOT COMPLETED|Overall Study||10
2382937|NCT01446237|5848472|P1|COMPLETED|Overall Study||115
2382938|NCT01446237|5848472|P1|STARTED|Overall Study||125
2382939|NCT01446159|5848484|P4|NOT COMPLETED|Overall Study||62
2382940|NCT01446159|5848485|P3|NOT COMPLETED|Overall Study||72
2382941|NCT01446159|5848486|P2|NOT COMPLETED|Overall Study||3
2382942|NCT01446159|5848487|P1|NOT COMPLETED|Overall Study||3
2382943|NCT01446159|5848484|P4|COMPLETED|Overall Study||23
2382944|NCT01446159|5848485|P3|COMPLETED|Overall Study||20
2382945|NCT01446159|5848486|P2|COMPLETED|Overall Study||0
2382946|NCT01446159|5848487|P1|COMPLETED|Overall Study||0
2382947|NCT01446159|5848484|P4|STARTED|Overall Study||85
2382948|NCT01446159|5848485|P3|STARTED|Overall Study||92
2382949|NCT01446159|5848486|P2|STARTED|Overall Study||3
2382950|NCT01446159|5848487|P1|STARTED|Overall Study||3
2382951|NCT01446042|5848562|P3|NOT COMPLETED|Overall Study||9
2382952|NCT01446042|5848563|P2|NOT COMPLETED|Overall Study||3
2382953|NCT01446042|5848564|P1|NOT COMPLETED|Overall Study||20
2382954|NCT01446042|5848562|P3|COMPLETED|Overall Study||69
2382955|NCT01446042|5848563|P2|COMPLETED|Overall Study||83
2382956|NCT01446042|5848564|P1|COMPLETED|Overall Study||122
2382957|NCT01446042|5848562|P3|STARTED|Overall Study||78
2382958|NCT01446042|5848563|P2|STARTED|Overall Study||86
2382959|NCT01446042|5848564|P1|STARTED|Overall Study||142
2382960|NCT01446003|5848575|P2|NOT COMPLETED|Period 2||0
2382961|NCT01446003|5848576|P1|NOT COMPLETED|Period 2||1
2382962|NCT01446003|5848575|P2|COMPLETED|Period 2||15
2382963|NCT01446003|5848576|P1|COMPLETED|Period 2||13
2382964|NCT01446003|5848575|P2|STARTED|Period 2||15
2382965|NCT01446003|5848576|P1|STARTED|Period 2||14
2382966|NCT01446003|5848575|P2|NOT COMPLETED|Period 1||0
2382967|NCT01446003|5848576|P1|NOT COMPLETED|Period 1||2
2382968|NCT01446003|5848575|P2|COMPLETED|Period 1||15
2382969|NCT01446003|5848576|P1|COMPLETED|Period 1||14
2382970|NCT01446003|5848575|P2|STARTED|Period 1||15
2382971|NCT01446003|5848576|P1|STARTED|Period 1||16
2382972|NCT01445951|5848597|P3|NOT COMPLETED|Overall Study||19
2382973|NCT01445951|5848598|P2|NOT COMPLETED|Overall Study||36
2382974|NCT01445951|5848599|P1|NOT COMPLETED|Overall Study||44
2382975|NCT01445951|5848597|P3|COMPLETED|Overall Study||151
2382976|NCT01445951|5848598|P2|COMPLETED|Overall Study||138
2382977|NCT01445951|5848599|P1|COMPLETED|Overall Study||130
2382978|NCT01445951|5848597|P3|STARTED|Overall Study||170
2382979|NCT01445951|5848598|P2|STARTED|Overall Study||174
2382980|NCT01445951|5848599|P1|STARTED|Overall Study||174
2382981|NCT01445886|5848637|P1|NOT COMPLETED|Overall Study||5
2382982|NCT01445886|5848637|P1|COMPLETED|Overall Study||28
2382983|NCT01445886|5848637|P1|STARTED|Overall Study||33
2382984|NCT01445873|5848647|P1|NOT COMPLETED|Overall Study||0
2382985|NCT01445873|5848647|P1|COMPLETED|Overall Study||36
2382986|NCT01445873|5848647|P1|STARTED|Overall Study||36
2382987|NCT01445847|5848677|P2|NOT COMPLETED|Overall Study||14
2382988|NCT01445847|5848678|P1|NOT COMPLETED|Overall Study||14
2382989|NCT01445847|5848677|P2|COMPLETED|Overall Study||36
2382990|NCT01445847|5848678|P1|COMPLETED|Overall Study||36
2382991|NCT01445847|5848677|P2|STARTED|Overall Study||50
2382992|NCT01445847|5848678|P1|STARTED|Overall Study||50
2382993|NCT01445769|5848684|P1|NOT COMPLETED|Overall Study||8
2382994|NCT01445769|5848684|P1|COMPLETED|Overall Study||37
2382995|NCT01445769|5848684|P1|STARTED|Overall Study||45
2382996|NCT01445678|5848704|P2|NOT COMPLETED|Overall Study||21
2382997|NCT01445678|5848705|P1|NOT COMPLETED|Overall Study||30
2382998|NCT01445678|5848704|P2|COMPLETED|Overall Study||476
2382999|NCT01445678|5848705|P1|COMPLETED|Overall Study||452
2383000|NCT01445678|5848704|P2|STARTED|Overall Study||497
2383001|NCT01445678|5848705|P1|STARTED|Overall Study||482
2383002|NCT01445652|5848723|P2|NOT COMPLETED|Overall Study||3
2383003|NCT01445652|5848724|P1|NOT COMPLETED|Overall Study||10
2383004|NCT01445652|5848723|P2|COMPLETED|Overall Study||50
2383005|NCT01445652|5848724|P1|COMPLETED|Overall Study||47
2383006|NCT01445652|5848723|P2|STARTED|Overall Study||53
2383007|NCT01445652|5848724|P1|STARTED|Overall Study||57
2383008|NCT01445626|5848732|P1|NOT COMPLETED|Overall Study||0
2383009|NCT01445626|5848732|P1|COMPLETED|Overall Study||87
2383010|NCT01445626|5848732|P1|STARTED|Overall Study||87
2383011|NCT01445613|5848742|P1|NOT COMPLETED|1-year Follow-up||77
2383012|NCT01445613|5848742|P1|COMPLETED|1-year Follow-up||1088
2383013|NCT01445613|5848742|P1|STARTED|1-year Follow-up||1165
2383014|NCT01445613|5848742|P1|NOT COMPLETED|30-day Follow-up||35
2383015|NCT01445613|5848742|P1|COMPLETED|30-day Follow-up||1165
2383016|NCT01445613|5848742|P1|STARTED|30-day Follow-up||1200
2383017|NCT01445548|5848760|P1|NOT COMPLETED|Overall Study||1
2383018|NCT01445548|5848760|P1|COMPLETED|Overall Study||5
2383019|NCT01445548|5848760|P1|STARTED|Overall Study||6
2383020|NCT01445301|5848785|P3|NOT COMPLETED|Overall Study||9
2383021|NCT01445301|5848786|P2|NOT COMPLETED|Overall Study||35
2383022|NCT01445301|5848787|P1|NOT COMPLETED|Overall Study||21
2383023|NCT01445301|5848785|P3|COMPLETED|Overall Study||290
2383024|NCT01445301|5848786|P2|COMPLETED|Overall Study||262
2383025|NCT01445301|5848787|P1|COMPLETED|Overall Study||183
2383026|NCT01445301|5848785|P3|STARTED|Overall Study||299
2383027|NCT01445301|5848786|P2|STARTED|Overall Study||297
2383028|NCT01445301|5848787|P1|STARTED|Overall Study||204
2383033|NCT01445028|5848845|P2|NOT COMPLETED|Overall Study||3
2383034|NCT01445028|5848846|P1|NOT COMPLETED|Overall Study||0
2383035|NCT01445028|5848845|P2|COMPLETED|Overall Study||51
2383036|NCT01445028|5848846|P1|COMPLETED|Overall Study||58
2383037|NCT01445028|5848845|P2|STARTED|Overall Study||54
2383038|NCT01445028|5848846|P1|STARTED|Overall Study||58
2383039|NCT01444924|5848854|P2|NOT COMPLETED|Overall Study||0
2383040|NCT01444924|5848855|P1|NOT COMPLETED|Overall Study||0
2383041|NCT01444924|5848854|P2|COMPLETED|Overall Study||33
2383042|NCT01444924|5848855|P1|COMPLETED|Overall Study||31
2383043|NCT01444924|5848854|P2|STARTED|Overall Study||33
2383044|NCT01444924|5848855|P1|STARTED|Overall Study||31
2383045|NCT01444911|5848865|P2|NOT COMPLETED|Overall Study||0
2383046|NCT01444911|5848866|P1|NOT COMPLETED|Overall Study||8
2383047|NCT01444911|5848865|P2|COMPLETED|Overall Study||13
2383048|NCT01444911|5848866|P1|COMPLETED|Overall Study||8
2383049|NCT01444911|5848865|P2|STARTED|Overall Study||13
2383050|NCT01444911|5848866|P1|STARTED|Overall Study||16
2383051|NCT01444898|5848878|P1|NOT COMPLETED|Overall Study||1
2383052|NCT01444898|5848878|P1|COMPLETED|Overall Study||9
2383053|NCT01444898|5848878|P1|STARTED|Overall Study||10
2383054|NCT01444781|5848893|P3|NOT COMPLETED|Overall Study||3
2383055|NCT01444781|5848894|P2|NOT COMPLETED|Overall Study||4
2383056|NCT01444781|5848895|P1|NOT COMPLETED|Overall Study||3
2383057|NCT01444781|5848893|P3|COMPLETED|Overall Study||272
2383058|NCT01444781|5848894|P2|COMPLETED|Overall Study||411
2383059|NCT01444781|5848895|P1|COMPLETED|Overall Study||413
2383060|NCT01444781|5848893|P3|STARTED|Overall Study||275
2383061|NCT01444781|5848894|P2|STARTED|Overall Study||415
2383062|NCT01444781|5848895|P1|STARTED|Overall Study||416
2383063|NCT01444742|5848933|P1|NOT COMPLETED|Overall Study||1
2383064|NCT01444742|5848933|P1|COMPLETED|Overall Study||80
2383065|NCT01444742|5848933|P1|STARTED|Overall Study||81
2383066|NCT01444651|5848940|P2|NOT COMPLETED|Overall Study||9
2383067|NCT01444651|5848941|P1|NOT COMPLETED|Overall Study||11
2383068|NCT01444651|5848940|P2|COMPLETED|Overall Study||28
2383069|NCT01444651|5848941|P1|COMPLETED|Overall Study||25
2383070|NCT01444651|5848940|P2|STARTED|Overall Study||37
2383071|NCT01444651|5848941|P1|STARTED|Overall Study||36
2383072|NCT01444456|5848957|P1|NOT COMPLETED|Overall Study||285
2383073|NCT01444456|5848957|P1|COMPLETED|Overall Study|Defined as 4 weeks after last dose of ESA or chemotherapy or 13 weeks after enrolment|977
2383074|NCT01444456|5848957|P1|Received Darbepoetin Alfa|Overall Study||1134
2383075|NCT01444456|5848957|P1|Received Darbepoetin Alfa or Other ESA|Overall Study||1158
2383076|NCT01444456|5848957|P1|STARTED|Overall Study||1262
2383077|NCT01444430|5848968|P2|NOT COMPLETED|Overall Study||81
2383078|NCT01444430|5848969|P1|NOT COMPLETED|Overall Study||61
2383079|NCT01444430|5848968|P2|COMPLETED|Overall Study||5766
2383080|NCT01444430|5848969|P1|COMPLETED|Overall Study||5785
2383081|NCT01444430|5848968|P2|STARTED|Overall Study||5847
2383082|NCT01444430|5848969|P1|STARTED|Overall Study||5846
2383083|NCT01444417|5848991|P2|NOT COMPLETED|Overall Study||1
2383084|NCT01444417|5848992|P1|NOT COMPLETED|Overall Study||2
2383085|NCT01444417|5848991|P2|COMPLETED|Overall Study||41
2383086|NCT01444417|5848992|P1|COMPLETED|Overall Study||18
2383087|NCT01444417|5848991|P2|Received Treatment|Overall Study||42
2383088|NCT01444417|5848992|P1|Received Treatment|Overall Study||19
2383089|NCT01444417|5848991|P2|STARTED|Overall Study||42
2383090|NCT01444417|5848992|P1|STARTED|Overall Study||20
2383091|NCT01444391|5849008|P1|NOT COMPLETED|Overall Study||1
2383092|NCT01444391|5849008|P1|COMPLETED|Overall Study||41
2383093|NCT01444391|5849008|P1|STARTED|Overall Study||42
2383094|NCT01444378|5849016|P1|NOT COMPLETED|Overall Study||17
2383095|NCT01444378|5849016|P1|COMPLETED|Overall Study||124
2383096|NCT01444378|5849016|P1|STARTED|Overall Study|A total of 141 patients were enrolled into MOMENTUM|141
2383097|NCT01444300|5849128|P2|NOT COMPLETED|Overall Study||0
2383098|NCT01444300|5849129|P1|NOT COMPLETED|Overall Study||4
2383099|NCT01444300|5849128|P2|COMPLETED|Overall Study||12
2383100|NCT01444300|5849129|P1|COMPLETED|Overall Study||8
2383101|NCT01444300|5849128|P2|STARTED|Overall Study||12
2383102|NCT01444300|5849129|P1|STARTED|Overall Study||12
2383103|NCT01444287|5849139|P1|NOT COMPLETED|Period 4||0
2383104|NCT01444287|5849139|P1|COMPLETED|Period 4||22
2383105|NCT01444287|5849139|P1|STARTED|Period 4||22
2383106|NCT01444287|5849139|P1|NOT COMPLETED|Period 3||0
2383107|NCT01444287|5849139|P1|COMPLETED|Period 3||22
2383108|NCT01444287|5849139|P1|STARTED|Period 3||22
2383109|NCT01444287|5849139|P1|NOT COMPLETED|Period 2||0
2383110|NCT01444287|5849139|P1|COMPLETED|Period 2||22
2383111|NCT01444287|5849139|P1|STARTED|Period 2||22
2383112|NCT01444287|5849139|P1|NOT COMPLETED|Period 1||0
2383113|NCT01444287|5849139|P1|COMPLETED|Period 1||22
2383114|NCT01444287|5849139|P1|STARTED|Period 1||22
2383115|NCT01444092|5849161|P1|NOT COMPLETED|Overall Study||17
2383116|NCT01444092|5849161|P1|COMPLETED|Overall Study||91
2383117|NCT01444092|5849161|P1|INFORMED CONSENT OBTAINED|Overall Study||108
2383118|NCT01444092|5849161|P1|STARTED|Overall Study||108
2383119|NCT01444027|5849170|P3|NOT COMPLETED|Overall Study||38
2383120|NCT01444027|5849171|P2|NOT COMPLETED|Overall Study||30
2383121|NCT01444027|5849172|P1|NOT COMPLETED|Overall Study||30
2383122|NCT01444027|5849170|P3|COMPLETED|Overall Study||133
2383123|NCT01444027|5849171|P2|COMPLETED|Overall Study||141
2383124|NCT01444027|5849172|P1|COMPLETED|Overall Study||142
2383125|NCT01444027|5849170|P3|3 Month Follow-up|Overall Study||133
2383126|NCT01444027|5849171|P2|3 Month Follow-up|Overall Study||141
2383127|NCT01444027|5849172|P1|3 Month Follow-up|Overall Study||142
2383128|NCT01444027|5849170|P3|1 Month Follow-up|Overall Study||141
2383129|NCT01444027|5849171|P2|1 Month Follow-up|Overall Study||159
2383130|NCT01444027|5849172|P1|1 Month Follow-up|Overall Study||160
2383131|NCT01444027|5849170|P3|Received Intervention as Assigned|Overall Study||147
2383132|NCT01444027|5849171|P2|Received Intervention as Assigned|Overall Study||161
2383133|NCT01444027|5849172|P1|Received Intervention as Assigned|Overall Study||168
2383134|NCT01444027|5849170|P3|STARTED|Overall Study||171
2383135|NCT01444027|5849171|P2|STARTED|Overall Study||171
2383136|NCT01444027|5849172|P1|STARTED|Overall Study||172
2383137|NCT01443923|5849194|P2|NOT COMPLETED|Overall Study||0
2383138|NCT01443923|5849195|P1|NOT COMPLETED|Overall Study||1
2383139|NCT01443923|5849194|P2|COMPLETED|Overall Study||1
2383140|NCT01443923|5849195|P1|COMPLETED|Overall Study||2
2383141|NCT01443923|5849194|P2|STARTED|Overall Study||1
2383142|NCT01443923|5849195|P1|STARTED|Overall Study||3
2383143|NCT01443858|5849212|P3|NOT COMPLETED|Overall Study||7
2383144|NCT01443858|5849213|P2|NOT COMPLETED|Overall Study||13
2383145|NCT01443858|5849214|P1|NOT COMPLETED|Overall Study||15
2383146|NCT01443858|5849212|P3|COMPLETED|Overall Study||18
2383147|NCT01443858|5849213|P2|COMPLETED|Overall Study||12
2383148|NCT01443858|5849214|P1|COMPLETED|Overall Study||10
2383149|NCT01443858|5849212|P3|STARTED|Overall Study||25
2383150|NCT01443858|5849213|P2|STARTED|Overall Study||25
2383151|NCT01443858|5849214|P1|STARTED|Overall Study||25
2383152|NCT01443845|5849236|P2|NOT COMPLETED|Overall Study||337
2383153|NCT01443845|5849237|P1|NOT COMPLETED|Overall Study||254
2383154|NCT01443845|5849236|P2|COMPLETED|Overall Study||841
2383155|NCT01443845|5849237|P1|COMPLETED|Overall Study||922
2383156|NCT01443845|5849236|P2|STARTED|Overall Study||1178
2383157|NCT01443845|5849237|P1|STARTED|Overall Study||1176
2383158|NCT01443546|5849252|P3|NOT COMPLETED|Overall Study||0
2383159|NCT01443546|5849253|P2|NOT COMPLETED|Overall Study||0
2383160|NCT01443546|5849254|P1|NOT COMPLETED|Overall Study||0
2383161|NCT01443546|5849252|P3|COMPLETED|Overall Study||8
2383162|NCT01443546|5849253|P2|COMPLETED|Overall Study||9
2383163|NCT01443546|5849254|P1|COMPLETED|Overall Study||9
2383164|NCT01443546|5849252|P3|STARTED|Overall Study||8
2383165|NCT01443546|5849253|P2|STARTED|Overall Study||9
2383166|NCT01443546|5849254|P1|STARTED|Overall Study||9
2383167|NCT01443494|5849274|P1|NOT COMPLETED|Overall Study||0
2383168|NCT01443494|5849274|P1|COMPLETED|Overall Study||19
2383169|NCT01443494|5849274|P1|STARTED|Overall Study||19
2383170|NCT01443442|5849281|P2|NOT COMPLETED|Overall Study||0
2383171|NCT01443442|5849282|P1|NOT COMPLETED|Overall Study||0
2383172|NCT01443442|5849281|P2|COMPLETED|Overall Study||11
2383173|NCT01443442|5849282|P1|COMPLETED|Overall Study||12
2383174|NCT01443442|5849281|P2|STARTED|Overall Study||11
2383175|NCT01443442|5849282|P1|STARTED|Overall Study||12
2383176|NCT01443403|5849292|P4|NOT COMPLETED|Overall Study||9
2383177|NCT01443403|5849293|P3|NOT COMPLETED|Overall Study||7
2383178|NCT01443403|5849294|P2|NOT COMPLETED|Overall Study||6
2383179|NCT01443403|5849295|P1|NOT COMPLETED|Overall Study||6
2383180|NCT01443403|5849292|P4|COMPLETED|Overall Study||52
2383181|NCT01443403|5849293|P3|COMPLETED|Overall Study||54
2383182|NCT01443403|5849294|P2|COMPLETED|Overall Study||55
2383183|NCT01443403|5849295|P1|COMPLETED|Overall Study||55
2383184|NCT01443403|5849292|P4|Received Treatment|Overall Study||61
2383185|NCT01443403|5849293|P3|Received Treatment|Overall Study||60
2383186|NCT01443403|5849294|P2|Received Treatment|Overall Study||61
2383187|NCT01443403|5849295|P1|Received Treatment|Overall Study||61
2383188|NCT01443403|5849292|P4|STARTED|Overall Study||61
2383189|NCT01443403|5849293|P3|STARTED|Overall Study||61
2383190|NCT01443403|5849294|P2|STARTED|Overall Study||61
2383191|NCT01443403|5849295|P1|STARTED|Overall Study||61
2383192|NCT01443364|5849442|P1|NOT COMPLETED|Overall Study||41
2383193|NCT01443364|5849442|P1|COMPLETED|Overall Study||91
2383194|NCT01443364|5849442|P1|STARTED|Overall Study||132
2383195|NCT01443130|5849571|P6|NOT COMPLETED|Overall Study||34
2383196|NCT01443130|5849572|P5|NOT COMPLETED|Overall Study||44
2383197|NCT01443130|5849573|P4|NOT COMPLETED|Overall Study||39
2383198|NCT01443130|5849574|P3|NOT COMPLETED|Overall Study||77
2383199|NCT01443130|5849575|P2|NOT COMPLETED|Overall Study||69
2383200|NCT01443130|5849576|P1|NOT COMPLETED|Overall Study||68
2383201|NCT01443130|5849571|P6|COMPLETED|Overall Study||225
2383202|NCT01443130|5849572|P5|COMPLETED|Overall Study||230
2383203|NCT01443130|5849573|P4|COMPLETED|Overall Study||231
2383204|NCT01443130|5849574|P3|COMPLETED|Overall Study||223
2383205|NCT01443130|5849575|P2|COMPLETED|Overall Study||231
2383206|NCT01443130|5849576|P1|COMPLETED|Overall Study||232
2383207|NCT01443130|5849571|P6|STARTED|Overall Study||259
2383208|NCT01443130|5849572|P5|STARTED|Overall Study||274
2383209|NCT01443130|5849573|P4|STARTED|Overall Study||270
2383210|NCT01443130|5849574|P3|STARTED|Overall Study||300
2383211|NCT01443130|5849575|P2|STARTED|Overall Study||300
2383212|NCT01443130|5849576|P1|STARTED|Overall Study||300
2383213|NCT01443078|5849626|P1|NOT COMPLETED|Overall Study||29
2383214|NCT01443078|5849626|P1|COMPLETED|Overall Study||13
2383215|NCT01443078|5849626|P1|STARTED|Overall Study||42
2383216|NCT01443026|5849633|P2|NOT COMPLETED|Overall Study||5
2383217|NCT01443026|5849634|P1|NOT COMPLETED|Overall Study||3
2383218|NCT01443026|5849633|P2|COMPLETED|Overall Study||32
2383219|NCT01443026|5849634|P1|COMPLETED|Overall Study||26
2383220|NCT01443026|5849633|P2|STARTED|Overall Study||37
2383221|NCT01443026|5849634|P1|STARTED|Overall Study||29
2383222|NCT01442844|5849642|P2|NOT COMPLETED|Overall Study||0
2383223|NCT01442844|5849643|P1|NOT COMPLETED|Overall Study||0
2383224|NCT01442844|5849642|P2|COMPLETED|Overall Study||2
2383225|NCT01442844|5849643|P1|COMPLETED|Overall Study||1
2383226|NCT01442844|5849642|P2|STARTED|Overall Study||2
2383227|NCT01442844|5849643|P1|STARTED|Overall Study||1
2383228|NCT01442779|5849649|P1|NOT COMPLETED|Overall Study||7
2383229|NCT01442779|5849649|P1|COMPLETED|Overall Study||11
2383230|NCT01442779|5849649|P1|STARTED|Overall Study||18
2383231|NCT01442714|5849655|P1|NOT COMPLETED|Overall Study||12
2383232|NCT01442714|5849655|P1|COMPLETED|Overall Study||21
2383233|NCT01442714|5849655|P1|STARTED|Overall Study||33
2383234|NCT01442688|5849663|P2|NOT COMPLETED|Second Intervention||0
2383235|NCT01442688|5849664|P1|NOT COMPLETED|Second Intervention||1
2383236|NCT01442688|5849663|P2|COMPLETED|Second Intervention||31
2383237|NCT01442688|5849664|P1|COMPLETED|Second Intervention||28
2383238|NCT01442688|5849663|P2|STARTED|Second Intervention||31
2383239|NCT01442688|5849664|P1|STARTED|Second Intervention||29
2383240|NCT01442688|5849663|P2|NOT COMPLETED|First Intervention||0
2383241|NCT01442688|5849664|P1|NOT COMPLETED|First Intervention||2
2383242|NCT01442688|5849663|P2|COMPLETED|First Intervention||31
2383243|NCT01442688|5849664|P1|COMPLETED|First Intervention||29
2383244|NCT01442688|5849663|P2|STARTED|First Intervention||31
2383245|NCT01442688|5849664|P1|STARTED|First Intervention||31
2383246|NCT01442675|5849672|P1|NOT COMPLETED|Overall Study||12
2383247|NCT01442675|5849672|P1|COMPLETED|Overall Study||822
2383248|NCT01442675|5849672|P1|Per-Protocol Analysis Set|Overall Study|The Per-Protocol Analysis Set are subjects with no pre-defined protocol deviations.|781
2383249|NCT01442675|5849672|P1|Safety Analysis Set|Overall Study|Safety Analysis Set are subjects who received study vaccine and for whom safety data were available.|831
2383250|NCT01442675|5849672|P1|STARTED|Overall Study||834
2383251|NCT01442493|5849684|P2|NOT COMPLETED|Overall Study||2
2383252|NCT01442493|5849685|P1|NOT COMPLETED|Overall Study||3
2383253|NCT01442493|5849684|P2|COMPLETED|Overall Study||149
2383254|NCT01442493|5849685|P1|COMPLETED|Overall Study||146
2383255|NCT01442493|5849684|P2|STARTED|Overall Study||151
2383256|NCT01442493|5849685|P1|STARTED|Overall Study||149
2383257|NCT01442376|5849706|P3|NOT COMPLETED|Overall Study||5
2383258|NCT01442376|5849707|P2|NOT COMPLETED|Overall Study||9
2383259|NCT01442376|5849708|P1|NOT COMPLETED|Overall Study||3
2383260|NCT01442376|5849706|P3|COMPLETED|Overall Study||159
2383261|NCT01442376|5849707|P2|COMPLETED|Overall Study||160
2383262|NCT01442376|5849708|P1|COMPLETED|Overall Study||166
2383263|NCT01442376|5849706|P3|STARTED|Overall Study|Randomized patients|164
2383264|NCT01442376|5849707|P2|STARTED|Overall Study|Randomized patients|169
2383265|NCT01442376|5849708|P1|STARTED|Overall Study|Randomized patients|169
2383266|NCT01442181|5849721|P2|NOT COMPLETED|Overall Study||3
2383267|NCT01442181|5849722|P1|NOT COMPLETED|Overall Study||4
2383268|NCT01442181|5849721|P2|COMPLETED|Overall Study||8
2383269|NCT01442181|5849722|P1|COMPLETED|Overall Study||10
2383270|NCT01442181|5849721|P2|STARTED|Overall Study||11
2383271|NCT01442181|5849722|P1|STARTED|Overall Study||14
2383272|NCT01442155|5849746|P1|NOT COMPLETED|Overall Study||65
2383273|NCT01442155|5849746|P1|COMPLETED|Overall Study||9
2383274|NCT01442155|5849746|P1|STARTED|Overall Study||74
2383275|NCT01442129|5849753|P2|NOT COMPLETED|Overall Study||0
2383276|NCT01442129|5849754|P1|NOT COMPLETED|Overall Study||0
2383277|NCT01442129|5849753|P2|COMPLETED|Overall Study||10
2383278|NCT01442129|5849754|P1|COMPLETED|Overall Study|Treatment withheld from 1 patient randomized before results of screening PRA known|20
2383279|NCT01442129|5849753|P2|STARTED|Overall Study||10
2383280|NCT01442129|5849754|P1|STARTED|Overall Study||20
2383281|NCT01442103|5849762|P1|NOT COMPLETED|Overall Study||2
2383282|NCT01442103|5849762|P1|COMPLETED|Overall Study||8
2383283|NCT01442103|5849762|P1|STARTED|Overall Study||10
2383284|NCT01442064|5849772|P6|NOT COMPLETED|Overall Study||99
2383285|NCT01442064|5849773|P5|NOT COMPLETED|Overall Study||106
2383286|NCT01442064|5849774|P4|NOT COMPLETED|Overall Study||98
2383287|NCT01442064|5849775|P3|NOT COMPLETED|Overall Study||104
2383288|NCT01442064|5849776|P2|NOT COMPLETED|Overall Study||101
2383289|NCT01442064|5849777|P1|NOT COMPLETED|Overall Study||97
2383290|NCT01442064|5849772|P6|COMPLETED|Overall Study||0
2383291|NCT01442064|5849773|P5|COMPLETED|Overall Study||1
2383292|NCT01442064|5849774|P4|COMPLETED|Overall Study||0
2383293|NCT01442064|5849775|P3|COMPLETED|Overall Study||0
2383294|NCT01442064|5849776|P2|COMPLETED|Overall Study||2
2383295|NCT01442064|5849777|P1|COMPLETED|Overall Study||0
2383296|NCT01442064|5849772|P6|Received Study Drug in Extension Study|Overall Study||81
2383297|NCT01442064|5849773|P5|Received Study Drug in Extension Study|Overall Study||89
2383298|NCT01442064|5849774|P4|Received Study Drug in Extension Study|Overall Study||70
2383299|NCT01442064|5849775|P3|Received Study Drug in Extension Study|Overall Study||60
2383300|NCT01442064|5849776|P2|Received Study Drug in Extension Study|Overall Study||70
2383301|NCT01442064|5849777|P1|Received Study Drug in Extension Study|Overall Study||61
2383302|NCT01442064|5849772|P6|Ranibizumab-Treated Subjects|Overall Study||99
2383303|NCT01442064|5849773|P5|Ranibizumab-Treated Subjects|Overall Study||107
2383304|NCT01442064|5849774|P4|Ranibizumab-Treated Subjects|Overall Study||96
2383305|NCT01442064|5849775|P3|Ranibizumab-Treated Subjects|Overall Study||104
2383306|NCT01442064|5849776|P2|Ranibizumab-Treated Subjects|Overall Study||103
2383307|NCT01442064|5849777|P1|Ranibizumab-Treated Subjects|Overall Study|Includes participants who received Ranibizumab in either the initial studies or the extension study.|93
2383308|NCT01442064|5849772|P6|STARTED|Overall Study||99
2383309|NCT01442064|5849773|P5|STARTED|Overall Study||107
2383310|NCT01442064|5849774|P4|STARTED|Overall Study||98
2383311|NCT01442064|5849775|P3|STARTED|Overall Study||104
2383312|NCT01442064|5849776|P2|STARTED|Overall Study||103
2383313|NCT01442064|5849777|P1|STARTED|Overall Study||97
2383314|NCT01442038|5849814|P2|NOT COMPLETED|Overall Study||279
2383315|NCT01442038|5849815|P1|NOT COMPLETED|Overall Study||303
2383316|NCT01442038|5849814|P2|COMPLETED|Overall Study||1040
2383317|NCT01442038|5849815|P1|COMPLETED|Overall Study||1029
2383318|NCT01442038|5849814|P2|STARTED|Overall Study||1319
2383319|NCT01442038|5849815|P1|STARTED|Overall Study||1332
2383320|NCT01441973|5849829|P2|NOT COMPLETED|Overall Study||16
2383321|NCT01441973|5849830|P1|NOT COMPLETED|Overall Study||15
2383322|NCT01441973|5849829|P2|COMPLETED|Overall Study|Still receiving treatment|0
2383323|NCT01441973|5849830|P1|COMPLETED|Overall Study|Still receiving treatment|0
2383324|NCT01441973|5849829|P2|STARTED|Overall Study||16
2383325|NCT01441973|5849830|P1|STARTED|Overall Study||15
2383326|NCT01441960|5849852|P2|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
2383327|NCT01441960|5849853|P1|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
2383328|NCT01441960|5849852|P2|COMPLETED|Second Neuromuscular Blocking Agent||13
2383329|NCT01441960|5849853|P1|COMPLETED|Second Neuromuscular Blocking Agent||18
2383330|NCT01441960|5849852|P2|STARTED|Second Neuromuscular Blocking Agent||13
2383331|NCT01441960|5849853|P1|STARTED|Second Neuromuscular Blocking Agent||18
2383332|NCT01441960|5849852|P2|NOT COMPLETED|First Neuromuscular Blocking Agent:||6
2383333|NCT01441960|5849853|P1|NOT COMPLETED|First Neuromuscular Blocking Agent:||8
2383334|NCT01441960|5849852|P2|COMPLETED|First Neuromuscular Blocking Agent:||13
2383335|NCT01441960|5849853|P1|COMPLETED|First Neuromuscular Blocking Agent:||18
2383336|NCT01441960|5849852|P2|STARTED|First Neuromuscular Blocking Agent:||19
2383337|NCT01441960|5849853|P1|STARTED|First Neuromuscular Blocking Agent:||26
2383338|NCT01441882|5849863|P1|NOT COMPLETED|Overall Study||6
2383339|NCT01441882|5849863|P1|COMPLETED|Overall Study||13
2383340|NCT01441882|5849863|P1|STARTED|Overall Study||19
2383341|NCT01441843|5849869|P2|NOT COMPLETED|Overall Study||5
2383342|NCT01441843|5849870|P1|NOT COMPLETED|Overall Study||12
2383343|NCT01441843|5849869|P2|COMPLETED|Overall Study||195
2383344|NCT01441843|5849870|P1|COMPLETED|Overall Study||188
2383345|NCT01441843|5849869|P2|STARTED|Overall Study||200
2383346|NCT01441843|5849870|P1|STARTED|Overall Study||200
2383347|NCT01441765|5849878|P2|NOT COMPLETED|Overall Study||0
2383348|NCT01441765|5849879|P1|NOT COMPLETED|Overall Study||1
2383349|NCT01441765|5849878|P2|COMPLETED|Overall Study|not opened|0
2383350|NCT01441765|5849879|P1|COMPLETED|Overall Study||10
2383351|NCT01441765|5849878|P2|STARTED|Overall Study|not opened|0
2383352|NCT01441765|5849879|P1|STARTED|Overall Study||11
2383353|NCT01441596|5849896|P3|NOT COMPLETED|Overall Study||4
2383354|NCT01441596|5849897|P2|NOT COMPLETED|Overall Study||3
2383355|NCT01441596|5849898|P1|NOT COMPLETED|Overall Study||4
2383356|NCT01441596|5849896|P3|COMPLETED|Overall Study||39
2383357|NCT01441596|5849897|P2|COMPLETED|Overall Study||35
2383358|NCT01441596|5849898|P1|COMPLETED|Overall Study||36
2383359|NCT01441596|5849896|P3|STARTED|Overall Study||43
2383360|NCT01441596|5849897|P2|STARTED|Overall Study||38
2383361|NCT01441596|5849898|P1|STARTED|Overall Study||40
2383362|NCT01441570|5849914|P2|NOT COMPLETED|Overall Study||0
2383363|NCT01441570|5849915|P1|NOT COMPLETED|Overall Study||0
2383364|NCT01441570|5849914|P2|COMPLETED|Overall Study||5
2383365|NCT01441570|5849915|P1|COMPLETED|Overall Study||6
2383366|NCT01441570|5849914|P2|STARTED|Overall Study||5
2383367|NCT01441570|5849915|P1|STARTED|Overall Study||6
2383368|NCT01441466|5849925|P2|NOT COMPLETED|Overall Study||0
2383369|NCT01441466|5849926|P1|NOT COMPLETED|Overall Study||0
2383370|NCT01441466|5849925|P2|COMPLETED|Overall Study||11
2383371|NCT01441466|5849926|P1|COMPLETED|Overall Study||37
2383372|NCT01441466|5849925|P2|STARTED|Overall Study||11
2383373|NCT01441466|5849926|P1|STARTED|Overall Study||37
2383374|NCT01441440|5849945|P3|NOT COMPLETED|Overall Study||22
2383375|NCT01441440|5849946|P2|NOT COMPLETED|Overall Study||23
2383376|NCT01441440|5849947|P1|NOT COMPLETED|Overall Study||17
2383377|NCT01441440|5849945|P3|COMPLETED|Overall Study||158
2383378|NCT01441440|5849946|P2|COMPLETED|Overall Study||151
2383379|NCT01441440|5849947|P1|COMPLETED|Overall Study||166
2383380|NCT01441440|5849945|P3|STARTED|Overall Study|Safety analysis set|180
2383381|NCT01441440|5849946|P2|STARTED|Overall Study|Safety analysis set|174
2383382|NCT01441440|5849947|P1|STARTED|Overall Study|Safety analysis set|183
2383383|NCT01441414|5849970|P1|NOT COMPLETED|Overall Study||15
2383384|NCT01441414|5849970|P1|COMPLETED|Overall Study||3
2383385|NCT01441414|5849970|P1|STARTED|Overall Study||18
2383386|NCT01441401|5849995|P1|NOT COMPLETED|Overall Study||0
2383387|NCT01441401|5849995|P1|COMPLETED|Overall Study|Number of participants whose survey form was collected was presented.|82
2383388|NCT01441401|5849995|P1|STARTED|Overall Study||82
2383389|NCT01441245|5850023|P2|NOT COMPLETED|Overall Study||0
2383390|NCT01441245|5850024|P1|NOT COMPLETED|Overall Study||0
2383391|NCT01441245|5850023|P2|COMPLETED|Overall Study||27
2383392|NCT01441245|5850024|P1|COMPLETED|Overall Study||30
2383393|NCT01441245|5850023|P2|STARTED|Overall Study||27
2383394|NCT01441245|5850024|P1|STARTED|Overall Study||30
2383395|NCT01441180|5850049|P3|NOT COMPLETED|Overall Study||3
2383396|NCT01441180|5850050|P2|NOT COMPLETED|Overall Study||1
2383397|NCT01441180|5850051|P1|NOT COMPLETED|Overall Study||1
2383398|NCT01441180|5850049|P3|COMPLETED|Overall Study||22
2383399|NCT01441180|5850050|P2|COMPLETED|Overall Study||24
2383400|NCT01441180|5850051|P1|COMPLETED|Overall Study||9
2383401|NCT01441180|5850049|P3|STARTED|Overall Study||25
2383402|NCT01441180|5850050|P2|STARTED|Overall Study||25
2383403|NCT01441180|5850051|P1|STARTED|Overall Study||10
2383404|NCT01441102|5850062|P1|NOT COMPLETED|Overall Study||3
2383405|NCT01441102|5850062|P1|COMPLETED|Overall Study||4
2383406|NCT01441102|5850062|P1|STARTED|Overall Study|Two participants withdrew prior to Month 6; therefore, two additional participants were enrolled.|7
2383407|NCT01441076|5850082|P1|NOT COMPLETED|Overall Study||2
2383408|NCT01441076|5850082|P1|COMPLETED|Overall Study||4
2383409|NCT01441076|5850082|P1|STARTED|Overall Study||6
2383410|NCT01441037|5850100|P1|NOT COMPLETED|Overall Study||0
2383411|NCT01441037|5850100|P1|COMPLETED|Overall Study||27
2383412|NCT01441037|5850100|P1|STARTED|Overall Study||27
2383413|NCT01440972|5850106|P2|NOT COMPLETED|Overall Study||2
2383414|NCT01440972|5850107|P1|NOT COMPLETED|Overall Study||3
2383415|NCT01440972|5850106|P2|COMPLETED|Overall Study||19
2383416|NCT01440972|5850107|P1|COMPLETED|Overall Study||21
2383417|NCT01440972|5850106|P2|STARTED|Overall Study||21
2383418|NCT01440972|5850107|P1|STARTED|Overall Study||24
2383419|NCT01440959|5850121|P1|NOT COMPLETED|Overall Study||0
2383420|NCT01440959|5850121|P1|COMPLETED|Overall Study||30
2383421|NCT01440959|5850121|P1|STARTED|Overall Study||30
2383422|NCT01440946|5850131|P2|NOT COMPLETED|Overall Study||1
2383423|NCT01440946|5850132|P1|NOT COMPLETED|Overall Study||2
2383424|NCT01440946|5850131|P2|COMPLETED|Overall Study||14
2383425|NCT01440946|5850132|P1|COMPLETED|Overall Study||13
2383426|NCT01440946|5850131|P2|STARTED|Overall Study||15
2383427|NCT01440946|5850132|P1|STARTED|Overall Study||15
2383428|NCT01440881|5850171|P2|NOT COMPLETED|Overall Study||1
2383429|NCT01440881|5850172|P1|NOT COMPLETED|Overall Study||0
2383430|NCT01440881|5850171|P2|COMPLETED|Overall Study||14
2383431|NCT01440881|5850172|P1|COMPLETED|Overall Study||14
2383432|NCT01440881|5850171|P2|STARTED|Overall Study||15
2383433|NCT01440881|5850172|P1|STARTED|Overall Study||14
2383434|NCT01440816|5850186|P2|NOT COMPLETED|Overall Study||11
2383435|NCT01440816|5850187|P1|NOT COMPLETED|Overall Study||1
2383436|NCT01440816|5850186|P2|COMPLETED|Overall Study||1
2383437|NCT01440816|5850187|P1|COMPLETED|Overall Study||2
2383438|NCT01440816|5850186|P2|STARTED|Overall Study||12
2383439|NCT01440816|5850187|P1|STARTED|Overall Study||3
2383440|NCT01440803|5850203|P2|NOT COMPLETED|Overall Study||4
2383441|NCT01440803|5850204|P1|NOT COMPLETED|Overall Study||2
2383442|NCT01440803|5850203|P2|COMPLETED|Overall Study||24
2383443|NCT01440803|5850204|P1|COMPLETED|Overall Study||11
2383444|NCT01440803|5850203|P2|Period 3 - Forteo Open Label|Overall Study||27
2383445|NCT01440803|5850204|P1|Period 3 - Forteo Open Label|Overall Study||13
2383446|NCT01440803|5850203|P2|Period 2 - Forteo/Forteo|Overall Study||28
2383447|NCT01440803|5850204|P1|Period 2 - Forteo/Forteo|Overall Study||13
2383448|NCT01440803|5850203|P2|Period 1 - Forteo/Placebo|Overall Study||28
2383449|NCT01440803|5850204|P1|Period 1 - Forteo/Placebo|Overall Study||13
2383450|NCT01440803|5850203|P2|STARTED|Overall Study||28
2383451|NCT01440803|5850204|P1|STARTED|Overall Study||13
2383452|NCT01440764|5850213|P7|NOT COMPLETED|Test Day 3||0
2383453|NCT01440764|5850214|P6|NOT COMPLETED|Test Day 3||0
2383454|NCT01440764|5850215|P5|NOT COMPLETED|Test Day 3||0
2383455|NCT01440764|5850216|P4|NOT COMPLETED|Test Day 3||0
2383456|NCT01440764|5850217|P3|NOT COMPLETED|Test Day 3||0
2383457|NCT01440764|5850218|P2|NOT COMPLETED|Test Day 3||0
2383458|NCT01440764|5850219|P1|NOT COMPLETED|Test Day 3||0
2383459|NCT01440764|5850213|P7|COMPLETED|Test Day 3||3
2383460|NCT01440764|5850214|P6|COMPLETED|Test Day 3||5
2383461|NCT01440764|5850215|P5|COMPLETED|Test Day 3||3
2383462|NCT01440764|5850216|P4|COMPLETED|Test Day 3||1
2383463|NCT01440764|5850217|P3|COMPLETED|Test Day 3||6
2383464|NCT01440764|5850218|P2|COMPLETED|Test Day 3||2
2383465|NCT01440764|5850219|P1|COMPLETED|Test Day 3||3
2383466|NCT01440764|5850213|P7|STARTED|Test Day 3||3
2383467|NCT01440764|5850214|P6|STARTED|Test Day 3||5
2383468|NCT01440764|5850215|P5|STARTED|Test Day 3||3
2383469|NCT01440764|5850216|P4|STARTED|Test Day 3||1
2383470|NCT01440764|5850217|P3|STARTED|Test Day 3||6
2383471|NCT01440764|5850218|P2|STARTED|Test Day 3||2
2383472|NCT01440764|5850219|P1|STARTED|Test Day 3||3
2383473|NCT01440764|5850213|P7|NOT COMPLETED|Test Day 2||0
2383474|NCT01440764|5850214|P6|NOT COMPLETED|Test Day 2||0
2383475|NCT01440764|5850215|P5|NOT COMPLETED|Test Day 2||0
2383476|NCT01440764|5850216|P4|NOT COMPLETED|Test Day 2||0
2383477|NCT01440764|5850217|P3|NOT COMPLETED|Test Day 2||0
2383478|NCT01440764|5850218|P2|NOT COMPLETED|Test Day 2||0
2383479|NCT01440764|5850219|P1|NOT COMPLETED|Test Day 2||0
2383480|NCT01440764|5850213|P7|COMPLETED|Test Day 2||3
2383481|NCT01440764|5850214|P6|COMPLETED|Test Day 2||5
2383482|NCT01440764|5850215|P5|COMPLETED|Test Day 2||3
2383483|NCT01440764|5850216|P4|COMPLETED|Test Day 2||1
2383484|NCT01440764|5850217|P3|COMPLETED|Test Day 2||6
2383485|NCT01440764|5850218|P2|COMPLETED|Test Day 2||2
2383486|NCT01440764|5850219|P1|COMPLETED|Test Day 2||3
2383487|NCT01440764|5850213|P7|STARTED|Test Day 2||3
2383488|NCT01440764|5850214|P6|STARTED|Test Day 2||5
2383489|NCT01440764|5850215|P5|STARTED|Test Day 2||3
2383490|NCT01440764|5850216|P4|STARTED|Test Day 2||1
2383491|NCT01440764|5850217|P3|STARTED|Test Day 2||6
2383492|NCT01440764|5850218|P2|STARTED|Test Day 2||2
2383493|NCT01440764|5850219|P1|STARTED|Test Day 2|Following Test Day 1, 1 subject withdrew from the study before beginning Test Day 2.|3
2383494|NCT01440764|5850213|P7|NOT COMPLETED|Test Day 1||0
2383495|NCT01440764|5850214|P6|NOT COMPLETED|Test Day 1||0
2383496|NCT01440764|5850215|P5|NOT COMPLETED|Test Day 1||0
2383497|NCT01440764|5850216|P4|NOT COMPLETED|Test Day 1||0
2383498|NCT01440764|5850217|P3|NOT COMPLETED|Test Day 1||0
2383499|NCT01440764|5850218|P2|NOT COMPLETED|Test Day 1||0
2383500|NCT01440764|5850219|P1|NOT COMPLETED|Test Day 1||0
2383501|NCT01440764|5850213|P7|COMPLETED|Test Day 1||3
2383502|NCT01440764|5850214|P6|COMPLETED|Test Day 1||5
2383503|NCT01440764|5850215|P5|COMPLETED|Test Day 1||3
2383504|NCT01440764|5850216|P4|COMPLETED|Test Day 1||1
2383505|NCT01440764|5850217|P3|COMPLETED|Test Day 1||6
2383506|NCT01440764|5850218|P2|COMPLETED|Test Day 1||2
2383507|NCT01440764|5850219|P1|COMPLETED|Test Day 1||4
2383508|NCT01440764|5850213|P7|STARTED|Test Day 1||3
2383509|NCT01440764|5850214|P6|STARTED|Test Day 1||5
2383510|NCT01440764|5850215|P5|STARTED|Test Day 1||3
2383511|NCT01440764|5850216|P4|STARTED|Test Day 1||1
2383512|NCT01440764|5850217|P3|STARTED|Test Day 1||6
2383513|NCT01440764|5850218|P2|STARTED|Test Day 1||2
2383514|NCT01440764|5850219|P1|STARTED|Test Day 1||4
2383515|NCT01440647|5850240|P2|NOT COMPLETED|Overall Study||3
2383516|NCT01440647|5850241|P1|NOT COMPLETED|Overall Study||2
2383517|NCT01440647|5850240|P2|COMPLETED|Overall Study||15
2383518|NCT01440647|5850241|P1|COMPLETED|Overall Study||14
2383519|NCT01440647|5850240|P2|STARTED|Overall Study||18
2383520|NCT01440647|5850241|P1|STARTED|Overall Study||16
2383521|NCT01440634|5850251|P2|NOT COMPLETED|Randomization Phase||10
2383522|NCT01440634|5850252|P1|NOT COMPLETED|Randomization Phase||6
2383523|NCT01440634|5850251|P2|COMPLETED|Randomization Phase||14
2383524|NCT01440634|5850252|P1|COMPLETED|Randomization Phase||24
2383525|NCT01440634|5850251|P2|STARTED|Randomization Phase||24
2383526|NCT01440634|5850252|P1|STARTED|Randomization Phase||30
2383527|NCT01440634|5850251|P2|NOT COMPLETED|Cross Sectional Phase||0
2383528|NCT01440634|5850252|P1|NOT COMPLETED|Cross Sectional Phase||0
2383529|NCT01440634|5850251|P2|COMPLETED|Cross Sectional Phase||347
2383530|NCT01440634|5850252|P1|COMPLETED|Cross Sectional Phase||0
2383531|NCT01440634|5850251|P2|STARTED|Cross Sectional Phase||347
2383532|NCT01440634|5850252|P1|STARTED|Cross Sectional Phase||0
2383533|NCT01440595|5850260|P3|NOT COMPLETED|Overall Study||1
2383534|NCT01440595|5850261|P2|NOT COMPLETED|Overall Study||3
2383535|NCT01440595|5850262|P1|NOT COMPLETED|Overall Study||1
2383536|NCT01440595|5850260|P3|COMPLETED|Overall Study||0
2383537|NCT01440595|5850261|P2|COMPLETED|Overall Study||0
2383538|NCT01440595|5850262|P1|COMPLETED|Overall Study||0
2383539|NCT01440595|5850260|P3|STARTED|Overall Study||1
2383540|NCT01440595|5850261|P2|STARTED|Overall Study||3
2383541|NCT01440595|5850262|P1|STARTED|Overall Study||1
2383542|NCT01440569|5850282|P2|NOT COMPLETED|Open-Label Rollover Phase||6
2383543|NCT01440569|5850283|P1|NOT COMPLETED|Open-Label Rollover Phase||47
2383544|NCT01440569|5850282|P2|COMPLETED|Open-Label Rollover Phase||7
2383545|NCT01440569|5850283|P1|COMPLETED|Open-Label Rollover Phase||204
2383546|NCT01440569|5850282|P2|STARTED|Open-Label Rollover Phase|1 participant who completed the Main Study did not enroll into the Rollover Phase.|13
2383547|NCT01440569|5850283|P1|STARTED|Open-Label Rollover Phase|9 participants who completed the Main Study did not enroll into the Rollover Phase.|251
2383548|NCT01440569|5850282|P2|NOT COMPLETED|Main Study||4
2383549|NCT01440569|5850283|P1|NOT COMPLETED|Main Study||36
2383550|NCT01440569|5850282|P2|COMPLETED|Main Study||14
2383551|NCT01440569|5850283|P1|COMPLETED|Main Study||260
2383552|NCT01440569|5850282|P2|Enrolled and Treated|Main Study||18
2383553|NCT01440569|5850283|P1|Enrolled and Treated|Main Study||295
2383554|NCT01440569|5850282|P2|STARTED|Main Study||18
2383555|NCT01440569|5850283|P1|STARTED|Main Study||296
2383556|NCT01440543|5850305|P4|NOT COMPLETED|Overall Study||6
2383557|NCT01440543|5850306|P3|NOT COMPLETED|Overall Study||2
2383558|NCT01440543|5850307|P2|NOT COMPLETED|Overall Study||4
2383559|NCT01440543|5850308|P1|NOT COMPLETED|Overall Study||4
2383560|NCT01440543|5850305|P4|COMPLETED|Overall Study||101
2383561|NCT01440543|5850306|P3|COMPLETED|Overall Study||100
2383562|NCT01440543|5850307|P2|COMPLETED|Overall Study||101
2383563|NCT01440543|5850308|P1|COMPLETED|Overall Study||102
2383564|NCT01440543|5850305|P4|STARTED|Overall Study||107
2383565|NCT01440543|5850306|P3|STARTED|Overall Study||102
2383566|NCT01440543|5850307|P2|STARTED|Overall Study||105
2383567|NCT01440543|5850308|P1|STARTED|Overall Study||106
2383568|NCT01440517|5850318|P1|NOT COMPLETED|Overall Study||1
2383569|NCT01440517|5850318|P1|COMPLETED|Overall Study||4
2383570|NCT01440517|5850318|P1|STARTED|Overall Study||5
2383571|NCT01440387|5850325|P2|NOT COMPLETED|Overall Study||0
2383572|NCT01440387|5850326|P1|NOT COMPLETED|Overall Study||0
2383573|NCT01440387|5850325|P2|COMPLETED|Overall Study||56
2383574|NCT01440387|5850326|P1|COMPLETED|Overall Study||56
2383575|NCT01440387|5850325|P2|STARTED|Overall Study||56
2383576|NCT01440387|5850326|P1|STARTED|Overall Study||56
2383577|NCT01440374|5850349|P4|NOT COMPLETED|Part 3: Extension||32
2383578|NCT01440374|5850350|P3|NOT COMPLETED|Part 3: Extension||0
2383579|NCT01440374|5850351|P2|NOT COMPLETED|Part 3: Extension||0
2383580|NCT01440374|5850352|P1|NOT COMPLETED|Part 3: Extension||0
2383581|NCT01440374|5850349|P4|COMPLETED|Part 3: Extension||27
2383582|NCT01440374|5850350|P3|COMPLETED|Part 3: Extension||0
2383583|NCT01440374|5850351|P2|COMPLETED|Part 3: Extension||0
2383584|NCT01440374|5850352|P1|COMPLETED|Part 3: Extension||0
2383585|NCT01440374|5850349|P4|STARTED|Part 3: Extension||59
2383586|NCT01440374|5850350|P3|STARTED|Part 3: Extension||0
2383587|NCT01440374|5850351|P2|STARTED|Part 3: Extension||0
2383588|NCT01440374|5850352|P1|STARTED|Part 3: Extension||0
2383589|NCT01440374|5850349|P4|NOT COMPLETED|Part 2; Double-blind Phase||0
2383590|NCT01440374|5850350|P3|NOT COMPLETED|Part 2; Double-blind Phase||55
2383591|NCT01440374|5850351|P2|NOT COMPLETED|Part 2; Double-blind Phase||20
2383592|NCT01440374|5850352|P1|NOT COMPLETED|Part 2; Double-blind Phase||0
2383593|NCT01440374|5850349|P4|COMPLETED|Part 2; Double-blind Phase||0
2383594|NCT01440374|5850350|P3|COMPLETED|Part 2; Double-blind Phase||43
2383595|NCT01440374|5850351|P2|COMPLETED|Part 2; Double-blind Phase||27
2383596|NCT01440374|5850352|P1|COMPLETED|Part 2; Double-blind Phase||0
2383597|NCT01440374|5850349|P4|STARTED|Part 2; Double-blind Phase||0
2383598|NCT01440374|5850350|P3|STARTED|Part 2; Double-blind Phase||98
2383599|NCT01440374|5850351|P2|STARTED|Part 2; Double-blind Phase||47
2383600|NCT01440374|5850352|P1|STARTED|Part 2; Double-blind Phase||0
2383601|NCT01440374|5850349|P4|NOT COMPLETED|Part 1: Open-label Phase||0
2383602|NCT01440374|5850350|P3|NOT COMPLETED|Part 1: Open-label Phase||0
2383603|NCT01440374|5850351|P2|NOT COMPLETED|Part 1: Open-label Phase||0
2383604|NCT01440374|5850352|P1|NOT COMPLETED|Part 1: Open-label Phase||6
2383605|NCT01440374|5850349|P4|COMPLETED|Part 1: Open-label Phase||0
2383606|NCT01440374|5850350|P3|COMPLETED|Part 1: Open-label Phase||0
2383607|NCT01440374|5850351|P2|COMPLETED|Part 1: Open-label Phase||0
2383608|NCT01440374|5850352|P1|COMPLETED|Part 1: Open-label Phase||11
2383609|NCT01440374|5850349|P4|STARTED|Part 1: Open-label Phase||0
2383610|NCT01440374|5850350|P3|STARTED|Part 1: Open-label Phase||0
2383611|NCT01440374|5850351|P2|STARTED|Part 1: Open-label Phase||0
2383612|NCT01440374|5850352|P1|STARTED|Part 1: Open-label Phase||17
2383613|NCT01440322|5850387|P2|NOT COMPLETED|Overall Study||1
2383614|NCT01440322|5850388|P1|NOT COMPLETED|Overall Study||7
2383615|NCT01440322|5850387|P2|COMPLETED|Overall Study||49
2383616|NCT01440322|5850388|P1|COMPLETED|Overall Study||90
2383617|NCT01440322|5850387|P2|STARTED|Overall Study||50
2383618|NCT01440322|5850388|P1|STARTED|Overall Study||97
2383619|NCT01440283|5850410|P1|NOT COMPLETED|Overall Study||10
2383620|NCT01440283|5850410|P1|COMPLETED|Overall Study||4
2383621|NCT01440283|5850410|P1|STARTED|Overall Study||14
2383622|NCT01440101|5850425|P3|NOT COMPLETED|Overall Study||1
2383623|NCT01440101|5850426|P2|NOT COMPLETED|Overall Study||4
2383624|NCT01440101|5850427|P1|NOT COMPLETED|Overall Study||2
2383625|NCT01440101|5850425|P3|COMPLETED|Overall Study||46
2383626|NCT01440101|5850426|P2|COMPLETED|Overall Study||43
2383627|NCT01440101|5850427|P1|COMPLETED|Overall Study||10
2383628|NCT01440101|5850425|P3|STARTED|Overall Study||47
2383629|NCT01440101|5850426|P2|STARTED|Overall Study||47
2383630|NCT01440101|5850427|P1|STARTED|Overall Study||12
2383631|NCT01440049|5850460|P1|NOT COMPLETED|Overall Study||5
2383632|NCT01440049|5850460|P1|COMPLETED|Overall Study||155
2383633|NCT01440049|5850460|P1|STARTED|Overall Study||160
2383634|NCT01439971|5850492|P5|NOT COMPLETED|Overall Study||1
2383635|NCT01439971|5850493|P4|NOT COMPLETED|Overall Study||0
2383636|NCT01439971|5850494|P3|NOT COMPLETED|Overall Study||2
2383637|NCT01439971|5850495|P2|NOT COMPLETED|Overall Study||1
2383638|NCT01439971|5850496|P1|NOT COMPLETED|Overall Study||0
2383639|NCT01439971|5850492|P5|COMPLETED|Overall Study||6
2383640|NCT01439971|5850493|P4|COMPLETED|Overall Study||6
2383641|NCT01439971|5850494|P3|COMPLETED|Overall Study||6
2383642|NCT01439971|5850495|P2|COMPLETED|Overall Study||6
2383643|NCT01439971|5850496|P1|COMPLETED|Overall Study||1
2383644|NCT01439971|5850492|P5|Received Treatment|Overall Study||6
2383645|NCT01439971|5850493|P4|Received Treatment|Overall Study||6
2383646|NCT01439971|5850494|P3|Received Treatment|Overall Study||6
2383647|NCT01439971|5850495|P2|Received Treatment|Overall Study||6
2383648|NCT01439971|5850496|P1|Received Treatment|Overall Study||1
2383649|NCT01439971|5850492|P5|STARTED|Overall Study||7
2383650|NCT01439971|5850493|P4|STARTED|Overall Study||6
2383651|NCT01439971|5850494|P3|STARTED|Overall Study||8
2383652|NCT01439971|5850495|P2|STARTED|Overall Study||7
2383653|NCT01439971|5850496|P1|STARTED|Overall Study||1
2383654|NCT01439945|5850676|P4|NOT COMPLETED|Optional Continuation Phase||0
2383655|NCT01439945|5850677|P3|NOT COMPLETED|Optional Continuation Phase||0
2383656|NCT01439945|5850678|P2|NOT COMPLETED|Optional Continuation Phase||0
2383657|NCT01439945|5850679|P1|NOT COMPLETED|Optional Continuation Phase||0
2383658|NCT01439945|5850676|P4|COMPLETED|Optional Continuation Phase||0
2383659|NCT01439945|5850677|P3|COMPLETED|Optional Continuation Phase||0
2383660|NCT01439945|5850678|P2|COMPLETED|Optional Continuation Phase||44
2383661|NCT01439945|5850679|P1|COMPLETED|Optional Continuation Phase||72
2383662|NCT01439945|5850676|P4|STARTED|Optional Continuation Phase||0
2383663|NCT01439945|5850677|P3|STARTED|Optional Continuation Phase||0
2383664|NCT01439945|5850678|P2|STARTED|Optional Continuation Phase||44
2383665|NCT01439945|5850679|P1|STARTED|Optional Continuation Phase||72
2383666|NCT01439945|5850676|P4|NOT COMPLETED|Double-Blind Treatment Phase||2
2383667|NCT01439945|5850677|P3|NOT COMPLETED|Double-Blind Treatment Phase||3
2383668|NCT01439945|5850678|P2|NOT COMPLETED|Double-Blind Treatment Phase||5
2383669|NCT01439945|5850679|P1|NOT COMPLETED|Double-Blind Treatment Phase||4
2383670|NCT01439945|5850676|P4|COMPLETED|Double-Blind Treatment Phase||46
2383671|NCT01439945|5850677|P3|COMPLETED|Double-Blind Treatment Phase||45
2383672|NCT01439945|5850678|P2|COMPLETED|Double-Blind Treatment Phase||91
2383673|NCT01439945|5850679|P1|COMPLETED|Double-Blind Treatment Phase||93
2383674|NCT01439945|5850676|P4|STARTED|Double-Blind Treatment Phase||48
2383675|NCT01439945|5850677|P3|STARTED|Double-Blind Treatment Phase||48
2383676|NCT01439945|5850678|P2|STARTED|Double-Blind Treatment Phase||96
2383677|NCT01439945|5850679|P1|STARTED|Double-Blind Treatment Phase||97
2383678|NCT01439880|5850704|P2|NOT COMPLETED|All-IP Period (Years 2 to 5)||140
2383679|NCT01439880|5850705|P1|NOT COMPLETED|All-IP Period (Years 2 to 5)||70
2383680|NCT01439880|5850704|P2|COMPLETED|All-IP Period (Years 2 to 5)||682
2383681|NCT01439880|5850705|P1|COMPLETED|All-IP Period (Years 2 to 5)||328
2383682|NCT01439880|5850704|P2|Received Evolocumab|All-IP Period (Years 2 to 5)||777
2383683|NCT01439880|5850705|P1|Received Evolocumab|All-IP Period (Years 2 to 5)||374
2383684|NCT01439880|5850704|P2|STARTED|All-IP Period (Years 2 to 5)||822
2383685|NCT01439880|5850705|P1|STARTED|All-IP Period (Years 2 to 5)||398
2383686|NCT01439880|5850704|P2|NOT COMPLETED|SOC-controlled Period (Year 1)||60
2383687|NCT01439880|5850705|P1|NOT COMPLETED|SOC-controlled Period (Year 1)||44
2383688|NCT01439880|5850704|P2|COMPLETED|SOC-controlled Period (Year 1)||822
2383689|NCT01439880|5850705|P1|COMPLETED|SOC-controlled Period (Year 1)||398
2383690|NCT01439880|5850704|P2|Received Evolocumab|SOC-controlled Period (Year 1)||881
2383691|NCT01439880|5850705|P1|Received Evolocumab|SOC-controlled Period (Year 1)||0
2383692|NCT01439880|5850704|P2|STARTED|SOC-controlled Period (Year 1)||882
2383693|NCT01439880|5850705|P1|STARTED|SOC-controlled Period (Year 1)||442
2383694|NCT01439867|5850748|P2|NOT COMPLETED|Overall Study||8
2383695|NCT01439867|5850749|P1|NOT COMPLETED|Overall Study||6
2383696|NCT01439867|5850748|P2|COMPLETED|Overall Study||2
2383697|NCT01439867|5850749|P1|COMPLETED|Overall Study||2
2383698|NCT01439867|5850748|P2|Received Treatment|Overall Study||10
2383699|NCT01439867|5850749|P1|Received Treatment|Overall Study||7
2383700|NCT01439867|5850748|P2|STARTED|Overall Study||10
2383701|NCT01439867|5850749|P1|STARTED|Overall Study||8
2383702|NCT01439854|5850790|P2|NOT COMPLETED|Overall Study||0
2383703|NCT01439854|5850791|P1|NOT COMPLETED|Overall Study||0
2383704|NCT01439854|5850790|P2|COMPLETED|Overall Study||10
2383705|NCT01439854|5850791|P1|COMPLETED|Overall Study||8
2383706|NCT01439854|5850790|P2|STARTED|Overall Study||10
2383707|NCT01439854|5850791|P1|STARTED|Overall Study||8
2383708|NCT01439724|5850801|P2|NOT COMPLETED|Overall Study||8
2383709|NCT01439724|5850802|P1|NOT COMPLETED|Overall Study||9
2383710|NCT01439724|5850801|P2|COMPLETED|Overall Study||39
2383711|NCT01439724|5850802|P1|COMPLETED|Overall Study||38
2383712|NCT01439724|5850801|P2|STARTED|Overall Study||47
2383713|NCT01439724|5850802|P1|STARTED|Overall Study||47
2383714|NCT01439711|5850808|P1|NOT COMPLETED|Overall Study||40
2383715|NCT01439711|5850808|P1|COMPLETED|Overall Study||68
2383716|NCT01439711|5850808|P1|STARTED|Overall Study||108
2383717|NCT01439672|5850819|P1|NOT COMPLETED|Overall Study||24
2383718|NCT01439672|5850819|P1|COMPLETED|Overall Study||11
2383719|NCT01439672|5850819|P1|STARTED|Overall Study||35
2383720|NCT01439633|5850823|P1|NOT COMPLETED|Overall Study||0
2383721|NCT01439633|5850823|P1|COMPLETED|Overall Study||22
2383722|NCT01439633|5850823|P1|STARTED|Overall Study||22
2383723|NCT01439620|5850827|P1|NOT COMPLETED|Overall Study||0
2383724|NCT01439620|5850827|P1|COMPLETED|Overall Study||7
2383725|NCT01439620|5850827|P1|STARTED|Overall Study||7
2383726|NCT01439594|5850831|P1|NOT COMPLETED|Overall Study||0
2383727|NCT01439594|5850831|P1|COMPLETED|Overall Study||17
2383728|NCT01439594|5850831|P1|STARTED|Overall Study||17
2383729|NCT01439581|5850837|P2|NOT COMPLETED|Overall Study||0
2383730|NCT01439581|5850838|P1|NOT COMPLETED|Overall Study||0
2383731|NCT01439581|5850837|P2|COMPLETED|Overall Study||212
2383732|NCT01439581|5850838|P1|COMPLETED|Overall Study||216
2383733|NCT01439581|5850837|P2|STARTED|Overall Study||212
2383734|NCT01439581|5850838|P1|STARTED|Overall Study||216
2383735|NCT01439568|5850846|P2|NOT COMPLETED|Overall Study||2
2383736|NCT01439568|5850847|P1|NOT COMPLETED|Overall Study||3
2383737|NCT01439568|5850846|P2|COMPLETED|Overall Study||41
2383738|NCT01439568|5850847|P1|COMPLETED|Overall Study||44
2383739|NCT01439568|5850846|P2|Received at Least One Dose of Study Drug|Overall Study||43
2383740|NCT01439568|5850847|P1|Received at Least One Dose of Study Drug|Overall Study||47
2383741|NCT01439568|5850846|P2|STARTED|Overall Study||43
2383742|NCT01439568|5850847|P1|STARTED|Overall Study||47
2383743|NCT01439555|5850859|P1|NOT COMPLETED|Overall Study||1
2383744|NCT01439555|5850859|P1|COMPLETED|Overall Study||10
2383745|NCT01439555|5850859|P1|STARTED|Overall Study||11
2383746|NCT01439373|5850871|P2|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||0
2383747|NCT01439373|5850872|P1|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||2
2383748|NCT01439373|5850871|P2|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||4
2383749|NCT01439373|5850872|P1|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||9
2383750|NCT01439373|5850871|P2|STARTED|Combined With PEG and RIBA (Day 2 to 28)||4
2383751|NCT01439373|5850872|P1|STARTED|Combined With PEG and RIBA (Day 2 to 28)||11
2383752|NCT01439373|5850871|P2|NOT COMPLETED|Monotherapy (Day 1)||1
2383753|NCT01439373|5850872|P1|NOT COMPLETED|Monotherapy (Day 1)||0
2383754|NCT01439373|5850871|P2|COMPLETED|Monotherapy (Day 1)||4
2383755|NCT01439373|5850872|P1|COMPLETED|Monotherapy (Day 1)||11
2383756|NCT01439373|5850871|P2|STARTED|Monotherapy (Day 1)||5
2383757|NCT01439373|5850872|P1|STARTED|Monotherapy (Day 1)||11
2383758|NCT01439360|5850915|P2|NOT COMPLETED|Overall Study||208
2383759|NCT01439360|5850916|P1|NOT COMPLETED|Overall Study||198
2383760|NCT01439360|5850915|P2|COMPLETED|Overall Study||5804
2383761|NCT01439360|5850916|P1|COMPLETED|Overall Study||5808
2383762|NCT01439360|5850915|P2|STARTED|Overall Study||6012
2383763|NCT01439360|5850916|P1|STARTED|Overall Study||6006
2383764|NCT01439282|5850966|P2|NOT COMPLETED|Overall Study||1
2383765|NCT01439282|5850967|P1|NOT COMPLETED|Overall Study||8
2383766|NCT01439282|5850966|P2|COMPLETED|Overall Study||9
2383767|NCT01439282|5850967|P1|COMPLETED|Overall Study||59
2383768|NCT01439282|5850966|P2|STARTED|Overall Study||10
2383769|NCT01439282|5850967|P1|STARTED|Overall Study||67
2383770|NCT01439204|5850979|P2|NOT COMPLETED|Overall Study||3
2383771|NCT01439204|5850980|P1|NOT COMPLETED|Overall Study||4
2383772|NCT01439204|5850979|P2|COMPLETED|Overall Study||33
2383773|NCT01439204|5850980|P1|COMPLETED|Overall Study||32
2383774|NCT01439204|5850979|P2|STARTED|Overall Study||36
2383775|NCT01439204|5850980|P1|STARTED|Overall Study||36
2383776|NCT01439165|5851014|P2|NOT COMPLETED|Overall Study||2
2383777|NCT01439165|5851015|P1|NOT COMPLETED|Overall Study||21
2383778|NCT01439165|5851014|P2|COMPLETED|Overall Study||326
2383779|NCT01439165|5851015|P1|COMPLETED|Overall Study||981
2383780|NCT01439165|5851014|P2|STARTED|Overall Study||328
2383781|NCT01439165|5851015|P1|STARTED|Overall Study||1002
2383782|NCT01439126|5851029|P2|NOT COMPLETED|Overall Study||42
2383783|NCT01439126|5851030|P1|NOT COMPLETED|Overall Study||31
2383784|NCT01439126|5851029|P2|COMPLETED|Overall Study||25
2383785|NCT01439126|5851030|P1|COMPLETED|Overall Study||37
2383786|NCT01439126|5851029|P2|STARTED|Overall Study||67
2383787|NCT01439126|5851030|P1|STARTED|Overall Study||68
2383788|NCT01439087|5851050|P1|NOT COMPLETED|Overall Study||0
2383789|NCT01439087|5851050|P1|COMPLETED|Overall Study||2
2383790|NCT01439087|5851050|P1|STARTED|Overall Study||2
2383791|NCT01439074|5851056|P2|NOT COMPLETED|Overall Study||13
2383792|NCT01439074|5851057|P1|NOT COMPLETED|Overall Study||9
2383793|NCT01439074|5851056|P2|COMPLETED|Overall Study||74
2383794|NCT01439074|5851057|P1|COMPLETED|Overall Study||66
2383795|NCT01439074|5851056|P2|STARTED|Overall Study||87
2383796|NCT01439074|5851057|P1|STARTED|Overall Study||75
2383797|NCT01439035|5851069|P1|NOT COMPLETED|Overall Study||0
2383798|NCT01439035|5851069|P1|COMPLETED|Overall Study||6
2383799|NCT01439035|5851069|P1|STARTED|Overall Study||6
2383800|NCT01439009|5851075|P2|NOT COMPLETED|Overall Study||3
2383801|NCT01439009|5851076|P1|NOT COMPLETED|Overall Study||8
2383802|NCT01439009|5851075|P2|COMPLETED|Overall Study||47
2383803|NCT01439009|5851076|P1|COMPLETED|Overall Study||42
2383804|NCT01439009|5851075|P2|STARTED|Overall Study||50
2383805|NCT01439009|5851076|P1|STARTED|Overall Study||50
2383806|NCT01438996|5851109|P3|NOT COMPLETED|Overall Study||0
2383807|NCT01438996|5851110|P2|NOT COMPLETED|Overall Study||1
2383808|NCT01438996|5851111|P1|NOT COMPLETED|Overall Study||4
2383809|NCT01438996|5851109|P3|COMPLETED|Overall Study||20
2383810|NCT01438996|5851110|P2|COMPLETED|Overall Study||12
2383811|NCT01438996|5851111|P1|COMPLETED|Overall Study||14
2383812|NCT01438996|5851109|P3|STARTED|Overall Study||20
2383813|NCT01438996|5851110|P2|STARTED|Overall Study||13
2383814|NCT01438996|5851111|P1|STARTED|Overall Study||18
2383815|NCT01438840|5851145|P3|NOT COMPLETED|Extension Phase||10
2383816|NCT01438840|5851146|P2|NOT COMPLETED|Extension Phase||0
2383817|NCT01438840|5851147|P1|NOT COMPLETED|Extension Phase||0
2383818|NCT01438840|5851145|P3|COMPLETED|Extension Phase||29
2383819|NCT01438840|5851146|P2|COMPLETED|Extension Phase||0
2383820|NCT01438840|5851147|P1|COMPLETED|Extension Phase||0
2383821|NCT01438840|5851145|P3|STARTED|Extension Phase|39 participants met eligibility criteria for the Extension Phase.|39
2383822|NCT01438840|5851146|P2|STARTED|Extension Phase||0
2383823|NCT01438840|5851147|P1|STARTED|Extension Phase||0
2383824|NCT01438840|5851145|P3|NOT COMPLETED|Core Study||0
2383825|NCT01438840|5851146|P2|NOT COMPLETED|Core Study||10
2383826|NCT01438840|5851147|P1|NOT COMPLETED|Core Study||16
2383827|NCT01438840|5851145|P3|COMPLETED|Core Study||0
2383828|NCT01438840|5851146|P2|COMPLETED|Core Study||22
2383829|NCT01438840|5851147|P1|COMPLETED|Core Study||1
2383830|NCT01438840|5851145|P3|STARTED|Core Study||0
2383831|NCT01438840|5851146|P2|STARTED|Core Study||32
2383832|NCT01438840|5851147|P1|STARTED|Core Study||17
2383833|NCT01438814|5851160|P2|NOT COMPLETED|Overall Study||14
2383834|NCT01438814|5851161|P1|NOT COMPLETED|Overall Study||14
2383835|NCT01438814|5851160|P2|COMPLETED|Overall Study||331
2383836|NCT01438814|5851161|P1|COMPLETED|Overall Study||330
2383837|NCT01438814|5851160|P2|STARTED|Overall Study||345
2383838|NCT01438814|5851161|P1|STARTED|Overall Study||344
2383839|NCT01438710|5851191|P2|NOT COMPLETED|Second Week of Treatment||0
2383840|NCT01438710|5851192|P1|NOT COMPLETED|Second Week of Treatment||1
2383841|NCT01438710|5851191|P2|COMPLETED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
2383842|NCT01438710|5851192|P1|COMPLETED|Second Week of Treatment||40
2383843|NCT01438710|5851191|P2|STARTED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
2383844|NCT01438710|5851192|P1|STARTED|Second Week of Treatment|Patients completing the first week will continue on LCP-Tacro treatment during the second week.|41
2383845|NCT01438710|5851191|P2|NOT COMPLETED|First Week of Treatment||3
2383846|NCT01438710|5851192|P1|NOT COMPLETED|First Week of Treatment||0
2383847|NCT01438710|5851191|P2|COMPLETED|First Week of Treatment||41
2383848|NCT01438710|5851192|P1|COMPLETED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
2383849|NCT01438710|5851191|P2|STARTED|First Week of Treatment||44
2383850|NCT01438710|5851192|P1|STARTED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
2383851|NCT01438541|5851197|P1|NOT COMPLETED|Overall Study||7
2383852|NCT01438541|5851197|P1|COMPLETED|Overall Study||22
2383853|NCT01438541|5851197|P1|STARTED|Overall Study||29
2383854|NCT01438489|5851206|P3|NOT COMPLETED|Overall Study||19
2383855|NCT01438489|5851207|P2|NOT COMPLETED|Overall Study||16
2383856|NCT01438489|5851208|P1|NOT COMPLETED|Overall Study||26
2383857|NCT01438489|5851206|P3|COMPLETED|Overall Study||85
2383858|NCT01438489|5851207|P2|COMPLETED|Overall Study||84
2383859|NCT01438489|5851208|P1|COMPLETED|Overall Study||77
2383860|NCT01438489|5851206|P3|STARTED|Overall Study||104
2383861|NCT01438489|5851207|P2|STARTED|Overall Study||100
2383862|NCT01438489|5851208|P1|STARTED|Overall Study||103
2383863|NCT01438476|5851253|P2|NOT COMPLETED|Overall Study||11
2383864|NCT01438476|5851254|P1|NOT COMPLETED|Overall Study||10
2383865|NCT01438476|5851253|P2|COMPLETED|Overall Study||34
2383866|NCT01438476|5851254|P1|COMPLETED|Overall Study||106
2383867|NCT01438476|5851253|P2|STARTED|Overall Study||45
2383868|NCT01438476|5851254|P1|STARTED|Overall Study||116
2383869|NCT01438424|5851260|P1|NOT COMPLETED|Overall Study||417
2383870|NCT01438424|5851260|P1|COMPLETED|Overall Study|Completed treatment|634
2383871|NCT01438424|5851260|P1|STARTED|Overall Study|Received treatment|1051
2383872|NCT01438307|5851298|P2|NOT COMPLETED|Overall Study||1
2383873|NCT01438307|5851299|P1|NOT COMPLETED|Overall Study||1
2383874|NCT01438307|5851298|P2|COMPLETED|Overall Study||13
2383875|NCT01438307|5851299|P1|COMPLETED|Overall Study||13
2383876|NCT01438307|5851298|P2|STARTED|Overall Study||14
2383877|NCT01438307|5851299|P1|STARTED|Overall Study||14
2383878|NCT01438294|5851313|P2|NOT COMPLETED|Overall Study||7
2383879|NCT01438294|5851314|P1|NOT COMPLETED|Overall Study||3
2383880|NCT01438294|5851313|P2|COMPLETED|Overall Study||13
2383881|NCT01438294|5851314|P1|COMPLETED|Overall Study||13
2383882|NCT01438294|5851313|P2|STARTED|Overall Study||20
2383883|NCT01438294|5851314|P1|STARTED|Overall Study||16
2383884|NCT01438229|5851324|P1|NOT COMPLETED|Overall Study||3
2383885|NCT01438229|5851324|P1|COMPLETED|Overall Study||44
2383886|NCT01438229|5851324|P1|Underwent Procedure|Overall Study||46
2383887|NCT01438229|5851324|P1|Excluded Due to Renal Artery Anatomy|Overall Study||1
2383888|NCT01438229|5851324|P1|STARTED|Overall Study||47
2383892|NCT01438151|5851364|P1|NOT COMPLETED|Overall Study||8
2383893|NCT01438151|5851364|P1|COMPLETED|Overall Study||3
2383894|NCT01438151|5851364|P1|STARTED|Overall Study||11
2383895|NCT01438060|5851370|P2|NOT COMPLETED|On Study Beyond Week 140||8
2383896|NCT01438060|5851371|P1|NOT COMPLETED|On Study Beyond Week 140||0
2383897|NCT01438060|5851370|P2|COMPLETED|On Study Beyond Week 140||1
2383898|NCT01438060|5851371|P1|COMPLETED|On Study Beyond Week 140||0
2383899|NCT01438060|5851370|P2|STARTED|On Study Beyond Week 140|9 participants in France who showed improvement at Week 140 continued treatment beyond 140 weeks|9
2383900|NCT01438060|5851371|P1|STARTED|On Study Beyond Week 140||0
2383901|NCT01438060|5851370|P2|NOT COMPLETED|Extension Phase: Week 10 to Week 130||56
2383902|NCT01438060|5851371|P1|NOT COMPLETED|Extension Phase: Week 10 to Week 130||58
2383903|NCT01438060|5851370|P2|COMPLETED|Extension Phase: Week 10 to Week 130||25
2383904|NCT01438060|5851371|P1|COMPLETED|Extension Phase: Week 10 to Week 130||22
2383905|NCT01438060|5851370|P2|STARTED|Extension Phase: Week 10 to Week 130|Of the 88 participants, who completed Acute Phase, 81 opted to enter 130-week extension phase|81
2383906|NCT01438060|5851371|P1|STARTED|Extension Phase: Week 10 to Week 130|80 out of the 84 participants entered extension phase. All were treated with open-label aripiprazole|80
2383907|NCT01438060|5851370|P2|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
2383908|NCT01438060|5851371|P1|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
2383909|NCT01438060|5851370|P2|COMPLETED|Acute Phase: Double-blind, 10 Weeks||88
2383910|NCT01438060|5851371|P1|COMPLETED|Acute Phase: Double-blind, 10 Weeks||84
2383911|NCT01438060|5851370|P2|STARTED|Acute Phase: Double-blind, 10 Weeks||106
2383912|NCT01438060|5851371|P1|STARTED|Acute Phase: Double-blind, 10 Weeks||102
2383913|NCT01437995|5851452|P3|NOT COMPLETED|Overall Study||20
2383914|NCT01437995|5851453|P2|NOT COMPLETED|Overall Study||18
2383915|NCT01437995|5851454|P1|NOT COMPLETED|Overall Study||11
2383916|NCT01437995|5851452|P3|COMPLETED|Overall Study||135
2383917|NCT01437995|5851453|P2|COMPLETED|Overall Study||131
2383918|NCT01437995|5851454|P1|COMPLETED|Overall Study||140
2383919|NCT01437995|5851452|P3|Included in Treatment Failure Analysis|Overall Study||151
2383920|NCT01437995|5851453|P2|Included in Treatment Failure Analysis|Overall Study||146
2383921|NCT01437995|5851454|P1|Included in Treatment Failure Analysis|Overall Study||150
2383922|NCT01437995|5851452|P3|STARTED|Overall Study||155
2383923|NCT01437995|5851453|P2|STARTED|Overall Study||149
2383924|NCT01437995|5851454|P1|STARTED|Overall Study||151
2383925|NCT01437943|5851476|P2|NOT COMPLETED|Overall Study||2
2383926|NCT01437943|5851477|P1|NOT COMPLETED|Overall Study||7
2383927|NCT01437943|5851476|P2|COMPLETED|Overall Study||1
2383928|NCT01437943|5851477|P1|COMPLETED|Overall Study||0
2383929|NCT01437943|5851476|P2|STARTED|Overall Study||3
2383930|NCT01437943|5851477|P1|STARTED|Overall Study||7
2383931|NCT01437878|5851485|P2|NOT COMPLETED|Overall Study||0
2383932|NCT01437878|5851486|P1|NOT COMPLETED|Overall Study||1
2383933|NCT01437878|5851485|P2|COMPLETED|Overall Study||1
2383934|NCT01437878|5851486|P1|COMPLETED|Overall Study||0
2383935|NCT01437878|5851485|P2|STARTED|Overall Study||1
2383936|NCT01437878|5851486|P1|STARTED|Overall Study|Patient discontinued the study prior to initiation of study treatment|1
2383937|NCT01437852|5851526|P1|NOT COMPLETED|Overall Study||0
2383938|NCT01437852|5851526|P1|COMPLETED|Overall Study||30
2383939|NCT01437852|5851526|P1|Received Autograft|Overall Study||30
2383940|NCT01437852|5851526|P1|Received StrataGraft Skin Tissue|Overall Study||30
2383941|NCT01437852|5851526|P1|STARTED|Overall Study||30
2383942|NCT01437605|5851534|P2|NOT COMPLETED|Overall Study||0
2383943|NCT01437605|5851535|P1|NOT COMPLETED|Overall Study||0
2383944|NCT01437605|5851534|P2|COMPLETED|Overall Study||5
2383945|NCT01437605|5851535|P1|COMPLETED|Overall Study||9
2383946|NCT01437605|5851534|P2|STARTED|Overall Study||5
2383947|NCT01437605|5851535|P1|STARTED|Overall Study||9
2383948|NCT01437540|5851553|P2|NOT COMPLETED|Overall Study||65
2383949|NCT01437540|5851554|P1|NOT COMPLETED|Overall Study||127
2383950|NCT01437540|5851553|P2|COMPLETED|Overall Study||133
2383951|NCT01437540|5851554|P1|COMPLETED|Overall Study||265
2383952|NCT01437540|5851553|P2|STARTED|Overall Study||198
2383953|NCT01437540|5851554|P1|STARTED|Overall Study||392
2383954|NCT01437501|5851568|P2|NOT COMPLETED|Overall Study||11
2383955|NCT01437501|5851569|P1|NOT COMPLETED|Overall Study||13
2383956|NCT01437501|5851568|P2|COMPLETED|Overall Study||132
2383957|NCT01437501|5851569|P1|COMPLETED|Overall Study||135
2383958|NCT01437501|5851568|P2|STARTED|Overall Study||143
2383959|NCT01437501|5851569|P1|STARTED|Overall Study||148
2383960|NCT01437488|5851577|P1|NOT COMPLETED|Overall Study||0
2383961|NCT01437488|5851577|P1|COMPLETED|Overall Study||14
2383962|NCT01437488|5851577|P1|STARTED|Overall Study||14
2383963|NCT01437449|5851584|P1|NOT COMPLETED|Overall Study||0
2383964|NCT01437449|5851584|P1|COMPLETED|Overall Study||27
2383965|NCT01437449|5851584|P1|STARTED|Overall Study||27
2383966|NCT01437423|5851591|P1|NOT COMPLETED|Overall Study||15
2383967|NCT01437423|5851591|P1|COMPLETED|Overall Study||647
2383968|NCT01437423|5851591|P1|STARTED|Overall Study||662
2383969|NCT01437397|5851603|P5|NOT COMPLETED|Overall Study||101
2383970|NCT01437397|5851604|P4|NOT COMPLETED|Overall Study||69
2383971|NCT01437397|5851605|P3|NOT COMPLETED|Overall Study||72
2383972|NCT01437397|5851606|P2|NOT COMPLETED|Overall Study||62
2383973|NCT01437397|5851607|P1|NOT COMPLETED|Overall Study||66
2383974|NCT01437397|5851603|P5|COMPLETED|Overall Study||236
2383975|NCT01437397|5851604|P4|COMPLETED|Overall Study||270
2383976|NCT01437397|5851605|P3|COMPLETED|Overall Study||268
2383977|NCT01437397|5851606|P2|COMPLETED|Overall Study||276
2383978|NCT01437397|5851607|P1|COMPLETED|Overall Study||272
2383979|NCT01437397|5851603|P5|STARTED|Overall Study||337
2383980|NCT01437397|5851604|P4|STARTED|Overall Study||339
2383981|NCT01437397|5851605|P3|STARTED|Overall Study||340
2383982|NCT01437397|5851606|P2|STARTED|Overall Study||338
2383983|NCT01437397|5851607|P1|STARTED|Overall Study||338
2383984|NCT01437319|5851634|P3|NOT COMPLETED|Phase II||37
2383985|NCT01437319|5851635|P2|NOT COMPLETED|Phase II||44
2383986|NCT01437319|5851636|P1|NOT COMPLETED|Phase II||0
2383987|NCT01437319|5851634|P3|COMPLETED|Phase II||75
2383988|NCT01437319|5851635|P2|COMPLETED|Phase II||71
2383989|NCT01437319|5851636|P1|COMPLETED|Phase II||0
2383990|NCT01437319|5851634|P3|STARTED|Phase II||112
2383991|NCT01437319|5851635|P2|STARTED|Phase II||115
2383992|NCT01437319|5851636|P1|STARTED|Phase II||0
2383993|NCT01437319|5851634|P3|NOT COMPLETED|Phase I||0
2383994|NCT01437319|5851635|P2|NOT COMPLETED|Phase I||0
2383995|NCT01437319|5851636|P1|NOT COMPLETED|Phase I||55
2383996|NCT01437319|5851634|P3|COMPLETED|Phase I||0
2383997|NCT01437319|5851635|P2|COMPLETED|Phase I||0
2383998|NCT01437319|5851636|P1|COMPLETED|Phase I||227
2383999|NCT01437319|5851634|P3|STARTED|Phase I||0
2384000|NCT01437319|5851635|P2|STARTED|Phase I||0
2384001|NCT01437319|5851636|P1|STARTED|Phase I||282
2384002|NCT01437267|5851651|P6|NOT COMPLETED|Overall Study||0
2384003|NCT01437267|5851652|P5|NOT COMPLETED|Overall Study||0
2384004|NCT01437267|5851653|P4|NOT COMPLETED|Overall Study||1
2384005|NCT01437267|5851654|P3|NOT COMPLETED|Overall Study||0
2384006|NCT01437267|5851655|P2|NOT COMPLETED|Overall Study||1
2384007|NCT01437267|5851656|P1|NOT COMPLETED|Overall Study||0
2384008|NCT01437267|5851651|P6|COMPLETED|Overall Study||20
2384009|NCT01437267|5851652|P5|COMPLETED|Overall Study||20
2384010|NCT01437267|5851653|P4|COMPLETED|Overall Study||19
2384011|NCT01437267|5851654|P3|COMPLETED|Overall Study||20
2384012|NCT01437267|5851655|P2|COMPLETED|Overall Study||19
2384013|NCT01437267|5851656|P1|COMPLETED|Overall Study||20
2384014|NCT01437267|5851651|P6|STARTED|Overall Study||20
2384015|NCT01437267|5851652|P5|STARTED|Overall Study||20
2384016|NCT01437267|5851653|P4|STARTED|Overall Study||20
2384017|NCT01437267|5851654|P3|STARTED|Overall Study||20
2384018|NCT01437267|5851655|P2|STARTED|Overall Study||20
2384019|NCT01437267|5851656|P1|STARTED|Overall Study||20
2384020|NCT01437124|5851694|P1|NOT COMPLETED|Overall Study||0
2384021|NCT01437124|5851694|P1|COMPLETED|Overall Study||83
2384022|NCT01437124|5851694|P1|STARTED|Overall Study||83
2384023|NCT01437111|5851699|P1|NOT COMPLETED|Overall Study||18
2384024|NCT01437111|5851699|P1|COMPLETED|Overall Study||182
2384025|NCT01437111|5851699|P1|Treated Participants|Overall Study||198
2384026|NCT01437111|5851699|P1|STARTED|Overall Study||200
2384027|NCT01437098|5851710|P1|NOT COMPLETED|Overall Study||13
2384028|NCT01437098|5851710|P1|COMPLETED|Overall Study||42
2384029|NCT01437098|5851710|P1|36 Months|Overall Study||36
2384030|NCT01437098|5851710|P1|24 Months|Overall Study||42
2384031|NCT01437098|5851710|P1|12 Months|Overall Study||45
2384032|NCT01437098|5851710|P1|6 Months|Overall Study||47
2384033|NCT01437098|5851710|P1|30 Days|Overall Study||51
2384034|NCT01437098|5851710|P1|STARTED|Overall Study||55
2384035|NCT01436799|5851767|P2|NOT COMPLETED|Overall Study||0
2384036|NCT01436799|5851768|P1|NOT COMPLETED|Overall Study||0
2384037|NCT01436799|5851767|P2|COMPLETED|Overall Study||20
2384038|NCT01436799|5851768|P1|COMPLETED|Overall Study||20
2384039|NCT01436799|5851767|P2|STARTED|Overall Study||20
2384040|NCT01436799|5851768|P1|STARTED|Overall Study||20
2384041|NCT01436643|5851777|P4|NOT COMPLETED|Core Phase (16 Weeks)||0
2384042|NCT01436643|5851778|P3|NOT COMPLETED|Core Phase (16 Weeks)||3
2384043|NCT01436643|5851779|P2|NOT COMPLETED|Core Phase (16 Weeks)||4
2384044|NCT01436643|5851780|P1|NOT COMPLETED|Core Phase (16 Weeks)||1
2384045|NCT01436643|5851777|P4|COMPLETED|Core Phase (16 Weeks)||0
2384046|NCT01436643|5851778|P3|COMPLETED|Core Phase (16 Weeks)||17
2384047|NCT01436643|5851779|P2|COMPLETED|Core Phase (16 Weeks)||11
2384048|NCT01436643|5851780|P1|COMPLETED|Core Phase (16 Weeks)||16
2384049|NCT01436643|5851777|P4|STARTED|Core Phase (16 Weeks)||0
2384050|NCT01436643|5851778|P3|STARTED|Core Phase (16 Weeks)||20
2384051|NCT01436643|5851779|P2|STARTED|Core Phase (16 Weeks)||15
2384052|NCT01436643|5851780|P1|STARTED|Core Phase (16 Weeks)||17
2384053|NCT01436643|5851777|P4|NOT COMPLETED|2-week Pre-treatment||10
2384054|NCT01436643|5851778|P3|NOT COMPLETED|2-week Pre-treatment||0
2384055|NCT01436643|5851779|P2|NOT COMPLETED|2-week Pre-treatment||0
2384056|NCT01436643|5851780|P1|NOT COMPLETED|2-week Pre-treatment||0
2384057|NCT01436643|5851777|P4|COMPLETED|2-week Pre-treatment||44
2384058|NCT01436643|5851778|P3|COMPLETED|2-week Pre-treatment||0
2384059|NCT01436643|5851779|P2|COMPLETED|2-week Pre-treatment||0
2384060|NCT01436643|5851780|P1|COMPLETED|2-week Pre-treatment||0
2384061|NCT01436643|5851777|P4|STARTED|2-week Pre-treatment||54
2384062|NCT01436643|5851778|P3|STARTED|2-week Pre-treatment||0
2384063|NCT01436643|5851779|P2|STARTED|2-week Pre-treatment||0
2384064|NCT01436643|5851780|P1|STARTED|2-week Pre-treatment||0
2384065|NCT01436526|5851792|P2|NOT COMPLETED|Period 2||0
2384066|NCT01436526|5851793|P1|NOT COMPLETED|Period 2||0
2384067|NCT01436526|5851792|P2|COMPLETED|Period 2||13
2384068|NCT01436526|5851793|P1|COMPLETED|Period 2||13
2384069|NCT01436526|5851792|P2|Participants Received Treatment|Period 2||13
2384070|NCT01436526|5851793|P1|Participants Received Treatment|Period 2||13
2384071|NCT01436526|5851792|P2|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
2384072|NCT01436526|5851793|P1|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
2384073|NCT01436526|5851792|P2|NOT COMPLETED|Period 1||0
2384074|NCT01436526|5851793|P1|NOT COMPLETED|Period 1||0
2384075|NCT01436526|5851792|P2|COMPLETED|Period 1||14
2384076|NCT01436526|5851793|P1|COMPLETED|Period 1||14
2384077|NCT01436526|5851792|P2|Participants Received Treatment|Period 1||14
2384078|NCT01436526|5851793|P1|Participants Received Treatment|Period 1||14
2384079|NCT01436526|5851792|P2|STARTED|Period 1||14
2384080|NCT01436526|5851793|P1|STARTED|Period 1||14
2384081|NCT01436500|5851815|P5|NOT COMPLETED|Overall Study||4
2384082|NCT01436500|5851816|P4|NOT COMPLETED|Overall Study||1
2384083|NCT01436500|5851817|P3|NOT COMPLETED|Overall Study||5
2384084|NCT01436500|5851818|P2|NOT COMPLETED|Overall Study||3
2384085|NCT01436500|5851819|P1|NOT COMPLETED|Overall Study||3
2384086|NCT01436500|5851815|P5|COMPLETED|Overall Study||9
2384087|NCT01436500|5851816|P4|COMPLETED|Overall Study||5
2384088|NCT01436500|5851817|P3|COMPLETED|Overall Study||7
2384089|NCT01436500|5851818|P2|COMPLETED|Overall Study||9
2384090|NCT01436500|5851819|P1|COMPLETED|Overall Study||9
2384091|NCT01436500|5851815|P5|STARTED|Overall Study||13
2384092|NCT01436500|5851816|P4|STARTED|Overall Study||6
2384093|NCT01436500|5851817|P3|STARTED|Overall Study||12
2384094|NCT01436500|5851818|P2|STARTED|Overall Study||12
2384095|NCT01436500|5851819|P1|STARTED|Overall Study||12
2384096|NCT01436435|5851852|P1|NOT COMPLETED|Overall Study||64
2384097|NCT01436435|5851852|P1|COMPLETED|Overall Study||177
2384098|NCT01436435|5851852|P1|STARTED|Overall Study||241
2384099|NCT01436396|5851863|P2|NOT COMPLETED|Overall Study||42
2384100|NCT01436396|5851864|P1|NOT COMPLETED|Overall Study||32
2384101|NCT01436396|5851863|P2|COMPLETED|Overall Study||354
2384102|NCT01436396|5851864|P1|COMPLETED|Overall Study||364
2384103|NCT01436396|5851863|P2|Vaccinated|Overall Study||393
2384104|NCT01436396|5851864|P1|Vaccinated|Overall Study||394
2384105|NCT01436396|5851863|P2|STARTED|Overall Study||396
2384106|NCT01436396|5851864|P1|STARTED|Overall Study||396
2384107|NCT01436370|5851904|P8|NOT COMPLETED|Overall Study||0
2384108|NCT01436370|5851905|P7|NOT COMPLETED|Overall Study||0
2384109|NCT01436370|5851906|P6|NOT COMPLETED|Overall Study||0
2384110|NCT01436370|5851907|P5|NOT COMPLETED|Overall Study||1
2384111|NCT01436370|5851908|P4|NOT COMPLETED|Overall Study||0
2384112|NCT01436370|5851909|P3|NOT COMPLETED|Overall Study||0
2384113|NCT01436370|5851910|P2|NOT COMPLETED|Overall Study||0
2384114|NCT01436370|5851911|P1|NOT COMPLETED|Overall Study||0
2384115|NCT01436370|5851904|P8|COMPLETED|Overall Study||16
2384116|NCT01436370|5851905|P7|COMPLETED|Overall Study||16
2384117|NCT01436370|5851906|P6|COMPLETED|Overall Study||19
2384118|NCT01436370|5851907|P5|COMPLETED|Overall Study||18
2384119|NCT01436370|5851908|P4|COMPLETED|Overall Study||10
2384120|NCT01436370|5851909|P3|COMPLETED|Overall Study||10
2384121|NCT01436370|5851910|P2|COMPLETED|Overall Study||6
2384122|NCT01436370|5851911|P1|COMPLETED|Overall Study||6
2384123|NCT01436370|5851904|P8|STARTED|Overall Study||16
2384124|NCT01436370|5851905|P7|STARTED|Overall Study||16
2384125|NCT01436370|5851906|P6|STARTED|Overall Study||19
2384126|NCT01436370|5851907|P5|STARTED|Overall Study||19
2384127|NCT01436370|5851908|P4|STARTED|Overall Study||10
2384128|NCT01436370|5851909|P3|STARTED|Overall Study||10
2384129|NCT01436370|5851910|P2|STARTED|Overall Study||6
2384130|NCT01436370|5851911|P1|STARTED|Overall Study||6
2384131|NCT01436357|5851991|P2|NOT COMPLETED|Overall Study||128
2384132|NCT01436357|5851992|P1|NOT COMPLETED|Overall Study||122
2384133|NCT01436357|5851991|P2|COMPLETED|Overall Study||146
2384134|NCT01436357|5851992|P1|COMPLETED|Overall Study||152
2384135|NCT01436357|5851991|P2|Stage 2|Overall Study||226
2384136|NCT01436357|5851992|P1|Stage 2|Overall Study||225
2384137|NCT01436357|5851991|P2|Stage 1|Overall Study||48
2384138|NCT01436357|5851992|P1|Stage 1|Overall Study||49
2384139|NCT01436357|5851991|P2|STARTED|Overall Study||274
2384140|NCT01436357|5851992|P1|STARTED|Overall Study||274
2384141|NCT01436305|5852013|P3|NOT COMPLETED|Overall Study||0
2384142|NCT01436305|5852014|P2|NOT COMPLETED|Overall Study||4
2384143|NCT01436305|5852015|P1|NOT COMPLETED|Overall Study||2
2384144|NCT01436305|5852013|P3|COMPLETED|Overall Study||7
2384145|NCT01436305|5852014|P2|COMPLETED|Overall Study||2
2384146|NCT01436305|5852015|P1|COMPLETED|Overall Study||4
2384147|NCT01436305|5852013|P3|STARTED|Overall Study||7
2384148|NCT01436305|5852014|P2|STARTED|Overall Study||6
2384149|NCT01436305|5852015|P1|STARTED|Overall Study||6
2384150|NCT01436279|5852112|P2|NOT COMPLETED|Overall Study||0
2384151|NCT01436279|5852113|P1|NOT COMPLETED|Overall Study||0
2384152|NCT01436279|5852112|P2|COMPLETED|Overall Study||20
2384153|NCT01436279|5852113|P1|COMPLETED|Overall Study||30
2384154|NCT01436279|5852112|P2|STARTED|Overall Study||20
2384155|NCT01436279|5852113|P1|STARTED|Overall Study||30
2384156|NCT01436266|5852135|P2|NOT COMPLETED|Overall Study||0
2384157|NCT01436266|5852136|P1|NOT COMPLETED|Overall Study||0
2384158|NCT01436266|5852135|P2|COMPLETED|Overall Study||1
2384159|NCT01436266|5852136|P1|COMPLETED|Overall Study||1
2384160|NCT01436266|5852135|P2|STARTED|Overall Study||1
2384161|NCT01436266|5852136|P1|STARTED|Overall Study||1
2384162|NCT01436253|5852142|P1|NOT COMPLETED|Overall Study||299
2384163|NCT01436253|5852142|P1|COMPLETED|Overall Study||1897
2384164|NCT01436253|5852142|P1|STARTED|Overall Study||2196
2384165|NCT01436201|5852147|P1|NOT COMPLETED|Overall Study||4
2384166|NCT01436201|5852147|P1|COMPLETED|Overall Study||20
2384167|NCT01436201|5852147|P1|Received at Least 1 Dose of Study Drug|Overall Study||24
2384168|NCT01436201|5852147|P1|STARTED|Overall Study||24
2384169|NCT01436175|5852157|P1|NOT COMPLETED|Overall Study||1270
2384170|NCT01436175|5852157|P1|COMPLETED|Overall Study||300
2384171|NCT01436175|5852157|P1|STARTED|Overall Study||1570
2384172|NCT01436162|5852184|P3|NOT COMPLETED|Randomized Phase||25
2384173|NCT01436162|5852185|P2|NOT COMPLETED|Randomized Phase||31
2384174|NCT01436162|5852186|P1|NOT COMPLETED|Randomized Phase||44
2384175|NCT01436162|5852184|P3|COMPLETED|Randomized Phase||189
2384176|NCT01436162|5852185|P2|COMPLETED|Randomized Phase||181
2384177|NCT01436162|5852186|P1|COMPLETED|Randomized Phase||353
2384178|NCT01436162|5852184|P3|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|214
2384179|NCT01436162|5852185|P2|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|212
2384180|NCT01436162|5852186|P1|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|397
2384181|NCT01436162|5852184|P3|NOT COMPLETED|Single-blind Lead-in Phase||0
2384182|NCT01436162|5852185|P2|NOT COMPLETED|Single-blind Lead-in Phase||0
2384183|NCT01436162|5852186|P1|NOT COMPLETED|Single-blind Lead-in Phase||282
2384184|NCT01436162|5852184|P3|COMPLETED|Single-blind Lead-in Phase||0
2384185|NCT01436162|5852185|P2|COMPLETED|Single-blind Lead-in Phase||0
2384186|NCT01436162|5852186|P1|COMPLETED|Single-blind Lead-in Phase||823
2384187|NCT01436162|5852184|P3|STARTED|Single-blind Lead-in Phase||0
2384188|NCT01436162|5852185|P2|STARTED|Single-blind Lead-in Phase||0
2384189|NCT01436162|5852186|P1|STARTED|Single-blind Lead-in Phase|Ten subjects were enrolled but not dosed.|1105
2384190|NCT01436149|5852220|P3|NOT COMPLETED|Randomized Phase||42
2384191|NCT01436149|5852221|P2|NOT COMPLETED|Randomized Phase||38
2384192|NCT01436149|5852222|P1|NOT COMPLETED|Randomized Phase||77
2384193|NCT01436149|5852220|P3|COMPLETED|Randomized Phase|1 subject completed the study without a Visit 14 MADRS and was not included in the completers set.|160
2384194|NCT01436149|5852221|P2|COMPLETED|Randomized Phase||164
2384195|NCT01436149|5852222|P1|COMPLETED|Randomized Phase||415
2384196|NCT01436149|5852220|P3|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
2384197|NCT01436149|5852221|P2|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
2384198|NCT01436149|5852222|P1|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|492
2384199|NCT01436149|5852220|P3|NOT COMPLETED|Antidepressant Lead-in Phase||0
2384200|NCT01436149|5852221|P2|NOT COMPLETED|Antidepressant Lead-in Phase||0
2384201|NCT01436149|5852222|P1|NOT COMPLETED|Antidepressant Lead-in Phase||366
2384202|NCT01436149|5852220|P3|COMPLETED|Antidepressant Lead-in Phase||0
2384203|NCT01436149|5852221|P2|COMPLETED|Antidepressant Lead-in Phase||0
2384204|NCT01436149|5852222|P1|COMPLETED|Antidepressant Lead-in Phase||896
2384205|NCT01436149|5852220|P3|STARTED|Antidepressant Lead-in Phase||0
2384206|NCT01436149|5852221|P2|STARTED|Antidepressant Lead-in Phase||0
2384207|NCT01436149|5852222|P1|STARTED|Antidepressant Lead-in Phase|Twenty-three subjects were enrolled but not dosed.|1262
2384208|NCT01436110|5852253|P3|NOT COMPLETED|Overall Study||23
2384209|NCT01436110|5852254|P2|NOT COMPLETED|Overall Study||26
2384210|NCT01436110|5852255|P1|NOT COMPLETED|Overall Study||39
2384211|NCT01436110|5852253|P3|COMPLETED|Overall Study||95
2384212|NCT01436110|5852254|P2|COMPLETED|Overall Study||91
2384213|NCT01436110|5852255|P1|COMPLETED|Overall Study||77
2384214|NCT01436110|5852253|P3|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
2384215|NCT01436110|5852254|P2|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|117
2384216|NCT01436110|5852255|P1|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
2384217|NCT01436110|5852253|P3|STARTED|Overall Study|These participants were randomized to trial medication.|118
2384218|NCT01436110|5852254|P2|STARTED|Overall Study|These participants were randomized to trial medication.|117
2384219|NCT01436110|5852255|P1|STARTED|Overall Study|These participants were randomized to trial medication.|116
2384220|NCT01436084|5852278|P1|NOT COMPLETED|Overall Study||4
2384221|NCT01436084|5852278|P1|COMPLETED|Overall Study||0
2384222|NCT01436084|5852278|P1|STARTED|Overall Study||4
2384223|NCT01436071|5852284|P2|NOT COMPLETED|Overall Study||14
2384224|NCT01436071|5852285|P1|NOT COMPLETED|Overall Study||26
2384225|NCT01436071|5852284|P2|COMPLETED|Overall Study||110
2384226|NCT01436071|5852285|P1|COMPLETED|Overall Study||98
2384227|NCT01436071|5852284|P2|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
2384228|NCT01436071|5852285|P1|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
2384229|NCT01436071|5852284|P2|STARTED|Overall Study|These participants were randomized to trial medication.|124
2384230|NCT01436071|5852285|P1|STARTED|Overall Study|These participants were randomized to trial medication.|124
2384231|NCT01436045|5852301|P2|NOT COMPLETED|Overall Study||0
2384232|NCT01436045|5852302|P1|NOT COMPLETED|Overall Study||0
2384233|NCT01436045|5852301|P2|COMPLETED|Overall Study||6
2384234|NCT01436045|5852302|P1|COMPLETED|Overall Study||6
2384235|NCT01436045|5852301|P2|STARTED|Overall Study||6
2384236|NCT01436045|5852302|P1|STARTED|Overall Study||6
2384237|NCT01436006|5852313|P1|NOT COMPLETED|Overall Study||37
2384238|NCT01436006|5852313|P1|COMPLETED|Overall Study||6663
2384239|NCT01436006|5852313|P1|STARTED|Overall Study||6700
2384240|NCT01435928|5852327|P3|NOT COMPLETED|Double Blind Phase - 28 Weeks||121
2384241|NCT01435928|5852328|P2|NOT COMPLETED|Double Blind Phase - 28 Weeks||116
2384242|NCT01435928|5852329|P1|NOT COMPLETED|Double Blind Phase - 28 Weeks||0
2384243|NCT01435928|5852327|P3|COMPLETED|Double Blind Phase - 28 Weeks||20
2384244|NCT01435928|5852328|P2|COMPLETED|Double Blind Phase - 28 Weeks||28
2384245|NCT01435928|5852329|P1|COMPLETED|Double Blind Phase - 28 Weeks||0
2384246|NCT01435928|5852327|P3|STARTED|Double Blind Phase - 28 Weeks||141
2384247|NCT01435928|5852328|P2|STARTED|Double Blind Phase - 28 Weeks||144
2384248|NCT01435928|5852329|P1|STARTED|Double Blind Phase - 28 Weeks||0
2384249|NCT01435928|5852327|P3|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
2384250|NCT01435928|5852328|P2|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
2384251|NCT01435928|5852329|P1|NOT COMPLETED|Open Label Phase - up to 24 Weeks||389
2384252|NCT01435928|5852327|P3|COMPLETED|Open Label Phase - up to 24 Weeks||0
2384253|NCT01435928|5852328|P2|COMPLETED|Open Label Phase - up to 24 Weeks||0
2384254|NCT01435928|5852329|P1|COMPLETED|Open Label Phase - up to 24 Weeks||287
2384255|NCT01435928|5852327|P3|STARTED|Open Label Phase - up to 24 Weeks||0
2384256|NCT01435928|5852328|P2|STARTED|Open Label Phase - up to 24 Weeks||0
2384257|NCT01435928|5852329|P1|STARTED|Open Label Phase - up to 24 Weeks||676
2384258|NCT01435824|5852356|P2|NOT COMPLETED|Second Intervention||0
2384259|NCT01435824|5852357|P1|NOT COMPLETED|Second Intervention||0
2384260|NCT01435824|5852356|P2|COMPLETED|Second Intervention||8
2384261|NCT01435824|5852357|P1|COMPLETED|Second Intervention||8
2384262|NCT01435824|5852356|P2|STARTED|Second Intervention||8
2384263|NCT01435824|5852357|P1|STARTED|Second Intervention||8
2384264|NCT01435824|5852356|P2|NOT COMPLETED|Washout of 1-2 Weeks||0
2384265|NCT01435824|5852357|P1|NOT COMPLETED|Washout of 1-2 Weeks||0
2384266|NCT01435824|5852356|P2|COMPLETED|Washout of 1-2 Weeks||8
2384267|NCT01435824|5852357|P1|COMPLETED|Washout of 1-2 Weeks||8
2384268|NCT01435824|5852356|P2|STARTED|Washout of 1-2 Weeks||8
2384269|NCT01435824|5852357|P1|STARTED|Washout of 1-2 Weeks||8
2384270|NCT01435824|5852356|P2|NOT COMPLETED|First Intervention||0
2384271|NCT01435824|5852357|P1|NOT COMPLETED|First Intervention||0
2384272|NCT01435824|5852356|P2|COMPLETED|First Intervention||8
2384273|NCT01435824|5852357|P1|COMPLETED|First Intervention||8
2384274|NCT01435824|5852356|P2|STARTED|First Intervention||8
2384275|NCT01435824|5852357|P1|STARTED|First Intervention||8
2384276|NCT01435798|5852375|P1|NOT COMPLETED|Overall Study||1
2384277|NCT01435798|5852375|P1|COMPLETED|Overall Study|Crossover design|25
2384278|NCT01435798|5852375|P1|100% MTD|Overall Study||25
2384279|NCT01435798|5852375|P1|50% MTD|Overall Study||25
2384280|NCT01435798|5852375|P1|25% MTD|Overall Study||26
2384281|NCT01435798|5852375|P1|0% MTD|Overall Study||25
2384282|NCT01435798|5852375|P1|STARTED|Overall Study|Crossover design|26
2384283|NCT01435772|5852392|P3|NOT COMPLETED|Overall Study||15
2384284|NCT01435772|5852393|P2|NOT COMPLETED|Overall Study||3
2384285|NCT01435772|5852394|P1|NOT COMPLETED|Overall Study||3
2384286|NCT01435772|5852392|P3|COMPLETED|Overall Study||0
2384287|NCT01435772|5852393|P2|COMPLETED|Overall Study||0
2384288|NCT01435772|5852394|P1|COMPLETED|Overall Study||0
2384289|NCT01435772|5852392|P3|STARTED|Overall Study||15
2384290|NCT01435772|5852393|P2|STARTED|Overall Study||3
2384291|NCT01435772|5852394|P1|STARTED|Overall Study||3
2384292|NCT01435759|5852444|P6|NOT COMPLETED|Double-blind Phase||9
2384293|NCT01435759|5852445|P5|NOT COMPLETED|Double-blind Phase||9
2384294|NCT01435759|5852446|P4|NOT COMPLETED|Double-blind Phase||9
2384295|NCT01435759|5852447|P3|NOT COMPLETED|Double-blind Phase||7
2384296|NCT01435759|5852448|P2|NOT COMPLETED|Double-blind Phase||7
2384297|NCT01435759|5852449|P1|NOT COMPLETED|Double-blind Phase||66
2384298|NCT01435759|5852444|P6|COMPLETED|Double-blind Phase||71
2384299|NCT01435759|5852445|P5|COMPLETED|Double-blind Phase||69
2384300|NCT01435759|5852446|P4|COMPLETED|Double-blind Phase||69
2384301|NCT01435759|5852447|P3|COMPLETED|Double-blind Phase||71
2384302|NCT01435759|5852448|P2|COMPLETED|Double-blind Phase||71
2384303|NCT01435759|5852449|P1|COMPLETED|Double-blind Phase||397
2384304|NCT01435759|5852444|P6|STARTED|Double-blind Phase||80
2384305|NCT01435759|5852445|P5|STARTED|Double-blind Phase||78
2384306|NCT01435759|5852446|P4|STARTED|Double-blind Phase|Two subjects were not dosed.|78
2384307|NCT01435759|5852447|P3|STARTED|Double-blind Phase|One subject was not dosed.|78
2384308|NCT01435759|5852448|P2|STARTED|Double-blind Phase||78
2384309|NCT01435759|5852449|P1|STARTED|Double-blind Phase|These subjects were not included in the Safety Dose Response Evaluable Set or Safety Analysis Set.|463
2384310|NCT01435759|5852444|P6|NOT COMPLETED|Antidepressant Lead-in Phase||0
2384311|NCT01435759|5852445|P5|NOT COMPLETED|Antidepressant Lead-in Phase||0
2384312|NCT01435759|5852446|P4|NOT COMPLETED|Antidepressant Lead-in Phase||0
2384313|NCT01435759|5852447|P3|NOT COMPLETED|Antidepressant Lead-in Phase||0
2384314|NCT01435759|5852448|P2|NOT COMPLETED|Antidepressant Lead-in Phase||0
2384315|NCT01435759|5852449|P1|NOT COMPLETED|Antidepressant Lead-in Phase||342
2384316|NCT01435759|5852444|P6|COMPLETED|Antidepressant Lead-in Phase||0
2384317|NCT01435759|5852445|P5|COMPLETED|Antidepressant Lead-in Phase||0
2384318|NCT01435759|5852446|P4|COMPLETED|Antidepressant Lead-in Phase||0
2384319|NCT01435759|5852447|P3|COMPLETED|Antidepressant Lead-in Phase||0
2384320|NCT01435759|5852448|P2|COMPLETED|Antidepressant Lead-in Phase||0
2384321|NCT01435759|5852449|P1|COMPLETED|Antidepressant Lead-in Phase||855
2384322|NCT01435759|5852444|P6|STARTED|Antidepressant Lead-in Phase||0
2384323|NCT01435759|5852445|P5|STARTED|Antidepressant Lead-in Phase||0
2384324|NCT01435759|5852446|P4|STARTED|Antidepressant Lead-in Phase||0
2384325|NCT01435759|5852447|P3|STARTED|Antidepressant Lead-in Phase||0
2384326|NCT01435759|5852448|P2|STARTED|Antidepressant Lead-in Phase||0
2384327|NCT01435759|5852449|P1|STARTED|Antidepressant Lead-in Phase|Of these 1197 subjects, 19 subjects were not dosed.|1197
2384328|NCT01435655|5852476|P1|NOT COMPLETED|Overall Study||3
2384329|NCT01435655|5852476|P1|COMPLETED|Overall Study||7
2384330|NCT01435655|5852476|P1|STARTED|Overall Study||10
2384331|NCT01435616|5852490|P2|NOT COMPLETED|Overall Study||80
2384332|NCT01435616|5852491|P1|NOT COMPLETED|Overall Study||171
2384333|NCT01435616|5852490|P2|COMPLETED|Overall Study||455
2384334|NCT01435616|5852491|P1|COMPLETED|Overall Study||832
2384335|NCT01435616|5852490|P2|Received at Least 1 Dose of Study Drug|Overall Study||535
2384336|NCT01435616|5852491|P1|Received at Least 1 Dose of Study Drug|Overall Study||1003
2384337|NCT01435616|5852490|P2|STARTED|Overall Study||535
2384338|NCT01435616|5852491|P1|STARTED|Overall Study||1003
2384339|NCT01435603|5852537|P2|NOT COMPLETED|Overall Study||35
2384340|NCT01435603|5852538|P1|NOT COMPLETED|Overall Study||39
2384341|NCT01435603|5852537|P2|COMPLETED|Overall Study||129
2384342|NCT01435603|5852538|P1|COMPLETED|Overall Study||128
2384343|NCT01435603|5852537|P2|STARTED|Overall Study||164
2384344|NCT01435603|5852538|P1|STARTED|Overall Study||167
2384345|NCT01435577|5852546|P2|NOT COMPLETED|Overall Study||52
2384346|NCT01435577|5852547|P1|NOT COMPLETED|Overall Study||17
2384347|NCT01435577|5852546|P2|COMPLETED|Overall Study||13
2384348|NCT01435577|5852547|P1|COMPLETED|Overall Study||47
2384349|NCT01435577|5852546|P2|STARTED|Overall Study||65
2384350|NCT01435577|5852547|P1|STARTED|Overall Study||64
2384351|NCT01435460|5852597|P2|NOT COMPLETED|Overall Study||6
2384352|NCT01435460|5852598|P1|NOT COMPLETED|Overall Study||11
2384353|NCT01435460|5852597|P2|COMPLETED|Overall Study||143
2384354|NCT01435460|5852598|P1|COMPLETED|Overall Study||140
2384355|NCT01435460|5852597|P2|STARTED|Overall Study||149
2384356|NCT01435460|5852598|P1|STARTED|Overall Study||151
2384357|NCT01435382|5852614|P4|NOT COMPLETED|Overall Study||1
2384358|NCT01435382|5852615|P3|NOT COMPLETED|Overall Study||1
2384359|NCT01435382|5852616|P2|NOT COMPLETED|Overall Study||2
2384360|NCT01435382|5852617|P1|NOT COMPLETED|Overall Study||1
2384361|NCT01435382|5852614|P4|COMPLETED|Overall Study||10
2384362|NCT01435382|5852615|P3|COMPLETED|Overall Study||12
2384363|NCT01435382|5852616|P2|COMPLETED|Overall Study||11
2384364|NCT01435382|5852617|P1|COMPLETED|Overall Study||11
2384365|NCT01435382|5852614|P4|STARTED|Overall Study||11
2384366|NCT01435382|5852615|P3|STARTED|Overall Study||13
2384367|NCT01435382|5852616|P2|STARTED|Overall Study||13
2384368|NCT01435382|5852617|P1|STARTED|Overall Study||12
2384369|NCT01435356|5852706|P2|NOT COMPLETED|Overall Study||24
2384370|NCT01435356|5852707|P1|NOT COMPLETED|Overall Study||32
2384371|NCT01435356|5852706|P2|COMPLETED|Overall Study||5
2384372|NCT01435356|5852707|P1|COMPLETED|Overall Study||16
2384373|NCT01435356|5852706|P2|STARTED|Overall Study||29
2384374|NCT01435356|5852707|P1|STARTED|Overall Study||48
2384375|NCT01435304|5852721|P2|NOT COMPLETED|Overall Study||0
2384376|NCT01435304|5852722|P1|NOT COMPLETED|Overall Study||0
2384377|NCT01435304|5852721|P2|COMPLETED|Overall Study||50
2384378|NCT01435304|5852722|P1|COMPLETED|Overall Study||50
2384379|NCT01435304|5852721|P2|STARTED|Overall Study||50
2384380|NCT01435304|5852722|P1|STARTED|Overall Study||50
2384381|NCT01435265|5852740|P2|NOT COMPLETED|Overall Study||1
2384382|NCT01435265|5852741|P1|NOT COMPLETED|Overall Study||0
2384383|NCT01435265|5852740|P2|COMPLETED|Overall Study||3
2384384|NCT01435265|5852741|P1|COMPLETED|Overall Study||3
2384385|NCT01435265|5852740|P2|STARTED|Overall Study||4
2384386|NCT01435265|5852741|P1|STARTED|Overall Study||3
2384387|NCT01435174|5852751|P1|NOT COMPLETED|Overall Study||9
2384388|NCT01435174|5852751|P1|COMPLETED|Overall Study||8
2384389|NCT01435174|5852751|P1|STARTED|Overall Study||17
2384390|NCT01435122|5852755|P1|NOT COMPLETED|Overall Study||8
2384391|NCT01435122|5852755|P1|COMPLETED|Overall Study||22
2384392|NCT01435122|5852755|P1|STARTED|Overall Study||30
2384393|NCT01435031|5852764|P1|NOT COMPLETED|ITT at 4 Years||7
2384394|NCT01435031|5852764|P1|COMPLETED|ITT at 4 Years||171
2384395|NCT01435031|5852764|P1|STARTED|ITT at 4 Years||178
2384396|NCT01435031|5852764|P1|NOT COMPLETED|ITT at 3 Years||11
2384397|NCT01435031|5852764|P1|COMPLETED|ITT at 3 Years||178
2384398|NCT01435031|5852764|P1|STARTED|ITT at 3 Years||189
2384399|NCT01435031|5852764|P1|NOT COMPLETED|ITT at 2 Years||13
2384400|NCT01435031|5852764|P1|COMPLETED|ITT at 2 Years||189
2384401|NCT01435031|5852764|P1|STARTED|ITT at 2 Years||202
2384402|NCT01435031|5852764|P1|NOT COMPLETED|ITT at 1 Year||9
2384403|NCT01435031|5852764|P1|COMPLETED|ITT at 1 Year||202
2384404|NCT01435031|5852764|P1|STARTED|ITT at 1 Year||211
2384405|NCT01435031|5852764|P1|NOT COMPLETED|ITT at 6 Months||5
2384406|NCT01435031|5852764|P1|COMPLETED|ITT at 6 Months||211
2384407|NCT01435031|5852764|P1|STARTED|ITT at 6 Months||216
2384408|NCT01435031|5852764|P1|NOT COMPLETED|ITT at 1 Month||6
2384409|NCT01435031|5852764|P1|COMPLETED|ITT at 1 Month||216
2384410|NCT01435031|5852764|P1|STARTED|ITT at 1 Month|ITT population|222
2384411|NCT01435018|5852865|P3|NOT COMPLETED|Overall Study||108
2384412|NCT01435018|5852866|P2|NOT COMPLETED|Overall Study||50
2384413|NCT01435018|5852867|P1|NOT COMPLETED|Overall Study||110
2384414|NCT01435018|5852865|P3|COMPLETED|Overall Study||31
2384415|NCT01435018|5852866|P2|COMPLETED|Overall Study||10
2384416|NCT01435018|5852867|P1|COMPLETED|Overall Study||25
2384417|NCT01435018|5852865|P3|STARTED|Overall Study||139
2384418|NCT01435018|5852866|P2|STARTED|Overall Study||60
2384419|NCT01435018|5852867|P1|STARTED|Overall Study||135
2384420|NCT01434823|5852952|P2|NOT COMPLETED|Overall Study||7
2384421|NCT01434823|5852953|P1|NOT COMPLETED|Overall Study||4
2384422|NCT01434823|5852952|P2|COMPLETED|Overall Study||778
2384423|NCT01434823|5852953|P1|COMPLETED|Overall Study||820
2384424|NCT01434823|5852952|P2|STARTED|Overall Study||785
2384425|NCT01434823|5852953|P1|STARTED|Overall Study||824
2384426|NCT01434810|5852971|P2|NOT COMPLETED|Overall Study||10
2384427|NCT01434810|5852972|P1|NOT COMPLETED|Overall Study||23
2384428|NCT01434810|5852971|P2|COMPLETED|Overall Study||213
2384429|NCT01434810|5852972|P1|COMPLETED|Overall Study||201
2384430|NCT01434810|5852971|P2|STARTED|Overall Study||223
2384431|NCT01434810|5852972|P1|STARTED|Overall Study||224
2384432|NCT01434745|5852984|P2|NOT COMPLETED|Overall Study||0
2384433|NCT01434745|5852985|P1|NOT COMPLETED|Overall Study||0
2384434|NCT01434745|5852984|P2|COMPLETED|Overall Study||0
2384435|NCT01434745|5852985|P1|COMPLETED|Overall Study||0
2384436|NCT01434745|5852984|P2|STARTED|Overall Study||0
2384437|NCT01434745|5852985|P1|STARTED|Overall Study||0
2384438|NCT01434693|5853007|P4|NOT COMPLETED|Overall Study||1
2384439|NCT01434693|5853008|P3|NOT COMPLETED|Overall Study||1
2384440|NCT01434693|5853009|P2|NOT COMPLETED|Overall Study||0
2384441|NCT01434693|5853010|P1|NOT COMPLETED|Overall Study||3
2384442|NCT01434693|5853007|P4|COMPLETED|Overall Study||8
2384443|NCT01434693|5853008|P3|COMPLETED|Overall Study||8
2384444|NCT01434693|5853009|P2|COMPLETED|Overall Study||9
2384445|NCT01434693|5853010|P1|COMPLETED|Overall Study||6
2384446|NCT01434693|5853007|P4|STARTED|Overall Study||9
2384447|NCT01434693|5853008|P3|STARTED|Overall Study||9
2384448|NCT01434693|5853009|P2|STARTED|Overall Study||9
2384449|NCT01434693|5853010|P1|STARTED|Overall Study||9
2384450|NCT01434680|5853024|P4|NOT COMPLETED|Overall Study||0
2384451|NCT01434680|5853025|P3|NOT COMPLETED|Overall Study||2
2384452|NCT01434680|5853026|P2|NOT COMPLETED|Overall Study||2
2384453|NCT01434680|5853027|P1|NOT COMPLETED|Overall Study||3
2384454|NCT01434680|5853024|P4|COMPLETED|Overall Study||119
2384455|NCT01434680|5853025|P3|COMPLETED|Overall Study||304
2384456|NCT01434680|5853026|P2|COMPLETED|Overall Study||266
2384457|NCT01434680|5853027|P1|COMPLETED|Overall Study||296
2384458|NCT01434680|5853024|P4|STARTED|Overall Study||119
2384459|NCT01434680|5853025|P3|STARTED|Overall Study||306
2384460|NCT01434680|5853026|P2|STARTED|Overall Study||268
2384461|NCT01434680|5853027|P1|STARTED|Overall Study||299
2384462|NCT01434667|5853044|P2|NOT COMPLETED|Overall Study||10
2384463|NCT01434667|5853045|P1|NOT COMPLETED|Overall Study||5
2384464|NCT01434667|5853044|P2|COMPLETED|Overall Study||65
2384465|NCT01434667|5853045|P1|COMPLETED|Overall Study||34
2384466|NCT01434667|5853044|P2|STARTED|Overall Study||75
2384467|NCT01434667|5853045|P1|STARTED|Overall Study||39
2384468|NCT01434654|5853071|P2|NOT COMPLETED|Overall Study||0
2384469|NCT01434654|5853072|P1|NOT COMPLETED|Overall Study||2
2384470|NCT01434654|5853071|P2|COMPLETED|Overall Study||12
2384471|NCT01434654|5853072|P1|COMPLETED|Overall Study||5
2384472|NCT01434654|5853071|P2|STARTED|Overall Study||12
2384473|NCT01434654|5853072|P1|STARTED|Overall Study||7
2384474|NCT01434641|5853084|P1|NOT COMPLETED|Overall Study||0
2384475|NCT01434641|5853084|P1|COMPLETED|Overall Study||102
2384476|NCT01434641|5853084|P1|STARTED|Overall Study||102
2384477|NCT01434511|5853089|P1|NOT COMPLETED|Overall Study||0
2384478|NCT01434511|5853089|P1|COMPLETED|Overall Study||1
2384479|NCT01434511|5853089|P1|STARTED|Overall Study||1
2384480|NCT01434342|5853108|P2|NOT COMPLETED|Overall Study||17
2384481|NCT01434342|5853109|P1|NOT COMPLETED|Overall Study||48
2384482|NCT01434342|5853108|P2|COMPLETED|Overall Study||31
2384483|NCT01434342|5853109|P1|COMPLETED|Overall Study||50
2384484|NCT01434342|5853108|P2|STARTED|Overall Study||48
2384485|NCT01434342|5853109|P1|STARTED|Overall Study||98
2384486|NCT01434290|5853119|P2|NOT COMPLETED|Overall Study||7
2384487|NCT01434290|5853120|P1|NOT COMPLETED|Overall Study||8
2384488|NCT01434290|5853119|P2|COMPLETED|Overall Study|Eligible subjects included in analysis|121
2384489|NCT01434290|5853120|P1|COMPLETED|Overall Study|Eligible subjects included in analysis|119
2384490|NCT01434290|5853119|P2|STARTED|Overall Study||128
2384491|NCT01434290|5853120|P1|STARTED|Overall Study||127
2384492|NCT01434186|5853148|P2|NOT COMPLETED|Overall Study||0
2384493|NCT01434186|5853149|P1|NOT COMPLETED|Overall Study||0
2384494|NCT01434186|5853148|P2|COMPLETED|Overall Study||4
2384495|NCT01434186|5853149|P1|COMPLETED|Overall Study||2
2384496|NCT01434186|5853148|P2|STARTED|Overall Study||4
2384497|NCT01434186|5853149|P1|STARTED|Overall Study||2
2384498|NCT01434121|5853158|P3|NOT COMPLETED|Overall Study||0
2384499|NCT01434121|5853159|P2|NOT COMPLETED|Overall Study||0
2384500|NCT01434121|5853160|P1|NOT COMPLETED|Overall Study||0
2384501|NCT01434121|5853158|P3|COMPLETED|Overall Study||8
2384502|NCT01434121|5853159|P2|COMPLETED|Overall Study||8
2384503|NCT01434121|5853160|P1|COMPLETED|Overall Study||8
2384504|NCT01434121|5853158|P3|STARTED|Overall Study||8
2384505|NCT01434121|5853159|P2|STARTED|Overall Study||8
2384506|NCT01434121|5853160|P1|STARTED|Overall Study||8
2384507|NCT01434030|5853186|P1|NOT COMPLETED|Overall Study||1
2384508|NCT01434030|5853186|P1|COMPLETED|Overall Study||56
2384509|NCT01434030|5853186|P1|STARTED|Overall Study||57
2384510|NCT01433978|5853193|P3|NOT COMPLETED|Extension Phase||6
2384511|NCT01433978|5853194|P2|NOT COMPLETED|Extension Phase||0
2384512|NCT01433978|5853195|P1|NOT COMPLETED|Extension Phase||0
2384513|NCT01433978|5853193|P3|COMPLETED|Extension Phase||0
2384514|NCT01433978|5853194|P2|COMPLETED|Extension Phase||0
2384515|NCT01433978|5853195|P1|COMPLETED|Extension Phase||0
2384516|NCT01433978|5853193|P3|STARTED|Extension Phase||6
2384517|NCT01433978|5853194|P2|STARTED|Extension Phase||0
2384518|NCT01433978|5853195|P1|STARTED|Extension Phase||0
2384519|NCT01433978|5853193|P3|NOT COMPLETED|Core Study||0
2384520|NCT01433978|5853194|P2|NOT COMPLETED|Core Study||11
2384521|NCT01433978|5853195|P1|NOT COMPLETED|Core Study||11
2384522|NCT01433978|5853193|P3|COMPLETED|Core Study||0
2384523|NCT01433978|5853194|P2|COMPLETED|Core Study||1
2384524|NCT01433978|5853195|P1|COMPLETED|Core Study||0
2384525|NCT01433978|5853193|P3|STARTED|Core Study||0
2384526|NCT01433978|5853194|P2|STARTED|Core Study||12
2384527|NCT01433978|5853195|P1|STARTED|Core Study||11
2384528|NCT01433913|5853204|P2|NOT COMPLETED|Overall Study||0
2384529|NCT01433913|5853205|P1|NOT COMPLETED|Overall Study||1
2384530|NCT01433913|5853204|P2|COMPLETED|Overall Study||10
2384531|NCT01433913|5853205|P1|COMPLETED|Overall Study||9
2384532|NCT01433913|5853204|P2|STARTED|Overall Study||10
2384533|NCT01433913|5853205|P1|STARTED|Overall Study||10
2384534|NCT01433731|5853241|P4|NOT COMPLETED|Overall Study||0
2384535|NCT01433731|5853242|P3|NOT COMPLETED|Overall Study||0
2384536|NCT01433731|5853243|P2|NOT COMPLETED|Overall Study||0
2384537|NCT01433731|5853244|P1|NOT COMPLETED|Overall Study||0
2384538|NCT01433731|5853241|P4|COMPLETED|Overall Study||5
2384539|NCT01433731|5853242|P3|COMPLETED|Overall Study||5
2384540|NCT01433731|5853243|P2|COMPLETED|Overall Study||5
2384541|NCT01433731|5853244|P1|COMPLETED|Overall Study||3
2384542|NCT01433731|5853241|P4|STARTED|Overall Study||5
2384543|NCT01433731|5853242|P3|STARTED|Overall Study||5
2384544|NCT01433731|5853243|P2|STARTED|Overall Study||5
2384545|NCT01433731|5853244|P1|STARTED|Overall Study||3
2384546|NCT01433549|5853252|P2|NOT COMPLETED|Phase 2: Second Study Product||1
2384547|NCT01433549|5853253|P1|NOT COMPLETED|Phase 2: Second Study Product||0
2384548|NCT01433549|5853252|P2|COMPLETED|Phase 2: Second Study Product||12
2384549|NCT01433549|5853253|P1|COMPLETED|Phase 2: Second Study Product||12
2384550|NCT01433549|5853252|P2|STARTED|Phase 2: Second Study Product||13
2384551|NCT01433549|5853253|P1|STARTED|Phase 2: Second Study Product||12
2384552|NCT01433549|5853252|P2|NOT COMPLETED|Phase 1: First Study Product||0
2384553|NCT01433549|5853253|P1|NOT COMPLETED|Phase 1: First Study Product||0
2384554|NCT01433549|5853252|P2|COMPLETED|Phase 1: First Study Product||13
2384555|NCT01433549|5853253|P1|COMPLETED|Phase 1: First Study Product||12
2384556|NCT01433549|5853252|P2|STARTED|Phase 1: First Study Product||13
2384557|NCT01433549|5853253|P1|STARTED|Phase 1: First Study Product||12
2384558|NCT01433471|5853263|P2|NOT COMPLETED|Overall Study||1
2384559|NCT01433471|5853264|P1|NOT COMPLETED|Overall Study||0
2384560|NCT01433471|5853263|P2|COMPLETED|Overall Study||1
2384561|NCT01433471|5853264|P1|COMPLETED|Overall Study||2
2384562|NCT01433471|5853263|P2|STARTED|Overall Study||2
2384563|NCT01433471|5853264|P1|STARTED|Overall Study||2
2384564|NCT01433354|5853280|P1|NOT COMPLETED|Overall Study||119
2384565|NCT01433354|5853280|P1|COMPLETED|Overall Study||0
2384566|NCT01433354|5853280|P1|STARTED|Overall Study|120 enrolled of which 119 were administered drug|119
2384567|NCT01433263|5853296|P2|NOT COMPLETED|Overall Study||12
2384568|NCT01433263|5853297|P1|NOT COMPLETED|Overall Study||19
2384569|NCT01433263|5853296|P2|COMPLETED|Overall Study||16
2384570|NCT01433263|5853297|P1|COMPLETED|Overall Study||10
2384571|NCT01433263|5853296|P2|STARTED|Overall Study||28
2384572|NCT01433263|5853297|P1|STARTED|Overall Study||29
2384573|NCT01433250|5853326|P2|NOT COMPLETED|Overall Study||3
2384574|NCT01433250|5853327|P1|NOT COMPLETED|Overall Study||3
2384575|NCT01433250|5853326|P2|COMPLETED|Overall Study||14
2384576|NCT01433250|5853327|P1|COMPLETED|Overall Study||19
2384577|NCT01433250|5853326|P2|STARTED|Overall Study||17
2384578|NCT01433250|5853327|P1|STARTED|Overall Study||22
2384579|NCT01433172|5853346|P3|NOT COMPLETED|Overall Study||1
2384580|NCT01433172|5853347|P2|NOT COMPLETED|Overall Study||3
2384581|NCT01433172|5853348|P1|NOT COMPLETED|Overall Study||0
2384582|NCT01433172|5853346|P3|COMPLETED|Overall Study||32
2384583|NCT01433172|5853347|P2|COMPLETED|Overall Study||34
2384584|NCT01433172|5853348|P1|COMPLETED|Overall Study||3
2384585|NCT01433172|5853346|P3|STARTED|Overall Study||33
2384586|NCT01433172|5853347|P2|STARTED|Overall Study||37
2384587|NCT01433172|5853348|P1|STARTED|Overall Study||3
2384588|NCT01433159|5853360|P2|NOT COMPLETED|Overall Study||1
2384589|NCT01433159|5853361|P1|NOT COMPLETED|Overall Study||2
2384590|NCT01433159|5853360|P2|COMPLETED|Overall Study||9
2384591|NCT01433159|5853361|P1|COMPLETED|Overall Study||7
2384592|NCT01433159|5853360|P2|STARTED|Overall Study||10
2384593|NCT01433159|5853361|P1|STARTED|Overall Study||9
2384594|NCT01433107|5853369|P2|NOT COMPLETED|Overall Study||17
2384595|NCT01433107|5853370|P1|NOT COMPLETED|Overall Study||27
2384596|NCT01433107|5853369|P2|COMPLETED|Overall Study||128
2384597|NCT01433107|5853370|P1|COMPLETED|Overall Study||118
2384598|NCT01433107|5853369|P2|STARTED|Overall Study||145
2384599|NCT01433107|5853370|P1|STARTED|Overall Study||145
2384600|NCT01433081|5853382|P2|NOT COMPLETED|Overall Study||2
2384601|NCT01433081|5853383|P1|NOT COMPLETED|Overall Study||2
2384602|NCT01433081|5853382|P2|COMPLETED|Overall Study||23
2384603|NCT01433081|5853383|P1|COMPLETED|Overall Study||23
2384604|NCT01433081|5853382|P2|STARTED|Overall Study||25
2384605|NCT01433081|5853383|P1|STARTED|Overall Study||25
2384606|NCT01433055|5853393|P2|NOT COMPLETED|Overall Study||0
2384607|NCT01433055|5853394|P1|NOT COMPLETED|Overall Study||2
2384608|NCT01433055|5853393|P2|COMPLETED|Overall Study||23
2384609|NCT01433055|5853394|P1|COMPLETED|Overall Study||27
2384610|NCT01433055|5853393|P2|STARTED|Overall Study||23
2384611|NCT01433055|5853394|P1|STARTED|Overall Study||29
2384612|NCT01433042|5853408|P1|NOT COMPLETED|Overall Study||1
2384613|NCT01433042|5853408|P1|COMPLETED|Overall Study||224
2384614|NCT01433042|5853408|P1|STARTED|Overall Study||225
2384615|NCT01433016|5853412|P1|NOT COMPLETED|Overall Study||0
2384616|NCT01433016|5853412|P1|COMPLETED|Overall Study||20
2384617|NCT01433016|5853412|P1|STARTED|Overall Study||20
2384618|NCT01432938|5853416|P2|NOT COMPLETED|Second Intervention||0
2384619|NCT01432938|5853417|P1|NOT COMPLETED|Second Intervention||1
2384620|NCT01432938|5853416|P2|COMPLETED|Second Intervention||14
2384621|NCT01432938|5853417|P1|COMPLETED|Second Intervention||11
2384622|NCT01432938|5853416|P2|STARTED|Second Intervention||14
2384623|NCT01432938|5853417|P1|STARTED|Second Intervention||12
2384624|NCT01432938|5853416|P2|NOT COMPLETED|Washout Period of at Least 24 Days||0
2384625|NCT01432938|5853417|P1|NOT COMPLETED|Washout Period of at Least 24 Days||0
2384626|NCT01432938|5853416|P2|COMPLETED|Washout Period of at Least 24 Days||14
2384627|NCT01432938|5853417|P1|COMPLETED|Washout Period of at Least 24 Days||12
2384628|NCT01432938|5853416|P2|STARTED|Washout Period of at Least 24 Days||14
2384629|NCT01432938|5853417|P1|STARTED|Washout Period of at Least 24 Days||12
2384630|NCT01432938|5853416|P2|NOT COMPLETED|First Intervention||0
2384631|NCT01432938|5853417|P1|NOT COMPLETED|First Intervention||2
2384632|NCT01432938|5853416|P2|COMPLETED|First Intervention||14
2384633|NCT01432938|5853417|P1|COMPLETED|First Intervention||12
2384634|NCT01432938|5853416|P2|Received at Least 1 Dose of Study Drug|First Intervention||14
2384635|NCT01432938|5853417|P1|Received at Least 1 Dose of Study Drug|First Intervention||14
2384636|NCT01432938|5853416|P2|STARTED|First Intervention||14
2384637|NCT01432938|5853417|P1|STARTED|First Intervention||14
2384638|NCT01432886|5853434|P2|NOT COMPLETED|Overall Study||0
2384639|NCT01432886|5853435|P1|NOT COMPLETED|Overall Study||0
2384640|NCT01432886|5853434|P2|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
2384641|NCT01432886|5853435|P1|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
2384642|NCT01432886|5853434|P2|STARTED|Overall Study||6
2384643|NCT01432886|5853435|P1|STARTED|Overall Study||6
2384644|NCT01432756|5853447|P4|NOT COMPLETED|Overall Study||1
2384645|NCT01432756|5853448|P3|NOT COMPLETED|Overall Study||2
2384646|NCT01432756|5853449|P2|NOT COMPLETED|Overall Study||0
2384647|NCT01432756|5853450|P1|NOT COMPLETED|Overall Study||1
2384648|NCT01432756|5853447|P4|COMPLETED|Overall Study||33
2384649|NCT01432756|5853448|P3|COMPLETED|Overall Study||30
2384650|NCT01432756|5853449|P2|COMPLETED|Overall Study||34
2384651|NCT01432756|5853450|P1|COMPLETED|Overall Study||31
2384652|NCT01432756|5853447|P4|STARTED|Overall Study||34
2384653|NCT01432756|5853448|P3|STARTED|Overall Study||32
2384654|NCT01432756|5853449|P2|STARTED|Overall Study||34
2384655|NCT01432756|5853450|P1|STARTED|Overall Study||32
2384656|NCT01432626|5853458|P1|NOT COMPLETED|Overall Study||7
2384657|NCT01432626|5853458|P1|COMPLETED|Overall Study|Completed both images|3
2384658|NCT01432626|5853458|P1|STARTED|Overall Study||10
2384659|NCT01432600|5853465|P3|NOT COMPLETED|Overall Study||1
2384660|NCT01432600|5853466|P2|NOT COMPLETED|Overall Study||1
2384661|NCT01432600|5853467|P1|NOT COMPLETED|Overall Study||0
2384662|NCT01432600|5853465|P3|COMPLETED|Overall Study||33
2384663|NCT01432600|5853466|P2|COMPLETED|Overall Study||35
2384664|NCT01432600|5853467|P1|COMPLETED|Overall Study||10
2384665|NCT01432600|5853465|P3|STARTED|Overall Study||34
2384666|NCT01432600|5853466|P2|STARTED|Overall Study||36
2384667|NCT01432600|5853467|P1|STARTED|Overall Study||10
2384668|NCT01432574|5853483|P1|NOT COMPLETED|Overall Study||3
2384669|NCT01432574|5853483|P1|COMPLETED|Overall Study||147
2384670|NCT01432574|5853483|P1|STARTED|Overall Study||150
2384671|NCT01432561|5853489|P1|NOT COMPLETED|Overall Study||0
2384672|NCT01432561|5853489|P1|COMPLETED|Overall Study||8
2384673|NCT01432561|5853489|P1|STARTED|Overall Study||8
2384674|NCT01432535|5853498|P3|NOT COMPLETED|Overall Study||0
2384675|NCT01432535|5853499|P2|NOT COMPLETED|Overall Study||0
2384676|NCT01432535|5853500|P1|NOT COMPLETED|Overall Study||0
2384677|NCT01432535|5853498|P3|COMPLETED|Overall Study||6
2384678|NCT01432535|5853499|P2|COMPLETED|Overall Study||7
2384679|NCT01432535|5853500|P1|COMPLETED|Overall Study||12
2384680|NCT01432535|5853498|P3|STARTED|Overall Study||6
2384681|NCT01432535|5853499|P2|STARTED|Overall Study|One participant later determined ineligible is not included in baseline/efficacy analyses.|7
2384682|NCT01432535|5853500|P1|STARTED|Overall Study||12
2384683|NCT01432457|5853529|P3|NOT COMPLETED|Overall Study||59
2384684|NCT01432457|5853530|P2|NOT COMPLETED|Overall Study||48
2384685|NCT01432457|5853531|P1|NOT COMPLETED|Overall Study||37
2384686|NCT01432457|5853529|P3|COMPLETED|Overall Study||253
2384687|NCT01432457|5853530|P2|COMPLETED|Overall Study||258
2384688|NCT01432457|5853531|P1|COMPLETED|Overall Study||269
2384689|NCT01432457|5853529|P3|STARTED|Overall Study||312
2384690|NCT01432457|5853530|P2|STARTED|Overall Study||306
2384691|NCT01432457|5853531|P1|STARTED|Overall Study||306
2384692|NCT01432444|5853560|P3|NOT COMPLETED|Extension Phase||192
2384693|NCT01432444|5853561|P2|NOT COMPLETED|Extension Phase||0
2384694|NCT01432444|5853562|P1|NOT COMPLETED|Extension Phase||0
2384695|NCT01432444|5853560|P3|COMPLETED|Extension Phase||0
2384696|NCT01432444|5853561|P2|COMPLETED|Extension Phase||0
2384697|NCT01432444|5853562|P1|COMPLETED|Extension Phase||0
2384698|NCT01432444|5853560|P3|STARTED|Extension Phase||192
2384699|NCT01432444|5853561|P2|STARTED|Extension Phase||0
2384700|NCT01432444|5853562|P1|STARTED|Extension Phase||0
2384701|NCT01432444|5853560|P3|NOT COMPLETED|Treatment Phase||0
2384702|NCT01432444|5853561|P2|NOT COMPLETED|Treatment Phase||140
2384703|NCT01432444|5853562|P1|NOT COMPLETED|Treatment Phase||0
2384704|NCT01432444|5853560|P3|COMPLETED|Treatment Phase||0
2384705|NCT01432444|5853561|P2|COMPLETED|Treatment Phase||293
2384706|NCT01432444|5853562|P1|COMPLETED|Treatment Phase||0
2384707|NCT01432444|5853560|P3|STARTED|Treatment Phase||0
2384708|NCT01432444|5853561|P2|STARTED|Treatment Phase||433
2384709|NCT01432444|5853562|P1|STARTED|Treatment Phase||0
2384710|NCT01432444|5853560|P3|NOT COMPLETED|Tolerability/Cross-titration Phase||0
2384711|NCT01432444|5853561|P2|NOT COMPLETED|Tolerability/Cross-titration Phase||0
2384712|NCT01432444|5853562|P1|NOT COMPLETED|Tolerability/Cross-titration Phase||60
2384713|NCT01432444|5853560|P3|COMPLETED|Tolerability/Cross-titration Phase||0
2384714|NCT01432444|5853561|P2|COMPLETED|Tolerability/Cross-titration Phase||0
2384715|NCT01432444|5853562|P1|COMPLETED|Tolerability/Cross-titration Phase||265
2384716|NCT01432444|5853560|P3|STARTED|Tolerability/Cross-titration Phase||0
2384717|NCT01432444|5853561|P2|STARTED|Tolerability/Cross-titration Phase||0
2384718|NCT01432444|5853562|P1|STARTED|Tolerability/Cross-titration Phase||325
2384719|NCT01432405|5853574|P2|NOT COMPLETED|Overall Study||2
2384720|NCT01432405|5853575|P1|NOT COMPLETED|Overall Study||1
2384721|NCT01432405|5853574|P2|COMPLETED|Overall Study||10
2384722|NCT01432405|5853575|P1|COMPLETED|Overall Study||11
2384723|NCT01432405|5853574|P2|STARTED|Overall Study||12
2384724|NCT01432405|5853575|P1|STARTED|Overall Study||12
2384725|NCT01432379|5853583|P1|NOT COMPLETED|Overall Study||385
2384726|NCT01432379|5853583|P1|COMPLETED|Overall Study||783
2384727|NCT01432379|5853583|P1|STARTED|Overall Study||1168
2384728|NCT01432366|5853588|P1|NOT COMPLETED|Overall Study||68
2384729|NCT01432366|5853588|P1|COMPLETED|Overall Study||392
2384730|NCT01432366|5853588|P1|STARTED|Overall Study||460
2384731|NCT01432327|5853610|P4|NOT COMPLETED|Posttest 1 Year||23
2384732|NCT01432327|5853611|P3|NOT COMPLETED|Posttest 1 Year||20
2384733|NCT01432327|5853612|P2|NOT COMPLETED|Posttest 1 Year||28
2384734|NCT01432327|5853613|P1|NOT COMPLETED|Posttest 1 Year||24
2384735|NCT01432327|5853610|P4|COMPLETED|Posttest 1 Year||31
2384736|NCT01432327|5853611|P3|COMPLETED|Posttest 1 Year||30
2384737|NCT01432327|5853612|P2|COMPLETED|Posttest 1 Year||27
2384738|NCT01432327|5853613|P1|COMPLETED|Posttest 1 Year||28
2384739|NCT01432327|5853610|P4|STARTED|Posttest 1 Year||54
2384740|NCT01432327|5853611|P3|STARTED|Posttest 1 Year||50
2384741|NCT01432327|5853612|P2|STARTED|Posttest 1 Year||55
2384742|NCT01432327|5853613|P1|STARTED|Posttest 1 Year||52
2384743|NCT01432327|5853610|P4|NOT COMPLETED|Posttest 6 Months||2
2384744|NCT01432327|5853611|P3|NOT COMPLETED|Posttest 6 Months||5
2384745|NCT01432327|5853612|P2|NOT COMPLETED|Posttest 6 Months||0
2384746|NCT01432327|5853613|P1|NOT COMPLETED|Posttest 6 Months||0
2384747|NCT01432327|5853610|P4|COMPLETED|Posttest 6 Months||54
2384748|NCT01432327|5853611|P3|COMPLETED|Posttest 6 Months||50
2384749|NCT01432327|5853612|P2|COMPLETED|Posttest 6 Months||55
2384750|NCT01432327|5853613|P1|COMPLETED|Posttest 6 Months||52
2384751|NCT01432327|5853610|P4|STARTED|Posttest 6 Months||56
2384752|NCT01432327|5853611|P3|STARTED|Posttest 6 Months||55
2384753|NCT01432327|5853612|P2|STARTED|Posttest 6 Months||55
2384754|NCT01432327|5853613|P1|STARTED|Posttest 6 Months||52
2384755|NCT01432327|5853610|P4|NOT COMPLETED|Posttest 3 Months||1
2384756|NCT01432327|5853611|P3|NOT COMPLETED|Posttest 3 Months||2
2384757|NCT01432327|5853612|P2|NOT COMPLETED|Posttest 3 Months||2
2384758|NCT01432327|5853613|P1|NOT COMPLETED|Posttest 3 Months||4
2384759|NCT01432327|5853610|P4|COMPLETED|Posttest 3 Months||56
2384760|NCT01432327|5853611|P3|COMPLETED|Posttest 3 Months||55
2384761|NCT01432327|5853612|P2|COMPLETED|Posttest 3 Months||55
2384762|NCT01432327|5853613|P1|COMPLETED|Posttest 3 Months||52
2384763|NCT01432327|5853610|P4|STARTED|Posttest 3 Months||57
2384764|NCT01432327|5853611|P3|STARTED|Posttest 3 Months||57
2384765|NCT01432327|5853612|P2|STARTED|Posttest 3 Months||57
2384766|NCT01432327|5853613|P1|STARTED|Posttest 3 Months||56
2384767|NCT01432327|5853610|P4|NOT COMPLETED|Baseline||0
2384768|NCT01432327|5853611|P3|NOT COMPLETED|Baseline||0
2384769|NCT01432327|5853612|P2|NOT COMPLETED|Baseline||0
2384770|NCT01432327|5853613|P1|NOT COMPLETED|Baseline||0
2384771|NCT01432327|5853610|P4|COMPLETED|Baseline||57
2384772|NCT01432327|5853611|P3|COMPLETED|Baseline||57
2384773|NCT01432327|5853612|P2|COMPLETED|Baseline||57
2384774|NCT01432327|5853613|P1|COMPLETED|Baseline||56
2384775|NCT01432327|5853610|P4|STARTED|Baseline||57
2384776|NCT01432327|5853611|P3|STARTED|Baseline||57
2384777|NCT01432327|5853612|P2|STARTED|Baseline||57
2384778|NCT01432327|5853613|P1|STARTED|Baseline||56
2384779|NCT01432275|5853623|P2|NOT COMPLETED|ADC With Calculator (10 Days)||2
2384780|NCT01432275|5853624|P1|NOT COMPLETED|ADC With Calculator (10 Days)||3
2384781|NCT01432275|5853623|P2|COMPLETED|ADC With Calculator (10 Days)||79
2384782|NCT01432275|5853624|P1|COMPLETED|ADC With Calculator (10 Days)||85
2384783|NCT01432275|5853623|P2|STARTED|ADC With Calculator (10 Days)||81
2384784|NCT01432275|5853624|P1|STARTED|ADC With Calculator (10 Days)||88
2384785|NCT01432275|5853623|P2|NOT COMPLETED|Second BG Meter System (7 Days)||3
2384786|NCT01432275|5853624|P1|NOT COMPLETED|Second BG Meter System (7 Days)||2
2384787|NCT01432275|5853623|P2|COMPLETED|Second BG Meter System (7 Days)||81
2384788|NCT01432275|5853624|P1|COMPLETED|Second BG Meter System (7 Days)||88
2384789|NCT01432275|5853623|P2|STARTED|Second BG Meter System (7 Days)||84
2384790|NCT01432275|5853624|P1|STARTED|Second BG Meter System (7 Days)||90
2384791|NCT01432275|5853623|P2|NOT COMPLETED|First BG Meter System (7 Days)||3
2384792|NCT01432275|5853624|P1|NOT COMPLETED|First BG Meter System (7 Days)||0
2384793|NCT01432275|5853623|P2|COMPLETED|First BG Meter System (7 Days)||84
2384794|NCT01432275|5853624|P1|COMPLETED|First BG Meter System (7 Days)||90
2384795|NCT01432275|5853623|P2|STARTED|First BG Meter System (7 Days)||87
2384796|NCT01432275|5853624|P1|STARTED|First BG Meter System (7 Days)||90
2384797|NCT01432262|5853633|P2|NOT COMPLETED|Overall Study||1
2384798|NCT01432262|5853634|P1|NOT COMPLETED|Overall Study||2
2384799|NCT01432262|5853633|P2|COMPLETED|Overall Study||161
2384800|NCT01432262|5853634|P1|COMPLETED|Overall Study||160
2384801|NCT01432262|5853633|P2|Vaccinated|Overall Study||161
2384802|NCT01432262|5853634|P1|Vaccinated|Overall Study||162
2384803|NCT01432262|5853633|P2|STARTED|Overall Study||162
2384804|NCT01432262|5853634|P1|STARTED|Overall Study||162
2384805|NCT01432236|5853652|P2|NOT COMPLETED|Overall Study||18
2384806|NCT01432236|5853653|P1|NOT COMPLETED|Overall Study||26
2384807|NCT01432236|5853652|P2|COMPLETED|Overall Study||79
2384808|NCT01432236|5853653|P1|COMPLETED|Overall Study||70
2384809|NCT01432236|5853652|P2|STARTED|Overall Study||97
2384810|NCT01432236|5853653|P1|STARTED|Overall Study||96
2384811|NCT01432171|5853700|P2|NOT COMPLETED|Overall Study||11
2384812|NCT01432171|5853701|P1|NOT COMPLETED|Overall Study||14
2384813|NCT01432171|5853700|P2|COMPLETED|Overall Study||8
2384814|NCT01432171|5853701|P1|COMPLETED|Overall Study||4
2384815|NCT01432171|5853700|P2|STARTED|Overall Study||19
2384816|NCT01432171|5853701|P1|STARTED|Overall Study||18
2384817|NCT01432145|5853707|P1|NOT COMPLETED|Overall Study||7
2384818|NCT01432145|5853707|P1|COMPLETED|Overall Study||67
2384819|NCT01432145|5853707|P1|STARTED|Overall Study|Corrected from 75. 75 was entered in error|74
2384820|NCT01432015|5853714|P2|NOT COMPLETED|Overall Study||0
2384821|NCT01432015|5853715|P1|NOT COMPLETED|Overall Study||0
2384822|NCT01432015|5853714|P2|COMPLETED|Overall Study||10
2384823|NCT01432015|5853715|P1|COMPLETED|Overall Study||10
2384824|NCT01432015|5853714|P2|STARTED|Overall Study||10
2384825|NCT01432015|5853715|P1|STARTED|Overall Study||10
2384826|NCT01431989|5853723|P2|NOT COMPLETED|Period 2||0
2384827|NCT01431989|5853724|P1|NOT COMPLETED|Period 2||0
2384828|NCT01431989|5853723|P2|COMPLETED|Period 2||14
2384829|NCT01431989|5853724|P1|COMPLETED|Period 2||14
2384830|NCT01431989|5853723|P2|STARTED|Period 2||14
2384831|NCT01431989|5853724|P1|STARTED|Period 2||14
2384832|NCT01431989|5853723|P2|NOT COMPLETED|14-Day Washout Period||0
2384833|NCT01431989|5853724|P1|NOT COMPLETED|14-Day Washout Period||0
2384834|NCT01431989|5853723|P2|COMPLETED|14-Day Washout Period||14
2384835|NCT01431989|5853724|P1|COMPLETED|14-Day Washout Period||14
2384836|NCT01431989|5853723|P2|STARTED|14-Day Washout Period||14
2384837|NCT01431989|5853724|P1|STARTED|14-Day Washout Period||14
2384838|NCT01431989|5853723|P2|NOT COMPLETED|Period 1||0
2384839|NCT01431989|5853724|P1|NOT COMPLETED|Period 1||0
2384840|NCT01431989|5853723|P2|COMPLETED|Period 1||14
2384841|NCT01431989|5853724|P1|COMPLETED|Period 1||14
2384842|NCT01431989|5853723|P2|STARTED|Period 1||14
2384843|NCT01431989|5853724|P1|STARTED|Period 1||14
2384844|NCT01431976|5853742|P1|NOT COMPLETED|Overall Study||14
2384845|NCT01431976|5853742|P1|COMPLETED|Overall Study||6
2384846|NCT01431976|5853742|P1|STARTED|Overall Study||20
2384847|NCT01431963|5853753|P1|NOT COMPLETED|Overall Study||35
2384848|NCT01431963|5853753|P1|COMPLETED|Overall Study||32
2384849|NCT01431963|5853753|P1|Complete ExP (gt= 24 Weeks)|Overall Study|(>=24 weeks); gt= abbreviation for greater than or equal to|19
2384850|NCT01431963|5853753|P1|Begin Extension Phase (ExP; gt= 24weeks)|Overall Study|Only Japanese participants in ExP,lamotrigine monotherapy was available in Korea. (>=24weeks)|19
2384851|NCT01431963|5853753|P1|Complete MP (24 Weeks)|Overall Study||42
2384852|NCT01431963|5853753|P1|Begin Maintenance Phase (MP; 24 Weeks)|Overall Study||52
2384853|NCT01431963|5853753|P1|Complete EP (6 Weeks)|Overall Study||52
2384854|NCT01431963|5853753|P1|Received Treatment|Overall Study||65
2384855|NCT01431963|5853753|P1|Begin Escalation Phase (EP; 6 Weeks)|Overall Study||67
2384856|NCT01431963|5853753|P1|STARTED|Overall Study||67
2384857|NCT01431950|5853761|P2|NOT COMPLETED|Overall Study||15
2384858|NCT01431950|5853762|P1|NOT COMPLETED|Overall Study||19
2384859|NCT01431950|5853761|P2|COMPLETED|Overall Study||104
2384860|NCT01431950|5853762|P1|COMPLETED|Overall Study||100
2384861|NCT01431950|5853761|P2|STARTED|Overall Study||119
2384862|NCT01431950|5853762|P1|STARTED|Overall Study||119
2384863|NCT01431846|5853779|P3|NOT COMPLETED|Overall Study||0
2384864|NCT01431846|5853780|P2|NOT COMPLETED|Overall Study||0
2384865|NCT01431846|5853781|P1|NOT COMPLETED|Overall Study||0
2384866|NCT01431846|5853779|P3|COMPLETED|Overall Study||8
2384867|NCT01431846|5853780|P2|COMPLETED|Overall Study||3
2384868|NCT01431846|5853781|P1|COMPLETED|Overall Study||8
2384869|NCT01431846|5853779|P3|STARTED|Overall Study||8
2384870|NCT01431846|5853780|P2|STARTED|Overall Study||3
2384871|NCT01431846|5853781|P1|STARTED|Overall Study||8
2384872|NCT01431794|5853794|P5|NOT COMPLETED|Overall Study||0
2384873|NCT01431794|5853795|P4|NOT COMPLETED|Overall Study||0
2384874|NCT01431794|5853796|P3|NOT COMPLETED|Overall Study||0
2384875|NCT01431794|5853797|P2|NOT COMPLETED|Overall Study||0
2384876|NCT01431794|5853798|P1|NOT COMPLETED|Overall Study||0
2384877|NCT01431794|5853794|P5|COMPLETED|Overall Study|not started due to early study's termination|0
2384878|NCT01431794|5853795|P4|COMPLETED|Overall Study|not started due to early study's termination|0
2384879|NCT01431794|5853796|P3|COMPLETED|Overall Study|not started due to early study's termination|0
2384880|NCT01431794|5853797|P2|COMPLETED|Overall Study|not started due to early study's termination|0
2384881|NCT01431794|5853798|P1|COMPLETED|Overall Study||13
2384882|NCT01431794|5853794|P5|STARTED|Overall Study|not started due to early study's termination|0
2384883|NCT01431794|5853795|P4|STARTED|Overall Study|not started due to early study's termination|0
2384884|NCT01431794|5853796|P3|STARTED|Overall Study|not started due to early study's termination|0
2384885|NCT01431794|5853797|P2|STARTED|Overall Study|not started due to early study's termination|0
2384886|NCT01431794|5853798|P1|STARTED|Overall Study||13
2384887|NCT01431755|5853816|P1|NOT COMPLETED|Overall Study||5
2384888|NCT01431755|5853816|P1|COMPLETED|Overall Study||49
2384889|NCT01431755|5853816|P1|STARTED|Overall Study||54
2384890|NCT01431716|5853827|P1|NOT COMPLETED|Overall Study||1
2384891|NCT01431716|5853827|P1|COMPLETED|Overall Study||41
2384892|NCT01431716|5853827|P1|STARTED|Overall Study||42
2384893|NCT01431703|5853844|P1|NOT COMPLETED|Overall Study||0
2384894|NCT01431703|5853844|P1|COMPLETED|Overall Study||326
2384895|NCT01431703|5853844|P1|STARTED|Overall Study||326
2384896|NCT01431534|5853851|P3|NOT COMPLETED|Extension Phase||0
2384897|NCT01431534|5853852|P2|NOT COMPLETED|Extension Phase||0
2384898|NCT01431534|5853853|P1|NOT COMPLETED|Extension Phase||0
2384899|NCT01431534|5853851|P3|COMPLETED|Extension Phase||2
2384900|NCT01431534|5853852|P2|COMPLETED|Extension Phase||0
2384901|NCT01431534|5853853|P1|COMPLETED|Extension Phase||0
2384902|NCT01431534|5853851|P3|STARTED|Extension Phase|Participants from Treatment Phase who continued in Extension Phase.|2
2384903|NCT01431534|5853852|P2|STARTED|Extension Phase|No participants continued in Extension Phase.|0
2384904|NCT01431534|5853853|P1|STARTED|Extension Phase|No participants continued in Extension Phase.|0
2384905|NCT01431534|5853851|P3|NOT COMPLETED|Treatment Phase||11
2384906|NCT01431534|5853852|P2|NOT COMPLETED|Treatment Phase||3
2384907|NCT01431534|5853853|P1|NOT COMPLETED|Treatment Phase||4
2384908|NCT01431534|5853851|P3|COMPLETED|Treatment Phase|Participants completing Treatment Phase could continue in Extension Phase.|2
2384909|NCT01431534|5853852|P2|COMPLETED|Treatment Phase||0
2384910|NCT01431534|5853853|P1|COMPLETED|Treatment Phase||0
2384911|NCT01431534|5853851|P3|STARTED|Treatment Phase||13
2384912|NCT01431534|5853852|P2|STARTED|Treatment Phase||3
2384913|NCT01431534|5853853|P1|STARTED|Treatment Phase||4
2384914|NCT01431521|5853868|P4|NOT COMPLETED|Overall Study||0
2384915|NCT01431521|5853869|P3|NOT COMPLETED|Overall Study||1
2384916|NCT01431521|5853870|P2|NOT COMPLETED|Overall Study||0
2384917|NCT01431521|5853871|P1|NOT COMPLETED|Overall Study||0
2384918|NCT01431521|5853868|P4|COMPLETED|Overall Study||5
2384919|NCT01431521|5853869|P3|COMPLETED|Overall Study||10
2384920|NCT01431521|5853870|P2|COMPLETED|Overall Study||5
2384921|NCT01431521|5853871|P1|COMPLETED|Overall Study||10
2384922|NCT01431521|5853868|P4|Treated|Overall Study||5
2384923|NCT01431521|5853869|P3|Treated|Overall Study||10
2384924|NCT01431521|5853870|P2|Treated|Overall Study||5
2384925|NCT01431521|5853871|P1|Treated|Overall Study||10
2384926|NCT01431521|5853868|P4|STARTED|Overall Study||5
2384927|NCT01431521|5853869|P3|STARTED|Overall Study||11
2384928|NCT01431521|5853870|P2|STARTED|Overall Study||5
2384929|NCT01431521|5853871|P1|STARTED|Overall Study||10
2384930|NCT01431508|5853892|P1|NOT COMPLETED|Overall Study||2
2384931|NCT01431508|5853892|P1|COMPLETED|Overall Study||13
2384932|NCT01431508|5853892|P1|STARTED|Overall Study||15
2384933|NCT01431391|5853898|P2|NOT COMPLETED|Overall Study||4
2384934|NCT01431391|5853899|P1|NOT COMPLETED|Overall Study||8
2384935|NCT01431391|5853898|P2|COMPLETED|Overall Study||30
2384936|NCT01431391|5853899|P1|COMPLETED|Overall Study||26
2384937|NCT01431391|5853898|P2|Received ≥1 Leaukapheresis|Overall Study||34
2384938|NCT01431391|5853899|P1|Received ≥1 Leaukapheresis|Overall Study||34
2384939|NCT01431391|5853898|P2|STARTED|Overall Study||34
2384940|NCT01431391|5853899|P1|STARTED|Overall Study||34
2384941|NCT01431339|5853909|P2|NOT COMPLETED|Overall Study||35
2384942|NCT01431339|5853910|P1|NOT COMPLETED|Overall Study||39
2384943|NCT01431339|5853909|P2|COMPLETED|Overall Study||333
2384944|NCT01431339|5853910|P1|COMPLETED|Overall Study||332
2384945|NCT01431339|5853909|P2|Safety Population|Overall Study||367
2384946|NCT01431339|5853910|P1|Safety Population|Overall Study||368
2384947|NCT01431339|5853909|P2|STARTED|Overall Study||368
2384948|NCT01431339|5853910|P1|STARTED|Overall Study||371
2384949|NCT01431313|5853925|P3|NOT COMPLETED|Overall Study||0
2384950|NCT01431313|5853926|P2|NOT COMPLETED|Overall Study||0
2384951|NCT01431313|5853927|P1|NOT COMPLETED|Overall Study||0
2384952|NCT01431313|5853925|P3|COMPLETED|Overall Study||8
2384953|NCT01431313|5853926|P2|COMPLETED|Overall Study||20
2384954|NCT01431313|5853927|P1|COMPLETED|Overall Study||20
2384955|NCT01431313|5853925|P3|STARTED|Overall Study||8
2384956|NCT01431313|5853926|P2|STARTED|Overall Study||20
2384957|NCT01431313|5853927|P1|STARTED|Overall Study||20
2384958|NCT01431300|5853959|P3|NOT COMPLETED|Overall Study||0
2384959|NCT01431300|5853960|P2|NOT COMPLETED|Overall Study||0
2384960|NCT01431300|5853961|P1|NOT COMPLETED|Overall Study||1
2384961|NCT01431300|5853959|P3|COMPLETED|Overall Study||10
2384962|NCT01431300|5853960|P2|COMPLETED|Overall Study||10
2384963|NCT01431300|5853961|P1|COMPLETED|Overall Study||10
2384964|NCT01431300|5853959|P3|STARTED|Overall Study||10
2384965|NCT01431300|5853960|P2|STARTED|Overall Study||10
2384966|NCT01431300|5853961|P1|STARTED|Overall Study|One subject with indeterminate pregnancy test, subject declined to proceed|11
2384967|NCT01431287|5853977|P5|NOT COMPLETED|Overall Study||77
2384968|NCT01431287|5853978|P4|NOT COMPLETED|Overall Study||63
2384969|NCT01431287|5853979|P3|NOT COMPLETED|Overall Study||97
2384970|NCT01431287|5853980|P2|NOT COMPLETED|Overall Study||98
2384971|NCT01431287|5853981|P1|NOT COMPLETED|Overall Study||98
2384972|NCT01431287|5853977|P5|COMPLETED|Overall Study||430
2384973|NCT01431287|5853978|P4|COMPLETED|Overall Study||445
2384974|NCT01431287|5853979|P3|COMPLETED|Overall Study||410
2384975|NCT01431287|5853980|P2|COMPLETED|Overall Study||409
2384976|NCT01431287|5853981|P1|COMPLETED|Overall Study||412
2384977|NCT01431287|5853977|P5|STARTED|Overall Study||507
2384978|NCT01431287|5853978|P4|STARTED|Overall Study||508
2384979|NCT01431287|5853979|P3|STARTED|Overall Study||507
2384980|NCT01431287|5853980|P2|STARTED|Overall Study||507
2384981|NCT01431287|5853981|P1|STARTED|Overall Study|started are actually the randomized|510
2384982|NCT01431274|5854143|P5|NOT COMPLETED|Overall Study||56
2384983|NCT01431274|5854144|P4|NOT COMPLETED|Overall Study||60
2384984|NCT01431274|5854145|P3|NOT COMPLETED|Overall Study||72
2384985|NCT01431274|5854146|P2|NOT COMPLETED|Overall Study||77
2384986|NCT01431274|5854147|P1|NOT COMPLETED|Overall Study||97
2384987|NCT01431274|5854143|P5|COMPLETED|Overall Study||466
2384988|NCT01431274|5854144|P4|COMPLETED|Overall Study||462
2384989|NCT01431274|5854145|P3|COMPLETED|Overall Study||455
2384990|NCT01431274|5854146|P2|COMPLETED|Overall Study||448
2384991|NCT01431274|5854147|P1|COMPLETED|Overall Study||431
2384992|NCT01431274|5854143|P5|STARTED|Overall Study||522
2384993|NCT01431274|5854144|P4|STARTED|Overall Study||522
2384994|NCT01431274|5854145|P3|STARTED|Overall Study||527
2384995|NCT01431274|5854146|P2|STARTED|Overall Study||525
2384996|NCT01431274|5854147|P1|STARTED|Overall Study||528
2384997|NCT01431170|5854306|P2|NOT COMPLETED|Overall Study||1
2384998|NCT01431170|5854307|P1|NOT COMPLETED|Overall Study||3
2384999|NCT01431170|5854306|P2|COMPLETED|Overall Study||11
2385000|NCT01431170|5854307|P1|COMPLETED|Overall Study||9
2385001|NCT01431170|5854306|P2|STARTED|Overall Study||12
2385002|NCT01431170|5854307|P1|STARTED|Overall Study||12
2385003|NCT01431144|5854325|P2|NOT COMPLETED|Overall Study||0
2385004|NCT01431144|5854326|P1|NOT COMPLETED|Overall Study||2
2385005|NCT01431144|5854325|P2|COMPLETED|Overall Study||14
2385006|NCT01431144|5854326|P1|COMPLETED|Overall Study||11
2385007|NCT01431144|5854325|P2|STARTED|Overall Study||14
2385008|NCT01431144|5854326|P1|STARTED|Overall Study||13
2385009|NCT01431131|5854334|P2|NOT COMPLETED|Overall Study||0
2385010|NCT01431131|5854335|P1|NOT COMPLETED|Overall Study||0
2385011|NCT01431131|5854334|P2|COMPLETED|Overall Study||12
2385012|NCT01431131|5854335|P1|COMPLETED|Overall Study||12
2385013|NCT01431131|5854334|P2|STARTED|Overall Study||12
2385014|NCT01431131|5854335|P1|STARTED|Overall Study||12
2385015|NCT01431105|5854343|P1|NOT COMPLETED|Overall Study||0
2385016|NCT01431105|5854343|P1|COMPLETED|Overall Study||34
2385017|NCT01431105|5854343|P1|STARTED|Overall Study||34
2385018|NCT01431079|5854349|P2|NOT COMPLETED|Overall Study||39
2385019|NCT01431079|5854350|P1|NOT COMPLETED|Overall Study||35
2385020|NCT01431079|5854349|P2|COMPLETED|Overall Study||6
2385021|NCT01431079|5854350|P1|COMPLETED|Overall Study||10
2385022|NCT01431079|5854349|P2|Post-test|Overall Study||45
2385023|NCT01431079|5854350|P1|Post-test|Overall Study||45
2385024|NCT01431079|5854349|P2|STARTED|Overall Study||45
2385025|NCT01431079|5854350|P1|STARTED|Overall Study||45
2385026|NCT01431014|5854404|P2|NOT COMPLETED|Overall Study||9
2385027|NCT01431014|5854405|P1|NOT COMPLETED|Overall Study||3
2385028|NCT01431014|5854404|P2|COMPLETED|Overall Study||25
2385029|NCT01431014|5854405|P1|COMPLETED|Overall Study||31
2385030|NCT01431014|5854404|P2|STARTED|Overall Study||34
2385031|NCT01431014|5854405|P1|STARTED|Overall Study||34
2385032|NCT01430819|5854413|P2|NOT COMPLETED|Overall Study||0
2385033|NCT01430819|5854414|P1|NOT COMPLETED|Overall Study||0
2385034|NCT01430819|5854413|P2|COMPLETED|Overall Study||150
2385035|NCT01430819|5854414|P1|COMPLETED|Overall Study||150
2385036|NCT01430819|5854413|P2|STARTED|Overall Study||150
2385037|NCT01430819|5854414|P1|STARTED|Overall Study||150
2385038|NCT01430754|5854429|P2|NOT COMPLETED|Randomized Phase||0
2385039|NCT01430754|5854430|P1|NOT COMPLETED|Randomized Phase||0
2385040|NCT01430754|5854429|P2|COMPLETED|Randomized Phase||10
2385041|NCT01430754|5854430|P1|COMPLETED|Randomized Phase||10
2385042|NCT01430754|5854429|P2|STARTED|Randomized Phase||10
2385043|NCT01430754|5854430|P1|STARTED|Randomized Phase||10
2385044|NCT01430754|5854429|P2|NOT COMPLETED|Run-In Phase||0
2385045|NCT01430754|5854430|P1|NOT COMPLETED|Run-In Phase||37
2385046|NCT01430754|5854429|P2|COMPLETED|Run-In Phase||0
2385047|NCT01430754|5854430|P1|COMPLETED|Run-In Phase|Defined as the number of patients who entered the randomized-withdrawal phase|20
2385048|NCT01430754|5854429|P2|Entrained - After Run-In Phase|Run-In Phase||0
2385049|NCT01430754|5854430|P1|Entrained - After Run-In Phase|Run-In Phase||24
2385050|NCT01430754|5854429|P2|STARTED|Run-In Phase|During the run-in phase, participants were treated with tasimelteon only.|0
2385051|NCT01430754|5854430|P1|STARTED|Run-In Phase||57
2385052|NCT01430741|5854452|P4|NOT COMPLETED|Overall Study||0
2385053|NCT01430741|5854453|P3|NOT COMPLETED|Overall Study||10
2385054|NCT01430741|5854454|P2|NOT COMPLETED|Overall Study||0
2385055|NCT01430741|5854455|P1|NOT COMPLETED|Overall Study||0
2385056|NCT01430741|5854452|P4|COMPLETED|Overall Study||81
2385057|NCT01430741|5854453|P3|COMPLETED|Overall Study||37
2385058|NCT01430741|5854454|P2|COMPLETED|Overall Study||87
2385059|NCT01430741|5854455|P1|COMPLETED|Overall Study||22
2385060|NCT01430741|5854452|P4|STARTED|Overall Study||81
2385061|NCT01430741|5854453|P3|STARTED|Overall Study||47
2385062|NCT01430741|5854454|P2|STARTED|Overall Study||87
2385063|NCT01430741|5854455|P1|STARTED|Overall Study||22
2385064|NCT01430624|5854488|P3|NOT COMPLETED|Overall Study||29
2385065|NCT01430624|5854489|P2|NOT COMPLETED|Overall Study||34
2385066|NCT01430624|5854490|P1|NOT COMPLETED|Overall Study||28
2385067|NCT01430624|5854488|P3|COMPLETED|Overall Study|Completed one or more follow-ups|52
2385068|NCT01430624|5854489|P2|COMPLETED|Overall Study|Completed one or more follow-ups|48
2385069|NCT01430624|5854490|P1|COMPLETED|Overall Study|Completed one or more follow-ups|54
2385070|NCT01430624|5854488|P3|Eligible Baseline Completes|Overall Study||79
2385071|NCT01430624|5854489|P2|Eligible Baseline Completes|Overall Study||77
2385072|NCT01430624|5854490|P1|Eligible Baseline Completes|Overall Study||77
2385073|NCT01430624|5854488|P3|STARTED|Overall Study||81
2385074|NCT01430624|5854489|P2|STARTED|Overall Study||82
2385075|NCT01430624|5854490|P1|STARTED|Overall Study|Initial potential eligible screened enrolled|82
2385076|NCT01430611|5854521|P2|NOT COMPLETED|Overall Study||15
2385077|NCT01430611|5854522|P1|NOT COMPLETED|Overall Study||17
2385078|NCT01430611|5854521|P2|COMPLETED|Overall Study||318
2385079|NCT01430611|5854522|P1|COMPLETED|Overall Study||315
2385080|NCT01430611|5854521|P2|STARTED|Overall Study||333
2385081|NCT01430611|5854522|P1|STARTED|Overall Study||332
2385082|NCT01430585|5854540|P1|NOT COMPLETED|Overall Study||14
2385083|NCT01430585|5854540|P1|COMPLETED|Overall Study||0
2385084|NCT01430585|5854540|P1|STARTED|Overall Study||14
2385085|NCT01430468|5854575|P2|NOT COMPLETED|Overall Study||2
2385086|NCT01430468|5854576|P1|NOT COMPLETED|Overall Study||3
2385087|NCT01430468|5854575|P2|COMPLETED|Overall Study||16
2385088|NCT01430468|5854576|P1|COMPLETED|Overall Study||15
2385089|NCT01430468|5854575|P2|STARTED|Overall Study||18
2385090|NCT01430468|5854576|P1|STARTED|Overall Study||18
2385091|NCT01430455|5854582|P1|NOT COMPLETED|Overall Study||2
2385092|NCT01430455|5854582|P1|COMPLETED|Overall Study||5
2385093|NCT01430455|5854582|P1|STARTED|Overall Study||7
2385094|NCT01430403|5854589|P3|NOT COMPLETED|Overall Study||8
2385095|NCT01430403|5854590|P2|NOT COMPLETED|Overall Study||9
2385096|NCT01430403|5854591|P1|NOT COMPLETED|Overall Study||17
2385097|NCT01430403|5854589|P3|COMPLETED|Overall Study||81
2385098|NCT01430403|5854590|P2|COMPLETED|Overall Study||121
2385099|NCT01430403|5854591|P1|COMPLETED|Overall Study||242
2385100|NCT01430403|5854589|P3|STARTED|Overall Study|Intent-to-treat|89
2385101|NCT01430403|5854590|P2|STARTED|Overall Study|Intent-to-treat|130
2385102|NCT01430403|5854591|P1|STARTED|Overall Study|Intent-to-treat|259
2385103|NCT01430325|5854644|P4|NOT COMPLETED|Overall Study||0
2385104|NCT01430325|5854645|P3|NOT COMPLETED|Overall Study||0
2385105|NCT01430325|5854646|P2|NOT COMPLETED|Overall Study||0
2385106|NCT01430325|5854647|P1|NOT COMPLETED|Overall Study||0
2385107|NCT01430325|5854644|P4|COMPLETED|Overall Study||12
2385108|NCT01430325|5854645|P3|COMPLETED|Overall Study||8
2385109|NCT01430325|5854646|P2|COMPLETED|Overall Study||12
2385110|NCT01430325|5854647|P1|COMPLETED|Overall Study||10
2385111|NCT01430325|5854644|P4|STARTED|Overall Study||12
2385112|NCT01430325|5854645|P3|STARTED|Overall Study||8
2385113|NCT01430325|5854646|P2|STARTED|Overall Study||12
2385114|NCT01430325|5854647|P1|STARTED|Overall Study||10
2385115|NCT01430299|5854667|P2|NOT COMPLETED|Overall Study||2
2385116|NCT01430299|5854668|P1|NOT COMPLETED|Overall Study||4
2385117|NCT01430299|5854667|P2|COMPLETED|Overall Study||21
2385118|NCT01430299|5854668|P1|COMPLETED|Overall Study||16
2385119|NCT01430299|5854667|P2|STARTED|Overall Study||23
2385120|NCT01430299|5854668|P1|STARTED|Overall Study||20
2385121|NCT01430182|5854676|P2|NOT COMPLETED|Overall Study||0
2385122|NCT01430182|5854677|P1|NOT COMPLETED|Overall Study||0
2385123|NCT01430182|5854676|P2|COMPLETED|Overall Study||8
2385124|NCT01430182|5854677|P1|COMPLETED|Overall Study||9
2385125|NCT01430182|5854676|P2|STARTED|Overall Study||8
2385126|NCT01430182|5854677|P1|STARTED|Overall Study||9
2385127|NCT01430169|5854683|P1|NOT COMPLETED|Overall Study||0
2385128|NCT01430169|5854683|P1|COMPLETED|Overall Study||20
2385129|NCT01430169|5854683|P1|STARTED|Overall Study||20
2385130|NCT01430130|5854698|P1|NOT COMPLETED|Overall Study||2
2385131|NCT01430130|5854698|P1|COMPLETED|Overall Study||10
2385132|NCT01430130|5854698|P1|STARTED|Overall Study||12
2385133|NCT01430104|5854704|P1|NOT COMPLETED|28-Day Teriparatide Treatment Period||1
2385134|NCT01430104|5854704|P1|COMPLETED|28-Day Teriparatide Treatment Period||28
2385135|NCT01430104|5854704|P1|Received at Least 1 Dose of Teriparatide|28-Day Teriparatide Treatment Period||29
2385136|NCT01430104|5854704|P1|STARTED|28-Day Teriparatide Treatment Period|1 participant withdrew from the study after completing the 14-day Lead-in Period.|29
2385137|NCT01430104|5854704|P1|NOT COMPLETED|14-Day Lead-In Period||0
2385138|NCT01430104|5854704|P1|COMPLETED|14-Day Lead-In Period||30
2385139|NCT01430104|5854704|P1|STARTED|14-Day Lead-In Period||30
2385140|NCT01430091|5854716|P1|NOT COMPLETED|Overall Study||0
2385141|NCT01430091|5854716|P1|COMPLETED|Overall Study||18
2385142|NCT01430091|5854716|P1|STARTED|Overall Study||18
2385143|NCT01429987|5854742|P4|NOT COMPLETED|Overall Study||66
2385144|NCT01429987|5854743|P3|NOT COMPLETED|Overall Study||36
2385145|NCT01429987|5854744|P2|NOT COMPLETED|Overall Study||62
2385146|NCT01429987|5854745|P1|NOT COMPLETED|Overall Study||49
2385147|NCT01429987|5854742|P4|COMPLETED|Overall Study||171
2385148|NCT01429987|5854743|P3|COMPLETED|Overall Study||202
2385149|NCT01429987|5854744|P2|COMPLETED|Overall Study||176
2385150|NCT01429987|5854745|P1|COMPLETED|Overall Study||189
2385151|NCT01429987|5854742|P4|STARTED|Overall Study||237
2385152|NCT01429987|5854743|P3|STARTED|Overall Study||238
2385153|NCT01429987|5854744|P2|STARTED|Overall Study||238
2385154|NCT01429987|5854745|P1|STARTED|Overall Study||238
2385155|NCT01429792|5854771|P1|NOT COMPLETED|Overall Study||406
2385156|NCT01429792|5854771|P1|COMPLETED|Overall Study||607
2385157|NCT01429792|5854771|P1|Genotype 4|Overall Study||5
2385158|NCT01429792|5854771|P1|Genotype 2 & 3|Overall Study||305
2385159|NCT01429792|5854771|P1|Genotype 1|Overall Study||687
2385160|NCT01429792|5854771|P1|STARTED|Overall Study||1013
2385161|NCT01429623|5854785|P2|NOT COMPLETED|Overall Study||59
2385162|NCT01429623|5854786|P1|NOT COMPLETED|Overall Study||51
2385163|NCT01429623|5854785|P2|COMPLETED|Overall Study||48
2385164|NCT01429623|5854786|P1|COMPLETED|Overall Study||51
2385165|NCT01429623|5854785|P2|Converted to Alzheimer's|Overall Study|21 of 103|21
2385166|NCT01429623|5854786|P1|Converted to Alzheimer's|Overall Study|14 of 99|14
2385167|NCT01429623|5854785|P2|STARTED|Overall Study|107 allocated, 4 lacked post baseline data|107
2385168|NCT01429623|5854786|P1|STARTED|Overall Study|103 allocated, 1 withdrew consent prior to first dose, 4 lacked post baseline data|102
2385169|NCT01429584|5854800|P2|NOT COMPLETED|Overall Study||1
2385170|NCT01429584|5854801|P1|NOT COMPLETED|Overall Study||1
2385171|NCT01429584|5854800|P2|COMPLETED|Overall Study||14
2385172|NCT01429584|5854801|P1|COMPLETED|Overall Study||14
2385173|NCT01429584|5854800|P2|STARTED|Overall Study||15
2385174|NCT01429584|5854801|P1|STARTED|Overall Study||15
2385175|NCT01429532|5854814|P3|NOT COMPLETED|Overall Study||0
2385176|NCT01429532|5854815|P2|NOT COMPLETED|Overall Study||0
2385177|NCT01429532|5854816|P1|NOT COMPLETED|Overall Study||0
2385178|NCT01429532|5854814|P3|COMPLETED|Overall Study||40
2385179|NCT01429532|5854815|P2|COMPLETED|Overall Study||40
2385180|NCT01429532|5854816|P1|COMPLETED|Overall Study||40
2385181|NCT01429532|5854814|P3|STARTED|Overall Study||40
2385182|NCT01429532|5854815|P2|STARTED|Overall Study||40
2385183|NCT01429532|5854816|P1|STARTED|Overall Study||40
2385184|NCT01429441|5854832|P2|NOT COMPLETED|Overall Study||23
2385185|NCT01429441|5854833|P1|NOT COMPLETED|Overall Study||38
2385186|NCT01429441|5854832|P2|COMPLETED|Overall Study||51
2385187|NCT01429441|5854833|P1|COMPLETED|Overall Study||108
2385188|NCT01429441|5854832|P2|STARTED|Overall Study||74
2385189|NCT01429441|5854833|P1|STARTED|Overall Study||146
2385190|NCT01429298|5854843|P2|NOT COMPLETED|Overall Study||6
2385191|NCT01429298|5854844|P1|NOT COMPLETED|Overall Study||4
2385192|NCT01429298|5854843|P2|COMPLETED|Overall Study||169
2385193|NCT01429298|5854844|P1|COMPLETED|Overall Study||171
2385194|NCT01429298|5854843|P2|Given IV Opioids|Overall Study|6 never given IV opioids|169
2385195|NCT01429298|5854844|P1|Given IV Opioids|Overall Study|4 never given IV opioids|171
2385196|NCT01429298|5854843|P2|STARTED|Overall Study||175
2385197|NCT01429298|5854844|P1|STARTED|Overall Study||175
2385198|NCT01429285|5854860|P2|NOT COMPLETED|Overall Study||9
2385199|NCT01429285|5854861|P1|NOT COMPLETED|Overall Study||22
2385200|NCT01429285|5854860|P2|COMPLETED|Overall Study||166
2385201|NCT01429285|5854861|P1|COMPLETED|Overall Study||153
2385202|NCT01429285|5854860|P2|Confirmation of no Duplicate Enrollment|Overall Study|2 patients were enrolled twice, at two separate ED visits, which was only noted at study conclusion|166
2385203|NCT01429285|5854861|P1|Confirmation of no Duplicate Enrollment|Overall Study|8 patients were enrolled twice at two separate ED visits, which was only noted at study conclusion.|153
2385204|NCT01429285|5854860|P2|Completed Primary Outcome Data|Overall Study|3 patients had missing data|168
2385205|NCT01429285|5854861|P1|Completed Primary Outcome Data|Overall Study|5 patients had missing data|161
2385206|NCT01429285|5854860|P2|Given IV Opioids|Overall Study|4 patients never given IV opioids|171
2385207|NCT01429285|5854861|P1|Given IV Opioids|Overall Study|9 patients never given IV opioids|166
2385208|NCT01429285|5854860|P2|STARTED|Overall Study||175
2385209|NCT01429285|5854861|P1|STARTED|Overall Study||175
2385210|NCT01429272|5854883|P4|NOT COMPLETED|Overall Study||5
2385211|NCT01429272|5854884|P3|NOT COMPLETED|Overall Study||4
2385212|NCT01429272|5854885|P2|NOT COMPLETED|Overall Study||9
2385213|NCT01429272|5854886|P1|NOT COMPLETED|Overall Study||6
2385214|NCT01429272|5854883|P4|COMPLETED|Overall Study||14
2385215|NCT01429272|5854884|P3|COMPLETED|Overall Study||15
2385216|NCT01429272|5854885|P2|COMPLETED|Overall Study||22
2385217|NCT01429272|5854886|P1|COMPLETED|Overall Study||24
2385218|NCT01429272|5854883|P4|STARTED|Overall Study||19
2385219|NCT01429272|5854884|P3|STARTED|Overall Study||19
2385220|NCT01429272|5854885|P2|STARTED|Overall Study||31
2385221|NCT01429272|5854886|P1|STARTED|Overall Study||30
2385222|NCT01429259|5854900|P1|NOT COMPLETED|Overall Study||0
2385223|NCT01429259|5854900|P1|COMPLETED|Overall Study||30
2385224|NCT01429259|5854900|P1|STARTED|Overall Study||30
2385225|NCT01429077|5854907|P2|NOT COMPLETED|Overall Study||3
2385226|NCT01429077|5854908|P1|NOT COMPLETED|Overall Study||0
2385227|NCT01429077|5854907|P2|COMPLETED|Overall Study||14
2385228|NCT01429077|5854908|P1|COMPLETED|Overall Study||19
2385229|NCT01429077|5854907|P2|Completed 6-week Intervention|Overall Study||17
2385230|NCT01429077|5854908|P1|Completed 6-week Intervention|Overall Study||19
2385231|NCT01429077|5854907|P2|STARTED|Overall Study||17
2385232|NCT01429077|5854908|P1|STARTED|Overall Study||19
2385233|NCT01429064|5854918|P4|NOT COMPLETED|Overall Study||0
2385234|NCT01429064|5854919|P3|NOT COMPLETED|Overall Study||0
2385235|NCT01429064|5854920|P2|NOT COMPLETED|Overall Study||0
2385236|NCT01429064|5854921|P1|NOT COMPLETED|Overall Study||0
2385237|NCT01429064|5854918|P4|COMPLETED|Overall Study||16
2385238|NCT01429064|5854919|P3|COMPLETED|Overall Study||19
2385239|NCT01429064|5854920|P2|COMPLETED|Overall Study||22
2385240|NCT01429064|5854921|P1|COMPLETED|Overall Study||19
2385241|NCT01429064|5854918|P4|STARTED|Overall Study||16
2385242|NCT01429064|5854919|P3|STARTED|Overall Study||19
2385243|NCT01429064|5854920|P2|STARTED|Overall Study||22
2385244|NCT01429064|5854921|P1|STARTED|Overall Study||19
2385245|NCT01429051|5854931|P1|NOT COMPLETED|Tolerability Phase||15
2385246|NCT01429051|5854931|P1|COMPLETED|Tolerability Phase||16
2385247|NCT01429051|5854931|P1|STARTED|Tolerability Phase|Participants entered directly from the Titration or Efficacy Phase|31
2385248|NCT01429051|5854931|P1|NOT COMPLETED|Efficacy Phase||2
2385249|NCT01429051|5854931|P1|COMPLETED|Efficacy Phase||13
2385250|NCT01429051|5854931|P1|STARTED|Efficacy Phase|Participants titrated to 200 or 400 μg INFS in Titration Phase|15
2385251|NCT01429051|5854931|P1|NOT COMPLETED|Titration Phase||12
2385252|NCT01429051|5854931|P1|COMPLETED|Titration Phase||33
2385253|NCT01429051|5854931|P1|STARTED|Titration Phase||45
2385254|NCT01428882|5854954|P2|NOT COMPLETED|Overall Study||10
2385255|NCT01428882|5854955|P1|NOT COMPLETED|Overall Study||6
2385256|NCT01428882|5854954|P2|COMPLETED|Overall Study||58
2385257|NCT01428882|5854955|P1|COMPLETED|Overall Study||61
2385258|NCT01428882|5854954|P2|STARTED|Overall Study||68
2385259|NCT01428882|5854955|P1|STARTED|Overall Study||67
2385260|NCT01428765|5854967|P1|NOT COMPLETED|Overall Study||0
2385261|NCT01428765|5854967|P1|COMPLETED|Overall Study||1063
2385262|NCT01428765|5854967|P1|STARTED|Overall Study||1063
2385263|NCT01428713|5854978|P2|NOT COMPLETED|Overall Study||5
2385264|NCT01428713|5854979|P1|NOT COMPLETED|Overall Study||3
2385265|NCT01428713|5854978|P2|COMPLETED|Overall Study||3
2385266|NCT01428713|5854979|P1|COMPLETED|Overall Study||6
2385267|NCT01428713|5854978|P2|STARTED|Overall Study||8
2385268|NCT01428713|5854979|P1|STARTED|Overall Study||9
2385269|NCT01428661|5854988|P3|NOT COMPLETED|Open Label Extension||320
2385270|NCT01428661|5854989|P2|NOT COMPLETED|Open Label Extension||0
2385271|NCT01428661|5854990|P1|NOT COMPLETED|Open Label Extension||0
2385272|NCT01428661|5854988|P3|COMPLETED|Open Label Extension||19
2385273|NCT01428661|5854989|P2|COMPLETED|Open Label Extension|Does not apply.|0
2385274|NCT01428661|5854990|P1|COMPLETED|Open Label Extension|Does not apply.|0
2385275|NCT01428661|5854988|P3|STARTED|Open Label Extension||339
2385276|NCT01428661|5854989|P2|STARTED|Open Label Extension|Does not apply.|0
2385277|NCT01428661|5854990|P1|STARTED|Open Label Extension|Does not apply.|0
2385278|NCT01428661|5854988|P3|NOT COMPLETED|Double-Masked Phase||0
2385279|NCT01428661|5854989|P2|NOT COMPLETED|Double-Masked Phase||49
2385280|NCT01428661|5854990|P1|NOT COMPLETED|Double-Masked Phase||57
2385281|NCT01428661|5854988|P3|COMPLETED|Double-Masked Phase|Does not apply.|0
2385282|NCT01428661|5854989|P2|COMPLETED|Double-Masked Phase||204
2385283|NCT01428661|5854990|P1|COMPLETED|Double-Masked Phase||197
2385284|NCT01428661|5854988|P3|STARTED|Double-Masked Phase|Does not apply.|0
2385285|NCT01428661|5854989|P2|STARTED|Double-Masked Phase||253
2385286|NCT01428661|5854990|P1|STARTED|Double-Masked Phase||254
2385287|NCT01428583|5854998|P1|NOT COMPLETED|Overall Study||237
2385288|NCT01428583|5854998|P1|COMPLETED|Overall Study||158
2385289|NCT01428583|5854998|P1|STARTED|Overall Study||395
2385290|NCT01428453|5855022|P2|NOT COMPLETED|Overall Study||9
2385291|NCT01428453|5855023|P1|NOT COMPLETED|Overall Study||6
2385292|NCT01428453|5855022|P2|COMPLETED|Overall Study||52
2385293|NCT01428453|5855023|P1|COMPLETED|Overall Study||56
2385294|NCT01428453|5855022|P2|STARTED|Overall Study||61
2385295|NCT01428453|5855023|P1|STARTED|Overall Study||62
2385296|NCT01428336|5855049|P2|NOT COMPLETED|Overall Study||0
2385297|NCT01428336|5855050|P1|NOT COMPLETED|Overall Study||0
2385298|NCT01428336|5855049|P2|COMPLETED|Overall Study||12
2385299|NCT01428336|5855050|P1|COMPLETED|Overall Study||10
2385300|NCT01428336|5855049|P2|STARTED|Overall Study||12
2385301|NCT01428336|5855050|P1|STARTED|Overall Study||10
2385302|NCT01428258|5855062|P2|NOT COMPLETED|Intervention 2||0
2385303|NCT01428258|5855063|P1|NOT COMPLETED|Intervention 2||0
2385304|NCT01428258|5855062|P2|COMPLETED|Intervention 2||15
2385305|NCT01428258|5855063|P1|COMPLETED|Intervention 2||15
2385306|NCT01428258|5855062|P2|STARTED|Intervention 2||15
2385307|NCT01428258|5855063|P1|STARTED|Intervention 2||15
2385308|NCT01428258|5855062|P2|NOT COMPLETED|Intervention 1||0
2385309|NCT01428258|5855063|P1|NOT COMPLETED|Intervention 1||2
2385310|NCT01428258|5855062|P2|COMPLETED|Intervention 1||15
2385311|NCT01428258|5855063|P1|COMPLETED|Intervention 1||15
2385312|NCT01428258|5855062|P2|STARTED|Intervention 1||15
2385313|NCT01428258|5855063|P1|STARTED|Intervention 1||17
2385314|NCT01428219|5855081|P1|NOT COMPLETED|Overall Study||3
2385315|NCT01428219|5855081|P1|COMPLETED|Overall Study||22
2385316|NCT01428219|5855081|P1|STARTED|Overall Study||25
2385317|NCT01428193|5855092|P1|NOT COMPLETED|Overall Study||2
2385318|NCT01428193|5855092|P1|COMPLETED|Overall Study||2
2385319|NCT01428193|5855092|P1|STARTED|Overall Study||4
2385320|NCT01428128|5855096|P1|NOT COMPLETED|Overall Study||17
2385321|NCT01428128|5855096|P1|COMPLETED|Overall Study||33
2385322|NCT01428128|5855096|P1|STARTED|Overall Study||50
2385323|NCT01428115|5855101|P1|NOT COMPLETED|Overall Study||21
2385324|NCT01428115|5855101|P1|COMPLETED|Overall Study||62
2385325|NCT01428115|5855101|P1|STARTED|Overall Study||83
2385326|NCT01428076|5855116|P2|NOT COMPLETED|Overall Study||1
2385327|NCT01428076|5855117|P1|NOT COMPLETED|Overall Study||0
2385328|NCT01428076|5855116|P2|COMPLETED|Overall Study||11
2385329|NCT01428076|5855117|P1|COMPLETED|Overall Study||9
2385330|NCT01428076|5855116|P2|STARTED|Overall Study||12
2385331|NCT01428076|5855117|P1|STARTED|Overall Study||9
2385332|NCT01428063|5855128|P3|NOT COMPLETED|Overall Study||1
2385333|NCT01428063|5855129|P2|NOT COMPLETED|Overall Study||10
2385334|NCT01428063|5855130|P1|NOT COMPLETED|Overall Study||10
2385335|NCT01428063|5855128|P3|COMPLETED|Overall Study||5
2385336|NCT01428063|5855129|P2|COMPLETED|Overall Study||112
2385337|NCT01428063|5855130|P1|COMPLETED|Overall Study||89
2385338|NCT01428063|5855128|P3|STARTED|Overall Study||6
2385339|NCT01428063|5855129|P2|STARTED|Overall Study||122
2385340|NCT01428063|5855130|P1|STARTED|Overall Study||99
2385341|NCT01428024|5855201|P2|NOT COMPLETED|Overall Study||1
2385342|NCT01428024|5855202|P1|NOT COMPLETED|Overall Study||1
2385343|NCT01428024|5855201|P2|COMPLETED|Overall Study||29
2385344|NCT01428024|5855202|P1|COMPLETED|Overall Study||29
2385345|NCT01428024|5855201|P2|STARTED|Overall Study||30
2385346|NCT01428024|5855202|P1|STARTED|Overall Study||30
2385347|NCT01427972|5855231|P12|NOT COMPLETED|Treatment Period 2 (21 Days)||0
2385348|NCT01427972|5855232|P11|NOT COMPLETED|Treatment Period 2 (21 Days)||0
2385349|NCT01427972|5855233|P10|NOT COMPLETED|Treatment Period 2 (21 Days)||0
2385350|NCT01427972|5855234|P9|NOT COMPLETED|Treatment Period 2 (21 Days)||0
2385351|NCT01427972|5855235|P8|NOT COMPLETED|Treatment Period 2 (21 Days)||0
2385352|NCT01427972|5855236|P7|NOT COMPLETED|Treatment Period 2 (21 Days)||0
2385353|NCT01427972|5855237|P6|NOT COMPLETED|Treatment Period 2 (21 Days)||0
2385354|NCT01427972|5855238|P5|NOT COMPLETED|Treatment Period 2 (21 Days)||0
2385355|NCT01427972|5855239|P4|NOT COMPLETED|Treatment Period 2 (21 Days)||0
2385356|NCT01427972|5855240|P3|NOT COMPLETED|Treatment Period 2 (21 Days)||0
2385357|NCT01427972|5855241|P2|NOT COMPLETED|Treatment Period 2 (21 Days)||1
2385358|NCT01427972|5855242|P1|NOT COMPLETED|Treatment Period 2 (21 Days)||0
2385359|NCT01427972|5855231|P12|COMPLETED|Treatment Period 2 (21 Days)||4
2385360|NCT01427972|5855232|P11|COMPLETED|Treatment Period 2 (21 Days)||3
2385361|NCT01427972|5855233|P10|COMPLETED|Treatment Period 2 (21 Days)||3
2385362|NCT01427972|5855234|P9|COMPLETED|Treatment Period 2 (21 Days)||3
2385363|NCT01427972|5855235|P8|COMPLETED|Treatment Period 2 (21 Days)||4
2385364|NCT01427972|5855236|P7|COMPLETED|Treatment Period 2 (21 Days)||3
2385365|NCT01427972|5855237|P6|COMPLETED|Treatment Period 2 (21 Days)||1
2385366|NCT01427972|5855238|P5|COMPLETED|Treatment Period 2 (21 Days)||4
2385367|NCT01427972|5855239|P4|COMPLETED|Treatment Period 2 (21 Days)||3
2385368|NCT01427972|5855240|P3|COMPLETED|Treatment Period 2 (21 Days)||4
2385369|NCT01427972|5855241|P2|COMPLETED|Treatment Period 2 (21 Days)||3
2385370|NCT01427972|5855242|P1|COMPLETED|Treatment Period 2 (21 Days)||3
2385371|NCT01427972|5855231|P12|STARTED|Treatment Period 2 (21 Days)||4
2385372|NCT01427972|5855232|P11|STARTED|Treatment Period 2 (21 Days)||3
2385373|NCT01427972|5855233|P10|STARTED|Treatment Period 2 (21 Days)||3
2385374|NCT01427972|5855234|P9|STARTED|Treatment Period 2 (21 Days)||3
2385375|NCT01427972|5855235|P8|STARTED|Treatment Period 2 (21 Days)||4
2385376|NCT01427972|5855236|P7|STARTED|Treatment Period 2 (21 Days)||3
2385377|NCT01427972|5855237|P6|STARTED|Treatment Period 2 (21 Days)||1
2385378|NCT01427972|5855238|P5|STARTED|Treatment Period 2 (21 Days)||4
2385379|NCT01427972|5855239|P4|STARTED|Treatment Period 2 (21 Days)||3
2385380|NCT01427972|5855240|P3|STARTED|Treatment Period 2 (21 Days)||4
2385381|NCT01427972|5855241|P2|STARTED|Treatment Period 2 (21 Days)||4
2385382|NCT01427972|5855242|P1|STARTED|Treatment Period 2 (21 Days)||3
2385383|NCT01427972|5855231|P12|NOT COMPLETED|Washout (at Least 28 Days)||0
2385384|NCT01427972|5855232|P11|NOT COMPLETED|Washout (at Least 28 Days)||0
2385385|NCT01427972|5855233|P10|NOT COMPLETED|Washout (at Least 28 Days)||0
2385386|NCT01427972|5855234|P9|NOT COMPLETED|Washout (at Least 28 Days)||0
2385387|NCT01427972|5855235|P8|NOT COMPLETED|Washout (at Least 28 Days)||0
2385388|NCT01427972|5855236|P7|NOT COMPLETED|Washout (at Least 28 Days)||0
2385389|NCT01427972|5855237|P6|NOT COMPLETED|Washout (at Least 28 Days)||2
2385390|NCT01427972|5855238|P5|NOT COMPLETED|Washout (at Least 28 Days)||0
2385391|NCT01427972|5855239|P4|NOT COMPLETED|Washout (at Least 28 Days)||0
2385392|NCT01427972|5855240|P3|NOT COMPLETED|Washout (at Least 28 Days)||0
2385393|NCT01427972|5855241|P2|NOT COMPLETED|Washout (at Least 28 Days)||0
2385394|NCT01427972|5855242|P1|NOT COMPLETED|Washout (at Least 28 Days)||0
2385395|NCT01427972|5855231|P12|COMPLETED|Washout (at Least 28 Days)||4
2385396|NCT01427972|5855232|P11|COMPLETED|Washout (at Least 28 Days)||3
2385397|NCT01427972|5855233|P10|COMPLETED|Washout (at Least 28 Days)||3
2385398|NCT01427972|5855234|P9|COMPLETED|Washout (at Least 28 Days)||3
2385399|NCT01427972|5855235|P8|COMPLETED|Washout (at Least 28 Days)||4
2385400|NCT01427972|5855236|P7|COMPLETED|Washout (at Least 28 Days)||3
2385401|NCT01427972|5855237|P6|COMPLETED|Washout (at Least 28 Days)||1
2385402|NCT01427972|5855238|P5|COMPLETED|Washout (at Least 28 Days)||4
2385403|NCT01427972|5855239|P4|COMPLETED|Washout (at Least 28 Days)||3
2385404|NCT01427972|5855240|P3|COMPLETED|Washout (at Least 28 Days)||4
2385405|NCT01427972|5855241|P2|COMPLETED|Washout (at Least 28 Days)||4
2385406|NCT01427972|5855242|P1|COMPLETED|Washout (at Least 28 Days)||3
2385407|NCT01427972|5855231|P12|STARTED|Washout (at Least 28 Days)||4
2385408|NCT01427972|5855232|P11|STARTED|Washout (at Least 28 Days)||3
2385409|NCT01427972|5855233|P10|STARTED|Washout (at Least 28 Days)||3
2385410|NCT01427972|5855234|P9|STARTED|Washout (at Least 28 Days)||3
2385411|NCT01427972|5855235|P8|STARTED|Washout (at Least 28 Days)||4
2385412|NCT01427972|5855236|P7|STARTED|Washout (at Least 28 Days)||3
2385413|NCT01427972|5855237|P6|STARTED|Washout (at Least 28 Days)||3
2385414|NCT01427972|5855238|P5|STARTED|Washout (at Least 28 Days)||4
2385415|NCT01427972|5855239|P4|STARTED|Washout (at Least 28 Days)||3
2385416|NCT01427972|5855240|P3|STARTED|Washout (at Least 28 Days)||4
2385417|NCT01427972|5855241|P2|STARTED|Washout (at Least 28 Days)||4
2385418|NCT01427972|5855242|P1|STARTED|Washout (at Least 28 Days)||3
2385419|NCT01427972|5855231|P12|NOT COMPLETED|Treatment Period 1 (21 Days)||0
2385420|NCT01427972|5855232|P11|NOT COMPLETED|Treatment Period 1 (21 Days)||0
2385421|NCT01427972|5855233|P10|NOT COMPLETED|Treatment Period 1 (21 Days)||0
2385422|NCT01427972|5855234|P9|NOT COMPLETED|Treatment Period 1 (21 Days)||0
2385423|NCT01427972|5855235|P8|NOT COMPLETED|Treatment Period 1 (21 Days)||1
2385424|NCT01427972|5855236|P7|NOT COMPLETED|Treatment Period 1 (21 Days)||0
2385425|NCT01427972|5855237|P6|NOT COMPLETED|Treatment Period 1 (21 Days)||0
2385426|NCT01427972|5855238|P5|NOT COMPLETED|Treatment Period 1 (21 Days)||0
2385427|NCT01427972|5855239|P4|NOT COMPLETED|Treatment Period 1 (21 Days)||0
2385428|NCT01427972|5855240|P3|NOT COMPLETED|Treatment Period 1 (21 Days)||0
2385429|NCT01427972|5855241|P2|NOT COMPLETED|Treatment Period 1 (21 Days)||0
2385430|NCT01427972|5855242|P1|NOT COMPLETED|Treatment Period 1 (21 Days)||0
2385431|NCT01427972|5855231|P12|COMPLETED|Treatment Period 1 (21 Days)||4
2385432|NCT01427972|5855232|P11|COMPLETED|Treatment Period 1 (21 Days)||3
2385433|NCT01427972|5855233|P10|COMPLETED|Treatment Period 1 (21 Days)||3
2385434|NCT01427972|5855234|P9|COMPLETED|Treatment Period 1 (21 Days)||3
2385435|NCT01427972|5855235|P8|COMPLETED|Treatment Period 1 (21 Days)||4
2385436|NCT01427972|5855236|P7|COMPLETED|Treatment Period 1 (21 Days)||3
2385437|NCT01427972|5855237|P6|COMPLETED|Treatment Period 1 (21 Days)||3
2385438|NCT01427972|5855238|P5|COMPLETED|Treatment Period 1 (21 Days)||4
2385439|NCT01427972|5855239|P4|COMPLETED|Treatment Period 1 (21 Days)||3
2385440|NCT01427972|5855240|P3|COMPLETED|Treatment Period 1 (21 Days)||4
2385441|NCT01427972|5855241|P2|COMPLETED|Treatment Period 1 (21 Days)||4
2385442|NCT01427972|5855242|P1|COMPLETED|Treatment Period 1 (21 Days)||3
2385443|NCT01427972|5855231|P12|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
2385444|NCT01427972|5855232|P11|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
2385445|NCT01427972|5855233|P10|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
2385446|NCT01427972|5855234|P9|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
2385447|NCT01427972|5855235|P8|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||5
2385448|NCT01427972|5855236|P7|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
2385449|NCT01427972|5855237|P6|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
2385450|NCT01427972|5855238|P5|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
2385451|NCT01427972|5855239|P4|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
2385452|NCT01427972|5855240|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
2385453|NCT01427972|5855241|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
2385454|NCT01427972|5855242|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
2385455|NCT01427972|5855231|P12|STARTED|Treatment Period 1 (21 Days)||4
2385456|NCT01427972|5855232|P11|STARTED|Treatment Period 1 (21 Days)||3
2385457|NCT01427972|5855233|P10|STARTED|Treatment Period 1 (21 Days)||3
2385458|NCT01427972|5855234|P9|STARTED|Treatment Period 1 (21 Days)||3
2385459|NCT01427972|5855235|P8|STARTED|Treatment Period 1 (21 Days)||5
2385460|NCT01427972|5855236|P7|STARTED|Treatment Period 1 (21 Days)||3
2385461|NCT01427972|5855237|P6|STARTED|Treatment Period 1 (21 Days)||3
2385462|NCT01427972|5855238|P5|STARTED|Treatment Period 1 (21 Days)||4
2385463|NCT01427972|5855239|P4|STARTED|Treatment Period 1 (21 Days)||3
2385464|NCT01427972|5855240|P3|STARTED|Treatment Period 1 (21 Days)||4
2385465|NCT01427972|5855241|P2|STARTED|Treatment Period 1 (21 Days)||4
2385466|NCT01427972|5855242|P1|STARTED|Treatment Period 1 (21 Days)||3
2385467|NCT01427933|5855268|P2|NOT COMPLETED|Overall Study||13
2385468|NCT01427933|5855269|P1|NOT COMPLETED|Overall Study||8
2385469|NCT01427933|5855268|P2|COMPLETED|Overall Study||57
2385470|NCT01427933|5855269|P1|COMPLETED|Overall Study||63
2385471|NCT01427933|5855268|P2|Received at Least 1 Dose of Study Drug|Overall Study||65
2385472|NCT01427933|5855269|P1|Received at Least 1 Dose of Study Drug|Overall Study||69
2385473|NCT01427933|5855268|P2|STARTED|Overall Study||70
2385474|NCT01427933|5855269|P1|STARTED|Overall Study||71
2385475|NCT01427920|5855289|P2|NOT COMPLETED|Overall Study||17
2385476|NCT01427920|5855290|P1|NOT COMPLETED|Overall Study||9
2385477|NCT01427920|5855289|P2|COMPLETED|Overall Study||157
2385478|NCT01427920|5855290|P1|COMPLETED|Overall Study||165
2385479|NCT01427920|5855289|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|173
2385480|NCT01427920|5855290|P1|Exposed|Overall Study||174
2385481|NCT01427920|5855289|P2|STARTED|Overall Study||174
2385482|NCT01427920|5855290|P1|STARTED|Overall Study||174
2385483|NCT01427907|5855310|P2|NOT COMPLETED|Overall Study||4
2385484|NCT01427907|5855311|P1|NOT COMPLETED|Overall Study||3
2385485|NCT01427907|5855310|P2|COMPLETED|Overall Study|Completed study|14
2385486|NCT01427907|5855311|P1|COMPLETED|Overall Study|Completed study|17
2385487|NCT01427907|5855310|P2|STARTED|Overall Study|Randomized|18
2385488|NCT01427907|5855311|P1|STARTED|Overall Study|Randomized|20
2385489|NCT01427881|5855317|P1|NOT COMPLETED|Overall Study||0
2385490|NCT01427881|5855317|P1|COMPLETED|Overall Study||43
2385491|NCT01427881|5855317|P1|STARTED|Overall Study||43
2385492|NCT01427803|5855332|P2|NOT COMPLETED|Overall Study||26
2385493|NCT01427803|5855333|P1|NOT COMPLETED|Overall Study||63
2385494|NCT01427803|5855332|P2|COMPLETED|Overall Study|130 participants interviewed. Remaining subjects continued in trial to collect safety information.|226
2385495|NCT01427803|5855333|P1|COMPLETED|Overall Study||463
2385496|NCT01427803|5855332|P2|Took Product|Overall Study|Those who took at least one dose of investigational product as logged in e diary & 1 on Health Log.|237
2385497|NCT01427803|5855333|P1|Took Product|Overall Study|Those who took at least one dose of investigational product. Only 502 qualified for data analysis.|508
2385498|NCT01427803|5855332|P2|Baseline Assessment|Overall Study|only interviewed participants were assessed|130
2385499|NCT01427803|5855333|P1|Baseline Assessment|Overall Study||516
2385500|NCT01427803|5855332|P2|Purchased Product|Overall Study||252
2385501|NCT01427803|5855333|P1|Purchased Product|Overall Study|Only 516 participants used e-diary|525
2385502|NCT01427803|5855332|P2|STARTED|Overall Study||252
2385503|NCT01427803|5855333|P1|STARTED|Overall Study||526
2385504|NCT01427751|5855347|P2|NOT COMPLETED|Overall Study||14
2385505|NCT01427751|5855348|P1|NOT COMPLETED|Overall Study||42
2385506|NCT01427751|5855347|P2|COMPLETED|Overall Study||139
2385507|NCT01427751|5855348|P1|COMPLETED|Overall Study||112
2385508|NCT01427751|5855347|P2|STARTED|Overall Study||153
2385509|NCT01427751|5855348|P1|STARTED|Overall Study||154
2385510|NCT01427738|5855368|P2|NOT COMPLETED|Overall Study||21
2385511|NCT01427738|5855369|P1|NOT COMPLETED|Overall Study||19
2385512|NCT01427738|5855368|P2|COMPLETED|Overall Study||90
2385513|NCT01427738|5855369|P1|COMPLETED|Overall Study||91
2385514|NCT01427738|5855368|P2|STARTED|Overall Study||111
2385515|NCT01427738|5855369|P1|STARTED|Overall Study||110
2385516|NCT01427608|5855389|P2|NOT COMPLETED|Overall Study||38
2385517|NCT01427608|5855390|P1|NOT COMPLETED|Overall Study||21
2385518|NCT01427608|5855389|P2|COMPLETED|Overall Study||24
2385519|NCT01427608|5855390|P1|COMPLETED|Overall Study||43
2385520|NCT01427608|5855389|P2|STARTED|Overall Study||62
2385521|NCT01427608|5855390|P1|STARTED|Overall Study||64
2385522|NCT01427517|5855405|P3|NOT COMPLETED|Overall Study||0
2385523|NCT01427517|5855406|P2|NOT COMPLETED|Overall Study||0
2385524|NCT01427517|5855407|P1|NOT COMPLETED|Overall Study||0
2385525|NCT01427517|5855405|P3|COMPLETED|Overall Study||3
2385526|NCT01427517|5855406|P2|COMPLETED|Overall Study||3
2385527|NCT01427517|5855407|P1|COMPLETED|Overall Study||3
2385528|NCT01427517|5855405|P3|STARTED|Overall Study||3
2385529|NCT01427517|5855406|P2|STARTED|Overall Study||3
2385530|NCT01427517|5855407|P1|STARTED|Overall Study||3
2385531|NCT01427504|5855421|P6|NOT COMPLETED|Overall Study||2
2385532|NCT01427504|5855422|P5|NOT COMPLETED|Overall Study||1
2385533|NCT01427504|5855423|P4|NOT COMPLETED|Overall Study||1
2385534|NCT01427504|5855424|P3|NOT COMPLETED|Overall Study||1
2385535|NCT01427504|5855425|P2|NOT COMPLETED|Overall Study||1
2385536|NCT01427504|5855426|P1|NOT COMPLETED|Overall Study||0
2385537|NCT01427504|5855421|P6|COMPLETED|Overall Study||4
2385538|NCT01427504|5855422|P5|COMPLETED|Overall Study||2
2385539|NCT01427504|5855423|P4|COMPLETED|Overall Study||5
2385540|NCT01427504|5855424|P3|COMPLETED|Overall Study||3
2385541|NCT01427504|5855425|P2|COMPLETED|Overall Study||2
2385542|NCT01427504|5855426|P1|COMPLETED|Overall Study||4
2385543|NCT01427504|5855421|P6|Received Combination|Overall Study||6
2385544|NCT01427504|5855422|P5|Received Combination|Overall Study||3
2385545|NCT01427504|5855423|P4|Received Combination|Overall Study||6
2385546|NCT01427504|5855424|P3|Received Combination|Overall Study||3
2385547|NCT01427504|5855425|P2|Received Combination|Overall Study||3
2385548|NCT01427504|5855426|P1|Received Combination|Overall Study||4
2385549|NCT01427504|5855421|P6|Received Etravirine|Overall Study||4
2385550|NCT01427504|5855422|P5|Received Etravirine|Overall Study||2
2385551|NCT01427504|5855423|P4|Received Etravirine|Overall Study||6
2385552|NCT01427504|5855424|P3|Received Etravirine|Overall Study||4
2385553|NCT01427504|5855425|P2|Received Etravirine|Overall Study||2
2385554|NCT01427504|5855426|P1|Received Etravirine|Overall Study||4
2385555|NCT01427504|5855421|P6|Received Boceprevir|Overall Study||4
2385556|NCT01427504|5855422|P5|Received Boceprevir|Overall Study||2
2385557|NCT01427504|5855423|P4|Received Boceprevir|Overall Study||5
2385558|NCT01427504|5855424|P3|Received Boceprevir|Overall Study||3
2385559|NCT01427504|5855425|P2|Received Boceprevir|Overall Study||3
2385560|NCT01427504|5855426|P1|Received Boceprevir|Overall Study||4
2385561|NCT01427504|5855421|P6|STARTED|Overall Study||6
2385562|NCT01427504|5855422|P5|STARTED|Overall Study||3
2385563|NCT01427504|5855423|P4|STARTED|Overall Study||6
2385564|NCT01427504|5855424|P3|STARTED|Overall Study||4
2385565|NCT01427504|5855425|P2|STARTED|Overall Study||3
2385566|NCT01427504|5855426|P1|STARTED|Overall Study||4
2385567|NCT01427309|5855447|P4|NOT COMPLETED|Overall Study||376
2385568|NCT01427309|5855448|P3|NOT COMPLETED|Overall Study||361
2385569|NCT01427309|5855449|P2|NOT COMPLETED|Overall Study||407
2385570|NCT01427309|5855450|P1|NOT COMPLETED|Overall Study||372
2385571|NCT01427309|5855447|P4|COMPLETED|Overall Study||8373
2385572|NCT01427309|5855448|P3|COMPLETED|Overall Study||8376
2385573|NCT01427309|5855449|P2|COMPLETED|Overall Study||6837
2385574|NCT01427309|5855450|P1|COMPLETED|Overall Study||6881
2385575|NCT01427309|5855447|P4|STARTED|Overall Study||8749
2385576|NCT01427309|5855448|P3|STARTED|Overall Study||8737
2385577|NCT01427309|5855449|P2|STARTED|Overall Study||7244
2385578|NCT01427309|5855450|P1|STARTED|Overall Study||7253
2385579|NCT01427296|5855490|P2|NOT COMPLETED|Overall Study||0
2385580|NCT01427296|5855491|P1|NOT COMPLETED|Overall Study||0
2385581|NCT01427296|5855490|P2|COMPLETED|Overall Study||1051
2385582|NCT01427296|5855491|P1|COMPLETED|Overall Study||1041
2385583|NCT01427296|5855490|P2|STARTED|Overall Study||1051
2385584|NCT01427296|5855491|P1|STARTED|Overall Study||1041
2385585|NCT01426958|5855497|P1|NOT COMPLETED|Overall Study||2
2385586|NCT01426958|5855497|P1|COMPLETED|Overall Study||22
2385587|NCT01426958|5855497|P1|STARTED|Overall Study||24
2385588|NCT01426867|5855514|P3|NOT COMPLETED|Overall Study||0
2385589|NCT01426867|5855515|P2|NOT COMPLETED|Overall Study||0
2385590|NCT01426867|5855516|P1|NOT COMPLETED|Overall Study||0
2385591|NCT01426867|5855514|P3|COMPLETED|Overall Study||34
2385592|NCT01426867|5855515|P2|COMPLETED|Overall Study||34
2385593|NCT01426867|5855516|P1|COMPLETED|Overall Study||33
2385594|NCT01426867|5855514|P3|STARTED|Overall Study||34
2385595|NCT01426867|5855515|P2|STARTED|Overall Study||34
2385596|NCT01426867|5855516|P1|STARTED|Overall Study||33
2385597|NCT01426854|5855526|P2|NOT COMPLETED|Overall Study||31
2385598|NCT01426854|5855527|P1|NOT COMPLETED|Overall Study||12
2385599|NCT01426854|5855526|P2|COMPLETED|Overall Study||98
2385600|NCT01426854|5855527|P1|COMPLETED|Overall Study||119
2385601|NCT01426854|5855526|P2|STARTED|Overall Study||129
2385602|NCT01426854|5855527|P1|STARTED|Overall Study||131
2385603|NCT01426789|5855537|P6|NOT COMPLETED|Part 2||0
2385604|NCT01426789|5855538|P5|NOT COMPLETED|Part 2||8
2385605|NCT01426789|5855539|P4|NOT COMPLETED|Part 2||1
2385606|NCT01426789|5855540|P3|NOT COMPLETED|Part 2||15
2385607|NCT01426789|5855541|P2|NOT COMPLETED|Part 2||0
2385608|NCT01426789|5855542|P1|NOT COMPLETED|Part 2||0
2385609|NCT01426789|5855537|P6|COMPLETED|Part 2||1
2385610|NCT01426789|5855538|P5|COMPLETED|Part 2||19
2385611|NCT01426789|5855539|P4|COMPLETED|Part 2||12
2385612|NCT01426789|5855540|P3|COMPLETED|Part 2||34
2385613|NCT01426789|5855541|P2|COMPLETED|Part 2||0
2385614|NCT01426789|5855542|P1|COMPLETED|Part 2||0
2385615|NCT01426789|5855537|P6|STARTED|Part 2||1
2385616|NCT01426789|5855538|P5|STARTED|Part 2||27
2385617|NCT01426789|5855539|P4|STARTED|Part 2||13
2385618|NCT01426789|5855540|P3|STARTED|Part 2||49
2385619|NCT01426789|5855541|P2|STARTED|Part 2||0
2385620|NCT01426789|5855542|P1|STARTED|Part 2||0
2385621|NCT01426789|5855537|P6|NOT COMPLETED|Part 1||0
2385622|NCT01426789|5855538|P5|NOT COMPLETED|Part 1||0
2385623|NCT01426789|5855539|P4|NOT COMPLETED|Part 1||0
2385624|NCT01426789|5855540|P3|NOT COMPLETED|Part 1||0
2385625|NCT01426789|5855541|P2|NOT COMPLETED|Part 1||4
2385626|NCT01426789|5855542|P1|NOT COMPLETED|Part 1||6
2385627|NCT01426789|5855537|P6|COMPLETED|Part 1||0
2385628|NCT01426789|5855538|P5|COMPLETED|Part 1||0
2385629|NCT01426789|5855539|P4|COMPLETED|Part 1||0
2385630|NCT01426789|5855540|P3|COMPLETED|Part 1||0
2385631|NCT01426789|5855541|P2|COMPLETED|Part 1||28
2385632|NCT01426789|5855542|P1|COMPLETED|Part 1||62
2385633|NCT01426789|5855537|P6|STARTED|Part 1||0
2385634|NCT01426789|5855538|P5|STARTED|Part 1||0
2385635|NCT01426789|5855539|P4|STARTED|Part 1||0
2385636|NCT01426789|5855540|P3|STARTED|Part 1||0
2385637|NCT01426789|5855541|P2|STARTED|Part 1||32
2385638|NCT01426789|5855542|P1|STARTED|Part 1||68
2385639|NCT01426763|5855558|P2|NOT COMPLETED|Overall Study||0
2385640|NCT01426763|5855559|P1|NOT COMPLETED|Overall Study||0
2385641|NCT01426763|5855558|P2|COMPLETED|Overall Study||6
2385642|NCT01426763|5855559|P1|COMPLETED|Overall Study||6
2385643|NCT01426763|5855558|P2|STARTED|Overall Study||6
2385644|NCT01426763|5855559|P1|STARTED|Overall Study||6
2385645|NCT01426581|5855567|P2|NOT COMPLETED|Overall Study||0
2385646|NCT01426581|5855568|P1|NOT COMPLETED|Overall Study||0
2385647|NCT01426581|5855567|P2|COMPLETED|Overall Study||58
2385648|NCT01426581|5855568|P1|COMPLETED|Overall Study||62
2385649|NCT01426581|5855567|P2|STARTED|Overall Study||58
2385650|NCT01426581|5855568|P1|STARTED|Overall Study||62
2385651|NCT01426555|5855584|P2|NOT COMPLETED|Overall Study||15
2385652|NCT01426555|5855585|P1|NOT COMPLETED|Overall Study||18
2385653|NCT01426555|5855584|P2|COMPLETED|Overall Study||20
2385654|NCT01426555|5855585|P1|COMPLETED|Overall Study||17
2385655|NCT01426555|5855584|P2|STARTED|Overall Study||35
2385656|NCT01426555|5855585|P1|STARTED|Overall Study||35
2385657|NCT01426516|5855595|P2|NOT COMPLETED|Overall Study||0
2385658|NCT01426516|5855596|P1|NOT COMPLETED|Overall Study||0
2385659|NCT01426516|5855595|P2|COMPLETED|Overall Study||17
2385660|NCT01426516|5855596|P1|COMPLETED|Overall Study||12
2385661|NCT01426516|5855595|P2|STARTED|Overall Study||17
2385662|NCT01426516|5855596|P1|STARTED|Overall Study||12
2385663|NCT01426438|5855604|P2|NOT COMPLETED|Overall Study||10
2385664|NCT01426438|5855605|P1|NOT COMPLETED|Overall Study||15
2385665|NCT01426438|5855604|P2|COMPLETED|Overall Study||39
2385666|NCT01426438|5855605|P1|COMPLETED|Overall Study||35
2385667|NCT01426438|5855604|P2|STARTED|Overall Study||49
2385668|NCT01426438|5855605|P1|STARTED|Overall Study||50
2385669|NCT01426425|5855637|P1|NOT COMPLETED|Overall Study||175
2385670|NCT01426425|5855637|P1|COMPLETED|Overall Study|The pre-specified modified intent-to-treat analysis set was used for the primary objectives.|397
2385671|NCT01426425|5855637|P1|Intent to Treat|Overall Study|Met all inclusion and no exclusion criteria.|399
2385672|NCT01426425|5855637|P1|EP Study|Overall Study|EP study used to assess inclusion and exclusion criteria.|550
2385673|NCT01426425|5855637|P1|STARTED|Overall Study||572
2385674|NCT01426412|5855652|P9|NOT COMPLETED|Overall Study||1
2385675|NCT01426412|5855653|P8|NOT COMPLETED|Overall Study||3
2385676|NCT01426412|5855654|P7|NOT COMPLETED|Overall Study||0
2385677|NCT01426412|5855655|P6|NOT COMPLETED|Overall Study||0
2385678|NCT01426412|5855656|P5|NOT COMPLETED|Overall Study||1
2385679|NCT01426412|5855657|P4|NOT COMPLETED|Overall Study||0
2385680|NCT01426412|5855658|P3|NOT COMPLETED|Overall Study||0
2385681|NCT01426412|5855659|P2|NOT COMPLETED|Overall Study||0
2385682|NCT01426412|5855660|P1|NOT COMPLETED|Overall Study||1
2385683|NCT01426412|5855652|P9|COMPLETED|Overall Study||16
2385684|NCT01426412|5855653|P8|COMPLETED|Overall Study||7
2385685|NCT01426412|5855654|P7|COMPLETED|Overall Study||6
2385686|NCT01426412|5855655|P6|COMPLETED|Overall Study||6
2385687|NCT01426412|5855656|P5|COMPLETED|Overall Study||5
2385688|NCT01426412|5855657|P4|COMPLETED|Overall Study||6
2385689|NCT01426412|5855658|P3|COMPLETED|Overall Study||6
2385690|NCT01426412|5855659|P2|COMPLETED|Overall Study||6
2385691|NCT01426412|5855660|P1|COMPLETED|Overall Study||5
2385692|NCT01426412|5855652|P9|Received at Least 1 Dose of Study Drug|Overall Study||17
2385693|NCT01426412|5855653|P8|Received at Least 1 Dose of Study Drug|Overall Study||10
2385694|NCT01426412|5855654|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
2385695|NCT01426412|5855655|P6|Received at Least 1 Dose of Study Drug|Overall Study||6
2385696|NCT01426412|5855656|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
2385697|NCT01426412|5855657|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
2385698|NCT01426412|5855658|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
2385699|NCT01426412|5855659|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
2385700|NCT01426412|5855660|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
2385701|NCT01426412|5855652|P9|STARTED|Overall Study||17
2385702|NCT01426412|5855653|P8|STARTED|Overall Study||10
2385703|NCT01426412|5855654|P7|STARTED|Overall Study||6
2385704|NCT01426412|5855655|P6|STARTED|Overall Study||6
2385705|NCT01426412|5855656|P5|STARTED|Overall Study||6
2385706|NCT01426412|5855657|P4|STARTED|Overall Study||6
2385707|NCT01426412|5855658|P3|STARTED|Overall Study||6
2385708|NCT01426412|5855659|P2|STARTED|Overall Study||6
2385709|NCT01426412|5855660|P1|STARTED|Overall Study||6
2385710|NCT01426386|5855723|P6|NOT COMPLETED|Overall Study||1
2385711|NCT01426386|5855724|P5|NOT COMPLETED|Overall Study||4
2385712|NCT01426386|5855725|P4|NOT COMPLETED|Overall Study||0
2385713|NCT01426386|5855726|P3|NOT COMPLETED|Overall Study||2
2385714|NCT01426386|5855727|P2|NOT COMPLETED|Overall Study||6
2385715|NCT01426386|5855728|P1|NOT COMPLETED|Overall Study||3
2385716|NCT01426386|5855723|P6|COMPLETED|Overall Study||42
2385717|NCT01426386|5855724|P5|COMPLETED|Overall Study||43
2385718|NCT01426386|5855725|P4|COMPLETED|Overall Study||44
2385719|NCT01426386|5855726|P3|COMPLETED|Overall Study||42
2385720|NCT01426386|5855727|P2|COMPLETED|Overall Study||39
2385721|NCT01426386|5855728|P1|COMPLETED|Overall Study||39
2385722|NCT01426386|5855723|P6|STARTED|Overall Study||43
2385723|NCT01426386|5855724|P5|STARTED|Overall Study||47
2385724|NCT01426386|5855725|P4|STARTED|Overall Study||44
2385725|NCT01426386|5855726|P3|STARTED|Overall Study||44
2385726|NCT01426386|5855727|P2|STARTED|Overall Study||45
2385727|NCT01426386|5855728|P1|STARTED|Overall Study||42
2385728|NCT01426373|5855784|P1|NOT COMPLETED|Overall Study||34
2385729|NCT01426373|5855784|P1|COMPLETED|Overall Study|Completed the last follow-up visit 12 months after last treatment|131
2385730|NCT01426373|5855784|P1|STARTED|Overall Study||165
2385731|NCT01426360|5855802|P2|NOT COMPLETED|Overall Study||0
2385732|NCT01426360|5855803|P1|NOT COMPLETED|Overall Study||0
2385733|NCT01426360|5855802|P2|COMPLETED|Overall Study||41
2385734|NCT01426360|5855803|P1|COMPLETED|Overall Study||38
2385735|NCT01426360|5855802|P2|STARTED|Overall Study||41
2385736|NCT01426360|5855803|P1|STARTED|Overall Study||38
2385737|NCT01426347|5855817|P2|NOT COMPLETED|Overall Study||3
2385738|NCT01426347|5855818|P1|NOT COMPLETED|Overall Study||7
2385739|NCT01426347|5855817|P2|COMPLETED|Overall Study||39
2385740|NCT01426347|5855818|P1|COMPLETED|Overall Study||34
2385741|NCT01426347|5855817|P2|STARTED|Overall Study||42
2385742|NCT01426347|5855818|P1|STARTED|Overall Study||41
2385743|NCT01426269|5855826|P3|NOT COMPLETED|Period 2: 40 Weeks||47
2385744|NCT01426269|5855827|P2|NOT COMPLETED|Period 2: 40 Weeks||38
2385745|NCT01426269|5855828|P1|NOT COMPLETED|Period 2: 40 Weeks||0
2385746|NCT01426269|5855826|P3|COMPLETED|Period 2: 40 Weeks||18
2385747|NCT01426269|5855827|P2|COMPLETED|Period 2: 40 Weeks||27
2385748|NCT01426269|5855828|P1|COMPLETED|Period 2: 40 Weeks||0
2385749|NCT01426269|5855826|P3|STARTED|Period 2: 40 Weeks||65
2385750|NCT01426269|5855827|P2|STARTED|Period 2: 40 Weeks||65
2385751|NCT01426269|5855828|P1|STARTED|Period 2: 40 Weeks||0
2385752|NCT01426269|5855826|P3|NOT COMPLETED|Eligibility for Period 2, Randomization||0
2385753|NCT01426269|5855827|P2|NOT COMPLETED|Eligibility for Period 2, Randomization||0
2385754|NCT01426269|5855828|P1|NOT COMPLETED|Eligibility for Period 2, Randomization||50
2385755|NCT01426269|5855826|P3|COMPLETED|Eligibility for Period 2, Randomization||0
2385756|NCT01426269|5855827|P2|COMPLETED|Eligibility for Period 2, Randomization||0
2385757|NCT01426269|5855828|P1|COMPLETED|Eligibility for Period 2, Randomization||130
2385758|NCT01426269|5855826|P3|STARTED|Eligibility for Period 2, Randomization||0
2385759|NCT01426269|5855827|P2|STARTED|Eligibility for Period 2, Randomization||0
2385760|NCT01426269|5855828|P1|STARTED|Eligibility for Period 2, Randomization||180
2385761|NCT01426269|5855826|P3|NOT COMPLETED|Period 1: 12 Weeks||0
2385762|NCT01426269|5855827|P2|NOT COMPLETED|Period 1: 12 Weeks||0
2385763|NCT01426269|5855828|P1|NOT COMPLETED|Period 1: 12 Weeks||55
2385764|NCT01426269|5855826|P3|COMPLETED|Period 1: 12 Weeks||0
2385765|NCT01426269|5855827|P2|COMPLETED|Period 1: 12 Weeks||0
2385766|NCT01426269|5855828|P1|COMPLETED|Period 1: 12 Weeks||180
2385767|NCT01426269|5855826|P3|STARTED|Period 1: 12 Weeks||0
2385768|NCT01426269|5855827|P2|STARTED|Period 1: 12 Weeks||0
2385769|NCT01426269|5855828|P1|STARTED|Period 1: 12 Weeks||235
2385770|NCT01426230|5855855|P2|NOT COMPLETED|Overall Study||27
2385771|NCT01426230|5855856|P1|NOT COMPLETED|Overall Study||31
2385772|NCT01426230|5855855|P2|COMPLETED|Overall Study||84
2385773|NCT01426230|5855856|P1|COMPLETED|Overall Study||55
2385774|NCT01426230|5855855|P2|STARTED|Overall Study||111
2385775|NCT01426230|5855856|P1|STARTED|Overall Study|90 patients were enrolled, but only 86 received study treatment.|86
2385776|NCT01426217|5855863|P2|NOT COMPLETED|Overall Study||14
2385777|NCT01426217|5855864|P1|NOT COMPLETED|Overall Study||8
2385778|NCT01426217|5855863|P2|COMPLETED|Overall Study||266
2385779|NCT01426217|5855864|P1|COMPLETED|Overall Study||306
2385780|NCT01426217|5855863|P2|STARTED|Overall Study||280
2385781|NCT01426217|5855864|P1|STARTED|Overall Study||314
2385782|NCT01426191|5855870|P1|NOT COMPLETED|Overall Study||0
2385783|NCT01426191|5855870|P1|COMPLETED|Overall Study||2032
2385784|NCT01426191|5855870|P1|STARTED|Overall Study||2032
2385785|NCT01426113|5855877|P2|NOT COMPLETED|Overall Study||2
2385786|NCT01426113|5855878|P1|NOT COMPLETED|Overall Study||1
2385787|NCT01426113|5855877|P2|COMPLETED|Overall Study||1
2385788|NCT01426113|5855878|P1|COMPLETED|Overall Study||2
2385789|NCT01426113|5855877|P2|STARTED|Overall Study||3
2385790|NCT01426113|5855878|P1|STARTED|Overall Study||3
2385791|NCT01426009|5855884|P1|NOT COMPLETED|Washout 4||1
2385792|NCT01426009|5855884|P1|COMPLETED|Washout 4||126
2385793|NCT01426009|5855884|P1|STARTED|Washout 4||127
2385794|NCT01426009|5855884|P1|NOT COMPLETED|Period 4-Fourth Intervention (7 Days)||1
2385795|NCT01426009|5855884|P1|COMPLETED|Period 4-Fourth Intervention (7 Days)||127
2385796|NCT01426009|5855884|P1|Placebo|Period 4-Fourth Intervention (7 Days)||10
2385797|NCT01426009|5855884|P1|Tiotropium Bromide|Period 4-Fourth Intervention (7 Days)||76
2385798|NCT01426009|5855884|P1|Ipratropium Bromide|Period 4-Fourth Intervention (7 Days)||8
2385799|NCT01426009|5855884|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||9
2385800|NCT01426009|5855884|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||8
2385801|NCT01426009|5855884|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||7
2385802|NCT01426009|5855884|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||10
2385803|NCT01426009|5855884|P1|STARTED|Period 4-Fourth Intervention (7 Days)||128
2385804|NCT01426009|5855884|P1|NOT COMPLETED|Washout 3||1
2385805|NCT01426009|5855884|P1|COMPLETED|Washout 3||128
2385806|NCT01426009|5855884|P1|STARTED|Washout 3||129
2385807|NCT01426009|5855884|P1|NOT COMPLETED|Period 3-Third Intervention (7 Days)||0
2385808|NCT01426009|5855884|P1|COMPLETED|Period 3-Third Intervention (7 Days)||129
2385809|NCT01426009|5855884|P1|Placebo|Period 3-Third Intervention (7 Days)||22
2385810|NCT01426009|5855884|P1|Ipratropium Bromide|Period 3-Third Intervention (7 Days)||23
2385811|NCT01426009|5855884|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||20
2385812|NCT01426009|5855884|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||22
2385813|NCT01426009|5855884|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||23
2385814|NCT01426009|5855884|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||19
2385815|NCT01426009|5855884|P1|STARTED|Period 3-Third Intervention (7 Days)||129
2385816|NCT01426009|5855884|P1|NOT COMPLETED|Washout 2||1
2385817|NCT01426009|5855884|P1|COMPLETED|Washout 2||129
2385818|NCT01426009|5855884|P1|STARTED|Washout 2||130
2385819|NCT01426009|5855884|P1|NOT COMPLETED|Period 2-Second Intervention (7 Days)||5
2385820|NCT01426009|5855884|P1|COMPLETED|Period 2-Second Intervention (7 Days)||130
2385821|NCT01426009|5855884|P1|Placebo|Period 2-Second Intervention (7 Days)||21
2385822|NCT01426009|5855884|P1|Ipratropium Bromide|Period 2-Second Intervention (7 Days)||21
2385823|NCT01426009|5855884|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||23
2385824|NCT01426009|5855884|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24
2385825|NCT01426009|5855884|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24
2385826|NCT01426009|5855884|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||22
2385827|NCT01426009|5855884|P1|STARTED|Period 2-Second Intervention (7 Days)||135
2385828|NCT01426009|5855884|P1|NOT COMPLETED|Washout 1||2
2385829|NCT01426009|5855884|P1|COMPLETED|Washout 1||135
2385830|NCT01426009|5855884|P1|STARTED|Washout 1||137
2385831|NCT01426009|5855884|P1|NOT COMPLETED|Period 1-First Intervention (7 Days)||2
2385832|NCT01426009|5855884|P1|COMPLETED|Period 1-First Intervention (7 Days)||137
2385833|NCT01426009|5855884|P1|Placebo|Period 1-First Intervention (7 Days)||24
2385834|NCT01426009|5855884|P1|Ipratropium Bromide|Period 1-First Intervention (7 Days)||23
2385835|NCT01426009|5855884|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23
2385836|NCT01426009|5855884|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||22
2385837|NCT01426009|5855884|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||24
2385838|NCT01426009|5855884|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23
2385839|NCT01426009|5855884|P1|STARTED|Period 1-First Intervention (7 Days)||139
2385840|NCT01425879|5855940|P1|NOT COMPLETED|Overall Study||0
2385841|NCT01425879|5855940|P1|COMPLETED|Overall Study||8
2385842|NCT01425879|5855940|P1|STARTED|Overall Study||8
2385843|NCT01425853|5855949|P2|NOT COMPLETED|Overall Study||77
2385844|NCT01425853|5855950|P1|NOT COMPLETED|Overall Study||64
2385845|NCT01425853|5855949|P2|COMPLETED|Overall Study||225
2385846|NCT01425853|5855950|P1|COMPLETED|Overall Study||240
2385847|NCT01425853|5855949|P2|Per Protocol (PP)|Overall Study||258
2385848|NCT01425853|5855950|P1|Per Protocol (PP)|Overall Study||264
2385849|NCT01425853|5855949|P2|Safety Population|Overall Study||299
2385850|NCT01425853|5855950|P1|Safety Population|Overall Study||304
2385851|NCT01425853|5855949|P2|STARTED|Overall Study||302
2385852|NCT01425853|5855950|P1|STARTED|Overall Study||304
2385853|NCT01425814|5855980|P6|NOT COMPLETED|Period 5||1
2385854|NCT01425814|5855981|P5|NOT COMPLETED|Period 5||0
2385855|NCT01425814|5855982|P4|NOT COMPLETED|Period 5||0
2385856|NCT01425814|5855983|P3|NOT COMPLETED|Period 5||1
2385857|NCT01425814|5855984|P2|NOT COMPLETED|Period 5||0
2385858|NCT01425814|5855985|P1|NOT COMPLETED|Period 5||0
2385859|NCT01425814|5855980|P6|COMPLETED|Period 5||11
2385860|NCT01425814|5855981|P5|COMPLETED|Period 5||12
2385861|NCT01425814|5855982|P4|COMPLETED|Period 5||10
2385862|NCT01425814|5855983|P3|COMPLETED|Period 5||10
2385863|NCT01425814|5855984|P2|COMPLETED|Period 5||9
2385864|NCT01425814|5855985|P1|COMPLETED|Period 5||11
2385865|NCT01425814|5855980|P6|STARTED|Period 5||12
2385866|NCT01425814|5855981|P5|STARTED|Period 5||12
2385867|NCT01425814|5855982|P4|STARTED|Period 5||10
2385868|NCT01425814|5855983|P3|STARTED|Period 5||11
2385869|NCT01425814|5855984|P2|STARTED|Period 5||9
2385870|NCT01425814|5855985|P1|STARTED|Period 5||11
2385871|NCT01425814|5855980|P6|NOT COMPLETED|Period 4||0
2385872|NCT01425814|5855981|P5|NOT COMPLETED|Period 4||0
2385873|NCT01425814|5855982|P4|NOT COMPLETED|Period 4||0
2385874|NCT01425814|5855983|P3|NOT COMPLETED|Period 4||1
2385875|NCT01425814|5855984|P2|NOT COMPLETED|Period 4||0
2385876|NCT01425814|5855985|P1|NOT COMPLETED|Period 4||1
2385877|NCT01425814|5855980|P6|COMPLETED|Period 4||12
2385878|NCT01425814|5855981|P5|COMPLETED|Period 4||12
2385879|NCT01425814|5855982|P4|COMPLETED|Period 4||10
2385880|NCT01425814|5855983|P3|COMPLETED|Period 4||11
2385881|NCT01425814|5855984|P2|COMPLETED|Period 4||9
2385882|NCT01425814|5855985|P1|COMPLETED|Period 4||11
2385883|NCT01425814|5855980|P6|STARTED|Period 4||12
2385884|NCT01425814|5855981|P5|STARTED|Period 4||12
2385885|NCT01425814|5855982|P4|STARTED|Period 4||10
2385886|NCT01425814|5855983|P3|STARTED|Period 4||12
2385887|NCT01425814|5855984|P2|STARTED|Period 4||9
2385888|NCT01425814|5855985|P1|STARTED|Period 4||12
2385889|NCT01425814|5855980|P6|NOT COMPLETED|Period 3||1
2385890|NCT01425814|5855981|P5|NOT COMPLETED|Period 3||0
2385891|NCT01425814|5855982|P4|NOT COMPLETED|Period 3||0
2385892|NCT01425814|5855983|P3|NOT COMPLETED|Period 3||0
2385893|NCT01425814|5855984|P2|NOT COMPLETED|Period 3||0
2385894|NCT01425814|5855985|P1|NOT COMPLETED|Period 3||0
2385895|NCT01425814|5855980|P6|COMPLETED|Period 3||12
2385896|NCT01425814|5855981|P5|COMPLETED|Period 3||12
2385897|NCT01425814|5855982|P4|COMPLETED|Period 3||10
2385898|NCT01425814|5855983|P3|COMPLETED|Period 3||12
2385899|NCT01425814|5855984|P2|COMPLETED|Period 3||9
2385900|NCT01425814|5855985|P1|COMPLETED|Period 3||12
2385901|NCT01425814|5855980|P6|STARTED|Period 3||13
2385902|NCT01425814|5855981|P5|STARTED|Period 3||12
2385903|NCT01425814|5855982|P4|STARTED|Period 3||10
2385904|NCT01425814|5855983|P3|STARTED|Period 3||12
2385905|NCT01425814|5855984|P2|STARTED|Period 3||9
2385906|NCT01425814|5855985|P1|STARTED|Period 3||12
2385907|NCT01425814|5855980|P6|NOT COMPLETED|Period 2||0
2385908|NCT01425814|5855981|P5|NOT COMPLETED|Period 2||0
2385909|NCT01425814|5855982|P4|NOT COMPLETED|Period 2||0
2385910|NCT01425814|5855983|P3|NOT COMPLETED|Period 2||0
2385911|NCT01425814|5855984|P2|NOT COMPLETED|Period 2||1
2385912|NCT01425814|5855985|P1|NOT COMPLETED|Period 2||0
2385913|NCT01425814|5855980|P6|COMPLETED|Period 2||13
2385914|NCT01425814|5855981|P5|COMPLETED|Period 2||12
2385915|NCT01425814|5855982|P4|COMPLETED|Period 2||10
2385916|NCT01425814|5855983|P3|COMPLETED|Period 2||12
2385917|NCT01425814|5855984|P2|COMPLETED|Period 2||9
2385918|NCT01425814|5855985|P1|COMPLETED|Period 2||12
2385919|NCT01425814|5855980|P6|STARTED|Period 2||13
2385920|NCT01425814|5855981|P5|STARTED|Period 2||12
2385921|NCT01425814|5855982|P4|STARTED|Period 2||10
2385922|NCT01425814|5855983|P3|STARTED|Period 2||12
2385923|NCT01425814|5855984|P2|STARTED|Period 2||10
2385924|NCT01425814|5855985|P1|STARTED|Period 2||12
2385925|NCT01425814|5855980|P6|NOT COMPLETED|Period 1||0
2385926|NCT01425814|5855981|P5|NOT COMPLETED|Period 1||0
2385927|NCT01425814|5855982|P4|NOT COMPLETED|Period 1||0
2385928|NCT01425814|5855983|P3|NOT COMPLETED|Period 1||0
2385929|NCT01425814|5855984|P2|NOT COMPLETED|Period 1||1
2385930|NCT01425814|5855985|P1|NOT COMPLETED|Period 1||0
2385931|NCT01425814|5855980|P6|COMPLETED|Period 1||13
2385932|NCT01425814|5855981|P5|COMPLETED|Period 1||12
2385933|NCT01425814|5855982|P4|COMPLETED|Period 1||10
2385934|NCT01425814|5855983|P3|COMPLETED|Period 1||12
2385935|NCT01425814|5855984|P2|COMPLETED|Period 1||10
2385936|NCT01425814|5855985|P1|COMPLETED|Period 1||12
2385937|NCT01425814|5855980|P6|STARTED|Period 1||13
2385938|NCT01425814|5855981|P5|STARTED|Period 1||12
2385939|NCT01425814|5855982|P4|STARTED|Period 1||10
2385940|NCT01425814|5855983|P3|STARTED|Period 1||12
2385941|NCT01425814|5855984|P2|STARTED|Period 1||11
2385942|NCT01425814|5855985|P1|STARTED|Period 1||12
2385943|NCT01425801|5856077|P6|NOT COMPLETED|Period 6||0
2385944|NCT01425801|5856078|P5|NOT COMPLETED|Period 6||0
2385945|NCT01425801|5856079|P4|NOT COMPLETED|Period 6||0
2385946|NCT01425801|5856080|P3|NOT COMPLETED|Period 6||0
2385947|NCT01425801|5856081|P2|NOT COMPLETED|Period 6||0
2385948|NCT01425801|5856082|P1|NOT COMPLETED|Period 6||0
2385949|NCT01425801|5856077|P6|COMPLETED|Period 6||10
2385950|NCT01425801|5856078|P5|COMPLETED|Period 6||11
2385951|NCT01425801|5856079|P4|COMPLETED|Period 6||12
2385952|NCT01425801|5856080|P3|COMPLETED|Period 6||7
2385953|NCT01425801|5856081|P2|COMPLETED|Period 6||9
2385954|NCT01425801|5856082|P1|COMPLETED|Period 6||9
2385955|NCT01425801|5856077|P6|STARTED|Period 6||10
2385956|NCT01425801|5856078|P5|STARTED|Period 6||11
2385957|NCT01425801|5856079|P4|STARTED|Period 6||12
2385958|NCT01425801|5856080|P3|STARTED|Period 6||7
2385959|NCT01425801|5856081|P2|STARTED|Period 6||9
2385960|NCT01425801|5856082|P1|STARTED|Period 6||9
2385961|NCT01425801|5856077|P6|NOT COMPLETED|Period 5||0
2385962|NCT01425801|5856078|P5|NOT COMPLETED|Period 5||0
2385963|NCT01425801|5856079|P4|NOT COMPLETED|Period 5||0
2385964|NCT01425801|5856080|P3|NOT COMPLETED|Period 5||0
2385965|NCT01425801|5856081|P2|NOT COMPLETED|Period 5||0
2385966|NCT01425801|5856082|P1|NOT COMPLETED|Period 5||0
2385967|NCT01425801|5856077|P6|COMPLETED|Period 5||10
2385968|NCT01425801|5856078|P5|COMPLETED|Period 5||11
2385969|NCT01425801|5856079|P4|COMPLETED|Period 5||12
2385970|NCT01425801|5856080|P3|COMPLETED|Period 5||7
2385971|NCT01425801|5856081|P2|COMPLETED|Period 5||9
2385972|NCT01425801|5856082|P1|COMPLETED|Period 5||9
2385973|NCT01425801|5856077|P6|STARTED|Period 5||10
2385974|NCT01425801|5856078|P5|STARTED|Period 5||11
2385975|NCT01425801|5856079|P4|STARTED|Period 5||12
2385976|NCT01425801|5856080|P3|STARTED|Period 5||7
2385977|NCT01425801|5856081|P2|STARTED|Period 5||9
2385978|NCT01425801|5856082|P1|STARTED|Period 5||9
2385979|NCT01425801|5856077|P6|NOT COMPLETED|Period 4||0
2385980|NCT01425801|5856078|P5|NOT COMPLETED|Period 4||0
2385981|NCT01425801|5856079|P4|NOT COMPLETED|Period 4||0
2385982|NCT01425801|5856080|P3|NOT COMPLETED|Period 4||1
2385983|NCT01425801|5856081|P2|NOT COMPLETED|Period 4||0
2385984|NCT01425801|5856082|P1|NOT COMPLETED|Period 4||0
2385985|NCT01425801|5856077|P6|COMPLETED|Period 4||10
2385986|NCT01425801|5856078|P5|COMPLETED|Period 4||11
2385987|NCT01425801|5856079|P4|COMPLETED|Period 4||12
2385988|NCT01425801|5856080|P3|COMPLETED|Period 4||7
2385989|NCT01425801|5856081|P2|COMPLETED|Period 4||9
2385990|NCT01425801|5856082|P1|COMPLETED|Period 4||9
2385991|NCT01425801|5856077|P6|STARTED|Period 4||10
2385992|NCT01425801|5856078|P5|STARTED|Period 4||11
2385993|NCT01425801|5856079|P4|STARTED|Period 4||12
2385994|NCT01425801|5856080|P3|STARTED|Period 4||8
2385995|NCT01425801|5856081|P2|STARTED|Period 4||9
2385996|NCT01425801|5856082|P1|STARTED|Period 4||9
2385997|NCT01425801|5856077|P6|NOT COMPLETED|Period 3||0
2385998|NCT01425801|5856078|P5|NOT COMPLETED|Period 3||0
2385999|NCT01425801|5856079|P4|NOT COMPLETED|Period 3||0
2386000|NCT01425801|5856080|P3|NOT COMPLETED|Period 3||1
2386001|NCT01425801|5856081|P2|NOT COMPLETED|Period 3||0
2386002|NCT01425801|5856082|P1|NOT COMPLETED|Period 3||0
2386003|NCT01425801|5856077|P6|COMPLETED|Period 3||10
2386004|NCT01425801|5856078|P5|COMPLETED|Period 3||11
2386005|NCT01425801|5856079|P4|COMPLETED|Period 3||12
2386006|NCT01425801|5856080|P3|COMPLETED|Period 3||8
2386007|NCT01425801|5856081|P2|COMPLETED|Period 3||9
2386008|NCT01425801|5856082|P1|COMPLETED|Period 3||9
2386009|NCT01425801|5856077|P6|STARTED|Period 3||10
2386010|NCT01425801|5856078|P5|STARTED|Period 3||11
2386011|NCT01425801|5856079|P4|STARTED|Period 3||12
2386012|NCT01425801|5856080|P3|STARTED|Period 3||9
2386013|NCT01425801|5856081|P2|STARTED|Period 3||9
2386014|NCT01425801|5856082|P1|STARTED|Period 3||9
2386015|NCT01425801|5856077|P6|NOT COMPLETED|Period 2||0
2386016|NCT01425801|5856078|P5|NOT COMPLETED|Period 2||1
2386017|NCT01425801|5856079|P4|NOT COMPLETED|Period 2||0
2386018|NCT01425801|5856080|P3|NOT COMPLETED|Period 2||0
2386019|NCT01425801|5856081|P2|NOT COMPLETED|Period 2||0
2386020|NCT01425801|5856082|P1|NOT COMPLETED|Period 2||0
2386021|NCT01425801|5856077|P6|COMPLETED|Period 2||10
2386022|NCT01425801|5856078|P5|COMPLETED|Period 2||11
2386023|NCT01425801|5856079|P4|COMPLETED|Period 2||12
2386024|NCT01425801|5856080|P3|COMPLETED|Period 2||9
2386025|NCT01425801|5856081|P2|COMPLETED|Period 2||9
2386026|NCT01425801|5856082|P1|COMPLETED|Period 2||9
2386027|NCT01425801|5856077|P6|STARTED|Period 2||10
2386028|NCT01425801|5856078|P5|STARTED|Period 2||12
2386029|NCT01425801|5856079|P4|STARTED|Period 2||12
2386030|NCT01425801|5856080|P3|STARTED|Period 2||9
2386031|NCT01425801|5856081|P2|STARTED|Period 2||9
2386032|NCT01425801|5856082|P1|STARTED|Period 2||9
2386033|NCT01425801|5856077|P6|NOT COMPLETED|Period 1||0
2386034|NCT01425801|5856078|P5|NOT COMPLETED|Period 1||1
2386035|NCT01425801|5856079|P4|NOT COMPLETED|Period 1||0
2386036|NCT01425801|5856080|P3|NOT COMPLETED|Period 1||0
2386037|NCT01425801|5856081|P2|NOT COMPLETED|Period 1||0
2386038|NCT01425801|5856082|P1|NOT COMPLETED|Period 1||0
2386039|NCT01425801|5856077|P6|COMPLETED|Period 1||10
2386040|NCT01425801|5856078|P5|COMPLETED|Period 1||12
2386041|NCT01425801|5856079|P4|COMPLETED|Period 1||12
2386042|NCT01425801|5856080|P3|COMPLETED|Period 1||9
2386043|NCT01425801|5856081|P2|COMPLETED|Period 1||9
2386044|NCT01425801|5856082|P1|COMPLETED|Period 1||9
2386045|NCT01425801|5856077|P6|STARTED|Period 1||10
2386046|NCT01425801|5856078|P5|STARTED|Period 1||13
2386047|NCT01425801|5856079|P4|STARTED|Period 1||12
2386048|NCT01425801|5856080|P3|STARTED|Period 1||9
2386049|NCT01425801|5856081|P2|STARTED|Period 1||9
2386050|NCT01425801|5856082|P1|STARTED|Period 1||9
2386051|NCT01425749|5856188|P2|NOT COMPLETED|Overall Study||1
2386052|NCT01425749|5856189|P1|NOT COMPLETED|Overall Study||0
2386053|NCT01425749|5856188|P2|COMPLETED|Overall Study||11
2386054|NCT01425749|5856189|P1|COMPLETED|Overall Study||13
2386055|NCT01425749|5856188|P2|STARTED|Overall Study||12
2386056|NCT01425749|5856189|P1|STARTED|Overall Study||13
2386057|NCT01425723|5856206|P2|NOT COMPLETED|Overall Study||18
2386058|NCT01425723|5856207|P1|NOT COMPLETED|Overall Study||4
2386059|NCT01425723|5856206|P2|COMPLETED|Overall Study||75
2386060|NCT01425723|5856207|P1|COMPLETED|Overall Study||23
2386061|NCT01425723|5856206|P2|Surgery Subgroup|Overall Study||15
2386062|NCT01425723|5856207|P1|Surgery Subgroup|Overall Study||1
2386063|NCT01425723|5856206|P2|Episodic|Overall Study||15
2386064|NCT01425723|5856207|P1|Episodic|Overall Study||0
2386065|NCT01425723|5856206|P2|Personalized Prophylaxis|Overall Study||17
2386066|NCT01425723|5856207|P1|Personalized Prophylaxis|Overall Study||2
2386067|NCT01425723|5856206|P2|Individualized Prophylaxis|Overall Study||31
2386068|NCT01425723|5856207|P1|Individualized Prophylaxis|Overall Study||5
2386069|NCT01425723|5856206|P2|Weekly Prophylaxis|Overall Study||51
2386070|NCT01425723|5856207|P1|Weekly Prophylaxis|Overall Study||23
2386071|NCT01425723|5856206|P2|STARTED|Overall Study||93
2386072|NCT01425723|5856207|P1|STARTED|Overall Study|13 participants in <6 Years Old Age Cohort and 14 participants in 6 to <12 Years Old Age Cohort.|27
2386073|NCT01425632|5856237|P3|NOT COMPLETED|Overall Study||4
2386074|NCT01425632|5856238|P2|NOT COMPLETED|Overall Study||1
2386075|NCT01425632|5856239|P1|NOT COMPLETED|Overall Study||1
2386076|NCT01425632|5856237|P3|COMPLETED|Overall Study||159
2386077|NCT01425632|5856238|P2|COMPLETED|Overall Study||165
2386078|NCT01425632|5856239|P1|COMPLETED|Overall Study||160
2386079|NCT01425632|5856237|P3|STARTED|Overall Study||163
2386080|NCT01425632|5856238|P2|STARTED|Overall Study||166
2386081|NCT01425632|5856239|P1|STARTED|Overall Study||161
2386082|NCT01425528|5856249|P2|NOT COMPLETED|Overall Study||1
2386083|NCT01425528|5856250|P1|NOT COMPLETED|Overall Study||1
2386084|NCT01425528|5856249|P2|COMPLETED|Overall Study||5
2386085|NCT01425528|5856250|P1|COMPLETED|Overall Study||5
2386086|NCT01425528|5856249|P2|STARTED|Overall Study||6
2386087|NCT01425528|5856250|P1|STARTED|Overall Study||6
2386088|NCT01425463|5856258|P2|NOT COMPLETED|Overall Study||24
2386089|NCT01425463|5856259|P1|NOT COMPLETED|Overall Study||24
2386090|NCT01425463|5856258|P2|COMPLETED|Overall Study||102
2386091|NCT01425463|5856259|P1|COMPLETED|Overall Study||106
2386092|NCT01425463|5856258|P2|Full Analysis Set|Overall Study||116
2386093|NCT01425463|5856259|P1|Full Analysis Set|Overall Study||122
2386094|NCT01425463|5856258|P2|Safety Set|Overall Study||122
2386095|NCT01425463|5856259|P1|Safety Set|Overall Study||126
2386096|NCT01425463|5856258|P2|STARTED|Overall Study||126
2386097|NCT01425463|5856259|P1|STARTED|Overall Study||130
2386098|NCT01425359|5856275|P2|NOT COMPLETED|Overall Study||22
2386099|NCT01425359|5856276|P1|NOT COMPLETED|Overall Study||19
2386100|NCT01425359|5856275|P2|COMPLETED|Overall Study||451
2386101|NCT01425359|5856276|P1|COMPLETED|Overall Study||457
2386102|NCT01425359|5856275|P2|STARTED|Overall Study||473
2386103|NCT01425359|5856276|P1|STARTED|Overall Study||476
2386104|NCT01425307|5856294|P2|NOT COMPLETED|Overall Study||19
2386105|NCT01425307|5856295|P1|NOT COMPLETED|Overall Study||19
2386106|NCT01425307|5856294|P2|COMPLETED|Overall Study|Treatment Phase: 41; 6-Month Follow-up:59|41
2386107|NCT01425307|5856295|P1|COMPLETED|Overall Study|Treatment Phase: 42; 6-Month Follow up: 58|42
2386108|NCT01425307|5856294|P2|STARTED|Overall Study|Randomized Sample: 60; Intention-to Treat Sample:60|60
2386109|NCT01425307|5856295|P1|STARTED|Overall Study|Randomized Sample: 61; Intention-to Treat Sample:61|61
2386110|NCT01425281|5856307|P2|NOT COMPLETED|At 5-year Clinical Follow-up||11
2386111|NCT01425281|5856308|P1|NOT COMPLETED|At 5-year Clinical Follow-up||32
2386112|NCT01425281|5856307|P2|COMPLETED|At 5-year Clinical Follow-up||125
2386113|NCT01425281|5856308|P1|COMPLETED|At 5-year Clinical Follow-up||256
2386114|NCT01425281|5856307|P2|STARTED|At 5-year Clinical Follow-up||136
2386115|NCT01425281|5856308|P1|STARTED|At 5-year Clinical Follow-up||288
2386116|NCT01425281|5856307|P2|NOT COMPLETED|At 4-year Clinical Follow-up||21
2386117|NCT01425281|5856308|P1|NOT COMPLETED|At 4-year Clinical Follow-up||30
2386118|NCT01425281|5856307|P2|COMPLETED|At 4-year Clinical Follow-up||136
2386119|NCT01425281|5856308|P1|COMPLETED|At 4-year Clinical Follow-up||288
2386120|NCT01425281|5856307|P2|STARTED|At 4-year Clinical Follow-up||157
2386121|NCT01425281|5856308|P1|STARTED|At 4-year Clinical Follow-up||318
2386122|NCT01425281|5856307|P2|NOT COMPLETED|At 3-year Clinical Follow-up||6
2386123|NCT01425281|5856308|P1|NOT COMPLETED|At 3-year Clinical Follow-up||5
2386124|NCT01425281|5856307|P2|COMPLETED|At 3-year Clinical Follow-up||157
2386125|NCT01425281|5856308|P1|COMPLETED|At 3-year Clinical Follow-up||318
2386126|NCT01425281|5856307|P2|STARTED|At 3-year Clinical Follow-up||163
2386127|NCT01425281|5856308|P1|STARTED|At 3-year Clinical Follow-up||323
2386128|NCT01425281|5856307|P2|NOT COMPLETED|At 2-year Clinical Follow-up||1
2386129|NCT01425281|5856308|P1|NOT COMPLETED|At 2-year Clinical Follow-up||6
2386130|NCT01425281|5856307|P2|COMPLETED|At 2-year Clinical Follow-up||163
2386131|NCT01425281|5856308|P1|COMPLETED|At 2-year Clinical Follow-up||323
2386132|NCT01425281|5856307|P2|STARTED|At 2-year Clinical Follow-up||164
2386133|NCT01425281|5856308|P1|STARTED|At 2-year Clinical Follow-up||329
2386134|NCT01425281|5856307|P2|NOT COMPLETED|At 1-year Clinical Follow-up||1
2386135|NCT01425281|5856308|P1|NOT COMPLETED|At 1-year Clinical Follow-up||2
2386136|NCT01425281|5856307|P2|COMPLETED|At 1-year Clinical Follow-up||164
2386137|NCT01425281|5856308|P1|COMPLETED|At 1-year Clinical Follow-up||329
2386138|NCT01425281|5856307|P2|STARTED|At 1-year Clinical Follow-up||165
2386139|NCT01425281|5856308|P1|STARTED|At 1-year Clinical Follow-up||331
2386140|NCT01425281|5856307|P2|NOT COMPLETED|At 180-day Clinical Follow-up||1
2386141|NCT01425281|5856308|P1|NOT COMPLETED|At 180-day Clinical Follow-up||3
2386142|NCT01425281|5856307|P2|COMPLETED|At 180-day Clinical Follow-up||165
2386143|NCT01425281|5856308|P1|COMPLETED|At 180-day Clinical Follow-up||331
2386144|NCT01425281|5856307|P2|STARTED|At 180-day Clinical Follow-up||166
2386145|NCT01425281|5856308|P1|STARTED|At 180-day Clinical Follow-up||334
2386146|NCT01425281|5856307|P2|NOT COMPLETED|At 30-day Clinical Follow-up||0
2386147|NCT01425281|5856308|P1|NOT COMPLETED|At 30-day Clinical Follow-up||1
2386148|NCT01425281|5856307|P2|COMPLETED|At 30-day Clinical Follow-up||166
2386149|NCT01425281|5856308|P1|COMPLETED|At 30-day Clinical Follow-up||334
2386150|NCT01425281|5856307|P2|STARTED|At 30-day Clinical Follow-up|Intent-to-Treat (ITT) Population|166
2386151|NCT01425281|5856308|P1|STARTED|At 30-day Clinical Follow-up|Intent-to-Treat (ITT) Population|335
2386152|NCT01425268|5856526|P2|NOT COMPLETED|Overall Study||0
2386153|NCT01425268|5856527|P1|NOT COMPLETED|Overall Study||8
2386154|NCT01425268|5856526|P2|COMPLETED|Overall Study||52
2386155|NCT01425268|5856527|P1|COMPLETED|Overall Study||98
2386156|NCT01425268|5856526|P2|STARTED|Overall Study|52 Subjects Randomized to Saline Arm / 52 Subjects Treated (Implanted)|52
2386157|NCT01425268|5856527|P1|STARTED|Overall Study|106 Subjects Randomized to AeroForm Arm / 98 Subjects Treated (Implanted)|106
2386158|NCT01425229|5856535|P1|NOT COMPLETED|Bosentan During Clarithromycin||0
2386159|NCT01425229|5856535|P1|COMPLETED|Bosentan During Clarithromycin||16
2386160|NCT01425229|5856535|P1|STARTED|Bosentan During Clarithromycin||16
2386161|NCT01425229|5856535|P1|NOT COMPLETED|Bosentan Steady-state||0
2386162|NCT01425229|5856535|P1|COMPLETED|Bosentan Steady-state||16
2386163|NCT01425229|5856535|P1|STARTED|Bosentan Steady-state||16
2386164|NCT01425229|5856535|P1|NOT COMPLETED|Bosentan Single Dose||0
2386165|NCT01425229|5856535|P1|COMPLETED|Bosentan Single Dose||16
2386166|NCT01425229|5856535|P1|STARTED|Bosentan Single Dose||16
2386167|NCT01425203|5856548|P3|NOT COMPLETED|Follow-up Phase||0
2386168|NCT01425203|5856549|P2|NOT COMPLETED|Follow-up Phase||0
2386169|NCT01425203|5856550|P1|NOT COMPLETED|Follow-up Phase||0
2386170|NCT01425203|5856548|P3|COMPLETED|Follow-up Phase||27
2386171|NCT01425203|5856549|P2|COMPLETED|Follow-up Phase||49
2386172|NCT01425203|5856550|P1|COMPLETED|Follow-up Phase||153
2386173|NCT01425203|5856548|P3|STARTED|Follow-up Phase|All participants treated in crossover arm entered follow-up.|27
2386174|NCT01425203|5856549|P2|STARTED|Follow-up Phase|27 starting treatment in PBO+PR Control arm switched to Crossover arm and 2 did not enter follow-up|49
2386175|NCT01425203|5856550|P1|STARTED|Follow-up Phase|6 participants who started treatment in RGT BOC + PR arm did not enter follow-up.|153
2386176|NCT01425203|5856548|P3|NOT COMPLETED|Crossover Phase||6
2386177|NCT01425203|5856549|P2|NOT COMPLETED|Crossover Phase||0
2386178|NCT01425203|5856550|P1|NOT COMPLETED|Crossover Phase||0
2386179|NCT01425203|5856548|P3|COMPLETED|Crossover Phase||21
2386180|NCT01425203|5856549|P2|COMPLETED|Crossover Phase||0
2386181|NCT01425203|5856550|P1|COMPLETED|Crossover Phase||0
2386182|NCT01425203|5856548|P3|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|27
2386183|NCT01425203|5856549|P2|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
2386184|NCT01425203|5856550|P1|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
2386185|NCT01425203|5856548|P3|NOT COMPLETED|Treatment Phase||0
2386186|NCT01425203|5856549|P2|NOT COMPLETED|Treatment Phase||37
2386187|NCT01425203|5856550|P1|NOT COMPLETED|Treatment Phase||27
2386188|NCT01425203|5856548|P3|COMPLETED|Treatment Phase||0
2386189|NCT01425203|5856549|P2|COMPLETED|Treatment Phase||42
2386190|NCT01425203|5856550|P1|COMPLETED|Treatment Phase||132
2386191|NCT01425203|5856548|P3|Treated (FAS)|Treatment Phase||0
2386192|NCT01425203|5856549|P2|Treated (FAS)|Treatment Phase||78
2386193|NCT01425203|5856550|P1|Treated (FAS)|Treatment Phase||159
2386194|NCT01425203|5856548|P3|STARTED|Treatment Phase||0
2386195|NCT01425203|5856549|P2|STARTED|Treatment Phase||79
2386196|NCT01425203|5856550|P1|STARTED|Treatment Phase||159
2386197|NCT01425190|5856567|P3|NOT COMPLETED|Overall Study||0
2386198|NCT01425190|5856568|P2|NOT COMPLETED|Overall Study||0
2386199|NCT01425190|5856569|P1|NOT COMPLETED|Overall Study||1
2386200|NCT01425190|5856567|P3|COMPLETED|Overall Study||0
2386201|NCT01425190|5856568|P2|COMPLETED|Overall Study||0
2386202|NCT01425190|5856569|P1|COMPLETED|Overall Study||15
2386203|NCT01425190|5856567|P3|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 3.|0
2386204|NCT01425190|5856568|P2|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 2.|0
2386205|NCT01425190|5856569|P1|STARTED|Overall Study||16
2386206|NCT01424943|5856588|P2|NOT COMPLETED|Overall Study||1
2386207|NCT01424943|5856589|P1|NOT COMPLETED|Overall Study||13
2386208|NCT01424943|5856588|P2|COMPLETED|Overall Study||23
2386209|NCT01424943|5856589|P1|COMPLETED|Overall Study||12
2386210|NCT01424943|5856588|P2|STARTED|Overall Study||24
2386211|NCT01424943|5856589|P1|STARTED|Overall Study||25
2386212|NCT01424930|5856605|P2|NOT COMPLETED|Overall Study||14
2386213|NCT01424930|5856606|P1|NOT COMPLETED|Overall Study||4
2386214|NCT01424930|5856605|P2|COMPLETED|Overall Study||4
2386215|NCT01424930|5856606|P1|COMPLETED|Overall Study||3
2386216|NCT01424930|5856605|P2|Completed Food Safety Evaluation|Overall Study||18
2386217|NCT01424930|5856606|P1|Completed Food Safety Evaluation|Overall Study||6
2386218|NCT01424930|5856605|P2|STARTED|Overall Study||18
2386219|NCT01424930|5856606|P1|STARTED|Overall Study||7
2386220|NCT01424813|5856620|P2|NOT COMPLETED|Overall Study||2
2386221|NCT01424813|5856621|P1|NOT COMPLETED|Overall Study||5
2386222|NCT01424813|5856620|P2|COMPLETED|Overall Study||77
2386223|NCT01424813|5856621|P1|COMPLETED|Overall Study||74
2386224|NCT01424813|5856620|P2|Treated|Overall Study|Safety set and full analysis set|78
2386225|NCT01424813|5856621|P1|Treated|Overall Study|Safety set and full analysis set|79
2386226|NCT01424813|5856620|P2|STARTED|Overall Study||79
2386227|NCT01424813|5856621|P1|STARTED|Overall Study||79
2386228|NCT01424670|5856641|P2|NOT COMPLETED|Continuation Period||14
2386229|NCT01424670|5856642|P1|NOT COMPLETED|Continuation Period||34
2386230|NCT01424670|5856641|P2|COMPLETED|Continuation Period||142
2386231|NCT01424670|5856642|P1|COMPLETED|Continuation Period||288
2386232|NCT01424670|5856641|P2|STARTED|Continuation Period||156
2386233|NCT01424670|5856642|P1|STARTED|Continuation Period||322
2386234|NCT01424670|5856641|P2|NOT COMPLETED|6-Month Intensive Period (182 Days)||14
2386235|NCT01424670|5856642|P1|NOT COMPLETED|6-Month Intensive Period (182 Days)||19
2386236|NCT01424670|5856641|P2|COMPLETED|6-Month Intensive Period (182 Days)||156
2386237|NCT01424670|5856642|P1|COMPLETED|6-Month Intensive Period (182 Days)||322
2386238|NCT01424670|5856641|P2|Received at Least 1 Dose of Study Drug|6-Month Intensive Period (182 Days)||170
2386239|NCT01424670|5856642|P1|Received at Least 1 Dose of Study Drug|6-Month Intensive Period (182 Days)||341
2386240|NCT01424670|5856641|P2|STARTED|6-Month Intensive Period (182 Days)||170
2386241|NCT01424670|5856642|P1|STARTED|6-Month Intensive Period (182 Days)||341
2386242|NCT01424644|5856664|P2|NOT COMPLETED|Overall Study||27
2386243|NCT01424644|5856665|P1|NOT COMPLETED|Overall Study||33
2386244|NCT01424644|5856664|P2|COMPLETED|Overall Study||372
2386245|NCT01424644|5856665|P1|COMPLETED|Overall Study||369
2386246|NCT01424644|5856664|P2|STARTED|Overall Study||399
2386247|NCT01424644|5856665|P1|STARTED|Overall Study||402
2386248|NCT01424566|5856679|P3|NOT COMPLETED|Double-blind Treatment||15
2386249|NCT01424566|5856680|P2|NOT COMPLETED|Double-blind Treatment||25
2386250|NCT01424566|5856681|P1|NOT COMPLETED|Double-blind Treatment||0
2386251|NCT01424566|5856679|P3|COMPLETED|Double-blind Treatment||88
2386252|NCT01424566|5856680|P2|COMPLETED|Double-blind Treatment||78
2386253|NCT01424566|5856681|P1|COMPLETED|Double-blind Treatment||0
2386254|NCT01424566|5856679|P3|ITT Population|Double-blind Treatment||103
2386255|NCT01424566|5856680|P2|ITT Population|Double-blind Treatment||103
2386256|NCT01424566|5856681|P1|ITT Population|Double-blind Treatment||0
2386257|NCT01424566|5856679|P3|Randomized Safety Population|Double-blind Treatment||103
2386258|NCT01424566|5856680|P2|Randomized Safety Population|Double-blind Treatment||103
2386259|NCT01424566|5856681|P1|Randomized Safety Population|Double-blind Treatment||0
2386260|NCT01424566|5856679|P3|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103
2386261|NCT01424566|5856680|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103
2386262|NCT01424566|5856681|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment||0
2386263|NCT01424566|5856679|P3|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103
2386264|NCT01424566|5856680|P2|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103
2386265|NCT01424566|5856681|P1|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the double-blind period.|0
2386266|NCT01424566|5856679|P3|NOT COMPLETED|Single-blind Treatment||0
2386267|NCT01424566|5856680|P2|NOT COMPLETED|Single-blind Treatment||0
2386268|NCT01424566|5856681|P1|NOT COMPLETED|Single-blind Treatment||200
2386269|NCT01424566|5856679|P3|COMPLETED|Single-blind Treatment||0
2386270|NCT01424566|5856680|P2|COMPLETED|Single-blind Treatment||0
2386271|NCT01424566|5856681|P1|COMPLETED|Single-blind Treatment||206
2386272|NCT01424566|5856679|P3|Met Randomization Criteria|Single-blind Treatment||0
2386273|NCT01424566|5856680|P2|Met Randomization Criteria|Single-blind Treatment||0
2386274|NCT01424566|5856681|P1|Met Randomization Criteria|Single-blind Treatment||206
2386275|NCT01424566|5856679|P3|Single-blind Safety Population|Single-blind Treatment||0
2386276|NCT01424566|5856680|P2|Single-blind Safety Population|Single-blind Treatment||0
2386277|NCT01424566|5856681|P1|Single-blind Safety Population|Single-blind Treatment||404
2386278|NCT01424566|5856679|P3|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0
2386279|NCT01424566|5856680|P2|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0
2386280|NCT01424566|5856681|P1|Received at Least 1 Dose of Study Drug|Single-blind Treatment|Two participants did not administer any study drug.|404
2386281|NCT01424566|5856679|P3|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0
2386282|NCT01424566|5856680|P2|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0
2386283|NCT01424566|5856681|P1|STARTED|Single-blind Treatment||406
2386284|NCT01424514|5856708|P2|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||0
2386285|NCT01424514|5856709|P1|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||1
2386286|NCT01424514|5856708|P2|COMPLETED|Period 3:Intervention Period 2 (14 Days)||19
2386287|NCT01424514|5856709|P1|COMPLETED|Period 3:Intervention Period 2 (14 Days)||18
2386288|NCT01424514|5856708|P2|STARTED|Period 3:Intervention Period 2 (14 Days)||19
2386289|NCT01424514|5856709|P1|STARTED|Period 3:Intervention Period 2 (14 Days)||19
2386290|NCT01424514|5856708|P2|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0
2386291|NCT01424514|5856709|P1|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0
2386292|NCT01424514|5856708|P2|COMPLETED|Period 2:Washout Period (4 Weeks)||19
2386293|NCT01424514|5856709|P1|COMPLETED|Period 2:Washout Period (4 Weeks)||19
2386294|NCT01424514|5856708|P2|STARTED|Period 2:Washout Period (4 Weeks)||19
2386295|NCT01424514|5856709|P1|STARTED|Period 2:Washout Period (4 Weeks)||19
2386296|NCT01424514|5856708|P2|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1
2386297|NCT01424514|5856709|P1|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1
2386298|NCT01424514|5856708|P2|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19
2386299|NCT01424514|5856709|P1|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19
2386300|NCT01424514|5856708|P2|STARTED|Period 1:Intervention Period 1 (14 Days)||20
2386301|NCT01424514|5856709|P1|STARTED|Period 1:Intervention Period 1 (14 Days)||20
2386302|NCT01424501|5856754|P6|NOT COMPLETED|Overall Study||0
2386303|NCT01424501|5856755|P5|NOT COMPLETED|Overall Study||0
2386304|NCT01424501|5856756|P4|NOT COMPLETED|Overall Study||0
2386305|NCT01424501|5856757|P3|NOT COMPLETED|Overall Study||2
2386306|NCT01424501|5856758|P2|NOT COMPLETED|Overall Study||1
2386307|NCT01424501|5856759|P1|NOT COMPLETED|Overall Study||1
2386308|NCT01424501|5856754|P6|COMPLETED|Overall Study||40
2386309|NCT01424501|5856755|P5|COMPLETED|Overall Study||40
2386310|NCT01424501|5856756|P4|COMPLETED|Overall Study||25
2386311|NCT01424501|5856757|P3|COMPLETED|Overall Study||22
2386312|NCT01424501|5856758|P2|COMPLETED|Overall Study||5
2386313|NCT01424501|5856759|P1|COMPLETED|Overall Study||6
2386314|NCT01424501|5856754|P6|STARTED|Overall Study||40
2386315|NCT01424501|5856755|P5|STARTED|Overall Study||40
2386316|NCT01424501|5856756|P4|STARTED|Overall Study||25
2386317|NCT01424501|5856757|P3|STARTED|Overall Study||24
2386318|NCT01424501|5856758|P2|STARTED|Overall Study||6
2386319|NCT01424501|5856759|P1|STARTED|Overall Study||7
2386320|NCT01424397|5856935|P12|NOT COMPLETED|Period-3 (8 Days)||0
2386321|NCT01424397|5856936|P11|NOT COMPLETED|Period-3 (8 Days)||0
2386322|NCT01424397|5856937|P10|NOT COMPLETED|Period-3 (8 Days)||0
2386323|NCT01424397|5856938|P9|NOT COMPLETED|Period-3 (8 Days)||0
2386324|NCT01424397|5856939|P8|NOT COMPLETED|Period-3 (8 Days)||0
2386325|NCT01424397|5856940|P7|NOT COMPLETED|Period-3 (8 Days)||0
2386326|NCT01424397|5856941|P6|NOT COMPLETED|Period-3 (8 Days)||0
2386327|NCT01424397|5856942|P5|NOT COMPLETED|Period-3 (8 Days)||0
2386328|NCT01424397|5856943|P4|NOT COMPLETED|Period-3 (8 Days)||0
2386329|NCT01424397|5856944|P3|NOT COMPLETED|Period-3 (8 Days)||0
2386330|NCT01424397|5856945|P2|NOT COMPLETED|Period-3 (8 Days)||0
2386331|NCT01424397|5856946|P1|NOT COMPLETED|Period-3 (8 Days)||0
2386332|NCT01424397|5856935|P12|COMPLETED|Period-3 (8 Days)||4
2386333|NCT01424397|5856936|P11|COMPLETED|Period-3 (8 Days)||4
2386334|NCT01424397|5856937|P10|COMPLETED|Period-3 (8 Days)||3
2386335|NCT01424397|5856938|P9|COMPLETED|Period-3 (8 Days)||4
2386336|NCT01424397|5856939|P8|COMPLETED|Period-3 (8 Days)||4
2386337|NCT01424397|5856940|P7|COMPLETED|Period-3 (8 Days)||4
2386338|NCT01424397|5856941|P6|COMPLETED|Period-3 (8 Days)||8
2386339|NCT01424397|5856942|P5|COMPLETED|Period-3 (8 Days)||8
2386340|NCT01424397|5856943|P4|COMPLETED|Period-3 (8 Days)||8
2386341|NCT01424397|5856944|P3|COMPLETED|Period-3 (8 Days)||7
2386342|NCT01424397|5856945|P2|COMPLETED|Period-3 (8 Days)||8
2386343|NCT01424397|5856946|P1|COMPLETED|Period-3 (8 Days)||7
2386344|NCT01424397|5856935|P12|STARTED|Period-3 (8 Days)||4
2386345|NCT01424397|5856936|P11|STARTED|Period-3 (8 Days)||4
2386346|NCT01424397|5856937|P10|STARTED|Period-3 (8 Days)||3
2386347|NCT01424397|5856938|P9|STARTED|Period-3 (8 Days)||4
2386348|NCT01424397|5856939|P8|STARTED|Period-3 (8 Days)||4
2386349|NCT01424397|5856940|P7|STARTED|Period-3 (8 Days)||4
2386350|NCT01424397|5856941|P6|STARTED|Period-3 (8 Days)||8
2386351|NCT01424397|5856942|P5|STARTED|Period-3 (8 Days)||8
2386352|NCT01424397|5856943|P4|STARTED|Period-3 (8 Days)||8
2386353|NCT01424397|5856944|P3|STARTED|Period-3 (8 Days)||7
2386354|NCT01424397|5856945|P2|STARTED|Period-3 (8 Days)||8
2386355|NCT01424397|5856946|P1|STARTED|Period-3 (8 Days)||7
2386356|NCT01424397|5856935|P12|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
2386357|NCT01424397|5856936|P11|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
2386358|NCT01424397|5856937|P10|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
2386359|NCT01424397|5856938|P9|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
2386360|NCT01424397|5856939|P8|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
2386361|NCT01424397|5856940|P7|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
2386362|NCT01424397|5856941|P6|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
2386363|NCT01424397|5856942|P5|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
2386364|NCT01424397|5856943|P4|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
2386365|NCT01424397|5856944|P3|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
2386366|NCT01424397|5856945|P2|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
2386367|NCT01424397|5856946|P1|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
2386368|NCT01424397|5856935|P12|COMPLETED|Washout Period-2 (14-20 Days)||4
2386369|NCT01424397|5856936|P11|COMPLETED|Washout Period-2 (14-20 Days)||4
2386370|NCT01424397|5856937|P10|COMPLETED|Washout Period-2 (14-20 Days)||3
2386371|NCT01424397|5856938|P9|COMPLETED|Washout Period-2 (14-20 Days)||4
2386372|NCT01424397|5856939|P8|COMPLETED|Washout Period-2 (14-20 Days)||4
2386373|NCT01424397|5856940|P7|COMPLETED|Washout Period-2 (14-20 Days)||4
2386374|NCT01424397|5856941|P6|COMPLETED|Washout Period-2 (14-20 Days)||8
2386375|NCT01424397|5856942|P5|COMPLETED|Washout Period-2 (14-20 Days)||8
2386376|NCT01424397|5856943|P4|COMPLETED|Washout Period-2 (14-20 Days)||8
2386377|NCT01424397|5856944|P3|COMPLETED|Washout Period-2 (14-20 Days)||7
2386378|NCT01424397|5856945|P2|COMPLETED|Washout Period-2 (14-20 Days)||8
2386379|NCT01424397|5856946|P1|COMPLETED|Washout Period-2 (14-20 Days)||7
2386380|NCT01424397|5856935|P12|STARTED|Washout Period-2 (14-20 Days)||4
2386381|NCT01424397|5856936|P11|STARTED|Washout Period-2 (14-20 Days)||4
2386382|NCT01424397|5856937|P10|STARTED|Washout Period-2 (14-20 Days)||3
2386383|NCT01424397|5856938|P9|STARTED|Washout Period-2 (14-20 Days)||4
2386384|NCT01424397|5856939|P8|STARTED|Washout Period-2 (14-20 Days)||4
2386385|NCT01424397|5856940|P7|STARTED|Washout Period-2 (14-20 Days)||4
2386386|NCT01424397|5856941|P6|STARTED|Washout Period-2 (14-20 Days)||8
2386387|NCT01424397|5856942|P5|STARTED|Washout Period-2 (14-20 Days)||8
2386388|NCT01424397|5856943|P4|STARTED|Washout Period-2 (14-20 Days)||8
2386389|NCT01424397|5856944|P3|STARTED|Washout Period-2 (14-20 Days)||7
2386390|NCT01424397|5856945|P2|STARTED|Washout Period-2 (14-20 Days)||8
2386391|NCT01424397|5856946|P1|STARTED|Washout Period-2 (14-20 Days)||7
2386392|NCT01424397|5856935|P12|NOT COMPLETED|Period-2 (8 Days)||0
2386393|NCT01424397|5856936|P11|NOT COMPLETED|Period-2 (8 Days)||0
2386394|NCT01424397|5856937|P10|NOT COMPLETED|Period-2 (8 Days)||0
2386395|NCT01424397|5856938|P9|NOT COMPLETED|Period-2 (8 Days)||0
2386396|NCT01424397|5856939|P8|NOT COMPLETED|Period-2 (8 Days)||0
2386397|NCT01424397|5856940|P7|NOT COMPLETED|Period-2 (8 Days)||0
2386398|NCT01424397|5856941|P6|NOT COMPLETED|Period-2 (8 Days)||0
2386399|NCT01424397|5856942|P5|NOT COMPLETED|Period-2 (8 Days)||0
2386400|NCT01424397|5856943|P4|NOT COMPLETED|Period-2 (8 Days)||0
2386401|NCT01424397|5856944|P3|NOT COMPLETED|Period-2 (8 Days)||1
2386402|NCT01424397|5856945|P2|NOT COMPLETED|Period-2 (8 Days)||0
2386403|NCT01424397|5856946|P1|NOT COMPLETED|Period-2 (8 Days)||0
2386404|NCT01424397|5856935|P12|COMPLETED|Period-2 (8 Days)||4
2386405|NCT01424397|5856936|P11|COMPLETED|Period-2 (8 Days)||4
2386406|NCT01424397|5856937|P10|COMPLETED|Period-2 (8 Days)||3
2386407|NCT01424397|5856938|P9|COMPLETED|Period-2 (8 Days)||4
2386408|NCT01424397|5856939|P8|COMPLETED|Period-2 (8 Days)||4
2386409|NCT01424397|5856940|P7|COMPLETED|Period-2 (8 Days)||4
2386410|NCT01424397|5856941|P6|COMPLETED|Period-2 (8 Days)||8
2386411|NCT01424397|5856942|P5|COMPLETED|Period-2 (8 Days)||8
2386412|NCT01424397|5856943|P4|COMPLETED|Period-2 (8 Days)||8
2386413|NCT01424397|5856944|P3|COMPLETED|Period-2 (8 Days)||7
2386414|NCT01424397|5856945|P2|COMPLETED|Period-2 (8 Days)||8
2386415|NCT01424397|5856946|P1|COMPLETED|Period-2 (8 Days)||7
2386416|NCT01424397|5856935|P12|STARTED|Period-2 (8 Days)||4
2386417|NCT01424397|5856936|P11|STARTED|Period-2 (8 Days)||4
2386418|NCT01424397|5856937|P10|STARTED|Period-2 (8 Days)||3
2386419|NCT01424397|5856938|P9|STARTED|Period-2 (8 Days)||4
2386420|NCT01424397|5856939|P8|STARTED|Period-2 (8 Days)||4
2386421|NCT01424397|5856940|P7|STARTED|Period-2 (8 Days)||4
2386422|NCT01424397|5856941|P6|STARTED|Period-2 (8 Days)||8
2386423|NCT01424397|5856942|P5|STARTED|Period-2 (8 Days)||8
2386424|NCT01424397|5856943|P4|STARTED|Period-2 (8 Days)||8
2386425|NCT01424397|5856944|P3|STARTED|Period-2 (8 Days)||8
2386426|NCT01424397|5856945|P2|STARTED|Period-2 (8 Days)||8
2386427|NCT01424397|5856946|P1|STARTED|Period-2 (8 Days)||7
2386428|NCT01424397|5856935|P12|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
2386429|NCT01424397|5856936|P11|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
2386430|NCT01424397|5856937|P10|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
2386431|NCT01424397|5856938|P9|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
2386432|NCT01424397|5856939|P8|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
2386433|NCT01424397|5856940|P7|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
2386434|NCT01424397|5856941|P6|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
2386435|NCT01424397|5856942|P5|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
2386436|NCT01424397|5856943|P4|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
2386437|NCT01424397|5856944|P3|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
2386438|NCT01424397|5856945|P2|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
2386439|NCT01424397|5856946|P1|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
2386440|NCT01424397|5856935|P12|COMPLETED|Washout Period-1 (14-20 Days)||4
2386441|NCT01424397|5856936|P11|COMPLETED|Washout Period-1 (14-20 Days)||4
2386442|NCT01424397|5856937|P10|COMPLETED|Washout Period-1 (14-20 Days)||3
2386443|NCT01424397|5856938|P9|COMPLETED|Washout Period-1 (14-20 Days)||4
2386444|NCT01424397|5856939|P8|COMPLETED|Washout Period-1 (14-20 Days)||4
2386445|NCT01424397|5856940|P7|COMPLETED|Washout Period-1 (14-20 Days)||4
2386446|NCT01424397|5856941|P6|COMPLETED|Washout Period-1 (14-20 Days)||8
2386447|NCT01424397|5856942|P5|COMPLETED|Washout Period-1 (14-20 Days)||8
2386448|NCT01424397|5856943|P4|COMPLETED|Washout Period-1 (14-20 Days)||8
2386449|NCT01424397|5856944|P3|COMPLETED|Washout Period-1 (14-20 Days)||8
2386450|NCT01424397|5856945|P2|COMPLETED|Washout Period-1 (14-20 Days)||8
2386451|NCT01424397|5856946|P1|COMPLETED|Washout Period-1 (14-20 Days)||7
2386452|NCT01424397|5856935|P12|STARTED|Washout Period-1 (14-20 Days)||4
2386453|NCT01424397|5856936|P11|STARTED|Washout Period-1 (14-20 Days)||4
2386454|NCT01424397|5856937|P10|STARTED|Washout Period-1 (14-20 Days)||3
2386455|NCT01424397|5856938|P9|STARTED|Washout Period-1 (14-20 Days)||4
2386456|NCT01424397|5856939|P8|STARTED|Washout Period-1 (14-20 Days)||4
2386457|NCT01424397|5856940|P7|STARTED|Washout Period-1 (14-20 Days)||4
2386458|NCT01424397|5856941|P6|STARTED|Washout Period-1 (14-20 Days)||8
2386459|NCT01424397|5856942|P5|STARTED|Washout Period-1 (14-20 Days)||8
2386460|NCT01424397|5856943|P4|STARTED|Washout Period-1 (14-20 Days)||8
2386461|NCT01424397|5856944|P3|STARTED|Washout Period-1 (14-20 Days)||8
2386462|NCT01424397|5856945|P2|STARTED|Washout Period-1 (14-20 Days)||8
2386463|NCT01424397|5856946|P1|STARTED|Washout Period-1 (14-20 Days)||7
2386464|NCT01424397|5856935|P12|NOT COMPLETED|Period-1 (8 Days)||0
2386465|NCT01424397|5856936|P11|NOT COMPLETED|Period-1 (8 Days)||0
2386466|NCT01424397|5856937|P10|NOT COMPLETED|Period-1 (8 Days)||0
2386467|NCT01424397|5856938|P9|NOT COMPLETED|Period-1 (8 Days)||0
2386468|NCT01424397|5856939|P8|NOT COMPLETED|Period-1 (8 Days)||0
2386469|NCT01424397|5856940|P7|NOT COMPLETED|Period-1 (8 Days)||0
2386470|NCT01424397|5856941|P6|NOT COMPLETED|Period-1 (8 Days)||0
2386471|NCT01424397|5856942|P5|NOT COMPLETED|Period-1 (8 Days)||0
2386472|NCT01424397|5856943|P4|NOT COMPLETED|Period-1 (8 Days)||0
2386473|NCT01424397|5856944|P3|NOT COMPLETED|Period-1 (8 Days)||0
2386474|NCT01424397|5856945|P2|NOT COMPLETED|Period-1 (8 Days)||0
2386475|NCT01424397|5856946|P1|NOT COMPLETED|Period-1 (8 Days)||0
2386476|NCT01424397|5856935|P12|COMPLETED|Period-1 (8 Days)||4
2386477|NCT01424397|5856936|P11|COMPLETED|Period-1 (8 Days)||4
2386478|NCT01424397|5856937|P10|COMPLETED|Period-1 (8 Days)||3
2386479|NCT01424397|5856938|P9|COMPLETED|Period-1 (8 Days)||4
2386480|NCT01424397|5856939|P8|COMPLETED|Period-1 (8 Days)||4
2386481|NCT01424397|5856940|P7|COMPLETED|Period-1 (8 Days)||4
2386482|NCT01424397|5856941|P6|COMPLETED|Period-1 (8 Days)||8
2386483|NCT01424397|5856942|P5|COMPLETED|Period-1 (8 Days)||8
2386484|NCT01424397|5856943|P4|COMPLETED|Period-1 (8 Days)||8
2386485|NCT01424397|5856944|P3|COMPLETED|Period-1 (8 Days)||8
2386486|NCT01424397|5856945|P2|COMPLETED|Period-1 (8 Days)||8
2386487|NCT01424397|5856946|P1|COMPLETED|Period-1 (8 Days)||7
2386488|NCT01424397|5856935|P12|STARTED|Period-1 (8 Days)||4
2386489|NCT01424397|5856936|P11|STARTED|Period-1 (8 Days)||4
2386490|NCT01424397|5856937|P10|STARTED|Period-1 (8 Days)||3
2386491|NCT01424397|5856938|P9|STARTED|Period-1 (8 Days)||4
2386492|NCT01424397|5856939|P8|STARTED|Period-1 (8 Days)||4
2386493|NCT01424397|5856940|P7|STARTED|Period-1 (8 Days)||4
2386494|NCT01424397|5856941|P6|STARTED|Period-1 (8 Days)||8
2386495|NCT01424397|5856942|P5|STARTED|Period-1 (8 Days)||8
2386496|NCT01424397|5856943|P4|STARTED|Period-1 (8 Days)||8
2386497|NCT01424397|5856944|P3|STARTED|Period-1 (8 Days)||8
2386498|NCT01424397|5856945|P2|STARTED|Period-1 (8 Days)||8
2386499|NCT01424397|5856946|P1|STARTED|Period-1 (8 Days)||7
2386500|NCT01424306|5856992|P6|NOT COMPLETED|Overall Study||0
2386501|NCT01424306|5856993|P5|NOT COMPLETED|Overall Study||1
2386502|NCT01424306|5856994|P4|NOT COMPLETED|Overall Study||0
2386503|NCT01424306|5856995|P3|NOT COMPLETED|Overall Study||0
2386504|NCT01424306|5856996|P2|NOT COMPLETED|Overall Study||0
2386505|NCT01424306|5856997|P1|NOT COMPLETED|Overall Study||0
2386506|NCT01424306|5856992|P6|COMPLETED|Overall Study||6
2386507|NCT01424306|5856993|P5|COMPLETED|Overall Study||4
2386508|NCT01424306|5856994|P4|COMPLETED|Overall Study||3
2386509|NCT01424306|5856995|P3|COMPLETED|Overall Study||3
2386510|NCT01424306|5856996|P2|COMPLETED|Overall Study||4
2386511|NCT01424306|5856997|P1|COMPLETED|Overall Study||4
2386512|NCT01424306|5856992|P6|STARTED|Overall Study||6
2386513|NCT01424306|5856993|P5|STARTED|Overall Study||5
2386514|NCT01424306|5856994|P4|STARTED|Overall Study||3
2386515|NCT01424306|5856995|P3|STARTED|Overall Study||3
2386516|NCT01424306|5856996|P2|STARTED|Overall Study||4
2386517|NCT01424306|5856997|P1|STARTED|Overall Study||4
2386518|NCT01424228|5857046|P2|NOT COMPLETED|Overall Study||47
2386519|NCT01424228|5857047|P1|NOT COMPLETED|Overall Study||56
2386520|NCT01424228|5857046|P2|COMPLETED|Overall Study||135
2386521|NCT01424228|5857047|P1|COMPLETED|Overall Study||126
2386522|NCT01424228|5857046|P2|STARTED|Overall Study||182
2386523|NCT01424228|5857047|P1|STARTED|Overall Study||182
2386524|NCT01424189|5857087|P2|NOT COMPLETED|Overall Study||6
2386525|NCT01424189|5857088|P1|NOT COMPLETED|Overall Study||13
2386526|NCT01424189|5857087|P2|COMPLETED|Overall Study||182
2386527|NCT01424189|5857088|P1|COMPLETED|Overall Study||373
2386528|NCT01424189|5857087|P2|STARTED|Overall Study||188
2386529|NCT01424189|5857088|P1|STARTED|Overall Study||386
2386530|NCT01424072|5857103|P3|NOT COMPLETED|Overall Study||0
2386531|NCT01424072|5857104|P2|NOT COMPLETED|Overall Study||0
2386532|NCT01424072|5857105|P1|NOT COMPLETED|Overall Study||0
2386533|NCT01424072|5857103|P3|COMPLETED|Overall Study||22
2386534|NCT01424072|5857104|P2|COMPLETED|Overall Study||26
2386535|NCT01424072|5857105|P1|COMPLETED|Overall Study||27
2386536|NCT01424072|5857103|P3|STARTED|Overall Study||22
2386537|NCT01424072|5857104|P2|STARTED|Overall Study||26
2386538|NCT01424072|5857105|P1|STARTED|Overall Study||27
2386539|NCT01424033|5857122|P1|NOT COMPLETED|Overall Study||5
2386540|NCT01424033|5857122|P1|COMPLETED|Overall Study||0
2386541|NCT01424033|5857122|P1|STARTED|Overall Study||5
2386542|NCT01423916|5857129|P3|NOT COMPLETED|Overall Study||7
2386543|NCT01423916|5857130|P2|NOT COMPLETED|Overall Study||20
2386544|NCT01423916|5857131|P1|NOT COMPLETED|Overall Study||11
2386545|NCT01423916|5857129|P3|COMPLETED|Overall Study||64
2386546|NCT01423916|5857130|P2|COMPLETED|Overall Study||53
2386547|NCT01423916|5857131|P1|COMPLETED|Overall Study||63
2386548|NCT01423916|5857129|P3|STARTED|Overall Study||71
2386549|NCT01423916|5857130|P2|STARTED|Overall Study||73
2386550|NCT01423916|5857131|P1|STARTED|Overall Study||74
2386551|NCT01423812|5857187|P2|NOT COMPLETED|Overall Study||4
2386552|NCT01423812|5857188|P1|NOT COMPLETED|Overall Study||3
2386553|NCT01423812|5857187|P2|COMPLETED|Overall Study||26
2386554|NCT01423812|5857188|P1|COMPLETED|Overall Study||27
2386555|NCT01423812|5857187|P2|STARTED|Overall Study||30
2386556|NCT01423812|5857188|P1|STARTED|Overall Study||30
2386557|NCT01423773|5857196|P2|NOT COMPLETED|Period 2, 2 Days||0
2386558|NCT01423773|5857197|P1|NOT COMPLETED|Period 2, 2 Days||0
2386559|NCT01423773|5857196|P2|COMPLETED|Period 2, 2 Days||10
2386560|NCT01423773|5857197|P1|COMPLETED|Period 2, 2 Days||10
2386561|NCT01423773|5857196|P2|STARTED|Period 2, 2 Days||10
2386562|NCT01423773|5857197|P1|STARTED|Period 2, 2 Days||10
2386563|NCT01423773|5857196|P2|NOT COMPLETED|Period One, 2 Days||0
2386564|NCT01423773|5857197|P1|NOT COMPLETED|Period One, 2 Days||0
2386565|NCT01423773|5857196|P2|COMPLETED|Period One, 2 Days||10
2386566|NCT01423773|5857197|P1|COMPLETED|Period One, 2 Days||10
2386567|NCT01423773|5857196|P2|STARTED|Period One, 2 Days||10
2386568|NCT01423773|5857197|P1|STARTED|Period One, 2 Days||10
2386569|NCT01423760|5857205|P2|NOT COMPLETED|Overall Study||0
2386570|NCT01423760|5857206|P1|NOT COMPLETED|Overall Study||0
2386571|NCT01423760|5857205|P2|COMPLETED|Overall Study||13
2386572|NCT01423760|5857206|P1|COMPLETED|Overall Study||14
2386573|NCT01423760|5857205|P2|Safety Analysis Set|Overall Study||8
2386574|NCT01423760|5857206|P1|Safety Analysis Set|Overall Study||12
2386575|NCT01423760|5857205|P2|Number of Non-treatment Subjects|Overall Study||5
2386576|NCT01423760|5857206|P1|Number of Non-treatment Subjects|Overall Study||2
2386577|NCT01423760|5857205|P2|Number of Tecemotide Subjects|Overall Study||8
2386578|NCT01423760|5857206|P1|Number of Tecemotide Subjects|Overall Study||12
2386579|NCT01423760|5857205|P2|STARTED|Overall Study||13
2386580|NCT01423760|5857206|P1|STARTED|Overall Study||14
2386581|NCT01423617|5857216|P2|NOT COMPLETED|Overall Study||1
2386582|NCT01423617|5857217|P1|NOT COMPLETED|Overall Study||0
2386583|NCT01423617|5857216|P2|COMPLETED|Overall Study||45
2386584|NCT01423617|5857217|P1|COMPLETED|Overall Study||46
2386585|NCT01423617|5857216|P2|STARTED|Overall Study||46
2386586|NCT01423617|5857217|P1|STARTED|Overall Study||46
2386587|NCT01423604|5857234|P2|NOT COMPLETED|Randomized||63
2386588|NCT01423604|5857235|P1|NOT COMPLETED|Randomized||63
2386589|NCT01423604|5857234|P2|COMPLETED|Randomized||0
2386590|NCT01423604|5857235|P1|COMPLETED|Randomized|As of 07August2015, 1 subject was receiving treatment in the randomized portion.|1
2386591|NCT01423604|5857234|P2|STARTED|Randomized||63
2386592|NCT01423604|5857235|P1|STARTED|Randomized||64
2386593|NCT01423604|5857234|P2|NOT COMPLETED|Safety Run-In||0
2386594|NCT01423604|5857235|P1|NOT COMPLETED|Safety Run-In||9
2386595|NCT01423604|5857234|P2|COMPLETED|Safety Run-In||0
2386596|NCT01423604|5857235|P1|COMPLETED|Safety Run-In||0
2386597|NCT01423604|5857234|P2|STARTED|Safety Run-In||0
2386598|NCT01423604|5857235|P1|STARTED|Safety Run-In||9
2386599|NCT01423253|5857250|P1|NOT COMPLETED|Overall Study||9
2386600|NCT01423253|5857250|P1|COMPLETED|Overall Study||39
2386601|NCT01423253|5857250|P1|STARTED|Overall Study||48
2386602|NCT01423162|5857263|P2|NOT COMPLETED|Overall Study||0
2386603|NCT01423162|5857264|P1|NOT COMPLETED|Overall Study||0
2386604|NCT01423162|5857263|P2|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|9
2386605|NCT01423162|5857264|P1|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|11
2386606|NCT01423162|5857263|P2|STARTED|Overall Study||9
2386607|NCT01423162|5857264|P1|STARTED|Overall Study||11
2386608|NCT01423084|5857272|P2|NOT COMPLETED|Overall Study||4
2386609|NCT01423084|5857273|P1|NOT COMPLETED|Overall Study||2
2386610|NCT01423084|5857272|P2|COMPLETED|Overall Study||170
2386611|NCT01423084|5857273|P1|COMPLETED|Overall Study||168
2386612|NCT01423084|5857272|P2|STARTED|Overall Study||174
2386613|NCT01423084|5857273|P1|STARTED|Overall Study||170
2386614|NCT01422915|5857303|P1|NOT COMPLETED|Overall Study||1
2386615|NCT01422915|5857303|P1|COMPLETED|Overall Study||3
2386616|NCT01422915|5857303|P1|STARTED|Overall Study|1 subject with abnormal liver chemistries removed during the first period.|4
2386617|NCT01422889|5857308|P1|NOT COMPLETED|Overall Study||9
2386618|NCT01422889|5857308|P1|COMPLETED|Overall Study|9 subjects did not receive a study stent therefore 1111 subjects were eligible for follow up.|1111
2386619|NCT01422889|5857308|P1|STARTED|Overall Study||1120
2386620|NCT01422876|5857323|P10|NOT COMPLETED|Week 52||17
2386621|NCT01422876|5857324|P9|NOT COMPLETED|Week 52||21
2386622|NCT01422876|5857325|P8|NOT COMPLETED|Week 52||23
2386623|NCT01422876|5857326|P7|NOT COMPLETED|Week 52||16
2386624|NCT01422876|5857327|P6|NOT COMPLETED|Week 52||17
2386625|NCT01422876|5857328|P5|NOT COMPLETED|Week 52||15
2386626|NCT01422876|5857329|P4|NOT COMPLETED|Week 52||18
2386627|NCT01422876|5857330|P3|NOT COMPLETED|Week 52||13
2386628|NCT01422876|5857331|P2|NOT COMPLETED|Week 52||10
2386629|NCT01422876|5857332|P1|NOT COMPLETED|Week 52||12
2386630|NCT01422876|5857323|P10|COMPLETED|Week 52||118
2386631|NCT01422876|5857324|P9|COMPLETED|Week 52||113
2386632|NCT01422876|5857325|P8|COMPLETED|Week 52||112
2386633|NCT01422876|5857326|P7|COMPLETED|Week 52||120
2386634|NCT01422876|5857327|P6|COMPLETED|Week 52||120
2386635|NCT01422876|5857328|P5|COMPLETED|Week 52||117
2386636|NCT01422876|5857329|P4|COMPLETED|Week 52||122
2386637|NCT01422876|5857330|P3|COMPLETED|Week 52||128
2386638|NCT01422876|5857331|P2|COMPLETED|Week 52||126
2386639|NCT01422876|5857332|P1|COMPLETED|Week 52||125
2386640|NCT01422876|5857323|P10|STARTED|Week 52||135
2386641|NCT01422876|5857324|P9|STARTED|Week 52||134
2386642|NCT01422876|5857325|P8|STARTED|Week 52||135
2386643|NCT01422876|5857326|P7|STARTED|Week 52||136
2386644|NCT01422876|5857327|P6|STARTED|Week 52||137
2386645|NCT01422876|5857328|P5|STARTED|Week 52||132
2386646|NCT01422876|5857329|P4|STARTED|Week 52||140
2386647|NCT01422876|5857330|P3|STARTED|Week 52||141
2386648|NCT01422876|5857331|P2|STARTED|Week 52||136
2386649|NCT01422876|5857332|P1|STARTED|Week 52||137
2386650|NCT01422876|5857323|P10|NOT COMPLETED|Week 24||10
2386651|NCT01422876|5857324|P9|NOT COMPLETED|Week 24||6
2386652|NCT01422876|5857325|P8|NOT COMPLETED|Week 24||7
2386653|NCT01422876|5857326|P7|NOT COMPLETED|Week 24||6
2386654|NCT01422876|5857327|P6|NOT COMPLETED|Week 24||6
2386655|NCT01422876|5857328|P5|NOT COMPLETED|Week 24||7
2386656|NCT01422876|5857329|P4|NOT COMPLETED|Week 24||8
2386657|NCT01422876|5857330|P3|NOT COMPLETED|Week 24||5
2386658|NCT01422876|5857331|P2|NOT COMPLETED|Week 24||3
2386659|NCT01422876|5857332|P1|NOT COMPLETED|Week 24||6
2386660|NCT01422876|5857323|P10|COMPLETED|Week 24||125
2386661|NCT01422876|5857324|P9|COMPLETED|Week 24||128
2386662|NCT01422876|5857325|P8|COMPLETED|Week 24||128
2386663|NCT01422876|5857326|P7|COMPLETED|Week 24||130
2386664|NCT01422876|5857327|P6|COMPLETED|Week 24||131
2386665|NCT01422876|5857328|P5|COMPLETED|Week 24||125
2386666|NCT01422876|5857329|P4|COMPLETED|Week 24||132
2386667|NCT01422876|5857330|P3|COMPLETED|Week 24||136
2386668|NCT01422876|5857331|P2|COMPLETED|Week 24||133
2386669|NCT01422876|5857332|P1|COMPLETED|Week 24||131
2386670|NCT01422876|5857323|P10|STARTED|Week 24||135
2386671|NCT01422876|5857324|P9|STARTED|Week 24||134
2386672|NCT01422876|5857325|P8|STARTED|Week 24||135
2386673|NCT01422876|5857326|P7|STARTED|Week 24||136
2386674|NCT01422876|5857327|P6|STARTED|Week 24||137
2386675|NCT01422876|5857328|P5|STARTED|Week 24||132
2386676|NCT01422876|5857329|P4|STARTED|Week 24||140
2386677|NCT01422876|5857330|P3|STARTED|Week 24||141
2386678|NCT01422876|5857331|P2|STARTED|Week 24||136
2386679|NCT01422876|5857332|P1|STARTED|Week 24||137
2386680|NCT01422850|5857379|P1|NOT COMPLETED|Overall Study||3
2386681|NCT01422850|5857379|P1|COMPLETED|Overall Study||18
2386682|NCT01422850|5857379|P1|Week 15|Overall Study|One patient withdrawn by PI due to increased PSA. Started bicalutamide treatment.|18
2386683|NCT01422850|5857379|P1|Week 14 - Third Treatment|Overall Study|One patient withdrawn by PI and referred to external radiotherapy due to progressive disease.|19
2386684|NCT01422850|5857379|P1|Week 9 - Second Treatment|Overall Study||20
2386685|NCT01422850|5857379|P1|Week 5|Overall Study|One patient withdrawn by PI due to progressive disease|20
2386686|NCT01422850|5857379|P1|Week 4 - First Treatment|Overall Study||21
2386687|NCT01422850|5857379|P1|STARTED|Overall Study||21
2386688|NCT01422824|5857385|P1|NOT COMPLETED|Overall Study||38
2386689|NCT01422824|5857385|P1|COMPLETED|Overall Study||147
2386690|NCT01422824|5857385|P1|Treated|Overall Study||184
2386691|NCT01422824|5857385|P1|STARTED|Overall Study||185
2386692|NCT01422720|5857390|P1|NOT COMPLETED|Overall Study||22
2386693|NCT01422720|5857390|P1|COMPLETED|Overall Study||50
2386694|NCT01422720|5857390|P1|Per-Protocol Set (PPS)|Overall Study||55
2386695|NCT01422720|5857390|P1|Full Analysis Set (FAS)|Overall Study||71
2386696|NCT01422720|5857390|P1|Safety Set|Overall Study||72
2386697|NCT01422720|5857390|P1|STARTED|Overall Study||72
2386698|NCT01422538|5857401|P3|NOT COMPLETED|Overall Study||2
2386699|NCT01422538|5857402|P2|NOT COMPLETED|Overall Study||2
2386700|NCT01422538|5857403|P1|NOT COMPLETED|Overall Study||0
2386701|NCT01422538|5857401|P3|COMPLETED|Overall Study||8
2386702|NCT01422538|5857402|P2|COMPLETED|Overall Study||8
2386703|NCT01422538|5857403|P1|COMPLETED|Overall Study||10
2386704|NCT01422538|5857401|P3|STARTED|Overall Study||10
2386705|NCT01422538|5857402|P2|STARTED|Overall Study||10
2386706|NCT01422538|5857403|P1|STARTED|Overall Study||10
2386707|NCT01422434|5857428|P3|NOT COMPLETED|Overall Study||6
2386708|NCT01422434|5857429|P2|NOT COMPLETED|Overall Study||5
2386709|NCT01422434|5857430|P1|NOT COMPLETED|Overall Study||11
2386710|NCT01422434|5857428|P3|COMPLETED|Overall Study||217
2386711|NCT01422434|5857429|P2|COMPLETED|Overall Study||221
2386712|NCT01422434|5857430|P1|COMPLETED|Overall Study||216
2386713|NCT01422434|5857428|P3|STARTED|Overall Study||223
2386714|NCT01422434|5857429|P2|STARTED|Overall Study||226
2386715|NCT01422434|5857430|P1|STARTED|Overall Study||227
2386716|NCT01422408|5857447|P1|NOT COMPLETED|Overall Study||4
2386717|NCT01422408|5857447|P1|COMPLETED|Overall Study||30
2386718|NCT01422408|5857447|P1|STARTED|Overall Study||34
2386719|NCT01422382|5857476|P1|NOT COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||1
2386720|NCT01422382|5857476|P1|COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||27
2386721|NCT01422382|5857476|P1|STARTED|NK-104 4mg QD and Diltiazem 240 mg QD||28
2386722|NCT01422382|5857476|P1|NOT COMPLETED|Diltiazem 240 mg QD||0
2386723|NCT01422382|5857476|P1|COMPLETED|Diltiazem 240 mg QD||28
2386724|NCT01422382|5857476|P1|STARTED|Diltiazem 240 mg QD||28
2386725|NCT01422382|5857476|P1|NOT COMPLETED|NK-104 4mg Once Daily (QD)||0
2386726|NCT01422382|5857476|P1|COMPLETED|NK-104 4mg Once Daily (QD)||28
2386727|NCT01422382|5857476|P1|STARTED|NK-104 4mg Once Daily (QD)||28
2386728|NCT01422369|5857481|P1|NOT COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||1
2386729|NCT01422369|5857481|P1|COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||27
2386730|NCT01422369|5857481|P1|STARTED|NK-104 4mg QD & Prezista 800mg/100mg QD||28
2386731|NCT01422369|5857481|P1|NOT COMPLETED|Prezista 800mg/100mg QD||0
2386732|NCT01422369|5857481|P1|COMPLETED|Prezista 800mg/100mg QD||28
2386733|NCT01422369|5857481|P1|STARTED|Prezista 800mg/100mg QD||28
2386734|NCT01422369|5857481|P1|NOT COMPLETED|NK-104 4mg QD||0
2386735|NCT01422369|5857481|P1|COMPLETED|NK-104 4mg QD||28
2386736|NCT01422369|5857481|P1|STARTED|NK-104 4mg QD||28
2386737|NCT01422356|5857486|P1|NOT COMPLETED|Overall Study||31
2386738|NCT01422356|5857486|P1|COMPLETED|Overall Study||169
2386739|NCT01422356|5857486|P1|STARTED|Overall Study||200
2386740|NCT01422304|5857492|P2|NOT COMPLETED|Overall Study||37
2386741|NCT01422304|5857493|P1|NOT COMPLETED|Overall Study||24
2386742|NCT01422304|5857492|P2|COMPLETED|Overall Study||563
2386743|NCT01422304|5857493|P1|COMPLETED|Overall Study||574
2386744|NCT01422304|5857492|P2|Treated|Overall Study|1 given sugammadex; thus All Participants as Treated (APaT) Ns are 596 Sugammadex, 588 Usual Care|589
2386745|NCT01422304|5857493|P1|Treated|Overall Study||595
2386746|NCT01422304|5857492|P2|STARTED|Overall Study|Randomized|600
2386747|NCT01422304|5857493|P1|STARTED|Overall Study|Randomized|598
2386748|NCT01422239|5857525|P2|NOT COMPLETED|Overall Study||3
2386749|NCT01422239|5857526|P1|NOT COMPLETED|Overall Study||4
2386750|NCT01422239|5857525|P2|COMPLETED|Overall Study||3
2386751|NCT01422239|5857526|P1|COMPLETED|Overall Study||10
2386752|NCT01422239|5857525|P2|STARTED|Overall Study||6
2386753|NCT01422239|5857526|P1|STARTED|Overall Study||14
2386754|NCT01422226|5857538|P2|NOT COMPLETED|Overall Study||0
2386755|NCT01422226|5857539|P1|NOT COMPLETED|Overall Study||0
2386756|NCT01422226|5857538|P2|COMPLETED|Overall Study||2
2386757|NCT01422226|5857539|P1|COMPLETED|Overall Study||1
2386758|NCT01422226|5857538|P2|STARTED|Overall Study||2
2386759|NCT01422226|5857539|P1|STARTED|Overall Study||1
2386760|NCT01422213|5857548|P3|NOT COMPLETED|Overall Study||29
2386761|NCT01422213|5857549|P2|NOT COMPLETED|Overall Study||22
2386762|NCT01422213|5857550|P1|NOT COMPLETED|Overall Study||33
2386763|NCT01422213|5857548|P3|COMPLETED|Overall Study||178
2386764|NCT01422213|5857549|P2|COMPLETED|Overall Study||173
2386765|NCT01422213|5857550|P1|COMPLETED|Overall Study||163
2386766|NCT01422213|5857548|P3|STARTED|Overall Study||207
2386767|NCT01422213|5857549|P2|STARTED|Overall Study||195
2386768|NCT01422213|5857550|P1|STARTED|Overall Study||196
2386769|NCT01422187|5857611|P3|NOT COMPLETED|Overall Study||0
2386770|NCT01422187|5857612|P2|NOT COMPLETED|Overall Study||1
2386771|NCT01422187|5857613|P1|NOT COMPLETED|Overall Study||1
2386772|NCT01422187|5857611|P3|COMPLETED|Overall Study||2
2386773|NCT01422187|5857612|P2|COMPLETED|Overall Study||8
2386774|NCT01422187|5857613|P1|COMPLETED|Overall Study||7
2386775|NCT01422187|5857611|P3|STARTED|Overall Study||2
2386776|NCT01422187|5857612|P2|STARTED|Overall Study||9
2386777|NCT01422187|5857613|P1|STARTED|Overall Study||8
2386778|NCT01422161|5857632|P2|NOT COMPLETED|Overall Study||0
2386779|NCT01422161|5857633|P1|NOT COMPLETED|Overall Study||0
2386780|NCT01422161|5857632|P2|COMPLETED|Overall Study||6
2386781|NCT01422161|5857633|P1|COMPLETED|Overall Study||10
2386782|NCT01422161|5857632|P2|STARTED|Overall Study||6
2386783|NCT01422161|5857633|P1|STARTED|Overall Study||10
2386784|NCT01422135|5857649|P6|NOT COMPLETED|Overall Study||1
2386785|NCT01422135|5857650|P5|NOT COMPLETED|Overall Study||0
2386786|NCT01422135|5857651|P4|NOT COMPLETED|Overall Study||0
2386787|NCT01422135|5857652|P3|NOT COMPLETED|Overall Study||1
2386788|NCT01422135|5857653|P2|NOT COMPLETED|Overall Study||0
2386789|NCT01422135|5857654|P1|NOT COMPLETED|Overall Study||0
2386790|NCT01422135|5857649|P6|COMPLETED|Overall Study||3
2386791|NCT01422135|5857650|P5|COMPLETED|Overall Study||4
2386792|NCT01422135|5857651|P4|COMPLETED|Overall Study||4
2386793|NCT01422135|5857652|P3|COMPLETED|Overall Study||3
2386794|NCT01422135|5857653|P2|COMPLETED|Overall Study||4
2386795|NCT01422135|5857654|P1|COMPLETED|Overall Study||4
2386796|NCT01422135|5857649|P6|STARTED|Overall Study||4
2386797|NCT01422135|5857650|P5|STARTED|Overall Study||4
2386798|NCT01422135|5857651|P4|STARTED|Overall Study||4
2386799|NCT01422135|5857652|P3|STARTED|Overall Study||4
2386800|NCT01422135|5857653|P2|STARTED|Overall Study||4
2386801|NCT01422135|5857654|P1|STARTED|Overall Study||4
2386802|NCT01422070|5857665|P2|NOT COMPLETED|Overall Study||0
2386803|NCT01422070|5857666|P1|NOT COMPLETED|Overall Study||0
2386804|NCT01422070|5857665|P2|COMPLETED|Overall Study||803
2386805|NCT01422070|5857666|P1|COMPLETED|Overall Study||5031
2386806|NCT01422070|5857665|P2|STARTED|Overall Study|Number of patients admitted to 27 intensive care units.|803
2386807|NCT01422070|5857666|P1|STARTED|Overall Study|Number of patients admitted to 140 intensive care units|5031
2386808|NCT01421719|5857677|P1|NOT COMPLETED|Overall Study||4
2386809|NCT01421719|5857677|P1|COMPLETED|Overall Study||16
2386810|NCT01421719|5857677|P1|STARTED|Overall Study||20
2386811|NCT01421667|5857686|P4|NOT COMPLETED|Overall Study||1
2386812|NCT01421667|5857687|P3|NOT COMPLETED|Overall Study||2
2386813|NCT01421667|5857688|P2|NOT COMPLETED|Overall Study||2
2386814|NCT01421667|5857689|P1|NOT COMPLETED|Overall Study||0
2386815|NCT01421667|5857686|P4|COMPLETED|Overall Study|Completed per protocol due to death [7] or study termination by sponsor [8]|15
2386816|NCT01421667|5857687|P3|COMPLETED|Overall Study|Completed per protocol due to death [33] or study termination by sponsor [18]|51
2386817|NCT01421667|5857688|P2|COMPLETED|Overall Study|Completed per protocol due to death [45] or study termination by sponsor [21]|66
2386818|NCT01421667|5857689|P1|COMPLETED|Overall Study|Completed per protocol due to death [24] or study termination by sponsor [11]|35
2386819|NCT01421667|5857686|P4|STARTED|Overall Study||16
2386820|NCT01421667|5857687|P3|STARTED|Overall Study||53
2386821|NCT01421667|5857688|P2|STARTED|Overall Study||68
2386822|NCT01421667|5857689|P1|STARTED|Overall Study||35
2386823|NCT01421654|5857741|P2|NOT COMPLETED|Overall Study||0
2386824|NCT01421654|5857742|P1|NOT COMPLETED|Overall Study||0
2386825|NCT01421654|5857741|P2|COMPLETED|Overall Study|10 subjects completed study, but 1 subject was found to not meet IEC at the end; data was not used.|9
2386826|NCT01421654|5857742|P1|COMPLETED|Overall Study||11
2386827|NCT01421654|5857741|P2|STARTED|Overall Study||9
2386828|NCT01421654|5857742|P1|STARTED|Overall Study||11
2386829|NCT01421641|5857750|P2|NOT COMPLETED|Overall Study||2
2386830|NCT01421641|5857751|P1|NOT COMPLETED|Overall Study||2
2386831|NCT01421641|5857750|P2|COMPLETED|Overall Study||35
2386832|NCT01421641|5857751|P1|COMPLETED|Overall Study||35
2386833|NCT01421641|5857750|P2|STARTED|Overall Study||37
2386834|NCT01421641|5857751|P1|STARTED|Overall Study||37
2386835|NCT01421589|5857761|P1|NOT COMPLETED|Overall Study||0
2386836|NCT01421589|5857761|P1|COMPLETED|Overall Study||15
2386837|NCT01421589|5857761|P1|STARTED|Overall Study||15
2386838|NCT01421511|5857773|P2|NOT COMPLETED|Overall Study||28
2386839|NCT01421511|5857774|P1|NOT COMPLETED|Overall Study||19
2386840|NCT01421511|5857773|P2|COMPLETED|Overall Study||306
2386841|NCT01421511|5857774|P1|COMPLETED|Overall Study||313
2386842|NCT01421511|5857773|P2|STARTED|Overall Study||334
2386843|NCT01421511|5857774|P1|STARTED|Overall Study||332
2386844|NCT01421498|5857796|P2|NOT COMPLETED|Overall Study||11
2386845|NCT01421498|5857797|P1|NOT COMPLETED|Overall Study||12
2386846|NCT01421498|5857796|P2|COMPLETED|Overall Study||284
2386847|NCT01421498|5857797|P1|COMPLETED|Overall Study||281
2386848|NCT01421498|5857796|P2|STARTED|Overall Study||295
2386849|NCT01421498|5857797|P1|STARTED|Overall Study||293
2386850|NCT01421472|5857809|P4|NOT COMPLETED|Overall Study||0
2386851|NCT01421472|5857810|P3|NOT COMPLETED|Overall Study||0
2386852|NCT01421472|5857811|P2|NOT COMPLETED|Overall Study||0
2386853|NCT01421472|5857812|P1|NOT COMPLETED|Overall Study||0
2386854|NCT01421472|5857809|P4|COMPLETED|Overall Study||32
2386855|NCT01421472|5857810|P3|COMPLETED|Overall Study||64
2386856|NCT01421472|5857811|P2|COMPLETED|Overall Study||33
2386857|NCT01421472|5857812|P1|COMPLETED|Overall Study||67
2386858|NCT01421472|5857809|P4|STARTED|Overall Study||32
2386859|NCT01421472|5857810|P3|STARTED|Overall Study||64
2386860|NCT01421472|5857811|P2|STARTED|Overall Study||33
2386861|NCT01421472|5857812|P1|STARTED|Overall Study||67
2386862|NCT01421459|5857824|P2|NOT COMPLETED|Overall Study||52
2386863|NCT01421459|5857825|P1|NOT COMPLETED|Overall Study||45
2386864|NCT01421459|5857824|P2|COMPLETED|Overall Study||328
2386865|NCT01421459|5857825|P1|COMPLETED|Overall Study||334
2386866|NCT01421459|5857824|P2|Received at Least 1 Dose of Study Drug|Overall Study||380
2386867|NCT01421459|5857825|P1|Received at Least 1 Dose of Study Drug|Overall Study||376
2386868|NCT01421459|5857824|P2|STARTED|Overall Study||380
2386869|NCT01421459|5857825|P1|STARTED|Overall Study||379
2386870|NCT01421355|5857859|P1|NOT COMPLETED|Overall Study||6
2386871|NCT01421355|5857859|P1|COMPLETED|Overall Study||15
2386872|NCT01421355|5857859|P1|STARTED|Overall Study||21
2386873|NCT01421342|5857866|P3|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||65
2386874|NCT01421342|5857867|P2|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||59
2386875|NCT01421342|5857868|P1|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||52
2386876|NCT01421342|5857866|P3|COMPLETED|Continuation of Treatment (Week 12 - 36)||203
2386877|NCT01421342|5857867|P2|COMPLETED|Continuation of Treatment (Week 12 - 36)||194
2386878|NCT01421342|5857868|P1|COMPLETED|Continuation of Treatment (Week 12 - 36)||152
2386879|NCT01421342|5857866|P3|STARTED|Continuation of Treatment (Week 12 - 36)||268
2386880|NCT01421342|5857867|P2|STARTED|Continuation of Treatment (Week 12 - 36)||253
2386881|NCT01421342|5857868|P1|STARTED|Continuation of Treatment (Week 12 - 36)||204
2386882|NCT01421342|5857866|P3|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||138
2386883|NCT01421342|5857867|P2|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||125
2386884|NCT01421342|5857868|P1|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||149
2386885|NCT01421342|5857866|P3|COMPLETED|Completed to Week 12 But Then Withdrawn||268
2386886|NCT01421342|5857867|P2|COMPLETED|Completed to Week 12 But Then Withdrawn||253
2386887|NCT01421342|5857868|P1|COMPLETED|Completed to Week 12 But Then Withdrawn||204
2386888|NCT01421342|5857866|P3|STARTED|Completed to Week 12 But Then Withdrawn||406
2386889|NCT01421342|5857867|P2|STARTED|Completed to Week 12 But Then Withdrawn||378
2386890|NCT01421342|5857868|P1|STARTED|Completed to Week 12 But Then Withdrawn||353
2386891|NCT01421342|5857866|P3|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||99
2386892|NCT01421342|5857867|P2|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||128
2386893|NCT01421342|5857868|P1|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||158
2386894|NCT01421342|5857866|P3|COMPLETED|Acute Treatment Phase (12 Weeks)||406
2386895|NCT01421342|5857867|P2|COMPLETED|Acute Treatment Phase (12 Weeks)||378
2386896|NCT01421342|5857868|P1|COMPLETED|Acute Treatment Phase (12 Weeks)||353
2386897|NCT01421342|5857866|P3|STARTED|Acute Treatment Phase (12 Weeks)||505
2386898|NCT01421342|5857867|P2|STARTED|Acute Treatment Phase (12 Weeks)||506
2386899|NCT01421342|5857868|P1|STARTED|Acute Treatment Phase (12 Weeks)||511
2386900|NCT01421303|5857885|P1|NOT COMPLETED|Overall Study||22
2386901|NCT01421303|5857885|P1|COMPLETED|Overall Study||58
2386902|NCT01421303|5857885|P1|STARTED|Overall Study||80
2386903|NCT01421277|5857912|P2|NOT COMPLETED|Overall Study||92
2386904|NCT01421277|5857913|P1|NOT COMPLETED|Overall Study||0
2386905|NCT01421277|5857912|P2|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|99
2386906|NCT01421277|5857913|P1|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|25
2386907|NCT01421277|5857912|P2|STARTED|Overall Study||191
2386908|NCT01421277|5857913|P1|STARTED|Overall Study||25
2386909|NCT01421225|5857925|P2|NOT COMPLETED|Overall Study||1
2386910|NCT01421225|5857926|P1|NOT COMPLETED|Overall Study||0
2386911|NCT01421225|5857925|P2|COMPLETED|Overall Study||5
2386912|NCT01421225|5857926|P1|COMPLETED|Overall Study||4
2386913|NCT01421225|5857925|P2|STARTED|Overall Study||6
2386914|NCT01421225|5857926|P1|STARTED|Overall Study||4
2386915|NCT01421147|5857940|P2|NOT COMPLETED|Extension Period||11
2386916|NCT01421147|5857941|P1|NOT COMPLETED|Extension Period||8
2386917|NCT01421147|5857940|P2|COMPLETED|Extension Period||245
2386918|NCT01421147|5857941|P1|COMPLETED|Extension Period||245
2386919|NCT01421147|5857940|P2|STARTED|Extension Period||256
2386920|NCT01421147|5857941|P1|STARTED|Extension Period||253
2386921|NCT01421147|5857940|P2|NOT COMPLETED|Treatment Period||11
2386922|NCT01421147|5857941|P1|NOT COMPLETED|Treatment Period||16
2386923|NCT01421147|5857940|P2|COMPLETED|Treatment Period||256
2386924|NCT01421147|5857941|P1|COMPLETED|Treatment Period||253
2386925|NCT01421147|5857940|P2|Received at Least 1 Dose of Study Drug|Treatment Period||267
2386926|NCT01421147|5857941|P1|Received at Least 1 Dose of Study Drug|Treatment Period||268
2386927|NCT01421147|5857940|P2|STARTED|Treatment Period||267
2386928|NCT01421147|5857941|P1|STARTED|Treatment Period||269
2386929|NCT01421134|5857973|P2|NOT COMPLETED|Overall Study||15
2386930|NCT01421134|5857974|P1|NOT COMPLETED|Overall Study||7
2386931|NCT01421134|5857973|P2|COMPLETED|Overall Study||87
2386932|NCT01421134|5857974|P1|COMPLETED|Overall Study||102
2386933|NCT01421134|5857973|P2|STARTED|Overall Study||102
2386934|NCT01421134|5857974|P1|STARTED|Overall Study||109
2386935|NCT01420965|5857995|P3|NOT COMPLETED|Overall Study||0
2386936|NCT01420965|5857996|P2|NOT COMPLETED|Overall Study||1
2386937|NCT01420965|5857997|P1|NOT COMPLETED|Overall Study||1
2386938|NCT01420965|5857995|P3|COMPLETED|Overall Study||3
2386939|NCT01420965|5857996|P2|COMPLETED|Overall Study||1
2386940|NCT01420965|5857997|P1|COMPLETED|Overall Study||1
2386941|NCT01420965|5857995|P3|STARTED|Overall Study||3
2386942|NCT01420965|5857996|P2|STARTED|Overall Study||2
2386943|NCT01420965|5857997|P1|STARTED|Overall Study||2
2386950|NCT01420848|5858028|P3|NOT COMPLETED|Overall Study||0
2386951|NCT01420848|5858029|P2|NOT COMPLETED|Overall Study||0
2386952|NCT01420848|5858030|P1|NOT COMPLETED|Overall Study||0
2386953|NCT01420848|5858028|P3|COMPLETED|Overall Study||22
2386954|NCT01420848|5858029|P2|COMPLETED|Overall Study||25
2386955|NCT01420848|5858030|P1|COMPLETED|Overall Study||24
2386956|NCT01420848|5858028|P3|STARTED|Overall Study||22
2386957|NCT01420848|5858029|P2|STARTED|Overall Study||25
2386958|NCT01420848|5858030|P1|STARTED|Overall Study||24
2386959|NCT01420653|5858045|P4|NOT COMPLETED|Overall Study||7
2386960|NCT01420653|5858046|P3|NOT COMPLETED|Overall Study||4
2386961|NCT01420653|5858047|P2|NOT COMPLETED|Overall Study||3
2386962|NCT01420653|5858048|P1|NOT COMPLETED|Overall Study||3
2386963|NCT01420653|5858045|P4|COMPLETED|Overall Study||68
2386964|NCT01420653|5858046|P3|COMPLETED|Overall Study||108
2386965|NCT01420653|5858047|P2|COMPLETED|Overall Study||108
2386966|NCT01420653|5858048|P1|COMPLETED|Overall Study||107
2386967|NCT01420653|5858045|P4|STARTED|Overall Study||75
2386968|NCT01420653|5858046|P3|STARTED|Overall Study||112
2386969|NCT01420653|5858047|P2|STARTED|Overall Study||111
2386970|NCT01420653|5858048|P1|STARTED|Overall Study||110
2386971|NCT01420549|5858060|P2|NOT COMPLETED|Overall Study||5
2386972|NCT01420549|5858061|P1|NOT COMPLETED|Overall Study||7
2386973|NCT01420549|5858060|P2|COMPLETED|Overall Study||58
2386974|NCT01420549|5858061|P1|COMPLETED|Overall Study||59
2386975|NCT01420549|5858060|P2|STARTED|Overall Study||63
2386976|NCT01420549|5858061|P1|STARTED|Overall Study||66
2386977|NCT01420289|5858069|P2|NOT COMPLETED|Overall Study||0
2386978|NCT01420289|5858070|P1|NOT COMPLETED|Overall Study||0
2386979|NCT01420289|5858069|P2|COMPLETED|Overall Study||16
2386980|NCT01420289|5858070|P1|COMPLETED|Overall Study||18
2386981|NCT01420289|5858069|P2|STARTED|Overall Study||16
2386982|NCT01420289|5858070|P1|STARTED|Overall Study||18
2386983|NCT01420146|5858082|P1|NOT COMPLETED|Overall Study||0
2386984|NCT01420146|5858082|P1|COMPLETED|Overall Study||20
2386985|NCT01420146|5858082|P1|STARTED|Overall Study||20
2386986|NCT01420081|5858095|P9|NOT COMPLETED|Overall Study||3
2386987|NCT01420081|5858096|P8|NOT COMPLETED|Overall Study||3
2386988|NCT01420081|5858097|P7|NOT COMPLETED|Overall Study||3
2386989|NCT01420081|5858098|P6|NOT COMPLETED|Overall Study||20
2386990|NCT01420081|5858099|P5|NOT COMPLETED|Overall Study||20
2386991|NCT01420081|5858100|P4|NOT COMPLETED|Overall Study||3
2386992|NCT01420081|5858101|P3|NOT COMPLETED|Overall Study||11
2386993|NCT01420081|5858102|P2|NOT COMPLETED|Overall Study||1
2386994|NCT01420081|5858103|P1|NOT COMPLETED|Overall Study||3
2386995|NCT01420081|5858095|P9|COMPLETED|Overall Study||0
2386996|NCT01420081|5858096|P8|COMPLETED|Overall Study||0
2386997|NCT01420081|5858097|P7|COMPLETED|Overall Study||0
2386998|NCT01420081|5858098|P6|COMPLETED|Overall Study||0
2386999|NCT01420081|5858099|P5|COMPLETED|Overall Study||0
2387000|NCT01420081|5858100|P4|COMPLETED|Overall Study||0
2387001|NCT01420081|5858101|P3|COMPLETED|Overall Study||0
2387002|NCT01420081|5858102|P2|COMPLETED|Overall Study||0
2387003|NCT01420081|5858103|P1|COMPLETED|Overall Study||0
2387004|NCT01420081|5858095|P9|STARTED|Overall Study||3
2387005|NCT01420081|5858096|P8|STARTED|Overall Study||3
2387006|NCT01420081|5858097|P7|STARTED|Overall Study||3
2387007|NCT01420081|5858098|P6|STARTED|Overall Study||20
2387008|NCT01420081|5858099|P5|STARTED|Overall Study||20
2387009|NCT01420081|5858100|P4|STARTED|Overall Study||3
2387010|NCT01420081|5858101|P3|STARTED|Overall Study||11
2387011|NCT01420081|5858102|P2|STARTED|Overall Study||1
2387012|NCT01420081|5858103|P1|STARTED|Overall Study||3
2387013|NCT01420068|5858184|P2|NOT COMPLETED|Overall Study||5
2387014|NCT01420068|5858185|P1|NOT COMPLETED|Overall Study||2
2387015|NCT01420068|5858184|P2|COMPLETED|Overall Study||50
2387016|NCT01420068|5858185|P1|COMPLETED|Overall Study||49
2387017|NCT01420068|5858184|P2|STARTED|Overall Study||55
2387018|NCT01420068|5858185|P1|STARTED|Overall Study||51
2387019|NCT01420016|5858207|P4|NOT COMPLETED|Safety Analysis||0
2387020|NCT01420016|5858208|P3|NOT COMPLETED|Safety Analysis||0
2387021|NCT01420016|5858209|P2|NOT COMPLETED|Safety Analysis||0
2387022|NCT01420016|5858210|P1|NOT COMPLETED|Safety Analysis||0
2387023|NCT01420016|5858207|P4|COMPLETED|Safety Analysis||5159
2387024|NCT01420016|5858208|P3|COMPLETED|Safety Analysis||6392
2387025|NCT01420016|5858209|P2|COMPLETED|Safety Analysis||0
2387026|NCT01420016|5858210|P1|COMPLETED|Safety Analysis||0
2387027|NCT01420016|5858207|P4|STARTED|Safety Analysis||5159
2387028|NCT01420016|5858208|P3|STARTED|Safety Analysis||6392
2387029|NCT01420016|5858209|P2|STARTED|Safety Analysis||0
2387030|NCT01420016|5858210|P1|STARTED|Safety Analysis||0
2387031|NCT01420016|5858207|P4|NOT COMPLETED|Primary Analysis||0
2387032|NCT01420016|5858208|P3|NOT COMPLETED|Primary Analysis||0
2387033|NCT01420016|5858209|P2|NOT COMPLETED|Primary Analysis||2540
2387034|NCT01420016|5858210|P1|NOT COMPLETED|Primary Analysis||2927
2387035|NCT01420016|5858207|P4|COMPLETED|Primary Analysis||0
2387036|NCT01420016|5858208|P3|COMPLETED|Primary Analysis||0
2387037|NCT01420016|5858209|P2|COMPLETED|Primary Analysis|Reflects patient participants included in final analysis.|3871
2387038|NCT01420016|5858210|P1|COMPLETED|Primary Analysis|Reflects patient participants included in final analysis.|4043
2387039|NCT01420016|5858207|P4|STARTED|Primary Analysis||0
2387040|NCT01420016|5858208|P3|STARTED|Primary Analysis||0
2387041|NCT01420016|5858209|P2|STARTED|Primary Analysis||6411
2387042|NCT01420016|5858210|P1|STARTED|Primary Analysis||6970
2387043|NCT01419977|5858218|P2|NOT COMPLETED|Overall Study||0
2387044|NCT01419977|5858219|P1|NOT COMPLETED|Overall Study||0
2387045|NCT01419977|5858218|P2|COMPLETED|Overall Study||13
2387046|NCT01419977|5858219|P1|COMPLETED|Overall Study||16
2387047|NCT01419977|5858218|P2|STARTED|Overall Study||13
2387048|NCT01419977|5858219|P1|STARTED|Overall Study||16
2387049|NCT01419795|5858233|P2|NOT COMPLETED|Overall Study||0
2387050|NCT01419795|5858234|P1|NOT COMPLETED|Overall Study||0
2387051|NCT01419795|5858233|P2|COMPLETED|Overall Study||0
2387052|NCT01419795|5858234|P1|COMPLETED|Overall Study||3
2387053|NCT01419795|5858233|P2|STARTED|Overall Study||0
2387054|NCT01419795|5858234|P1|STARTED|Overall Study||3
2387055|NCT01419769|5858256|P1|NOT COMPLETED|Overall Study||4
2387056|NCT01419769|5858256|P1|COMPLETED|Overall Study||29
2387057|NCT01419769|5858256|P1|STARTED|Overall Study||33
2387058|NCT01419717|5858269|P1|NOT COMPLETED|Overall Study||125
2387059|NCT01419717|5858269|P1|COMPLETED|Overall Study||4
2387060|NCT01419717|5858269|P1|Received Denosumab|Overall Study||128
2387061|NCT01419717|5858269|P1|STARTED|Overall Study||129
2387062|NCT01419639|5858274|P1|NOT COMPLETED|Overall Study||1
2387063|NCT01419639|5858274|P1|COMPLETED|Overall Study||9
2387064|NCT01419639|5858274|P1|STARTED|Overall Study||10
2387065|NCT01419626|5858283|P3|NOT COMPLETED|Overall Study||3
2387066|NCT01419626|5858284|P2|NOT COMPLETED|Overall Study||3
2387067|NCT01419626|5858285|P1|NOT COMPLETED|Overall Study||4
2387068|NCT01419626|5858283|P3|COMPLETED|Overall Study||44
2387069|NCT01419626|5858284|P2|COMPLETED|Overall Study||44
2387070|NCT01419626|5858285|P1|COMPLETED|Overall Study||42
2387071|NCT01419626|5858283|P3|STARTED|Overall Study||47
2387072|NCT01419626|5858284|P2|STARTED|Overall Study||47
2387073|NCT01419626|5858285|P1|STARTED|Overall Study||46
2387074|NCT01419314|5858316|P2|NOT COMPLETED|Follow-up at Week 6 of the Trial||2
2387075|NCT01419314|5858317|P1|NOT COMPLETED|Follow-up at Week 6 of the Trial||1
2387076|NCT01419314|5858316|P2|COMPLETED|Follow-up at Week 6 of the Trial||19
2387077|NCT01419314|5858317|P1|COMPLETED|Follow-up at Week 6 of the Trial|2 people who missed the first follow-up, returned for the final follow-up at week 6 (n=18).|16
2387078|NCT01419314|5858316|P2|STARTED|Follow-up at Week 6 of the Trial|2 participants did not return for their final follow-up|21
2387079|NCT01419314|5858317|P1|STARTED|Follow-up at Week 6 of the Trial||17
2387080|NCT01419314|5858316|P2|NOT COMPLETED|Follow-up at Week 3 of the Trial||1
2387081|NCT01419314|5858317|P1|NOT COMPLETED|Follow-up at Week 3 of the Trial||6
2387082|NCT01419314|5858316|P2|COMPLETED|Follow-up at Week 3 of the Trial||21
2387083|NCT01419314|5858317|P1|COMPLETED|Follow-up at Week 3 of the Trial||17
2387084|NCT01419314|5858316|P2|STARTED|Follow-up at Week 3 of the Trial|one participant failed to return for the 3 week follow-up|22
2387085|NCT01419314|5858317|P1|STARTED|Follow-up at Week 3 of the Trial|3 participants discontinued the trial, 3 failed to return for additional follow-ups.|23
2387086|NCT01419314|5858316|P2|NOT COMPLETED|Start of Study||0
2387087|NCT01419314|5858317|P1|NOT COMPLETED|Start of Study||0
2387088|NCT01419314|5858316|P2|COMPLETED|Start of Study||22
2387089|NCT01419314|5858317|P1|COMPLETED|Start of Study||23
2387090|NCT01419314|5858316|P2|STARTED|Start of Study|No comfort issues reported.|22
2387091|NCT01419314|5858317|P1|STARTED|Start of Study|minor comfort issues were reported within the first 2 weeks of the trial|23
2387092|NCT01419275|5858337|P1|NOT COMPLETED|Overall Study||0
2387093|NCT01419275|5858337|P1|COMPLETED|Overall Study||126
2387094|NCT01419275|5858337|P1|STARTED|Overall Study||126
2387095|NCT01419249|5858343|P2|NOT COMPLETED|Overall Study||0
2387096|NCT01419249|5858344|P1|NOT COMPLETED|Overall Study||0
2387097|NCT01419249|5858343|P2|COMPLETED|Overall Study||140
2387098|NCT01419249|5858344|P1|COMPLETED|Overall Study||318
2387099|NCT01419249|5858343|P2|STARTED|Overall Study||140
2387100|NCT01419249|5858344|P1|STARTED|Overall Study||318
2387101|NCT01419236|5858358|P2|NOT COMPLETED|Overall Study||5
2387102|NCT01419236|5858359|P1|NOT COMPLETED|Overall Study||5
2387103|NCT01419236|5858358|P2|COMPLETED|Overall Study||35
2387104|NCT01419236|5858359|P1|COMPLETED|Overall Study||31
2387105|NCT01419236|5858358|P2|Received at Least 1 Dose of Study Drug|Overall Study||39
2387106|NCT01419236|5858359|P1|Received at Least 1 Dose of Study Drug|Overall Study||35
2387107|NCT01419236|5858358|P2|STARTED|Overall Study||40
2387108|NCT01419236|5858359|P1|STARTED|Overall Study||36
2387109|NCT01419197|5858383|P2|NOT COMPLETED|Overall Study||198
2387110|NCT01419197|5858384|P1|NOT COMPLETED|Overall Study||404
2387111|NCT01419197|5858383|P2|COMPLETED|Overall Study||0
2387112|NCT01419197|5858384|P1|COMPLETED|Overall Study||0
2387113|NCT01419197|5858383|P2|Switched to Trastuzumab Emtansine|Overall Study||94
2387114|NCT01419197|5858384|P1|Switched to Trastuzumab Emtansine|Overall Study||0
2387115|NCT01419197|5858383|P2|STARTED|Overall Study||198
2387116|NCT01419197|5858384|P1|STARTED|Overall Study||404
2387117|NCT01419184|5858409|P2|NOT COMPLETED|Overall Study||15
2387118|NCT01419184|5858410|P1|NOT COMPLETED|Overall Study||10
2387119|NCT01419184|5858409|P2|COMPLETED|Overall Study|13 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|106
2387120|NCT01419184|5858410|P1|COMPLETED|Overall Study|6 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|118
2387121|NCT01419184|5858409|P2|Received at Least 1 Dose of Study Drug|Overall Study||106
2387122|NCT01419184|5858410|P1|Received at Least 1 Dose of Study Drug|Overall Study||118
2387123|NCT01419184|5858409|P2|STARTED|Overall Study||121
2387124|NCT01419184|5858410|P1|STARTED|Overall Study||128
2387125|NCT01419171|5858426|P1|NOT COMPLETED|Overall Study||0
2387126|NCT01419171|5858426|P1|COMPLETED|Overall Study||328
2387127|NCT01419171|5858426|P1|STARTED|Overall Study||328
2387128|NCT01419080|5858443|P1|NOT COMPLETED|Overall Study||131
2387129|NCT01419080|5858443|P1|COMPLETED|Overall Study||666
2387130|NCT01419080|5858443|P1|STARTED|Overall Study||797
2387131|NCT01419028|5858449|P1|NOT COMPLETED|Overall Study||0
2387132|NCT01419028|5858449|P1|COMPLETED|Overall Study||48
2387133|NCT01419028|5858449|P1|STARTED|Overall Study||48
2387134|NCT01418937|5858454|P1|NOT COMPLETED|Overall Study||8
2387135|NCT01418937|5858454|P1|COMPLETED|Overall Study||156
2387136|NCT01418937|5858454|P1|STARTED|Overall Study||164
2387137|NCT01418703|5858463|P4|NOT COMPLETED|Overall Study||0
2387138|NCT01418703|5858464|P3|NOT COMPLETED|Overall Study||0
2387139|NCT01418703|5858465|P2|NOT COMPLETED|Overall Study||0
2387140|NCT01418703|5858466|P1|NOT COMPLETED|Overall Study||0
2387141|NCT01418703|5858463|P4|COMPLETED|Overall Study||6
2387142|NCT01418703|5858464|P3|COMPLETED|Overall Study||6
2387143|NCT01418703|5858465|P2|COMPLETED|Overall Study||13
2387144|NCT01418703|5858466|P1|COMPLETED|Overall Study||13
2387145|NCT01418703|5858463|P4|STARTED|Overall Study||6
2387146|NCT01418703|5858464|P3|STARTED|Overall Study||6
2387147|NCT01418703|5858465|P2|STARTED|Overall Study||13
2387148|NCT01418703|5858466|P1|STARTED|Overall Study||13
2387149|NCT01418482|5858477|P1|NOT COMPLETED|Overall Study||0
2387150|NCT01418482|5858477|P1|COMPLETED|Overall Study||15
2387151|NCT01418482|5858477|P1|STARTED|Overall Study||15
2387152|NCT01418378|5858485|P2|NOT COMPLETED|Overall Study||5
2387153|NCT01418378|5858486|P1|NOT COMPLETED|Overall Study||1
2387154|NCT01418378|5858485|P2|COMPLETED|Overall Study||83
2387155|NCT01418378|5858486|P1|COMPLETED|Overall Study||89
2387156|NCT01418378|5858485|P2|Subjects Who Received Study Implant|Overall Study|the number of subjects implanted with study implant|88
2387157|NCT01418378|5858486|P1|Subjects Who Received Study Implant|Overall Study|the number of subjects implanted with study implant|90
2387158|NCT01418378|5858485|P2|STARTED|Overall Study|A total of 191 subjects were enrolled into the study. 13/191 did not receive a study implant|88
2387159|NCT01418378|5858486|P1|STARTED|Overall Study|A total of 191 subjects were enrolled into the study. 13/191 did not receive a study implant|90
2387160|NCT01418365|5858560|P2|NOT COMPLETED|Second Intervention||1
2387161|NCT01418365|5858561|P1|NOT COMPLETED|Second Intervention||0
2387162|NCT01418365|5858560|P2|COMPLETED|Second Intervention||13
2387163|NCT01418365|5858561|P1|COMPLETED|Second Intervention||14
2387164|NCT01418365|5858560|P2|STARTED|Second Intervention||14
2387165|NCT01418365|5858561|P1|STARTED|Second Intervention||14
2387166|NCT01418365|5858560|P2|NOT COMPLETED|First Intervention||1
2387167|NCT01418365|5858561|P1|NOT COMPLETED|First Intervention||1
2387168|NCT01418365|5858560|P2|COMPLETED|First Intervention||14
2387169|NCT01418365|5858561|P1|COMPLETED|First Intervention||14
2387170|NCT01418365|5858560|P2|STARTED|First Intervention||15
2387171|NCT01418365|5858561|P1|STARTED|First Intervention||15
2387172|NCT01418209|5858572|P3|NOT COMPLETED|Overall Study||4
2387173|NCT01418209|5858573|P2|NOT COMPLETED|Overall Study||3
2387174|NCT01418209|5858574|P1|NOT COMPLETED|Overall Study||2
2387175|NCT01418209|5858572|P3|COMPLETED|Overall Study||142
2387176|NCT01418209|5858573|P2|COMPLETED|Overall Study||93
2387177|NCT01418209|5858574|P1|COMPLETED|Overall Study||95
2387178|NCT01418209|5858572|P3|STARTED|Overall Study||146
2387179|NCT01418209|5858573|P2|STARTED|Overall Study||96
2387180|NCT01418209|5858574|P1|STARTED|Overall Study||97
2387181|NCT01418001|5858603|P1|NOT COMPLETED|Overall Study||0
2387182|NCT01418001|5858603|P1|COMPLETED|Overall Study||5
2387183|NCT01418001|5858603|P1|STARTED|Overall Study||5
2387184|NCT01417936|5858608|P1|NOT COMPLETED|Overall Study||0
2387185|NCT01417936|5858608|P1|COMPLETED|Overall Study||26
2387186|NCT01417936|5858608|P1|STARTED|Overall Study||26
2387187|NCT01417741|5858629|P2|NOT COMPLETED|Overall Study||0
2387188|NCT01417741|5858630|P1|NOT COMPLETED|Overall Study||0
2387189|NCT01417741|5858629|P2|COMPLETED|Overall Study|only 73 received the post op day phone phone call|86
2387190|NCT01417741|5858630|P1|COMPLETED|Overall Study||75
2387191|NCT01417741|5858629|P2|STARTED|Overall Study||86
2387192|NCT01417741|5858630|P1|STARTED|Overall Study||75
2387193|NCT01417481|5858638|P2|NOT COMPLETED|Second Period (8 Weeks)||0
2387194|NCT01417481|5858639|P1|NOT COMPLETED|Second Period (8 Weeks)||0
2387195|NCT01417481|5858638|P2|COMPLETED|Second Period (8 Weeks)||5
2387196|NCT01417481|5858639|P1|COMPLETED|Second Period (8 Weeks)||8
2387197|NCT01417481|5858638|P2|STARTED|Second Period (8 Weeks)||5
2387198|NCT01417481|5858639|P1|STARTED|Second Period (8 Weeks)||8
2387199|NCT01417481|5858638|P2|NOT COMPLETED|Washout (2 Weeks)||0
2387200|NCT01417481|5858639|P1|NOT COMPLETED|Washout (2 Weeks)||0
2387201|NCT01417481|5858638|P2|COMPLETED|Washout (2 Weeks)||5
2387202|NCT01417481|5858639|P1|COMPLETED|Washout (2 Weeks)||8
2387203|NCT01417481|5858638|P2|STARTED|Washout (2 Weeks)||5
2387204|NCT01417481|5858639|P1|STARTED|Washout (2 Weeks)||8
2387205|NCT01417481|5858638|P2|NOT COMPLETED|First Intervention (8 Weeks)||2
2387206|NCT01417481|5858639|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
2387207|NCT01417481|5858638|P2|COMPLETED|First Intervention (8 Weeks)||5
2387208|NCT01417481|5858639|P1|COMPLETED|First Intervention (8 Weeks)||8
2387209|NCT01417481|5858638|P2|STARTED|First Intervention (8 Weeks)||7
2387210|NCT01417481|5858639|P1|STARTED|First Intervention (8 Weeks)||8
2387211|NCT01417455|5858671|P8|NOT COMPLETED|Overall Study||0
2387212|NCT01417455|5858672|P7|NOT COMPLETED|Overall Study||0
2387213|NCT01417455|5858673|P6|NOT COMPLETED|Overall Study||0
2387214|NCT01417455|5858674|P5|NOT COMPLETED|Overall Study||0
2387215|NCT01417455|5858675|P4|NOT COMPLETED|Overall Study||0
2387216|NCT01417455|5858676|P3|NOT COMPLETED|Overall Study||0
2387217|NCT01417455|5858677|P2|NOT COMPLETED|Overall Study||0
2387218|NCT01417455|5858678|P1|NOT COMPLETED|Overall Study||0
2387219|NCT01417455|5858671|P8|COMPLETED|Overall Study||25
2387220|NCT01417455|5858672|P7|COMPLETED|Overall Study||13
2387221|NCT01417455|5858673|P6|COMPLETED|Overall Study||13
2387222|NCT01417455|5858674|P5|COMPLETED|Overall Study||30
2387223|NCT01417455|5858675|P4|COMPLETED|Overall Study||17
2387224|NCT01417455|5858676|P3|COMPLETED|Overall Study||17
2387225|NCT01417455|5858677|P2|COMPLETED|Overall Study||16
2387226|NCT01417455|5858678|P1|COMPLETED|Overall Study||16
2387227|NCT01417455|5858671|P8|STARTED|Overall Study||25
2387228|NCT01417455|5858672|P7|STARTED|Overall Study||13
2387229|NCT01417455|5858673|P6|STARTED|Overall Study||13
2387230|NCT01417455|5858674|P5|STARTED|Overall Study||30
2387231|NCT01417455|5858675|P4|STARTED|Overall Study||17
2387232|NCT01417455|5858676|P3|STARTED|Overall Study||17
2387233|NCT01417455|5858677|P2|STARTED|Overall Study||16
2387234|NCT01417455|5858678|P1|STARTED|Overall Study||16
2387235|NCT01417377|5858704|P1|NOT COMPLETED|Overall Study||13
2387236|NCT01417377|5858704|P1|COMPLETED|Overall Study||9
2387237|NCT01417377|5858704|P1|Treated|Overall Study||21
2387238|NCT01417377|5858704|P1|STARTED|Overall Study||22
2387239|NCT01417195|5858713|P2|NOT COMPLETED|Overall Study||1
2387240|NCT01417195|5858714|P1|NOT COMPLETED|Overall Study||3
2387241|NCT01417195|5858713|P2|COMPLETED|Overall Study||61
2387242|NCT01417195|5858714|P1|COMPLETED|Overall Study||57
2387243|NCT01417195|5858713|P2|STARTED|Overall Study||62
2387244|NCT01417195|5858714|P1|STARTED|Overall Study||60
2387245|NCT01417156|5858730|P1|NOT COMPLETED|Overall Study||14
2387246|NCT01417156|5858730|P1|COMPLETED|Overall Study||6
2387247|NCT01417156|5858730|P1|STARTED|Overall Study||20
2387248|NCT01417104|5858740|P2|NOT COMPLETED|Overall Study||2
2387249|NCT01417104|5858741|P1|NOT COMPLETED|Overall Study||6
2387250|NCT01417104|5858740|P2|COMPLETED|Overall Study||35
2387251|NCT01417104|5858741|P1|COMPLETED|Overall Study||28
2387252|NCT01417104|5858740|P2|STARTED|Overall Study||37
2387253|NCT01417104|5858741|P1|STARTED|Overall Study||34
2387254|NCT01417078|5858751|P1|NOT COMPLETED|Overall Study||1
2387255|NCT01417078|5858751|P1|COMPLETED|Overall Study||30
2387256|NCT01417078|5858751|P1|STARTED|Overall Study||31
2387257|NCT01417026|5858763|P2|NOT COMPLETED|Overall Study||0
2387258|NCT01417026|5858764|P1|NOT COMPLETED|Overall Study||2
2387259|NCT01417026|5858763|P2|COMPLETED|Overall Study||13
2387260|NCT01417026|5858764|P1|COMPLETED|Overall Study||14
2387261|NCT01417026|5858763|P2|STARTED|Overall Study||13
2387262|NCT01417026|5858764|P1|STARTED|Overall Study||16
2387263|NCT01417000|5858776|P2|NOT COMPLETED|Overall Study||29
2387264|NCT01417000|5858777|P1|NOT COMPLETED|Overall Study||61
2387265|NCT01417000|5858776|P2|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0
2387266|NCT01417000|5858777|P1|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0
2387267|NCT01417000|5858776|P2|STARTED|Overall Study|31 subjects randomized into Cy/GVAX arm; 29 subjects received ≥ 1 protocol-specified drug.|29
2387268|NCT01417000|5858777|P1|STARTED|Overall Study|62 subjects randomized into Cy/GVAX + CRS-207 arm; 61 subjects received ≥ 1 protocol-specified drug.|61
2387269|NCT01416987|5858785|P1|NOT COMPLETED|Overall Study||0
2387270|NCT01416987|5858785|P1|COMPLETED|Overall Study||600
2387271|NCT01416987|5858785|P1|STARTED|Overall Study||600
2387272|NCT01416805|5858794|P2|NOT COMPLETED|Overall Study||4
2387273|NCT01416805|5858795|P1|NOT COMPLETED|Overall Study||4
2387274|NCT01416805|5858794|P2|COMPLETED|Overall Study||47
2387275|NCT01416805|5858795|P1|COMPLETED|Overall Study||45
2387276|NCT01416805|5858794|P2|STARTED|Overall Study||51
2387277|NCT01416805|5858795|P1|STARTED|Overall Study||49
2387278|NCT01416636|5858805|P2|NOT COMPLETED|Overall Study||6
2387279|NCT01416636|5858806|P1|NOT COMPLETED|Overall Study||8
2387280|NCT01416636|5858805|P2|COMPLETED|Overall Study||46
2387281|NCT01416636|5858806|P1|COMPLETED|Overall Study||45
2387282|NCT01416636|5858805|P2|STARTED|Overall Study||52
2387283|NCT01416636|5858806|P1|STARTED|Overall Study||53
2387284|NCT01416610|5858834|P1|NOT COMPLETED|Overall Study||43
2387285|NCT01416610|5858834|P1|COMPLETED|Overall Study||45
2387286|NCT01416610|5858834|P1|Completed Follow-up|Overall Study||45
2387287|NCT01416610|5858834|P1|Completed Treatment|Overall Study||47
2387288|NCT01416610|5858834|P1|Per Protocol|Overall Study||83
2387289|NCT01416610|5858834|P1|Safety Population|Overall Study||86
2387290|NCT01416610|5858834|P1|Intention to Treat|Overall Study||88
2387291|NCT01416610|5858834|P1|STARTED|Overall Study||88
2387292|NCT01416584|5858851|P3|NOT COMPLETED|Overall Study||1
2387293|NCT01416584|5858852|P2|NOT COMPLETED|Overall Study||2
2387294|NCT01416584|5858853|P1|NOT COMPLETED|Overall Study||3
2387295|NCT01416584|5858851|P3|COMPLETED|Overall Study||32
2387296|NCT01416584|5858852|P2|COMPLETED|Overall Study||33
2387297|NCT01416584|5858853|P1|COMPLETED|Overall Study||27
2387298|NCT01416584|5858851|P3|STARTED|Overall Study||33
2387299|NCT01416584|5858852|P2|STARTED|Overall Study||35
2387300|NCT01416584|5858853|P1|STARTED|Overall Study||30
2387301|NCT01416571|5858888|P1|NOT COMPLETED|Overall Study||2
2387302|NCT01416571|5858888|P1|COMPLETED|Overall Study|Number of subjects completed at Day 385.|76
2387303|NCT01416571|5858888|P1|STARTED|Overall Study||78
2387304|NCT01416389|5858917|P2|NOT COMPLETED|Overall Study||0
2387305|NCT01416389|5858918|P1|NOT COMPLETED|Overall Study||3
2387306|NCT01416389|5858917|P2|COMPLETED|Overall Study||13
2387307|NCT01416389|5858918|P1|COMPLETED|Overall Study||23
2387308|NCT01416389|5858917|P2|Received at Least 1 Dose of Study Drug|Overall Study||13
2387309|NCT01416389|5858918|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
2387310|NCT01416389|5858917|P2|STARTED|Overall Study||13
2387311|NCT01416389|5858918|P1|STARTED|Overall Study||26
2387312|NCT01416272|5858935|P1|NOT COMPLETED|Overall Study||4
2387313|NCT01416272|5858935|P1|COMPLETED|Overall Study||8
2387314|NCT01416272|5858935|P1|STARTED|Overall Study||12
2387315|NCT01416181|5858943|P2|NOT COMPLETED|Part 2||286
2387316|NCT01416181|5858944|P1|NOT COMPLETED|Part 2||271
2387317|NCT01416181|5858943|P2|COMPLETED|Part 2||6
2387318|NCT01416181|5858944|P1|COMPLETED|Part 2||3
2387319|NCT01416181|5858943|P2|Completed Treatment for > 96 Weeks|Part 2||0
2387320|NCT01416181|5858944|P1|Completed Treatment for > 96 Weeks|Part 2||1
2387321|NCT01416181|5858943|P2|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|0
2387322|NCT01416181|5858944|P1|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|1
2387323|NCT01416181|5858943|P2|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|111
2387324|NCT01416181|5858944|P1|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|98
2387325|NCT01416181|5858943|P2|STARTED|Part 2||292
2387326|NCT01416181|5858944|P1|STARTED|Part 2||274
2387327|NCT01416181|5858943|P2|NOT COMPLETED|Part 1||114
2387328|NCT01416181|5858944|P1|NOT COMPLETED|Part 1||137
2387329|NCT01416181|5858943|P2|COMPLETED|Part 1|Completed Study through Week 108|326
2387330|NCT01416181|5858944|P1|COMPLETED|Part 1|Completed Study through Week 108|312
2387331|NCT01416181|5858943|P2|Withdrew Prior to Dosing|Part 1||1
2387332|NCT01416181|5858944|P1|Withdrew Prior to Dosing|Part 1||0
2387333|NCT01416181|5858943|P2|STARTED|Part 1||440
2387334|NCT01416181|5858944|P1|STARTED|Part 1||449
2387335|NCT01416155|5859006|P1|NOT COMPLETED|Overall Study||58
2387336|NCT01416155|5859006|P1|COMPLETED|Overall Study||39
2387337|NCT01416155|5859006|P1|STARTED|Overall Study||97
2387338|NCT01416142|5859013|P3|NOT COMPLETED|PureVision2 HD||1
2387339|NCT01416142|5859014|P2|NOT COMPLETED|PureVision2 HD||0
2387340|NCT01416142|5859015|P1|NOT COMPLETED|PureVision2 HD||0
2387341|NCT01416142|5859013|P3|COMPLETED|PureVision2 HD||62
2387342|NCT01416142|5859014|P2|COMPLETED|PureVision2 HD||0
2387343|NCT01416142|5859015|P1|COMPLETED|PureVision2 HD||0
2387344|NCT01416142|5859013|P3|STARTED|PureVision2 HD||63
2387345|NCT01416142|5859014|P2|STARTED|PureVision2 HD||0
2387346|NCT01416142|5859015|P1|STARTED|PureVision2 HD||0
2387347|NCT01416142|5859013|P3|NOT COMPLETED|Cross Over at Movie Intermission||0
2387348|NCT01416142|5859014|P2|NOT COMPLETED|Cross Over at Movie Intermission||0
2387349|NCT01416142|5859015|P1|NOT COMPLETED|Cross Over at Movie Intermission||0
2387350|NCT01416142|5859013|P3|COMPLETED|Cross Over at Movie Intermission||0
2387351|NCT01416142|5859014|P2|COMPLETED|Cross Over at Movie Intermission||31
2387352|NCT01416142|5859015|P1|COMPLETED|Cross Over at Movie Intermission||32
2387353|NCT01416142|5859013|P3|STARTED|Cross Over at Movie Intermission||0
2387354|NCT01416142|5859014|P2|STARTED|Cross Over at Movie Intermission||31
2387355|NCT01416142|5859015|P1|STARTED|Cross Over at Movie Intermission||32
2387356|NCT01416129|5859026|P2|NOT COMPLETED|Experimental Condition: Brimless||0
2387357|NCT01416129|5859027|P1|NOT COMPLETED|Experimental Condition: Brimless||0
2387358|NCT01416129|5859026|P2|COMPLETED|Experimental Condition: Brimless||5
2387359|NCT01416129|5859027|P1|COMPLETED|Experimental Condition: Brimless||5
2387360|NCT01416129|5859026|P2|STARTED|Experimental Condition: Brimless||5
2387361|NCT01416129|5859027|P1|STARTED|Experimental Condition: Brimless||5
2387362|NCT01416129|5859026|P2|NOT COMPLETED|Control Condition: Ischial Containment||0
2387363|NCT01416129|5859027|P1|NOT COMPLETED|Control Condition: Ischial Containment||0
2387364|NCT01416129|5859026|P2|COMPLETED|Control Condition: Ischial Containment||5
2387365|NCT01416129|5859027|P1|COMPLETED|Control Condition: Ischial Containment||5
2387366|NCT01416129|5859026|P2|STARTED|Control Condition: Ischial Containment||5
2387367|NCT01416129|5859027|P1|STARTED|Control Condition: Ischial Containment||5
2387368|NCT01416025|5859035|P2|NOT COMPLETED|Overall Study||0
2387369|NCT01416025|5859036|P1|NOT COMPLETED|Overall Study||0
2387370|NCT01416025|5859035|P2|COMPLETED|Overall Study||15
2387371|NCT01416025|5859036|P1|COMPLETED|Overall Study||14
2387372|NCT01416025|5859035|P2|STARTED|Overall Study||15
2387373|NCT01416025|5859036|P1|STARTED|Overall Study||14
2387374|NCT01415986|5859042|P1|NOT COMPLETED|Overall Study||1
2387375|NCT01415986|5859042|P1|COMPLETED|Overall Study|Study terminated|0
2387376|NCT01415986|5859042|P1|STARTED|Overall Study||1
2387377|NCT01415960|5859047|P1|NOT COMPLETED|Overall Study||12
2387378|NCT01415960|5859047|P1|COMPLETED|Overall Study|Patients completed Study (151) Per protocol Patients (146)|151
2387379|NCT01415960|5859047|P1|PK Subgroup|Overall Study||30
2387380|NCT01415960|5859047|P1|ITT|Overall Study||161
2387381|NCT01415960|5859047|P1|STARTED|Overall Study||163
2387382|NCT01415934|5859059|P2|NOT COMPLETED|Overall Study||7
2387383|NCT01415934|5859060|P1|NOT COMPLETED|Overall Study||3
2387384|NCT01415934|5859059|P2|COMPLETED|Overall Study||182
2387385|NCT01415934|5859060|P1|COMPLETED|Overall Study||189
2387386|NCT01415934|5859059|P2|STARTED|Overall Study||189
2387387|NCT01415934|5859060|P1|STARTED|Overall Study||192
2387388|NCT01415921|5859068|P2|NOT COMPLETED|Overall Study||3
2387389|NCT01415921|5859069|P1|NOT COMPLETED|Overall Study||3
2387390|NCT01415921|5859068|P2|COMPLETED|Overall Study||14
2387391|NCT01415921|5859069|P1|COMPLETED|Overall Study||13
2387392|NCT01415921|5859068|P2|STARTED|Overall Study||17
2387393|NCT01415921|5859069|P1|STARTED|Overall Study||16
2387394|NCT01415908|5859079|P2|NOT COMPLETED|Overall Study||0
2387395|NCT01415908|5859080|P1|NOT COMPLETED|Overall Study||1
2387396|NCT01415908|5859079|P2|COMPLETED|Overall Study||4
2387397|NCT01415908|5859080|P1|COMPLETED|Overall Study||10
2387398|NCT01415908|5859079|P2|STARTED|Overall Study||4
2387399|NCT01415908|5859080|P1|STARTED|Overall Study||11
2387400|NCT01415583|5859108|P2|NOT COMPLETED|Overall Study||0
2387401|NCT01415583|5859109|P1|NOT COMPLETED|Overall Study||0
2387402|NCT01415583|5859108|P2|COMPLETED|Overall Study||157
2387403|NCT01415583|5859109|P1|COMPLETED|Overall Study||157
2387404|NCT01415583|5859108|P2|STARTED|Overall Study||157
2387405|NCT01415583|5859109|P1|STARTED|Overall Study||157
2387406|NCT01415531|5859117|P2|NOT COMPLETED|Overall Study||37
2387407|NCT01415531|5859118|P1|NOT COMPLETED|Overall Study||25
2387408|NCT01415531|5859117|P2|COMPLETED|Overall Study||390
2387409|NCT01415531|5859118|P1|COMPLETED|Overall Study||189
2387410|NCT01415531|5859117|P2|STARTED|Overall Study||427
2387411|NCT01415531|5859118|P1|STARTED|Overall Study||214
2387412|NCT01415518|5859128|P2|NOT COMPLETED|Overall Study||31
2387413|NCT01415518|5859129|P1|NOT COMPLETED|Overall Study||16
2387414|NCT01415518|5859128|P2|COMPLETED|Overall Study||261
2387415|NCT01415518|5859129|P1|COMPLETED|Overall Study||276
2387416|NCT01415518|5859128|P2|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 292 patients. Safety analysis used 292-3=289 patients.|289
2387417|NCT01415518|5859129|P1|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 290 patients. Safety analysis used 290+3=293 patients.|290
2387418|NCT01415518|5859128|P2|Patients Who Received Study Treatment|Overall Study||292
2387419|NCT01415518|5859129|P1|Patients Who Received Study Treatment|Overall Study||290
2387420|NCT01415518|5859128|P2|STARTED|Overall Study||292
2387421|NCT01415518|5859129|P1|STARTED|Overall Study||292
2387422|NCT01415453|5859181|P1|NOT COMPLETED|Overall Study||0
2387423|NCT01415453|5859181|P1|COMPLETED|Overall Study||1
2387424|NCT01415453|5859181|P1|Imaging Study|Overall Study||1
2387425|NCT01415453|5859181|P1|STARTED|Overall Study||1
2387426|NCT01415440|5859188|P3|NOT COMPLETED|Overall Study||2
2387427|NCT01415440|5859189|P2|NOT COMPLETED|Overall Study||1
2387428|NCT01415440|5859190|P1|NOT COMPLETED|Overall Study||4
2387429|NCT01415440|5859188|P3|COMPLETED|Overall Study||27
2387430|NCT01415440|5859189|P2|COMPLETED|Overall Study||28
2387431|NCT01415440|5859190|P1|COMPLETED|Overall Study||37
2387432|NCT01415440|5859188|P3|STARTED|Overall Study||29
2387433|NCT01415440|5859189|P2|STARTED|Overall Study||29
2387434|NCT01415440|5859190|P1|STARTED|Overall Study||41
2387435|NCT01415427|5859201|P4|NOT COMPLETED|Overall Study||56
2387436|NCT01415427|5859202|P3|NOT COMPLETED|Overall Study||58
2387437|NCT01415427|5859203|P2|NOT COMPLETED|Overall Study||29
2387438|NCT01415427|5859204|P1|NOT COMPLETED|Overall Study||29
2387439|NCT01415427|5859201|P4|COMPLETED|Overall Study||0
2387440|NCT01415427|5859202|P3|COMPLETED|Overall Study||1
2387441|NCT01415427|5859203|P2|COMPLETED|Overall Study||0
2387442|NCT01415427|5859204|P1|COMPLETED|Overall Study||0
2387443|NCT01415427|5859201|P4|STARTED|Overall Study||56
2387444|NCT01415427|5859202|P3|STARTED|Overall Study||59
2387445|NCT01415427|5859203|P2|STARTED|Overall Study||29
2387446|NCT01415427|5859204|P1|STARTED|Overall Study||29
2387447|NCT01415401|5859241|P1|NOT COMPLETED|Overall Study||7
2387448|NCT01415401|5859241|P1|COMPLETED|Overall Study||47
2387449|NCT01415401|5859241|P1|STARTED|Overall Study||54
2387450|NCT01415349|5859246|P2|NOT COMPLETED|Treatment Period 2||0
2387451|NCT01415349|5859247|P1|NOT COMPLETED|Treatment Period 2||0
2387452|NCT01415349|5859246|P2|COMPLETED|Treatment Period 2||19
2387453|NCT01415349|5859247|P1|COMPLETED|Treatment Period 2||21
2387454|NCT01415349|5859246|P2|STARTED|Treatment Period 2||19
2387455|NCT01415349|5859247|P1|STARTED|Treatment Period 2||21
2387456|NCT01415349|5859246|P2|NOT COMPLETED|Treatment Period 1||2
2387457|NCT01415349|5859247|P1|NOT COMPLETED|Treatment Period 1||0
2387458|NCT01415349|5859246|P2|COMPLETED|Treatment Period 1||19
2387459|NCT01415349|5859247|P1|COMPLETED|Treatment Period 1||21
2387460|NCT01415349|5859246|P2|STARTED|Treatment Period 1||21
2387461|NCT01415349|5859247|P1|STARTED|Treatment Period 1||21
2387462|NCT01415232|5859255|P1|NOT COMPLETED|Overall Study||0
2387463|NCT01415232|5859255|P1|COMPLETED|Overall Study||160
2387464|NCT01415232|5859255|P1|STARTED|Overall Study||160
2387465|NCT01414855|5859259|P1|NOT COMPLETED|Overall Study||29
2387466|NCT01414855|5859259|P1|COMPLETED|Overall Study||71
2387467|NCT01414855|5859259|P1|STARTED|Overall Study||100
2387468|NCT01414634|5859275|P8|NOT COMPLETED|Overall Study||0
2387469|NCT01414634|5859276|P7|NOT COMPLETED|Overall Study||0
2387470|NCT01414634|5859277|P6|NOT COMPLETED|Overall Study||0
2387471|NCT01414634|5859278|P5|NOT COMPLETED|Overall Study||0
2387472|NCT01414634|5859279|P4|NOT COMPLETED|Overall Study||0
2387473|NCT01414634|5859280|P3|NOT COMPLETED|Overall Study||0
2387474|NCT01414634|5859281|P2|NOT COMPLETED|Overall Study||0
2387475|NCT01414634|5859282|P1|NOT COMPLETED|Overall Study||0
2387476|NCT01414634|5859275|P8|COMPLETED|Overall Study||1
2387477|NCT01414634|5859276|P7|COMPLETED|Overall Study||1
2387478|NCT01414634|5859277|P6|COMPLETED|Overall Study||2
2387479|NCT01414634|5859278|P5|COMPLETED|Overall Study||1
2387480|NCT01414634|5859279|P4|COMPLETED|Overall Study||1
2387481|NCT01414634|5859280|P3|COMPLETED|Overall Study||1
2387482|NCT01414634|5859281|P2|COMPLETED|Overall Study||1
2387483|NCT01414634|5859282|P1|COMPLETED|Overall Study||1
2387484|NCT01414634|5859275|P8|STARTED|Overall Study||1
2387485|NCT01414634|5859276|P7|STARTED|Overall Study||1
2387486|NCT01414634|5859277|P6|STARTED|Overall Study||2
2387487|NCT01414634|5859278|P5|STARTED|Overall Study||1
2387488|NCT01414634|5859279|P4|STARTED|Overall Study||1
2387489|NCT01414634|5859280|P3|STARTED|Overall Study||1
2387490|NCT01414634|5859281|P2|STARTED|Overall Study||1
2387491|NCT01414634|5859282|P1|STARTED|Overall Study||1
2387492|NCT01414413|5859295|P2|NOT COMPLETED|Overall Study||0
2387493|NCT01414413|5859296|P1|NOT COMPLETED|Overall Study||0
2387494|NCT01414413|5859295|P2|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8466
2387495|NCT01414413|5859296|P1|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8194
2387496|NCT01414413|5859295|P2|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8466
2387497|NCT01414413|5859296|P1|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8194
2387498|NCT01414257|5859308|P1|NOT COMPLETED|Overall Study||22
2387499|NCT01414257|5859308|P1|COMPLETED|Overall Study||2838
2387500|NCT01414257|5859308|P1|STARTED|Overall Study||2860
2387501|NCT01414244|5859321|P2|NOT COMPLETED|Overall Study||0
2387502|NCT01414244|5859322|P1|NOT COMPLETED|Overall Study||0
2387503|NCT01414244|5859321|P2|COMPLETED|Overall Study||52
2387504|NCT01414244|5859322|P1|COMPLETED|Overall Study||54
2387505|NCT01414244|5859321|P2|STARTED|Overall Study||52
2387506|NCT01414244|5859322|P1|STARTED|Overall Study||54
2387507|NCT01414205|5859336|P2|NOT COMPLETED|Overall Study||7
2387508|NCT01414205|5859337|P1|NOT COMPLETED|Overall Study||7
2387509|NCT01414205|5859336|P2|COMPLETED|Overall Study||32
2387510|NCT01414205|5859337|P1|COMPLETED|Overall Study||34
2387511|NCT01414205|5859336|P2|Received Study Drug|Overall Study||38
2387512|NCT01414205|5859337|P1|Received Study Drug|Overall Study||40
2387513|NCT01414205|5859336|P2|STARTED|Overall Study||39
2387514|NCT01414205|5859337|P1|STARTED|Overall Study||41
2387515|NCT01414192|5859373|P4|NOT COMPLETED|Overall Study||0
2387516|NCT01414192|5859374|P3|NOT COMPLETED|Overall Study||0
2387517|NCT01414192|5859375|P2|NOT COMPLETED|Overall Study||0
2387518|NCT01414192|5859376|P1|NOT COMPLETED|Overall Study||0
2387519|NCT01414192|5859373|P4|COMPLETED|Overall Study||1726
2387520|NCT01414192|5859374|P3|COMPLETED|Overall Study||424
2387521|NCT01414192|5859375|P2|COMPLETED|Overall Study||575
2387522|NCT01414192|5859376|P1|COMPLETED|Overall Study||490
2387523|NCT01414192|5859373|P4|STARTED|Overall Study||1726
2387524|NCT01414192|5859374|P3|STARTED|Overall Study||424
2387525|NCT01414192|5859375|P2|STARTED|Overall Study||575
2387526|NCT01414192|5859376|P1|STARTED|Overall Study||490
2387527|NCT01414166|5859406|P2|NOT COMPLETED|Overall Study||83
2387528|NCT01414166|5859407|P1|NOT COMPLETED|Overall Study||91
2387529|NCT01414166|5859406|P2|COMPLETED|Overall Study||39
2387530|NCT01414166|5859407|P1|COMPLETED|Overall Study||31
2387531|NCT01414166|5859406|P2|Treated|Overall Study||121
2387532|NCT01414166|5859407|P1|Treated|Overall Study||120
2387533|NCT01414166|5859406|P2|STARTED|Overall Study||122
2387534|NCT01414166|5859407|P1|STARTED|Overall Study||122
2387535|NCT01414153|5859433|P4|NOT COMPLETED|Overall Study||4
2387536|NCT01414153|5859434|P3|NOT COMPLETED|Overall Study||4
2387537|NCT01414153|5859435|P2|NOT COMPLETED|Overall Study||2
2387538|NCT01414153|5859436|P1|NOT COMPLETED|Overall Study||8
2387539|NCT01414153|5859433|P4|COMPLETED|Overall Study||37
2387540|NCT01414153|5859434|P3|COMPLETED|Overall Study||35
2387541|NCT01414153|5859435|P2|COMPLETED|Overall Study||38
2387542|NCT01414153|5859436|P1|COMPLETED|Overall Study||30
2387543|NCT01414153|5859433|P4|STARTED|Overall Study||41
2387544|NCT01414153|5859434|P3|STARTED|Overall Study||39
2387545|NCT01414153|5859435|P2|STARTED|Overall Study||40
2387546|NCT01414153|5859436|P1|STARTED|Overall Study||38
2387547|NCT01414114|5859470|P1|NOT COMPLETED|Overall Study||5
2387548|NCT01414114|5859470|P1|COMPLETED|Overall Study|Completed 12-week treatment period|32
2387549|NCT01414114|5859470|P1|STARTED|Overall Study||37
2387550|NCT01414036|5859490|P2|NOT COMPLETED|Completed 3 Month Survey||5
2387551|NCT01414036|5859491|P1|NOT COMPLETED|Completed 3 Month Survey||9
2387552|NCT01414036|5859490|P2|COMPLETED|Completed 3 Month Survey||19
2387553|NCT01414036|5859491|P1|COMPLETED|Completed 3 Month Survey||14
2387554|NCT01414036|5859490|P2|STARTED|Completed 3 Month Survey||24
2387555|NCT01414036|5859491|P1|STARTED|Completed 3 Month Survey||23
2387556|NCT01414036|5859490|P2|NOT COMPLETED|Received Allocated Intervention||13
2387557|NCT01414036|5859491|P1|NOT COMPLETED|Received Allocated Intervention||0
2387558|NCT01414036|5859490|P2|COMPLETED|Received Allocated Intervention||11
2387559|NCT01414036|5859491|P1|COMPLETED|Received Allocated Intervention||23
2387560|NCT01414036|5859490|P2|STARTED|Received Allocated Intervention||24
2387561|NCT01414036|5859491|P1|STARTED|Received Allocated Intervention||23
2387562|NCT01414010|5859505|P4|NOT COMPLETED|Overall Study||0
2387563|NCT01414010|5859506|P3|NOT COMPLETED|Overall Study||0
2387564|NCT01414010|5859507|P2|NOT COMPLETED|Overall Study||0
2387565|NCT01414010|5859508|P1|NOT COMPLETED|Overall Study||2
2387566|NCT01414010|5859505|P4|COMPLETED|Overall Study||8
2387567|NCT01414010|5859506|P3|COMPLETED|Overall Study||8
2387568|NCT01414010|5859507|P2|COMPLETED|Overall Study||8
2387569|NCT01414010|5859508|P1|COMPLETED|Overall Study||6
2387570|NCT01414010|5859505|P4|STARTED|Overall Study||8
2387571|NCT01414010|5859506|P3|STARTED|Overall Study||8
2387572|NCT01414010|5859507|P2|STARTED|Overall Study||8
2387573|NCT01414010|5859508|P1|STARTED|Overall Study||8
2387574|NCT01413958|5859526|P2|NOT COMPLETED|Overall Study||1
2387575|NCT01413958|5859527|P1|NOT COMPLETED|Overall Study||0
2387576|NCT01413958|5859526|P2|COMPLETED|Overall Study||286
2387577|NCT01413958|5859527|P1|COMPLETED|Overall Study||288
2387578|NCT01413958|5859526|P2|STARTED|Overall Study||287
2387579|NCT01413958|5859527|P1|STARTED|Overall Study||288
2387580|NCT01413750|5859562|P4|NOT COMPLETED|Overall Study||0
2387581|NCT01413750|5859563|P3|NOT COMPLETED|Overall Study||0
2387582|NCT01413750|5859564|P2|NOT COMPLETED|Overall Study||0
2387583|NCT01413750|5859565|P1|NOT COMPLETED|Overall Study||0
2387584|NCT01413750|5859562|P4|COMPLETED|Overall Study||7
2387585|NCT01413750|5859563|P3|COMPLETED|Overall Study||4
2387586|NCT01413750|5859564|P2|COMPLETED|Overall Study||6
2387587|NCT01413750|5859565|P1|COMPLETED|Overall Study||6
2387588|NCT01413750|5859562|P4|STARTED|Overall Study||7
2387589|NCT01413750|5859563|P3|STARTED|Overall Study||4
2387590|NCT01413750|5859564|P2|STARTED|Overall Study||6
2387591|NCT01413750|5859565|P1|STARTED|Overall Study||6
2387592|NCT01413542|5859578|P4|NOT COMPLETED|Overall Study||1
2387593|NCT01413542|5859579|P3|NOT COMPLETED|Overall Study||3
2387594|NCT01413542|5859580|P2|NOT COMPLETED|Overall Study||0
2387595|NCT01413542|5859581|P1|NOT COMPLETED|Overall Study||1
2387596|NCT01413542|5859578|P4|COMPLETED|Overall Study||7
2387597|NCT01413542|5859579|P3|COMPLETED|Overall Study||6
2387598|NCT01413542|5859580|P2|COMPLETED|Overall Study||6
2387599|NCT01413542|5859581|P1|COMPLETED|Overall Study||5
2387600|NCT01413542|5859578|P4|STARTED|Overall Study||8
2387601|NCT01413542|5859579|P3|STARTED|Overall Study||9
2387602|NCT01413542|5859580|P2|STARTED|Overall Study||6
2387603|NCT01413542|5859581|P1|STARTED|Overall Study||6
2387604|NCT01413516|5859596|P2|NOT COMPLETED|Overall Study||0
2387605|NCT01413516|5859597|P1|NOT COMPLETED|Overall Study||0
2387606|NCT01413516|5859596|P2|COMPLETED|Overall Study||9
2387607|NCT01413516|5859597|P1|COMPLETED|Overall Study||8
2387608|NCT01413516|5859596|P2|STARTED|Overall Study||9
2387609|NCT01413516|5859597|P1|STARTED|Overall Study||8
2387610|NCT01413503|5859603|P1|NOT COMPLETED|Overall Study||1
2387611|NCT01413503|5859603|P1|COMPLETED|Overall Study||49
2387612|NCT01413503|5859603|P1|STARTED|Overall Study||50
2387613|NCT01413360|5859607|P1|NOT COMPLETED|Overall Study||3
2387614|NCT01413360|5859607|P1|COMPLETED|Overall Study||7
2387615|NCT01413360|5859607|P1|STARTED|Overall Study||10
2387616|NCT01413204|5859615|P3|NOT COMPLETED|Overall Study||19
2387617|NCT01413204|5859616|P2|NOT COMPLETED|Overall Study||6
2387618|NCT01413204|5859617|P1|NOT COMPLETED|Overall Study||6
2387619|NCT01413204|5859615|P3|COMPLETED|Overall Study||74
2387620|NCT01413204|5859616|P2|COMPLETED|Overall Study||83
2387621|NCT01413204|5859617|P1|COMPLETED|Overall Study||84
2387622|NCT01413204|5859615|P3|STARTED|Overall Study||93
2387623|NCT01413204|5859616|P2|STARTED|Overall Study||89
2387624|NCT01413204|5859617|P1|STARTED|Overall Study||90
2387628|NCT01413087|5859637|P2|NOT COMPLETED|Overall Study||0
2387629|NCT01413087|5859638|P1|NOT COMPLETED|Overall Study||0
2387630|NCT01413087|5859637|P2|COMPLETED|Overall Study||6
2387631|NCT01413087|5859638|P1|COMPLETED|Overall Study||6
2387632|NCT01413087|5859637|P2|STARTED|Overall Study||6
2387633|NCT01413087|5859638|P1|STARTED|Overall Study||6
2387634|NCT01412983|5859664|P2|NOT COMPLETED|2nd Period||0
2387635|NCT01412983|5859665|P1|NOT COMPLETED|2nd Period||0
2387636|NCT01412983|5859664|P2|COMPLETED|2nd Period||46
2387637|NCT01412983|5859665|P1|COMPLETED|2nd Period||50
2387638|NCT01412983|5859664|P2|STARTED|2nd Period||46
2387639|NCT01412983|5859665|P1|STARTED|2nd Period||50
2387640|NCT01412983|5859664|P2|NOT COMPLETED|1st Period||4
2387641|NCT01412983|5859665|P1|NOT COMPLETED|1st Period||0
2387642|NCT01412983|5859664|P2|COMPLETED|1st Period||46
2387643|NCT01412983|5859665|P1|COMPLETED|1st Period||50
2387644|NCT01412983|5859664|P2|STARTED|1st Period||50
2387645|NCT01412983|5859665|P1|STARTED|1st Period||50
2387646|NCT01412957|5859675|P2|NOT COMPLETED|Overall Study||157
2387647|NCT01412957|5859676|P1|NOT COMPLETED|Overall Study||149
2387648|NCT01412957|5859675|P2|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|31
2387649|NCT01412957|5859676|P1|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|40
2387650|NCT01412957|5859675|P2|STARTED|Overall Study||188
2387651|NCT01412957|5859676|P1|STARTED|Overall Study||189
2387652|NCT01412944|5859698|P6|NOT COMPLETED|Follow-up||0
2387653|NCT01412944|5859699|P5|NOT COMPLETED|Follow-up||0
2387654|NCT01412944|5859700|P4|NOT COMPLETED|Follow-up||0
2387655|NCT01412944|5859701|P3|NOT COMPLETED|Follow-up||0
2387656|NCT01412944|5859702|P2|NOT COMPLETED|Follow-up||0
2387657|NCT01412944|5859703|P1|NOT COMPLETED|Follow-up||0
2387658|NCT01412944|5859698|P6|COMPLETED|Follow-up||0
2387659|NCT01412944|5859699|P5|COMPLETED|Follow-up||2
2387660|NCT01412944|5859700|P4|COMPLETED|Follow-up||1
2387661|NCT01412944|5859701|P3|COMPLETED|Follow-up||2
2387662|NCT01412944|5859702|P2|COMPLETED|Follow-up||0
2387663|NCT01412944|5859703|P1|COMPLETED|Follow-up||0
2387664|NCT01412944|5859698|P6|STARTED|Follow-up||0
2387665|NCT01412944|5859699|P5|STARTED|Follow-up||2
2387666|NCT01412944|5859700|P4|STARTED|Follow-up||1
2387667|NCT01412944|5859701|P3|STARTED|Follow-up||2
2387668|NCT01412944|5859702|P2|STARTED|Follow-up||0
2387669|NCT01412944|5859703|P1|STARTED|Follow-up||0
2387670|NCT01412944|5859698|P6|NOT COMPLETED|Entire: IV + Maintenance||0
2387671|NCT01412944|5859699|P5|NOT COMPLETED|Entire: IV + Maintenance||0
2387672|NCT01412944|5859700|P4|NOT COMPLETED|Entire: IV + Maintenance||0
2387673|NCT01412944|5859701|P3|NOT COMPLETED|Entire: IV + Maintenance||0
2387674|NCT01412944|5859702|P2|NOT COMPLETED|Entire: IV + Maintenance||5
2387675|NCT01412944|5859703|P1|NOT COMPLETED|Entire: IV + Maintenance||2
2387676|NCT01412944|5859698|P6|COMPLETED|Entire: IV + Maintenance||0
2387677|NCT01412944|5859699|P5|COMPLETED|Entire: IV + Maintenance||0
2387678|NCT01412944|5859700|P4|COMPLETED|Entire: IV + Maintenance||0
2387679|NCT01412944|5859701|P3|COMPLETED|Entire: IV + Maintenance||0
2387680|NCT01412944|5859702|P2|COMPLETED|Entire: IV + Maintenance||17
2387681|NCT01412944|5859703|P1|COMPLETED|Entire: IV + Maintenance||19
2387682|NCT01412944|5859698|P6|STARTED|Entire: IV + Maintenance||0
2387683|NCT01412944|5859699|P5|STARTED|Entire: IV + Maintenance||0
2387684|NCT01412944|5859700|P4|STARTED|Entire: IV + Maintenance||0
2387685|NCT01412944|5859701|P3|STARTED|Entire: IV + Maintenance||0
2387686|NCT01412944|5859702|P2|STARTED|Entire: IV + Maintenance||22
2387687|NCT01412944|5859703|P1|STARTED|Entire: IV + Maintenance||21
2387688|NCT01412944|5859698|P6|NOT COMPLETED|Entire: IV + Maintenance||2
2387689|NCT01412944|5859699|P5|NOT COMPLETED|Entire: IV + Maintenance||3
2387690|NCT01412944|5859700|P4|NOT COMPLETED|Entire: IV + Maintenance||1
2387691|NCT01412944|5859701|P3|NOT COMPLETED|Entire: IV + Maintenance||1
2387692|NCT01412944|5859702|P2|NOT COMPLETED|Entire: IV + Maintenance||0
2387693|NCT01412944|5859703|P1|NOT COMPLETED|Entire: IV + Maintenance||0
2387694|NCT01412944|5859698|P6|COMPLETED|Entire: IV + Maintenance||6
2387695|NCT01412944|5859699|P5|COMPLETED|Entire: IV + Maintenance||11
2387696|NCT01412944|5859700|P4|COMPLETED|Entire: IV + Maintenance||5
2387697|NCT01412944|5859701|P3|COMPLETED|Entire: IV + Maintenance||14
2387698|NCT01412944|5859702|P2|COMPLETED|Entire: IV + Maintenance||0
2387699|NCT01412944|5859703|P1|COMPLETED|Entire: IV + Maintenance||0
2387700|NCT01412944|5859698|P6|STARTED|Entire: IV + Maintenance||8
2387701|NCT01412944|5859699|P5|STARTED|Entire: IV + Maintenance||14
2387702|NCT01412944|5859700|P4|STARTED|Entire: IV + Maintenance||6
2387703|NCT01412944|5859701|P3|STARTED|Entire: IV + Maintenance||15
2387704|NCT01412944|5859702|P2|STARTED|Entire: IV + Maintenance||0
2387705|NCT01412944|5859703|P1|STARTED|Entire: IV + Maintenance||0
2387706|NCT01412944|5859698|P6|NOT COMPLETED|IV: Per CAIN457A2307||0
2387707|NCT01412944|5859699|P5|NOT COMPLETED|IV: Per CAIN457A2307||0
2387708|NCT01412944|5859700|P4|NOT COMPLETED|IV: Per CAIN457A2307||0
2387709|NCT01412944|5859701|P3|NOT COMPLETED|IV: Per CAIN457A2307||0
2387710|NCT01412944|5859702|P2|NOT COMPLETED|IV: Per CAIN457A2307||2
2387711|NCT01412944|5859703|P1|NOT COMPLETED|IV: Per CAIN457A2307||1
2387712|NCT01412944|5859698|P6|COMPLETED|IV: Per CAIN457A2307||0
2387713|NCT01412944|5859699|P5|COMPLETED|IV: Per CAIN457A2307||0
2387714|NCT01412944|5859700|P4|COMPLETED|IV: Per CAIN457A2307||0
2387715|NCT01412944|5859701|P3|COMPLETED|IV: Per CAIN457A2307||0
2387716|NCT01412944|5859702|P2|COMPLETED|IV: Per CAIN457A2307||20
2387717|NCT01412944|5859703|P1|COMPLETED|IV: Per CAIN457A2307||20
2387718|NCT01412944|5859698|P6|STARTED|IV: Per CAIN457A2307||0
2387719|NCT01412944|5859699|P5|STARTED|IV: Per CAIN457A2307||0
2387720|NCT01412944|5859700|P4|STARTED|IV: Per CAIN457A2307||0
2387721|NCT01412944|5859701|P3|STARTED|IV: Per CAIN457A2307||0
2387722|NCT01412944|5859702|P2|STARTED|IV: Per CAIN457A2307||22
2387723|NCT01412944|5859703|P1|STARTED|IV: Per CAIN457A2307||21
2387724|NCT01412944|5859698|P6|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||2
2387725|NCT01412944|5859699|P5|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
2387726|NCT01412944|5859700|P4|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
2387727|NCT01412944|5859701|P3|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||1
2387728|NCT01412944|5859702|P2|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
2387729|NCT01412944|5859703|P1|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
2387730|NCT01412944|5859698|P6|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
2387731|NCT01412944|5859699|P5|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
2387732|NCT01412944|5859700|P4|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
2387733|NCT01412944|5859701|P3|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
2387734|NCT01412944|5859702|P2|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
2387735|NCT01412944|5859703|P1|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
2387736|NCT01412944|5859698|P6|STARTED|IV: Per Previous CAIN457A2304 Treatment||8
2387737|NCT01412944|5859699|P5|STARTED|IV: Per Previous CAIN457A2304 Treatment||14
2387738|NCT01412944|5859700|P4|STARTED|IV: Per Previous CAIN457A2304 Treatment||6
2387826|NCT01412281|5860004|P2|COMPLETED|Overall Study||110
2387739|NCT01412944|5859701|P3|STARTED|IV: Per Previous CAIN457A2304 Treatment||15
2387740|NCT01412944|5859702|P2|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
2387741|NCT01412944|5859703|P1|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
2387742|NCT01412918|5859739|P2|NOT COMPLETED|Overall Study||0
2387743|NCT01412918|5859740|P1|NOT COMPLETED|Overall Study||0
2387744|NCT01412918|5859739|P2|COMPLETED|Overall Study||1
2387745|NCT01412918|5859740|P1|COMPLETED|Overall Study||20
2387746|NCT01412918|5859739|P2|STARTED|Overall Study||1
2387747|NCT01412918|5859740|P1|STARTED|Overall Study||20
2387748|NCT01412879|5859749|P3|NOT COMPLETED|Consolidation Therapy||0
2387749|NCT01412879|5859750|P2|NOT COMPLETED|Consolidation Therapy||0
2387750|NCT01412879|5859751|P1|NOT COMPLETED|Consolidation Therapy||0
2387751|NCT01412879|5859749|P3|COMPLETED|Consolidation Therapy||26
2387752|NCT01412879|5859750|P2|COMPLETED|Consolidation Therapy||0
2387753|NCT01412879|5859751|P1|COMPLETED|Consolidation Therapy||0
2387754|NCT01412879|5859749|P3|STARTED|Consolidation Therapy|Only eligible patients who are able to have stem cell harvested receive consolidation therapy.|26
2387755|NCT01412879|5859750|P2|STARTED|Consolidation Therapy||0
2387756|NCT01412879|5859751|P1|STARTED|Consolidation Therapy||0
2387757|NCT01412879|5859749|P3|NOT COMPLETED|Initial Registration (Induction Therapy)||0
2387758|NCT01412879|5859750|P2|NOT COMPLETED|Initial Registration (Induction Therapy)||8
2387759|NCT01412879|5859751|P1|NOT COMPLETED|Initial Registration (Induction Therapy)||13
2387760|NCT01412879|5859749|P3|COMPLETED|Initial Registration (Induction Therapy)||0
2387761|NCT01412879|5859750|P2|COMPLETED|Initial Registration (Induction Therapy)||27
2387762|NCT01412879|5859751|P1|COMPLETED|Initial Registration (Induction Therapy)||5
2387763|NCT01412879|5859749|P3|Treatment Started|Initial Registration (Induction Therapy)||0
2387764|NCT01412879|5859750|P2|Treatment Started|Initial Registration (Induction Therapy)||35
2387765|NCT01412879|5859751|P1|Treatment Started|Initial Registration (Induction Therapy)||17
2387766|NCT01412879|5859749|P3|STARTED|Initial Registration (Induction Therapy)||0
2387767|NCT01412879|5859750|P2|STARTED|Initial Registration (Induction Therapy)||35
2387768|NCT01412879|5859751|P1|STARTED|Initial Registration (Induction Therapy)||18
2387769|NCT01412866|5859767|P2|NOT COMPLETED|Overall Study||2
2387770|NCT01412866|5859768|P1|NOT COMPLETED|Overall Study||1
2387771|NCT01412866|5859767|P2|COMPLETED|Overall Study||64
2387772|NCT01412866|5859768|P1|COMPLETED|Overall Study||57
2387773|NCT01412866|5859767|P2|STARTED|Overall Study||66
2387774|NCT01412866|5859768|P1|STARTED|Overall Study||58
2387775|NCT01412801|5859780|P6|NOT COMPLETED|Overall Study||3
2387776|NCT01412801|5859781|P5|NOT COMPLETED|Overall Study||3
2387777|NCT01412801|5859782|P4|NOT COMPLETED|Overall Study||4
2387778|NCT01412801|5859783|P3|NOT COMPLETED|Overall Study||7
2387779|NCT01412801|5859784|P2|NOT COMPLETED|Overall Study||5
2387780|NCT01412801|5859785|P1|NOT COMPLETED|Overall Study||4
2387781|NCT01412801|5859780|P6|COMPLETED|Overall Study||84
2387782|NCT01412801|5859781|P5|COMPLETED|Overall Study||85
2387783|NCT01412801|5859782|P4|COMPLETED|Overall Study||87
2387784|NCT01412801|5859783|P3|COMPLETED|Overall Study||83
2387785|NCT01412801|5859784|P2|COMPLETED|Overall Study||84
2387786|NCT01412801|5859785|P1|COMPLETED|Overall Study||87
2387787|NCT01412801|5859780|P6|STARTED|Overall Study||87
2387788|NCT01412801|5859781|P5|STARTED|Overall Study||88
2387789|NCT01412801|5859782|P4|STARTED|Overall Study||91
2387790|NCT01412801|5859783|P3|STARTED|Overall Study||90
2387791|NCT01412801|5859784|P2|STARTED|Overall Study||89
2387792|NCT01412801|5859785|P1|STARTED|Overall Study||91
2387793|NCT01412710|5859824|P2|NOT COMPLETED|Overall Study||5
2387794|NCT01412710|5859825|P1|NOT COMPLETED|Overall Study||4
2387795|NCT01412710|5859824|P2|COMPLETED|Overall Study||22
2387796|NCT01412710|5859825|P1|COMPLETED|Overall Study||46
2387797|NCT01412710|5859824|P2|STARTED|Overall Study||27
2387798|NCT01412710|5859825|P1|STARTED|Overall Study||50
2387799|NCT01412554|5859833|P1|NOT COMPLETED|Overall Study||0
2387800|NCT01412554|5859833|P1|COMPLETED|Overall Study||103
2387801|NCT01412554|5859833|P1|STARTED|Overall Study|103 persons re-examined in 2012-13 out of 158 persons originally examined in 1991-96.|103
2387802|NCT01412541|5859839|P2|NOT COMPLETED|Overall Study||20
2387803|NCT01412541|5859840|P1|NOT COMPLETED|Overall Study||36
2387804|NCT01412541|5859839|P2|COMPLETED|Overall Study||140
2387805|NCT01412541|5859840|P1|COMPLETED|Overall Study||280
2387806|NCT01412541|5859839|P2|STARTED|Overall Study||160
2387807|NCT01412541|5859840|P1|STARTED|Overall Study||316
2387808|NCT01412424|5859948|P1|NOT COMPLETED|Extension Treatment Period||6
2387809|NCT01412424|5859948|P1|COMPLETED|Extension Treatment Period||82
2387810|NCT01412424|5859948|P1|STARTED|Extension Treatment Period|86% of participants who completed the core period voluntarily entered the optional extension period.|88
2387811|NCT01412424|5859948|P1|NOT COMPLETED|Core Treatment Period||53
2387812|NCT01412424|5859948|P1|COMPLETED|Core Treatment Period||102
2387813|NCT01412424|5859948|P1|STARTED|Core Treatment Period||155
2387814|NCT01412333|5859966|P2|NOT COMPLETED|Overall Study||57
2387815|NCT01412333|5859967|P1|NOT COMPLETED|Overall Study||98
2387816|NCT01412333|5859966|P2|COMPLETED|Overall Study||360
2387817|NCT01412333|5859967|P1|COMPLETED|Overall Study||320
2387818|NCT01412333|5859966|P2|STARTED|Overall Study||417
2387819|NCT01412333|5859967|P1|STARTED|Overall Study||418
2387820|NCT01412281|5860002|P4|NOT COMPLETED|Overall Study||0
2387821|NCT01412281|5860003|P3|NOT COMPLETED|Overall Study||0
2387822|NCT01412281|5860004|P2|NOT COMPLETED|Overall Study||0
2387823|NCT01412281|5860005|P1|NOT COMPLETED|Overall Study||0
2387824|NCT01412281|5860002|P4|COMPLETED|Overall Study||110
2387825|NCT01412281|5860003|P3|COMPLETED|Overall Study||110
2387827|NCT01412281|5860005|P1|COMPLETED|Overall Study||110
2387828|NCT01412281|5860002|P4|STARTED|Overall Study||110
2387829|NCT01412281|5860003|P3|STARTED|Overall Study||110
2387830|NCT01412281|5860004|P2|STARTED|Overall Study||110
2387831|NCT01412281|5860005|P1|STARTED|Overall Study||110
2387832|NCT01412229|5860027|P1|NOT COMPLETED|Overall Study||1
2387833|NCT01412229|5860027|P1|COMPLETED|Overall Study||38
2387834|NCT01412229|5860027|P1|STARTED|Overall Study||39
2387835|NCT01412164|5860039|P1|NOT COMPLETED|Overall Study||47
2387836|NCT01412164|5860039|P1|COMPLETED|Overall Study||683
2387837|NCT01412164|5860039|P1|STARTED|Overall Study||730
2387838|NCT01412151|5860050|P1|NOT COMPLETED|Week 306 - 310 - Washout Period||2
2387839|NCT01412151|5860050|P1|COMPLETED|Week 306 - 310 - Washout Period||3
2387840|NCT01412151|5860050|P1|STARTED|Week 306 - 310 - Washout Period||5
2387841|NCT01412151|5860050|P1|NOT COMPLETED|Week 0 - 306 - Treatment Period||5
2387842|NCT01412151|5860050|P1|COMPLETED|Week 0 - 306 - Treatment Period||5
2387843|NCT01412151|5860050|P1|STARTED|Week 0 - 306 - Treatment Period||10
2387844|NCT01412086|5860056|P1|NOT COMPLETED|Overall Study||0
2387845|NCT01412086|5860056|P1|COMPLETED|Overall Study||112
2387846|NCT01412086|5860056|P1|STARTED|Overall Study||112
2387847|NCT01412060|5860061|P3|NOT COMPLETED|Double-blind Treatment Phase (DBP)||83
2387848|NCT01412060|5860062|P2|NOT COMPLETED|Double-blind Treatment Phase (DBP)||83
2387849|NCT01412060|5860063|P1|NOT COMPLETED|Double-blind Treatment Phase (DBP)||0
2387850|NCT01412060|5860061|P3|COMPLETED|Double-blind Treatment Phase (DBP)||18
2387851|NCT01412060|5860062|P2|COMPLETED|Double-blind Treatment Phase (DBP)||16
2387852|NCT01412060|5860063|P1|COMPLETED|Double-blind Treatment Phase (DBP)||0
2387853|NCT01412060|5860061|P3|STARTED|Double-blind Treatment Phase (DBP)||101
2387854|NCT01412060|5860062|P2|STARTED|Double-blind Treatment Phase (DBP)||99
2387855|NCT01412060|5860063|P1|STARTED|Double-blind Treatment Phase (DBP)||0
2387856|NCT01412060|5860061|P3|NOT COMPLETED|Period Between SP and DBP||0
2387857|NCT01412060|5860062|P2|NOT COMPLETED|Period Between SP and DBP||0
2387858|NCT01412060|5860063|P1|NOT COMPLETED|Period Between SP and DBP||64
2387859|NCT01412060|5860061|P3|COMPLETED|Period Between SP and DBP||0
2387860|NCT01412060|5860062|P2|COMPLETED|Period Between SP and DBP||0
2387861|NCT01412060|5860063|P1|COMPLETED|Period Between SP and DBP||200
2387862|NCT01412060|5860061|P3|STARTED|Period Between SP and DBP||0
2387863|NCT01412060|5860062|P2|STARTED|Period Between SP and DBP||0
2387864|NCT01412060|5860063|P1|STARTED|Period Between SP and DBP||264
2387865|NCT01412060|5860061|P3|NOT COMPLETED|Open-label Stabilization Period (SP)||0
2387866|NCT01412060|5860062|P2|NOT COMPLETED|Open-label Stabilization Period (SP)||0
2387867|NCT01412060|5860063|P1|NOT COMPLETED|Open-label Stabilization Period (SP)||100
2387868|NCT01412060|5860061|P3|COMPLETED|Open-label Stabilization Period (SP)||0
2387869|NCT01412060|5860062|P2|COMPLETED|Open-label Stabilization Period (SP)||0
2387870|NCT01412060|5860063|P1|COMPLETED|Open-label Stabilization Period (SP)||264
2387871|NCT01412060|5860061|P3|STARTED|Open-label Stabilization Period (SP)||0
2387872|NCT01412060|5860062|P2|STARTED|Open-label Stabilization Period (SP)||0
2387873|NCT01412060|5860063|P1|STARTED|Open-label Stabilization Period (SP)||364
2387874|NCT01412060|5860061|P3|NOT COMPLETED|Period Between RIP and SP||0
2387875|NCT01412060|5860062|P2|NOT COMPLETED|Period Between RIP and SP||0
2387876|NCT01412060|5860063|P1|NOT COMPLETED|Period Between RIP and SP||54
2387877|NCT01412060|5860061|P3|COMPLETED|Period Between RIP and SP||0
2387878|NCT01412060|5860062|P2|COMPLETED|Period Between RIP and SP||0
2387879|NCT01412060|5860063|P1|COMPLETED|Period Between RIP and SP||364
2387880|NCT01412060|5860061|P3|STARTED|Period Between RIP and SP||0
2387881|NCT01412060|5860062|P2|STARTED|Period Between RIP and SP||0
2387882|NCT01412060|5860063|P1|STARTED|Period Between RIP and SP||418
2387883|NCT01412060|5860061|P3|NOT COMPLETED|Open-label Run-in Period (RIP)||0
2387884|NCT01412060|5860062|P2|NOT COMPLETED|Open-label Run-in Period (RIP)||0
2387885|NCT01412060|5860063|P1|NOT COMPLETED|Open-label Run-in Period (RIP)||347
2387886|NCT01412060|5860061|P3|COMPLETED|Open-label Run-in Period (RIP)||0
2387887|NCT01412060|5860062|P2|COMPLETED|Open-label Run-in Period (RIP)||0
2387888|NCT01412060|5860063|P1|COMPLETED|Open-label Run-in Period (RIP)||418
2387889|NCT01412060|5860061|P3|STARTED|Open-label Run-in Period (RIP)||0
2387890|NCT01412060|5860062|P2|STARTED|Open-label Run-in Period (RIP)||0
2387891|NCT01412060|5860063|P1|STARTED|Open-label Run-in Period (RIP)||765
2387892|NCT01412021|5860073|P1|NOT COMPLETED|Overall Study||19
2387893|NCT01412021|5860073|P1|COMPLETED|Overall Study||356
2387894|NCT01412021|5860073|P1|Case Report Forms Locked|Overall Study||368
2387895|NCT01412021|5860073|P1|STARTED|Overall Study||375
2387896|NCT01411995|5860110|P2|NOT COMPLETED|Overall Study||1
2387897|NCT01411995|5860111|P1|NOT COMPLETED|Overall Study||0
2387898|NCT01411995|5860110|P2|COMPLETED|Overall Study||99
2387899|NCT01411995|5860111|P1|COMPLETED|Overall Study||100
2387900|NCT01411995|5860110|P2|STARTED|Overall Study||100
2387901|NCT01411995|5860111|P1|STARTED|Overall Study||100
2387902|NCT01411917|5860119|P2|NOT COMPLETED|Overall Study||1
2387903|NCT01411917|5860120|P1|NOT COMPLETED|Overall Study||0
2387904|NCT01411917|5860119|P2|COMPLETED|Overall Study||36
2387905|NCT01411917|5860120|P1|COMPLETED|Overall Study||32
2387906|NCT01411917|5860119|P2|STARTED|Overall Study||37
2387907|NCT01411917|5860120|P1|STARTED|Overall Study||32
2387908|NCT01411891|5860142|P2|NOT COMPLETED|Overall Study||2
2387909|NCT01411891|5860143|P1|NOT COMPLETED|Overall Study||3
2387910|NCT01411891|5860142|P2|COMPLETED|Overall Study||48
2387911|NCT01411891|5860143|P1|COMPLETED|Overall Study||47
2387912|NCT01411891|5860142|P2|STARTED|Overall Study||50
2387913|NCT01411891|5860143|P1|STARTED|Overall Study||50
2387914|NCT01411852|5860153|P2|NOT COMPLETED|Hospital Intervention Phase||18
2387915|NCT01411852|5860154|P1|NOT COMPLETED|Hospital Intervention Phase||24
2387916|NCT01411852|5860153|P2|COMPLETED|Hospital Intervention Phase|18 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|71
2387917|NCT01411852|5860154|P1|COMPLETED|Hospital Intervention Phase|24 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|59
2387918|NCT01411852|5860153|P2|STARTED|Hospital Intervention Phase||89
2387919|NCT01411852|5860154|P1|STARTED|Hospital Intervention Phase||83
2387920|NCT01411852|5860153|P2|NOT COMPLETED|Prehospital Intervention Phase||7
2387921|NCT01411852|5860154|P1|NOT COMPLETED|Prehospital Intervention Phase||12
2387922|NCT01411852|5860153|P2|COMPLETED|Prehospital Intervention Phase|7 patients had intervention stopped prior to hospital arrival|89
2387923|NCT01411852|5860154|P1|COMPLETED|Prehospital Intervention Phase|12 patients had the intervention stopped prior to hospital arrival|83
2387924|NCT01411852|5860153|P2|STARTED|Prehospital Intervention Phase|One patient was in police custody at the time of enrollment. Patient's data omitted from analyses.|96
2387925|NCT01411852|5860154|P1|STARTED|Prehospital Intervention Phase|1 patient randomized to 2000 mL bolus arm but received 250 mL bolus. Analyzed in 2000 mL arm.|95
2387926|NCT01411839|5860199|P2|NOT COMPLETED|Overall Study||3
2387927|NCT01411839|5860200|P1|NOT COMPLETED|Overall Study||4
2387928|NCT01411839|5860199|P2|COMPLETED|Overall Study||17
2387929|NCT01411839|5860200|P1|COMPLETED|Overall Study||16
2387930|NCT01411839|5860199|P2|STARTED|Overall Study||20
2387931|NCT01411839|5860200|P1|STARTED|Overall Study||20
2387932|NCT01411774|5860212|P2|NOT COMPLETED|Overall Study||3
2387933|NCT01411774|5860213|P1|NOT COMPLETED|Overall Study||0
2387934|NCT01411774|5860212|P2|COMPLETED|Overall Study||67
2387935|NCT01411774|5860213|P1|COMPLETED|Overall Study||72
2387936|NCT01411774|5860212|P2|STARTED|Overall Study||70
2387937|NCT01411774|5860213|P1|STARTED|Overall Study||72
2387938|NCT01411696|5860221|P1|NOT COMPLETED|Overall Study||0
2387939|NCT01411696|5860221|P1|COMPLETED|Overall Study||289
2387940|NCT01411696|5860221|P1|STARTED|Overall Study||289
2387941|NCT01411592|5860230|P2|NOT COMPLETED|Overall Study||0
2387942|NCT01411592|5860231|P1|NOT COMPLETED|Overall Study||0
2387943|NCT01411592|5860230|P2|COMPLETED|Overall Study||16
2387944|NCT01411592|5860231|P1|COMPLETED|Overall Study||14
2387945|NCT01411592|5860230|P2|5-Year Time Frame|Overall Study||16
2387946|NCT01411592|5860231|P1|5-Year Time Frame|Overall Study||14
2387947|NCT01411592|5860230|P2|STARTED|Overall Study||16
2387948|NCT01411592|5860231|P1|STARTED|Overall Study||14
2387949|NCT01411527|5860241|P2|NOT COMPLETED|Overall Study||0
2387950|NCT01411527|5860242|P1|NOT COMPLETED|Overall Study||0
2387951|NCT01411527|5860241|P2|COMPLETED|Overall Study||93
2387952|NCT01411527|5860242|P1|COMPLETED|Overall Study||1864
2387953|NCT01411527|5860241|P2|STARTED|Overall Study||93
2387954|NCT01411527|5860242|P1|STARTED|Overall Study||1864
2387955|NCT01411501|5860251|P4|NOT COMPLETED|Overall Study||7
2387956|NCT01411501|5860252|P3|NOT COMPLETED|Overall Study||6
2387957|NCT01411501|5860253|P2|NOT COMPLETED|Overall Study||6
2387958|NCT01411501|5860254|P1|NOT COMPLETED|Overall Study||10
2387959|NCT01411501|5860251|P4|COMPLETED|Overall Study||163
2387960|NCT01411501|5860252|P3|COMPLETED|Overall Study||159
2387961|NCT01411501|5860253|P2|COMPLETED|Overall Study||166
2387962|NCT01411501|5860254|P1|COMPLETED|Overall Study||158
2387963|NCT01411501|5860251|P4|STARTED|Overall Study||170
2387964|NCT01411501|5860252|P3|STARTED|Overall Study||165
2387965|NCT01411501|5860253|P2|STARTED|Overall Study||172
2387966|NCT01411501|5860254|P1|STARTED|Overall Study||168
2387967|NCT01411488|5860286|P2|NOT COMPLETED|Overall Study||5
2387968|NCT01411488|5860287|P1|NOT COMPLETED|Overall Study||6
2387969|NCT01411488|5860286|P2|COMPLETED|Overall Study||38
2387970|NCT01411488|5860287|P1|COMPLETED|Overall Study||41
2387971|NCT01411488|5860286|P2|STARTED|Overall Study||43
2387972|NCT01411488|5860287|P1|STARTED|Overall Study||47
2388003|NCT01411241|5860328|P2|NOT COMPLETED|Overall Study||22
2388004|NCT01411241|5860329|P1|NOT COMPLETED|Overall Study||11
2388005|NCT01411241|5860328|P2|COMPLETED|Overall Study||293
2388006|NCT01411241|5860329|P1|COMPLETED|Overall Study||298
2388007|NCT01411241|5860328|P2|STARTED|Overall Study||315
2388008|NCT01411241|5860329|P1|STARTED|Overall Study||309
2388009|NCT01411228|5860354|P3|NOT COMPLETED|Overall Study||1
2388010|NCT01411228|5860355|P2|NOT COMPLETED|Overall Study||0
2388011|NCT01411228|5860356|P1|NOT COMPLETED|Overall Study||1
2388012|NCT01411228|5860354|P3|COMPLETED|Overall Study||4
2388013|NCT01411228|5860355|P2|COMPLETED|Overall Study||5
2388014|NCT01411228|5860356|P1|COMPLETED|Overall Study||4
2388015|NCT01411228|5860354|P3|STARTED|Overall Study||5
2388016|NCT01411228|5860355|P2|STARTED|Overall Study||5
2388017|NCT01411228|5860356|P1|STARTED|Overall Study||5
2388018|NCT01411215|5860378|P2|NOT COMPLETED|Overall Study||84
2388019|NCT01411215|5860379|P1|NOT COMPLETED|Overall Study||66
2388020|NCT01411215|5860378|P2|COMPLETED|Overall Study||7
2388021|NCT01411215|5860379|P1|COMPLETED|Overall Study||3
2388022|NCT01411215|5860378|P2|Treated|Overall Study|1 participant was considered as screen failure and therefore not treated.|90
2388023|NCT01411215|5860379|P1|Treated|Overall Study||69
2388024|NCT01411215|5860378|P2|STARTED|Overall Study||91
2388025|NCT01411215|5860379|P1|STARTED|Overall Study||69
2388026|NCT01411137|5860412|P1|NOT COMPLETED|Part 3: Open-Label Extension||0
2388027|NCT01411137|5860412|P1|COMPLETED|Part 3: Open-Label Extension||12
2388028|NCT01411137|5860412|P1|STARTED|Part 3: Open-Label Extension|Two sites with 11 completers of Part 2 did not participate in Part 3. Two subjects lost contact.|12
2388029|NCT01411137|5860412|P1|NOT COMPLETED|Part 2: Open-Label Extension||7
2388030|NCT01411137|5860412|P1|COMPLETED|Part 2: Open-Label Extension||25
2388031|NCT01411137|5860412|P1|STARTED|Part 2: Open-Label Extension|1 subject who completed Part 1 did not elect to continue into Part 2.|32
2388032|NCT01411137|5860412|P1|NOT COMPLETED|Part 1: Dose Conversion||10
2388033|NCT01411137|5860412|P1|COMPLETED|Part 1: Dose Conversion||33
2388034|NCT01411137|5860412|P1|STARTED|Part 1: Dose Conversion||43
2388035|NCT01411085|5860431|P1|NOT COMPLETED|Overall Study||3
2388036|NCT01411085|5860431|P1|COMPLETED|Overall Study||7
2388037|NCT01411085|5860431|P1|STARTED|Overall Study||10
2388038|NCT01410812|5860438|P3|NOT COMPLETED|Overall Study||0
2388039|NCT01410812|5860439|P2|NOT COMPLETED|Overall Study||0
2388040|NCT01410812|5860440|P1|NOT COMPLETED|Overall Study||0
2388041|NCT01410812|5860438|P3|COMPLETED|Overall Study||76
2388042|NCT01410812|5860439|P2|COMPLETED|Overall Study||75
2388043|NCT01410812|5860440|P1|COMPLETED|Overall Study||75
2388044|NCT01410812|5860438|P3|STARTED|Overall Study||76
2388045|NCT01410812|5860439|P2|STARTED|Overall Study||75
2388046|NCT01410812|5860440|P1|STARTED|Overall Study||75
2388047|NCT01410799|5860451|P1|NOT COMPLETED|Overall Study||13
2388048|NCT01410799|5860451|P1|COMPLETED|Overall Study||0
2388049|NCT01410799|5860451|P1|STARTED|Overall Study||13
2388050|NCT01410773|5860460|P1|NOT COMPLETED|Overall Study||0
2388051|NCT01410773|5860460|P1|COMPLETED|Overall Study||110
2388052|NCT01410773|5860460|P1|STARTED|Overall Study||110
2388053|NCT01410604|5860467|P2|NOT COMPLETED|Overall Study||2
2388054|NCT01410604|5860468|P1|NOT COMPLETED|Overall Study||3
2388055|NCT01410604|5860467|P2|COMPLETED|Overall Study||14
2388056|NCT01410604|5860468|P1|COMPLETED|Overall Study||12
2388057|NCT01410604|5860467|P2|STARTED|Overall Study||16
2388058|NCT01410604|5860468|P1|STARTED|Overall Study||15
2388059|NCT01410565|5860490|P3|NOT COMPLETED|Double Blind Phase||0
2388060|NCT01410565|5860491|P2|NOT COMPLETED|Double Blind Phase||15
2388061|NCT01410565|5860492|P1|NOT COMPLETED|Double Blind Phase||13
2388062|NCT01410565|5860490|P3|COMPLETED|Double Blind Phase||0
2388063|NCT01410565|5860491|P2|COMPLETED|Double Blind Phase||0
2388064|NCT01410565|5860492|P1|COMPLETED|Double Blind Phase||0
2388065|NCT01410565|5860490|P3|STARTED|Double Blind Phase||0
2388066|NCT01410565|5860491|P2|STARTED|Double Blind Phase||15
2388067|NCT01410565|5860492|P1|STARTED|Double Blind Phase|All 66 patients received one dose of Apaziquone in the open label phase.|13
2388068|NCT01410565|5860490|P3|NOT COMPLETED|Open Label Phase Apaziquone||8
2388069|NCT01410565|5860491|P2|NOT COMPLETED|Open Label Phase Apaziquone||0
2388070|NCT01410565|5860492|P1|NOT COMPLETED|Open Label Phase Apaziquone||0
2388071|NCT01410565|5860490|P3|COMPLETED|Open Label Phase Apaziquone||58
2388072|NCT01410565|5860491|P2|COMPLETED|Open Label Phase Apaziquone||0
2388073|NCT01410565|5860492|P1|COMPLETED|Open Label Phase Apaziquone||0
2388074|NCT01410565|5860490|P3|STARTED|Open Label Phase Apaziquone||66
2388075|NCT01410565|5860491|P2|STARTED|Open Label Phase Apaziquone||0
2388076|NCT01410565|5860492|P1|STARTED|Open Label Phase Apaziquone||0
2388077|NCT01410552|5860502|P1|NOT COMPLETED|Overall Study||136
2388078|NCT01410552|5860502|P1|COMPLETED|Overall Study||877
2388079|NCT01410552|5860502|P1|STARTED|Overall Study||1013
2388080|NCT01410474|5860509|P2|NOT COMPLETED|Overall Study||1
2388081|NCT01410474|5860510|P1|NOT COMPLETED|Overall Study||0
2388082|NCT01410474|5860509|P2|COMPLETED|Overall Study||167
2388083|NCT01410474|5860510|P1|COMPLETED|Overall Study||173
2388084|NCT01410474|5860509|P2|STARTED|Overall Study||168
2388085|NCT01410474|5860510|P1|STARTED|Overall Study||173
2388086|NCT01410448|5860533|P2|NOT COMPLETED|Overall Study||35
2388087|NCT01410448|5860534|P1|NOT COMPLETED|Overall Study||12
2388088|NCT01410448|5860533|P2|COMPLETED|Overall Study||155
2388089|NCT01410448|5860534|P1|COMPLETED|Overall Study||181
2388090|NCT01410448|5860533|P2|Modified ITT Analysis Set|Overall Study||149
2388091|NCT01410448|5860534|P1|Modified ITT Analysis Set|Overall Study||161
2388092|NCT01410448|5860533|P2|Intent-to Treat (ITT) Analysis Set|Overall Study||190
2388093|NCT01410448|5860534|P1|Intent-to Treat (ITT) Analysis Set|Overall Study||193
2388094|NCT01410448|5860533|P2|STARTED|Overall Study||190
2388095|NCT01410448|5860534|P1|STARTED|Overall Study||193
2388096|NCT01410409|5860574|P2|NOT COMPLETED|Overall Study||4
2388097|NCT01410409|5860575|P1|NOT COMPLETED|Overall Study||1
2388098|NCT01410409|5860574|P2|COMPLETED|Overall Study||46
2388099|NCT01410409|5860575|P1|COMPLETED|Overall Study||49
2388100|NCT01410409|5860574|P2|STARTED|Overall Study||50
2388101|NCT01410409|5860575|P1|STARTED|Overall Study||50
2388102|NCT01410357|5860599|P2|NOT COMPLETED|Overall Study||24
2388103|NCT01410357|5860600|P1|NOT COMPLETED|Overall Study||26
2388104|NCT01410357|5860599|P2|COMPLETED|Overall Study||76
2388105|NCT01410357|5860600|P1|COMPLETED|Overall Study||74
2388106|NCT01410357|5860599|P2|STARTED|Overall Study||100
2388107|NCT01410357|5860600|P1|STARTED|Overall Study||100
2388108|NCT01410344|5860654|P1|NOT COMPLETED|Overall Study||3
2388109|NCT01410344|5860654|P1|COMPLETED|Overall Study||17
2388110|NCT01410344|5860654|P1|STARTED|Overall Study||20
2388111|NCT01410240|5860671|P3|NOT COMPLETED|Overall Study||2
2388112|NCT01410240|5860672|P2|NOT COMPLETED|Overall Study||1
2388113|NCT01410240|5860673|P1|NOT COMPLETED|Overall Study||1
2388114|NCT01410240|5860671|P3|COMPLETED|Overall Study||10
2388115|NCT01410240|5860672|P2|COMPLETED|Overall Study||52
2388116|NCT01410240|5860673|P1|COMPLETED|Overall Study||52
2388117|NCT01410240|5860671|P3|STARTED|Overall Study||12
2388118|NCT01410240|5860672|P2|STARTED|Overall Study||53
2388119|NCT01410240|5860673|P1|STARTED|Overall Study||53
2388120|NCT01410227|5860744|P4|NOT COMPLETED|Overall Study||1
2388121|NCT01410227|5860745|P3|NOT COMPLETED|Overall Study||2
2388122|NCT01410227|5860746|P2|NOT COMPLETED|Overall Study||0
2388123|NCT01410227|5860747|P1|NOT COMPLETED|Overall Study||4
2388124|NCT01410227|5860744|P4|COMPLETED|Overall Study||5
2388125|NCT01410227|5860745|P3|COMPLETED|Overall Study||13
2388126|NCT01410227|5860746|P2|COMPLETED|Overall Study||8
2388127|NCT01410227|5860747|P1|COMPLETED|Overall Study||4
2388128|NCT01410227|5860744|P4|STARTED|Overall Study||6
2388129|NCT01410227|5860745|P3|STARTED|Overall Study||15
2388130|NCT01410227|5860746|P2|STARTED|Overall Study||8
2388131|NCT01410227|5860747|P1|STARTED|Overall Study||8
2388132|NCT01410110|5860819|P2|NOT COMPLETED|Overall Study||2
2388133|NCT01410110|5860820|P1|NOT COMPLETED|Overall Study||4
2388134|NCT01410110|5860819|P2|COMPLETED|Overall Study||22
2388135|NCT01410110|5860820|P1|COMPLETED|Overall Study||20
2388136|NCT01410110|5860819|P2|6 Month Follow-up|Overall Study||22
2388137|NCT01410110|5860820|P1|6 Month Follow-up|Overall Study||20
2388138|NCT01410110|5860819|P2|3 Months (End of Intervention)|Overall Study||22
2388139|NCT01410110|5860820|P1|3 Months (End of Intervention)|Overall Study||20
2388140|NCT01410110|5860819|P2|Randomization|Overall Study||24
2388141|NCT01410110|5860820|P1|Randomization|Overall Study||24
2388142|NCT01410110|5860819|P2|STARTED|Overall Study||24
2388143|NCT01410110|5860820|P1|STARTED|Overall Study||24
2388144|NCT01410097|5860844|P2|NOT COMPLETED|Overall Study||3
2388145|NCT01410097|5860845|P1|NOT COMPLETED|Overall Study||5
2388146|NCT01410097|5860844|P2|COMPLETED|Overall Study||530
2388147|NCT01410097|5860845|P1|COMPLETED|Overall Study||551
2388148|NCT01410097|5860844|P2|STARTED|Overall Study||533
2388149|NCT01410097|5860845|P1|STARTED|Overall Study||556
2388150|NCT01410084|5860869|P2|NOT COMPLETED|Overall Study||3
2388151|NCT01410084|5860870|P1|NOT COMPLETED|Overall Study||1
2388152|NCT01410084|5860869|P2|COMPLETED|Overall Study||27
2388153|NCT01410084|5860870|P1|COMPLETED|Overall Study||37
2388154|NCT01410084|5860869|P2|STARTED|Overall Study||30
2388155|NCT01410084|5860870|P1|STARTED|Overall Study||38
2388156|NCT01410058|5860882|P2|NOT COMPLETED|Day 35||0
2388157|NCT01410058|5860883|P1|NOT COMPLETED|Day 35||0
2388158|NCT01410058|5860882|P2|COMPLETED|Day 35||6
2388159|NCT01410058|5860883|P1|COMPLETED|Day 35||13
2388160|NCT01410058|5860882|P2|STARTED|Day 35||6
2388161|NCT01410058|5860883|P1|STARTED|Day 35||13
2388162|NCT01410058|5860882|P2|NOT COMPLETED|Baseline Day 22||0
2388163|NCT01410058|5860883|P1|NOT COMPLETED|Baseline Day 22||0
2388164|NCT01410058|5860882|P2|COMPLETED|Baseline Day 22||6
2388165|NCT01410058|5860883|P1|COMPLETED|Baseline Day 22||13
2388166|NCT01410058|5860882|P2|STARTED|Baseline Day 22||6
2388167|NCT01410058|5860883|P1|STARTED|Baseline Day 22||13
2388168|NCT01410058|5860882|P2|NOT COMPLETED|Washout Day 0||0
2388169|NCT01410058|5860883|P1|NOT COMPLETED|Washout Day 0||0
2388170|NCT01410058|5860882|P2|COMPLETED|Washout Day 0||6
2388171|NCT01410058|5860883|P1|COMPLETED|Washout Day 0||13
2388172|NCT01410058|5860882|P2|STARTED|Washout Day 0||6
2388173|NCT01410058|5860883|P1|STARTED|Washout Day 0||13
2388174|NCT01409993|5860895|P4|NOT COMPLETED|Overall Study||5
2388175|NCT01409993|5860896|P3|NOT COMPLETED|Overall Study||3
2388176|NCT01409993|5860897|P2|NOT COMPLETED|Overall Study||5
2388177|NCT01409993|5860898|P1|NOT COMPLETED|Overall Study||4
2388178|NCT01409993|5860895|P4|COMPLETED|Overall Study||8
2388179|NCT01409993|5860896|P3|COMPLETED|Overall Study||11
2388180|NCT01409993|5860897|P2|COMPLETED|Overall Study||21
2388181|NCT01409993|5860898|P1|COMPLETED|Overall Study||21
2388182|NCT01409993|5860895|P4|STARTED|Overall Study||13
2388183|NCT01409993|5860896|P3|STARTED|Overall Study||14
2388184|NCT01409993|5860897|P2|STARTED|Overall Study||26
2388185|NCT01409993|5860898|P1|STARTED|Overall Study||25
2388186|NCT01409837|5860918|P2|NOT COMPLETED|Overall Study||2
2388187|NCT01409837|5860919|P1|NOT COMPLETED|Overall Study||3
2388188|NCT01409837|5860918|P2|COMPLETED|Overall Study||14
2388189|NCT01409837|5860919|P1|COMPLETED|Overall Study||14
2388190|NCT01409837|5860918|P2|282nd Week|Overall Study||14
2388191|NCT01409837|5860919|P1|282nd Week|Overall Study||14
2388192|NCT01409837|5860918|P2|186th Week|Overall Study||14
2388193|NCT01409837|5860919|P1|186th Week|Overall Study|Moved away to another location|14
2388194|NCT01409837|5860918|P2|138th Week|Overall Study||14
2388195|NCT01409837|5860919|P1|138th Week|Overall Study||15
2388196|NCT01409837|5860918|P2|114th Week|Overall Study||14
2388197|NCT01409837|5860919|P1|114th Week|Overall Study||15
2388198|NCT01409837|5860918|P2|102nd Week|Overall Study|Married another wife|14
2388199|NCT01409837|5860919|P1|102nd Week|Overall Study||15
2388200|NCT01409837|5860918|P2|96th Week|Overall Study||15
2388201|NCT01409837|5860919|P1|96th Week|Overall Study||15
2388202|NCT01409837|5860918|P2|48th Week|Overall Study||15
2388203|NCT01409837|5860919|P1|48th Week|Overall Study|Lost to follow-up|15
2388204|NCT01409837|5860918|P2|24th Week|Overall Study|Diagnosed with Lymphocytic Lymphoma and withdrawn|15
2388205|NCT01409837|5860919|P1|24th Week|Overall Study||16
2388206|NCT01409837|5860918|P2|12th Week|Overall Study||16
2388207|NCT01409837|5860919|P1|12th Week|Overall Study|Moved away to another location|16
2388208|NCT01409837|5860918|P2|6th Week|Overall Study||16
2388209|NCT01409837|5860919|P1|6th Week|Overall Study||17
2388210|NCT01409837|5860918|P2|STARTED|Overall Study||16
2388211|NCT01409837|5860919|P1|STARTED|Overall Study||17
2388212|NCT01409707|5860944|P3|NOT COMPLETED|Overall Study||16
2388213|NCT01409707|5860945|P2|NOT COMPLETED|Overall Study||17
2388214|NCT01409707|5860946|P1|NOT COMPLETED|Overall Study||5
2388215|NCT01409707|5860944|P3|COMPLETED|Overall Study||24
2388216|NCT01409707|5860945|P2|COMPLETED|Overall Study||28
2388217|NCT01409707|5860946|P1|COMPLETED|Overall Study||36
2388218|NCT01409707|5860944|P3|STARTED|Overall Study||40
2388219|NCT01409707|5860945|P2|STARTED|Overall Study||45
2388220|NCT01409707|5860946|P1|STARTED|Overall Study||41
2388221|NCT01409564|5860958|P2|NOT COMPLETED|Overall Study||5
2388222|NCT01409564|5860959|P1|NOT COMPLETED|Overall Study||5
2388223|NCT01409564|5860958|P2|COMPLETED|Overall Study||18
2388224|NCT01409564|5860959|P1|COMPLETED|Overall Study||18
2388225|NCT01409564|5860958|P2|STARTED|Overall Study||23
2388226|NCT01409564|5860959|P1|STARTED|Overall Study||23
2388227|NCT01409434|5860977|P1|NOT COMPLETED|Overall Study||4
2388228|NCT01409434|5860977|P1|COMPLETED|Overall Study||40
2388229|NCT01409434|5860977|P1|STARTED|Overall Study||44
2388230|NCT01409382|5860987|P2|NOT COMPLETED|Overall Study||80
2388231|NCT01409382|5860988|P1|NOT COMPLETED|Overall Study||81
2388232|NCT01409382|5860987|P2|COMPLETED|Overall Study||160
2388233|NCT01409382|5860988|P1|COMPLETED|Overall Study||159
2388234|NCT01409382|5860987|P2|STARTED|Overall Study||240
2388235|NCT01409382|5860988|P1|STARTED|Overall Study||240
2388236|NCT01409291|5861002|P2|NOT COMPLETED|Overall Study||9
2388237|NCT01409291|5861003|P1|NOT COMPLETED|Overall Study||7
2388238|NCT01409291|5861002|P2|COMPLETED|Overall Study||19
2388239|NCT01409291|5861003|P1|COMPLETED|Overall Study||29
2388240|NCT01409291|5861002|P2|STARTED|Overall Study||28
2388241|NCT01409291|5861003|P1|STARTED|Overall Study||36
2388242|NCT01409239|5861013|P2|NOT COMPLETED|Overall Study||0
2388243|NCT01409239|5861014|P1|NOT COMPLETED|Overall Study||0
2388244|NCT01409239|5861013|P2|COMPLETED|Overall Study||17
2388245|NCT01409239|5861014|P1|COMPLETED|Overall Study||16
2388246|NCT01409239|5861013|P2|STARTED|Overall Study||17
2388247|NCT01409239|5861014|P1|STARTED|Overall Study||16
2388248|NCT01409213|5861020|P1|NOT COMPLETED|Overall Study||0
2388249|NCT01409213|5861020|P1|COMPLETED|Overall Study||1523
2388250|NCT01409213|5861020|P1|STARTED|Overall Study||1523
2388251|NCT01409096|5861027|P2|NOT COMPLETED|Overall Study||5
2388252|NCT01409096|5861028|P1|NOT COMPLETED|Overall Study||2
2388253|NCT01409096|5861027|P2|COMPLETED|Overall Study||35
2388254|NCT01409096|5861028|P1|COMPLETED|Overall Study||38
2388255|NCT01409096|5861027|P2|STARTED|Overall Study||40
2388256|NCT01409096|5861028|P1|STARTED|Overall Study||40
2388257|NCT01409031|5861042|P2|NOT COMPLETED|Overall Study||0
2388258|NCT01409031|5861043|P1|NOT COMPLETED|Overall Study||1
2388259|NCT01409031|5861042|P2|COMPLETED|Overall Study||2
2388260|NCT01409031|5861043|P1|COMPLETED|Overall Study||0
2388261|NCT01409031|5861042|P2|STARTED|Overall Study||2
2388262|NCT01409031|5861043|P1|STARTED|Overall Study||1
2388263|NCT01408992|5861059|P1|NOT COMPLETED|Overall Study||0
2388264|NCT01408992|5861059|P1|COMPLETED|Overall Study||558
2388265|NCT01408992|5861059|P1|STARTED|Overall Study||558
2388266|NCT01408914|5861074|P3|NOT COMPLETED|Overall Study||13
2388267|NCT01408914|5861075|P2|NOT COMPLETED|Overall Study||12
2388268|NCT01408914|5861076|P1|NOT COMPLETED|Overall Study||12
2388269|NCT01408914|5861074|P3|COMPLETED|Overall Study||47
2388270|NCT01408914|5861075|P2|COMPLETED|Overall Study||48
2388271|NCT01408914|5861076|P1|COMPLETED|Overall Study||48
2388272|NCT01408914|5861074|P3|STARTED|Overall Study||60
2388273|NCT01408914|5861075|P2|STARTED|Overall Study||60
2388274|NCT01408914|5861076|P1|STARTED|Overall Study||60
2388275|NCT01408901|5861094|P4|NOT COMPLETED|26-Week Follow-Up||1
2388276|NCT01408901|5861095|P3|NOT COMPLETED|26-Week Follow-Up||0
2388277|NCT01408901|5861096|P2|NOT COMPLETED|26-Week Follow-Up||2
2388278|NCT01408901|5861097|P1|NOT COMPLETED|26-Week Follow-Up||1
2388279|NCT01408901|5861094|P4|COMPLETED|26-Week Follow-Up||46
2388280|NCT01408901|5861095|P3|COMPLETED|26-Week Follow-Up||50
2388281|NCT01408901|5861096|P2|COMPLETED|26-Week Follow-Up||50
2388282|NCT01408901|5861097|P1|COMPLETED|26-Week Follow-Up||48
2388283|NCT01408901|5861094|P4|STARTED|26-Week Follow-Up||47
2388284|NCT01408901|5861095|P3|STARTED|26-Week Follow-Up||50
2388285|NCT01408901|5861096|P2|STARTED|26-Week Follow-Up||52
2388286|NCT01408901|5861097|P1|STARTED|26-Week Follow-Up||49
2388287|NCT01408901|5861094|P4|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||3
2388288|NCT01408901|5861095|P3|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||0
2388289|NCT01408901|5861096|P2|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||2
2388290|NCT01408901|5861097|P1|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||1
2388291|NCT01408901|5861094|P4|COMPLETED|12-Week Follow-Up (Primary Endpoint)||46
2388292|NCT01408901|5861095|P3|COMPLETED|12-Week Follow-Up (Primary Endpoint)||50
2388293|NCT01408901|5861096|P2|COMPLETED|12-Week Follow-Up (Primary Endpoint)||50
2388294|NCT01408901|5861097|P1|COMPLETED|12-Week Follow-Up (Primary Endpoint)||49
2388295|NCT01408901|5861094|P4|STARTED|12-Week Follow-Up (Primary Endpoint)||49
2388296|NCT01408901|5861095|P3|STARTED|12-Week Follow-Up (Primary Endpoint)||50
2388297|NCT01408901|5861096|P2|STARTED|12-Week Follow-Up (Primary Endpoint)||52
2388298|NCT01408901|5861097|P1|STARTED|12-Week Follow-Up (Primary Endpoint)||50
2388299|NCT01408901|5861094|P4|NOT COMPLETED|6-Week Follow-Up||4
2388300|NCT01408901|5861095|P3|NOT COMPLETED|6-Week Follow-Up||3
2388301|NCT01408901|5861096|P2|NOT COMPLETED|6-Week Follow-Up||2
2388302|NCT01408901|5861097|P1|NOT COMPLETED|6-Week Follow-Up||3
2388303|NCT01408901|5861094|P4|COMPLETED|6-Week Follow-Up||47
2388304|NCT01408901|5861095|P3|COMPLETED|6-Week Follow-Up||50
2388305|NCT01408901|5861096|P2|COMPLETED|6-Week Follow-Up||51
2388306|NCT01408901|5861097|P1|COMPLETED|6-Week Follow-Up||50
2388307|NCT01408901|5861094|P4|STARTED|6-Week Follow-Up||51
2388308|NCT01408901|5861095|P3|STARTED|6-Week Follow-Up||53
2388309|NCT01408901|5861096|P2|STARTED|6-Week Follow-Up||53
2388310|NCT01408901|5861097|P1|STARTED|6-Week Follow-Up||53
2388311|NCT01408888|5861123|P2|NOT COMPLETED|Second Intervention||0
2388312|NCT01408888|5861124|P1|NOT COMPLETED|Second Intervention||2
2388313|NCT01408888|5861123|P2|COMPLETED|Second Intervention||8
2388314|NCT01408888|5861124|P1|COMPLETED|Second Intervention||16
2388315|NCT01408888|5861123|P2|STARTED|Second Intervention||8
2388316|NCT01408888|5861124|P1|STARTED|Second Intervention||18
2388317|NCT01408888|5861123|P2|NOT COMPLETED|Washout of at Least 21 Days||0
2388318|NCT01408888|5861124|P1|NOT COMPLETED|Washout of at Least 21 Days||0
2388319|NCT01408888|5861123|P2|COMPLETED|Washout of at Least 21 Days||8
2388320|NCT01408888|5861124|P1|COMPLETED|Washout of at Least 21 Days||18
2388321|NCT01408888|5861123|P2|STARTED|Washout of at Least 21 Days||8
2388322|NCT01408888|5861124|P1|STARTED|Washout of at Least 21 Days||18
2388323|NCT01408888|5861123|P2|NOT COMPLETED|First Intervention||3
2388324|NCT01408888|5861124|P1|NOT COMPLETED|First Intervention||0
2388325|NCT01408888|5861123|P2|COMPLETED|First Intervention||8
2388326|NCT01408888|5861124|P1|COMPLETED|First Intervention||18
2388327|NCT01408888|5861123|P2|Received at Least 1 Dose of Drug|First Intervention||11
2388328|NCT01408888|5861124|P1|Received at Least 1 Dose of Drug|First Intervention||18
2388329|NCT01408888|5861123|P2|STARTED|First Intervention||11
2388330|NCT01408888|5861124|P1|STARTED|First Intervention||18
2388331|NCT01408862|5861147|P1|NOT COMPLETED|Overall Study||0
2388332|NCT01408862|5861147|P1|COMPLETED|Overall Study||20
2388333|NCT01408862|5861147|P1|STARTED|Overall Study||20
2388334|NCT01408732|5861152|P2|NOT COMPLETED|Overall Study||2
2388335|NCT01408732|5861153|P1|NOT COMPLETED|Overall Study||2
2388336|NCT01408732|5861152|P2|COMPLETED|Overall Study||7
2388337|NCT01408732|5861153|P1|COMPLETED|Overall Study||7
2388338|NCT01408732|5861152|P2|STARTED|Overall Study||9
2388339|NCT01408732|5861153|P1|STARTED|Overall Study||9
2388340|NCT01408719|5861179|P20|NOT COMPLETED|Fourth Intervention (35 Days)||0
2388341|NCT01408719|5861180|P19|NOT COMPLETED|Fourth Intervention (35 Days)||0
2388342|NCT01408719|5861181|P18|NOT COMPLETED|Fourth Intervention (35 Days)||0
2388343|NCT01408719|5861182|P17|NOT COMPLETED|Fourth Intervention (35 Days)||0
2388344|NCT01408719|5861183|P16|NOT COMPLETED|Fourth Intervention (35 Days)||0
2388345|NCT01408719|5861184|P15|NOT COMPLETED|Fourth Intervention (35 Days)||0
2388346|NCT01408719|5861185|P14|NOT COMPLETED|Fourth Intervention (35 Days)||0
2388347|NCT01408719|5861186|P13|NOT COMPLETED|Fourth Intervention (35 Days)||0
2388348|NCT01408719|5861187|P12|NOT COMPLETED|Fourth Intervention (35 Days)||0
2388349|NCT01408719|5861188|P11|NOT COMPLETED|Fourth Intervention (35 Days)||0
2388350|NCT01408719|5861189|P10|NOT COMPLETED|Fourth Intervention (35 Days)||0
2388351|NCT01408719|5861190|P9|NOT COMPLETED|Fourth Intervention (35 Days)||0
2388352|NCT01408719|5861191|P8|NOT COMPLETED|Fourth Intervention (35 Days)||0
2388353|NCT01408719|5861192|P7|NOT COMPLETED|Fourth Intervention (35 Days)||0
2388354|NCT01408719|5861193|P6|NOT COMPLETED|Fourth Intervention (35 Days)||0
2388355|NCT01408719|5861194|P5|NOT COMPLETED|Fourth Intervention (35 Days)||0
2388356|NCT01408719|5861195|P4|NOT COMPLETED|Fourth Intervention (35 Days)||0
2388357|NCT01408719|5861196|P3|NOT COMPLETED|Fourth Intervention (35 Days)||0
2388358|NCT01408719|5861197|P2|NOT COMPLETED|Fourth Intervention (35 Days)||0
2388359|NCT01408719|5861198|P1|NOT COMPLETED|Fourth Intervention (35 Days)||0
2388360|NCT01408719|5861179|P20|COMPLETED|Fourth Intervention (35 Days)||1
2388361|NCT01408719|5861180|P19|COMPLETED|Fourth Intervention (35 Days)||0
2388362|NCT01408719|5861181|P18|COMPLETED|Fourth Intervention (35 Days)||2
2388363|NCT01408719|5861182|P17|COMPLETED|Fourth Intervention (35 Days)||2
2388364|NCT01408719|5861183|P16|COMPLETED|Fourth Intervention (35 Days)||1
2388365|NCT01408719|5861184|P15|COMPLETED|Fourth Intervention (35 Days)||1
2388366|NCT01408719|5861185|P14|COMPLETED|Fourth Intervention (35 Days)||3
2388367|NCT01408719|5861186|P13|COMPLETED|Fourth Intervention (35 Days)||1
2388368|NCT01408719|5861187|P12|COMPLETED|Fourth Intervention (35 Days)||2
2388369|NCT01408719|5861188|P11|COMPLETED|Fourth Intervention (35 Days)||2
2388370|NCT01408719|5861189|P10|COMPLETED|Fourth Intervention (35 Days)||1
2388371|NCT01408719|5861190|P9|COMPLETED|Fourth Intervention (35 Days)||1
2388372|NCT01408719|5861191|P8|COMPLETED|Fourth Intervention (35 Days)||2
2388373|NCT01408719|5861192|P7|COMPLETED|Fourth Intervention (35 Days)||2
2388374|NCT01408719|5861193|P6|COMPLETED|Fourth Intervention (35 Days)||3
2388375|NCT01408719|5861194|P5|COMPLETED|Fourth Intervention (35 Days)||3
2388376|NCT01408719|5861195|P4|COMPLETED|Fourth Intervention (35 Days)||2
2388377|NCT01408719|5861196|P3|COMPLETED|Fourth Intervention (35 Days)||1
2388378|NCT01408719|5861197|P2|COMPLETED|Fourth Intervention (35 Days)||3
2388379|NCT01408719|5861198|P1|COMPLETED|Fourth Intervention (35 Days)||2
2388380|NCT01408719|5861179|P20|STARTED|Fourth Intervention (35 Days)||1
2388381|NCT01408719|5861180|P19|STARTED|Fourth Intervention (35 Days)||0
2388382|NCT01408719|5861181|P18|STARTED|Fourth Intervention (35 Days)||2
2388383|NCT01408719|5861182|P17|STARTED|Fourth Intervention (35 Days)||2
2388384|NCT01408719|5861183|P16|STARTED|Fourth Intervention (35 Days)||1
2388385|NCT01408719|5861184|P15|STARTED|Fourth Intervention (35 Days)||1
2388386|NCT01408719|5861185|P14|STARTED|Fourth Intervention (35 Days)||3
2388387|NCT01408719|5861186|P13|STARTED|Fourth Intervention (35 Days)||1
2388388|NCT01408719|5861187|P12|STARTED|Fourth Intervention (35 Days)||2
2388389|NCT01408719|5861188|P11|STARTED|Fourth Intervention (35 Days)||2
2388390|NCT01408719|5861189|P10|STARTED|Fourth Intervention (35 Days)||1
2388391|NCT01408719|5861190|P9|STARTED|Fourth Intervention (35 Days)||1
2388392|NCT01408719|5861191|P8|STARTED|Fourth Intervention (35 Days)||2
2388393|NCT01408719|5861192|P7|STARTED|Fourth Intervention (35 Days)||2
2388394|NCT01408719|5861193|P6|STARTED|Fourth Intervention (35 Days)||3
2388395|NCT01408719|5861194|P5|STARTED|Fourth Intervention (35 Days)||3
2388396|NCT01408719|5861195|P4|STARTED|Fourth Intervention (35 Days)||2
2388397|NCT01408719|5861196|P3|STARTED|Fourth Intervention (35 Days)||1
2388398|NCT01408719|5861197|P2|STARTED|Fourth Intervention (35 Days)||3
2388399|NCT01408719|5861198|P1|STARTED|Fourth Intervention (35 Days)||2
2388400|NCT01408719|5861179|P20|NOT COMPLETED|Washout Period (28 Days)||0
2388401|NCT01408719|5861180|P19|NOT COMPLETED|Washout Period (28 Days)||0
2388402|NCT01408719|5861181|P18|NOT COMPLETED|Washout Period (28 Days)||0
2388403|NCT01408719|5861182|P17|NOT COMPLETED|Washout Period (28 Days)||0
2388404|NCT01408719|5861183|P16|NOT COMPLETED|Washout Period (28 Days)||0
2388405|NCT01408719|5861184|P15|NOT COMPLETED|Washout Period (28 Days)||0
2388406|NCT01408719|5861185|P14|NOT COMPLETED|Washout Period (28 Days)||0
2388407|NCT01408719|5861186|P13|NOT COMPLETED|Washout Period (28 Days)||0
2388408|NCT01408719|5861187|P12|NOT COMPLETED|Washout Period (28 Days)||0
2388409|NCT01408719|5861188|P11|NOT COMPLETED|Washout Period (28 Days)||0
2388410|NCT01408719|5861189|P10|NOT COMPLETED|Washout Period (28 Days)||0
2388411|NCT01408719|5861190|P9|NOT COMPLETED|Washout Period (28 Days)||0
2388412|NCT01408719|5861191|P8|NOT COMPLETED|Washout Period (28 Days)||0
2388413|NCT01408719|5861192|P7|NOT COMPLETED|Washout Period (28 Days)||0
2388414|NCT01408719|5861193|P6|NOT COMPLETED|Washout Period (28 Days)||0
2388415|NCT01408719|5861194|P5|NOT COMPLETED|Washout Period (28 Days)||0
2388416|NCT01408719|5861195|P4|NOT COMPLETED|Washout Period (28 Days)||0
2388417|NCT01408719|5861196|P3|NOT COMPLETED|Washout Period (28 Days)||0
2388418|NCT01408719|5861197|P2|NOT COMPLETED|Washout Period (28 Days)||0
2388419|NCT01408719|5861198|P1|NOT COMPLETED|Washout Period (28 Days)||0
2388420|NCT01408719|5861179|P20|COMPLETED|Washout Period (28 Days)||1
2388421|NCT01408719|5861180|P19|COMPLETED|Washout Period (28 Days)||0
2388422|NCT01408719|5861181|P18|COMPLETED|Washout Period (28 Days)||2
2388423|NCT01408719|5861182|P17|COMPLETED|Washout Period (28 Days)||2
2388424|NCT01408719|5861183|P16|COMPLETED|Washout Period (28 Days)||1
2388425|NCT01408719|5861184|P15|COMPLETED|Washout Period (28 Days)||1
2388426|NCT01408719|5861185|P14|COMPLETED|Washout Period (28 Days)||3
2388427|NCT01408719|5861186|P13|COMPLETED|Washout Period (28 Days)||1
2388428|NCT01408719|5861187|P12|COMPLETED|Washout Period (28 Days)||2
2388429|NCT01408719|5861188|P11|COMPLETED|Washout Period (28 Days)||2
2388430|NCT01408719|5861189|P10|COMPLETED|Washout Period (28 Days)||1
2388431|NCT01408719|5861190|P9|COMPLETED|Washout Period (28 Days)||1
2388432|NCT01408719|5861191|P8|COMPLETED|Washout Period (28 Days)||2
2388433|NCT01408719|5861192|P7|COMPLETED|Washout Period (28 Days)||2
2388434|NCT01408719|5861193|P6|COMPLETED|Washout Period (28 Days)||3
2388435|NCT01408719|5861194|P5|COMPLETED|Washout Period (28 Days)||3
2388436|NCT01408719|5861195|P4|COMPLETED|Washout Period (28 Days)||2
2388437|NCT01408719|5861196|P3|COMPLETED|Washout Period (28 Days)||1
2388438|NCT01408719|5861197|P2|COMPLETED|Washout Period (28 Days)||3
2388439|NCT01408719|5861198|P1|COMPLETED|Washout Period (28 Days)||2
2388440|NCT01408719|5861179|P20|STARTED|Washout Period (28 Days)||1
2388441|NCT01408719|5861180|P19|STARTED|Washout Period (28 Days)||0
2388442|NCT01408719|5861181|P18|STARTED|Washout Period (28 Days)||2
2388443|NCT01408719|5861182|P17|STARTED|Washout Period (28 Days)||2
2388444|NCT01408719|5861183|P16|STARTED|Washout Period (28 Days)||1
2388445|NCT01408719|5861184|P15|STARTED|Washout Period (28 Days)||1
2388446|NCT01408719|5861185|P14|STARTED|Washout Period (28 Days)||3
2388447|NCT01408719|5861186|P13|STARTED|Washout Period (28 Days)||1
2388448|NCT01408719|5861187|P12|STARTED|Washout Period (28 Days)||2
2388449|NCT01408719|5861188|P11|STARTED|Washout Period (28 Days)||2
2388450|NCT01408719|5861189|P10|STARTED|Washout Period (28 Days)||1
2388451|NCT01408719|5861190|P9|STARTED|Washout Period (28 Days)||1
2388452|NCT01408719|5861191|P8|STARTED|Washout Period (28 Days)||2
2388453|NCT01408719|5861192|P7|STARTED|Washout Period (28 Days)||2
2388454|NCT01408719|5861193|P6|STARTED|Washout Period (28 Days)||3
2388455|NCT01408719|5861194|P5|STARTED|Washout Period (28 Days)||3
2388456|NCT01408719|5861195|P4|STARTED|Washout Period (28 Days)||2
2388457|NCT01408719|5861196|P3|STARTED|Washout Period (28 Days)||1
2388458|NCT01408719|5861197|P2|STARTED|Washout Period (28 Days)||3
2388459|NCT01408719|5861198|P1|STARTED|Washout Period (28 Days)||2
2388460|NCT01408719|5861179|P20|NOT COMPLETED|Third Intervention (35 Days)||0
2388461|NCT01408719|5861180|P19|NOT COMPLETED|Third Intervention (35 Days)||0
2388462|NCT01408719|5861181|P18|NOT COMPLETED|Third Intervention (35 Days)||0
2388463|NCT01408719|5861182|P17|NOT COMPLETED|Third Intervention (35 Days)||0
2388464|NCT01408719|5861183|P16|NOT COMPLETED|Third Intervention (35 Days)||0
2388465|NCT01408719|5861184|P15|NOT COMPLETED|Third Intervention (35 Days)||0
2388466|NCT01408719|5861185|P14|NOT COMPLETED|Third Intervention (35 Days)||0
2388467|NCT01408719|5861186|P13|NOT COMPLETED|Third Intervention (35 Days)||0
2388468|NCT01408719|5861187|P12|NOT COMPLETED|Third Intervention (35 Days)||0
2388469|NCT01408719|5861188|P11|NOT COMPLETED|Third Intervention (35 Days)||0
2388470|NCT01408719|5861189|P10|NOT COMPLETED|Third Intervention (35 Days)||0
2388471|NCT01408719|5861190|P9|NOT COMPLETED|Third Intervention (35 Days)||0
2388472|NCT01408719|5861191|P8|NOT COMPLETED|Third Intervention (35 Days)||1
2388473|NCT01408719|5861192|P7|NOT COMPLETED|Third Intervention (35 Days)||0
2388474|NCT01408719|5861193|P6|NOT COMPLETED|Third Intervention (35 Days)||0
2388475|NCT01408719|5861194|P5|NOT COMPLETED|Third Intervention (35 Days)||0
2388476|NCT01408719|5861195|P4|NOT COMPLETED|Third Intervention (35 Days)||0
2388477|NCT01408719|5861196|P3|NOT COMPLETED|Third Intervention (35 Days)||0
2388478|NCT01408719|5861197|P2|NOT COMPLETED|Third Intervention (35 Days)||0
2388479|NCT01408719|5861198|P1|NOT COMPLETED|Third Intervention (35 Days)||0
2388480|NCT01408719|5861179|P20|COMPLETED|Third Intervention (35 Days)||1
2388481|NCT01408719|5861180|P19|COMPLETED|Third Intervention (35 Days)||0
2388482|NCT01408719|5861181|P18|COMPLETED|Third Intervention (35 Days)||2
2388483|NCT01408719|5861182|P17|COMPLETED|Third Intervention (35 Days)||2
2388484|NCT01408719|5861183|P16|COMPLETED|Third Intervention (35 Days)||1
2388485|NCT01408719|5861184|P15|COMPLETED|Third Intervention (35 Days)||1
2388486|NCT01408719|5861185|P14|COMPLETED|Third Intervention (35 Days)||3
2388487|NCT01408719|5861186|P13|COMPLETED|Third Intervention (35 Days)||2
2388488|NCT01408719|5861187|P12|COMPLETED|Third Intervention (35 Days)||2
2388489|NCT01408719|5861188|P11|COMPLETED|Third Intervention (35 Days)||2
2388490|NCT01408719|5861189|P10|COMPLETED|Third Intervention (35 Days)||1
2388491|NCT01408719|5861190|P9|COMPLETED|Third Intervention (35 Days)||1
2388492|NCT01408719|5861191|P8|COMPLETED|Third Intervention (35 Days)||2
2388493|NCT01408719|5861192|P7|COMPLETED|Third Intervention (35 Days)||2
2388494|NCT01408719|5861193|P6|COMPLETED|Third Intervention (35 Days)||3
2388495|NCT01408719|5861194|P5|COMPLETED|Third Intervention (35 Days)||3
2388496|NCT01408719|5861195|P4|COMPLETED|Third Intervention (35 Days)||2
2388497|NCT01408719|5861196|P3|COMPLETED|Third Intervention (35 Days)||1
2388498|NCT01408719|5861197|P2|COMPLETED|Third Intervention (35 Days)||3
2388499|NCT01408719|5861198|P1|COMPLETED|Third Intervention (35 Days)||2
2388500|NCT01408719|5861179|P20|STARTED|Third Intervention (35 Days)||1
2388501|NCT01408719|5861180|P19|STARTED|Third Intervention (35 Days)||0
2388502|NCT01408719|5861181|P18|STARTED|Third Intervention (35 Days)||2
2388503|NCT01408719|5861182|P17|STARTED|Third Intervention (35 Days)||2
2388504|NCT01408719|5861183|P16|STARTED|Third Intervention (35 Days)||1
2388505|NCT01408719|5861184|P15|STARTED|Third Intervention (35 Days)||1
2388506|NCT01408719|5861185|P14|STARTED|Third Intervention (35 Days)||3
2388507|NCT01408719|5861186|P13|STARTED|Third Intervention (35 Days)||2
2388508|NCT01408719|5861187|P12|STARTED|Third Intervention (35 Days)||2
2388509|NCT01408719|5861188|P11|STARTED|Third Intervention (35 Days)||2
2388510|NCT01408719|5861189|P10|STARTED|Third Intervention (35 Days)||1
2388511|NCT01408719|5861190|P9|STARTED|Third Intervention (35 Days)||1
2388512|NCT01408719|5861191|P8|STARTED|Third Intervention (35 Days)||3
2388513|NCT01408719|5861192|P7|STARTED|Third Intervention (35 Days)||2
2388514|NCT01408719|5861193|P6|STARTED|Third Intervention (35 Days)||3
2388515|NCT01408719|5861194|P5|STARTED|Third Intervention (35 Days)||3
2388516|NCT01408719|5861195|P4|STARTED|Third Intervention (35 Days)||2
2388517|NCT01408719|5861196|P3|STARTED|Third Intervention (35 Days)||1
2388518|NCT01408719|5861197|P2|STARTED|Third Intervention (35 Days)||3
2388519|NCT01408719|5861198|P1|STARTED|Third Intervention (35 Days)||2
2388520|NCT01408719|5861179|P20|NOT COMPLETED|Washout Period (28 Days)||0
2388521|NCT01408719|5861180|P19|NOT COMPLETED|Washout Period (28 Days)||0
2388522|NCT01408719|5861181|P18|NOT COMPLETED|Washout Period (28 Days)||0
2388523|NCT01408719|5861182|P17|NOT COMPLETED|Washout Period (28 Days)||0
2388524|NCT01408719|5861183|P16|NOT COMPLETED|Washout Period (28 Days)||0
2388525|NCT01408719|5861184|P15|NOT COMPLETED|Washout Period (28 Days)||0
2388526|NCT01408719|5861185|P14|NOT COMPLETED|Washout Period (28 Days)||0
2388527|NCT01408719|5861186|P13|NOT COMPLETED|Washout Period (28 Days)||0
2388528|NCT01408719|5861187|P12|NOT COMPLETED|Washout Period (28 Days)||0
2388529|NCT01408719|5861188|P11|NOT COMPLETED|Washout Period (28 Days)||0
2388530|NCT01408719|5861189|P10|NOT COMPLETED|Washout Period (28 Days)||0
2388531|NCT01408719|5861190|P9|NOT COMPLETED|Washout Period (28 Days)||0
2388532|NCT01408719|5861191|P8|NOT COMPLETED|Washout Period (28 Days)||0
2388533|NCT01408719|5861192|P7|NOT COMPLETED|Washout Period (28 Days)||0
2388534|NCT01408719|5861193|P6|NOT COMPLETED|Washout Period (28 Days)||0
2388535|NCT01408719|5861194|P5|NOT COMPLETED|Washout Period (28 Days)||0
2388536|NCT01408719|5861195|P4|NOT COMPLETED|Washout Period (28 Days)||0
2388537|NCT01408719|5861196|P3|NOT COMPLETED|Washout Period (28 Days)||0
2388538|NCT01408719|5861197|P2|NOT COMPLETED|Washout Period (28 Days)||0
2388539|NCT01408719|5861198|P1|NOT COMPLETED|Washout Period (28 Days)||0
2388540|NCT01408719|5861179|P20|COMPLETED|Washout Period (28 Days)||1
2388541|NCT01408719|5861180|P19|COMPLETED|Washout Period (28 Days)||0
2388542|NCT01408719|5861181|P18|COMPLETED|Washout Period (28 Days)||2
2388543|NCT01408719|5861182|P17|COMPLETED|Washout Period (28 Days)||2
2388544|NCT01408719|5861183|P16|COMPLETED|Washout Period (28 Days)||1
2388545|NCT01408719|5861184|P15|COMPLETED|Washout Period (28 Days)||1
2388546|NCT01408719|5861185|P14|COMPLETED|Washout Period (28 Days)||3
2388547|NCT01408719|5861186|P13|COMPLETED|Washout Period (28 Days)||2
2388548|NCT01408719|5861187|P12|COMPLETED|Washout Period (28 Days)||2
2388549|NCT01408719|5861188|P11|COMPLETED|Washout Period (28 Days)||2
2388550|NCT01408719|5861189|P10|COMPLETED|Washout Period (28 Days)||1
2388551|NCT01408719|5861190|P9|COMPLETED|Washout Period (28 Days)||1
2388552|NCT01408719|5861191|P8|COMPLETED|Washout Period (28 Days)||3
2388553|NCT01408719|5861192|P7|COMPLETED|Washout Period (28 Days)||2
2388554|NCT01408719|5861193|P6|COMPLETED|Washout Period (28 Days)||3
2388555|NCT01408719|5861194|P5|COMPLETED|Washout Period (28 Days)||3
2388556|NCT01408719|5861195|P4|COMPLETED|Washout Period (28 Days)||2
2388557|NCT01408719|5861196|P3|COMPLETED|Washout Period (28 Days)||1
2388558|NCT01408719|5861197|P2|COMPLETED|Washout Period (28 Days)||3
2388559|NCT01408719|5861198|P1|COMPLETED|Washout Period (28 Days)||2
2388560|NCT01408719|5861179|P20|STARTED|Washout Period (28 Days)||1
2388561|NCT01408719|5861180|P19|STARTED|Washout Period (28 Days)||0
2388562|NCT01408719|5861181|P18|STARTED|Washout Period (28 Days)||2
2388563|NCT01408719|5861182|P17|STARTED|Washout Period (28 Days)||2
2388564|NCT01408719|5861183|P16|STARTED|Washout Period (28 Days)||1
2388565|NCT01408719|5861184|P15|STARTED|Washout Period (28 Days)||1
2388566|NCT01408719|5861185|P14|STARTED|Washout Period (28 Days)||3
2388567|NCT01408719|5861186|P13|STARTED|Washout Period (28 Days)||2
2388568|NCT01408719|5861187|P12|STARTED|Washout Period (28 Days)||2
2388569|NCT01408719|5861188|P11|STARTED|Washout Period (28 Days)||2
2388570|NCT01408719|5861189|P10|STARTED|Washout Period (28 Days)||1
2388571|NCT01408719|5861190|P9|STARTED|Washout Period (28 Days)||1
2388572|NCT01408719|5861191|P8|STARTED|Washout Period (28 Days)||3
2388573|NCT01408719|5861192|P7|STARTED|Washout Period (28 Days)||2
2388574|NCT01408719|5861193|P6|STARTED|Washout Period (28 Days)||3
2388575|NCT01408719|5861194|P5|STARTED|Washout Period (28 Days)||3
2388576|NCT01408719|5861195|P4|STARTED|Washout Period (28 Days)||2
2388577|NCT01408719|5861196|P3|STARTED|Washout Period (28 Days)||1
2388578|NCT01408719|5861197|P2|STARTED|Washout Period (28 Days)||3
2388579|NCT01408719|5861198|P1|STARTED|Washout Period (28 Days)||2
2388580|NCT01408719|5861179|P20|NOT COMPLETED|Second Intervention (35 Days)||0
2388581|NCT01408719|5861180|P19|NOT COMPLETED|Second Intervention (35 Days)||0
2388582|NCT01408719|5861181|P18|NOT COMPLETED|Second Intervention (35 Days)||0
2388583|NCT01408719|5861182|P17|NOT COMPLETED|Second Intervention (35 Days)||0
2388584|NCT01408719|5861183|P16|NOT COMPLETED|Second Intervention (35 Days)||0
2388585|NCT01408719|5861184|P15|NOT COMPLETED|Second Intervention (35 Days)||0
2388586|NCT01408719|5861185|P14|NOT COMPLETED|Second Intervention (35 Days)||1
2388587|NCT01408719|5861186|P13|NOT COMPLETED|Second Intervention (35 Days)||0
2388588|NCT01408719|5861187|P12|NOT COMPLETED|Second Intervention (35 Days)||0
2388589|NCT01408719|5861188|P11|NOT COMPLETED|Second Intervention (35 Days)||0
2388590|NCT01408719|5861189|P10|NOT COMPLETED|Second Intervention (35 Days)||0
2388591|NCT01408719|5861190|P9|NOT COMPLETED|Second Intervention (35 Days)||0
2388592|NCT01408719|5861191|P8|NOT COMPLETED|Second Intervention (35 Days)||0
2388593|NCT01408719|5861192|P7|NOT COMPLETED|Second Intervention (35 Days)||0
2388594|NCT01408719|5861193|P6|NOT COMPLETED|Second Intervention (35 Days)||0
2388595|NCT01408719|5861194|P5|NOT COMPLETED|Second Intervention (35 Days)||0
2388596|NCT01408719|5861195|P4|NOT COMPLETED|Second Intervention (35 Days)||0
2388597|NCT01408719|5861196|P3|NOT COMPLETED|Second Intervention (35 Days)||0
2388598|NCT01408719|5861197|P2|NOT COMPLETED|Second Intervention (35 Days)||0
2388599|NCT01408719|5861198|P1|NOT COMPLETED|Second Intervention (35 Days)||0
2388600|NCT01408719|5861179|P20|COMPLETED|Second Intervention (35 Days)||1
2388601|NCT01408719|5861180|P19|COMPLETED|Second Intervention (35 Days)||0
2388602|NCT01408719|5861181|P18|COMPLETED|Second Intervention (35 Days)||2
2388603|NCT01408719|5861182|P17|COMPLETED|Second Intervention (35 Days)||2
2388604|NCT01408719|5861183|P16|COMPLETED|Second Intervention (35 Days)||2
2388605|NCT01408719|5861184|P15|COMPLETED|Second Intervention (35 Days)||1
2388606|NCT01408719|5861185|P14|COMPLETED|Second Intervention (35 Days)||3
2388607|NCT01408719|5861186|P13|COMPLETED|Second Intervention (35 Days)||2
2388608|NCT01408719|5861187|P12|COMPLETED|Second Intervention (35 Days)||2
2388609|NCT01408719|5861188|P11|COMPLETED|Second Intervention (35 Days)||2
2388610|NCT01408719|5861189|P10|COMPLETED|Second Intervention (35 Days)||1
2388611|NCT01408719|5861190|P9|COMPLETED|Second Intervention (35 Days)||1
2388612|NCT01408719|5861191|P8|COMPLETED|Second Intervention (35 Days)||3
2388613|NCT01408719|5861192|P7|COMPLETED|Second Intervention (35 Days)||2
2388614|NCT01408719|5861193|P6|COMPLETED|Second Intervention (35 Days)||3
2388615|NCT01408719|5861194|P5|COMPLETED|Second Intervention (35 Days)||3
2388616|NCT01408719|5861195|P4|COMPLETED|Second Intervention (35 Days)||2
2388617|NCT01408719|5861196|P3|COMPLETED|Second Intervention (35 Days)||1
2388618|NCT01408719|5861197|P2|COMPLETED|Second Intervention (35 Days)||3
2388619|NCT01408719|5861198|P1|COMPLETED|Second Intervention (35 Days)||2
2388620|NCT01408719|5861179|P20|STARTED|Second Intervention (35 Days)||1
2388621|NCT01408719|5861180|P19|STARTED|Second Intervention (35 Days)||0
2388622|NCT01408719|5861181|P18|STARTED|Second Intervention (35 Days)||2
2388623|NCT01408719|5861182|P17|STARTED|Second Intervention (35 Days)||2
2388624|NCT01408719|5861183|P16|STARTED|Second Intervention (35 Days)||2
2388625|NCT01408719|5861184|P15|STARTED|Second Intervention (35 Days)||1
2388626|NCT01408719|5861185|P14|STARTED|Second Intervention (35 Days)||4
2388627|NCT01408719|5861186|P13|STARTED|Second Intervention (35 Days)||2
2388628|NCT01408719|5861187|P12|STARTED|Second Intervention (35 Days)||2
2388629|NCT01408719|5861188|P11|STARTED|Second Intervention (35 Days)||2
2388630|NCT01408719|5861189|P10|STARTED|Second Intervention (35 Days)||1
2388631|NCT01408719|5861190|P9|STARTED|Second Intervention (35 Days)||1
2388632|NCT01408719|5861191|P8|STARTED|Second Intervention (35 Days)||3
2388633|NCT01408719|5861192|P7|STARTED|Second Intervention (35 Days)||2
2388634|NCT01408719|5861193|P6|STARTED|Second Intervention (35 Days)||3
2388635|NCT01408719|5861194|P5|STARTED|Second Intervention (35 Days)||3
2388636|NCT01408719|5861195|P4|STARTED|Second Intervention (35 Days)||2
2388637|NCT01408719|5861196|P3|STARTED|Second Intervention (35 Days)||1
2388638|NCT01408719|5861197|P2|STARTED|Second Intervention (35 Days)||3
2388639|NCT01408719|5861198|P1|STARTED|Second Intervention (35 Days)||2
2388640|NCT01408719|5861179|P20|NOT COMPLETED|Washout Period (28 Days)||0
2388641|NCT01408719|5861180|P19|NOT COMPLETED|Washout Period (28 Days)||0
2388642|NCT01408719|5861181|P18|NOT COMPLETED|Washout Period (28 Days)||0
2388643|NCT01408719|5861182|P17|NOT COMPLETED|Washout Period (28 Days)||0
2388644|NCT01408719|5861183|P16|NOT COMPLETED|Washout Period (28 Days)||0
2388645|NCT01408719|5861184|P15|NOT COMPLETED|Washout Period (28 Days)||0
2388646|NCT01408719|5861185|P14|NOT COMPLETED|Washout Period (28 Days)||0
2388647|NCT01408719|5861186|P13|NOT COMPLETED|Washout Period (28 Days)||0
2388648|NCT01408719|5861187|P12|NOT COMPLETED|Washout Period (28 Days)||0
2388649|NCT01408719|5861188|P11|NOT COMPLETED|Washout Period (28 Days)||0
2388650|NCT01408719|5861189|P10|NOT COMPLETED|Washout Period (28 Days)||0
2388651|NCT01408719|5861190|P9|NOT COMPLETED|Washout Period (28 Days)||0
2388652|NCT01408719|5861191|P8|NOT COMPLETED|Washout Period (28 Days)||0
2388653|NCT01408719|5861192|P7|NOT COMPLETED|Washout Period (28 Days)||0
2388654|NCT01408719|5861193|P6|NOT COMPLETED|Washout Period (28 Days)||0
2388655|NCT01408719|5861194|P5|NOT COMPLETED|Washout Period (28 Days)||0
2388656|NCT01408719|5861195|P4|NOT COMPLETED|Washout Period (28 Days)||0
2388657|NCT01408719|5861196|P3|NOT COMPLETED|Washout Period (28 Days)||0
2388658|NCT01408719|5861197|P2|NOT COMPLETED|Washout Period (28 Days)||0
2388659|NCT01408719|5861198|P1|NOT COMPLETED|Washout Period (28 Days)||0
2388660|NCT01408719|5861179|P20|COMPLETED|Washout Period (28 Days)||1
2388661|NCT01408719|5861180|P19|COMPLETED|Washout Period (28 Days)||0
2388662|NCT01408719|5861181|P18|COMPLETED|Washout Period (28 Days)||2
2388663|NCT01408719|5861182|P17|COMPLETED|Washout Period (28 Days)||2
2388664|NCT01408719|5861183|P16|COMPLETED|Washout Period (28 Days)||2
2388665|NCT01408719|5861184|P15|COMPLETED|Washout Period (28 Days)||1
2388666|NCT01408719|5861185|P14|COMPLETED|Washout Period (28 Days)||4
2388667|NCT01408719|5861186|P13|COMPLETED|Washout Period (28 Days)||2
2388668|NCT01408719|5861187|P12|COMPLETED|Washout Period (28 Days)||2
2388669|NCT01408719|5861188|P11|COMPLETED|Washout Period (28 Days)||2
2388670|NCT01408719|5861189|P10|COMPLETED|Washout Period (28 Days)||1
2388671|NCT01408719|5861190|P9|COMPLETED|Washout Period (28 Days)||1
2388672|NCT01408719|5861191|P8|COMPLETED|Washout Period (28 Days)||3
2388673|NCT01408719|5861192|P7|COMPLETED|Washout Period (28 Days)||2
2388674|NCT01408719|5861193|P6|COMPLETED|Washout Period (28 Days)||3
2388675|NCT01408719|5861194|P5|COMPLETED|Washout Period (28 Days)||3
2388676|NCT01408719|5861195|P4|COMPLETED|Washout Period (28 Days)||2
2388677|NCT01408719|5861196|P3|COMPLETED|Washout Period (28 Days)||1
2388678|NCT01408719|5861197|P2|COMPLETED|Washout Period (28 Days)||3
2388679|NCT01408719|5861198|P1|COMPLETED|Washout Period (28 Days)||2
2388680|NCT01408719|5861179|P20|STARTED|Washout Period (28 Days)||1
2388681|NCT01408719|5861180|P19|STARTED|Washout Period (28 Days)||0
2388682|NCT01408719|5861181|P18|STARTED|Washout Period (28 Days)||2
2388683|NCT01408719|5861182|P17|STARTED|Washout Period (28 Days)||2
2388684|NCT01408719|5861183|P16|STARTED|Washout Period (28 Days)||2
2388685|NCT01408719|5861184|P15|STARTED|Washout Period (28 Days)||1
2388686|NCT01408719|5861185|P14|STARTED|Washout Period (28 Days)||4
2388687|NCT01408719|5861186|P13|STARTED|Washout Period (28 Days)||2
2388688|NCT01408719|5861187|P12|STARTED|Washout Period (28 Days)||2
2388689|NCT01408719|5861188|P11|STARTED|Washout Period (28 Days)||2
2388690|NCT01408719|5861189|P10|STARTED|Washout Period (28 Days)||1
2388691|NCT01408719|5861190|P9|STARTED|Washout Period (28 Days)||1
2388692|NCT01408719|5861191|P8|STARTED|Washout Period (28 Days)||3
2388693|NCT01408719|5861192|P7|STARTED|Washout Period (28 Days)||2
2388694|NCT01408719|5861193|P6|STARTED|Washout Period (28 Days)||3
2388695|NCT01408719|5861194|P5|STARTED|Washout Period (28 Days)||3
2388696|NCT01408719|5861195|P4|STARTED|Washout Period (28 Days)||2
2388697|NCT01408719|5861196|P3|STARTED|Washout Period (28 Days)||1
2388698|NCT01408719|5861197|P2|STARTED|Washout Period (28 Days)||3
2388699|NCT01408719|5861198|P1|STARTED|Washout Period (28 Days)||2
2388700|NCT01408719|5861179|P20|NOT COMPLETED|First Intervention (35 Days)||0
2388701|NCT01408719|5861180|P19|NOT COMPLETED|First Intervention (35 Days)||1
2388702|NCT01408719|5861181|P18|NOT COMPLETED|First Intervention (35 Days)||0
2388703|NCT01408719|5861182|P17|NOT COMPLETED|First Intervention (35 Days)||1
2388704|NCT01408719|5861183|P16|NOT COMPLETED|First Intervention (35 Days)||0
2388705|NCT01408719|5861184|P15|NOT COMPLETED|First Intervention (35 Days)||0
2388706|NCT01408719|5861185|P14|NOT COMPLETED|First Intervention (35 Days)||1
2388707|NCT01408719|5861186|P13|NOT COMPLETED|First Intervention (35 Days)||0
2388708|NCT01408719|5861187|P12|NOT COMPLETED|First Intervention (35 Days)||0
2388709|NCT01408719|5861188|P11|NOT COMPLETED|First Intervention (35 Days)||0
2388710|NCT01408719|5861189|P10|NOT COMPLETED|First Intervention (35 Days)||0
2388711|NCT01408719|5861190|P9|NOT COMPLETED|First Intervention (35 Days)||1
2388712|NCT01408719|5861191|P8|NOT COMPLETED|First Intervention (35 Days)||0
2388713|NCT01408719|5861192|P7|NOT COMPLETED|First Intervention (35 Days)||0
2388714|NCT01408719|5861193|P6|NOT COMPLETED|First Intervention (35 Days)||0
2388715|NCT01408719|5861194|P5|NOT COMPLETED|First Intervention (35 Days)||1
2388716|NCT01408719|5861195|P4|NOT COMPLETED|First Intervention (35 Days)||0
2388717|NCT01408719|5861196|P3|NOT COMPLETED|First Intervention (35 Days)||1
2388718|NCT01408719|5861197|P2|NOT COMPLETED|First Intervention (35 Days)||0
2388719|NCT01408719|5861198|P1|NOT COMPLETED|First Intervention (35 Days)||0
2388720|NCT01408719|5861179|P20|COMPLETED|First Intervention (35 Days)||1
2388721|NCT01408719|5861180|P19|COMPLETED|First Intervention (35 Days)||0
2388722|NCT01408719|5861181|P18|COMPLETED|First Intervention (35 Days)||2
2388723|NCT01408719|5861182|P17|COMPLETED|First Intervention (35 Days)||2
2388724|NCT01408719|5861183|P16|COMPLETED|First Intervention (35 Days)||2
2388725|NCT01408719|5861184|P15|COMPLETED|First Intervention (35 Days)||1
2388726|NCT01408719|5861185|P14|COMPLETED|First Intervention (35 Days)||4
2388727|NCT01408719|5861186|P13|COMPLETED|First Intervention (35 Days)||2
2388728|NCT01408719|5861187|P12|COMPLETED|First Intervention (35 Days)||2
2388729|NCT01408719|5861188|P11|COMPLETED|First Intervention (35 Days)||2
2388730|NCT01408719|5861189|P10|COMPLETED|First Intervention (35 Days)||1
2388731|NCT01408719|5861190|P9|COMPLETED|First Intervention (35 Days)||1
2388732|NCT01408719|5861191|P8|COMPLETED|First Intervention (35 Days)||3
2388733|NCT01408719|5861192|P7|COMPLETED|First Intervention (35 Days)||2
2388734|NCT01408719|5861193|P6|COMPLETED|First Intervention (35 Days)||3
2388735|NCT01408719|5861194|P5|COMPLETED|First Intervention (35 Days)||3
2388736|NCT01408719|5861195|P4|COMPLETED|First Intervention (35 Days)||2
2388737|NCT01408719|5861196|P3|COMPLETED|First Intervention (35 Days)||1
2388738|NCT01408719|5861197|P2|COMPLETED|First Intervention (35 Days)||3
2388739|NCT01408719|5861198|P1|COMPLETED|First Intervention (35 Days)||2
2388740|NCT01408719|5861179|P20|STARTED|First Intervention (35 Days)||1
2388741|NCT01408719|5861180|P19|STARTED|First Intervention (35 Days)||1
2388742|NCT01408719|5861181|P18|STARTED|First Intervention (35 Days)||2
2388743|NCT01408719|5861182|P17|STARTED|First Intervention (35 Days)||3
2388744|NCT01408719|5861183|P16|STARTED|First Intervention (35 Days)||2
2388745|NCT01408719|5861184|P15|STARTED|First Intervention (35 Days)||1
2388746|NCT01408719|5861185|P14|STARTED|First Intervention (35 Days)||5
2388747|NCT01408719|5861186|P13|STARTED|First Intervention (35 Days)||2
2388748|NCT01408719|5861187|P12|STARTED|First Intervention (35 Days)||2
2388749|NCT01408719|5861188|P11|STARTED|First Intervention (35 Days)||2
2388750|NCT01408719|5861189|P10|STARTED|First Intervention (35 Days)||1
2388751|NCT01408719|5861190|P9|STARTED|First Intervention (35 Days)||2
2388752|NCT01408719|5861191|P8|STARTED|First Intervention (35 Days)||3
2388753|NCT01408719|5861192|P7|STARTED|First Intervention (35 Days)||2
2388754|NCT01408719|5861193|P6|STARTED|First Intervention (35 Days)||3
2388755|NCT01408719|5861194|P5|STARTED|First Intervention (35 Days)||4
2388756|NCT01408719|5861195|P4|STARTED|First Intervention (35 Days)||2
2388757|NCT01408719|5861196|P3|STARTED|First Intervention (35 Days)||2
2388758|NCT01408719|5861197|P2|STARTED|First Intervention (35 Days)||3
2388759|NCT01408719|5861198|P1|STARTED|First Intervention (35 Days)||2
2388760|NCT01408706|5861210|P2|NOT COMPLETED|Overall Study||0
2388761|NCT01408706|5861211|P1|NOT COMPLETED|Overall Study||1
2388762|NCT01408706|5861210|P2|COMPLETED|Overall Study||30
2388763|NCT01408706|5861211|P1|COMPLETED|Overall Study||29
2388764|NCT01408706|5861210|P2|STARTED|Overall Study||30
2388765|NCT01408706|5861211|P1|STARTED|Overall Study||30
2388766|NCT01408641|5861223|P2|NOT COMPLETED|Overall Study||0
2388767|NCT01408641|5861224|P1|NOT COMPLETED|Overall Study||1
2388768|NCT01408641|5861223|P2|COMPLETED|Overall Study||0
2388769|NCT01408641|5861224|P1|COMPLETED|Overall Study||0
2388770|NCT01408641|5861223|P2|STARTED|Overall Study||0
2388771|NCT01408641|5861224|P1|STARTED|Overall Study||1
2388772|NCT01408628|5861232|P1|NOT COMPLETED|Completed 6 Month Follow-Up||14
2388773|NCT01408628|5861232|P1|COMPLETED|Completed 6 Month Follow-Up||25
2388774|NCT01408628|5861232|P1|STARTED|Completed 6 Month Follow-Up||39
2388775|NCT01408628|5861232|P1|NOT COMPLETED|Started Classes/Intervention||0
2388776|NCT01408628|5861232|P1|COMPLETED|Started Classes/Intervention||39
2388777|NCT01408628|5861232|P1|STARTED|Started Classes/Intervention||39
2388778|NCT01408628|5861232|P1|NOT COMPLETED|Consented||12
2388779|NCT01408628|5861232|P1|COMPLETED|Consented||39
2388780|NCT01408628|5861232|P1|STARTED|Consented||51
2388781|NCT01408576|5861241|P3|NOT COMPLETED|Overall Study||508
2388782|NCT01408576|5861242|P2|NOT COMPLETED|Overall Study||498
2388783|NCT01408576|5861243|P1|NOT COMPLETED|Overall Study||188
2388784|NCT01408576|5861241|P3|COMPLETED|Overall Study||0
2388785|NCT01408576|5861242|P2|COMPLETED|Overall Study||0
2388786|NCT01408576|5861243|P1|COMPLETED|Overall Study||56
2388787|NCT01408576|5861241|P3|STARTED|Overall Study||508
2388788|NCT01408576|5861242|P2|STARTED|Overall Study||498
2388789|NCT01408576|5861243|P1|STARTED|Overall Study||244
2388790|NCT01408563|5861290|P1|NOT COMPLETED|Overall Study||2
2388791|NCT01408563|5861290|P1|COMPLETED|Overall Study||31
2388792|NCT01408563|5861290|P1|Received Transplant|Overall Study||31
2388793|NCT01408563|5861290|P1|STARTED|Overall Study||33
2388794|NCT01408537|5861306|P1|NOT COMPLETED|Overall Study||8
2388795|NCT01408537|5861306|P1|COMPLETED|Overall Study||144
2388796|NCT01408537|5861306|P1|STARTED|Overall Study||152
2388797|NCT01408485|5861322|P1|NOT COMPLETED|Overall Study||21
2388798|NCT01408485|5861322|P1|COMPLETED|Overall Study||179
2388799|NCT01408485|5861322|P1|STARTED|Overall Study||200
2388800|NCT01408329|5861330|P2|NOT COMPLETED|Overall Study||4
2388801|NCT01408329|5861331|P1|NOT COMPLETED|Overall Study||3
2388802|NCT01408329|5861330|P2|COMPLETED|Overall Study||11
2388803|NCT01408329|5861331|P1|COMPLETED|Overall Study||10
2388804|NCT01408329|5861330|P2|STARTED|Overall Study||15
2388805|NCT01408329|5861331|P1|STARTED|Overall Study||13
2388806|NCT01408303|5861340|P3|NOT COMPLETED|Overall Study||6
2388807|NCT01408303|5861341|P2|NOT COMPLETED|Overall Study||12
2388808|NCT01408303|5861342|P1|NOT COMPLETED|Overall Study||6
2388809|NCT01408303|5861340|P3|COMPLETED|Overall Study||210
2388810|NCT01408303|5861341|P2|COMPLETED|Overall Study||204
2388811|NCT01408303|5861342|P1|COMPLETED|Overall Study||209
2388812|NCT01408303|5861340|P3|STARTED|Overall Study||216
2388813|NCT01408303|5861341|P2|STARTED|Overall Study||216
2388814|NCT01408303|5861342|P1|STARTED|Overall Study||215
2388815|NCT01408277|5861352|P2|NOT COMPLETED|Overall Study||4
2388816|NCT01408277|5861353|P1|NOT COMPLETED|Overall Study||8
2388817|NCT01408277|5861352|P2|COMPLETED|Overall Study||23
2388818|NCT01408277|5861353|P1|COMPLETED|Overall Study||20
2388819|NCT01408277|5861352|P2|STARTED|Overall Study||27
2388820|NCT01408277|5861353|P1|STARTED|Overall Study||28
2388821|NCT01408043|5861359|P1|NOT COMPLETED|Overall Study||1
2388822|NCT01408043|5861359|P1|COMPLETED|Overall Study||24
2388823|NCT01408043|5861359|P1|STARTED|Overall Study||25
2388824|NCT01408030|5861378|P4|NOT COMPLETED|Observation Phase (Off Drug)||4
2388825|NCT01408030|5861379|P3|NOT COMPLETED|Observation Phase (Off Drug)||6
2388826|NCT01408030|5861380|P2|NOT COMPLETED|Observation Phase (Off Drug)||6
2388827|NCT01408030|5861381|P1|NOT COMPLETED|Observation Phase (Off Drug)||4
2388828|NCT01408030|5861378|P4|COMPLETED|Observation Phase (Off Drug)||21
2388829|NCT01408030|5861379|P3|COMPLETED|Observation Phase (Off Drug)||26
2388830|NCT01408030|5861380|P2|COMPLETED|Observation Phase (Off Drug)||18
2388831|NCT01408030|5861381|P1|COMPLETED|Observation Phase (Off Drug)||22
2388832|NCT01408030|5861378|P4|STARTED|Observation Phase (Off Drug)||25
2388833|NCT01408030|5861379|P3|STARTED|Observation Phase (Off Drug)||32
2388834|NCT01408030|5861380|P2|STARTED|Observation Phase (Off Drug)||24
2388835|NCT01408030|5861381|P1|STARTED|Observation Phase (Off Drug)||26
2388836|NCT01408030|5861378|P4|NOT COMPLETED|Treatment Phase (on Drug)||3
2388837|NCT01408030|5861379|P3|NOT COMPLETED|Treatment Phase (on Drug)||1
2388838|NCT01408030|5861380|P2|NOT COMPLETED|Treatment Phase (on Drug)||7
2388839|NCT01408030|5861381|P1|NOT COMPLETED|Treatment Phase (on Drug)||3
2388840|NCT01408030|5861378|P4|COMPLETED|Treatment Phase (on Drug)||25
2388841|NCT01408030|5861379|P3|COMPLETED|Treatment Phase (on Drug)||32
2388842|NCT01408030|5861380|P2|COMPLETED|Treatment Phase (on Drug)||24
2388843|NCT01408030|5861381|P1|COMPLETED|Treatment Phase (on Drug)||26
2388844|NCT01408030|5861378|P4|STARTED|Treatment Phase (on Drug)||28
2388845|NCT01408030|5861379|P3|STARTED|Treatment Phase (on Drug)||33
2388846|NCT01408030|5861380|P2|STARTED|Treatment Phase (on Drug)||31
2388847|NCT01408030|5861381|P1|STARTED|Treatment Phase (on Drug)||29
2388848|NCT01407952|5861413|P2|NOT COMPLETED|Overall Study||37
2388849|NCT01407952|5861414|P1|NOT COMPLETED|Overall Study||46
2388850|NCT01407952|5861413|P2|COMPLETED|Overall Study||266
2388851|NCT01407952|5861414|P1|COMPLETED|Overall Study||251
2388852|NCT01407952|5861413|P2|STARTED|Overall Study||303
2388853|NCT01407952|5861414|P1|STARTED|Overall Study||297
2388854|NCT01407926|5861440|P1|NOT COMPLETED|Overall Study||55
2388855|NCT01407926|5861440|P1|COMPLETED|Overall Study||87
2388856|NCT01407926|5861440|P1|STARTED|Overall Study||142
2388857|NCT01407575|5861457|P2|NOT COMPLETED|Overall Study||1
2388858|NCT01407575|5861458|P1|NOT COMPLETED|Overall Study||2
2388859|NCT01407575|5861457|P2|COMPLETED|Overall Study||5
2388860|NCT01407575|5861458|P1|COMPLETED|Overall Study||5
2388861|NCT01407575|5861457|P2|STARTED|Overall Study||6
2388862|NCT01407575|5861458|P1|STARTED|Overall Study||7
2388863|NCT01407523|5861476|P1|NOT COMPLETED|Overall Study||0
2388864|NCT01407523|5861476|P1|COMPLETED|Overall Study||16
2388865|NCT01407523|5861476|P1|STARTED|Overall Study||16
2388866|NCT01407367|5861488|P2|NOT COMPLETED|Overall Study||78
2388867|NCT01407367|5861489|P1|NOT COMPLETED|Overall Study||40
2388868|NCT01407367|5861488|P2|COMPLETED|Overall Study||164
2388869|NCT01407367|5861489|P1|COMPLETED|Overall Study||68
2388870|NCT01407367|5861488|P2|STARTED|Overall Study||242
2388871|NCT01407367|5861489|P1|STARTED|Overall Study||108
2388872|NCT01407354|5861503|P2|NOT COMPLETED|Second Intervention||2
2388873|NCT01407354|5861504|P1|NOT COMPLETED|Second Intervention||0
2388874|NCT01407354|5861503|P2|COMPLETED|Second Intervention||13
2388875|NCT01407354|5861504|P1|COMPLETED|Second Intervention||18
2388876|NCT01407354|5861503|P2|STARTED|Second Intervention||15
2388877|NCT01407354|5861504|P1|STARTED|Second Intervention||18
2388878|NCT01407354|5861503|P2|NOT COMPLETED|First Intervention||2
2388879|NCT01407354|5861504|P1|NOT COMPLETED|First Intervention||2
2388880|NCT01407354|5861503|P2|COMPLETED|First Intervention||15
2388881|NCT01407354|5861504|P1|COMPLETED|First Intervention||18
2388882|NCT01407354|5861503|P2|STARTED|First Intervention||17
2388883|NCT01407354|5861504|P1|STARTED|First Intervention||20
2388884|NCT01407276|5861520|P8|NOT COMPLETED|Overall Study||1
2388885|NCT01407276|5861521|P7|NOT COMPLETED|Overall Study||0
2388886|NCT01407276|5861522|P6|NOT COMPLETED|Overall Study||0
2388887|NCT01407276|5861523|P5|NOT COMPLETED|Overall Study||0
2388888|NCT01407276|5861524|P4|NOT COMPLETED|Overall Study||0
2388889|NCT01407276|5861525|P3|NOT COMPLETED|Overall Study||0
2388890|NCT01407276|5861526|P2|NOT COMPLETED|Overall Study||0
2388891|NCT01407276|5861527|P1|NOT COMPLETED|Overall Study||0
2388892|NCT01407276|5861520|P8|COMPLETED|Overall Study||6
2388893|NCT01407276|5861521|P7|COMPLETED|Overall Study||6
2388894|NCT01407276|5861522|P6|COMPLETED|Overall Study||6
2388895|NCT01407276|5861523|P5|COMPLETED|Overall Study||6
2388896|NCT01407276|5861524|P4|COMPLETED|Overall Study||6
2388897|NCT01407276|5861525|P3|COMPLETED|Overall Study||6
2388898|NCT01407276|5861526|P2|COMPLETED|Overall Study||6
2388899|NCT01407276|5861527|P1|COMPLETED|Overall Study||6
2388900|NCT01407276|5861520|P8|STARTED|Overall Study||7
2388901|NCT01407276|5861521|P7|STARTED|Overall Study||6
2388902|NCT01407276|5861522|P6|STARTED|Overall Study||6
2388903|NCT01407276|5861523|P5|STARTED|Overall Study||6
2388904|NCT01407276|5861524|P4|STARTED|Overall Study||6
2388905|NCT01407276|5861525|P3|STARTED|Overall Study||6
2388906|NCT01407276|5861526|P2|STARTED|Overall Study||6
2388907|NCT01407276|5861527|P1|STARTED|Overall Study||6
2388908|NCT01407094|5861654|P3|NOT COMPLETED|Stage 2||15
2388909|NCT01407094|5861655|P2|NOT COMPLETED|Stage 2||11
2388910|NCT01407094|5861656|P1|NOT COMPLETED|Stage 2||21
2388911|NCT01407094|5861654|P3|COMPLETED|Stage 2||38
2388912|NCT01407094|5861655|P2|COMPLETED|Stage 2||35
2388913|NCT01407094|5861656|P1|COMPLETED|Stage 2||113
2388914|NCT01407094|5861654|P3|STARTED|Stage 2|Stage 2 BUP includes Stage 1 SERT non-responders (n=54); 1 early exit (n=53).|53
2388915|NCT01407094|5861655|P2|STARTED|Stage 2|Stage 2 PBO includes Stage 1 PBO responders (n=47); 1 early exit (n=46).|46
2388916|NCT01407094|5861656|P1|STARTED|Stage 2|Stage 2 SERT includes Stage 1 SERT responders (n=61) and Stage 1 PBO non-responders (n=73).|134
2388917|NCT01407094|5861654|P3|NOT COMPLETED|Stage 1||0
2388918|NCT01407094|5861655|P2|NOT COMPLETED|Stage 1||27
2388919|NCT01407094|5861656|P1|NOT COMPLETED|Stage 1||34
2388920|NCT01407094|5861654|P3|COMPLETED|Stage 1||0
2388921|NCT01407094|5861655|P2|COMPLETED|Stage 1|Four participants completed Stage 1 but did not continue to Stage 2.|123
2388922|NCT01407094|5861656|P1|COMPLETED|Stage 1|One participant completed Stage 1 but did not continue to Stage 2.|112
2388923|NCT01407094|5861654|P3|STARTED|Stage 1|Bupropion (BUP) was used only in Stage 2 for non-responders to SERT.|0
2388924|NCT01407094|5861655|P2|STARTED|Stage 1|Stage 1 Placebo (PBO): 27 exited.|150
2388925|NCT01407094|5861656|P1|STARTED|Stage 1|Stage 1 Sertraline (SERT): 34 exited|146
2388926|NCT01407068|5861664|P1|NOT COMPLETED|Overall Study||0
2388927|NCT01407068|5861664|P1|COMPLETED|Overall Study||60
2388928|NCT01407068|5861664|P1|STARTED|Overall Study||60
2388929|NCT01406990|5861673|P1|NOT COMPLETED|Overall Study||0
2388930|NCT01406990|5861673|P1|COMPLETED|Overall Study||15
2388931|NCT01406990|5861673|P1|STARTED|Overall Study||15
2388932|NCT01406938|5861679|P6|NOT COMPLETED|Follow up||3
2388933|NCT01406938|5861680|P5|NOT COMPLETED|Follow up||9
2388934|NCT01406938|5861681|P4|NOT COMPLETED|Follow up||3
2388935|NCT01406938|5861682|P3|NOT COMPLETED|Follow up||8
2388936|NCT01406938|5861683|P2|NOT COMPLETED|Follow up||5
2388937|NCT01406938|5861684|P1|NOT COMPLETED|Follow up||8
2388938|NCT01406938|5861679|P6|COMPLETED|Follow up||32
2388939|NCT01406938|5861680|P5|COMPLETED|Follow up||31
2388940|NCT01406938|5861681|P4|COMPLETED|Follow up||36
2388941|NCT01406938|5861682|P3|COMPLETED|Follow up||32
2388942|NCT01406938|5861683|P2|COMPLETED|Follow up||18
2388943|NCT01406938|5861684|P1|COMPLETED|Follow up||18
2388944|NCT01406938|5861679|P6|STARTED|Follow up||35
2388945|NCT01406938|5861680|P5|STARTED|Follow up||40
2388946|NCT01406938|5861681|P4|STARTED|Follow up||39
2388947|NCT01406938|5861682|P3|STARTED|Follow up||40
2388948|NCT01406938|5861683|P2|STARTED|Follow up||23
2388949|NCT01406938|5861684|P1|STARTED|Follow up||26
2388950|NCT01406938|5861679|P6|NOT COMPLETED|Maintenance Period||16
2388951|NCT01406938|5861680|P5|NOT COMPLETED|Maintenance Period||25
2388952|NCT01406938|5861681|P4|NOT COMPLETED|Maintenance Period||18
2388953|NCT01406938|5861682|P3|NOT COMPLETED|Maintenance Period||17
2388954|NCT01406938|5861683|P2|NOT COMPLETED|Maintenance Period||0
2388955|NCT01406938|5861684|P1|NOT COMPLETED|Maintenance Period||0
2388956|NCT01406938|5861679|P6|COMPLETED|Maintenance Period||201
2388957|NCT01406938|5861680|P5|COMPLETED|Maintenance Period||181
2388958|NCT01406938|5861681|P4|COMPLETED|Maintenance Period||199
2388959|NCT01406938|5861682|P3|COMPLETED|Maintenance Period||186
2388960|NCT01406938|5861683|P2|COMPLETED|Maintenance Period||0
2388961|NCT01406938|5861684|P1|COMPLETED|Maintenance Period||0
2388962|NCT01406938|5861679|P6|FAS: Patients Assigned Treatment Drug|Maintenance Period||217
2388963|NCT01406938|5861680|P5|FAS: Patients Assigned Treatment Drug|Maintenance Period||206
2388964|NCT01406938|5861681|P4|FAS: Patients Assigned Treatment Drug|Maintenance Period||216
2388965|NCT01406938|5861682|P3|FAS: Patients Assigned Treatment Drug|Maintenance Period||203
2388966|NCT01406938|5861683|P2|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
2388967|NCT01406938|5861684|P1|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
2388968|NCT01406938|5861679|P6|STARTED|Maintenance Period||217
2388969|NCT01406938|5861680|P5|STARTED|Maintenance Period||206
2388970|NCT01406938|5861681|P4|STARTED|Maintenance Period||217
2388971|NCT01406938|5861682|P3|STARTED|Maintenance Period||203
2388972|NCT01406938|5861683|P2|STARTED|Maintenance Period||0
2388973|NCT01406938|5861684|P1|STARTED|Maintenance Period||0
2388974|NCT01406938|5861679|P6|NOT COMPLETED|Induction Period||0
2388975|NCT01406938|5861680|P5|NOT COMPLETED|Induction Period||0
2388976|NCT01406938|5861681|P4|NOT COMPLETED|Induction Period||0
2388977|NCT01406938|5861682|P3|NOT COMPLETED|Induction Period||0
2388978|NCT01406938|5861683|P2|NOT COMPLETED|Induction Period||20
2388979|NCT01406938|5861684|P1|NOT COMPLETED|Induction Period||18
2388980|NCT01406938|5861679|P6|COMPLETED|Induction Period||0
2388981|NCT01406938|5861680|P5|COMPLETED|Induction Period||0
2388982|NCT01406938|5861681|P4|COMPLETED|Induction Period||0
2388983|NCT01406938|5861682|P3|COMPLETED|Induction Period||0
2388984|NCT01406938|5861683|P2|COMPLETED|Induction Period||464
2388985|NCT01406938|5861684|P1|COMPLETED|Induction Period||464
2388986|NCT01406938|5861679|P6|FAS:Patients Assigned Study Treatment|Induction Period||0
2388987|NCT01406938|5861680|P5|FAS:Patients Assigned Study Treatment|Induction Period||0
2388988|NCT01406938|5861681|P4|FAS:Patients Assigned Study Treatment|Induction Period||0
2388989|NCT01406938|5861682|P3|FAS:Patients Assigned Study Treatment|Induction Period||0
2388990|NCT01406938|5861683|P2|FAS:Patients Assigned Study Treatment|Induction Period||483
2388991|NCT01406938|5861684|P1|FAS:Patients Assigned Study Treatment|Induction Period||482
2388992|NCT01406938|5861679|P6|STARTED|Induction Period||0
2388993|NCT01406938|5861680|P5|STARTED|Induction Period||0
2388994|NCT01406938|5861681|P4|STARTED|Induction Period||0
2388995|NCT01406938|5861682|P3|STARTED|Induction Period||0
2388996|NCT01406938|5861683|P2|STARTED|Induction Period||484
2388997|NCT01406938|5861684|P1|STARTED|Induction Period||482
2388998|NCT01406873|5861802|P2|NOT COMPLETED|Overall Study||1
2388999|NCT01406873|5861803|P1|NOT COMPLETED|Overall Study||1
2389000|NCT01406873|5861802|P2|COMPLETED|Overall Study||20
2389001|NCT01406873|5861803|P1|COMPLETED|Overall Study||20
2389002|NCT01406873|5861802|P2|STARTED|Overall Study||21
2389003|NCT01406873|5861803|P1|STARTED|Overall Study||21
2389004|NCT01406860|5861821|P2|NOT COMPLETED|Overall Study||0
2389005|NCT01406860|5861822|P1|NOT COMPLETED|Overall Study||0
2389006|NCT01406860|5861821|P2|COMPLETED|Overall Study||8
2389007|NCT01406860|5861822|P1|COMPLETED|Overall Study||11
2389008|NCT01406860|5861821|P2|STARTED|Overall Study||8
2389009|NCT01406860|5861822|P1|STARTED|Overall Study||11
2389010|NCT01406795|5861834|P1|NOT COMPLETED|Overall Study||1
2389011|NCT01406795|5861834|P1|COMPLETED|Overall Study||0
2389012|NCT01406795|5861834|P1|STARTED|Overall Study||1
2389013|NCT01406717|5861850|P2|NOT COMPLETED|Overall Study||31
2389014|NCT01406717|5861851|P1|NOT COMPLETED|Overall Study||43
2389015|NCT01406717|5861850|P2|COMPLETED|Overall Study||149
2389016|NCT01406717|5861851|P1|COMPLETED|Overall Study||137
2389017|NCT01406717|5861850|P2|STARTED|Overall Study||180
2389018|NCT01406717|5861851|P1|STARTED|Overall Study||180
2389019|NCT01406652|5861881|P2|NOT COMPLETED|Overall Study||20
2389020|NCT01406652|5861882|P1|NOT COMPLETED|Overall Study||20
2389021|NCT01406652|5861881|P2|COMPLETED|Overall Study||95
2389022|NCT01406652|5861882|P1|COMPLETED|Overall Study||89
2389023|NCT01406652|5861881|P2|STARTED|Overall Study||115
2389024|NCT01406652|5861882|P1|STARTED|Overall Study||109
2389025|NCT01406574|5861890|P4|NOT COMPLETED|Overall Study||4
2389026|NCT01406574|5861891|P3|NOT COMPLETED|Overall Study||1
2389027|NCT01406574|5861892|P2|NOT COMPLETED|Overall Study||1
2389028|NCT01406574|5861893|P1|NOT COMPLETED|Overall Study||1
2389029|NCT01406574|5861890|P4|COMPLETED|Overall Study||1
2389030|NCT01406574|5861891|P3|COMPLETED|Overall Study||6
2389031|NCT01406574|5861892|P2|COMPLETED|Overall Study||3
2389032|NCT01406574|5861893|P1|COMPLETED|Overall Study||6
2389033|NCT01406574|5861890|P4|STARTED|Overall Study||5
2389034|NCT01406574|5861891|P3|STARTED|Overall Study||7
2389035|NCT01406574|5861892|P2|STARTED|Overall Study||4
2389036|NCT01406574|5861893|P1|STARTED|Overall Study||7
2389037|NCT01406223|5861909|P4|NOT COMPLETED|Overall Study||16
2389038|NCT01406223|5861910|P3|NOT COMPLETED|Overall Study||18
2389039|NCT01406223|5861911|P2|NOT COMPLETED|Overall Study||12
2389040|NCT01406223|5861912|P1|NOT COMPLETED|Overall Study||12
2389041|NCT01406223|5861909|P4|COMPLETED|Overall Study||3
2389042|NCT01406223|5861910|P3|COMPLETED|Overall Study||2
2389043|NCT01406223|5861911|P2|COMPLETED|Overall Study||7
2389044|NCT01406223|5861912|P1|COMPLETED|Overall Study||6
2389045|NCT01406223|5861909|P4|STARTED|Overall Study||19
2389046|NCT01406223|5861910|P3|STARTED|Overall Study||20
2389047|NCT01406223|5861911|P2|STARTED|Overall Study||19
2389048|NCT01406223|5861912|P1|STARTED|Overall Study||18
2389049|NCT01406015|5861928|P2|NOT COMPLETED|Overall Study||3
2389050|NCT01406015|5861929|P1|NOT COMPLETED|Overall Study||3
2389051|NCT01406015|5861928|P2|COMPLETED|Overall Study||16
2389052|NCT01406015|5861929|P1|COMPLETED|Overall Study||16
2389053|NCT01406015|5861928|P2|STARTED|Overall Study||19
2389054|NCT01406015|5861929|P1|STARTED|Overall Study||19
2389055|NCT01405950|5861945|P4|NOT COMPLETED|Overall Study||0
2389056|NCT01405950|5861946|P3|NOT COMPLETED|Overall Study||0
2389057|NCT01405950|5861947|P2|NOT COMPLETED|Overall Study||0
2389058|NCT01405950|5861948|P1|NOT COMPLETED|Overall Study||1
2389059|NCT01405950|5861945|P4|COMPLETED|Overall Study||0
2389060|NCT01405950|5861946|P3|COMPLETED|Overall Study||0
2389061|NCT01405950|5861947|P2|COMPLETED|Overall Study||2
2389062|NCT01405950|5861948|P1|COMPLETED|Overall Study||7
2389063|NCT01405950|5861945|P4|STARTED|Overall Study||0
2389064|NCT01405950|5861946|P3|STARTED|Overall Study||0
2389065|NCT01405950|5861947|P2|STARTED|Overall Study||2
2389066|NCT01405950|5861948|P1|STARTED|Overall Study||8
2389067|NCT01405937|5861962|P2|NOT COMPLETED|Overall Study||0
2389068|NCT01405937|5861963|P1|NOT COMPLETED|Overall Study||0
2389069|NCT01405937|5861962|P2|COMPLETED|Overall Study||26
2389070|NCT01405937|5861963|P1|COMPLETED|Overall Study||25
2389071|NCT01405937|5861962|P2|STARTED|Overall Study||26
2389072|NCT01405937|5861963|P1|STARTED|Overall Study||25
2389073|NCT01405924|5861983|P1|NOT COMPLETED|Overall Study||10
2389074|NCT01405924|5861983|P1|COMPLETED|Overall Study||101
2389075|NCT01405924|5861983|P1|STARTED|Overall Study||111
2389076|NCT01405911|5861996|P3|NOT COMPLETED|Overall Study||1
2389077|NCT01405911|5861997|P2|NOT COMPLETED|Overall Study||3
2389078|NCT01405911|5861998|P1|NOT COMPLETED|Overall Study||4
2389079|NCT01405911|5861996|P3|COMPLETED|Overall Study||76
2389080|NCT01405911|5861997|P2|COMPLETED|Overall Study||79
2389081|NCT01405911|5861998|P1|COMPLETED|Overall Study||79
2389082|NCT01405911|5861996|P3|Treated|Overall Study||77
2389083|NCT01405911|5861997|P2|Treated|Overall Study|1 participant received study drug but was discontinued due to pre-treatment lab AE.|82
2389084|NCT01405911|5861998|P1|Treated|Overall Study||82
2389085|NCT01405911|5861996|P3|STARTED|Overall Study||77
2389086|NCT01405911|5861997|P2|STARTED|Overall Study||82
2389087|NCT01405911|5861998|P1|STARTED|Overall Study||83
2389088|NCT01405898|5862017|P2|NOT COMPLETED|Overall Study||2
2389089|NCT01405898|5862018|P1|NOT COMPLETED|Overall Study||2
2389090|NCT01405898|5862017|P2|COMPLETED|Overall Study||32
2389091|NCT01405898|5862018|P1|COMPLETED|Overall Study||32
2389092|NCT01405898|5862017|P2|STARTED|Overall Study||34
2389093|NCT01405898|5862018|P1|STARTED|Overall Study||34
2389094|NCT01405820|5862042|P6|NOT COMPLETED|Open-Label Treatment Period||2
2389095|NCT01405820|5862043|P5|NOT COMPLETED|Open-Label Treatment Period||2
2389096|NCT01405820|5862044|P4|NOT COMPLETED|Open-Label Treatment Period||5
2389097|NCT01405820|5862045|P3|NOT COMPLETED|Open-Label Treatment Period||3
2389098|NCT01405820|5862046|P2|NOT COMPLETED|Open-Label Treatment Period||2
2389099|NCT01405820|5862047|P1|NOT COMPLETED|Open-Label Treatment Period||4
2389100|NCT01405820|5862042|P6|COMPLETED|Open-Label Treatment Period||30
2389101|NCT01405820|5862043|P5|COMPLETED|Open-Label Treatment Period||40
2389102|NCT01405820|5862044|P4|COMPLETED|Open-Label Treatment Period||37
2389103|NCT01405820|5862045|P3|COMPLETED|Open-Label Treatment Period||39
2389104|NCT01405820|5862046|P2|COMPLETED|Open-Label Treatment Period||33
2389105|NCT01405820|5862047|P1|COMPLETED|Open-Label Treatment Period||40
2389106|NCT01405820|5862042|P6|STARTED|Open-Label Treatment Period||32
2389107|NCT01405820|5862043|P5|STARTED|Open-Label Treatment Period||42
2389108|NCT01405820|5862044|P4|STARTED|Open-Label Treatment Period||42
2389109|NCT01405820|5862045|P3|STARTED|Open-Label Treatment Period||42
2389110|NCT01405820|5862046|P2|STARTED|Open-Label Treatment Period||35
2389111|NCT01405820|5862047|P1|STARTED|Open-Label Treatment Period|1 participant discontinued randomized period due to an adverse event but entered open-label period.|44
2389112|NCT01405820|5862042|P6|NOT COMPLETED|Randomized Treatment Period||37
2389113|NCT01405820|5862043|P5|NOT COMPLETED|Randomized Treatment Period||45
2389114|NCT01405820|5862044|P4|NOT COMPLETED|Randomized Treatment Period||51
2389115|NCT01405820|5862045|P3|NOT COMPLETED|Randomized Treatment Period||43
2389116|NCT01405820|5862046|P2|NOT COMPLETED|Randomized Treatment Period||10
2389117|NCT01405820|5862047|P1|NOT COMPLETED|Randomized Treatment Period||11
2389118|NCT01405820|5862042|P6|COMPLETED|Randomized Treatment Period||1
2389119|NCT01405820|5862043|P5|COMPLETED|Randomized Treatment Period||2
2389120|NCT01405820|5862044|P4|COMPLETED|Randomized Treatment Period||3
2389121|NCT01405820|5862045|P3|COMPLETED|Randomized Treatment Period||9
2389122|NCT01405820|5862046|P2|COMPLETED|Randomized Treatment Period||35
2389123|NCT01405820|5862047|P1|COMPLETED|Randomized Treatment Period||43
2389124|NCT01405820|5862042|P6|Safety Population|Randomized Treatment Period||38
2389125|NCT01405820|5862043|P5|Safety Population|Randomized Treatment Period||47
2389126|NCT01405820|5862044|P4|Safety Population|Randomized Treatment Period|1 participant did not receive any study medication.|53
2389127|NCT01405820|5862045|P3|Safety Population|Randomized Treatment Period||52
2389128|NCT01405820|5862046|P2|Safety Population|Randomized Treatment Period||45
2389129|NCT01405820|5862047|P1|Safety Population|Randomized Treatment Period||54
2389130|NCT01405820|5862042|P6|STARTED|Randomized Treatment Period||38
2389131|NCT01405820|5862043|P5|STARTED|Randomized Treatment Period||47
2389132|NCT01405820|5862044|P4|STARTED|Randomized Treatment Period||54
2389133|NCT01405820|5862045|P3|STARTED|Randomized Treatment Period||52
2389134|NCT01405820|5862046|P2|STARTED|Randomized Treatment Period||45
2389135|NCT01405820|5862047|P1|STARTED|Randomized Treatment Period||54
2389136|NCT01405794|5862067|P1|NOT COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||0
2389137|NCT01405794|5862067|P1|COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||12
2389138|NCT01405794|5862067|P1|STARTED|Second Dose 32ppm Oral Silver (14 Days)||12
2389139|NCT01405794|5862067|P1|NOT COMPLETED|72 hr Washout||0
2389140|NCT01405794|5862067|P1|COMPLETED|72 hr Washout||12
2389141|NCT01405794|5862067|P1|STARTED|72 hr Washout||12
2389142|NCT01405794|5862067|P1|NOT COMPLETED|First Dose Placebo (14 Days)||0
2389143|NCT01405794|5862067|P1|COMPLETED|First Dose Placebo (14 Days)||12
2389144|NCT01405794|5862067|P1|STARTED|First Dose Placebo (14 Days)||12
2389145|NCT01405768|5862143|P2|NOT COMPLETED|Overall Study||0
2389146|NCT01405768|5862144|P1|NOT COMPLETED|Overall Study||4
2389147|NCT01405768|5862143|P2|COMPLETED|Overall Study||28
2389148|NCT01405768|5862144|P1|COMPLETED|Overall Study||24
2389149|NCT01405768|5862143|P2|STARTED|Overall Study||28
2389150|NCT01405768|5862144|P1|STARTED|Overall Study||28
2389151|NCT01405742|5862156|P2|NOT COMPLETED|Overall Study||0
2389152|NCT01405742|5862157|P1|NOT COMPLETED|Overall Study||1
2389153|NCT01405742|5862156|P2|COMPLETED|Overall Study||2
2389154|NCT01405742|5862157|P1|COMPLETED|Overall Study||1
2389155|NCT01405742|5862156|P2|STARTED|Overall Study||2
2389156|NCT01405742|5862157|P1|STARTED|Overall Study||2
2389157|NCT01405560|5862167|P1|NOT COMPLETED|Overall Study||1
2389158|NCT01405560|5862167|P1|COMPLETED|Overall Study||41
2389159|NCT01405560|5862167|P1|STARTED|Overall Study||42
2389160|NCT01405508|5862182|P4|NOT COMPLETED|Overall Study||0
2389161|NCT01405508|5862183|P3|NOT COMPLETED|Overall Study||0
2389162|NCT01405508|5862184|P2|NOT COMPLETED|Overall Study||1
2389163|NCT01405508|5862185|P1|NOT COMPLETED|Overall Study||1
2389164|NCT01405508|5862182|P4|COMPLETED|Overall Study||26
2389165|NCT01405508|5862183|P3|COMPLETED|Overall Study||27
2389166|NCT01405508|5862184|P2|COMPLETED|Overall Study||25
2389167|NCT01405508|5862185|P1|COMPLETED|Overall Study||25
2389168|NCT01405508|5862182|P4|STARTED|Overall Study||26
2389169|NCT01405508|5862183|P3|STARTED|Overall Study||27
2389170|NCT01405508|5862184|P2|STARTED|Overall Study||26
2389171|NCT01405508|5862185|P1|STARTED|Overall Study||26
2389172|NCT01405469|5862203|P1|NOT COMPLETED|Overall Study||0
2389173|NCT01405469|5862203|P1|COMPLETED|Overall Study||16
2389174|NCT01405469|5862203|P1|STARTED|Overall Study||16
2389175|NCT01405456|5862217|P2|NOT COMPLETED|Overall Study||1
2389176|NCT01405456|5862218|P1|NOT COMPLETED|Overall Study||3
2389177|NCT01405456|5862217|P2|COMPLETED|Overall Study||20
2389178|NCT01405456|5862218|P1|COMPLETED|Overall Study||22
2389179|NCT01405456|5862217|P2|STARTED|Overall Study||21
2389180|NCT01405456|5862218|P1|STARTED|Overall Study||25
2389181|NCT01405313|5862246|P1|NOT COMPLETED|Overall Study||0
2389182|NCT01405313|5862246|P1|COMPLETED|Overall Study||21
2389183|NCT01405313|5862246|P1|STARTED|Overall Study||21
2389184|NCT01405196|5862258|P4|NOT COMPLETED|Overall Study||9
2389185|NCT01405196|5862259|P3|NOT COMPLETED|Overall Study||23
2389186|NCT01405196|5862260|P2|NOT COMPLETED|Overall Study||12
2389187|NCT01405196|5862261|P1|NOT COMPLETED|Overall Study||11
2389188|NCT01405196|5862258|P4|COMPLETED|Overall Study||36
2389189|NCT01405196|5862259|P3|COMPLETED|Overall Study||23
2389190|NCT01405196|5862260|P2|COMPLETED|Overall Study||35
2389191|NCT01405196|5862261|P1|COMPLETED|Overall Study||34
2389192|NCT01405196|5862258|P4|STARTED|Overall Study||45
2389193|NCT01405196|5862259|P3|STARTED|Overall Study||46
2389194|NCT01405196|5862260|P2|STARTED|Overall Study||47
2389195|NCT01405196|5862261|P1|STARTED|Overall Study||45
2389196|NCT01405053|5862348|P2|NOT COMPLETED|Overall Study||8
2389197|NCT01405053|5862349|P1|NOT COMPLETED|Overall Study||10
2389198|NCT01405053|5862348|P2|COMPLETED|Overall Study||4
2389199|NCT01405053|5862349|P1|COMPLETED|Overall Study||15
2389200|NCT01405053|5862348|P2|STARTED|Overall Study||12
2389201|NCT01405053|5862349|P1|STARTED|Overall Study||25
2389202|NCT01405027|5862375|P2|NOT COMPLETED|Overall Study||51
2389203|NCT01405027|5862376|P1|NOT COMPLETED|Overall Study||32
2389204|NCT01405027|5862375|P2|COMPLETED|Overall Study||62
2389205|NCT01405027|5862376|P1|COMPLETED|Overall Study||52
2389206|NCT01405027|5862375|P2|STARTED|Overall Study||113
2389207|NCT01405027|5862376|P1|STARTED|Overall Study||84
2389208|NCT01404988|5862393|P3|NOT COMPLETED|Overall Study||3
2389209|NCT01404988|5862394|P2|NOT COMPLETED|Overall Study||4
2389210|NCT01404988|5862395|P1|NOT COMPLETED|Overall Study||6
2389211|NCT01404988|5862393|P3|COMPLETED|Overall Study||30
2389212|NCT01404988|5862394|P2|COMPLETED|Overall Study||29
2389213|NCT01404988|5862395|P1|COMPLETED|Overall Study||27
2389214|NCT01404988|5862393|P3|STARTED|Overall Study||33
2389215|NCT01404988|5862394|P2|STARTED|Overall Study||33
2389216|NCT01404988|5862395|P1|STARTED|Overall Study||33
2389217|NCT01404936|5862412|P1|NOT COMPLETED|Overall Study||0
2389218|NCT01404936|5862412|P1|COMPLETED|Overall Study||30
2389219|NCT01404936|5862412|P1|STARTED|Overall Study||30
2389220|NCT01404923|5862418|P2|NOT COMPLETED|Overall Study||17
2389221|NCT01404923|5862419|P1|NOT COMPLETED|Overall Study||23
2389222|NCT01404923|5862418|P2|COMPLETED|Overall Study||197
2389223|NCT01404923|5862419|P1|COMPLETED|Overall Study||199
2389224|NCT01404923|5862418|P2|STARTED|Overall Study||214
2389225|NCT01404923|5862419|P1|STARTED|Overall Study||222
2389226|NCT01404832|5862427|P1|NOT COMPLETED|Overall Study||0
2389227|NCT01404832|5862427|P1|COMPLETED|Overall Study||21
2389228|NCT01404832|5862427|P1|STARTED|Overall Study||21
2389229|NCT01404650|5862432|P1|NOT COMPLETED|Overall Study||0
2389230|NCT01404650|5862432|P1|COMPLETED|Overall Study||25
2389231|NCT01404650|5862432|P1|STARTED|Overall Study|Twenty-five patients received a median of 2 cycles of AUY922.|25
2389232|NCT01404611|5862442|P3|NOT COMPLETED|Overall Study||5
2389233|NCT01404611|5862443|P2|NOT COMPLETED|Overall Study||19
2389234|NCT01404611|5862444|P1|NOT COMPLETED|Overall Study||8
2389235|NCT01404611|5862442|P3|COMPLETED|Overall Study||106
2389236|NCT01404611|5862443|P2|COMPLETED|Overall Study||89
2389237|NCT01404611|5862444|P1|COMPLETED|Overall Study||104
2389238|NCT01404611|5862442|P3|STARTED|Overall Study||111
2389239|NCT01404611|5862443|P2|STARTED|Overall Study||108
2389240|NCT01404611|5862444|P1|STARTED|Overall Study||112
2389241|NCT01404572|5862452|P3|NOT COMPLETED|Overall Study||0
2389242|NCT01404572|5862453|P2|NOT COMPLETED|Overall Study||0
2389243|NCT01404572|5862454|P1|NOT COMPLETED|Overall Study||0
2389244|NCT01404572|5862452|P3|COMPLETED|Overall Study||4
2389245|NCT01404572|5862453|P2|COMPLETED|Overall Study||4
2389246|NCT01404572|5862454|P1|COMPLETED|Overall Study||4
2389247|NCT01404572|5862452|P3|STARTED|Overall Study||4
2389248|NCT01404572|5862453|P2|STARTED|Overall Study||4
2389249|NCT01404572|5862454|P1|STARTED|Overall Study||4
2389250|NCT01404559|5862485|P4|NOT COMPLETED|Overall Study||0
2389251|NCT01404559|5862486|P3|NOT COMPLETED|Overall Study||0
2389252|NCT01404559|5862487|P2|NOT COMPLETED|Overall Study||0
2389253|NCT01404559|5862488|P1|NOT COMPLETED|Overall Study||0
2389254|NCT01404559|5862485|P4|COMPLETED|Overall Study||14
2389255|NCT01404559|5862486|P3|COMPLETED|Overall Study||4
2389256|NCT01404559|5862487|P2|COMPLETED|Overall Study||5
2389257|NCT01404559|5862488|P1|COMPLETED|Overall Study||5
2389258|NCT01404559|5862485|P4|STARTED|Overall Study||14
2389259|NCT01404559|5862486|P3|STARTED|Overall Study||4
2389260|NCT01404559|5862487|P2|STARTED|Overall Study||5
2389261|NCT01404559|5862488|P1|STARTED|Overall Study||5
2389262|NCT01404429|5862501|P2|NOT COMPLETED|Overall Study||7
2389263|NCT01404429|5862502|P1|NOT COMPLETED|Overall Study||9
2389264|NCT01404429|5862501|P2|COMPLETED|Overall Study||46
2389265|NCT01404429|5862502|P1|COMPLETED|Overall Study||38
2389266|NCT01404429|5862501|P2|STARTED|Overall Study||53
2389267|NCT01404429|5862502|P1|STARTED|Overall Study||47
2389268|NCT01404325|5862516|P2|NOT COMPLETED|Overall Study||2
2389269|NCT01404325|5862517|P1|NOT COMPLETED|Overall Study||4
2389270|NCT01404325|5862516|P2|COMPLETED|Overall Study||61
2389271|NCT01404325|5862517|P1|COMPLETED|Overall Study||63
2389272|NCT01404325|5862516|P2|STARTED|Overall Study||63
2389273|NCT01404325|5862517|P1|STARTED|Overall Study||67
2389274|NCT01404312|5862575|P2|NOT COMPLETED|Overall Study||311
2389275|NCT01404312|5862576|P1|NOT COMPLETED|Overall Study||298
2389276|NCT01404312|5862575|P2|COMPLETED|Overall Study||1193
2389277|NCT01404312|5862576|P1|COMPLETED|Overall Study||1198
2389278|NCT01404312|5862575|P2|STARTED|Overall Study||1504
2389279|NCT01404312|5862576|P1|STARTED|Overall Study||1496
2389280|NCT01404260|5862598|P2|NOT COMPLETED|Overall Study||9
2389281|NCT01404260|5862599|P1|NOT COMPLETED|Overall Study||3
2389282|NCT01404260|5862598|P2|COMPLETED|Overall Study||101
2389283|NCT01404260|5862599|P1|COMPLETED|Overall Study||106
2389284|NCT01404260|5862598|P2|STARTED|Overall Study||110
2389285|NCT01404260|5862599|P1|STARTED|Overall Study||109
2389286|NCT01404234|5862605|P1|NOT COMPLETED|Overall Study||2
2389287|NCT01404234|5862605|P1|COMPLETED|Overall Study||59
2389288|NCT01404234|5862605|P1|STARTED|Overall Study||61
2389289|NCT01404208|5862621|P2|NOT COMPLETED|Overall Study||0
2389290|NCT01404208|5862622|P1|NOT COMPLETED|Overall Study||3
2389291|NCT01404208|5862621|P2|COMPLETED|Overall Study||72
2389292|NCT01404208|5862622|P1|COMPLETED|Overall Study||67
2389293|NCT01404208|5862621|P2|STARTED|Overall Study||72
2389294|NCT01404208|5862622|P1|STARTED|Overall Study||70
2389295|NCT01404078|5862632|P2|NOT COMPLETED|Overall Study||20
2389296|NCT01404078|5862633|P1|NOT COMPLETED|Overall Study||18
2389297|NCT01404078|5862632|P2|COMPLETED|Overall Study||237
2389298|NCT01404078|5862633|P1|COMPLETED|Overall Study||243
2389299|NCT01404078|5862632|P2|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|257
2389300|NCT01404078|5862633|P1|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|261
2389301|NCT01404039|5862648|P13|NOT COMPLETED|Overall Study||0
2389302|NCT01404039|5862649|P12|NOT COMPLETED|Overall Study||0
2389303|NCT01404039|5862650|P11|NOT COMPLETED|Overall Study||1
2389304|NCT01404039|5862651|P10|NOT COMPLETED|Overall Study||1
2389305|NCT01404039|5862652|P9|NOT COMPLETED|Overall Study||0
2389306|NCT01404039|5862653|P8|NOT COMPLETED|Overall Study||0
2389307|NCT01404039|5862654|P7|NOT COMPLETED|Overall Study||0
2389308|NCT01404039|5862655|P6|NOT COMPLETED|Overall Study||0
2389309|NCT01404039|5862656|P5|NOT COMPLETED|Overall Study||0
2389310|NCT01404039|5862657|P4|NOT COMPLETED|Overall Study||0
2389311|NCT01404039|5862658|P3|NOT COMPLETED|Overall Study||0
2389312|NCT01404039|5862659|P2|NOT COMPLETED|Overall Study||0
2389313|NCT01404039|5862660|P1|NOT COMPLETED|Overall Study||1
2389314|NCT01404039|5862648|P13|COMPLETED|Overall Study||0
2389315|NCT01404039|5862649|P12|COMPLETED|Overall Study||0
2389316|NCT01404039|5862650|P11|COMPLETED|Overall Study||14
2389317|NCT01404039|5862651|P10|COMPLETED|Overall Study||14
2389318|NCT01404039|5862652|P9|COMPLETED|Overall Study||15
2389319|NCT01404039|5862653|P8|COMPLETED|Overall Study||15
2389320|NCT01404039|5862654|P7|COMPLETED|Overall Study||10
2389321|NCT01404039|5862655|P6|COMPLETED|Overall Study||10
2389322|NCT01404039|5862656|P5|COMPLETED|Overall Study||10
2389323|NCT01404039|5862657|P4|COMPLETED|Overall Study||10
2389324|NCT01404039|5862658|P3|COMPLETED|Overall Study||5
2389325|NCT01404039|5862659|P2|COMPLETED|Overall Study||5
2389326|NCT01404039|5862660|P1|COMPLETED|Overall Study||4
2389327|NCT01404039|5862648|P13|STARTED|Overall Study||0
2389328|NCT01404039|5862649|P12|STARTED|Overall Study||0
2389329|NCT01404039|5862650|P11|STARTED|Overall Study||15
2389330|NCT01404039|5862651|P10|STARTED|Overall Study||15
2389331|NCT01404039|5862652|P9|STARTED|Overall Study||15
2389332|NCT01404039|5862653|P8|STARTED|Overall Study||15
2389333|NCT01404039|5862654|P7|STARTED|Overall Study||10
2389334|NCT01404039|5862655|P6|STARTED|Overall Study||10
2389335|NCT01404039|5862656|P5|STARTED|Overall Study||10
2389336|NCT01404039|5862657|P4|STARTED|Overall Study||10
2389337|NCT01404039|5862658|P3|STARTED|Overall Study||5
2389338|NCT01404039|5862659|P2|STARTED|Overall Study||5
2389339|NCT01404039|5862660|P1|STARTED|Overall Study||5
2389340|NCT01403987|5862687|P3|NOT COMPLETED|Overall Study||18
2389341|NCT01403987|5862688|P2|NOT COMPLETED|Overall Study||17
2389342|NCT01403987|5862689|P1|NOT COMPLETED|Overall Study||18
2389343|NCT01403987|5862687|P3|COMPLETED|Overall Study||50
2389344|NCT01403987|5862688|P2|COMPLETED|Overall Study||17
2389345|NCT01403987|5862689|P1|COMPLETED|Overall Study||16
2389346|NCT01403987|5862687|P3|STARTED|Overall Study||68
2389347|NCT01403987|5862688|P2|STARTED|Overall Study||34
2389348|NCT01403987|5862689|P1|STARTED|Overall Study||34
2389349|NCT01403805|5862705|P2|NOT COMPLETED|Overall Study||7
2389350|NCT01403805|5862706|P1|NOT COMPLETED|Overall Study||0
2389351|NCT01403805|5862705|P2|COMPLETED|Overall Study||98
2389352|NCT01403805|5862706|P1|COMPLETED|Overall Study||94
2389353|NCT01403805|5862705|P2|Pneumonia Diagnosis|Overall Study||2
2389354|NCT01403805|5862706|P1|Pneumonia Diagnosis|Overall Study||21
2389355|NCT01403805|5862705|P2|STARTED|Overall Study||105
2389356|NCT01403805|5862706|P1|STARTED|Overall Study||94
2389357|NCT01403610|5862722|P4|NOT COMPLETED|Overall Study||0
2389358|NCT01403610|5862723|P3|NOT COMPLETED|Overall Study||0
2389359|NCT01403610|5862724|P2|NOT COMPLETED|Overall Study||3
2389360|NCT01403610|5862725|P1|NOT COMPLETED|Overall Study||2
2389361|NCT01403610|5862722|P4|COMPLETED|Overall Study||13
2389362|NCT01403610|5862723|P3|COMPLETED|Overall Study||4
2389363|NCT01403610|5862724|P2|COMPLETED|Overall Study||3
2389364|NCT01403610|5862725|P1|COMPLETED|Overall Study||3
2389365|NCT01403610|5862722|P4|STARTED|Overall Study||13
2389366|NCT01403610|5862723|P3|STARTED|Overall Study||4
2389367|NCT01403610|5862724|P2|STARTED|Overall Study||6
2389368|NCT01403610|5862725|P1|STARTED|Overall Study||5
2389369|NCT01403441|5862735|P1|NOT COMPLETED|Overall Study||0
2389370|NCT01403441|5862735|P1|COMPLETED|Overall Study||3
2389371|NCT01403441|5862735|P1|STARTED|Overall Study||3
2389372|NCT01403376|5862745|P3|NOT COMPLETED|Overall Study||0
2389373|NCT01403376|5862746|P2|NOT COMPLETED|Overall Study||0
2389374|NCT01403376|5862747|P1|NOT COMPLETED|Overall Study||0
2389375|NCT01403376|5862745|P3|COMPLETED|Overall Study||46
2389376|NCT01403376|5862746|P2|COMPLETED|Overall Study||41
2389377|NCT01403376|5862747|P1|COMPLETED|Overall Study||41
2389378|NCT01403376|5862745|P3|STARTED|Overall Study||46
2389379|NCT01403376|5862746|P2|STARTED|Overall Study||41
2389380|NCT01403376|5862747|P1|STARTED|Overall Study||41
2389381|NCT01403246|5862767|P1|NOT COMPLETED|Overall Study||0
2389382|NCT01403246|5862767|P1|COMPLETED|Overall Study||9
2389383|NCT01403246|5862767|P1|STARTED|Overall Study||9
2389384|NCT01403194|5862771|P1|NOT COMPLETED|Overall Study||10
2389385|NCT01403194|5862771|P1|COMPLETED|Overall Study||1
2389386|NCT01403194|5862771|P1|STARTED|Overall Study||11
2389387|NCT01403116|5862779|P2|NOT COMPLETED|Overall Study||27
2389388|NCT01403116|5862780|P1|NOT COMPLETED|Overall Study||32
2389389|NCT01403116|5862779|P2|COMPLETED|Overall Study||133
2389390|NCT01403116|5862780|P1|COMPLETED|Overall Study||129
2389391|NCT01403116|5862779|P2|Randomized in Error/ No Treatment Recvd|Overall Study||3
2389392|NCT01403116|5862780|P1|Randomized in Error/ No Treatment Recvd|Overall Study||1
2389393|NCT01403116|5862779|P2|Randomized|Overall Study||163
2389394|NCT01403116|5862780|P1|Randomized|Overall Study||162
2389395|NCT01403116|5862779|P2|STARTED|Overall Study||160
2389396|NCT01403116|5862780|P1|STARTED|Overall Study||161
2389397|NCT01403090|5862787|P1|NOT COMPLETED|Overall Study||0
2389398|NCT01403090|5862787|P1|COMPLETED|Overall Study||8
2389399|NCT01403090|5862787|P1|STARTED|Overall Study||8
2389400|NCT01403051|5862793|P2|NOT COMPLETED|Overall Study||6
2389401|NCT01403051|5862794|P1|NOT COMPLETED|Overall Study||10
2389402|NCT01403051|5862793|P2|COMPLETED|Overall Study||80
2389403|NCT01403051|5862794|P1|COMPLETED|Overall Study||71
2389404|NCT01403051|5862793|P2|Initiated Study Treatment|Overall Study||86
2389405|NCT01403051|5862794|P1|Initiated Study Treatment|Overall Study||81
2389406|NCT01403051|5862793|P2|STARTED|Overall Study||86
2389407|NCT01403051|5862794|P1|STARTED|Overall Study||81
2389408|NCT01402986|5862830|P4|NOT COMPLETED|Overall Study||22
2389409|NCT01402986|5862831|P3|NOT COMPLETED|Overall Study||8
2389410|NCT01402986|5862832|P2|NOT COMPLETED|Overall Study||15
2389411|NCT01402986|5862833|P1|NOT COMPLETED|Overall Study||9
2389412|NCT01402986|5862830|P4|COMPLETED|Overall Study||129
2389413|NCT01402986|5862831|P3|COMPLETED|Overall Study||67
2389414|NCT01402986|5862832|P2|COMPLETED|Overall Study||135
2389415|NCT01402986|5862833|P1|COMPLETED|Overall Study||67
2389416|NCT01402986|5862830|P4|STARTED|Overall Study||151
2389417|NCT01402986|5862831|P3|STARTED|Overall Study||75
2389418|NCT01402986|5862832|P2|STARTED|Overall Study||150
2389419|NCT01402986|5862833|P1|STARTED|Overall Study||76
2389420|NCT01402947|5862968|P2|NOT COMPLETED|Second Intervention||0
2389421|NCT01402947|5862969|P1|NOT COMPLETED|Second Intervention||0
2389422|NCT01402947|5862968|P2|COMPLETED|Second Intervention||14
2389423|NCT01402947|5862969|P1|COMPLETED|Second Intervention||15
2389424|NCT01402947|5862968|P2|STARTED|Second Intervention||14
2389425|NCT01402947|5862969|P1|STARTED|Second Intervention||15
2389426|NCT01402947|5862968|P2|NOT COMPLETED|First Intervention||1
2389427|NCT01402947|5862969|P1|NOT COMPLETED|First Intervention||0
2389428|NCT01402947|5862968|P2|COMPLETED|First Intervention||14
2389429|NCT01402947|5862969|P1|COMPLETED|First Intervention||15
2389430|NCT01402947|5862968|P2|STARTED|First Intervention||15
2389431|NCT01402947|5862969|P1|STARTED|First Intervention||15
2389432|NCT01402869|5862980|P3|NOT COMPLETED|Overall Study||1
2389433|NCT01402869|5862981|P2|NOT COMPLETED|Overall Study||0
2389434|NCT01402869|5862982|P1|NOT COMPLETED|Overall Study||0
2389435|NCT01402869|5862980|P3|COMPLETED|Overall Study||30
2389436|NCT01402869|5862981|P2|COMPLETED|Overall Study||30
2389437|NCT01402869|5862982|P1|COMPLETED|Overall Study||30
2389438|NCT01402869|5862980|P3|STARTED|Overall Study||31
2389439|NCT01402869|5862981|P2|STARTED|Overall Study||30
2389440|NCT01402869|5862982|P1|STARTED|Overall Study||30
2389441|NCT01402817|5862996|P1|NOT COMPLETED|Overall Study||11
2389442|NCT01402817|5862996|P1|COMPLETED|Overall Study||8
2389443|NCT01402817|5862996|P1|STARTED|Overall Study||19
2389444|NCT01402700|5863001|P1|NOT COMPLETED|Overall Study||7
2389445|NCT01402700|5863001|P1|COMPLETED|Overall Study||68
2389446|NCT01402700|5863001|P1|STARTED|Overall Study||75
2389447|NCT01402570|5863005|P1|NOT COMPLETED|Overall Study||1
2389448|NCT01402570|5863005|P1|COMPLETED|Overall Study||19
2389449|NCT01402570|5863005|P1|STARTED|Overall Study||20
2389450|NCT01402544|5863012|P1|NOT COMPLETED|Overall Study||6
2389451|NCT01402544|5863012|P1|COMPLETED|Overall Study||6
2389452|NCT01402544|5863012|P1|STARTED|Overall Study||12
2389453|NCT01402531|5863018|P1|NOT COMPLETED|Overall Study||0
2389454|NCT01402531|5863018|P1|COMPLETED|Overall Study||0
2389455|NCT01402531|5863018|P1|STARTED|Overall Study||0
2389456|NCT01402427|5863024|P2|NOT COMPLETED|Overall Study||0
2389457|NCT01402427|5863025|P1|NOT COMPLETED|Overall Study||0
2389458|NCT01402427|5863024|P2|COMPLETED|Overall Study||294
2389459|NCT01402427|5863025|P1|COMPLETED|Overall Study||297
2389460|NCT01402427|5863024|P2|STARTED|Overall Study||294
2389461|NCT01402427|5863025|P1|STARTED|Overall Study||297
2389462|NCT01402375|5863049|P6|NOT COMPLETED|Overall Study||0
2389463|NCT01402375|5863050|P5|NOT COMPLETED|Overall Study||0
2389464|NCT01402375|5863051|P4|NOT COMPLETED|Overall Study||0
2389465|NCT01402375|5863052|P3|NOT COMPLETED|Overall Study||0
2389466|NCT01402375|5863053|P2|NOT COMPLETED|Overall Study||0
2389467|NCT01402375|5863054|P1|NOT COMPLETED|Overall Study||0
2389468|NCT01402375|5863049|P6|COMPLETED|Overall Study||120
2389469|NCT01402375|5863050|P5|COMPLETED|Overall Study||120
2389470|NCT01402375|5863051|P4|COMPLETED|Overall Study||120
2389471|NCT01402375|5863052|P3|COMPLETED|Overall Study||120
2389472|NCT01402375|5863053|P2|COMPLETED|Overall Study||120
2389473|NCT01402375|5863054|P1|COMPLETED|Overall Study||120
2389474|NCT01402375|5863049|P6|STARTED|Overall Study||120
2389475|NCT01402375|5863050|P5|STARTED|Overall Study||120
2389476|NCT01402375|5863051|P4|STARTED|Overall Study||120
2389477|NCT01402375|5863052|P3|STARTED|Overall Study||120
2389478|NCT01402375|5863053|P2|STARTED|Overall Study||120
2389479|NCT01402375|5863054|P1|STARTED|Overall Study||120
2389480|NCT01402284|5863086|P1|NOT COMPLETED|Overall Study||14
2389481|NCT01402284|5863086|P1|COMPLETED|Overall Study||31
2389482|NCT01402284|5863086|P1|STARTED|Overall Study||45
2389483|NCT01402141|5863099|P2|NOT COMPLETED|Overall Study||2
2389484|NCT01402141|5863100|P1|NOT COMPLETED|Overall Study||1
2389485|NCT01402141|5863099|P2|COMPLETED|Overall Study||28
2389486|NCT01402141|5863100|P1|COMPLETED|Overall Study||29
2389487|NCT01402141|5863099|P2|STARTED|Overall Study||30
2389488|NCT01402141|5863100|P1|STARTED|Overall Study||30
2389489|NCT01402128|5863122|P2|NOT COMPLETED|Overall Study||0
2389490|NCT01402128|5863123|P1|NOT COMPLETED|Overall Study||1
2389491|NCT01402128|5863122|P2|COMPLETED|Overall Study||40
2389492|NCT01402128|5863123|P1|COMPLETED|Overall Study||39
2389493|NCT01402128|5863122|P2|STARTED|Overall Study||40
2389494|NCT01402128|5863123|P1|STARTED|Overall Study||40
2389495|NCT01402115|5863151|P2|NOT COMPLETED|Overall Study||1
2389496|NCT01402115|5863152|P1|NOT COMPLETED|Overall Study||1
2389497|NCT01402115|5863151|P2|COMPLETED|Overall Study||29
2389498|NCT01402115|5863152|P1|COMPLETED|Overall Study||29
2389499|NCT01402115|5863151|P2|STARTED|Overall Study||30
2389500|NCT01402115|5863152|P1|STARTED|Overall Study||30
2389501|NCT01402102|5863168|P2|NOT COMPLETED|Overall Study||3
2389502|NCT01402102|5863169|P1|NOT COMPLETED|Overall Study||2
2389503|NCT01402102|5863168|P2|COMPLETED|Overall Study||27
2389504|NCT01402102|5863169|P1|COMPLETED|Overall Study||28
2389505|NCT01402102|5863168|P2|STARTED|Overall Study||30
2389506|NCT01402102|5863169|P1|STARTED|Overall Study||30
2389513|NCT01402050|5863198|P2|NOT COMPLETED|Overall Study||0
2389514|NCT01402050|5863199|P1|NOT COMPLETED|Overall Study||0
2389515|NCT01402050|5863198|P2|COMPLETED|Overall Study||191
2389516|NCT01402050|5863199|P1|COMPLETED|Overall Study||185
2389517|NCT01402050|5863198|P2|STARTED|Overall Study||191
2389518|NCT01402050|5863199|P1|STARTED|Overall Study||185
2389519|NCT01402011|5863208|P3|NOT COMPLETED|Nine Month Follow-up||0
2389520|NCT01402011|5863209|P2|NOT COMPLETED|Nine Month Follow-up||1
2389521|NCT01402011|5863210|P1|NOT COMPLETED|Nine Month Follow-up||0
2389522|NCT01402011|5863208|P3|COMPLETED|Nine Month Follow-up||26
2389523|NCT01402011|5863209|P2|COMPLETED|Nine Month Follow-up||19
2389524|NCT01402011|5863210|P1|COMPLETED|Nine Month Follow-up||27
2389525|NCT01402011|5863208|P3|STARTED|Nine Month Follow-up||26
2389526|NCT01402011|5863209|P2|STARTED|Nine Month Follow-up||20
2389527|NCT01402011|5863210|P1|STARTED|Nine Month Follow-up||27
2389528|NCT01402011|5863208|P3|NOT COMPLETED|Active Treatment Period||0
2389529|NCT01402011|5863209|P2|NOT COMPLETED|Active Treatment Period||3
2389530|NCT01402011|5863210|P1|NOT COMPLETED|Active Treatment Period||1
2389531|NCT01402011|5863208|P3|COMPLETED|Active Treatment Period||26
2389532|NCT01402011|5863209|P2|COMPLETED|Active Treatment Period||20
2389533|NCT01402011|5863210|P1|COMPLETED|Active Treatment Period||27
2389534|NCT01402011|5863208|P3|STARTED|Active Treatment Period||26
2389535|NCT01402011|5863209|P2|STARTED|Active Treatment Period||23
2389536|NCT01402011|5863210|P1|STARTED|Active Treatment Period||28
2389537|NCT01402011|5863208|P3|NOT COMPLETED|Delayed Treatment Period||0
2389538|NCT01402011|5863209|P2|NOT COMPLETED|Delayed Treatment Period||0
2389539|NCT01402011|5863210|P1|NOT COMPLETED|Delayed Treatment Period||1
2389540|NCT01402011|5863208|P3|COMPLETED|Delayed Treatment Period||26
2389541|NCT01402011|5863209|P2|COMPLETED|Delayed Treatment Period||23
2389542|NCT01402011|5863210|P1|COMPLETED|Delayed Treatment Period|One patient with needle phobia declined to be treated before the 1st set of injections|28
2389543|NCT01402011|5863208|P3|STARTED|Delayed Treatment Period||26
2389544|NCT01402011|5863209|P2|STARTED|Delayed Treatment Period||23
2389545|NCT01402011|5863210|P1|STARTED|Delayed Treatment Period||29
2389546|NCT01401959|5863239|P3|NOT COMPLETED|Treated||5
2389547|NCT01401959|5863240|P2|NOT COMPLETED|Treated||8
2389548|NCT01401959|5863241|P1|NOT COMPLETED|Treated||7
2389549|NCT01401959|5863239|P3|COMPLETED|Treated||26
2389550|NCT01401959|5863240|P2|COMPLETED|Treated||34
2389551|NCT01401959|5863241|P1|COMPLETED|Treated||46
2389552|NCT01401959|5863239|P3|STARTED|Treated||31
2389553|NCT01401959|5863240|P2|STARTED|Treated||42
2389554|NCT01401959|5863241|P1|STARTED|Treated||53
2389555|NCT01401959|5863239|P3|NOT COMPLETED|Enrolled||0
2389556|NCT01401959|5863240|P2|NOT COMPLETED|Enrolled||0
2389557|NCT01401959|5863241|P1|NOT COMPLETED|Enrolled||1
2389558|NCT01401959|5863239|P3|COMPLETED|Enrolled||31
2389559|NCT01401959|5863240|P2|COMPLETED|Enrolled||42
2389560|NCT01401959|5863241|P1|COMPLETED|Enrolled||53
2389561|NCT01401959|5863239|P3|STARTED|Enrolled||31
2389562|NCT01401959|5863240|P2|STARTED|Enrolled||42
2389563|NCT01401959|5863241|P1|STARTED|Enrolled||54
2389564|NCT01401907|5863257|P2|NOT COMPLETED|Overall Study||51
2389565|NCT01401907|5863258|P1|NOT COMPLETED|Overall Study||57
2389566|NCT01401907|5863257|P2|COMPLETED|Overall Study||124
2389567|NCT01401907|5863258|P1|COMPLETED|Overall Study||118
2389568|NCT01401907|5863257|P2|12 Week Outcomes|Overall Study||153
2389569|NCT01401907|5863258|P1|12 Week Outcomes|Overall Study||148
2389570|NCT01401907|5863257|P2|STARTED|Overall Study||175
2389571|NCT01401907|5863258|P1|STARTED|Overall Study||175
2389572|NCT01401842|5863278|P2|NOT COMPLETED|Overall Study||67
2389573|NCT01401842|5863279|P1|NOT COMPLETED|Overall Study||68
2389574|NCT01401842|5863278|P2|COMPLETED|Overall Study||217
2389575|NCT01401842|5863279|P1|COMPLETED|Overall Study||230
2389576|NCT01401842|5863278|P2|STARTED|Overall Study||284
2389577|NCT01401842|5863279|P1|STARTED|Overall Study||298
2389578|NCT01401699|5863289|P1|NOT COMPLETED|Overall Study||0
2389579|NCT01401699|5863289|P1|COMPLETED|Overall Study||109
2389580|NCT01401699|5863289|P1|STARTED|Overall Study||109
2389581|NCT01401647|5863296|P3|NOT COMPLETED|Overall Study||3
2389582|NCT01401647|5863297|P2|NOT COMPLETED|Overall Study||8
2389583|NCT01401647|5863298|P1|NOT COMPLETED|Overall Study||4
2389584|NCT01401647|5863296|P3|COMPLETED|Overall Study||1056
2389585|NCT01401647|5863297|P2|COMPLETED|Overall Study||985
2389586|NCT01401647|5863298|P1|COMPLETED|Overall Study||968
2389587|NCT01401647|5863296|P3|STARTED|Overall Study||1059
2389588|NCT01401647|5863297|P2|STARTED|Overall Study||993
2389589|NCT01401647|5863298|P1|STARTED|Overall Study||972
2389590|NCT01401595|5863311|P2|NOT COMPLETED|Imaging and Treatment (for NE Arm)||0
2389591|NCT01401595|5863312|P1|NOT COMPLETED|Imaging and Treatment (for NE Arm)||14
2389592|NCT01401595|5863311|P2|COMPLETED|Imaging and Treatment (for NE Arm)||10
2389593|NCT01401595|5863312|P1|COMPLETED|Imaging and Treatment (for NE Arm)||18
2389594|NCT01401595|5863311|P2|STARTED|Imaging and Treatment (for NE Arm)||10
2389595|NCT01401595|5863312|P1|STARTED|Imaging and Treatment (for NE Arm)||32
2389596|NCT01401595|5863311|P2|NOT COMPLETED|Recruitment and Screening||2
2389597|NCT01401595|5863312|P1|NOT COMPLETED|Recruitment and Screening||43
2389598|NCT01401595|5863311|P2|COMPLETED|Recruitment and Screening|10 of the 12 remained eligible/interested after the initial screening visit.|10
2389599|NCT01401595|5863312|P1|COMPLETED|Recruitment and Screening|Of the 75, 32 remained interested/eligible after the initial screening period.|32
2389600|NCT01401595|5863311|P2|STARTED|Recruitment and Screening|Of 32 calls, 12 control subjects attended an initial screening visit.|12
2389601|NCT01401595|5863312|P1|STARTED|Recruitment and Screening|Of 345 calls, 75 potential NES subjects attended the screening visit and provided informed consent.|75
2389602|NCT01401582|5863323|P2|NOT COMPLETED|Overall Study||117
2389603|NCT01401582|5863324|P1|NOT COMPLETED|Overall Study||110
2389604|NCT01401582|5863323|P2|COMPLETED|Overall Study||291
2389605|NCT01401582|5863324|P1|COMPLETED|Overall Study||116
2389606|NCT01401582|5863323|P2|Baseline Completed|Overall Study||348
2389607|NCT01401582|5863324|P1|Baseline Completed|Overall Study||168
2389608|NCT01401582|5863323|P2|STARTED|Overall Study||408
2389609|NCT01401582|5863324|P1|STARTED|Overall Study||226
2389610|NCT01401543|5863340|P4|NOT COMPLETED|Fourth Intervention||0
2389611|NCT01401543|5863341|P3|NOT COMPLETED|Fourth Intervention||0
2389612|NCT01401543|5863342|P2|NOT COMPLETED|Fourth Intervention||0
2389613|NCT01401543|5863343|P1|NOT COMPLETED|Fourth Intervention||0
2389614|NCT01401543|5863340|P4|COMPLETED|Fourth Intervention||6
2389615|NCT01401543|5863341|P3|COMPLETED|Fourth Intervention||6
2389616|NCT01401543|5863342|P2|COMPLETED|Fourth Intervention||6
2389617|NCT01401543|5863343|P1|COMPLETED|Fourth Intervention||6
2389618|NCT01401543|5863340|P4|STARTED|Fourth Intervention||6
2389619|NCT01401543|5863341|P3|STARTED|Fourth Intervention||6
2389620|NCT01401543|5863342|P2|STARTED|Fourth Intervention||6
2389621|NCT01401543|5863343|P1|STARTED|Fourth Intervention||6
2389622|NCT01401543|5863340|P4|NOT COMPLETED|Third Washout Period of 1 Week||0
2389623|NCT01401543|5863341|P3|NOT COMPLETED|Third Washout Period of 1 Week||0
2389624|NCT01401543|5863342|P2|NOT COMPLETED|Third Washout Period of 1 Week||0
2389625|NCT01401543|5863343|P1|NOT COMPLETED|Third Washout Period of 1 Week||0
2389626|NCT01401543|5863340|P4|COMPLETED|Third Washout Period of 1 Week||6
2389627|NCT01401543|5863341|P3|COMPLETED|Third Washout Period of 1 Week||6
2389628|NCT01401543|5863342|P2|COMPLETED|Third Washout Period of 1 Week||6
2389629|NCT01401543|5863343|P1|COMPLETED|Third Washout Period of 1 Week||6
2389630|NCT01401543|5863340|P4|STARTED|Third Washout Period of 1 Week||6
2389631|NCT01401543|5863341|P3|STARTED|Third Washout Period of 1 Week||6
2389632|NCT01401543|5863342|P2|STARTED|Third Washout Period of 1 Week||6
2389633|NCT01401543|5863343|P1|STARTED|Third Washout Period of 1 Week||6
2389634|NCT01401543|5863340|P4|NOT COMPLETED|Third Intervention||0
2389635|NCT01401543|5863341|P3|NOT COMPLETED|Third Intervention||0
2389636|NCT01401543|5863342|P2|NOT COMPLETED|Third Intervention||0
2389637|NCT01401543|5863343|P1|NOT COMPLETED|Third Intervention||0
2389638|NCT01401543|5863340|P4|COMPLETED|Third Intervention||6
2389639|NCT01401543|5863341|P3|COMPLETED|Third Intervention||6
2389640|NCT01401543|5863342|P2|COMPLETED|Third Intervention||6
2389641|NCT01401543|5863343|P1|COMPLETED|Third Intervention||6
2389642|NCT01401543|5863340|P4|STARTED|Third Intervention||6
2389643|NCT01401543|5863341|P3|STARTED|Third Intervention||6
2389644|NCT01401543|5863342|P2|STARTED|Third Intervention||6
2389645|NCT01401543|5863343|P1|STARTED|Third Intervention||6
2389646|NCT01401543|5863340|P4|NOT COMPLETED|Second Washout Period of 1 Week||0
2389647|NCT01401543|5863341|P3|NOT COMPLETED|Second Washout Period of 1 Week||0
2389648|NCT01401543|5863342|P2|NOT COMPLETED|Second Washout Period of 1 Week||0
2389649|NCT01401543|5863343|P1|NOT COMPLETED|Second Washout Period of 1 Week||0
2389650|NCT01401543|5863340|P4|COMPLETED|Second Washout Period of 1 Week||6
2389651|NCT01401543|5863341|P3|COMPLETED|Second Washout Period of 1 Week||6
2389652|NCT01401543|5863342|P2|COMPLETED|Second Washout Period of 1 Week||6
2389653|NCT01401543|5863343|P1|COMPLETED|Second Washout Period of 1 Week||6
2389654|NCT01401543|5863340|P4|STARTED|Second Washout Period of 1 Week||6
2389655|NCT01401543|5863341|P3|STARTED|Second Washout Period of 1 Week||6
2389656|NCT01401543|5863342|P2|STARTED|Second Washout Period of 1 Week||6
2389657|NCT01401543|5863343|P1|STARTED|Second Washout Period of 1 Week||6
2389658|NCT01401543|5863340|P4|NOT COMPLETED|Second Intervention||0
2389659|NCT01401543|5863341|P3|NOT COMPLETED|Second Intervention||0
2389660|NCT01401543|5863342|P2|NOT COMPLETED|Second Intervention||0
2389661|NCT01401543|5863343|P1|NOT COMPLETED|Second Intervention||0
2389662|NCT01401543|5863340|P4|COMPLETED|Second Intervention||6
2389663|NCT01401543|5863341|P3|COMPLETED|Second Intervention||6
2389664|NCT01401543|5863342|P2|COMPLETED|Second Intervention||6
2389665|NCT01401543|5863343|P1|COMPLETED|Second Intervention||6
2389666|NCT01401543|5863340|P4|STARTED|Second Intervention||6
2389667|NCT01401543|5863341|P3|STARTED|Second Intervention||6
2389668|NCT01401543|5863342|P2|STARTED|Second Intervention||6
2389669|NCT01401543|5863343|P1|STARTED|Second Intervention||6
2389670|NCT01401543|5863340|P4|NOT COMPLETED|First Washout Period of 1 Week||0
2389671|NCT01401543|5863341|P3|NOT COMPLETED|First Washout Period of 1 Week||0
2389672|NCT01401543|5863342|P2|NOT COMPLETED|First Washout Period of 1 Week||0
2389673|NCT01401543|5863343|P1|NOT COMPLETED|First Washout Period of 1 Week||0
2389674|NCT01401543|5863340|P4|COMPLETED|First Washout Period of 1 Week||6
2389675|NCT01401543|5863341|P3|COMPLETED|First Washout Period of 1 Week||6
2389676|NCT01401543|5863342|P2|COMPLETED|First Washout Period of 1 Week||6
2389677|NCT01401543|5863343|P1|COMPLETED|First Washout Period of 1 Week||6
2389678|NCT01401543|5863340|P4|STARTED|First Washout Period of 1 Week||6
2389679|NCT01401543|5863341|P3|STARTED|First Washout Period of 1 Week||6
2389680|NCT01401543|5863342|P2|STARTED|First Washout Period of 1 Week||6
2389681|NCT01401543|5863343|P1|STARTED|First Washout Period of 1 Week||6
2389682|NCT01401543|5863340|P4|NOT COMPLETED|First Intervention||0
2389683|NCT01401543|5863341|P3|NOT COMPLETED|First Intervention||0
2389684|NCT01401543|5863342|P2|NOT COMPLETED|First Intervention||0
2389685|NCT01401543|5863343|P1|NOT COMPLETED|First Intervention||0
2389686|NCT01401543|5863340|P4|COMPLETED|First Intervention||6
2389687|NCT01401543|5863341|P3|COMPLETED|First Intervention||6
2389688|NCT01401543|5863342|P2|COMPLETED|First Intervention||6
2389689|NCT01401543|5863343|P1|COMPLETED|First Intervention||6
2389690|NCT01401543|5863340|P4|STARTED|First Intervention||6
2389691|NCT01401543|5863341|P3|STARTED|First Intervention||6
2389692|NCT01401543|5863342|P2|STARTED|First Intervention||6
2389693|NCT01401543|5863343|P1|STARTED|First Intervention||6
2389694|NCT01401530|5863368|P3|NOT COMPLETED|Overall Study||3
2389695|NCT01401530|5863369|P2|NOT COMPLETED|Overall Study||6
2389696|NCT01401530|5863370|P1|NOT COMPLETED|Overall Study||3
2389697|NCT01401530|5863368|P3|COMPLETED|Overall Study||0
2389698|NCT01401530|5863369|P2|COMPLETED|Overall Study||1
2389699|NCT01401530|5863370|P1|COMPLETED|Overall Study||0
2389700|NCT01401530|5863368|P3|STARTED|Overall Study||3
2389701|NCT01401530|5863369|P2|STARTED|Overall Study||7
2389702|NCT01401530|5863370|P1|STARTED|Overall Study||3
2389703|NCT01401517|5863410|P3|NOT COMPLETED|Overall Study||3
2389704|NCT01401517|5863411|P2|NOT COMPLETED|Overall Study||2
2389705|NCT01401517|5863412|P1|NOT COMPLETED|Overall Study||3
2389706|NCT01401517|5863410|P3|COMPLETED|Overall Study||15
2389707|NCT01401517|5863411|P2|COMPLETED|Overall Study||17
2389708|NCT01401517|5863412|P1|COMPLETED|Overall Study||15
2389709|NCT01401517|5863410|P3|STARTED|Overall Study||18
2389710|NCT01401517|5863411|P2|STARTED|Overall Study||19
2389711|NCT01401517|5863412|P1|STARTED|Overall Study||18
2389712|NCT01401478|5863420|P1|NOT COMPLETED|Overall Study||31
2389713|NCT01401478|5863420|P1|COMPLETED|Overall Study||55
2389714|NCT01401478|5863420|P1|STARTED|Overall Study||86
2389715|NCT01401465|5863433|P2|NOT COMPLETED|Treatment Period 2||2
2389716|NCT01401465|5863434|P1|NOT COMPLETED|Treatment Period 2||0
2389717|NCT01401465|5863433|P2|COMPLETED|Treatment Period 2||144
2389718|NCT01401465|5863434|P1|COMPLETED|Treatment Period 2||150
2389719|NCT01401465|5863433|P2|STARTED|Treatment Period 2||146
2389720|NCT01401465|5863434|P1|STARTED|Treatment Period 2||150
2389721|NCT01401465|5863433|P2|NOT COMPLETED|Washout||0
2389722|NCT01401465|5863434|P1|NOT COMPLETED|Washout||0
2389723|NCT01401465|5863433|P2|COMPLETED|Washout||146
2389724|NCT01401465|5863434|P1|COMPLETED|Washout||150
2389725|NCT01401465|5863433|P2|STARTED|Washout||146
2389726|NCT01401465|5863434|P1|STARTED|Washout||150
2389727|NCT01401465|5863433|P2|NOT COMPLETED|Treatment Period 1||16
2389728|NCT01401465|5863434|P1|NOT COMPLETED|Treatment Period 1||15
2389729|NCT01401465|5863433|P2|COMPLETED|Treatment Period 1||146
2389730|NCT01401465|5863434|P1|COMPLETED|Treatment Period 1||150
2389731|NCT01401465|5863433|P2|STARTED|Treatment Period 1||162
2389732|NCT01401465|5863434|P1|STARTED|Treatment Period 1||165
2389733|NCT01401452|5863497|P1|NOT COMPLETED|Overall Study||72
2389734|NCT01401452|5863497|P1|COMPLETED|Overall Study||174
2389735|NCT01401452|5863497|P1|Visit 5 (9 Months)|Overall Study||175
2389736|NCT01401452|5863497|P1|Visit 4 (6 Months)|Overall Study||172
2389737|NCT01401452|5863497|P1|Visit 3 (3 Months)|Overall Study||217
2389738|NCT01401452|5863497|P1|Visit 2 (1 Month)|Overall Study||225
2389739|NCT01401452|5863497|P1|Visit 1 (Baseline)|Overall Study||246
2389740|NCT01401452|5863497|P1|STARTED|Overall Study||246
2389741|NCT01401361|5863509|P1|NOT COMPLETED|Overall Study||28
2389742|NCT01401361|5863509|P1|COMPLETED|Overall Study|16 subjects were withdrawn prior to the use of the investigational device|122
2389743|NCT01401361|5863509|P1|STARTED|Overall Study||150
2389744|NCT01401322|5863515|P1|NOT COMPLETED|Overall Study||2
2389745|NCT01401322|5863515|P1|COMPLETED|Overall Study||3
2389746|NCT01401322|5863515|P1|STARTED|Overall Study||5
2389747|NCT01401283|5863521|P2|NOT COMPLETED|Overall Study||10
2389748|NCT01401283|5863522|P1|NOT COMPLETED|Overall Study||10
2389749|NCT01401283|5863521|P2|COMPLETED|Overall Study||81
2389750|NCT01401283|5863522|P1|COMPLETED|Overall Study||79
2389751|NCT01401283|5863521|P2|STARTED|Overall Study||91
2389752|NCT01401283|5863522|P1|STARTED|Overall Study||89
2389753|NCT01401257|5863534|P4|NOT COMPLETED|Overall Study||2
2389754|NCT01401257|5863535|P3|NOT COMPLETED|Overall Study||3
2389755|NCT01401257|5863536|P2|NOT COMPLETED|Overall Study||2
2389756|NCT01401257|5863537|P1|NOT COMPLETED|Overall Study||0
2389757|NCT01401257|5863534|P4|COMPLETED|Overall Study||17
2389758|NCT01401257|5863535|P3|COMPLETED|Overall Study||16
2389759|NCT01401257|5863536|P2|COMPLETED|Overall Study||19
2389760|NCT01401257|5863537|P1|COMPLETED|Overall Study||21
2389761|NCT01401257|5863534|P4|STARTED|Overall Study||19
2389762|NCT01401257|5863535|P3|STARTED|Overall Study||19
2389763|NCT01401257|5863536|P2|STARTED|Overall Study||21
2389764|NCT01401257|5863537|P1|STARTED|Overall Study||21
2389765|NCT01401166|5863549|P4|NOT COMPLETED|Safety Follow-Up Period||19
2389766|NCT01401166|5863550|P3|NOT COMPLETED|Safety Follow-Up Period||17
2389767|NCT01401166|5863551|P2|NOT COMPLETED|Safety Follow-Up Period||18
2389768|NCT01401166|5863552|P1|NOT COMPLETED|Safety Follow-Up Period||25
2389769|NCT01401166|5863549|P4|COMPLETED|Safety Follow-Up Period||100
2389770|NCT01401166|5863550|P3|COMPLETED|Safety Follow-Up Period||104
2389771|NCT01401166|5863551|P2|COMPLETED|Safety Follow-Up Period||106
2389772|NCT01401166|5863552|P1|COMPLETED|Safety Follow-Up Period||99
2389773|NCT01401166|5863549|P4|STARTED|Safety Follow-Up Period|All 119 randomized participants entered follow-up regardless of whether they received treatment.|119
2389774|NCT01401166|5863550|P3|STARTED|Safety Follow-Up Period|All 121 randomized participants entered follow-up regardless of whether they received treatment.|121
2389775|NCT01401166|5863551|P2|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
2389776|NCT01401166|5863552|P1|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
2389777|NCT01401166|5863549|P4|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||3
2389778|NCT01401166|5863550|P3|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||2
2389779|NCT01401166|5863551|P2|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||7
2389780|NCT01401166|5863552|P1|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||4
2389781|NCT01401166|5863549|P4|COMPLETED|Continuation Treatment (Cycles 9 to 18)||102
2389782|NCT01401166|5863550|P3|COMPLETED|Continuation Treatment (Cycles 9 to 18)||105
2389783|NCT01401166|5863551|P2|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
2389784|NCT01401166|5863552|P1|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
2389785|NCT01401166|5863549|P4|STARTED|Continuation Treatment (Cycles 9 to 18)||105
2389786|NCT01401166|5863550|P3|STARTED|Continuation Treatment (Cycles 9 to 18)||107
2389787|NCT01401166|5863551|P2|STARTED|Continuation Treatment (Cycles 9 to 18)||116
2389788|NCT01401166|5863552|P1|STARTED|Continuation Treatment (Cycles 9 to 18)||113
2389789|NCT01401166|5863549|P4|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||11
2389790|NCT01401166|5863550|P3|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||12
2389791|NCT01401166|5863551|P2|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||4
2389792|NCT01401166|5863552|P1|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||6
2389793|NCT01401166|5863549|P4|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||105
2389794|NCT01401166|5863550|P3|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||107
2389795|NCT01401166|5863551|P2|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||116
2389796|NCT01401166|5863552|P1|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||113
2389797|NCT01401166|5863549|P4|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||116
2389798|NCT01401166|5863550|P3|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
2389799|NCT01401166|5863551|P2|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||120
2389800|NCT01401166|5863552|P1|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
2389801|NCT01401166|5863549|P4|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
2389802|NCT01401166|5863550|P3|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
2389803|NCT01401166|5863551|P2|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
2389804|NCT01401166|5863552|P1|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||3
2389805|NCT01401166|5863549|P4|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||116
2389806|NCT01401166|5863550|P3|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
2389807|NCT01401166|5863551|P2|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||120
2389808|NCT01401166|5863552|P1|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
2389809|NCT01401166|5863549|P4|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 119 participants were randomized, but 1 did not receive any treatment.|118
2389810|NCT01401166|5863550|P3|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 121 participants were randomized who all received study treatment.|121
2389811|NCT01401166|5863551|P2|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
2389812|NCT01401166|5863552|P1|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
2389813|NCT01401153|5863588|P2|NOT COMPLETED|Second Test Day||5
2389814|NCT01401153|5863589|P1|NOT COMPLETED|Second Test Day||0
2389815|NCT01401153|5863588|P2|COMPLETED|Second Test Day||60
2389816|NCT01401153|5863589|P1|COMPLETED|Second Test Day||45
2389817|NCT01401153|5863588|P2|STARTED|Second Test Day||65
2389818|NCT01401153|5863589|P1|STARTED|Second Test Day||45
2389819|NCT01401153|5863588|P2|NOT COMPLETED|First Test Day||10
2389820|NCT01401153|5863589|P1|NOT COMPLETED|First Test Day||1
2389821|NCT01401153|5863588|P2|COMPLETED|First Test Day||45
2389822|NCT01401153|5863589|P1|COMPLETED|First Test Day||65
2389823|NCT01401153|5863588|P2|STARTED|First Test Day||55
2389824|NCT01401153|5863589|P1|STARTED|First Test Day||66
2389825|NCT01401101|5863623|P2|NOT COMPLETED|Overall Study||27
2389826|NCT01401101|5863624|P1|NOT COMPLETED|Overall Study||22
2389827|NCT01401101|5863623|P2|COMPLETED|Overall Study||171
2389828|NCT01401101|5863624|P1|COMPLETED|Overall Study||184
2389829|NCT01401101|5863623|P2|STARTED|Overall Study||198
2389830|NCT01401101|5863624|P1|STARTED|Overall Study||206
2389831|NCT01401062|5863636|P2|NOT COMPLETED|Overall Study||8
2389832|NCT01401062|5863637|P1|NOT COMPLETED|Overall Study||11
2389833|NCT01401062|5863636|P2|COMPLETED|Overall Study|At time of data entry, these 4 patients are still undergoing follow-up|4
2389834|NCT01401062|5863637|P1|COMPLETED|Overall Study||0
2389835|NCT01401062|5863636|P2|STARTED|Overall Study||12
2389836|NCT01401062|5863637|P1|STARTED|Overall Study||11
2389837|NCT01401049|5863645|P2|NOT COMPLETED|Overall Study||0
2389838|NCT01401049|5863646|P1|NOT COMPLETED|Overall Study||0
2389839|NCT01401049|5863645|P2|COMPLETED|Overall Study||0
2389840|NCT01401049|5863646|P1|COMPLETED|Overall Study||0
2389841|NCT01401049|5863645|P2|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
2389842|NCT01401049|5863646|P1|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
2389843|NCT01401023|5863654|P1|NOT COMPLETED|Overall Study||0
2389844|NCT01401023|5863654|P1|COMPLETED|Overall Study||10
2389845|NCT01401023|5863654|P1|STARTED|Overall Study||10
2389846|NCT01401010|5863664|P2|NOT COMPLETED|Overall Study||0
2389847|NCT01401010|5863665|P1|NOT COMPLETED|Overall Study||1
2389848|NCT01401010|5863664|P2|COMPLETED|Overall Study||6
2389849|NCT01401010|5863665|P1|COMPLETED|Overall Study||5
2389850|NCT01401010|5863664|P2|STARTED|Overall Study||6
2389851|NCT01401010|5863665|P1|STARTED|Overall Study||6
2389852|NCT01400958|5863690|P2|NOT COMPLETED|Overall Study||2
2389853|NCT01400958|5863691|P1|NOT COMPLETED|Overall Study||1
2389854|NCT01400958|5863690|P2|COMPLETED|Overall Study||1
2389855|NCT01400958|5863691|P1|COMPLETED|Overall Study||2
2389856|NCT01400958|5863690|P2|STARTED|Overall Study||3
2389857|NCT01400958|5863691|P1|STARTED|Overall Study||3
2389858|NCT01400932|5863701|P2|NOT COMPLETED|Overall Study||15
2389859|NCT01400932|5863702|P1|NOT COMPLETED|Overall Study||14
2389860|NCT01400932|5863701|P2|COMPLETED|Overall Study||167
2389861|NCT01400932|5863702|P1|COMPLETED|Overall Study||164
2389862|NCT01400932|5863701|P2|STARTED|Overall Study||182
2389863|NCT01400932|5863702|P1|STARTED|Overall Study||178
2389864|NCT01400919|5863724|P1|NOT COMPLETED|Overall Study||8
2389865|NCT01400919|5863724|P1|COMPLETED|Overall Study||67
2389866|NCT01400919|5863724|P1|STARTED|Overall Study||75
2389867|NCT01400906|5863728|P6|NOT COMPLETED|Treatment Period 3||0
2389868|NCT01400906|5863729|P5|NOT COMPLETED|Treatment Period 3||0
2389869|NCT01400906|5863730|P4|NOT COMPLETED|Treatment Period 3||0
2389870|NCT01400906|5863731|P3|NOT COMPLETED|Treatment Period 3||0
2389871|NCT01400906|5863732|P2|NOT COMPLETED|Treatment Period 3||0
2389872|NCT01400906|5863733|P1|NOT COMPLETED|Treatment Period 3||0
2389873|NCT01400906|5863728|P6|COMPLETED|Treatment Period 3||5
2389874|NCT01400906|5863729|P5|COMPLETED|Treatment Period 3||6
2389875|NCT01400906|5863730|P4|COMPLETED|Treatment Period 3||6
2389876|NCT01400906|5863731|P3|COMPLETED|Treatment Period 3||6
2389877|NCT01400906|5863732|P2|COMPLETED|Treatment Period 3||6
2389878|NCT01400906|5863733|P1|COMPLETED|Treatment Period 3||6
2389879|NCT01400906|5863728|P6|STARTED|Treatment Period 3||5
2389880|NCT01400906|5863729|P5|STARTED|Treatment Period 3||6
2389881|NCT01400906|5863730|P4|STARTED|Treatment Period 3||6
2389882|NCT01400906|5863731|P3|STARTED|Treatment Period 3||6
2389883|NCT01400906|5863732|P2|STARTED|Treatment Period 3||6
2389884|NCT01400906|5863733|P1|STARTED|Treatment Period 3||6
2389885|NCT01400906|5863728|P6|NOT COMPLETED|Washout Period 2||0
2389886|NCT01400906|5863729|P5|NOT COMPLETED|Washout Period 2||0
2389887|NCT01400906|5863730|P4|NOT COMPLETED|Washout Period 2||0
2389888|NCT01400906|5863731|P3|NOT COMPLETED|Washout Period 2||0
2389889|NCT01400906|5863732|P2|NOT COMPLETED|Washout Period 2||0
2389890|NCT01400906|5863733|P1|NOT COMPLETED|Washout Period 2||0
2389891|NCT01400906|5863728|P6|COMPLETED|Washout Period 2||5
2389892|NCT01400906|5863729|P5|COMPLETED|Washout Period 2||6
2389893|NCT01400906|5863730|P4|COMPLETED|Washout Period 2||6
2389894|NCT01400906|5863731|P3|COMPLETED|Washout Period 2||6
2389895|NCT01400906|5863732|P2|COMPLETED|Washout Period 2||6
2389896|NCT01400906|5863733|P1|COMPLETED|Washout Period 2||6
2389897|NCT01400906|5863728|P6|STARTED|Washout Period 2||5
2389898|NCT01400906|5863729|P5|STARTED|Washout Period 2||6
2389899|NCT01400906|5863730|P4|STARTED|Washout Period 2||6
2389900|NCT01400906|5863731|P3|STARTED|Washout Period 2||6
2389901|NCT01400906|5863732|P2|STARTED|Washout Period 2||6
2389902|NCT01400906|5863733|P1|STARTED|Washout Period 2||6
2389903|NCT01400906|5863728|P6|NOT COMPLETED|Treatment Period 2||0
2389904|NCT01400906|5863729|P5|NOT COMPLETED|Treatment Period 2||0
2389905|NCT01400906|5863730|P4|NOT COMPLETED|Treatment Period 2||0
2389906|NCT01400906|5863731|P3|NOT COMPLETED|Treatment Period 2||0
2389907|NCT01400906|5863732|P2|NOT COMPLETED|Treatment Period 2||0
2389908|NCT01400906|5863733|P1|NOT COMPLETED|Treatment Period 2||0
2389909|NCT01400906|5863728|P6|COMPLETED|Treatment Period 2||5
2389910|NCT01400906|5863729|P5|COMPLETED|Treatment Period 2||6
2389911|NCT01400906|5863730|P4|COMPLETED|Treatment Period 2||6
2389912|NCT01400906|5863731|P3|COMPLETED|Treatment Period 2||6
2389913|NCT01400906|5863732|P2|COMPLETED|Treatment Period 2||6
2389914|NCT01400906|5863733|P1|COMPLETED|Treatment Period 2||6
2389915|NCT01400906|5863728|P6|STARTED|Treatment Period 2||5
2389916|NCT01400906|5863729|P5|STARTED|Treatment Period 2||6
2389917|NCT01400906|5863730|P4|STARTED|Treatment Period 2||6
2389918|NCT01400906|5863731|P3|STARTED|Treatment Period 2||6
2389919|NCT01400906|5863732|P2|STARTED|Treatment Period 2||6
2389920|NCT01400906|5863733|P1|STARTED|Treatment Period 2||6
2389921|NCT01400906|5863728|P6|NOT COMPLETED|Washout Period 1||0
2389922|NCT01400906|5863729|P5|NOT COMPLETED|Washout Period 1||0
2389923|NCT01400906|5863730|P4|NOT COMPLETED|Washout Period 1||0
2389924|NCT01400906|5863731|P3|NOT COMPLETED|Washout Period 1||0
2389925|NCT01400906|5863732|P2|NOT COMPLETED|Washout Period 1||0
2389926|NCT01400906|5863733|P1|NOT COMPLETED|Washout Period 1||0
2389927|NCT01400906|5863728|P6|COMPLETED|Washout Period 1||5
2389928|NCT01400906|5863729|P5|COMPLETED|Washout Period 1||6
2389929|NCT01400906|5863730|P4|COMPLETED|Washout Period 1||6
2389930|NCT01400906|5863731|P3|COMPLETED|Washout Period 1||6
2389931|NCT01400906|5863732|P2|COMPLETED|Washout Period 1||6
2389932|NCT01400906|5863733|P1|COMPLETED|Washout Period 1||6
2389933|NCT01400906|5863728|P6|STARTED|Washout Period 1||5
2389934|NCT01400906|5863729|P5|STARTED|Washout Period 1||6
2389935|NCT01400906|5863730|P4|STARTED|Washout Period 1||6
2389936|NCT01400906|5863731|P3|STARTED|Washout Period 1||6
2389937|NCT01400906|5863732|P2|STARTED|Washout Period 1||6
2389938|NCT01400906|5863733|P1|STARTED|Washout Period 1||6
2389939|NCT01400906|5863728|P6|NOT COMPLETED|Treatment Period 1||0
2389940|NCT01400906|5863729|P5|NOT COMPLETED|Treatment Period 1||0
2389941|NCT01400906|5863730|P4|NOT COMPLETED|Treatment Period 1||0
2389942|NCT01400906|5863731|P3|NOT COMPLETED|Treatment Period 1||0
2389943|NCT01400906|5863732|P2|NOT COMPLETED|Treatment Period 1||0
2389944|NCT01400906|5863733|P1|NOT COMPLETED|Treatment Period 1||0
2389945|NCT01400906|5863728|P6|COMPLETED|Treatment Period 1||5
2389946|NCT01400906|5863729|P5|COMPLETED|Treatment Period 1||6
2389947|NCT01400906|5863730|P4|COMPLETED|Treatment Period 1||6
2389948|NCT01400906|5863731|P3|COMPLETED|Treatment Period 1||6
2389949|NCT01400906|5863732|P2|COMPLETED|Treatment Period 1||6
2389950|NCT01400906|5863733|P1|COMPLETED|Treatment Period 1||6
2389951|NCT01400906|5863728|P6|STARTED|Treatment Period 1||5
2389952|NCT01400906|5863729|P5|STARTED|Treatment Period 1||6
2389953|NCT01400906|5863730|P4|STARTED|Treatment Period 1||6
2389954|NCT01400906|5863731|P3|STARTED|Treatment Period 1||6
2389955|NCT01400906|5863732|P2|STARTED|Treatment Period 1||6
2389956|NCT01400906|5863733|P1|STARTED|Treatment Period 1||6
2389957|NCT01400893|5863767|P2|NOT COMPLETED|Overall Study||27
2389958|NCT01400893|5863768|P1|NOT COMPLETED|Overall Study||27
2389959|NCT01400893|5863767|P2|COMPLETED|Overall Study||38
2389960|NCT01400893|5863768|P1|COMPLETED|Overall Study||42
2389961|NCT01400893|5863767|P2|STARTED|Overall Study||65
2389962|NCT01400893|5863768|P1|STARTED|Overall Study||69
2389963|NCT01400880|5863776|P1|NOT COMPLETED|Overall Study||2
2389964|NCT01400880|5863776|P1|COMPLETED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|101
2389965|NCT01400880|5863776|P1|STARTED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|103
2389966|NCT01400841|5863780|P1|NOT COMPLETED|Extended Study Phase (2 Years)||2
2389967|NCT01400841|5863780|P1|COMPLETED|Extended Study Phase (2 Years)||11
2389968|NCT01400841|5863780|P1|STARTED|Extended Study Phase (2 Years)|"1 subject refused further participation~1 subject death prior to agreeing to extended follow-up"|13
2389969|NCT01400841|5863780|P1|NOT COMPLETED|Initial Study Phase (6 Months)||1
2389970|NCT01400841|5863780|P1|COMPLETED|Initial Study Phase (6 Months)||15
2389971|NCT01400841|5863780|P1|STARTED|Initial Study Phase (6 Months)|2 of the 18 consented subjects did not receive the device|16
2389972|NCT01400698|5863818|P6|NOT COMPLETED|Overall Study||6
2389973|NCT01400698|5863819|P5|NOT COMPLETED|Overall Study||7
2389974|NCT01400698|5863820|P4|NOT COMPLETED|Overall Study||8
2389975|NCT01400698|5863821|P3|NOT COMPLETED|Overall Study||2
2389976|NCT01400698|5863822|P2|NOT COMPLETED|Overall Study||11
2389977|NCT01400698|5863823|P1|NOT COMPLETED|Overall Study||15
2389978|NCT01400698|5863818|P6|COMPLETED|Overall Study||9
2389979|NCT01400698|5863819|P5|COMPLETED|Overall Study||7
2389980|NCT01400698|5863820|P4|COMPLETED|Overall Study||6
2389981|NCT01400698|5863821|P3|COMPLETED|Overall Study||0
2389982|NCT01400698|5863822|P2|COMPLETED|Overall Study||12
2389983|NCT01400698|5863823|P1|COMPLETED|Overall Study||8
2389984|NCT01400698|5863818|P6|STARTED|Overall Study||15
2389985|NCT01400698|5863819|P5|STARTED|Overall Study||14
2389986|NCT01400698|5863820|P4|STARTED|Overall Study||14
2389987|NCT01400698|5863821|P3|STARTED|Overall Study||2
2389988|NCT01400698|5863822|P2|STARTED|Overall Study||23
2389989|NCT01400698|5863823|P1|STARTED|Overall Study||23
2389990|NCT01400516|5863847|P2|NOT COMPLETED|Extension Trial||0
2389991|NCT01400516|5863848|P1|NOT COMPLETED|Extension Trial||0
2389992|NCT01400516|5863847|P2|COMPLETED|Extension Trial||7
2389993|NCT01400516|5863848|P1|COMPLETED|Extension Trial||6
2389994|NCT01400516|5863847|P2|STARTED|Extension Trial|Only 7 participants in the Teriparatide arm entered the Extension Trial.|7
2389995|NCT01400516|5863848|P1|STARTED|Extension Trial|Only 6 participants in the Control arm entered the Extension Trial.|6
2389996|NCT01400516|5863847|P2|NOT COMPLETED|Primary Trial||2
2389997|NCT01400516|5863848|P1|NOT COMPLETED|Primary Trial||0
2389998|NCT01400516|5863847|P2|COMPLETED|Primary Trial||12
2389999|NCT01400516|5863848|P1|COMPLETED|Primary Trial||12
2390000|NCT01400516|5863847|P2|STARTED|Primary Trial||14
2390001|NCT01400516|5863848|P1|STARTED|Primary Trial||12
2390002|NCT01400503|5863858|P1|NOT COMPLETED|Overall Study||60
2390003|NCT01400503|5863858|P1|COMPLETED|Overall Study||0
2390004|NCT01400503|5863858|P1|STARTED|Overall Study||60
2390005|NCT01400477|5863869|P2|NOT COMPLETED|Overall Study||0
2390006|NCT01400477|5863870|P1|NOT COMPLETED|Overall Study||2
2390007|NCT01400477|5863869|P2|COMPLETED|Overall Study||40
2390008|NCT01400477|5863870|P1|COMPLETED|Overall Study||38
2390009|NCT01400477|5863869|P2|STARTED|Overall Study||40
2390010|NCT01400477|5863870|P1|STARTED|Overall Study||40
2390011|NCT01400451|5863881|P3|NOT COMPLETED|Combination Treatment (or Intended)||2
2390012|NCT01400451|5863882|P2|NOT COMPLETED|Combination Treatment (or Intended)||4
2390013|NCT01400451|5863883|P1|NOT COMPLETED|Combination Treatment (or Intended)||6
2390014|NCT01400451|5863881|P3|COMPLETED|Combination Treatment (or Intended)||0
2390015|NCT01400451|5863882|P2|COMPLETED|Combination Treatment (or Intended)||0
2390016|NCT01400451|5863883|P1|COMPLETED|Combination Treatment (or Intended)||0
2390017|NCT01400451|5863881|P3|STARTED|Combination Treatment (or Intended)|Did not start Ipilimumab but remained on vemurafenib alone.|2
2390018|NCT01400451|5863882|P2|STARTED|Combination Treatment (or Intended)||4
2390019|NCT01400451|5863883|P1|STARTED|Combination Treatment (or Intended)||6
2390020|NCT01400451|5863881|P3|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
2390021|NCT01400451|5863882|P2|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
2390022|NCT01400451|5863883|P1|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
2390023|NCT01400451|5863881|P3|COMPLETED|28 Day Lead In With Vemurafenib Alone||2
2390024|NCT01400451|5863882|P2|COMPLETED|28 Day Lead In With Vemurafenib Alone||4
2390025|NCT01400451|5863883|P1|COMPLETED|28 Day Lead In With Vemurafenib Alone||6
2390026|NCT01400451|5863881|P3|STARTED|28 Day Lead In With Vemurafenib Alone||2
2390027|NCT01400451|5863882|P2|STARTED|28 Day Lead In With Vemurafenib Alone||4
2390028|NCT01400451|5863883|P1|STARTED|28 Day Lead In With Vemurafenib Alone||6
2390029|NCT01400425|5863897|P1|NOT COMPLETED|Overall Study||10
2390030|NCT01400425|5863897|P1|COMPLETED|Overall Study||229
2390031|NCT01400425|5863897|P1|STARTED|Overall Study||239
2390032|NCT01400412|5863910|P2|NOT COMPLETED|Overall Study||17
2390033|NCT01400412|5863911|P1|NOT COMPLETED|Overall Study||10
2390034|NCT01400412|5863910|P2|COMPLETED|Overall Study||115
2390035|NCT01400412|5863911|P1|COMPLETED|Overall Study||120
2390036|NCT01400412|5863910|P2|STARTED|Overall Study||132
2390037|NCT01400412|5863911|P1|STARTED|Overall Study||130
2390038|NCT01400243|5863957|P2|NOT COMPLETED|Overall Study||11
2390039|NCT01400243|5863958|P1|NOT COMPLETED|Overall Study||8
2390040|NCT01400243|5863957|P2|COMPLETED|Overall Study||52
2390041|NCT01400243|5863958|P1|COMPLETED|Overall Study||56
2390042|NCT01400243|5863957|P2|STARTED|Overall Study||63
2390043|NCT01400243|5863958|P1|STARTED|Overall Study||64
2390044|NCT01400139|5863980|P1|NOT COMPLETED|HYD Extension Period||23
2390045|NCT01400139|5863980|P1|COMPLETED|HYD Extension Period||83
2390046|NCT01400139|5863980|P1|STARTED|HYD Extension Period|Subjects completing the Core Study were offered an option to enter the 24-week open-label Extension|106
2390047|NCT01400139|5863980|P1|NOT COMPLETED|HYD Core Study||512
2390048|NCT01400139|5863980|P1|COMPLETED|HYD Core Study||410
2390049|NCT01400139|5863980|P1|STARTED|HYD Core Study||922
2390050|NCT01400113|5864003|P2|NOT COMPLETED|Overall Study||1
2390051|NCT01400113|5864004|P1|NOT COMPLETED|Overall Study||1
2390052|NCT01400113|5864003|P2|COMPLETED|Overall Study||59
2390053|NCT01400113|5864004|P1|COMPLETED|Overall Study||59
2390054|NCT01400113|5864003|P2|STARTED|Overall Study||60
2390055|NCT01400113|5864004|P1|STARTED|Overall Study||60
2390056|NCT01399905|5864012|P2|NOT COMPLETED|Overall Study||1
2390057|NCT01399905|5864013|P1|NOT COMPLETED|Overall Study||1
2390058|NCT01399905|5864012|P2|COMPLETED|Overall Study|Subject was treated at least one dose of carbidopa before withdrawing from the study.|6
2390059|NCT01399905|5864013|P1|COMPLETED|Overall Study|Subject withdrew from the study before receiving treatment.|6
2390060|NCT01399905|5864012|P2|STARTED|Overall Study||7
2390061|NCT01399905|5864013|P1|STARTED|Overall Study||7
2390062|NCT01399866|5864027|P2|NOT COMPLETED|Overall Study||2
2390063|NCT01399866|5864028|P1|NOT COMPLETED|Overall Study||4
2390064|NCT01399866|5864027|P2|COMPLETED|Overall Study||28
2390065|NCT01399866|5864028|P1|COMPLETED|Overall Study||28
2390066|NCT01399866|5864027|P2|STARTED|Overall Study||30
2390067|NCT01399866|5864028|P1|STARTED|Overall Study||32
2390068|NCT01399827|5864046|P2|NOT COMPLETED|Overall Study||0
2390069|NCT01399827|5864047|P1|NOT COMPLETED|Overall Study||0
2390070|NCT01399827|5864046|P2|COMPLETED|Overall Study||1
2390071|NCT01399827|5864047|P1|COMPLETED|Overall Study||1
2390072|NCT01399827|5864046|P2|STARTED|Overall Study||1
2390073|NCT01399827|5864047|P1|STARTED|Overall Study||1
2390074|NCT01399788|5864061|P2|NOT COMPLETED|Second Intervention Period||0
2390075|NCT01399788|5864062|P1|NOT COMPLETED|Second Intervention Period||0
2390076|NCT01399788|5864061|P2|COMPLETED|Second Intervention Period||18
2390077|NCT01399788|5864062|P1|COMPLETED|Second Intervention Period||17
2390078|NCT01399788|5864061|P2|STARTED|Second Intervention Period||18
2390079|NCT01399788|5864062|P1|STARTED|Second Intervention Period||17
2390080|NCT01399788|5864061|P2|NOT COMPLETED|Washout Period (at Least 1 Week)||0
2390081|NCT01399788|5864062|P1|NOT COMPLETED|Washout Period (at Least 1 Week)||0
2390082|NCT01399788|5864061|P2|COMPLETED|Washout Period (at Least 1 Week)||18
2390083|NCT01399788|5864062|P1|COMPLETED|Washout Period (at Least 1 Week)||17
2390084|NCT01399788|5864061|P2|STARTED|Washout Period (at Least 1 Week)||18
2390085|NCT01399788|5864062|P1|STARTED|Washout Period (at Least 1 Week)||17
2390086|NCT01399788|5864061|P2|NOT COMPLETED|First Intervention Period||0
2390087|NCT01399788|5864062|P1|NOT COMPLETED|First Intervention Period||1
2390088|NCT01399788|5864061|P2|COMPLETED|First Intervention Period||18
2390089|NCT01399788|5864062|P1|COMPLETED|First Intervention Period||17
2390090|NCT01399788|5864061|P2|STARTED|First Intervention Period||18
2390091|NCT01399788|5864062|P1|STARTED|First Intervention Period||18
2390092|NCT01399723|5864084|P2|NOT COMPLETED|Overall Study||1
2390093|NCT01399723|5864085|P1|NOT COMPLETED|Overall Study||0
2390094|NCT01399723|5864084|P2|COMPLETED|Overall Study||263
2390095|NCT01399723|5864085|P1|COMPLETED|Overall Study||263
2390096|NCT01399723|5864084|P2|STARTED|Overall Study||264
2390097|NCT01399723|5864085|P1|STARTED|Overall Study||263
2390098|NCT01399697|5864098|P3|NOT COMPLETED|Overall Study||4
2390099|NCT01399697|5864099|P2|NOT COMPLETED|Overall Study||3
2390100|NCT01399697|5864100|P1|NOT COMPLETED|Overall Study||41
2390101|NCT01399697|5864098|P3|COMPLETED|Overall Study||78
2390102|NCT01399697|5864099|P2|COMPLETED|Overall Study||80
2390103|NCT01399697|5864100|P1|COMPLETED|Overall Study||55
2390104|NCT01399697|5864098|P3|STARTED|Overall Study||82
2390105|NCT01399697|5864099|P2|STARTED|Overall Study||83
2390106|NCT01399697|5864100|P1|STARTED|Overall Study||96
2390107|NCT01399619|5864127|P4|NOT COMPLETED|Overall Study||17
2390108|NCT01399619|5864128|P3|NOT COMPLETED|Overall Study||12
2390109|NCT01399619|5864129|P2|NOT COMPLETED|Overall Study||0
2390110|NCT01399619|5864130|P1|NOT COMPLETED|Overall Study||25
2390111|NCT01399619|5864127|P4|COMPLETED|Overall Study||0
2390112|NCT01399619|5864128|P3|COMPLETED|Overall Study||74
2390113|NCT01399619|5864129|P2|COMPLETED|Overall Study||84
2390114|NCT01399619|5864130|P1|COMPLETED|Overall Study||98
2390115|NCT01399619|5864127|P4|STARTED|Overall Study||17
2390116|NCT01399619|5864128|P3|STARTED|Overall Study||86
2390117|NCT01399619|5864129|P2|STARTED|Overall Study||84
2390118|NCT01399619|5864130|P1|STARTED|Overall Study||123
2390119|NCT01399593|5864193|P2|NOT COMPLETED|Overall Study||2
2390120|NCT01399593|5864194|P1|NOT COMPLETED|Overall Study||3
2390121|NCT01399593|5864193|P2|COMPLETED|Overall Study||49
2390122|NCT01399593|5864194|P1|COMPLETED|Overall Study||48
2390123|NCT01399593|5864193|P2|STARTED|Overall Study||51
2390124|NCT01399593|5864194|P1|STARTED|Overall Study||51
2390125|NCT01399268|5864202|P2|NOT COMPLETED|Overall Study||0
2390126|NCT01399268|5864203|P1|NOT COMPLETED|Overall Study||0
2390127|NCT01399268|5864202|P2|COMPLETED|Overall Study||15
2390128|NCT01399268|5864203|P1|COMPLETED|Overall Study||15
2390129|NCT01399268|5864202|P2|STARTED|Overall Study||15
2390130|NCT01399268|5864203|P1|STARTED|Overall Study||15
2390131|NCT01399229|5864221|P3|NOT COMPLETED|Overall Study||0
2390132|NCT01399229|5864222|P2|NOT COMPLETED|Overall Study||0
2390133|NCT01399229|5864223|P1|NOT COMPLETED|Overall Study||0
2390134|NCT01399229|5864221|P3|COMPLETED|Overall Study||5
2390135|NCT01399229|5864222|P2|COMPLETED|Overall Study||5
2390136|NCT01399229|5864223|P1|COMPLETED|Overall Study||20
2390137|NCT01399229|5864221|P3|STARTED|Overall Study||5
2390138|NCT01399229|5864222|P2|STARTED|Overall Study||5
2390139|NCT01399229|5864223|P1|STARTED|Overall Study||20
2390140|NCT01399190|5864227|P1|NOT COMPLETED|Overall Study||20
2390141|NCT01399190|5864227|P1|COMPLETED|Overall Study||48
2390142|NCT01399190|5864227|P1|Evaluable for Primary Endpoint Analysis|Overall Study||60
2390143|NCT01399190|5864227|P1|Included in Final Analysis|Overall Study||63
2390144|NCT01399190|5864227|P1|STARTED|Overall Study||68
2390145|NCT01399125|5864235|P2|NOT COMPLETED|Overall Study||60
2390146|NCT01399125|5864236|P1|NOT COMPLETED|Overall Study||51
2390147|NCT01399125|5864235|P2|COMPLETED|Overall Study||193
2390148|NCT01399125|5864236|P1|COMPLETED|Overall Study||197
2390149|NCT01399125|5864235|P2|Per Protocol (PP) Population|Overall Study||188
2390150|NCT01399125|5864236|P1|Per Protocol (PP) Population|Overall Study||192
2390151|NCT01399125|5864235|P2|STARTED|Overall Study||253
2390152|NCT01399125|5864236|P1|STARTED|Overall Study||248
2390153|NCT01399099|5864250|P1|NOT COMPLETED|Overall Study||31
2390154|NCT01399099|5864250|P1|COMPLETED|Overall Study||36
2390155|NCT01399099|5864250|P1|6 Months|Overall Study||47
2390156|NCT01399099|5864250|P1|STARTED|Overall Study||67
2390157|NCT01399047|5864257|P2|NOT COMPLETED|Overall Study||1
2390158|NCT01399047|5864258|P1|NOT COMPLETED|Overall Study||0
2390159|NCT01399047|5864257|P2|COMPLETED|Overall Study||8
2390160|NCT01399047|5864258|P1|COMPLETED|Overall Study||10
2390161|NCT01399047|5864257|P2|STARTED|Overall Study||9
2390162|NCT01399047|5864258|P1|STARTED|Overall Study||10
2390163|NCT01399008|5864275|P3|NOT COMPLETED|Overall Study||2
2390164|NCT01399008|5864276|P2|NOT COMPLETED|Overall Study||5
2390165|NCT01399008|5864277|P1|NOT COMPLETED|Overall Study||3
2390166|NCT01399008|5864275|P3|COMPLETED|Overall Study||31
2390167|NCT01399008|5864276|P2|COMPLETED|Overall Study||27
2390168|NCT01399008|5864277|P1|COMPLETED|Overall Study||32
2390169|NCT01399008|5864275|P3|STARTED|Overall Study||33
2390170|NCT01399008|5864276|P2|STARTED|Overall Study||32
2390171|NCT01399008|5864277|P1|STARTED|Overall Study||35
2390172|NCT01398982|5864287|P2|NOT COMPLETED|Overall Study||2
2390173|NCT01398982|5864288|P1|NOT COMPLETED|Overall Study||6
2390174|NCT01398982|5864287|P2|COMPLETED|Overall Study||47
2390175|NCT01398982|5864288|P1|COMPLETED|Overall Study||38
2390176|NCT01398982|5864287|P2|STARTED|Overall Study||49
2390177|NCT01398982|5864288|P1|STARTED|Overall Study||44
2390178|NCT01398956|5864294|P1|NOT COMPLETED|Overall Study||10
2390179|NCT01398956|5864294|P1|COMPLETED|Overall Study||34
2390180|NCT01398956|5864294|P1|STARTED|Overall Study||44
2390181|NCT01398943|5864302|P4|NOT COMPLETED|Second Intervention (1 Day)||0
2390182|NCT01398943|5864303|P3|NOT COMPLETED|Second Intervention (1 Day)||0
2390183|NCT01398943|5864304|P2|NOT COMPLETED|Second Intervention (1 Day)||0
2390184|NCT01398943|5864305|P1|NOT COMPLETED|Second Intervention (1 Day)||0
2390185|NCT01398943|5864302|P4|COMPLETED|Second Intervention (1 Day)||15
2390186|NCT01398943|5864303|P3|COMPLETED|Second Intervention (1 Day)||15
2390187|NCT01398943|5864304|P2|COMPLETED|Second Intervention (1 Day)||15
2390188|NCT01398943|5864305|P1|COMPLETED|Second Intervention (1 Day)||15
2390189|NCT01398943|5864302|P4|STARTED|Second Intervention (1 Day)||15
2390190|NCT01398943|5864303|P3|STARTED|Second Intervention (1 Day)||15
2390191|NCT01398943|5864304|P2|STARTED|Second Intervention (1 Day)||15
2390192|NCT01398943|5864305|P1|STARTED|Second Intervention (1 Day)||15
2390193|NCT01398943|5864302|P4|NOT COMPLETED|Washout (2-7 Days)||0
2390194|NCT01398943|5864303|P3|NOT COMPLETED|Washout (2-7 Days)||0
2390195|NCT01398943|5864304|P2|NOT COMPLETED|Washout (2-7 Days)||0
2390196|NCT01398943|5864305|P1|NOT COMPLETED|Washout (2-7 Days)||0
2390197|NCT01398943|5864302|P4|COMPLETED|Washout (2-7 Days)||15
2390198|NCT01398943|5864303|P3|COMPLETED|Washout (2-7 Days)||15
2390199|NCT01398943|5864304|P2|COMPLETED|Washout (2-7 Days)||15
2390200|NCT01398943|5864305|P1|COMPLETED|Washout (2-7 Days)||15
2390201|NCT01398943|5864302|P4|STARTED|Washout (2-7 Days)||15
2390202|NCT01398943|5864303|P3|STARTED|Washout (2-7 Days)||15
2390203|NCT01398943|5864304|P2|STARTED|Washout (2-7 Days)||15
2390204|NCT01398943|5864305|P1|STARTED|Washout (2-7 Days)||15
2390205|NCT01398943|5864302|P4|NOT COMPLETED|First Intervention (1 Day)||0
2390206|NCT01398943|5864303|P3|NOT COMPLETED|First Intervention (1 Day)||0
2390207|NCT01398943|5864304|P2|NOT COMPLETED|First Intervention (1 Day)||0
2390208|NCT01398943|5864305|P1|NOT COMPLETED|First Intervention (1 Day)||0
2390209|NCT01398943|5864302|P4|COMPLETED|First Intervention (1 Day)||15
2390210|NCT01398943|5864303|P3|COMPLETED|First Intervention (1 Day)||15
2390211|NCT01398943|5864304|P2|COMPLETED|First Intervention (1 Day)||15
2390212|NCT01398943|5864305|P1|COMPLETED|First Intervention (1 Day)||15
2390213|NCT01398943|5864302|P4|STARTED|First Intervention (1 Day)||15
2390214|NCT01398943|5864303|P3|STARTED|First Intervention (1 Day)||15
2390215|NCT01398943|5864304|P2|STARTED|First Intervention (1 Day)||15
2390216|NCT01398943|5864305|P1|STARTED|First Intervention (1 Day)||15
2390217|NCT01398852|5864313|P1|NOT COMPLETED|Overall Study||372
2390218|NCT01398852|5864313|P1|COMPLETED|Overall Study||0
2390219|NCT01398852|5864313|P1|STARTED|Overall Study|Due to termination of the study the exact number of participants enrolled is unknown at this time.|372
2390220|NCT01398839|5864319|P2|NOT COMPLETED|Overall Study||0
2390221|NCT01398839|5864320|P1|NOT COMPLETED|Overall Study||0
2390222|NCT01398839|5864319|P2|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|37
2390223|NCT01398839|5864320|P1|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|35
2390224|NCT01398839|5864319|P2|STARTED|Overall Study||37
2390225|NCT01398839|5864320|P1|STARTED|Overall Study||35
2390226|NCT01398787|5864326|P1|NOT COMPLETED|Overall Study||1
2390227|NCT01398787|5864326|P1|COMPLETED|Overall Study||197
2390228|NCT01398787|5864326|P1|STARTED|Overall Study||198
2390229|NCT01398514|5864344|P2|NOT COMPLETED|Overall Study||6
2390230|NCT01398514|5864345|P1|NOT COMPLETED|Overall Study||8
2390231|NCT01398514|5864344|P2|COMPLETED|Overall Study||20
2390232|NCT01398514|5864345|P1|COMPLETED|Overall Study||18
2390233|NCT01398514|5864344|P2|STARTED|Overall Study||26
2390234|NCT01398514|5864345|P1|STARTED|Overall Study||26
2390235|NCT01398475|5864357|P4|NOT COMPLETED|Overall Study||0
2390236|NCT01398475|5864358|P3|NOT COMPLETED|Overall Study||0
2390237|NCT01398475|5864359|P2|NOT COMPLETED|Overall Study||0
2390238|NCT01398475|5864360|P1|NOT COMPLETED|Overall Study||0
2390239|NCT01398475|5864357|P4|COMPLETED|Overall Study||4
2390240|NCT01398475|5864358|P3|COMPLETED|Overall Study||4
2390241|NCT01398475|5864359|P2|COMPLETED|Overall Study||3
2390242|NCT01398475|5864360|P1|COMPLETED|Overall Study||4
2390243|NCT01398475|5864357|P4|Received Fourth Intervention|Overall Study||4
2390244|NCT01398475|5864358|P3|Received Fourth Intervention|Overall Study||4
2390245|NCT01398475|5864359|P2|Received Fourth Intervention|Overall Study||3
2390246|NCT01398475|5864360|P1|Received Fourth Intervention|Overall Study||4
2390247|NCT01398475|5864357|P4|Received Third Intervention|Overall Study||4
2390248|NCT01398475|5864358|P3|Received Third Intervention|Overall Study||4
2390249|NCT01398475|5864359|P2|Received Third Intervention|Overall Study||3
2390250|NCT01398475|5864360|P1|Received Third Intervention|Overall Study||4
2390251|NCT01398475|5864357|P4|Received Second Intervention|Overall Study||4
2390252|NCT01398475|5864358|P3|Received Second Intervention|Overall Study||4
2390253|NCT01398475|5864359|P2|Received Second Intervention|Overall Study||3
2390254|NCT01398475|5864360|P1|Received Second Intervention|Overall Study||4
2390255|NCT01398475|5864357|P4|Received First Intervention|Overall Study||4
2390256|NCT01398475|5864358|P3|Received First Intervention|Overall Study||4
2390257|NCT01398475|5864359|P2|Received First Intervention|Overall Study||3
2390258|NCT01398475|5864360|P1|Received First Intervention|Overall Study||4
2390259|NCT01398475|5864357|P4|STARTED|Overall Study||4
2390260|NCT01398475|5864358|P3|STARTED|Overall Study||4
2390261|NCT01398475|5864359|P2|STARTED|Overall Study||3
2390262|NCT01398475|5864360|P1|STARTED|Overall Study||4
2390263|NCT01398410|5864380|P2|NOT COMPLETED|Overall Study||56
2390264|NCT01398410|5864381|P1|NOT COMPLETED|Overall Study||58
2390265|NCT01398410|5864380|P2|COMPLETED|Overall Study||148
2390266|NCT01398410|5864381|P1|COMPLETED|Overall Study||143
2390267|NCT01398410|5864380|P2|STARTED|Overall Study||204
2390268|NCT01398410|5864381|P1|STARTED|Overall Study|Treated participants (all participants who received at least one dose of rabeprazole).|201
2390269|NCT01398358|5864392|P3|NOT COMPLETED|Overall Study||21
2390270|NCT01398358|5864393|P2|NOT COMPLETED|Overall Study||23
2390271|NCT01398358|5864394|P1|NOT COMPLETED|Overall Study||15
2390272|NCT01398358|5864392|P3|COMPLETED|Overall Study||234
2390273|NCT01398358|5864393|P2|COMPLETED|Overall Study||201
2390274|NCT01398358|5864394|P1|COMPLETED|Overall Study||203
2390275|NCT01398358|5864392|P3|STARTED|Overall Study||255
2390276|NCT01398358|5864393|P2|STARTED|Overall Study||224
2390277|NCT01398358|5864394|P1|STARTED|Overall Study||218
2390278|NCT01398280|5864407|P2|NOT COMPLETED|Overall Study||0
2390279|NCT01398280|5864408|P1|NOT COMPLETED|Overall Study||4
2390280|NCT01398280|5864407|P2|COMPLETED|Overall Study||4
2390281|NCT01398280|5864408|P1|COMPLETED|Overall Study||7
2390282|NCT01398280|5864407|P2|STARTED|Overall Study||4
2390283|NCT01398280|5864408|P1|STARTED|Overall Study||11
2390284|NCT01398176|5864416|P2|NOT COMPLETED|Overall Study||6
2390285|NCT01398176|5864417|P1|NOT COMPLETED|Overall Study||3
2390286|NCT01398176|5864416|P2|COMPLETED|Overall Study||19
2390287|NCT01398176|5864417|P1|COMPLETED|Overall Study||23
2390288|NCT01398176|5864416|P2|STARTED|Overall Study||25
2390289|NCT01398176|5864417|P1|STARTED|Overall Study||26
2390290|NCT01398059|5864423|P6|NOT COMPLETED|Overall Study||0
2390291|NCT01398059|5864424|P5|NOT COMPLETED|Overall Study||0
2390292|NCT01398059|5864425|P4|NOT COMPLETED|Overall Study||0
2390293|NCT01398059|5864426|P3|NOT COMPLETED|Overall Study||0
2390294|NCT01398059|5864427|P2|NOT COMPLETED|Overall Study||0
2390295|NCT01398059|5864428|P1|NOT COMPLETED|Overall Study||0
2390296|NCT01398059|5864423|P6|COMPLETED|Overall Study||2
2390297|NCT01398059|5864424|P5|COMPLETED|Overall Study||4
2390298|NCT01398059|5864425|P4|COMPLETED|Overall Study||2
2390299|NCT01398059|5864426|P3|COMPLETED|Overall Study||4
2390300|NCT01398059|5864427|P2|COMPLETED|Overall Study||3
2390301|NCT01398059|5864428|P1|COMPLETED|Overall Study||4
2390302|NCT01398059|5864423|P6|STARTED|Overall Study||2
2390303|NCT01398059|5864424|P5|STARTED|Overall Study||4
2390304|NCT01398059|5864425|P4|STARTED|Overall Study||2
2390305|NCT01398059|5864426|P3|STARTED|Overall Study||4
2390306|NCT01398059|5864427|P2|STARTED|Overall Study||3
2390307|NCT01398059|5864428|P1|STARTED|Overall Study||4
2390308|NCT01397890|5864450|P2|NOT COMPLETED|Overall Study||31
2390309|NCT01397890|5864451|P1|NOT COMPLETED|Overall Study||23
2390310|NCT01397890|5864450|P2|COMPLETED|Overall Study||260
2390311|NCT01397890|5864451|P1|COMPLETED|Overall Study||264
2390312|NCT01397890|5864450|P2|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =291+1-3=289.|287
2390313|NCT01397890|5864451|P1|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =287+3-1=289. 3 and 1 pts in respective groups received opposite treatment.|286
2390314|NCT01397890|5864450|P2|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|290
2390315|NCT01397890|5864451|P1|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|287
2390316|NCT01397890|5864450|P2|STARTED|Overall Study||291
2390317|NCT01397890|5864451|P1|STARTED|Overall Study||287
2390318|NCT01397851|5864505|P2|NOT COMPLETED|Overall Study||46
2390319|NCT01397851|5864506|P1|NOT COMPLETED|Overall Study||79
2390320|NCT01397851|5864505|P2|COMPLETED|Overall Study||39917
2390321|NCT01397851|5864506|P1|COMPLETED|Overall Study||41555
2390322|NCT01397851|5864505|P2|STARTED|Overall Study||39963
2390323|NCT01397851|5864506|P1|STARTED|Overall Study||41634
2390324|NCT01397825|5864522|P5|NOT COMPLETED|Overall Study||0
2390325|NCT01397825|5864523|P4|NOT COMPLETED|Overall Study||3
2390326|NCT01397825|5864524|P3|NOT COMPLETED|Overall Study||25
2390327|NCT01397825|5864525|P2|NOT COMPLETED|Overall Study||4
2390328|NCT01397825|5864526|P1|NOT COMPLETED|Overall Study||13
2390329|NCT01397825|5864522|P5|COMPLETED|Overall Study||0
2390330|NCT01397825|5864523|P4|COMPLETED|Overall Study||0
2390331|NCT01397825|5864524|P3|COMPLETED|Overall Study||0
2390332|NCT01397825|5864525|P2|COMPLETED|Overall Study||0
2390333|NCT01397825|5864526|P1|COMPLETED|Overall Study||0
2390334|NCT01397825|5864522|P5|STARTED|Overall Study||0
2390335|NCT01397825|5864523|P4|STARTED|Overall Study||3
2390336|NCT01397825|5864524|P3|STARTED|Overall Study||25
2390337|NCT01397825|5864525|P2|STARTED|Overall Study||4
2390338|NCT01397825|5864526|P1|STARTED|Overall Study||13
2390339|NCT01397786|5864596|P3|NOT COMPLETED|Phase B||138
2390340|NCT01397786|5864597|P2|NOT COMPLETED|Phase B||95
2390341|NCT01397786|5864598|P1|NOT COMPLETED|Phase B||303
2390342|NCT01397786|5864596|P3|COMPLETED|Phase B||91
2390343|NCT01397786|5864597|P2|COMPLETED|Phase B||109
2390344|NCT01397786|5864598|P1|COMPLETED|Phase B||308
2390345|NCT01397786|5864596|P3|STARTED|Phase B||229
2390346|NCT01397786|5864597|P2|STARTED|Phase B||204
2390347|NCT01397786|5864598|P1|STARTED|Phase B||611
2390348|NCT01397786|5864596|P3|NOT COMPLETED|Phase A||28
2390349|NCT01397786|5864597|P2|NOT COMPLETED|Phase A||0
2390350|NCT01397786|5864598|P1|NOT COMPLETED|Phase A||0
2390351|NCT01397786|5864596|P3|COMPLETED|Phase A||199
2390352|NCT01397786|5864597|P2|COMPLETED|Phase A||0
2390353|NCT01397786|5864598|P1|COMPLETED|Phase A||12
2390354|NCT01397786|5864596|P3|STARTED|Phase A||227
2390355|NCT01397786|5864597|P2|STARTED|Phase A||0
2390356|NCT01397786|5864598|P1|STARTED|Phase A|Subjects in NCT01668797 Phase A at IA-related study termination rolled over to NCT01397786 Phase A.|12
2390357|NCT01397747|5864664|P1|NOT COMPLETED|Overall Study||1027
2390358|NCT01397747|5864664|P1|COMPLETED|Overall Study||9989
2390359|NCT01397747|5864664|P1|STARTED|Overall Study||11016
2390360|NCT01397695|5864669|P1|NOT COMPLETED|Overall Study||0
2390361|NCT01397695|5864669|P1|COMPLETED|Overall Study||0
2390362|NCT01397695|5864669|P1|STARTED|Overall Study||0
2390363|NCT01397656|5864675|P2|NOT COMPLETED|Overall Study||0
2390364|NCT01397656|5864676|P1|NOT COMPLETED|Overall Study||0
2390365|NCT01397656|5864675|P2|COMPLETED|Overall Study||30
2390366|NCT01397656|5864676|P1|COMPLETED|Overall Study||33
2390367|NCT01397656|5864675|P2|STARTED|Overall Study||30
2390368|NCT01397656|5864676|P1|STARTED|Overall Study||33
2390369|NCT01397617|5864691|P3|NOT COMPLETED|Overall Study||29
2390370|NCT01397617|5864692|P2|NOT COMPLETED|Overall Study||23
2390371|NCT01397617|5864693|P1|NOT COMPLETED|Overall Study||31
2390372|NCT01397617|5864691|P3|COMPLETED|Overall Study||31
2390373|NCT01397617|5864692|P2|COMPLETED|Overall Study||30
2390374|NCT01397617|5864693|P1|COMPLETED|Overall Study||33
2390375|NCT01397617|5864691|P3|STARTED|Overall Study||60
2390376|NCT01397617|5864692|P2|STARTED|Overall Study||53
2390377|NCT01397617|5864693|P1|STARTED|Overall Study||64
2390378|NCT01397591|5864704|P1|NOT COMPLETED|Overall Study||0
2390379|NCT01397591|5864704|P1|COMPLETED|Overall Study||2
2390380|NCT01397591|5864704|P1|STARTED|Overall Study||2
2390381|NCT01397552|5864714|P2|NOT COMPLETED|Overall Study||1
2390382|NCT01397552|5864715|P1|NOT COMPLETED|Overall Study||3
2390383|NCT01397552|5864714|P2|COMPLETED|Overall Study||3
2390384|NCT01397552|5864715|P1|COMPLETED|Overall Study||1
2390385|NCT01397552|5864714|P2|STARTED|Overall Study||4
2390386|NCT01397552|5864715|P1|STARTED|Overall Study||4
2390387|NCT01397461|5864724|P3|NOT COMPLETED|Overall Study||2
2390388|NCT01397461|5864725|P2|NOT COMPLETED|Overall Study||6
2390389|NCT01397461|5864726|P1|NOT COMPLETED|Overall Study||2
2390390|NCT01397461|5864724|P3|COMPLETED|Overall Study||152
2390391|NCT01397461|5864725|P2|COMPLETED|Overall Study||150
2390392|NCT01397461|5864726|P1|COMPLETED|Overall Study||153
2390393|NCT01397461|5864724|P3|STARTED|Overall Study||154
2390394|NCT01397461|5864725|P2|STARTED|Overall Study||156
2390395|NCT01397461|5864726|P1|STARTED|Overall Study||155
2390396|NCT01397448|5864737|P3|NOT COMPLETED|Overall Study||18
2390397|NCT01397448|5864738|P2|NOT COMPLETED|Overall Study||15
2390398|NCT01397448|5864739|P1|NOT COMPLETED|Overall Study||18
2390399|NCT01397448|5864737|P3|COMPLETED|Overall Study||140
2390400|NCT01397448|5864738|P2|COMPLETED|Overall Study||142
2390401|NCT01397448|5864739|P1|COMPLETED|Overall Study||138
2390402|NCT01397448|5864737|P3|STARTED|Overall Study||158
2390403|NCT01397448|5864738|P2|STARTED|Overall Study|158 participants were randomized but 1 participant was not treated with drug.|157
2390404|NCT01397448|5864739|P1|STARTED|Overall Study||156
2390405|NCT01397422|5864754|P4|NOT COMPLETED|Overall Study||8
2390406|NCT01397422|5864755|P3|NOT COMPLETED|Overall Study||3
2390407|NCT01397422|5864756|P2|NOT COMPLETED|Overall Study||3
2390408|NCT01397422|5864757|P1|NOT COMPLETED|Overall Study||2
2390409|NCT01397422|5864754|P4|COMPLETED|Overall Study||12
2390410|NCT01397422|5864755|P3|COMPLETED|Overall Study|AE = adverse event; eGFR = estimated glomerular filtration rate|18
2390411|NCT01397422|5864756|P2|COMPLETED|Overall Study||17
2390412|NCT01397422|5864757|P1|COMPLETED|Overall Study||20
2390413|NCT01397422|5864754|P4|STARTED|Overall Study||20
2390414|NCT01397422|5864755|P3|STARTED|Overall Study|Of the 3 participants who discontinued, 1 withdrew due to both an AE and an eGFR < 50 mL/min/1.73m^2|21
2390415|NCT01397422|5864756|P2|STARTED|Overall Study||20
2390416|NCT01397422|5864757|P1|STARTED|Overall Study||22
2390417|NCT01397409|5864797|P10|NOT COMPLETED|Stage 3||0
2390418|NCT01397409|5864798|P9|NOT COMPLETED|Stage 3||0
2390419|NCT01397409|5864799|P8|NOT COMPLETED|Stage 3||2
2390420|NCT01397409|5864800|P7|NOT COMPLETED|Stage 3||0
2390421|NCT01397409|5864801|P6|NOT COMPLETED|Stage 3||0
2390422|NCT01397409|5864802|P5|NOT COMPLETED|Stage 3||0
2390423|NCT01397409|5864803|P4|NOT COMPLETED|Stage 3||0
2390424|NCT01397409|5864804|P3|NOT COMPLETED|Stage 3||0
2390425|NCT01397409|5864805|P2|NOT COMPLETED|Stage 3||0
2390426|NCT01397409|5864806|P1|NOT COMPLETED|Stage 3||0
2390427|NCT01397409|5864797|P10|COMPLETED|Stage 3||16
2390428|NCT01397409|5864798|P9|COMPLETED|Stage 3||25
2390429|NCT01397409|5864799|P8|COMPLETED|Stage 3||21
2390430|NCT01397409|5864800|P7|COMPLETED|Stage 3||0
2390431|NCT01397409|5864801|P6|COMPLETED|Stage 3||0
2390432|NCT01397409|5864802|P5|COMPLETED|Stage 3||0
2390433|NCT01397409|5864803|P4|COMPLETED|Stage 3||0
2390434|NCT01397409|5864804|P3|COMPLETED|Stage 3||0
2390435|NCT01397409|5864805|P2|COMPLETED|Stage 3||0
2390436|NCT01397409|5864806|P1|COMPLETED|Stage 3||0
2390437|NCT01397409|5864797|P10|STARTED|Stage 3||16
2390438|NCT01397409|5864798|P9|STARTED|Stage 3||25
2390439|NCT01397409|5864799|P8|STARTED|Stage 3||23
2390440|NCT01397409|5864800|P7|STARTED|Stage 3||0
2390441|NCT01397409|5864801|P6|STARTED|Stage 3||0
2390442|NCT01397409|5864802|P5|STARTED|Stage 3||0
2390443|NCT01397409|5864803|P4|STARTED|Stage 3||0
2390444|NCT01397409|5864804|P3|STARTED|Stage 3||0
2390445|NCT01397409|5864805|P2|STARTED|Stage 3||0
2390446|NCT01397409|5864806|P1|STARTED|Stage 3||0
2390447|NCT01397409|5864797|P10|NOT COMPLETED|Stage 2||0
2390448|NCT01397409|5864798|P9|NOT COMPLETED|Stage 2||0
2390449|NCT01397409|5864799|P8|NOT COMPLETED|Stage 2||0
2390450|NCT01397409|5864800|P7|NOT COMPLETED|Stage 2||0
2390451|NCT01397409|5864801|P6|NOT COMPLETED|Stage 2||4
2390452|NCT01397409|5864802|P5|NOT COMPLETED|Stage 2||8
2390453|NCT01397409|5864803|P4|NOT COMPLETED|Stage 2||0
2390454|NCT01397409|5864804|P3|NOT COMPLETED|Stage 2||0
2390455|NCT01397409|5864805|P2|NOT COMPLETED|Stage 2||0
2390456|NCT01397409|5864806|P1|NOT COMPLETED|Stage 2||0
2390457|NCT01397409|5864797|P10|COMPLETED|Stage 2||0
2390458|NCT01397409|5864798|P9|COMPLETED|Stage 2||0
2390459|NCT01397409|5864799|P8|COMPLETED|Stage 2||0
2390460|NCT01397409|5864800|P7|COMPLETED|Stage 2||58
2390461|NCT01397409|5864801|P6|COMPLETED|Stage 2||54
2390462|NCT01397409|5864802|P5|COMPLETED|Stage 2||59
2390463|NCT01397409|5864803|P4|COMPLETED|Stage 2||0
2390464|NCT01397409|5864804|P3|COMPLETED|Stage 2||0
2390465|NCT01397409|5864805|P2|COMPLETED|Stage 2||0
2390466|NCT01397409|5864806|P1|COMPLETED|Stage 2||0
2390467|NCT01397409|5864797|P10|STARTED|Stage 2||0
2390468|NCT01397409|5864798|P9|STARTED|Stage 2||0
2390469|NCT01397409|5864799|P8|STARTED|Stage 2||0
2390470|NCT01397409|5864800|P7|STARTED|Stage 2||58
2390471|NCT01397409|5864801|P6|STARTED|Stage 2||58
2390472|NCT01397409|5864802|P5|STARTED|Stage 2||67
2390473|NCT01397409|5864803|P4|STARTED|Stage 2||0
2390474|NCT01397409|5864804|P3|STARTED|Stage 2||0
2390475|NCT01397409|5864805|P2|STARTED|Stage 2||0
2390476|NCT01397409|5864806|P1|STARTED|Stage 2||0
2390477|NCT01397409|5864797|P10|NOT COMPLETED|Stage 1||0
2390478|NCT01397409|5864798|P9|NOT COMPLETED|Stage 1||0
2390479|NCT01397409|5864799|P8|NOT COMPLETED|Stage 1||0
2390480|NCT01397409|5864800|P7|NOT COMPLETED|Stage 1||0
2390481|NCT01397409|5864801|P6|NOT COMPLETED|Stage 1||0
2390482|NCT01397409|5864802|P5|NOT COMPLETED|Stage 1||0
2390483|NCT01397409|5864803|P4|NOT COMPLETED|Stage 1||0
2390484|NCT01397409|5864804|P3|NOT COMPLETED|Stage 1||0
2390485|NCT01397409|5864805|P2|NOT COMPLETED|Stage 1||0
2390486|NCT01397409|5864806|P1|NOT COMPLETED|Stage 1||0
2390487|NCT01397409|5864797|P10|COMPLETED|Stage 1||0
2390488|NCT01397409|5864798|P9|COMPLETED|Stage 1||0
2390489|NCT01397409|5864799|P8|COMPLETED|Stage 1||0
2390490|NCT01397409|5864800|P7|COMPLETED|Stage 1||0
2390491|NCT01397409|5864801|P6|COMPLETED|Stage 1||0
2390492|NCT01397409|5864802|P5|COMPLETED|Stage 1||0
2390493|NCT01397409|5864803|P4|COMPLETED|Stage 1||3
2390494|NCT01397409|5864804|P3|COMPLETED|Stage 1||6
2390495|NCT01397409|5864805|P2|COMPLETED|Stage 1||6
2390496|NCT01397409|5864806|P1|COMPLETED|Stage 1||9
2390497|NCT01397409|5864797|P10|STARTED|Stage 1||0
2390498|NCT01397409|5864798|P9|STARTED|Stage 1||0
2390499|NCT01397409|5864799|P8|STARTED|Stage 1||0
2390500|NCT01397409|5864800|P7|STARTED|Stage 1||0
2390501|NCT01397409|5864801|P6|STARTED|Stage 1||0
2390502|NCT01397409|5864802|P5|STARTED|Stage 1||0
2390503|NCT01397409|5864803|P4|STARTED|Stage 1||3
2390504|NCT01397409|5864804|P3|STARTED|Stage 1||6
2390505|NCT01397409|5864805|P2|STARTED|Stage 1||6
2390506|NCT01397409|5864806|P1|STARTED|Stage 1||9
2390507|NCT01397253|5864846|P2|NOT COMPLETED|Overall Study||149
2390508|NCT01397253|5864847|P1|NOT COMPLETED|Overall Study||126
2390509|NCT01397253|5864846|P2|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|243
2390510|NCT01397253|5864847|P1|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|317
2390511|NCT01397253|5864846|P2|STARTED|Overall Study||392
2390512|NCT01397253|5864847|P1|STARTED|Overall Study||443
2390513|NCT01397084|5864853|P1|NOT COMPLETED|Overall Study||8
2390514|NCT01397084|5864853|P1|COMPLETED|Overall Study||100
2390515|NCT01397084|5864853|P1|STARTED|Overall Study||108
2390516|NCT01397071|5864860|P1|NOT COMPLETED|Consumption of Beef Patty With Avocado||0
2390517|NCT01397071|5864860|P1|COMPLETED|Consumption of Beef Patty With Avocado||11
2390518|NCT01397071|5864860|P1|STARTED|Consumption of Beef Patty With Avocado||11
2390519|NCT01397071|5864860|P1|NOT COMPLETED|Consumption of Beef Patty Alone||0
2390520|NCT01397071|5864860|P1|COMPLETED|Consumption of Beef Patty Alone||11
2390521|NCT01397071|5864860|P1|STARTED|Consumption of Beef Patty Alone||11
2390522|NCT01396551|5864868|P1|NOT COMPLETED|Overall Study||0
2390523|NCT01396551|5864868|P1|COMPLETED|Overall Study||69
2390524|NCT01396551|5864868|P1|STARTED|Overall Study||69
2390525|NCT01396525|5864872|P1|NOT COMPLETED|Overall Study||26
2390526|NCT01396525|5864872|P1|COMPLETED|Overall Study||127
2390527|NCT01396525|5864872|P1|STARTED|Overall Study||153
2390528|NCT01396512|5864972|P2|NOT COMPLETED|Overall Study||1
2390529|NCT01396512|5864973|P1|NOT COMPLETED|Overall Study||0
2390530|NCT01396512|5864972|P2|COMPLETED|Overall Study||136
2390531|NCT01396512|5864973|P1|COMPLETED|Overall Study||137
2390532|NCT01396512|5864972|P2|STARTED|Overall Study||137
2390533|NCT01396512|5864973|P1|STARTED|Overall Study||137
2390534|NCT01396447|5864989|P4|NOT COMPLETED|Overall Study||52
2390535|NCT01396447|5864990|P3|NOT COMPLETED|Overall Study||30
2390536|NCT01396447|5864991|P2|NOT COMPLETED|Overall Study||40
2390537|NCT01396447|5864992|P1|NOT COMPLETED|Overall Study||43
2390538|NCT01396447|5864989|P4|COMPLETED|Overall Study||94
2390539|NCT01396447|5864990|P3|COMPLETED|Overall Study||117
2390540|NCT01396447|5864991|P2|COMPLETED|Overall Study||103
2390541|NCT01396447|5864992|P1|COMPLETED|Overall Study||105
2390542|NCT01396447|5864989|P4|Received Treatment|Overall Study||146
2390543|NCT01396447|5864990|P3|Received Treatment|Overall Study||146
2390544|NCT01396447|5864991|P2|Received Treatment|Overall Study||141
2390545|NCT01396447|5864992|P1|Received Treatment|Overall Study||145
2390546|NCT01396447|5864989|P4|STARTED|Overall Study||146
2390547|NCT01396447|5864990|P3|STARTED|Overall Study||147
2390548|NCT01396447|5864991|P2|STARTED|Overall Study||143
2390549|NCT01396447|5864992|P1|STARTED|Overall Study||148
2390550|NCT01396434|5865009|P3|NOT COMPLETED|Overall Study||0
2390551|NCT01396434|5865010|P2|NOT COMPLETED|Overall Study||0
2390552|NCT01396434|5865011|P1|NOT COMPLETED|Overall Study||11
2390553|NCT01396434|5865009|P3|COMPLETED|Overall Study||14
2390554|NCT01396434|5865010|P2|COMPLETED|Overall Study||175
2390555|NCT01396434|5865011|P1|COMPLETED|Overall Study||2806
2390556|NCT01396434|5865009|P3|STARTED|Overall Study||14
2390557|NCT01396434|5865010|P2|STARTED|Overall Study||175
2390558|NCT01396434|5865011|P1|STARTED|Overall Study||2817
2390559|NCT01396421|5865023|P4|NOT COMPLETED|Overall Study||75
2390560|NCT01396421|5865024|P3|NOT COMPLETED|Overall Study||34
2390561|NCT01396421|5865025|P2|NOT COMPLETED|Overall Study||58
2390562|NCT01396421|5865026|P1|NOT COMPLETED|Overall Study||59
2390563|NCT01396421|5865023|P4|COMPLETED|Overall Study||109
2390564|NCT01396421|5865024|P3|COMPLETED|Overall Study||56
2390565|NCT01396421|5865025|P2|COMPLETED|Overall Study||124
2390566|NCT01396421|5865026|P1|COMPLETED|Overall Study||121
2390567|NCT01396421|5865023|P4|STARTED|Overall Study||184
2390568|NCT01396421|5865024|P3|STARTED|Overall Study||90
2390569|NCT01396421|5865025|P2|STARTED|Overall Study||182
2390570|NCT01396421|5865026|P1|STARTED|Overall Study||180
2390571|NCT01396395|5865098|P2|NOT COMPLETED|Overall Study||27
2390572|NCT01396395|5865099|P1|NOT COMPLETED|Overall Study||40
2390573|NCT01396395|5865098|P2|COMPLETED|Overall Study||175
2390574|NCT01396395|5865099|P1|COMPLETED|Overall Study||160
2390575|NCT01396395|5865098|P2|Safety Analysis Set|Overall Study|4 subjects randomized to standard+nicorandil were included in standard as no nicorandil was received|205
2390576|NCT01396395|5865099|P1|Safety Analysis Set|Overall Study|1 subject randomized to standard was included in standard+nicorandil as nicorandil was received.|197
2390577|NCT01396395|5865098|P2|STARTED|Overall Study||202
2390578|NCT01396395|5865099|P1|STARTED|Overall Study||200
2390579|NCT01396382|5865134|P1|NOT COMPLETED|Overall Study||0
2390580|NCT01396382|5865134|P1|COMPLETED|Overall Study||97
2390581|NCT01396382|5865134|P1|STARTED|Overall Study||97
2390582|NCT01396317|5865141|P2|NOT COMPLETED|Overall Study||0
2390583|NCT01396317|5865142|P1|NOT COMPLETED|Overall Study||1
2390584|NCT01396317|5865141|P2|COMPLETED|Overall Study||10
2390585|NCT01396317|5865142|P1|COMPLETED|Overall Study||9
2390586|NCT01396317|5865141|P2|STARTED|Overall Study||10
2390587|NCT01396317|5865142|P1|STARTED|Overall Study||10
2390588|NCT01396265|5865156|P1|NOT COMPLETED|Rifa+Afatinib||1
2390589|NCT01396265|5865156|P1|COMPLETED|Rifa+Afatinib||21
2390590|NCT01396265|5865156|P1|STARTED|Rifa+Afatinib||22
2390591|NCT01396265|5865156|P1|NOT COMPLETED|Washout||0
2390592|NCT01396265|5865156|P1|COMPLETED|Washout||22
2390593|NCT01396265|5865156|P1|STARTED|Washout||22
2390594|NCT01396265|5865156|P1|NOT COMPLETED|Afatinib||0
2390595|NCT01396265|5865156|P1|COMPLETED|Afatinib||22
2390596|NCT01396265|5865156|P1|STARTED|Afatinib||22
2390597|NCT01396239|5865183|P4|NOT COMPLETED|Overall Study||0
2390598|NCT01396239|5865184|P3|NOT COMPLETED|Overall Study||0
2390599|NCT01396239|5865185|P2|NOT COMPLETED|Overall Study||0
2390600|NCT01396239|5865186|P1|NOT COMPLETED|Overall Study||0
2390601|NCT01396239|5865183|P4|COMPLETED|Overall Study||2
2390602|NCT01396239|5865184|P3|COMPLETED|Overall Study||4
2390603|NCT01396239|5865185|P2|COMPLETED|Overall Study||2
2390604|NCT01396239|5865186|P1|COMPLETED|Overall Study||4
2390605|NCT01396239|5865183|P4|STARTED|Overall Study||2
2390606|NCT01396239|5865184|P3|STARTED|Overall Study||4
2390607|NCT01396239|5865185|P2|STARTED|Overall Study||2
2390608|NCT01396239|5865186|P1|STARTED|Overall Study||4
2390609|NCT01396226|5865209|P2|NOT COMPLETED|Overall Study||0
2390610|NCT01396226|5865210|P1|NOT COMPLETED|Overall Study||0
2390611|NCT01396226|5865209|P2|COMPLETED|Overall Study||6
2390612|NCT01396226|5865210|P1|COMPLETED|Overall Study||12
2390613|NCT01396226|5865209|P2|Patients Who Completed Treatment|Overall Study||6
2390614|NCT01396226|5865210|P1|Patients Who Completed Treatment|Overall Study||12
2390615|NCT01396226|5865209|P2|Patients Who Received Treatment|Overall Study||6
2390616|NCT01396226|5865210|P1|Patients Who Received Treatment|Overall Study||12
2390617|NCT01396226|5865209|P2|STARTED|Overall Study||6
2390618|NCT01396226|5865210|P1|STARTED|Overall Study||12
2390619|NCT01396187|5865245|P5|NOT COMPLETED|Overall Study||1
2390620|NCT01396187|5865246|P4|NOT COMPLETED|Overall Study||0
2390621|NCT01396187|5865247|P3|NOT COMPLETED|Overall Study||1
2390622|NCT01396187|5865248|P2|NOT COMPLETED|Overall Study||3
2390623|NCT01396187|5865249|P1|NOT COMPLETED|Overall Study||1
2390624|NCT01396187|5865245|P5|COMPLETED|Overall Study||9
2390625|NCT01396187|5865246|P4|COMPLETED|Overall Study||10
2390626|NCT01396187|5865247|P3|COMPLETED|Overall Study||9
2390627|NCT01396187|5865248|P2|COMPLETED|Overall Study||9
2390628|NCT01396187|5865249|P1|COMPLETED|Overall Study||7
2390629|NCT01396187|5865245|P5|STARTED|Overall Study||10
2390630|NCT01396187|5865246|P4|STARTED|Overall Study||10
2390631|NCT01396187|5865247|P3|STARTED|Overall Study||10
2390632|NCT01396187|5865248|P2|STARTED|Overall Study||12
2390633|NCT01396187|5865249|P1|STARTED|Overall Study||8
2390634|NCT01396161|5865349|P7|NOT COMPLETED|Overall Study||1
2390635|NCT01396161|5865350|P6|NOT COMPLETED|Overall Study||0
2390636|NCT01396161|5865351|P5|NOT COMPLETED|Overall Study||1
2390637|NCT01396161|5865352|P4|NOT COMPLETED|Overall Study||0
2390638|NCT01396161|5865353|P3|NOT COMPLETED|Overall Study||0
2390639|NCT01396161|5865354|P2|NOT COMPLETED|Overall Study||0
2390640|NCT01396161|5865355|P1|NOT COMPLETED|Overall Study||0
2390641|NCT01396161|5865349|P7|COMPLETED|Overall Study||10
2390642|NCT01396161|5865350|P6|COMPLETED|Overall Study||9
2390643|NCT01396161|5865351|P5|COMPLETED|Overall Study||8
2390644|NCT01396161|5865352|P4|COMPLETED|Overall Study||9
2390645|NCT01396161|5865353|P3|COMPLETED|Overall Study||9
2390646|NCT01396161|5865354|P2|COMPLETED|Overall Study||5
2390647|NCT01396161|5865355|P1|COMPLETED|Overall Study||12
2390648|NCT01396161|5865349|P7|STARTED|Overall Study||11
2390649|NCT01396161|5865350|P6|STARTED|Overall Study||9
2390650|NCT01396161|5865351|P5|STARTED|Overall Study||9
2390651|NCT01396161|5865352|P4|STARTED|Overall Study||9
2390652|NCT01396161|5865353|P3|STARTED|Overall Study||9
2390653|NCT01396161|5865354|P2|STARTED|Overall Study||5
2390654|NCT01396161|5865355|P1|STARTED|Overall Study||12
2390655|NCT01396148|5865408|P1|NOT COMPLETED|Overall Study||1
2390656|NCT01396148|5865408|P1|COMPLETED|Overall Study||5
2390657|NCT01396148|5865408|P1|STARTED|Overall Study||6
2390658|NCT01396083|5865438|P2|NOT COMPLETED|Overall Study||47
2390659|NCT01396083|5865439|P1|NOT COMPLETED|Overall Study||11
2390660|NCT01396083|5865438|P2|COMPLETED|Overall Study||72
2390661|NCT01396083|5865439|P1|COMPLETED|Overall Study||113
2390662|NCT01396083|5865438|P2|STARTED|Overall Study||119
2390663|NCT01396083|5865439|P1|STARTED|Overall Study||124
2390664|NCT01396070|5865463|P1|NOT COMPLETED|Overall Study||19
2390665|NCT01396070|5865463|P1|COMPLETED|Overall Study||17
2390666|NCT01396070|5865463|P1|STARTED|Overall Study||36
2390667|NCT01396057|5865472|P2|NOT COMPLETED|Overall Study||18
2390668|NCT01396057|5865473|P1|NOT COMPLETED|Overall Study||11
2390669|NCT01396057|5865472|P2|COMPLETED|Overall Study||100
2390670|NCT01396057|5865473|P1|COMPLETED|Overall Study||115
2390671|NCT01396057|5865472|P2|STARTED|Overall Study||118
2390672|NCT01396057|5865473|P1|STARTED|Overall Study||126
2390673|NCT01396044|5865499|P2|NOT COMPLETED|Overall Study||0
2390674|NCT01396044|5865500|P1|NOT COMPLETED|Overall Study||0
2390675|NCT01396044|5865499|P2|COMPLETED|Overall Study||171
2390676|NCT01396044|5865500|P1|COMPLETED|Overall Study||125
2390677|NCT01396044|5865499|P2|STARTED|Overall Study||171
2390678|NCT01396044|5865500|P1|STARTED|Overall Study||125
2390679|NCT01396005|5865522|P2|NOT COMPLETED|Overall Study||2
2390680|NCT01396005|5865523|P1|NOT COMPLETED|Overall Study||0
2390681|NCT01396005|5865522|P2|COMPLETED|Overall Study||9
2390682|NCT01396005|5865523|P1|COMPLETED|Overall Study||10
2390683|NCT01396005|5865522|P2|STARTED|Overall Study||11
2390684|NCT01396005|5865523|P1|STARTED|Overall Study||10
2390685|NCT01395966|5865542|P3|NOT COMPLETED|Overall Study||8
2390686|NCT01395966|5865543|P2|NOT COMPLETED|Overall Study||19
2390687|NCT01395966|5865544|P1|NOT COMPLETED|Overall Study||10
2390688|NCT01395966|5865542|P3|COMPLETED|Overall Study||104
2390689|NCT01395966|5865543|P2|COMPLETED|Overall Study||91
2390690|NCT01395966|5865544|P1|COMPLETED|Overall Study||99
2390691|NCT01395966|5865542|P3|STARTED|Overall Study||112
2390692|NCT01395966|5865543|P2|STARTED|Overall Study||110
2390693|NCT01395966|5865544|P1|STARTED|Overall Study||109
2390694|NCT01395914|5865554|P2|NOT COMPLETED|Overall Study||37
2390695|NCT01395914|5865555|P1|NOT COMPLETED|Overall Study||72
2390696|NCT01395914|5865554|P2|COMPLETED|Overall Study||131
2390697|NCT01395914|5865555|P1|COMPLETED|Overall Study||273
2390698|NCT01395914|5865554|P2|Safety Population|Overall Study||167
2390699|NCT01395914|5865555|P1|Safety Population|Overall Study||343
2390700|NCT01395914|5865554|P2|ITT Population|Overall Study||168
2390701|NCT01395914|5865555|P1|ITT Population|Overall Study||345
2390702|NCT01395914|5865554|P2|STARTED|Overall Study||168
2390703|NCT01395914|5865555|P1|STARTED|Overall Study||345
2390704|NCT01395901|5865569|P2|NOT COMPLETED|Overall Study||5
2390705|NCT01395901|5865570|P1|NOT COMPLETED|Overall Study||10
2390706|NCT01395901|5865569|P2|COMPLETED|Overall Study|Treated patients completing the study|329
2390707|NCT01395901|5865570|P1|COMPLETED|Overall Study|Treated patients completing the study|326
2390708|NCT01395901|5865569|P2|STARTED|Overall Study|Randomized Population|334
2390709|NCT01395901|5865570|P1|STARTED|Overall Study|Randomized Population|336
2390710|NCT01395888|5865586|P3|NOT COMPLETED|Treatment Period (TP)||17
2390711|NCT01395888|5865587|P2|NOT COMPLETED|Treatment Period (TP)||15
2390712|NCT01395888|5865588|P1|NOT COMPLETED|Treatment Period (TP)||0
2390713|NCT01395888|5865586|P3|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|113
2390714|NCT01395888|5865587|P2|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|112
2390715|NCT01395888|5865588|P1|COMPLETED|Treatment Period (TP)||0
2390716|NCT01395888|5865586|P3|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|113
2390717|NCT01395888|5865587|P2|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|112
2390718|NCT01395888|5865588|P1|Completed the Treatment Period|Treatment Period (TP)||0
2390719|NCT01395888|5865586|P3|STARTED|Treatment Period (TP)||130
2390720|NCT01395888|5865587|P2|STARTED|Treatment Period (TP)||127
2390721|NCT01395888|5865588|P1|STARTED|Treatment Period (TP)||0
2390722|NCT01395888|5865586|P3|NOT COMPLETED|2-week Run-in Period||0
2390723|NCT01395888|5865587|P2|NOT COMPLETED|2-week Run-in Period||0
2390724|NCT01395888|5865588|P1|NOT COMPLETED|2-week Run-in Period||22
2390725|NCT01395888|5865586|P3|COMPLETED|2-week Run-in Period||0
2390726|NCT01395888|5865587|P2|COMPLETED|2-week Run-in Period||0
2390727|NCT01395888|5865588|P1|COMPLETED|2-week Run-in Period||257
2390728|NCT01395888|5865586|P3|STARTED|2-week Run-in Period||0
2390729|NCT01395888|5865587|P2|STARTED|2-week Run-in Period||0
2390730|NCT01395888|5865588|P1|STARTED|2-week Run-in Period||279
2390731|NCT01395823|5865596|P2|NOT COMPLETED|Overall Study||9
2390732|NCT01395823|5865597|P1|NOT COMPLETED|Overall Study||15
2390733|NCT01395823|5865596|P2|COMPLETED|Overall Study||130
2390734|NCT01395823|5865597|P1|COMPLETED|Overall Study||122
2390735|NCT01395823|5865596|P2|STARTED|Overall Study||139
2390736|NCT01395823|5865597|P1|STARTED|Overall Study||137
2390737|NCT01395810|5865607|P4|NOT COMPLETED|Overall Study||0
2390738|NCT01395810|5865608|P3|NOT COMPLETED|Overall Study||0
2390739|NCT01395810|5865609|P2|NOT COMPLETED|Overall Study||4
2390740|NCT01395810|5865610|P1|NOT COMPLETED|Overall Study||2
2390741|NCT01395810|5865607|P4|COMPLETED|Overall Study||5
2390742|NCT01395810|5865608|P3|COMPLETED|Overall Study||0
2390743|NCT01395810|5865609|P2|COMPLETED|Overall Study||44
2390744|NCT01395810|5865610|P1|COMPLETED|Overall Study||16
2390745|NCT01395810|5865607|P4|After Switching the Arms|Overall Study||5
2390746|NCT01395810|5865608|P3|After Switching the Arms|Overall Study|No subjects started in this arm initially, 2 patients in 40 IU/kg arm switched to this arm.|2
2390747|NCT01395810|5865609|P2|After Switching the Arms|Overall Study|48 subjects started in this arm, 3 subjects in 10 IU/kg+1 subject in on-demand switched to this arm|52
2390748|NCT01395810|5865610|P1|After Switching the Arms|Overall Study|18 subjects started in this arm and additional 3 subjects from 40 IU/kg switched to this arm|21
2390749|NCT01395810|5865607|P4|STARTED|Overall Study||5
2390750|NCT01395810|5865608|P3|STARTED|Overall Study||0
2390751|NCT01395810|5865609|P2|STARTED|Overall Study||48
2390752|NCT01395810|5865610|P1|STARTED|Overall Study||18
2390753|NCT01395797|5865644|P6|NOT COMPLETED|Overall Study||3
2390754|NCT01395797|5865645|P5|NOT COMPLETED|Overall Study||2
2390755|NCT01395797|5865646|P4|NOT COMPLETED|Overall Study||2
2390756|NCT01395797|5865647|P3|NOT COMPLETED|Overall Study||4
2390757|NCT01395797|5865648|P2|NOT COMPLETED|Overall Study||1
2390758|NCT01395797|5865649|P1|NOT COMPLETED|Overall Study||3
2390759|NCT01395797|5865644|P6|COMPLETED|Overall Study||14
2390760|NCT01395797|5865645|P5|COMPLETED|Overall Study||7
2390761|NCT01395797|5865646|P4|COMPLETED|Overall Study||13
2390762|NCT01395797|5865647|P3|COMPLETED|Overall Study||14
2390763|NCT01395797|5865648|P2|COMPLETED|Overall Study||3
2390764|NCT01395797|5865649|P1|COMPLETED|Overall Study||16
2390765|NCT01395797|5865644|P6|STARTED|Overall Study||17
2390766|NCT01395797|5865645|P5|STARTED|Overall Study||9
2390767|NCT01395797|5865646|P4|STARTED|Overall Study||15
2390768|NCT01395797|5865647|P3|STARTED|Overall Study||18
2390769|NCT01395797|5865648|P2|STARTED|Overall Study||4
2390770|NCT01395797|5865649|P1|STARTED|Overall Study||19
2390771|NCT01395784|5865669|P1|NOT COMPLETED|Overall Study||15
2390772|NCT01395784|5865669|P1|COMPLETED|Overall Study||17
2390773|NCT01395784|5865669|P1|STARTED|Overall Study||32
2390774|NCT01395758|5865676|P3|NOT COMPLETED|Crossover Period||0
2390775|NCT01395758|5865677|P2|NOT COMPLETED|Crossover Period||0
2390776|NCT01395758|5865678|P1|NOT COMPLETED|Crossover Period||0
2390777|NCT01395758|5865676|P3|COMPLETED|Crossover Period||26
2390778|NCT01395758|5865677|P2|COMPLETED|Crossover Period||0
2390779|NCT01395758|5865678|P1|COMPLETED|Crossover Period||0
2390780|NCT01395758|5865676|P3|STARTED|Crossover Period||26
2390781|NCT01395758|5865677|P2|STARTED|Crossover Period||0
2390782|NCT01395758|5865678|P1|STARTED|Crossover Period||0
2390783|NCT01395758|5865676|P3|NOT COMPLETED|Open-label Treatment Period||0
2390784|NCT01395758|5865677|P2|NOT COMPLETED|Open-label Treatment Period||0
2390785|NCT01395758|5865678|P1|NOT COMPLETED|Open-label Treatment Period||4
2390786|NCT01395758|5865676|P3|COMPLETED|Open-label Treatment Period||0
2390787|NCT01395758|5865677|P2|COMPLETED|Open-label Treatment Period||45
2390788|NCT01395758|5865678|P1|COMPLETED|Open-label Treatment Period||47
2390789|NCT01395758|5865676|P3|STARTED|Open-label Treatment Period||0
2390790|NCT01395758|5865677|P2|STARTED|Open-label Treatment Period||45
2390791|NCT01395758|5865678|P1|STARTED|Open-label Treatment Period||51
2390792|NCT01395537|5865689|P1|NOT COMPLETED|Phase II||0
2390793|NCT01395537|5865689|P1|COMPLETED|Phase II||1
2390794|NCT01395537|5865689|P1|STARTED|Phase II||1
2390795|NCT01395537|5865689|P1|NOT COMPLETED|Phase I||0
2390796|NCT01395537|5865689|P1|COMPLETED|Phase I||13
2390797|NCT01395537|5865689|P1|STARTED|Phase I||13
2390798|NCT01395524|5865698|P3|NOT COMPLETED|Overall Study||17
2390799|NCT01395524|5865699|P2|NOT COMPLETED|Overall Study||16
2390800|NCT01395524|5865700|P1|NOT COMPLETED|Overall Study||18
2390801|NCT01395524|5865698|P3|COMPLETED|Overall Study||89
2390802|NCT01395524|5865699|P2|COMPLETED|Overall Study||83
2390803|NCT01395524|5865700|P1|COMPLETED|Overall Study||79
2390804|NCT01395524|5865698|P3|STARTED|Overall Study||106
2390805|NCT01395524|5865699|P2|STARTED|Overall Study||99
2390806|NCT01395524|5865700|P1|STARTED|Overall Study||97
2390807|NCT01395394|5865723|P3|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
2390808|NCT01395394|5865724|P2|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
2390809|NCT01395394|5865725|P1|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
2390810|NCT01395394|5865723|P3|COMPLETED|Study Visit 2 (Non-responders Only)||0
2390811|NCT01395394|5865724|P2|COMPLETED|Study Visit 2 (Non-responders Only)||0
2390812|NCT01395394|5865725|P1|COMPLETED|Study Visit 2 (Non-responders Only)||3
2390813|NCT01395394|5865723|P3|STARTED|Study Visit 2 (Non-responders Only)||0
2390814|NCT01395394|5865724|P2|STARTED|Study Visit 2 (Non-responders Only)||0
2390815|NCT01395394|5865725|P1|STARTED|Study Visit 2 (Non-responders Only)||3
2390816|NCT01395394|5865723|P3|NOT COMPLETED|Baseline Study Visit||0
2390817|NCT01395394|5865724|P2|NOT COMPLETED|Baseline Study Visit||0
2390818|NCT01395394|5865725|P1|NOT COMPLETED|Baseline Study Visit||1
2390819|NCT01395394|5865723|P3|COMPLETED|Baseline Study Visit||5
2390820|NCT01395394|5865724|P2|COMPLETED|Baseline Study Visit||3
2390821|NCT01395394|5865725|P1|COMPLETED|Baseline Study Visit||3
2390822|NCT01395394|5865723|P3|STARTED|Baseline Study Visit||5
2390823|NCT01395394|5865724|P2|STARTED|Baseline Study Visit||3
2390824|NCT01395394|5865725|P1|STARTED|Baseline Study Visit||4
2390825|NCT01395368|5865736|P1|NOT COMPLETED|Overall Study||16
2390826|NCT01395368|5865736|P1|COMPLETED|Overall Study||92
2390827|NCT01395368|5865736|P1|STARTED|Overall Study||108
2390828|NCT01395329|5865743|P3|NOT COMPLETED|Overall Study||0
2390829|NCT01395329|5865744|P2|NOT COMPLETED|Overall Study||0
2390830|NCT01395329|5865745|P1|NOT COMPLETED|Overall Study||0
2390831|NCT01395329|5865743|P3|COMPLETED|Overall Study||14
2390832|NCT01395329|5865744|P2|COMPLETED|Overall Study||14
2390833|NCT01395329|5865745|P1|COMPLETED|Overall Study||14
2390834|NCT01395329|5865743|P3|STARTED|Overall Study||14
2390835|NCT01395329|5865744|P2|STARTED|Overall Study||14
2390836|NCT01395329|5865745|P1|STARTED|Overall Study||14
2390837|NCT01395316|5865792|P1|NOT COMPLETED|Overall Study||3
2390838|NCT01395316|5865792|P1|COMPLETED|Overall Study||5
2390839|NCT01395316|5865792|P1|STARTED|Overall Study||8
2390840|NCT01395277|5865798|P2|NOT COMPLETED|Overall Study||0
2390841|NCT01395277|5865799|P1|NOT COMPLETED|Overall Study||0
2390842|NCT01395277|5865798|P2|COMPLETED|Overall Study||15
2390843|NCT01395277|5865799|P1|COMPLETED|Overall Study||15
2390844|NCT01395277|5865798|P2|STARTED|Overall Study||15
2390845|NCT01395277|5865799|P1|STARTED|Overall Study||15
2390846|NCT01395043|5865807|P1|NOT COMPLETED|Overall Study||0
2390847|NCT01395043|5865807|P1|COMPLETED|Overall Study||15
2390848|NCT01395043|5865807|P1|STARTED|Overall Study||15
2390849|NCT01395030|5865812|P1|NOT COMPLETED|Overall Study||7
2390850|NCT01395030|5865812|P1|COMPLETED|Overall Study||57
2390851|NCT01395030|5865812|P1|Adequate Tissue for Analysis|Overall Study||50
2390852|NCT01395030|5865812|P1|Complete FCH PET/CT|Overall Study||57
2390853|NCT01395030|5865812|P1|STARTED|Overall Study||64
2390854|NCT01395017|5865822|P2|NOT COMPLETED|Overall Study||102
2390855|NCT01395017|5865823|P1|NOT COMPLETED|Overall Study||100
2390856|NCT01395017|5865822|P2|COMPLETED|Overall Study||0
2390857|NCT01395017|5865823|P1|COMPLETED|Overall Study||0
2390858|NCT01395017|5865822|P2|Treated|Overall Study||101
2390859|NCT01395017|5865823|P1|Treated|Overall Study||98
2390860|NCT01395017|5865822|P2|STARTED|Overall Study||102
2390861|NCT01395017|5865823|P1|STARTED|Overall Study||100
2390862|NCT01394991|5865833|P2|NOT COMPLETED|Overall Study||72
2390863|NCT01394991|5865834|P1|NOT COMPLETED|Overall Study||59
2390864|NCT01394991|5865833|P2|COMPLETED|Overall Study||190
2390865|NCT01394991|5865834|P1|COMPLETED|Overall Study||183
2390866|NCT01394991|5865833|P2|STARTED|Overall Study||262
2390867|NCT01394991|5865834|P1|STARTED|Overall Study||242
2390868|NCT01394978|5865856|P2|NOT COMPLETED|Overall Study||31
2390869|NCT01394978|5865857|P1|NOT COMPLETED|Overall Study||21
2390870|NCT01394978|5865856|P2|COMPLETED|Overall Study||245
2390871|NCT01394978|5865857|P1|COMPLETED|Overall Study||147
2390872|NCT01394978|5865856|P2|STARTED|Overall Study||276
2390873|NCT01394978|5865857|P1|STARTED|Overall Study||168
2390874|NCT01394952|5865865|P2|NOT COMPLETED|Overall Study||17
2390875|NCT01394952|5865866|P1|NOT COMPLETED|Overall Study||17
2390876|NCT01394952|5865865|P2|COMPLETED|Overall Study||4932
2390877|NCT01394952|5865866|P1|COMPLETED|Overall Study||4935
2390878|NCT01394952|5865865|P2|Received at Least One Dose of Study Drug|Overall Study||4943
2390879|NCT01394952|5865866|P1|Received at Least One Dose of Study Drug|Overall Study||4949
2390880|NCT01394952|5865865|P2|STARTED|Overall Study||4949
2390881|NCT01394952|5865866|P1|STARTED|Overall Study||4952
2390882|NCT01394926|5865882|P1|NOT COMPLETED|Overall Study||0
2390883|NCT01394926|5865882|P1|COMPLETED|Overall Study||21
2390884|NCT01394926|5865882|P1|STARTED|Overall Study||21
2390885|NCT01394718|5865893|P2|NOT COMPLETED|Overall Study||1
2390886|NCT01394718|5865894|P1|NOT COMPLETED|Overall Study||2
2390887|NCT01394718|5865893|P2|COMPLETED|Overall Study||29
2390888|NCT01394718|5865894|P1|COMPLETED|Overall Study||28
2390889|NCT01394718|5865893|P2|STARTED|Overall Study||30
2390890|NCT01394718|5865894|P1|STARTED|Overall Study||30
2390891|NCT01394705|5865908|P2|NOT COMPLETED|Overall Study||2
2390892|NCT01394705|5865909|P1|NOT COMPLETED|Overall Study||2
2390893|NCT01394705|5865908|P2|COMPLETED|Overall Study||19
2390894|NCT01394705|5865909|P1|COMPLETED|Overall Study||19
2390895|NCT01394705|5865908|P2|STARTED|Overall Study||21
2390896|NCT01394705|5865909|P1|STARTED|Overall Study||21
2390897|NCT01394692|5865919|P2|NOT COMPLETED|Overall Study||0
2390898|NCT01394692|5865920|P1|NOT COMPLETED|Overall Study||0
2390899|NCT01394692|5865919|P2|COMPLETED|Overall Study||29
2390900|NCT01394692|5865920|P1|COMPLETED|Overall Study||29
2390901|NCT01394692|5865919|P2|STARTED|Overall Study||29
2390902|NCT01394692|5865920|P1|STARTED|Overall Study||29
2390903|NCT01394627|5865926|P2|NOT COMPLETED|Second Intervention (1 Day)||0
2390904|NCT01394627|5865927|P1|NOT COMPLETED|Second Intervention (1 Day)||0
2390905|NCT01394627|5865926|P2|COMPLETED|Second Intervention (1 Day)||12
2390906|NCT01394627|5865927|P1|COMPLETED|Second Intervention (1 Day)||7
2390907|NCT01394627|5865926|P2|STARTED|Second Intervention (1 Day)||12
2390908|NCT01394627|5865927|P1|STARTED|Second Intervention (1 Day)||7
2390909|NCT01394627|5865926|P2|NOT COMPLETED|Washout (1-3 Months)||0
2390910|NCT01394627|5865927|P1|NOT COMPLETED|Washout (1-3 Months)||1
2390911|NCT01394627|5865926|P2|COMPLETED|Washout (1-3 Months)||12
2390912|NCT01394627|5865927|P1|COMPLETED|Washout (1-3 Months)||7
2390913|NCT01394627|5865926|P2|STARTED|Washout (1-3 Months)||12
2390914|NCT01394627|5865927|P1|STARTED|Washout (1-3 Months)||8
2390915|NCT01394627|5865926|P2|NOT COMPLETED|First Intervention (1 Day)||1
2390916|NCT01394627|5865927|P1|NOT COMPLETED|First Intervention (1 Day)||0
2390917|NCT01394627|5865926|P2|COMPLETED|First Intervention (1 Day)||12
2390918|NCT01394627|5865927|P1|COMPLETED|First Intervention (1 Day)||8
2390919|NCT01394627|5865926|P2|STARTED|First Intervention (1 Day)||13
2390920|NCT01394627|5865927|P1|STARTED|First Intervention (1 Day)||8
2390921|NCT01394614|5865937|P2|NOT COMPLETED|Overall Study||0
2390922|NCT01394614|5865938|P1|NOT COMPLETED|Overall Study||0
2390923|NCT01394614|5865937|P2|COMPLETED|Overall Study||16
2390924|NCT01394614|5865938|P1|COMPLETED|Overall Study||8
2390925|NCT01394614|5865937|P2|STARTED|Overall Study||16
2390926|NCT01394614|5865938|P1|STARTED|Overall Study||8
2390927|NCT01394523|5865947|P3|NOT COMPLETED|Overall Study||0
2390928|NCT01394523|5865948|P2|NOT COMPLETED|Overall Study||0
2390929|NCT01394523|5865949|P1|NOT COMPLETED|Overall Study||1
2390930|NCT01394523|5865947|P3|COMPLETED|Overall Study||13
2390931|NCT01394523|5865948|P2|COMPLETED|Overall Study||13
2390932|NCT01394523|5865949|P1|COMPLETED|Overall Study||12
2390933|NCT01394523|5865947|P3|STARTED|Overall Study||13
2390934|NCT01394523|5865948|P2|STARTED|Overall Study||13
2390935|NCT01394523|5865949|P1|STARTED|Overall Study||13
2390936|NCT01394510|5865957|P1|NOT COMPLETED|Overall Study||0
2390937|NCT01394510|5865957|P1|COMPLETED|Overall Study||13
2390938|NCT01394510|5865957|P1|STARTED|Overall Study||13
2390939|NCT01394276|5865963|P1|NOT COMPLETED|Overall Study||62
2390940|NCT01394276|5865963|P1|COMPLETED|Overall Study||260
2390941|NCT01394276|5865963|P1|STARTED|Overall Study||322
2390942|NCT01394250|5865987|P2|NOT COMPLETED|Successful IV Placement & Follow-Up||11
2390943|NCT01394250|5865988|P1|NOT COMPLETED|Successful IV Placement & Follow-Up||6
2390944|NCT01394250|5865987|P2|COMPLETED|Successful IV Placement & Follow-Up||110
2390945|NCT01394250|5865988|P1|COMPLETED|Successful IV Placement & Follow-Up||114
2390946|NCT01394250|5865987|P2|STARTED|Successful IV Placement & Follow-Up||121
2390947|NCT01394250|5865988|P1|STARTED|Successful IV Placement & Follow-Up||120
2390948|NCT01394250|5865987|P2|NOT COMPLETED|Randomization and IV Placement Attempt||13
2390949|NCT01394250|5865988|P1|NOT COMPLETED|Randomization and IV Placement Attempt||14
2390950|NCT01394250|5865987|P2|COMPLETED|Randomization and IV Placement Attempt||121
2390951|NCT01394250|5865988|P1|COMPLETED|Randomization and IV Placement Attempt||120
2390952|NCT01394250|5865987|P2|STARTED|Randomization and IV Placement Attempt||134
2390953|NCT01394250|5865988|P1|STARTED|Randomization and IV Placement Attempt||134
2390954|NCT01394211|5865996|P1|NOT COMPLETED|Overall Study||2
2390955|NCT01394211|5865996|P1|COMPLETED|Overall Study||0
2390956|NCT01394211|5865996|P1|STARTED|Overall Study||2
2390957|NCT01394185|5866002|P6|NOT COMPLETED|Overall Study||1
2390958|NCT01394185|5866003|P5|NOT COMPLETED|Overall Study||4
2390959|NCT01394185|5866004|P4|NOT COMPLETED|Overall Study||1
2390960|NCT01394185|5866005|P3|NOT COMPLETED|Overall Study||0
2390961|NCT01394185|5866006|P2|NOT COMPLETED|Overall Study||0
2390962|NCT01394185|5866007|P1|NOT COMPLETED|Overall Study||6
2390963|NCT01394185|5866002|P6|COMPLETED|Overall Study||2
2390964|NCT01394185|5866003|P5|COMPLETED|Overall Study||2
2390965|NCT01394185|5866004|P4|COMPLETED|Overall Study||3
2390966|NCT01394185|5866005|P3|COMPLETED|Overall Study||2
2390967|NCT01394185|5866006|P2|COMPLETED|Overall Study||2
2390968|NCT01394185|5866007|P1|COMPLETED|Overall Study||2
2390969|NCT01394185|5866002|P6|STARTED|Overall Study||3
2390970|NCT01394185|5866003|P5|STARTED|Overall Study||6
2390971|NCT01394185|5866004|P4|STARTED|Overall Study||4
2390972|NCT01394185|5866005|P3|STARTED|Overall Study||2
2390973|NCT01394185|5866006|P2|STARTED|Overall Study||2
2390974|NCT01394185|5866007|P1|STARTED|Overall Study||8
2390975|NCT01394159|5866020|P2|NOT COMPLETED|Overall Study||0
2390976|NCT01394159|5866021|P1|NOT COMPLETED|Overall Study||0
2390977|NCT01394159|5866020|P2|COMPLETED|Overall Study||28
2390978|NCT01394159|5866021|P1|COMPLETED|Overall Study||28
2390979|NCT01394159|5866020|P2|STARTED|Overall Study||28
2390980|NCT01394159|5866021|P1|STARTED|Overall Study||28
2390981|NCT01394081|5866033|P2|NOT COMPLETED|Overall Study||0
2390982|NCT01394081|5866034|P1|NOT COMPLETED|Overall Study||0
2390983|NCT01394081|5866033|P2|COMPLETED|Overall Study||102
2390984|NCT01394081|5866034|P1|COMPLETED|Overall Study||101
2390985|NCT01394081|5866033|P2|STARTED|Overall Study||102
2390986|NCT01394081|5866034|P1|STARTED|Overall Study||101
2390987|NCT01394003|5866050|P8|NOT COMPLETED|Overall Study||0
2390988|NCT01394003|5866051|P7|NOT COMPLETED|Overall Study||0
2390989|NCT01394003|5866052|P6|NOT COMPLETED|Overall Study||0
2390990|NCT01394003|5866053|P5|NOT COMPLETED|Overall Study||0
2390991|NCT01394003|5866054|P4|NOT COMPLETED|Overall Study||0
2390992|NCT01394003|5866055|P3|NOT COMPLETED|Overall Study||0
2390993|NCT01394003|5866056|P2|NOT COMPLETED|Overall Study||0
2390994|NCT01394003|5866057|P1|NOT COMPLETED|Overall Study||0
2390995|NCT01394003|5866050|P8|COMPLETED|Overall Study||2
2390996|NCT01394003|5866051|P7|COMPLETED|Overall Study||6
2390997|NCT01394003|5866052|P6|COMPLETED|Overall Study||3
2390998|NCT01394003|5866053|P5|COMPLETED|Overall Study||3
2390999|NCT01394003|5866054|P4|COMPLETED|Overall Study||6
2391000|NCT01394003|5866055|P3|COMPLETED|Overall Study||3
2391001|NCT01394003|5866056|P2|COMPLETED|Overall Study||8
2391002|NCT01394003|5866057|P1|COMPLETED|Overall Study||3
2391003|NCT01394003|5866050|P8|Received at Least 1 Dose of Study Drug|Overall Study||2
2391004|NCT01394003|5866051|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
2391005|NCT01394003|5866052|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
2391006|NCT01394003|5866053|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
2391007|NCT01394003|5866054|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
2391008|NCT01394003|5866055|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
2391009|NCT01394003|5866056|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
2391010|NCT01394003|5866057|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
2391011|NCT01394003|5866050|P8|STARTED|Overall Study||2
2391012|NCT01394003|5866051|P7|STARTED|Overall Study||6
2391013|NCT01394003|5866052|P6|STARTED|Overall Study||3
2391014|NCT01394003|5866053|P5|STARTED|Overall Study||3
2391015|NCT01394003|5866054|P4|STARTED|Overall Study||6
2391016|NCT01394003|5866055|P3|STARTED|Overall Study||3
2391017|NCT01394003|5866056|P2|STARTED|Overall Study||8
2391018|NCT01394003|5866057|P1|STARTED|Overall Study||3
2391019|NCT01393964|5866096|P3|NOT COMPLETED|Overall Study||9
2391020|NCT01393964|5866097|P2|NOT COMPLETED|Overall Study||9
2391021|NCT01393964|5866098|P1|NOT COMPLETED|Overall Study||8
2391022|NCT01393964|5866096|P3|COMPLETED|Overall Study|Completed=treatment on-going|0
2391023|NCT01393964|5866097|P2|COMPLETED|Overall Study|Completed=treatment on-going|0
2391024|NCT01393964|5866098|P1|COMPLETED|Overall Study|Completed=treatment on-going|0
2391025|NCT01393964|5866096|P3|STARTED|Overall Study||9
2391026|NCT01393964|5866097|P2|STARTED|Overall Study||9
2391027|NCT01393964|5866098|P1|STARTED|Overall Study||8
2391028|NCT01393899|5866139|P3|NOT COMPLETED|Overall Study||23
2391029|NCT01393899|5866140|P2|NOT COMPLETED|Overall Study||28
2391030|NCT01393899|5866141|P1|NOT COMPLETED|Overall Study||32
2391031|NCT01393899|5866139|P3|COMPLETED|Overall Study||38
2391032|NCT01393899|5866140|P2|COMPLETED|Overall Study||32
2391033|NCT01393899|5866141|P1|COMPLETED|Overall Study||27
2391034|NCT01393899|5866139|P3|STARTED|Overall Study||61
2391035|NCT01393899|5866140|P2|STARTED|Overall Study||60
2391036|NCT01393899|5866141|P1|STARTED|Overall Study||59
2391043|NCT01393743|5866210|P3|NOT COMPLETED|Extension Phase||60
2391044|NCT01393743|5866211|P2|NOT COMPLETED|Extension Phase||0
2391045|NCT01393743|5866212|P1|NOT COMPLETED|Extension Phase||0
2391046|NCT01393743|5866210|P3|COMPLETED|Extension Phase||78
2391047|NCT01393743|5866211|P2|COMPLETED|Extension Phase||0
2391048|NCT01393743|5866212|P1|COMPLETED|Extension Phase||0
2391049|NCT01393743|5866210|P3|STARTED|Extension Phase|Continuation into the Extension Phase was optional.|138
2391050|NCT01393743|5866211|P2|STARTED|Extension Phase||0
2391051|NCT01393743|5866212|P1|STARTED|Extension Phase||0
2391052|NCT01393743|5866210|P3|NOT COMPLETED|Core Study||0
2391053|NCT01393743|5866211|P2|NOT COMPLETED|Core Study||13
2391054|NCT01393743|5866212|P1|NOT COMPLETED|Core Study||10
2391055|NCT01393743|5866210|P3|COMPLETED|Core Study||0
2391056|NCT01393743|5866211|P2|COMPLETED|Core Study||68
2391057|NCT01393743|5866212|P1|COMPLETED|Core Study||72
2391058|NCT01393743|5866210|P3|STARTED|Core Study||0
2391059|NCT01393743|5866211|P2|STARTED|Core Study|Treated|81
2391060|NCT01393743|5866212|P1|STARTED|Core Study|Treated|82
2391061|NCT01393730|5866235|P1|NOT COMPLETED|Overall Study||6
2391062|NCT01393730|5866235|P1|COMPLETED|Overall Study||34
2391063|NCT01393730|5866235|P1|Evaluable AR Mutation|Overall Study||14
2391064|NCT01393730|5866235|P1|Evaluable AR Amplification|Overall Study||21
2391065|NCT01393730|5866235|P1|Treated|Overall Study||38
2391066|NCT01393730|5866235|P1|STARTED|Overall Study||40
2391067|NCT01393717|5866247|P2|NOT COMPLETED|Overall Study||0
2391068|NCT01393717|5866248|P1|NOT COMPLETED|Overall Study||0
2391069|NCT01393717|5866247|P2|COMPLETED|Overall Study||20
2391070|NCT01393717|5866248|P1|COMPLETED|Overall Study||37
2391071|NCT01393717|5866247|P2|STARTED|Overall Study||20
2391072|NCT01393717|5866248|P1|STARTED|Overall Study||37
2391073|NCT01393704|5866262|P2|NOT COMPLETED|Overall Study||0
2391074|NCT01393704|5866263|P1|NOT COMPLETED|Overall Study||0
2391075|NCT01393704|5866262|P2|COMPLETED|Overall Study||76
2391076|NCT01393704|5866263|P1|COMPLETED|Overall Study||76
2391077|NCT01393704|5866262|P2|STARTED|Overall Study||76
2391078|NCT01393704|5866263|P1|STARTED|Overall Study||76
2391079|NCT01393626|5866281|P4|NOT COMPLETED|Overall Study||1
2391080|NCT01393626|5866282|P3|NOT COMPLETED|Overall Study||12
2391081|NCT01393626|5866283|P2|NOT COMPLETED|Overall Study||12
2391082|NCT01393626|5866284|P1|NOT COMPLETED|Overall Study||18
2391083|NCT01393626|5866281|P4|COMPLETED|Overall Study||15
2391084|NCT01393626|5866282|P3|COMPLETED|Overall Study||74
2391085|NCT01393626|5866283|P2|COMPLETED|Overall Study||74
2391086|NCT01393626|5866284|P1|COMPLETED|Overall Study||73
2391087|NCT01393626|5866281|P4|STARTED|Overall Study||16
2391088|NCT01393626|5866282|P3|STARTED|Overall Study||86
2391089|NCT01393626|5866283|P2|STARTED|Overall Study||86
2391090|NCT01393626|5866284|P1|STARTED|Overall Study||91
2391091|NCT01393613|5866364|P4|NOT COMPLETED|Overall Study||66
2391092|NCT01393613|5866365|P3|NOT COMPLETED|Overall Study||54
2391093|NCT01393613|5866366|P2|NOT COMPLETED|Overall Study||57
2391094|NCT01393613|5866367|P1|NOT COMPLETED|Overall Study||39
2391095|NCT01393613|5866364|P4|COMPLETED|Overall Study||118
2391096|NCT01393613|5866365|P3|COMPLETED|Overall Study||130
2391097|NCT01393613|5866366|P2|COMPLETED|Overall Study||129
2391098|NCT01393613|5866367|P1|COMPLETED|Overall Study||81
2391099|NCT01393613|5866364|P4|STARTED|Overall Study||184
2391100|NCT01393613|5866365|P3|STARTED|Overall Study||184
2391101|NCT01393613|5866366|P2|STARTED|Overall Study||186
2391102|NCT01393613|5866367|P1|STARTED|Overall Study||120
2391103|NCT01393600|5866429|P4|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
2391104|NCT01393600|5866430|P3|NOT COMPLETED|Follow-up Period (Day 29 to 35)||1
2391105|NCT01393600|5866431|P2|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
2391106|NCT01393600|5866432|P1|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
2391107|NCT01393600|5866429|P4|COMPLETED|Follow-up Period (Day 29 to 35)||8
2391108|NCT01393600|5866430|P3|COMPLETED|Follow-up Period (Day 29 to 35)||6
2391109|NCT01393600|5866431|P2|COMPLETED|Follow-up Period (Day 29 to 35)||7
2391110|NCT01393600|5866432|P1|COMPLETED|Follow-up Period (Day 29 to 35)||9
2391111|NCT01393600|5866429|P4|STARTED|Follow-up Period (Day 29 to 35)||8
2391112|NCT01393600|5866430|P3|STARTED|Follow-up Period (Day 29 to 35)||7
2391113|NCT01393600|5866431|P2|STARTED|Follow-up Period (Day 29 to 35)||7
2391114|NCT01393600|5866432|P1|STARTED|Follow-up Period (Day 29 to 35)||9
2391115|NCT01393600|5866429|P4|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||1
2391116|NCT01393600|5866430|P3|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||2
2391117|NCT01393600|5866431|P2|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
2391118|NCT01393600|5866432|P1|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
2391119|NCT01393600|5866429|P4|COMPLETED|Treatment Period 2 (Day 15 to 28)||8
2391120|NCT01393600|5866430|P3|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
2391121|NCT01393600|5866431|P2|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
2391122|NCT01393600|5866432|P1|COMPLETED|Treatment Period 2 (Day 15 to 28)||9
2391123|NCT01393600|5866429|P4|STARTED|Treatment Period 2 (Day 15 to 28)||9
2391124|NCT01393600|5866430|P3|STARTED|Treatment Period 2 (Day 15 to 28)||9
2391125|NCT01393600|5866431|P2|STARTED|Treatment Period 2 (Day 15 to 28)||7
2391126|NCT01393600|5866432|P1|STARTED|Treatment Period 2 (Day 15 to 28)||9
2391127|NCT01393600|5866429|P4|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
2391128|NCT01393600|5866430|P3|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
2391129|NCT01393600|5866431|P2|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
2391130|NCT01393600|5866432|P1|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||0
2391131|NCT01393600|5866429|P4|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
2391132|NCT01393600|5866430|P3|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
2391133|NCT01393600|5866431|P2|COMPLETED|Treatment Period 1 (Day 1 to 14)||7
2391134|NCT01393600|5866432|P1|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
2391135|NCT01393600|5866429|P4|STARTED|Treatment Period 1 (Day 1 to 14)||10
2391136|NCT01393600|5866430|P3|STARTED|Treatment Period 1 (Day 1 to 14)||10
2391137|NCT01393600|5866431|P2|STARTED|Treatment Period 1 (Day 1 to 14)||8
2391138|NCT01393600|5866432|P1|STARTED|Treatment Period 1 (Day 1 to 14)||9
2391139|NCT01393457|5866451|P4|NOT COMPLETED|Overall Study||12
2391140|NCT01393457|5866452|P3|NOT COMPLETED|Overall Study||15
2391141|NCT01393457|5866453|P2|NOT COMPLETED|Overall Study||12
2391142|NCT01393457|5866454|P1|NOT COMPLETED|Overall Study||12
2391143|NCT01393457|5866451|P4|COMPLETED|Overall Study||15
2391144|NCT01393457|5866452|P3|COMPLETED|Overall Study||16
2391145|NCT01393457|5866453|P2|COMPLETED|Overall Study||14
2391146|NCT01393457|5866454|P1|COMPLETED|Overall Study||14
2391147|NCT01393457|5866451|P4|STARTED|Overall Study||27
2391148|NCT01393457|5866452|P3|STARTED|Overall Study||31
2391149|NCT01393457|5866453|P2|STARTED|Overall Study||26
2391150|NCT01393457|5866454|P1|STARTED|Overall Study||26
2391151|NCT01393444|5866468|P1|NOT COMPLETED|Overall Study||3
2391152|NCT01393444|5866468|P1|COMPLETED|Overall Study|2015: Third implanted subject completed the study. This fulfilled the requirements of our grant.|3
2391153|NCT01393444|5866468|P1|Sixth (3rd Implanted) Subject|Overall Study|2014: Individual with brachial plexus injury enrolled and was eligible. Implanted in 2015.|1
2391154|NCT01393444|5866468|P1|Fifth (2nd Implanted) Subject Enrolled|Overall Study|2013: Individual with ALS enrolled and was eligible. Implanted in 2014.|1
2391155|NCT01393444|5866468|P1|Fourth Subject Enrolled|Overall Study|2013: Fourth participant enrolled. Ineligible.|1
2391156|NCT01393444|5866468|P1|Third Subject Enrolled|Overall Study|2013: Third participant enrolled. Withdrew due to family commitments.|1
2391157|NCT01393444|5866468|P1|Second Subject Enrolled|Overall Study|2012: Second participant enrolled. Ineligible.|1
2391158|NCT01393444|5866468|P1|First (1st Implanted) Subject Enrolled|Overall Study|2011: Individual with cervical spinal cord injury enrolled and was eligible. Implanted in 2011.|1
2391159|NCT01393444|5866468|P1|STARTED|Overall Study||6
2391160|NCT01393405|5866473|P3|NOT COMPLETED|Maintenance Period Week||24
2391161|NCT01393405|5866474|P2|NOT COMPLETED|Maintenance Period Week||29
2391162|NCT01393405|5866475|P1|NOT COMPLETED|Maintenance Period Week||0
2391163|NCT01393405|5866473|P3|COMPLETED|Maintenance Period Week||16
2391164|NCT01393405|5866474|P2|COMPLETED|Maintenance Period Week||15
2391165|NCT01393405|5866475|P1|COMPLETED|Maintenance Period Week||0
2391166|NCT01393405|5866473|P3|STARTED|Maintenance Period Week||40
2391167|NCT01393405|5866474|P2|STARTED|Maintenance Period Week||44
2391168|NCT01393405|5866475|P1|STARTED|Maintenance Period Week||0
2391169|NCT01393405|5866473|P3|NOT COMPLETED|Induction Period (week1-16)||0
2391170|NCT01393405|5866474|P2|NOT COMPLETED|Induction Period (week1-16)||0
2391171|NCT01393405|5866475|P1|NOT COMPLETED|Induction Period (week1-16)||95
2391172|NCT01393405|5866473|P3|COMPLETED|Induction Period (week1-16)||0
2391173|NCT01393405|5866474|P2|COMPLETED|Induction Period (week1-16)||0
2391174|NCT01393405|5866475|P1|COMPLETED|Induction Period (week1-16)||84
2391175|NCT01393405|5866473|P3|STARTED|Induction Period (week1-16)||0
2391176|NCT01393405|5866474|P2|STARTED|Induction Period (week1-16)||0
2391177|NCT01393405|5866475|P1|STARTED|Induction Period (week1-16)||179
2391178|NCT01393392|5866494|P2|NOT COMPLETED|Overall Study||19
2391179|NCT01393392|5866495|P1|NOT COMPLETED|Overall Study||11
2391180|NCT01393392|5866494|P2|COMPLETED|Overall Study||24
2391181|NCT01393392|5866495|P1|COMPLETED|Overall Study||33
2391182|NCT01393392|5866494|P2|STARTED|Overall Study||43
2391183|NCT01393392|5866495|P1|STARTED|Overall Study||44
2391184|NCT01393301|5866513|P2|NOT COMPLETED|Overall Study||3
2391185|NCT01393301|5866514|P1|NOT COMPLETED|Overall Study||9
2391186|NCT01393301|5866513|P2|COMPLETED|Overall Study||24
2391187|NCT01393301|5866514|P1|COMPLETED|Overall Study||17
2391188|NCT01393301|5866513|P2|STARTED|Overall Study||27
2391189|NCT01393301|5866514|P1|STARTED|Overall Study||26
2391190|NCT01393158|5866527|P2|NOT COMPLETED|Overall Study||0
2391191|NCT01393158|5866528|P1|NOT COMPLETED|Overall Study||1
2391192|NCT01393158|5866527|P2|COMPLETED|Overall Study||10
2391193|NCT01393158|5866528|P1|COMPLETED|Overall Study||5
2391194|NCT01393158|5866527|P2|STARTED|Overall Study||10
2391195|NCT01393158|5866528|P1|STARTED|Overall Study||6
2391196|NCT01393132|5866542|P2|NOT COMPLETED|Overall Study||0
2391197|NCT01393132|5866543|P1|NOT COMPLETED|Overall Study||0
2391198|NCT01393132|5866542|P2|COMPLETED|Overall Study||3
2391199|NCT01393132|5866543|P1|COMPLETED|Overall Study||6
2391200|NCT01393132|5866542|P2|STARTED|Overall Study||3
2391201|NCT01393132|5866543|P1|STARTED|Overall Study||6
2391202|NCT01393106|5866555|P1|NOT COMPLETED|Overall Study||5
2391203|NCT01393106|5866555|P1|COMPLETED|Overall Study|Completed: Disease Progression/Death|20
2391204|NCT01393106|5866555|P1|STARTED|Overall Study||25
2391205|NCT01392989|5866572|P1|NOT COMPLETED|CIK Cell Infusion||0
2391206|NCT01392989|5866572|P1|COMPLETED|CIK Cell Infusion||31
2391207|NCT01392989|5866572|P1|STARTED|CIK Cell Infusion||31
2391208|NCT01392989|5866572|P1|NOT COMPLETED|Total Lymphoid Irradiation (TLI)||0
2391209|NCT01392989|5866572|P1|COMPLETED|Total Lymphoid Irradiation (TLI)||44
2391210|NCT01392989|5866572|P1|STARTED|Total Lymphoid Irradiation (TLI)||44
2391211|NCT01392963|5866582|P2|NOT COMPLETED|Week 24 Follow-up||0
2391212|NCT01392963|5866583|P1|NOT COMPLETED|Week 24 Follow-up||2
2391213|NCT01392963|5866582|P2|COMPLETED|Week 24 Follow-up||17
2391214|NCT01392963|5866583|P1|COMPLETED|Week 24 Follow-up||9
2391215|NCT01392963|5866582|P2|STARTED|Week 24 Follow-up||17
2391216|NCT01392963|5866583|P1|STARTED|Week 24 Follow-up||11
2391217|NCT01392963|5866582|P2|NOT COMPLETED|Week 12 (Second Intervention)||0
2391218|NCT01392963|5866583|P1|NOT COMPLETED|Week 12 (Second Intervention)||0
2391219|NCT01392963|5866582|P2|COMPLETED|Week 12 (Second Intervention)||17
2391220|NCT01392963|5866583|P1|COMPLETED|Week 12 (Second Intervention)||11
2391221|NCT01392963|5866582|P2|STARTED|Week 12 (Second Intervention)||17
2391222|NCT01392963|5866583|P1|STARTED|Week 12 (Second Intervention)||11
2391223|NCT01392963|5866582|P2|NOT COMPLETED|Week 0 (First Intervention)||2
2391224|NCT01392963|5866583|P1|NOT COMPLETED|Week 0 (First Intervention)||0
2391225|NCT01392963|5866582|P2|COMPLETED|Week 0 (First Intervention)||17
2391226|NCT01392963|5866583|P1|COMPLETED|Week 0 (First Intervention)||11
2391227|NCT01392963|5866582|P2|STARTED|Week 0 (First Intervention)||19
2391228|NCT01392963|5866583|P1|STARTED|Week 0 (First Intervention)||11
2391229|NCT01392742|5866591|P1|NOT COMPLETED|Overall Study||201
2391230|NCT01392742|5866591|P1|COMPLETED|Overall Study||242
2391231|NCT01392742|5866591|P1|STARTED|Overall Study||443
2391232|NCT01392703|5866606|P3|NOT COMPLETED|Day 9||0
2391233|NCT01392703|5866607|P2|NOT COMPLETED|Day 9||0
2391234|NCT01392703|5866608|P1|NOT COMPLETED|Day 9||0
2391235|NCT01392703|5866606|P3|COMPLETED|Day 9||25
2391236|NCT01392703|5866607|P2|COMPLETED|Day 9||26
2391237|NCT01392703|5866608|P1|COMPLETED|Day 9||26
2391238|NCT01392703|5866606|P3|STARTED|Day 9||25
2391239|NCT01392703|5866607|P2|STARTED|Day 9||26
2391240|NCT01392703|5866608|P1|STARTED|Day 9||26
2391241|NCT01392703|5866606|P3|NOT COMPLETED|Day 5||0
2391242|NCT01392703|5866607|P2|NOT COMPLETED|Day 5||0
2391243|NCT01392703|5866608|P1|NOT COMPLETED|Day 5||0
2391244|NCT01392703|5866606|P3|COMPLETED|Day 5||26
2391245|NCT01392703|5866607|P2|COMPLETED|Day 5||25
2391246|NCT01392703|5866608|P1|COMPLETED|Day 5||26
2391247|NCT01392703|5866606|P3|STARTED|Day 5||26
2391248|NCT01392703|5866607|P2|STARTED|Day 5|1 participant no longer met dosing criteria and dropped out during washout period prior to Day 5.|25
2391249|NCT01392703|5866608|P1|STARTED|Day 5||26
2391250|NCT01392703|5866606|P3|NOT COMPLETED|Day 1||0
2391251|NCT01392703|5866607|P2|NOT COMPLETED|Day 1||0
2391252|NCT01392703|5866608|P1|NOT COMPLETED|Day 1||0
2391253|NCT01392703|5866606|P3|COMPLETED|Day 1||26
2391254|NCT01392703|5866607|P2|COMPLETED|Day 1||26
2391255|NCT01392703|5866608|P1|COMPLETED|Day 1||26
2391256|NCT01392703|5866606|P3|STARTED|Day 1||26
2391257|NCT01392703|5866607|P2|STARTED|Day 1||26
2391258|NCT01392703|5866608|P1|STARTED|Day 1||26
2391259|NCT01392677|5866637|P2|NOT COMPLETED|Overall Study||8
2391260|NCT01392677|5866638|P1|NOT COMPLETED|Overall Study||8
2391261|NCT01392677|5866637|P2|COMPLETED|Overall Study||101
2391262|NCT01392677|5866638|P1|COMPLETED|Overall Study||101
2391263|NCT01392677|5866637|P2|STARTED|Overall Study||109
2391264|NCT01392677|5866638|P1|STARTED|Overall Study||109
2391265|NCT01392625|5866654|P2|NOT COMPLETED|Overall Study||1
2391266|NCT01392625|5866655|P1|NOT COMPLETED|Overall Study||2
2391267|NCT01392625|5866654|P2|COMPLETED|Overall Study||18
2391268|NCT01392625|5866655|P1|COMPLETED|Overall Study||16
2391269|NCT01392625|5866654|P2|STARTED|Overall Study||19
2391270|NCT01392625|5866655|P1|STARTED|Overall Study||18
2391271|NCT01392573|5866673|P2|NOT COMPLETED|Overall Study||35
2391272|NCT01392573|5866674|P1|NOT COMPLETED|Overall Study||32
2391273|NCT01392573|5866673|P2|COMPLETED|Overall Study||171
2391274|NCT01392573|5866674|P1|COMPLETED|Overall Study||175
2391275|NCT01392573|5866673|P2|Exposed|Overall Study||206
2391276|NCT01392573|5866674|P1|Exposed|Overall Study||207
2391277|NCT01392573|5866673|P2|STARTED|Overall Study||206
2391278|NCT01392573|5866674|P1|STARTED|Overall Study||207
2391279|NCT01392560|5866682|P1|NOT COMPLETED|Overall Study||12
2391280|NCT01392560|5866682|P1|COMPLETED|Overall Study||40
2391281|NCT01392560|5866682|P1|STARTED|Overall Study||52
2391282|NCT01392547|5866688|P1|NOT COMPLETED|Overall Study||8
2391283|NCT01392547|5866688|P1|COMPLETED|Overall Study||64
2391284|NCT01392547|5866688|P1|STARTED|Overall Study|567 bleeds by 69 subjects, 340 were treated with vatreptacog alfa and 227 with rFVIIa|72
2391285|NCT01392495|5866702|P1|NOT COMPLETED|Overall Study||16
2391286|NCT01392495|5866702|P1|COMPLETED|Overall Study||1
2391287|NCT01392495|5866702|P1|Received 400 mg|Overall Study||13
2391288|NCT01392495|5866702|P1|Received 200 mg|Overall Study||4
2391289|NCT01392495|5866702|P1|STARTED|Overall Study||17
2391290|NCT01392443|5866714|P1|NOT COMPLETED|Overall Study||68
2391291|NCT01392443|5866714|P1|COMPLETED|Overall Study||52
2391292|NCT01392443|5866714|P1|STARTED|Overall Study||120
2391293|NCT01392378|5866727|P5|NOT COMPLETED|Toddler Dose||1
2391294|NCT01392378|5866728|P4|NOT COMPLETED|Toddler Dose||2
2391295|NCT01392378|5866729|P3|NOT COMPLETED|Toddler Dose||0
2391296|NCT01392378|5866730|P2|NOT COMPLETED|Toddler Dose||1
2391297|NCT01392378|5866731|P1|NOT COMPLETED|Toddler Dose||0
2391298|NCT01392378|5866727|P5|COMPLETED|Toddler Dose||208
2391299|NCT01392378|5866728|P4|COMPLETED|Toddler Dose||173
2391300|NCT01392378|5866729|P3|COMPLETED|Toddler Dose||170
2391301|NCT01392378|5866730|P2|COMPLETED|Toddler Dose||172
2391302|NCT01392378|5866731|P1|COMPLETED|Toddler Dose||169
2391303|NCT01392378|5866727|P5|STARTED|Toddler Dose||209
2391304|NCT01392378|5866728|P4|STARTED|Toddler Dose||175
2391305|NCT01392378|5866729|P3|STARTED|Toddler Dose||170
2391306|NCT01392378|5866730|P2|STARTED|Toddler Dose||173
2391307|NCT01392378|5866731|P1|STARTED|Toddler Dose||169
2391308|NCT01392378|5866727|P5|NOT COMPLETED|After Infant Series||1
2391309|NCT01392378|5866728|P4|NOT COMPLETED|After Infant Series||0
2391310|NCT01392378|5866729|P3|NOT COMPLETED|After Infant Series||2
2391311|NCT01392378|5866730|P2|NOT COMPLETED|After Infant Series||1
2391312|NCT01392378|5866731|P1|NOT COMPLETED|After Infant Series||0
2391313|NCT01392378|5866727|P5|COMPLETED|After Infant Series||209
2391314|NCT01392378|5866728|P4|COMPLETED|After Infant Series||175
2391315|NCT01392378|5866729|P3|COMPLETED|After Infant Series||170
2391316|NCT01392378|5866730|P2|COMPLETED|After Infant Series||173
2391317|NCT01392378|5866731|P1|COMPLETED|After Infant Series||169
2391318|NCT01392378|5866727|P5|STARTED|After Infant Series||210
2391319|NCT01392378|5866728|P4|STARTED|After Infant Series||175
2391320|NCT01392378|5866729|P3|STARTED|After Infant Series||172
2391321|NCT01392378|5866730|P2|STARTED|After Infant Series||174
2391322|NCT01392378|5866731|P1|STARTED|After Infant Series||169
2391323|NCT01392378|5866727|P5|NOT COMPLETED|Infant Series||0
2391324|NCT01392378|5866728|P4|NOT COMPLETED|Infant Series||2
2391325|NCT01392378|5866729|P3|NOT COMPLETED|Infant Series||0
2391326|NCT01392378|5866730|P2|NOT COMPLETED|Infant Series||2
2391327|NCT01392378|5866731|P1|NOT COMPLETED|Infant Series||4
2391328|NCT01392378|5866727|P5|COMPLETED|Infant Series||210
2391329|NCT01392378|5866728|P4|COMPLETED|Infant Series||175
2391330|NCT01392378|5866729|P3|COMPLETED|Infant Series||172
2391331|NCT01392378|5866730|P2|COMPLETED|Infant Series||174
2391332|NCT01392378|5866731|P1|COMPLETED|Infant Series||169
2391333|NCT01392378|5866727|P5|Vaccinated Dose 3|Infant Series||210
2391334|NCT01392378|5866728|P4|Vaccinated Dose 3|Infant Series||176
2391335|NCT01392378|5866729|P3|Vaccinated Dose 3|Infant Series||172
2391336|NCT01392378|5866730|P2|Vaccinated Dose 3|Infant Series||174
2391337|NCT01392378|5866731|P1|Vaccinated Dose 3|Infant Series||170
2391338|NCT01392378|5866727|P5|Vaccinated Dose 2|Infant Series||210
2391339|NCT01392378|5866728|P4|Vaccinated Dose 2|Infant Series||177
2391340|NCT01392378|5866729|P3|Vaccinated Dose 2|Infant Series||172
2391341|NCT01392378|5866730|P2|Vaccinated Dose 2|Infant Series||174
2391342|NCT01392378|5866731|P1|Vaccinated Dose 2|Infant Series||171
2391343|NCT01392378|5866727|P5|Vaccinated Dose 1|Infant Series||210
2391344|NCT01392378|5866728|P4|Vaccinated Dose 1|Infant Series||177
2391345|NCT01392378|5866729|P3|Vaccinated Dose 1|Infant Series||172
2391346|NCT01392378|5866730|P2|Vaccinated Dose 1|Infant Series||176
2391347|NCT01392378|5866731|P1|Vaccinated Dose 1|Infant Series||173
2391348|NCT01392378|5866727|P5|STARTED|Infant Series||210
2391349|NCT01392378|5866728|P4|STARTED|Infant Series||177
2391350|NCT01392378|5866729|P3|STARTED|Infant Series||172
2391351|NCT01392378|5866730|P2|STARTED|Infant Series||176
2391352|NCT01392378|5866731|P1|STARTED|Infant Series||173
2391353|NCT01392326|5866871|P3|NOT COMPLETED|Overall Study||48
2391354|NCT01392326|5866872|P2|NOT COMPLETED|Overall Study||35
2391355|NCT01392326|5866873|P1|NOT COMPLETED|Overall Study||47
2391356|NCT01392326|5866871|P3|COMPLETED|Overall Study||154
2391357|NCT01392326|5866872|P2|COMPLETED|Overall Study||167
2391358|NCT01392326|5866873|P1|COMPLETED|Overall Study||155
2391359|NCT01392326|5866871|P3|STARTED|Overall Study||202
2391360|NCT01392326|5866872|P2|STARTED|Overall Study||202
2391361|NCT01392326|5866873|P1|STARTED|Overall Study||202
2391362|NCT01392300|5866910|P3|NOT COMPLETED|Open Label Extension (OLEX) Period||51
2391363|NCT01392300|5866911|P2|NOT COMPLETED|Open Label Extension (OLEX) Period||0
2391364|NCT01392300|5866912|P1|NOT COMPLETED|Open Label Extension (OLEX) Period||0
2391365|NCT01392300|5866910|P3|COMPLETED|Open Label Extension (OLEX) Period||248
2391366|NCT01392300|5866911|P2|COMPLETED|Open Label Extension (OLEX) Period||0
2391367|NCT01392300|5866912|P1|COMPLETED|Open Label Extension (OLEX) Period||0
2391368|NCT01392300|5866910|P3|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|299
2391369|NCT01392300|5866911|P2|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
2391370|NCT01392300|5866912|P1|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
2391371|NCT01392300|5866910|P3|NOT COMPLETED|Main Period (MP)||0
2391372|NCT01392300|5866911|P2|NOT COMPLETED|Main Period (MP)||7
2391373|NCT01392300|5866912|P1|NOT COMPLETED|Main Period (MP)||11
2391374|NCT01392300|5866910|P3|COMPLETED|Main Period (MP)||0
2391375|NCT01392300|5866911|P2|COMPLETED|Main Period (MP)||100
2391376|NCT01392300|5866912|P1|COMPLETED|Main Period (MP)||199
2391377|NCT01392300|5866910|P3|STARTED|Main Period (MP)||0
2391378|NCT01392300|5866911|P2|STARTED|Main Period (MP)||107
2391379|NCT01392300|5866912|P1|STARTED|Main Period (MP)||210
2391380|NCT01392170|5867017|P1|NOT COMPLETED|Overall Study||2
2391381|NCT01392170|5867017|P1|COMPLETED|Overall Study||0
2391382|NCT01392170|5867017|P1|STARTED|Overall Study||2
2391383|NCT01392053|5867023|P2|NOT COMPLETED|Overall Study||0
2391384|NCT01392053|5867024|P1|NOT COMPLETED|Overall Study||0
2391385|NCT01392053|5867023|P2|COMPLETED|Overall Study||23
2391386|NCT01392053|5867024|P1|COMPLETED|Overall Study||23
2391387|NCT01392053|5867023|P2|STARTED|Overall Study||23
2391388|NCT01392053|5867024|P1|STARTED|Overall Study||23
2391389|NCT01391858|5867044|P2|NOT COMPLETED|Overall Study||0
2391390|NCT01391858|5867045|P1|NOT COMPLETED|Overall Study||2
2391391|NCT01391858|5867044|P2|COMPLETED|Overall Study||24
2391392|NCT01391858|5867045|P1|COMPLETED|Overall Study||23
2391393|NCT01391858|5867044|P2|STARTED|Overall Study||24
2391394|NCT01391858|5867045|P1|STARTED|Overall Study||25
2391395|NCT01391819|5867065|P1|NOT COMPLETED|Overall Study||402
2391396|NCT01391819|5867065|P1|COMPLETED|Overall Study||1714
2391397|NCT01391819|5867065|P1|STARTED|Overall Study||2116
2391398|NCT01391793|5867109|P2|NOT COMPLETED|Overall Study||144
2391399|NCT01391793|5867110|P1|NOT COMPLETED|Overall Study||147
2391400|NCT01391793|5867109|P2|COMPLETED|Overall Study||131
2391401|NCT01391793|5867110|P1|COMPLETED|Overall Study||124
2391402|NCT01391793|5867109|P2|Had a Positive Urine Culture|Overall Study||188
2391403|NCT01391793|5867110|P1|Had a Positive Urine Culture|Overall Study||197
2391404|NCT01391793|5867109|P2|STARTED|Overall Study||275
2391405|NCT01391793|5867110|P1|STARTED|Overall Study||271
2391406|NCT01391663|5867124|P4|NOT COMPLETED|Overall Study||0
2391407|NCT01391663|5867125|P3|NOT COMPLETED|Overall Study||1
2391408|NCT01391663|5867126|P2|NOT COMPLETED|Overall Study||0
2391409|NCT01391663|5867127|P1|NOT COMPLETED|Overall Study||0
2391410|NCT01391663|5867124|P4|COMPLETED|Overall Study||12
2391411|NCT01391663|5867125|P3|COMPLETED|Overall Study||11
2391412|NCT01391663|5867126|P2|COMPLETED|Overall Study||12
2391413|NCT01391663|5867127|P1|COMPLETED|Overall Study||12
2391414|NCT01391663|5867124|P4|STARTED|Overall Study||12
2391415|NCT01391663|5867125|P3|STARTED|Overall Study||12
2391416|NCT01391663|5867126|P2|STARTED|Overall Study||12
2391417|NCT01391663|5867127|P1|STARTED|Overall Study||12
2391418|NCT01391611|5867157|P1|NOT COMPLETED|Overall Study||22
2391419|NCT01391611|5867157|P1|COMPLETED|Overall Study||3
2391420|NCT01391611|5867157|P1|STARTED|Overall Study||25
2391421|NCT01391559|5867162|P2|NOT COMPLETED|Second Intervention||0
2391422|NCT01391559|5867163|P1|NOT COMPLETED|Second Intervention||0
2391423|NCT01391559|5867162|P2|COMPLETED|Second Intervention||10
2391424|NCT01391559|5867163|P1|COMPLETED|Second Intervention||10
2391425|NCT01391559|5867162|P2|STARTED|Second Intervention||10
2391426|NCT01391559|5867163|P1|STARTED|Second Intervention||10
2391427|NCT01391559|5867162|P2|NOT COMPLETED|First Intervention||0
2391428|NCT01391559|5867163|P1|NOT COMPLETED|First Intervention||0
2391429|NCT01391559|5867162|P2|COMPLETED|First Intervention||10
2391430|NCT01391559|5867163|P1|COMPLETED|First Intervention||10
2391431|NCT01391559|5867162|P2|STARTED|First Intervention||10
2391432|NCT01391559|5867163|P1|STARTED|First Intervention||10
2391433|NCT01391546|5867171|P2|NOT COMPLETED|Overall Study||0
2391434|NCT01391546|5867172|P1|NOT COMPLETED|Overall Study||1
2391435|NCT01391546|5867171|P2|COMPLETED|Overall Study||177
2391436|NCT01391546|5867172|P1|COMPLETED|Overall Study||176
2391437|NCT01391546|5867171|P2|Vaccinated|Overall Study||177
2391438|NCT01391546|5867172|P1|Vaccinated|Overall Study||176
2391439|NCT01391546|5867171|P2|STARTED|Overall Study||177
2391440|NCT01391546|5867172|P1|STARTED|Overall Study||177
2391441|NCT01391507|5867194|P4|NOT COMPLETED|Overall Study||7
2391442|NCT01391507|5867195|P3|NOT COMPLETED|Overall Study||4
2391443|NCT01391507|5867196|P2|NOT COMPLETED|Overall Study||4
2391444|NCT01391507|5867197|P1|NOT COMPLETED|Overall Study||4
2391445|NCT01391507|5867194|P4|COMPLETED|Overall Study||5
2391446|NCT01391507|5867195|P3|COMPLETED|Overall Study||2
2391447|NCT01391507|5867196|P2|COMPLETED|Overall Study||4
2391448|NCT01391507|5867197|P1|COMPLETED|Overall Study||6
2391449|NCT01391507|5867194|P4|STARTED|Overall Study||12
2391450|NCT01391507|5867195|P3|STARTED|Overall Study||6
2391451|NCT01391507|5867196|P2|STARTED|Overall Study||8
2391452|NCT01391507|5867197|P1|STARTED|Overall Study||10
2391453|NCT01391468|5867245|P2|NOT COMPLETED|Overall Study||2
2391454|NCT01391468|5867246|P1|NOT COMPLETED|Overall Study||6
2391455|NCT01391468|5867245|P2|COMPLETED|Overall Study||21
2391456|NCT01391468|5867246|P1|COMPLETED|Overall Study||18
2391457|NCT01391468|5867245|P2|STARTED|Overall Study||23
2391458|NCT01391468|5867246|P1|STARTED|Overall Study||24
2391459|NCT01391325|5867258|P1|NOT COMPLETED|Overall Study||494
2391460|NCT01391325|5867258|P1|COMPLETED|Overall Study||1238
2391461|NCT01391325|5867258|P1|STARTED|Overall Study||1732
2391462|NCT01391312|5867267|P2|NOT COMPLETED|Overall Study||1
2391463|NCT01391312|5867268|P1|NOT COMPLETED|Overall Study||2
2391464|NCT01391312|5867267|P2|COMPLETED|Overall Study||19
2391465|NCT01391312|5867268|P1|COMPLETED|Overall Study||18
2391466|NCT01391312|5867267|P2|STARTED|Overall Study||20
2391467|NCT01391312|5867268|P1|STARTED|Overall Study||20
2391468|NCT01391299|5867281|P3|NOT COMPLETED|Overall Study||2
2391469|NCT01391299|5867282|P2|NOT COMPLETED|Overall Study||1
2391470|NCT01391299|5867283|P1|NOT COMPLETED|Overall Study||0
2391471|NCT01391299|5867281|P3|COMPLETED|Overall Study||56
2391472|NCT01391299|5867282|P2|COMPLETED|Overall Study||59
2391473|NCT01391299|5867283|P1|COMPLETED|Overall Study||57
2391474|NCT01391299|5867281|P3|STARTED|Overall Study||58
2391475|NCT01391299|5867282|P2|STARTED|Overall Study||60
2391476|NCT01391299|5867283|P1|STARTED|Overall Study||57
2391477|NCT01391286|5867305|P2|NOT COMPLETED|Overall Study||0
2391478|NCT01391286|5867306|P1|NOT COMPLETED|Overall Study||0
2391479|NCT01391286|5867305|P2|COMPLETED|Overall Study||18
2391480|NCT01391286|5867306|P1|COMPLETED|Overall Study||18
2391481|NCT01391286|5867305|P2|STARTED|Overall Study||18
2391482|NCT01391286|5867306|P1|STARTED|Overall Study||18
2391483|NCT01391273|5867320|P2|NOT COMPLETED|Overall Study||2
2391484|NCT01391273|5867321|P1|NOT COMPLETED|Overall Study||4
2391485|NCT01391273|5867320|P2|COMPLETED|Overall Study||83
2391486|NCT01391273|5867321|P1|COMPLETED|Overall Study||84
2391487|NCT01391273|5867320|P2|STARTED|Overall Study||85
2391488|NCT01391273|5867321|P1|STARTED|Overall Study||88
2391489|NCT01391130|5867335|P2|NOT COMPLETED|Overall Study||6
2391490|NCT01391130|5867336|P1|NOT COMPLETED|Overall Study||6
2391491|NCT01391130|5867335|P2|COMPLETED|Overall Study||31
2391492|NCT01391130|5867336|P1|COMPLETED|Overall Study||67
2391493|NCT01391130|5867335|P2|Received At Least One Dose of Study Drug|Overall Study||36
2391494|NCT01391130|5867336|P1|Received At Least One Dose of Study Drug|Overall Study||72
2391495|NCT01391130|5867335|P2|STARTED|Overall Study||37
2391496|NCT01391130|5867336|P1|STARTED|Overall Study||73
2391497|NCT01391013|5867352|P2|NOT COMPLETED|Overall Study||0
2391498|NCT01391013|5867353|P1|NOT COMPLETED|Overall Study||0
2391499|NCT01391013|5867352|P2|COMPLETED|Overall Study||15
2391500|NCT01391013|5867353|P1|COMPLETED|Overall Study||15
2391501|NCT01391013|5867352|P2|STARTED|Overall Study||15
2391502|NCT01391013|5867353|P1|STARTED|Overall Study||15
2391503|NCT01391000|5867393|P2|NOT COMPLETED|Overall Study||0
2391504|NCT01391000|5867394|P1|NOT COMPLETED|Overall Study||2
2391505|NCT01391000|5867393|P2|COMPLETED|Overall Study||35
2391506|NCT01391000|5867394|P1|COMPLETED|Overall Study||33
2391507|NCT01391000|5867393|P2|STARTED|Overall Study||35
2391508|NCT01391000|5867394|P1|STARTED|Overall Study||35
2391509|NCT01390948|5867407|P3|NOT COMPLETED|Overall Study||3
2391510|NCT01390948|5867408|P2|NOT COMPLETED|Overall Study||62
2391511|NCT01390948|5867409|P1|NOT COMPLETED|Overall Study||59
2391512|NCT01390948|5867407|P3|COMPLETED|Overall Study||0
2391513|NCT01390948|5867408|P2|COMPLETED|Overall Study||0
2391514|NCT01390948|5867409|P1|COMPLETED|Overall Study||0
2391515|NCT01390948|5867407|P3|Treated|Overall Study||3
2391516|NCT01390948|5867408|P2|Treated|Overall Study||60
2391517|NCT01390948|5867409|P1|Treated|Overall Study||56
2391518|NCT01390948|5867407|P3|STARTED|Overall Study||3
2391519|NCT01390948|5867408|P2|STARTED|Overall Study||62
2391520|NCT01390948|5867409|P1|STARTED|Overall Study||59
2391521|NCT01390909|5867448|P6|NOT COMPLETED|Overall Study||0
2391522|NCT01390909|5867449|P5|NOT COMPLETED|Overall Study||0
2391523|NCT01390909|5867450|P4|NOT COMPLETED|Overall Study||0
2391524|NCT01390909|5867451|P3|NOT COMPLETED|Overall Study||0
2391525|NCT01390909|5867452|P2|NOT COMPLETED|Overall Study||0
2391526|NCT01390909|5867453|P1|NOT COMPLETED|Overall Study||0
2391527|NCT01390909|5867448|P6|COMPLETED|Overall Study||613
2391528|NCT01390909|5867449|P5|COMPLETED|Overall Study||613
2391529|NCT01390909|5867450|P4|COMPLETED|Overall Study||602
2391530|NCT01390909|5867451|P3|COMPLETED|Overall Study||3552
2391531|NCT01390909|5867452|P2|COMPLETED|Overall Study||3552
2391532|NCT01390909|5867453|P1|COMPLETED|Overall Study||3454
2391533|NCT01390909|5867448|P6|Participants in Subgroup|Overall Study||0
2391534|NCT01390909|5867449|P5|Participants in Subgroup|Overall Study||602
2391535|NCT01390909|5867450|P4|Participants in Subgroup|Overall Study||0
2391536|NCT01390909|5867451|P3|Participants in Subgroup|Overall Study||0
2391537|NCT01390909|5867452|P2|Participants in Subgroup|Overall Study||3454
2391538|NCT01390909|5867453|P1|Participants in Subgroup|Overall Study||0
2391539|NCT01390909|5867448|P6|STARTED|Overall Study||613
2391540|NCT01390909|5867449|P5|STARTED|Overall Study||613
2391541|NCT01390909|5867450|P4|STARTED|Overall Study||602
2391542|NCT01390909|5867451|P3|STARTED|Overall Study||3552
2391543|NCT01390909|5867452|P2|STARTED|Overall Study||3552
2391544|NCT01390909|5867453|P1|STARTED|Overall Study||3454
2391545|NCT01390870|5867471|P1|NOT COMPLETED|Overall Study||0
2391546|NCT01390870|5867471|P1|COMPLETED|Overall Study||400
2391547|NCT01390870|5867471|P1|STARTED|Overall Study||400
2391548|NCT01390857|5867475|P1|NOT COMPLETED|Overall Study||10
2391549|NCT01390857|5867475|P1|COMPLETED|Overall Study||369
2391550|NCT01390857|5867475|P1|STARTED|Overall Study||379
2391551|NCT01390844|5867486|P4|NOT COMPLETED|Follow-Up Phase||0
2391552|NCT01390844|5867487|P3|NOT COMPLETED|Follow-Up Phase||1
2391553|NCT01390844|5867488|P2|NOT COMPLETED|Follow-Up Phase||1
2391554|NCT01390844|5867489|P1|NOT COMPLETED|Follow-Up Phase||1
2391555|NCT01390844|5867486|P4|COMPLETED|Follow-Up Phase||8
2391556|NCT01390844|5867487|P3|COMPLETED|Follow-Up Phase||25
2391557|NCT01390844|5867488|P2|COMPLETED|Follow-Up Phase||36
2391558|NCT01390844|5867489|P1|COMPLETED|Follow-Up Phase||92
2391559|NCT01390844|5867486|P4|STARTED|Follow-Up Phase||8
2391560|NCT01390844|5867487|P3|STARTED|Follow-Up Phase||26
2391561|NCT01390844|5867488|P2|STARTED|Follow-Up Phase||37
2391562|NCT01390844|5867489|P1|STARTED|Follow-Up Phase||93
2391563|NCT01390844|5867486|P4|NOT COMPLETED|Treatment Phase||19
2391564|NCT01390844|5867487|P3|NOT COMPLETED|Treatment Phase||31
2391565|NCT01390844|5867488|P2|NOT COMPLETED|Treatment Phase||28
2391566|NCT01390844|5867489|P1|NOT COMPLETED|Treatment Phase||40
2391567|NCT01390844|5867486|P4|COMPLETED|Treatment Phase||8
2391568|NCT01390844|5867487|P3|COMPLETED|Treatment Phase||26
2391569|NCT01390844|5867488|P2|COMPLETED|Treatment Phase||37
2391570|NCT01390844|5867489|P1|COMPLETED|Treatment Phase||93
2391571|NCT01390844|5867486|P4|Followed Good Clinical Practice (GCP)|Treatment Phase||24
2391572|NCT01390844|5867487|P3|Followed Good Clinical Practice (GCP)|Treatment Phase||47
2391573|NCT01390844|5867488|P2|Followed Good Clinical Practice (GCP)|Treatment Phase||65
2391574|NCT01390844|5867489|P1|Followed Good Clinical Practice (GCP)|Treatment Phase||133
2391575|NCT01390844|5867486|P4|STARTED|Treatment Phase||27
2391576|NCT01390844|5867487|P3|STARTED|Treatment Phase||57
2391577|NCT01390844|5867488|P2|STARTED|Treatment Phase||65
2391578|NCT01390844|5867489|P1|STARTED|Treatment Phase||133
2391579|NCT01390818|5867530|P15|NOT COMPLETED|Overall Study||0
2391580|NCT01390818|5867531|P14|NOT COMPLETED|Overall Study||0
2391581|NCT01390818|5867532|P13|NOT COMPLETED|Overall Study||0
2391582|NCT01390818|5867533|P12|NOT COMPLETED|Overall Study||0
2391583|NCT01390818|5867534|P11|NOT COMPLETED|Overall Study||0
2391584|NCT01390818|5867535|P10|NOT COMPLETED|Overall Study||0
2391585|NCT01390818|5867536|P9|NOT COMPLETED|Overall Study||0
2391586|NCT01390818|5867537|P8|NOT COMPLETED|Overall Study||0
2391587|NCT01390818|5867538|P7|NOT COMPLETED|Overall Study||0
2391588|NCT01390818|5867539|P6|NOT COMPLETED|Overall Study||0
2391589|NCT01390818|5867540|P5|NOT COMPLETED|Overall Study||0
2391590|NCT01390818|5867541|P4|NOT COMPLETED|Overall Study||0
2391591|NCT01390818|5867542|P3|NOT COMPLETED|Overall Study||0
2391592|NCT01390818|5867543|P2|NOT COMPLETED|Overall Study||0
2391593|NCT01390818|5867544|P1|NOT COMPLETED|Overall Study||0
2391594|NCT01390818|5867530|P15|COMPLETED|Overall Study||15
2391595|NCT01390818|5867531|P14|COMPLETED|Overall Study||18
2391596|NCT01390818|5867532|P13|COMPLETED|Overall Study||24
2391597|NCT01390818|5867533|P12|COMPLETED|Overall Study||26
2391598|NCT01390818|5867534|P11|COMPLETED|Overall Study||4
2391599|NCT01390818|5867535|P10|COMPLETED|Overall Study||3
2391600|NCT01390818|5867536|P9|COMPLETED|Overall Study||3
2391601|NCT01390818|5867537|P8|COMPLETED|Overall Study||14
2391602|NCT01390818|5867538|P7|COMPLETED|Overall Study||19
2391603|NCT01390818|5867539|P6|COMPLETED|Overall Study||3
2391604|NCT01390818|5867540|P5|COMPLETED|Overall Study||4
2391605|NCT01390818|5867541|P4|COMPLETED|Overall Study||4
2391606|NCT01390818|5867542|P3|COMPLETED|Overall Study||3
2391607|NCT01390818|5867543|P2|COMPLETED|Overall Study||3
2391608|NCT01390818|5867544|P1|COMPLETED|Overall Study||3
2391609|NCT01390818|5867530|P15|STARTED|Overall Study||15
2391610|NCT01390818|5867531|P14|STARTED|Overall Study||18
2391611|NCT01390818|5867532|P13|STARTED|Overall Study||24
2391612|NCT01390818|5867533|P12|STARTED|Overall Study||26
2391613|NCT01390818|5867534|P11|STARTED|Overall Study||4
2391614|NCT01390818|5867535|P10|STARTED|Overall Study||3
2391615|NCT01390818|5867536|P9|STARTED|Overall Study||3
2391616|NCT01390818|5867537|P8|STARTED|Overall Study||14
2391617|NCT01390818|5867538|P7|STARTED|Overall Study||19
2391618|NCT01390818|5867539|P6|STARTED|Overall Study||3
2391619|NCT01390818|5867540|P5|STARTED|Overall Study||4
2391620|NCT01390818|5867541|P4|STARTED|Overall Study||4
2391621|NCT01390818|5867542|P3|STARTED|Overall Study||3
2391622|NCT01390818|5867543|P2|STARTED|Overall Study||3
2391623|NCT01390818|5867544|P1|STARTED|Overall Study||3
2391624|NCT01390779|5867816|P1|NOT COMPLETED|Overall Study||1
2391625|NCT01390779|5867816|P1|COMPLETED|Overall Study||32
2391626|NCT01390779|5867816|P1|STARTED|Overall Study||33
2391627|NCT01390649|5867821|P1|NOT COMPLETED|Overall Study||1
2391628|NCT01390649|5867821|P1|COMPLETED|Overall Study||56
2391629|NCT01390649|5867821|P1|STARTED|Overall Study|Subjects treated with Privigen|57
2391630|NCT01390441|5867831|P5|NOT COMPLETED|Extension Period||0
2391631|NCT01390441|5867832|P4|NOT COMPLETED|Extension Period||1
2391632|NCT01390441|5867833|P3|NOT COMPLETED|Extension Period||0
2391633|NCT01390441|5867834|P2|NOT COMPLETED|Extension Period||1
2391634|NCT01390441|5867835|P1|NOT COMPLETED|Extension Period||3
2391635|NCT01390441|5867831|P5|COMPLETED|Extension Period||3
2391636|NCT01390441|5867832|P4|COMPLETED|Extension Period||0
2391637|NCT01390441|5867833|P3|COMPLETED|Extension Period||1
2391638|NCT01390441|5867834|P2|COMPLETED|Extension Period||12
2391639|NCT01390441|5867835|P1|COMPLETED|Extension Period||12
2391640|NCT01390441|5867831|P5|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|3
2391641|NCT01390441|5867832|P4|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
2391642|NCT01390441|5867833|P3|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
2391643|NCT01390441|5867834|P2|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|13
2391644|NCT01390441|5867835|P1|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|15
2391645|NCT01390441|5867831|P5|NOT COMPLETED|Treatment Period||11
2391646|NCT01390441|5867832|P4|NOT COMPLETED|Treatment Period||13
2391647|NCT01390441|5867833|P3|NOT COMPLETED|Treatment Period||10
2391648|NCT01390441|5867834|P2|NOT COMPLETED|Treatment Period||1
2391649|NCT01390441|5867835|P1|NOT COMPLETED|Treatment Period||1
2391650|NCT01390441|5867831|P5|COMPLETED|Treatment Period||7
2391651|NCT01390441|5867832|P4|COMPLETED|Treatment Period||6
2391652|NCT01390441|5867833|P3|COMPLETED|Treatment Period||8
2391653|NCT01390441|5867834|P2|COMPLETED|Treatment Period||21
2391654|NCT01390441|5867835|P1|COMPLETED|Treatment Period||22
2391655|NCT01390441|5867831|P5|STARTED|Treatment Period||18
2391656|NCT01390441|5867832|P4|STARTED|Treatment Period||19
2391657|NCT01390441|5867833|P3|STARTED|Treatment Period||18
2391658|NCT01390441|5867834|P2|STARTED|Treatment Period||22
2391659|NCT01390441|5867835|P1|STARTED|Treatment Period||23
2391660|NCT01390428|5867900|P6|NOT COMPLETED|Overall Study||0
2391661|NCT01390428|5867901|P5|NOT COMPLETED|Overall Study||1
2391662|NCT01390428|5867902|P4|NOT COMPLETED|Overall Study||0
2391663|NCT01390428|5867903|P3|NOT COMPLETED|Overall Study||1
2391664|NCT01390428|5867904|P2|NOT COMPLETED|Overall Study||0
2391665|NCT01390428|5867905|P1|NOT COMPLETED|Overall Study||0
2391666|NCT01390428|5867900|P6|COMPLETED|Overall Study||8
2391667|NCT01390428|5867901|P5|COMPLETED|Overall Study||7
2391668|NCT01390428|5867902|P4|COMPLETED|Overall Study||9
2391669|NCT01390428|5867903|P3|COMPLETED|Overall Study||8
2391670|NCT01390428|5867904|P2|COMPLETED|Overall Study||8
2391671|NCT01390428|5867905|P1|COMPLETED|Overall Study||8
2391672|NCT01390428|5867900|P6|STARTED|Overall Study||8
2391673|NCT01390428|5867901|P5|STARTED|Overall Study||8
2391674|NCT01390428|5867902|P4|STARTED|Overall Study||9
2391675|NCT01390428|5867903|P3|STARTED|Overall Study||9
2391676|NCT01390428|5867904|P2|STARTED|Overall Study||8
2391677|NCT01390428|5867905|P1|STARTED|Overall Study||8
2391678|NCT01390415|5867957|P2|NOT COMPLETED|Overall Study||0
2391679|NCT01390415|5867958|P1|NOT COMPLETED|Overall Study||0
2391680|NCT01390415|5867957|P2|COMPLETED|Overall Study||37
2391681|NCT01390415|5867958|P1|COMPLETED|Overall Study||99
2391682|NCT01390415|5867957|P2|STARTED|Overall Study||37
2391683|NCT01390415|5867958|P1|STARTED|Overall Study||99
2391684|NCT01390402|5867968|P1|NOT COMPLETED|Overall Study||5
2391685|NCT01390402|5867968|P1|COMPLETED|Overall Study||1
2391686|NCT01390402|5867968|P1|STARTED|Overall Study||6
2391687|NCT01390389|5867974|P2|NOT COMPLETED|Overall Study||1
2391688|NCT01390389|5867975|P1|NOT COMPLETED|Overall Study||4
2391689|NCT01390389|5867974|P2|COMPLETED|Overall Study||8
2391690|NCT01390389|5867975|P1|COMPLETED|Overall Study||6
2391691|NCT01390389|5867974|P2|STARTED|Overall Study||9
2391692|NCT01390389|5867975|P1|STARTED|Overall Study||10
2391693|NCT01390298|5867985|P1|NOT COMPLETED|Overall Study||24
2391694|NCT01390298|5867985|P1|COMPLETED|Overall Study||31
2391695|NCT01390298|5867985|P1|STARTED|Overall Study||55
2391696|NCT01390272|5867991|P2|NOT COMPLETED|Overall Study||15
2391697|NCT01390272|5867992|P1|NOT COMPLETED|Overall Study||17
2391698|NCT01390272|5867991|P2|COMPLETED|Overall Study||178
2391699|NCT01390272|5867992|P1|COMPLETED|Overall Study||175
2391700|NCT01390272|5867991|P2|18 Month Follow up|Overall Study|33 of 193 in the LPN control group had missing blood pressure measurement|160
2391701|NCT01390272|5867992|P1|18 Month Follow up|Overall Study|37 of 192 participants in the Titration Intervention group had missing blood pressure measurement|155
2391702|NCT01390272|5867991|P2|12 Month Follow up|Overall Study|34 of 193 in the LPN control group had missing blood pressure measurement|159
2391703|NCT01390272|5867992|P1|12 Month Follow up|Overall Study|53 of 192 participants in the Titration Intervention group had missing measurement|139
2391704|NCT01390272|5867991|P2|6 Month Follow up|Overall Study|22 of 193 in the LPN control group had missing blood pressure measurement|171
2391705|NCT01390272|5867992|P1|6 Month Follow up|Overall Study|30 of 192 participants in the Titration Intervention group had missing blood pressure measurement|162
2391706|NCT01390272|5867991|P2|STARTED|Overall Study||193
2391707|NCT01390272|5867992|P1|STARTED|Overall Study||192
2391708|NCT01390259|5868022|P2|NOT COMPLETED|Overall Study||0
2391709|NCT01390259|5868023|P1|NOT COMPLETED|Overall Study||0
2391710|NCT01390259|5868022|P2|COMPLETED|Overall Study||6
2391711|NCT01390259|5868023|P1|COMPLETED|Overall Study||5
2391712|NCT01390259|5868022|P2|STARTED|Overall Study||6
2391713|NCT01390259|5868023|P1|STARTED|Overall Study||5
2391714|NCT01390246|5868034|P2|NOT COMPLETED|Overall Study||25
2391715|NCT01390246|5868035|P1|NOT COMPLETED|Overall Study||20
2391716|NCT01390246|5868034|P2|COMPLETED|Overall Study||10
2391717|NCT01390246|5868035|P1|COMPLETED|Overall Study||10
2391718|NCT01390246|5868034|P2|Visit 7: 36-38 Weeks Gestation|Overall Study||10
2391719|NCT01390246|5868035|P1|Visit 7: 36-38 Weeks Gestation|Overall Study||10
2391720|NCT01390246|5868034|P2|Visit 6: End of Treatment|Overall Study||15
2391721|NCT01390246|5868035|P1|Visit 6: End of Treatment|Overall Study||15
2391722|NCT01390246|5868034|P2|Visit 2: Quit Day|Overall Study||24
2391723|NCT01390246|5868035|P1|Visit 2: Quit Day|Overall Study||24
2391724|NCT01390246|5868034|P2|STARTED|Overall Study||35
2391725|NCT01390246|5868035|P1|STARTED|Overall Study||30
2391726|NCT01390233|5868050|P3|NOT COMPLETED|Overall Study||6
2391727|NCT01390233|5868051|P2|NOT COMPLETED|Overall Study||2
2391728|NCT01390233|5868052|P1|NOT COMPLETED|Overall Study||5
2391729|NCT01390233|5868050|P3|COMPLETED|Overall Study||30
2391730|NCT01390233|5868051|P2|COMPLETED|Overall Study||29
2391731|NCT01390233|5868052|P1|COMPLETED|Overall Study||30
2391732|NCT01390233|5868050|P3|STARTED|Overall Study||36
2391733|NCT01390233|5868051|P2|STARTED|Overall Study||31
2391734|NCT01390233|5868052|P1|STARTED|Overall Study||35
2391735|NCT01390220|5868060|P3|NOT COMPLETED|Comparative Phase||0
2391736|NCT01390220|5868061|P2|NOT COMPLETED|Comparative Phase||1
2391737|NCT01390220|5868062|P1|NOT COMPLETED|Comparative Phase||0
2391738|NCT01390220|5868060|P3|COMPLETED|Comparative Phase||67
2391739|NCT01390220|5868061|P2|COMPLETED|Comparative Phase||133
2391740|NCT01390220|5868062|P1|COMPLETED|Comparative Phase|This arm not applicable in CP|0
2391741|NCT01390220|5868060|P3|STARTED|Comparative Phase||67
2391742|NCT01390220|5868061|P2|STARTED|Comparative Phase||134
2391743|NCT01390220|5868062|P1|STARTED|Comparative Phase|This arm not applicable in CP|0
2391744|NCT01390220|5868060|P3|NOT COMPLETED|Test Dose Phase||0
2391745|NCT01390220|5868061|P2|NOT COMPLETED|Test Dose Phase||0
2391746|NCT01390220|5868062|P1|NOT COMPLETED|Test Dose Phase||91
2391747|NCT01390220|5868060|P3|COMPLETED|Test Dose Phase||0
2391748|NCT01390220|5868061|P2|COMPLETED|Test Dose Phase||0
2391749|NCT01390220|5868062|P1|COMPLETED|Test Dose Phase||201
2391750|NCT01390220|5868060|P3|STARTED|Test Dose Phase|This arm not applicable in TDP.|0
2391751|NCT01390220|5868061|P2|STARTED|Test Dose Phase|This arm not applicable in TDP.|0
2391752|NCT01390220|5868062|P1|STARTED|Test Dose Phase||292
2391753|NCT01390181|5868077|P1|NOT COMPLETED|Overall Study||4
2391754|NCT01390181|5868077|P1|COMPLETED|Overall Study||0
2391755|NCT01390181|5868077|P1|STARTED|Overall Study||4
2391756|NCT01390064|5868083|P2|NOT COMPLETED|Overall Study||0
2391757|NCT01390064|5868084|P1|NOT COMPLETED|Overall Study||0
2391758|NCT01390064|5868083|P2|COMPLETED|Overall Study||3
2391759|NCT01390064|5868084|P1|COMPLETED|Overall Study||3
2391760|NCT01390064|5868083|P2|STARTED|Overall Study||3
2391761|NCT01390064|5868084|P1|STARTED|Overall Study||3
2391762|NCT01390038|5868090|P1|NOT COMPLETED|Overall Study||8
2391763|NCT01390038|5868090|P1|COMPLETED|Overall Study||149
2391764|NCT01390038|5868090|P1|STARTED|Overall Study||157
2391765|NCT01389973|5868100|P1|NOT COMPLETED|Overall Study||20
2391766|NCT01389973|5868100|P1|COMPLETED|Overall Study||0
2391767|NCT01389973|5868100|P1|STARTED|Overall Study||20
2391768|NCT01389882|5868110|P2|NOT COMPLETED|Overall Study||4
2391769|NCT01389882|5868111|P1|NOT COMPLETED|Overall Study||1
2391770|NCT01389882|5868110|P2|COMPLETED|Overall Study||7
2391771|NCT01389882|5868111|P1|COMPLETED|Overall Study||12
2391772|NCT01389882|5868110|P2|STARTED|Overall Study||11
2391773|NCT01389882|5868111|P1|STARTED|Overall Study||13
2391774|NCT01389856|5868141|P2|NOT COMPLETED|Overall Study||0
2391775|NCT01389856|5868142|P1|NOT COMPLETED|Overall Study||0
2391776|NCT01389856|5868141|P2|COMPLETED|Overall Study||8
2391777|NCT01389856|5868142|P1|COMPLETED|Overall Study||13
2391778|NCT01389856|5868141|P2|STARTED|Overall Study|Randomized and treated.|8
2391779|NCT01389856|5868142|P1|STARTED|Overall Study|Randomized and treated. An additional 2 patients were randomized but not treated.|13
2391780|NCT01389817|5868199|P2|NOT COMPLETED|Overall Study||0
2391781|NCT01389817|5868200|P1|NOT COMPLETED|Overall Study||4
2391782|NCT01389817|5868199|P2|COMPLETED|Overall Study||0
2391783|NCT01389817|5868200|P1|COMPLETED|Overall Study||0
2391784|NCT01389817|5868199|P2|STARTED|Overall Study||0
2391785|NCT01389817|5868200|P1|STARTED|Overall Study||4
2391786|NCT01389765|5868206|P2|NOT COMPLETED|Second Intervention (Day 1)||0
2391787|NCT01389765|5868207|P1|NOT COMPLETED|Second Intervention (Day 1)||0
2391788|NCT01389765|5868206|P2|COMPLETED|Second Intervention (Day 1)||12
2391789|NCT01389765|5868207|P1|COMPLETED|Second Intervention (Day 1)||12
2391790|NCT01389765|5868206|P2|STARTED|Second Intervention (Day 1)||12
2391791|NCT01389765|5868207|P1|STARTED|Second Intervention (Day 1)||12
2391792|NCT01389765|5868206|P2|NOT COMPLETED|Washout Period (7 Days)||0
2391793|NCT01389765|5868207|P1|NOT COMPLETED|Washout Period (7 Days)||0
2391794|NCT01389765|5868206|P2|COMPLETED|Washout Period (7 Days)||12
2391795|NCT01389765|5868207|P1|COMPLETED|Washout Period (7 Days)||12
2391796|NCT01389765|5868206|P2|STARTED|Washout Period (7 Days)||12
2391797|NCT01389765|5868207|P1|STARTED|Washout Period (7 Days)||12
2391798|NCT01389765|5868206|P2|NOT COMPLETED|First Intervention (Day 1)||0
2391799|NCT01389765|5868207|P1|NOT COMPLETED|First Intervention (Day 1)||0
2391800|NCT01389765|5868206|P2|COMPLETED|First Intervention (Day 1)||12
2391801|NCT01389765|5868207|P1|COMPLETED|First Intervention (Day 1)||12
2391802|NCT01389765|5868206|P2|STARTED|First Intervention (Day 1)||12
2391803|NCT01389765|5868207|P1|STARTED|First Intervention (Day 1)||12
2391804|NCT01389752|5868217|P2|NOT COMPLETED|Study Period 2||0
2391805|NCT01389752|5868218|P1|NOT COMPLETED|Study Period 2||1
2391806|NCT01389752|5868217|P2|COMPLETED|Study Period 2||9
2391807|NCT01389752|5868218|P1|COMPLETED|Study Period 2||10
2391808|NCT01389752|5868217|P2|STARTED|Study Period 2||9
2391809|NCT01389752|5868218|P1|STARTED|Study Period 2||11
2391810|NCT01389752|5868217|P2|NOT COMPLETED|Study Period 1||2
2391811|NCT01389752|5868218|P1|NOT COMPLETED|Study Period 1||0
2391812|NCT01389752|5868217|P2|COMPLETED|Study Period 1||9
2391813|NCT01389752|5868218|P1|COMPLETED|Study Period 1||11
2391814|NCT01389752|5868217|P2|STARTED|Study Period 1||11
2391815|NCT01389752|5868218|P1|STARTED|Study Period 1||11
2391816|NCT01389596|5868231|P3|NOT COMPLETED|Overall Study||10
2391817|NCT01389596|5868232|P2|NOT COMPLETED|Overall Study||16
2391818|NCT01389596|5868233|P1|NOT COMPLETED|Overall Study||10
2391819|NCT01389596|5868231|P3|COMPLETED|Overall Study||84
2391820|NCT01389596|5868232|P2|COMPLETED|Overall Study||81
2391821|NCT01389596|5868233|P1|COMPLETED|Overall Study||94
2391822|NCT01389596|5868231|P3|STARTED|Overall Study||94
2391823|NCT01389596|5868232|P2|STARTED|Overall Study||97
2391824|NCT01389596|5868233|P1|STARTED|Overall Study||104
2391825|NCT01389323|5868292|P1|NOT COMPLETED|Follow-up Period (up to 48 Weeks)||37
2391826|NCT01389323|5868292|P1|COMPLETED|Follow-up Period (up to 48 Weeks)||184
2391827|NCT01389323|5868292|P1|STARTED|Follow-up Period (up to 48 Weeks)|Out of 246 participants who entered the treatment period, 221 continued in the follow-up period.|221
2391828|NCT01389323|5868292|P1|NOT COMPLETED|Treatment Period (up to 48 Weeks)||95
2391829|NCT01389323|5868292|P1|COMPLETED|Treatment Period (up to 48 Weeks)||151
2391830|NCT01389323|5868292|P1|STARTED|Treatment Period (up to 48 Weeks)||246
2391831|NCT01389284|5868315|P3|NOT COMPLETED|Overall Study||0
2391832|NCT01389284|5868316|P2|NOT COMPLETED|Overall Study||0
2391833|NCT01389284|5868317|P1|NOT COMPLETED|Overall Study||0
2391834|NCT01389284|5868315|P3|COMPLETED|Overall Study||60
2391835|NCT01389284|5868316|P2|COMPLETED|Overall Study||120
2391836|NCT01389284|5868317|P1|COMPLETED|Overall Study||120
2391837|NCT01389284|5868315|P3|STARTED|Overall Study||60
2391838|NCT01389284|5868316|P2|STARTED|Overall Study||120
2391839|NCT01389284|5868317|P1|STARTED|Overall Study||120
2391840|NCT01389258|5868349|P1|NOT COMPLETED|Overall Study||5
2391841|NCT01389258|5868349|P1|COMPLETED|Overall Study||40
2391842|NCT01389258|5868349|P1|STARTED|Overall Study||45
2391843|NCT01389128|5868361|P2|NOT COMPLETED|Overall Study||6
2391844|NCT01389128|5868362|P1|NOT COMPLETED|Overall Study||5
2391845|NCT01389128|5868361|P2|COMPLETED|Overall Study||34
2391846|NCT01389128|5868362|P1|COMPLETED|Overall Study||35
2391847|NCT01389128|5868361|P2|STARTED|Overall Study||40
2391848|NCT01389128|5868362|P1|STARTED|Overall Study||40
2391849|NCT01389102|5868386|P6|NOT COMPLETED|Overall Study||8
2391850|NCT01389102|5868387|P5|NOT COMPLETED|Overall Study||13
2391851|NCT01389102|5868388|P4|NOT COMPLETED|Overall Study||7
2391852|NCT01389102|5868389|P3|NOT COMPLETED|Overall Study||19
2391853|NCT01389102|5868390|P2|NOT COMPLETED|Overall Study||12
2391854|NCT01389102|5868391|P1|NOT COMPLETED|Overall Study||18
2391855|NCT01389102|5868386|P6|COMPLETED|Overall Study||68
2391856|NCT01389102|5868387|P5|COMPLETED|Overall Study||61
2391857|NCT01389102|5868388|P4|COMPLETED|Overall Study||69
2391858|NCT01389102|5868389|P3|COMPLETED|Overall Study||58
2391859|NCT01389102|5868390|P2|COMPLETED|Overall Study||64
2391860|NCT01389102|5868391|P1|COMPLETED|Overall Study||57
2391861|NCT01389102|5868386|P6|STARTED|Overall Study||76
2391862|NCT01389102|5868387|P5|STARTED|Overall Study||74
2391863|NCT01389102|5868388|P4|STARTED|Overall Study||76
2391864|NCT01389102|5868389|P3|STARTED|Overall Study||77
2391865|NCT01389102|5868390|P2|STARTED|Overall Study||76
2391866|NCT01389102|5868391|P1|STARTED|Overall Study||75
2391867|NCT01389076|5868411|P1|NOT COMPLETED|Overall Study||0
2391868|NCT01389076|5868411|P1|COMPLETED|Overall Study||22
2391869|NCT01389076|5868411|P1|STARTED|Overall Study||22
2391870|NCT01388985|5868421|P2|NOT COMPLETED|Overall Study||38
2391871|NCT01388985|5868422|P1|NOT COMPLETED|Overall Study||49
2391872|NCT01388985|5868421|P2|COMPLETED|Overall Study|From those 200, 28 were excluded from the per protocol analysis.|211
2391873|NCT01388985|5868422|P1|COMPLETED|Overall Study|From those 200, 15 were excluded from the per protocol analysis.|200
2391874|NCT01388985|5868421|P2|Primary Vaccination Period|Overall Study||238
2391875|NCT01388985|5868422|P1|Primary Vaccination Period|Overall Study||231
2391876|NCT01388985|5868421|P2|STARTED|Overall Study|1 participant (from the 250 enrolled) did not receive any vaccination because of consent withdrawal.|249
2391877|NCT01388985|5868422|P1|STARTED|Overall Study|1 participant (from the 250 enrolled) did not receive any vaccination because of consent withdrawal.|249
2391878|NCT01388946|5868438|P2|NOT COMPLETED|Overall Study||3
2391879|NCT01388946|5868439|P1|NOT COMPLETED|Overall Study||6
2391880|NCT01388946|5868438|P2|COMPLETED|Overall Study||52
2391881|NCT01388946|5868439|P1|COMPLETED|Overall Study||49
2391882|NCT01388946|5868438|P2|STARTED|Overall Study||55
2391883|NCT01388946|5868439|P1|STARTED|Overall Study||55
2391884|NCT01388920|5868474|P3|NOT COMPLETED|Overall Study||0
2391885|NCT01388920|5868475|P2|NOT COMPLETED|Overall Study||0
2391886|NCT01388920|5868476|P1|NOT COMPLETED|Overall Study||0
2391887|NCT01388920|5868474|P3|COMPLETED|Overall Study||0
2391888|NCT01388920|5868475|P2|COMPLETED|Overall Study||1
2391889|NCT01388920|5868476|P1|COMPLETED|Overall Study||1
2391890|NCT01388920|5868474|P3|STARTED|Overall Study||0
2391891|NCT01388920|5868475|P2|STARTED|Overall Study||1
2391892|NCT01388920|5868476|P1|STARTED|Overall Study||1
2391893|NCT01388907|5868486|P2|NOT COMPLETED|Overall Study||0
2391894|NCT01388907|5868487|P1|NOT COMPLETED|Overall Study||2
2391895|NCT01388907|5868486|P2|COMPLETED|Overall Study||28
2391896|NCT01388907|5868487|P1|COMPLETED|Overall Study||31
2391897|NCT01388907|5868486|P2|STARTED|Overall Study||28
2391898|NCT01388907|5868487|P1|STARTED|Overall Study||33
2391899|NCT01388816|5868503|P4|NOT COMPLETED|Overall Study||0
2391900|NCT01388816|5868504|P3|NOT COMPLETED|Overall Study||3
2391901|NCT01388816|5868505|P2|NOT COMPLETED|Overall Study||4
2391902|NCT01388816|5868506|P1|NOT COMPLETED|Overall Study||2
2391903|NCT01388816|5868503|P4|COMPLETED|Overall Study||44
2391904|NCT01388816|5868504|P3|COMPLETED|Overall Study||41
2391905|NCT01388816|5868505|P2|COMPLETED|Overall Study||39
2391906|NCT01388816|5868506|P1|COMPLETED|Overall Study||43
2391907|NCT01388816|5868503|P4|STARTED|Overall Study||44
2391908|NCT01388816|5868504|P3|STARTED|Overall Study||44
2391909|NCT01388816|5868505|P2|STARTED|Overall Study||43
2391910|NCT01388816|5868506|P1|STARTED|Overall Study||45
2391911|NCT01388790|5868535|P1|NOT COMPLETED|Overall Study||8
2391912|NCT01388790|5868535|P1|COMPLETED|Overall Study||32
2391913|NCT01388790|5868535|P1|STARTED|Overall Study||40
2391914|NCT01388777|5868540|P1|NOT COMPLETED|Overall Study||0
2391915|NCT01388777|5868540|P1|COMPLETED|Overall Study||1
2391916|NCT01388777|5868540|P1|Cryoablation|Overall Study||1
2391917|NCT01388777|5868540|P1|STARTED|Overall Study||1
2391918|NCT01388647|5868546|P2|NOT COMPLETED|Overall Study||2
2391919|NCT01388647|5868547|P1|NOT COMPLETED|Overall Study||1
2391920|NCT01388647|5868546|P2|COMPLETED|Overall Study|two subjects ended study treatment due to adverse events|4
2391921|NCT01388647|5868547|P1|COMPLETED|Overall Study|one subject ended study treatment due to adverse events|5
2391922|NCT01388647|5868546|P2|STARTED|Overall Study||6
2391923|NCT01388647|5868547|P1|STARTED|Overall Study||6
2391924|NCT01388543|5868560|P2|NOT COMPLETED|Day 14||4
2391925|NCT01388543|5868561|P1|NOT COMPLETED|Day 14||1
2391926|NCT01388543|5868560|P2|COMPLETED|Day 14||12
2391927|NCT01388543|5868561|P1|COMPLETED|Day 14||14
2391928|NCT01388543|5868560|P2|STARTED|Day 14||16
2391929|NCT01388543|5868561|P1|STARTED|Day 14||15
2391930|NCT01388543|5868560|P2|NOT COMPLETED|Day 7, Primary End Point||0
2391931|NCT01388543|5868561|P1|NOT COMPLETED|Day 7, Primary End Point||0
2391932|NCT01388543|5868560|P2|COMPLETED|Day 7, Primary End Point||16
2391933|NCT01388543|5868561|P1|COMPLETED|Day 7, Primary End Point||15
2391934|NCT01388543|5868560|P2|STARTED|Day 7, Primary End Point||16
2391935|NCT01388543|5868561|P1|STARTED|Day 7, Primary End Point||15
2391936|NCT01388530|5868567|P1|NOT COMPLETED|Overall Study||5
2391937|NCT01388530|5868567|P1|COMPLETED|Overall Study||20
2391938|NCT01388530|5868567|P1|STARTED|Overall Study||25
2391939|NCT01388491|5868576|P2|NOT COMPLETED|Overall Study||29
2391940|NCT01388491|5868577|P1|NOT COMPLETED|Overall Study||34
2391941|NCT01388491|5868576|P2|COMPLETED|Overall Study||114
2391942|NCT01388491|5868577|P1|COMPLETED|Overall Study||116
2391943|NCT01388491|5868576|P2|Per Protocol (PP) Population|Overall Study||121
2391944|NCT01388491|5868577|P1|Per Protocol (PP) Population|Overall Study|PP: all data from ITT participants obtained prior to any major protocol violations|125
2391945|NCT01388491|5868576|P2|Intent-to-Treat (ITT) Population|Overall Study||136
2391946|NCT01388491|5868577|P1|Intent-to-Treat (ITT) Population|Overall Study|ITT:participants in safety population with baseline (BL) + ≥1 post-BL prothrombin fragment 1+2 value|140
2391947|NCT01388491|5868576|P2|Safety Population|Overall Study||142
2391948|NCT01388491|5868577|P1|Safety Population|Overall Study|Safety: all randomized participants who took 1 or more doses of study drug|145
2391949|NCT01388491|5868576|P2|STARTED|Overall Study||143
2391950|NCT01388491|5868577|P1|STARTED|Overall Study|number randomized|150
2391951|NCT01388361|5868612|P3|NOT COMPLETED|Overall Study||14
2391952|NCT01388361|5868613|P2|NOT COMPLETED|Overall Study||12
2391953|NCT01388361|5868614|P1|NOT COMPLETED|Overall Study||12
2391954|NCT01388361|5868612|P3|COMPLETED|Overall Study||75
2391955|NCT01388361|5868613|P2|COMPLETED|Overall Study||76
2391956|NCT01388361|5868614|P1|COMPLETED|Overall Study||224
2391957|NCT01388361|5868612|P3|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug.|86
2391958|NCT01388361|5868613|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|87
2391959|NCT01388361|5868614|P1|Exposed|Overall Study|Two subjects withdrew prior to exposure to IDeg during NN1250-3948|234
2391960|NCT01388361|5868612|P3|STARTED|Overall Study||89
2391961|NCT01388361|5868613|P2|STARTED|Overall Study||88
2391962|NCT01388361|5868614|P1|STARTED|Overall Study||236
2391963|NCT01388166|5868631|P1|NOT COMPLETED|Overall Study||59
2391964|NCT01388166|5868631|P1|COMPLETED|Overall Study||1194
2391965|NCT01388166|5868631|P1|STARTED|Overall Study||1253
2391966|NCT01387815|5868639|P2|NOT COMPLETED|Overall Study||104
2391967|NCT01387815|5868640|P1|NOT COMPLETED|Overall Study||140
2391968|NCT01387815|5868639|P2|COMPLETED|Overall Study||189
2391969|NCT01387815|5868640|P1|COMPLETED|Overall Study||162
2391970|NCT01387815|5868639|P2|STARTED|Overall Study||293
2391971|NCT01387815|5868640|P1|STARTED|Overall Study||302
2391972|NCT01387789|5868934|P1|NOT COMPLETED|Overall Study||8
2391973|NCT01387789|5868934|P1|COMPLETED|Overall Study||63
2391974|NCT01387789|5868934|P1|STARTED|Overall Study||71
2391975|NCT01387737|5868948|P2|NOT COMPLETED|Overall Study||74
2391976|NCT01387737|5868949|P1|NOT COMPLETED|Overall Study||52
2391977|NCT01387737|5868948|P2|COMPLETED|Overall Study||641
2391978|NCT01387737|5868949|P1|COMPLETED|Overall Study||532
2391979|NCT01387737|5868948|P2|STARTED|Overall Study||715
2391980|NCT01387737|5868949|P1|STARTED|Overall Study||584
2391981|NCT01387672|5868961|P6|NOT COMPLETED|Overall Study||0
2391982|NCT01387672|5868962|P5|NOT COMPLETED|Overall Study||4
2391983|NCT01387672|5868963|P4|NOT COMPLETED|Overall Study||4
2391984|NCT01387672|5868964|P3|NOT COMPLETED|Overall Study||5
2391985|NCT01387672|5868965|P2|NOT COMPLETED|Overall Study||7
2391986|NCT01387672|5868966|P1|NOT COMPLETED|Overall Study||7
2391987|NCT01387672|5868961|P6|COMPLETED|Overall Study||37
2391988|NCT01387672|5868962|P5|COMPLETED|Overall Study||34
2391989|NCT01387672|5868963|P4|COMPLETED|Overall Study||35
2391990|NCT01387672|5868964|P3|COMPLETED|Overall Study||33
2391991|NCT01387672|5868965|P2|COMPLETED|Overall Study||31
2391992|NCT01387672|5868966|P1|COMPLETED|Overall Study||32
2391993|NCT01387672|5868961|P6|STARTED|Overall Study||37
2391994|NCT01387672|5868962|P5|STARTED|Overall Study||38
2391995|NCT01387672|5868963|P4|STARTED|Overall Study||39
2391996|NCT01387672|5868964|P3|STARTED|Overall Study||38
2391997|NCT01387672|5868965|P2|STARTED|Overall Study||38
2391998|NCT01387672|5868966|P1|STARTED|Overall Study||39
2391999|NCT01387607|5868983|P2|NOT COMPLETED|Overall Study||45
2392000|NCT01387607|5868984|P1|NOT COMPLETED|Overall Study||51
2392001|NCT01387607|5868983|P2|COMPLETED|Overall Study||125
2392002|NCT01387607|5868984|P1|COMPLETED|Overall Study||122
2392003|NCT01387607|5868983|P2|Received Treatment|Overall Study||164
2392004|NCT01387607|5868984|P1|Received Treatment|Overall Study||170
2392005|NCT01387607|5868983|P2|STARTED|Overall Study||170
2392006|NCT01387607|5868984|P1|STARTED|Overall Study||173
2392007|NCT01387594|5869038|P2|NOT COMPLETED|Overall Study||3
2392008|NCT01387594|5869039|P1|NOT COMPLETED|Overall Study||0
2392009|NCT01387594|5869038|P2|COMPLETED|Overall Study||36
2392010|NCT01387594|5869039|P1|COMPLETED|Overall Study||10
2392011|NCT01387594|5869038|P2|STARTED|Overall Study||39
2392012|NCT01387594|5869039|P1|STARTED|Overall Study||10
2392013|NCT01387581|5869054|P3|NOT COMPLETED|Overall Study||3
2392014|NCT01387581|5869055|P2|NOT COMPLETED|Overall Study||6
2392015|NCT01387581|5869056|P1|NOT COMPLETED|Overall Study||7
2392016|NCT01387581|5869054|P3|COMPLETED|Overall Study||9
2392017|NCT01387581|5869055|P2|COMPLETED|Overall Study||101
2392018|NCT01387581|5869056|P1|COMPLETED|Overall Study||101
2392019|NCT01387581|5869054|P3|STARTED|Overall Study||12
2392020|NCT01387581|5869055|P2|STARTED|Overall Study||107
2392021|NCT01387581|5869056|P1|STARTED|Overall Study||108
2392022|NCT01387542|5869067|P1|NOT COMPLETED|Overall Study||8
2392023|NCT01387542|5869067|P1|COMPLETED|Overall Study||32
2392024|NCT01387542|5869067|P1|Treated|Overall Study||38
2392025|NCT01387542|5869067|P1|STARTED|Overall Study||40
2392026|NCT01387464|5869076|P2|NOT COMPLETED|Overall Study||1
2392027|NCT01387464|5869077|P1|NOT COMPLETED|Overall Study||1
2392028|NCT01387464|5869076|P2|COMPLETED|Overall Study||29
2392029|NCT01387464|5869077|P1|COMPLETED|Overall Study||29
2392030|NCT01387464|5869076|P2|Per-Protocol Population|Overall Study||29
2392031|NCT01387464|5869077|P1|Per-Protocol Population|Overall Study|Safety subjects who completed surgery|29
2392032|NCT01387464|5869076|P2|Safety Population|Overall Study||29
2392033|NCT01387464|5869077|P1|Safety Population|Overall Study||30
2392034|NCT01387464|5869076|P2|STARTED|Overall Study||30
2392035|NCT01387464|5869077|P1|STARTED|Overall Study||30
2392036|NCT01387347|5869085|P2|NOT COMPLETED|Overall Study||1
2392037|NCT01387347|5869086|P1|NOT COMPLETED|Overall Study||2
2392038|NCT01387347|5869085|P2|COMPLETED|Overall Study||35
2392039|NCT01387347|5869086|P1|COMPLETED|Overall Study||34
2392040|NCT01387347|5869085|P2|STARTED|Overall Study||36
2392041|NCT01387347|5869086|P1|STARTED|Overall Study||36
2392042|NCT01387282|5869098|P2|NOT COMPLETED|Overall Study||47
2392043|NCT01387282|5869099|P1|NOT COMPLETED|Overall Study||97
2392044|NCT01387282|5869098|P2|COMPLETED|Overall Study||118
2392045|NCT01387282|5869099|P1|COMPLETED|Overall Study||233
2392046|NCT01387282|5869098|P2|Safety Population|Overall Study||161
2392047|NCT01387282|5869099|P1|Safety Population|Overall Study||330
2392048|NCT01387282|5869098|P2|MITT Population|Overall Study||136
2392049|NCT01387282|5869099|P1|MITT Population|Overall Study||268
2392050|NCT01387282|5869098|P2|ITT Population|Overall Study||165
2392051|NCT01387282|5869099|P1|ITT Population|Overall Study||330
2392052|NCT01387282|5869098|P2|STARTED|Overall Study||165
2392053|NCT01387282|5869099|P1|STARTED|Overall Study||330
2392054|NCT01387269|5869115|P2|NOT COMPLETED|Overall Study||40
2392055|NCT01387269|5869116|P1|NOT COMPLETED|Overall Study||92
2392056|NCT01387269|5869115|P2|COMPLETED|Overall Study||121
2392057|NCT01387269|5869116|P1|COMPLETED|Overall Study||231
2392058|NCT01387269|5869115|P2|Safety Population|Overall Study||161
2392059|NCT01387269|5869116|P1|Safety Population|Overall Study||320
2392060|NCT01387269|5869115|P2|MITT Population|Overall Study||141
2392061|NCT01387269|5869116|P1|MITT Population|Overall Study||284
2392062|NCT01387269|5869115|P2|ITT Population|Overall Study||161
2392063|NCT01387269|5869116|P1|ITT Population|Overall Study||323
2392064|NCT01387269|5869115|P2|STARTED|Overall Study||161
2392065|NCT01387269|5869116|P1|STARTED|Overall Study||323
2392066|NCT01387230|5869133|P3|NOT COMPLETED|Overall Study||13
2392067|NCT01387230|5869134|P2|NOT COMPLETED|Overall Study||7
2392068|NCT01387230|5869135|P1|NOT COMPLETED|Overall Study||18
2392069|NCT01387230|5869133|P3|COMPLETED|Overall Study||56
2392070|NCT01387230|5869134|P2|COMPLETED|Overall Study||62
2392071|NCT01387230|5869135|P1|COMPLETED|Overall Study||50
2392072|NCT01387230|5869133|P3|STARTED|Overall Study||69
2392073|NCT01387230|5869134|P2|STARTED|Overall Study||69
2392074|NCT01387230|5869135|P1|STARTED|Overall Study||68
2392075|NCT01387178|5869151|P2|NOT COMPLETED|Overall Study||0
2392076|NCT01387178|5869152|P1|NOT COMPLETED|Overall Study||0
2392077|NCT01387178|5869151|P2|COMPLETED|Overall Study||10641
2392078|NCT01387178|5869152|P1|COMPLETED|Overall Study||11582
2392079|NCT01387178|5869151|P2|STARTED|Overall Study||10641
2392080|NCT01387178|5869152|P1|STARTED|Overall Study||11582
2392081|NCT01387139|5869164|P2|NOT COMPLETED|Overall Study||0
2392082|NCT01387139|5869165|P1|NOT COMPLETED|Overall Study||0
2392083|NCT01387139|5869164|P2|COMPLETED|Overall Study||84
2392084|NCT01387139|5869165|P1|COMPLETED|Overall Study||99
2392085|NCT01387139|5869164|P2|STARTED|Overall Study||84
2392086|NCT01387139|5869165|P1|STARTED|Overall Study||99
2392087|NCT01387074|5869181|P1|NOT COMPLETED|Overall Study||8
2392088|NCT01387074|5869181|P1|COMPLETED|Overall Study||100
2392089|NCT01387074|5869181|P1|STARTED|Overall Study||108
2392090|NCT01387022|5869194|P2|NOT COMPLETED|Overall Study||4
2392091|NCT01387022|5869195|P1|NOT COMPLETED|Overall Study||1
2392092|NCT01387022|5869194|P2|COMPLETED|Overall Study||26
2392093|NCT01387022|5869195|P1|COMPLETED|Overall Study||28
2392094|NCT01387022|5869194|P2|STARTED|Overall Study||30
2392095|NCT01387022|5869195|P1|STARTED|Overall Study||29
2392096|NCT01386983|5869213|P2|NOT COMPLETED|Overall Study||0
2392097|NCT01386983|5869214|P1|NOT COMPLETED|Overall Study||0
2392098|NCT01386983|5869213|P2|COMPLETED|Overall Study||68
2392099|NCT01386983|5869214|P1|COMPLETED|Overall Study||264
2392100|NCT01386983|5869213|P2|STARTED|Overall Study||68
2392101|NCT01386983|5869214|P1|STARTED|Overall Study||264
2392102|NCT01386944|5869222|P1|NOT COMPLETED|Overall Study||56
2392103|NCT01386944|5869222|P1|COMPLETED|Overall Study||46
2392104|NCT01386944|5869222|P1|STARTED|Overall Study||102
2392105|NCT01386788|5869232|P1|NOT COMPLETED|Overall Study||2
2392106|NCT01386788|5869232|P1|COMPLETED|Overall Study||100
2392107|NCT01386788|5869232|P1|STARTED|Overall Study||102
2392108|NCT01386684|5869237|P1|NOT COMPLETED|Overall Study||293
2392109|NCT01386684|5869237|P1|COMPLETED|Overall Study||259
2392110|NCT01386684|5869237|P1|STARTED|Overall Study||552
2392111|NCT01386658|5869278|P2|NOT COMPLETED|Icatibant Exposure 3||0
2392112|NCT01386658|5869279|P1|NOT COMPLETED|Icatibant Exposure 3||0
2392113|NCT01386658|5869278|P2|COMPLETED|Icatibant Exposure 3||9
2392114|NCT01386658|5869279|P1|COMPLETED|Icatibant Exposure 3||0
2392115|NCT01386658|5869278|P2|STARTED|Icatibant Exposure 3||9
2392116|NCT01386658|5869279|P1|STARTED|Icatibant Exposure 3||0
2392117|NCT01386658|5869278|P2|NOT COMPLETED|Icatibant Exposure 2||0
2392118|NCT01386658|5869279|P1|NOT COMPLETED|Icatibant Exposure 2||0
2392119|NCT01386658|5869278|P2|COMPLETED|Icatibant Exposure 2||9
2392120|NCT01386658|5869279|P1|COMPLETED|Icatibant Exposure 2||0
2392121|NCT01386658|5869278|P2|STARTED|Icatibant Exposure 2||9
2392122|NCT01386658|5869279|P1|STARTED|Icatibant Exposure 2||0
2392123|NCT01386658|5869278|P2|NOT COMPLETED|Initial Icatibant Exposure||12
2392124|NCT01386658|5869279|P1|NOT COMPLETED|Initial Icatibant Exposure||0
2392125|NCT01386658|5869278|P2|COMPLETED|Initial Icatibant Exposure||9
2392126|NCT01386658|5869279|P1|COMPLETED|Initial Icatibant Exposure||11
2392127|NCT01386658|5869278|P2|STARTED|Initial Icatibant Exposure||21
2392128|NCT01386658|5869279|P1|STARTED|Initial Icatibant Exposure||11
2392129|NCT01386632|5869344|P2|NOT COMPLETED|Overall Study||4
2392130|NCT01386632|5869345|P1|NOT COMPLETED|Overall Study||5
2392131|NCT01386632|5869344|P2|COMPLETED|Overall Study||21
2392132|NCT01386632|5869345|P1|COMPLETED|Overall Study||20
2392133|NCT01386632|5869344|P2|STARTED|Overall Study||25
2392134|NCT01386632|5869345|P1|STARTED|Overall Study||25
2392135|NCT01386606|5869357|P4|NOT COMPLETED|Overall Study||1
2392136|NCT01386606|5869358|P3|NOT COMPLETED|Overall Study||3
2392137|NCT01386606|5869359|P2|NOT COMPLETED|Overall Study||4
2392138|NCT01386606|5869360|P1|NOT COMPLETED|Overall Study||4
2392139|NCT01386606|5869357|P4|COMPLETED|Overall Study||13
2392140|NCT01386606|5869358|P3|COMPLETED|Overall Study||13
2392141|NCT01386606|5869359|P2|COMPLETED|Overall Study||10
2392142|NCT01386606|5869360|P1|COMPLETED|Overall Study||12
2392143|NCT01386606|5869357|P4|STARTED|Overall Study||14
2392144|NCT01386606|5869358|P3|STARTED|Overall Study||16
2392145|NCT01386606|5869359|P2|STARTED|Overall Study||14
2392146|NCT01386606|5869360|P1|STARTED|Overall Study||16
2392147|NCT01386554|5869391|P3|NOT COMPLETED|Overall Study||6
2392148|NCT01386554|5869392|P2|NOT COMPLETED|Overall Study||9
2392149|NCT01386554|5869393|P1|NOT COMPLETED|Overall Study||3
2392150|NCT01386554|5869391|P3|COMPLETED|Overall Study||15
2392151|NCT01386554|5869392|P2|COMPLETED|Overall Study||26
2392152|NCT01386554|5869393|P1|COMPLETED|Overall Study||1
2392153|NCT01386554|5869391|P3|STARTED|Overall Study||21
2392154|NCT01386554|5869392|P2|STARTED|Overall Study||35
2392155|NCT01386554|5869393|P1|STARTED|Overall Study||4
2392156|NCT01386528|5869404|P1|NOT COMPLETED|Overall Study||0
2392157|NCT01386528|5869404|P1|COMPLETED|Overall Study||13
2392158|NCT01386528|5869404|P1|STARTED|Overall Study||13
2392159|NCT01386125|5869416|P2|NOT COMPLETED|Overall Study||37
2392160|NCT01386125|5869417|P1|NOT COMPLETED|Overall Study||25
2392161|NCT01386125|5869416|P2|COMPLETED|Overall Study||336
2392162|NCT01386125|5869417|P1|COMPLETED|Overall Study||350
2392163|NCT01386125|5869416|P2|STARTED|Overall Study||373
2392164|NCT01386125|5869417|P1|STARTED|Overall Study||375
2392165|NCT01386008|5869425|P1|NOT COMPLETED|Overall Study||20
2392166|NCT01386008|5869425|P1|COMPLETED|Overall Study||0
2392167|NCT01386008|5869425|P1|STARTED|Overall Study||20
2392168|NCT01385995|5869434|P2|NOT COMPLETED|Period 2, 2 Months||0
2392169|NCT01385995|5869435|P1|NOT COMPLETED|Period 2, 2 Months||0
2392170|NCT01385995|5869434|P2|COMPLETED|Period 2, 2 Months||25
2392171|NCT01385995|5869435|P1|COMPLETED|Period 2, 2 Months||24
2392172|NCT01385995|5869434|P2|STARTED|Period 2, 2 Months||25
2392173|NCT01385995|5869435|P1|STARTED|Period 2, 2 Months||24
2392174|NCT01385995|5869434|P2|NOT COMPLETED|Washout Period, 1 Month||0
2392175|NCT01385995|5869435|P1|NOT COMPLETED|Washout Period, 1 Month||0
2392176|NCT01385995|5869434|P2|COMPLETED|Washout Period, 1 Month||25
2392177|NCT01385995|5869435|P1|COMPLETED|Washout Period, 1 Month||24
2392178|NCT01385995|5869434|P2|STARTED|Washout Period, 1 Month||25
2392179|NCT01385995|5869435|P1|STARTED|Washout Period, 1 Month||24
2392180|NCT01385995|5869434|P2|NOT COMPLETED|Period 1, 2 Months||0
2392181|NCT01385995|5869435|P1|NOT COMPLETED|Period 1, 2 Months||1
2392182|NCT01385995|5869434|P2|COMPLETED|Period 1, 2 Months||25
2392183|NCT01385995|5869435|P1|COMPLETED|Period 1, 2 Months||24
2392184|NCT01385995|5869434|P2|STARTED|Period 1, 2 Months||25
2392185|NCT01385995|5869435|P1|STARTED|Period 1, 2 Months||25
2392186|NCT01385748|5869452|P3|NOT COMPLETED|Overall Study||13
2392187|NCT01385748|5869453|P2|NOT COMPLETED|Overall Study||14
2392188|NCT01385748|5869454|P1|NOT COMPLETED|Overall Study||15
2392189|NCT01385748|5869452|P3|COMPLETED|Overall Study||49
2392190|NCT01385748|5869453|P2|COMPLETED|Overall Study||51
2392191|NCT01385748|5869454|P1|COMPLETED|Overall Study||41
2392192|NCT01385748|5869452|P3|STARTED|Overall Study||62
2392193|NCT01385748|5869453|P2|STARTED|Overall Study||65
2392194|NCT01385748|5869454|P1|STARTED|Overall Study||56
2392195|NCT01385696|5869499|P2|NOT COMPLETED|Overall Study||0
2392196|NCT01385696|5869500|P1|NOT COMPLETED|Overall Study||0
2392197|NCT01385696|5869499|P2|COMPLETED|Overall Study||64
2392198|NCT01385696|5869500|P1|COMPLETED|Overall Study||66
2392199|NCT01385696|5869499|P2|STARTED|Overall Study|1 patient used Handihaler® once only, Genuair® zero times, & was excluded from the safety population|64
2392200|NCT01385696|5869500|P1|STARTED|Overall Study||66
2392201|NCT01385644|5869511|P2|NOT COMPLETED|Overall Study||0
2392202|NCT01385644|5869512|P1|NOT COMPLETED|Overall Study||0
2392203|NCT01385644|5869511|P2|COMPLETED|Overall Study||4
2392204|NCT01385644|5869512|P1|COMPLETED|Overall Study||4
2392205|NCT01385644|5869511|P2|STARTED|Overall Study||4
2392206|NCT01385644|5869512|P1|STARTED|Overall Study||4
2392207|NCT01385579|5869526|P2|NOT COMPLETED|Overall Study||0
2392208|NCT01385579|5869527|P1|NOT COMPLETED|Overall Study||0
2392209|NCT01385579|5869526|P2|COMPLETED|Overall Study||104
2392210|NCT01385579|5869527|P1|COMPLETED|Overall Study||98
2392211|NCT01385579|5869526|P2|STARTED|Overall Study||104
2392212|NCT01385579|5869527|P1|STARTED|Overall Study||98
2392213|NCT01385566|5869539|P6|NOT COMPLETED|Overall Study||0
2392214|NCT01385566|5869540|P5|NOT COMPLETED|Overall Study||0
2392215|NCT01385566|5869541|P4|NOT COMPLETED|Overall Study||1
2392216|NCT01385566|5869542|P3|NOT COMPLETED|Overall Study||0
2392217|NCT01385566|5869543|P2|NOT COMPLETED|Overall Study||0
2392218|NCT01385566|5869544|P1|NOT COMPLETED|Overall Study||1
2392219|NCT01385566|5869539|P6|COMPLETED|Overall Study||34
2392220|NCT01385566|5869540|P5|COMPLETED|Overall Study||34
2392221|NCT01385566|5869541|P4|COMPLETED|Overall Study||34
2392222|NCT01385566|5869542|P3|COMPLETED|Overall Study||34
2392223|NCT01385566|5869543|P2|COMPLETED|Overall Study||34
2392224|NCT01385566|5869544|P1|COMPLETED|Overall Study||51
2392225|NCT01385566|5869539|P6|STARTED|Overall Study||34
2392226|NCT01385566|5869540|P5|STARTED|Overall Study||34
2392227|NCT01385566|5869541|P4|STARTED|Overall Study||35
2392228|NCT01385566|5869542|P3|STARTED|Overall Study||34
2392229|NCT01385566|5869543|P2|STARTED|Overall Study||34
2392230|NCT01385566|5869544|P1|STARTED|Overall Study||52
2392231|NCT01385371|5869598|P2|NOT COMPLETED|Overall Study||97
2392232|NCT01385371|5869599|P1|NOT COMPLETED|Overall Study||149
2392233|NCT01385371|5869598|P2|COMPLETED|Overall Study||652
2392234|NCT01385371|5869599|P1|COMPLETED|Overall Study||603
2392235|NCT01385371|5869598|P2|STARTED|Overall Study||749
2392236|NCT01385371|5869599|P1|STARTED|Overall Study||752
2392237|NCT01385306|5869619|P1|NOT COMPLETED|Overall Study||0
2392238|NCT01385306|5869619|P1|COMPLETED|Overall Study||6
2392239|NCT01385306|5869619|P1|STARTED|Overall Study||6
2392240|NCT01385293|5869627|P1|NOT COMPLETED|Overall Study||0
2392241|NCT01385293|5869627|P1|COMPLETED|Overall Study||30
2392242|NCT01385293|5869627|P1|STARTED|Overall Study||30
2392243|NCT01385280|5869637|P1|NOT COMPLETED|Overall Study||0
2392244|NCT01385280|5869637|P1|COMPLETED|Overall Study||13
2392245|NCT01385280|5869637|P1|STARTED|Overall Study||13
2392246|NCT01385202|5869647|P1|NOT COMPLETED|Overall Study||18
2392247|NCT01385202|5869647|P1|COMPLETED|Overall Study||154
2392248|NCT01385202|5869647|P1|Undergoing Ablation|Overall Study||160
2392249|NCT01385202|5869647|P1|Study Catheter Inserted|Overall Study||161
2392250|NCT01385202|5869647|P1|STARTED|Overall Study|Per protocol, enrolled subjects were defined as those who signed inform consent form.|172
2392251|NCT01385189|5869659|P5|NOT COMPLETED|Overall Study||2
2392252|NCT01385189|5869660|P4|NOT COMPLETED|Overall Study||1
2392253|NCT01385189|5869661|P3|NOT COMPLETED|Overall Study||0
2392254|NCT01385189|5869662|P2|NOT COMPLETED|Overall Study||1
2392255|NCT01385189|5869663|P1|NOT COMPLETED|Overall Study||1
2392256|NCT01385189|5869659|P5|COMPLETED|Overall Study||6
2392257|NCT01385189|5869660|P4|COMPLETED|Overall Study||3
2392258|NCT01385189|5869661|P3|COMPLETED|Overall Study||4
2392259|NCT01385189|5869662|P2|COMPLETED|Overall Study||11
2392260|NCT01385189|5869663|P1|COMPLETED|Overall Study||11
2392261|NCT01385189|5869659|P5|STARTED|Overall Study||8
2392262|NCT01385189|5869660|P4|STARTED|Overall Study||4
2392263|NCT01385189|5869661|P3|STARTED|Overall Study||4
2392264|NCT01385189|5869662|P2|STARTED|Overall Study||12
2392265|NCT01385189|5869663|P1|STARTED|Overall Study||12
2392266|NCT01385176|5869684|P2|NOT COMPLETED|6-18 Month All VNS Active||3
2392267|NCT01385176|5869685|P1|NOT COMPLETED|6-18 Month All VNS Active||4
2392268|NCT01385176|5869684|P2|COMPLETED|6-18 Month All VNS Active||27
2392269|NCT01385176|5869685|P1|COMPLETED|6-18 Month All VNS Active||58
2392270|NCT01385176|5869684|P2|STARTED|6-18 Month All VNS Active|Primary Study Phase ended with completion of the 18 months follow-up visit for the last patient|30
2392271|NCT01385176|5869685|P1|STARTED|6-18 Month All VNS Active|Primary Study Phase ended with completion of the 18 months follow-up visit for the last patient|62
2392272|NCT01385176|5869684|P2|NOT COMPLETED|Randomization Phase||2
2392273|NCT01385176|5869685|P1|NOT COMPLETED|Randomization Phase||1
2392274|NCT01385176|5869684|P2|COMPLETED|Randomization Phase|The study randomization phase ended after all patients have had their 6 month follow-up visit.|30
2392275|NCT01385176|5869685|P1|COMPLETED|Randomization Phase|The study randomization phase ended after all patients have had their 6 month follow-up visit.|62
2392276|NCT01385176|5869684|P2|STARTED|Randomization Phase|The randomization phase of the study started after implant of the investigational device system.|32
2392277|NCT01385176|5869685|P1|STARTED|Randomization Phase|The randomization phase of the study started after implant of the investigational device system.|63
2392278|NCT01385137|5869701|P2|NOT COMPLETED|Evaluable for Primary Endpoint||24
2392279|NCT01385137|5869702|P1|NOT COMPLETED|Evaluable for Primary Endpoint||29
2392280|NCT01385137|5869701|P2|COMPLETED|Evaluable for Primary Endpoint||107
2392281|NCT01385137|5869702|P1|COMPLETED|Evaluable for Primary Endpoint||102
2392282|NCT01385137|5869701|P2|STARTED|Evaluable for Primary Endpoint||131
2392283|NCT01385137|5869702|P1|STARTED|Evaluable for Primary Endpoint||131
2392284|NCT01385137|5869701|P2|NOT COMPLETED|Evaluable at Baseline||4
2392285|NCT01385137|5869702|P1|NOT COMPLETED|Evaluable at Baseline||9
2392286|NCT01385137|5869701|P2|COMPLETED|Evaluable at Baseline||127
2392287|NCT01385137|5869702|P1|COMPLETED|Evaluable at Baseline||122
2392288|NCT01385137|5869701|P2|STARTED|Evaluable at Baseline||131
2392289|NCT01385137|5869702|P1|STARTED|Evaluable at Baseline||131
2392290|NCT01385098|5869716|P1|NOT COMPLETED|Overall Study||14
2392291|NCT01385098|5869716|P1|COMPLETED|Overall Study|14 subjects did not complete. 4 subjects loss to follow-up & 10 subjects could not tolerate suppl.|23
2392292|NCT01385098|5869716|P1|STARTED|Overall Study||37
2392293|NCT01385033|5869724|P6|NOT COMPLETED|Part III||0
2392294|NCT01385033|5869725|P5|NOT COMPLETED|Part III||0
2392295|NCT01385033|5869726|P4|NOT COMPLETED|Part III||0
2392296|NCT01385033|5869727|P3|NOT COMPLETED|Part III||0
2392297|NCT01385033|5869728|P2|NOT COMPLETED|Part III||0
2392298|NCT01385033|5869729|P1|NOT COMPLETED|Part III||0
2392299|NCT01385033|5869724|P6|COMPLETED|Part III||0
2392300|NCT01385033|5869725|P5|COMPLETED|Part III||0
2392301|NCT01385033|5869726|P4|COMPLETED|Part III||0
2392302|NCT01385033|5869727|P3|COMPLETED|Part III||0
2392303|NCT01385033|5869728|P2|COMPLETED|Part III||0
2392304|NCT01385033|5869729|P1|COMPLETED|Part III||0
2392305|NCT01385033|5869724|P6|STARTED|Part III||0
2392306|NCT01385033|5869725|P5|STARTED|Part III||0
2392307|NCT01385033|5869726|P4|STARTED|Part III||0
2392308|NCT01385033|5869727|P3|STARTED|Part III||0
2392309|NCT01385033|5869728|P2|STARTED|Part III||0
2392310|NCT01385033|5869729|P1|STARTED|Part III||0
2392311|NCT01385033|5869724|P6|NOT COMPLETED|Part II||0
2392312|NCT01385033|5869725|P5|NOT COMPLETED|Part II||0
2392313|NCT01385033|5869726|P4|NOT COMPLETED|Part II||0
2392314|NCT01385033|5869727|P3|NOT COMPLETED|Part II||0
2392315|NCT01385033|5869728|P2|NOT COMPLETED|Part II||0
2392316|NCT01385033|5869729|P1|NOT COMPLETED|Part II||0
2392317|NCT01385033|5869724|P6|COMPLETED|Part II||0
2392318|NCT01385033|5869725|P5|COMPLETED|Part II||0
2392319|NCT01385033|5869726|P4|COMPLETED|Part II||0
2392320|NCT01385033|5869727|P3|COMPLETED|Part II||0
2392321|NCT01385033|5869728|P2|COMPLETED|Part II||0
2392322|NCT01385033|5869729|P1|COMPLETED|Part II||0
2392323|NCT01385033|5869724|P6|STARTED|Part II||0
2392324|NCT01385033|5869725|P5|STARTED|Part II||0
2392325|NCT01385033|5869726|P4|STARTED|Part II||0
2392326|NCT01385033|5869727|P3|STARTED|Part II||0
2392327|NCT01385033|5869728|P2|STARTED|Part II||0
2392328|NCT01385033|5869729|P1|STARTED|Part II||0
2392329|NCT01385033|5869724|P6|NOT COMPLETED|Part I||0
2392330|NCT01385033|5869725|P5|NOT COMPLETED|Part I||0
2392331|NCT01385033|5869726|P4|NOT COMPLETED|Part I||0
2392332|NCT01385033|5869727|P3|NOT COMPLETED|Part I||0
2392333|NCT01385033|5869728|P2|NOT COMPLETED|Part I||0
2392334|NCT01385033|5869729|P1|NOT COMPLETED|Part I||0
2392335|NCT01385033|5869724|P6|COMPLETED|Part I||0
2392336|NCT01385033|5869725|P5|COMPLETED|Part I||0
2392337|NCT01385033|5869726|P4|COMPLETED|Part I||0
2392338|NCT01385033|5869727|P3|COMPLETED|Part I||0
2392339|NCT01385033|5869728|P2|COMPLETED|Part I||14
2392340|NCT01385033|5869729|P1|COMPLETED|Part I||6
2392341|NCT01385033|5869724|P6|STARTED|Part I||0
2392342|NCT01385033|5869725|P5|STARTED|Part I||0
2392343|NCT01385033|5869726|P4|STARTED|Part I||0
2392344|NCT01385033|5869727|P3|STARTED|Part I||0
2392345|NCT01385033|5869728|P2|STARTED|Part I|These subjects did not participate in Part II or III|14
2392346|NCT01385033|5869729|P1|STARTED|Part I|These subjects did not participate in Part II or III|6
2392347|NCT01384877|5869738|P2|NOT COMPLETED|Treatment 2||2
2392348|NCT01384877|5869739|P1|NOT COMPLETED|Treatment 2||2
2392349|NCT01384877|5869738|P2|COMPLETED|Treatment 2||11
2392350|NCT01384877|5869739|P1|COMPLETED|Treatment 2||14
2392351|NCT01384877|5869738|P2|STARTED|Treatment 2|2 Patients died between treatment periods|13
2392352|NCT01384877|5869739|P1|STARTED|Treatment 2|1 Patient died between treatment periods|16
2392353|NCT01384877|5869738|P2|NOT COMPLETED|Treatment 1||0
2392354|NCT01384877|5869739|P1|NOT COMPLETED|Treatment 1||0
2392355|NCT01384877|5869738|P2|COMPLETED|Treatment 1||15
2392356|NCT01384877|5869739|P1|COMPLETED|Treatment 1||17
2392357|NCT01384877|5869738|P2|STARTED|Treatment 1||15
2392358|NCT01384877|5869739|P1|STARTED|Treatment 1||17
2392359|NCT01384760|5869765|P2|NOT COMPLETED|Overall Study||6
2392360|NCT01384760|5869766|P1|NOT COMPLETED|Overall Study||16
2392361|NCT01384760|5869765|P2|COMPLETED|Overall Study||37
2392362|NCT01384760|5869766|P1|COMPLETED|Overall Study||45
2392363|NCT01384760|5869765|P2|Randomized|Overall Study||43
2392364|NCT01384760|5869766|P1|Randomized|Overall Study||61
2392365|NCT01384760|5869765|P2|STARTED|Overall Study||43
2392366|NCT01384760|5869766|P1|STARTED|Overall Study||61
2392367|NCT01384734|5869779|P5|NOT COMPLETED|Overall Study||29
2392368|NCT01384734|5869780|P4|NOT COMPLETED|Overall Study||28
2392369|NCT01384734|5869781|P3|NOT COMPLETED|Overall Study||23
2392370|NCT01384734|5869782|P2|NOT COMPLETED|Overall Study||24
2392371|NCT01384734|5869783|P1|NOT COMPLETED|Overall Study||17
2392372|NCT01384734|5869779|P5|COMPLETED|Overall Study||22
2392373|NCT01384734|5869780|P4|COMPLETED|Overall Study||22
2392374|NCT01384734|5869781|P3|COMPLETED|Overall Study||28
2392375|NCT01384734|5869782|P2|COMPLETED|Overall Study||25
2392376|NCT01384734|5869783|P1|COMPLETED|Overall Study||33
2392377|NCT01384734|5869779|P5|STARTED|Overall Study||51
2392378|NCT01384734|5869780|P4|STARTED|Overall Study||50
2392379|NCT01384734|5869781|P3|STARTED|Overall Study||51
2392380|NCT01384734|5869782|P2|STARTED|Overall Study||49
2392381|NCT01384734|5869783|P1|STARTED|Overall Study||50
2392382|NCT01384591|5869866|P3|NOT COMPLETED|Overall Study||0
2392383|NCT01384591|5869867|P2|NOT COMPLETED|Overall Study||0
2392384|NCT01384591|5869868|P1|NOT COMPLETED|Overall Study||0
2392385|NCT01384591|5869866|P3|COMPLETED|Overall Study||2
2392386|NCT01384591|5869867|P2|COMPLETED|Overall Study||2
2392387|NCT01384591|5869868|P1|COMPLETED|Overall Study||2
2392388|NCT01384591|5869866|P3|STARTED|Overall Study||2
2392389|NCT01384591|5869867|P2|STARTED|Overall Study||2
2392390|NCT01384591|5869868|P1|STARTED|Overall Study||2
2392391|NCT01384539|5869998|P2|NOT COMPLETED|Overall Study||7
2392392|NCT01384539|5869999|P1|NOT COMPLETED|Overall Study||6
2392393|NCT01384539|5869998|P2|COMPLETED|Overall Study||57
2392394|NCT01384539|5869999|P1|COMPLETED|Overall Study||58
2392395|NCT01384539|5869998|P2|STARTED|Overall Study||64
2392396|NCT01384539|5869999|P1|STARTED|Overall Study||64
2392397|NCT01384292|5870012|P3|NOT COMPLETED|Part B||0
2392398|NCT01384292|5870013|P2|NOT COMPLETED|Part B||0
2392399|NCT01384292|5870014|P1|NOT COMPLETED|Part B||1
2392400|NCT01384292|5870012|P3|COMPLETED|Part B||0
2392401|NCT01384292|5870013|P2|COMPLETED|Part B||6
2392402|NCT01384292|5870014|P1|COMPLETED|Part B||2
2392403|NCT01384292|5870012|P3|STARTED|Part B||0
2392404|NCT01384292|5870013|P2|STARTED|Part B||6
2392405|NCT01384292|5870014|P1|STARTED|Part B||3
2392406|NCT01384292|5870012|P3|NOT COMPLETED|Part A||0
2392407|NCT01384292|5870013|P2|NOT COMPLETED|Part A||0
2392408|NCT01384292|5870014|P1|NOT COMPLETED|Part A||0
2392409|NCT01384292|5870012|P3|COMPLETED|Part A||4
2392410|NCT01384292|5870013|P2|COMPLETED|Part A||5
2392411|NCT01384292|5870014|P1|COMPLETED|Part A||5
2392412|NCT01384292|5870012|P3|STARTED|Part A||4
2392413|NCT01384292|5870013|P2|STARTED|Part A||5
2392414|NCT01384292|5870014|P1|STARTED|Part A||5
2392415|NCT01384019|5870026|P2|NOT COMPLETED|Overall Study||6
2392416|NCT01384019|5870027|P1|NOT COMPLETED|Overall Study||10
2392417|NCT01384019|5870026|P2|COMPLETED|Overall Study||55
2392418|NCT01384019|5870027|P1|COMPLETED|Overall Study||55
2392419|NCT01384019|5870026|P2|STARTED|Overall Study||61
2392420|NCT01384019|5870027|P1|STARTED|Overall Study||65
2392421|NCT01383993|5870036|P3|NOT COMPLETED|Overall Study||1
2392422|NCT01383993|5870037|P2|NOT COMPLETED|Overall Study||1
2392423|NCT01383993|5870038|P1|NOT COMPLETED|Overall Study||3
2392424|NCT01383993|5870036|P3|COMPLETED|Overall Study||1
2392425|NCT01383993|5870037|P2|COMPLETED|Overall Study||3
2392426|NCT01383993|5870038|P1|COMPLETED|Overall Study||12
2392427|NCT01383993|5870036|P3|STARTED|Overall Study||2
2392428|NCT01383993|5870037|P2|STARTED|Overall Study||4
2392429|NCT01383993|5870038|P1|STARTED|Overall Study||15
2392430|NCT01383954|5870085|P1|NOT COMPLETED|Overall Study||14
2392431|NCT01383954|5870085|P1|COMPLETED|Overall Study||38
2392432|NCT01383954|5870085|P1|Safety Population: Received Treatment|Overall Study||48
2392433|NCT01383954|5870085|P1|STARTED|Overall Study||52
2392434|NCT01383928|5870093|P3|NOT COMPLETED|Overall Study||40
2392435|NCT01383928|5870094|P2|NOT COMPLETED|Overall Study||7
2392436|NCT01383928|5870095|P1|NOT COMPLETED|Overall Study||5
2392437|NCT01383928|5870093|P3|COMPLETED|Overall Study||10
2392438|NCT01383928|5870094|P2|COMPLETED|Overall Study||0
2392439|NCT01383928|5870095|P1|COMPLETED|Overall Study||2
2392440|NCT01383928|5870093|P3|STARTED|Overall Study||50
2392441|NCT01383928|5870094|P2|STARTED|Overall Study||7
2392442|NCT01383928|5870095|P1|STARTED|Overall Study||7
2392443|NCT01383720|5870137|P1|NOT COMPLETED|Overall Study||0
2392444|NCT01383720|5870137|P1|COMPLETED|Overall Study|Study is continuing to 5 years. All patients are still in the study.|11
2392445|NCT01383720|5870137|P1|Primary Endpoint (Discharge/7 Days)|Overall Study||11
2392446|NCT01383720|5870137|P1|STARTED|Overall Study||11
2392447|NCT01383707|5870159|P1|NOT COMPLETED|Overall Study||72
2392448|NCT01383707|5870159|P1|COMPLETED|Overall Study||5
2392449|NCT01383707|5870159|P1|STARTED|Overall Study||77
2392450|NCT01383681|5870168|P1|NOT COMPLETED|Overall Study||46
2392451|NCT01383681|5870168|P1|COMPLETED|Overall Study||189
2392452|NCT01383681|5870168|P1|STARTED|Overall Study||235
2392453|NCT01383616|5870175|P2|NOT COMPLETED|Overall Study||23
2392454|NCT01383616|5870176|P1|NOT COMPLETED|Overall Study||17
2392455|NCT01383616|5870175|P2|COMPLETED|Overall Study||21
2392456|NCT01383616|5870176|P1|COMPLETED|Overall Study||23
2392457|NCT01383616|5870175|P2|STARTED|Overall Study||44
2392458|NCT01383616|5870176|P1|STARTED|Overall Study||40
2392459|NCT01383499|5870199|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
2392460|NCT01383499|5870200|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
2392461|NCT01383499|5870201|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
2392462|NCT01383499|5870202|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
2392463|NCT01383499|5870199|P4|COMPLETED|Period 3 (4 Weeks)||25
2392464|NCT01383499|5870200|P3|COMPLETED|Period 3 (4 Weeks)||25
2392465|NCT01383499|5870201|P2|COMPLETED|Period 3 (4 Weeks)||24
2392466|NCT01383499|5870202|P1|COMPLETED|Period 3 (4 Weeks)||26
2392467|NCT01383499|5870199|P4|STARTED|Period 3 (4 Weeks)||25
2392468|NCT01383499|5870200|P3|STARTED|Period 3 (4 Weeks)||25
2392469|NCT01383499|5870201|P2|STARTED|Period 3 (4 Weeks)||24
2392470|NCT01383499|5870202|P1|STARTED|Period 3 (4 Weeks)||26
2392471|NCT01383499|5870199|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
2392472|NCT01383499|5870200|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
2392473|NCT01383499|5870201|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
2392474|NCT01383499|5870202|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
2392475|NCT01383499|5870199|P4|COMPLETED|Period 2 (4 Weeks)||25
2392476|NCT01383499|5870200|P3|COMPLETED|Period 2 (4 Weeks)||25
2392477|NCT01383499|5870201|P2|COMPLETED|Period 2 (4 Weeks)||24
2392478|NCT01383499|5870202|P1|COMPLETED|Period 2 (4 Weeks)||26
2392479|NCT01383499|5870199|P4|STARTED|Period 2 (4 Weeks)||25
2392480|NCT01383499|5870200|P3|STARTED|Period 2 (4 Weeks)||25
2392481|NCT01383499|5870201|P2|STARTED|Period 2 (4 Weeks)||24
2392482|NCT01383499|5870202|P1|STARTED|Period 2 (4 Weeks)||26
2392483|NCT01383499|5870199|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
2392484|NCT01383499|5870200|P3|NOT COMPLETED|Period 1 (4 Weeks)||0
2392485|NCT01383499|5870201|P2|NOT COMPLETED|Period 1 (4 Weeks)||0
2392486|NCT01383499|5870202|P1|NOT COMPLETED|Period 1 (4 Weeks)||1
2392487|NCT01383499|5870199|P4|COMPLETED|Period 1 (4 Weeks)||25
2392488|NCT01383499|5870200|P3|COMPLETED|Period 1 (4 Weeks)||25
2392489|NCT01383499|5870201|P2|COMPLETED|Period 1 (4 Weeks)||24
2392490|NCT01383499|5870202|P1|COMPLETED|Period 1 (4 Weeks)||26
2392491|NCT01383499|5870199|P4|STARTED|Period 1 (4 Weeks)||25
2392492|NCT01383499|5870200|P3|STARTED|Period 1 (4 Weeks)||25
2392493|NCT01383499|5870201|P2|STARTED|Period 1 (4 Weeks)||24
2392494|NCT01383499|5870202|P1|STARTED|Period 1 (4 Weeks)||27
2392495|NCT01383486|5870252|P1|NOT COMPLETED|Overall Study||18
2392496|NCT01383486|5870252|P1|COMPLETED|Overall Study|Took any study medication and gave estimated duration of pain (Selection Evaluation Population)|235
2392497|NCT01383486|5870252|P1|Treated|Overall Study|Number of participants who took any study medication (Safety Population)|237
2392498|NCT01383486|5870252|P1|STARTED|Overall Study|Number of participants who were provided with investigational products|253
2392499|NCT01383447|5870258|P1|NOT COMPLETED|Overall Study||2
2392500|NCT01383447|5870258|P1|COMPLETED|Overall Study||0
2392501|NCT01383447|5870258|P1|STARTED|Overall Study||2
2392502|NCT01383421|5870266|P1|NOT COMPLETED|Overall Study||346
2392503|NCT01383421|5870266|P1|COMPLETED|Overall Study||679
2392504|NCT01383421|5870266|P1|STARTED|Overall Study|ITT population: all enrolled participants who received at least 1 dose of study drug.|1025
2392505|NCT01383356|5870329|P2|NOT COMPLETED|Period 2||0
2392506|NCT01383356|5870330|P1|NOT COMPLETED|Period 2||0
2392507|NCT01383356|5870329|P2|COMPLETED|Period 2|Completed period 2.|23
2392508|NCT01383356|5870330|P1|COMPLETED|Period 2|Completed period 2.|21
2392509|NCT01383356|5870329|P2|STARTED|Period 2|Entered and treated.|23
2392510|NCT01383356|5870330|P1|STARTED|Period 2|Entered and treated.|21
2392511|NCT01383356|5870329|P2|NOT COMPLETED|Washout Period (at Least 35 Days)||0
2392512|NCT01383356|5870330|P1|NOT COMPLETED|Washout Period (at Least 35 Days)||0
2392513|NCT01383356|5870329|P2|COMPLETED|Washout Period (at Least 35 Days)||23
2392514|NCT01383356|5870330|P1|COMPLETED|Washout Period (at Least 35 Days)||21
2392515|NCT01383356|5870329|P2|STARTED|Washout Period (at Least 35 Days)||23
2392516|NCT01383356|5870330|P1|STARTED|Washout Period (at Least 35 Days)||21
2392517|NCT01383356|5870329|P2|NOT COMPLETED|Period 1||6
2392518|NCT01383356|5870330|P1|NOT COMPLETED|Period 1||8
2392519|NCT01383356|5870329|P2|COMPLETED|Period 1|Completed period 1.|23
2392520|NCT01383356|5870330|P1|COMPLETED|Period 1|Completed period 1.|21
2392521|NCT01383356|5870329|P2|STARTED|Period 1|Entered and treated.|29
2392522|NCT01383356|5870330|P1|STARTED|Period 1|Entered and treated.|29
2392523|NCT01383317|5870342|P2|NOT COMPLETED|Overall Study||2
2392524|NCT01383317|5870343|P1|NOT COMPLETED|Overall Study||3
2392525|NCT01383317|5870342|P2|COMPLETED|Overall Study||33
2392526|NCT01383317|5870343|P1|COMPLETED|Overall Study||26
2392527|NCT01383317|5870342|P2|STARTED|Overall Study||35
2392528|NCT01383317|5870343|P1|STARTED|Overall Study||29
2392529|NCT01383213|5870367|P2|NOT COMPLETED|Overall Study||0
2392530|NCT01383213|5870368|P1|NOT COMPLETED|Overall Study||0
2392531|NCT01383213|5870367|P2|COMPLETED|Overall Study||41
2392532|NCT01383213|5870368|P1|COMPLETED|Overall Study||40
2392533|NCT01383213|5870367|P2|STARTED|Overall Study||41
2392534|NCT01383213|5870368|P1|STARTED|Overall Study||40
2392535|NCT01383200|5870376|P2|NOT COMPLETED|Overall Study||0
2392536|NCT01383200|5870377|P1|NOT COMPLETED|Overall Study||0
2392537|NCT01383200|5870376|P2|COMPLETED|Overall Study||6
2392538|NCT01383200|5870377|P1|COMPLETED|Overall Study||5
2392539|NCT01383200|5870376|P2|STARTED|Overall Study||6
2392540|NCT01383200|5870377|P1|STARTED|Overall Study||5
2392541|NCT01383174|5870385|P2|NOT COMPLETED|6 Month Assessment||1
2392542|NCT01383174|5870386|P1|NOT COMPLETED|6 Month Assessment||5
2392543|NCT01383174|5870385|P2|COMPLETED|6 Month Assessment|These 73 completed the 6 month assessment and completed the study.|73
2392544|NCT01383174|5870386|P1|COMPLETED|6 Month Assessment|These 71 completed the 6 month assessment and completed the study.|71
2392545|NCT01383174|5870385|P2|STARTED|6 Month Assessment||74
2392546|NCT01383174|5870386|P1|STARTED|6 Month Assessment|All 76 people were contacted at 6 months;1 person returned and 5 did not return to study at 6 months|76
2392547|NCT01383174|5870385|P2|NOT COMPLETED|3 Month Assessment||1
2392548|NCT01383174|5870386|P1|NOT COMPLETED|3 Month Assessment||6
2392549|NCT01383174|5870385|P2|COMPLETED|3 Month Assessment|These 74 completed the 3 month assessment and continued in the study.|74
2392550|NCT01383174|5870386|P1|COMPLETED|3 Month Assessment|These 70 completed the 3 month assessment and continued in the study.|70
2392551|NCT01383174|5870385|P2|STARTED|3 Month Assessment||75
2392552|NCT01383174|5870386|P1|STARTED|3 Month Assessment||76
2392553|NCT01383174|5870385|P2|NOT COMPLETED|Baseline Assessment||0
2392554|NCT01383174|5870386|P1|NOT COMPLETED|Baseline Assessment||0
2392555|NCT01383174|5870385|P2|COMPLETED|Baseline Assessment|These 75 completed the baseline assessment and continued in the study.|75
2392556|NCT01383174|5870386|P1|COMPLETED|Baseline Assessment|These 76 completed the baseline assessment and continued in the study.|76
2392557|NCT01383174|5870385|P2|STARTED|Baseline Assessment||75
2392558|NCT01383174|5870386|P1|STARTED|Baseline Assessment||76
2392559|NCT01383161|5870412|P2|NOT COMPLETED|Overall Study||4
2392560|NCT01383161|5870413|P1|NOT COMPLETED|Overall Study||5
2392561|NCT01383161|5870412|P2|COMPLETED|Overall Study||17
2392562|NCT01383161|5870413|P1|COMPLETED|Overall Study||20
2392563|NCT01383161|5870412|P2|STARTED|Overall Study||21
2392564|NCT01383161|5870413|P1|STARTED|Overall Study||25
2392565|NCT01383096|5870432|P3|NOT COMPLETED|Fifth Intervention (8 Days)||0
2392566|NCT01383096|5870433|P2|NOT COMPLETED|Fifth Intervention (8 Days)||0
2392567|NCT01383096|5870434|P1|NOT COMPLETED|Fifth Intervention (8 Days)||2
2392568|NCT01383096|5870432|P3|COMPLETED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
2392569|NCT01383096|5870433|P2|COMPLETED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
2392570|NCT01383096|5870434|P1|COMPLETED|Fifth Intervention (8 Days)||11
2392571|NCT01383096|5870432|P3|STARTED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
2392572|NCT01383096|5870433|P2|STARTED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
2392573|NCT01383096|5870434|P1|STARTED|Fifth Intervention (8 Days)||13
2392574|NCT01383096|5870432|P3|NOT COMPLETED|Fourth Intervention (8 Days)||0
2392575|NCT01383096|5870433|P2|NOT COMPLETED|Fourth Intervention (8 Days)||0
2392576|NCT01383096|5870434|P1|NOT COMPLETED|Fourth Intervention (8 Days)||2
2392577|NCT01383096|5870432|P3|COMPLETED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
2392578|NCT01383096|5870433|P2|COMPLETED|Fourth Intervention (8 Days)||12
2392579|NCT01383096|5870434|P1|COMPLETED|Fourth Intervention (8 Days)||13
2392580|NCT01383096|5870432|P3|STARTED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
2392581|NCT01383096|5870433|P2|STARTED|Fourth Intervention (8 Days)||12
2392582|NCT01383096|5870434|P1|STARTED|Fourth Intervention (8 Days)||15
2392583|NCT01383096|5870432|P3|NOT COMPLETED|Third Intervention (8 Days)||0
2392584|NCT01383096|5870433|P2|NOT COMPLETED|Third Intervention (8 Days)||4
2392585|NCT01383096|5870434|P1|NOT COMPLETED|Third Intervention (8 Days)||4
2392586|NCT01383096|5870432|P3|COMPLETED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
2392587|NCT01383096|5870433|P2|COMPLETED|Third Intervention (8 Days)||12
2392588|NCT01383096|5870434|P1|COMPLETED|Third Intervention (8 Days)||15
2392589|NCT01383096|5870432|P3|STARTED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
2392590|NCT01383096|5870433|P2|STARTED|Third Intervention (8 Days)||16
2392591|NCT01383096|5870434|P1|STARTED|Third Intervention (8 Days)||19
2392592|NCT01383096|5870432|P3|NOT COMPLETED|Second Intervention (8 Days)||2
2392593|NCT01383096|5870433|P2|NOT COMPLETED|Second Intervention (8 Days)||1
2392594|NCT01383096|5870434|P1|NOT COMPLETED|Second Intervention (8 Days)||0
2392595|NCT01383096|5870432|P3|COMPLETED|Second Intervention (8 Days)||14
2392596|NCT01383096|5870433|P2|COMPLETED|Second Intervention (8 Days)||16
2392597|NCT01383096|5870434|P1|COMPLETED|Second Intervention (8 Days)||19
2392598|NCT01383096|5870432|P3|STARTED|Second Intervention (8 Days)||16
2392599|NCT01383096|5870433|P2|STARTED|Second Intervention (8 Days)||17
2392600|NCT01383096|5870434|P1|STARTED|Second Intervention (8 Days)||19
2392601|NCT01383096|5870432|P3|NOT COMPLETED|First Intervention (8 Days)||0
2392602|NCT01383096|5870433|P2|NOT COMPLETED|First Intervention (8 Days)||0
2392603|NCT01383096|5870434|P1|NOT COMPLETED|First Intervention (8 Days)||0
2392604|NCT01383096|5870432|P3|COMPLETED|First Intervention (8 Days)||16
2392605|NCT01383096|5870433|P2|COMPLETED|First Intervention (8 Days)||17
2392606|NCT01383096|5870434|P1|COMPLETED|First Intervention (8 Days)||19
2392607|NCT01383096|5870432|P3|STARTED|First Intervention (8 Days)||16
2392608|NCT01383096|5870433|P2|STARTED|First Intervention (8 Days)||17
2392609|NCT01383096|5870434|P1|STARTED|First Intervention (8 Days)||19
2392613|NCT01383005|5870522|P2|NOT COMPLETED|Overall Study||0
2392614|NCT01383005|5870523|P1|NOT COMPLETED|Overall Study||0
2392615|NCT01383005|5870522|P2|COMPLETED|Overall Study||60
2392616|NCT01383005|5870523|P1|COMPLETED|Overall Study||34
2392617|NCT01383005|5870522|P2|STARTED|Overall Study||60
2392618|NCT01383005|5870523|P1|STARTED|Overall Study||34
2392619|NCT01382940|5870542|P1|NOT COMPLETED|Overall Study||73
2392620|NCT01382940|5870542|P1|COMPLETED|Overall Study||278
2392621|NCT01382940|5870542|P1|Received Day 182 Infusion|Overall Study||278
2392622|NCT01382940|5870542|P1|Received Day 168 Infusion|Overall Study||290
2392623|NCT01382940|5870542|P1|Received Day 15 Infusions|Overall Study||341
2392624|NCT01382940|5870542|P1|Received Day 1 Infusion|Overall Study||351
2392625|NCT01382940|5870542|P1|STARTED|Overall Study||351
2392626|NCT01382901|5870554|P2|NOT COMPLETED|Overall Study||14
2392627|NCT01382901|5870555|P1|NOT COMPLETED|Overall Study||17
2392628|NCT01382901|5870554|P2|COMPLETED|Overall Study||7
2392629|NCT01382901|5870555|P1|COMPLETED|Overall Study||7
2392630|NCT01382901|5870554|P2|STARTED|Overall Study||21
2392631|NCT01382901|5870555|P1|STARTED|Overall Study||24
2392632|NCT01382719|5870565|P4|NOT COMPLETED|Overall Study||33
2392633|NCT01382719|5870566|P3|NOT COMPLETED|Overall Study||34
2392634|NCT01382719|5870567|P2|NOT COMPLETED|Overall Study||19
2392635|NCT01382719|5870568|P1|NOT COMPLETED|Overall Study||18
2392636|NCT01382719|5870565|P4|COMPLETED|Overall Study||66
2392637|NCT01382719|5870566|P3|COMPLETED|Overall Study||66
2392638|NCT01382719|5870567|P2|COMPLETED|Overall Study||81
2392639|NCT01382719|5870568|P1|COMPLETED|Overall Study||80
2392640|NCT01382719|5870565|P4|Subjects Not Dosed|Overall Study||1
2392641|NCT01382719|5870566|P3|Subjects Not Dosed|Overall Study||1
2392642|NCT01382719|5870567|P2|Subjects Not Dosed|Overall Study||0
2392643|NCT01382719|5870568|P1|Subjects Not Dosed|Overall Study||1
2392644|NCT01382719|5870565|P4|STARTED|Overall Study||99
2392645|NCT01382719|5870566|P3|STARTED|Overall Study||100
2392646|NCT01382719|5870567|P2|STARTED|Overall Study||100
2392647|NCT01382719|5870568|P1|STARTED|Overall Study||98
2392648|NCT01382602|5870604|P2|NOT COMPLETED|Overall Study||4
2392649|NCT01382602|5870605|P1|NOT COMPLETED|Overall Study||0
2392650|NCT01382602|5870604|P2|COMPLETED|Overall Study||46
2392651|NCT01382602|5870605|P1|COMPLETED|Overall Study||93
2392652|NCT01382602|5870604|P2|STARTED|Overall Study||50
2392653|NCT01382602|5870605|P1|STARTED|Overall Study||93
2392654|NCT01382446|5870613|P2|NOT COMPLETED|Overall Study||4
2392655|NCT01382446|5870614|P1|NOT COMPLETED|Overall Study||3
2392656|NCT01382446|5870613|P2|COMPLETED|Overall Study||29
2392657|NCT01382446|5870614|P1|COMPLETED|Overall Study||30
2392658|NCT01382446|5870613|P2|STARTED|Overall Study||33
2392659|NCT01382446|5870614|P1|STARTED|Overall Study||33
2392660|NCT01382303|5870622|P2|NOT COMPLETED|Overall Study||17
2392661|NCT01382303|5870623|P1|NOT COMPLETED|Overall Study||35
2392662|NCT01382303|5870622|P2|COMPLETED|Overall Study||70
2392663|NCT01382303|5870623|P1|COMPLETED|Overall Study||52
2392664|NCT01382303|5870622|P2|STARTED|Overall Study||87
2392665|NCT01382303|5870623|P1|STARTED|Overall Study||87
2392666|NCT01382251|5870641|P2|NOT COMPLETED|Overall Study||21
2392667|NCT01382251|5870642|P1|NOT COMPLETED|Overall Study||21
2392668|NCT01382251|5870641|P2|COMPLETED|Overall Study||102
2392669|NCT01382251|5870642|P1|COMPLETED|Overall Study||102
2392670|NCT01382251|5870641|P2|STARTED|Overall Study||123
2392671|NCT01382251|5870642|P1|STARTED|Overall Study||123
2392672|NCT01382225|5870655|P2|NOT COMPLETED|Overall Study||7
2392673|NCT01382225|5870656|P1|NOT COMPLETED|Overall Study||14
2392674|NCT01382225|5870655|P2|COMPLETED|Overall Study||722
2392675|NCT01382225|5870656|P1|COMPLETED|Overall Study||711
2392676|NCT01382225|5870655|P2|STARTED|Overall Study||729
2392677|NCT01382225|5870656|P1|STARTED|Overall Study||725
2392678|NCT01382212|5870678|P1|NOT COMPLETED|Overall Study||2
2392679|NCT01382212|5870678|P1|COMPLETED|Overall Study||11
2392680|NCT01382212|5870678|P1|STARTED|Overall Study||13
2392681|NCT01382186|5870704|P2|NOT COMPLETED|Overall Study||0
2392682|NCT01382186|5870705|P1|NOT COMPLETED|Overall Study||1
2392683|NCT01382186|5870704|P2|COMPLETED|Overall Study||819
2392684|NCT01382186|5870705|P1|COMPLETED|Overall Study||32
2392685|NCT01382186|5870704|P2|STARTED|Overall Study||819
2392686|NCT01382186|5870705|P1|STARTED|Overall Study||33
2392687|NCT01382108|5870721|P2|NOT COMPLETED|Overall Study||0
2392688|NCT01382108|5870722|P1|NOT COMPLETED|Overall Study||0
2392689|NCT01382108|5870721|P2|COMPLETED|Overall Study||19
2392690|NCT01382108|5870722|P1|COMPLETED|Overall Study||20
2392691|NCT01382108|5870721|P2|STARTED|Overall Study||19
2392692|NCT01382108|5870722|P1|STARTED|Overall Study||20
2392693|NCT01381952|5870732|P1|NOT COMPLETED|Overall Study||0
2392694|NCT01381952|5870732|P1|COMPLETED|Overall Study||20
2392695|NCT01381952|5870732|P1|Collected Dose and Image Information|Overall Study||20
2392696|NCT01381952|5870732|P1|STARTED|Overall Study||20
2392697|NCT01381926|5870741|P2|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
2392698|NCT01381926|5870742|P1|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
2392699|NCT01381926|5870741|P2|COMPLETED|Low/High Dose of 2nd Treatment (2months)||4
2392700|NCT01381926|5870742|P1|COMPLETED|Low/High Dose of 2nd Treatment (2months)||3
2392701|NCT01381926|5870741|P2|STARTED|Low/High Dose of 2nd Treatment (2months)||4
2392702|NCT01381926|5870742|P1|STARTED|Low/High Dose of 2nd Treatment (2months)||3
2392703|NCT01381926|5870741|P2|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||1
2392704|NCT01381926|5870742|P1|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||2
2392705|NCT01381926|5870741|P2|COMPLETED|Low/High Dose of 1st Treatment (2months)||4
2392706|NCT01381926|5870742|P1|COMPLETED|Low/High Dose of 1st Treatment (2months)||3
2392707|NCT01381926|5870741|P2|STARTED|Low/High Dose of 1st Treatment (2months)||5
2392708|NCT01381926|5870742|P1|STARTED|Low/High Dose of 1st Treatment (2months)||5
2392709|NCT01381900|5870755|P3|NOT COMPLETED|Overall Study||12
2392710|NCT01381900|5870756|P2|NOT COMPLETED|Overall Study||9
2392711|NCT01381900|5870757|P1|NOT COMPLETED|Overall Study||9
2392712|NCT01381900|5870755|P3|COMPLETED|Overall Study||215
2392713|NCT01381900|5870756|P2|COMPLETED|Overall Study||214
2392714|NCT01381900|5870757|P1|COMPLETED|Overall Study||217
2392715|NCT01381900|5870755|P3|STARTED|Overall Study||227
2392716|NCT01381900|5870756|P2|STARTED|Overall Study||223
2392717|NCT01381900|5870757|P1|STARTED|Overall Study||226
2392718|NCT01381874|5870780|P3|NOT COMPLETED|Overall Study||76
2392719|NCT01381874|5870781|P2|NOT COMPLETED|Overall Study||63
2392720|NCT01381874|5870782|P1|NOT COMPLETED|Overall Study||77
2392721|NCT01381874|5870780|P3|COMPLETED|Overall Study||30
2392722|NCT01381874|5870781|P2|COMPLETED|Overall Study||26
2392723|NCT01381874|5870782|P1|COMPLETED|Overall Study||25
2392724|NCT01381874|5870780|P3|Treated|Overall Study||104
2392725|NCT01381874|5870781|P2|Treated|Overall Study||87
2392726|NCT01381874|5870782|P1|Treated|Overall Study||102
2392727|NCT01381874|5870780|P3|STARTED|Overall Study||106
2392728|NCT01381874|5870781|P2|STARTED|Overall Study||89
2392729|NCT01381874|5870782|P1|STARTED|Overall Study||102
2392730|NCT01381861|5870808|P1|NOT COMPLETED|Overall Study||0
2392731|NCT01381861|5870808|P1|COMPLETED|Overall Study||23
2392732|NCT01381861|5870808|P1|STARTED|Overall Study||23
2392733|NCT01381679|5870819|P1|NOT COMPLETED|Overall Study||888
2392734|NCT01381679|5870819|P1|COMPLETED|Overall Study||794
2392735|NCT01381679|5870819|P1|STARTED|Overall Study||1682
2392736|NCT01381575|5870834|P3|NOT COMPLETED|Overall Study||20
2392737|NCT01381575|5870835|P2|NOT COMPLETED|Overall Study||39
2392738|NCT01381575|5870836|P1|NOT COMPLETED|Overall Study||26
2392739|NCT01381575|5870834|P3|COMPLETED|Overall Study||395
2392740|NCT01381575|5870835|P2|COMPLETED|Overall Study||443
2392741|NCT01381575|5870836|P1|COMPLETED|Overall Study||524
2392742|NCT01381575|5870834|P3|STARTED|Overall Study||415
2392743|NCT01381575|5870835|P2|STARTED|Overall Study||482
2392744|NCT01381575|5870836|P1|STARTED|Overall Study||550
2392745|NCT01381562|5870893|P3|NOT COMPLETED|Overall Study||0
2392746|NCT01381562|5870894|P2|NOT COMPLETED|Overall Study||1
2392747|NCT01381562|5870895|P1|NOT COMPLETED|Overall Study||0
2392748|NCT01381562|5870893|P3|COMPLETED|Overall Study||5
2392749|NCT01381562|5870894|P2|COMPLETED|Overall Study||3
2392750|NCT01381562|5870895|P1|COMPLETED|Overall Study||5
2392751|NCT01381562|5870893|P3|STARTED|Overall Study||5
2392752|NCT01381562|5870894|P2|STARTED|Overall Study||4
2392753|NCT01381562|5870895|P1|STARTED|Overall Study||5
2392754|NCT01381549|5870963|P3|NOT COMPLETED|Overall Study||1
2392755|NCT01381549|5870964|P2|NOT COMPLETED|Overall Study||0
2392756|NCT01381549|5870965|P1|NOT COMPLETED|Overall Study||0
2392757|NCT01381549|5870963|P3|COMPLETED|Overall Study||5
2392758|NCT01381549|5870964|P2|COMPLETED|Overall Study||8
2392759|NCT01381549|5870965|P1|COMPLETED|Overall Study||6
2392760|NCT01381549|5870963|P3|STARTED|Overall Study||6
2392761|NCT01381549|5870964|P2|STARTED|Overall Study||8
2392762|NCT01381549|5870965|P1|STARTED|Overall Study||6
2392763|NCT01381471|5871060|P1|NOT COMPLETED|Overall Study||0
2392764|NCT01381471|5871060|P1|COMPLETED|Overall Study||11060
2392765|NCT01381471|5871060|P1|STARTED|Overall Study||11060
2392766|NCT01381406|5871067|P2|NOT COMPLETED|Overall Study||0
2392767|NCT01381406|5871068|P1|NOT COMPLETED|Overall Study||0
2392768|NCT01381406|5871067|P2|COMPLETED|Overall Study||852
2392769|NCT01381406|5871068|P1|COMPLETED|Overall Study||2481
2392770|NCT01381406|5871067|P2|STARTED|Overall Study||852
2392771|NCT01381406|5871068|P1|STARTED|Overall Study||2481
2392772|NCT01381120|5871080|P2|NOT COMPLETED|Overall Study||9
2392773|NCT01381120|5871081|P1|NOT COMPLETED|Overall Study||11
2392774|NCT01381120|5871080|P2|COMPLETED|Overall Study||18
2392775|NCT01381120|5871081|P1|COMPLETED|Overall Study||39
2392776|NCT01381120|5871080|P2|STARTED|Overall Study||27
2392777|NCT01381120|5871081|P1|STARTED|Overall Study||50
2392778|NCT01381068|5871091|P2|NOT COMPLETED|Overall Study||0
2392779|NCT01381068|5871092|P1|NOT COMPLETED|Overall Study||1
2392780|NCT01381068|5871091|P2|COMPLETED|Overall Study||24
2392781|NCT01381068|5871092|P1|COMPLETED|Overall Study||24
2392782|NCT01381068|5871091|P2|STARTED|Overall Study||24
2392783|NCT01381068|5871092|P1|STARTED|Overall Study||25
2392784|NCT01381016|5871112|P2|NOT COMPLETED|Overall Study||6
2392785|NCT01381016|5871113|P1|NOT COMPLETED|Overall Study||3
2392786|NCT01381016|5871112|P2|COMPLETED|Overall Study||11
2392787|NCT01381016|5871113|P1|COMPLETED|Overall Study||10
2392788|NCT01381016|5871112|P2|STARTED|Overall Study||17
2392789|NCT01381016|5871113|P1|STARTED|Overall Study||13
2392790|NCT01380834|5871123|P2|NOT COMPLETED|Overall Study||0
2392791|NCT01380834|5871124|P1|NOT COMPLETED|Overall Study||1
2392792|NCT01380834|5871123|P2|COMPLETED|Overall Study||42
2392793|NCT01380834|5871124|P1|COMPLETED|Overall Study||41
2392794|NCT01380834|5871123|P2|STARTED|Overall Study||42
2392795|NCT01380834|5871124|P1|STARTED|Overall Study||42
2392796|NCT01380782|5871136|P4|NOT COMPLETED|Overall Study||4
2392797|NCT01380782|5871137|P3|NOT COMPLETED|Overall Study||11
2392798|NCT01380782|5871138|P2|NOT COMPLETED|Overall Study||10
2392799|NCT01380782|5871139|P1|NOT COMPLETED|Overall Study||12
2392800|NCT01380782|5871136|P4|COMPLETED|Overall Study||0
2392801|NCT01380782|5871137|P3|COMPLETED|Overall Study||0
2392802|NCT01380782|5871138|P2|COMPLETED|Overall Study||0
2392803|NCT01380782|5871139|P1|COMPLETED|Overall Study||0
2392804|NCT01380782|5871136|P4|STARTED|Overall Study||4
2392805|NCT01380782|5871137|P3|STARTED|Overall Study||11
2392806|NCT01380782|5871138|P2|STARTED|Overall Study||10
2392807|NCT01380782|5871139|P1|STARTED|Overall Study||12
2392808|NCT01380769|5871162|P2|NOT COMPLETED|Overall Study||14
2392809|NCT01380769|5871163|P1|NOT COMPLETED|Overall Study||9
2392810|NCT01380769|5871162|P2|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|43
2392811|NCT01380769|5871163|P1|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|91
2392812|NCT01380769|5871162|P2|STARTED|Overall Study||57
2392813|NCT01380769|5871163|P1|STARTED|Overall Study||100
2392814|NCT01380743|5871175|P4|NOT COMPLETED|Overall Study||0
2392815|NCT01380743|5871176|P3|NOT COMPLETED|Overall Study||0
2392816|NCT01380743|5871177|P2|NOT COMPLETED|Overall Study||0
2392817|NCT01380743|5871178|P1|NOT COMPLETED|Overall Study||0
2392818|NCT01380743|5871175|P4|COMPLETED|Overall Study||7
2392819|NCT01380743|5871176|P3|COMPLETED|Overall Study||6
2392820|NCT01380743|5871177|P2|COMPLETED|Overall Study||6
2392821|NCT01380743|5871178|P1|COMPLETED|Overall Study||6
2392822|NCT01380743|5871175|P4|Received at Least 1 Dose of Study Drug|Overall Study||7
2392823|NCT01380743|5871176|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
2392824|NCT01380743|5871177|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
2392825|NCT01380743|5871178|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
2392826|NCT01380743|5871175|P4|STARTED|Overall Study||7
2392827|NCT01380743|5871176|P3|STARTED|Overall Study||6
2392828|NCT01380743|5871177|P2|STARTED|Overall Study||6
2392829|NCT01380743|5871178|P1|STARTED|Overall Study||6
2392830|NCT01380730|5871224|P8|NOT COMPLETED|Overall Study||0
2392831|NCT01380730|5871225|P7|NOT COMPLETED|Overall Study||0
2392832|NCT01380730|5871226|P6|NOT COMPLETED|Overall Study||0
2392833|NCT01380730|5871227|P5|NOT COMPLETED|Overall Study||1
2392834|NCT01380730|5871228|P4|NOT COMPLETED|Overall Study||0
2392835|NCT01380730|5871229|P3|NOT COMPLETED|Overall Study||0
2392836|NCT01380730|5871230|P2|NOT COMPLETED|Overall Study||0
2392837|NCT01380730|5871231|P1|NOT COMPLETED|Overall Study||0
2392838|NCT01380730|5871224|P8|COMPLETED|Overall Study||80
2392839|NCT01380730|5871225|P7|COMPLETED|Overall Study||79
2392840|NCT01380730|5871226|P6|COMPLETED|Overall Study||79
2392841|NCT01380730|5871227|P5|COMPLETED|Overall Study||77
2392842|NCT01380730|5871228|P4|COMPLETED|Overall Study||79
2392843|NCT01380730|5871229|P3|COMPLETED|Overall Study||79
2392844|NCT01380730|5871230|P2|COMPLETED|Overall Study||79
2392845|NCT01380730|5871231|P1|COMPLETED|Overall Study||78
2392846|NCT01380730|5871224|P8|Received Treatment|Overall Study||80
2392847|NCT01380730|5871225|P7|Received Treatment|Overall Study||79
2392848|NCT01380730|5871226|P6|Received Treatment|Overall Study||79
2392849|NCT01380730|5871227|P5|Received Treatment|Overall Study||78
2392850|NCT01380730|5871228|P4|Received Treatment|Overall Study||79
2392851|NCT01380730|5871229|P3|Received Treatment|Overall Study||79
2392852|NCT01380730|5871230|P2|Received Treatment|Overall Study|2 participants did not receive treatment but were followed until the end of study|77
2392853|NCT01380730|5871231|P1|Received Treatment|Overall Study||78
2392854|NCT01380730|5871224|P8|STARTED|Overall Study||80
2392855|NCT01380730|5871225|P7|STARTED|Overall Study||79
2392856|NCT01380730|5871226|P6|STARTED|Overall Study||79
2392857|NCT01380730|5871227|P5|STARTED|Overall Study||78
2392858|NCT01380730|5871228|P4|STARTED|Overall Study||79
2392859|NCT01380730|5871229|P3|STARTED|Overall Study||79
2392860|NCT01380730|5871230|P2|STARTED|Overall Study||79
2392861|NCT01380730|5871231|P1|STARTED|Overall Study||78
2392862|NCT01380691|5871289|P4|NOT COMPLETED|Period 2||0
2392863|NCT01380691|5871290|P3|NOT COMPLETED|Period 2||0
2392864|NCT01380691|5871291|P2|NOT COMPLETED|Period 2||0
2392865|NCT01380691|5871292|P1|NOT COMPLETED|Period 2||0
2392866|NCT01380691|5871289|P4|COMPLETED|Period 2||6
2392867|NCT01380691|5871290|P3|COMPLETED|Period 2||6
2392868|NCT01380691|5871291|P2|COMPLETED|Period 2||7
2392869|NCT01380691|5871292|P1|COMPLETED|Period 2||7
2392870|NCT01380691|5871289|P4|STARTED|Period 2||6
2392871|NCT01380691|5871290|P3|STARTED|Period 2||6
2392872|NCT01380691|5871291|P2|STARTED|Period 2||7
2392873|NCT01380691|5871292|P1|STARTED|Period 2||7
2392874|NCT01380691|5871289|P4|NOT COMPLETED|Washout (7 Days)||1
2392875|NCT01380691|5871290|P3|NOT COMPLETED|Washout (7 Days)||1
2392876|NCT01380691|5871291|P2|NOT COMPLETED|Washout (7 Days)||0
2392877|NCT01380691|5871292|P1|NOT COMPLETED|Washout (7 Days)||0
2392878|NCT01380691|5871289|P4|COMPLETED|Washout (7 Days)||6
2392879|NCT01380691|5871290|P3|COMPLETED|Washout (7 Days)||6
2392880|NCT01380691|5871291|P2|COMPLETED|Washout (7 Days)||7
2392881|NCT01380691|5871292|P1|COMPLETED|Washout (7 Days)||7
2392882|NCT01380691|5871289|P4|STARTED|Washout (7 Days)||7
2392883|NCT01380691|5871290|P3|STARTED|Washout (7 Days)||7
2392884|NCT01380691|5871291|P2|STARTED|Washout (7 Days)||7
2392885|NCT01380691|5871292|P1|STARTED|Washout (7 Days)||7
2392886|NCT01380691|5871289|P4|NOT COMPLETED|Period 1||0
2392887|NCT01380691|5871290|P3|NOT COMPLETED|Period 1||0
2392888|NCT01380691|5871291|P2|NOT COMPLETED|Period 1||0
2392889|NCT01380691|5871292|P1|NOT COMPLETED|Period 1||0
2392890|NCT01380691|5871289|P4|COMPLETED|Period 1||7
2392891|NCT01380691|5871290|P3|COMPLETED|Period 1||7
2392892|NCT01380691|5871291|P2|COMPLETED|Period 1||7
2392893|NCT01380691|5871292|P1|COMPLETED|Period 1||7
2392894|NCT01380691|5871289|P4|STARTED|Period 1||7
2392895|NCT01380691|5871290|P3|STARTED|Period 1||7
2392896|NCT01380691|5871291|P2|STARTED|Period 1||7
2392897|NCT01380691|5871292|P1|STARTED|Period 1||7
2392898|NCT01380639|5871344|P2|NOT COMPLETED|Overall Study||4
2392899|NCT01380639|5871345|P1|NOT COMPLETED|Overall Study||6
2392900|NCT01380639|5871344|P2|COMPLETED|Overall Study||36
2392901|NCT01380639|5871345|P1|COMPLETED|Overall Study||36
2392902|NCT01380639|5871344|P2|STARTED|Overall Study||40
2392903|NCT01380639|5871345|P1|STARTED|Overall Study||42
2392916|NCT01380379|5871360|P1|NOT COMPLETED|Overall Study||1
2392917|NCT01380379|5871360|P1|COMPLETED|Overall Study||8
2392918|NCT01380379|5871360|P1|STARTED|Overall Study||9
2392919|NCT01380366|5871365|P1|NOT COMPLETED|Overall Study||0
2392920|NCT01380366|5871365|P1|COMPLETED|Overall Study||15
2392921|NCT01380366|5871365|P1|STARTED|Overall Study||15
2392922|NCT01380327|5871373|P3|NOT COMPLETED|Overall Study||7
2392923|NCT01380327|5871374|P2|NOT COMPLETED|Overall Study||3
2392924|NCT01380327|5871375|P1|NOT COMPLETED|Overall Study||3
2392925|NCT01380327|5871373|P3|COMPLETED|Overall Study||21
2392926|NCT01380327|5871374|P2|COMPLETED|Overall Study||28
2392927|NCT01380327|5871375|P1|COMPLETED|Overall Study||27
2392928|NCT01380327|5871373|P3|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|28
2392929|NCT01380327|5871374|P2|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|31
2392930|NCT01380327|5871375|P1|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|30
2392931|NCT01380197|5871397|P2|NOT COMPLETED|Overall Study||0
2392932|NCT01380197|5871398|P1|NOT COMPLETED|Overall Study||0
2392933|NCT01380197|5871397|P2|COMPLETED|Overall Study||20
2392934|NCT01380197|5871398|P1|COMPLETED|Overall Study||20
2392935|NCT01380197|5871397|P2|STARTED|Overall Study||20
2392936|NCT01380197|5871398|P1|STARTED|Overall Study||20
2392937|NCT01380184|5871406|P1|NOT COMPLETED|Part 2||14
2392938|NCT01380184|5871406|P1|COMPLETED|Part 2||0
2392939|NCT01380184|5871406|P1|STARTED|Part 2||14
2392940|NCT01380184|5871406|P1|NOT COMPLETED|Washout Period (≥2 Days)||0
2392941|NCT01380184|5871406|P1|COMPLETED|Washout Period (≥2 Days)||14
2392942|NCT01380184|5871406|P1|STARTED|Washout Period (≥2 Days)||14
2392943|NCT01380184|5871406|P1|NOT COMPLETED|Part 1 (19 Days)||1
2392944|NCT01380184|5871406|P1|COMPLETED|Part 1 (19 Days)||14
2392945|NCT01380184|5871406|P1|STARTED|Part 1 (19 Days)||15
2392946|NCT01380145|5871417|P1|NOT COMPLETED|Overall Study||4
2392947|NCT01380145|5871417|P1|COMPLETED|Overall Study||9
2392948|NCT01380145|5871417|P1|STARTED|Overall Study||13
2392949|NCT01380093|5871425|P9|NOT COMPLETED|Treatment Phase: Third Intervention||2
2392950|NCT01380093|5871426|P8|NOT COMPLETED|Treatment Phase: Third Intervention||0
2392951|NCT01380093|5871427|P7|NOT COMPLETED|Treatment Phase: Third Intervention||0
2392952|NCT01380093|5871428|P6|NOT COMPLETED|Treatment Phase: Third Intervention||0
2392953|NCT01380093|5871429|P5|NOT COMPLETED|Treatment Phase: Third Intervention||0
2392954|NCT01380093|5871430|P4|NOT COMPLETED|Treatment Phase: Third Intervention||0
2392955|NCT01380093|5871431|P3|NOT COMPLETED|Treatment Phase: Third Intervention||0
2392956|NCT01380093|5871432|P2|NOT COMPLETED|Treatment Phase: Third Intervention||0
2392957|NCT01380093|5871433|P1|NOT COMPLETED|Treatment Phase: Third Intervention||0
2392958|NCT01380093|5871425|P9|COMPLETED|Treatment Phase: Third Intervention||4
2392959|NCT01380093|5871426|P8|COMPLETED|Treatment Phase: Third Intervention||6
2392960|NCT01380093|5871427|P7|COMPLETED|Treatment Phase: Third Intervention||6
2392961|NCT01380093|5871428|P6|COMPLETED|Treatment Phase: Third Intervention||6
2392962|NCT01380093|5871429|P5|COMPLETED|Treatment Phase: Third Intervention||6
2392963|NCT01380093|5871430|P4|COMPLETED|Treatment Phase: Third Intervention||5
2392964|NCT01380093|5871431|P3|COMPLETED|Treatment Phase: Third Intervention||0
2392965|NCT01380093|5871432|P2|COMPLETED|Treatment Phase: Third Intervention||0
2392966|NCT01380093|5871433|P1|COMPLETED|Treatment Phase: Third Intervention||0
2392967|NCT01380093|5871425|P9|STARTED|Treatment Phase: Third Intervention||6
2392968|NCT01380093|5871426|P8|STARTED|Treatment Phase: Third Intervention||6
2392969|NCT01380093|5871427|P7|STARTED|Treatment Phase: Third Intervention||6
2392970|NCT01380093|5871428|P6|STARTED|Treatment Phase: Third Intervention||6
2392971|NCT01380093|5871429|P5|STARTED|Treatment Phase: Third Intervention||6
2392972|NCT01380093|5871430|P4|STARTED|Treatment Phase: Third Intervention||5
2392973|NCT01380093|5871431|P3|STARTED|Treatment Phase: Third Intervention||0
2392974|NCT01380093|5871432|P2|STARTED|Treatment Phase: Third Intervention||0
2392975|NCT01380093|5871433|P1|STARTED|Treatment Phase: Third Intervention||0
2392976|NCT01380093|5871425|P9|NOT COMPLETED|Treatment Phase: Washout Period||0
2392977|NCT01380093|5871426|P8|NOT COMPLETED|Treatment Phase: Washout Period||0
2392978|NCT01380093|5871427|P7|NOT COMPLETED|Treatment Phase: Washout Period||0
2392979|NCT01380093|5871428|P6|NOT COMPLETED|Treatment Phase: Washout Period||0
2392980|NCT01380093|5871429|P5|NOT COMPLETED|Treatment Phase: Washout Period||0
2392981|NCT01380093|5871430|P4|NOT COMPLETED|Treatment Phase: Washout Period||0
2392982|NCT01380093|5871431|P3|NOT COMPLETED|Treatment Phase: Washout Period||0
2392983|NCT01380093|5871432|P2|NOT COMPLETED|Treatment Phase: Washout Period||0
2392984|NCT01380093|5871433|P1|NOT COMPLETED|Treatment Phase: Washout Period||0
2392985|NCT01380093|5871425|P9|COMPLETED|Treatment Phase: Washout Period||6
2392986|NCT01380093|5871426|P8|COMPLETED|Treatment Phase: Washout Period||6
2392987|NCT01380093|5871427|P7|COMPLETED|Treatment Phase: Washout Period||6
2392988|NCT01380093|5871428|P6|COMPLETED|Treatment Phase: Washout Period||6
2392989|NCT01380093|5871429|P5|COMPLETED|Treatment Phase: Washout Period||6
2392990|NCT01380093|5871430|P4|COMPLETED|Treatment Phase: Washout Period||5
2392991|NCT01380093|5871431|P3|COMPLETED|Treatment Phase: Washout Period||0
2392992|NCT01380093|5871432|P2|COMPLETED|Treatment Phase: Washout Period||0
2392993|NCT01380093|5871433|P1|COMPLETED|Treatment Phase: Washout Period||0
2392994|NCT01380093|5871425|P9|STARTED|Treatment Phase: Washout Period||6
2392995|NCT01380093|5871426|P8|STARTED|Treatment Phase: Washout Period||6
2392996|NCT01380093|5871427|P7|STARTED|Treatment Phase: Washout Period||6
2392997|NCT01380093|5871428|P6|STARTED|Treatment Phase: Washout Period||6
2392998|NCT01380093|5871429|P5|STARTED|Treatment Phase: Washout Period||6
2392999|NCT01380093|5871430|P4|STARTED|Treatment Phase: Washout Period||5
2393000|NCT01380093|5871431|P3|STARTED|Treatment Phase: Washout Period||0
2393001|NCT01380093|5871432|P2|STARTED|Treatment Phase: Washout Period||0
2393002|NCT01380093|5871433|P1|STARTED|Treatment Phase: Washout Period||0
2393003|NCT01380093|5871425|P9|NOT COMPLETED|Treatment Phase: Second Intervention||0
2393004|NCT01380093|5871426|P8|NOT COMPLETED|Treatment Phase: Second Intervention||0
2393005|NCT01380093|5871427|P7|NOT COMPLETED|Treatment Phase: Second Intervention||0
2393006|NCT01380093|5871428|P6|NOT COMPLETED|Treatment Phase: Second Intervention||0
2393007|NCT01380093|5871429|P5|NOT COMPLETED|Treatment Phase: Second Intervention||0
2393008|NCT01380093|5871430|P4|NOT COMPLETED|Treatment Phase: Second Intervention||1
2393009|NCT01380093|5871431|P3|NOT COMPLETED|Treatment Phase: Second Intervention||0
2393010|NCT01380093|5871432|P2|NOT COMPLETED|Treatment Phase: Second Intervention||0
2393011|NCT01380093|5871433|P1|NOT COMPLETED|Treatment Phase: Second Intervention||0
2393012|NCT01380093|5871425|P9|COMPLETED|Treatment Phase: Second Intervention||6
2393013|NCT01380093|5871426|P8|COMPLETED|Treatment Phase: Second Intervention||6
2393014|NCT01380093|5871427|P7|COMPLETED|Treatment Phase: Second Intervention||6
2393015|NCT01380093|5871428|P6|COMPLETED|Treatment Phase: Second Intervention||6
2393016|NCT01380093|5871429|P5|COMPLETED|Treatment Phase: Second Intervention||6
2393017|NCT01380093|5871430|P4|COMPLETED|Treatment Phase: Second Intervention||5
2393018|NCT01380093|5871431|P3|COMPLETED|Treatment Phase: Second Intervention||0
2393019|NCT01380093|5871432|P2|COMPLETED|Treatment Phase: Second Intervention||0
2393020|NCT01380093|5871433|P1|COMPLETED|Treatment Phase: Second Intervention||0
2393021|NCT01380093|5871425|P9|STARTED|Treatment Phase: Second Intervention||6
2393022|NCT01380093|5871426|P8|STARTED|Treatment Phase: Second Intervention||6
2393023|NCT01380093|5871427|P7|STARTED|Treatment Phase: Second Intervention||6
2393024|NCT01380093|5871428|P6|STARTED|Treatment Phase: Second Intervention||6
2393025|NCT01380093|5871429|P5|STARTED|Treatment Phase: Second Intervention||6
2393026|NCT01380093|5871430|P4|STARTED|Treatment Phase: Second Intervention||6
2393027|NCT01380093|5871431|P3|STARTED|Treatment Phase: Second Intervention||0
2393028|NCT01380093|5871432|P2|STARTED|Treatment Phase: Second Intervention||0
2393029|NCT01380093|5871433|P1|STARTED|Treatment Phase: Second Intervention||0
2393030|NCT01380093|5871425|P9|NOT COMPLETED|Treatment Phase: Washout Period||0
2393031|NCT01380093|5871426|P8|NOT COMPLETED|Treatment Phase: Washout Period||0
2393032|NCT01380093|5871427|P7|NOT COMPLETED|Treatment Phase: Washout Period||0
2393033|NCT01380093|5871428|P6|NOT COMPLETED|Treatment Phase: Washout Period||0
2393034|NCT01380093|5871429|P5|NOT COMPLETED|Treatment Phase: Washout Period||0
2393035|NCT01380093|5871430|P4|NOT COMPLETED|Treatment Phase: Washout Period||0
2393036|NCT01380093|5871431|P3|NOT COMPLETED|Treatment Phase: Washout Period||0
2393037|NCT01380093|5871432|P2|NOT COMPLETED|Treatment Phase: Washout Period||0
2393038|NCT01380093|5871433|P1|NOT COMPLETED|Treatment Phase: Washout Period||0
2393039|NCT01380093|5871425|P9|COMPLETED|Treatment Phase: Washout Period||6
2393040|NCT01380093|5871426|P8|COMPLETED|Treatment Phase: Washout Period||6
2393041|NCT01380093|5871427|P7|COMPLETED|Treatment Phase: Washout Period||6
2393042|NCT01380093|5871428|P6|COMPLETED|Treatment Phase: Washout Period||6
2393043|NCT01380093|5871429|P5|COMPLETED|Treatment Phase: Washout Period||6
2393044|NCT01380093|5871430|P4|COMPLETED|Treatment Phase: Washout Period||6
2393045|NCT01380093|5871431|P3|COMPLETED|Treatment Phase: Washout Period||0
2393046|NCT01380093|5871432|P2|COMPLETED|Treatment Phase: Washout Period||0
2393047|NCT01380093|5871433|P1|COMPLETED|Treatment Phase: Washout Period||0
2393048|NCT01380093|5871425|P9|STARTED|Treatment Phase: Washout Period||6
2393049|NCT01380093|5871426|P8|STARTED|Treatment Phase: Washout Period||6
2393050|NCT01380093|5871427|P7|STARTED|Treatment Phase: Washout Period||6
2393051|NCT01380093|5871428|P6|STARTED|Treatment Phase: Washout Period||6
2393052|NCT01380093|5871429|P5|STARTED|Treatment Phase: Washout Period||6
2393053|NCT01380093|5871430|P4|STARTED|Treatment Phase: Washout Period||6
2393054|NCT01380093|5871431|P3|STARTED|Treatment Phase: Washout Period||0
2393055|NCT01380093|5871432|P2|STARTED|Treatment Phase: Washout Period||0
2393056|NCT01380093|5871433|P1|STARTED|Treatment Phase: Washout Period||0
2393057|NCT01380093|5871425|P9|NOT COMPLETED|Treatment Phase: First Intervention||0
2393058|NCT01380093|5871426|P8|NOT COMPLETED|Treatment Phase: First Intervention||0
2393059|NCT01380093|5871427|P7|NOT COMPLETED|Treatment Phase: First Intervention||0
2393060|NCT01380093|5871428|P6|NOT COMPLETED|Treatment Phase: First Intervention||0
2393061|NCT01380093|5871429|P5|NOT COMPLETED|Treatment Phase: First Intervention||0
2393062|NCT01380093|5871430|P4|NOT COMPLETED|Treatment Phase: First Intervention||0
2393063|NCT01380093|5871431|P3|NOT COMPLETED|Treatment Phase: First Intervention||0
2393064|NCT01380093|5871432|P2|NOT COMPLETED|Treatment Phase: First Intervention||0
2393065|NCT01380093|5871433|P1|NOT COMPLETED|Treatment Phase: First Intervention||0
2393066|NCT01380093|5871425|P9|COMPLETED|Treatment Phase: First Intervention||6
2393067|NCT01380093|5871426|P8|COMPLETED|Treatment Phase: First Intervention||6
2393068|NCT01380093|5871427|P7|COMPLETED|Treatment Phase: First Intervention||6
2393069|NCT01380093|5871428|P6|COMPLETED|Treatment Phase: First Intervention||6
2393070|NCT01380093|5871429|P5|COMPLETED|Treatment Phase: First Intervention||6
2393071|NCT01380093|5871430|P4|COMPLETED|Treatment Phase: First Intervention||6
2393072|NCT01380093|5871431|P3|COMPLETED|Treatment Phase: First Intervention||0
2393073|NCT01380093|5871432|P2|COMPLETED|Treatment Phase: First Intervention||0
2393074|NCT01380093|5871433|P1|COMPLETED|Treatment Phase: First Intervention||0
2393075|NCT01380093|5871425|P9|STARTED|Treatment Phase: First Intervention||6
2393076|NCT01380093|5871426|P8|STARTED|Treatment Phase: First Intervention||6
2393077|NCT01380093|5871427|P7|STARTED|Treatment Phase: First Intervention||6
2393078|NCT01380093|5871428|P6|STARTED|Treatment Phase: First Intervention||6
2393079|NCT01380093|5871429|P5|STARTED|Treatment Phase: First Intervention||6
2393080|NCT01380093|5871430|P4|STARTED|Treatment Phase: First Intervention||6
2393081|NCT01380093|5871431|P3|STARTED|Treatment Phase: First Intervention||0
2393082|NCT01380093|5871432|P2|STARTED|Treatment Phase: First Intervention||0
2393083|NCT01380093|5871433|P1|STARTED|Treatment Phase: First Intervention||0
2393084|NCT01380093|5871425|P9|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
2393085|NCT01380093|5871426|P8|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
2393086|NCT01380093|5871427|P7|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
2393087|NCT01380093|5871428|P6|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
2393088|NCT01380093|5871429|P5|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
2393089|NCT01380093|5871430|P4|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
2393090|NCT01380093|5871431|P3|NOT COMPLETED|Drug Discrimination Phase: Day 2||13
2393091|NCT01380093|5871432|P2|NOT COMPLETED|Drug Discrimination Phase: Day 2||9
2393092|NCT01380093|5871433|P1|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
2393093|NCT01380093|5871425|P9|COMPLETED|Drug Discrimination Phase: Day 2||0
2393094|NCT01380093|5871426|P8|COMPLETED|Drug Discrimination Phase: Day 2||0
2393095|NCT01380093|5871427|P7|COMPLETED|Drug Discrimination Phase: Day 2||0
2393096|NCT01380093|5871428|P6|COMPLETED|Drug Discrimination Phase: Day 2||0
2393097|NCT01380093|5871429|P5|COMPLETED|Drug Discrimination Phase: Day 2||0
2393098|NCT01380093|5871430|P4|COMPLETED|Drug Discrimination Phase: Day 2||0
2393099|NCT01380093|5871431|P3|COMPLETED|Drug Discrimination Phase: Day 2||16
2393100|NCT01380093|5871432|P2|COMPLETED|Drug Discrimination Phase: Day 2||20
2393101|NCT01380093|5871433|P1|COMPLETED|Drug Discrimination Phase: Day 2||0
2393102|NCT01380093|5871425|P9|STARTED|Drug Discrimination Phase: Day 2||0
2393103|NCT01380093|5871426|P8|STARTED|Drug Discrimination Phase: Day 2||0
2393104|NCT01380093|5871427|P7|STARTED|Drug Discrimination Phase: Day 2||0
2393105|NCT01380093|5871428|P6|STARTED|Drug Discrimination Phase: Day 2||0
2393106|NCT01380093|5871429|P5|STARTED|Drug Discrimination Phase: Day 2||0
2393107|NCT01380093|5871430|P4|STARTED|Drug Discrimination Phase: Day 2||0
2393108|NCT01380093|5871431|P3|STARTED|Drug Discrimination Phase: Day 2||29
2393109|NCT01380093|5871432|P2|STARTED|Drug Discrimination Phase: Day 2||29
2393110|NCT01380093|5871433|P1|STARTED|Drug Discrimination Phase: Day 2||0
2393111|NCT01380093|5871425|P9|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
2393112|NCT01380093|5871426|P8|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
2393113|NCT01380093|5871427|P7|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
2393114|NCT01380093|5871428|P6|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
2393115|NCT01380093|5871429|P5|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
2393116|NCT01380093|5871430|P4|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
2393117|NCT01380093|5871431|P3|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
2393118|NCT01380093|5871432|P2|NOT COMPLETED|Drug Discrimination Phase: Day 1||1
2393119|NCT01380093|5871433|P1|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
2393120|NCT01380093|5871425|P9|COMPLETED|Drug Discrimination Phase: Day 1||0
2393121|NCT01380093|5871426|P8|COMPLETED|Drug Discrimination Phase: Day 1||0
2393122|NCT01380093|5871427|P7|COMPLETED|Drug Discrimination Phase: Day 1||0
2393123|NCT01380093|5871428|P6|COMPLETED|Drug Discrimination Phase: Day 1||0
2393124|NCT01380093|5871429|P5|COMPLETED|Drug Discrimination Phase: Day 1||0
2393125|NCT01380093|5871430|P4|COMPLETED|Drug Discrimination Phase: Day 1||0
2393126|NCT01380093|5871431|P3|COMPLETED|Drug Discrimination Phase: Day 1||29
2393127|NCT01380093|5871432|P2|COMPLETED|Drug Discrimination Phase: Day 1||29
2393128|NCT01380093|5871433|P1|COMPLETED|Drug Discrimination Phase: Day 1||0
2393129|NCT01380093|5871425|P9|STARTED|Drug Discrimination Phase: Day 1||0
2393130|NCT01380093|5871426|P8|STARTED|Drug Discrimination Phase: Day 1||0
2393131|NCT01380093|5871427|P7|STARTED|Drug Discrimination Phase: Day 1||0
2393132|NCT01380093|5871428|P6|STARTED|Drug Discrimination Phase: Day 1||0
2393133|NCT01380093|5871429|P5|STARTED|Drug Discrimination Phase: Day 1||0
2393134|NCT01380093|5871430|P4|STARTED|Drug Discrimination Phase: Day 1||0
2393135|NCT01380093|5871431|P3|STARTED|Drug Discrimination Phase: Day 1||29
2393136|NCT01380093|5871432|P2|STARTED|Drug Discrimination Phase: Day 1||30
2393137|NCT01380093|5871433|P1|STARTED|Drug Discrimination Phase: Day 1||0
2393138|NCT01380093|5871425|P9|NOT COMPLETED|Naloxone Challenge Phase||0
2393139|NCT01380093|5871426|P8|NOT COMPLETED|Naloxone Challenge Phase||0
2393140|NCT01380093|5871427|P7|NOT COMPLETED|Naloxone Challenge Phase||0
2393141|NCT01380093|5871428|P6|NOT COMPLETED|Naloxone Challenge Phase||0
2393142|NCT01380093|5871429|P5|NOT COMPLETED|Naloxone Challenge Phase||0
2393143|NCT01380093|5871430|P4|NOT COMPLETED|Naloxone Challenge Phase||0
2393144|NCT01380093|5871431|P3|NOT COMPLETED|Naloxone Challenge Phase||0
2393145|NCT01380093|5871432|P2|NOT COMPLETED|Naloxone Challenge Phase||0
2393146|NCT01380093|5871433|P1|NOT COMPLETED|Naloxone Challenge Phase||21
2393147|NCT01380093|5871425|P9|COMPLETED|Naloxone Challenge Phase||0
2393148|NCT01380093|5871426|P8|COMPLETED|Naloxone Challenge Phase||0
2393149|NCT01380093|5871427|P7|COMPLETED|Naloxone Challenge Phase||0
2393150|NCT01380093|5871428|P6|COMPLETED|Naloxone Challenge Phase||0
2393151|NCT01380093|5871429|P5|COMPLETED|Naloxone Challenge Phase||0
2393152|NCT01380093|5871430|P4|COMPLETED|Naloxone Challenge Phase||0
2393153|NCT01380093|5871431|P3|COMPLETED|Naloxone Challenge Phase||0
2393154|NCT01380093|5871432|P2|COMPLETED|Naloxone Challenge Phase||0
2393155|NCT01380093|5871433|P1|COMPLETED|Naloxone Challenge Phase||59
2393156|NCT01380093|5871425|P9|TREATED|Naloxone Challenge Phase||0
2393157|NCT01380093|5871426|P8|TREATED|Naloxone Challenge Phase||0
2393158|NCT01380093|5871427|P7|TREATED|Naloxone Challenge Phase||0
2393159|NCT01380093|5871428|P6|TREATED|Naloxone Challenge Phase||0
2393160|NCT01380093|5871429|P5|TREATED|Naloxone Challenge Phase||0
2393161|NCT01380093|5871430|P4|TREATED|Naloxone Challenge Phase||0
2393162|NCT01380093|5871431|P3|TREATED|Naloxone Challenge Phase||0
2393163|NCT01380093|5871432|P2|TREATED|Naloxone Challenge Phase||0
2393164|NCT01380093|5871433|P1|TREATED|Naloxone Challenge Phase||59
2393165|NCT01380093|5871425|P9|STARTED|Naloxone Challenge Phase||0
2393166|NCT01380093|5871426|P8|STARTED|Naloxone Challenge Phase||0
2393167|NCT01380093|5871427|P7|STARTED|Naloxone Challenge Phase||0
2393168|NCT01380093|5871428|P6|STARTED|Naloxone Challenge Phase||0
2393169|NCT01380093|5871429|P5|STARTED|Naloxone Challenge Phase||0
2393170|NCT01380093|5871430|P4|STARTED|Naloxone Challenge Phase||0
2393171|NCT01380093|5871431|P3|STARTED|Naloxone Challenge Phase||0
2393172|NCT01380093|5871432|P2|STARTED|Naloxone Challenge Phase||0
2393173|NCT01380093|5871433|P1|STARTED|Naloxone Challenge Phase||80
2393174|NCT01380080|5871725|P2|NOT COMPLETED|Overall Study||23
2393175|NCT01380080|5871726|P1|NOT COMPLETED|Overall Study||33
2393176|NCT01380080|5871725|P2|COMPLETED|Overall Study||403
2393177|NCT01380080|5871726|P1|COMPLETED|Overall Study||391
2393178|NCT01380080|5871725|P2|STARTED|Overall Study||426
2393179|NCT01380080|5871726|P1|STARTED|Overall Study||424
2393180|NCT01379963|5871742|P1|NOT COMPLETED|Overall Study||0
2393181|NCT01379963|5871742|P1|COMPLETED|Overall Study||780
2393182|NCT01379963|5871742|P1|STARTED|Overall Study||780
2393183|NCT01379937|5871751|P4|NOT COMPLETED|Overall Study||1
2393184|NCT01379937|5871752|P3|NOT COMPLETED|Overall Study||2
2393185|NCT01379937|5871753|P2|NOT COMPLETED|Overall Study||3
2393186|NCT01379937|5871754|P1|NOT COMPLETED|Overall Study||1
2393187|NCT01379937|5871751|P4|COMPLETED|Overall Study||103
2393188|NCT01379937|5871752|P3|COMPLETED|Overall Study||102
2393189|NCT01379937|5871753|P2|COMPLETED|Overall Study||153
2393190|NCT01379937|5871754|P1|COMPLETED|Overall Study||155
2393191|NCT01379937|5871751|P4|STARTED|Overall Study||104
2393192|NCT01379937|5871752|P3|STARTED|Overall Study||104
2393193|NCT01379937|5871753|P2|STARTED|Overall Study||156
2393194|NCT01379937|5871754|P1|STARTED|Overall Study||156
2393195|NCT01379781|5871836|P2|NOT COMPLETED|Overall Study||8
2393196|NCT01379781|5871837|P1|NOT COMPLETED|Overall Study||11
2393197|NCT01379781|5871836|P2|COMPLETED|Overall Study||19
2393198|NCT01379781|5871837|P1|COMPLETED|Overall Study||16
2393199|NCT01379781|5871836|P2|STARTED|Overall Study||27
2393200|NCT01379781|5871837|P1|STARTED|Overall Study||27
2393201|NCT01379768|5871846|P3|NOT COMPLETED|Overall Study||0
2393202|NCT01379768|5871847|P2|NOT COMPLETED|Overall Study||1
2393203|NCT01379768|5871848|P1|NOT COMPLETED|Overall Study||3
2393204|NCT01379768|5871846|P3|COMPLETED|Overall Study||20
2393205|NCT01379768|5871847|P2|COMPLETED|Overall Study||21
2393206|NCT01379768|5871848|P1|COMPLETED|Overall Study||20
2393207|NCT01379768|5871846|P3|STARTED|Overall Study||20
2393208|NCT01379768|5871847|P2|STARTED|Overall Study||22
2393209|NCT01379768|5871848|P1|STARTED|Overall Study||23
2393210|NCT01379703|5871871|P3|NOT COMPLETED|9 Months Through 18 Months||0
2393211|NCT01379703|5871872|P2|NOT COMPLETED|9 Months Through 18 Months||230
2393212|NCT01379703|5871873|P1|NOT COMPLETED|9 Months Through 18 Months||0
2393213|NCT01379703|5871871|P3|COMPLETED|9 Months Through 18 Months||0
2393214|NCT01379703|5871872|P2|COMPLETED|9 Months Through 18 Months||854
2393215|NCT01379703|5871873|P1|COMPLETED|9 Months Through 18 Months||0
2393216|NCT01379703|5871871|P3|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
2393217|NCT01379703|5871872|P2|STARTED|9 Months Through 18 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
2393218|NCT01379703|5871873|P1|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
2393219|NCT01379703|5871871|P3|NOT COMPLETED|Study Start Through 9 Months||143
2393220|NCT01379703|5871872|P2|NOT COMPLETED|Study Start Through 9 Months||122
2393221|NCT01379703|5871873|P1|NOT COMPLETED|Study Start Through 9 Months||4
2393222|NCT01379703|5871871|P3|COMPLETED|Study Start Through 9 Months||873
2393223|NCT01379703|5871872|P2|COMPLETED|Study Start Through 9 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
2393224|NCT01379703|5871873|P1|COMPLETED|Study Start Through 9 Months||62
2393225|NCT01379703|5871871|P3|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir tablet formulation (only) during study (1016/2288)|1016
2393226|NCT01379703|5871872|P2|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir capsule formulation (only) during study (1206/2288)|1206
2393227|NCT01379703|5871873|P1|STARTED|Study Start Through 9 Months|Participants taking lopinavir/ritonavir tablets/capsules or oral solution during the study (66/2288)|66
2393228|NCT01379664|5871936|P2|NOT COMPLETED|Overall Study||0
2393229|NCT01379664|5871937|P1|NOT COMPLETED|Overall Study||0
2393230|NCT01379664|5871936|P2|COMPLETED|Overall Study||870
2393231|NCT01379664|5871937|P1|COMPLETED|Overall Study||714
2393232|NCT01379664|5871936|P2|STARTED|Overall Study||870
2393233|NCT01379664|5871937|P1|STARTED|Overall Study||714
2393234|NCT01379651|5871949|P2|NOT COMPLETED|Overall Study||0
2393235|NCT01379651|5871950|P1|NOT COMPLETED|Overall Study||0
2393236|NCT01379651|5871949|P2|COMPLETED|Overall Study||10
2393237|NCT01379651|5871950|P1|COMPLETED|Overall Study||10
2393238|NCT01379651|5871949|P2|STARTED|Overall Study||10
2393239|NCT01379651|5871950|P1|STARTED|Overall Study||10
2393240|NCT01379625|5871960|P2|NOT COMPLETED|Overall Study||0
2393241|NCT01379625|5871961|P1|NOT COMPLETED|Overall Study||0
2393242|NCT01379625|5871960|P2|COMPLETED|Overall Study||16
2393243|NCT01379625|5871961|P1|COMPLETED|Overall Study||16
2393244|NCT01379625|5871960|P2|STARTED|Overall Study||16
2393245|NCT01379625|5871961|P1|STARTED|Overall Study||16
2393246|NCT01379534|5871973|P2|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||2
2393247|NCT01379534|5871974|P1|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||4
2393248|NCT01379534|5871973|P2|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
2393249|NCT01379534|5871974|P1|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
2393250|NCT01379534|5871973|P2|STARTED|Tumor Assessment Follow-up (f/u) Phase||2
2393251|NCT01379534|5871974|P1|STARTED|Tumor Assessment Follow-up (f/u) Phase|All participants discontinued the Treatment Phase. Of these, only 6 qualified for f/u tumor assess..|4
2393252|NCT01379534|5871973|P2|NOT COMPLETED|Treatment Phase||31
2393253|NCT01379534|5871974|P1|NOT COMPLETED|Treatment Phase||22
2393254|NCT01379534|5871973|P2|COMPLETED|Treatment Phase||0
2393255|NCT01379534|5871974|P1|COMPLETED|Treatment Phase||0
2393256|NCT01379534|5871973|P2|STARTED|Treatment Phase||31
2393257|NCT01379534|5871974|P1|STARTED|Treatment Phase||22
2393258|NCT01379521|5871994|P2|NOT COMPLETED|Post-Treatment Evaluations||21
2393259|NCT01379521|5871995|P1|NOT COMPLETED|Post-Treatment Evaluations||25
2393260|NCT01379521|5871994|P2|COMPLETED|Post-Treatment Evaluations||0
2393261|NCT01379521|5871995|P1|COMPLETED|Post-Treatment Evaluations||0
2393262|NCT01379521|5871994|P2|STARTED|Post-Treatment Evaluations||21
2393263|NCT01379521|5871995|P1|STARTED|Post-Treatment Evaluations||25
2393264|NCT01379521|5871994|P2|NOT COMPLETED|Overall Study -Treatment Period||26
2393265|NCT01379521|5871995|P1|NOT COMPLETED|Overall Study -Treatment Period||33
2393266|NCT01379521|5871994|P2|COMPLETED|Overall Study -Treatment Period||0
2393267|NCT01379521|5871995|P1|COMPLETED|Overall Study -Treatment Period||0
2393268|NCT01379521|5871994|P2|STARTED|Overall Study -Treatment Period||26
2393269|NCT01379521|5871995|P1|STARTED|Overall Study -Treatment Period||33
2393270|NCT01379508|5872017|P4|NOT COMPLETED|Extension Period Weeks 109-156||0
2393271|NCT01379508|5872018|P3|NOT COMPLETED|Extension Period Weeks 109-156||14
2393272|NCT01379508|5872019|P2|NOT COMPLETED|Extension Period Weeks 109-156||3
2393273|NCT01379508|5872020|P1|NOT COMPLETED|Extension Period Weeks 109-156||19
2393274|NCT01379508|5872017|P4|COMPLETED|Extension Period Weeks 109-156||10
2393275|NCT01379508|5872018|P3|COMPLETED|Extension Period Weeks 109-156||65
2393276|NCT01379508|5872019|P2|COMPLETED|Extension Period Weeks 109-156||14
2393277|NCT01379508|5872020|P1|COMPLETED|Extension Period Weeks 109-156||45
2393278|NCT01379508|5872017|P4|STARTED|Extension Period Weeks 109-156||10
2393279|NCT01379508|5872018|P3|STARTED|Extension Period Weeks 109-156||79
2393280|NCT01379508|5872019|P2|STARTED|Extension Period Weeks 109-156||17
2393281|NCT01379508|5872020|P1|STARTED|Extension Period Weeks 109-156||64
2393282|NCT01379508|5872017|P4|NOT COMPLETED|Treatment to Week 104||0
2393283|NCT01379508|5872018|P3|NOT COMPLETED|Treatment to Week 104||13
2393284|NCT01379508|5872019|P2|NOT COMPLETED|Treatment to Week 104||3
2393285|NCT01379508|5872020|P1|NOT COMPLETED|Treatment to Week 104||19
2393286|NCT01379508|5872017|P4|COMPLETED|Treatment to Week 104||11
2393287|NCT01379508|5872018|P3|COMPLETED|Treatment to Week 104||96
2393288|NCT01379508|5872019|P2|COMPLETED|Treatment to Week 104||19
2393289|NCT01379508|5872020|P1|COMPLETED|Treatment to Week 104||80
2393290|NCT01379508|5872017|P4|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||11
2393291|NCT01379508|5872018|P3|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||105
2393292|NCT01379508|5872019|P2|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||21
2393293|NCT01379508|5872020|P1|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||91
2393294|NCT01379508|5872017|P4|Completed Wk 24|Treatment to Week 104||11
2393295|NCT01379508|5872018|P3|Completed Wk 24|Treatment to Week 104||107
2393296|NCT01379508|5872019|P2|Completed Wk 24|Treatment to Week 104||22
2393297|NCT01379508|5872020|P1|Completed Wk 24|Treatment to Week 104||93
2393298|NCT01379508|5872017|P4|STARTED|Treatment to Week 104||11
2393299|NCT01379508|5872018|P3|STARTED|Treatment to Week 104||109
2393300|NCT01379508|5872019|P2|STARTED|Treatment to Week 104||22
2393301|NCT01379508|5872020|P1|STARTED|Treatment to Week 104||99
2393302|NCT01379222|5872046|P1|NOT COMPLETED|Overall Study||73
2393303|NCT01379222|5872046|P1|COMPLETED|Overall Study||105
2393304|NCT01379222|5872046|P1|STARTED|Overall Study||178
2393305|NCT01379183|5872052|P2|NOT COMPLETED|Overall Study||0
2393306|NCT01379183|5872053|P1|NOT COMPLETED|Overall Study||0
2393307|NCT01379183|5872052|P2|COMPLETED|Overall Study||21
2393308|NCT01379183|5872053|P1|COMPLETED|Overall Study||19
2393309|NCT01379183|5872052|P2|STARTED|Overall Study||21
2393310|NCT01379183|5872053|P1|STARTED|Overall Study||19
2393311|NCT01378988|5872071|P2|NOT COMPLETED|Overall Study||0
2393312|NCT01378988|5872072|P1|NOT COMPLETED|Overall Study||0
2393313|NCT01378988|5872071|P2|COMPLETED|Overall Study||3
2393314|NCT01378988|5872072|P1|COMPLETED|Overall Study||2
2393315|NCT01378988|5872071|P2|STARTED|Overall Study||3
2393316|NCT01378988|5872072|P1|STARTED|Overall Study||2
2393317|NCT01378975|5872102|P2|NOT COMPLETED|Overall Study||50
2393318|NCT01378975|5872103|P1|NOT COMPLETED|Overall Study||86
2393319|NCT01378975|5872102|P2|COMPLETED|Overall Study||6
2393320|NCT01378975|5872103|P1|COMPLETED|Overall Study||4
2393321|NCT01378975|5872102|P2|STARTED|Overall Study||56
2393322|NCT01378975|5872103|P1|STARTED|Overall Study||90
2393323|NCT01378962|5872129|P1|NOT COMPLETED|Overall Study||17
2393324|NCT01378962|5872129|P1|COMPLETED|Overall Study||33
2393325|NCT01378962|5872129|P1|STARTED|Overall Study||50
2393326|NCT01378520|5872142|P2|NOT COMPLETED|Second Intervention (Day 4-6)||0
2393327|NCT01378520|5872143|P1|NOT COMPLETED|Second Intervention (Day 4-6)||0
2393328|NCT01378520|5872142|P2|COMPLETED|Second Intervention (Day 4-6)||10
2393329|NCT01378520|5872143|P1|COMPLETED|Second Intervention (Day 4-6)||10
2393330|NCT01378520|5872142|P2|STARTED|Second Intervention (Day 4-6)||10
2393331|NCT01378520|5872143|P1|STARTED|Second Intervention (Day 4-6)||10
2393332|NCT01378520|5872142|P2|NOT COMPLETED|First Intervention (Day 2-3)||0
2393333|NCT01378520|5872143|P1|NOT COMPLETED|First Intervention (Day 2-3)||0
2393334|NCT01378520|5872142|P2|COMPLETED|First Intervention (Day 2-3)||10
2393335|NCT01378520|5872143|P1|COMPLETED|First Intervention (Day 2-3)||10
2393336|NCT01378520|5872142|P2|STARTED|First Intervention (Day 2-3)||10
2393337|NCT01378520|5872143|P1|STARTED|First Intervention (Day 2-3)||10
2393338|NCT01378429|5872155|P2|NOT COMPLETED|Overall Study||0
2393339|NCT01378429|5872156|P1|NOT COMPLETED|Overall Study||1
2393340|NCT01378429|5872155|P2|COMPLETED|Overall Study||47
2393341|NCT01378429|5872156|P1|COMPLETED|Overall Study||41
2393342|NCT01378429|5872155|P2|STARTED|Overall Study||47
2393343|NCT01378429|5872156|P1|STARTED|Overall Study||42
2393344|NCT01378416|5872188|P1|NOT COMPLETED|Overall Study||0
2393345|NCT01378416|5872188|P1|COMPLETED|Overall Study||16
2393346|NCT01378416|5872188|P1|STARTED|Overall Study||16
2393347|NCT01378377|5872199|P3|NOT COMPLETED|Overall Study||0
2393348|NCT01378377|5872200|P2|NOT COMPLETED|Overall Study||0
2393349|NCT01378377|5872201|P1|NOT COMPLETED|Overall Study||0
2393350|NCT01378377|5872199|P3|COMPLETED|Overall Study||6
2393351|NCT01378377|5872200|P2|COMPLETED|Overall Study||23
2393352|NCT01378377|5872201|P1|COMPLETED|Overall Study||4
2393353|NCT01378377|5872199|P3|STARTED|Overall Study||6
2393354|NCT01378377|5872200|P2|STARTED|Overall Study||23
2393355|NCT01378377|5872201|P1|STARTED|Overall Study||4
2393356|NCT01378325|5872269|P2|NOT COMPLETED|Overall Study||1
2393357|NCT01378325|5872270|P1|NOT COMPLETED|Overall Study||0
2393358|NCT01378325|5872269|P2|COMPLETED|Overall Study||39
2393359|NCT01378325|5872270|P1|COMPLETED|Overall Study||40
2393360|NCT01378325|5872269|P2|STARTED|Overall Study||40
2393361|NCT01378325|5872270|P1|STARTED|Overall Study||40
2393362|NCT01378299|5872276|P1|NOT COMPLETED|Overall Study||31
2393363|NCT01378299|5872276|P1|COMPLETED|Overall Study||74
2393364|NCT01378299|5872276|P1|BMI Group 3|Overall Study||27
2393365|NCT01378299|5872276|P1|BMI Group 2|Overall Study||40
2393366|NCT01378299|5872276|P1|BMI group1|Overall Study||38
2393367|NCT01378299|5872276|P1|STARTED|Overall Study||105
2393368|NCT01378221|5872315|P2|NOT COMPLETED|Overall Study||9
2393369|NCT01378221|5872316|P1|NOT COMPLETED|Overall Study||7
2393370|NCT01378221|5872315|P2|COMPLETED|Overall Study||30
2393371|NCT01378221|5872316|P1|COMPLETED|Overall Study||29
2393372|NCT01378221|5872315|P2|STARTED|Overall Study||39
2393373|NCT01378221|5872316|P1|STARTED|Overall Study||36
2393374|NCT01378195|5872324|P2|NOT COMPLETED|Overall Study||18
2393375|NCT01378195|5872325|P1|NOT COMPLETED|Overall Study||29
2393376|NCT01378195|5872324|P2|COMPLETED|Overall Study||57
2393377|NCT01378195|5872325|P1|COMPLETED|Overall Study||46
2393378|NCT01378195|5872324|P2|STARTED|Overall Study||75
2393379|NCT01378195|5872325|P1|STARTED|Overall Study||75
2393380|NCT01378117|5872338|P3|NOT COMPLETED|Overall Study||3
2393381|NCT01378117|5872339|P2|NOT COMPLETED|Overall Study||1
2393382|NCT01378117|5872340|P1|NOT COMPLETED|Overall Study||4
2393383|NCT01378117|5872338|P3|COMPLETED|Overall Study||26
2393384|NCT01378117|5872339|P2|COMPLETED|Overall Study||29
2393385|NCT01378117|5872340|P1|COMPLETED|Overall Study||27
2393386|NCT01378117|5872338|P3|STARTED|Overall Study||29
2393387|NCT01378117|5872339|P2|STARTED|Overall Study||30
2393388|NCT01378117|5872340|P1|STARTED|Overall Study||31
2393389|NCT01378104|5872374|P2|NOT COMPLETED|Overall Study||26
2393390|NCT01378104|5872375|P1|NOT COMPLETED|Overall Study||27
2393391|NCT01378104|5872374|P2|COMPLETED|Overall Study||60
2393392|NCT01378104|5872375|P1|COMPLETED|Overall Study||65
2393393|NCT01378104|5872374|P2|STARTED|Overall Study||86
2393394|NCT01378104|5872375|P1|STARTED|Overall Study||92
2393395|NCT01378065|5872383|P1|NOT COMPLETED|Overall Study||0
2393396|NCT01378065|5872383|P1|COMPLETED|Overall Study||30
2393397|NCT01378065|5872383|P1|12 Months|Overall Study||30
2393398|NCT01378065|5872383|P1|6 Months|Overall Study||30
2393399|NCT01378065|5872383|P1|3 Months|Overall Study||30
2393400|NCT01378065|5872383|P1|6 Week|Overall Study||30
2393401|NCT01378065|5872383|P1|STARTED|Overall Study|31 subjects were enrolled/consented. However, 1 subject was not implanted with a study device.|30
2393402|NCT01377987|5872420|P2|NOT COMPLETED|Second Intervention (7 Days)||0
2393403|NCT01377987|5872421|P1|NOT COMPLETED|Second Intervention (7 Days)||0
2393404|NCT01377987|5872420|P2|COMPLETED|Second Intervention (7 Days)||14
2393405|NCT01377987|5872421|P1|COMPLETED|Second Intervention (7 Days)||13
2393406|NCT01377987|5872420|P2|STARTED|Second Intervention (7 Days)||14
2393407|NCT01377987|5872421|P1|STARTED|Second Intervention (7 Days)||13
2393408|NCT01377987|5872420|P2|NOT COMPLETED|Washout (7 Days)||1
2393409|NCT01377987|5872421|P1|NOT COMPLETED|Washout (7 Days)||1
2393410|NCT01377987|5872420|P2|COMPLETED|Washout (7 Days)||14
2393411|NCT01377987|5872421|P1|COMPLETED|Washout (7 Days)||13
2393412|NCT01377987|5872420|P2|STARTED|Washout (7 Days)||15
2393413|NCT01377987|5872421|P1|STARTED|Washout (7 Days)||14
2393414|NCT01377987|5872420|P2|NOT COMPLETED|First Intervention (7 Days)||0
2393415|NCT01377987|5872421|P1|NOT COMPLETED|First Intervention (7 Days)||0
2393416|NCT01377987|5872420|P2|COMPLETED|First Intervention (7 Days)||15
2393417|NCT01377987|5872421|P1|COMPLETED|First Intervention (7 Days)||14
2393418|NCT01377987|5872420|P2|STARTED|First Intervention (7 Days)||15
2393419|NCT01377987|5872421|P1|STARTED|First Intervention (7 Days)||14
2393420|NCT01377922|5872439|P2|NOT COMPLETED|Overall Study||0
2393421|NCT01377922|5872440|P1|NOT COMPLETED|Overall Study||1
2393422|NCT01377922|5872439|P2|COMPLETED|Overall Study||16
2393423|NCT01377922|5872440|P1|COMPLETED|Overall Study||21
2393424|NCT01377922|5872439|P2|STARTED|Overall Study||16
2393425|NCT01377922|5872440|P1|STARTED|Overall Study||22
2393426|NCT01377636|5872452|P1|NOT COMPLETED|Overall Study||0
2393427|NCT01377636|5872452|P1|COMPLETED|Overall Study||20
2393428|NCT01377636|5872452|P1|STARTED|Overall Study||20
2393429|NCT01377623|5872466|P2|NOT COMPLETED|Overall Study||5
2393430|NCT01377623|5872467|P1|NOT COMPLETED|Overall Study||7
2393431|NCT01377623|5872466|P2|COMPLETED|Overall Study||28
2393432|NCT01377623|5872467|P1|COMPLETED|Overall Study||26
2393433|NCT01377623|5872466|P2|STARTED|Overall Study||33
2393434|NCT01377623|5872467|P1|STARTED|Overall Study||33
2393435|NCT01377584|5872487|P6|NOT COMPLETED|Overall Study||3
2393436|NCT01377584|5872488|P5|NOT COMPLETED|Overall Study||3
2393437|NCT01377584|5872489|P4|NOT COMPLETED|Overall Study||4
2393438|NCT01377584|5872490|P3|NOT COMPLETED|Overall Study||4
2393439|NCT01377584|5872491|P2|NOT COMPLETED|Overall Study||3
2393440|NCT01377584|5872492|P1|NOT COMPLETED|Overall Study||3
2393441|NCT01377584|5872487|P6|COMPLETED|Overall Study||9
2393442|NCT01377584|5872488|P5|COMPLETED|Overall Study||9
2393443|NCT01377584|5872489|P4|COMPLETED|Overall Study||6
2393444|NCT01377584|5872490|P3|COMPLETED|Overall Study||6
2393445|NCT01377584|5872491|P2|COMPLETED|Overall Study||5
2393446|NCT01377584|5872492|P1|COMPLETED|Overall Study||5
2393447|NCT01377584|5872487|P6|STARTED|Overall Study||12
2393448|NCT01377584|5872488|P5|STARTED|Overall Study||12
2393449|NCT01377584|5872489|P4|STARTED|Overall Study||10
2393450|NCT01377584|5872490|P3|STARTED|Overall Study||10
2393451|NCT01377584|5872491|P2|STARTED|Overall Study||8
2393452|NCT01377584|5872492|P1|STARTED|Overall Study||8
2393453|NCT01377480|5872525|P4|NOT COMPLETED|Overall Study||11
2393454|NCT01377480|5872526|P3|NOT COMPLETED|Overall Study||10
2393455|NCT01377480|5872527|P2|NOT COMPLETED|Overall Study||1
2393456|NCT01377480|5872528|P1|NOT COMPLETED|Overall Study||0
2393457|NCT01377480|5872525|P4|COMPLETED|Overall Study||19
2393458|NCT01377480|5872526|P3|COMPLETED|Overall Study||18
2393459|NCT01377480|5872527|P2|COMPLETED|Overall Study||29
2393460|NCT01377480|5872528|P1|COMPLETED|Overall Study||32
2393461|NCT01377480|5872525|P4|STARTED|Overall Study||30
2393462|NCT01377480|5872526|P3|STARTED|Overall Study|2 participants received only POS and were analyzed as part of the posaconazole group|28
2393463|NCT01377480|5872527|P2|STARTED|Overall Study||30
2393464|NCT01377480|5872528|P1|STARTED|Overall Study|Includes 2 participants randomized to POS + BNZ but who only received POS|32
2393465|NCT01377467|5872540|P2|NOT COMPLETED|Overall Study||0
2393466|NCT01377467|5872541|P1|NOT COMPLETED|Overall Study||0
2393467|NCT01377467|5872540|P2|COMPLETED|Overall Study||44
2393468|NCT01377467|5872541|P1|COMPLETED|Overall Study||46
2393469|NCT01377467|5872540|P2|STARTED|Overall Study||44
2393470|NCT01377467|5872541|P1|STARTED|Overall Study||46
2393471|NCT01377441|5872589|P2|NOT COMPLETED|Overall Study||0
2393472|NCT01377441|5872590|P1|NOT COMPLETED|Overall Study||0
2393473|NCT01377441|5872589|P2|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
2393474|NCT01377441|5872590|P1|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
2393475|NCT01377441|5872589|P2|STARTED|Overall Study||0
2393476|NCT01377441|5872590|P1|STARTED|Overall Study||0
2393477|NCT01377402|5872598|P1|NOT COMPLETED|Overall Study||0
2393478|NCT01377402|5872598|P1|COMPLETED|Overall Study||982
2393479|NCT01377402|5872598|P1|STARTED|Overall Study||982
2393480|NCT01377389|5872604|P1|NOT COMPLETED|Overall Study||3
2393481|NCT01377389|5872604|P1|COMPLETED|Overall Study||27
2393482|NCT01377389|5872604|P1|STARTED|Overall Study||30
2393483|NCT01377233|5872618|P5|NOT COMPLETED|Double-blind||2
2393484|NCT01377233|5872619|P4|NOT COMPLETED|Double-blind||4
2393485|NCT01377233|5872620|P3|NOT COMPLETED|Double-blind||2
2393486|NCT01377233|5872621|P2|NOT COMPLETED|Double-blind||1
2393487|NCT01377233|5872622|P1|NOT COMPLETED|Double-blind||0
2393488|NCT01377233|5872618|P5|COMPLETED|Double-blind||8
2393489|NCT01377233|5872619|P4|COMPLETED|Double-blind||7
2393490|NCT01377233|5872620|P3|COMPLETED|Double-blind||8
2393491|NCT01377233|5872621|P2|COMPLETED|Double-blind||10
2393492|NCT01377233|5872622|P1|COMPLETED|Double-blind||0
2393493|NCT01377233|5872618|P5|STARTED|Double-blind||10
2393494|NCT01377233|5872619|P4|STARTED|Double-blind||11
2393495|NCT01377233|5872620|P3|STARTED|Double-blind||10
2393496|NCT01377233|5872621|P2|STARTED|Double-blind||11
2393497|NCT01377233|5872622|P1|STARTED|Double-blind||0
2393498|NCT01377233|5872618|P5|NOT COMPLETED|Open-label||0
2393499|NCT01377233|5872619|P4|NOT COMPLETED|Open-label||0
2393500|NCT01377233|5872620|P3|NOT COMPLETED|Open-label||0
2393501|NCT01377233|5872621|P2|NOT COMPLETED|Open-label||0
2393502|NCT01377233|5872622|P1|NOT COMPLETED|Open-label||4
2393503|NCT01377233|5872618|P5|COMPLETED|Open-label||0
2393504|NCT01377233|5872619|P4|COMPLETED|Open-label||0
2393505|NCT01377233|5872620|P3|COMPLETED|Open-label||0
2393506|NCT01377233|5872621|P2|COMPLETED|Open-label||0
2393507|NCT01377233|5872622|P1|COMPLETED|Open-label||42
2393508|NCT01377233|5872618|P5|STARTED|Open-label||0
2393509|NCT01377233|5872619|P4|STARTED|Open-label||0
2393510|NCT01377233|5872620|P3|STARTED|Open-label||0
2393511|NCT01377233|5872621|P2|STARTED|Open-label||0
2393512|NCT01377233|5872622|P1|STARTED|Open-label||46
2393513|NCT01377194|5872649|P3|NOT COMPLETED|Overall Study||46
2393514|NCT01377194|5872650|P2|NOT COMPLETED|Overall Study||43
2393515|NCT01377194|5872651|P1|NOT COMPLETED|Overall Study||32
2393516|NCT01377194|5872649|P3|COMPLETED|Overall Study||142
2393517|NCT01377194|5872650|P2|COMPLETED|Overall Study||145
2393518|NCT01377194|5872651|P1|COMPLETED|Overall Study||154
2393519|NCT01377194|5872649|P3|STARTED|Overall Study||188
2393520|NCT01377194|5872650|P2|STARTED|Overall Study||188
2393521|NCT01377194|5872651|P1|STARTED|Overall Study||186
2393522|NCT01377012|5872665|P3|NOT COMPLETED|Extension Study, Weeks 104-260||68
2393523|NCT01377012|5872666|P2|NOT COMPLETED|Extension Study, Weeks 104-260||71
2393524|NCT01377012|5872667|P1|NOT COMPLETED|Extension Study, Weeks 104-260||57
2393525|NCT01377012|5872665|P3|COMPLETED|Extension Study, Weeks 104-260||0
2393526|NCT01377012|5872666|P2|COMPLETED|Extension Study, Weeks 104-260||0
2393527|NCT01377012|5872667|P1|COMPLETED|Extension Study, Weeks 104-260||0
2393528|NCT01377012|5872665|P3|STARTED|Extension Study, Weeks 104-260||68
2393529|NCT01377012|5872666|P2|STARTED|Extension Study, Weeks 104-260||71
2393530|NCT01377012|5872667|P1|STARTED|Extension Study, Weeks 104-260||57
2393531|NCT01377012|5872665|P3|NOT COMPLETED|Core Study||134
2393532|NCT01377012|5872666|P2|NOT COMPLETED|Core Study||132
2393533|NCT01377012|5872667|P1|NOT COMPLETED|Core Study||134
2393534|NCT01377012|5872665|P3|COMPLETED|Core Study||80
2393535|NCT01377012|5872666|P2|COMPLETED|Core Study||81
2393536|NCT01377012|5872667|P1|COMPLETED|Core Study||76
2393537|NCT01377012|5872665|P3|wk 24 Re-randomized to AIN 150 mg Res|Core Study||34
2393538|NCT01377012|5872666|P2|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
2393539|NCT01377012|5872667|P1|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
2393540|NCT01377012|5872665|P3|wk 24 Re-randomized to AIN 75 mg Res|Core Study|Res= responder|38
2393541|NCT01377012|5872666|P2|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
2393542|NCT01377012|5872667|P1|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
2393543|NCT01377012|5872665|P3|wk16 Re-randomized to AIN 150mg NR|Core Study||53
2393544|NCT01377012|5872666|P2|wk16 Re-randomized to AIN 150mg NR|Core Study||0
2393545|NCT01377012|5872667|P1|wk16 Re-randomized to AIN 150mg NR|Core Study||0
2393546|NCT01377012|5872665|P3|wk16 Re-randomized to AIN 75mg NR|Core Study|NR=Non-responder|56
2393547|NCT01377012|5872666|P2|wk16 Re-randomized to AIN 75mg NR|Core Study||0
2393548|NCT01377012|5872667|P1|wk16 Re-randomized to AIN 75mg NR|Core Study||0
2393549|NCT01377012|5872665|P3|STARTED|Core Study||214
2393550|NCT01377012|5872666|P2|STARTED|Core Study||213
2393551|NCT01377012|5872667|P1|STARTED|Core Study||210
2393552|NCT01376908|5872704|P2|NOT COMPLETED|Overall Study||3
2393553|NCT01376908|5872705|P1|NOT COMPLETED|Overall Study||2
2393554|NCT01376908|5872704|P2|COMPLETED|Overall Study||26
2393555|NCT01376908|5872705|P1|COMPLETED|Overall Study||25
2393556|NCT01376908|5872704|P2|STARTED|Overall Study||29
2393557|NCT01376908|5872705|P1|STARTED|Overall Study||27
2393558|NCT01376804|5872738|P1|NOT COMPLETED|Follow-up Period||0
2393559|NCT01376804|5872738|P1|COMPLETED|Follow-up Period||55
2393560|NCT01376804|5872738|P1|STARTED|Follow-up Period|6 of the 7 patients who withdrew from treatment continued to the Follow-up Period.|55
2393561|NCT01376804|5872738|P1|NOT COMPLETED|Treatment Period||8
2393562|NCT01376804|5872738|P1|COMPLETED|Treatment Period||49
2393563|NCT01376804|5872738|P1|Received Study Drug|Treatment Period||56
2393564|NCT01376804|5872738|P1|STARTED|Treatment Period||57
2393565|NCT01376700|5872749|P1|NOT COMPLETED|Overall Study||16
2393566|NCT01376700|5872749|P1|COMPLETED|Overall Study||3
2393567|NCT01376700|5872749|P1|STARTED|Overall Study||19
2393568|NCT01376557|5872770|P5|NOT COMPLETED|Overall Study||7
2393569|NCT01376557|5872771|P4|NOT COMPLETED|Overall Study||6
2393570|NCT01376557|5872772|P3|NOT COMPLETED|Overall Study||5
2393571|NCT01376557|5872773|P2|NOT COMPLETED|Overall Study||6
2393572|NCT01376557|5872774|P1|NOT COMPLETED|Overall Study||8
2393573|NCT01376557|5872770|P5|COMPLETED|Overall Study||53
2393574|NCT01376557|5872771|P4|COMPLETED|Overall Study||54
2393575|NCT01376557|5872772|P3|COMPLETED|Overall Study||55
2393576|NCT01376557|5872773|P2|COMPLETED|Overall Study||54
2393577|NCT01376557|5872774|P1|COMPLETED|Overall Study||51
2393578|NCT01376557|5872770|P5|STARTED|Overall Study||60
2393579|NCT01376557|5872771|P4|STARTED|Overall Study||60
2393580|NCT01376557|5872772|P3|STARTED|Overall Study||60
2393581|NCT01376557|5872773|P2|STARTED|Overall Study||60
2393582|NCT01376557|5872774|P1|STARTED|Overall Study||59
2393583|NCT01376388|5872811|P1|NOT COMPLETED|Overall Study||18
2393584|NCT01376388|5872811|P1|COMPLETED|Overall Study||112
2393585|NCT01376388|5872811|P1|STARTED|Overall Study||130
2393586|NCT01376362|5872826|P1|NOT COMPLETED|Overall Study||0
2393587|NCT01376362|5872826|P1|COMPLETED|Overall Study||5
2393588|NCT01376362|5872826|P1|STARTED|Overall Study||5
2393589|NCT01376349|5872849|P3|NOT COMPLETED|Optional Continuation Phase||0
2393590|NCT01376349|5872850|P2|NOT COMPLETED|Optional Continuation Phase||0
2393591|NCT01376349|5872851|P1|NOT COMPLETED|Optional Continuation Phase||0
2393592|NCT01376349|5872849|P3|COMPLETED|Optional Continuation Phase||94
2393593|NCT01376349|5872850|P2|COMPLETED|Optional Continuation Phase||0
2393594|NCT01376349|5872851|P1|COMPLETED|Optional Continuation Phase||0
2393595|NCT01376349|5872849|P3|STARTED|Optional Continuation Phase|Patients completing Arm III Placebo were offered the option of continuing High Dose DHEA|94
2393596|NCT01376349|5872850|P2|STARTED|Optional Continuation Phase||0
2393597|NCT01376349|5872851|P1|STARTED|Optional Continuation Phase||0
2393598|NCT01376349|5872849|P3|NOT COMPLETED|Raondomized Treatment||29
2393599|NCT01376349|5872850|P2|NOT COMPLETED|Raondomized Treatment||35
2393600|NCT01376349|5872851|P1|NOT COMPLETED|Raondomized Treatment||24
2393601|NCT01376349|5872849|P3|COMPLETED|Raondomized Treatment||118
2393602|NCT01376349|5872850|P2|COMPLETED|Raondomized Treatment||114
2393603|NCT01376349|5872851|P1|COMPLETED|Raondomized Treatment||123
2393604|NCT01376349|5872849|P3|STARTED|Raondomized Treatment||147
2393605|NCT01376349|5872850|P2|STARTED|Raondomized Treatment||149
2393606|NCT01376349|5872851|P1|STARTED|Raondomized Treatment||147
2393607|NCT01376323|5872865|P5|NOT COMPLETED|Overall Study||1
2393608|NCT01376323|5872866|P4|NOT COMPLETED|Overall Study||5
2393609|NCT01376323|5872867|P3|NOT COMPLETED|Overall Study||3
2393610|NCT01376323|5872868|P2|NOT COMPLETED|Overall Study||1
2393611|NCT01376323|5872869|P1|NOT COMPLETED|Overall Study||2
2393612|NCT01376323|5872865|P5|COMPLETED|Overall Study||17
2393613|NCT01376323|5872866|P4|COMPLETED|Overall Study||14
2393614|NCT01376323|5872867|P3|COMPLETED|Overall Study||16
2393615|NCT01376323|5872868|P2|COMPLETED|Overall Study||17
2393616|NCT01376323|5872869|P1|COMPLETED|Overall Study||18
2393617|NCT01376323|5872865|P5|STARTED|Overall Study||18
2393618|NCT01376323|5872866|P4|STARTED|Overall Study||19
2393619|NCT01376323|5872867|P3|STARTED|Overall Study||19
2393620|NCT01376323|5872868|P2|STARTED|Overall Study||18
2393621|NCT01376323|5872869|P1|STARTED|Overall Study||20
2393622|NCT01376310|5872953|P2|NOT COMPLETED|Overall Study||11
2393623|NCT01376310|5872954|P1|NOT COMPLETED|Overall Study||36
2393624|NCT01376310|5872953|P2|COMPLETED|Overall Study||22
2393625|NCT01376310|5872954|P1|COMPLETED|Overall Study||90
2393626|NCT01376310|5872953|P2|STARTED|Overall Study||33
2393627|NCT01376310|5872954|P1|STARTED|Overall Study||126
2393628|NCT01376297|5872962|P2|NOT COMPLETED|Overall Study||49
2393629|NCT01376297|5872963|P1|NOT COMPLETED|Overall Study||128
2393630|NCT01376297|5872962|P2|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|55
2393631|NCT01376297|5872963|P1|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|181
2393632|NCT01376297|5872962|P2|STARTED|Overall Study|number of randomised patients|104
2393633|NCT01376297|5872963|P1|STARTED|Overall Study|number of randomised patients|309
2393634|NCT01376245|5872973|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||26
2393635|NCT01376245|5872974|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||23
2393636|NCT01376245|5872975|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||25
2393637|NCT01376245|5872976|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||32
2393638|NCT01376245|5872977|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
2393639|NCT01376245|5872973|P5|COMPLETED|24-week, Double-blind Treatment Period||134
2393640|NCT01376245|5872974|P4|COMPLETED|24-week, Double-blind Treatment Period||138
2393641|NCT01376245|5872975|P3|COMPLETED|24-week, Double-blind Treatment Period||135
2393642|NCT01376245|5872976|P2|COMPLETED|24-week, Double-blind Treatment Period||130
2393643|NCT01376245|5872977|P1|COMPLETED|24-week, Double-blind Treatment Period||0
2393644|NCT01376245|5872973|P5|STARTED|24-week, Double-blind Treatment Period||160
2393645|NCT01376245|5872974|P4|STARTED|24-week, Double-blind Treatment Period||161
2393646|NCT01376245|5872975|P3|STARTED|24-week, Double-blind Treatment Period||160
2393647|NCT01376245|5872976|P2|STARTED|24-week, Double-blind Treatment Period||162
2393648|NCT01376245|5872977|P1|STARTED|24-week, Double-blind Treatment Period||0
2393649|NCT01376245|5872973|P5|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
2393650|NCT01376245|5872974|P4|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
2393651|NCT01376245|5872975|P3|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
2393652|NCT01376245|5872976|P2|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
2393653|NCT01376245|5872977|P1|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||101
2393654|NCT01376245|5872973|P5|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
2393655|NCT01376245|5872974|P4|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
2393656|NCT01376245|5872975|P3|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
2393657|NCT01376245|5872976|P2|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
2393658|NCT01376245|5872977|P1|COMPLETED|2-wk Single-blind Placebo Run-in Period||643
2393659|NCT01376245|5872973|P5|STARTED|2-wk Single-blind Placebo Run-in Period||0
2393660|NCT01376245|5872974|P4|STARTED|2-wk Single-blind Placebo Run-in Period||0
2393661|NCT01376245|5872975|P3|STARTED|2-wk Single-blind Placebo Run-in Period||0
2393662|NCT01376245|5872976|P2|STARTED|2-wk Single-blind Placebo Run-in Period||0
2393663|NCT01376245|5872977|P1|STARTED|2-wk Single-blind Placebo Run-in Period||744
2393664|NCT01376167|5872994|P3|NOT COMPLETED|Overall Study||6
2393665|NCT01376167|5872995|P2|NOT COMPLETED|Overall Study||10
2393666|NCT01376167|5872996|P1|NOT COMPLETED|Overall Study||4
2393667|NCT01376167|5872994|P3|COMPLETED|Overall Study||123
2393668|NCT01376167|5872995|P2|COMPLETED|Overall Study||250
2393669|NCT01376167|5872996|P1|COMPLETED|Overall Study||129
2393670|NCT01376167|5872994|P3|STARTED|Overall Study||129
2393671|NCT01376167|5872995|P2|STARTED|Overall Study||260
2393672|NCT01376167|5872996|P1|STARTED|Overall Study||133
2393673|NCT01376089|5873067|P2|NOT COMPLETED|Overall Study||4
2393674|NCT01376089|5873068|P1|NOT COMPLETED|Overall Study||3
2393675|NCT01376089|5873067|P2|COMPLETED|Overall Study||144
2393676|NCT01376089|5873068|P1|COMPLETED|Overall Study||148
2393677|NCT01376089|5873067|P2|STARTED|Overall Study||148
2393678|NCT01376089|5873068|P1|STARTED|Overall Study||151
2393679|NCT01376050|5873080|P2|NOT COMPLETED|Overall Study||0
2393680|NCT01376050|5873081|P1|NOT COMPLETED|Overall Study||0
2393681|NCT01376050|5873080|P2|COMPLETED|Overall Study||11
2393682|NCT01376050|5873081|P1|COMPLETED|Overall Study||13
2393683|NCT01376050|5873080|P2|STARTED|Overall Study||11
2393684|NCT01376050|5873081|P1|STARTED|Overall Study||13
2393685|NCT01376037|5873091|P2|NOT COMPLETED|Overall Study||2
2393686|NCT01376037|5873092|P1|NOT COMPLETED|Overall Study||0
2393687|NCT01376037|5873091|P2|COMPLETED|Overall Study||29
2393688|NCT01376037|5873092|P1|COMPLETED|Overall Study||31
2393689|NCT01376037|5873091|P2|STARTED|Overall Study||31
2393690|NCT01376037|5873092|P1|STARTED|Overall Study||31
2393691|NCT01375946|5873098|P6|NOT COMPLETED|Overall Study||0
2393692|NCT01375946|5873099|P5|NOT COMPLETED|Overall Study||0
2393693|NCT01375946|5873100|P4|NOT COMPLETED|Overall Study||0
2393694|NCT01375946|5873101|P3|NOT COMPLETED|Overall Study||0
2393695|NCT01375946|5873102|P2|NOT COMPLETED|Overall Study||0
2393696|NCT01375946|5873103|P1|NOT COMPLETED|Overall Study||0
2393697|NCT01375946|5873098|P6|COMPLETED|Overall Study||4
2393698|NCT01375946|5873099|P5|COMPLETED|Overall Study||4
2393699|NCT01375946|5873100|P4|COMPLETED|Overall Study||4
2393700|NCT01375946|5873101|P3|COMPLETED|Overall Study||4
2393701|NCT01375946|5873102|P2|COMPLETED|Overall Study||4
2393702|NCT01375946|5873103|P1|COMPLETED|Overall Study||4
2393703|NCT01375946|5873098|P6|STARTED|Overall Study||4
2393704|NCT01375946|5873099|P5|STARTED|Overall Study||4
2393705|NCT01375946|5873100|P4|STARTED|Overall Study||4
2393706|NCT01375946|5873101|P3|STARTED|Overall Study||4
2393707|NCT01375946|5873102|P2|STARTED|Overall Study||4
2393708|NCT01375946|5873103|P1|STARTED|Overall Study||4
2393709|NCT01375777|5873120|P9|NOT COMPLETED|Overall Study||2
2393710|NCT01375777|5873121|P8|NOT COMPLETED|Overall Study||2
2393711|NCT01375777|5873122|P7|NOT COMPLETED|Overall Study||2
2393712|NCT01375777|5873123|P6|NOT COMPLETED|Overall Study||1
2393713|NCT01375777|5873124|P5|NOT COMPLETED|Overall Study||1
2393714|NCT01375777|5873125|P4|NOT COMPLETED|Overall Study||0
2393715|NCT01375777|5873126|P3|NOT COMPLETED|Overall Study||1
2393716|NCT01375777|5873127|P2|NOT COMPLETED|Overall Study||3
2393717|NCT01375777|5873128|P1|NOT COMPLETED|Overall Study||2
2393718|NCT01375777|5873120|P9|COMPLETED|Overall Study||44
2393719|NCT01375777|5873121|P8|COMPLETED|Overall Study||44
2393720|NCT01375777|5873122|P7|COMPLETED|Overall Study||44
2393721|NCT01375777|5873123|P6|COMPLETED|Overall Study||44
2393722|NCT01375777|5873124|P5|COMPLETED|Overall Study||45
2393723|NCT01375777|5873125|P4|COMPLETED|Overall Study||45
2393724|NCT01375777|5873126|P3|COMPLETED|Overall Study||45
2393725|NCT01375777|5873127|P2|COMPLETED|Overall Study||42
2393726|NCT01375777|5873128|P1|COMPLETED|Overall Study||44
2393727|NCT01375777|5873120|P9|Received Treatment|Overall Study||45
2393728|NCT01375777|5873121|P8|Received Treatment|Overall Study||45
2393729|NCT01375777|5873122|P7|Received Treatment|Overall Study||45
2393730|NCT01375777|5873123|P6|Received Treatment|Overall Study||45
2393731|NCT01375777|5873124|P5|Received Treatment|Overall Study||46
2393732|NCT01375777|5873125|P4|Received Treatment|Overall Study||45
2393733|NCT01375777|5873126|P3|Received Treatment|Overall Study||45
2393734|NCT01375777|5873127|P2|Received Treatment|Overall Study||45
2393735|NCT01375777|5873128|P1|Received Treatment|Overall Study||45
2393736|NCT01375777|5873120|P9|STARTED|Overall Study||46
2393737|NCT01375777|5873121|P8|STARTED|Overall Study||46
2393738|NCT01375777|5873122|P7|STARTED|Overall Study||46
2393739|NCT01375777|5873123|P6|STARTED|Overall Study||45
2393740|NCT01375777|5873124|P5|STARTED|Overall Study||46
2393741|NCT01375777|5873125|P4|STARTED|Overall Study||45
2393742|NCT01375777|5873126|P3|STARTED|Overall Study||46
2393743|NCT01375777|5873127|P2|STARTED|Overall Study||45
2393744|NCT01375777|5873128|P1|STARTED|Overall Study||46
2393745|NCT01375764|5873198|P5|NOT COMPLETED|Overall Study||1
2393746|NCT01375764|5873199|P4|NOT COMPLETED|Overall Study||1
2393747|NCT01375764|5873200|P3|NOT COMPLETED|Overall Study||0
2393748|NCT01375764|5873201|P2|NOT COMPLETED|Overall Study||1
2393749|NCT01375764|5873202|P1|NOT COMPLETED|Overall Study||2
2393750|NCT01375764|5873198|P5|COMPLETED|Overall Study||31
2393751|NCT01375764|5873199|P4|COMPLETED|Overall Study||31
2393752|NCT01375764|5873200|P3|COMPLETED|Overall Study||32
2393753|NCT01375764|5873201|P2|COMPLETED|Overall Study||30
2393754|NCT01375764|5873202|P1|COMPLETED|Overall Study||31
2393755|NCT01375764|5873198|P5|Received Treatment|Overall Study||32
2393756|NCT01375764|5873199|P4|Received Treatment|Overall Study||31
2393757|NCT01375764|5873200|P3|Received Treatment|Overall Study||32
2393758|NCT01375764|5873201|P2|Received Treatment|Overall Study||30
2393759|NCT01375764|5873202|P1|Received Treatment|Overall Study||32
2393760|NCT01375764|5873198|P5|STARTED|Overall Study||32
2393761|NCT01375764|5873199|P4|STARTED|Overall Study||32
2393762|NCT01375764|5873200|P3|STARTED|Overall Study||32
2393763|NCT01375764|5873201|P2|STARTED|Overall Study||31
2393764|NCT01375764|5873202|P1|STARTED|Overall Study||33
2393765|NCT01375751|5873248|P3|NOT COMPLETED|Overall Study||0
2393766|NCT01375751|5873249|P2|NOT COMPLETED|Overall Study||1
2393767|NCT01375751|5873250|P1|NOT COMPLETED|Overall Study||0
2393768|NCT01375751|5873248|P3|COMPLETED|Overall Study||56
2393769|NCT01375751|5873249|P2|COMPLETED|Overall Study||55
2393770|NCT01375751|5873250|P1|COMPLETED|Overall Study||56
2393771|NCT01375751|5873248|P3|Received Treatment|Overall Study||56
2393772|NCT01375751|5873249|P2|Received Treatment|Overall Study||55
2393773|NCT01375751|5873250|P1|Received Treatment|Overall Study||56
2393774|NCT01375751|5873248|P3|STARTED|Overall Study||56
2393775|NCT01375751|5873249|P2|STARTED|Overall Study||56
2393776|NCT01375751|5873250|P1|STARTED|Overall Study||56
2393777|NCT01375660|5873275|P2|NOT COMPLETED|Overall Study||16
2393778|NCT01375660|5873276|P1|NOT COMPLETED|Overall Study||16
2393779|NCT01375660|5873275|P2|COMPLETED|Overall Study||87
2393780|NCT01375660|5873276|P1|COMPLETED|Overall Study||86
2393781|NCT01375660|5873275|P2|STARTED|Overall Study||103
2393782|NCT01375660|5873276|P1|STARTED|Overall Study||102
2393783|NCT01375608|5873294|P1|NOT COMPLETED|Overall Study||2
2393784|NCT01375608|5873294|P1|COMPLETED|Overall Study||8
2393785|NCT01375608|5873294|P1|STARTED|Overall Study||10
2393786|NCT01375569|5873298|P1|NOT COMPLETED|Overall Study||0
2393787|NCT01375569|5873298|P1|COMPLETED|Overall Study||11
2393788|NCT01375569|5873298|P1|STARTED|Overall Study||11
2393789|NCT01375491|5873306|P3|NOT COMPLETED|Overall Study||0
2393790|NCT01375491|5873307|P2|NOT COMPLETED|Overall Study||1
2393791|NCT01375491|5873308|P1|NOT COMPLETED|Overall Study||2
2393792|NCT01375491|5873306|P3|COMPLETED|Overall Study||15
2393793|NCT01375491|5873307|P2|COMPLETED|Overall Study||12
2393794|NCT01375491|5873308|P1|COMPLETED|Overall Study||9
2393795|NCT01375491|5873306|P3|STARTED|Overall Study||15
2393796|NCT01375491|5873307|P2|STARTED|Overall Study||13
2393797|NCT01375491|5873308|P1|STARTED|Overall Study||11
2393798|NCT01375374|5873322|P1|NOT COMPLETED|Overall Study||1
2393799|NCT01375374|5873322|P1|COMPLETED|Overall Study||10
2393800|NCT01375374|5873322|P1|STARTED|Overall Study||11
2393801|NCT01375205|5873331|P2|NOT COMPLETED|Overall Study||13
2393802|NCT01375205|5873332|P1|NOT COMPLETED|Overall Study||21
2393803|NCT01375205|5873331|P2|COMPLETED|Overall Study||33
2393804|NCT01375205|5873332|P1|COMPLETED|Overall Study||33
2393805|NCT01375205|5873331|P2|STARTED|Overall Study||46
2393806|NCT01375205|5873332|P1|STARTED|Overall Study||54
2393807|NCT01375140|5873352|P1|NOT COMPLETED|Overall Study||0
2393808|NCT01375140|5873352|P1|COMPLETED|Overall Study||31
2393809|NCT01375140|5873352|P1|STARTED|Overall Study||31
2393810|NCT01375127|5873362|P6|NOT COMPLETED|Overall Study||0
2393811|NCT01375127|5873363|P5|NOT COMPLETED|Overall Study||0
2393812|NCT01375127|5873364|P4|NOT COMPLETED|Overall Study||0
2393813|NCT01375127|5873365|P3|NOT COMPLETED|Overall Study||0
2393814|NCT01375127|5873366|P2|NOT COMPLETED|Overall Study||0
2393815|NCT01375127|5873367|P1|NOT COMPLETED|Overall Study||0
2393816|NCT01375127|5873362|P6|COMPLETED|Overall Study||3
2393817|NCT01375127|5873363|P5|COMPLETED|Overall Study||5
2393818|NCT01375127|5873364|P4|COMPLETED|Overall Study||33
2393819|NCT01375127|5873365|P3|COMPLETED|Overall Study||40
2393820|NCT01375127|5873366|P2|COMPLETED|Overall Study||1
2393821|NCT01375127|5873367|P1|COMPLETED|Overall Study||1
2393822|NCT01375127|5873362|P6|STARTED|Overall Study||3
2393823|NCT01375127|5873363|P5|STARTED|Overall Study||5
2393824|NCT01375127|5873364|P4|STARTED|Overall Study||33
2393825|NCT01375127|5873365|P3|STARTED|Overall Study||40
2393826|NCT01375127|5873366|P2|STARTED|Overall Study||1
2393827|NCT01375127|5873367|P1|STARTED|Overall Study||1
2393828|NCT01375075|5873405|P6|NOT COMPLETED|Overall Study||3
2393829|NCT01375075|5873406|P5|NOT COMPLETED|Overall Study||0
2393830|NCT01375075|5873407|P4|NOT COMPLETED|Overall Study||1
2393831|NCT01375075|5873408|P3|NOT COMPLETED|Overall Study||3
2393832|NCT01375075|5873409|P2|NOT COMPLETED|Overall Study||1
2393833|NCT01375075|5873410|P1|NOT COMPLETED|Overall Study||1
2393834|NCT01375075|5873405|P6|COMPLETED|Overall Study||25
2393835|NCT01375075|5873406|P5|COMPLETED|Overall Study||27
2393836|NCT01375075|5873407|P4|COMPLETED|Overall Study||27
2393837|NCT01375075|5873408|P3|COMPLETED|Overall Study||24
2393838|NCT01375075|5873409|P2|COMPLETED|Overall Study||27
2393839|NCT01375075|5873410|P1|COMPLETED|Overall Study||26
2393840|NCT01375075|5873405|P6|Received at Least One Dose of Study Drug|Overall Study||28
2393841|NCT01375075|5873406|P5|Received at Least One Dose of Study Drug|Overall Study||27
2393842|NCT01375075|5873407|P4|Received at Least One Dose of Study Drug|Overall Study||28
2393843|NCT01375075|5873408|P3|Received at Least One Dose of Study Drug|Overall Study||27
2393844|NCT01375075|5873409|P2|Received at Least One Dose of Study Drug|Overall Study||28
2393845|NCT01375075|5873410|P1|Received at Least One Dose of Study Drug|Overall Study||27
2393846|NCT01375075|5873405|P6|STARTED|Overall Study||28
2393847|NCT01375075|5873406|P5|STARTED|Overall Study||27
2393848|NCT01375075|5873407|P4|STARTED|Overall Study||28
2393849|NCT01375075|5873408|P3|STARTED|Overall Study||27
2393850|NCT01375075|5873409|P2|STARTED|Overall Study||28
2393851|NCT01375075|5873410|P1|STARTED|Overall Study||27
2393852|NCT01375049|5873494|P1|NOT COMPLETED|Overall Study||50
2393853|NCT01375049|5873494|P1|COMPLETED|Overall Study||55
2393854|NCT01375049|5873494|P1|STARTED|Overall Study||105
2393855|NCT01375010|5873511|P2|NOT COMPLETED|Overall Study||4
2393856|NCT01375010|5873512|P1|NOT COMPLETED|Overall Study||12
2393857|NCT01375010|5873511|P2|COMPLETED|Overall Study||38
2393858|NCT01375010|5873512|P1|COMPLETED|Overall Study||31
2393859|NCT01375010|5873511|P2|STARTED|Overall Study||42
2393860|NCT01375010|5873512|P1|STARTED|Overall Study||43
2393861|NCT01374971|5873526|P1|NOT COMPLETED|Overall Study||1
2393862|NCT01374971|5873526|P1|COMPLETED|Overall Study||11
2393863|NCT01374971|5873526|P1|STARTED|Overall Study||12
2393864|NCT01374919|5873531|P1|NOT COMPLETED|Overall Study||2
2393865|NCT01374919|5873531|P1|COMPLETED|Overall Study||58
2393866|NCT01374919|5873531|P1|STARTED|Overall Study||60
2393867|NCT01374906|5873538|P2|NOT COMPLETED|Overall Study||48
2393868|NCT01374906|5873539|P1|NOT COMPLETED|Overall Study||40
2393869|NCT01374906|5873538|P2|COMPLETED|Overall Study||28
2393870|NCT01374906|5873539|P1|COMPLETED|Overall Study||34
2393871|NCT01374906|5873538|P2|Completed Extension Phase|Overall Study||15
2393872|NCT01374906|5873539|P1|Completed Extension Phase|Overall Study||24
2393873|NCT01374906|5873538|P2|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||26
2393874|NCT01374906|5873539|P1|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||16
2393875|NCT01374906|5873538|P2|Completed Core Phase/Entered Ext. Phase|Overall Study||41
2393876|NCT01374906|5873539|P1|Completed Core Phase/Entered Ext. Phase|Overall Study||40
2393877|NCT01374906|5873538|P2|Completed Core/Did Not Enter Ext. Phase|Overall Study||13
2393878|NCT01374906|5873539|P1|Completed Core/Did Not Enter Ext. Phase|Overall Study||10
2393879|NCT01374906|5873538|P2|Completed Core Phase|Overall Study||54
2393880|NCT01374906|5873539|P1|Completed Core Phase|Overall Study||50
2393881|NCT01374906|5873538|P2|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||22
2393882|NCT01374906|5873539|P1|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||24
2393883|NCT01374906|5873538|P2|STARTED|Overall Study||76
2393884|NCT01374906|5873539|P1|STARTED|Overall Study||74
2393885|NCT01374802|5873606|P1|NOT COMPLETED|Overall Study||0
2393886|NCT01374802|5873606|P1|COMPLETED|Overall Study||14
2393887|NCT01374802|5873606|P1|STARTED|Overall Study||14
2393888|NCT01374568|5873620|P2|NOT COMPLETED|Overall Study||2
2393889|NCT01374568|5873621|P1|NOT COMPLETED|Overall Study||0
2393890|NCT01374568|5873620|P2|COMPLETED|Overall Study||1
2393891|NCT01374568|5873621|P1|COMPLETED|Overall Study||2
2393892|NCT01374568|5873620|P2|STARTED|Overall Study||3
2393893|NCT01374568|5873621|P1|STARTED|Overall Study||2
2393894|NCT01374516|5873631|P2|NOT COMPLETED|Surveillance Expansion Period||1253
2393895|NCT01374516|5873632|P1|NOT COMPLETED|Surveillance Expansion Period||2349
2393896|NCT01374516|5873631|P2|COMPLETED|Surveillance Expansion Period||5387
2393897|NCT01374516|5873632|P1|COMPLETED|Surveillance Expansion Period||10932
2393898|NCT01374516|5873631|P2|STARTED|Surveillance Expansion Period||6640
2393899|NCT01374516|5873632|P1|STARTED|Surveillance Expansion Period||13281
2393900|NCT01374516|5873631|P2|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||309
2393901|NCT01374516|5873632|P1|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||639
2393902|NCT01374516|5873631|P2|COMPLETED|Vaccination Phase (Up to 25 Months)||6640
2393903|NCT01374516|5873632|P1|COMPLETED|Vaccination Phase (Up to 25 Months)||13281
2393904|NCT01374516|5873631|P2|STARTED|Vaccination Phase (Up to 25 Months)||6949
2393905|NCT01374516|5873632|P1|STARTED|Vaccination Phase (Up to 25 Months)||13920
2393906|NCT01374451|5873666|P2|NOT COMPLETED|Overall Study||0
2393907|NCT01374451|5873667|P1|NOT COMPLETED|Overall Study||1
2393908|NCT01374451|5873666|P2|COMPLETED|Overall Study||81
2393909|NCT01374451|5873667|P1|COMPLETED|Overall Study||78
2393910|NCT01374451|5873666|P2|STARTED|Overall Study||81
2393911|NCT01374451|5873667|P1|STARTED|Overall Study||79
2393912|NCT01374438|5873696|P2|NOT COMPLETED|Overall Study||0
2393913|NCT01374438|5873697|P1|NOT COMPLETED|Overall Study||0
2393914|NCT01374438|5873696|P2|COMPLETED|Overall Study||13
2393915|NCT01374438|5873697|P1|COMPLETED|Overall Study||16
2393916|NCT01374438|5873696|P2|STARTED|Overall Study||13
2393917|NCT01374438|5873697|P1|STARTED|Overall Study||16
2393918|NCT01374425|5873713|P2|NOT COMPLETED|Overall Study||188
2393919|NCT01374425|5873714|P1|NOT COMPLETED|Overall Study||188
2393920|NCT01374425|5873713|P2|COMPLETED|Overall Study||0
2393921|NCT01374425|5873714|P1|COMPLETED|Overall Study||0
2393922|NCT01374425|5873713|P2|STARTED|Overall Study||188
2393923|NCT01374425|5873714|P1|STARTED|Overall Study||188
2393924|NCT01374269|5873794|P2|NOT COMPLETED|Overall Study||5
2393925|NCT01374269|5873795|P1|NOT COMPLETED|Overall Study||6
2393926|NCT01374269|5873794|P2|COMPLETED|Overall Study||39
2393927|NCT01374269|5873795|P1|COMPLETED|Overall Study||40
2393928|NCT01374269|5873794|P2|STARTED|Overall Study||44
2393929|NCT01374269|5873795|P1|STARTED|Overall Study||46
2393930|NCT01374217|5873923|P1|NOT COMPLETED|Overall Study||13
2393931|NCT01374217|5873923|P1|COMPLETED|Overall Study||0
2393932|NCT01374217|5873923|P1|STARTED|Overall Study||13
2393933|NCT01374178|5873931|P2|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||0
2393934|NCT01374178|5873932|P1|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||2
2393935|NCT01374178|5873931|P2|COMPLETED|Period 2 (up to 24 Hours After Dosing)||5
2393936|NCT01374178|5873932|P1|COMPLETED|Period 2 (up to 24 Hours After Dosing)||8
2393937|NCT01374178|5873931|P2|STARTED|Period 2 (up to 24 Hours After Dosing)||5
2393938|NCT01374178|5873932|P1|STARTED|Period 2 (up to 24 Hours After Dosing)||10
2393939|NCT01374178|5873931|P2|NOT COMPLETED|Washout Period of at Least 7 Days||0
2393940|NCT01374178|5873932|P1|NOT COMPLETED|Washout Period of at Least 7 Days||1
2393941|NCT01374178|5873931|P2|COMPLETED|Washout Period of at Least 7 Days||5
2393942|NCT01374178|5873932|P1|COMPLETED|Washout Period of at Least 7 Days||10
2393943|NCT01374178|5873931|P2|STARTED|Washout Period of at Least 7 Days||5
2393944|NCT01374178|5873932|P1|STARTED|Washout Period of at Least 7 Days||11
2393945|NCT01374178|5873931|P2|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
2393946|NCT01374178|5873932|P1|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
2393947|NCT01374178|5873931|P2|COMPLETED|Period 1 (up to 24 Hours After Dosing)||5
2393948|NCT01374178|5873932|P1|COMPLETED|Period 1 (up to 24 Hours After Dosing)||11
2393949|NCT01374178|5873931|P2|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||5
2393950|NCT01374178|5873932|P1|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||11
2393951|NCT01374178|5873931|P2|STARTED|Period 1 (up to 24 Hours After Dosing)||5
2393952|NCT01374178|5873932|P1|STARTED|Period 1 (up to 24 Hours After Dosing)||11
2393953|NCT01374087|5873950|P2|NOT COMPLETED|Overall Study||15
2393954|NCT01374087|5873951|P1|NOT COMPLETED|Overall Study||16
2393955|NCT01374087|5873950|P2|COMPLETED|Overall Study||0
2393956|NCT01374087|5873951|P1|COMPLETED|Overall Study||0
2393957|NCT01374087|5873950|P2|STARTED|Overall Study||15
2393958|NCT01374087|5873951|P1|STARTED|Overall Study||16
2393959|NCT01373931|5873971|P2|NOT COMPLETED|Period 2||0
2393960|NCT01373931|5873972|P1|NOT COMPLETED|Period 2||0
2393961|NCT01373931|5873971|P2|COMPLETED|Period 2||8
2393962|NCT01373931|5873972|P1|COMPLETED|Period 2||6
2393963|NCT01373931|5873971|P2|STARTED|Period 2||8
2393964|NCT01373931|5873972|P1|STARTED|Period 2||6
2393965|NCT01373931|5873971|P2|NOT COMPLETED|Period 1||2
2393966|NCT01373931|5873972|P1|NOT COMPLETED|Period 1||2
2393967|NCT01373931|5873971|P2|COMPLETED|Period 1||8
2393968|NCT01373931|5873972|P1|COMPLETED|Period 1||6
2393969|NCT01373931|5873971|P2|STARTED|Period 1||10
2393970|NCT01373931|5873972|P1|STARTED|Period 1||8
2393971|NCT01373931|5873971|P2|NOT COMPLETED|Lead-in Period||0
2393972|NCT01373931|5873972|P1|NOT COMPLETED|Lead-in Period||2
2393973|NCT01373931|5873971|P2|COMPLETED|Lead-in Period||10
2393974|NCT01373931|5873972|P1|COMPLETED|Lead-in Period||8
2393975|NCT01373931|5873971|P2|Received at Least 1 Dose of Study Drug|Lead-in Period||10
2393976|NCT01373931|5873972|P1|Received at Least 1 Dose of Study Drug|Lead-in Period||8
2393977|NCT01373931|5873971|P2|STARTED|Lead-in Period||10
2393978|NCT01373931|5873972|P1|STARTED|Lead-in Period||10
2393979|NCT01373918|5873985|P2|NOT COMPLETED|Overall Study||1
2393980|NCT01373918|5873986|P1|NOT COMPLETED|Overall Study||0
2393981|NCT01373918|5873985|P2|COMPLETED|Overall Study||15
2393982|NCT01373918|5873986|P1|COMPLETED|Overall Study||20
2393983|NCT01373918|5873985|P2|STARTED|Overall Study||16
2393984|NCT01373918|5873986|P1|STARTED|Overall Study||20
2393985|NCT01373671|5873998|P1|NOT COMPLETED|Overall Study||92
2393986|NCT01373671|5873998|P1|COMPLETED|Overall Study||672
2393987|NCT01373671|5873998|P1|STARTED|Overall Study||764
2393988|NCT01373580|5874003|P1|NOT COMPLETED|Overall Study||56
2393989|NCT01373580|5874003|P1|COMPLETED|Overall Study||317
2393990|NCT01373580|5874003|P1|STARTED|Overall Study||373
2393991|NCT01373489|5874011|P2|NOT COMPLETED|Overall Study||13
2393992|NCT01373489|5874012|P1|NOT COMPLETED|Overall Study||15
2393993|NCT01373489|5874011|P2|COMPLETED|Overall Study||41
2393994|NCT01373489|5874012|P1|COMPLETED|Overall Study||44
2393995|NCT01373489|5874011|P2|STARTED|Overall Study||54
2393996|NCT01373489|5874012|P1|STARTED|Overall Study||59
2393997|NCT01373450|5874018|P6|NOT COMPLETED|Crossover Period 4||0
2393998|NCT01373450|5874019|P5|NOT COMPLETED|Crossover Period 4||0
2393999|NCT01373450|5874020|P4|NOT COMPLETED|Crossover Period 4||0
2394000|NCT01373450|5874021|P3|NOT COMPLETED|Crossover Period 4||0
2394001|NCT01373450|5874022|P2|NOT COMPLETED|Crossover Period 4||0
2394002|NCT01373450|5874023|P1|NOT COMPLETED|Crossover Period 4||0
2394003|NCT01373450|5874018|P6|COMPLETED|Crossover Period 4||2
2394004|NCT01373450|5874019|P5|COMPLETED|Crossover Period 4||2
2394005|NCT01373450|5874020|P4|COMPLETED|Crossover Period 4||2
2394006|NCT01373450|5874021|P3|COMPLETED|Crossover Period 4||2
2394007|NCT01373450|5874022|P2|COMPLETED|Crossover Period 4||2
2394008|NCT01373450|5874023|P1|COMPLETED|Crossover Period 4||2
2394009|NCT01373450|5874018|P6|STARTED|Crossover Period 4||2
2394010|NCT01373450|5874019|P5|STARTED|Crossover Period 4||2
2394011|NCT01373450|5874020|P4|STARTED|Crossover Period 4||2
2394012|NCT01373450|5874021|P3|STARTED|Crossover Period 4||2
2394013|NCT01373450|5874022|P2|STARTED|Crossover Period 4||2
2394014|NCT01373450|5874023|P1|STARTED|Crossover Period 4||2
2394015|NCT01373450|5874018|P6|NOT COMPLETED|7 Day Wash-out||0
2394016|NCT01373450|5874019|P5|NOT COMPLETED|7 Day Wash-out||0
2394017|NCT01373450|5874020|P4|NOT COMPLETED|7 Day Wash-out||0
2394018|NCT01373450|5874021|P3|NOT COMPLETED|7 Day Wash-out||0
2394019|NCT01373450|5874022|P2|NOT COMPLETED|7 Day Wash-out||0
2394020|NCT01373450|5874023|P1|NOT COMPLETED|7 Day Wash-out||0
2394021|NCT01373450|5874018|P6|COMPLETED|7 Day Wash-out||2
2394022|NCT01373450|5874019|P5|COMPLETED|7 Day Wash-out||2
2394023|NCT01373450|5874020|P4|COMPLETED|7 Day Wash-out||2
2394024|NCT01373450|5874021|P3|COMPLETED|7 Day Wash-out||2
2394025|NCT01373450|5874022|P2|COMPLETED|7 Day Wash-out||2
2394026|NCT01373450|5874023|P1|COMPLETED|7 Day Wash-out||2
2394027|NCT01373450|5874018|P6|STARTED|7 Day Wash-out||2
2394028|NCT01373450|5874019|P5|STARTED|7 Day Wash-out||2
2394029|NCT01373450|5874020|P4|STARTED|7 Day Wash-out||2
2394030|NCT01373450|5874021|P3|STARTED|7 Day Wash-out||2
2394031|NCT01373450|5874022|P2|STARTED|7 Day Wash-out||2
2394032|NCT01373450|5874023|P1|STARTED|7 Day Wash-out||2
2394033|NCT01373450|5874018|P6|NOT COMPLETED|Crossover Period 3||0
2394034|NCT01373450|5874019|P5|NOT COMPLETED|Crossover Period 3||0
2394035|NCT01373450|5874020|P4|NOT COMPLETED|Crossover Period 3||0
2394036|NCT01373450|5874021|P3|NOT COMPLETED|Crossover Period 3||0
2394037|NCT01373450|5874022|P2|NOT COMPLETED|Crossover Period 3||0
2394038|NCT01373450|5874023|P1|NOT COMPLETED|Crossover Period 3||0
2394039|NCT01373450|5874018|P6|COMPLETED|Crossover Period 3||2
2394040|NCT01373450|5874019|P5|COMPLETED|Crossover Period 3||2
2394041|NCT01373450|5874020|P4|COMPLETED|Crossover Period 3||2
2394042|NCT01373450|5874021|P3|COMPLETED|Crossover Period 3||2
2394043|NCT01373450|5874022|P2|COMPLETED|Crossover Period 3||2
2394044|NCT01373450|5874023|P1|COMPLETED|Crossover Period 3||2
2394045|NCT01373450|5874018|P6|STARTED|Crossover Period 3||2
2394046|NCT01373450|5874019|P5|STARTED|Crossover Period 3||2
2394047|NCT01373450|5874020|P4|STARTED|Crossover Period 3||2
2394048|NCT01373450|5874021|P3|STARTED|Crossover Period 3||2
2394049|NCT01373450|5874022|P2|STARTED|Crossover Period 3||2
2394050|NCT01373450|5874023|P1|STARTED|Crossover Period 3||2
2394051|NCT01373450|5874018|P6|NOT COMPLETED|7 Day Wash-out||0
2394052|NCT01373450|5874019|P5|NOT COMPLETED|7 Day Wash-out||0
2394053|NCT01373450|5874020|P4|NOT COMPLETED|7 Day Wash-out||0
2394054|NCT01373450|5874021|P3|NOT COMPLETED|7 Day Wash-out||0
2394055|NCT01373450|5874022|P2|NOT COMPLETED|7 Day Wash-out||0
2394056|NCT01373450|5874023|P1|NOT COMPLETED|7 Day Wash-out||0
2394057|NCT01373450|5874018|P6|COMPLETED|7 Day Wash-out||2
2394058|NCT01373450|5874019|P5|COMPLETED|7 Day Wash-out||2
2394059|NCT01373450|5874020|P4|COMPLETED|7 Day Wash-out||2
2394060|NCT01373450|5874021|P3|COMPLETED|7 Day Wash-out||2
2394061|NCT01373450|5874022|P2|COMPLETED|7 Day Wash-out||2
2394062|NCT01373450|5874023|P1|COMPLETED|7 Day Wash-out||2
2394063|NCT01373450|5874018|P6|STARTED|7 Day Wash-out||2
2394064|NCT01373450|5874019|P5|STARTED|7 Day Wash-out||2
2394065|NCT01373450|5874020|P4|STARTED|7 Day Wash-out||2
2394066|NCT01373450|5874021|P3|STARTED|7 Day Wash-out||2
2394067|NCT01373450|5874022|P2|STARTED|7 Day Wash-out||2
2394068|NCT01373450|5874023|P1|STARTED|7 Day Wash-out||2
2394069|NCT01373450|5874018|P6|NOT COMPLETED|Crossover Period 2||0
2394070|NCT01373450|5874019|P5|NOT COMPLETED|Crossover Period 2||0
2394071|NCT01373450|5874020|P4|NOT COMPLETED|Crossover Period 2||0
2394072|NCT01373450|5874021|P3|NOT COMPLETED|Crossover Period 2||0
2394073|NCT01373450|5874022|P2|NOT COMPLETED|Crossover Period 2||0
2394074|NCT01373450|5874023|P1|NOT COMPLETED|Crossover Period 2||0
2394075|NCT01373450|5874018|P6|COMPLETED|Crossover Period 2||2
2394076|NCT01373450|5874019|P5|COMPLETED|Crossover Period 2||2
2394077|NCT01373450|5874020|P4|COMPLETED|Crossover Period 2||2
2394078|NCT01373450|5874021|P3|COMPLETED|Crossover Period 2||2
2394079|NCT01373450|5874022|P2|COMPLETED|Crossover Period 2||2
2394080|NCT01373450|5874023|P1|COMPLETED|Crossover Period 2||2
2394081|NCT01373450|5874018|P6|STARTED|Crossover Period 2||2
2394082|NCT01373450|5874019|P5|STARTED|Crossover Period 2||2
2394083|NCT01373450|5874020|P4|STARTED|Crossover Period 2||2
2394084|NCT01373450|5874021|P3|STARTED|Crossover Period 2||2
2394085|NCT01373450|5874022|P2|STARTED|Crossover Period 2||2
2394086|NCT01373450|5874023|P1|STARTED|Crossover Period 2||2
2394087|NCT01373450|5874018|P6|NOT COMPLETED|7 Day Wash-out||0
2394088|NCT01373450|5874019|P5|NOT COMPLETED|7 Day Wash-out||0
2394089|NCT01373450|5874020|P4|NOT COMPLETED|7 Day Wash-out||0
2394090|NCT01373450|5874021|P3|NOT COMPLETED|7 Day Wash-out||0
2394091|NCT01373450|5874022|P2|NOT COMPLETED|7 Day Wash-out||0
2394092|NCT01373450|5874023|P1|NOT COMPLETED|7 Day Wash-out||0
2394093|NCT01373450|5874018|P6|COMPLETED|7 Day Wash-out||2
2394094|NCT01373450|5874019|P5|COMPLETED|7 Day Wash-out||2
2394095|NCT01373450|5874020|P4|COMPLETED|7 Day Wash-out||2
2394096|NCT01373450|5874021|P3|COMPLETED|7 Day Wash-out||2
2394097|NCT01373450|5874022|P2|COMPLETED|7 Day Wash-out||2
2394098|NCT01373450|5874023|P1|COMPLETED|7 Day Wash-out||2
2394099|NCT01373450|5874018|P6|STARTED|7 Day Wash-out||2
2394100|NCT01373450|5874019|P5|STARTED|7 Day Wash-out||2
2394101|NCT01373450|5874020|P4|STARTED|7 Day Wash-out||2
2394102|NCT01373450|5874021|P3|STARTED|7 Day Wash-out||2
2394103|NCT01373450|5874022|P2|STARTED|7 Day Wash-out||2
2394104|NCT01373450|5874023|P1|STARTED|7 Day Wash-out||2
2394105|NCT01373450|5874018|P6|NOT COMPLETED|Crossover Period 1||0
2394106|NCT01373450|5874019|P5|NOT COMPLETED|Crossover Period 1||0
2394107|NCT01373450|5874020|P4|NOT COMPLETED|Crossover Period 1||0
2394108|NCT01373450|5874021|P3|NOT COMPLETED|Crossover Period 1||0
2394109|NCT01373450|5874022|P2|NOT COMPLETED|Crossover Period 1||0
2394110|NCT01373450|5874023|P1|NOT COMPLETED|Crossover Period 1||0
2394111|NCT01373450|5874018|P6|COMPLETED|Crossover Period 1||2
2394112|NCT01373450|5874019|P5|COMPLETED|Crossover Period 1||2
2394113|NCT01373450|5874020|P4|COMPLETED|Crossover Period 1||2
2394114|NCT01373450|5874021|P3|COMPLETED|Crossover Period 1||2
2394115|NCT01373450|5874022|P2|COMPLETED|Crossover Period 1||2
2394116|NCT01373450|5874023|P1|COMPLETED|Crossover Period 1||2
2394117|NCT01373450|5874018|P6|STARTED|Crossover Period 1||2
2394118|NCT01373450|5874019|P5|STARTED|Crossover Period 1||2
2394119|NCT01373450|5874020|P4|STARTED|Crossover Period 1||2
2394120|NCT01373450|5874021|P3|STARTED|Crossover Period 1||2
2394121|NCT01373450|5874022|P2|STARTED|Crossover Period 1||2
2394122|NCT01373450|5874023|P1|STARTED|Crossover Period 1||2
2394123|NCT01373346|5874045|P1|NOT COMPLETED|Overall Study||1
2394124|NCT01373346|5874045|P1|COMPLETED|Overall Study||14
2394125|NCT01373346|5874045|P1|STARTED|Overall Study||15
2394126|NCT01373294|5874068|P2|NOT COMPLETED|Overall Study||0
2394127|NCT01373294|5874069|P1|NOT COMPLETED|Overall Study||1
2394128|NCT01373294|5874068|P2|COMPLETED|Overall Study||2
2394129|NCT01373294|5874069|P1|COMPLETED|Overall Study||14
2394130|NCT01373294|5874068|P2|STARTED|Overall Study||2
2394131|NCT01373294|5874069|P1|STARTED|Overall Study||15
2394132|NCT01373281|5874078|P2|NOT COMPLETED|Surveillance Expansion Period||118
2394133|NCT01373281|5874079|P1|NOT COMPLETED|Surveillance Expansion Period||202
2394134|NCT01373281|5874078|P2|COMPLETED|Surveillance Expansion Period||3279
2394135|NCT01373281|5874079|P1|COMPLETED|Surveillance Expansion Period||6595
2394136|NCT01373281|5874078|P2|STARTED|Surveillance Expansion Period||3397
2394137|NCT01373281|5874079|P1|STARTED|Surveillance Expansion Period||6797
2394138|NCT01373281|5874078|P2|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||27
2394139|NCT01373281|5874079|P1|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||54
2394140|NCT01373281|5874078|P2|COMPLETED|Vaccination Phase (Up to 25 Months)||3397
2394141|NCT01373281|5874079|P1|COMPLETED|Vaccination Phase (Up to 25 Months)||6797
2394142|NCT01373281|5874078|P2|STARTED|Vaccination Phase (Up to 25 Months)||3424
2394143|NCT01373281|5874079|P1|STARTED|Vaccination Phase (Up to 25 Months)||6851
2394144|NCT01373242|5874111|P1|NOT COMPLETED|Overall Study||16
2394145|NCT01373242|5874111|P1|COMPLETED|Overall Study||38
2394146|NCT01373242|5874111|P1|STARTED|Overall Study||54
2394147|NCT01373229|5874127|P1|NOT COMPLETED|Overall Study||6
2394148|NCT01373229|5874127|P1|COMPLETED|Overall Study||9
2394149|NCT01373229|5874127|P1|STARTED|Overall Study||15
2394150|NCT01373164|5874141|P5|NOT COMPLETED|Overall Study||2
2394151|NCT01373164|5874142|P4|NOT COMPLETED|Overall Study||12
2394152|NCT01373164|5874143|P3|NOT COMPLETED|Overall Study||1
2394153|NCT01373164|5874144|P2|NOT COMPLETED|Overall Study||1
2394154|NCT01373164|5874145|P1|NOT COMPLETED|Overall Study||0
2394155|NCT01373164|5874141|P5|COMPLETED|Overall Study||50
2394156|NCT01373164|5874142|P4|COMPLETED|Overall Study||92
2394157|NCT01373164|5874143|P3|COMPLETED|Overall Study||4
2394158|NCT01373164|5874144|P2|COMPLETED|Overall Study||3
2394159|NCT01373164|5874145|P1|COMPLETED|Overall Study||5
2394160|NCT01373164|5874141|P5|Received at Least One Dose|Overall Study||52
2394161|NCT01373164|5874142|P4|Received at Least One Dose|Overall Study||103
2394162|NCT01373164|5874143|P3|Received at Least One Dose|Overall Study||5
2394163|NCT01373164|5874144|P2|Received at Least One Dose|Overall Study||4
2394164|NCT01373164|5874145|P1|Received at Least One Dose|Overall Study||5
2394165|NCT01373164|5874141|P5|STARTED|Overall Study||52
2394166|NCT01373164|5874142|P4|STARTED|Overall Study||104
2394167|NCT01373164|5874143|P3|STARTED|Overall Study||5
2394168|NCT01373164|5874144|P2|STARTED|Overall Study||4
2394169|NCT01373164|5874145|P1|STARTED|Overall Study||5
2394170|NCT01372995|5874179|P3|NOT COMPLETED|Overall Study||1
2394171|NCT01372995|5874180|P2|NOT COMPLETED|Overall Study||1
2394172|NCT01372995|5874181|P1|NOT COMPLETED|Overall Study||0
2394173|NCT01372995|5874179|P3|COMPLETED|Overall Study|The transferred participant was included in the intent to treat analyses.|10
2394174|NCT01372995|5874180|P2|COMPLETED|Overall Study||9
2394175|NCT01372995|5874181|P1|COMPLETED|Overall Study||10
2394176|NCT01372995|5874179|P3|STARTED|Overall Study|One participant was transferred to comfort care prior to completing the intervention.|11
2394177|NCT01372995|5874180|P2|STARTED|Overall Study||10
2394178|NCT01372995|5874181|P1|STARTED|Overall Study||10
2394179|NCT01372878|5874228|P1|NOT COMPLETED|Overall Study||184
2394180|NCT01372878|5874228|P1|COMPLETED|Overall Study||700
2394181|NCT01372878|5874228|P1|STARTED|Overall Study||884
2394182|NCT01372813|5874233|P1|NOT COMPLETED|Overall Study||0
2394183|NCT01372813|5874233|P1|COMPLETED|Overall Study||3
2394184|NCT01372813|5874233|P1|STARTED|Overall Study||3
2394185|NCT01372774|5874248|P2|NOT COMPLETED|Overall Study||5
2394186|NCT01372774|5874249|P1|NOT COMPLETED|Overall Study||4
2394187|NCT01372774|5874248|P2|COMPLETED|Overall Study||93
2394188|NCT01372774|5874249|P1|COMPLETED|Overall Study||92
2394189|NCT01372774|5874248|P2|STARTED|Overall Study||98
2394190|NCT01372774|5874249|P1|STARTED|Overall Study||96
2394191|NCT01372748|5874265|P2|NOT COMPLETED|Overall Study||39
2394192|NCT01372748|5874266|P1|NOT COMPLETED|Overall Study||23
2394193|NCT01372748|5874265|P2|COMPLETED|Overall Study|defined as having vital status|12603
2394194|NCT01372748|5874266|P1|COMPLETED|Overall Study|defined as having vital status|11022
2394195|NCT01372748|5874265|P2|STARTED|Overall Study||12642
2394196|NCT01372748|5874266|P1|STARTED|Overall Study||11045
2394197|NCT01372618|5874274|P1|NOT COMPLETED|Overall Study||9
2394198|NCT01372618|5874274|P1|COMPLETED|Overall Study||0
2394199|NCT01372618|5874274|P1|STARTED|Overall Study||9
2394200|NCT01372605|5874282|P2|NOT COMPLETED|Overall Study||10
2394201|NCT01372605|5874283|P1|NOT COMPLETED|Overall Study||12
2394202|NCT01372605|5874282|P2|COMPLETED|Overall Study||145
2394203|NCT01372605|5874283|P1|COMPLETED|Overall Study||137
2394204|NCT01372605|5874282|P2|STARTED|Overall Study||155
2394205|NCT01372605|5874283|P1|STARTED|Overall Study||149
2394206|NCT01372501|5874309|P1|NOT COMPLETED|Overall Study||5
2394207|NCT01372501|5874309|P1|COMPLETED|Overall Study||14
2394208|NCT01372501|5874309|P1|STARTED|Overall Study||19
2394209|NCT01372462|5874314|P1|NOT COMPLETED|No Treatment Control||0
2394210|NCT01372462|5874314|P1|COMPLETED|No Treatment Control||15
2394211|NCT01372462|5874314|P1|STARTED|No Treatment Control||15
2394212|NCT01372462|5874314|P1|NOT COMPLETED|Oxygen Nasal Cannula||0
2394213|NCT01372462|5874314|P1|COMPLETED|Oxygen Nasal Cannula||15
2394214|NCT01372462|5874314|P1|STARTED|Oxygen Nasal Cannula||15
2394215|NCT01372462|5874314|P1|NOT COMPLETED|NIOV - Oxygen||0
2394216|NCT01372462|5874314|P1|COMPLETED|NIOV - Oxygen||15
2394217|NCT01372462|5874314|P1|STARTED|NIOV - Oxygen||15
2394218|NCT01372462|5874314|P1|NOT COMPLETED|NIOV - Room Air||0
2394219|NCT01372462|5874314|P1|COMPLETED|NIOV - Room Air||15
2394220|NCT01372462|5874314|P1|STARTED|NIOV - Room Air||15
2394221|NCT01372410|5874332|P8|NOT COMPLETED|Treatment Period 3 (7 Days)||0
2394222|NCT01372410|5874333|P7|NOT COMPLETED|Treatment Period 3 (7 Days)||0
2394223|NCT01372410|5874334|P6|NOT COMPLETED|Treatment Period 3 (7 Days)||1
2394224|NCT01372410|5874335|P5|NOT COMPLETED|Treatment Period 3 (7 Days)||0
2394225|NCT01372410|5874336|P4|NOT COMPLETED|Treatment Period 3 (7 Days)||0
2394226|NCT01372410|5874337|P3|NOT COMPLETED|Treatment Period 3 (7 Days)||1
2394227|NCT01372410|5874338|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||0
2394228|NCT01372410|5874339|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
2394229|NCT01372410|5874332|P8|COMPLETED|Treatment Period 3 (7 Days)||18
2394230|NCT01372410|5874333|P7|COMPLETED|Treatment Period 3 (7 Days)||15
2394231|NCT01372410|5874334|P6|COMPLETED|Treatment Period 3 (7 Days)||18
2394232|NCT01372410|5874335|P5|COMPLETED|Treatment Period 3 (7 Days)||20
2394233|NCT01372410|5874336|P4|COMPLETED|Treatment Period 3 (7 Days)||22
2394234|NCT01372410|5874337|P3|COMPLETED|Treatment Period 3 (7 Days)||15
2394235|NCT01372410|5874338|P2|COMPLETED|Treatment Period 3 (7 Days)||18
2394236|NCT01372410|5874339|P1|COMPLETED|Treatment Period 3 (7 Days)||21
2394237|NCT01372410|5874332|P8|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
2394238|NCT01372410|5874333|P7|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|15
2394239|NCT01372410|5874334|P6|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
2394240|NCT01372410|5874335|P5|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|20
2394241|NCT01372410|5874336|P4|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
2394242|NCT01372410|5874337|P3|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
2394243|NCT01372410|5874338|P2|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
2394244|NCT01372410|5874339|P1|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
2394245|NCT01372410|5874332|P8|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
2394246|NCT01372410|5874333|P7|NOT COMPLETED|Washout Period 2 (10-14 Days)||1
2394247|NCT01372410|5874334|P6|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
2394248|NCT01372410|5874335|P5|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
2394249|NCT01372410|5874336|P4|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
2394250|NCT01372410|5874337|P3|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
2394251|NCT01372410|5874338|P2|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
2394252|NCT01372410|5874339|P1|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
2394253|NCT01372410|5874332|P8|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
2394254|NCT01372410|5874333|P7|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
2394255|NCT01372410|5874334|P6|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|16
2394256|NCT01372410|5874335|P5|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
2394257|NCT01372410|5874336|P4|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
2394258|NCT01372410|5874337|P3|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|22
2394259|NCT01372410|5874338|P2|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
2394260|NCT01372410|5874339|P1|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
2394261|NCT01372410|5874332|P8|STARTED|Washout Period 2 (10-14 Days)||19
2394262|NCT01372410|5874333|P7|STARTED|Washout Period 2 (10-14 Days)||21
2394263|NCT01372410|5874334|P6|STARTED|Washout Period 2 (10-14 Days)||16
2394264|NCT01372410|5874335|P5|STARTED|Washout Period 2 (10-14 Days)||19
2394265|NCT01372410|5874336|P4|STARTED|Washout Period 2 (10-14 Days)||17
2394266|NCT01372410|5874337|P3|STARTED|Washout Period 2 (10-14 Days)||22
2394267|NCT01372410|5874338|P2|STARTED|Washout Period 2 (10-14 Days)||21
2394268|NCT01372410|5874339|P1|STARTED|Washout Period 2 (10-14 Days)||19
2394269|NCT01372410|5874332|P8|NOT COMPLETED|Treatment Period 2 (7 Days)||0
2394270|NCT01372410|5874333|P7|NOT COMPLETED|Treatment Period 2 (7 Days)||0
2394271|NCT01372410|5874334|P6|NOT COMPLETED|Treatment Period 2 (7 Days)||0
2394272|NCT01372410|5874335|P5|NOT COMPLETED|Treatment Period 2 (7 Days)||0
2394273|NCT01372410|5874336|P4|NOT COMPLETED|Treatment Period 2 (7 Days)||0
2394274|NCT01372410|5874337|P3|NOT COMPLETED|Treatment Period 2 (7 Days)||0
2394275|NCT01372410|5874338|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||0
2394276|NCT01372410|5874339|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
2394277|NCT01372410|5874332|P8|COMPLETED|Treatment Period 2 (7 Days)||19
2394278|NCT01372410|5874333|P7|COMPLETED|Treatment Period 2 (7 Days)||21
2394279|NCT01372410|5874334|P6|COMPLETED|Treatment Period 2 (7 Days)||16
2394280|NCT01372410|5874335|P5|COMPLETED|Treatment Period 2 (7 Days)||19
2394281|NCT01372410|5874336|P4|COMPLETED|Treatment Period 2 (7 Days)||17
2394282|NCT01372410|5874337|P3|COMPLETED|Treatment Period 2 (7 Days)||22
2394283|NCT01372410|5874338|P2|COMPLETED|Treatment Period 2 (7 Days)||21
2394284|NCT01372410|5874339|P1|COMPLETED|Treatment Period 2 (7 Days)||19
2394285|NCT01372410|5874332|P8|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
2394286|NCT01372410|5874333|P7|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
2394287|NCT01372410|5874334|P6|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
2394288|NCT01372410|5874335|P5|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
2394289|NCT01372410|5874336|P4|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|17
2394290|NCT01372410|5874337|P3|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
2394291|NCT01372410|5874338|P2|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
2394292|NCT01372410|5874339|P1|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
2394293|NCT01372410|5874332|P8|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
2394294|NCT01372410|5874333|P7|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
2394295|NCT01372410|5874334|P6|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
2394296|NCT01372410|5874335|P5|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
2394297|NCT01372410|5874336|P4|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
2394298|NCT01372410|5874337|P3|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
2394299|NCT01372410|5874338|P2|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
2394300|NCT01372410|5874339|P1|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
2394301|NCT01372410|5874332|P8|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
2394302|NCT01372410|5874333|P7|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
2394303|NCT01372410|5874334|P6|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
2394304|NCT01372410|5874335|P5|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
2394305|NCT01372410|5874336|P4|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
2394306|NCT01372410|5874337|P3|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
2394307|NCT01372410|5874338|P2|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
2394308|NCT01372410|5874339|P1|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
2394309|NCT01372410|5874332|P8|STARTED|Washout Period 1 (10-14 Days)||19
2394310|NCT01372410|5874333|P7|STARTED|Washout Period 1 (10-14 Days)||20
2394311|NCT01372410|5874334|P6|STARTED|Washout Period 1 (10-14 Days)||21
2394312|NCT01372410|5874335|P5|STARTED|Washout Period 1 (10-14 Days)||19
2394313|NCT01372410|5874336|P4|STARTED|Washout Period 1 (10-14 Days)||20
2394314|NCT01372410|5874337|P3|STARTED|Washout Period 1 (10-14 Days)||19
2394315|NCT01372410|5874338|P2|STARTED|Washout Period 1 (10-14 Days)||19
2394316|NCT01372410|5874339|P1|STARTED|Washout Period 1 (10-14 Days)||19
2394317|NCT01372410|5874332|P8|NOT COMPLETED|Treatment Period 1 (7 Days)||0
2394318|NCT01372410|5874333|P7|NOT COMPLETED|Treatment Period 1 (7 Days)||2
2394319|NCT01372410|5874334|P6|NOT COMPLETED|Treatment Period 1 (7 Days)||0
2394320|NCT01372410|5874335|P5|NOT COMPLETED|Treatment Period 1 (7 Days)||2
2394321|NCT01372410|5874336|P4|NOT COMPLETED|Treatment Period 1 (7 Days)||0
2394322|NCT01372410|5874337|P3|NOT COMPLETED|Treatment Period 1 (7 Days)||0
2394323|NCT01372410|5874338|P2|NOT COMPLETED|Treatment Period 1 (7 Days)||2
2394324|NCT01372410|5874339|P1|NOT COMPLETED|Treatment Period 1 (7 Days)||1
2394325|NCT01372410|5874332|P8|COMPLETED|Treatment Period 1 (7 Days)||19
2394326|NCT01372410|5874333|P7|COMPLETED|Treatment Period 1 (7 Days)||20
2394327|NCT01372410|5874334|P6|COMPLETED|Treatment Period 1 (7 Days)||21
2394328|NCT01372410|5874335|P5|COMPLETED|Treatment Period 1 (7 Days)||19
2394329|NCT01372410|5874336|P4|COMPLETED|Treatment Period 1 (7 Days)||20
2394330|NCT01372410|5874337|P3|COMPLETED|Treatment Period 1 (7 Days)||19
2394331|NCT01372410|5874338|P2|COMPLETED|Treatment Period 1 (7 Days)||19
2394332|NCT01372410|5874339|P1|COMPLETED|Treatment Period 1 (7 Days)||19
2394333|NCT01372410|5874332|P8|STARTED|Treatment Period 1 (7 Days)||19
2394334|NCT01372410|5874333|P7|STARTED|Treatment Period 1 (7 Days)||22
2394335|NCT01372410|5874334|P6|STARTED|Treatment Period 1 (7 Days)||21
2394336|NCT01372410|5874335|P5|STARTED|Treatment Period 1 (7 Days)||21
2394337|NCT01372410|5874336|P4|STARTED|Treatment Period 1 (7 Days)||20
2394338|NCT01372410|5874337|P3|STARTED|Treatment Period 1 (7 Days)||19
2394339|NCT01372410|5874338|P2|STARTED|Treatment Period 1 (7 Days)||21
2394340|NCT01372410|5874339|P1|STARTED|Treatment Period 1 (7 Days)||20
2394341|NCT01372384|5874376|P1|NOT COMPLETED|Overall Study||3
2394342|NCT01372384|5874376|P1|COMPLETED|Overall Study||3
2394343|NCT01372384|5874376|P1|STARTED|Overall Study||6
2394344|NCT01372202|5874386|P3|NOT COMPLETED|Overall Study||0
2394345|NCT01372202|5874387|P2|NOT COMPLETED|Overall Study||0
2394346|NCT01372202|5874388|P1|NOT COMPLETED|Overall Study||0
2394347|NCT01372202|5874386|P3|COMPLETED|Overall Study||9
2394348|NCT01372202|5874387|P2|COMPLETED|Overall Study||9
2394349|NCT01372202|5874388|P1|COMPLETED|Overall Study||13
2394350|NCT01372202|5874386|P3|STARTED|Overall Study||9
2394351|NCT01372202|5874387|P2|STARTED|Overall Study||9
2394352|NCT01372202|5874388|P1|STARTED|Overall Study||13
2394353|NCT01372150|5874408|P3|NOT COMPLETED|Overall Study||16
2394354|NCT01372150|5874409|P2|NOT COMPLETED|Overall Study||14
2394355|NCT01372150|5874410|P1|NOT COMPLETED|Overall Study||13
2394356|NCT01372150|5874408|P3|COMPLETED|Overall Study||99
2394357|NCT01372150|5874409|P2|COMPLETED|Overall Study||99
2394358|NCT01372150|5874410|P1|COMPLETED|Overall Study||99
2394359|NCT01372150|5874408|P3|Treated|Overall Study||115
2394360|NCT01372150|5874409|P2|Treated|Overall Study||112
2394361|NCT01372150|5874410|P1|Treated|Overall Study||112
2394362|NCT01372150|5874408|P3|STARTED|Overall Study||115
2394363|NCT01372150|5874409|P2|STARTED|Overall Study||113
2394364|NCT01372150|5874410|P1|STARTED|Overall Study||112
2394365|NCT01372085|5874437|P10|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
2394366|NCT01372085|5874438|P9|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
2394367|NCT01372085|5874439|P8|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
2394368|NCT01372085|5874440|P7|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
2394369|NCT01372085|5874441|P6|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
2394370|NCT01372085|5874442|P5|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
2394371|NCT01372085|5874443|P4|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
2394372|NCT01372085|5874444|P3|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
2394373|NCT01372085|5874445|P2|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
2394374|NCT01372085|5874446|P1|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
2394375|NCT01372085|5874437|P10|COMPLETED|Forth Intervention (Period 4a/4b)||1
2394376|NCT01372085|5874438|P9|COMPLETED|Forth Intervention (Period 4a/4b)||1
2394377|NCT01372085|5874439|P8|COMPLETED|Forth Intervention (Period 4a/4b)||1
2394378|NCT01372085|5874440|P7|COMPLETED|Forth Intervention (Period 4a/4b)||3
2394379|NCT01372085|5874441|P6|COMPLETED|Forth Intervention (Period 4a/4b)||5
2394380|NCT01372085|5874442|P5|COMPLETED|Forth Intervention (Period 4a/4b)||2
2394381|NCT01372085|5874443|P4|COMPLETED|Forth Intervention (Period 4a/4b)||1
2394382|NCT01372085|5874444|P3|COMPLETED|Forth Intervention (Period 4a/4b)||2
2394383|NCT01372085|5874445|P2|COMPLETED|Forth Intervention (Period 4a/4b)||0
2394384|NCT01372085|5874446|P1|COMPLETED|Forth Intervention (Period 4a/4b)||0
2394385|NCT01372085|5874437|P10|STARTED|Forth Intervention (Period 4a/4b)|One pt was enrolled directly into P4b to fulfill requirement for safety and tolerability assessment.|1
2394386|NCT01372085|5874438|P9|STARTED|Forth Intervention (Period 4a/4b)||1
2394387|NCT01372085|5874439|P8|STARTED|Forth Intervention (Period 4a/4b)||1
2394388|NCT01372085|5874440|P7|STARTED|Forth Intervention (Period 4a/4b)||3
2394389|NCT01372085|5874441|P6|STARTED|Forth Intervention (Period 4a/4b)||5
2394390|NCT01372085|5874442|P5|STARTED|Forth Intervention (Period 4a/4b)||2
2394391|NCT01372085|5874443|P4|STARTED|Forth Intervention (Period 4a/4b)||1
2394392|NCT01372085|5874444|P3|STARTED|Forth Intervention (Period 4a/4b)||2
2394393|NCT01372085|5874445|P2|STARTED|Forth Intervention (Period 4a/4b)||0
2394394|NCT01372085|5874446|P1|STARTED|Forth Intervention (Period 4a/4b)||0
2394395|NCT01372085|5874437|P10|NOT COMPLETED|Washout Period 3||0
2394396|NCT01372085|5874438|P9|NOT COMPLETED|Washout Period 3||0
2394397|NCT01372085|5874439|P8|NOT COMPLETED|Washout Period 3||0
2394398|NCT01372085|5874440|P7|NOT COMPLETED|Washout Period 3||0
2394399|NCT01372085|5874441|P6|NOT COMPLETED|Washout Period 3||2
2394400|NCT01372085|5874442|P5|NOT COMPLETED|Washout Period 3||0
2394401|NCT01372085|5874443|P4|NOT COMPLETED|Washout Period 3||0
2394402|NCT01372085|5874444|P3|NOT COMPLETED|Washout Period 3||0
2394403|NCT01372085|5874445|P2|NOT COMPLETED|Washout Period 3||0
2394404|NCT01372085|5874446|P1|NOT COMPLETED|Washout Period 3||0
2394405|NCT01372085|5874437|P10|COMPLETED|Washout Period 3||0
2394406|NCT01372085|5874438|P9|COMPLETED|Washout Period 3||1
2394407|NCT01372085|5874439|P8|COMPLETED|Washout Period 3||1
2394408|NCT01372085|5874440|P7|COMPLETED|Washout Period 3||3
2394409|NCT01372085|5874441|P6|COMPLETED|Washout Period 3|Two participants (pts) discontinued Washout P3 and were replaced in P3.|5
2394410|NCT01372085|5874442|P5|COMPLETED|Washout Period 3||2
2394411|NCT01372085|5874443|P4|COMPLETED|Washout Period 3||1
2394412|NCT01372085|5874444|P3|COMPLETED|Washout Period 3||2
2394413|NCT01372085|5874445|P2|COMPLETED|Washout Period 3||0
2394414|NCT01372085|5874446|P1|COMPLETED|Washout Period 3||0
2394415|NCT01372085|5874437|P10|STARTED|Washout Period 3||0
2394416|NCT01372085|5874438|P9|STARTED|Washout Period 3||1
2394417|NCT01372085|5874439|P8|STARTED|Washout Period 3||1
2394418|NCT01372085|5874440|P7|STARTED|Washout Period 3||3
2394419|NCT01372085|5874441|P6|STARTED|Washout Period 3||7
2394420|NCT01372085|5874442|P5|STARTED|Washout Period 3||2
2394421|NCT01372085|5874443|P4|STARTED|Washout Period 3||1
2394422|NCT01372085|5874444|P3|STARTED|Washout Period 3||2
2394423|NCT01372085|5874445|P2|STARTED|Washout Period 3||0
2394424|NCT01372085|5874446|P1|STARTED|Washout Period 3||0
2394425|NCT01372085|5874437|P10|NOT COMPLETED|Third Intervention (Period 3)||0
2394426|NCT01372085|5874438|P9|NOT COMPLETED|Third Intervention (Period 3)||0
2394427|NCT01372085|5874439|P8|NOT COMPLETED|Third Intervention (Period 3)||0
2394428|NCT01372085|5874440|P7|NOT COMPLETED|Third Intervention (Period 3)||0
2394429|NCT01372085|5874441|P6|NOT COMPLETED|Third Intervention (Period 3)||0
2394430|NCT01372085|5874442|P5|NOT COMPLETED|Third Intervention (Period 3)||0
2394431|NCT01372085|5874443|P4|NOT COMPLETED|Third Intervention (Period 3)||0
2394432|NCT01372085|5874444|P3|NOT COMPLETED|Third Intervention (Period 3)||0
2394433|NCT01372085|5874445|P2|NOT COMPLETED|Third Intervention (Period 3)||0
2394434|NCT01372085|5874446|P1|NOT COMPLETED|Third Intervention (Period 3)||0
2394435|NCT01372085|5874437|P10|COMPLETED|Third Intervention (Period 3)||0
2394436|NCT01372085|5874438|P9|COMPLETED|Third Intervention (Period 3)||1
2394437|NCT01372085|5874439|P8|COMPLETED|Third Intervention (Period 3)||1
2394438|NCT01372085|5874440|P7|COMPLETED|Third Intervention (Period 3)||3
2394439|NCT01372085|5874441|P6|COMPLETED|Third Intervention (Period 3)||7
2394440|NCT01372085|5874442|P5|COMPLETED|Third Intervention (Period 3)||2
2394441|NCT01372085|5874443|P4|COMPLETED|Third Intervention (Period 3)||1
2394442|NCT01372085|5874444|P3|COMPLETED|Third Intervention (Period 3)||2
2394443|NCT01372085|5874445|P2|COMPLETED|Third Intervention (Period 3)||0
2394444|NCT01372085|5874446|P1|COMPLETED|Third Intervention (Period 3)||0
2394445|NCT01372085|5874437|P10|STARTED|Third Intervention (Period 3)||0
2394446|NCT01372085|5874438|P9|STARTED|Third Intervention (Period 3)||1
2394447|NCT01372085|5874439|P8|STARTED|Third Intervention (Period 3)||1
2394448|NCT01372085|5874440|P7|STARTED|Third Intervention (Period 3)||3
2394449|NCT01372085|5874441|P6|STARTED|Third Intervention (Period 3)|Replacement pts repeated Period (P) 3 to fulfill requirement for P3 versus P4a comparison.|7
2394450|NCT01372085|5874442|P5|STARTED|Third Intervention (Period 3)||2
2394451|NCT01372085|5874443|P4|STARTED|Third Intervention (Period 3)||1
2394452|NCT01372085|5874444|P3|STARTED|Third Intervention (Period 3)||2
2394453|NCT01372085|5874445|P2|STARTED|Third Intervention (Period 3)||0
2394454|NCT01372085|5874446|P1|STARTED|Third Intervention (Period 3)||0
2394455|NCT01372085|5874437|P10|NOT COMPLETED|Washout Period 2||0
2394456|NCT01372085|5874438|P9|NOT COMPLETED|Washout Period 2||0
2394457|NCT01372085|5874439|P8|NOT COMPLETED|Washout Period 2||0
2394458|NCT01372085|5874440|P7|NOT COMPLETED|Washout Period 2||0
2394459|NCT01372085|5874441|P6|NOT COMPLETED|Washout Period 2||0
2394460|NCT01372085|5874442|P5|NOT COMPLETED|Washout Period 2||1
2394461|NCT01372085|5874443|P4|NOT COMPLETED|Washout Period 2||0
2394462|NCT01372085|5874444|P3|NOT COMPLETED|Washout Period 2||0
2394463|NCT01372085|5874445|P2|NOT COMPLETED|Washout Period 2||0
2394464|NCT01372085|5874446|P1|NOT COMPLETED|Washout Period 2||0
2394465|NCT01372085|5874437|P10|COMPLETED|Washout Period 2||0
2394466|NCT01372085|5874438|P9|COMPLETED|Washout Period 2||1
2394467|NCT01372085|5874439|P8|COMPLETED|Washout Period 2||1
2394468|NCT01372085|5874440|P7|COMPLETED|Washout Period 2||3
2394469|NCT01372085|5874441|P6|COMPLETED|Washout Period 2||5
2394470|NCT01372085|5874442|P5|COMPLETED|Washout Period 2|One participant discontinued Washout Period 2 and was replaced in Period 1.|2
2394471|NCT01372085|5874443|P4|COMPLETED|Washout Period 2||1
2394472|NCT01372085|5874444|P3|COMPLETED|Washout Period 2||2
2394473|NCT01372085|5874445|P2|COMPLETED|Washout Period 2||0
2394474|NCT01372085|5874446|P1|COMPLETED|Washout Period 2||0
2394475|NCT01372085|5874437|P10|STARTED|Washout Period 2||0
2394476|NCT01372085|5874438|P9|STARTED|Washout Period 2||1
2394477|NCT01372085|5874439|P8|STARTED|Washout Period 2||1
2394478|NCT01372085|5874440|P7|STARTED|Washout Period 2||3
2394479|NCT01372085|5874441|P6|STARTED|Washout Period 2||5
2394480|NCT01372085|5874442|P5|STARTED|Washout Period 2||3
2394481|NCT01372085|5874443|P4|STARTED|Washout Period 2||1
2394482|NCT01372085|5874444|P3|STARTED|Washout Period 2||2
2394483|NCT01372085|5874445|P2|STARTED|Washout Period 2||0
2394484|NCT01372085|5874446|P1|STARTED|Washout Period 2||0
2394485|NCT01372085|5874437|P10|NOT COMPLETED|Second Intervention (Period 2)||0
2394486|NCT01372085|5874438|P9|NOT COMPLETED|Second Intervention (Period 2)||0
2394487|NCT01372085|5874439|P8|NOT COMPLETED|Second Intervention (Period 2)||0
2394488|NCT01372085|5874440|P7|NOT COMPLETED|Second Intervention (Period 2)||0
2394489|NCT01372085|5874441|P6|NOT COMPLETED|Second Intervention (Period 2)||0
2394490|NCT01372085|5874442|P5|NOT COMPLETED|Second Intervention (Period 2)||0
2394491|NCT01372085|5874443|P4|NOT COMPLETED|Second Intervention (Period 2)||0
2394492|NCT01372085|5874444|P3|NOT COMPLETED|Second Intervention (Period 2)||0
2394493|NCT01372085|5874445|P2|NOT COMPLETED|Second Intervention (Period 2)||0
2394494|NCT01372085|5874446|P1|NOT COMPLETED|Second Intervention (Period 2)||0
2394495|NCT01372085|5874437|P10|COMPLETED|Second Intervention (Period 2)||0
2394496|NCT01372085|5874438|P9|COMPLETED|Second Intervention (Period 2)||1
2394497|NCT01372085|5874439|P8|COMPLETED|Second Intervention (Period 2)||1
2394498|NCT01372085|5874440|P7|COMPLETED|Second Intervention (Period 2)||3
2394499|NCT01372085|5874441|P6|COMPLETED|Second Intervention (Period 2)||5
2394500|NCT01372085|5874442|P5|COMPLETED|Second Intervention (Period 2)||3
2394501|NCT01372085|5874443|P4|COMPLETED|Second Intervention (Period 2)||1
2394502|NCT01372085|5874444|P3|COMPLETED|Second Intervention (Period 2)||2
2394503|NCT01372085|5874445|P2|COMPLETED|Second Intervention (Period 2)||0
2394504|NCT01372085|5874446|P1|COMPLETED|Second Intervention (Period 2)||0
2394505|NCT01372085|5874437|P10|STARTED|Second Intervention (Period 2)||0
2394506|NCT01372085|5874438|P9|STARTED|Second Intervention (Period 2)||1
2394507|NCT01372085|5874439|P8|STARTED|Second Intervention (Period 2)||1
2394508|NCT01372085|5874440|P7|STARTED|Second Intervention (Period 2)||3
2394509|NCT01372085|5874441|P6|STARTED|Second Intervention (Period 2)||5
2394510|NCT01372085|5874442|P5|STARTED|Second Intervention (Period 2)||3
2394511|NCT01372085|5874443|P4|STARTED|Second Intervention (Period 2)||1
2394512|NCT01372085|5874444|P3|STARTED|Second Intervention (Period 2)||2
2394513|NCT01372085|5874445|P2|STARTED|Second Intervention (Period 2)||0
2394514|NCT01372085|5874446|P1|STARTED|Second Intervention (Period 2)||0
2394515|NCT01372085|5874437|P10|NOT COMPLETED|Washout Period 1||0
2394516|NCT01372085|5874438|P9|NOT COMPLETED|Washout Period 1||0
2394517|NCT01372085|5874439|P8|NOT COMPLETED|Washout Period 1||0
2394518|NCT01372085|5874440|P7|NOT COMPLETED|Washout Period 1||0
2394519|NCT01372085|5874441|P6|NOT COMPLETED|Washout Period 1||0
2394520|NCT01372085|5874442|P5|NOT COMPLETED|Washout Period 1||0
2394521|NCT01372085|5874443|P4|NOT COMPLETED|Washout Period 1||0
2394522|NCT01372085|5874444|P3|NOT COMPLETED|Washout Period 1||0
2394523|NCT01372085|5874445|P2|NOT COMPLETED|Washout Period 1||0
2394524|NCT01372085|5874446|P1|NOT COMPLETED|Washout Period 1||0
2394525|NCT01372085|5874437|P10|COMPLETED|Washout Period 1||0
2394526|NCT01372085|5874438|P9|COMPLETED|Washout Period 1||1
2394527|NCT01372085|5874439|P8|COMPLETED|Washout Period 1||1
2394528|NCT01372085|5874440|P7|COMPLETED|Washout Period 1||3
2394529|NCT01372085|5874441|P6|COMPLETED|Washout Period 1||5
2394530|NCT01372085|5874442|P5|COMPLETED|Washout Period 1||3
2394531|NCT01372085|5874443|P4|COMPLETED|Washout Period 1||1
2394532|NCT01372085|5874444|P3|COMPLETED|Washout Period 1||2
2394533|NCT01372085|5874445|P2|COMPLETED|Washout Period 1||0
2394534|NCT01372085|5874446|P1|COMPLETED|Washout Period 1||0
2394535|NCT01372085|5874437|P10|STARTED|Washout Period 1||0
2394536|NCT01372085|5874438|P9|STARTED|Washout Period 1||1
2394537|NCT01372085|5874439|P8|STARTED|Washout Period 1||1
2394538|NCT01372085|5874440|P7|STARTED|Washout Period 1||3
2394539|NCT01372085|5874441|P6|STARTED|Washout Period 1||5
2394540|NCT01372085|5874442|P5|STARTED|Washout Period 1||3
2394541|NCT01372085|5874443|P4|STARTED|Washout Period 1||1
2394542|NCT01372085|5874444|P3|STARTED|Washout Period 1||2
2394543|NCT01372085|5874445|P2|STARTED|Washout Period 1|Pts completed one period and did not enter washout for Part A.|0
2394544|NCT01372085|5874446|P1|STARTED|Washout Period 1|Pts completed one period and did not enter washout for Part A.|0
2394545|NCT01372085|5874437|P10|NOT COMPLETED|First Intervention (Period 1)||0
2394546|NCT01372085|5874438|P9|NOT COMPLETED|First Intervention (Period 1)||0
2394547|NCT01372085|5874439|P8|NOT COMPLETED|First Intervention (Period 1)||0
2394548|NCT01372085|5874440|P7|NOT COMPLETED|First Intervention (Period 1)||0
2394549|NCT01372085|5874441|P6|NOT COMPLETED|First Intervention (Period 1)||0
2394550|NCT01372085|5874442|P5|NOT COMPLETED|First Intervention (Period 1)||0
2394551|NCT01372085|5874443|P4|NOT COMPLETED|First Intervention (Period 1)||0
2394552|NCT01372085|5874444|P3|NOT COMPLETED|First Intervention (Period 1)||0
2394553|NCT01372085|5874445|P2|NOT COMPLETED|First Intervention (Period 1)||0
2394554|NCT01372085|5874446|P1|NOT COMPLETED|First Intervention (Period 1)||0
2394555|NCT01372085|5874437|P10|COMPLETED|First Intervention (Period 1)||0
2394556|NCT01372085|5874438|P9|COMPLETED|First Intervention (Period 1)||1
2394557|NCT01372085|5874439|P8|COMPLETED|First Intervention (Period 1)||1
2394558|NCT01372085|5874440|P7|COMPLETED|First Intervention (Period 1)||3
2394559|NCT01372085|5874441|P6|COMPLETED|First Intervention (Period 1)||5
2394560|NCT01372085|5874442|P5|COMPLETED|First Intervention (Period 1)||3
2394561|NCT01372085|5874443|P4|COMPLETED|First Intervention (Period 1)||1
2394562|NCT01372085|5874444|P3|COMPLETED|First Intervention (Period 1)||2
2394563|NCT01372085|5874445|P2|COMPLETED|First Intervention (Period 1)||2
2394564|NCT01372085|5874446|P1|COMPLETED|First Intervention (Period 1)||8
2394565|NCT01372085|5874437|P10|STARTED|First Intervention (Period 1)||0
2394566|NCT01372085|5874438|P9|STARTED|First Intervention (Period 1)||1
2394567|NCT01372085|5874439|P8|STARTED|First Intervention (Period 1)||1
2394568|NCT01372085|5874440|P7|STARTED|First Intervention (Period 1)||3
2394569|NCT01372085|5874441|P6|STARTED|First Intervention (Period 1)||5
2394570|NCT01372085|5874442|P5|STARTED|First Intervention (Period 1)|Replacement participant repeated Periods 1, 2 to fulfill treatment arm comparison requirements.|3
2394571|NCT01372085|5874443|P4|STARTED|First Intervention (Period 1)||1
2394572|NCT01372085|5874444|P3|STARTED|First Intervention (Period 1)||2
2394573|NCT01372085|5874445|P2|STARTED|First Intervention (Period 1)||2
2394574|NCT01372085|5874446|P1|STARTED|First Intervention (Period 1)||8
2394575|NCT01371994|5874478|P2|NOT COMPLETED|Overall Study||42
2394576|NCT01371994|5874479|P1|NOT COMPLETED|Overall Study||57
2394577|NCT01371994|5874478|P2|COMPLETED|Overall Study||278
2394578|NCT01371994|5874479|P1|COMPLETED|Overall Study||263
2394579|NCT01371994|5874478|P2|Received Treatment|Overall Study||313
2394580|NCT01371994|5874479|P1|Received Treatment|Overall Study||310
2394581|NCT01371994|5874478|P2|STARTED|Overall Study||320
2394582|NCT01371994|5874479|P1|STARTED|Overall Study||320
2394583|NCT01371877|5874523|P2|NOT COMPLETED|Overall Study||4
2394584|NCT01371877|5874524|P1|NOT COMPLETED|Overall Study||0
2394585|NCT01371877|5874523|P2|COMPLETED|Overall Study||17
2394586|NCT01371877|5874524|P1|COMPLETED|Overall Study||21
2394587|NCT01371877|5874523|P2|STARTED|Overall Study||21
2394588|NCT01371877|5874524|P1|STARTED|Overall Study||21
2394589|NCT01371851|5874536|P2|NOT COMPLETED|Overall Study||9
2394590|NCT01371851|5874537|P1|NOT COMPLETED|Overall Study||8
2394591|NCT01371851|5874536|P2|COMPLETED|Overall Study||2
2394592|NCT01371851|5874537|P1|COMPLETED|Overall Study||3
2394593|NCT01371851|5874536|P2|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
2394594|NCT01371851|5874537|P1|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
2394595|NCT01371838|5874545|P2|NOT COMPLETED|Overall Study||66
2394596|NCT01371838|5874546|P1|NOT COMPLETED|Overall Study||49
2394597|NCT01371838|5874545|P2|COMPLETED|Overall Study||317
2394598|NCT01371838|5874546|P1|COMPLETED|Overall Study||332
2394599|NCT01371838|5874545|P2|STARTED|Overall Study||383
2394600|NCT01371838|5874546|P1|STARTED|Overall Study||381
2394601|NCT01371825|5874582|P1|NOT COMPLETED|Overall Study||4
2394602|NCT01371825|5874582|P1|COMPLETED|Overall Study||5
2394603|NCT01371825|5874582|P1|Received at Least 1 Dose of Study Drug|Overall Study||9
2394604|NCT01371825|5874582|P1|STARTED|Overall Study||9
2394605|NCT01371786|5874595|P2|NOT COMPLETED|Overall Study||0
2394606|NCT01371786|5874596|P1|NOT COMPLETED|Overall Study||0
2394607|NCT01371786|5874595|P2|COMPLETED|Overall Study||7
2394608|NCT01371786|5874596|P1|COMPLETED|Overall Study||7
2394609|NCT01371786|5874595|P2|STARTED|Overall Study||7
2394610|NCT01371786|5874596|P1|STARTED|Overall Study||7
2394611|NCT01371747|5874616|P6|NOT COMPLETED|Overall Study||14
2394612|NCT01371747|5874617|P5|NOT COMPLETED|Overall Study||7
2394613|NCT01371747|5874618|P4|NOT COMPLETED|Overall Study||9
2394614|NCT01371747|5874619|P3|NOT COMPLETED|Overall Study||24
2394615|NCT01371747|5874620|P2|NOT COMPLETED|Overall Study||23
2394616|NCT01371747|5874621|P1|NOT COMPLETED|Overall Study||18
2394617|NCT01371747|5874616|P6|COMPLETED|Overall Study||16
2394618|NCT01371747|5874617|P5|COMPLETED|Overall Study||21
2394619|NCT01371747|5874618|P4|COMPLETED|Overall Study||17
2394620|NCT01371747|5874619|P3|COMPLETED|Overall Study||50
2394621|NCT01371747|5874620|P2|COMPLETED|Overall Study||51
2394622|NCT01371747|5874621|P1|COMPLETED|Overall Study||56
2394623|NCT01371747|5874616|P6|STARTED|Overall Study||30
2394624|NCT01371747|5874617|P5|STARTED|Overall Study||28
2394625|NCT01371747|5874618|P4|STARTED|Overall Study||26
2394626|NCT01371747|5874619|P3|STARTED|Overall Study||74
2394627|NCT01371747|5874620|P2|STARTED|Overall Study||74
2394628|NCT01371747|5874621|P1|STARTED|Overall Study||74
2394629|NCT01371734|5874686|P3|NOT COMPLETED|Overall Study||17
2394630|NCT01371734|5874687|P2|NOT COMPLETED|Overall Study||19
2394631|NCT01371734|5874688|P1|NOT COMPLETED|Overall Study||23
2394632|NCT01371734|5874686|P3|COMPLETED|Overall Study||104
2394633|NCT01371734|5874687|P2|COMPLETED|Overall Study||103
2394634|NCT01371734|5874688|P1|COMPLETED|Overall Study||97
2394635|NCT01371734|5874686|P3|STARTED|Overall Study||121
2394636|NCT01371734|5874687|P2|STARTED|Overall Study||122
2394637|NCT01371734|5874688|P1|STARTED|Overall Study||120
2394638|NCT01371721|5874708|P3|NOT COMPLETED|Overall Study||30
2394639|NCT01371721|5874709|P2|NOT COMPLETED|Overall Study||24
2394640|NCT01371721|5874710|P1|NOT COMPLETED|Overall Study||29
2394641|NCT01371721|5874708|P3|COMPLETED|Overall Study||62
2394642|NCT01371721|5874709|P2|COMPLETED|Overall Study||65
2394643|NCT01371721|5874710|P1|COMPLETED|Overall Study||59
2394644|NCT01371721|5874708|P3|Treated|Overall Study||92
2394645|NCT01371721|5874709|P2|Treated|Overall Study||89
2394646|NCT01371721|5874710|P1|Treated|Overall Study||87
2394647|NCT01371721|5874708|P3|STARTED|Overall Study||92
2394648|NCT01371721|5874709|P2|STARTED|Overall Study||89
2394649|NCT01371721|5874710|P1|STARTED|Overall Study||88
2394650|NCT01371708|5874743|P3|NOT COMPLETED|Overall Study||39
2394651|NCT01371708|5874744|P2|NOT COMPLETED|Overall Study||30
2394652|NCT01371708|5874745|P1|NOT COMPLETED|Overall Study||26
2394653|NCT01371708|5874743|P3|COMPLETED|Overall Study||59
2394654|NCT01371708|5874744|P2|COMPLETED|Overall Study||63
2394655|NCT01371708|5874745|P1|COMPLETED|Overall Study||66
2394656|NCT01371708|5874743|P3|Received Treatment|Overall Study||97
2394657|NCT01371708|5874744|P2|Received Treatment|Overall Study||93
2394658|NCT01371708|5874745|P1|Received Treatment|Overall Study||91
2394659|NCT01371708|5874743|P3|STARTED|Overall Study||98
2394660|NCT01371708|5874744|P2|STARTED|Overall Study||93
2394661|NCT01371708|5874745|P1|STARTED|Overall Study||92
2394662|NCT01371656|5874777|P2|NOT COMPLETED|Overall Study||14
2394663|NCT01371656|5874778|P1|NOT COMPLETED|Overall Study||64
2394664|NCT01371656|5874777|P2|COMPLETED|Overall Study||296
2394665|NCT01371656|5874778|P1|COMPLETED|Overall Study||250
2394666|NCT01371656|5874777|P2|STARTED|Overall Study||310
2394667|NCT01371656|5874778|P1|STARTED|Overall Study||314
2394668|NCT01371643|5874798|P2|NOT COMPLETED|Overall Study||0
2394669|NCT01371643|5874799|P1|NOT COMPLETED|Overall Study||3
2394670|NCT01371643|5874798|P2|COMPLETED|Overall Study||26
2394671|NCT01371643|5874799|P1|COMPLETED|Overall Study||12
2394672|NCT01371643|5874798|P2|STARTED|Overall Study||26
2394673|NCT01371643|5874799|P1|STARTED|Overall Study||15
2394674|NCT01371565|5874809|P1|NOT COMPLETED|Overall Study||3
2394675|NCT01371565|5874809|P1|COMPLETED|Overall Study||1
2394676|NCT01371565|5874809|P1|STARTED|Overall Study||4
2394677|NCT01371552|5874813|P6|NOT COMPLETED|Part 2, One Week||0
2394678|NCT01371552|5874814|P5|NOT COMPLETED|Part 2, One Week||0
2394679|NCT01371552|5874815|P4|NOT COMPLETED|Part 2, One Week||0
2394680|NCT01371552|5874816|P3|NOT COMPLETED|Part 2, One Week||0
2394681|NCT01371552|5874817|P2|NOT COMPLETED|Part 2, One Week||0
2394682|NCT01371552|5874818|P1|NOT COMPLETED|Part 2, One Week||0
2394683|NCT01371552|5874813|P6|COMPLETED|Part 2, One Week||18
2394684|NCT01371552|5874814|P5|COMPLETED|Part 2, One Week||15
2394685|NCT01371552|5874815|P4|COMPLETED|Part 2, One Week||20
2394686|NCT01371552|5874816|P3|COMPLETED|Part 2, One Week||18
2394687|NCT01371552|5874817|P2|COMPLETED|Part 2, One Week||17
2394688|NCT01371552|5874818|P1|COMPLETED|Part 2, One Week||18
2394689|NCT01371552|5874813|P6|STARTED|Part 2, One Week||18
2394690|NCT01371552|5874814|P5|STARTED|Part 2, One Week||15
2394691|NCT01371552|5874815|P4|STARTED|Part 2, One Week||20
2394692|NCT01371552|5874816|P3|STARTED|Part 2, One Week||18
2394693|NCT01371552|5874817|P2|STARTED|Part 2, One Week||17
2394694|NCT01371552|5874818|P1|STARTED|Part 2, One Week|One participant discontinued between Part 1 and Part 2 due to inconvenience|18
2394695|NCT01371552|5874813|P6|NOT COMPLETED|Part 1, Third 3 Days||1
2394696|NCT01371552|5874814|P5|NOT COMPLETED|Part 1, Third 3 Days||1
2394697|NCT01371552|5874815|P4|NOT COMPLETED|Part 1, Third 3 Days||0
2394698|NCT01371552|5874816|P3|NOT COMPLETED|Part 1, Third 3 Days||0
2394699|NCT01371552|5874817|P2|NOT COMPLETED|Part 1, Third 3 Days||0
2394700|NCT01371552|5874818|P1|NOT COMPLETED|Part 1, Third 3 Days||0
2394701|NCT01371552|5874813|P6|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to discomfort, but continued into Part 2.|17
2394702|NCT01371552|5874814|P5|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to randomization error, but continued into Part 2.|14
2394703|NCT01371552|5874815|P4|COMPLETED|Part 1, Third 3 Days||20
2394704|NCT01371552|5874816|P3|COMPLETED|Part 1, Third 3 Days||18
2394705|NCT01371552|5874817|P2|COMPLETED|Part 1, Third 3 Days||17
2394706|NCT01371552|5874818|P1|COMPLETED|Part 1, Third 3 Days||19
2394707|NCT01371552|5874813|P6|STARTED|Part 1, Third 3 Days||18
2394708|NCT01371552|5874814|P5|STARTED|Part 1, Third 3 Days||15
2394709|NCT01371552|5874815|P4|STARTED|Part 1, Third 3 Days||20
2394710|NCT01371552|5874816|P3|STARTED|Part 1, Third 3 Days||18
2394711|NCT01371552|5874817|P2|STARTED|Part 1, Third 3 Days||17
2394712|NCT01371552|5874818|P1|STARTED|Part 1, Third 3 Days||19
2394713|NCT01371552|5874813|P6|NOT COMPLETED|Part 1, Second 3 Days||0
2394714|NCT01371552|5874814|P5|NOT COMPLETED|Part 1, Second 3 Days||0
2394715|NCT01371552|5874815|P4|NOT COMPLETED|Part 1, Second 3 Days||0
2394716|NCT01371552|5874816|P3|NOT COMPLETED|Part 1, Second 3 Days||0
2394717|NCT01371552|5874817|P2|NOT COMPLETED|Part 1, Second 3 Days||0
2394718|NCT01371552|5874818|P1|NOT COMPLETED|Part 1, Second 3 Days||1
2394719|NCT01371552|5874813|P6|COMPLETED|Part 1, Second 3 Days||18
2394720|NCT01371552|5874814|P5|COMPLETED|Part 1, Second 3 Days||15
2394721|NCT01371552|5874815|P4|COMPLETED|Part 1, Second 3 Days||20
2394722|NCT01371552|5874816|P3|COMPLETED|Part 1, Second 3 Days||18
2394723|NCT01371552|5874817|P2|COMPLETED|Part 1, Second 3 Days||17
2394724|NCT01371552|5874818|P1|COMPLETED|Part 1, Second 3 Days|One subject did not complete period due to discomfort but continued to next, as allowed by protocol|18
2394725|NCT01371552|5874813|P6|STARTED|Part 1, Second 3 Days||18
2394726|NCT01371552|5874814|P5|STARTED|Part 1, Second 3 Days||15
2394727|NCT01371552|5874815|P4|STARTED|Part 1, Second 3 Days||20
2394728|NCT01371552|5874816|P3|STARTED|Part 1, Second 3 Days|1 subject discontinued after First 3 days due to positive slit lamp findings unrelated to lens wear|18
2394729|NCT01371552|5874817|P2|STARTED|Part 1, Second 3 Days||17
2394730|NCT01371552|5874818|P1|STARTED|Part 1, Second 3 Days||19
2394731|NCT01371552|5874813|P6|NOT COMPLETED|Part 1, First 3 Days||0
2394732|NCT01371552|5874814|P5|NOT COMPLETED|Part 1, First 3 Days||0
2394733|NCT01371552|5874815|P4|NOT COMPLETED|Part 1, First 3 Days||0
2394734|NCT01371552|5874816|P3|NOT COMPLETED|Part 1, First 3 Days||1
2394735|NCT01371552|5874817|P2|NOT COMPLETED|Part 1, First 3 Days||0
2394736|NCT01371552|5874818|P1|NOT COMPLETED|Part 1, First 3 Days||0
2394737|NCT01371552|5874813|P6|COMPLETED|Part 1, First 3 Days||18
2394738|NCT01371552|5874814|P5|COMPLETED|Part 1, First 3 Days||15
2394739|NCT01371552|5874815|P4|COMPLETED|Part 1, First 3 Days||20
2394740|NCT01371552|5874816|P3|COMPLETED|Part 1, First 3 Days||19
2394741|NCT01371552|5874817|P2|COMPLETED|Part 1, First 3 Days||17
2394742|NCT01371552|5874818|P1|COMPLETED|Part 1, First 3 Days||19
2394743|NCT01371552|5874813|P6|STARTED|Part 1, First 3 Days||18
2394744|NCT01371552|5874814|P5|STARTED|Part 1, First 3 Days||15
2394745|NCT01371552|5874815|P4|STARTED|Part 1, First 3 Days||20
2394746|NCT01371552|5874816|P3|STARTED|Part 1, First 3 Days||20
2394747|NCT01371552|5874817|P2|STARTED|Part 1, First 3 Days||17
2394748|NCT01371552|5874818|P1|STARTED|Part 1, First 3 Days||19
2394749|NCT01371539|5874845|P2|NOT COMPLETED|Period Two: One Week||3
2394750|NCT01371539|5874846|P1|NOT COMPLETED|Period Two: One Week||0
2394751|NCT01371539|5874845|P2|COMPLETED|Period Two: One Week||47
2394752|NCT01371539|5874846|P1|COMPLETED|Period Two: One Week||53
2394753|NCT01371539|5874845|P2|STARTED|Period Two: One Week||50
2394754|NCT01371539|5874846|P1|STARTED|Period Two: One Week||53
2394755|NCT01371539|5874845|P2|NOT COMPLETED|Period One: One Week||1
2394756|NCT01371539|5874846|P1|NOT COMPLETED|Period One: One Week||0
2394757|NCT01371539|5874845|P2|COMPLETED|Period One: One Week||50
2394758|NCT01371539|5874846|P1|COMPLETED|Period One: One Week||53
2394759|NCT01371539|5874845|P2|STARTED|Period One: One Week||51
2394760|NCT01371539|5874846|P1|STARTED|Period One: One Week||53
2394761|NCT01371110|5874856|P2|NOT COMPLETED|Overall Study||0
2394762|NCT01371110|5874857|P1|NOT COMPLETED|Overall Study||0
2394763|NCT01371110|5874856|P2|COMPLETED|Overall Study||2
2394764|NCT01371110|5874857|P1|COMPLETED|Overall Study||1
2394765|NCT01371110|5874856|P2|STARTED|Overall Study||2
2394766|NCT01371110|5874857|P1|STARTED|Overall Study||1
2394767|NCT01371006|5874867|P2|NOT COMPLETED|Overall Study||0
2394768|NCT01371006|5874868|P1|NOT COMPLETED|Overall Study||1
2394769|NCT01371006|5874867|P2|COMPLETED|Overall Study||15
2394770|NCT01371006|5874868|P1|COMPLETED|Overall Study||13
2394771|NCT01371006|5874867|P2|STARTED|Overall Study||15
2394772|NCT01371006|5874868|P1|STARTED|Overall Study||14
2394773|NCT01370863|5874909|P2|NOT COMPLETED|Overall Study||3
2394774|NCT01370863|5874910|P1|NOT COMPLETED|Overall Study||2
2394775|NCT01370863|5874909|P2|COMPLETED|Overall Study||30
2394776|NCT01370863|5874910|P1|COMPLETED|Overall Study||32
2394777|NCT01370863|5874909|P2|STARTED|Overall Study||33
2394778|NCT01370863|5874910|P1|STARTED|Overall Study||34
2394779|NCT01370837|5874923|P3|NOT COMPLETED|Overall Study||0
2394780|NCT01370837|5874924|P2|NOT COMPLETED|Overall Study||0
2394781|NCT01370837|5874925|P1|NOT COMPLETED|Overall Study||0
2394782|NCT01370837|5874923|P3|COMPLETED|Overall Study||17
2394783|NCT01370837|5874924|P2|COMPLETED|Overall Study||12
2394784|NCT01370837|5874925|P1|COMPLETED|Overall Study||12
2394785|NCT01370837|5874923|P3|STARTED|Overall Study||17
2394786|NCT01370837|5874924|P2|STARTED|Overall Study||12
2394787|NCT01370837|5874925|P1|STARTED|Overall Study||12
2394788|NCT01370733|5874935|P2|NOT COMPLETED|Overall Study||22
2394789|NCT01370733|5874936|P1|NOT COMPLETED|Overall Study||17
2394790|NCT01370733|5874935|P2|COMPLETED|Overall Study||77
2394791|NCT01370733|5874936|P1|COMPLETED|Overall Study||86
2394792|NCT01370733|5874935|P2|STARTED|Overall Study||99
2394793|NCT01370733|5874936|P1|STARTED|Overall Study||103
2394794|NCT01370694|5874958|P1|NOT COMPLETED|Overall Study||6
2394795|NCT01370694|5874958|P1|COMPLETED|Overall Study||1
2394796|NCT01370694|5874958|P1|STARTED|Overall Study||7
2394797|NCT01370655|5874980|P12|NOT COMPLETED|Period 2||0
2394798|NCT01370655|5874981|P11|NOT COMPLETED|Period 2||1
2394799|NCT01370655|5874982|P10|NOT COMPLETED|Period 2||0
2394800|NCT01370655|5874983|P9|NOT COMPLETED|Period 2||2
2394801|NCT01370655|5874984|P8|NOT COMPLETED|Period 2||1
2394802|NCT01370655|5874985|P7|NOT COMPLETED|Period 2||1
2394803|NCT01370655|5874986|P6|NOT COMPLETED|Period 2||0
2394804|NCT01370655|5874987|P5|NOT COMPLETED|Period 2||1
2394805|NCT01370655|5874988|P4|NOT COMPLETED|Period 2||0
2394806|NCT01370655|5874989|P3|NOT COMPLETED|Period 2||2
2394807|NCT01370655|5874990|P2|NOT COMPLETED|Period 2||0
2394808|NCT01370655|5874991|P1|NOT COMPLETED|Period 2||0
2394809|NCT01370655|5874980|P12|COMPLETED|Period 2||3
2394810|NCT01370655|5874981|P11|COMPLETED|Period 2||2
2394811|NCT01370655|5874982|P10|COMPLETED|Period 2||2
2394812|NCT01370655|5874983|P9|COMPLETED|Period 2||1
2394813|NCT01370655|5874984|P8|COMPLETED|Period 2||3
2394814|NCT01370655|5874985|P7|COMPLETED|Period 2||2
2394815|NCT01370655|5874986|P6|COMPLETED|Period 2||4
2394816|NCT01370655|5874987|P5|COMPLETED|Period 2||2
2394817|NCT01370655|5874988|P4|COMPLETED|Period 2||3
2394818|NCT01370655|5874989|P3|COMPLETED|Period 2||1
2394819|NCT01370655|5874990|P2|COMPLETED|Period 2||7
2394820|NCT01370655|5874991|P1|COMPLETED|Period 2||5
2394821|NCT01370655|5874980|P12|STARTED|Period 2||3
2394822|NCT01370655|5874981|P11|STARTED|Period 2||3
2394823|NCT01370655|5874982|P10|STARTED|Period 2||2
2394824|NCT01370655|5874983|P9|STARTED|Period 2||3
2394825|NCT01370655|5874984|P8|STARTED|Period 2||4
2394826|NCT01370655|5874985|P7|STARTED|Period 2||3
2394827|NCT01370655|5874986|P6|STARTED|Period 2||4
2394828|NCT01370655|5874987|P5|STARTED|Period 2||3
2394829|NCT01370655|5874988|P4|STARTED|Period 2||3
2394830|NCT01370655|5874989|P3|STARTED|Period 2||3
2394831|NCT01370655|5874990|P2|STARTED|Period 2||7
2394832|NCT01370655|5874991|P1|STARTED|Period 2||5
2394833|NCT01370655|5874980|P12|NOT COMPLETED|Period 1||0
2394834|NCT01370655|5874981|P11|NOT COMPLETED|Period 1||0
2394835|NCT01370655|5874982|P10|NOT COMPLETED|Period 1||0
2394836|NCT01370655|5874983|P9|NOT COMPLETED|Period 1||0
2394837|NCT01370655|5874984|P8|NOT COMPLETED|Period 1||0
2394838|NCT01370655|5874985|P7|NOT COMPLETED|Period 1||1
2394839|NCT01370655|5874986|P6|NOT COMPLETED|Period 1||0
2394840|NCT01370655|5874987|P5|NOT COMPLETED|Period 1||0
2394841|NCT01370655|5874988|P4|NOT COMPLETED|Period 1||0
2394842|NCT01370655|5874989|P3|NOT COMPLETED|Period 1||0
2394843|NCT01370655|5874990|P2|NOT COMPLETED|Period 1||0
2394844|NCT01370655|5874991|P1|NOT COMPLETED|Period 1||2
2394845|NCT01370655|5874980|P12|COMPLETED|Period 1||3
2394846|NCT01370655|5874981|P11|COMPLETED|Period 1||3
2394847|NCT01370655|5874982|P10|COMPLETED|Period 1||2
2394848|NCT01370655|5874983|P9|COMPLETED|Period 1||3
2394849|NCT01370655|5874984|P8|COMPLETED|Period 1||4
2394850|NCT01370655|5874985|P7|COMPLETED|Period 1||3
2394851|NCT01370655|5874986|P6|COMPLETED|Period 1||4
2394852|NCT01370655|5874987|P5|COMPLETED|Period 1||3
2394853|NCT01370655|5874988|P4|COMPLETED|Period 1||3
2394854|NCT01370655|5874989|P3|COMPLETED|Period 1||3
2394855|NCT01370655|5874990|P2|COMPLETED|Period 1||7
2394856|NCT01370655|5874991|P1|COMPLETED|Period 1||5
2394857|NCT01370655|5874980|P12|STARTED|Period 1||3
2394858|NCT01370655|5874981|P11|STARTED|Period 1||3
2394859|NCT01370655|5874982|P10|STARTED|Period 1||2
2394860|NCT01370655|5874983|P9|STARTED|Period 1||3
2394861|NCT01370655|5874984|P8|STARTED|Period 1||4
2394862|NCT01370655|5874985|P7|STARTED|Period 1||4
2394863|NCT01370655|5874986|P6|STARTED|Period 1||4
2394864|NCT01370655|5874987|P5|STARTED|Period 1||3
2394865|NCT01370655|5874988|P4|STARTED|Period 1||3
2394866|NCT01370655|5874989|P3|STARTED|Period 1||3
2394867|NCT01370655|5874990|P2|STARTED|Period 1||7
2394868|NCT01370655|5874991|P1|STARTED|Period 1||7
2394869|NCT01370642|5875028|P3|NOT COMPLETED|Overall Study||29
2394870|NCT01370642|5875029|P2|NOT COMPLETED|Overall Study||6
2394871|NCT01370642|5875030|P1|NOT COMPLETED|Overall Study||8
2394872|NCT01370642|5875028|P3|COMPLETED|Overall Study||69
2394873|NCT01370642|5875029|P2|COMPLETED|Overall Study||92
2394874|NCT01370642|5875030|P1|COMPLETED|Overall Study||90
2394875|NCT01370642|5875028|P3|FAS Population|Overall Study||98
2394876|NCT01370642|5875029|P2|FAS Population|Overall Study||97
2394877|NCT01370642|5875030|P1|FAS Population|Overall Study||98
2394878|NCT01370642|5875028|P3|STARTED|Overall Study||98
2394879|NCT01370642|5875029|P2|STARTED|Overall Study||98
2394880|NCT01370642|5875030|P1|STARTED|Overall Study||98
2394881|NCT01370629|5875059|P1|NOT COMPLETED|Overall Study||6
2394882|NCT01370629|5875059|P1|COMPLETED|Overall Study||2009
2394883|NCT01370629|5875059|P1|STARTED|Overall Study||2015
2394884|NCT01370616|5875069|P2|NOT COMPLETED|Overall Study||67
2394885|NCT01370616|5875070|P1|NOT COMPLETED|Overall Study||62
2394886|NCT01370616|5875069|P2|COMPLETED|Overall Study||216
2394887|NCT01370616|5875070|P1|COMPLETED|Overall Study||220
2394888|NCT01370616|5875069|P2|Treated|Overall Study||275
2394889|NCT01370616|5875070|P1|Treated|Overall Study||275
2394890|NCT01370616|5875069|P2|STARTED|Overall Study|Participants randomized|283
2394891|NCT01370616|5875070|P1|STARTED|Overall Study|Participants randomized|282
2394892|NCT01370603|5875094|P2|NOT COMPLETED|Period 2||4
2394893|NCT01370603|5875095|P1|NOT COMPLETED|Period 2||3
2394894|NCT01370603|5875094|P2|COMPLETED|Period 2||146
2394895|NCT01370603|5875095|P1|COMPLETED|Period 2||138
2394896|NCT01370603|5875094|P2|STARTED|Period 2||150
2394897|NCT01370603|5875095|P1|STARTED|Period 2||141
2394898|NCT01370603|5875094|P2|NOT COMPLETED|Crossover Washout||4
2394899|NCT01370603|5875095|P1|NOT COMPLETED|Crossover Washout||9
2394900|NCT01370603|5875094|P2|COMPLETED|Crossover Washout||150
2394901|NCT01370603|5875095|P1|COMPLETED|Crossover Washout||141
2394902|NCT01370603|5875094|P2|STARTED|Crossover Washout||154
2394903|NCT01370603|5875095|P1|STARTED|Crossover Washout||150
2394904|NCT01370603|5875094|P2|NOT COMPLETED|Period 1||10
2394905|NCT01370603|5875095|P1|NOT COMPLETED|Period 1||14
2394906|NCT01370603|5875094|P2|COMPLETED|Period 1||154
2394907|NCT01370603|5875095|P1|COMPLETED|Period 1||150
2394908|NCT01370603|5875094|P2|STARTED|Period 1||164
2394909|NCT01370603|5875095|P1|STARTED|Period 1||164
2394910|NCT01370590|5875113|P2|NOT COMPLETED|Period 2||2
2394911|NCT01370590|5875114|P1|NOT COMPLETED|Period 2||1
2394912|NCT01370590|5875113|P2|COMPLETED|Period 2||184
2394913|NCT01370590|5875114|P1|COMPLETED|Period 2||180
2394914|NCT01370590|5875113|P2|STARTED|Period 2||186
2394915|NCT01370590|5875114|P1|STARTED|Period 2||181
2394916|NCT01370590|5875113|P2|NOT COMPLETED|Crossover Washout Period||6
2394917|NCT01370590|5875114|P1|NOT COMPLETED|Crossover Washout Period||6
2394918|NCT01370590|5875113|P2|COMPLETED|Crossover Washout Period||186
2394919|NCT01370590|5875114|P1|COMPLETED|Crossover Washout Period||181
2394920|NCT01370590|5875113|P2|STARTED|Crossover Washout Period||192
2394921|NCT01370590|5875114|P1|STARTED|Crossover Washout Period||187
2394922|NCT01370590|5875113|P2|NOT COMPLETED|Period 1||11
2394923|NCT01370590|5875114|P1|NOT COMPLETED|Period 1||16
2394924|NCT01370590|5875113|P2|COMPLETED|Period 1||192
2394925|NCT01370590|5875114|P1|COMPLETED|Period 1||187
2394926|NCT01370590|5875113|P2|STARTED|Period 1||203
2394927|NCT01370590|5875114|P1|STARTED|Period 1||203
2394928|NCT01370564|5875130|P1|NOT COMPLETED|Overall Study||0
2394929|NCT01370564|5875130|P1|COMPLETED|Overall Study||21
2394930|NCT01370564|5875130|P1|STARTED|Overall Study||21
2394931|NCT01370538|5875142|P2|NOT COMPLETED|Overall Study||19
2394932|NCT01370538|5875143|P1|NOT COMPLETED|Overall Study||19
2394933|NCT01370538|5875142|P2|COMPLETED|Overall Study||152
2394934|NCT01370538|5875143|P1|COMPLETED|Overall Study||151
2394935|NCT01370538|5875142|P2|Patients Who Completed Treatment|Overall Study||152
2394936|NCT01370538|5875143|P1|Patients Who Completed Treatment|Overall Study||151
2394937|NCT01370538|5875142|P2|Patients Who Received Treatment|Overall Study||161
2394938|NCT01370538|5875143|P1|Patients Who Received Treatment|Overall Study||165
2394939|NCT01370538|5875142|P2|STARTED|Overall Study||171
2394940|NCT01370538|5875143|P1|STARTED|Overall Study||170
2394941|NCT01370525|5875159|P2|NOT COMPLETED|Overall Study||11
2394942|NCT01370525|5875160|P1|NOT COMPLETED|Overall Study||8
2394943|NCT01370525|5875159|P2|COMPLETED|Overall Study||158
2394944|NCT01370525|5875160|P1|COMPLETED|Overall Study||163
2394945|NCT01370525|5875159|P2|Patients Who Completed Treatment|Overall Study||158
2394946|NCT01370525|5875160|P1|Patients Who Completed Treatment|Overall Study||163
2394947|NCT01370525|5875159|P2|Patients Who Received Treatment|Overall Study||163
2394948|NCT01370525|5875160|P1|Patients Who Received Treatment|Overall Study||168
2394949|NCT01370525|5875159|P2|STARTED|Overall Study||169
2394950|NCT01370525|5875160|P1|STARTED|Overall Study||171
2394951|NCT01370499|5875176|P2|NOT COMPLETED|Overall Study||44
2394952|NCT01370499|5875177|P1|NOT COMPLETED|Overall Study||111
2394953|NCT01370499|5875176|P2|COMPLETED|Overall Study||49
2394954|NCT01370499|5875177|P1|COMPLETED|Overall Study||84
2394955|NCT01370499|5875176|P2|Received at Least 1 Dose of Study Drug|Overall Study||92
2394956|NCT01370499|5875177|P1|Received at Least 1 Dose of Study Drug|Overall Study||195
2394957|NCT01370499|5875176|P2|Entered Abrupt Discontinuation Phase|Overall Study|One participant who entered the abrupt discontinuation phase did not receive study drug.|85
2394958|NCT01370499|5875177|P1|Entered Abrupt Discontinuation Phase|Overall Study||188
2394959|NCT01370499|5875176|P2|STARTED|Overall Study||93
2394960|NCT01370499|5875177|P1|STARTED|Overall Study||195
2394961|NCT01370460|5875211|P2|NOT COMPLETED|Overall Study||0
2394962|NCT01370460|5875212|P1|NOT COMPLETED|Overall Study||0
2394963|NCT01370460|5875211|P2|COMPLETED|Overall Study||51
2394964|NCT01370460|5875212|P1|COMPLETED|Overall Study||50
2394965|NCT01370460|5875211|P2|STARTED|Overall Study||51
2394966|NCT01370460|5875212|P1|STARTED|Overall Study||50
2394967|NCT01370408|5875219|P1|NOT COMPLETED|Overall Study||9
2394968|NCT01370408|5875219|P1|COMPLETED|Overall Study||76
2394969|NCT01370408|5875219|P1|STARTED|Overall Study||85
2394970|NCT01370369|5875230|P1|NOT COMPLETED|Overall Study||0
2394971|NCT01370369|5875230|P1|COMPLETED|Overall Study||20
2394972|NCT01370369|5875230|P1|STARTED|Overall Study||20
2394973|NCT01370356|5875279|P2|NOT COMPLETED|Overall Study||227
2394974|NCT01370356|5875280|P1|NOT COMPLETED|Overall Study||192
2394975|NCT01370356|5875279|P2|COMPLETED|Overall Study||515
2394976|NCT01370356|5875280|P1|COMPLETED|Overall Study||559
2394977|NCT01370356|5875279|P2|STARTED|Overall Study||742
2394978|NCT01370356|5875280|P1|STARTED|Overall Study||751
2394979|NCT01370317|5875296|P2|NOT COMPLETED|Overall Study||1
2394980|NCT01370317|5875297|P1|NOT COMPLETED|Overall Study||1
2394981|NCT01370317|5875296|P2|COMPLETED|Overall Study||8
2394982|NCT01370317|5875297|P1|COMPLETED|Overall Study||17
2394983|NCT01370317|5875296|P2|STARTED|Overall Study||9
2394984|NCT01370317|5875297|P1|STARTED|Overall Study||18
2394985|NCT01370265|5875308|P2|NOT COMPLETED|Second Intervention||0
2394986|NCT01370265|5875309|P1|NOT COMPLETED|Second Intervention||0
2394987|NCT01370265|5875308|P2|COMPLETED|Second Intervention||5
2394988|NCT01370265|5875309|P1|COMPLETED|Second Intervention||5
2394989|NCT01370265|5875308|P2|STARTED|Second Intervention||5
2394990|NCT01370265|5875309|P1|STARTED|Second Intervention||5
2394991|NCT01370265|5875308|P2|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
2394992|NCT01370265|5875309|P1|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
2394993|NCT01370265|5875308|P2|COMPLETED|Washout Period (50-minute Period Decay)||5
2394994|NCT01370265|5875309|P1|COMPLETED|Washout Period (50-minute Period Decay)||5
2394995|NCT01370265|5875308|P2|STARTED|Washout Period (50-minute Period Decay)||5
2394996|NCT01370265|5875309|P1|STARTED|Washout Period (50-minute Period Decay)||5
2394997|NCT01370265|5875308|P2|NOT COMPLETED|First Intervention||1
2394998|NCT01370265|5875309|P1|NOT COMPLETED|First Intervention||1
2394999|NCT01370265|5875308|P2|COMPLETED|First Intervention||5
2395000|NCT01370265|5875309|P1|COMPLETED|First Intervention||5
2395001|NCT01370265|5875308|P2|STARTED|First Intervention||6
2395002|NCT01370265|5875309|P1|STARTED|First Intervention||6
2395003|NCT01370265|5875308|P2|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
2395004|NCT01370265|5875309|P1|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
2395005|NCT01370265|5875308|P2|COMPLETED|Washout Period (50-minute Period Decay)||6
2395006|NCT01370265|5875309|P1|COMPLETED|Washout Period (50-minute Period Decay)||6
2395007|NCT01370265|5875308|P2|STARTED|Washout Period (50-minute Period Decay)||6
2395008|NCT01370265|5875309|P1|STARTED|Washout Period (50-minute Period Decay)||6
2395009|NCT01370265|5875308|P2|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
2395010|NCT01370265|5875309|P1|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
2395011|NCT01370265|5875308|P2|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
2395012|NCT01370265|5875309|P1|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
2395013|NCT01370265|5875308|P2|STARTED|Resting Myocardial Blood Flow (MBF)||6
2395014|NCT01370265|5875309|P1|STARTED|Resting Myocardial Blood Flow (MBF)||6
2395015|NCT01370213|5875329|P3|NOT COMPLETED|Overall Study||0
2395016|NCT01370213|5875330|P2|NOT COMPLETED|Overall Study||2
2395017|NCT01370213|5875331|P1|NOT COMPLETED|Overall Study||1
2395018|NCT01370213|5875329|P3|COMPLETED|Overall Study||1
2395019|NCT01370213|5875330|P2|COMPLETED|Overall Study||15
2395020|NCT01370213|5875331|P1|COMPLETED|Overall Study||6
2395021|NCT01370213|5875329|P3|STARTED|Overall Study||1
2395022|NCT01370213|5875330|P2|STARTED|Overall Study||17
2395023|NCT01370213|5875331|P1|STARTED|Overall Study||7
2395024|NCT01370083|5875351|P2|NOT COMPLETED|Overall Study||1
2395025|NCT01370083|5875352|P1|NOT COMPLETED|Overall Study||2
2395026|NCT01370083|5875351|P2|COMPLETED|Overall Study||6
2395027|NCT01370083|5875352|P1|COMPLETED|Overall Study||5
2395028|NCT01370083|5875351|P2|STARTED|Overall Study||7
2395029|NCT01370083|5875352|P1|STARTED|Overall Study||7
2395030|NCT01370005|5875365|P3|NOT COMPLETED|Overall Study||11
2395031|NCT01370005|5875366|P2|NOT COMPLETED|Overall Study||11
2395032|NCT01370005|5875367|P1|NOT COMPLETED|Overall Study||16
2395033|NCT01370005|5875365|P3|COMPLETED|Overall Study||266
2395034|NCT01370005|5875366|P2|COMPLETED|Overall Study||265
2395035|NCT01370005|5875367|P1|COMPLETED|Overall Study||256
2395036|NCT01370005|5875365|P3|STARTED|Overall Study||277
2395037|NCT01370005|5875366|P2|STARTED|Overall Study||276
2395038|NCT01370005|5875367|P1|STARTED|Overall Study||272
2395039|NCT01369888|5875424|P4|NOT COMPLETED|Overall Study||0
2395040|NCT01369888|5875425|P3|NOT COMPLETED|Overall Study||0
2395041|NCT01369888|5875426|P2|NOT COMPLETED|Overall Study||0
2395042|NCT01369888|5875427|P1|NOT COMPLETED|Overall Study||0
2395043|NCT01369888|5875424|P4|COMPLETED|Overall Study||0
2395044|NCT01369888|5875425|P3|COMPLETED|Overall Study||0
2395045|NCT01369888|5875426|P2|COMPLETED|Overall Study||2
2395046|NCT01369888|5875427|P1|COMPLETED|Overall Study||1
2395047|NCT01369888|5875424|P4|STARTED|Overall Study||0
2395048|NCT01369888|5875425|P3|STARTED|Overall Study||0
2395049|NCT01369888|5875426|P2|STARTED|Overall Study||2
2395050|NCT01369888|5875427|P1|STARTED|Overall Study||1
2395051|NCT01369875|5875437|P2|NOT COMPLETED|Overall Study||0
2395052|NCT01369875|5875438|P1|NOT COMPLETED|Overall Study||0
2395053|NCT01369875|5875437|P2|COMPLETED|Overall Study||1
2395054|NCT01369875|5875438|P1|COMPLETED|Overall Study||1
2395055|NCT01369875|5875437|P2|STARTED|Overall Study||1
2395056|NCT01369875|5875438|P1|STARTED|Overall Study||1
2395057|NCT01369849|5875449|P3|NOT COMPLETED|Overall Study||1
2395058|NCT01369849|5875450|P2|NOT COMPLETED|Overall Study||1
2395059|NCT01369849|5875451|P1|NOT COMPLETED|Overall Study||0
2395060|NCT01369849|5875449|P3|COMPLETED|Overall Study||4
2395061|NCT01369849|5875450|P2|COMPLETED|Overall Study||3
2395062|NCT01369849|5875451|P1|COMPLETED|Overall Study||6
2395063|NCT01369849|5875449|P3|STARTED|Overall Study||5
2395064|NCT01369849|5875450|P2|STARTED|Overall Study||4
2395065|NCT01369849|5875451|P1|STARTED|Overall Study||6
2395066|NCT01369784|5875473|P1|NOT COMPLETED|Overall Study||12
2395067|NCT01369784|5875473|P1|COMPLETED|Overall Study||146
2395068|NCT01369784|5875473|P1|STARTED|Overall Study||158
2395069|NCT01369758|5875498|P1|NOT COMPLETED|Overall Study||0
2395070|NCT01369758|5875498|P1|COMPLETED|Overall Study||290
2395071|NCT01369758|5875498|P1|STARTED|Overall Study||290
2395072|NCT01369745|5875508|P5|NOT COMPLETED|Overall Study||18
2395073|NCT01369745|5875509|P4|NOT COMPLETED|Overall Study||20
2395074|NCT01369745|5875510|P3|NOT COMPLETED|Overall Study||2
2395075|NCT01369745|5875511|P2|NOT COMPLETED|Overall Study||13
2395076|NCT01369745|5875512|P1|NOT COMPLETED|Overall Study||7
2395077|NCT01369745|5875508|P5|COMPLETED|Overall Study||65
2395078|NCT01369745|5875509|P4|COMPLETED|Overall Study||64
2395079|NCT01369745|5875510|P3|COMPLETED|Overall Study||16
2395080|NCT01369745|5875511|P2|COMPLETED|Overall Study||28
2395081|NCT01369745|5875512|P1|COMPLETED|Overall Study||25
2395082|NCT01369745|5875508|P5|STARTED|Overall Study||83
2395083|NCT01369745|5875509|P4|STARTED|Overall Study||84
2395084|NCT01369745|5875510|P3|STARTED|Overall Study||18
2395085|NCT01369745|5875511|P2|STARTED|Overall Study||41
2395086|NCT01369745|5875512|P1|STARTED|Overall Study||32
2395087|NCT01369732|5875546|P2|NOT COMPLETED|Overall Study||2
2395088|NCT01369732|5875547|P1|NOT COMPLETED|Overall Study||4
2395089|NCT01369732|5875546|P2|COMPLETED|Overall Study||31
2395090|NCT01369732|5875547|P1|COMPLETED|Overall Study||29
2395091|NCT01369732|5875546|P2|STARTED|Overall Study||33
2395092|NCT01369732|5875547|P1|STARTED|Overall Study||33
2395093|NCT01369706|5875553|P1|NOT COMPLETED|Overall Study||0
2395094|NCT01369706|5875553|P1|COMPLETED|Overall Study||388
2395095|NCT01369706|5875553|P1|STARTED|Overall Study||388
2395096|NCT01369680|5875561|P4|NOT COMPLETED|Overall Study||2
2395097|NCT01369680|5875562|P3|NOT COMPLETED|Overall Study||1
2395098|NCT01369680|5875563|P2|NOT COMPLETED|Overall Study||0
2395099|NCT01369680|5875564|P1|NOT COMPLETED|Overall Study||0
2395100|NCT01369680|5875561|P4|COMPLETED|Overall Study||1
2395101|NCT01369680|5875562|P3|COMPLETED|Overall Study||2
2395102|NCT01369680|5875563|P2|COMPLETED|Overall Study||3
2395103|NCT01369680|5875564|P1|COMPLETED|Overall Study||3
2395104|NCT01369680|5875561|P4|STARTED|Overall Study||3
2395105|NCT01369680|5875562|P3|STARTED|Overall Study||3
2395106|NCT01369680|5875563|P2|STARTED|Overall Study||3
2395107|NCT01369680|5875564|P1|STARTED|Overall Study||3
2395108|NCT01369641|5875585|P1|NOT COMPLETED|Overall Study||1
2395109|NCT01369641|5875585|P1|COMPLETED|Overall Study||0
2395110|NCT01369641|5875585|P1|STARTED|Overall Study||1
2395111|NCT01369615|5875591|P2|NOT COMPLETED|Overall Study||2
2395112|NCT01369615|5875592|P1|NOT COMPLETED|Overall Study||0
2395113|NCT01369615|5875591|P2|COMPLETED|Overall Study||12
2395114|NCT01369615|5875592|P1|COMPLETED|Overall Study||9
2395115|NCT01369615|5875591|P2|STARTED|Overall Study||14
2395116|NCT01369615|5875592|P1|STARTED|Overall Study||9
2395117|NCT01369511|5875602|P4|NOT COMPLETED|Overall Study||11
2395118|NCT01369511|5875603|P3|NOT COMPLETED|Overall Study||11
2395119|NCT01369511|5875604|P2|NOT COMPLETED|Overall Study||13
2395120|NCT01369511|5875605|P1|NOT COMPLETED|Overall Study||13
2395121|NCT01369511|5875602|P4|COMPLETED|Overall Study||89
2395122|NCT01369511|5875603|P3|COMPLETED|Overall Study||87
2395123|NCT01369511|5875604|P2|COMPLETED|Overall Study||91
2395124|NCT01369511|5875605|P1|COMPLETED|Overall Study||85
2395214|NCT01369069|5875883|P2|COMPLETED|Overall Study||554
2395125|NCT01369511|5875602|P4|Received at Least 1 Dose of Study Drug|Overall Study||100
2395126|NCT01369511|5875603|P3|Received at Least 1 Dose of Study Drug|Overall Study||98
2395127|NCT01369511|5875604|P2|Received at Least 1 Dose of Study Drug|Overall Study|One participant was a screen failure and inadvertently randomized but did not receive study drug.|103
2395128|NCT01369511|5875605|P1|Received at Least 1 Dose of Study Drug|Overall Study||98
2395129|NCT01369511|5875602|P4|STARTED|Overall Study||100
2395130|NCT01369511|5875603|P3|STARTED|Overall Study||98
2395131|NCT01369511|5875604|P2|STARTED|Overall Study||104
2395132|NCT01369511|5875605|P1|STARTED|Overall Study||98
2395133|NCT01369485|5875621|P2|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||40
2395134|NCT01369485|5875622|P1|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||33
2395135|NCT01369485|5875621|P2|COMPLETED|Open Label Phase (Week 12 to Month 12)||26
2395136|NCT01369485|5875622|P1|COMPLETED|Open Label Phase (Week 12 to Month 12)||24
2395137|NCT01369485|5875621|P2|STARTED|Open Label Phase (Week 12 to Month 12)||66
2395138|NCT01369485|5875622|P1|STARTED|Open Label Phase (Week 12 to Month 12)||57
2395139|NCT01369485|5875621|P2|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||17
2395140|NCT01369485|5875622|P1|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||23
2395141|NCT01369485|5875621|P2|COMPLETED|Randomized Phase (Day 0 to Week 12)||66
2395142|NCT01369485|5875622|P1|COMPLETED|Randomized Phase (Day 0 to Week 12)||57
2395143|NCT01369485|5875621|P2|STARTED|Randomized Phase (Day 0 to Week 12)||83
2395144|NCT01369485|5875622|P1|STARTED|Randomized Phase (Day 0 to Week 12)||80
2395145|NCT01369355|5875668|P6|NOT COMPLETED|Overall Study||272
2395146|NCT01369355|5875669|P5|NOT COMPLETED|Overall Study||154
2395147|NCT01369355|5875670|P4|NOT COMPLETED|Overall Study||30
2395148|NCT01369355|5875671|P3|NOT COMPLETED|Overall Study||31
2395149|NCT01369355|5875672|P2|NOT COMPLETED|Overall Study||29
2395150|NCT01369355|5875673|P1|NOT COMPLETED|Overall Study||31
2395151|NCT01369355|5875668|P6|COMPLETED|Overall Study||204
2395152|NCT01369355|5875669|P5|COMPLETED|Overall Study||131
2395153|NCT01369355|5875670|P4|COMPLETED|Overall Study||93
2395154|NCT01369355|5875671|P3|COMPLETED|Overall Study||101
2395155|NCT01369355|5875672|P2|COMPLETED|Overall Study||103
2395156|NCT01369355|5875673|P1|COMPLETED|Overall Study||102
2395157|NCT01369355|5875668|P6|Treated|Overall Study||476
2395158|NCT01369355|5875669|P5|Treated|Overall Study||285
2395159|NCT01369355|5875670|P4|Treated|Overall Study||123
2395160|NCT01369355|5875671|P3|Treated|Overall Study||131
2395161|NCT01369355|5875672|P2|Treated|Overall Study||132
2395162|NCT01369355|5875673|P1|Treated|Overall Study||133
2395163|NCT01369355|5875668|P6|STARTED|Overall Study||476
2395164|NCT01369355|5875669|P5|STARTED|Overall Study||285
2395165|NCT01369355|5875670|P4|STARTED|Overall Study||123
2395166|NCT01369355|5875671|P3|STARTED|Overall Study||132
2395167|NCT01369355|5875672|P2|STARTED|Overall Study||132
2395168|NCT01369355|5875673|P1|STARTED|Overall Study||133
2395169|NCT01369342|5875702|P3|NOT COMPLETED|Overall Study||3
2395170|NCT01369342|5875703|P2|NOT COMPLETED|Overall Study||9
2395171|NCT01369342|5875704|P1|NOT COMPLETED|Overall Study||13
2395172|NCT01369342|5875702|P3|COMPLETED|Overall Study||210
2395173|NCT01369342|5875703|P2|COMPLETED|Overall Study||204
2395174|NCT01369342|5875704|P1|COMPLETED|Overall Study||201
2395175|NCT01369342|5875702|P3|STARTED|Overall Study||213
2395176|NCT01369342|5875703|P2|STARTED|Overall Study||213
2395177|NCT01369342|5875704|P1|STARTED|Overall Study||214
2395178|NCT01369329|5875727|P3|NOT COMPLETED|Overall Study||14
2395179|NCT01369329|5875728|P2|NOT COMPLETED|Overall Study||11
2395180|NCT01369329|5875729|P1|NOT COMPLETED|Overall Study||12
2395181|NCT01369329|5875727|P3|COMPLETED|Overall Study||245
2395182|NCT01369329|5875728|P2|COMPLETED|Overall Study||243
2395183|NCT01369329|5875729|P1|COMPLETED|Overall Study||244
2395184|NCT01369329|5875727|P3|STARTED|Overall Study||259
2395185|NCT01369329|5875728|P2|STARTED|Overall Study||254
2395186|NCT01369329|5875729|P1|STARTED|Overall Study||256
2395187|NCT01369225|5875755|P6|NOT COMPLETED|Overall Study||0
2395188|NCT01369225|5875756|P5|NOT COMPLETED|Overall Study||2
2395189|NCT01369225|5875757|P4|NOT COMPLETED|Overall Study||2
2395190|NCT01369225|5875758|P3|NOT COMPLETED|Overall Study||3
2395191|NCT01369225|5875759|P2|NOT COMPLETED|Overall Study||0
2395192|NCT01369225|5875760|P1|NOT COMPLETED|Overall Study||2
2395193|NCT01369225|5875755|P6|COMPLETED|Overall Study||9
2395194|NCT01369225|5875756|P5|COMPLETED|Overall Study||10
2395195|NCT01369225|5875757|P4|COMPLETED|Overall Study||8
2395196|NCT01369225|5875758|P3|COMPLETED|Overall Study||9
2395197|NCT01369225|5875759|P2|COMPLETED|Overall Study||3
2395198|NCT01369225|5875760|P1|COMPLETED|Overall Study||4
2395199|NCT01369225|5875755|P6|STARTED|Overall Study||9
2395200|NCT01369225|5875756|P5|STARTED|Overall Study||12
2395201|NCT01369225|5875757|P4|STARTED|Overall Study||10
2395202|NCT01369225|5875758|P3|STARTED|Overall Study||12
2395203|NCT01369225|5875759|P2|STARTED|Overall Study||3
2395204|NCT01369225|5875760|P1|STARTED|Overall Study||6
2395209|NCT01369108|5875874|P1|NOT COMPLETED|Overall Study||11
2395210|NCT01369108|5875874|P1|COMPLETED|Overall Study||49
2395211|NCT01369108|5875874|P1|STARTED|Overall Study|120 teeth|60
2395212|NCT01369069|5875883|P2|NOT COMPLETED|Overall Study||16
2395213|NCT01369069|5875884|P1|NOT COMPLETED|Overall Study||17
2395215|NCT01369069|5875884|P1|COMPLETED|Overall Study||564
2395216|NCT01369069|5875883|P2|STARTED|Overall Study||570
2395217|NCT01369069|5875884|P1|STARTED|Overall Study||581
2395218|NCT01369030|5875900|P1|NOT COMPLETED|Overall Study||40
2395219|NCT01369030|5875900|P1|COMPLETED|Overall Study||554
2395220|NCT01369030|5875900|P1|STARTED|Overall Study||594
2395221|NCT01368965|5875906|P1|NOT COMPLETED|Overall Study||12
2395222|NCT01368965|5875906|P1|COMPLETED|Overall Study||40
2395223|NCT01368965|5875906|P1|Subject Withdrawal Prior to Treatment|Overall Study||2
2395224|NCT01368965|5875906|P1|STARTED|Overall Study|Two subjects withdrew consent prior to study treatment. Data analyses are based on 52 subjects.|52
2395225|NCT01368900|5875915|P1|NOT COMPLETED|Overall Study||7
2395226|NCT01368900|5875915|P1|COMPLETED|Overall Study||61
2395227|NCT01368900|5875915|P1|STARTED|Overall Study||68
2395228|NCT01368874|5875928|P3|NOT COMPLETED|Overall Study||1
2395229|NCT01368874|5875929|P2|NOT COMPLETED|Overall Study||0
2395230|NCT01368874|5875930|P1|NOT COMPLETED|Overall Study||3
2395231|NCT01368874|5875928|P3|COMPLETED|Overall Study||24
2395232|NCT01368874|5875929|P2|COMPLETED|Overall Study||5
2395233|NCT01368874|5875930|P1|COMPLETED|Overall Study||31
2395234|NCT01368874|5875928|P3|STARTED|Overall Study||25
2395235|NCT01368874|5875929|P2|STARTED|Overall Study||5
2395236|NCT01368874|5875930|P1|STARTED|Overall Study||34
2395237|NCT01368835|5875990|P1|NOT COMPLETED|Overall Study||33
2395238|NCT01368835|5875990|P1|COMPLETED|Overall Study||70
2395239|NCT01368835|5875990|P1|STARTED|Overall Study|103 Subjects Enrolled|103
2395240|NCT01368809|5875999|P2|NOT COMPLETED|Overall Study||0
2395241|NCT01368809|5876000|P1|NOT COMPLETED|Overall Study||0
2395242|NCT01368809|5875999|P2|COMPLETED|Overall Study||50
2395243|NCT01368809|5876000|P1|COMPLETED|Overall Study||50
2395244|NCT01368809|5875999|P2|STARTED|Overall Study||50
2395245|NCT01368809|5876000|P1|STARTED|Overall Study||50
2395246|NCT01368653|5876012|P2|NOT COMPLETED|Overall Study||9
2395247|NCT01368653|5876013|P1|NOT COMPLETED|Overall Study||6
2395248|NCT01368653|5876012|P2|COMPLETED|Overall Study||37
2395249|NCT01368653|5876013|P1|COMPLETED|Overall Study||41
2395250|NCT01368653|5876012|P2|Randomized to Advice Only in Phase 2|Overall Study||10
2395251|NCT01368653|5876013|P1|Randomized to Advice Only in Phase 2|Overall Study||10
2395252|NCT01368653|5876012|P2|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|9
2395253|NCT01368653|5876013|P1|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|11
2395254|NCT01368653|5876012|P2|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|19
2395255|NCT01368653|5876013|P1|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|21
2395256|NCT01368653|5876012|P2|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|20
2395257|NCT01368653|5876013|P1|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|29
2395258|NCT01368653|5876012|P2|Completed 4-week Follow-up|Overall Study||37
2395259|NCT01368653|5876013|P1|Completed 4-week Follow-up|Overall Study||44
2395260|NCT01368653|5876012|P2|STARTED|Overall Study||46
2395261|NCT01368653|5876013|P1|STARTED|Overall Study||47
2395262|NCT01368614|5876029|P4|NOT COMPLETED|Study Period||3
2395263|NCT01368614|5876030|P3|NOT COMPLETED|Study Period||2
2395264|NCT01368614|5876031|P2|NOT COMPLETED|Study Period||1
2395265|NCT01368614|5876032|P1|NOT COMPLETED|Study Period||0
2395266|NCT01368614|5876029|P4|COMPLETED|Study Period||8
2395267|NCT01368614|5876030|P3|COMPLETED|Study Period||8
2395268|NCT01368614|5876031|P2|COMPLETED|Study Period||10
2395269|NCT01368614|5876032|P1|COMPLETED|Study Period||0
2395270|NCT01368614|5876029|P4|STARTED|Study Period||11
2395271|NCT01368614|5876030|P3|STARTED|Study Period||10
2395272|NCT01368614|5876031|P2|STARTED|Study Period||11
2395273|NCT01368614|5876032|P1|STARTED|Study Period||0
2395274|NCT01368614|5876029|P4|NOT COMPLETED|Screening Period||0
2395275|NCT01368614|5876030|P3|NOT COMPLETED|Screening Period||0
2395276|NCT01368614|5876031|P2|NOT COMPLETED|Screening Period||0
2395277|NCT01368614|5876032|P1|NOT COMPLETED|Screening Period||58
2395278|NCT01368614|5876029|P4|COMPLETED|Screening Period||0
2395279|NCT01368614|5876030|P3|COMPLETED|Screening Period||0
2395280|NCT01368614|5876031|P2|COMPLETED|Screening Period||0
2395281|NCT01368614|5876032|P1|COMPLETED|Screening Period||32
2395282|NCT01368614|5876029|P4|STARTED|Screening Period||0
2395283|NCT01368614|5876030|P3|STARTED|Screening Period||0
2395284|NCT01368614|5876031|P2|STARTED|Screening Period||0
2395285|NCT01368614|5876032|P1|STARTED|Screening Period||90
2395286|NCT01368562|5876085|P1|NOT COMPLETED|Overall Study||19
2395287|NCT01368562|5876085|P1|COMPLETED|Overall Study||7
2395288|NCT01368562|5876085|P1|Received at Least 1 Dose of Study Drug|Overall Study||25
2395289|NCT01368562|5876085|P1|STARTED|Overall Study||26
2395290|NCT01368536|5876092|P3|NOT COMPLETED|Overall Study||59
2395291|NCT01368536|5876093|P2|NOT COMPLETED|Overall Study||59
2395292|NCT01368536|5876094|P1|NOT COMPLETED|Overall Study||51
2395293|NCT01368536|5876092|P3|COMPLETED|Overall Study||83
2395294|NCT01368536|5876093|P2|COMPLETED|Overall Study||78
2395295|NCT01368536|5876094|P1|COMPLETED|Overall Study||87
2395296|NCT01368536|5876092|P3|Full Analysis Set|Overall Study|One patient was excluded from efficacy analysis as there was no post baseline data|141
2395297|NCT01368536|5876093|P2|Full Analysis Set|Overall Study||137
2395298|NCT01368536|5876094|P1|Full Analysis Set|Overall Study||138
2395299|NCT01368536|5876092|P3|STARTED|Overall Study||142
2395300|NCT01368536|5876093|P2|STARTED|Overall Study||137
2395301|NCT01368536|5876094|P1|STARTED|Overall Study||138
2395302|NCT01368497|5876115|P1|NOT COMPLETED|Overall Study||2
2395303|NCT01368497|5876115|P1|COMPLETED|Overall Study||58
2395304|NCT01368497|5876115|P1|End of Treatment|Overall Study|Five discontinued study drugs early and completed the follow-up period per protocol.|60
2395305|NCT01368497|5876115|P1|STARTED|Overall Study||60
2395306|NCT01368432|5876143|P2|NOT COMPLETED|Overall Study||1
2395307|NCT01368432|5876144|P1|NOT COMPLETED|Overall Study||0
2395308|NCT01368432|5876143|P2|COMPLETED|Overall Study||7
2395309|NCT01368432|5876144|P1|COMPLETED|Overall Study||6
2395310|NCT01368432|5876143|P2|STARTED|Overall Study||8
2395311|NCT01368432|5876144|P1|STARTED|Overall Study||6
2395312|NCT01368406|5876178|P2|NOT COMPLETED|Overall Study||13
2395313|NCT01368406|5876179|P1|NOT COMPLETED|Overall Study||21
2395314|NCT01368406|5876178|P2|COMPLETED|Overall Study||66
2395315|NCT01368406|5876179|P1|COMPLETED|Overall Study||60
2395316|NCT01368406|5876178|P2|STARTED|Overall Study||79
2395317|NCT01368406|5876179|P1|STARTED|Overall Study||81
2395318|NCT01368276|5876187|P2|NOT COMPLETED|Overall Study||10
2395319|NCT01368276|5876188|P1|NOT COMPLETED|Overall Study||1
2395320|NCT01368276|5876187|P2|COMPLETED|Overall Study||18
2395321|NCT01368276|5876188|P1|COMPLETED|Overall Study||2
2395322|NCT01368276|5876187|P2|STARTED|Overall Study||28
2395323|NCT01368276|5876188|P1|STARTED|Overall Study||3
2395324|NCT01368263|5876201|P3|NOT COMPLETED|Overall Study||0
2395325|NCT01368263|5876202|P2|NOT COMPLETED|Overall Study||0
2395326|NCT01368263|5876203|P1|NOT COMPLETED|Overall Study||0
2395327|NCT01368263|5876201|P3|COMPLETED|Overall Study||1
2395328|NCT01368263|5876202|P2|COMPLETED|Overall Study||1
2395329|NCT01368263|5876203|P1|COMPLETED|Overall Study||6
2395330|NCT01368263|5876201|P3|STARTED|Overall Study||1
2395331|NCT01368263|5876202|P2|STARTED|Overall Study||1
2395332|NCT01368263|5876203|P1|STARTED|Overall Study||6
2395333|NCT01368211|5876225|P2|NOT COMPLETED|Second Platelets Transfusion||2
2395334|NCT01368211|5876226|P1|NOT COMPLETED|Second Platelets Transfusion||1
2395335|NCT01368211|5876225|P2|COMPLETED|Second Platelets Transfusion||5
2395336|NCT01368211|5876226|P1|COMPLETED|Second Platelets Transfusion||7
2395337|NCT01368211|5876225|P2|STARTED|Second Platelets Transfusion||7
2395338|NCT01368211|5876226|P1|STARTED|Second Platelets Transfusion||8
2395339|NCT01368211|5876225|P2|NOT COMPLETED|First Platelets Transfusion||0
2395340|NCT01368211|5876226|P1|NOT COMPLETED|First Platelets Transfusion||0
2395341|NCT01368211|5876225|P2|COMPLETED|First Platelets Transfusion||7
2395342|NCT01368211|5876226|P1|COMPLETED|First Platelets Transfusion||8
2395343|NCT01368211|5876225|P2|STARTED|First Platelets Transfusion||7
2395344|NCT01368211|5876226|P1|STARTED|First Platelets Transfusion||8
2395345|NCT01368185|5876234|P1|NOT COMPLETED|Overall Study||0
2395346|NCT01368185|5876234|P1|COMPLETED|Overall Study||1705
2395347|NCT01368185|5876234|P1|STARTED|Overall Study||1705
2395348|NCT01368081|5876254|P13|NOT COMPLETED|Overall Study||7
2395349|NCT01368081|5876255|P12|NOT COMPLETED|Overall Study||3
2395350|NCT01368081|5876256|P11|NOT COMPLETED|Overall Study||9
2395351|NCT01368081|5876257|P10|NOT COMPLETED|Overall Study||10
2395352|NCT01368081|5876258|P9|NOT COMPLETED|Overall Study||8
2395353|NCT01368081|5876259|P8|NOT COMPLETED|Overall Study||7
2395354|NCT01368081|5876260|P7|NOT COMPLETED|Overall Study||12
2395355|NCT01368081|5876261|P6|NOT COMPLETED|Overall Study||10
2395356|NCT01368081|5876262|P5|NOT COMPLETED|Overall Study||2
2395357|NCT01368081|5876263|P4|NOT COMPLETED|Overall Study||5
2395358|NCT01368081|5876264|P3|NOT COMPLETED|Overall Study||4
2395359|NCT01368081|5876265|P2|NOT COMPLETED|Overall Study||9
2395360|NCT01368081|5876266|P1|NOT COMPLETED|Overall Study||10
2395361|NCT01368081|5876254|P13|COMPLETED|Overall Study||63
2395362|NCT01368081|5876255|P12|COMPLETED|Overall Study||67
2395363|NCT01368081|5876256|P11|COMPLETED|Overall Study||62
2395364|NCT01368081|5876257|P10|COMPLETED|Overall Study||58
2395365|NCT01368081|5876258|P9|COMPLETED|Overall Study||62
2395366|NCT01368081|5876259|P8|COMPLETED|Overall Study||62
2395367|NCT01368081|5876260|P7|COMPLETED|Overall Study||124
2395368|NCT01368081|5876261|P6|COMPLETED|Overall Study||127
2395369|NCT01368081|5876262|P5|COMPLETED|Overall Study||63
2395370|NCT01368081|5876263|P4|COMPLETED|Overall Study||63
2395371|NCT01368081|5876264|P3|COMPLETED|Overall Study||59
2395372|NCT01368081|5876265|P2|COMPLETED|Overall Study||128
2395373|NCT01368081|5876266|P1|COMPLETED|Overall Study||126
2395374|NCT01368081|5876254|P13|STARTED|Overall Study||70
2395375|NCT01368081|5876255|P12|STARTED|Overall Study||70
2395376|NCT01368081|5876256|P11|STARTED|Overall Study||71
2395377|NCT01368081|5876257|P10|STARTED|Overall Study||68
2395378|NCT01368081|5876258|P9|STARTED|Overall Study||70
2395379|NCT01368081|5876259|P8|STARTED|Overall Study||69
2395380|NCT01368081|5876260|P7|STARTED|Overall Study||136
2395381|NCT01368081|5876261|P6|STARTED|Overall Study||137
2395382|NCT01368081|5876262|P5|STARTED|Overall Study||65
2395383|NCT01368081|5876263|P4|STARTED|Overall Study||68
2395384|NCT01368081|5876264|P3|STARTED|Overall Study||63
2395385|NCT01368081|5876265|P2|STARTED|Overall Study||137
2395386|NCT01368081|5876266|P1|STARTED|Overall Study||136
2395387|NCT01368042|5876320|P1|NOT COMPLETED|Overall Study||30
2395388|NCT01368042|5876320|P1|COMPLETED|Overall Study||235
2395389|NCT01368042|5876320|P1|STARTED|Overall Study||265
2395390|NCT01367886|5876340|P1|NOT COMPLETED|Overall Study||7
2395391|NCT01367886|5876340|P1|COMPLETED|Overall Study||14
2395392|NCT01367886|5876340|P1|STARTED|Overall Study||21
2395393|NCT01367860|5876349|P2|NOT COMPLETED|Overall Study||0
2395394|NCT01367860|5876350|P1|NOT COMPLETED|Overall Study||0
2395395|NCT01367860|5876349|P2|COMPLETED|Overall Study||20
2395396|NCT01367860|5876350|P1|COMPLETED|Overall Study||20
2395397|NCT01367860|5876349|P2|STARTED|Overall Study||20
2395398|NCT01367860|5876350|P1|STARTED|Overall Study||20
2395399|NCT01367847|5876390|P2|NOT COMPLETED|Overall Study||2
2395400|NCT01367847|5876391|P1|NOT COMPLETED|Overall Study||2
2395401|NCT01367847|5876390|P2|COMPLETED|Overall Study||7
2395402|NCT01367847|5876391|P1|COMPLETED|Overall Study||8
2395403|NCT01367847|5876390|P2|STARTED|Overall Study||9
2395404|NCT01367847|5876391|P1|STARTED|Overall Study||10
2395405|NCT01367834|5876407|P2|NOT COMPLETED|Overall Study||3
2395406|NCT01367834|5876408|P1|NOT COMPLETED|Overall Study||2
2395407|NCT01367834|5876407|P2|COMPLETED|Overall Study||3
2395408|NCT01367834|5876408|P1|COMPLETED|Overall Study||9
2395409|NCT01367834|5876407|P2|STARTED|Overall Study||6
2395410|NCT01367834|5876408|P1|STARTED|Overall Study||11
2395411|NCT01367704|5876432|P2|NOT COMPLETED|Overall Study||161
2395412|NCT01367704|5876433|P1|NOT COMPLETED|Overall Study||47
2395413|NCT01367704|5876432|P2|COMPLETED|Overall Study||847
2395414|NCT01367704|5876433|P1|COMPLETED|Overall Study||951
2395415|NCT01367704|5876432|P2|STARTED|Overall Study||1008
2395416|NCT01367704|5876433|P1|STARTED|Overall Study||998
2395417|NCT01367665|5876445|P2|NOT COMPLETED|Overall Study||55
2395418|NCT01367665|5876446|P1|NOT COMPLETED|Overall Study||442
2395419|NCT01367665|5876445|P2|COMPLETED|Overall Study||41
2395420|NCT01367665|5876446|P1|COMPLETED|Overall Study||677
2395421|NCT01367665|5876445|P2|STARTED|Overall Study||96
2395422|NCT01367665|5876446|P1|STARTED|Overall Study||1119
2395423|NCT01367457|5876477|P3|NOT COMPLETED|Overall Study||0
2395424|NCT01367457|5876478|P2|NOT COMPLETED|Overall Study||0
2395425|NCT01367457|5876479|P1|NOT COMPLETED|Overall Study||188
2395426|NCT01367457|5876477|P3|COMPLETED|Overall Study||26
2395427|NCT01367457|5876478|P2|COMPLETED|Overall Study||23
2395428|NCT01367457|5876479|P1|COMPLETED|Overall Study||5
2395429|NCT01367457|5876477|P3|STARTED|Overall Study||26
2395430|NCT01367457|5876478|P2|STARTED|Overall Study||23
2395431|NCT01367457|5876479|P1|STARTED|Overall Study||193
2395432|NCT01367262|5876499|P1|NOT COMPLETED|Overall Study||0
2395433|NCT01367262|5876499|P1|COMPLETED|Overall Study||6
2395434|NCT01367262|5876499|P1|STARTED|Overall Study||6
2395435|NCT01367249|5876512|P2|NOT COMPLETED|Overall Study||16
2395436|NCT01367249|5876513|P1|NOT COMPLETED|Overall Study||9
2395437|NCT01367249|5876512|P2|COMPLETED|Overall Study||202
2395438|NCT01367249|5876513|P1|COMPLETED|Overall Study||213
2395439|NCT01367249|5876512|P2|STARTED|Overall Study||218
2395440|NCT01367249|5876513|P1|STARTED|Overall Study||222
2395441|NCT01367236|5876523|P2|NOT COMPLETED|Overall Study||1
2395442|NCT01367236|5876524|P1|NOT COMPLETED|Overall Study||3
2395443|NCT01367236|5876523|P2|COMPLETED|Overall Study||29
2395444|NCT01367236|5876524|P1|COMPLETED|Overall Study||27
2395445|NCT01367236|5876523|P2|STARTED|Overall Study||30
2395446|NCT01367236|5876524|P1|STARTED|Overall Study||30
2395447|NCT01367158|5876543|P11|NOT COMPLETED|Overall Study||1
2395448|NCT01367158|5876544|P10|NOT COMPLETED|Overall Study||0
2395449|NCT01367158|5876545|P9|NOT COMPLETED|Overall Study||0
2395450|NCT01367158|5876546|P8|NOT COMPLETED|Overall Study||2
2395451|NCT01367158|5876547|P7|NOT COMPLETED|Overall Study||0
2395452|NCT01367158|5876548|P6|NOT COMPLETED|Overall Study||2
2395453|NCT01367158|5876549|P5|NOT COMPLETED|Overall Study||2
2395454|NCT01367158|5876550|P4|NOT COMPLETED|Overall Study||1
2395455|NCT01367158|5876551|P3|NOT COMPLETED|Overall Study||1
2395456|NCT01367158|5876552|P2|NOT COMPLETED|Overall Study||3
2395457|NCT01367158|5876553|P1|NOT COMPLETED|Overall Study||0
2395458|NCT01367158|5876543|P11|COMPLETED|Overall Study||72
2395459|NCT01367158|5876544|P10|COMPLETED|Overall Study||50
2395460|NCT01367158|5876545|P9|COMPLETED|Overall Study||23
2395461|NCT01367158|5876546|P8|COMPLETED|Overall Study||47
2395462|NCT01367158|5876547|P7|COMPLETED|Overall Study||25
2395463|NCT01367158|5876548|P6|COMPLETED|Overall Study||46
2395464|NCT01367158|5876549|P5|COMPLETED|Overall Study||23
2395465|NCT01367158|5876550|P4|COMPLETED|Overall Study||48
2395466|NCT01367158|5876551|P3|COMPLETED|Overall Study||23
2395467|NCT01367158|5876552|P2|COMPLETED|Overall Study||46
2395468|NCT01367158|5876553|P1|COMPLETED|Overall Study||25
2395469|NCT01367158|5876543|P11|STARTED|Overall Study||73
2395470|NCT01367158|5876544|P10|STARTED|Overall Study||50
2395471|NCT01367158|5876545|P9|STARTED|Overall Study||23
2395472|NCT01367158|5876546|P8|STARTED|Overall Study||49
2395473|NCT01367158|5876547|P7|STARTED|Overall Study||25
2395474|NCT01367158|5876548|P6|STARTED|Overall Study||48
2395475|NCT01367158|5876549|P5|STARTED|Overall Study||25
2395476|NCT01367158|5876550|P4|STARTED|Overall Study||49
2395477|NCT01367158|5876551|P3|STARTED|Overall Study||24
2395478|NCT01367158|5876552|P2|STARTED|Overall Study||49
2395479|NCT01367158|5876553|P1|STARTED|Overall Study||25
2395480|NCT01367119|5876697|P2|NOT COMPLETED|Overall Study||1
2395481|NCT01367119|5876698|P1|NOT COMPLETED|Overall Study||2
2395482|NCT01367119|5876697|P2|COMPLETED|Overall Study||16
2395483|NCT01367119|5876698|P1|COMPLETED|Overall Study||19
2395484|NCT01367119|5876697|P2|STARTED|Overall Study||17
2395485|NCT01367119|5876698|P1|STARTED|Overall Study||21
2395486|NCT01367080|5876710|P2|NOT COMPLETED|2nd Administration||0
2395487|NCT01367080|5876711|P1|NOT COMPLETED|2nd Administration||0
2395488|NCT01367080|5876710|P2|COMPLETED|2nd Administration||6
2395489|NCT01367080|5876711|P1|COMPLETED|2nd Administration||6
2395490|NCT01367080|5876710|P2|STARTED|2nd Administration||6
2395491|NCT01367080|5876711|P1|STARTED|2nd Administration||6
2395492|NCT01367080|5876710|P2|NOT COMPLETED|1st Administration||0
2395493|NCT01367080|5876711|P1|NOT COMPLETED|1st Administration||0
2395494|NCT01367080|5876710|P2|COMPLETED|1st Administration||6
2395495|NCT01367080|5876711|P1|COMPLETED|1st Administration||6
2395496|NCT01367080|5876710|P2|STARTED|1st Administration||6
2395497|NCT01367080|5876711|P1|STARTED|1st Administration||6
2395498|NCT01366976|5876725|P2|NOT COMPLETED|Overall Study||0
2395499|NCT01366976|5876726|P1|NOT COMPLETED|Overall Study||0
2395500|NCT01366976|5876725|P2|COMPLETED|Overall Study||30
2395501|NCT01366976|5876726|P1|COMPLETED|Overall Study||30
2395502|NCT01366976|5876725|P2|STARTED|Overall Study||30
2395503|NCT01366976|5876726|P1|STARTED|Overall Study||30
2395504|NCT01366885|5876738|P1|NOT COMPLETED|Overall Study||1
2395505|NCT01366885|5876738|P1|COMPLETED|Overall Study|We completed our study when the last child born had reached 36 months of age.|19
2395506|NCT01366885|5876738|P1|STARTED|Overall Study|We started recruiting in February 2008 and recruited 20 mothers.|20
2395507|NCT01366872|5876743|P1|NOT COMPLETED|Overall Study||0
2395508|NCT01366872|5876743|P1|COMPLETED|Overall Study||50
2395509|NCT01366872|5876743|P1|STARTED|Overall Study||50
2395510|NCT01366846|5876753|P4|NOT COMPLETED|Overall Study||1
2395511|NCT01366846|5876754|P3|NOT COMPLETED|Overall Study||1
2395512|NCT01366846|5876755|P2|NOT COMPLETED|Overall Study||4
2395513|NCT01366846|5876756|P1|NOT COMPLETED|Overall Study||3
2395514|NCT01366846|5876753|P4|COMPLETED|Overall Study||45
2395515|NCT01366846|5876754|P3|COMPLETED|Overall Study||46
2395516|NCT01366846|5876755|P2|COMPLETED|Overall Study||224
2395517|NCT01366846|5876756|P1|COMPLETED|Overall Study||232
2395518|NCT01366846|5876753|P4|STARTED|Overall Study||46
2395519|NCT01366846|5876754|P3|STARTED|Overall Study||47
2395520|NCT01366846|5876755|P2|STARTED|Overall Study||228
2395521|NCT01366846|5876756|P1|STARTED|Overall Study||235
2395522|NCT01366638|5876779|P3|NOT COMPLETED|Overall Study||6
2395523|NCT01366638|5876780|P2|NOT COMPLETED|Overall Study||0
2395524|NCT01366638|5876781|P1|NOT COMPLETED|Overall Study||1
2395525|NCT01366638|5876779|P3|COMPLETED|Overall Study||20
2395526|NCT01366638|5876780|P2|COMPLETED|Overall Study||29
2395527|NCT01366638|5876781|P1|COMPLETED|Overall Study||23
2395528|NCT01366638|5876779|P3|STARTED|Overall Study||26
2395529|NCT01366638|5876780|P2|STARTED|Overall Study||29
2395530|NCT01366638|5876781|P1|STARTED|Overall Study||24
2395531|NCT01366534|5876818|P3|NOT COMPLETED|Overall Study||0
2395532|NCT01366534|5876819|P2|NOT COMPLETED|Overall Study||2
2395533|NCT01366534|5876820|P1|NOT COMPLETED|Overall Study||2
2395534|NCT01366534|5876818|P3|COMPLETED|Overall Study||12
2395535|NCT01366534|5876819|P2|COMPLETED|Overall Study||25
2395536|NCT01366534|5876820|P1|COMPLETED|Overall Study||26
2395537|NCT01366534|5876818|P3|STARTED|Overall Study||12
2395538|NCT01366534|5876819|P2|STARTED|Overall Study||27
2395539|NCT01366534|5876820|P1|STARTED|Overall Study||28
2395540|NCT01366521|5876870|P4|NOT COMPLETED|Overall Study||0
2395541|NCT01366521|5876871|P3|NOT COMPLETED|Overall Study||2
2395542|NCT01366521|5876872|P2|NOT COMPLETED|Overall Study||1
2395543|NCT01366521|5876873|P1|NOT COMPLETED|Overall Study||1
2395544|NCT01366521|5876870|P4|COMPLETED|Overall Study||11
2395545|NCT01366521|5876871|P3|COMPLETED|Overall Study||21
2395546|NCT01366521|5876872|P2|COMPLETED|Overall Study||14
2395547|NCT01366521|5876873|P1|COMPLETED|Overall Study||20
2395548|NCT01366521|5876870|P4|STARTED|Overall Study||11
2395549|NCT01366521|5876871|P3|STARTED|Overall Study||23
2395550|NCT01366521|5876872|P2|STARTED|Overall Study||15
2395551|NCT01366521|5876873|P1|STARTED|Overall Study||21
2395552|NCT01366495|5876952|P4|NOT COMPLETED|HIV Study||0
2395553|NCT01366495|5876953|P3|NOT COMPLETED|HIV Study||0
2395554|NCT01366495|5876954|P2|NOT COMPLETED|HIV Study||0
2395555|NCT01366495|5876955|P1|NOT COMPLETED|HIV Study||1
2395556|NCT01366495|5876952|P4|COMPLETED|HIV Study||0
2395557|NCT01366495|5876953|P3|COMPLETED|HIV Study||0
2395558|NCT01366495|5876954|P2|COMPLETED|HIV Study||50
2395559|NCT01366495|5876955|P1|COMPLETED|HIV Study||49
2395560|NCT01366495|5876952|P4|STARTED|HIV Study||0
2395561|NCT01366495|5876953|P3|STARTED|HIV Study||0
2395562|NCT01366495|5876954|P2|STARTED|HIV Study||50
2395563|NCT01366495|5876955|P1|STARTED|HIV Study||50
2395564|NCT01366495|5876952|P4|NOT COMPLETED|Testing Study||0
2395565|NCT01366495|5876953|P3|NOT COMPLETED|Testing Study||0
2395566|NCT01366495|5876954|P2|NOT COMPLETED|Testing Study||0
2395567|NCT01366495|5876955|P1|NOT COMPLETED|Testing Study||0
2395568|NCT01366495|5876952|P4|COMPLETED|Testing Study||348
2395569|NCT01366495|5876953|P3|COMPLETED|Testing Study||349
2395570|NCT01366495|5876954|P2|COMPLETED|Testing Study||0
2395571|NCT01366495|5876955|P1|COMPLETED|Testing Study||0
2395572|NCT01366495|5876952|P4|STARTED|Testing Study||348
2395573|NCT01366495|5876953|P3|STARTED|Testing Study||349
2395574|NCT01366495|5876954|P2|STARTED|Testing Study||0
2395575|NCT01366495|5876955|P1|STARTED|Testing Study||0
2395576|NCT01366443|5876969|P1|NOT COMPLETED|Overall Study||3
2395577|NCT01366443|5876969|P1|COMPLETED|Overall Study||285
2395578|NCT01366443|5876969|P1|STARTED|Overall Study||288
2395579|NCT01366417|5876974|P1|NOT COMPLETED|Overall Study||18
2395580|NCT01366417|5876974|P1|COMPLETED|Overall Study|25 subjects included in the analysis|25
2395581|NCT01366417|5876974|P1|Excluded From Analysis|Overall Study|3 subjects did not have qualifying Treatment Day microbial counts and were excluded from analysis|3
2395582|NCT01366417|5876974|P1|Discontinued Prior to Treatment|Overall Study|5 eligible subjects were not treated because enrollment target of 25 was met and enrollment closed.|5
2395583|NCT01366417|5876974|P1|Completed the Study|Overall Study|treatment baseline microbial counts not available until after treatment; subjects not evaluable|28
2395584|NCT01366417|5876974|P1|Completed Treatment Visit|Overall Study|28 subjects were treated with ChloraPrep and 70% Isopropyl Alcohol (single topical treatment)|28
2395585|NCT01366417|5876974|P1|Completed Screen Visit|Overall Study|33 subjects had qualifying screening bacterial counts and were eligible for the Treatment Visit|33
2395586|NCT01366417|5876974|P1|Signed Informed Consent|Overall Study|Microbial samples were taken from 43 subjects for screening baseline.|43
2395587|NCT01366417|5876974|P1|STARTED|Overall Study||43
2395588|NCT01366209|5876983|P2|NOT COMPLETED|Overall Study||36
2395589|NCT01366209|5876984|P1|NOT COMPLETED|Overall Study||35
2395590|NCT01366209|5876983|P2|COMPLETED|Overall Study||241
2395591|NCT01366209|5876984|P1|COMPLETED|Overall Study|Participants completing study assessment at Week 52 were completers, even if treatment was withdrawn|243
2395592|NCT01366209|5876983|P2|STARTED|Overall Study||277
2395593|NCT01366209|5876984|P1|STARTED|Overall Study||278
2395594|NCT01366196|5876992|P2|NOT COMPLETED|Overall Study||0
2395595|NCT01366196|5876993|P1|NOT COMPLETED|Overall Study||0
2395596|NCT01366196|5876992|P2|COMPLETED|Overall Study||43
2395597|NCT01366196|5876993|P1|COMPLETED|Overall Study||43
2395598|NCT01366196|5876992|P2|STARTED|Overall Study||43
2395599|NCT01366196|5876993|P1|STARTED|Overall Study||43
2395600|NCT01366092|5877007|P1|NOT COMPLETED|Overall Study||4
2395601|NCT01366092|5877007|P1|COMPLETED|Overall Study||31
2395602|NCT01366092|5877007|P1|STARTED|Overall Study||35
2395603|NCT01365910|5877016|P1|NOT COMPLETED|Overall Study||30
2395604|NCT01365910|5877016|P1|COMPLETED|Overall Study||0
2395605|NCT01365910|5877016|P1|STARTED|Overall Study||30
2395606|NCT01365845|5877023|P3|NOT COMPLETED|Treatment Phase||0
2395607|NCT01365845|5877024|P2|NOT COMPLETED|Treatment Phase||0
2395608|NCT01365845|5877025|P1|NOT COMPLETED|Treatment Phase||0
2395609|NCT01365845|5877023|P3|COMPLETED|Treatment Phase||18
2395610|NCT01365845|5877024|P2|COMPLETED|Treatment Phase||0
2395611|NCT01365845|5877025|P1|COMPLETED|Treatment Phase||0
2395612|NCT01365845|5877023|P3|STARTED|Treatment Phase||18
2395613|NCT01365845|5877024|P2|STARTED|Treatment Phase||0
2395614|NCT01365845|5877025|P1|STARTED|Treatment Phase||0
2395615|NCT01365845|5877023|P3|NOT COMPLETED|Induction Phase||0
2395616|NCT01365845|5877024|P2|NOT COMPLETED|Induction Phase||0
2395617|NCT01365845|5877025|P1|NOT COMPLETED|Induction Phase||0
2395618|NCT01365845|5877023|P3|COMPLETED|Induction Phase||0
2395619|NCT01365845|5877024|P2|COMPLETED|Induction Phase||0
2395620|NCT01365845|5877025|P1|COMPLETED|Induction Phase||18
2395621|NCT01365845|5877023|P3|STARTED|Induction Phase||0
2395622|NCT01365845|5877024|P2|STARTED|Induction Phase||0
2395623|NCT01365845|5877025|P1|STARTED|Induction Phase||18
2395624|NCT01365819|5877032|P2|NOT COMPLETED|Overall Study||13
2395625|NCT01365819|5877033|P1|NOT COMPLETED|Overall Study||13
2395626|NCT01365819|5877032|P2|COMPLETED|Overall Study||14
2395627|NCT01365819|5877033|P1|COMPLETED|Overall Study||12
2395628|NCT01365819|5877032|P2|STARTED|Overall Study||27
2395629|NCT01365819|5877033|P1|STARTED|Overall Study||25
2395630|NCT01365793|5877051|P4|NOT COMPLETED|Overall Study||2
2395631|NCT01365793|5877052|P3|NOT COMPLETED|Overall Study||7
2395632|NCT01365793|5877053|P2|NOT COMPLETED|Overall Study||7
2395633|NCT01365793|5877054|P1|NOT COMPLETED|Overall Study||2
2395634|NCT01365793|5877051|P4|COMPLETED|Overall Study||347
2395635|NCT01365793|5877052|P3|COMPLETED|Overall Study||338
2395636|NCT01365793|5877053|P2|COMPLETED|Overall Study||344
2395637|NCT01365793|5877054|P1|COMPLETED|Overall Study||342
2395638|NCT01365793|5877051|P4|STARTED|Overall Study||349
2395639|NCT01365793|5877052|P3|STARTED|Overall Study||345
2395640|NCT01365793|5877053|P2|STARTED|Overall Study||351
2395641|NCT01365793|5877054|P1|STARTED|Overall Study||344
2395642|NCT01365650|5877080|P1|NOT COMPLETED|Treatment C||0
2395643|NCT01365650|5877080|P1|COMPLETED|Treatment C||24
2395644|NCT01365650|5877080|P1|STARTED|Treatment C||24
2395645|NCT01365650|5877080|P1|NOT COMPLETED|Treatment B||0
2395646|NCT01365650|5877080|P1|COMPLETED|Treatment B||24
2395647|NCT01365650|5877080|P1|STARTED|Treatment B||24
2395648|NCT01365650|5877080|P1|NOT COMPLETED|Treatment A||0
2395649|NCT01365650|5877080|P1|COMPLETED|Treatment A||24
2395650|NCT01365650|5877080|P1|STARTED|Treatment A||24
2395651|NCT01365624|5877105|P2|NOT COMPLETED|Overall Study||0
2395652|NCT01365624|5877106|P1|NOT COMPLETED|Overall Study||0
2395653|NCT01365624|5877105|P2|COMPLETED|Overall Study||15
2395654|NCT01365624|5877106|P1|COMPLETED|Overall Study||15
2395655|NCT01365624|5877105|P2|STARTED|Overall Study||15
2395656|NCT01365624|5877106|P1|STARTED|Overall Study||15
2395657|NCT01365611|5877122|P1|NOT COMPLETED|Overall Study||0
2395658|NCT01365611|5877122|P1|COMPLETED|Overall Study||36
2395659|NCT01365611|5877122|P1|STARTED|Overall Study||36
2395660|NCT01365585|5877138|P1|NOT COMPLETED|Overall Study||0
2395661|NCT01365585|5877138|P1|COMPLETED|Overall Study||227
2395662|NCT01365585|5877138|P1|STARTED|Overall Study||227
2395663|NCT01365546|5877152|P1|NOT COMPLETED|Overall Study||11
2395664|NCT01365546|5877152|P1|COMPLETED|Overall Study||30
2395665|NCT01365546|5877152|P1|STARTED|Overall Study|in this study 41 patients were screened but only 30 patients completed the study.|41
2395666|NCT01365507|5877162|P2|NOT COMPLETED|Overall Study||9
2395667|NCT01365507|5877163|P1|NOT COMPLETED|Overall Study||9
2395668|NCT01365507|5877162|P2|COMPLETED|Overall Study||131
2395669|NCT01365507|5877163|P1|COMPLETED|Overall Study||127
2395670|NCT01365507|5877162|P2|Exposed|Overall Study||140
2395671|NCT01365507|5877163|P1|Exposed|Overall Study|Two subjects withdrew before exposure to trial drug|134
2395672|NCT01365507|5877162|P2|STARTED|Overall Study||140
2395673|NCT01365507|5877163|P1|STARTED|Overall Study||136
2395674|NCT01365494|5877179|P2|NOT COMPLETED|Overall Study||3
2395675|NCT01365494|5877180|P1|NOT COMPLETED|Overall Study||2
2395676|NCT01365494|5877179|P2|COMPLETED|Overall Study||121
2395677|NCT01365494|5877180|P1|COMPLETED|Overall Study||124
2395678|NCT01365494|5877179|P2|STARTED|Overall Study||124
2395679|NCT01365494|5877180|P1|STARTED|Overall Study||126
2395680|NCT01365481|5877196|P4|NOT COMPLETED|Overall Study||7
2395681|NCT01365481|5877197|P3|NOT COMPLETED|Overall Study||4
2395682|NCT01365481|5877198|P2|NOT COMPLETED|Overall Study||15
2395683|NCT01365481|5877199|P1|NOT COMPLETED|Overall Study||7
2395684|NCT01365481|5877196|P4|COMPLETED|Overall Study||50
2395685|NCT01365481|5877197|P3|COMPLETED|Overall Study||14
2395686|NCT01365481|5877198|P2|COMPLETED|Overall Study||37
2395687|NCT01365481|5877199|P1|COMPLETED|Overall Study||16
2395688|NCT01365481|5877196|P4|STARTED|Overall Study||57
2395689|NCT01365481|5877197|P3|STARTED|Overall Study||18
2395690|NCT01365481|5877198|P2|STARTED|Overall Study||52
2395691|NCT01365481|5877199|P1|STARTED|Overall Study||23
2395692|NCT01365468|5877219|P2|NOT COMPLETED|Overall Study||0
2395693|NCT01365468|5877220|P1|NOT COMPLETED|Overall Study||4
2395694|NCT01365468|5877219|P2|COMPLETED|Overall Study||5
2395695|NCT01365468|5877220|P1|COMPLETED|Overall Study||0
2395696|NCT01365468|5877219|P2|STARTED|Overall Study||5
2395697|NCT01365468|5877220|P1|STARTED|Overall Study||4
2395698|NCT01365455|5877235|P5|NOT COMPLETED|Follow-up Period||0
2395699|NCT01365455|5877236|P4|NOT COMPLETED|Follow-up Period||0
2395700|NCT01365455|5877237|P3|NOT COMPLETED|Follow-up Period||0
2395701|NCT01365455|5877238|P2|NOT COMPLETED|Follow-up Period||0
2395702|NCT01365455|5877239|P1|NOT COMPLETED|Follow-up Period||0
2395703|NCT01365455|5877235|P5|COMPLETED|Follow-up Period||0
2395704|NCT01365455|5877236|P4|COMPLETED|Follow-up Period||0
2395705|NCT01365455|5877237|P3|COMPLETED|Follow-up Period||18
2395706|NCT01365455|5877238|P2|COMPLETED|Follow-up Period||47
2395707|NCT01365455|5877239|P1|COMPLETED|Follow-up Period||58
2395708|NCT01365455|5877235|P5|STARTED|Follow-up Period||0
2395709|NCT01365455|5877236|P4|STARTED|Follow-up Period||0
2395710|NCT01365455|5877237|P3|STARTED|Follow-up Period||18
2395711|NCT01365455|5877238|P2|STARTED|Follow-up Period||47
2395712|NCT01365455|5877239|P1|STARTED|Follow-up Period||58
2395713|NCT01365455|5877235|P5|NOT COMPLETED|Maintenance Period||13
2395714|NCT01365455|5877236|P4|NOT COMPLETED|Maintenance Period||9
2395715|NCT01365455|5877237|P3|NOT COMPLETED|Maintenance Period||3
2395716|NCT01365455|5877238|P2|NOT COMPLETED|Maintenance Period||23
2395717|NCT01365455|5877239|P1|NOT COMPLETED|Maintenance Period||29
2395718|NCT01365455|5877235|P5|COMPLETED|Maintenance Period||92
2395719|NCT01365455|5877236|P4|COMPLETED|Maintenance Period||100
2395720|NCT01365455|5877237|P3|COMPLETED|Maintenance Period||15
2395721|NCT01365455|5877238|P2|COMPLETED|Maintenance Period||215
2395722|NCT01365455|5877239|P1|COMPLETED|Maintenance Period||201
2395723|NCT01365455|5877235|P5|STARTED|Maintenance Period||105
2395724|NCT01365455|5877236|P4|STARTED|Maintenance Period||109
2395725|NCT01365455|5877237|P3|STARTED|Maintenance Period||18
2395726|NCT01365455|5877238|P2|STARTED|Maintenance Period||238
2395727|NCT01365455|5877239|P1|STARTED|Maintenance Period||230
2395728|NCT01365455|5877235|P5|NOT COMPLETED|Induction Period||0
2395729|NCT01365455|5877236|P4|NOT COMPLETED|Induction Period||0
2395730|NCT01365455|5877237|P3|NOT COMPLETED|Induction Period||16
2395731|NCT01365455|5877238|P2|NOT COMPLETED|Induction Period||7
2395732|NCT01365455|5877239|P1|NOT COMPLETED|Induction Period||15
2395733|NCT01365455|5877235|P5|COMPLETED|Induction Period||0
2395734|NCT01365455|5877236|P4|COMPLETED|Induction Period||0
2395735|NCT01365455|5877237|P3|COMPLETED|Induction Period||232
2395736|NCT01365455|5877238|P2|COMPLETED|Induction Period||238
2395737|NCT01365455|5877239|P1|COMPLETED|Induction Period||230
2395738|NCT01365455|5877235|P5|STARTED|Induction Period||0
2395739|NCT01365455|5877236|P4|STARTED|Induction Period||0
2395740|NCT01365455|5877237|P3|STARTED|Induction Period||248
2395741|NCT01365455|5877238|P2|STARTED|Induction Period||245
2395742|NCT01365455|5877239|P1|STARTED|Induction Period||245
2395743|NCT01365273|5877329|P2|NOT COMPLETED|Overall Study||1
2395744|NCT01365273|5877330|P1|NOT COMPLETED|Overall Study||2
2395745|NCT01365273|5877329|P2|COMPLETED|Overall Study||20
2395746|NCT01365273|5877330|P1|COMPLETED|Overall Study||20
2395747|NCT01365273|5877329|P2|Compl. Pts, Not Evaluable for Pain.|Overall Study||4
2395748|NCT01365273|5877330|P1|Compl. Pts, Not Evaluable for Pain.|Overall Study||2
2395749|NCT01365273|5877329|P2|STARTED|Overall Study||21
2395750|NCT01365273|5877330|P1|STARTED|Overall Study||22
2395751|NCT01365130|5877340|P1|NOT COMPLETED|Overall Study||2
2395752|NCT01365130|5877340|P1|COMPLETED|Overall Study||13
2395753|NCT01365130|5877340|P1|STARTED|Overall Study|15 patients were enrolled to the study but only 13 went on to begin treatment|15
2395754|NCT01365091|5877349|P4|NOT COMPLETED|Period 2||0
2395755|NCT01365091|5877350|P3|NOT COMPLETED|Period 2||1
2395756|NCT01365091|5877351|P2|NOT COMPLETED|Period 2||0
2395757|NCT01365091|5877352|P1|NOT COMPLETED|Period 2||1
2395758|NCT01365091|5877349|P4|COMPLETED|Period 2||25
2395759|NCT01365091|5877350|P3|COMPLETED|Period 2||24
2395760|NCT01365091|5877351|P2|COMPLETED|Period 2||26
2395761|NCT01365091|5877352|P1|COMPLETED|Period 2||25
2395762|NCT01365091|5877349|P4|STARTED|Period 2||25
2395763|NCT01365091|5877350|P3|STARTED|Period 2||25
2395764|NCT01365091|5877351|P2|STARTED|Period 2||26
2395765|NCT01365091|5877352|P1|STARTED|Period 2||26
2395766|NCT01365091|5877349|P4|NOT COMPLETED|Period 1||3
2395767|NCT01365091|5877350|P3|NOT COMPLETED|Period 1||3
2395768|NCT01365091|5877351|P2|NOT COMPLETED|Period 1||2
2395769|NCT01365091|5877352|P1|NOT COMPLETED|Period 1||2
2395770|NCT01365091|5877349|P4|COMPLETED|Period 1||25
2395771|NCT01365091|5877350|P3|COMPLETED|Period 1||25
2395772|NCT01365091|5877351|P2|COMPLETED|Period 1||26
2395773|NCT01365091|5877352|P1|COMPLETED|Period 1||26
2395774|NCT01365091|5877349|P4|STARTED|Period 1||28
2395775|NCT01365091|5877350|P3|STARTED|Period 1||28
2395776|NCT01365091|5877351|P2|STARTED|Period 1||28
2395777|NCT01365091|5877352|P1|STARTED|Period 1||28
2395778|NCT01365052|5877380|P2|NOT COMPLETED|Overall Study||4
2395779|NCT01365052|5877381|P1|NOT COMPLETED|Overall Study||4
2395780|NCT01365052|5877380|P2|COMPLETED|Overall Study||105
2395781|NCT01365052|5877381|P1|COMPLETED|Overall Study||213
2395782|NCT01365052|5877380|P2|STARTED|Overall Study||109
2395783|NCT01365052|5877381|P1|STARTED|Overall Study||217
2395784|NCT01365039|5877397|P2|NOT COMPLETED|Overall Study||0
2395785|NCT01365039|5877398|P1|NOT COMPLETED|Overall Study||1
2395786|NCT01365039|5877397|P2|COMPLETED|Overall Study||87
2395787|NCT01365039|5877398|P1|COMPLETED|Overall Study||85
2395788|NCT01365039|5877397|P2|STARTED|Overall Study||87
2395789|NCT01365039|5877398|P1|STARTED|Overall Study||86
2395790|NCT01364922|5877409|P3|NOT COMPLETED|Double-Blind (DB) Period||5
2395791|NCT01364922|5877410|P2|NOT COMPLETED|Double-Blind (DB) Period||5
2395792|NCT01364922|5877411|P1|NOT COMPLETED|Double-Blind (DB) Period||0
2395793|NCT01364922|5877409|P3|COMPLETED|Double-Blind (DB) Period||42
2395794|NCT01364922|5877410|P2|COMPLETED|Double-Blind (DB) Period||94
2395795|NCT01364922|5877411|P1|COMPLETED|Double-Blind (DB) Period||0
2395796|NCT01364922|5877409|P3|STARTED|Double-Blind (DB) Period||47
2395797|NCT01364922|5877410|P2|STARTED|Double-Blind (DB) Period||99
2395798|NCT01364922|5877411|P1|STARTED|Double-Blind (DB) Period||0
2395799|NCT01364922|5877409|P3|NOT COMPLETED|Open-label (OL) Period||0
2395800|NCT01364922|5877410|P2|NOT COMPLETED|Open-label (OL) Period||0
2395801|NCT01364922|5877411|P1|NOT COMPLETED|Open-label (OL) Period||22
2395802|NCT01364922|5877409|P3|COMPLETED|Open-label (OL) Period||0
2395803|NCT01364922|5877410|P2|COMPLETED|Open-label (OL) Period||0
2395804|NCT01364922|5877411|P1|COMPLETED|Open-label (OL) Period||146
2395805|NCT01364922|5877409|P3|STARTED|Open-label (OL) Period||0
2395806|NCT01364922|5877410|P2|STARTED|Open-label (OL) Period||0
2395807|NCT01364922|5877411|P1|STARTED|Open-label (OL) Period||168
2395808|NCT01364896|5877422|P1|NOT COMPLETED|Overall Study||0
2395809|NCT01364896|5877422|P1|COMPLETED|Overall Study||46
2395810|NCT01364896|5877422|P1|STARTED|Overall Study||46
2395811|NCT01364870|5877433|P3|NOT COMPLETED|Overall Study||14
2395812|NCT01364870|5877434|P2|NOT COMPLETED|Overall Study||30
2395813|NCT01364870|5877435|P1|NOT COMPLETED|Overall Study||22
2395814|NCT01364870|5877433|P3|COMPLETED|Overall Study||58
2395815|NCT01364870|5877434|P2|COMPLETED|Overall Study||93
2395816|NCT01364870|5877435|P1|COMPLETED|Overall Study||100
2395817|NCT01364870|5877433|P3|STARTED|Overall Study||72
2395818|NCT01364870|5877434|P2|STARTED|Overall Study||123
2395819|NCT01364870|5877435|P1|STARTED|Overall Study||122
2395820|NCT01364740|5877446|P1|NOT COMPLETED|Overall Study||0
2395821|NCT01364740|5877446|P1|COMPLETED|Overall Study||10
2395822|NCT01364740|5877446|P1|STARTED|Overall Study||10
2395823|NCT01364727|5877454|P1|NOT COMPLETED|Overall Study||2
2395824|NCT01364727|5877454|P1|COMPLETED|Overall Study||33
2395825|NCT01364727|5877454|P1|STARTED|Overall Study||35
2395826|NCT01364649|5877462|P2|NOT COMPLETED|Overall Study||43
2395827|NCT01364649|5877463|P1|NOT COMPLETED|Overall Study||56
2395828|NCT01364649|5877462|P2|COMPLETED|Overall Study||179
2395829|NCT01364649|5877463|P1|COMPLETED|Overall Study||169
2395830|NCT01364649|5877462|P2|STARTED|Overall Study||222
2395831|NCT01364649|5877463|P1|STARTED|Overall Study||225
2395832|NCT01364623|5877476|P4|NOT COMPLETED|Multiple Dose||0
2395833|NCT01364623|5877477|P3|NOT COMPLETED|Multiple Dose||0
2395834|NCT01364623|5877478|P2|NOT COMPLETED|Multiple Dose||0
2395835|NCT01364623|5877479|P1|NOT COMPLETED|Multiple Dose||0
2395836|NCT01364623|5877476|P4|COMPLETED|Multiple Dose||8
2395837|NCT01364623|5877477|P3|COMPLETED|Multiple Dose||0
2395838|NCT01364623|5877478|P2|COMPLETED|Multiple Dose||0
2395839|NCT01364623|5877479|P1|COMPLETED|Multiple Dose||0
2395840|NCT01364623|5877476|P4|STARTED|Multiple Dose||8
2395841|NCT01364623|5877477|P3|STARTED|Multiple Dose||0
2395842|NCT01364623|5877478|P2|STARTED|Multiple Dose||0
2395843|NCT01364623|5877479|P1|STARTED|Multiple Dose||0
2395844|NCT01364623|5877476|P4|NOT COMPLETED|Single Dose||0
2395845|NCT01364623|5877477|P3|NOT COMPLETED|Single Dose||0
2395846|NCT01364623|5877478|P2|NOT COMPLETED|Single Dose||0
2395847|NCT01364623|5877479|P1|NOT COMPLETED|Single Dose||0
2395848|NCT01364623|5877476|P4|COMPLETED|Single Dose||0
2395849|NCT01364623|5877477|P3|COMPLETED|Single Dose||8
2395850|NCT01364623|5877478|P2|COMPLETED|Single Dose||8
2395851|NCT01364623|5877479|P1|COMPLETED|Single Dose||8
2395852|NCT01364623|5877476|P4|STARTED|Single Dose||0
2395853|NCT01364623|5877477|P3|STARTED|Single Dose||8
2395854|NCT01364623|5877478|P2|STARTED|Single Dose||8
2395855|NCT01364623|5877479|P1|STARTED|Single Dose||8
2395856|NCT01364584|5877504|P2|NOT COMPLETED|Overall Study||0
2395857|NCT01364584|5877505|P1|NOT COMPLETED|Overall Study||0
2395858|NCT01364584|5877504|P2|COMPLETED|Overall Study||12
2395859|NCT01364584|5877505|P1|COMPLETED|Overall Study||11
2395860|NCT01364584|5877504|P2|STARTED|Overall Study||12
2395861|NCT01364584|5877505|P1|STARTED|Overall Study||11
2395862|NCT01364558|5877539|P3|NOT COMPLETED|Dose Three||0
2395863|NCT01364558|5877540|P2|NOT COMPLETED|Dose Three||0
2395864|NCT01364558|5877541|P1|NOT COMPLETED|Dose Three||0
2395865|NCT01364558|5877539|P3|COMPLETED|Dose Three||8
2395866|NCT01364558|5877540|P2|COMPLETED|Dose Three||8
2395867|NCT01364558|5877541|P1|COMPLETED|Dose Three||8
2395868|NCT01364558|5877539|P3|STARTED|Dose Three||8
2395869|NCT01364558|5877540|P2|STARTED|Dose Three||8
2395870|NCT01364558|5877541|P1|STARTED|Dose Three||8
2395871|NCT01364558|5877539|P3|NOT COMPLETED|Dose Two||0
2395872|NCT01364558|5877540|P2|NOT COMPLETED|Dose Two||0
2395873|NCT01364558|5877541|P1|NOT COMPLETED|Dose Two||0
2395874|NCT01364558|5877539|P3|COMPLETED|Dose Two||8
2395875|NCT01364558|5877540|P2|COMPLETED|Dose Two||8
2395876|NCT01364558|5877541|P1|COMPLETED|Dose Two||8
2395877|NCT01364558|5877539|P3|STARTED|Dose Two||8
2395878|NCT01364558|5877540|P2|STARTED|Dose Two||8
2395879|NCT01364558|5877541|P1|STARTED|Dose Two||8
2395880|NCT01364558|5877539|P3|NOT COMPLETED|Dose One||0
2395881|NCT01364558|5877540|P2|NOT COMPLETED|Dose One||0
2395882|NCT01364558|5877541|P1|NOT COMPLETED|Dose One||0
2395883|NCT01364558|5877539|P3|COMPLETED|Dose One||8
2395884|NCT01364558|5877540|P2|COMPLETED|Dose One||8
2395885|NCT01364558|5877541|P1|COMPLETED|Dose One||8
2395886|NCT01364558|5877539|P3|STARTED|Dose One||8
2395887|NCT01364558|5877540|P2|STARTED|Dose One||8
2395888|NCT01364558|5877541|P1|STARTED|Dose One||8
2395889|NCT01364428|5877551|P2|NOT COMPLETED|Overall Study||15
2395890|NCT01364428|5877552|P1|NOT COMPLETED|Overall Study||20
2395891|NCT01364428|5877551|P2|COMPLETED|Overall Study||172
2395892|NCT01364428|5877552|P1|COMPLETED|Overall Study||166
2395893|NCT01364428|5877551|P2|Exposed|Overall Study||187
2395894|NCT01364428|5877552|P1|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|184
2395895|NCT01364428|5877551|P2|STARTED|Overall Study||187
2395896|NCT01364428|5877552|P1|STARTED|Overall Study||186
2395897|NCT01364389|5877569|P3|NOT COMPLETED|Overall Study||1
2395898|NCT01364389|5877570|P2|NOT COMPLETED|Overall Study||1
2395899|NCT01364389|5877571|P1|NOT COMPLETED|Overall Study||2
2395900|NCT01364389|5877569|P3|COMPLETED|Overall Study||4
2395901|NCT01364389|5877570|P2|COMPLETED|Overall Study||5
2395902|NCT01364389|5877571|P1|COMPLETED|Overall Study||3
2395903|NCT01364389|5877569|P3|Pharmacodynamic (PD) Analysis Set|Overall Study|One patient excluded: did not receive study drug; received placebo caps. and infusion only in error.|4
2395904|NCT01364389|5877570|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||6
2395905|NCT01364389|5877571|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||5
2395906|NCT01364389|5877569|P3|STARTED|Overall Study||5
2395907|NCT01364389|5877570|P2|STARTED|Overall Study||6
2395908|NCT01364389|5877571|P1|STARTED|Overall Study||5
2395909|NCT01364298|5877590|P2|NOT COMPLETED|Overall Study||23
2395910|NCT01364298|5877591|P1|NOT COMPLETED|Overall Study||14
2395911|NCT01364298|5877590|P2|COMPLETED|Overall Study||154
2395912|NCT01364298|5877591|P1|COMPLETED|Overall Study||162
2395913|NCT01364298|5877590|P2|Treated|Overall Study||174
2395914|NCT01364298|5877591|P1|Treated|Overall Study||174
2395915|NCT01364298|5877590|P2|STARTED|Overall Study||177
2395916|NCT01364298|5877591|P1|STARTED|Overall Study||176
2395917|NCT01364259|5877615|P2|NOT COMPLETED|Overall Study||0
2395918|NCT01364259|5877616|P1|NOT COMPLETED|Overall Study||0
2395919|NCT01364259|5877615|P2|COMPLETED|Overall Study||8
2395920|NCT01364259|5877616|P1|COMPLETED|Overall Study||9
2395921|NCT01364259|5877615|P2|STARTED|Overall Study||8
2395922|NCT01364259|5877616|P1|STARTED|Overall Study||9
2395923|NCT01364233|5877624|P1|NOT COMPLETED|Overall Study||1
2395924|NCT01364233|5877624|P1|COMPLETED|Overall Study||9
2395925|NCT01364233|5877624|P1|STARTED|Overall Study||10
2395926|NCT01364207|5877628|P2|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
2395927|NCT01364207|5877629|P1|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
2395928|NCT01364207|5877628|P2|COMPLETED|Second Visit (~1.5-2 Hours)||54
2395929|NCT01364207|5877629|P1|COMPLETED|Second Visit (~1.5-2 Hours)||52
2395930|NCT01364207|5877628|P2|STARTED|Second Visit (~1.5-2 Hours)||54
2395931|NCT01364207|5877629|P1|STARTED|Second Visit (~1.5-2 Hours)||52
2395932|NCT01364207|5877628|P2|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||4
2395933|NCT01364207|5877629|P1|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||2
2395934|NCT01364207|5877628|P2|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||54
2395935|NCT01364207|5877629|P1|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||52
2395936|NCT01364207|5877628|P2|STARTED|Time Between Visits (2 Days to 4 Weeks)||58
2395937|NCT01364207|5877629|P1|STARTED|Time Between Visits (2 Days to 4 Weeks)||54
2395938|NCT01364207|5877628|P2|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
2395939|NCT01364207|5877629|P1|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
2395940|NCT01364207|5877628|P2|COMPLETED|First Visit (~1.5-2 Hours)||58
2395941|NCT01364207|5877629|P1|COMPLETED|First Visit (~1.5-2 Hours)||54
2395942|NCT01364207|5877628|P2|STARTED|First Visit (~1.5-2 Hours)||58
2395943|NCT01364207|5877629|P1|STARTED|First Visit (~1.5-2 Hours)||54
2395944|NCT01364090|5877640|P3|NOT COMPLETED|Overall Study||6
2395945|NCT01364090|5877641|P2|NOT COMPLETED|Overall Study||14
2395946|NCT01364090|5877642|P1|NOT COMPLETED|Overall Study||3
2395947|NCT01364090|5877640|P3|COMPLETED|Overall Study||0
2395948|NCT01364090|5877641|P2|COMPLETED|Overall Study||12
2395949|NCT01364090|5877642|P1|COMPLETED|Overall Study||58
2395950|NCT01364090|5877640|P3|STARTED|Overall Study||6
2395951|NCT01364090|5877641|P2|STARTED|Overall Study||26
2395952|NCT01364090|5877642|P1|STARTED|Overall Study||61
2395953|NCT01363999|5877650|P1|NOT COMPLETED|D: RO4607381/ F49 Tablet||0
2395954|NCT01363999|5877650|P1|COMPLETED|D: RO4607381/ F49 Tablet||24
2395955|NCT01363999|5877650|P1|STARTED|D: RO4607381/ F49 Tablet||24
2395956|NCT01363999|5877650|P1|NOT COMPLETED|C: RO5317116/ F04 Active-coated Tablet||0
2395957|NCT01363999|5877650|P1|COMPLETED|C: RO5317116/ F04 Active-coated Tablet||24
2395958|NCT01363999|5877650|P1|STARTED|C: RO5317116/ F04 Active-coated Tablet||24
2395959|NCT01363999|5877650|P1|NOT COMPLETED|B: RO5317116/F03 Bilayer Tablet||0
2395960|NCT01363999|5877650|P1|COMPLETED|B: RO5317116/F03 Bilayer Tablet||24
2395961|NCT01363999|5877650|P1|STARTED|B: RO5317116/F03 Bilayer Tablet||24
2395962|NCT01363999|5877650|P1|NOT COMPLETED|A: RO5317116/F01 Bilayer Tablet||0
2395963|NCT01363999|5877650|P1|COMPLETED|A: RO5317116/F01 Bilayer Tablet||24
2395964|NCT01363999|5877650|P1|STARTED|A: RO5317116/F01 Bilayer Tablet||24
2395965|NCT01363986|5877669|P1|NOT COMPLETED|Overall Study||1
2395966|NCT01363986|5877669|P1|COMPLETED|Overall Study||2
2395967|NCT01363986|5877669|P1|STARTED|Overall Study||3
2395968|NCT01363908|5877679|P2|NOT COMPLETED|Chronic Dosing (CD) Phase||6
2395969|NCT01363908|5877680|P1|NOT COMPLETED|Chronic Dosing (CD) Phase||10
2395970|NCT01363908|5877679|P2|COMPLETED|Chronic Dosing (CD) Phase||10
2395971|NCT01363908|5877680|P1|COMPLETED|Chronic Dosing (CD) Phase||3
2395972|NCT01363908|5877679|P2|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|16
2395973|NCT01363908|5877680|P1|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|13
2395974|NCT01363908|5877679|P2|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
2395975|NCT01363908|5877680|P1|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
2395976|NCT01363908|5877679|P2|COMPLETED|Pharmacokinetic (PK) Phase||8
2395977|NCT01363908|5877680|P1|COMPLETED|Pharmacokinetic (PK) Phase||8
2395978|NCT01363908|5877679|P2|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
2395979|NCT01363908|5877680|P1|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
2395980|NCT01363908|5877679|P2|NOT COMPLETED|Screening/Enrollment||0
2395981|NCT01363908|5877680|P1|NOT COMPLETED|Screening/Enrollment||1
2395982|NCT01363908|5877679|P2|COMPLETED|Screening/Enrollment||16
2395983|NCT01363908|5877680|P1|COMPLETED|Screening/Enrollment|One participant did not receive investigational product.|13
2395984|NCT01363908|5877679|P2|STARTED|Screening/Enrollment||16
2395985|NCT01363908|5877680|P1|STARTED|Screening/Enrollment||14
2395986|NCT01363843|5877710|P1|NOT COMPLETED|Overall Study||1
2395987|NCT01363843|5877710|P1|COMPLETED|Overall Study|39 enrolled, 36 completed 8 cycles of mFOLFOX6, 35 completed chemo-radiation, 38 underwent surgery.|38
2395988|NCT01363843|5877710|P1|STARTED|Overall Study||39
2395989|NCT01363765|5877717|P2|NOT COMPLETED|Overall Study||4731
2395990|NCT01363765|5877718|P1|NOT COMPLETED|Overall Study||5800
2395991|NCT01363765|5877717|P2|COMPLETED|Overall Study|Samples contributing to observation arm. Excluded were duplicates, non-residents, missing age.|11705
2395992|NCT01363765|5877718|P1|COMPLETED|Overall Study|Excluded were duplicates, non-residents, missing age, unavailability of system (smears done instead)|12522
2395993|NCT01363765|5877717|P2|STARTED|Overall Study|This is number of participants enrolled, each with one sample considered in baseline arm.|16436
2395994|NCT01363765|5877718|P1|STARTED|Overall Study|This is number of participants enrolled, each with one sample submitted to Xpert in intervention arm|18322
2395995|NCT01363713|5877730|P1|NOT COMPLETED|Overall Study||6
2395996|NCT01363713|5877730|P1|COMPLETED|Overall Study|Analysed (n=130)|124
2395997|NCT01363713|5877730|P1|ALLOCATED|Overall Study||130
2395998|NCT01363713|5877730|P1|STARTED|Overall Study|Assessed for eligibility|130
2395999|NCT01363700|5877739|P5|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
2396000|NCT01363700|5877740|P4|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
2396001|NCT01363700|5877741|P3|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
2396002|NCT01363700|5877742|P2|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
2396003|NCT01363700|5877743|P1|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
2396004|NCT01363700|5877739|P5|COMPLETED|Epinastine vs Olopatadine Period2||43
2396005|NCT01363700|5877740|P4|COMPLETED|Epinastine vs Olopatadine Period2||43
2396006|NCT01363700|5877741|P3|COMPLETED|Epinastine vs Olopatadine Period2||0
2396007|NCT01363700|5877742|P2|COMPLETED|Epinastine vs Olopatadine Period2||0
2396008|NCT01363700|5877743|P1|COMPLETED|Epinastine vs Olopatadine Period2||0
2396009|NCT01363700|5877739|P5|STARTED|Epinastine vs Olopatadine Period2||43
2396010|NCT01363700|5877740|P4|STARTED|Epinastine vs Olopatadine Period2||43
2396011|NCT01363700|5877741|P3|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
2396012|NCT01363700|5877742|P2|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
2396013|NCT01363700|5877743|P1|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
2396014|NCT01363700|5877739|P5|NOT COMPLETED|Epinastine vs Placebo Period1||0
2396015|NCT01363700|5877740|P4|NOT COMPLETED|Epinastine vs Placebo Period1||0
2396016|NCT01363700|5877741|P3|NOT COMPLETED|Epinastine vs Placebo Period1||0
2396017|NCT01363700|5877742|P2|NOT COMPLETED|Epinastine vs Placebo Period1||1
2396018|NCT01363700|5877743|P1|NOT COMPLETED|Epinastine vs Placebo Period1||0
2396019|NCT01363700|5877739|P5|COMPLETED|Epinastine vs Placebo Period1||0
2396020|NCT01363700|5877740|P4|COMPLETED|Epinastine vs Placebo Period1||0
2396021|NCT01363700|5877741|P3|COMPLETED|Epinastine vs Placebo Period1||22
2396022|NCT01363700|5877742|P2|COMPLETED|Epinastine vs Placebo Period1||21
2396023|NCT01363700|5877743|P1|COMPLETED|Epinastine vs Placebo Period1||43
2396024|NCT01363700|5877739|P5|STARTED|Epinastine vs Placebo Period1|No Allocation|0
2396025|NCT01363700|5877740|P4|STARTED|Epinastine vs Placebo Period1|No Allocation|0
2396026|NCT01363700|5877741|P3|STARTED|Epinastine vs Placebo Period1||22
2396027|NCT01363700|5877742|P2|STARTED|Epinastine vs Placebo Period1||22
2396028|NCT01363700|5877743|P1|STARTED|Epinastine vs Placebo Period1||43
2396029|NCT01363661|5877762|P2|NOT COMPLETED|Overall Study||4
2396030|NCT01363661|5877763|P1|NOT COMPLETED|Overall Study||14
2396031|NCT01363661|5877762|P2|COMPLETED|Overall Study||28
2396032|NCT01363661|5877763|P1|COMPLETED|Overall Study||18
2396033|NCT01363661|5877762|P2|STARTED|Overall Study||32
2396034|NCT01363661|5877763|P1|STARTED|Overall Study||32
2396035|NCT01363492|5877779|P1|NOT COMPLETED|Overall Study||0
2396036|NCT01363492|5877779|P1|COMPLETED|Overall Study||14
2396037|NCT01363492|5877779|P1|STARTED|Overall Study||14
2396038|NCT01363479|5877794|P2|NOT COMPLETED|Overall Study||21
2396039|NCT01363479|5877795|P1|NOT COMPLETED|Overall Study||12
2396040|NCT01363479|5877794|P2|COMPLETED|Overall Study||351
2396041|NCT01363479|5877795|P1|COMPLETED|Overall Study||359
2396042|NCT01363479|5877794|P2|STARTED|Overall Study|number of randomised patients|372
2396043|NCT01363479|5877795|P1|STARTED|Overall Study|number of randomised patients|371
2396044|NCT01363440|5877804|P3|NOT COMPLETED|Overall Study||27
2396045|NCT01363440|5877805|P2|NOT COMPLETED|Overall Study||31
2396046|NCT01363440|5877806|P1|NOT COMPLETED|Overall Study||23
2396047|NCT01363440|5877804|P3|COMPLETED|Overall Study|Completed Week 100|127
2396048|NCT01363440|5877805|P2|COMPLETED|Overall Study|Completed Week 100|125
2396049|NCT01363440|5877806|P1|COMPLETED|Overall Study|Completed Week 100|133
2396050|NCT01363440|5877804|P3|Completed Week 100|Overall Study||127
2396051|NCT01363440|5877805|P2|Completed Week 100|Overall Study||125
2396052|NCT01363440|5877806|P1|Completed Week 100|Overall Study||133
2396053|NCT01363440|5877804|P3|Completed Week 52|Overall Study||144
2396054|NCT01363440|5877805|P2|Completed Week 52|Overall Study||146
2396055|NCT01363440|5877806|P1|Completed Week 52|Overall Study||145
2396056|NCT01363440|5877804|P3|Participants Received Treatment|Overall Study|safety analysis set (SAF)|152
2396057|NCT01363440|5877805|P2|Participants Received Treatment|Overall Study|safety analysis set (SAF)|155
2396058|NCT01363440|5877806|P1|Participants Received Treatment|Overall Study|safety analysis set (SAF)|154
2396059|NCT01363440|5877804|P3|STARTED|Overall Study|randomized|154
2396060|NCT01363440|5877805|P2|STARTED|Overall Study|randomized|156
2396061|NCT01363440|5877806|P1|STARTED|Overall Study|randomized|156
2396062|NCT01363401|5877837|P2|NOT COMPLETED|Overall Study||4
2396063|NCT01363401|5877838|P1|NOT COMPLETED|Overall Study||2
2396064|NCT01363401|5877837|P2|COMPLETED|Overall Study||27
2396065|NCT01363401|5877838|P1|COMPLETED|Overall Study||39
2396066|NCT01363401|5877837|P2|STARTED|Overall Study||31
2396067|NCT01363401|5877838|P1|STARTED|Overall Study|"Including 8 subjects of Phase 1 safety assessment. (Called Modified ITT in this clinical trials)"|41
2396068|NCT01363349|5877852|P2|NOT COMPLETED|Overall Study||70
2396069|NCT01363349|5877853|P1|NOT COMPLETED|Overall Study||67
2396070|NCT01363349|5877852|P2|COMPLETED|Overall Study||66
2396071|NCT01363349|5877853|P1|COMPLETED|Overall Study||66
2396072|NCT01363349|5877852|P2|Randomized|Overall Study||136
2396073|NCT01363349|5877853|P1|Randomized|Overall Study||133
2396074|NCT01363349|5877852|P2|STARTED|Overall Study||136
2396075|NCT01363349|5877853|P1|STARTED|Overall Study||133
2396076|NCT01363297|5877864|P5|NOT COMPLETED|Overall Study||31
2396077|NCT01363297|5877865|P4|NOT COMPLETED|Overall Study||10
2396078|NCT01363297|5877866|P3|NOT COMPLETED|Overall Study||6
2396079|NCT01363297|5877867|P2|NOT COMPLETED|Overall Study||6
2396080|NCT01363297|5877868|P1|NOT COMPLETED|Overall Study||3
2396081|NCT01363297|5877864|P5|COMPLETED|Overall Study||4
2396082|NCT01363297|5877865|P4|COMPLETED|Overall Study||3
2396083|NCT01363297|5877866|P3|COMPLETED|Overall Study||3
2396084|NCT01363297|5877867|P2|COMPLETED|Overall Study||6
2396085|NCT01363297|5877868|P1|COMPLETED|Overall Study||0
2396086|NCT01363297|5877864|P5|STARTED|Overall Study||35
2396087|NCT01363297|5877865|P4|STARTED|Overall Study||13
2396088|NCT01363297|5877866|P3|STARTED|Overall Study||9
2396089|NCT01363297|5877867|P2|STARTED|Overall Study||12
2396090|NCT01363297|5877868|P1|STARTED|Overall Study||3
2396091|NCT01363258|5877960|P2|NOT COMPLETED|Overall Study||0
2396092|NCT01363258|5877961|P1|NOT COMPLETED|Overall Study||0
2396093|NCT01363258|5877960|P2|COMPLETED|Overall Study||46
2396094|NCT01363258|5877961|P1|COMPLETED|Overall Study||54
2396095|NCT01363258|5877960|P2|STARTED|Overall Study||46
2396096|NCT01363258|5877961|P1|STARTED|Overall Study||54
2396097|NCT01363076|5877971|P2|NOT COMPLETED|Overall Study||1
2396098|NCT01363076|5877972|P1|NOT COMPLETED|Overall Study||0
2396099|NCT01363076|5877971|P2|COMPLETED|Overall Study||12
2396100|NCT01363076|5877972|P1|COMPLETED|Overall Study||7
2396101|NCT01363076|5877971|P2|STARTED|Overall Study||13
2396102|NCT01363076|5877972|P1|STARTED|Overall Study||7
2396103|NCT01363050|5877990|P1|NOT COMPLETED|Overall Study||0
2396104|NCT01363050|5877990|P1|COMPLETED|Overall Study||15
2396105|NCT01363050|5877990|P1|STARTED|Overall Study||15
2396106|NCT01363011|5878004|P2|NOT COMPLETED|Extension Phase||8
2396107|NCT01363011|5878005|P1|NOT COMPLETED|Extension Phase||5
2396108|NCT01363011|5878004|P2|COMPLETED|Extension Phase||41
2396109|NCT01363011|5878005|P1|COMPLETED|Extension Phase||13
2396110|NCT01363011|5878004|P2|STARTED|Extension Phase|15 participants who completed the main study did not enroll into the extension phase.|49
2396111|NCT01363011|5878005|P1|STARTED|Extension Phase|11 participants who completed the main study did not enroll into the extension phase.|18
2396112|NCT01363011|5878004|P2|NOT COMPLETED|Main Study||9
2396113|NCT01363011|5878005|P1|NOT COMPLETED|Main Study||4
2396114|NCT01363011|5878004|P2|COMPLETED|Main Study||64
2396115|NCT01363011|5878005|P1|COMPLETED|Main Study||29
2396116|NCT01363011|5878004|P2|STARTED|Main Study||73
2396117|NCT01363011|5878005|P1|STARTED|Main Study||33
2396118|NCT01362959|5878047|P2|NOT COMPLETED|Overall Study||0
2396119|NCT01362959|5878048|P1|NOT COMPLETED|Overall Study||0
2396120|NCT01362959|5878047|P2|COMPLETED|Overall Study||26
2396121|NCT01362959|5878048|P1|COMPLETED|Overall Study||21
2396122|NCT01362959|5878047|P2|STARTED|Overall Study||26
2396123|NCT01362959|5878048|P1|STARTED|Overall Study||21
2396124|NCT01362946|5878062|P2|NOT COMPLETED|Second Behavior Modification Block||0
2396125|NCT01362946|5878063|P1|NOT COMPLETED|Second Behavior Modification Block||0
2396126|NCT01362946|5878062|P2|COMPLETED|Second Behavior Modification Block||24
2396127|NCT01362946|5878063|P1|COMPLETED|Second Behavior Modification Block||23
2396128|NCT01362946|5878062|P2|STARTED|Second Behavior Modification Block||24
2396129|NCT01362946|5878063|P1|STARTED|Second Behavior Modification Block|1 participant withdrew after last but before this treatment period - illness unrelated to study.|23
2396130|NCT01362946|5878062|P2|NOT COMPLETED|First Behavior Modification Block||0
2396131|NCT01362946|5878063|P1|NOT COMPLETED|First Behavior Modification Block||0
2396132|NCT01362946|5878062|P2|COMPLETED|First Behavior Modification Block||24
2396133|NCT01362946|5878063|P1|COMPLETED|First Behavior Modification Block||24
2396134|NCT01362946|5878062|P2|STARTED|First Behavior Modification Block||24
2396135|NCT01362946|5878063|P1|STARTED|First Behavior Modification Block||24
2396136|NCT01362907|5878096|P2|NOT COMPLETED|Period 2, One Week||0
2396137|NCT01362907|5878097|P1|NOT COMPLETED|Period 2, One Week||0
2396138|NCT01362907|5878096|P2|COMPLETED|Period 2, One Week||20
2396139|NCT01362907|5878097|P1|COMPLETED|Period 2, One Week||20
2396140|NCT01362907|5878096|P2|STARTED|Period 2, One Week||20
2396141|NCT01362907|5878097|P1|STARTED|Period 2, One Week||20
2396142|NCT01362907|5878096|P2|NOT COMPLETED|Period 1, One Week||0
2396143|NCT01362907|5878097|P1|NOT COMPLETED|Period 1, One Week||0
2396144|NCT01362907|5878096|P2|COMPLETED|Period 1, One Week||20
2396145|NCT01362907|5878097|P1|COMPLETED|Period 1, One Week||20
2396146|NCT01362907|5878096|P2|STARTED|Period 1, One Week||20
2396147|NCT01362907|5878097|P1|STARTED|Period 1, One Week||20
2396148|NCT01362894|5878111|P2|NOT COMPLETED|Period Two, 1 Week||0
2396149|NCT01362894|5878112|P1|NOT COMPLETED|Period Two, 1 Week||0
2396150|NCT01362894|5878111|P2|COMPLETED|Period Two, 1 Week||115
2396151|NCT01362894|5878112|P1|COMPLETED|Period Two, 1 Week||118
2396152|NCT01362894|5878111|P2|STARTED|Period Two, 1 Week|Three participants discontinued between Periods 1 and 2 due to unacceptable vision.|115
2396153|NCT01362894|5878112|P1|STARTED|Period Two, 1 Week|Two participants discontinued between Periods 1 and 2 due to discomfort (1) and poor fit (1).|118
2396154|NCT01362894|5878111|P2|NOT COMPLETED|Period One, 1 Week||0
2396155|NCT01362894|5878112|P1|NOT COMPLETED|Period One, 1 Week||0
2396156|NCT01362894|5878111|P2|COMPLETED|Period One, 1 Week||117
2396157|NCT01362894|5878112|P1|COMPLETED|Period One, 1 Week||119
2396158|NCT01362894|5878111|P2|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|117
2396159|NCT01362894|5878112|P1|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|119
2396160|NCT01362790|5878132|P7|NOT COMPLETED|Dose De-escalation of Regimen A||0
2396161|NCT01362790|5878133|P6|NOT COMPLETED|Dose De-escalation of Regimen A||0
2396162|NCT01362790|5878134|P5|NOT COMPLETED|Dose De-escalation of Regimen A||6
2396163|NCT01362790|5878135|P4|NOT COMPLETED|Dose De-escalation of Regimen A||0
2396164|NCT01362790|5878136|P3|NOT COMPLETED|Dose De-escalation of Regimen A||0
2396165|NCT01362790|5878137|P2|NOT COMPLETED|Dose De-escalation of Regimen A||0
2396166|NCT01362790|5878138|P1|NOT COMPLETED|Dose De-escalation of Regimen A||0
2396167|NCT01362790|5878132|P7|COMPLETED|Dose De-escalation of Regimen A||0
2396168|NCT01362790|5878133|P6|COMPLETED|Dose De-escalation of Regimen A||0
2396169|NCT01362790|5878134|P5|COMPLETED|Dose De-escalation of Regimen A||2
2396170|NCT01362790|5878135|P4|COMPLETED|Dose De-escalation of Regimen A||0
2396171|NCT01362790|5878136|P3|COMPLETED|Dose De-escalation of Regimen A||0
2396172|NCT01362790|5878137|P2|COMPLETED|Dose De-escalation of Regimen A||0
2396173|NCT01362790|5878138|P1|COMPLETED|Dose De-escalation of Regimen A||0
2396174|NCT01362790|5878132|P7|STARTED|Dose De-escalation of Regimen A||0
2396175|NCT01362790|5878133|P6|STARTED|Dose De-escalation of Regimen A||0
2396176|NCT01362790|5878134|P5|STARTED|Dose De-escalation of Regimen A||8
2396177|NCT01362790|5878135|P4|STARTED|Dose De-escalation of Regimen A||0
2396178|NCT01362790|5878136|P3|STARTED|Dose De-escalation of Regimen A||0
2396179|NCT01362790|5878137|P2|STARTED|Dose De-escalation of Regimen A||0
2396180|NCT01362790|5878138|P1|STARTED|Dose De-escalation of Regimen A||0
2396181|NCT01362790|5878132|P7|NOT COMPLETED|Pilot Phase & Phase 2||0
2396182|NCT01362790|5878133|P6|NOT COMPLETED|Pilot Phase & Phase 2||4
2396183|NCT01362790|5878134|P5|NOT COMPLETED|Pilot Phase & Phase 2||0
2396184|NCT01362790|5878135|P4|NOT COMPLETED|Pilot Phase & Phase 2||14
2396185|NCT01362790|5878136|P3|NOT COMPLETED|Pilot Phase & Phase 2||5
2396186|NCT01362790|5878137|P2|NOT COMPLETED|Pilot Phase & Phase 2||8
2396187|NCT01362790|5878138|P1|NOT COMPLETED|Pilot Phase & Phase 2||10
2396188|NCT01362790|5878132|P7|COMPLETED|Pilot Phase & Phase 2||0
2396189|NCT01362790|5878133|P6|COMPLETED|Pilot Phase & Phase 2||0
2396190|NCT01362790|5878134|P5|COMPLETED|Pilot Phase & Phase 2||0
2396191|NCT01362790|5878135|P4|COMPLETED|Pilot Phase & Phase 2||1
2396192|NCT01362790|5878136|P3|COMPLETED|Pilot Phase & Phase 2||2
2396193|NCT01362790|5878137|P2|COMPLETED|Pilot Phase & Phase 2||0
2396194|NCT01362790|5878138|P1|COMPLETED|Pilot Phase & Phase 2||1
2396195|NCT01362790|5878132|P7|STARTED|Pilot Phase & Phase 2||0
2396196|NCT01362790|5878133|P6|STARTED|Pilot Phase & Phase 2||4
2396197|NCT01362790|5878134|P5|STARTED|Pilot Phase & Phase 2||0
2396198|NCT01362790|5878135|P4|STARTED|Pilot Phase & Phase 2||15
2396199|NCT01362790|5878136|P3|STARTED|Pilot Phase & Phase 2||7
2396200|NCT01362790|5878137|P2|STARTED|Pilot Phase & Phase 2||8
2396201|NCT01362790|5878138|P1|STARTED|Pilot Phase & Phase 2||11
2396202|NCT01362686|5878188|P3|NOT COMPLETED|Overall Study||10
2396203|NCT01362686|5878189|P2|NOT COMPLETED|Overall Study||12
2396204|NCT01362686|5878190|P1|NOT COMPLETED|Overall Study||8
2396205|NCT01362686|5878188|P3|COMPLETED|Overall Study||53
2396206|NCT01362686|5878189|P2|COMPLETED|Overall Study||54
2396207|NCT01362686|5878190|P1|COMPLETED|Overall Study||59
2396208|NCT01362686|5878188|P3|STARTED|Overall Study||63
2396209|NCT01362686|5878189|P2|STARTED|Overall Study||66
2396210|NCT01362686|5878190|P1|STARTED|Overall Study||67
2396211|NCT01362608|5878206|P2|NOT COMPLETED|Overall Study||8
2396212|NCT01362608|5878207|P1|NOT COMPLETED|Overall Study||4
2396213|NCT01362608|5878206|P2|COMPLETED|Overall Study||61
2396214|NCT01362608|5878207|P1|COMPLETED|Overall Study||63
2396215|NCT01362608|5878206|P2|STARTED|Overall Study||69
2396216|NCT01362608|5878207|P1|STARTED|Overall Study||67
2396217|NCT01362530|5878245|P2|NOT COMPLETED|Optional Extension (Cycles 2-6)||0
2396218|NCT01362530|5878246|P1|NOT COMPLETED|Optional Extension (Cycles 2-6)||125
2396219|NCT01362530|5878245|P2|COMPLETED|Optional Extension (Cycles 2-6)||0
2396220|NCT01362530|5878246|P1|COMPLETED|Optional Extension (Cycles 2-6)||46
2396221|NCT01362530|5878245|P2|STARTED|Optional Extension (Cycles 2-6)||0
2396222|NCT01362530|5878246|P1|STARTED|Optional Extension (Cycles 2-6)||171
2396223|NCT01362530|5878245|P2|NOT COMPLETED|Base Study (Cycle 1)||3
2396224|NCT01362530|5878246|P1|NOT COMPLETED|Base Study (Cycle 1)||5
2396225|NCT01362530|5878245|P2|COMPLETED|Base Study (Cycle 1)||149
2396226|NCT01362530|5878246|P1|COMPLETED|Base Study (Cycle 1)||150
2396227|NCT01362530|5878245|P2|Received Study Treatment|Base Study (Cycle 1)||150
2396228|NCT01362530|5878246|P1|Received Study Treatment|Base Study (Cycle 1)||152
2396229|NCT01362530|5878245|P2|STARTED|Base Study (Cycle 1)||152
2396230|NCT01362530|5878246|P1|STARTED|Base Study (Cycle 1)||155
2396231|NCT01362517|5878259|P1|NOT COMPLETED|Overall Study||2
2396232|NCT01362517|5878259|P1|COMPLETED|Overall Study||129
2396233|NCT01362517|5878259|P1|STARTED|Overall Study||131
2396234|NCT01362491|5878270|P3|NOT COMPLETED|Overall Study||0
2396235|NCT01362491|5878271|P2|NOT COMPLETED|Overall Study||0
2396236|NCT01362491|5878272|P1|NOT COMPLETED|Overall Study||1
2396237|NCT01362491|5878270|P3|COMPLETED|Overall Study||46
2396238|NCT01362491|5878271|P2|COMPLETED|Overall Study||89
2396239|NCT01362491|5878272|P1|COMPLETED|Overall Study||90
2396240|NCT01362491|5878270|P3|STARTED|Overall Study||46
2396241|NCT01362491|5878271|P2|STARTED|Overall Study||89
2396242|NCT01362491|5878272|P1|STARTED|Overall Study||91
2396243|NCT01362439|5878320|P1|NOT COMPLETED|Overall Study||15
2396244|NCT01362439|5878320|P1|COMPLETED|Overall Study||118
2396245|NCT01362439|5878320|P1|STARTED|Overall Study||133
2396246|NCT01362348|5878335|P1|NOT COMPLETED|Overall Study||14
2396247|NCT01362348|5878335|P1|COMPLETED|Overall Study||5
2396248|NCT01362348|5878335|P1|STARTED|Overall Study||19
2396249|NCT01362322|5878354|P2|NOT COMPLETED|Overall Study||7
2396250|NCT01362322|5878355|P1|NOT COMPLETED|Overall Study||5
2396251|NCT01362322|5878354|P2|COMPLETED|Overall Study||329
2396252|NCT01362322|5878355|P1|COMPLETED|Overall Study||330
2396253|NCT01362322|5878354|P2|STARTED|Overall Study||336
2396254|NCT01362322|5878355|P1|STARTED|Overall Study||335
2396255|NCT01362296|5878387|P4|NOT COMPLETED|Crossover Phase||2
2396256|NCT01362296|5878388|P3|NOT COMPLETED|Crossover Phase||23
2396257|NCT01362296|5878389|P2|NOT COMPLETED|Crossover Phase||0
2396258|NCT01362296|5878390|P1|NOT COMPLETED|Crossover Phase||0
2396259|NCT01362296|5878387|P4|COMPLETED|Crossover Phase||0
2396260|NCT01362296|5878388|P3|COMPLETED|Crossover Phase||0
2396261|NCT01362296|5878389|P2|COMPLETED|Crossover Phase||0
2396262|NCT01362296|5878390|P1|COMPLETED|Crossover Phase||0
2396263|NCT01362296|5878387|P4|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|2
2396264|NCT01362296|5878388|P3|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|23
2396265|NCT01362296|5878389|P2|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
2396266|NCT01362296|5878390|P1|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
2396267|NCT01362296|5878387|P4|NOT COMPLETED|Randomized Phase (RP)||0
2396268|NCT01362296|5878388|P3|NOT COMPLETED|Randomized Phase (RP)||0
2396269|NCT01362296|5878389|P2|NOT COMPLETED|Randomized Phase (RP)||43
2396270|NCT01362296|5878390|P1|NOT COMPLETED|Randomized Phase (RP)||87
2396271|NCT01362296|5878387|P4|COMPLETED|Randomized Phase (RP)||0
2396272|NCT01362296|5878388|P3|COMPLETED|Randomized Phase (RP)||0
2396273|NCT01362296|5878389|P2|COMPLETED|Randomized Phase (RP)||0
2396274|NCT01362296|5878390|P1|COMPLETED|Randomized Phase (RP)||0
2396275|NCT01362296|5878387|P4|STARTED|Randomized Phase (RP)||0
2396276|NCT01362296|5878388|P3|STARTED|Randomized Phase (RP)||0
2396277|NCT01362296|5878389|P2|STARTED|Randomized Phase (RP)||43
2396278|NCT01362296|5878390|P1|STARTED|Randomized Phase (RP)||87
2396279|NCT01362244|5878438|P2|NOT COMPLETED|Overall Study||32
2396280|NCT01362244|5878439|P1|NOT COMPLETED|Overall Study||32
2396281|NCT01362244|5878438|P2|COMPLETED|Overall Study||19
2396282|NCT01362244|5878439|P1|COMPLETED|Overall Study||22
2396283|NCT01362244|5878438|P2|STARTED|Overall Study||51
2396284|NCT01362244|5878439|P1|STARTED|Overall Study||54
2396285|NCT01362205|5878512|P2|NOT COMPLETED|Overall Study||0
2396286|NCT01362205|5878513|P1|NOT COMPLETED|Overall Study||0
2396287|NCT01362205|5878512|P2|COMPLETED|Overall Study||27
2396288|NCT01362205|5878513|P1|COMPLETED|Overall Study||22
2396289|NCT01362205|5878512|P2|STARTED|Overall Study||27
2396290|NCT01362205|5878513|P1|STARTED|Overall Study||22
2396291|NCT01362192|5878539|P1|NOT COMPLETED|Overall Study||4
2396292|NCT01362192|5878539|P1|COMPLETED|Overall Study||16
2396293|NCT01362192|5878539|P1|STARTED|Overall Study||20
2396294|NCT01362140|5878551|P2|NOT COMPLETED|Overall Study||11
2396295|NCT01362140|5878552|P1|NOT COMPLETED|Overall Study||10
2396296|NCT01362140|5878551|P2|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|87
2396297|NCT01362140|5878552|P1|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|39
2396298|NCT01362140|5878551|P2|Received Treatment|Overall Study||97
2396299|NCT01362140|5878552|P1|Received Treatment|Overall Study||49
2396300|NCT01362140|5878551|P2|STARTED|Overall Study||98
2396301|NCT01362140|5878552|P1|STARTED|Overall Study||49
2396302|NCT01362062|5878576|P2|NOT COMPLETED|Overall Study||0
2396303|NCT01362062|5878577|P1|NOT COMPLETED|Overall Study||26
2396304|NCT01362062|5878576|P2|COMPLETED|Overall Study||62
2396305|NCT01362062|5878577|P1|COMPLETED|Overall Study||22
2396306|NCT01362062|5878576|P2|STARTED|Overall Study||62
2396307|NCT01362062|5878577|P1|STARTED|Overall Study||48
2396308|NCT01362049|5878598|P4|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
2396309|NCT01362049|5878599|P3|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||2
2396310|NCT01362049|5878600|P2|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
2396311|NCT01362049|5878601|P1|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||5
2396312|NCT01362049|5878598|P4|COMPLETED|Follow-Up at 52 Weeks (12 Months)||21
2396313|NCT01362049|5878599|P3|COMPLETED|Follow-Up at 52 Weeks (12 Months)||28
2396314|NCT01362049|5878600|P2|COMPLETED|Follow-Up at 52 Weeks (12 Months)||13
2396315|NCT01362049|5878601|P1|COMPLETED|Follow-Up at 52 Weeks (12 Months)||18
2396316|NCT01362049|5878598|P4|STARTED|Follow-Up at 52 Weeks (12 Months)||24
2396317|NCT01362049|5878599|P3|STARTED|Follow-Up at 52 Weeks (12 Months)||30
2396318|NCT01362049|5878600|P2|STARTED|Follow-Up at 52 Weeks (12 Months)||16
2396319|NCT01362049|5878601|P1|STARTED|Follow-Up at 52 Weeks (12 Months)||23
2396320|NCT01362049|5878598|P4|NOT COMPLETED|Follow-Up at 7 Weeks||1
2396321|NCT01362049|5878599|P3|NOT COMPLETED|Follow-Up at 7 Weeks||2
2396322|NCT01362049|5878600|P2|NOT COMPLETED|Follow-Up at 7 Weeks||3
2396323|NCT01362049|5878601|P1|NOT COMPLETED|Follow-Up at 7 Weeks||3
2396324|NCT01362049|5878598|P4|COMPLETED|Follow-Up at 7 Weeks||24
2396325|NCT01362049|5878599|P3|COMPLETED|Follow-Up at 7 Weeks||30
2396326|NCT01362049|5878600|P2|COMPLETED|Follow-Up at 7 Weeks||16
2396327|NCT01362049|5878601|P1|COMPLETED|Follow-Up at 7 Weeks||23
2396328|NCT01362049|5878598|P4|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||25
2396329|NCT01362049|5878599|P3|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||32
2396330|NCT01362049|5878600|P2|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||18
2396331|NCT01362049|5878601|P1|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||26
2396332|NCT01362049|5878598|P4|STARTED|Follow-Up at 7 Weeks||25
2396333|NCT01362049|5878599|P3|STARTED|Follow-Up at 7 Weeks||32
2396334|NCT01362049|5878600|P2|STARTED|Follow-Up at 7 Weeks||19
2396335|NCT01362049|5878601|P1|STARTED|Follow-Up at 7 Weeks||26
2396336|NCT01361919|5878642|P3|NOT COMPLETED|Overall Study||10
2396337|NCT01361919|5878643|P2|NOT COMPLETED|Overall Study||12
2396338|NCT01361919|5878644|P1|NOT COMPLETED|Overall Study||10
2396339|NCT01361919|5878642|P3|COMPLETED|Overall Study||88
2396340|NCT01361919|5878643|P2|COMPLETED|Overall Study||88
2396341|NCT01361919|5878644|P1|COMPLETED|Overall Study||90
2396342|NCT01361919|5878642|P3|STARTED|Overall Study||98
2396343|NCT01361919|5878643|P2|STARTED|Overall Study||100
2396344|NCT01361919|5878644|P1|STARTED|Overall Study||100
2396345|NCT01361867|5878658|P1|NOT COMPLETED|Overall Study||0
2396346|NCT01361867|5878658|P1|COMPLETED|Overall Study||15
2396347|NCT01361867|5878658|P1|STARTED|Overall Study||15
2396348|NCT01361854|5878663|P2|NOT COMPLETED|Second Intervention||0
2396349|NCT01361854|5878664|P1|NOT COMPLETED|Second Intervention||0
2396350|NCT01361854|5878663|P2|COMPLETED|Second Intervention||48
2396351|NCT01361854|5878664|P1|COMPLETED|Second Intervention||47
2396352|NCT01361854|5878663|P2|STARTED|Second Intervention||48
2396353|NCT01361854|5878664|P1|STARTED|Second Intervention||47
2396354|NCT01361854|5878663|P2|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
2396355|NCT01361854|5878664|P1|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
2396356|NCT01361854|5878663|P2|COMPLETED|Wash-out, Maximum 2 Weeks||48
2396357|NCT01361854|5878664|P1|COMPLETED|Wash-out, Maximum 2 Weeks||47
2396358|NCT01361854|5878663|P2|STARTED|Wash-out, Maximum 2 Weeks||48
2396359|NCT01361854|5878664|P1|STARTED|Wash-out, Maximum 2 Weeks||47
2396360|NCT01361854|5878663|P2|NOT COMPLETED|Day 1||3
2396361|NCT01361854|5878664|P1|NOT COMPLETED|Day 1||4
2396362|NCT01361854|5878663|P2|COMPLETED|Day 1||48
2396363|NCT01361854|5878664|P1|COMPLETED|Day 1||47
2396364|NCT01361854|5878663|P2|STARTED|Day 1||51
2396365|NCT01361854|5878664|P1|STARTED|Day 1||51
2396366|NCT01361633|5878672|P2|NOT COMPLETED|Overall Study||3
2396367|NCT01361633|5878673|P1|NOT COMPLETED|Overall Study||6
2396368|NCT01361633|5878672|P2|COMPLETED|Overall Study||23
2396369|NCT01361633|5878673|P1|COMPLETED|Overall Study||19
2396370|NCT01361633|5878672|P2|STARTED|Overall Study||26
2396371|NCT01361633|5878673|P1|STARTED|Overall Study||25
2396372|NCT01361620|5878679|P1|NOT COMPLETED|Overall Study||0
2396373|NCT01361620|5878679|P1|COMPLETED|Overall Study||132
2396374|NCT01361620|5878679|P1|STARTED|Overall Study||132
2396375|NCT01361607|5878685|P2|NOT COMPLETED|Overall Study||41
2396376|NCT01361607|5878686|P1|NOT COMPLETED|Overall Study||64
2396377|NCT01361607|5878685|P2|COMPLETED|Overall Study||158
2396378|NCT01361607|5878686|P1|COMPLETED|Overall Study||136
2396379|NCT01361607|5878685|P2|ITT Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as placebo-treated|199
2396380|NCT01361607|5878686|P1|ITT Population|Overall Study||198
2396381|NCT01361607|5878685|P2|Safety Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as nabiximols-treated|198
2396382|NCT01361607|5878686|P1|Safety Population|Overall Study|One participant randomized to nabiximols received placebo Day 22 but analyzed as nabiximols-treated|199
2396383|NCT01361607|5878685|P2|Received at Least 1 Dose of Study Drug|Overall Study||199
2396384|NCT01361607|5878686|P1|Received at Least 1 Dose of Study Drug|Overall Study||198
2396385|NCT01361607|5878685|P2|STARTED|Overall Study||199
2396386|NCT01361607|5878686|P1|STARTED|Overall Study|Two participants randomized to nabiximols did not receive any study drug|200
2396387|NCT01361594|5878714|P2|NOT COMPLETED|Overall Study||2
2396388|NCT01361594|5878715|P1|NOT COMPLETED|Overall Study||1
2396389|NCT01361594|5878714|P2|COMPLETED|Overall Study||151
2396390|NCT01361594|5878715|P1|COMPLETED|Overall Study||151
2396391|NCT01361594|5878714|P2|STARTED|Overall Study||153
2396392|NCT01361594|5878715|P1|STARTED|Overall Study||152
2396393|NCT01361568|5878729|P6|NOT COMPLETED|Overall Study||2
2396394|NCT01361568|5878730|P5|NOT COMPLETED|Overall Study||1
2396395|NCT01361568|5878731|P4|NOT COMPLETED|Overall Study||0
2396396|NCT01361568|5878732|P3|NOT COMPLETED|Overall Study||0
2396397|NCT01361568|5878733|P2|NOT COMPLETED|Overall Study||1
2396398|NCT01361568|5878734|P1|NOT COMPLETED|Overall Study||2
2396399|NCT01361568|5878729|P6|COMPLETED|Overall Study||11
2396400|NCT01361568|5878730|P5|COMPLETED|Overall Study||6
2396401|NCT01361568|5878731|P4|COMPLETED|Overall Study||21
2396402|NCT01361568|5878732|P3|COMPLETED|Overall Study||20
2396403|NCT01361568|5878733|P2|COMPLETED|Overall Study||70
2396404|NCT01361568|5878734|P1|COMPLETED|Overall Study||69
2396405|NCT01361568|5878729|P6|STARTED|Overall Study||13
2396406|NCT01361568|5878730|P5|STARTED|Overall Study||7
2396407|NCT01361568|5878731|P4|STARTED|Overall Study||21
2396408|NCT01361568|5878732|P3|STARTED|Overall Study||20
2396409|NCT01361568|5878733|P2|STARTED|Overall Study||71
2396410|NCT01361568|5878734|P1|STARTED|Overall Study||71
2396411|NCT01361464|5878764|P1|NOT COMPLETED|Overall Study||3
2396412|NCT01361464|5878764|P1|COMPLETED|Overall Study||18
2396413|NCT01361464|5878764|P1|STARTED|Overall Study||21
2396414|NCT01361308|5878773|P2|NOT COMPLETED|Overall Study||30
2396415|NCT01361308|5878774|P1|NOT COMPLETED|Overall Study||35
2396416|NCT01361308|5878773|P2|COMPLETED|Overall Study||278
2396417|NCT01361308|5878774|P1|COMPLETED|Overall Study||271
2396418|NCT01361308|5878773|P2|STARTED|Overall Study||308
2396419|NCT01361308|5878774|P1|STARTED|Overall Study||306
2396420|NCT01361217|5878814|P1|NOT COMPLETED|Overall Study||0
2396421|NCT01361217|5878814|P1|COMPLETED|Overall Study||10
2396422|NCT01361217|5878814|P1|STARTED|Overall Study||10
2396423|NCT01361178|5878822|P2|NOT COMPLETED|Overall Study||0
2396424|NCT01361178|5878823|P1|NOT COMPLETED|Overall Study||13
2396425|NCT01361178|5878822|P2|COMPLETED|Overall Study||11
2396426|NCT01361178|5878823|P1|COMPLETED|Overall Study||109
2396427|NCT01361178|5878822|P2|STARTED|Overall Study||11
2396428|NCT01361178|5878823|P1|STARTED|Overall Study||122
2396429|NCT01361126|5878831|P2|NOT COMPLETED|Overall Study||2
2396430|NCT01361126|5878832|P1|NOT COMPLETED|Overall Study||0
2396431|NCT01361126|5878831|P2|COMPLETED|Overall Study||2
2396432|NCT01361126|5878832|P1|COMPLETED|Overall Study||13
2396433|NCT01361126|5878831|P2|STARTED|Overall Study||4
2396434|NCT01361126|5878832|P1|STARTED|Overall Study||13
2396435|NCT01361113|5878847|P1|NOT COMPLETED|Overall Study||0
2396436|NCT01361113|5878847|P1|COMPLETED|Overall Study||21
2396437|NCT01361113|5878847|P1|STARTED|Overall Study||21
2396438|NCT01361048|5878858|P3|NOT COMPLETED|Overall Study||1
2396439|NCT01361048|5878859|P2|NOT COMPLETED|Overall Study||0
2396440|NCT01361048|5878860|P1|NOT COMPLETED|Overall Study||0
2396441|NCT01361048|5878858|P3|COMPLETED|Overall Study||9
2396442|NCT01361048|5878859|P2|COMPLETED|Overall Study||10
2396443|NCT01361048|5878860|P1|COMPLETED|Overall Study||20
2396444|NCT01361048|5878858|P3|STARTED|Overall Study||10
2396445|NCT01361048|5878859|P2|STARTED|Overall Study||10
2396446|NCT01361048|5878860|P1|STARTED|Overall Study||20
2396447|NCT01361009|5878871|P1|NOT COMPLETED|Overall Study||116
2396448|NCT01361009|5878871|P1|COMPLETED|Overall Study||1901
2396449|NCT01361009|5878871|P1|STARTED|Overall Study||2017
2396450|NCT01360996|5878881|P3|NOT COMPLETED|Overall Study||2
2396451|NCT01360996|5878882|P2|NOT COMPLETED|Overall Study||3
2396452|NCT01360996|5878883|P1|NOT COMPLETED|Overall Study||6
2396453|NCT01360996|5878881|P3|COMPLETED|Overall Study||21
2396454|NCT01360996|5878882|P2|COMPLETED|Overall Study||18
2396455|NCT01360996|5878883|P1|COMPLETED|Overall Study||14
2396456|NCT01360996|5878881|P3|STARTED|Overall Study||23
2396457|NCT01360996|5878882|P2|STARTED|Overall Study||21
2396458|NCT01360996|5878883|P1|STARTED|Overall Study||20
2396459|NCT01360866|5878906|P4|NOT COMPLETED|Overall Study||22
2396460|NCT01360866|5878907|P3|NOT COMPLETED|Overall Study||519
2396461|NCT01360866|5878908|P2|NOT COMPLETED|Overall Study||287
2396462|NCT01360866|5878909|P1|NOT COMPLETED|Overall Study||221
2396463|NCT01360866|5878906|P4|COMPLETED|Overall Study||54
2396464|NCT01360866|5878907|P3|COMPLETED|Overall Study||1126
2396465|NCT01360866|5878908|P2|COMPLETED|Overall Study||420
2396466|NCT01360866|5878909|P1|COMPLETED|Overall Study||295
2396467|NCT01360866|5878906|P4|STARTED|Overall Study||76
2396468|NCT01360866|5878907|P3|STARTED|Overall Study||1645
2396469|NCT01360866|5878908|P2|STARTED|Overall Study||707
2396470|NCT01360866|5878909|P1|STARTED|Overall Study||516
2396471|NCT01360840|5878938|P3|NOT COMPLETED|Overall Study||9
2396472|NCT01360840|5878939|P2|NOT COMPLETED|Overall Study||10
2396473|NCT01360840|5878940|P1|NOT COMPLETED|Overall Study||10
2396474|NCT01360840|5878938|P3|COMPLETED|Overall Study||51
2396475|NCT01360840|5878939|P2|COMPLETED|Overall Study||50
2396476|NCT01360840|5878940|P1|COMPLETED|Overall Study||50
2396477|NCT01360840|5878938|P3|STARTED|Overall Study||60
2396478|NCT01360840|5878939|P2|STARTED|Overall Study||60
2396479|NCT01360840|5878940|P1|STARTED|Overall Study||60
2396480|NCT01360762|5878990|P1|NOT COMPLETED|Whole Study Period||36
2396481|NCT01360762|5878990|P1|COMPLETED|Whole Study Period||38
2396482|NCT01360762|5878990|P1|STARTED|Whole Study Period||74
2396483|NCT01360762|5878990|P1|NOT COMPLETED|Main Study Period (12-month Treatment)||29
2396484|NCT01360762|5878990|P1|COMPLETED|Main Study Period (12-month Treatment)||45
2396485|NCT01360762|5878990|P1|STARTED|Main Study Period (12-month Treatment)||74
2396486|NCT01360645|5879000|P4|NOT COMPLETED|Phase A+||24
2396487|NCT01360645|5879001|P3|NOT COMPLETED|Phase A+||0
2396488|NCT01360645|5879002|P2|NOT COMPLETED|Phase A+||0
2396489|NCT01360645|5879003|P1|NOT COMPLETED|Phase A+||0
2396490|NCT01360645|5879000|P4|COMPLETED|Phase A+||307
2396491|NCT01360645|5879001|P3|COMPLETED|Phase A+||0
2396492|NCT01360645|5879002|P2|COMPLETED|Phase A+||0
2396493|NCT01360645|5879003|P1|COMPLETED|Phase A+||0
2396494|NCT01360645|5879000|P4|STARTED|Phase A+||331
2396495|NCT01360645|5879001|P3|STARTED|Phase A+||0
2396496|NCT01360645|5879002|P2|STARTED|Phase A+||0
2396497|NCT01360645|5879003|P1|STARTED|Phase A+||0
2396498|NCT01360645|5879000|P4|NOT COMPLETED|Phase B (6 Weeks)||0
2396499|NCT01360645|5879001|P3|NOT COMPLETED|Phase B (6 Weeks)||13
2396500|NCT01360645|5879002|P2|NOT COMPLETED|Phase B (6 Weeks)||14
2396501|NCT01360645|5879003|P1|NOT COMPLETED|Phase B (6 Weeks)||0
2396502|NCT01360645|5879000|P4|COMPLETED|Phase B (6 Weeks)||0
2396503|NCT01360645|5879001|P3|COMPLETED|Phase B (6 Weeks)||178
2396504|NCT01360645|5879002|P2|COMPLETED|Phase B (6 Weeks)||174
2396505|NCT01360645|5879003|P1|COMPLETED|Phase B (6 Weeks)||0
2396506|NCT01360645|5879000|P4|STARTED|Phase B (6 Weeks)||0
2396507|NCT01360645|5879001|P3|STARTED|Phase B (6 Weeks)||191
2396508|NCT01360645|5879002|P2|STARTED|Phase B (6 Weeks)||188
2396509|NCT01360645|5879003|P1|STARTED|Phase B (6 Weeks)||0
2396510|NCT01360645|5879000|P4|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
2396511|NCT01360645|5879001|P3|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
2396512|NCT01360645|5879002|P2|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
2396513|NCT01360645|5879003|P1|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||114
2396514|NCT01360645|5879000|P4|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
2396515|NCT01360645|5879001|P3|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
2396516|NCT01360645|5879002|P2|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
2396517|NCT01360645|5879003|P1|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||710
2396518|NCT01360645|5879000|P4|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
2396519|NCT01360645|5879001|P3|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
2396520|NCT01360645|5879002|P2|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
2396521|NCT01360645|5879003|P1|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)|826 participants were enrolled but 2 participants discontinued trial before taking study medication.|824
2396522|NCT01360632|5879058|P5|NOT COMPLETED|Phase A+||25
2396523|NCT01360632|5879059|P4|NOT COMPLETED|Phase A+||0
2396524|NCT01360632|5879060|P3|NOT COMPLETED|Phase A+||0
2396525|NCT01360632|5879061|P2|NOT COMPLETED|Phase A+||0
2396526|NCT01360632|5879062|P1|NOT COMPLETED|Phase A+||0
2396527|NCT01360632|5879058|P5|COMPLETED|Phase A+||575
2396528|NCT01360632|5879059|P4|COMPLETED|Phase A+||0
2396529|NCT01360632|5879060|P3|COMPLETED|Phase A+||0
2396530|NCT01360632|5879061|P2|COMPLETED|Phase A+||0
2396531|NCT01360632|5879062|P1|COMPLETED|Phase A+||0
2396532|NCT01360632|5879058|P5|STARTED|Phase A+||600
2396533|NCT01360632|5879059|P4|STARTED|Phase A+||0
2396534|NCT01360632|5879060|P3|STARTED|Phase A+||0
2396535|NCT01360632|5879061|P2|STARTED|Phase A+||0
2396536|NCT01360632|5879062|P1|STARTED|Phase A+||0
2396537|NCT01360632|5879058|P5|NOT COMPLETED|Phase B (6 Weeks)||0
2396538|NCT01360632|5879059|P4|NOT COMPLETED|Phase B (6 Weeks)||13
2396539|NCT01360632|5879060|P3|NOT COMPLETED|Phase B (6 Weeks)||20
2396540|NCT01360632|5879061|P2|NOT COMPLETED|Phase B (6 Weeks)||10
2396541|NCT01360632|5879062|P1|NOT COMPLETED|Phase B (6 Weeks)||0
2396542|NCT01360632|5879058|P5|COMPLETED|Phase B (6 Weeks)||0
2396543|NCT01360632|5879059|P4|COMPLETED|Phase B (6 Weeks)||208
2396544|NCT01360632|5879060|P3|COMPLETED|Phase B (6 Weeks)||210
2396545|NCT01360632|5879061|P2|COMPLETED|Phase B (6 Weeks)||216
2396546|NCT01360632|5879062|P1|COMPLETED|Phase B (6 Weeks)||0
2396547|NCT01360632|5879058|P5|STARTED|Phase B (6 Weeks)||0
2396548|NCT01360632|5879059|P4|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|221
2396549|NCT01360632|5879060|P3|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|230
2396550|NCT01360632|5879061|P2|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|226
2396551|NCT01360632|5879062|P1|STARTED|Phase B (6 Weeks)||0
2396552|NCT01360632|5879058|P5|NOT COMPLETED|Phase A (8 Weeks)||0
2396553|NCT01360632|5879059|P4|NOT COMPLETED|Phase A (8 Weeks)||0
2396554|NCT01360632|5879060|P3|NOT COMPLETED|Phase A (8 Weeks)||0
2396555|NCT01360632|5879061|P2|NOT COMPLETED|Phase A (8 Weeks)||0
2396556|NCT01360632|5879062|P1|NOT COMPLETED|Phase A (8 Weeks)||255
2396557|NCT01360632|5879058|P5|COMPLETED|Phase A (8 Weeks)||0
2396558|NCT01360632|5879059|P4|COMPLETED|Phase A (8 Weeks)||0
2396559|NCT01360632|5879060|P3|COMPLETED|Phase A (8 Weeks)||0
2396560|NCT01360632|5879061|P2|COMPLETED|Phase A (8 Weeks)||0
2396561|NCT01360632|5879062|P1|COMPLETED|Phase A (8 Weeks)||1277
2396562|NCT01360632|5879058|P5|STARTED|Phase A (8 Weeks)||0
2396563|NCT01360632|5879059|P4|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
2396564|NCT01360632|5879060|P3|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
2396565|NCT01360632|5879061|P2|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
2396566|NCT01360632|5879062|P1|STARTED|Phase A (8 Weeks)|A total of 1539 participants were enrolled, 7 discontinued before taking any sponsor-provided ADT|1532
2396567|NCT01360554|5879141|P2|NOT COMPLETED|Overall Study||439
2396568|NCT01360554|5879142|P1|NOT COMPLETED|Overall Study||439
2396569|NCT01360554|5879141|P2|COMPLETED|Overall Study||0
2396570|NCT01360554|5879142|P1|COMPLETED|Overall Study||0
2396571|NCT01360554|5879141|P2|Treated|Overall Study||436
2396572|NCT01360554|5879142|P1|Treated|Overall Study||436
2396573|NCT01360554|5879141|P2|STARTED|Overall Study|Three participants were randomized but not treated.|439
2396574|NCT01360554|5879142|P1|STARTED|Overall Study|Three participants were randomized but not treated.|439
2396575|NCT01360450|5879180|P2|NOT COMPLETED|Overall Study||0
2396576|NCT01360450|5879181|P1|NOT COMPLETED|Overall Study||0
2396577|NCT01360450|5879180|P2|COMPLETED|Overall Study||6
2396578|NCT01360450|5879181|P1|COMPLETED|Overall Study||6
2396579|NCT01360450|5879180|P2|Completed Treatment|Overall Study||6
2396580|NCT01360450|5879181|P1|Completed Treatment|Overall Study||6
2396581|NCT01360450|5879180|P2|STARTED|Overall Study||6
2396582|NCT01360450|5879181|P1|STARTED|Overall Study||6
2396583|NCT01360398|5879191|P1|NOT COMPLETED|Overall Study||22
2396584|NCT01360398|5879191|P1|COMPLETED|Overall Study||105
2396585|NCT01360398|5879191|P1|STARTED|Overall Study||127
2396586|NCT01360229|5879215|P2|NOT COMPLETED|Overall Study||2
2396587|NCT01360229|5879216|P1|NOT COMPLETED|Overall Study||3
2396588|NCT01360229|5879215|P2|COMPLETED|Overall Study||45
2396589|NCT01360229|5879216|P1|COMPLETED|Overall Study||44
2396590|NCT01360229|5879215|P2|STARTED|Overall Study||47
2396591|NCT01360229|5879216|P1|STARTED|Overall Study||47
2396592|NCT01360021|5879225|P3|NOT COMPLETED|Overall Study||7
2396593|NCT01360021|5879226|P2|NOT COMPLETED|Overall Study||4
2396594|NCT01360021|5879227|P1|NOT COMPLETED|Overall Study||8
2396595|NCT01360021|5879225|P3|COMPLETED|Overall Study|Patients who completed study|65
2396596|NCT01360021|5879226|P2|COMPLETED|Overall Study|Patients who completed study|67
2396597|NCT01360021|5879227|P1|COMPLETED|Overall Study|Patients who completed study|63
2396598|NCT01360021|5879225|P3|STARTED|Overall Study|Patients randomized|72
2396599|NCT01360021|5879226|P2|STARTED|Overall Study|Patients randomized|71
2396600|NCT01360021|5879227|P1|STARTED|Overall Study|Patients randomized|71
2396601|NCT01359943|5879253|P3|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
2396602|NCT01359943|5879254|P2|NOT COMPLETED|Follow-up (Weeks 52 - 60)||15
2396603|NCT01359943|5879255|P1|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
2396604|NCT01359943|5879253|P3|COMPLETED|Follow-up (Weeks 52 - 60)||36
2396605|NCT01359943|5879254|P2|COMPLETED|Follow-up (Weeks 52 - 60)||69
2396606|NCT01359943|5879255|P1|COMPLETED|Follow-up (Weeks 52 - 60)||78
2396607|NCT01359943|5879253|P3|STARTED|Follow-up (Weeks 52 - 60)||44
2396608|NCT01359943|5879254|P2|STARTED|Follow-up (Weeks 52 - 60)||84
2396609|NCT01359943|5879255|P1|STARTED|Follow-up (Weeks 52 - 60)||86
2396610|NCT01359943|5879253|P3|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
2396611|NCT01359943|5879254|P2|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||13
2396612|NCT01359943|5879255|P1|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
2396613|NCT01359943|5879253|P3|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||36
2396614|NCT01359943|5879254|P2|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||71
2396615|NCT01359943|5879255|P1|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||78
2396616|NCT01359943|5879253|P3|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||44
2396617|NCT01359943|5879254|P2|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)|One participant, who was continuing as of week 12, did not receive study drug at week 16.|84
2396618|NCT01359943|5879255|P1|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||86
2396619|NCT01359943|5879253|P3|NOT COMPLETED|Double-blind (Weeks 0 - 16)||0
2396620|NCT01359943|5879254|P2|NOT COMPLETED|Double-blind (Weeks 0 - 16)||4
2396621|NCT01359943|5879255|P1|NOT COMPLETED|Double-blind (Weeks 0 - 16)||2
2396622|NCT01359943|5879253|P3|COMPLETED|Double-blind (Weeks 0 - 16)||44
2396623|NCT01359943|5879254|P2|COMPLETED|Double-blind (Weeks 0 - 16)||85
2396624|NCT01359943|5879255|P1|COMPLETED|Double-blind (Weeks 0 - 16)||86
2396625|NCT01359943|5879253|P3|STARTED|Double-blind (Weeks 0 - 16)||44
2396626|NCT01359943|5879254|P2|STARTED|Double-blind (Weeks 0 - 16)||89
2396627|NCT01359943|5879255|P1|STARTED|Double-blind (Weeks 0 - 16)||88
2396628|NCT01359904|5879303|P2|NOT COMPLETED|Overall Study||0
2396629|NCT01359904|5879304|P1|NOT COMPLETED|Overall Study||1
2396630|NCT01359904|5879303|P2|COMPLETED|Overall Study||19
2396631|NCT01359904|5879304|P1|COMPLETED|Overall Study||14
2396632|NCT01359904|5879303|P2|STARTED|Overall Study||19
2396633|NCT01359904|5879304|P1|STARTED|Overall Study||15
2396634|NCT01359748|5879320|P4|NOT COMPLETED|Overall Study||0
2396635|NCT01359748|5879321|P3|NOT COMPLETED|Overall Study||0
2396636|NCT01359748|5879322|P2|NOT COMPLETED|Overall Study||0
2396637|NCT01359748|5879323|P1|NOT COMPLETED|Overall Study||0
2396638|NCT01359748|5879320|P4|COMPLETED|Overall Study||11
2396639|NCT01359748|5879321|P3|COMPLETED|Overall Study||10
2396640|NCT01359748|5879322|P2|COMPLETED|Overall Study||20
2396641|NCT01359748|5879323|P1|COMPLETED|Overall Study||48
2396642|NCT01359748|5879320|P4|STARTED|Overall Study||11
2396643|NCT01359748|5879321|P3|STARTED|Overall Study||10
2396644|NCT01359748|5879322|P2|STARTED|Overall Study||20
2396645|NCT01359748|5879323|P1|STARTED|Overall Study||48
2396646|NCT01359735|5879333|P2|NOT COMPLETED|Overall Study||0
2396647|NCT01359735|5879334|P1|NOT COMPLETED|Overall Study||0
2396648|NCT01359735|5879333|P2|COMPLETED|Overall Study||4
2396649|NCT01359735|5879334|P1|COMPLETED|Overall Study||4
2396650|NCT01359735|5879333|P2|STARTED|Overall Study||4
2396651|NCT01359735|5879334|P1|STARTED|Overall Study||4
2396652|NCT01359644|5879358|P10|NOT COMPLETED|Follow-up Period||0
2396653|NCT01359644|5879359|P9|NOT COMPLETED|Follow-up Period||0
2396654|NCT01359644|5879360|P8|NOT COMPLETED|Follow-up Period||2
2396655|NCT01359644|5879361|P7|NOT COMPLETED|Follow-up Period||1
2396656|NCT01359644|5879362|P6|NOT COMPLETED|Follow-up Period||1
2396657|NCT01359644|5879363|P5|NOT COMPLETED|Follow-up Period||0
2396658|NCT01359644|5879364|P4|NOT COMPLETED|Follow-up Period||0
2396659|NCT01359644|5879365|P3|NOT COMPLETED|Follow-up Period||0
2396660|NCT01359644|5879366|P2|NOT COMPLETED|Follow-up Period||0
2396661|NCT01359644|5879367|P1|NOT COMPLETED|Follow-up Period||0
2396662|NCT01359644|5879358|P10|COMPLETED|Follow-up Period||20
2396663|NCT01359644|5879359|P9|COMPLETED|Follow-up Period||21
2396664|NCT01359644|5879360|P8|COMPLETED|Follow-up Period||39
2396665|NCT01359644|5879361|P7|COMPLETED|Follow-up Period||40
2396666|NCT01359644|5879362|P6|COMPLETED|Follow-up Period||12
2396667|NCT01359644|5879363|P5|COMPLETED|Follow-up Period||15
2396668|NCT01359644|5879364|P4|COMPLETED|Follow-up Period||14
2396669|NCT01359644|5879365|P3|COMPLETED|Follow-up Period||14
2396670|NCT01359644|5879366|P2|COMPLETED|Follow-up Period||16
2396671|NCT01359644|5879367|P1|COMPLETED|Follow-up Period||15
2396672|NCT01359644|5879358|P10|STARTED|Follow-up Period||20
2396673|NCT01359644|5879359|P9|STARTED|Follow-up Period||21
2396674|NCT01359644|5879360|P8|STARTED|Follow-up Period||41
2396675|NCT01359644|5879361|P7|STARTED|Follow-up Period||41
2396676|NCT01359644|5879362|P6|STARTED|Follow-up Period||13
2396677|NCT01359644|5879363|P5|STARTED|Follow-up Period||15
2396678|NCT01359644|5879364|P4|STARTED|Follow-up Period||14
2396679|NCT01359644|5879365|P3|STARTED|Follow-up Period||14
2396680|NCT01359644|5879366|P2|STARTED|Follow-up Period||16
2396681|NCT01359644|5879367|P1|STARTED|Follow-up Period||15
2396682|NCT01359644|5879358|P10|NOT COMPLETED|Treatment Period||0
2396683|NCT01359644|5879359|P9|NOT COMPLETED|Treatment Period||0
2396684|NCT01359644|5879360|P8|NOT COMPLETED|Treatment Period||0
2396685|NCT01359644|5879361|P7|NOT COMPLETED|Treatment Period||0
2396686|NCT01359644|5879362|P6|NOT COMPLETED|Treatment Period||2
2396687|NCT01359644|5879363|P5|NOT COMPLETED|Treatment Period||0
2396688|NCT01359644|5879364|P4|NOT COMPLETED|Treatment Period||0
2396689|NCT01359644|5879365|P3|NOT COMPLETED|Treatment Period||1
2396690|NCT01359644|5879366|P2|NOT COMPLETED|Treatment Period||1
2396691|NCT01359644|5879367|P1|NOT COMPLETED|Treatment Period||0
2396692|NCT01359644|5879358|P10|COMPLETED|Treatment Period||20
2396693|NCT01359644|5879359|P9|COMPLETED|Treatment Period||21
2396694|NCT01359644|5879360|P8|COMPLETED|Treatment Period||41
2396695|NCT01359644|5879361|P7|COMPLETED|Treatment Period||41
2396696|NCT01359644|5879362|P6|COMPLETED|Treatment Period||12
2396697|NCT01359644|5879363|P5|COMPLETED|Treatment Period||15
2396698|NCT01359644|5879364|P4|COMPLETED|Treatment Period||14
2396699|NCT01359644|5879365|P3|COMPLETED|Treatment Period||13
2396700|NCT01359644|5879366|P2|COMPLETED|Treatment Period||15
2396701|NCT01359644|5879367|P1|COMPLETED|Treatment Period||15
2396702|NCT01359644|5879358|P10|STARTED|Treatment Period||20
2396703|NCT01359644|5879359|P9|STARTED|Treatment Period||21
2396704|NCT01359644|5879360|P8|STARTED|Treatment Period||41
2396705|NCT01359644|5879361|P7|STARTED|Treatment Period||41
2396706|NCT01359644|5879362|P6|STARTED|Treatment Period||14
2396707|NCT01359644|5879363|P5|STARTED|Treatment Period||15
2396708|NCT01359644|5879364|P4|STARTED|Treatment Period||14
2396709|NCT01359644|5879365|P3|STARTED|Treatment Period||14
2396710|NCT01359644|5879366|P2|STARTED|Treatment Period||16
2396711|NCT01359644|5879367|P1|STARTED|Treatment Period||15
2396712|NCT01359449|5879411|P2|NOT COMPLETED|Overall Study||4
2396713|NCT01359449|5879412|P1|NOT COMPLETED|Overall Study||4
2396714|NCT01359449|5879411|P2|COMPLETED|Overall Study||58
2396715|NCT01359449|5879412|P1|COMPLETED|Overall Study||57
2396716|NCT01359449|5879411|P2|STARTED|Overall Study||62
2396717|NCT01359449|5879412|P1|STARTED|Overall Study||61
2396718|NCT01359410|5879436|P2|NOT COMPLETED|Overall Study||0
2396719|NCT01359410|5879437|P1|NOT COMPLETED|Overall Study||0
2396720|NCT01359410|5879436|P2|COMPLETED|Overall Study||46
2396721|NCT01359410|5879437|P1|COMPLETED|Overall Study||54
2396722|NCT01359410|5879436|P2|STARTED|Overall Study||46
2396723|NCT01359410|5879437|P1|STARTED|Overall Study||54
2396724|NCT01359371|5879451|P1|NOT COMPLETED|Overall Study||0
2396725|NCT01359371|5879451|P1|COMPLETED|Overall Study||41
2396726|NCT01359371|5879451|P1|STARTED|Overall Study||41
2396727|NCT01359254|5879458|P2|NOT COMPLETED|Overall Study||0
2396728|NCT01359254|5879459|P1|NOT COMPLETED|Overall Study||1
2396729|NCT01359254|5879458|P2|COMPLETED|Overall Study||0
2396730|NCT01359254|5879459|P1|COMPLETED|Overall Study||0
2396731|NCT01359254|5879458|P2|STARTED|Overall Study||0
2396732|NCT01359254|5879459|P1|STARTED|Overall Study||1
2396733|NCT01359150|5879469|P2|NOT COMPLETED|Overall Study||5
2396734|NCT01359150|5879470|P1|NOT COMPLETED|Overall Study||7
2396735|NCT01359150|5879469|P2|COMPLETED|Overall Study||106
2396736|NCT01359150|5879470|P1|COMPLETED|Overall Study||105
2396737|NCT01359150|5879469|P2|STARTED|Overall Study||111
2396738|NCT01359150|5879470|P1|STARTED|Overall Study||112
2396739|NCT01359111|5879492|P1|NOT COMPLETED|Overall Study||0
2396740|NCT01359111|5879492|P1|COMPLETED|Overall Study||20
2396741|NCT01359111|5879492|P1|STARTED|Overall Study||20
2396742|NCT01359046|5879501|P2|NOT COMPLETED|Overall Study||17
2396743|NCT01359046|5879502|P1|NOT COMPLETED|Overall Study||7
2396744|NCT01359046|5879501|P2|COMPLETED|Overall Study||127
2396745|NCT01359046|5879502|P1|COMPLETED|Overall Study||137
2396746|NCT01359046|5879501|P2|STARTED|Overall Study||144
2396747|NCT01359046|5879502|P1|STARTED|Overall Study||144
2396748|NCT01359007|5879510|P1|NOT COMPLETED|Overall Study||2
2396749|NCT01359007|5879510|P1|COMPLETED|Overall Study||3
2396750|NCT01359007|5879510|P1|STARTED|Overall Study||5
2396751|NCT01358981|5879525|P7|NOT COMPLETED|Period 4||0
2396752|NCT01358981|5879526|P6|NOT COMPLETED|Period 4||0
2396753|NCT01358981|5879527|P5|NOT COMPLETED|Period 4||0
2396754|NCT01358981|5879528|P4|NOT COMPLETED|Period 4||0
2396755|NCT01358981|5879529|P3|NOT COMPLETED|Period 4||0
2396756|NCT01358981|5879530|P2|NOT COMPLETED|Period 4||0
2396757|NCT01358981|5879531|P1|NOT COMPLETED|Period 4||0
2396758|NCT01358981|5879525|P7|COMPLETED|Period 4||0
2396759|NCT01358981|5879526|P6|COMPLETED|Period 4||0
2396760|NCT01358981|5879527|P5|COMPLETED|Period 4||0
2396761|NCT01358981|5879528|P4|COMPLETED|Period 4||2
2396762|NCT01358981|5879529|P3|COMPLETED|Period 4||2
2396763|NCT01358981|5879530|P2|COMPLETED|Period 4||2
2396764|NCT01358981|5879531|P1|COMPLETED|Period 4||2
2396765|NCT01358981|5879525|P7|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
2396766|NCT01358981|5879526|P6|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
2396767|NCT01358981|5879527|P5|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
2396768|NCT01358981|5879528|P4|STARTED|Period 4||2
2396769|NCT01358981|5879529|P3|STARTED|Period 4||2
2396770|NCT01358981|5879530|P2|STARTED|Period 4||2
2396771|NCT01358981|5879531|P1|STARTED|Period 4||2
2396772|NCT01358981|5879525|P7|NOT COMPLETED|Period 3||0
2396773|NCT01358981|5879526|P6|NOT COMPLETED|Period 3||0
2396774|NCT01358981|5879527|P5|NOT COMPLETED|Period 3||0
2396775|NCT01358981|5879528|P4|NOT COMPLETED|Period 3||0
2396776|NCT01358981|5879529|P3|NOT COMPLETED|Period 3||0
2396777|NCT01358981|5879530|P2|NOT COMPLETED|Period 3||0
2396778|NCT01358981|5879531|P1|NOT COMPLETED|Period 3||0
2396779|NCT01358981|5879525|P7|COMPLETED|Period 3||3
2396780|NCT01358981|5879526|P6|COMPLETED|Period 3||3
2396781|NCT01358981|5879527|P5|COMPLETED|Period 3||3
2396782|NCT01358981|5879528|P4|COMPLETED|Period 3||2
2396783|NCT01358981|5879529|P3|COMPLETED|Period 3||2
2396784|NCT01358981|5879530|P2|COMPLETED|Period 3||2
2396785|NCT01358981|5879531|P1|COMPLETED|Period 3||2
2396786|NCT01358981|5879525|P7|STARTED|Period 3||3
2396787|NCT01358981|5879526|P6|STARTED|Period 3||3
2396788|NCT01358981|5879527|P5|STARTED|Period 3||3
2396789|NCT01358981|5879528|P4|STARTED|Period 3||2
2396790|NCT01358981|5879529|P3|STARTED|Period 3||2
2396791|NCT01358981|5879530|P2|STARTED|Period 3||2
2396792|NCT01358981|5879531|P1|STARTED|Period 3||2
2396793|NCT01358981|5879525|P7|NOT COMPLETED|Period 2||0
2396794|NCT01358981|5879526|P6|NOT COMPLETED|Period 2||0
2396795|NCT01358981|5879527|P5|NOT COMPLETED|Period 2||0
2396796|NCT01358981|5879528|P4|NOT COMPLETED|Period 2||0
2396797|NCT01358981|5879529|P3|NOT COMPLETED|Period 2||0
2396798|NCT01358981|5879530|P2|NOT COMPLETED|Period 2||0
2396799|NCT01358981|5879531|P1|NOT COMPLETED|Period 2||0
2396800|NCT01358981|5879525|P7|COMPLETED|Period 2||3
2396801|NCT01358981|5879526|P6|COMPLETED|Period 2||3
2396802|NCT01358981|5879527|P5|COMPLETED|Period 2||3
2396803|NCT01358981|5879528|P4|COMPLETED|Period 2||2
2396804|NCT01358981|5879529|P3|COMPLETED|Period 2||2
2396805|NCT01358981|5879530|P2|COMPLETED|Period 2||2
2396806|NCT01358981|5879531|P1|COMPLETED|Period 2||2
2396807|NCT01358981|5879525|P7|STARTED|Period 2||3
2396808|NCT01358981|5879526|P6|STARTED|Period 2||3
2396809|NCT01358981|5879527|P5|STARTED|Period 2||3
2396810|NCT01358981|5879528|P4|STARTED|Period 2|One participant who withdrew in period 1 was replaced by another participant in period 2.|2
2396811|NCT01358981|5879529|P3|STARTED|Period 2||2
2396812|NCT01358981|5879530|P2|STARTED|Period 2||2
2396813|NCT01358981|5879531|P1|STARTED|Period 2||2
2396814|NCT01358981|5879525|P7|NOT COMPLETED|Period 1||0
2396815|NCT01358981|5879526|P6|NOT COMPLETED|Period 1||0
2396816|NCT01358981|5879527|P5|NOT COMPLETED|Period 1||0
2396817|NCT01358981|5879528|P4|NOT COMPLETED|Period 1||1
2396818|NCT01358981|5879529|P3|NOT COMPLETED|Period 1||0
2396819|NCT01358981|5879530|P2|NOT COMPLETED|Period 1||0
2396820|NCT01358981|5879531|P1|NOT COMPLETED|Period 1||0
2396821|NCT01358981|5879525|P7|COMPLETED|Period 1||3
2396822|NCT01358981|5879526|P6|COMPLETED|Period 1||3
2396823|NCT01358981|5879527|P5|COMPLETED|Period 1||3
2396824|NCT01358981|5879528|P4|COMPLETED|Period 1||1
2396825|NCT01358981|5879529|P3|COMPLETED|Period 1||2
2396826|NCT01358981|5879530|P2|COMPLETED|Period 1||2
2396827|NCT01358981|5879531|P1|COMPLETED|Period 1||2
2396828|NCT01358981|5879525|P7|Received at Least 1dose of Study Drug|Period 1||3
2396829|NCT01358981|5879526|P6|Received at Least 1dose of Study Drug|Period 1||3
2396830|NCT01358981|5879527|P5|Received at Least 1dose of Study Drug|Period 1||3
2396831|NCT01358981|5879528|P4|Received at Least 1dose of Study Drug|Period 1||2
2396832|NCT01358981|5879529|P3|Received at Least 1dose of Study Drug|Period 1||2
2396833|NCT01358981|5879530|P2|Received at Least 1dose of Study Drug|Period 1||2
2396834|NCT01358981|5879531|P1|Received at Least 1dose of Study Drug|Period 1||2
2396835|NCT01358981|5879525|P7|STARTED|Period 1||3
2396836|NCT01358981|5879526|P6|STARTED|Period 1||3
2396837|NCT01358981|5879527|P5|STARTED|Period 1||3
2396838|NCT01358981|5879528|P4|STARTED|Period 1||2
2396839|NCT01358981|5879529|P3|STARTED|Period 1||2
2396840|NCT01358981|5879530|P2|STARTED|Period 1||2
2396841|NCT01358981|5879531|P1|STARTED|Period 1||2
2396842|NCT01358968|5879592|P4|NOT COMPLETED|Continued Access Phase||7
2396843|NCT01358968|5879593|P3|NOT COMPLETED|Continued Access Phase||12
2396844|NCT01358968|5879594|P2|NOT COMPLETED|Continued Access Phase||0
2396845|NCT01358968|5879595|P1|NOT COMPLETED|Continued Access Phase||0
2396846|NCT01358968|5879592|P4|COMPLETED|Continued Access Phase||0
2396847|NCT01358968|5879593|P3|COMPLETED|Continued Access Phase||0
2396848|NCT01358968|5879594|P2|COMPLETED|Continued Access Phase||0
2396849|NCT01358968|5879595|P1|COMPLETED|Continued Access Phase||0
2396850|NCT01358968|5879592|P4|Received at Least 1 Dose of Study Drug|Continued Access Phase||7
2396851|NCT01358968|5879593|P3|Received at Least 1 Dose of Study Drug|Continued Access Phase||12
2396852|NCT01358968|5879594|P2|Received at Least 1 Dose of Study Drug|Continued Access Phase||0
2396853|NCT01358968|5879595|P1|Received at Least 1 Dose of Study Drug|Continued Access Phase||0
2396854|NCT01358968|5879592|P4|STARTED|Continued Access Phase||7
2396855|NCT01358968|5879593|P3|STARTED|Continued Access Phase||12
2396856|NCT01358968|5879594|P2|STARTED|Continued Access Phase||0
2396857|NCT01358968|5879595|P1|STARTED|Continued Access Phase||0
2396858|NCT01358968|5879592|P4|NOT COMPLETED|Period 2||0
2396859|NCT01358968|5879593|P3|NOT COMPLETED|Period 2||0
2396860|NCT01358968|5879594|P2|NOT COMPLETED|Period 2||1
2396861|NCT01358968|5879595|P1|NOT COMPLETED|Period 2||0
2396862|NCT01358968|5879592|P4|COMPLETED|Period 2||0
2396863|NCT01358968|5879593|P3|COMPLETED|Period 2||0
2396864|NCT01358968|5879594|P2|COMPLETED|Period 2||19
2396865|NCT01358968|5879595|P1|COMPLETED|Period 2||0
2396866|NCT01358968|5879592|P4|Received at Least 1 Dose of Study Drug|Period 2||0
2396867|NCT01358968|5879593|P3|Received at Least 1 Dose of Study Drug|Period 2||0
2396868|NCT01358968|5879594|P2|Received at Least 1 Dose of Study Drug|Period 2||19
2396869|NCT01358968|5879595|P1|Received at Least 1 Dose of Study Drug|Period 2||0
2396870|NCT01358968|5879592|P4|STARTED|Period 2||0
2396871|NCT01358968|5879593|P3|STARTED|Period 2||0
2396872|NCT01358968|5879594|P2|STARTED|Period 2||20
2396873|NCT01358968|5879595|P1|STARTED|Period 2||0
2396874|NCT01358968|5879592|P4|NOT COMPLETED|Period 1||0
2396875|NCT01358968|5879593|P3|NOT COMPLETED|Period 1||0
2396876|NCT01358968|5879594|P2|NOT COMPLETED|Period 1||0
2396877|NCT01358968|5879595|P1|NOT COMPLETED|Period 1||0
2396878|NCT01358968|5879592|P4|COMPLETED|Period 1||0
2396879|NCT01358968|5879593|P3|COMPLETED|Period 1||0
2396880|NCT01358968|5879594|P2|COMPLETED|Period 1||0
2396881|NCT01358968|5879595|P1|COMPLETED|Period 1||20
2396882|NCT01358968|5879592|P4|Received at Least 1 Dose of Study Drug|Period 1||0
2396883|NCT01358968|5879593|P3|Received at Least 1 Dose of Study Drug|Period 1||0
2396884|NCT01358968|5879594|P2|Received at Least 1 Dose of Study Drug|Period 1||0
2396885|NCT01358968|5879595|P1|Received at Least 1 Dose of Study Drug|Period 1||20
2396886|NCT01358968|5879592|P4|STARTED|Period 1||0
2396887|NCT01358968|5879593|P3|STARTED|Period 1||0
2396888|NCT01358968|5879594|P2|STARTED|Period 1||0
2396889|NCT01358968|5879595|P1|STARTED|Period 1||20
2396890|NCT01358877|5879611|P2|NOT COMPLETED|Overall Study||2404
2396891|NCT01358877|5879612|P1|NOT COMPLETED|Overall Study||2400
2396892|NCT01358877|5879611|P2|COMPLETED|Overall Study||0
2396893|NCT01358877|5879612|P1|COMPLETED|Overall Study||0
2396894|NCT01358877|5879611|P2|Received Study Drug (Safety Population)|Overall Study|38 pertuzumab participants did not receive pertuzumab and were included in placebo arm.|2405
2396895|NCT01358877|5879612|P1|Received Study Drug (Safety Population)|Overall Study|24 placebo participants received at least 1 dose of pertuzumab and were included in pertuzumab arm.|2364
2396896|NCT01358877|5879611|P2|Did Not Receive Study Drug|Overall Study||13
2396897|NCT01358877|5879612|P1|Did Not Receive Study Drug|Overall Study||22
2396898|NCT01358877|5879611|P2|STARTED|Overall Study||2404
2396899|NCT01358877|5879612|P1|STARTED|Overall Study||2400
2396900|NCT01358864|5879682|P8|NOT COMPLETED|Overall Study||55
2396901|NCT01358864|5879683|P7|NOT COMPLETED|Overall Study||65
2396902|NCT01358864|5879684|P6|NOT COMPLETED|Overall Study||13
2396903|NCT01358864|5879685|P5|NOT COMPLETED|Overall Study||11
2396904|NCT01358864|5879686|P4|NOT COMPLETED|Overall Study||19
2396905|NCT01358864|5879687|P3|NOT COMPLETED|Overall Study||16
2396906|NCT01358864|5879688|P2|NOT COMPLETED|Overall Study||13
2396907|NCT01358864|5879689|P1|NOT COMPLETED|Overall Study||31
2396908|NCT01358864|5879682|P8|COMPLETED|Overall Study||85
2396909|NCT01358864|5879683|P7|COMPLETED|Overall Study||81
2396910|NCT01358864|5879684|P6|COMPLETED|Overall Study||42
2396911|NCT01358864|5879685|P5|COMPLETED|Overall Study||46
2396912|NCT01358864|5879686|P4|COMPLETED|Overall Study||10
2396913|NCT01358864|5879687|P3|COMPLETED|Overall Study||87
2396914|NCT01358864|5879688|P2|COMPLETED|Overall Study||86
2396915|NCT01358864|5879689|P1|COMPLETED|Overall Study||18
2396916|NCT01358864|5879682|P8|STARTED|Overall Study||140
2396917|NCT01358864|5879683|P7|STARTED|Overall Study||146
2396918|NCT01358864|5879684|P6|STARTED|Overall Study||55
2396919|NCT01358864|5879685|P5|STARTED|Overall Study||57
2396920|NCT01358864|5879686|P4|STARTED|Overall Study||29
2396921|NCT01358864|5879687|P3|STARTED|Overall Study||103
2396922|NCT01358864|5879688|P2|STARTED|Overall Study||99
2396923|NCT01358864|5879689|P1|STARTED|Overall Study||49
2396924|NCT01358825|5879780|P2|NOT COMPLETED|Overall Study||1
2396925|NCT01358825|5879781|P1|NOT COMPLETED|Overall Study||0
2396926|NCT01358825|5879780|P2|COMPLETED|Overall Study||45
2396927|NCT01358825|5879781|P1|COMPLETED|Overall Study||12
2396928|NCT01358825|5879780|P2|STARTED|Overall Study||46
2396929|NCT01358825|5879781|P1|STARTED|Overall Study||12
2396930|NCT01358760|5879805|P3|NOT COMPLETED|Overall Study||25
2396931|NCT01358760|5879806|P2|NOT COMPLETED|Overall Study||20
2396932|NCT01358760|5879807|P1|NOT COMPLETED|Overall Study||22
2396933|NCT01358760|5879805|P3|COMPLETED|Overall Study||125
2396934|NCT01358760|5879806|P2|COMPLETED|Overall Study||128
2396935|NCT01358760|5879807|P1|COMPLETED|Overall Study||130
2396936|NCT01358760|5879805|P3|ITT Population|Overall Study||134
2396937|NCT01358760|5879806|P2|ITT Population|Overall Study||134
2396938|NCT01358760|5879807|P1|ITT Population|Overall Study||139
2396939|NCT01358760|5879805|P3|Safety Population|Overall Study||148
2396940|NCT01358760|5879806|P2|Safety Population|Overall Study||143
2396941|NCT01358760|5879807|P1|Safety Population|Overall Study||150
2396942|NCT01358760|5879805|P3|STARTED|Overall Study||150
2396943|NCT01358760|5879806|P2|STARTED|Overall Study||148
2396944|NCT01358760|5879807|P1|STARTED|Overall Study||152
2396945|NCT01358734|5879842|P3|NOT COMPLETED|Overall Study||34
2396946|NCT01358734|5879843|P2|NOT COMPLETED|Overall Study||39
2396947|NCT01358734|5879844|P1|NOT COMPLETED|Overall Study||15
2396948|NCT01358734|5879842|P3|COMPLETED|Overall Study||0
2396949|NCT01358734|5879843|P2|COMPLETED|Overall Study||0
2396950|NCT01358734|5879844|P1|COMPLETED|Overall Study||0
2396951|NCT01358734|5879842|P3|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|32
2396952|NCT01358734|5879843|P2|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|38
2396953|NCT01358734|5879844|P1|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|14
2396954|NCT01358734|5879842|P3|STARTED|Overall Study||34
2396955|NCT01358734|5879843|P2|STARTED|Overall Study||39
2396956|NCT01358734|5879844|P1|STARTED|Overall Study||15
2396957|NCT01358721|5879892|P4|NOT COMPLETED|Overall Study||24
2396958|NCT01358721|5879893|P3|NOT COMPLETED|Overall Study||22
2396959|NCT01358721|5879894|P2|NOT COMPLETED|Overall Study||22
2396960|NCT01358721|5879895|P1|NOT COMPLETED|Overall Study||21
2396961|NCT01358721|5879892|P4|COMPLETED|Overall Study||0
2396962|NCT01358721|5879893|P3|COMPLETED|Overall Study||1
2396963|NCT01358721|5879894|P2|COMPLETED|Overall Study||0
2396964|NCT01358721|5879895|P1|COMPLETED|Overall Study||1
2396965|NCT01358721|5879892|P4|STARTED|Overall Study||24
2396966|NCT01358721|5879893|P3|STARTED|Overall Study||23
2396967|NCT01358721|5879894|P2|STARTED|Overall Study||22
2396968|NCT01358721|5879895|P1|STARTED|Overall Study||22
2396969|NCT01358708|5879947|P2|NOT COMPLETED|Open-Label Treatment Phase||0
2396970|NCT01358708|5879948|P1|NOT COMPLETED|Open-Label Treatment Phase||0
2396971|NCT01358708|5879947|P2|COMPLETED|Open-Label Treatment Phase||12
2396972|NCT01358708|5879948|P1|COMPLETED|Open-Label Treatment Phase||5
2396973|NCT01358708|5879947|P2|STARTED|Open-Label Treatment Phase|Number of subjects on PLACEBO during double-blind treatment and entering the Open-Label Phase|12
2396974|NCT01358708|5879948|P1|STARTED|Open-Label Treatment Phase|Number of subjects on LACTEOL® during double-blind treatment and entering the Open-Label Phase|5
2396975|NCT01358708|5879947|P2|NOT COMPLETED|Double-Blind Treatment Phase||0
2396976|NCT01358708|5879948|P1|NOT COMPLETED|Double-Blind Treatment Phase||3
2396977|NCT01358708|5879947|P2|COMPLETED|Double-Blind Treatment Phase||13
2396978|NCT01358708|5879948|P1|COMPLETED|Double-Blind Treatment Phase||10
2396979|NCT01358708|5879947|P2|Received Study Medication|Double-Blind Treatment Phase||13
2396980|NCT01358708|5879948|P1|Received Study Medication|Double-Blind Treatment Phase|For 1 subject, unused med not returned to the site and intake of study medication not confirmed.|12
2396981|NCT01358708|5879947|P2|Randomized|Double-Blind Treatment Phase||13
2396982|NCT01358708|5879948|P1|Randomized|Double-Blind Treatment Phase||13
2396983|NCT01358708|5879947|P2|STARTED|Double-Blind Treatment Phase||13
2396984|NCT01358708|5879948|P1|STARTED|Double-Blind Treatment Phase||13
2396985|NCT01358578|5879971|P6|NOT COMPLETED|Follow-up Period||0
2396986|NCT01358578|5879972|P5|NOT COMPLETED|Follow-up Period||0
2396987|NCT01358578|5879973|P4|NOT COMPLETED|Follow-up Period||19
2396988|NCT01358578|5879974|P3|NOT COMPLETED|Follow-up Period||5
2396989|NCT01358578|5879975|P2|NOT COMPLETED|Follow-up Period||6
2396990|NCT01358578|5879976|P1|NOT COMPLETED|Follow-up Period||10
2396991|NCT01358578|5879971|P6|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
2396992|NCT01358578|5879972|P5|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
2396993|NCT01358578|5879973|P4|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|260
2396994|NCT01358578|5879974|P3|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|21
2396995|NCT01358578|5879975|P2|COMPLETED|Follow-up Period||119
2396996|NCT01358578|5879976|P1|COMPLETED|Follow-up Period||138
2396997|NCT01358578|5879971|P6|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
2396998|NCT01358578|5879972|P5|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
2396999|NCT01358578|5879973|P4|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|279
2397000|NCT01358578|5879974|P3|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|26
2397001|NCT01358578|5879975|P2|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 300 mg dose|125
2397002|NCT01358578|5879976|P1|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 150 mg dose|148
2397003|NCT01358578|5879971|P6|NOT COMPLETED|Maintenance Period||11
2397004|NCT01358578|5879972|P5|NOT COMPLETED|Maintenance Period||17
2397005|NCT01358578|5879973|P4|NOT COMPLETED|Maintenance Period||42
2397006|NCT01358578|5879974|P3|NOT COMPLETED|Maintenance Period||2
2397007|NCT01358578|5879975|P2|NOT COMPLETED|Maintenance Period||22
2397008|NCT01358578|5879976|P1|NOT COMPLETED|Maintenance Period||39
2397009|NCT01358578|5879971|P6|COMPLETED|Maintenance Period||131
2397010|NCT01358578|5879972|P5|COMPLETED|Maintenance Period||125
2397011|NCT01358578|5879973|P4|COMPLETED|Maintenance Period||263
2397012|NCT01358578|5879974|P3|COMPLETED|Maintenance Period||15
2397013|NCT01358578|5879975|P2|COMPLETED|Maintenance Period||290
2397014|NCT01358578|5879976|P1|COMPLETED|Maintenance Period||276
2397015|NCT01358578|5879971|P6|STARTED|Maintenance Period||142
2397016|NCT01358578|5879972|P5|STARTED|Maintenance Period||142
2397017|NCT01358578|5879973|P4|STARTED|Maintenance Period||305
2397018|NCT01358578|5879974|P3|STARTED|Maintenance Period||17
2397019|NCT01358578|5879975|P2|STARTED|Maintenance Period||312
2397020|NCT01358578|5879976|P1|STARTED|Maintenance Period||315
2397021|NCT01358578|5879971|P6|NOT COMPLETED|Induction Period||0
2397022|NCT01358578|5879972|P5|NOT COMPLETED|Induction Period||0
2397023|NCT01358578|5879973|P4|NOT COMPLETED|Induction Period||21
2397024|NCT01358578|5879974|P3|NOT COMPLETED|Induction Period||25
2397025|NCT01358578|5879975|P2|NOT COMPLETED|Induction Period||15
2397026|NCT01358578|5879976|P1|NOT COMPLETED|Induction Period||12
2397027|NCT01358578|5879971|P6|COMPLETED|Induction Period|These groups are populated after the induction period|0
2397028|NCT01358578|5879972|P5|COMPLETED|Induction Period|These groups are populated after the induction period|0
2397029|NCT01358578|5879973|P4|COMPLETED|Induction Period||305
2397030|NCT01358578|5879974|P3|COMPLETED|Induction Period||301
2397031|NCT01358578|5879975|P2|COMPLETED|Induction Period||312
2397032|NCT01358578|5879976|P1|COMPLETED|Induction Period||315
2397033|NCT01358578|5879971|P6|STARTED|Induction Period|These groups are populated after the induction period|0
2397034|NCT01358578|5879972|P5|STARTED|Induction Period|These groups are populated after the induction period|0
2397035|NCT01358578|5879973|P4|STARTED|Induction Period||326
2397036|NCT01358578|5879974|P3|STARTED|Induction Period||326
2397037|NCT01358578|5879975|P2|STARTED|Induction Period||327
2397038|NCT01358578|5879976|P1|STARTED|Induction Period||327
2397039|NCT01358526|5880028|P3|NOT COMPLETED|Double-blind Phase||121
2397040|NCT01358526|5880029|P2|NOT COMPLETED|Double-blind Phase||80
2397041|NCT01358526|5880030|P1|NOT COMPLETED|Double-blind Phase||0
2397042|NCT01358526|5880028|P3|COMPLETED|Double-blind Phase||181
2397043|NCT01358526|5880029|P2|COMPLETED|Double-blind Phase||218
2397044|NCT01358526|5880030|P1|COMPLETED|Double-blind Phase||0
2397045|NCT01358526|5880028|P3|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|302
2397046|NCT01358526|5880029|P2|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|298
2397047|NCT01358526|5880030|P1|STARTED|Double-blind Phase||0
2397048|NCT01358526|5880028|P3|NOT COMPLETED|Open-label Titration Period||0
2397049|NCT01358526|5880029|P2|NOT COMPLETED|Open-label Titration Period||0
2397050|NCT01358526|5880030|P1|NOT COMPLETED|Open-label Titration Period||494
2397051|NCT01358526|5880028|P3|COMPLETED|Open-label Titration Period||0
2397052|NCT01358526|5880029|P2|COMPLETED|Open-label Titration Period||0
2397053|NCT01358526|5880030|P1|COMPLETED|Open-label Titration Period|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|601
2397054|NCT01358526|5880028|P3|STARTED|Open-label Titration Period||0
2397055|NCT01358526|5880029|P2|STARTED|Open-label Titration Period||0
2397056|NCT01358526|5880030|P1|STARTED|Open-label Titration Period||1095
2397057|NCT01358357|5880047|P3|NOT COMPLETED|Double-Blind Phase||0
2397058|NCT01358357|5880048|P2|NOT COMPLETED|Double-Blind Phase||100
2397059|NCT01358357|5880049|P1|NOT COMPLETED|Double-Blind Phase||80
2397060|NCT01358357|5880047|P3|COMPLETED|Double-Blind Phase||0
2397061|NCT01358357|5880048|P2|COMPLETED|Double-Blind Phase||150
2397062|NCT01358357|5880049|P1|COMPLETED|Double-Blind Phase||166
2397063|NCT01358357|5880047|P3|STARTED|Double-Blind Phase||0
2397064|NCT01358357|5880048|P2|STARTED|Double-Blind Phase||250
2397065|NCT01358357|5880049|P1|STARTED|Double-Blind Phase||246
2397066|NCT01358357|5880047|P3|NOT COMPLETED|Open Label Phase||462
2397067|NCT01358357|5880048|P2|NOT COMPLETED|Open Label Phase||0
2397068|NCT01358357|5880049|P1|NOT COMPLETED|Open Label Phase||0
2397069|NCT01358357|5880047|P3|COMPLETED|Open Label Phase||503
2397070|NCT01358357|5880048|P2|COMPLETED|Open Label Phase||0
2397071|NCT01358357|5880049|P1|COMPLETED|Open Label Phase||0
2397072|NCT01358357|5880047|P3|STARTED|Open Label Phase||965
2397073|NCT01358357|5880048|P2|STARTED|Open Label Phase||0
2397074|NCT01358357|5880049|P1|STARTED|Open Label Phase||0
2397075|NCT01358266|5880085|P3|NOT COMPLETED|Open-Label Period||70
2397076|NCT01358266|5880086|P2|NOT COMPLETED|Open-Label Period||44
2397077|NCT01358266|5880087|P1|NOT COMPLETED|Open-Label Period||56
2397078|NCT01358266|5880085|P3|COMPLETED|Open-Label Period||44
2397079|NCT01358266|5880086|P2|COMPLETED|Open-Label Period||58
2397080|NCT01358266|5880087|P1|COMPLETED|Open-Label Period||63
2397081|NCT01358266|5880085|P3|STARTED|Open-Label Period||114
2397082|NCT01358266|5880086|P2|STARTED|Open-Label Period||102
2397083|NCT01358266|5880087|P1|STARTED|Open-Label Period||119
2397084|NCT01358266|5880085|P3|NOT COMPLETED|Double-Masked Period||39
2397085|NCT01358266|5880086|P2|NOT COMPLETED|Double-Masked Period||46
2397086|NCT01358266|5880087|P1|NOT COMPLETED|Double-Masked Period||33
2397087|NCT01358266|5880085|P3|COMPLETED|Double-Masked Period||137
2397088|NCT01358266|5880086|P2|COMPLETED|Double-Masked Period||162
2397089|NCT01358266|5880087|P1|COMPLETED|Double-Masked Period||175
2397090|NCT01358266|5880085|P3|STARTED|Double-Masked Period||176
2397091|NCT01358266|5880086|P2|STARTED|Double-Masked Period||208
2397092|NCT01358266|5880087|P1|STARTED|Double-Masked Period||208
2397093|NCT01358175|5880114|P3|NOT COMPLETED|Overall Study||32
2397094|NCT01358175|5880115|P2|NOT COMPLETED|Overall Study||28
2397095|NCT01358175|5880116|P1|NOT COMPLETED|Overall Study||21
2397096|NCT01358175|5880114|P3|COMPLETED|Overall Study||90
2397097|NCT01358175|5880115|P2|COMPLETED|Overall Study||97
2397098|NCT01358175|5880116|P1|COMPLETED|Overall Study||103
2397099|NCT01358175|5880114|P3|STARTED|Overall Study||122
2397100|NCT01358175|5880115|P2|STARTED|Overall Study||125
2397101|NCT01358175|5880116|P1|STARTED|Overall Study||124
2397102|NCT01357980|5880153|P4|NOT COMPLETED|Overall Study||0
2397103|NCT01357980|5880154|P3|NOT COMPLETED|Overall Study||1
2397104|NCT01357980|5880155|P2|NOT COMPLETED|Overall Study||1
2397105|NCT01357980|5880156|P1|NOT COMPLETED|Overall Study||0
2397106|NCT01357980|5880153|P4|COMPLETED|Overall Study||7
2397107|NCT01357980|5880154|P3|COMPLETED|Overall Study||16
2397108|NCT01357980|5880155|P2|COMPLETED|Overall Study||6
2397109|NCT01357980|5880156|P1|COMPLETED|Overall Study||16
2397110|NCT01357980|5880153|P4|STARTED|Overall Study||7
2397111|NCT01357980|5880154|P3|STARTED|Overall Study||17
2397112|NCT01357980|5880155|P2|STARTED|Overall Study||7
2397113|NCT01357980|5880156|P1|STARTED|Overall Study||16
2397114|NCT01357915|5880200|P2|NOT COMPLETED|Overall Study||0
2397115|NCT01357915|5880201|P1|NOT COMPLETED|Overall Study||3
2397116|NCT01357915|5880200|P2|COMPLETED|Overall Study||17
2397117|NCT01357915|5880201|P1|COMPLETED|Overall Study||27
2397118|NCT01357915|5880200|P2|STARTED|Overall Study||17
2397119|NCT01357915|5880201|P1|STARTED|Overall Study||30
2397120|NCT01357889|5880219|P2|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||4
2397121|NCT01357889|5880220|P1|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||3
2397122|NCT01357889|5880219|P2|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
2397123|NCT01357889|5880220|P1|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
2397124|NCT01357889|5880219|P2|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|142
2397125|NCT01357889|5880220|P1|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|141
2397126|NCT01357889|5880219|P2|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
2397127|NCT01357889|5880220|P1|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
2397128|NCT01357889|5880219|P2|COMPLETED|Multiple-dose Phase (MDP) (Overall)||126
2397129|NCT01357889|5880220|P1|COMPLETED|Multiple-dose Phase (MDP) (Overall)||125
2397130|NCT01357889|5880219|P2|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|142
2397131|NCT01357889|5880220|P1|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|141
2397132|NCT01357889|5880219|P2|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||2
2397133|NCT01357889|5880220|P1|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||4
2397134|NCT01357889|5880219|P2|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||79
2397135|NCT01357889|5880220|P1|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||82
2397136|NCT01357889|5880219|P2|STARTED|Single-dose Phase (BE Phase: 28 Days)||81
2397137|NCT01357889|5880220|P1|STARTED|Single-dose Phase (BE Phase: 28 Days)||86
2397138|NCT01357850|5880264|P4|NOT COMPLETED|Overall Study||0
2397139|NCT01357850|5880265|P3|NOT COMPLETED|Overall Study||0
2397140|NCT01357850|5880266|P2|NOT COMPLETED|Overall Study||0
2397141|NCT01357850|5880267|P1|NOT COMPLETED|Overall Study||1
2397142|NCT01357850|5880264|P4|COMPLETED|Overall Study||27
2397143|NCT01357850|5880265|P3|COMPLETED|Overall Study||13
2397144|NCT01357850|5880266|P2|COMPLETED|Overall Study||12
2397145|NCT01357850|5880267|P1|COMPLETED|Overall Study||29
2397146|NCT01357850|5880264|P4|STARTED|Overall Study||27
2397147|NCT01357850|5880265|P3|STARTED|Overall Study||13
2397148|NCT01357850|5880266|P2|STARTED|Overall Study||12
2397149|NCT01357850|5880267|P1|STARTED|Overall Study||30
2397150|NCT01357720|5880341|P2|NOT COMPLETED|Overall Study||5
2397151|NCT01357720|5880342|P1|NOT COMPLETED|Overall Study||2
2397152|NCT01357720|5880341|P2|COMPLETED|Overall Study||195
2397153|NCT01357720|5880342|P1|COMPLETED|Overall Study||198
2397154|NCT01357720|5880341|P2|STARTED|Overall Study||200
2397155|NCT01357720|5880342|P1|STARTED|Overall Study||200
2397156|NCT01357655|5880358|P2|NOT COMPLETED|Overall Study||0
2397157|NCT01357655|5880359|P1|NOT COMPLETED|Overall Study||66
2397158|NCT01357655|5880358|P2|COMPLETED|Overall Study||0
2397159|NCT01357655|5880359|P1|COMPLETED|Overall Study||0
2397160|NCT01357655|5880358|P2|STARTED|Overall Study||0
2397161|NCT01357655|5880359|P1|STARTED|Overall Study||66
2397162|NCT01357616|5880376|P2|NOT COMPLETED|Overall Study||9
2397163|NCT01357616|5880377|P1|NOT COMPLETED|Overall Study||10
2397164|NCT01357616|5880376|P2|COMPLETED|Overall Study||153
2397165|NCT01357616|5880377|P1|COMPLETED|Overall Study||156
2397166|NCT01357616|5880376|P2|STARTED|Overall Study||162
2397167|NCT01357616|5880377|P1|STARTED|Overall Study||166
2397168|NCT01357577|5880391|P2|NOT COMPLETED|Overall Study||26
2397169|NCT01357577|5880392|P1|NOT COMPLETED|Overall Study||37
2397170|NCT01357577|5880391|P2|COMPLETED|Overall Study||39
2397171|NCT01357577|5880392|P1|COMPLETED|Overall Study||27
2397172|NCT01357577|5880391|P2|Post-Treatment Assessment Completed|Overall Study||39
2397173|NCT01357577|5880392|P1|Post-Treatment Assessment Completed|Overall Study||24
2397174|NCT01357577|5880391|P2|STARTED|Overall Study||65
2397175|NCT01357577|5880392|P1|STARTED|Overall Study||64
2397176|NCT01357564|5880408|P2|NOT COMPLETED|Long-term (8-month) Follow-up||16
2397177|NCT01357564|5880409|P1|NOT COMPLETED|Long-term (8-month) Follow-up||2
2397178|NCT01357564|5880408|P2|COMPLETED|Long-term (8-month) Follow-up||102
2397179|NCT01357564|5880409|P1|COMPLETED|Long-term (8-month) Follow-up||104
2397180|NCT01357564|5880408|P2|STARTED|Long-term (8-month) Follow-up||118
2397181|NCT01357564|5880409|P1|STARTED|Long-term (8-month) Follow-up||106
2397182|NCT01357564|5880408|P2|NOT COMPLETED|Short-term (4-month) Follow up||50
2397183|NCT01357564|5880409|P1|NOT COMPLETED|Short-term (4-month) Follow up||48
2397184|NCT01357564|5880408|P2|COMPLETED|Short-term (4-month) Follow up||118
2397185|NCT01357564|5880409|P1|COMPLETED|Short-term (4-month) Follow up||106
2397186|NCT01357564|5880408|P2|STARTED|Short-term (4-month) Follow up||168
2397187|NCT01357564|5880409|P1|STARTED|Short-term (4-month) Follow up||154
2397188|NCT01357551|5880419|P2|NOT COMPLETED|Overall Study||11
2397189|NCT01357551|5880420|P1|NOT COMPLETED|Overall Study||22
2397190|NCT01357551|5880419|P2|COMPLETED|Overall Study||101
2397191|NCT01357551|5880420|P1|COMPLETED|Overall Study||88
2397192|NCT01357551|5880419|P2|STARTED|Overall Study||112
2397193|NCT01357551|5880420|P1|STARTED|Overall Study||110
2397194|NCT01357512|5880434|P2|NOT COMPLETED|Overall Study||5
2397195|NCT01357512|5880435|P1|NOT COMPLETED|Overall Study||12
2397196|NCT01357512|5880434|P2|COMPLETED|Overall Study||60
2397197|NCT01357512|5880435|P1|COMPLETED|Overall Study||53
2397198|NCT01357512|5880434|P2|STARTED|Overall Study||65
2397199|NCT01357512|5880435|P1|STARTED|Overall Study||65
2397200|NCT01357239|5880447|P4|NOT COMPLETED|Stratum II: Partially-Methylated||2
2397201|NCT01357239|5880448|P3|NOT COMPLETED|Stratum II: Partially-Methylated||1
2397202|NCT01357239|5880449|P2|NOT COMPLETED|Stratum II: Partially-Methylated||0
2397203|NCT01357239|5880450|P1|NOT COMPLETED|Stratum II: Partially-Methylated||0
2397204|NCT01357239|5880447|P4|COMPLETED|Stratum II: Partially-Methylated||18
2397205|NCT01357239|5880448|P3|COMPLETED|Stratum II: Partially-Methylated||21
2397206|NCT01357239|5880449|P2|COMPLETED|Stratum II: Partially-Methylated||21
2397207|NCT01357239|5880450|P1|COMPLETED|Stratum II: Partially-Methylated||23
2397208|NCT01357239|5880447|P4|STARTED|Stratum II: Partially-Methylated||20
2397209|NCT01357239|5880448|P3|STARTED|Stratum II: Partially-Methylated||22
2397210|NCT01357239|5880449|P2|STARTED|Stratum II: Partially-Methylated||21
2397211|NCT01357239|5880450|P1|STARTED|Stratum II: Partially-Methylated||23
2397212|NCT01357239|5880447|P4|NOT COMPLETED|Stratum I: Fully-Methylated||0
2397213|NCT01357239|5880448|P3|NOT COMPLETED|Stratum I: Fully-Methylated||1
2397214|NCT01357239|5880449|P2|NOT COMPLETED|Stratum I: Fully-Methylated||0
2397215|NCT01357239|5880450|P1|NOT COMPLETED|Stratum I: Fully-Methylated||0
2397216|NCT01357239|5880447|P4|COMPLETED|Stratum I: Fully-Methylated||22
2397217|NCT01357239|5880448|P3|COMPLETED|Stratum I: Fully-Methylated||16
2397218|NCT01357239|5880449|P2|COMPLETED|Stratum I: Fully-Methylated||6
2397219|NCT01357239|5880450|P1|COMPLETED|Stratum I: Fully-Methylated||8
2397220|NCT01357239|5880447|P4|STARTED|Stratum I: Fully-Methylated||22
2397221|NCT01357239|5880448|P3|STARTED|Stratum I: Fully-Methylated||17
2397222|NCT01357239|5880449|P2|STARTED|Stratum I: Fully-Methylated||6
2397223|NCT01357239|5880450|P1|STARTED|Stratum I: Fully-Methylated||8
2397224|NCT01357239|5880447|P4|NOT COMPLETED|Stratum: All Patients||2
2397225|NCT01357239|5880448|P3|NOT COMPLETED|Stratum: All Patients||2
2397226|NCT01357239|5880449|P2|NOT COMPLETED|Stratum: All Patients||0
2397227|NCT01357239|5880450|P1|NOT COMPLETED|Stratum: All Patients||0
2397228|NCT01357239|5880447|P4|COMPLETED|Stratum: All Patients||40
2397229|NCT01357239|5880448|P3|COMPLETED|Stratum: All Patients||37
2397230|NCT01357239|5880449|P2|COMPLETED|Stratum: All Patients||27
2397231|NCT01357239|5880450|P1|COMPLETED|Stratum: All Patients||31
2397232|NCT01357239|5880447|P4|STARTED|Stratum: All Patients||42
2397233|NCT01357239|5880448|P3|STARTED|Stratum: All Patients||39
2397234|NCT01357239|5880449|P2|STARTED|Stratum: All Patients||27
2397235|NCT01357239|5880450|P1|STARTED|Stratum: All Patients||31
2397236|NCT01357161|5880508|P3|NOT COMPLETED|Part 2 (Double-Blind Comparison)||62
2397237|NCT01357161|5880509|P2|NOT COMPLETED|Part 2 (Double-Blind Comparison)||59
2397238|NCT01357161|5880510|P1|NOT COMPLETED|Part 2 (Double-Blind Comparison)||0
2397239|NCT01357161|5880508|P3|COMPLETED|Part 2 (Double-Blind Comparison)||0
2397240|NCT01357161|5880509|P2|COMPLETED|Part 2 (Double-Blind Comparison)||0
2397241|NCT01357161|5880510|P1|COMPLETED|Part 2 (Double-Blind Comparison)||0
2397242|NCT01357161|5880508|P3|Treated|Part 2 (Double-Blind Comparison)||60
2397243|NCT01357161|5880509|P2|Treated|Part 2 (Double-Blind Comparison)||59
2397244|NCT01357161|5880510|P1|Treated|Part 2 (Double-Blind Comparison)||0
2397245|NCT01357161|5880508|P3|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|62
2397246|NCT01357161|5880509|P2|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|59
2397247|NCT01357161|5880510|P1|STARTED|Part 2 (Double-Blind Comparison)||0
2397248|NCT01357161|5880508|P3|NOT COMPLETED|Part 1 (Open Label Run-in)||0
2397249|NCT01357161|5880509|P2|NOT COMPLETED|Part 1 (Open Label Run-in)||0
2397250|NCT01357161|5880510|P1|NOT COMPLETED|Part 1 (Open Label Run-in)||15
2397251|NCT01357161|5880508|P3|COMPLETED|Part 1 (Open Label Run-in)||0
2397252|NCT01357161|5880509|P2|COMPLETED|Part 1 (Open Label Run-in)||0
2397253|NCT01357161|5880510|P1|COMPLETED|Part 1 (Open Label Run-in)||0
2397254|NCT01357161|5880508|P3|STARTED|Part 1 (Open Label Run-in)||0
2397255|NCT01357161|5880509|P2|STARTED|Part 1 (Open Label Run-in)||0
2397256|NCT01357161|5880510|P1|STARTED|Part 1 (Open Label Run-in)||15
2397257|NCT01357148|5880539|P1|NOT COMPLETED|Overall Study||0
2397258|NCT01357148|5880539|P1|COMPLETED|Overall Study||143
2397259|NCT01357148|5880539|P1|STARTED|Overall Study||143
2397260|NCT01357135|5880549|P3|NOT COMPLETED|Overall Study||263
2397261|NCT01357135|5880550|P2|NOT COMPLETED|Overall Study||223
2397262|NCT01357135|5880551|P1|NOT COMPLETED|Overall Study||598
2397263|NCT01357135|5880549|P3|COMPLETED|Overall Study||583
2397264|NCT01357135|5880550|P2|COMPLETED|Overall Study||510
2397265|NCT01357135|5880551|P1|COMPLETED|Overall Study||1276
2397266|NCT01357135|5880549|P3|STARTED|Overall Study||846
2397267|NCT01357135|5880550|P2|STARTED|Overall Study||733
2397268|NCT01357135|5880551|P1|STARTED|Overall Study||1874
2397269|NCT01356966|5880562|P2|NOT COMPLETED|Overall Study||2
2397270|NCT01356966|5880563|P1|NOT COMPLETED|Overall Study||2
2397271|NCT01356966|5880562|P2|COMPLETED|Overall Study||12
2397272|NCT01356966|5880563|P1|COMPLETED|Overall Study||16
2397273|NCT01356966|5880562|P2|STARTED|Overall Study||14
2397274|NCT01356966|5880563|P1|STARTED|Overall Study||18
2397275|NCT01356940|5880575|P2|NOT COMPLETED|Second Intervention (28 Days)||0
2397276|NCT01356940|5880576|P1|NOT COMPLETED|Second Intervention (28 Days)||1
2397277|NCT01356940|5880575|P2|COMPLETED|Second Intervention (28 Days)||21
2397278|NCT01356940|5880576|P1|COMPLETED|Second Intervention (28 Days)||20
2397279|NCT01356940|5880575|P2|STARTED|Second Intervention (28 Days)||21
2397280|NCT01356940|5880576|P1|STARTED|Second Intervention (28 Days)||21
2397281|NCT01356940|5880575|P2|NOT COMPLETED|Washout (14 Days)||0
2397282|NCT01356940|5880576|P1|NOT COMPLETED|Washout (14 Days)||0
2397283|NCT01356940|5880575|P2|COMPLETED|Washout (14 Days)||21
2397284|NCT01356940|5880576|P1|COMPLETED|Washout (14 Days)||21
2397285|NCT01356940|5880575|P2|STARTED|Washout (14 Days)||21
2397286|NCT01356940|5880576|P1|STARTED|Washout (14 Days)||21
2397287|NCT01356940|5880575|P2|NOT COMPLETED|First Intervention (28 Days)||0
2397288|NCT01356940|5880576|P1|NOT COMPLETED|First Intervention (28 Days)||1
2397289|NCT01356940|5880575|P2|COMPLETED|First Intervention (28 Days)||21
2397290|NCT01356940|5880576|P1|COMPLETED|First Intervention (28 Days)||21
2397291|NCT01356940|5880575|P2|STARTED|First Intervention (28 Days)||21
2397292|NCT01356940|5880576|P1|STARTED|First Intervention (28 Days)||22
2397293|NCT01356667|5880586|P2|NOT COMPLETED|Overall Study||6
2397294|NCT01356667|5880587|P1|NOT COMPLETED|Overall Study||4
2397295|NCT01356667|5880586|P2|COMPLETED|Overall Study||0
2397296|NCT01356667|5880587|P1|COMPLETED|Overall Study||0
2397297|NCT01356667|5880586|P2|STARTED|Overall Study||6
2397298|NCT01356667|5880587|P1|STARTED|Overall Study||4
2397299|NCT01356628|5880597|P1|NOT COMPLETED|Overall Study||0
2397300|NCT01356628|5880597|P1|COMPLETED|Overall Study||23
2397301|NCT01356628|5880597|P1|STARTED|Overall Study||23
2397302|NCT01356602|5880605|P3|NOT COMPLETED|Overall Study||24
2397303|NCT01356602|5880606|P2|NOT COMPLETED|Overall Study||15
2397304|NCT01356602|5880607|P1|NOT COMPLETED|Overall Study||9
2397305|NCT01356602|5880605|P3|COMPLETED|Overall Study||108
2397306|NCT01356602|5880606|P2|COMPLETED|Overall Study||117
2397307|NCT01356602|5880607|P1|COMPLETED|Overall Study||124
2397308|NCT01356602|5880605|P3|Full Analysis Set|Overall Study||129
2397309|NCT01356602|5880606|P2|Full Analysis Set|Overall Study||129
2397310|NCT01356602|5880607|P1|Full Analysis Set|Overall Study||131
2397311|NCT01356602|5880605|P3|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
2397312|NCT01356602|5880606|P2|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
2397313|NCT01356602|5880607|P1|Safety Set|Overall Study|In this arm, 1 patient had only 3 placebo injections and 3 patients also took other active drug.|133
2397314|NCT01356602|5880605|P3|STARTED|Overall Study||132
2397315|NCT01356602|5880606|P2|STARTED|Overall Study||132
2397316|NCT01356602|5880607|P1|STARTED|Overall Study||133
2397317|NCT01356589|5880666|P1|NOT COMPLETED|Overall Study||5
2397318|NCT01356589|5880666|P1|COMPLETED|Overall Study||1283
2397319|NCT01356589|5880666|P1|Treated|Overall Study||1285
2397320|NCT01356589|5880666|P1|STARTED|Overall Study||1288
2397321|NCT01356498|5880678|P6|NOT COMPLETED|Overall Study||14
2397322|NCT01356498|5880679|P5|NOT COMPLETED|Overall Study||20
2397323|NCT01356498|5880680|P4|NOT COMPLETED|Overall Study||14
2397324|NCT01356498|5880681|P3|NOT COMPLETED|Overall Study||12
2397325|NCT01356498|5880682|P2|NOT COMPLETED|Overall Study||8
2397326|NCT01356498|5880683|P1|NOT COMPLETED|Overall Study||11
2397327|NCT01356498|5880678|P6|COMPLETED|Overall Study||2
2397328|NCT01356498|5880679|P5|COMPLETED|Overall Study||8
2397329|NCT01356498|5880680|P4|COMPLETED|Overall Study||8
2397330|NCT01356498|5880681|P3|COMPLETED|Overall Study||11
2397331|NCT01356498|5880682|P2|COMPLETED|Overall Study||17
2397332|NCT01356498|5880683|P1|COMPLETED|Overall Study||24
2397333|NCT01356498|5880678|P6|STARTED|Overall Study||16
2397334|NCT01356498|5880679|P5|STARTED|Overall Study||28
2397335|NCT01356498|5880680|P4|STARTED|Overall Study||22
2397336|NCT01356498|5880681|P3|STARTED|Overall Study||23
2397337|NCT01356498|5880682|P2|STARTED|Overall Study|2 other patients received no investigational drug in C0407 but elected to be followed in Observation|25
2397338|NCT01356498|5880683|P1|STARTED|Overall Study||35
2397339|NCT01356407|5880723|P2|NOT COMPLETED|Overall Study||4
2397340|NCT01356407|5880724|P1|NOT COMPLETED|Overall Study||6
2397341|NCT01356407|5880723|P2|COMPLETED|Overall Study||146
2397342|NCT01356407|5880724|P1|COMPLETED|Overall Study||144
2397343|NCT01356407|5880723|P2|STARTED|Overall Study||150
2397344|NCT01356407|5880724|P1|STARTED|Overall Study||150
2397345|NCT01356277|5880742|P2|NOT COMPLETED|Intervention Interval||7
2397346|NCT01356277|5880743|P1|NOT COMPLETED|Intervention Interval||10
2397347|NCT01356277|5880742|P2|COMPLETED|Intervention Interval||81
2397348|NCT01356277|5880743|P1|COMPLETED|Intervention Interval||66
2397349|NCT01356277|5880742|P2|STARTED|Intervention Interval||88
2397350|NCT01356277|5880743|P1|STARTED|Intervention Interval||76
2397351|NCT01356277|5880742|P2|NOT COMPLETED|Run-in||0
2397352|NCT01356277|5880743|P1|NOT COMPLETED|Run-in||5
2397353|NCT01356277|5880742|P2|COMPLETED|Run-in||88
2397354|NCT01356277|5880743|P1|COMPLETED|Run-in||76
2397355|NCT01356277|5880742|P2|STARTED|Run-in||88
2397356|NCT01356277|5880743|P1|STARTED|Run-in||81
2397357|NCT01356147|5880763|P2|NOT COMPLETED|Overall Study||0
2397358|NCT01356147|5880764|P1|NOT COMPLETED|Overall Study||0
2397359|NCT01356147|5880763|P2|COMPLETED|Overall Study||6
2397360|NCT01356147|5880764|P1|COMPLETED|Overall Study||5
2397361|NCT01356147|5880763|P2|STARTED|Overall Study||6
2397362|NCT01356147|5880764|P1|STARTED|Overall Study||5
2397363|NCT01355978|5880774|P1|NOT COMPLETED|Overall Study||4
2397364|NCT01355978|5880774|P1|COMPLETED|Overall Study||18
2397365|NCT01355978|5880774|P1|STARTED|Overall Study||22
2397366|NCT01355796|5880780|P2|NOT COMPLETED|Overall Study||0
2397367|NCT01355796|5880781|P1|NOT COMPLETED|Overall Study||0
2397368|NCT01355796|5880780|P2|COMPLETED|Overall Study||15
2397369|NCT01355796|5880781|P1|COMPLETED|Overall Study||15
2397370|NCT01355796|5880780|P2|Second Intervention for 14 Days|Overall Study||15
2397371|NCT01355796|5880781|P1|Second Intervention for 14 Days|Overall Study||15
2397372|NCT01355796|5880780|P2|Washout Period for 7 Days|Overall Study||15
2397373|NCT01355796|5880781|P1|Washout Period for 7 Days|Overall Study||15
2397374|NCT01355796|5880780|P2|First Intervention for 14 Days|Overall Study||15
2397375|NCT01355796|5880781|P1|First Intervention for 14 Days|Overall Study||15
2397376|NCT01355796|5880780|P2|STARTED|Overall Study||15
2397377|NCT01355796|5880781|P1|STARTED|Overall Study||15
2397378|NCT01355705|5880789|P1|NOT COMPLETED|Overall Study||0
2397379|NCT01355705|5880789|P1|COMPLETED|Overall Study||14
2397380|NCT01355705|5880789|P1|STARTED|Overall Study||14
2397381|NCT01355679|5880796|P1|NOT COMPLETED|Overall Study||2
2397382|NCT01355679|5880796|P1|COMPLETED|Overall Study||14
2397383|NCT01355679|5880796|P1|STARTED|Overall Study||16
2397384|NCT01355627|5880805|P2|NOT COMPLETED|Overall Study||38
2397385|NCT01355627|5880806|P1|NOT COMPLETED|Overall Study||33
2397386|NCT01355627|5880805|P2|COMPLETED|Overall Study||326
2397387|NCT01355627|5880806|P1|COMPLETED|Overall Study||329
2397388|NCT01355627|5880805|P2|Full Analysis Set|Overall Study|One participant randomized to Current Practice actually received TachoSil®.|365
2397389|NCT01355627|5880806|P1|Full Analysis Set|Overall Study|One participant's data for final follow-up is missing, completion status could not be confirmed.|361
2397390|NCT01355627|5880805|P2|Safety Analysis Set|Overall Study||364
2397391|NCT01355627|5880806|P1|Safety Analysis Set|Overall Study||362
2397392|NCT01355627|5880805|P2|STARTED|Overall Study||364
2397393|NCT01355627|5880806|P1|STARTED|Overall Study||362
2397394|NCT01355588|5880818|P4|NOT COMPLETED|Fourth Intervention (After Washout)||0
2397395|NCT01355588|5880819|P3|NOT COMPLETED|Fourth Intervention (After Washout)||0
2397396|NCT01355588|5880820|P2|NOT COMPLETED|Fourth Intervention (After Washout)||0
2397397|NCT01355588|5880821|P1|NOT COMPLETED|Fourth Intervention (After Washout)||0
2397398|NCT01355588|5880818|P4|COMPLETED|Fourth Intervention (After Washout)||4
2397399|NCT01355588|5880819|P3|COMPLETED|Fourth Intervention (After Washout)||4
2397400|NCT01355588|5880820|P2|COMPLETED|Fourth Intervention (After Washout)||4
2397401|NCT01355588|5880821|P1|COMPLETED|Fourth Intervention (After Washout)||4
2397402|NCT01355588|5880818|P4|STARTED|Fourth Intervention (After Washout)||4
2397403|NCT01355588|5880819|P3|STARTED|Fourth Intervention (After Washout)||4
2397404|NCT01355588|5880820|P2|STARTED|Fourth Intervention (After Washout)||4
2397405|NCT01355588|5880821|P1|STARTED|Fourth Intervention (After Washout)||4
2397406|NCT01355588|5880818|P4|NOT COMPLETED|Washout (3-7 Days)||0
2397407|NCT01355588|5880819|P3|NOT COMPLETED|Washout (3-7 Days)||0
2397408|NCT01355588|5880820|P2|NOT COMPLETED|Washout (3-7 Days)||0
2397409|NCT01355588|5880821|P1|NOT COMPLETED|Washout (3-7 Days)||0
2397410|NCT01355588|5880818|P4|COMPLETED|Washout (3-7 Days)||4
2397411|NCT01355588|5880819|P3|COMPLETED|Washout (3-7 Days)||4
2397412|NCT01355588|5880820|P2|COMPLETED|Washout (3-7 Days)||4
2397413|NCT01355588|5880821|P1|COMPLETED|Washout (3-7 Days)||4
2397414|NCT01355588|5880818|P4|STARTED|Washout (3-7 Days)||4
2397415|NCT01355588|5880819|P3|STARTED|Washout (3-7 Days)||4
2397416|NCT01355588|5880820|P2|STARTED|Washout (3-7 Days)||4
2397417|NCT01355588|5880821|P1|STARTED|Washout (3-7 Days)||4
2397418|NCT01355588|5880818|P4|NOT COMPLETED|Third Intervention (After Washout)||0
2397419|NCT01355588|5880819|P3|NOT COMPLETED|Third Intervention (After Washout)||0
2397420|NCT01355588|5880820|P2|NOT COMPLETED|Third Intervention (After Washout)||0
2397421|NCT01355588|5880821|P1|NOT COMPLETED|Third Intervention (After Washout)||0
2397422|NCT01355588|5880818|P4|COMPLETED|Third Intervention (After Washout)||4
2397423|NCT01355588|5880819|P3|COMPLETED|Third Intervention (After Washout)||4
2397424|NCT01355588|5880820|P2|COMPLETED|Third Intervention (After Washout)||4
2397425|NCT01355588|5880821|P1|COMPLETED|Third Intervention (After Washout)||4
2397426|NCT01355588|5880818|P4|STARTED|Third Intervention (After Washout)||4
2397427|NCT01355588|5880819|P3|STARTED|Third Intervention (After Washout)||4
2397428|NCT01355588|5880820|P2|STARTED|Third Intervention (After Washout)||4
2397429|NCT01355588|5880821|P1|STARTED|Third Intervention (After Washout)||4
2397430|NCT01355588|5880818|P4|NOT COMPLETED|Washout (3-7 Days)||0
2397431|NCT01355588|5880819|P3|NOT COMPLETED|Washout (3-7 Days)||0
2397432|NCT01355588|5880820|P2|NOT COMPLETED|Washout (3-7 Days)||0
2397433|NCT01355588|5880821|P1|NOT COMPLETED|Washout (3-7 Days)||0
2397434|NCT01355588|5880818|P4|COMPLETED|Washout (3-7 Days)||4
2397435|NCT01355588|5880819|P3|COMPLETED|Washout (3-7 Days)||4
2397436|NCT01355588|5880820|P2|COMPLETED|Washout (3-7 Days)||4
2397437|NCT01355588|5880821|P1|COMPLETED|Washout (3-7 Days)||4
2397438|NCT01355588|5880818|P4|STARTED|Washout (3-7 Days)||4
2397439|NCT01355588|5880819|P3|STARTED|Washout (3-7 Days)||4
2397440|NCT01355588|5880820|P2|STARTED|Washout (3-7 Days)||4
2397441|NCT01355588|5880821|P1|STARTED|Washout (3-7 Days)||4
2397442|NCT01355588|5880818|P4|NOT COMPLETED|Second Intervention (After Washout)||0
2397443|NCT01355588|5880819|P3|NOT COMPLETED|Second Intervention (After Washout)||0
2397444|NCT01355588|5880820|P2|NOT COMPLETED|Second Intervention (After Washout)||0
2397445|NCT01355588|5880821|P1|NOT COMPLETED|Second Intervention (After Washout)||0
2397446|NCT01355588|5880818|P4|COMPLETED|Second Intervention (After Washout)||4
2397447|NCT01355588|5880819|P3|COMPLETED|Second Intervention (After Washout)||4
2397448|NCT01355588|5880820|P2|COMPLETED|Second Intervention (After Washout)||4
2397449|NCT01355588|5880821|P1|COMPLETED|Second Intervention (After Washout)||4
2397450|NCT01355588|5880818|P4|STARTED|Second Intervention (After Washout)||4
2397451|NCT01355588|5880819|P3|STARTED|Second Intervention (After Washout)||4
2397452|NCT01355588|5880820|P2|STARTED|Second Intervention (After Washout)||4
2397453|NCT01355588|5880821|P1|STARTED|Second Intervention (After Washout)||4
2397454|NCT01355588|5880818|P4|NOT COMPLETED|Washout (3-7 Days)||0
2397455|NCT01355588|5880819|P3|NOT COMPLETED|Washout (3-7 Days)||0
2397456|NCT01355588|5880820|P2|NOT COMPLETED|Washout (3-7 Days)||0
2397457|NCT01355588|5880821|P1|NOT COMPLETED|Washout (3-7 Days)||0
2397458|NCT01355588|5880818|P4|COMPLETED|Washout (3-7 Days)||4
2397459|NCT01355588|5880819|P3|COMPLETED|Washout (3-7 Days)||4
2397460|NCT01355588|5880820|P2|COMPLETED|Washout (3-7 Days)||4
2397461|NCT01355588|5880821|P1|COMPLETED|Washout (3-7 Days)||4
2397462|NCT01355588|5880818|P4|STARTED|Washout (3-7 Days)||4
2397463|NCT01355588|5880819|P3|STARTED|Washout (3-7 Days)||4
2397464|NCT01355588|5880820|P2|STARTED|Washout (3-7 Days)||4
2397465|NCT01355588|5880821|P1|STARTED|Washout (3-7 Days)||4
2397466|NCT01355588|5880818|P4|NOT COMPLETED|First Intervention (Day 1)||0
2397467|NCT01355588|5880819|P3|NOT COMPLETED|First Intervention (Day 1)||0
2397468|NCT01355588|5880820|P2|NOT COMPLETED|First Intervention (Day 1)||0
2397469|NCT01355588|5880821|P1|NOT COMPLETED|First Intervention (Day 1)||0
2397470|NCT01355588|5880818|P4|COMPLETED|First Intervention (Day 1)||4
2397471|NCT01355588|5880819|P3|COMPLETED|First Intervention (Day 1)||4
2397472|NCT01355588|5880820|P2|COMPLETED|First Intervention (Day 1)||4
2397473|NCT01355588|5880821|P1|COMPLETED|First Intervention (Day 1)||4
2397474|NCT01355588|5880818|P4|STARTED|First Intervention (Day 1)||4
2397475|NCT01355588|5880819|P3|STARTED|First Intervention (Day 1)||4
2397476|NCT01355588|5880820|P2|STARTED|First Intervention (Day 1)||4
2397477|NCT01355588|5880821|P1|STARTED|First Intervention (Day 1)||4
2397478|NCT01355523|5880845|P2|NOT COMPLETED|Overall Study||10
2397479|NCT01355523|5880846|P1|NOT COMPLETED|Overall Study||1
2397480|NCT01355523|5880845|P2|COMPLETED|Overall Study||16
2397481|NCT01355523|5880846|P1|COMPLETED|Overall Study||27
2397482|NCT01355523|5880845|P2|STARTED|Overall Study||26
2397483|NCT01355523|5880846|P1|STARTED|Overall Study||28
2397484|NCT01355484|5880890|P2|NOT COMPLETED|Overall Study||54
2397485|NCT01355484|5880891|P1|NOT COMPLETED|Overall Study||51
2397486|NCT01355484|5880890|P2|COMPLETED|Overall Study||107
2397487|NCT01355484|5880891|P1|COMPLETED|Overall Study||109
2397488|NCT01355484|5880890|P2|STARTED|Overall Study||161
2397489|NCT01355484|5880891|P1|STARTED|Overall Study||160
2397490|NCT01355471|5880901|P2|NOT COMPLETED|Overall Study||3
2397491|NCT01355471|5880902|P1|NOT COMPLETED|Overall Study||7
2397492|NCT01355471|5880901|P2|COMPLETED|Overall Study||142
2397493|NCT01355471|5880902|P1|COMPLETED|Overall Study||141
2397494|NCT01355471|5880901|P2|STARTED|Overall Study||145
2397495|NCT01355471|5880902|P1|STARTED|Overall Study||148
2397496|NCT01355458|5880910|P2|NOT COMPLETED|Overall Study||4
2397497|NCT01355458|5880911|P1|NOT COMPLETED|Overall Study||2
2397498|NCT01355458|5880910|P2|COMPLETED|Overall Study||127
2397499|NCT01355458|5880911|P1|COMPLETED|Overall Study||127
2397500|NCT01355458|5880910|P2|STARTED|Overall Study||131
2397501|NCT01355458|5880911|P1|STARTED|Overall Study||129
2397502|NCT01355419|5880917|P1|NOT COMPLETED|Overall Study||8
2397503|NCT01355419|5880917|P1|COMPLETED|Overall Study||142
2397504|NCT01355419|5880917|P1|STARTED|Overall Study||150
2397505|NCT01355302|5880922|P3|NOT COMPLETED|Phase 2||0
2397506|NCT01355302|5880923|P2|NOT COMPLETED|Phase 2||0
2397507|NCT01355302|5880924|P1|NOT COMPLETED|Phase 2||0
2397508|NCT01355302|5880922|P3|COMPLETED|Phase 2||0
2397509|NCT01355302|5880923|P2|COMPLETED|Phase 2||0
2397510|NCT01355302|5880924|P1|COMPLETED|Phase 2||0
2397511|NCT01355302|5880922|P3|STARTED|Phase 2|The study was terminated prior to enrollment|0
2397512|NCT01355302|5880923|P2|STARTED|Phase 2|The study was terminated prior to enrollment|0
2397604|NCT01354938|5881052|P1|STARTED|Overall Study||220
2397513|NCT01355302|5880924|P1|STARTED|Phase 2|Treatment arm not designated for phase 2.|0
2397514|NCT01355302|5880922|P3|NOT COMPLETED|Phase 1b||0
2397515|NCT01355302|5880923|P2|NOT COMPLETED|Phase 1b||0
2397516|NCT01355302|5880924|P1|NOT COMPLETED|Phase 1b||6
2397517|NCT01355302|5880922|P3|COMPLETED|Phase 1b||0
2397518|NCT01355302|5880923|P2|COMPLETED|Phase 1b||0
2397519|NCT01355302|5880924|P1|COMPLETED|Phase 1b|The subject who completed 6 cycles was withdrawn by sponsor request.|1
2397520|NCT01355302|5880922|P3|STARTED|Phase 1b||0
2397521|NCT01355302|5880923|P2|STARTED|Phase 1b||0
2397522|NCT01355302|5880924|P1|STARTED|Phase 1b|Replaced 1 subject; who discontinued study drug in first cycle|7
2397523|NCT01355289|5880939|P5|NOT COMPLETED|Open Label Extension||34
2397524|NCT01355289|5880940|P4|NOT COMPLETED|Open Label Extension||0
2397525|NCT01355289|5880941|P3|NOT COMPLETED|Open Label Extension||0
2397526|NCT01355289|5880942|P2|NOT COMPLETED|Open Label Extension||0
2397527|NCT01355289|5880943|P1|NOT COMPLETED|Open Label Extension||0
2397528|NCT01355289|5880939|P5|COMPLETED|Open Label Extension||28
2397529|NCT01355289|5880940|P4|COMPLETED|Open Label Extension||0
2397530|NCT01355289|5880941|P3|COMPLETED|Open Label Extension||0
2397531|NCT01355289|5880942|P2|COMPLETED|Open Label Extension||0
2397532|NCT01355289|5880943|P1|COMPLETED|Open Label Extension||0
2397533|NCT01355289|5880939|P5|STARTED|Open Label Extension||62
2397534|NCT01355289|5880940|P4|STARTED|Open Label Extension||0
2397535|NCT01355289|5880941|P3|STARTED|Open Label Extension||0
2397536|NCT01355289|5880942|P2|STARTED|Open Label Extension||0
2397537|NCT01355289|5880943|P1|STARTED|Open Label Extension||0
2397538|NCT01355289|5880939|P5|NOT COMPLETED|Core Study||0
2397539|NCT01355289|5880940|P4|NOT COMPLETED|Core Study||2
2397540|NCT01355289|5880941|P3|NOT COMPLETED|Core Study||0
2397541|NCT01355289|5880942|P2|NOT COMPLETED|Core Study||0
2397542|NCT01355289|5880943|P1|NOT COMPLETED|Core Study||1
2397543|NCT01355289|5880939|P5|COMPLETED|Core Study||0
2397544|NCT01355289|5880940|P4|COMPLETED|Core Study||12
2397545|NCT01355289|5880941|P3|COMPLETED|Core Study||18
2397546|NCT01355289|5880942|P2|COMPLETED|Core Study||16
2397547|NCT01355289|5880943|P1|COMPLETED|Core Study||16
2397548|NCT01355289|5880939|P5|STARTED|Core Study||0
2397549|NCT01355289|5880940|P4|STARTED|Core Study||14
2397550|NCT01355289|5880941|P3|STARTED|Core Study||18
2397551|NCT01355289|5880942|P2|STARTED|Core Study||16
2397552|NCT01355289|5880943|P1|STARTED|Core Study||17
2397553|NCT01355224|5880970|P4|NOT COMPLETED|Overall Study||29
2397554|NCT01355224|5880971|P3|NOT COMPLETED|Overall Study||19
2397555|NCT01355224|5880972|P2|NOT COMPLETED|Overall Study||23
2397556|NCT01355224|5880973|P1|NOT COMPLETED|Overall Study||31
2397557|NCT01355224|5880970|P4|COMPLETED|Overall Study||172
2397558|NCT01355224|5880971|P3|COMPLETED|Overall Study||177
2397559|NCT01355224|5880972|P2|COMPLETED|Overall Study||180
2397560|NCT01355224|5880973|P1|COMPLETED|Overall Study||167
2397561|NCT01355224|5880970|P4|Competed Baseline|Overall Study||193
2397562|NCT01355224|5880971|P3|Competed Baseline|Overall Study||193
2397563|NCT01355224|5880972|P2|Competed Baseline|Overall Study||200
2397564|NCT01355224|5880973|P1|Competed Baseline|Overall Study||191
2397565|NCT01355224|5880970|P4|STARTED|Overall Study||201
2397566|NCT01355224|5880971|P3|STARTED|Overall Study||196
2397567|NCT01355224|5880972|P2|STARTED|Overall Study||203
2397568|NCT01355224|5880973|P1|STARTED|Overall Study||198
2397569|NCT01355081|5880996|P3|NOT COMPLETED|Overall Study||11
2397570|NCT01355081|5880997|P2|NOT COMPLETED|Overall Study||10
2397571|NCT01355081|5880998|P1|NOT COMPLETED|Overall Study||7
2397572|NCT01355081|5880996|P3|COMPLETED|Overall Study||113
2397573|NCT01355081|5880997|P2|COMPLETED|Overall Study||113
2397574|NCT01355081|5880998|P1|COMPLETED|Overall Study||112
2397575|NCT01355081|5880996|P3|STARTED|Overall Study||124
2397576|NCT01355081|5880997|P2|STARTED|Overall Study||123
2397577|NCT01355081|5880998|P1|STARTED|Overall Study||119
2397578|NCT01355068|5881021|P2|NOT COMPLETED|Second Intervention Period||0
2397579|NCT01355068|5881022|P1|NOT COMPLETED|Second Intervention Period||0
2397580|NCT01355068|5881021|P2|COMPLETED|Second Intervention Period||11
2397581|NCT01355068|5881022|P1|COMPLETED|Second Intervention Period||13
2397582|NCT01355068|5881021|P2|STARTED|Second Intervention Period||11
2397583|NCT01355068|5881022|P1|STARTED|Second Intervention Period||13
2397584|NCT01355068|5881021|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2397585|NCT01355068|5881022|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2397586|NCT01355068|5881021|P2|COMPLETED|Washout Period (at Least 7 Days)||11
2397587|NCT01355068|5881022|P1|COMPLETED|Washout Period (at Least 7 Days)||13
2397588|NCT01355068|5881021|P2|STARTED|Washout Period (at Least 7 Days)||11
2397589|NCT01355068|5881022|P1|STARTED|Washout Period (at Least 7 Days)||13
2397590|NCT01355068|5881021|P2|NOT COMPLETED|First Intervention Period||2
2397591|NCT01355068|5881022|P1|NOT COMPLETED|First Intervention Period||0
2397592|NCT01355068|5881021|P2|COMPLETED|First Intervention Period||11
2397593|NCT01355068|5881022|P1|COMPLETED|First Intervention Period||13
2397594|NCT01355068|5881021|P2|STARTED|First Intervention Period||13
2397595|NCT01355068|5881022|P1|STARTED|First Intervention Period||13
2397596|NCT01354990|5881038|P1|NOT COMPLETED|Overall Study||0
2397597|NCT01354990|5881038|P1|COMPLETED|Overall Study||2974
2397598|NCT01354990|5881038|P1|STARTED|Overall Study||2974
2397599|NCT01354951|5881045|P1|NOT COMPLETED|Overall Study||2
2397600|NCT01354951|5881045|P1|COMPLETED|Overall Study||1
2397601|NCT01354951|5881045|P1|STARTED|Overall Study||3
2397602|NCT01354938|5881052|P1|NOT COMPLETED|Overall Study||1
2397603|NCT01354938|5881052|P1|COMPLETED|Overall Study||219
2397605|NCT01354899|5881058|P1|NOT COMPLETED|Overall Study||3
2397606|NCT01354899|5881058|P1|COMPLETED|Overall Study||21
2397607|NCT01354899|5881058|P1|STARTED|Overall Study||24
2397608|NCT01354652|5881066|P3|NOT COMPLETED|Overall Study||0
2397609|NCT01354652|5881067|P2|NOT COMPLETED|Overall Study||2
2397610|NCT01354652|5881068|P1|NOT COMPLETED|Overall Study||3
2397611|NCT01354652|5881066|P3|COMPLETED|Overall Study||0
2397612|NCT01354652|5881067|P2|COMPLETED|Overall Study||0
2397613|NCT01354652|5881068|P1|COMPLETED|Overall Study||0
2397614|NCT01354652|5881066|P3|STARTED|Overall Study||0
2397615|NCT01354652|5881067|P2|STARTED|Overall Study||2
2397616|NCT01354652|5881068|P1|STARTED|Overall Study||3
2397617|NCT01354496|5881093|P6|NOT COMPLETED|Period 3||0
2397618|NCT01354496|5881094|P5|NOT COMPLETED|Period 3||0
2397619|NCT01354496|5881095|P4|NOT COMPLETED|Period 3||0
2397620|NCT01354496|5881096|P3|NOT COMPLETED|Period 3||0
2397621|NCT01354496|5881097|P2|NOT COMPLETED|Period 3||0
2397622|NCT01354496|5881098|P1|NOT COMPLETED|Period 3||0
2397623|NCT01354496|5881093|P6|COMPLETED|Period 3||6
2397624|NCT01354496|5881094|P5|COMPLETED|Period 3||5
2397625|NCT01354496|5881095|P4|COMPLETED|Period 3||4
2397626|NCT01354496|5881096|P3|COMPLETED|Period 3||4
2397627|NCT01354496|5881097|P2|COMPLETED|Period 3||5
2397628|NCT01354496|5881098|P1|COMPLETED|Period 3||6
2397629|NCT01354496|5881093|P6|STARTED|Period 3||6
2397630|NCT01354496|5881094|P5|STARTED|Period 3||5
2397631|NCT01354496|5881095|P4|STARTED|Period 3||4
2397632|NCT01354496|5881096|P3|STARTED|Period 3||4
2397633|NCT01354496|5881097|P2|STARTED|Period 3||5
2397634|NCT01354496|5881098|P1|STARTED|Period 3||6
2397635|NCT01354496|5881093|P6|NOT COMPLETED|Washout (at Least 14 Days)||0
2397636|NCT01354496|5881094|P5|NOT COMPLETED|Washout (at Least 14 Days)||0
2397637|NCT01354496|5881095|P4|NOT COMPLETED|Washout (at Least 14 Days)||1
2397638|NCT01354496|5881096|P3|NOT COMPLETED|Washout (at Least 14 Days)||0
2397639|NCT01354496|5881097|P2|NOT COMPLETED|Washout (at Least 14 Days)||1
2397640|NCT01354496|5881098|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
2397641|NCT01354496|5881093|P6|COMPLETED|Washout (at Least 14 Days)||6
2397642|NCT01354496|5881094|P5|COMPLETED|Washout (at Least 14 Days)||5
2397643|NCT01354496|5881095|P4|COMPLETED|Washout (at Least 14 Days)||4
2397644|NCT01354496|5881096|P3|COMPLETED|Washout (at Least 14 Days)||4
2397645|NCT01354496|5881097|P2|COMPLETED|Washout (at Least 14 Days)||5
2397646|NCT01354496|5881098|P1|COMPLETED|Washout (at Least 14 Days)||6
2397647|NCT01354496|5881093|P6|STARTED|Washout (at Least 14 Days)||6
2397648|NCT01354496|5881094|P5|STARTED|Washout (at Least 14 Days)||5
2397649|NCT01354496|5881095|P4|STARTED|Washout (at Least 14 Days)||5
2397650|NCT01354496|5881096|P3|STARTED|Washout (at Least 14 Days)||4
2397651|NCT01354496|5881097|P2|STARTED|Washout (at Least 14 Days)||6
2397652|NCT01354496|5881098|P1|STARTED|Washout (at Least 14 Days)||6
2397653|NCT01354496|5881093|P6|NOT COMPLETED|Period 2||0
2397654|NCT01354496|5881094|P5|NOT COMPLETED|Period 2||0
2397655|NCT01354496|5881095|P4|NOT COMPLETED|Period 2||1
2397656|NCT01354496|5881096|P3|NOT COMPLETED|Period 2||0
2397657|NCT01354496|5881097|P2|NOT COMPLETED|Period 2||0
2397658|NCT01354496|5881098|P1|NOT COMPLETED|Period 2||0
2397659|NCT01354496|5881093|P6|COMPLETED|Period 2||6
2397660|NCT01354496|5881094|P5|COMPLETED|Period 2||5
2397661|NCT01354496|5881095|P4|COMPLETED|Period 2||5
2397662|NCT01354496|5881096|P3|COMPLETED|Period 2||4
2397663|NCT01354496|5881097|P2|COMPLETED|Period 2||6
2397664|NCT01354496|5881098|P1|COMPLETED|Period 2||6
2397665|NCT01354496|5881093|P6|STARTED|Period 2||6
2397666|NCT01354496|5881094|P5|STARTED|Period 2||5
2397667|NCT01354496|5881095|P4|STARTED|Period 2||6
2397668|NCT01354496|5881096|P3|STARTED|Period 2||4
2397669|NCT01354496|5881097|P2|STARTED|Period 2||6
2397670|NCT01354496|5881098|P1|STARTED|Period 2||6
2397671|NCT01354496|5881093|P6|NOT COMPLETED|Washout (at Least 14 Days)||0
2397672|NCT01354496|5881094|P5|NOT COMPLETED|Washout (at Least 14 Days)||0
2397673|NCT01354496|5881095|P4|NOT COMPLETED|Washout (at Least 14 Days)||0
2397674|NCT01354496|5881096|P3|NOT COMPLETED|Washout (at Least 14 Days)||0
2397675|NCT01354496|5881097|P2|NOT COMPLETED|Washout (at Least 14 Days)||0
2397676|NCT01354496|5881098|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
2397677|NCT01354496|5881093|P6|COMPLETED|Washout (at Least 14 Days)||6
2397678|NCT01354496|5881094|P5|COMPLETED|Washout (at Least 14 Days)||5
2397679|NCT01354496|5881095|P4|COMPLETED|Washout (at Least 14 Days)||6
2397680|NCT01354496|5881096|P3|COMPLETED|Washout (at Least 14 Days)||4
2397681|NCT01354496|5881097|P2|COMPLETED|Washout (at Least 14 Days)||6
2397682|NCT01354496|5881098|P1|COMPLETED|Washout (at Least 14 Days)||6
2397683|NCT01354496|5881093|P6|STARTED|Washout (at Least 14 Days)||6
2397684|NCT01354496|5881094|P5|STARTED|Washout (at Least 14 Days)||5
2397685|NCT01354496|5881095|P4|STARTED|Washout (at Least 14 Days)||6
2397686|NCT01354496|5881096|P3|STARTED|Washout (at Least 14 Days)||4
2397687|NCT01354496|5881097|P2|STARTED|Washout (at Least 14 Days)||6
2397688|NCT01354496|5881098|P1|STARTED|Washout (at Least 14 Days)||6
2397689|NCT01354496|5881093|P6|NOT COMPLETED|Period 1||0
2397690|NCT01354496|5881094|P5|NOT COMPLETED|Period 1||0
2397691|NCT01354496|5881095|P4|NOT COMPLETED|Period 1||0
2397692|NCT01354496|5881096|P3|NOT COMPLETED|Period 1||2
2397693|NCT01354496|5881097|P2|NOT COMPLETED|Period 1||0
2397694|NCT01354496|5881098|P1|NOT COMPLETED|Period 1||0
2397695|NCT01354496|5881093|P6|COMPLETED|Period 1||6
2397696|NCT01354496|5881094|P5|COMPLETED|Period 1||5
2397697|NCT01354496|5881095|P4|COMPLETED|Period 1||6
2397698|NCT01354496|5881096|P3|COMPLETED|Period 1||4
2397699|NCT01354496|5881097|P2|COMPLETED|Period 1||6
2397700|NCT01354496|5881098|P1|COMPLETED|Period 1||6
2397701|NCT01354496|5881093|P6|Received at Least 1 Dose of Study Drug|Period 1||6
2397702|NCT01354496|5881094|P5|Received at Least 1 Dose of Study Drug|Period 1||5
2397703|NCT01354496|5881095|P4|Received at Least 1 Dose of Study Drug|Period 1||6
2397704|NCT01354496|5881096|P3|Received at Least 1 Dose of Study Drug|Period 1||6
2397705|NCT01354496|5881097|P2|Received at Least 1 Dose of Study Drug|Period 1||6
2397706|NCT01354496|5881098|P1|Received at Least 1 Dose of Study Drug|Period 1||6
2397707|NCT01354496|5881093|P6|STARTED|Period 1||6
2397708|NCT01354496|5881094|P5|STARTED|Period 1||5
2397709|NCT01354496|5881095|P4|STARTED|Period 1||6
2397710|NCT01354496|5881096|P3|STARTED|Period 1||6
2397711|NCT01354496|5881097|P2|STARTED|Period 1||6
2397712|NCT01354496|5881098|P1|STARTED|Period 1||6
2397713|NCT01354444|5881127|P2|NOT COMPLETED|Overall Study||4
2397714|NCT01354444|5881128|P1|NOT COMPLETED|Overall Study||8
2397715|NCT01354444|5881127|P2|COMPLETED|Overall Study||11
2397716|NCT01354444|5881128|P1|COMPLETED|Overall Study||6
2397717|NCT01354444|5881127|P2|STARTED|Overall Study||15
2397718|NCT01354444|5881128|P1|STARTED|Overall Study||14
2397719|NCT01354431|5881141|P3|NOT COMPLETED|Participants Treated||54
2397720|NCT01354431|5881142|P2|NOT COMPLETED|Participants Treated||54
2397721|NCT01354431|5881143|P1|NOT COMPLETED|Participants Treated||59
2397722|NCT01354431|5881141|P3|COMPLETED|Participants Treated||0
2397723|NCT01354431|5881142|P2|COMPLETED|Participants Treated||0
2397724|NCT01354431|5881143|P1|COMPLETED|Participants Treated||0
2397725|NCT01354431|5881141|P3|STARTED|Participants Treated||54
2397726|NCT01354431|5881142|P2|STARTED|Participants Treated||54
2397727|NCT01354431|5881143|P1|STARTED|Participants Treated||59
2397728|NCT01354431|5881141|P3|NOT COMPLETED|Randomized to Enter Treatment Period||0
2397729|NCT01354431|5881142|P2|NOT COMPLETED|Randomized to Enter Treatment Period||0
2397730|NCT01354431|5881143|P1|NOT COMPLETED|Randomized to Enter Treatment Period||1
2397731|NCT01354431|5881141|P3|COMPLETED|Randomized to Enter Treatment Period||54
2397732|NCT01354431|5881142|P2|COMPLETED|Randomized to Enter Treatment Period||54
2397733|NCT01354431|5881143|P1|COMPLETED|Randomized to Enter Treatment Period||59
2397734|NCT01354431|5881141|P3|STARTED|Randomized to Enter Treatment Period||54
2397735|NCT01354431|5881142|P2|STARTED|Randomized to Enter Treatment Period||54
2397736|NCT01354431|5881143|P1|STARTED|Randomized to Enter Treatment Period||60
2397737|NCT01354314|5881167|P4|NOT COMPLETED|Overall Study||6
2397738|NCT01354314|5881168|P3|NOT COMPLETED|Overall Study||8
2397739|NCT01354314|5881169|P2|NOT COMPLETED|Overall Study||3
2397740|NCT01354314|5881170|P1|NOT COMPLETED|Overall Study||6
2397741|NCT01354314|5881167|P4|COMPLETED|Overall Study||5
2397742|NCT01354314|5881168|P3|COMPLETED|Overall Study||3
2397743|NCT01354314|5881169|P2|COMPLETED|Overall Study||8
2397744|NCT01354314|5881170|P1|COMPLETED|Overall Study||6
2397745|NCT01354314|5881167|P4|Completed (ITT)|Overall Study||10
2397746|NCT01354314|5881168|P3|Completed (ITT)|Overall Study||9
2397747|NCT01354314|5881169|P2|Completed (ITT)|Overall Study||11
2397748|NCT01354314|5881170|P1|Completed (ITT)|Overall Study||11
2397749|NCT01354314|5881167|P4|STARTED|Overall Study||11
2397750|NCT01354314|5881168|P3|STARTED|Overall Study||11
2397751|NCT01354314|5881169|P2|STARTED|Overall Study||11
2397752|NCT01354314|5881170|P1|STARTED|Overall Study||12
2397753|NCT01354223|5881306|P2|NOT COMPLETED|Overall Study||1
2397754|NCT01354223|5881307|P1|NOT COMPLETED|Overall Study||3
2397755|NCT01354223|5881306|P2|COMPLETED|Overall Study||29
2397756|NCT01354223|5881307|P1|COMPLETED|Overall Study||57
2397757|NCT01354223|5881306|P2|STARTED|Overall Study||30
2397758|NCT01354223|5881307|P1|STARTED|Overall Study||60
2397759|NCT01354197|5881323|P1|NOT COMPLETED|Overall Study||0
2397760|NCT01354197|5881323|P1|COMPLETED|Overall Study||4652
2397761|NCT01354197|5881323|P1|STARTED|Overall Study||4652
2397762|NCT01354145|5881331|P2|NOT COMPLETED|Overall Study||34
2397763|NCT01354145|5881332|P1|NOT COMPLETED|Overall Study||39
2397764|NCT01354145|5881331|P2|COMPLETED|Overall Study||63
2397765|NCT01354145|5881332|P1|COMPLETED|Overall Study||58
2397766|NCT01354145|5881331|P2|STARTED|Overall Study||97
2397767|NCT01354145|5881332|P1|STARTED|Overall Study||97
2397768|NCT01354132|5881366|P2|NOT COMPLETED|1 Month Post Study Medication||3
2397769|NCT01354132|5881367|P1|NOT COMPLETED|1 Month Post Study Medication||1
2397770|NCT01354132|5881366|P2|COMPLETED|1 Month Post Study Medication||16
2397771|NCT01354132|5881367|P1|COMPLETED|1 Month Post Study Medication||21
2397772|NCT01354132|5881366|P2|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||16
2397773|NCT01354132|5881367|P1|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||21
2397774|NCT01354132|5881366|P2|STARTED|1 Month Post Study Medication||19
2397775|NCT01354132|5881367|P1|STARTED|1 Month Post Study Medication||22
2397776|NCT01354132|5881366|P2|NOT COMPLETED|Double Blind (Visits 1-7)||11
2397777|NCT01354132|5881367|P1|NOT COMPLETED|Double Blind (Visits 1-7)||9
2397778|NCT01354132|5881366|P2|COMPLETED|Double Blind (Visits 1-7)||19
2397779|NCT01354132|5881367|P1|COMPLETED|Double Blind (Visits 1-7)||22
2397780|NCT01354132|5881366|P2|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||4
2397781|NCT01354132|5881367|P1|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||2
2397782|NCT01354132|5881366|P2|Stopped After First Visit|Double Blind (Visits 1-7)||2
2397783|NCT01354132|5881367|P1|Stopped After First Visit|Double Blind (Visits 1-7)||3
2397784|NCT01354132|5881366|P2|Completed More Than 1 Visit|Double Blind (Visits 1-7)||5
2397785|NCT01354132|5881367|P1|Completed More Than 1 Visit|Double Blind (Visits 1-7)||4
2397786|NCT01354132|5881366|P2|STARTED|Double Blind (Visits 1-7)|11 did not compete 7 study visits|30
2397787|NCT01354132|5881367|P1|STARTED|Double Blind (Visits 1-7)|9 did not compete 7 study visits|31
2397788|NCT01354132|5881366|P2|NOT COMPLETED|Randomization||1
2397789|NCT01354132|5881367|P1|NOT COMPLETED|Randomization||1
2397790|NCT01354132|5881366|P2|COMPLETED|Randomization||30
2397791|NCT01354132|5881367|P1|COMPLETED|Randomization||31
2397792|NCT01354132|5881366|P2|STARTED|Randomization|1 never took study medication due to subject withdrawal|31
2397793|NCT01354132|5881367|P1|STARTED|Randomization|1 never took study medication dropped by physician decision (White matter lesion on MRI)|32
2397794|NCT01354106|5881405|P1|NOT COMPLETED|Overall Study||2
2397795|NCT01354106|5881405|P1|COMPLETED|Overall Study||24
2397796|NCT01354106|5881405|P1|STARTED|Overall Study||26
2397797|NCT01354028|5881411|P2|NOT COMPLETED|Overall Study||5
2397798|NCT01354028|5881412|P1|NOT COMPLETED|Overall Study||2
2397799|NCT01354028|5881411|P2|COMPLETED|Overall Study||10
2397800|NCT01354028|5881412|P1|COMPLETED|Overall Study||13
2397801|NCT01354028|5881411|P2|STARTED|Overall Study||15
2397802|NCT01354028|5881412|P1|STARTED|Overall Study||15
2397803|NCT01354015|5881426|P2|NOT COMPLETED|Overall Study||5
2397804|NCT01354015|5881427|P1|NOT COMPLETED|Overall Study||6
2397805|NCT01354015|5881426|P2|COMPLETED|Overall Study||43
2397806|NCT01354015|5881427|P1|COMPLETED|Overall Study||44
2397807|NCT01354015|5881426|P2|STARTED|Overall Study||48
2397808|NCT01354015|5881427|P1|STARTED|Overall Study||50
2397809|NCT01353976|5881437|P2|NOT COMPLETED|Overall Study||51
2397810|NCT01353976|5881438|P1|NOT COMPLETED|Overall Study||48
2397811|NCT01353976|5881437|P2|COMPLETED|Overall Study||83
2397812|NCT01353976|5881438|P1|COMPLETED|Overall Study||82
2397813|NCT01353976|5881437|P2|STARTED|Overall Study||134
2397814|NCT01353976|5881438|P1|STARTED|Overall Study||130
2397815|NCT01353963|5881448|P1|NOT COMPLETED|Overall Study||2
2397816|NCT01353963|5881448|P1|COMPLETED|Overall Study||11
2397817|NCT01353963|5881448|P1|STARTED|Overall Study||13
2397818|NCT01353911|5881466|P8|NOT COMPLETED|Overall Study||15
2397819|NCT01353911|5881467|P7|NOT COMPLETED|Overall Study||6
2397820|NCT01353911|5881468|P6|NOT COMPLETED|Overall Study||7
2397821|NCT01353911|5881469|P5|NOT COMPLETED|Overall Study||6
2397822|NCT01353911|5881470|P4|NOT COMPLETED|Overall Study||2
2397823|NCT01353911|5881471|P3|NOT COMPLETED|Overall Study||9
2397824|NCT01353911|5881472|P2|NOT COMPLETED|Overall Study||9
2397825|NCT01353911|5881473|P1|NOT COMPLETED|Overall Study||8
2397826|NCT01353911|5881466|P8|COMPLETED|Overall Study||51
2397827|NCT01353911|5881467|P7|COMPLETED|Overall Study||30
2397828|NCT01353911|5881468|P6|COMPLETED|Overall Study||36
2397829|NCT01353911|5881469|P5|COMPLETED|Overall Study||23
2397830|NCT01353911|5881470|P4|COMPLETED|Overall Study||22
2397831|NCT01353911|5881471|P3|COMPLETED|Overall Study||59
2397832|NCT01353911|5881472|P2|COMPLETED|Overall Study||57
2397833|NCT01353911|5881473|P1|COMPLETED|Overall Study||28
2397834|NCT01353911|5881466|P8|STARTED|Overall Study||66
2397835|NCT01353911|5881467|P7|STARTED|Overall Study||36
2397836|NCT01353911|5881468|P6|STARTED|Overall Study||43
2397837|NCT01353911|5881469|P5|STARTED|Overall Study||29
2397838|NCT01353911|5881470|P4|STARTED|Overall Study||24
2397839|NCT01353911|5881471|P3|STARTED|Overall Study||68
2397840|NCT01353911|5881472|P2|STARTED|Overall Study||66
2397841|NCT01353911|5881473|P1|STARTED|Overall Study||36
2397842|NCT01353898|5881553|P6|NOT COMPLETED|Overall Study||1
2397843|NCT01353898|5881554|P5|NOT COMPLETED|Overall Study||0
2397844|NCT01353898|5881555|P4|NOT COMPLETED|Overall Study||0
2397845|NCT01353898|5881556|P3|NOT COMPLETED|Overall Study||0
2397846|NCT01353898|5881557|P2|NOT COMPLETED|Overall Study||0
2397847|NCT01353898|5881558|P1|NOT COMPLETED|Overall Study||0
2397848|NCT01353898|5881553|P6|COMPLETED|Overall Study||1
2397849|NCT01353898|5881554|P5|COMPLETED|Overall Study||2
2397850|NCT01353898|5881555|P4|COMPLETED|Overall Study||2
2397851|NCT01353898|5881556|P3|COMPLETED|Overall Study||2
2397852|NCT01353898|5881557|P2|COMPLETED|Overall Study||2
2397853|NCT01353898|5881558|P1|COMPLETED|Overall Study||2
2397854|NCT01353898|5881553|P6|STARTED|Overall Study||2
2397855|NCT01353898|5881554|P5|STARTED|Overall Study||2
2397856|NCT01353898|5881555|P4|STARTED|Overall Study||2
2397857|NCT01353898|5881556|P3|STARTED|Overall Study||2
2397858|NCT01353898|5881557|P2|STARTED|Overall Study||2
2397859|NCT01353898|5881558|P1|STARTED|Overall Study||2
2397860|NCT01353859|5881584|P1|NOT COMPLETED|Overall Study||4
2397861|NCT01353859|5881584|P1|COMPLETED|Overall Study||35
2397862|NCT01353859|5881584|P1|STARTED|Overall Study||39
2397863|NCT01353703|5881599|P2|NOT COMPLETED|Overall Study||0
2397864|NCT01353703|5881600|P1|NOT COMPLETED|Overall Study||1
2397865|NCT01353703|5881599|P2|COMPLETED|Overall Study||112
2397866|NCT01353703|5881600|P1|COMPLETED|Overall Study||111
2397867|NCT01353703|5881599|P2|STARTED|Overall Study||112
2397868|NCT01353703|5881600|P1|STARTED|Overall Study||112
2397869|NCT01353664|5881646|P1|NOT COMPLETED|Overall Study||19
2397870|NCT01353664|5881646|P1|COMPLETED|Overall Study|Completed = Number of participants who continued on Romidepsin treatment|0
2397871|NCT01353664|5881646|P1|STARTED|Overall Study|Participants who received at least 1 dose of study drug.|19
2397872|NCT01353586|5881652|P2|NOT COMPLETED|Overall Study||2
2397873|NCT01353586|5881653|P1|NOT COMPLETED|Overall Study||7
2397874|NCT01353586|5881652|P2|COMPLETED|Overall Study||17
2397875|NCT01353586|5881653|P1|COMPLETED|Overall Study||160
2397876|NCT01353586|5881652|P2|Participated in SNA Substudy|Overall Study||19
2397877|NCT01353586|5881653|P1|Participated in SNA Substudy|Overall Study||19
2397878|NCT01353586|5881652|P2|Participated in Roll-in Phase|Overall Study||0
2397879|NCT01353586|5881653|P1|Participated in Roll-in Phase|Overall Study||22
2397880|NCT01353586|5881652|P2|Participated in Workflow Phase|Overall Study||0
2397881|NCT01353586|5881653|P1|Participated in Workflow Phase|Overall Study||20
2397882|NCT01353586|5881652|P2|STARTED|Overall Study||19
2397883|NCT01353586|5881653|P1|STARTED|Overall Study||167
2397884|NCT01353508|5881671|P4|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
2397885|NCT01353508|5881672|P3|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
2397886|NCT01353508|5881673|P2|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
2397887|NCT01353508|5881674|P1|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||1
2397888|NCT01353508|5881671|P4|COMPLETED|Period 2 - Second Intervention (7 Days)||7
2397889|NCT01353508|5881672|P3|COMPLETED|Period 2 - Second Intervention (7 Days)||8
2397890|NCT01353508|5881673|P2|COMPLETED|Period 2 - Second Intervention (7 Days)||8
2397891|NCT01353508|5881674|P1|COMPLETED|Period 2 - Second Intervention (7 Days)||7
2397892|NCT01353508|5881671|P4|STARTED|Period 2 - Second Intervention (7 Days)||7
2397893|NCT01353508|5881672|P3|STARTED|Period 2 - Second Intervention (7 Days)||8
2397894|NCT01353508|5881673|P2|STARTED|Period 2 - Second Intervention (7 Days)||8
2397895|NCT01353508|5881674|P1|STARTED|Period 2 - Second Intervention (7 Days)||8
2397896|NCT01353508|5881671|P4|NOT COMPLETED|Period 1 - First Intervention (7 Days)||1
2397897|NCT01353508|5881672|P3|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
2397898|NCT01353508|5881673|P2|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
2397899|NCT01353508|5881674|P1|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
2397900|NCT01353508|5881671|P4|COMPLETED|Period 1 - First Intervention (7 Days)||7
2397901|NCT01353508|5881672|P3|COMPLETED|Period 1 - First Intervention (7 Days)||8
2397902|NCT01353508|5881673|P2|COMPLETED|Period 1 - First Intervention (7 Days)||8
2397903|NCT01353508|5881674|P1|COMPLETED|Period 1 - First Intervention (7 Days)||8
2397904|NCT01353508|5881671|P4|STARTED|Period 1 - First Intervention (7 Days)||8
2397905|NCT01353508|5881672|P3|STARTED|Period 1 - First Intervention (7 Days)||8
2397906|NCT01353508|5881673|P2|STARTED|Period 1 - First Intervention (7 Days)||8
2397907|NCT01353508|5881674|P1|STARTED|Period 1 - First Intervention (7 Days)||8
2397908|NCT01353274|5881752|P1|NOT COMPLETED|Overall Study||28
2397909|NCT01353274|5881752|P1|COMPLETED|Overall Study||1129
2397910|NCT01353274|5881752|P1|STARTED|Overall Study||1157
2397911|NCT01353222|5881762|P2|NOT COMPLETED|Overall Study||72
2397912|NCT01353222|5881763|P1|NOT COMPLETED|Overall Study||70
2397913|NCT01353222|5881762|P2|COMPLETED|Overall Study||0
2397914|NCT01353222|5881763|P1|COMPLETED|Overall Study||0
2397915|NCT01353222|5881762|P2|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||72
2397916|NCT01353222|5881763|P1|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||0
2397917|NCT01353222|5881762|P2|DN24-02 Arm ≥1 Leukapheresis|Overall Study||0
2397918|NCT01353222|5881763|P1|DN24-02 Arm ≥1 Leukapheresis|Overall Study||67
2397919|NCT01353222|5881762|P2|STARTED|Overall Study||72
2397920|NCT01353222|5881763|P1|STARTED|Overall Study||70
2397921|NCT01353196|5881771|P2|NOT COMPLETED|Overall Study||11
2397922|NCT01353196|5881772|P1|NOT COMPLETED|Overall Study||29
2397923|NCT01353196|5881771|P2|COMPLETED|Overall Study||59
2397924|NCT01353196|5881772|P1|COMPLETED|Overall Study||71
2397925|NCT01353196|5881771|P2|STARTED|Overall Study||70
2397926|NCT01353196|5881772|P1|STARTED|Overall Study||100
2397927|NCT01353144|5881780|P2|NOT COMPLETED|Overall Study||8
2397928|NCT01353144|5881781|P1|NOT COMPLETED|Overall Study||9
2397929|NCT01353144|5881780|P2|COMPLETED|Overall Study||81
2397930|NCT01353144|5881781|P1|COMPLETED|Overall Study||80
2397931|NCT01353144|5881780|P2|STARTED|Overall Study||89
2397932|NCT01353144|5881781|P1|STARTED|Overall Study||89
2397933|NCT01353079|5881791|P2|NOT COMPLETED|Overall Study||21
2397934|NCT01353079|5881792|P1|NOT COMPLETED|Overall Study||27
2397935|NCT01353079|5881791|P2|COMPLETED|Overall Study||190
2397936|NCT01353079|5881792|P1|COMPLETED|Overall Study||191
2397937|NCT01353079|5881791|P2|STARTED|Overall Study||211
2397938|NCT01353079|5881792|P1|STARTED|Overall Study||218
2397939|NCT01352845|5881806|P2|NOT COMPLETED|Overall Study||203
2397940|NCT01352845|5881807|P1|NOT COMPLETED|Overall Study||671
2397941|NCT01352845|5881806|P2|COMPLETED|Overall Study||619
2397942|NCT01352845|5881807|P1|COMPLETED|Overall Study||1800
2397943|NCT01352845|5881806|P2|STARTED|Overall Study||822
2397944|NCT01352845|5881807|P1|STARTED|Overall Study||2471
2397945|NCT01352793|5881896|P2|NOT COMPLETED|Overall Study||245
2397946|NCT01352793|5881897|P1|NOT COMPLETED|Overall Study||585
2397947|NCT01352793|5881896|P2|COMPLETED|Overall Study||1663
2397948|NCT01352793|5881897|P1|COMPLETED|Overall Study||3219
2397949|NCT01352793|5881896|P2|Vaccination 3|Overall Study||1710
2397950|NCT01352793|5881897|P1|Vaccination 3|Overall Study||3314
2397951|NCT01352793|5881896|P2|Vaccination 2|Overall Study||1806
2397952|NCT01352793|5881897|P1|Vaccination 2|Overall Study||3530
2397953|NCT01352793|5881896|P2|Vaccination 1|Overall Study||1908
2397954|NCT01352793|5881897|P1|Vaccination 1|Overall Study||3796
2397955|NCT01352793|5881896|P2|STARTED|Overall Study||1908
2397956|NCT01352793|5881897|P1|STARTED|Overall Study||3804
2397957|NCT01352741|5881921|P2|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
2397958|NCT01352741|5881922|P1|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
2397959|NCT01352741|5881921|P2|COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
2397960|NCT01352741|5881922|P1|COMPLETED|Open-Label Tapentadol Pick-Up Arm||37
2397961|NCT01352741|5881921|P2|STARTED|Open-Label Tapentadol Pick-Up Arm|Participants did not continue treatment. They were switched to tapentadol PR or discontinued.|0
2397962|NCT01352741|5881922|P1|STARTED|Open-Label Tapentadol Pick-Up Arm|19 from tapentadol in the comparative phase and 18 from tapentadol & pregabalin entered this arm.|37
2397963|NCT01352741|5881921|P2|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||0
2397964|NCT01352741|5881922|P1|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||8
2397965|NCT01352741|5881921|P2|COMPLETED|Open-Label Tapentadol Continuation Arm||0
2397966|NCT01352741|5881922|P1|COMPLETED|Open-Label Tapentadol Continuation Arm||51
2397967|NCT01352741|5881921|P2|Full Analysis Set|Open-Label Tapentadol Continuation Arm||0
2397968|NCT01352741|5881922|P1|Full Analysis Set|Open-Label Tapentadol Continuation Arm||57
2397969|NCT01352741|5881921|P2|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||0
2397970|NCT01352741|5881922|P1|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||2
2397971|NCT01352741|5881921|P2|STARTED|Open-Label Tapentadol Continuation Arm|In this period no tapentadol PR and pregabalin treatment was planned by the protocol.|0
2397972|NCT01352741|5881922|P1|STARTED|Open-Label Tapentadol Continuation Arm|59 of the 73 participants that did not qualify for the comparative period entered this arm.|59
2397973|NCT01352741|5881921|P2|NOT COMPLETED|Double-blind Comparative Period||26
2397974|NCT01352741|5881922|P1|NOT COMPLETED|Double-blind Comparative Period||28
2397975|NCT01352741|5881921|P2|COMPLETED|Double-blind Comparative Period||133
2397976|NCT01352741|5881922|P1|COMPLETED|Double-blind Comparative Period||126
2397977|NCT01352741|5881921|P2|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||137
2397978|NCT01352741|5881922|P1|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||123
2397979|NCT01352741|5881921|P2|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||137
2397980|NCT01352741|5881922|P1|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||123
2397981|NCT01352741|5881921|P2|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||137
2397982|NCT01352741|5881922|P1|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||123
2397983|NCT01352741|5881921|P2|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||137
2397984|NCT01352741|5881922|P1|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||123
2397985|NCT01352741|5881921|P2|EQ-5D Per Protocol Set|Double-blind Comparative Period||143
2397986|NCT01352741|5881922|P1|EQ-5D Per Protocol Set|Double-blind Comparative Period||131
2397987|NCT01352741|5881921|P2|SF-12 Per Protocol Set|Double-blind Comparative Period||143
2397988|NCT01352741|5881922|P1|SF-12 Per Protocol Set|Double-blind Comparative Period||131
2397989|NCT01352741|5881921|P2|painDetect Per Protocol Set|Double-blind Comparative Period||127
2397990|NCT01352741|5881922|P1|painDetect Per Protocol Set|Double-blind Comparative Period||109
2397991|NCT01352741|5881921|P2|Per Protocol Set|Double-blind Comparative Period||149
2397992|NCT01352741|5881922|P1|Per Protocol Set|Double-blind Comparative Period||139
2397993|NCT01352741|5881921|P2|Major Protocol Deviations|Double-blind Comparative Period||8
2397994|NCT01352741|5881922|P1|Major Protocol Deviations|Double-blind Comparative Period||13
2397995|NCT01352741|5881921|P2|Full Analysis Set|Double-blind Comparative Period||157
2397996|NCT01352741|5881922|P1|Full Analysis Set|Double-blind Comparative Period||152
2397997|NCT01352741|5881921|P2|No Pain Assessments Available|Double-blind Comparative Period||2
2397998|NCT01352741|5881922|P1|No Pain Assessments Available|Double-blind Comparative Period||2
2397999|NCT01352741|5881921|P2|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||18
2398000|NCT01352741|5881922|P1|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||19
2398001|NCT01352741|5881921|P2|STARTED|Double-blind Comparative Period|159 of the 313 participants that qualified were randomized to tapentadol and pregabalin treatment.|159
2398002|NCT01352741|5881922|P1|STARTED|Double-blind Comparative Period|Of the 313 participants that qualified for randomization 154 were randomized to tapentadol.|154
2398003|NCT01352741|5881921|P2|NOT COMPLETED|Open-label Tapentadol Titration Period||0
2398004|NCT01352741|5881922|P1|NOT COMPLETED|Open-label Tapentadol Titration Period||73
2398005|NCT01352741|5881921|P2|COMPLETED|Open-label Tapentadol Titration Period||0
2398006|NCT01352741|5881922|P1|COMPLETED|Open-label Tapentadol Titration Period|59 of 73 participants not completing the titration period entered the open-label continuation arm.|372
2398007|NCT01352741|5881921|P2|Full Analysis Set|Open-label Tapentadol Titration Period||0
2398008|NCT01352741|5881922|P1|Full Analysis Set|Open-label Tapentadol Titration Period||436
2398009|NCT01352741|5881921|P2|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||0
2398010|NCT01352741|5881922|P1|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||59
2398011|NCT01352741|5881921|P2|STARTED|Open-label Tapentadol Titration Period||0
2398012|NCT01352741|5881922|P1|STARTED|Open-label Tapentadol Titration Period|All participants started with 2 x 50 mg tapentadol PR and titrated upwards in steps of 100 mg/day.|445
2398013|NCT01352715|5882016|P2|NOT COMPLETED|Overall Study||46
2398014|NCT01352715|5882017|P1|NOT COMPLETED|Overall Study||45
2398015|NCT01352715|5882016|P2|COMPLETED|Overall Study||209
2398016|NCT01352715|5882017|P1|COMPLETED|Overall Study||215
2398017|NCT01352715|5882016|P2|STARTED|Overall Study||255
2398018|NCT01352715|5882017|P1|STARTED|Overall Study||260
2398019|NCT01352637|5882043|P4|NOT COMPLETED|Drug||35
2398020|NCT01352637|5882044|P3|NOT COMPLETED|Drug||25
2398021|NCT01352637|5882045|P2|NOT COMPLETED|Drug||0
2398022|NCT01352637|5882046|P1|NOT COMPLETED|Drug||0
2398023|NCT01352637|5882043|P4|COMPLETED|Drug||62
2398024|NCT01352637|5882044|P3|COMPLETED|Drug||70
2398025|NCT01352637|5882045|P2|COMPLETED|Drug||0
2398026|NCT01352637|5882046|P1|COMPLETED|Drug||0
2398027|NCT01352637|5882043|P4|STARTED|Drug||97
2398028|NCT01352637|5882044|P3|STARTED|Drug||95
2398029|NCT01352637|5882045|P2|STARTED|Drug||0
2398030|NCT01352637|5882046|P1|STARTED|Drug||0
2398031|NCT01352637|5882043|P4|NOT COMPLETED|Exposure Therapy||0
2398032|NCT01352637|5882044|P3|NOT COMPLETED|Exposure Therapy||0
2398033|NCT01352637|5882045|P2|NOT COMPLETED|Exposure Therapy||33
2398034|NCT01352637|5882046|P1|NOT COMPLETED|Exposure Therapy||27
2398035|NCT01352637|5882043|P4|COMPLETED|Exposure Therapy||0
2398036|NCT01352637|5882044|P3|COMPLETED|Exposure Therapy||0
2398037|NCT01352637|5882045|P2|COMPLETED|Exposure Therapy||62
2398038|NCT01352637|5882046|P1|COMPLETED|Exposure Therapy||70
2398039|NCT01352637|5882043|P4|STARTED|Exposure Therapy||0
2398040|NCT01352637|5882044|P3|STARTED|Exposure Therapy||0
2398041|NCT01352637|5882045|P2|STARTED|Exposure Therapy||95
2398042|NCT01352637|5882046|P1|STARTED|Exposure Therapy||97
2398043|NCT01352585|5882056|P1|NOT COMPLETED|Overall Study||11
2398044|NCT01352585|5882056|P1|COMPLETED|Overall Study||36
2398045|NCT01352585|5882056|P1|STARTED|Overall Study||47
2398046|NCT01352546|5882067|P1|NOT COMPLETED|Overall Study||0
2398047|NCT01352546|5882067|P1|COMPLETED|Overall Study||31
2398048|NCT01352546|5882067|P1|STARTED|Overall Study||31
2398049|NCT01352507|5882073|P2|NOT COMPLETED|Extension Phase||0
2398050|NCT01352507|5882074|P1|NOT COMPLETED|Extension Phase||0
2398051|NCT01352507|5882073|P2|COMPLETED|Extension Phase||173
2398052|NCT01352507|5882074|P1|COMPLETED|Extension Phase||164
2398053|NCT01352507|5882073|P2|STARTED|Extension Phase||173
2398054|NCT01352507|5882074|P1|STARTED|Extension Phase||164
2398055|NCT01352507|5882073|P2|NOT COMPLETED|Treatment Period 2||3
2398056|NCT01352507|5882074|P1|NOT COMPLETED|Treatment Period 2||6
2398057|NCT01352507|5882073|P2|COMPLETED|Treatment Period 2|Seven participants who completed Treatment Period 2 chose not to enter the Extension Phase.|180
2398058|NCT01352507|5882074|P1|COMPLETED|Treatment Period 2|Six participants who completed Treatment Period 2 chose not to enter the Extension Phase.|170
2398059|NCT01352507|5882073|P2|Received Treatment|Treatment Period 2||181
2398060|NCT01352507|5882074|P1|Received Treatment|Treatment Period 2||173
2398061|NCT01352507|5882073|P2|STARTED|Treatment Period 2||183
2398062|NCT01352507|5882074|P1|STARTED|Treatment Period 2||176
2398063|NCT01352507|5882073|P2|NOT COMPLETED|Washout Period||1
2398064|NCT01352507|5882074|P1|NOT COMPLETED|Washout Period||0
2398065|NCT01352507|5882073|P2|COMPLETED|Washout Period||183
2398066|NCT01352507|5882074|P1|COMPLETED|Washout Period||176
2398067|NCT01352507|5882073|P2|STARTED|Washout Period||184
2398068|NCT01352507|5882074|P1|STARTED|Washout Period||176
2398069|NCT01352507|5882073|P2|NOT COMPLETED|Treatment Period 1||9
2398070|NCT01352507|5882074|P1|NOT COMPLETED|Treatment Period 1||14
2398071|NCT01352507|5882073|P2|COMPLETED|Treatment Period 1||184
2398072|NCT01352507|5882074|P1|COMPLETED|Treatment Period 1||176
2398073|NCT01352507|5882073|P2|Received Treatment|Treatment Period 1||188
2398074|NCT01352507|5882074|P1|Received Treatment|Treatment Period 1||182
2398075|NCT01352507|5882073|P2|STARTED|Treatment Period 1||193
2398076|NCT01352507|5882074|P1|STARTED|Treatment Period 1||190
2398077|NCT01352468|5882107|P2|NOT COMPLETED|Overall Study||4
2398078|NCT01352468|5882108|P1|NOT COMPLETED|Overall Study||5
2398079|NCT01352468|5882107|P2|COMPLETED|Overall Study||18
2398080|NCT01352468|5882108|P1|COMPLETED|Overall Study||17
2398081|NCT01352468|5882107|P2|STARTED|Overall Study||22
2398082|NCT01352468|5882108|P1|STARTED|Overall Study||22
2398083|NCT01352442|5882118|P1|NOT COMPLETED|Overall Study||12
2398084|NCT01352442|5882118|P1|COMPLETED|Overall Study||139
2398085|NCT01352442|5882118|P1|STARTED|Overall Study||151
2398086|NCT01352416|5882127|P4|NOT COMPLETED|Overall Study||1
2398087|NCT01352416|5882128|P3|NOT COMPLETED|Overall Study||2
2398088|NCT01352416|5882129|P2|NOT COMPLETED|Overall Study||2
2398089|NCT01352416|5882130|P1|NOT COMPLETED|Overall Study||1
2398090|NCT01352416|5882127|P4|COMPLETED|Overall Study||1
2398091|NCT01352416|5882128|P3|COMPLETED|Overall Study||0
2398092|NCT01352416|5882129|P2|COMPLETED|Overall Study||5
2398093|NCT01352416|5882130|P1|COMPLETED|Overall Study||3
2398094|NCT01352416|5882127|P4|STARTED|Overall Study||2
2398095|NCT01352416|5882128|P3|STARTED|Overall Study||2
2398096|NCT01352416|5882129|P2|STARTED|Overall Study||7
2398097|NCT01352416|5882130|P1|STARTED|Overall Study||4
2398098|NCT01352286|5882140|P1|NOT COMPLETED|Overall Study||0
2398099|NCT01352286|5882140|P1|COMPLETED|Overall Study||25
2398100|NCT01352286|5882140|P1|Received T-cells|Overall Study||25
2398101|NCT01352286|5882140|P1|STARTED|Overall Study||25
2398102|NCT01352221|5882152|P4|NOT COMPLETED|Open-label Phase||11
2398103|NCT01352221|5882153|P3|NOT COMPLETED|Open-label Phase||13
2398104|NCT01352221|5882154|P2|NOT COMPLETED|Open-label Phase||0
2398105|NCT01352221|5882155|P1|NOT COMPLETED|Open-label Phase||0
2398106|NCT01352221|5882152|P4|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|36
2398107|NCT01352221|5882153|P3|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|37
2398108|NCT01352221|5882154|P2|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
2398109|NCT01352221|5882155|P1|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
2398110|NCT01352221|5882152|P4|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|47
2398111|NCT01352221|5882153|P3|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|50
2398112|NCT01352221|5882154|P2|STARTED|Open-label Phase|Not Applicable to open-label phase|0
2398113|NCT01352221|5882155|P1|STARTED|Open-label Phase|Not Applicable to open-label phase|0
2398114|NCT01352221|5882152|P4|NOT COMPLETED|Double-blind Phase||0
2398115|NCT01352221|5882153|P3|NOT COMPLETED|Double-blind Phase||0
2398116|NCT01352221|5882154|P2|NOT COMPLETED|Double-blind Phase||11
2398117|NCT01352221|5882155|P1|NOT COMPLETED|Double-blind Phase||9
2398118|NCT01352221|5882152|P4|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
2398119|NCT01352221|5882153|P3|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
2398120|NCT01352221|5882154|P2|COMPLETED|Double-blind Phase||53
2398121|NCT01352221|5882155|P1|COMPLETED|Double-blind Phase||55
2398122|NCT01352221|5882152|P4|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
2398123|NCT01352221|5882153|P3|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
2398124|NCT01352221|5882154|P2|STARTED|Double-blind Phase||64
2398125|NCT01352221|5882155|P1|STARTED|Double-blind Phase||64
2398126|NCT01352117|5882215|P2|NOT COMPLETED|Overall Study||24
2398127|NCT01352117|5882216|P1|NOT COMPLETED|Overall Study||21
2398128|NCT01352117|5882215|P2|COMPLETED|Overall Study||72
2398129|NCT01352117|5882216|P1|COMPLETED|Overall Study||75
2398130|NCT01352117|5882215|P2|Study Week 96 Data Potential|Overall Study||61
2398131|NCT01352117|5882216|P1|Study Week 96 Data Potential|Overall Study||58
2398132|NCT01352117|5882215|P2|Study Week 48 Data Potential|Overall Study||83
2398133|NCT01352117|5882216|P1|Study Week 48 Data Potential|Overall Study||80
2398134|NCT01352117|5882215|P2|Entered Step 2 to Initiate Delayed ET|Overall Study|Only Arm A participants could enter Step 2 to receive delayed ET.|0
2398135|NCT01352117|5882216|P1|Entered Step 2 to Initiate Delayed ET|Overall Study||32
2398136|NCT01352117|5882215|P2|STARTED|Overall Study||96
2398137|NCT01352117|5882216|P1|STARTED|Overall Study||96
2398138|NCT01351740|5882270|P2|NOT COMPLETED|Overall Study||6
2398139|NCT01351740|5882271|P1|NOT COMPLETED|Overall Study||2
2398140|NCT01351740|5882270|P2|COMPLETED|Overall Study||19
2398141|NCT01351740|5882271|P1|COMPLETED|Overall Study||23
2398142|NCT01351740|5882270|P2|STARTED|Overall Study||25
2398143|NCT01351740|5882271|P1|STARTED|Overall Study||25
2398144|NCT01351623|5882279|P1|NOT COMPLETED|Overall Study||9
2398145|NCT01351623|5882279|P1|COMPLETED|Overall Study||35
2398146|NCT01351623|5882279|P1|STARTED|Overall Study||44
2398147|NCT01351506|5882285|P1|NOT COMPLETED|Overall Study||137
2398148|NCT01351506|5882285|P1|COMPLETED|Overall Study||465
2398149|NCT01351506|5882285|P1|STARTED|Overall Study||602
2398150|NCT01351480|5882295|P1|NOT COMPLETED|Overall Study||8
2398151|NCT01351480|5882295|P1|COMPLETED|Overall Study||26
2398152|NCT01351480|5882295|P1|STARTED|Overall Study||34
2398153|NCT01351415|5882305|P2|NOT COMPLETED|Overall Study||240
2398154|NCT01351415|5882306|P1|NOT COMPLETED|Overall Study||245
2398155|NCT01351415|5882305|P2|COMPLETED|Overall Study||0
2398156|NCT01351415|5882306|P1|COMPLETED|Overall Study||0
2398157|NCT01351415|5882305|P2|Treated Participants|Overall Study||232
2398158|NCT01351415|5882306|P1|Treated Participants|Overall Study||243
2398159|NCT01351415|5882305|P2|STARTED|Overall Study||240
2398160|NCT01351415|5882306|P1|STARTED|Overall Study||245
2398161|NCT01351376|5882328|P2|NOT COMPLETED|Overall Study||0
2398162|NCT01351376|5882329|P1|NOT COMPLETED|Overall Study||0
2398163|NCT01351376|5882328|P2|COMPLETED|Overall Study||11
2398164|NCT01351376|5882329|P1|COMPLETED|Overall Study||10
2398165|NCT01351376|5882328|P2|STARTED|Overall Study||11
2398166|NCT01351376|5882329|P1|STARTED|Overall Study||10
2398167|NCT01351350|5882342|P5|NOT COMPLETED|Overall Study||7
2398168|NCT01351350|5882343|P4|NOT COMPLETED|Overall Study||13
2398169|NCT01351350|5882344|P3|NOT COMPLETED|Overall Study||11
2398170|NCT01351350|5882345|P2|NOT COMPLETED|Overall Study||29
2398171|NCT01351350|5882346|P1|NOT COMPLETED|Overall Study||8
2398172|NCT01351350|5882342|P5|COMPLETED|Overall Study||0
2398173|NCT01351350|5882343|P4|COMPLETED|Overall Study||0
2398174|NCT01351350|5882344|P3|COMPLETED|Overall Study||0
2398175|NCT01351350|5882345|P2|COMPLETED|Overall Study||0
2398176|NCT01351350|5882346|P1|COMPLETED|Overall Study||0
2398177|NCT01351350|5882342|P5|Dose-escalation Evaluable|Overall Study||0
2398178|NCT01351350|5882343|P4|Dose-escalation Evaluable|Overall Study||0
2398179|NCT01351350|5882344|P3|Dose-escalation Evaluable|Overall Study||10
2398180|NCT01351350|5882345|P2|Dose-escalation Evaluable|Overall Study||23
2398181|NCT01351350|5882346|P1|Dose-escalation Evaluable|Overall Study||7
2398182|NCT01351350|5882342|P5|Treated|Overall Study||7
2398183|NCT01351350|5882343|P4|Treated|Overall Study||13
2398184|NCT01351350|5882344|P3|Treated|Overall Study||10
2398185|NCT01351350|5882345|P2|Treated|Overall Study||29
2398186|NCT01351350|5882346|P1|Treated|Overall Study||8
2398187|NCT01351350|5882342|P5|STARTED|Overall Study||7
2398188|NCT01351350|5882343|P4|STARTED|Overall Study||13
2398189|NCT01351350|5882344|P3|STARTED|Overall Study||11
2398190|NCT01351350|5882345|P2|STARTED|Overall Study||29
2398191|NCT01351350|5882346|P1|STARTED|Overall Study||8
2398192|NCT01351337|5882459|P1|NOT COMPLETED|Overall Study||0
2398193|NCT01351337|5882459|P1|COMPLETED|Overall Study||58
2398194|NCT01351337|5882459|P1|STARTED|Overall Study||58
2398195|NCT01351090|5882468|P3|NOT COMPLETED|Overall Study||6
2398196|NCT01351090|5882469|P2|NOT COMPLETED|Overall Study||11
2398197|NCT01351090|5882470|P1|NOT COMPLETED|Overall Study||11
2398198|NCT01351090|5882468|P3|COMPLETED|Overall Study||36
2398199|NCT01351090|5882469|P2|COMPLETED|Overall Study||31
2398200|NCT01351090|5882470|P1|COMPLETED|Overall Study||32
2398201|NCT01351090|5882468|P3|STARTED|Overall Study||42
2398202|NCT01351090|5882469|P2|STARTED|Overall Study||42
2398203|NCT01351090|5882470|P1|STARTED|Overall Study||43
2398204|NCT01351077|5882489|P2|NOT COMPLETED|Overall Study||0
2398205|NCT01351077|5882490|P1|NOT COMPLETED|Overall Study||0
2398206|NCT01351077|5882489|P2|COMPLETED|Overall Study||180
2398207|NCT01351077|5882490|P1|COMPLETED|Overall Study||180
2398208|NCT01351077|5882489|P2|STARTED|Overall Study||180
2398209|NCT01351077|5882490|P1|STARTED|Overall Study||180
2398210|NCT01351064|5882506|P2|NOT COMPLETED|Overall Study||0
2398211|NCT01351064|5882507|P1|NOT COMPLETED|Overall Study||0
2398212|NCT01351064|5882506|P2|COMPLETED|Overall Study||42
2398213|NCT01351064|5882507|P1|COMPLETED|Overall Study||42
2398214|NCT01351064|5882506|P2|STARTED|Overall Study||42
2398215|NCT01351064|5882507|P1|STARTED|Overall Study||42
2398216|NCT01351025|5882517|P2|NOT COMPLETED|Week 44 - 48||0
2398217|NCT01351025|5882518|P1|NOT COMPLETED|Week 44 - 48||0
2398218|NCT01351025|5882517|P2|COMPLETED|Week 44 - 48||43
2398219|NCT01351025|5882518|P1|COMPLETED|Week 44 - 48||42
2398220|NCT01351025|5882517|P2|STARTED|Week 44 - 48||43
2398221|NCT01351025|5882518|P1|STARTED|Week 44 - 48||42
2398222|NCT01351025|5882517|P2|NOT COMPLETED|Week 24 - 44||4
2398223|NCT01351025|5882518|P1|NOT COMPLETED|Week 24 - 44||1
2398224|NCT01351025|5882517|P2|COMPLETED|Week 24 - 44||43
2398225|NCT01351025|5882518|P1|COMPLETED|Week 24 - 44||42
2398226|NCT01351025|5882517|P2|STARTED|Week 24 - 44||47
2398227|NCT01351025|5882518|P1|STARTED|Week 24 - 44||43
2398228|NCT01351025|5882517|P2|NOT COMPLETED|Week 20 - 24||0
2398229|NCT01351025|5882518|P1|NOT COMPLETED|Week 20 - 24||0
2398230|NCT01351025|5882517|P2|COMPLETED|Week 20 - 24||47
2398231|NCT01351025|5882518|P1|COMPLETED|Week 20 - 24||43
2398232|NCT01351025|5882517|P2|STARTED|Week 20 - 24||47
2398233|NCT01351025|5882518|P1|STARTED|Week 20 - 24||43
2398234|NCT01351025|5882517|P2|NOT COMPLETED|Week 0 - 20||1
2398235|NCT01351025|5882518|P1|NOT COMPLETED|Week 0 - 20||3
2398236|NCT01351025|5882517|P2|COMPLETED|Week 0 - 20||47
2398237|NCT01351025|5882518|P1|COMPLETED|Week 0 - 20||43
2398238|NCT01351025|5882517|P2|STARTED|Week 0 - 20||48
2398239|NCT01351025|5882518|P1|STARTED|Week 0 - 20||46
2398240|NCT01350999|5882551|P3|NOT COMPLETED|Overall Study||21
2398241|NCT01350999|5882552|P2|NOT COMPLETED|Overall Study||14
2398242|NCT01350999|5882553|P1|NOT COMPLETED|Overall Study||8
2398243|NCT01350999|5882551|P3|COMPLETED|Overall Study||146
2398244|NCT01350999|5882552|P2|COMPLETED|Overall Study||157
2398245|NCT01350999|5882553|P1|COMPLETED|Overall Study||157
2398246|NCT01350999|5882551|P3|Treated|Overall Study||167
2398247|NCT01350999|5882552|P2|Treated|Overall Study||171
2398248|NCT01350999|5882553|P1|Treated|Overall Study||165
2398249|NCT01350999|5882551|P3|STARTED|Overall Study||167
2398250|NCT01350999|5882552|P2|STARTED|Overall Study||171
2398251|NCT01350999|5882553|P1|STARTED|Overall Study||165
2398252|NCT01350973|5882591|P3|NOT COMPLETED|Overall Study||8
2398253|NCT01350973|5882592|P2|NOT COMPLETED|Overall Study||8
2398254|NCT01350973|5882593|P1|NOT COMPLETED|Overall Study||6
2398255|NCT01350973|5882591|P3|COMPLETED|Overall Study||187
2398256|NCT01350973|5882592|P2|COMPLETED|Overall Study||202
2398257|NCT01350973|5882593|P1|COMPLETED|Overall Study||200
2398258|NCT01350973|5882591|P3|Received Treatment|Overall Study||195
2398259|NCT01350973|5882592|P2|Received Treatment|Overall Study||210
2398260|NCT01350973|5882593|P1|Received Treatment|Overall Study||205
2398261|NCT01350973|5882591|P3|STARTED|Overall Study||195
2398262|NCT01350973|5882592|P2|STARTED|Overall Study||210
2398263|NCT01350973|5882593|P1|STARTED|Overall Study||206
2398264|NCT01350947|5882628|P1|NOT COMPLETED|Overall Study||0
2398265|NCT01350947|5882628|P1|COMPLETED|Overall Study||11
2398266|NCT01350947|5882628|P1|STARTED|Overall Study||11
2398267|NCT01350934|5882634|P2|NOT COMPLETED|Extension Study||4
2398268|NCT01350934|5882635|P1|NOT COMPLETED|Extension Study||5
2398269|NCT01350934|5882634|P2|COMPLETED|Extension Study||101
2398270|NCT01350934|5882635|P1|COMPLETED|Extension Study||95
2398271|NCT01350934|5882634|P2|STARTED|Extension Study||105
2398272|NCT01350934|5882635|P1|STARTED|Extension Study||100
2398273|NCT01350934|5882634|P2|NOT COMPLETED|Base Study||3
2398274|NCT01350934|5882635|P1|NOT COMPLETED|Base Study||11
2398275|NCT01350934|5882634|P2|COMPLETED|Base Study||105
2398276|NCT01350934|5882635|P1|COMPLETED|Base Study||100
2398277|NCT01350934|5882634|P2|STARTED|Base Study||108
2398278|NCT01350934|5882635|P1|STARTED|Base Study||111
2398279|NCT01350804|5882657|P4|NOT COMPLETED|Extension Study, Weeks 52 - 260||23
2398280|NCT01350804|5882658|P3|NOT COMPLETED|Extension Study, Weeks 52 - 260||72
2398281|NCT01350804|5882659|P2|NOT COMPLETED|Extension Study, Weeks 52 - 260||79
2398282|NCT01350804|5882660|P1|NOT COMPLETED|Extension Study, Weeks 52 - 260||80
2398283|NCT01350804|5882657|P4|COMPLETED|Extension Study, Weeks 52 - 260||0
2398284|NCT01350804|5882658|P3|COMPLETED|Extension Study, Weeks 52 - 260||0
2398285|NCT01350804|5882659|P2|COMPLETED|Extension Study, Weeks 52 - 260||0
2398286|NCT01350804|5882660|P1|COMPLETED|Extension Study, Weeks 52 - 260||0
2398287|NCT01350804|5882657|P4|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|23
2398288|NCT01350804|5882658|P3|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|72
2398289|NCT01350804|5882659|P2|STARTED|Extension Study, Weeks 52 - 260||79
2398290|NCT01350804|5882660|P1|STARTED|Extension Study, Weeks 52 - 260||80
2398291|NCT01350804|5882657|P4|NOT COMPLETED|Core Study||26
2398292|NCT01350804|5882658|P3|NOT COMPLETED|Core Study||47
2398293|NCT01350804|5882659|P2|NOT COMPLETED|Core Study||47
2398294|NCT01350804|5882660|P1|NOT COMPLETED|Core Study||41
2398295|NCT01350804|5882657|P4|COMPLETED|Core Study||112
2398296|NCT01350804|5882658|P3|COMPLETED|Core Study||91
2398297|NCT01350804|5882659|P2|COMPLETED|Core Study||90
2398298|NCT01350804|5882660|P1|COMPLETED|Core Study||97
2398299|NCT01350804|5882657|P4|Full Analysis Set|Core Study||138
2398300|NCT01350804|5882658|P3|Full Analysis Set|Core Study||138
2398301|NCT01350804|5882659|P2|Full Analysis Set|Core Study||137
2398302|NCT01350804|5882660|P1|Full Analysis Set|Core Study||138
2398303|NCT01350804|5882657|P4|Treatment Switch to AIN457 at Week 24|Core Study||37
2398304|NCT01350804|5882658|P3|Treatment Switch to AIN457 at Week 24|Core Study||45
2398305|NCT01350804|5882659|P2|Treatment Switch to AIN457 at Week 24|Core Study||0
2398306|NCT01350804|5882660|P1|Treatment Switch to AIN457 at Week 24|Core Study||0
2398307|NCT01350804|5882657|P4|Tratment Switch to AIN457 at Week 16|Core Study||0
2398308|NCT01350804|5882658|P3|Tratment Switch to AIN457 at Week 16|Core Study|15 participantsdiscontinued prior to the treatment switch|78
2398309|NCT01350804|5882659|P2|Tratment Switch to AIN457 at Week 16|Core Study||0
2398310|NCT01350804|5882660|P1|Tratment Switch to AIN457 at Week 16|Core Study||0
2398311|NCT01350804|5882657|P4|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|137
2398312|NCT01350804|5882658|P3|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|139
2398313|NCT01350804|5882659|P2|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|136
2398314|NCT01350804|5882660|P1|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|137
2398315|NCT01350804|5882657|P4|STARTED|Core Study||138
2398316|NCT01350804|5882658|P3|STARTED|Core Study||138
2398317|NCT01350804|5882659|P2|STARTED|Core Study||137
2398318|NCT01350804|5882660|P1|STARTED|Core Study||138
2398319|NCT01350583|5882749|P1|NOT COMPLETED|Overall Study||0
2398320|NCT01350583|5882749|P1|COMPLETED|Overall Study||2
2398321|NCT01350583|5882749|P1|STARTED|Overall Study||2
2398322|NCT01350544|5882757|P2|NOT COMPLETED|Overall Study||22
2398323|NCT01350544|5882758|P1|NOT COMPLETED|Overall Study||23
2398324|NCT01350544|5882757|P2|COMPLETED|Overall Study||86
2398325|NCT01350544|5882758|P1|COMPLETED|Overall Study||85
2398326|NCT01350544|5882757|P2|STARTED|Overall Study||108
2398327|NCT01350544|5882758|P1|STARTED|Overall Study||108
2398328|NCT01350505|5882764|P1|NOT COMPLETED|Overall Study||4
2398329|NCT01350505|5882764|P1|COMPLETED|Overall Study||17
2398330|NCT01350505|5882764|P1|STARTED|Overall Study||21
2398331|NCT01350479|5882770|P2|NOT COMPLETED|Overall Study||0
2398332|NCT01350479|5882771|P1|NOT COMPLETED|Overall Study||0
2398333|NCT01350479|5882770|P2|COMPLETED|Overall Study||106
2398334|NCT01350479|5882771|P1|COMPLETED|Overall Study||94
2398335|NCT01350479|5882770|P2|STARTED|Overall Study||106
2398336|NCT01350479|5882771|P1|STARTED|Overall Study||94
2398337|NCT01350453|5882779|P2|NOT COMPLETED|Overall Study||1
2398338|NCT01350453|5882780|P1|NOT COMPLETED|Overall Study||2
2398339|NCT01350453|5882779|P2|COMPLETED|Overall Study||7
2398340|NCT01350453|5882780|P1|COMPLETED|Overall Study||9
2398341|NCT01350453|5882779|P2|STARTED|Overall Study||8
2398342|NCT01350453|5882780|P1|STARTED|Overall Study||11
2398343|NCT01350414|5882794|P1|NOT COMPLETED|Overall Study||19
2398344|NCT01350414|5882794|P1|COMPLETED|Overall Study||162
2398345|NCT01350414|5882794|P1|Year 5|Overall Study||162
2398346|NCT01350414|5882794|P1|Year 4|Overall Study||159
2398347|NCT01350414|5882794|P1|Year 3|Overall Study||162
2398348|NCT01350414|5882794|P1|Year 2|Overall Study||165
2398349|NCT01350414|5882794|P1|STARTED|Overall Study||181
2398350|NCT01350401|5882811|P1|NOT COMPLETED|Overall Study||0
2398351|NCT01350401|5882811|P1|COMPLETED|Overall Study||4
2398352|NCT01350401|5882811|P1|STARTED|Overall Study||4
2398353|NCT01350388|5882823|P2|NOT COMPLETED|Overall Study||1
2398354|NCT01350388|5882824|P1|NOT COMPLETED|Overall Study||3
2398355|NCT01350388|5882823|P2|COMPLETED|Overall Study||39
2398356|NCT01350388|5882824|P1|COMPLETED|Overall Study||37
2398357|NCT01350388|5882823|P2|STARTED|Overall Study||40
2398358|NCT01350388|5882824|P1|STARTED|Overall Study||40
2398359|NCT01350271|5882843|P3|NOT COMPLETED|Overall Study||26
2398360|NCT01350271|5882844|P2|NOT COMPLETED|Overall Study||17
2398361|NCT01350271|5882845|P1|NOT COMPLETED|Overall Study||21
2398362|NCT01350271|5882843|P3|COMPLETED|Overall Study||48
2398363|NCT01350271|5882844|P2|COMPLETED|Overall Study||53
2398364|NCT01350271|5882845|P1|COMPLETED|Overall Study||49
2398365|NCT01350271|5882843|P3|STARTED|Overall Study||74
2398366|NCT01350271|5882844|P2|STARTED|Overall Study||70
2398367|NCT01350271|5882845|P1|STARTED|Overall Study||70
2398368|NCT01350258|5882859|P1|NOT COMPLETED|Overall Study||0
2398369|NCT01350258|5882859|P1|COMPLETED|Overall Study||8
2398370|NCT01350258|5882859|P1|STARTED|Overall Study||8
2398371|NCT01350245|5882868|P1|NOT COMPLETED|Overall Study||0
2398372|NCT01350245|5882868|P1|COMPLETED|Overall Study||28
2398373|NCT01350245|5882868|P1|STARTED|Overall Study||28
2398374|NCT01350232|5882873|P1|NOT COMPLETED|Overall Study||0
2398375|NCT01350232|5882873|P1|COMPLETED|Overall Study||2
2398376|NCT01350232|5882873|P1|STARTED|Overall Study||2
2398377|NCT01350141|5882887|P3|NOT COMPLETED|Overall Study||1
2398378|NCT01350141|5882888|P2|NOT COMPLETED|Overall Study||0
2398379|NCT01350141|5882889|P1|NOT COMPLETED|Overall Study||3
2398380|NCT01350141|5882887|P3|COMPLETED|Overall Study||15
2398381|NCT01350141|5882888|P2|COMPLETED|Overall Study||15
2398382|NCT01350141|5882889|P1|COMPLETED|Overall Study||12
2398383|NCT01350141|5882887|P3|Treated|Overall Study||16
2398384|NCT01350141|5882888|P2|Treated|Overall Study||15
2398385|NCT01350141|5882889|P1|Treated|Overall Study||14
2398386|NCT01350141|5882887|P3|STARTED|Overall Study||16
2398387|NCT01350141|5882888|P2|STARTED|Overall Study||15
2398388|NCT01350141|5882889|P1|STARTED|Overall Study||15
2398389|NCT01350128|5882923|P1|NOT COMPLETED|Overall Study||14
2398390|NCT01350128|5882923|P1|COMPLETED|Overall Study||89
2398391|NCT01350128|5882923|P1|Atrovent HFA 34 µg BID|Overall Study||48
2398392|NCT01350128|5882923|P1|Placebo MDI BID|Overall Study||48
2398393|NCT01350128|5882923|P1|GP MDI 4.6 µg BID|Overall Study||45
2398394|NCT01350128|5882923|P1|GP MDI 9 µg BID|Overall Study||49
2398395|NCT01350128|5882923|P1|GP MDI 18 µg BID|Overall Study||49
2398396|NCT01350128|5882923|P1|GP MDI 36 µg BID|Overall Study|Glycopyrronium Metered Dose Inhaler|49
2398397|NCT01350128|5882923|P1|STARTED|Overall Study||103
2398398|NCT01350115|5882987|P2|NOT COMPLETED|Long Term Follow-Up (All Patients)||2
2398399|NCT01350115|5882988|P1|NOT COMPLETED|Long Term Follow-Up (All Patients)||1
2398400|NCT01350115|5882987|P2|COMPLETED|Long Term Follow-Up (All Patients)||0
2398401|NCT01350115|5882988|P1|COMPLETED|Long Term Follow-Up (All Patients)||7
2398402|NCT01350115|5882987|P2|STARTED|Long Term Follow-Up (All Patients)||2
2398403|NCT01350115|5882988|P1|STARTED|Long Term Follow-Up (All Patients)||8
2398404|NCT01350115|5882987|P2|NOT COMPLETED|Core Study (All Patients)||0
2398405|NCT01350115|5882988|P1|NOT COMPLETED|Core Study (All Patients)||0
2398406|NCT01350115|5882987|P2|COMPLETED|Core Study (All Patients)||2
2398407|NCT01350115|5882988|P1|COMPLETED|Core Study (All Patients)||8
2398408|NCT01350115|5882987|P2|Pharmacodynamic Set|Core Study (All Patients)||2
2398409|NCT01350115|5882988|P1|Pharmacodynamic Set|Core Study (All Patients)||7
2398410|NCT01350115|5882987|P2|Safety Anlysis Set|Core Study (All Patients)||2
2398411|NCT01350115|5882988|P1|Safety Anlysis Set|Core Study (All Patients)||8
2398412|NCT01350115|5882987|P2|STARTED|Core Study (All Patients)||2
2398413|NCT01350115|5882988|P1|STARTED|Core Study (All Patients)||8
2398414|NCT01350102|5883004|P4|NOT COMPLETED|Overall Study||0
2398415|NCT01350102|5883005|P3|NOT COMPLETED|Overall Study||1
2398416|NCT01350102|5883006|P2|NOT COMPLETED|Overall Study||0
2398417|NCT01350102|5883007|P1|NOT COMPLETED|Overall Study||0
2398418|NCT01350102|5883004|P4|COMPLETED|Overall Study||0
2398419|NCT01350102|5883005|P3|COMPLETED|Overall Study||0
2398420|NCT01350102|5883006|P2|COMPLETED|Overall Study||1
2398421|NCT01350102|5883007|P1|COMPLETED|Overall Study||0
2398422|NCT01350102|5883004|P4|STARTED|Overall Study||0
2398423|NCT01350102|5883005|P3|STARTED|Overall Study||1
2398424|NCT01350102|5883006|P2|STARTED|Overall Study||1
2398425|NCT01350102|5883007|P1|STARTED|Overall Study||0
2398426|NCT01349972|5883027|P2|NOT COMPLETED|Overall Study||2
2398427|NCT01349972|5883028|P1|NOT COMPLETED|Overall Study||5
2398428|NCT01349972|5883027|P2|COMPLETED|Overall Study||56
2398429|NCT01349972|5883028|P1|COMPLETED|Overall Study||109
2398430|NCT01349972|5883027|P2|STARTED|Overall Study||58
2398431|NCT01349972|5883028|P1|STARTED|Overall Study||114
2398432|NCT01349959|5883044|P1|NOT COMPLETED|Overall Study||7
2398433|NCT01349959|5883044|P1|COMPLETED|Overall Study||33
2398434|NCT01349959|5883044|P1|STARTED|Overall Study||40
2398435|NCT01349933|5883055|P1|NOT COMPLETED|Overall Study||0
2398436|NCT01349933|5883055|P1|COMPLETED|Overall Study||21
2398437|NCT01349933|5883055|P1|STARTED|Overall Study||21
2398438|NCT01349920|5883065|P1|NOT COMPLETED|Overall Study||0
2398439|NCT01349920|5883065|P1|COMPLETED|Overall Study||15
2398440|NCT01349920|5883065|P1|STARTED|Overall Study||15
2398441|NCT01349907|5883085|P2|NOT COMPLETED|Overall Study||43
2398442|NCT01349907|5883086|P1|NOT COMPLETED|Overall Study||139
2398443|NCT01349907|5883085|P2|COMPLETED|Overall Study||38
2398444|NCT01349907|5883086|P1|COMPLETED|Overall Study||102
2398445|NCT01349907|5883085|P2|STARTED|Overall Study|Enrolled and Treated|81
2398446|NCT01349907|5883086|P1|STARTED|Overall Study|Enrolled and Treated|241
2398447|NCT01349829|5883124|P2|NOT COMPLETED|Overall Study||23
2398448|NCT01349829|5883125|P1|NOT COMPLETED|Overall Study||9
2398449|NCT01349829|5883124|P2|COMPLETED|Overall Study||102
2398450|NCT01349829|5883125|P1|COMPLETED|Overall Study||117
2398451|NCT01349829|5883124|P2|STARTED|Overall Study||125
2398452|NCT01349829|5883125|P1|STARTED|Overall Study||126
2398453|NCT01349816|5883143|P1|NOT COMPLETED|Overall Study||30
2398454|NCT01349816|5883143|P1|COMPLETED|Overall Study||155
2398455|NCT01349816|5883143|P1|FF MDI 9.6 µg|Overall Study||61
2398456|NCT01349816|5883143|P1|GFF MDI 9/9.6 µg|Overall Study||57
2398457|NCT01349816|5883143|P1|GFF MDI 18/9.6 µg|Overall Study||57
2398458|NCT01349816|5883143|P1|GFF MDI 36/9.6 µg|Overall Study||56
2398459|NCT01349816|5883143|P1|GFF MDI 36/7.2 µg|Overall Study||58
2398460|NCT01349816|5883143|P1|GP MDI 36 µg|Overall Study||61
2398461|NCT01349816|5883143|P1|STARTED|Overall Study||185
2398462|NCT01349803|5883209|P4|NOT COMPLETED|Overall Study||2
2398463|NCT01349803|5883210|P3|NOT COMPLETED|Overall Study||3
2398464|NCT01349803|5883211|P2|NOT COMPLETED|Overall Study||1
2398465|NCT01349803|5883212|P1|NOT COMPLETED|Overall Study||1
2398466|NCT01349803|5883209|P4|COMPLETED|Overall Study||57
2398467|NCT01349803|5883210|P3|COMPLETED|Overall Study||57
2398468|NCT01349803|5883211|P2|COMPLETED|Overall Study||57
2398469|NCT01349803|5883212|P1|COMPLETED|Overall Study||59
2398470|NCT01349803|5883209|P4|STARTED|Overall Study||59
2398471|NCT01349803|5883210|P3|STARTED|Overall Study||60
2398472|NCT01349803|5883211|P2|STARTED|Overall Study||58
2398473|NCT01349803|5883212|P1|STARTED|Overall Study||60
2398474|NCT01349790|5883282|P1|NOT COMPLETED|Overall Study||9
2398475|NCT01349790|5883282|P1|COMPLETED|Overall Study||31
2398476|NCT01349790|5883282|P1|STARTED|Overall Study||40
2398477|NCT01349673|5883301|P1|NOT COMPLETED|Overall Study||114
2398478|NCT01349673|5883301|P1|COMPLETED|Overall Study||0
2398479|NCT01349673|5883301|P1|Received At Least 1 Dose Of Study Drug|Overall Study||114
2398480|NCT01349673|5883301|P1|Participants Entered Cycle 8|Overall Study||1
2398481|NCT01349673|5883301|P1|Participants Entered Cycle 7|Overall Study||3
2398482|NCT01349673|5883301|P1|Participants Entered Cycle 6|Overall Study||5
2398483|NCT01349673|5883301|P1|Participants Entered Cycle 5|Overall Study||12
2398484|NCT01349673|5883301|P1|Participants Entered Cycle 4|Overall Study||22
2398485|NCT01349673|5883301|P1|Participants Entered Cycle 3|Overall Study||41
2398486|NCT01349673|5883301|P1|Participants Entered Cycle 2|Overall Study||65
2398487|NCT01349673|5883301|P1|Participants Entered Cycle 1|Overall Study||114
2398488|NCT01349673|5883301|P1|STARTED|Overall Study||114
2398489|NCT01349660|5883311|P3|NOT COMPLETED|Overall Study||76
2398490|NCT01349660|5883312|P2|NOT COMPLETED|Overall Study||6
2398491|NCT01349660|5883313|P1|NOT COMPLETED|Overall Study||6
2398492|NCT01349660|5883311|P3|COMPLETED|Overall Study||0
2398493|NCT01349660|5883312|P2|COMPLETED|Overall Study||0
2398494|NCT01349660|5883313|P1|COMPLETED|Overall Study||0
2398495|NCT01349660|5883311|P3|STARTED|Overall Study||76
2398496|NCT01349660|5883312|P2|STARTED|Overall Study||6
2398497|NCT01349660|5883313|P1|STARTED|Overall Study||6
2398498|NCT01349595|5883331|P2|NOT COMPLETED|Overall Study||2
2398499|NCT01349595|5883332|P1|NOT COMPLETED|Overall Study||2
2398500|NCT01349595|5883331|P2|COMPLETED|Overall Study||0
2398501|NCT01349595|5883332|P1|COMPLETED|Overall Study||0
2398502|NCT01349595|5883331|P2|STARTED|Overall Study||2
2398503|NCT01349595|5883332|P1|STARTED|Overall Study||2
2398504|NCT01349569|5883338|P1|NOT COMPLETED|Overall Study||4
2398505|NCT01349569|5883338|P1|COMPLETED|Overall Study||12
2398506|NCT01349569|5883338|P1|STARTED|Overall Study||16
2398507|NCT01349491|5883350|P2|NOT COMPLETED|Overall Study||0
2398508|NCT01349491|5883351|P1|NOT COMPLETED|Overall Study||0
2398509|NCT01349491|5883350|P2|COMPLETED|Overall Study||5
2398510|NCT01349491|5883351|P1|COMPLETED|Overall Study||5
2398511|NCT01349491|5883350|P2|STARTED|Overall Study||5
2398512|NCT01349491|5883351|P1|STARTED|Overall Study||5
2398513|NCT01349465|5883359|P2|NOT COMPLETED|Overall Study||22
2398514|NCT01349465|5883360|P1|NOT COMPLETED|Overall Study||18
2398515|NCT01349465|5883359|P2|COMPLETED|Overall Study||27
2398516|NCT01349465|5883360|P1|COMPLETED|Overall Study||182
2398517|NCT01349465|5883359|P2|STARTED|Overall Study||49
2398518|NCT01349465|5883360|P1|STARTED|Overall Study||200
2398519|NCT01349231|5883372|P1|NOT COMPLETED|Overall Study||0
2398520|NCT01349231|5883372|P1|COMPLETED|Overall Study||10
2398521|NCT01349231|5883372|P1|STARTED|Overall Study||10
2398522|NCT01349192|5883381|P2|NOT COMPLETED|Overall Study||6
2398523|NCT01349192|5883382|P1|NOT COMPLETED|Overall Study||3
2398524|NCT01349192|5883381|P2|COMPLETED|Overall Study||17
2398525|NCT01349192|5883382|P1|COMPLETED|Overall Study||21
2398526|NCT01349192|5883381|P2|Withdrawals|Overall Study||6
2398527|NCT01349192|5883382|P1|Withdrawals|Overall Study||3
2398528|NCT01349192|5883381|P2|Evaluable for Primary Endpoint|Overall Study||19
2398529|NCT01349192|5883382|P1|Evaluable for Primary Endpoint|Overall Study||22
2398530|NCT01349192|5883381|P2|STARTED|Overall Study||23
2398531|NCT01349192|5883382|P1|STARTED|Overall Study||24
2398532|NCT01349114|5883396|P2|NOT COMPLETED|Overall Study||0
2398533|NCT01349114|5883397|P1|NOT COMPLETED|Overall Study||0
2398534|NCT01349114|5883396|P2|COMPLETED|Overall Study||11
2398535|NCT01349114|5883397|P1|COMPLETED|Overall Study||10
2398536|NCT01349114|5883396|P2|STARTED|Overall Study||11
2398537|NCT01349114|5883397|P1|STARTED|Overall Study||10
2398538|NCT01349049|5883414|P9|NOT COMPLETED|Overall Study||55
2398539|NCT01349049|5883415|P8|NOT COMPLETED|Overall Study||4
2398540|NCT01349049|5883416|P7|NOT COMPLETED|Overall Study||5
2398541|NCT01349049|5883417|P6|NOT COMPLETED|Overall Study||6
2398542|NCT01349049|5883418|P5|NOT COMPLETED|Overall Study||3
2398543|NCT01349049|5883419|P4|NOT COMPLETED|Overall Study||3
2398544|NCT01349049|5883420|P3|NOT COMPLETED|Overall Study||3
2398545|NCT01349049|5883421|P2|NOT COMPLETED|Overall Study||7
2398546|NCT01349049|5883422|P1|NOT COMPLETED|Overall Study||3
2398547|NCT01349049|5883414|P9|COMPLETED|Overall Study||1
2398548|NCT01349049|5883415|P8|COMPLETED|Overall Study||0
2398549|NCT01349049|5883416|P7|COMPLETED|Overall Study||0
2398550|NCT01349049|5883417|P6|COMPLETED|Overall Study||0
2398551|NCT01349049|5883418|P5|COMPLETED|Overall Study||0
2398552|NCT01349049|5883419|P4|COMPLETED|Overall Study||0
2398553|NCT01349049|5883420|P3|COMPLETED|Overall Study||0
2398554|NCT01349049|5883421|P2|COMPLETED|Overall Study||0
2398555|NCT01349049|5883422|P1|COMPLETED|Overall Study||0
2398556|NCT01349049|5883414|P9|STARTED|Overall Study||56
2398557|NCT01349049|5883415|P8|STARTED|Overall Study||4
2398558|NCT01349049|5883416|P7|STARTED|Overall Study||5
2398559|NCT01349049|5883417|P6|STARTED|Overall Study||6
2398560|NCT01349049|5883418|P5|STARTED|Overall Study||3
2398561|NCT01349049|5883419|P4|STARTED|Overall Study||3
2398562|NCT01349049|5883420|P3|STARTED|Overall Study||3
2398563|NCT01349049|5883421|P2|STARTED|Overall Study||7
2398564|NCT01349049|5883422|P1|STARTED|Overall Study||3
2398565|NCT01349036|5883476|P2|NOT COMPLETED|Overall Study||24
2398566|NCT01349036|5883477|P1|NOT COMPLETED|Overall Study||14
2398567|NCT01349036|5883476|P2|COMPLETED|Overall Study||0
2398568|NCT01349036|5883477|P1|COMPLETED|Overall Study||0
2398569|NCT01349036|5883476|P2|STARTED|Overall Study||24
2398570|NCT01349036|5883477|P1|STARTED|Overall Study||14
2398571|NCT01348854|5883495|P2|NOT COMPLETED|Overall Study||1
2398572|NCT01348854|5883496|P1|NOT COMPLETED|Overall Study||3
2398573|NCT01348854|5883495|P2|COMPLETED|Overall Study|9 eyes of 5 participants|5
2398574|NCT01348854|5883496|P1|COMPLETED|Overall Study|47 eyes of 31 participants|31
2398575|NCT01348854|5883495|P2|STARTED|Overall Study|10 eyes of 6 participants|6
2398576|NCT01348854|5883496|P1|STARTED|Overall Study|53 eyes of 34 participants|34
2398577|NCT01348789|5883504|P1|NOT COMPLETED|Overall Study||4
2398578|NCT01348789|5883504|P1|COMPLETED|Overall Study|4 subjects did not complete all 3 treatments but were evaluated for primary and secondary endpoints.|33
2398579|NCT01348789|5883504|P1|STARTED|Overall Study||37
2398580|NCT01348776|5883515|P1|NOT COMPLETED|Overall Study||3
2398581|NCT01348776|5883515|P1|COMPLETED|Overall Study||84
2398582|NCT01348776|5883515|P1|STARTED|Overall Study|3 subjects were lost to follow-up: 2 after the 1-month follow-up, 1 after performing 4 treatments|87
2398583|NCT01348763|5883528|P1|NOT COMPLETED|Without Tenofovir/Emtricitabine (11 Day)||0
2398584|NCT01348763|5883528|P1|COMPLETED|Without Tenofovir/Emtricitabine (11 Day)||11
2398585|NCT01348763|5883528|P1|STARTED|Without Tenofovir/Emtricitabine (11 Day)||11
2398586|NCT01348763|5883528|P1|NOT COMPLETED|With Tenofovir/Emtricitabine (10 Days)||2
2398587|NCT01348763|5883528|P1|COMPLETED|With Tenofovir/Emtricitabine (10 Days)||11
2398588|NCT01348763|5883528|P1|STARTED|With Tenofovir/Emtricitabine (10 Days)||13
2398589|NCT01348698|5883533|P1|NOT COMPLETED|Overall Study||72
2398590|NCT01348698|5883533|P1|COMPLETED|Overall Study||2
2398591|NCT01348698|5883533|P1|STARTED|Overall Study||74
2398592|NCT01348607|5883543|P3|NOT COMPLETED|Overall Study||0
2398593|NCT01348607|5883544|P2|NOT COMPLETED|Overall Study||0
2398594|NCT01348607|5883545|P1|NOT COMPLETED|Overall Study||0
2398595|NCT01348607|5883543|P3|COMPLETED|Overall Study||0
2398596|NCT01348607|5883544|P2|COMPLETED|Overall Study||0
2398597|NCT01348607|5883545|P1|COMPLETED|Overall Study||1
2398598|NCT01348607|5883543|P3|STARTED|Overall Study||0
2398599|NCT01348607|5883544|P2|STARTED|Overall Study||0
2398600|NCT01348607|5883545|P1|STARTED|Overall Study||1
2398607|NCT01348490|5883575|P1|NOT COMPLETED|Overall Study||24
2398608|NCT01348490|5883575|P1|COMPLETED|Overall Study||42
2398609|NCT01348490|5883575|P1|STARTED|Overall Study||66
2398610|NCT01348425|5883633|P2|NOT COMPLETED|Overall Study||1
2398611|NCT01348425|5883634|P1|NOT COMPLETED|Overall Study||1
2398612|NCT01348425|5883633|P2|COMPLETED|Overall Study||13
2398613|NCT01348425|5883634|P1|COMPLETED|Overall Study||30
2398614|NCT01348425|5883633|P2|STARTED|Overall Study||14
2398615|NCT01348425|5883634|P1|STARTED|Overall Study||31
2398616|NCT01348347|5883642|P3|NOT COMPLETED|Overall Study||6
2398617|NCT01348347|5883643|P2|NOT COMPLETED|Overall Study||6
2398618|NCT01348347|5883644|P1|NOT COMPLETED|Overall Study||3
2398619|NCT01348347|5883642|P3|COMPLETED|Overall Study||0
2398620|NCT01348347|5883643|P2|COMPLETED|Overall Study||0
2398621|NCT01348347|5883644|P1|COMPLETED|Overall Study||0
2398622|NCT01348347|5883642|P3|STARTED|Overall Study||6
2398623|NCT01348347|5883643|P2|STARTED|Overall Study||6
2398624|NCT01348347|5883644|P1|STARTED|Overall Study||3
2398625|NCT01348165|5883675|P7|NOT COMPLETED|Overall Study||1
2398626|NCT01348165|5883676|P6|NOT COMPLETED|Overall Study||0
2398627|NCT01348165|5883677|P5|NOT COMPLETED|Overall Study||0
2398628|NCT01348165|5883678|P4|NOT COMPLETED|Overall Study||0
2398629|NCT01348165|5883679|P3|NOT COMPLETED|Overall Study||0
2398630|NCT01348165|5883680|P2|NOT COMPLETED|Overall Study||0
2398631|NCT01348165|5883681|P1|NOT COMPLETED|Overall Study||0
2398632|NCT01348165|5883675|P7|COMPLETED|Overall Study||5
2398633|NCT01348165|5883676|P6|COMPLETED|Overall Study||1
2398634|NCT01348165|5883677|P5|COMPLETED|Overall Study||6
2398635|NCT01348165|5883678|P4|COMPLETED|Overall Study||6
2398636|NCT01348165|5883679|P3|COMPLETED|Overall Study||6
2398637|NCT01348165|5883680|P2|COMPLETED|Overall Study||5
2398638|NCT01348165|5883681|P1|COMPLETED|Overall Study||10
2398639|NCT01348165|5883675|P7|STARTED|Overall Study||6
2398640|NCT01348165|5883676|P6|STARTED|Overall Study||1
2398641|NCT01348165|5883677|P5|STARTED|Overall Study||6
2398642|NCT01348165|5883678|P4|STARTED|Overall Study||6
2398643|NCT01348165|5883679|P3|STARTED|Overall Study||6
2398644|NCT01348165|5883680|P2|STARTED|Overall Study||5
2398645|NCT01348165|5883681|P1|STARTED|Overall Study||10
2398646|NCT01348139|5883810|P6|NOT COMPLETED|Period 6||0
2398647|NCT01348139|5883811|P5|NOT COMPLETED|Period 6||0
2398648|NCT01348139|5883812|P4|NOT COMPLETED|Period 6||0
2398649|NCT01348139|5883813|P3|NOT COMPLETED|Period 6||0
2398650|NCT01348139|5883814|P2|NOT COMPLETED|Period 6||0
2398651|NCT01348139|5883815|P1|NOT COMPLETED|Period 6||0
2398652|NCT01348139|5883810|P6|COMPLETED|Period 6||4
2398653|NCT01348139|5883811|P5|COMPLETED|Period 6||5
2398654|NCT01348139|5883812|P4|COMPLETED|Period 6||4
2398655|NCT01348139|5883813|P3|COMPLETED|Period 6||4
2398656|NCT01348139|5883814|P2|COMPLETED|Period 6||4
2398657|NCT01348139|5883815|P1|COMPLETED|Period 6||4
2398658|NCT01348139|5883810|P6|STARTED|Period 6||4
2398659|NCT01348139|5883811|P5|STARTED|Period 6||5
2398660|NCT01348139|5883812|P4|STARTED|Period 6||4
2398661|NCT01348139|5883813|P3|STARTED|Period 6||4
2398662|NCT01348139|5883814|P2|STARTED|Period 6||4
2398663|NCT01348139|5883815|P1|STARTED|Period 6||4
2398664|NCT01348139|5883810|P6|NOT COMPLETED|Period 5||0
2398665|NCT01348139|5883811|P5|NOT COMPLETED|Period 5||0
2398666|NCT01348139|5883812|P4|NOT COMPLETED|Period 5||0
2398667|NCT01348139|5883813|P3|NOT COMPLETED|Period 5||0
2398668|NCT01348139|5883814|P2|NOT COMPLETED|Period 5||0
2398669|NCT01348139|5883815|P1|NOT COMPLETED|Period 5||0
2398670|NCT01348139|5883810|P6|COMPLETED|Period 5||4
2398671|NCT01348139|5883811|P5|COMPLETED|Period 5||5
2398672|NCT01348139|5883812|P4|COMPLETED|Period 5||4
2398673|NCT01348139|5883813|P3|COMPLETED|Period 5||4
2398674|NCT01348139|5883814|P2|COMPLETED|Period 5||4
2398675|NCT01348139|5883815|P1|COMPLETED|Period 5||4
2398676|NCT01348139|5883810|P6|STARTED|Period 5||4
2398677|NCT01348139|5883811|P5|STARTED|Period 5||5
2398678|NCT01348139|5883812|P4|STARTED|Period 5||4
2398679|NCT01348139|5883813|P3|STARTED|Period 5||4
2398680|NCT01348139|5883814|P2|STARTED|Period 5||4
2398681|NCT01348139|5883815|P1|STARTED|Period 5||4
2398682|NCT01348139|5883810|P6|NOT COMPLETED|Period 4||0
2398683|NCT01348139|5883811|P5|NOT COMPLETED|Period 4||0
2398684|NCT01348139|5883812|P4|NOT COMPLETED|Period 4||0
2398685|NCT01348139|5883813|P3|NOT COMPLETED|Period 4||0
2398686|NCT01348139|5883814|P2|NOT COMPLETED|Period 4||0
2398687|NCT01348139|5883815|P1|NOT COMPLETED|Period 4||0
2398688|NCT01348139|5883810|P6|COMPLETED|Period 4||4
2398689|NCT01348139|5883811|P5|COMPLETED|Period 4||5
2398690|NCT01348139|5883812|P4|COMPLETED|Period 4||4
2398691|NCT01348139|5883813|P3|COMPLETED|Period 4||4
2398692|NCT01348139|5883814|P2|COMPLETED|Period 4||4
2398693|NCT01348139|5883815|P1|COMPLETED|Period 4||4
2398694|NCT01348139|5883810|P6|STARTED|Period 4||4
2398695|NCT01348139|5883811|P5|STARTED|Period 4||5
2398696|NCT01348139|5883812|P4|STARTED|Period 4||4
2398697|NCT01348139|5883813|P3|STARTED|Period 4||4
2398698|NCT01348139|5883814|P2|STARTED|Period 4||4
2398699|NCT01348139|5883815|P1|STARTED|Period 4||4
2398700|NCT01348139|5883810|P6|NOT COMPLETED|Period 3||0
2398701|NCT01348139|5883811|P5|NOT COMPLETED|Period 3||0
2398702|NCT01348139|5883812|P4|NOT COMPLETED|Period 3||0
2398703|NCT01348139|5883813|P3|NOT COMPLETED|Period 3||0
2398704|NCT01348139|5883814|P2|NOT COMPLETED|Period 3||0
2398705|NCT01348139|5883815|P1|NOT COMPLETED|Period 3||0
2398706|NCT01348139|5883810|P6|COMPLETED|Period 3||4
2398707|NCT01348139|5883811|P5|COMPLETED|Period 3||5
2398708|NCT01348139|5883812|P4|COMPLETED|Period 3||4
2398709|NCT01348139|5883813|P3|COMPLETED|Period 3||4
2398710|NCT01348139|5883814|P2|COMPLETED|Period 3||4
2398711|NCT01348139|5883815|P1|COMPLETED|Period 3||4
2398712|NCT01348139|5883810|P6|STARTED|Period 3||4
2398713|NCT01348139|5883811|P5|STARTED|Period 3||5
2398714|NCT01348139|5883812|P4|STARTED|Period 3||4
2398715|NCT01348139|5883813|P3|STARTED|Period 3||4
2398716|NCT01348139|5883814|P2|STARTED|Period 3||4
2398717|NCT01348139|5883815|P1|STARTED|Period 3||4
2398718|NCT01348139|5883810|P6|NOT COMPLETED|Period 2||0
2398719|NCT01348139|5883811|P5|NOT COMPLETED|Period 2||0
2398720|NCT01348139|5883812|P4|NOT COMPLETED|Period 2||0
2398721|NCT01348139|5883813|P3|NOT COMPLETED|Period 2||0
2398722|NCT01348139|5883814|P2|NOT COMPLETED|Period 2||0
2398723|NCT01348139|5883815|P1|NOT COMPLETED|Period 2||0
2398724|NCT01348139|5883810|P6|COMPLETED|Period 2||4
2398725|NCT01348139|5883811|P5|COMPLETED|Period 2||5
2398726|NCT01348139|5883812|P4|COMPLETED|Period 2||4
2398727|NCT01348139|5883813|P3|COMPLETED|Period 2||4
2398728|NCT01348139|5883814|P2|COMPLETED|Period 2||4
2398729|NCT01348139|5883815|P1|COMPLETED|Period 2||4
2398730|NCT01348139|5883810|P6|STARTED|Period 2||4
2398731|NCT01348139|5883811|P5|STARTED|Period 2||5
2398732|NCT01348139|5883812|P4|STARTED|Period 2||4
2398733|NCT01348139|5883813|P3|STARTED|Period 2||4
2398734|NCT01348139|5883814|P2|STARTED|Period 2||4
2398735|NCT01348139|5883815|P1|STARTED|Period 2||4
2398736|NCT01348139|5883810|P6|NOT COMPLETED|Period 1||0
2398737|NCT01348139|5883811|P5|NOT COMPLETED|Period 1||0
2398738|NCT01348139|5883812|P4|NOT COMPLETED|Period 1||0
2398739|NCT01348139|5883813|P3|NOT COMPLETED|Period 1||0
2398740|NCT01348139|5883814|P2|NOT COMPLETED|Period 1||0
2398741|NCT01348139|5883815|P1|NOT COMPLETED|Period 1||1
2398742|NCT01348139|5883810|P6|COMPLETED|Period 1||4
2398743|NCT01348139|5883811|P5|COMPLETED|Period 1||5
2398744|NCT01348139|5883812|P4|COMPLETED|Period 1||4
2398745|NCT01348139|5883813|P3|COMPLETED|Period 1||4
2398746|NCT01348139|5883814|P2|COMPLETED|Period 1||4
2398747|NCT01348139|5883815|P1|COMPLETED|Period 1||4
2398748|NCT01348139|5883810|P6|STARTED|Period 1||4
2398749|NCT01348139|5883811|P5|STARTED|Period 1||5
2398750|NCT01348139|5883812|P4|STARTED|Period 1||4
2398751|NCT01348139|5883813|P3|STARTED|Period 1||4
2398752|NCT01348139|5883814|P2|STARTED|Period 1||4
2398753|NCT01348139|5883815|P1|STARTED|Period 1||5
2398754|NCT01348100|5883896|P7|NOT COMPLETED|Overall Study||3
2398755|NCT01348100|5883897|P6|NOT COMPLETED|Overall Study||2
2398756|NCT01348100|5883898|P5|NOT COMPLETED|Overall Study||1
2398757|NCT01348100|5883899|P4|NOT COMPLETED|Overall Study||1
2398758|NCT01348100|5883900|P3|NOT COMPLETED|Overall Study||2
2398759|NCT01348100|5883901|P2|NOT COMPLETED|Overall Study||0
2398760|NCT01348100|5883902|P1|NOT COMPLETED|Overall Study||0
2398761|NCT01348100|5883896|P7|COMPLETED|Overall Study||13
2398762|NCT01348100|5883897|P6|COMPLETED|Overall Study||14
2398763|NCT01348100|5883898|P5|COMPLETED|Overall Study||14
2398764|NCT01348100|5883899|P4|COMPLETED|Overall Study||14
2398765|NCT01348100|5883900|P3|COMPLETED|Overall Study||13
2398766|NCT01348100|5883901|P2|COMPLETED|Overall Study||2
2398767|NCT01348100|5883902|P1|COMPLETED|Overall Study||2
2398768|NCT01348100|5883896|P7|STARTED|Overall Study||16
2398769|NCT01348100|5883897|P6|STARTED|Overall Study||16
2398770|NCT01348100|5883898|P5|STARTED|Overall Study||15
2398771|NCT01348100|5883899|P4|STARTED|Overall Study||15
2398772|NCT01348100|5883900|P3|STARTED|Overall Study||15
2398773|NCT01348100|5883901|P2|STARTED|Overall Study||2
2398774|NCT01348100|5883902|P1|STARTED|Overall Study||2
2398775|NCT01348087|5883947|P1|NOT COMPLETED|Overall Study||148
2398776|NCT01348087|5883947|P1|COMPLETED|Overall Study||0
2398777|NCT01348087|5883947|P1|STARTED|Overall Study||148
2398778|NCT01347931|5883961|P1|NOT COMPLETED|NIOV System||0
2398779|NCT01347931|5883961|P1|COMPLETED|NIOV System||29
2398780|NCT01347931|5883961|P1|STARTED|NIOV System||29
2398781|NCT01347931|5883961|P1|NOT COMPLETED|Standard Oxygen Therapy||1
2398782|NCT01347931|5883961|P1|COMPLETED|Standard Oxygen Therapy||29
2398783|NCT01347931|5883961|P1|STARTED|Standard Oxygen Therapy||30
2398784|NCT01347879|5883973|P2|NOT COMPLETED|Overall Study||17
2398785|NCT01347879|5883974|P1|NOT COMPLETED|Overall Study||7
2398786|NCT01347879|5883973|P2|COMPLETED|Overall Study||83
2398787|NCT01347879|5883974|P1|COMPLETED|Overall Study||46
2398788|NCT01347879|5883973|P2|STARTED|Overall Study||100
2398789|NCT01347879|5883974|P1|STARTED|Overall Study||53
2398790|NCT01347866|5884023|P17|NOT COMPLETED|Overall Study||2
2398791|NCT01347866|5884024|P16|NOT COMPLETED|Overall Study||4
2398792|NCT01347866|5884025|P15|NOT COMPLETED|Overall Study||3
2398793|NCT01347866|5884026|P14|NOT COMPLETED|Overall Study||7
2398794|NCT01347866|5884027|P13|NOT COMPLETED|Overall Study||7
2398795|NCT01347866|5884028|P12|NOT COMPLETED|Overall Study||4
2398796|NCT01347866|5884029|P11|NOT COMPLETED|Overall Study||3
2398797|NCT01347866|5884030|P10|NOT COMPLETED|Overall Study||7
2398798|NCT01347866|5884031|P9|NOT COMPLETED|Overall Study||31
2398799|NCT01347866|5884032|P8|NOT COMPLETED|Overall Study||4
2398800|NCT01347866|5884033|P7|NOT COMPLETED|Overall Study||6
2398801|NCT01347866|5884034|P6|NOT COMPLETED|Overall Study||3
2398802|NCT01347866|5884035|P5|NOT COMPLETED|Overall Study||7
2398803|NCT01347866|5884036|P4|NOT COMPLETED|Overall Study||7
2398804|NCT01347866|5884037|P3|NOT COMPLETED|Overall Study||1
2398805|NCT01347866|5884038|P2|NOT COMPLETED|Overall Study||1
2398806|NCT01347866|5884039|P1|NOT COMPLETED|Overall Study||5
2398807|NCT01347866|5884023|P17|COMPLETED|Overall Study||0
2398808|NCT01347866|5884024|P16|COMPLETED|Overall Study||0
2398809|NCT01347866|5884025|P15|COMPLETED|Overall Study||0
2398810|NCT01347866|5884026|P14|COMPLETED|Overall Study||0
2398811|NCT01347866|5884027|P13|COMPLETED|Overall Study||0
2398812|NCT01347866|5884028|P12|COMPLETED|Overall Study||0
2398813|NCT01347866|5884029|P11|COMPLETED|Overall Study||0
2398814|NCT01347866|5884030|P10|COMPLETED|Overall Study||0
2398815|NCT01347866|5884031|P9|COMPLETED|Overall Study||0
2398816|NCT01347866|5884032|P8|COMPLETED|Overall Study||0
2398817|NCT01347866|5884033|P7|COMPLETED|Overall Study||0
2398818|NCT01347866|5884034|P6|COMPLETED|Overall Study||0
2398819|NCT01347866|5884035|P5|COMPLETED|Overall Study||0
2398820|NCT01347866|5884036|P4|COMPLETED|Overall Study||0
2398821|NCT01347866|5884037|P3|COMPLETED|Overall Study||0
2398822|NCT01347866|5884038|P2|COMPLETED|Overall Study||0
2398823|NCT01347866|5884039|P1|COMPLETED|Overall Study||0
2398824|NCT01347866|5884023|P17|STARTED|Overall Study||2
2398825|NCT01347866|5884024|P16|STARTED|Overall Study||4
2398826|NCT01347866|5884025|P15|STARTED|Overall Study||3
2398827|NCT01347866|5884026|P14|STARTED|Overall Study||7
2398828|NCT01347866|5884027|P13|STARTED|Overall Study||7
2398829|NCT01347866|5884028|P12|STARTED|Overall Study||4
2398830|NCT01347866|5884029|P11|STARTED|Overall Study||3
2398831|NCT01347866|5884030|P10|STARTED|Overall Study||7
2398832|NCT01347866|5884031|P9|STARTED|Overall Study||31
2398833|NCT01347866|5884032|P8|STARTED|Overall Study||4
2398834|NCT01347866|5884033|P7|STARTED|Overall Study||6
2398835|NCT01347866|5884034|P6|STARTED|Overall Study||3
2398836|NCT01347866|5884035|P5|STARTED|Overall Study||7
2398837|NCT01347866|5884036|P4|STARTED|Overall Study||7
2398838|NCT01347866|5884037|P3|STARTED|Overall Study||1
2398839|NCT01347866|5884038|P2|STARTED|Overall Study||1
2398840|NCT01347866|5884039|P1|STARTED|Overall Study||5
2398841|NCT01347840|5884413|P1|NOT COMPLETED|Overall Study||1
2398842|NCT01347840|5884413|P1|COMPLETED|Overall Study||0
2398843|NCT01347840|5884413|P1|STARTED|Overall Study|1 subject enrolled but withdrew consent|1
2398844|NCT01347788|5884426|P3|NOT COMPLETED|Overall Study||0
2398845|NCT01347788|5884427|P2|NOT COMPLETED|Overall Study||0
2398846|NCT01347788|5884428|P1|NOT COMPLETED|Overall Study||0
2398847|NCT01347788|5884426|P3|COMPLETED|Overall Study||13
2398848|NCT01347788|5884427|P2|COMPLETED|Overall Study||10
2398849|NCT01347788|5884428|P1|COMPLETED|Overall Study||11
2398850|NCT01347788|5884426|P3|STARTED|Overall Study||13
2398851|NCT01347788|5884427|P2|STARTED|Overall Study||10
2398852|NCT01347788|5884428|P1|STARTED|Overall Study||11
2398853|NCT01347762|5884440|P4|NOT COMPLETED|Overall Study||8
2398854|NCT01347762|5884441|P3|NOT COMPLETED|Overall Study||9
2398855|NCT01347762|5884442|P2|NOT COMPLETED|Overall Study||2
2398856|NCT01347762|5884443|P1|NOT COMPLETED|Overall Study||4
2398857|NCT01347762|5884440|P4|COMPLETED|Overall Study||10
2398858|NCT01347762|5884441|P3|COMPLETED|Overall Study||7
2398859|NCT01347762|5884442|P2|COMPLETED|Overall Study||6
2398860|NCT01347762|5884443|P1|COMPLETED|Overall Study||6
2398861|NCT01347762|5884440|P4|STARTED|Overall Study||18
2398862|NCT01347762|5884441|P3|STARTED|Overall Study||16
2398863|NCT01347762|5884442|P2|STARTED|Overall Study||8
2398864|NCT01347762|5884443|P1|STARTED|Overall Study||10
2398865|NCT01347710|5884469|P1|NOT COMPLETED|Overall Study||31
2398866|NCT01347710|5884469|P1|COMPLETED|Overall Study||764
2398867|NCT01347710|5884469|P1|STARTED|Overall Study||795
2398868|NCT01347632|5884484|P1|NOT COMPLETED|Overall Study||2
2398869|NCT01347632|5884484|P1|COMPLETED|Overall Study||33
2398870|NCT01347632|5884484|P1|STARTED|Overall Study||35
2398871|NCT01347580|5884491|P2|NOT COMPLETED|Overall Study||56
2398872|NCT01347580|5884492|P1|NOT COMPLETED|Overall Study||65
2398873|NCT01347580|5884491|P2|COMPLETED|Overall Study|based on randomized treatment|897
2398874|NCT01347580|5884492|P1|COMPLETED|Overall Study|based on randomized treatment|844
2398875|NCT01347580|5884491|P2|Safety Population|Overall Study|based on actual treatment|950
2398876|NCT01347580|5884492|P1|Safety Population|Overall Study|based on actual treatment|908
2398877|NCT01347580|5884491|P2|Modified Intent to Treat Population|Overall Study|based on randomized treatment|952
2398878|NCT01347580|5884492|P1|Modified Intent to Treat Population|Overall Study|based on randomized treatment|906
2398879|NCT01347580|5884491|P2|STARTED|Overall Study|based on randomized treatment|953
2398880|NCT01347580|5884492|P1|STARTED|Overall Study|based on randomized treatment|909
2398881|NCT01347554|5884522|P2|NOT COMPLETED|Overall Study||11
2398882|NCT01347554|5884523|P1|NOT COMPLETED|Overall Study||7
2398883|NCT01347554|5884522|P2|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=11) were excluded.|231
2398884|NCT01347554|5884523|P1|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=7) were excluded.|230
2398885|NCT01347554|5884522|P2|STARTED|Overall Study||242
2398886|NCT01347554|5884523|P1|STARTED|Overall Study||237
2398887|NCT01347255|5884535|P1|NOT COMPLETED|Overall Study||0
2398888|NCT01347255|5884535|P1|COMPLETED|Overall Study||24
2398889|NCT01347255|5884535|P1|STARTED|Overall Study||24
2398890|NCT01347112|5884560|P2|NOT COMPLETED|Overall Study||12
2398891|NCT01347112|5884561|P1|NOT COMPLETED|Overall Study||4
2398892|NCT01347112|5884560|P2|COMPLETED|Overall Study||5
2398893|NCT01347112|5884561|P1|COMPLETED|Overall Study||12
2398894|NCT01347112|5884560|P2|STARTED|Overall Study||17
2398895|NCT01347112|5884561|P1|STARTED|Overall Study||16
2398896|NCT01347086|5884581|P10|NOT COMPLETED|Overall Study||1
2398897|NCT01347086|5884582|P9|NOT COMPLETED|Overall Study||0
2398898|NCT01347086|5884583|P8|NOT COMPLETED|Overall Study||1
2398899|NCT01347086|5884584|P7|NOT COMPLETED|Overall Study||1
2398900|NCT01347086|5884585|P6|NOT COMPLETED|Overall Study||0
2398901|NCT01347086|5884586|P5|NOT COMPLETED|Overall Study||0
2398902|NCT01347086|5884587|P4|NOT COMPLETED|Overall Study||0
2398903|NCT01347086|5884588|P3|NOT COMPLETED|Overall Study||1
2398904|NCT01347086|5884589|P2|NOT COMPLETED|Overall Study||0
2398905|NCT01347086|5884590|P1|NOT COMPLETED|Overall Study||0
2398906|NCT01347086|5884581|P10|COMPLETED|Overall Study||6
2398907|NCT01347086|5884582|P9|COMPLETED|Overall Study||6
2398908|NCT01347086|5884583|P8|COMPLETED|Overall Study||6
2398909|NCT01347086|5884584|P7|COMPLETED|Overall Study||6
2398910|NCT01347086|5884585|P6|COMPLETED|Overall Study||6
2398911|NCT01347086|5884586|P5|COMPLETED|Overall Study||6
2398912|NCT01347086|5884587|P4|COMPLETED|Overall Study||6
2398913|NCT01347086|5884588|P3|COMPLETED|Overall Study||6
2398914|NCT01347086|5884589|P2|COMPLETED|Overall Study||6
2398915|NCT01347086|5884590|P1|COMPLETED|Overall Study||2
2398916|NCT01347086|5884581|P10|STARTED|Overall Study|One subject was not treated.|7
2398917|NCT01347086|5884582|P9|STARTED|Overall Study||6
2398918|NCT01347086|5884583|P8|STARTED|Overall Study|One subject was not treated.|7
2398919|NCT01347086|5884584|P7|STARTED|Overall Study|"2 participants treated together with each dose level of Deleobuvir.~1 subject was not treated."|7
2398920|NCT01347086|5884585|P6|STARTED|Overall Study||6
2398921|NCT01347086|5884586|P5|STARTED|Overall Study||6
2398922|NCT01347086|5884587|P4|STARTED|Overall Study||6
2398923|NCT01347086|5884588|P3|STARTED|Overall Study|"2 participants were treated together with each dose level of Deleobuvir.~1 subject was not treated."|7
2398924|NCT01347086|5884589|P2|STARTED|Overall Study||6
2398925|NCT01347086|5884590|P1|STARTED|Overall Study||2
2398926|NCT01347073|5884689|P1|NOT COMPLETED|Overall Study||2
2398927|NCT01347073|5884689|P1|COMPLETED|Overall Study||21
2398928|NCT01347073|5884689|P1|STARTED|Overall Study||23
2398929|NCT01347060|5884703|P2|NOT COMPLETED|Overall Study||0
2398930|NCT01347060|5884704|P1|NOT COMPLETED|Overall Study||0
2398931|NCT01347060|5884703|P2|COMPLETED|Overall Study||7580
2398932|NCT01347060|5884704|P1|COMPLETED|Overall Study||9868
2398933|NCT01347060|5884703|P2|STARTED|Overall Study||7580
2398934|NCT01347060|5884704|P1|STARTED|Overall Study||9868
2398935|NCT01347034|5884716|P2|NOT COMPLETED|Overall Study||0
2398936|NCT01347034|5884717|P1|NOT COMPLETED|Overall Study||0
2398937|NCT01347034|5884716|P2|COMPLETED|Overall Study||14
2398938|NCT01347034|5884717|P1|COMPLETED|Overall Study||6
2398939|NCT01347034|5884716|P2|STARTED|Overall Study||14
2398940|NCT01347034|5884717|P1|STARTED|Overall Study||6
2398941|NCT01347008|5884727|P2|NOT COMPLETED|Overall Study||0
2398942|NCT01347008|5884728|P1|NOT COMPLETED|Overall Study||0
2398943|NCT01347008|5884727|P2|COMPLETED|Overall Study||20
2398944|NCT01347008|5884728|P1|COMPLETED|Overall Study||21
2398945|NCT01347008|5884727|P2|STARTED|Overall Study||20
2398946|NCT01347008|5884728|P1|STARTED|Overall Study||21
2398947|NCT01346852|5884740|P2|NOT COMPLETED|Overall Study||0
2398948|NCT01346852|5884741|P1|NOT COMPLETED|Overall Study||0
2398949|NCT01346852|5884740|P2|COMPLETED|Overall Study||59684
2398950|NCT01346852|5884741|P1|COMPLETED|Overall Study||41753
2398951|NCT01346852|5884740|P2|STARTED|Overall Study||59684
2398952|NCT01346852|5884741|P1|STARTED|Overall Study||41753
2398953|NCT01346839|5884751|P2|NOT COMPLETED|Overall Study||209
2398954|NCT01346839|5884752|P1|NOT COMPLETED|Overall Study||314
2398955|NCT01346839|5884751|P2|COMPLETED|Overall Study|All triggers were applied retrospectively on 7/19/2012.|364
2398956|NCT01346839|5884752|P1|COMPLETED|Overall Study||369
2398957|NCT01346839|5884751|P2|STARTED|Overall Study||573
2398958|NCT01346839|5884752|P1|STARTED|Overall Study||683
2398959|NCT01346774|5884768|P2|NOT COMPLETED|Overall Study||17
2398960|NCT01346774|5884769|P1|NOT COMPLETED|Overall Study||13
2398961|NCT01346774|5884768|P2|COMPLETED|Overall Study||63
2398962|NCT01346774|5884769|P1|COMPLETED|Overall Study||67
2398963|NCT01346774|5884768|P2|STARTED|Overall Study||80
2398964|NCT01346774|5884769|P1|STARTED|Overall Study||80
2398965|NCT01346696|5884775|P1|NOT COMPLETED|Overall Study||1
2398966|NCT01346696|5884775|P1|COMPLETED|Overall Study||44
2398967|NCT01346696|5884775|P1|STARTED|Overall Study||45
2398968|NCT01346683|5884786|P1|NOT COMPLETED|Overall Study||0
2398969|NCT01346683|5884786|P1|COMPLETED|Overall Study||45
2398970|NCT01346683|5884786|P1|STARTED|Overall Study||45
2398971|NCT01346592|5884797|P3|NOT COMPLETED|Overall Study||78
2398972|NCT01346592|5884798|P2|NOT COMPLETED|Overall Study||89
2398973|NCT01346592|5884799|P1|NOT COMPLETED|Overall Study||153
2398974|NCT01346592|5884797|P3|COMPLETED|Overall Study||1408
2398975|NCT01346592|5884798|P2|COMPLETED|Overall Study||1389
2398976|NCT01346592|5884799|P1|COMPLETED|Overall Study||2983
2398977|NCT01346592|5884797|P3|STARTED|Overall Study||1486
2398978|NCT01346592|5884798|P2|STARTED|Overall Study||1478
2398979|NCT01346592|5884799|P1|STARTED|Overall Study||3136
2398980|NCT01346540|5884891|P2|NOT COMPLETED|Overall Study||12
2398981|NCT01346540|5884892|P1|NOT COMPLETED|Overall Study||3
2398982|NCT01346540|5884891|P2|COMPLETED|Overall Study||0
2398983|NCT01346540|5884892|P1|COMPLETED|Overall Study||1
2398984|NCT01346540|5884891|P2|STARTED|Overall Study||12
2398985|NCT01346540|5884892|P1|STARTED|Overall Study||4
2398986|NCT01346514|5884903|P2|NOT COMPLETED|Overall Study||37
2398987|NCT01346514|5884904|P1|NOT COMPLETED|Overall Study||29
2398988|NCT01346514|5884903|P2|COMPLETED|Overall Study|Number of patients completing BL-12 months.|53
2398989|NCT01346514|5884904|P1|COMPLETED|Overall Study|Number of patients completing BL-12 months|62
2398990|NCT01346514|5884903|P2|12 Month Assessment|Overall Study||53
2398991|NCT01346514|5884904|P1|12 Month Assessment|Overall Study||62
2398992|NCT01346514|5884903|P2|9 Month Assessment|Overall Study||59
2398993|NCT01346514|5884904|P1|9 Month Assessment|Overall Study||67
2398994|NCT01346514|5884903|P2|6 Month Assessment|Overall Study||61
2398995|NCT01346514|5884904|P1|6 Month Assessment|Overall Study||74
2398996|NCT01346514|5884903|P2|3 Month Assessment|Overall Study||68
2398997|NCT01346514|5884904|P1|3 Month Assessment|Overall Study||83
2398998|NCT01346514|5884903|P2|STARTED|Overall Study||90
2398999|NCT01346514|5884904|P1|STARTED|Overall Study||91
2399000|NCT01346501|5884924|P2|NOT COMPLETED|Overall Study||13
2399001|NCT01346501|5884925|P1|NOT COMPLETED|Overall Study||11
2399002|NCT01346501|5884924|P2|COMPLETED|Overall Study||80
2399003|NCT01346501|5884925|P1|COMPLETED|Overall Study||68
2399004|NCT01346501|5884924|P2|STARTED|Overall Study||93
2399005|NCT01346501|5884925|P1|STARTED|Overall Study||79
2399006|NCT01346488|5884938|P1|NOT COMPLETED|Overall Study||706
2399007|NCT01346488|5884938|P1|COMPLETED|Overall Study||1262
2399008|NCT01346488|5884938|P1|STARTED|Overall Study||1968
2399009|NCT01346475|5884958|P2|NOT COMPLETED|Second Intervention||0
2399010|NCT01346475|5884959|P1|NOT COMPLETED|Second Intervention||0
2399011|NCT01346475|5884958|P2|COMPLETED|Second Intervention||25
2399012|NCT01346475|5884959|P1|COMPLETED|Second Intervention||18
2399013|NCT01346475|5884958|P2|STARTED|Second Intervention||25
2399014|NCT01346475|5884959|P1|STARTED|Second Intervention||18
2399015|NCT01346475|5884958|P2|NOT COMPLETED|First Intervention||3
2399016|NCT01346475|5884959|P1|NOT COMPLETED|First Intervention||4
2399017|NCT01346475|5884958|P2|COMPLETED|First Intervention||25
2399018|NCT01346475|5884959|P1|COMPLETED|First Intervention||18
2399019|NCT01346475|5884958|P2|STARTED|First Intervention||28
2399020|NCT01346475|5884959|P1|STARTED|First Intervention||22
2399024|NCT01346397|5884978|P2|NOT COMPLETED|Overall Study||0
2399025|NCT01346397|5884979|P1|NOT COMPLETED|Overall Study||0
2399026|NCT01346397|5884978|P2|COMPLETED|Overall Study||85
2399027|NCT01346397|5884979|P1|COMPLETED|Overall Study||85
2399028|NCT01346397|5884978|P2|STARTED|Overall Study||85
2399029|NCT01346397|5884979|P1|STARTED|Overall Study||85
2399030|NCT01346293|5884989|P2|NOT COMPLETED|Overall Study||21
2399031|NCT01346293|5884990|P1|NOT COMPLETED|Overall Study||67
2399032|NCT01346293|5884989|P2|COMPLETED|Overall Study||608
2399033|NCT01346293|5884990|P1|COMPLETED|Overall Study||2676
2399034|NCT01346293|5884989|P2|STARTED|Overall Study||629
2399035|NCT01346293|5884990|P1|STARTED|Overall Study||2743
2399036|NCT01346189|5885020|P4|NOT COMPLETED|Overall Study||11
2399037|NCT01346189|5885021|P3|NOT COMPLETED|Overall Study||14
2399038|NCT01346189|5885022|P2|NOT COMPLETED|Overall Study||17
2399039|NCT01346189|5885023|P1|NOT COMPLETED|Overall Study||16
2399040|NCT01346189|5885020|P4|COMPLETED|Overall Study|366 patients (58 primary care physicians) included in analysis|355
2399041|NCT01346189|5885021|P3|COMPLETED|Overall Study|346 patients (58 primary care physicians) included in analysis|332
2399042|NCT01346189|5885022|P2|COMPLETED|Overall Study|358 Patients (58 primary care physicians) included in analysis|341
2399043|NCT01346189|5885023|P1|COMPLETED|Overall Study|433 patients (64 primary care physicians) included in analysis|417
2399044|NCT01346189|5885020|P4|STARTED|Overall Study||366
2399045|NCT01346189|5885021|P3|STARTED|Overall Study||346
2399046|NCT01346189|5885022|P2|STARTED|Overall Study||358
2399047|NCT01346189|5885023|P1|STARTED|Overall Study||433
2399048|NCT01346176|5885040|P3|NOT COMPLETED|Completed Satisfaction Survey||6
2399049|NCT01346176|5885041|P2|NOT COMPLETED|Completed Satisfaction Survey||4
2399050|NCT01346176|5885042|P1|NOT COMPLETED|Completed Satisfaction Survey||6
2399051|NCT01346176|5885040|P3|COMPLETED|Completed Satisfaction Survey||27
2399052|NCT01346176|5885041|P2|COMPLETED|Completed Satisfaction Survey||22
2399053|NCT01346176|5885042|P1|COMPLETED|Completed Satisfaction Survey||29
2399054|NCT01346176|5885040|P3|STARTED|Completed Satisfaction Survey||33
2399055|NCT01346176|5885041|P2|STARTED|Completed Satisfaction Survey||26
2399056|NCT01346176|5885042|P1|STARTED|Completed Satisfaction Survey||35
2399057|NCT01346176|5885040|P3|NOT COMPLETED|Completed Advance Directive||10
2399058|NCT01346176|5885041|P2|NOT COMPLETED|Completed Advance Directive||14
2399059|NCT01346176|5885042|P1|NOT COMPLETED|Completed Advance Directive||13
2399060|NCT01346176|5885040|P3|COMPLETED|Completed Advance Directive||33
2399061|NCT01346176|5885041|P2|COMPLETED|Completed Advance Directive||26
2399062|NCT01346176|5885042|P1|COMPLETED|Completed Advance Directive||35
2399063|NCT01346176|5885040|P3|STARTED|Completed Advance Directive||43
2399064|NCT01346176|5885041|P2|STARTED|Completed Advance Directive||40
2399065|NCT01346176|5885042|P1|STARTED|Completed Advance Directive||48
2399066|NCT01346176|5885040|P3|NOT COMPLETED|Recruited||0
2399067|NCT01346176|5885041|P2|NOT COMPLETED|Recruited||0
2399068|NCT01346176|5885042|P1|NOT COMPLETED|Recruited||1
2399069|NCT01346176|5885040|P3|COMPLETED|Recruited||43
2399070|NCT01346176|5885041|P2|COMPLETED|Recruited||40
2399071|NCT01346176|5885042|P1|COMPLETED|Recruited||48
2399072|NCT01346176|5885040|P3|STARTED|Recruited||43
2399073|NCT01346176|5885041|P2|STARTED|Recruited||40
2399074|NCT01346176|5885042|P1|STARTED|Recruited||49
2399075|NCT01346085|5885053|P1|NOT COMPLETED|Overall Study||0
2399076|NCT01346085|5885053|P1|COMPLETED|Overall Study||10
2399077|NCT01346085|5885053|P1|STARTED|Overall Study||10
2399078|NCT01346072|5885060|P2|NOT COMPLETED|Overall Study||0
2399079|NCT01346072|5885061|P1|NOT COMPLETED|Overall Study||0
2399080|NCT01346072|5885060|P2|COMPLETED|Overall Study||10
2399081|NCT01346072|5885061|P1|COMPLETED|Overall Study||11
2399082|NCT01346072|5885060|P2|STARTED|Overall Study||10
2399083|NCT01346072|5885061|P1|STARTED|Overall Study||11
2399084|NCT01346059|5885071|P2|NOT COMPLETED|Overall Study||0
2399085|NCT01346059|5885072|P1|NOT COMPLETED|Overall Study||1
2399086|NCT01346059|5885071|P2|COMPLETED|Overall Study||1
2399087|NCT01346059|5885072|P1|COMPLETED|Overall Study||0
2399088|NCT01346059|5885071|P2|STARTED|Overall Study||1
2399089|NCT01346059|5885072|P1|STARTED|Overall Study||1
2399090|NCT01345929|5885084|P2|NOT COMPLETED|Overall Study||19
2399091|NCT01345929|5885085|P1|NOT COMPLETED|Overall Study||21
2399092|NCT01345929|5885084|P2|COMPLETED|Overall Study||516
2399093|NCT01345929|5885085|P1|COMPLETED|Overall Study||512
2399094|NCT01345929|5885084|P2|STARTED|Overall Study||535
2399095|NCT01345929|5885085|P1|STARTED|Overall Study||533
2399096|NCT01345786|5885097|P4|NOT COMPLETED|Overall Study||3
2399097|NCT01345786|5885098|P3|NOT COMPLETED|Overall Study||5
2399098|NCT01345786|5885099|P2|NOT COMPLETED|Overall Study||8
2399099|NCT01345786|5885100|P1|NOT COMPLETED|Overall Study||6
2399100|NCT01345786|5885097|P4|COMPLETED|Overall Study||35
2399101|NCT01345786|5885098|P3|COMPLETED|Overall Study||33
2399102|NCT01345786|5885099|P2|COMPLETED|Overall Study||33
2399103|NCT01345786|5885100|P1|COMPLETED|Overall Study||35
2399104|NCT01345786|5885097|P4|Treated|Overall Study||37
2399105|NCT01345786|5885098|P3|Treated|Overall Study||37
2399106|NCT01345786|5885099|P2|Treated|Overall Study||41
2399107|NCT01345786|5885100|P1|Treated|Overall Study||41
2399108|NCT01345786|5885097|P4|STARTED|Overall Study|Number randomized|38
2399109|NCT01345786|5885098|P3|STARTED|Overall Study|Number randomized|38
2399110|NCT01345786|5885099|P2|STARTED|Overall Study|Number randomized|41
2399111|NCT01345786|5885100|P1|STARTED|Overall Study|Number randomized|41
2399112|NCT01345721|5885149|P3|NOT COMPLETED|Overall Study||0
2399113|NCT01345721|5885150|P2|NOT COMPLETED|Overall Study||0
2399114|NCT01345721|5885151|P1|NOT COMPLETED|Overall Study||0
2399115|NCT01345721|5885149|P3|COMPLETED|Overall Study||65
2399116|NCT01345721|5885150|P2|COMPLETED|Overall Study||66
2399117|NCT01345721|5885151|P1|COMPLETED|Overall Study||74
2399118|NCT01345721|5885149|P3|STARTED|Overall Study||65
2399119|NCT01345721|5885150|P2|STARTED|Overall Study||66
2399120|NCT01345721|5885151|P1|STARTED|Overall Study||74
2399121|NCT01345682|5885180|P2|NOT COMPLETED|Overall Study||161
2399122|NCT01345682|5885181|P1|NOT COMPLETED|Overall Study||322
2399123|NCT01345682|5885180|P2|COMPLETED|Overall Study||0
2399124|NCT01345682|5885181|P1|COMPLETED|Overall Study||0
2399125|NCT01345682|5885180|P2|STARTED|Overall Study|Randomised|161
2399126|NCT01345682|5885181|P1|STARTED|Overall Study|Randomised|322
2399127|NCT01345669|5885215|P2|NOT COMPLETED|Overall Study||119
2399128|NCT01345669|5885216|P1|NOT COMPLETED|Overall Study||287
2399129|NCT01345669|5885215|P2|COMPLETED|Overall Study||87
2399130|NCT01345669|5885216|P1|COMPLETED|Overall Study||124
2399131|NCT01345669|5885215|P2|STARTED|Overall Study||206
2399132|NCT01345669|5885216|P1|STARTED|Overall Study||411
2399133|NCT01345630|5885234|P2|NOT COMPLETED|Overall Study||359
2399134|NCT01345630|5885235|P1|NOT COMPLETED|Overall Study||361
2399135|NCT01345630|5885234|P2|COMPLETED|Overall Study||42
2399136|NCT01345630|5885235|P1|COMPLETED|Overall Study||35
2399137|NCT01345630|5885234|P2|STARTED|Overall Study||401
2399138|NCT01345630|5885235|P1|STARTED|Overall Study||396
2399139|NCT01345591|5885291|P1|NOT COMPLETED|Overall Study||1
2399140|NCT01345591|5885291|P1|COMPLETED|Overall Study||19
2399141|NCT01345591|5885291|P1|STARTED|Overall Study||20
2399142|NCT01345318|5885300|P1|NOT COMPLETED|Overall Study||80
2399143|NCT01345318|5885300|P1|COMPLETED|Overall Study||111
2399144|NCT01345318|5885300|P1|STARTED|Overall Study||191
2399145|NCT01345292|5885308|P3|NOT COMPLETED|Overall Study||1
2399146|NCT01345292|5885309|P2|NOT COMPLETED|Overall Study||0
2399147|NCT01345292|5885310|P1|NOT COMPLETED|Overall Study||2
2399148|NCT01345292|5885308|P3|COMPLETED|Overall Study||74
2399149|NCT01345292|5885309|P2|COMPLETED|Overall Study||76
2399150|NCT01345292|5885310|P1|COMPLETED|Overall Study||73
2399151|NCT01345292|5885308|P3|STARTED|Overall Study||75
2399152|NCT01345292|5885309|P2|STARTED|Overall Study||76
2399153|NCT01345292|5885310|P1|STARTED|Overall Study||75
2399154|NCT01345253|5885341|P2|NOT COMPLETED|Open-label Phase (Up to Year 5 Week 44)||144
2399155|NCT01345253|5885342|P1|NOT COMPLETED|Open-label Phase (Up to Year 5 Week 44)||65
2399156|NCT01345253|5885341|P2|COMPLETED|Open-label Phase (Up to Year 5 Week 44)||146
2399157|NCT01345253|5885342|P1|COMPLETED|Open-label Phase (Up to Year 5 Week 44)||69
2399158|NCT01345253|5885341|P2|STARTED|Open-label Phase (Up to Year 5 Week 44)|Only eligible China par. enrolled in OL phase from MITT + additional 16 China par. from Safety Pop|290
2399159|NCT01345253|5885342|P1|STARTED|Open-label Phase (Up to Year 5 Week 44)|Only eligible China par. enrolled in OL phase from MITT + additional 9 China par. from Safety Pop|134
2399160|NCT01345253|5885341|P2|NOT COMPLETED|Double-blind (DB) Phase (52 Weeks)||79
2399161|NCT01345253|5885342|P1|NOT COMPLETED|Double-blind (DB) Phase (52 Weeks)||56
2399162|NCT01345253|5885341|P2|COMPLETED|Double-blind (DB) Phase (52 Weeks)||372
2399163|NCT01345253|5885342|P1|COMPLETED|Double-blind (DB) Phase (52 Weeks)||170
2399164|NCT01345253|5885341|P2|STARTED|Double-blind (DB) Phase (52 Weeks)||451
2399165|NCT01345253|5885342|P1|STARTED|Double-blind (DB) Phase (52 Weeks)||226
2399166|NCT01345240|5885363|P5|NOT COMPLETED|Overall Study||10
2399167|NCT01345240|5885364|P4|NOT COMPLETED|Overall Study||9
2399168|NCT01345240|5885365|P3|NOT COMPLETED|Overall Study||18
2399169|NCT01345240|5885366|P2|NOT COMPLETED|Overall Study||14
2399170|NCT01345240|5885367|P1|NOT COMPLETED|Overall Study||11
2399171|NCT01345240|5885363|P5|COMPLETED|Overall Study||129
2399172|NCT01345240|5885364|P4|COMPLETED|Overall Study||132
2399173|NCT01345240|5885365|P3|COMPLETED|Overall Study||123
2399174|NCT01345240|5885366|P2|COMPLETED|Overall Study||128
2399175|NCT01345240|5885367|P1|COMPLETED|Overall Study||131
2399176|NCT01345240|5885363|P5|STARTED|Overall Study||139
2399177|NCT01345240|5885364|P4|STARTED|Overall Study||141
2399178|NCT01345240|5885365|P3|STARTED|Overall Study||141
2399179|NCT01345240|5885366|P2|STARTED|Overall Study||142
2399180|NCT01345240|5885367|P1|STARTED|Overall Study||142
2399181|NCT01345188|5885487|P1|NOT COMPLETED|Crossover Ranolazine/Placebo 6 Weeks||1
2399182|NCT01345188|5885487|P1|COMPLETED|Crossover Ranolazine/Placebo 6 Weeks||25
2399183|NCT01345188|5885487|P1|STARTED|Crossover Ranolazine/Placebo 6 Weeks||26
2399184|NCT01345188|5885487|P1|NOT COMPLETED|Randomization Ranolazine/Placebo 6 Weeks||2
2399185|NCT01345188|5885487|P1|COMPLETED|Randomization Ranolazine/Placebo 6 Weeks||26
2399186|NCT01345188|5885487|P1|STARTED|Randomization Ranolazine/Placebo 6 Weeks||28
2399187|NCT01345162|5885499|P2|NOT COMPLETED|Overall Study||4
2399188|NCT01345162|5885500|P1|NOT COMPLETED|Overall Study||2
2399189|NCT01345162|5885499|P2|COMPLETED|Overall Study||96
2399190|NCT01345162|5885500|P1|COMPLETED|Overall Study||98
2399191|NCT01345162|5885499|P2|STARTED|Overall Study||100
2399192|NCT01345162|5885500|P1|STARTED|Overall Study||100
2399193|NCT01345123|5885509|P3|NOT COMPLETED|Overall Study||88
2399194|NCT01345123|5885510|P2|NOT COMPLETED|Overall Study||85
2399195|NCT01345123|5885511|P1|NOT COMPLETED|Overall Study||79
2399196|NCT01345123|5885509|P3|COMPLETED|Overall Study|3291 - 88 study participants who were no longer health plan eligible members (zero eligible months)|3203
2399197|NCT01345123|5885510|P2|COMPLETED|Overall Study|3311 - 85 study participants who were no longer health plan eligible members (zero eligible months)|3226
2399198|NCT01345123|5885511|P1|COMPLETED|Overall Study|3323 - 79 study participants who were no longer health plan eligible members (zero eligible months)|3244
2399199|NCT01345123|5885509|P3|STARTED|Overall Study||3291
2399200|NCT01345123|5885510|P2|STARTED|Overall Study||3311
2399201|NCT01345123|5885511|P1|STARTED|Overall Study||3323
2399202|NCT01345058|5885533|P2|NOT COMPLETED|Overall Study||0
2399203|NCT01345058|5885534|P1|NOT COMPLETED|Overall Study||5
2399204|NCT01345058|5885533|P2|COMPLETED|Overall Study||36
2399205|NCT01345058|5885534|P1|COMPLETED|Overall Study||15
2399206|NCT01345058|5885533|P2|Received Lacosamide|Overall Study||0
2399207|NCT01345058|5885534|P1|Received Lacosamide|Overall Study||19
2399208|NCT01345058|5885533|P2|STARTED|Overall Study||36
2399209|NCT01345058|5885534|P1|STARTED|Overall Study||20
2399210|NCT01345019|5885550|P2|NOT COMPLETED|Overall Study||272
2399211|NCT01345019|5885551|P1|NOT COMPLETED|Overall Study||263
2399212|NCT01345019|5885550|P2|COMPLETED|Overall Study|Still on study as of the data cut-off date|587
2399213|NCT01345019|5885551|P1|COMPLETED|Overall Study|Still on study as of the data cut-off date|596
2399214|NCT01345019|5885550|P2|Received Treatment|Overall Study||850
2399215|NCT01345019|5885551|P1|Received Treatment|Overall Study||852
2399216|NCT01345019|5885550|P2|STARTED|Overall Study||859
2399217|NCT01345019|5885551|P1|STARTED|Overall Study||859
2399218|NCT01344876|5885571|P5|NOT COMPLETED|Overall Study||1
2399219|NCT01344876|5885572|P4|NOT COMPLETED|Overall Study||3
2399220|NCT01344876|5885573|P3|NOT COMPLETED|Overall Study||1
2399221|NCT01344876|5885574|P2|NOT COMPLETED|Overall Study||0
2399222|NCT01344876|5885575|P1|NOT COMPLETED|Overall Study||1
2399223|NCT01344876|5885571|P5|COMPLETED|Overall Study||2
2399224|NCT01344876|5885572|P4|COMPLETED|Overall Study||3
2399225|NCT01344876|5885573|P3|COMPLETED|Overall Study||3
2399226|NCT01344876|5885574|P2|COMPLETED|Overall Study||3
2399227|NCT01344876|5885575|P1|COMPLETED|Overall Study||3
2399228|NCT01344876|5885571|P5|STARTED|Overall Study||3
2399229|NCT01344876|5885572|P4|STARTED|Overall Study||6
2399230|NCT01344876|5885573|P3|STARTED|Overall Study||4
2399231|NCT01344876|5885574|P2|STARTED|Overall Study||3
2399232|NCT01344876|5885575|P1|STARTED|Overall Study||4
2399233|NCT01344824|5885589|P1|NOT COMPLETED|Overall Study||37
2399234|NCT01344824|5885589|P1|COMPLETED|Overall Study||1
2399235|NCT01344824|5885589|P1|STARTED|Overall Study||38
2399236|NCT01344759|5885597|P2|NOT COMPLETED|Overall Study||2
2399237|NCT01344759|5885598|P1|NOT COMPLETED|Overall Study||0
2399238|NCT01344759|5885597|P2|COMPLETED|Overall Study|Two of the original DEX group subjects were removed, due to receiving dexmedetomidine and propofol.|28
2399239|NCT01344759|5885598|P1|COMPLETED|Overall Study||30
2399240|NCT01344759|5885597|P2|STARTED|Overall Study||30
2399241|NCT01344759|5885598|P1|STARTED|Overall Study||30
2399242|NCT01344629|5885630|P2|NOT COMPLETED|Crossover Period 4||0
2399243|NCT01344629|5885631|P1|NOT COMPLETED|Crossover Period 4||0
2399244|NCT01344629|5885630|P2|COMPLETED|Crossover Period 4||31
2399245|NCT01344629|5885631|P1|COMPLETED|Crossover Period 4||32
2399246|NCT01344629|5885630|P2|STARTED|Crossover Period 4||31
2399247|NCT01344629|5885631|P1|STARTED|Crossover Period 4||32
2399248|NCT01344629|5885630|P2|NOT COMPLETED|Crossover Period 3||0
2399249|NCT01344629|5885631|P1|NOT COMPLETED|Crossover Period 3||0
2399250|NCT01344629|5885630|P2|COMPLETED|Crossover Period 3||31
2399251|NCT01344629|5885631|P1|COMPLETED|Crossover Period 3||32
2399252|NCT01344629|5885630|P2|STARTED|Crossover Period 3||31
2399253|NCT01344629|5885631|P1|STARTED|Crossover Period 3||32
2399254|NCT01344629|5885630|P2|NOT COMPLETED|Crossover Period 2||1
2399255|NCT01344629|5885631|P1|NOT COMPLETED|Crossover Period 2||0
2399256|NCT01344629|5885630|P2|COMPLETED|Crossover Period 2||31
2399257|NCT01344629|5885631|P1|COMPLETED|Crossover Period 2||32
2399258|NCT01344629|5885630|P2|STARTED|Crossover Period 2||32
2399259|NCT01344629|5885631|P1|STARTED|Crossover Period 2||32
2399260|NCT01344629|5885630|P2|NOT COMPLETED|Crossover Period 1||0
2399261|NCT01344629|5885631|P1|NOT COMPLETED|Crossover Period 1||0
2399262|NCT01344629|5885630|P2|COMPLETED|Crossover Period 1||32
2399263|NCT01344629|5885631|P1|COMPLETED|Crossover Period 1||32
2399264|NCT01344629|5885630|P2|STARTED|Crossover Period 1||32
2399265|NCT01344629|5885631|P1|STARTED|Crossover Period 1||32
2399266|NCT01344616|5885651|P2|NOT COMPLETED|Overall Study||44
2399267|NCT01344616|5885652|P1|NOT COMPLETED|Overall Study||35
2399268|NCT01344616|5885651|P2|COMPLETED|Overall Study||194
2399269|NCT01344616|5885652|P1|COMPLETED|Overall Study||209
2399270|NCT01344616|5885651|P2|STARTED|Overall Study||238
2399271|NCT01344616|5885652|P1|STARTED|Overall Study||244
2399272|NCT01344538|5885660|P2|NOT COMPLETED|Overall Study||1
2399273|NCT01344538|5885661|P1|NOT COMPLETED|Overall Study||2
2399274|NCT01344538|5885660|P2|COMPLETED|Overall Study||16
2399275|NCT01344538|5885661|P1|COMPLETED|Overall Study||14
2399276|NCT01344538|5885660|P2|STARTED|Overall Study||17
2399277|NCT01344538|5885661|P1|STARTED|Overall Study||16
2399278|NCT01344460|5885667|P1|NOT COMPLETED|Overall Study||3
2399279|NCT01344460|5885667|P1|COMPLETED|Overall Study||312
2399280|NCT01344460|5885667|P1|Fulfilled Requirements of FAS Population|Overall Study|Full analysis set (FAS)|292
2399281|NCT01344460|5885667|P1|STARTED|Overall Study|Participants received study drug; Safety analysis set|315
2399282|NCT01344447|5885712|P1|NOT COMPLETED|Overall Study||8
2399283|NCT01344447|5885712|P1|COMPLETED|Overall Study||471
2399284|NCT01344447|5885712|P1|Fulfilled Requirement of FAS Population|Overall Study|Full Analysis Set (FAS)|457
2399285|NCT01344447|5885712|P1|STARTED|Overall Study|Participant received study drug; Safety analysis set|479
2399286|NCT01344369|5885756|P2|NOT COMPLETED|Second Intervention||1
2399287|NCT01344369|5885757|P1|NOT COMPLETED|Second Intervention||0
2399288|NCT01344369|5885756|P2|COMPLETED|Second Intervention||16
2399289|NCT01344369|5885757|P1|COMPLETED|Second Intervention||17
2399290|NCT01344369|5885756|P2|STARTED|Second Intervention||17
2399291|NCT01344369|5885757|P1|STARTED|Second Intervention||17
2399292|NCT01344369|5885756|P2|NOT COMPLETED|Washout of 28 Days||1
2399293|NCT01344369|5885757|P1|NOT COMPLETED|Washout of 28 Days||1
2399294|NCT01344369|5885756|P2|COMPLETED|Washout of 28 Days||17
2399295|NCT01344369|5885757|P1|COMPLETED|Washout of 28 Days||17
2399296|NCT01344369|5885756|P2|STARTED|Washout of 28 Days||18
2399297|NCT01344369|5885757|P1|STARTED|Washout of 28 Days||18
2399298|NCT01344369|5885756|P2|NOT COMPLETED|First Intervention||0
2399299|NCT01344369|5885757|P1|NOT COMPLETED|First Intervention||0
2399300|NCT01344369|5885756|P2|COMPLETED|First Intervention||18
2399301|NCT01344369|5885757|P1|COMPLETED|First Intervention||18
2399302|NCT01344369|5885756|P2|STARTED|First Intervention||18
2399303|NCT01344369|5885757|P1|STARTED|First Intervention||18
2399304|NCT01344226|5885773|P1|NOT COMPLETED|Overall Study||8
2399305|NCT01344226|5885773|P1|COMPLETED|Overall Study||41
2399306|NCT01344226|5885773|P1|STARTED|Overall Study||49
2399307|NCT01344161|5885782|P2|NOT COMPLETED|Overall Study||3
2399308|NCT01344161|5885783|P1|NOT COMPLETED|Overall Study||5
2399309|NCT01344161|5885782|P2|COMPLETED|Overall Study||39
2399310|NCT01344161|5885783|P1|COMPLETED|Overall Study||38
2399311|NCT01344161|5885782|P2|STARTED|Overall Study||42
2399312|NCT01344161|5885783|P1|STARTED|Overall Study||43
2399313|NCT01344057|5885795|P1|NOT COMPLETED|Overall Study||1
2399314|NCT01344057|5885795|P1|COMPLETED|Overall Study||62
2399315|NCT01344057|5885795|P1|STARTED|Overall Study||63
2399316|NCT01343901|5885802|P1|NOT COMPLETED|Overall Study||113
2399317|NCT01343901|5885802|P1|COMPLETED|Overall Study||97
2399318|NCT01343901|5885802|P1|Efficacy Population|Overall Study||205
2399319|NCT01343901|5885802|P1|STARTED|Overall Study||210
2399320|NCT01343888|5885826|P3|NOT COMPLETED|Overall Study||22
2399321|NCT01343888|5885827|P2|NOT COMPLETED|Overall Study||39
2399322|NCT01343888|5885828|P1|NOT COMPLETED|Overall Study||25
2399323|NCT01343888|5885826|P3|COMPLETED|Overall Study||110
2399324|NCT01343888|5885827|P2|COMPLETED|Overall Study||222
2399325|NCT01343888|5885828|P1|COMPLETED|Overall Study||234
2399326|NCT01343888|5885826|P3|STARTED|Overall Study|133 subject randomized; 132 subjects treated with at least one dose; 1 subject was not treated|132
2399327|NCT01343888|5885827|P2|STARTED|Overall Study|262 subject randomized; 261 subjects treated with at least one dose; 1 subject was not treated|261
2399328|NCT01343888|5885828|P1|STARTED|Overall Study|261 subject randomized; 259 subjects treated with at least one dose; 2 subjects were not treated|259
2399329|NCT01343823|5885870|P4|NOT COMPLETED|Overall Study||1
2399330|NCT01343823|5885871|P3|NOT COMPLETED|Overall Study||0
2399331|NCT01343823|5885872|P2|NOT COMPLETED|Overall Study||0
2399332|NCT01343823|5885873|P1|NOT COMPLETED|Overall Study||2
2399333|NCT01343823|5885870|P4|COMPLETED|Overall Study||19
2399334|NCT01343823|5885871|P3|COMPLETED|Overall Study||19
2399335|NCT01343823|5885872|P2|COMPLETED|Overall Study||20
2399336|NCT01343823|5885873|P1|COMPLETED|Overall Study||18
2399337|NCT01343823|5885870|P4|STARTED|Overall Study||20
2399338|NCT01343823|5885871|P3|STARTED|Overall Study||19
2399339|NCT01343823|5885872|P2|STARTED|Overall Study||20
2399340|NCT01343823|5885873|P1|STARTED|Overall Study||20
2399341|NCT01343693|5885887|P1|NOT COMPLETED|Overall Study||9
2399342|NCT01343693|5885887|P1|COMPLETED|Overall Study||110
2399343|NCT01343693|5885887|P1|STARTED|Overall Study||119
2399344|NCT01343667|5885894|P2|NOT COMPLETED|Overall Study||56
2399345|NCT01343667|5885895|P1|NOT COMPLETED|Overall Study||12
2399346|NCT01343667|5885894|P2|COMPLETED|Overall Study||916
2399347|NCT01343667|5885895|P1|COMPLETED|Overall Study||413
2399348|NCT01343667|5885894|P2|STARTED|Overall Study||972
2399349|NCT01343667|5885895|P1|STARTED|Overall Study||425
2399350|NCT01343485|5885903|P2|NOT COMPLETED|Overall Study||134
2399351|NCT01343485|5885904|P1|NOT COMPLETED|Overall Study||149
2399352|NCT01343485|5885903|P2|COMPLETED|Overall Study||46
2399353|NCT01343485|5885904|P1|COMPLETED|Overall Study||36
2399354|NCT01343485|5885903|P2|STARTED|Overall Study||180
2399355|NCT01343485|5885904|P1|STARTED|Overall Study||185
2399356|NCT01343407|5885910|P6|NOT COMPLETED|Third Treatment Period (Part 2)||0
2399357|NCT01343407|5885911|P5|NOT COMPLETED|Third Treatment Period (Part 2)||0
2399358|NCT01343407|5885912|P4|NOT COMPLETED|Third Treatment Period (Part 2)||0
2399359|NCT01343407|5885913|P3|NOT COMPLETED|Third Treatment Period (Part 2)||0
2399360|NCT01343407|5885914|P2|NOT COMPLETED|Third Treatment Period (Part 2)||0
2399361|NCT01343407|5885915|P1|NOT COMPLETED|Third Treatment Period (Part 2)||0
2399362|NCT01343407|5885910|P6|COMPLETED|Third Treatment Period (Part 2)||3
2399363|NCT01343407|5885911|P5|COMPLETED|Third Treatment Period (Part 2)||3
2399364|NCT01343407|5885912|P4|COMPLETED|Third Treatment Period (Part 2)||3
2399365|NCT01343407|5885913|P3|COMPLETED|Third Treatment Period (Part 2)||1
2399366|NCT01343407|5885914|P2|COMPLETED|Third Treatment Period (Part 2)||2
2399367|NCT01343407|5885915|P1|COMPLETED|Third Treatment Period (Part 2)||2
2399368|NCT01343407|5885910|P6|STARTED|Third Treatment Period (Part 2)||3
2399369|NCT01343407|5885911|P5|STARTED|Third Treatment Period (Part 2)||3
2399370|NCT01343407|5885912|P4|STARTED|Third Treatment Period (Part 2)||3
2399371|NCT01343407|5885913|P3|STARTED|Third Treatment Period (Part 2)||1
2399372|NCT01343407|5885914|P2|STARTED|Third Treatment Period (Part 2)||2
2399373|NCT01343407|5885915|P1|STARTED|Third Treatment Period (Part 2)||2
2399374|NCT01343407|5885910|P6|NOT COMPLETED|Second Washout (Part 2)||0
2399375|NCT01343407|5885911|P5|NOT COMPLETED|Second Washout (Part 2)||0
2399376|NCT01343407|5885912|P4|NOT COMPLETED|Second Washout (Part 2)||0
2399377|NCT01343407|5885913|P3|NOT COMPLETED|Second Washout (Part 2)||1
2399378|NCT01343407|5885914|P2|NOT COMPLETED|Second Washout (Part 2)||0
2399379|NCT01343407|5885915|P1|NOT COMPLETED|Second Washout (Part 2)||0
2399380|NCT01343407|5885910|P6|COMPLETED|Second Washout (Part 2)||3
2399381|NCT01343407|5885911|P5|COMPLETED|Second Washout (Part 2)||3
2399382|NCT01343407|5885912|P4|COMPLETED|Second Washout (Part 2)||3
2399383|NCT01343407|5885913|P3|COMPLETED|Second Washout (Part 2)||1
2399384|NCT01343407|5885914|P2|COMPLETED|Second Washout (Part 2)||2
2399385|NCT01343407|5885915|P1|COMPLETED|Second Washout (Part 2)||2
2399386|NCT01343407|5885910|P6|STARTED|Second Washout (Part 2)||3
2399387|NCT01343407|5885911|P5|STARTED|Second Washout (Part 2)||3
2399388|NCT01343407|5885912|P4|STARTED|Second Washout (Part 2)||3
2399389|NCT01343407|5885913|P3|STARTED|Second Washout (Part 2)||2
2399390|NCT01343407|5885914|P2|STARTED|Second Washout (Part 2)||2
2399391|NCT01343407|5885915|P1|STARTED|Second Washout (Part 2)||2
2399392|NCT01343407|5885910|P6|NOT COMPLETED|Second Treatment Period (Part 2)||0
2399393|NCT01343407|5885911|P5|NOT COMPLETED|Second Treatment Period (Part 2)||0
2399394|NCT01343407|5885912|P4|NOT COMPLETED|Second Treatment Period (Part 2)||0
2399395|NCT01343407|5885913|P3|NOT COMPLETED|Second Treatment Period (Part 2)||1
2399396|NCT01343407|5885914|P2|NOT COMPLETED|Second Treatment Period (Part 2)||0
2399576|NCT01342523|5886325|P32|NOT COMPLETED|Overall Study||1
2399397|NCT01343407|5885915|P1|NOT COMPLETED|Second Treatment Period (Part 2)||0
2399398|NCT01343407|5885910|P6|COMPLETED|Second Treatment Period (Part 2)||3
2399399|NCT01343407|5885911|P5|COMPLETED|Second Treatment Period (Part 2)||3
2399400|NCT01343407|5885912|P4|COMPLETED|Second Treatment Period (Part 2)||3
2399401|NCT01343407|5885913|P3|COMPLETED|Second Treatment Period (Part 2)||2
2399402|NCT01343407|5885914|P2|COMPLETED|Second Treatment Period (Part 2)||2
2399403|NCT01343407|5885915|P1|COMPLETED|Second Treatment Period (Part 2)||2
2399404|NCT01343407|5885910|P6|STARTED|Second Treatment Period (Part 2)||3
2399405|NCT01343407|5885911|P5|STARTED|Second Treatment Period (Part 2)||3
2399406|NCT01343407|5885912|P4|STARTED|Second Treatment Period (Part 2)||3
2399407|NCT01343407|5885913|P3|STARTED|Second Treatment Period (Part 2)||3
2399408|NCT01343407|5885914|P2|STARTED|Second Treatment Period (Part 2)||2
2399409|NCT01343407|5885915|P1|STARTED|Second Treatment Period (Part 2)||2
2399410|NCT01343407|5885910|P6|NOT COMPLETED|First Washout (Part 2)||0
2399411|NCT01343407|5885911|P5|NOT COMPLETED|First Washout (Part 2)||0
2399412|NCT01343407|5885912|P4|NOT COMPLETED|First Washout (Part 2)||0
2399413|NCT01343407|5885913|P3|NOT COMPLETED|First Washout (Part 2)||0
2399414|NCT01343407|5885914|P2|NOT COMPLETED|First Washout (Part 2)||0
2399415|NCT01343407|5885915|P1|NOT COMPLETED|First Washout (Part 2)||0
2399416|NCT01343407|5885910|P6|COMPLETED|First Washout (Part 2)||3
2399417|NCT01343407|5885911|P5|COMPLETED|First Washout (Part 2)||3
2399418|NCT01343407|5885912|P4|COMPLETED|First Washout (Part 2)||3
2399419|NCT01343407|5885913|P3|COMPLETED|First Washout (Part 2)||3
2399420|NCT01343407|5885914|P2|COMPLETED|First Washout (Part 2)||2
2399421|NCT01343407|5885915|P1|COMPLETED|First Washout (Part 2)||2
2399422|NCT01343407|5885910|P6|STARTED|First Washout (Part 2)||3
2399423|NCT01343407|5885911|P5|STARTED|First Washout (Part 2)||3
2399424|NCT01343407|5885912|P4|STARTED|First Washout (Part 2)||3
2399425|NCT01343407|5885913|P3|STARTED|First Washout (Part 2)||3
2399426|NCT01343407|5885914|P2|STARTED|First Washout (Part 2)||2
2399427|NCT01343407|5885915|P1|STARTED|First Washout (Part 2)||2
2399428|NCT01343407|5885910|P6|NOT COMPLETED|First Treatment Period (Part 2)||0
2399429|NCT01343407|5885911|P5|NOT COMPLETED|First Treatment Period (Part 2)||0
2399430|NCT01343407|5885912|P4|NOT COMPLETED|First Treatment Period (Part 2)||0
2399431|NCT01343407|5885913|P3|NOT COMPLETED|First Treatment Period (Part 2)||0
2399432|NCT01343407|5885914|P2|NOT COMPLETED|First Treatment Period (Part 2)||0
2399433|NCT01343407|5885915|P1|NOT COMPLETED|First Treatment Period (Part 2)||0
2399434|NCT01343407|5885910|P6|COMPLETED|First Treatment Period (Part 2)||3
2399435|NCT01343407|5885911|P5|COMPLETED|First Treatment Period (Part 2)||3
2399436|NCT01343407|5885912|P4|COMPLETED|First Treatment Period (Part 2)||3
2399437|NCT01343407|5885913|P3|COMPLETED|First Treatment Period (Part 2)||3
2399438|NCT01343407|5885914|P2|COMPLETED|First Treatment Period (Part 2)||2
2399439|NCT01343407|5885915|P1|COMPLETED|First Treatment Period (Part 2)||2
2399440|NCT01343407|5885910|P6|STARTED|First Treatment Period (Part 2)||3
2399441|NCT01343407|5885911|P5|STARTED|First Treatment Period (Part 2)||3
2399442|NCT01343407|5885912|P4|STARTED|First Treatment Period (Part 2)||3
2399443|NCT01343407|5885913|P3|STARTED|First Treatment Period (Part 2)||3
2399444|NCT01343407|5885914|P2|STARTED|First Treatment Period (Part 2)||2
2399445|NCT01343407|5885915|P1|STARTED|First Treatment Period (Part 2)||2
2399446|NCT01343368|5885943|P2|NOT COMPLETED|Overall Study||0
2399447|NCT01343368|5885944|P1|NOT COMPLETED|Overall Study||2
2399448|NCT01343368|5885943|P2|COMPLETED|Overall Study||10
2399449|NCT01343368|5885944|P1|COMPLETED|Overall Study||7
2399450|NCT01343368|5885943|P2|STARTED|Overall Study||10
2399451|NCT01343368|5885944|P1|STARTED|Overall Study||9
2399452|NCT01343277|5885980|P2|NOT COMPLETED|Overall Study||193
2399453|NCT01343277|5885981|P1|NOT COMPLETED|Overall Study||384
2399454|NCT01343277|5885980|P2|COMPLETED|Overall Study||0
2399455|NCT01343277|5885981|P1|COMPLETED|Overall Study||0
2399456|NCT01343277|5885980|P2|Treated|Overall Study||172
2399457|NCT01343277|5885981|P1|Treated|Overall Study||378
2399458|NCT01343277|5885980|P2|STARTED|Overall Study||193
2399459|NCT01343277|5885981|P1|STARTED|Overall Study||384
2399460|NCT01343251|5885999|P2|NOT COMPLETED|Overall Study||0
2399461|NCT01343251|5886000|P1|NOT COMPLETED|Overall Study||0
2399462|NCT01343251|5885999|P2|COMPLETED|Overall Study||17
2399463|NCT01343251|5886000|P1|COMPLETED|Overall Study||16
2399464|NCT01343251|5885999|P2|STARTED|Overall Study||17
2399465|NCT01343251|5886000|P1|STARTED|Overall Study||16
2399466|NCT01343095|5886017|P3|NOT COMPLETED|Overall Study||0
2399467|NCT01343095|5886018|P2|NOT COMPLETED|Overall Study||0
2399468|NCT01343095|5886019|P1|NOT COMPLETED|Overall Study||0
2399469|NCT01343095|5886017|P3|COMPLETED|Overall Study||3
2399470|NCT01343095|5886018|P2|COMPLETED|Overall Study||3
2399471|NCT01343095|5886019|P1|COMPLETED|Overall Study||2
2399472|NCT01343095|5886017|P3|STARTED|Overall Study||3
2399473|NCT01343095|5886018|P2|STARTED|Overall Study||3
2399474|NCT01343095|5886019|P1|STARTED|Overall Study||2
2399475|NCT01343082|5886042|P3|NOT COMPLETED|Treatment Period , Switched to DE-111||12
2399476|NCT01343082|5886043|P2|NOT COMPLETED|Treatment Period , Switched to DE-111||9
2399477|NCT01343082|5886044|P1|NOT COMPLETED|Treatment Period , Switched to DE-111||5
2399478|NCT01343082|5886042|P3|COMPLETED|Treatment Period , Switched to DE-111||31
2399479|NCT01343082|5886043|P2|COMPLETED|Treatment Period , Switched to DE-111||36
2399480|NCT01343082|5886044|P1|COMPLETED|Treatment Period , Switched to DE-111||43
2399481|NCT01343082|5886042|P3|STARTED|Treatment Period , Switched to DE-111||43
2399482|NCT01343082|5886043|P2|STARTED|Treatment Period , Switched to DE-111||45
2399483|NCT01343082|5886044|P1|STARTED|Treatment Period , Switched to DE-111||48
2399484|NCT01343082|5886042|P3|NOT COMPLETED|The run-in Period||5
2399485|NCT01343082|5886043|P2|NOT COMPLETED|The run-in Period||4
2399486|NCT01343082|5886044|P1|NOT COMPLETED|The run-in Period||3
2399487|NCT01343082|5886042|P3|COMPLETED|The run-in Period||43
2399488|NCT01343082|5886043|P2|COMPLETED|The run-in Period||45
2399489|NCT01343082|5886044|P1|COMPLETED|The run-in Period||48
2399490|NCT01343082|5886042|P3|STARTED|The run-in Period||48
2399491|NCT01343082|5886043|P2|STARTED|The run-in Period||49
2399492|NCT01343082|5886044|P1|STARTED|The run-in Period||51
2399493|NCT01343056|5886052|P4|NOT COMPLETED|Overall Study||9
2399494|NCT01343056|5886053|P3|NOT COMPLETED|Overall Study||3
2399495|NCT01343056|5886054|P2|NOT COMPLETED|Overall Study||5
2399496|NCT01343056|5886055|P1|NOT COMPLETED|Overall Study||7
2399497|NCT01343056|5886052|P4|COMPLETED|Overall Study||29
2399498|NCT01343056|5886053|P3|COMPLETED|Overall Study||29
2399499|NCT01343056|5886054|P2|COMPLETED|Overall Study||31
2399500|NCT01343056|5886055|P1|COMPLETED|Overall Study||28
2399501|NCT01343056|5886052|P4|STARTED|Overall Study||38
2399502|NCT01343056|5886053|P3|STARTED|Overall Study||32
2399503|NCT01343056|5886054|P2|STARTED|Overall Study||36
2399504|NCT01343056|5886055|P1|STARTED|Overall Study||35
2399505|NCT01343004|5886096|P3|NOT COMPLETED|Overall Study||160
2399506|NCT01343004|5886097|P2|NOT COMPLETED|Overall Study||218
2399507|NCT01343004|5886098|P1|NOT COMPLETED|Overall Study||184
2399508|NCT01343004|5886096|P3|COMPLETED|Overall Study||658
2399509|NCT01343004|5886097|P2|COMPLETED|Overall Study||606
2399510|NCT01343004|5886098|P1|COMPLETED|Overall Study||637
2399511|NCT01343004|5886096|P3|STARTED|Overall Study||818
2399512|NCT01343004|5886097|P2|STARTED|Overall Study||824
2399513|NCT01343004|5886098|P1|STARTED|Overall Study||821
2399514|NCT01342965|5886123|P2|NOT COMPLETED|Overall Study||107
2399515|NCT01342965|5886124|P1|NOT COMPLETED|Overall Study||109
2399516|NCT01342965|5886123|P2|COMPLETED|Overall Study||0
2399517|NCT01342965|5886124|P1|COMPLETED|Overall Study||1
2399518|NCT01342965|5886123|P2|Received Treatment|Overall Study||104
2399519|NCT01342965|5886124|P1|Received Treatment|Overall Study||110
2399520|NCT01342965|5886123|P2|STARTED|Overall Study||107
2399521|NCT01342965|5886124|P1|STARTED|Overall Study||110
2399522|NCT01342926|5886142|P4|NOT COMPLETED|Overall Study||12
2399523|NCT01342926|5886143|P3|NOT COMPLETED|Overall Study||14
2399524|NCT01342926|5886144|P2|NOT COMPLETED|Overall Study||15
2399525|NCT01342926|5886145|P1|NOT COMPLETED|Overall Study||9
2399526|NCT01342926|5886142|P4|COMPLETED|Overall Study||39
2399527|NCT01342926|5886143|P3|COMPLETED|Overall Study||34
2399528|NCT01342926|5886144|P2|COMPLETED|Overall Study||31
2399529|NCT01342926|5886145|P1|COMPLETED|Overall Study||37
2399530|NCT01342926|5886142|P4|STARTED|Overall Study||51
2399531|NCT01342926|5886143|P3|STARTED|Overall Study||48
2399532|NCT01342926|5886144|P2|STARTED|Overall Study||46
2399533|NCT01342926|5886145|P1|STARTED|Overall Study||46
2399534|NCT01342913|5886225|P3|NOT COMPLETED|Double-Blind Treatment Period||23
2399535|NCT01342913|5886226|P2|NOT COMPLETED|Double-Blind Treatment Period||16
2399536|NCT01342913|5886227|P1|NOT COMPLETED|Double-Blind Treatment Period||0
2399537|NCT01342913|5886225|P3|COMPLETED|Double-Blind Treatment Period||243
2399538|NCT01342913|5886226|P2|COMPLETED|Double-Blind Treatment Period||246
2399539|NCT01342913|5886227|P1|COMPLETED|Double-Blind Treatment Period||0
2399540|NCT01342913|5886225|P3|STARTED|Double-Blind Treatment Period||266
2399541|NCT01342913|5886226|P2|STARTED|Double-Blind Treatment Period||262
2399542|NCT01342913|5886227|P1|STARTED|Double-Blind Treatment Period||0
2399543|NCT01342913|5886225|P3|NOT COMPLETED|2-week Run-in Period||0
2399544|NCT01342913|5886226|P2|NOT COMPLETED|2-week Run-in Period||0
2399545|NCT01342913|5886227|P1|NOT COMPLETED|2-week Run-in Period||174
2399546|NCT01342913|5886225|P3|COMPLETED|2-week Run-in Period||0
2399547|NCT01342913|5886226|P2|COMPLETED|2-week Run-in Period||0
2399548|NCT01342913|5886227|P1|COMPLETED|2-week Run-in Period||528
2399549|NCT01342913|5886225|P3|STARTED|2-week Run-in Period||0
2399550|NCT01342913|5886226|P2|STARTED|2-week Run-in Period||0
2399551|NCT01342913|5886227|P1|STARTED|2-week Run-in Period||702
2399552|NCT01342887|5886237|P1|NOT COMPLETED|Overall Study||2
2399553|NCT01342887|5886237|P1|COMPLETED|Overall Study||4
2399554|NCT01342887|5886237|P1|STARTED|Overall Study||6
2399555|NCT01342770|5886244|P1|NOT COMPLETED|Overall Study||0
2399556|NCT01342770|5886244|P1|COMPLETED|Overall Study||6
2399557|NCT01342770|5886244|P1|STARTED|Overall Study||6
2399558|NCT01342757|5886262|P1|NOT COMPLETED|Overall Study||0
2399559|NCT01342757|5886262|P1|COMPLETED|Overall Study||12
2399560|NCT01342757|5886262|P1|STARTED|Overall Study||12
2399561|NCT01342666|5886271|P2|NOT COMPLETED|Overall Study||0
2399562|NCT01342666|5886272|P1|NOT COMPLETED|Overall Study||0
2399563|NCT01342666|5886271|P2|COMPLETED|Overall Study||24
2399564|NCT01342666|5886272|P1|COMPLETED|Overall Study||26
2399565|NCT01342666|5886271|P2|STARTED|Overall Study||24
2399566|NCT01342666|5886272|P1|STARTED|Overall Study||26
2399567|NCT01342640|5886278|P1|NOT COMPLETED|Overall Study||41
2399568|NCT01342640|5886278|P1|COMPLETED|Overall Study||29
2399569|NCT01342640|5886278|P1|STARTED|Overall Study||70
2399570|NCT01342549|5886286|P2|NOT COMPLETED|Overall Study||0
2399571|NCT01342549|5886287|P1|NOT COMPLETED|Overall Study||0
2399572|NCT01342549|5886286|P2|COMPLETED|Overall Study||31
2399573|NCT01342549|5886287|P1|COMPLETED|Overall Study||31
2399574|NCT01342549|5886286|P2|STARTED|Overall Study||31
2399575|NCT01342549|5886287|P1|STARTED|Overall Study||31
2399577|NCT01342523|5886326|P31|NOT COMPLETED|Overall Study||1
2399578|NCT01342523|5886327|P30|NOT COMPLETED|Overall Study||1
2399579|NCT01342523|5886328|P29|NOT COMPLETED|Overall Study||1
2399580|NCT01342523|5886329|P28|NOT COMPLETED|Overall Study||1
2399581|NCT01342523|5886330|P27|NOT COMPLETED|Overall Study||1
2399582|NCT01342523|5886331|P26|NOT COMPLETED|Overall Study||2
2399583|NCT01342523|5886332|P25|NOT COMPLETED|Overall Study||1
2399584|NCT01342523|5886333|P24|NOT COMPLETED|Overall Study||1
2399585|NCT01342523|5886334|P23|NOT COMPLETED|Overall Study||0
2399586|NCT01342523|5886335|P22|NOT COMPLETED|Overall Study||0
2399587|NCT01342523|5886336|P21|NOT COMPLETED|Overall Study||0
2399588|NCT01342523|5886337|P20|NOT COMPLETED|Overall Study||0
2399589|NCT01342523|5886338|P19|NOT COMPLETED|Overall Study||0
2399590|NCT01342523|5886339|P18|NOT COMPLETED|Overall Study||0
2399591|NCT01342523|5886340|P17|NOT COMPLETED|Overall Study||1
2399592|NCT01342523|5886341|P16|NOT COMPLETED|Overall Study||0
2399593|NCT01342523|5886342|P15|NOT COMPLETED|Overall Study||1
2399594|NCT01342523|5886343|P14|NOT COMPLETED|Overall Study||2
2399595|NCT01342523|5886344|P13|NOT COMPLETED|Overall Study||0
2399596|NCT01342523|5886345|P12|NOT COMPLETED|Overall Study||2
2399597|NCT01342523|5886346|P11|NOT COMPLETED|Overall Study||0
2399598|NCT01342523|5886347|P10|NOT COMPLETED|Overall Study||0
2399599|NCT01342523|5886348|P9|NOT COMPLETED|Overall Study||0
2399600|NCT01342523|5886349|P8|NOT COMPLETED|Overall Study||0
2399601|NCT01342523|5886350|P7|NOT COMPLETED|Overall Study||0
2399602|NCT01342523|5886351|P6|NOT COMPLETED|Overall Study||0
2399603|NCT01342523|5886352|P5|NOT COMPLETED|Overall Study||0
2399604|NCT01342523|5886353|P4|NOT COMPLETED|Overall Study||1
2399605|NCT01342523|5886354|P3|NOT COMPLETED|Overall Study||0
2399606|NCT01342523|5886355|P2|NOT COMPLETED|Overall Study||0
2399607|NCT01342523|5886356|P1|NOT COMPLETED|Overall Study||1
2399608|NCT01342523|5886325|P32|COMPLETED|Overall Study||27
2399609|NCT01342523|5886326|P31|COMPLETED|Overall Study||30
2399610|NCT01342523|5886327|P30|COMPLETED|Overall Study||28
2399611|NCT01342523|5886328|P29|COMPLETED|Overall Study||34
2399612|NCT01342523|5886329|P28|COMPLETED|Overall Study||30
2399613|NCT01342523|5886330|P27|COMPLETED|Overall Study||33
2399614|NCT01342523|5886331|P26|COMPLETED|Overall Study||36
2399615|NCT01342523|5886332|P25|COMPLETED|Overall Study||36
2399616|NCT01342523|5886333|P24|COMPLETED|Overall Study||35
2399617|NCT01342523|5886334|P23|COMPLETED|Overall Study||36
2399618|NCT01342523|5886335|P22|COMPLETED|Overall Study||30
2399619|NCT01342523|5886336|P21|COMPLETED|Overall Study||29
2399620|NCT01342523|5886337|P20|COMPLETED|Overall Study||27
2399621|NCT01342523|5886338|P19|COMPLETED|Overall Study||21
2399622|NCT01342523|5886339|P18|COMPLETED|Overall Study||27
2399623|NCT01342523|5886340|P17|COMPLETED|Overall Study||28
2399624|NCT01342523|5886341|P16|COMPLETED|Overall Study||32
2399625|NCT01342523|5886342|P15|COMPLETED|Overall Study||37
2399626|NCT01342523|5886343|P14|COMPLETED|Overall Study||36
2399627|NCT01342523|5886344|P13|COMPLETED|Overall Study||39
2399628|NCT01342523|5886345|P12|COMPLETED|Overall Study||36
2399629|NCT01342523|5886346|P11|COMPLETED|Overall Study||38
2399630|NCT01342523|5886347|P10|COMPLETED|Overall Study||28
2399631|NCT01342523|5886348|P9|COMPLETED|Overall Study||28
2399632|NCT01342523|5886349|P8|COMPLETED|Overall Study||27
2399633|NCT01342523|5886350|P7|COMPLETED|Overall Study||22
2399634|NCT01342523|5886351|P6|COMPLETED|Overall Study||36
2399635|NCT01342523|5886352|P5|COMPLETED|Overall Study||36
2399636|NCT01342523|5886353|P4|COMPLETED|Overall Study||32
2399637|NCT01342523|5886354|P3|COMPLETED|Overall Study||36
2399638|NCT01342523|5886355|P2|COMPLETED|Overall Study||32
2399639|NCT01342523|5886356|P1|COMPLETED|Overall Study||34
2399640|NCT01342523|5886325|P32|STARTED|Overall Study||28
2399641|NCT01342523|5886326|P31|STARTED|Overall Study||31
2399642|NCT01342523|5886327|P30|STARTED|Overall Study||29
2399643|NCT01342523|5886328|P29|STARTED|Overall Study||35
2399644|NCT01342523|5886329|P28|STARTED|Overall Study||31
2399645|NCT01342523|5886330|P27|STARTED|Overall Study||34
2399646|NCT01342523|5886331|P26|STARTED|Overall Study||38
2399647|NCT01342523|5886332|P25|STARTED|Overall Study||37
2399648|NCT01342523|5886333|P24|STARTED|Overall Study||36
2399649|NCT01342523|5886334|P23|STARTED|Overall Study||36
2399650|NCT01342523|5886335|P22|STARTED|Overall Study||30
2399651|NCT01342523|5886336|P21|STARTED|Overall Study||29
2399652|NCT01342523|5886337|P20|STARTED|Overall Study||27
2399653|NCT01342523|5886338|P19|STARTED|Overall Study||21
2399654|NCT01342523|5886339|P18|STARTED|Overall Study||27
2399655|NCT01342523|5886340|P17|STARTED|Overall Study||29
2399656|NCT01342523|5886341|P16|STARTED|Overall Study||32
2399657|NCT01342523|5886342|P15|STARTED|Overall Study||38
2399658|NCT01342523|5886343|P14|STARTED|Overall Study||38
2399659|NCT01342523|5886344|P13|STARTED|Overall Study||39
2399660|NCT01342523|5886345|P12|STARTED|Overall Study||38
2399661|NCT01342523|5886346|P11|STARTED|Overall Study||38
2399662|NCT01342523|5886347|P10|STARTED|Overall Study||28
2399663|NCT01342523|5886348|P9|STARTED|Overall Study||28
2399664|NCT01342523|5886349|P8|STARTED|Overall Study||27
2399665|NCT01342523|5886350|P7|STARTED|Overall Study||22
2399666|NCT01342523|5886351|P6|STARTED|Overall Study||36
2399667|NCT01342523|5886352|P5|STARTED|Overall Study||36
2399668|NCT01342523|5886353|P4|STARTED|Overall Study||33
2399669|NCT01342523|5886354|P3|STARTED|Overall Study||36
2399670|NCT01342523|5886355|P2|STARTED|Overall Study||32
2399671|NCT01342523|5886356|P1|STARTED|Overall Study||35
2399672|NCT01342510|5886373|P4|NOT COMPLETED|Overall Study||11
2399673|NCT01342510|5886374|P3|NOT COMPLETED|Overall Study||13
2399674|NCT01342510|5886375|P2|NOT COMPLETED|Overall Study||6
2399675|NCT01342510|5886376|P1|NOT COMPLETED|Overall Study||12
2399676|NCT01342510|5886373|P4|COMPLETED|Overall Study||39
2399677|NCT01342510|5886374|P3|COMPLETED|Overall Study||37
2399678|NCT01342510|5886375|P2|COMPLETED|Overall Study||44
2399679|NCT01342510|5886376|P1|COMPLETED|Overall Study||38
2399680|NCT01342510|5886373|P4|STARTED|Overall Study||50
2399681|NCT01342510|5886374|P3|STARTED|Overall Study||50
2399682|NCT01342510|5886375|P2|STARTED|Overall Study||50
2399683|NCT01342510|5886376|P1|STARTED|Overall Study||50
2399684|NCT01342484|5886393|P3|NOT COMPLETED|Overall Study||1
2399685|NCT01342484|5886394|P2|NOT COMPLETED|Overall Study||0
2399686|NCT01342484|5886395|P1|NOT COMPLETED|Overall Study||2
2399687|NCT01342484|5886393|P3|COMPLETED|Overall Study||13
2399688|NCT01342484|5886394|P2|COMPLETED|Overall Study||10
2399689|NCT01342484|5886395|P1|COMPLETED|Overall Study||13
2399690|NCT01342484|5886393|P3|STARTED|Overall Study||14
2399691|NCT01342484|5886394|P2|STARTED|Overall Study||10
2399692|NCT01342484|5886395|P1|STARTED|Overall Study||15
2399693|NCT01342471|5886411|P2|NOT COMPLETED|Overall Study||6
2399694|NCT01342471|5886412|P1|NOT COMPLETED|Overall Study||5
2399695|NCT01342471|5886411|P2|COMPLETED|Overall Study||23
2399696|NCT01342471|5886412|P1|COMPLETED|Overall Study||24
2399697|NCT01342471|5886411|P2|STARTED|Overall Study||29
2399698|NCT01342471|5886412|P1|STARTED|Overall Study||29
2399699|NCT01342458|5886428|P2|NOT COMPLETED|Overall Study||4
2399700|NCT01342458|5886429|P1|NOT COMPLETED|Overall Study||2
2399701|NCT01342458|5886428|P2|COMPLETED|Overall Study||24
2399702|NCT01342458|5886429|P1|COMPLETED|Overall Study||26
2399703|NCT01342458|5886428|P2|STARTED|Overall Study||28
2399704|NCT01342458|5886429|P1|STARTED|Overall Study||28
2399705|NCT01342445|5886451|P2|NOT COMPLETED|Overall Study||2
2399706|NCT01342445|5886452|P1|NOT COMPLETED|Overall Study||0
2399707|NCT01342445|5886451|P2|COMPLETED|Overall Study||22
2399708|NCT01342445|5886452|P1|COMPLETED|Overall Study||26
2399709|NCT01342445|5886451|P2|STARTED|Overall Study||24
2399710|NCT01342445|5886452|P1|STARTED|Overall Study||26
2399711|NCT01342341|5886468|P2|NOT COMPLETED|Overall Study||4
2399712|NCT01342341|5886469|P1|NOT COMPLETED|Overall Study||4
2399713|NCT01342341|5886468|P2|COMPLETED|Overall Study||20
2399714|NCT01342341|5886469|P1|COMPLETED|Overall Study||20
2399715|NCT01342341|5886468|P2|STARTED|Overall Study||24
2399716|NCT01342341|5886469|P1|STARTED|Overall Study||24
2399717|NCT01342211|5886480|P5|NOT COMPLETED|Overall Study||2
2399718|NCT01342211|5886481|P4|NOT COMPLETED|Overall Study||2
2399719|NCT01342211|5886482|P3|NOT COMPLETED|Overall Study||0
2399720|NCT01342211|5886483|P2|NOT COMPLETED|Overall Study||2
2399721|NCT01342211|5886484|P1|NOT COMPLETED|Overall Study||0
2399722|NCT01342211|5886480|P5|COMPLETED|Overall Study||16
2399723|NCT01342211|5886481|P4|COMPLETED|Overall Study||17
2399724|NCT01342211|5886482|P3|COMPLETED|Overall Study||18
2399725|NCT01342211|5886483|P2|COMPLETED|Overall Study||17
2399726|NCT01342211|5886484|P1|COMPLETED|Overall Study||19
2399727|NCT01342211|5886480|P5|Treated|Overall Study||17
2399728|NCT01342211|5886481|P4|Treated|Overall Study||19
2399729|NCT01342211|5886482|P3|Treated|Overall Study||18
2399730|NCT01342211|5886483|P2|Treated|Overall Study||17
2399731|NCT01342211|5886484|P1|Treated|Overall Study||19
2399732|NCT01342211|5886480|P5|STARTED|Overall Study||18
2399733|NCT01342211|5886481|P4|STARTED|Overall Study||19
2399734|NCT01342211|5886482|P3|STARTED|Overall Study||18
2399735|NCT01342211|5886483|P2|STARTED|Overall Study||19
2399736|NCT01342211|5886484|P1|STARTED|Overall Study||19
2399737|NCT01342172|5886550|P1|NOT COMPLETED|Overall Study||0
2399738|NCT01342172|5886550|P1|COMPLETED|Overall Study||9
2399739|NCT01342172|5886550|P1|STARTED|Overall Study||9
2399740|NCT01342107|5886563|P2|NOT COMPLETED|Overall Study||0
2399741|NCT01342107|5886564|P1|NOT COMPLETED|Overall Study||0
2399742|NCT01342107|5886563|P2|COMPLETED|Overall Study||32
2399743|NCT01342107|5886564|P1|COMPLETED|Overall Study||34
2399744|NCT01342107|5886563|P2|STARTED|Overall Study||32
2399745|NCT01342107|5886564|P1|STARTED|Overall Study||34
2399746|NCT01342094|5886572|P2|NOT COMPLETED|Overall Study||3
2399747|NCT01342094|5886573|P1|NOT COMPLETED|Overall Study||5
2399748|NCT01342094|5886572|P2|COMPLETED|Overall Study||81
2399749|NCT01342094|5886573|P1|COMPLETED|Overall Study||77
2399750|NCT01342094|5886572|P2|STARTED|Overall Study||84
2399751|NCT01342094|5886573|P1|STARTED|Overall Study||82
2399752|NCT01342081|5886582|P3|NOT COMPLETED|Overall Study||1
2399753|NCT01342081|5886583|P2|NOT COMPLETED|Overall Study||2
2399754|NCT01342081|5886584|P1|NOT COMPLETED|Overall Study||2
2399755|NCT01342081|5886582|P3|COMPLETED|Overall Study||163
2399756|NCT01342081|5886583|P2|COMPLETED|Overall Study||162
2399757|NCT01342081|5886584|P1|COMPLETED|Overall Study||159
2399758|NCT01342081|5886582|P3|STARTED|Overall Study||164
2399759|NCT01342081|5886583|P2|STARTED|Overall Study||164
2399760|NCT01342081|5886584|P1|STARTED|Overall Study||161
2399761|NCT01342029|5886592|P2|NOT COMPLETED|Period 2||0
2399762|NCT01342029|5886593|P1|NOT COMPLETED|Period 2||2
2399763|NCT01342029|5886592|P2|COMPLETED|Period 2||67
2399764|NCT01342029|5886593|P1|COMPLETED|Period 2||65
2399765|NCT01342029|5886592|P2|Dropout|Period 2||0
2399766|NCT01342029|5886593|P1|Dropout|Period 2||2
2399767|NCT01342029|5886592|P2|STARTED|Period 2||67
2399768|NCT01342029|5886593|P1|STARTED|Period 2||67
2399769|NCT01342029|5886592|P2|NOT COMPLETED|Washout||4
2399770|NCT01342029|5886593|P1|NOT COMPLETED|Washout||0
2399771|NCT01342029|5886592|P2|COMPLETED|Washout||67
2399772|NCT01342029|5886593|P1|COMPLETED|Washout||67
2399773|NCT01342029|5886592|P2|STARTED|Washout||71
2399774|NCT01342029|5886593|P1|STARTED|Washout||67
2399775|NCT01342029|5886592|P2|NOT COMPLETED|Period 1||1
2399776|NCT01342029|5886593|P1|NOT COMPLETED|Period 1||3
2399777|NCT01342029|5886592|P2|COMPLETED|Period 1||71
2399778|NCT01342029|5886593|P1|COMPLETED|Period 1||67
2399779|NCT01342029|5886592|P2|Dropout|Period 1||1
2399780|NCT01342029|5886593|P1|Dropout|Period 1||3
2399781|NCT01342029|5886592|P2|STARTED|Period 1||72
2399782|NCT01342029|5886593|P1|STARTED|Period 1||70
2399783|NCT01341990|5886603|P2|NOT COMPLETED|Overall Study||1
2399784|NCT01341990|5886604|P1|NOT COMPLETED|Overall Study||3
2399785|NCT01341990|5886603|P2|COMPLETED|Overall Study||32
2399786|NCT01341990|5886604|P1|COMPLETED|Overall Study||32
2399787|NCT01341990|5886603|P2|STARTED|Overall Study||33
2399788|NCT01341990|5886604|P1|STARTED|Overall Study||35
2399789|NCT01341977|5886614|P2|NOT COMPLETED|Overall Study||15
2399790|NCT01341977|5886615|P1|NOT COMPLETED|Overall Study||14
2399791|NCT01341977|5886614|P2|COMPLETED|Overall Study||270
2399792|NCT01341977|5886615|P1|COMPLETED|Overall Study||274
2399793|NCT01341977|5886614|P2|STARTED|Overall Study||285
2399794|NCT01341977|5886615|P1|STARTED|Overall Study||288
2399795|NCT01341912|5886621|P1|NOT COMPLETED|Overall Study||0
2399796|NCT01341912|5886621|P1|COMPLETED|Overall Study||3
2399797|NCT01341912|5886621|P1|STARTED|Overall Study||3
2399798|NCT01341782|5886628|P2|NOT COMPLETED|Overall Study||14
2399799|NCT01341782|5886629|P1|NOT COMPLETED|Overall Study||15
2399800|NCT01341782|5886628|P2|COMPLETED|Overall Study||114
2399801|NCT01341782|5886629|P1|COMPLETED|Overall Study||112
2399802|NCT01341782|5886628|P2|STARTED|Overall Study||128
2399803|NCT01341782|5886629|P1|STARTED|Overall Study||127
2399804|NCT01341639|5886647|P2|NOT COMPLETED|Post-Treatment||3
2399805|NCT01341639|5886648|P1|NOT COMPLETED|Post-Treatment||0
2399806|NCT01341639|5886647|P2|COMPLETED|Post-Treatment||545
2399807|NCT01341639|5886648|P1|COMPLETED|Post-Treatment||539
2399808|NCT01341639|5886647|P2|STARTED|Post-Treatment||548
2399809|NCT01341639|5886648|P1|STARTED|Post-Treatment||539
2399810|NCT01341639|5886647|P2|NOT COMPLETED|Toddler Dose||34
2399811|NCT01341639|5886648|P1|NOT COMPLETED|Toddler Dose||51
2399812|NCT01341639|5886647|P2|COMPLETED|Toddler Dose||548
2399813|NCT01341639|5886648|P1|COMPLETED|Toddler Dose||539
2399814|NCT01341639|5886647|P2|STARTED|Toddler Dose|One participant randomized to the PR5I group mistakenly received INFANRIX™ hexa instead|582
2399815|NCT01341639|5886648|P1|STARTED|Toddler Dose|One participant randomized to the PR5I group mistakenly received INFANRIX™ hexa instead|590
2399816|NCT01341639|5886647|P2|NOT COMPLETED|Interim Period||9
2399817|NCT01341639|5886648|P1|NOT COMPLETED|Interim Period||8
2399818|NCT01341639|5886647|P2|COMPLETED|Interim Period||581
2399819|NCT01341639|5886648|P1|COMPLETED|Interim Period||591
2399820|NCT01341639|5886647|P2|STARTED|Interim Period||590
2399821|NCT01341639|5886648|P1|STARTED|Interim Period||599
2399822|NCT01341639|5886647|P2|NOT COMPLETED|Infant Series||32
2399823|NCT01341639|5886648|P1|NOT COMPLETED|Infant Series||29
2399824|NCT01341639|5886647|P2|COMPLETED|Infant Series||590
2399825|NCT01341639|5886648|P1|COMPLETED|Infant Series||599
2399826|NCT01341639|5886647|P2|Treated|Infant Series||605
2399827|NCT01341639|5886648|P1|Treated|Infant Series||610
2399828|NCT01341639|5886647|P2|Site 0048 Excluded|Infant Series||606
2399829|NCT01341639|5886648|P1|Site 0048 Excluded|Infant Series||611
2399830|NCT01341639|5886647|P2|STARTED|Infant Series||622
2399831|NCT01341639|5886648|P1|STARTED|Infant Series||628
2399832|NCT01341600|5886672|P3|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
2399833|NCT01341600|5886673|P2|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
2399834|NCT01341600|5886674|P1|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
2399835|NCT01341600|5886672|P3|COMPLETED|Clopidogrel Plus Omeprazole||4
2399836|NCT01341600|5886673|P2|COMPLETED|Clopidogrel Plus Omeprazole||5
2399837|NCT01341600|5886674|P1|COMPLETED|Clopidogrel Plus Omeprazole||5
2399838|NCT01341600|5886672|P3|STARTED|Clopidogrel Plus Omeprazole||4
2399839|NCT01341600|5886673|P2|STARTED|Clopidogrel Plus Omeprazole||5
2399840|NCT01341600|5886674|P1|STARTED|Clopidogrel Plus Omeprazole||5
2399841|NCT01341600|5886672|P3|NOT COMPLETED|Clopidogrel 225 mg||0
2399842|NCT01341600|5886673|P2|NOT COMPLETED|Clopidogrel 225 mg||0
2399843|NCT01341600|5886674|P1|NOT COMPLETED|Clopidogrel 225 mg||0
2399844|NCT01341600|5886672|P3|COMPLETED|Clopidogrel 225 mg||6
2399845|NCT01341600|5886673|P2|COMPLETED|Clopidogrel 225 mg||6
2399846|NCT01341600|5886674|P1|COMPLETED|Clopidogrel 225 mg||6
2399847|NCT01341600|5886672|P3|STARTED|Clopidogrel 225 mg||6
2399848|NCT01341600|5886673|P2|STARTED|Clopidogrel 225 mg||6
2399849|NCT01341600|5886674|P1|STARTED|Clopidogrel 225 mg||6
2399850|NCT01341600|5886672|P3|NOT COMPLETED|Clopidogrel 150 mg||0
2399851|NCT01341600|5886673|P2|NOT COMPLETED|Clopidogrel 150 mg||0
2399852|NCT01341600|5886674|P1|NOT COMPLETED|Clopidogrel 150 mg||0
2399853|NCT01341600|5886672|P3|COMPLETED|Clopidogrel 150 mg||6
2399854|NCT01341600|5886673|P2|COMPLETED|Clopidogrel 150 mg||6
2399855|NCT01341600|5886674|P1|COMPLETED|Clopidogrel 150 mg||6
2399856|NCT01341600|5886672|P3|STARTED|Clopidogrel 150 mg||6
2399857|NCT01341600|5886673|P2|STARTED|Clopidogrel 150 mg||6
2399858|NCT01341600|5886674|P1|STARTED|Clopidogrel 150 mg||6
2399859|NCT01341600|5886672|P3|NOT COMPLETED|Clopidogrel 75 mg||0
2399860|NCT01341600|5886673|P2|NOT COMPLETED|Clopidogrel 75 mg||0
2399861|NCT01341600|5886674|P1|NOT COMPLETED|Clopidogrel 75 mg||0
2399862|NCT01341600|5886672|P3|COMPLETED|Clopidogrel 75 mg||6
2399863|NCT01341600|5886673|P2|COMPLETED|Clopidogrel 75 mg||6
2399864|NCT01341600|5886674|P1|COMPLETED|Clopidogrel 75 mg||6
2399865|NCT01341600|5886672|P3|STARTED|Clopidogrel 75 mg||6
2399866|NCT01341600|5886673|P2|STARTED|Clopidogrel 75 mg||6
2399867|NCT01341600|5886674|P1|STARTED|Clopidogrel 75 mg||6
2399868|NCT01341587|5886693|P2|NOT COMPLETED|Overall Study||10
2399869|NCT01341587|5886694|P1|NOT COMPLETED|Overall Study||4
2399870|NCT01341587|5886693|P2|COMPLETED|Overall Study||0
2399871|NCT01341587|5886694|P1|COMPLETED|Overall Study||0
2399872|NCT01341587|5886693|P2|STARTED|Overall Study||10
2399873|NCT01341587|5886694|P1|STARTED|Overall Study||4
2399874|NCT01341470|5886706|P6|NOT COMPLETED|Overall Study||1
2399875|NCT01341470|5886707|P5|NOT COMPLETED|Overall Study||0
2399876|NCT01341470|5886708|P4|NOT COMPLETED|Overall Study||1
2399877|NCT01341470|5886709|P3|NOT COMPLETED|Overall Study||1
2399878|NCT01341470|5886710|P2|NOT COMPLETED|Overall Study||0
2399879|NCT01341470|5886711|P1|NOT COMPLETED|Overall Study||0
2399880|NCT01341470|5886706|P6|COMPLETED|Overall Study||9
2399881|NCT01341470|5886707|P5|COMPLETED|Overall Study||2
2399882|NCT01341470|5886708|P4|COMPLETED|Overall Study||9
2399883|NCT01341470|5886709|P3|COMPLETED|Overall Study||9
2399884|NCT01341470|5886710|P2|COMPLETED|Overall Study||9
2399885|NCT01341470|5886711|P1|COMPLETED|Overall Study||6
2399886|NCT01341470|5886706|P6|Received at Least 1 Dose of Study Drug|Overall Study||10
2399887|NCT01341470|5886707|P5|Received at Least 1 Dose of Study Drug|Overall Study||2
2399888|NCT01341470|5886708|P4|Received at Least 1 Dose of Study Drug|Overall Study||10
2399889|NCT01341470|5886709|P3|Received at Least 1 Dose of Study Drug|Overall Study||10
2399890|NCT01341470|5886710|P2|Received at Least 1 Dose of Study Drug|Overall Study||9
2399891|NCT01341470|5886711|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
2399892|NCT01341470|5886706|P6|STARTED|Overall Study||10
2399893|NCT01341470|5886707|P5|STARTED|Overall Study||2
2399894|NCT01341470|5886708|P4|STARTED|Overall Study||10
2399895|NCT01341470|5886709|P3|STARTED|Overall Study||10
2399896|NCT01341470|5886710|P2|STARTED|Overall Study||9
2399897|NCT01341470|5886711|P1|STARTED|Overall Study||6
2399898|NCT01341457|5886745|P2|NOT COMPLETED|Overall Study||0
2399899|NCT01341457|5886746|P1|NOT COMPLETED|Overall Study||2
2399900|NCT01341457|5886745|P2|COMPLETED|Overall Study||10
2399901|NCT01341457|5886746|P1|COMPLETED|Overall Study||5
2399902|NCT01341457|5886745|P2|Received at Least One Dose of Study Drug|Overall Study||10
2399903|NCT01341457|5886746|P1|Received at Least One Dose of Study Drug|Overall Study||7
2399904|NCT01341457|5886745|P2|STARTED|Overall Study||10
2399905|NCT01341457|5886746|P1|STARTED|Overall Study||7
2399906|NCT01341444|5886764|P2|NOT COMPLETED|Overall Study||3
2399907|NCT01341444|5886765|P1|NOT COMPLETED|Overall Study||5
2399908|NCT01341444|5886764|P2|COMPLETED|Overall Study||29
2399909|NCT01341444|5886765|P1|COMPLETED|Overall Study||26
2399910|NCT01341444|5886764|P2|STARTED|Overall Study||32
2399911|NCT01341444|5886765|P1|STARTED|Overall Study||31
2399912|NCT01341301|5886771|P1|NOT COMPLETED|Overall Study||0
2399913|NCT01341301|5886771|P1|COMPLETED|Overall Study||25
2399914|NCT01341301|5886771|P1|STARTED|Overall Study||25
2399915|NCT01341067|5886778|P1|NOT COMPLETED|Overall Study||4
2399916|NCT01341067|5886778|P1|COMPLETED|Overall Study||26
2399917|NCT01341067|5886778|P1|STARTED|Overall Study||30
2399918|NCT01340976|5886791|P6|NOT COMPLETED|Overall Study||1
2399919|NCT01340976|5886792|P5|NOT COMPLETED|Overall Study||2
2399920|NCT01340976|5886793|P4|NOT COMPLETED|Overall Study||3
2399921|NCT01340976|5886794|P3|NOT COMPLETED|Overall Study||3
2399922|NCT01340976|5886795|P2|NOT COMPLETED|Overall Study||2
2399923|NCT01340976|5886796|P1|NOT COMPLETED|Overall Study||4
2399924|NCT01340976|5886791|P6|COMPLETED|Overall Study||6
2399925|NCT01340976|5886792|P5|COMPLETED|Overall Study||5
2399926|NCT01340976|5886793|P4|COMPLETED|Overall Study||2
2399927|NCT01340976|5886794|P3|COMPLETED|Overall Study||4
2399928|NCT01340976|5886795|P2|COMPLETED|Overall Study||1
2399929|NCT01340976|5886796|P1|COMPLETED|Overall Study||0
2399930|NCT01340976|5886791|P6|Received at Least 1 Dose of Study Drug|Overall Study||7
2399931|NCT01340976|5886792|P5|Received at Least 1 Dose of Study Drug|Overall Study||7
2399932|NCT01340976|5886793|P4|Received at Least 1 Dose of Study Drug|Overall Study||5
2399933|NCT01340976|5886794|P3|Received at Least 1 Dose of Study Drug|Overall Study||7
2399934|NCT01340976|5886795|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
2399935|NCT01340976|5886796|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
2399936|NCT01340976|5886791|P6|STARTED|Overall Study||7
2399937|NCT01340976|5886792|P5|STARTED|Overall Study||7
2399938|NCT01340976|5886793|P4|STARTED|Overall Study||5
2399939|NCT01340976|5886794|P3|STARTED|Overall Study||7
2399940|NCT01340976|5886795|P2|STARTED|Overall Study||3
2399941|NCT01340976|5886796|P1|STARTED|Overall Study||4
2399942|NCT01340937|5886834|P4|NOT COMPLETED|Period 3: Toddler Vaccinations||10
2399943|NCT01340937|5886835|P3|NOT COMPLETED|Period 3: Toddler Vaccinations||9
2399944|NCT01340937|5886836|P2|NOT COMPLETED|Period 3: Toddler Vaccinations||17
2399945|NCT01340937|5886837|P1|NOT COMPLETED|Period 3: Toddler Vaccinations||9
2399946|NCT01340937|5886834|P4|COMPLETED|Period 3: Toddler Vaccinations||319
2399947|NCT01340937|5886835|P3|COMPLETED|Period 3: Toddler Vaccinations||660
2399948|NCT01340937|5886836|P2|COMPLETED|Period 3: Toddler Vaccinations||641
2399949|NCT01340937|5886837|P1|COMPLETED|Period 3: Toddler Vaccinations||666
2399950|NCT01340937|5886834|P4|STARTED|Period 3: Toddler Vaccinations||329
2399951|NCT01340937|5886835|P3|STARTED|Period 3: Toddler Vaccinations||669
2399952|NCT01340937|5886836|P2|STARTED|Period 3: Toddler Vaccinations||658
2399953|NCT01340937|5886837|P1|STARTED|Period 3: Toddler Vaccinations||675
2399954|NCT01340937|5886834|P4|NOT COMPLETED|Period 2: Interim Period||41
2399955|NCT01340937|5886835|P3|NOT COMPLETED|Period 2: Interim Period||84
2399956|NCT01340937|5886836|P2|NOT COMPLETED|Period 2: Interim Period||79
2399957|NCT01340937|5886837|P1|NOT COMPLETED|Period 2: Interim Period||67
2399958|NCT01340937|5886834|P4|COMPLETED|Period 2: Interim Period||329
2399959|NCT01340937|5886835|P3|COMPLETED|Period 2: Interim Period||669
2399960|NCT01340937|5886836|P2|COMPLETED|Period 2: Interim Period||658
2399961|NCT01340937|5886837|P1|COMPLETED|Period 2: Interim Period||675
2399962|NCT01340937|5886834|P4|STARTED|Period 2: Interim Period||370
2399963|NCT01340937|5886835|P3|STARTED|Period 2: Interim Period||753
2399964|NCT01340937|5886836|P2|STARTED|Period 2: Interim Period||737
2399965|NCT01340937|5886837|P1|STARTED|Period 2: Interim Period||742
2399966|NCT01340937|5886834|P4|NOT COMPLETED|Period 1: Infant Series||32
2399967|NCT01340937|5886835|P3|NOT COMPLETED|Period 1: Infant Series||56
2399968|NCT01340937|5886836|P2|NOT COMPLETED|Period 1: Infant Series||60
2399969|NCT01340937|5886837|P1|NOT COMPLETED|Period 1: Infant Series||58
2399970|NCT01340937|5886834|P4|COMPLETED|Period 1: Infant Series||370
2399971|NCT01340937|5886835|P3|COMPLETED|Period 1: Infant Series||753
2399972|NCT01340937|5886836|P2|COMPLETED|Period 1: Infant Series||737
2399973|NCT01340937|5886837|P1|COMPLETED|Period 1: Infant Series||742
2399974|NCT01340937|5886834|P4|STARTED|Period 1: Infant Series||402
2399975|NCT01340937|5886835|P3|STARTED|Period 1: Infant Series||809
2399976|NCT01340937|5886836|P2|STARTED|Period 1: Infant Series||797
2399977|NCT01340937|5886837|P1|STARTED|Period 1: Infant Series||800
2399978|NCT01340898|5886997|P3|NOT COMPLETED|Booster Phase||7
2399979|NCT01340898|5886998|P2|NOT COMPLETED|Booster Phase||2
2399980|NCT01340898|5886999|P1|NOT COMPLETED|Booster Phase||10
2399981|NCT01340898|5886997|P3|COMPLETED|Booster Phase||163
2399982|NCT01340898|5886998|P2|COMPLETED|Booster Phase||164
2399983|NCT01340898|5886999|P1|COMPLETED|Booster Phase||332
2399984|NCT01340898|5886997|P3|STARTED|Booster Phase||170
2399985|NCT01340898|5886998|P2|STARTED|Booster Phase||166
2399986|NCT01340898|5886999|P1|STARTED|Booster Phase||342
2399987|NCT01340898|5886997|P3|NOT COMPLETED|Primary Phase||6
2399988|NCT01340898|5886998|P2|NOT COMPLETED|Primary Phase||9
2399989|NCT01340898|5886999|P1|NOT COMPLETED|Primary Phase||16
2399990|NCT01340898|5886997|P3|COMPLETED|Primary Phase||181
2399991|NCT01340898|5886998|P2|COMPLETED|Primary Phase||178
2399992|NCT01340898|5886999|P1|COMPLETED|Primary Phase||360
2399993|NCT01340898|5886997|P3|STARTED|Primary Phase||187
2399994|NCT01340898|5886998|P2|STARTED|Primary Phase||187
2399995|NCT01340898|5886999|P1|STARTED|Primary Phase||376
2399996|NCT01340872|5887101|P4|NOT COMPLETED|Open-label Phase||11
2399997|NCT01340872|5887102|P3|NOT COMPLETED|Open-label Phase||13
2399998|NCT01340872|5887103|P2|NOT COMPLETED|Open-label Phase||0
2399999|NCT01340872|5887104|P1|NOT COMPLETED|Open-label Phase||0
2400000|NCT01340872|5887101|P4|COMPLETED|Open-label Phase||36
2400001|NCT01340872|5887102|P3|COMPLETED|Open-label Phase||37
2400002|NCT01340872|5887103|P2|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
2400003|NCT01340872|5887104|P1|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
2400004|NCT01340872|5887101|P4|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|47
2400005|NCT01340872|5887102|P3|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|50
2400006|NCT01340872|5887103|P2|STARTED|Open-label Phase|Not Applicable to open-label phase|0
2400007|NCT01340872|5887104|P1|STARTED|Open-label Phase|Not Applicable to open-label phase|0
2400008|NCT01340872|5887101|P4|NOT COMPLETED|Double-blind Phase||0
2400009|NCT01340872|5887102|P3|NOT COMPLETED|Double-blind Phase||0
2400010|NCT01340872|5887103|P2|NOT COMPLETED|Double-blind Phase||11
2400011|NCT01340872|5887104|P1|NOT COMPLETED|Double-blind Phase||9
2400012|NCT01340872|5887101|P4|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
2400013|NCT01340872|5887102|P3|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
2400014|NCT01340872|5887103|P2|COMPLETED|Double-blind Phase||53
2400015|NCT01340872|5887104|P1|COMPLETED|Double-blind Phase||55
2400016|NCT01340872|5887101|P4|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
2400017|NCT01340872|5887102|P3|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
2400018|NCT01340872|5887103|P2|STARTED|Double-blind Phase||64
2400019|NCT01340872|5887104|P1|STARTED|Double-blind Phase||64
2400020|NCT01340794|5887164|P2|NOT COMPLETED|Overall Study||1
2400021|NCT01340794|5887165|P1|NOT COMPLETED|Overall Study||0
2400022|NCT01340794|5887164|P2|COMPLETED|Overall Study||4
2400023|NCT01340794|5887165|P1|COMPLETED|Overall Study||2
2400024|NCT01340794|5887164|P2|STARTED|Overall Study||5
2400025|NCT01340794|5887165|P1|STARTED|Overall Study||2
2400026|NCT01340768|5887181|P2|NOT COMPLETED|Overall Study||5
2400027|NCT01340768|5887182|P1|NOT COMPLETED|Overall Study||17
2400028|NCT01340768|5887181|P2|COMPLETED|Overall Study||429
2400029|NCT01340768|5887182|P1|COMPLETED|Overall Study||419
2400030|NCT01340768|5887181|P2|STARTED|Overall Study||434
2400031|NCT01340768|5887182|P1|STARTED|Overall Study||436
2400032|NCT01340664|5887193|P3|NOT COMPLETED|Overall Study||13
2400033|NCT01340664|5887194|P2|NOT COMPLETED|Overall Study||8
2400034|NCT01340664|5887195|P1|NOT COMPLETED|Overall Study||7
2400035|NCT01340664|5887193|P3|COMPLETED|Overall Study||80
2400036|NCT01340664|5887194|P2|COMPLETED|Overall Study||85
2400037|NCT01340664|5887195|P1|COMPLETED|Overall Study||86
2400038|NCT01340664|5887193|P3|STARTED|Overall Study||93
2400039|NCT01340664|5887194|P2|STARTED|Overall Study||93
2400040|NCT01340664|5887195|P1|STARTED|Overall Study||93
2400041|NCT01340651|5887212|P1|NOT COMPLETED|Overall Study||17
2400042|NCT01340651|5887212|P1|COMPLETED|Overall Study||24
2400043|NCT01340651|5887212|P1|STARTED|Overall Study||41
2400044|NCT01340625|5887228|P2|NOT COMPLETED|Second Intervention||0
2400045|NCT01340625|5887229|P1|NOT COMPLETED|Second Intervention||0
2400046|NCT01340625|5887228|P2|COMPLETED|Second Intervention||18
2400047|NCT01340625|5887229|P1|COMPLETED|Second Intervention||16
2400048|NCT01340625|5887228|P2|STARTED|Second Intervention||18
2400049|NCT01340625|5887229|P1|STARTED|Second Intervention||16
2400050|NCT01340625|5887228|P2|NOT COMPLETED|Washout Period of 28 Days||0
2400051|NCT01340625|5887229|P1|NOT COMPLETED|Washout Period of 28 Days||1
2400052|NCT01340625|5887228|P2|COMPLETED|Washout Period of 28 Days||18
2400053|NCT01340625|5887229|P1|COMPLETED|Washout Period of 28 Days||16
2400054|NCT01340625|5887228|P2|STARTED|Washout Period of 28 Days||18
2400055|NCT01340625|5887229|P1|STARTED|Washout Period of 28 Days||17
2400056|NCT01340625|5887228|P2|NOT COMPLETED|First Intervention||0
2400057|NCT01340625|5887229|P1|NOT COMPLETED|First Intervention||1
2400058|NCT01340625|5887228|P2|COMPLETED|First Intervention||18
2400059|NCT01340625|5887229|P1|COMPLETED|First Intervention||17
2400060|NCT01340625|5887228|P2|STARTED|First Intervention||18
2400061|NCT01340625|5887229|P1|STARTED|First Intervention||18
2400062|NCT01340586|5887247|P2|NOT COMPLETED|Overall Study||0
2400063|NCT01340586|5887248|P1|NOT COMPLETED|Overall Study||0
2400064|NCT01340586|5887247|P2|COMPLETED|Overall Study||8
2400065|NCT01340586|5887248|P1|COMPLETED|Overall Study||8
2400066|NCT01340586|5887247|P2|STARTED|Overall Study||8
2400067|NCT01340586|5887248|P1|STARTED|Overall Study||8
2400068|NCT01340573|5887313|P1|NOT COMPLETED|Overall Study||3
2400069|NCT01340573|5887313|P1|COMPLETED|Overall Study||0
2400070|NCT01340573|5887313|P1|STARTED|Overall Study||3
2400071|NCT01340495|5887334|P1|NOT COMPLETED|Overall Study||1
2400072|NCT01340495|5887334|P1|COMPLETED|Overall Study||69
2400073|NCT01340495|5887334|P1|STARTED|Overall Study||70
2400074|NCT01340300|5887345|P4|NOT COMPLETED|Overall Study||14
2400075|NCT01340300|5887346|P3|NOT COMPLETED|Overall Study||15
2400076|NCT01340300|5887347|P2|NOT COMPLETED|Overall Study||9
2400077|NCT01340300|5887348|P1|NOT COMPLETED|Overall Study||9
2400078|NCT01340300|5887345|P4|COMPLETED|Overall Study||20
2400079|NCT01340300|5887346|P3|COMPLETED|Overall Study||20
2400080|NCT01340300|5887347|P2|COMPLETED|Overall Study||26
2400081|NCT01340300|5887348|P1|COMPLETED|Overall Study||26
2400082|NCT01340300|5887345|P4|Follow-up Blood Sample|Overall Study||18
2400083|NCT01340300|5887346|P3|Follow-up Blood Sample|Overall Study||19
2400084|NCT01340300|5887347|P2|Follow-up Blood Sample|Overall Study||26
2400085|NCT01340300|5887348|P1|Follow-up Blood Sample|Overall Study||25
2400086|NCT01340300|5887345|P4|Baseline Blood Sample|Overall Study||29
2400087|NCT01340300|5887346|P3|Baseline Blood Sample|Overall Study||32
2400088|NCT01340300|5887347|P2|Baseline Blood Sample|Overall Study||34
2400089|NCT01340300|5887348|P1|Baseline Blood Sample|Overall Study||33
2400090|NCT01340300|5887345|P4|STARTED|Overall Study||34
2400091|NCT01340300|5887346|P3|STARTED|Overall Study||35
2400092|NCT01340300|5887347|P2|STARTED|Overall Study||35
2400093|NCT01340300|5887348|P1|STARTED|Overall Study||35
2400094|NCT01340209|5887381|P3|NOT COMPLETED|Overall Study||8
2400095|NCT01340209|5887382|P2|NOT COMPLETED|Overall Study||8
2400096|NCT01340209|5887383|P1|NOT COMPLETED|Overall Study||5
2400097|NCT01340209|5887381|P3|COMPLETED|Overall Study||106
2400098|NCT01340209|5887382|P2|COMPLETED|Overall Study||106
2400099|NCT01340209|5887383|P1|COMPLETED|Overall Study||52
2400100|NCT01340209|5887381|P3|STARTED|Overall Study||114
2400101|NCT01340209|5887382|P2|STARTED|Overall Study||114
2400102|NCT01340209|5887383|P1|STARTED|Overall Study||57
2400103|NCT01340196|5887418|P1|NOT COMPLETED|Treat. Period 3 (Faldaprevir)||2
2400104|NCT01340196|5887418|P1|COMPLETED|Treat. Period 3 (Faldaprevir)||14
2400105|NCT01340196|5887418|P1|STARTED|Treat. Period 3 (Faldaprevir)||16
2400106|NCT01340196|5887418|P1|NOT COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||0
2400107|NCT01340196|5887418|P1|COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
2400108|NCT01340196|5887418|P1|STARTED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
2400109|NCT01340196|5887418|P1|NOT COMPLETED|Treat. Period 1 (Tenofovir)||0
2400110|NCT01340196|5887418|P1|COMPLETED|Treat. Period 1 (Tenofovir)||16
2400111|NCT01340196|5887418|P1|STARTED|Treat. Period 1 (Tenofovir)||16
2400112|NCT01340144|5887449|P2|NOT COMPLETED|Overall Study||58
2400113|NCT01340144|5887450|P1|NOT COMPLETED|Overall Study||72
2400114|NCT01340144|5887449|P2|COMPLETED|Overall Study||567
2400115|NCT01340144|5887450|P1|COMPLETED|Overall Study||553
2400116|NCT01340144|5887449|P2|STARTED|Overall Study||625
2400117|NCT01340144|5887450|P1|STARTED|Overall Study||625
2400118|NCT01340066|5887458|P3|NOT COMPLETED|5 Week Double Blind Randomization Period||3
2400119|NCT01340066|5887459|P2|NOT COMPLETED|5 Week Double Blind Randomization Period||5
2400120|NCT01340066|5887460|P1|NOT COMPLETED|5 Week Double Blind Randomization Period||0
2400121|NCT01340066|5887458|P3|COMPLETED|5 Week Double Blind Randomization Period||31
2400122|NCT01340066|5887459|P2|COMPLETED|5 Week Double Blind Randomization Period||28
2400123|NCT01340066|5887460|P1|COMPLETED|5 Week Double Blind Randomization Period||0
2400124|NCT01340066|5887458|P3|STARTED|5 Week Double Blind Randomization Period||34
2400125|NCT01340066|5887459|P2|STARTED|5 Week Double Blind Randomization Period||33
2400126|NCT01340066|5887460|P1|STARTED|5 Week Double Blind Randomization Period||0
2400127|NCT01340066|5887458|P3|NOT COMPLETED|Placebo Run in Period||0
2400128|NCT01340066|5887459|P2|NOT COMPLETED|Placebo Run in Period||0
2400129|NCT01340066|5887460|P1|NOT COMPLETED|Placebo Run in Period||27
2400130|NCT01340066|5887458|P3|COMPLETED|Placebo Run in Period||0
2400131|NCT01340066|5887459|P2|COMPLETED|Placebo Run in Period||0
2400132|NCT01340066|5887460|P1|COMPLETED|Placebo Run in Period|Completed run in period and were eligible for randomization|67
2400133|NCT01340066|5887458|P3|STARTED|Placebo Run in Period||0
2400134|NCT01340066|5887459|P2|STARTED|Placebo Run in Period||0
2400135|NCT01340066|5887460|P1|STARTED|Placebo Run in Period||94
2400136|NCT01340053|5887471|P4|NOT COMPLETED|Overall Study||3
2400137|NCT01340053|5887472|P3|NOT COMPLETED|Overall Study||4
2400138|NCT01340053|5887473|P2|NOT COMPLETED|Overall Study||2
2400139|NCT01340053|5887474|P1|NOT COMPLETED|Overall Study||4
2400140|NCT01340053|5887471|P4|COMPLETED|Overall Study||43
2400141|NCT01340053|5887472|P3|COMPLETED|Overall Study||43
2400142|NCT01340053|5887473|P2|COMPLETED|Overall Study||44
2400143|NCT01340053|5887474|P1|COMPLETED|Overall Study||43
2400144|NCT01340053|5887471|P4|STARTED|Overall Study||46
2400145|NCT01340053|5887472|P3|STARTED|Overall Study||47
2400146|NCT01340053|5887473|P2|STARTED|Overall Study||46
2400147|NCT01340053|5887474|P1|STARTED|Overall Study||47
2400148|NCT01340027|5887500|P12|NOT COMPLETED|Overall Study||4
2400149|NCT01340027|5887501|P11|NOT COMPLETED|Overall Study||2
2400150|NCT01340027|5887502|P10|NOT COMPLETED|Overall Study||6
2400151|NCT01340027|5887503|P9|NOT COMPLETED|Overall Study||8
2400152|NCT01340027|5887504|P8|NOT COMPLETED|Overall Study||7
2400153|NCT01340027|5887505|P7|NOT COMPLETED|Overall Study||7
2400154|NCT01340027|5887506|P6|NOT COMPLETED|Overall Study||4
2400155|NCT01340027|5887507|P5|NOT COMPLETED|Overall Study||10
2400156|NCT01340027|5887508|P4|NOT COMPLETED|Overall Study||4
2400157|NCT01340027|5887509|P3|NOT COMPLETED|Overall Study||4
2400158|NCT01340027|5887510|P2|NOT COMPLETED|Overall Study||7
2400159|NCT01340027|5887511|P1|NOT COMPLETED|Overall Study||5
2400160|NCT01340027|5887500|P12|COMPLETED|Overall Study||77
2400161|NCT01340027|5887501|P11|COMPLETED|Overall Study||79
2400162|NCT01340027|5887502|P10|COMPLETED|Overall Study||146
2400163|NCT01340027|5887503|P9|COMPLETED|Overall Study||136
2400164|NCT01340027|5887504|P8|COMPLETED|Overall Study||142
2400165|NCT01340027|5887505|P7|COMPLETED|Overall Study||142
2400166|NCT01340027|5887506|P6|COMPLETED|Overall Study||74
2400167|NCT01340027|5887507|P5|COMPLETED|Overall Study||146
2400168|NCT01340027|5887508|P4|COMPLETED|Overall Study||75
2400169|NCT01340027|5887509|P3|COMPLETED|Overall Study||75
2400170|NCT01340027|5887510|P2|COMPLETED|Overall Study||71
2400171|NCT01340027|5887511|P1|COMPLETED|Overall Study||76
2400172|NCT01340027|5887500|P12|Received Treatment|Overall Study||81
2400173|NCT01340027|5887501|P11|Received Treatment|Overall Study||81
2400174|NCT01340027|5887502|P10|Received Treatment|Overall Study||152
2400175|NCT01340027|5887503|P9|Received Treatment|Overall Study||144
2400176|NCT01340027|5887504|P8|Received Treatment|Overall Study||149
2400177|NCT01340027|5887505|P7|Received Treatment|Overall Study||149
2400178|NCT01340027|5887506|P6|Received Treatment|Overall Study||78
2400179|NCT01340027|5887507|P5|Received Treatment|Overall Study||156
2400180|NCT01340027|5887508|P4|Received Treatment|Overall Study||79
2400181|NCT01340027|5887509|P3|Received Treatment|Overall Study||78
2400182|NCT01340027|5887510|P2|Received Treatment|Overall Study||78
2400183|NCT01340027|5887511|P1|Received Treatment|Overall Study||81
2400184|NCT01340027|5887500|P12|STARTED|Overall Study||81
2400185|NCT01340027|5887501|P11|STARTED|Overall Study||81
2400186|NCT01340027|5887502|P10|STARTED|Overall Study||152
2400187|NCT01340027|5887503|P9|STARTED|Overall Study||144
2400188|NCT01340027|5887504|P8|STARTED|Overall Study||149
2400189|NCT01340027|5887505|P7|STARTED|Overall Study||149
2400190|NCT01340027|5887506|P6|STARTED|Overall Study||78
2400191|NCT01340027|5887507|P5|STARTED|Overall Study||156
2400192|NCT01340027|5887508|P4|STARTED|Overall Study||79
2400193|NCT01340027|5887509|P3|STARTED|Overall Study||79
2400194|NCT01340027|5887510|P2|STARTED|Overall Study||78
2400195|NCT01340027|5887511|P1|STARTED|Overall Study||81
2400196|NCT01340014|5887887|P2|NOT COMPLETED|Period 2, Second 7 Days||1
2400197|NCT01340014|5887888|P1|NOT COMPLETED|Period 2, Second 7 Days||0
2400198|NCT01340014|5887887|P2|COMPLETED|Period 2, Second 7 Days||56
2400199|NCT01340014|5887888|P1|COMPLETED|Period 2, Second 7 Days||53
2400200|NCT01340014|5887887|P2|STARTED|Period 2, Second 7 Days||57
2400201|NCT01340014|5887888|P1|STARTED|Period 2, Second 7 Days||53
2400202|NCT01340014|5887887|P2|NOT COMPLETED|Period 1, First 7 Days||0
2400203|NCT01340014|5887888|P1|NOT COMPLETED|Period 1, First 7 Days||2
2400204|NCT01340014|5887887|P2|COMPLETED|Period 1, First 7 Days||57
2400205|NCT01340014|5887888|P1|COMPLETED|Period 1, First 7 Days||53
2400206|NCT01340014|5887887|P2|STARTED|Period 1, First 7 Days||57
2400207|NCT01340014|5887888|P1|STARTED|Period 1, First 7 Days||55
2400208|NCT01339936|5887896|P1|NOT COMPLETED|Overall Study||2
2400209|NCT01339936|5887896|P1|COMPLETED|Overall Study|plus 1 excluded from analysis set|36
2400210|NCT01339936|5887896|P1|STARTED|Overall Study|plus 2 screen failures|38
2400211|NCT01339923|5887909|P7|NOT COMPLETED|Overall Study||14
2400212|NCT01339923|5887910|P6|NOT COMPLETED|Overall Study||9
2400213|NCT01339923|5887911|P5|NOT COMPLETED|Overall Study||5
2400214|NCT01339923|5887912|P4|NOT COMPLETED|Overall Study||4
2400215|NCT01339923|5887913|P3|NOT COMPLETED|Overall Study||8
2400216|NCT01339923|5887914|P2|NOT COMPLETED|Overall Study||16
2400217|NCT01339923|5887915|P1|NOT COMPLETED|Overall Study||14
2400218|NCT01339923|5887909|P7|COMPLETED|Overall Study||111
2400219|NCT01339923|5887910|P6|COMPLETED|Overall Study||117
2400220|NCT01339923|5887911|P5|COMPLETED|Overall Study||295
2400221|NCT01339923|5887912|P4|COMPLETED|Overall Study||100
2400222|NCT01339923|5887913|P3|COMPLETED|Overall Study||243
2400223|NCT01339923|5887914|P2|COMPLETED|Overall Study||234
2400224|NCT01339923|5887915|P1|COMPLETED|Overall Study||239
2400225|NCT01339923|5887909|P7|STARTED|Overall Study||125
2400226|NCT01339923|5887910|P6|STARTED|Overall Study||126
2400227|NCT01339923|5887911|P5|STARTED|Overall Study||300
2400228|NCT01339923|5887912|P4|STARTED|Overall Study||104
2400229|NCT01339923|5887913|P3|STARTED|Overall Study||251
2400230|NCT01339923|5887914|P2|STARTED|Overall Study||250
2400231|NCT01339923|5887915|P1|STARTED|Overall Study||253
2400232|NCT01339910|5887986|P2|NOT COMPLETED|Overall Study||4
2400233|NCT01339910|5887987|P1|NOT COMPLETED|Overall Study||3
2400234|NCT01339910|5887986|P2|COMPLETED|Overall Study||133
2400235|NCT01339910|5887987|P1|COMPLETED|Overall Study||132
2400236|NCT01339910|5887986|P2|STARTED|Overall Study||137
2400237|NCT01339910|5887987|P1|STARTED|Overall Study||135
2400238|NCT01339897|5888025|P4|NOT COMPLETED|Overall Study||1
2400239|NCT01339897|5888026|P3|NOT COMPLETED|Overall Study||0
2400240|NCT01339897|5888027|P2|NOT COMPLETED|Overall Study||0
2400241|NCT01339897|5888028|P1|NOT COMPLETED|Overall Study||1
2400242|NCT01339897|5888025|P4|COMPLETED|Overall Study||5
2400243|NCT01339897|5888026|P3|COMPLETED|Overall Study||6
2400244|NCT01339897|5888027|P2|COMPLETED|Overall Study||6
2400245|NCT01339897|5888028|P1|COMPLETED|Overall Study||6
2400246|NCT01339897|5888025|P4|STARTED|Overall Study||6
2400247|NCT01339897|5888026|P3|STARTED|Overall Study||6
2400248|NCT01339897|5888027|P2|STARTED|Overall Study||6
2400249|NCT01339897|5888028|P1|STARTED|Overall Study||7
2400250|NCT01339858|5888056|P2|NOT COMPLETED|Overall Study||12
2400251|NCT01339858|5888057|P1|NOT COMPLETED|Overall Study||16
2400252|NCT01339858|5888056|P2|COMPLETED|Overall Study||18
2400253|NCT01339858|5888057|P1|COMPLETED|Overall Study||14
2400254|NCT01339858|5888056|P2|STARTED|Overall Study||30
2400255|NCT01339858|5888057|P1|STARTED|Overall Study||30
2400256|NCT01339832|5888081|P1|NOT COMPLETED|Overall Study||14
2400257|NCT01339832|5888081|P1|COMPLETED|Overall Study||37
2400258|NCT01339832|5888081|P1|STARTED|Overall Study||51
2400259|NCT01339429|5888092|P1|NOT COMPLETED|Overall Study||4
2400260|NCT01339429|5888092|P1|COMPLETED|Overall Study||37
2400261|NCT01339429|5888092|P1|STARTED|Overall Study||41
2400262|NCT01339416|5888097|P1|NOT COMPLETED|Overall Study||0
2400263|NCT01339416|5888097|P1|COMPLETED|Overall Study||8202
2400264|NCT01339416|5888097|P1|STARTED|Overall Study||8202
2400265|NCT01339403|5888109|P2|NOT COMPLETED|Overall Study||0
2400266|NCT01339403|5888110|P1|NOT COMPLETED|Overall Study||0
2400267|NCT01339403|5888109|P2|COMPLETED|Overall Study||257600
2400268|NCT01339403|5888110|P1|COMPLETED|Overall Study||24768
2400269|NCT01339403|5888109|P2|STARTED|Overall Study||257600
2400270|NCT01339403|5888110|P1|STARTED|Overall Study||24768
2400271|NCT01339390|5888132|P2|NOT COMPLETED|Overall Study||156
2400272|NCT01339390|5888133|P1|NOT COMPLETED|Overall Study||157
2400273|NCT01339390|5888132|P2|COMPLETED|Overall Study||1442
2400274|NCT01339390|5888133|P1|COMPLETED|Overall Study||1414
2400275|NCT01339390|5888132|P2|STARTED|Overall Study||1598
2400276|NCT01339390|5888133|P1|STARTED|Overall Study||1571
2400277|NCT01339299|5888141|P2|NOT COMPLETED|Overall Study||0
2400278|NCT01339299|5888142|P1|NOT COMPLETED|Overall Study||0
2400279|NCT01339299|5888141|P2|COMPLETED|Overall Study||50
2400280|NCT01339299|5888142|P1|COMPLETED|Overall Study||50
2400281|NCT01339299|5888141|P2|STARTED|Overall Study||50
2400282|NCT01339299|5888142|P1|STARTED|Overall Study||50
2400283|NCT01339273|5888150|P2|NOT COMPLETED|Overall Study||8
2400284|NCT01339273|5888151|P1|NOT COMPLETED|Overall Study||8
2400285|NCT01339273|5888150|P2|COMPLETED|Overall Study||28
2400286|NCT01339273|5888151|P1|COMPLETED|Overall Study||28
2400287|NCT01339273|5888150|P2|STARTED|Overall Study||36
2400288|NCT01339273|5888151|P1|STARTED|Overall Study||36
2400289|NCT01339260|5888185|P2|NOT COMPLETED|Multi-cycle Extension||193
2400290|NCT01339260|5888186|P1|NOT COMPLETED|Multi-cycle Extension||186
2400291|NCT01339260|5888185|P2|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|458
2400292|NCT01339260|5888186|P1|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|449
2400293|NCT01339260|5888185|P2|Safety Population|Multi-cycle Extension|Patients receiving palonosetron|651
2400294|NCT01339260|5888186|P1|Safety Population|Multi-cycle Extension|Patients receiving netupitant/palonosetron combination|635
2400295|NCT01339260|5888185|P2|STARTED|Multi-cycle Extension|Patients scheduled to palonosetron|651
2400296|NCT01339260|5888186|P1|STARTED|Multi-cycle Extension|Patients scheduled to netupitant/palonosetron combination|635
2400297|NCT01339260|5888185|P2|NOT COMPLETED|Cycle 1||10
2400298|NCT01339260|5888186|P1|NOT COMPLETED|Cycle 1||7
2400299|NCT01339260|5888185|P2|COMPLETED|Cycle 1||719
2400300|NCT01339260|5888186|P1|COMPLETED|Cycle 1||719
2400301|NCT01339260|5888185|P2|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to palonosetron|725
2400302|NCT01339260|5888186|P1|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to netupitant/palonosetron combination|724
2400303|NCT01339260|5888185|P2|Safety Population|Cycle 1|Patients receiving palonosetron|725
2400304|NCT01339260|5888186|P1|Safety Population|Cycle 1|Patients receiving netupitant/palonosetron combination|725
2400305|NCT01339260|5888185|P2|STARTED|Cycle 1|Intent-To-Treat: randomized patients|729
2400306|NCT01339260|5888186|P1|STARTED|Cycle 1|Intent-To-Treat: randomized patients|726
2400307|NCT01339247|5888198|P2|NOT COMPLETED|Period 2||0
2400308|NCT01339247|5888199|P1|NOT COMPLETED|Period 2||0
2400309|NCT01339247|5888198|P2|COMPLETED|Period 2||30
2400310|NCT01339247|5888199|P1|COMPLETED|Period 2||30
2400311|NCT01339247|5888198|P2|STARTED|Period 2||30
2400312|NCT01339247|5888199|P1|STARTED|Period 2||30
2400313|NCT01339247|5888198|P2|NOT COMPLETED|Period 1||0
2400314|NCT01339247|5888199|P1|NOT COMPLETED|Period 1||0
2400315|NCT01339247|5888198|P2|COMPLETED|Period 1||30
2400316|NCT01339247|5888199|P1|COMPLETED|Period 1||30
2400317|NCT01339247|5888198|P2|STARTED|Period 1||30
2400318|NCT01339247|5888199|P1|STARTED|Period 1||30
2400319|NCT01339091|5888211|P2|NOT COMPLETED|Overall Study||28
2400320|NCT01339091|5888212|P1|NOT COMPLETED|Overall Study||27
2400321|NCT01339091|5888211|P2|COMPLETED|Overall Study||257
2400322|NCT01339091|5888212|P1|COMPLETED|Overall Study||261
2400323|NCT01339091|5888211|P2|Safety Population|Overall Study||284
2400324|NCT01339091|5888212|P1|Safety Population|Overall Study||284
2400325|NCT01339091|5888211|P2|STARTED|Overall Study||285
2400326|NCT01339091|5888212|P1|STARTED|Overall Study||288
2400327|NCT01339052|5888226|P2|NOT COMPLETED|Overall Study||50
2400328|NCT01339052|5888227|P1|NOT COMPLETED|Overall Study||15
2400329|NCT01339052|5888226|P2|COMPLETED|Overall Study||0
2400330|NCT01339052|5888227|P1|COMPLETED|Overall Study||0
2400331|NCT01339052|5888226|P2|Evaluable Plasma Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
2400332|NCT01339052|5888227|P1|Evaluable Plasma Sample at Surgery|Overall Study||13
2400333|NCT01339052|5888226|P2|Evaluable Tumor Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
2400334|NCT01339052|5888227|P1|Evaluable Tumor Sample at Surgery|Overall Study||14
2400335|NCT01339052|5888226|P2|Measurable Disease|Overall Study|Radiographic response evaluated on participants with measurable disease only.|40
2400336|NCT01339052|5888227|P1|Measurable Disease|Overall Study||11
2400337|NCT01339052|5888226|P2|STARTED|Overall Study||50
2400338|NCT01339052|5888227|P1|STARTED|Overall Study||15
2400339|NCT01339013|5888247|P1|NOT COMPLETED|Overall Study||0
2400340|NCT01339013|5888247|P1|COMPLETED|Overall Study||6
2400341|NCT01339013|5888247|P1|STARTED|Overall Study||6
2400342|NCT01339000|5888253|P2|NOT COMPLETED|Overall Study||0
2400343|NCT01339000|5888254|P1|NOT COMPLETED|Overall Study||1
2400344|NCT01339000|5888253|P2|COMPLETED|Overall Study||0
2400345|NCT01339000|5888254|P1|COMPLETED|Overall Study||0
2400346|NCT01339000|5888253|P2|STARTED|Overall Study||0
2400347|NCT01339000|5888254|P1|STARTED|Overall Study|The patient received day 1, 29, 36, 43, 50, and 57 vaccines but did not receive interleukin-7 (IL-7)|1
2400348|NCT01338987|5888273|P5|NOT COMPLETED|Overall Study||0
2400349|NCT01338987|5888274|P4|NOT COMPLETED|Overall Study||0
2400350|NCT01338987|5888275|P3|NOT COMPLETED|Overall Study||2
2400351|NCT01338987|5888276|P2|NOT COMPLETED|Overall Study||1
2400352|NCT01338987|5888277|P1|NOT COMPLETED|Overall Study||2
2400353|NCT01338987|5888273|P5|COMPLETED|Overall Study||2
2400354|NCT01338987|5888274|P4|COMPLETED|Overall Study||31
2400355|NCT01338987|5888275|P3|COMPLETED|Overall Study||20
2400356|NCT01338987|5888276|P2|COMPLETED|Overall Study||8
2400357|NCT01338987|5888277|P1|COMPLETED|Overall Study||10
2400358|NCT01338987|5888273|P5|STARTED|Overall Study||2
2400359|NCT01338987|5888274|P4|STARTED|Overall Study||31
2400360|NCT01338987|5888275|P3|STARTED|Overall Study||22
2400361|NCT01338987|5888276|P2|STARTED|Overall Study||9
2400362|NCT01338987|5888277|P1|STARTED|Overall Study||12
2400363|NCT01338870|5888298|P6|NOT COMPLETED|Overall Study||6
2400364|NCT01338870|5888299|P5|NOT COMPLETED|Overall Study||6
2400365|NCT01338870|5888300|P4|NOT COMPLETED|Overall Study||9
2400366|NCT01338870|5888301|P3|NOT COMPLETED|Overall Study||11
2400367|NCT01338870|5888302|P2|NOT COMPLETED|Overall Study||12
2400368|NCT01338870|5888303|P1|NOT COMPLETED|Overall Study||9
2400369|NCT01338870|5888298|P6|COMPLETED|Overall Study||44
2400370|NCT01338870|5888299|P5|COMPLETED|Overall Study||46
2400371|NCT01338870|5888300|P4|COMPLETED|Overall Study||41
2400372|NCT01338870|5888301|P3|COMPLETED|Overall Study||39
2400373|NCT01338870|5888302|P2|COMPLETED|Overall Study||37
2400374|NCT01338870|5888303|P1|COMPLETED|Overall Study||41
2400375|NCT01338870|5888298|P6|STARTED|Overall Study||50
2400376|NCT01338870|5888299|P5|STARTED|Overall Study||52
2400377|NCT01338870|5888300|P4|STARTED|Overall Study||50
2400378|NCT01338870|5888301|P3|STARTED|Overall Study||50
2400379|NCT01338870|5888302|P2|STARTED|Overall Study||49
2400380|NCT01338870|5888303|P1|STARTED|Overall Study||50
2400381|NCT01338857|5888353|P1|NOT COMPLETED|Overall Study||11
2400382|NCT01338857|5888353|P1|COMPLETED|Overall Study||1
2400383|NCT01338857|5888353|P1|STARTED|Overall Study||12
2400384|NCT01338818|5888358|P1|NOT COMPLETED|Overall Study||36
2400385|NCT01338818|5888358|P1|COMPLETED|Overall Study||262
2400386|NCT01338818|5888358|P1|STARTED|Overall Study||298
2400387|NCT01338792|5888364|P1|NOT COMPLETED|Overall Study||4
2400388|NCT01338792|5888364|P1|COMPLETED|Overall Study||43
2400389|NCT01338792|5888364|P1|STARTED|Overall Study||47
2400390|NCT01338649|5888372|P2|NOT COMPLETED|Overall Study||0
2400391|NCT01338649|5888373|P1|NOT COMPLETED|Overall Study||0
2400392|NCT01338649|5888372|P2|COMPLETED|Overall Study||14
2400393|NCT01338649|5888373|P1|COMPLETED|Overall Study||13
2400394|NCT01338649|5888372|P2|STARTED|Overall Study||14
2400395|NCT01338649|5888373|P1|STARTED|Overall Study||13
2400396|NCT01338636|5888379|P1|NOT COMPLETED|Overall Study||8
2400397|NCT01338636|5888379|P1|COMPLETED|Overall Study||22
2400398|NCT01338636|5888379|P1|STARTED|Overall Study||30
2400399|NCT01338610|5888393|P3|NOT COMPLETED|Overall Study||1
2400400|NCT01338610|5888394|P2|NOT COMPLETED|Overall Study||1
2400401|NCT01338610|5888395|P1|NOT COMPLETED|Overall Study||5
2400402|NCT01338610|5888393|P3|COMPLETED|Overall Study||28
2400403|NCT01338610|5888394|P2|COMPLETED|Overall Study||55
2400404|NCT01338610|5888395|P1|COMPLETED|Overall Study||34
2400405|NCT01338610|5888393|P3|STARTED|Overall Study||29
2400406|NCT01338610|5888394|P2|STARTED|Overall Study||56
2400407|NCT01338610|5888395|P1|STARTED|Overall Study||39
2400408|NCT01338506|5888404|P2|NOT COMPLETED|Overall Study||14
2400409|NCT01338506|5888405|P1|NOT COMPLETED|Overall Study||25
2400410|NCT01338506|5888404|P2|COMPLETED|Overall Study||13
2400411|NCT01338506|5888405|P1|COMPLETED|Overall Study||29
2400412|NCT01338506|5888404|P2|STARTED|Overall Study||27
2400413|NCT01338506|5888405|P1|STARTED|Overall Study||54
2400414|NCT01338493|5888421|P1|NOT COMPLETED|24 Months Follow up||0
2400415|NCT01338493|5888421|P1|COMPLETED|24 Months Follow up||104
2400416|NCT01338493|5888421|P1|STARTED|24 Months Follow up||104
2400417|NCT01338493|5888421|P1|NOT COMPLETED|12 Months Follow up||9
2400418|NCT01338493|5888421|P1|COMPLETED|12 Months Follow up||104
2400419|NCT01338493|5888421|P1|STARTED|12 Months Follow up||113
2400420|NCT01338493|5888421|P1|NOT COMPLETED|6 Months Follow up||19
2400421|NCT01338493|5888421|P1|COMPLETED|6 Months Follow up||113
2400422|NCT01338493|5888421|P1|STARTED|6 Months Follow up||132
2400423|NCT01338493|5888421|P1|NOT COMPLETED|Discharge||2
2400424|NCT01338493|5888421|P1|COMPLETED|Discharge||132
2400425|NCT01338493|5888421|P1|STARTED|Discharge||134
2400426|NCT01338493|5888421|P1|NOT COMPLETED|Implant||0
2400427|NCT01338493|5888421|P1|COMPLETED|Implant||134
2400428|NCT01338493|5888421|P1|STARTED|Implant||134
2400429|NCT01338493|5888421|P1|NOT COMPLETED|Enrolled||5
2400430|NCT01338493|5888421|P1|COMPLETED|Enrolled||134
2400431|NCT01338493|5888421|P1|STARTED|Enrolled||139
2400440|NCT01338298|5888451|P2|NOT COMPLETED|Overall Study||3
2400441|NCT01338298|5888452|P1|NOT COMPLETED|Overall Study||4
2400442|NCT01338298|5888451|P2|COMPLETED|Overall Study||15
2400443|NCT01338298|5888452|P1|COMPLETED|Overall Study||20
2400444|NCT01338298|5888451|P2|STARTED|Overall Study||18
2400445|NCT01338298|5888452|P1|STARTED|Overall Study||24
2400446|NCT01338025|5888462|P2|NOT COMPLETED|Overall Study||11
2400447|NCT01338025|5888463|P1|NOT COMPLETED|Overall Study||11
2400448|NCT01338025|5888462|P2|COMPLETED|Overall Study||6
2400449|NCT01338025|5888463|P1|COMPLETED|Overall Study||5
2400450|NCT01338025|5888462|P2|STARTED|Overall Study||17
2400451|NCT01338025|5888463|P1|STARTED|Overall Study||16
2400452|NCT01338012|5888475|P1|NOT COMPLETED|Overall Study||8
2400453|NCT01338012|5888475|P1|COMPLETED|Overall Study||0
2400454|NCT01338012|5888475|P1|STARTED|Overall Study||8
2400455|NCT01337986|5888481|P2|NOT COMPLETED|Overall Study||5
2400456|NCT01337986|5888482|P1|NOT COMPLETED|Overall Study||3
2400457|NCT01337986|5888481|P2|COMPLETED|Overall Study||18
2400458|NCT01337986|5888482|P1|COMPLETED|Overall Study||20
2400459|NCT01337986|5888481|P2|STARTED|Overall Study||23
2400460|NCT01337986|5888482|P1|STARTED|Overall Study||23
2400461|NCT01337973|5888519|P3|NOT COMPLETED|Overall Study||11
2400462|NCT01337973|5888520|P2|NOT COMPLETED|Overall Study||15
2400463|NCT01337973|5888521|P1|NOT COMPLETED|Overall Study||16
2400464|NCT01337973|5888519|P3|COMPLETED|Overall Study||49
2400465|NCT01337973|5888520|P2|COMPLETED|Overall Study||45
2400466|NCT01337973|5888521|P1|COMPLETED|Overall Study||44
2400467|NCT01337973|5888519|P3|STARTED|Overall Study||60
2400468|NCT01337973|5888520|P2|STARTED|Overall Study||60
2400469|NCT01337973|5888521|P1|STARTED|Overall Study||60
2400470|NCT01337960|5888535|P3|NOT COMPLETED|Overall Study||0
2400471|NCT01337960|5888536|P2|NOT COMPLETED|Overall Study||0
2400472|NCT01337960|5888537|P1|NOT COMPLETED|Overall Study||2
2400473|NCT01337960|5888535|P3|COMPLETED|Overall Study||6
2400474|NCT01337960|5888536|P2|COMPLETED|Overall Study||14
2400475|NCT01337960|5888537|P1|COMPLETED|Overall Study||12
2400476|NCT01337960|5888535|P3|STARTED|Overall Study||6
2400477|NCT01337960|5888536|P2|STARTED|Overall Study||14
2400478|NCT01337960|5888537|P1|STARTED|Overall Study||14
2400479|NCT01337739|5888559|P2|NOT COMPLETED|Overall Study||0
2400480|NCT01337739|5888560|P1|NOT COMPLETED|Overall Study||0
2400481|NCT01337739|5888559|P2|COMPLETED|Overall Study||4
2400482|NCT01337739|5888560|P1|COMPLETED|Overall Study||6
2400483|NCT01337739|5888559|P2|STARTED|Overall Study||4
2400484|NCT01337739|5888560|P1|STARTED|Overall Study||6
2400485|NCT01337674|5888570|P4|NOT COMPLETED|Treatment Period 2||0
2400486|NCT01337674|5888571|P3|NOT COMPLETED|Treatment Period 2||1
2400487|NCT01337674|5888572|P2|NOT COMPLETED|Treatment Period 2||0
2400488|NCT01337674|5888573|P1|NOT COMPLETED|Treatment Period 2||0
2400489|NCT01337674|5888570|P4|COMPLETED|Treatment Period 2||6
2400490|NCT01337674|5888571|P3|COMPLETED|Treatment Period 2||5
2400491|NCT01337674|5888572|P2|COMPLETED|Treatment Period 2||6
2400492|NCT01337674|5888573|P1|COMPLETED|Treatment Period 2||6
2400493|NCT01337674|5888570|P4|STARTED|Treatment Period 2||6
2400494|NCT01337674|5888571|P3|STARTED|Treatment Period 2||6
2400495|NCT01337674|5888572|P2|STARTED|Treatment Period 2||6
2400496|NCT01337674|5888573|P1|STARTED|Treatment Period 2||6
2400497|NCT01337674|5888570|P4|NOT COMPLETED|Two-week Washout Period||0
2400498|NCT01337674|5888571|P3|NOT COMPLETED|Two-week Washout Period||0
2400499|NCT01337674|5888572|P2|NOT COMPLETED|Two-week Washout Period||0
2400500|NCT01337674|5888573|P1|NOT COMPLETED|Two-week Washout Period||0
2400501|NCT01337674|5888570|P4|COMPLETED|Two-week Washout Period||6
2400502|NCT01337674|5888571|P3|COMPLETED|Two-week Washout Period||6
2400503|NCT01337674|5888572|P2|COMPLETED|Two-week Washout Period||6
2400504|NCT01337674|5888573|P1|COMPLETED|Two-week Washout Period||6
2400505|NCT01337674|5888570|P4|STARTED|Two-week Washout Period||6
2400506|NCT01337674|5888571|P3|STARTED|Two-week Washout Period||6
2400507|NCT01337674|5888572|P2|STARTED|Two-week Washout Period||6
2400508|NCT01337674|5888573|P1|STARTED|Two-week Washout Period||6
2400509|NCT01337674|5888570|P4|NOT COMPLETED|Treatment Period 1||1
2400510|NCT01337674|5888571|P3|NOT COMPLETED|Treatment Period 1||0
2400511|NCT01337674|5888572|P2|NOT COMPLETED|Treatment Period 1||1
2400512|NCT01337674|5888573|P1|NOT COMPLETED|Treatment Period 1||0
2400513|NCT01337674|5888570|P4|COMPLETED|Treatment Period 1||6
2400514|NCT01337674|5888571|P3|COMPLETED|Treatment Period 1||6
2400515|NCT01337674|5888572|P2|COMPLETED|Treatment Period 1||6
2400516|NCT01337674|5888573|P1|COMPLETED|Treatment Period 1||6
2400517|NCT01337674|5888570|P4|STARTED|Treatment Period 1|The discontinued participant was replaced|7
2400518|NCT01337674|5888571|P3|STARTED|Treatment Period 1||6
2400519|NCT01337674|5888572|P2|STARTED|Treatment Period 1|The discontinued participant was replaced|7
2400520|NCT01337674|5888573|P1|STARTED|Treatment Period 1||6
2400521|NCT01337635|5888591|P2|NOT COMPLETED|Overall Study||1
2400522|NCT01337635|5888592|P1|NOT COMPLETED|Overall Study||0
2400523|NCT01337635|5888591|P2|COMPLETED|Overall Study||3
2400524|NCT01337635|5888592|P1|COMPLETED|Overall Study||3
2400525|NCT01337635|5888591|P2|STARTED|Overall Study||4
2400526|NCT01337635|5888592|P1|STARTED|Overall Study||3
2400527|NCT01337609|5888603|P3|NOT COMPLETED|Overall Study||0
2400528|NCT01337609|5888604|P2|NOT COMPLETED|Overall Study||0
2400529|NCT01337609|5888605|P1|NOT COMPLETED|Overall Study||1
2400530|NCT01337609|5888603|P3|COMPLETED|Overall Study||2
2400531|NCT01337609|5888604|P2|COMPLETED|Overall Study||2
2400532|NCT01337609|5888605|P1|COMPLETED|Overall Study||0
2400533|NCT01337609|5888603|P3|STARTED|Overall Study||2
2400534|NCT01337609|5888604|P2|STARTED|Overall Study||2
2400535|NCT01337609|5888605|P1|STARTED|Overall Study||1
2400536|NCT01337596|5888634|P9|NOT COMPLETED|Overall Study||0
2400537|NCT01337596|5888635|P8|NOT COMPLETED|Overall Study||0
2400538|NCT01337596|5888636|P7|NOT COMPLETED|Overall Study||0
2400539|NCT01337596|5888637|P6|NOT COMPLETED|Overall Study||0
2400540|NCT01337596|5888638|P5|NOT COMPLETED|Overall Study||2
2400541|NCT01337596|5888639|P4|NOT COMPLETED|Overall Study||0
2400542|NCT01337596|5888640|P3|NOT COMPLETED|Overall Study||0
2400543|NCT01337596|5888641|P2|NOT COMPLETED|Overall Study||0
2400544|NCT01337596|5888642|P1|NOT COMPLETED|Overall Study||0
2400545|NCT01337596|5888634|P9|COMPLETED|Overall Study||7
2400546|NCT01337596|5888635|P8|COMPLETED|Overall Study||2
2400547|NCT01337596|5888636|P7|COMPLETED|Overall Study||12
2400548|NCT01337596|5888637|P6|COMPLETED|Overall Study||7
2400549|NCT01337596|5888638|P5|COMPLETED|Overall Study||5
2400550|NCT01337596|5888639|P4|COMPLETED|Overall Study||7
2400551|NCT01337596|5888640|P3|COMPLETED|Overall Study||7
2400552|NCT01337596|5888641|P2|COMPLETED|Overall Study||7
2400553|NCT01337596|5888642|P1|COMPLETED|Overall Study||7
2400554|NCT01337596|5888634|P9|Safety Population|Overall Study||7
2400555|NCT01337596|5888635|P8|Safety Population|Overall Study||2
2400556|NCT01337596|5888636|P7|Safety Population|Overall Study||12
2400557|NCT01337596|5888637|P6|Safety Population|Overall Study||7
2400558|NCT01337596|5888638|P5|Safety Population|Overall Study||7
2400559|NCT01337596|5888639|P4|Safety Population|Overall Study||7
2400560|NCT01337596|5888640|P3|Safety Population|Overall Study||7
2400561|NCT01337596|5888641|P2|Safety Population|Overall Study||7
2400562|NCT01337596|5888642|P1|Safety Population|Overall Study||7
2400563|NCT01337596|5888634|P9|STARTED|Overall Study||7
2400564|NCT01337596|5888635|P8|STARTED|Overall Study||2
2400565|NCT01337596|5888636|P7|STARTED|Overall Study||12
2400566|NCT01337596|5888637|P6|STARTED|Overall Study||7
2400567|NCT01337596|5888638|P5|STARTED|Overall Study||7
2400568|NCT01337596|5888639|P4|STARTED|Overall Study||7
2400569|NCT01337596|5888640|P3|STARTED|Overall Study||7
2400570|NCT01337596|5888641|P2|STARTED|Overall Study||7
2400571|NCT01337596|5888642|P1|STARTED|Overall Study||7
2400572|NCT01337336|5888678|P2|NOT COMPLETED|Overall Study||0
2400573|NCT01337336|5888679|P1|NOT COMPLETED|Overall Study||0
2400574|NCT01337336|5888678|P2|COMPLETED|Overall Study||2923
2400575|NCT01337336|5888679|P1|COMPLETED|Overall Study||1078
2400576|NCT01337336|5888678|P2|STARTED|Overall Study||2923
2400577|NCT01337336|5888679|P1|STARTED|Overall Study||1078
2400578|NCT01337297|5888693|P2|NOT COMPLETED|Overall Study||6
2400579|NCT01337297|5888694|P1|NOT COMPLETED|Overall Study||5
2400580|NCT01337297|5888693|P2|COMPLETED|Overall Study||3
2400581|NCT01337297|5888694|P1|COMPLETED|Overall Study||6
2400582|NCT01337297|5888693|P2|STARTED|Overall Study||9
2400583|NCT01337297|5888694|P1|STARTED|Overall Study||11
2400584|NCT01337167|5888702|P2|NOT COMPLETED|Toddler Vaccinations||13
2400585|NCT01337167|5888703|P1|NOT COMPLETED|Toddler Vaccinations||14
2400586|NCT01337167|5888702|P2|COMPLETED|Toddler Vaccinations||407
2400587|NCT01337167|5888703|P1|COMPLETED|Toddler Vaccinations||829
2400588|NCT01337167|5888702|P2|STARTED|Toddler Vaccinations||420
2400589|NCT01337167|5888703|P1|STARTED|Toddler Vaccinations||843
2400590|NCT01337167|5888702|P2|NOT COMPLETED|Interim Period||40
2400591|NCT01337167|5888703|P1|NOT COMPLETED|Interim Period||81
2400592|NCT01337167|5888702|P2|COMPLETED|Interim Period||420
2400593|NCT01337167|5888703|P1|COMPLETED|Interim Period||843
2400594|NCT01337167|5888702|P2|STARTED|Interim Period||460
2400595|NCT01337167|5888703|P1|STARTED|Interim Period||924
2400596|NCT01337167|5888702|P2|NOT COMPLETED|Infant Series||27
2400597|NCT01337167|5888703|P1|NOT COMPLETED|Infant Series||62
2400598|NCT01337167|5888702|P2|COMPLETED|Infant Series||460
2400599|NCT01337167|5888703|P1|COMPLETED|Infant Series||924
2400600|NCT01337167|5888702|P2|STARTED|Infant Series||487
2400601|NCT01337167|5888703|P1|STARTED|Infant Series||986
2400602|NCT01337115|5888771|P2|NOT COMPLETED|Overall Study||0
2400603|NCT01337115|5888772|P1|NOT COMPLETED|Overall Study||2
2400604|NCT01337115|5888771|P2|COMPLETED|Overall Study||25
2400605|NCT01337115|5888772|P1|COMPLETED|Overall Study|2 patients could not be assessed after 12h because of catheter dislocation|23
2400606|NCT01337115|5888771|P2|STARTED|Overall Study||25
2400607|NCT01337115|5888772|P1|STARTED|Overall Study||25
2400608|NCT01337089|5888784|P1|NOT COMPLETED|Overall Study||404
2400609|NCT01337089|5888784|P1|COMPLETED|Overall Study||256
2400610|NCT01337089|5888784|P1|Efficacy Dataset|Overall Study|One participant withdrew after administering nabiximols, but no efficacy data were collected.|659
2400611|NCT01337089|5888784|P1|Safety Population|Overall Study||660
2400612|NCT01337089|5888784|P1|Received at Least 1 Dose of Study Drug|Overall Study||660
2400613|NCT01337089|5888784|P1|STARTED|Overall Study||660
2400614|NCT01337076|5888792|P1|NOT COMPLETED|Overall Study||2
2400615|NCT01337076|5888792|P1|COMPLETED|Overall Study|subjects met the primary endpoint of 6 months postimplant activation|19
2400616|NCT01337076|5888792|P1|STARTED|Overall Study|subjects implanted|21
2400617|NCT01337050|5888799|P3|NOT COMPLETED|Overall Study||19
2400618|NCT01337050|5888800|P2|NOT COMPLETED|Overall Study||13
2400619|NCT01337050|5888801|P1|NOT COMPLETED|Overall Study||4
2400620|NCT01337050|5888799|P3|COMPLETED|Overall Study||0
2400621|NCT01337050|5888800|P2|COMPLETED|Overall Study||0
2400622|NCT01337050|5888801|P1|COMPLETED|Overall Study||0
2400623|NCT01337050|5888799|P3|STARTED|Overall Study||19
2400624|NCT01337050|5888800|P2|STARTED|Overall Study||13
2400625|NCT01337050|5888801|P1|STARTED|Overall Study||4
2400626|NCT01336972|5888862|P3|NOT COMPLETED|Overall Study||0
2400627|NCT01336972|5888863|P2|NOT COMPLETED|Overall Study||1
2400628|NCT01336972|5888864|P1|NOT COMPLETED|Overall Study||1
2400629|NCT01336972|5888862|P3|COMPLETED|Overall Study||9
2400630|NCT01336972|5888863|P2|COMPLETED|Overall Study||9
2400631|NCT01336972|5888864|P1|COMPLETED|Overall Study||9
2400632|NCT01336972|5888862|P3|STARTED|Overall Study||9
2400633|NCT01336972|5888863|P2|STARTED|Overall Study||10
2400634|NCT01336972|5888864|P1|STARTED|Overall Study||10
2400635|NCT01336959|5888902|P3|NOT COMPLETED|Overall Study||1
2400636|NCT01336959|5888903|P2|NOT COMPLETED|Overall Study||5
2400637|NCT01336959|5888904|P1|NOT COMPLETED|Overall Study||0
2400638|NCT01336959|5888902|P3|COMPLETED|Overall Study||40
2400639|NCT01336959|5888903|P2|COMPLETED|Overall Study||37
2400640|NCT01336959|5888904|P1|COMPLETED|Overall Study||8
2400641|NCT01336959|5888902|P3|STARTED|Overall Study||41
2400642|NCT01336959|5888903|P2|STARTED|Overall Study||42
2400643|NCT01336959|5888904|P1|STARTED|Overall Study||8
2400644|NCT01336933|5888915|P1|NOT COMPLETED|Overall Study||1
2400645|NCT01336933|5888915|P1|COMPLETED|Overall Study||33
2400646|NCT01336933|5888915|P1|STARTED|Overall Study||34
2400647|NCT01336894|5888926|P2|NOT COMPLETED|Follow-up||7
2400648|NCT01336894|5888927|P1|NOT COMPLETED|Follow-up||2
2400649|NCT01336894|5888926|P2|COMPLETED|Follow-up||0
2400650|NCT01336894|5888927|P1|COMPLETED|Follow-up||2
2400651|NCT01336894|5888926|P2|STARTED|Follow-up||7
2400652|NCT01336894|5888927|P1|STARTED|Follow-up||4
2400653|NCT01336894|5888926|P2|NOT COMPLETED|Protocol Interventions||0
2400654|NCT01336894|5888927|P1|NOT COMPLETED|Protocol Interventions||0
2400655|NCT01336894|5888926|P2|COMPLETED|Protocol Interventions||7
2400656|NCT01336894|5888927|P1|COMPLETED|Protocol Interventions||4
2400657|NCT01336894|5888926|P2|STARTED|Protocol Interventions||7
2400658|NCT01336894|5888927|P1|STARTED|Protocol Interventions||4
2400659|NCT01336803|5888945|P1|NOT COMPLETED|Overall Study||0
2400660|NCT01336803|5888945|P1|COMPLETED|Overall Study||21
2400661|NCT01336803|5888945|P1|Lymphoma|Overall Study||7
2400662|NCT01336803|5888945|P1|Osteomyelitis|Overall Study||4
2400663|NCT01336803|5888945|P1|Bone Sarcoma|Overall Study||10
2400664|NCT01336803|5888945|P1|STARTED|Overall Study||21
2400665|NCT01336764|5888959|P2|NOT COMPLETED|Overall Study||5
2400666|NCT01336764|5888960|P1|NOT COMPLETED|Overall Study||5
2400667|NCT01336764|5888959|P2|COMPLETED|Overall Study||5
2400668|NCT01336764|5888960|P1|COMPLETED|Overall Study||7
2400669|NCT01336764|5888959|P2|STARTED|Overall Study||10
2400670|NCT01336764|5888960|P1|STARTED|Overall Study||12
2400671|NCT01336738|5888971|P5|NOT COMPLETED|Overall Study||10
2400672|NCT01336738|5888972|P4|NOT COMPLETED|Overall Study||7
2400673|NCT01336738|5888973|P3|NOT COMPLETED|Overall Study||8
2400674|NCT01336738|5888974|P2|NOT COMPLETED|Overall Study||9
2400675|NCT01336738|5888975|P1|NOT COMPLETED|Overall Study||7
2400676|NCT01336738|5888971|P5|COMPLETED|Overall Study||43
2400677|NCT01336738|5888972|P4|COMPLETED|Overall Study||47
2400678|NCT01336738|5888973|P3|COMPLETED|Overall Study||45
2400679|NCT01336738|5888974|P2|COMPLETED|Overall Study||45
2400680|NCT01336738|5888975|P1|COMPLETED|Overall Study||45
2400681|NCT01336738|5888971|P5|STARTED|Overall Study||53
2400682|NCT01336738|5888972|P4|STARTED|Overall Study||54
2400683|NCT01336738|5888973|P3|STARTED|Overall Study||53
2400684|NCT01336738|5888974|P2|STARTED|Overall Study||54
2400685|NCT01336738|5888975|P1|STARTED|Overall Study||52
2400686|NCT01336712|5889017|P1|NOT COMPLETED|Overall Study||3
2400687|NCT01336712|5889017|P1|COMPLETED|Overall Study||27
2400688|NCT01336712|5889017|P1|STARTED|Overall Study||30
2400689|NCT01336647|5889030|P3|NOT COMPLETED|Overall Study||3
2400690|NCT01336647|5889031|P2|NOT COMPLETED|Overall Study||1
2400691|NCT01336647|5889032|P1|NOT COMPLETED|Overall Study||4
2400692|NCT01336647|5889030|P3|COMPLETED|Overall Study||44
2400693|NCT01336647|5889031|P2|COMPLETED|Overall Study||48
2400694|NCT01336647|5889032|P1|COMPLETED|Overall Study||42
2400695|NCT01336647|5889030|P3|STARTED|Overall Study||47
2400696|NCT01336647|5889031|P2|STARTED|Overall Study||49
2400697|NCT01336647|5889032|P1|STARTED|Overall Study||46
2400698|NCT01336634|5889046|P3|NOT COMPLETED|Overall Study||36
2400699|NCT01336634|5889047|P2|NOT COMPLETED|Overall Study||57
2400700|NCT01336634|5889048|P1|NOT COMPLETED|Overall Study||84
2400701|NCT01336634|5889046|P3|COMPLETED|Overall Study||0
2400702|NCT01336634|5889047|P2|COMPLETED|Overall Study||0
2400703|NCT01336634|5889048|P1|COMPLETED|Overall Study||0
2400704|NCT01336634|5889046|P3|STARTED|Overall Study||36
2400705|NCT01336634|5889047|P2|STARTED|Overall Study||57
2400706|NCT01336634|5889048|P1|STARTED|Overall Study||84
2400707|NCT01336621|5889089|P1|NOT COMPLETED|SFUCP (up to 2.6 Years)||9
2400708|NCT01336621|5889089|P1|COMPLETED|SFUCP (up to 2.6 Years)||0
2400709|NCT01336621|5889089|P1|STARTED|SFUCP (up to 2.6 Years)||9
2400710|NCT01336621|5889089|P1|NOT COMPLETED|Primary Reporting Phase (Upto 5.8 Years)||98
2400711|NCT01336621|5889089|P1|COMPLETED|Primary Reporting Phase (Upto 5.8 Years)||0
2400712|NCT01336621|5889089|P1|STARTED|Primary Reporting Phase (Upto 5.8 Years)||98
2400713|NCT01336608|5889139|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||24
2400714|NCT01336608|5889140|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||30
2400715|NCT01336608|5889141|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||44
2400716|NCT01336608|5889142|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
2400717|NCT01336608|5889139|P4|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|111
2400718|NCT01336608|5889140|P3|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|124
2400719|NCT01336608|5889141|P2|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|97
2400720|NCT01336608|5889142|P1|COMPLETED|24-week, Double-blind Treatment Period||0
2400721|NCT01336608|5889139|P4|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|110
2400722|NCT01336608|5889140|P3|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|124
2400723|NCT01336608|5889141|P2|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|96
2400724|NCT01336608|5889142|P1|Completed the Treatment Period|24-week, Double-blind Treatment Period||0
2400725|NCT01336608|5889139|P4|STARTED|24-week, Double-blind Treatment Period||135
2400726|NCT01336608|5889140|P3|STARTED|24-week, Double-blind Treatment Period||154
2400727|NCT01336608|5889141|P2|STARTED|24-week, Double-blind Treatment Period||141
2400728|NCT01336608|5889142|P1|STARTED|24-week, Double-blind Treatment Period||0
2400729|NCT01336608|5889139|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
2400730|NCT01336608|5889140|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
2400731|NCT01336608|5889141|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
2400732|NCT01336608|5889142|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||115
2400733|NCT01336608|5889139|P4|COMPLETED|2-week, Single-blind Run-In Period||0
2400734|NCT01336608|5889140|P3|COMPLETED|2-week, Single-blind Run-In Period||0
2400735|NCT01336608|5889141|P2|COMPLETED|2-week, Single-blind Run-In Period||0
2400736|NCT01336608|5889142|P1|COMPLETED|2-week, Single-blind Run-In Period||444
2400737|NCT01336608|5889139|P4|STARTED|2-week, Single-blind Run-In Period||0
2400738|NCT01336608|5889140|P3|STARTED|2-week, Single-blind Run-In Period||0
2400739|NCT01336608|5889141|P2|STARTED|2-week, Single-blind Run-In Period||0
2400740|NCT01336608|5889142|P1|STARTED|2-week, Single-blind Run-In Period||559
2400741|NCT01336569|5889156|P1|NOT COMPLETED|Overall Study||4
2400742|NCT01336569|5889156|P1|COMPLETED|Overall Study||45
2400743|NCT01336569|5889156|P1|STARTED|Overall Study||49
2400744|NCT01336413|5889162|P2|NOT COMPLETED|Overall Study||8
2400745|NCT01336413|5889163|P1|NOT COMPLETED|Overall Study||1
2400746|NCT01336413|5889162|P2|COMPLETED|Overall Study||18
2400747|NCT01336413|5889163|P1|COMPLETED|Overall Study||26
2400748|NCT01336413|5889162|P2|STARTED|Overall Study||26
2400749|NCT01336413|5889163|P1|STARTED|Overall Study||27
2400750|NCT01336296|5889187|P2|NOT COMPLETED|Overall Study||4
2400751|NCT01336296|5889188|P1|NOT COMPLETED|Overall Study||5
2400752|NCT01336296|5889187|P2|COMPLETED|Overall Study||17
2400753|NCT01336296|5889188|P1|COMPLETED|Overall Study||35
2400754|NCT01336296|5889187|P2|STARTED|Overall Study||21
2400755|NCT01336296|5889188|P1|STARTED|Overall Study||40
2400756|NCT01336205|5889204|P2|NOT COMPLETED|Overall Study||89
2400757|NCT01336205|5889205|P1|NOT COMPLETED|Overall Study||233
2400758|NCT01336205|5889204|P2|COMPLETED|Overall Study||192
2400759|NCT01336205|5889205|P1|COMPLETED|Overall Study||330
2400760|NCT01336205|5889204|P2|STARTED|Overall Study||281
2400761|NCT01336205|5889205|P1|STARTED|Overall Study||563
2400762|NCT01336140|5889217|P2|NOT COMPLETED|Overall Study||0
2400763|NCT01336140|5889218|P1|NOT COMPLETED|Overall Study||0
2400764|NCT01336140|5889217|P2|COMPLETED|Overall Study||150
2400765|NCT01336140|5889218|P1|COMPLETED|Overall Study||150
2400766|NCT01336140|5889217|P2|STARTED|Overall Study||150
2400767|NCT01336140|5889218|P1|STARTED|Overall Study||150
2400768|NCT01336023|5889233|P3|NOT COMPLETED|Week 27 to 52||28
2400769|NCT01336023|5889234|P2|NOT COMPLETED|Week 27 to 52||44
2400770|NCT01336023|5889235|P1|NOT COMPLETED|Week 27 to 52||28
2400771|NCT01336023|5889233|P3|COMPLETED|Week 27 to 52||285
2400772|NCT01336023|5889234|P2|COMPLETED|Week 27 to 52||621
2400773|NCT01336023|5889235|P1|COMPLETED|Week 27 to 52||305
2400774|NCT01336023|5889233|P3|STARTED|Week 27 to 52|From the main trial, 29 subjects were not enrolled in the extension (week 27-52).|313
2400775|NCT01336023|5889234|P2|STARTED|Week 27 to 52|From the main trial, 71 subjects were not enrolled in the extension (week 27-52).|665
2400776|NCT01336023|5889235|P1|STARTED|Week 27 to 52|From the main trial, 33 subjects were not enrolled in the extension (week 27-52).|333
2400777|NCT01336023|5889233|P3|NOT COMPLETED|Week 0 to Week 26||73
2400778|NCT01336023|5889234|P2|NOT COMPLETED|Week 0 to Week 26||98
2400779|NCT01336023|5889235|P1|NOT COMPLETED|Week 0 to Week 26||48
2400780|NCT01336023|5889233|P3|COMPLETED|Week 0 to Week 26||342
2400781|NCT01336023|5889234|P2|COMPLETED|Week 0 to Week 26||736
2400782|NCT01336023|5889235|P1|COMPLETED|Week 0 to Week 26||366
2400783|NCT01336023|5889233|P3|Exposed|Week 0 to Week 26|2 subjects withdrew before exposure to trial drug and were not included in the analysis|413
2400784|NCT01336023|5889234|P2|Exposed|Week 0 to Week 26|8 subjects withdrew before exposure to trial drug and were not included in the analysis|826
2400785|NCT01336023|5889235|P1|Exposed|Week 0 to Week 26|1 subject withdrew before exposure to trial drug and was not included in the analysis|413
2400786|NCT01336023|5889233|P3|STARTED|Week 0 to Week 26||415
2400787|NCT01336023|5889234|P2|STARTED|Week 0 to Week 26||834
2400788|NCT01336023|5889235|P1|STARTED|Week 0 to Week 26||414
2400789|NCT01335997|5889256|P2|NOT COMPLETED|Period III||79
2400790|NCT01335997|5889257|P1|NOT COMPLETED|Period III||78
2400791|NCT01335997|5889256|P2|COMPLETED|Period III||4
2400792|NCT01335997|5889257|P1|COMPLETED|Period III||6
2400793|NCT01335997|5889256|P2|STARTED|Period III||83
2400794|NCT01335997|5889257|P1|STARTED|Period III||84
2400795|NCT01335997|5889256|P2|NOT COMPLETED|Period I and II||479
2400796|NCT01335997|5889257|P1|NOT COMPLETED|Period I and II||493
2400797|NCT01335997|5889256|P2|COMPLETED|Period I and II||83
2400798|NCT01335997|5889257|P1|COMPLETED|Period I and II||84
2400799|NCT01335997|5889256|P2|STARTED|Period I and II||562
2400800|NCT01335997|5889257|P1|STARTED|Period I and II||577
2400801|NCT01335971|5889270|P3|NOT COMPLETED|Overall Study||1
2400802|NCT01335971|5889271|P2|NOT COMPLETED|Overall Study||1
2400803|NCT01335971|5889272|P1|NOT COMPLETED|Overall Study||2
2400804|NCT01335971|5889270|P3|COMPLETED|Overall Study||28
2400805|NCT01335971|5889271|P2|COMPLETED|Overall Study||28
2400806|NCT01335971|5889272|P1|COMPLETED|Overall Study||29
2400807|NCT01335971|5889270|P3|STARTED|Overall Study||29
2400808|NCT01335971|5889271|P2|STARTED|Overall Study||29
2400809|NCT01335971|5889272|P1|STARTED|Overall Study||31
2400810|NCT01335932|5889309|P2|NOT COMPLETED|Overall Study||4
2400811|NCT01335932|5889310|P1|NOT COMPLETED|Overall Study||0
2400812|NCT01335932|5889309|P2|COMPLETED|Overall Study||72
2400813|NCT01335932|5889310|P1|COMPLETED|Overall Study||84
2400814|NCT01335932|5889309|P2|STARTED|Overall Study||76
2400815|NCT01335932|5889310|P1|STARTED|Overall Study||84
2400816|NCT01335867|5889450|P2|NOT COMPLETED|Overall Study||4
2400817|NCT01335867|5889451|P1|NOT COMPLETED|Overall Study||7
2400818|NCT01335867|5889450|P2|COMPLETED|Overall Study||12
2400819|NCT01335867|5889451|P1|COMPLETED|Overall Study||9
2400820|NCT01335867|5889450|P2|STARTED|Overall Study||16
2400821|NCT01335867|5889451|P1|STARTED|Overall Study||16
2400822|NCT01335789|5889467|P2|NOT COMPLETED|Overall Study||0
2400823|NCT01335789|5889468|P1|NOT COMPLETED|Overall Study||0
2400824|NCT01335789|5889467|P2|COMPLETED|Overall Study||8
2400825|NCT01335789|5889468|P1|COMPLETED|Overall Study||8
2400826|NCT01335789|5889467|P2|STARTED|Overall Study||8
2400827|NCT01335789|5889468|P1|STARTED|Overall Study||8
2400828|NCT01335750|5889478|P1|NOT COMPLETED|Overall Study||0
2400829|NCT01335750|5889478|P1|COMPLETED|Overall Study||32
2400830|NCT01335750|5889478|P1|STARTED|Overall Study||32
2400831|NCT01335724|5889499|P2|NOT COMPLETED|Overall Study||0
2400832|NCT01335724|5889500|P1|NOT COMPLETED|Overall Study||0
2400833|NCT01335724|5889499|P2|COMPLETED|Overall Study||36
2400834|NCT01335724|5889500|P1|COMPLETED|Overall Study||36
2400835|NCT01335724|5889499|P2|STARTED|Overall Study||36
2400836|NCT01335724|5889500|P1|STARTED|Overall Study||36
2400837|NCT01335698|5889515|P5|NOT COMPLETED|Treatment Stage 2||1
2400838|NCT01335698|5889516|P4|NOT COMPLETED|Treatment Stage 2||8
2400839|NCT01335698|5889517|P3|NOT COMPLETED|Treatment Stage 2||5
2400840|NCT01335698|5889518|P2|NOT COMPLETED|Treatment Stage 2||3
2400841|NCT01335698|5889519|P1|NOT COMPLETED|Treatment Stage 2||11
2400842|NCT01335698|5889515|P5|COMPLETED|Treatment Stage 2||5
2400843|NCT01335698|5889516|P4|COMPLETED|Treatment Stage 2||18
2400844|NCT01335698|5889517|P3|COMPLETED|Treatment Stage 2||11
2400845|NCT01335698|5889518|P2|COMPLETED|Treatment Stage 2||1
2400846|NCT01335698|5889519|P1|COMPLETED|Treatment Stage 2||4
2400847|NCT01335698|5889515|P5|STARTED|Treatment Stage 2||6
2400848|NCT01335698|5889516|P4|STARTED|Treatment Stage 2||26
2400849|NCT01335698|5889517|P3|STARTED|Treatment Stage 2||16
2400850|NCT01335698|5889518|P2|STARTED|Treatment Stage 2||4
2400851|NCT01335698|5889519|P1|STARTED|Treatment Stage 2||15
2400852|NCT01335698|5889515|P5|NOT COMPLETED|Treatment Stage 1||2
2400853|NCT01335698|5889516|P4|NOT COMPLETED|Treatment Stage 1||9
2400854|NCT01335698|5889517|P3|NOT COMPLETED|Treatment Stage 1||5
2400855|NCT01335698|5889518|P2|NOT COMPLETED|Treatment Stage 1||8
2400856|NCT01335698|5889519|P1|NOT COMPLETED|Treatment Stage 1||8
2400857|NCT01335698|5889515|P5|COMPLETED|Treatment Stage 1||6
2400858|NCT01335698|5889516|P4|COMPLETED|Treatment Stage 1||26
2400859|NCT01335698|5889517|P3|COMPLETED|Treatment Stage 1||16
2400860|NCT01335698|5889518|P2|COMPLETED|Treatment Stage 1||4
2400861|NCT01335698|5889519|P1|COMPLETED|Treatment Stage 1||15
2400862|NCT01335698|5889515|P5|STARTED|Treatment Stage 1||8
2400863|NCT01335698|5889516|P4|STARTED|Treatment Stage 1||35
2400864|NCT01335698|5889517|P3|STARTED|Treatment Stage 1||21
2400865|NCT01335698|5889518|P2|STARTED|Treatment Stage 1||12
2400866|NCT01335698|5889519|P1|STARTED|Treatment Stage 1||23
2400867|NCT01335685|5889584|P8|NOT COMPLETED|Overall Study||3
2400868|NCT01335685|5889585|P7|NOT COMPLETED|Overall Study||2
2400869|NCT01335685|5889586|P6|NOT COMPLETED|Overall Study||5
2400870|NCT01335685|5889587|P5|NOT COMPLETED|Overall Study||0
2400871|NCT01335685|5889588|P4|NOT COMPLETED|Overall Study||11
2400872|NCT01335685|5889589|P3|NOT COMPLETED|Overall Study||2
2400873|NCT01335685|5889590|P2|NOT COMPLETED|Overall Study||1
2400874|NCT01335685|5889591|P1|NOT COMPLETED|Overall Study||3
2400875|NCT01335685|5889584|P8|COMPLETED|Overall Study||3
2400876|NCT01335685|5889585|P7|COMPLETED|Overall Study||2
2400877|NCT01335685|5889586|P6|COMPLETED|Overall Study||1
2400878|NCT01335685|5889587|P5|COMPLETED|Overall Study||5
2400879|NCT01335685|5889588|P4|COMPLETED|Overall Study||15
2400880|NCT01335685|5889589|P3|COMPLETED|Overall Study||1
2400881|NCT01335685|5889590|P2|COMPLETED|Overall Study||3
2400882|NCT01335685|5889591|P1|COMPLETED|Overall Study||4
2400883|NCT01335685|5889584|P8|STARTED|Overall Study||6
2400884|NCT01335685|5889585|P7|STARTED|Overall Study||4
2400885|NCT01335685|5889586|P6|STARTED|Overall Study||6
2400886|NCT01335685|5889587|P5|STARTED|Overall Study||5
2400887|NCT01335685|5889588|P4|STARTED|Overall Study||26
2400888|NCT01335685|5889589|P3|STARTED|Overall Study||3
2400889|NCT01335685|5889590|P2|STARTED|Overall Study||4
2400890|NCT01335685|5889591|P1|STARTED|Overall Study||7
2400891|NCT01335620|5889693|P1|NOT COMPLETED|Overall Study||0
2400892|NCT01335620|5889693|P1|COMPLETED|Overall Study||19
2400893|NCT01335620|5889693|P1|STARTED|Overall Study||19
2400894|NCT01335542|5889702|P2|NOT COMPLETED|Overall Study||0
2400895|NCT01335542|5889703|P1|NOT COMPLETED|Overall Study||0
2400896|NCT01335542|5889702|P2|COMPLETED|Overall Study||45
2400897|NCT01335542|5889703|P1|COMPLETED|Overall Study||45
2400898|NCT01335542|5889702|P2|STARTED|Overall Study||45
2400899|NCT01335542|5889703|P1|STARTED|Overall Study||45
2400900|NCT01335477|5889711|P2|NOT COMPLETED|Overall Study||59
2400901|NCT01335477|5889712|P1|NOT COMPLETED|Overall Study||41
2400902|NCT01335477|5889711|P2|COMPLETED|Overall Study||272
2400903|NCT01335477|5889712|P1|COMPLETED|Overall Study||179
2400904|NCT01335477|5889711|P2|STARTED|Overall Study||331
2400905|NCT01335477|5889712|P1|STARTED|Overall Study||220
2400906|NCT01335464|5889776|P2|NOT COMPLETED|Overall Study||49
2400907|NCT01335464|5889777|P1|NOT COMPLETED|Overall Study||32
2400908|NCT01335464|5889776|P2|COMPLETED|Overall Study||260
2400909|NCT01335464|5889777|P1|COMPLETED|Overall Study||174
2400910|NCT01335464|5889776|P2|STARTED|Overall Study||309
2400911|NCT01335464|5889777|P1|STARTED|Overall Study||206
2400912|NCT01335308|5889842|P3|NOT COMPLETED|Overall Study||81
2400913|NCT01335308|5889843|P2|NOT COMPLETED|Overall Study||67
2400914|NCT01335308|5889844|P1|NOT COMPLETED|Overall Study||40
2400915|NCT01335308|5889842|P3|COMPLETED|Overall Study||154
2400916|NCT01335308|5889843|P2|COMPLETED|Overall Study||145
2400917|NCT01335308|5889844|P1|COMPLETED|Overall Study||158
2400918|NCT01335308|5889842|P3|STARTED|Overall Study||235
2400919|NCT01335308|5889843|P2|STARTED|Overall Study||212
2400920|NCT01335308|5889844|P1|STARTED|Overall Study||198
2400921|NCT01335230|5889865|P4|NOT COMPLETED|Overall Study||0
2400922|NCT01335230|5889866|P3|NOT COMPLETED|Overall Study||0
2400923|NCT01335230|5889867|P2|NOT COMPLETED|Overall Study||0
2400924|NCT01335230|5889868|P1|NOT COMPLETED|Overall Study||0
2400925|NCT01335230|5889865|P4|COMPLETED|Overall Study|subjects|10
2400926|NCT01335230|5889866|P3|COMPLETED|Overall Study|subjects|10
2400927|NCT01335230|5889867|P2|COMPLETED|Overall Study|subjects|10
2400928|NCT01335230|5889868|P1|COMPLETED|Overall Study|subjects|10
2400929|NCT01335230|5889865|P4|STARTED|Overall Study|subjects|10
2400930|NCT01335230|5889866|P3|STARTED|Overall Study|subjects|10
2400931|NCT01335230|5889867|P2|STARTED|Overall Study|subjects|10
2400932|NCT01335230|5889868|P1|STARTED|Overall Study|subjects|10
2400933|NCT01335204|5889878|P1|NOT COMPLETED|Overall Study||0
2400934|NCT01335204|5889878|P1|COMPLETED|Overall Study||4
2400935|NCT01335204|5889878|P1|STARTED|Overall Study||4
2400936|NCT01335191|5889889|P2|NOT COMPLETED|Overall Study||0
2400937|NCT01335191|5889890|P1|NOT COMPLETED|Overall Study||0
2400938|NCT01335191|5889889|P2|COMPLETED|Overall Study||11
2400939|NCT01335191|5889890|P1|COMPLETED|Overall Study||16
2400940|NCT01335191|5889889|P2|STARTED|Overall Study||11
2400941|NCT01335191|5889890|P1|STARTED|Overall Study||16
2400942|NCT01335061|5889896|P1|NOT COMPLETED|Overall Study||0
2400943|NCT01335061|5889896|P1|COMPLETED|Overall Study||25
2400944|NCT01335061|5889896|P1|STARTED|Overall Study||25
2400945|NCT01334957|5889911|P1|NOT COMPLETED|Overall Study||0
2400946|NCT01334957|5889911|P1|COMPLETED|Overall Study||300
2400947|NCT01334957|5889911|P1|Received Multiple Doses|Overall Study||48
2400948|NCT01334957|5889911|P1|Received Single Dose|Overall Study||252
2400949|NCT01334957|5889911|P1|STARTED|Overall Study||300
2400950|NCT01334944|5889919|P2|NOT COMPLETED|Overall Study||0
2400951|NCT01334944|5889920|P1|NOT COMPLETED|Overall Study||0
2400952|NCT01334944|5889919|P2|COMPLETED|Overall Study||139
2400953|NCT01334944|5889920|P1|COMPLETED|Overall Study||11
2400954|NCT01334944|5889919|P2|Received Multiple Doses|Overall Study||43
2400955|NCT01334944|5889920|P1|Received Multiple Doses|Overall Study||10
2400956|NCT01334944|5889919|P2|Received Singel Dose|Overall Study||96
2400957|NCT01334944|5889920|P1|Received Singel Dose|Overall Study||1
2400958|NCT01334944|5889919|P2|STARTED|Overall Study||139
2400959|NCT01334944|5889920|P1|STARTED|Overall Study||11
2400960|NCT01334918|5889946|P2|NOT COMPLETED|Overall Study||1
2400961|NCT01334918|5889947|P1|NOT COMPLETED|Overall Study||8
2400962|NCT01334918|5889946|P2|COMPLETED|Overall Study||60
2400963|NCT01334918|5889947|P1|COMPLETED|Overall Study||55
2400964|NCT01334918|5889946|P2|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|61
2400965|NCT01334918|5889947|P1|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|57
2400966|NCT01334918|5889946|P2|STARTED|Overall Study||61
2400967|NCT01334918|5889947|P1|STARTED|Overall Study||63
2400968|NCT01334866|5889973|P1|NOT COMPLETED|Overall Study||19
2400969|NCT01334866|5889973|P1|COMPLETED|Overall Study||72
2400970|NCT01334866|5889973|P1|STARTED|Overall Study|91 subjects were enrolled in the study; with 89 subjects receiving the study treatment.|91
2400971|NCT01334723|5889983|P2|NOT COMPLETED|Overall Study||0
2400972|NCT01334723|5889984|P1|NOT COMPLETED|Overall Study||0
2400973|NCT01334723|5889983|P2|COMPLETED|Overall Study||17739
2400974|NCT01334723|5889984|P1|COMPLETED|Overall Study||17293
2400975|NCT01334723|5889983|P2|STARTED|Overall Study||17739
2400976|NCT01334723|5889984|P1|STARTED|Overall Study||17293
2400977|NCT01334710|5890010|P1|NOT COMPLETED|Overall Study||3
2400978|NCT01334710|5890010|P1|COMPLETED|Overall Study|Due to safety signals in a parallel trial ON OSI906 in hepatocellular cancer the trial was stopped.|0
2400979|NCT01334710|5890010|P1|STARTED|Overall Study||3
2400980|NCT01334606|5890015|P1|NOT COMPLETED|Overall Study||18
2400981|NCT01334606|5890015|P1|COMPLETED|Overall Study||3
2400982|NCT01334606|5890015|P1|STARTED|Overall Study||21
2400983|NCT01334554|5890023|P2|NOT COMPLETED|Overall Study||2
2400984|NCT01334554|5890024|P1|NOT COMPLETED|Overall Study||4
2400985|NCT01334554|5890023|P2|COMPLETED|Overall Study||21
2400986|NCT01334554|5890024|P1|COMPLETED|Overall Study||19
2400987|NCT01334554|5890023|P2|STARTED|Overall Study||23
2400988|NCT01334554|5890024|P1|STARTED|Overall Study||23
2400989|NCT01334515|5890034|P2|NOT COMPLETED|Overall Study||29
2400990|NCT01334515|5890035|P1|NOT COMPLETED|Overall Study||12
2400991|NCT01334515|5890034|P2|COMPLETED|Overall Study||7
2400992|NCT01334515|5890035|P1|COMPLETED|Overall Study||4
2400993|NCT01334515|5890034|P2|STARTED|Overall Study||36
2400994|NCT01334515|5890035|P1|STARTED|Overall Study||16
2400995|NCT01334229|5890045|P2|NOT COMPLETED|Overall Study||0
2400996|NCT01334229|5890046|P1|NOT COMPLETED|Overall Study||0
2400997|NCT01334229|5890045|P2|COMPLETED|Overall Study||11
2400998|NCT01334229|5890046|P1|COMPLETED|Overall Study||11
2400999|NCT01334229|5890045|P2|STARTED|Overall Study||11
2401000|NCT01334229|5890046|P1|STARTED|Overall Study||11
2401001|NCT01334216|5890064|P2|NOT COMPLETED|Overall Study||0
2401002|NCT01334216|5890065|P1|NOT COMPLETED|Overall Study||0
2401003|NCT01334216|5890064|P2|COMPLETED|Overall Study||194
2401004|NCT01334216|5890065|P1|COMPLETED|Overall Study||168
2401005|NCT01334216|5890064|P2|STARTED|Overall Study||194
2401006|NCT01334216|5890065|P1|STARTED|Overall Study||168
2401007|NCT01334125|5890073|P2|NOT COMPLETED|Overall Study||3
2401008|NCT01334125|5890074|P1|NOT COMPLETED|Overall Study||3
2401009|NCT01334125|5890073|P2|COMPLETED|Overall Study|3 subjects left for college and moved out of the area|10
2401010|NCT01334125|5890074|P1|COMPLETED|Overall Study|3 subjects move to another city|12
2401011|NCT01334125|5890073|P2|STARTED|Overall Study||13
2401012|NCT01334125|5890074|P1|STARTED|Overall Study||15
2401013|NCT01333956|5890090|P4|NOT COMPLETED|Overall Study||2
2401014|NCT01333956|5890091|P3|NOT COMPLETED|Overall Study||1
2401015|NCT01333956|5890092|P2|NOT COMPLETED|Overall Study||4
2401016|NCT01333956|5890093|P1|NOT COMPLETED|Overall Study||2
2401017|NCT01333956|5890090|P4|COMPLETED|Overall Study||28
2401018|NCT01333956|5890091|P3|COMPLETED|Overall Study||29
2401019|NCT01333956|5890092|P2|COMPLETED|Overall Study||26
2401020|NCT01333956|5890093|P1|COMPLETED|Overall Study||28
2401021|NCT01333956|5890090|P4|STARTED|Overall Study||30
2401022|NCT01333956|5890091|P3|STARTED|Overall Study||30
2401023|NCT01333956|5890092|P2|STARTED|Overall Study||30
2401024|NCT01333956|5890093|P1|STARTED|Overall Study||30
2401025|NCT01333943|5890129|P2|NOT COMPLETED|Overall Study||0
2401026|NCT01333943|5890130|P1|NOT COMPLETED|Overall Study||1
2401027|NCT01333943|5890129|P2|COMPLETED|Overall Study||47
2401028|NCT01333943|5890130|P1|COMPLETED|Overall Study||46
2401029|NCT01333943|5890129|P2|STARTED|Overall Study||47
2401030|NCT01333943|5890130|P1|STARTED|Overall Study||47
2401031|NCT01333865|5890146|P1|NOT COMPLETED|Overall Study||2
2401032|NCT01333865|5890146|P1|COMPLETED|Overall Study|2 participants were withdrawn. One was still analyzed, but one was withdrawn too early for analysis|17
2401033|NCT01333865|5890146|P1|STARTED|Overall Study|25 participants signed consent, but only 19 completed screening and were analyzed at baseline.|19
2401034|NCT01333813|5890151|P1|NOT COMPLETED|Overall Study||0
2401035|NCT01333813|5890151|P1|COMPLETED|Overall Study||297
2401036|NCT01333813|5890151|P1|STARTED|Overall Study||297
2401037|NCT01333722|5890166|P2|NOT COMPLETED|Overall Study||3
2401038|NCT01333722|5890167|P1|NOT COMPLETED|Overall Study||0
2401039|NCT01333722|5890166|P2|COMPLETED|Overall Study||46
2401040|NCT01333722|5890167|P1|COMPLETED|Overall Study||51
2401041|NCT01333722|5890166|P2|STARTED|Overall Study||49
2401042|NCT01333722|5890167|P1|STARTED|Overall Study||51
2401043|NCT01333592|5890181|P2|NOT COMPLETED|Overall Study||17
2401044|NCT01333592|5890182|P1|NOT COMPLETED|Overall Study||9
2401045|NCT01333592|5890181|P2|COMPLETED|Overall Study||52
2401046|NCT01333592|5890182|P1|COMPLETED|Overall Study||58
2401047|NCT01333592|5890181|P2|STARTED|Overall Study||69
2401048|NCT01333592|5890182|P1|STARTED|Overall Study||67
2401049|NCT01333501|5890192|P2|NOT COMPLETED|Overall Study||21
2401050|NCT01333501|5890193|P1|NOT COMPLETED|Overall Study||9
2401051|NCT01333501|5890192|P2|COMPLETED|Overall Study||30
2401052|NCT01333501|5890193|P1|COMPLETED|Overall Study||97
2401053|NCT01333501|5890192|P2|Safety Population|Overall Study||47
2401054|NCT01333501|5890193|P1|Safety Population|Overall Study||104
2401055|NCT01333501|5890192|P2|Full Analysis Set (FAS)|Overall Study||28
2401056|NCT01333501|5890193|P1|Full Analysis Set (FAS)|Overall Study||80
2401057|NCT01333501|5890192|P2|STARTED|Overall Study||51
2401058|NCT01333501|5890193|P1|STARTED|Overall Study||106
2401059|NCT01333488|5890242|P3|NOT COMPLETED|Overall Study||0
2401060|NCT01333488|5890243|P2|NOT COMPLETED|Overall Study||0
2401061|NCT01333488|5890244|P1|NOT COMPLETED|Overall Study||0
2401062|NCT01333488|5890242|P3|COMPLETED|Overall Study||3
2401063|NCT01333488|5890243|P2|COMPLETED|Overall Study||1
2401064|NCT01333488|5890244|P1|COMPLETED|Overall Study||2
2401065|NCT01333488|5890242|P3|STARTED|Overall Study||3
2401066|NCT01333488|5890243|P2|STARTED|Overall Study||1
2401067|NCT01333488|5890244|P1|STARTED|Overall Study||2
2401068|NCT01333475|5890260|P2|NOT COMPLETED|Overall Study||3
2401069|NCT01333475|5890261|P1|NOT COMPLETED|Overall Study||2
2401070|NCT01333475|5890260|P2|COMPLETED|Overall Study||6
2401071|NCT01333475|5890261|P1|COMPLETED|Overall Study||10
2401072|NCT01333475|5890260|P2|STARTED|Overall Study||9
2401073|NCT01333475|5890261|P1|STARTED|Overall Study||12
2401074|NCT01333436|5890271|P2|NOT COMPLETED|Overall Study||0
2401075|NCT01333436|5890272|P1|NOT COMPLETED|Overall Study||0
2401076|NCT01333436|5890271|P2|COMPLETED|Overall Study||50
2401077|NCT01333436|5890272|P1|COMPLETED|Overall Study||43
2401078|NCT01333436|5890271|P2|STARTED|Overall Study||50
2401079|NCT01333436|5890272|P1|STARTED|Overall Study||43
2401080|NCT01333397|5890287|P5|NOT COMPLETED|Overall Study||0
2401081|NCT01333397|5890288|P4|NOT COMPLETED|Overall Study||1
2401082|NCT01333397|5890289|P3|NOT COMPLETED|Overall Study||0
2401083|NCT01333397|5890290|P2|NOT COMPLETED|Overall Study||0
2401084|NCT01333397|5890291|P1|NOT COMPLETED|Overall Study||1
2401085|NCT01333397|5890287|P5|COMPLETED|Overall Study||35
2401086|NCT01333397|5890288|P4|COMPLETED|Overall Study||34
2401087|NCT01333397|5890289|P3|COMPLETED|Overall Study||35
2401088|NCT01333397|5890290|P2|COMPLETED|Overall Study||36
2401089|NCT01333397|5890291|P1|COMPLETED|Overall Study||34
2401090|NCT01333397|5890287|P5|STARTED|Overall Study||35
2401091|NCT01333397|5890288|P4|STARTED|Overall Study||35
2401092|NCT01333397|5890289|P3|STARTED|Overall Study||35
2401093|NCT01333397|5890290|P2|STARTED|Overall Study||36
2401094|NCT01333397|5890291|P1|STARTED|Overall Study||35
2401095|NCT01333189|5890365|P2|NOT COMPLETED|Overall Study||2
2401096|NCT01333189|5890366|P1|NOT COMPLETED|Overall Study||2
2401097|NCT01333189|5890365|P2|COMPLETED|Overall Study||11
2401098|NCT01333189|5890366|P1|COMPLETED|Overall Study||11
2401099|NCT01333189|5890365|P2|STARTED|Overall Study||13
2401100|NCT01333189|5890366|P1|STARTED|Overall Study||13
2401101|NCT01333111|5890397|P3|NOT COMPLETED|Overall Study||2
2401102|NCT01333111|5890398|P2|NOT COMPLETED|Overall Study||3
2401103|NCT01333111|5890399|P1|NOT COMPLETED|Overall Study||2
2401104|NCT01333111|5890397|P3|COMPLETED|Overall Study||13
2401105|NCT01333111|5890398|P2|COMPLETED|Overall Study||26
2401106|NCT01333111|5890399|P1|COMPLETED|Overall Study||28
2401107|NCT01333111|5890397|P3|STARTED|Overall Study||15
2401108|NCT01333111|5890398|P2|STARTED|Overall Study||29
2401109|NCT01333111|5890399|P1|STARTED|Overall Study||30
2401110|NCT01333098|5890423|P1|NOT COMPLETED|Overall Study||3
2401111|NCT01333098|5890423|P1|COMPLETED|Overall Study||12
2401112|NCT01333098|5890423|P1|STARTED|Overall Study||15
2401113|NCT01333072|5890434|P2|NOT COMPLETED|Overall Study||4
2401114|NCT01333072|5890435|P1|NOT COMPLETED|Overall Study||6
2401115|NCT01333072|5890434|P2|COMPLETED|Overall Study||27
2401116|NCT01333072|5890435|P1|COMPLETED|Overall Study||24
2401117|NCT01333072|5890434|P2|STARTED|Overall Study||31
2401118|NCT01333072|5890435|P1|STARTED|Overall Study||30
2401119|NCT01333059|5890443|P2|NOT COMPLETED|Overall Study||3
2401120|NCT01333059|5890444|P1|NOT COMPLETED|Overall Study||6
2401121|NCT01333059|5890443|P2|COMPLETED|Overall Study||8
2401122|NCT01333059|5890444|P1|COMPLETED|Overall Study||8
2401123|NCT01333059|5890443|P2|STARTED|Overall Study||11
2401124|NCT01333059|5890444|P1|STARTED|Overall Study||14
2401125|NCT01332994|5890454|P1|NOT COMPLETED|Overall Study||71
2401126|NCT01332994|5890454|P1|COMPLETED|Overall Study||448
2401127|NCT01332994|5890454|P1|Completed Week 66 (TCZ/RTX)|Overall Study||25
2401128|NCT01332994|5890454|P1|Completed Week 32 (TCZ/RTX)|Overall Study||26
2401129|NCT01332994|5890454|P1|Completed Week 32 (TCZ/TCZ)|Overall Study||200
2401130|NCT01332994|5890454|P1|Completed Week 16|Overall Study||463
2401131|NCT01332994|5890454|P1|STARTED|Overall Study||519
2401132|NCT01332981|5890510|P1|NOT COMPLETED|Overall Study||0
2401133|NCT01332981|5890510|P1|COMPLETED|Overall Study||220
2401134|NCT01332981|5890510|P1|STARTED|Overall Study||220
2401135|NCT01332968|5890523|P8|NOT COMPLETED|Follow-Up Period||531
2401136|NCT01332968|5890524|P7|NOT COMPLETED|Follow-Up Period||542
2401137|NCT01332968|5890525|P6|NOT COMPLETED|Follow-Up Period||0
2401138|NCT01332968|5890526|P5|NOT COMPLETED|Follow-Up Period||0
2401139|NCT01332968|5890527|P4|NOT COMPLETED|Follow-Up Period||0
2401140|NCT01332968|5890528|P3|NOT COMPLETED|Follow-Up Period||0
2401141|NCT01332968|5890529|P2|NOT COMPLETED|Follow-Up Period||0
2401142|NCT01332968|5890530|P1|NOT COMPLETED|Follow-Up Period||0
2401143|NCT01332968|5890523|P8|COMPLETED|Follow-Up Period||0
2401144|NCT01332968|5890524|P7|COMPLETED|Follow-Up Period||0
2401145|NCT01332968|5890525|P6|COMPLETED|Follow-Up Period||0
2401146|NCT01332968|5890526|P5|COMPLETED|Follow-Up Period||0
2401147|NCT01332968|5890527|P4|COMPLETED|Follow-Up Period||0
2401148|NCT01332968|5890528|P3|COMPLETED|Follow-Up Period||0
2401149|NCT01332968|5890529|P2|COMPLETED|Follow-Up Period||0
2401150|NCT01332968|5890530|P1|COMPLETED|Follow-Up Period||0
2401151|NCT01332968|5890523|P8|STARTED|Follow-Up Period||531
2401152|NCT01332968|5890524|P7|STARTED|Follow-Up Period||542
2401153|NCT01332968|5890525|P6|STARTED|Follow-Up Period||0
2401154|NCT01332968|5890526|P5|STARTED|Follow-Up Period||0
2401155|NCT01332968|5890527|P4|STARTED|Follow-Up Period||0
2401156|NCT01332968|5890528|P3|STARTED|Follow-Up Period||0
2401157|NCT01332968|5890529|P2|STARTED|Follow-Up Period||0
2401158|NCT01332968|5890530|P1|STARTED|Follow-Up Period||0
2401159|NCT01332968|5890523|P8|NOT COMPLETED|Maintenance/Observation Period||0
2401160|NCT01332968|5890524|P7|NOT COMPLETED|Maintenance/Observation Period||0
2401161|NCT01332968|5890525|P6|NOT COMPLETED|Maintenance/Observation Period||9
2401162|NCT01332968|5890526|P5|NOT COMPLETED|Maintenance/Observation Period||10
2401163|NCT01332968|5890527|P4|NOT COMPLETED|Maintenance/Observation Period||207
2401164|NCT01332968|5890528|P3|NOT COMPLETED|Maintenance/Observation Period||213
2401165|NCT01332968|5890529|P2|NOT COMPLETED|Maintenance/Observation Period||0
2401166|NCT01332968|5890530|P1|NOT COMPLETED|Maintenance/Observation Period||0
2401167|NCT01332968|5890523|P8|COMPLETED|Maintenance/Observation Period||0
2401168|NCT01332968|5890524|P7|COMPLETED|Maintenance/Observation Period||0
2401169|NCT01332968|5890525|P6|COMPLETED|Maintenance/Observation Period||2
2401170|NCT01332968|5890526|P5|COMPLETED|Maintenance/Observation Period||2
2401171|NCT01332968|5890527|P4|COMPLETED|Maintenance/Observation Period||417
2401172|NCT01332968|5890528|P3|COMPLETED|Maintenance/Observation Period||399
2401173|NCT01332968|5890529|P2|COMPLETED|Maintenance/Observation Period||0
2401174|NCT01332968|5890530|P1|COMPLETED|Maintenance/Observation Period||0
2401175|NCT01332968|5890523|P8|STARTED|Maintenance/Observation Period||0
2401176|NCT01332968|5890524|P7|STARTED|Maintenance/Observation Period||0
2401177|NCT01332968|5890525|P6|STARTED|Maintenance/Observation Period||11
2401178|NCT01332968|5890526|P5|STARTED|Maintenance/Observation Period||12
2401179|NCT01332968|5890527|P4|STARTED|Maintenance/Observation Period||624
2401180|NCT01332968|5890528|P3|STARTED|Maintenance/Observation Period||612
2401181|NCT01332968|5890529|P2|STARTED|Maintenance/Observation Period||0
2401182|NCT01332968|5890530|P1|STARTED|Maintenance/Observation Period||0
2401183|NCT01332968|5890523|P8|NOT COMPLETED|Induction Period||0
2401184|NCT01332968|5890524|P7|NOT COMPLETED|Induction Period||0
2401185|NCT01332968|5890525|P6|NOT COMPLETED|Induction Period||0
2401186|NCT01332968|5890526|P5|NOT COMPLETED|Induction Period||0
2401187|NCT01332968|5890527|P4|NOT COMPLETED|Induction Period||0
2401188|NCT01332968|5890528|P3|NOT COMPLETED|Induction Period||0
2401189|NCT01332968|5890529|P2|NOT COMPLETED|Induction Period||56
2401190|NCT01332968|5890530|P1|NOT COMPLETED|Induction Period||58
2401191|NCT01332968|5890523|P8|COMPLETED|Induction Period||0
2401192|NCT01332968|5890524|P7|COMPLETED|Induction Period||0
2401193|NCT01332968|5890525|P6|COMPLETED|Induction Period||0
2401194|NCT01332968|5890526|P5|COMPLETED|Induction Period||0
2401195|NCT01332968|5890527|P4|COMPLETED|Induction Period||0
2401196|NCT01332968|5890528|P3|COMPLETED|Induction Period||0
2401197|NCT01332968|5890529|P2|COMPLETED|Induction Period||646
2401198|NCT01332968|5890530|P1|COMPLETED|Induction Period||641
2401199|NCT01332968|5890523|P8|STARTED|Induction Period||0
2401200|NCT01332968|5890524|P7|STARTED|Induction Period||0
2401201|NCT01332968|5890525|P6|STARTED|Induction Period||0
2401202|NCT01332968|5890526|P5|STARTED|Induction Period||0
2401203|NCT01332968|5890527|P4|STARTED|Induction Period||0
2401204|NCT01332968|5890528|P3|STARTED|Induction Period||0
2401205|NCT01332968|5890529|P2|STARTED|Induction Period||702
2401206|NCT01332968|5890530|P1|STARTED|Induction Period||699
2401207|NCT01332851|5890596|P2|NOT COMPLETED|Overall Study||13
2401208|NCT01332851|5890597|P1|NOT COMPLETED|Overall Study||11
2401209|NCT01332851|5890596|P2|COMPLETED|Overall Study||110
2401210|NCT01332851|5890597|P1|COMPLETED|Overall Study||113
2401211|NCT01332851|5890596|P2|Completed Follow up 3|Overall Study|Includes 3 new caregivers enrolled due to initial parent no longer parenting|110
2401212|NCT01332851|5890597|P1|Completed Follow up 3|Overall Study|Includes 3 new caregivers enrolled due to initial parent no longer parenting|113
2401213|NCT01332851|5890596|P2|Completed Follow up 2|Overall Study|Includes 4 new caregivers enrolled due to initial parent no longer parenting|111
2401214|NCT01332851|5890597|P1|Completed Follow up 2|Overall Study|Includes 1 new caregiver enrolled due to initial parent no longer parenting|111
2401215|NCT01332851|5890596|P2|Completed Follow up 1|Overall Study|Includes 1 new caregiver enrolled due to initial parent no longer parenting|112
2401216|NCT01332851|5890597|P1|Completed Follow up 1|Overall Study||116
2401217|NCT01332851|5890596|P2|Completed Intervention|Overall Study|4 no intervention, 9 <full dose, 110 full dose; 4 new caregivers enrolled-initial parent dropped out|110
2401218|NCT01332851|5890597|P1|Completed Intervention|Overall Study|9 no intervention, 8 <full dose, 107 full dose; 3 new caregivers enrolled-initial parent dropped out|107
2401219|NCT01332851|5890596|P2|STARTED|Overall Study||123
2401220|NCT01332851|5890597|P1|STARTED|Overall Study||124
2401221|NCT01332799|5890631|P2|NOT COMPLETED|Overall Study||10
2401222|NCT01332799|5890632|P1|NOT COMPLETED|Overall Study||10
2401223|NCT01332799|5890631|P2|COMPLETED|Overall Study||0
2401224|NCT01332799|5890632|P1|COMPLETED|Overall Study||0
2401225|NCT01332799|5890631|P2|STARTED|Overall Study||10
2401226|NCT01332799|5890632|P1|STARTED|Overall Study||10
2401227|NCT01332721|5890642|P1|NOT COMPLETED|Overall Study||0
2401228|NCT01332721|5890642|P1|COMPLETED|Overall Study||38
2401229|NCT01332721|5890642|P1|STARTED|Overall Study||38
2401230|NCT01332630|5890648|P1|NOT COMPLETED|Overall Study||3
2401231|NCT01332630|5890648|P1|COMPLETED|Overall Study||21
2401232|NCT01332630|5890648|P1|STARTED|Overall Study||24
2401233|NCT01332578|5890652|P2|NOT COMPLETED|Period II||0
2401234|NCT01332578|5890653|P1|NOT COMPLETED|Period II||0
2401235|NCT01332578|5890652|P2|COMPLETED|Period II||13
2401236|NCT01332578|5890653|P1|COMPLETED|Period II||12
2401237|NCT01332578|5890652|P2|STARTED|Period II||13
2401238|NCT01332578|5890653|P1|STARTED|Period II||12
2401239|NCT01332578|5890652|P2|NOT COMPLETED|Washout Period||0
2401240|NCT01332578|5890653|P1|NOT COMPLETED|Washout Period||0
2401241|NCT01332578|5890652|P2|COMPLETED|Washout Period||13
2401242|NCT01332578|5890653|P1|COMPLETED|Washout Period||12
2401243|NCT01332578|5890652|P2|STARTED|Washout Period||13
2401244|NCT01332578|5890653|P1|STARTED|Washout Period||12
2401245|NCT01332578|5890652|P2|NOT COMPLETED|Period I||0
2401246|NCT01332578|5890653|P1|NOT COMPLETED|Period I||0
2401247|NCT01332578|5890652|P2|COMPLETED|Period I||13
2401248|NCT01332578|5890653|P1|COMPLETED|Period I||12
2401249|NCT01332578|5890652|P2|STARTED|Period I||13
2401250|NCT01332578|5890653|P1|STARTED|Period I||12
2401251|NCT01332500|5890676|P4|NOT COMPLETED|Overall Study||0
2401252|NCT01332500|5890677|P3|NOT COMPLETED|Overall Study||0
2401253|NCT01332500|5890678|P2|NOT COMPLETED|Overall Study||0
2401254|NCT01332500|5890679|P1|NOT COMPLETED|Overall Study||0
2401255|NCT01332500|5890676|P4|COMPLETED|Overall Study||5806
2401256|NCT01332500|5890677|P3|COMPLETED|Overall Study||2903
2401257|NCT01332500|5890678|P2|COMPLETED|Overall Study||39771
2401258|NCT01332500|5890679|P1|COMPLETED|Overall Study||13257
2401259|NCT01332500|5890676|P4|STARTED|Overall Study||5806
2401260|NCT01332500|5890677|P3|STARTED|Overall Study||2903
2401261|NCT01332500|5890678|P2|STARTED|Overall Study||39771
2401262|NCT01332500|5890679|P1|STARTED|Overall Study||13257
2401263|NCT01332487|5890699|P2|NOT COMPLETED|Overall Study||0
2401264|NCT01332487|5890700|P1|NOT COMPLETED|Overall Study||0
2401265|NCT01332487|5890699|P2|COMPLETED|Overall Study||3063
2401266|NCT01332487|5890700|P1|COMPLETED|Overall Study||5554
2401267|NCT01332487|5890699|P2|STARTED|Overall Study||3063
2401268|NCT01332487|5890700|P1|STARTED|Overall Study||5554
2401269|NCT01332461|5890710|P2|NOT COMPLETED|Overall Study||0
2401270|NCT01332461|5890711|P1|NOT COMPLETED|Overall Study||0
2401271|NCT01332461|5890710|P2|COMPLETED|Overall Study||4386
2401272|NCT01332461|5890711|P1|COMPLETED|Overall Study||1291
2401273|NCT01332461|5890710|P2|STARTED|Overall Study||4386
2401274|NCT01332461|5890711|P1|STARTED|Overall Study||1291
2401275|NCT01332435|5890725|P4|NOT COMPLETED|Overall Study||0
2401276|NCT01332435|5890726|P3|NOT COMPLETED|Overall Study||0
2401277|NCT01332435|5890727|P2|NOT COMPLETED|Overall Study||0
2401278|NCT01332435|5890728|P1|NOT COMPLETED|Overall Study||0
2401279|NCT01332435|5890725|P4|COMPLETED|Overall Study||1656
2401280|NCT01332435|5890726|P3|COMPLETED|Overall Study||2604
2401281|NCT01332435|5890727|P2|COMPLETED|Overall Study||1064
2401282|NCT01332435|5890728|P1|COMPLETED|Overall Study||1572
2401283|NCT01332435|5890725|P4|STARTED|Overall Study||1656
2401284|NCT01332435|5890726|P3|STARTED|Overall Study||2604
2401285|NCT01332435|5890727|P2|STARTED|Overall Study||1064
2401286|NCT01332435|5890728|P1|STARTED|Overall Study||1572
2401287|NCT01332357|5890758|P1|NOT COMPLETED|Overall Study||0
2401288|NCT01332357|5890758|P1|COMPLETED|Overall Study||6139
2401289|NCT01332357|5890758|P1|STARTED|Overall Study||6139
2401290|NCT01332331|5890764|P2|NOT COMPLETED|Overall Study||2
2401291|NCT01332331|5890765|P1|NOT COMPLETED|Overall Study||2
2401292|NCT01332331|5890764|P2|COMPLETED|Overall Study||18
2401293|NCT01332331|5890765|P1|COMPLETED|Overall Study||19
2401294|NCT01332331|5890764|P2|STARTED|Overall Study||20
2401295|NCT01332331|5890765|P1|STARTED|Overall Study||21
2401296|NCT01332318|5890817|P4|NOT COMPLETED|Overall Study||2
2401297|NCT01332318|5890818|P3|NOT COMPLETED|Overall Study||1
2401298|NCT01332318|5890819|P2|NOT COMPLETED|Overall Study||4
2401299|NCT01332318|5890820|P1|NOT COMPLETED|Overall Study||2
2401300|NCT01332318|5890817|P4|COMPLETED|Overall Study||28
2401301|NCT01332318|5890818|P3|COMPLETED|Overall Study||33
2401302|NCT01332318|5890819|P2|COMPLETED|Overall Study||28
2401303|NCT01332318|5890820|P1|COMPLETED|Overall Study||32
2401304|NCT01332318|5890817|P4|STARTED|Overall Study||30
2401305|NCT01332318|5890818|P3|STARTED|Overall Study||34
2401306|NCT01332318|5890819|P2|STARTED|Overall Study||32
2401307|NCT01332318|5890820|P1|STARTED|Overall Study||34
2401308|NCT01332305|5890931|P5|NOT COMPLETED|Overall Study||12
2401309|NCT01332305|5890932|P4|NOT COMPLETED|Overall Study||8
2401310|NCT01332305|5890933|P3|NOT COMPLETED|Overall Study||14
2401311|NCT01332305|5890934|P2|NOT COMPLETED|Overall Study||14
2401312|NCT01332305|5890935|P1|NOT COMPLETED|Overall Study||10
2401313|NCT01332305|5890931|P5|COMPLETED|Overall Study||33
2401314|NCT01332305|5890932|P4|COMPLETED|Overall Study||30
2401315|NCT01332305|5890933|P3|COMPLETED|Overall Study||31
2401316|NCT01332305|5890934|P2|COMPLETED|Overall Study||34
2401317|NCT01332305|5890935|P1|COMPLETED|Overall Study||31
2401318|NCT01332305|5890931|P5|STARTED|Overall Study||45
2401319|NCT01332305|5890932|P4|STARTED|Overall Study||38
2401320|NCT01332305|5890933|P3|STARTED|Overall Study||45
2401321|NCT01332305|5890934|P2|STARTED|Overall Study||48
2401322|NCT01332305|5890935|P1|STARTED|Overall Study||41
2401323|NCT01332292|5890957|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
2401324|NCT01332292|5890958|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||1
2401325|NCT01332292|5890957|P2|COMPLETED|Treatment Period 2 (14 Days)||11
2401326|NCT01332292|5890958|P1|COMPLETED|Treatment Period 2 (14 Days)||11
2401327|NCT01332292|5890957|P2|STARTED|Treatment Period 2 (14 Days)||12
2401328|NCT01332292|5890958|P1|STARTED|Treatment Period 2 (14 Days)||12
2401329|NCT01332292|5890957|P2|NOT COMPLETED|Washout Period (>=7 Days)||0
2401330|NCT01332292|5890958|P1|NOT COMPLETED|Washout Period (>=7 Days)||0
2401331|NCT01332292|5890957|P2|COMPLETED|Washout Period (>=7 Days)||12
2401332|NCT01332292|5890958|P1|COMPLETED|Washout Period (>=7 Days)||12
2401333|NCT01332292|5890957|P2|STARTED|Washout Period (>=7 Days)||12
2401334|NCT01332292|5890958|P1|STARTED|Washout Period (>=7 Days)||12
2401335|NCT01332292|5890957|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
2401336|NCT01332292|5890958|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
2401337|NCT01332292|5890957|P2|COMPLETED|Treatment Period 1 (14 Days)||12
2401338|NCT01332292|5890958|P1|COMPLETED|Treatment Period 1 (14 Days)||12
2401339|NCT01332292|5890957|P2|STARTED|Treatment Period 1 (14 Days)||13
2401340|NCT01332292|5890958|P1|STARTED|Treatment Period 1 (14 Days)||14
2401341|NCT01332253|5891020|P2|NOT COMPLETED|Overall Study||0
2401342|NCT01332253|5891021|P1|NOT COMPLETED|Overall Study||0
2401343|NCT01332253|5891020|P2|COMPLETED|Overall Study||79
2401344|NCT01332253|5891021|P1|COMPLETED|Overall Study||82
2401345|NCT01332253|5891020|P2|STARTED|Overall Study||79
2401346|NCT01332253|5891021|P1|STARTED|Overall Study||82
2401347|NCT01332227|5891049|P2|NOT COMPLETED|Overall Study||5
2401348|NCT01332227|5891050|P1|NOT COMPLETED|Overall Study||16
2401349|NCT01332227|5891049|P2|COMPLETED|Overall Study||32
2401350|NCT01332227|5891050|P1|COMPLETED|Overall Study||56
2401351|NCT01332227|5891049|P2|STARTED|Overall Study|Participants who received treatment|37
2401352|NCT01332227|5891050|P1|STARTED|Overall Study|Participants who received treatment|72
2401353|NCT01332188|5891072|P4|NOT COMPLETED|Overall Study||0
2401354|NCT01332188|5891073|P3|NOT COMPLETED|Overall Study||4
2401355|NCT01332188|5891074|P2|NOT COMPLETED|Overall Study||1
2401356|NCT01332188|5891075|P1|NOT COMPLETED|Overall Study||2
2401357|NCT01332188|5891072|P4|COMPLETED|Overall Study||25
2401358|NCT01332188|5891073|P3|COMPLETED|Overall Study||21
2401359|NCT01332188|5891074|P2|COMPLETED|Overall Study||25
2401360|NCT01332188|5891075|P1|COMPLETED|Overall Study||23
2401361|NCT01332188|5891072|P4|STARTED|Overall Study||25
2401362|NCT01332188|5891073|P3|STARTED|Overall Study||25
2401363|NCT01332188|5891074|P2|STARTED|Overall Study||26
2401364|NCT01332188|5891075|P1|STARTED|Overall Study||25
2401365|NCT01332149|5891231|P2|NOT COMPLETED|Overall Study||38
2401366|NCT01332149|5891232|P1|NOT COMPLETED|Overall Study||30
2401367|NCT01332149|5891231|P2|COMPLETED|Overall Study||271
2401368|NCT01332149|5891232|P1|COMPLETED|Overall Study||284
2401369|NCT01332149|5891231|P2|Treated|Overall Study||307
2401370|NCT01332149|5891232|P1|Treated|Overall Study||313
2401371|NCT01332149|5891231|P2|STARTED|Overall Study|Assigned to study treatment.|309
2401372|NCT01332149|5891232|P1|STARTED|Overall Study|Assigned to study treatment.|314
2401373|NCT01332123|5891286|P1|NOT COMPLETED|Overall Study||0
2401374|NCT01332123|5891286|P1|COMPLETED|Overall Study||10
2401375|NCT01332123|5891286|P1|STARTED|Overall Study||10
2401376|NCT01332071|5891291|P2|NOT COMPLETED|Period 2||0
2401377|NCT01332071|5891292|P1|NOT COMPLETED|Period 2||0
2401378|NCT01332071|5891291|P2|COMPLETED|Period 2||13
2401379|NCT01332071|5891292|P1|COMPLETED|Period 2||13
2401380|NCT01332071|5891291|P2|STARTED|Period 2||13
2401381|NCT01332071|5891292|P1|STARTED|Period 2||13
2401382|NCT01332071|5891291|P2|NOT COMPLETED|7-Day Washout Period||0
2401383|NCT01332071|5891292|P1|NOT COMPLETED|7-Day Washout Period||0
2401384|NCT01332071|5891291|P2|COMPLETED|7-Day Washout Period||13
2401385|NCT01332071|5891292|P1|COMPLETED|7-Day Washout Period||13
2401386|NCT01332071|5891291|P2|STARTED|7-Day Washout Period||13
2401387|NCT01332071|5891292|P1|STARTED|7-Day Washout Period||13
2401388|NCT01332071|5891291|P2|NOT COMPLETED|Period 1||0
2401389|NCT01332071|5891292|P1|NOT COMPLETED|Period 1||0
2401390|NCT01332071|5891291|P2|COMPLETED|Period 1||13
2401391|NCT01332071|5891292|P1|COMPLETED|Period 1||13
2401392|NCT01332071|5891291|P2|STARTED|Period 1||13
2401393|NCT01332071|5891292|P1|STARTED|Period 1||13
2401394|NCT01332019|5891310|P2|NOT COMPLETED|Overall Study||122
2401395|NCT01332019|5891311|P1|NOT COMPLETED|Overall Study||113
2401396|NCT01332019|5891310|P2|COMPLETED|Overall Study||425
2401397|NCT01332019|5891311|P1|COMPLETED|Overall Study||417
2401398|NCT01332019|5891310|P2|STARTED|Overall Study||547
2401399|NCT01332019|5891311|P1|STARTED|Overall Study||530
2401400|NCT01331837|5891395|P2|NOT COMPLETED|Overall Study||67
2401401|NCT01331837|5891396|P1|NOT COMPLETED|Overall Study||56
2401402|NCT01331837|5891395|P2|COMPLETED|Overall Study||1475
2401403|NCT01331837|5891396|P1|COMPLETED|Overall Study||1482
2401404|NCT01331837|5891395|P2|STARTED|Overall Study||1542
2401405|NCT01331837|5891396|P1|STARTED|Overall Study||1538
2401406|NCT01331824|5891436|P1|NOT COMPLETED|Overall Study||13
2401407|NCT01331824|5891436|P1|COMPLETED|Overall Study||9
2401408|NCT01331824|5891436|P1|STARTED|Overall Study||22
2401409|NCT01331694|5891449|P6|NOT COMPLETED|Overall Study||0
2401410|NCT01331694|5891450|P5|NOT COMPLETED|Overall Study||0
2401411|NCT01331694|5891451|P4|NOT COMPLETED|Overall Study||0
2401412|NCT01331694|5891452|P3|NOT COMPLETED|Overall Study||0
2401413|NCT01331694|5891453|P2|NOT COMPLETED|Overall Study||0
2401414|NCT01331694|5891454|P1|NOT COMPLETED|Overall Study||0
2401415|NCT01331694|5891449|P6|COMPLETED|Overall Study||9126
2401416|NCT01331694|5891450|P5|COMPLETED|Overall Study||10617
2401417|NCT01331694|5891451|P4|COMPLETED|Overall Study||12595
2401418|NCT01331694|5891452|P3|COMPLETED|Overall Study||12659
2401419|NCT01331694|5891453|P2|COMPLETED|Overall Study||14449
2401420|NCT01331694|5891454|P1|COMPLETED|Overall Study||16684
2401421|NCT01331694|5891449|P6|STARTED|Overall Study||9126
2401422|NCT01331694|5891450|P5|STARTED|Overall Study||10617
2401423|NCT01331694|5891451|P4|STARTED|Overall Study||12595
2401424|NCT01331694|5891452|P3|STARTED|Overall Study||12659
2401425|NCT01331694|5891453|P2|STARTED|Overall Study||14449
2401426|NCT01331694|5891454|P1|STARTED|Overall Study||16684
2401427|NCT01331681|5891471|P3|NOT COMPLETED|Overall Study||35
2401428|NCT01331681|5891472|P2|NOT COMPLETED|Overall Study||34
2401429|NCT01331681|5891473|P1|NOT COMPLETED|Overall Study||35
2401430|NCT01331681|5891471|P3|COMPLETED|Overall Study|Completed Week 148|100
2401431|NCT01331681|5891472|P2|COMPLETED|Overall Study|Completed Week 148|101
2401432|NCT01331681|5891473|P1|COMPLETED|Overall Study|Completed Week 148|101
2401433|NCT01331681|5891471|P3|Completed Week 148|Overall Study||100
2401434|NCT01331681|5891472|P2|Completed Week 148|Overall Study||101
2401435|NCT01331681|5891473|P1|Completed Week 148|Overall Study||101
2401436|NCT01331681|5891471|P3|Completed Week 100|Overall Study||105
2401437|NCT01331681|5891472|P2|Completed Week 100|Overall Study||110
2401438|NCT01331681|5891473|P1|Completed Week 100|Overall Study||115
2401439|NCT01331681|5891471|P3|Completed Week 52|Overall Study||115
2401440|NCT01331681|5891472|P2|Completed Week 52|Overall Study||121
2401441|NCT01331681|5891473|P1|Completed Week 52|Overall Study||125
2401442|NCT01331681|5891471|P3|Participants Received Treatment|Overall Study|safety population|133
2401443|NCT01331681|5891472|P2|Participants Received Treatment|Overall Study|safety population|135
2401444|NCT01331681|5891473|P1|Participants Received Treatment|Overall Study|safety population|136
2401445|NCT01331681|5891471|P3|STARTED|Overall Study|randomized|135
2401446|NCT01331681|5891472|P2|STARTED|Overall Study|randomized|135
2401447|NCT01331681|5891473|P1|STARTED|Overall Study|randomized|136
2401448|NCT01331408|5891499|P1|NOT COMPLETED|Overall Study||11
2401449|NCT01331408|5891499|P1|COMPLETED|Overall Study||50
2401450|NCT01331408|5891499|P1|STARTED|Overall Study||61
2401451|NCT01331304|5891507|P2|NOT COMPLETED|Overall Study||60
2401452|NCT01331304|5891508|P1|NOT COMPLETED|Overall Study||58
2401453|NCT01331304|5891507|P2|COMPLETED|Overall Study||182
2401454|NCT01331304|5891508|P1|COMPLETED|Overall Study||182
2401455|NCT01331304|5891507|P2|STARTED|Overall Study||242
2401456|NCT01331304|5891508|P1|STARTED|Overall Study||240
2401457|NCT01331291|5891522|P2|NOT COMPLETED|Overall Study||9
2401458|NCT01331291|5891523|P1|NOT COMPLETED|Overall Study||2
2401459|NCT01331291|5891522|P2|COMPLETED|Overall Study||0
2401460|NCT01331291|5891523|P1|COMPLETED|Overall Study||0
2401461|NCT01331291|5891522|P2|STARTED|Overall Study||9
2401462|NCT01331291|5891523|P1|STARTED|Overall Study||2
2401463|NCT01331213|5891536|P2|NOT COMPLETED|Overall Study||0
2401464|NCT01331213|5891537|P1|NOT COMPLETED|Overall Study||0
2401465|NCT01331213|5891536|P2|COMPLETED|Overall Study||10
2401466|NCT01331213|5891537|P1|COMPLETED|Overall Study||8
2401467|NCT01331213|5891536|P2|STARTED|Overall Study||10
2401468|NCT01331213|5891537|P1|STARTED|Overall Study||8
2401469|NCT01331161|5891557|P2|NOT COMPLETED|Overall Study||2
2401470|NCT01331161|5891558|P1|NOT COMPLETED|Overall Study||1
2401471|NCT01331161|5891557|P2|COMPLETED|Overall Study||31
2401472|NCT01331161|5891558|P1|COMPLETED|Overall Study||43
2401473|NCT01331161|5891557|P2|STARTED|Overall Study||33
2401474|NCT01331161|5891558|P1|STARTED|Overall Study||44
2401475|NCT01331109|5891566|P1|NOT COMPLETED|Overall Study||57
2401476|NCT01331109|5891566|P1|COMPLETED|Overall Study||0
2401477|NCT01331109|5891566|P1|STARTED|Overall Study||57
2401478|NCT01331005|5891578|P2|NOT COMPLETED|Overall Study||4
2401479|NCT01331005|5891579|P1|NOT COMPLETED|Overall Study||4
2401480|NCT01331005|5891578|P2|COMPLETED|Overall Study||57
2401481|NCT01331005|5891579|P1|COMPLETED|Overall Study||60
2401482|NCT01331005|5891578|P2|STARTED|Overall Study||61
2401483|NCT01331005|5891579|P1|STARTED|Overall Study||64
2401484|NCT01330966|5891589|P1|NOT COMPLETED|Overall Study||5
2401485|NCT01330966|5891589|P1|COMPLETED|Overall Study|Tumor responses evaluable in 42 of 47 pts; 5 pts discontinued prior to first tumor assessment.|42
2401486|NCT01330966|5891589|P1|STARTED|Overall Study||47
2401487|NCT01330953|5891600|P5|NOT COMPLETED|Overall Study||0
2401488|NCT01330953|5891601|P4|NOT COMPLETED|Overall Study||0
2401489|NCT01330953|5891602|P3|NOT COMPLETED|Overall Study||0
2401490|NCT01330953|5891603|P2|NOT COMPLETED|Overall Study||0
2401491|NCT01330953|5891604|P1|NOT COMPLETED|Overall Study||0
2401492|NCT01330953|5891600|P5|COMPLETED|Overall Study||6
2401493|NCT01330953|5891601|P4|COMPLETED|Overall Study||6
2401494|NCT01330953|5891602|P3|COMPLETED|Overall Study||6
2401495|NCT01330953|5891603|P2|COMPLETED|Overall Study||6
2401496|NCT01330953|5891604|P1|COMPLETED|Overall Study||8
2401497|NCT01330953|5891600|P5|STARTED|Overall Study||6
2401498|NCT01330953|5891601|P4|STARTED|Overall Study||6
2401499|NCT01330953|5891602|P3|STARTED|Overall Study||6
2401500|NCT01330953|5891603|P2|STARTED|Overall Study||6
2401501|NCT01330953|5891604|P1|STARTED|Overall Study||8
2401502|NCT01330914|5891650|P1|NOT COMPLETED|Overall Study||7
2401503|NCT01330914|5891650|P1|COMPLETED|Overall Study||48
2401504|NCT01330914|5891650|P1|STARTED|Overall Study||55
2401505|NCT01330628|5891658|P2|NOT COMPLETED|Overall Study||40
2401506|NCT01330628|5891659|P1|NOT COMPLETED|Overall Study||70
2401507|NCT01330628|5891658|P2|COMPLETED|Overall Study||42
2401508|NCT01330628|5891659|P1|COMPLETED|Overall Study||100
2401509|NCT01330628|5891658|P2|6 Month Follow-up|Overall Study||60
2401510|NCT01330628|5891659|P1|6 Month Follow-up|Overall Study||135
2401511|NCT01330628|5891658|P2|30 Day Follow-up|Overall Study||73
2401512|NCT01330628|5891659|P1|30 Day Follow-up|Overall Study||165
2401513|NCT01330628|5891658|P2|STARTED|Overall Study||82
2401514|NCT01330628|5891659|P1|STARTED|Overall Study||170
2401515|NCT01330459|5891669|P2|NOT COMPLETED|Overall Study||2
2401516|NCT01330459|5891670|P1|NOT COMPLETED|Overall Study||0
2401517|NCT01330459|5891669|P2|COMPLETED|Overall Study||58
2401518|NCT01330459|5891670|P1|COMPLETED|Overall Study||61
2401519|NCT01330459|5891669|P2|STARTED|Overall Study||60
2401520|NCT01330459|5891670|P1|STARTED|Overall Study||61
2401521|NCT01330433|5891686|P2|NOT COMPLETED|Overall Study||3
2401522|NCT01330433|5891687|P1|NOT COMPLETED|Overall Study||2
2401523|NCT01330433|5891686|P2|COMPLETED|Overall Study||16
2401524|NCT01330433|5891687|P1|COMPLETED|Overall Study||14
2401525|NCT01330433|5891686|P2|STARTED|Overall Study||19
2401526|NCT01330433|5891687|P1|STARTED|Overall Study||16
2401527|NCT01330420|5891707|P1|NOT COMPLETED|Overall Study||4
2401528|NCT01330420|5891707|P1|COMPLETED|Overall Study||24
2401529|NCT01330420|5891707|P1|STARTED|Overall Study||28
2401530|NCT01330394|5891717|P2|NOT COMPLETED|Overall Study||0
2401531|NCT01330394|5891718|P1|NOT COMPLETED|Overall Study||0
2401532|NCT01330394|5891717|P2|COMPLETED|Overall Study||16
2401533|NCT01330394|5891718|P1|COMPLETED|Overall Study||17
2401534|NCT01330394|5891717|P2|STARTED|Overall Study||16
2401535|NCT01330394|5891718|P1|STARTED|Overall Study||17
2401536|NCT01330381|5891726|P3|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||18
2401537|NCT01330381|5891727|P2|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||0
2401538|NCT01330381|5891728|P1|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||10
2401539|NCT01330381|5891726|P3|COMPLETED|Open-label Treatment Period (16 Weeks)||81
2401540|NCT01330381|5891727|P2|COMPLETED|Open-label Treatment Period (16 Weeks)||0
2401541|NCT01330381|5891728|P1|COMPLETED|Open-label Treatment Period (16 Weeks)||88
2401542|NCT01330381|5891726|P3|STARTED|Open-label Treatment Period (16 Weeks)||99
2401543|NCT01330381|5891727|P2|STARTED|Open-label Treatment Period (16 Weeks)||0
2401544|NCT01330381|5891728|P1|STARTED|Open-label Treatment Period (16 Weeks)||98
2401545|NCT01330381|5891726|P3|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||0
2401546|NCT01330381|5891727|P2|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||7
2401547|NCT01330381|5891728|P1|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||11
2401548|NCT01330381|5891726|P3|COMPLETED|Double-blind Treatment Period (8 Weeks)||0
2401549|NCT01330381|5891727|P2|COMPLETED|Double-blind Treatment Period (8 Weeks)||101
2401550|NCT01330381|5891728|P1|COMPLETED|Double-blind Treatment Period (8 Weeks)||96
2401551|NCT01330381|5891726|P3|Received Treatment|Double-blind Treatment Period (8 Weeks)||0
2401552|NCT01330381|5891727|P2|Received Treatment|Double-blind Treatment Period (8 Weeks)||107
2401553|NCT01330381|5891728|P1|Received Treatment|Double-blind Treatment Period (8 Weeks)||106
2401554|NCT01330381|5891726|P3|STARTED|Double-blind Treatment Period (8 Weeks)||0
2401555|NCT01330381|5891727|P2|STARTED|Double-blind Treatment Period (8 Weeks)||108
2401556|NCT01330381|5891728|P1|STARTED|Double-blind Treatment Period (8 Weeks)||107
2401557|NCT01330355|5891774|P2|NOT COMPLETED|Overall Study||0
2401558|NCT01330355|5891775|P1|NOT COMPLETED|Overall Study||0
2401559|NCT01330355|5891774|P2|COMPLETED|Overall Study||17
2401560|NCT01330355|5891775|P1|COMPLETED|Overall Study||16
2401561|NCT01330355|5891774|P2|STARTED|Overall Study||17
2401562|NCT01330355|5891775|P1|STARTED|Overall Study||16
2401563|NCT01330316|5891789|P2|NOT COMPLETED|Overall Study||15
2401564|NCT01330316|5891790|P1|NOT COMPLETED|Overall Study||2
2401565|NCT01330316|5891789|P2|COMPLETED|Overall Study||60
2401566|NCT01330316|5891790|P1|COMPLETED|Overall Study||41
2401567|NCT01330316|5891789|P2|STARTED|Overall Study||75
2401568|NCT01330316|5891790|P1|STARTED|Overall Study||43
2401569|NCT01330303|5891826|P2|NOT COMPLETED|Period 2||0
2401570|NCT01330303|5891827|P1|NOT COMPLETED|Period 2||0
2401571|NCT01330303|5891826|P2|COMPLETED|Period 2||18
2401572|NCT01330303|5891827|P1|COMPLETED|Period 2||19
2401573|NCT01330303|5891826|P2|STARTED|Period 2||18
2401574|NCT01330303|5891827|P1|STARTED|Period 2||19
2401575|NCT01330303|5891826|P2|NOT COMPLETED|7-Day Washout Period||0
2401576|NCT01330303|5891827|P1|NOT COMPLETED|7-Day Washout Period||0
2401577|NCT01330303|5891826|P2|COMPLETED|7-Day Washout Period||18
2401578|NCT01330303|5891827|P1|COMPLETED|7-Day Washout Period||19
2401579|NCT01330303|5891826|P2|STARTED|7-Day Washout Period||18
2401580|NCT01330303|5891827|P1|STARTED|7-Day Washout Period||19
2401581|NCT01330303|5891826|P2|NOT COMPLETED|Period 1||2
2401582|NCT01330303|5891827|P1|NOT COMPLETED|Period 1||1
2401583|NCT01330303|5891826|P2|COMPLETED|Period 1||18
2401584|NCT01330303|5891827|P1|COMPLETED|Period 1||19
2401585|NCT01330303|5891826|P2|STARTED|Period 1||20
2401586|NCT01330303|5891827|P1|STARTED|Period 1||20
2401587|NCT01330290|5891837|P1|NOT COMPLETED|Overall Study||0
2401588|NCT01330290|5891837|P1|COMPLETED|Overall Study|As this is a cross-sectional study, the terms completed/not completed are not applicable.|148
2401589|NCT01330290|5891837|P1|STARTED|Overall Study||148
2401590|NCT01330134|5891863|P2|NOT COMPLETED|Overall Study||0
2401591|NCT01330134|5891864|P1|NOT COMPLETED|Overall Study||0
2401592|NCT01330134|5891863|P2|COMPLETED|Overall Study||237
2401593|NCT01330134|5891864|P1|COMPLETED|Overall Study||244
2401594|NCT01330134|5891863|P2|STARTED|Overall Study||237
2401595|NCT01330134|5891864|P1|STARTED|Overall Study||244
2401596|NCT01330108|5891874|P1|NOT COMPLETED|Overall Study||4
2401597|NCT01330108|5891874|P1|COMPLETED|Overall Study||28
2401598|NCT01330108|5891874|P1|STARTED|Overall Study||32
2401599|NCT01330043|5891881|P2|NOT COMPLETED|Overall Study||4
2401600|NCT01330043|5891882|P1|NOT COMPLETED|Overall Study||0
2401601|NCT01330043|5891881|P2|COMPLETED|Overall Study||108
2401602|NCT01330043|5891882|P1|COMPLETED|Overall Study||111
2401603|NCT01330043|5891881|P2|STARTED|Overall Study||112
2401604|NCT01330043|5891882|P1|STARTED|Overall Study||111
2401605|NCT01330030|5891892|P2|NOT COMPLETED|Overall Study||17
2401606|NCT01330030|5891893|P1|NOT COMPLETED|Overall Study||16
2401607|NCT01330030|5891892|P2|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
2401608|NCT01330030|5891893|P1|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
2401609|NCT01330030|5891892|P2|STARTED|Overall Study||122
2401610|NCT01330030|5891893|P1|STARTED|Overall Study||121
2401611|NCT01330017|5891904|P5|NOT COMPLETED|Overall Study||3
2401612|NCT01330017|5891905|P4|NOT COMPLETED|Overall Study||12
2401613|NCT01330017|5891906|P3|NOT COMPLETED|Overall Study||8
2401614|NCT01330017|5891907|P2|NOT COMPLETED|Overall Study||4
2401615|NCT01330017|5891908|P1|NOT COMPLETED|Overall Study||5
2401616|NCT01330017|5891904|P5|COMPLETED|Overall Study||100
2401617|NCT01330017|5891905|P4|COMPLETED|Overall Study||100
2401618|NCT01330017|5891906|P3|COMPLETED|Overall Study||99
2401619|NCT01330017|5891907|P2|COMPLETED|Overall Study||104
2401620|NCT01330017|5891908|P1|COMPLETED|Overall Study||104
2401621|NCT01330017|5891904|P5|STARTED|Overall Study||103
2401622|NCT01330017|5891905|P4|STARTED|Overall Study||112
2401623|NCT01330017|5891906|P3|STARTED|Overall Study||107
2401624|NCT01330017|5891907|P2|STARTED|Overall Study||108
2401625|NCT01330017|5891908|P1|STARTED|Overall Study||109
2401626|NCT01329978|5891957|P5|NOT COMPLETED|Rerandomization Treatment Period||4
2401627|NCT01329978|5891958|P4|NOT COMPLETED|Rerandomization Treatment Period||5
2401628|NCT01329978|5891959|P3|NOT COMPLETED|Rerandomization Treatment Period||0
2401629|NCT01329978|5891960|P2|NOT COMPLETED|Rerandomization Treatment Period||0
2401630|NCT01329978|5891961|P1|NOT COMPLETED|Rerandomization Treatment Period||0
2401631|NCT01329978|5891957|P5|COMPLETED|Rerandomization Treatment Period||71
2401632|NCT01329978|5891958|P4|COMPLETED|Rerandomization Treatment Period||70
2401633|NCT01329978|5891959|P3|COMPLETED|Rerandomization Treatment Period||0
2401634|NCT01329978|5891960|P2|COMPLETED|Rerandomization Treatment Period||0
2401635|NCT01329978|5891961|P1|COMPLETED|Rerandomization Treatment Period||0
2401636|NCT01329978|5891957|P5|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
2401637|NCT01329978|5891958|P4|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
2401638|NCT01329978|5891959|P3|STARTED|Rerandomization Treatment Period||0
2401639|NCT01329978|5891960|P2|STARTED|Rerandomization Treatment Period||0
2401640|NCT01329978|5891961|P1|STARTED|Rerandomization Treatment Period||0
2401641|NCT01329978|5891957|P5|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
2401642|NCT01329978|5891958|P4|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
2401643|NCT01329978|5891959|P3|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||5
2401644|NCT01329978|5891960|P2|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||13
2401645|NCT01329978|5891961|P1|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||4
2401646|NCT01329978|5891957|P5|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
2401647|NCT01329978|5891958|P4|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
2401648|NCT01329978|5891959|P3|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|150 participants were re-randomized after 12 weeks of treatment.|150
2401649|NCT01329978|5891960|P2|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|112
2401650|NCT01329978|5891961|P1|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|48
2401651|NCT01329978|5891957|P5|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
2401652|NCT01329978|5891958|P4|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
2401653|NCT01329978|5891959|P3|STARTED|Sofosbuvir+PEG+RBV Treatment Period||155
2401654|NCT01329978|5891960|P2|STARTED|Sofosbuvir+PEG+RBV Treatment Period||125
2401655|NCT01329978|5891961|P1|STARTED|Sofosbuvir+PEG+RBV Treatment Period||52
2401656|NCT01329939|5892035|P4|NOT COMPLETED|Overall Study||5
2401657|NCT01329939|5892036|P3|NOT COMPLETED|Overall Study||1
2401658|NCT01329939|5892037|P2|NOT COMPLETED|Overall Study||1
2401659|NCT01329939|5892038|P1|NOT COMPLETED|Overall Study||3
2401660|NCT01329939|5892035|P4|COMPLETED|Overall Study||4
2401661|NCT01329939|5892036|P3|COMPLETED|Overall Study||4
2401662|NCT01329939|5892037|P2|COMPLETED|Overall Study||4
2401663|NCT01329939|5892038|P1|COMPLETED|Overall Study||4
2401664|NCT01329939|5892035|P4|STARTED|Overall Study||9
2401665|NCT01329939|5892036|P3|STARTED|Overall Study||5
2401666|NCT01329939|5892037|P2|STARTED|Overall Study||5
2401667|NCT01329939|5892038|P1|STARTED|Overall Study||7
2401668|NCT01329848|5892076|P1|NOT COMPLETED|Overall Study||29
2401669|NCT01329848|5892076|P1|COMPLETED|Overall Study||54
2401670|NCT01329848|5892076|P1|STARTED|Overall Study||83
2401671|NCT01329679|5892081|P2|NOT COMPLETED|Overall Study||0
2401672|NCT01329679|5892082|P1|NOT COMPLETED|Overall Study||0
2401673|NCT01329679|5892081|P2|COMPLETED|Overall Study||13
2401674|NCT01329679|5892082|P1|COMPLETED|Overall Study||13
2401675|NCT01329679|5892081|P2|STARTED|Overall Study||13
2401676|NCT01329679|5892082|P1|STARTED|Overall Study||13
2401677|NCT01329562|5892102|P2|NOT COMPLETED|Overall Study||7
2401678|NCT01329562|5892103|P1|NOT COMPLETED|Overall Study||9
2401679|NCT01329562|5892102|P2|COMPLETED|Overall Study||14
2401680|NCT01329562|5892103|P1|COMPLETED|Overall Study||11
2401681|NCT01329562|5892102|P2|STARTED|Overall Study||21
2401682|NCT01329562|5892103|P1|STARTED|Overall Study||20
2401683|NCT01329549|5892152|P1|NOT COMPLETED|Overall Study||2
2401684|NCT01329549|5892152|P1|COMPLETED|Overall Study||0
2401685|NCT01329549|5892152|P1|STARTED|Overall Study||2
2401686|NCT01329419|5892163|P1|NOT COMPLETED|Overall Study||235
2401687|NCT01329419|5892163|P1|COMPLETED|Overall Study||4158
2401688|NCT01329419|5892163|P1|STARTED|Overall Study||4393
2401689|NCT01329380|5892169|P1|NOT COMPLETED|Overall Study||29
2401690|NCT01329380|5892169|P1|COMPLETED|Overall Study||374
2401691|NCT01329380|5892169|P1|Safety Population|Overall Study||396
2401692|NCT01329380|5892169|P1|STARTED|Overall Study||403
2401693|NCT01329263|5892181|P2|NOT COMPLETED|Overall Study||23
2401694|NCT01329263|5892182|P1|NOT COMPLETED|Overall Study||5
2401695|NCT01329263|5892181|P2|COMPLETED|Overall Study||22
2401696|NCT01329263|5892182|P1|COMPLETED|Overall Study||10
2401697|NCT01329263|5892181|P2|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||22
2401698|NCT01329263|5892182|P1|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||10
2401699|NCT01329263|5892181|P2|Completed Period 2 Own or CCrush Menthol|Overall Study||30
2401700|NCT01329263|5892182|P1|Completed Period 2 Own or CCrush Menthol|Overall Study||10
2401701|NCT01329263|5892181|P2|Completed Period 1 Own Menthol|Overall Study||45
2401702|NCT01329263|5892182|P1|Completed Period 1 Own Menthol|Overall Study||15
2401703|NCT01329263|5892181|P2|STARTED|Overall Study||45
2401704|NCT01329263|5892182|P1|STARTED|Overall Study||15
2401705|NCT01329198|5892196|P2|NOT COMPLETED|Overall Study||0
2401706|NCT01329198|5892197|P1|NOT COMPLETED|Overall Study||0
2401707|NCT01329198|5892196|P2|COMPLETED|Overall Study||2
2401708|NCT01329198|5892197|P1|COMPLETED|Overall Study||3
2401709|NCT01329198|5892196|P2|STARTED|Overall Study||2
2401710|NCT01329198|5892197|P1|STARTED|Overall Study||3
2401711|NCT01329185|5892210|P2|NOT COMPLETED|Overall Study||0
2401712|NCT01329185|5892211|P1|NOT COMPLETED|Overall Study||0
2401713|NCT01329185|5892210|P2|COMPLETED|Overall Study||7
2401714|NCT01329185|5892211|P1|COMPLETED|Overall Study||10
2401715|NCT01329185|5892210|P2|PTLD|Overall Study||0
2401716|NCT01329185|5892211|P1|PTLD|Overall Study||1
2401717|NCT01329185|5892210|P2|CMV Disease|Overall Study||0
2401718|NCT01329185|5892211|P1|CMV Disease|Overall Study||1
2401719|NCT01329185|5892210|P2|STARTED|Overall Study||7
2401720|NCT01329185|5892211|P1|STARTED|Overall Study||10
2401721|NCT01329029|5892219|P2|NOT COMPLETED|Overall Study||192
2401722|NCT01329029|5892220|P1|NOT COMPLETED|Overall Study||269
2401723|NCT01329029|5892219|P2|COMPLETED|Overall Study||780
2401724|NCT01329029|5892220|P1|COMPLETED|Overall Study||704
2401725|NCT01329029|5892219|P2|Safety Population|Overall Study||967
2401726|NCT01329029|5892220|P1|Safety Population|Overall Study||968
2401727|NCT01329029|5892219|P2|Full Analysis Set (FAS)|Overall Study||966
2401728|NCT01329029|5892220|P1|Full Analysis Set (FAS)|Overall Study||969
2401729|NCT01329029|5892219|P2|STARTED|Overall Study||972
2401730|NCT01329029|5892220|P1|STARTED|Overall Study||973
2401731|NCT01328964|5892293|P3|NOT COMPLETED|Overall Study||0
2401732|NCT01328964|5892294|P2|NOT COMPLETED|Overall Study||0
2401733|NCT01328964|5892295|P1|NOT COMPLETED|Overall Study||0
2401734|NCT01328964|5892293|P3|COMPLETED|Overall Study||4424
2401735|NCT01328964|5892294|P2|COMPLETED|Overall Study||3270
2401736|NCT01328964|5892295|P1|COMPLETED|Overall Study||2212
2401737|NCT01328964|5892293|P3|STARTED|Overall Study||4424
2401738|NCT01328964|5892294|P2|STARTED|Overall Study||3270
2401739|NCT01328964|5892295|P1|STARTED|Overall Study||2212
2401740|NCT01328951|5892310|P2|NOT COMPLETED|Overall Study||322
2401741|NCT01328951|5892311|P1|NOT COMPLETED|Overall Study||321
2401742|NCT01328951|5892310|P2|COMPLETED|Overall Study||0
2401743|NCT01328951|5892311|P1|COMPLETED|Overall Study||0
2401744|NCT01328951|5892310|P2|STARTED|Overall Study||322
2401745|NCT01328951|5892311|P1|STARTED|Overall Study||321
2401746|NCT01328873|5892335|P1|NOT COMPLETED|Overall Study||0
2401747|NCT01328873|5892335|P1|COMPLETED|Overall Study||49
2401748|NCT01328873|5892335|P1|STARTED|Overall Study||49
2401749|NCT01328782|5892347|P3|NOT COMPLETED|Overall Study||0
2401750|NCT01328782|5892348|P2|NOT COMPLETED|Overall Study||0
2401751|NCT01328782|5892349|P1|NOT COMPLETED|Overall Study||0
2401752|NCT01328782|5892347|P3|COMPLETED|Overall Study||39
2401753|NCT01328782|5892348|P2|COMPLETED|Overall Study||42
2401754|NCT01328782|5892349|P1|COMPLETED|Overall Study||43
2401755|NCT01328782|5892347|P3|STARTED|Overall Study||39
2401756|NCT01328782|5892348|P2|STARTED|Overall Study||42
2401757|NCT01328782|5892349|P1|STARTED|Overall Study||43
2401758|NCT01328769|5892371|P2|NOT COMPLETED|Overall Study||1
2401759|NCT01328769|5892372|P1|NOT COMPLETED|Overall Study||0
2401760|NCT01328769|5892371|P2|COMPLETED|Overall Study||23
2401761|NCT01328769|5892372|P1|COMPLETED|Overall Study||25
2401762|NCT01328769|5892371|P2|STARTED|Overall Study||24
2401763|NCT01328769|5892372|P1|STARTED|Overall Study||25
2401764|NCT01328756|5892380|P1|NOT COMPLETED|Overall Study||123
2401765|NCT01328756|5892380|P1|COMPLETED|Overall Study||191
2401766|NCT01328756|5892380|P1|STARTED|Overall Study||314
2401767|NCT01328743|5892399|P2|NOT COMPLETED|Overall Study||10
2401768|NCT01328743|5892400|P1|NOT COMPLETED|Overall Study||9
2401769|NCT01328743|5892399|P2|COMPLETED|Overall Study||79
2401770|NCT01328743|5892400|P1|COMPLETED|Overall Study||82
2401771|NCT01328743|5892399|P2|STARTED|Overall Study||89
2401772|NCT01328743|5892400|P1|STARTED|Overall Study||91
2401773|NCT01328717|5892416|P1|NOT COMPLETED|Overall Study||1
2401774|NCT01328717|5892416|P1|COMPLETED|Overall Study||77
2401775|NCT01328717|5892416|P1|STARTED|Overall Study||78
2401776|NCT01328587|5892421|P1|NOT COMPLETED|Overall Study||0
2401777|NCT01328587|5892421|P1|COMPLETED|Overall Study||34
2401778|NCT01328587|5892421|P1|STARTED|Overall Study||34
2401779|NCT01328574|5892425|P1|NOT COMPLETED|Overall Study||1
2401780|NCT01328574|5892425|P1|COMPLETED|Overall Study||12
2401781|NCT01328574|5892425|P1|STARTED|Overall Study||13
2401782|NCT01328548|5892439|P2|NOT COMPLETED|Overall Study||0
2401783|NCT01328548|5892440|P1|NOT COMPLETED|Overall Study||4
2401784|NCT01328548|5892439|P2|COMPLETED|Overall Study||50
2401785|NCT01328548|5892440|P1|COMPLETED|Overall Study||187
2401786|NCT01328548|5892439|P2|STARTED|Overall Study||50
2401787|NCT01328548|5892440|P1|STARTED|Overall Study||191
2401788|NCT01328535|5892458|P1|NOT COMPLETED|Overall Study||1
2401789|NCT01328535|5892458|P1|COMPLETED|Overall Study||24
2401790|NCT01328535|5892458|P1|STARTED|Overall Study||25
2401791|NCT01328496|5892469|P2|NOT COMPLETED|Overall Study||0
2401792|NCT01328496|5892470|P1|NOT COMPLETED|Overall Study||1
2401793|NCT01328496|5892469|P2|COMPLETED|Overall Study||4
2401794|NCT01328496|5892470|P1|COMPLETED|Overall Study||9
2401795|NCT01328496|5892469|P2|STARTED|Overall Study||4
2401796|NCT01328496|5892470|P1|STARTED|Overall Study||10
2401797|NCT01328444|5892488|P6|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
2401798|NCT01328444|5892489|P5|NOT COMPLETED|Treatment Period 2 (12 Weeks)||8
2401799|NCT01328444|5892490|P4|NOT COMPLETED|Treatment Period 2 (12 Weeks)||5
2401800|NCT01328444|5892491|P3|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
2401801|NCT01328444|5892492|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
2401802|NCT01328444|5892493|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||11
2401803|NCT01328444|5892488|P6|COMPLETED|Treatment Period 2 (12 Weeks)||59
2401804|NCT01328444|5892489|P5|COMPLETED|Treatment Period 2 (12 Weeks)||63
2401805|NCT01328444|5892490|P4|COMPLETED|Treatment Period 2 (12 Weeks)||30
2401806|NCT01328444|5892491|P3|COMPLETED|Treatment Period 2 (12 Weeks)||19
2401807|NCT01328444|5892492|P2|COMPLETED|Treatment Period 2 (12 Weeks)||22
2401808|NCT01328444|5892493|P1|COMPLETED|Treatment Period 2 (12 Weeks)||65
2401809|NCT01328444|5892488|P6|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|66
2401810|NCT01328444|5892489|P5|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|71
2401811|NCT01328444|5892490|P4|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|35
2401812|NCT01328444|5892491|P3|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|22
2401813|NCT01328444|5892492|P2|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|23
2401814|NCT01328444|5892493|P1|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|76
2401815|NCT01328444|5892488|P6|NOT COMPLETED|Washout Period (14 Days)||4
2401816|NCT01328444|5892489|P5|NOT COMPLETED|Washout Period (14 Days)||1
2401817|NCT01328444|5892490|P4|NOT COMPLETED|Washout Period (14 Days)||1
2401818|NCT01328444|5892491|P3|NOT COMPLETED|Washout Period (14 Days)||0
2401819|NCT01328444|5892492|P2|NOT COMPLETED|Washout Period (14 Days)||1
2401820|NCT01328444|5892493|P1|NOT COMPLETED|Washout Period (14 Days)||1
2401821|NCT01328444|5892488|P6|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|68
2401822|NCT01328444|5892489|P5|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|66
2401823|NCT01328444|5892490|P4|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|32
2401824|NCT01328444|5892491|P3|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|25
2401825|NCT01328444|5892492|P2|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
2401826|NCT01328444|5892493|P1|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|82
2401827|NCT01328444|5892488|P6|STARTED|Washout Period (14 Days)||72
2401828|NCT01328444|5892489|P5|STARTED|Washout Period (14 Days)||67
2401829|NCT01328444|5892490|P4|STARTED|Washout Period (14 Days)||33
2401830|NCT01328444|5892491|P3|STARTED|Washout Period (14 Days)||25
2401831|NCT01328444|5892492|P2|STARTED|Washout Period (14 Days)||21
2401832|NCT01328444|5892493|P1|STARTED|Washout Period (14 Days)||83
2401833|NCT01328444|5892488|P6|NOT COMPLETED|Treatment Period 1 (12 Weeks)||6
2401834|NCT01328444|5892489|P5|NOT COMPLETED|Treatment Period 1 (12 Weeks)||14
2401835|NCT01328444|5892490|P4|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8
2401836|NCT01328444|5892491|P3|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
2401837|NCT01328444|5892492|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
2401838|NCT01328444|5892493|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11
2401839|NCT01328444|5892488|P6|COMPLETED|Treatment Period 1 (12 Weeks)||72
2401840|NCT01328444|5892489|P5|COMPLETED|Treatment Period 1 (12 Weeks)||67
2401841|NCT01328444|5892490|P4|COMPLETED|Treatment Period 1 (12 Weeks)||33
2401842|NCT01328444|5892491|P3|COMPLETED|Treatment Period 1 (12 Weeks)||25
2401843|NCT01328444|5892492|P2|COMPLETED|Treatment Period 1 (12 Weeks)||21
2401844|NCT01328444|5892493|P1|COMPLETED|Treatment Period 1 (12 Weeks)||83
2401845|NCT01328444|5892488|P6|STARTED|Treatment Period 1 (12 Weeks)||78
2401846|NCT01328444|5892489|P5|STARTED|Treatment Period 1 (12 Weeks)||81
2401847|NCT01328444|5892490|P4|STARTED|Treatment Period 1 (12 Weeks)||41
2401848|NCT01328444|5892491|P3|STARTED|Treatment Period 1 (12 Weeks)||28
2401849|NCT01328444|5892492|P2|STARTED|Treatment Period 1 (12 Weeks)||26
2401850|NCT01328444|5892493|P1|STARTED|Treatment Period 1 (12 Weeks)||94
2401851|NCT01328431|5892539|P2|NOT COMPLETED|12 Month (12M)||97
2401852|NCT01328431|5892540|P1|NOT COMPLETED|12 Month (12M)||84
2401853|NCT01328431|5892539|P2|COMPLETED|12 Month (12M)||289
2401854|NCT01328431|5892540|P1|COMPLETED|12 Month (12M)||304
2401855|NCT01328431|5892539|P2|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|386
2401856|NCT01328431|5892540|P1|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|388
2401857|NCT01328431|5892539|P2|NOT COMPLETED|3 Month (3M)||72
2401858|NCT01328431|5892540|P1|NOT COMPLETED|3 Month (3M)||77
2401859|NCT01328431|5892539|P2|COMPLETED|3 Month (3M)||316
2401860|NCT01328431|5892540|P1|COMPLETED|3 Month (3M)||313
2401861|NCT01328431|5892539|P2|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|388
2401862|NCT01328431|5892540|P1|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|390
2401863|NCT01328431|5892539|P2|NOT COMPLETED|1 Month (1M)||58
2401864|NCT01328431|5892540|P1|NOT COMPLETED|1 Month (1M)||55
2401865|NCT01328431|5892539|P2|COMPLETED|1 Month (1M)||330
2401866|NCT01328431|5892540|P1|COMPLETED|1 Month (1M)||335
2401867|NCT01328431|5892539|P2|STARTED|1 Month (1M)||388
2401868|NCT01328431|5892540|P1|STARTED|1 Month (1M)||390
2401869|NCT01328431|5892539|P2|NOT COMPLETED|Baseline||2
2401870|NCT01328431|5892540|P1|NOT COMPLETED|Baseline||0
2401871|NCT01328431|5892539|P2|COMPLETED|Baseline|Two subjects enrolled in study twice. Protocol violation.|388
2401872|NCT01328431|5892540|P1|COMPLETED|Baseline||390
2401873|NCT01328431|5892539|P2|STARTED|Baseline||390
2401874|NCT01328431|5892540|P1|STARTED|Baseline||390
2401875|NCT01328405|5892550|P2|NOT COMPLETED|Overall Study||0
2401876|NCT01328405|5892551|P1|NOT COMPLETED|Overall Study||0
2401877|NCT01328405|5892550|P2|COMPLETED|Overall Study||48
2401878|NCT01328405|5892551|P1|COMPLETED|Overall Study||52
2401879|NCT01328405|5892550|P2|STARTED|Overall Study||48
2401880|NCT01328405|5892551|P1|STARTED|Overall Study||52
2401881|NCT01328379|5892568|P3|NOT COMPLETED|Overall Study||0
2401882|NCT01328379|5892569|P2|NOT COMPLETED|Overall Study||0
2401883|NCT01328379|5892570|P1|NOT COMPLETED|Overall Study||1
2401884|NCT01328379|5892568|P3|COMPLETED|Overall Study||143
2401885|NCT01328379|5892569|P2|COMPLETED|Overall Study||144
2401886|NCT01328379|5892570|P1|COMPLETED|Overall Study||142
2401887|NCT01328379|5892568|P3|STARTED|Overall Study||143
2401888|NCT01328379|5892569|P2|STARTED|Overall Study||144
2401889|NCT01328379|5892570|P1|STARTED|Overall Study||143
2401890|NCT01328366|5892596|P1|NOT COMPLETED|Overall Study||10
2401891|NCT01328366|5892596|P1|COMPLETED|Overall Study||143
2401892|NCT01328366|5892596|P1|STARTED|Overall Study||153
2401893|NCT01328249|5892616|P2|NOT COMPLETED|Overall Study||3
2401894|NCT01328249|5892617|P1|NOT COMPLETED|Overall Study||7
2401895|NCT01328249|5892616|P2|COMPLETED|Overall Study||23
2401896|NCT01328249|5892617|P1|COMPLETED|Overall Study||48
2401897|NCT01328249|5892616|P2|STARTED|Overall Study||26
2401898|NCT01328249|5892617|P1|STARTED|Overall Study||55
2401899|NCT01328184|5892625|P1|NOT COMPLETED|Overall Study||0
2401900|NCT01328184|5892625|P1|COMPLETED|Overall Study||18
2401901|NCT01328184|5892625|P1|STARTED|Overall Study||18
2401902|NCT01328158|5892665|P1|NOT COMPLETED|Overall Study||0
2401903|NCT01328158|5892665|P1|COMPLETED|Overall Study||220
2401904|NCT01328158|5892665|P1|STARTED|Overall Study||220
2401905|NCT01328080|5892703|P1|NOT COMPLETED|Overall Study||5
2401906|NCT01328080|5892703|P1|COMPLETED|Overall Study||6
2401907|NCT01328080|5892703|P1|STARTED|Overall Study|11 subjects consented; 1 withdrew consent before first UVB treatment|11
2401908|NCT01328054|5892707|P2|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||5
2401909|NCT01328054|5892708|P1|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
2401910|NCT01328054|5892707|P2|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||53
2401911|NCT01328054|5892708|P1|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
2401912|NCT01328054|5892707|P2|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)|One par. was double dosed with lapatinib due to a dosing error - reason for difference in # Started.|58
2401913|NCT01328054|5892708|P1|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)||0
2401914|NCT01328054|5892707|P2|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
2401915|NCT01328054|5892708|P1|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
2401916|NCT01328054|5892707|P2|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
2401917|NCT01328054|5892708|P1|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||57
2401918|NCT01328054|5892707|P2|STARTED|Placebo on Day 1 and Day 2 (2 Days)||0
2401919|NCT01328054|5892708|P1|STARTED|Placebo on Day 1 and Day 2 (2 Days)||57
2401920|NCT01328041|5892733|P1|NOT COMPLETED|Overall Study||57
2401921|NCT01328041|5892733|P1|COMPLETED|Overall Study||126
2401922|NCT01328041|5892733|P1|STARTED|Overall Study||183
2401923|NCT01328002|5892755|P2|NOT COMPLETED|Double-Blind Period||0
2401924|NCT01328002|5892756|P1|NOT COMPLETED|Double-Blind Period||2
2401925|NCT01328002|5892755|P2|COMPLETED|Double-Blind Period||6
2401926|NCT01328002|5892756|P1|COMPLETED|Double-Blind Period||12
2401927|NCT01328002|5892755|P2|STARTED|Double-Blind Period||6
2401928|NCT01328002|5892756|P1|STARTED|Double-Blind Period||14
2401929|NCT01328002|5892755|P2|NOT COMPLETED|Open-Label Period||0
2401930|NCT01328002|5892756|P1|NOT COMPLETED|Open-Label Period||96
2401931|NCT01328002|5892755|P2|COMPLETED|Open-Label Period||0
2401932|NCT01328002|5892756|P1|COMPLETED|Open-Label Period||20
2401933|NCT01328002|5892755|P2|STARTED|Open-Label Period||0
2401934|NCT01328002|5892756|P1|STARTED|Open-Label Period||116
2401935|NCT01327989|5892765|P1|NOT COMPLETED|Overall Study||14
2401936|NCT01327989|5892765|P1|COMPLETED|Overall Study||188
2401937|NCT01327989|5892765|P1|STARTED|Overall Study||202
2401938|NCT01327976|5892779|P2|NOT COMPLETED|Overall Study||7
2401939|NCT01327976|5892780|P1|NOT COMPLETED|Overall Study||8
2401940|NCT01327976|5892779|P2|COMPLETED|Overall Study||70
2401941|NCT01327976|5892780|P1|COMPLETED|Overall Study||154
2401942|NCT01327976|5892779|P2|STARTED|Overall Study||77
2401943|NCT01327976|5892780|P1|STARTED|Overall Study||162
2401944|NCT01327885|5892792|P2|NOT COMPLETED|Overall Study||224
2401945|NCT01327885|5892793|P1|NOT COMPLETED|Overall Study||228
2401946|NCT01327885|5892792|P2|COMPLETED|Overall Study||0
2401947|NCT01327885|5892793|P1|COMPLETED|Overall Study||0
2401948|NCT01327885|5892792|P2|STARTED|Overall Study||224
2401949|NCT01327885|5892793|P1|STARTED|Overall Study||228
2401950|NCT01327846|5892809|P4|NOT COMPLETED|Extension Phase||1706
2401951|NCT01327846|5892810|P3|NOT COMPLETED|Extension Phase||1092
2401952|NCT01327846|5892811|P2|NOT COMPLETED|Extension Phase||1144
2401953|NCT01327846|5892812|P1|NOT COMPLETED|Extension Phase||1099
2401954|NCT01327846|5892809|P4|COMPLETED|Extension Phase||238
2401955|NCT01327846|5892810|P3|COMPLETED|Extension Phase||187
2401956|NCT01327846|5892811|P2|COMPLETED|Extension Phase||143
2401957|NCT01327846|5892812|P1|COMPLETED|Extension Phase||168
2401958|NCT01327846|5892809|P4|Details Missing|Extension Phase||0
2401959|NCT01327846|5892810|P3|Details Missing|Extension Phase||1
2401960|NCT01327846|5892811|P2|Details Missing|Extension Phase||1
2401961|NCT01327846|5892812|P1|Details Missing|Extension Phase||0
2401962|NCT01327846|5892809|P4|Completed Treatment Period|Extension Phase||60
2401963|NCT01327846|5892810|P3|Completed Treatment Period|Extension Phase||49
2401964|NCT01327846|5892811|P2|Completed Treatment Period|Extension Phase||45
2401965|NCT01327846|5892812|P1|Completed Treatment Period|Extension Phase||41
2401966|NCT01327846|5892809|P4|Stopped/Discontinued Study at Washout|Extension Phase||178
2401967|NCT01327846|5892810|P3|Stopped/Discontinued Study at Washout|Extension Phase||137
2401968|NCT01327846|5892811|P2|Stopped/Discontinued Study at Washout|Extension Phase||97
2401969|NCT01327846|5892812|P1|Stopped/Discontinued Study at Washout|Extension Phase||127
2401970|NCT01327846|5892809|P4|STARTED|Extension Phase||1944
2401971|NCT01327846|5892810|P3|STARTED|Extension Phase||1279
2401972|NCT01327846|5892811|P2|STARTED|Extension Phase||1287
2401973|NCT01327846|5892812|P1|STARTED|Extension Phase||1267
2401974|NCT01327846|5892809|P4|NOT COMPLETED|Core Phase||33
2401975|NCT01327846|5892810|P3|NOT COMPLETED|Core Phase||26
2401976|NCT01327846|5892811|P2|NOT COMPLETED|Core Phase||32
2401977|NCT01327846|5892812|P1|NOT COMPLETED|Core Phase||28
2401978|NCT01327846|5892809|P4|COMPLETED|Core Phase||3311
2401979|NCT01327846|5892810|P3|COMPLETED|Core Phase||2144
2401980|NCT01327846|5892811|P2|COMPLETED|Core Phase||2252
2401981|NCT01327846|5892812|P1|COMPLETED|Core Phase||2235
2401982|NCT01327846|5892809|P4|STARTED|Core Phase||3344
2401983|NCT01327846|5892810|P3|STARTED|Core Phase||2170
2401984|NCT01327846|5892811|P2|STARTED|Core Phase||2284
2401985|NCT01327846|5892812|P1|STARTED|Core Phase||2263
2401986|NCT01327703|5892887|P2|NOT COMPLETED|Second Treatment Period||2
2401987|NCT01327703|5892888|P1|NOT COMPLETED|Second Treatment Period||1
2401988|NCT01327703|5892887|P2|COMPLETED|Second Treatment Period||42
2401989|NCT01327703|5892888|P1|COMPLETED|Second Treatment Period||39
2401990|NCT01327703|5892887|P2|STARTED|Second Treatment Period|One participant discontinued between first and second treatment periods due to adverse event.|44
2401991|NCT01327703|5892888|P1|STARTED|Second Treatment Period|Two participants discontinued between first and second treatment periods due to adverse event.|40
2401992|NCT01327703|5892887|P2|NOT COMPLETED|First Treatment Period||0
2401993|NCT01327703|5892888|P1|NOT COMPLETED|First Treatment Period||0
2401994|NCT01327703|5892887|P2|COMPLETED|First Treatment Period||45
2401995|NCT01327703|5892888|P1|COMPLETED|First Treatment Period||42
2401996|NCT01327703|5892887|P2|STARTED|First Treatment Period||45
2401997|NCT01327703|5892888|P1|STARTED|First Treatment Period||42
2401998|NCT01327677|5892922|P2|NOT COMPLETED|Overall Study||13
2401999|NCT01327677|5892923|P1|NOT COMPLETED|Overall Study||20
2402000|NCT01327677|5892922|P2|COMPLETED|Overall Study||56
2402001|NCT01327677|5892923|P1|COMPLETED|Overall Study||48
2402002|NCT01327677|5892922|P2|STARTED|Overall Study||69
2402003|NCT01327677|5892923|P1|STARTED|Overall Study||68
2402004|NCT01327651|5892944|P9|NOT COMPLETED|Post Study Follow-up||2
2402005|NCT01327651|5892945|P8|NOT COMPLETED|Post Study Follow-up||1
2402006|NCT01327651|5892946|P7|NOT COMPLETED|Post Study Follow-up||4
2402007|NCT01327651|5892947|P6|NOT COMPLETED|Post Study Follow-up||0
2402008|NCT01327651|5892948|P5|NOT COMPLETED|Post Study Follow-up||0
2402009|NCT01327651|5892949|P4|NOT COMPLETED|Post Study Follow-up||0
2402010|NCT01327651|5892950|P3|NOT COMPLETED|Post Study Follow-up||1
2402011|NCT01327651|5892951|P2|NOT COMPLETED|Post Study Follow-up||1
2402012|NCT01327651|5892952|P1|NOT COMPLETED|Post Study Follow-up||0
2402013|NCT01327651|5892944|P9|COMPLETED|Post Study Follow-up||47
2402014|NCT01327651|5892945|P8|COMPLETED|Post Study Follow-up||49
2402015|NCT01327651|5892946|P7|COMPLETED|Post Study Follow-up||45
2402016|NCT01327651|5892947|P6|COMPLETED|Post Study Follow-up||59
2402017|NCT01327651|5892948|P5|COMPLETED|Post Study Follow-up||56
2402018|NCT01327651|5892949|P4|COMPLETED|Post Study Follow-up||57
2402019|NCT01327651|5892950|P3|COMPLETED|Post Study Follow-up||55
2402020|NCT01327651|5892951|P2|COMPLETED|Post Study Follow-up||55
2402021|NCT01327651|5892952|P1|COMPLETED|Post Study Follow-up||56
2402022|NCT01327651|5892944|P9|STARTED|Post Study Follow-up||49
2402023|NCT01327651|5892945|P8|STARTED|Post Study Follow-up||50
2402024|NCT01327651|5892946|P7|STARTED|Post Study Follow-up||49
2402025|NCT01327651|5892947|P6|STARTED|Post Study Follow-up||59
2402026|NCT01327651|5892948|P5|STARTED|Post Study Follow-up||56
2402027|NCT01327651|5892949|P4|STARTED|Post Study Follow-up||57
2402028|NCT01327651|5892950|P3|STARTED|Post Study Follow-up||56
2402029|NCT01327651|5892951|P2|STARTED|Post Study Follow-up||56
2402030|NCT01327651|5892952|P1|STARTED|Post Study Follow-up||56
2402031|NCT01327651|5892944|P9|NOT COMPLETED|Self-administered Dosing Period||11
2402032|NCT01327651|5892945|P8|NOT COMPLETED|Self-administered Dosing Period||10
2402033|NCT01327651|5892946|P7|NOT COMPLETED|Self-administered Dosing Period||10
2402034|NCT01327651|5892947|P6|NOT COMPLETED|Self-administered Dosing Period||0
2402035|NCT01327651|5892948|P5|NOT COMPLETED|Self-administered Dosing Period||3
2402036|NCT01327651|5892949|P4|NOT COMPLETED|Self-administered Dosing Period||3
2402037|NCT01327651|5892950|P3|NOT COMPLETED|Self-administered Dosing Period||4
2402038|NCT01327651|5892951|P2|NOT COMPLETED|Self-administered Dosing Period||3
2402039|NCT01327651|5892952|P1|NOT COMPLETED|Self-administered Dosing Period||4
2402040|NCT01327651|5892944|P9|COMPLETED|Self-administered Dosing Period||49
2402041|NCT01327651|5892945|P8|COMPLETED|Self-administered Dosing Period||50
2402042|NCT01327651|5892946|P7|COMPLETED|Self-administered Dosing Period||49
2402043|NCT01327651|5892947|P6|COMPLETED|Self-administered Dosing Period||59
2402044|NCT01327651|5892948|P5|COMPLETED|Self-administered Dosing Period||56
2402045|NCT01327651|5892949|P4|COMPLETED|Self-administered Dosing Period||57
2402046|NCT01327651|5892950|P3|COMPLETED|Self-administered Dosing Period||56
2402047|NCT01327651|5892951|P2|COMPLETED|Self-administered Dosing Period||56
2402048|NCT01327651|5892952|P1|COMPLETED|Self-administered Dosing Period||56
2402049|NCT01327651|5892944|P9|Week 26|Self-administered Dosing Period||49
2402050|NCT01327651|5892945|P8|Week 26|Self-administered Dosing Period||51
2402051|NCT01327651|5892946|P7|Week 26|Self-administered Dosing Period||50
2402052|NCT01327651|5892947|P6|Week 26|Self-administered Dosing Period||58
2402053|NCT01327651|5892948|P5|Week 26|Self-administered Dosing Period||56
2402054|NCT01327651|5892949|P4|Week 26|Self-administered Dosing Period||57
2402055|NCT01327651|5892950|P3|Week 26|Self-administered Dosing Period||53
2402056|NCT01327651|5892951|P2|Week 26|Self-administered Dosing Period||56
2402057|NCT01327651|5892952|P1|Week 26|Self-administered Dosing Period||58
2402058|NCT01327651|5892944|P9|Week 22|Self-administered Dosing Period||51
2402059|NCT01327651|5892945|P8|Week 22|Self-administered Dosing Period||50
2402060|NCT01327651|5892946|P7|Week 22|Self-administered Dosing Period||50
2402061|NCT01327651|5892947|P6|Week 22|Self-administered Dosing Period||59
2402062|NCT01327651|5892948|P5|Week 22|Self-administered Dosing Period||56
2402063|NCT01327651|5892949|P4|Week 22|Self-administered Dosing Period||58
2402064|NCT01327651|5892950|P3|Week 22|Self-administered Dosing Period||55
2402065|NCT01327651|5892951|P2|Week 22|Self-administered Dosing Period||56
2402066|NCT01327651|5892952|P1|Week 22|Self-administered Dosing Period||59
2402067|NCT01327651|5892944|P9|Week 18|Self-administered Dosing Period||53
2402068|NCT01327651|5892945|P8|Week 18|Self-administered Dosing Period||49
2402069|NCT01327651|5892946|P7|Week 18|Self-administered Dosing Period||53
2402070|NCT01327651|5892947|P6|Week 18|Self-administered Dosing Period||59
2402071|NCT01327651|5892948|P5|Week 18|Self-administered Dosing Period||57
2402072|NCT01327651|5892949|P4|Week 18|Self-administered Dosing Period||60
2402073|NCT01327651|5892950|P3|Week 18|Self-administered Dosing Period||56
2402074|NCT01327651|5892951|P2|Week 18|Self-administered Dosing Period||56
2402075|NCT01327651|5892952|P1|Week 18|Self-administered Dosing Period||57
2402076|NCT01327651|5892944|P9|Week 14|Self-administered Dosing Period||54
2402077|NCT01327651|5892945|P8|Week 14|Self-administered Dosing Period||51
2402078|NCT01327651|5892946|P7|Week 14|Self-administered Dosing Period||54
2402079|NCT01327651|5892947|P6|Week 14|Self-administered Dosing Period||59
2402080|NCT01327651|5892948|P5|Week 14|Self-administered Dosing Period||58
2402081|NCT01327651|5892949|P4|Week 14|Self-administered Dosing Period||60
2402082|NCT01327651|5892950|P3|Week 14|Self-administered Dosing Period||57
2402083|NCT01327651|5892951|P2|Week 14|Self-administered Dosing Period||55
2402084|NCT01327651|5892952|P1|Week 14|Self-administered Dosing Period||59
2402085|NCT01327651|5892944|P9|Week 10|Self-administered Dosing Period||56
2402086|NCT01327651|5892945|P8|Week 10|Self-administered Dosing Period||57
2402087|NCT01327651|5892946|P7|Week 10|Self-administered Dosing Period||57
2402088|NCT01327651|5892947|P6|Week 10|Self-administered Dosing Period||59
2402089|NCT01327651|5892948|P5|Week 10|Self-administered Dosing Period||59
2402090|NCT01327651|5892949|P4|Week 10|Self-administered Dosing Period||60
2402091|NCT01327651|5892950|P3|Week 10|Self-administered Dosing Period||60
2402092|NCT01327651|5892951|P2|Week 10|Self-administered Dosing Period||58
2402093|NCT01327651|5892952|P1|Week 10|Self-administered Dosing Period||59
2402094|NCT01327651|5892944|P9|STARTED|Self-administered Dosing Period||60
2402095|NCT01327651|5892945|P8|STARTED|Self-administered Dosing Period||60
2402096|NCT01327651|5892946|P7|STARTED|Self-administered Dosing Period||59
2402097|NCT01327651|5892947|P6|STARTED|Self-administered Dosing Period||59
2402098|NCT01327651|5892948|P5|STARTED|Self-administered Dosing Period||59
2402099|NCT01327651|5892949|P4|STARTED|Self-administered Dosing Period||60
2402100|NCT01327651|5892950|P3|STARTED|Self-administered Dosing Period||60
2402101|NCT01327651|5892951|P2|STARTED|Self-administered Dosing Period||59
2402102|NCT01327651|5892952|P1|STARTED|Self-administered Dosing Period||60
2402103|NCT01327599|5893071|P1|NOT COMPLETED|Overall Study||3
2402104|NCT01327599|5893071|P1|COMPLETED|Overall Study||57
2402105|NCT01327599|5893071|P1|STARTED|Overall Study||60
2402106|NCT01327573|5893081|P2|NOT COMPLETED|Overall Study||1
2402107|NCT01327573|5893082|P1|NOT COMPLETED|Overall Study||3
2402108|NCT01327573|5893081|P2|COMPLETED|Overall Study||4
2402109|NCT01327573|5893082|P1|COMPLETED|Overall Study||8
2402110|NCT01327573|5893081|P2|Received Treatment/Control as Allocated|Overall Study||5
2402111|NCT01327573|5893082|P1|Received Treatment/Control as Allocated|Overall Study||10
2402112|NCT01327573|5893081|P2|STARTED|Overall Study||5
2402113|NCT01327573|5893082|P1|STARTED|Overall Study||11
2402114|NCT01327547|5893093|P2|NOT COMPLETED|Overall Study||22
2402115|NCT01327547|5893094|P1|NOT COMPLETED|Overall Study||20
2402116|NCT01327547|5893093|P2|COMPLETED|Overall Study||45
2402117|NCT01327547|5893094|P1|COMPLETED|Overall Study||50
2402118|NCT01327547|5893093|P2|Randomized and Not Treated|Overall Study|Randomized but was withdrawn prior to receiving treatment due to poor venous access.|1
2402119|NCT01327547|5893094|P1|Randomized and Not Treated|Overall Study||0
2402120|NCT01327547|5893093|P2|STARTED|Overall Study||67
2402121|NCT01327547|5893094|P1|STARTED|Overall Study||70
2402122|NCT01327508|5893147|P2|NOT COMPLETED|Overall Study||0
2402123|NCT01327508|5893148|P1|NOT COMPLETED|Overall Study||0
2402124|NCT01327508|5893147|P2|COMPLETED|Overall Study||30
2402125|NCT01327508|5893148|P1|COMPLETED|Overall Study||30
2402126|NCT01327508|5893147|P2|STARTED|Overall Study||30
2402127|NCT01327508|5893148|P1|STARTED|Overall Study||30
2402128|NCT01327495|5893162|P6|NOT COMPLETED|Overall Study||2
2402129|NCT01327495|5893163|P5|NOT COMPLETED|Overall Study||3
2402130|NCT01327495|5893164|P4|NOT COMPLETED|Overall Study||0
2402131|NCT01327495|5893165|P3|NOT COMPLETED|Overall Study||2
2402132|NCT01327495|5893166|P2|NOT COMPLETED|Overall Study||2
2402133|NCT01327495|5893167|P1|NOT COMPLETED|Overall Study||2
2402134|NCT01327495|5893162|P6|COMPLETED|Overall Study|1 subject withdrawn d/t elevated LFTs, 1 dropped out d/t ski accident|9
2402135|NCT01327495|5893163|P5|COMPLETED|Overall Study|1 dropped out pre drug finish, 2 non-compliant subjects dropped|8
2402136|NCT01327495|5893164|P4|COMPLETED|Overall Study||9
2402137|NCT01327495|5893165|P3|COMPLETED|Overall Study|1 withdrawn due to injection AE. 1 drop-out (declined prostate biopsy and final visit).|8
2402138|NCT01327495|5893166|P2|COMPLETED|Overall Study|1 subject declined prostate biopsy & no-showed to final visit, 1 subject dropped d/t elevated LFTs.|9
2402139|NCT01327495|5893167|P1|COMPLETED|Overall Study|1 dropped due to decreased libido & energy, 1 dropped due to too much pain with acyline injections|8
2402140|NCT01327495|5893162|P6|STARTED|Overall Study||11
2402141|NCT01327495|5893163|P5|STARTED|Overall Study||11
2402142|NCT01327495|5893164|P4|STARTED|Overall Study||9
2402143|NCT01327495|5893165|P3|STARTED|Overall Study||10
2402144|NCT01327495|5893166|P2|STARTED|Overall Study||11
2402145|NCT01327495|5893167|P1|STARTED|Overall Study||10
2402146|NCT01327482|5893259|P1|NOT COMPLETED|Overall Study||1
2402147|NCT01327482|5893259|P1|COMPLETED|Overall Study|The 10th participant completed 2/3 visits|9
2402148|NCT01327482|5893259|P1|STARTED|Overall Study||10
2402149|NCT01327339|5893264|P1|NOT COMPLETED|Overall Study||8
2402150|NCT01327339|5893264|P1|COMPLETED|Overall Study||747
2402151|NCT01327339|5893264|P1|STARTED|Overall Study||755
2402152|NCT01327313|5893274|P4|NOT COMPLETED|Overall Study||0
2402153|NCT01327313|5893275|P3|NOT COMPLETED|Overall Study||0
2402154|NCT01327313|5893276|P2|NOT COMPLETED|Overall Study||0
2402155|NCT01327313|5893277|P1|NOT COMPLETED|Overall Study||0
2402156|NCT01327313|5893274|P4|COMPLETED|Overall Study||7
2402157|NCT01327313|5893275|P3|COMPLETED|Overall Study||6
2402158|NCT01327313|5893276|P2|COMPLETED|Overall Study||6
2402159|NCT01327313|5893277|P1|COMPLETED|Overall Study||8
2402160|NCT01327313|5893274|P4|STARTED|Overall Study||7
2402161|NCT01327313|5893275|P3|STARTED|Overall Study||6
2402162|NCT01327313|5893276|P2|STARTED|Overall Study||6
2402163|NCT01327313|5893277|P1|STARTED|Overall Study||8
2402164|NCT01327300|5893399|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
2402165|NCT01327300|5893400|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
2402166|NCT01327300|5893399|P2|COMPLETED|Second Intervention (12 Weeks)||2
2402167|NCT01327300|5893400|P1|COMPLETED|Second Intervention (12 Weeks)||4
2402168|NCT01327300|5893399|P2|STARTED|Second Intervention (12 Weeks)||2
2402169|NCT01327300|5893400|P1|STARTED|Second Intervention (12 Weeks)||4
2402170|NCT01327300|5893399|P2|NOT COMPLETED|Washout (3 Weeks)||0
2402171|NCT01327300|5893400|P1|NOT COMPLETED|Washout (3 Weeks)||1
2402172|NCT01327300|5893399|P2|COMPLETED|Washout (3 Weeks)||2
2402173|NCT01327300|5893400|P1|COMPLETED|Washout (3 Weeks)||4
2402174|NCT01327300|5893399|P2|STARTED|Washout (3 Weeks)||2
2402175|NCT01327300|5893400|P1|STARTED|Washout (3 Weeks)||5
2402176|NCT01327300|5893399|P2|NOT COMPLETED|First Intervention (12 Weeks)||0
2402177|NCT01327300|5893400|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
2402178|NCT01327300|5893399|P2|COMPLETED|First Intervention (12 Weeks)||2
2402179|NCT01327300|5893400|P1|COMPLETED|First Intervention (12 Weeks)||5
2402180|NCT01327300|5893399|P2|STARTED|First Intervention (12 Weeks)||2
2402181|NCT01327300|5893400|P1|STARTED|First Intervention (12 Weeks)||5
2402182|NCT01327274|5893416|P1|NOT COMPLETED|Overall Study||0
2402183|NCT01327274|5893416|P1|COMPLETED|Overall Study||15
2402184|NCT01327274|5893416|P1|STARTED|Overall Study||15
2402185|NCT01327157|5893425|P2|NOT COMPLETED|91-180||0
2402186|NCT01327157|5893426|P1|NOT COMPLETED|91-180||0
2402187|NCT01327157|5893425|P2|COMPLETED|91-180||0
2402188|NCT01327157|5893426|P1|COMPLETED|91-180||7
2402189|NCT01327157|5893425|P2|STARTED|91-180||0
2402190|NCT01327157|5893426|P1|STARTED|91-180||7
2402191|NCT01327157|5893425|P2|NOT COMPLETED|01-90||0
2402192|NCT01327157|5893426|P1|NOT COMPLETED|01-90||0
2402193|NCT01327157|5893425|P2|COMPLETED|01-90||7
2402194|NCT01327157|5893426|P1|COMPLETED|01-90||7
2402195|NCT01327157|5893425|P2|STARTED|01-90||7
2402196|NCT01327157|5893426|P1|STARTED|01-90||7
2402197|NCT01327053|5893440|P2|NOT COMPLETED|Overall Study||151
2402198|NCT01327053|5893441|P1|NOT COMPLETED|Overall Study||79
2402199|NCT01327053|5893440|P2|COMPLETED|Overall Study||0
2402200|NCT01327053|5893441|P1|COMPLETED|Overall Study||0
2402201|NCT01327053|5893440|P2|Post-treatment Follow-up|Overall Study||40
2402202|NCT01327053|5893441|P1|Post-treatment Follow-up|Overall Study||19
2402203|NCT01327053|5893440|P2|Survival Follow-up|Overall Study||49
2402204|NCT01327053|5893441|P1|Survival Follow-up|Overall Study||33
2402205|NCT01327053|5893440|P2|Patients Cont. to Next Phase of Trial|Overall Study||89
2402206|NCT01327053|5893441|P1|Patients Cont. to Next Phase of Trial|Overall Study||52
2402207|NCT01327053|5893440|P2|Untreated|Overall Study|one patient randomized to LDE225 (sonidegib) 800 mg did not receive study treatment|1
2402208|NCT01327053|5893441|P1|Untreated|Overall Study||0
2402209|NCT01327053|5893440|P2|STARTED|Overall Study||151
2402210|NCT01327053|5893441|P1|STARTED|Overall Study||79
2402211|NCT01326962|5893515|P1|NOT COMPLETED|Overall Study||7
2402212|NCT01326962|5893515|P1|COMPLETED|Overall Study||21
2402213|NCT01326962|5893515|P1|STARTED|Overall Study||28
2402214|NCT01326910|5893533|P2|NOT COMPLETED|Overall Study||3
2402215|NCT01326910|5893534|P1|NOT COMPLETED|Overall Study||4
2402216|NCT01326910|5893533|P2|COMPLETED|Overall Study||42
2402217|NCT01326910|5893534|P1|COMPLETED|Overall Study||41
2402218|NCT01326910|5893533|P2|STARTED|Overall Study||45
2402219|NCT01326910|5893534|P1|STARTED|Overall Study||45
2402220|NCT01326845|5893548|P2|NOT COMPLETED|Overall Study||5
2402221|NCT01326845|5893549|P1|NOT COMPLETED|Overall Study||7
2402222|NCT01326845|5893548|P2|COMPLETED|Overall Study|Study terminated early|0
2402223|NCT01326845|5893549|P1|COMPLETED|Overall Study|Study terminated early|0
2402224|NCT01326845|5893548|P2|STARTED|Overall Study||5
2402225|NCT01326845|5893549|P1|STARTED|Overall Study||7
2402226|NCT01326780|5893575|P4|NOT COMPLETED|Overall Study||13
2402227|NCT01326780|5893576|P3|NOT COMPLETED|Overall Study||6
2402228|NCT01326780|5893577|P2|NOT COMPLETED|Overall Study||9
2402229|NCT01326780|5893578|P1|NOT COMPLETED|Overall Study||13
2402230|NCT01326780|5893575|P4|COMPLETED|Overall Study||94
2402231|NCT01326780|5893576|P3|COMPLETED|Overall Study||103
2402232|NCT01326780|5893577|P2|COMPLETED|Overall Study||100
2402233|NCT01326780|5893578|P1|COMPLETED|Overall Study||93
2402234|NCT01326780|5893575|P4|STARTED|Overall Study||107
2402235|NCT01326780|5893576|P3|STARTED|Overall Study||109
2402236|NCT01326780|5893577|P2|STARTED|Overall Study||109
2402237|NCT01326780|5893578|P1|STARTED|Overall Study||106
2402238|NCT01326728|5893610|P2|NOT COMPLETED|Overall Study||9
2402239|NCT01326728|5893611|P1|NOT COMPLETED|Overall Study||47
2402240|NCT01326728|5893610|P2|COMPLETED|Overall Study||0
2402241|NCT01326728|5893611|P1|COMPLETED|Overall Study||0
2402242|NCT01326728|5893610|P2|STARTED|Overall Study||9
2402243|NCT01326728|5893611|P1|STARTED|Overall Study||47
2402244|NCT01326702|5893635|P7|NOT COMPLETED|Overall Study||7
2402245|NCT01326702|5893636|P6|NOT COMPLETED|Overall Study||8
2402246|NCT01326702|5893637|P5|NOT COMPLETED|Overall Study||4
2402247|NCT01326702|5893638|P4|NOT COMPLETED|Overall Study||3
2402248|NCT01326702|5893639|P3|NOT COMPLETED|Overall Study||5
2402249|NCT01326702|5893640|P2|NOT COMPLETED|Overall Study||2
2402250|NCT01326702|5893641|P1|NOT COMPLETED|Overall Study||2
2402251|NCT01326702|5893635|P7|COMPLETED|Overall Study||0
2402252|NCT01326702|5893636|P6|COMPLETED|Overall Study||7
2402253|NCT01326702|5893637|P5|COMPLETED|Overall Study||1
2402254|NCT01326702|5893638|P4|COMPLETED|Overall Study||1
2402255|NCT01326702|5893639|P3|COMPLETED|Overall Study||1
2402256|NCT01326702|5893640|P2|COMPLETED|Overall Study||1
2402257|NCT01326702|5893641|P1|COMPLETED|Overall Study||1
2402258|NCT01326702|5893635|P7|STARTED|Overall Study||7
2402259|NCT01326702|5893636|P6|STARTED|Overall Study||15
2402260|NCT01326702|5893637|P5|STARTED|Overall Study||5
2402261|NCT01326702|5893638|P4|STARTED|Overall Study||4
2402262|NCT01326702|5893639|P3|STARTED|Overall Study||6
2402263|NCT01326702|5893640|P2|STARTED|Overall Study||3
2402264|NCT01326702|5893641|P1|STARTED|Overall Study||3
2402265|NCT01326546|5893697|P2|NOT COMPLETED|Overall Study||13
2402266|NCT01326546|5893698|P1|NOT COMPLETED|Overall Study||17
2402267|NCT01326546|5893697|P2|COMPLETED|Overall Study||176
2402268|NCT01326546|5893698|P1|COMPLETED|Overall Study||172
2402269|NCT01326546|5893697|P2|STARTED|Overall Study||189
2402270|NCT01326546|5893698|P1|STARTED|Overall Study||189
2402271|NCT01326533|5893706|P2|NOT COMPLETED|Overall Study||0
2402272|NCT01326533|5893707|P1|NOT COMPLETED|Overall Study||4
2402273|NCT01326533|5893706|P2|COMPLETED|Overall Study||15
2402274|NCT01326533|5893707|P1|COMPLETED|Overall Study||13
2402275|NCT01326533|5893706|P2|STARTED|Overall Study||15
2402276|NCT01326533|5893707|P1|STARTED|Overall Study||17
2402277|NCT01326481|5893715|P1|NOT COMPLETED|10 mg/kg TRC105, 1000 mg/m2 Cape||0
2402278|NCT01326481|5893715|P1|COMPLETED|10 mg/kg TRC105, 1000 mg/m2 Cape||15
2402279|NCT01326481|5893715|P1|STARTED|10 mg/kg TRC105, 1000 mg/m2 Cape||15
2402280|NCT01326481|5893715|P1|NOT COMPLETED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||1
2402281|NCT01326481|5893715|P1|COMPLETED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||3
2402282|NCT01326481|5893715|P1|STARTED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||4
2402283|NCT01326026|5893724|P2|NOT COMPLETED|Overall Study||13
2402284|NCT01326026|5893725|P1|NOT COMPLETED|Overall Study||12
2402285|NCT01326026|5893724|P2|COMPLETED|Overall Study||98
2402286|NCT01326026|5893725|P1|COMPLETED|Overall Study||99
2402287|NCT01326026|5893724|P2|Exposed|Overall Study||111
2402288|NCT01326026|5893725|P1|Exposed|Overall Study|One subject withdrew before exposure to trial drug|110
2402289|NCT01326026|5893724|P2|STARTED|Overall Study||111
2402290|NCT01326026|5893725|P1|STARTED|Overall Study||111
2402291|NCT01325870|5893742|P3|NOT COMPLETED|Overall Study||8
2402292|NCT01325870|5893743|P2|NOT COMPLETED|Overall Study||13
2402293|NCT01325870|5893744|P1|NOT COMPLETED|Overall Study||11
2402294|NCT01325870|5893742|P3|COMPLETED|Overall Study||6
2402295|NCT01325870|5893743|P2|COMPLETED|Overall Study||3
2402296|NCT01325870|5893744|P1|COMPLETED|Overall Study||7
2402297|NCT01325870|5893742|P3|STARTED|Overall Study||14
2402298|NCT01325870|5893743|P2|STARTED|Overall Study||16
2402299|NCT01325870|5893744|P1|STARTED|Overall Study||18
2402300|NCT01325792|5893758|P1|NOT COMPLETED|Overall Study||17
2402301|NCT01325792|5893758|P1|COMPLETED|Overall Study||87
2402302|NCT01325792|5893758|P1|STARTED|Overall Study||104
2402303|NCT01325714|5893765|P2|NOT COMPLETED|Overall Study||31
2402304|NCT01325714|5893766|P1|NOT COMPLETED|Overall Study||34
2402305|NCT01325714|5893765|P2|COMPLETED|Overall Study||71
2402306|NCT01325714|5893766|P1|COMPLETED|Overall Study||67
2402307|NCT01325714|5893765|P2|12 Month Assessment|Overall Study||71
2402308|NCT01325714|5893766|P1|12 Month Assessment|Overall Study||67
2402309|NCT01325714|5893765|P2|6 Month Asessment|Overall Study||82
2402310|NCT01325714|5893766|P1|6 Month Asessment|Overall Study||75
2402311|NCT01325714|5893765|P2|3 Month Assessment|Overall Study||86
2402312|NCT01325714|5893766|P1|3 Month Assessment|Overall Study||82
2402313|NCT01325714|5893765|P2|STARTED|Overall Study||102
2402314|NCT01325714|5893766|P1|STARTED|Overall Study||101
2402315|NCT01325701|5893790|P2|NOT COMPLETED|Overall Study||3
2402316|NCT01325701|5893791|P1|NOT COMPLETED|Overall Study||21
2402317|NCT01325701|5893790|P2|COMPLETED|Overall Study||5
2402318|NCT01325701|5893791|P1|COMPLETED|Overall Study||49
2402319|NCT01325701|5893790|P2|STARTED|Overall Study||8
2402320|NCT01325701|5893791|P1|STARTED|Overall Study||70
2402321|NCT01325623|5893801|P1|NOT COMPLETED|Overall Study||3
2402322|NCT01325623|5893801|P1|COMPLETED|Overall Study||28
2402323|NCT01325623|5893801|P1|STARTED|Overall Study||31
2402324|NCT01325584|5893843|P1|NOT COMPLETED|Overall Study||1
2402325|NCT01325584|5893843|P1|COMPLETED|Overall Study||11
2402326|NCT01325584|5893843|P1|STARTED|Overall Study||12
2402327|NCT01325532|5893853|P2|NOT COMPLETED|Overall Study||0
2402328|NCT01325532|5893854|P1|NOT COMPLETED|Overall Study||2
2402329|NCT01325532|5893853|P2|COMPLETED|Overall Study||13
2402330|NCT01325532|5893854|P1|COMPLETED|Overall Study||15
2402331|NCT01325532|5893853|P2|STARTED|Overall Study||13
2402332|NCT01325532|5893854|P1|STARTED|Overall Study||17
2402333|NCT01325493|5893866|P2|NOT COMPLETED|Overall Study||3
2402334|NCT01325493|5893867|P1|NOT COMPLETED|Overall Study||1
2402335|NCT01325493|5893866|P2|COMPLETED|Overall Study||21
2402336|NCT01325493|5893867|P1|COMPLETED|Overall Study||29
2402337|NCT01325493|5893866|P2|STARTED|Overall Study||24
2402338|NCT01325493|5893867|P1|STARTED|Overall Study||30
2402339|NCT01325428|5893879|P1|NOT COMPLETED|Part B||3
2402340|NCT01325428|5893879|P1|COMPLETED|Part B||7
2402341|NCT01325428|5893879|P1|STARTED|Part B||10
2402342|NCT01325428|5893879|P1|NOT COMPLETED|Part A||16
2402343|NCT01325428|5893879|P1|COMPLETED|Part A||10
2402344|NCT01325428|5893879|P1|STARTED|Part A||26
2402345|NCT01325350|5893899|P5|NOT COMPLETED|Overall Study||12
2402346|NCT01325350|5893900|P4|NOT COMPLETED|Overall Study||9
2402347|NCT01325350|5893901|P3|NOT COMPLETED|Overall Study||17
2402348|NCT01325350|5893902|P2|NOT COMPLETED|Overall Study||5
2402349|NCT01325350|5893903|P1|NOT COMPLETED|Overall Study||6
2402350|NCT01325350|5893899|P5|COMPLETED|Overall Study||50
2402351|NCT01325350|5893900|P4|COMPLETED|Overall Study||52
2402352|NCT01325350|5893901|P3|COMPLETED|Overall Study||44
2402353|NCT01325350|5893902|P2|COMPLETED|Overall Study||56
2402354|NCT01325350|5893903|P1|COMPLETED|Overall Study||55
2402355|NCT01325350|5893899|P5|STARTED|Overall Study||62
2402356|NCT01325350|5893900|P4|STARTED|Overall Study||61
2402357|NCT01325350|5893901|P3|STARTED|Overall Study||61
2402358|NCT01325350|5893902|P2|STARTED|Overall Study||61
2402359|NCT01325350|5893903|P1|STARTED|Overall Study||61
2402360|NCT01325337|5893945|P5|NOT COMPLETED|Overall Study||8
2402361|NCT01325337|5893946|P4|NOT COMPLETED|Overall Study||10
2402362|NCT01325337|5893947|P3|NOT COMPLETED|Overall Study||9
2402363|NCT01325337|5893948|P2|NOT COMPLETED|Overall Study||9
2402364|NCT01325337|5893949|P1|NOT COMPLETED|Overall Study||5
2402365|NCT01325337|5893945|P5|COMPLETED|Overall Study||53
2402366|NCT01325337|5893946|P4|COMPLETED|Overall Study||52
2402367|NCT01325337|5893947|P3|COMPLETED|Overall Study||53
2402368|NCT01325337|5893948|P2|COMPLETED|Overall Study||52
2402369|NCT01325337|5893949|P1|COMPLETED|Overall Study||56
2402370|NCT01325337|5893945|P5|STARTED|Overall Study||61
2402371|NCT01325337|5893946|P4|STARTED|Overall Study||62
2402372|NCT01325337|5893947|P3|STARTED|Overall Study||62
2402373|NCT01325337|5893948|P2|STARTED|Overall Study||61
2402374|NCT01325337|5893949|P1|STARTED|Overall Study||61
2402375|NCT01325311|5893988|P2|NOT COMPLETED|Overall Study||0
2402376|NCT01325311|5893989|P1|NOT COMPLETED|Overall Study||0
2402377|NCT01325311|5893988|P2|COMPLETED|Overall Study||7
2402378|NCT01325311|5893989|P1|COMPLETED|Overall Study||8
2402379|NCT01325311|5893988|P2|STARTED|Overall Study||7
2402380|NCT01325311|5893989|P1|STARTED|Overall Study||8
2402381|NCT01325207|5894029|P6|NOT COMPLETED|Follow-up Every 3 Months Until Death||1
2402382|NCT01325207|5894030|P5|NOT COMPLETED|Follow-up Every 3 Months Until Death||1
2402383|NCT01325207|5894031|P4|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
2402384|NCT01325207|5894032|P3|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
2402385|NCT01325207|5894033|P2|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
2402386|NCT01325207|5894034|P1|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
2402387|NCT01325207|5894029|P6|COMPLETED|Follow-up Every 3 Months Until Death||18
2402388|NCT01325207|5894030|P5|COMPLETED|Follow-up Every 3 Months Until Death||6
2402389|NCT01325207|5894031|P4|COMPLETED|Follow-up Every 3 Months Until Death||1
2402390|NCT01325207|5894032|P3|COMPLETED|Follow-up Every 3 Months Until Death||1
2402391|NCT01325207|5894033|P2|COMPLETED|Follow-up Every 3 Months Until Death||3
2402392|NCT01325207|5894034|P1|COMPLETED|Follow-up Every 3 Months Until Death||3
2402393|NCT01325207|5894029|P6|STARTED|Follow-up Every 3 Months Until Death||19
2402394|NCT01325207|5894030|P5|STARTED|Follow-up Every 3 Months Until Death||7
2402395|NCT01325207|5894031|P4|STARTED|Follow-up Every 3 Months Until Death||1
2402396|NCT01325207|5894032|P3|STARTED|Follow-up Every 3 Months Until Death||1
2402397|NCT01325207|5894033|P2|STARTED|Follow-up Every 3 Months Until Death||3
2402398|NCT01325207|5894034|P1|STARTED|Follow-up Every 3 Months Until Death||3
2402399|NCT01325207|5894029|P6|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||5
2402400|NCT01325207|5894030|P5|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
2402401|NCT01325207|5894031|P4|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
2402402|NCT01325207|5894032|P3|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
2402403|NCT01325207|5894033|P2|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||2
2402404|NCT01325207|5894034|P1|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
2402405|NCT01325207|5894029|P6|COMPLETED|Started 9th Week/Cycle 3 of Treatment||9
2402406|NCT01325207|5894030|P5|COMPLETED|Started 9th Week/Cycle 3 of Treatment||3
2402407|NCT01325207|5894031|P4|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
2402408|NCT01325207|5894032|P3|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
2402409|NCT01325207|5894033|P2|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
2402410|NCT01325207|5894034|P1|COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
2402411|NCT01325207|5894029|P6|STARTED|Started 9th Week/Cycle 3 of Treatment||14
2402412|NCT01325207|5894030|P5|STARTED|Started 9th Week/Cycle 3 of Treatment||3
2402413|NCT01325207|5894031|P4|STARTED|Started 9th Week/Cycle 3 of Treatment||1
2402414|NCT01325207|5894032|P3|STARTED|Started 9th Week/Cycle 3 of Treatment||1
2402415|NCT01325207|5894033|P2|STARTED|Started 9th Week/Cycle 3 of Treatment||2
2402416|NCT01325207|5894034|P1|STARTED|Started 9th Week/Cycle 3 of Treatment||2
2402417|NCT01325207|5894029|P6|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||5
2402418|NCT01325207|5894030|P5|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
2402419|NCT01325207|5894031|P4|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||0
2402420|NCT01325207|5894032|P3|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||0
2402421|NCT01325207|5894033|P2|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
2402422|NCT01325207|5894034|P1|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
2402423|NCT01325207|5894029|P6|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||14
2402424|NCT01325207|5894030|P5|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||3
2402425|NCT01325207|5894031|P4|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
2402426|NCT01325207|5894032|P3|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
2402427|NCT01325207|5894033|P2|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
2402428|NCT01325207|5894034|P1|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
2402429|NCT01325207|5894029|P6|STARTED|Completed 8 Weeks/2 Cycles of Treatment||19
2402430|NCT01325207|5894030|P5|STARTED|Completed 8 Weeks/2 Cycles of Treatment||5
2402431|NCT01325207|5894031|P4|STARTED|Completed 8 Weeks/2 Cycles of Treatment||1
2402432|NCT01325207|5894032|P3|STARTED|Completed 8 Weeks/2 Cycles of Treatment||1
2402433|NCT01325207|5894033|P2|STARTED|Completed 8 Weeks/2 Cycles of Treatment||3
2402434|NCT01325207|5894034|P1|STARTED|Completed 8 Weeks/2 Cycles of Treatment||3
2402435|NCT01325207|5894029|P6|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
2402436|NCT01325207|5894030|P5|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||2
2402437|NCT01325207|5894031|P4|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
2402438|NCT01325207|5894032|P3|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
2402439|NCT01325207|5894033|P2|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
2402440|NCT01325207|5894034|P1|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
2402441|NCT01325207|5894029|P6|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||19
2402442|NCT01325207|5894030|P5|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||5
2402443|NCT01325207|5894031|P4|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||1
2402444|NCT01325207|5894032|P3|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||1
2402445|NCT01325207|5894033|P2|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||3
2402446|NCT01325207|5894034|P1|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||3
2402447|NCT01325207|5894029|P6|STARTED|Completed 4 Weeks/1 Cycle of Treatment||19
2402448|NCT01325207|5894030|P5|STARTED|Completed 4 Weeks/1 Cycle of Treatment||7
2402449|NCT01325207|5894031|P4|STARTED|Completed 4 Weeks/1 Cycle of Treatment||1
2402450|NCT01325207|5894032|P3|STARTED|Completed 4 Weeks/1 Cycle of Treatment||1
2402451|NCT01325207|5894033|P2|STARTED|Completed 4 Weeks/1 Cycle of Treatment||3
2402452|NCT01325207|5894034|P1|STARTED|Completed 4 Weeks/1 Cycle of Treatment||3
2402453|NCT01325181|5894059|P2|NOT COMPLETED|Overall Study||2
2402454|NCT01325181|5894060|P1|NOT COMPLETED|Overall Study||0
2402455|NCT01325181|5894059|P2|COMPLETED|Overall Study||14
2402456|NCT01325181|5894060|P1|COMPLETED|Overall Study||18
2402457|NCT01325181|5894059|P2|STARTED|Overall Study||16
2402458|NCT01325181|5894060|P1|STARTED|Overall Study||18
2402459|NCT01324999|5894066|P1|NOT COMPLETED|Overall Study||5
2402460|NCT01324999|5894066|P1|COMPLETED|Overall Study||7
2402461|NCT01324999|5894066|P1|STARTED|Overall Study||12
2402462|NCT01324947|5894077|P1|NOT COMPLETED|Overall Study||74
2402463|NCT01324947|5894077|P1|COMPLETED|Overall Study||0
2402464|NCT01324947|5894077|P1|Efficacy Evaluable Population (EEP)|Overall Study|Participants who received ≥ 1 dose of study drug and had at least 1 postbaseline efficacy assessment|64
2402465|NCT01324947|5894077|P1|Safety Population|Overall Study|Safety Population includes those who were enrolled and received at least one dose of study drug|73
2402466|NCT01324947|5894077|P1|STARTED|Overall Study||74
2402467|NCT01324882|5894090|P2|NOT COMPLETED|Overall Study||0
2402468|NCT01324882|5894091|P1|NOT COMPLETED|Overall Study||0
2402469|NCT01324882|5894090|P2|COMPLETED|Overall Study|30 patients had the colonoscopy|30
2402470|NCT01324882|5894091|P1|COMPLETED|Overall Study|27 patients had the colonoscopy|27
2402471|NCT01324882|5894090|P2|STARTED|Overall Study|30 patients were randomized to this arm|30
2402472|NCT01324882|5894091|P1|STARTED|Overall Study|27 patients were randomized to this arm.|27
2402473|NCT01324830|5894118|P19|NOT COMPLETED|Overall Study||6
2402474|NCT01324830|5894119|P18|NOT COMPLETED|Overall Study||6
2402475|NCT01324830|5894120|P17|NOT COMPLETED|Overall Study||3
2402476|NCT01324830|5894121|P16|NOT COMPLETED|Overall Study||3
2402477|NCT01324830|5894122|P15|NOT COMPLETED|Overall Study||1
2402478|NCT01324830|5894123|P14|NOT COMPLETED|Overall Study||1
2402479|NCT01324830|5894124|P13|NOT COMPLETED|Overall Study||1
2402480|NCT01324830|5894125|P12|NOT COMPLETED|Overall Study||1
2402481|NCT01324830|5894126|P11|NOT COMPLETED|Overall Study||4
2402482|NCT01324830|5894127|P10|NOT COMPLETED|Overall Study||6
2402483|NCT01324830|5894128|P9|NOT COMPLETED|Overall Study||5
2402484|NCT01324830|5894129|P8|NOT COMPLETED|Overall Study||3
2402485|NCT01324830|5894130|P7|NOT COMPLETED|Overall Study||3
2402486|NCT01324830|5894131|P6|NOT COMPLETED|Overall Study||7
2402487|NCT01324830|5894132|P5|NOT COMPLETED|Overall Study||7
2402488|NCT01324830|5894133|P4|NOT COMPLETED|Overall Study||3
2402489|NCT01324830|5894134|P3|NOT COMPLETED|Overall Study||3
2402490|NCT01324830|5894135|P2|NOT COMPLETED|Overall Study||3
2402491|NCT01324830|5894136|P1|NOT COMPLETED|Overall Study||3
2402492|NCT01324830|5894118|P19|COMPLETED|Overall Study||0
2402493|NCT01324830|5894119|P18|COMPLETED|Overall Study||0
2402494|NCT01324830|5894120|P17|COMPLETED|Overall Study||0
2402495|NCT01324830|5894121|P16|COMPLETED|Overall Study||0
2402496|NCT01324830|5894122|P15|COMPLETED|Overall Study||0
2402497|NCT01324830|5894123|P14|COMPLETED|Overall Study||0
2402498|NCT01324830|5894124|P13|COMPLETED|Overall Study||0
2402499|NCT01324830|5894125|P12|COMPLETED|Overall Study||0
2402500|NCT01324830|5894126|P11|COMPLETED|Overall Study||0
2402501|NCT01324830|5894127|P10|COMPLETED|Overall Study||0
2402502|NCT01324830|5894128|P9|COMPLETED|Overall Study||0
2402503|NCT01324830|5894129|P8|COMPLETED|Overall Study||0
2402504|NCT01324830|5894130|P7|COMPLETED|Overall Study||0
2402505|NCT01324830|5894131|P6|COMPLETED|Overall Study||0
2402506|NCT01324830|5894132|P5|COMPLETED|Overall Study||0
2402507|NCT01324830|5894133|P4|COMPLETED|Overall Study||0
2402508|NCT01324830|5894134|P3|COMPLETED|Overall Study||0
2402509|NCT01324830|5894135|P2|COMPLETED|Overall Study||0
2402510|NCT01324830|5894136|P1|COMPLETED|Overall Study||0
2402511|NCT01324830|5894118|P19|STARTED|Overall Study||6
2402512|NCT01324830|5894119|P18|STARTED|Overall Study||6
2402513|NCT01324830|5894120|P17|STARTED|Overall Study||3
2402514|NCT01324830|5894121|P16|STARTED|Overall Study||3
2402515|NCT01324830|5894122|P15|STARTED|Overall Study||1
2402516|NCT01324830|5894123|P14|STARTED|Overall Study||1
2402517|NCT01324830|5894124|P13|STARTED|Overall Study||1
2402518|NCT01324830|5894125|P12|STARTED|Overall Study||1
2402519|NCT01324830|5894126|P11|STARTED|Overall Study||4
2402520|NCT01324830|5894127|P10|STARTED|Overall Study||6
2402521|NCT01324830|5894128|P9|STARTED|Overall Study||5
2402522|NCT01324830|5894129|P8|STARTED|Overall Study||3
2402523|NCT01324830|5894130|P7|STARTED|Overall Study||3
2402524|NCT01324830|5894131|P6|STARTED|Overall Study||7
2402525|NCT01324830|5894132|P5|STARTED|Overall Study||7
2402526|NCT01324830|5894133|P4|STARTED|Overall Study||3
2402527|NCT01324830|5894134|P3|STARTED|Overall Study||3
2402528|NCT01324830|5894135|P2|STARTED|Overall Study||3
2402529|NCT01324830|5894136|P1|STARTED|Overall Study||3
2402530|NCT01324700|5894252|P4|NOT COMPLETED|Overall Study||11
2402531|NCT01324700|5894253|P3|NOT COMPLETED|Overall Study||16
2402532|NCT01324700|5894254|P2|NOT COMPLETED|Overall Study||4
2402533|NCT01324700|5894255|P1|NOT COMPLETED|Overall Study||9
2402534|NCT01324700|5894252|P4|COMPLETED|Overall Study||37
2402535|NCT01324700|5894253|P3|COMPLETED|Overall Study||33
2402536|NCT01324700|5894254|P2|COMPLETED|Overall Study||16
2402537|NCT01324700|5894255|P1|COMPLETED|Overall Study||13
2402538|NCT01324700|5894252|P4|STARTED|Overall Study||48
2402539|NCT01324700|5894253|P3|STARTED|Overall Study||49
2402540|NCT01324700|5894254|P2|STARTED|Overall Study||20
2402541|NCT01324700|5894255|P1|STARTED|Overall Study||22
2402542|NCT01324687|5894271|P2|NOT COMPLETED|Overall Study||15
2402543|NCT01324687|5894272|P1|NOT COMPLETED|Overall Study||0
2402544|NCT01324687|5894271|P2|COMPLETED|Overall Study||479
2402545|NCT01324687|5894272|P1|COMPLETED|Overall Study||1058
2402546|NCT01324687|5894271|P2|STARTED|Overall Study||494
2402547|NCT01324687|5894272|P1|STARTED|Overall Study||1058
2402548|NCT01324622|5894282|P2|NOT COMPLETED|Overall Study||7
2402549|NCT01324622|5894283|P1|NOT COMPLETED|Overall Study||9
2402550|NCT01324622|5894282|P2|COMPLETED|Overall Study||4
2402551|NCT01324622|5894283|P1|COMPLETED|Overall Study||4
2402552|NCT01324622|5894282|P2|STARTED|Overall Study||11
2402553|NCT01324622|5894283|P1|STARTED|Overall Study||13
2402554|NCT01324570|5894313|P2|NOT COMPLETED|Overall Study||14
2402555|NCT01324570|5894314|P1|NOT COMPLETED|Overall Study||4
2402556|NCT01324570|5894313|P2|COMPLETED|Overall Study||21
2402557|NCT01324570|5894314|P1|COMPLETED|Overall Study||2
2402558|NCT01324570|5894313|P2|STARTED|Overall Study||35
2402559|NCT01324570|5894314|P1|STARTED|Overall Study||6
2402560|NCT01324453|5894328|P2|NOT COMPLETED|Overall Study||0
2402561|NCT01324453|5894329|P1|NOT COMPLETED|Overall Study||0
2402562|NCT01324453|5894328|P2|COMPLETED|Overall Study||49
2402563|NCT01324453|5894329|P1|COMPLETED|Overall Study||54
2402564|NCT01324453|5894328|P2|STARTED|Overall Study||49
2402565|NCT01324453|5894329|P1|STARTED|Overall Study||54
2402566|NCT01324440|5894351|P2|NOT COMPLETED|Overall Study||1
2402567|NCT01324440|5894352|P1|NOT COMPLETED|Overall Study||0
2402568|NCT01324440|5894351|P2|COMPLETED|Overall Study||31
2402569|NCT01324440|5894352|P1|COMPLETED|Overall Study||32
2402570|NCT01324440|5894351|P2|STARTED|Overall Study||32
2402571|NCT01324440|5894352|P1|STARTED|Overall Study||32
2402572|NCT01324401|5894366|P2|NOT COMPLETED|Overall Study||6
2402573|NCT01324401|5894367|P1|NOT COMPLETED|Overall Study||1
2402574|NCT01324401|5894366|P2|COMPLETED|Overall Study|three (3) unable to complete due to adverse events|20
2402575|NCT01324401|5894367|P1|COMPLETED|Overall Study|one (1) could not tolerate minimum starting dose|3
2402576|NCT01324401|5894366|P2|STARTED|Overall Study|3 excluded from ITT analysis: 1 screen fail, 2 voluntary withdrawal pre-treatment|26
2402577|NCT01324401|5894367|P1|STARTED|Overall Study||4
2402578|NCT01324388|5894378|P4|NOT COMPLETED|Part 2 of Study: Second Intervention||0
2402579|NCT01324388|5894379|P3|NOT COMPLETED|Part 2 of Study: Second Intervention||1
2402580|NCT01324388|5894380|P2|NOT COMPLETED|Part 2 of Study: Second Intervention||0
2402581|NCT01324388|5894381|P1|NOT COMPLETED|Part 2 of Study: Second Intervention||0
2402582|NCT01324388|5894378|P4|COMPLETED|Part 2 of Study: Second Intervention||9
2402583|NCT01324388|5894379|P3|COMPLETED|Part 2 of Study: Second Intervention||9
2402584|NCT01324388|5894380|P2|COMPLETED|Part 2 of Study: Second Intervention||0
2402585|NCT01324388|5894381|P1|COMPLETED|Part 2 of Study: Second Intervention||0
2402586|NCT01324388|5894378|P4|STARTED|Part 2 of Study: Second Intervention||9
2402587|NCT01324388|5894379|P3|STARTED|Part 2 of Study: Second Intervention||10
2402588|NCT01324388|5894380|P2|STARTED|Part 2 of Study: Second Intervention||0
2402589|NCT01324388|5894381|P1|STARTED|Part 2 of Study: Second Intervention||0
2402590|NCT01324388|5894378|P4|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
2402591|NCT01324388|5894379|P3|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
2402592|NCT01324388|5894380|P2|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
2402593|NCT01324388|5894381|P1|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
2402594|NCT01324388|5894378|P4|COMPLETED|Part 2: Washout of at Least 21 Days||9
2402595|NCT01324388|5894379|P3|COMPLETED|Part 2: Washout of at Least 21 Days||10
2402596|NCT01324388|5894380|P2|COMPLETED|Part 2: Washout of at Least 21 Days||0
2402597|NCT01324388|5894381|P1|COMPLETED|Part 2: Washout of at Least 21 Days||0
2402598|NCT01324388|5894378|P4|STARTED|Part 2: Washout of at Least 21 Days||9
2402599|NCT01324388|5894379|P3|STARTED|Part 2: Washout of at Least 21 Days||10
2402600|NCT01324388|5894380|P2|STARTED|Part 2: Washout of at Least 21 Days||0
2402601|NCT01324388|5894381|P1|STARTED|Part 2: Washout of at Least 21 Days||0
2402602|NCT01324388|5894378|P4|NOT COMPLETED|Part 2 of Study: First Intervention||1
2402603|NCT01324388|5894379|P3|NOT COMPLETED|Part 2 of Study: First Intervention||0
2402604|NCT01324388|5894380|P2|NOT COMPLETED|Part 2 of Study: First Intervention||0
2402605|NCT01324388|5894381|P1|NOT COMPLETED|Part 2 of Study: First Intervention||0
2402606|NCT01324388|5894378|P4|COMPLETED|Part 2 of Study: First Intervention||9
2402607|NCT01324388|5894379|P3|COMPLETED|Part 2 of Study: First Intervention||10
2402608|NCT01324388|5894380|P2|COMPLETED|Part 2 of Study: First Intervention||0
2402609|NCT01324388|5894381|P1|COMPLETED|Part 2 of Study: First Intervention||0
2402610|NCT01324388|5894378|P4|STARTED|Part 2 of Study: First Intervention||10
2402611|NCT01324388|5894379|P3|STARTED|Part 2 of Study: First Intervention||10
2402612|NCT01324388|5894380|P2|STARTED|Part 2 of Study: First Intervention||0
2402613|NCT01324388|5894381|P1|STARTED|Part 2 of Study: First Intervention||0
2402614|NCT01324388|5894378|P4|NOT COMPLETED|Part 1 of Study||0
2402615|NCT01324388|5894379|P3|NOT COMPLETED|Part 1 of Study||0
2402616|NCT01324388|5894380|P2|NOT COMPLETED|Part 1 of Study||2
2402617|NCT01324388|5894381|P1|NOT COMPLETED|Part 1 of Study||4
2402618|NCT01324388|5894378|P4|COMPLETED|Part 1 of Study||0
2402619|NCT01324388|5894379|P3|COMPLETED|Part 1 of Study||0
2402620|NCT01324388|5894380|P2|COMPLETED|Part 1 of Study||6
2402621|NCT01324388|5894381|P1|COMPLETED|Part 1 of Study||19
2402622|NCT01324388|5894378|P4|Received at Least 1 Dose|Part 1 of Study||0
2402623|NCT01324388|5894379|P3|Received at Least 1 Dose|Part 1 of Study||0
2402624|NCT01324388|5894380|P2|Received at Least 1 Dose|Part 1 of Study||8
2402625|NCT01324388|5894381|P1|Received at Least 1 Dose|Part 1 of Study||23
2402626|NCT01324388|5894378|P4|STARTED|Part 1 of Study||0
2402627|NCT01324388|5894379|P3|STARTED|Part 1 of Study||0
2402628|NCT01324388|5894380|P2|STARTED|Part 1 of Study||8
2402629|NCT01324388|5894381|P1|STARTED|Part 1 of Study||23
2402630|NCT01324349|5894402|P2|NOT COMPLETED|Overall Study||2
2402631|NCT01324349|5894403|P1|NOT COMPLETED|Overall Study||1
2402632|NCT01324349|5894402|P2|COMPLETED|Overall Study||16
2402633|NCT01324349|5894403|P1|COMPLETED|Overall Study||31
2402634|NCT01324349|5894402|P2|STARTED|Overall Study||18
2402635|NCT01324349|5894403|P1|STARTED|Overall Study||32
2402636|NCT01324323|5894413|P1|NOT COMPLETED|Overall Study||1
2402637|NCT01324323|5894413|P1|COMPLETED|Overall Study||13
2402638|NCT01324323|5894413|P1|STARTED|Overall Study||14
2402639|NCT01324310|5894433|P1|NOT COMPLETED|Overall Study||2
2402640|NCT01324310|5894433|P1|COMPLETED|Overall Study||13
2402641|NCT01324310|5894433|P1|STARTED|Overall Study||15
2402642|NCT01324271|5894453|P2|NOT COMPLETED|Overall Study||0
2402643|NCT01324271|5894454|P1|NOT COMPLETED|Overall Study||4
2402644|NCT01324271|5894453|P2|COMPLETED|Overall Study||28
2402645|NCT01324271|5894454|P1|COMPLETED|Overall Study||53
2402646|NCT01324271|5894453|P2|STARTED|Overall Study||28
2402647|NCT01324271|5894454|P1|STARTED|Overall Study||57
2402648|NCT01324128|5894462|P4|NOT COMPLETED|Stage 2||3
2402649|NCT01324128|5894463|P3|NOT COMPLETED|Stage 2||8
2402650|NCT01324128|5894464|P2|NOT COMPLETED|Stage 2||0
2402651|NCT01324128|5894465|P1|NOT COMPLETED|Stage 2||0
2402652|NCT01324128|5894462|P4|COMPLETED|Stage 2||46
2402653|NCT01324128|5894463|P3|COMPLETED|Stage 2||42
2402654|NCT01324128|5894464|P2|COMPLETED|Stage 2||0
2402655|NCT01324128|5894465|P1|COMPLETED|Stage 2||0
2402656|NCT01324128|5894462|P4|STARTED|Stage 2||49
2402657|NCT01324128|5894463|P3|STARTED|Stage 2||50
2402658|NCT01324128|5894464|P2|STARTED|Stage 2||0
2402659|NCT01324128|5894465|P1|STARTED|Stage 2||0
2402660|NCT01324128|5894462|P4|NOT COMPLETED|Stage 1||0
2402661|NCT01324128|5894463|P3|NOT COMPLETED|Stage 1||0
2402662|NCT01324128|5894464|P2|NOT COMPLETED|Stage 1||56
2402663|NCT01324128|5894465|P1|NOT COMPLETED|Stage 1||195
2402664|NCT01324128|5894462|P4|COMPLETED|Stage 1||0
2402665|NCT01324128|5894463|P3|COMPLETED|Stage 1||0
2402666|NCT01324128|5894464|P2|COMPLETED|Stage 1||293
2402667|NCT01324128|5894465|P1|COMPLETED|Stage 1||515
2402668|NCT01324128|5894462|P4|STARTED|Stage 1||0
2402669|NCT01324128|5894463|P3|STARTED|Stage 1||0
2402670|NCT01324128|5894464|P2|STARTED|Stage 1||349
2402671|NCT01324128|5894465|P1|STARTED|Stage 1||710
2402672|NCT01324102|5894477|P2|NOT COMPLETED|Overall Study||6
2402673|NCT01324102|5894478|P1|NOT COMPLETED|Overall Study||1
2402674|NCT01324102|5894477|P2|COMPLETED|Overall Study||6
2402675|NCT01324102|5894478|P1|COMPLETED|Overall Study||10
2402676|NCT01324102|5894477|P2|STARTED|Overall Study|Yoga group 4 and 6|12
2402677|NCT01324102|5894478|P1|STARTED|Overall Study|Yoga groups 3 and 5 (not including pre-randomization group)|11
2402678|NCT01324024|5894485|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
2402679|NCT01324024|5894486|P1|NOT COMPLETED|Second Intervention (4 Weeks)||2
2402680|NCT01324024|5894485|P2|COMPLETED|Second Intervention (4 Weeks)||16
2402681|NCT01324024|5894486|P1|COMPLETED|Second Intervention (4 Weeks)||16
2402682|NCT01324024|5894485|P2|STARTED|Second Intervention (4 Weeks)||17
2402683|NCT01324024|5894486|P1|STARTED|Second Intervention (4 Weeks)||18
2402684|NCT01324024|5894485|P2|NOT COMPLETED|Washout (2 Weeks)||0
2402685|NCT01324024|5894486|P1|NOT COMPLETED|Washout (2 Weeks)||0
2402686|NCT01324024|5894485|P2|COMPLETED|Washout (2 Weeks)||17
2402687|NCT01324024|5894486|P1|COMPLETED|Washout (2 Weeks)||18
2402688|NCT01324024|5894485|P2|STARTED|Washout (2 Weeks)||17
2402689|NCT01324024|5894486|P1|STARTED|Washout (2 Weeks)||18
2402690|NCT01324024|5894485|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
2402691|NCT01324024|5894486|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
2402692|NCT01324024|5894485|P2|COMPLETED|First Intervention (4 Weeks)||17
2402693|NCT01324024|5894486|P1|COMPLETED|First Intervention (4 Weeks)||18
2402694|NCT01324024|5894485|P2|STARTED|First Intervention (4 Weeks)||17
2402695|NCT01324024|5894486|P1|STARTED|First Intervention (4 Weeks)||18
2402696|NCT01323998|5894504|P5|NOT COMPLETED|Overall Study||0
2402697|NCT01323998|5894505|P4|NOT COMPLETED|Overall Study||0
2402698|NCT01323998|5894506|P3|NOT COMPLETED|Overall Study||0
2402699|NCT01323998|5894507|P2|NOT COMPLETED|Overall Study||0
2402700|NCT01323998|5894508|P1|NOT COMPLETED|Overall Study||0
2402701|NCT01323998|5894504|P5|COMPLETED|Overall Study||6735
2402702|NCT01323998|5894505|P4|COMPLETED|Overall Study||12052
2402703|NCT01323998|5894506|P3|COMPLETED|Overall Study||10294
2402704|NCT01323998|5894507|P2|COMPLETED|Overall Study||18681
2402705|NCT01323998|5894508|P1|COMPLETED|Overall Study||200631
2402706|NCT01323998|5894504|P5|STARTED|Overall Study||6735
2402707|NCT01323998|5894505|P4|STARTED|Overall Study||12052
2402708|NCT01323998|5894506|P3|STARTED|Overall Study||10294
2402709|NCT01323998|5894507|P2|STARTED|Overall Study||18681
2402710|NCT01323998|5894508|P1|STARTED|Overall Study||200631
2402711|NCT01323972|5894524|P4|NOT COMPLETED|Overall Study||1
2402712|NCT01323972|5894525|P3|NOT COMPLETED|Overall Study||2
2402713|NCT01323972|5894526|P2|NOT COMPLETED|Overall Study||3
2402714|NCT01323972|5894527|P1|NOT COMPLETED|Overall Study||2
2402715|NCT01323972|5894524|P4|COMPLETED|Overall Study||79
2402716|NCT01323972|5894525|P3|COMPLETED|Overall Study||78
2402717|NCT01323972|5894526|P2|COMPLETED|Overall Study||76
2402718|NCT01323972|5894527|P1|COMPLETED|Overall Study||79
2402719|NCT01323972|5894524|P4|STARTED|Overall Study||80
2402720|NCT01323972|5894525|P3|STARTED|Overall Study||80
2402721|NCT01323972|5894526|P2|STARTED|Overall Study||79
2402722|NCT01323972|5894527|P1|STARTED|Overall Study||81
2402723|NCT01323959|5894562|P3|NOT COMPLETED|Overall Study||0
2402724|NCT01323959|5894563|P2|NOT COMPLETED|Overall Study||0
2402725|NCT01323959|5894564|P1|NOT COMPLETED|Overall Study||0
2402726|NCT01323959|5894562|P3|COMPLETED|Overall Study||72
2402727|NCT01323959|5894563|P2|COMPLETED|Overall Study||72
2402728|NCT01323959|5894564|P1|COMPLETED|Overall Study||67
2402729|NCT01323959|5894562|P3|STARTED|Overall Study||72
2402730|NCT01323959|5894563|P2|STARTED|Overall Study||72
2402731|NCT01323959|5894564|P1|STARTED|Overall Study||67
2402732|NCT01323946|5894623|P3|NOT COMPLETED|Overall Study||0
2402733|NCT01323946|5894624|P2|NOT COMPLETED|Overall Study||3
2402734|NCT01323946|5894625|P1|NOT COMPLETED|Overall Study||3
2402735|NCT01323946|5894623|P3|COMPLETED|Overall Study||33
2402736|NCT01323946|5894624|P2|COMPLETED|Overall Study||31
2402737|NCT01323946|5894625|P1|COMPLETED|Overall Study||43
2402738|NCT01323946|5894623|P3|STARTED|Overall Study||33
2402739|NCT01323946|5894624|P2|STARTED|Overall Study||34
2402740|NCT01323946|5894625|P1|STARTED|Overall Study||46
2402741|NCT01323920|5894746|P1|NOT COMPLETED|Overall Study||6
2402742|NCT01323920|5894746|P1|COMPLETED|Overall Study||29
2402743|NCT01323920|5894746|P1|STARTED|Overall Study||35
2402744|NCT01323855|5894758|P5|NOT COMPLETED|Overall Study||0
2402745|NCT01323855|5894759|P4|NOT COMPLETED|Overall Study||0
2402746|NCT01323855|5894760|P3|NOT COMPLETED|Overall Study||0
2402747|NCT01323855|5894761|P2|NOT COMPLETED|Overall Study||0
2402748|NCT01323855|5894762|P1|NOT COMPLETED|Overall Study||0
2402749|NCT01323855|5894758|P5|COMPLETED|Overall Study||11
2402750|NCT01323855|5894759|P4|COMPLETED|Overall Study||9
2402751|NCT01323855|5894760|P3|COMPLETED|Overall Study||8
2402752|NCT01323855|5894761|P2|COMPLETED|Overall Study||9
2402753|NCT01323855|5894762|P1|COMPLETED|Overall Study||9
2402754|NCT01323855|5894758|P5|STARTED|Overall Study||11
2402755|NCT01323855|5894759|P4|STARTED|Overall Study||9
2402756|NCT01323855|5894760|P3|STARTED|Overall Study||8
2402757|NCT01323855|5894761|P2|STARTED|Overall Study||9
2402758|NCT01323855|5894762|P1|STARTED|Overall Study||9
2402759|NCT01323790|5894787|P3|NOT COMPLETED|Overall Study||45
2402760|NCT01323790|5894788|P2|NOT COMPLETED|Overall Study||60
2402761|NCT01323790|5894789|P1|NOT COMPLETED|Overall Study||55
2402762|NCT01323790|5894787|P3|COMPLETED|Overall Study||188
2402763|NCT01323790|5894788|P2|COMPLETED|Overall Study||174
2402764|NCT01323790|5894789|P1|COMPLETED|Overall Study||178
2402765|NCT01323790|5894787|P3|STARTED|Overall Study||233
2402766|NCT01323790|5894788|P2|STARTED|Overall Study||234
2402767|NCT01323790|5894789|P1|STARTED|Overall Study||233
2402768|NCT01323777|5894827|P1|NOT COMPLETED|Overall Study||0
2402769|NCT01323777|5894827|P1|COMPLETED|Overall Study||65
2402770|NCT01323777|5894827|P1|STARTED|Overall Study||65
2402771|NCT01323673|5894840|P2|NOT COMPLETED|Overall Study||5
2402772|NCT01323673|5894841|P1|NOT COMPLETED|Overall Study||3
2402773|NCT01323673|5894840|P2|COMPLETED|Overall Study||58
2402774|NCT01323673|5894841|P1|COMPLETED|Overall Study||59
2402775|NCT01323673|5894840|P2|STARTED|Overall Study||63
2402776|NCT01323673|5894841|P1|STARTED|Overall Study||62
2402777|NCT01323660|5894861|P6|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
2402778|NCT01323660|5894862|P5|NOT COMPLETED|Treatment Period 2 (12 Weeks)||4
2402779|NCT01323660|5894863|P4|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
2402780|NCT01323660|5894864|P3|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
2402781|NCT01323660|5894865|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
2402782|NCT01323660|5894866|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||12
2402783|NCT01323660|5894861|P6|COMPLETED|Treatment Period 2 (12 Weeks)||51
2402784|NCT01323660|5894862|P5|COMPLETED|Treatment Period 2 (12 Weeks)||55
2402785|NCT01323660|5894863|P4|COMPLETED|Treatment Period 2 (12 Weeks)||25
2402786|NCT01323660|5894864|P3|COMPLETED|Treatment Period 2 (12 Weeks)||14
2402787|NCT01323660|5894865|P2|COMPLETED|Treatment Period 2 (12 Weeks)||17
2402788|NCT01323660|5894866|P1|COMPLETED|Treatment Period 2 (12 Weeks)||55
2402789|NCT01323660|5894861|P6|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|58
2402790|NCT01323660|5894862|P5|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|59
2402791|NCT01323660|5894863|P4|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|28
2402792|NCT01323660|5894864|P3|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|17
2402793|NCT01323660|5894865|P2|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|18
2402794|NCT01323660|5894866|P1|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|67
2402795|NCT01323660|5894861|P6|NOT COMPLETED|Washout Period (14 Days)||2
2402796|NCT01323660|5894862|P5|NOT COMPLETED|Washout Period (14 Days)||3
2402797|NCT01323660|5894863|P4|NOT COMPLETED|Washout Period (14 Days)||3
2402798|NCT01323660|5894864|P3|NOT COMPLETED|Washout Period (14 Days)||1
2402799|NCT01323660|5894865|P2|NOT COMPLETED|Washout Period (14 Days)||0
2402800|NCT01323660|5894866|P1|NOT COMPLETED|Washout Period (14 Days)||0
2402801|NCT01323660|5894861|P6|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|59
2402802|NCT01323660|5894862|P5|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|58
2402803|NCT01323660|5894863|P4|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|28
2402804|NCT01323660|5894864|P3|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
2402805|NCT01323660|5894865|P2|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
2402806|NCT01323660|5894866|P1|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|65
2402807|NCT01323660|5894861|P6|STARTED|Washout Period (14 Days)||61
2402808|NCT01323660|5894862|P5|STARTED|Washout Period (14 Days)||61
2402809|NCT01323660|5894863|P4|STARTED|Washout Period (14 Days)||31
2402810|NCT01323660|5894864|P3|STARTED|Washout Period (14 Days)||19
2402811|NCT01323660|5894865|P2|STARTED|Washout Period (14 Days)||21
2402812|NCT01323660|5894866|P1|STARTED|Washout Period (14 Days)||65
2402813|NCT01323660|5894861|P6|NOT COMPLETED|Treatment Period 1 (12 Weeks)||9
2402814|NCT01323660|5894862|P5|NOT COMPLETED|Treatment Period 1 (12 Weeks)||10
2402815|NCT01323660|5894863|P4|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
2402816|NCT01323660|5894864|P3|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
2402817|NCT01323660|5894865|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||1
2402818|NCT01323660|5894866|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||19
2402819|NCT01323660|5894861|P6|COMPLETED|Treatment Period 1 (12 Weeks)||61
2402820|NCT01323660|5894862|P5|COMPLETED|Treatment Period 1 (12 Weeks)||61
2402821|NCT01323660|5894863|P4|COMPLETED|Treatment Period 1 (12 Weeks)||31
2402822|NCT01323660|5894864|P3|COMPLETED|Treatment Period 1 (12 Weeks)||19
2402823|NCT01323660|5894865|P2|COMPLETED|Treatment Period 1 (12 Weeks)||21
2402824|NCT01323660|5894866|P1|COMPLETED|Treatment Period 1 (12 Weeks)||65
2402825|NCT01323660|5894861|P6|STARTED|Treatment Period 1 (12 Weeks)||70
2402826|NCT01323660|5894862|P5|STARTED|Treatment Period 1 (12 Weeks)||71
2402827|NCT01323660|5894863|P4|STARTED|Treatment Period 1 (12 Weeks)||36
2402828|NCT01323660|5894864|P3|STARTED|Treatment Period 1 (12 Weeks)||24
2402829|NCT01323660|5894865|P2|STARTED|Treatment Period 1 (12 Weeks)||22
2402830|NCT01323660|5894866|P1|STARTED|Treatment Period 1 (12 Weeks)||84
2402831|NCT01323647|5894912|P2|NOT COMPLETED|Overall Study||0
2402832|NCT01323647|5894913|P1|NOT COMPLETED|Overall Study||9
2402833|NCT01323647|5894912|P2|COMPLETED|Overall Study||487
2402834|NCT01323647|5894913|P1|COMPLETED|Overall Study||461
2402835|NCT01323647|5894912|P2|STARTED|Overall Study||487
2402836|NCT01323647|5894913|P1|STARTED|Overall Study||470
2402837|NCT01323634|5894930|P3|NOT COMPLETED|Double-Blind (DB) Treatment Period||22
2402838|NCT01323634|5894931|P2|NOT COMPLETED|Double-Blind (DB) Treatment Period||25
2402839|NCT01323634|5894932|P1|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
2402840|NCT01323634|5894930|P3|COMPLETED|Double-Blind (DB) Treatment Period||239
2402841|NCT01323634|5894931|P2|COMPLETED|Double-Blind (DB) Treatment Period||235
2402842|NCT01323634|5894932|P1|COMPLETED|Double-Blind (DB) Treatment Period||0
2402843|NCT01323634|5894930|P3|STARTED|Double-Blind (DB) Treatment Period||261
2402844|NCT01323634|5894931|P2|STARTED|Double-Blind (DB) Treatment Period||260
2402845|NCT01323634|5894932|P1|STARTED|Double-Blind (DB) Treatment Period||0
2402846|NCT01323634|5894930|P3|NOT COMPLETED|2-week Run-in Period||0
2402847|NCT01323634|5894931|P2|NOT COMPLETED|2-week Run-in Period||0
2402848|NCT01323634|5894932|P1|NOT COMPLETED|2-week Run-in Period||212
2402849|NCT01323634|5894930|P3|COMPLETED|2-week Run-in Period||0
2402850|NCT01323634|5894931|P2|COMPLETED|2-week Run-in Period||0
2402851|NCT01323634|5894932|P1|COMPLETED|2-week Run-in Period||521
2402852|NCT01323634|5894930|P3|STARTED|2-week Run-in Period||0
2402853|NCT01323634|5894931|P2|STARTED|2-week Run-in Period||0
2402854|NCT01323634|5894932|P1|STARTED|2-week Run-in Period||733
2402855|NCT01323621|5894942|P3|NOT COMPLETED|12-week, Double-blind Treatment Period||20
2402856|NCT01323621|5894943|P2|NOT COMPLETED|12-week, Double-blind Treatment Period||15
2402857|NCT01323621|5894944|P1|NOT COMPLETED|12-week, Double-blind Treatment Period||0
2402858|NCT01323621|5894942|P3|COMPLETED|12-week, Double-blind Treatment Period||239
2402859|NCT01323621|5894943|P2|COMPLETED|12-week, Double-blind Treatment Period||237
2402860|NCT01323621|5894944|P1|COMPLETED|12-week, Double-blind Treatment Period||0
2402861|NCT01323621|5894942|P3|STARTED|12-week, Double-blind Treatment Period||259
2402862|NCT01323621|5894943|P2|STARTED|12-week, Double-blind Treatment Period||252
2402863|NCT01323621|5894944|P1|STARTED|12-week, Double-blind Treatment Period||0
2402864|NCT01323621|5894942|P3|NOT COMPLETED|2-week, Single-blind Run In Period||0
2402865|NCT01323621|5894943|P2|NOT COMPLETED|2-week, Single-blind Run In Period||0
2402866|NCT01323621|5894944|P1|NOT COMPLETED|2-week, Single-blind Run In Period||228
2402867|NCT01323621|5894942|P3|COMPLETED|2-week, Single-blind Run In Period||0
2402868|NCT01323621|5894943|P2|COMPLETED|2-week, Single-blind Run In Period||0
2402869|NCT01323621|5894944|P1|COMPLETED|2-week, Single-blind Run In Period||511
2402870|NCT01323621|5894942|P3|STARTED|2-week, Single-blind Run In Period||0
2402871|NCT01323621|5894943|P2|STARTED|2-week, Single-blind Run In Period||0
2402872|NCT01323621|5894944|P1|STARTED|2-week, Single-blind Run In Period||739
2402873|NCT01323595|5894954|P2|NOT COMPLETED|Overall Study||21
2402874|NCT01323595|5894955|P1|NOT COMPLETED|Overall Study||23
2402875|NCT01323595|5894954|P2|COMPLETED|Overall Study|Remaining subjects did not return questionaire|18
2402876|NCT01323595|5894955|P1|COMPLETED|Overall Study|Remaining subjects did not return questionnaire|16
2402877|NCT01323595|5894954|P2|STARTED|Overall Study||39
2402878|NCT01323595|5894955|P1|STARTED|Overall Study||39
2402879|NCT01323582|5894965|P2|NOT COMPLETED|Weeks 8-11 (Period 2)||1
2402880|NCT01323582|5894966|P1|NOT COMPLETED|Weeks 8-11 (Period 2)||0
2402881|NCT01323582|5894965|P2|COMPLETED|Weeks 8-11 (Period 2)||10
2402882|NCT01323582|5894966|P1|COMPLETED|Weeks 8-11 (Period 2)||10
2402883|NCT01323582|5894965|P2|STARTED|Weeks 8-11 (Period 2)||11
2402884|NCT01323582|5894966|P1|STARTED|Weeks 8-11 (Period 2)||10
2402885|NCT01323582|5894965|P2|NOT COMPLETED|Weeks 5-7 (Washout)||1
2402886|NCT01323582|5894966|P1|NOT COMPLETED|Weeks 5-7 (Washout)||0
2402887|NCT01323582|5894965|P2|COMPLETED|Weeks 5-7 (Washout)||11
2402888|NCT01323582|5894966|P1|COMPLETED|Weeks 5-7 (Washout)||10
2402889|NCT01323582|5894965|P2|STARTED|Weeks 5-7 (Washout)||12
2402890|NCT01323582|5894966|P1|STARTED|Weeks 5-7 (Washout)||10
2402891|NCT01323582|5894965|P2|NOT COMPLETED|Weeks 1-4 (First Period)||2
2402892|NCT01323582|5894966|P1|NOT COMPLETED|Weeks 1-4 (First Period)||2
2402893|NCT01323582|5894965|P2|COMPLETED|Weeks 1-4 (First Period)||12
2402894|NCT01323582|5894966|P1|COMPLETED|Weeks 1-4 (First Period)||10
2402895|NCT01323582|5894965|P2|STARTED|Weeks 1-4 (First Period)||14
2402896|NCT01323582|5894966|P1|STARTED|Weeks 1-4 (First Period)||12
2402897|NCT01323517|5894982|P1|NOT COMPLETED|Overall Study||0
2402898|NCT01323517|5894982|P1|COMPLETED|Overall Study||26
2402899|NCT01323517|5894982|P1|STARTED|Overall Study||26
2402900|NCT01323478|5894989|P1|NOT COMPLETED|Overall Study||24
2402901|NCT01323478|5894989|P1|COMPLETED|Overall Study||47
2402902|NCT01323478|5894989|P1|STARTED|Overall Study||71
2402903|NCT01323387|5895002|P1|NOT COMPLETED|Overall Study||84
2402904|NCT01323387|5895002|P1|COMPLETED|Overall Study||94
2402905|NCT01323387|5895002|P1|STARTED|Overall Study||178
2402906|NCT01323270|5895015|P2|NOT COMPLETED|Overall Study||29
2402907|NCT01323270|5895016|P1|NOT COMPLETED|Overall Study||43
2402908|NCT01323270|5895015|P2|COMPLETED|Overall Study||347
2402909|NCT01323270|5895016|P1|COMPLETED|Overall Study||330
2402910|NCT01323270|5895015|P2|STARTED|Overall Study||376
2402911|NCT01323270|5895016|P1|STARTED|Overall Study||373
2402912|NCT01323192|5895038|P2|NOT COMPLETED|Overall Study||6
2402913|NCT01323192|5895039|P1|NOT COMPLETED|Overall Study||9
2402914|NCT01323192|5895038|P2|COMPLETED|Overall Study||135
2402915|NCT01323192|5895039|P1|COMPLETED|Overall Study||134
2402916|NCT01323192|5895038|P2|STARTED|Overall Study||141
2402917|NCT01323192|5895039|P1|STARTED|Overall Study||143
2402918|NCT01323153|5895057|P2|NOT COMPLETED|Overall Study||8
2402919|NCT01323153|5895058|P1|NOT COMPLETED|Overall Study||17
2402920|NCT01323153|5895057|P2|COMPLETED|Overall Study||142
2402921|NCT01323153|5895058|P1|COMPLETED|Overall Study||133
2402922|NCT01323153|5895057|P2|STARTED|Overall Study||150
2402923|NCT01323153|5895058|P1|STARTED|Overall Study||150
2402924|NCT01323140|5895064|P1|NOT COMPLETED|Overall Study||2
2402925|NCT01323140|5895064|P1|COMPLETED|Overall Study||38
2402926|NCT01323140|5895064|P1|STARTED|Overall Study||40
2402927|NCT01323010|5895070|P2|NOT COMPLETED|Overall Study||0
2402928|NCT01323010|5895071|P1|NOT COMPLETED|Overall Study||0
2402929|NCT01323010|5895070|P2|COMPLETED|Overall Study||59
2402930|NCT01323010|5895071|P1|COMPLETED|Overall Study||60
2402931|NCT01323010|5895070|P2|STARTED|Overall Study||59
2402932|NCT01323010|5895071|P1|STARTED|Overall Study||60
2402933|NCT01322971|5895122|P2|NOT COMPLETED|Overall Study||1
2402934|NCT01322971|5895123|P1|NOT COMPLETED|Overall Study||1
2402935|NCT01322971|5895122|P2|COMPLETED|Overall Study||0
2402936|NCT01322971|5895123|P1|COMPLETED|Overall Study||0
2402937|NCT01322971|5895122|P2|STARTED|Overall Study||1
2402938|NCT01322971|5895123|P1|STARTED|Overall Study||1
2402939|NCT01322945|5895137|P2|NOT COMPLETED|Overall Study||0
2402940|NCT01322945|5895138|P1|NOT COMPLETED|Overall Study||0
2402941|NCT01322945|5895137|P2|COMPLETED|Overall Study||42
2402942|NCT01322945|5895138|P1|COMPLETED|Overall Study||52
2402943|NCT01322945|5895137|P2|STARTED|Overall Study||42
2402944|NCT01322945|5895138|P1|STARTED|Overall Study||52
2402945|NCT01322841|5895148|P2|NOT COMPLETED|Overall Study||0
2402946|NCT01322841|5895149|P1|NOT COMPLETED|Overall Study||0
2402947|NCT01322841|5895148|P2|COMPLETED|Overall Study||1123
2402948|NCT01322841|5895149|P1|COMPLETED|Overall Study||1116
2402949|NCT01322841|5895148|P2|STARTED|Overall Study||1123
2402950|NCT01322841|5895149|P1|STARTED|Overall Study||1116
2402951|NCT01322815|5895159|P2|NOT COMPLETED|Overall Study||0
2402952|NCT01322815|5895160|P1|NOT COMPLETED|Overall Study||0
2402953|NCT01322815|5895159|P2|COMPLETED|Overall Study||4
2402954|NCT01322815|5895160|P1|COMPLETED|Overall Study||7
2402955|NCT01322815|5895159|P2|STARTED|Overall Study||4
2402956|NCT01322815|5895160|P1|STARTED|Overall Study||7
2402957|NCT01322633|5895168|P2|NOT COMPLETED|Overall Study||0
2402958|NCT01322633|5895169|P1|NOT COMPLETED|Overall Study||0
2402959|NCT01322633|5895168|P2|COMPLETED|Overall Study||27686
2402960|NCT01322633|5895169|P1|COMPLETED|Overall Study||34178
2402961|NCT01322633|5895168|P2|STARTED|Overall Study||27686
2402962|NCT01322633|5895169|P1|STARTED|Overall Study||34178
2402963|NCT01322607|5895181|P2|NOT COMPLETED|Overall Study||0
2402964|NCT01322607|5895182|P1|NOT COMPLETED|Overall Study||1
2402965|NCT01322607|5895181|P2|COMPLETED|Overall Study||9
2402966|NCT01322607|5895182|P1|COMPLETED|Overall Study||10
2402967|NCT01322607|5895181|P2|STARTED|Overall Study||9
2402968|NCT01322607|5895182|P1|STARTED|Overall Study||11
2402969|NCT01322594|5895200|P6|NOT COMPLETED|Overall Study||0
2402970|NCT01322594|5895201|P5|NOT COMPLETED|Overall Study||0
2402971|NCT01322594|5895202|P4|NOT COMPLETED|Overall Study||0
2402972|NCT01322594|5895203|P3|NOT COMPLETED|Overall Study||0
2402973|NCT01322594|5895204|P2|NOT COMPLETED|Overall Study||0
2402974|NCT01322594|5895205|P1|NOT COMPLETED|Overall Study||0
2402975|NCT01322594|5895200|P6|COMPLETED|Overall Study||6
2402976|NCT01322594|5895201|P5|COMPLETED|Overall Study||7
2402977|NCT01322594|5895202|P4|COMPLETED|Overall Study||6
2402978|NCT01322594|5895203|P3|COMPLETED|Overall Study||3
2402979|NCT01322594|5895204|P2|COMPLETED|Overall Study||3
2402980|NCT01322594|5895205|P1|COMPLETED|Overall Study||6
2402981|NCT01322594|5895200|P6|STARTED|Overall Study||6
2402982|NCT01322594|5895201|P5|STARTED|Overall Study||7
2402983|NCT01322594|5895202|P4|STARTED|Overall Study||6
2402984|NCT01322594|5895203|P3|STARTED|Overall Study||3
2402985|NCT01322594|5895204|P2|STARTED|Overall Study||3
2402986|NCT01322594|5895205|P1|STARTED|Overall Study|RANDOMIZED SUBJECTS THROUGH STUDY DAY 240-300|6
2402987|NCT01322490|5895288|P3|NOT COMPLETED|Long Term Follow-up Period||413
2402988|NCT01322490|5895289|P2|NOT COMPLETED|Long Term Follow-up Period||408
2402989|NCT01322490|5895290|P1|NOT COMPLETED|Long Term Follow-up Period||409
2402990|NCT01322490|5895288|P3|COMPLETED|Long Term Follow-up Period||0
2402991|NCT01322490|5895289|P2|COMPLETED|Long Term Follow-up Period||0
2402992|NCT01322490|5895290|P1|COMPLETED|Long Term Follow-up Period||0
2402993|NCT01322490|5895288|P3|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|413
2402994|NCT01322490|5895289|P2|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|408
2402995|NCT01322490|5895290|P1|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|409
2402996|NCT01322490|5895288|P3|NOT COMPLETED|Treatment Period||153
2402997|NCT01322490|5895289|P2|NOT COMPLETED|Treatment Period||153
2402998|NCT01322490|5895290|P1|NOT COMPLETED|Treatment Period||132
2402999|NCT01322490|5895288|P3|COMPLETED|Treatment Period||280
2403000|NCT01322490|5895289|P2|COMPLETED|Treatment Period||279
2403001|NCT01322490|5895290|P1|COMPLETED|Treatment Period||300
2403002|NCT01322490|5895288|P3|Treated|Treatment Period||428
2403003|NCT01322490|5895289|P2|Treated|Treatment Period||429
2403004|NCT01322490|5895290|P1|Treated|Treatment Period||429
2403005|NCT01322490|5895288|P3|STARTED|Treatment Period||433
2403006|NCT01322490|5895289|P2|STARTED|Treatment Period||432
2403007|NCT01322490|5895290|P1|STARTED|Treatment Period||432
2403008|NCT01322386|5895303|P2|NOT COMPLETED|Overall Study||2
2403009|NCT01322386|5895304|P1|NOT COMPLETED|Overall Study||0
2403010|NCT01322386|5895303|P2|COMPLETED|Overall Study||9
2403011|NCT01322386|5895304|P1|COMPLETED|Overall Study||10
2403012|NCT01322386|5895303|P2|STARTED|Overall Study||11
2403013|NCT01322386|5895304|P1|STARTED|Overall Study||10
2403014|NCT01322360|5895312|P1|NOT COMPLETED|Overall Study||0
2403015|NCT01322360|5895312|P1|COMPLETED|Overall Study||50
2403016|NCT01322360|5895312|P1|STARTED|Overall Study||50
2403017|NCT01322347|5895319|P2|NOT COMPLETED|Overall Study||35
2403018|NCT01322347|5895320|P1|NOT COMPLETED|Overall Study||51
2403019|NCT01322347|5895319|P2|COMPLETED|Overall Study||112
2403020|NCT01322347|5895320|P1|COMPLETED|Overall Study||96
2403021|NCT01322347|5895319|P2|Completed St 3|Overall Study||86
2403022|NCT01322347|5895320|P1|Completed St 3|Overall Study||82
2403023|NCT01322347|5895319|P2|Enrolled in St 3|Overall Study||113
2403024|NCT01322347|5895320|P1|Enrolled in St 3|Overall Study||101
2403025|NCT01322347|5895319|P2|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||90
2403026|NCT01322347|5895320|P1|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||68
2403027|NCT01322347|5895319|P2|Completed 48 Wks in St 2|Overall Study||22
2403028|NCT01322347|5895320|P1|Completed 48 Wks in St 2|Overall Study||28
2403029|NCT01322347|5895319|P2|STARTED|Overall Study||147
2403030|NCT01322347|5895320|P1|STARTED|Overall Study||147
2403031|NCT01322048|5895357|P2|NOT COMPLETED|Overall Study||0
2403032|NCT01322048|5895358|P1|NOT COMPLETED|Overall Study||0
2403033|NCT01322048|5895357|P2|COMPLETED|Overall Study||26
2403034|NCT01322048|5895358|P1|COMPLETED|Overall Study||21
2403035|NCT01322048|5895357|P2|STARTED|Overall Study||26
2403036|NCT01322048|5895358|P1|STARTED|Overall Study||21
2403037|NCT01322022|5895368|P2|NOT COMPLETED|Overall Study||2
2403038|NCT01322022|5895369|P1|NOT COMPLETED|Overall Study||5
2403039|NCT01322022|5895368|P2|COMPLETED|Overall Study||18
2403040|NCT01322022|5895369|P1|COMPLETED|Overall Study||15
2403041|NCT01322022|5895368|P2|Week 4|Overall Study||18
2403042|NCT01322022|5895369|P1|Week 4|Overall Study||15
2403043|NCT01322022|5895368|P2|STARTED|Overall Study||20
2403044|NCT01322022|5895369|P1|STARTED|Overall Study||20
2403045|NCT01322009|5895383|P2|NOT COMPLETED|Overall Study||3
2403046|NCT01322009|5895384|P1|NOT COMPLETED|Overall Study||0
2403047|NCT01322009|5895383|P2|COMPLETED|Overall Study||4
2403048|NCT01322009|5895384|P1|COMPLETED|Overall Study||7
2403049|NCT01322009|5895383|P2|STARTED|Overall Study||7
2403050|NCT01322009|5895384|P1|STARTED|Overall Study||7
2403051|NCT01321879|5895392|P1|NOT COMPLETED|Overall Study||14
2403052|NCT01321879|5895392|P1|COMPLETED|Overall Study||25
2403053|NCT01321879|5895392|P1|STARTED|Overall Study||39
2403054|NCT01321749|5895398|P2|NOT COMPLETED|Overall Study||22
2403055|NCT01321749|5895399|P1|NOT COMPLETED|Overall Study||13
2403056|NCT01321749|5895398|P2|COMPLETED|Overall Study||30
2403057|NCT01321749|5895399|P1|COMPLETED|Overall Study||38
2403058|NCT01321749|5895398|P2|STARTED|Overall Study||52
2403059|NCT01321749|5895399|P1|STARTED|Overall Study||51
2403060|NCT01321723|5895408|P3|NOT COMPLETED|Overall Study||4
2403061|NCT01321723|5895409|P2|NOT COMPLETED|Overall Study||5
2403062|NCT01321723|5895410|P1|NOT COMPLETED|Overall Study||5
2403063|NCT01321723|5895408|P3|COMPLETED|Overall Study||28
2403064|NCT01321723|5895409|P2|COMPLETED|Overall Study||28
2403065|NCT01321723|5895410|P1|COMPLETED|Overall Study||27
2403066|NCT01321723|5895408|P3|STARTED|Overall Study||32
2403067|NCT01321723|5895409|P2|STARTED|Overall Study||33
2403068|NCT01321723|5895410|P1|STARTED|Overall Study||32
2403069|NCT01321710|5895432|P3|NOT COMPLETED|Overall Study||0
2403070|NCT01321710|5895433|P2|NOT COMPLETED|Overall Study||5
2403071|NCT01321710|5895434|P1|NOT COMPLETED|Overall Study||4
2403072|NCT01321710|5895432|P3|COMPLETED|Overall Study||44
2403073|NCT01321710|5895433|P2|COMPLETED|Overall Study||53
2403074|NCT01321710|5895434|P1|COMPLETED|Overall Study||46
2403075|NCT01321710|5895432|P3|STARTED|Overall Study||44
2403076|NCT01321710|5895433|P2|STARTED|Overall Study||58
2403077|NCT01321710|5895434|P1|STARTED|Overall Study||50
2403078|NCT01321697|5895449|P1|NOT COMPLETED|Overall Study||7
2403079|NCT01321697|5895449|P1|COMPLETED|Overall Study||0
2403080|NCT01321697|5895449|P1|STARTED|Overall Study||7
2403081|NCT01321606|5895455|P4|NOT COMPLETED|Overall Study||1
2403082|NCT01321606|5895456|P3|NOT COMPLETED|Overall Study||0
2403083|NCT01321606|5895457|P2|NOT COMPLETED|Overall Study||0
2403084|NCT01321606|5895458|P1|NOT COMPLETED|Overall Study||0
2403085|NCT01321606|5895455|P4|COMPLETED|Overall Study||28
2403086|NCT01321606|5895456|P3|COMPLETED|Overall Study||34
2403087|NCT01321606|5895457|P2|COMPLETED|Overall Study||32
2403088|NCT01321606|5895458|P1|COMPLETED|Overall Study||18
2403089|NCT01321606|5895455|P4|STARTED|Overall Study||29
2403090|NCT01321606|5895456|P3|STARTED|Overall Study||34
2403091|NCT01321606|5895457|P2|STARTED|Overall Study||32
2403092|NCT01321606|5895458|P1|STARTED|Overall Study||18
2403093|NCT01321554|5895478|P4|NOT COMPLETED|OOL Lenvatinib Treatment Period||2
2403094|NCT01321554|5895479|P3|NOT COMPLETED|OOL Lenvatinib Treatment Period||28
2403095|NCT01321554|5895480|P2|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
2403096|NCT01321554|5895481|P1|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
2403097|NCT01321554|5895478|P4|COMPLETED|OOL Lenvatinib Treatment Period|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|25
2403098|NCT01321554|5895479|P3|COMPLETED|OOL Lenvatinib Treatment Period|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|54
2403099|NCT01321554|5895480|P2|COMPLETED|OOL Lenvatinib Treatment Period||0
2403100|NCT01321554|5895481|P1|COMPLETED|OOL Lenvatinib Treatment Period||0
2403101|NCT01321554|5895478|P4|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||3
2403102|NCT01321554|5895479|P3|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||18
2403103|NCT01321554|5895480|P2|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||0
2403104|NCT01321554|5895481|P1|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||0
2403105|NCT01321554|5895478|P4|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||22
2403106|NCT01321554|5895479|P3|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||36
2403107|NCT01321554|5895480|P2|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||0
2403108|NCT01321554|5895481|P1|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||0
2403109|NCT01321554|5895478|P4|STARTED|OOL Lenvatinib Treatment Period||27
2403110|NCT01321554|5895479|P3|STARTED|OOL Lenvatinib Treatment Period||82
2403111|NCT01321554|5895480|P2|STARTED|OOL Lenvatinib Treatment Period||0
2403112|NCT01321554|5895481|P1|STARTED|OOL Lenvatinib Treatment Period||0
2403113|NCT01321554|5895478|P4|NOT COMPLETED|Randomization Phase||0
2403114|NCT01321554|5895479|P3|NOT COMPLETED|Randomization Phase||0
2403115|NCT01321554|5895480|P2|NOT COMPLETED|Randomization Phase||4
2403116|NCT01321554|5895481|P1|NOT COMPLETED|Randomization Phase||45
2403117|NCT01321554|5895478|P4|COMPLETED|Randomization Phase||0
2403118|NCT01321554|5895479|P3|COMPLETED|Randomization Phase||0
2403119|NCT01321554|5895480|P2|COMPLETED|Randomization Phase|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|127
2403120|NCT01321554|5895481|P1|COMPLETED|Randomization Phase|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|216
2403121|NCT01321554|5895478|P4|Discontinued Due to Disease Progression|Randomization Phase||0
2403122|NCT01321554|5895479|P3|Discontinued Due to Disease Progression|Randomization Phase||0
2403123|NCT01321554|5895480|P2|Discontinued Due to Disease Progression|Randomization Phase||119
2403124|NCT01321554|5895481|P1|Discontinued Due to Disease Progression|Randomization Phase||94
2403125|NCT01321554|5895478|P4|Treatment Ongoing at Data Cutoff|Randomization Phase||0
2403126|NCT01321554|5895479|P3|Treatment Ongoing at Data Cutoff|Randomization Phase||0
2403127|NCT01321554|5895480|P2|Treatment Ongoing at Data Cutoff|Randomization Phase||8
2403128|NCT01321554|5895481|P1|Treatment Ongoing at Data Cutoff|Randomization Phase||122
2403129|NCT01321554|5895478|P4|STARTED|Randomization Phase||0
2403130|NCT01321554|5895479|P3|STARTED|Randomization Phase||0
2403131|NCT01321554|5895480|P2|STARTED|Randomization Phase||131
2403132|NCT01321554|5895481|P1|STARTED|Randomization Phase||261
2403133|NCT01321073|5895494|P1|NOT COMPLETED|Overall Study||7
2403134|NCT01321073|5895494|P1|COMPLETED|Overall Study||57
2403135|NCT01321073|5895494|P1|STARTED|Overall Study||64
2403136|NCT01321008|5895498|P1|NOT COMPLETED|Overall Study||1
2403137|NCT01321008|5895498|P1|COMPLETED|Overall Study||0
2403138|NCT01321008|5895498|P1|STARTED|Overall Study||1
2403139|NCT01320943|5895504|P2|NOT COMPLETED|Overall Study||2
2403140|NCT01320943|5895505|P1|NOT COMPLETED|Overall Study||1
2403141|NCT01320943|5895504|P2|COMPLETED|Overall Study||20
2403142|NCT01320943|5895505|P1|COMPLETED|Overall Study||20
2403143|NCT01320943|5895504|P2|STARTED|Overall Study||22
2403144|NCT01320943|5895505|P1|STARTED|Overall Study|13 participants did not restart TDF; 8 participants restarted TDF during the study.|21
2403145|NCT01320826|5895524|P1|NOT COMPLETED|Overall Study||0
2403146|NCT01320826|5895524|P1|COMPLETED|Overall Study||577
2403147|NCT01320826|5895524|P1|STARTED|Overall Study||577
2403148|NCT01320735|5895539|P1|NOT COMPLETED|Overall Study||106
2403149|NCT01320735|5895539|P1|COMPLETED|Overall Study||194
2403150|NCT01320735|5895539|P1|STARTED|Overall Study||300
2403151|NCT01320722|5895561|P5|NOT COMPLETED|Overall Study||8
2403152|NCT01320722|5895562|P4|NOT COMPLETED|Overall Study||14
2403153|NCT01320722|5895563|P3|NOT COMPLETED|Overall Study||7
2403154|NCT01320722|5895564|P2|NOT COMPLETED|Overall Study||6
2403155|NCT01320722|5895565|P1|NOT COMPLETED|Overall Study||3
2403156|NCT01320722|5895561|P5|COMPLETED|Overall Study||45
2403157|NCT01320722|5895562|P4|COMPLETED|Overall Study||35
2403158|NCT01320722|5895563|P3|COMPLETED|Overall Study||40
2403159|NCT01320722|5895564|P2|COMPLETED|Overall Study||41
2403160|NCT01320722|5895565|P1|COMPLETED|Overall Study||43
2403161|NCT01320722|5895561|P5|Received Intervention|Overall Study||51
2403162|NCT01320722|5895562|P4|Received Intervention|Overall Study||48
2403163|NCT01320722|5895563|P3|Received Intervention|Overall Study||46
2403164|NCT01320722|5895564|P2|Received Intervention|Overall Study||45
2403165|NCT01320722|5895565|P1|Received Intervention|Overall Study||43
2403166|NCT01320722|5895561|P5|STARTED|Overall Study||53
2403167|NCT01320722|5895562|P4|STARTED|Overall Study||49
2403168|NCT01320722|5895563|P3|STARTED|Overall Study||47
2403169|NCT01320722|5895564|P2|STARTED|Overall Study||47
2403170|NCT01320722|5895565|P1|STARTED|Overall Study||46
2403171|NCT01320683|5895602|P1|NOT COMPLETED|Overall Study||1
2403172|NCT01320683|5895602|P1|COMPLETED|Overall Study||0
2403173|NCT01320683|5895602|P1|STARTED|Overall Study||1
2403174|NCT01320553|5895611|P4|NOT COMPLETED|Overall Study||1
2403175|NCT01320553|5895612|P3|NOT COMPLETED|Overall Study||2
2403176|NCT01320553|5895613|P2|NOT COMPLETED|Overall Study||4
2403177|NCT01320553|5895614|P1|NOT COMPLETED|Overall Study||1
2403178|NCT01320553|5895611|P4|COMPLETED|Overall Study||29
2403179|NCT01320553|5895612|P3|COMPLETED|Overall Study||29
2403180|NCT01320553|5895613|P2|COMPLETED|Overall Study||26
2403181|NCT01320553|5895614|P1|COMPLETED|Overall Study||30
2403182|NCT01320553|5895611|P4|STARTED|Overall Study||30
2403183|NCT01320553|5895612|P3|STARTED|Overall Study||31
2403184|NCT01320553|5895613|P2|STARTED|Overall Study||30
2403185|NCT01320553|5895614|P1|STARTED|Overall Study||31
2403186|NCT01320293|5895628|P1|NOT COMPLETED|Overall Study||2
2403187|NCT01320293|5895628|P1|COMPLETED|Overall Study||16
2403188|NCT01320293|5895628|P1|STARTED|Overall Study||18
2403189|NCT01320202|5895636|P2|NOT COMPLETED|Overall Study||44
2403190|NCT01320202|5895637|P1|NOT COMPLETED|Overall Study||56
2403191|NCT01320202|5895636|P2|COMPLETED|Overall Study||109
2403192|NCT01320202|5895637|P1|COMPLETED|Overall Study||96
2403193|NCT01320202|5895636|P2|Completed St 3|Overall Study||82
2403194|NCT01320202|5895637|P1|Completed St 3|Overall Study||79
2403195|NCT01320202|5895636|P2|Enrolled in St 3|Overall Study||109
2403196|NCT01320202|5895637|P1|Enrolled in St 3|Overall Study||98
2403197|NCT01320202|5895636|P2|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||82
2403198|NCT01320202|5895637|P1|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||69
2403199|NCT01320202|5895636|P2|Comp 48 Wks in St 2|Overall Study||27
2403200|NCT01320202|5895637|P1|Comp 48 Wks in St 2|Overall Study||27
2403201|NCT01320202|5895636|P2|STARTED|Overall Study||153
2403202|NCT01320202|5895637|P1|STARTED|Overall Study||152
2403203|NCT01320150|5895674|P1|NOT COMPLETED|Overall Study||66
2403204|NCT01320150|5895674|P1|COMPLETED|Overall Study||245
2403205|NCT01320150|5895674|P1|Non-PPP|Overall Study||211
2403206|NCT01320150|5895674|P1|PPP|Overall Study||34
2403207|NCT01320150|5895674|P1|STARTED|Overall Study||311
2403208|NCT01320137|5895680|P2|NOT COMPLETED|Overall Study||0
2403209|NCT01320137|5895681|P1|NOT COMPLETED|Overall Study||0
2403210|NCT01320137|5895680|P2|COMPLETED|Overall Study||40
2403211|NCT01320137|5895681|P1|COMPLETED|Overall Study||40
2403212|NCT01320137|5895680|P2|STARTED|Overall Study||40
2403213|NCT01320137|5895681|P1|STARTED|Overall Study||40
2403214|NCT01320072|5895695|P2|NOT COMPLETED|Overall Study||0
2403215|NCT01320072|5895696|P1|NOT COMPLETED|Overall Study||0
2403216|NCT01320072|5895695|P2|COMPLETED|Overall Study||13
2403217|NCT01320072|5895696|P1|COMPLETED|Overall Study||16
2403218|NCT01320072|5895695|P2|STARTED|Overall Study||13
2403219|NCT01320072|5895696|P1|STARTED|Overall Study||16
2403220|NCT01320033|5895708|P3|NOT COMPLETED|Overall Study||53
2403221|NCT01320033|5895709|P2|NOT COMPLETED|Overall Study||64
2403222|NCT01320033|5895710|P1|NOT COMPLETED|Overall Study||58
2403223|NCT01320033|5895708|P3|COMPLETED|Overall Study||169
2403224|NCT01320033|5895709|P2|COMPLETED|Overall Study||160
2403225|NCT01320033|5895710|P1|COMPLETED|Overall Study||158
2403226|NCT01320033|5895708|P3|STARTED|Overall Study||222
2403227|NCT01320033|5895709|P2|STARTED|Overall Study||224
2403228|NCT01320033|5895710|P1|STARTED|Overall Study||216
2403229|NCT01319994|5895738|P2|NOT COMPLETED|Overall Study||6
2403230|NCT01319994|5895739|P1|NOT COMPLETED|Overall Study||7
2403231|NCT01319994|5895738|P2|COMPLETED|Overall Study||21
2403232|NCT01319994|5895739|P1|COMPLETED|Overall Study||19
2403233|NCT01319994|5895738|P2|Did Not Develop Overt Diabetes|Overall Study||21
2403234|NCT01319994|5895739|P1|Did Not Develop Overt Diabetes|Overall Study||19
2403235|NCT01319994|5895738|P2|Glucocorticoid Dose as Inc Cri|Overall Study||22
2403236|NCT01319994|5895739|P1|Glucocorticoid Dose as Inc Cri|Overall Study||19
2403237|NCT01319994|5895738|P2|Tolerated at Least 1.7g/Day Dose|Overall Study||24
2403238|NCT01319994|5895739|P1|Tolerated at Least 1.7g/Day Dose|Overall Study||19
2403239|NCT01319994|5895738|P2|Abto Keep Appoinment Shedule|Overall Study||24
2403240|NCT01319994|5895739|P1|Abto Keep Appoinment Shedule|Overall Study||23
2403241|NCT01319994|5895738|P2|STARTED|Overall Study||27
2403242|NCT01319994|5895739|P1|STARTED|Overall Study||26
2403243|NCT01319877|5895749|P2|NOT COMPLETED|Overall Study||45
2403244|NCT01319877|5895750|P1|NOT COMPLETED|Overall Study||108
2403245|NCT01319877|5895749|P2|COMPLETED|Overall Study||108
2403246|NCT01319877|5895750|P1|COMPLETED|Overall Study||345
2403247|NCT01319877|5895749|P2|STARTED|Overall Study||153
2403248|NCT01319877|5895750|P1|STARTED|Overall Study||453
2403249|NCT01319851|5895785|P1|NOT COMPLETED|Overall Study||0
2403250|NCT01319851|5895785|P1|COMPLETED|Overall Study||3
2403251|NCT01319851|5895785|P1|STARTED|Overall Study||3
2403252|NCT01319812|5895797|P2|NOT COMPLETED|Overall Study||22
2403253|NCT01319812|5895798|P1|NOT COMPLETED|Overall Study||16
2403254|NCT01319812|5895797|P2|COMPLETED|Overall Study||280
2403255|NCT01319812|5895798|P1|COMPLETED|Overall Study||145
2403256|NCT01319812|5895797|P2|STARTED|Overall Study||302
2403257|NCT01319812|5895798|P1|STARTED|Overall Study||161
2403258|NCT01319799|5895879|P1|NOT COMPLETED|Overall Study||0
2403259|NCT01319799|5895879|P1|COMPLETED|Overall Study||10
2403260|NCT01319799|5895879|P1|STARTED|Overall Study||10
2403261|NCT01319773|5895889|P5|NOT COMPLETED|Overall Study||0
2403262|NCT01319773|5895890|P4|NOT COMPLETED|Overall Study||0
2403263|NCT01319773|5895891|P3|NOT COMPLETED|Overall Study||0
2403264|NCT01319773|5895892|P2|NOT COMPLETED|Overall Study||0
2403265|NCT01319773|5895893|P1|NOT COMPLETED|Overall Study||0
2403266|NCT01319773|5895889|P5|COMPLETED|Overall Study||8
2403267|NCT01319773|5895890|P4|COMPLETED|Overall Study||8
2403268|NCT01319773|5895891|P3|COMPLETED|Overall Study||8
2403269|NCT01319773|5895892|P2|COMPLETED|Overall Study||10
2403270|NCT01319773|5895893|P1|COMPLETED|Overall Study||10
2403271|NCT01319773|5895889|P5|STARTED|Overall Study||8
2403272|NCT01319773|5895890|P4|STARTED|Overall Study||8
2403273|NCT01319773|5895891|P3|STARTED|Overall Study||8
2403274|NCT01319773|5895892|P2|STARTED|Overall Study||10
2403275|NCT01319773|5895893|P1|STARTED|Overall Study||10
2403276|NCT01319760|5895909|P2|NOT COMPLETED|Overall Study||0
2403277|NCT01319760|5895910|P1|NOT COMPLETED|Overall Study||0
2403278|NCT01319760|5895909|P2|COMPLETED|Overall Study||5
2403279|NCT01319760|5895910|P1|COMPLETED|Overall Study|The study experienced a very low enrollment rate. the sponsor decided to stop the study.|0
2403280|NCT01319760|5895909|P2|STARTED|Overall Study||5
2403281|NCT01319760|5895910|P1|STARTED|Overall Study|The study experienced a very low enrollment rate. the sponsor decided to stop the study.|0
2403282|NCT01319721|5895918|P2|NOT COMPLETED|Overall Study||6
2403283|NCT01319721|5895919|P1|NOT COMPLETED|Overall Study||1
2403284|NCT01319721|5895918|P2|COMPLETED|Overall Study|The unit of measure is eyes.|42
2403285|NCT01319721|5895919|P1|COMPLETED|Overall Study|The unit of measure is eyes.|47
2403286|NCT01319721|5895918|P2|STARTED|Overall Study|The unit of measure is eyes.|48
2403287|NCT01319721|5895919|P1|STARTED|Overall Study|The unit of measure is eyes.|48
2403288|NCT01319617|5895933|P1|NOT COMPLETED|Overall Study||1
2403289|NCT01319617|5895933|P1|COMPLETED|Overall Study||40
2403290|NCT01319617|5895933|P1|STARTED|Overall Study||41
2403291|NCT01319552|5895937|P1|NOT COMPLETED|Overall Study||0
2403292|NCT01319552|5895937|P1|COMPLETED|Overall Study||14
2403293|NCT01319552|5895937|P1|STARTED|Overall Study||14
2403294|NCT01319539|5895942|P1|NOT COMPLETED|Overall Study||0
2403295|NCT01319539|5895942|P1|COMPLETED|Overall Study||12
2403296|NCT01319539|5895942|P1|STARTED|Overall Study||12
2403297|NCT01319500|5895952|P2|NOT COMPLETED|Overall Study||0
2403298|NCT01319500|5895953|P1|NOT COMPLETED|Overall Study||0
2403299|NCT01319500|5895952|P2|COMPLETED|Overall Study||2589
2403300|NCT01319500|5895953|P1|COMPLETED|Overall Study||1187
2403301|NCT01319500|5895952|P2|STARTED|Overall Study||2589
2403302|NCT01319500|5895953|P1|STARTED|Overall Study||1187
2403303|NCT01319422|5895972|P2|NOT COMPLETED|Overall Study||0
2403304|NCT01319422|5895973|P1|NOT COMPLETED|Overall Study||1
2403305|NCT01319422|5895972|P2|COMPLETED|Overall Study||20
2403306|NCT01319422|5895973|P1|COMPLETED|Overall Study||19
2403307|NCT01319422|5895972|P2|STARTED|Overall Study||20
2403308|NCT01319422|5895973|P1|STARTED|Overall Study||20
2403309|NCT01319396|5895987|P1|NOT COMPLETED|Overall Study||0
2403310|NCT01319396|5895987|P1|COMPLETED|Overall Study||24
2403311|NCT01319396|5895987|P1|STARTED|Overall Study||24
2403312|NCT01319383|5895991|P2|NOT COMPLETED|Overall Study||10
2403313|NCT01319383|5895992|P1|NOT COMPLETED|Overall Study||12
2403314|NCT01319383|5895991|P2|COMPLETED|Overall Study||3
2403315|NCT01319383|5895992|P1|COMPLETED|Overall Study||0
2403316|NCT01319383|5895991|P2|Step 4|Overall Study|Only 3/6 completed the study.|3
2403317|NCT01319383|5895992|P1|Step 4|Overall Study|Arm 1 did not have a Step 4|0
2403318|NCT01319383|5895991|P2|Step 3|Overall Study|3 Arm 1 participants enrolled here; 6/7 had in vivo response to 2 VOR doses given 72 hours apart.|6
2403319|NCT01319383|5895992|P1|Step 3|Overall Study|None who qualified for the 2 series of 11 doses of VOR (taken M-T-W & off for 4 days for 4 wks).|0
2403320|NCT01319383|5895991|P2|Step 2|Overall Study||0
2403321|NCT01319383|5895992|P1|Step 2|Overall Study|The 4 without ex vivo response (Step 1) took a single dose to see if in vivo response would occur|4
2403322|NCT01319383|5895991|P2|Step 2|Overall Study|The 7 participants without an in vivo response to single dose of VOR 400 mg PO were terminated.|4
2403323|NCT01319383|5895992|P1|Step 2|Overall Study|These participants demonstrated an ex vivo response in Step 1|8
2403324|NCT01319383|5895991|P2|Step 1|Overall Study|The 2 participants without an ex vivo response were terminated from the study.|11
2403325|NCT01319383|5895992|P1|Step 1|Overall Study||8
2403326|NCT01319383|5895991|P2|STARTED|Overall Study||13
2403327|NCT01319383|5895992|P1|STARTED|Overall Study||12
2403328|NCT01319318|5896009|P1|NOT COMPLETED|Overall Study||0
2403329|NCT01319318|5896009|P1|COMPLETED|Overall Study||25
2403330|NCT01319318|5896009|P1|STARTED|Overall Study||25
2403331|NCT01319110|5896015|P2|NOT COMPLETED|Overall Study||0
2403332|NCT01319110|5896016|P1|NOT COMPLETED|Overall Study||0
2403333|NCT01319110|5896015|P2|COMPLETED|Overall Study||5
2403334|NCT01319110|5896016|P1|COMPLETED|Overall Study||5
2403335|NCT01319110|5896015|P2|STARTED|Overall Study||5
2403336|NCT01319110|5896016|P1|STARTED|Overall Study||5
2403337|NCT01319045|5896024|P1|NOT COMPLETED|Overall Study||2
2403338|NCT01319045|5896024|P1|COMPLETED|Overall Study|Study was discontinued due to low enrollment|3
2403339|NCT01319045|5896024|P1|STARTED|Overall Study||5
2403340|NCT01318993|5896031|P1|NOT COMPLETED|Overall Study||398
2403341|NCT01318993|5896031|P1|COMPLETED|Overall Study||0
2403342|NCT01318993|5896031|P1|STARTED|Overall Study||398
2403343|NCT01318967|5896047|P1|NOT COMPLETED|Overall Study||0
2403344|NCT01318967|5896047|P1|COMPLETED|Overall Study||10
2403345|NCT01318967|5896047|P1|STARTED|Overall Study||10
2403346|NCT01318915|5896052|P1|NOT COMPLETED|Overall Study||1
2403347|NCT01318915|5896052|P1|COMPLETED|Overall Study||9
2403348|NCT01318915|5896052|P1|STARTED|Overall Study||10
2403349|NCT01318876|5896077|P1|NOT COMPLETED|Day 29 Survey||1825
2403350|NCT01318876|5896077|P1|COMPLETED|Day 29 Survey||5724
2403351|NCT01318876|5896077|P1|STARTED|Day 29 Survey|All participants with a valid e-mail, have received the second survey|7549
2403352|NCT01318876|5896077|P1|NOT COMPLETED|Day 8 Survey||1820
2403353|NCT01318876|5896077|P1|COMPLETED|Day 8 Survey||5825
2403354|NCT01318876|5896077|P1|STARTED|Day 8 Survey||7645
2403355|NCT01318811|5896084|P2|NOT COMPLETED|Overall Study||4
2403356|NCT01318811|5896085|P1|NOT COMPLETED|Overall Study||1
2403357|NCT01318811|5896084|P2|COMPLETED|Overall Study||4
2403358|NCT01318811|5896085|P1|COMPLETED|Overall Study||3
2403359|NCT01318811|5896084|P2|STARTED|Overall Study||8
2403360|NCT01318811|5896085|P1|STARTED|Overall Study||4
2403361|NCT01318733|5896093|P1|NOT COMPLETED|Overall Study||170
2403362|NCT01318733|5896093|P1|COMPLETED|Overall Study||279
2403363|NCT01318733|5896093|P1|STARTED|Overall Study||449
2403364|NCT01318694|5896101|P4|NOT COMPLETED|Overall Study||68
2403365|NCT01318694|5896102|P3|NOT COMPLETED|Overall Study||43
2403366|NCT01318694|5896103|P2|NOT COMPLETED|Overall Study||58
2403367|NCT01318694|5896104|P1|NOT COMPLETED|Overall Study||52
2403368|NCT01318694|5896101|P4|COMPLETED|Overall Study||200
2403369|NCT01318694|5896102|P3|COMPLETED|Overall Study||225
2403370|NCT01318694|5896103|P2|COMPLETED|Overall Study||212
2403371|NCT01318694|5896104|P1|COMPLETED|Overall Study||223
2403372|NCT01318694|5896101|P4|Safety Set|Overall Study||265
2403373|NCT01318694|5896102|P3|Safety Set|Overall Study||265
2403374|NCT01318694|5896103|P2|Safety Set|Overall Study||268
2403375|NCT01318694|5896104|P1|Safety Set|Overall Study||273
2403376|NCT01318694|5896101|P4|Full Analysis Set|Overall Study||268
2403377|NCT01318694|5896102|P3|Full Analysis Set|Overall Study||265
2403378|NCT01318694|5896103|P2|Full Analysis Set|Overall Study||270
2403379|NCT01318694|5896104|P1|Full Analysis Set|Overall Study||274
2403380|NCT01318694|5896101|P4|STARTED|Overall Study||268
2403381|NCT01318694|5896102|P3|STARTED|Overall Study||268
2403382|NCT01318694|5896103|P2|STARTED|Overall Study||270
2403383|NCT01318694|5896104|P1|STARTED|Overall Study||275
2403384|NCT01318538|5896160|P3|NOT COMPLETED|Overall Study||0
2403385|NCT01318538|5896161|P2|NOT COMPLETED|Overall Study||0
2403386|NCT01318538|5896162|P1|NOT COMPLETED|Overall Study||0
2403387|NCT01318538|5896160|P3|COMPLETED|Overall Study||8
2403388|NCT01318538|5896161|P2|COMPLETED|Overall Study||106
2403389|NCT01318538|5896162|P1|COMPLETED|Overall Study||52
2403390|NCT01318538|5896160|P3|STARTED|Overall Study||8
2403391|NCT01318538|5896161|P2|STARTED|Overall Study||106
2403392|NCT01318538|5896162|P1|STARTED|Overall Study||52
2403393|NCT01318512|5896186|P1|NOT COMPLETED|Maintenance Period (6 Months)||11
2403394|NCT01318512|5896186|P1|COMPLETED|Maintenance Period (6 Months)||329
2403395|NCT01318512|5896186|P1|STARTED|Maintenance Period (6 Months)||340
2403396|NCT01318512|5896186|P1|NOT COMPLETED|Titration Period (4 Months)||0
2403397|NCT01318512|5896186|P1|COMPLETED|Titration Period (4 Months)||340
2403398|NCT01318512|5896186|P1|STARTED|Titration Period (4 Months)||340
2403399|NCT01318499|5896205|P3|NOT COMPLETED|Overall Study||147
2403400|NCT01318499|5896206|P2|NOT COMPLETED|Overall Study||76
2403401|NCT01318499|5896207|P1|NOT COMPLETED|Overall Study||65
2403402|NCT01318499|5896205|P3|COMPLETED|Overall Study||121
2403403|NCT01318499|5896206|P2|COMPLETED|Overall Study||458
2403404|NCT01318499|5896207|P1|COMPLETED|Overall Study||475
2403405|NCT01318499|5896205|P3|STARTED|Overall Study||268
2403406|NCT01318499|5896206|P2|STARTED|Overall Study||534
2403407|NCT01318499|5896207|P1|STARTED|Overall Study||540
2403408|NCT01318408|5896225|P1|NOT COMPLETED|Overall Study||8
2403409|NCT01318408|5896225|P1|COMPLETED|Overall Study||16
2403410|NCT01318408|5896225|P1|STARTED|Overall Study||24
2403411|NCT01318382|5896230|P1|NOT COMPLETED|Overall Study||13
2403412|NCT01318382|5896230|P1|COMPLETED|Overall Study||289
2403413|NCT01318382|5896230|P1|STARTED|Overall Study||302
2403414|NCT01318278|5896240|P3|NOT COMPLETED|Overall Study||0
2403415|NCT01318278|5896241|P2|NOT COMPLETED|Overall Study||0
2403416|NCT01318278|5896242|P1|NOT COMPLETED|Overall Study||0
2403417|NCT01318278|5896240|P3|COMPLETED|Overall Study||50
2403418|NCT01318278|5896241|P2|COMPLETED|Overall Study||10
2403419|NCT01318278|5896242|P1|COMPLETED|Overall Study||10
2403420|NCT01318278|5896240|P3|STARTED|Overall Study||50
2403421|NCT01318278|5896241|P2|STARTED|Overall Study||10
2403422|NCT01318278|5896242|P1|STARTED|Overall Study||10
2403423|NCT01318135|5896288|P8|NOT COMPLETED|Entered - Long-Term Extension Study||3
2403424|NCT01318135|5896289|P7|NOT COMPLETED|Entered - Long-Term Extension Study||1
2403425|NCT01318135|5896290|P6|NOT COMPLETED|Entered - Long-Term Extension Study||4
2403426|NCT01318135|5896291|P5|NOT COMPLETED|Entered - Long-Term Extension Study||9
2403427|NCT01318135|5896292|P4|NOT COMPLETED|Entered - Long-Term Extension Study||7
2403428|NCT01318135|5896293|P3|NOT COMPLETED|Entered - Long-Term Extension Study||8
2403429|NCT01318135|5896294|P2|NOT COMPLETED|Entered - Long-Term Extension Study||13
2403430|NCT01318135|5896295|P1|NOT COMPLETED|Entered - Long-Term Extension Study||17
2403431|NCT01318135|5896288|P8|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|46
2403432|NCT01318135|5896289|P7|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|49
2403433|NCT01318135|5896290|P6|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|83
2403434|NCT01318135|5896291|P5|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|81
2403435|NCT01318135|5896292|P4|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|42
2403436|NCT01318135|5896293|P3|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|38
2403437|NCT01318135|5896294|P2|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|89
2403438|NCT01318135|5896295|P1|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|80
2403439|NCT01318135|5896288|P8|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|49
2403440|NCT01318135|5896289|P7|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|50
2403441|NCT01318135|5896290|P6|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|87
2403442|NCT01318135|5896291|P5|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|90
2403443|NCT01318135|5896292|P4|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|49
2403444|NCT01318135|5896293|P3|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|46
2403445|NCT01318135|5896294|P2|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|102
2403446|NCT01318135|5896295|P1|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|97
2403447|NCT01318135|5896288|P8|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
2403448|NCT01318135|5896289|P7|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
2403449|NCT01318135|5896290|P6|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
2403450|NCT01318135|5896291|P5|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
2403451|NCT01318135|5896292|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
2403452|NCT01318135|5896293|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
2403453|NCT01318135|5896294|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
2403454|NCT01318135|5896295|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
2403455|NCT01318135|5896288|P8|COMPLETED|Enrolled - Long-Term Extension Study||49
2403456|NCT01318135|5896289|P7|COMPLETED|Enrolled - Long-Term Extension Study||50
2403457|NCT01318135|5896290|P6|COMPLETED|Enrolled - Long-Term Extension Study||90
2403458|NCT01318135|5896291|P5|COMPLETED|Enrolled - Long-Term Extension Study||91
2403459|NCT01318135|5896292|P4|COMPLETED|Enrolled - Long-Term Extension Study||49
2403460|NCT01318135|5896293|P3|COMPLETED|Enrolled - Long-Term Extension Study||46
2403461|NCT01318135|5896294|P2|COMPLETED|Enrolled - Long-Term Extension Study||102
2403462|NCT01318135|5896295|P1|COMPLETED|Enrolled - Long-Term Extension Study||97
2403463|NCT01318135|5896288|P8|STARTED|Enrolled - Long-Term Extension Study||49
2403464|NCT01318135|5896289|P7|STARTED|Enrolled - Long-Term Extension Study||50
2403465|NCT01318135|5896290|P6|STARTED|Enrolled - Long-Term Extension Study||90
2403466|NCT01318135|5896291|P5|STARTED|Enrolled - Long-Term Extension Study||91
2403467|NCT01318135|5896292|P4|STARTED|Enrolled - Long-Term Extension Study||49
2403468|NCT01318135|5896293|P3|STARTED|Enrolled - Long-Term Extension Study||46
2403469|NCT01318135|5896294|P2|STARTED|Enrolled - Long-Term Extension Study||102
2403470|NCT01318135|5896295|P1|STARTED|Enrolled - Long-Term Extension Study||99
2403471|NCT01318122|5896427|P4|NOT COMPLETED|Entered - Long-Term Extension Study||4
2403472|NCT01318122|5896428|P3|NOT COMPLETED|Entered - Long-Term Extension Study||6
2403473|NCT01318122|5896429|P2|NOT COMPLETED|Entered - Long-Term Extension Study||11
2403474|NCT01318122|5896430|P1|NOT COMPLETED|Entered - Long-Term Extension Study||9
2403475|NCT01318122|5896427|P4|COMPLETED|Entered - Long-Term Extension Study||48
2403476|NCT01318122|5896428|P3|COMPLETED|Entered - Long-Term Extension Study||49
2403477|NCT01318122|5896429|P2|COMPLETED|Entered - Long-Term Extension Study||99
2403478|NCT01318122|5896430|P1|COMPLETED|Entered - Long-Term Extension Study||96
2403479|NCT01318122|5896427|P4|STARTED|Entered - Long-Term Extension Study||52
2403480|NCT01318122|5896428|P3|STARTED|Entered - Long-Term Extension Study||55
2403481|NCT01318122|5896429|P2|STARTED|Entered - Long-Term Extension Study||110
2403482|NCT01318122|5896430|P1|STARTED|Entered - Long-Term Extension Study||105
2403483|NCT01318122|5896427|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
2403484|NCT01318122|5896428|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
2403485|NCT01318122|5896429|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
2403486|NCT01318122|5896430|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
2403487|NCT01318122|5896427|P4|COMPLETED|Enrolled - Long-Term Extension Study||52
2403488|NCT01318122|5896428|P3|COMPLETED|Enrolled - Long-Term Extension Study||55
2403489|NCT01318122|5896429|P2|COMPLETED|Enrolled - Long-Term Extension Study||110
2403490|NCT01318122|5896430|P1|COMPLETED|Enrolled - Long-Term Extension Study||105
2403491|NCT01318122|5896427|P4|STARTED|Enrolled - Long-Term Extension Study||53
2403492|NCT01318122|5896428|P3|STARTED|Enrolled - Long-Term Extension Study||57
2403493|NCT01318122|5896429|P2|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|110
2403494|NCT01318122|5896430|P1|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|106
2403495|NCT01318109|5896499|P3|NOT COMPLETED|Overall Study||0
2403496|NCT01318109|5896500|P2|NOT COMPLETED|Overall Study||3
2403497|NCT01318109|5896501|P1|NOT COMPLETED|Overall Study||1
2403498|NCT01318109|5896499|P3|COMPLETED|Overall Study||100
2403499|NCT01318109|5896500|P2|COMPLETED|Overall Study||93
2403500|NCT01318109|5896501|P1|COMPLETED|Overall Study||91
2403501|NCT01318109|5896499|P3|STARTED|Overall Study||100
2403502|NCT01318109|5896500|P2|STARTED|Overall Study||96
2403503|NCT01318109|5896501|P1|STARTED|Overall Study||92
2403504|NCT01318083|5896536|P3|NOT COMPLETED|Overall Study||5
2403505|NCT01318083|5896537|P2|NOT COMPLETED|Overall Study||2
2403506|NCT01318083|5896538|P1|NOT COMPLETED|Overall Study||6
2403507|NCT01318083|5896536|P3|COMPLETED|Overall Study||98
2403508|NCT01318083|5896537|P2|COMPLETED|Overall Study||102
2403509|NCT01318083|5896538|P1|COMPLETED|Overall Study||99
2403510|NCT01318083|5896536|P3|STARTED|Overall Study||103
2403511|NCT01318083|5896537|P2|STARTED|Overall Study||104
2403512|NCT01318083|5896538|P1|STARTED|Overall Study||105
2403513|NCT01318070|5896573|P3|NOT COMPLETED|Overall Study||7
2403514|NCT01318070|5896574|P2|NOT COMPLETED|Overall Study||2
2403515|NCT01318070|5896575|P1|NOT COMPLETED|Overall Study||2
2403516|NCT01318070|5896573|P3|COMPLETED|Overall Study||108
2403517|NCT01318070|5896574|P2|COMPLETED|Overall Study||111
2403518|NCT01318070|5896575|P1|COMPLETED|Overall Study||109
2403519|NCT01318070|5896573|P3|STARTED|Overall Study||115
2403520|NCT01318070|5896574|P2|STARTED|Overall Study||113
2403521|NCT01318070|5896575|P1|STARTED|Overall Study||111
2403522|NCT01318018|5896609|P2|NOT COMPLETED|Overall Study||0
2403523|NCT01318018|5896610|P1|NOT COMPLETED|Overall Study||0
2403524|NCT01318018|5896609|P2|COMPLETED|Overall Study||10
2403525|NCT01318018|5896610|P1|COMPLETED|Overall Study||10
2403526|NCT01318018|5896609|P2|STARTED|Overall Study||10
2403527|NCT01318018|5896610|P1|STARTED|Overall Study||10
2403528|NCT01317901|5896618|P2|NOT COMPLETED|Overall Study||0
2403529|NCT01317901|5896619|P1|NOT COMPLETED|Overall Study||0
2403530|NCT01317901|5896618|P2|COMPLETED|Overall Study||6
2403531|NCT01317901|5896619|P1|COMPLETED|Overall Study||6
2403532|NCT01317901|5896618|P2|STARTED|Overall Study||6
2403533|NCT01317901|5896619|P1|STARTED|Overall Study||6
2403534|NCT01317797|5896628|P3|NOT COMPLETED|Overall Study||1
2403535|NCT01317797|5896629|P2|NOT COMPLETED|Overall Study||1
2403536|NCT01317797|5896630|P1|NOT COMPLETED|Overall Study||0
2403537|NCT01317797|5896628|P3|COMPLETED|Overall Study||8
2403538|NCT01317797|5896629|P2|COMPLETED|Overall Study||6
2403539|NCT01317797|5896630|P1|COMPLETED|Overall Study||8
2403540|NCT01317797|5896628|P3|STARTED|Overall Study||9
2403541|NCT01317797|5896629|P2|STARTED|Overall Study||7
2403542|NCT01317797|5896630|P1|STARTED|Overall Study||8
2403543|NCT01317667|5896685|P3|NOT COMPLETED|Overall Study||0
2403544|NCT01317667|5896686|P2|NOT COMPLETED|Overall Study||0
2403545|NCT01317667|5896687|P1|NOT COMPLETED|Overall Study||0
2403546|NCT01317667|5896685|P3|COMPLETED|Overall Study|The original trial design was modified to limit the number of vaccinations in Group 3 to 1 dose.|10
2403547|NCT01317667|5896686|P2|COMPLETED|Overall Study||10
2403548|NCT01317667|5896687|P1|COMPLETED|Overall Study||10
2403549|NCT01317667|5896685|P3|STARTED|Overall Study||10
2403550|NCT01317667|5896686|P2|STARTED|Overall Study||10
2403551|NCT01317667|5896687|P1|STARTED|Overall Study||10
2403552|NCT01317641|5896707|P9|NOT COMPLETED|Overall Study||5
2403553|NCT01317641|5896708|P8|NOT COMPLETED|Overall Study||5
2403554|NCT01317641|5896709|P7|NOT COMPLETED|Overall Study||3
2403555|NCT01317641|5896710|P6|NOT COMPLETED|Overall Study||0
2403556|NCT01317641|5896711|P5|NOT COMPLETED|Overall Study||0
2403557|NCT01317641|5896712|P4|NOT COMPLETED|Overall Study||1
2403558|NCT01317641|5896713|P3|NOT COMPLETED|Overall Study||0
2403559|NCT01317641|5896714|P2|NOT COMPLETED|Overall Study||1
2403560|NCT01317641|5896715|P1|NOT COMPLETED|Overall Study||1
2403561|NCT01317641|5896707|P9|COMPLETED|Overall Study||31
2403562|NCT01317641|5896708|P8|COMPLETED|Overall Study||33
2403563|NCT01317641|5896709|P7|COMPLETED|Overall Study||35
2403564|NCT01317641|5896710|P6|COMPLETED|Overall Study||3
2403565|NCT01317641|5896711|P5|COMPLETED|Overall Study||3
2403566|NCT01317641|5896712|P4|COMPLETED|Overall Study||3
2403567|NCT01317641|5896713|P3|COMPLETED|Overall Study||3
2403568|NCT01317641|5896714|P2|COMPLETED|Overall Study||6
2403569|NCT01317641|5896715|P1|COMPLETED|Overall Study||3
2403570|NCT01317641|5896707|P9|STARTED|Overall Study||36
2403571|NCT01317641|5896708|P8|STARTED|Overall Study||38
2403572|NCT01317641|5896709|P7|STARTED|Overall Study||38
2403573|NCT01317641|5896710|P6|STARTED|Overall Study||3
2403574|NCT01317641|5896711|P5|STARTED|Overall Study||3
2403575|NCT01317641|5896712|P4|STARTED|Overall Study||4
2403576|NCT01317641|5896713|P3|STARTED|Overall Study||3
2403577|NCT01317641|5896714|P2|STARTED|Overall Study||7
2403578|NCT01317641|5896715|P1|STARTED|Overall Study||4
2403579|NCT01317615|5896817|P1|NOT COMPLETED|Overall Study||49
2403580|NCT01317615|5896817|P1|COMPLETED|Overall Study||0
2403581|NCT01317615|5896817|P1|STARTED|Overall Study||49
2403582|NCT01317550|5896830|P4|NOT COMPLETED|Overall Study||0
2403583|NCT01317550|5896831|P3|NOT COMPLETED|Overall Study||0
2403584|NCT01317550|5896832|P2|NOT COMPLETED|Overall Study||0
2403585|NCT01317550|5896833|P1|NOT COMPLETED|Overall Study||2
2403586|NCT01317550|5896830|P4|COMPLETED|Overall Study||3
2403587|NCT01317550|5896831|P3|COMPLETED|Overall Study||3
2403588|NCT01317550|5896832|P2|COMPLETED|Overall Study||3
2403589|NCT01317550|5896833|P1|COMPLETED|Overall Study||3
2403590|NCT01317550|5896830|P4|STARTED|Overall Study||3
2403591|NCT01317550|5896831|P3|STARTED|Overall Study||3
2403592|NCT01317550|5896832|P2|STARTED|Overall Study||3
2403593|NCT01317550|5896833|P1|STARTED|Overall Study||5
2403594|NCT01317472|5896845|P2|NOT COMPLETED|Overall Study||0
2403595|NCT01317472|5896846|P1|NOT COMPLETED|Overall Study||2
2403596|NCT01317472|5896845|P2|COMPLETED|Overall Study||2
2403597|NCT01317472|5896846|P1|COMPLETED|Overall Study||7
2403598|NCT01317472|5896845|P2|STARTED|Overall Study||2
2403599|NCT01317472|5896846|P1|STARTED|Overall Study||9
2403600|NCT01317199|5896856|P4|NOT COMPLETED|Randomized Phase 2||17
2403601|NCT01317199|5896857|P3|NOT COMPLETED|Randomized Phase 2||21
2403602|NCT01317199|5896858|P2|NOT COMPLETED|Randomized Phase 2||11
2403603|NCT01317199|5896859|P1|NOT COMPLETED|Randomized Phase 2||0
2403604|NCT01317199|5896856|P4|COMPLETED|Randomized Phase 2||32
2403605|NCT01317199|5896857|P3|COMPLETED|Randomized Phase 2||35
2403606|NCT01317199|5896858|P2|COMPLETED|Randomized Phase 2||13
2403607|NCT01317199|5896859|P1|COMPLETED|Randomized Phase 2||0
2403608|NCT01317199|5896856|P4|STARTED|Randomized Phase 2||49
2403609|NCT01317199|5896857|P3|STARTED|Randomized Phase 2||56
2403610|NCT01317199|5896858|P2|STARTED|Randomized Phase 2||24
2403611|NCT01317199|5896859|P1|STARTED|Randomized Phase 2||0
2403612|NCT01317199|5896856|P4|NOT COMPLETED|Dose-escalation Phase 1||0
2403613|NCT01317199|5896857|P3|NOT COMPLETED|Dose-escalation Phase 1||0
2403614|NCT01317199|5896858|P2|NOT COMPLETED|Dose-escalation Phase 1||0
2403615|NCT01317199|5896859|P1|NOT COMPLETED|Dose-escalation Phase 1||7
2403616|NCT01317199|5896856|P4|COMPLETED|Dose-escalation Phase 1||0
2403617|NCT01317199|5896857|P3|COMPLETED|Dose-escalation Phase 1||0
2403618|NCT01317199|5896858|P2|COMPLETED|Dose-escalation Phase 1||0
2403619|NCT01317199|5896859|P1|COMPLETED|Dose-escalation Phase 1||7
2403620|NCT01317199|5896856|P4|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
2403621|NCT01317199|5896857|P3|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
2403622|NCT01317199|5896858|P2|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
2403623|NCT01317199|5896859|P1|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||6
2403624|NCT01317199|5896856|P4|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
2403625|NCT01317199|5896857|P3|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
2403626|NCT01317199|5896858|P2|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
2403627|NCT01317199|5896859|P1|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
2403628|NCT01317199|5896856|P4|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
2403629|NCT01317199|5896857|P3|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
2403630|NCT01317199|5896858|P2|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
2403631|NCT01317199|5896859|P1|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
2403632|NCT01317199|5896856|P4|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
2403633|NCT01317199|5896857|P3|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
2403634|NCT01317199|5896858|P2|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
2403635|NCT01317199|5896859|P1|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
2403636|NCT01317199|5896856|P4|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
2403637|NCT01317199|5896857|P3|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
2403638|NCT01317199|5896858|P2|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
2403639|NCT01317199|5896859|P1|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||2
2403640|NCT01317199|5896856|P4|STARTED|Dose-escalation Phase 1||0
2403641|NCT01317199|5896857|P3|STARTED|Dose-escalation Phase 1||0
2403642|NCT01317199|5896858|P2|STARTED|Dose-escalation Phase 1||0
2403643|NCT01317199|5896859|P1|STARTED|Dose-escalation Phase 1||14
2403652|NCT01317095|5896899|P2|NOT COMPLETED|Overall Study||0
2403653|NCT01317095|5896900|P1|NOT COMPLETED|Overall Study||0
2403654|NCT01317095|5896899|P2|COMPLETED|Overall Study||41
2403655|NCT01317095|5896900|P1|COMPLETED|Overall Study||39
2403656|NCT01317095|5896899|P2|STARTED|Overall Study||41
2403657|NCT01317095|5896900|P1|STARTED|Overall Study||39
2403658|NCT01317030|5896914|P2|NOT COMPLETED|Overall Study||0
2403659|NCT01317030|5896915|P1|NOT COMPLETED|Overall Study||0
2403660|NCT01317030|5896914|P2|COMPLETED|Overall Study||13
2403661|NCT01317030|5896915|P1|COMPLETED|Overall Study||12
2403662|NCT01317030|5896914|P2|STARTED|Overall Study||13
2403663|NCT01317030|5896915|P1|STARTED|Overall Study||12
2403664|NCT01317004|5896923|P2|NOT COMPLETED|Overall Study||9
2403665|NCT01317004|5896924|P1|NOT COMPLETED|Overall Study||4
2403666|NCT01317004|5896923|P2|COMPLETED|Overall Study||5
2403667|NCT01317004|5896924|P1|COMPLETED|Overall Study||47
2403668|NCT01317004|5896923|P2|Safety Set|Overall Study||11
2403669|NCT01317004|5896924|P1|Safety Set|Overall Study||50
2403670|NCT01317004|5896923|P2|STARTED|Overall Study||14
2403671|NCT01317004|5896924|P1|STARTED|Overall Study||51
2403672|NCT01316939|5896945|P3|NOT COMPLETED|Overall Study||69
2403673|NCT01316939|5896946|P2|NOT COMPLETED|Overall Study||68
2403674|NCT01316939|5896947|P1|NOT COMPLETED|Overall Study||63
2403675|NCT01316939|5896945|P3|COMPLETED|Overall Study||7
2403676|NCT01316939|5896946|P2|COMPLETED|Overall Study||9
2403677|NCT01316939|5896947|P1|COMPLETED|Overall Study||13
2403678|NCT01316939|5896945|P3|STARTED|Overall Study||76
2403679|NCT01316939|5896946|P2|STARTED|Overall Study||77
2403680|NCT01316939|5896947|P1|STARTED|Overall Study||76
2403681|NCT01316926|5897027|P2|NOT COMPLETED|Period 2||0
2403682|NCT01316926|5897028|P1|NOT COMPLETED|Period 2||0
2403683|NCT01316926|5897027|P2|COMPLETED|Period 2||30
2403684|NCT01316926|5897028|P1|COMPLETED|Period 2||29
2403685|NCT01316926|5897027|P2|STARTED|Period 2||30
2403686|NCT01316926|5897028|P1|STARTED|Period 2|One participant completed Period 1, but did not appear in Period 2|29
2403687|NCT01316926|5897027|P2|NOT COMPLETED|Period 1||0
2403688|NCT01316926|5897028|P1|NOT COMPLETED|Period 1||0
2403689|NCT01316926|5897027|P2|COMPLETED|Period 1||30
2403690|NCT01316926|5897028|P1|COMPLETED|Period 1||30
2403691|NCT01316926|5897027|P2|STARTED|Period 1||30
2403692|NCT01316926|5897028|P1|STARTED|Period 1||30
2403693|NCT01316913|5897042|P4|NOT COMPLETED|Overall Study||39
2403694|NCT01316913|5897043|P3|NOT COMPLETED|Overall Study||49
2403695|NCT01316913|5897044|P2|NOT COMPLETED|Overall Study||54
2403696|NCT01316913|5897045|P1|NOT COMPLETED|Overall Study||57
2403697|NCT01316913|5897042|P4|COMPLETED|Overall Study||176
2403698|NCT01316913|5897043|P3|COMPLETED|Overall Study||166
2403699|NCT01316913|5897044|P2|COMPLETED|Overall Study||163
2403700|NCT01316913|5897045|P1|COMPLETED|Overall Study||165
2403701|NCT01316913|5897042|P4|STARTED|Overall Study||215
2403702|NCT01316913|5897043|P3|STARTED|Overall Study||215
2403703|NCT01316913|5897044|P2|STARTED|Overall Study||217
2403704|NCT01316913|5897045|P1|STARTED|Overall Study||222
2403705|NCT01316900|5897067|P4|NOT COMPLETED|Overall Study||31
2403706|NCT01316900|5897068|P3|NOT COMPLETED|Overall Study||41
2403707|NCT01316900|5897069|P2|NOT COMPLETED|Overall Study||31
2403708|NCT01316900|5897070|P1|NOT COMPLETED|Overall Study||44
2403709|NCT01316900|5897067|P4|COMPLETED|Overall Study||177
2403710|NCT01316900|5897068|P3|COMPLETED|Overall Study||173
2403711|NCT01316900|5897069|P2|COMPLETED|Overall Study||181
2403712|NCT01316900|5897070|P1|COMPLETED|Overall Study||165
2403713|NCT01316900|5897067|P4|STARTED|Overall Study||208
2403714|NCT01316900|5897068|P3|STARTED|Overall Study||214
2403715|NCT01316900|5897069|P2|STARTED|Overall Study||212
2403716|NCT01316900|5897070|P1|STARTED|Overall Study||209
2403717|NCT01316887|5897091|P3|NOT COMPLETED|Overall Study||83
2403718|NCT01316887|5897092|P2|NOT COMPLETED|Overall Study||94
2403719|NCT01316887|5897093|P1|NOT COMPLETED|Overall Study||43
2403720|NCT01316887|5897091|P3|COMPLETED|Overall Study||143
2403721|NCT01316887|5897092|P2|COMPLETED|Overall Study||133
2403722|NCT01316887|5897093|P1|COMPLETED|Overall Study||66
2403723|NCT01316887|5897091|P3|STARTED|Overall Study||226
2403724|NCT01316887|5897092|P2|STARTED|Overall Study||227
2403725|NCT01316887|5897093|P1|STARTED|Overall Study||109
2403726|NCT01316770|5897155|P2|NOT COMPLETED|Overall Study||0
2403727|NCT01316770|5897156|P1|NOT COMPLETED|Overall Study||0
2403728|NCT01316770|5897155|P2|COMPLETED|Overall Study||9
2403729|NCT01316770|5897156|P1|COMPLETED|Overall Study||9
2403730|NCT01316770|5897155|P2|STARTED|Overall Study|Each study participant received the placebo parotid irrigation on the other side of mouth.|9
2403731|NCT01316770|5897156|P1|STARTED|Overall Study|Each study participant received the dexamethasone parotid irrigation on one side of mouth.|9
2403732|NCT01316692|5897218|P1|NOT COMPLETED|Overall Study||12
2403733|NCT01316692|5897218|P1|COMPLETED|Overall Study||0
2403734|NCT01316692|5897218|P1|STARTED|Overall Study||12
2403735|NCT01316614|5897227|P1|NOT COMPLETED|Overall Study||37
2403736|NCT01316614|5897227|P1|COMPLETED|Overall Study||100
2403737|NCT01316614|5897227|P1|STARTED|Overall Study||137
2403738|NCT01316575|5897244|P2|NOT COMPLETED|Overall Study||1
2403739|NCT01316575|5897245|P1|NOT COMPLETED|Overall Study||2
2403740|NCT01316575|5897244|P2|COMPLETED|Overall Study||19
2403741|NCT01316575|5897245|P1|COMPLETED|Overall Study||18
2403742|NCT01316575|5897244|P2|STARTED|Overall Study||20
2403743|NCT01316575|5897245|P1|STARTED|Overall Study||20
2403744|NCT01316510|5897259|P2|NOT COMPLETED|Overall Study||0
2403745|NCT01316510|5897260|P1|NOT COMPLETED|Overall Study||0
2403746|NCT01316510|5897259|P2|COMPLETED|Overall Study||12
2403747|NCT01316510|5897260|P1|COMPLETED|Overall Study||12
2403748|NCT01316510|5897259|P2|STARTED|Overall Study||12
2403749|NCT01316510|5897260|P1|STARTED|Overall Study||12
2403750|NCT01316419|5897268|P1|NOT COMPLETED|Overall Study||265
2403751|NCT01316419|5897268|P1|COMPLETED|Overall Study||1824
2403752|NCT01316419|5897268|P1|STARTED|Overall Study||2089
2403753|NCT01316380|5897294|P3|NOT COMPLETED|Overall Study||3
2403754|NCT01316380|5897295|P2|NOT COMPLETED|Overall Study||5
2403755|NCT01316380|5897296|P1|NOT COMPLETED|Overall Study||2
2403756|NCT01316380|5897294|P3|COMPLETED|Overall Study||152
2403757|NCT01316380|5897295|P2|COMPLETED|Overall Study||149
2403758|NCT01316380|5897296|P1|COMPLETED|Overall Study||154
2403759|NCT01316380|5897294|P3|STARTED|Overall Study||155
2403760|NCT01316380|5897295|P2|STARTED|Overall Study||154
2403761|NCT01316380|5897296|P1|STARTED|Overall Study||156
2403762|NCT01316341|5897337|P3|NOT COMPLETED|Overall Study||0
2403763|NCT01316341|5897338|P2|NOT COMPLETED|Overall Study||0
2403764|NCT01316341|5897339|P1|NOT COMPLETED|Overall Study||0
2403765|NCT01316341|5897337|P3|COMPLETED|Overall Study||9
2403766|NCT01316341|5897338|P2|COMPLETED|Overall Study||9
2403767|NCT01316341|5897339|P1|COMPLETED|Overall Study||6
2403768|NCT01316341|5897337|P3|STARTED|Overall Study||9
2403769|NCT01316341|5897338|P2|STARTED|Overall Study||9
2403770|NCT01316341|5897339|P1|STARTED|Overall Study||6
2403771|NCT01316315|5897407|P2|NOT COMPLETED|Sequence 2||0
2403772|NCT01316315|5897408|P1|NOT COMPLETED|Sequence 2||0
2403773|NCT01316315|5897407|P2|COMPLETED|Sequence 2||7
2403774|NCT01316315|5897408|P1|COMPLETED|Sequence 2||7
2403775|NCT01316315|5897407|P2|STARTED|Sequence 2||7
2403776|NCT01316315|5897408|P1|STARTED|Sequence 2||7
2403777|NCT01316315|5897407|P2|NOT COMPLETED|Sequence 1||0
2403778|NCT01316315|5897408|P1|NOT COMPLETED|Sequence 1||0
2403779|NCT01316315|5897407|P2|COMPLETED|Sequence 1||7
2403780|NCT01316315|5897408|P1|COMPLETED|Sequence 1||7
2403781|NCT01316315|5897407|P2|STARTED|Sequence 1||7
2403782|NCT01316315|5897408|P1|STARTED|Sequence 1||7
2403783|NCT01316302|5897422|P2|NOT COMPLETED|Overall Study||11
2403784|NCT01316302|5897423|P1|NOT COMPLETED|Overall Study||10
2403785|NCT01316302|5897422|P2|COMPLETED|Overall Study||22
2403786|NCT01316302|5897423|P1|COMPLETED|Overall Study||20
2403787|NCT01316302|5897422|P2|STARTED|Overall Study||33
2403788|NCT01316302|5897423|P1|STARTED|Overall Study||30
2403789|NCT01316276|5897433|P1|NOT COMPLETED|Overall Study||67
2403790|NCT01316276|5897433|P1|COMPLETED|Overall Study||139
2403791|NCT01316276|5897433|P1|STARTED|Overall Study||206
2403792|NCT01316263|5897454|P2|NOT COMPLETED|Overall Study||0
2403793|NCT01316263|5897455|P1|NOT COMPLETED|Overall Study||0
2403794|NCT01316263|5897454|P2|COMPLETED|Overall Study||14
2403795|NCT01316263|5897455|P1|COMPLETED|Overall Study||7
2403796|NCT01316263|5897454|P2|Received Any Study Drug|Overall Study||14
2403797|NCT01316263|5897455|P1|Received Any Study Drug|Overall Study||7
2403798|NCT01316263|5897454|P2|STARTED|Overall Study||14
2403799|NCT01316263|5897455|P1|STARTED|Overall Study||7
2403800|NCT01316224|5897481|P1|NOT COMPLETED|Overall Study||10
2403801|NCT01316224|5897481|P1|COMPLETED|Overall Study||42
2403802|NCT01316224|5897481|P1|Completed Visit 4 to Rheumatologist|Overall Study||28
2403803|NCT01316224|5897481|P1|Completed Visit 4 to Dermatologist|Overall Study||42
2403804|NCT01316224|5897481|P1|Completed Visit 3 to Rheumatologist|Overall Study||39
2403805|NCT01316224|5897481|P1|Completed Visit 3 to Dermatologist|Overall Study||48
2403806|NCT01316224|5897481|P1|Completed Visit 2 to Dermatologist|Overall Study||51
2403807|NCT01316224|5897481|P1|Completed Visit 1 to Rheumatologist|Overall Study||49
2403808|NCT01316224|5897481|P1|Completed Visit 1 to Dermatologist|Overall Study||52
2403809|NCT01316224|5897481|P1|STARTED|Overall Study||52
2403810|NCT01316055|5897498|P3|NOT COMPLETED|Overall Study||0
2403811|NCT01316055|5897499|P2|NOT COMPLETED|Overall Study||0
2403812|NCT01316055|5897500|P1|NOT COMPLETED|Overall Study||1
2403813|NCT01316055|5897498|P3|COMPLETED|Overall Study||12
2403814|NCT01316055|5897499|P2|COMPLETED|Overall Study||17
2403815|NCT01316055|5897500|P1|COMPLETED|Overall Study||12
2403816|NCT01316055|5897498|P3|STARTED|Overall Study||12
2403817|NCT01316055|5897499|P2|STARTED|Overall Study||17
2403818|NCT01316055|5897500|P1|STARTED|Overall Study||13
2403819|NCT01316042|5897516|P2|NOT COMPLETED|Overall Study||1
2403820|NCT01316042|5897517|P1|NOT COMPLETED|Overall Study||0
2403821|NCT01316042|5897516|P2|COMPLETED|Overall Study||1
2403822|NCT01316042|5897517|P1|COMPLETED|Overall Study||2
2403823|NCT01316042|5897516|P2|STARTED|Overall Study||2
2403824|NCT01316042|5897517|P1|STARTED|Overall Study||2
2403825|NCT01315873|5897523|P1|NOT COMPLETED|Overall Study||0
2403826|NCT01315873|5897523|P1|COMPLETED|Overall Study||24
2403827|NCT01315873|5897523|P1|STARTED|Overall Study||24
2403828|NCT01315847|5897531|P2|NOT COMPLETED|Part III, Period 2||0
2403829|NCT01315847|5897532|P1|NOT COMPLETED|Part III, Period 2||0
2403830|NCT01315847|5897531|P2|COMPLETED|Part III, Period 2||3
2403831|NCT01315847|5897532|P1|COMPLETED|Part III, Period 2||0
2403832|NCT01315847|5897531|P2|Received [11C]MK-4232|Part III, Period 2||3
2403833|NCT01315847|5897532|P1|Received [11C]MK-4232|Part III, Period 2||0
2403834|NCT01315847|5897531|P2|Received Telcagepant|Part III, Period 2||3
2403835|NCT01315847|5897532|P1|Received Telcagepant|Part III, Period 2||0
2403836|NCT01315847|5897531|P2|STARTED|Part III, Period 2||3
2403837|NCT01315847|5897532|P1|STARTED|Part III, Period 2||0
2403838|NCT01315847|5897531|P2|NOT COMPLETED|Part III, Period 1||1
2403839|NCT01315847|5897532|P1|NOT COMPLETED|Part III, Period 1||0
2403840|NCT01315847|5897531|P2|COMPLETED|Part III, Period 1||3
2403841|NCT01315847|5897532|P1|COMPLETED|Part III, Period 1||0
2403842|NCT01315847|5897531|P2|Received [11C]MK-4232|Part III, Period 1|One of these participants received [11C]MK-4232 only at baseline.|4
2403843|NCT01315847|5897532|P1|Received [11C]MK-4232|Part III, Period 1||0
2403844|NCT01315847|5897531|P2|Received Telcagepant|Part III, Period 1||4
2403845|NCT01315847|5897532|P1|Received Telcagepant|Part III, Period 1||0
2403846|NCT01315847|5897531|P2|STARTED|Part III, Period 1|Subjects who participated in Part III did not participate in Part I.|4
2403847|NCT01315847|5897532|P1|STARTED|Part III, Period 1||0
2403848|NCT01315847|5897531|P2|NOT COMPLETED|Part I, Period 2||0
2403849|NCT01315847|5897532|P1|NOT COMPLETED|Part I, Period 2||0
2403850|NCT01315847|5897531|P2|COMPLETED|Part I, Period 2||0
2403851|NCT01315847|5897532|P1|COMPLETED|Part I, Period 2||3
2403852|NCT01315847|5897531|P2|Received [11C]MK-4232|Part I, Period 2||0
2403853|NCT01315847|5897532|P1|Received [11C]MK-4232|Part I, Period 2||3
2403854|NCT01315847|5897531|P2|Received Telcagepant|Part I, Period 2||0
2403855|NCT01315847|5897532|P1|Received Telcagepant|Part I, Period 2||3
2403856|NCT01315847|5897531|P2|STARTED|Part I, Period 2||0
2403857|NCT01315847|5897532|P1|STARTED|Part I, Period 2|One of these subjects did not participate in Part I, Period 1.|3
2403858|NCT01315847|5897531|P2|NOT COMPLETED|Part I, Period 1||0
2403859|NCT01315847|5897532|P1|NOT COMPLETED|Part I, Period 1||3
2403860|NCT01315847|5897531|P2|COMPLETED|Part I, Period 1||0
2403861|NCT01315847|5897532|P1|COMPLETED|Part I, Period 1||2
2403862|NCT01315847|5897531|P2|Received [11C]MK-4232|Part I, Period 1||0
2403863|NCT01315847|5897532|P1|Received [11C]MK-4232|Part I, Period 1|One of these participants received [11C]MK-4232 only at baseline.|5
2403864|NCT01315847|5897531|P2|Received Telcagepant|Part I, Period 1||0
2403865|NCT01315847|5897532|P1|Received Telcagepant|Part I, Period 1||5
2403866|NCT01315847|5897531|P2|STARTED|Part I, Period 1||0
2403867|NCT01315847|5897532|P1|STARTED|Part I, Period 1|Subjects who participated in Part I did not participate in Part III.|5
2403868|NCT01315678|5897546|P2|NOT COMPLETED|Overall Study||6
2403869|NCT01315678|5897547|P1|NOT COMPLETED|Overall Study||14
2403870|NCT01315678|5897546|P2|COMPLETED|Overall Study||140
2403871|NCT01315678|5897547|P1|COMPLETED|Overall Study||134
2403872|NCT01315678|5897546|P2|STARTED|Overall Study||146
2403873|NCT01315678|5897547|P1|STARTED|Overall Study||148
2403874|NCT01315665|5897567|P2|NOT COMPLETED|Overall Study||0
2403875|NCT01315665|5897568|P1|NOT COMPLETED|Overall Study||0
2403876|NCT01315665|5897567|P2|COMPLETED|Overall Study||5
2403877|NCT01315665|5897568|P1|COMPLETED|Overall Study||10
2403878|NCT01315665|5897567|P2|STARTED|Overall Study||5
2403879|NCT01315665|5897568|P1|STARTED|Overall Study||10
2403880|NCT01315574|5897584|P2|NOT COMPLETED|Overall Study||0
2403881|NCT01315574|5897585|P1|NOT COMPLETED|Overall Study||0
2403882|NCT01315574|5897584|P2|COMPLETED|Overall Study||7
2403883|NCT01315574|5897585|P1|COMPLETED|Overall Study||7
2403884|NCT01315574|5897584|P2|STARTED|Overall Study||7
2403885|NCT01315574|5897585|P1|STARTED|Overall Study||7
2403886|NCT01315353|5897598|P3|NOT COMPLETED|Overall Study||13
2403887|NCT01315353|5897599|P2|NOT COMPLETED|Overall Study||23
2403888|NCT01315353|5897600|P1|NOT COMPLETED|Overall Study||29
2403889|NCT01315353|5897598|P3|COMPLETED|Overall Study||166
2403890|NCT01315353|5897599|P2|COMPLETED|Overall Study||120
2403891|NCT01315353|5897600|P1|COMPLETED|Overall Study||116
2403892|NCT01315353|5897598|P3|STARTED|Overall Study||179
2403893|NCT01315353|5897599|P2|STARTED|Overall Study||143
2403894|NCT01315353|5897600|P1|STARTED|Overall Study||145
2403895|NCT01315249|5897627|P2|NOT COMPLETED|Overall Study||47
2403896|NCT01315249|5897628|P1|NOT COMPLETED|Overall Study||44
2403897|NCT01315249|5897627|P2|COMPLETED|Overall Study||217
2403898|NCT01315249|5897628|P1|COMPLETED|Overall Study||215
2403899|NCT01315249|5897627|P2|STARTED|Overall Study||264
2403900|NCT01315249|5897628|P1|STARTED|Overall Study||259
2403901|NCT01315236|5897656|P2|NOT COMPLETED|12-Month Follow-up Period||1
2403902|NCT01315236|5897657|P1|NOT COMPLETED|12-Month Follow-up Period||1
2403903|NCT01315236|5897656|P2|COMPLETED|12-Month Follow-up Period||31
2403904|NCT01315236|5897657|P1|COMPLETED|12-Month Follow-up Period||26
2403905|NCT01315236|5897656|P2|STARTED|12-Month Follow-up Period|Some subjects did not consent to the 12 month safety.|32
2403906|NCT01315236|5897657|P1|STARTED|12-Month Follow-up Period|Some subjects did not consent to the 12 month safety.|27
2403907|NCT01315236|5897656|P2|NOT COMPLETED|Open-label Phase||2
2403908|NCT01315236|5897657|P1|NOT COMPLETED|Open-label Phase||1
2403909|NCT01315236|5897656|P2|COMPLETED|Open-label Phase||41
2403910|NCT01315236|5897657|P1|COMPLETED|Open-label Phase||34
2403911|NCT01315236|5897656|P2|STARTED|Open-label Phase|Some subjects did not consent to the open label after the double blind phase.|43
2403912|NCT01315236|5897657|P1|STARTED|Open-label Phase|Some subjects did not consent to the open label after the double blind phase.|35
2403913|NCT01315236|5897656|P2|NOT COMPLETED|Double-blind Phase||0
2403914|NCT01315236|5897657|P1|NOT COMPLETED|Double-blind Phase||4
2403915|NCT01315236|5897656|P2|COMPLETED|Double-blind Phase||45
2403916|NCT01315236|5897657|P1|COMPLETED|Double-blind Phase||40
2403917|NCT01315236|5897656|P2|STARTED|Double-blind Phase||45
2403918|NCT01315236|5897657|P1|STARTED|Double-blind Phase||44
2403919|NCT01315158|5897681|P2|NOT COMPLETED|Overall Study||0
2403920|NCT01315158|5897682|P1|NOT COMPLETED|Overall Study||0
2403921|NCT01315158|5897681|P2|COMPLETED|Overall Study||19
2403922|NCT01315158|5897682|P1|COMPLETED|Overall Study||17
2403923|NCT01315158|5897681|P2|STARTED|Overall Study||19
2403924|NCT01315158|5897682|P1|STARTED|Overall Study||17
2403925|NCT01315145|5897706|P2|NOT COMPLETED|Overall Study||5
2403926|NCT01315145|5897707|P1|NOT COMPLETED|Overall Study||17
2403927|NCT01315145|5897706|P2|COMPLETED|Overall Study||11
2403928|NCT01315145|5897707|P1|COMPLETED|Overall Study||105
2403929|NCT01315145|5897706|P2|STARTED|Overall Study||16
2403930|NCT01315145|5897707|P1|STARTED|Overall Study||122
2403931|NCT01315132|5897713|P1|NOT COMPLETED|Overall Study||1
2403932|NCT01315132|5897713|P1|COMPLETED|Overall Study||46
2403933|NCT01315132|5897713|P1|STARTED|Overall Study||47
2403934|NCT01315028|5897720|P2|NOT COMPLETED|Overall Study||1
2403935|NCT01315028|5897721|P1|NOT COMPLETED|Overall Study||1
2403936|NCT01315028|5897720|P2|COMPLETED|Overall Study||9
2403937|NCT01315028|5897721|P1|COMPLETED|Overall Study||9
2403938|NCT01315028|5897720|P2|STARTED|Overall Study||10
2403939|NCT01315028|5897721|P1|STARTED|Overall Study||10
2403940|NCT01315002|5897733|P2|NOT COMPLETED|Overall Study||5
2403941|NCT01315002|5897734|P1|NOT COMPLETED|Overall Study||5
2403942|NCT01315002|5897733|P2|COMPLETED|Overall Study||55
2403943|NCT01315002|5897734|P1|COMPLETED|Overall Study||56
2403944|NCT01315002|5897733|P2|STARTED|Overall Study||60
2403945|NCT01315002|5897734|P1|STARTED|Overall Study||61
2403946|NCT01314963|5897740|P1|NOT COMPLETED|Overall Study||0
2403947|NCT01314963|5897740|P1|COMPLETED|Overall Study||50
2403948|NCT01314963|5897740|P1|STARTED|Overall Study||50
2403949|NCT01314911|5897748|P2|NOT COMPLETED|Overall Study||6
2403950|NCT01314911|5897749|P1|NOT COMPLETED|Overall Study||5
2403951|NCT01314911|5897748|P2|COMPLETED|Overall Study||274
2403952|NCT01314911|5897749|P1|COMPLETED|Overall Study||273
2403953|NCT01314911|5897748|P2|STARTED|Overall Study||280
2403954|NCT01314911|5897749|P1|STARTED|Overall Study||278
2403955|NCT01314872|5897800|P15|NOT COMPLETED|Period 2||24
2403956|NCT01314872|5897801|P14|NOT COMPLETED|Period 2||53
2403957|NCT01314872|5897802|P13|NOT COMPLETED|Period 2||60
2403958|NCT01314872|5897803|P12|NOT COMPLETED|Period 2||48
2403959|NCT01314872|5897804|P11|NOT COMPLETED|Period 2||0
2403960|NCT01314872|5897805|P10|NOT COMPLETED|Period 2||0
2403961|NCT01314872|5897806|P9|NOT COMPLETED|Period 2||0
2403962|NCT01314872|5897807|P8|NOT COMPLETED|Period 2||0
2403963|NCT01314872|5897808|P7|NOT COMPLETED|Period 2||0
2403964|NCT01314872|5897809|P6|NOT COMPLETED|Period 2||0
2403965|NCT01314872|5897810|P5|NOT COMPLETED|Period 2||0
2403966|NCT01314872|5897811|P4|NOT COMPLETED|Period 2||0
2403967|NCT01314872|5897812|P3|NOT COMPLETED|Period 2||0
2403968|NCT01314872|5897813|P2|NOT COMPLETED|Period 2||0
2403969|NCT01314872|5897814|P1|NOT COMPLETED|Period 2||0
2403970|NCT01314872|5897800|P15|COMPLETED|Period 2||110
2403971|NCT01314872|5897801|P14|COMPLETED|Period 2||187
2403972|NCT01314872|5897802|P13|COMPLETED|Period 2||188
2403973|NCT01314872|5897803|P12|COMPLETED|Period 2||175
2403974|NCT01314872|5897804|P11|COMPLETED|Period 2||0
2403975|NCT01314872|5897805|P10|COMPLETED|Period 2||0
2403976|NCT01314872|5897806|P9|COMPLETED|Period 2||0
2403977|NCT01314872|5897807|P8|COMPLETED|Period 2||0
2403978|NCT01314872|5897808|P7|COMPLETED|Period 2||0
2403979|NCT01314872|5897809|P6|COMPLETED|Period 2||0
2403980|NCT01314872|5897810|P5|COMPLETED|Period 2||0
2403981|NCT01314872|5897811|P4|COMPLETED|Period 2||0
2403982|NCT01314872|5897812|P3|COMPLETED|Period 2||0
2403983|NCT01314872|5897813|P2|COMPLETED|Period 2||0
2403984|NCT01314872|5897814|P1|COMPLETED|Period 2||0
2403985|NCT01314872|5897800|P15|STARTED|Period 2||134
2403986|NCT01314872|5897801|P14|STARTED|Period 2||240
2403987|NCT01314872|5897802|P13|STARTED|Period 2||248
2403988|NCT01314872|5897803|P12|STARTED|Period 2||223
2403989|NCT01314872|5897804|P11|STARTED|Period 2||0
2403990|NCT01314872|5897805|P10|STARTED|Period 2||0
2403991|NCT01314872|5897806|P9|STARTED|Period 2||0
2403992|NCT01314872|5897807|P8|STARTED|Period 2||0
2403993|NCT01314872|5897808|P7|STARTED|Period 2||0
2403994|NCT01314872|5897809|P6|STARTED|Period 2||0
2403995|NCT01314872|5897810|P5|STARTED|Period 2||0
2403996|NCT01314872|5897811|P4|STARTED|Period 2||0
2403997|NCT01314872|5897812|P3|STARTED|Period 2||0
2403998|NCT01314872|5897813|P2|STARTED|Period 2||0
2403999|NCT01314872|5897814|P1|STARTED|Period 2||0
2404000|NCT01314872|5897800|P15|NOT COMPLETED|Treatment Period 1||0
2404001|NCT01314872|5897801|P14|NOT COMPLETED|Treatment Period 1||0
2404002|NCT01314872|5897802|P13|NOT COMPLETED|Treatment Period 1||0
2404003|NCT01314872|5897803|P12|NOT COMPLETED|Treatment Period 1||0
2404004|NCT01314872|5897804|P11|NOT COMPLETED|Treatment Period 1||3
2404005|NCT01314872|5897805|P10|NOT COMPLETED|Treatment Period 1||4
2404006|NCT01314872|5897806|P9|NOT COMPLETED|Treatment Period 1||6
2404007|NCT01314872|5897807|P8|NOT COMPLETED|Treatment Period 1||7
2404008|NCT01314872|5897808|P7|NOT COMPLETED|Treatment Period 1||8
2404009|NCT01314872|5897809|P6|NOT COMPLETED|Treatment Period 1||7
2404010|NCT01314872|5897810|P5|NOT COMPLETED|Treatment Period 1||7
2404011|NCT01314872|5897811|P4|NOT COMPLETED|Treatment Period 1||7
2404012|NCT01314872|5897812|P3|NOT COMPLETED|Treatment Period 1||6
2404013|NCT01314872|5897813|P2|NOT COMPLETED|Treatment Period 1||6
2404014|NCT01314872|5897814|P1|NOT COMPLETED|Treatment Period 1||10
2404015|NCT01314872|5897800|P15|COMPLETED|Treatment Period 1||0
2404016|NCT01314872|5897801|P14|COMPLETED|Treatment Period 1||0
2404017|NCT01314872|5897802|P13|COMPLETED|Treatment Period 1||0
2404018|NCT01314872|5897803|P12|COMPLETED|Treatment Period 1||0
2404019|NCT01314872|5897804|P11|COMPLETED|Treatment Period 1||107
2404020|NCT01314872|5897805|P10|COMPLETED|Treatment Period 1||118
2404021|NCT01314872|5897806|P9|COMPLETED|Treatment Period 1||106
2404022|NCT01314872|5897807|P8|COMPLETED|Treatment Period 1||57
2404023|NCT01314872|5897808|P7|COMPLETED|Treatment Period 1||126
2404024|NCT01314872|5897809|P6|COMPLETED|Treatment Period 1||128
2404025|NCT01314872|5897810|P5|COMPLETED|Treatment Period 1||142
2404026|NCT01314872|5897811|P4|COMPLETED|Treatment Period 1||143
2404027|NCT01314872|5897812|P3|COMPLETED|Treatment Period 1||128
2404028|NCT01314872|5897813|P2|COMPLETED|Treatment Period 1||138
2404029|NCT01314872|5897814|P1|COMPLETED|Treatment Period 1||131
2404030|NCT01314872|5897800|P15|STARTED|Treatment Period 1||0
2404031|NCT01314872|5897801|P14|STARTED|Treatment Period 1||0
2404032|NCT01314872|5897802|P13|STARTED|Treatment Period 1||0
2404033|NCT01314872|5897803|P12|STARTED|Treatment Period 1||0
2404034|NCT01314872|5897804|P11|STARTED|Treatment Period 1||110
2404035|NCT01314872|5897805|P10|STARTED|Treatment Period 1||122
2404036|NCT01314872|5897806|P9|STARTED|Treatment Period 1||112
2404037|NCT01314872|5897807|P8|STARTED|Treatment Period 1||64
2404038|NCT01314872|5897808|P7|STARTED|Treatment Period 1||134
2404039|NCT01314872|5897809|P6|STARTED|Treatment Period 1||135
2404040|NCT01314872|5897810|P5|STARTED|Treatment Period 1||149
2404041|NCT01314872|5897811|P4|STARTED|Treatment Period 1||150
2404042|NCT01314872|5897812|P3|STARTED|Treatment Period 1||134
2404043|NCT01314872|5897813|P2|STARTED|Treatment Period 1||144
2404044|NCT01314872|5897814|P1|STARTED|Treatment Period 1||141
2404045|NCT01314742|5897907|P2|NOT COMPLETED|Overall Study||0
2404046|NCT01314742|5897908|P1|NOT COMPLETED|Overall Study||0
2404047|NCT01314742|5897907|P2|COMPLETED|Overall Study||21
2404048|NCT01314742|5897908|P1|COMPLETED|Overall Study||20
2404049|NCT01314742|5897907|P2|STARTED|Overall Study||21
2404050|NCT01314742|5897908|P1|STARTED|Overall Study||20
2404051|NCT01314716|5897918|P2|NOT COMPLETED|Open-Label Phase||12
2404052|NCT01314716|5897919|P1|NOT COMPLETED|Open-Label Phase||10
2404053|NCT01314716|5897918|P2|COMPLETED|Open-Label Phase||98
2404054|NCT01314716|5897919|P1|COMPLETED|Open-Label Phase||102
2404055|NCT01314716|5897918|P2|STARTED|Open-Label Phase|13 participants in this group did not continue from the randomized to the open-label phase.|110
2404056|NCT01314716|5897919|P1|STARTED|Open-Label Phase|7 participants in this group did not continue from the randomized to the open-label phase.|112
2404057|NCT01314716|5897918|P2|NOT COMPLETED|Double-Blind Phase||15
2404058|NCT01314716|5897919|P1|NOT COMPLETED|Double-Blind Phase||17
2404059|NCT01314716|5897918|P2|COMPLETED|Double-Blind Phase||123
2404060|NCT01314716|5897919|P1|COMPLETED|Double-Blind Phase||119
2404061|NCT01314716|5897918|P2|Randomized and Treated|Double-Blind Phase||137
2404062|NCT01314716|5897919|P1|Randomized and Treated|Double-Blind Phase||135
2404063|NCT01314716|5897918|P2|STARTED|Double-Blind Phase||138
2404064|NCT01314716|5897919|P1|STARTED|Double-Blind Phase||136
2404065|NCT01314703|5897931|P1|NOT COMPLETED|Overall Study||8
2404066|NCT01314703|5897931|P1|COMPLETED|Overall Study||27
2404067|NCT01314703|5897931|P1|Discontinued When Enrollment Completed|Overall Study||3
2404068|NCT01314703|5897931|P1|Non Qualified Bacterial Screening Counts|Overall Study||3
2404069|NCT01314703|5897931|P1|Excluded Prior to Screening Baseline|Overall Study||2
2404070|NCT01314703|5897931|P1|Completed Study|Overall Study||27
2404071|NCT01314703|5897931|P1|Completed Treatment Visit|Overall Study||27
2404072|NCT01314703|5897931|P1|Completed Screen Visit|Overall Study||33
2404073|NCT01314703|5897931|P1|Signed Informed Consent|Overall Study||35
2404074|NCT01314703|5897931|P1|STARTED|Overall Study||35
2404075|NCT01314443|5897940|P4|NOT COMPLETED|Overall Study||2
2404076|NCT01314443|5897941|P3|NOT COMPLETED|Overall Study||2
2404077|NCT01314443|5897942|P2|NOT COMPLETED|Overall Study||3
2404078|NCT01314443|5897943|P1|NOT COMPLETED|Overall Study||4
2404079|NCT01314443|5897940|P4|COMPLETED|Overall Study||13
2404080|NCT01314443|5897941|P3|COMPLETED|Overall Study||13
2404081|NCT01314443|5897942|P2|COMPLETED|Overall Study||16
2404082|NCT01314443|5897943|P1|COMPLETED|Overall Study||14
2404083|NCT01314443|5897940|P4|STARTED|Overall Study||15
2404084|NCT01314443|5897941|P3|STARTED|Overall Study||15
2404085|NCT01314443|5897942|P2|STARTED|Overall Study||19
2404086|NCT01314443|5897943|P1|STARTED|Overall Study||18
2404087|NCT01314417|5897961|P1|NOT COMPLETED|Overall Study||0
2404088|NCT01314417|5897961|P1|COMPLETED|Overall Study||2
2404089|NCT01314417|5897961|P1|STARTED|Overall Study||2
2404090|NCT01314313|5897992|P2|NOT COMPLETED|Overall Study||311
2404091|NCT01314313|5897993|P1|NOT COMPLETED|Overall Study||227
2404092|NCT01314313|5897992|P2|COMPLETED|Overall Study||710
2404093|NCT01314313|5897993|P1|COMPLETED|Overall Study||784
2404094|NCT01314313|5897992|P2|Valve Implanted|Overall Study||936
2404095|NCT01314313|5897993|P1|Valve Implanted|Overall Study||974
2404096|NCT01314313|5897992|P2|As Treated|Overall Study||944
2404097|NCT01314313|5897993|P1|As Treated|Overall Study||994
2404098|NCT01314313|5897992|P2|STARTED|Overall Study||1021
2404099|NCT01314313|5897993|P1|STARTED|Overall Study||1011
2404100|NCT01314261|5898013|P4|NOT COMPLETED|Overall Study||3
2404101|NCT01314261|5898014|P3|NOT COMPLETED|Overall Study||3
2404102|NCT01314261|5898015|P2|NOT COMPLETED|Overall Study||4
2404103|NCT01314261|5898016|P1|NOT COMPLETED|Overall Study||2
2404104|NCT01314261|5898013|P4|COMPLETED|Overall Study||6
2404105|NCT01314261|5898014|P3|COMPLETED|Overall Study||7
2404106|NCT01314261|5898015|P2|COMPLETED|Overall Study||5
2404107|NCT01314261|5898016|P1|COMPLETED|Overall Study||7
2404108|NCT01314261|5898013|P4|Discontinued pegIFN/RBV|Overall Study||1
2404109|NCT01314261|5898014|P3|Discontinued pegIFN/RBV|Overall Study||5
2404110|NCT01314261|5898015|P2|Discontinued pegIFN/RBV|Overall Study||4
2404111|NCT01314261|5898016|P1|Discontinued pegIFN/RBV|Overall Study||1
2404112|NCT01314261|5898013|P4|Discontinued ABT-267 or Placebo|Overall Study||0
2404113|NCT01314261|5898014|P3|Discontinued ABT-267 or Placebo|Overall Study||1
2404114|NCT01314261|5898015|P2|Discontinued ABT-267 or Placebo|Overall Study||0
2404115|NCT01314261|5898016|P1|Discontinued ABT-267 or Placebo|Overall Study||1
2404116|NCT01314261|5898013|P4|STARTED|Overall Study||9
2404117|NCT01314261|5898014|P3|STARTED|Overall Study||10
2404118|NCT01314261|5898015|P2|STARTED|Overall Study||9
2404119|NCT01314261|5898016|P1|STARTED|Overall Study||9
2404120|NCT01314118|5898067|P1|NOT COMPLETED|Overall Study||131
2404121|NCT01314118|5898067|P1|COMPLETED|Overall Study||0
2404122|NCT01314118|5898067|P1|STARTED|Overall Study||131
2404123|NCT01314105|5898076|P2|NOT COMPLETED|Overall Study||12
2404124|NCT01314105|5898077|P1|NOT COMPLETED|Overall Study||7
2404125|NCT01314105|5898076|P2|COMPLETED|Overall Study||0
2404126|NCT01314105|5898077|P1|COMPLETED|Overall Study||0
2404127|NCT01314105|5898076|P2|STARTED|Overall Study||12
2404128|NCT01314105|5898077|P1|STARTED|Overall Study||7
2404129|NCT01314014|5898119|P1|NOT COMPLETED|Overall Study||0
2404130|NCT01314014|5898119|P1|COMPLETED|Overall Study|Treatment continued for as long as the subject derived benefit.|22
2404131|NCT01314014|5898119|P1|STARTED|Overall Study||22
2404132|NCT01314001|5898130|P6|NOT COMPLETED|Overall Study||71
2404133|NCT01314001|5898131|P5|NOT COMPLETED|Overall Study||72
2404134|NCT01314001|5898132|P4|NOT COMPLETED|Overall Study||69
2404135|NCT01314001|5898133|P3|NOT COMPLETED|Overall Study||69
2404136|NCT01314001|5898134|P2|NOT COMPLETED|Overall Study||69
2404137|NCT01314001|5898135|P1|NOT COMPLETED|Overall Study||75
2404138|NCT01314001|5898130|P6|COMPLETED|Overall Study||129
2404139|NCT01314001|5898131|P5|COMPLETED|Overall Study||148
2404140|NCT01314001|5898132|P4|COMPLETED|Overall Study||122
2404141|NCT01314001|5898133|P3|COMPLETED|Overall Study||158
2404142|NCT01314001|5898134|P2|COMPLETED|Overall Study||124
2404143|NCT01314001|5898135|P1|COMPLETED|Overall Study||140
2404144|NCT01314001|5898130|P6|6-Month Follow Up Survey|Overall Study||139
2404145|NCT01314001|5898131|P5|6-Month Follow Up Survey|Overall Study||157
2404146|NCT01314001|5898132|P4|6-Month Follow Up Survey|Overall Study||135
2404147|NCT01314001|5898133|P3|6-Month Follow Up Survey|Overall Study||165
2404148|NCT01314001|5898134|P2|6-Month Follow Up Survey|Overall Study||137
2404149|NCT01314001|5898135|P1|6-Month Follow Up Survey|Overall Study||146
2404150|NCT01314001|5898130|P6|End-of-Treatment Visit|Overall Study||160
2404151|NCT01314001|5898131|P5|End-of-Treatment Visit|Overall Study||174
2404152|NCT01314001|5898132|P4|End-of-Treatment Visit|Overall Study||146
2404153|NCT01314001|5898133|P3|End-of-Treatment Visit|Overall Study||179
2404154|NCT01314001|5898134|P2|End-of-Treatment Visit|Overall Study||141
2404155|NCT01314001|5898135|P1|End-of-Treatment Visit|Overall Study||156
2404156|NCT01314001|5898130|P6|STARTED|Overall Study||200
2404157|NCT01314001|5898131|P5|STARTED|Overall Study||220
2404158|NCT01314001|5898132|P4|STARTED|Overall Study||191
2404159|NCT01314001|5898133|P3|STARTED|Overall Study||227
2404160|NCT01314001|5898134|P2|STARTED|Overall Study||193
2404161|NCT01314001|5898135|P1|STARTED|Overall Study||215
2404162|NCT01313936|5898181|P2|NOT COMPLETED|Overall Study||0
2404163|NCT01313936|5898182|P1|NOT COMPLETED|Overall Study||0
2404164|NCT01313936|5898181|P2|COMPLETED|Overall Study||26
2404165|NCT01313936|5898182|P1|COMPLETED|Overall Study||6
2404166|NCT01313936|5898181|P2|STARTED|Overall Study||26
2404167|NCT01313936|5898182|P1|STARTED|Overall Study||6
2404168|NCT01313923|5898195|P1|NOT COMPLETED|Overall Study||3
2404169|NCT01313923|5898195|P1|COMPLETED|Overall Study||0
2404170|NCT01313923|5898195|P1|STARTED|Overall Study||3
2404171|NCT01313910|5898199|P1|NOT COMPLETED|Overall Study||0
2404172|NCT01313910|5898199|P1|COMPLETED|Overall Study||8
2404173|NCT01313910|5898199|P1|STARTED|Overall Study||8
2404174|NCT01313897|5898207|P1|NOT COMPLETED|Overall Study||2
2404175|NCT01313897|5898207|P1|COMPLETED|Overall Study||8
2404176|NCT01313897|5898207|P1|STARTED|Overall Study||10
2404177|NCT01313884|5898211|P1|NOT COMPLETED|Overall Study||1
2404178|NCT01313884|5898211|P1|COMPLETED|Overall Study||2
2404179|NCT01313884|5898211|P1|STARTED|Overall Study||3
2404180|NCT01313858|5898219|P3|NOT COMPLETED|Overall Study||238
2404181|NCT01313858|5898220|P2|NOT COMPLETED|Overall Study||270
2404182|NCT01313858|5898221|P1|NOT COMPLETED|Overall Study||286
2404183|NCT01313858|5898219|P3|COMPLETED|Overall Study||305
2404184|NCT01313858|5898220|P2|COMPLETED|Overall Study||276
2404185|NCT01313858|5898221|P1|COMPLETED|Overall Study||238
2404186|NCT01313858|5898219|P3|STARTED|Overall Study||543
2404187|NCT01313858|5898220|P2|STARTED|Overall Study||546
2404188|NCT01313858|5898221|P1|STARTED|Overall Study||524
2404189|NCT01313780|5898244|P2|NOT COMPLETED|Overall Study||28
2404190|NCT01313780|5898245|P1|NOT COMPLETED|Overall Study||25
2404191|NCT01313780|5898244|P2|COMPLETED|Overall Study|PPS|31
2404192|NCT01313780|5898245|P1|COMPLETED|Overall Study|PPS|33
2404193|NCT01313780|5898244|P2|STARTED|Overall Study|FAS|59
2404194|NCT01313780|5898245|P1|STARTED|Overall Study|FAS|58
2404195|NCT01313767|5898255|P2|NOT COMPLETED|Overall Study||2
2404196|NCT01313767|5898256|P1|NOT COMPLETED|Overall Study||7
2404197|NCT01313767|5898255|P2|COMPLETED|Overall Study||96
2404198|NCT01313767|5898256|P1|COMPLETED|Overall Study||91
2404199|NCT01313767|5898255|P2|STARTED|Overall Study||98
2404200|NCT01313767|5898256|P1|STARTED|Overall Study||98
2404201|NCT01313728|5898298|P1|NOT COMPLETED|Baseline to Completion||0
2404202|NCT01313728|5898298|P1|COMPLETED|Baseline to Completion||25
2404203|NCT01313728|5898298|P1|STARTED|Baseline to Completion||25
2404204|NCT01313728|5898298|P1|NOT COMPLETED|Informed Consent to Baseline||1
2404205|NCT01313728|5898298|P1|COMPLETED|Informed Consent to Baseline|One subject withdrew after signing informed consent, but prior to Baseline measurements being taken.|25
2404206|NCT01313728|5898298|P1|STARTED|Informed Consent to Baseline||26
2404207|NCT01313689|5898318|P5|NOT COMPLETED|24-Week Randomization 2||15
2404208|NCT01313689|5898319|P4|NOT COMPLETED|24-Week Randomization 2||1
2404209|NCT01313689|5898320|P3|NOT COMPLETED|24-Week Randomization 2||3
2404210|NCT01313689|5898321|P2|NOT COMPLETED|24-Week Randomization 2||0
2404211|NCT01313689|5898322|P1|NOT COMPLETED|24-Week Randomization 2||0
2404212|NCT01313689|5898318|P5|COMPLETED|24-Week Randomization 2||27
2404213|NCT01313689|5898319|P4|COMPLETED|24-Week Randomization 2||12
2404214|NCT01313689|5898320|P3|COMPLETED|24-Week Randomization 2||21
2404215|NCT01313689|5898321|P2|COMPLETED|24-Week Randomization 2||0
2404216|NCT01313689|5898322|P1|COMPLETED|24-Week Randomization 2||0
2404217|NCT01313689|5898318|P5|STARTED|24-Week Randomization 2|OFA Participants who did not enter Randomization 2.|42
2404218|NCT01313689|5898319|P4|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|13
2404219|NCT01313689|5898320|P3|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|24
2404220|NCT01313689|5898321|P2|STARTED|24-Week Randomization 2||0
2404221|NCT01313689|5898322|P1|STARTED|24-Week Randomization 2||0
2404222|NCT01313689|5898318|P5|NOT COMPLETED|24-Week Randomization 1||0
2404223|NCT01313689|5898319|P4|NOT COMPLETED|24-Week Randomization 1||0
2404224|NCT01313689|5898320|P3|NOT COMPLETED|24-Week Randomization 1||0
2404225|NCT01313689|5898321|P2|NOT COMPLETED|24-Week Randomization 1||10
2404226|NCT01313689|5898322|P1|NOT COMPLETED|24-Week Randomization 1||19
2404227|NCT01313689|5898318|P5|COMPLETED|24-Week Randomization 1||0
2404228|NCT01313689|5898319|P4|COMPLETED|24-Week Randomization 1||0
2404229|NCT01313689|5898320|P3|COMPLETED|24-Week Randomization 1||0
2404230|NCT01313689|5898321|P2|COMPLETED|24-Week Randomization 1|Par. that did not receive OFA salvage continued visits for Follow-up and overall survival assessment|33
2404231|NCT01313689|5898322|P1|COMPLETED|24-Week Randomization 1|Par. not entering Randomization 2 continued visits for Follow-up and overall survival assessment|60
2404232|NCT01313689|5898318|P5|STARTED|24-Week Randomization 1||0
2404233|NCT01313689|5898319|P4|STARTED|24-Week Randomization 1||0
2404234|NCT01313689|5898320|P3|STARTED|24-Week Randomization 1||0
2404235|NCT01313689|5898321|P2|STARTED|24-Week Randomization 1|Of the 43 participants in the PC arm, 22 entered the OFA Salvage arm.|43
2404236|NCT01313689|5898322|P1|STARTED|24-Week Randomization 1||79
2404237|NCT01313676|5898401|P4|NOT COMPLETED|Overall Study||994
2404238|NCT01313676|5898402|P3|NOT COMPLETED|Overall Study||1088
2404239|NCT01313676|5898403|P2|NOT COMPLETED|Overall Study||1113
2404240|NCT01313676|5898404|P1|NOT COMPLETED|Overall Study||1250
2404241|NCT01313676|5898401|P4|COMPLETED|Overall Study||3146
2404242|NCT01313676|5898402|P3|COMPLETED|Overall Study||3052
2404243|NCT01313676|5898403|P2|COMPLETED|Overall Study||3044
2404244|NCT01313676|5898404|P1|COMPLETED|Overall Study||2881
2404245|NCT01313676|5898401|P4|STARTED|Overall Study||4140
2404246|NCT01313676|5898402|P3|STARTED|Overall Study||4140
2404247|NCT01313676|5898403|P2|STARTED|Overall Study||4157
2404248|NCT01313676|5898404|P1|STARTED|Overall Study||4131
2404249|NCT01313663|5898424|P2|NOT COMPLETED|Overall Study||8
2404250|NCT01313663|5898425|P1|NOT COMPLETED|Overall Study||4
2404251|NCT01313663|5898424|P2|COMPLETED|Overall Study||3
2404252|NCT01313663|5898425|P1|COMPLETED|Overall Study||5
2404253|NCT01313663|5898424|P2|STARTED|Overall Study||11
2404254|NCT01313663|5898425|P1|STARTED|Overall Study||9
2404255|NCT01313650|5898463|P4|NOT COMPLETED|Overall Study||81
2404256|NCT01313650|5898464|P3|NOT COMPLETED|Overall Study||103
2404257|NCT01313650|5898465|P2|NOT COMPLETED|Overall Study||94
2404258|NCT01313650|5898466|P1|NOT COMPLETED|Overall Study||76
2404259|NCT01313650|5898463|P4|COMPLETED|Overall Study||332
2404260|NCT01313650|5898464|P3|COMPLETED|Overall Study||318
2404261|NCT01313650|5898465|P2|COMPLETED|Overall Study||324
2404262|NCT01313650|5898466|P1|COMPLETED|Overall Study||204
2404263|NCT01313650|5898463|P4|STARTED|Overall Study||413
2404264|NCT01313650|5898464|P3|STARTED|Overall Study||421
2404265|NCT01313650|5898465|P2|STARTED|Overall Study||418
2404266|NCT01313650|5898466|P1|STARTED|Overall Study||280
2404267|NCT01313637|5898492|P4|NOT COMPLETED|Overall Study||78
2404268|NCT01313637|5898493|P3|NOT COMPLETED|Overall Study||106
2404269|NCT01313637|5898494|P2|NOT COMPLETED|Overall Study||95
2404270|NCT01313637|5898495|P1|NOT COMPLETED|Overall Study||92
2404271|NCT01313637|5898492|P4|COMPLETED|Overall Study||325
2404272|NCT01313637|5898493|P3|COMPLETED|Overall Study||298
2404273|NCT01313637|5898494|P2|COMPLETED|Overall Study||312
2404274|NCT01313637|5898495|P1|COMPLETED|Overall Study||183
2404275|NCT01313637|5898492|P4|STARTED|Overall Study||403
2404276|NCT01313637|5898493|P3|STARTED|Overall Study||404
2404277|NCT01313637|5898494|P2|STARTED|Overall Study||407
2404278|NCT01313637|5898495|P1|STARTED|Overall Study||275
2404279|NCT01313624|5898519|P2|NOT COMPLETED|Open-Label Phase||13
2404280|NCT01313624|5898520|P1|NOT COMPLETED|Open-Label Phase||4
2404281|NCT01313624|5898519|P2|COMPLETED|Open-Label Phase||109
2404282|NCT01313624|5898520|P1|COMPLETED|Open-Label Phase||92
2404283|NCT01313624|5898519|P2|STARTED|Open-Label Phase||122
2404284|NCT01313624|5898520|P1|STARTED|Open-Label Phase||96
2404285|NCT01313624|5898519|P2|NOT COMPLETED|Double-Blind Phase||10
2404286|NCT01313624|5898520|P1|NOT COMPLETED|Double-Blind Phase||38
2404287|NCT01313624|5898519|P2|COMPLETED|Double-Blind Phase||122
2404288|NCT01313624|5898520|P1|COMPLETED|Double-Blind Phase||96
2404289|NCT01313624|5898519|P2|STARTED|Double-Blind Phase||132
2404290|NCT01313624|5898520|P1|STARTED|Double-Blind Phase||134
2404291|NCT01313559|5898534|P2|NOT COMPLETED|Overall Study||2
2404292|NCT01313559|5898535|P1|NOT COMPLETED|Overall Study||4
2404293|NCT01313559|5898534|P2|COMPLETED|Overall Study||0
2404294|NCT01313559|5898535|P1|COMPLETED|Overall Study||0
2404295|NCT01313559|5898534|P2|STARTED|Overall Study||2
2404296|NCT01313559|5898535|P1|STARTED|Overall Study||4
2404297|NCT01313520|5898549|P2|NOT COMPLETED|Overall Study||0
2404298|NCT01313520|5898550|P1|NOT COMPLETED|Overall Study||0
2404299|NCT01313520|5898549|P2|COMPLETED|Overall Study||31
2404300|NCT01313520|5898550|P1|COMPLETED|Overall Study||30
2404301|NCT01313520|5898549|P2|STARTED|Overall Study||31
2404302|NCT01313520|5898550|P1|STARTED|Overall Study||30
2404303|NCT01313507|5898570|P1|NOT COMPLETED|Overall Study||0
2404304|NCT01313507|5898570|P1|COMPLETED|Overall Study||21
2404305|NCT01313507|5898570|P1|STARTED|Overall Study||21
2404306|NCT01313494|5898578|P2|NOT COMPLETED|Overall Study||50
2404307|NCT01313494|5898579|P1|NOT COMPLETED|Overall Study||67
2404308|NCT01313494|5898578|P2|COMPLETED|Overall Study||263
2404309|NCT01313494|5898579|P1|COMPLETED|Overall Study||246
2404310|NCT01313494|5898578|P2|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|311
2404311|NCT01313494|5898579|P1|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|315
2404312|NCT01313494|5898578|P2|STARTED|Overall Study||313
2404313|NCT01313494|5898579|P1|STARTED|Overall Study||313
2404314|NCT01313416|5898631|P1|NOT COMPLETED|Overall Study||0
2404315|NCT01313416|5898631|P1|COMPLETED|Overall Study||2
2404316|NCT01313416|5898631|P1|STARTED|Overall Study||2
2404317|NCT01313312|5898636|P1|NOT COMPLETED|Overall Study||36
2404318|NCT01313312|5898636|P1|COMPLETED|Overall Study||222
2404319|NCT01313312|5898636|P1|Cycle 5|Overall Study||11
2404320|NCT01313312|5898636|P1|Cycle 4|Overall Study||81
2404321|NCT01313312|5898636|P1|Cycle 3|Overall Study||175
2404322|NCT01313312|5898636|P1|Cycle 2|Overall Study||229
2404323|NCT01313312|5898636|P1|Cycle 1|Overall Study||254
2404324|NCT01313312|5898636|P1|STARTED|Overall Study||258
2404325|NCT01313299|5898683|P3|NOT COMPLETED|Overall Study||4
2404326|NCT01313299|5898684|P2|NOT COMPLETED|Overall Study||3
2404327|NCT01313299|5898685|P1|NOT COMPLETED|Overall Study||7
2404328|NCT01313299|5898683|P3|COMPLETED|Overall Study||77
2404329|NCT01313299|5898684|P2|COMPLETED|Overall Study||78
2404330|NCT01313299|5898685|P1|COMPLETED|Overall Study||74
2404331|NCT01313299|5898683|P3|STARTED|Overall Study||81
2404332|NCT01313299|5898684|P2|STARTED|Overall Study||81
2404333|NCT01313299|5898685|P1|STARTED|Overall Study||81
2404334|NCT01313286|5898699|P2|NOT COMPLETED|Period 2||0
2404335|NCT01313286|5898700|P1|NOT COMPLETED|Period 2||0
2404336|NCT01313286|5898699|P2|COMPLETED|Period 2||8
2404337|NCT01313286|5898700|P1|COMPLETED|Period 2||6
2404338|NCT01313286|5898699|P2|STARTED|Period 2||8
2404339|NCT01313286|5898700|P1|STARTED|Period 2||6
2404340|NCT01313286|5898699|P2|NOT COMPLETED|Period 1||0
2404341|NCT01313286|5898700|P1|NOT COMPLETED|Period 1||2
2404342|NCT01313286|5898699|P2|COMPLETED|Period 1||8
2404343|NCT01313286|5898700|P1|COMPLETED|Period 1||6
2404344|NCT01313286|5898699|P2|STARTED|Period 1||8
2404345|NCT01313286|5898700|P1|STARTED|Period 1||8
2404346|NCT01313273|5898710|P2|NOT COMPLETED|Overall Study||1
2404347|NCT01313273|5898711|P1|NOT COMPLETED|Overall Study||2
2404348|NCT01313273|5898710|P2|COMPLETED|Overall Study||0
2404349|NCT01313273|5898711|P1|COMPLETED|Overall Study||0
2404350|NCT01313273|5898710|P2|STARTED|Overall Study||1
2404351|NCT01313273|5898711|P1|STARTED|Overall Study||2
2404352|NCT01313221|5898726|P3|NOT COMPLETED|Overall Study||23
2404353|NCT01313221|5898727|P2|NOT COMPLETED|Overall Study||8
2404354|NCT01313221|5898728|P1|NOT COMPLETED|Overall Study||12
2404355|NCT01313221|5898726|P3|COMPLETED|Overall Study||0
2404356|NCT01313221|5898727|P2|COMPLETED|Overall Study||135
2404357|NCT01313221|5898728|P1|COMPLETED|Overall Study||132
2404358|NCT01313221|5898726|P3|Randomized|Overall Study||0
2404359|NCT01313221|5898727|P2|Randomized|Overall Study||143
2404360|NCT01313221|5898728|P1|Randomized|Overall Study||144
2404361|NCT01313221|5898726|P3|STARTED|Overall Study||23
2404362|NCT01313221|5898727|P2|STARTED|Overall Study||143
2404363|NCT01313221|5898728|P1|STARTED|Overall Study||144
2404364|NCT01313208|5898780|P2|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||3
2404365|NCT01313208|5898781|P1|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||6
2404366|NCT01313208|5898780|P2|COMPLETED|Open-label Phase (Weeks 13 - 24)||98
2404367|NCT01313208|5898781|P1|COMPLETED|Open-label Phase (Weeks 13 - 24)||92
2404368|NCT01313208|5898780|P2|STARTED|Open-label Phase (Weeks 13 - 24)||101
2404369|NCT01313208|5898781|P1|STARTED|Open-label Phase (Weeks 13 - 24)||98
2404370|NCT01313208|5898780|P2|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||5
2404371|NCT01313208|5898781|P1|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||6
2404372|NCT01313208|5898780|P2|COMPLETED|Double-blind Phase (Weeks 1 - 12)||101
2404373|NCT01313208|5898781|P1|COMPLETED|Double-blind Phase (Weeks 1 - 12)||98
2404374|NCT01313208|5898780|P2|STARTED|Double-blind Phase (Weeks 1 - 12)||106
2404375|NCT01313208|5898781|P1|STARTED|Double-blind Phase (Weeks 1 - 12)||104
2404376|NCT01313182|5898871|P2|NOT COMPLETED|Overall Study||92
2404377|NCT01313182|5898872|P1|NOT COMPLETED|Overall Study||66
2404378|NCT01313182|5898871|P2|COMPLETED|Overall Study||763
2404379|NCT01313182|5898872|P1|COMPLETED|Overall Study||776
2404380|NCT01313182|5898871|P2|STARTED|Overall Study||855
2404381|NCT01313182|5898872|P1|STARTED|Overall Study||842
2404382|NCT01313117|5898884|P1|NOT COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
2404383|NCT01313117|5898884|P1|COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||0
2404384|NCT01313117|5898884|P1|STARTED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
2404385|NCT01313117|5898884|P1|NOT COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||0
2404386|NCT01313117|5898884|P1|COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
2404387|NCT01313117|5898884|P1|STARTED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
2404388|NCT01313117|5898884|P1|NOT COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||0
2404389|NCT01313117|5898884|P1|COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
2404390|NCT01313117|5898884|P1|STARTED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
2404391|NCT01313117|5898884|P1|NOT COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
2404392|NCT01313117|5898884|P1|COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
2404393|NCT01313117|5898884|P1|STARTED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||2
2404394|NCT01313117|5898884|P1|NOT COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||0
2404395|NCT01313117|5898884|P1|COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
2404396|NCT01313117|5898884|P1|STARTED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
2404397|NCT01313078|5898891|P1|NOT COMPLETED|Overall Study||3
2404398|NCT01313078|5898891|P1|COMPLETED|Overall Study||1
2404399|NCT01313078|5898891|P1|STARTED|Overall Study||4
2404400|NCT01313039|5898896|P1|NOT COMPLETED|Overall Study||2
2404401|NCT01313039|5898896|P1|COMPLETED|Overall Study||2
2404402|NCT01313039|5898896|P1|STARTED|Overall Study||4
2404403|NCT01312961|5898902|P2|NOT COMPLETED|Overall Study||7
2404404|NCT01312961|5898903|P1|NOT COMPLETED|Overall Study||17
2404405|NCT01312961|5898902|P2|COMPLETED|Overall Study||45
2404406|NCT01312961|5898903|P1|COMPLETED|Overall Study||35
2404407|NCT01312961|5898902|P2|Treated|Overall Study||52
2404408|NCT01312961|5898903|P1|Treated|Overall Study||52
2404409|NCT01312961|5898902|P2|STARTED|Overall Study||52
2404410|NCT01312961|5898903|P1|STARTED|Overall Study||52
2404411|NCT01312948|5898929|P1|NOT COMPLETED|Overall Study||0
2404412|NCT01312948|5898929|P1|COMPLETED|Overall Study||6
2404413|NCT01312948|5898929|P1|STARTED|Overall Study||6
2404414|NCT01312909|5898939|P3|NOT COMPLETED|Overall Study||47
2404415|NCT01312909|5898940|P2|NOT COMPLETED|Overall Study||36
2404416|NCT01312909|5898941|P1|NOT COMPLETED|Overall Study||42
2404417|NCT01312909|5898939|P3|COMPLETED|Overall Study||53
2404418|NCT01312909|5898940|P2|COMPLETED|Overall Study||67
2404419|NCT01312909|5898941|P1|COMPLETED|Overall Study||67
2404420|NCT01312909|5898939|P3|Treated|Overall Study||99
2404421|NCT01312909|5898940|P2|Treated|Overall Study||100
2404422|NCT01312909|5898941|P1|Treated|Overall Study||108
2404423|NCT01312909|5898939|P3|STARTED|Overall Study||100
2404424|NCT01312909|5898940|P2|STARTED|Overall Study||103
2404425|NCT01312909|5898941|P1|STARTED|Overall Study||109
2404426|NCT01312844|5898990|P2|NOT COMPLETED|Overall Study||0
2404427|NCT01312844|5898991|P1|NOT COMPLETED|Overall Study||0
2404428|NCT01312844|5898990|P2|COMPLETED|Overall Study||3
2404429|NCT01312844|5898991|P1|COMPLETED|Overall Study||4
2404430|NCT01312844|5898990|P2|STARTED|Overall Study||3
2404431|NCT01312844|5898991|P1|STARTED|Overall Study||4
2404432|NCT01312818|5899013|P1|NOT COMPLETED|Overall Study||0
2404433|NCT01312818|5899013|P1|COMPLETED|Overall Study||2
2404434|NCT01312818|5899013|P1|STARTED|Overall Study||2
2404435|NCT01312805|5899021|P2|NOT COMPLETED|Overall Study||0
2404436|NCT01312805|5899022|P1|NOT COMPLETED|Overall Study||0
2404437|NCT01312805|5899021|P2|COMPLETED|Overall Study||1082
2404438|NCT01312805|5899022|P1|COMPLETED|Overall Study||1016
2404439|NCT01312805|5899021|P2|STARTED|Overall Study||1082
2404440|NCT01312805|5899022|P1|STARTED|Overall Study||1016
2404441|NCT01312766|5899030|P2|NOT COMPLETED|Overall Study||5
2404442|NCT01312766|5899031|P1|NOT COMPLETED|Overall Study||6
2404443|NCT01312766|5899030|P2|COMPLETED|Overall Study||130
2404444|NCT01312766|5899031|P1|COMPLETED|Overall Study||129
2404445|NCT01312766|5899030|P2|STARTED|Overall Study||135
2404446|NCT01312766|5899031|P1|STARTED|Overall Study||135
2404447|NCT01312675|5899063|P2|NOT COMPLETED|Overall Study||0
2404448|NCT01312675|5899064|P1|NOT COMPLETED|Overall Study||0
2404449|NCT01312675|5899063|P2|COMPLETED|Overall Study||7
2404450|NCT01312675|5899064|P1|COMPLETED|Overall Study||9
2404451|NCT01312675|5899063|P2|STARTED|Overall Study||7
2404452|NCT01312675|5899064|P1|STARTED|Overall Study||9
2404453|NCT01312519|5899072|P2|NOT COMPLETED|Overall Study||0
2404454|NCT01312519|5899073|P1|NOT COMPLETED|Overall Study||0
2404455|NCT01312519|5899072|P2|COMPLETED|Overall Study||24
2404456|NCT01312519|5899073|P1|COMPLETED|Overall Study||26
2404457|NCT01312519|5899072|P2|STARTED|Overall Study||24
2404458|NCT01312519|5899073|P1|STARTED|Overall Study||26
2404459|NCT01312467|5899081|P1|NOT COMPLETED|Overall Study||13
2404460|NCT01312467|5899081|P1|COMPLETED|Overall Study||32
2404461|NCT01312467|5899081|P1|STARTED|Overall Study||45
2404462|NCT01312428|5899090|P2|NOT COMPLETED|Overall Study||4
2404463|NCT01312428|5899091|P1|NOT COMPLETED|Overall Study||3
2404464|NCT01312428|5899090|P2|COMPLETED|Overall Study||0
2404465|NCT01312428|5899091|P1|COMPLETED|Overall Study||0
2404466|NCT01312428|5899090|P2|STARTED|Overall Study||4
2404467|NCT01312428|5899091|P1|STARTED|Overall Study||3
2404468|NCT01312272|5899101|P2|NOT COMPLETED|Overall Study||1
2404469|NCT01312272|5899102|P1|NOT COMPLETED|Overall Study||0
2404470|NCT01312272|5899101|P2|COMPLETED|Overall Study||11
2404471|NCT01312272|5899102|P1|COMPLETED|Overall Study||12
2404472|NCT01312272|5899101|P2|STARTED|Overall Study||12
2404473|NCT01312272|5899102|P1|STARTED|Overall Study||12
2404474|NCT01312233|5899121|P3|NOT COMPLETED|Overall Study||7
2404475|NCT01312233|5899122|P2|NOT COMPLETED|Overall Study||0
2404476|NCT01312233|5899123|P1|NOT COMPLETED|Overall Study||2
2404477|NCT01312233|5899121|P3|COMPLETED|Overall Study||36
2404478|NCT01312233|5899122|P2|COMPLETED|Overall Study||44
2404479|NCT01312233|5899123|P1|COMPLETED|Overall Study||42
2404480|NCT01312233|5899121|P3|STARTED|Overall Study||43
2404481|NCT01312233|5899122|P2|STARTED|Overall Study||44
2404482|NCT01312233|5899123|P1|STARTED|Overall Study||44
2404483|NCT01312181|5899146|P3|NOT COMPLETED|Overall Study||8
2404484|NCT01312181|5899147|P2|NOT COMPLETED|Overall Study||6
2404485|NCT01312181|5899148|P1|NOT COMPLETED|Overall Study||2
2404486|NCT01312181|5899146|P3|COMPLETED|Overall Study||75
2404487|NCT01312181|5899147|P2|COMPLETED|Overall Study||71
2404488|NCT01312181|5899148|P1|COMPLETED|Overall Study||78
2404489|NCT01312181|5899146|P3|STARTED|Overall Study||83
2404490|NCT01312181|5899147|P2|STARTED|Overall Study||77
2404491|NCT01312181|5899148|P1|STARTED|Overall Study||80
2404492|NCT01312129|5899161|P2|NOT COMPLETED|Second Intervention (24 Hours)||1
2404493|NCT01312129|5899162|P1|NOT COMPLETED|Second Intervention (24 Hours)||0
2404494|NCT01312129|5899161|P2|COMPLETED|Second Intervention (24 Hours)||6
2404495|NCT01312129|5899162|P1|COMPLETED|Second Intervention (24 Hours)||6
2404496|NCT01312129|5899161|P2|Alcohol Cue|Second Intervention (24 Hours)||6
2404497|NCT01312129|5899162|P1|Alcohol Cue|Second Intervention (24 Hours)||6
2404498|NCT01312129|5899161|P2|Control Cue|Second Intervention (24 Hours)||6
2404499|NCT01312129|5899162|P1|Control Cue|Second Intervention (24 Hours)||6
2404500|NCT01312129|5899161|P2|STARTED|Second Intervention (24 Hours)||7
2404501|NCT01312129|5899162|P1|STARTED|Second Intervention (24 Hours)||6
2404502|NCT01312129|5899161|P2|NOT COMPLETED|Washout (1 Week)||0
2404503|NCT01312129|5899162|P1|NOT COMPLETED|Washout (1 Week)||0
2404504|NCT01312129|5899161|P2|COMPLETED|Washout (1 Week)||7
2404505|NCT01312129|5899162|P1|COMPLETED|Washout (1 Week)||6
2404506|NCT01312129|5899161|P2|STARTED|Washout (1 Week)||7
2404507|NCT01312129|5899162|P1|STARTED|Washout (1 Week)||6
2404508|NCT01312129|5899161|P2|NOT COMPLETED|First Intervention (24 Hours)||0
2404509|NCT01312129|5899162|P1|NOT COMPLETED|First Intervention (24 Hours)||0
2404510|NCT01312129|5899161|P2|COMPLETED|First Intervention (24 Hours)||7
2404511|NCT01312129|5899162|P1|COMPLETED|First Intervention (24 Hours)||6
2404512|NCT01312129|5899161|P2|Alcohol Cue|First Intervention (24 Hours)||7
2404513|NCT01312129|5899162|P1|Alcohol Cue|First Intervention (24 Hours)||6
2404514|NCT01312129|5899161|P2|Control Cue|First Intervention (24 Hours)||7
2404515|NCT01312129|5899162|P1|Control Cue|First Intervention (24 Hours)||6
2404516|NCT01312129|5899161|P2|STARTED|First Intervention (24 Hours)||7
2404517|NCT01312129|5899162|P1|STARTED|First Intervention (24 Hours)||6
2404518|NCT01312038|5899170|P2|NOT COMPLETED|Overall Study||0
2404519|NCT01312038|5899171|P1|NOT COMPLETED|Overall Study||0
2404520|NCT01312038|5899170|P2|COMPLETED|Overall Study||12
2404521|NCT01312038|5899171|P1|COMPLETED|Overall Study||13
2404522|NCT01312038|5899170|P2|STARTED|Overall Study||12
2404523|NCT01312038|5899171|P1|STARTED|Overall Study||13
2404524|NCT01311895|5899179|P2|NOT COMPLETED|Overall Study||0
2404525|NCT01311895|5899180|P1|NOT COMPLETED|Overall Study||0
2404526|NCT01311895|5899179|P2|COMPLETED|Overall Study||175
2404527|NCT01311895|5899180|P1|COMPLETED|Overall Study||175
2404528|NCT01311895|5899179|P2|STARTED|Overall Study||175
2404529|NCT01311895|5899180|P1|STARTED|Overall Study||175
2404530|NCT01311687|5899192|P2|NOT COMPLETED|PFS Follow-up Phase||0
2404531|NCT01311687|5899193|P1|NOT COMPLETED|PFS Follow-up Phase||0
2404532|NCT01311687|5899192|P2|COMPLETED|PFS Follow-up Phase||8
2404533|NCT01311687|5899193|P1|COMPLETED|PFS Follow-up Phase||11
2404534|NCT01311687|5899192|P2|Crossed-over to Pomalidomide|PFS Follow-up Phase||0
2404535|NCT01311687|5899193|P1|Crossed-over to Pomalidomide|PFS Follow-up Phase||11
2404536|NCT01311687|5899192|P2|STARTED|PFS Follow-up Phase||8
2404537|NCT01311687|5899193|P1|STARTED|PFS Follow-up Phase||11
2404538|NCT01311687|5899192|P2|NOT COMPLETED|Treatment Phase||0
2404539|NCT01311687|5899193|P1|NOT COMPLETED|Treatment Phase||0
2404540|NCT01311687|5899192|P2|COMPLETED|Treatment Phase||153
2404541|NCT01311687|5899193|P1|COMPLETED|Treatment Phase||302
2404542|NCT01311687|5899192|P2|Crossed-over to Pomalidomide|Treatment Phase|After Amendment 4 participants still on HD-Dex treatment were permitted to crossover to pomalidomide|11
2404543|NCT01311687|5899193|P1|Crossed-over to Pomalidomide|Treatment Phase|Not applicable to participants initially randomized to receive pomalidomide|0
2404544|NCT01311687|5899192|P2|Received Study Drug|Treatment Phase||150
2404545|NCT01311687|5899193|P1|Received Study Drug|Treatment Phase||300
2404546|NCT01311687|5899192|P2|STARTED|Treatment Phase||153
2404547|NCT01311687|5899193|P1|STARTED|Treatment Phase||302
2404548|NCT01311661|5899247|P1|NOT COMPLETED|Overall Study||7
2404549|NCT01311661|5899247|P1|COMPLETED|Overall Study||199
2404550|NCT01311661|5899247|P1|Received Olo 10 mcg qd|Overall Study||102
2404551|NCT01311661|5899247|P1|Received Olo 5 mcg Bid|Overall Study||101
2404552|NCT01311661|5899247|P1|Received Olo 5 mcg qd|Overall Study||101
2404553|NCT01311661|5899247|P1|Received Olo 2.5 mcg Bid|Overall Study||101
2404554|NCT01311661|5899247|P1|Received Placebo|Overall Study||201
2404555|NCT01311661|5899247|P1|STARTED|Overall Study|Entered and treated|206
2404556|NCT01311557|5899391|P2|NOT COMPLETED|Overall Study||6
2404557|NCT01311557|5899392|P1|NOT COMPLETED|Overall Study||5
2404558|NCT01311557|5899391|P2|COMPLETED|Overall Study||645
2404559|NCT01311557|5899392|P1|COMPLETED|Overall Study||646
2404560|NCT01311557|5899391|P2|STARTED|Overall Study||651
2404561|NCT01311557|5899392|P1|STARTED|Overall Study||651
2404562|NCT01311505|5899408|P2|NOT COMPLETED|Second Intervention Period||0
2404563|NCT01311505|5899409|P1|NOT COMPLETED|Second Intervention Period||0
2404564|NCT01311505|5899408|P2|COMPLETED|Second Intervention Period||10
2404565|NCT01311505|5899409|P1|COMPLETED|Second Intervention Period||10
2404566|NCT01311505|5899408|P2|STARTED|Second Intervention Period||10
2404567|NCT01311505|5899409|P1|STARTED|Second Intervention Period||10
2404568|NCT01311505|5899408|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2404569|NCT01311505|5899409|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2404570|NCT01311505|5899408|P2|COMPLETED|Washout Period (at Least 7 Days)||10
2404571|NCT01311505|5899409|P1|COMPLETED|Washout Period (at Least 7 Days)||10
2404572|NCT01311505|5899408|P2|STARTED|Washout Period (at Least 7 Days)||10
2404573|NCT01311505|5899409|P1|STARTED|Washout Period (at Least 7 Days)||10
2404574|NCT01311505|5899408|P2|NOT COMPLETED|First Intervention Period||1
2404575|NCT01311505|5899409|P1|NOT COMPLETED|First Intervention Period||0
2404576|NCT01311505|5899408|P2|COMPLETED|First Intervention Period||10
2404577|NCT01311505|5899409|P1|COMPLETED|First Intervention Period||10
2404578|NCT01311505|5899408|P2|STARTED|First Intervention Period||11
2404579|NCT01311505|5899409|P1|STARTED|First Intervention Period||10
2404580|NCT01311362|5899437|P1|NOT COMPLETED|Ambrisentan and SJW||0
2404581|NCT01311362|5899437|P1|COMPLETED|Ambrisentan and SJW||20
2404582|NCT01311362|5899437|P1|STARTED|Ambrisentan and SJW||20
2404583|NCT01311362|5899437|P1|NOT COMPLETED|Ambrisentan Steady-state||0
2404584|NCT01311362|5899437|P1|COMPLETED|Ambrisentan Steady-state||20
2404585|NCT01311362|5899437|P1|STARTED|Ambrisentan Steady-state||20
2404586|NCT01311362|5899437|P1|NOT COMPLETED|Ambrisentan Single Dose||0
2404587|NCT01311362|5899437|P1|COMPLETED|Ambrisentan Single Dose||20
2404588|NCT01311362|5899437|P1|STARTED|Ambrisentan Single Dose|All 20 study participants completed each study period. Total number of study participants: 20|20
2404589|NCT01311102|5899450|P2|NOT COMPLETED|Overall Study||0
2404590|NCT01311102|5899451|P1|NOT COMPLETED|Overall Study||0
2404591|NCT01311102|5899450|P2|COMPLETED|Overall Study||20
2404592|NCT01311102|5899451|P1|COMPLETED|Overall Study||20
2404593|NCT01311102|5899450|P2|STARTED|Overall Study||20
2404594|NCT01311102|5899451|P1|STARTED|Overall Study||20
2404595|NCT01311024|5899465|P2|NOT COMPLETED|Overall Study||22
2404596|NCT01311024|5899466|P1|NOT COMPLETED|Overall Study||35
2404597|NCT01311024|5899465|P2|COMPLETED|Overall Study||789
2404598|NCT01311024|5899466|P1|COMPLETED|Overall Study||1495
2404599|NCT01311024|5899465|P2|STARTED|Overall Study||811
2404600|NCT01311024|5899466|P1|STARTED|Overall Study||1530
2404601|NCT01310868|5899472|P1|NOT COMPLETED|Overall Study||13
2404602|NCT01310868|5899472|P1|COMPLETED|Overall Study||59
2404603|NCT01310868|5899472|P1|STARTED|Overall Study||72
2404604|NCT01310855|5899480|P2|NOT COMPLETED|Overall Study||0
2404605|NCT01310855|5899481|P1|NOT COMPLETED|Overall Study||0
2404606|NCT01310855|5899480|P2|COMPLETED|Overall Study||19
2404607|NCT01310855|5899481|P1|COMPLETED|Overall Study||19
2404608|NCT01310855|5899480|P2|STARTED|Overall Study||19
2404609|NCT01310855|5899481|P1|STARTED|Overall Study||19
2404610|NCT01310803|5899489|P2|NOT COMPLETED|Overall Study||0
2404611|NCT01310803|5899490|P1|NOT COMPLETED|Overall Study||1
2404612|NCT01310803|5899489|P2|COMPLETED|Overall Study||0
2404613|NCT01310803|5899490|P1|COMPLETED|Overall Study||0
2404614|NCT01310803|5899489|P2|STARTED|Overall Study||0
2404615|NCT01310803|5899490|P1|STARTED|Overall Study||1
2404616|NCT01310777|5899501|P3|NOT COMPLETED|Overall Study||30
2404617|NCT01310777|5899502|P2|NOT COMPLETED|Overall Study||14
2404618|NCT01310777|5899503|P1|NOT COMPLETED|Overall Study||33
2404619|NCT01310777|5899501|P3|COMPLETED|Overall Study||145
2404620|NCT01310777|5899502|P2|COMPLETED|Overall Study||178
2404621|NCT01310777|5899503|P1|COMPLETED|Overall Study||160
2404622|NCT01310777|5899501|P3|STARTED|Overall Study||175
2404623|NCT01310777|5899502|P2|STARTED|Overall Study||192
2404624|NCT01310777|5899503|P1|STARTED|Overall Study||193
2404625|NCT01310699|5899513|P2|NOT COMPLETED|Overall Study||6
2404626|NCT01310699|5899514|P1|NOT COMPLETED|Overall Study||4
2404627|NCT01310699|5899513|P2|COMPLETED|Overall Study||143
2404628|NCT01310699|5899514|P1|COMPLETED|Overall Study||128
2404629|NCT01310699|5899513|P2|STARTED|Overall Study||149
2404630|NCT01310699|5899514|P1|STARTED|Overall Study||132
2404631|NCT01310582|5899526|P2|NOT COMPLETED|Overall Study||0
2404632|NCT01310582|5899527|P1|NOT COMPLETED|Overall Study||0
2404633|NCT01310582|5899526|P2|COMPLETED|Overall Study||26
2404634|NCT01310582|5899527|P1|COMPLETED|Overall Study||31
2404635|NCT01310582|5899526|P2|STARTED|Overall Study||26
2404636|NCT01310582|5899527|P1|STARTED|Overall Study||31
2404637|NCT01310413|5899541|P7|NOT COMPLETED|From Day U0 to Day U385||3
2404638|NCT01310413|5899542|P6|NOT COMPLETED|From Day U0 to Day U385||0
2404639|NCT01310413|5899543|P5|NOT COMPLETED|From Day U0 to Day U385||0
2404640|NCT01310413|5899544|P4|NOT COMPLETED|From Day U0 to Day U385||0
2404641|NCT01310413|5899545|P3|NOT COMPLETED|From Day U0 to Day U385||0
2404642|NCT01310413|5899546|P2|NOT COMPLETED|From Day U0 to Day U385||0
2404643|NCT01310413|5899547|P1|NOT COMPLETED|From Day U0 to Day U385||0
2404644|NCT01310413|5899541|P7|COMPLETED|From Day U0 to Day U385|Upto Day U42|152
2404645|NCT01310413|5899542|P6|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
2404646|NCT01310413|5899543|P5|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
2404647|NCT01310413|5899544|P4|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
2404648|NCT01310413|5899545|P3|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
2404649|NCT01310413|5899546|P2|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
2404650|NCT01310413|5899547|P1|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
2404651|NCT01310413|5899541|P7|STARTED|From Day U0 to Day U385|Upto Day U42|155
2404652|NCT01310413|5899542|P6|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
2404653|NCT01310413|5899543|P5|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
2404654|NCT01310413|5899544|P4|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
2404655|NCT01310413|5899545|P3|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
2404656|NCT01310413|5899546|P2|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
2404657|NCT01310413|5899547|P1|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
2404658|NCT01310413|5899541|P7|NOT COMPLETED|Day 0 to Day 385||0
2404659|NCT01310413|5899542|P6|NOT COMPLETED|Day 0 to Day 385||3
2404660|NCT01310413|5899543|P5|NOT COMPLETED|Day 0 to Day 385||3
2404661|NCT01310413|5899544|P4|NOT COMPLETED|Day 0 to Day 385||8
2404662|NCT01310413|5899545|P3|NOT COMPLETED|Day 0 to Day 385||7
2404663|NCT01310413|5899546|P2|NOT COMPLETED|Day 0 to Day 385||8
2404664|NCT01310413|5899547|P1|NOT COMPLETED|Day 0 to Day 385||27
2404665|NCT01310413|5899541|P7|COMPLETED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
2404666|NCT01310413|5899542|P6|COMPLETED|Day 0 to Day 385||77
2404667|NCT01310413|5899543|P5|COMPLETED|Day 0 to Day 385||73
2404668|NCT01310413|5899544|P4|COMPLETED|Day 0 to Day 385||67
2404669|NCT01310413|5899545|P3|COMPLETED|Day 0 to Day 385||203
2404670|NCT01310413|5899546|P2|COMPLETED|Day 0 to Day 385||190
2404671|NCT01310413|5899547|P1|COMPLETED|Day 0 to Day 385||172
2404672|NCT01310413|5899541|P7|STARTED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
2404673|NCT01310413|5899542|P6|STARTED|Day 0 to Day 385||80
2404674|NCT01310413|5899543|P5|STARTED|Day 0 to Day 385||76
2404675|NCT01310413|5899544|P4|STARTED|Day 0 to Day 385||75
2404676|NCT01310413|5899545|P3|STARTED|Day 0 to Day 385||210
2404677|NCT01310413|5899546|P2|STARTED|Day 0 to Day 385||198
2404678|NCT01310413|5899547|P1|STARTED|Day 0 to Day 385||199
2404679|NCT01310400|5899703|P3|NOT COMPLETED|Overall Study||30
2404680|NCT01310400|5899704|P2|NOT COMPLETED|Overall Study||32
2404681|NCT01310400|5899705|P1|NOT COMPLETED|Overall Study||28
2404682|NCT01310400|5899703|P3|COMPLETED|Overall Study||422
2404683|NCT01310400|5899704|P2|COMPLETED|Overall Study||420
2404684|NCT01310400|5899705|P1|COMPLETED|Overall Study||424
2404685|NCT01310400|5899703|P3|STARTED|Overall Study||452
2404686|NCT01310400|5899704|P2|STARTED|Overall Study||452
2404687|NCT01310400|5899705|P1|STARTED|Overall Study||452
2404688|NCT01310179|5899722|P1|NOT COMPLETED|Overall Study||0
2404689|NCT01310179|5899722|P1|COMPLETED|Overall Study||12
2404690|NCT01310179|5899722|P1|STARTED|Overall Study||12
2404691|NCT01310127|5899729|P2|NOT COMPLETED|Overall Study||1
2404692|NCT01310127|5899730|P1|NOT COMPLETED|Overall Study||2
2404693|NCT01310127|5899729|P2|COMPLETED|Overall Study||10
2404694|NCT01310127|5899730|P1|COMPLETED|Overall Study||10
2404695|NCT01310127|5899729|P2|STARTED|Overall Study||11
2404696|NCT01310127|5899730|P1|STARTED|Overall Study||12
2404697|NCT01310075|5899744|P2|NOT COMPLETED|Overall Study||10
2404698|NCT01310075|5899745|P1|NOT COMPLETED|Overall Study||14
2404699|NCT01310075|5899744|P2|COMPLETED|Overall Study||35
2404700|NCT01310075|5899745|P1|COMPLETED|Overall Study||31
2404701|NCT01310075|5899744|P2|STARTED|Overall Study||45
2404702|NCT01310075|5899745|P1|STARTED|Overall Study||45
2404703|NCT01310036|5899751|P1|NOT COMPLETED|Overall Study||202
2404704|NCT01310036|5899751|P1|COMPLETED|Overall Study||6
2404705|NCT01310036|5899751|P1|STARTED|Overall Study||208
2404706|NCT01309997|5899764|P2|NOT COMPLETED|Overall Study||6
2404707|NCT01309997|5899765|P1|NOT COMPLETED|Overall Study||5
2404708|NCT01309997|5899764|P2|COMPLETED|Overall Study||31
2404709|NCT01309997|5899765|P1|COMPLETED|Overall Study||30
2404710|NCT01309997|5899764|P2|Crossed Over to Second Arm|Overall Study||23
2404711|NCT01309997|5899765|P1|Crossed Over to Second Arm|Overall Study||19
2404712|NCT01309997|5899764|P2|Remained on First Arm Only|Overall Study||14
2404713|NCT01309997|5899765|P1|Remained on First Arm Only|Overall Study||16
2404714|NCT01309997|5899764|P2|STARTED|Overall Study||37
2404715|NCT01309997|5899765|P1|STARTED|Overall Study||35
2404716|NCT01309919|5899789|P2|NOT COMPLETED|Overall Study||48
2404717|NCT01309919|5899790|P1|NOT COMPLETED|Overall Study||17
2404718|NCT01309919|5899789|P2|COMPLETED|Overall Study||27
2404719|NCT01309919|5899790|P1|COMPLETED|Overall Study||58
2404720|NCT01309919|5899789|P2|STARTED|Overall Study||75
2404721|NCT01309919|5899790|P1|STARTED|Overall Study||75
2404722|NCT01309893|5899802|P2|NOT COMPLETED|Week 2 - Crossover Intervention||1
2404723|NCT01309893|5899803|P1|NOT COMPLETED|Week 2 - Crossover Intervention||1
2404724|NCT01309893|5899802|P2|COMPLETED|Week 2 - Crossover Intervention||32
2404725|NCT01309893|5899803|P1|COMPLETED|Week 2 - Crossover Intervention||32
2404726|NCT01309893|5899802|P2|STARTED|Week 2 - Crossover Intervention||33
2404727|NCT01309893|5899803|P1|STARTED|Week 2 - Crossover Intervention||33
2404728|NCT01309893|5899802|P2|NOT COMPLETED|Week 1 - First Intervention||0
2404729|NCT01309893|5899803|P1|NOT COMPLETED|Week 1 - First Intervention||0
2404730|NCT01309893|5899802|P2|COMPLETED|Week 1 - First Intervention||33
2404731|NCT01309893|5899803|P1|COMPLETED|Week 1 - First Intervention||33
2404732|NCT01309893|5899802|P2|STARTED|Week 1 - First Intervention||33
2404733|NCT01309893|5899803|P1|STARTED|Week 1 - First Intervention||33
2404734|NCT01309880|5899813|P2|NOT COMPLETED|Overall Study||0
2404735|NCT01309880|5899814|P1|NOT COMPLETED|Overall Study||0
2404736|NCT01309880|5899813|P2|COMPLETED|Overall Study||33
2404737|NCT01309880|5899814|P1|COMPLETED|Overall Study||33
2404738|NCT01309880|5899813|P2|STARTED|Overall Study||33
2404739|NCT01309880|5899814|P1|STARTED|Overall Study||33
2404740|NCT01309841|5899827|P3|NOT COMPLETED|Overall Study||37
2404741|NCT01309841|5899828|P2|NOT COMPLETED|Overall Study||41
2404742|NCT01309841|5899829|P1|NOT COMPLETED|Overall Study||39
2404743|NCT01309841|5899827|P3|COMPLETED|Overall Study||180
2404744|NCT01309841|5899828|P2|COMPLETED|Overall Study||177
2404745|NCT01309841|5899829|P1|COMPLETED|Overall Study||178
2404746|NCT01309841|5899827|P3|STARTED|Overall Study||217
2404747|NCT01309841|5899828|P2|STARTED|Overall Study||218
2404748|NCT01309841|5899829|P1|STARTED|Overall Study||217
2404749|NCT01309828|5899869|P2|NOT COMPLETED|Overall Study||16
2404750|NCT01309828|5899870|P1|NOT COMPLETED|Overall Study||16
2404751|NCT01309828|5899869|P2|COMPLETED|Overall Study||60
2404752|NCT01309828|5899870|P1|COMPLETED|Overall Study||61
2404753|NCT01309828|5899869|P2|STARTED|Overall Study||76
2404754|NCT01309828|5899870|P1|STARTED|Overall Study||77
2404755|NCT01309802|5899884|P2|NOT COMPLETED|Overall Study||9
2404756|NCT01309802|5899885|P1|NOT COMPLETED|Overall Study||12
2404757|NCT01309802|5899884|P2|COMPLETED|Overall Study||14
2404758|NCT01309802|5899885|P1|COMPLETED|Overall Study||13
2404759|NCT01309802|5899884|P2|STARTED|Overall Study||23
2404760|NCT01309802|5899885|P1|STARTED|Overall Study||25
2404761|NCT01309737|5899904|P5|NOT COMPLETED|Week 16 to 52||33
2404762|NCT01309737|5899905|P4|NOT COMPLETED|Week 16 to 52||34
2404763|NCT01309737|5899906|P3|NOT COMPLETED|Week 16 to 52||0
2404764|NCT01309737|5899907|P2|NOT COMPLETED|Week 16 to 52||103
2404765|NCT01309737|5899908|P1|NOT COMPLETED|Week 16 to 52||133
2404766|NCT01309737|5899904|P5|COMPLETED|Week 16 to 52||44
2404767|NCT01309737|5899905|P4|COMPLETED|Week 16 to 52||41
2404768|NCT01309737|5899906|P3|COMPLETED|Week 16 to 52||0
2404769|NCT01309737|5899907|P2|COMPLETED|Week 16 to 52||238
2404770|NCT01309737|5899908|P1|COMPLETED|Week 16 to 52||198
2404771|NCT01309737|5899904|P5|STARTED|Week 16 to 52||77
2404772|NCT01309737|5899905|P4|STARTED|Week 16 to 52||75
2404773|NCT01309737|5899906|P3|STARTED|Week 16 to 52||0
2404774|NCT01309737|5899907|P2|STARTED|Week 16 to 52||341
2404775|NCT01309737|5899908|P1|STARTED|Week 16 to 52||331
2404776|NCT01309737|5899904|P5|NOT COMPLETED|Week 0 to 16||0
2404777|NCT01309737|5899905|P4|NOT COMPLETED|Week 0 to 16||0
2404778|NCT01309737|5899906|P3|NOT COMPLETED|Week 0 to 16||44
2404779|NCT01309737|5899907|P2|NOT COMPLETED|Week 0 to 16||40
2404780|NCT01309737|5899908|P1|NOT COMPLETED|Week 0 to 16||52
2404781|NCT01309737|5899904|P5|COMPLETED|Week 0 to 16||0
2404782|NCT01309737|5899905|P4|COMPLETED|Week 0 to 16||0
2404783|NCT01309737|5899906|P3|COMPLETED|Week 0 to 16||152
2404784|NCT01309737|5899907|P2|COMPLETED|Week 0 to 16||341
2404785|NCT01309737|5899908|P1|COMPLETED|Week 0 to 16||331
2404786|NCT01309737|5899904|P5|Treated|Week 0 to 16||0
2404787|NCT01309737|5899905|P4|Treated|Week 0 to 16||0
2404788|NCT01309737|5899906|P3|Treated|Week 0 to 16||196
2404789|NCT01309737|5899907|P2|Treated|Week 0 to 16||381
2404790|NCT01309737|5899908|P1|Treated|Week 0 to 16||382
2404791|NCT01309737|5899904|P5|STARTED|Week 0 to 16||0
2404792|NCT01309737|5899905|P4|STARTED|Week 0 to 16||0
2404793|NCT01309737|5899906|P3|STARTED|Week 0 to 16||196
2404794|NCT01309737|5899907|P2|STARTED|Week 0 to 16||381
2404795|NCT01309737|5899908|P1|STARTED|Week 0 to 16||383
2404796|NCT01309672|5900103|P1|NOT COMPLETED|Overall Study||37
2404797|NCT01309672|5900103|P1|COMPLETED|Overall Study||4
2404798|NCT01309672|5900103|P1|Received Protocol Treatment|Overall Study||40
2404799|NCT01309672|5900103|P1|STARTED|Overall Study||41
2404800|NCT01309659|5900113|P2|NOT COMPLETED|Overall Study||1
2404801|NCT01309659|5900114|P1|NOT COMPLETED|Overall Study||0
2404802|NCT01309659|5900113|P2|COMPLETED|Overall Study||9
2404803|NCT01309659|5900114|P1|COMPLETED|Overall Study||9
2404804|NCT01309659|5900113|P2|STARTED|Overall Study||10
2404805|NCT01309659|5900114|P1|STARTED|Overall Study||9
2404806|NCT01309646|5900156|P2|NOT COMPLETED|Overall Study||0
2404807|NCT01309646|5900157|P1|NOT COMPLETED|Overall Study||0
2404808|NCT01309646|5900156|P2|COMPLETED|Overall Study||227
2404809|NCT01309646|5900157|P1|COMPLETED|Overall Study||224
2404810|NCT01309646|5900156|P2|STARTED|Overall Study||227
2404811|NCT01309646|5900157|P1|STARTED|Overall Study||224
2404812|NCT01309581|5900197|P2|NOT COMPLETED|Overall Study||0
2404813|NCT01309581|5900198|P1|NOT COMPLETED|Overall Study||0
2404814|NCT01309581|5900197|P2|COMPLETED|Overall Study||1
2404815|NCT01309581|5900198|P1|COMPLETED|Overall Study||2
2404816|NCT01309581|5900197|P2|STARTED|Overall Study||1
2404817|NCT01309581|5900198|P1|STARTED|Overall Study||2
2404818|NCT01309451|5900208|P2|NOT COMPLETED|Overall Study||3
2404819|NCT01309451|5900209|P1|NOT COMPLETED|Overall Study||2
2404820|NCT01309451|5900208|P2|COMPLETED|Overall Study|unit of measure is number of eyes|18
2404821|NCT01309451|5900209|P1|COMPLETED|Overall Study|unit of measure is number of eyes|17
2404822|NCT01309451|5900208|P2|STARTED|Overall Study|unit of measure is number of eyes|21
2404823|NCT01309451|5900209|P1|STARTED|Overall Study|unit of measure is number of eyes|19
2404824|NCT01309386|5900219|P2|NOT COMPLETED|Overall Study||21
2404825|NCT01309386|5900220|P1|NOT COMPLETED|Overall Study||22
2404826|NCT01309386|5900219|P2|COMPLETED|Overall Study||29
2404827|NCT01309386|5900220|P1|COMPLETED|Overall Study||28
2404828|NCT01309386|5900219|P2|STARTED|Overall Study||50
2404829|NCT01309386|5900220|P1|STARTED|Overall Study||50
2404830|NCT01309360|5900241|P3|NOT COMPLETED|Overall Study||0
2404831|NCT01309360|5900242|P2|NOT COMPLETED|Overall Study||0
2404832|NCT01309360|5900243|P1|NOT COMPLETED|Overall Study||0
2404833|NCT01309360|5900241|P3|COMPLETED|Overall Study||40
2404834|NCT01309360|5900242|P2|COMPLETED|Overall Study||40
2404835|NCT01309360|5900243|P1|COMPLETED|Overall Study||40
2404836|NCT01309360|5900241|P3|STARTED|Overall Study||40
2404837|NCT01309360|5900242|P2|STARTED|Overall Study||40
2404838|NCT01309360|5900243|P1|STARTED|Overall Study||40
2404839|NCT01309308|5900268|P2|NOT COMPLETED|Overall Study||4
2404840|NCT01309308|5900269|P1|NOT COMPLETED|Overall Study||6
2404841|NCT01309308|5900268|P2|COMPLETED|Overall Study||71
2404842|NCT01309308|5900269|P1|COMPLETED|Overall Study||69
2404843|NCT01309308|5900268|P2|STARTED|Overall Study||75
2404844|NCT01309308|5900269|P1|STARTED|Overall Study||75
2404845|NCT01309282|5900277|P1|NOT COMPLETED|Overall Study||1
2404846|NCT01309282|5900277|P1|COMPLETED|Overall Study||8
2404847|NCT01309282|5900277|P1|STARTED|Overall Study||9
2404848|NCT01309269|5900294|P1|NOT COMPLETED|Overall Study||840
2404849|NCT01309269|5900294|P1|COMPLETED|Overall Study||245
2404850|NCT01309269|5900294|P1|Treated|Overall Study||978
2404851|NCT01309269|5900294|P1|STARTED|Overall Study||1085
2404852|NCT01309243|5900302|P2|NOT COMPLETED|Extension Phase||0
2404853|NCT01309243|5900303|P1|NOT COMPLETED|Extension Phase||6
2404854|NCT01309243|5900302|P2|COMPLETED|Extension Phase||117
2404855|NCT01309243|5900303|P1|COMPLETED|Extension Phase||34
2404856|NCT01309243|5900302|P2|STARTED|Extension Phase|117 participants from the Randomized Phase continued the study in the Extension Phase.|117
2404857|NCT01309243|5900303|P1|STARTED|Extension Phase|40 participants from the Randomized Phase continued the study in the Extension Phase.|40
2404858|NCT01309243|5900302|P2|NOT COMPLETED|Randomized Phase Through Week 96||109
2404859|NCT01309243|5900303|P1|NOT COMPLETED|Randomized Phase Through Week 96||84
2404860|NCT01309243|5900302|P2|COMPLETED|Randomized Phase Through Week 96||290
2404861|NCT01309243|5900303|P1|COMPLETED|Randomized Phase Through Week 96||316
2404862|NCT01309243|5900302|P2|Randomized and Treated|Randomized Phase Through Week 96||392
2404863|NCT01309243|5900303|P1|Randomized and Treated|Randomized Phase Through Week 96||394
2404864|NCT01309243|5900302|P2|STARTED|Randomized Phase Through Week 96||399
2404865|NCT01309243|5900303|P1|STARTED|Randomized Phase Through Week 96||400
2404866|NCT01309204|5900329|P2|NOT COMPLETED|Overall Study||75
2404867|NCT01309204|5900330|P1|NOT COMPLETED|Overall Study||67
2404868|NCT01309204|5900329|P2|COMPLETED|Overall Study||361
2404869|NCT01309204|5900330|P1|COMPLETED|Overall Study||385
2404870|NCT01309204|5900329|P2|STARTED|Overall Study||436
2404871|NCT01309204|5900330|P1|STARTED|Overall Study||452
2404872|NCT01309165|5900338|P2|NOT COMPLETED|Overall Study||7
2404873|NCT01309165|5900339|P1|NOT COMPLETED|Overall Study||6
2404874|NCT01309165|5900338|P2|COMPLETED|Overall Study||9
2404875|NCT01309165|5900339|P1|COMPLETED|Overall Study||13
2404876|NCT01309165|5900338|P2|Included in Primary Analysis|Overall Study||12
2404877|NCT01309165|5900339|P1|Included in Primary Analysis|Overall Study||14
2404878|NCT01309165|5900338|P2|Received Allocated Intervention|Overall Study||14
2404879|NCT01309165|5900339|P1|Received Allocated Intervention|Overall Study||16
2404880|NCT01309165|5900338|P2|STARTED|Overall Study||16
2404881|NCT01309165|5900339|P1|STARTED|Overall Study||19
2404882|NCT01309100|5900351|P1|NOT COMPLETED|Overall Study||2
2404883|NCT01309100|5900351|P1|COMPLETED|Overall Study||142
2404884|NCT01309100|5900351|P1|STARTED|Overall Study||144
2404885|NCT01308918|5900362|P1|NOT COMPLETED|Overall Study||0
2404886|NCT01308918|5900362|P1|COMPLETED|Overall Study||50
2404887|NCT01308918|5900362|P1|STARTED|Overall Study||50
2404888|NCT01308853|5900369|P1|NOT COMPLETED|Overall Study||4
2404889|NCT01308853|5900369|P1|COMPLETED|Overall Study||20
2404890|NCT01308853|5900369|P1|STARTED|Overall Study||24
2404891|NCT01308840|5900374|P1|NOT COMPLETED|Overall Study||0
2404892|NCT01308840|5900374|P1|COMPLETED|Overall Study||31
2404893|NCT01308840|5900374|P1|STARTED|Overall Study||31
2404894|NCT01308814|5900383|P2|NOT COMPLETED|Overall Study||23
2404895|NCT01308814|5900384|P1|NOT COMPLETED|Overall Study||17
2404896|NCT01308814|5900383|P2|COMPLETED|Overall Study||63
2404897|NCT01308814|5900384|P1|COMPLETED|Overall Study||69
2404898|NCT01308814|5900383|P2|STARTED|Overall Study||86
2404899|NCT01308814|5900384|P1|STARTED|Overall Study||86
2404900|NCT01308788|5900404|P2|NOT COMPLETED|2-year Treatment||11
2404901|NCT01308788|5900405|P1|NOT COMPLETED|2-year Treatment||4
2404902|NCT01308788|5900404|P2|COMPLETED|2-year Treatment||10
2404903|NCT01308788|5900405|P1|COMPLETED|2-year Treatment||10
2404904|NCT01308788|5900404|P2|STARTED|2-year Treatment||21
2404905|NCT01308788|5900405|P1|STARTED|2-year Treatment||14
2404906|NCT01308788|5900404|P2|NOT COMPLETED|6-month Treatment||0
2404907|NCT01308788|5900405|P1|NOT COMPLETED|6-month Treatment||0
2404908|NCT01308788|5900404|P2|COMPLETED|6-month Treatment||21
2404909|NCT01308788|5900405|P1|COMPLETED|6-month Treatment||14
2404910|NCT01308788|5900404|P2|STARTED|6-month Treatment||21
2404911|NCT01308788|5900405|P1|STARTED|6-month Treatment||14
2404912|NCT01308762|5900440|P3|NOT COMPLETED|Overall Study||0
2404913|NCT01308762|5900441|P2|NOT COMPLETED|Overall Study||1
2404914|NCT01308762|5900442|P1|NOT COMPLETED|Overall Study||0
2404915|NCT01308762|5900440|P3|COMPLETED|Overall Study||6
2404916|NCT01308762|5900441|P2|COMPLETED|Overall Study|One patient was withdrawn as they were retrospecively found to have been ineligible at study entry|6
2404917|NCT01308762|5900442|P1|COMPLETED|Overall Study||6
2404918|NCT01308762|5900440|P3|STARTED|Overall Study||6
2404919|NCT01308762|5900441|P2|STARTED|Overall Study||7
2404920|NCT01308762|5900442|P1|STARTED|Overall Study||6
2404921|NCT01308749|5900455|P2|NOT COMPLETED|Period 2: Open Label Treatment||2
2404922|NCT01308749|5900456|P1|NOT COMPLETED|Period 2: Open Label Treatment||0
2404923|NCT01308749|5900455|P2|COMPLETED|Period 2: Open Label Treatment||11
2404924|NCT01308749|5900456|P1|COMPLETED|Period 2: Open Label Treatment||11
2404925|NCT01308749|5900455|P2|STARTED|Period 2: Open Label Treatment||13
2404926|NCT01308749|5900456|P1|STARTED|Period 2: Open Label Treatment||11
2404927|NCT01308749|5900455|P2|NOT COMPLETED|Period 1: Double Blind Treatment||0
2404928|NCT01308749|5900456|P1|NOT COMPLETED|Period 1: Double Blind Treatment||1
2404929|NCT01308749|5900455|P2|COMPLETED|Period 1: Double Blind Treatment||13
2404930|NCT01308749|5900456|P1|COMPLETED|Period 1: Double Blind Treatment||11
2404931|NCT01308749|5900455|P2|STARTED|Period 1: Double Blind Treatment||13
2404932|NCT01308749|5900456|P1|STARTED|Period 1: Double Blind Treatment||12
2404933|NCT01308736|5900486|P2|NOT COMPLETED|Overall Study||5
2404934|NCT01308736|5900487|P1|NOT COMPLETED|Overall Study||6
2404935|NCT01308736|5900486|P2|COMPLETED|Overall Study||27
2404936|NCT01308736|5900487|P1|COMPLETED|Overall Study||25
2404937|NCT01308736|5900486|P2|STARTED|Overall Study||32
2404938|NCT01308736|5900487|P1|STARTED|Overall Study||31
2404939|NCT01308619|5900495|P2|NOT COMPLETED|Overall Study||3
2404940|NCT01308619|5900496|P1|NOT COMPLETED|Overall Study||7
2404941|NCT01308619|5900495|P2|COMPLETED|Overall Study||83
2404942|NCT01308619|5900496|P1|COMPLETED|Overall Study||77
2404943|NCT01308619|5900495|P2|STARTED|Overall Study||86
2404944|NCT01308619|5900496|P1|STARTED|Overall Study||84
2404945|NCT01308580|5900510|P2|NOT COMPLETED|Overall Study||7
2404946|NCT01308580|5900511|P1|NOT COMPLETED|Overall Study||12
2404947|NCT01308580|5900510|P2|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|595
2404948|NCT01308580|5900511|P1|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|586
2404949|NCT01308580|5900510|P2|Treated|Overall Study|Random assignment, was not actual treatment in some cases|588
2404950|NCT01308580|5900511|P1|Treated|Overall Study|Random assignment, was not actual treatment in some cases|587
2404951|NCT01308580|5900510|P2|STARTED|Overall Study||602
2404952|NCT01308580|5900511|P1|STARTED|Overall Study||598
2404953|NCT01308567|5900554|P3|NOT COMPLETED|Overall Study||4
2404954|NCT01308567|5900555|P2|NOT COMPLETED|Overall Study||4
2404955|NCT01308567|5900556|P1|NOT COMPLETED|Overall Study||2
2404956|NCT01308567|5900554|P3|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|384
2404957|NCT01308567|5900555|P2|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|385
2404958|NCT01308567|5900556|P1|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|389
2404959|NCT01308567|5900554|P3|Treated|Overall Study|For 2 participants, actual treatment received was Cabazitaxel 20 mg/m^2.|377
2404960|NCT01308567|5900555|P2|Treated|Overall Study|For 15 participants, actual treatment received was Cabazitaxel 25 mg/m^2.|382
2404961|NCT01308567|5900556|P1|Treated|Overall Study|For 1 participant, actual treatment received was Cabazitaxel 25 mg/m^2.|388
2404962|NCT01308567|5900554|P3|STARTED|Overall Study|Randomized|388
2404963|NCT01308567|5900555|P2|STARTED|Overall Study|Randomized|389
2404964|NCT01308567|5900556|P1|STARTED|Overall Study|Randomized|391
2404965|NCT01308476|5900596|P2|NOT COMPLETED|Overall Study||2
2404966|NCT01308476|5900597|P1|NOT COMPLETED|Overall Study||3
2404967|NCT01308476|5900596|P2|COMPLETED|Overall Study||45
2404968|NCT01308476|5900597|P1|COMPLETED|Overall Study||45
2404969|NCT01308476|5900596|P2|STARTED|Overall Study|Entered and treated.|47
2404970|NCT01308476|5900597|P1|STARTED|Overall Study|Entered and treated.|48
2404971|NCT01308463|5900617|P1|NOT COMPLETED|Overall Study||29
2404972|NCT01308463|5900617|P1|COMPLETED|Overall Study||0
2404973|NCT01308463|5900617|P1|12 Years|Overall Study||2
2404974|NCT01308463|5900617|P1|11 Years|Overall Study||8
2404975|NCT01308463|5900617|P1|10 Years|Overall Study||8
2404976|NCT01308463|5900617|P1|9 Years|Overall Study||11
2404977|NCT01308463|5900617|P1|8 Years|Overall Study||14
2404978|NCT01308463|5900617|P1|7 Years|Overall Study||12
2404979|NCT01308463|5900617|P1|6 Years|Overall Study||11
2404980|NCT01308463|5900617|P1|5 Years|Overall Study||20
2404981|NCT01308463|5900617|P1|4 Years|Overall Study||20
2404982|NCT01308463|5900617|P1|3 Years|Overall Study||17
2404983|NCT01308463|5900617|P1|2 Years|Overall Study||18
2404984|NCT01308463|5900617|P1|1 Year|Overall Study||21
2404985|NCT01308463|5900617|P1|6 Months|Overall Study||23
2404986|NCT01308463|5900617|P1|STARTED|Overall Study||29
2404987|NCT01308450|5900624|P1|NOT COMPLETED|Overall Study||2
2404988|NCT01308450|5900624|P1|COMPLETED|Overall Study|Last subject was enrolled 06/28/2011|300
2404989|NCT01308450|5900624|P1|STARTED|Overall Study|302 subjects were screen. 300 subjects were enrolled in this one site, one visit study.|302
2404990|NCT01308424|5900630|P3|NOT COMPLETED|Randomization||2
2404991|NCT01308424|5900631|P2|NOT COMPLETED|Randomization||3
2404992|NCT01308424|5900632|P1|NOT COMPLETED|Randomization||0
2404993|NCT01308424|5900630|P3|COMPLETED|Randomization||82
2404994|NCT01308424|5900631|P2|COMPLETED|Randomization||84
2404995|NCT01308424|5900632|P1|COMPLETED|Randomization||0
2404996|NCT01308424|5900630|P3|STARTED|Randomization||84
2404997|NCT01308424|5900631|P2|STARTED|Randomization||87
2404998|NCT01308424|5900632|P1|STARTED|Randomization||0
2404999|NCT01308424|5900630|P3|NOT COMPLETED|Baseline Eligibility||0
2405000|NCT01308424|5900631|P2|NOT COMPLETED|Baseline Eligibility||0
2405001|NCT01308424|5900632|P1|NOT COMPLETED|Baseline Eligibility||71
2405002|NCT01308424|5900630|P3|COMPLETED|Baseline Eligibility||0
2405003|NCT01308424|5900631|P2|COMPLETED|Baseline Eligibility||0
2405004|NCT01308424|5900632|P1|COMPLETED|Baseline Eligibility|Completed baseline run in and were eligible for randomization|171
2405005|NCT01308424|5900630|P3|STARTED|Baseline Eligibility||0
2405006|NCT01308424|5900631|P2|STARTED|Baseline Eligibility||0
2405007|NCT01308424|5900632|P1|STARTED|Baseline Eligibility||242
2405008|NCT01308008|5900641|P2|NOT COMPLETED|12 Months||4
2405009|NCT01308008|5900642|P1|NOT COMPLETED|12 Months||8
2405010|NCT01308008|5900641|P2|COMPLETED|12 Months||58
2405011|NCT01308008|5900642|P1|COMPLETED|12 Months||46
2405012|NCT01308008|5900641|P2|STARTED|12 Months||62
2405013|NCT01308008|5900642|P1|STARTED|12 Months||54
2405014|NCT01308008|5900641|P2|NOT COMPLETED|6 Months||9
2405015|NCT01308008|5900642|P1|NOT COMPLETED|6 Months||8
2405016|NCT01308008|5900641|P2|COMPLETED|6 Months||62
2405017|NCT01308008|5900642|P1|COMPLETED|6 Months||54
2405018|NCT01308008|5900641|P2|STARTED|6 Months||71
2405019|NCT01308008|5900642|P1|STARTED|6 Months||62
2405020|NCT01308008|5900641|P2|NOT COMPLETED|4 Weeks||2
2405021|NCT01308008|5900642|P1|NOT COMPLETED|4 Weeks||9
2405022|NCT01308008|5900641|P2|COMPLETED|4 Weeks||71
2405023|NCT01308008|5900642|P1|COMPLETED|4 Weeks||62
2405024|NCT01308008|5900641|P2|STARTED|4 Weeks||73
2405025|NCT01308008|5900642|P1|STARTED|4 Weeks||71
2405026|NCT01307956|5900652|P1|NOT COMPLETED|Overall Study||0
2405027|NCT01307956|5900652|P1|COMPLETED|Overall Study||11
2405028|NCT01307956|5900652|P1|STARTED|Overall Study||11
2405029|NCT01307930|5900659|P1|NOT COMPLETED|Overall Study||2
2405030|NCT01307930|5900659|P1|COMPLETED|Overall Study||18
2405031|NCT01307930|5900659|P1|STARTED|Overall Study||20
2405032|NCT01307891|5900665|P2|NOT COMPLETED|Overall Study||1
2405033|NCT01307891|5900666|P1|NOT COMPLETED|Overall Study||3
2405034|NCT01307891|5900665|P2|COMPLETED|Overall Study||21
2405035|NCT01307891|5900666|P1|COMPLETED|Overall Study||39
2405036|NCT01307891|5900665|P2|STARTED|Overall Study||22
2405037|NCT01307891|5900666|P1|STARTED|Overall Study||42
2405038|NCT01307787|5900678|P2|NOT COMPLETED|Overall Study||0
2405039|NCT01307787|5900679|P1|NOT COMPLETED|Overall Study||2
2405040|NCT01307787|5900678|P2|COMPLETED|Overall Study||15
2405041|NCT01307787|5900679|P1|COMPLETED|Overall Study||17
2405042|NCT01307787|5900678|P2|T2= After 22 Weeks at Follow-up|Overall Study||15
2405043|NCT01307787|5900679|P1|T2= After 22 Weeks at Follow-up|Overall Study||17
2405044|NCT01307787|5900678|P2|T1= After 9 Weeks Post Intervention|Overall Study||15
2405045|NCT01307787|5900679|P1|T1= After 9 Weeks Post Intervention|Overall Study||18
2405046|NCT01307787|5900678|P2|STARTED|Overall Study||15
2405047|NCT01307787|5900679|P1|STARTED|Overall Study||19
2405048|NCT01307748|5900702|P3|NOT COMPLETED|Overall Study||0
2405049|NCT01307748|5900703|P2|NOT COMPLETED|Overall Study||0
2405050|NCT01307748|5900704|P1|NOT COMPLETED|Overall Study||0
2405051|NCT01307748|5900702|P3|COMPLETED|Overall Study||30
2405052|NCT01307748|5900703|P2|COMPLETED|Overall Study||31
2405053|NCT01307748|5900704|P1|COMPLETED|Overall Study||31
2405054|NCT01307748|5900702|P3|STARTED|Overall Study||30
2405055|NCT01307748|5900703|P2|STARTED|Overall Study||31
2405056|NCT01307748|5900704|P1|STARTED|Overall Study||31
2405057|NCT01307631|5900718|P2|NOT COMPLETED|Overall Study||0
2405058|NCT01307631|5900719|P1|NOT COMPLETED|Overall Study||0
2405059|NCT01307631|5900718|P2|COMPLETED|Overall Study||28
2405060|NCT01307631|5900719|P1|COMPLETED|Overall Study||9
2405061|NCT01307631|5900718|P2|STARTED|Overall Study||28
2405062|NCT01307631|5900719|P1|STARTED|Overall Study||9
2405063|NCT01307618|5900729|P2|NOT COMPLETED|Overall Study||0
2405064|NCT01307618|5900730|P1|NOT COMPLETED|Overall Study||0
2405065|NCT01307618|5900729|P2|COMPLETED|Overall Study||5
2405066|NCT01307618|5900730|P1|COMPLETED|Overall Study||5
2405067|NCT01307618|5900729|P2|STARTED|Overall Study||5
2405068|NCT01307618|5900730|P1|STARTED|Overall Study||5
2405069|NCT01307579|5900748|P2|NOT COMPLETED|Overall Study||145
2405070|NCT01307579|5900749|P1|NOT COMPLETED|Overall Study||140
2405071|NCT01307579|5900748|P2|COMPLETED|Overall Study||115
2405072|NCT01307579|5900749|P1|COMPLETED|Overall Study||117
2405073|NCT01307579|5900748|P2|STARTED|Overall Study||260
2405074|NCT01307579|5900749|P1|STARTED|Overall Study||257
2405075|NCT01307501|5900761|P1|NOT COMPLETED|Overall Study||23
2405076|NCT01307501|5900761|P1|COMPLETED|Overall Study||17
2405077|NCT01307501|5900761|P1|Intent-to-Treat (ITT) Population|Overall Study||40
2405078|NCT01307501|5900761|P1|STARTED|Overall Study||40
2405079|NCT01307462|5900774|P1|NOT COMPLETED|Overall Study||1
2405080|NCT01307462|5900774|P1|COMPLETED|Overall Study||35
2405081|NCT01307462|5900774|P1|STARTED|Overall Study||36
2405082|NCT01307449|5900791|P4|NOT COMPLETED|Overall Study||0
2405083|NCT01307449|5900792|P3|NOT COMPLETED|Overall Study||0
2405084|NCT01307449|5900793|P2|NOT COMPLETED|Overall Study||0
2405085|NCT01307449|5900794|P1|NOT COMPLETED|Overall Study||1
2405086|NCT01307449|5900791|P4|COMPLETED|Overall Study||11
2405087|NCT01307449|5900792|P3|COMPLETED|Overall Study||11
2405088|NCT01307449|5900793|P2|COMPLETED|Overall Study||33
2405089|NCT01307449|5900794|P1|COMPLETED|Overall Study||32
2405090|NCT01307449|5900791|P4|STARTED|Overall Study||11
2405091|NCT01307449|5900792|P3|STARTED|Overall Study||11
2405092|NCT01307449|5900793|P2|STARTED|Overall Study||33
2405093|NCT01307449|5900794|P1|STARTED|Overall Study||33
2405094|NCT01307423|5900827|P9|NOT COMPLETED|Long-term Safety Phase (Year 5)||3
2405095|NCT01307423|5900828|P8|NOT COMPLETED|Long-term Safety Phase (Year 5)||1
2405096|NCT01307423|5900829|P7|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
2405097|NCT01307423|5900830|P6|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
2405098|NCT01307423|5900831|P5|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
2405099|NCT01307423|5900832|P4|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
2405100|NCT01307423|5900833|P3|NOT COMPLETED|Long-term Safety Phase (Year 5)||6
2405101|NCT01307423|5900834|P2|NOT COMPLETED|Long-term Safety Phase (Year 5)||10
2405102|NCT01307423|5900835|P1|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
2405103|NCT01307423|5900827|P9|COMPLETED|Long-term Safety Phase (Year 5)||41
2405104|NCT01307423|5900828|P8|COMPLETED|Long-term Safety Phase (Year 5)||37
2405105|NCT01307423|5900829|P7|COMPLETED|Long-term Safety Phase (Year 5)||0
2405106|NCT01307423|5900830|P6|COMPLETED|Long-term Safety Phase (Year 5)||0
2405107|NCT01307423|5900831|P5|COMPLETED|Long-term Safety Phase (Year 5)||0
2405108|NCT01307423|5900832|P4|COMPLETED|Long-term Safety Phase (Year 5)||0
2405109|NCT01307423|5900833|P3|COMPLETED|Long-term Safety Phase (Year 5)||80
2405110|NCT01307423|5900834|P2|COMPLETED|Long-term Safety Phase (Year 5)||71
2405111|NCT01307423|5900835|P1|COMPLETED|Long-term Safety Phase (Year 5)||0
2405112|NCT01307423|5900827|P9|STARTED|Long-term Safety Phase (Year 5)||44
2405113|NCT01307423|5900828|P8|STARTED|Long-term Safety Phase (Year 5)||38
2405114|NCT01307423|5900829|P7|STARTED|Long-term Safety Phase (Year 5)||0
2405115|NCT01307423|5900830|P6|STARTED|Long-term Safety Phase (Year 5)||0
2405116|NCT01307423|5900831|P5|STARTED|Long-term Safety Phase (Year 5)||0
2405117|NCT01307423|5900832|P4|STARTED|Long-term Safety Phase (Year 5)||0
2405118|NCT01307423|5900833|P3|STARTED|Long-term Safety Phase (Year 5)||86
2405119|NCT01307423|5900834|P2|STARTED|Long-term Safety Phase (Year 5)||81
2405120|NCT01307423|5900835|P1|STARTED|Long-term Safety Phase (Year 5)||0
2405121|NCT01307423|5900827|P9|NOT COMPLETED|Long-term Safety Phase (Year 4)||5
2405122|NCT01307423|5900828|P8|NOT COMPLETED|Long-term Safety Phase (Year 4)||2
2405123|NCT01307423|5900829|P7|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
2405124|NCT01307423|5900830|P6|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
2405125|NCT01307423|5900831|P5|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
2405126|NCT01307423|5900832|P4|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
2405127|NCT01307423|5900833|P3|NOT COMPLETED|Long-term Safety Phase (Year 4)||5
2405128|NCT01307423|5900834|P2|NOT COMPLETED|Long-term Safety Phase (Year 4)||8
2405129|NCT01307423|5900835|P1|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
2405130|NCT01307423|5900827|P9|COMPLETED|Long-term Safety Phase (Year 4)||44
2405131|NCT01307423|5900828|P8|COMPLETED|Long-term Safety Phase (Year 4)||38
2405132|NCT01307423|5900829|P7|COMPLETED|Long-term Safety Phase (Year 4)||0
2405133|NCT01307423|5900830|P6|COMPLETED|Long-term Safety Phase (Year 4)||0
2405134|NCT01307423|5900831|P5|COMPLETED|Long-term Safety Phase (Year 4)||0
2405135|NCT01307423|5900832|P4|COMPLETED|Long-term Safety Phase (Year 4)||0
2405136|NCT01307423|5900833|P3|COMPLETED|Long-term Safety Phase (Year 4)||86
2405137|NCT01307423|5900834|P2|COMPLETED|Long-term Safety Phase (Year 4)||81
2405138|NCT01307423|5900835|P1|COMPLETED|Long-term Safety Phase (Year 4)||0
2405139|NCT01307423|5900827|P9|STARTED|Long-term Safety Phase (Year 4)||49
2405140|NCT01307423|5900828|P8|STARTED|Long-term Safety Phase (Year 4)||40
2405141|NCT01307423|5900829|P7|STARTED|Long-term Safety Phase (Year 4)||0
2405142|NCT01307423|5900830|P6|STARTED|Long-term Safety Phase (Year 4)||0
2405143|NCT01307423|5900831|P5|STARTED|Long-term Safety Phase (Year 4)||0
2405144|NCT01307423|5900832|P4|STARTED|Long-term Safety Phase (Year 4)||0
2405145|NCT01307423|5900833|P3|STARTED|Long-term Safety Phase (Year 4)||91
2405146|NCT01307423|5900834|P2|STARTED|Long-term Safety Phase (Year 4)|1 participant who completed Year 3 did not continue treatment in Year 4|89
2405147|NCT01307423|5900835|P1|STARTED|Long-term Safety Phase (Year 4)||0
2405148|NCT01307423|5900827|P9|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
2405149|NCT01307423|5900828|P8|NOT COMPLETED|Long-term Safety Phase (Year 3)||8
2405150|NCT01307423|5900829|P7|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
2405151|NCT01307423|5900830|P6|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
2405152|NCT01307423|5900831|P5|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
2405153|NCT01307423|5900832|P4|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
2405154|NCT01307423|5900833|P3|NOT COMPLETED|Long-term Safety Phase (Year 3)||18
2405155|NCT01307423|5900834|P2|NOT COMPLETED|Long-term Safety Phase (Year 3)||9
2405156|NCT01307423|5900835|P1|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
2405157|NCT01307423|5900827|P9|COMPLETED|Long-term Safety Phase (Year 3)||49
2405158|NCT01307423|5900828|P8|COMPLETED|Long-term Safety Phase (Year 3)||40
2405159|NCT01307423|5900829|P7|COMPLETED|Long-term Safety Phase (Year 3)||0
2405160|NCT01307423|5900830|P6|COMPLETED|Long-term Safety Phase (Year 3)||0
2405161|NCT01307423|5900831|P5|COMPLETED|Long-term Safety Phase (Year 3)||0
2405162|NCT01307423|5900832|P4|COMPLETED|Long-term Safety Phase (Year 3)||0
2405163|NCT01307423|5900833|P3|COMPLETED|Long-term Safety Phase (Year 3)||91
2405164|NCT01307423|5900834|P2|COMPLETED|Long-term Safety Phase (Year 3)||90
2405165|NCT01307423|5900835|P1|COMPLETED|Long-term Safety Phase (Year 3)||0
2405166|NCT01307423|5900827|P9|STARTED|Long-term Safety Phase (Year 3)||60
2405167|NCT01307423|5900828|P8|STARTED|Long-term Safety Phase (Year 3)||48
2405168|NCT01307423|5900829|P7|STARTED|Long-term Safety Phase (Year 3)||0
2405169|NCT01307423|5900830|P6|STARTED|Long-term Safety Phase (Year 3)||0
2405170|NCT01307423|5900831|P5|STARTED|Long-term Safety Phase (Year 3)||0
2405171|NCT01307423|5900832|P4|STARTED|Long-term Safety Phase (Year 3)||0
2405172|NCT01307423|5900833|P3|STARTED|Long-term Safety Phase (Year 3)||109
2405173|NCT01307423|5900834|P2|STARTED|Long-term Safety Phase (Year 3)||99
2405174|NCT01307423|5900835|P1|STARTED|Long-term Safety Phase (Year 3)||0
2405175|NCT01307423|5900827|P9|NOT COMPLETED|Long-term Safety Phase (Year 2)||7
2405176|NCT01307423|5900828|P8|NOT COMPLETED|Long-term Safety Phase (Year 2)||9
2405177|NCT01307423|5900829|P7|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
2405178|NCT01307423|5900830|P6|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
2405179|NCT01307423|5900831|P5|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
2405180|NCT01307423|5900832|P4|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
2405181|NCT01307423|5900833|P3|NOT COMPLETED|Long-term Safety Phase (Year 2)||25
2405182|NCT01307423|5900834|P2|NOT COMPLETED|Long-term Safety Phase (Year 2)||23
2405183|NCT01307423|5900835|P1|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
2405184|NCT01307423|5900827|P9|COMPLETED|Long-term Safety Phase (Year 2)||60
2405185|NCT01307423|5900828|P8|COMPLETED|Long-term Safety Phase (Year 2)||48
2405186|NCT01307423|5900829|P7|COMPLETED|Long-term Safety Phase (Year 2)||0
2405187|NCT01307423|5900830|P6|COMPLETED|Long-term Safety Phase (Year 2)||0
2405188|NCT01307423|5900831|P5|COMPLETED|Long-term Safety Phase (Year 2)||0
2405189|NCT01307423|5900832|P4|COMPLETED|Long-term Safety Phase (Year 2)||0
2405190|NCT01307423|5900833|P3|COMPLETED|Long-term Safety Phase (Year 2)||109
2405191|NCT01307423|5900834|P2|COMPLETED|Long-term Safety Phase (Year 2)||99
2405192|NCT01307423|5900835|P1|COMPLETED|Long-term Safety Phase (Year 2)||0
2405193|NCT01307423|5900827|P9|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 30 mg EE and XO are combined;5 patients finished Wk 52;no entry into LTSP|67
2405194|NCT01307423|5900828|P8|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 20 mg EE and XO are combined;15 patients finished Wk 52;no entry into LTSP|57
2405195|NCT01307423|5900829|P7|STARTED|Long-term Safety Phase (Year 2)||0
2405196|NCT01307423|5900830|P6|STARTED|Long-term Safety Phase (Year 2)||0
2405197|NCT01307423|5900831|P5|STARTED|Long-term Safety Phase (Year 2)||0
2405198|NCT01307423|5900832|P4|STARTED|Long-term Safety Phase (Year 2)||0
2405199|NCT01307423|5900833|P3|STARTED|Long-term Safety Phase (Year 2)|7 participants who completed Week 52 did not enter the long-term safety phase|134
2405200|NCT01307423|5900834|P2|STARTED|Long-term Safety Phase (Year 2)|10 participants who completed Week 52 did not enter the long-term safety phase|122
2405201|NCT01307423|5900835|P1|STARTED|Long-term Safety Phase (Year 2)||0
2405202|NCT01307423|5900827|P9|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
2405203|NCT01307423|5900828|P8|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
2405204|NCT01307423|5900829|P7|NOT COMPLETED|Active Treatment Phase (Week 25-52)||1
2405205|NCT01307423|5900830|P6|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
2405206|NCT01307423|5900831|P5|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
2405207|NCT01307423|5900832|P4|NOT COMPLETED|Active Treatment Phase (Week 25-52)||8
2405208|NCT01307423|5900833|P3|NOT COMPLETED|Active Treatment Phase (Week 25-52)||9
2405209|NCT01307423|5900834|P2|NOT COMPLETED|Active Treatment Phase (Week 25-52)||19
2405210|NCT01307423|5900835|P1|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
2405211|NCT01307423|5900827|P9|COMPLETED|Active Treatment Phase (Week 25-52)||0
2405212|NCT01307423|5900828|P8|COMPLETED|Active Treatment Phase (Week 25-52)||0
2405213|NCT01307423|5900829|P7|COMPLETED|Active Treatment Phase (Week 25-52)||25
2405214|NCT01307423|5900830|P6|COMPLETED|Active Treatment Phase (Week 25-52)||43
2405215|NCT01307423|5900831|P5|COMPLETED|Active Treatment Phase (Week 25-52)||23
2405216|NCT01307423|5900832|P4|COMPLETED|Active Treatment Phase (Week 25-52)||38
2405217|NCT01307423|5900833|P3|COMPLETED|Active Treatment Phase (Week 25-52)||141
2405218|NCT01307423|5900834|P2|COMPLETED|Active Treatment Phase (Week 25-52)||132
2405219|NCT01307423|5900835|P1|COMPLETED|Active Treatment Phase (Week 25-52)||0
2405220|NCT01307423|5900827|P9|STARTED|Active Treatment Phase (Week 25-52)||0
2405221|NCT01307423|5900828|P8|STARTED|Active Treatment Phase (Week 25-52)||0
2405222|NCT01307423|5900829|P7|STARTED|Active Treatment Phase (Week 25-52)||26
2405223|NCT01307423|5900830|P6|STARTED|Active Treatment Phase (Week 25-52)|Six participants who escaped early and completed Week 24 did not enter the active treatment phase|46
2405224|NCT01307423|5900831|P5|STARTED|Active Treatment Phase (Week 25-52)||26
2405225|NCT01307423|5900832|P4|STARTED|Active Treatment Phase (Week 25-52)|Four participants who escaped early and completed Week 24 did not enter the active treatment phase.|46
2405226|NCT01307423|5900833|P3|STARTED|Active Treatment Phase (Week 25-52)|Five participants who completed Week 24 did not enter active treatment phase|150
2405227|NCT01307423|5900834|P2|STARTED|Active Treatment Phase (Week 25-52)|Nine participants who completed Week 24 did not enter active treatment phase|151
2405228|NCT01307423|5900835|P1|STARTED|Active Treatment Phase (Week 25-52)||0
2405229|NCT01307423|5900827|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2405230|NCT01307423|5900828|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2405231|NCT01307423|5900829|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2405232|NCT01307423|5900830|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2405233|NCT01307423|5900831|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2405234|NCT01307423|5900832|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2405235|NCT01307423|5900833|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
2405236|NCT01307423|5900834|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||15
2405237|NCT01307423|5900835|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
2405238|NCT01307423|5900827|P9|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2405239|NCT01307423|5900828|P8|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2405240|NCT01307423|5900829|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2405241|NCT01307423|5900830|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2405242|NCT01307423|5900831|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2405243|NCT01307423|5900832|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2405244|NCT01307423|5900833|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||155
2405245|NCT01307423|5900834|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||160
2405246|NCT01307423|5900835|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants did not escape early and finished Week 24 did not enter the active treatment phase|156
2405247|NCT01307423|5900827|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2405248|NCT01307423|5900828|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2405249|NCT01307423|5900829|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2405250|NCT01307423|5900830|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2405251|NCT01307423|5900831|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2405252|NCT01307423|5900832|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2405253|NCT01307423|5900833|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||79
2405254|NCT01307423|5900834|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||73
2405255|NCT01307423|5900835|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|One participant who escaped early did not complete Week 24|103
2405256|NCT01307423|5900827|P9|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2405257|NCT01307423|5900828|P8|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2405258|NCT01307423|5900829|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2405259|NCT01307423|5900830|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2405260|NCT01307423|5900831|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2405261|NCT01307423|5900832|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2405262|NCT01307423|5900833|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
2405263|NCT01307423|5900834|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||168
2405264|NCT01307423|5900835|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
2405265|NCT01307423|5900827|P9|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
2405266|NCT01307423|5900828|P8|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
2405267|NCT01307423|5900829|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
2405268|NCT01307423|5900830|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
2405269|NCT01307423|5900831|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
2405270|NCT01307423|5900832|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
2405271|NCT01307423|5900833|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
2405272|NCT01307423|5900834|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
2405273|NCT01307423|5900835|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||176
2405274|NCT01307423|5900827|P9|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
2405275|NCT01307423|5900828|P8|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
2405276|NCT01307423|5900829|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
2405277|NCT01307423|5900830|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
2405278|NCT01307423|5900831|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
2405279|NCT01307423|5900832|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
2405280|NCT01307423|5900833|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||177
2405281|NCT01307423|5900834|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||175
2405282|NCT01307423|5900835|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||176
2405283|NCT01307397|5901019|P1|NOT COMPLETED|Overall Study||0
2405284|NCT01307397|5901019|P1|COMPLETED|Overall Study|A participant completed study in case of progressive disease, adverse events or consent withdrawn|3219
2405285|NCT01307397|5901019|P1|STARTED|Overall Study||3219
2405286|NCT01307319|5901041|P3|NOT COMPLETED|Overall Study||7
2405287|NCT01307319|5901042|P2|NOT COMPLETED|Overall Study||8
2405288|NCT01307319|5901043|P1|NOT COMPLETED|Overall Study||4
2405289|NCT01307319|5901041|P3|COMPLETED|Overall Study||227
2405290|NCT01307319|5901042|P2|COMPLETED|Overall Study||234
2405291|NCT01307319|5901043|P1|COMPLETED|Overall Study||235
2405292|NCT01307319|5901041|P3|ITT Population|Overall Study||234
2405293|NCT01307319|5901042|P2|ITT Population|Overall Study||241
2405294|NCT01307319|5901043|P1|ITT Population|Overall Study|One participant provided no post-baseline assessment.|238
2405295|NCT01307319|5901041|P3|Safety Population|Overall Study||234
2405296|NCT01307319|5901042|P2|Safety Population|Overall Study|One participant was randomized in error and did not receive study medication.|241
2405297|NCT01307319|5901043|P1|Safety Population|Overall Study||239
2405298|NCT01307319|5901041|P3|STARTED|Overall Study|Randomized|234
2405299|NCT01307319|5901042|P2|STARTED|Overall Study|Randomized|242
2405300|NCT01307319|5901043|P1|STARTED|Overall Study|Randomized|239
2405301|NCT01307111|5901057|P2|NOT COMPLETED|1-2 Week IUD Check up||2
2405302|NCT01307111|5901058|P1|NOT COMPLETED|1-2 Week IUD Check up||2
2405303|NCT01307111|5901057|P2|COMPLETED|1-2 Week IUD Check up||38
2405304|NCT01307111|5901058|P1|COMPLETED|1-2 Week IUD Check up||38
2405305|NCT01307111|5901057|P2|STARTED|1-2 Week IUD Check up||40
2405306|NCT01307111|5901058|P1|STARTED|1-2 Week IUD Check up||40
2405307|NCT01307111|5901057|P2|NOT COMPLETED|IUD Insertion||0
2405308|NCT01307111|5901058|P1|NOT COMPLETED|IUD Insertion||2
2405309|NCT01307111|5901057|P2|COMPLETED|IUD Insertion||40
2405310|NCT01307111|5901058|P1|COMPLETED|IUD Insertion||40
2405311|NCT01307111|5901057|P2|STARTED|IUD Insertion||40
2405312|NCT01307111|5901058|P1|STARTED|IUD Insertion||42
2405313|NCT01307098|5901069|P3|NOT COMPLETED|Overall Study||0
2405314|NCT01307098|5901070|P2|NOT COMPLETED|Overall Study||0
2405315|NCT01307098|5901071|P1|NOT COMPLETED|Overall Study||0
2405316|NCT01307098|5901069|P3|COMPLETED|Overall Study||3
2405317|NCT01307098|5901070|P2|COMPLETED|Overall Study||3
2405318|NCT01307098|5901071|P1|COMPLETED|Overall Study||3
2405319|NCT01307098|5901069|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
2405320|NCT01307098|5901070|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
2405321|NCT01307098|5901071|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
2405322|NCT01307098|5901069|P3|STARTED|Overall Study||3
2405323|NCT01307098|5901070|P2|STARTED|Overall Study||3
2405324|NCT01307098|5901071|P1|STARTED|Overall Study||3
2405325|NCT01307046|5901081|P2|NOT COMPLETED|Overall Study||11
2405326|NCT01307046|5901082|P1|NOT COMPLETED|Overall Study||12
2405327|NCT01307046|5901081|P2|COMPLETED|Overall Study||159
2405328|NCT01307046|5901082|P1|COMPLETED|Overall Study||154
2405329|NCT01307046|5901081|P2|STARTED|Overall Study||170
2405330|NCT01307046|5901082|P1|STARTED|Overall Study||166
2405331|NCT01307033|5901094|P4|NOT COMPLETED|44-week Open-label Extension||12
2405332|NCT01307033|5901095|P3|NOT COMPLETED|44-week Open-label Extension||11
2405333|NCT01307033|5901096|P2|NOT COMPLETED|44-week Open-label Extension||0
2405334|NCT01307033|5901097|P1|NOT COMPLETED|44-week Open-label Extension||0
2405335|NCT01307033|5901094|P4|COMPLETED|44-week Open-label Extension||115
2405336|NCT01307033|5901095|P3|COMPLETED|44-week Open-label Extension||120
2405337|NCT01307033|5901096|P2|COMPLETED|44-week Open-label Extension||0
2405338|NCT01307033|5901097|P1|COMPLETED|44-week Open-label Extension||0
2405339|NCT01307033|5901094|P4|STARTED|44-week Open-label Extension||127
2405340|NCT01307033|5901095|P3|STARTED|44-week Open-label Extension||131
2405341|NCT01307033|5901096|P2|STARTED|44-week Open-label Extension||0
2405342|NCT01307033|5901097|P1|STARTED|44-week Open-label Extension||0
2405343|NCT01307033|5901094|P4|NOT COMPLETED|8-week Double-blind Period||0
2405344|NCT01307033|5901095|P3|NOT COMPLETED|8-week Double-blind Period||0
2405345|NCT01307033|5901096|P2|NOT COMPLETED|8-week Double-blind Period||7
2405346|NCT01307033|5901097|P1|NOT COMPLETED|8-week Double-blind Period||13
2405347|NCT01307033|5901094|P4|COMPLETED|8-week Double-blind Period||0
2405348|NCT01307033|5901095|P3|COMPLETED|8-week Double-blind Period||0
2405349|NCT01307033|5901096|P2|COMPLETED|8-week Double-blind Period||127
2405350|NCT01307033|5901097|P1|COMPLETED|8-week Double-blind Period||131
2405351|NCT01307033|5901094|P4|STARTED|8-week Double-blind Period||0
2405352|NCT01307033|5901095|P3|STARTED|8-week Double-blind Period||0
2405353|NCT01307033|5901096|P2|STARTED|8-week Double-blind Period||134
2405354|NCT01307033|5901097|P1|STARTED|8-week Double-blind Period||144
2405355|NCT01307020|5901119|P10|NOT COMPLETED|Overall Study||0
2405356|NCT01307020|5901120|P9|NOT COMPLETED|Overall Study||0
2405357|NCT01307020|5901121|P8|NOT COMPLETED|Overall Study||0
2405358|NCT01307020|5901122|P7|NOT COMPLETED|Overall Study||1
2405359|NCT01307020|5901123|P6|NOT COMPLETED|Overall Study||0
2405360|NCT01307020|5901124|P5|NOT COMPLETED|Overall Study||0
2405361|NCT01307020|5901125|P4|NOT COMPLETED|Overall Study||1
2405362|NCT01307020|5901126|P3|NOT COMPLETED|Overall Study||1
2405363|NCT01307020|5901127|P2|NOT COMPLETED|Overall Study||1
2405364|NCT01307020|5901128|P1|NOT COMPLETED|Overall Study||0
2405365|NCT01307020|5901119|P10|COMPLETED|Overall Study||62
2405366|NCT01307020|5901120|P9|COMPLETED|Overall Study||61
2405367|NCT01307020|5901121|P8|COMPLETED|Overall Study||60
2405368|NCT01307020|5901122|P7|COMPLETED|Overall Study||58
2405369|NCT01307020|5901123|P6|COMPLETED|Overall Study||61
2405370|NCT01307020|5901124|P5|COMPLETED|Overall Study||60
2405371|NCT01307020|5901125|P4|COMPLETED|Overall Study||60
2405372|NCT01307020|5901126|P3|COMPLETED|Overall Study||62
2405373|NCT01307020|5901127|P2|COMPLETED|Overall Study||62
2405374|NCT01307020|5901128|P1|COMPLETED|Overall Study||61
2405375|NCT01307020|5901119|P10|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
2405376|NCT01307020|5901120|P9|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
2405377|NCT01307020|5901121|P8|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
2405378|NCT01307020|5901122|P7|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
2405379|NCT01307020|5901123|P6|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
2405380|NCT01307020|5901124|P5|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
2405381|NCT01307020|5901125|P4|ITT (>= 1 Assessment Post Randomization)|Overall Study||61
2405382|NCT01307020|5901126|P3|ITT (>= 1 Assessment Post Randomization)|Overall Study||63
2405383|NCT01307020|5901127|P2|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
2405384|NCT01307020|5901128|P1|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
2405385|NCT01307020|5901119|P10|Safety Population|Overall Study||62
2405386|NCT01307020|5901120|P9|Safety Population|Overall Study||61
2405387|NCT01307020|5901121|P8|Safety Population|Overall Study||60
2405388|NCT01307020|5901122|P7|Safety Population|Overall Study||59
2405389|NCT01307020|5901123|P6|Safety Population|Overall Study||61
2405390|NCT01307020|5901124|P5|Safety Population|Overall Study||60
2405391|NCT01307020|5901125|P4|Safety Population|Overall Study||61
2405392|NCT01307020|5901126|P3|Safety Population|Overall Study||63
2405393|NCT01307020|5901127|P2|Safety Population|Overall Study||63
2405394|NCT01307020|5901128|P1|Safety Population|Overall Study||61
2405395|NCT01307020|5901119|P10|STARTED|Overall Study||62
2405396|NCT01307020|5901120|P9|STARTED|Overall Study||61
2405397|NCT01307020|5901121|P8|STARTED|Overall Study||60
2405398|NCT01307020|5901122|P7|STARTED|Overall Study||59
2405399|NCT01307020|5901123|P6|STARTED|Overall Study||61
2405400|NCT01307020|5901124|P5|STARTED|Overall Study||60
2405401|NCT01307020|5901125|P4|STARTED|Overall Study||61
2405402|NCT01307020|5901126|P3|STARTED|Overall Study||63
2405403|NCT01307020|5901127|P2|STARTED|Overall Study||63
2405404|NCT01307020|5901128|P1|STARTED|Overall Study||61
2405405|NCT01307007|5901172|P2|NOT COMPLETED|Overall Study||0
2405406|NCT01307007|5901173|P1|NOT COMPLETED|Overall Study||0
2405407|NCT01307007|5901172|P2|COMPLETED|Overall Study||30
2405408|NCT01307007|5901173|P1|COMPLETED|Overall Study||25
2405409|NCT01307007|5901172|P2|STARTED|Overall Study||30
2405410|NCT01307007|5901173|P1|STARTED|Overall Study||25
2405411|NCT01306968|5901183|P4|NOT COMPLETED|Overall Study||4
2405412|NCT01306968|5901184|P3|NOT COMPLETED|Overall Study||1
2405413|NCT01306968|5901185|P2|NOT COMPLETED|Overall Study||3
2405414|NCT01306968|5901186|P1|NOT COMPLETED|Overall Study||1
2405415|NCT01306968|5901183|P4|COMPLETED|Overall Study||21
2405416|NCT01306968|5901184|P3|COMPLETED|Overall Study||23
2405417|NCT01306968|5901185|P2|COMPLETED|Overall Study||20
2405418|NCT01306968|5901186|P1|COMPLETED|Overall Study||6
2405419|NCT01306968|5901183|P4|STARTED|Overall Study|2 participants withdrew before chamber sessions were initiated|25
2405420|NCT01306968|5901184|P3|STARTED|Overall Study||24
2405421|NCT01306968|5901185|P2|STARTED|Overall Study||23
2405422|NCT01306968|5901186|P1|STARTED|Overall Study||7
2405423|NCT01306942|5901211|P4|NOT COMPLETED|Phase II||16
2405424|NCT01306942|5901212|P3|NOT COMPLETED|Phase II||0
2405425|NCT01306942|5901213|P2|NOT COMPLETED|Phase II||0
2405426|NCT01306942|5901214|P1|NOT COMPLETED|Phase II||2
2405427|NCT01306942|5901211|P4|COMPLETED|Phase II||11
2405428|NCT01306942|5901212|P3|COMPLETED|Phase II||0
2405429|NCT01306942|5901213|P2|COMPLETED|Phase II||0
2405430|NCT01306942|5901214|P1|COMPLETED|Phase II||0
2405431|NCT01306942|5901211|P4|STARTED|Phase II||27
2405432|NCT01306942|5901212|P3|STARTED|Phase II||0
2405433|NCT01306942|5901213|P2|STARTED|Phase II|Dasatinib 140mg was not the RP2D, so these patients were not included in the phase II analyses.|0
2405434|NCT01306942|5901214|P1|STARTED|Phase II|Two patients from phase I with measurable disease and RP2D were included in the phase II analyses.|2
2405435|NCT01306942|5901211|P4|NOT COMPLETED|Phase I||0
2405436|NCT01306942|5901212|P3|NOT COMPLETED|Phase I||0
2405437|NCT01306942|5901213|P2|NOT COMPLETED|Phase I||3
2405438|NCT01306942|5901214|P1|NOT COMPLETED|Phase I||5
2405439|NCT01306942|5901211|P4|COMPLETED|Phase I||0
2405440|NCT01306942|5901212|P3|COMPLETED|Phase I||0
2405441|NCT01306942|5901213|P2|COMPLETED|Phase I||1
2405442|NCT01306942|5901214|P1|COMPLETED|Phase I||1
2405443|NCT01306942|5901211|P4|STARTED|Phase I||0
2405444|NCT01306942|5901212|P3|STARTED|Phase I||0
2405445|NCT01306942|5901213|P2|STARTED|Phase I||4
2405446|NCT01306942|5901214|P1|STARTED|Phase I||6
2405447|NCT01306890|5901246|P1|NOT COMPLETED|Overall Study||1519
2405448|NCT01306890|5901246|P1|COMPLETED|Overall Study|Subjects were alive at the end of the study and had completed at least 3 years of follow up.|457
2405449|NCT01306890|5901246|P1|STARTED|Overall Study||1976
2405450|NCT01306877|5901253|P2|NOT COMPLETED|Overall Study||4
2405451|NCT01306877|5901254|P1|NOT COMPLETED|Overall Study||3
2405452|NCT01306877|5901253|P2|COMPLETED|Overall Study||67
2405453|NCT01306877|5901254|P1|COMPLETED|Overall Study||75
2405454|NCT01306877|5901253|P2|STARTED|Overall Study||71
2405455|NCT01306877|5901254|P1|STARTED|Overall Study||78
2405456|NCT01306656|5901274|P2|NOT COMPLETED|Overall Study||0
2405457|NCT01306656|5901275|P1|NOT COMPLETED|Overall Study||1
2405458|NCT01306656|5901274|P2|COMPLETED|Overall Study||2
2405459|NCT01306656|5901275|P1|COMPLETED|Overall Study||6
2405460|NCT01306656|5901274|P2|STARTED|Overall Study||2
2405461|NCT01306656|5901275|P1|STARTED|Overall Study||7
2405462|NCT01306643|5901287|P1|NOT COMPLETED|Overall Study||13
2405463|NCT01306643|5901287|P1|COMPLETED|Overall Study|Completed Study was defined as participants who completed through Cycle 12 (Week 48) per protocol.|5
2405464|NCT01306643|5901287|P1|STARTED|Overall Study||18
2405465|NCT01306617|5901299|P3|NOT COMPLETED|Overall Study||5
2405466|NCT01306617|5901300|P2|NOT COMPLETED|Overall Study||1
2405467|NCT01306617|5901301|P1|NOT COMPLETED|Overall Study||1
2405468|NCT01306617|5901299|P3|COMPLETED|Overall Study|The number of participants who completed study drug|12
2405469|NCT01306617|5901300|P2|COMPLETED|Overall Study|The number of participants who completed study drug|13
2405470|NCT01306617|5901301|P1|COMPLETED|Overall Study|The number of participants who completed study drug|18
2405471|NCT01306617|5901299|P3|STARTED|Overall Study||17
2405472|NCT01306617|5901300|P2|STARTED|Overall Study||14
2405473|NCT01306617|5901301|P1|STARTED|Overall Study||19
2405474|NCT01306305|5901344|P2|NOT COMPLETED|Overall Study||0
2405475|NCT01306305|5901345|P1|NOT COMPLETED|Overall Study||2
2405476|NCT01306305|5901344|P2|COMPLETED|Overall Study||55
2405477|NCT01306305|5901345|P1|COMPLETED|Overall Study||53
2405478|NCT01306305|5901344|P2|STARTED|Overall Study||55
2405479|NCT01306305|5901345|P1|STARTED|Overall Study||55
2405480|NCT01306292|5901361|P4|NOT COMPLETED|Second Injection||0
2405481|NCT01306292|5901362|P3|NOT COMPLETED|Second Injection||1
2405482|NCT01306292|5901363|P2|NOT COMPLETED|Second Injection||0
2405483|NCT01306292|5901364|P1|NOT COMPLETED|Second Injection||0
2405484|NCT01306292|5901361|P4|COMPLETED|Second Injection||10
2405485|NCT01306292|5901362|P3|COMPLETED|Second Injection|1 subject completed both injections but not 24-hour follow-up; all other values were recorded.|7
2405486|NCT01306292|5901363|P2|COMPLETED|Second Injection||8
2405487|NCT01306292|5901364|P1|COMPLETED|Second Injection||10
2405488|NCT01306292|5901361|P4|STARTED|Second Injection||10
2405489|NCT01306292|5901362|P3|STARTED|Second Injection||8
2405490|NCT01306292|5901363|P2|STARTED|Second Injection||8
2405491|NCT01306292|5901364|P1|STARTED|Second Injection||10
2405492|NCT01306292|5901361|P4|NOT COMPLETED|Washout (at Least 10 Minutes)||0
2405493|NCT01306292|5901362|P3|NOT COMPLETED|Washout (at Least 10 Minutes)||0
2405494|NCT01306292|5901363|P2|NOT COMPLETED|Washout (at Least 10 Minutes)||0
2405495|NCT01306292|5901364|P1|NOT COMPLETED|Washout (at Least 10 Minutes)||0
2405496|NCT01306292|5901361|P4|COMPLETED|Washout (at Least 10 Minutes)||10
2405497|NCT01306292|5901362|P3|COMPLETED|Washout (at Least 10 Minutes)||8
2405498|NCT01306292|5901363|P2|COMPLETED|Washout (at Least 10 Minutes)||8
2405499|NCT01306292|5901364|P1|COMPLETED|Washout (at Least 10 Minutes)||10
2405500|NCT01306292|5901361|P4|STARTED|Washout (at Least 10 Minutes)||10
2405501|NCT01306292|5901362|P3|STARTED|Washout (at Least 10 Minutes)||8
2405502|NCT01306292|5901363|P2|STARTED|Washout (at Least 10 Minutes)||8
2405503|NCT01306292|5901364|P1|STARTED|Washout (at Least 10 Minutes)||10
2405504|NCT01306292|5901361|P4|NOT COMPLETED|First Injection||0
2405505|NCT01306292|5901362|P3|NOT COMPLETED|First Injection||0
2405506|NCT01306292|5901363|P2|NOT COMPLETED|First Injection||0
2405507|NCT01306292|5901364|P1|NOT COMPLETED|First Injection||0
2405508|NCT01306292|5901361|P4|COMPLETED|First Injection||10
2405509|NCT01306292|5901362|P3|COMPLETED|First Injection||8
2405510|NCT01306292|5901363|P2|COMPLETED|First Injection||8
2405511|NCT01306292|5901364|P1|COMPLETED|First Injection||10
2405512|NCT01306292|5901361|P4|STARTED|First Injection||10
2405513|NCT01306292|5901362|P3|STARTED|First Injection||8
2405514|NCT01306292|5901363|P2|STARTED|First Injection||8
2405515|NCT01306292|5901364|P1|STARTED|First Injection||10
2405516|NCT01306253|5901382|P2|NOT COMPLETED|Overall Study||1
2405517|NCT01306253|5901383|P1|NOT COMPLETED|Overall Study||1
2405518|NCT01306253|5901382|P2|COMPLETED|Overall Study||56
2405519|NCT01306253|5901383|P1|COMPLETED|Overall Study||56
2405520|NCT01306253|5901382|P2|STARTED|Overall Study||57
2405521|NCT01306253|5901383|P1|STARTED|Overall Study||57
2405522|NCT01306214|5901400|P3|NOT COMPLETED|Overall Study||22
2405523|NCT01306214|5901401|P2|NOT COMPLETED|Overall Study||28
2405524|NCT01306214|5901402|P1|NOT COMPLETED|Overall Study||28
2405525|NCT01306214|5901400|P3|COMPLETED|Overall Study||168
2405526|NCT01306214|5901401|P2|COMPLETED|Overall Study||159
2405527|NCT01306214|5901402|P1|COMPLETED|Overall Study||161
2405528|NCT01306214|5901400|P3|STARTED|Overall Study||190
2405529|NCT01306214|5901401|P2|STARTED|Overall Study||187
2405530|NCT01306214|5901402|P1|STARTED|Overall Study||189
2405531|NCT01306201|5901419|P1|NOT COMPLETED|Overall Study||10
2405532|NCT01306201|5901419|P1|COMPLETED|Overall Study|Total of 10 subjects were excluded from analysis|53
2405533|NCT01306201|5901419|P1|STARTED|Overall Study||63
2405534|NCT01306175|5901427|P1|NOT COMPLETED|Second Intervention||0
2405535|NCT01306175|5901427|P1|COMPLETED|Second Intervention||20
2405536|NCT01306175|5901427|P1|STARTED|Second Intervention||20
2405537|NCT01306175|5901427|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
2405538|NCT01306175|5901427|P1|COMPLETED|Washout Period of at Least 14 Days||20
2405539|NCT01306175|5901427|P1|STARTED|Washout Period of at Least 14 Days||20
2405540|NCT01306175|5901427|P1|NOT COMPLETED|First Intervention||0
2405541|NCT01306175|5901427|P1|COMPLETED|First Intervention||20
2405542|NCT01306175|5901427|P1|STARTED|First Intervention||20
2405543|NCT01306162|5901441|P4|NOT COMPLETED|Period 4||0
2405544|NCT01306162|5901442|P3|NOT COMPLETED|Period 4||0
2405545|NCT01306162|5901443|P2|NOT COMPLETED|Period 4||0
2405546|NCT01306162|5901444|P1|NOT COMPLETED|Period 4||0
2405547|NCT01306162|5901441|P4|COMPLETED|Period 4||8
2405548|NCT01306162|5901442|P3|COMPLETED|Period 4||9
2405549|NCT01306162|5901443|P2|COMPLETED|Period 4||8
2405550|NCT01306162|5901444|P1|COMPLETED|Period 4||9
2405551|NCT01306162|5901441|P4|STARTED|Period 4||8
2405552|NCT01306162|5901442|P3|STARTED|Period 4||9
2405553|NCT01306162|5901443|P2|STARTED|Period 4||8
2405554|NCT01306162|5901444|P1|STARTED|Period 4||9
2405555|NCT01306162|5901441|P4|NOT COMPLETED|Washout 2||0
2405556|NCT01306162|5901442|P3|NOT COMPLETED|Washout 2||0
2405557|NCT01306162|5901443|P2|NOT COMPLETED|Washout 2||0
2405558|NCT01306162|5901444|P1|NOT COMPLETED|Washout 2||0
2405559|NCT01306162|5901441|P4|COMPLETED|Washout 2||8
2405560|NCT01306162|5901442|P3|COMPLETED|Washout 2||9
2405561|NCT01306162|5901443|P2|COMPLETED|Washout 2||8
2405562|NCT01306162|5901444|P1|COMPLETED|Washout 2||9
2405563|NCT01306162|5901441|P4|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|8
2405564|NCT01306162|5901442|P3|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|9
2405565|NCT01306162|5901443|P2|STARTED|Washout 2|No washout period. Treatment D followed directly after treatment E.|8
2405566|NCT01306162|5901444|P1|STARTED|Washout 2|No washout period. Treatment E followed directly after treatment D.|9
2405567|NCT01306162|5901441|P4|NOT COMPLETED|Period 3||0
2405568|NCT01306162|5901442|P3|NOT COMPLETED|Period 3||0
2405569|NCT01306162|5901443|P2|NOT COMPLETED|Period 3||0
2405570|NCT01306162|5901444|P1|NOT COMPLETED|Period 3||0
2405571|NCT01306162|5901441|P4|COMPLETED|Period 3||8
2405572|NCT01306162|5901442|P3|COMPLETED|Period 3||9
2405573|NCT01306162|5901443|P2|COMPLETED|Period 3||8
2405574|NCT01306162|5901444|P1|COMPLETED|Period 3||9
2405575|NCT01306162|5901441|P4|STARTED|Period 3||8
2405576|NCT01306162|5901442|P3|STARTED|Period 3||9
2405577|NCT01306162|5901443|P2|STARTED|Period 3||8
2405578|NCT01306162|5901444|P1|STARTED|Period 3||9
2405579|NCT01306162|5901441|P4|NOT COMPLETED|Period 2||0
2405580|NCT01306162|5901442|P3|NOT COMPLETED|Period 2||0
2405581|NCT01306162|5901443|P2|NOT COMPLETED|Period 2||0
2405582|NCT01306162|5901444|P1|NOT COMPLETED|Period 2||0
2405583|NCT01306162|5901441|P4|COMPLETED|Period 2||8
2405584|NCT01306162|5901442|P3|COMPLETED|Period 2||9
2405585|NCT01306162|5901443|P2|COMPLETED|Period 2||8
2405586|NCT01306162|5901444|P1|COMPLETED|Period 2||9
2405587|NCT01306162|5901441|P4|STARTED|Period 2|No washout phase after Period 2.|8
2405588|NCT01306162|5901442|P3|STARTED|Period 2|No washout phase after Period 2.|9
2405589|NCT01306162|5901443|P2|STARTED|Period 2|No washout phase after Period 2.|8
2405590|NCT01306162|5901444|P1|STARTED|Period 2|No washout phase after Period 2.|9
2405591|NCT01306162|5901441|P4|NOT COMPLETED|Washout 1||0
2405592|NCT01306162|5901442|P3|NOT COMPLETED|Washout 1||0
2405593|NCT01306162|5901443|P2|NOT COMPLETED|Washout 1||1
2405594|NCT01306162|5901444|P1|NOT COMPLETED|Washout 1||0
2405595|NCT01306162|5901441|P4|COMPLETED|Washout 1||8
2405596|NCT01306162|5901442|P3|COMPLETED|Washout 1||9
2405597|NCT01306162|5901443|P2|COMPLETED|Washout 1||8
2405598|NCT01306162|5901444|P1|COMPLETED|Washout 1||9
2405599|NCT01306162|5901441|P4|STARTED|Washout 1|No washout period.Treatment E followed directly after treatment C.|8
2405600|NCT01306162|5901442|P3|STARTED|Washout 1|No washout period. Treatment D followed directly after treatment B.|9
2405601|NCT01306162|5901443|P2|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
2405602|NCT01306162|5901444|P1|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
2405603|NCT01306162|5901441|P4|NOT COMPLETED|Period 1||1
2405604|NCT01306162|5901442|P3|NOT COMPLETED|Period 1||0
2405605|NCT01306162|5901443|P2|NOT COMPLETED|Period 1||0
2405606|NCT01306162|5901444|P1|NOT COMPLETED|Period 1||0
2405607|NCT01306162|5901441|P4|COMPLETED|Period 1||8
2405608|NCT01306162|5901442|P3|COMPLETED|Period 1||9
2405609|NCT01306162|5901443|P2|COMPLETED|Period 1||9
2405610|NCT01306162|5901444|P1|COMPLETED|Period 1||9
2405611|NCT01306162|5901441|P4|STARTED|Period 1||9
2405612|NCT01306162|5901442|P3|STARTED|Period 1||9
2405613|NCT01306162|5901443|P2|STARTED|Period 1||9
2405614|NCT01306162|5901444|P1|STARTED|Period 1||9
2405615|NCT01306058|5901472|P1|NOT COMPLETED|Overall Study||2
2405616|NCT01306058|5901472|P1|COMPLETED|Overall Study||25
2405617|NCT01306058|5901472|P1|STARTED|Overall Study||27
2405618|NCT01306032|5901499|P6|NOT COMPLETED|Disease Progression/Crossover||0
2405619|NCT01306032|5901500|P5|NOT COMPLETED|Disease Progression/Crossover||0
2405620|NCT01306032|5901501|P4|NOT COMPLETED|Disease Progression/Crossover||3
2405621|NCT01306032|5901502|P3|NOT COMPLETED|Disease Progression/Crossover||0
2405622|NCT01306032|5901503|P2|NOT COMPLETED|Disease Progression/Crossover||2
2405623|NCT01306032|5901504|P1|NOT COMPLETED|Disease Progression/Crossover||0
2405624|NCT01306032|5901499|P6|COMPLETED|Disease Progression/Crossover||0
2405625|NCT01306032|5901500|P5|COMPLETED|Disease Progression/Crossover||0
2405626|NCT01306032|5901501|P4|COMPLETED|Disease Progression/Crossover||26
2405627|NCT01306032|5901502|P3|COMPLETED|Disease Progression/Crossover||0
2405628|NCT01306032|5901503|P2|COMPLETED|Disease Progression/Crossover||14
2405629|NCT01306032|5901504|P1|COMPLETED|Disease Progression/Crossover||0
2405630|NCT01306032|5901499|P6|STARTED|Disease Progression/Crossover||0
2405631|NCT01306032|5901500|P5|STARTED|Disease Progression/Crossover||0
2405632|NCT01306032|5901501|P4|STARTED|Disease Progression/Crossover||29
2405633|NCT01306032|5901502|P3|STARTED|Disease Progression/Crossover||0
2405634|NCT01306032|5901503|P2|STARTED|Disease Progression/Crossover||16
2405635|NCT01306032|5901504|P1|STARTED|Disease Progression/Crossover||0
2405636|NCT01306032|5901499|P6|NOT COMPLETED|First Intervention||2
2405637|NCT01306032|5901500|P5|NOT COMPLETED|First Intervention||2
2405638|NCT01306032|5901501|P4|NOT COMPLETED|First Intervention||1
2405639|NCT01306032|5901502|P3|NOT COMPLETED|First Intervention||2
2405640|NCT01306032|5901503|P2|NOT COMPLETED|First Intervention||2
2405641|NCT01306032|5901504|P1|NOT COMPLETED|First Intervention||1
2405642|NCT01306032|5901499|P6|COMPLETED|First Intervention||0
2405643|NCT01306032|5901500|P5|COMPLETED|First Intervention||0
2405644|NCT01306032|5901501|P4|COMPLETED|First Intervention||37
2405645|NCT01306032|5901502|P3|COMPLETED|First Intervention||35
2405646|NCT01306032|5901503|P2|COMPLETED|First Intervention||18
2405647|NCT01306032|5901504|P1|COMPLETED|First Intervention||21
2405648|NCT01306032|5901499|P6|STARTED|First Intervention||2
2405649|NCT01306032|5901500|P5|STARTED|First Intervention||2
2405650|NCT01306032|5901501|P4|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|38
2405651|NCT01306032|5901502|P3|STARTED|First Intervention||37
2405652|NCT01306032|5901503|P2|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|20
2405653|NCT01306032|5901504|P1|STARTED|First Intervention||22
2405654|NCT01305941|5901556|P1|NOT COMPLETED|Overall Study||10
2405655|NCT01305941|5901556|P1|COMPLETED|Overall Study||22
2405656|NCT01305941|5901556|P1|STARTED|Overall Study||32
2405657|NCT01305811|5901570|P2|NOT COMPLETED|Overall Study||11
2405658|NCT01305811|5901571|P1|NOT COMPLETED|Overall Study||8
2405659|NCT01305811|5901570|P2|COMPLETED|Overall Study||41
2405660|NCT01305811|5901571|P1|COMPLETED|Overall Study||44
2405661|NCT01305811|5901570|P2|STARTED|Overall Study||52
2405662|NCT01305811|5901571|P1|STARTED|Overall Study||52
2405663|NCT01305772|5901581|P2|NOT COMPLETED|Overall Study||0
2405664|NCT01305772|5901582|P1|NOT COMPLETED|Overall Study||0
2405665|NCT01305772|5901581|P2|COMPLETED|Overall Study||1
2405666|NCT01305772|5901582|P1|COMPLETED|Overall Study||5
2405667|NCT01305772|5901581|P2|RT + Panitumumab Dose #2 / #3|Overall Study||1
2405668|NCT01305772|5901582|P1|RT + Panitumumab Dose #2 / #3|Overall Study|RT and doses #2 and #3 of panitumumab administered to patients regardless of 2nd biopsy status.|5
2405669|NCT01305772|5901581|P2|Surgery/Biopsy #2|Overall Study||1
2405670|NCT01305772|5901582|P1|Surgery/Biopsy #2|Overall Study|2nd research tissue sample not collected for 4 patients due to safety risk to subject.|1
2405671|NCT01305772|5901581|P2|Research PET/CT #2|Overall Study||1
2405672|NCT01305772|5901582|P1|Research PET/CT #2|Overall Study||5
2405673|NCT01305772|5901581|P2|Panitumumab Dose #1|Overall Study||1
2405674|NCT01305772|5901582|P1|Panitumumab Dose #1|Overall Study||5
2405675|NCT01305772|5901581|P2|Research PET/CT #1|Overall Study||1
2405676|NCT01305772|5901582|P1|Research PET/CT #1|Overall Study||5
2405677|NCT01305772|5901581|P2|Genomic Screening + Biopsy #1|Overall Study||1
2405678|NCT01305772|5901582|P1|Genomic Screening + Biopsy #1|Overall Study||5
2405679|NCT01305772|5901581|P2|STARTED|Overall Study||1
2405680|NCT01305772|5901582|P1|STARTED|Overall Study||5
2405681|NCT01305655|5901589|P1|NOT COMPLETED|Overall Study||0
2405682|NCT01305655|5901589|P1|COMPLETED|Overall Study|December 31, 2014|47
2405683|NCT01305655|5901589|P1|STARTED|Overall Study|July 2008|47
2405684|NCT01305577|5901596|P3|NOT COMPLETED|Overall Study||10
2405685|NCT01305577|5901597|P2|NOT COMPLETED|Overall Study||11
2405686|NCT01305577|5901598|P1|NOT COMPLETED|Overall Study||13
2405687|NCT01305577|5901596|P3|COMPLETED|Overall Study||112
2405688|NCT01305577|5901597|P2|COMPLETED|Overall Study||110
2405689|NCT01305577|5901598|P1|COMPLETED|Overall Study||107
2405690|NCT01305577|5901596|P3|Received Treatment|Overall Study||122
2405691|NCT01305577|5901597|P2|Received Treatment|Overall Study||121
2405692|NCT01305577|5901598|P1|Received Treatment|Overall Study||119
2405693|NCT01305577|5901596|P3|STARTED|Overall Study||122
2405694|NCT01305577|5901597|P2|STARTED|Overall Study||121
2405695|NCT01305577|5901598|P1|STARTED|Overall Study||120
2405696|NCT01305564|5901627|P1|NOT COMPLETED|Overall Study||37
2405697|NCT01305564|5901627|P1|COMPLETED|Overall Study||163
2405698|NCT01305564|5901627|P1|STARTED|Overall Study||200
2405699|NCT01305473|5901642|P1|NOT COMPLETED|Overall Study||0
2405700|NCT01305473|5901642|P1|COMPLETED|Overall Study||90
2405701|NCT01305473|5901642|P1|STARTED|Overall Study||90
2405702|NCT01305408|5901654|P2|NOT COMPLETED|Overall Study||31
2405703|NCT01305408|5901655|P1|NOT COMPLETED|Overall Study||32
2405704|NCT01305408|5901654|P2|COMPLETED|Overall Study||169
2405705|NCT01305408|5901655|P1|COMPLETED|Overall Study||167
2405706|NCT01305408|5901654|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
2405707|NCT01305408|5901655|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
2405708|NCT01305408|5901654|P2|Safety Population|Overall Study|Treated participants.|200
2405709|NCT01305408|5901655|P1|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|198
2405710|NCT01305408|5901654|P2|STARTED|Overall Study||200
2405711|NCT01305408|5901655|P1|STARTED|Overall Study||199
2405712|NCT01305356|5901707|P2|NOT COMPLETED|Overall Study||0
2405713|NCT01305356|5901708|P1|NOT COMPLETED|Overall Study||0
2405714|NCT01305356|5901707|P2|COMPLETED|Overall Study||167
2405715|NCT01305356|5901708|P1|COMPLETED|Overall Study||132
2405716|NCT01305356|5901707|P2|STARTED|Overall Study||167
2405717|NCT01305356|5901708|P1|STARTED|Overall Study||132
2405718|NCT01305265|5901724|P2|NOT COMPLETED|Overall Study||6
2405719|NCT01305265|5901725|P1|NOT COMPLETED|Overall Study||2
2405720|NCT01305265|5901724|P2|COMPLETED|Overall Study||64
2405721|NCT01305265|5901725|P1|COMPLETED|Overall Study||69
2405722|NCT01305265|5901724|P2|STARTED|Overall Study||70
2405723|NCT01305265|5901725|P1|STARTED|Overall Study||71
2405724|NCT01305252|5901733|P2|NOT COMPLETED|Overall Study||0
2405725|NCT01305252|5901734|P1|NOT COMPLETED|Overall Study||1
2405726|NCT01305252|5901733|P2|COMPLETED|Overall Study||11
2405727|NCT01305252|5901734|P1|COMPLETED|Overall Study||9
2405728|NCT01305252|5901733|P2|STARTED|Overall Study||11
2405729|NCT01305252|5901734|P1|STARTED|Overall Study||10
2405730|NCT01305239|5901748|P1|NOT COMPLETED|Overall Study||23
2405731|NCT01305239|5901748|P1|COMPLETED|Overall Study||375
2405732|NCT01305239|5901748|P1|Intent to Treat Population|Overall Study||287
2405733|NCT01305239|5901748|P1|Safety Set|Overall Study||397
2405734|NCT01305239|5901748|P1|STARTED|Overall Study||398
2405735|NCT01305213|5901758|P2|NOT COMPLETED|Overall Study||0
2405736|NCT01305213|5901759|P1|NOT COMPLETED|Overall Study||0
2405737|NCT01305213|5901758|P2|COMPLETED|Overall Study||54
2405738|NCT01305213|5901759|P1|COMPLETED|Overall Study||53
2405739|NCT01305213|5901758|P2|STARTED|Overall Study||54
2405740|NCT01305213|5901759|P1|STARTED|Overall Study||53
2405741|NCT01305200|5901778|P3|NOT COMPLETED|Overall Study||3
2405742|NCT01305200|5901779|P2|NOT COMPLETED|Overall Study||31
2405743|NCT01305200|5901780|P1|NOT COMPLETED|Overall Study||29
2405744|NCT01305200|5901778|P3|COMPLETED|Overall Study||0
2405745|NCT01305200|5901779|P2|COMPLETED|Overall Study||81
2405746|NCT01305200|5901780|P1|COMPLETED|Overall Study||82
2405747|NCT01305200|5901778|P3|STARTED|Overall Study||3
2405748|NCT01305200|5901779|P2|STARTED|Overall Study||112
2405749|NCT01305200|5901780|P1|STARTED|Overall Study||111
2405750|NCT01305044|5901810|P2|NOT COMPLETED|Overall Study||6
2405751|NCT01305044|5901811|P1|NOT COMPLETED|Overall Study||3
2405752|NCT01305044|5901810|P2|COMPLETED|Overall Study||25
2405753|NCT01305044|5901811|P1|COMPLETED|Overall Study||29
2405754|NCT01305044|5901810|P2|STARTED|Overall Study||31
2405755|NCT01305044|5901811|P1|STARTED|Overall Study||32
2405756|NCT01304966|5901835|P1|NOT COMPLETED|Overall Study||0
2405757|NCT01304966|5901835|P1|COMPLETED|Overall Study||15
2405758|NCT01304966|5901835|P1|STARTED|Overall Study||15
2405759|NCT01304940|5901843|P2|NOT COMPLETED|Overall Study||0
2405760|NCT01304940|5901844|P1|NOT COMPLETED|Overall Study||3
2405761|NCT01304940|5901843|P2|COMPLETED|Overall Study||25
2405762|NCT01304940|5901844|P1|COMPLETED|Overall Study|these participants met severity requirement and were included in study analyses|22
2405763|NCT01304940|5901843|P2|Completed Study|Overall Study|recruitment ended when 25 participants completed study procedures|25
2405764|NCT01304940|5901844|P1|Completed Study|Overall Study|recruitment ended when 25 participants completed study procedures|25
2405765|NCT01304940|5901843|P2|STARTED|Overall Study||25
2405766|NCT01304940|5901844|P1|STARTED|Overall Study||25
2405767|NCT01304706|5901850|P1|NOT COMPLETED|Overall Study||17
2405768|NCT01304706|5901850|P1|COMPLETED|Overall Study||104
2405769|NCT01304706|5901850|P1|STARTED|Overall Study||121
2405770|NCT01304693|5901859|P5|NOT COMPLETED|Overall Study||1
2405771|NCT01304693|5901860|P4|NOT COMPLETED|Overall Study||1
2405772|NCT01304693|5901861|P3|NOT COMPLETED|Overall Study||1
2405773|NCT01304693|5901862|P2|NOT COMPLETED|Overall Study||0
2405774|NCT01304693|5901863|P1|NOT COMPLETED|Overall Study||0
2405775|NCT01304693|5901859|P5|COMPLETED|Overall Study||60
2405776|NCT01304693|5901860|P4|COMPLETED|Overall Study||39
2405777|NCT01304693|5901861|P3|COMPLETED|Overall Study||47
2405778|NCT01304693|5901862|P2|COMPLETED|Overall Study||35
2405779|NCT01304693|5901863|P1|COMPLETED|Overall Study||10
2405780|NCT01304693|5901859|P5|STARTED|Overall Study||61
2405781|NCT01304693|5901860|P4|STARTED|Overall Study||40
2405782|NCT01304693|5901861|P3|STARTED|Overall Study||48
2405783|NCT01304693|5901862|P2|STARTED|Overall Study||35
2405784|NCT01304693|5901863|P1|STARTED|Overall Study||10
2405785|NCT01304641|5901882|P2|NOT COMPLETED|Overall Study||0
2405786|NCT01304641|5901883|P1|NOT COMPLETED|Overall Study||0
2405787|NCT01304641|5901882|P2|COMPLETED|Overall Study||20132
2405788|NCT01304641|5901883|P1|COMPLETED|Overall Study||11470
2405789|NCT01304641|5901882|P2|STARTED|Overall Study||20132
2405790|NCT01304641|5901883|P1|STARTED|Overall Study||11470
2405791|NCT01304589|5901901|P1|NOT COMPLETED|Overall Study||13
2405792|NCT01304589|5901901|P1|COMPLETED|Overall Study||18
2405793|NCT01304589|5901901|P1|STARTED|Overall Study||31
2405794|NCT01304498|5901910|P2|NOT COMPLETED|Overall Study||5
2405795|NCT01304498|5901911|P1|NOT COMPLETED|Overall Study||6
2405796|NCT01304498|5901910|P2|COMPLETED|Overall Study||295
2405797|NCT01304498|5901911|P1|COMPLETED|Overall Study||294
2405798|NCT01304498|5901910|P2|Received ≥1 Dose|Overall Study||300
2405799|NCT01304498|5901911|P1|Received ≥1 Dose|Overall Study||300
2405800|NCT01304498|5901910|P2|STARTED|Overall Study||300
2405801|NCT01304498|5901911|P1|STARTED|Overall Study||300
2405802|NCT01304329|5901931|P6|NOT COMPLETED|Third Intervention (3 Days)||0
2405803|NCT01304329|5901932|P5|NOT COMPLETED|Third Intervention (3 Days)||0
2405804|NCT01304329|5901933|P4|NOT COMPLETED|Third Intervention (3 Days)||0
2405805|NCT01304329|5901934|P3|NOT COMPLETED|Third Intervention (3 Days)||0
2405806|NCT01304329|5901935|P2|NOT COMPLETED|Third Intervention (3 Days)||1
2405807|NCT01304329|5901936|P1|NOT COMPLETED|Third Intervention (3 Days)||0
2405808|NCT01304329|5901931|P6|COMPLETED|Third Intervention (3 Days)||3
2405809|NCT01304329|5901932|P5|COMPLETED|Third Intervention (3 Days)||3
2405810|NCT01304329|5901933|P4|COMPLETED|Third Intervention (3 Days)||3
2405811|NCT01304329|5901934|P3|COMPLETED|Third Intervention (3 Days)||3
2405812|NCT01304329|5901935|P2|COMPLETED|Third Intervention (3 Days)||2
2405813|NCT01304329|5901936|P1|COMPLETED|Third Intervention (3 Days)||3
2405814|NCT01304329|5901931|P6|STARTED|Third Intervention (3 Days)||3
2405815|NCT01304329|5901932|P5|STARTED|Third Intervention (3 Days)||3
2405816|NCT01304329|5901933|P4|STARTED|Third Intervention (3 Days)||3
2405817|NCT01304329|5901934|P3|STARTED|Third Intervention (3 Days)||3
2405818|NCT01304329|5901935|P2|STARTED|Third Intervention (3 Days)||3
2405819|NCT01304329|5901936|P1|STARTED|Third Intervention (3 Days)||3
2405820|NCT01304329|5901931|P6|NOT COMPLETED|Second Intervention (3 Days)||0
2405821|NCT01304329|5901932|P5|NOT COMPLETED|Second Intervention (3 Days)||0
2405822|NCT01304329|5901933|P4|NOT COMPLETED|Second Intervention (3 Days)||0
2405823|NCT01304329|5901934|P3|NOT COMPLETED|Second Intervention (3 Days)||0
2405824|NCT01304329|5901935|P2|NOT COMPLETED|Second Intervention (3 Days)||0
2405825|NCT01304329|5901936|P1|NOT COMPLETED|Second Intervention (3 Days)||0
2405826|NCT01304329|5901931|P6|COMPLETED|Second Intervention (3 Days)||3
2405827|NCT01304329|5901932|P5|COMPLETED|Second Intervention (3 Days)||3
2405828|NCT01304329|5901933|P4|COMPLETED|Second Intervention (3 Days)||3
2405829|NCT01304329|5901934|P3|COMPLETED|Second Intervention (3 Days)||3
2405830|NCT01304329|5901935|P2|COMPLETED|Second Intervention (3 Days)||3
2405831|NCT01304329|5901936|P1|COMPLETED|Second Intervention (3 Days)||3
2405832|NCT01304329|5901931|P6|STARTED|Second Intervention (3 Days)||3
2405833|NCT01304329|5901932|P5|STARTED|Second Intervention (3 Days)||3
2405834|NCT01304329|5901933|P4|STARTED|Second Intervention (3 Days)||3
2405835|NCT01304329|5901934|P3|STARTED|Second Intervention (3 Days)||3
2405836|NCT01304329|5901935|P2|STARTED|Second Intervention (3 Days)||3
2405837|NCT01304329|5901936|P1|STARTED|Second Intervention (3 Days)||3
2405838|NCT01304329|5901931|P6|NOT COMPLETED|First Intervention (3 Days)||0
2405839|NCT01304329|5901932|P5|NOT COMPLETED|First Intervention (3 Days)||0
2405840|NCT01304329|5901933|P4|NOT COMPLETED|First Intervention (3 Days)||0
2405841|NCT01304329|5901934|P3|NOT COMPLETED|First Intervention (3 Days)||0
2405842|NCT01304329|5901935|P2|NOT COMPLETED|First Intervention (3 Days)||0
2405843|NCT01304329|5901936|P1|NOT COMPLETED|First Intervention (3 Days)||0
2405844|NCT01304329|5901931|P6|COMPLETED|First Intervention (3 Days)||3
2405845|NCT01304329|5901932|P5|COMPLETED|First Intervention (3 Days)||3
2405846|NCT01304329|5901933|P4|COMPLETED|First Intervention (3 Days)||3
2405847|NCT01304329|5901934|P3|COMPLETED|First Intervention (3 Days)||3
2405848|NCT01304329|5901935|P2|COMPLETED|First Intervention (3 Days)||3
2405849|NCT01304329|5901936|P1|COMPLETED|First Intervention (3 Days)||3
2405850|NCT01304329|5901931|P6|STARTED|First Intervention (3 Days)||3
2405851|NCT01304329|5901932|P5|STARTED|First Intervention (3 Days)||3
2405852|NCT01304329|5901933|P4|STARTED|First Intervention (3 Days)||3
2405853|NCT01304329|5901934|P3|STARTED|First Intervention (3 Days)||3
2405854|NCT01304329|5901935|P2|STARTED|First Intervention (3 Days)||3
2405855|NCT01304329|5901936|P1|STARTED|First Intervention (3 Days)||3
2405856|NCT01304316|5901953|P1|NOT COMPLETED|Overall Study||0
2405857|NCT01304316|5901953|P1|COMPLETED|Overall Study||12
2405858|NCT01304316|5901953|P1|STARTED|Overall Study||12
2405859|NCT01304277|5901967|P1|NOT COMPLETED|Treatment (Replagal AF, Week 2- EOS)||0
2405860|NCT01304277|5901967|P1|COMPLETED|Treatment (Replagal AF, Week 2- EOS)||17
2405861|NCT01304277|5901967|P1|STARTED|Treatment (Replagal AF, Week 2- EOS)||17
2405862|NCT01304277|5901967|P1|NOT COMPLETED|Screening (Replagal RB, Week 0- Week 2)||0
2405863|NCT01304277|5901967|P1|COMPLETED|Screening (Replagal RB, Week 0- Week 2)||17
2405864|NCT01304277|5901967|P1|STARTED|Screening (Replagal RB, Week 0- Week 2)||17
2405865|NCT01304238|5901989|P10|NOT COMPLETED|Overall Study||0
2405866|NCT01304238|5901990|P9|NOT COMPLETED|Overall Study||0
2405867|NCT01304238|5901991|P8|NOT COMPLETED|Overall Study||0
2405868|NCT01304238|5901992|P7|NOT COMPLETED|Overall Study||0
2405869|NCT01304238|5901993|P6|NOT COMPLETED|Overall Study||0
2405870|NCT01304238|5901994|P5|NOT COMPLETED|Overall Study||0
2405871|NCT01304238|5901995|P4|NOT COMPLETED|Overall Study||0
2405872|NCT01304238|5901996|P3|NOT COMPLETED|Overall Study||0
2405873|NCT01304238|5901997|P2|NOT COMPLETED|Overall Study||0
2405874|NCT01304238|5901998|P1|NOT COMPLETED|Overall Study||0
2405875|NCT01304238|5901989|P10|COMPLETED|Overall Study||3
2405876|NCT01304238|5901990|P9|COMPLETED|Overall Study||1
2405877|NCT01304238|5901991|P8|COMPLETED|Overall Study||4
2405878|NCT01304238|5901992|P7|COMPLETED|Overall Study||5
2405879|NCT01304238|5901993|P6|COMPLETED|Overall Study||11
2405880|NCT01304238|5901994|P5|COMPLETED|Overall Study||11
2405881|NCT01304238|5901995|P4|COMPLETED|Overall Study||78
2405882|NCT01304238|5901996|P3|COMPLETED|Overall Study||46
2405883|NCT01304238|5901997|P2|COMPLETED|Overall Study||4
2405884|NCT01304238|5901998|P1|COMPLETED|Overall Study||32
2405885|NCT01304238|5901989|P10|STARTED|Overall Study||3
2405886|NCT01304238|5901990|P9|STARTED|Overall Study||1
2405887|NCT01304238|5901991|P8|STARTED|Overall Study||4
2405888|NCT01304238|5901992|P7|STARTED|Overall Study||5
2405889|NCT01304238|5901993|P6|STARTED|Overall Study||11
2405890|NCT01304238|5901994|P5|STARTED|Overall Study||11
2405891|NCT01304238|5901995|P4|STARTED|Overall Study||78
2405892|NCT01304238|5901996|P3|STARTED|Overall Study||46
2405893|NCT01304238|5901997|P2|STARTED|Overall Study||4
2405894|NCT01304238|5901998|P1|STARTED|Overall Study||32
2405895|NCT01304147|5902070|P2|NOT COMPLETED|Second Intervention (7days)||1
2405896|NCT01304147|5902071|P1|NOT COMPLETED|Second Intervention (7days)||1
2405897|NCT01304147|5902070|P2|COMPLETED|Second Intervention (7days)||9
2405898|NCT01304147|5902071|P1|COMPLETED|Second Intervention (7days)||9
2405899|NCT01304147|5902070|P2|STARTED|Second Intervention (7days)||10
2405900|NCT01304147|5902071|P1|STARTED|Second Intervention (7days)||10
2405901|NCT01304147|5902070|P2|NOT COMPLETED|Washout (1 Day)||0
2405902|NCT01304147|5902071|P1|NOT COMPLETED|Washout (1 Day)||0
2405903|NCT01304147|5902070|P2|COMPLETED|Washout (1 Day)||10
2405904|NCT01304147|5902071|P1|COMPLETED|Washout (1 Day)||10
2405905|NCT01304147|5902070|P2|STARTED|Washout (1 Day)||10
2405906|NCT01304147|5902071|P1|STARTED|Washout (1 Day)||10
2405907|NCT01304147|5902070|P2|NOT COMPLETED|First Intervention (7days)||0
2405908|NCT01304147|5902071|P1|NOT COMPLETED|First Intervention (7days)||0
2405909|NCT01304147|5902070|P2|COMPLETED|First Intervention (7days)||10
2405910|NCT01304147|5902071|P1|COMPLETED|First Intervention (7days)||10
2405911|NCT01304147|5902070|P2|STARTED|First Intervention (7days)||10
2405912|NCT01304147|5902071|P1|STARTED|First Intervention (7days)||10
2405913|NCT01304082|5902079|P5|NOT COMPLETED|Overall Study||0
2405914|NCT01304082|5902080|P4|NOT COMPLETED|Overall Study||0
2405915|NCT01304082|5902081|P3|NOT COMPLETED|Overall Study||0
2405916|NCT01304082|5902082|P2|NOT COMPLETED|Overall Study||0
2405917|NCT01304082|5902083|P1|NOT COMPLETED|Overall Study||0
2405918|NCT01304082|5902079|P5|COMPLETED|Overall Study||5
2405919|NCT01304082|5902080|P4|COMPLETED|Overall Study||8
2405920|NCT01304082|5902081|P3|COMPLETED|Overall Study||11
2405921|NCT01304082|5902082|P2|COMPLETED|Overall Study||2
2405922|NCT01304082|5902083|P1|COMPLETED|Overall Study||3
2405923|NCT01304082|5902079|P5|Third Intervention|Overall Study||5
2405924|NCT01304082|5902080|P4|Third Intervention|Overall Study||8
2405925|NCT01304082|5902081|P3|Third Intervention|Overall Study||11
2405926|NCT01304082|5902082|P2|Third Intervention|Overall Study||2
2405927|NCT01304082|5902083|P1|Third Intervention|Overall Study||3
2405928|NCT01304082|5902079|P5|Second Intervention|Overall Study||5
2405929|NCT01304082|5902080|P4|Second Intervention|Overall Study||8
2405930|NCT01304082|5902081|P3|Second Intervention|Overall Study||11
2405931|NCT01304082|5902082|P2|Second Intervention|Overall Study||2
2405932|NCT01304082|5902083|P1|Second Intervention|Overall Study||3
2405933|NCT01304082|5902079|P5|First Intervention|Overall Study||5
2405934|NCT01304082|5902080|P4|First Intervention|Overall Study||8
2405935|NCT01304082|5902081|P3|First Intervention|Overall Study||11
2405936|NCT01304082|5902082|P2|First Intervention|Overall Study||2
2405937|NCT01304082|5902083|P1|First Intervention|Overall Study||3
2405938|NCT01304082|5902079|P5|STARTED|Overall Study||5
2405939|NCT01304082|5902080|P4|STARTED|Overall Study||8
2405940|NCT01304082|5902081|P3|STARTED|Overall Study||11
2405941|NCT01304082|5902082|P2|STARTED|Overall Study||2
2405942|NCT01304082|5902083|P1|STARTED|Overall Study||3
2405943|NCT01303965|5902102|P2|NOT COMPLETED|Overall Study||10
2405944|NCT01303965|5902103|P1|NOT COMPLETED|Overall Study||3
2405945|NCT01303965|5902102|P2|COMPLETED|Overall Study||1
2405946|NCT01303965|5902103|P1|COMPLETED|Overall Study||0
2405947|NCT01303965|5902102|P2|STARTED|Overall Study||11
2405948|NCT01303965|5902103|P1|STARTED|Overall Study||3
2405949|NCT01303939|5902117|P2|NOT COMPLETED|Overall Study||0
2405950|NCT01303939|5902118|P1|NOT COMPLETED|Overall Study||7
2405951|NCT01303939|5902117|P2|COMPLETED|Overall Study||15
2405952|NCT01303939|5902118|P1|COMPLETED|Overall Study|Matched controls not found for comparisons. Only best matched glaucoma patients were included.|15
2405953|NCT01303939|5902117|P2|STARTED|Overall Study||15
2405954|NCT01303939|5902118|P1|STARTED|Overall Study||22
2405955|NCT01303861|5902131|P4|NOT COMPLETED|Overall Study||59
2405956|NCT01303861|5902132|P3|NOT COMPLETED|Overall Study||36
2405957|NCT01303861|5902133|P2|NOT COMPLETED|Overall Study||25
2405958|NCT01303861|5902134|P1|NOT COMPLETED|Overall Study||58
2405959|NCT01303861|5902131|P4|COMPLETED|Overall Study||54
2405960|NCT01303861|5902132|P3|COMPLETED|Overall Study||19
2405961|NCT01303861|5902133|P2|COMPLETED|Overall Study||25
2405962|NCT01303861|5902134|P1|COMPLETED|Overall Study||51
2405963|NCT01303861|5902131|P4|Finished Treatment Phase|Overall Study||72
2405964|NCT01303861|5902132|P3|Finished Treatment Phase|Overall Study||39
2405965|NCT01303861|5902133|P2|Finished Treatment Phase|Overall Study||34
2405966|NCT01303861|5902134|P1|Finished Treatment Phase|Overall Study||71
2405967|NCT01303861|5902131|P4|STARTED|Overall Study||113
2405968|NCT01303861|5902132|P3|STARTED|Overall Study||55
2405969|NCT01303861|5902133|P2|STARTED|Overall Study||50
2405970|NCT01303861|5902134|P1|STARTED|Overall Study||109
2405971|NCT01303835|5902155|P2|NOT COMPLETED|Overall Study||25
2405972|NCT01303835|5902156|P1|NOT COMPLETED|Overall Study||19
2405973|NCT01303835|5902155|P2|COMPLETED|Overall Study||31
2405974|NCT01303835|5902156|P1|COMPLETED|Overall Study||35
2405975|NCT01303835|5902155|P2|STARTED|Overall Study||56
2405976|NCT01303835|5902156|P1|STARTED|Overall Study||54
2405977|NCT01303744|5902170|P4|NOT COMPLETED|Overall Study||0
2405978|NCT01303744|5902171|P3|NOT COMPLETED|Overall Study||0
2405979|NCT01303744|5902172|P2|NOT COMPLETED|Overall Study||0
2405980|NCT01303744|5902173|P1|NOT COMPLETED|Overall Study||0
2405981|NCT01303744|5902170|P4|COMPLETED|Overall Study||24
2405982|NCT01303744|5902171|P3|COMPLETED|Overall Study||24
2405983|NCT01303744|5902172|P2|COMPLETED|Overall Study||24
2405984|NCT01303744|5902173|P1|COMPLETED|Overall Study||24
2405985|NCT01303744|5902170|P4|STARTED|Overall Study||24
2405986|NCT01303744|5902171|P3|STARTED|Overall Study||24
2405987|NCT01303744|5902172|P2|STARTED|Overall Study||24
2405988|NCT01303744|5902173|P1|STARTED|Overall Study||24
2405989|NCT01303627|5902193|P2|NOT COMPLETED|Overall Study||1
2405990|NCT01303627|5902194|P1|NOT COMPLETED|Overall Study||0
2405991|NCT01303627|5902193|P2|COMPLETED|Overall Study|One patient excluded from the study because of the failure while performing uretero-renoscopy|20
2405992|NCT01303627|5902194|P1|COMPLETED|Overall Study||21
2405993|NCT01303627|5902193|P2|STARTED|Overall Study||21
2405994|NCT01303627|5902194|P1|STARTED|Overall Study||21
2405995|NCT01303510|5902202|P2|NOT COMPLETED|Overall Study||0
2405996|NCT01303510|5902203|P1|NOT COMPLETED|Overall Study||1
2405997|NCT01303510|5902202|P2|COMPLETED|Overall Study||56
2405998|NCT01303510|5902203|P1|COMPLETED|Overall Study||54
2405999|NCT01303510|5902202|P2|STARTED|Overall Study||56
2406000|NCT01303510|5902203|P1|STARTED|Overall Study||55
2406001|NCT01303445|5902217|P2|NOT COMPLETED|Follow-up Period (14 Days)||1
2406002|NCT01303445|5902218|P1|NOT COMPLETED|Follow-up Period (14 Days)||0
2406003|NCT01303445|5902217|P2|COMPLETED|Follow-up Period (14 Days)||25
2406004|NCT01303445|5902218|P1|COMPLETED|Follow-up Period (14 Days)||26
2406005|NCT01303445|5902217|P2|STARTED|Follow-up Period (14 Days)||26
2406006|NCT01303445|5902218|P1|STARTED|Follow-up Period (14 Days)||26
2406007|NCT01303445|5902217|P2|NOT COMPLETED|Fourth Intervention (7 Days)||0
2406008|NCT01303445|5902218|P1|NOT COMPLETED|Fourth Intervention (7 Days)||1
2406009|NCT01303445|5902217|P2|COMPLETED|Fourth Intervention (7 Days)||26
2406010|NCT01303445|5902218|P1|COMPLETED|Fourth Intervention (7 Days)||26
2406011|NCT01303445|5902217|P2|STARTED|Fourth Intervention (7 Days)||26
2406012|NCT01303445|5902218|P1|STARTED|Fourth Intervention (7 Days)||27
2406013|NCT01303445|5902217|P2|NOT COMPLETED|Third Intervention (7 Days)||0
2406014|NCT01303445|5902218|P1|NOT COMPLETED|Third Intervention (7 Days)||0
2406015|NCT01303445|5902217|P2|COMPLETED|Third Intervention (7 Days)||26
2406016|NCT01303445|5902218|P1|COMPLETED|Third Intervention (7 Days)||27
2406017|NCT01303445|5902217|P2|STARTED|Third Intervention (7 Days)||26
2406018|NCT01303445|5902218|P1|STARTED|Third Intervention (7 Days)||27
2406019|NCT01303445|5902217|P2|NOT COMPLETED|Washout (14 Days)||2
2406020|NCT01303445|5902218|P1|NOT COMPLETED|Washout (14 Days)||1
2406021|NCT01303445|5902217|P2|COMPLETED|Washout (14 Days)||26
2406022|NCT01303445|5902218|P1|COMPLETED|Washout (14 Days)||27
2406023|NCT01303445|5902217|P2|STARTED|Washout (14 Days)||28
2406024|NCT01303445|5902218|P1|STARTED|Washout (14 Days)||28
2406025|NCT01303445|5902217|P2|NOT COMPLETED|Second Intervention (7 Days)||2
2406026|NCT01303445|5902218|P1|NOT COMPLETED|Second Intervention (7 Days)||1
2406027|NCT01303445|5902217|P2|COMPLETED|Second Intervention (7 Days)||28
2406028|NCT01303445|5902218|P1|COMPLETED|Second Intervention (7 Days)||28
2406029|NCT01303445|5902217|P2|STARTED|Second Intervention (7 Days)||30
2406030|NCT01303445|5902218|P1|STARTED|Second Intervention (7 Days)||29
2406031|NCT01303445|5902217|P2|NOT COMPLETED|First Intervention (7 Days)||0
2406032|NCT01303445|5902218|P1|NOT COMPLETED|First Intervention (7 Days)||1
2406033|NCT01303445|5902217|P2|COMPLETED|First Intervention (7 Days)||30
2406034|NCT01303445|5902218|P1|COMPLETED|First Intervention (7 Days)||29
2406035|NCT01303445|5902217|P2|STARTED|First Intervention (7 Days)||30
2406036|NCT01303445|5902218|P1|STARTED|First Intervention (7 Days)||30
2406037|NCT01303419|5902248|P1|NOT COMPLETED|Overall Study||96
2406038|NCT01303419|5902248|P1|COMPLETED|Overall Study||128
2406039|NCT01303419|5902248|P1|STARTED|Overall Study|Subjects who met all Inclusion and none of the Exclusion criteria|224
2406040|NCT01303406|5902258|P2|NOT COMPLETED|Overall Study||1
2406041|NCT01303406|5902259|P1|NOT COMPLETED|Overall Study||0
2406042|NCT01303406|5902258|P2|COMPLETED|Overall Study||15
2406043|NCT01303406|5902259|P1|COMPLETED|Overall Study||13
2406044|NCT01303406|5902258|P2|STARTED|Overall Study||16
2406045|NCT01303406|5902259|P1|STARTED|Overall Study||13
2406046|NCT01303380|5902267|P1|NOT COMPLETED|Overall Study||1
2406047|NCT01303380|5902267|P1|COMPLETED|Overall Study||8
2406048|NCT01303380|5902267|P1|STARTED|Overall Study||9
2406049|NCT01303224|5902297|P4|NOT COMPLETED|Overall Study||10
2406050|NCT01303224|5902298|P3|NOT COMPLETED|Overall Study||6
2406051|NCT01303224|5902299|P2|NOT COMPLETED|Overall Study||11
2406052|NCT01303224|5902300|P1|NOT COMPLETED|Overall Study||11
2406053|NCT01303224|5902297|P4|COMPLETED|Overall Study||133
2406054|NCT01303224|5902298|P3|COMPLETED|Overall Study||133
2406055|NCT01303224|5902299|P2|COMPLETED|Overall Study||131
2406056|NCT01303224|5902300|P1|COMPLETED|Overall Study||130
2406057|NCT01303224|5902297|P4|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|142
2406058|NCT01303224|5902298|P3|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|139
2406059|NCT01303224|5902299|P2|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|138
2406060|NCT01303224|5902300|P1|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|140
2406061|NCT01303224|5902297|P4|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|143
2406062|NCT01303224|5902298|P3|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|139
2406063|NCT01303224|5902299|P2|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|142
2406064|NCT01303224|5902300|P1|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|141
2406065|NCT01303159|5902326|P1|NOT COMPLETED|Overall Study||23
2406066|NCT01303159|5902326|P1|COMPLETED|Overall Study||6
2406067|NCT01303159|5902326|P1|STARTED|Overall Study||29
2406068|NCT01303003|5902333|P2|NOT COMPLETED|Overall Study||0
2406069|NCT01303003|5902334|P1|NOT COMPLETED|Overall Study||0
2406070|NCT01303003|5902333|P2|COMPLETED|Overall Study||0
2406071|NCT01303003|5902334|P1|COMPLETED|Overall Study||0
2406072|NCT01303003|5902333|P2|STARTED|Overall Study||0
2406073|NCT01303003|5902334|P1|STARTED|Overall Study||0
2406074|NCT01302964|5902344|P2|NOT COMPLETED|Overall Study||0
2406075|NCT01302964|5902345|P1|NOT COMPLETED|Overall Study||1
2406076|NCT01302964|5902344|P2|COMPLETED|Overall Study||10
2406077|NCT01302964|5902345|P1|COMPLETED|Overall Study||19
2406078|NCT01302964|5902344|P2|STARTED|Overall Study||10
2406079|NCT01302964|5902345|P1|STARTED|Overall Study||20
2406080|NCT01302938|5902355|P2|NOT COMPLETED|Overall Study||0
2406081|NCT01302938|5902356|P1|NOT COMPLETED|Overall Study||2
2406082|NCT01302938|5902355|P2|COMPLETED|Overall Study||6
2406083|NCT01302938|5902356|P1|COMPLETED|Overall Study||10
2406084|NCT01302938|5902355|P2|STARTED|Overall Study||6
2406085|NCT01302938|5902356|P1|STARTED|Overall Study||12
2406086|NCT01302899|5902401|P2|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
2406087|NCT01302899|5902402|P1|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
2406088|NCT01302899|5902401|P2|COMPLETED|Period 4 (Weeks 19 to 26)||3
2406089|NCT01302899|5902402|P1|COMPLETED|Period 4 (Weeks 19 to 26)||3
2406090|NCT01302899|5902401|P2|STARTED|Period 4 (Weeks 19 to 26)||3
2406091|NCT01302899|5902402|P1|STARTED|Period 4 (Weeks 19 to 26)||3
2406092|NCT01302899|5902401|P2|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
2406093|NCT01302899|5902402|P1|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
2406094|NCT01302899|5902401|P2|COMPLETED|Period 3 (Weeks 13 to 18)||3
2406095|NCT01302899|5902402|P1|COMPLETED|Period 3 (Weeks 13 to 18)||3
2406096|NCT01302899|5902401|P2|STARTED|Period 3 (Weeks 13 to 18)||3
2406097|NCT01302899|5902402|P1|STARTED|Period 3 (Weeks 13 to 18)||3
2406098|NCT01302899|5902401|P2|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
2406099|NCT01302899|5902402|P1|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
2406100|NCT01302899|5902401|P2|COMPLETED|Period 2 (Weeks 7 to 12)||3
2406101|NCT01302899|5902402|P1|COMPLETED|Period 2 (Weeks 7 to 12)||3
2406102|NCT01302899|5902401|P2|STARTED|Period 2 (Weeks 7 to 12)||4
2406103|NCT01302899|5902402|P1|STARTED|Period 2 (Weeks 7 to 12)||4
2406104|NCT01302899|5902401|P2|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
2406105|NCT01302899|5902402|P1|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
2406106|NCT01302899|5902401|P2|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
2406107|NCT01302899|5902402|P1|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
2406108|NCT01302899|5902401|P2|STARTED|Period 1 (Day 1 to End of Week 6)||4
2406109|NCT01302899|5902402|P1|STARTED|Period 1 (Day 1 to End of Week 6)||4
2406110|NCT01302860|5902452|P1|NOT COMPLETED|Overall Study||0
2406111|NCT01302860|5902452|P1|COMPLETED|Overall Study||17
2406112|NCT01302860|5902452|P1|STARTED|Overall Study||17
2406113|NCT01302834|5902466|P2|NOT COMPLETED|Overall Study||26
2406114|NCT01302834|5902467|P1|NOT COMPLETED|Overall Study||18
2406115|NCT01302834|5902466|P2|COMPLETED|Overall Study||399
2406116|NCT01302834|5902467|P1|COMPLETED|Overall Study||406
2406117|NCT01302834|5902466|P2|Progressed|Overall Study||122
2406118|NCT01302834|5902467|P1|Progressed|Overall Study||76
2406119|NCT01302834|5902466|P2|Feeding Tube Assessed|Overall Study||356
2406120|NCT01302834|5902467|P1|Feeding Tube Assessed|Overall Study||368
2406121|NCT01302834|5902466|P2|Dental Health Assessed 5 Years PT|Overall Study||43
2406122|NCT01302834|5902467|P1|Dental Health Assessed 5 Years PT|Overall Study||44
2406123|NCT01302834|5902466|P2|Dental Health Assessed 2 Years PT|Overall Study||201
2406124|NCT01302834|5902467|P1|Dental Health Assessed 2 Years PT|Overall Study||208
2406125|NCT01302834|5902466|P2|Dental Health Assessed 1 Year PT|Overall Study||267
2406126|NCT01302834|5902467|P1|Dental Health Assessed 1 Year PT|Overall Study||267
2406127|NCT01302834|5902466|P2|AE Assessed 5 Years PT|Overall Study||86
2406128|NCT01302834|5902467|P1|AE Assessed 5 Years PT|Overall Study||92
2406129|NCT01302834|5902466|P2|AE Assessed 2 Years PT|Overall Study||303
2406130|NCT01302834|5902467|P1|AE Assessed 2 Years PT|Overall Study||311
2406131|NCT01302834|5902466|P2|AE Assessment 1 Year PT|Overall Study||351
2406132|NCT01302834|5902467|P1|AE Assessment 1 Year PT|Overall Study||360
2406133|NCT01302834|5902466|P2|AE Assessed 6 Months PT|Overall Study||352
2406134|NCT01302834|5902467|P1|AE Assessed 6 Months PT|Overall Study||361
2406135|NCT01302834|5902466|P2|AE Assessed 3 Months PT|Overall Study||367
2406136|NCT01302834|5902467|P1|AE Assessed 3 Months PT|Overall Study||359
2406137|NCT01302834|5902466|P2|AE Assessed 1 Month Post-treatment (PT)|Overall Study||363
2406138|NCT01302834|5902467|P1|AE Assessed 1 Month Post-treatment (PT)|Overall Study||369
2406139|NCT01302834|5902466|P2|Started Treatment|Overall Study||394
2406140|NCT01302834|5902467|P1|Started Treatment|Overall Study||398
2406141|NCT01302834|5902466|P2|Eligible|Overall Study||399
2406142|NCT01302834|5902467|P1|Eligible|Overall Study||406
2406143|NCT01302834|5902466|P2|STARTED|Overall Study||425
2406144|NCT01302834|5902467|P1|STARTED|Overall Study||424
2406145|NCT01302743|5902512|P3|NOT COMPLETED|Overall Study||2
2406146|NCT01302743|5902513|P2|NOT COMPLETED|Overall Study||1
2406147|NCT01302743|5902514|P1|NOT COMPLETED|Overall Study||1
2406148|NCT01302743|5902512|P3|COMPLETED|Overall Study||8
2406149|NCT01302743|5902513|P2|COMPLETED|Overall Study||7
2406150|NCT01302743|5902514|P1|COMPLETED|Overall Study||6
2406151|NCT01302743|5902512|P3|STARTED|Overall Study||10
2406152|NCT01302743|5902513|P2|STARTED|Overall Study||8
2406153|NCT01302743|5902514|P1|STARTED|Overall Study||7
2406154|NCT01302691|5902527|P2|NOT COMPLETED|Overall Study||6
2406155|NCT01302691|5902528|P1|NOT COMPLETED|Overall Study||10
2406156|NCT01302691|5902527|P2|COMPLETED|Overall Study||157
2406157|NCT01302691|5902528|P1|COMPLETED|Overall Study||154
2406158|NCT01302691|5902527|P2|STARTED|Overall Study||163
2406159|NCT01302691|5902528|P1|STARTED|Overall Study||164
2406160|NCT01302548|5902548|P2|NOT COMPLETED|Overall Study||1
2406161|NCT01302548|5902549|P1|NOT COMPLETED|Overall Study||2
2406162|NCT01302548|5902548|P2|COMPLETED|Overall Study||18
2406163|NCT01302548|5902549|P1|COMPLETED|Overall Study||12
2406164|NCT01302548|5902548|P2|STARTED|Overall Study||19
2406165|NCT01302548|5902549|P1|STARTED|Overall Study||14
2406166|NCT01302483|5902561|P2|NOT COMPLETED|Overall Study||0
2406167|NCT01302483|5902562|P1|NOT COMPLETED|Overall Study||0
2406168|NCT01302483|5902561|P2|COMPLETED|Overall Study||15
2406169|NCT01302483|5902562|P1|COMPLETED|Overall Study||30
2406170|NCT01302483|5902561|P2|STARTED|Overall Study||15
2406171|NCT01302483|5902562|P1|STARTED|Overall Study||30
2406172|NCT01302444|5902578|P2|NOT COMPLETED|Overall Study||0
2406173|NCT01302444|5902579|P1|NOT COMPLETED|Overall Study||0
2406174|NCT01302444|5902578|P2|COMPLETED|Overall Study||0
2406175|NCT01302444|5902579|P1|COMPLETED|Overall Study||1
2406176|NCT01302444|5902578|P2|STARTED|Overall Study||0
2406177|NCT01302444|5902579|P1|STARTED|Overall Study||1
2406178|NCT01302418|5902599|P1|NOT COMPLETED|Overall Study||18
2406179|NCT01302418|5902599|P1|COMPLETED|Overall Study||254
2406180|NCT01302418|5902599|P1|STARTED|Overall Study||272
2406181|NCT01302392|5902605|P2|NOT COMPLETED|Overall Study||1
2406182|NCT01302392|5902606|P1|NOT COMPLETED|Overall Study||7
2406183|NCT01302392|5902605|P2|COMPLETED|Overall Study||156
2406184|NCT01302392|5902606|P1|COMPLETED|Overall Study||151
2406185|NCT01302392|5902605|P2|Treated|Overall Study||157
2406186|NCT01302392|5902606|P1|Treated|Overall Study||153
2406187|NCT01302392|5902605|P2|STARTED|Overall Study||157
2406188|NCT01302392|5902606|P1|STARTED|Overall Study||158
2406189|NCT01302366|5902626|P1|NOT COMPLETED|Overall Study||5
2406190|NCT01302366|5902626|P1|COMPLETED|Overall Study||15
2406191|NCT01302366|5902626|P1|STARTED|Overall Study||20
2406192|NCT01302119|5902634|P2|NOT COMPLETED|Overall Study||28
2406193|NCT01302119|5902635|P1|NOT COMPLETED|Overall Study||50
2406194|NCT01302119|5902634|P2|COMPLETED|Overall Study||177
2406195|NCT01302119|5902635|P1|COMPLETED|Overall Study||349
2406196|NCT01302119|5902634|P2|STARTED|Overall Study||205
2406197|NCT01302119|5902635|P1|STARTED|Overall Study||399
2406198|NCT01302067|5902650|P3|NOT COMPLETED|Overall Study||98
2406199|NCT01302067|5902651|P2|NOT COMPLETED|Overall Study||34
2406200|NCT01302067|5902652|P1|NOT COMPLETED|Overall Study||78
2406201|NCT01302067|5902650|P3|COMPLETED|Overall Study||681
2406202|NCT01302067|5902651|P2|COMPLETED|Overall Study||352
2406203|NCT01302067|5902652|P1|COMPLETED|Overall Study||712
2406204|NCT01302067|5902650|P3|STARTED|Overall Study||779
2406205|NCT01302067|5902651|P2|STARTED|Overall Study||386
2406206|NCT01302067|5902652|P1|STARTED|Overall Study||790
2406207|NCT01302054|5902723|P3|NOT COMPLETED|Double-Blind Treatment Phase||46
2406208|NCT01302054|5902724|P2|NOT COMPLETED|Double-Blind Treatment Phase||27
2406209|NCT01302054|5902725|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
2406210|NCT01302054|5902723|P3|COMPLETED|Double-Blind Treatment Phase||255
2406211|NCT01302054|5902724|P2|COMPLETED|Double-Blind Treatment Phase||281
2406212|NCT01302054|5902725|P1|COMPLETED|Double-Blind Treatment Phase||0
2406213|NCT01302054|5902723|P3|STARTED|Double-Blind Treatment Phase||301
2406214|NCT01302054|5902724|P2|STARTED|Double-Blind Treatment Phase||308
2406215|NCT01302054|5902725|P1|STARTED|Double-Blind Treatment Phase||0
2406216|NCT01302054|5902723|P3|NOT COMPLETED|Between Open-Label and Double Blind||0
2406217|NCT01302054|5902724|P2|NOT COMPLETED|Between Open-Label and Double Blind||0
2406218|NCT01302054|5902725|P1|NOT COMPLETED|Between Open-Label and Double Blind||2
2406219|NCT01302054|5902723|P3|COMPLETED|Between Open-Label and Double Blind||0
2406220|NCT01302054|5902724|P2|COMPLETED|Between Open-Label and Double Blind||0
2406221|NCT01302054|5902725|P1|COMPLETED|Between Open-Label and Double Blind||609
2406222|NCT01302054|5902723|P3|STARTED|Between Open-Label and Double Blind||0
2406223|NCT01302054|5902724|P2|STARTED|Between Open-Label and Double Blind||0
2406224|NCT01302054|5902725|P1|STARTED|Between Open-Label and Double Blind||611
2406225|NCT01302054|5902723|P3|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
2406226|NCT01302054|5902724|P2|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
2406227|NCT01302054|5902725|P1|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||379
2406228|NCT01302054|5902723|P3|COMPLETED|Tolterodine Open-Label Run-In Phase||0
2406229|NCT01302054|5902724|P2|COMPLETED|Tolterodine Open-Label Run-In Phase||0
2406230|NCT01302054|5902725|P1|COMPLETED|Tolterodine Open-Label Run-In Phase||611
2406231|NCT01302054|5902723|P3|STARTED|Tolterodine Open-Label Run-In Phase||0
2406232|NCT01302054|5902724|P2|STARTED|Tolterodine Open-Label Run-In Phase||0
2406233|NCT01302054|5902725|P1|STARTED|Tolterodine Open-Label Run-In Phase||990
2406234|NCT01302041|5902752|P1|NOT COMPLETED|Overall Study||40
2406235|NCT01302041|5902752|P1|COMPLETED|Overall Study|Participants who discontinued treatment and completed the 30-day follow-up visit|27
2406236|NCT01302041|5902752|P1|Treatment Received|Overall Study||67
2406237|NCT01302041|5902752|P1|STARTED|Overall Study||67
2406238|NCT01301963|5902783|P2|NOT COMPLETED|Overall Study||0
2406239|NCT01301963|5902784|P1|NOT COMPLETED|Overall Study||0
2406240|NCT01301963|5902783|P2|COMPLETED|Overall Study||4
2406241|NCT01301963|5902784|P1|COMPLETED|Overall Study||5
2406242|NCT01301963|5902783|P2|STARTED|Overall Study||4
2406243|NCT01301963|5902784|P1|STARTED|Overall Study||5
2406244|NCT01301950|5902794|P2|NOT COMPLETED|Overall Study||1
2406245|NCT01301950|5902795|P1|NOT COMPLETED|Overall Study||0
2406246|NCT01301950|5902794|P2|COMPLETED|Overall Study||14
2406247|NCT01301950|5902795|P1|COMPLETED|Overall Study||15
2406248|NCT01301950|5902794|P2|STARTED|Overall Study||15
2406249|NCT01301950|5902795|P1|STARTED|Overall Study||15
2406250|NCT01301833|5902813|P4|NOT COMPLETED|Overall Study||7
2406251|NCT01301833|5902814|P3|NOT COMPLETED|Overall Study||7
2406252|NCT01301833|5902815|P2|NOT COMPLETED|Overall Study||8
2406253|NCT01301833|5902816|P1|NOT COMPLETED|Overall Study||15
2406254|NCT01301833|5902813|P4|COMPLETED|Overall Study||68
2406255|NCT01301833|5902814|P3|COMPLETED|Overall Study||88
2406256|NCT01301833|5902815|P2|COMPLETED|Overall Study||72
2406257|NCT01301833|5902816|P1|COMPLETED|Overall Study||197
2406258|NCT01301833|5902813|P4|STARTED|Overall Study||75
2406259|NCT01301833|5902814|P3|STARTED|Overall Study||95
2406260|NCT01301833|5902815|P2|STARTED|Overall Study||80
2406261|NCT01301833|5902816|P1|STARTED|Overall Study||212
2406262|NCT01301742|5902842|P2|NOT COMPLETED|Second Intervention||0
2406263|NCT01301742|5902843|P1|NOT COMPLETED|Second Intervention||0
2406264|NCT01301742|5902842|P2|COMPLETED|Second Intervention||9
2406265|NCT01301742|5902843|P1|COMPLETED|Second Intervention||9
2406266|NCT01301742|5902842|P2|STARTED|Second Intervention||9
2406267|NCT01301742|5902843|P1|STARTED|Second Intervention||9
2406268|NCT01301742|5902842|P2|NOT COMPLETED|Washout Period of at Least 7 Days||0
2406269|NCT01301742|5902843|P1|NOT COMPLETED|Washout Period of at Least 7 Days||0
2406270|NCT01301742|5902842|P2|COMPLETED|Washout Period of at Least 7 Days||9
2406271|NCT01301742|5902843|P1|COMPLETED|Washout Period of at Least 7 Days||9
2406272|NCT01301742|5902842|P2|STARTED|Washout Period of at Least 7 Days||9
2406273|NCT01301742|5902843|P1|STARTED|Washout Period of at Least 7 Days||9
2406274|NCT01301742|5902842|P2|NOT COMPLETED|First Intervention||0
2406275|NCT01301742|5902843|P1|NOT COMPLETED|First Intervention||0
2406276|NCT01301742|5902842|P2|COMPLETED|First Intervention||9
2406277|NCT01301742|5902843|P1|COMPLETED|First Intervention||9
2406278|NCT01301742|5902842|P2|STARTED|First Intervention||9
2406279|NCT01301742|5902843|P1|STARTED|First Intervention||9
2406280|NCT01301729|5902854|P1|NOT COMPLETED|Overall Study||4
2406281|NCT01301729|5902854|P1|COMPLETED|Overall Study||28
2406282|NCT01301729|5902854|P1|STARTED|Overall Study||32
2406283|NCT01301625|5902865|P1|NOT COMPLETED|Overall Study||35
2406284|NCT01301625|5902865|P1|COMPLETED|Overall Study||43
2406285|NCT01301625|5902865|P1|STARTED|Overall Study||78
2406286|NCT01301508|5902937|P2|NOT COMPLETED|Overall Study||3
2406287|NCT01301508|5902938|P1|NOT COMPLETED|Overall Study||1
2406288|NCT01301508|5902937|P2|COMPLETED|Overall Study||22
2406289|NCT01301508|5902938|P1|COMPLETED|Overall Study||20
2406290|NCT01301508|5902937|P2|STARTED|Overall Study||25
2406291|NCT01301508|5902938|P1|STARTED|Overall Study||21
2406292|NCT01301456|5902968|P12|NOT COMPLETED|Stage 2||0
2406293|NCT01301456|5902969|P11|NOT COMPLETED|Stage 2||1
2406294|NCT01301456|5902970|P10|NOT COMPLETED|Stage 2||0
2406295|NCT01301456|5902971|P9|NOT COMPLETED|Stage 2||0
2406296|NCT01301456|5902972|P8|NOT COMPLETED|Stage 2||0
2406297|NCT01301456|5902973|P7|NOT COMPLETED|Stage 2||0
2406298|NCT01301456|5902974|P6|NOT COMPLETED|Stage 2||0
2406299|NCT01301456|5902975|P5|NOT COMPLETED|Stage 2||0
2406300|NCT01301456|5902976|P4|NOT COMPLETED|Stage 2||0
2406301|NCT01301456|5902977|P3|NOT COMPLETED|Stage 2||0
2406302|NCT01301456|5902978|P2|NOT COMPLETED|Stage 2||0
2406303|NCT01301456|5902979|P1|NOT COMPLETED|Stage 2||0
2406304|NCT01301456|5902968|P12|COMPLETED|Stage 2||6
2406305|NCT01301456|5902969|P11|COMPLETED|Stage 2||6
2406306|NCT01301456|5902970|P10|COMPLETED|Stage 2||7
2406307|NCT01301456|5902971|P9|COMPLETED|Stage 2||5
2406308|NCT01301456|5902972|P8|COMPLETED|Stage 2||7
2406309|NCT01301456|5902973|P7|COMPLETED|Stage 2||0
2406310|NCT01301456|5902974|P6|COMPLETED|Stage 2||0
2406311|NCT01301456|5902975|P5|COMPLETED|Stage 2||0
2406312|NCT01301456|5902976|P4|COMPLETED|Stage 2||0
2406313|NCT01301456|5902977|P3|COMPLETED|Stage 2||0
2406314|NCT01301456|5902978|P2|COMPLETED|Stage 2||0
2406315|NCT01301456|5902979|P1|COMPLETED|Stage 2||0
2406316|NCT01301456|5902968|P12|Received Treatment|Stage 2||6
2406317|NCT01301456|5902969|P11|Received Treatment|Stage 2||7
2406318|NCT01301456|5902970|P10|Received Treatment|Stage 2||7
2406319|NCT01301456|5902971|P9|Received Treatment|Stage 2||5
2406320|NCT01301456|5902972|P8|Received Treatment|Stage 2||7
2406321|NCT01301456|5902973|P7|Received Treatment|Stage 2||0
2406322|NCT01301456|5902974|P6|Received Treatment|Stage 2||0
2406323|NCT01301456|5902975|P5|Received Treatment|Stage 2||0
2406324|NCT01301456|5902976|P4|Received Treatment|Stage 2||0
2406325|NCT01301456|5902977|P3|Received Treatment|Stage 2||0
2406326|NCT01301456|5902978|P2|Received Treatment|Stage 2||0
2406327|NCT01301456|5902979|P1|Received Treatment|Stage 2||0
2406328|NCT01301456|5902968|P12|STARTED|Stage 2||6
2406329|NCT01301456|5902969|P11|STARTED|Stage 2||7
2406330|NCT01301456|5902970|P10|STARTED|Stage 2||7
2406331|NCT01301456|5902971|P9|STARTED|Stage 2||5
2406332|NCT01301456|5902972|P8|STARTED|Stage 2||7
2406333|NCT01301456|5902973|P7|STARTED|Stage 2||0
2406334|NCT01301456|5902974|P6|STARTED|Stage 2||0
2406335|NCT01301456|5902975|P5|STARTED|Stage 2||0
2406336|NCT01301456|5902976|P4|STARTED|Stage 2||0
2406337|NCT01301456|5902977|P3|STARTED|Stage 2||0
2406338|NCT01301456|5902978|P2|STARTED|Stage 2||0
2406339|NCT01301456|5902979|P1|STARTED|Stage 2||0
2406340|NCT01301456|5902968|P12|NOT COMPLETED|Stage 1||0
2406341|NCT01301456|5902969|P11|NOT COMPLETED|Stage 1||0
2406342|NCT01301456|5902970|P10|NOT COMPLETED|Stage 1||0
2406343|NCT01301456|5902971|P9|NOT COMPLETED|Stage 1||0
2406344|NCT01301456|5902972|P8|NOT COMPLETED|Stage 1||0
2406345|NCT01301456|5902973|P7|NOT COMPLETED|Stage 1||1
2406346|NCT01301456|5902974|P6|NOT COMPLETED|Stage 1||0
2406347|NCT01301456|5902975|P5|NOT COMPLETED|Stage 1||1
2406348|NCT01301456|5902976|P4|NOT COMPLETED|Stage 1||0
2406349|NCT01301456|5902977|P3|NOT COMPLETED|Stage 1||1
2406350|NCT01301456|5902978|P2|NOT COMPLETED|Stage 1||0
2406351|NCT01301456|5902979|P1|NOT COMPLETED|Stage 1||0
2406352|NCT01301456|5902968|P12|COMPLETED|Stage 1||0
2406353|NCT01301456|5902969|P11|COMPLETED|Stage 1||0
2406354|NCT01301456|5902970|P10|COMPLETED|Stage 1||0
2406355|NCT01301456|5902971|P9|COMPLETED|Stage 1||0
2406356|NCT01301456|5902972|P8|COMPLETED|Stage 1||0
2406357|NCT01301456|5902973|P7|COMPLETED|Stage 1||7
2406358|NCT01301456|5902974|P6|COMPLETED|Stage 1||5
2406359|NCT01301456|5902975|P5|COMPLETED|Stage 1||6
2406360|NCT01301456|5902976|P4|COMPLETED|Stage 1||6
2406361|NCT01301456|5902977|P3|COMPLETED|Stage 1||5
2406362|NCT01301456|5902978|P2|COMPLETED|Stage 1||5
2406363|NCT01301456|5902979|P1|COMPLETED|Stage 1||15
2406364|NCT01301456|5902968|P12|Received Treatment|Stage 1||0
2406365|NCT01301456|5902969|P11|Received Treatment|Stage 1||0
2406366|NCT01301456|5902970|P10|Received Treatment|Stage 1||0
2406367|NCT01301456|5902971|P9|Received Treatment|Stage 1||0
2406368|NCT01301456|5902972|P8|Received Treatment|Stage 1||0
2406369|NCT01301456|5902973|P7|Received Treatment|Stage 1||7
2406370|NCT01301456|5902974|P6|Received Treatment|Stage 1||5
2406371|NCT01301456|5902975|P5|Received Treatment|Stage 1||7
2406372|NCT01301456|5902976|P4|Received Treatment|Stage 1||6
2406373|NCT01301456|5902977|P3|Received Treatment|Stage 1||6
2406374|NCT01301456|5902978|P2|Received Treatment|Stage 1||5
2406375|NCT01301456|5902979|P1|Received Treatment|Stage 1||15
2406376|NCT01301456|5902968|P12|STARTED|Stage 1||0
2406377|NCT01301456|5902969|P11|STARTED|Stage 1||0
2406378|NCT01301456|5902970|P10|STARTED|Stage 1||0
2406379|NCT01301456|5902971|P9|STARTED|Stage 1||0
2406380|NCT01301456|5902972|P8|STARTED|Stage 1||0
2406381|NCT01301456|5902973|P7|STARTED|Stage 1||8
2406382|NCT01301456|5902974|P6|STARTED|Stage 1||5
2406383|NCT01301456|5902975|P5|STARTED|Stage 1||7
2406384|NCT01301456|5902976|P4|STARTED|Stage 1||6
2406385|NCT01301456|5902977|P3|STARTED|Stage 1||6
2406386|NCT01301456|5902978|P2|STARTED|Stage 1||5
2406387|NCT01301456|5902979|P1|STARTED|Stage 1||15
2406388|NCT01301391|5903205|P1|NOT COMPLETED|Overall Study||26
2406389|NCT01301391|5903205|P1|COMPLETED|Overall Study||4
2406390|NCT01301391|5903205|P1|STARTED|Overall Study|On treatment until disease progression, patient withdrawal of consent, or unacceptable toxicity.|30
2406391|NCT01301274|5903217|P2|NOT COMPLETED|Overall Study||1
2406392|NCT01301274|5903218|P1|NOT COMPLETED|Overall Study||2
2406393|NCT01301274|5903217|P2|COMPLETED|Overall Study||31
2406394|NCT01301274|5903218|P1|COMPLETED|Overall Study||32
2406395|NCT01301274|5903217|P2|STARTED|Overall Study||32
2406396|NCT01301274|5903218|P1|STARTED|Overall Study||34
2406397|NCT01301092|5903233|P3|NOT COMPLETED|Overall Study||1
2406398|NCT01301092|5903234|P2|NOT COMPLETED|Overall Study||0
2406399|NCT01301092|5903235|P1|NOT COMPLETED|Overall Study||0
2406400|NCT01301092|5903233|P3|COMPLETED|Overall Study||7
2406401|NCT01301092|5903234|P2|COMPLETED|Overall Study||16
2406402|NCT01301092|5903235|P1|COMPLETED|Overall Study||6
2406403|NCT01301092|5903233|P3|STARTED|Overall Study||8
2406404|NCT01301092|5903234|P2|STARTED|Overall Study||16
2406405|NCT01301092|5903235|P1|STARTED|Overall Study||6
2406406|NCT01301079|5903252|P2|NOT COMPLETED|Overall Study||2
2406407|NCT01301079|5903253|P1|NOT COMPLETED|Overall Study||2
2406408|NCT01301079|5903252|P2|COMPLETED|Overall Study||28
2406409|NCT01301079|5903253|P1|COMPLETED|Overall Study||28
2406410|NCT01301079|5903252|P2|STARTED|Overall Study||30
2406411|NCT01301079|5903253|P1|STARTED|Overall Study||30
2406412|NCT01301066|5903331|P2|NOT COMPLETED|Overall Study||35
2406413|NCT01301066|5903332|P1|NOT COMPLETED|Overall Study||27
2406414|NCT01301066|5903331|P2|COMPLETED|Overall Study||91
2406415|NCT01301066|5903332|P1|COMPLETED|Overall Study||99
2406416|NCT01301066|5903331|P2|STARTED|Overall Study||126
2406417|NCT01301066|5903332|P1|STARTED|Overall Study||126
2406418|NCT01301027|5903340|P2|NOT COMPLETED|Overall Study||10
2406419|NCT01301027|5903341|P1|NOT COMPLETED|Overall Study||8
2406420|NCT01301027|5903340|P2|COMPLETED|Overall Study||37
2406421|NCT01301027|5903341|P1|COMPLETED|Overall Study||40
2406422|NCT01301027|5903340|P2|STARTED|Overall Study||47
2406423|NCT01301027|5903341|P1|STARTED|Overall Study||48
2406424|NCT01301001|5903353|P2|NOT COMPLETED|Second Intervention||0
2406425|NCT01301001|5903354|P1|NOT COMPLETED|Second Intervention||4
2406426|NCT01301001|5903353|P2|COMPLETED|Second Intervention||36
2406427|NCT01301001|5903354|P1|COMPLETED|Second Intervention||30
2406428|NCT01301001|5903353|P2|STARTED|Second Intervention||36
2406429|NCT01301001|5903354|P1|STARTED|Second Intervention||34
2406430|NCT01301001|5903353|P2|NOT COMPLETED|Washout (2 Weeks)||0
2406431|NCT01301001|5903354|P1|NOT COMPLETED|Washout (2 Weeks)||0
2406432|NCT01301001|5903353|P2|COMPLETED|Washout (2 Weeks)||36
2406433|NCT01301001|5903354|P1|COMPLETED|Washout (2 Weeks)||34
2406434|NCT01301001|5903353|P2|STARTED|Washout (2 Weeks)||36
2406435|NCT01301001|5903354|P1|STARTED|Washout (2 Weeks)||34
2406436|NCT01301001|5903353|P2|NOT COMPLETED|First Intervention||9
2406437|NCT01301001|5903354|P1|NOT COMPLETED|First Intervention||10
2406438|NCT01301001|5903353|P2|COMPLETED|First Intervention||36
2406439|NCT01301001|5903354|P1|COMPLETED|First Intervention||34
2406440|NCT01301001|5903353|P2|STARTED|First Intervention||45
2406441|NCT01301001|5903354|P1|STARTED|First Intervention||44
2406442|NCT01300949|5903367|P3|NOT COMPLETED|Overall Study||0
2406443|NCT01300949|5903368|P2|NOT COMPLETED|Overall Study||0
2406444|NCT01300949|5903369|P1|NOT COMPLETED|Overall Study||0
2406445|NCT01300949|5903367|P3|COMPLETED|Overall Study||35
2406446|NCT01300949|5903368|P2|COMPLETED|Overall Study||125
2406447|NCT01300949|5903369|P1|COMPLETED|Overall Study||154
2406448|NCT01300949|5903367|P3|STARTED|Overall Study||35
2406449|NCT01300949|5903368|P2|STARTED|Overall Study||125
2406450|NCT01300949|5903369|P1|STARTED|Overall Study||154
2406451|NCT01300923|5903377|P2|NOT COMPLETED|Overall Study||2
2406452|NCT01300923|5903378|P1|NOT COMPLETED|Overall Study||0
2406453|NCT01300923|5903377|P2|COMPLETED|Overall Study||0
2406454|NCT01300923|5903378|P1|COMPLETED|Overall Study||12
2406455|NCT01300923|5903377|P2|STARTED|Overall Study||2
2406456|NCT01300923|5903378|P1|STARTED|Overall Study||12
2406457|NCT01300819|5903391|P2|NOT COMPLETED|Overall Study||44
2406458|NCT01300819|5903392|P1|NOT COMPLETED|Overall Study||22
2406459|NCT01300819|5903391|P2|COMPLETED|Overall Study||180
2406460|NCT01300819|5903392|P1|COMPLETED|Overall Study||103
2406461|NCT01300819|5903391|P2|STARTED|Overall Study||224
2406462|NCT01300819|5903392|P1|STARTED|Overall Study||125
2406463|NCT01300767|5903420|P1|NOT COMPLETED|Overall Study||4
2406464|NCT01300767|5903420|P1|COMPLETED|Overall Study||70
2406465|NCT01300767|5903420|P1|STARTED|Overall Study||74
2406466|NCT01300741|5903448|P1|NOT COMPLETED|Overall Study||3
2406467|NCT01300741|5903448|P1|COMPLETED|Overall Study||72
2406468|NCT01300741|5903448|P1|STARTED|Overall Study||75
2406469|NCT01300728|5903478|P2|NOT COMPLETED|Overall Study||1
2406470|NCT01300728|5903479|P1|NOT COMPLETED|Overall Study||2
2406471|NCT01300728|5903478|P2|COMPLETED|Overall Study||25
2406472|NCT01300728|5903479|P1|COMPLETED|Overall Study||24
2406473|NCT01300728|5903478|P2|STARTED|Overall Study||26
2406474|NCT01300728|5903479|P1|STARTED|Overall Study||26
2406475|NCT01300650|5903493|P1|NOT COMPLETED|Overall Study||1
2406476|NCT01300650|5903493|P1|COMPLETED|Overall Study||7
2406477|NCT01300650|5903493|P1|STARTED|Overall Study||8
2406478|NCT01300624|5903499|P1|NOT COMPLETED|Overall Study||0
2406479|NCT01300624|5903499|P1|COMPLETED|Overall Study||11
2406480|NCT01300624|5903499|P1|STARTED|Overall Study||11
2406481|NCT01300572|5903509|P1|NOT COMPLETED|Overall Study||1
2406482|NCT01300572|5903509|P1|COMPLETED|Overall Study||15
2406483|NCT01300572|5903509|P1|STARTED|Overall Study||16
2406484|NCT01300559|5903524|P2|NOT COMPLETED|Overall Study||0
2406485|NCT01300559|5903525|P1|NOT COMPLETED|Overall Study||0
2406486|NCT01300559|5903524|P2|COMPLETED|Overall Study||30
2406487|NCT01300559|5903525|P1|COMPLETED|Overall Study||30
2406488|NCT01300559|5903524|P2|STARTED|Overall Study||30
2406489|NCT01300559|5903525|P1|STARTED|Overall Study||30
2406490|NCT01300546|5903533|P2|NOT COMPLETED|Overall Study||6
2406491|NCT01300546|5903534|P1|NOT COMPLETED|Overall Study||1
2406492|NCT01300546|5903533|P2|COMPLETED|Overall Study||14
2406493|NCT01300546|5903534|P1|COMPLETED|Overall Study||18
2406494|NCT01300546|5903533|P2|STARTED|Overall Study||20
2406495|NCT01300546|5903534|P1|STARTED|Overall Study||19
2406496|NCT01300455|5903564|P2|NOT COMPLETED|Period 2||0
2406497|NCT01300455|5903565|P1|NOT COMPLETED|Period 2||0
2406498|NCT01300455|5903564|P2|COMPLETED|Period 2||13
2406499|NCT01300455|5903565|P1|COMPLETED|Period 2||12
2406500|NCT01300455|5903564|P2|STARTED|Period 2||13
2406501|NCT01300455|5903565|P1|STARTED|Period 2||12
2406502|NCT01300455|5903564|P2|NOT COMPLETED|Washout||0
2406503|NCT01300455|5903565|P1|NOT COMPLETED|Washout||1
2406504|NCT01300455|5903564|P2|COMPLETED|Washout||13
2406505|NCT01300455|5903565|P1|COMPLETED|Washout||12
2406506|NCT01300455|5903564|P2|STARTED|Washout||13
2406507|NCT01300455|5903565|P1|STARTED|Washout||13
2406508|NCT01300455|5903564|P2|NOT COMPLETED|Period 1||0
2406509|NCT01300455|5903565|P1|NOT COMPLETED|Period 1||0
2406510|NCT01300455|5903564|P2|COMPLETED|Period 1||13
2406511|NCT01300455|5903565|P1|COMPLETED|Period 1||13
2406512|NCT01300455|5903564|P2|STARTED|Period 1||13
2406513|NCT01300455|5903565|P1|STARTED|Period 1||13
2406514|NCT01300351|5903585|P2|NOT COMPLETED|Overall Study||38
2406515|NCT01300351|5903586|P1|NOT COMPLETED|Overall Study||36
2406516|NCT01300351|5903585|P2|COMPLETED|Overall Study||72
2406517|NCT01300351|5903586|P1|COMPLETED|Overall Study||75
2406518|NCT01300351|5903585|P2|Received Study Treatment|Overall Study||110
2406519|NCT01300351|5903586|P1|Received Study Treatment|Overall Study||109
2406520|NCT01300351|5903585|P2|STARTED|Overall Study||110
2406521|NCT01300351|5903586|P1|STARTED|Overall Study||111
2406522|NCT01300338|5903602|P2|NOT COMPLETED|Overall Study||0
2406523|NCT01300338|5903603|P1|NOT COMPLETED|Overall Study||5
2406524|NCT01300338|5903602|P2|COMPLETED|Overall Study||25
2406525|NCT01300338|5903603|P1|COMPLETED|Overall Study||20
2406526|NCT01300338|5903602|P2|STARTED|Overall Study||25
2406527|NCT01300338|5903603|P1|STARTED|Overall Study||25
2406528|NCT01300286|5903611|P1|NOT COMPLETED|Overall Study||1
2406529|NCT01300286|5903611|P1|COMPLETED|Overall Study||22
2406530|NCT01300286|5903611|P1|STARTED|Overall Study||23
2406531|NCT01300260|5903621|P2|NOT COMPLETED|Period 2 of Study: Second Intervention||1
2406532|NCT01300260|5903622|P1|NOT COMPLETED|Period 2 of Study: Second Intervention||0
2406533|NCT01300260|5903621|P2|COMPLETED|Period 2 of Study: Second Intervention||15
2406534|NCT01300260|5903622|P1|COMPLETED|Period 2 of Study: Second Intervention||14
2406535|NCT01300260|5903621|P2|STARTED|Period 2 of Study: Second Intervention||16
2406536|NCT01300260|5903622|P1|STARTED|Period 2 of Study: Second Intervention||14
2406537|NCT01300260|5903621|P2|NOT COMPLETED|Washout Period of at Least 28 Days||0
2406538|NCT01300260|5903622|P1|NOT COMPLETED|Washout Period of at Least 28 Days||0
2406539|NCT01300260|5903621|P2|COMPLETED|Washout Period of at Least 28 Days||16
2406540|NCT01300260|5903622|P1|COMPLETED|Washout Period of at Least 28 Days||14
2406541|NCT01300260|5903621|P2|STARTED|Washout Period of at Least 28 Days||16
2406542|NCT01300260|5903622|P1|STARTED|Washout Period of at Least 28 Days||14
2406543|NCT01300260|5903621|P2|NOT COMPLETED|Period 1 of Study: First Intervention||1
2406544|NCT01300260|5903622|P1|NOT COMPLETED|Period 1 of Study: First Intervention||1
2406545|NCT01300260|5903621|P2|COMPLETED|Period 1 of Study: First Intervention||16
2406546|NCT01300260|5903622|P1|COMPLETED|Period 1 of Study: First Intervention||14
2406547|NCT01300260|5903621|P2|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||17
2406548|NCT01300260|5903622|P1|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||15
2406549|NCT01300260|5903621|P2|STARTED|Period 1 of Study: First Intervention||17
2406550|NCT01300260|5903622|P1|STARTED|Period 1 of Study: First Intervention||15
2406551|NCT01300247|5903654|P2|NOT COMPLETED|Overall Study||2
2406552|NCT01300247|5903655|P1|NOT COMPLETED|Overall Study||4
2406553|NCT01300247|5903654|P2|COMPLETED|Overall Study||18
2406554|NCT01300247|5903655|P1|COMPLETED|Overall Study||17
2406555|NCT01300247|5903654|P2|STARTED|Overall Study||20
2406556|NCT01300247|5903655|P1|STARTED|Overall Study||21
2406557|NCT01300234|5903687|P2|NOT COMPLETED|Overall Study||27
2406558|NCT01300234|5903688|P1|NOT COMPLETED|Overall Study||28
2406559|NCT01300234|5903687|P2|COMPLETED|Overall Study||228
2406560|NCT01300234|5903688|P1|COMPLETED|Overall Study||229
2406561|NCT01300234|5903687|P2|STARTED|Overall Study||255
2406562|NCT01300234|5903688|P1|STARTED|Overall Study||257
2406563|NCT01300052|5903724|P2|NOT COMPLETED|Overall Study||3
2406564|NCT01300052|5903725|P1|NOT COMPLETED|Overall Study||6
2406565|NCT01300052|5903724|P2|COMPLETED|Overall Study||19
2406566|NCT01300052|5903725|P1|COMPLETED|Overall Study||40
2406567|NCT01300052|5903724|P2|STARTED|Overall Study||22
2406568|NCT01300052|5903725|P1|STARTED|Overall Study||46
2406569|NCT01299961|5903743|P1|NOT COMPLETED|Overall Study||6
2406570|NCT01299961|5903743|P1|COMPLETED|Overall Study||19
2406571|NCT01299961|5903743|P1|STARTED|Overall Study||25
2406572|NCT01299909|5903752|P3|NOT COMPLETED|Overall Study||17
2406573|NCT01299909|5903753|P2|NOT COMPLETED|Overall Study||18
2406574|NCT01299909|5903754|P1|NOT COMPLETED|Overall Study||22
2406575|NCT01299909|5903752|P3|COMPLETED|Overall Study||23
2406576|NCT01299909|5903753|P2|COMPLETED|Overall Study||49
2406577|NCT01299909|5903754|P1|COMPLETED|Overall Study||46
2406578|NCT01299909|5903752|P3|STARTED|Overall Study||40
2406579|NCT01299909|5903753|P2|STARTED|Overall Study||67
2406580|NCT01299909|5903754|P1|STARTED|Overall Study||68
2406581|NCT01299896|5903769|P2|NOT COMPLETED|Overall Study||18
2406582|NCT01299896|5903770|P1|NOT COMPLETED|Overall Study||1
2406583|NCT01299896|5903769|P2|COMPLETED|Overall Study||296
2406584|NCT01299896|5903770|P1|COMPLETED|Overall Study||318
2406585|NCT01299896|5903769|P2|STARTED|Overall Study||314
2406586|NCT01299896|5903770|P1|STARTED|Overall Study||319
2406587|NCT01299805|5903778|P2|NOT COMPLETED|Overall Study||0
2406588|NCT01299805|5903779|P1|NOT COMPLETED|Overall Study||2
2406589|NCT01299805|5903778|P2|COMPLETED|Overall Study||5
2406590|NCT01299805|5903779|P1|COMPLETED|Overall Study||10
2406591|NCT01299805|5903778|P2|STARTED|Overall Study||5
2406592|NCT01299805|5903779|P1|STARTED|Overall Study||12
2406593|NCT01299766|5903809|P2|NOT COMPLETED|Overall Study||23
2406594|NCT01299766|5903810|P1|NOT COMPLETED|Overall Study||34
2406595|NCT01299766|5903809|P2|COMPLETED|Overall Study||87
2406596|NCT01299766|5903810|P1|COMPLETED|Overall Study||77
2406597|NCT01299766|5903809|P2|STARTED|Overall Study||110
2406598|NCT01299766|5903810|P1|STARTED|Overall Study||111
2406599|NCT01299610|5903821|P3|NOT COMPLETED|Overall Study||0
2406600|NCT01299610|5903822|P2|NOT COMPLETED|Overall Study||0
2406601|NCT01299610|5903823|P1|NOT COMPLETED|Overall Study||0
2406602|NCT01299610|5903821|P3|COMPLETED|Overall Study||10
2406603|NCT01299610|5903822|P2|COMPLETED|Overall Study||5
2406604|NCT01299610|5903823|P1|COMPLETED|Overall Study||10
2406605|NCT01299610|5903821|P3|STARTED|Overall Study||10
2406606|NCT01299610|5903822|P2|STARTED|Overall Study||5
2406607|NCT01299610|5903823|P1|STARTED|Overall Study||10
2406608|NCT01299584|5903868|P1|NOT COMPLETED|Overall Study||9
2406609|NCT01299584|5903868|P1|COMPLETED|Overall Study||766
2406610|NCT01299584|5903868|P1|STARTED|Overall Study||775
2406611|NCT01299571|5903875|P1|NOT COMPLETED|Overall Study||107
2406612|NCT01299571|5903875|P1|COMPLETED|Overall Study||3870
2406613|NCT01299571|5903875|P1|STARTED|Overall Study||3977
2406614|NCT01299480|5903886|P5|NOT COMPLETED|Overall Study||20
2406615|NCT01299480|5903887|P4|NOT COMPLETED|Overall Study||25
2406616|NCT01299480|5903888|P3|NOT COMPLETED|Overall Study||41
2406617|NCT01299480|5903889|P2|NOT COMPLETED|Overall Study||35
2406618|NCT01299480|5903890|P1|NOT COMPLETED|Overall Study||42
2406619|NCT01299480|5903886|P5|COMPLETED|Overall Study||123
2406620|NCT01299480|5903887|P4|COMPLETED|Overall Study||261
2406621|NCT01299480|5903888|P3|COMPLETED|Overall Study||386
2406622|NCT01299480|5903889|P2|COMPLETED|Overall Study||395
2406623|NCT01299480|5903890|P1|COMPLETED|Overall Study||385
2406624|NCT01299480|5903886|P5|STARTED|Overall Study||143
2406625|NCT01299480|5903887|P4|STARTED|Overall Study||286
2406626|NCT01299480|5903888|P3|STARTED|Overall Study||427
2406627|NCT01299480|5903889|P2|STARTED|Overall Study||430
2406628|NCT01299480|5903890|P1|STARTED|Overall Study||427
2406629|NCT01299454|5903929|P4|NOT COMPLETED|Overall Study||0
2406630|NCT01299454|5903930|P3|NOT COMPLETED|Overall Study||0
2406631|NCT01299454|5903931|P2|NOT COMPLETED|Overall Study||0
2406632|NCT01299454|5903932|P1|NOT COMPLETED|Overall Study||0
2406633|NCT01299454|5903929|P4|COMPLETED|Overall Study||23
2406634|NCT01299454|5903930|P3|COMPLETED|Overall Study||6
2406635|NCT01299454|5903931|P2|COMPLETED|Overall Study||8
2406636|NCT01299454|5903932|P1|COMPLETED|Overall Study||8
2406637|NCT01299454|5903929|P4|STARTED|Overall Study||23
2406638|NCT01299454|5903930|P3|STARTED|Overall Study||6
2406639|NCT01299454|5903931|P2|STARTED|Overall Study||8
2406640|NCT01299454|5903932|P1|STARTED|Overall Study||8
2406641|NCT01299389|5904092|P4|NOT COMPLETED|Post-observational||6
2406642|NCT01299389|5904093|P3|NOT COMPLETED|Post-observational||12
2406643|NCT01299389|5904094|P2|NOT COMPLETED|Post-observational||0
2406644|NCT01299389|5904095|P1|NOT COMPLETED|Post-observational||0
2406645|NCT01299389|5904092|P4|COMPLETED|Post-observational||149
2406646|NCT01299389|5904093|P3|COMPLETED|Post-observational||144
2406647|NCT01299389|5904094|P2|COMPLETED|Post-observational||0
2406648|NCT01299389|5904095|P1|COMPLETED|Post-observational||0
2406649|NCT01299389|5904092|P4|STARTED|Post-observational||155
2406650|NCT01299389|5904093|P3|STARTED|Post-observational||156
2406651|NCT01299389|5904094|P2|STARTED|Post-observational||0
2406652|NCT01299389|5904095|P1|STARTED|Post-observational||0
2406653|NCT01299389|5904092|P4|NOT COMPLETED|Double-blind||0
2406654|NCT01299389|5904093|P3|NOT COMPLETED|Double-blind||0
2406655|NCT01299389|5904094|P2|NOT COMPLETED|Double-blind||64
2406656|NCT01299389|5904095|P1|NOT COMPLETED|Double-blind||109
2406657|NCT01299389|5904092|P4|COMPLETED|Double-blind||0
2406658|NCT01299389|5904093|P3|COMPLETED|Double-blind||0
2406659|NCT01299389|5904094|P2|COMPLETED|Double-blind||95
2406660|NCT01299389|5904095|P1|COMPLETED|Double-blind||55
2406661|NCT01299389|5904092|P4|STARTED|Double-blind||0
2406662|NCT01299389|5904093|P3|STARTED|Double-blind||0
2406663|NCT01299389|5904094|P2|STARTED|Double-blind||159
2406664|NCT01299389|5904095|P1|STARTED|Double-blind||164
2406665|NCT01299376|5904117|P2|NOT COMPLETED|Extension (Weeks 9 to 52)||15
2406666|NCT01299376|5904118|P1|NOT COMPLETED|Extension (Weeks 9 to 52)||10
2406667|NCT01299376|5904117|P2|COMPLETED|Extension (Weeks 9 to 52)||118
2406668|NCT01299376|5904118|P1|COMPLETED|Extension (Weeks 9 to 52)||124
2406669|NCT01299376|5904117|P2|STARTED|Extension (Weeks 9 to 52)||133
2406670|NCT01299376|5904118|P1|STARTED|Extension (Weeks 9 to 52)||134
2406671|NCT01299376|5904117|P2|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||12
2406672|NCT01299376|5904118|P1|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||7
2406673|NCT01299376|5904117|P2|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||133
2406674|NCT01299376|5904118|P1|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||134
2406675|NCT01299376|5904117|P2|STARTED|Double-blind Treatment (Weeks 1 to 8)||145
2406676|NCT01299376|5904118|P1|STARTED|Double-blind Treatment (Weeks 1 to 8)||141
2406677|NCT01299285|5904148|P1|NOT COMPLETED|Overall Study||0
2406678|NCT01299285|5904148|P1|COMPLETED|Overall Study||6
2406679|NCT01299285|5904148|P1|STARTED|Overall Study||6
2406680|NCT01299272|5904161|P4|NOT COMPLETED|Double-blind (DB) Randomized Period||58
2406681|NCT01299272|5904162|P3|NOT COMPLETED|Double-blind (DB) Randomized Period||70
2406682|NCT01299272|5904163|P2|NOT COMPLETED|Double-blind (DB) Randomized Period||0
2406683|NCT01299272|5904164|P1|NOT COMPLETED|Double-blind (DB) Randomized Period||0
2406684|NCT01299272|5904161|P4|COMPLETED|Double-blind (DB) Randomized Period||234
2406685|NCT01299272|5904162|P3|COMPLETED|Double-blind (DB) Randomized Period||224
2406686|NCT01299272|5904163|P2|COMPLETED|Double-blind (DB) Randomized Period||0
2406687|NCT01299272|5904164|P1|COMPLETED|Double-blind (DB) Randomized Period||0
2406688|NCT01299272|5904161|P4|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period entered the DC Period.|268
2406689|NCT01299272|5904162|P3|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the abrupt DC Period.|132
2406690|NCT01299272|5904163|P2|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0
2406691|NCT01299272|5904164|P1|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0
2406692|NCT01299272|5904161|P4|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
2406693|NCT01299272|5904162|P3|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the taper DC Period.|129
2406694|NCT01299272|5904163|P2|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
2406695|NCT01299272|5904164|P1|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
2406696|NCT01299272|5904161|P4|STARTED|Double-blind (DB) Randomized Period||292
2406697|NCT01299272|5904162|P3|STARTED|Double-blind (DB) Randomized Period||294
2406698|NCT01299272|5904163|P2|STARTED|Double-blind (DB) Randomized Period||0
2406699|NCT01299272|5904164|P1|STARTED|Double-blind (DB) Randomized Period||0
2406700|NCT01299272|5904161|P4|NOT COMPLETED|Stabilization Open-label (OL) Period||0
2406701|NCT01299272|5904162|P3|NOT COMPLETED|Stabilization Open-label (OL) Period||0
2406702|NCT01299272|5904163|P2|NOT COMPLETED|Stabilization Open-label (OL) Period||249
2406703|NCT01299272|5904164|P1|NOT COMPLETED|Stabilization Open-label (OL) Period||0
2406704|NCT01299272|5904161|P4|COMPLETED|Stabilization Open-label (OL) Period||0
2406705|NCT01299272|5904162|P3|COMPLETED|Stabilization Open-label (OL) Period||0
2406706|NCT01299272|5904163|P2|COMPLETED|Stabilization Open-label (OL) Period|Participants who completed the Stabilization OL Period were randomized to the DB Period.|586
2406707|NCT01299272|5904164|P1|COMPLETED|Stabilization Open-label (OL) Period||0
2406708|NCT01299272|5904161|P4|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
2406709|NCT01299272|5904162|P3|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
2406710|NCT01299272|5904163|P2|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period|Participants who discontinued the Stabilization OL Period had the option to enter the DC Period.|164
2406711|NCT01299272|5904164|P1|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
2406712|NCT01299272|5904161|P4|STARTED|Stabilization Open-label (OL) Period||0
2406713|NCT01299272|5904162|P3|STARTED|Stabilization Open-label (OL) Period||0
2406714|NCT01299272|5904163|P2|STARTED|Stabilization Open-label (OL) Period||835
2406715|NCT01299272|5904164|P1|STARTED|Stabilization Open-label (OL) Period||0
2406716|NCT01299272|5904161|P4|NOT COMPLETED|Acute Open-label (OL) Period||0
2406717|NCT01299272|5904162|P3|NOT COMPLETED|Acute Open-label (OL) Period||0
2406718|NCT01299272|5904163|P2|NOT COMPLETED|Acute Open-label (OL) Period||0
2406719|NCT01299272|5904164|P1|NOT COMPLETED|Acute Open-label (OL) Period||414
2406720|NCT01299272|5904161|P4|COMPLETED|Acute Open-label (OL) Period||0
2406721|NCT01299272|5904162|P3|COMPLETED|Acute Open-label (OL) Period||0
2406722|NCT01299272|5904163|P2|COMPLETED|Acute Open-label (OL) Period||0
2406723|NCT01299272|5904164|P1|COMPLETED|Acute Open-label (OL) Period|Participants who completed the Acute OL Period entered the Stabilization OL Period.|835
2406724|NCT01299272|5904161|P4|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
2406725|NCT01299272|5904162|P3|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
2406726|NCT01299272|5904163|P2|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
2406727|NCT01299272|5904164|P1|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period|Participants who discontinued the Acute OL Period had the option to enter the DC Period.|271
2406728|NCT01299272|5904161|P4|STARTED|Acute Open-label (OL) Period||0
2406729|NCT01299272|5904162|P3|STARTED|Acute Open-label (OL) Period||0
2406730|NCT01299272|5904163|P2|STARTED|Acute Open-label (OL) Period||0
2406731|NCT01299272|5904164|P1|STARTED|Acute Open-label (OL) Period||1249
2406732|NCT01299116|5904219|P3|NOT COMPLETED|Overall Study||11
2406733|NCT01299116|5904220|P2|NOT COMPLETED|Overall Study||9
2406734|NCT01299116|5904221|P1|NOT COMPLETED|Overall Study||65
2406735|NCT01299116|5904219|P3|COMPLETED|Overall Study||184
2406736|NCT01299116|5904220|P2|COMPLETED|Overall Study||168
2406737|NCT01299116|5904221|P1|COMPLETED|Overall Study||457
2406738|NCT01299116|5904219|P3|STARTED|Overall Study||195
2406739|NCT01299116|5904220|P2|STARTED|Overall Study||177
2406740|NCT01299116|5904221|P1|STARTED|Overall Study||522
2406741|NCT01299103|5904238|P3|NOT COMPLETED|Overall Study||2
2406742|NCT01299103|5904239|P2|NOT COMPLETED|Overall Study||2
2406743|NCT01299103|5904240|P1|NOT COMPLETED|Overall Study||0
2406744|NCT01299103|5904238|P3|COMPLETED|Overall Study||8
2406745|NCT01299103|5904239|P2|COMPLETED|Overall Study||13
2406746|NCT01299103|5904240|P1|COMPLETED|Overall Study||15
2406747|NCT01299103|5904238|P3|STARTED|Overall Study||10
2406748|NCT01299103|5904239|P2|STARTED|Overall Study||15
2406749|NCT01299103|5904240|P1|STARTED|Overall Study||15
2406750|NCT01299090|5904251|P1|NOT COMPLETED|Overall Study||0
2406751|NCT01299090|5904251|P1|COMPLETED|Overall Study||49
2406752|NCT01299090|5904251|P1|STARTED|Overall Study||49
2406753|NCT01299077|5904256|P1|NOT COMPLETED|Overall Study||0
2406754|NCT01299077|5904256|P1|COMPLETED|Overall Study||478
2406755|NCT01299077|5904256|P1|STARTED|Overall Study||478
2406756|NCT01299038|5904266|P2|NOT COMPLETED|Overall Study||0
2406757|NCT01299038|5904267|P1|NOT COMPLETED|Overall Study||1
2406758|NCT01299038|5904266|P2|COMPLETED|Overall Study|Evaluable|10
2406759|NCT01299038|5904267|P1|COMPLETED|Overall Study|Evaluable|9
2406760|NCT01299038|5904266|P2|STARTED|Overall Study|Consented|10
2406761|NCT01299038|5904267|P1|STARTED|Overall Study|Consented|10
2406762|NCT01299025|5904275|P2|NOT COMPLETED|Overall Study||1
2406763|NCT01299025|5904276|P1|NOT COMPLETED|Overall Study||3
2406764|NCT01299025|5904275|P2|COMPLETED|Overall Study||41
2406765|NCT01299025|5904276|P1|COMPLETED|Overall Study||39
2406766|NCT01299025|5904275|P2|STARTED|Overall Study||42
2406767|NCT01299025|5904276|P1|STARTED|Overall Study||42
2406768|NCT01298921|5904290|P2|NOT COMPLETED|Overall Study||0
2406769|NCT01298921|5904291|P1|NOT COMPLETED|Overall Study||0
2406770|NCT01298921|5904290|P2|COMPLETED|Overall Study||0
2406771|NCT01298921|5904291|P1|COMPLETED|Overall Study||0
2406772|NCT01298921|5904290|P2|STARTED|Overall Study||0
2406773|NCT01298921|5904291|P1|STARTED|Overall Study||0
2406774|NCT01298778|5904301|P2|NOT COMPLETED|Overall Study||6
2406775|NCT01298778|5904302|P1|NOT COMPLETED|Overall Study||3
2406776|NCT01298778|5904301|P2|COMPLETED|Overall Study||30
2406777|NCT01298778|5904302|P1|COMPLETED|Overall Study||30
2406778|NCT01298778|5904301|P2|STARTED|Overall Study||36
2406779|NCT01298778|5904302|P1|STARTED|Overall Study||33
2406780|NCT01298765|5904322|P1|NOT COMPLETED|Long-Term Treatment Period||99
2406781|NCT01298765|5904322|P1|COMPLETED|Long-Term Treatment Period||127
2406782|NCT01298765|5904322|P1|STARTED|Long-Term Treatment Period||226
2406783|NCT01298765|5904322|P1|NOT COMPLETED|Titration Period||76
2406784|NCT01298765|5904322|P1|COMPLETED|Titration Period||226
2406785|NCT01298765|5904322|P1|STARTED|Titration Period||302
2406786|NCT01298700|5904332|P2|NOT COMPLETED|Overall Study||100
2406787|NCT01298700|5904333|P1|NOT COMPLETED|Overall Study||101
2406788|NCT01298700|5904332|P2|COMPLETED|Overall Study||303
2406789|NCT01298700|5904333|P1|COMPLETED|Overall Study||302
2406790|NCT01298700|5904332|P2|Safety Population: Received Study Drug|Overall Study||398
2406791|NCT01298700|5904333|P1|Safety Population: Received Study Drug|Overall Study||400
2406792|NCT01298700|5904332|P2|STARTED|Overall Study||403
2406793|NCT01298700|5904333|P1|STARTED|Overall Study||403
2406794|NCT01298661|5904344|P3|NOT COMPLETED|Overall Study||2
2406795|NCT01298661|5904345|P2|NOT COMPLETED|Overall Study||0
2406796|NCT01298661|5904346|P1|NOT COMPLETED|Overall Study||2
2406797|NCT01298661|5904344|P3|COMPLETED|Overall Study||32
2406798|NCT01298661|5904345|P2|COMPLETED|Overall Study||24
2406799|NCT01298661|5904346|P1|COMPLETED|Overall Study||31
2406800|NCT01298661|5904344|P3|STARTED|Overall Study||34
2406801|NCT01298661|5904345|P2|STARTED|Overall Study||24
2406802|NCT01298661|5904346|P1|STARTED|Overall Study||33
2406803|NCT01298648|5904424|P1|NOT COMPLETED|Overall Study||23
2406804|NCT01298648|5904424|P1|COMPLETED|Overall Study||1693
2406805|NCT01298648|5904424|P1|STARTED|Overall Study||1716
2406806|NCT01298596|5904435|P2|NOT COMPLETED|Overall Study||33
2406807|NCT01298596|5904436|P1|NOT COMPLETED|Overall Study||28
2406808|NCT01298596|5904435|P2|COMPLETED|Overall Study||167
2406809|NCT01298596|5904436|P1|COMPLETED|Overall Study||172
2406810|NCT01298596|5904435|P2|STARTED|Overall Study||200
2406811|NCT01298596|5904436|P1|STARTED|Overall Study||200
2406812|NCT01298570|5904446|P2|NOT COMPLETED|Overall Study||61
2406813|NCT01298570|5904447|P1|NOT COMPLETED|Overall Study||120
2406814|NCT01298570|5904446|P2|COMPLETED|Overall Study||0
2406815|NCT01298570|5904447|P1|COMPLETED|Overall Study||0
2406816|NCT01298570|5904446|P2|STARTED|Overall Study||61
2406817|NCT01298570|5904447|P1|STARTED|Overall Study||120
2406818|NCT01298544|5904463|P1|NOT COMPLETED|Overall Study||0
2406819|NCT01298544|5904463|P1|COMPLETED|Overall Study||335
2406820|NCT01298544|5904463|P1|STARTED|Overall Study||335
2406821|NCT01298531|5904474|P2|NOT COMPLETED|Overall Study||7
2406822|NCT01298531|5904475|P1|NOT COMPLETED|Overall Study||9
2406823|NCT01298531|5904474|P2|COMPLETED|Overall Study||41
2406824|NCT01298531|5904475|P1|COMPLETED|Overall Study||33
2406825|NCT01298531|5904474|P2|STARTED|Overall Study||48
2406826|NCT01298531|5904475|P1|STARTED|Overall Study||42
2406827|NCT01298518|5904604|P3|NOT COMPLETED|Overall Study||1
2406828|NCT01298518|5904605|P2|NOT COMPLETED|Overall Study||0
2406829|NCT01298518|5904606|P1|NOT COMPLETED|Overall Study||0
2406830|NCT01298518|5904604|P3|COMPLETED|Overall Study||15
2406831|NCT01298518|5904605|P2|COMPLETED|Overall Study||16
2406832|NCT01298518|5904606|P1|COMPLETED|Overall Study||16
2406833|NCT01298518|5904604|P3|STARTED|Overall Study||16
2406834|NCT01298518|5904605|P2|STARTED|Overall Study||16
2406835|NCT01298518|5904606|P1|STARTED|Overall Study||16
2406836|NCT01298492|5904658|P1|NOT COMPLETED|Overall Study||119
2406837|NCT01298492|5904658|P1|COMPLETED|Overall Study||149
2406838|NCT01298492|5904658|P1|STARTED|Overall Study||268
2406839|NCT01298362|5904666|P2|NOT COMPLETED|Overall Study||43
2406840|NCT01298362|5904667|P1|NOT COMPLETED|Overall Study||38
2406841|NCT01298362|5904666|P2|COMPLETED|Overall Study||123
2406842|NCT01298362|5904667|P1|COMPLETED|Overall Study||86
2406843|NCT01298362|5904666|P2|STARTED|Overall Study||166
2406844|NCT01298362|5904667|P1|STARTED|Overall Study||124
2406845|NCT01298323|5904687|P2|NOT COMPLETED|Overall Study||88
2406846|NCT01298323|5904688|P1|NOT COMPLETED|Overall Study||86
2406847|NCT01298323|5904687|P2|COMPLETED|Overall Study||15
2406848|NCT01298323|5904688|P1|COMPLETED|Overall Study||16
2406849|NCT01298323|5904687|P2|Ongoing|Overall Study||55
2406850|NCT01298323|5904688|P1|Ongoing|Overall Study||55
2406851|NCT01298323|5904687|P2|STARTED|Overall Study||103
2406852|NCT01298323|5904688|P1|STARTED|Overall Study||102
2406853|NCT01298219|5904696|P2|NOT COMPLETED|Overall Study||36
2406854|NCT01298219|5904697|P1|NOT COMPLETED|Overall Study||50
2406855|NCT01298219|5904696|P2|COMPLETED|Overall Study||184
2406856|NCT01298219|5904697|P1|COMPLETED|Overall Study||169
2406857|NCT01298219|5904696|P2|Safety Analysis Set|Overall Study||220
2406858|NCT01298219|5904697|P1|Safety Analysis Set|Overall Study||219
2406859|NCT01298219|5904696|P2|Intention to Treat (ITT)|Overall Study||220
2406860|NCT01298219|5904697|P1|Intention to Treat (ITT)|Overall Study||219
2406861|NCT01298219|5904696|P2|STARTED|Overall Study||220
2406862|NCT01298219|5904697|P1|STARTED|Overall Study||219
2406863|NCT01298193|5904711|P1|NOT COMPLETED|Efficacy Phase (Second Cycle)||1
2406864|NCT01298193|5904711|P1|COMPLETED|Efficacy Phase (Second Cycle)||23
2406865|NCT01298193|5904711|P1|STARTED|Efficacy Phase (Second Cycle)||24
2406866|NCT01298193|5904711|P1|NOT COMPLETED|Observational Phase (First Cycle)||27
2406867|NCT01298193|5904711|P1|COMPLETED|Observational Phase (First Cycle)|From these 185 completed patients, only 24 experiment emesis on Cycle 1 (NCR) (efficacy phase).|185
2406868|NCT01298193|5904711|P1|STARTED|Observational Phase (First Cycle)||212
2406869|NCT01298167|5904726|P2|NOT COMPLETED|Overall Study||0
2406870|NCT01298167|5904727|P1|NOT COMPLETED|Overall Study||1
2406871|NCT01298167|5904726|P2|COMPLETED|Overall Study||8
2406872|NCT01298167|5904727|P1|COMPLETED|Overall Study||5
2406873|NCT01298167|5904726|P2|STARTED|Overall Study||8
2406874|NCT01298167|5904727|P1|STARTED|Overall Study||6
2406875|NCT01298141|5904733|P1|NOT COMPLETED|Overall Study||31
2406876|NCT01298141|5904733|P1|COMPLETED|Overall Study||140
2406877|NCT01298141|5904733|P1|Treated|Overall Study||167
2406878|NCT01298141|5904733|P1|STARTED|Overall Study||171
2406879|NCT01298128|5904745|P2|NOT COMPLETED|Overall Study||8
2406880|NCT01298128|5904746|P1|NOT COMPLETED|Overall Study||9
2406881|NCT01298128|5904745|P2|COMPLETED|Overall Study||27
2406882|NCT01298128|5904746|P1|COMPLETED|Overall Study||26
2406883|NCT01298128|5904745|P2|STARTED|Overall Study||35
2406884|NCT01298128|5904746|P1|STARTED|Overall Study||35
2406885|NCT01298063|5904757|P5|NOT COMPLETED|Overall Study||0
2406886|NCT01298063|5904758|P4|NOT COMPLETED|Overall Study||0
2406887|NCT01298063|5904759|P3|NOT COMPLETED|Overall Study||0
2406888|NCT01298063|5904760|P2|NOT COMPLETED|Overall Study||0
2406889|NCT01298063|5904761|P1|NOT COMPLETED|Overall Study||0
2406890|NCT01298063|5904757|P5|COMPLETED|Overall Study||8
2406891|NCT01298063|5904758|P4|COMPLETED|Overall Study||8
2406892|NCT01298063|5904759|P3|COMPLETED|Overall Study||8
2406893|NCT01298063|5904760|P2|COMPLETED|Overall Study||3
2406894|NCT01298063|5904761|P1|COMPLETED|Overall Study||8
2406895|NCT01298063|5904757|P5|STARTED|Overall Study||8
2406896|NCT01298063|5904758|P4|STARTED|Overall Study||8
2406897|NCT01298063|5904759|P3|STARTED|Overall Study||8
2406898|NCT01298063|5904760|P2|STARTED|Overall Study||3
2406899|NCT01298063|5904761|P1|STARTED|Overall Study||8
2406900|NCT01297985|5904790|P2|NOT COMPLETED|Overall Study||53
2406901|NCT01297985|5904791|P1|NOT COMPLETED|Overall Study||55
2406902|NCT01297985|5904790|P2|COMPLETED|Overall Study||163
2406903|NCT01297985|5904791|P1|COMPLETED|Overall Study||157
2406904|NCT01297985|5904790|P2|STARTED|Overall Study||216
2406905|NCT01297985|5904791|P1|STARTED|Overall Study||212
2406906|NCT01297920|5904808|P3|NOT COMPLETED|Overall Study||57
2406907|NCT01297920|5904809|P2|NOT COMPLETED|Overall Study||27
2406908|NCT01297920|5904810|P1|NOT COMPLETED|Overall Study||58
2406909|NCT01297920|5904808|P3|COMPLETED|Overall Study||178
2406910|NCT01297920|5904809|P2|COMPLETED|Overall Study||207
2406911|NCT01297920|5904810|P1|COMPLETED|Overall Study||163
2406912|NCT01297920|5904808|P3|STARTED|Overall Study||235
2406913|NCT01297920|5904809|P2|STARTED|Overall Study||234
2406914|NCT01297920|5904810|P1|STARTED|Overall Study||221
2406915|NCT01297595|5904818|P2|NOT COMPLETED|Second Intervention Period||0
2406916|NCT01297595|5904819|P1|NOT COMPLETED|Second Intervention Period||0
2406917|NCT01297595|5904818|P2|COMPLETED|Second Intervention Period||11
2406918|NCT01297595|5904819|P1|COMPLETED|Second Intervention Period||11
2406919|NCT01297595|5904818|P2|STARTED|Second Intervention Period||11
2406920|NCT01297595|5904819|P1|STARTED|Second Intervention Period||11
2406921|NCT01297595|5904818|P2|NOT COMPLETED|Washout Period (At Least 14 Days)||0
2406922|NCT01297595|5904819|P1|NOT COMPLETED|Washout Period (At Least 14 Days)||0
2406923|NCT01297595|5904818|P2|COMPLETED|Washout Period (At Least 14 Days)||11
2406924|NCT01297595|5904819|P1|COMPLETED|Washout Period (At Least 14 Days)||11
2406925|NCT01297595|5904818|P2|STARTED|Washout Period (At Least 14 Days)||11
2406926|NCT01297595|5904819|P1|STARTED|Washout Period (At Least 14 Days)||11
2406927|NCT01297595|5904818|P2|NOT COMPLETED|First Intervention Period||0
2406928|NCT01297595|5904819|P1|NOT COMPLETED|First Intervention Period||0
2406929|NCT01297595|5904818|P2|COMPLETED|First Intervention Period||11
2406930|NCT01297595|5904819|P1|COMPLETED|First Intervention Period||11
2406931|NCT01297595|5904818|P2|STARTED|First Intervention Period||11
2406932|NCT01297595|5904819|P1|STARTED|First Intervention Period||11
2406933|NCT01297517|5904854|P3|NOT COMPLETED|Overall Study||27
2406934|NCT01297517|5904855|P2|NOT COMPLETED|Overall Study||12
2406935|NCT01297517|5904856|P1|NOT COMPLETED|Overall Study||27
2406936|NCT01297517|5904854|P3|COMPLETED|Overall Study||193
2406937|NCT01297517|5904855|P2|COMPLETED|Overall Study||214
2406938|NCT01297517|5904856|P1|COMPLETED|Overall Study||187
2406939|NCT01297517|5904854|P3|STARTED|Overall Study||220
2406940|NCT01297517|5904855|P2|STARTED|Overall Study||226
2406941|NCT01297517|5904856|P1|STARTED|Overall Study||214
2406942|NCT01297504|5904864|P1|NOT COMPLETED|Overall Study||67
2406943|NCT01297504|5904864|P1|COMPLETED|Overall Study||397
2406944|NCT01297504|5904864|P1|Participants Studied|Overall Study|Six participants were eliminated due to invalid consent, previous palivizumab or no study visits|458
2406945|NCT01297504|5904864|P1|STARTED|Overall Study||464
2406946|NCT01297491|5904878|P2|NOT COMPLETED|Overall Study||33
2406947|NCT01297491|5904879|P1|NOT COMPLETED|Overall Study||30
2406948|NCT01297491|5904878|P2|COMPLETED|Overall Study||0
2406949|NCT01297491|5904879|P1|COMPLETED|Overall Study||0
2406950|NCT01297491|5904878|P2|STARTED|Overall Study||33
2406951|NCT01297491|5904879|P1|STARTED|Overall Study||30
2406952|NCT01297465|5904897|P2|NOT COMPLETED|Overall Study||10
2406953|NCT01297465|5904898|P1|NOT COMPLETED|Overall Study||8
2406954|NCT01297465|5904897|P2|COMPLETED|Overall Study||93
2406955|NCT01297465|5904898|P1|COMPLETED|Overall Study||91
2406956|NCT01297465|5904897|P2|STARTED|Overall Study||103
2406957|NCT01297465|5904898|P1|STARTED|Overall Study||99
2406958|NCT01297348|5904932|P2|NOT COMPLETED|Overall Study||0
2406959|NCT01297348|5904933|P1|NOT COMPLETED|Overall Study||0
2406960|NCT01297348|5904932|P2|COMPLETED|Overall Study||586401
2406961|NCT01297348|5904933|P1|COMPLETED|Overall Study||12281
2406962|NCT01297348|5904932|P2|STARTED|Overall Study||586401
2406963|NCT01297348|5904933|P1|STARTED|Overall Study||12281
2406964|NCT01297335|5904943|P1|NOT COMPLETED|Overall Study||0
2406965|NCT01297335|5904943|P1|COMPLETED|Overall Study||10
2406966|NCT01297335|5904943|P1|STARTED|Overall Study||10
2406967|NCT01297322|5904951|P2|NOT COMPLETED|Overall Study||4
2406968|NCT01297322|5904952|P1|NOT COMPLETED|Overall Study||1
2406969|NCT01297322|5904951|P2|COMPLETED|Overall Study||274
2406970|NCT01297322|5904952|P1|COMPLETED|Overall Study||141
2406971|NCT01297322|5904951|P2|STARTED|Overall Study||278
2406972|NCT01297322|5904952|P1|STARTED|Overall Study||142
2406973|NCT01297309|5904971|P1|NOT COMPLETED|Overall Study||14
2406974|NCT01297309|5904971|P1|COMPLETED|Overall Study||37
2406975|NCT01297309|5904971|P1|Started Extension Period|Overall Study||46
2406976|NCT01297309|5904971|P1|Treated|Overall Study||49
2406977|NCT01297309|5904971|P1|STARTED|Overall Study||51
2406978|NCT01297283|5904988|P1|NOT COMPLETED|Overall Study||19
2406979|NCT01297283|5904988|P1|COMPLETED|Overall Study||176
2406980|NCT01297283|5904988|P1|STARTED|Overall Study||195
2406981|NCT01297270|5904996|P3|NOT COMPLETED|Overall Study||29
2406982|NCT01297270|5904997|P2|NOT COMPLETED|Overall Study||72
2406983|NCT01297270|5904998|P1|NOT COMPLETED|Overall Study||45
2406984|NCT01297270|5904996|P3|COMPLETED|Overall Study||103
2406985|NCT01297270|5904997|P2|COMPLETED|Overall Study||192
2406986|NCT01297270|5904998|P1|COMPLETED|Overall Study||217
2406987|NCT01297270|5904996|P3|STARTED|Overall Study||132
2406988|NCT01297270|5904997|P2|STARTED|Overall Study||264
2406989|NCT01297270|5904998|P1|STARTED|Overall Study||262
2406990|NCT01297257|5905036|P1|NOT COMPLETED|Overall Study||0
2406991|NCT01297257|5905036|P1|COMPLETED|Overall Study||7740
2406992|NCT01297257|5905036|P1|STARTED|Overall Study||7740
2406993|NCT01297062|5905047|P7|NOT COMPLETED|Overall Study||8
2406994|NCT01297062|5905048|P6|NOT COMPLETED|Overall Study||1
2406995|NCT01297062|5905049|P5|NOT COMPLETED|Overall Study||2
2406996|NCT01297062|5905050|P4|NOT COMPLETED|Overall Study||1
2406997|NCT01297062|5905051|P3|NOT COMPLETED|Overall Study||2
2406998|NCT01297062|5905052|P2|NOT COMPLETED|Overall Study||1
2406999|NCT01297062|5905053|P1|NOT COMPLETED|Overall Study||4
2407000|NCT01297062|5905047|P7|COMPLETED|Overall Study||0
2407001|NCT01297062|5905048|P6|COMPLETED|Overall Study||13
2407002|NCT01297062|5905049|P5|COMPLETED|Overall Study||13
2407003|NCT01297062|5905050|P4|COMPLETED|Overall Study||13
2407004|NCT01297062|5905051|P3|COMPLETED|Overall Study||12
2407005|NCT01297062|5905052|P2|COMPLETED|Overall Study||13
2407006|NCT01297062|5905053|P1|COMPLETED|Overall Study||11
2407007|NCT01297062|5905047|P7|Evaluable Population|Overall Study||0
2407008|NCT01297062|5905048|P6|Evaluable Population|Overall Study||13
2407009|NCT01297062|5905049|P5|Evaluable Population|Overall Study||13
2407010|NCT01297062|5905050|P4|Evaluable Population|Overall Study||13
2407011|NCT01297062|5905051|P3|Evaluable Population|Overall Study||12
2407012|NCT01297062|5905052|P2|Evaluable Population|Overall Study||12
2407013|NCT01297062|5905053|P1|Evaluable Population|Overall Study||11
2407014|NCT01297062|5905047|P7|Intent to Treat (ITT)|Overall Study||0
2407015|NCT01297062|5905048|P6|Intent to Treat (ITT)|Overall Study||14
2407016|NCT01297062|5905049|P5|Intent to Treat (ITT)|Overall Study||15
2407017|NCT01297062|5905050|P4|Intent to Treat (ITT)|Overall Study||14
2407018|NCT01297062|5905051|P3|Intent to Treat (ITT)|Overall Study||14
2407019|NCT01297062|5905052|P2|Intent to Treat (ITT)|Overall Study||14
2407020|NCT01297062|5905053|P1|Intent to Treat (ITT)|Overall Study||15
2407021|NCT01297062|5905047|P7|STARTED|Overall Study||8
2407022|NCT01297062|5905048|P6|STARTED|Overall Study||14
2407023|NCT01297062|5905049|P5|STARTED|Overall Study||15
2407024|NCT01297062|5905050|P4|STARTED|Overall Study||14
2407025|NCT01297062|5905051|P3|STARTED|Overall Study||14
2407026|NCT01297062|5905052|P2|STARTED|Overall Study||14
2407027|NCT01297062|5905053|P1|STARTED|Overall Study||15
2407028|NCT01296841|5905077|P2|NOT COMPLETED|Overall Study||0
2407029|NCT01296841|5905078|P1|NOT COMPLETED|Overall Study||0
2407030|NCT01296841|5905077|P2|COMPLETED|Overall Study||15
2407031|NCT01296841|5905078|P1|COMPLETED|Overall Study||19
2407032|NCT01296841|5905077|P2|STARTED|Overall Study||15
2407033|NCT01296841|5905078|P1|STARTED|Overall Study||19
2407034|NCT01296815|5905090|P2|NOT COMPLETED|Overall Study||0
2407035|NCT01296815|5905091|P1|NOT COMPLETED|Overall Study||0
2407036|NCT01296815|5905090|P2|COMPLETED|Overall Study||7
2407037|NCT01296815|5905091|P1|COMPLETED|Overall Study||7
2407038|NCT01296815|5905090|P2|STARTED|Overall Study||7
2407039|NCT01296815|5905091|P1|STARTED|Overall Study||7
2407040|NCT01296763|5905100|P3|NOT COMPLETED|Overall Study||0
2407041|NCT01296763|5905101|P2|NOT COMPLETED|Overall Study||0
2407042|NCT01296763|5905102|P1|NOT COMPLETED|Overall Study||0
2407043|NCT01296763|5905100|P3|COMPLETED|Overall Study||6
2407044|NCT01296763|5905101|P2|COMPLETED|Overall Study||5
2407045|NCT01296763|5905102|P1|COMPLETED|Overall Study||7
2407046|NCT01296763|5905100|P3|STARTED|Overall Study||6
2407047|NCT01296763|5905101|P2|STARTED|Overall Study||5
2407048|NCT01296763|5905102|P1|STARTED|Overall Study||7
2407049|NCT01296698|5905115|P2|NOT COMPLETED|Overall Study||13
2407050|NCT01296698|5905116|P1|NOT COMPLETED|Overall Study||244
2407051|NCT01296698|5905115|P2|COMPLETED|Overall Study||0
2407052|NCT01296698|5905116|P1|COMPLETED|Overall Study||0
2407053|NCT01296698|5905115|P2|STARTED|Overall Study||13
2407054|NCT01296698|5905116|P1|STARTED|Overall Study||244
2407055|NCT01296672|5905170|P2|NOT COMPLETED|Overall Study||18
2407056|NCT01296672|5905171|P1|NOT COMPLETED|Overall Study||73
2407057|NCT01296672|5905170|P2|COMPLETED|Overall Study||59
2407058|NCT01296672|5905171|P1|COMPLETED|Overall Study||233
2407059|NCT01296672|5905170|P2|STARTED|Overall Study||77
2407060|NCT01296672|5905171|P1|STARTED|Overall Study||306
2407061|NCT01296646|5905183|P2|NOT COMPLETED|Overall Study||11
2407062|NCT01296646|5905184|P1|NOT COMPLETED|Overall Study||11
2407063|NCT01296646|5905183|P2|COMPLETED|Overall Study||29
2407064|NCT01296646|5905184|P1|COMPLETED|Overall Study||29
2407065|NCT01296646|5905183|P2|STARTED|Overall Study||40
2407066|NCT01296646|5905184|P1|STARTED|Overall Study||40
2407067|NCT01296568|5905192|P1|NOT COMPLETED|Continued Access Phase||3
2407068|NCT01296568|5905192|P1|COMPLETED|Continued Access Phase|After study discontinuation participants assessed for disease progression (21-day safety follow-up).|0
2407069|NCT01296568|5905192|P1|STARTED|Continued Access Phase||3
2407070|NCT01296568|5905192|P1|NOT COMPLETED|[^14C]LY2603618 Single Dose and Washout||0
2407071|NCT01296568|5905192|P1|COMPLETED|[^14C]LY2603618 Single Dose and Washout||3
2407072|NCT01296568|5905192|P1|STARTED|[^14C]LY2603618 Single Dose and Washout||3
2407073|NCT01296412|5905208|P2|NOT COMPLETED|Overall Study||70
2407074|NCT01296412|5905209|P1|NOT COMPLETED|Overall Study||51
2407075|NCT01296412|5905208|P2|COMPLETED|Overall Study||257
2407076|NCT01296412|5905209|P1|COMPLETED|Overall Study||275
2407077|NCT01296412|5905208|P2|STARTED|Overall Study||327
2407078|NCT01296412|5905209|P1|STARTED|Overall Study||326
2407079|NCT01296360|5905223|P2|NOT COMPLETED|Overall Study||8
2407080|NCT01296360|5905224|P1|NOT COMPLETED|Overall Study||6
2407081|NCT01296360|5905223|P2|COMPLETED|Overall Study||142
2407082|NCT01296360|5905224|P1|COMPLETED|Overall Study||144
2407083|NCT01296360|5905223|P2|Visit 2a (Month 13)|Overall Study||0
2407084|NCT01296360|5905224|P1|Visit 2a (Month 13)|Overall Study|visit in Booster Group only: ~13 months after immunization in IC51-323 (i.e., 1 month post booster)|148
2407085|NCT01296360|5905223|P2|Visit 2 (Month 12)|Overall Study||149
2407086|NCT01296360|5905224|P1|Visit 2 (Month 12)|Overall Study|booster was administered|148
2407087|NCT01296360|5905223|P2|STARTED|Overall Study||150
2407088|NCT01296360|5905224|P1|STARTED|Overall Study||150
2407089|NCT01296347|5905232|P2|NOT COMPLETED|12 Month Follow up||3
2407090|NCT01296347|5905233|P1|NOT COMPLETED|12 Month Follow up||4
2407091|NCT01296347|5905232|P2|COMPLETED|12 Month Follow up||28
2407092|NCT01296347|5905233|P1|COMPLETED|12 Month Follow up||28
2407093|NCT01296347|5905232|P2|STARTED|12 Month Follow up||31
2407094|NCT01296347|5905233|P1|STARTED|12 Month Follow up||32
2407095|NCT01296347|5905232|P2|NOT COMPLETED|6 Month Follow up||2
2407096|NCT01296347|5905233|P1|NOT COMPLETED|6 Month Follow up||2
2407097|NCT01296347|5905232|P2|COMPLETED|6 Month Follow up||31
2407098|NCT01296347|5905233|P1|COMPLETED|6 Month Follow up||32
2407099|NCT01296347|5905232|P2|STARTED|6 Month Follow up||33
2407100|NCT01296347|5905233|P1|STARTED|6 Month Follow up||34
2407101|NCT01296347|5905232|P2|NOT COMPLETED|3 Month Follow up||1
2407102|NCT01296347|5905233|P1|NOT COMPLETED|3 Month Follow up||1
2407103|NCT01296347|5905232|P2|COMPLETED|3 Month Follow up||33
2407104|NCT01296347|5905233|P1|COMPLETED|3 Month Follow up||34
2407105|NCT01296347|5905232|P2|STARTED|3 Month Follow up||34
2407106|NCT01296347|5905233|P1|STARTED|3 Month Follow up||35
2407107|NCT01296347|5905232|P2|NOT COMPLETED|6 Week Follow up||1
2407108|NCT01296347|5905233|P1|NOT COMPLETED|6 Week Follow up||0
2407109|NCT01296347|5905232|P2|COMPLETED|6 Week Follow up||34
2407110|NCT01296347|5905233|P1|COMPLETED|6 Week Follow up||35
2407111|NCT01296347|5905232|P2|STARTED|6 Week Follow up||35
2407112|NCT01296347|5905233|P1|STARTED|6 Week Follow up||35
2407113|NCT01296347|5905232|P2|NOT COMPLETED|Allocation||4
2407114|NCT01296347|5905233|P1|NOT COMPLETED|Allocation||3
2407115|NCT01296347|5905232|P2|COMPLETED|Allocation||35
2407116|NCT01296347|5905233|P1|COMPLETED|Allocation||35
2407117|NCT01296347|5905232|P2|STARTED|Allocation||39
2407118|NCT01296347|5905233|P1|STARTED|Allocation||38
2407119|NCT01296191|5905251|P2|NOT COMPLETED|Overall Study||1
2407120|NCT01296191|5905252|P1|NOT COMPLETED|Overall Study||3
2407121|NCT01296191|5905251|P2|COMPLETED|Overall Study||59
2407122|NCT01296191|5905252|P1|COMPLETED|Overall Study||57
2407123|NCT01296191|5905251|P2|STARTED|Overall Study||60
2407124|NCT01296191|5905252|P1|STARTED|Overall Study||60
2407125|NCT01296152|5905258|P1|NOT COMPLETED|Overall Study||1
2407126|NCT01296152|5905258|P1|COMPLETED|Overall Study||24
2407127|NCT01296152|5905258|P1|STARTED|Overall Study||25
2407128|NCT01296035|5905285|P1|NOT COMPLETED|Overall Study||1
2407129|NCT01296035|5905285|P1|COMPLETED|Overall Study||7
2407130|NCT01296035|5905285|P1|STARTED|Overall Study||8
2407131|NCT01295905|5905292|P2|NOT COMPLETED|Overall Study||0
2407132|NCT01295905|5905293|P1|NOT COMPLETED|Overall Study||2
2407133|NCT01295905|5905292|P2|COMPLETED|Overall Study||30
2407134|NCT01295905|5905293|P1|COMPLETED|Overall Study||58
2407135|NCT01295905|5905292|P2|STARTED|Overall Study||30
2407136|NCT01295905|5905293|P1|STARTED|Overall Study||60
2407137|NCT01295879|5905305|P1|NOT COMPLETED|Overall Study||0
2407138|NCT01295879|5905305|P1|COMPLETED|Overall Study||29
2407139|NCT01295879|5905305|P1|STARTED|Overall Study||29
2407140|NCT01295840|5905311|P1|NOT COMPLETED|Overall Study||1
2407141|NCT01295840|5905311|P1|COMPLETED|Overall Study||50
2407142|NCT01295840|5905311|P1|STARTED|Overall Study||51
2407143|NCT01295827|5905337|P15|NOT COMPLETED|Overall Study||0
2407144|NCT01295827|5905338|P14|NOT COMPLETED|Overall Study||0
2407145|NCT01295827|5905339|P13|NOT COMPLETED|Overall Study||0
2407146|NCT01295827|5905340|P12|NOT COMPLETED|Overall Study||186
2407147|NCT01295827|5905341|P11|NOT COMPLETED|Overall Study||276
2407148|NCT01295827|5905342|P10|NOT COMPLETED|Overall Study||55
2407149|NCT01295827|5905343|P9|NOT COMPLETED|Overall Study||169
2407150|NCT01295827|5905344|P8|NOT COMPLETED|Overall Study||297
2407151|NCT01295827|5905345|P7|NOT COMPLETED|Overall Study||146
2407152|NCT01295827|5905346|P6|NOT COMPLETED|Overall Study||6
2407153|NCT01295827|5905347|P5|NOT COMPLETED|Overall Study||2
2407154|NCT01295827|5905348|P4|NOT COMPLETED|Overall Study||4
2407155|NCT01295827|5905349|P3|NOT COMPLETED|Overall Study||12
2407156|NCT01295827|5905350|P2|NOT COMPLETED|Overall Study||3
2407157|NCT01295827|5905351|P1|NOT COMPLETED|Overall Study||4
2407158|NCT01295827|5905337|P15|COMPLETED|Overall Study||0
2407159|NCT01295827|5905338|P14|COMPLETED|Overall Study||0
2407160|NCT01295827|5905339|P13|COMPLETED|Overall Study||0
2407161|NCT01295827|5905340|P12|COMPLETED|Overall Study||17
2407162|NCT01295827|5905341|P11|COMPLETED|Overall Study||20
2407163|NCT01295827|5905342|P10|COMPLETED|Overall Study||6
2407164|NCT01295827|5905343|P9|COMPLETED|Overall Study||14
2407165|NCT01295827|5905344|P8|COMPLETED|Overall Study||24
2407166|NCT01295827|5905345|P7|COMPLETED|Overall Study||18
2407167|NCT01295827|5905346|P6|COMPLETED|Overall Study||0
2407168|NCT01295827|5905347|P5|COMPLETED|Overall Study||1
2407169|NCT01295827|5905348|P4|COMPLETED|Overall Study||0
2407170|NCT01295827|5905349|P3|COMPLETED|Overall Study||0
2407171|NCT01295827|5905350|P2|COMPLETED|Overall Study||0
2407172|NCT01295827|5905351|P1|COMPLETED|Overall Study||0
2407173|NCT01295827|5905337|P15|Treated (All Treated Population)|Overall Study||0
2407174|NCT01295827|5905338|P14|Treated (All Treated Population)|Overall Study||0
2407175|NCT01295827|5905339|P13|Treated (All Treated Population)|Overall Study||0
2407176|NCT01295827|5905340|P12|Treated (All Treated Population)|Overall Study||202
2407177|NCT01295827|5905341|P11|Treated (All Treated Population)|Overall Study||287
2407178|NCT01295827|5905342|P10|Treated (All Treated Population)|Overall Study||61
2407179|NCT01295827|5905343|P9|Treated (All Treated Population)|Overall Study||180
2407180|NCT01295827|5905344|P8|Treated (All Treated Population)|Overall Study||313
2407181|NCT01295827|5905345|P7|Treated (All Treated Population)|Overall Study||162
2407182|NCT01295827|5905346|P6|Treated (All Treated Population)|Overall Study||6
2407183|NCT01295827|5905347|P5|Treated (All Treated Population)|Overall Study||3
2407184|NCT01295827|5905348|P4|Treated (All Treated Population)|Overall Study||4
2407185|NCT01295827|5905349|P3|Treated (All Treated Population)|Overall Study||10
2407186|NCT01295827|5905350|P2|Treated (All Treated Population)|Overall Study||3
2407187|NCT01295827|5905351|P1|Treated (All Treated Population)|Overall Study||4
2407188|NCT01295827|5905337|P15|STARTED|Overall Study||0
2407189|NCT01295827|5905338|P14|STARTED|Overall Study||0
2407190|NCT01295827|5905339|P13|STARTED|Overall Study||0
2407191|NCT01295827|5905340|P12|STARTED|Overall Study||203
2407192|NCT01295827|5905341|P11|STARTED|Overall Study||296
2407193|NCT01295827|5905342|P10|STARTED|Overall Study||61
2407194|NCT01295827|5905343|P9|STARTED|Overall Study||183
2407195|NCT01295827|5905344|P8|STARTED|Overall Study||321
2407196|NCT01295827|5905345|P7|STARTED|Overall Study||164
2407197|NCT01295827|5905346|P6|STARTED|Overall Study||6
2407198|NCT01295827|5905347|P5|STARTED|Overall Study||3
2407199|NCT01295827|5905348|P4|STARTED|Overall Study||4
2407200|NCT01295827|5905349|P3|STARTED|Overall Study||12
2407201|NCT01295827|5905350|P2|STARTED|Overall Study||3
2407202|NCT01295827|5905351|P1|STARTED|Overall Study||4
2407203|NCT01295814|5905724|P2|NOT COMPLETED|Overall Study||2
2407204|NCT01295814|5905725|P1|NOT COMPLETED|Overall Study||2
2407205|NCT01295814|5905724|P2|COMPLETED|Overall Study||19
2407206|NCT01295814|5905725|P1|COMPLETED|Overall Study||20
2407207|NCT01295814|5905724|P2|STARTED|Overall Study||21
2407208|NCT01295814|5905725|P1|STARTED|Overall Study||22
2407209|NCT01295710|5905741|P2|NOT COMPLETED|Overall Study||50
2407210|NCT01295710|5905742|P1|NOT COMPLETED|Overall Study||78
2407211|NCT01295710|5905741|P2|COMPLETED|Overall Study||78
2407212|NCT01295710|5905742|P1|COMPLETED|Overall Study||48
2407213|NCT01295710|5905741|P2|STARTED|Overall Study|Randomized and treated|128
2407214|NCT01295710|5905742|P1|STARTED|Overall Study|Randomized and treated|126
2407215|NCT01295671|5905805|P3|NOT COMPLETED|Overall Study||3
2407216|NCT01295671|5905806|P2|NOT COMPLETED|Overall Study||7
2407217|NCT01295671|5905807|P1|NOT COMPLETED|Overall Study||7
2407218|NCT01295671|5905805|P3|COMPLETED|Overall Study||66
2407219|NCT01295671|5905806|P2|COMPLETED|Overall Study||60
2407220|NCT01295671|5905807|P1|COMPLETED|Overall Study||60
2407221|NCT01295671|5905805|P3|STARTED|Overall Study||69
2407222|NCT01295671|5905806|P2|STARTED|Overall Study||67
2407223|NCT01295671|5905807|P1|STARTED|Overall Study||67
2407224|NCT01295515|5905845|P1|NOT COMPLETED|Overall Study||0
2407225|NCT01295515|5905845|P1|COMPLETED|Overall Study||7
2407226|NCT01295515|5905845|P1|STARTED|Overall Study||7
2407227|NCT01295320|5905853|P1|NOT COMPLETED|Overall Study||10
2407228|NCT01295320|5905853|P1|COMPLETED|Overall Study||119
2407229|NCT01295320|5905853|P1|STARTED|Overall Study||129
2407230|NCT01295281|5905870|P2|NOT COMPLETED|Second Intervention (7days)||0
2407231|NCT01295281|5905871|P1|NOT COMPLETED|Second Intervention (7days)||0
2407232|NCT01295281|5905870|P2|COMPLETED|Second Intervention (7days)||51
2407233|NCT01295281|5905871|P1|COMPLETED|Second Intervention (7days)||53
2407234|NCT01295281|5905870|P2|STARTED|Second Intervention (7days)||51
2407235|NCT01295281|5905871|P1|STARTED|Second Intervention (7days)||53
2407236|NCT01295281|5905870|P2|NOT COMPLETED|First Intervention (7 Days)||1
2407237|NCT01295281|5905871|P1|NOT COMPLETED|First Intervention (7 Days)||0
2407238|NCT01295281|5905870|P2|COMPLETED|First Intervention (7 Days)||51
2407239|NCT01295281|5905871|P1|COMPLETED|First Intervention (7 Days)||53
2407240|NCT01295281|5905870|P2|STARTED|First Intervention (7 Days)||52
2407241|NCT01295281|5905871|P1|STARTED|First Intervention (7 Days)||53
2407242|NCT01295216|5905879|P2|NOT COMPLETED|Overall Study||34
2407243|NCT01295216|5905880|P1|NOT COMPLETED|Overall Study||50
2407244|NCT01295216|5905879|P2|COMPLETED|Overall Study||287
2407245|NCT01295216|5905880|P1|COMPLETED|Overall Study||266
2407246|NCT01295216|5905879|P2|STARTED|Overall Study||321
2407247|NCT01295216|5905880|P1|STARTED|Overall Study||316
2407248|NCT01295112|5905898|P2|NOT COMPLETED|Overall Study||0
2407249|NCT01295112|5905899|P1|NOT COMPLETED|Overall Study||0
2407250|NCT01295112|5905898|P2|COMPLETED|Overall Study||33
2407251|NCT01295112|5905899|P1|COMPLETED|Overall Study||35
2407252|NCT01295112|5905898|P2|STARTED|Overall Study||33
2407253|NCT01295112|5905899|P1|STARTED|Overall Study||35
2407254|NCT01295034|5905909|P2|NOT COMPLETED|Overall Study||5
2407255|NCT01295034|5905910|P1|NOT COMPLETED|Overall Study||5
2407256|NCT01295034|5905909|P2|COMPLETED|Overall Study||25
2407257|NCT01295034|5905910|P1|COMPLETED|Overall Study||27
2407258|NCT01295034|5905909|P2|STARTED|Overall Study||30
2407259|NCT01295034|5905910|P1|STARTED|Overall Study||32
2407260|NCT01294917|5905918|P1|NOT COMPLETED|Overall Study||6
2407261|NCT01294917|5905918|P1|COMPLETED|Overall Study||36
2407262|NCT01294917|5905918|P1|Received OptiFree RepleniSH MPS|Overall Study||36
2407263|NCT01294917|5905918|P1|Received Clear Care|Overall Study||36
2407264|NCT01294917|5905918|P1|Received Investigational MPS|Overall Study||36
2407265|NCT01294917|5905918|P1|STARTED|Overall Study||42
2407266|NCT01294800|5905928|P4|NOT COMPLETED|Overall Study||16
2407267|NCT01294800|5905929|P3|NOT COMPLETED|Overall Study||17
2407268|NCT01294800|5905930|P2|NOT COMPLETED|Overall Study||10
2407269|NCT01294800|5905931|P1|NOT COMPLETED|Overall Study||11
2407270|NCT01294800|5905928|P4|COMPLETED|Overall Study||97
2407271|NCT01294800|5905929|P3|COMPLETED|Overall Study||96
2407272|NCT01294800|5905930|P2|COMPLETED|Overall Study||103
2407273|NCT01294800|5905931|P1|COMPLETED|Overall Study||100
2407274|NCT01294800|5905928|P4|STARTED|Overall Study||113
2407275|NCT01294800|5905929|P3|STARTED|Overall Study||113
2407276|NCT01294800|5905930|P2|STARTED|Overall Study||113
2407277|NCT01294800|5905931|P1|STARTED|Overall Study||111
2407278|NCT01294787|5905957|P6|NOT COMPLETED|Period 3||0
2407279|NCT01294787|5905958|P5|NOT COMPLETED|Period 3||1
2407280|NCT01294787|5905959|P4|NOT COMPLETED|Period 3||0
2407281|NCT01294787|5905960|P3|NOT COMPLETED|Period 3||0
2407282|NCT01294787|5905961|P2|NOT COMPLETED|Period 3||0
2407283|NCT01294787|5905962|P1|NOT COMPLETED|Period 3||0
2407284|NCT01294787|5905957|P6|COMPLETED|Period 3||13
2407285|NCT01294787|5905958|P5|COMPLETED|Period 3||13
2407286|NCT01294787|5905959|P4|COMPLETED|Period 3||9
2407287|NCT01294787|5905960|P3|COMPLETED|Period 3||13
2407288|NCT01294787|5905961|P2|COMPLETED|Period 3||13
2407289|NCT01294787|5905962|P1|COMPLETED|Period 3||12
2407290|NCT01294787|5905957|P6|STARTED|Period 3||13
2407291|NCT01294787|5905958|P5|STARTED|Period 3||14
2407292|NCT01294787|5905959|P4|STARTED|Period 3||9
2407293|NCT01294787|5905960|P3|STARTED|Period 3||13
2407294|NCT01294787|5905961|P2|STARTED|Period 3||13
2407295|NCT01294787|5905962|P1|STARTED|Period 3||12
2407296|NCT01294787|5905957|P6|NOT COMPLETED|Period 2||0
2407297|NCT01294787|5905958|P5|NOT COMPLETED|Period 2||0
2407298|NCT01294787|5905959|P4|NOT COMPLETED|Period 2||2
2407299|NCT01294787|5905960|P3|NOT COMPLETED|Period 2||0
2407300|NCT01294787|5905961|P2|NOT COMPLETED|Period 2||3
2407301|NCT01294787|5905962|P1|NOT COMPLETED|Period 2||0
2407302|NCT01294787|5905957|P6|COMPLETED|Period 2||13
2407303|NCT01294787|5905958|P5|COMPLETED|Period 2||14
2407304|NCT01294787|5905959|P4|COMPLETED|Period 2||9
2407305|NCT01294787|5905960|P3|COMPLETED|Period 2||13
2407306|NCT01294787|5905961|P2|COMPLETED|Period 2||13
2407307|NCT01294787|5905962|P1|COMPLETED|Period 2||12
2407308|NCT01294787|5905957|P6|STARTED|Period 2||13
2407309|NCT01294787|5905958|P5|STARTED|Period 2||14
2407310|NCT01294787|5905959|P4|STARTED|Period 2||11
2407311|NCT01294787|5905960|P3|STARTED|Period 2||13
2407312|NCT01294787|5905961|P2|STARTED|Period 2||16
2407313|NCT01294787|5905962|P1|STARTED|Period 2||12
2407314|NCT01294787|5905957|P6|NOT COMPLETED|Period 1||2
2407315|NCT01294787|5905958|P5|NOT COMPLETED|Period 1||2
2407316|NCT01294787|5905959|P4|NOT COMPLETED|Period 1||1
2407317|NCT01294787|5905960|P3|NOT COMPLETED|Period 1||1
2407318|NCT01294787|5905961|P2|NOT COMPLETED|Period 1||0
2407319|NCT01294787|5905962|P1|NOT COMPLETED|Period 1||0
2407320|NCT01294787|5905957|P6|COMPLETED|Period 1||13
2407321|NCT01294787|5905958|P5|COMPLETED|Period 1||14
2407322|NCT01294787|5905959|P4|COMPLETED|Period 1||11
2407323|NCT01294787|5905960|P3|COMPLETED|Period 1||13
2407324|NCT01294787|5905961|P2|COMPLETED|Period 1||16
2407325|NCT01294787|5905962|P1|COMPLETED|Period 1||12
2407326|NCT01294787|5905957|P6|STARTED|Period 1|One randomized participant did not receive study drug|15
2407327|NCT01294787|5905958|P5|STARTED|Period 1||16
2407328|NCT01294787|5905959|P4|STARTED|Period 1||12
2407329|NCT01294787|5905960|P3|STARTED|Period 1||14
2407330|NCT01294787|5905961|P2|STARTED|Period 1||16
2407331|NCT01294787|5905962|P1|STARTED|Period 1||12
2407332|NCT01294748|5906006|P2|NOT COMPLETED|Overall Study||2
2407333|NCT01294748|5906007|P1|NOT COMPLETED|Overall Study||5
2407334|NCT01294748|5906006|P2|COMPLETED|Overall Study|At 270 days|59
2407335|NCT01294748|5906007|P1|COMPLETED|Overall Study|At 270 days|118
2407336|NCT01294748|5906006|P2|STARTED|Overall Study||61
2407337|NCT01294748|5906007|P1|STARTED|Overall Study||123
2407338|NCT01294709|5906033|P2|NOT COMPLETED|Period 2||0
2407339|NCT01294709|5906034|P1|NOT COMPLETED|Period 2||1
2407340|NCT01294709|5906033|P2|COMPLETED|Period 2||31
2407341|NCT01294709|5906034|P1|COMPLETED|Period 2||28
2407342|NCT01294709|5906033|P2|STARTED|Period 2||31
2407343|NCT01294709|5906034|P1|STARTED|Period 2||29
2407344|NCT01294709|5906033|P2|NOT COMPLETED|Washout Period||1
2407345|NCT01294709|5906034|P1|NOT COMPLETED|Washout Period||1
2407346|NCT01294709|5906033|P2|COMPLETED|Washout Period||31
2407347|NCT01294709|5906034|P1|COMPLETED|Washout Period||29
2407348|NCT01294709|5906033|P2|STARTED|Washout Period||32
2407349|NCT01294709|5906034|P1|STARTED|Washout Period||30
2407350|NCT01294709|5906033|P2|NOT COMPLETED|Period 1||1
2407351|NCT01294709|5906034|P1|NOT COMPLETED|Period 1||1
2407352|NCT01294709|5906033|P2|COMPLETED|Period 1||32
2407353|NCT01294709|5906034|P1|COMPLETED|Period 1||30
2407354|NCT01294709|5906033|P2|STARTED|Period 1||33
2407355|NCT01294709|5906034|P1|STARTED|Period 1||31
2407356|NCT01294696|5906053|P1|NOT COMPLETED|Overall Study||74
2407357|NCT01294696|5906053|P1|COMPLETED|Overall Study||1187
2407358|NCT01294696|5906053|P1|STARTED|Overall Study||1261
2407359|NCT01294683|5906067|P2|NOT COMPLETED|Post Crossover (Period III)||32
2407360|NCT01294683|5906068|P1|NOT COMPLETED|Post Crossover (Period III)||33
2407361|NCT01294683|5906067|P2|COMPLETED|Post Crossover (Period III)||190
2407362|NCT01294683|5906068|P1|COMPLETED|Post Crossover (Period III)||199
2407363|NCT01294683|5906067|P2|STARTED|Post Crossover (Period III)||222
2407364|NCT01294683|5906068|P1|STARTED|Post Crossover (Period III)||232
2407365|NCT01294683|5906067|P2|NOT COMPLETED|Precrossover (Periods I/II)||266
2407366|NCT01294683|5906068|P1|NOT COMPLETED|Precrossover (Periods I/II)||257
2407367|NCT01294683|5906067|P2|COMPLETED|Precrossover (Periods I/II)||222
2407368|NCT01294683|5906068|P1|COMPLETED|Precrossover (Periods I/II)||232
2407369|NCT01294683|5906067|P2|Treated|Precrossover (Periods I/II)||486
2407370|NCT01294683|5906068|P1|Treated|Precrossover (Periods I/II)||486
2407371|NCT01294683|5906067|P2|STARTED|Precrossover (Periods I/II)||488
2407372|NCT01294683|5906068|P1|STARTED|Precrossover (Periods I/II)||489
2407373|NCT01294644|5906121|P3|NOT COMPLETED|Overall Study||14
2407374|NCT01294644|5906122|P2|NOT COMPLETED|Overall Study||10
2407375|NCT01294644|5906123|P1|NOT COMPLETED|Overall Study||10
2407376|NCT01294644|5906121|P3|COMPLETED|Overall Study||103
2407377|NCT01294644|5906122|P2|COMPLETED|Overall Study||112
2407378|NCT01294644|5906123|P1|COMPLETED|Overall Study||111
2407379|NCT01294644|5906121|P3|Received Treatment|Overall Study||114
2407380|NCT01294644|5906122|P2|Received Treatment|Overall Study||122
2407381|NCT01294644|5906123|P1|Received Treatment|Overall Study||118
2407382|NCT01294644|5906121|P3|STARTED|Overall Study||117
2407383|NCT01294644|5906122|P2|STARTED|Overall Study||122
2407384|NCT01294644|5906123|P1|STARTED|Overall Study||121
2407385|NCT01294592|5906154|P2|NOT COMPLETED|Overall Study||73
2407386|NCT01294592|5906155|P1|NOT COMPLETED|Overall Study||77
2407387|NCT01294592|5906154|P2|COMPLETED|Overall Study||300
2407388|NCT01294592|5906155|P1|COMPLETED|Overall Study||292
2407389|NCT01294592|5906154|P2|STARTED|Overall Study||373
2407390|NCT01294592|5906155|P1|STARTED|Overall Study||369
2407391|NCT01294579|5906183|P1|NOT COMPLETED|Overall Study||35
2407392|NCT01294579|5906183|P1|COMPLETED|Overall Study||14
2407393|NCT01294579|5906183|P1|STARTED|Overall Study||49
2407394|NCT01294553|5906193|P1|NOT COMPLETED|Overall Study||269
2407395|NCT01294553|5906193|P1|COMPLETED|Overall Study||713
2407396|NCT01294553|5906193|P1|STARTED|Overall Study||982
2407397|NCT01294514|5906199|P1|NOT COMPLETED|Overall Study||1
2407398|NCT01294514|5906199|P1|COMPLETED|Overall Study||26
2407399|NCT01294514|5906199|P1|STARTED|Overall Study||27
2407400|NCT01294462|5906209|P2|NOT COMPLETED|Overall Study||63
2407401|NCT01294462|5906210|P1|NOT COMPLETED|Overall Study||66
2407402|NCT01294462|5906209|P2|COMPLETED|Overall Study||337
2407403|NCT01294462|5906210|P1|COMPLETED|Overall Study||335
2407404|NCT01294462|5906209|P2|Received Randomized Treatment|Overall Study||380
2407405|NCT01294462|5906210|P1|Received Randomized Treatment|Overall Study||387
2407406|NCT01294462|5906209|P2|STARTED|Overall Study||400
2407407|NCT01294462|5906210|P1|STARTED|Overall Study||401
2407408|NCT01294449|5906224|P2|NOT COMPLETED|Overall Study||15
2407409|NCT01294449|5906225|P1|NOT COMPLETED|Overall Study||12
2407410|NCT01294449|5906224|P2|COMPLETED|Overall Study||237
2407411|NCT01294449|5906225|P1|COMPLETED|Overall Study||144
2407412|NCT01294449|5906224|P2|Consent to Registry|Overall Study||245
2407413|NCT01294449|5906225|P1|Consent to Registry|Overall Study||149
2407414|NCT01294449|5906224|P2|STARTED|Overall Study||252
2407415|NCT01294449|5906225|P1|STARTED|Overall Study||156
2407416|NCT01294436|5906233|P2|NOT COMPLETED|Overall Study||70
2407417|NCT01294436|5906234|P1|NOT COMPLETED|Overall Study||28
2407418|NCT01294436|5906233|P2|COMPLETED|Overall Study||409
2407419|NCT01294436|5906234|P1|COMPLETED|Overall Study||221
2407420|NCT01294436|5906233|P2|STARTED|Overall Study||479
2407421|NCT01294436|5906234|P1|STARTED|Overall Study||249
2407422|NCT01294423|5906269|P3|NOT COMPLETED|Overall Study||8
2407423|NCT01294423|5906270|P2|NOT COMPLETED|Overall Study||9
2407424|NCT01294423|5906271|P1|NOT COMPLETED|Overall Study||5
2407425|NCT01294423|5906269|P3|COMPLETED|Overall Study||79
2407426|NCT01294423|5906270|P2|COMPLETED|Overall Study||79
2407427|NCT01294423|5906271|P1|COMPLETED|Overall Study||81
2407428|NCT01294423|5906269|P3|STARTED|Overall Study||87
2407429|NCT01294423|5906270|P2|STARTED|Overall Study||88
2407430|NCT01294423|5906271|P1|STARTED|Overall Study||86
2407431|NCT01294397|5906285|P1|NOT COMPLETED|Overall Study||2
2407432|NCT01294397|5906285|P1|COMPLETED|Overall Study||17
2407433|NCT01294397|5906285|P1|STARTED|Overall Study||19
2407434|NCT01294384|5906298|P3|NOT COMPLETED|Overall Study||9
2407435|NCT01294384|5906299|P2|NOT COMPLETED|Overall Study||6
2407436|NCT01294384|5906300|P1|NOT COMPLETED|Overall Study||4
2407437|NCT01294384|5906298|P3|COMPLETED|Overall Study||95
2407438|NCT01294384|5906299|P2|COMPLETED|Overall Study||94
2407439|NCT01294384|5906300|P1|COMPLETED|Overall Study||97
2407440|NCT01294384|5906298|P3|STARTED|Overall Study||104
2407441|NCT01294384|5906299|P2|STARTED|Overall Study||100
2407442|NCT01294384|5906300|P1|STARTED|Overall Study||101
2407443|NCT01294371|5906329|P1|NOT COMPLETED|Overall Study||34
2407444|NCT01294371|5906329|P1|COMPLETED|Overall Study||357
2407445|NCT01294371|5906329|P1|Treated|Overall Study||390
2407446|NCT01294371|5906329|P1|STARTED|Overall Study||391
2407447|NCT01294358|5906337|P5|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||1
2407448|NCT01294358|5906338|P4|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
2407449|NCT01294358|5906339|P3|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
2407450|NCT01294358|5906340|P2|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
2407451|NCT01294358|5906341|P1|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
2407452|NCT01294358|5906337|P5|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
2407453|NCT01294358|5906338|P4|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
2407454|NCT01294358|5906339|P3|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
2407455|NCT01294358|5906340|P2|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
2407456|NCT01294358|5906341|P1|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
2407457|NCT01294358|5906337|P5|STARTED|Cohort 5: 3/8/12-3/9/12|1 participant from 96mg move to 115mg.|1
2407458|NCT01294358|5906338|P4|STARTED|Cohort 5: 3/8/12-3/9/12||0
2407459|NCT01294358|5906339|P3|STARTED|Cohort 5: 3/8/12-3/9/12||0
2407460|NCT01294358|5906340|P2|STARTED|Cohort 5: 3/8/12-3/9/12||0
2407461|NCT01294358|5906341|P1|STARTED|Cohort 5: 3/8/12-3/9/12||0
2407462|NCT01294358|5906337|P5|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
2407463|NCT01294358|5906338|P4|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||1
2407464|NCT01294358|5906339|P3|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
2407465|NCT01294358|5906340|P2|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
2407466|NCT01294358|5906341|P1|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
2407467|NCT01294358|5906337|P5|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
2407468|NCT01294358|5906338|P4|COMPLETED|Cohort 4: 12/30/11-2/17/17||1
2407469|NCT01294358|5906339|P3|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
2407470|NCT01294358|5906340|P2|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
2407471|NCT01294358|5906341|P1|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
2407472|NCT01294358|5906337|P5|STARTED|Cohort 4: 12/30/11-2/17/17||0
2407473|NCT01294358|5906338|P4|STARTED|Cohort 4: 12/30/11-2/17/17|2 participants from 72mg move to 96mg.|2
2407474|NCT01294358|5906339|P3|STARTED|Cohort 4: 12/30/11-2/17/17||0
2407475|NCT01294358|5906340|P2|STARTED|Cohort 4: 12/30/11-2/17/17||0
2407476|NCT01294358|5906341|P1|STARTED|Cohort 4: 12/30/11-2/17/17||0
2407477|NCT01294358|5906337|P5|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
2407478|NCT01294358|5906338|P4|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
2407479|NCT01294358|5906339|P3|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||2
2407480|NCT01294358|5906340|P2|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
2407481|NCT01294358|5906341|P1|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
2407482|NCT01294358|5906337|P5|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
2407483|NCT01294358|5906338|P4|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
2407484|NCT01294358|5906339|P3|COMPLETED|Cohort 3: 12/1/11-10/6/12||2
2407485|NCT01294358|5906340|P2|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
2407486|NCT01294358|5906341|P1|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
2407487|NCT01294358|5906337|P5|STARTED|Cohort 3: 12/1/11-10/6/12||0
2407488|NCT01294358|5906338|P4|STARTED|Cohort 3: 12/1/11-10/6/12||0
2407489|NCT01294358|5906339|P3|STARTED|Cohort 3: 12/1/11-10/6/12|4 participants from 36mg move to 72mg.|4
2407490|NCT01294358|5906340|P2|STARTED|Cohort 3: 12/1/11-10/6/12||0
2407491|NCT01294358|5906341|P1|STARTED|Cohort 3: 12/1/11-10/6/12||0
2407492|NCT01294358|5906337|P5|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
2407493|NCT01294358|5906338|P4|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
2407494|NCT01294358|5906339|P3|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
2407495|NCT01294358|5906340|P2|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||2
2407496|NCT01294358|5906341|P1|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
2407497|NCT01294358|5906337|P5|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
2407498|NCT01294358|5906338|P4|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
2407499|NCT01294358|5906339|P3|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
2407500|NCT01294358|5906340|P2|COMPLETED|Cohort 2: 6/9/11-9/17/12||4
2407501|NCT01294358|5906341|P1|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
2407502|NCT01294358|5906337|P5|STARTED|Cohort 2: 6/9/11-9/17/12||0
2407503|NCT01294358|5906338|P4|STARTED|Cohort 2: 6/9/11-9/17/12||0
2407504|NCT01294358|5906339|P3|STARTED|Cohort 2: 6/9/11-9/17/12||0
2407505|NCT01294358|5906340|P2|STARTED|Cohort 2: 6/9/11-9/17/12|4 participants from 18mg move to 36mg and 2 additional participants were enrolled at this dose.|6
2407506|NCT01294358|5906341|P1|STARTED|Cohort 2: 6/9/11-9/17/12||0
2407507|NCT01294358|5906337|P5|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
2407508|NCT01294358|5906338|P4|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
2407509|NCT01294358|5906339|P3|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
2407510|NCT01294358|5906340|P2|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
2407511|NCT01294358|5906341|P1|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
2407512|NCT01294358|5906337|P5|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
2407513|NCT01294358|5906338|P4|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
2407514|NCT01294358|5906339|P3|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
2407515|NCT01294358|5906340|P2|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
2407516|NCT01294358|5906341|P1|COMPLETED|Cohort 1: 5/11/11-11/9/11||4
2407517|NCT01294358|5906337|P5|STARTED|Cohort 1: 5/11/11-11/9/11||0
2407518|NCT01294358|5906338|P4|STARTED|Cohort 1: 5/11/11-11/9/11||0
2407519|NCT01294358|5906339|P3|STARTED|Cohort 1: 5/11/11-11/9/11||0
2407520|NCT01294358|5906340|P2|STARTED|Cohort 1: 5/11/11-11/9/11||0
2407521|NCT01294358|5906341|P1|STARTED|Cohort 1: 5/11/11-11/9/11||4
2407522|NCT01294319|5906403|P8|NOT COMPLETED|Overall Study||0
2407523|NCT01294319|5906404|P7|NOT COMPLETED|Overall Study||0
2407524|NCT01294319|5906405|P6|NOT COMPLETED|Overall Study||0
2407525|NCT01294319|5906406|P5|NOT COMPLETED|Overall Study||0
2407526|NCT01294319|5906407|P4|NOT COMPLETED|Overall Study||0
2407527|NCT01294319|5906408|P3|NOT COMPLETED|Overall Study||0
2407528|NCT01294319|5906409|P2|NOT COMPLETED|Overall Study||0
2407529|NCT01294319|5906410|P1|NOT COMPLETED|Overall Study||0
2407530|NCT01294319|5906403|P8|COMPLETED|Overall Study||5
2407531|NCT01294319|5906404|P7|COMPLETED|Overall Study||5
2407532|NCT01294319|5906405|P6|COMPLETED|Overall Study||4
2407533|NCT01294319|5906406|P5|COMPLETED|Overall Study||5
2407534|NCT01294319|5906407|P4|COMPLETED|Overall Study||5
2407535|NCT01294319|5906408|P3|COMPLETED|Overall Study||5
2407536|NCT01294319|5906409|P2|COMPLETED|Overall Study||6
2407537|NCT01294319|5906410|P1|COMPLETED|Overall Study||4
2407538|NCT01294319|5906403|P8|STARTED|Overall Study||5
2407539|NCT01294319|5906404|P7|STARTED|Overall Study||5
2407540|NCT01294319|5906405|P6|STARTED|Overall Study||4
2407541|NCT01294319|5906406|P5|STARTED|Overall Study||5
2407542|NCT01294319|5906407|P4|STARTED|Overall Study||5
2407543|NCT01294319|5906408|P3|STARTED|Overall Study||5
2407544|NCT01294319|5906409|P2|STARTED|Overall Study||6
2407545|NCT01294319|5906410|P1|STARTED|Overall Study||4
2407546|NCT01294306|5906420|P2|NOT COMPLETED|Overall Study||0
2407547|NCT01294306|5906421|P1|NOT COMPLETED|Overall Study||0
2407548|NCT01294306|5906420|P2|COMPLETED|Overall Study||35
2407549|NCT01294306|5906421|P1|COMPLETED|Overall Study||45
2407550|NCT01294306|5906420|P2|STARTED|Overall Study||35
2407551|NCT01294306|5906421|P1|STARTED|Overall Study||45
2407552|NCT01294267|5906435|P1|NOT COMPLETED|Overall Study||0
2407553|NCT01294267|5906435|P1|COMPLETED|Overall Study||20
2407554|NCT01294267|5906435|P1|STARTED|Overall Study||20
2407555|NCT01294241|5906441|P1|NOT COMPLETED|Overall Study||0
2407556|NCT01294241|5906441|P1|COMPLETED|Overall Study||10
2407557|NCT01294241|5906441|P1|STARTED|Overall Study||10
2407558|NCT01294228|5906449|P1|NOT COMPLETED|Overall Study||0
2407559|NCT01294228|5906449|P1|COMPLETED|Overall Study||1001
2407560|NCT01294228|5906449|P1|STARTED|Overall Study||1001
2407561|NCT01294163|5906456|P3|NOT COMPLETED|Overall Study||3
2407562|NCT01294163|5906457|P2|NOT COMPLETED|Overall Study||0
2407563|NCT01294163|5906458|P1|NOT COMPLETED|Overall Study||1
2407564|NCT01294163|5906456|P3|COMPLETED|Overall Study||163
2407565|NCT01294163|5906457|P2|COMPLETED|Overall Study||165
2407566|NCT01294163|5906458|P1|COMPLETED|Overall Study||177
2407567|NCT01294163|5906456|P3|STARTED|Overall Study||166
2407568|NCT01294163|5906457|P2|STARTED|Overall Study||165
2407569|NCT01294163|5906458|P1|STARTED|Overall Study||178
2407570|NCT01294150|5906469|P2|NOT COMPLETED|Overall Study||2
2407571|NCT01294150|5906470|P1|NOT COMPLETED|Overall Study||2
2407572|NCT01294150|5906469|P2|COMPLETED|Overall Study||64
2407573|NCT01294150|5906470|P1|COMPLETED|Overall Study||138
2407574|NCT01294150|5906469|P2|STARTED|Overall Study||66
2407575|NCT01294150|5906470|P1|STARTED|Overall Study||140
2407576|NCT01294098|5906483|P3|NOT COMPLETED|Overall Study||1
2407577|NCT01294098|5906484|P2|NOT COMPLETED|Overall Study||1
2407578|NCT01294098|5906485|P1|NOT COMPLETED|Overall Study||0
2407579|NCT01294098|5906483|P3|COMPLETED|Overall Study||0
2407580|NCT01294098|5906484|P2|COMPLETED|Overall Study||0
2407581|NCT01294098|5906485|P1|COMPLETED|Overall Study||0
2407582|NCT01294098|5906483|P3|STARTED|Overall Study||1
2407583|NCT01294098|5906484|P2|STARTED|Overall Study||1
2407584|NCT01294098|5906485|P1|STARTED|Overall Study||0
2407585|NCT01294046|5906499|P1|NOT COMPLETED|Overall Study||3
2407586|NCT01294046|5906499|P1|COMPLETED|Overall Study||0
2407587|NCT01294046|5906499|P1|STARTED|Overall Study||3
2407588|NCT01293968|5906514|P2|NOT COMPLETED|Overall Study||3
2407589|NCT01293968|5906515|P1|NOT COMPLETED|Overall Study||3
2407590|NCT01293968|5906514|P2|COMPLETED|Overall Study||14
2407591|NCT01293968|5906515|P1|COMPLETED|Overall Study||17
2407592|NCT01293968|5906514|P2|STARTED|Overall Study||17
2407593|NCT01293968|5906515|P1|STARTED|Overall Study||20
2407594|NCT01293825|5906521|P1|NOT COMPLETED|Overall Study||10
2407595|NCT01293825|5906521|P1|COMPLETED|Overall Study||20
2407596|NCT01293825|5906521|P1|STARTED|Overall Study||30
2407597|NCT01293695|5906535|P2|NOT COMPLETED|Overall Study||7
2407598|NCT01293695|5906536|P1|NOT COMPLETED|Overall Study||15
2407599|NCT01293695|5906535|P2|COMPLETED|Overall Study||87
2407600|NCT01293695|5906536|P1|COMPLETED|Overall Study||78
2407601|NCT01293695|5906535|P2|STARTED|Overall Study||94
2407602|NCT01293695|5906536|P1|STARTED|Overall Study||93
2407606|NCT01293539|5906555|P1|NOT COMPLETED|Overall Study||1
2407607|NCT01293539|5906555|P1|COMPLETED|Overall Study||9
2407608|NCT01293539|5906555|P1|STARTED|Overall Study||10
2407609|NCT01293240|5906559|P1|NOT COMPLETED|Overall Study||2
2407610|NCT01293240|5906559|P1|COMPLETED|Overall Study||115
2407611|NCT01293240|5906559|P1|STARTED|Overall Study||117
2407612|NCT01293123|5906576|P2|NOT COMPLETED|Overall Study||1
2407613|NCT01293123|5906577|P1|NOT COMPLETED|Overall Study||0
2407614|NCT01293123|5906576|P2|COMPLETED|Overall Study||0
2407615|NCT01293123|5906577|P1|COMPLETED|Overall Study||1
2407616|NCT01293123|5906576|P2|STARTED|Overall Study||1
2407617|NCT01293123|5906577|P1|STARTED|Overall Study||1
2407618|NCT01293084|5906591|P1|NOT COMPLETED|Overall Study||5
2407619|NCT01293084|5906591|P1|COMPLETED|Overall Study||12
2407620|NCT01293084|5906591|P1|STARTED|Overall Study||17
2407621|NCT01293032|5906603|P4|NOT COMPLETED|Treatment||1
2407622|NCT01293032|5906604|P3|NOT COMPLETED|Treatment||1
2407623|NCT01293032|5906605|P2|NOT COMPLETED|Treatment||5
2407624|NCT01293032|5906606|P1|NOT COMPLETED|Treatment||2
2407625|NCT01293032|5906603|P4|COMPLETED|Treatment||13
2407626|NCT01293032|5906604|P3|COMPLETED|Treatment||10
2407627|NCT01293032|5906605|P2|COMPLETED|Treatment||14
2407628|NCT01293032|5906606|P1|COMPLETED|Treatment||10
2407629|NCT01293032|5906603|P4|STARTED|Treatment||14
2407630|NCT01293032|5906604|P3|STARTED|Treatment||11
2407631|NCT01293032|5906605|P2|STARTED|Treatment|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|19
2407632|NCT01293032|5906606|P1|STARTED|Treatment||12
2407633|NCT01293032|5906603|P4|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
2407634|NCT01293032|5906604|P3|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||5
2407635|NCT01293032|5906605|P2|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
2407636|NCT01293032|5906606|P1|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
2407637|NCT01293032|5906603|P4|COMPLETED|Recurrence Score(RS)Assigned/Randomized||14
2407638|NCT01293032|5906604|P3|COMPLETED|Recurrence Score(RS)Assigned/Randomized|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|11
2407639|NCT01293032|5906605|P2|COMPLETED|Recurrence Score(RS)Assigned/Randomized||17
2407640|NCT01293032|5906606|P1|COMPLETED|Recurrence Score(RS)Assigned/Randomized||12
2407641|NCT01293032|5906603|P4|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||14
2407642|NCT01293032|5906604|P3|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||16
2407643|NCT01293032|5906605|P2|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||17
2407644|NCT01293032|5906606|P1|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||12
2407645|NCT01293032|5906603|P4|STARTED|Recurrence Score(RS)Assigned/Randomized||14
2407646|NCT01293032|5906604|P3|STARTED|Recurrence Score(RS)Assigned/Randomized||16
2407647|NCT01293032|5906605|P2|STARTED|Recurrence Score(RS)Assigned/Randomized||17
2407648|NCT01293032|5906606|P1|STARTED|Recurrence Score(RS)Assigned/Randomized||12
2407649|NCT01293006|5906617|P4|NOT COMPLETED|Period 2||0
2407650|NCT01293006|5906618|P3|NOT COMPLETED|Period 2||0
2407651|NCT01293006|5906619|P2|NOT COMPLETED|Period 2||0
2407652|NCT01293006|5906620|P1|NOT COMPLETED|Period 2||1
2407653|NCT01293006|5906617|P4|COMPLETED|Period 2||3
2407654|NCT01293006|5906618|P3|COMPLETED|Period 2||9
2407655|NCT01293006|5906619|P2|COMPLETED|Period 2||2
2407656|NCT01293006|5906620|P1|COMPLETED|Period 2||10
2407657|NCT01293006|5906617|P4|STARTED|Period 2||3
2407658|NCT01293006|5906618|P3|STARTED|Period 2||9
2407659|NCT01293006|5906619|P2|STARTED|Period 2||2
2407660|NCT01293006|5906620|P1|STARTED|Period 2||11
2407661|NCT01293006|5906617|P4|NOT COMPLETED|Washout||0
2407662|NCT01293006|5906618|P3|NOT COMPLETED|Washout||0
2407663|NCT01293006|5906619|P2|NOT COMPLETED|Washout||0
2407664|NCT01293006|5906620|P1|NOT COMPLETED|Washout||0
2407665|NCT01293006|5906617|P4|COMPLETED|Washout||3
2407666|NCT01293006|5906618|P3|COMPLETED|Washout||9
2407667|NCT01293006|5906619|P2|COMPLETED|Washout||2
2407668|NCT01293006|5906620|P1|COMPLETED|Washout||11
2407669|NCT01293006|5906617|P4|STARTED|Washout||3
2407670|NCT01293006|5906618|P3|STARTED|Washout||9
2407671|NCT01293006|5906619|P2|STARTED|Washout||2
2407672|NCT01293006|5906620|P1|STARTED|Washout||11
2407673|NCT01293006|5906617|P4|NOT COMPLETED|Period 1||0
2407674|NCT01293006|5906618|P3|NOT COMPLETED|Period 1||0
2407675|NCT01293006|5906619|P2|NOT COMPLETED|Period 1||0
2407676|NCT01293006|5906620|P1|NOT COMPLETED|Period 1||0
2407677|NCT01293006|5906617|P4|COMPLETED|Period 1||3
2407678|NCT01293006|5906618|P3|COMPLETED|Period 1||9
2407679|NCT01293006|5906619|P2|COMPLETED|Period 1||2
2407680|NCT01293006|5906620|P1|COMPLETED|Period 1||11
2407681|NCT01293006|5906617|P4|STARTED|Period 1||3
2407682|NCT01293006|5906618|P3|STARTED|Period 1||9
2407683|NCT01293006|5906619|P2|STARTED|Period 1||2
2407684|NCT01293006|5906620|P1|STARTED|Period 1||11
2407685|NCT01292928|5906641|P1|NOT COMPLETED|Overall Study||24
2407686|NCT01292928|5906641|P1|COMPLETED|Overall Study||275
2407687|NCT01292928|5906641|P1|Completed 12-Month Clinical Follow-up|Overall Study||266
2407688|NCT01292928|5906641|P1|STARTED|Overall Study||299
2407689|NCT01292876|5906658|P1|NOT COMPLETED|Overall Study||4
2407690|NCT01292876|5906658|P1|COMPLETED|Overall Study||13
2407691|NCT01292876|5906658|P1|STARTED|Overall Study||17
2407692|NCT01292837|5906664|P1|NOT COMPLETED|Overall Study||2
2407693|NCT01292837|5906664|P1|COMPLETED|Overall Study||11
2407694|NCT01292837|5906664|P1|STARTED|Overall Study||13
2407695|NCT01292798|5906673|P1|NOT COMPLETED|Overall Study||0
2407696|NCT01292798|5906673|P1|COMPLETED|Overall Study||43
2407697|NCT01292798|5906673|P1|Persistent DME After 3 Months|Overall Study|Subjects with persistent DME after 3 monthly injections of 0.5 mg of ranibizumab|29
2407698|NCT01292798|5906673|P1|STARTED|Overall Study||43
2407699|NCT01292746|5906679|P1|NOT COMPLETED|Overall Study||0
2407700|NCT01292746|5906679|P1|COMPLETED|Overall Study||14
2407701|NCT01292746|5906679|P1|STARTED|Overall Study||14
2407702|NCT01292642|5906683|P1|NOT COMPLETED|Overall Study||5
2407703|NCT01292642|5906683|P1|COMPLETED|Overall Study||7
2407704|NCT01292642|5906683|P1|STARTED|Overall Study||12
2407705|NCT01292629|5906691|P1|NOT COMPLETED|Overall Study||0
2407706|NCT01292629|5906691|P1|COMPLETED|Overall Study||125
2407707|NCT01292629|5906691|P1|STARTED|Overall Study||125
2407708|NCT01292603|5906701|P6|NOT COMPLETED|Overall Survival Status||10
2407709|NCT01292603|5906702|P5|NOT COMPLETED|Overall Survival Status||16
2407710|NCT01292603|5906703|P4|NOT COMPLETED|Overall Survival Status||1
2407711|NCT01292603|5906704|P3|NOT COMPLETED|Overall Survival Status||3
2407712|NCT01292603|5906705|P2|NOT COMPLETED|Overall Survival Status||1
2407713|NCT01292603|5906706|P1|NOT COMPLETED|Overall Survival Status||3
2407714|NCT01292603|5906701|P6|COMPLETED|Overall Survival Status||78
2407715|NCT01292603|5906702|P5|COMPLETED|Overall Survival Status||72
2407716|NCT01292603|5906703|P4|COMPLETED|Overall Survival Status||7
2407717|NCT01292603|5906704|P3|COMPLETED|Overall Survival Status||20
2407718|NCT01292603|5906705|P2|COMPLETED|Overall Survival Status||16
2407719|NCT01292603|5906706|P1|COMPLETED|Overall Survival Status||13
2407720|NCT01292603|5906701|P6|STARTED|Overall Survival Status||88
2407721|NCT01292603|5906702|P5|STARTED|Overall Survival Status||88
2407722|NCT01292603|5906703|P4|STARTED|Overall Survival Status||8
2407723|NCT01292603|5906704|P3|STARTED|Overall Survival Status||23
2407724|NCT01292603|5906705|P2|STARTED|Overall Survival Status||17
2407725|NCT01292603|5906706|P1|STARTED|Overall Survival Status||16
2407726|NCT01292603|5906701|P6|NOT COMPLETED|Part 2: Regular Follow-Up||12
2407727|NCT01292603|5906702|P5|NOT COMPLETED|Part 2: Regular Follow-Up||19
2407728|NCT01292603|5906703|P4|NOT COMPLETED|Part 2: Regular Follow-Up||0
2407729|NCT01292603|5906704|P3|NOT COMPLETED|Part 2: Regular Follow-Up||0
2407730|NCT01292603|5906705|P2|NOT COMPLETED|Part 2: Regular Follow-Up||0
2407731|NCT01292603|5906706|P1|NOT COMPLETED|Part 2: Regular Follow-Up||0
2407732|NCT01292603|5906701|P6|COMPLETED|Part 2: Regular Follow-Up||75
2407733|NCT01292603|5906702|P5|COMPLETED|Part 2: Regular Follow-Up||68
2407734|NCT01292603|5906703|P4|COMPLETED|Part 2: Regular Follow-Up||0
2407735|NCT01292603|5906704|P3|COMPLETED|Part 2: Regular Follow-Up||0
2407736|NCT01292603|5906705|P2|COMPLETED|Part 2: Regular Follow-Up||0
2407737|NCT01292603|5906706|P1|COMPLETED|Part 2: Regular Follow-Up||0
2407738|NCT01292603|5906701|P6|STARTED|Part 2: Regular Follow-Up|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|87
2407739|NCT01292603|5906702|P5|STARTED|Part 2: Regular Follow-Up|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|87
2407740|NCT01292603|5906703|P4|STARTED|Part 2: Regular Follow-Up||0
2407741|NCT01292603|5906704|P3|STARTED|Part 2: Regular Follow-Up||0
2407742|NCT01292603|5906705|P2|STARTED|Part 2: Regular Follow-Up||0
2407743|NCT01292603|5906706|P1|STARTED|Part 2: Regular Follow-Up||0
2407744|NCT01292603|5906701|P6|NOT COMPLETED|Part 2: Dose Confirmation Period||15
2407745|NCT01292603|5906702|P5|NOT COMPLETED|Part 2: Dose Confirmation Period||16
2407746|NCT01292603|5906703|P4|NOT COMPLETED|Part 2: Dose Confirmation Period||0
2407747|NCT01292603|5906704|P3|NOT COMPLETED|Part 2: Dose Confirmation Period||0
2407748|NCT01292603|5906705|P2|NOT COMPLETED|Part 2: Dose Confirmation Period||0
2407749|NCT01292603|5906706|P1|NOT COMPLETED|Part 2: Dose Confirmation Period||0
2407750|NCT01292603|5906701|P6|COMPLETED|Part 2: Dose Confirmation Period||73
2407751|NCT01292603|5906702|P5|COMPLETED|Part 2: Dose Confirmation Period||72
2407752|NCT01292603|5906703|P4|COMPLETED|Part 2: Dose Confirmation Period||0
2407753|NCT01292603|5906704|P3|COMPLETED|Part 2: Dose Confirmation Period||0
2407754|NCT01292603|5906705|P2|COMPLETED|Part 2: Dose Confirmation Period||0
2407755|NCT01292603|5906706|P1|COMPLETED|Part 2: Dose Confirmation Period||0
2407756|NCT01292603|5906701|P6|STARTED|Part 2: Dose Confirmation Period||88
2407757|NCT01292603|5906702|P5|STARTED|Part 2: Dose Confirmation Period||88
2407758|NCT01292603|5906703|P4|STARTED|Part 2: Dose Confirmation Period||0
2407759|NCT01292603|5906704|P3|STARTED|Part 2: Dose Confirmation Period||0
2407760|NCT01292603|5906705|P2|STARTED|Part 2: Dose Confirmation Period||0
2407761|NCT01292603|5906706|P1|STARTED|Part 2: Dose Confirmation Period||0
2407762|NCT01292603|5906701|P6|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
2407763|NCT01292603|5906702|P5|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
2407764|NCT01292603|5906703|P4|NOT COMPLETED|Part 1: Regular Follow-Up Period||1
2407765|NCT01292603|5906704|P3|NOT COMPLETED|Part 1: Regular Follow-Up Period||6
2407766|NCT01292603|5906705|P2|NOT COMPLETED|Part 1: Regular Follow-Up Period||7
2407767|NCT01292603|5906706|P1|NOT COMPLETED|Part 1: Regular Follow-Up Period||6
2407768|NCT01292603|5906701|P6|COMPLETED|Part 1: Regular Follow-Up Period||0
2407769|NCT01292603|5906702|P5|COMPLETED|Part 1: Regular Follow-Up Period||0
2407770|NCT01292603|5906703|P4|COMPLETED|Part 1: Regular Follow-Up Period||7
2407771|NCT01292603|5906704|P3|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|17
2407772|NCT01292603|5906705|P2|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|10
2407773|NCT01292603|5906706|P1|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|10
2407774|NCT01292603|5906701|P6|STARTED|Part 1: Regular Follow-Up Period||0
2407775|NCT01292603|5906702|P5|STARTED|Part 1: Regular Follow-Up Period||0
2407776|NCT01292603|5906703|P4|STARTED|Part 1: Regular Follow-Up Period||8
2407777|NCT01292603|5906704|P3|STARTED|Part 1: Regular Follow-Up Period||23
2407778|NCT01292603|5906705|P2|STARTED|Part 1: Regular Follow-Up Period||17
2407779|NCT01292603|5906706|P1|STARTED|Part 1: Regular Follow-Up Period||16
2407780|NCT01292603|5906701|P6|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
2407781|NCT01292603|5906702|P5|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
2407782|NCT01292603|5906703|P4|NOT COMPLETED|Part 1: Pilot Dose Selection Period||8
2407783|NCT01292603|5906704|P3|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
2407784|NCT01292603|5906705|P2|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
2407785|NCT01292603|5906706|P1|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
2407786|NCT01292603|5906701|P6|COMPLETED|Part 1: Pilot Dose Selection Period||0
2407787|NCT01292603|5906702|P5|COMPLETED|Part 1: Pilot Dose Selection Period||0
2407788|NCT01292603|5906703|P4|COMPLETED|Part 1: Pilot Dose Selection Period||0
2407789|NCT01292603|5906704|P3|COMPLETED|Part 1: Pilot Dose Selection Period||23
2407790|NCT01292603|5906705|P2|COMPLETED|Part 1: Pilot Dose Selection Period||17
2407791|NCT01292603|5906706|P1|COMPLETED|Part 1: Pilot Dose Selection Period||16
2407792|NCT01292603|5906701|P6|STARTED|Part 1: Pilot Dose Selection Period||0
2407793|NCT01292603|5906702|P5|STARTED|Part 1: Pilot Dose Selection Period||0
2407794|NCT01292603|5906703|P4|STARTED|Part 1: Pilot Dose Selection Period|These participants were withdrawn prior to SC treatment.|8
2407795|NCT01292603|5906704|P3|STARTED|Part 1: Pilot Dose Selection Period|1 participant received a dose of 1000mg of rituximab by oversight.|23
2407796|NCT01292603|5906705|P2|STARTED|Part 1: Pilot Dose Selection Period||17
2407797|NCT01292603|5906706|P1|STARTED|Part 1: Pilot Dose Selection Period||16
2407798|NCT01292538|5906752|P2|NOT COMPLETED|Overall Study||0
2407799|NCT01292538|5906753|P1|NOT COMPLETED|Overall Study||0
2407800|NCT01292538|5906752|P2|COMPLETED|Overall Study||32
2407801|NCT01292538|5906753|P1|COMPLETED|Overall Study||35
2407802|NCT01292538|5906752|P2|STARTED|Overall Study||32
2407803|NCT01292538|5906753|P1|STARTED|Overall Study||35
2407804|NCT01292486|5906759|P1|NOT COMPLETED|Overall Study||6
2407805|NCT01292486|5906759|P1|COMPLETED|Overall Study||26
2407806|NCT01292486|5906759|P1|STARTED|Overall Study||32
2407807|NCT01292473|5906773|P4|NOT COMPLETED|Overall Study||12
2407808|NCT01292473|5906774|P3|NOT COMPLETED|Overall Study||9
2407809|NCT01292473|5906775|P2|NOT COMPLETED|Overall Study||7
2407810|NCT01292473|5906776|P1|NOT COMPLETED|Overall Study||5
2407811|NCT01292473|5906773|P4|COMPLETED|Overall Study||67
2407812|NCT01292473|5906774|P3|COMPLETED|Overall Study||74
2407813|NCT01292473|5906775|P2|COMPLETED|Overall Study||75
2407814|NCT01292473|5906776|P1|COMPLETED|Overall Study||74
2407815|NCT01292473|5906773|P4|STARTED|Overall Study||79
2407816|NCT01292473|5906774|P3|STARTED|Overall Study||83
2407817|NCT01292473|5906775|P2|STARTED|Overall Study||82
2407818|NCT01292473|5906776|P1|STARTED|Overall Study||79
2407819|NCT01292304|5906818|P1|NOT COMPLETED|Overall Study||0
2407820|NCT01292304|5906818|P1|COMPLETED|Overall Study||10
2407821|NCT01292304|5906818|P1|STARTED|Overall Study||10
2407822|NCT01292265|5906826|P1|NOT COMPLETED|Overall Study||0
2407823|NCT01292265|5906826|P1|COMPLETED|Overall Study||3
2407824|NCT01292265|5906826|P1|STARTED|Overall Study||3
2407825|NCT01292239|5906835|P2|NOT COMPLETED|Overall Study||7
2407826|NCT01292239|5906836|P1|NOT COMPLETED|Overall Study||4
2407827|NCT01292239|5906835|P2|COMPLETED|Overall Study||53
2407828|NCT01292239|5906836|P1|COMPLETED|Overall Study||119
2407829|NCT01292239|5906835|P2|STARTED|Overall Study||60
2407830|NCT01292239|5906836|P1|STARTED|Overall Study||123
2407831|NCT01292226|5906857|P1|NOT COMPLETED|Overall Study||13
2407832|NCT01292226|5906857|P1|COMPLETED|Overall Study||32
2407833|NCT01292226|5906857|P1|STARTED|Overall Study||45
2407834|NCT01292187|5906890|P2|NOT COMPLETED|Overall Study||13
2407835|NCT01292187|5906891|P1|NOT COMPLETED|Overall Study||17
2407836|NCT01292187|5906890|P2|COMPLETED|Overall Study||30
2407837|NCT01292187|5906891|P1|COMPLETED|Overall Study||69
2407838|NCT01292187|5906890|P2|STARTED|Overall Study||43
2407839|NCT01292187|5906891|P1|STARTED|Overall Study||86
2407840|NCT01292135|5906901|P2|NOT COMPLETED|Overall Study||9
2407841|NCT01292135|5906902|P1|NOT COMPLETED|Overall Study||0
2407842|NCT01292135|5906901|P2|COMPLETED|Overall Study||21
2407843|NCT01292135|5906902|P1|COMPLETED|Overall Study||3
2407844|NCT01292135|5906901|P2|STARTED|Overall Study||30
2407845|NCT01292135|5906902|P1|STARTED|Overall Study||3
2407846|NCT01292070|5906920|P1|NOT COMPLETED|Overall Study||0
2407847|NCT01292070|5906920|P1|COMPLETED|Overall Study||4
2407848|NCT01292070|5906920|P1|STARTED|Overall Study||4
2407849|NCT01292057|5906926|P2|NOT COMPLETED|Overall Study||2
2407850|NCT01292057|5906927|P1|NOT COMPLETED|Overall Study||2
2407851|NCT01292057|5906926|P2|COMPLETED|Overall Study||48
2407852|NCT01292057|5906927|P1|COMPLETED|Overall Study||47
2407853|NCT01292057|5906926|P2|STARTED|Overall Study||50
2407854|NCT01292057|5906927|P1|STARTED|Overall Study||49
2407855|NCT01292005|5906937|P2|NOT COMPLETED|Overall Study||0
2407856|NCT01292005|5906938|P1|NOT COMPLETED|Overall Study||0
2407857|NCT01292005|5906937|P2|COMPLETED|Overall Study||14
2407858|NCT01292005|5906938|P1|COMPLETED|Overall Study||14
2407859|NCT01292005|5906937|P2|STARTED|Overall Study||14
2407860|NCT01292005|5906938|P1|STARTED|Overall Study||14
2407861|NCT01291836|5906962|P2|NOT COMPLETED|Overall Study||0
2407862|NCT01291836|5906963|P1|NOT COMPLETED|Overall Study||0
2407863|NCT01291836|5906962|P2|COMPLETED|Overall Study||71
2407864|NCT01291836|5906963|P1|COMPLETED|Overall Study||930
2407865|NCT01291836|5906962|P2|STARTED|Overall Study||71
2407866|NCT01291836|5906963|P1|STARTED|Overall Study||930
2407867|NCT01291784|5906969|P3|NOT COMPLETED|Overall Study||0
2407868|NCT01291784|5906970|P2|NOT COMPLETED|Overall Study||1
2407869|NCT01291784|5906971|P1|NOT COMPLETED|Overall Study||0
2407870|NCT01291784|5906969|P3|COMPLETED|Overall Study||1
2407871|NCT01291784|5906970|P2|COMPLETED|Overall Study||0
2407872|NCT01291784|5906971|P1|COMPLETED|Overall Study||1
2407873|NCT01291784|5906969|P3|STARTED|Overall Study||1
2407874|NCT01291784|5906970|P2|STARTED|Overall Study||1
2407875|NCT01291784|5906971|P1|STARTED|Overall Study||1
2407876|NCT01291498|5906991|P1|NOT COMPLETED|Overall Study||1
2407877|NCT01291498|5906991|P1|COMPLETED|Overall Study||0
2407878|NCT01291498|5906991|P1|STARTED|Overall Study||1
2407879|NCT01291277|5906999|P2|NOT COMPLETED|Overall Study||3
2407880|NCT01291277|5907000|P1|NOT COMPLETED|Overall Study||5
2407881|NCT01291277|5906999|P2|COMPLETED|Overall Study||42
2407882|NCT01291277|5907000|P1|COMPLETED|Overall Study||40
2407883|NCT01291277|5906999|P2|STARTED|Overall Study||45
2407884|NCT01291277|5907000|P1|STARTED|Overall Study||45
2407885|NCT01291264|5907006|P1|NOT COMPLETED|Overall Study||0
2407886|NCT01291264|5907006|P1|COMPLETED|Overall Study||260
2407887|NCT01291264|5907006|P1|STARTED|Overall Study||260
2407888|NCT01291225|5907012|P2|NOT COMPLETED|Overall Study||39
2407889|NCT01291225|5907013|P1|NOT COMPLETED|Overall Study||85
2407890|NCT01291225|5907012|P2|COMPLETED|Overall Study||121
2407891|NCT01291225|5907013|P1|COMPLETED|Overall Study||66
2407892|NCT01291225|5907012|P2|STARTED|Overall Study||160
2407893|NCT01291225|5907013|P1|STARTED|Overall Study||151
2407894|NCT01291173|5907027|P4|NOT COMPLETED|Overall Study||13
2407895|NCT01291173|5907028|P3|NOT COMPLETED|Overall Study||13
2407896|NCT01291173|5907029|P2|NOT COMPLETED|Overall Study||15
2407897|NCT01291173|5907030|P1|NOT COMPLETED|Overall Study||17
2407898|NCT01291173|5907027|P4|COMPLETED|Overall Study||52
2407899|NCT01291173|5907028|P3|COMPLETED|Overall Study||52
2407900|NCT01291173|5907029|P2|COMPLETED|Overall Study||51
2407901|NCT01291173|5907030|P1|COMPLETED|Overall Study||47
2407902|NCT01291173|5907027|P4|STARTED|Overall Study||65
2407903|NCT01291173|5907028|P3|STARTED|Overall Study||65
2407904|NCT01291173|5907029|P2|STARTED|Overall Study||66
2407905|NCT01291173|5907030|P1|STARTED|Overall Study||64
2407906|NCT01291160|5907094|P2|NOT COMPLETED|Overall Study||16
2407907|NCT01291160|5907095|P1|NOT COMPLETED|Overall Study||18
2407908|NCT01291160|5907094|P2|COMPLETED|Overall Study||48
2407909|NCT01291160|5907095|P1|COMPLETED|Overall Study||48
2407910|NCT01291160|5907094|P2|STARTED|Overall Study||64
2407911|NCT01291160|5907095|P1|STARTED|Overall Study||66
2407912|NCT01291108|5907105|P6|NOT COMPLETED|Month 2 (Adjunctive Therapy)||1
2407913|NCT01291108|5907106|P5|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
2407914|NCT01291108|5907107|P4|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
2407915|NCT01291108|5907108|P3|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
2407916|NCT01291108|5907109|P2|NOT COMPLETED|Month 2 (Adjunctive Therapy)||2
2407917|NCT01291108|5907110|P1|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
2407918|NCT01291108|5907105|P6|COMPLETED|Month 2 (Adjunctive Therapy)||25
2407919|NCT01291108|5907106|P5|COMPLETED|Month 2 (Adjunctive Therapy)||34
2407920|NCT01291108|5907107|P4|COMPLETED|Month 2 (Adjunctive Therapy)||0
2407921|NCT01291108|5907108|P3|COMPLETED|Month 2 (Adjunctive Therapy)||24
2407922|NCT01291108|5907109|P2|COMPLETED|Month 2 (Adjunctive Therapy)||38
2407923|NCT01291108|5907110|P1|COMPLETED|Month 2 (Adjunctive Therapy)||0
2407924|NCT01291108|5907105|P6|STARTED|Month 2 (Adjunctive Therapy)||26
2407925|NCT01291108|5907106|P5|STARTED|Month 2 (Adjunctive Therapy)||34
2407926|NCT01291108|5907107|P4|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
2407927|NCT01291108|5907108|P3|STARTED|Month 2 (Adjunctive Therapy)||24
2407928|NCT01291108|5907109|P2|STARTED|Month 2 (Adjunctive Therapy)||40
2407929|NCT01291108|5907110|P1|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
2407930|NCT01291108|5907105|P6|NOT COMPLETED|Month 1 (Monotherapy)||0
2407931|NCT01291108|5907106|P5|NOT COMPLETED|Month 1 (Monotherapy)||0
2407932|NCT01291108|5907107|P4|NOT COMPLETED|Month 1 (Monotherapy)||0
2407933|NCT01291108|5907108|P3|NOT COMPLETED|Month 1 (Monotherapy)||0
2407934|NCT01291108|5907109|P2|NOT COMPLETED|Month 1 (Monotherapy)||0
2407935|NCT01291108|5907110|P1|NOT COMPLETED|Month 1 (Monotherapy)||1
2407936|NCT01291108|5907105|P6|COMPLETED|Month 1 (Monotherapy)||0
2407937|NCT01291108|5907106|P5|COMPLETED|Month 1 (Monotherapy)||0
2407938|NCT01291108|5907107|P4|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|60
2407939|NCT01291108|5907108|P3|COMPLETED|Month 1 (Monotherapy)||0
2407940|NCT01291108|5907109|P2|COMPLETED|Month 1 (Monotherapy)||0
2407941|NCT01291108|5907110|P1|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|64
2407942|NCT01291108|5907105|P6|STARTED|Month 1 (Monotherapy)||0
2407943|NCT01291108|5907106|P5|STARTED|Month 1 (Monotherapy)||0
2407944|NCT01291108|5907107|P4|STARTED|Month 1 (Monotherapy)||60
2407945|NCT01291108|5907108|P3|STARTED|Month 1 (Monotherapy)||0
2407946|NCT01291108|5907109|P2|STARTED|Month 1 (Monotherapy)||0
2407947|NCT01291108|5907110|P1|STARTED|Month 1 (Monotherapy)||65
2407948|NCT01291056|5907126|P2|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
2407949|NCT01291056|5907127|P1|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
2407950|NCT01291056|5907126|P2|COMPLETED|Intervention Two (Menstration Days 3-7)||10
2407951|NCT01291056|5907127|P1|COMPLETED|Intervention Two (Menstration Days 3-7)||10
2407952|NCT01291056|5907126|P2|STARTED|Intervention Two (Menstration Days 3-7)||10
2407953|NCT01291056|5907127|P1|STARTED|Intervention Two (Menstration Days 3-7)||10
2407954|NCT01291056|5907126|P2|NOT COMPLETED|Washout||0
2407955|NCT01291056|5907127|P1|NOT COMPLETED|Washout||0
2407956|NCT01291056|5907126|P2|COMPLETED|Washout||10
2407957|NCT01291056|5907127|P1|COMPLETED|Washout||10
2407958|NCT01291056|5907126|P2|STARTED|Washout||10
2407959|NCT01291056|5907127|P1|STARTED|Washout||10
2407960|NCT01291056|5907126|P2|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
2407961|NCT01291056|5907127|P1|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
2407962|NCT01291056|5907126|P2|COMPLETED|Intervention One (Menstraution Day 3-7)||10
2407963|NCT01291056|5907127|P1|COMPLETED|Intervention One (Menstraution Day 3-7)||10
2407964|NCT01291056|5907126|P2|STARTED|Intervention One (Menstraution Day 3-7)||10
2407965|NCT01291056|5907127|P1|STARTED|Intervention One (Menstraution Day 3-7)||10
2407966|NCT01291017|5907139|P1|NOT COMPLETED|Overall Study||5
2407967|NCT01291017|5907139|P1|COMPLETED|Overall Study||14
2407968|NCT01291017|5907139|P1|STARTED|Overall Study||19
2407969|NCT01290978|5907147|P1|NOT COMPLETED|Overall Study||0
2407970|NCT01290978|5907147|P1|COMPLETED|Overall Study||22
2407971|NCT01290978|5907147|P1|STARTED|Overall Study||22
2407972|NCT01290952|5907156|P2|NOT COMPLETED|Overall Study||14
2407973|NCT01290952|5907157|P1|NOT COMPLETED|Overall Study||12
2407974|NCT01290952|5907156|P2|COMPLETED|Overall Study||193
2407975|NCT01290952|5907157|P1|COMPLETED|Overall Study||192
2407976|NCT01290952|5907156|P2|STARTED|Overall Study||207
2407977|NCT01290952|5907157|P1|STARTED|Overall Study||204
2407978|NCT01290913|5907165|P1|NOT COMPLETED|Overall Study||1
2407979|NCT01290913|5907165|P1|COMPLETED|Overall Study||12
2407980|NCT01290913|5907165|P1|STARTED|Overall Study||13
2407981|NCT01290887|5907172|P2|NOT COMPLETED|Overall Study||536
2407982|NCT01290887|5907173|P1|NOT COMPLETED|Overall Study||466
2407983|NCT01290887|5907172|P2|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|35
2407984|NCT01290887|5907173|P1|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|15
2407985|NCT01290887|5907172|P2|Safety Analysis Set|Overall Study||571
2407986|NCT01290887|5907173|P1|Safety Analysis Set|Overall Study|One patient was enrolled but not treated.|480
2407987|NCT01290887|5907172|P2|STARTED|Overall Study||571
2407988|NCT01290887|5907173|P1|STARTED|Overall Study||481
2407989|NCT01290874|5907213|P2|NOT COMPLETED|Overall Study||404
2407990|NCT01290874|5907214|P1|NOT COMPLETED|Overall Study||410
2407991|NCT01290874|5907213|P2|COMPLETED|Overall Study||134
2407992|NCT01290874|5907214|P1|COMPLETED|Overall Study||122
2407993|NCT01290874|5907213|P2|STARTED|Overall Study||538
2407994|NCT01290874|5907214|P1|STARTED|Overall Study||532
2407995|NCT01290822|5907234|P1|NOT COMPLETED|Overall Study||11
2407996|NCT01290822|5907234|P1|COMPLETED|Overall Study||1
2407997|NCT01290822|5907234|P1|STARTED|Overall Study||12
2407998|NCT01290796|5907243|P1|NOT COMPLETED|Overall Study||30
2407999|NCT01290796|5907243|P1|COMPLETED|Overall Study||123
2408000|NCT01290796|5907243|P1|STARTED|Overall Study||153
2408001|NCT01290757|5907259|P2|NOT COMPLETED|Overall Study||2
2408002|NCT01290757|5907260|P1|NOT COMPLETED|Overall Study||2
2408003|NCT01290757|5907259|P2|COMPLETED|Overall Study||88
2408004|NCT01290757|5907260|P1|COMPLETED|Overall Study||88
2408005|NCT01290757|5907259|P2|STARTED|Overall Study||90
2408006|NCT01290757|5907260|P1|STARTED|Overall Study||90
2408007|NCT01290731|5907276|P1|NOT COMPLETED|Overall Study||1
2408008|NCT01290731|5907276|P1|COMPLETED|Overall Study||48
2408009|NCT01290731|5907276|P1|STARTED|Overall Study||49
2408010|NCT01290718|5907288|P1|NOT COMPLETED|Overall Study||4
2408011|NCT01290718|5907288|P1|COMPLETED|Overall Study||0
2408012|NCT01290718|5907288|P1|STARTED|Overall Study||4
2408013|NCT01290679|5907297|P2|NOT COMPLETED|Overall Study||21
2408014|NCT01290679|5907298|P1|NOT COMPLETED|Overall Study||16
2408015|NCT01290679|5907297|P2|COMPLETED|Overall Study||113
2408016|NCT01290679|5907298|P1|COMPLETED|Overall Study||241
2408017|NCT01290679|5907297|P2|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|134
2408018|NCT01290679|5907298|P1|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|257
2408019|NCT01290666|5907367|P1|NOT COMPLETED|Overall Study||38
2408020|NCT01290666|5907367|P1|COMPLETED|Overall Study||55
2408021|NCT01290666|5907367|P1|STARTED|Overall Study||93
2408022|NCT01290640|5907373|P2|NOT COMPLETED|Overall Study||0
2408023|NCT01290640|5907374|P1|NOT COMPLETED|Overall Study||0
2408024|NCT01290640|5907373|P2|COMPLETED|Overall Study||10
2408025|NCT01290640|5907374|P1|COMPLETED|Overall Study||12
2408026|NCT01290640|5907373|P2|STARTED|Overall Study||10
2408027|NCT01290640|5907374|P1|STARTED|Overall Study||12
2408028|NCT01290627|5907385|P3|NOT COMPLETED|Overall Study||0
2408029|NCT01290627|5907386|P2|NOT COMPLETED|Overall Study||0
2408030|NCT01290627|5907387|P1|NOT COMPLETED|Overall Study||0
2408031|NCT01290627|5907385|P3|COMPLETED|Overall Study||10
2408032|NCT01290627|5907386|P2|COMPLETED|Overall Study||10
2408033|NCT01290627|5907387|P1|COMPLETED|Overall Study||10
2408034|NCT01290627|5907385|P3|STARTED|Overall Study||10
2408035|NCT01290627|5907386|P2|STARTED|Overall Study||10
2408036|NCT01290627|5907387|P1|STARTED|Overall Study||10
2408037|NCT01290614|5907409|P2|NOT COMPLETED|Overall Study||0
2408038|NCT01290614|5907410|P1|NOT COMPLETED|Overall Study||552
2408039|NCT01290614|5907409|P2|COMPLETED|Overall Study||1129
2408040|NCT01290614|5907410|P1|COMPLETED|Overall Study||518
2408041|NCT01290614|5907409|P2|STARTED|Overall Study||1129
2408042|NCT01290614|5907410|P1|STARTED|Overall Study||1070
2408043|NCT01290601|5907420|P4|NOT COMPLETED|Overall Study||0
2408044|NCT01290601|5907421|P3|NOT COMPLETED|Overall Study||0
2408045|NCT01290601|5907422|P2|NOT COMPLETED|Overall Study||5
2408046|NCT01290601|5907423|P1|NOT COMPLETED|Overall Study||11
2408047|NCT01290601|5907420|P4|COMPLETED|Overall Study||0
2408048|NCT01290601|5907421|P3|COMPLETED|Overall Study||0
2408049|NCT01290601|5907422|P2|COMPLETED|Overall Study||19
2408050|NCT01290601|5907423|P1|COMPLETED|Overall Study||35
2408051|NCT01290601|5907420|P4|STARTED|Overall Study||0
2408052|NCT01290601|5907421|P3|STARTED|Overall Study||0
2408053|NCT01290601|5907422|P2|STARTED|Overall Study||24
2408054|NCT01290601|5907423|P1|STARTED|Overall Study||46
2408055|NCT01290536|5907437|P1|NOT COMPLETED|Overall Study||0
2408056|NCT01290536|5907437|P1|COMPLETED|Overall Study||42
2408057|NCT01290536|5907437|P1|STARTED|Overall Study||42
2408058|NCT01290523|5907444|P1|NOT COMPLETED|Overall Study||3
2408059|NCT01290523|5907444|P1|COMPLETED|Overall Study||11
2408060|NCT01290523|5907444|P1|STARTED|Overall Study||14
2408061|NCT01290484|5907449|P1|NOT COMPLETED|Overall Study||0
2408062|NCT01290484|5907449|P1|COMPLETED|Overall Study||7
2408063|NCT01290484|5907449|P1|STARTED|Overall Study||7
2408064|NCT01290445|5907456|P3|NOT COMPLETED|Overall Study||0
2408065|NCT01290445|5907457|P2|NOT COMPLETED|Overall Study||0
2408066|NCT01290445|5907458|P1|NOT COMPLETED|Overall Study||0
2408067|NCT01290445|5907456|P3|COMPLETED|Overall Study||806438
2408068|NCT01290445|5907457|P2|COMPLETED|Overall Study||78412
2408069|NCT01290445|5907458|P1|COMPLETED|Overall Study||335
2408070|NCT01290445|5907456|P3|STARTED|Overall Study||806438
2408071|NCT01290445|5907457|P2|STARTED|Overall Study||78412
2408072|NCT01290445|5907458|P1|STARTED|Overall Study||335
2408073|NCT01290341|5907483|P2|NOT COMPLETED|Overall Study||29
2408074|NCT01290341|5907484|P1|NOT COMPLETED|Overall Study||92
2408075|NCT01290341|5907483|P2|COMPLETED|Overall Study||258
2408076|NCT01290341|5907484|P1|COMPLETED|Overall Study||481
2408077|NCT01290341|5907483|P2|STARTED|Overall Study||287
2408078|NCT01290341|5907484|P1|STARTED|Overall Study||573
2408079|NCT01290315|5907496|P4|NOT COMPLETED|Overall Study||5
2408080|NCT01290315|5907497|P3|NOT COMPLETED|Overall Study||0
2408081|NCT01290315|5907498|P2|NOT COMPLETED|Overall Study||3
2408082|NCT01290315|5907499|P1|NOT COMPLETED|Overall Study||3
2408083|NCT01290315|5907496|P4|COMPLETED|Overall Study||8
2408084|NCT01290315|5907497|P3|COMPLETED|Overall Study||10
2408085|NCT01290315|5907498|P2|COMPLETED|Overall Study||9
2408086|NCT01290315|5907499|P1|COMPLETED|Overall Study||11
2408087|NCT01290315|5907496|P4|STARTED|Overall Study||13
2408088|NCT01290315|5907497|P3|STARTED|Overall Study||10
2408089|NCT01290315|5907498|P2|STARTED|Overall Study||12
2408090|NCT01290315|5907499|P1|STARTED|Overall Study||14
2408091|NCT01290263|5907521|P5|NOT COMPLETED|Overall Study||37
2408092|NCT01290263|5907522|P4|NOT COMPLETED|Overall Study||27
2408093|NCT01290263|5907523|P3|NOT COMPLETED|Overall Study||7
2408094|NCT01290263|5907524|P2|NOT COMPLETED|Overall Study||3
2408095|NCT01290263|5907525|P1|NOT COMPLETED|Overall Study||11
2408096|NCT01290263|5907521|P5|COMPLETED|Overall Study||0
2408097|NCT01290263|5907522|P4|COMPLETED|Overall Study||0
2408098|NCT01290263|5907523|P3|COMPLETED|Overall Study||0
2408099|NCT01290263|5907524|P2|COMPLETED|Overall Study||0
2408100|NCT01290263|5907525|P1|COMPLETED|Overall Study||0
2408101|NCT01290263|5907521|P5|STARTED|Overall Study||37
2408102|NCT01290263|5907522|P4|STARTED|Overall Study||27
2408103|NCT01290263|5907523|P3|STARTED|Overall Study||7
2408104|NCT01290263|5907524|P2|STARTED|Overall Study||3
2408105|NCT01290263|5907525|P1|STARTED|Overall Study||11
2408106|NCT01290237|5907543|P2|NOT COMPLETED|Overall Study||2
2408107|NCT01290237|5907544|P1|NOT COMPLETED|Overall Study||11
2408108|NCT01290237|5907543|P2|COMPLETED|Overall Study||27
2408109|NCT01290237|5907544|P1|COMPLETED|Overall Study||19
2408110|NCT01290237|5907543|P2|STARTED|Overall Study||29
2408111|NCT01290237|5907544|P1|STARTED|Overall Study||30
2408112|NCT01290224|5907552|P1|NOT COMPLETED|Overall Study||5
2408113|NCT01290224|5907552|P1|COMPLETED|Overall Study||5
2408114|NCT01290224|5907552|P1|STARTED|Overall Study||10
2408115|NCT01290094|5907563|P1|NOT COMPLETED|Overall Study||6
2408116|NCT01290094|5907563|P1|COMPLETED|Overall Study||35
2408117|NCT01290094|5907563|P1|STARTED|Overall Study||41
2408118|NCT01290068|5907576|P2|NOT COMPLETED|Overall Study||6
2408119|NCT01290068|5907577|P1|NOT COMPLETED|Overall Study||7
2408120|NCT01290068|5907576|P2|COMPLETED|Overall Study||94
2408121|NCT01290068|5907577|P1|COMPLETED|Overall Study||101
2408122|NCT01290068|5907576|P2|Implanted|Overall Study||98
2408123|NCT01290068|5907577|P1|Implanted|Overall Study||108
2408124|NCT01290068|5907576|P2|STARTED|Overall Study||100
2408125|NCT01290068|5907577|P1|STARTED|Overall Study||108
2408126|NCT01290029|5907589|P1|NOT COMPLETED|Overall Study||2
2408127|NCT01290029|5907589|P1|COMPLETED|Overall Study||12
2408128|NCT01290029|5907589|P1|Received Study Treatment|Overall Study||12
2408129|NCT01290029|5907589|P1|STARTED|Overall Study||14
2408130|NCT01289990|5907615|P13|NOT COMPLETED|Overall Study||98
2408131|NCT01289990|5907616|P12|NOT COMPLETED|Overall Study||68
2408132|NCT01289990|5907617|P11|NOT COMPLETED|Overall Study||76
2408133|NCT01289990|5907618|P10|NOT COMPLETED|Overall Study||86
2408134|NCT01289990|5907619|P9|NOT COMPLETED|Overall Study||75
2408135|NCT01289990|5907620|P8|NOT COMPLETED|Overall Study||55
2408136|NCT01289990|5907621|P7|NOT COMPLETED|Overall Study||88
2408137|NCT01289990|5907622|P6|NOT COMPLETED|Overall Study||74
2408138|NCT01289990|5907623|P5|NOT COMPLETED|Overall Study||72
2408139|NCT01289990|5907624|P4|NOT COMPLETED|Overall Study||87
2408140|NCT01289990|5907625|P3|NOT COMPLETED|Overall Study||109
2408141|NCT01289990|5907626|P2|NOT COMPLETED|Overall Study||81
2408142|NCT01289990|5907627|P1|NOT COMPLETED|Overall Study||77
2408143|NCT01289990|5907615|P13|COMPLETED|Overall Study||127
2408144|NCT01289990|5907616|P12|COMPLETED|Overall Study||150
2408145|NCT01289990|5907617|P11|COMPLETED|Overall Study||150
2408146|NCT01289990|5907618|P10|COMPLETED|Overall Study||121
2408147|NCT01289990|5907619|P9|COMPLETED|Overall Study||139
2408148|NCT01289990|5907620|P8|COMPLETED|Overall Study||162
2408149|NCT01289990|5907621|P7|COMPLETED|Overall Study||78
2408150|NCT01289990|5907622|P6|COMPLETED|Overall Study||94
2408151|NCT01289990|5907623|P5|COMPLETED|Overall Study||93
2408152|NCT01289990|5907624|P4|COMPLETED|Overall Study||136
2408153|NCT01289990|5907625|P3|COMPLETED|Overall Study||119
2408154|NCT01289990|5907626|P2|COMPLETED|Overall Study||143
2408155|NCT01289990|5907627|P1|COMPLETED|Overall Study||147
2408156|NCT01289990|5907615|P13|STARTED|Overall Study||225
2408157|NCT01289990|5907616|P12|STARTED|Overall Study||218
2408158|NCT01289990|5907617|P11|STARTED|Overall Study||226
2408159|NCT01289990|5907618|P10|STARTED|Overall Study||207
2408160|NCT01289990|5907619|P9|STARTED|Overall Study||214
2408161|NCT01289990|5907620|P8|STARTED|Overall Study||217
2408162|NCT01289990|5907621|P7|STARTED|Overall Study||166
2408163|NCT01289990|5907622|P6|STARTED|Overall Study||168
2408164|NCT01289990|5907623|P5|STARTED|Overall Study||165
2408165|NCT01289990|5907624|P4|STARTED|Overall Study||223
2408166|NCT01289990|5907625|P3|STARTED|Overall Study||228
2408167|NCT01289990|5907626|P2|STARTED|Overall Study||224
2408168|NCT01289990|5907627|P1|STARTED|Overall Study||224
2408169|NCT01289912|5907813|P2|NOT COMPLETED|Overall Study||2
2408170|NCT01289912|5907814|P1|NOT COMPLETED|Overall Study||3
2408171|NCT01289912|5907813|P2|COMPLETED|Overall Study||13
2408172|NCT01289912|5907814|P1|COMPLETED|Overall Study||29
2408173|NCT01289912|5907813|P2|STARTED|Overall Study||15
2408174|NCT01289912|5907814|P1|STARTED|Overall Study||32
2408175|NCT01289847|5907844|P1|NOT COMPLETED|Overall Study||1
2408176|NCT01289847|5907844|P1|COMPLETED|Overall Study||24
2408177|NCT01289847|5907844|P1|STARTED|Overall Study||25
2408178|NCT01289821|5907853|P1|NOT COMPLETED|Survival Follow-up Period||18
2408179|NCT01289821|5907853|P1|COMPLETED|Survival Follow-up Period|34 participants died and completed survival follow-up period.|34
2408180|NCT01289821|5907853|P1|STARTED|Survival Follow-up Period||52
2408181|NCT01289821|5907853|P1|NOT COMPLETED|Safety Follow-up Period||5
2408182|NCT01289821|5907853|P1|COMPLETED|Safety Follow-up Period||49
2408183|NCT01289821|5907853|P1|STARTED|Safety Follow-up Period||54
2408184|NCT01289821|5907853|P1|NOT COMPLETED|Treatment Period||54
2408185|NCT01289821|5907853|P1|COMPLETED|Treatment Period||0
2408186|NCT01289821|5907853|P1|Participants Received Regorafenib|Treatment Period||54
2408187|NCT01289821|5907853|P1|STARTED|Treatment Period||54
2408188|NCT01289782|5907864|P2|NOT COMPLETED|Overall Study||12
2408189|NCT01289782|5907865|P1|NOT COMPLETED|Overall Study||25
2408190|NCT01289782|5907864|P2|COMPLETED|Overall Study||118
2408191|NCT01289782|5907865|P1|COMPLETED|Overall Study||239
2408192|NCT01289782|5907864|P2|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|130
2408193|NCT01289782|5907865|P1|STARTED|Overall Study||264
2408194|NCT01289678|5907934|P1|NOT COMPLETED|Overall Study||6
2408195|NCT01289678|5907934|P1|COMPLETED|Overall Study||12
2408196|NCT01289678|5907934|P1|STARTED|Overall Study||18
2408197|NCT01289639|5907941|P3|NOT COMPLETED|Overall Study||0
2408198|NCT01289639|5907942|P2|NOT COMPLETED|Overall Study||0
2408199|NCT01289639|5907943|P1|NOT COMPLETED|Overall Study||1
2408200|NCT01289639|5907941|P3|COMPLETED|Overall Study||0
2408201|NCT01289639|5907942|P2|COMPLETED|Overall Study||6
2408202|NCT01289639|5907943|P1|COMPLETED|Overall Study||4
2408203|NCT01289639|5907941|P3|STARTED|Overall Study||0
2408204|NCT01289639|5907942|P2|STARTED|Overall Study||6
2408205|NCT01289639|5907943|P1|STARTED|Overall Study||5
2408206|NCT01289574|5907969|P3|NOT COMPLETED|Overall Study||3
2408207|NCT01289574|5907970|P2|NOT COMPLETED|Overall Study||3
2408208|NCT01289574|5907971|P1|NOT COMPLETED|Overall Study||7
2408209|NCT01289574|5907969|P3|COMPLETED|Overall Study||60
2408210|NCT01289574|5907970|P2|COMPLETED|Overall Study||57
2408211|NCT01289574|5907971|P1|COMPLETED|Overall Study||51
2408212|NCT01289574|5907969|P3|STARTED|Overall Study||63
2408213|NCT01289574|5907970|P2|STARTED|Overall Study||60
2408214|NCT01289574|5907971|P1|STARTED|Overall Study||58
2408215|NCT01289548|5907988|P3|NOT COMPLETED|Overall Study||0
2408216|NCT01289548|5907989|P2|NOT COMPLETED|Overall Study||0
2408217|NCT01289548|5907990|P1|NOT COMPLETED|Overall Study||0
2408218|NCT01289548|5907988|P3|COMPLETED|Overall Study||40
2408219|NCT01289548|5907989|P2|COMPLETED|Overall Study||40
2408220|NCT01289548|5907990|P1|COMPLETED|Overall Study||40
2408221|NCT01289548|5907988|P3|Recipients|Overall Study||20
2408222|NCT01289548|5907989|P2|Recipients|Overall Study||20
2408223|NCT01289548|5907990|P1|Recipients|Overall Study||20
2408224|NCT01289548|5907988|P3|Donors|Overall Study||20
2408225|NCT01289548|5907989|P2|Donors|Overall Study||20
2408226|NCT01289548|5907990|P1|Donors|Overall Study||20
2408227|NCT01289548|5907988|P3|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
2408228|NCT01289548|5907989|P2|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
2408229|NCT01289548|5907990|P1|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
2408230|NCT01289522|5908034|P1|NOT COMPLETED|Overall Study||11
2408231|NCT01289522|5908034|P1|COMPLETED|Overall Study||43
2408232|NCT01289522|5908034|P1|STARTED|Overall Study||54
2408242|NCT01289418|5908065|P1|NOT COMPLETED|Day 29 Survey||2468
2408243|NCT01289418|5908065|P1|COMPLETED|Day 29 Survey||4057
2408244|NCT01289418|5908065|P1|STARTED|Day 29 Survey||6525
2408245|NCT01289418|5908065|P1|NOT COMPLETED|Day 8 Survey||2218
2408246|NCT01289418|5908065|P1|COMPLETED|Day 8 Survey||4307
2408247|NCT01289418|5908065|P1|STARTED|Day 8 Survey||6525
2408248|NCT01289392|5908074|P3|NOT COMPLETED|Overall Study||0
2408249|NCT01289392|5908075|P2|NOT COMPLETED|Overall Study||0
2408250|NCT01289392|5908076|P1|NOT COMPLETED|Overall Study||0
2408251|NCT01289392|5908074|P3|COMPLETED|Overall Study||7
2408252|NCT01289392|5908075|P2|COMPLETED|Overall Study||9
2408253|NCT01289392|5908076|P1|COMPLETED|Overall Study||9
2408254|NCT01289392|5908074|P3|STARTED|Overall Study||7
2408255|NCT01289392|5908075|P2|STARTED|Overall Study||9
2408256|NCT01289392|5908076|P1|STARTED|Overall Study||9
2408257|NCT01289275|5908088|P4|NOT COMPLETED|Overall Study||0
2408258|NCT01289275|5908089|P3|NOT COMPLETED|Overall Study||0
2408259|NCT01289275|5908090|P2|NOT COMPLETED|Overall Study||0
2408260|NCT01289275|5908091|P1|NOT COMPLETED|Overall Study||0
2408261|NCT01289275|5908088|P4|COMPLETED|Overall Study||316
2408262|NCT01289275|5908089|P3|COMPLETED|Overall Study||317
2408263|NCT01289275|5908090|P2|COMPLETED|Overall Study||320
2408264|NCT01289275|5908091|P1|COMPLETED|Overall Study||317
2408265|NCT01289275|5908088|P4|STARTED|Overall Study||316
2408266|NCT01289275|5908089|P3|STARTED|Overall Study||317
2408267|NCT01289275|5908090|P2|STARTED|Overall Study||320
2408268|NCT01289275|5908091|P1|STARTED|Overall Study||317
2408269|NCT01289210|5908113|P1|NOT COMPLETED|Overall Study||1
2408270|NCT01289210|5908113|P1|COMPLETED|Overall Study||1
2408271|NCT01289210|5908113|P1|STARTED|Overall Study||2
2408272|NCT01289119|5908123|P6|NOT COMPLETED|Overall Study||4
2408273|NCT01289119|5908124|P5|NOT COMPLETED|Overall Study||5
2408274|NCT01289119|5908125|P4|NOT COMPLETED|Overall Study||6
2408275|NCT01289119|5908126|P3|NOT COMPLETED|Overall Study||9
2408276|NCT01289119|5908127|P2|NOT COMPLETED|Overall Study||9
2408277|NCT01289119|5908128|P1|NOT COMPLETED|Overall Study||9
2408278|NCT01289119|5908123|P6|COMPLETED|Overall Study||57
2408279|NCT01289119|5908124|P5|COMPLETED|Overall Study||58
2408280|NCT01289119|5908125|P4|COMPLETED|Overall Study||93
2408281|NCT01289119|5908126|P3|COMPLETED|Overall Study||89
2408282|NCT01289119|5908127|P2|COMPLETED|Overall Study||83
2408283|NCT01289119|5908128|P1|COMPLETED|Overall Study||84
2408284|NCT01289119|5908123|P6|Treated|Overall Study||61
2408285|NCT01289119|5908124|P5|Treated|Overall Study||63
2408286|NCT01289119|5908125|P4|Treated|Overall Study||99
2408287|NCT01289119|5908126|P3|Treated|Overall Study||98
2408288|NCT01289119|5908127|P2|Treated|Overall Study||92
2408289|NCT01289119|5908128|P1|Treated|Overall Study|Patients who took at least one dose of double-blind study drug.|92
2408290|NCT01289119|5908123|P6|STARTED|Overall Study||61
2408291|NCT01289119|5908124|P5|STARTED|Overall Study||63
2408292|NCT01289119|5908125|P4|STARTED|Overall Study||99
2408293|NCT01289119|5908126|P3|STARTED|Overall Study||98
2408294|NCT01289119|5908127|P2|STARTED|Overall Study||92
2408295|NCT01289119|5908128|P1|STARTED|Overall Study||93
2408296|NCT01289080|5908210|P2|NOT COMPLETED|Overall Study||0
2408297|NCT01289080|5908211|P1|NOT COMPLETED|Overall Study||0
2408298|NCT01289080|5908210|P2|COMPLETED|Overall Study||10
2408299|NCT01289080|5908211|P1|COMPLETED|Overall Study||9
2408300|NCT01289080|5908210|P2|STARTED|Overall Study||10
2408301|NCT01289080|5908211|P1|STARTED|Overall Study||9
2408302|NCT01289067|5908242|P1|NOT COMPLETED|Overall Study||0
2408303|NCT01289067|5908242|P1|COMPLETED|Overall Study||13
2408304|NCT01289067|5908242|P1|STARTED|Overall Study||13
2408305|NCT01289041|5908249|P1|NOT COMPLETED|Overall Study||70
2408306|NCT01289041|5908249|P1|COMPLETED|Overall Study||0
2408307|NCT01289041|5908249|P1|STARTED|Overall Study||70
2408308|NCT01289028|5908261|P1|NOT COMPLETED|Overall Study||83
2408309|NCT01289028|5908261|P1|COMPLETED|Overall Study||42
2408310|NCT01289028|5908261|P1|STARTED|Overall Study||125
2408311|NCT01289015|5908275|P2|NOT COMPLETED|Overall Study||54
2408312|NCT01289015|5908276|P1|NOT COMPLETED|Overall Study||99
2408313|NCT01289015|5908275|P2|COMPLETED|Overall Study||230
2408314|NCT01289015|5908276|P1|COMPLETED|Overall Study||472
2408315|NCT01289015|5908275|P2|STARTED|Overall Study||284
2408316|NCT01289015|5908276|P1|STARTED|Overall Study||571
2408317|NCT01288989|5908289|P5|NOT COMPLETED|Overall Study||6
2408318|NCT01288989|5908290|P4|NOT COMPLETED|Overall Study||1
2408319|NCT01288989|5908291|P3|NOT COMPLETED|Overall Study||0
2408320|NCT01288989|5908292|P2|NOT COMPLETED|Overall Study||0
2408321|NCT01288989|5908293|P1|NOT COMPLETED|Overall Study||1
2408322|NCT01288989|5908289|P5|COMPLETED|Overall Study||15
2408323|NCT01288989|5908290|P4|COMPLETED|Overall Study||10
2408324|NCT01288989|5908291|P3|COMPLETED|Overall Study||3
2408325|NCT01288989|5908292|P2|COMPLETED|Overall Study||3
2408326|NCT01288989|5908293|P1|COMPLETED|Overall Study||5
2408327|NCT01288989|5908289|P5|Received at Least 1 Dose of Study Drug|Overall Study||21
2408328|NCT01288989|5908290|P4|Received at Least 1 Dose of Study Drug|Overall Study||11
2408329|NCT01288989|5908291|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
2408330|NCT01288989|5908292|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
2408331|NCT01288989|5908293|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
2408332|NCT01288989|5908289|P5|STARTED|Overall Study||21
2408333|NCT01288989|5908290|P4|STARTED|Overall Study||11
2408334|NCT01288989|5908291|P3|STARTED|Overall Study||3
2408335|NCT01288989|5908292|P2|STARTED|Overall Study||3
2408336|NCT01288989|5908293|P1|STARTED|Overall Study||6
2408337|NCT01288976|5908354|P3|NOT COMPLETED|Overall Study||20
2408338|NCT01288976|5908355|P2|NOT COMPLETED|Overall Study||27
2408339|NCT01288976|5908356|P1|NOT COMPLETED|Overall Study||178
2408340|NCT01288976|5908354|P3|COMPLETED|Overall Study||85
2408341|NCT01288976|5908355|P2|COMPLETED|Overall Study||22
2408342|NCT01288976|5908356|P1|COMPLETED|Overall Study||389
2408343|NCT01288976|5908354|P3|STARTED|Overall Study||105
2408344|NCT01288976|5908355|P2|STARTED|Overall Study||49
2408345|NCT01288976|5908356|P1|STARTED|Overall Study||567
2408346|NCT01288911|5908385|P2|NOT COMPLETED|Open-label Period (All Enzalutamide)||9
2408347|NCT01288911|5908386|P1|NOT COMPLETED|Open-label Period (All Enzalutamide)||42
2408348|NCT01288911|5908385|P2|COMPLETED|Open-label Period (All Enzalutamide)||0
2408349|NCT01288911|5908386|P1|COMPLETED|Open-label Period (All Enzalutamide)||0
2408350|NCT01288911|5908385|P2|Received Treatment|Open-label Period (All Enzalutamide)||9
2408351|NCT01288911|5908386|P1|Received Treatment|Open-label Period (All Enzalutamide)||42
2408352|NCT01288911|5908385|P2|STARTED|Open-label Period (All Enzalutamide)||9
2408353|NCT01288911|5908386|P1|STARTED|Open-label Period (All Enzalutamide)||42
2408354|NCT01288911|5908385|P2|NOT COMPLETED|Double-blind Period||182
2408355|NCT01288911|5908386|P1|NOT COMPLETED|Double-blind Period||142
2408356|NCT01288911|5908385|P2|COMPLETED|Double-blind Period|Indicates participants were still receiving treatment at the data cut-off date of 19 October 2014.|9
2408357|NCT01288911|5908386|P1|COMPLETED|Double-blind Period|Indicates participants were still receiving treatment at the data cut-off date of 19 October 2014.|42
2408358|NCT01288911|5908385|P2|Received Treatment|Double-blind Period||189
2408359|NCT01288911|5908386|P1|Received Treatment|Double-blind Period||183
2408360|NCT01288911|5908385|P2|STARTED|Double-blind Period||191
2408361|NCT01288911|5908386|P1|STARTED|Double-blind Period||184
2408362|NCT01288859|5908417|P6|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
2408363|NCT01288859|5908418|P5|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
2408364|NCT01288859|5908419|P4|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
2408365|NCT01288859|5908420|P3|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
2408366|NCT01288859|5908421|P2|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
2408367|NCT01288859|5908422|P1|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
2408368|NCT01288859|5908417|P6|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
2408369|NCT01288859|5908418|P5|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
2408370|NCT01288859|5908419|P4|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
2408371|NCT01288859|5908420|P3|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
2408372|NCT01288859|5908421|P2|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
2408373|NCT01288859|5908422|P1|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
2408374|NCT01288859|5908417|P6|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
2408375|NCT01288859|5908418|P5|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
2408376|NCT01288859|5908419|P4|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
2408377|NCT01288859|5908420|P3|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
2408378|NCT01288859|5908421|P2|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
2408379|NCT01288859|5908422|P1|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
2408380|NCT01288859|5908417|P6|NOT COMPLETED|Washout Period of 1 Week||0
2408381|NCT01288859|5908418|P5|NOT COMPLETED|Washout Period of 1 Week||0
2408382|NCT01288859|5908419|P4|NOT COMPLETED|Washout Period of 1 Week||0
2408383|NCT01288859|5908420|P3|NOT COMPLETED|Washout Period of 1 Week||0
2408384|NCT01288859|5908421|P2|NOT COMPLETED|Washout Period of 1 Week||0
2408385|NCT01288859|5908422|P1|NOT COMPLETED|Washout Period of 1 Week||0
2408386|NCT01288859|5908417|P6|COMPLETED|Washout Period of 1 Week||0
2408387|NCT01288859|5908418|P5|COMPLETED|Washout Period of 1 Week||5
2408388|NCT01288859|5908419|P4|COMPLETED|Washout Period of 1 Week||5
2408389|NCT01288859|5908420|P3|COMPLETED|Washout Period of 1 Week||0
2408390|NCT01288859|5908421|P2|COMPLETED|Washout Period of 1 Week||0
2408391|NCT01288859|5908422|P1|COMPLETED|Washout Period of 1 Week||0
2408392|NCT01288859|5908417|P6|STARTED|Washout Period of 1 Week||0
2408393|NCT01288859|5908418|P5|STARTED|Washout Period of 1 Week||5
2408394|NCT01288859|5908419|P4|STARTED|Washout Period of 1 Week||5
2408395|NCT01288859|5908420|P3|STARTED|Washout Period of 1 Week||0
2408396|NCT01288859|5908421|P2|STARTED|Washout Period of 1 Week||0
2408397|NCT01288859|5908422|P1|STARTED|Washout Period of 1 Week||0
2408398|NCT01288859|5908417|P6|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
2408399|NCT01288859|5908418|P5|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
2408400|NCT01288859|5908419|P4|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
2408401|NCT01288859|5908420|P3|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
2408402|NCT01288859|5908421|P2|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
2408403|NCT01288859|5908422|P1|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
2408404|NCT01288859|5908417|P6|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
2408405|NCT01288859|5908418|P5|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
2408406|NCT01288859|5908419|P4|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
2408407|NCT01288859|5908420|P3|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
2408408|NCT01288859|5908421|P2|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
2408409|NCT01288859|5908422|P1|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
2408410|NCT01288859|5908417|P6|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
2408411|NCT01288859|5908418|P5|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
2408412|NCT01288859|5908419|P4|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
2408413|NCT01288859|5908420|P3|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
2408414|NCT01288859|5908421|P2|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
2408415|NCT01288859|5908422|P1|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
2408416|NCT01288859|5908417|P6|NOT COMPLETED|Washout Period of 1 Week||0
2408417|NCT01288859|5908418|P5|NOT COMPLETED|Washout Period of 1 Week||0
2408418|NCT01288859|5908419|P4|NOT COMPLETED|Washout Period of 1 Week||0
2408419|NCT01288859|5908420|P3|NOT COMPLETED|Washout Period of 1 Week||0
2408420|NCT01288859|5908421|P2|NOT COMPLETED|Washout Period of 1 Week||0
2408421|NCT01288859|5908422|P1|NOT COMPLETED|Washout Period of 1 Week||0
2408422|NCT01288859|5908417|P6|COMPLETED|Washout Period of 1 Week||0
2408423|NCT01288859|5908418|P5|COMPLETED|Washout Period of 1 Week||5
2408424|NCT01288859|5908419|P4|COMPLETED|Washout Period of 1 Week||5
2408425|NCT01288859|5908420|P3|COMPLETED|Washout Period of 1 Week||0
2408426|NCT01288859|5908421|P2|COMPLETED|Washout Period of 1 Week||0
2408427|NCT01288859|5908422|P1|COMPLETED|Washout Period of 1 Week||0
2408428|NCT01288859|5908417|P6|STARTED|Washout Period of 1 Week||0
2408429|NCT01288859|5908418|P5|STARTED|Washout Period of 1 Week||5
2408430|NCT01288859|5908419|P4|STARTED|Washout Period of 1 Week||5
2408431|NCT01288859|5908420|P3|STARTED|Washout Period of 1 Week||0
2408432|NCT01288859|5908421|P2|STARTED|Washout Period of 1 Week||0
2408433|NCT01288859|5908422|P1|STARTED|Washout Period of 1 Week||0
2408434|NCT01288859|5908417|P6|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
2408435|NCT01288859|5908418|P5|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
2408436|NCT01288859|5908419|P4|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
2408437|NCT01288859|5908420|P3|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
2408438|NCT01288859|5908421|P2|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
2408439|NCT01288859|5908422|P1|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
2408440|NCT01288859|5908417|P6|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
2408441|NCT01288859|5908418|P5|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
2408442|NCT01288859|5908419|P4|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
2408443|NCT01288859|5908420|P3|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
2408444|NCT01288859|5908421|P2|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
2408445|NCT01288859|5908422|P1|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
2408446|NCT01288859|5908417|P6|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
2408447|NCT01288859|5908418|P5|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
2408448|NCT01288859|5908419|P4|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
2408449|NCT01288859|5908420|P3|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
2408450|NCT01288859|5908421|P2|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
2408451|NCT01288859|5908422|P1|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
2408452|NCT01288859|5908417|P6|NOT COMPLETED|Washout Period of 1 Week||0
2408453|NCT01288859|5908418|P5|NOT COMPLETED|Washout Period of 1 Week||0
2408454|NCT01288859|5908419|P4|NOT COMPLETED|Washout Period of 1 Week||0
2408455|NCT01288859|5908420|P3|NOT COMPLETED|Washout Period of 1 Week||0
2408456|NCT01288859|5908421|P2|NOT COMPLETED|Washout Period of 1 Week||0
2408457|NCT01288859|5908422|P1|NOT COMPLETED|Washout Period of 1 Week||0
2408458|NCT01288859|5908417|P6|COMPLETED|Washout Period of 1 Week||0
2408459|NCT01288859|5908418|P5|COMPLETED|Washout Period of 1 Week||0
2408460|NCT01288859|5908419|P4|COMPLETED|Washout Period of 1 Week||0
2408461|NCT01288859|5908420|P3|COMPLETED|Washout Period of 1 Week||5
2408462|NCT01288859|5908421|P2|COMPLETED|Washout Period of 1 Week||5
2408463|NCT01288859|5908422|P1|COMPLETED|Washout Period of 1 Week||0
2408464|NCT01288859|5908417|P6|STARTED|Washout Period of 1 Week||0
2408465|NCT01288859|5908418|P5|STARTED|Washout Period of 1 Week||0
2408466|NCT01288859|5908419|P4|STARTED|Washout Period of 1 Week||0
2408467|NCT01288859|5908420|P3|STARTED|Washout Period of 1 Week||5
2408468|NCT01288859|5908421|P2|STARTED|Washout Period of 1 Week||5
2408469|NCT01288859|5908422|P1|STARTED|Washout Period of 1 Week||0
2408470|NCT01288859|5908417|P6|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
2408471|NCT01288859|5908418|P5|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
2408472|NCT01288859|5908419|P4|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
2408473|NCT01288859|5908420|P3|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
2408474|NCT01288859|5908421|P2|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
2408475|NCT01288859|5908422|P1|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
2408476|NCT01288859|5908417|P6|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
2408477|NCT01288859|5908418|P5|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
2408478|NCT01288859|5908419|P4|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
2408479|NCT01288859|5908420|P3|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
2408480|NCT01288859|5908421|P2|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
2408481|NCT01288859|5908422|P1|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
2408482|NCT01288859|5908417|P6|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
2408483|NCT01288859|5908418|P5|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
2408484|NCT01288859|5908419|P4|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
2408485|NCT01288859|5908420|P3|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
2408486|NCT01288859|5908421|P2|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
2408487|NCT01288859|5908422|P1|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
2408488|NCT01288859|5908417|P6|NOT COMPLETED|Washout Period of 1 Week||0
2408489|NCT01288859|5908418|P5|NOT COMPLETED|Washout Period of 1 Week||0
2408490|NCT01288859|5908419|P4|NOT COMPLETED|Washout Period of 1 Week||0
2408491|NCT01288859|5908420|P3|NOT COMPLETED|Washout Period of 1 Week||0
2408492|NCT01288859|5908421|P2|NOT COMPLETED|Washout Period of 1 Week||0
2408493|NCT01288859|5908422|P1|NOT COMPLETED|Washout Period of 1 Week||0
2408494|NCT01288859|5908417|P6|COMPLETED|Washout Period of 1 Week||5
2408495|NCT01288859|5908418|P5|COMPLETED|Washout Period of 1 Week||0
2408496|NCT01288859|5908419|P4|COMPLETED|Washout Period of 1 Week||0
2408497|NCT01288859|5908420|P3|COMPLETED|Washout Period of 1 Week||0
2408498|NCT01288859|5908421|P2|COMPLETED|Washout Period of 1 Week||0
2408499|NCT01288859|5908422|P1|COMPLETED|Washout Period of 1 Week||5
2408500|NCT01288859|5908417|P6|STARTED|Washout Period of 1 Week||5
2408501|NCT01288859|5908418|P5|STARTED|Washout Period of 1 Week||0
2408502|NCT01288859|5908419|P4|STARTED|Washout Period of 1 Week||0
2408503|NCT01288859|5908420|P3|STARTED|Washout Period of 1 Week||0
2408504|NCT01288859|5908421|P2|STARTED|Washout Period of 1 Week||0
2408505|NCT01288859|5908422|P1|STARTED|Washout Period of 1 Week||5
2408506|NCT01288859|5908417|P6|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
2408507|NCT01288859|5908418|P5|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
2408508|NCT01288859|5908419|P4|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
2408509|NCT01288859|5908420|P3|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
2408510|NCT01288859|5908421|P2|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
2408511|NCT01288859|5908422|P1|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
2408512|NCT01288859|5908417|P6|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
2408513|NCT01288859|5908418|P5|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
2408514|NCT01288859|5908419|P4|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
2408515|NCT01288859|5908420|P3|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
2408516|NCT01288859|5908421|P2|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
2408517|NCT01288859|5908422|P1|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
2408518|NCT01288859|5908417|P6|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
2408519|NCT01288859|5908418|P5|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
2408520|NCT01288859|5908419|P4|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
2408521|NCT01288859|5908420|P3|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
2408522|NCT01288859|5908421|P2|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
2408523|NCT01288859|5908422|P1|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
2408524|NCT01288859|5908417|P6|NOT COMPLETED|Washout Period of 1 Week||0
2408525|NCT01288859|5908418|P5|NOT COMPLETED|Washout Period of 1 Week||0
2408526|NCT01288859|5908419|P4|NOT COMPLETED|Washout Period of 1 Week||0
2408527|NCT01288859|5908420|P3|NOT COMPLETED|Washout Period of 1 Week||0
2408528|NCT01288859|5908421|P2|NOT COMPLETED|Washout Period of 1 Week||0
2408529|NCT01288859|5908422|P1|NOT COMPLETED|Washout Period of 1 Week||0
2408530|NCT01288859|5908417|P6|COMPLETED|Washout Period of 1 Week||5
2408531|NCT01288859|5908418|P5|COMPLETED|Washout Period of 1 Week||0
2408532|NCT01288859|5908419|P4|COMPLETED|Washout Period of 1 Week||0
2408533|NCT01288859|5908420|P3|COMPLETED|Washout Period of 1 Week||0
2408534|NCT01288859|5908421|P2|COMPLETED|Washout Period of 1 Week||0
2408535|NCT01288859|5908422|P1|COMPLETED|Washout Period of 1 Week||5
2408536|NCT01288859|5908417|P6|STARTED|Washout Period of 1 Week||5
2408537|NCT01288859|5908418|P5|STARTED|Washout Period of 1 Week||0
2408538|NCT01288859|5908419|P4|STARTED|Washout Period of 1 Week||0
2408539|NCT01288859|5908420|P3|STARTED|Washout Period of 1 Week||0
2408540|NCT01288859|5908421|P2|STARTED|Washout Period of 1 Week||0
2408541|NCT01288859|5908422|P1|STARTED|Washout Period of 1 Week||5
2408542|NCT01288859|5908417|P6|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
2408543|NCT01288859|5908418|P5|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
2408544|NCT01288859|5908419|P4|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
2408545|NCT01288859|5908420|P3|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
2408546|NCT01288859|5908421|P2|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
2408547|NCT01288859|5908422|P1|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
2408548|NCT01288859|5908417|P6|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
2408549|NCT01288859|5908418|P5|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
2408550|NCT01288859|5908419|P4|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
2408551|NCT01288859|5908420|P3|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
2408552|NCT01288859|5908421|P2|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
2408553|NCT01288859|5908422|P1|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
2408554|NCT01288859|5908417|P6|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
2408555|NCT01288859|5908418|P5|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
2408556|NCT01288859|5908419|P4|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
2408557|NCT01288859|5908420|P3|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
2408558|NCT01288859|5908421|P2|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
2408559|NCT01288859|5908422|P1|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
2408560|NCT01288833|5908450|P2|NOT COMPLETED|Overall Study||0
2408561|NCT01288833|5908451|P1|NOT COMPLETED|Overall Study||0
2408562|NCT01288833|5908450|P2|COMPLETED|Overall Study||281
2408563|NCT01288833|5908451|P1|COMPLETED|Overall Study||277
2408564|NCT01288833|5908450|P2|STARTED|Overall Study||281
2408565|NCT01288833|5908451|P1|STARTED|Overall Study||277
2408566|NCT01288807|5908465|P1|NOT COMPLETED|Overall Study||0
2408567|NCT01288807|5908465|P1|COMPLETED|Overall Study||8
2408568|NCT01288807|5908465|P1|STARTED|Overall Study||8
2408569|NCT01288781|5908475|P2|NOT COMPLETED|Overall Study||0
2408570|NCT01288781|5908476|P1|NOT COMPLETED|Overall Study||0
2408571|NCT01288781|5908475|P2|COMPLETED|Overall Study||12
2408572|NCT01288781|5908476|P1|COMPLETED|Overall Study||11
2408573|NCT01288781|5908475|P2|STARTED|Overall Study||12
2408574|NCT01288781|5908476|P1|STARTED|Overall Study||11
2408575|NCT01288729|5908496|P2|NOT COMPLETED|Overall Study||0
2408576|NCT01288729|5908497|P1|NOT COMPLETED|Overall Study||1
2408577|NCT01288729|5908496|P2|COMPLETED|Overall Study||10
2408578|NCT01288729|5908497|P1|COMPLETED|Overall Study||9
2408579|NCT01288729|5908496|P2|STARTED|Overall Study||10
2408580|NCT01288729|5908497|P1|STARTED|Overall Study||10
2408581|NCT01288612|5908506|P3|NOT COMPLETED|Overall Study||82
2408582|NCT01288612|5908507|P2|NOT COMPLETED|Overall Study||82
2408583|NCT01288612|5908508|P1|NOT COMPLETED|Overall Study||89
2408584|NCT01288612|5908506|P3|COMPLETED|Overall Study||76
2408585|NCT01288612|5908507|P2|COMPLETED|Overall Study||69
2408586|NCT01288612|5908508|P1|COMPLETED|Overall Study||61
2408587|NCT01288612|5908506|P3|Agreed to Take Part|Overall Study||76
2408588|NCT01288612|5908507|P2|Agreed to Take Part|Overall Study||72
2408589|NCT01288612|5908508|P1|Agreed to Take Part|Overall Study||61
2408590|NCT01288612|5908506|P3|Contacted|Overall Study||138
2408591|NCT01288612|5908507|P2|Contacted|Overall Study||135
2408592|NCT01288612|5908508|P1|Contacted|Overall Study||139
2408593|NCT01288612|5908506|P3|STARTED|Overall Study||158
2408594|NCT01288612|5908507|P2|STARTED|Overall Study||151
2408595|NCT01288612|5908508|P1|STARTED|Overall Study||150
2408596|NCT01288534|5908537|P1|NOT COMPLETED|Overall Study||0
2408597|NCT01288534|5908537|P1|COMPLETED|Overall Study||68
2408598|NCT01288534|5908537|P1|STARTED|Overall Study||68
2408599|NCT01288521|5908547|P2|NOT COMPLETED|Overall Study||0
2408600|NCT01288521|5908548|P1|NOT COMPLETED|Overall Study||0
2408601|NCT01288521|5908547|P2|COMPLETED|Overall Study||5
2408602|NCT01288521|5908548|P1|COMPLETED|Overall Study||3
2408603|NCT01288521|5908547|P2|STARTED|Overall Study||5
2408604|NCT01288521|5908548|P1|STARTED|Overall Study||3
2408605|NCT01288469|5908557|P3|NOT COMPLETED|Overall Study||2
2408606|NCT01288469|5908558|P2|NOT COMPLETED|Overall Study||3
2408607|NCT01288469|5908559|P1|NOT COMPLETED|Overall Study||7
2408608|NCT01288469|5908557|P3|COMPLETED|Overall Study||28
2408609|NCT01288469|5908558|P2|COMPLETED|Overall Study||28
2408610|NCT01288469|5908559|P1|COMPLETED|Overall Study||24
2408611|NCT01288469|5908557|P3|Treated|Overall Study||30
2408612|NCT01288469|5908558|P2|Treated|Overall Study||31
2408613|NCT01288469|5908559|P1|Treated|Overall Study||31
2408614|NCT01288469|5908557|P3|STARTED|Overall Study|Randomized|30
2408615|NCT01288469|5908558|P2|STARTED|Overall Study|Randomized|31
2408616|NCT01288469|5908559|P1|STARTED|Overall Study|Randomized|31
2408617|NCT01288443|5908591|P6|NOT COMPLETED|Overall Study||5
2408618|NCT01288443|5908592|P5|NOT COMPLETED|Overall Study||7
2408619|NCT01288443|5908593|P4|NOT COMPLETED|Overall Study||4
2408620|NCT01288443|5908594|P3|NOT COMPLETED|Overall Study||1
2408621|NCT01288443|5908595|P2|NOT COMPLETED|Overall Study||1
2408622|NCT01288443|5908596|P1|NOT COMPLETED|Overall Study||0
2408623|NCT01288443|5908591|P6|COMPLETED|Overall Study||25
2408624|NCT01288443|5908592|P5|COMPLETED|Overall Study||23
2408625|NCT01288443|5908593|P4|COMPLETED|Overall Study||27
2408626|NCT01288443|5908594|P3|COMPLETED|Overall Study||30
2408627|NCT01288443|5908595|P2|COMPLETED|Overall Study||29
2408628|NCT01288443|5908596|P1|COMPLETED|Overall Study||31
2408629|NCT01288443|5908591|P6|Treated|Overall Study||30
2408630|NCT01288443|5908592|P5|Treated|Overall Study||29
2408631|NCT01288443|5908593|P4|Treated|Overall Study||31
2408632|NCT01288443|5908594|P3|Treated|Overall Study||31
2408633|NCT01288443|5908595|P2|Treated|Overall Study||30
2408634|NCT01288443|5908596|P1|Treated|Overall Study||31
2408635|NCT01288443|5908591|P6|STARTED|Overall Study|Randomized|30
2408636|NCT01288443|5908592|P5|STARTED|Overall Study|Randomized|30
2408637|NCT01288443|5908593|P4|STARTED|Overall Study|Randomized|31
2408638|NCT01288443|5908594|P3|STARTED|Overall Study|Randomized|31
2408639|NCT01288443|5908595|P2|STARTED|Overall Study|Randomized|30
2408640|NCT01288443|5908596|P1|STARTED|Overall Study|Randomized|31
2408641|NCT01288287|5908646|P1|NOT COMPLETED|Overall Study||46
2408642|NCT01288287|5908646|P1|COMPLETED|Overall Study||103
2408643|NCT01288287|5908646|P1|Full Analysis Set|Overall Study||111
2408644|NCT01288287|5908646|P1|Safety Set|Overall Study||147
2408645|NCT01288287|5908646|P1|STARTED|Overall Study||149
2408646|NCT01288209|5908661|P2|NOT COMPLETED|Overall Study||3
2408647|NCT01288209|5908662|P1|NOT COMPLETED|Overall Study||2
2408648|NCT01288209|5908661|P2|COMPLETED|Overall Study||50
2408649|NCT01288209|5908662|P1|COMPLETED|Overall Study||51
2408650|NCT01288209|5908661|P2|STARTED|Overall Study||53
2408651|NCT01288209|5908662|P1|STARTED|Overall Study||53
2408652|NCT01288079|5908692|P4|NOT COMPLETED|Overall Study||17
2408653|NCT01288079|5908693|P3|NOT COMPLETED|Overall Study||19
2408654|NCT01288079|5908694|P2|NOT COMPLETED|Overall Study||27
2408655|NCT01288079|5908695|P1|NOT COMPLETED|Overall Study||20
2408656|NCT01288079|5908692|P4|COMPLETED|Overall Study||18
2408657|NCT01288079|5908693|P3|COMPLETED|Overall Study||18
2408658|NCT01288079|5908694|P2|COMPLETED|Overall Study||9
2408659|NCT01288079|5908695|P1|COMPLETED|Overall Study||17
2408660|NCT01288079|5908692|P4|STARTED|Overall Study||35
2408661|NCT01288079|5908693|P3|STARTED|Overall Study||37
2408662|NCT01288079|5908694|P2|STARTED|Overall Study||36
2408663|NCT01288079|5908695|P1|STARTED|Overall Study||37
2408664|NCT01288053|5908705|P1|NOT COMPLETED|Overall Study||1
2408665|NCT01288053|5908705|P1|COMPLETED|Overall Study||8
2408666|NCT01288053|5908705|P1|STARTED|Overall Study||9
2408667|NCT01288027|5908709|P1|NOT COMPLETED|Overall Study||0
2408668|NCT01288027|5908709|P1|COMPLETED|Overall Study||16
2408669|NCT01288027|5908709|P1|Full Analysis Set (FAS)|Overall Study|All participants who received at least 1 complete infusion of alglucosidase alfa.|16
2408670|NCT01288027|5908709|P1|STARTED|Overall Study||16
2408671|NCT01287897|5908723|P4|NOT COMPLETED|Overall Study||7
2408672|NCT01287897|5908724|P3|NOT COMPLETED|Overall Study||12
2408673|NCT01287897|5908725|P2|NOT COMPLETED|Overall Study||11
2408674|NCT01287897|5908726|P1|NOT COMPLETED|Overall Study||11
2408675|NCT01287897|5908723|P4|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|33
2408676|NCT01287897|5908724|P3|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
2408677|NCT01287897|5908725|P2|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|58
2408678|NCT01287897|5908726|P1|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
2408679|NCT01287897|5908723|P4|Enrolled in NCT01345318|Overall Study||29
2408680|NCT01287897|5908724|P3|Enrolled in NCT01345318|Overall Study||56
2408681|NCT01287897|5908725|P2|Enrolled in NCT01345318|Overall Study||50
2408682|NCT01287897|5908726|P1|Enrolled in NCT01345318|Overall Study||56
2408683|NCT01287897|5908723|P4|Completed Follow-up Period|Overall Study||4
2408684|NCT01287897|5908724|P3|Completed Follow-up Period|Overall Study||3
2408685|NCT01287897|5908725|P2|Completed Follow-up Period|Overall Study||8
2408686|NCT01287897|5908726|P1|Completed Follow-up Period|Overall Study||3
2408687|NCT01287897|5908723|P4|Completed Treatment Period|Overall Study||29
2408688|NCT01287897|5908724|P3|Completed Treatment Period|Overall Study||58
2408689|NCT01287897|5908725|P2|Completed Treatment Period|Overall Study||52
2408690|NCT01287897|5908726|P1|Completed Treatment Period|Overall Study||58
2408691|NCT01287897|5908723|P4|Treated|Overall Study||40
2408692|NCT01287897|5908724|P3|Treated|Overall Study||71
2408693|NCT01287897|5908725|P2|Treated|Overall Study||67
2408694|NCT01287897|5908726|P1|Treated|Overall Study||69
2408695|NCT01287897|5908723|P4|STARTED|Overall Study|Enrollment was halted before reaching the planned sample size due to safety findings in NCT01405196.|40
2408696|NCT01287897|5908724|P3|STARTED|Overall Study||71
2408697|NCT01287897|5908725|P2|STARTED|Overall Study||69
2408698|NCT01287897|5908726|P1|STARTED|Overall Study||70
2408699|NCT01287832|5908777|P2|NOT COMPLETED|Overall Study||1
2408700|NCT01287832|5908778|P1|NOT COMPLETED|Overall Study||1
2408701|NCT01287832|5908777|P2|COMPLETED|Overall Study||4
2408702|NCT01287832|5908778|P1|COMPLETED|Overall Study||5
2408703|NCT01287832|5908777|P2|STARTED|Overall Study||5
2408704|NCT01287832|5908778|P1|STARTED|Overall Study||6
2408705|NCT01287754|5908786|P2|NOT COMPLETED|Overall Study||21
2408706|NCT01287754|5908787|P1|NOT COMPLETED|Overall Study||3
2408707|NCT01287754|5908786|P2|COMPLETED|Overall Study||0
2408708|NCT01287754|5908787|P1|COMPLETED|Overall Study||0
2408709|NCT01287754|5908786|P2|STARTED|Overall Study||21
2408710|NCT01287754|5908787|P1|STARTED|Overall Study||3
2408711|NCT01287741|5908799|P2|NOT COMPLETED|Overall Study||615
2408712|NCT01287741|5908800|P1|NOT COMPLETED|Overall Study||626
2408713|NCT01287741|5908799|P2|COMPLETED|Overall Study||91
2408714|NCT01287741|5908800|P1|COMPLETED|Overall Study||86
2408715|NCT01287741|5908799|P2|STARTED|Overall Study||706
2408716|NCT01287741|5908800|P1|STARTED|Overall Study||712
2408717|NCT01287611|5908836|P2|NOT COMPLETED|Overall Study||19
2408718|NCT01287611|5908837|P1|NOT COMPLETED|Overall Study||33
2408719|NCT01287611|5908836|P2|COMPLETED|Overall Study||65
2408720|NCT01287611|5908837|P1|COMPLETED|Overall Study||51
2408721|NCT01287611|5908836|P2|The Number of Patients Who Underwent C/S|Overall Study||84
2408722|NCT01287611|5908837|P1|The Number of Patients Who Underwent C/S|Overall Study||84
2408723|NCT01287611|5908836|P2|STARTED|Overall Study||84
2408724|NCT01287611|5908837|P1|STARTED|Overall Study||84
2408725|NCT01287520|5908854|P9|NOT COMPLETED|Overall Study||5
2408726|NCT01287520|5908855|P8|NOT COMPLETED|Overall Study||5
2408727|NCT01287520|5908856|P7|NOT COMPLETED|Overall Study||2
2408728|NCT01287520|5908857|P6|NOT COMPLETED|Overall Study||4
2408729|NCT01287520|5908858|P5|NOT COMPLETED|Overall Study||3
2408730|NCT01287520|5908859|P4|NOT COMPLETED|Overall Study||7
2408731|NCT01287520|5908860|P3|NOT COMPLETED|Overall Study||5
2408732|NCT01287520|5908861|P2|NOT COMPLETED|Overall Study||7
2408733|NCT01287520|5908862|P1|NOT COMPLETED|Overall Study||3
2408734|NCT01287520|5908854|P9|COMPLETED|Overall Study||0
2408735|NCT01287520|5908855|P8|COMPLETED|Overall Study||0
2408736|NCT01287520|5908856|P7|COMPLETED|Overall Study||0
2408737|NCT01287520|5908857|P6|COMPLETED|Overall Study||0
2408738|NCT01287520|5908858|P5|COMPLETED|Overall Study||0
2408739|NCT01287520|5908859|P4|COMPLETED|Overall Study||0
2408740|NCT01287520|5908860|P3|COMPLETED|Overall Study||0
2408741|NCT01287520|5908861|P2|COMPLETED|Overall Study||0
2408742|NCT01287520|5908862|P1|COMPLETED|Overall Study||0
2408743|NCT01287520|5908854|P9|STARTED|Overall Study||5
2408744|NCT01287520|5908855|P8|STARTED|Overall Study||5
2408745|NCT01287520|5908856|P7|STARTED|Overall Study||2
2408746|NCT01287520|5908857|P6|STARTED|Overall Study||4
2408747|NCT01287520|5908858|P5|STARTED|Overall Study||3
2408748|NCT01287520|5908859|P4|STARTED|Overall Study|One participant who received study drug but did not complete Cycle 1 was replaced.|7
2408749|NCT01287520|5908860|P3|STARTED|Overall Study||5
2408750|NCT01287520|5908861|P2|STARTED|Overall Study|One participant who received study drug but did not complete Cycle 1 was replaced.|7
2408751|NCT01287520|5908862|P1|STARTED|Overall Study||3
2408752|NCT01287416|5908926|P2|NOT COMPLETED|6 Month Follow-up||2
2408753|NCT01287416|5908927|P1|NOT COMPLETED|6 Month Follow-up||3
2408754|NCT01287416|5908926|P2|COMPLETED|6 Month Follow-up||22
2408755|NCT01287416|5908927|P1|COMPLETED|6 Month Follow-up||28
2408756|NCT01287416|5908926|P2|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|24
2408757|NCT01287416|5908927|P1|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|31
2408758|NCT01287416|5908926|P2|NOT COMPLETED|Pre-post Training||25
2408759|NCT01287416|5908927|P1|NOT COMPLETED|Pre-post Training||22
2408760|NCT01287416|5908926|P2|COMPLETED|Pre-post Training||23
2408761|NCT01287416|5908927|P1|COMPLETED|Pre-post Training||26
2408762|NCT01287416|5908926|P2|Post Training Questionnaire|Pre-post Training||23
2408763|NCT01287416|5908927|P1|Post Training Questionnaire|Pre-post Training||26
2408764|NCT01287416|5908926|P2|Training Workshop|Pre-post Training|number of people that showed up for the training session|24
2408765|NCT01287416|5908927|P1|Training Workshop|Pre-post Training|number of people that showed up for the training session|31
2408766|NCT01287416|5908926|P2|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
2408767|NCT01287416|5908927|P1|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
2408768|NCT01287403|5908963|P1|NOT COMPLETED|6th and Last Intervention (1 Day)||0
2408769|NCT01287403|5908963|P1|COMPLETED|6th and Last Intervention (1 Day)||13
2408770|NCT01287403|5908963|P1|STARTED|6th and Last Intervention (1 Day)||13
2408771|NCT01287403|5908963|P1|NOT COMPLETED|Washout (7 Days)||0
2408772|NCT01287403|5908963|P1|COMPLETED|Washout (7 Days)||13
2408773|NCT01287403|5908963|P1|STARTED|Washout (7 Days)||13
2408774|NCT01287403|5908963|P1|NOT COMPLETED|5th Intervention (1 Day)||0
2408775|NCT01287403|5908963|P1|COMPLETED|5th Intervention (1 Day)||13
2408776|NCT01287403|5908963|P1|STARTED|5th Intervention (1 Day)||13
2408777|NCT01287403|5908963|P1|NOT COMPLETED|Washout (7 Days)||0
2408778|NCT01287403|5908963|P1|COMPLETED|Washout (7 Days)||13
2408779|NCT01287403|5908963|P1|STARTED|Washout (7 Days)||13
2408780|NCT01287403|5908963|P1|NOT COMPLETED|4th Intervention (1 Day)||0
2408781|NCT01287403|5908963|P1|COMPLETED|4th Intervention (1 Day)||13
2408782|NCT01287403|5908963|P1|STARTED|4th Intervention (1 Day)||13
2408783|NCT01287403|5908963|P1|NOT COMPLETED|Washout (7 Days)||0
2408784|NCT01287403|5908963|P1|COMPLETED|Washout (7 Days)||13
2408785|NCT01287403|5908963|P1|STARTED|Washout (7 Days)||13
2408786|NCT01287403|5908963|P1|NOT COMPLETED|3rd Intervention (1 Day)||0
2408787|NCT01287403|5908963|P1|COMPLETED|3rd Intervention (1 Day)||13
2408788|NCT01287403|5908963|P1|STARTED|3rd Intervention (1 Day)||13
2408789|NCT01287403|5908963|P1|NOT COMPLETED|Washout (7 Days)||0
2408790|NCT01287403|5908963|P1|COMPLETED|Washout (7 Days)||13
2408791|NCT01287403|5908963|P1|STARTED|Washout (7 Days)||13
2408792|NCT01287403|5908963|P1|NOT COMPLETED|2nd Intervention (1 Day)||0
2408793|NCT01287403|5908963|P1|COMPLETED|2nd Intervention (1 Day)||13
2408794|NCT01287403|5908963|P1|STARTED|2nd Intervention (1 Day)||13
2408795|NCT01287403|5908963|P1|NOT COMPLETED|Washout 7 Days||0
2408796|NCT01287403|5908963|P1|COMPLETED|Washout 7 Days||13
2408797|NCT01287403|5908963|P1|STARTED|Washout 7 Days||13
2408798|NCT01287403|5908963|P1|NOT COMPLETED|1st Intervention (1 Day)||1
2408799|NCT01287403|5908963|P1|COMPLETED|1st Intervention (1 Day)|"The adverse event was linked to the intake of refined wheat flour"|13
2408800|NCT01287403|5908963|P1|STARTED|1st Intervention (1 Day)||14
2408801|NCT01287403|5908963|P1|NOT COMPLETED|Diet Restriction (7 Days)||0
2408802|NCT01287403|5908963|P1|COMPLETED|Diet Restriction (7 Days)||14
2408803|NCT01287403|5908963|P1|STARTED|Diet Restriction (7 Days)||14
2408804|NCT01287377|5908980|P3|NOT COMPLETED|Overall Study||0
2408805|NCT01287377|5908981|P2|NOT COMPLETED|Overall Study||0
2408806|NCT01287377|5908982|P1|NOT COMPLETED|Overall Study||0
2408807|NCT01287377|5908980|P3|COMPLETED|Overall Study|Study Complete|82
2408808|NCT01287377|5908981|P2|COMPLETED|Overall Study|Study Complete|81
2408809|NCT01287377|5908982|P1|COMPLETED|Overall Study|Study Complete|80
2408810|NCT01287377|5908980|P3|STARTED|Overall Study||82
2408811|NCT01287377|5908981|P2|STARTED|Overall Study||81
2408812|NCT01287377|5908982|P1|STARTED|Overall Study||80
2408813|NCT01287364|5908995|P2|NOT COMPLETED|Overall Study||10
2408814|NCT01287364|5908996|P1|NOT COMPLETED|Overall Study||9
2408815|NCT01287364|5908995|P2|COMPLETED|Overall Study||81
2408816|NCT01287364|5908996|P1|COMPLETED|Overall Study||85
2408817|NCT01287364|5908995|P2|STARTED|Overall Study||91
2408818|NCT01287364|5908996|P1|STARTED|Overall Study||94
2408819|NCT01287221|5909018|P2|NOT COMPLETED|Overall Study||5
2408820|NCT01287221|5909019|P1|NOT COMPLETED|Overall Study||4
2408821|NCT01287221|5909018|P2|COMPLETED|Overall Study||45
2408822|NCT01287221|5909019|P1|COMPLETED|Overall Study||46
2408823|NCT01287221|5909018|P2|Completed 12 Months Follow-up|Overall Study||39
2408824|NCT01287221|5909019|P1|Completed 12 Months Follow-up|Overall Study||40
2408825|NCT01287221|5909018|P2|Completed 9 Months Follow-up|Overall Study||40
2408826|NCT01287221|5909019|P1|Completed 9 Months Follow-up|Overall Study||42
2408827|NCT01287221|5909018|P2|Completed 6 Months Follow-up|Overall Study||43
2408828|NCT01287221|5909019|P1|Completed 6 Months Follow-up|Overall Study||47
2408829|NCT01287221|5909018|P2|Completed 3 Months Follow-up|Overall Study||50
2408830|NCT01287221|5909019|P1|Completed 3 Months Follow-up|Overall Study||49
2408831|NCT01287221|5909018|P2|STARTED|Overall Study||50
2408832|NCT01287221|5909019|P1|STARTED|Overall Study||50
2408833|NCT01287208|5909039|P2|NOT COMPLETED|Phase 2: Team Competition||0
2408834|NCT01287208|5909040|P1|NOT COMPLETED|Phase 2: Team Competition||0
2408835|NCT01287208|5909039|P2|COMPLETED|Phase 2: Team Competition||49
2408836|NCT01287208|5909040|P1|COMPLETED|Phase 2: Team Competition||50
2408837|NCT01287208|5909039|P2|STARTED|Phase 2: Team Competition||49
2408838|NCT01287208|5909040|P1|STARTED|Phase 2: Team Competition||50
2408839|NCT01287208|5909039|P2|NOT COMPLETED|Phase 1: Randomized Phase||3
2408840|NCT01287208|5909040|P1|NOT COMPLETED|Phase 1: Randomized Phase||2
2408841|NCT01287208|5909039|P2|COMPLETED|Phase 1: Randomized Phase||49
2408842|NCT01287208|5909040|P1|COMPLETED|Phase 1: Randomized Phase||50
2408843|NCT01287208|5909039|P2|STARTED|Phase 1: Randomized Phase||52
2408844|NCT01287208|5909040|P1|STARTED|Phase 1: Randomized Phase||52
2408845|NCT01287195|5909054|P1|NOT COMPLETED|Overall Study||2
2408846|NCT01287195|5909054|P1|COMPLETED|Overall Study||4
2408847|NCT01287195|5909054|P1|STARTED|Overall Study||6
2408848|NCT01287117|5909069|P4|NOT COMPLETED|Overall Study||12
2408849|NCT01287117|5909070|P3|NOT COMPLETED|Overall Study||16
2408850|NCT01287117|5909071|P2|NOT COMPLETED|Overall Study||14
2408851|NCT01287117|5909072|P1|NOT COMPLETED|Overall Study||15
2408852|NCT01287117|5909069|P4|COMPLETED|Overall Study||69
2408853|NCT01287117|5909070|P3|COMPLETED|Overall Study||64
2408854|NCT01287117|5909071|P2|COMPLETED|Overall Study||64
2408855|NCT01287117|5909072|P1|COMPLETED|Overall Study||65
2408856|NCT01287117|5909069|P4|Received Treatment|Overall Study||81
2408857|NCT01287117|5909070|P3|Received Treatment|Overall Study||80
2408858|NCT01287117|5909071|P2|Received Treatment|Overall Study||77
2408859|NCT01287117|5909072|P1|Received Treatment|Overall Study||80
2408860|NCT01287117|5909069|P4|STARTED|Overall Study||81
2408861|NCT01287117|5909070|P3|STARTED|Overall Study||80
2408862|NCT01287117|5909071|P2|STARTED|Overall Study||78
2408863|NCT01287117|5909072|P1|STARTED|Overall Study||80
2408864|NCT01287104|5909122|P4|NOT COMPLETED|Overall Study||3
2408865|NCT01287104|5909123|P3|NOT COMPLETED|Overall Study||7
2408866|NCT01287104|5909124|P2|NOT COMPLETED|Overall Study||5
2408867|NCT01287104|5909125|P1|NOT COMPLETED|Overall Study||1
2408868|NCT01287104|5909122|P4|COMPLETED|Overall Study||8
2408869|NCT01287104|5909123|P3|COMPLETED|Overall Study||5
2408870|NCT01287104|5909124|P2|COMPLETED|Overall Study||2
2408871|NCT01287104|5909125|P1|COMPLETED|Overall Study||3
2408872|NCT01287104|5909122|P4|STARTED|Overall Study||11
2408873|NCT01287104|5909123|P3|STARTED|Overall Study||12
2408874|NCT01287104|5909124|P2|STARTED|Overall Study||7
2408875|NCT01287104|5909125|P1|STARTED|Overall Study||4
2408876|NCT01287065|5909158|P6|NOT COMPLETED|Treatment Period 3||0
2408877|NCT01287065|5909159|P5|NOT COMPLETED|Treatment Period 3||0
2408878|NCT01287065|5909160|P4|NOT COMPLETED|Treatment Period 3||0
2408879|NCT01287065|5909161|P3|NOT COMPLETED|Treatment Period 3||0
2408880|NCT01287065|5909162|P2|NOT COMPLETED|Treatment Period 3||0
2408881|NCT01287065|5909163|P1|NOT COMPLETED|Treatment Period 3||0
2408882|NCT01287065|5909158|P6|COMPLETED|Treatment Period 3||4
2408883|NCT01287065|5909159|P5|COMPLETED|Treatment Period 3||4
2408884|NCT01287065|5909160|P4|COMPLETED|Treatment Period 3||4
2408885|NCT01287065|5909161|P3|COMPLETED|Treatment Period 3||4
2408886|NCT01287065|5909162|P2|COMPLETED|Treatment Period 3||4
2408887|NCT01287065|5909163|P1|COMPLETED|Treatment Period 3||4
2408888|NCT01287065|5909158|P6|STARTED|Treatment Period 3||4
2408889|NCT01287065|5909159|P5|STARTED|Treatment Period 3||4
2408890|NCT01287065|5909160|P4|STARTED|Treatment Period 3||4
2408891|NCT01287065|5909161|P3|STARTED|Treatment Period 3||4
2408892|NCT01287065|5909162|P2|STARTED|Treatment Period 3||4
2408893|NCT01287065|5909163|P1|STARTED|Treatment Period 3||4
2408894|NCT01287065|5909158|P6|NOT COMPLETED|Washout Period 2||0
2408895|NCT01287065|5909159|P5|NOT COMPLETED|Washout Period 2||0
2408896|NCT01287065|5909160|P4|NOT COMPLETED|Washout Period 2||0
2408897|NCT01287065|5909161|P3|NOT COMPLETED|Washout Period 2||0
2408898|NCT01287065|5909162|P2|NOT COMPLETED|Washout Period 2||0
2408899|NCT01287065|5909163|P1|NOT COMPLETED|Washout Period 2||0
2408900|NCT01287065|5909158|P6|COMPLETED|Washout Period 2||4
2408901|NCT01287065|5909159|P5|COMPLETED|Washout Period 2||4
2408902|NCT01287065|5909160|P4|COMPLETED|Washout Period 2||4
2408903|NCT01287065|5909161|P3|COMPLETED|Washout Period 2||4
2408904|NCT01287065|5909162|P2|COMPLETED|Washout Period 2||4
2408905|NCT01287065|5909163|P1|COMPLETED|Washout Period 2||4
2408906|NCT01287065|5909158|P6|STARTED|Washout Period 2||4
2408907|NCT01287065|5909159|P5|STARTED|Washout Period 2||4
2408908|NCT01287065|5909160|P4|STARTED|Washout Period 2||4
2408909|NCT01287065|5909161|P3|STARTED|Washout Period 2||4
2408910|NCT01287065|5909162|P2|STARTED|Washout Period 2||4
2408911|NCT01287065|5909163|P1|STARTED|Washout Period 2||4
2408912|NCT01287065|5909158|P6|NOT COMPLETED|Treatment Period 2||0
2408913|NCT01287065|5909159|P5|NOT COMPLETED|Treatment Period 2||0
2408914|NCT01287065|5909160|P4|NOT COMPLETED|Treatment Period 2||0
2408915|NCT01287065|5909161|P3|NOT COMPLETED|Treatment Period 2||0
2408916|NCT01287065|5909162|P2|NOT COMPLETED|Treatment Period 2||0
2408917|NCT01287065|5909163|P1|NOT COMPLETED|Treatment Period 2||0
2408918|NCT01287065|5909158|P6|COMPLETED|Treatment Period 2||4
2408919|NCT01287065|5909159|P5|COMPLETED|Treatment Period 2||4
2408920|NCT01287065|5909160|P4|COMPLETED|Treatment Period 2||4
2408921|NCT01287065|5909161|P3|COMPLETED|Treatment Period 2||4
2408922|NCT01287065|5909162|P2|COMPLETED|Treatment Period 2||4
2408923|NCT01287065|5909163|P1|COMPLETED|Treatment Period 2||4
2408924|NCT01287065|5909158|P6|STARTED|Treatment Period 2||4
2408925|NCT01287065|5909159|P5|STARTED|Treatment Period 2||4
2408926|NCT01287065|5909160|P4|STARTED|Treatment Period 2||4
2408927|NCT01287065|5909161|P3|STARTED|Treatment Period 2||4
2408928|NCT01287065|5909162|P2|STARTED|Treatment Period 2||4
2408929|NCT01287065|5909163|P1|STARTED|Treatment Period 2||4
2408930|NCT01287065|5909158|P6|NOT COMPLETED|Washout Period 1||0
2408931|NCT01287065|5909159|P5|NOT COMPLETED|Washout Period 1||0
2408932|NCT01287065|5909160|P4|NOT COMPLETED|Washout Period 1||0
2408933|NCT01287065|5909161|P3|NOT COMPLETED|Washout Period 1||0
2408934|NCT01287065|5909162|P2|NOT COMPLETED|Washout Period 1||0
2408935|NCT01287065|5909163|P1|NOT COMPLETED|Washout Period 1||0
2408936|NCT01287065|5909158|P6|COMPLETED|Washout Period 1||4
2408937|NCT01287065|5909159|P5|COMPLETED|Washout Period 1||4
2408938|NCT01287065|5909160|P4|COMPLETED|Washout Period 1||4
2408939|NCT01287065|5909161|P3|COMPLETED|Washout Period 1||4
2408940|NCT01287065|5909162|P2|COMPLETED|Washout Period 1||4
2408941|NCT01287065|5909163|P1|COMPLETED|Washout Period 1||4
2408942|NCT01287065|5909158|P6|STARTED|Washout Period 1||4
2408943|NCT01287065|5909159|P5|STARTED|Washout Period 1||4
2408944|NCT01287065|5909160|P4|STARTED|Washout Period 1||4
2408945|NCT01287065|5909161|P3|STARTED|Washout Period 1||4
2408946|NCT01287065|5909162|P2|STARTED|Washout Period 1||4
2408947|NCT01287065|5909163|P1|STARTED|Washout Period 1||4
2408948|NCT01287065|5909158|P6|NOT COMPLETED|Treatment Period 1||1
2408949|NCT01287065|5909159|P5|NOT COMPLETED|Treatment Period 1||1
2408950|NCT01287065|5909160|P4|NOT COMPLETED|Treatment Period 1||0
2408951|NCT01287065|5909161|P3|NOT COMPLETED|Treatment Period 1||0
2408952|NCT01287065|5909162|P2|NOT COMPLETED|Treatment Period 1||0
2408953|NCT01287065|5909163|P1|NOT COMPLETED|Treatment Period 1||0
2408954|NCT01287065|5909158|P6|COMPLETED|Treatment Period 1||4
2408955|NCT01287065|5909159|P5|COMPLETED|Treatment Period 1||4
2408956|NCT01287065|5909160|P4|COMPLETED|Treatment Period 1||4
2408957|NCT01287065|5909161|P3|COMPLETED|Treatment Period 1||4
2408958|NCT01287065|5909162|P2|COMPLETED|Treatment Period 1||4
2408959|NCT01287065|5909163|P1|COMPLETED|Treatment Period 1||4
2408960|NCT01287065|5909158|P6|STARTED|Treatment Period 1||5
2408961|NCT01287065|5909159|P5|STARTED|Treatment Period 1||5
2408962|NCT01287065|5909160|P4|STARTED|Treatment Period 1||4
2408963|NCT01287065|5909161|P3|STARTED|Treatment Period 1||4
2408964|NCT01287065|5909162|P2|STARTED|Treatment Period 1||4
2408965|NCT01287065|5909163|P1|STARTED|Treatment Period 1||4
2408966|NCT01287039|5909182|P2|NOT COMPLETED|Overall Study||27
2408967|NCT01287039|5909183|P1|NOT COMPLETED|Overall Study||29
2408968|NCT01287039|5909182|P2|COMPLETED|Overall Study||218
2408969|NCT01287039|5909183|P1|COMPLETED|Overall Study||215
2408970|NCT01287039|5909182|P2|STARTED|Overall Study||245
2408971|NCT01287039|5909183|P1|STARTED|Overall Study||244
2408972|NCT01287013|5909216|P3|NOT COMPLETED|Overall Study||21
2408973|NCT01287013|5909217|P2|NOT COMPLETED|Overall Study||5
2408974|NCT01287013|5909218|P1|NOT COMPLETED|Overall Study||3
2408975|NCT01287013|5909216|P3|COMPLETED|Overall Study||0
2408976|NCT01287013|5909217|P2|COMPLETED|Overall Study||29
2408977|NCT01287013|5909218|P1|COMPLETED|Overall Study||29
2408978|NCT01287013|5909216|P3|STARTED|Overall Study||21
2408979|NCT01287013|5909217|P2|STARTED|Overall Study||34
2408980|NCT01287013|5909218|P1|STARTED|Overall Study||32
2408981|NCT01286987|5909248|P15|NOT COMPLETED|Part 2: Dose Expansion||2
2408982|NCT01286987|5909249|P14|NOT COMPLETED|Part 2: Dose Expansion||24
2408983|NCT01286987|5909250|P13|NOT COMPLETED|Part 2: Dose Expansion||12
2408984|NCT01286987|5909251|P12|NOT COMPLETED|Part 2: Dose Expansion||10
2408985|NCT01286987|5909252|P11|NOT COMPLETED|Part 2: Dose Expansion||10
2408986|NCT01286987|5909253|P10|NOT COMPLETED|Part 2: Dose Expansion||11
2408987|NCT01286987|5909254|P9|NOT COMPLETED|Part 2: Dose Expansion||0
2408988|NCT01286987|5909255|P8|NOT COMPLETED|Part 2: Dose Expansion||0
2408989|NCT01286987|5909256|P7|NOT COMPLETED|Part 2: Dose Expansion||0
2408990|NCT01286987|5909257|P6|NOT COMPLETED|Part 2: Dose Expansion||0
2408991|NCT01286987|5909258|P5|NOT COMPLETED|Part 2: Dose Expansion||0
2408992|NCT01286987|5909259|P4|NOT COMPLETED|Part 2: Dose Expansion||0
2408993|NCT01286987|5909260|P3|NOT COMPLETED|Part 2: Dose Expansion||0
2408994|NCT01286987|5909261|P2|NOT COMPLETED|Part 2: Dose Expansion||0
2408995|NCT01286987|5909262|P1|NOT COMPLETED|Part 2: Dose Expansion||0
2408996|NCT01286987|5909248|P15|COMPLETED|Part 2: Dose Expansion||1
2408997|NCT01286987|5909249|P14|COMPLETED|Part 2: Dose Expansion||0
2408998|NCT01286987|5909250|P13|COMPLETED|Part 2: Dose Expansion||0
2408999|NCT01286987|5909251|P12|COMPLETED|Part 2: Dose Expansion||1
2409000|NCT01286987|5909252|P11|COMPLETED|Part 2: Dose Expansion||2
2409001|NCT01286987|5909253|P10|COMPLETED|Part 2: Dose Expansion||1
2409002|NCT01286987|5909254|P9|COMPLETED|Part 2: Dose Expansion||0
2409003|NCT01286987|5909255|P8|COMPLETED|Part 2: Dose Expansion||0
2409004|NCT01286987|5909256|P7|COMPLETED|Part 2: Dose Expansion||0
2409005|NCT01286987|5909257|P6|COMPLETED|Part 2: Dose Expansion||0
2409006|NCT01286987|5909258|P5|COMPLETED|Part 2: Dose Expansion||0
2409007|NCT01286987|5909259|P4|COMPLETED|Part 2: Dose Expansion||0
2409008|NCT01286987|5909260|P3|COMPLETED|Part 2: Dose Expansion||0
2409009|NCT01286987|5909261|P2|COMPLETED|Part 2: Dose Expansion||0
2409010|NCT01286987|5909262|P1|COMPLETED|Part 2: Dose Expansion||0
2409011|NCT01286987|5909248|P15|Treated|Part 2: Dose Expansion||3
2409012|NCT01286987|5909249|P14|Treated|Part 2: Dose Expansion||23
2409013|NCT01286987|5909250|P13|Treated|Part 2: Dose Expansion||12
2409014|NCT01286987|5909251|P12|Treated|Part 2: Dose Expansion||10
2409015|NCT01286987|5909252|P11|Treated|Part 2: Dose Expansion||11
2409016|NCT01286987|5909253|P10|Treated|Part 2: Dose Expansion||12
2409017|NCT01286987|5909254|P9|Treated|Part 2: Dose Expansion||0
2409018|NCT01286987|5909255|P8|Treated|Part 2: Dose Expansion||0
2409019|NCT01286987|5909256|P7|Treated|Part 2: Dose Expansion||0
2409020|NCT01286987|5909257|P6|Treated|Part 2: Dose Expansion||0
2409021|NCT01286987|5909258|P5|Treated|Part 2: Dose Expansion||0
2409022|NCT01286987|5909259|P4|Treated|Part 2: Dose Expansion||0
2409023|NCT01286987|5909260|P3|Treated|Part 2: Dose Expansion||0
2409024|NCT01286987|5909261|P2|Treated|Part 2: Dose Expansion||0
2409025|NCT01286987|5909262|P1|Treated|Part 2: Dose Expansion||0
2409026|NCT01286987|5909248|P15|STARTED|Part 2: Dose Expansion||3
2409027|NCT01286987|5909249|P14|STARTED|Part 2: Dose Expansion||24
2409028|NCT01286987|5909250|P13|STARTED|Part 2: Dose Expansion||12
2409029|NCT01286987|5909251|P12|STARTED|Part 2: Dose Expansion||11
2409030|NCT01286987|5909252|P11|STARTED|Part 2: Dose Expansion||12
2409031|NCT01286987|5909253|P10|STARTED|Part 2: Dose Expansion||12
2409032|NCT01286987|5909254|P9|STARTED|Part 2: Dose Expansion||0
2409033|NCT01286987|5909255|P8|STARTED|Part 2: Dose Expansion||0
2409034|NCT01286987|5909256|P7|STARTED|Part 2: Dose Expansion||0
2409035|NCT01286987|5909257|P6|STARTED|Part 2: Dose Expansion||0
2409036|NCT01286987|5909258|P5|STARTED|Part 2: Dose Expansion||0
2409037|NCT01286987|5909259|P4|STARTED|Part 2: Dose Expansion||0
2409038|NCT01286987|5909260|P3|STARTED|Part 2: Dose Expansion||0
2409039|NCT01286987|5909261|P2|STARTED|Part 2: Dose Expansion||0
2409040|NCT01286987|5909262|P1|STARTED|Part 2: Dose Expansion||0
2409041|NCT01286987|5909248|P15|NOT COMPLETED|Part 1: Dose Escalation||0
2409042|NCT01286987|5909249|P14|NOT COMPLETED|Part 1: Dose Escalation||0
2409043|NCT01286987|5909250|P13|NOT COMPLETED|Part 1: Dose Escalation||0
2409044|NCT01286987|5909251|P12|NOT COMPLETED|Part 1: Dose Escalation||0
2409045|NCT01286987|5909252|P11|NOT COMPLETED|Part 1: Dose Escalation||0
2409046|NCT01286987|5909253|P10|NOT COMPLETED|Part 1: Dose Escalation||0
2409047|NCT01286987|5909254|P9|NOT COMPLETED|Part 1: Dose Escalation||6
2409048|NCT01286987|5909255|P8|NOT COMPLETED|Part 1: Dose Escalation||5
2409049|NCT01286987|5909256|P7|NOT COMPLETED|Part 1: Dose Escalation||5
2409050|NCT01286987|5909257|P6|NOT COMPLETED|Part 1: Dose Escalation||6
2409051|NCT01286987|5909258|P5|NOT COMPLETED|Part 1: Dose Escalation||3
2409052|NCT01286987|5909259|P4|NOT COMPLETED|Part 1: Dose Escalation||3
2409053|NCT01286987|5909260|P3|NOT COMPLETED|Part 1: Dose Escalation||3
2409054|NCT01286987|5909261|P2|NOT COMPLETED|Part 1: Dose Escalation||3
2409055|NCT01286987|5909262|P1|NOT COMPLETED|Part 1: Dose Escalation||3
2409056|NCT01286987|5909248|P15|COMPLETED|Part 1: Dose Escalation||0
2409057|NCT01286987|5909249|P14|COMPLETED|Part 1: Dose Escalation||0
2409058|NCT01286987|5909250|P13|COMPLETED|Part 1: Dose Escalation||0
2409059|NCT01286987|5909251|P12|COMPLETED|Part 1: Dose Escalation||0
2409060|NCT01286987|5909252|P11|COMPLETED|Part 1: Dose Escalation||0
2409061|NCT01286987|5909253|P10|COMPLETED|Part 1: Dose Escalation||0
2409062|NCT01286987|5909254|P9|COMPLETED|Part 1: Dose Escalation||0
2409063|NCT01286987|5909255|P8|COMPLETED|Part 1: Dose Escalation||1
2409064|NCT01286987|5909256|P7|COMPLETED|Part 1: Dose Escalation||1
2409065|NCT01286987|5909257|P6|COMPLETED|Part 1: Dose Escalation||0
2409066|NCT01286987|5909258|P5|COMPLETED|Part 1: Dose Escalation||0
2409067|NCT01286987|5909259|P4|COMPLETED|Part 1: Dose Escalation||0
2409068|NCT01286987|5909260|P3|COMPLETED|Part 1: Dose Escalation||0
2409069|NCT01286987|5909261|P2|COMPLETED|Part 1: Dose Escalation||0
2409070|NCT01286987|5909262|P1|COMPLETED|Part 1: Dose Escalation||0
2409071|NCT01286987|5909248|P15|Breast Cancer|Part 1: Dose Escalation||0
2409072|NCT01286987|5909249|P14|Breast Cancer|Part 1: Dose Escalation||0
2409073|NCT01286987|5909250|P13|Breast Cancer|Part 1: Dose Escalation||0
2409074|NCT01286987|5909251|P12|Breast Cancer|Part 1: Dose Escalation||0
2409075|NCT01286987|5909252|P11|Breast Cancer|Part 1: Dose Escalation||0
2409076|NCT01286987|5909253|P10|Breast Cancer|Part 1: Dose Escalation||0
2409077|NCT01286987|5909254|P9|Breast Cancer|Part 1: Dose Escalation||3
2409078|NCT01286987|5909255|P8|Breast Cancer|Part 1: Dose Escalation||2
2409079|NCT01286987|5909256|P7|Breast Cancer|Part 1: Dose Escalation||2
2409080|NCT01286987|5909257|P6|Breast Cancer|Part 1: Dose Escalation||1
2409081|NCT01286987|5909258|P5|Breast Cancer|Part 1: Dose Escalation||0
2409082|NCT01286987|5909259|P4|Breast Cancer|Part 1: Dose Escalation||0
2409083|NCT01286987|5909260|P3|Breast Cancer|Part 1: Dose Escalation||0
2409084|NCT01286987|5909261|P2|Breast Cancer|Part 1: Dose Escalation||0
2409085|NCT01286987|5909262|P1|Breast Cancer|Part 1: Dose Escalation||0
2409086|NCT01286987|5909248|P15|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
2409087|NCT01286987|5909249|P14|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
2409088|NCT01286987|5909250|P13|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
2409089|NCT01286987|5909251|P12|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
2409090|NCT01286987|5909252|P11|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
2409091|NCT01286987|5909253|P10|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
2409092|NCT01286987|5909254|P9|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||2
2409093|NCT01286987|5909255|P8|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
2409094|NCT01286987|5909256|P7|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||4
2409095|NCT01286987|5909257|P6|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||4
2409096|NCT01286987|5909258|P5|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
2409097|NCT01286987|5909259|P4|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
2409098|NCT01286987|5909260|P3|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||2
2409099|NCT01286987|5909261|P2|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||1
2409100|NCT01286987|5909262|P1|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||1
2409101|NCT01286987|5909248|P15|Pancreatic Cancer|Part 1: Dose Escalation||0
2409102|NCT01286987|5909249|P14|Pancreatic Cancer|Part 1: Dose Escalation||0
2409103|NCT01286987|5909250|P13|Pancreatic Cancer|Part 1: Dose Escalation||0
2409104|NCT01286987|5909251|P12|Pancreatic Cancer|Part 1: Dose Escalation||0
2409105|NCT01286987|5909252|P11|Pancreatic Cancer|Part 1: Dose Escalation||0
2409106|NCT01286987|5909253|P10|Pancreatic Cancer|Part 1: Dose Escalation||0
2409107|NCT01286987|5909254|P9|Pancreatic Cancer|Part 1: Dose Escalation||0
2409108|NCT01286987|5909255|P8|Pancreatic Cancer|Part 1: Dose Escalation||0
2409109|NCT01286987|5909256|P7|Pancreatic Cancer|Part 1: Dose Escalation||0
2409110|NCT01286987|5909257|P6|Pancreatic Cancer|Part 1: Dose Escalation||0
2409111|NCT01286987|5909258|P5|Pancreatic Cancer|Part 1: Dose Escalation||0
2409112|NCT01286987|5909259|P4|Pancreatic Cancer|Part 1: Dose Escalation||0
2409113|NCT01286987|5909260|P3|Pancreatic Cancer|Part 1: Dose Escalation||0
2409114|NCT01286987|5909261|P2|Pancreatic Cancer|Part 1: Dose Escalation||2
2409115|NCT01286987|5909262|P1|Pancreatic Cancer|Part 1: Dose Escalation||1
2409116|NCT01286987|5909248|P15|Ewing Cancer|Part 1: Dose Escalation||0
2409117|NCT01286987|5909249|P14|Ewing Cancer|Part 1: Dose Escalation||0
2409118|NCT01286987|5909250|P13|Ewing Cancer|Part 1: Dose Escalation||0
2409119|NCT01286987|5909251|P12|Ewing Cancer|Part 1: Dose Escalation||0
2409120|NCT01286987|5909252|P11|Ewing Cancer|Part 1: Dose Escalation||0
2409121|NCT01286987|5909253|P10|Ewing Cancer|Part 1: Dose Escalation||0
2409122|NCT01286987|5909254|P9|Ewing Cancer|Part 1: Dose Escalation||1
2409123|NCT01286987|5909255|P8|Ewing Cancer|Part 1: Dose Escalation||1
2409124|NCT01286987|5909256|P7|Ewing Cancer|Part 1: Dose Escalation||0
2409125|NCT01286987|5909257|P6|Ewing Cancer|Part 1: Dose Escalation||0
2409126|NCT01286987|5909258|P5|Ewing Cancer|Part 1: Dose Escalation||0
2409127|NCT01286987|5909259|P4|Ewing Cancer|Part 1: Dose Escalation||0
2409128|NCT01286987|5909260|P3|Ewing Cancer|Part 1: Dose Escalation||0
2409129|NCT01286987|5909261|P2|Ewing Cancer|Part 1: Dose Escalation||0
2409130|NCT01286987|5909262|P1|Ewing Cancer|Part 1: Dose Escalation||0
2409131|NCT01286987|5909248|P15|Prostate Cancer|Part 1: Dose Escalation||0
2409132|NCT01286987|5909249|P14|Prostate Cancer|Part 1: Dose Escalation||0
2409133|NCT01286987|5909250|P13|Prostate Cancer|Part 1: Dose Escalation||0
2409134|NCT01286987|5909251|P12|Prostate Cancer|Part 1: Dose Escalation||0
2409135|NCT01286987|5909252|P11|Prostate Cancer|Part 1: Dose Escalation||0
2409136|NCT01286987|5909253|P10|Prostate Cancer|Part 1: Dose Escalation||0
2409137|NCT01286987|5909254|P9|Prostate Cancer|Part 1: Dose Escalation||0
2409138|NCT01286987|5909255|P8|Prostate Cancer|Part 1: Dose Escalation||0
2409139|NCT01286987|5909256|P7|Prostate Cancer|Part 1: Dose Escalation||0
2409140|NCT01286987|5909257|P6|Prostate Cancer|Part 1: Dose Escalation||1
2409141|NCT01286987|5909258|P5|Prostate Cancer|Part 1: Dose Escalation||0
2409142|NCT01286987|5909259|P4|Prostate Cancer|Part 1: Dose Escalation||0
2409143|NCT01286987|5909260|P3|Prostate Cancer|Part 1: Dose Escalation||0
2409144|NCT01286987|5909261|P2|Prostate Cancer|Part 1: Dose Escalation||0
2409145|NCT01286987|5909262|P1|Prostate Cancer|Part 1: Dose Escalation||0
2409146|NCT01286987|5909248|P15|Colorectal Cancer|Part 1: Dose Escalation||0
2409147|NCT01286987|5909249|P14|Colorectal Cancer|Part 1: Dose Escalation||0
2409148|NCT01286987|5909250|P13|Colorectal Cancer|Part 1: Dose Escalation||0
2409149|NCT01286987|5909251|P12|Colorectal Cancer|Part 1: Dose Escalation||0
2409150|NCT01286987|5909252|P11|Colorectal Cancer|Part 1: Dose Escalation||0
2409151|NCT01286987|5909253|P10|Colorectal Cancer|Part 1: Dose Escalation||0
2409152|NCT01286987|5909254|P9|Colorectal Cancer|Part 1: Dose Escalation||0
2409153|NCT01286987|5909255|P8|Colorectal Cancer|Part 1: Dose Escalation||0
2409154|NCT01286987|5909256|P7|Colorectal Cancer|Part 1: Dose Escalation||0
2409155|NCT01286987|5909257|P6|Colorectal Cancer|Part 1: Dose Escalation||0
2409156|NCT01286987|5909258|P5|Colorectal Cancer|Part 1: Dose Escalation||0
2409157|NCT01286987|5909259|P4|Colorectal Cancer|Part 1: Dose Escalation||0
2409158|NCT01286987|5909260|P3|Colorectal Cancer|Part 1: Dose Escalation||1
2409159|NCT01286987|5909261|P2|Colorectal Cancer|Part 1: Dose Escalation||0
2409160|NCT01286987|5909262|P1|Colorectal Cancer|Part 1: Dose Escalation||1
2409161|NCT01286987|5909248|P15|STARTED|Part 1: Dose Escalation||0
2409162|NCT01286987|5909249|P14|STARTED|Part 1: Dose Escalation||0
2409163|NCT01286987|5909250|P13|STARTED|Part 1: Dose Escalation||0
2409164|NCT01286987|5909251|P12|STARTED|Part 1: Dose Escalation||0
2409165|NCT01286987|5909252|P11|STARTED|Part 1: Dose Escalation||0
2409166|NCT01286987|5909253|P10|STARTED|Part 1: Dose Escalation||0
2409167|NCT01286987|5909254|P9|STARTED|Part 1: Dose Escalation||6
2409168|NCT01286987|5909255|P8|STARTED|Part 1: Dose Escalation||6
2409169|NCT01286987|5909256|P7|STARTED|Part 1: Dose Escalation||6
2409170|NCT01286987|5909257|P6|STARTED|Part 1: Dose Escalation||6
2409171|NCT01286987|5909258|P5|STARTED|Part 1: Dose Escalation||3
2409172|NCT01286987|5909259|P4|STARTED|Part 1: Dose Escalation||3
2409173|NCT01286987|5909260|P3|STARTED|Part 1: Dose Escalation||3
2409174|NCT01286987|5909261|P2|STARTED|Part 1: Dose Escalation||3
2409175|NCT01286987|5909262|P1|STARTED|Part 1: Dose Escalation||3
2409176|NCT01286870|5909403|P1|NOT COMPLETED|Overall Study||0
2409177|NCT01286870|5909403|P1|COMPLETED|Overall Study||11
2409178|NCT01286870|5909403|P1|STARTED|Overall Study||11
2409179|NCT01286818|5909408|P1|NOT COMPLETED|Overall Study||0
2409180|NCT01286818|5909408|P1|COMPLETED|Overall Study||6
2409181|NCT01286818|5909408|P1|Completed DLT Assessment Period|Overall Study||5
2409182|NCT01286818|5909408|P1|STARTED|Overall Study||6
2409183|NCT01286805|5909422|P2|NOT COMPLETED|Overall Study||1
2409184|NCT01286805|5909423|P1|NOT COMPLETED|Overall Study||0
2409185|NCT01286805|5909422|P2|COMPLETED|Overall Study||41
2409186|NCT01286805|5909423|P1|COMPLETED|Overall Study||41
2409187|NCT01286805|5909422|P2|STARTED|Overall Study||42
2409188|NCT01286805|5909423|P1|STARTED|Overall Study||41
2409189|NCT01286779|5909443|P1|NOT COMPLETED|Overall Study||19
2409190|NCT01286779|5909443|P1|COMPLETED|Overall Study||96
2409191|NCT01286779|5909443|P1|STARTED|Overall Study||115
2409192|NCT01286753|5909495|P2|NOT COMPLETED|Overall Study||25
2409193|NCT01286753|5909496|P1|NOT COMPLETED|Overall Study||26
2409194|NCT01286753|5909495|P2|COMPLETED|Overall Study||0
2409195|NCT01286753|5909496|P1|COMPLETED|Overall Study||0
2409196|NCT01286753|5909495|P2|STARTED|Overall Study||25
2409197|NCT01286753|5909496|P1|STARTED|Overall Study||26
2409198|NCT01286740|5909514|P1|NOT COMPLETED|Overall Study||2
2409199|NCT01286740|5909514|P1|COMPLETED|Overall Study||48
2409200|NCT01286740|5909514|P1|Week 12 (Primary Endpoint)|Overall Study||49
2409201|NCT01286740|5909514|P1|Enrolled and Treated|Overall Study||49
2409202|NCT01286740|5909514|P1|STARTED|Overall Study||50
2409203|NCT01286558|5909532|P2|NOT COMPLETED|Overall Study||2
2409204|NCT01286558|5909533|P1|NOT COMPLETED|Overall Study||1
2409205|NCT01286558|5909532|P2|COMPLETED|Overall Study||111
2409206|NCT01286558|5909533|P1|COMPLETED|Overall Study||111
2409207|NCT01286558|5909532|P2|STARTED|Overall Study||113
2409208|NCT01286558|5909533|P1|STARTED|Overall Study||112
2409209|NCT01286493|5909563|P1|NOT COMPLETED|Overall Study||3
2409210|NCT01286493|5909563|P1|COMPLETED|Overall Study||30
2409211|NCT01286493|5909563|P1|STARTED|Overall Study||33
2409212|NCT01286480|5909569|P2|NOT COMPLETED|Overall Study||3
2409213|NCT01286480|5909570|P1|NOT COMPLETED|Overall Study||5
2409214|NCT01286480|5909569|P2|COMPLETED|Overall Study||31
2409215|NCT01286480|5909570|P1|COMPLETED|Overall Study||27
2409216|NCT01286480|5909569|P2|STARTED|Overall Study||34
2409217|NCT01286480|5909570|P1|STARTED|Overall Study||32
2409218|NCT01286454|5909578|P11|NOT COMPLETED|Part II- Sixth Intervention Period||0
2409219|NCT01286454|5909579|P10|NOT COMPLETED|Part II- Sixth Intervention Period||0
2409220|NCT01286454|5909580|P9|NOT COMPLETED|Part II- Sixth Intervention Period||0
2409221|NCT01286454|5909581|P8|NOT COMPLETED|Part II- Sixth Intervention Period||0
2409222|NCT01286454|5909582|P7|NOT COMPLETED|Part II- Sixth Intervention Period||0
2409223|NCT01286454|5909583|P6|NOT COMPLETED|Part II- Sixth Intervention Period||0
2409224|NCT01286454|5909584|P5|NOT COMPLETED|Part II- Sixth Intervention Period||0
2409225|NCT01286454|5909585|P4|NOT COMPLETED|Part II- Sixth Intervention Period||0
2409226|NCT01286454|5909586|P3|NOT COMPLETED|Part II- Sixth Intervention Period||0
2409227|NCT01286454|5909587|P2|NOT COMPLETED|Part II- Sixth Intervention Period||0
2409228|NCT01286454|5909588|P1|NOT COMPLETED|Part II- Sixth Intervention Period||0
2409229|NCT01286454|5909578|P11|COMPLETED|Part II- Sixth Intervention Period||20
2409230|NCT01286454|5909579|P10|COMPLETED|Part II- Sixth Intervention Period||0
2409231|NCT01286454|5909580|P9|COMPLETED|Part II- Sixth Intervention Period||0
2409232|NCT01286454|5909581|P8|COMPLETED|Part II- Sixth Intervention Period||0
2409233|NCT01286454|5909582|P7|COMPLETED|Part II- Sixth Intervention Period||0
2409234|NCT01286454|5909583|P6|COMPLETED|Part II- Sixth Intervention Period||0
2409235|NCT01286454|5909584|P5|COMPLETED|Part II- Sixth Intervention Period||0
2409236|NCT01286454|5909585|P4|COMPLETED|Part II- Sixth Intervention Period||0
2409237|NCT01286454|5909586|P3|COMPLETED|Part II- Sixth Intervention Period||0
2409238|NCT01286454|5909587|P2|COMPLETED|Part II- Sixth Intervention Period||0
2409239|NCT01286454|5909588|P1|COMPLETED|Part II- Sixth Intervention Period||0
2409240|NCT01286454|5909578|P11|STARTED|Part II- Sixth Intervention Period||20
2409241|NCT01286454|5909579|P10|STARTED|Part II- Sixth Intervention Period||0
2409242|NCT01286454|5909580|P9|STARTED|Part II- Sixth Intervention Period||0
2409243|NCT01286454|5909581|P8|STARTED|Part II- Sixth Intervention Period||0
2409244|NCT01286454|5909582|P7|STARTED|Part II- Sixth Intervention Period||0
2409245|NCT01286454|5909583|P6|STARTED|Part II- Sixth Intervention Period||0
2409246|NCT01286454|5909584|P5|STARTED|Part II- Sixth Intervention Period||0
2409247|NCT01286454|5909585|P4|STARTED|Part II- Sixth Intervention Period||0
2409248|NCT01286454|5909586|P3|STARTED|Part II- Sixth Intervention Period||0
2409249|NCT01286454|5909587|P2|STARTED|Part II- Sixth Intervention Period||0
2409250|NCT01286454|5909588|P1|STARTED|Part II- Sixth Intervention Period||0
2409251|NCT01286454|5909578|P11|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
2409252|NCT01286454|5909579|P10|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
2409253|NCT01286454|5909580|P9|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
2409254|NCT01286454|5909581|P8|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
2409255|NCT01286454|5909582|P7|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
2409256|NCT01286454|5909583|P6|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
2409257|NCT01286454|5909584|P5|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
2409258|NCT01286454|5909585|P4|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
2409259|NCT01286454|5909586|P3|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
2409260|NCT01286454|5909587|P2|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
2409261|NCT01286454|5909588|P1|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
2409262|NCT01286454|5909578|P11|COMPLETED|Washout Period (Approximately 2 Weeks)||0
2409263|NCT01286454|5909579|P10|COMPLETED|Washout Period (Approximately 2 Weeks)||2
2409264|NCT01286454|5909580|P9|COMPLETED|Washout Period (Approximately 2 Weeks)||2
2409265|NCT01286454|5909581|P8|COMPLETED|Washout Period (Approximately 2 Weeks)||2
2409266|NCT01286454|5909582|P7|COMPLETED|Washout Period (Approximately 2 Weeks)||2
2409267|NCT01286454|5909583|P6|COMPLETED|Washout Period (Approximately 2 Weeks)||2
2409268|NCT01286454|5909584|P5|COMPLETED|Washout Period (Approximately 2 Weeks)||2
2409269|NCT01286454|5909585|P4|COMPLETED|Washout Period (Approximately 2 Weeks)||2
2409270|NCT01286454|5909586|P3|COMPLETED|Washout Period (Approximately 2 Weeks)||2
2409271|NCT01286454|5909587|P2|COMPLETED|Washout Period (Approximately 2 Weeks)||2
2409272|NCT01286454|5909588|P1|COMPLETED|Washout Period (Approximately 2 Weeks)||2
2409273|NCT01286454|5909578|P11|STARTED|Washout Period (Approximately 2 Weeks)||0
2409274|NCT01286454|5909579|P10|STARTED|Washout Period (Approximately 2 Weeks)||2
2409275|NCT01286454|5909580|P9|STARTED|Washout Period (Approximately 2 Weeks)||2
2409276|NCT01286454|5909581|P8|STARTED|Washout Period (Approximately 2 Weeks)||2
2409277|NCT01286454|5909582|P7|STARTED|Washout Period (Approximately 2 Weeks)||2
2409278|NCT01286454|5909583|P6|STARTED|Washout Period (Approximately 2 Weeks)||2
2409279|NCT01286454|5909584|P5|STARTED|Washout Period (Approximately 2 Weeks)||2
2409280|NCT01286454|5909585|P4|STARTED|Washout Period (Approximately 2 Weeks)||2
2409281|NCT01286454|5909586|P3|STARTED|Washout Period (Approximately 2 Weeks)||2
2409282|NCT01286454|5909587|P2|STARTED|Washout Period (Approximately 2 Weeks)||2
2409283|NCT01286454|5909588|P1|STARTED|Washout Period (Approximately 2 Weeks)||2
2409284|NCT01286454|5909578|P11|NOT COMPLETED|Fifth Intervention Period||0
2409285|NCT01286454|5909579|P10|NOT COMPLETED|Fifth Intervention Period||0
2409286|NCT01286454|5909580|P9|NOT COMPLETED|Fifth Intervention Period||0
2409287|NCT01286454|5909581|P8|NOT COMPLETED|Fifth Intervention Period||0
2409288|NCT01286454|5909582|P7|NOT COMPLETED|Fifth Intervention Period||0
2409289|NCT01286454|5909583|P6|NOT COMPLETED|Fifth Intervention Period||0
2409290|NCT01286454|5909584|P5|NOT COMPLETED|Fifth Intervention Period||0
2409291|NCT01286454|5909585|P4|NOT COMPLETED|Fifth Intervention Period||0
2409292|NCT01286454|5909586|P3|NOT COMPLETED|Fifth Intervention Period||0
2409293|NCT01286454|5909587|P2|NOT COMPLETED|Fifth Intervention Period||0
2409294|NCT01286454|5909588|P1|NOT COMPLETED|Fifth Intervention Period||0
2409295|NCT01286454|5909578|P11|COMPLETED|Fifth Intervention Period||0
2409296|NCT01286454|5909579|P10|COMPLETED|Fifth Intervention Period||2
2409297|NCT01286454|5909580|P9|COMPLETED|Fifth Intervention Period||2
2409298|NCT01286454|5909581|P8|COMPLETED|Fifth Intervention Period||2
2409299|NCT01286454|5909582|P7|COMPLETED|Fifth Intervention Period||2
2409300|NCT01286454|5909583|P6|COMPLETED|Fifth Intervention Period||2
2409301|NCT01286454|5909584|P5|COMPLETED|Fifth Intervention Period||2
2409302|NCT01286454|5909585|P4|COMPLETED|Fifth Intervention Period||2
2409303|NCT01286454|5909586|P3|COMPLETED|Fifth Intervention Period||2
2409304|NCT01286454|5909587|P2|COMPLETED|Fifth Intervention Period||2
2409305|NCT01286454|5909588|P1|COMPLETED|Fifth Intervention Period||2
2409306|NCT01286454|5909578|P11|STARTED|Fifth Intervention Period||0
2409307|NCT01286454|5909579|P10|STARTED|Fifth Intervention Period||2
2409308|NCT01286454|5909580|P9|STARTED|Fifth Intervention Period||2
2409309|NCT01286454|5909581|P8|STARTED|Fifth Intervention Period||2
2409310|NCT01286454|5909582|P7|STARTED|Fifth Intervention Period||2
2409311|NCT01286454|5909583|P6|STARTED|Fifth Intervention Period||2
2409312|NCT01286454|5909584|P5|STARTED|Fifth Intervention Period||2
2409313|NCT01286454|5909585|P4|STARTED|Fifth Intervention Period||2
2409314|NCT01286454|5909586|P3|STARTED|Fifth Intervention Period||2
2409315|NCT01286454|5909587|P2|STARTED|Fifth Intervention Period||2
2409316|NCT01286454|5909588|P1|STARTED|Fifth Intervention Period||2
2409317|NCT01286454|5909578|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409318|NCT01286454|5909579|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409319|NCT01286454|5909580|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409320|NCT01286454|5909581|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409321|NCT01286454|5909582|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409322|NCT01286454|5909583|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409323|NCT01286454|5909584|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409324|NCT01286454|5909585|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409325|NCT01286454|5909586|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409326|NCT01286454|5909587|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409327|NCT01286454|5909588|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409328|NCT01286454|5909578|P11|COMPLETED|Washout Period (At Least 3 Days)||0
2409329|NCT01286454|5909579|P10|COMPLETED|Washout Period (At Least 3 Days)||2
2409330|NCT01286454|5909580|P9|COMPLETED|Washout Period (At Least 3 Days)||2
2409331|NCT01286454|5909581|P8|COMPLETED|Washout Period (At Least 3 Days)||2
2409332|NCT01286454|5909582|P7|COMPLETED|Washout Period (At Least 3 Days)||2
2409333|NCT01286454|5909583|P6|COMPLETED|Washout Period (At Least 3 Days)||2
2409334|NCT01286454|5909584|P5|COMPLETED|Washout Period (At Least 3 Days)||2
2409335|NCT01286454|5909585|P4|COMPLETED|Washout Period (At Least 3 Days)||2
2409336|NCT01286454|5909586|P3|COMPLETED|Washout Period (At Least 3 Days)||2
2409337|NCT01286454|5909587|P2|COMPLETED|Washout Period (At Least 3 Days)||2
2409338|NCT01286454|5909588|P1|COMPLETED|Washout Period (At Least 3 Days)||2
2409339|NCT01286454|5909578|P11|STARTED|Washout Period (At Least 3 Days)||0
2409340|NCT01286454|5909579|P10|STARTED|Washout Period (At Least 3 Days)||2
2409341|NCT01286454|5909580|P9|STARTED|Washout Period (At Least 3 Days)||2
2409342|NCT01286454|5909581|P8|STARTED|Washout Period (At Least 3 Days)||2
2409343|NCT01286454|5909582|P7|STARTED|Washout Period (At Least 3 Days)||2
2409344|NCT01286454|5909583|P6|STARTED|Washout Period (At Least 3 Days)||2
2409345|NCT01286454|5909584|P5|STARTED|Washout Period (At Least 3 Days)||2
2409346|NCT01286454|5909585|P4|STARTED|Washout Period (At Least 3 Days)||2
2409347|NCT01286454|5909586|P3|STARTED|Washout Period (At Least 3 Days)||2
2409348|NCT01286454|5909587|P2|STARTED|Washout Period (At Least 3 Days)||2
2409349|NCT01286454|5909588|P1|STARTED|Washout Period (At Least 3 Days)||2
2409350|NCT01286454|5909578|P11|NOT COMPLETED|Fourth Intervention Period||0
2409351|NCT01286454|5909579|P10|NOT COMPLETED|Fourth Intervention Period||0
2409352|NCT01286454|5909580|P9|NOT COMPLETED|Fourth Intervention Period||0
2409353|NCT01286454|5909581|P8|NOT COMPLETED|Fourth Intervention Period||0
2409354|NCT01286454|5909582|P7|NOT COMPLETED|Fourth Intervention Period||0
2409355|NCT01286454|5909583|P6|NOT COMPLETED|Fourth Intervention Period||0
2409356|NCT01286454|5909584|P5|NOT COMPLETED|Fourth Intervention Period||0
2409357|NCT01286454|5909585|P4|NOT COMPLETED|Fourth Intervention Period||0
2409358|NCT01286454|5909586|P3|NOT COMPLETED|Fourth Intervention Period||0
2409359|NCT01286454|5909587|P2|NOT COMPLETED|Fourth Intervention Period||0
2409360|NCT01286454|5909588|P1|NOT COMPLETED|Fourth Intervention Period||0
2409361|NCT01286454|5909578|P11|COMPLETED|Fourth Intervention Period||0
2409362|NCT01286454|5909579|P10|COMPLETED|Fourth Intervention Period||2
2409363|NCT01286454|5909580|P9|COMPLETED|Fourth Intervention Period||2
2409364|NCT01286454|5909581|P8|COMPLETED|Fourth Intervention Period||2
2409365|NCT01286454|5909582|P7|COMPLETED|Fourth Intervention Period||2
2409366|NCT01286454|5909583|P6|COMPLETED|Fourth Intervention Period||2
2409367|NCT01286454|5909584|P5|COMPLETED|Fourth Intervention Period||2
2409368|NCT01286454|5909585|P4|COMPLETED|Fourth Intervention Period||2
2409369|NCT01286454|5909586|P3|COMPLETED|Fourth Intervention Period||2
2409370|NCT01286454|5909587|P2|COMPLETED|Fourth Intervention Period||2
2409371|NCT01286454|5909588|P1|COMPLETED|Fourth Intervention Period||2
2409372|NCT01286454|5909578|P11|STARTED|Fourth Intervention Period||0
2409373|NCT01286454|5909579|P10|STARTED|Fourth Intervention Period||2
2409374|NCT01286454|5909580|P9|STARTED|Fourth Intervention Period||2
2409375|NCT01286454|5909581|P8|STARTED|Fourth Intervention Period||2
2409376|NCT01286454|5909582|P7|STARTED|Fourth Intervention Period||2
2409377|NCT01286454|5909583|P6|STARTED|Fourth Intervention Period||2
2409378|NCT01286454|5909584|P5|STARTED|Fourth Intervention Period||2
2409379|NCT01286454|5909585|P4|STARTED|Fourth Intervention Period||2
2409380|NCT01286454|5909586|P3|STARTED|Fourth Intervention Period||2
2409381|NCT01286454|5909587|P2|STARTED|Fourth Intervention Period||2
2409382|NCT01286454|5909588|P1|STARTED|Fourth Intervention Period||2
2409383|NCT01286454|5909578|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409384|NCT01286454|5909579|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409385|NCT01286454|5909580|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409386|NCT01286454|5909581|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409387|NCT01286454|5909582|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409388|NCT01286454|5909583|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409389|NCT01286454|5909584|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409390|NCT01286454|5909585|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409391|NCT01286454|5909586|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409392|NCT01286454|5909587|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409393|NCT01286454|5909588|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409394|NCT01286454|5909578|P11|COMPLETED|Washout Period (At Least 3 Days)||0
2409395|NCT01286454|5909579|P10|COMPLETED|Washout Period (At Least 3 Days)||2
2409396|NCT01286454|5909580|P9|COMPLETED|Washout Period (At Least 3 Days)||2
2409397|NCT01286454|5909581|P8|COMPLETED|Washout Period (At Least 3 Days)||2
2409398|NCT01286454|5909582|P7|COMPLETED|Washout Period (At Least 3 Days)||2
2409399|NCT01286454|5909583|P6|COMPLETED|Washout Period (At Least 3 Days)||2
2409400|NCT01286454|5909584|P5|COMPLETED|Washout Period (At Least 3 Days)||2
2409401|NCT01286454|5909585|P4|COMPLETED|Washout Period (At Least 3 Days)||2
2409402|NCT01286454|5909586|P3|COMPLETED|Washout Period (At Least 3 Days)||2
2409403|NCT01286454|5909587|P2|COMPLETED|Washout Period (At Least 3 Days)||2
2409404|NCT01286454|5909588|P1|COMPLETED|Washout Period (At Least 3 Days)||2
2409405|NCT01286454|5909578|P11|STARTED|Washout Period (At Least 3 Days)||0
2409406|NCT01286454|5909579|P10|STARTED|Washout Period (At Least 3 Days)||2
2409407|NCT01286454|5909580|P9|STARTED|Washout Period (At Least 3 Days)||2
2409408|NCT01286454|5909581|P8|STARTED|Washout Period (At Least 3 Days)||2
2409409|NCT01286454|5909582|P7|STARTED|Washout Period (At Least 3 Days)||2
2409410|NCT01286454|5909583|P6|STARTED|Washout Period (At Least 3 Days)||2
2409411|NCT01286454|5909584|P5|STARTED|Washout Period (At Least 3 Days)||2
2409412|NCT01286454|5909585|P4|STARTED|Washout Period (At Least 3 Days)||2
2409413|NCT01286454|5909586|P3|STARTED|Washout Period (At Least 3 Days)||2
2409414|NCT01286454|5909587|P2|STARTED|Washout Period (At Least 3 Days)||2
2409415|NCT01286454|5909588|P1|STARTED|Washout Period (At Least 3 Days)||2
2409416|NCT01286454|5909578|P11|NOT COMPLETED|Third Intervention Period||0
2409417|NCT01286454|5909579|P10|NOT COMPLETED|Third Intervention Period||0
2409418|NCT01286454|5909580|P9|NOT COMPLETED|Third Intervention Period||0
2409419|NCT01286454|5909581|P8|NOT COMPLETED|Third Intervention Period||0
2409420|NCT01286454|5909582|P7|NOT COMPLETED|Third Intervention Period||0
2409421|NCT01286454|5909583|P6|NOT COMPLETED|Third Intervention Period||0
2409422|NCT01286454|5909584|P5|NOT COMPLETED|Third Intervention Period||0
2409423|NCT01286454|5909585|P4|NOT COMPLETED|Third Intervention Period||0
2409424|NCT01286454|5909586|P3|NOT COMPLETED|Third Intervention Period||0
2409425|NCT01286454|5909587|P2|NOT COMPLETED|Third Intervention Period||0
2409426|NCT01286454|5909588|P1|NOT COMPLETED|Third Intervention Period||0
2409427|NCT01286454|5909578|P11|COMPLETED|Third Intervention Period||0
2409428|NCT01286454|5909579|P10|COMPLETED|Third Intervention Period||2
2409429|NCT01286454|5909580|P9|COMPLETED|Third Intervention Period||2
2409430|NCT01286454|5909581|P8|COMPLETED|Third Intervention Period||2
2409431|NCT01286454|5909582|P7|COMPLETED|Third Intervention Period||2
2409432|NCT01286454|5909583|P6|COMPLETED|Third Intervention Period||2
2409433|NCT01286454|5909584|P5|COMPLETED|Third Intervention Period||2
2409434|NCT01286454|5909585|P4|COMPLETED|Third Intervention Period||2
2409435|NCT01286454|5909586|P3|COMPLETED|Third Intervention Period||2
2409436|NCT01286454|5909587|P2|COMPLETED|Third Intervention Period||2
2409437|NCT01286454|5909588|P1|COMPLETED|Third Intervention Period||2
2409438|NCT01286454|5909578|P11|STARTED|Third Intervention Period||0
2409439|NCT01286454|5909579|P10|STARTED|Third Intervention Period||2
2409440|NCT01286454|5909580|P9|STARTED|Third Intervention Period||2
2409441|NCT01286454|5909581|P8|STARTED|Third Intervention Period||2
2409442|NCT01286454|5909582|P7|STARTED|Third Intervention Period||2
2409443|NCT01286454|5909583|P6|STARTED|Third Intervention Period||2
2409444|NCT01286454|5909584|P5|STARTED|Third Intervention Period||2
2409445|NCT01286454|5909585|P4|STARTED|Third Intervention Period||2
2409446|NCT01286454|5909586|P3|STARTED|Third Intervention Period||2
2409447|NCT01286454|5909587|P2|STARTED|Third Intervention Period||2
2409448|NCT01286454|5909588|P1|STARTED|Third Intervention Period||2
2409449|NCT01286454|5909578|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409450|NCT01286454|5909579|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409451|NCT01286454|5909580|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409452|NCT01286454|5909581|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409453|NCT01286454|5909582|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409454|NCT01286454|5909583|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409455|NCT01286454|5909584|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409456|NCT01286454|5909585|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409457|NCT01286454|5909586|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409458|NCT01286454|5909587|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409459|NCT01286454|5909588|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409460|NCT01286454|5909578|P11|COMPLETED|Washout Period (At Least 3 Days)||0
2409461|NCT01286454|5909579|P10|COMPLETED|Washout Period (At Least 3 Days)||2
2409462|NCT01286454|5909580|P9|COMPLETED|Washout Period (At Least 3 Days)||2
2409463|NCT01286454|5909581|P8|COMPLETED|Washout Period (At Least 3 Days)||2
2409464|NCT01286454|5909582|P7|COMPLETED|Washout Period (At Least 3 Days)||2
2409465|NCT01286454|5909583|P6|COMPLETED|Washout Period (At Least 3 Days)||2
2409466|NCT01286454|5909584|P5|COMPLETED|Washout Period (At Least 3 Days)||2
2409467|NCT01286454|5909585|P4|COMPLETED|Washout Period (At Least 3 Days)||2
2409468|NCT01286454|5909586|P3|COMPLETED|Washout Period (At Least 3 Days)||2
2409469|NCT01286454|5909587|P2|COMPLETED|Washout Period (At Least 3 Days)||2
2409470|NCT01286454|5909588|P1|COMPLETED|Washout Period (At Least 3 Days)||2
2409471|NCT01286454|5909578|P11|STARTED|Washout Period (At Least 3 Days)||0
2409472|NCT01286454|5909579|P10|STARTED|Washout Period (At Least 3 Days)||2
2409473|NCT01286454|5909580|P9|STARTED|Washout Period (At Least 3 Days)||2
2409474|NCT01286454|5909581|P8|STARTED|Washout Period (At Least 3 Days)||2
2409475|NCT01286454|5909582|P7|STARTED|Washout Period (At Least 3 Days)||2
2409476|NCT01286454|5909583|P6|STARTED|Washout Period (At Least 3 Days)||2
2409477|NCT01286454|5909584|P5|STARTED|Washout Period (At Least 3 Days)||2
2409478|NCT01286454|5909585|P4|STARTED|Washout Period (At Least 3 Days)||2
2409479|NCT01286454|5909586|P3|STARTED|Washout Period (At Least 3 Days)||2
2409480|NCT01286454|5909587|P2|STARTED|Washout Period (At Least 3 Days)||2
2409481|NCT01286454|5909588|P1|STARTED|Washout Period (At Least 3 Days)||2
2409482|NCT01286454|5909578|P11|NOT COMPLETED|Second Intervention Period||0
2409483|NCT01286454|5909579|P10|NOT COMPLETED|Second Intervention Period||0
2409484|NCT01286454|5909580|P9|NOT COMPLETED|Second Intervention Period||0
2409485|NCT01286454|5909581|P8|NOT COMPLETED|Second Intervention Period||0
2409486|NCT01286454|5909582|P7|NOT COMPLETED|Second Intervention Period||0
2409487|NCT01286454|5909583|P6|NOT COMPLETED|Second Intervention Period||0
2409488|NCT01286454|5909584|P5|NOT COMPLETED|Second Intervention Period||0
2409489|NCT01286454|5909585|P4|NOT COMPLETED|Second Intervention Period||0
2409490|NCT01286454|5909586|P3|NOT COMPLETED|Second Intervention Period||0
2409491|NCT01286454|5909587|P2|NOT COMPLETED|Second Intervention Period||0
2409492|NCT01286454|5909588|P1|NOT COMPLETED|Second Intervention Period||0
2409493|NCT01286454|5909578|P11|COMPLETED|Second Intervention Period||0
2409494|NCT01286454|5909579|P10|COMPLETED|Second Intervention Period||2
2409495|NCT01286454|5909580|P9|COMPLETED|Second Intervention Period||2
2409496|NCT01286454|5909581|P8|COMPLETED|Second Intervention Period||2
2409497|NCT01286454|5909582|P7|COMPLETED|Second Intervention Period||2
2409498|NCT01286454|5909583|P6|COMPLETED|Second Intervention Period||2
2409499|NCT01286454|5909584|P5|COMPLETED|Second Intervention Period||2
2409500|NCT01286454|5909585|P4|COMPLETED|Second Intervention Period||2
2409501|NCT01286454|5909586|P3|COMPLETED|Second Intervention Period||2
2409502|NCT01286454|5909587|P2|COMPLETED|Second Intervention Period||2
2409503|NCT01286454|5909588|P1|COMPLETED|Second Intervention Period||2
2409504|NCT01286454|5909578|P11|STARTED|Second Intervention Period||0
2409505|NCT01286454|5909579|P10|STARTED|Second Intervention Period||2
2409506|NCT01286454|5909580|P9|STARTED|Second Intervention Period||2
2409507|NCT01286454|5909581|P8|STARTED|Second Intervention Period||2
2409508|NCT01286454|5909582|P7|STARTED|Second Intervention Period||2
2409509|NCT01286454|5909583|P6|STARTED|Second Intervention Period||2
2409510|NCT01286454|5909584|P5|STARTED|Second Intervention Period||2
2409511|NCT01286454|5909585|P4|STARTED|Second Intervention Period||2
2409512|NCT01286454|5909586|P3|STARTED|Second Intervention Period||2
2409513|NCT01286454|5909587|P2|STARTED|Second Intervention Period||2
2409514|NCT01286454|5909588|P1|STARTED|Second Intervention Period||2
2409515|NCT01286454|5909578|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409516|NCT01286454|5909579|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409517|NCT01286454|5909580|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409518|NCT01286454|5909581|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409519|NCT01286454|5909582|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409520|NCT01286454|5909583|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409521|NCT01286454|5909584|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409522|NCT01286454|5909585|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409523|NCT01286454|5909586|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409524|NCT01286454|5909587|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409525|NCT01286454|5909588|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
2409526|NCT01286454|5909578|P11|COMPLETED|Washout Period (At Least 3 Days)||0
2409527|NCT01286454|5909579|P10|COMPLETED|Washout Period (At Least 3 Days)||2
2409528|NCT01286454|5909580|P9|COMPLETED|Washout Period (At Least 3 Days)||2
2409529|NCT01286454|5909581|P8|COMPLETED|Washout Period (At Least 3 Days)||2
2409530|NCT01286454|5909582|P7|COMPLETED|Washout Period (At Least 3 Days)||2
2409531|NCT01286454|5909583|P6|COMPLETED|Washout Period (At Least 3 Days)||2
2409532|NCT01286454|5909584|P5|COMPLETED|Washout Period (At Least 3 Days)||2
2409533|NCT01286454|5909585|P4|COMPLETED|Washout Period (At Least 3 Days)||2
2409534|NCT01286454|5909586|P3|COMPLETED|Washout Period (At Least 3 Days)||2
2409535|NCT01286454|5909587|P2|COMPLETED|Washout Period (At Least 3 Days)||2
2409536|NCT01286454|5909588|P1|COMPLETED|Washout Period (At Least 3 Days)||2
2409537|NCT01286454|5909578|P11|STARTED|Washout Period (At Least 3 Days)||0
2409538|NCT01286454|5909579|P10|STARTED|Washout Period (At Least 3 Days)||2
2409539|NCT01286454|5909580|P9|STARTED|Washout Period (At Least 3 Days)||2
2409540|NCT01286454|5909581|P8|STARTED|Washout Period (At Least 3 Days)||2
2409541|NCT01286454|5909582|P7|STARTED|Washout Period (At Least 3 Days)||2
2409542|NCT01286454|5909583|P6|STARTED|Washout Period (At Least 3 Days)||2
2409543|NCT01286454|5909584|P5|STARTED|Washout Period (At Least 3 Days)||2
2409544|NCT01286454|5909585|P4|STARTED|Washout Period (At Least 3 Days)||2
2409545|NCT01286454|5909586|P3|STARTED|Washout Period (At Least 3 Days)||2
2409546|NCT01286454|5909587|P2|STARTED|Washout Period (At Least 3 Days)||2
2409547|NCT01286454|5909588|P1|STARTED|Washout Period (At Least 3 Days)||2
2409548|NCT01286454|5909578|P11|NOT COMPLETED|Part I- First Intervention Period||0
2409549|NCT01286454|5909579|P10|NOT COMPLETED|Part I- First Intervention Period||0
2409550|NCT01286454|5909580|P9|NOT COMPLETED|Part I- First Intervention Period||0
2409551|NCT01286454|5909581|P8|NOT COMPLETED|Part I- First Intervention Period||0
2409552|NCT01286454|5909582|P7|NOT COMPLETED|Part I- First Intervention Period||0
2409553|NCT01286454|5909583|P6|NOT COMPLETED|Part I- First Intervention Period||0
2409554|NCT01286454|5909584|P5|NOT COMPLETED|Part I- First Intervention Period||0
2409555|NCT01286454|5909585|P4|NOT COMPLETED|Part I- First Intervention Period||0
2409556|NCT01286454|5909586|P3|NOT COMPLETED|Part I- First Intervention Period||0
2409557|NCT01286454|5909587|P2|NOT COMPLETED|Part I- First Intervention Period||0
2409558|NCT01286454|5909588|P1|NOT COMPLETED|Part I- First Intervention Period||0
2409559|NCT01286454|5909578|P11|COMPLETED|Part I- First Intervention Period||0
2409560|NCT01286454|5909579|P10|COMPLETED|Part I- First Intervention Period||2
2409561|NCT01286454|5909580|P9|COMPLETED|Part I- First Intervention Period||2
2409562|NCT01286454|5909581|P8|COMPLETED|Part I- First Intervention Period||2
2409563|NCT01286454|5909582|P7|COMPLETED|Part I- First Intervention Period||2
2409564|NCT01286454|5909583|P6|COMPLETED|Part I- First Intervention Period||2
2409565|NCT01286454|5909584|P5|COMPLETED|Part I- First Intervention Period||2
2409566|NCT01286454|5909585|P4|COMPLETED|Part I- First Intervention Period||2
2409567|NCT01286454|5909586|P3|COMPLETED|Part I- First Intervention Period||2
2409568|NCT01286454|5909587|P2|COMPLETED|Part I- First Intervention Period||2
2409569|NCT01286454|5909588|P1|COMPLETED|Part I- First Intervention Period||2
2409570|NCT01286454|5909578|P11|STARTED|Part I- First Intervention Period||0
2409571|NCT01286454|5909579|P10|STARTED|Part I- First Intervention Period||2
2409572|NCT01286454|5909580|P9|STARTED|Part I- First Intervention Period||2
2409573|NCT01286454|5909581|P8|STARTED|Part I- First Intervention Period||2
2409574|NCT01286454|5909582|P7|STARTED|Part I- First Intervention Period||2
2409575|NCT01286454|5909583|P6|STARTED|Part I- First Intervention Period||2
2409576|NCT01286454|5909584|P5|STARTED|Part I- First Intervention Period||2
2409577|NCT01286454|5909585|P4|STARTED|Part I- First Intervention Period||2
2409578|NCT01286454|5909586|P3|STARTED|Part I- First Intervention Period||2
2409579|NCT01286454|5909587|P2|STARTED|Part I- First Intervention Period||2
2409580|NCT01286454|5909588|P1|STARTED|Part I- First Intervention Period||2
2409581|NCT01286441|5909630|P4|NOT COMPLETED|Overall Study||11
2409582|NCT01286441|5909631|P3|NOT COMPLETED|Overall Study||7
2409583|NCT01286441|5909632|P2|NOT COMPLETED|Overall Study||7
2409584|NCT01286441|5909633|P1|NOT COMPLETED|Overall Study||7
2409585|NCT01286441|5909630|P4|COMPLETED|Overall Study||37
2409586|NCT01286441|5909631|P3|COMPLETED|Overall Study||39
2409587|NCT01286441|5909632|P2|COMPLETED|Overall Study||37
2409588|NCT01286441|5909633|P1|COMPLETED|Overall Study||38
2409589|NCT01286441|5909630|P4|STARTED|Overall Study||48
2409590|NCT01286441|5909631|P3|STARTED|Overall Study||46
2409591|NCT01286441|5909632|P2|STARTED|Overall Study||44
2409592|NCT01286441|5909633|P1|STARTED|Overall Study||45
2409593|NCT01286402|5909649|P2|NOT COMPLETED|Overall Study||0
2409594|NCT01286402|5909650|P1|NOT COMPLETED|Overall Study||0
2409595|NCT01286402|5909649|P2|COMPLETED|Overall Study||6
2409596|NCT01286402|5909650|P1|COMPLETED|Overall Study||5
2409597|NCT01286402|5909649|P2|STARTED|Overall Study||6
2409598|NCT01286402|5909650|P1|STARTED|Overall Study||5
2409599|NCT01286324|5909658|P2|NOT COMPLETED|Overall Study||0
2409600|NCT01286324|5909659|P1|NOT COMPLETED|Overall Study||0
2409601|NCT01286324|5909658|P2|COMPLETED|Overall Study||17
2409602|NCT01286324|5909659|P1|COMPLETED|Overall Study||17
2409603|NCT01286324|5909658|P2|STARTED|Overall Study||17
2409604|NCT01286324|5909659|P1|STARTED|Overall Study||17
2409605|NCT01286311|5909677|P2|NOT COMPLETED|Overall Study||0
2409606|NCT01286311|5909678|P1|NOT COMPLETED|Overall Study||14
2409607|NCT01286311|5909677|P2|COMPLETED|Overall Study|217 patients (of the 15 physician randomized to the intervention) completed the study.|232
2409608|NCT01286311|5909678|P1|COMPLETED|Overall Study|204 patients (of the 14 physician randomized to the intervention) completed the study.|218
2409609|NCT01286311|5909677|P2|STARTED|Overall Study|217 patients (of the 15 physician randomized to the intervention) started the study.|232
2409610|NCT01286311|5909678|P1|STARTED|Overall Study|218 patients (of the 14 physician randomized to the intervention) started the study.|232
2409611|NCT01286272|5909694|P2|NOT COMPLETED|Overall Study||3
2409612|NCT01286272|5909695|P1|NOT COMPLETED|Overall Study||1
2409613|NCT01286272|5909694|P2|COMPLETED|Overall Study||62
2409614|NCT01286272|5909695|P1|COMPLETED|Overall Study||66
2409615|NCT01286272|5909694|P2|STARTED|Overall Study||65
2409616|NCT01286272|5909695|P1|STARTED|Overall Study||67
2409617|NCT01286207|5909708|P3|NOT COMPLETED|Overall Study||90
2409618|NCT01286207|5909709|P2|NOT COMPLETED|Overall Study||248
2409619|NCT01286207|5909710|P1|NOT COMPLETED|Overall Study||298
2409620|NCT01286207|5909708|P3|COMPLETED|Overall Study||261
2409621|NCT01286207|5909709|P2|COMPLETED|Overall Study||609
2409622|NCT01286207|5909710|P1|COMPLETED|Overall Study||453
2409623|NCT01286207|5909708|P3|STARTED|Overall Study||351
2409624|NCT01286207|5909709|P2|STARTED|Overall Study||857
2409625|NCT01286207|5909710|P1|STARTED|Overall Study||751
2409626|NCT01286168|5909730|P1|NOT COMPLETED|Overall Study||3
2409627|NCT01286168|5909730|P1|COMPLETED|Overall Study||101
2409628|NCT01286168|5909730|P1|STARTED|Overall Study||104
2409629|NCT01286129|5909744|P2|NOT COMPLETED|Overall Study||5
2409630|NCT01286129|5909745|P1|NOT COMPLETED|Overall Study||8
2409631|NCT01286129|5909744|P2|COMPLETED|Overall Study||13
2409632|NCT01286129|5909745|P1|COMPLETED|Overall Study||19
2409633|NCT01286129|5909744|P2|STARTED|Overall Study||18
2409634|NCT01286129|5909745|P1|STARTED|Overall Study||27
2409635|NCT01286077|5909755|P2|NOT COMPLETED|Overall Study||7
2409636|NCT01286077|5909756|P1|NOT COMPLETED|Overall Study||10
2409637|NCT01286077|5909755|P2|COMPLETED|Overall Study||46
2409638|NCT01286077|5909756|P1|COMPLETED|Overall Study||41
2409639|NCT01286077|5909755|P2|STARTED|Overall Study|One patient did not have any post-baseline assessment and was excluded from the ITT population.|53
2409723|NCT01285609|5909916|P2|Treated With Chemotherapy (1st Dose)|Randomized||473
2409640|NCT01286077|5909756|P1|STARTED|Overall Study|One patient did not start treatment and was excluded from the Intent to Treat (ITT) population.|51
2409641|NCT01286012|5909792|P2|NOT COMPLETED|Overall Study||14
2409642|NCT01286012|5909793|P1|NOT COMPLETED|Overall Study||13
2409643|NCT01286012|5909792|P2|COMPLETED|Overall Study||40
2409644|NCT01286012|5909793|P1|COMPLETED|Overall Study||41
2409645|NCT01286012|5909792|P2|STARTED|Overall Study|3 patients randomized to placebo did not receive study drug.|54
2409646|NCT01286012|5909793|P1|STARTED|Overall Study|2 patients randomized to SFP did not receive study drug.|54
2409647|NCT01285960|5909807|P1|NOT COMPLETED|Overall Study||6
2409648|NCT01285960|5909807|P1|COMPLETED|Overall Study|An additional 2 subjects receiving fewer than 10 sonications were included in the safety population|102
2409649|NCT01285960|5909807|P1|STARTED|Overall Study|2 subjects receiving fewer than 10 sonications were added to the 106 for safety population of 108|108
2409650|NCT01285947|5909813|P2|NOT COMPLETED|Overall Study||0
2409651|NCT01285947|5909814|P1|NOT COMPLETED|Overall Study||0
2409652|NCT01285947|5909813|P2|COMPLETED|Overall Study||10
2409653|NCT01285947|5909814|P1|COMPLETED|Overall Study||10
2409654|NCT01285947|5909813|P2|STARTED|Overall Study||10
2409655|NCT01285947|5909814|P1|STARTED|Overall Study||10
2409656|NCT01285908|5909820|P3|NOT COMPLETED|Treatment Crossover||0
2409657|NCT01285908|5909821|P2|NOT COMPLETED|Treatment Crossover||0
2409658|NCT01285908|5909822|P1|NOT COMPLETED|Treatment Crossover||0
2409659|NCT01285908|5909820|P3|COMPLETED|Treatment Crossover||2
2409660|NCT01285908|5909821|P2|COMPLETED|Treatment Crossover||2
2409661|NCT01285908|5909822|P1|COMPLETED|Treatment Crossover||0
2409662|NCT01285908|5909820|P3|STARTED|Treatment Crossover||2
2409663|NCT01285908|5909821|P2|STARTED|Treatment Crossover|One subject in treatment crossover did not complete baseline testing as unable to complete tasks|2
2409664|NCT01285908|5909822|P1|STARTED|Treatment Crossover||0
2409665|NCT01285908|5909820|P3|NOT COMPLETED|Baseline Measurement||0
2409666|NCT01285908|5909821|P2|NOT COMPLETED|Baseline Measurement||0
2409667|NCT01285908|5909822|P1|NOT COMPLETED|Baseline Measurement||3
2409668|NCT01285908|5909820|P3|COMPLETED|Baseline Measurement||0
2409669|NCT01285908|5909821|P2|COMPLETED|Baseline Measurement||0
2409670|NCT01285908|5909822|P1|COMPLETED|Baseline Measurement||3
2409671|NCT01285908|5909820|P3|STARTED|Baseline Measurement||0
2409672|NCT01285908|5909821|P2|STARTED|Baseline Measurement||0
2409673|NCT01285908|5909822|P1|STARTED|Baseline Measurement||6
2409674|NCT01285843|5909856|P2|NOT COMPLETED|Overall Study||2
2409675|NCT01285843|5909857|P1|NOT COMPLETED|Overall Study||2
2409676|NCT01285843|5909856|P2|COMPLETED|Overall Study||18
2409677|NCT01285843|5909857|P1|COMPLETED|Overall Study||18
2409678|NCT01285843|5909856|P2|STARTED|Overall Study||20
2409679|NCT01285843|5909857|P1|STARTED|Overall Study||20
2409680|NCT01285791|5909872|P3|NOT COMPLETED|Overall Study||0
2409681|NCT01285791|5909873|P2|NOT COMPLETED|Overall Study||0
2409682|NCT01285791|5909874|P1|NOT COMPLETED|Overall Study||0
2409683|NCT01285791|5909872|P3|COMPLETED|Overall Study||13
2409684|NCT01285791|5909873|P2|COMPLETED|Overall Study||15
2409685|NCT01285791|5909874|P1|COMPLETED|Overall Study||11
2409686|NCT01285791|5909872|P3|STARTED|Overall Study||13
2409687|NCT01285791|5909873|P2|STARTED|Overall Study||15
2409688|NCT01285791|5909874|P1|STARTED|Overall Study||11
2409689|NCT01285713|5909884|P2|NOT COMPLETED|Overall Study||0
2409690|NCT01285713|5909885|P1|NOT COMPLETED|Overall Study||0
2409691|NCT01285713|5909884|P2|COMPLETED|Overall Study||41
2409692|NCT01285713|5909885|P1|COMPLETED|Overall Study||42
2409693|NCT01285713|5909884|P2|STARTED|Overall Study||41
2409694|NCT01285713|5909885|P1|STARTED|Overall Study||42
2409695|NCT01285635|5909894|P3|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
2409696|NCT01285635|5909895|P2|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
2409697|NCT01285635|5909896|P1|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
2409698|NCT01285635|5909894|P3|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
2409699|NCT01285635|5909895|P2|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
2409700|NCT01285635|5909896|P1|COMPLETED|Second Intervention (10, 3 Week Cycles)||13
2409701|NCT01285635|5909894|P3|STARTED|Second Intervention (10, 3 Week Cycles)||11
2409702|NCT01285635|5909895|P2|STARTED|Second Intervention (10, 3 Week Cycles)||11
2409703|NCT01285635|5909896|P1|STARTED|Second Intervention (10, 3 Week Cycles)||13
2409704|NCT01285635|5909894|P3|NOT COMPLETED|First Intervention (2 Weeks)||0
2409705|NCT01285635|5909895|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
2409706|NCT01285635|5909896|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
2409707|NCT01285635|5909894|P3|COMPLETED|First Intervention (2 Weeks)||11
2409708|NCT01285635|5909895|P2|COMPLETED|First Intervention (2 Weeks)||11
2409709|NCT01285635|5909896|P1|COMPLETED|First Intervention (2 Weeks)||13
2409710|NCT01285635|5909894|P3|STARTED|First Intervention (2 Weeks)||11
2409711|NCT01285635|5909895|P2|STARTED|First Intervention (2 Weeks)||11
2409712|NCT01285635|5909896|P1|STARTED|First Intervention (2 Weeks)||13
2409713|NCT01285609|5909916|P2|NOT COMPLETED|Treated With Blinded Therapy||359
2409714|NCT01285609|5909917|P1|NOT COMPLETED|Treated With Blinded Therapy||387
2409715|NCT01285609|5909916|P2|COMPLETED|Treated With Blinded Therapy||2
2409716|NCT01285609|5909917|P1|COMPLETED|Treated With Blinded Therapy||1
2409717|NCT01285609|5909916|P2|STARTED|Treated With Blinded Therapy||361
2409718|NCT01285609|5909917|P1|STARTED|Treated With Blinded Therapy||388
2409719|NCT01285609|5909916|P2|NOT COMPLETED|Randomized||116
2409720|NCT01285609|5909917|P1|NOT COMPLETED|Randomized||91
2409721|NCT01285609|5909916|P2|COMPLETED|Randomized||361
2409722|NCT01285609|5909917|P1|COMPLETED|Randomized||388
2409892|NCT01284621|5910664|P4|STARTED|Washout Period 2 (7 Days)||4
2409724|NCT01285609|5909917|P1|Treated With Chemotherapy (1st Dose)|Randomized||475
2409725|NCT01285609|5909916|P2|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|477
2409726|NCT01285609|5909917|P1|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|479
2409727|NCT01285518|5909935|P8|NOT COMPLETED|Overall Study||0
2409728|NCT01285518|5909936|P7|NOT COMPLETED|Overall Study||0
2409729|NCT01285518|5909937|P6|NOT COMPLETED|Overall Study||1
2409730|NCT01285518|5909938|P5|NOT COMPLETED|Overall Study||0
2409731|NCT01285518|5909939|P4|NOT COMPLETED|Overall Study||0
2409732|NCT01285518|5909940|P3|NOT COMPLETED|Overall Study||0
2409733|NCT01285518|5909941|P2|NOT COMPLETED|Overall Study||0
2409734|NCT01285518|5909942|P1|NOT COMPLETED|Overall Study||0
2409735|NCT01285518|5909935|P8|COMPLETED|Overall Study||14
2409736|NCT01285518|5909936|P7|COMPLETED|Overall Study||10
2409737|NCT01285518|5909937|P6|COMPLETED|Overall Study||9
2409738|NCT01285518|5909938|P5|COMPLETED|Overall Study||10
2409739|NCT01285518|5909939|P4|COMPLETED|Overall Study||10
2409740|NCT01285518|5909940|P3|COMPLETED|Overall Study||10
2409741|NCT01285518|5909941|P2|COMPLETED|Overall Study||10
2409742|NCT01285518|5909942|P1|COMPLETED|Overall Study||10
2409743|NCT01285518|5909935|P8|STARTED|Overall Study||14
2409744|NCT01285518|5909936|P7|STARTED|Overall Study||10
2409745|NCT01285518|5909937|P6|STARTED|Overall Study||10
2409746|NCT01285518|5909938|P5|STARTED|Overall Study||10
2409747|NCT01285518|5909939|P4|STARTED|Overall Study||10
2409748|NCT01285518|5909940|P3|STARTED|Overall Study||10
2409749|NCT01285518|5909941|P2|STARTED|Overall Study||10
2409750|NCT01285518|5909942|P1|STARTED|Overall Study||10
2409751|NCT01285492|5910202|P2|NOT COMPLETED|Overall Study||1
2409752|NCT01285492|5910203|P1|NOT COMPLETED|Overall Study||17
2409753|NCT01285492|5910202|P2|COMPLETED|Overall Study||38
2409754|NCT01285492|5910203|P1|COMPLETED|Overall Study||104
2409755|NCT01285492|5910202|P2|Safety Set (for Demographics)|Overall Study|All patients who took study drug|39
2409756|NCT01285492|5910203|P1|Safety Set (for Demographics)|Overall Study|All patients who took study drug; 2 patients did not|119
2409757|NCT01285492|5910202|P2|STARTED|Overall Study|All patients randomized to this group|39
2409758|NCT01285492|5910203|P1|STARTED|Overall Study|All patients randomized to this group|121
2409759|NCT01285427|5910221|P1|NOT COMPLETED|Overall Study||1
2409760|NCT01285427|5910221|P1|COMPLETED|Overall Study|One sample be discarded per FDA, sample drawn with heparin tube, not specified in protocol.|299
2409761|NCT01285427|5910221|P1|STARTED|Overall Study||300
2409762|NCT01285401|5910235|P2|NOT COMPLETED|Overall Study||29
2409763|NCT01285401|5910236|P1|NOT COMPLETED|Overall Study||17
2409764|NCT01285401|5910235|P2|COMPLETED|Overall Study||88
2409765|NCT01285401|5910236|P1|COMPLETED|Overall Study||98
2409766|NCT01285401|5910235|P2|Treated|Overall Study||116
2409767|NCT01285401|5910236|P1|Treated|Overall Study||113
2409768|NCT01285401|5910235|P2|STARTED|Overall Study||117
2409769|NCT01285401|5910236|P1|STARTED|Overall Study||115
2409770|NCT01285349|5910277|P3|NOT COMPLETED|Overall Study||27
2409771|NCT01285349|5910278|P2|NOT COMPLETED|Overall Study||20
2409772|NCT01285349|5910279|P1|NOT COMPLETED|Overall Study||27
2409773|NCT01285349|5910277|P3|COMPLETED|Overall Study||157
2409774|NCT01285349|5910278|P2|COMPLETED|Overall Study||170
2409775|NCT01285349|5910279|P1|COMPLETED|Overall Study||163
2409776|NCT01285349|5910277|P3|STARTED|Overall Study||184
2409777|NCT01285349|5910278|P2|STARTED|Overall Study||190
2409778|NCT01285349|5910279|P1|STARTED|Overall Study||190
2409779|NCT01285323|5910292|P2|NOT COMPLETED|Overall Study||30
2409780|NCT01285323|5910293|P1|NOT COMPLETED|Overall Study||33
2409781|NCT01285323|5910292|P2|COMPLETED|Overall Study||202
2409782|NCT01285323|5910293|P1|COMPLETED|Overall Study||199
2409783|NCT01285323|5910292|P2|Safety Analysis Set|Overall Study||232
2409784|NCT01285323|5910293|P1|Safety Analysis Set|Overall Study|Participants who received at least 1 dose of study drug|232
2409785|NCT01285323|5910292|P2|Full Analysis Set|Overall Study||232
2409786|NCT01285323|5910293|P1|Full Analysis Set|Overall Study|Randomized participants who received at least 1 dose of study drug|232
2409787|NCT01285323|5910292|P2|STARTED|Overall Study||232
2409788|NCT01285323|5910293|P1|STARTED|Overall Study||232
2409789|NCT01285310|5910328|P5|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||19
2409790|NCT01285310|5910329|P4|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||10
2409791|NCT01285310|5910330|P3|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||26
2409792|NCT01285310|5910331|P2|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||32
2409793|NCT01285310|5910332|P1|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||0
2409794|NCT01285310|5910328|P5|COMPLETED|Active Treatment Phase: Weeks 25-52||23
2409795|NCT01285310|5910329|P4|COMPLETED|Active Treatment Phase: Weeks 25-52||17
2409796|NCT01285310|5910330|P3|COMPLETED|Active Treatment Phase: Weeks 25-52||34
2409797|NCT01285310|5910331|P2|COMPLETED|Active Treatment Phase: Weeks 25-52||31
2409798|NCT01285310|5910332|P1|COMPLETED|Active Treatment Phase: Weeks 25-52||0
2409799|NCT01285310|5910328|P5|STARTED|Active Treatment Phase: Weeks 25-52||42
2409800|NCT01285310|5910329|P4|STARTED|Active Treatment Phase: Weeks 25-52||27
2409801|NCT01285310|5910330|P3|STARTED|Active Treatment Phase: Weeks 25-52||60
2409802|NCT01285310|5910331|P2|STARTED|Active Treatment Phase: Weeks 25-52||63
2409803|NCT01285310|5910332|P1|STARTED|Active Treatment Phase: Weeks 25-52||0
2409804|NCT01285310|5910328|P5|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
2409805|NCT01285310|5910329|P4|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
2409806|NCT01285310|5910330|P3|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
2409807|NCT01285310|5910331|P2|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
2409808|NCT01285310|5910332|P1|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||9
2409809|NCT01285310|5910328|P5|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
2409810|NCT01285310|5910329|P4|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
2409811|NCT01285310|5910330|P3|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter active treatment phase|61
2409812|NCT01285310|5910331|P2|COMPLETED|Placebo Controlled Phase: Weeks 0-24|Four participants chose not to enter the active treatment phase|67
2409813|NCT01285310|5910332|P1|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter the active treatment phase|70
2409814|NCT01285310|5910328|P5|STARTED|Placebo Controlled Phase: Weeks 0-24||0
2409815|NCT01285310|5910329|P4|STARTED|Placebo Controlled Phase: Weeks 0-24||0
2409816|NCT01285310|5910330|P3|STARTED|Placebo Controlled Phase: Weeks 0-24||76
2409817|NCT01285310|5910331|P2|STARTED|Placebo Controlled Phase: Weeks 0-24||82
2409818|NCT01285310|5910332|P1|STARTED|Placebo Controlled Phase: Weeks 0-24||79
2409819|NCT01285076|5910565|P1|NOT COMPLETED|Overall Study||0
2409820|NCT01285076|5910565|P1|COMPLETED|Overall Study||834
2409821|NCT01285076|5910565|P1|STARTED|Overall Study||834
2409822|NCT01285050|5910578|P1|NOT COMPLETED|Overall Study||1
2409823|NCT01285050|5910578|P1|COMPLETED|Overall Study||19
2409824|NCT01285050|5910578|P1|STARTED|Overall Study||20
2409825|NCT01285024|5910585|P2|NOT COMPLETED|Overall Study||0
2409826|NCT01285024|5910586|P1|NOT COMPLETED|Overall Study||0
2409827|NCT01285024|5910585|P2|COMPLETED|Overall Study||60
2409828|NCT01285024|5910586|P1|COMPLETED|Overall Study||49
2409829|NCT01285024|5910585|P2|STARTED|Overall Study||60
2409830|NCT01285024|5910586|P1|STARTED|Overall Study||49
2409831|NCT01284959|5910597|P3|NOT COMPLETED|Overall Study||1
2409832|NCT01284959|5910598|P2|NOT COMPLETED|Overall Study||0
2409833|NCT01284959|5910599|P1|NOT COMPLETED|Overall Study||1
2409834|NCT01284959|5910597|P3|COMPLETED|Overall Study||10
2409835|NCT01284959|5910598|P2|COMPLETED|Overall Study||12
2409836|NCT01284959|5910599|P1|COMPLETED|Overall Study||10
2409837|NCT01284959|5910597|P3|STARTED|Overall Study||11
2409838|NCT01284959|5910598|P2|STARTED|Overall Study||12
2409839|NCT01284959|5910599|P1|STARTED|Overall Study||11
2409840|NCT01284634|5910629|P4|NOT COMPLETED|Overall Study||1
2409841|NCT01284634|5910630|P3|NOT COMPLETED|Overall Study||2
2409842|NCT01284634|5910631|P2|NOT COMPLETED|Overall Study||0
2409843|NCT01284634|5910632|P1|NOT COMPLETED|Overall Study||1
2409844|NCT01284634|5910629|P4|COMPLETED|Overall Study||4
2409845|NCT01284634|5910630|P3|COMPLETED|Overall Study||5
2409846|NCT01284634|5910631|P2|COMPLETED|Overall Study||6
2409847|NCT01284634|5910632|P1|COMPLETED|Overall Study||6
2409848|NCT01284634|5910629|P4|Intent to Treat (ITT) Analysis Set|Overall Study||5
2409849|NCT01284634|5910630|P3|Intent to Treat (ITT) Analysis Set|Overall Study||7
2409850|NCT01284634|5910631|P2|Intent to Treat (ITT) Analysis Set|Overall Study||6
2409851|NCT01284634|5910632|P1|Intent to Treat (ITT) Analysis Set|Overall Study||7
2409852|NCT01284634|5910629|P4|Received at Least 1 Dose of Study Drug|Overall Study||5
2409853|NCT01284634|5910630|P3|Received at Least 1 Dose of Study Drug|Overall Study||7
2409854|NCT01284634|5910631|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
2409855|NCT01284634|5910632|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
2409856|NCT01284634|5910629|P4|STARTED|Overall Study||5
2409857|NCT01284634|5910630|P3|STARTED|Overall Study||7
2409858|NCT01284634|5910631|P2|STARTED|Overall Study||6
2409859|NCT01284634|5910632|P1|STARTED|Overall Study||7
2409860|NCT01284621|5910662|P6|NOT COMPLETED|Third Intervention (8 Days)||0
2409861|NCT01284621|5910663|P5|NOT COMPLETED|Third Intervention (8 Days)||0
2409862|NCT01284621|5910664|P4|NOT COMPLETED|Third Intervention (8 Days)||0
2409863|NCT01284621|5910665|P3|NOT COMPLETED|Third Intervention (8 Days)||0
2409864|NCT01284621|5910666|P2|NOT COMPLETED|Third Intervention (8 Days)||0
2409865|NCT01284621|5910667|P1|NOT COMPLETED|Third Intervention (8 Days)||0
2409866|NCT01284621|5910662|P6|COMPLETED|Third Intervention (8 Days)||4
2409867|NCT01284621|5910663|P5|COMPLETED|Third Intervention (8 Days)||3
2409868|NCT01284621|5910664|P4|COMPLETED|Third Intervention (8 Days)||4
2409869|NCT01284621|5910665|P3|COMPLETED|Third Intervention (8 Days)||4
2409870|NCT01284621|5910666|P2|COMPLETED|Third Intervention (8 Days)||4
2409871|NCT01284621|5910667|P1|COMPLETED|Third Intervention (8 Days)||3
2409872|NCT01284621|5910662|P6|STARTED|Third Intervention (8 Days)||4
2409873|NCT01284621|5910663|P5|STARTED|Third Intervention (8 Days)||3
2409874|NCT01284621|5910664|P4|STARTED|Third Intervention (8 Days)||4
2409875|NCT01284621|5910665|P3|STARTED|Third Intervention (8 Days)||4
2409876|NCT01284621|5910666|P2|STARTED|Third Intervention (8 Days)||4
2409877|NCT01284621|5910667|P1|STARTED|Third Intervention (8 Days)||3
2409878|NCT01284621|5910662|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
2409879|NCT01284621|5910663|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
2409880|NCT01284621|5910664|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
2409881|NCT01284621|5910665|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
2409882|NCT01284621|5910666|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
2409883|NCT01284621|5910667|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
2409884|NCT01284621|5910662|P6|COMPLETED|Washout Period 2 (7 Days)||4
2409885|NCT01284621|5910663|P5|COMPLETED|Washout Period 2 (7 Days)||3
2409886|NCT01284621|5910664|P4|COMPLETED|Washout Period 2 (7 Days)||4
2409887|NCT01284621|5910665|P3|COMPLETED|Washout Period 2 (7 Days)||4
2409888|NCT01284621|5910666|P2|COMPLETED|Washout Period 2 (7 Days)||4
2409889|NCT01284621|5910667|P1|COMPLETED|Washout Period 2 (7 Days)||3
2409890|NCT01284621|5910662|P6|STARTED|Washout Period 2 (7 Days)||4
2409891|NCT01284621|5910663|P5|STARTED|Washout Period 2 (7 Days)||3
2409893|NCT01284621|5910665|P3|STARTED|Washout Period 2 (7 Days)||4
2409894|NCT01284621|5910666|P2|STARTED|Washout Period 2 (7 Days)||4
2409895|NCT01284621|5910667|P1|STARTED|Washout Period 2 (7 Days)||3
2409896|NCT01284621|5910662|P6|NOT COMPLETED|Second Intervention (8 Days)||0
2409897|NCT01284621|5910663|P5|NOT COMPLETED|Second Intervention (8 Days)||0
2409898|NCT01284621|5910664|P4|NOT COMPLETED|Second Intervention (8 Days)||0
2409899|NCT01284621|5910665|P3|NOT COMPLETED|Second Intervention (8 Days)||0
2409900|NCT01284621|5910666|P2|NOT COMPLETED|Second Intervention (8 Days)||0
2409901|NCT01284621|5910667|P1|NOT COMPLETED|Second Intervention (8 Days)||0
2409902|NCT01284621|5910662|P6|COMPLETED|Second Intervention (8 Days)||4
2409903|NCT01284621|5910663|P5|COMPLETED|Second Intervention (8 Days)||3
2409904|NCT01284621|5910664|P4|COMPLETED|Second Intervention (8 Days)||4
2409905|NCT01284621|5910665|P3|COMPLETED|Second Intervention (8 Days)||4
2409906|NCT01284621|5910666|P2|COMPLETED|Second Intervention (8 Days)||4
2409907|NCT01284621|5910667|P1|COMPLETED|Second Intervention (8 Days)||3
2409908|NCT01284621|5910662|P6|STARTED|Second Intervention (8 Days)||4
2409909|NCT01284621|5910663|P5|STARTED|Second Intervention (8 Days)||3
2409910|NCT01284621|5910664|P4|STARTED|Second Intervention (8 Days)||4
2409911|NCT01284621|5910665|P3|STARTED|Second Intervention (8 Days)||4
2409912|NCT01284621|5910666|P2|STARTED|Second Intervention (8 Days)||4
2409913|NCT01284621|5910667|P1|STARTED|Second Intervention (8 Days)||3
2409914|NCT01284621|5910662|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
2409915|NCT01284621|5910663|P5|NOT COMPLETED|Washout Period 1 (7 Days)||1
2409916|NCT01284621|5910664|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
2409917|NCT01284621|5910665|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
2409918|NCT01284621|5910666|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
2409919|NCT01284621|5910667|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
2409920|NCT01284621|5910662|P6|COMPLETED|Washout Period 1 (7 Days)||4
2409921|NCT01284621|5910663|P5|COMPLETED|Washout Period 1 (7 Days)||3
2409922|NCT01284621|5910664|P4|COMPLETED|Washout Period 1 (7 Days)||4
2409923|NCT01284621|5910665|P3|COMPLETED|Washout Period 1 (7 Days)||4
2409924|NCT01284621|5910666|P2|COMPLETED|Washout Period 1 (7 Days)||4
2409925|NCT01284621|5910667|P1|COMPLETED|Washout Period 1 (7 Days)||3
2409926|NCT01284621|5910662|P6|STARTED|Washout Period 1 (7 Days)||4
2409927|NCT01284621|5910663|P5|STARTED|Washout Period 1 (7 Days)||4
2409928|NCT01284621|5910664|P4|STARTED|Washout Period 1 (7 Days)||4
2409929|NCT01284621|5910665|P3|STARTED|Washout Period 1 (7 Days)||4
2409930|NCT01284621|5910666|P2|STARTED|Washout Period 1 (7 Days)||4
2409931|NCT01284621|5910667|P1|STARTED|Washout Period 1 (7 Days)||3
2409932|NCT01284621|5910662|P6|NOT COMPLETED|First Intervention (8 Days)||0
2409933|NCT01284621|5910663|P5|NOT COMPLETED|First Intervention (8 Days)||0
2409934|NCT01284621|5910664|P4|NOT COMPLETED|First Intervention (8 Days)||0
2409935|NCT01284621|5910665|P3|NOT COMPLETED|First Intervention (8 Days)||0
2409936|NCT01284621|5910666|P2|NOT COMPLETED|First Intervention (8 Days)||0
2409937|NCT01284621|5910667|P1|NOT COMPLETED|First Intervention (8 Days)||0
2409938|NCT01284621|5910662|P6|COMPLETED|First Intervention (8 Days)||4
2409939|NCT01284621|5910663|P5|COMPLETED|First Intervention (8 Days)||4
2409940|NCT01284621|5910664|P4|COMPLETED|First Intervention (8 Days)||4
2409941|NCT01284621|5910665|P3|COMPLETED|First Intervention (8 Days)||4
2409942|NCT01284621|5910666|P2|COMPLETED|First Intervention (8 Days)||4
2409943|NCT01284621|5910667|P1|COMPLETED|First Intervention (8 Days)||3
2409944|NCT01284621|5910662|P6|STARTED|First Intervention (8 Days)||4
2409945|NCT01284621|5910663|P5|STARTED|First Intervention (8 Days)||4
2409946|NCT01284621|5910664|P4|STARTED|First Intervention (8 Days)||4
2409947|NCT01284621|5910665|P3|STARTED|First Intervention (8 Days)||4
2409948|NCT01284621|5910666|P2|STARTED|First Intervention (8 Days)||4
2409949|NCT01284621|5910667|P1|STARTED|First Intervention (8 Days)||3
2409950|NCT01284517|5910711|P2|NOT COMPLETED|Overall Study||36
2409951|NCT01284517|5910712|P1|NOT COMPLETED|Overall Study||32
2409952|NCT01284517|5910711|P2|COMPLETED|Overall Study||140
2409953|NCT01284517|5910712|P1|COMPLETED|Overall Study||148
2409954|NCT01284517|5910711|P2|STARTED|Overall Study||176
2409955|NCT01284517|5910712|P1|STARTED|Overall Study||180
2409956|NCT01284504|5910724|P2|NOT COMPLETED|Overall Study||0
2409957|NCT01284504|5910725|P1|NOT COMPLETED|Overall Study||0
2409958|NCT01284504|5910724|P2|COMPLETED|Overall Study||0
2409959|NCT01284504|5910725|P1|COMPLETED|Overall Study||0
2409960|NCT01284504|5910724|P2|STARTED|Overall Study||0
2409961|NCT01284504|5910725|P1|STARTED|Overall Study||0
2409962|NCT01284491|5910735|P1|NOT COMPLETED|Overall Study||13
2409963|NCT01284491|5910735|P1|COMPLETED|Overall Study||0
2409964|NCT01284491|5910735|P1|STARTED|Overall Study||13
2409965|NCT01284426|5910741|P1|NOT COMPLETED|Overall Study||2
2409966|NCT01284426|5910741|P1|COMPLETED|Overall Study||92
2409967|NCT01284426|5910741|P1|STARTED|Overall Study||94
2409968|NCT01284361|5910745|P1|NOT COMPLETED|Overall Study||9
2409969|NCT01284361|5910745|P1|COMPLETED|Overall Study||82
2409970|NCT01284361|5910745|P1|STARTED|Overall Study||91
2409971|NCT01284335|5910765|P13|NOT COMPLETED|Overall Study||0
2409972|NCT01284335|5910766|P12|NOT COMPLETED|Overall Study||0
2409973|NCT01284335|5910767|P11|NOT COMPLETED|Overall Study||0
2409974|NCT01284335|5910768|P10|NOT COMPLETED|Overall Study||0
2409975|NCT01284335|5910769|P9|NOT COMPLETED|Overall Study||0
2409976|NCT01284335|5910770|P8|NOT COMPLETED|Overall Study||0
2409977|NCT01284335|5910771|P7|NOT COMPLETED|Overall Study||0
2409978|NCT01284335|5910772|P6|NOT COMPLETED|Overall Study||0
2409979|NCT01284335|5910773|P5|NOT COMPLETED|Overall Study||0
2409980|NCT01284335|5910774|P4|NOT COMPLETED|Overall Study||0
2409981|NCT01284335|5910775|P3|NOT COMPLETED|Overall Study||0
2409982|NCT01284335|5910776|P2|NOT COMPLETED|Overall Study||0
2409983|NCT01284335|5910777|P1|NOT COMPLETED|Overall Study||0
2409984|NCT01284335|5910765|P13|COMPLETED|Overall Study||12
2409985|NCT01284335|5910766|P12|COMPLETED|Overall Study||16
2409986|NCT01284335|5910767|P11|COMPLETED|Overall Study||45
2409987|NCT01284335|5910768|P10|COMPLETED|Overall Study||14
2409988|NCT01284335|5910769|P9|COMPLETED|Overall Study||4
2409989|NCT01284335|5910770|P8|COMPLETED|Overall Study||6
2409990|NCT01284335|5910771|P7|COMPLETED|Overall Study||19
2409991|NCT01284335|5910772|P6|COMPLETED|Overall Study||26
2409992|NCT01284335|5910773|P5|COMPLETED|Overall Study||24
2409993|NCT01284335|5910774|P4|COMPLETED|Overall Study||5
2409994|NCT01284335|5910775|P3|COMPLETED|Overall Study||5
2409995|NCT01284335|5910776|P2|COMPLETED|Overall Study||33
2409996|NCT01284335|5910777|P1|COMPLETED|Overall Study||25
2409997|NCT01284335|5910765|P13|Received at Least One Dose of Study Drug|Overall Study||12
2409998|NCT01284335|5910766|P12|Received at Least One Dose of Study Drug|Overall Study||16
2409999|NCT01284335|5910767|P11|Received at Least One Dose of Study Drug|Overall Study||45
2410000|NCT01284335|5910768|P10|Received at Least One Dose of Study Drug|Overall Study||14
2410001|NCT01284335|5910769|P9|Received at Least One Dose of Study Drug|Overall Study||4
2410002|NCT01284335|5910770|P8|Received at Least One Dose of Study Drug|Overall Study||6
2410003|NCT01284335|5910771|P7|Received at Least One Dose of Study Drug|Overall Study||19
2410004|NCT01284335|5910772|P6|Received at Least One Dose of Study Drug|Overall Study||26
2410005|NCT01284335|5910773|P5|Received at Least One Dose of Study Drug|Overall Study||24
2410006|NCT01284335|5910774|P4|Received at Least One Dose of Study Drug|Overall Study||5
2410007|NCT01284335|5910775|P3|Received at Least One Dose of Study Drug|Overall Study||5
2410008|NCT01284335|5910776|P2|Received at Least One Dose of Study Drug|Overall Study||33
2410009|NCT01284335|5910777|P1|Received at Least One Dose of Study Drug|Overall Study||25
2410010|NCT01284335|5910765|P13|STARTED|Overall Study||12
2410011|NCT01284335|5910766|P12|STARTED|Overall Study||16
2410012|NCT01284335|5910767|P11|STARTED|Overall Study||45
2410013|NCT01284335|5910768|P10|STARTED|Overall Study||14
2410014|NCT01284335|5910769|P9|STARTED|Overall Study||4
2410015|NCT01284335|5910770|P8|STARTED|Overall Study||6
2410016|NCT01284335|5910771|P7|STARTED|Overall Study||19
2410017|NCT01284335|5910772|P6|STARTED|Overall Study||26
2410018|NCT01284335|5910773|P5|STARTED|Overall Study||24
2410019|NCT01284335|5910774|P4|STARTED|Overall Study||5
2410020|NCT01284335|5910775|P3|STARTED|Overall Study||5
2410021|NCT01284335|5910776|P2|STARTED|Overall Study||33
2410022|NCT01284335|5910777|P1|STARTED|Overall Study||25
2410023|NCT01284296|5910825|P1|NOT COMPLETED|Overall Study||0
2410024|NCT01284296|5910825|P1|COMPLETED|Overall Study||20
2410025|NCT01284296|5910825|P1|STARTED|Overall Study||20
2410026|NCT01284244|5910832|P2|NOT COMPLETED|Overall Study||0
2410027|NCT01284244|5910833|P1|NOT COMPLETED|Overall Study||0
2410028|NCT01284244|5910832|P2|COMPLETED|Overall Study||18
2410029|NCT01284244|5910833|P1|COMPLETED|Overall Study||18
2410030|NCT01284244|5910832|P2|STARTED|Overall Study||18
2410031|NCT01284244|5910833|P1|STARTED|Overall Study||18
2410032|NCT01284140|5910841|P2|NOT COMPLETED|Subjects With Paired 24hr Collections||6
2410033|NCT01284140|5910842|P1|NOT COMPLETED|Subjects With Paired 24hr Collections||5
2410034|NCT01284140|5910841|P2|COMPLETED|Subjects With Paired 24hr Collections||5
2410035|NCT01284140|5910842|P1|COMPLETED|Subjects With Paired 24hr Collections||6
2410036|NCT01284140|5910841|P2|STARTED|Subjects With Paired 24hr Collections||11
2410037|NCT01284140|5910842|P1|STARTED|Subjects With Paired 24hr Collections||11
2410038|NCT01284140|5910841|P2|NOT COMPLETED|Randomization and Intervention||0
2410039|NCT01284140|5910842|P1|NOT COMPLETED|Randomization and Intervention||0
2410040|NCT01284140|5910841|P2|COMPLETED|Randomization and Intervention||11
2410041|NCT01284140|5910842|P1|COMPLETED|Randomization and Intervention||11
2410042|NCT01284140|5910841|P2|STARTED|Randomization and Intervention||11
2410043|NCT01284140|5910842|P1|STARTED|Randomization and Intervention||11
2410044|NCT01284127|5910856|P1|NOT COMPLETED|Overall Study||7
2410045|NCT01284127|5910856|P1|COMPLETED|Overall Study||31
2410046|NCT01284127|5910856|P1|STARTED|Overall Study||38
2410047|NCT01284114|5910865|P1|NOT COMPLETED|Overall Study||4
2410048|NCT01284114|5910865|P1|COMPLETED|Overall Study||19
2410049|NCT01284114|5910865|P1|STARTED|Overall Study||23
2410050|NCT01284062|5910877|P4|NOT COMPLETED|Overall Study||14
2410051|NCT01284062|5910878|P3|NOT COMPLETED|Overall Study||6
2410052|NCT01284062|5910879|P2|NOT COMPLETED|Overall Study||8
2410053|NCT01284062|5910880|P1|NOT COMPLETED|Overall Study||11
2410054|NCT01284062|5910877|P4|COMPLETED|Overall Study||7
2410055|NCT01284062|5910878|P3|COMPLETED|Overall Study||15
2410056|NCT01284062|5910879|P2|COMPLETED|Overall Study||13
2410057|NCT01284062|5910880|P1|COMPLETED|Overall Study||10
2410058|NCT01284062|5910877|P4|STARTED|Overall Study||21
2410059|NCT01284062|5910878|P3|STARTED|Overall Study||21
2410060|NCT01284062|5910879|P2|STARTED|Overall Study||21
2410061|NCT01284062|5910880|P1|STARTED|Overall Study||21
2410062|NCT01283971|5910954|P2|NOT COMPLETED|Overall Study||12
2410063|NCT01283971|5910955|P1|NOT COMPLETED|Overall Study||15
2410064|NCT01283971|5910954|P2|COMPLETED|Overall Study||36
2410065|NCT01283971|5910955|P1|COMPLETED|Overall Study||33
2410066|NCT01283971|5910954|P2|Intent to Treat Population|Overall Study||48
2410067|NCT01283971|5910955|P1|Intent to Treat Population|Overall Study||46
2410068|NCT01283971|5910954|P2|STARTED|Overall Study||48
2410069|NCT01283971|5910955|P1|STARTED|Overall Study||48
2410070|NCT01283581|5911002|P3|NOT COMPLETED|Overall Study||20
2410071|NCT01283581|5911003|P2|NOT COMPLETED|Overall Study||14
2410072|NCT01283581|5911004|P1|NOT COMPLETED|Overall Study||12
2410073|NCT01283581|5911002|P3|COMPLETED|Overall Study||78
2410074|NCT01283581|5911003|P2|COMPLETED|Overall Study||63
2410075|NCT01283581|5911004|P1|COMPLETED|Overall Study||69
2410076|NCT01283581|5911002|P3|STARTED|Overall Study||98
2410077|NCT01283581|5911003|P2|STARTED|Overall Study||77
2410078|NCT01283581|5911004|P1|STARTED|Overall Study||81
2410079|NCT01283555|5911030|P2|NOT COMPLETED|Second Intervention||0
2410080|NCT01283555|5911031|P1|NOT COMPLETED|Second Intervention||0
2410081|NCT01283555|5911030|P2|COMPLETED|Second Intervention||12
2410082|NCT01283555|5911031|P1|COMPLETED|Second Intervention||13
2410083|NCT01283555|5911030|P2|STARTED|Second Intervention||12
2410084|NCT01283555|5911031|P1|STARTED|Second Intervention||13
2410085|NCT01283555|5911030|P2|NOT COMPLETED|Washout Period of at Least 21 Days||0
2410086|NCT01283555|5911031|P1|NOT COMPLETED|Washout Period of at Least 21 Days||0
2410087|NCT01283555|5911030|P2|COMPLETED|Washout Period of at Least 21 Days||12
2410088|NCT01283555|5911031|P1|COMPLETED|Washout Period of at Least 21 Days||13
2410089|NCT01283555|5911030|P2|STARTED|Washout Period of at Least 21 Days||12
2410090|NCT01283555|5911031|P1|STARTED|Washout Period of at Least 21 Days||13
2410091|NCT01283555|5911030|P2|NOT COMPLETED|First Intervention||0
2410092|NCT01283555|5911031|P1|NOT COMPLETED|First Intervention||0
2410093|NCT01283555|5911030|P2|COMPLETED|First Intervention||12
2410094|NCT01283555|5911031|P1|COMPLETED|First Intervention||13
2410095|NCT01283555|5911030|P2|STARTED|First Intervention||12
2410096|NCT01283555|5911031|P1|STARTED|First Intervention||13
2410097|NCT01283542|5911074|P1|NOT COMPLETED|Extension Phase||3
2410098|NCT01283542|5911074|P1|COMPLETED|Extension Phase||10
2410099|NCT01283542|5911074|P1|Safety Analysis Set|Extension Phase||13
2410100|NCT01283542|5911074|P1|Full Analysis Set (FAS)|Extension Phase||13
2410101|NCT01283542|5911074|P1|STARTED|Extension Phase||13
2410102|NCT01283542|5911074|P1|NOT COMPLETED|Main Phase||7
2410103|NCT01283542|5911074|P1|COMPLETED|Main Phase||13
2410104|NCT01283542|5911074|P1|Safety Analysis Set|Main Phase||20
2410105|NCT01283542|5911074|P1|Full Analysis Set (FAS)|Main Phase||20
2410106|NCT01283542|5911074|P1|STARTED|Main Phase||20
2410107|NCT01283516|5911139|P9|NOT COMPLETED|Overall Study||255
2410108|NCT01283516|5911140|P8|NOT COMPLETED|Overall Study||5
2410109|NCT01283516|5911141|P7|NOT COMPLETED|Overall Study||10
2410110|NCT01283516|5911142|P6|NOT COMPLETED|Overall Study||10
2410111|NCT01283516|5911143|P5|NOT COMPLETED|Overall Study||14
2410112|NCT01283516|5911144|P4|NOT COMPLETED|Overall Study||3
2410113|NCT01283516|5911145|P3|NOT COMPLETED|Overall Study||3
2410114|NCT01283516|5911146|P2|NOT COMPLETED|Overall Study||2
2410115|NCT01283516|5911147|P1|NOT COMPLETED|Overall Study||2
2410116|NCT01283516|5911139|P9|COMPLETED|Overall Study||0
2410117|NCT01283516|5911140|P8|COMPLETED|Overall Study||0
2410118|NCT01283516|5911141|P7|COMPLETED|Overall Study||0
2410119|NCT01283516|5911142|P6|COMPLETED|Overall Study||0
2410120|NCT01283516|5911143|P5|COMPLETED|Overall Study||0
2410121|NCT01283516|5911144|P4|COMPLETED|Overall Study||0
2410122|NCT01283516|5911145|P3|COMPLETED|Overall Study||0
2410123|NCT01283516|5911146|P2|COMPLETED|Overall Study||0
2410124|NCT01283516|5911147|P1|COMPLETED|Overall Study|Completed - see explanation in Recruitment Details.|0
2410125|NCT01283516|5911139|P9|Non-NSCLC|Overall Study|Small number of patients at 750 mg - non-NSCLC, assessment limited, not included in efficacy tables|9
2410126|NCT01283516|5911140|P8|Non-NSCLC|Overall Study||0
2410127|NCT01283516|5911141|P7|Non-NSCLC|Overall Study||1
2410128|NCT01283516|5911142|P6|Non-NSCLC|Overall Study||0
2410129|NCT01283516|5911143|P5|Non-NSCLC|Overall Study||2
2410130|NCT01283516|5911144|P4|Non-NSCLC|Overall Study||0
2410131|NCT01283516|5911145|P3|Non-NSCLC|Overall Study||1
2410132|NCT01283516|5911146|P2|Non-NSCLC|Overall Study||1
2410133|NCT01283516|5911147|P1|Non-NSCLC|Overall Study||0
2410134|NCT01283516|5911139|P9|Dose-Determining Set (DDS)|Overall Study||8
2410135|NCT01283516|5911140|P8|Dose-Determining Set (DDS)|Overall Study||5
2410136|NCT01283516|5911141|P7|Dose-Determining Set (DDS)|Overall Study||10
2410137|NCT01283516|5911142|P6|Dose-Determining Set (DDS)|Overall Study||8
2410138|NCT01283516|5911143|P5|Dose-Determining Set (DDS)|Overall Study||14
2410139|NCT01283516|5911144|P4|Dose-Determining Set (DDS)|Overall Study||3
2410140|NCT01283516|5911145|P3|Dose-Determining Set (DDS)|Overall Study||3
2410141|NCT01283516|5911146|P2|Dose-Determining Set (DDS)|Overall Study||1
2410142|NCT01283516|5911147|P1|Dose-Determining Set (DDS)|Overall Study||2
2410143|NCT01283516|5911139|P9|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||246
2410144|NCT01283516|5911140|P8|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||5
2410145|NCT01283516|5911141|P7|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||9
2410146|NCT01283516|5911142|P6|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||10
2410147|NCT01283516|5911143|P5|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||12
2410148|NCT01283516|5911144|P4|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||3
2410149|NCT01283516|5911145|P3|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
2410150|NCT01283516|5911146|P2|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||1
2410151|NCT01283516|5911147|P1|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
2410152|NCT01283516|5911139|P9|STARTED|Overall Study||255
2410153|NCT01283516|5911140|P8|STARTED|Overall Study||5
2410154|NCT01283516|5911141|P7|STARTED|Overall Study||10
2410155|NCT01283516|5911142|P6|STARTED|Overall Study||10
2410156|NCT01283516|5911143|P5|STARTED|Overall Study||14
2410157|NCT01283516|5911144|P4|STARTED|Overall Study||3
2410158|NCT01283516|5911145|P3|STARTED|Overall Study||3
2410159|NCT01283516|5911146|P2|STARTED|Overall Study||2
2410160|NCT01283516|5911147|P1|STARTED|Overall Study|Started = Full Analysis Set and Safety Set|2
2410161|NCT01283464|5911269|P2|NOT COMPLETED|Overall Study||1
2410162|NCT01283464|5911270|P1|NOT COMPLETED|Overall Study||2
2410163|NCT01283464|5911269|P2|COMPLETED|Overall Study||11
2410164|NCT01283464|5911270|P1|COMPLETED|Overall Study||10
2410165|NCT01283464|5911269|P2|STARTED|Overall Study||12
2410166|NCT01283464|5911270|P1|STARTED|Overall Study||12
2410167|NCT01283386|5911278|P2|NOT COMPLETED|Overall Study||12
2410168|NCT01283386|5911279|P1|NOT COMPLETED|Overall Study||8
2410169|NCT01283386|5911278|P2|COMPLETED|Overall Study||4
2410170|NCT01283386|5911279|P1|COMPLETED|Overall Study||2
2410171|NCT01283386|5911278|P2|STARTED|Overall Study||16
2410172|NCT01283386|5911279|P1|STARTED|Overall Study||10
2410173|NCT01283334|5911303|P1|NOT COMPLETED|Overall Study||7
2410174|NCT01283334|5911303|P1|COMPLETED|Overall Study||13
2410175|NCT01283334|5911303|P1|STARTED|Overall Study||20
2410176|NCT01283321|5911311|P2|NOT COMPLETED|Overall Study||0
2410177|NCT01283321|5911312|P1|NOT COMPLETED|Overall Study||0
2410178|NCT01283321|5911311|P2|COMPLETED|Overall Study||10
2410179|NCT01283321|5911312|P1|COMPLETED|Overall Study||10
2410180|NCT01283321|5911311|P2|STARTED|Overall Study||10
2410181|NCT01283321|5911312|P1|STARTED|Overall Study||10
2410182|NCT01283282|5911326|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
2410183|NCT01283282|5911327|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
2410184|NCT01283282|5911326|P2|COMPLETED|Second Intervention (6 Weeks)||19
2410185|NCT01283282|5911327|P1|COMPLETED|Second Intervention (6 Weeks)||22
2410186|NCT01283282|5911326|P2|STARTED|Second Intervention (6 Weeks)||19
2410187|NCT01283282|5911327|P1|STARTED|Second Intervention (6 Weeks)||22
2410188|NCT01283282|5911326|P2|NOT COMPLETED|First Intervention (6 Weeks)||4
2410189|NCT01283282|5911327|P1|NOT COMPLETED|First Intervention (6 Weeks)||3
2410190|NCT01283282|5911326|P2|COMPLETED|First Intervention (6 Weeks)||19
2410191|NCT01283282|5911327|P1|COMPLETED|First Intervention (6 Weeks)||22
2410192|NCT01283282|5911326|P2|STARTED|First Intervention (6 Weeks)||23
2410193|NCT01283282|5911327|P1|STARTED|First Intervention (6 Weeks)||25
2410194|NCT01283152|5911347|P2|NOT COMPLETED|Overall Study||0
2410195|NCT01283152|5911348|P1|NOT COMPLETED|Overall Study||2
2410196|NCT01283152|5911347|P2|COMPLETED|Overall Study||25
2410197|NCT01283152|5911348|P1|COMPLETED|Overall Study||23
2410198|NCT01283152|5911347|P2|24-hr HESA Attempted|Overall Study||25
2410199|NCT01283152|5911348|P1|24-hr HESA Attempted|Overall Study||25
2410200|NCT01283152|5911347|P2|Study Treatment Received|Overall Study||25
2410201|NCT01283152|5911348|P1|Study Treatment Received|Overall Study||25
2410202|NCT01283152|5911347|P2|ITT Population|Overall Study||25
2410203|NCT01283152|5911348|P1|ITT Population|Overall Study||25
2410204|NCT01283152|5911347|P2|STARTED|Overall Study||25
2410205|NCT01283152|5911348|P1|STARTED|Overall Study||25
2410206|NCT01283139|5911362|P4|NOT COMPLETED|Overall Study||15
2410207|NCT01283139|5911363|P3|NOT COMPLETED|Overall Study||18
2410208|NCT01283139|5911364|P2|NOT COMPLETED|Overall Study||18
2410209|NCT01283139|5911365|P1|NOT COMPLETED|Overall Study||17
2410210|NCT01283139|5911362|P4|COMPLETED|Overall Study||92
2410211|NCT01283139|5911363|P3|COMPLETED|Overall Study||91
2410212|NCT01283139|5911364|P2|COMPLETED|Overall Study||90
2410213|NCT01283139|5911365|P1|COMPLETED|Overall Study||91
2410214|NCT01283139|5911362|P4|STARTED|Overall Study||107
2410215|NCT01283139|5911363|P3|STARTED|Overall Study||109
2410216|NCT01283139|5911364|P2|STARTED|Overall Study||108
2410217|NCT01283139|5911365|P1|STARTED|Overall Study||108
2410218|NCT01283035|5911407|P1|NOT COMPLETED|Overall Study||1
2410219|NCT01283035|5911407|P1|COMPLETED|Overall Study||5
2410220|NCT01283035|5911407|P1|STARTED|Overall Study||6
2410221|NCT01283022|5911416|P1|NOT COMPLETED|Overall Study||0
2410222|NCT01283022|5911416|P1|COMPLETED|Overall Study||24
2410223|NCT01283022|5911416|P1|STARTED|Overall Study||24
2410224|NCT01282866|5911422|P1|NOT COMPLETED|Overall Study||1
2410225|NCT01282866|5911422|P1|COMPLETED|Overall Study||34
2410226|NCT01282866|5911422|P1|STARTED|Overall Study||35
2410227|NCT01282814|5911430|P2|NOT COMPLETED|Second Intervention||0
2410228|NCT01282814|5911431|P1|NOT COMPLETED|Second Intervention||0
2410229|NCT01282814|5911430|P2|COMPLETED|Second Intervention||9
2410230|NCT01282814|5911431|P1|COMPLETED|Second Intervention||10
2410231|NCT01282814|5911430|P2|STARTED|Second Intervention||9
2410232|NCT01282814|5911431|P1|STARTED|Second Intervention||10
2410233|NCT01282814|5911430|P2|NOT COMPLETED|Washout of 7 Days||0
2410234|NCT01282814|5911431|P1|NOT COMPLETED|Washout of 7 Days||2
2410235|NCT01282814|5911430|P2|COMPLETED|Washout of 7 Days||9
2410236|NCT01282814|5911431|P1|COMPLETED|Washout of 7 Days||10
2410237|NCT01282814|5911430|P2|STARTED|Washout of 7 Days||9
2410238|NCT01282814|5911431|P1|STARTED|Washout of 7 Days||12
2410239|NCT01282814|5911430|P2|NOT COMPLETED|First Intervention||3
2410240|NCT01282814|5911431|P1|NOT COMPLETED|First Intervention||0
2410241|NCT01282814|5911430|P2|COMPLETED|First Intervention||9
2410242|NCT01282814|5911431|P1|COMPLETED|First Intervention||12
2410243|NCT01282814|5911430|P2|STARTED|First Intervention||12
2410244|NCT01282814|5911431|P1|STARTED|First Intervention||12
2410245|NCT01282801|5911443|P2|NOT COMPLETED|Second Intervention||1
2410246|NCT01282801|5911444|P1|NOT COMPLETED|Second Intervention||0
2410247|NCT01282801|5911443|P2|COMPLETED|Second Intervention||8
2410248|NCT01282801|5911444|P1|COMPLETED|Second Intervention||9
2410249|NCT01282801|5911443|P2|STARTED|Second Intervention||9
2410250|NCT01282801|5911444|P1|STARTED|Second Intervention||9
2410251|NCT01282801|5911443|P2|NOT COMPLETED|Washout of 7 Days||0
2410252|NCT01282801|5911444|P1|NOT COMPLETED|Washout of 7 Days||0
2410253|NCT01282801|5911443|P2|COMPLETED|Washout of 7 Days||9
2410254|NCT01282801|5911444|P1|COMPLETED|Washout of 7 Days||9
2410255|NCT01282801|5911443|P2|STARTED|Washout of 7 Days||9
2410256|NCT01282801|5911444|P1|STARTED|Washout of 7 Days||9
2410257|NCT01282801|5911443|P2|NOT COMPLETED|First Intervention||0
2410258|NCT01282801|5911444|P1|NOT COMPLETED|First Intervention||0
2410259|NCT01282801|5911443|P2|COMPLETED|First Intervention||9
2410260|NCT01282801|5911444|P1|COMPLETED|First Intervention||9
2410261|NCT01282801|5911443|P2|STARTED|First Intervention||9
2410262|NCT01282801|5911444|P1|STARTED|First Intervention||9
2410263|NCT01282723|5911460|P1|NOT COMPLETED|Overall Study||0
2410264|NCT01282723|5911460|P1|COMPLETED|Overall Study||20
2410265|NCT01282723|5911460|P1|STARTED|Overall Study||20
2410266|NCT01282710|5911464|P1|NOT COMPLETED|Overall Study||0
2410267|NCT01282710|5911464|P1|COMPLETED|Overall Study||20
2410268|NCT01282710|5911464|P1|STARTED|Overall Study||20
2410269|NCT01282476|5911468|P1|NOT COMPLETED|Overall Study||11
2410270|NCT01282476|5911468|P1|COMPLETED|Overall Study||7
2410271|NCT01282476|5911468|P1|STARTED|Overall Study||18
2410272|NCT01282463|5911477|P3|NOT COMPLETED|Overall Study||4
2410273|NCT01282463|5911478|P2|NOT COMPLETED|Overall Study||4
2410274|NCT01282463|5911479|P1|NOT COMPLETED|Overall Study||8
2410275|NCT01282463|5911477|P3|COMPLETED|Overall Study||46
2410276|NCT01282463|5911478|P2|COMPLETED|Overall Study||45
2410277|NCT01282463|5911479|P1|COMPLETED|Overall Study||41
2410278|NCT01282463|5911477|P3|Received at Least 1 Dose of Study Drug|Overall Study||49
2410279|NCT01282463|5911478|P2|Received at Least 1 Dose of Study Drug|Overall Study||46
2410280|NCT01282463|5911479|P1|Received at Least 1 Dose of Study Drug|Overall Study||45
2410281|NCT01282463|5911477|P3|STARTED|Overall Study||50
2410282|NCT01282463|5911478|P2|STARTED|Overall Study||49
2410283|NCT01282463|5911479|P1|STARTED|Overall Study||49
2410284|NCT01282424|5911517|P1|NOT COMPLETED|Long-term Follow-up Period (5 Years)||64
2410285|NCT01282424|5911517|P1|COMPLETED|Long-term Follow-up Period (5 Years)||20
2410286|NCT01282424|5911517|P1|STARTED|Long-term Follow-up Period (5 Years)|Participants did not have to complete the TP in order to enter the Long-term Follow-up Period.|84
2410287|NCT01282424|5911517|P1|NOT COMPLETED|Treatment Period (TP) (81 Months)||46
2410288|NCT01282424|5911517|P1|COMPLETED|Treatment Period (TP) (81 Months)||79
2410289|NCT01282424|5911517|P1|Completed: Death|Treatment Period (TP) (81 Months)||9
2410290|NCT01282424|5911517|P1|Completed: Disease Progression|Treatment Period (TP) (81 Months)||70
2410291|NCT01282424|5911517|P1|STARTED|Treatment Period (TP) (81 Months)||125
2410292|NCT01282372|5911534|P1|NOT COMPLETED|Overall Study||79
2410293|NCT01282372|5911534|P1|COMPLETED|Overall Study||421
2410294|NCT01282372|5911534|P1|STARTED|Overall Study||500
2410295|NCT01282294|5911562|P1|NOT COMPLETED|Overall Study||19
2410296|NCT01282294|5911562|P1|COMPLETED|Overall Study||81
2410297|NCT01282294|5911562|P1|12 Months|Overall Study||86
2410298|NCT01282294|5911562|P1|6 Months|Overall Study||94
2410299|NCT01282294|5911562|P1|3 Months|Overall Study||95
2410300|NCT01282294|5911562|P1|6 Weeks|Overall Study||95
2410301|NCT01282294|5911562|P1|Post-operative|Overall Study||99
2410302|NCT01282294|5911562|P1|Intra-operative|Overall Study||99
2410303|NCT01282294|5911562|P1|STARTED|Overall Study||100
2410304|NCT01282242|5911582|P2|NOT COMPLETED|Overall Study||0
2410305|NCT01282242|5911583|P1|NOT COMPLETED|Overall Study||0
2410306|NCT01282242|5911582|P2|COMPLETED|Overall Study||8
2410307|NCT01282242|5911583|P1|COMPLETED|Overall Study||80
2410308|NCT01282242|5911582|P2|STARTED|Overall Study||8
2410309|NCT01282242|5911583|P1|STARTED|Overall Study||80
2410310|NCT01282229|5911591|P1|NOT COMPLETED|Overall Study||2
2410311|NCT01282229|5911591|P1|COMPLETED|Overall Study|57 Participants contributed 228 quadrants (57*4)|57
2410312|NCT01282229|5911591|P1|STARTED|Overall Study|59 Participants contributed 236 quadrants (59*4)|59
2410313|NCT01282216|5911623|P4|NOT COMPLETED|Overall Study||8
2410314|NCT01282216|5911624|P3|NOT COMPLETED|Overall Study||33
2410315|NCT01282216|5911625|P2|NOT COMPLETED|Overall Study||0
2410316|NCT01282216|5911626|P1|NOT COMPLETED|Overall Study||0
2410317|NCT01282216|5911623|P4|COMPLETED|Overall Study||0
2410318|NCT01282216|5911624|P3|COMPLETED|Overall Study||19
2410319|NCT01282216|5911625|P2|COMPLETED|Overall Study||26
2410320|NCT01282216|5911626|P1|COMPLETED|Overall Study||18
2410321|NCT01282216|5911623|P4|STARTED|Overall Study||8
2410322|NCT01282216|5911624|P3|STARTED|Overall Study||52
2410323|NCT01282216|5911625|P2|STARTED|Overall Study||26
2410324|NCT01282216|5911626|P1|STARTED|Overall Study||18
2410325|NCT01282203|5911636|P1|NOT COMPLETED|Overall Study||1
2410326|NCT01282203|5911636|P1|COMPLETED|Overall Study||1121
2410327|NCT01282203|5911636|P1|STARTED|Overall Study||1122
2410328|NCT01282164|5911658|P2|NOT COMPLETED|Overall Study||0
2410329|NCT01282164|5911659|P1|NOT COMPLETED|Overall Study||1
2410330|NCT01282164|5911658|P2|COMPLETED|Overall Study||14
2410331|NCT01282164|5911659|P1|COMPLETED|Overall Study||28
2410332|NCT01282164|5911658|P2|STARTED|Overall Study||14
2410333|NCT01282164|5911659|P1|STARTED|Overall Study||29
2410334|NCT01282138|5911684|P2|NOT COMPLETED|CAPT||0
2410335|NCT01282138|5911685|P1|NOT COMPLETED|CAPT||0
2410336|NCT01282138|5911684|P2|COMPLETED|CAPT||7
2410337|NCT01282138|5911685|P1|COMPLETED|CAPT||6
2410338|NCT01282138|5911684|P2|STARTED|CAPT||7
2410339|NCT01282138|5911685|P1|STARTED|CAPT||6
2410340|NCT01282138|5911684|P2|NOT COMPLETED|EEC||0
2410341|NCT01282138|5911685|P1|NOT COMPLETED|EEC||0
2410342|NCT01282138|5911684|P2|COMPLETED|EEC||7
2410343|NCT01282138|5911685|P1|COMPLETED|EEC||6
2410344|NCT01282138|5911684|P2|STARTED|EEC||7
2410345|NCT01282138|5911685|P1|STARTED|EEC||6
2410346|NCT01282086|5911693|P1|NOT COMPLETED|Overall Study||0
2410347|NCT01282086|5911693|P1|COMPLETED|Overall Study||1365
2410348|NCT01282086|5911693|P1|STARTED|Overall Study||1365
2410349|NCT01281956|5911710|P2|NOT COMPLETED|2nd Intervention (3 Months)||0
2410350|NCT01281956|5911711|P1|NOT COMPLETED|2nd Intervention (3 Months)||1
2410351|NCT01281956|5911710|P2|COMPLETED|2nd Intervention (3 Months)||5
2410352|NCT01281956|5911711|P1|COMPLETED|2nd Intervention (3 Months)||4
2410353|NCT01281956|5911710|P2|STARTED|2nd Intervention (3 Months)||5
2410354|NCT01281956|5911711|P1|STARTED|2nd Intervention (3 Months)||5
2410355|NCT01281956|5911710|P2|NOT COMPLETED|1st Intervention (3 Months)||0
2410356|NCT01281956|5911711|P1|NOT COMPLETED|1st Intervention (3 Months)||0
2410357|NCT01281956|5911710|P2|COMPLETED|1st Intervention (3 Months)||5
2410358|NCT01281956|5911711|P1|COMPLETED|1st Intervention (3 Months)||5
2410359|NCT01281956|5911710|P2|STARTED|1st Intervention (3 Months)||5
2410360|NCT01281956|5911711|P1|STARTED|1st Intervention (3 Months)||5
2410361|NCT01281917|5911742|P1|NOT COMPLETED|Overall Study||1
2410362|NCT01281917|5911742|P1|COMPLETED|Overall Study||39
2410363|NCT01281917|5911742|P1|STARTED|Overall Study||40
2410364|NCT01281865|5911754|P2|NOT COMPLETED|Overall Study||1
2410365|NCT01281865|5911755|P1|NOT COMPLETED|Overall Study||3
2410366|NCT01281865|5911754|P2|COMPLETED|Overall Study||1
2410367|NCT01281865|5911755|P1|COMPLETED|Overall Study||9
2410368|NCT01281865|5911754|P2|STARTED|Overall Study||2
2410369|NCT01281865|5911755|P1|STARTED|Overall Study||12
2410370|NCT01281839|5911763|P2|NOT COMPLETED|Overall Study||14
2410371|NCT01281839|5911764|P1|NOT COMPLETED|Overall Study||10
2410372|NCT01281839|5911763|P2|COMPLETED|Overall Study||119
2410373|NCT01281839|5911764|P1|COMPLETED|Overall Study||250
2410374|NCT01281839|5911763|P2|STARTED|Overall Study||133
2410375|NCT01281839|5911764|P1|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|260
2410376|NCT01281644|5911825|P1|NOT COMPLETED|Overall Study||5
2410377|NCT01281644|5911825|P1|COMPLETED|Overall Study||18
2410378|NCT01281644|5911825|P1|STARTED|Overall Study||23
2410379|NCT01281501|5911835|P2|NOT COMPLETED|Overall Study||0
2410380|NCT01281501|5911836|P1|NOT COMPLETED|Overall Study||0
2410381|NCT01281501|5911835|P2|COMPLETED|Overall Study||43
2410382|NCT01281501|5911836|P1|COMPLETED|Overall Study||44
2410383|NCT01281501|5911835|P2|STARTED|Overall Study||43
2410384|NCT01281501|5911836|P1|STARTED|Overall Study||44
2410385|NCT01281475|5911850|P2|NOT COMPLETED|Overall Study||8
2410386|NCT01281475|5911851|P1|NOT COMPLETED|Overall Study||4
2410387|NCT01281475|5911850|P2|COMPLETED|Overall Study||26
2410388|NCT01281475|5911851|P1|COMPLETED|Overall Study||29
2410389|NCT01281475|5911850|P2|STARTED|Overall Study||34
2410390|NCT01281475|5911851|P1|STARTED|Overall Study||33
2410391|NCT01281306|5911866|P7|NOT COMPLETED|Overall Study||7
2410392|NCT01281306|5911867|P6|NOT COMPLETED|Overall Study||7
2410393|NCT01281306|5911868|P5|NOT COMPLETED|Overall Study||9
2410394|NCT01281306|5911869|P4|NOT COMPLETED|Overall Study||11
2410395|NCT01281306|5911870|P3|NOT COMPLETED|Overall Study||8
2410396|NCT01281306|5911871|P2|NOT COMPLETED|Overall Study||4
2410397|NCT01281306|5911872|P1|NOT COMPLETED|Overall Study||8
2410398|NCT01281306|5911866|P7|COMPLETED|Overall Study||51
2410399|NCT01281306|5911867|P6|COMPLETED|Overall Study||135
2410400|NCT01281306|5911868|P5|COMPLETED|Overall Study||134
2410401|NCT01281306|5911869|P4|COMPLETED|Overall Study||123
2410402|NCT01281306|5911870|P3|COMPLETED|Overall Study||133
2410403|NCT01281306|5911871|P2|COMPLETED|Overall Study||141
2410404|NCT01281306|5911872|P1|COMPLETED|Overall Study||136
2410405|NCT01281306|5911866|P7|Ambulatory Blood Pressure Monitoring Set|Overall Study||35
2410406|NCT01281306|5911867|P6|Ambulatory Blood Pressure Monitoring Set|Overall Study||91
2410407|NCT01281306|5911868|P5|Ambulatory Blood Pressure Monitoring Set|Overall Study||93
2410408|NCT01281306|5911869|P4|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
2410409|NCT01281306|5911870|P3|Ambulatory Blood Pressure Monitoring Set|Overall Study||92
2410410|NCT01281306|5911871|P2|Ambulatory Blood Pressure Monitoring Set|Overall Study||99
2410411|NCT01281306|5911872|P1|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
2410412|NCT01281306|5911866|P7|Safety Set|Overall Study||58
2410413|NCT01281306|5911867|P6|Safety Set|Overall Study||142
2410414|NCT01281306|5911868|P5|Safety Set|Overall Study||143
2410415|NCT01281306|5911869|P4|Safety Set|Overall Study||133
2410416|NCT01281306|5911870|P3|Safety Set|Overall Study||141
2410417|NCT01281306|5911871|P2|Safety Set|Overall Study||145
2410418|NCT01281306|5911872|P1|Safety Set|Overall Study||143
2410419|NCT01281306|5911866|P7|Full Analysis Set|Overall Study||58
2410420|NCT01281306|5911867|P6|Full Analysis Set|Overall Study||142
2410421|NCT01281306|5911868|P5|Full Analysis Set|Overall Study||143
2410422|NCT01281306|5911869|P4|Full Analysis Set|Overall Study||133
2410423|NCT01281306|5911870|P3|Full Analysis Set|Overall Study||141
2410424|NCT01281306|5911871|P2|Full Analysis Set|Overall Study||145
2410425|NCT01281306|5911872|P1|Full Analysis Set|Overall Study||143
2410426|NCT01281306|5911866|P7|STARTED|Overall Study||58
2410427|NCT01281306|5911867|P6|STARTED|Overall Study||142
2410428|NCT01281306|5911868|P5|STARTED|Overall Study||143
2410429|NCT01281306|5911869|P4|STARTED|Overall Study||134
2410430|NCT01281306|5911870|P3|STARTED|Overall Study||141
2410431|NCT01281306|5911871|P2|STARTED|Overall Study||145
2410432|NCT01281306|5911872|P1|STARTED|Overall Study||144
2410433|NCT01281202|5911988|P2|NOT COMPLETED|Overall Study||36
2410434|NCT01281202|5911989|P1|NOT COMPLETED|Overall Study||28
2410435|NCT01281202|5911988|P2|COMPLETED|Overall Study||68
2410436|NCT01281202|5911989|P1|COMPLETED|Overall Study||75
2410437|NCT01281202|5911988|P2|STARTED|Overall Study||104
2410438|NCT01281202|5911989|P1|STARTED|Overall Study||103
2410439|NCT01281124|5911997|P1|NOT COMPLETED|Overall Study||1
2410440|NCT01281124|5911997|P1|COMPLETED|Overall Study||0
2410441|NCT01281124|5911997|P1|STARTED|Overall Study||1
2410442|NCT01281007|5912005|P2|NOT COMPLETED|Overall Study||8
2410443|NCT01281007|5912006|P1|NOT COMPLETED|Overall Study||4
2410444|NCT01281007|5912005|P2|COMPLETED|Overall Study||67
2410445|NCT01281007|5912006|P1|COMPLETED|Overall Study||71
2410446|NCT01281007|5912005|P2|STARTED|Overall Study||75
2410447|NCT01281007|5912006|P1|STARTED|Overall Study||75
2410448|NCT01280981|5912012|P1|NOT COMPLETED|Overall Study||92
2410449|NCT01280981|5912012|P1|COMPLETED|Overall Study||196
2410450|NCT01280981|5912012|P1|Intent to Treat (ITT) Population|Overall Study|Participants who took drug during at least one menstrual cycle|260
2410451|NCT01280981|5912012|P1|STARTED|Overall Study||288
2410452|NCT01280968|5912023|P2|NOT COMPLETED|Overall Study||3
2410453|NCT01280968|5912024|P1|NOT COMPLETED|Overall Study||18
2410454|NCT01280968|5912023|P2|COMPLETED|Overall Study||4
2410455|NCT01280968|5912024|P1|COMPLETED|Overall Study||27
2410456|NCT01280968|5912023|P2|STARTED|Overall Study||7
2410457|NCT01280968|5912024|P1|STARTED|Overall Study||45
2410458|NCT01280955|5912040|P1|NOT COMPLETED|Overall Study||3
2410459|NCT01280955|5912040|P1|COMPLETED|Overall Study||27
2410460|NCT01280955|5912040|P1|STARTED|Overall Study||30
2410461|NCT01280942|5912073|P2|NOT COMPLETED|Overall Study||0
2410462|NCT01280942|5912074|P1|NOT COMPLETED|Overall Study||0
2410463|NCT01280942|5912073|P2|COMPLETED|Overall Study||9911
2410464|NCT01280942|5912074|P1|COMPLETED|Overall Study||10120
2410465|NCT01280942|5912073|P2|STARTED|Overall Study||9911
2410466|NCT01280942|5912074|P1|STARTED|Overall Study||10120
2410467|NCT01280903|5912084|P2|NOT COMPLETED|Overall Study||16
2410468|NCT01280903|5912085|P1|NOT COMPLETED|Overall Study||23
2410469|NCT01280903|5912084|P2|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|75
2410470|NCT01280903|5912085|P1|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|68
2410471|NCT01280903|5912084|P2|STARTED|Overall Study||91
2410472|NCT01280903|5912085|P1|STARTED|Overall Study||91
2410473|NCT01280721|5912149|P1|NOT COMPLETED|Overall Study||22
2410474|NCT01280721|5912149|P1|COMPLETED|Overall Study||113
2410475|NCT01280721|5912149|P1|STARTED|Overall Study||135
2410476|NCT01280695|5912169|P5|NOT COMPLETED|Overall Study||2
2410477|NCT01280695|5912170|P4|NOT COMPLETED|Overall Study||4
2410478|NCT01280695|5912171|P3|NOT COMPLETED|Overall Study||5
2410479|NCT01280695|5912172|P2|NOT COMPLETED|Overall Study||1
2410480|NCT01280695|5912173|P1|NOT COMPLETED|Overall Study||0
2410481|NCT01280695|5912169|P5|COMPLETED|Overall Study||24
2410482|NCT01280695|5912170|P4|COMPLETED|Overall Study||22
2410483|NCT01280695|5912171|P3|COMPLETED|Overall Study||21
2410484|NCT01280695|5912172|P2|COMPLETED|Overall Study||24
2410485|NCT01280695|5912173|P1|COMPLETED|Overall Study||26
2410486|NCT01280695|5912169|P5|STARTED|Overall Study||26
2410487|NCT01280695|5912170|P4|STARTED|Overall Study||26
2410488|NCT01280695|5912171|P3|STARTED|Overall Study||26
2410489|NCT01280695|5912172|P2|STARTED|Overall Study||25
2410490|NCT01280695|5912173|P1|STARTED|Overall Study||26
2410491|NCT01280656|5912213|P3|NOT COMPLETED|Overall Study||63
2410492|NCT01280656|5912214|P2|NOT COMPLETED|Overall Study||47
2410493|NCT01280656|5912215|P1|NOT COMPLETED|Overall Study||3
2410494|NCT01280656|5912213|P3|COMPLETED|Overall Study||223
2410495|NCT01280656|5912214|P2|COMPLETED|Overall Study||265
2410496|NCT01280656|5912215|P1|COMPLETED|Overall Study||59
2410497|NCT01280656|5912213|P3|STARTED|Overall Study||286
2410498|NCT01280656|5912214|P2|STARTED|Overall Study||312
2410499|NCT01280656|5912215|P1|STARTED|Overall Study||62
2410500|NCT01280604|5912261|P2|NOT COMPLETED|Overall Study||5
2410501|NCT01280604|5912262|P1|NOT COMPLETED|Overall Study||9
2410502|NCT01280604|5912261|P2|COMPLETED|Overall Study||28
2410503|NCT01280604|5912262|P1|COMPLETED|Overall Study||24
2410504|NCT01280604|5912261|P2|Subjects Meeting All Inclusion Criteria|Overall Study||29
2410505|NCT01280604|5912262|P1|Subjects Meeting All Inclusion Criteria|Overall Study||25
2410506|NCT01280604|5912261|P2|STARTED|Overall Study||33
2410507|NCT01280604|5912262|P1|STARTED|Overall Study||33
2410508|NCT01280591|5912282|P4|NOT COMPLETED|Overall Study||3
2410509|NCT01280591|5912283|P3|NOT COMPLETED|Overall Study||0
2410510|NCT01280591|5912284|P2|NOT COMPLETED|Overall Study||0
2410511|NCT01280591|5912285|P1|NOT COMPLETED|Overall Study||0
2410512|NCT01280591|5912282|P4|COMPLETED|Overall Study||99
2410513|NCT01280591|5912283|P3|COMPLETED|Overall Study||203
2410514|NCT01280591|5912284|P2|COMPLETED|Overall Study||204
2410515|NCT01280591|5912285|P1|COMPLETED|Overall Study||203
2410516|NCT01280591|5912282|P4|STARTED|Overall Study||102
2410517|NCT01280591|5912283|P3|STARTED|Overall Study||203
2410518|NCT01280591|5912284|P2|STARTED|Overall Study||204
2410519|NCT01280591|5912285|P1|STARTED|Overall Study||203
2410520|NCT01280552|5912377|P2|NOT COMPLETED|Overall Study||1
2410521|NCT01280552|5912378|P1|NOT COMPLETED|Overall Study||6
2410522|NCT01280552|5912377|P2|COMPLETED|Overall Study||42
2410523|NCT01280552|5912378|P1|COMPLETED|Overall Study|Survival is still being assessed|75
2410524|NCT01280552|5912377|P2|STARTED|Overall Study||43
2410525|NCT01280552|5912378|P1|STARTED|Overall Study||81
2410526|NCT01280409|5912392|P2|NOT COMPLETED|Overall Study||19
2410527|NCT01280409|5912393|P1|NOT COMPLETED|Overall Study||16
2410528|NCT01280409|5912392|P2|COMPLETED|Overall Study||36
2410529|NCT01280409|5912393|P1|COMPLETED|Overall Study||43
2410530|NCT01280409|5912392|P2|STARTED|Overall Study||55
2410531|NCT01280409|5912393|P1|STARTED|Overall Study||59
2410532|NCT01280357|5912423|P1|NOT COMPLETED|Overall Study||26
2410533|NCT01280357|5912423|P1|COMPLETED|Overall Study||34
2410534|NCT01280357|5912423|P1|STARTED|Overall Study||60
2410535|NCT01280266|5912432|P2|NOT COMPLETED|Second Intervention (Week 5-9)||0
2410536|NCT01280266|5912433|P1|NOT COMPLETED|Second Intervention (Week 5-9)||0
2410537|NCT01280266|5912432|P2|COMPLETED|Second Intervention (Week 5-9)||12
2410538|NCT01280266|5912433|P1|COMPLETED|Second Intervention (Week 5-9)||14
2410539|NCT01280266|5912432|P2|STARTED|Second Intervention (Week 5-9)||12
2410540|NCT01280266|5912433|P1|STARTED|Second Intervention (Week 5-9)||14
2410541|NCT01280266|5912432|P2|NOT COMPLETED|Washout Period (Week 4-5)||0
2410542|NCT01280266|5912433|P1|NOT COMPLETED|Washout Period (Week 4-5)||0
2410543|NCT01280266|5912432|P2|COMPLETED|Washout Period (Week 4-5)||12
2410544|NCT01280266|5912433|P1|COMPLETED|Washout Period (Week 4-5)||14
2410545|NCT01280266|5912432|P2|STARTED|Washout Period (Week 4-5)||12
2410546|NCT01280266|5912433|P1|STARTED|Washout Period (Week 4-5)||14
2410547|NCT01280266|5912432|P2|NOT COMPLETED|First Intervention (Week 1-4)||2
2410548|NCT01280266|5912433|P1|NOT COMPLETED|First Intervention (Week 1-4)||1
2410549|NCT01280266|5912432|P2|COMPLETED|First Intervention (Week 1-4)||12
2410550|NCT01280266|5912433|P1|COMPLETED|First Intervention (Week 1-4)||14
2410551|NCT01280266|5912432|P2|STARTED|First Intervention (Week 1-4)||14
2410552|NCT01280266|5912433|P1|STARTED|First Intervention (Week 1-4)||15
2410553|NCT01280201|5912455|P1|NOT COMPLETED|Overall Study||0
2410554|NCT01280201|5912455|P1|COMPLETED|Overall Study||44
2410555|NCT01280201|5912455|P1|STARTED|Overall Study||44
2410556|NCT01280123|5912467|P3|NOT COMPLETED|Overall Study||1
2410557|NCT01280123|5912468|P2|NOT COMPLETED|Overall Study||4
2410558|NCT01280123|5912469|P1|NOT COMPLETED|Overall Study||1
2410559|NCT01280123|5912467|P3|COMPLETED|Overall Study||70
2410560|NCT01280123|5912468|P2|COMPLETED|Overall Study||63
2410561|NCT01280123|5912469|P1|COMPLETED|Overall Study||71
2410562|NCT01280123|5912467|P3|STARTED|Overall Study||71
2410563|NCT01280123|5912468|P2|STARTED|Overall Study||67
2410564|NCT01280123|5912469|P1|STARTED|Overall Study||72
2410565|NCT01280110|5912494|P2|NOT COMPLETED|Overall Study||0
2410566|NCT01280110|5912495|P1|NOT COMPLETED|Overall Study||0
2410567|NCT01280110|5912494|P2|COMPLETED|Overall Study||22
2410568|NCT01280110|5912495|P1|COMPLETED|Overall Study||22
2410569|NCT01280110|5912494|P2|STARTED|Overall Study||22
2410570|NCT01280110|5912495|P1|STARTED|Overall Study||22
2410571|NCT01280058|5912505|P2|NOT COMPLETED|Overall Study||0
2410572|NCT01280058|5912506|P1|NOT COMPLETED|Overall Study||0
2410573|NCT01280058|5912505|P2|COMPLETED|Overall Study||37
2410574|NCT01280058|5912506|P1|COMPLETED|Overall Study||36
2410575|NCT01280058|5912505|P2|STARTED|Overall Study||37
2410576|NCT01280058|5912506|P1|STARTED|Overall Study||36
2410577|NCT01279954|5912524|P2|NOT COMPLETED|Overall Study||4
2410578|NCT01279954|5912525|P1|NOT COMPLETED|Overall Study||3
2410579|NCT01279954|5912524|P2|COMPLETED|Overall Study||1
2410580|NCT01279954|5912525|P1|COMPLETED|Overall Study||2
2410581|NCT01279954|5912524|P2|STARTED|Overall Study||5
2410582|NCT01279954|5912525|P1|STARTED|Overall Study||5
2410583|NCT01279850|5912536|P1|NOT COMPLETED|Overall Study||91
2410584|NCT01279850|5912536|P1|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|800
2410585|NCT01279850|5912536|P1|STARTED|Overall Study||891
2410586|NCT01279681|5912552|P2|NOT COMPLETED|Overall Study||17
2410587|NCT01279681|5912553|P1|NOT COMPLETED|Overall Study||15
2410588|NCT01279681|5912552|P2|COMPLETED|Overall Study||0
2410589|NCT01279681|5912553|P1|COMPLETED|Overall Study||0
2410590|NCT01279681|5912552|P2|STARTED|Overall Study||17
2410591|NCT01279681|5912553|P1|STARTED|Overall Study||15
2410592|NCT01279616|5912565|P1|NOT COMPLETED|Overall Study||7
2410593|NCT01279616|5912565|P1|COMPLETED|Overall Study||1
2410594|NCT01279616|5912565|P1|STARTED|Overall Study||8
2410595|NCT01279564|5912571|P2|NOT COMPLETED|Overall Study||0
2410596|NCT01279564|5912572|P1|NOT COMPLETED|Overall Study||0
2410597|NCT01279564|5912571|P2|COMPLETED|Overall Study||32
2410598|NCT01279564|5912572|P1|COMPLETED|Overall Study||40
2410599|NCT01279564|5912571|P2|STARTED|Overall Study||32
2410600|NCT01279564|5912572|P1|STARTED|Overall Study||40
2410601|NCT01279486|5912578|P1|NOT COMPLETED|Overall Study||1
2410602|NCT01279486|5912578|P1|COMPLETED|Overall Study|1 result questionnaire was not returned so 119 volunteers results were used for consumer accuracy.|119
2410603|NCT01279486|5912578|P1|STARTED|Overall Study||120
2410604|NCT01279447|5912584|P2|NOT COMPLETED|Overall Study||1
2410605|NCT01279447|5912585|P1|NOT COMPLETED|Overall Study||3
2410606|NCT01279447|5912584|P2|COMPLETED|Overall Study||33
2410607|NCT01279447|5912585|P1|COMPLETED|Overall Study||31
2410608|NCT01279447|5912584|P2|STARTED|Overall Study||34
2410609|NCT01279447|5912585|P1|STARTED|Overall Study||34
2410610|NCT01279343|5912593|P2|NOT COMPLETED|Overall Study||6
2410611|NCT01279343|5912594|P1|NOT COMPLETED|Overall Study||2
2410612|NCT01279343|5912593|P2|COMPLETED|Overall Study||58
2410613|NCT01279343|5912594|P1|COMPLETED|Overall Study||57
2410614|NCT01279343|5912593|P2|STARTED|Overall Study||64
2410615|NCT01279343|5912594|P1|STARTED|Overall Study||59
2410616|NCT01279317|5912618|P2|NOT COMPLETED|Period 2||0
2410617|NCT01279317|5912619|P1|NOT COMPLETED|Period 2||0
2410618|NCT01279317|5912618|P2|COMPLETED|Period 2||6
2410619|NCT01279317|5912619|P1|COMPLETED|Period 2||6
2410620|NCT01279317|5912618|P2|STARTED|Period 2||6
2410621|NCT01279317|5912619|P1|STARTED|Period 2||6
2410622|NCT01279317|5912618|P2|NOT COMPLETED|Washout||0
2410623|NCT01279317|5912619|P1|NOT COMPLETED|Washout||0
2410624|NCT01279317|5912618|P2|COMPLETED|Washout||6
2410625|NCT01279317|5912619|P1|COMPLETED|Washout||6
2410626|NCT01279317|5912618|P2|STARTED|Washout||6
2410627|NCT01279317|5912619|P1|STARTED|Washout||6
2410628|NCT01279317|5912618|P2|NOT COMPLETED|Period 1||0
2410629|NCT01279317|5912619|P1|NOT COMPLETED|Period 1||0
2410630|NCT01279317|5912618|P2|COMPLETED|Period 1||6
2410631|NCT01279317|5912619|P1|COMPLETED|Period 1||6
2410632|NCT01279317|5912618|P2|STARTED|Period 1||6
2410633|NCT01279317|5912619|P1|STARTED|Period 1||6
2410634|NCT01279265|5912626|P2|NOT COMPLETED|Overall Study||6
2410635|NCT01279265|5912627|P1|NOT COMPLETED|Overall Study||4
2410636|NCT01279265|5912626|P2|COMPLETED|Overall Study||11
2410637|NCT01279265|5912627|P1|COMPLETED|Overall Study||9
2410638|NCT01279265|5912626|P2|STARTED|Overall Study||17
2410639|NCT01279265|5912627|P1|STARTED|Overall Study||13
2410640|NCT01279200|5912639|P2|NOT COMPLETED|Overall Study||7
2410641|NCT01279200|5912640|P1|NOT COMPLETED|Overall Study||2
2410642|NCT01279200|5912639|P2|COMPLETED|Overall Study||4
2410643|NCT01279200|5912640|P1|COMPLETED|Overall Study||8
2410644|NCT01279200|5912639|P2|STARTED|Overall Study||11
2410645|NCT01279200|5912640|P1|STARTED|Overall Study||10
2410646|NCT01279187|5912650|P2|NOT COMPLETED|Overall Study||0
2410647|NCT01279187|5912651|P1|NOT COMPLETED|Overall Study||0
2410648|NCT01279187|5912650|P2|COMPLETED|Overall Study||13
2410649|NCT01279187|5912651|P1|COMPLETED|Overall Study||14
2410650|NCT01279187|5912650|P2|STARTED|Overall Study||13
2410651|NCT01279187|5912651|P1|STARTED|Overall Study||14
2410652|NCT01279109|5912667|P2|NOT COMPLETED|Overall Study||12
2410653|NCT01279109|5912668|P1|NOT COMPLETED|Overall Study||13
2410654|NCT01279109|5912667|P2|COMPLETED|Overall Study||55
2410655|NCT01279109|5912668|P1|COMPLETED|Overall Study||55
2410656|NCT01279109|5912667|P2|STARTED|Overall Study||67
2410657|NCT01279109|5912668|P1|STARTED|Overall Study||68
2410658|NCT01279070|5912678|P2|NOT COMPLETED|Overall Study||4
2410659|NCT01279070|5912679|P1|NOT COMPLETED|Overall Study||5
2410660|NCT01279070|5912678|P2|COMPLETED|Overall Study|4 outpatients left the leisure group up to 2 months after starting Leisure group.|24
2410661|NCT01279070|5912679|P1|COMPLETED|Overall Study|5 outpatients left the treatment up to 2 months after starting REPYFLEC.|29
2410662|NCT01279070|5912678|P2|STARTED|Overall Study|28 outpatients were randomly assigned to 32 sessions of leisure group.|28
2410663|NCT01279070|5912679|P1|STARTED|Overall Study|34 outpatients were randomly assigned to 32 sessions of REPYFLEC.|34
2410664|NCT01279044|5912698|P3|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||3
2410665|NCT01279044|5912699|P2|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||11
2410666|NCT01279044|5912700|P1|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||0
2410667|NCT01279044|5912698|P3|COMPLETED|PHASE 2 - Randmonized Controlled Trial||161
2410668|NCT01279044|5912699|P2|COMPLETED|PHASE 2 - Randmonized Controlled Trial||151
2410669|NCT01279044|5912700|P1|COMPLETED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
2410670|NCT01279044|5912698|P3|STARTED|PHASE 2 - Randmonized Controlled Trial||164
2410671|NCT01279044|5912699|P2|STARTED|PHASE 2 - Randmonized Controlled Trial||162
2410672|NCT01279044|5912700|P1|STARTED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
2410673|NCT01279044|5912698|P3|NOT COMPLETED|PHASE 1 - Formative||0
2410674|NCT01279044|5912699|P2|NOT COMPLETED|PHASE 1 - Formative||0
2410675|NCT01279044|5912700|P1|NOT COMPLETED|PHASE 1 - Formative||0
2410676|NCT01279044|5912698|P3|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
2410677|NCT01279044|5912699|P2|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
2410678|NCT01279044|5912700|P1|COMPLETED|PHASE 1 - Formative||59
2410679|NCT01279044|5912698|P3|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
2410680|NCT01279044|5912699|P2|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
2410681|NCT01279044|5912700|P1|STARTED|PHASE 1 - Formative||59
2410682|NCT01278953|5912720|P2|NOT COMPLETED|Overall Study||11
2410683|NCT01278953|5912721|P1|NOT COMPLETED|Overall Study||9
2410684|NCT01278953|5912720|P2|COMPLETED|Overall Study||134
2410685|NCT01278953|5912721|P1|COMPLETED|Overall Study||146
2410686|NCT01278953|5912720|P2|STARTED|Overall Study||145
2410687|NCT01278953|5912721|P1|STARTED|Overall Study||155
2410688|NCT01278927|5912733|P4|NOT COMPLETED|Overall Study||0
2410689|NCT01278927|5912734|P3|NOT COMPLETED|Overall Study||0
2410690|NCT01278927|5912735|P2|NOT COMPLETED|Overall Study||0
2410691|NCT01278927|5912736|P1|NOT COMPLETED|Overall Study||0
2410692|NCT01278927|5912733|P4|COMPLETED|Overall Study||175
2410693|NCT01278927|5912734|P3|COMPLETED|Overall Study||178
2410694|NCT01278927|5912735|P2|COMPLETED|Overall Study||178
2410695|NCT01278927|5912736|P1|COMPLETED|Overall Study||180
2410696|NCT01278927|5912733|P4|STARTED|Overall Study||175
2410697|NCT01278927|5912734|P3|STARTED|Overall Study||178
2410698|NCT01278927|5912735|P2|STARTED|Overall Study||178
2410699|NCT01278927|5912736|P1|STARTED|Overall Study||180
2410700|NCT01278862|5912776|P2|NOT COMPLETED|Overall Study||1
2410701|NCT01278862|5912777|P1|NOT COMPLETED|Overall Study||1
2410702|NCT01278862|5912776|P2|COMPLETED|Overall Study||42
2410703|NCT01278862|5912777|P1|COMPLETED|Overall Study||44
2410704|NCT01278862|5912776|P2|STARTED|Overall Study||43
2410705|NCT01278862|5912777|P1|STARTED|Overall Study||45
2410706|NCT01278797|5912785|P2|NOT COMPLETED|Period 2||0
2410707|NCT01278797|5912786|P1|NOT COMPLETED|Period 2||0
2410708|NCT01278797|5912785|P2|COMPLETED|Period 2||13
2410709|NCT01278797|5912786|P1|COMPLETED|Period 2||13
2410710|NCT01278797|5912785|P2|STARTED|Period 2||13
2410711|NCT01278797|5912786|P1|STARTED|Period 2||13
2410712|NCT01278797|5912785|P2|NOT COMPLETED|Washout Period of 21 Days||0
2410713|NCT01278797|5912786|P1|NOT COMPLETED|Washout Period of 21 Days||0
2410714|NCT01278797|5912785|P2|COMPLETED|Washout Period of 21 Days||13
2410715|NCT01278797|5912786|P1|COMPLETED|Washout Period of 21 Days||13
2410716|NCT01278797|5912785|P2|STARTED|Washout Period of 21 Days||13
2410717|NCT01278797|5912786|P1|STARTED|Washout Period of 21 Days||13
2410718|NCT01278797|5912785|P2|NOT COMPLETED|Period 1||1
2410719|NCT01278797|5912786|P1|NOT COMPLETED|Period 1||1
2410720|NCT01278797|5912785|P2|COMPLETED|Period 1||13
2410721|NCT01278797|5912786|P1|COMPLETED|Period 1||13
2410722|NCT01278797|5912785|P2|STARTED|Period 1||14
2410723|NCT01278797|5912786|P1|STARTED|Period 1||14
2410724|NCT01278745|5912798|P4|NOT COMPLETED|Overall Study||78
2410725|NCT01278745|5912799|P3|NOT COMPLETED|Overall Study||121
2410726|NCT01278745|5912800|P2|NOT COMPLETED|Overall Study||6
2410727|NCT01278745|5912801|P1|NOT COMPLETED|Overall Study||5
2410728|NCT01278745|5912798|P4|COMPLETED|Overall Study||0
2410729|NCT01278745|5912799|P3|COMPLETED|Overall Study||0
2410730|NCT01278745|5912800|P2|COMPLETED|Overall Study||68
2410731|NCT01278745|5912801|P1|COMPLETED|Overall Study||84
2410732|NCT01278745|5912798|P4|STARTED|Overall Study||78
2410733|NCT01278745|5912799|P3|STARTED|Overall Study||121
2410734|NCT01278745|5912800|P2|STARTED|Overall Study||74
2410735|NCT01278745|5912801|P1|STARTED|Overall Study||89
2410736|NCT01278615|5912833|P1|NOT COMPLETED|Overall Study||2
2410737|NCT01278615|5912833|P1|COMPLETED|Overall Study||14
2410738|NCT01278615|5912833|P1|STARTED|Overall Study||16
2410739|NCT01278485|5912843|P1|NOT COMPLETED|Overall Study||0
2410740|NCT01278485|5912843|P1|COMPLETED|Overall Study||719
2410741|NCT01278485|5912843|P1|STARTED|Overall Study||719
2410742|NCT01278407|5912859|P5|NOT COMPLETED|Extension Phase||30
2410743|NCT01278407|5912860|P4|NOT COMPLETED|Extension Phase||12
2410744|NCT01278407|5912861|P3|NOT COMPLETED|Extension Phase||0
2410745|NCT01278407|5912862|P2|NOT COMPLETED|Extension Phase||0
2410746|NCT01278407|5912863|P1|NOT COMPLETED|Extension Phase||0
2410747|NCT01278407|5912859|P5|COMPLETED|Extension Phase||66
2410748|NCT01278407|5912860|P4|COMPLETED|Extension Phase||34
2410749|NCT01278407|5912861|P3|COMPLETED|Extension Phase||0
2410750|NCT01278407|5912862|P2|COMPLETED|Extension Phase||0
2410751|NCT01278407|5912863|P1|COMPLETED|Extension Phase||0
2410752|NCT01278407|5912859|P5|STARTED|Extension Phase||96
2410753|NCT01278407|5912860|P4|STARTED|Extension Phase||46
2410754|NCT01278407|5912861|P3|STARTED|Extension Phase||0
2410755|NCT01278407|5912862|P2|STARTED|Extension Phase||0
2410756|NCT01278407|5912863|P1|STARTED|Extension Phase||0
2410757|NCT01278407|5912859|P5|NOT COMPLETED|Confirmatory Phase||0
2410758|NCT01278407|5912860|P4|NOT COMPLETED|Confirmatory Phase||0
2410759|NCT01278407|5912861|P3|NOT COMPLETED|Confirmatory Phase||6
2410760|NCT01278407|5912862|P2|NOT COMPLETED|Confirmatory Phase||16
2410761|NCT01278407|5912863|P1|NOT COMPLETED|Confirmatory Phase||9
2410762|NCT01278407|5912859|P5|COMPLETED|Confirmatory Phase||0
2410763|NCT01278407|5912860|P4|COMPLETED|Confirmatory Phase||0
2410764|NCT01278407|5912861|P3|COMPLETED|Confirmatory Phase||43
2410765|NCT01278407|5912862|P2|COMPLETED|Confirmatory Phase||31
2410766|NCT01278407|5912863|P1|COMPLETED|Confirmatory Phase||37
2410767|NCT01278407|5912859|P5|STARTED|Confirmatory Phase||0
2410768|NCT01278407|5912860|P4|STARTED|Confirmatory Phase||0
2410769|NCT01278407|5912861|P3|STARTED|Confirmatory Phase||49
2410770|NCT01278407|5912862|P2|STARTED|Confirmatory Phase||47
2410771|NCT01278407|5912863|P1|STARTED|Confirmatory Phase||46
2410772|NCT01278394|5912876|P1|NOT COMPLETED|Overall Study||1
2410773|NCT01278394|5912876|P1|COMPLETED|Overall Study||28
2410774|NCT01278394|5912876|P1|STARTED|Overall Study||29
2410775|NCT01278342|5912889|P3|NOT COMPLETED|Overall Study||0
2410776|NCT01278342|5912890|P2|NOT COMPLETED|Overall Study||1
2410777|NCT01278342|5912891|P1|NOT COMPLETED|Overall Study||4
2410778|NCT01278342|5912889|P3|COMPLETED|Overall Study||32
2410779|NCT01278342|5912890|P2|COMPLETED|Overall Study||30
2410780|NCT01278342|5912891|P1|COMPLETED|Overall Study||3
2410781|NCT01278342|5912889|P3|STARTED|Overall Study||32
2410782|NCT01278342|5912890|P2|STARTED|Overall Study||31
2410783|NCT01278342|5912891|P1|STARTED|Overall Study||7
2410784|NCT01278303|5912905|P1|NOT COMPLETED|Overall Study||0
2410785|NCT01278303|5912905|P1|COMPLETED|Overall Study||82
2410786|NCT01278303|5912905|P1|STARTED|Overall Study||82
2410787|NCT01278173|5912911|P1|NOT COMPLETED|Overall Study||27
2410788|NCT01278173|5912911|P1|COMPLETED|Overall Study||38
2410789|NCT01278173|5912911|P1|STARTED|Overall Study||65
2410790|NCT01278160|5912918|P2|NOT COMPLETED|Overall Study||6
2410791|NCT01278160|5912919|P1|NOT COMPLETED|Overall Study||5
2410792|NCT01278160|5912918|P2|COMPLETED|Overall Study||84
2410793|NCT01278160|5912919|P1|COMPLETED|Overall Study||84
2410794|NCT01278160|5912918|P2|STARTED|Overall Study||90
2410795|NCT01278160|5912919|P1|STARTED|Overall Study||89
2410796|NCT01278030|5912935|P2|NOT COMPLETED|Overall Study||4
2410797|NCT01278030|5912936|P1|NOT COMPLETED|Overall Study||8
2410798|NCT01278030|5912935|P2|COMPLETED|Overall Study||31
2410799|NCT01278030|5912936|P1|COMPLETED|Overall Study||35
2410800|NCT01278030|5912935|P2|STARTED|Overall Study||35
2410801|NCT01278030|5912936|P1|STARTED|Overall Study||43
2410802|NCT01277887|5912944|P2|NOT COMPLETED|Post-Quit Treatment Phase||5
2410803|NCT01277887|5912945|P1|NOT COMPLETED|Post-Quit Treatment Phase||3
2410804|NCT01277887|5912944|P2|COMPLETED|Post-Quit Treatment Phase||5
2410805|NCT01277887|5912945|P1|COMPLETED|Post-Quit Treatment Phase||3
2410806|NCT01277887|5912944|P2|STARTED|Post-Quit Treatment Phase||10
2410807|NCT01277887|5912945|P1|STARTED|Post-Quit Treatment Phase||6
2410808|NCT01277887|5912944|P2|NOT COMPLETED|Pre-Quit Treatment Phase||0
2410809|NCT01277887|5912945|P1|NOT COMPLETED|Pre-Quit Treatment Phase||3
2410810|NCT01277887|5912944|P2|COMPLETED|Pre-Quit Treatment Phase||10
2410811|NCT01277887|5912945|P1|COMPLETED|Pre-Quit Treatment Phase||6
2410812|NCT01277887|5912944|P2|Entered Study|Pre-Quit Treatment Phase||10
2410813|NCT01277887|5912945|P1|Entered Study|Pre-Quit Treatment Phase||7
2410814|NCT01277887|5912944|P2|STARTED|Pre-Quit Treatment Phase||10
2410815|NCT01277887|5912945|P1|STARTED|Pre-Quit Treatment Phase||9
2410816|NCT01277861|5912957|P2|NOT COMPLETED|Overall Study||2
2410817|NCT01277861|5912958|P1|NOT COMPLETED|Overall Study||2
2410818|NCT01277861|5912957|P2|COMPLETED|Overall Study||47
2410819|NCT01277861|5912958|P1|COMPLETED|Overall Study||49
2410820|NCT01277861|5912957|P2|STARTED|Overall Study||49
2410821|NCT01277861|5912958|P1|STARTED|Overall Study||51
2410822|NCT01277822|5912970|P2|NOT COMPLETED|Overall Study||11
2410823|NCT01277822|5912971|P1|NOT COMPLETED|Overall Study||15
2410824|NCT01277822|5912970|P2|COMPLETED|Overall Study||155
2410825|NCT01277822|5912971|P1|COMPLETED|Overall Study||153
2410826|NCT01277822|5912970|P2|STARTED|Overall Study||166
2410827|NCT01277822|5912971|P1|STARTED|Overall Study||168
2410828|NCT01277783|5912991|P1|NOT COMPLETED|Overall Study||0
2410829|NCT01277783|5912991|P1|COMPLETED|Overall Study||138
2410830|NCT01277783|5912991|P1|STARTED|Overall Study||138
2410831|NCT01277757|5913007|P1|NOT COMPLETED|Overall Study||2
2410832|NCT01277757|5913007|P1|COMPLETED|Overall Study||28
2410833|NCT01277757|5913007|P1|STARTED|Overall Study||30
2410834|NCT01277744|5913014|P1|NOT COMPLETED|Overall Study||2
2410835|NCT01277744|5913014|P1|COMPLETED|Overall Study||20
2410836|NCT01277744|5913014|P1|STARTED|Overall Study||22
2410837|NCT01277718|5913019|P2|NOT COMPLETED|Period 3 - Third Intervention||0
2410838|NCT01277718|5913020|P1|NOT COMPLETED|Period 3 - Third Intervention||0
2410839|NCT01277718|5913019|P2|COMPLETED|Period 3 - Third Intervention||7
2410840|NCT01277718|5913020|P1|COMPLETED|Period 3 - Third Intervention||10
2410841|NCT01277718|5913019|P2|STARTED|Period 3 - Third Intervention||7
2410842|NCT01277718|5913020|P1|STARTED|Period 3 - Third Intervention||10
2410843|NCT01277718|5913019|P2|NOT COMPLETED|Washout Period of 13 Days||0
2410844|NCT01277718|5913020|P1|NOT COMPLETED|Washout Period of 13 Days||0
2410845|NCT01277718|5913019|P2|COMPLETED|Washout Period of 13 Days||7
2410846|NCT01277718|5913020|P1|COMPLETED|Washout Period of 13 Days||10
2410847|NCT01277718|5913019|P2|STARTED|Washout Period of 13 Days||7
2410848|NCT01277718|5913020|P1|STARTED|Washout Period of 13 Days||10
2410849|NCT01277718|5913019|P2|NOT COMPLETED|Period 2 - Second Intervention||3
2410850|NCT01277718|5913020|P1|NOT COMPLETED|Period 2 - Second Intervention||0
2410851|NCT01277718|5913019|P2|COMPLETED|Period 2 - Second Intervention||7
2410852|NCT01277718|5913020|P1|COMPLETED|Period 2 - Second Intervention||10
2410853|NCT01277718|5913019|P2|STARTED|Period 2 - Second Intervention||10
2410854|NCT01277718|5913020|P1|STARTED|Period 2 - Second Intervention||10
2410855|NCT01277718|5913019|P2|NOT COMPLETED|Washout Period of 13 Days||0
2410856|NCT01277718|5913020|P1|NOT COMPLETED|Washout Period of 13 Days||0
2410857|NCT01277718|5913019|P2|COMPLETED|Washout Period of 13 Days||10
2410858|NCT01277718|5913020|P1|COMPLETED|Washout Period of 13 Days||10
2410859|NCT01277718|5913019|P2|STARTED|Washout Period of 13 Days||10
2410860|NCT01277718|5913020|P1|STARTED|Washout Period of 13 Days||10
2410861|NCT01277718|5913019|P2|NOT COMPLETED|Period 1 - First Intervention||0
2410862|NCT01277718|5913020|P1|NOT COMPLETED|Period 1 - First Intervention||0
2410863|NCT01277718|5913019|P2|COMPLETED|Period 1 - First Intervention||10
2410864|NCT01277718|5913020|P1|COMPLETED|Period 1 - First Intervention||10
2410865|NCT01277718|5913019|P2|STARTED|Period 1 - First Intervention||10
2410866|NCT01277718|5913020|P1|STARTED|Period 1 - First Intervention||10
2410867|NCT01277666|5913034|P3|NOT COMPLETED|Overall Study||49
2410868|NCT01277666|5913035|P2|NOT COMPLETED|Overall Study||59
2410869|NCT01277666|5913036|P1|NOT COMPLETED|Overall Study||45
2410870|NCT01277666|5913034|P3|COMPLETED|Overall Study||153
2410871|NCT01277666|5913035|P2|COMPLETED|Overall Study||144
2410872|NCT01277666|5913036|P1|COMPLETED|Overall Study||158
2410873|NCT01277666|5913034|P3|STARTED|Overall Study||202
2410874|NCT01277666|5913035|P2|STARTED|Overall Study||203
2410875|NCT01277666|5913036|P1|STARTED|Overall Study||203
2410876|NCT01277601|5913069|P4|NOT COMPLETED|Overall Study||36
2410877|NCT01277601|5913070|P3|NOT COMPLETED|Overall Study||27
2410878|NCT01277601|5913071|P2|NOT COMPLETED|Overall Study||48
2410879|NCT01277601|5913072|P1|NOT COMPLETED|Overall Study||37
2410880|NCT01277601|5913069|P4|COMPLETED|Overall Study||150
2410881|NCT01277601|5913070|P3|COMPLETED|Overall Study||163
2410882|NCT01277601|5913071|P2|COMPLETED|Overall Study||139
2410883|NCT01277601|5913072|P1|COMPLETED|Overall Study||151
2410884|NCT01277601|5913069|P4|STARTED|Overall Study||186
2410885|NCT01277601|5913070|P3|STARTED|Overall Study||190
2410886|NCT01277601|5913071|P2|STARTED|Overall Study||187
2410887|NCT01277601|5913072|P1|STARTED|Overall Study||188
2410888|NCT01277549|5913163|P2|NOT COMPLETED|Overall Study||14
2410889|NCT01277549|5913164|P1|NOT COMPLETED|Overall Study||26
2410890|NCT01277549|5913163|P2|COMPLETED|Overall Study||15
2410891|NCT01277549|5913164|P1|COMPLETED|Overall Study||15
2410892|NCT01277549|5913163|P2|STARTED|Overall Study||29
2410893|NCT01277549|5913164|P1|STARTED|Overall Study||41
2410894|NCT01277523|5913181|P3|NOT COMPLETED|Overall Study||0
2410895|NCT01277523|5913182|P2|NOT COMPLETED|Overall Study||1
2410896|NCT01277523|5913183|P1|NOT COMPLETED|Overall Study||3
2410897|NCT01277523|5913181|P3|COMPLETED|Overall Study||130
2410898|NCT01277523|5913182|P2|COMPLETED|Overall Study||126
2410899|NCT01277523|5913183|P1|COMPLETED|Overall Study||132
2410900|NCT01277523|5913181|P3|STARTED|Overall Study||130
2410901|NCT01277523|5913182|P2|STARTED|Overall Study||127
2410902|NCT01277523|5913183|P1|STARTED|Overall Study||135
2410903|NCT01277510|5913235|P2|NOT COMPLETED|Open-label Phase||3
2410904|NCT01277510|5913236|P1|NOT COMPLETED|Open-label Phase||7
2410905|NCT01277510|5913235|P2|COMPLETED|Open-label Phase|Completed investigational product|1
2410906|NCT01277510|5913236|P1|COMPLETED|Open-label Phase|Completed investigational product|1
2410907|NCT01277510|5913235|P2|Received Investigational Product|Open-label Phase||4
2410908|NCT01277510|5913236|P1|Received Investigational Product|Open-label Phase||6
2410909|NCT01277510|5913235|P2|STARTED|Open-label Phase||4
2410910|NCT01277510|5913236|P1|STARTED|Open-label Phase||8
2410911|NCT01277510|5913235|P2|NOT COMPLETED|Double-blind Phase||18
2410912|NCT01277510|5913236|P1|NOT COMPLETED|Double-blind Phase||13
2410913|NCT01277510|5913235|P2|COMPLETED|Double-blind Phase|Completed investigational product|4
2410914|NCT01277510|5913236|P1|COMPLETED|Double-blind Phase|Completed investigational product|8
2410915|NCT01277510|5913235|P2|Received Investigational Product|Double-blind Phase||22
2410916|NCT01277510|5913236|P1|Received Investigational Product|Double-blind Phase||21
2410917|NCT01277510|5913235|P2|STARTED|Double-blind Phase||22
2410918|NCT01277510|5913236|P1|STARTED|Double-blind Phase||21
2410919|NCT01277354|5913260|P2|NOT COMPLETED|Overall Study||0
2410920|NCT01277354|5913261|P1|NOT COMPLETED|Overall Study||0
2410921|NCT01277354|5913260|P2|COMPLETED|Overall Study||1
2410922|NCT01277354|5913261|P1|COMPLETED|Overall Study||1
2410923|NCT01277354|5913260|P2|STARTED|Overall Study||1
2410924|NCT01277354|5913261|P1|STARTED|Overall Study||1
2410925|NCT01277302|5913270|P3|NOT COMPLETED|8-Month Alternate Dose Regimen Period||6
2410926|NCT01277302|5913271|P2|NOT COMPLETED|8-Month Alternate Dose Regimen Period||4
2410927|NCT01277302|5913272|P1|NOT COMPLETED|8-Month Alternate Dose Regimen Period||5
2410928|NCT01277302|5913270|P3|COMPLETED|8-Month Alternate Dose Regimen Period||13
2410929|NCT01277302|5913271|P2|COMPLETED|8-Month Alternate Dose Regimen Period||82
2410930|NCT01277302|5913272|P1|COMPLETED|8-Month Alternate Dose Regimen Period||80
2410931|NCT01277302|5913270|P3|STARTED|8-Month Alternate Dose Regimen Period||19
2410932|NCT01277302|5913271|P2|STARTED|8-Month Alternate Dose Regimen Period||86
2410933|NCT01277302|5913272|P1|STARTED|8-Month Alternate Dose Regimen Period||85
2410934|NCT01277302|5913270|P3|NOT COMPLETED|7-Month Fixed Treatment Period||12
2410935|NCT01277302|5913271|P2|NOT COMPLETED|7-Month Fixed Treatment Period||0
2410936|NCT01277302|5913272|P1|NOT COMPLETED|7-Month Fixed Treatment Period||0
2410937|NCT01277302|5913270|P3|COMPLETED|7-Month Fixed Treatment Period||19
2410938|NCT01277302|5913271|P2|COMPLETED|7-Month Fixed Treatment Period||86
2410939|NCT01277302|5913272|P1|COMPLETED|7-Month Fixed Treatment Period||85
2410940|NCT01277302|5913270|P3|STARTED|7-Month Fixed Treatment Period||31
2410941|NCT01277302|5913271|P2|STARTED|7-Month Fixed Treatment Period||86
2410942|NCT01277302|5913272|P1|STARTED|7-Month Fixed Treatment Period||85
2410943|NCT01277211|5913304|P2|NOT COMPLETED|Overall Study||63
2410944|NCT01277211|5913305|P1|NOT COMPLETED|Overall Study||150
2410945|NCT01277211|5913304|P2|COMPLETED|Overall Study||182
2410946|NCT01277211|5913305|P1|COMPLETED|Overall Study||588
2410947|NCT01277211|5913304|P2|Treated|Overall Study||232
2410948|NCT01277211|5913305|P1|Treated|Overall Study||714
2410949|NCT01277211|5913304|P2|STARTED|Overall Study||245
2410950|NCT01277211|5913305|P1|STARTED|Overall Study||738
2410951|NCT01277159|5913320|P5|NOT COMPLETED|Overall Study||5
2410952|NCT01277159|5913321|P4|NOT COMPLETED|Overall Study||3
2410953|NCT01277159|5913322|P3|NOT COMPLETED|Overall Study||3
2410954|NCT01277159|5913323|P2|NOT COMPLETED|Overall Study||1
2410955|NCT01277159|5913324|P1|NOT COMPLETED|Overall Study||4
2410956|NCT01277159|5913320|P5|COMPLETED|Overall Study||16
2410957|NCT01277159|5913321|P4|COMPLETED|Overall Study||19
2410958|NCT01277159|5913322|P3|COMPLETED|Overall Study||19
2410959|NCT01277159|5913323|P2|COMPLETED|Overall Study||21
2410960|NCT01277159|5913324|P1|COMPLETED|Overall Study||17
2410961|NCT01277159|5913320|P5|STARTED|Overall Study||21
2410962|NCT01277159|5913321|P4|STARTED|Overall Study||22
2410963|NCT01277159|5913322|P3|STARTED|Overall Study||22
2410964|NCT01277159|5913323|P2|STARTED|Overall Study||22
2410965|NCT01277159|5913324|P1|STARTED|Overall Study||21
2410966|NCT01277081|5913338|P2|NOT COMPLETED|Overall Study||0
2410967|NCT01277081|5913339|P1|NOT COMPLETED|Overall Study||0
2410968|NCT01277081|5913338|P2|COMPLETED|Overall Study||100
2410969|NCT01277081|5913339|P1|COMPLETED|Overall Study||100
2410970|NCT01277081|5913338|P2|STARTED|Overall Study||100
2410971|NCT01277081|5913339|P1|STARTED|Overall Study||100
2410972|NCT01277042|5913357|P2|NOT COMPLETED|Overall Study||5
2410973|NCT01277042|5913358|P1|NOT COMPLETED|Overall Study||8
2410974|NCT01277042|5913357|P2|COMPLETED|Overall Study||601
2410975|NCT01277042|5913358|P1|COMPLETED|Overall Study||598
2410976|NCT01277042|5913357|P2|STARTED|Overall Study||606
2410977|NCT01277042|5913358|P1|STARTED|Overall Study||606
2410978|NCT01276847|5913383|P3|NOT COMPLETED|Overall Study||0
2410979|NCT01276847|5913384|P2|NOT COMPLETED|Overall Study||0
2410980|NCT01276847|5913385|P1|NOT COMPLETED|Overall Study||1
2410981|NCT01276847|5913383|P3|COMPLETED|Overall Study||20
2410982|NCT01276847|5913384|P2|COMPLETED|Overall Study||10
2410983|NCT01276847|5913385|P1|COMPLETED|Overall Study||9
2410984|NCT01276847|5913383|P3|STARTED|Overall Study||20
2410985|NCT01276847|5913384|P2|STARTED|Overall Study||10
2410986|NCT01276847|5913385|P1|STARTED|Overall Study||10
2410987|NCT01276821|5913395|P2|NOT COMPLETED|Overall Study||1
2410988|NCT01276821|5913396|P1|NOT COMPLETED|Overall Study||0
2410989|NCT01276821|5913395|P2|COMPLETED|Overall Study||49
2410990|NCT01276821|5913396|P1|COMPLETED|Overall Study||50
2410991|NCT01276821|5913395|P2|STARTED|Overall Study||50
2410992|NCT01276821|5913396|P1|STARTED|Overall Study||50
2410993|NCT01276756|5913416|P2|NOT COMPLETED|Overall Study||2
2410994|NCT01276756|5913417|P1|NOT COMPLETED|Overall Study||5
2410995|NCT01276756|5913416|P2|COMPLETED|Overall Study||48
2410996|NCT01276756|5913417|P1|COMPLETED|Overall Study||45
2410997|NCT01276756|5913416|P2|STARTED|Overall Study||50
2410998|NCT01276756|5913417|P1|STARTED|Overall Study||50
2410999|NCT01276652|5913434|P3|NOT COMPLETED|Period 2: Observational||0
2411000|NCT01276652|5913435|P2|NOT COMPLETED|Period 2: Observational||0
2411001|NCT01276652|5913436|P1|NOT COMPLETED|Period 2: Observational||0
2411002|NCT01276652|5913434|P3|COMPLETED|Period 2: Observational||5
2411003|NCT01276652|5913435|P2|COMPLETED|Period 2: Observational||8
2411004|NCT01276652|5913436|P1|COMPLETED|Period 2: Observational||9
2411005|NCT01276652|5913434|P3|STARTED|Period 2: Observational|Subjects were only enrolled in the Observational arm during Period 2.|5
2411006|NCT01276652|5913435|P2|STARTED|Period 2: Observational||8
2411007|NCT01276652|5913436|P1|STARTED|Period 2: Observational||9
2411008|NCT01276652|5913434|P3|NOT COMPLETED|Period 1: Randomization||0
2411009|NCT01276652|5913435|P2|NOT COMPLETED|Period 1: Randomization||0
2411010|NCT01276652|5913436|P1|NOT COMPLETED|Period 1: Randomization||0
2411011|NCT01276652|5913434|P3|COMPLETED|Period 1: Randomization||0
2411012|NCT01276652|5913435|P2|COMPLETED|Period 1: Randomization||8
2411013|NCT01276652|5913436|P1|COMPLETED|Period 1: Randomization||9
2411014|NCT01276652|5913434|P3|STARTED|Period 1: Randomization|No subjects were enrolled in this arm during Period 1.|0
2411015|NCT01276652|5913435|P2|STARTED|Period 1: Randomization||8
2411016|NCT01276652|5913436|P1|STARTED|Period 1: Randomization||9
2411017|NCT01276639|5913462|P5|NOT COMPLETED|Week 16 to 52||21
2411018|NCT01276639|5913463|P4|NOT COMPLETED|Week 16 to 52||16
2411019|NCT01276639|5913464|P3|NOT COMPLETED|Week 16 to 52||0
2411020|NCT01276639|5913465|P2|NOT COMPLETED|Week 16 to 52||101
2411021|NCT01276639|5913466|P1|NOT COMPLETED|Week 16 to 52||127
2411022|NCT01276639|5913462|P5|COMPLETED|Week 16 to 52||45
2411023|NCT01276639|5913463|P4|COMPLETED|Week 16 to 52||50
2411024|NCT01276639|5913464|P3|COMPLETED|Week 16 to 52||0
2411025|NCT01276639|5913465|P2|COMPLETED|Week 16 to 52||219
2411026|NCT01276639|5913466|P1|COMPLETED|Week 16 to 52||186
2411027|NCT01276639|5913462|P5|STARTED|Week 16 to 52||66
2411028|NCT01276639|5913463|P4|STARTED|Week 16 to 52||66
2411029|NCT01276639|5913464|P3|STARTED|Week 16 to 52||0
2411030|NCT01276639|5913465|P2|STARTED|Week 16 to 52||320
2411031|NCT01276639|5913466|P1|STARTED|Week 16 to 52||313
2411032|NCT01276639|5913462|P5|NOT COMPLETED|Week 0 to 16||0
2411033|NCT01276639|5913463|P4|NOT COMPLETED|Week 0 to 16||0
2411034|NCT01276639|5913464|P3|NOT COMPLETED|Week 0 to 16||45
2411035|NCT01276639|5913465|P2|NOT COMPLETED|Week 0 to 16||41
2411036|NCT01276639|5913466|P1|NOT COMPLETED|Week 0 to 16||50
2411037|NCT01276639|5913462|P5|COMPLETED|Week 0 to 16||0
2411038|NCT01276639|5913463|P4|COMPLETED|Week 0 to 16||0
2411039|NCT01276639|5913464|P3|COMPLETED|Week 0 to 16||132
2411040|NCT01276639|5913465|P2|COMPLETED|Week 0 to 16||320
2411041|NCT01276639|5913466|P1|COMPLETED|Week 0 to 16||313
2411042|NCT01276639|5913462|P5|Treated|Week 0 to 16||0
2411043|NCT01276639|5913463|P4|Treated|Week 0 to 16||0
2411044|NCT01276639|5913464|P3|Treated|Week 0 to 16||177
2411045|NCT01276639|5913465|P2|Treated|Week 0 to 16||360
2411046|NCT01276639|5913466|P1|Treated|Week 0 to 16||363
2411047|NCT01276639|5913462|P5|STARTED|Week 0 to 16||0
2411048|NCT01276639|5913463|P4|STARTED|Week 0 to 16||0
2411049|NCT01276639|5913464|P3|STARTED|Week 0 to 16||177
2411050|NCT01276639|5913465|P2|STARTED|Week 0 to 16||361
2411051|NCT01276639|5913466|P1|STARTED|Week 0 to 16||363
2411052|NCT01276535|5913661|P1|NOT COMPLETED|Overall Study||0
2411053|NCT01276535|5913661|P1|COMPLETED|Overall Study||12
2411054|NCT01276535|5913661|P1|STARTED|Overall Study||12
2411055|NCT01276509|5913671|P4|NOT COMPLETED|Overall Study||5
2411056|NCT01276509|5913672|P3|NOT COMPLETED|Overall Study||5
2411057|NCT01276509|5913673|P2|NOT COMPLETED|Overall Study||12
2411058|NCT01276509|5913674|P1|NOT COMPLETED|Overall Study||13
2411059|NCT01276509|5913671|P4|COMPLETED|Overall Study||58
2411060|NCT01276509|5913672|P3|COMPLETED|Overall Study||63
2411061|NCT01276509|5913673|P2|COMPLETED|Overall Study||53
2411062|NCT01276509|5913674|P1|COMPLETED|Overall Study||53
2411063|NCT01276509|5913671|P4|STARTED|Overall Study||63
2411064|NCT01276509|5913672|P3|STARTED|Overall Study||68
2411065|NCT01276509|5913673|P2|STARTED|Overall Study||65
2411066|NCT01276509|5913674|P1|STARTED|Overall Study||66
2411067|NCT01276457|5913727|P2|NOT COMPLETED|Extension Study||2
2411068|NCT01276457|5913728|P1|NOT COMPLETED|Extension Study||6
2411069|NCT01276457|5913727|P2|COMPLETED|Extension Study||110
2411070|NCT01276457|5913728|P1|COMPLETED|Extension Study||105
2411071|NCT01276457|5913727|P2|STARTED|Extension Study||112
2411072|NCT01276457|5913728|P1|STARTED|Extension Study||111
2411073|NCT01276457|5913727|P2|NOT COMPLETED|Core Study||20
2411074|NCT01276457|5913728|P1|NOT COMPLETED|Core Study||13
2411075|NCT01276457|5913727|P2|COMPLETED|Core Study||123
2411076|NCT01276457|5913728|P1|COMPLETED|Core Study||129
2411077|NCT01276457|5913727|P2|STARTED|Core Study||143
2411078|NCT01276457|5913728|P1|STARTED|Core Study||142
2411079|NCT01276353|5913742|P2|NOT COMPLETED|Extension||9
2411080|NCT01276353|5913743|P1|NOT COMPLETED|Extension||7
2411081|NCT01276353|5913742|P2|COMPLETED|Extension||14
2411082|NCT01276353|5913743|P1|COMPLETED|Extension||12
2411083|NCT01276353|5913742|P2|STARTED|Extension||23
2411084|NCT01276353|5913743|P1|STARTED|Extension||19
2411085|NCT01276353|5913742|P2|NOT COMPLETED|Double-blind||0
2411086|NCT01276353|5913743|P1|NOT COMPLETED|Double-blind||3
2411087|NCT01276353|5913742|P2|COMPLETED|Double-blind||23
2411088|NCT01276353|5913743|P1|COMPLETED|Double-blind||19
2411089|NCT01276353|5913742|P2|STARTED|Double-blind||23
2411090|NCT01276353|5913743|P1|STARTED|Double-blind||22
2411091|NCT01276327|5913755|P2|NOT COMPLETED|Overall Study||3
2411092|NCT01276327|5913756|P1|NOT COMPLETED|Overall Study||2
2411093|NCT01276327|5913755|P2|COMPLETED|Overall Study||29
2411094|NCT01276327|5913756|P1|COMPLETED|Overall Study||30
2411095|NCT01276327|5913755|P2|STARTED|Overall Study||32
2411096|NCT01276327|5913756|P1|STARTED|Overall Study||32
2411097|NCT01276314|5913782|P4|NOT COMPLETED|Overall Study||5
2411098|NCT01276314|5913783|P3|NOT COMPLETED|Overall Study||4
2411099|NCT01276314|5913784|P2|NOT COMPLETED|Overall Study||10
2411100|NCT01276314|5913785|P1|NOT COMPLETED|Overall Study||10
2411101|NCT01276314|5913782|P4|COMPLETED|Overall Study||17
2411102|NCT01276314|5913783|P3|COMPLETED|Overall Study||18
2411103|NCT01276314|5913784|P2|COMPLETED|Overall Study||33
2411104|NCT01276314|5913785|P1|COMPLETED|Overall Study||38
2411105|NCT01276314|5913782|P4|STARTED|Overall Study||22
2411106|NCT01276314|5913783|P3|STARTED|Overall Study||22
2411107|NCT01276314|5913784|P2|STARTED|Overall Study||43
2411108|NCT01276314|5913785|P1|STARTED|Overall Study||48
2411109|NCT01276301|5913795|P2|NOT COMPLETED|Second Intervention||0
2411110|NCT01276301|5913796|P1|NOT COMPLETED|Second Intervention||0
2411111|NCT01276301|5913795|P2|COMPLETED|Second Intervention||8
2411112|NCT01276301|5913796|P1|COMPLETED|Second Intervention||8
2411113|NCT01276301|5913795|P2|STARTED|Second Intervention||8
2411114|NCT01276301|5913796|P1|STARTED|Second Intervention||8
2411115|NCT01276301|5913795|P2|NOT COMPLETED|Washout Period of 7 Days||0
2411116|NCT01276301|5913796|P1|NOT COMPLETED|Washout Period of 7 Days||0
2411117|NCT01276301|5913795|P2|COMPLETED|Washout Period of 7 Days||8
2411118|NCT01276301|5913796|P1|COMPLETED|Washout Period of 7 Days||8
2411119|NCT01276301|5913795|P2|STARTED|Washout Period of 7 Days||8
2411120|NCT01276301|5913796|P1|STARTED|Washout Period of 7 Days||8
2411121|NCT01276301|5913795|P2|NOT COMPLETED|First Intervention||0
2411122|NCT01276301|5913796|P1|NOT COMPLETED|First Intervention||0
2411123|NCT01276301|5913795|P2|COMPLETED|First Intervention||8
2411124|NCT01276301|5913796|P1|COMPLETED|First Intervention||8
2411125|NCT01276301|5913795|P2|STARTED|First Intervention||8
2411126|NCT01276301|5913796|P1|STARTED|First Intervention||8
2411127|NCT01276288|5913823|P4|NOT COMPLETED|Overall Study||0
2411128|NCT01276288|5913824|P3|NOT COMPLETED|Overall Study||0
2411129|NCT01276288|5913825|P2|NOT COMPLETED|Overall Study||1
2411130|NCT01276288|5913826|P1|NOT COMPLETED|Overall Study||2
2411131|NCT01276288|5913823|P4|COMPLETED|Overall Study||5
2411132|NCT01276288|5913824|P3|COMPLETED|Overall Study||5
2411133|NCT01276288|5913825|P2|COMPLETED|Overall Study||5
2411134|NCT01276288|5913826|P1|COMPLETED|Overall Study||5
2411135|NCT01276288|5913823|P4|Received EMPA+TOR|Overall Study||5
2411136|NCT01276288|5913824|P3|Received EMPA+TOR|Overall Study||5
2411137|NCT01276288|5913825|P2|Received EMPA+TOR|Overall Study||0
2411138|NCT01276288|5913826|P1|Received EMPA+TOR|Overall Study||0
2411139|NCT01276288|5913823|P4|Received EMPA+HCT|Overall Study||0
2411140|NCT01276288|5913824|P3|Received EMPA+HCT|Overall Study||0
2411141|NCT01276288|5913825|P2|Received EMPA+HCT|Overall Study||5
2411142|NCT01276288|5913826|P1|Received EMPA+HCT|Overall Study||5
2411143|NCT01276288|5913823|P4|Received EMPA|Overall Study||5
2411144|NCT01276288|5913824|P3|Received EMPA|Overall Study||5
2411145|NCT01276288|5913825|P2|Received EMPA|Overall Study||5
2411146|NCT01276288|5913826|P1|Received EMPA|Overall Study||6
2411147|NCT01276288|5913823|P4|STARTED|Overall Study||5
2411148|NCT01276288|5913824|P3|STARTED|Overall Study||5
2411149|NCT01276288|5913825|P2|STARTED|Overall Study||6
2411150|NCT01276288|5913826|P1|STARTED|Overall Study||7
2411151|NCT01276223|5913953|P3|NOT COMPLETED|Overall Study||3
2411152|NCT01276223|5913954|P2|NOT COMPLETED|Overall Study||4
2411153|NCT01276223|5913955|P1|NOT COMPLETED|Overall Study||11
2411154|NCT01276223|5913953|P3|COMPLETED|Overall Study||101
2411155|NCT01276223|5913954|P2|COMPLETED|Overall Study||103
2411156|NCT01276223|5913955|P1|COMPLETED|Overall Study||67
2411157|NCT01276223|5913953|P3|STARTED|Overall Study||104
2411158|NCT01276223|5913954|P2|STARTED|Overall Study||107
2411159|NCT01276223|5913955|P1|STARTED|Overall Study||78
2411160|NCT01276197|5913964|P2|NOT COMPLETED|Overall Study||110
2411161|NCT01276197|5913965|P1|NOT COMPLETED|Overall Study||108
2411162|NCT01276197|5913964|P2|COMPLETED|Overall Study||200
2411163|NCT01276197|5913965|P1|COMPLETED|Overall Study||200
2411164|NCT01276197|5913964|P2|STARTED|Overall Study||310
2411165|NCT01276197|5913965|P1|STARTED|Overall Study||308
2411166|NCT01276171|5913976|P3|NOT COMPLETED|Overall Study||0
2411167|NCT01276171|5913977|P2|NOT COMPLETED|Overall Study||0
2411168|NCT01276171|5913978|P1|NOT COMPLETED|Overall Study||0
2411169|NCT01276171|5913976|P3|COMPLETED|Overall Study||256
2411170|NCT01276171|5913977|P2|COMPLETED|Overall Study||244
2411171|NCT01276171|5913978|P1|COMPLETED|Overall Study||249
2411172|NCT01276171|5913976|P3|STARTED|Overall Study||256
2411173|NCT01276171|5913977|P2|STARTED|Overall Study||244
2411174|NCT01276171|5913978|P1|STARTED|Overall Study||249
2411175|NCT01276106|5913996|P4|NOT COMPLETED|Overall Study||13
2411176|NCT01276106|5913997|P3|NOT COMPLETED|Overall Study||16
2411177|NCT01276106|5913998|P2|NOT COMPLETED|Overall Study||9
2411178|NCT01276106|5913999|P1|NOT COMPLETED|Overall Study||12
2411179|NCT01276106|5913996|P4|COMPLETED|Overall Study||52
2411180|NCT01276106|5913997|P3|COMPLETED|Overall Study||49
2411181|NCT01276106|5913998|P2|COMPLETED|Overall Study||55
2411182|NCT01276106|5913999|P1|COMPLETED|Overall Study||53
2411183|NCT01276106|5913996|P4|STARTED|Overall Study||65
2411184|NCT01276106|5913997|P3|STARTED|Overall Study||65
2411185|NCT01276106|5913998|P2|STARTED|Overall Study||64
2411186|NCT01276106|5913999|P1|STARTED|Overall Study||65
2411187|NCT01276054|5914011|P2|NOT COMPLETED|Overall Study||2
2411188|NCT01276054|5914012|P1|NOT COMPLETED|Overall Study||2
2411189|NCT01276054|5914011|P2|COMPLETED|Overall Study||0
2411190|NCT01276054|5914012|P1|COMPLETED|Overall Study||0
2411191|NCT01276054|5914011|P2|STARTED|Overall Study||2
2411192|NCT01276054|5914012|P1|STARTED|Overall Study||2
2411193|NCT01275833|5914020|P2|NOT COMPLETED|Overall Study||1
2411194|NCT01275833|5914021|P1|NOT COMPLETED|Overall Study||1
2411195|NCT01275833|5914020|P2|COMPLETED|Overall Study||0
2411196|NCT01275833|5914021|P1|COMPLETED|Overall Study||0
2411197|NCT01275833|5914020|P2|STARTED|Overall Study||1
2411198|NCT01275833|5914021|P1|STARTED|Overall Study||1
2411199|NCT01275755|5914029|P2|NOT COMPLETED|Run-out Placebo Period||0
2411200|NCT01275755|5914030|P1|NOT COMPLETED|Run-out Placebo Period||1
2411201|NCT01275755|5914029|P2|COMPLETED|Run-out Placebo Period||37
2411202|NCT01275755|5914030|P1|COMPLETED|Run-out Placebo Period||38
2411203|NCT01275755|5914029|P2|STARTED|Run-out Placebo Period||37
2411204|NCT01275755|5914030|P1|STARTED|Run-out Placebo Period||39
2411205|NCT01275755|5914029|P2|NOT COMPLETED|Double-blind Treatment Period||3
2411206|NCT01275755|5914030|P1|NOT COMPLETED|Double-blind Treatment Period||2
2411207|NCT01275755|5914029|P2|COMPLETED|Double-blind Treatment Period||37
2411208|NCT01275755|5914030|P1|COMPLETED|Double-blind Treatment Period||39
2411209|NCT01275755|5914029|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||40
2411210|NCT01275755|5914030|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||41
2411211|NCT01275755|5914029|P2|STARTED|Double-blind Treatment Period||40
2411212|NCT01275755|5914030|P1|STARTED|Double-blind Treatment Period||41
2411213|NCT01275755|5914029|P2|NOT COMPLETED|Run-in Placebo Period||0
2411214|NCT01275755|5914030|P1|NOT COMPLETED|Run-in Placebo Period||0
2411215|NCT01275755|5914029|P2|COMPLETED|Run-in Placebo Period||40
2411216|NCT01275755|5914030|P1|COMPLETED|Run-in Placebo Period||41
2411217|NCT01275755|5914029|P2|STARTED|Run-in Placebo Period||40
2411218|NCT01275755|5914030|P1|STARTED|Run-in Placebo Period||41
2411219|NCT01275664|5914036|P1|NOT COMPLETED|Overall Study||0
2411220|NCT01275664|5914036|P1|COMPLETED|Overall Study||4
2411221|NCT01275664|5914036|P1|STARTED|Overall Study||4
2411222|NCT01275625|5914044|P1|NOT COMPLETED|Overall Study||13
2411223|NCT01275625|5914044|P1|COMPLETED|Overall Study||64
2411224|NCT01275625|5914044|P1|Treated|Overall Study||77
2411225|NCT01275625|5914044|P1|STARTED|Overall Study||77
2411226|NCT01275586|5914058|P1|NOT COMPLETED|Overall Study||3
2411227|NCT01275586|5914058|P1|COMPLETED|Overall Study||3
2411228|NCT01275586|5914058|P1|STARTED|Overall Study||6
2411229|NCT01275430|5914062|P1|NOT COMPLETED|Overall Study||9
2411230|NCT01275430|5914062|P1|COMPLETED|Overall Study||18
2411231|NCT01275430|5914062|P1|STARTED|Overall Study||27
2411232|NCT01275365|5914074|P4|NOT COMPLETED|Overall Study||3
2411233|NCT01275365|5914075|P3|NOT COMPLETED|Overall Study||5
2411234|NCT01275365|5914076|P2|NOT COMPLETED|Overall Study||3
2411235|NCT01275365|5914077|P1|NOT COMPLETED|Overall Study||3
2411236|NCT01275365|5914074|P4|COMPLETED|Overall Study||19
2411237|NCT01275365|5914075|P3|COMPLETED|Overall Study||17
2411238|NCT01275365|5914076|P2|COMPLETED|Overall Study||21
2411239|NCT01275365|5914077|P1|COMPLETED|Overall Study||21
2411240|NCT01275365|5914074|P4|STARTED|Overall Study||22
2411241|NCT01275365|5914075|P3|STARTED|Overall Study||22
2411242|NCT01275365|5914076|P2|STARTED|Overall Study||24
2411243|NCT01275365|5914077|P1|STARTED|Overall Study||24
2411244|NCT01275339|5914127|P4|NOT COMPLETED|Overall Study||0
2411245|NCT01275339|5914128|P3|NOT COMPLETED|Overall Study||1
2411246|NCT01275339|5914129|P2|NOT COMPLETED|Overall Study||0
2411247|NCT01275339|5914130|P1|NOT COMPLETED|Overall Study||1
2411248|NCT01275339|5914127|P4|COMPLETED|Overall Study||4
2411249|NCT01275339|5914128|P3|COMPLETED|Overall Study||3
2411250|NCT01275339|5914129|P2|COMPLETED|Overall Study||0
2411251|NCT01275339|5914130|P1|COMPLETED|Overall Study||1
2411252|NCT01275339|5914127|P4|STARTED|Overall Study||4
2411253|NCT01275339|5914128|P3|STARTED|Overall Study||4
2411254|NCT01275339|5914129|P2|STARTED|Overall Study||0
2411255|NCT01275339|5914130|P1|STARTED|Overall Study||2
2411256|NCT01275313|5914142|P2|NOT COMPLETED|Overall Study||52
2411257|NCT01275313|5914143|P1|NOT COMPLETED|Overall Study||25
2411258|NCT01275313|5914142|P2|COMPLETED|Overall Study||79
2411259|NCT01275313|5914143|P1|COMPLETED|Overall Study||102
2411260|NCT01275313|5914142|P2|STARTED|Overall Study||131
2411261|NCT01275313|5914143|P1|STARTED|Overall Study||127
2411262|NCT01275196|5914151|P2|NOT COMPLETED|Overall Study||21
2411263|NCT01275196|5914152|P1|NOT COMPLETED|Overall Study||20
2411264|NCT01275196|5914151|P2|COMPLETED|Overall Study||113
2411265|NCT01275196|5914152|P1|COMPLETED|Overall Study||113
2411266|NCT01275196|5914151|P2|Intended to Continue Into Extension|Overall Study||113
2411267|NCT01275196|5914152|P1|Intended to Continue Into Extension|Overall Study||112
2411268|NCT01275196|5914151|P2|STARTED|Overall Study||134
2411269|NCT01275196|5914152|P1|STARTED|Overall Study||133
2411270|NCT01275170|5914199|P8|NOT COMPLETED|Part 2: Period 2||0
2411271|NCT01275170|5914200|P7|NOT COMPLETED|Part 2: Period 2||0
2411272|NCT01275170|5914201|P6|NOT COMPLETED|Part 2: Period 2||0
2411273|NCT01275170|5914202|P5|NOT COMPLETED|Part 2: Period 2||0
2411274|NCT01275170|5914203|P4|NOT COMPLETED|Part 2: Period 2||0
2411275|NCT01275170|5914204|P3|NOT COMPLETED|Part 2: Period 2||0
2411276|NCT01275170|5914205|P2|NOT COMPLETED|Part 2: Period 2||0
2411277|NCT01275170|5914206|P1|NOT COMPLETED|Part 2: Period 2||0
2411278|NCT01275170|5914199|P8|COMPLETED|Part 2: Period 2||6
2411279|NCT01275170|5914200|P7|COMPLETED|Part 2: Period 2||6
2411280|NCT01275170|5914201|P6|COMPLETED|Part 2: Period 2||0
2411281|NCT01275170|5914202|P5|COMPLETED|Part 2: Period 2||0
2411282|NCT01275170|5914203|P4|COMPLETED|Part 2: Period 2||0
2411283|NCT01275170|5914204|P3|COMPLETED|Part 2: Period 2||0
2411284|NCT01275170|5914205|P2|COMPLETED|Part 2: Period 2||0
2411285|NCT01275170|5914206|P1|COMPLETED|Part 2: Period 2||0
2411286|NCT01275170|5914199|P8|STARTED|Part 2: Period 2||6
2411287|NCT01275170|5914200|P7|STARTED|Part 2: Period 2||6
2411288|NCT01275170|5914201|P6|STARTED|Part 2: Period 2|Panel F participated in Part 1, Period 1 and Part 2, Period 1.|0
2411289|NCT01275170|5914202|P5|STARTED|Part 2: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
2411290|NCT01275170|5914203|P4|STARTED|Part 2: Period 2||0
2411291|NCT01275170|5914204|P3|STARTED|Part 2: Period 2||0
2411292|NCT01275170|5914205|P2|STARTED|Part 2: Period 2||0
2411293|NCT01275170|5914206|P1|STARTED|Part 2: Period 2||0
2411294|NCT01275170|5914199|P8|NOT COMPLETED|Part 2: Period 1||0
2411295|NCT01275170|5914200|P7|NOT COMPLETED|Part 2: Period 1||0
2411296|NCT01275170|5914201|P6|NOT COMPLETED|Part 2: Period 1||0
2411297|NCT01275170|5914202|P5|NOT COMPLETED|Part 2: Period 1||0
2411298|NCT01275170|5914203|P4|NOT COMPLETED|Part 2: Period 1||0
2411299|NCT01275170|5914204|P3|NOT COMPLETED|Part 2: Period 1||0
2411300|NCT01275170|5914205|P2|NOT COMPLETED|Part 2: Period 1||0
2411301|NCT01275170|5914206|P1|NOT COMPLETED|Part 2: Period 1||0
2411302|NCT01275170|5914199|P8|COMPLETED|Part 2: Period 1||6
2411303|NCT01275170|5914200|P7|COMPLETED|Part 2: Period 1||6
2411304|NCT01275170|5914201|P6|COMPLETED|Part 2: Period 1||6
2411305|NCT01275170|5914202|P5|COMPLETED|Part 2: Period 1||6
2411306|NCT01275170|5914203|P4|COMPLETED|Part 2: Period 1||0
2411307|NCT01275170|5914204|P3|COMPLETED|Part 2: Period 1||0
2411308|NCT01275170|5914205|P2|COMPLETED|Part 2: Period 1||0
2411309|NCT01275170|5914206|P1|COMPLETED|Part 2: Period 1||0
2411310|NCT01275170|5914199|P8|STARTED|Part 2: Period 1||6
2411311|NCT01275170|5914200|P7|STARTED|Part 2: Period 1||6
2411312|NCT01275170|5914201|P6|STARTED|Part 2: Period 1||6
2411313|NCT01275170|5914202|P5|STARTED|Part 2: Period 1||6
2411314|NCT01275170|5914203|P4|STARTED|Part 2: Period 1||0
2411315|NCT01275170|5914204|P3|STARTED|Part 2: Period 1||0
2411316|NCT01275170|5914205|P2|STARTED|Part 2: Period 1||0
2411317|NCT01275170|5914206|P1|STARTED|Part 2: Period 1||0
2411318|NCT01275170|5914199|P8|NOT COMPLETED|Part 1: Period 2||0
2411319|NCT01275170|5914200|P7|NOT COMPLETED|Part 1: Period 2||0
2411320|NCT01275170|5914201|P6|NOT COMPLETED|Part 1: Period 2||0
2411321|NCT01275170|5914202|P5|NOT COMPLETED|Part 1: Period 2||0
2411322|NCT01275170|5914203|P4|NOT COMPLETED|Part 1: Period 2||0
2411323|NCT01275170|5914204|P3|NOT COMPLETED|Part 1: Period 2||0
2411324|NCT01275170|5914205|P2|NOT COMPLETED|Part 1: Period 2||0
2411325|NCT01275170|5914206|P1|NOT COMPLETED|Part 1: Period 2||0
2411326|NCT01275170|5914199|P8|COMPLETED|Part 1: Period 2||6
2411327|NCT01275170|5914200|P7|COMPLETED|Part 1: Period 2||6
2411328|NCT01275170|5914201|P6|COMPLETED|Part 1: Period 2||0
2411329|NCT01275170|5914202|P5|COMPLETED|Part 1: Period 2||0
2411330|NCT01275170|5914203|P4|COMPLETED|Part 1: Period 2||0
2411331|NCT01275170|5914204|P3|COMPLETED|Part 1: Period 2||0
2411332|NCT01275170|5914205|P2|COMPLETED|Part 1: Period 2||0
2411333|NCT01275170|5914206|P1|COMPLETED|Part 1: Period 2||0
2411334|NCT01275170|5914199|P8|STARTED|Part 1: Period 2||6
2411335|NCT01275170|5914200|P7|STARTED|Part 1: Period 2||6
2411336|NCT01275170|5914201|P6|STARTED|Part 1: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
2411337|NCT01275170|5914202|P5|STARTED|Part 1: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
2411338|NCT01275170|5914203|P4|STARTED|Part 1: Period 2|Panel D participated in Part 1, Period 1 only.|0
2411339|NCT01275170|5914204|P3|STARTED|Part 1: Period 2|Panel C participated in Part 1, Period 1 only.|0
2411340|NCT01275170|5914205|P2|STARTED|Part 1: Period 2|Panel B participated in Part 1, Period 1 only.|0
2411341|NCT01275170|5914206|P1|STARTED|Part 1: Period 2|Panel A participated in Part 1, Period 1 only.|0
2411342|NCT01275170|5914199|P8|NOT COMPLETED|Part 1: Period 1||0
2411343|NCT01275170|5914200|P7|NOT COMPLETED|Part 1: Period 1||0
2411344|NCT01275170|5914201|P6|NOT COMPLETED|Part 1: Period 1||0
2411345|NCT01275170|5914202|P5|NOT COMPLETED|Part 1: Period 1||0
2411346|NCT01275170|5914203|P4|NOT COMPLETED|Part 1: Period 1||0
2411347|NCT01275170|5914204|P3|NOT COMPLETED|Part 1: Period 1||0
2411348|NCT01275170|5914205|P2|NOT COMPLETED|Part 1: Period 1||0
2411349|NCT01275170|5914206|P1|NOT COMPLETED|Part 1: Period 1||1
2411350|NCT01275170|5914199|P8|COMPLETED|Part 1: Period 1||6
2411351|NCT01275170|5914200|P7|COMPLETED|Part 1: Period 1||6
2411352|NCT01275170|5914201|P6|COMPLETED|Part 1: Period 1||6
2411353|NCT01275170|5914202|P5|COMPLETED|Part 1: Period 1||6
2411354|NCT01275170|5914203|P4|COMPLETED|Part 1: Period 1||6
2411355|NCT01275170|5914204|P3|COMPLETED|Part 1: Period 1||6
2411356|NCT01275170|5914205|P2|COMPLETED|Part 1: Period 1||6
2411357|NCT01275170|5914206|P1|COMPLETED|Part 1: Period 1||6
2411358|NCT01275170|5914199|P8|Treated|Part 1: Period 1||6
2411359|NCT01275170|5914200|P7|Treated|Part 1: Period 1||6
2411360|NCT01275170|5914201|P6|Treated|Part 1: Period 1||6
2411361|NCT01275170|5914202|P5|Treated|Part 1: Period 1||6
2411362|NCT01275170|5914203|P4|Treated|Part 1: Period 1||6
2411363|NCT01275170|5914204|P3|Treated|Part 1: Period 1||6
2411364|NCT01275170|5914205|P2|Treated|Part 1: Period 1||6
2411365|NCT01275170|5914206|P1|Treated|Part 1: Period 1||6
2411366|NCT01275170|5914199|P8|STARTED|Part 1: Period 1||6
2411367|NCT01275170|5914200|P7|STARTED|Part 1: Period 1||6
2411368|NCT01275170|5914201|P6|STARTED|Part 1: Period 1||6
2411369|NCT01275170|5914202|P5|STARTED|Part 1: Period 1||6
2411370|NCT01275170|5914203|P4|STARTED|Part 1: Period 1||6
2411371|NCT01275170|5914204|P3|STARTED|Part 1: Period 1||6
2411372|NCT01275170|5914205|P2|STARTED|Part 1: Period 1||6
2411373|NCT01275170|5914206|P1|STARTED|Part 1: Period 1||7
2411374|NCT01275144|5914424|P2|NOT COMPLETED|Second Intervention (6 Days)||0
2411375|NCT01275144|5914425|P1|NOT COMPLETED|Second Intervention (6 Days)||1
2411376|NCT01275144|5914424|P2|COMPLETED|Second Intervention (6 Days)||14
2411377|NCT01275144|5914425|P1|COMPLETED|Second Intervention (6 Days)||13
2411378|NCT01275144|5914424|P2|STARTED|Second Intervention (6 Days)||14
2411379|NCT01275144|5914425|P1|STARTED|Second Intervention (6 Days)||14
2411380|NCT01275144|5914424|P2|NOT COMPLETED|Washout (7 Days)||0
2411381|NCT01275144|5914425|P1|NOT COMPLETED|Washout (7 Days)||0
2411382|NCT01275144|5914424|P2|COMPLETED|Washout (7 Days)||14
2411383|NCT01275144|5914425|P1|COMPLETED|Washout (7 Days)||14
2411384|NCT01275144|5914424|P2|STARTED|Washout (7 Days)||14
2411385|NCT01275144|5914425|P1|STARTED|Washout (7 Days)||14
2411386|NCT01275144|5914424|P2|NOT COMPLETED|First Intervention (6 Days)||0
2411387|NCT01275144|5914425|P1|NOT COMPLETED|First Intervention (6 Days)||0
2411388|NCT01275144|5914424|P2|COMPLETED|First Intervention (6 Days)||14
2411389|NCT01275144|5914425|P1|COMPLETED|First Intervention (6 Days)||14
2411390|NCT01275144|5914424|P2|Received at Least 1 Dose of Study Drug|First Intervention (6 Days)||14
2411391|NCT01275144|5914425|P1|Received at Least 1 Dose of Study Drug|First Intervention (6 Days)||14
2411392|NCT01275144|5914424|P2|STARTED|First Intervention (6 Days)||14
2411393|NCT01275144|5914425|P1|STARTED|First Intervention (6 Days)||14
2411394|NCT01275131|5914483|P4|NOT COMPLETED|Period 2 (Crossover)||2
2411395|NCT01275131|5914484|P3|NOT COMPLETED|Period 2 (Crossover)||1
2411396|NCT01275131|5914485|P2|NOT COMPLETED|Period 2 (Crossover)||1
2411397|NCT01275131|5914486|P1|NOT COMPLETED|Period 2 (Crossover)||1
2411398|NCT01275131|5914483|P4|COMPLETED|Period 2 (Crossover)||8
2411399|NCT01275131|5914484|P3|COMPLETED|Period 2 (Crossover)||9
2411400|NCT01275131|5914485|P2|COMPLETED|Period 2 (Crossover)||8
2411401|NCT01275131|5914486|P1|COMPLETED|Period 2 (Crossover)||8
2411402|NCT01275131|5914483|P4|STARTED|Period 2 (Crossover)||10
2411403|NCT01275131|5914484|P3|STARTED|Period 2 (Crossover)||10
2411404|NCT01275131|5914485|P2|STARTED|Period 2 (Crossover)||9
2411405|NCT01275131|5914486|P1|STARTED|Period 2 (Crossover)||9
2411406|NCT01275131|5914483|P4|NOT COMPLETED|5- to 14-Day Washout Period||0
2411407|NCT01275131|5914484|P3|NOT COMPLETED|5- to 14-Day Washout Period||0
2411408|NCT01275131|5914485|P2|NOT COMPLETED|5- to 14-Day Washout Period||0
2411409|NCT01275131|5914486|P1|NOT COMPLETED|5- to 14-Day Washout Period||0
2411410|NCT01275131|5914483|P4|COMPLETED|5- to 14-Day Washout Period||10
2411411|NCT01275131|5914484|P3|COMPLETED|5- to 14-Day Washout Period||10
2411412|NCT01275131|5914485|P2|COMPLETED|5- to 14-Day Washout Period||9
2411413|NCT01275131|5914486|P1|COMPLETED|5- to 14-Day Washout Period||9
2411414|NCT01275131|5914483|P4|STARTED|5- to 14-Day Washout Period||10
2411415|NCT01275131|5914484|P3|STARTED|5- to 14-Day Washout Period||10
2411416|NCT01275131|5914485|P2|STARTED|5- to 14-Day Washout Period||9
2411417|NCT01275131|5914486|P1|STARTED|5- to 14-Day Washout Period||9
2411418|NCT01275131|5914483|P4|NOT COMPLETED|Period 1||2
2411419|NCT01275131|5914484|P3|NOT COMPLETED|Period 1||3
2411420|NCT01275131|5914485|P2|NOT COMPLETED|Period 1||0
2411421|NCT01275131|5914486|P1|NOT COMPLETED|Period 1||2
2411422|NCT01275131|5914483|P4|COMPLETED|Period 1||10
2411423|NCT01275131|5914484|P3|COMPLETED|Period 1||10
2411424|NCT01275131|5914485|P2|COMPLETED|Period 1||9
2411425|NCT01275131|5914486|P1|COMPLETED|Period 1||9
2411426|NCT01275131|5914483|P4|Received at Least One Dose of Study Drug|Period 1||12
2411427|NCT01275131|5914484|P3|Received at Least One Dose of Study Drug|Period 1||13
2411428|NCT01275131|5914485|P2|Received at Least One Dose of Study Drug|Period 1||9
2411429|NCT01275131|5914486|P1|Received at Least One Dose of Study Drug|Period 1||11
2411430|NCT01275131|5914483|P4|STARTED|Period 1||12
2411431|NCT01275131|5914484|P3|STARTED|Period 1||13
2411432|NCT01275131|5914485|P2|STARTED|Period 1||9
2411433|NCT01275131|5914486|P1|STARTED|Period 1||11
2411434|NCT01275092|5914520|P1|NOT COMPLETED|Overall Study||0
2411435|NCT01275092|5914520|P1|COMPLETED|Overall Study||164
2411436|NCT01275092|5914520|P1|STARTED|Overall Study||164
2411437|NCT01275066|5914529|P3|NOT COMPLETED|Overall Study||1
2411438|NCT01275066|5914530|P2|NOT COMPLETED|Overall Study||0
2411439|NCT01275066|5914531|P1|NOT COMPLETED|Overall Study||1
2411440|NCT01275066|5914529|P3|COMPLETED|Overall Study||57
2411441|NCT01275066|5914530|P2|COMPLETED|Overall Study||59
2411442|NCT01275066|5914531|P1|COMPLETED|Overall Study||59
2411443|NCT01275066|5914529|P3|Treated|Overall Study||58
2411444|NCT01275066|5914530|P2|Treated|Overall Study||59
2411445|NCT01275066|5914531|P1|Treated|Overall Study||59
2411446|NCT01275066|5914529|P3|STARTED|Overall Study||58
2411447|NCT01275066|5914530|P2|STARTED|Overall Study||59
2411448|NCT01275066|5914531|P1|STARTED|Overall Study||60
2411449|NCT01275053|5914545|P1|NOT COMPLETED|Overall Study||0
2411450|NCT01275053|5914545|P1|COMPLETED|Overall Study||12
2411451|NCT01275053|5914545|P1|STARTED|Overall Study||12
2411452|NCT01274897|5914551|P2|NOT COMPLETED|Overall Study||0
2411453|NCT01274897|5914552|P1|NOT COMPLETED|Overall Study||0
2411454|NCT01274897|5914551|P2|COMPLETED|Overall Study||153
2411455|NCT01274897|5914552|P1|COMPLETED|Overall Study||297
2411456|NCT01274897|5914551|P2|STARTED|Overall Study||153
2411457|NCT01274897|5914552|P1|STARTED|Overall Study||297
2411458|NCT01274715|5914564|P1|NOT COMPLETED|Overall Study||4
2411459|NCT01274715|5914564|P1|COMPLETED|Overall Study||8
2411460|NCT01274715|5914564|P1|Screened Out at Baseline|Overall Study||3
2411461|NCT01274715|5914564|P1|STARTED|Overall Study||12
2411462|NCT01274637|5914571|P2|NOT COMPLETED|Overall Study||2
2411463|NCT01274637|5914572|P1|NOT COMPLETED|Overall Study||0
2411464|NCT01274637|5914571|P2|COMPLETED|Overall Study||30
2411465|NCT01274637|5914572|P1|COMPLETED|Overall Study||30
2411466|NCT01274637|5914571|P2|STARTED|Overall Study||32
2411467|NCT01274637|5914572|P1|STARTED|Overall Study||30
2411468|NCT01274611|5914588|P1|NOT COMPLETED|Overall Study||0
2411469|NCT01274611|5914588|P1|COMPLETED|Overall Study||20
2411470|NCT01274611|5914588|P1|STARTED|Overall Study||20
2411471|NCT01274585|5914598|P2|NOT COMPLETED|Overall Study||0
2411472|NCT01274585|5914599|P1|NOT COMPLETED|Overall Study||0
2411473|NCT01274585|5914598|P2|COMPLETED|Overall Study||3
2411474|NCT01274585|5914599|P1|COMPLETED|Overall Study||2
2411475|NCT01274585|5914598|P2|STARTED|Overall Study||3
2411476|NCT01274585|5914599|P1|STARTED|Overall Study||2
2411477|NCT01274559|5914611|P2|NOT COMPLETED|Overall Study||145
2411478|NCT01274559|5914612|P1|NOT COMPLETED|Overall Study||197
2411479|NCT01274559|5914611|P2|COMPLETED|Overall Study||441
2411480|NCT01274559|5914612|P1|COMPLETED|Overall Study||390
2411481|NCT01274559|5914611|P2|Treated|Overall Study||572
2411482|NCT01274559|5914612|P1|Treated|Overall Study||572
2411483|NCT01274559|5914611|P2|STARTED|Overall Study||586
2411484|NCT01274559|5914612|P1|STARTED|Overall Study||587
2411485|NCT01274533|5914662|P1|NOT COMPLETED|Overall Study||4
2411486|NCT01274533|5914662|P1|COMPLETED|Overall Study||0
2411487|NCT01274533|5914662|P1|STARTED|Overall Study||4
2411488|NCT01274429|5914667|P1|NOT COMPLETED|Overall Study||5
2411489|NCT01274429|5914667|P1|COMPLETED|Overall Study||0
2411490|NCT01274429|5914667|P1|STARTED|Overall Study||5
2411491|NCT01274182|5914675|P3|NOT COMPLETED|Overall Study||12
2411492|NCT01274182|5914676|P2|NOT COMPLETED|Overall Study||18
2411493|NCT01274182|5914677|P1|NOT COMPLETED|Overall Study||21
2411494|NCT01274182|5914675|P3|COMPLETED|Overall Study||80
2411495|NCT01274182|5914676|P2|COMPLETED|Overall Study||69
2411496|NCT01274182|5914677|P1|COMPLETED|Overall Study||112
2411497|NCT01274182|5914675|P3|24 Weeks|Overall Study||84
2411498|NCT01274182|5914676|P2|24 Weeks|Overall Study||83
2411499|NCT01274182|5914677|P1|24 Weeks|Overall Study||123
2411500|NCT01274182|5914675|P3|STARTED|Overall Study||92
2411501|NCT01274182|5914676|P2|STARTED|Overall Study||87
2411502|NCT01274182|5914677|P1|STARTED|Overall Study||133
2411503|NCT01273896|5914714|P1|NOT COMPLETED|Overall Study||0
2411504|NCT01273896|5914714|P1|COMPLETED|Overall Study||22
2411505|NCT01273896|5914714|P1|STARTED|Overall Study||22
2411506|NCT01273883|5914718|P2|NOT COMPLETED|Second Intervention||1
2411507|NCT01273883|5914719|P1|NOT COMPLETED|Second Intervention||2
2411508|NCT01273883|5914718|P2|COMPLETED|Second Intervention||17
2411509|NCT01273883|5914719|P1|COMPLETED|Second Intervention||15
2411510|NCT01273883|5914718|P2|STARTED|Second Intervention||18
2411511|NCT01273883|5914719|P1|STARTED|Second Intervention||17
2411512|NCT01273883|5914718|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
2411513|NCT01273883|5914719|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
2411514|NCT01273883|5914718|P2|COMPLETED|Washout Period of 2 Weeks||18
2411515|NCT01273883|5914719|P1|COMPLETED|Washout Period of 2 Weeks||17
2411516|NCT01273883|5914718|P2|STARTED|Washout Period of 2 Weeks||18
2411517|NCT01273883|5914719|P1|STARTED|Washout Period of 2 Weeks||17
2411518|NCT01273883|5914718|P2|NOT COMPLETED|First Intervention||1
2411519|NCT01273883|5914719|P1|NOT COMPLETED|First Intervention||2
2411520|NCT01273883|5914718|P2|COMPLETED|First Intervention||18
2411521|NCT01273883|5914719|P1|COMPLETED|First Intervention||17
2411522|NCT01273883|5914718|P2|STARTED|First Intervention|Received at least 1 dose of study drug.|19
2411523|NCT01273883|5914719|P1|STARTED|First Intervention|Received at least 1 dose of study drug.|19
2411524|NCT01273857|5914733|P2|NOT COMPLETED|Overall Study||0
2411525|NCT01273857|5914734|P1|NOT COMPLETED|Overall Study||0
2411526|NCT01273857|5914733|P2|COMPLETED|Overall Study||7
2411527|NCT01273857|5914734|P1|COMPLETED|Overall Study||7
2411528|NCT01273857|5914733|P2|STARTED|Overall Study||7
2411529|NCT01273857|5914734|P1|STARTED|Overall Study||7
2411530|NCT01273818|5914745|P3|NOT COMPLETED|Overall Study||9
2411531|NCT01273818|5914746|P2|NOT COMPLETED|Overall Study||2
2411532|NCT01273818|5914747|P1|NOT COMPLETED|Overall Study||13
2411533|NCT01273818|5914745|P3|COMPLETED|Overall Study||91
2411534|NCT01273818|5914746|P2|COMPLETED|Overall Study||98
2411535|NCT01273818|5914747|P1|COMPLETED|Overall Study||87
2411536|NCT01273818|5914745|P3|STARTED|Overall Study||100
2411537|NCT01273818|5914746|P2|STARTED|Overall Study||100
2411538|NCT01273818|5914747|P1|STARTED|Overall Study||100
2411539|NCT01273805|5914757|P2|NOT COMPLETED|Overall Study||10
2411540|NCT01273805|5914758|P1|NOT COMPLETED|Overall Study||10
2411541|NCT01273805|5914757|P2|COMPLETED|Overall Study||0
2411542|NCT01273805|5914758|P1|COMPLETED|Overall Study||0
2411543|NCT01273805|5914757|P2|STARTED|Overall Study||10
2411544|NCT01273805|5914758|P1|STARTED|Overall Study||10
2411545|NCT01273766|5914777|P3|NOT COMPLETED|Overall Study||0
2411546|NCT01273766|5914778|P2|NOT COMPLETED|Overall Study||0
2411547|NCT01273766|5914779|P1|NOT COMPLETED|Overall Study||0
2411548|NCT01273766|5914777|P3|COMPLETED|Overall Study||5
2411549|NCT01273766|5914778|P2|COMPLETED|Overall Study||7
2411550|NCT01273766|5914779|P1|COMPLETED|Overall Study||4
2411551|NCT01273766|5914777|P3|STARTED|Overall Study||5
2411552|NCT01273766|5914778|P2|STARTED|Overall Study||7
2411553|NCT01273766|5914779|P1|STARTED|Overall Study||4
2411554|NCT01273623|5914789|P1|NOT COMPLETED|Overall Study||29
2411555|NCT01273623|5914789|P1|COMPLETED|Overall Study|met IVUS criteria|26
2411556|NCT01273623|5914789|P1|STARTED|Overall Study|met angiographic criteria|55
2411557|NCT01273597|5914796|P1|NOT COMPLETED|Overall Study||8
2411558|NCT01273597|5914796|P1|COMPLETED|Overall Study||52
2411559|NCT01273597|5914796|P1|STARTED|Overall Study||60
2411560|NCT01273519|5914811|P3|NOT COMPLETED|Overall Study||8
2411561|NCT01273519|5914812|P2|NOT COMPLETED|Overall Study||5
2411562|NCT01273519|5914813|P1|NOT COMPLETED|Overall Study||19
2411563|NCT01273519|5914811|P3|COMPLETED|Overall Study||39
2411564|NCT01273519|5914812|P2|COMPLETED|Overall Study||25
2411565|NCT01273519|5914813|P1|COMPLETED|Overall Study||59
2411566|NCT01273519|5914811|P3|STARTED|Overall Study||47
2411567|NCT01273519|5914812|P2|STARTED|Overall Study||30
2411568|NCT01273519|5914813|P1|STARTED|Overall Study||78
2411569|NCT01273181|5914850|P4|NOT COMPLETED|Phase 2, Dose 2||1
2411570|NCT01273181|5914851|P3|NOT COMPLETED|Phase 2, Dose 2||0
2411571|NCT01273181|5914852|P2|NOT COMPLETED|Phase 2, Dose 2||0
2411572|NCT01273181|5914853|P1|NOT COMPLETED|Phase 2, Dose 2||0
2411573|NCT01273181|5914850|P4|COMPLETED|Phase 2, Dose 2||0
2411574|NCT01273181|5914851|P3|COMPLETED|Phase 2, Dose 2||0
2411575|NCT01273181|5914852|P2|COMPLETED|Phase 2, Dose 2||0
2411576|NCT01273181|5914853|P1|COMPLETED|Phase 2, Dose 2||0
2411577|NCT01273181|5914850|P4|STARTED|Phase 2, Dose 2||1
2411578|NCT01273181|5914851|P3|STARTED|Phase 2, Dose 2||0
2411579|NCT01273181|5914852|P2|STARTED|Phase 2, Dose 2||0
2411580|NCT01273181|5914853|P1|STARTED|Phase 2, Dose 2||0
2411581|NCT01273181|5914850|P4|NOT COMPLETED|Phase 2, Dose 1||0
2411582|NCT01273181|5914851|P3|NOT COMPLETED|Phase 2, Dose 1||1
2411583|NCT01273181|5914852|P2|NOT COMPLETED|Phase 2, Dose 1||0
2411584|NCT01273181|5914853|P1|NOT COMPLETED|Phase 2, Dose 1||0
2411585|NCT01273181|5914850|P4|COMPLETED|Phase 2, Dose 1||0
2411586|NCT01273181|5914851|P3|COMPLETED|Phase 2, Dose 1||1
2411587|NCT01273181|5914852|P2|COMPLETED|Phase 2, Dose 1||0
2411588|NCT01273181|5914853|P1|COMPLETED|Phase 2, Dose 1||0
2411589|NCT01273181|5914850|P4|STARTED|Phase 2, Dose 1||0
2411590|NCT01273181|5914851|P3|STARTED|Phase 2, Dose 1||2
2411591|NCT01273181|5914852|P2|STARTED|Phase 2, Dose 1||0
2411592|NCT01273181|5914853|P1|STARTED|Phase 2, Dose 1||0
2411593|NCT01273181|5914850|P4|NOT COMPLETED|Phase I, Dose 2||0
2411594|NCT01273181|5914851|P3|NOT COMPLETED|Phase I, Dose 2||0
2411595|NCT01273181|5914852|P2|NOT COMPLETED|Phase I, Dose 2||1
2411596|NCT01273181|5914853|P1|NOT COMPLETED|Phase I, Dose 2||0
2411597|NCT01273181|5914850|P4|COMPLETED|Phase I, Dose 2||0
2411598|NCT01273181|5914851|P3|COMPLETED|Phase I, Dose 2||0
2411599|NCT01273181|5914852|P2|COMPLETED|Phase I, Dose 2||2
2411600|NCT01273181|5914853|P1|COMPLETED|Phase I, Dose 2||0
2411601|NCT01273181|5914850|P4|STARTED|Phase I, Dose 2||0
2411602|NCT01273181|5914851|P3|STARTED|Phase I, Dose 2||0
2411603|NCT01273181|5914852|P2|STARTED|Phase I, Dose 2||3
2411604|NCT01273181|5914853|P1|STARTED|Phase I, Dose 2||0
2411605|NCT01273181|5914850|P4|NOT COMPLETED|Phase I, Dose 1||0
2411606|NCT01273181|5914851|P3|NOT COMPLETED|Phase I, Dose 1||0
2411607|NCT01273181|5914852|P2|NOT COMPLETED|Phase I, Dose 1||0
2411608|NCT01273181|5914853|P1|NOT COMPLETED|Phase I, Dose 1||1
2411609|NCT01273181|5914850|P4|COMPLETED|Phase I, Dose 1||0
2411610|NCT01273181|5914851|P3|COMPLETED|Phase I, Dose 1||0
2411611|NCT01273181|5914852|P2|COMPLETED|Phase I, Dose 1||0
2411612|NCT01273181|5914853|P1|COMPLETED|Phase I, Dose 1||2
2411613|NCT01273181|5914850|P4|STARTED|Phase I, Dose 1||0
2411614|NCT01273181|5914851|P3|STARTED|Phase I, Dose 1||0
2411615|NCT01273181|5914852|P2|STARTED|Phase I, Dose 1||0
2411616|NCT01273181|5914853|P1|STARTED|Phase I, Dose 1||3
2411617|NCT01273155|5914871|P7|NOT COMPLETED|Overall Study||6
2411618|NCT01273155|5914872|P6|NOT COMPLETED|Overall Study||5
2411619|NCT01273155|5914873|P5|NOT COMPLETED|Overall Study||2
2411620|NCT01273155|5914874|P4|NOT COMPLETED|Overall Study||1
2411621|NCT01273155|5914875|P3|NOT COMPLETED|Overall Study||12
2411622|NCT01273155|5914876|P2|NOT COMPLETED|Overall Study||4
2411623|NCT01273155|5914877|P1|NOT COMPLETED|Overall Study||2
2411624|NCT01273155|5914871|P7|COMPLETED|Overall Study||2
2411625|NCT01273155|5914872|P6|COMPLETED|Overall Study||5
2411626|NCT01273155|5914873|P5|COMPLETED|Overall Study||3
2411627|NCT01273155|5914874|P4|COMPLETED|Overall Study||4
2411628|NCT01273155|5914875|P3|COMPLETED|Overall Study||6
2411629|NCT01273155|5914876|P2|COMPLETED|Overall Study||8
2411630|NCT01273155|5914877|P1|COMPLETED|Overall Study||12
2411631|NCT01273155|5914871|P7|STARTED|Overall Study||8
2411632|NCT01273155|5914872|P6|STARTED|Overall Study||10
2411633|NCT01273155|5914873|P5|STARTED|Overall Study||5
2411634|NCT01273155|5914874|P4|STARTED|Overall Study||5
2411635|NCT01273155|5914875|P3|STARTED|Overall Study||18
2411636|NCT01273155|5914876|P2|STARTED|Overall Study||12
2411637|NCT01273155|5914877|P1|STARTED|Overall Study||14
2411638|NCT01273064|5914954|P5|NOT COMPLETED|Overall Study||10
2411639|NCT01273064|5914955|P4|NOT COMPLETED|Overall Study||20
2411640|NCT01273064|5914956|P3|NOT COMPLETED|Overall Study||31
2411641|NCT01273064|5914957|P2|NOT COMPLETED|Overall Study||30
2411642|NCT01273064|5914958|P1|NOT COMPLETED|Overall Study||23
2411643|NCT01273064|5914954|P5|COMPLETED|Overall Study||0
2411644|NCT01273064|5914955|P4|COMPLETED|Overall Study||0
2411645|NCT01273064|5914956|P3|COMPLETED|Overall Study||0
2411646|NCT01273064|5914957|P2|COMPLETED|Overall Study||0
2411647|NCT01273064|5914958|P1|COMPLETED|Overall Study||0
2411648|NCT01273064|5914954|P5|STARTED|Overall Study|Began study on the placebo arm, and crossed over to CTS-1027 15 mg at Wk 12 due to lack of response|10
2411649|NCT01273064|5914955|P4|STARTED|Overall Study||20
2411650|NCT01273064|5914956|P3|STARTED|Overall Study||31
2411651|NCT01273064|5914957|P2|STARTED|Overall Study||30
2411652|NCT01273064|5914958|P1|STARTED|Overall Study||23
2411653|NCT01273038|5914977|P2|NOT COMPLETED|Second Intervention (14 Days)||2
2411654|NCT01273038|5914978|P1|NOT COMPLETED|Second Intervention (14 Days)||0
2411655|NCT01273038|5914977|P2|COMPLETED|Second Intervention (14 Days)||8
2411656|NCT01273038|5914978|P1|COMPLETED|Second Intervention (14 Days)||10
2411657|NCT01273038|5914977|P2|STARTED|Second Intervention (14 Days)||10
2411658|NCT01273038|5914978|P1|STARTED|Second Intervention (14 Days)||10
2411659|NCT01273038|5914977|P2|NOT COMPLETED|First Intervention (14 Days)||0
2411660|NCT01273038|5914978|P1|NOT COMPLETED|First Intervention (14 Days)||0
2411661|NCT01273038|5914977|P2|COMPLETED|First Intervention (14 Days)||10
2411662|NCT01273038|5914978|P1|COMPLETED|First Intervention (14 Days)||10
2411663|NCT01273038|5914977|P2|STARTED|First Intervention (14 Days)||10
2411664|NCT01273038|5914978|P1|STARTED|First Intervention (14 Days)||10
2411665|NCT01272960|5914986|P2|NOT COMPLETED|Overall Study||0
2411666|NCT01272960|5914987|P1|NOT COMPLETED|Overall Study||0
2411667|NCT01272960|5914986|P2|COMPLETED|Overall Study||15
2411668|NCT01272960|5914987|P1|COMPLETED|Overall Study||14
2411669|NCT01272960|5914986|P2|STARTED|Overall Study||15
2411670|NCT01272960|5914987|P1|STARTED|Overall Study||14
2411671|NCT01272947|5915001|P2|NOT COMPLETED|Overall Study||2
2411672|NCT01272947|5915002|P1|NOT COMPLETED|Overall Study||2
2411673|NCT01272947|5915001|P2|COMPLETED|Overall Study||98
2411674|NCT01272947|5915002|P1|COMPLETED|Overall Study||102
2411675|NCT01272947|5915001|P2|STARTED|Overall Study||100
2411676|NCT01272947|5915002|P1|STARTED|Overall Study||104
2411677|NCT01272934|5915012|P2|NOT COMPLETED|Overall Study||2
2411678|NCT01272934|5915013|P1|NOT COMPLETED|Overall Study||0
2411679|NCT01272934|5915012|P2|COMPLETED|Overall Study||101
2411680|NCT01272934|5915013|P1|COMPLETED|Overall Study||102
2411681|NCT01272934|5915012|P2|STARTED|Overall Study||103
2411682|NCT01272934|5915013|P1|STARTED|Overall Study||102
2411683|NCT01272921|5915023|P2|NOT COMPLETED|Overall Study||1
2411684|NCT01272921|5915024|P1|NOT COMPLETED|Overall Study||2
2411685|NCT01272921|5915023|P2|COMPLETED|Overall Study||70
2411686|NCT01272921|5915024|P1|COMPLETED|Overall Study||69
2411687|NCT01272921|5915023|P2|STARTED|Overall Study||71
2411688|NCT01272921|5915024|P1|STARTED|Overall Study||71
2411689|NCT01272908|5915032|P1|NOT COMPLETED|Re-Treatment Period||6
2411690|NCT01272908|5915032|P1|COMPLETED|Re-Treatment Period||71
2411691|NCT01272908|5915032|P1|STARTED|Re-Treatment Period|Only participants with active disease as characterized by DAS-28 score ≥2.6 were included.|77
2411692|NCT01272908|5915032|P1|NOT COMPLETED|Initial Treatment Period||8
2411693|NCT01272908|5915032|P1|COMPLETED|Initial Treatment Period||112
2411694|NCT01272908|5915032|P1|STARTED|Initial Treatment Period||120
2411695|NCT01272882|5915066|P1|NOT COMPLETED|Overall Study||0
2411696|NCT01272882|5915066|P1|COMPLETED|Overall Study||13
2411697|NCT01272882|5915066|P1|STARTED|Overall Study||13
2411698|NCT01272869|5915072|P2|NOT COMPLETED|Period 2 (14 Days)||0
2411699|NCT01272869|5915073|P1|NOT COMPLETED|Period 2 (14 Days)||1
2411700|NCT01272869|5915072|P2|COMPLETED|Period 2 (14 Days)||10
2411701|NCT01272869|5915073|P1|COMPLETED|Period 2 (14 Days)||9
2411702|NCT01272869|5915072|P2|STARTED|Period 2 (14 Days)||10
2411703|NCT01272869|5915073|P1|STARTED|Period 2 (14 Days)||10
2411704|NCT01272869|5915072|P2|NOT COMPLETED|Period 1 (14 Days)||0
2411705|NCT01272869|5915073|P1|NOT COMPLETED|Period 1 (14 Days)||0
2411706|NCT01272869|5915072|P2|COMPLETED|Period 1 (14 Days)||10
2411707|NCT01272869|5915073|P1|COMPLETED|Period 1 (14 Days)||10
2411708|NCT01272869|5915072|P2|STARTED|Period 1 (14 Days)||10
2411709|NCT01272869|5915073|P1|STARTED|Period 1 (14 Days)||10
2411710|NCT01272830|5915081|P2|NOT COMPLETED|Overall Study||5
2411711|NCT01272830|5915082|P1|NOT COMPLETED|Overall Study||8
2411712|NCT01272830|5915081|P2|COMPLETED|Overall Study||21
2411713|NCT01272830|5915082|P1|COMPLETED|Overall Study||17
2411714|NCT01272830|5915081|P2|STARTED|Overall Study||26
2411715|NCT01272830|5915082|P1|STARTED|Overall Study||25
2411716|NCT01272804|5915100|P6|NOT COMPLETED|Overall Study||1
2411717|NCT01272804|5915101|P5|NOT COMPLETED|Overall Study||2
2411718|NCT01272804|5915102|P4|NOT COMPLETED|Overall Study||0
2411719|NCT01272804|5915103|P3|NOT COMPLETED|Overall Study||0
2411720|NCT01272804|5915104|P2|NOT COMPLETED|Overall Study||0
2411721|NCT01272804|5915105|P1|NOT COMPLETED|Overall Study||1
2411722|NCT01272804|5915100|P6|COMPLETED|Overall Study||15
2411723|NCT01272804|5915101|P5|COMPLETED|Overall Study||7
2411724|NCT01272804|5915102|P4|COMPLETED|Overall Study||9
2411725|NCT01272804|5915103|P3|COMPLETED|Overall Study||9
2411726|NCT01272804|5915104|P2|COMPLETED|Overall Study||9
2411727|NCT01272804|5915105|P1|COMPLETED|Overall Study||8
2411728|NCT01272804|5915100|P6|STARTED|Overall Study||16
2411729|NCT01272804|5915101|P5|STARTED|Overall Study||9
2411730|NCT01272804|5915102|P4|STARTED|Overall Study||9
2411731|NCT01272804|5915103|P3|STARTED|Overall Study||9
2411732|NCT01272804|5915104|P2|STARTED|Overall Study||9
2411733|NCT01272804|5915105|P1|STARTED|Overall Study||9
2411734|NCT01272661|5915263|P3|NOT COMPLETED|Overall Study||72
2411735|NCT01272661|5915264|P2|NOT COMPLETED|Overall Study||209
2411736|NCT01272661|5915265|P1|NOT COMPLETED|Overall Study||126
2411737|NCT01272661|5915263|P3|COMPLETED|Overall Study||314
2411738|NCT01272661|5915264|P2|COMPLETED|Overall Study||288
2411739|NCT01272661|5915265|P1|COMPLETED|Overall Study||287
2411740|NCT01272661|5915263|P3|STARTED|Overall Study||386
2411741|NCT01272661|5915264|P2|STARTED|Overall Study||497
2411742|NCT01272661|5915265|P1|STARTED|Overall Study||413
2411743|NCT01272635|5915290|P4|NOT COMPLETED|Overall Study||23
2411744|NCT01272635|5915291|P3|NOT COMPLETED|Overall Study||31
2411745|NCT01272635|5915292|P2|NOT COMPLETED|Overall Study||20
2411746|NCT01272635|5915293|P1|NOT COMPLETED|Overall Study||31
2411747|NCT01272635|5915290|P4|COMPLETED|Overall Study||129
2411748|NCT01272635|5915291|P3|COMPLETED|Overall Study||117
2411749|NCT01272635|5915292|P2|COMPLETED|Overall Study||134
2411750|NCT01272635|5915293|P1|COMPLETED|Overall Study||122
2411751|NCT01272635|5915290|P4|STARTED|Overall Study||152
2411752|NCT01272635|5915291|P3|STARTED|Overall Study||148
2411753|NCT01272635|5915292|P2|STARTED|Overall Study||154
2411754|NCT01272635|5915293|P1|STARTED|Overall Study||153
2411755|NCT01272583|5915311|P2|NOT COMPLETED|Overall Study||0
2411756|NCT01272583|5915312|P1|NOT COMPLETED|Overall Study||0
2411757|NCT01272583|5915311|P2|COMPLETED|Overall Study||8
2411758|NCT01272583|5915312|P1|COMPLETED|Overall Study||8
2411759|NCT01272583|5915311|P2|STARTED|Overall Study||8
2411760|NCT01272583|5915312|P1|STARTED|Overall Study||8
2411761|NCT01272388|5915343|P2|NOT COMPLETED|Overall Study||0
2411762|NCT01272388|5915344|P1|NOT COMPLETED|Overall Study||0
2411763|NCT01272388|5915343|P2|COMPLETED|Overall Study||0
2411764|NCT01272388|5915344|P1|COMPLETED|Overall Study||1
2411765|NCT01272388|5915343|P2|STARTED|Overall Study||0
2411766|NCT01272388|5915344|P1|STARTED|Overall Study||1
2411767|NCT01272284|5915352|P1|NOT COMPLETED|12-month Follow-up Visit||4
2411768|NCT01272284|5915352|P1|COMPLETED|12-month Follow-up Visit||105
2411769|NCT01272284|5915352|P1|STARTED|12-month Follow-up Visit||109
2411770|NCT01272284|5915352|P1|NOT COMPLETED|6-month Follow-up Visit||3
2411771|NCT01272284|5915352|P1|COMPLETED|6-month Follow-up Visit||109
2411772|NCT01272284|5915352|P1|STARTED|6-month Follow-up Visit||112
2411773|NCT01272284|5915352|P1|NOT COMPLETED|3-month Follow-up Visit||1
2411774|NCT01272284|5915352|P1|COMPLETED|3-month Follow-up Visit||112
2411775|NCT01272284|5915352|P1|STARTED|3-month Follow-up Visit||113
2411776|NCT01272245|5915366|P1|NOT COMPLETED|Overall Study||0
2411777|NCT01272245|5915366|P1|COMPLETED|Overall Study||36
2411778|NCT01272245|5915366|P1|STARTED|Overall Study||36
2411779|NCT01272232|5915377|P3|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||5
2411780|NCT01272232|5915378|P2|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||10
2411781|NCT01272232|5915379|P1|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||14
2411782|NCT01272232|5915377|P3|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||135
2411783|NCT01272232|5915378|P2|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||154
2411784|NCT01272232|5915379|P1|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||310
2411785|NCT01272232|5915377|P3|STARTED|Off Drug Follow-up Period (Weeks 56-68)||140
2411786|NCT01272232|5915378|P2|STARTED|Off Drug Follow-up Period (Weeks 56-68)||164
2411787|NCT01272232|5915379|P1|STARTED|Off Drug Follow-up Period (Weeks 56-68)||324
2411788|NCT01272232|5915377|P3|NOT COMPLETED|Weeks 0-56||72
2411789|NCT01272232|5915378|P2|NOT COMPLETED|Weeks 0-56||47
2411790|NCT01272232|5915379|P1|NOT COMPLETED|Weeks 0-56||99
2411791|NCT01272232|5915377|P3|COMPLETED|Weeks 0-56||140
2411792|NCT01272232|5915378|P2|COMPLETED|Weeks 0-56||164
2411793|NCT01272232|5915379|P1|COMPLETED|Weeks 0-56||324
2411794|NCT01272232|5915377|P3|Exposed|Weeks 0-56||212
2411795|NCT01272232|5915378|P2|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|210
2411796|NCT01272232|5915379|P1|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|422
2411797|NCT01272232|5915377|P3|STARTED|Weeks 0-56||212
2411798|NCT01272232|5915378|P2|STARTED|Weeks 0-56||211
2411799|NCT01272232|5915379|P1|STARTED|Weeks 0-56||423
2411800|NCT01272219|5915424|P6|NOT COMPLETED|Main + Extension Period: Week 0-172||422
2411801|NCT01272219|5915425|P5|NOT COMPLETED|Main + Extension Period: Week 0-172||722
2411802|NCT01272219|5915426|P4|NOT COMPLETED|Main + Extension Period: Week 0-172||0
2411803|NCT01272219|5915427|P3|NOT COMPLETED|Main + Extension Period: Week 0-172||0
2411804|NCT01272219|5915428|P2|NOT COMPLETED|Main + Extension Period: Week 0-172||0
2411805|NCT01272219|5915429|P1|NOT COMPLETED|Main + Extension Period: Week 0-172||0
2411806|NCT01272219|5915424|P6|COMPLETED|Main + Extension Period: Week 0-172||327
2411807|NCT01272219|5915425|P5|COMPLETED|Main + Extension Period: Week 0-172||783
2411808|NCT01272219|5915426|P4|COMPLETED|Main + Extension Period: Week 0-172||0
2411809|NCT01272219|5915427|P3|COMPLETED|Main + Extension Period: Week 0-172||0
2411810|NCT01272219|5915428|P2|COMPLETED|Main + Extension Period: Week 0-172||0
2411811|NCT01272219|5915429|P1|COMPLETED|Main + Extension Period: Week 0-172||0
2411812|NCT01272219|5915424|P6|Exposed|Main + Extension Period: Week 0-172||747
2411813|NCT01272219|5915425|P5|Exposed|Main + Extension Period: Week 0-172||1501
2411814|NCT01272219|5915426|P4|Exposed|Main + Extension Period: Week 0-172||0
2411815|NCT01272219|5915427|P3|Exposed|Main + Extension Period: Week 0-172||0
2411816|NCT01272219|5915428|P2|Exposed|Main + Extension Period: Week 0-172||0
2411817|NCT01272219|5915429|P1|Exposed|Main + Extension Period: Week 0-172||0
2411818|NCT01272219|5915424|P6|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|749
2411819|NCT01272219|5915425|P5|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|1505
2411820|NCT01272219|5915426|P4|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main and re-randomised period|0
2411821|NCT01272219|5915427|P3|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
2411822|NCT01272219|5915428|P2|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
2411823|NCT01272219|5915429|P1|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main period|0
2411824|NCT01272219|5915424|P6|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
2411825|NCT01272219|5915425|P5|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
2411826|NCT01272219|5915426|P4|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||15
2411827|NCT01272219|5915427|P3|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||7
2411828|NCT01272219|5915428|P2|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||9
2411829|NCT01272219|5915429|P1|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
2411830|NCT01272219|5915424|P6|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
2411831|NCT01272219|5915425|P5|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
2411832|NCT01272219|5915426|P4|COMPLETED|Re-randomised Period: Week 56 to Week 68||289
2411833|NCT01272219|5915427|P3|COMPLETED|Re-randomised Period: Week 56 to Week 68||343
2411834|NCT01272219|5915428|P2|COMPLETED|Re-randomised Period: Week 56 to Week 68||342
2411835|NCT01272219|5915429|P1|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
2411836|NCT01272219|5915424|P6|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
2411837|NCT01272219|5915425|P5|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
2411838|NCT01272219|5915426|P4|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|304
2411839|NCT01272219|5915427|P3|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|350
2411840|NCT01272219|5915428|P2|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|351
2411841|NCT01272219|5915429|P1|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
2411842|NCT01272219|5915424|P6|NOT COMPLETED|Main Period: Week 0 to Week 56||252
2411843|NCT01272219|5915425|P5|NOT COMPLETED|Main Period: Week 0 to Week 56||418
2411844|NCT01272219|5915426|P4|NOT COMPLETED|Main Period: Week 0 to Week 56||191
2411845|NCT01272219|5915427|P3|NOT COMPLETED|Main Period: Week 0 to Week 56||0
2411846|NCT01272219|5915428|P2|NOT COMPLETED|Main Period: Week 0 to Week 56||0
2411847|NCT01272219|5915429|P1|NOT COMPLETED|Main Period: Week 0 to Week 56||280
2411848|NCT01272219|5915424|P6|COMPLETED|Main Period: Week 0 to Week 56||505
2411849|NCT01272219|5915425|P5|COMPLETED|Main Period: Week 0 to Week 56||1110
2411850|NCT01272219|5915426|P4|COMPLETED|Main Period: Week 0 to Week 56||296
2411851|NCT01272219|5915427|P3|COMPLETED|Main Period: Week 0 to Week 56||0
2411852|NCT01272219|5915428|P2|COMPLETED|Main Period: Week 0 to Week 56||0
2411853|NCT01272219|5915429|P1|COMPLETED|Main Period: Week 0 to Week 56||679
2411854|NCT01272219|5915424|P6|Exposed|Main Period: Week 0 to Week 56||755
2411855|NCT01272219|5915425|P5|Exposed|Main Period: Week 0 to Week 56||1524
2411856|NCT01272219|5915426|P4|Exposed|Main Period: Week 0 to Week 56||487
2411857|NCT01272219|5915427|P3|Exposed|Main Period: Week 0 to Week 56||0
2411858|NCT01272219|5915428|P2|Exposed|Main Period: Week 0 to Week 56||0
2411859|NCT01272219|5915429|P1|Exposed|Main Period: Week 0 to Week 56||957
2411860|NCT01272219|5915424|P6|STARTED|Main Period: Week 0 to Week 56||757
2411861|NCT01272219|5915425|P5|STARTED|Main Period: Week 0 to Week 56||1528
2411862|NCT01272219|5915426|P4|STARTED|Main Period: Week 0 to Week 56||487
2411863|NCT01272219|5915427|P3|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
2411864|NCT01272219|5915428|P2|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
2411865|NCT01272219|5915429|P1|STARTED|Main Period: Week 0 to Week 56||959
2411866|NCT01272193|5915463|P2|NOT COMPLETED|Overall Study||12
2411867|NCT01272193|5915464|P1|NOT COMPLETED|Overall Study||10
2411868|NCT01272193|5915463|P2|COMPLETED|Overall Study||137
2411869|NCT01272193|5915464|P1|COMPLETED|Overall Study||137
2411870|NCT01272193|5915463|P2|STARTED|Overall Study||149
2411871|NCT01272193|5915464|P1|STARTED|Overall Study||147
2411872|NCT01272180|5915484|P4|NOT COMPLETED|Overall Study||14
2411873|NCT01272180|5915485|P3|NOT COMPLETED|Overall Study||13
2411874|NCT01272180|5915486|P2|NOT COMPLETED|Overall Study||21
2411875|NCT01272180|5915487|P1|NOT COMPLETED|Overall Study||17
2411876|NCT01272180|5915484|P4|COMPLETED|Overall Study||107
2411877|NCT01272180|5915485|P3|COMPLETED|Overall Study||109
2411878|NCT01272180|5915486|P2|COMPLETED|Overall Study||100
2411879|NCT01272180|5915487|P1|COMPLETED|Overall Study||103
2411880|NCT01272180|5915484|P4|STARTED|Overall Study||121
2411881|NCT01272180|5915485|P3|STARTED|Overall Study||122
2411882|NCT01272180|5915486|P2|STARTED|Overall Study||121
2411883|NCT01272180|5915487|P1|STARTED|Overall Study||120
2411884|NCT01272141|5915524|P1|NOT COMPLETED|Overall Study||0
2411885|NCT01272141|5915524|P1|COMPLETED|Overall Study||5
2411886|NCT01272141|5915524|P1|STARTED|Overall Study||5
2411887|NCT01272076|5915529|P1|NOT COMPLETED|Overall Study||0
2411888|NCT01272076|5915529|P1|COMPLETED|Overall Study||52
2411889|NCT01272076|5915529|P1|STARTED|Overall Study||52
2411890|NCT01272011|5915536|P3|NOT COMPLETED|Overall Study||0
2411891|NCT01272011|5915537|P2|NOT COMPLETED|Overall Study||2
2411892|NCT01272011|5915538|P1|NOT COMPLETED|Overall Study||0
2411893|NCT01272011|5915536|P3|COMPLETED|Overall Study||3
2411894|NCT01272011|5915537|P2|COMPLETED|Overall Study||8
2411895|NCT01272011|5915538|P1|COMPLETED|Overall Study||3
2411896|NCT01272011|5915536|P3|STARTED|Overall Study||3
2411897|NCT01272011|5915537|P2|STARTED|Overall Study||10
2411898|NCT01272011|5915538|P1|STARTED|Overall Study||3
2411899|NCT01271946|5915551|P2|NOT COMPLETED|Overall Study||0
2411900|NCT01271946|5915552|P1|NOT COMPLETED|Overall Study||0
2411901|NCT01271946|5915551|P2|COMPLETED|Overall Study||5
2411902|NCT01271946|5915552|P1|COMPLETED|Overall Study||346
2411903|NCT01271946|5915551|P2|STARTED|Overall Study||5
2411904|NCT01271946|5915552|P1|STARTED|Overall Study||346
2411905|NCT01271933|5915574|P3|NOT COMPLETED|Double-Blind Phase||12
2411906|NCT01271933|5915575|P2|NOT COMPLETED|Double-Blind Phase||17
2411907|NCT01271933|5915576|P1|NOT COMPLETED|Double-Blind Phase||0
2411908|NCT01271933|5915574|P3|COMPLETED|Double-Blind Phase||47
2411909|NCT01271933|5915575|P2|COMPLETED|Double-Blind Phase||46
2411910|NCT01271933|5915576|P1|COMPLETED|Double-Blind Phase||0
2411911|NCT01271933|5915574|P3|Treated|Double-Blind Phase||58
2411912|NCT01271933|5915575|P2|Treated|Double-Blind Phase||63
2411913|NCT01271933|5915576|P1|Treated|Double-Blind Phase||0
2411914|NCT01271933|5915574|P3|STARTED|Double-Blind Phase||59
2411915|NCT01271933|5915575|P2|STARTED|Double-Blind Phase||63
2411916|NCT01271933|5915576|P1|STARTED|Double-Blind Phase||0
2411917|NCT01271933|5915574|P3|NOT COMPLETED|Single-Blind Phase||0
2411918|NCT01271933|5915575|P2|NOT COMPLETED|Single-Blind Phase||0
2411919|NCT01271933|5915576|P1|NOT COMPLETED|Single-Blind Phase||121
2411920|NCT01271933|5915574|P3|COMPLETED|Single-Blind Phase||0
2411921|NCT01271933|5915575|P2|COMPLETED|Single-Blind Phase||0
2411922|NCT01271933|5915576|P1|COMPLETED|Single-Blind Phase||320
2411923|NCT01271933|5915574|P3|STARTED|Single-Blind Phase||0
2411924|NCT01271933|5915575|P2|STARTED|Single-Blind Phase||0
2411925|NCT01271933|5915576|P1|STARTED|Single-Blind Phase||441
2411926|NCT01271907|5915676|P3|NOT COMPLETED|Overall Study||0
2411927|NCT01271907|5915677|P2|NOT COMPLETED|Overall Study||0
2411928|NCT01271907|5915678|P1|NOT COMPLETED|Overall Study||0
2411929|NCT01271907|5915676|P3|COMPLETED|Overall Study||0
2411930|NCT01271907|5915677|P2|COMPLETED|Overall Study||0
2411931|NCT01271907|5915678|P1|COMPLETED|Overall Study||3
2411932|NCT01271907|5915676|P3|STARTED|Overall Study||0
2411933|NCT01271907|5915677|P2|STARTED|Overall Study||0
2411934|NCT01271907|5915678|P1|STARTED|Overall Study||3
2411935|NCT01271868|5915692|P1|NOT COMPLETED|Treatment Study||0
2411936|NCT01271868|5915692|P1|COMPLETED|Treatment Study||9
2411937|NCT01271868|5915692|P1|STARTED|Treatment Study||9
2411938|NCT01271868|5915692|P1|NOT COMPLETED|Pharmacokinetic Study||0
2411939|NCT01271868|5915692|P1|COMPLETED|Pharmacokinetic Study||9
2411940|NCT01271868|5915692|P1|STARTED|Pharmacokinetic Study||9
2411941|NCT01271855|5915705|P2|NOT COMPLETED|Overall Study||0
2411942|NCT01271855|5915706|P1|NOT COMPLETED|Overall Study||0
2411943|NCT01271855|5915705|P2|COMPLETED|Overall Study||52
2411944|NCT01271855|5915706|P1|COMPLETED|Overall Study||48
2411945|NCT01271855|5915705|P2|STARTED|Overall Study||52
2411946|NCT01271855|5915706|P1|STARTED|Overall Study||48
2411947|NCT01271803|5915719|P3|NOT COMPLETED|Overall Study||2
2411948|NCT01271803|5915720|P2|NOT COMPLETED|Overall Study||39
2411949|NCT01271803|5915721|P1|NOT COMPLETED|Overall Study||55
2411950|NCT01271803|5915719|P3|COMPLETED|Overall Study||0
2411951|NCT01271803|5915720|P2|COMPLETED|Overall Study||24
2411952|NCT01271803|5915721|P1|COMPLETED|Overall Study||11
2411953|NCT01271803|5915719|P3|STARTED|Overall Study||2
2411954|NCT01271803|5915720|P2|STARTED|Overall Study||63
2411955|NCT01271803|5915721|P1|STARTED|Overall Study||66
2411956|NCT01271725|5915883|P2|NOT COMPLETED|Part B||12
2411957|NCT01271725|5915884|P1|NOT COMPLETED|Part B||0
2411958|NCT01271725|5915883|P2|COMPLETED|Part B|Patient deemed to have completed the trial once they showed progressive disease according to RECIST|27
2411959|NCT01271725|5915884|P1|COMPLETED|Part B||0
2411960|NCT01271725|5915883|P2|STARTED|Part B||39
2411961|NCT01271725|5915884|P1|STARTED|Part B||0
2411962|NCT01271725|5915883|P2|NOT COMPLETED|Part A||0
2411963|NCT01271725|5915884|P1|NOT COMPLETED|Part A||35
2411964|NCT01271725|5915883|P2|COMPLETED|Part A||0
2411965|NCT01271725|5915884|P1|COMPLETED|Part A||39
2411966|NCT01271725|5915883|P2|STARTED|Part A||0
2411967|NCT01271725|5915884|P1|STARTED|Part A|Started are the treated patients|74
2411968|NCT01271712|5915913|P2|NOT COMPLETED|Survival Follow-up||6
2411969|NCT01271712|5915914|P1|NOT COMPLETED|Survival Follow-up||15
2411970|NCT01271712|5915913|P2|COMPLETED|Survival Follow-up|33 participants died and completed survival follow-up.|33
2411971|NCT01271712|5915914|P1|COMPLETED|Survival Follow-up|85 participants died and completed survival follow-up.|85
2411972|NCT01271712|5915913|P2|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|39
2411973|NCT01271712|5915914|P1|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|100
2411974|NCT01271712|5915913|P2|NOT COMPLETED|Safety Follow-up||15
2411975|NCT01271712|5915914|P1|NOT COMPLETED|Safety Follow-up||21
2411976|NCT01271712|5915913|P2|COMPLETED|Safety Follow-up||37
2411977|NCT01271712|5915914|P1|COMPLETED|Safety Follow-up||97
2411978|NCT01271712|5915913|P2|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|52
2411979|NCT01271712|5915914|P1|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|118
2411980|NCT01271712|5915913|P2|NOT COMPLETED|Open Label Treatment||58
2411981|NCT01271712|5915914|P1|NOT COMPLETED|Open Label Treatment||91
2411982|NCT01271712|5915913|P2|COMPLETED|Open Label Treatment||0
2411983|NCT01271712|5915914|P1|COMPLETED|Open Label Treatment||0
2411984|NCT01271712|5915913|P2|STARTED|Open Label Treatment||58
2411985|NCT01271712|5915914|P1|STARTED|Open Label Treatment||91
2411986|NCT01271712|5915913|P2|NOT COMPLETED|Double Blind Treatment||8
2411987|NCT01271712|5915914|P1|NOT COMPLETED|Double Blind Treatment||42
2411988|NCT01271712|5915913|P2|COMPLETED|Double Blind Treatment|58 participants started open-label treatment with regorafenib|58
2411989|NCT01271712|5915914|P1|COMPLETED|Double Blind Treatment|91 participants started open-label treatment with regorafenib|91
2411990|NCT01271712|5915913|P2|Participants Received Treatment|Double Blind Treatment||66
2411991|NCT01271712|5915914|P1|Participants Received Treatment|Double Blind Treatment||132
2411992|NCT01271712|5915913|P2|STARTED|Double Blind Treatment||66
2411993|NCT01271712|5915914|P1|STARTED|Double Blind Treatment||133
2411994|NCT01271686|5915935|P1|NOT COMPLETED|Overall Study||0
2411995|NCT01271686|5915935|P1|COMPLETED|Overall Study||16
2411996|NCT01271686|5915935|P1|STARTED|Overall Study||16
2411997|NCT01271543|5915941|P2|NOT COMPLETED|Overall Study||1
2411998|NCT01271543|5915942|P1|NOT COMPLETED|Overall Study||1
2411999|NCT01271543|5915941|P2|COMPLETED|Overall Study||29
2412000|NCT01271543|5915942|P1|COMPLETED|Overall Study||29
2412001|NCT01271543|5915941|P2|STARTED|Overall Study||30
2412002|NCT01271543|5915942|P1|STARTED|Overall Study||30
2412003|NCT01271452|5915952|P2|NOT COMPLETED|Overall Study||8
2412004|NCT01271452|5915953|P1|NOT COMPLETED|Overall Study||7
2412005|NCT01271452|5915952|P2|COMPLETED|Overall Study||104
2412006|NCT01271452|5915953|P1|COMPLETED|Overall Study||105
2412007|NCT01271452|5915952|P2|STARTED|Overall Study||112
2412008|NCT01271452|5915953|P1|STARTED|Overall Study||112
2412009|NCT01271413|5915975|P2|NOT COMPLETED|Overall Study||8
2412010|NCT01271413|5915976|P1|NOT COMPLETED|Overall Study||9
2412011|NCT01271413|5915975|P2|COMPLETED|Overall Study||28
2412012|NCT01271413|5915976|P1|COMPLETED|Overall Study||28
2412013|NCT01271413|5915975|P2|STARTED|Overall Study||36
2412014|NCT01271413|5915976|P1|STARTED|Overall Study||37
2412015|NCT01271244|5915984|P2|NOT COMPLETED|Overall Study||3
2412016|NCT01271244|5915985|P1|NOT COMPLETED|Overall Study||7
2412017|NCT01271244|5915984|P2|COMPLETED|Overall Study||5
2412018|NCT01271244|5915985|P1|COMPLETED|Overall Study||11
2412019|NCT01271244|5915984|P2|STARTED|Overall Study||8
2412020|NCT01271244|5915985|P1|STARTED|Overall Study||18
2412021|NCT01271036|5915995|P2|NOT COMPLETED|Overall Study||0
2412022|NCT01271036|5915996|P1|NOT COMPLETED|Overall Study||0
2412023|NCT01271036|5915995|P2|COMPLETED|Overall Study||62
2412024|NCT01271036|5915996|P1|COMPLETED|Overall Study||62
2412025|NCT01271036|5915995|P2|STARTED|Overall Study||62
2412026|NCT01271036|5915996|P1|STARTED|Overall Study||62
2412027|NCT01271010|5916010|P1|NOT COMPLETED|Overall Study||61
2412028|NCT01271010|5916010|P1|COMPLETED|Overall Study||28
2412029|NCT01271010|5916010|P1|STARTED|Overall Study||89
2412030|NCT01270971|5916025|P2|NOT COMPLETED|Overall Study||23
2412031|NCT01270971|5916026|P1|NOT COMPLETED|Overall Study||52
2412032|NCT01270971|5916025|P2|COMPLETED|Overall Study||171
2412033|NCT01270971|5916026|P1|COMPLETED|Overall Study||348
2412034|NCT01270971|5916025|P2|STARTED|Overall Study||194
2412035|NCT01270971|5916026|P1|STARTED|Overall Study||400
2412036|NCT01270958|5916038|P1|NOT COMPLETED|Overall Study||4
2412037|NCT01270958|5916038|P1|COMPLETED|Overall Study||56
2412038|NCT01270958|5916038|P1|STARTED|Overall Study||60
2412039|NCT01270919|5916062|P1|NOT COMPLETED|Overall Study||0
2412040|NCT01270919|5916062|P1|COMPLETED|Overall Study||0
2412041|NCT01270919|5916062|P1|STARTED|Overall Study|One participant was enrolled but was censored.|0
2412042|NCT01270880|5916067|P1|NOT COMPLETED|Overall Study||1
2412043|NCT01270880|5916067|P1|COMPLETED|Overall Study||17
2412044|NCT01270880|5916067|P1|STARTED|Overall Study||18
2412045|NCT01270867|5916078|P2|NOT COMPLETED|Overall Study||0
2412046|NCT01270867|5916079|P1|NOT COMPLETED|Overall Study||1
2412047|NCT01270867|5916078|P2|COMPLETED|Overall Study||88
2412048|NCT01270867|5916079|P1|COMPLETED|Overall Study||89
2412049|NCT01270867|5916078|P2|STARTED|Overall Study||88
2412050|NCT01270867|5916079|P1|STARTED|Overall Study||90
2412051|NCT01270841|5916097|P4|NOT COMPLETED|Overall Study||13
2412052|NCT01270841|5916098|P3|NOT COMPLETED|Overall Study||11
2412053|NCT01270841|5916099|P2|NOT COMPLETED|Overall Study||14
2412054|NCT01270841|5916100|P1|NOT COMPLETED|Overall Study||13
2412055|NCT01270841|5916097|P4|COMPLETED|Overall Study||20
2412056|NCT01270841|5916098|P3|COMPLETED|Overall Study||18
2412057|NCT01270841|5916099|P2|COMPLETED|Overall Study||19
2412058|NCT01270841|5916100|P1|COMPLETED|Overall Study||16
2412059|NCT01270841|5916097|P4|STARTED|Overall Study||33
2412060|NCT01270841|5916098|P3|STARTED|Overall Study||29
2412061|NCT01270841|5916099|P2|STARTED|Overall Study||33
2412062|NCT01270841|5916100|P1|STARTED|Overall Study||29
2412063|NCT01270828|5916124|P3|NOT COMPLETED|Double Blind Phase||0
2412064|NCT01270828|5916125|P2|NOT COMPLETED|Double Blind Phase||45
2412065|NCT01270828|5916126|P1|NOT COMPLETED|Double Blind Phase||26
2412066|NCT01270828|5916124|P3|COMPLETED|Double Blind Phase||0
2412067|NCT01270828|5916125|P2|COMPLETED|Double Blind Phase||160
2412068|NCT01270828|5916126|P1|COMPLETED|Double Blind Phase||182
2412069|NCT01270828|5916124|P3|STARTED|Double Blind Phase||0
2412070|NCT01270828|5916125|P2|STARTED|Double Blind Phase||205
2412071|NCT01270828|5916126|P1|STARTED|Double Blind Phase||208
2412072|NCT01270828|5916124|P3|NOT COMPLETED|Pregabalin CR SB||146
2412073|NCT01270828|5916125|P2|NOT COMPLETED|Pregabalin CR SB||0
2412074|NCT01270828|5916126|P1|NOT COMPLETED|Pregabalin CR SB||0
2412075|NCT01270828|5916124|P3|COMPLETED|Pregabalin CR SB||660
2412076|NCT01270828|5916125|P2|COMPLETED|Pregabalin CR SB||0
2412077|NCT01270828|5916126|P1|COMPLETED|Pregabalin CR SB||0
2412078|NCT01270828|5916124|P3|STARTED|Pregabalin CR SB||806
2412079|NCT01270828|5916125|P2|STARTED|Pregabalin CR SB||0
2412080|NCT01270828|5916126|P1|STARTED|Pregabalin CR SB||0
2412081|NCT01270802|5916168|P2|NOT COMPLETED|Overall Study||1
2412082|NCT01270802|5916169|P1|NOT COMPLETED|Overall Study||2
2412083|NCT01270802|5916168|P2|COMPLETED|Overall Study||14
2412084|NCT01270802|5916169|P1|COMPLETED|Overall Study||13
2412085|NCT01270802|5916168|P2|STARTED|Overall Study||15
2412086|NCT01270802|5916169|P1|STARTED|Overall Study||15
2412087|NCT01270711|5916185|P8|NOT COMPLETED|Part 2: Effectiveness||0
2412088|NCT01270711|5916186|P7|NOT COMPLETED|Part 2: Effectiveness||0
2412089|NCT01270711|5916187|P6|NOT COMPLETED|Part 2: Effectiveness||0
2412090|NCT01270711|5916188|P5|NOT COMPLETED|Part 2: Effectiveness||0
2412091|NCT01270711|5916189|P4|NOT COMPLETED|Part 2: Effectiveness||0
2412092|NCT01270711|5916190|P3|NOT COMPLETED|Part 2: Effectiveness||0
2412093|NCT01270711|5916191|P2|NOT COMPLETED|Part 2: Effectiveness||0
2412094|NCT01270711|5916192|P1|NOT COMPLETED|Part 2: Effectiveness||0
2412095|NCT01270711|5916185|P8|COMPLETED|Part 2: Effectiveness||48
2412096|NCT01270711|5916186|P7|COMPLETED|Part 2: Effectiveness||2
2412097|NCT01270711|5916187|P6|COMPLETED|Part 2: Effectiveness||11
2412098|NCT01270711|5916188|P5|COMPLETED|Part 2: Effectiveness||0
2412099|NCT01270711|5916189|P4|COMPLETED|Part 2: Effectiveness||0
2412100|NCT01270711|5916190|P3|COMPLETED|Part 2: Effectiveness||0
2412101|NCT01270711|5916191|P2|COMPLETED|Part 2: Effectiveness||0
2412102|NCT01270711|5916192|P1|COMPLETED|Part 2: Effectiveness||0
2412103|NCT01270711|5916185|P8|STARTED|Part 2: Effectiveness||48
2412104|NCT01270711|5916186|P7|STARTED|Part 2: Effectiveness||2
2412105|NCT01270711|5916187|P6|STARTED|Part 2: Effectiveness||11
2412106|NCT01270711|5916188|P5|STARTED|Part 2: Effectiveness||0
2412107|NCT01270711|5916189|P4|STARTED|Part 2: Effectiveness||0
2412108|NCT01270711|5916190|P3|STARTED|Part 2: Effectiveness||0
2412109|NCT01270711|5916191|P2|STARTED|Part 2: Effectiveness||0
2412110|NCT01270711|5916192|P1|STARTED|Part 2: Effectiveness||0
2412111|NCT01270711|5916185|P8|NOT COMPLETED|Part 1: Compliance||0
2412112|NCT01270711|5916186|P7|NOT COMPLETED|Part 1: Compliance||0
2412113|NCT01270711|5916187|P6|NOT COMPLETED|Part 1: Compliance||0
2412114|NCT01270711|5916188|P5|NOT COMPLETED|Part 1: Compliance||0
2412115|NCT01270711|5916189|P4|NOT COMPLETED|Part 1: Compliance||0
2412116|NCT01270711|5916190|P3|NOT COMPLETED|Part 1: Compliance||0
2412117|NCT01270711|5916191|P2|NOT COMPLETED|Part 1: Compliance||0
2412118|NCT01270711|5916192|P1|NOT COMPLETED|Part 1: Compliance||0
2412119|NCT01270711|5916185|P8|COMPLETED|Part 1: Compliance||0
2412120|NCT01270711|5916186|P7|COMPLETED|Part 1: Compliance||0
2412121|NCT01270711|5916187|P6|COMPLETED|Part 1: Compliance||0
2412122|NCT01270711|5916188|P5|COMPLETED|Part 1: Compliance||2024
2412123|NCT01270711|5916189|P4|COMPLETED|Part 1: Compliance||5486
2412124|NCT01270711|5916190|P3|COMPLETED|Part 1: Compliance||326
2412125|NCT01270711|5916191|P2|COMPLETED|Part 1: Compliance||6580
2412126|NCT01270711|5916192|P1|COMPLETED|Part 1: Compliance||7537
2412127|NCT01270711|5916185|P8|STARTED|Part 1: Compliance||0
2412128|NCT01270711|5916186|P7|STARTED|Part 1: Compliance||0
2412129|NCT01270711|5916187|P6|STARTED|Part 1: Compliance||0
2412130|NCT01270711|5916188|P5|STARTED|Part 1: Compliance||2024
2412131|NCT01270711|5916189|P4|STARTED|Part 1: Compliance||5486
2412132|NCT01270711|5916190|P3|STARTED|Part 1: Compliance||326
2412133|NCT01270711|5916191|P2|STARTED|Part 1: Compliance||6580
2412134|NCT01270711|5916192|P1|STARTED|Part 1: Compliance||7537
2412135|NCT01270659|5916293|P4|NOT COMPLETED|Overall Study||0
2412136|NCT01270659|5916294|P3|NOT COMPLETED|Overall Study||0
2412137|NCT01270659|5916295|P2|NOT COMPLETED|Overall Study||0
2412138|NCT01270659|5916296|P1|NOT COMPLETED|Overall Study||0
2412139|NCT01270659|5916293|P4|COMPLETED|Overall Study||25
2412140|NCT01270659|5916294|P3|COMPLETED|Overall Study||4
2412141|NCT01270659|5916295|P2|COMPLETED|Overall Study||25
2412142|NCT01270659|5916296|P1|COMPLETED|Overall Study||6
2412143|NCT01270659|5916293|P4|STARTED|Overall Study||25
2412144|NCT01270659|5916294|P3|STARTED|Overall Study||4
2412145|NCT01270659|5916295|P2|STARTED|Overall Study||25
2412146|NCT01270659|5916296|P1|STARTED|Overall Study||6
2412147|NCT01270620|5916316|P2|NOT COMPLETED|Overall Study||3
2412148|NCT01270620|5916317|P1|NOT COMPLETED|Overall Study||1
2412149|NCT01270620|5916316|P2|COMPLETED|Overall Study||47
2412150|NCT01270620|5916317|P1|COMPLETED|Overall Study||49
2412151|NCT01270620|5916316|P2|STARTED|Overall Study||50
2412152|NCT01270620|5916317|P1|STARTED|Overall Study||50
2412153|NCT01270581|5916369|P2|NOT COMPLETED|Overall Study||0
2412154|NCT01270581|5916370|P1|NOT COMPLETED|Overall Study||1
2412155|NCT01270581|5916369|P2|COMPLETED|Overall Study||3
2412156|NCT01270581|5916370|P1|COMPLETED|Overall Study||3
2412157|NCT01270581|5916369|P2|STARTED|Overall Study||3
2412158|NCT01270581|5916370|P1|STARTED|Overall Study||4
2412159|NCT01270555|5916376|P1|NOT COMPLETED|Overall Study||13
2412160|NCT01270555|5916376|P1|COMPLETED|Overall Study||19
2412161|NCT01270555|5916376|P1|STARTED|Overall Study||32
2412162|NCT01270542|5916388|P2|NOT COMPLETED|Overall Study||1
2412163|NCT01270542|5916389|P1|NOT COMPLETED|Overall Study||1
2412164|NCT01270542|5916388|P2|COMPLETED|Overall Study||8
2412165|NCT01270542|5916389|P1|COMPLETED|Overall Study||9
2412166|NCT01270542|5916388|P2|STARTED|Overall Study||9
2412167|NCT01270542|5916389|P1|STARTED|Overall Study||10
2412168|NCT01270529|5916402|P3|NOT COMPLETED|Overall Study||0
2412169|NCT01270529|5916403|P2|NOT COMPLETED|Overall Study||0
2412170|NCT01270529|5916404|P1|NOT COMPLETED|Overall Study||0
2412171|NCT01270529|5916402|P3|COMPLETED|Overall Study||25
2412172|NCT01270529|5916403|P2|COMPLETED|Overall Study||7
2412173|NCT01270529|5916404|P1|COMPLETED|Overall Study||12
2412174|NCT01270529|5916402|P3|STARTED|Overall Study||25
2412175|NCT01270529|5916403|P2|STARTED|Overall Study||7
2412176|NCT01270529|5916404|P1|STARTED|Overall Study||12
2412177|NCT01270503|5916412|P1|NOT COMPLETED|Overall Study||1
2412178|NCT01270503|5916412|P1|COMPLETED|Overall Study||537
2412179|NCT01270503|5916412|P1|STARTED|Overall Study||538
2412180|NCT01270464|5916420|P3|NOT COMPLETED|Overall Study||18
2412181|NCT01270464|5916421|P2|NOT COMPLETED|Overall Study||12
2412182|NCT01270464|5916422|P1|NOT COMPLETED|Overall Study||20
2412183|NCT01270464|5916420|P3|COMPLETED|Overall Study||88
2412184|NCT01270464|5916421|P2|COMPLETED|Overall Study||92
2412185|NCT01270464|5916422|P1|COMPLETED|Overall Study||85
2412186|NCT01270464|5916420|P3|Pharmacokinetic Analysis Set|Overall Study||103
2412187|NCT01270464|5916421|P2|Pharmacokinetic Analysis Set|Overall Study||103
2412188|NCT01270464|5916422|P1|Pharmacokinetic Analysis Set|Overall Study||105
2412189|NCT01270464|5916420|P3|Full Analysis Set|Overall Study||103
2412190|NCT01270464|5916421|P2|Full Analysis Set|Overall Study||103
2412191|NCT01270464|5916422|P1|Full Analysis Set|Overall Study||105
2412192|NCT01270464|5916420|P3|Safety Analysis Set|Overall Study||103
2412193|NCT01270464|5916421|P2|Safety Analysis Set|Overall Study||103
2412194|NCT01270464|5916422|P1|Safety Analysis Set|Overall Study||105
2412195|NCT01270464|5916420|P3|STARTED|Overall Study||106
2412196|NCT01270464|5916421|P2|STARTED|Overall Study||104
2412197|NCT01270464|5916422|P1|STARTED|Overall Study||105
2412198|NCT01270256|5916471|P2|NOT COMPLETED|Overall Study||0
2412199|NCT01270256|5916472|P1|NOT COMPLETED|Overall Study||1
2412200|NCT01270256|5916471|P2|COMPLETED|Overall Study||20
2412201|NCT01270256|5916472|P1|COMPLETED|Overall Study||20
2412202|NCT01270256|5916471|P2|STARTED|Overall Study||20
2412203|NCT01270256|5916472|P1|STARTED|Overall Study||21
2412204|NCT01270139|5916481|P3|NOT COMPLETED|Overall Study||20
2412205|NCT01270139|5916482|P2|NOT COMPLETED|Overall Study||26
2412206|NCT01270139|5916483|P1|NOT COMPLETED|Overall Study||18
2412207|NCT01270139|5916481|P3|COMPLETED|Overall Study|Pre-treatment evaluable population|40
2412208|NCT01270139|5916482|P2|COMPLETED|Overall Study|Pre-treatment evaluable population|34
2412209|NCT01270139|5916483|P1|COMPLETED|Overall Study|Pre-treatment evaluable population|42
2412210|NCT01270139|5916481|P3|STARTED|Overall Study|Intention-to-treat population|60
2412211|NCT01270139|5916482|P2|STARTED|Overall Study|Intention-to-treat population|60
2412212|NCT01270139|5916483|P1|STARTED|Overall Study|Intention-to-treat population|60
2412213|NCT01270126|5916543|P2|NOT COMPLETED|Overall Study||0
2412214|NCT01270126|5916544|P1|NOT COMPLETED|Overall Study||0
2412215|NCT01270126|5916543|P2|COMPLETED|Overall Study||10
2412216|NCT01270126|5916544|P1|COMPLETED|Overall Study||12
2412217|NCT01270126|5916543|P2|STARTED|Overall Study||10
2412218|NCT01270126|5916544|P1|STARTED|Overall Study||12
2412219|NCT01269918|5916552|P2|NOT COMPLETED|Overall Study||3
2412220|NCT01269918|5916553|P1|NOT COMPLETED|Overall Study||0
2412221|NCT01269918|5916552|P2|COMPLETED|Overall Study||68
2412222|NCT01269918|5916553|P1|COMPLETED|Overall Study||71
2412223|NCT01269918|5916552|P2|STARTED|Overall Study||71
2412224|NCT01269918|5916553|P1|STARTED|Overall Study||71
2412225|NCT01269801|5916587|P2|NOT COMPLETED|Overall Study||3
2412226|NCT01269801|5916588|P1|NOT COMPLETED|Overall Study||0
2412227|NCT01269801|5916587|P2|COMPLETED|Overall Study||77
2412228|NCT01269801|5916588|P1|COMPLETED|Overall Study||74
2412229|NCT01269801|5916587|P2|STARTED|Overall Study||80
2412230|NCT01269801|5916588|P1|STARTED|Overall Study||74
2412231|NCT01269749|5916596|P2|NOT COMPLETED|Overall Study||0
2412232|NCT01269749|5916597|P1|NOT COMPLETED|Overall Study||0
2412233|NCT01269749|5916596|P2|COMPLETED|Overall Study||3
2412234|NCT01269749|5916597|P1|COMPLETED|Overall Study||16
2412235|NCT01269749|5916596|P2|STARTED|Overall Study||3
2412236|NCT01269749|5916597|P1|STARTED|Overall Study||16
2412237|NCT01269736|5916607|P2|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
2412238|NCT01269736|5916608|P1|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
2412239|NCT01269736|5916607|P2|COMPLETED|Patient Outcomes (Hospital Admissions)|43799 unique patients assessed overall (at any time point) by end of study.|43799
2412240|NCT01269736|5916608|P1|COMPLETED|Patient Outcomes (Hospital Admissions)|52085 unique patients assessed overall (at any time point) by end of study.|52085
2412241|NCT01269736|5916607|P2|30 Months Assessment|Patient Outcomes (Hospital Admissions)|13265 unique patients, assessed at 6 hospitals.|13265
2412242|NCT01269736|5916608|P1|30 Months Assessment|Patient Outcomes (Hospital Admissions)|16702 unique patients, assessed at 7 hospitals.|16702
2412243|NCT01269736|5916607|P2|15 Months Assessment|Patient Outcomes (Hospital Admissions)|14075 unique patients, assessed at 6 hospitals.|14075
2412244|NCT01269736|5916608|P1|15 Months Assessment|Patient Outcomes (Hospital Admissions)|18031 unique patients, assessed at 7 hospitals.|18031
2412245|NCT01269736|5916607|P2|Baseline Assessment|Patient Outcomes (Hospital Admissions)|16549 unique patients, assessed at 6 hospitals.|16549
2412246|NCT01269736|5916608|P1|Baseline Assessment|Patient Outcomes (Hospital Admissions)|17352 unique patients, assessed at 7 hospitals.|17352
2412247|NCT01269736|5916607|P2|STARTED|Patient Outcomes (Hospital Admissions)|16459 unique patients were assessed at 6 hospitals at the initiation of the study.|43799
2412248|NCT01269736|5916608|P1|STARTED|Patient Outcomes (Hospital Admissions)|17352 unique patients were assessed at 7 hospitals at the initiation of the study.|52085
2412249|NCT01269736|5916607|P2|NOT COMPLETED|Patient Quality of Care Assessments||0
2412250|NCT01269736|5916608|P1|NOT COMPLETED|Patient Quality of Care Assessments||0
2412251|NCT01269736|5916607|P2|COMPLETED|Patient Quality of Care Assessments|2288 unique patients assessed overall (at any time point) by end of study.|2288
2412252|NCT01269736|5916608|P1|COMPLETED|Patient Quality of Care Assessments|2299 unique patients assessed overall (at any time point) by end of study.|2299
2412253|NCT01269736|5916607|P2|30 Months Assessment|Patient Quality of Care Assessments|626 unique patients, assessed at 7 hospitals.|626
2412254|NCT01269736|5916608|P1|30 Months Assessment|Patient Quality of Care Assessments|697 unique patients, assessed at 8 hospitals.|697
2412255|NCT01269736|5916607|P2|15 Months Assessment|Patient Quality of Care Assessments|773 unique patients, assessed at 8 hospitals.|773
2412256|NCT01269736|5916608|P1|15 Months Assessment|Patient Quality of Care Assessments|687 unique patients, assessed at 8 hospitals.|687
2412257|NCT01269736|5916607|P2|Baseline Assessment|Patient Quality of Care Assessments|889 unique patients, assessed at 8 hospitals.|889
2412258|NCT01269736|5916608|P1|Baseline Assessment|Patient Quality of Care Assessments|915 unique patients, assessed at 9 hospitals.|915
2412259|NCT01269736|5916607|P2|STARTED|Patient Quality of Care Assessments|889 unique patients were assessed at 8 hospitals at the initiation of the study.|2288
2412260|NCT01269736|5916608|P1|STARTED|Patient Quality of Care Assessments|915 unique patients were assessed at 9 hospitals at the initiation of the study.|2299
2412261|NCT01269736|5916607|P2|NOT COMPLETED|Nurses' Knowledge Assessments||0
2412262|NCT01269736|5916608|P1|NOT COMPLETED|Nurses' Knowledge Assessments||0
2412263|NCT01269736|5916607|P2|COMPLETED|Nurses' Knowledge Assessments|1428 unique nurses assessed overall (at any time point) by end of study.|1428
2412264|NCT01269736|5916608|P1|COMPLETED|Nurses' Knowledge Assessments|1585 unique nurses assessed overall (at any time point) by end of study.|1585
2412265|NCT01269736|5916607|P2|30 Months Assessment|Nurses' Knowledge Assessments|926 unique nurses, assessed at 8 hospitals.|926
2412266|NCT01269736|5916608|P1|30 Months Assessment|Nurses' Knowledge Assessments|741 unique nurses, assessed at 8 hospitals.|741
2412267|NCT01269736|5916607|P2|15 Months Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|782
2412268|NCT01269736|5916608|P1|15 Months Assessment|Nurses' Knowledge Assessments|1108 unique nurses, assessed at 9 hospitals.|1108
2412269|NCT01269736|5916607|P2|Baseline Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|866
2412270|NCT01269736|5916608|P1|Baseline Assessment|Nurses' Knowledge Assessments|873 unique nurses, assessed at 9 hospitals.|873
2412271|NCT01269736|5916607|P2|STARTED|Nurses' Knowledge Assessments|866 unique nurses were assessed at 8 hospitals at the initiation of the study.|1428
2412272|NCT01269736|5916608|P1|STARTED|Nurses' Knowledge Assessments|873 unique nurses were assessed at 9 hospitals at the initiation of the study.|1585
2412273|NCT01269710|5916620|P1|NOT COMPLETED|Overall Study||3
2412274|NCT01269710|5916620|P1|COMPLETED|Overall Study|This refers to Week 52.|1
2412275|NCT01269710|5916620|P1|Week 36|Overall Study||2
2412276|NCT01269710|5916620|P1|Week 12|Overall Study||3
2412277|NCT01269710|5916620|P1|STARTED|Overall Study||4
2412278|NCT01269346|5916628|P1|NOT COMPLETED|Extension Phase||43
2412279|NCT01269346|5916628|P1|COMPLETED|Extension Phase||0
2412280|NCT01269346|5916628|P1|STARTED|Extension Phase|Out of 52 participants randomized, only 43 continued into the Extension Phase of the study.|43
2412281|NCT01269346|5916628|P1|NOT COMPLETED|Treatment Phase||9
2412282|NCT01269346|5916628|P1|COMPLETED|Treatment Phase||43
2412283|NCT01269346|5916628|P1|Completed 6 Cycles|Treatment Phase||45
2412284|NCT01269346|5916628|P1|STARTED|Treatment Phase||52
2412285|NCT01269125|5916639|P3|NOT COMPLETED|Overall Study||0
2412286|NCT01269125|5916640|P2|NOT COMPLETED|Overall Study||5
2412287|NCT01269125|5916641|P1|NOT COMPLETED|Overall Study||7
2412288|NCT01269125|5916639|P3|COMPLETED|Overall Study||60
2412289|NCT01269125|5916640|P2|COMPLETED|Overall Study|OHSS:4; premature luteinization: 1|55
2412290|NCT01269125|5916641|P1|COMPLETED|Overall Study|lost to follow up:4; OHSS: 2; premature luteinization: 1|53
2412291|NCT01269125|5916639|P3|STARTED|Overall Study||60
2412292|NCT01269125|5916640|P2|STARTED|Overall Study||60
2412293|NCT01269125|5916641|P1|STARTED|Overall Study||60
2412294|NCT01269047|5916664|P3|NOT COMPLETED|Overall Study||1
2412295|NCT01269047|5916665|P2|NOT COMPLETED|Overall Study||2
2412296|NCT01269047|5916666|P1|NOT COMPLETED|Overall Study||1
2412297|NCT01269047|5916664|P3|COMPLETED|Overall Study||10
2412298|NCT01269047|5916665|P2|COMPLETED|Overall Study||11
2412299|NCT01269047|5916666|P1|COMPLETED|Overall Study||12
2412300|NCT01269047|5916664|P3|STARTED|Overall Study||11
2412301|NCT01269047|5916665|P2|STARTED|Overall Study||13
2412302|NCT01269047|5916666|P1|STARTED|Overall Study||13
2412303|NCT01268943|5916685|P4|NOT COMPLETED|Overall Study||0
2412304|NCT01268943|5916686|P3|NOT COMPLETED|Overall Study||0
2412305|NCT01268943|5916687|P2|NOT COMPLETED|Overall Study||0
2412306|NCT01268943|5916688|P1|NOT COMPLETED|Overall Study||0
2412307|NCT01268943|5916685|P4|COMPLETED|Overall Study||6
2412308|NCT01268943|5916686|P3|COMPLETED|Overall Study||3
2412309|NCT01268943|5916687|P2|COMPLETED|Overall Study||3
2412310|NCT01268943|5916688|P1|COMPLETED|Overall Study||6
2412311|NCT01268943|5916685|P4|STARTED|Overall Study||6
2412312|NCT01268943|5916686|P3|STARTED|Overall Study||3
2412313|NCT01268943|5916687|P2|STARTED|Overall Study||3
2412314|NCT01268943|5916688|P1|STARTED|Overall Study||6
2412315|NCT01268891|5916700|P2|NOT COMPLETED|Overall Study||8
2412316|NCT01268891|5916701|P1|NOT COMPLETED|Overall Study||8
2412317|NCT01268891|5916700|P2|COMPLETED|Overall Study||58
2412318|NCT01268891|5916701|P1|COMPLETED|Overall Study||58
2412319|NCT01268891|5916700|P2|STARTED|Overall Study||66
2412320|NCT01268891|5916701|P1|STARTED|Overall Study||66
2412321|NCT01268683|5916713|P1|NOT COMPLETED|Overall Study||0
2412322|NCT01268683|5916713|P1|COMPLETED|Overall Study||10
2412323|NCT01268683|5916713|P1|STARTED|Overall Study||10
2412324|NCT01268644|5916720|P1|NOT COMPLETED|Phase C (Weeks 20-24) Off Leptin Therapy||0
2412325|NCT01268644|5916720|P1|COMPLETED|Phase C (Weeks 20-24) Off Leptin Therapy||7
2412326|NCT01268644|5916720|P1|STARTED|Phase C (Weeks 20-24) Off Leptin Therapy||7
2412327|NCT01268644|5916720|P1|NOT COMPLETED|Phase B (Weeks 12-20) Leptin Therapy||0
2412328|NCT01268644|5916720|P1|COMPLETED|Phase B (Weeks 12-20) Leptin Therapy||7
2412329|NCT01268644|5916720|P1|STARTED|Phase B (Weeks 12-20) Leptin Therapy|One subject withdrew after 12 weeks .|7
2412330|NCT01268644|5916720|P1|NOT COMPLETED|Phase A (Weeks 0–12) Leptin Therapy||0
2412331|NCT01268644|5916720|P1|COMPLETED|Phase A (Weeks 0–12) Leptin Therapy||8
2412332|NCT01268644|5916720|P1|STARTED|Phase A (Weeks 0–12) Leptin Therapy||8
2412333|NCT01268644|5916720|P1|NOT COMPLETED|Baseline Period (Week 0)||0
2412334|NCT01268644|5916720|P1|COMPLETED|Baseline Period (Week 0)||8
2412335|NCT01268644|5916720|P1|STARTED|Baseline Period (Week 0)||8
2412336|NCT01268566|5916727|P1|NOT COMPLETED|Overall Study||43
2412337|NCT01268566|5916727|P1|COMPLETED|Overall Study||13
2412338|NCT01268566|5916727|P1|STARTED|Overall Study||56
2412339|NCT01268553|5916745|P1|NOT COMPLETED|Overall Study||0
2412340|NCT01268553|5916745|P1|COMPLETED|Overall Study||6
2412341|NCT01268553|5916745|P1|STARTED|Overall Study||6
2412342|NCT01268514|5916754|P1|NOT COMPLETED|Overall Study||41
2412343|NCT01268514|5916754|P1|COMPLETED|Overall Study||74
2412344|NCT01268514|5916754|P1|Participants Who Received the Device|Overall Study||114
2412345|NCT01268514|5916754|P1|STARTED|Overall Study||115
2412346|NCT01268501|5916763|P1|NOT COMPLETED|Overall Study||9
2412347|NCT01268501|5916763|P1|COMPLETED|Overall Study||87
2412348|NCT01268501|5916763|P1|STARTED|Overall Study||96
2412349|NCT01268488|5916767|P1|NOT COMPLETED|Overall Study||5
2412350|NCT01268488|5916767|P1|COMPLETED|Overall Study||93
2412351|NCT01268488|5916767|P1|STARTED|Overall Study||98
2412352|NCT01268306|5916774|P1|NOT COMPLETED|Overall Study||1
2412353|NCT01268306|5916774|P1|COMPLETED|Overall Study||7
2412354|NCT01268306|5916774|P1|STARTED|Overall Study||8
2412355|NCT01268293|5916778|P1|NOT COMPLETED|Overall Study||9
2412356|NCT01268293|5916778|P1|COMPLETED|Overall Study||0
2412357|NCT01268293|5916778|P1|Completed Cycle 1|Overall Study||9
2412358|NCT01268293|5916778|P1|STARTED|Overall Study||9
2412359|NCT01268267|5916783|P1|NOT COMPLETED|Overall Study||1
2412360|NCT01268267|5916783|P1|COMPLETED|Overall Study||93
2412361|NCT01268267|5916783|P1|STARTED|Overall Study||94
2412362|NCT01268189|5916790|P1|NOT COMPLETED|Overall Study||3
2412363|NCT01268189|5916790|P1|COMPLETED|Overall Study||17
2412364|NCT01268189|5916790|P1|STARTED|Overall Study||20
2412365|NCT01268150|5916804|P1|NOT COMPLETED|Extension Phase||27
2412366|NCT01268150|5916804|P1|COMPLETED|Extension Phase||1
2412367|NCT01268150|5916804|P1|Treatment Ongoing at Data Cutoff Date|Extension Phase||1
2412368|NCT01268150|5916804|P1|STARTED|Extension Phase|28 participants discontinued study drug in Treatment Phase so did not enter the Extension Phase|28
2412369|NCT01268150|5916804|P1|NOT COMPLETED|Treatment Phase||28
2412370|NCT01268150|5916804|P1|COMPLETED|Treatment Phase||28
2412371|NCT01268150|5916804|P1|STARTED|Treatment Phase||56
2412372|NCT01268111|5916814|P2|NOT COMPLETED|Overall Study||0
2412373|NCT01268111|5916815|P1|NOT COMPLETED|Overall Study||0
2412374|NCT01268111|5916814|P2|COMPLETED|Overall Study||6
2412375|NCT01268111|5916815|P1|COMPLETED|Overall Study||6
2412376|NCT01268111|5916814|P2|STARTED|Overall Study||6
2412377|NCT01268111|5916815|P1|STARTED|Overall Study||6
2412378|NCT01268098|5916823|P2|NOT COMPLETED|Overall Study||0
2412379|NCT01268098|5916824|P1|NOT COMPLETED|Overall Study||1
2412380|NCT01268098|5916823|P2|COMPLETED|Overall Study||23
2412381|NCT01268098|5916824|P1|COMPLETED|Overall Study||18
2412382|NCT01268098|5916823|P2|STARTED|Overall Study||23
2412383|NCT01268098|5916824|P1|STARTED|Overall Study||19
2412384|NCT01268046|5916836|P4|NOT COMPLETED|Overall Study||1
2412385|NCT01268046|5916837|P3|NOT COMPLETED|Overall Study||1
2412386|NCT01268046|5916838|P2|NOT COMPLETED|Overall Study||0
2412387|NCT01268046|5916839|P1|NOT COMPLETED|Overall Study||1
2412388|NCT01268046|5916836|P4|COMPLETED|Overall Study||7
2412389|NCT01268046|5916837|P3|COMPLETED|Overall Study||7
2412390|NCT01268046|5916838|P2|COMPLETED|Overall Study||9
2412391|NCT01268046|5916839|P1|COMPLETED|Overall Study||12
2412392|NCT01268046|5916836|P4|STARTED|Overall Study||8
2412393|NCT01268046|5916837|P3|STARTED|Overall Study||8
2412394|NCT01268046|5916838|P2|STARTED|Overall Study||9
2412395|NCT01268046|5916839|P1|STARTED|Overall Study||13
2412396|NCT01267994|5916849|P1|NOT COMPLETED|Overall Study||2
2412397|NCT01267994|5916849|P1|COMPLETED|Overall Study|Excluded from analysis, could not reach first milestone (day 28) for efficacy assessment, n=2|10
2412398|NCT01267994|5916849|P1|STARTED|Overall Study|Declined to participate. n=1 Did not receive intervention due to infeciton, n=1|12
2412399|NCT01267955|5916854|P1|NOT COMPLETED|Stage 2 (6 Months)||6
2412400|NCT01267955|5916854|P1|COMPLETED|Stage 2 (6 Months)||39
2412401|NCT01267955|5916854|P1|STARTED|Stage 2 (6 Months)||45
2412402|NCT01267955|5916854|P1|NOT COMPLETED|Stage 1 (6 Months)||3
2412403|NCT01267955|5916854|P1|COMPLETED|Stage 1 (6 Months)||17
2412404|NCT01267955|5916854|P1|STARTED|Stage 1 (6 Months)||20
2412405|NCT01267929|5916860|P2|NOT COMPLETED|Overall Study||0
2412406|NCT01267929|5916861|P1|NOT COMPLETED|Overall Study||0
2412407|NCT01267929|5916860|P2|COMPLETED|Overall Study||15
2412408|NCT01267929|5916861|P1|COMPLETED|Overall Study||15
2412409|NCT01267929|5916860|P2|STARTED|Overall Study||15
2412410|NCT01267929|5916861|P1|STARTED|Overall Study||15
2412411|NCT01267864|5916870|P3|NOT COMPLETED|Overall Study||0
2412412|NCT01267864|5916871|P2|NOT COMPLETED|Overall Study||0
2412413|NCT01267864|5916872|P1|NOT COMPLETED|Overall Study||0
2412414|NCT01267864|5916870|P3|COMPLETED|Overall Study||110
2412415|NCT01267864|5916871|P2|COMPLETED|Overall Study||110
2412416|NCT01267864|5916872|P1|COMPLETED|Overall Study||110
2412417|NCT01267864|5916870|P3|STARTED|Overall Study||110
2412418|NCT01267864|5916871|P2|STARTED|Overall Study||110
2412419|NCT01267864|5916872|P1|STARTED|Overall Study||110
2412420|NCT01267825|5916891|P2|NOT COMPLETED|Overall Study||0
2412421|NCT01267825|5916892|P1|NOT COMPLETED|Overall Study||1
2412422|NCT01267825|5916891|P2|COMPLETED|Overall Study||0
2412423|NCT01267825|5916892|P1|COMPLETED|Overall Study||0
2412424|NCT01267825|5916891|P2|STARTED|Overall Study||0
2412425|NCT01267825|5916892|P1|STARTED|Overall Study||1
2412426|NCT01267422|5916902|P2|NOT COMPLETED|Safety and Efficacy Study||0
2412427|NCT01267422|5916903|P1|NOT COMPLETED|Safety and Efficacy Study||0
2412428|NCT01267422|5916902|P2|COMPLETED|Safety and Efficacy Study||4
2412429|NCT01267422|5916903|P1|COMPLETED|Safety and Efficacy Study||5
2412430|NCT01267422|5916902|P2|STARTED|Safety and Efficacy Study||4
2412431|NCT01267422|5916903|P1|STARTED|Safety and Efficacy Study||5
2412432|NCT01267422|5916902|P2|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
2412433|NCT01267422|5916903|P1|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
2412434|NCT01267422|5916902|P2|COMPLETED|Intravitreal rAAV2-ND4 Injection||4
2412435|NCT01267422|5916903|P1|COMPLETED|Intravitreal rAAV2-ND4 Injection||5
2412436|NCT01267422|5916902|P2|STARTED|Intravitreal rAAV2-ND4 Injection||4
2412437|NCT01267422|5916903|P1|STARTED|Intravitreal rAAV2-ND4 Injection||5
2412438|NCT01267292|5916923|P2|NOT COMPLETED|Overall Study||6
2412439|NCT01267292|5916924|P1|NOT COMPLETED|Overall Study||4
2412440|NCT01267292|5916923|P2|COMPLETED|Overall Study||20
2412441|NCT01267292|5916924|P1|COMPLETED|Overall Study||20
2412442|NCT01267292|5916923|P2|STARTED|Overall Study||26
2412443|NCT01267292|5916924|P1|STARTED|Overall Study||24
2412444|NCT01267279|5916960|P2|NOT COMPLETED|Overall Study||6
2412445|NCT01267279|5916961|P1|NOT COMPLETED|Overall Study||2
2412446|NCT01267279|5916960|P2|COMPLETED|Overall Study||21
2412447|NCT01267279|5916961|P1|COMPLETED|Overall Study||22
2412448|NCT01267279|5916960|P2|STARTED|Overall Study||27
2412449|NCT01267279|5916961|P1|STARTED|Overall Study||24
2412450|NCT01267266|5916967|P2|NOT COMPLETED|Randomized Phase||0
2412451|NCT01267266|5916968|P1|NOT COMPLETED|Randomized Phase||0
2412452|NCT01267266|5916967|P2|COMPLETED|Randomized Phase||5
2412453|NCT01267266|5916968|P1|COMPLETED|Randomized Phase||3
2412454|NCT01267266|5916967|P2|STARTED|Randomized Phase|5 of 8 patients randomized to placebo.|5
2412455|NCT01267266|5916968|P1|STARTED|Randomized Phase|3 of 8 patients randomized to saracatinib.|3
2412456|NCT01267266|5916967|P2|NOT COMPLETED|Lead-in Phase||0
2412457|NCT01267266|5916968|P1|NOT COMPLETED|Lead-in Phase||23
2412458|NCT01267266|5916967|P2|COMPLETED|Lead-in Phase||0
2412459|NCT01267266|5916968|P1|COMPLETED|Lead-in Phase|12 patients had radiographic progression, 8 clinical progression, 2 toxicity, 1 withdrawal.|8
2412460|NCT01267266|5916967|P2|STARTED|Lead-in Phase||0
2412461|NCT01267266|5916968|P1|STARTED|Lead-in Phase||31
2412462|NCT01267266|5916967|P2|NOT COMPLETED|Enrollment Phase||0
2412463|NCT01267266|5916968|P1|NOT COMPLETED|Enrollment Phase||2
2412464|NCT01267266|5916967|P2|COMPLETED|Enrollment Phase||0
2412465|NCT01267266|5916968|P1|COMPLETED|Enrollment Phase|Two patients signed consent but did not proceed to treatment.|31
2412466|NCT01267266|5916967|P2|STARTED|Enrollment Phase||0
2412467|NCT01267266|5916968|P1|STARTED|Enrollment Phase||33
2412468|NCT01267253|5916981|P1|NOT COMPLETED|Overall Study||3
2412469|NCT01267253|5916981|P1|COMPLETED|Overall Study|Eligible and treated patients|28
2412470|NCT01267253|5916981|P1|STARTED|Overall Study||31
2412471|NCT01267240|5916989|P1|NOT COMPLETED|Overall Study||0
2412472|NCT01267240|5916989|P1|COMPLETED|Overall Study||25
2412473|NCT01267240|5916989|P1|STARTED|Overall Study||25
2412474|NCT01267227|5916999|P4|NOT COMPLETED|Overall Study||3
2412475|NCT01267227|5917000|P3|NOT COMPLETED|Overall Study||2
2412476|NCT01267227|5917001|P2|NOT COMPLETED|Overall Study||1
2412477|NCT01267227|5917002|P1|NOT COMPLETED|Overall Study||1
2412478|NCT01267227|5916999|P4|COMPLETED|Overall Study||17
2412479|NCT01267227|5917000|P3|COMPLETED|Overall Study||18
2412480|NCT01267227|5917001|P2|COMPLETED|Overall Study||19
2412481|NCT01267227|5917002|P1|COMPLETED|Overall Study||19
2412482|NCT01267227|5916999|P4|STARTED|Overall Study||20
2412483|NCT01267227|5917000|P3|STARTED|Overall Study||20
2412484|NCT01267227|5917001|P2|STARTED|Overall Study||20
2412485|NCT01267227|5917002|P1|STARTED|Overall Study||20
2412486|NCT01267201|5917020|P6|NOT COMPLETED|Third Intervention Period||0
2412487|NCT01267201|5917021|P5|NOT COMPLETED|Third Intervention Period||0
2412488|NCT01267201|5917022|P4|NOT COMPLETED|Third Intervention Period||0
2412489|NCT01267201|5917023|P3|NOT COMPLETED|Third Intervention Period||0
2412490|NCT01267201|5917024|P2|NOT COMPLETED|Third Intervention Period||0
2412491|NCT01267201|5917025|P1|NOT COMPLETED|Third Intervention Period||0
2412492|NCT01267201|5917020|P6|COMPLETED|Third Intervention Period||4
2412493|NCT01267201|5917021|P5|COMPLETED|Third Intervention Period||4
2412494|NCT01267201|5917022|P4|COMPLETED|Third Intervention Period||4
2412495|NCT01267201|5917023|P3|COMPLETED|Third Intervention Period||4
2412496|NCT01267201|5917024|P2|COMPLETED|Third Intervention Period||3
2412497|NCT01267201|5917025|P1|COMPLETED|Third Intervention Period||3
2412498|NCT01267201|5917020|P6|STARTED|Third Intervention Period||4
2412499|NCT01267201|5917021|P5|STARTED|Third Intervention Period||4
2412500|NCT01267201|5917022|P4|STARTED|Third Intervention Period||4
2412501|NCT01267201|5917023|P3|STARTED|Third Intervention Period||4
2412502|NCT01267201|5917024|P2|STARTED|Third Intervention Period||3
2412503|NCT01267201|5917025|P1|STARTED|Third Intervention Period||3
2412504|NCT01267201|5917020|P6|NOT COMPLETED|Washout Period (At Least 2 Days)||0
2412505|NCT01267201|5917021|P5|NOT COMPLETED|Washout Period (At Least 2 Days)||0
2412506|NCT01267201|5917022|P4|NOT COMPLETED|Washout Period (At Least 2 Days)||0
2412507|NCT01267201|5917023|P3|NOT COMPLETED|Washout Period (At Least 2 Days)||0
2412508|NCT01267201|5917024|P2|NOT COMPLETED|Washout Period (At Least 2 Days)||0
2412509|NCT01267201|5917025|P1|NOT COMPLETED|Washout Period (At Least 2 Days)||0
2412510|NCT01267201|5917020|P6|COMPLETED|Washout Period (At Least 2 Days)||4
2412511|NCT01267201|5917021|P5|COMPLETED|Washout Period (At Least 2 Days)||4
2412512|NCT01267201|5917022|P4|COMPLETED|Washout Period (At Least 2 Days)||4
2412513|NCT01267201|5917023|P3|COMPLETED|Washout Period (At Least 2 Days)||4
2412514|NCT01267201|5917024|P2|COMPLETED|Washout Period (At Least 2 Days)||3
2412515|NCT01267201|5917025|P1|COMPLETED|Washout Period (At Least 2 Days)||3
2412516|NCT01267201|5917020|P6|STARTED|Washout Period (At Least 2 Days)||4
2412517|NCT01267201|5917021|P5|STARTED|Washout Period (At Least 2 Days)||4
2412518|NCT01267201|5917022|P4|STARTED|Washout Period (At Least 2 Days)||4
2412519|NCT01267201|5917023|P3|STARTED|Washout Period (At Least 2 Days)||4
2412520|NCT01267201|5917024|P2|STARTED|Washout Period (At Least 2 Days)||3
2412521|NCT01267201|5917025|P1|STARTED|Washout Period (At Least 2 Days)||3
2412522|NCT01267201|5917020|P6|NOT COMPLETED|Second Intervention Period||0
2412523|NCT01267201|5917021|P5|NOT COMPLETED|Second Intervention Period||0
2412524|NCT01267201|5917022|P4|NOT COMPLETED|Second Intervention Period||0
2412525|NCT01267201|5917023|P3|NOT COMPLETED|Second Intervention Period||0
2412526|NCT01267201|5917024|P2|NOT COMPLETED|Second Intervention Period||1
2412527|NCT01267201|5917025|P1|NOT COMPLETED|Second Intervention Period||0
2412528|NCT01267201|5917020|P6|COMPLETED|Second Intervention Period||4
2412529|NCT01267201|5917021|P5|COMPLETED|Second Intervention Period||4
2412530|NCT01267201|5917022|P4|COMPLETED|Second Intervention Period||4
2412531|NCT01267201|5917023|P3|COMPLETED|Second Intervention Period||4
2412532|NCT01267201|5917024|P2|COMPLETED|Second Intervention Period||3
2412533|NCT01267201|5917025|P1|COMPLETED|Second Intervention Period||3
2412534|NCT01267201|5917020|P6|STARTED|Second Intervention Period||4
2412535|NCT01267201|5917021|P5|STARTED|Second Intervention Period||4
2412536|NCT01267201|5917022|P4|STARTED|Second Intervention Period||4
2412537|NCT01267201|5917023|P3|STARTED|Second Intervention Period||4
2412538|NCT01267201|5917024|P2|STARTED|Second Intervention Period||4
2412539|NCT01267201|5917025|P1|STARTED|Second Intervention Period||3
2412540|NCT01267201|5917020|P6|NOT COMPLETED|Washout Period (At Least 2 Days)||0
2412541|NCT01267201|5917021|P5|NOT COMPLETED|Washout Period (At Least 2 Days)||0
2412542|NCT01267201|5917022|P4|NOT COMPLETED|Washout Period (At Least 2 Days)||0
2412543|NCT01267201|5917023|P3|NOT COMPLETED|Washout Period (At Least 2 Days)||0
2412544|NCT01267201|5917024|P2|NOT COMPLETED|Washout Period (At Least 2 Days)||0
2412545|NCT01267201|5917025|P1|NOT COMPLETED|Washout Period (At Least 2 Days)||0
2412546|NCT01267201|5917020|P6|COMPLETED|Washout Period (At Least 2 Days)||4
2412547|NCT01267201|5917021|P5|COMPLETED|Washout Period (At Least 2 Days)||4
2412548|NCT01267201|5917022|P4|COMPLETED|Washout Period (At Least 2 Days)||4
2412549|NCT01267201|5917023|P3|COMPLETED|Washout Period (At Least 2 Days)||4
2412550|NCT01267201|5917024|P2|COMPLETED|Washout Period (At Least 2 Days)||4
2412551|NCT01267201|5917025|P1|COMPLETED|Washout Period (At Least 2 Days)||3
2412552|NCT01267201|5917020|P6|STARTED|Washout Period (At Least 2 Days)||4
2412553|NCT01267201|5917021|P5|STARTED|Washout Period (At Least 2 Days)||4
2412554|NCT01267201|5917022|P4|STARTED|Washout Period (At Least 2 Days)||4
2412555|NCT01267201|5917023|P3|STARTED|Washout Period (At Least 2 Days)||4
2412556|NCT01267201|5917024|P2|STARTED|Washout Period (At Least 2 Days)||4
2412557|NCT01267201|5917025|P1|STARTED|Washout Period (At Least 2 Days)||3
2412558|NCT01267201|5917020|P6|NOT COMPLETED|First Intervention Period||0
2412559|NCT01267201|5917021|P5|NOT COMPLETED|First Intervention Period||0
2412560|NCT01267201|5917022|P4|NOT COMPLETED|First Intervention Period||0
2412561|NCT01267201|5917023|P3|NOT COMPLETED|First Intervention Period||0
2412562|NCT01267201|5917024|P2|NOT COMPLETED|First Intervention Period||0
2412563|NCT01267201|5917025|P1|NOT COMPLETED|First Intervention Period||1
2412564|NCT01267201|5917020|P6|COMPLETED|First Intervention Period||4
2412565|NCT01267201|5917021|P5|COMPLETED|First Intervention Period||4
2412566|NCT01267201|5917022|P4|COMPLETED|First Intervention Period||4
2412567|NCT01267201|5917023|P3|COMPLETED|First Intervention Period||4
2412568|NCT01267201|5917024|P2|COMPLETED|First Intervention Period||4
2412569|NCT01267201|5917025|P1|COMPLETED|First Intervention Period||3
2412570|NCT01267201|5917020|P6|STARTED|First Intervention Period||4
2412571|NCT01267201|5917021|P5|STARTED|First Intervention Period||4
2412572|NCT01267201|5917022|P4|STARTED|First Intervention Period||4
2412573|NCT01267201|5917023|P3|STARTED|First Intervention Period||4
2412574|NCT01267201|5917024|P2|STARTED|First Intervention Period||4
2412575|NCT01267201|5917025|P1|STARTED|First Intervention Period||4
2412576|NCT01267175|5917042|P1|NOT COMPLETED|Overall Study||2
2412577|NCT01267175|5917042|P1|COMPLETED|Overall Study||29
2412578|NCT01267175|5917042|P1|STARTED|Overall Study||31
2412579|NCT01267136|5917049|P2|NOT COMPLETED|Overall Study||6
2412580|NCT01267136|5917050|P1|NOT COMPLETED|Overall Study||4
2412581|NCT01267136|5917049|P2|COMPLETED|Overall Study||36
2412582|NCT01267136|5917050|P1|COMPLETED|Overall Study||38
2412583|NCT01267136|5917049|P2|STARTED|Overall Study||42
2412584|NCT01267136|5917050|P1|STARTED|Overall Study||42
2412585|NCT01267045|5917060|P2|NOT COMPLETED|6-month Outcome||3
2412586|NCT01267045|5917061|P1|NOT COMPLETED|6-month Outcome||0
2412587|NCT01267045|5917060|P2|COMPLETED|6-month Outcome||23
2412588|NCT01267045|5917061|P1|COMPLETED|6-month Outcome||22
2412589|NCT01267045|5917060|P2|STARTED|6-month Outcome||26
2412590|NCT01267045|5917061|P1|STARTED|6-month Outcome||22
2412591|NCT01267045|5917060|P2|NOT COMPLETED|2-month Outcomes||3
2412592|NCT01267045|5917061|P1|NOT COMPLETED|2-month Outcomes||4
2412593|NCT01267045|5917060|P2|COMPLETED|2-month Outcomes||26
2412594|NCT01267045|5917061|P1|COMPLETED|2-month Outcomes||22
2412595|NCT01267045|5917060|P2|STARTED|2-month Outcomes||29
2412596|NCT01267045|5917061|P1|STARTED|2-month Outcomes||26
2412597|NCT01267019|5917096|P3|NOT COMPLETED|Overall Study||6
2412598|NCT01267019|5917097|P2|NOT COMPLETED|Overall Study||6
2412599|NCT01267019|5917098|P1|NOT COMPLETED|Overall Study||6
2412600|NCT01267019|5917096|P3|COMPLETED|Overall Study||47
2412601|NCT01267019|5917097|P2|COMPLETED|Overall Study||47
2412602|NCT01267019|5917098|P1|COMPLETED|Overall Study||41
2412603|NCT01267019|5917096|P3|STARTED|Overall Study||53
2412604|NCT01267019|5917097|P2|STARTED|Overall Study||53
2412605|NCT01267019|5917098|P1|STARTED|Overall Study||47
2412606|NCT01266993|5917114|P2|NOT COMPLETED|Booster Phase (Month 69)||2
2412607|NCT01266993|5917115|P1|NOT COMPLETED|Booster Phase (Month 69)||5
2412608|NCT01266993|5917114|P2|COMPLETED|Booster Phase (Month 69)||60
2412609|NCT01266993|5917115|P1|COMPLETED|Booster Phase (Month 69)||174
2412610|NCT01266993|5917114|P2|STARTED|Booster Phase (Month 69)||62
2412611|NCT01266993|5917115|P1|STARTED|Booster Phase (Month 69)||179
2412612|NCT01266993|5917114|P2|NOT COMPLETED|Persistence Phase (Month 68)||0
2412613|NCT01266993|5917115|P1|NOT COMPLETED|Persistence Phase (Month 68)||0
2412614|NCT01266993|5917114|P2|COMPLETED|Persistence Phase (Month 68)||62
2412615|NCT01266993|5917115|P1|COMPLETED|Persistence Phase (Month 68)||179
2412616|NCT01266993|5917114|P2|STARTED|Persistence Phase (Month 68)||62
2412617|NCT01266993|5917115|P1|STARTED|Persistence Phase (Month 68)||179
2412618|NCT01266993|5917114|P2|NOT COMPLETED|Persistence Phase (Month 56)||0
2412619|NCT01266993|5917115|P1|NOT COMPLETED|Persistence Phase (Month 56)||0
2412620|NCT01266993|5917114|P2|COMPLETED|Persistence Phase (Month 56)||67
2412621|NCT01266993|5917115|P1|COMPLETED|Persistence Phase (Month 56)||193
2412622|NCT01266993|5917114|P2|STARTED|Persistence Phase (Month 56)||67
2412623|NCT01266993|5917115|P1|STARTED|Persistence Phase (Month 56)||193
2412624|NCT01266993|5917114|P2|NOT COMPLETED|Persistence Phase (Month 44)||0
2412625|NCT01266993|5917115|P1|NOT COMPLETED|Persistence Phase (Month 44)||0
2412626|NCT01266993|5917114|P2|COMPLETED|Persistence Phase (Month 44)||68
2412627|NCT01266993|5917115|P1|COMPLETED|Persistence Phase (Month 44)||193
2412628|NCT01266993|5917114|P2|STARTED|Persistence Phase (Month 44)||68
2412629|NCT01266993|5917115|P1|STARTED|Persistence Phase (Month 44)||193
2412630|NCT01266993|5917114|P2|NOT COMPLETED|Persistence Phase (Month 32)||0
2412631|NCT01266993|5917115|P1|NOT COMPLETED|Persistence Phase (Month 32)||0
2412632|NCT01266993|5917114|P2|COMPLETED|Persistence Phase (Month 32)||72
2412633|NCT01266993|5917115|P1|COMPLETED|Persistence Phase (Month 32)||199
2412634|NCT01266993|5917114|P2|STARTED|Persistence Phase (Month 32)||72
2412635|NCT01266993|5917115|P1|STARTED|Persistence Phase (Month 32)||199
2412636|NCT01266967|5917185|P2|NOT COMPLETED|Overall Study||83
2412637|NCT01266967|5917186|P1|NOT COMPLETED|Overall Study||89
2412638|NCT01266967|5917185|P2|COMPLETED|Overall Study||0
2412639|NCT01266967|5917186|P1|COMPLETED|Overall Study||0
2412640|NCT01266967|5917185|P2|STARTED|Overall Study||83
2412641|NCT01266967|5917186|P1|STARTED|Overall Study||89
2412642|NCT01266876|5917238|P5|NOT COMPLETED|Overall Study||0
2412643|NCT01266876|5917239|P4|NOT COMPLETED|Overall Study||1
2412644|NCT01266876|5917240|P3|NOT COMPLETED|Overall Study||0
2412645|NCT01266876|5917241|P2|NOT COMPLETED|Overall Study||0
2412646|NCT01266876|5917242|P1|NOT COMPLETED|Overall Study||0
2412647|NCT01266876|5917238|P5|COMPLETED|Overall Study||16
2412648|NCT01266876|5917239|P4|COMPLETED|Overall Study||14
2412649|NCT01266876|5917240|P3|COMPLETED|Overall Study||16
2412650|NCT01266876|5917241|P2|COMPLETED|Overall Study||15
2412651|NCT01266876|5917242|P1|COMPLETED|Overall Study||15
2412652|NCT01266876|5917238|P5|STARTED|Overall Study||16
2412653|NCT01266876|5917239|P4|STARTED|Overall Study||15
2412654|NCT01266876|5917240|P3|STARTED|Overall Study||16
2412655|NCT01266876|5917241|P2|STARTED|Overall Study||15
2412656|NCT01266876|5917242|P1|STARTED|Overall Study||15
2412657|NCT01266850|5917349|P5|NOT COMPLETED|Overall Study||30
2412658|NCT01266850|5917350|P4|NOT COMPLETED|Overall Study||28
2412659|NCT01266850|5917351|P3|NOT COMPLETED|Overall Study||24
2412660|NCT01266850|5917352|P2|NOT COMPLETED|Overall Study||36
2412661|NCT01266850|5917353|P1|NOT COMPLETED|Overall Study||30
2412662|NCT01266850|5917349|P5|COMPLETED|Overall Study||297
2412663|NCT01266850|5917350|P4|COMPLETED|Overall Study||301
2412664|NCT01266850|5917351|P3|COMPLETED|Overall Study||214
2412665|NCT01266850|5917352|P2|COMPLETED|Overall Study||212
2412666|NCT01266850|5917353|P1|COMPLETED|Overall Study||212
2412667|NCT01266850|5917349|P5|Received Third Vaccine|Overall Study||299
2412668|NCT01266850|5917350|P4|Received Third Vaccine|Overall Study||0
2412669|NCT01266850|5917351|P3|Received Third Vaccine|Overall Study||217
2412670|NCT01266850|5917352|P2|Received Third Vaccine|Overall Study||221
2412671|NCT01266850|5917353|P1|Received Third Vaccine|Overall Study||221
2412672|NCT01266850|5917349|P5|Received Second Vaccine|Overall Study||307
2412673|NCT01266850|5917350|P4|Received Second Vaccine|Overall Study||311
2412674|NCT01266850|5917351|P3|Received Second Vaccine|Overall Study||227
2412675|NCT01266850|5917352|P2|Received Second Vaccine|Overall Study||233
2412676|NCT01266850|5917353|P1|Received Second Vaccine|Overall Study||231
2412677|NCT01266850|5917349|P5|STARTED|Overall Study||327
2412678|NCT01266850|5917350|P4|STARTED|Overall Study||329
2412679|NCT01266850|5917351|P3|STARTED|Overall Study||238
2412680|NCT01266850|5917352|P2|STARTED|Overall Study||248
2412681|NCT01266850|5917353|P1|STARTED|Overall Study||242
2412682|NCT01266824|5917407|P2|NOT COMPLETED|Overall Study||3
2412683|NCT01266824|5917408|P1|NOT COMPLETED|Overall Study||2
2412684|NCT01266824|5917407|P2|COMPLETED|Overall Study||0
2412685|NCT01266824|5917408|P1|COMPLETED|Overall Study||0
2412686|NCT01266824|5917407|P2|STARTED|Overall Study||3
2412687|NCT01266824|5917408|P1|STARTED|Overall Study||2
2412696|NCT01266590|5917426|P1|NOT COMPLETED|Overall Study||6
2412697|NCT01266590|5917426|P1|COMPLETED|Overall Study||24
2412698|NCT01266590|5917426|P1|STARTED|Overall Study||30
2412699|NCT01266447|5917437|P1|NOT COMPLETED|Overall Study||0
2412700|NCT01266447|5917437|P1|COMPLETED|Overall Study|Eligible and treated patients|27
2412701|NCT01266447|5917437|P1|STARTED|Overall Study||27
2412702|NCT01266317|5917446|P1|NOT COMPLETED|Overall Study||2
2412703|NCT01266317|5917446|P1|COMPLETED|Overall Study||7
2412704|NCT01266317|5917446|P1|STARTED|Overall Study|One additional patient was a protocol violation post consent when autoantibodies returned positive|9
2412705|NCT01266291|5917451|P1|NOT COMPLETED|Overall Study||1
2412706|NCT01266291|5917451|P1|COMPLETED|Overall Study||0
2412707|NCT01266291|5917451|P1|STARTED|Overall Study||1
2412708|NCT01266265|5917458|P2|NOT COMPLETED|Overall Study||190
2412709|NCT01266265|5917459|P1|NOT COMPLETED|Overall Study||205
2412710|NCT01266265|5917458|P2|COMPLETED|Overall Study||477
2412711|NCT01266265|5917459|P1|COMPLETED|Overall Study||461
2412712|NCT01266265|5917458|P2|STARTED|Overall Study||667
2412713|NCT01266265|5917459|P1|STARTED|Overall Study||666
2412714|NCT01266161|5917467|P2|NOT COMPLETED|Overall Study||1
2412715|NCT01266161|5917468|P1|NOT COMPLETED|Overall Study||4
2412716|NCT01266161|5917467|P2|COMPLETED|Overall Study||53
2412717|NCT01266161|5917468|P1|COMPLETED|Overall Study||48
2412718|NCT01266161|5917467|P2|STARTED|Overall Study||54
2412719|NCT01266161|5917468|P1|STARTED|Overall Study||52
2412720|NCT01266148|5917500|P2|NOT COMPLETED|Overall Study||3
2412721|NCT01266148|5917501|P1|NOT COMPLETED|Overall Study||7
2412722|NCT01266148|5917500|P2|COMPLETED|Overall Study||56
2412723|NCT01266148|5917501|P1|COMPLETED|Overall Study||49
2412724|NCT01266148|5917500|P2|STARTED|Overall Study||59
2412725|NCT01266148|5917501|P1|STARTED|Overall Study||56
2412726|NCT01266122|5917529|P2|NOT COMPLETED|Overall Study||6
2412727|NCT01266122|5917530|P1|NOT COMPLETED|Overall Study||6
2412728|NCT01266122|5917529|P2|COMPLETED|Overall Study||42
2412729|NCT01266122|5917530|P1|COMPLETED|Overall Study||42
2412730|NCT01266122|5917529|P2|STARTED|Overall Study||48
2412731|NCT01266122|5917530|P1|STARTED|Overall Study||48
2412732|NCT01266070|5917538|P1|NOT COMPLETED|Overall Study||4
2412733|NCT01266070|5917538|P1|COMPLETED|Overall Study||2
2412734|NCT01266070|5917538|P1|STARTED|Overall Study||6
2412735|NCT01266031|5917546|P3|NOT COMPLETED|Overall Study||2
2412736|NCT01266031|5917547|P2|NOT COMPLETED|Overall Study||3
2412737|NCT01266031|5917548|P1|NOT COMPLETED|Overall Study||0
2412738|NCT01266031|5917546|P3|COMPLETED|Overall Study||47
2412739|NCT01266031|5917547|P2|COMPLETED|Overall Study||38
2412740|NCT01266031|5917548|P1|COMPLETED|Overall Study||6
2412741|NCT01266031|5917546|P3|STARTED|Overall Study||49
2412742|NCT01266031|5917547|P2|STARTED|Overall Study||41
2412743|NCT01266031|5917548|P1|STARTED|Overall Study||6
2412744|NCT01266018|5917575|P2|NOT COMPLETED|Overall Study||1
2412745|NCT01266018|5917576|P1|NOT COMPLETED|Overall Study||1
2412746|NCT01266018|5917575|P2|COMPLETED|Overall Study||12
2412747|NCT01266018|5917576|P1|COMPLETED|Overall Study|Defined as evaluable for the primary endpoint|8
2412748|NCT01266018|5917575|P2|STARTED|Overall Study||13
2412749|NCT01266018|5917576|P1|STARTED|Overall Study||9
2412750|NCT01265992|5917587|P1|NOT COMPLETED|Overall Study||9
2412751|NCT01265992|5917587|P1|COMPLETED|Overall Study||41
2412752|NCT01265992|5917587|P1|Received Treatment|Overall Study||49
2412753|NCT01265992|5917587|P1|STARTED|Overall Study||50
2412754|NCT01265966|5917603|P3|NOT COMPLETED|Overall Study||2
2412755|NCT01265966|5917604|P2|NOT COMPLETED|Overall Study||2
2412756|NCT01265966|5917605|P1|NOT COMPLETED|Overall Study||3
2412757|NCT01265966|5917603|P3|COMPLETED|Overall Study||27
2412758|NCT01265966|5917604|P2|COMPLETED|Overall Study||39
2412759|NCT01265966|5917605|P1|COMPLETED|Overall Study||44
2412760|NCT01265966|5917603|P3|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
2412761|NCT01265966|5917604|P2|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
2412762|NCT01265966|5917605|P1|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|3
2412763|NCT01265966|5917603|P3|STARTED|Overall Study||29
2412764|NCT01265966|5917604|P2|STARTED|Overall Study||41
2412765|NCT01265966|5917605|P1|STARTED|Overall Study||47
2412766|NCT01265953|5917615|P2|NOT COMPLETED|Overall Study||3
2412767|NCT01265953|5917616|P1|NOT COMPLETED|Overall Study||5
2412768|NCT01265953|5917615|P2|COMPLETED|Overall Study||45
2412769|NCT01265953|5917616|P1|COMPLETED|Overall Study||45
2412770|NCT01265953|5917615|P2|STARTED|Overall Study||48
2412771|NCT01265953|5917616|P1|STARTED|Overall Study||50
2412772|NCT01265875|5917628|P1|NOT COMPLETED|Overall Study||1
2412773|NCT01265875|5917628|P1|COMPLETED|Overall Study||11
2412774|NCT01265875|5917628|P1|STARTED|Overall Study||12
2412775|NCT01265823|5917636|P1|NOT COMPLETED|Overall Study||7
2412776|NCT01265823|5917636|P1|COMPLETED|Overall Study||143
2412777|NCT01265823|5917636|P1|STARTED|Overall Study||150
2412778|NCT01265797|5917665|P2|NOT COMPLETED|Open Label Month||1
2412779|NCT01265797|5917666|P1|NOT COMPLETED|Open Label Month||0
2412780|NCT01265797|5917665|P2|COMPLETED|Open Label Month||26
2412781|NCT01265797|5917666|P1|COMPLETED|Open Label Month||24
2412782|NCT01265797|5917665|P2|STARTED|Open Label Month||27
2412783|NCT01265797|5917666|P1|STARTED|Open Label Month||24
2412784|NCT01265797|5917665|P2|NOT COMPLETED|Blinded Month||2
2412785|NCT01265797|5917666|P1|NOT COMPLETED|Blinded Month||10
2412786|NCT01265797|5917665|P2|COMPLETED|Blinded Month||27
2412787|NCT01265797|5917666|P1|COMPLETED|Blinded Month||24
2412788|NCT01265797|5917665|P2|STARTED|Blinded Month||29
2412789|NCT01265797|5917666|P1|STARTED|Blinded Month||34
2412790|NCT01265797|5917665|P2|NOT COMPLETED|Run-in Month||5
2412791|NCT01265797|5917666|P1|NOT COMPLETED|Run-in Month||0
2412792|NCT01265797|5917665|P2|COMPLETED|Run-in Month||29
2412793|NCT01265797|5917666|P1|COMPLETED|Run-in Month||34
2412794|NCT01265797|5917665|P2|STARTED|Run-in Month||34
2412795|NCT01265797|5917666|P1|STARTED|Run-in Month||34
2412796|NCT01265784|5917697|P3|NOT COMPLETED|Overall Study||4
2412797|NCT01265784|5917698|P2|NOT COMPLETED|Overall Study||8
2412798|NCT01265784|5917699|P1|NOT COMPLETED|Overall Study||12
2412799|NCT01265784|5917697|P3|COMPLETED|Overall Study||26
2412800|NCT01265784|5917698|P2|COMPLETED|Overall Study||49
2412801|NCT01265784|5917699|P1|COMPLETED|Overall Study||44
2412802|NCT01265784|5917697|P3|Received at Least 1 Dose of Study Drug|Overall Study||29
2412803|NCT01265784|5917698|P2|Received at Least 1 Dose of Study Drug|Overall Study||56
2412804|NCT01265784|5917699|P1|Received at Least 1 Dose of Study Drug|Overall Study|1 participant randomized to TP-434 1.5 mg/kg took ertapenem. Results are included in ertapenem arm.|54
2412805|NCT01265784|5917697|P3|STARTED|Overall Study||30
2412806|NCT01265784|5917698|P2|STARTED|Overall Study||57
2412807|NCT01265784|5917699|P1|STARTED|Overall Study||56
2412808|NCT01265719|5917767|P2|NOT COMPLETED|Overall Study||13
2412809|NCT01265719|5917768|P1|NOT COMPLETED|Overall Study||14
2412810|NCT01265719|5917767|P2|COMPLETED|Overall Study||60
2412811|NCT01265719|5917768|P1|COMPLETED|Overall Study||88
2412812|NCT01265719|5917767|P2|STARTED|Overall Study||73
2412813|NCT01265719|5917768|P1|STARTED|Overall Study||102
2412814|NCT01265667|5917802|P2|NOT COMPLETED|Overall Study||13
2412815|NCT01265667|5917803|P1|NOT COMPLETED|Overall Study||20
2412816|NCT01265667|5917802|P2|COMPLETED|Overall Study||135
2412817|NCT01265667|5917803|P1|COMPLETED|Overall Study||125
2412818|NCT01265667|5917802|P2|STARTED|Overall Study||148
2412819|NCT01265667|5917803|P1|STARTED|Overall Study||145
2412820|NCT01265615|5917819|P4|NOT COMPLETED|Overall Study||3
2412821|NCT01265615|5917820|P3|NOT COMPLETED|Overall Study||4
2412822|NCT01265615|5917821|P2|NOT COMPLETED|Overall Study||2
2412823|NCT01265615|5917822|P1|NOT COMPLETED|Overall Study||2
2412824|NCT01265615|5917819|P4|COMPLETED|Overall Study||27
2412825|NCT01265615|5917820|P3|COMPLETED|Overall Study||26
2412826|NCT01265615|5917821|P2|COMPLETED|Overall Study||28
2412827|NCT01265615|5917822|P1|COMPLETED|Overall Study||28
2412828|NCT01265615|5917819|P4|STARTED|Overall Study||30
2412829|NCT01265615|5917820|P3|STARTED|Overall Study||30
2412830|NCT01265615|5917821|P2|STARTED|Overall Study||30
2412831|NCT01265615|5917822|P1|STARTED|Overall Study||30
2412832|NCT01265563|5917873|P5|NOT COMPLETED|Overall Study||2
2412833|NCT01265563|5917874|P4|NOT COMPLETED|Overall Study||0
2412834|NCT01265563|5917875|P3|NOT COMPLETED|Overall Study||1
2412835|NCT01265563|5917876|P2|NOT COMPLETED|Overall Study||1
2412836|NCT01265563|5917877|P1|NOT COMPLETED|Overall Study||0
2412837|NCT01265563|5917873|P5|COMPLETED|Overall Study||14
2412838|NCT01265563|5917874|P4|COMPLETED|Overall Study||16
2412839|NCT01265563|5917875|P3|COMPLETED|Overall Study||16
2412840|NCT01265563|5917876|P2|COMPLETED|Overall Study||12
2412841|NCT01265563|5917877|P1|COMPLETED|Overall Study||16
2412842|NCT01265563|5917873|P5|STARTED|Overall Study||16
2412843|NCT01265563|5917874|P4|STARTED|Overall Study||16
2412844|NCT01265563|5917875|P3|STARTED|Overall Study||17
2412845|NCT01265563|5917876|P2|STARTED|Overall Study||13
2412846|NCT01265563|5917877|P1|STARTED|Overall Study||16
2412847|NCT01265550|5917903|P4|NOT COMPLETED|Post Randomization||0
2412848|NCT01265550|5917904|P3|NOT COMPLETED|Post Randomization||20
2412849|NCT01265550|5917905|P2|NOT COMPLETED|Post Randomization||8
2412850|NCT01265550|5917906|P1|NOT COMPLETED|Post Randomization||15
2412851|NCT01265550|5917903|P4|COMPLETED|Post Randomization||0
2412852|NCT01265550|5917904|P3|COMPLETED|Post Randomization||6
2412853|NCT01265550|5917905|P2|COMPLETED|Post Randomization||19
2412854|NCT01265550|5917906|P1|COMPLETED|Post Randomization||10
2412855|NCT01265550|5917903|P4|STARTED|Post Randomization||0
2412856|NCT01265550|5917904|P3|STARTED|Post Randomization||26
2412857|NCT01265550|5917905|P2|STARTED|Post Randomization||27
2412858|NCT01265550|5917906|P1|STARTED|Post Randomization||25
2412859|NCT01265550|5917903|P4|NOT COMPLETED|Pre Randomization||288
2412860|NCT01265550|5917904|P3|NOT COMPLETED|Pre Randomization||0
2412861|NCT01265550|5917905|P2|NOT COMPLETED|Pre Randomization||0
2412862|NCT01265550|5917906|P1|NOT COMPLETED|Pre Randomization||0
2412863|NCT01265550|5917903|P4|COMPLETED|Pre Randomization||78
2412864|NCT01265550|5917904|P3|COMPLETED|Pre Randomization||0
2412865|NCT01265550|5917905|P2|COMPLETED|Pre Randomization||0
2412866|NCT01265550|5917906|P1|COMPLETED|Pre Randomization||0
2412867|NCT01265550|5917903|P4|STARTED|Pre Randomization||366
2412868|NCT01265550|5917904|P3|STARTED|Pre Randomization||0
2412869|NCT01265550|5917905|P2|STARTED|Pre Randomization||0
2412870|NCT01265550|5917906|P1|STARTED|Pre Randomization||0
2412871|NCT01265537|5917998|P2|NOT COMPLETED|Overall Study||2
2412872|NCT01265537|5917999|P1|NOT COMPLETED|Overall Study||2
2412873|NCT01265537|5917998|P2|COMPLETED|Overall Study||13
2412874|NCT01265537|5917999|P1|COMPLETED|Overall Study||13
2412875|NCT01265537|5917998|P2|STARTED|Overall Study||15
2412876|NCT01265537|5917999|P1|STARTED|Overall Study||15
2412877|NCT01265524|5918029|P2|NOT COMPLETED|Overall Study||6
2412878|NCT01265524|5918030|P1|NOT COMPLETED|Overall Study||18
2412879|NCT01265524|5918029|P2|COMPLETED|Overall Study||46
2412880|NCT01265524|5918030|P1|COMPLETED|Overall Study||41
2412881|NCT01265524|5918029|P2|STARTED|Overall Study||52
2412882|NCT01265524|5918030|P1|STARTED|Overall Study||59
2412883|NCT01265511|5918050|P2|NOT COMPLETED|Overall Study||3
2412884|NCT01265511|5918051|P1|NOT COMPLETED|Overall Study||2
2412885|NCT01265511|5918050|P2|COMPLETED|Overall Study||5
2412886|NCT01265511|5918051|P1|COMPLETED|Overall Study||0
2412887|NCT01265511|5918050|P2|STARTED|Overall Study||8
2412888|NCT01265511|5918051|P1|STARTED|Overall Study||2
2412889|NCT01265498|5918065|P2|NOT COMPLETED|Overall Study||33
2412890|NCT01265498|5918066|P1|NOT COMPLETED|Overall Study||31
2412891|NCT01265498|5918065|P2|COMPLETED|Overall Study||109
2412892|NCT01265498|5918066|P1|COMPLETED|Overall Study||110
2412893|NCT01265498|5918065|P2|Both Baseline and Week 72 Biopsy|Overall Study||98
2412894|NCT01265498|5918066|P1|Both Baseline and Week 72 Biopsy|Overall Study||102
2412895|NCT01265498|5918065|P2|STARTED|Overall Study||142
2412896|NCT01265498|5918066|P1|STARTED|Overall Study||141
2412897|NCT01265459|5918169|P3|NOT COMPLETED|Overall Study||2
2412898|NCT01265459|5918170|P2|NOT COMPLETED|Overall Study||0
2412899|NCT01265459|5918171|P1|NOT COMPLETED|Overall Study||0
2412900|NCT01265459|5918169|P3|COMPLETED|Overall Study||20
2412901|NCT01265459|5918170|P2|COMPLETED|Overall Study||23
2412902|NCT01265459|5918171|P1|COMPLETED|Overall Study||23
2412903|NCT01265459|5918169|P3|STARTED|Overall Study||22
2412904|NCT01265459|5918170|P2|STARTED|Overall Study||23
2412905|NCT01265459|5918171|P1|STARTED|Overall Study||23
2412906|NCT01265446|5918193|P2|NOT COMPLETED|Overall Study||0
2412907|NCT01265446|5918194|P1|NOT COMPLETED|Overall Study||1
2412908|NCT01265446|5918193|P2|COMPLETED|Overall Study||125
2412909|NCT01265446|5918194|P1|COMPLETED|Overall Study||124
2412910|NCT01265446|5918193|P2|STARTED|Overall Study||125
2412911|NCT01265446|5918194|P1|STARTED|Overall Study||125
2412912|NCT01265420|5918202|P1|NOT COMPLETED|Overall Study||1
2412913|NCT01265420|5918202|P1|COMPLETED|Overall Study|One patient was seen at Day 10 but did not return for Day 30 evaluation|6
2412914|NCT01265420|5918202|P1|STARTED|Overall Study||7
2412915|NCT01265394|5918206|P1|NOT COMPLETED|Overall Study||37
2412916|NCT01265394|5918206|P1|COMPLETED|Overall Study||181
2412917|NCT01265394|5918206|P1|STARTED|Overall Study||218
2412918|NCT01265056|5918213|P2|NOT COMPLETED|Follow up||3
2412919|NCT01265056|5918214|P1|NOT COMPLETED|Follow up||7
2412920|NCT01265056|5918213|P2|COMPLETED|Follow up||24
2412921|NCT01265056|5918214|P1|COMPLETED|Follow up||19
2412922|NCT01265056|5918213|P2|STARTED|Follow up||27
2412923|NCT01265056|5918214|P1|STARTED|Follow up||26
2412924|NCT01265056|5918213|P2|NOT COMPLETED|Initial Study Period||2
2412925|NCT01265056|5918214|P1|NOT COMPLETED|Initial Study Period||2
2412926|NCT01265056|5918213|P2|COMPLETED|Initial Study Period||25
2412927|NCT01265056|5918214|P1|COMPLETED|Initial Study Period||24
2412928|NCT01265056|5918213|P2|STARTED|Initial Study Period||27
2412929|NCT01265056|5918214|P1|STARTED|Initial Study Period||26
2412930|NCT01264952|5918227|P3|NOT COMPLETED|Overall Study||0
2412931|NCT01264952|5918228|P2|NOT COMPLETED|Overall Study||0
2412932|NCT01264952|5918229|P1|NOT COMPLETED|Overall Study||0
2412933|NCT01264952|5918227|P3|COMPLETED|Overall Study||8
2412934|NCT01264952|5918228|P2|COMPLETED|Overall Study||2
2412935|NCT01264952|5918229|P1|COMPLETED|Overall Study||6
2412936|NCT01264952|5918227|P3|STARTED|Overall Study||8
2412937|NCT01264952|5918228|P2|STARTED|Overall Study||2
2412938|NCT01264952|5918229|P1|STARTED|Overall Study||6
2412939|NCT01264939|5918245|P2|NOT COMPLETED|Overall Study||28
2412940|NCT01264939|5918246|P1|NOT COMPLETED|Overall Study||18
2412941|NCT01264939|5918245|P2|COMPLETED|Overall Study||224
2412942|NCT01264939|5918246|P1|COMPLETED|Overall Study||66
2412943|NCT01264939|5918245|P2|STARTED|Overall Study||252
2412944|NCT01264939|5918246|P1|STARTED|Overall Study||84
2412945|NCT01264887|5918272|P1|NOT COMPLETED|Overall Study||31
2412946|NCT01264887|5918272|P1|COMPLETED|Overall Study||0
2412947|NCT01264887|5918272|P1|STARTED|Overall Study||31
2412948|NCT01264835|5918283|P1|NOT COMPLETED|Overall Study||1
2412949|NCT01264835|5918283|P1|COMPLETED|Overall Study||1
2412950|NCT01264835|5918283|P1|STARTED|Overall Study||2
2412951|NCT01264770|5918293|P6|NOT COMPLETED|Overall Study||6
2412952|NCT01264770|5918294|P5|NOT COMPLETED|Overall Study||8
2412953|NCT01264770|5918295|P4|NOT COMPLETED|Overall Study||6
2412954|NCT01264770|5918296|P3|NOT COMPLETED|Overall Study||16
2412955|NCT01264770|5918297|P2|NOT COMPLETED|Overall Study||10
2412956|NCT01264770|5918298|P1|NOT COMPLETED|Overall Study||18
2412957|NCT01264770|5918293|P6|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
2412958|NCT01264770|5918294|P5|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
2412959|NCT01264770|5918295|P4|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|48
2412960|NCT01264770|5918296|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|41
2412961|NCT01264770|5918297|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|38
2412962|NCT01264770|5918298|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|36
2412963|NCT01264770|5918293|P6|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|0
2412964|NCT01264770|5918294|P5|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
2412965|NCT01264770|5918295|P4|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|3
2412966|NCT01264770|5918296|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
2412967|NCT01264770|5918297|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|5
2412968|NCT01264770|5918298|P1|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
2412969|NCT01264770|5918293|P6|STARTED|Overall Study|Patients who received treatment|25
2412970|NCT01264770|5918294|P5|STARTED|Overall Study|Patients who received treatment|27
2412971|NCT01264770|5918295|P4|STARTED|Overall Study|Patients who received treatment|54
2412972|NCT01264770|5918296|P3|STARTED|Overall Study|Patients who received treatment|57
2412973|NCT01264770|5918297|P2|STARTED|Overall Study|Patients who received treatment|48
2412974|NCT01264770|5918298|P1|STARTED|Overall Study|Patients who received treatment|54
2412975|NCT01264718|5918384|P2|NOT COMPLETED|Overall Study||43
2412976|NCT01264718|5918385|P1|NOT COMPLETED|Overall Study||49
2412977|NCT01264718|5918384|P2|COMPLETED|Overall Study||114
2412978|NCT01264718|5918385|P1|COMPLETED|Overall Study||123
2412979|NCT01264718|5918384|P2|STARTED|Overall Study||157
2412980|NCT01264718|5918385|P1|STARTED|Overall Study||172
2412981|NCT01264679|5918397|P1|NOT COMPLETED|Overall Study||5
2412982|NCT01264679|5918397|P1|COMPLETED|Overall Study||3
2412983|NCT01264679|5918397|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
2412984|NCT01264679|5918397|P1|STARTED|Overall Study||8
2412985|NCT01264614|5918405|P2|NOT COMPLETED|Overall Study||2
2412986|NCT01264614|5918406|P1|NOT COMPLETED|Overall Study||1
2412987|NCT01264614|5918405|P2|COMPLETED|Overall Study||7
2412988|NCT01264614|5918406|P1|COMPLETED|Overall Study||12
2412989|NCT01264614|5918405|P2|STARTED|Overall Study||9
2412990|NCT01264614|5918406|P1|STARTED|Overall Study||13
2412991|NCT01264601|5918422|P2|NOT COMPLETED|Overall Study||0
2412992|NCT01264601|5918423|P1|NOT COMPLETED|Overall Study||0
2412993|NCT01264601|5918422|P2|COMPLETED|Overall Study||14
2412994|NCT01264601|5918423|P1|COMPLETED|Overall Study||17
2412995|NCT01264601|5918422|P2|STARTED|Overall Study||14
2412996|NCT01264601|5918423|P1|STARTED|Overall Study||17
2413000|NCT01264380|5918436|P3|NOT COMPLETED|Period C||14
2413001|NCT01264380|5918437|P2|NOT COMPLETED|Period C||0
2413002|NCT01264380|5918438|P1|NOT COMPLETED|Period C||0
2413003|NCT01264380|5918436|P3|COMPLETED|Period C||2
2413004|NCT01264380|5918437|P2|COMPLETED|Period C||0
2413005|NCT01264380|5918438|P1|COMPLETED|Period C||0
2413006|NCT01264380|5918436|P3|STARTED|Period C||16
2413007|NCT01264380|5918437|P2|STARTED|Period C||0
2413008|NCT01264380|5918438|P1|STARTED|Period C||0
2413009|NCT01264380|5918436|P3|NOT COMPLETED|Period B||0
2413010|NCT01264380|5918437|P2|NOT COMPLETED|Period B||0
2413011|NCT01264380|5918438|P1|NOT COMPLETED|Period B||0
2413012|NCT01264380|5918436|P3|COMPLETED|Period B||0
2413013|NCT01264380|5918437|P2|COMPLETED|Period B||8
2413014|NCT01264380|5918438|P1|COMPLETED|Period B||8
2413015|NCT01264380|5918436|P3|STARTED|Period B||0
2413016|NCT01264380|5918437|P2|STARTED|Period B||8
2413017|NCT01264380|5918438|P1|STARTED|Period B||8
2413018|NCT01264380|5918436|P3|NOT COMPLETED|Period A||0
2413019|NCT01264380|5918437|P2|NOT COMPLETED|Period A||0
2413020|NCT01264380|5918438|P1|NOT COMPLETED|Period A||0
2413021|NCT01264380|5918436|P3|COMPLETED|Period A||0
2413022|NCT01264380|5918437|P2|COMPLETED|Period A||8
2413023|NCT01264380|5918438|P1|COMPLETED|Period A||8
2413024|NCT01264380|5918436|P3|STARTED|Period A||0
2413025|NCT01264380|5918437|P2|STARTED|Period A||8
2413026|NCT01264380|5918438|P1|STARTED|Period A||8
2413027|NCT01264081|5918459|P1|NOT COMPLETED|Analysis||0
2413028|NCT01264081|5918459|P1|COMPLETED|Analysis||2
2413029|NCT01264081|5918459|P1|STARTED|Analysis||2
2413030|NCT01264081|5918459|P1|NOT COMPLETED|Started Treatment||2
2413031|NCT01264081|5918459|P1|COMPLETED|Started Treatment||2
2413032|NCT01264081|5918459|P1|STARTED|Started Treatment||4
2413033|NCT01264081|5918459|P1|NOT COMPLETED|Participants Screened||30
2413034|NCT01264081|5918459|P1|COMPLETED|Participants Screened||4
2413035|NCT01264081|5918459|P1|STARTED|Participants Screened||34
2413036|NCT01264016|5918464|P1|NOT COMPLETED|Overall Study||2
2413037|NCT01264016|5918464|P1|COMPLETED|Overall Study||94
2413038|NCT01264016|5918464|P1|STARTED|Overall Study||96
2413039|NCT01263938|5918470|P1|NOT COMPLETED|Overall Study||0
2413040|NCT01263938|5918470|P1|COMPLETED|Overall Study||5
2413041|NCT01263938|5918470|P1|STARTED|Overall Study||5
2413042|NCT01263925|5918479|P2|NOT COMPLETED|Overall Study||52
2413043|NCT01263925|5918480|P1|NOT COMPLETED|Overall Study||51
2413044|NCT01263925|5918479|P2|COMPLETED|Overall Study||233
2413045|NCT01263925|5918480|P1|COMPLETED|Overall Study||225
2413046|NCT01263925|5918479|P2|Full Analysis Set|Overall Study||272
2413047|NCT01263925|5918480|P1|Full Analysis Set|Overall Study||269
2413048|NCT01263925|5918479|P2|STARTED|Overall Study||285
2413049|NCT01263925|5918480|P1|STARTED|Overall Study||276
2413050|NCT01263873|5918514|P2|NOT COMPLETED|Overall Study||1
2413051|NCT01263873|5918515|P1|NOT COMPLETED|Overall Study||1
2413052|NCT01263873|5918514|P2|COMPLETED|Overall Study||29
2413053|NCT01263873|5918515|P1|COMPLETED|Overall Study||29
2413054|NCT01263873|5918514|P2|STARTED|Overall Study||30
2413055|NCT01263873|5918515|P1|STARTED|Overall Study||30
2413056|NCT01263782|5918529|P4|NOT COMPLETED|Overall Study||1
2413057|NCT01263782|5918530|P3|NOT COMPLETED|Overall Study||3
2413058|NCT01263782|5918531|P2|NOT COMPLETED|Overall Study||0
2413059|NCT01263782|5918532|P1|NOT COMPLETED|Overall Study||0
2413060|NCT01263782|5918529|P4|COMPLETED|Overall Study||5
2413061|NCT01263782|5918530|P3|COMPLETED|Overall Study||3
2413062|NCT01263782|5918531|P2|COMPLETED|Overall Study||6
2413063|NCT01263782|5918532|P1|COMPLETED|Overall Study||6
2413064|NCT01263782|5918529|P4|STARTED|Overall Study||6
2413065|NCT01263782|5918530|P3|STARTED|Overall Study||6
2413066|NCT01263782|5918531|P2|STARTED|Overall Study||6
2413067|NCT01263782|5918532|P1|STARTED|Overall Study||6
2413068|NCT01263717|5918548|P2|NOT COMPLETED|Overall Study||6
2413069|NCT01263717|5918549|P1|NOT COMPLETED|Overall Study||5
2413070|NCT01263717|5918548|P2|COMPLETED|Overall Study||20
2413071|NCT01263717|5918549|P1|COMPLETED|Overall Study||23
2413072|NCT01263717|5918548|P2|Baseline Visit|Overall Study||22
2413073|NCT01263717|5918549|P1|Baseline Visit|Overall Study||28
2413074|NCT01263717|5918548|P2|STARTED|Overall Study||26
2413075|NCT01263717|5918549|P1|STARTED|Overall Study||28
2413076|NCT01263704|5918577|P1|NOT COMPLETED|Overall Study||29
2413077|NCT01263704|5918577|P1|COMPLETED|Overall Study||13
2413078|NCT01263704|5918577|P1|STARTED|Overall Study||42
2413079|NCT01263691|5918592|P6|NOT COMPLETED|Overall Study||0
2413080|NCT01263691|5918593|P5|NOT COMPLETED|Overall Study||0
2413081|NCT01263691|5918594|P4|NOT COMPLETED|Overall Study||1
2413082|NCT01263691|5918595|P3|NOT COMPLETED|Overall Study||1
2413083|NCT01263691|5918596|P2|NOT COMPLETED|Overall Study||0
2413084|NCT01263691|5918597|P1|NOT COMPLETED|Overall Study||3
2413085|NCT01263691|5918592|P6|COMPLETED|Overall Study||15
2413086|NCT01263691|5918593|P5|COMPLETED|Overall Study||18
2413087|NCT01263691|5918594|P4|COMPLETED|Overall Study||18
2413088|NCT01263691|5918595|P3|COMPLETED|Overall Study||16
2413089|NCT01263691|5918596|P2|COMPLETED|Overall Study||18
2413090|NCT01263691|5918597|P1|COMPLETED|Overall Study||15
2413091|NCT01263691|5918592|P6|STARTED|Overall Study||15
2413092|NCT01263691|5918593|P5|STARTED|Overall Study||18
2413093|NCT01263691|5918594|P4|STARTED|Overall Study||19
2413094|NCT01263691|5918595|P3|STARTED|Overall Study||17
2413095|NCT01263691|5918596|P2|STARTED|Overall Study||18
2413096|NCT01263691|5918597|P1|STARTED|Overall Study||18
2413097|NCT01263665|5918707|P1|NOT COMPLETED|Overall Study||9
2413098|NCT01263665|5918707|P1|COMPLETED|Overall Study||62
2413099|NCT01263665|5918707|P1|STARTED|Overall Study||71
2413100|NCT01263639|5918714|P2|NOT COMPLETED|Overall Study||79
2413101|NCT01263639|5918715|P1|NOT COMPLETED|Overall Study||73
2413102|NCT01263639|5918714|P2|COMPLETED|Overall Study||42
2413103|NCT01263639|5918715|P1|COMPLETED|Overall Study||34
2413104|NCT01263639|5918714|P2|STARTED|Overall Study||121
2413105|NCT01263639|5918715|P1|STARTED|Overall Study||107
2413106|NCT01263561|5918723|P2|NOT COMPLETED|Overall Study||2
2413107|NCT01263561|5918724|P1|NOT COMPLETED|Overall Study||1
2413108|NCT01263561|5918723|P2|COMPLETED|Overall Study||31
2413109|NCT01263561|5918724|P1|COMPLETED|Overall Study||30
2413110|NCT01263561|5918723|P2|STARTED|Overall Study||33
2413111|NCT01263561|5918724|P1|STARTED|Overall Study||31
2413112|NCT01263509|5918736|P4|NOT COMPLETED|Entered - Long-Term Extension Study||2
2413113|NCT01263509|5918737|P3|NOT COMPLETED|Entered - Long-Term Extension Study||5
2413114|NCT01263509|5918738|P2|NOT COMPLETED|Entered - Long-Term Extension Study||12
2413115|NCT01263509|5918739|P1|NOT COMPLETED|Entered - Long-Term Extension Study||8
2413116|NCT01263509|5918736|P4|COMPLETED|Entered - Long-Term Extension Study||24
2413117|NCT01263509|5918737|P3|COMPLETED|Entered - Long-Term Extension Study||27
2413118|NCT01263509|5918738|P2|COMPLETED|Entered - Long-Term Extension Study||48
2413119|NCT01263509|5918739|P1|COMPLETED|Entered - Long-Term Extension Study||53
2413120|NCT01263509|5918736|P4|STARTED|Entered - Long-Term Extension Study||26
2413121|NCT01263509|5918737|P3|STARTED|Entered - Long-Term Extension Study||32
2413122|NCT01263509|5918738|P2|STARTED|Entered - Long-Term Extension Study||60
2413123|NCT01263509|5918739|P1|STARTED|Entered - Long-Term Extension Study||61
2413124|NCT01263509|5918736|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
2413125|NCT01263509|5918737|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
2413126|NCT01263509|5918738|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
2413127|NCT01263509|5918739|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
2413128|NCT01263509|5918736|P4|COMPLETED|Enrolled - Long-Term Extension Study||26
2413129|NCT01263509|5918737|P3|COMPLETED|Enrolled - Long-Term Extension Study||32
2413130|NCT01263509|5918738|P2|COMPLETED|Enrolled - Long-Term Extension Study||60
2413131|NCT01263509|5918739|P1|COMPLETED|Enrolled - Long-Term Extension Study||61
2413132|NCT01263509|5918736|P4|STARTED|Enrolled - Long-Term Extension Study||26
2413133|NCT01263509|5918737|P3|STARTED|Enrolled - Long-Term Extension Study||32
2413134|NCT01263509|5918738|P2|STARTED|Enrolled - Long-Term Extension Study||60
2413135|NCT01263509|5918739|P1|STARTED|Enrolled - Long-Term Extension Study||61
2413136|NCT01263496|5918868|P9|NOT COMPLETED|Entered - Long-Term Extension Study||3
2413137|NCT01263496|5918869|P8|NOT COMPLETED|Entered - Long-Term Extension Study||1
2413138|NCT01263496|5918870|P7|NOT COMPLETED|Entered - Long-Term Extension Study||1
2413139|NCT01263496|5918871|P6|NOT COMPLETED|Entered - Long-Term Extension Study||1
2413140|NCT01263496|5918872|P5|NOT COMPLETED|Entered - Long-Term Extension Study||10
2413141|NCT01263496|5918873|P4|NOT COMPLETED|Entered - Long-Term Extension Study||6
2413142|NCT01263496|5918874|P3|NOT COMPLETED|Entered - Long-Term Extension Study||10
2413143|NCT01263496|5918875|P2|NOT COMPLETED|Entered - Long-Term Extension Study||13
2413144|NCT01263496|5918876|P1|NOT COMPLETED|Entered - Long-Term Extension Study||9
2413145|NCT01263496|5918868|P9|COMPLETED|Entered - Long-Term Extension Study||15
2413146|NCT01263496|5918869|P8|COMPLETED|Entered - Long-Term Extension Study||16
2413147|NCT01263496|5918870|P7|COMPLETED|Entered - Long-Term Extension Study||16
2413148|NCT01263496|5918871|P6|COMPLETED|Entered - Long-Term Extension Study||16
2413149|NCT01263496|5918872|P5|COMPLETED|Entered - Long-Term Extension Study||61
2413150|NCT01263496|5918873|P4|COMPLETED|Entered - Long-Term Extension Study||68
2413151|NCT01263496|5918874|P3|COMPLETED|Entered - Long-Term Extension Study||62
2413152|NCT01263496|5918875|P2|COMPLETED|Entered - Long-Term Extension Study||59
2413153|NCT01263496|5918876|P1|COMPLETED|Entered - Long-Term Extension Study||62
2413154|NCT01263496|5918868|P9|STARTED|Entered - Long-Term Extension Study||18
2413155|NCT01263496|5918869|P8|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|17
2413156|NCT01263496|5918870|P7|STARTED|Entered - Long-Term Extension Study||17
2413157|NCT01263496|5918871|P6|STARTED|Entered - Long-Term Extension Study||17
2413158|NCT01263496|5918872|P5|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|71
2413159|NCT01263496|5918873|P4|STARTED|Entered - Long-Term Extension Study||74
2413160|NCT01263496|5918874|P3|STARTED|Entered - Long-Term Extension Study||72
2413161|NCT01263496|5918875|P2|STARTED|Entered - Long-Term Extension Study|3 participants did not enter from previous period (1 voluntary withdraw; 2 did not meet criteria).|72
2413162|NCT01263496|5918876|P1|STARTED|Entered - Long-Term Extension Study||71
2413163|NCT01263496|5918868|P9|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
2413164|NCT01263496|5918869|P8|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
2413165|NCT01263496|5918870|P7|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
2413166|NCT01263496|5918871|P6|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
2413167|NCT01263496|5918872|P5|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
2413168|NCT01263496|5918873|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
2413169|NCT01263496|5918874|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
2413170|NCT01263496|5918875|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
2413171|NCT01263496|5918876|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
2413172|NCT01263496|5918868|P9|COMPLETED|Enrolled - Long-Term Extension Study||18
2413173|NCT01263496|5918869|P8|COMPLETED|Enrolled - Long-Term Extension Study||18
2413174|NCT01263496|5918870|P7|COMPLETED|Enrolled - Long-Term Extension Study||17
2413175|NCT01263496|5918871|P6|COMPLETED|Enrolled - Long-Term Extension Study||17
2413176|NCT01263496|5918872|P5|COMPLETED|Enrolled - Long-Term Extension Study||72
2413177|NCT01263496|5918873|P4|COMPLETED|Enrolled - Long-Term Extension Study||74
2413178|NCT01263496|5918874|P3|COMPLETED|Enrolled - Long-Term Extension Study||72
2413179|NCT01263496|5918875|P2|COMPLETED|Enrolled - Long-Term Extension Study||75
2413180|NCT01263496|5918876|P1|COMPLETED|Enrolled - Long-Term Extension Study||71
2413181|NCT01263496|5918868|P9|STARTED|Enrolled - Long-Term Extension Study||18
2413182|NCT01263496|5918869|P8|STARTED|Enrolled - Long-Term Extension Study||18
2413183|NCT01263496|5918870|P7|STARTED|Enrolled - Long-Term Extension Study||17
2413184|NCT01263496|5918871|P6|STARTED|Enrolled - Long-Term Extension Study||17
2413185|NCT01263496|5918872|P5|STARTED|Enrolled - Long-Term Extension Study||74
2413186|NCT01263496|5918873|P4|STARTED|Enrolled - Long-Term Extension Study||75
2413187|NCT01263496|5918874|P3|STARTED|Enrolled - Long-Term Extension Study||72
2413188|NCT01263496|5918875|P2|STARTED|Enrolled - Long-Term Extension Study||75
2413189|NCT01263496|5918876|P1|STARTED|Enrolled - Long-Term Extension Study||72
2413190|NCT01263483|5919171|P3|NOT COMPLETED|Overall Study||5
2413191|NCT01263483|5919172|P2|NOT COMPLETED|Overall Study||2
2413192|NCT01263483|5919173|P1|NOT COMPLETED|Overall Study||7
2413193|NCT01263483|5919171|P3|COMPLETED|Overall Study||74
2413194|NCT01263483|5919172|P2|COMPLETED|Overall Study||74
2413195|NCT01263483|5919173|P1|COMPLETED|Overall Study||68
2413196|NCT01263483|5919171|P3|STARTED|Overall Study||79
2413197|NCT01263483|5919172|P2|STARTED|Overall Study||76
2413198|NCT01263483|5919173|P1|STARTED|Overall Study||75
2413199|NCT01263470|5919235|P6|NOT COMPLETED|Overall Study||5
2413200|NCT01263470|5919236|P5|NOT COMPLETED|Overall Study||3
2413201|NCT01263470|5919237|P4|NOT COMPLETED|Overall Study||3
2413202|NCT01263470|5919238|P3|NOT COMPLETED|Overall Study||4
2413203|NCT01263470|5919239|P2|NOT COMPLETED|Overall Study||5
2413204|NCT01263470|5919240|P1|NOT COMPLETED|Overall Study||2
2413205|NCT01263470|5919235|P6|COMPLETED|Overall Study||78
2413206|NCT01263470|5919236|P5|COMPLETED|Overall Study||76
2413207|NCT01263470|5919237|P4|COMPLETED|Overall Study||77
2413208|NCT01263470|5919238|P3|COMPLETED|Overall Study||80
2413209|NCT01263470|5919239|P2|COMPLETED|Overall Study||74
2413210|NCT01263470|5919240|P1|COMPLETED|Overall Study||73
2413211|NCT01263470|5919235|P6|STARTED|Overall Study||83
2413212|NCT01263470|5919236|P5|STARTED|Overall Study||79
2413213|NCT01263470|5919237|P4|STARTED|Overall Study||80
2413214|NCT01263470|5919238|P3|STARTED|Overall Study||84
2413215|NCT01263470|5919239|P2|STARTED|Overall Study||79
2413216|NCT01263470|5919240|P1|STARTED|Overall Study||75
2413217|NCT01263444|5919350|P1|NOT COMPLETED|Overall Study||10
2413218|NCT01263444|5919350|P1|COMPLETED|Overall Study||37
2413219|NCT01263444|5919350|P1|STARTED|Overall Study||47
2413220|NCT01263314|5919359|P8|NOT COMPLETED|Period 3||0
2413221|NCT01263314|5919360|P7|NOT COMPLETED|Period 3||0
2413222|NCT01263314|5919361|P6|NOT COMPLETED|Period 3||0
2413223|NCT01263314|5919362|P5|NOT COMPLETED|Period 3||0
2413224|NCT01263314|5919363|P4|NOT COMPLETED|Period 3||0
2413225|NCT01263314|5919364|P3|NOT COMPLETED|Period 3||0
2413226|NCT01263314|5919365|P2|NOT COMPLETED|Period 3||0
2413227|NCT01263314|5919366|P1|NOT COMPLETED|Period 3||0
2413228|NCT01263314|5919359|P8|COMPLETED|Period 3||2
2413229|NCT01263314|5919360|P7|COMPLETED|Period 3||2
2413230|NCT01263314|5919361|P6|COMPLETED|Period 3||2
2413231|NCT01263314|5919362|P5|COMPLETED|Period 3||2
2413232|NCT01263314|5919363|P4|COMPLETED|Period 3||2
2413233|NCT01263314|5919364|P3|COMPLETED|Period 3||2
2413234|NCT01263314|5919365|P2|COMPLETED|Period 3||2
2413235|NCT01263314|5919366|P1|COMPLETED|Period 3||2
2413236|NCT01263314|5919359|P8|STARTED|Period 3||2
2413237|NCT01263314|5919360|P7|STARTED|Period 3||2
2413238|NCT01263314|5919361|P6|STARTED|Period 3||2
2413239|NCT01263314|5919362|P5|STARTED|Period 3||2
2413240|NCT01263314|5919363|P4|STARTED|Period 3||2
2413241|NCT01263314|5919364|P3|STARTED|Period 3||2
2413242|NCT01263314|5919365|P2|STARTED|Period 3||2
2413243|NCT01263314|5919366|P1|STARTED|Period 3||2
2413244|NCT01263314|5919359|P8|NOT COMPLETED|Period 2||0
2413245|NCT01263314|5919360|P7|NOT COMPLETED|Period 2||0
2413246|NCT01263314|5919361|P6|NOT COMPLETED|Period 2||0
2413247|NCT01263314|5919362|P5|NOT COMPLETED|Period 2||0
2413248|NCT01263314|5919363|P4|NOT COMPLETED|Period 2||0
2413249|NCT01263314|5919364|P3|NOT COMPLETED|Period 2||0
2413250|NCT01263314|5919365|P2|NOT COMPLETED|Period 2||0
2413251|NCT01263314|5919366|P1|NOT COMPLETED|Period 2||0
2413252|NCT01263314|5919359|P8|COMPLETED|Period 2||2
2413253|NCT01263314|5919360|P7|COMPLETED|Period 2||2
2413254|NCT01263314|5919361|P6|COMPLETED|Period 2||2
2413255|NCT01263314|5919362|P5|COMPLETED|Period 2||2
2413256|NCT01263314|5919363|P4|COMPLETED|Period 2||2
2413257|NCT01263314|5919364|P3|COMPLETED|Period 2||2
2413258|NCT01263314|5919365|P2|COMPLETED|Period 2||2
2413259|NCT01263314|5919366|P1|COMPLETED|Period 2||2
2413260|NCT01263314|5919359|P8|STARTED|Period 2||2
2413261|NCT01263314|5919360|P7|STARTED|Period 2||2
2413262|NCT01263314|5919361|P6|STARTED|Period 2||2
2413263|NCT01263314|5919362|P5|STARTED|Period 2||2
2413264|NCT01263314|5919363|P4|STARTED|Period 2||2
2413265|NCT01263314|5919364|P3|STARTED|Period 2||2
2413266|NCT01263314|5919365|P2|STARTED|Period 2||2
2413267|NCT01263314|5919366|P1|STARTED|Period 2||2
2413268|NCT01263314|5919359|P8|NOT COMPLETED|Period 1||0
2413269|NCT01263314|5919360|P7|NOT COMPLETED|Period 1||0
2413270|NCT01263314|5919361|P6|NOT COMPLETED|Period 1||0
2413271|NCT01263314|5919362|P5|NOT COMPLETED|Period 1||0
2413272|NCT01263314|5919363|P4|NOT COMPLETED|Period 1||0
2413273|NCT01263314|5919364|P3|NOT COMPLETED|Period 1||0
2413274|NCT01263314|5919365|P2|NOT COMPLETED|Period 1||0
2413275|NCT01263314|5919366|P1|NOT COMPLETED|Period 1||0
2413276|NCT01263314|5919359|P8|COMPLETED|Period 1||2
2413277|NCT01263314|5919360|P7|COMPLETED|Period 1||2
2413278|NCT01263314|5919361|P6|COMPLETED|Period 1||2
2413279|NCT01263314|5919362|P5|COMPLETED|Period 1||2
2413280|NCT01263314|5919363|P4|COMPLETED|Period 1||2
2413281|NCT01263314|5919364|P3|COMPLETED|Period 1||2
2413282|NCT01263314|5919365|P2|COMPLETED|Period 1||2
2413283|NCT01263314|5919366|P1|COMPLETED|Period 1||2
2413284|NCT01263314|5919359|P8|STARTED|Period 1||2
2413285|NCT01263314|5919360|P7|STARTED|Period 1||2
2413286|NCT01263314|5919361|P6|STARTED|Period 1||2
2413287|NCT01263314|5919362|P5|STARTED|Period 1||2
2413288|NCT01263314|5919363|P4|STARTED|Period 1||2
2413289|NCT01263314|5919364|P3|STARTED|Period 1||2
2413290|NCT01263314|5919365|P2|STARTED|Period 1||2
2413291|NCT01263314|5919366|P1|STARTED|Period 1||2
2413292|NCT01263301|5919474|P2|NOT COMPLETED|Overall Study||0
2413293|NCT01263301|5919475|P1|NOT COMPLETED|Overall Study||0
2413294|NCT01263301|5919474|P2|COMPLETED|Overall Study||11
2413295|NCT01263301|5919475|P1|COMPLETED|Overall Study||5
2413296|NCT01263301|5919474|P2|STARTED|Overall Study||11
2413297|NCT01263301|5919475|P1|STARTED|Overall Study||5
2413298|NCT01263223|5919487|P2|NOT COMPLETED|7-day Follow-up||1
2413299|NCT01263223|5919488|P1|NOT COMPLETED|7-day Follow-up||1
2413300|NCT01263223|5919487|P2|COMPLETED|7-day Follow-up|One participant who did not complete received 36-mg LY2216684 in Period 3.|10
2413301|NCT01263223|5919488|P1|COMPLETED|7-day Follow-up|One participant who did not complete received Placebo in Period 3.|11
2413302|NCT01263223|5919487|P2|STARTED|7-day Follow-up||11
2413303|NCT01263223|5919488|P1|STARTED|7-day Follow-up||12
2413304|NCT01263223|5919487|P2|NOT COMPLETED|Period 3||0
2413305|NCT01263223|5919488|P1|NOT COMPLETED|Period 3||0
2413306|NCT01263223|5919487|P2|COMPLETED|Period 3||11
2413307|NCT01263223|5919488|P1|COMPLETED|Period 3||12
2413308|NCT01263223|5919487|P2|STARTED|Period 3||11
2413309|NCT01263223|5919488|P1|STARTED|Period 3||12
2413310|NCT01263223|5919487|P2|NOT COMPLETED|Period 2||1
2413311|NCT01263223|5919488|P1|NOT COMPLETED|Period 2||0
2413312|NCT01263223|5919487|P2|COMPLETED|Period 2||11
2413313|NCT01263223|5919488|P1|COMPLETED|Period 2||12
2413314|NCT01263223|5919487|P2|STARTED|Period 2||12
2413315|NCT01263223|5919488|P1|STARTED|Period 2||12
2413316|NCT01263223|5919487|P2|NOT COMPLETED|3-Day Washout||0
2413317|NCT01263223|5919488|P1|NOT COMPLETED|3-Day Washout||0
2413318|NCT01263223|5919487|P2|COMPLETED|3-Day Washout||12
2413319|NCT01263223|5919488|P1|COMPLETED|3-Day Washout||12
2413320|NCT01263223|5919487|P2|STARTED|3-Day Washout||12
2413321|NCT01263223|5919488|P1|STARTED|3-Day Washout||12
2413322|NCT01263223|5919487|P2|NOT COMPLETED|Period 1||0
2413323|NCT01263223|5919488|P1|NOT COMPLETED|Period 1||0
2413324|NCT01263223|5919487|P2|COMPLETED|Period 1||12
2413325|NCT01263223|5919488|P1|COMPLETED|Period 1||12
2413326|NCT01263223|5919487|P2|STARTED|Period 1||12
2413327|NCT01263223|5919488|P1|STARTED|Period 1||12
2413328|NCT01263197|5919511|P6|NOT COMPLETED|Third Intervention (Period 3)||0
2413329|NCT01263197|5919512|P5|NOT COMPLETED|Third Intervention (Period 3)||0
2413330|NCT01263197|5919513|P4|NOT COMPLETED|Third Intervention (Period 3)||0
2413331|NCT01263197|5919514|P3|NOT COMPLETED|Third Intervention (Period 3)||0
2413332|NCT01263197|5919515|P2|NOT COMPLETED|Third Intervention (Period 3)||1
2413333|NCT01263197|5919516|P1|NOT COMPLETED|Third Intervention (Period 3)||0
2413334|NCT01263197|5919511|P6|COMPLETED|Third Intervention (Period 3)||6
2413335|NCT01263197|5919512|P5|COMPLETED|Third Intervention (Period 3)||7
2413336|NCT01263197|5919513|P4|COMPLETED|Third Intervention (Period 3)||7
2413337|NCT01263197|5919514|P3|COMPLETED|Third Intervention (Period 3)||8
2413338|NCT01263197|5919515|P2|COMPLETED|Third Intervention (Period 3)||7
2413339|NCT01263197|5919516|P1|COMPLETED|Third Intervention (Period 3)||8
2413340|NCT01263197|5919511|P6|STARTED|Third Intervention (Period 3)||6
2413341|NCT01263197|5919512|P5|STARTED|Third Intervention (Period 3)||7
2413342|NCT01263197|5919513|P4|STARTED|Third Intervention (Period 3)||7
2413343|NCT01263197|5919514|P3|STARTED|Third Intervention (Period 3)||8
2413344|NCT01263197|5919515|P2|STARTED|Third Intervention (Period 3)||8
2413345|NCT01263197|5919516|P1|STARTED|Third Intervention (Period 3)||8
2413346|NCT01263197|5919511|P6|NOT COMPLETED|Washout Period 2||1
2413347|NCT01263197|5919512|P5|NOT COMPLETED|Washout Period 2||0
2413348|NCT01263197|5919513|P4|NOT COMPLETED|Washout Period 2||1
2413349|NCT01263197|5919514|P3|NOT COMPLETED|Washout Period 2||0
2413350|NCT01263197|5919515|P2|NOT COMPLETED|Washout Period 2||0
2413351|NCT01263197|5919516|P1|NOT COMPLETED|Washout Period 2||0
2413352|NCT01263197|5919511|P6|COMPLETED|Washout Period 2||6
2413353|NCT01263197|5919512|P5|COMPLETED|Washout Period 2||7
2413354|NCT01263197|5919513|P4|COMPLETED|Washout Period 2||7
2413355|NCT01263197|5919514|P3|COMPLETED|Washout Period 2||8
2413356|NCT01263197|5919515|P2|COMPLETED|Washout Period 2||8
2413357|NCT01263197|5919516|P1|COMPLETED|Washout Period 2||8
2413358|NCT01263197|5919511|P6|STARTED|Washout Period 2||7
2413359|NCT01263197|5919512|P5|STARTED|Washout Period 2||7
2413360|NCT01263197|5919513|P4|STARTED|Washout Period 2||8
2413361|NCT01263197|5919514|P3|STARTED|Washout Period 2||8
2413362|NCT01263197|5919515|P2|STARTED|Washout Period 2||8
2413363|NCT01263197|5919516|P1|STARTED|Washout Period 2||8
2413364|NCT01263197|5919511|P6|NOT COMPLETED|Second Intervention (Period 2)||0
2413365|NCT01263197|5919512|P5|NOT COMPLETED|Second Intervention (Period 2)||0
2413366|NCT01263197|5919513|P4|NOT COMPLETED|Second Intervention (Period 2)||0
2413367|NCT01263197|5919514|P3|NOT COMPLETED|Second Intervention (Period 2)||0
2413368|NCT01263197|5919515|P2|NOT COMPLETED|Second Intervention (Period 2)||0
2413369|NCT01263197|5919516|P1|NOT COMPLETED|Second Intervention (Period 2)||0
2413370|NCT01263197|5919511|P6|COMPLETED|Second Intervention (Period 2)||7
2413371|NCT01263197|5919512|P5|COMPLETED|Second Intervention (Period 2)||7
2413372|NCT01263197|5919513|P4|COMPLETED|Second Intervention (Period 2)||8
2413373|NCT01263197|5919514|P3|COMPLETED|Second Intervention (Period 2)||8
2413374|NCT01263197|5919515|P2|COMPLETED|Second Intervention (Period 2)||8
2413375|NCT01263197|5919516|P1|COMPLETED|Second Intervention (Period 2)||8
2413376|NCT01263197|5919511|P6|STARTED|Second Intervention (Period 2)||7
2413377|NCT01263197|5919512|P5|STARTED|Second Intervention (Period 2)||7
2413378|NCT01263197|5919513|P4|STARTED|Second Intervention (Period 2)||8
2413379|NCT01263197|5919514|P3|STARTED|Second Intervention (Period 2)||8
2413380|NCT01263197|5919515|P2|STARTED|Second Intervention (Period 2)||8
2413381|NCT01263197|5919516|P1|STARTED|Second Intervention (Period 2)||8
2413382|NCT01263197|5919511|P6|NOT COMPLETED|Washout Period 1||0
2413383|NCT01263197|5919512|P5|NOT COMPLETED|Washout Period 1||1
2413384|NCT01263197|5919513|P4|NOT COMPLETED|Washout Period 1||0
2413385|NCT01263197|5919514|P3|NOT COMPLETED|Washout Period 1||0
2413386|NCT01263197|5919515|P2|NOT COMPLETED|Washout Period 1||0
2413387|NCT01263197|5919516|P1|NOT COMPLETED|Washout Period 1||0
2413388|NCT01263197|5919511|P6|COMPLETED|Washout Period 1||7
2413389|NCT01263197|5919512|P5|COMPLETED|Washout Period 1||7
2413390|NCT01263197|5919513|P4|COMPLETED|Washout Period 1||8
2413391|NCT01263197|5919514|P3|COMPLETED|Washout Period 1||8
2413392|NCT01263197|5919515|P2|COMPLETED|Washout Period 1||8
2413393|NCT01263197|5919516|P1|COMPLETED|Washout Period 1||8
2413394|NCT01263197|5919511|P6|STARTED|Washout Period 1||7
2413395|NCT01263197|5919512|P5|STARTED|Washout Period 1||8
2413396|NCT01263197|5919513|P4|STARTED|Washout Period 1||8
2413397|NCT01263197|5919514|P3|STARTED|Washout Period 1||8
2413398|NCT01263197|5919515|P2|STARTED|Washout Period 1||8
2413399|NCT01263197|5919516|P1|STARTED|Washout Period 1||8
2413400|NCT01263197|5919511|P6|NOT COMPLETED|First Intervention (Period 1)||1
2413401|NCT01263197|5919512|P5|NOT COMPLETED|First Intervention (Period 1)||0
2413402|NCT01263197|5919513|P4|NOT COMPLETED|First Intervention (Period 1)||0
2413403|NCT01263197|5919514|P3|NOT COMPLETED|First Intervention (Period 1)||0
2413404|NCT01263197|5919515|P2|NOT COMPLETED|First Intervention (Period 1)||0
2413405|NCT01263197|5919516|P1|NOT COMPLETED|First Intervention (Period 1)||0
2413406|NCT01263197|5919511|P6|COMPLETED|First Intervention (Period 1)||7
2413407|NCT01263197|5919512|P5|COMPLETED|First Intervention (Period 1)||8
2413408|NCT01263197|5919513|P4|COMPLETED|First Intervention (Period 1)||8
2413409|NCT01263197|5919514|P3|COMPLETED|First Intervention (Period 1)||8
2413410|NCT01263197|5919515|P2|COMPLETED|First Intervention (Period 1)||8
2413411|NCT01263197|5919516|P1|COMPLETED|First Intervention (Period 1)||8
2413412|NCT01263197|5919511|P6|STARTED|First Intervention (Period 1)||8
2413413|NCT01263197|5919512|P5|STARTED|First Intervention (Period 1)||8
2413414|NCT01263197|5919513|P4|STARTED|First Intervention (Period 1)||8
2413415|NCT01263197|5919514|P3|STARTED|First Intervention (Period 1)||8
2413416|NCT01263197|5919515|P2|STARTED|First Intervention (Period 1)||8
2413417|NCT01263197|5919516|P1|STARTED|First Intervention (Period 1)||8
2413418|NCT01263132|5919544|P2|NOT COMPLETED|Overall Study||0
2413419|NCT01263132|5919545|P1|NOT COMPLETED|Overall Study||0
2413420|NCT01263132|5919544|P2|COMPLETED|Overall Study||37
2413421|NCT01263132|5919545|P1|COMPLETED|Overall Study||38
2413422|NCT01263132|5919544|P2|STARTED|Overall Study||37
2413423|NCT01263132|5919545|P1|STARTED|Overall Study||38
2413424|NCT01263119|5919559|P1|NOT COMPLETED|Period 2||2
2413425|NCT01263119|5919559|P1|COMPLETED|Period 2||14
2413426|NCT01263119|5919559|P1|STARTED|Period 2||16
2413427|NCT01263119|5919559|P1|NOT COMPLETED|Period 1||2
2413428|NCT01263119|5919559|P1|COMPLETED|Period 1||16
2413429|NCT01263119|5919559|P1|STARTED|Period 1||18
2413430|NCT01263106|5919580|P2|NOT COMPLETED|Period 2 (7 Days)||0
2413431|NCT01263106|5919581|P1|NOT COMPLETED|Period 2 (7 Days)||0
2413432|NCT01263106|5919580|P2|COMPLETED|Period 2 (7 Days)||9
2413433|NCT01263106|5919581|P1|COMPLETED|Period 2 (7 Days)||10
2413434|NCT01263106|5919580|P2|STARTED|Period 2 (7 Days)||9
2413435|NCT01263106|5919581|P1|STARTED|Period 2 (7 Days)||10
2413436|NCT01263106|5919580|P2|NOT COMPLETED|Washout (at Least 7 Days)||1
2413437|NCT01263106|5919581|P1|NOT COMPLETED|Washout (at Least 7 Days)||1
2413438|NCT01263106|5919580|P2|COMPLETED|Washout (at Least 7 Days)||9
2413439|NCT01263106|5919581|P1|COMPLETED|Washout (at Least 7 Days)||10
2413440|NCT01263106|5919580|P2|STARTED|Washout (at Least 7 Days)||10
2413441|NCT01263106|5919581|P1|STARTED|Washout (at Least 7 Days)||11
2413442|NCT01263106|5919580|P2|NOT COMPLETED|Period 1 (7 Days)||0
2413443|NCT01263106|5919581|P1|NOT COMPLETED|Period 1 (7 Days)||0
2413444|NCT01263106|5919580|P2|COMPLETED|Period 1 (7 Days)|Period 1: 1 participant took LY + theophylline but was not given theophylline alone.|10
2413445|NCT01263106|5919581|P1|COMPLETED|Period 1 (7 Days)|Period 1: 1 participant took theophylline alone but was not given LY + theophylline.|11
2413446|NCT01263106|5919580|P2|STARTED|Period 1 (7 Days)||10
2413447|NCT01263106|5919581|P1|STARTED|Period 1 (7 Days)||11
2413448|NCT01263093|5919596|P2|NOT COMPLETED|Period 2||0
2413449|NCT01263093|5919597|P1|NOT COMPLETED|Period 2||1
2413450|NCT01263093|5919596|P2|COMPLETED|Period 2||23
2413451|NCT01263093|5919597|P1|COMPLETED|Period 2||22
2413452|NCT01263093|5919596|P2|STARTED|Period 2||23
2413453|NCT01263093|5919597|P1|STARTED|Period 2||23
2413454|NCT01263093|5919596|P2|NOT COMPLETED|Washout||0
2413455|NCT01263093|5919597|P1|NOT COMPLETED|Washout||1
2413456|NCT01263093|5919596|P2|COMPLETED|Washout||23
2413457|NCT01263093|5919597|P1|COMPLETED|Washout||23
2413458|NCT01263093|5919596|P2|STARTED|Washout||23
2413459|NCT01263093|5919597|P1|STARTED|Washout||24
2413460|NCT01263093|5919596|P2|NOT COMPLETED|Period 1||0
2413461|NCT01263093|5919597|P1|NOT COMPLETED|Period 1||0
2413462|NCT01263093|5919596|P2|COMPLETED|Period 1||23
2413463|NCT01263093|5919597|P1|COMPLETED|Period 1||24
2413464|NCT01263093|5919596|P2|STARTED|Period 1||23
2413465|NCT01263093|5919597|P1|STARTED|Period 1||24
2413466|NCT01263054|5919614|P2|NOT COMPLETED|Overall Study||6
2413467|NCT01263054|5919615|P1|NOT COMPLETED|Overall Study||5
2413468|NCT01263054|5919614|P2|COMPLETED|Overall Study||28
2413469|NCT01263054|5919615|P1|COMPLETED|Overall Study||24
2413470|NCT01263054|5919614|P2|STARTED|Overall Study||34
2413471|NCT01263054|5919615|P1|STARTED|Overall Study||29
2413472|NCT01263028|5919633|P1|NOT COMPLETED|Overall Study||6
2413473|NCT01263028|5919633|P1|COMPLETED|Overall Study||0
2413474|NCT01263028|5919633|P1|STARTED|Overall Study||6
2413475|NCT01263015|5919643|P2|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||31
2413476|NCT01263015|5919644|P1|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||24
2413477|NCT01263015|5919643|P2|COMPLETED|Open-label Phase: 48 Weeks Duration||278
2413478|NCT01263015|5919644|P1|COMPLETED|Open-label Phase: 48 Weeks Duration||317
2413479|NCT01263015|5919643|P2|STARTED|Open-label Phase: 48 Weeks Duration||309
2413480|NCT01263015|5919644|P1|STARTED|Open-label Phase: 48 Weeks Duration||341
2413481|NCT01263015|5919643|P2|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||109
2413482|NCT01263015|5919644|P1|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||72
2413483|NCT01263015|5919643|P2|COMPLETED|Double-blind Phase: 96 Weeks Duration||310
2413484|NCT01263015|5919644|P1|COMPLETED|Double-blind Phase: 96 Weeks Duration||342
2413485|NCT01263015|5919643|P2|STARTED|Double-blind Phase: 96 Weeks Duration||419
2413486|NCT01263015|5919644|P1|STARTED|Double-blind Phase: 96 Weeks Duration||414
2413487|NCT01262989|5919670|P2|NOT COMPLETED|Period 2||1
2413488|NCT01262989|5919671|P1|NOT COMPLETED|Period 2||0
2413489|NCT01262989|5919670|P2|COMPLETED|Period 2||16
2413490|NCT01262989|5919671|P1|COMPLETED|Period 2||19
2413491|NCT01262989|5919670|P2|STARTED|Period 2||17
2413492|NCT01262989|5919671|P1|STARTED|Period 2||19
2413493|NCT01262989|5919670|P2|NOT COMPLETED|7-Day Washout Period||0
2413494|NCT01262989|5919671|P1|NOT COMPLETED|7-Day Washout Period||0
2413495|NCT01262989|5919670|P2|COMPLETED|7-Day Washout Period||17
2413496|NCT01262989|5919671|P1|COMPLETED|7-Day Washout Period||19
2413497|NCT01262989|5919670|P2|STARTED|7-Day Washout Period||17
2413498|NCT01262989|5919671|P1|STARTED|7-Day Washout Period||19
2413499|NCT01262989|5919670|P2|NOT COMPLETED|Period 1||3
2413500|NCT01262989|5919671|P1|NOT COMPLETED|Period 1||1
2413501|NCT01262989|5919670|P2|COMPLETED|Period 1||17
2413502|NCT01262989|5919671|P1|COMPLETED|Period 1||19
2413503|NCT01262989|5919670|P2|STARTED|Period 1||20
2413504|NCT01262989|5919671|P1|STARTED|Period 1||20
2413505|NCT01262976|5919687|P6|NOT COMPLETED|Up to Year 3||4
2413506|NCT01262976|5919688|P5|NOT COMPLETED|Up to Year 3||2
2413507|NCT01262976|5919689|P4|NOT COMPLETED|Up to Year 3||5
2413508|NCT01262976|5919690|P3|NOT COMPLETED|Up to Year 3||7
2413509|NCT01262976|5919691|P2|NOT COMPLETED|Up to Year 3||2
2413510|NCT01262976|5919692|P1|NOT COMPLETED|Up to Year 3||6
2413511|NCT01262976|5919687|P6|COMPLETED|Up to Year 3||36
2413512|NCT01262976|5919688|P5|COMPLETED|Up to Year 3||38
2413513|NCT01262976|5919689|P4|COMPLETED|Up to Year 3||35
2413514|NCT01262976|5919690|P3|COMPLETED|Up to Year 3||33
2413515|NCT01262976|5919691|P2|COMPLETED|Up to Year 3||38
2413516|NCT01262976|5919692|P1|COMPLETED|Up to Year 3||34
2413517|NCT01262976|5919687|P6|STARTED|Up to Year 3||40
2413518|NCT01262976|5919688|P5|STARTED|Up to Year 3||40
2413519|NCT01262976|5919689|P4|STARTED|Up to Year 3||40
2413520|NCT01262976|5919690|P3|STARTED|Up to Year 3||40
2413521|NCT01262976|5919691|P2|STARTED|Up to Year 3||40
2413522|NCT01262976|5919692|P1|STARTED|Up to Year 3||40
2413523|NCT01262976|5919687|P6|NOT COMPLETED|Up to Year 2||5
2413524|NCT01262976|5919688|P5|NOT COMPLETED|Up to Year 2||4
2413525|NCT01262976|5919689|P4|NOT COMPLETED|Up to Year 2||4
2413526|NCT01262976|5919690|P3|NOT COMPLETED|Up to Year 2||5
2413527|NCT01262976|5919691|P2|NOT COMPLETED|Up to Year 2||1
2413528|NCT01262976|5919692|P1|NOT COMPLETED|Up to Year 2||5
2413529|NCT01262976|5919687|P6|COMPLETED|Up to Year 2||35
2413530|NCT01262976|5919688|P5|COMPLETED|Up to Year 2||36
2413531|NCT01262976|5919689|P4|COMPLETED|Up to Year 2||36
2413532|NCT01262976|5919690|P3|COMPLETED|Up to Year 2||35
2413533|NCT01262976|5919691|P2|COMPLETED|Up to Year 2||39
2413534|NCT01262976|5919692|P1|COMPLETED|Up to Year 2||35
2413535|NCT01262976|5919687|P6|STARTED|Up to Year 2||40
2413536|NCT01262976|5919688|P5|STARTED|Up to Year 2||40
2413537|NCT01262976|5919689|P4|STARTED|Up to Year 2||40
2413538|NCT01262976|5919690|P3|STARTED|Up to Year 2||40
2413539|NCT01262976|5919691|P2|STARTED|Up to Year 2||40
2413540|NCT01262976|5919692|P1|STARTED|Up to Year 2||40
2413541|NCT01262976|5919687|P6|NOT COMPLETED|Up to Year 1||9
2413542|NCT01262976|5919688|P5|NOT COMPLETED|Up to Year 1||11
2413543|NCT01262976|5919689|P4|NOT COMPLETED|Up to Year 1||4
2413544|NCT01262976|5919690|P3|NOT COMPLETED|Up to Year 1||3
2413545|NCT01262976|5919691|P2|NOT COMPLETED|Up to Year 1||1
2413546|NCT01262976|5919692|P1|NOT COMPLETED|Up to Year 1||9
2413547|NCT01262976|5919687|P6|COMPLETED|Up to Year 1||31
2413548|NCT01262976|5919688|P5|COMPLETED|Up to Year 1||29
2413549|NCT01262976|5919689|P4|COMPLETED|Up to Year 1||36
2413550|NCT01262976|5919690|P3|COMPLETED|Up to Year 1||37
2413551|NCT01262976|5919691|P2|COMPLETED|Up to Year 1||39
2413552|NCT01262976|5919692|P1|COMPLETED|Up to Year 1||31
2413553|NCT01262976|5919687|P6|STARTED|Up to Year 1||40
2413554|NCT01262976|5919688|P5|STARTED|Up to Year 1||40
2413555|NCT01262976|5919689|P4|STARTED|Up to Year 1||40
2413556|NCT01262976|5919690|P3|STARTED|Up to Year 1||40
2413557|NCT01262976|5919691|P2|STARTED|Up to Year 1||40
2413558|NCT01262976|5919692|P1|STARTED|Up to Year 1||40
2413559|NCT01262976|5919687|P6|NOT COMPLETED|Up to Month 7||4
2413560|NCT01262976|5919688|P5|NOT COMPLETED|Up to Month 7||2
2413561|NCT01262976|5919689|P4|NOT COMPLETED|Up to Month 7||6
2413562|NCT01262976|5919690|P3|NOT COMPLETED|Up to Month 7||6
2413563|NCT01262976|5919691|P2|NOT COMPLETED|Up to Month 7||0
2413564|NCT01262976|5919692|P1|NOT COMPLETED|Up to Month 7||5
2413565|NCT01262976|5919687|P6|COMPLETED|Up to Month 7||36
2413566|NCT01262976|5919688|P5|COMPLETED|Up to Month 7||38
2413567|NCT01262976|5919689|P4|COMPLETED|Up to Month 7||34
2413568|NCT01262976|5919690|P3|COMPLETED|Up to Month 7||34
2413569|NCT01262976|5919691|P2|COMPLETED|Up to Month 7||40
2413570|NCT01262976|5919692|P1|COMPLETED|Up to Month 7||35
2413571|NCT01262976|5919687|P6|STARTED|Up to Month 7||40
2413572|NCT01262976|5919688|P5|STARTED|Up to Month 7||40
2413573|NCT01262976|5919689|P4|STARTED|Up to Month 7||40
2413574|NCT01262976|5919690|P3|STARTED|Up to Month 7||40
2413575|NCT01262976|5919691|P2|STARTED|Up to Month 7||40
2413576|NCT01262976|5919692|P1|STARTED|Up to Month 7||40
2413577|NCT01262976|5919687|P6|NOT COMPLETED|Up to Month 2||4
2413578|NCT01262976|5919688|P5|NOT COMPLETED|Up to Month 2||2
2413579|NCT01262976|5919689|P4|NOT COMPLETED|Up to Month 2||2
2413580|NCT01262976|5919690|P3|NOT COMPLETED|Up to Month 2||1
2413581|NCT01262976|5919691|P2|NOT COMPLETED|Up to Month 2||1
2413582|NCT01262976|5919692|P1|NOT COMPLETED|Up to Month 2||3
2413583|NCT01262976|5919687|P6|COMPLETED|Up to Month 2||36
2413584|NCT01262976|5919688|P5|COMPLETED|Up to Month 2||38
2413585|NCT01262976|5919689|P4|COMPLETED|Up to Month 2||38
2413586|NCT01262976|5919690|P3|COMPLETED|Up to Month 2||39
2413587|NCT01262976|5919691|P2|COMPLETED|Up to Month 2||39
2413588|NCT01262976|5919692|P1|COMPLETED|Up to Month 2||37
2413589|NCT01262976|5919687|P6|STARTED|Up to Month 2||40
2413590|NCT01262976|5919688|P5|STARTED|Up to Month 2||40
2413591|NCT01262976|5919689|P4|STARTED|Up to Month 2||40
2413592|NCT01262976|5919690|P3|STARTED|Up to Month 2||40
2413593|NCT01262976|5919691|P2|STARTED|Up to Month 2||40
2413594|NCT01262976|5919692|P1|STARTED|Up to Month 2||40
2413595|NCT01262898|5919848|P4|NOT COMPLETED|Overall Study||0
2413596|NCT01262898|5919849|P3|NOT COMPLETED|Overall Study||0
2413597|NCT01262898|5919850|P2|NOT COMPLETED|Overall Study||2
2413598|NCT01262898|5919851|P1|NOT COMPLETED|Overall Study||3
2413599|NCT01262898|5919848|P4|COMPLETED|Overall Study||22
2413600|NCT01262898|5919849|P3|COMPLETED|Overall Study||18
2413601|NCT01262898|5919850|P2|COMPLETED|Overall Study||16
2413602|NCT01262898|5919851|P1|COMPLETED|Overall Study||18
2413603|NCT01262898|5919848|P4|STARTED|Overall Study||22
2413604|NCT01262898|5919849|P3|STARTED|Overall Study||18
2413605|NCT01262898|5919850|P2|STARTED|Overall Study||18
2413606|NCT01262898|5919851|P1|STARTED|Overall Study||21
2413607|NCT01262872|5919979|P8|NOT COMPLETED|Step 2||6
2413608|NCT01262872|5919980|P7|NOT COMPLETED|Step 2||9
2413609|NCT01262872|5919981|P6|NOT COMPLETED|Step 2||9
2413610|NCT01262872|5919982|P5|NOT COMPLETED|Step 2||5
2413611|NCT01262872|5919983|P4|NOT COMPLETED|Step 2||10
2413612|NCT01262872|5919984|P3|NOT COMPLETED|Step 2||9
2413613|NCT01262872|5919985|P2|NOT COMPLETED|Step 2||0
2413614|NCT01262872|5919986|P1|NOT COMPLETED|Step 2||0
2413615|NCT01262872|5919979|P8|COMPLETED|Step 2||194
2413616|NCT01262872|5919980|P7|COMPLETED|Step 2||191
2413617|NCT01262872|5919981|P6|COMPLETED|Step 2||191
2413618|NCT01262872|5919982|P5|COMPLETED|Step 2||195
2413619|NCT01262872|5919983|P4|COMPLETED|Step 2||190
2413620|NCT01262872|5919984|P3|COMPLETED|Step 2||191
2413621|NCT01262872|5919985|P2|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
2413622|NCT01262872|5919986|P1|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
2413623|NCT01262872|5919979|P8|STARTED|Step 2||200
2413624|NCT01262872|5919980|P7|STARTED|Step 2||200
2413625|NCT01262872|5919981|P6|STARTED|Step 2||200
2413626|NCT01262872|5919982|P5|STARTED|Step 2||200
2413627|NCT01262872|5919983|P4|STARTED|Step 2||200
2413628|NCT01262872|5919984|P3|STARTED|Step 2||200
2413629|NCT01262872|5919985|P2|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
2413630|NCT01262872|5919986|P1|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
2413631|NCT01262872|5919979|P8|NOT COMPLETED|Step 1||0
2413632|NCT01262872|5919980|P7|NOT COMPLETED|Step 1||0
2413633|NCT01262872|5919981|P6|NOT COMPLETED|Step 1||0
2413634|NCT01262872|5919982|P5|NOT COMPLETED|Step 1||0
2413635|NCT01262872|5919983|P4|NOT COMPLETED|Step 1||0
2413636|NCT01262872|5919984|P3|NOT COMPLETED|Step 1||0
2413637|NCT01262872|5919985|P2|NOT COMPLETED|Step 1||0
2413638|NCT01262872|5919986|P1|NOT COMPLETED|Step 1||0
2413639|NCT01262872|5919979|P8|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
2413640|NCT01262872|5919980|P7|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
2413720|NCT01262456|5920474|P1|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||124
2413641|NCT01262872|5919981|P6|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
2413642|NCT01262872|5919982|P5|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
2413643|NCT01262872|5919983|P4|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone|0
2413644|NCT01262872|5919984|P3|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
2413645|NCT01262872|5919985|P2|COMPLETED|Step 1||60
2413646|NCT01262872|5919986|P1|COMPLETED|Step 1||60
2413647|NCT01262872|5919979|P8|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
2413648|NCT01262872|5919980|P7|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
2413649|NCT01262872|5919981|P6|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
2413650|NCT01262872|5919982|P5|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
2413651|NCT01262872|5919983|P4|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
2413652|NCT01262872|5919984|P3|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
2413653|NCT01262872|5919985|P2|STARTED|Step 1||60
2413654|NCT01262872|5919986|P1|STARTED|Step 1||60
2413655|NCT01262846|5920253|P2|NOT COMPLETED|Overall Study||3
2413656|NCT01262846|5920254|P1|NOT COMPLETED|Overall Study||2
2413657|NCT01262846|5920253|P2|COMPLETED|Overall Study||97
2413658|NCT01262846|5920254|P1|COMPLETED|Overall Study||93
2413659|NCT01262846|5920253|P2|STARTED|Overall Study||100
2413660|NCT01262846|5920254|P1|STARTED|Overall Study||95
2413661|NCT01262820|5920260|P1|NOT COMPLETED|Overall Study||15
2413662|NCT01262820|5920260|P1|COMPLETED|Overall Study||0
2413663|NCT01262820|5920260|P1|STARTED|Overall Study||15
2413664|NCT01262755|5920267|P1|NOT COMPLETED|Overall Study||0
2413665|NCT01262755|5920267|P1|COMPLETED|Overall Study||450
2413666|NCT01262755|5920267|P1|STARTED|Overall Study||450
2413667|NCT01262677|5920274|P3|NOT COMPLETED|Overall Study||12
2413668|NCT01262677|5920275|P2|NOT COMPLETED|Overall Study||15
2413669|NCT01262677|5920276|P1|NOT COMPLETED|Overall Study||9
2413670|NCT01262677|5920274|P3|COMPLETED|Overall Study||98
2413671|NCT01262677|5920275|P2|COMPLETED|Overall Study||98
2413672|NCT01262677|5920276|P1|COMPLETED|Overall Study||91
2413673|NCT01262677|5920274|P3|STARTED|Overall Study||110
2413674|NCT01262677|5920275|P2|STARTED|Overall Study||113
2413675|NCT01262677|5920276|P1|STARTED|Overall Study||100
2413676|NCT01262651|5920367|P2|NOT COMPLETED|Overall Study||48
2413677|NCT01262651|5920368|P1|NOT COMPLETED|Overall Study||58
2413678|NCT01262651|5920367|P2|COMPLETED|Overall Study||150
2413679|NCT01262651|5920368|P1|COMPLETED|Overall Study||141
2413680|NCT01262651|5920367|P2|ITT Population|Overall Study||198
2413681|NCT01262651|5920368|P1|ITT Population|Overall Study||199
2413682|NCT01262651|5920367|P2|Safety Population|Overall Study||198
2413683|NCT01262651|5920368|P1|Safety Population|Overall Study||199
2413684|NCT01262651|5920367|P2|Received at Least 1 Dose of Study Drug|Overall Study||198
2413685|NCT01262651|5920368|P1|Received at Least 1 Dose of Study Drug|Overall Study||199
2413686|NCT01262651|5920367|P2|STARTED|Overall Study||198
2413687|NCT01262651|5920368|P1|STARTED|Overall Study||199
2413688|NCT01262599|5920396|P2|NOT COMPLETED|Overall Study||0
2413689|NCT01262599|5920397|P1|NOT COMPLETED|Overall Study||0
2413690|NCT01262599|5920396|P2|COMPLETED|Overall Study||16
2413691|NCT01262599|5920397|P1|COMPLETED|Overall Study||16
2413692|NCT01262599|5920396|P2|STARTED|Overall Study||16
2413693|NCT01262599|5920397|P1|STARTED|Overall Study||16
2413694|NCT01262573|5920409|P2|NOT COMPLETED|Overall Study||1
2413695|NCT01262573|5920410|P1|NOT COMPLETED|Overall Study||0
2413696|NCT01262573|5920409|P2|COMPLETED|Overall Study||31
2413697|NCT01262573|5920410|P1|COMPLETED|Overall Study||32
2413698|NCT01262573|5920409|P2|STARTED|Overall Study||32
2413699|NCT01262573|5920410|P1|STARTED|Overall Study||32
2413700|NCT01262560|5920421|P3|NOT COMPLETED|Overall Study||2
2413701|NCT01262560|5920422|P2|NOT COMPLETED|Overall Study||1
2413702|NCT01262560|5920423|P1|NOT COMPLETED|Overall Study||0
2413703|NCT01262560|5920421|P3|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|54
2413704|NCT01262560|5920422|P2|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
2413705|NCT01262560|5920423|P1|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
2413706|NCT01262560|5920421|P3|STARTED|Overall Study||56
2413707|NCT01262560|5920422|P2|STARTED|Overall Study||54
2413708|NCT01262560|5920423|P1|STARTED|Overall Study||53
2413709|NCT01262547|5920458|P1|NOT COMPLETED|Overall Study||0
2413710|NCT01262547|5920458|P1|COMPLETED|Overall Study||3
2413711|NCT01262547|5920458|P1|STARTED|Overall Study||3
2413712|NCT01262456|5920472|P3|NOT COMPLETED|1-Month Open-Label Extension Period||5
2413713|NCT01262456|5920473|P2|NOT COMPLETED|1-Month Open-Label Extension Period||3
2413714|NCT01262456|5920474|P1|NOT COMPLETED|1-Month Open-Label Extension Period||4
2413715|NCT01262456|5920472|P3|COMPLETED|1-Month Open-Label Extension Period||98
2413716|NCT01262456|5920473|P2|COMPLETED|1-Month Open-Label Extension Period||97
2413717|NCT01262456|5920474|P1|COMPLETED|1-Month Open-Label Extension Period||120
2413718|NCT01262456|5920472|P3|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period|1 subject was randomized to Desmopressin 75 μg but received 50 μg. Also true in Double-Blind Period|102
2413719|NCT01262456|5920473|P2|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||101
2413721|NCT01262456|5920472|P3|STARTED|1-Month Open-Label Extension Period||103
2413722|NCT01262456|5920473|P2|STARTED|1-Month Open-Label Extension Period||100
2413723|NCT01262456|5920474|P1|STARTED|1-Month Open-Label Extension Period||124
2413724|NCT01262456|5920472|P3|NOT COMPLETED|3-Month Double-Blind Period||26
2413725|NCT01262456|5920473|P2|NOT COMPLETED|3-Month Double-Blind Period||23
2413726|NCT01262456|5920474|P1|NOT COMPLETED|3-Month Double-Blind Period||19
2413727|NCT01262456|5920472|P3|COMPLETED|3-Month Double-Blind Period||103
2413728|NCT01262456|5920473|P2|COMPLETED|3-Month Double-Blind Period||100
2413729|NCT01262456|5920474|P1|COMPLETED|3-Month Double-Blind Period||124
2413730|NCT01262456|5920472|P3|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|122
2413731|NCT01262456|5920473|P2|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|119
2413732|NCT01262456|5920474|P1|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|143
2413733|NCT01262456|5920472|P3|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|124
2413734|NCT01262456|5920473|P2|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|119
2413735|NCT01262456|5920474|P1|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|142
2413736|NCT01262456|5920472|P3|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|129
2413737|NCT01262456|5920473|P2|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|123
2413738|NCT01262456|5920474|P1|STARTED|3-Month Double-Blind Period|Intent-to-Treat (ITT) population: randomized participants regardless of exposure to treatment|143
2413739|NCT01262365|5920518|P3|NOT COMPLETED|Overall Study||94
2413740|NCT01262365|5920519|P2|NOT COMPLETED|Overall Study||81
2413741|NCT01262365|5920520|P1|NOT COMPLETED|Overall Study||90
2413742|NCT01262365|5920518|P3|COMPLETED|Overall Study||171
2413743|NCT01262365|5920519|P2|COMPLETED|Overall Study||181
2413744|NCT01262365|5920520|P1|COMPLETED|Overall Study||176
2413745|NCT01262365|5920518|P3|STARTED|Overall Study||265
2413746|NCT01262365|5920519|P2|STARTED|Overall Study||262
2413747|NCT01262365|5920520|P1|STARTED|Overall Study||266
2413748|NCT01262352|5920545|P2|NOT COMPLETED|Period 2||0
2413749|NCT01262352|5920546|P1|NOT COMPLETED|Period 2||0
2413750|NCT01262352|5920545|P2|COMPLETED|Period 2||8
2413751|NCT01262352|5920546|P1|COMPLETED|Period 2||9
2413752|NCT01262352|5920545|P2|Dosed|Period 2||8
2413753|NCT01262352|5920546|P1|Dosed|Period 2||9
2413754|NCT01262352|5920545|P2|STARTED|Period 2||8
2413755|NCT01262352|5920546|P1|STARTED|Period 2||9
2413756|NCT01262352|5920545|P2|NOT COMPLETED|Washout||2
2413757|NCT01262352|5920546|P1|NOT COMPLETED|Washout||1
2413758|NCT01262352|5920545|P2|COMPLETED|Washout||8
2413759|NCT01262352|5920546|P1|COMPLETED|Washout||9
2413760|NCT01262352|5920545|P2|STARTED|Washout||10
2413761|NCT01262352|5920546|P1|STARTED|Washout||10
2413762|NCT01262352|5920545|P2|NOT COMPLETED|Period 1||0
2413763|NCT01262352|5920546|P1|NOT COMPLETED|Period 1||1
2413764|NCT01262352|5920545|P2|COMPLETED|Period 1||10
2413765|NCT01262352|5920546|P1|COMPLETED|Period 1||10
2413766|NCT01262352|5920545|P2|Dosed|Period 1||10
2413767|NCT01262352|5920546|P1|Dosed|Period 1||10
2413768|NCT01262352|5920545|P2|STARTED|Period 1||10
2413769|NCT01262352|5920546|P1|STARTED|Period 1||11
2413770|NCT01262339|5920558|P1|NOT COMPLETED|Overall Study||0
2413771|NCT01262339|5920558|P1|COMPLETED|Overall Study||2
2413772|NCT01262339|5920558|P1|STARTED|Overall Study||2
2413773|NCT01262287|5920564|P2|NOT COMPLETED|Overall Study||1
2413774|NCT01262287|5920565|P1|NOT COMPLETED|Overall Study||2
2413775|NCT01262287|5920564|P2|COMPLETED|Overall Study||18
2413776|NCT01262287|5920565|P1|COMPLETED|Overall Study||18
2413777|NCT01262287|5920564|P2|STARTED|Overall Study||19
2413778|NCT01262287|5920565|P1|STARTED|Overall Study||20
2413779|NCT01262131|5920578|P3|NOT COMPLETED|Overall Study||0
2413780|NCT01262131|5920579|P2|NOT COMPLETED|Overall Study||0
2413781|NCT01262131|5920580|P1|NOT COMPLETED|Overall Study||0
2413782|NCT01262131|5920578|P3|COMPLETED|Overall Study||4
2413783|NCT01262131|5920579|P2|COMPLETED|Overall Study||4
2413784|NCT01262131|5920580|P1|COMPLETED|Overall Study||5
2413785|NCT01262131|5920578|P3|STARTED|Overall Study||4
2413786|NCT01262131|5920579|P2|STARTED|Overall Study||4
2413787|NCT01262131|5920580|P1|STARTED|Overall Study||5
2413788|NCT01262118|5920590|P2|NOT COMPLETED|Treatment Period (6 Weeks)||0
2413789|NCT01262118|5920591|P1|NOT COMPLETED|Treatment Period (6 Weeks)||0
2413790|NCT01262118|5920590|P2|COMPLETED|Treatment Period (6 Weeks)||0
2413791|NCT01262118|5920591|P1|COMPLETED|Treatment Period (6 Weeks)||36
2413792|NCT01262118|5920590|P2|STARTED|Treatment Period (6 Weeks)||0
2413793|NCT01262118|5920591|P1|STARTED|Treatment Period (6 Weeks)||36
2413794|NCT01262118|5920590|P2|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
2413795|NCT01262118|5920591|P1|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
2413796|NCT01262118|5920590|P2|COMPLETED|Baseline Assessment Period (3 Days)||33
2413797|NCT01262118|5920591|P1|COMPLETED|Baseline Assessment Period (3 Days)||36
2413798|NCT01262118|5920590|P2|STARTED|Baseline Assessment Period (3 Days)||33
2413799|NCT01262118|5920591|P1|STARTED|Baseline Assessment Period (3 Days)||36
2413800|NCT01262105|5920617|P2|NOT COMPLETED|Overall Study||0
2413801|NCT01262105|5920618|P1|NOT COMPLETED|Overall Study||0
2413802|NCT01262105|5920617|P2|COMPLETED|Overall Study||10
2413803|NCT01262105|5920618|P1|COMPLETED|Overall Study||13
2413804|NCT01262105|5920617|P2|STARTED|Overall Study||10
2413805|NCT01262105|5920618|P1|STARTED|Overall Study||13
2413806|NCT01262092|5920626|P2|NOT COMPLETED|Gabapentin Taper||0
2413807|NCT01262092|5920627|P1|NOT COMPLETED|Gabapentin Taper||1
2413808|NCT01262092|5920626|P2|COMPLETED|Gabapentin Taper||11
2413809|NCT01262092|5920627|P1|COMPLETED|Gabapentin Taper||9
2413810|NCT01262092|5920626|P2|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|11
2413811|NCT01262092|5920627|P1|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|10
2413812|NCT01262092|5920626|P2|NOT COMPLETED|Buprenorphine Taper||1
2413813|NCT01262092|5920627|P1|NOT COMPLETED|Buprenorphine Taper||1
2413814|NCT01262092|5920626|P2|COMPLETED|Buprenorphine Taper||12
2413815|NCT01262092|5920627|P1|COMPLETED|Buprenorphine Taper||11
2413816|NCT01262092|5920626|P2|STARTED|Buprenorphine Taper||13
2413817|NCT01262092|5920627|P1|STARTED|Buprenorphine Taper|One left the study prior to starting the taper due to pharmacy error (started taper in wk 2)|12
2413818|NCT01262092|5920626|P2|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||1
2413819|NCT01262092|5920627|P1|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||3
2413820|NCT01262092|5920626|P2|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
2413821|NCT01262092|5920627|P1|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
2413822|NCT01262092|5920626|P2|STARTED|Buprenorphine+Gabapentin/Plac Induction||14
2413823|NCT01262092|5920627|P1|STARTED|Buprenorphine+Gabapentin/Plac Induction||16
2413824|NCT01262027|5920633|P1|NOT COMPLETED|Overall Study||5
2413825|NCT01262027|5920633|P1|COMPLETED|Overall Study||17
2413826|NCT01262027|5920633|P1|STARTED|Overall Study||22
2413827|NCT01261975|5920638|P1|NOT COMPLETED|Overall Study||1
2413828|NCT01261975|5920638|P1|COMPLETED|Overall Study|35 Participants 70 eyes completed|35
2413829|NCT01261975|5920638|P1|STARTED|Overall Study|36 Participants 72 eyes started|36
2413830|NCT01261793|5920660|P3|NOT COMPLETED|Overall Study||82
2413831|NCT01261793|5920661|P2|NOT COMPLETED|Overall Study||91
2413832|NCT01261793|5920662|P1|NOT COMPLETED|Overall Study||85
2413833|NCT01261793|5920660|P3|COMPLETED|Overall Study||184
2413834|NCT01261793|5920661|P2|COMPLETED|Overall Study||171
2413835|NCT01261793|5920662|P1|COMPLETED|Overall Study||178
2413836|NCT01261793|5920660|P3|STARTED|Overall Study||266
2413837|NCT01261793|5920661|P2|STARTED|Overall Study||262
2413838|NCT01261793|5920662|P1|STARTED|Overall Study||263
2413839|NCT01261780|5920687|P2|NOT COMPLETED|Overall Study||2
2413840|NCT01261780|5920688|P1|NOT COMPLETED|Overall Study||2
2413841|NCT01261780|5920687|P2|COMPLETED|Overall Study||5
2413842|NCT01261780|5920688|P1|COMPLETED|Overall Study||5
2413843|NCT01261780|5920687|P2|STARTED|Overall Study||7
2413844|NCT01261780|5920688|P1|STARTED|Overall Study||7
2413845|NCT01261624|5920698|P2|NOT COMPLETED|Week 13 to Week 24||1
2413846|NCT01261624|5920699|P1|NOT COMPLETED|Week 13 to Week 24||0
2413847|NCT01261624|5920698|P2|COMPLETED|Week 13 to Week 24||10
2413848|NCT01261624|5920699|P1|COMPLETED|Week 13 to Week 24||1
2413849|NCT01261624|5920698|P2|STARTED|Week 13 to Week 24|Of 6 pts of HDTC: 3 non-responders went out of study, 3 continued. 8 swithched from LDTC to HDTC|11
2413850|NCT01261624|5920699|P1|STARTED|Week 13 to Week 24|Of 9 pts from LDTC: 5 non-responders switched to HDTC; 4 pts responded, but 3 switched to HDTC|1
2413851|NCT01261624|5920698|P2|NOT COMPLETED|Week 0 to Week 12||3
2413852|NCT01261624|5920699|P1|NOT COMPLETED|Week 0 to Week 12||1
2413853|NCT01261624|5920698|P2|COMPLETED|Week 0 to Week 12||3
2413854|NCT01261624|5920699|P1|COMPLETED|Week 0 to Week 12||9
2413855|NCT01261624|5920698|P2|STARTED|Week 0 to Week 12||6
2413856|NCT01261624|5920699|P1|STARTED|Week 0 to Week 12||10
2413857|NCT01261611|5920719|P3|NOT COMPLETED|Treatment Cycle 5||0
2413858|NCT01261611|5920720|P2|NOT COMPLETED|Treatment Cycle 5||0
2413859|NCT01261611|5920721|P1|NOT COMPLETED|Treatment Cycle 5||3
2413860|NCT01261611|5920719|P3|COMPLETED|Treatment Cycle 5||0
2413861|NCT01261611|5920720|P2|COMPLETED|Treatment Cycle 5||0
2413862|NCT01261611|5920721|P1|COMPLETED|Treatment Cycle 5||217
2413863|NCT01261611|5920719|P3|STARTED|Treatment Cycle 5||0
2413864|NCT01261611|5920720|P2|STARTED|Treatment Cycle 5||0
2413865|NCT01261611|5920721|P1|STARTED|Treatment Cycle 5||220
2413866|NCT01261611|5920719|P3|NOT COMPLETED|Treatment Cycle 4||0
2413867|NCT01261611|5920720|P2|NOT COMPLETED|Treatment Cycle 4||0
2413868|NCT01261611|5920721|P1|NOT COMPLETED|Treatment Cycle 4||96
2413869|NCT01261611|5920719|P3|COMPLETED|Treatment Cycle 4||0
2413870|NCT01261611|5920720|P2|COMPLETED|Treatment Cycle 4||0
2413871|NCT01261611|5920721|P1|COMPLETED|Treatment Cycle 4||220
2413872|NCT01261611|5920719|P3|STARTED|Treatment Cycle 4||0
2413873|NCT01261611|5920720|P2|STARTED|Treatment Cycle 4||0
2413874|NCT01261611|5920721|P1|STARTED|Treatment Cycle 4||316
2413875|NCT01261611|5920719|P3|NOT COMPLETED|Treatment Cycle 3||0
2413876|NCT01261611|5920720|P2|NOT COMPLETED|Treatment Cycle 3||0
2413877|NCT01261611|5920721|P1|NOT COMPLETED|Treatment Cycle 3||30
2413878|NCT01261611|5920719|P3|COMPLETED|Treatment Cycle 3||0
2413879|NCT01261611|5920720|P2|COMPLETED|Treatment Cycle 3||0
2413880|NCT01261611|5920721|P1|COMPLETED|Treatment Cycle 3||316
2413881|NCT01261611|5920719|P3|STARTED|Treatment Cycle 3||0
2413882|NCT01261611|5920720|P2|STARTED|Treatment Cycle 3||0
2413883|NCT01261611|5920721|P1|STARTED|Treatment Cycle 3||346
2413884|NCT01261611|5920719|P3|NOT COMPLETED|Treatment Cycle 2||0
2413885|NCT01261611|5920720|P2|NOT COMPLETED|Treatment Cycle 2||0
2413886|NCT01261611|5920721|P1|NOT COMPLETED|Treatment Cycle 2||13
2413887|NCT01261611|5920719|P3|COMPLETED|Treatment Cycle 2||0
2413888|NCT01261611|5920720|P2|COMPLETED|Treatment Cycle 2||0
2413889|NCT01261611|5920721|P1|COMPLETED|Treatment Cycle 2||346
2413890|NCT01261611|5920719|P3|STARTED|Treatment Cycle 2||0
2413891|NCT01261611|5920720|P2|STARTED|Treatment Cycle 2||0
2413892|NCT01261611|5920721|P1|STARTED|Treatment Cycle 2|All but 1 who completed DB period entered the open label period. This subject remained at Cycle 1.|359
2413893|NCT01261611|5920719|P3|NOT COMPLETED|Treatment Cycle 1||2
2413894|NCT01261611|5920720|P2|NOT COMPLETED|Treatment Cycle 1||3
2413895|NCT01261611|5920721|P1|NOT COMPLETED|Treatment Cycle 1||4
2413896|NCT01261611|5920719|P3|COMPLETED|Treatment Cycle 1||52
2413897|NCT01261611|5920720|P2|COMPLETED|Treatment Cycle 1||156
2413898|NCT01261611|5920721|P1|COMPLETED|Treatment Cycle 1||152
2413899|NCT01261611|5920719|P3|STARTED|Treatment Cycle 1||54
2413900|NCT01261611|5920720|P2|STARTED|Treatment Cycle 1||159
2413901|NCT01261611|5920721|P1|STARTED|Treatment Cycle 1||156
2413902|NCT01261559|5920759|P2|NOT COMPLETED|Overall Study||0
2413903|NCT01261559|5920760|P1|NOT COMPLETED|Overall Study||0
2413904|NCT01261559|5920759|P2|COMPLETED|Overall Study||36
2413905|NCT01261559|5920760|P1|COMPLETED|Overall Study||36
2413906|NCT01261559|5920759|P2|STARTED|Overall Study||36
2413907|NCT01261559|5920760|P1|STARTED|Overall Study||36
2413908|NCT01261507|5920772|P1|NOT COMPLETED|Overall Study||0
2413909|NCT01261507|5920772|P1|COMPLETED|Overall Study||15
2413910|NCT01261507|5920772|P1|STARTED|Overall Study||15
2413911|NCT01261390|5920785|P4|NOT COMPLETED|Overall Study||8
2413912|NCT01261390|5920786|P3|NOT COMPLETED|Overall Study||7
2413913|NCT01261390|5920787|P2|NOT COMPLETED|Overall Study||9
2413914|NCT01261390|5920788|P1|NOT COMPLETED|Overall Study||7
2413915|NCT01261390|5920785|P4|COMPLETED|Overall Study|14 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
2413916|NCT01261390|5920786|P3|COMPLETED|Overall Study|16 of the 35 participants that completed the study in this arm were under the 6-Month protocol.|35
2413917|NCT01261390|5920787|P2|COMPLETED|Overall Study|12 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
2413918|NCT01261390|5920788|P1|COMPLETED|Overall Study|14 of the 37 participants that completed the study in this arm were under the 6-Month protocol.|37
2413919|NCT01261390|5920785|P4|12-Month Visit|Overall Study||19
2413920|NCT01261390|5920786|P3|12-Month Visit|Overall Study||19
2413921|NCT01261390|5920787|P2|12-Month Visit|Overall Study||21
2413922|NCT01261390|5920788|P1|12-Month Visit|Overall Study||23
2413923|NCT01261390|5920785|P4|6-Month Visit|Overall Study|For 14 of the 32 participants in this arm, this was their final visit.|32
2413924|NCT01261390|5920786|P3|6-Month Visit|Overall Study|For 16 of the 34 participants in this arm, this was their final visit.|34
2413925|NCT01261390|5920787|P2|6-Month Visit|Overall Study|For 12 of the 34 participants in this arm, this was their final visit.|34
2413926|NCT01261390|5920788|P1|6-Month Visit|Overall Study|For 14 of the 30 participants in this arm, this was their final visit.|37
2413927|NCT01261390|5920785|P4|STARTED|Overall Study|15 of the 41 participants only had to complete a 6-month follow-up assessment.|41
2413928|NCT01261390|5920786|P3|STARTED|Overall Study|16 of the 42 participants only had to complete a 6-month follow-up assessment.|42
2413929|NCT01261390|5920787|P2|STARTED|Overall Study|15 of the 42 participants only had to complete a 6-month follow-up assessment.|42
2413930|NCT01261390|5920788|P1|STARTED|Overall Study|15 of the 44 participants only had to complete a 6-month follow-up assessment.|44
2413931|NCT01261325|5920953|P3|NOT COMPLETED|Overall Study||26
2413932|NCT01261325|5920954|P2|NOT COMPLETED|Overall Study||29
2413933|NCT01261325|5920955|P1|NOT COMPLETED|Overall Study||17
2413934|NCT01261325|5920953|P3|COMPLETED|Overall Study||225
2413935|NCT01261325|5920954|P2|COMPLETED|Overall Study||225
2413936|NCT01261325|5920955|P1|COMPLETED|Overall Study||246
2413937|NCT01261325|5920953|P3|STARTED|Overall Study||251
2413938|NCT01261325|5920954|P2|STARTED|Overall Study||254
2413939|NCT01261325|5920955|P1|STARTED|Overall Study||263
2413940|NCT01261247|5920987|P1|NOT COMPLETED|Overall Study||2
2413941|NCT01261247|5920987|P1|COMPLETED|Overall Study||39
2413942|NCT01261247|5920987|P1|STARTED|Overall Study||41
2413943|NCT01261052|5920994|P1|NOT COMPLETED|APD Only Intervention (33 Hours)||0
2413944|NCT01261052|5920994|P1|COMPLETED|APD Only Intervention (33 Hours)||14
2413945|NCT01261052|5920994|P1|STARTED|APD Only Intervention (33 Hours)||14
2413946|NCT01261052|5920994|P1|NOT COMPLETED|FMPD/APD Intervention (33 Hours)||0
2413947|NCT01261052|5920994|P1|COMPLETED|FMPD/APD Intervention (33 Hours)||14
2413948|NCT01261052|5920994|P1|STARTED|FMPD/APD Intervention (33 Hours)||14
2413949|NCT01261000|5921000|P1|NOT COMPLETED|Overall Study||1
2413950|NCT01261000|5921000|P1|COMPLETED|Overall Study||7
2413951|NCT01261000|5921000|P1|STARTED|Overall Study||8
2413952|NCT01260948|5921006|P2|NOT COMPLETED|Second Intervention||1
2413953|NCT01260948|5921007|P1|NOT COMPLETED|Second Intervention||0
2413954|NCT01260948|5921006|P2|COMPLETED|Second Intervention||9
2413955|NCT01260948|5921007|P1|COMPLETED|Second Intervention||12
2413956|NCT01260948|5921006|P2|STARTED|Second Intervention||10
2413957|NCT01260948|5921007|P1|STARTED|Second Intervention||12
2413958|NCT01260948|5921006|P2|NOT COMPLETED|Washout of 28 Days||3
2413959|NCT01260948|5921007|P1|NOT COMPLETED|Washout of 28 Days||1
2413960|NCT01260948|5921006|P2|COMPLETED|Washout of 28 Days||10
2413961|NCT01260948|5921007|P1|COMPLETED|Washout of 28 Days||12
2413962|NCT01260948|5921006|P2|STARTED|Washout of 28 Days||13
2413963|NCT01260948|5921007|P1|STARTED|Washout of 28 Days||13
2413964|NCT01260948|5921006|P2|NOT COMPLETED|First Intervention||0
2413965|NCT01260948|5921007|P1|NOT COMPLETED|First Intervention||0
2413966|NCT01260948|5921006|P2|COMPLETED|First Intervention||13
2413967|NCT01260948|5921007|P1|COMPLETED|First Intervention||13
2413968|NCT01260948|5921006|P2|STARTED|First Intervention||13
2413969|NCT01260948|5921007|P1|STARTED|First Intervention||13
2413970|NCT01260922|5921017|P2|NOT COMPLETED|Second Intervention||2
2413971|NCT01260922|5921018|P1|NOT COMPLETED|Second Intervention||0
2413972|NCT01260922|5921017|P2|COMPLETED|Second Intervention||8
2413973|NCT01260922|5921018|P1|COMPLETED|Second Intervention||9
2413974|NCT01260922|5921017|P2|STARTED|Second Intervention||10
2413975|NCT01260922|5921018|P1|STARTED|Second Intervention||9
2413976|NCT01260922|5921017|P2|NOT COMPLETED|Washout of 28 Days||2
2413977|NCT01260922|5921018|P1|NOT COMPLETED|Washout of 28 Days||4
2413978|NCT01260922|5921017|P2|COMPLETED|Washout of 28 Days||10
2413979|NCT01260922|5921018|P1|COMPLETED|Washout of 28 Days||9
2413980|NCT01260922|5921017|P2|STARTED|Washout of 28 Days||12
2413981|NCT01260922|5921018|P1|STARTED|Washout of 28 Days||13
2413982|NCT01260922|5921017|P2|NOT COMPLETED|First Intervention||1
2413983|NCT01260922|5921018|P1|NOT COMPLETED|First Intervention||0
2413984|NCT01260922|5921017|P2|COMPLETED|First Intervention||12
2413985|NCT01260922|5921018|P1|COMPLETED|First Intervention||13
2413986|NCT01260922|5921017|P2|STARTED|First Intervention||13
2413987|NCT01260922|5921018|P1|STARTED|First Intervention||13
2413988|NCT01260896|5921028|P2|NOT COMPLETED|Second Intervention||0
2413989|NCT01260896|5921029|P1|NOT COMPLETED|Second Intervention||0
2413990|NCT01260896|5921028|P2|COMPLETED|Second Intervention||12
2413991|NCT01260896|5921029|P1|COMPLETED|Second Intervention||10
2413992|NCT01260896|5921028|P2|STARTED|Second Intervention||12
2413993|NCT01260896|5921029|P1|STARTED|Second Intervention||10
2413994|NCT01260896|5921028|P2|NOT COMPLETED|Washout of 7 Days||0
2413995|NCT01260896|5921029|P1|NOT COMPLETED|Washout of 7 Days||0
2413996|NCT01260896|5921028|P2|COMPLETED|Washout of 7 Days||12
2413997|NCT01260896|5921029|P1|COMPLETED|Washout of 7 Days||10
2413998|NCT01260896|5921028|P2|STARTED|Washout of 7 Days||12
2413999|NCT01260896|5921029|P1|STARTED|Washout of 7 Days||10
2414000|NCT01260896|5921028|P2|NOT COMPLETED|First Intervention||0
2414001|NCT01260896|5921029|P1|NOT COMPLETED|First Intervention||2
2414002|NCT01260896|5921028|P2|COMPLETED|First Intervention||12
2414003|NCT01260896|5921029|P1|COMPLETED|First Intervention||10
2414004|NCT01260896|5921028|P2|STARTED|First Intervention||12
2414005|NCT01260896|5921029|P1|STARTED|First Intervention||12
2414006|NCT01260883|5921048|P3|NOT COMPLETED|Overall Study||0
2414007|NCT01260883|5921049|P2|NOT COMPLETED|Overall Study||0
2414008|NCT01260883|5921050|P1|NOT COMPLETED|Overall Study||0
2414009|NCT01260883|5921048|P3|COMPLETED|Overall Study||18
2414010|NCT01260883|5921049|P2|COMPLETED|Overall Study||11
2414011|NCT01260883|5921050|P1|COMPLETED|Overall Study||22
2414012|NCT01260883|5921048|P3|STARTED|Overall Study||18
2414013|NCT01260883|5921049|P2|STARTED|Overall Study||11
2414014|NCT01260883|5921050|P1|STARTED|Overall Study||22
2414015|NCT01260701|5921087|P1|NOT COMPLETED|Overall Study||75
2414016|NCT01260701|5921087|P1|COMPLETED|Overall Study||0
2414017|NCT01260701|5921087|P1|Eligible and Began Protocol Therapy|Overall Study||70
2414018|NCT01260701|5921087|P1|Eligible|Overall Study||71
2414019|NCT01260701|5921087|P1|STARTED|Overall Study||75
2414020|NCT01260688|5921096|P2|NOT COMPLETED|Overall Study||0
2414021|NCT01260688|5921097|P1|NOT COMPLETED|Overall Study||0
2414022|NCT01260688|5921096|P2|COMPLETED|Overall Study||11
2414023|NCT01260688|5921097|P1|COMPLETED|Overall Study||11
2414024|NCT01260688|5921096|P2|STARTED|Overall Study||11
2414025|NCT01260688|5921097|P1|STARTED|Overall Study||11
2414026|NCT01260662|5921134|P3|NOT COMPLETED|Overall Study||0
2414027|NCT01260662|5921135|P2|NOT COMPLETED|Overall Study||0
2414028|NCT01260662|5921136|P1|NOT COMPLETED|Overall Study||0
2414029|NCT01260662|5921134|P3|COMPLETED|Overall Study||96
2414030|NCT01260662|5921135|P2|COMPLETED|Overall Study||85
2414031|NCT01260662|5921136|P1|COMPLETED|Overall Study||90
2414032|NCT01260662|5921134|P3|STARTED|Overall Study||96
2414033|NCT01260662|5921135|P2|STARTED|Overall Study||85
2414034|NCT01260662|5921136|P1|STARTED|Overall Study||90
2414035|NCT01260649|5921155|P2|NOT COMPLETED|Overall Study||1
2414036|NCT01260649|5921156|P1|NOT COMPLETED|Overall Study||2
2414037|NCT01260649|5921155|P2|COMPLETED|Overall Study||8
2414038|NCT01260649|5921156|P1|COMPLETED|Overall Study||6
2414039|NCT01260649|5921155|P2|STARTED|Overall Study||9
2414040|NCT01260649|5921156|P1|STARTED|Overall Study||8
2414041|NCT01260584|5921168|P4|NOT COMPLETED|Period 2||1
2414042|NCT01260584|5921169|P3|NOT COMPLETED|Period 2||5
2414043|NCT01260584|5921170|P2|NOT COMPLETED|Period 2||3
2414044|NCT01260584|5921171|P1|NOT COMPLETED|Period 2||1
2414045|NCT01260584|5921168|P4|COMPLETED|Period 2||26
2414046|NCT01260584|5921169|P3|COMPLETED|Period 2||20
2414047|NCT01260584|5921170|P2|COMPLETED|Period 2||25
2414048|NCT01260584|5921171|P1|COMPLETED|Period 2||26
2414049|NCT01260584|5921168|P4|STARTED|Period 2||27
2414050|NCT01260584|5921169|P3|STARTED|Period 2||25
2414051|NCT01260584|5921170|P2|STARTED|Period 2||28
2414052|NCT01260584|5921171|P1|STARTED|Period 2||27
2414053|NCT01260584|5921168|P4|NOT COMPLETED|Period 1||1
2414054|NCT01260584|5921169|P3|NOT COMPLETED|Period 1||2
2414055|NCT01260584|5921170|P2|NOT COMPLETED|Period 1||0
2414056|NCT01260584|5921171|P1|NOT COMPLETED|Period 1||0
2414057|NCT01260584|5921168|P4|COMPLETED|Period 1||27
2414058|NCT01260584|5921169|P3|COMPLETED|Period 1||25
2414059|NCT01260584|5921170|P2|COMPLETED|Period 1||28
2414060|NCT01260584|5921171|P1|COMPLETED|Period 1||27
2414061|NCT01260584|5921168|P4|STARTED|Period 1||28
2414062|NCT01260584|5921169|P3|STARTED|Period 1||27
2414063|NCT01260584|5921170|P2|STARTED|Period 1||28
2414064|NCT01260584|5921171|P1|STARTED|Period 1||27
2414065|NCT01260493|5921207|P2|NOT COMPLETED|Overall Study||4
2414066|NCT01260493|5921208|P1|NOT COMPLETED|Overall Study||16
2414067|NCT01260493|5921207|P2|COMPLETED|Overall Study||85
2414068|NCT01260493|5921208|P1|COMPLETED|Overall Study||76
2414069|NCT01260493|5921207|P2|STARTED|Overall Study||89
2414070|NCT01260493|5921208|P1|STARTED|Overall Study||92
2414071|NCT01260467|5921214|P1|NOT COMPLETED|Overall Study||2
2414072|NCT01260467|5921214|P1|COMPLETED|Overall Study||2
2414073|NCT01260467|5921214|P1|STARTED|Overall Study||4
2414074|NCT01260454|5921220|P1|NOT COMPLETED|Overall Study||0
2414075|NCT01260454|5921220|P1|COMPLETED|Overall Study||6
2414076|NCT01260454|5921220|P1|STARTED|Overall Study||6
2414077|NCT01260350|5921246|P22|NOT COMPLETED|Overall Study||0
2414078|NCT01260350|5921247|P21|NOT COMPLETED|Overall Study||3
2414079|NCT01260350|5921248|P20|NOT COMPLETED|Overall Study||0
2414080|NCT01260350|5921249|P19|NOT COMPLETED|Overall Study||0
2414081|NCT01260350|5921250|P18|NOT COMPLETED|Overall Study||1
2414082|NCT01260350|5921251|P17|NOT COMPLETED|Overall Study||0
2414083|NCT01260350|5921252|P16|NOT COMPLETED|Overall Study||0
2414084|NCT01260350|5921253|P15|NOT COMPLETED|Overall Study||0
2414085|NCT01260350|5921254|P14|NOT COMPLETED|Overall Study||0
2414086|NCT01260350|5921255|P13|NOT COMPLETED|Overall Study||0
2414087|NCT01260350|5921256|P12|NOT COMPLETED|Overall Study||0
2414088|NCT01260350|5921257|P11|NOT COMPLETED|Overall Study||0
2414089|NCT01260350|5921258|P10|NOT COMPLETED|Overall Study||0
2414090|NCT01260350|5921259|P9|NOT COMPLETED|Overall Study||1
2414091|NCT01260350|5921260|P8|NOT COMPLETED|Overall Study||0
2414092|NCT01260350|5921261|P7|NOT COMPLETED|Overall Study||0
2414093|NCT01260350|5921262|P6|NOT COMPLETED|Overall Study||0
2414094|NCT01260350|5921263|P5|NOT COMPLETED|Overall Study||0
2414095|NCT01260350|5921264|P4|NOT COMPLETED|Overall Study||0
2414096|NCT01260350|5921265|P3|NOT COMPLETED|Overall Study||0
2414097|NCT01260350|5921266|P2|NOT COMPLETED|Overall Study||0
2414098|NCT01260350|5921267|P1|NOT COMPLETED|Overall Study||0
2414099|NCT01260350|5921246|P22|COMPLETED|Overall Study||0
2414100|NCT01260350|5921247|P21|COMPLETED|Overall Study||22
2414101|NCT01260350|5921248|P20|COMPLETED|Overall Study||14
2414102|NCT01260350|5921249|P19|COMPLETED|Overall Study||0
2414103|NCT01260350|5921250|P18|COMPLETED|Overall Study||9
2414104|NCT01260350|5921251|P17|COMPLETED|Overall Study||9
2414105|NCT01260350|5921252|P16|COMPLETED|Overall Study||10
2414106|NCT01260350|5921253|P15|COMPLETED|Overall Study||25
2414107|NCT01260350|5921254|P14|COMPLETED|Overall Study||10
2414108|NCT01260350|5921255|P13|COMPLETED|Overall Study||25
2414109|NCT01260350|5921256|P12|COMPLETED|Overall Study||9
2414110|NCT01260350|5921257|P11|COMPLETED|Overall Study||10
2414111|NCT01260350|5921258|P10|COMPLETED|Overall Study||25
2414112|NCT01260350|5921259|P9|COMPLETED|Overall Study||24
2414113|NCT01260350|5921260|P8|COMPLETED|Overall Study||25
2414114|NCT01260350|5921261|P7|COMPLETED|Overall Study||10
2414115|NCT01260350|5921262|P6|COMPLETED|Overall Study||10
2414116|NCT01260350|5921263|P5|COMPLETED|Overall Study||10
2414117|NCT01260350|5921264|P4|COMPLETED|Overall Study||11
2414118|NCT01260350|5921265|P3|COMPLETED|Overall Study||10
2414119|NCT01260350|5921266|P2|COMPLETED|Overall Study||9
2414120|NCT01260350|5921267|P1|COMPLETED|Overall Study||10
2414121|NCT01260350|5921246|P22|STARTED|Overall Study||0
2414122|NCT01260350|5921247|P21|STARTED|Overall Study||25
2414123|NCT01260350|5921248|P20|STARTED|Overall Study||14
2414124|NCT01260350|5921249|P19|STARTED|Overall Study||0
2414125|NCT01260350|5921250|P18|STARTED|Overall Study||10
2414126|NCT01260350|5921251|P17|STARTED|Overall Study||9
2414127|NCT01260350|5921252|P16|STARTED|Overall Study||10
2414128|NCT01260350|5921253|P15|STARTED|Overall Study||25
2414129|NCT01260350|5921254|P14|STARTED|Overall Study||10
2414130|NCT01260350|5921255|P13|STARTED|Overall Study||25
2414131|NCT01260350|5921256|P12|STARTED|Overall Study||9
2414132|NCT01260350|5921257|P11|STARTED|Overall Study||10
2414133|NCT01260350|5921258|P10|STARTED|Overall Study||25
2414134|NCT01260350|5921259|P9|STARTED|Overall Study||25
2414135|NCT01260350|5921260|P8|STARTED|Overall Study||25
2414136|NCT01260350|5921261|P7|STARTED|Overall Study||10
2414137|NCT01260350|5921262|P6|STARTED|Overall Study||10
2414138|NCT01260350|5921263|P5|STARTED|Overall Study||10
2414139|NCT01260350|5921264|P4|STARTED|Overall Study||11
2414140|NCT01260350|5921265|P3|STARTED|Overall Study||10
2414141|NCT01260350|5921266|P2|STARTED|Overall Study||9
2414142|NCT01260350|5921267|P1|STARTED|Overall Study||10
2414143|NCT01260324|5921459|P2|NOT COMPLETED|Overall Study||0
2414144|NCT01260324|5921460|P1|NOT COMPLETED|Overall Study||0
2414145|NCT01260324|5921459|P2|COMPLETED|Overall Study||20000
2414146|NCT01260324|5921460|P1|COMPLETED|Overall Study||1283
2414147|NCT01260324|5921459|P2|STARTED|Overall Study||20000
2414148|NCT01260324|5921460|P1|STARTED|Overall Study||1283
2414149|NCT01260311|5921474|P1|NOT COMPLETED|Overall Study||127
2414150|NCT01260311|5921474|P1|COMPLETED|Overall Study||381
2414151|NCT01260311|5921474|P1|STARTED|Overall Study||508
2414152|NCT01260272|5921484|P2|NOT COMPLETED|Overall Study||2
2414153|NCT01260272|5921485|P1|NOT COMPLETED|Overall Study||2
2414154|NCT01260272|5921484|P2|COMPLETED|Overall Study||30
2414155|NCT01260272|5921485|P1|COMPLETED|Overall Study||15
2414156|NCT01260272|5921484|P2|STARTED|Overall Study||32
2414157|NCT01260272|5921485|P1|STARTED|Overall Study||17
2414158|NCT01260194|5921505|P1|NOT COMPLETED|Overall Study||1
2414159|NCT01260194|5921505|P1|COMPLETED|Overall Study||3
2414160|NCT01260194|5921505|P1|STARTED|Overall Study||4
2414161|NCT01260181|5921517|P1|NOT COMPLETED|Overall Study||1
2414162|NCT01260181|5921517|P1|COMPLETED|Overall Study||29
2414163|NCT01260181|5921517|P1|STARTED|Overall Study||30
2414164|NCT01260142|5921532|P6|NOT COMPLETED|Treatment Period 2||0
2414165|NCT01260142|5921533|P5|NOT COMPLETED|Treatment Period 2||0
2414166|NCT01260142|5921534|P4|NOT COMPLETED|Treatment Period 2||0
2414167|NCT01260142|5921535|P3|NOT COMPLETED|Treatment Period 2||0
2414168|NCT01260142|5921536|P2|NOT COMPLETED|Treatment Period 2||0
2414169|NCT01260142|5921537|P1|NOT COMPLETED|Treatment Period 2||0
2414170|NCT01260142|5921532|P6|COMPLETED|Treatment Period 2||3
2414171|NCT01260142|5921533|P5|COMPLETED|Treatment Period 2||4
2414172|NCT01260142|5921534|P4|COMPLETED|Treatment Period 2||6
2414173|NCT01260142|5921535|P3|COMPLETED|Treatment Period 2||6
2414174|NCT01260142|5921536|P2|COMPLETED|Treatment Period 2||5
2414175|NCT01260142|5921537|P1|COMPLETED|Treatment Period 2||5
2414176|NCT01260142|5921532|P6|STARTED|Treatment Period 2||3
2414177|NCT01260142|5921533|P5|STARTED|Treatment Period 2||4
2414178|NCT01260142|5921534|P4|STARTED|Treatment Period 2||6
2414179|NCT01260142|5921535|P3|STARTED|Treatment Period 2||6
2414180|NCT01260142|5921536|P2|STARTED|Treatment Period 2||5
2414181|NCT01260142|5921537|P1|STARTED|Treatment Period 2||5
2414182|NCT01260142|5921532|P6|NOT COMPLETED|Treatment Period 1||3
2414183|NCT01260142|5921533|P5|NOT COMPLETED|Treatment Period 1||2
2414184|NCT01260142|5921534|P4|NOT COMPLETED|Treatment Period 1||0
2414185|NCT01260142|5921535|P3|NOT COMPLETED|Treatment Period 1||0
2414186|NCT01260142|5921536|P2|NOT COMPLETED|Treatment Period 1||1
2414187|NCT01260142|5921537|P1|NOT COMPLETED|Treatment Period 1||1
2414188|NCT01260142|5921532|P6|COMPLETED|Treatment Period 1||3
2414189|NCT01260142|5921533|P5|COMPLETED|Treatment Period 1||4
2414190|NCT01260142|5921534|P4|COMPLETED|Treatment Period 1||6
2414191|NCT01260142|5921535|P3|COMPLETED|Treatment Period 1||6
2414192|NCT01260142|5921536|P2|COMPLETED|Treatment Period 1||5
2414193|NCT01260142|5921537|P1|COMPLETED|Treatment Period 1||5
2414194|NCT01260142|5921532|P6|STARTED|Treatment Period 1||6
2414195|NCT01260142|5921533|P5|STARTED|Treatment Period 1||6
2414196|NCT01260142|5921534|P4|STARTED|Treatment Period 1||6
2414197|NCT01260142|5921535|P3|STARTED|Treatment Period 1||6
2414198|NCT01260142|5921536|P2|STARTED|Treatment Period 1||6
2414199|NCT01260142|5921537|P1|STARTED|Treatment Period 1||6
2414200|NCT01259856|5921589|P2|NOT COMPLETED|Overall Study||74
2414201|NCT01259856|5921590|P1|NOT COMPLETED|Overall Study||69
2414202|NCT01259856|5921589|P2|COMPLETED|Overall Study||12
2414203|NCT01259856|5921590|P1|COMPLETED|Overall Study||13
2414204|NCT01259856|5921589|P2|STARTED|Overall Study||86
2414205|NCT01259856|5921590|P1|STARTED|Overall Study||82
2414206|NCT01259726|5921614|P4|NOT COMPLETED|Overall Study||5
2414207|NCT01259726|5921615|P3|NOT COMPLETED|Overall Study||4
2414208|NCT01259726|5921616|P2|NOT COMPLETED|Overall Study||4
2414209|NCT01259726|5921617|P1|NOT COMPLETED|Overall Study||5
2414210|NCT01259726|5921614|P4|COMPLETED|Overall Study||36
2414211|NCT01259726|5921615|P3|COMPLETED|Overall Study||39
2414212|NCT01259726|5921616|P2|COMPLETED|Overall Study||37
2414213|NCT01259726|5921617|P1|COMPLETED|Overall Study||38
2414214|NCT01259726|5921614|P4|Treated|Overall Study||39
2414215|NCT01259726|5921615|P3|Treated|Overall Study||41
2414216|NCT01259726|5921616|P2|Treated|Overall Study||37
2414217|NCT01259726|5921617|P1|Treated|Overall Study||40
2414218|NCT01259726|5921614|P4|STARTED|Overall Study||41
2414219|NCT01259726|5921615|P3|STARTED|Overall Study||43
2414220|NCT01259726|5921616|P2|STARTED|Overall Study||41
2414221|NCT01259726|5921617|P1|STARTED|Overall Study||43
2414222|NCT01259713|5921649|P2|NOT COMPLETED|Overall Study||41
2414223|NCT01259713|5921650|P1|NOT COMPLETED|Overall Study||95
2414224|NCT01259713|5921649|P2|COMPLETED|Overall Study||77
2414225|NCT01259713|5921650|P1|COMPLETED|Overall Study||142
2414226|NCT01259713|5921649|P2|STARTED|Overall Study||118
2414227|NCT01259713|5921650|P1|STARTED|Overall Study||237
2414228|NCT01259596|5921674|P2|NOT COMPLETED|Overall Study||6
2414229|NCT01259596|5921675|P1|NOT COMPLETED|Overall Study||4
2414230|NCT01259596|5921674|P2|COMPLETED|Overall Study||65
2414231|NCT01259596|5921675|P1|COMPLETED|Overall Study||66
2414232|NCT01259596|5921674|P2|STARTED|Overall Study||71
2414233|NCT01259596|5921675|P1|STARTED|Overall Study||70
2414234|NCT01259492|5921697|P4|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||81
2414235|NCT01259492|5921698|P3|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||50
2414236|NCT01259492|5921699|P2|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||69
2414237|NCT01259492|5921700|P1|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||54
2414238|NCT01259492|5921697|P4|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|42
2414239|NCT01259492|5921698|P3|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|70
2414240|NCT01259492|5921699|P2|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|63
2414241|NCT01259492|5921700|P1|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|60
2414242|NCT01259492|5921697|P4|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||115
2414243|NCT01259492|5921698|P3|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||114
2414244|NCT01259492|5921699|P2|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||128
2414245|NCT01259492|5921700|P1|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||110
2414246|NCT01259492|5921697|P4|STARTED|Period 3 (Week 15 to End of Week 40)||123
2414247|NCT01259492|5921698|P3|STARTED|Period 3 (Week 15 to End of Week 40)||120
2414248|NCT01259492|5921699|P2|STARTED|Period 3 (Week 15 to End of Week 40)||132
2414249|NCT01259492|5921700|P1|STARTED|Period 3 (Week 15 to End of Week 40)|In period 3, all 489 patients who completed period 2 were re-randomized to 4 arms.|114
2414250|NCT01259492|5921697|P4|NOT COMPLETED|Period 2 (Week 10 to Week 14)||28
2414251|NCT01259492|5921698|P3|NOT COMPLETED|Period 2 (Week 10 to Week 14)||24
2414252|NCT01259492|5921699|P2|NOT COMPLETED|Period 2 (Week 10 to Week 14)||18
2414253|NCT01259492|5921700|P1|NOT COMPLETED|Period 2 (Week 10 to Week 14)||25
2414254|NCT01259492|5921697|P4|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|125
2414255|NCT01259492|5921698|P3|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|114
2414256|NCT01259492|5921699|P2|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|123
2414257|NCT01259492|5921700|P1|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|127
2414258|NCT01259492|5921697|P4|STARTED|Period 2 (Week 10 to Week 14)||153
2414259|NCT01259492|5921698|P3|STARTED|Period 2 (Week 10 to Week 14)||138
2414260|NCT01259492|5921699|P2|STARTED|Period 2 (Week 10 to Week 14)||141
2414261|NCT01259492|5921700|P1|STARTED|Period 2 (Week 10 to Week 14)|Treatment arms including Placebo indicate patients belong to respective treatment arms in Period 1|152
2414262|NCT01259492|5921697|P4|NOT COMPLETED|Period 1 (9 Weeks)||28
2414263|NCT01259492|5921698|P3|NOT COMPLETED|Period 1 (9 Weeks)||43
2414264|NCT01259492|5921699|P2|NOT COMPLETED|Period 1 (9 Weeks)||41
2414265|NCT01259492|5921700|P1|NOT COMPLETED|Period 1 (9 Weeks)||29
2414266|NCT01259492|5921697|P4|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|153
2414267|NCT01259492|5921698|P3|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|138
2414268|NCT01259492|5921699|P2|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|141
2414269|NCT01259492|5921700|P1|COMPLETED|Period 1 (9 Weeks)|"Completed indicates patients entered Period 2."|152
2414270|NCT01259492|5921697|P4|Full Analysis Set|Period 1 (9 Weeks)||172
2414271|NCT01259492|5921698|P3|Full Analysis Set|Period 1 (9 Weeks)||179
2414272|NCT01259492|5921699|P2|Full Analysis Set|Period 1 (9 Weeks)||175
2414273|NCT01259492|5921700|P1|Full Analysis Set|Period 1 (9 Weeks)||174
2414274|NCT01259492|5921697|P4|STARTED|Period 1 (9 Weeks)||181
2414275|NCT01259492|5921698|P3|STARTED|Period 1 (9 Weeks)||181
2414276|NCT01259492|5921699|P2|STARTED|Period 1 (9 Weeks)||182
2414277|NCT01259492|5921700|P1|STARTED|Period 1 (9 Weeks)||181
2414278|NCT01259466|5921749|P2|NOT COMPLETED|Overall Study||9
2414279|NCT01259466|5921750|P1|NOT COMPLETED|Overall Study||1
2414280|NCT01259466|5921749|P2|COMPLETED|Overall Study||18
2414281|NCT01259466|5921750|P1|COMPLETED|Overall Study||26
2414282|NCT01259466|5921749|P2|STARTED|Overall Study||27
2414283|NCT01259466|5921750|P1|STARTED|Overall Study||27
2414284|NCT01259440|5921760|P2|NOT COMPLETED|Overall Study||0
2414285|NCT01259440|5921761|P1|NOT COMPLETED|Overall Study||0
2414286|NCT01259440|5921760|P2|COMPLETED|Overall Study||10
2414287|NCT01259440|5921761|P1|COMPLETED|Overall Study||13
2414288|NCT01259440|5921760|P2|STARTED|Overall Study||10
2414289|NCT01259440|5921761|P1|STARTED|Overall Study||13
2414290|NCT01259427|5921769|P2|NOT COMPLETED|Overall Study||14
2414291|NCT01259427|5921770|P1|NOT COMPLETED|Overall Study||18
2414292|NCT01259427|5921769|P2|COMPLETED|Overall Study||110
2414293|NCT01259427|5921770|P1|COMPLETED|Overall Study||106
2414294|NCT01259427|5921769|P2|STARTED|Overall Study||124
2414295|NCT01259427|5921770|P1|STARTED|Overall Study||124
2414296|NCT01259401|5921788|P2|NOT COMPLETED|4-month Follow-up||2
2414297|NCT01259401|5921789|P1|NOT COMPLETED|4-month Follow-up||0
2414298|NCT01259401|5921788|P2|COMPLETED|4-month Follow-up||19
2414299|NCT01259401|5921789|P1|COMPLETED|4-month Follow-up||21
2414300|NCT01259401|5921788|P2|STARTED|4-month Follow-up||21
2414301|NCT01259401|5921789|P1|STARTED|4-month Follow-up||21
2414302|NCT01259401|5921788|P2|NOT COMPLETED|End of 4-week Intervention||0
2414303|NCT01259401|5921789|P1|NOT COMPLETED|End of 4-week Intervention||0
2414304|NCT01259401|5921788|P2|COMPLETED|End of 4-week Intervention||21
2414305|NCT01259401|5921789|P1|COMPLETED|End of 4-week Intervention||21
2414306|NCT01259401|5921788|P2|STARTED|End of 4-week Intervention||21
2414307|NCT01259401|5921789|P1|STARTED|End of 4-week Intervention||21
2414308|NCT01259388|5921799|P2|NOT COMPLETED|Overall Study||1
2414309|NCT01259388|5921800|P1|NOT COMPLETED|Overall Study||5
2414310|NCT01259388|5921799|P2|COMPLETED|Overall Study||11
2414311|NCT01259388|5921800|P1|COMPLETED|Overall Study||6
2414312|NCT01259388|5921799|P2|STARTED|Overall Study||12
2414313|NCT01259388|5921800|P1|STARTED|Overall Study||11
2414314|NCT01259375|5921810|P1|NOT COMPLETED|Overall Study||1
2414315|NCT01259375|5921810|P1|COMPLETED|Overall Study||23
2414316|NCT01259375|5921810|P1|STARTED|Overall Study||24
2414317|NCT01259297|5921827|P8|NOT COMPLETED|Double Blind Randomized Period||3
2414318|NCT01259297|5921828|P7|NOT COMPLETED|Double Blind Randomized Period||6
2414319|NCT01259297|5921829|P6|NOT COMPLETED|Double Blind Randomized Period||8
2414320|NCT01259297|5921830|P5|NOT COMPLETED|Double Blind Randomized Period||4
2414321|NCT01259297|5921831|P4|NOT COMPLETED|Double Blind Randomized Period||4
2414322|NCT01259297|5921832|P3|NOT COMPLETED|Double Blind Randomized Period||1
2414323|NCT01259297|5921833|P2|NOT COMPLETED|Double Blind Randomized Period||3
2414324|NCT01259297|5921834|P1|NOT COMPLETED|Double Blind Randomized Period||2
2414325|NCT01259297|5921827|P8|COMPLETED|Double Blind Randomized Period||196
2414326|NCT01259297|5921828|P7|COMPLETED|Double Blind Randomized Period||190
2414327|NCT01259297|5921829|P6|COMPLETED|Double Blind Randomized Period||245
2414328|NCT01259297|5921830|P5|COMPLETED|Double Blind Randomized Period||247
2414329|NCT01259297|5921831|P4|COMPLETED|Double Blind Randomized Period||191
2414330|NCT01259297|5921832|P3|COMPLETED|Double Blind Randomized Period||188
2414331|NCT01259297|5921833|P2|COMPLETED|Double Blind Randomized Period||229
2414332|NCT01259297|5921834|P1|COMPLETED|Double Blind Randomized Period||242
2414333|NCT01259297|5921827|P8|STARTED|Double Blind Randomized Period||199
2414334|NCT01259297|5921828|P7|STARTED|Double Blind Randomized Period||196
2414335|NCT01259297|5921829|P6|STARTED|Double Blind Randomized Period||253
2414336|NCT01259297|5921830|P5|STARTED|Double Blind Randomized Period||251
2414337|NCT01259297|5921831|P4|STARTED|Double Blind Randomized Period||195
2414338|NCT01259297|5921832|P3|STARTED|Double Blind Randomized Period||189
2414339|NCT01259297|5921833|P2|STARTED|Double Blind Randomized Period||232
2414340|NCT01259297|5921834|P1|STARTED|Double Blind Randomized Period||244
2414341|NCT01259297|5921827|P8|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
2414342|NCT01259297|5921828|P7|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
2414343|NCT01259297|5921829|P6|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
2414344|NCT01259297|5921830|P5|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
2414345|NCT01259297|5921831|P4|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
2414346|NCT01259297|5921832|P3|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||222
2414347|NCT01259297|5921833|P2|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
2414348|NCT01259297|5921834|P1|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||355
2414349|NCT01259297|5921827|P8|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
2414350|NCT01259297|5921828|P7|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
2414351|NCT01259297|5921829|P6|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
2414352|NCT01259297|5921830|P5|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
2414353|NCT01259297|5921831|P4|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
2414354|NCT01259297|5921832|P3|COMPLETED|Run-in Open Label Period (4-5 Weeks)||779
2414355|NCT01259297|5921833|P2|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
2414356|NCT01259297|5921834|P1|COMPLETED|Run-in Open Label Period (4-5 Weeks)||980
2414357|NCT01259297|5921827|P8|STARTED|Run-in Open Label Period (4-5 Weeks)||0
2414358|NCT01259297|5921828|P7|STARTED|Run-in Open Label Period (4-5 Weeks)||0
2414359|NCT01259297|5921829|P6|STARTED|Run-in Open Label Period (4-5 Weeks)||0
2414360|NCT01259297|5921830|P5|STARTED|Run-in Open Label Period (4-5 Weeks)||0
2414361|NCT01259297|5921831|P4|STARTED|Run-in Open Label Period (4-5 Weeks)||0
2414362|NCT01259297|5921832|P3|STARTED|Run-in Open Label Period (4-5 Weeks)||1001
2414363|NCT01259297|5921833|P2|STARTED|Run-in Open Label Period (4-5 Weeks)||0
2414364|NCT01259297|5921834|P1|STARTED|Run-in Open Label Period (4-5 Weeks)||1335
2414365|NCT01259284|5921865|P3|NOT COMPLETED|Overall Study||0
2414366|NCT01259284|5921866|P2|NOT COMPLETED|Overall Study||0
2414367|NCT01259284|5921867|P1|NOT COMPLETED|Overall Study||2
2414368|NCT01259284|5921865|P3|COMPLETED|Overall Study||0
2414369|NCT01259284|5921866|P2|COMPLETED|Overall Study||0
2414370|NCT01259284|5921867|P1|COMPLETED|Overall Study||0
2414371|NCT01259284|5921865|P3|STARTED|Overall Study||0
2414372|NCT01259284|5921866|P2|STARTED|Overall Study||0
2414373|NCT01259284|5921867|P1|STARTED|Overall Study||2
2414374|NCT01259245|5921877|P2|NOT COMPLETED|Overall Study||26
2414375|NCT01259245|5921878|P1|NOT COMPLETED|Overall Study||28
2414376|NCT01259245|5921877|P2|COMPLETED|Overall Study|24 discontinued intervention and 2 deceased|68
2414377|NCT01259245|5921878|P1|COMPLETED|Overall Study|27 were lost to follow-up and 1 deceased|70
2414378|NCT01259245|5921877|P2|STARTED|Overall Study||94
2414379|NCT01259245|5921878|P1|STARTED|Overall Study||98
2414380|NCT01259115|5921902|P2|NOT COMPLETED|Period 2||0
2414381|NCT01259115|5921903|P1|NOT COMPLETED|Period 2||1
2414382|NCT01259115|5921902|P2|COMPLETED|Period 2||9
2414383|NCT01259115|5921903|P1|COMPLETED|Period 2||6
2414384|NCT01259115|5921902|P2|STARTED|Period 2||9
2414385|NCT01259115|5921903|P1|STARTED|Period 2||7
2414386|NCT01259115|5921902|P2|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
2414387|NCT01259115|5921903|P1|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
2414388|NCT01259115|5921902|P2|COMPLETED|Period: Washout Period of 4 to 18 Days||9
2414389|NCT01259115|5921903|P1|COMPLETED|Period: Washout Period of 4 to 18 Days||7
2414390|NCT01259115|5921902|P2|STARTED|Period: Washout Period of 4 to 18 Days||9
2414391|NCT01259115|5921903|P1|STARTED|Period: Washout Period of 4 to 18 Days||7
2414392|NCT01259115|5921902|P2|NOT COMPLETED|Period 1||1
2414393|NCT01259115|5921903|P1|NOT COMPLETED|Period 1||3
2414394|NCT01259115|5921902|P2|COMPLETED|Period 1||9
2414395|NCT01259115|5921903|P1|COMPLETED|Period 1||7
2414396|NCT01259115|5921902|P2|STARTED|Period 1||10
2414397|NCT01259115|5921903|P1|STARTED|Period 1||10
2414398|NCT01259102|5921939|P5|NOT COMPLETED|Overall Study||1
2414399|NCT01259102|5921940|P4|NOT COMPLETED|Overall Study||2
2414400|NCT01259102|5921941|P3|NOT COMPLETED|Overall Study||2
2414401|NCT01259102|5921942|P2|NOT COMPLETED|Overall Study||0
2414402|NCT01259102|5921943|P1|NOT COMPLETED|Overall Study||1
2414403|NCT01259102|5921939|P5|COMPLETED|Overall Study||13
2414404|NCT01259102|5921940|P4|COMPLETED|Overall Study||12
2414405|NCT01259102|5921941|P3|COMPLETED|Overall Study||13
2414406|NCT01259102|5921942|P2|COMPLETED|Overall Study||14
2414407|NCT01259102|5921943|P1|COMPLETED|Overall Study||12
2414408|NCT01259102|5921939|P5|STARTED|Overall Study||14
2414409|NCT01259102|5921940|P4|STARTED|Overall Study||14
2414410|NCT01259102|5921941|P3|STARTED|Overall Study||15
2414411|NCT01259102|5921942|P2|STARTED|Overall Study||14
2414412|NCT01259102|5921943|P1|STARTED|Overall Study||13
2414413|NCT01259089|5922000|P6|NOT COMPLETED|Survival Follow up for Two Years||19
2414414|NCT01259089|5922001|P5|NOT COMPLETED|Survival Follow up for Two Years||6
2414415|NCT01259089|5922002|P4|NOT COMPLETED|Survival Follow up for Two Years||3
2414416|NCT01259089|5922003|P3|NOT COMPLETED|Survival Follow up for Two Years||2
2414417|NCT01259089|5922004|P2|NOT COMPLETED|Survival Follow up for Two Years||2
2414418|NCT01259089|5922005|P1|NOT COMPLETED|Survival Follow up for Two Years||3
2414419|NCT01259089|5922000|P6|COMPLETED|Survival Follow up for Two Years||0
2414420|NCT01259089|5922001|P5|COMPLETED|Survival Follow up for Two Years||0
2414421|NCT01259089|5922002|P4|COMPLETED|Survival Follow up for Two Years||0
2414422|NCT01259089|5922003|P3|COMPLETED|Survival Follow up for Two Years||1
2414423|NCT01259089|5922004|P2|COMPLETED|Survival Follow up for Two Years||1
2414424|NCT01259089|5922005|P1|COMPLETED|Survival Follow up for Two Years||0
2414425|NCT01259089|5922000|P6|STARTED|Survival Follow up for Two Years||19
2414426|NCT01259089|5922001|P5|STARTED|Survival Follow up for Two Years||6
2414427|NCT01259089|5922002|P4|STARTED|Survival Follow up for Two Years||3
2414428|NCT01259089|5922003|P3|STARTED|Survival Follow up for Two Years||3
2414429|NCT01259089|5922004|P2|STARTED|Survival Follow up for Two Years||3
2414430|NCT01259089|5922005|P1|STARTED|Survival Follow up for Two Years||3
2414431|NCT01259089|5922000|P6|NOT COMPLETED|Continued Treatment After 8 Weeks||1
2414432|NCT01259089|5922001|P5|NOT COMPLETED|Continued Treatment After 8 Weeks||2
2414433|NCT01259089|5922002|P4|NOT COMPLETED|Continued Treatment After 8 Weeks||1
2414434|NCT01259089|5922003|P3|NOT COMPLETED|Continued Treatment After 8 Weeks||1
2414435|NCT01259089|5922004|P2|NOT COMPLETED|Continued Treatment After 8 Weeks||1
2414436|NCT01259089|5922005|P1|NOT COMPLETED|Continued Treatment After 8 Weeks||2
2414437|NCT01259089|5922000|P6|COMPLETED|Continued Treatment After 8 Weeks||7
2414438|NCT01259089|5922001|P5|COMPLETED|Continued Treatment After 8 Weeks||0
2414439|NCT01259089|5922002|P4|COMPLETED|Continued Treatment After 8 Weeks||1
2414440|NCT01259089|5922003|P3|COMPLETED|Continued Treatment After 8 Weeks||1
2414441|NCT01259089|5922004|P2|COMPLETED|Continued Treatment After 8 Weeks||2
2414442|NCT01259089|5922005|P1|COMPLETED|Continued Treatment After 8 Weeks||1
2414443|NCT01259089|5922000|P6|STARTED|Continued Treatment After 8 Weeks||8
2414444|NCT01259089|5922001|P5|STARTED|Continued Treatment After 8 Weeks||2
2414445|NCT01259089|5922002|P4|STARTED|Continued Treatment After 8 Weeks||2
2414446|NCT01259089|5922003|P3|STARTED|Continued Treatment After 8 Weeks||2
2414447|NCT01259089|5922004|P2|STARTED|Continued Treatment After 8 Weeks||3
2414448|NCT01259089|5922005|P1|STARTED|Continued Treatment After 8 Weeks||3
2414449|NCT01259089|5922000|P6|NOT COMPLETED|Confirmed Response at 8 Weeks||10
2414450|NCT01259089|5922001|P5|NOT COMPLETED|Confirmed Response at 8 Weeks||4
2414451|NCT01259089|5922002|P4|NOT COMPLETED|Confirmed Response at 8 Weeks||1
2414452|NCT01259089|5922003|P3|NOT COMPLETED|Confirmed Response at 8 Weeks||1
2414453|NCT01259089|5922004|P2|NOT COMPLETED|Confirmed Response at 8 Weeks||0
2414454|NCT01259089|5922005|P1|NOT COMPLETED|Confirmed Response at 8 Weeks||0
2414455|NCT01259089|5922000|P6|COMPLETED|Confirmed Response at 8 Weeks||8
2414456|NCT01259089|5922001|P5|COMPLETED|Confirmed Response at 8 Weeks||2
2414457|NCT01259089|5922002|P4|COMPLETED|Confirmed Response at 8 Weeks||2
2414458|NCT01259089|5922003|P3|COMPLETED|Confirmed Response at 8 Weeks||2
2414459|NCT01259089|5922004|P2|COMPLETED|Confirmed Response at 8 Weeks||3
2414460|NCT01259089|5922005|P1|COMPLETED|Confirmed Response at 8 Weeks||3
2414461|NCT01259089|5922000|P6|STARTED|Confirmed Response at 8 Weeks||18
2414462|NCT01259089|5922001|P5|STARTED|Confirmed Response at 8 Weeks||6
2414463|NCT01259089|5922002|P4|STARTED|Confirmed Response at 8 Weeks||3
2414464|NCT01259089|5922003|P3|STARTED|Confirmed Response at 8 Weeks||3
2414465|NCT01259089|5922004|P2|STARTED|Confirmed Response at 8 Weeks||3
2414466|NCT01259089|5922005|P1|STARTED|Confirmed Response at 8 Weeks||3
2414467|NCT01259089|5922000|P6|NOT COMPLETED|Reached First Response at 4 Weeks||2
2414468|NCT01259089|5922001|P5|NOT COMPLETED|Reached First Response at 4 Weeks||0
2414469|NCT01259089|5922002|P4|NOT COMPLETED|Reached First Response at 4 Weeks||0
2414470|NCT01259089|5922003|P3|NOT COMPLETED|Reached First Response at 4 Weeks||0
2414471|NCT01259089|5922004|P2|NOT COMPLETED|Reached First Response at 4 Weeks||0
2414472|NCT01259089|5922005|P1|NOT COMPLETED|Reached First Response at 4 Weeks||0
2414473|NCT01259089|5922000|P6|COMPLETED|Reached First Response at 4 Weeks||18
2414474|NCT01259089|5922001|P5|COMPLETED|Reached First Response at 4 Weeks||6
2414475|NCT01259089|5922002|P4|COMPLETED|Reached First Response at 4 Weeks||3
2414476|NCT01259089|5922003|P3|COMPLETED|Reached First Response at 4 Weeks||3
2414477|NCT01259089|5922004|P2|COMPLETED|Reached First Response at 4 Weeks||3
2414478|NCT01259089|5922005|P1|COMPLETED|Reached First Response at 4 Weeks||3
2414479|NCT01259089|5922000|P6|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||18
2414480|NCT01259089|5922001|P5|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||6
2414481|NCT01259089|5922002|P4|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
2414482|NCT01259089|5922003|P3|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
2414483|NCT01259089|5922004|P2|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
2414484|NCT01259089|5922005|P1|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
2414485|NCT01259089|5922000|P6|Started Treatment on Study|Reached First Response at 4 Weeks||19
2414486|NCT01259089|5922001|P5|Started Treatment on Study|Reached First Response at 4 Weeks||6
2414487|NCT01259089|5922002|P4|Started Treatment on Study|Reached First Response at 4 Weeks||3
2414488|NCT01259089|5922003|P3|Started Treatment on Study|Reached First Response at 4 Weeks||3
2414489|NCT01259089|5922004|P2|Started Treatment on Study|Reached First Response at 4 Weeks||3
2414490|NCT01259089|5922005|P1|Started Treatment on Study|Reached First Response at 4 Weeks||3
2414491|NCT01259089|5922000|P6|STARTED|Reached First Response at 4 Weeks||20
2414492|NCT01259089|5922001|P5|STARTED|Reached First Response at 4 Weeks||6
2414493|NCT01259089|5922002|P4|STARTED|Reached First Response at 4 Weeks||3
2414494|NCT01259089|5922003|P3|STARTED|Reached First Response at 4 Weeks||3
2414495|NCT01259089|5922004|P2|STARTED|Reached First Response at 4 Weeks||3
2414496|NCT01259089|5922005|P1|STARTED|Reached First Response at 4 Weeks||3
2414497|NCT01259063|5922024|P1|NOT COMPLETED|Overall Study||0
2414498|NCT01259063|5922024|P1|COMPLETED|Overall Study||33
2414499|NCT01259063|5922024|P1|STARTED|Overall Study||33
2414500|NCT01259024|5922033|P1|NOT COMPLETED|Overall Study||1
2414501|NCT01259024|5922033|P1|COMPLETED|Overall Study||0
2414502|NCT01259024|5922033|P1|STARTED|Overall Study||1
2414503|NCT01259011|5922042|P2|NOT COMPLETED|After Patient Death||0
2414504|NCT01259011|5922043|P1|NOT COMPLETED|After Patient Death||0
2414505|NCT01259011|5922042|P2|COMPLETED|After Patient Death||28
2414506|NCT01259011|5922043|P1|COMPLETED|After Patient Death||17
2414507|NCT01259011|5922042|P2|STARTED|After Patient Death|of 109 patient-surrogate dyads/pairs randomized, 28 surrogates of patients who died|28
2414508|NCT01259011|5922043|P1|STARTED|After Patient Death|of 101 patient-surrogate dyads/pairs randomized, 17 surrogates of patients who died|17
2414509|NCT01259011|5922042|P2|NOT COMPLETED|Main Study Period||0
2414510|NCT01259011|5922043|P1|NOT COMPLETED|Main Study Period||0
2414511|NCT01259011|5922042|P2|COMPLETED|Main Study Period||109
2414512|NCT01259011|5922043|P1|COMPLETED|Main Study Period||101
2414513|NCT01259011|5922042|P2|STARTED|Main Study Period|109 dyads (=218 individuals)|109
2414514|NCT01259011|5922043|P1|STARTED|Main Study Period|101 dyads (=202 individuals)|101
2414515|NCT01258998|5922053|P1|NOT COMPLETED|Overall Study||1
2414516|NCT01258998|5922053|P1|COMPLETED|Overall Study||59
2414517|NCT01258998|5922053|P1|STARTED|Overall Study||60
2414518|NCT01258985|5922059|P2|NOT COMPLETED|Overall Study||0
2414519|NCT01258985|5922060|P1|NOT COMPLETED|Overall Study||0
2414520|NCT01258985|5922059|P2|COMPLETED|Overall Study||98
2414521|NCT01258985|5922060|P1|COMPLETED|Overall Study||106
2414522|NCT01258985|5922059|P2|STARTED|Overall Study||98
2414523|NCT01258985|5922060|P1|STARTED|Overall Study||106
2414524|NCT01258855|5922088|P2|NOT COMPLETED|Overall Study||0
2414525|NCT01258855|5922089|P1|NOT COMPLETED|Overall Study||0
2414526|NCT01258855|5922088|P2|COMPLETED|Overall Study||29
2414527|NCT01258855|5922089|P1|COMPLETED|Overall Study||55
2414528|NCT01258855|5922088|P2|STARTED|Overall Study||29
2414529|NCT01258855|5922089|P1|STARTED|Overall Study||55
2414530|NCT01258803|5922107|P6|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
2414531|NCT01258803|5922108|P5|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
2414532|NCT01258803|5922109|P4|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
2414533|NCT01258803|5922110|P3|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
2414534|NCT01258803|5922111|P2|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
2414535|NCT01258803|5922112|P1|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
2414536|NCT01258803|5922107|P6|COMPLETED|Treatment Period 4 (1 Dose)||15
2414537|NCT01258803|5922108|P5|COMPLETED|Treatment Period 4 (1 Dose)||15
2414538|NCT01258803|5922109|P4|COMPLETED|Treatment Period 4 (1 Dose)||15
2414539|NCT01258803|5922110|P3|COMPLETED|Treatment Period 4 (1 Dose)||14
2414540|NCT01258803|5922111|P2|COMPLETED|Treatment Period 4 (1 Dose)||14
2414541|NCT01258803|5922112|P1|COMPLETED|Treatment Period 4 (1 Dose)||14
2414542|NCT01258803|5922107|P6|STARTED|Treatment Period 4 (1 Dose)||15
2414543|NCT01258803|5922108|P5|STARTED|Treatment Period 4 (1 Dose)||15
2414544|NCT01258803|5922109|P4|STARTED|Treatment Period 4 (1 Dose)||15
2414545|NCT01258803|5922110|P3|STARTED|Treatment Period 4 (1 Dose)||14
2414546|NCT01258803|5922111|P2|STARTED|Treatment Period 4 (1 Dose)||14
2414547|NCT01258803|5922112|P1|STARTED|Treatment Period 4 (1 Dose)||14
2414548|NCT01258803|5922107|P6|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
2414549|NCT01258803|5922108|P5|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
2414550|NCT01258803|5922109|P4|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
2414551|NCT01258803|5922110|P3|NOT COMPLETED|Treatment Period 3 (1 Dose)||1
2414552|NCT01258803|5922111|P2|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
2414553|NCT01258803|5922112|P1|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
2414554|NCT01258803|5922107|P6|COMPLETED|Treatment Period 3 (1 Dose)||15
2414555|NCT01258803|5922108|P5|COMPLETED|Treatment Period 3 (1 Dose)||15
2414556|NCT01258803|5922109|P4|COMPLETED|Treatment Period 3 (1 Dose)||15
2414557|NCT01258803|5922110|P3|COMPLETED|Treatment Period 3 (1 Dose)||14
2414558|NCT01258803|5922111|P2|COMPLETED|Treatment Period 3 (1 Dose)||14
2414559|NCT01258803|5922112|P1|COMPLETED|Treatment Period 3 (1 Dose)||14
2414560|NCT01258803|5922107|P6|STARTED|Treatment Period 3 (1 Dose)||15
2414561|NCT01258803|5922108|P5|STARTED|Treatment Period 3 (1 Dose)||15
2414562|NCT01258803|5922109|P4|STARTED|Treatment Period 3 (1 Dose)||15
2414563|NCT01258803|5922110|P3|STARTED|Treatment Period 3 (1 Dose)||15
2414564|NCT01258803|5922111|P2|STARTED|Treatment Period 3 (1 Dose)||14
2414565|NCT01258803|5922112|P1|STARTED|Treatment Period 3 (1 Dose)||14
2414566|NCT01258803|5922107|P6|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
2414567|NCT01258803|5922108|P5|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
2414568|NCT01258803|5922109|P4|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
2414569|NCT01258803|5922110|P3|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
2414570|NCT01258803|5922111|P2|NOT COMPLETED|Treatment Period 2 (1 Dose)||2
2414571|NCT01258803|5922112|P1|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
2414572|NCT01258803|5922107|P6|COMPLETED|Treatment Period 2 (1 Dose)||15
2414573|NCT01258803|5922108|P5|COMPLETED|Treatment Period 2 (1 Dose)||15
2414574|NCT01258803|5922109|P4|COMPLETED|Treatment Period 2 (1 Dose)||15
2414575|NCT01258803|5922110|P3|COMPLETED|Treatment Period 2 (1 Dose)||15
2414576|NCT01258803|5922111|P2|COMPLETED|Treatment Period 2 (1 Dose)||14
2414577|NCT01258803|5922112|P1|COMPLETED|Treatment Period 2 (1 Dose)||14
2414578|NCT01258803|5922107|P6|STARTED|Treatment Period 2 (1 Dose)||16
2414579|NCT01258803|5922108|P5|STARTED|Treatment Period 2 (1 Dose)||15
2414580|NCT01258803|5922109|P4|STARTED|Treatment Period 2 (1 Dose)||15
2414581|NCT01258803|5922110|P3|STARTED|Treatment Period 2 (1 Dose)||15
2414582|NCT01258803|5922111|P2|STARTED|Treatment Period 2 (1 Dose)||16
2414583|NCT01258803|5922112|P1|STARTED|Treatment Period 2 (1 Dose)||15
2414584|NCT01258803|5922107|P6|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
2414585|NCT01258803|5922108|P5|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
2414586|NCT01258803|5922109|P4|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
2414587|NCT01258803|5922110|P3|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
2414588|NCT01258803|5922111|P2|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
2414589|NCT01258803|5922112|P1|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
2414590|NCT01258803|5922107|P6|COMPLETED|Treatment Period 1 (1 Dose)||16
2414591|NCT01258803|5922108|P5|COMPLETED|Treatment Period 1 (1 Dose)||15
2414592|NCT01258803|5922109|P4|COMPLETED|Treatment Period 1 (1 Dose)||15
2414593|NCT01258803|5922110|P3|COMPLETED|Treatment Period 1 (1 Dose)||15
2414594|NCT01258803|5922111|P2|COMPLETED|Treatment Period 1 (1 Dose)||16
2414595|NCT01258803|5922112|P1|COMPLETED|Treatment Period 1 (1 Dose)||15
2414596|NCT01258803|5922107|P6|STARTED|Treatment Period 1 (1 Dose)||16
2414597|NCT01258803|5922108|P5|STARTED|Treatment Period 1 (1 Dose)||15
2414598|NCT01258803|5922109|P4|STARTED|Treatment Period 1 (1 Dose)||15
2414599|NCT01258803|5922110|P3|STARTED|Treatment Period 1 (1 Dose)||15
2414600|NCT01258803|5922111|P2|STARTED|Treatment Period 1 (1 Dose)||16
2414601|NCT01258803|5922112|P1|STARTED|Treatment Period 1 (1 Dose)||15
2414602|NCT01258790|5922140|P2|NOT COMPLETED|Overall Study||0
2414603|NCT01258790|5922141|P1|NOT COMPLETED|Overall Study||0
2414604|NCT01258790|5922140|P2|COMPLETED|Overall Study||6
2414605|NCT01258790|5922141|P1|COMPLETED|Overall Study||6
2414606|NCT01258790|5922140|P2|STARTED|Overall Study||6
2414607|NCT01258790|5922141|P1|STARTED|Overall Study||6
2414608|NCT01258738|5922149|P2|NOT COMPLETED|Open-label Period||21
2414609|NCT01258738|5922150|P1|NOT COMPLETED|Open-label Period||17
2414610|NCT01258738|5922149|P2|COMPLETED|Open-label Period||85
2414611|NCT01258738|5922150|P1|COMPLETED|Open-label Period||85
2414612|NCT01258738|5922149|P2|STARTED|Open-label Period||106
2414613|NCT01258738|5922150|P1|STARTED|Open-label Period||102
2414614|NCT01258738|5922149|P2|NOT COMPLETED|Double-blind Period||7
2414615|NCT01258738|5922150|P1|NOT COMPLETED|Double-blind Period||9
2414616|NCT01258738|5922149|P2|COMPLETED|Double-blind Period|Only 106 participants entered the open label period.|107
2414617|NCT01258738|5922150|P1|COMPLETED|Double-blind Period||102
2414618|NCT01258738|5922149|P2|Treated|Double-blind Period||113
2414619|NCT01258738|5922150|P1|Treated|Double-blind Period||111
2414620|NCT01258738|5922149|P2|STARTED|Double-blind Period||114
2414621|NCT01258738|5922150|P1|STARTED|Double-blind Period||111
2414622|NCT01258660|5922288|P2|NOT COMPLETED|Overall Study||11
2414623|NCT01258660|5922289|P1|NOT COMPLETED|Overall Study||11
2414624|NCT01258660|5922288|P2|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
2414625|NCT01258660|5922289|P1|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
2414626|NCT01258660|5922288|P2|Completed Treatment|Overall Study||81
2414627|NCT01258660|5922289|P1|Completed Treatment|Overall Study||79
2414628|NCT01258660|5922288|P2|Received Treatment|Overall Study||82
2414629|NCT01258660|5922289|P1|Received Treatment|Overall Study||79
2414630|NCT01258660|5922288|P2|STARTED|Overall Study|randomized and received at least one dose of treatment|86
2414631|NCT01258660|5922289|P1|STARTED|Overall Study|randomized and received at least one dose of treatment|86
2414632|NCT01258608|5922308|P2|NOT COMPLETED|Overall Study||19
2414633|NCT01258608|5922309|P1|NOT COMPLETED|Overall Study||21
2414634|NCT01258608|5922308|P2|COMPLETED|Overall Study||31
2414635|NCT01258608|5922309|P1|COMPLETED|Overall Study||30
2414636|NCT01258608|5922308|P2|STARTED|Overall Study||50
2414637|NCT01258608|5922309|P1|STARTED|Overall Study||51
2414638|NCT01258595|5922357|P2|NOT COMPLETED|Overall Study||1
2414639|NCT01258595|5922358|P1|NOT COMPLETED|Overall Study||1
2414640|NCT01258595|5922357|P2|COMPLETED|Overall Study||151
2414641|NCT01258595|5922358|P1|COMPLETED|Overall Study||147
2414642|NCT01258595|5922357|P2|STARTED|Overall Study||152
2414643|NCT01258595|5922358|P1|STARTED|Overall Study||148
2414644|NCT01258582|5922374|P2|NOT COMPLETED|Overall Study||258
2414645|NCT01258582|5922375|P1|NOT COMPLETED|Overall Study||282
2414646|NCT01258582|5922374|P2|COMPLETED|Overall Study||563
2414647|NCT01258582|5922375|P1|COMPLETED|Overall Study||548
2414648|NCT01258582|5922374|P2|STARTED|Overall Study||821
2414649|NCT01258582|5922375|P1|STARTED|Overall Study||830
2414650|NCT01258504|5922381|P1|NOT COMPLETED|Bosentan and SJW||0
2414651|NCT01258504|5922381|P1|COMPLETED|Bosentan and SJW||13
2414652|NCT01258504|5922381|P1|STARTED|Bosentan and SJW||13
2414653|NCT01258504|5922381|P1|NOT COMPLETED|Bosentan Steady-state||0
2414654|NCT01258504|5922381|P1|COMPLETED|Bosentan Steady-state||13
2414655|NCT01258504|5922381|P1|STARTED|Bosentan Steady-state||13
2414656|NCT01258504|5922381|P1|NOT COMPLETED|Bosentan Single Dose||0
2414657|NCT01258504|5922381|P1|COMPLETED|Bosentan Single Dose||13
2414658|NCT01258504|5922381|P1|STARTED|Bosentan Single Dose||13
2414659|NCT01258387|5922400|P7|NOT COMPLETED|Overall Study||0
2414660|NCT01258387|5922401|P6|NOT COMPLETED|Overall Study||0
2414661|NCT01258387|5922402|P5|NOT COMPLETED|Overall Study||0
2414662|NCT01258387|5922403|P4|NOT COMPLETED|Overall Study||0
2414663|NCT01258387|5922404|P3|NOT COMPLETED|Overall Study||0
2414664|NCT01258387|5922405|P2|NOT COMPLETED|Overall Study||0
2414665|NCT01258387|5922406|P1|NOT COMPLETED|Overall Study||0
2414666|NCT01258387|5922400|P7|COMPLETED|Overall Study||4
2414667|NCT01258387|5922401|P6|COMPLETED|Overall Study||6
2414668|NCT01258387|5922402|P5|COMPLETED|Overall Study||6
2414669|NCT01258387|5922403|P4|COMPLETED|Overall Study||6
2414670|NCT01258387|5922404|P3|COMPLETED|Overall Study||6
2414671|NCT01258387|5922405|P2|COMPLETED|Overall Study||6
2414672|NCT01258387|5922406|P1|COMPLETED|Overall Study||6
2414673|NCT01258387|5922400|P7|Patients Randomized to Placebo|Overall Study||1
2414674|NCT01258387|5922401|P6|Patients Randomized to Placebo|Overall Study||2
2414675|NCT01258387|5922402|P5|Patients Randomized to Placebo|Overall Study||2
2414676|NCT01258387|5922403|P4|Patients Randomized to Placebo|Overall Study||2
2414677|NCT01258387|5922404|P3|Patients Randomized to Placebo|Overall Study||2
2414678|NCT01258387|5922405|P2|Patients Randomized to Placebo|Overall Study||2
2414679|NCT01258387|5922406|P1|Patients Randomized to Placebo|Overall Study||2
2414680|NCT01258387|5922400|P7|Patients Randomized to GGF2|Overall Study||3
2414681|NCT01258387|5922401|P6|Patients Randomized to GGF2|Overall Study||4
2414682|NCT01258387|5922402|P5|Patients Randomized to GGF2|Overall Study||4
2414683|NCT01258387|5922403|P4|Patients Randomized to GGF2|Overall Study||4
2414684|NCT01258387|5922404|P3|Patients Randomized to GGF2|Overall Study||4
2414685|NCT01258387|5922405|P2|Patients Randomized to GGF2|Overall Study||4
2414686|NCT01258387|5922406|P1|Patients Randomized to GGF2|Overall Study||4
2414687|NCT01258387|5922400|P7|STARTED|Overall Study||4
2414688|NCT01258387|5922401|P6|STARTED|Overall Study||6
2414689|NCT01258387|5922402|P5|STARTED|Overall Study||6
2414690|NCT01258387|5922403|P4|STARTED|Overall Study||6
2414691|NCT01258387|5922404|P3|STARTED|Overall Study||6
2414692|NCT01258387|5922405|P2|STARTED|Overall Study||6
2414693|NCT01258387|5922406|P1|STARTED|Overall Study||6
2414694|NCT01258374|5922448|P1|NOT COMPLETED|Overall Study||0
2414695|NCT01258374|5922448|P1|COMPLETED|Overall Study||15
2414696|NCT01258374|5922448|P1|STARTED|Overall Study||15
2414697|NCT01258348|5922455|P5|NOT COMPLETED|Overall Study||6
2414698|NCT01258348|5922456|P4|NOT COMPLETED|Overall Study||6
2414699|NCT01258348|5922457|P3|NOT COMPLETED|Overall Study||3
2414700|NCT01258348|5922458|P2|NOT COMPLETED|Overall Study||5
2414701|NCT01258348|5922459|P1|NOT COMPLETED|Overall Study||1
2414702|NCT01258348|5922455|P5|COMPLETED|Overall Study||0
2414703|NCT01258348|5922456|P4|COMPLETED|Overall Study||0
2414704|NCT01258348|5922457|P3|COMPLETED|Overall Study||0
2414705|NCT01258348|5922458|P2|COMPLETED|Overall Study||0
2414706|NCT01258348|5922459|P1|COMPLETED|Overall Study||0
2414707|NCT01258348|5922455|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
2414708|NCT01258348|5922456|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
2414709|NCT01258348|5922457|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
2414710|NCT01258348|5922458|P2|Received at Least 1 Dose of Study Drug|Overall Study||5
2414711|NCT01258348|5922459|P1|Received at Least 1 Dose of Study Drug|Overall Study||1
2414712|NCT01258348|5922455|P5|STARTED|Overall Study||6
2414713|NCT01258348|5922456|P4|STARTED|Overall Study||6
2414714|NCT01258348|5922457|P3|STARTED|Overall Study||3
2414715|NCT01258348|5922458|P2|STARTED|Overall Study||5
2414716|NCT01258348|5922459|P1|STARTED|Overall Study||1
2414717|NCT01258153|5922487|P3|NOT COMPLETED|Overall Study||1
2414718|NCT01258153|5922488|P2|NOT COMPLETED|Overall Study||1
2414719|NCT01258153|5922489|P1|NOT COMPLETED|Overall Study||1
2414720|NCT01258153|5922487|P3|COMPLETED|Overall Study||36
2414721|NCT01258153|5922488|P2|COMPLETED|Overall Study||37
2414722|NCT01258153|5922489|P1|COMPLETED|Overall Study||39
2414723|NCT01258153|5922487|P3|STARTED|Overall Study||37
2414724|NCT01258153|5922488|P2|STARTED|Overall Study||38
2414725|NCT01258153|5922489|P1|STARTED|Overall Study||40
2414726|NCT01258101|5922516|P4|NOT COMPLETED|Overall Study||25
2414727|NCT01258101|5922517|P3|NOT COMPLETED|Overall Study||11
2414728|NCT01258101|5922518|P2|NOT COMPLETED|Overall Study||34
2414729|NCT01258101|5922519|P1|NOT COMPLETED|Overall Study||33
2414730|NCT01258101|5922516|P4|COMPLETED|Overall Study||27
2414731|NCT01258101|5922517|P3|COMPLETED|Overall Study||22
2414732|NCT01258101|5922518|P2|COMPLETED|Overall Study||110
2414733|NCT01258101|5922519|P1|COMPLETED|Overall Study||118
2414734|NCT01258101|5922516|P4|Standard Analysis Population|Overall Study||26
2414735|NCT01258101|5922517|P3|Standard Analysis Population|Overall Study||21
2414736|NCT01258101|5922518|P2|Standard Analysis Population|Overall Study||110
2414737|NCT01258101|5922519|P1|Standard Analysis Population|Overall Study||115
2414738|NCT01258101|5922516|P4|Safety Analysis Population|Overall Study||48
2414739|NCT01258101|5922517|P3|Safety Analysis Population|Overall Study||30
2414740|NCT01258101|5922518|P2|Safety Analysis Population|Overall Study||141
2414741|NCT01258101|5922519|P1|Safety Analysis Population|Overall Study||144
2414742|NCT01258101|5922516|P4|STARTED|Overall Study||52
2414743|NCT01258101|5922517|P3|STARTED|Overall Study||33
2414744|NCT01258101|5922518|P2|STARTED|Overall Study||144
2414745|NCT01258101|5922519|P1|STARTED|Overall Study||151
2414746|NCT01258049|5922571|P2|NOT COMPLETED|Overall Study||2
2414747|NCT01258049|5922572|P1|NOT COMPLETED|Overall Study||2
2414748|NCT01258049|5922571|P2|COMPLETED|Overall Study||72
2414749|NCT01258049|5922572|P1|COMPLETED|Overall Study||75
2414750|NCT01258049|5922571|P2|STARTED|Overall Study||74
2414751|NCT01258049|5922572|P1|STARTED|Overall Study||77
2414752|NCT01257880|5922610|P2|NOT COMPLETED|Overall Study||0
2414753|NCT01257880|5922611|P1|NOT COMPLETED|Overall Study||0
2414754|NCT01257880|5922610|P2|COMPLETED|Overall Study||19
2414755|NCT01257880|5922611|P1|COMPLETED|Overall Study||12
2414756|NCT01257880|5922610|P2|STARTED|Overall Study||19
2414757|NCT01257880|5922611|P1|STARTED|Overall Study||12
2414758|NCT01257802|5922621|P2|NOT COMPLETED|Overall Study||6
2414759|NCT01257802|5922622|P1|NOT COMPLETED|Overall Study||1
2414760|NCT01257802|5922621|P2|COMPLETED|Overall Study||2
2414761|NCT01257802|5922622|P1|COMPLETED|Overall Study||5
2414762|NCT01257802|5922621|P2|6 Month / 24 Week Visit|Overall Study||2
2414763|NCT01257802|5922622|P1|6 Month / 24 Week Visit|Overall Study||5
2414764|NCT01257802|5922621|P2|STARTED|Overall Study||8
2414765|NCT01257802|5922622|P1|STARTED|Overall Study||6
2414766|NCT01257750|5922636|P1|NOT COMPLETED|Overall Study||0
2414767|NCT01257750|5922636|P1|COMPLETED|Overall Study||20
2414768|NCT01257750|5922636|P1|STARTED|Overall Study||20
2414769|NCT01257737|5922649|P2|NOT COMPLETED|Overall Study||4
2414770|NCT01257737|5922650|P1|NOT COMPLETED|Overall Study||2
2414771|NCT01257737|5922649|P2|COMPLETED|Overall Study||39
2414772|NCT01257737|5922650|P1|COMPLETED|Overall Study||43
2414773|NCT01257737|5922649|P2|STARTED|Overall Study||43
2414774|NCT01257737|5922650|P1|STARTED|Overall Study||45
2414775|NCT01257698|5922670|P2|NOT COMPLETED|Overall Study||0
2414776|NCT01257698|5922671|P1|NOT COMPLETED|Overall Study||4
2414777|NCT01257698|5922670|P2|COMPLETED|Overall Study||9
2414778|NCT01257698|5922671|P1|COMPLETED|Overall Study||8
2414779|NCT01257698|5922670|P2|STARTED|Overall Study||9
2414780|NCT01257698|5922671|P1|STARTED|Overall Study||12
2414781|NCT01257581|5922680|P3|NOT COMPLETED|Overall Study||6
2414782|NCT01257581|5922681|P2|NOT COMPLETED|Overall Study||3
2414783|NCT01257581|5922682|P1|NOT COMPLETED|Overall Study||5
2414784|NCT01257581|5922680|P3|COMPLETED|Overall Study||11
2414785|NCT01257581|5922681|P2|COMPLETED|Overall Study||18
2414786|NCT01257581|5922682|P1|COMPLETED|Overall Study||17
2414787|NCT01257581|5922680|P3|STARTED|Overall Study||17
2414788|NCT01257581|5922681|P2|STARTED|Overall Study||21
2414789|NCT01257581|5922682|P1|STARTED|Overall Study||22
2414790|NCT01257568|5922720|P1|NOT COMPLETED|Overall Study||33
2414791|NCT01257568|5922720|P1|COMPLETED|Overall Study||7
2414792|NCT01257568|5922720|P1|STARTED|Overall Study||40
2414793|NCT01257542|5922734|P2|NOT COMPLETED|Overall Study||7
2414794|NCT01257542|5922735|P1|NOT COMPLETED|Overall Study||3
2414795|NCT01257542|5922734|P2|COMPLETED|Overall Study||45
2414796|NCT01257542|5922735|P1|COMPLETED|Overall Study||52
2414797|NCT01257542|5922734|P2|STARTED|Overall Study||52
2414798|NCT01257542|5922735|P1|STARTED|Overall Study||55
2414799|NCT01257503|5922755|P2|NOT COMPLETED|Overall Study||11
2414800|NCT01257503|5922756|P1|NOT COMPLETED|Overall Study||8
2414801|NCT01257503|5922755|P2|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|119
2414802|NCT01257503|5922756|P1|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|125
2414803|NCT01257503|5922755|P2|Returned Dosage Logbooks|Overall Study||80
2414804|NCT01257503|5922756|P1|Returned Dosage Logbooks|Overall Study||75
2414805|NCT01257503|5922755|P2|Returned Symptom Diaries|Overall Study||83
2414806|NCT01257503|5922756|P1|Returned Symptom Diaries|Overall Study||80
2414807|NCT01257503|5922755|P2|STARTED|Overall Study||130
2414808|NCT01257503|5922756|P1|STARTED|Overall Study||133
2414809|NCT01257438|5922772|P2|NOT COMPLETED|Overall Study||46
2414810|NCT01257438|5922773|P1|NOT COMPLETED|Overall Study||30
2414811|NCT01257438|5922772|P2|COMPLETED|Overall Study||97
2414812|NCT01257438|5922773|P1|COMPLETED|Overall Study||102
2414813|NCT01257438|5922772|P2|STARTED|Overall Study||143
2414814|NCT01257438|5922773|P1|STARTED|Overall Study||132
2414815|NCT01257425|5922785|P2|NOT COMPLETED|Overall Study||6
2414816|NCT01257425|5922786|P1|NOT COMPLETED|Overall Study||6
2414817|NCT01257425|5922785|P2|COMPLETED|Overall Study||45
2414818|NCT01257425|5922786|P1|COMPLETED|Overall Study||46
2414819|NCT01257425|5922785|P2|STARTED|Overall Study||51
2414820|NCT01257425|5922786|P1|STARTED|Overall Study||52
2414821|NCT01257347|5922808|P4|NOT COMPLETED|Overall Study||0
2414822|NCT01257347|5922809|P3|NOT COMPLETED|Overall Study||0
2414823|NCT01257347|5922810|P2|NOT COMPLETED|Overall Study||0
2414824|NCT01257347|5922811|P1|NOT COMPLETED|Overall Study||0
2414825|NCT01257347|5922808|P4|COMPLETED|Overall Study||65
2414826|NCT01257347|5922809|P3|COMPLETED|Overall Study||35
2414827|NCT01257347|5922810|P2|COMPLETED|Overall Study||12
2414828|NCT01257347|5922811|P1|COMPLETED|Overall Study||12
2414829|NCT01257347|5922808|P4|STARTED|Overall Study||65
2414830|NCT01257347|5922809|P3|STARTED|Overall Study||35
2414831|NCT01257347|5922810|P2|STARTED|Overall Study|Median patients per provider = 4; range 1-13 (65 patients)|12
2414832|NCT01257347|5922811|P1|STARTED|Overall Study|Median patients per provider = 3; range 1-10 (35 patients)|12
2414833|NCT01257230|5922828|P3|NOT COMPLETED|Overall Study||6
2414834|NCT01257230|5922829|P2|NOT COMPLETED|Overall Study||10
2414835|NCT01257230|5922830|P1|NOT COMPLETED|Overall Study||6
2414836|NCT01257230|5922828|P3|COMPLETED|Overall Study||129
2414837|NCT01257230|5922829|P2|COMPLETED|Overall Study||115
2414838|NCT01257230|5922830|P1|COMPLETED|Overall Study||132
2414839|NCT01257230|5922828|P3|STARTED|Overall Study||135
2414840|NCT01257230|5922829|P2|STARTED|Overall Study||125
2414841|NCT01257230|5922830|P1|STARTED|Overall Study||138
2414842|NCT01257217|5922885|P2|NOT COMPLETED|Overall Study||0
2414843|NCT01257217|5922886|P1|NOT COMPLETED|Overall Study||2
2414844|NCT01257217|5922885|P2|COMPLETED|Overall Study||10
2414845|NCT01257217|5922886|P1|COMPLETED|Overall Study||13
2414846|NCT01257217|5922885|P2|STARTED|Overall Study||10
2414847|NCT01257217|5922886|P1|STARTED|Overall Study||15
2414848|NCT01257204|5922907|P3|NOT COMPLETED|Follow-up Period (up to Week 48)||10
2414849|NCT01257204|5922908|P2|NOT COMPLETED|Follow-up Period (up to Week 48)||6
2414850|NCT01257204|5922909|P1|NOT COMPLETED|Follow-up Period (up to Week 48)||1
2414851|NCT01257204|5922907|P3|COMPLETED|Follow-up Period (up to Week 48)||39
2414852|NCT01257204|5922908|P2|COMPLETED|Follow-up Period (up to Week 48)||41
2414853|NCT01257204|5922909|P1|COMPLETED|Follow-up Period (up to Week 48)||48
2414854|NCT01257204|5922907|P3|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
2414855|NCT01257204|5922908|P2|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|47
2414856|NCT01257204|5922909|P1|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
2414857|NCT01257204|5922907|P3|NOT COMPLETED|Treatment Period (up to Week 24)||9
2414858|NCT01257204|5922908|P2|NOT COMPLETED|Treatment Period (up to Week 24)||6
2414859|NCT01257204|5922909|P1|NOT COMPLETED|Treatment Period (up to Week 24)||5
2414860|NCT01257204|5922907|P3|COMPLETED|Treatment Period (up to Week 24)||42
2414861|NCT01257204|5922908|P2|COMPLETED|Treatment Period (up to Week 24)||44
2414862|NCT01257204|5922909|P1|COMPLETED|Treatment Period (up to Week 24)||45
2414863|NCT01257204|5922907|P3|STARTED|Treatment Period (up to Week 24)||51
2414864|NCT01257204|5922908|P2|STARTED|Treatment Period (up to Week 24)||50
2414865|NCT01257204|5922909|P1|STARTED|Treatment Period (up to Week 24)||50
2414866|NCT01256983|5922955|P2|NOT COMPLETED|Overall Study||3
2414867|NCT01256983|5922956|P1|NOT COMPLETED|Overall Study||1
2414868|NCT01256983|5922955|P2|COMPLETED|Overall Study||12
2414869|NCT01256983|5922956|P1|COMPLETED|Overall Study||14
2414870|NCT01256983|5922955|P2|STARTED|Overall Study||15
2414871|NCT01256983|5922956|P1|STARTED|Overall Study||15
2414872|NCT01256944|5922964|P2|NOT COMPLETED|Overall Study||0
2414873|NCT01256944|5922965|P1|NOT COMPLETED|Overall Study||0
2414874|NCT01256944|5922964|P2|COMPLETED|Overall Study||220
2414875|NCT01256944|5922965|P1|COMPLETED|Overall Study||70
2414876|NCT01256944|5922964|P2|STARTED|Overall Study||220
2414877|NCT01256944|5922965|P1|STARTED|Overall Study||70
2414878|NCT01256918|5922993|P1|NOT COMPLETED|Overall Study||0
2414879|NCT01256918|5922993|P1|COMPLETED|Overall Study||200
2414880|NCT01256918|5922993|P1|Full Thickness Nuclear Crack Achieved|Overall Study||200
2414881|NCT01256918|5922993|P1|STARTED|Overall Study||200
2414882|NCT01256879|5923004|P1|NOT COMPLETED|Overall Study||1
2414883|NCT01256879|5923004|P1|COMPLETED|Overall Study||24
2414884|NCT01256879|5923004|P1|Commercial Cimetidine Solution|Overall Study|24 started this intervention and 24 completed|24
2414885|NCT01256879|5923004|P1|Sorbitol-free Cimetidine Solution|Overall Study|24 started this intervention and 24 completed|24
2414886|NCT01256879|5923004|P1|CimTest-B|Overall Study|24 started this intervention and 24 completed|24
2414887|NCT01256879|5923004|P1|CimTest-A|Overall Study|25 started this intervention but only 24 completed|25
2414888|NCT01256879|5923004|P1|STARTED|Overall Study|25 started in this cross-over study but only 24 completed|25
2414889|NCT01256840|5923017|P3|NOT COMPLETED|Overall Study||0
2414890|NCT01256840|5923018|P2|NOT COMPLETED|Overall Study||0
2414891|NCT01256840|5923019|P1|NOT COMPLETED|Overall Study||0
2414892|NCT01256840|5923017|P3|COMPLETED|Overall Study||25
2414893|NCT01256840|5923018|P2|COMPLETED|Overall Study||16
2414894|NCT01256840|5923019|P1|COMPLETED|Overall Study||30
2414895|NCT01256840|5923017|P3|STARTED|Overall Study||25
2414896|NCT01256840|5923018|P2|STARTED|Overall Study||16
2414897|NCT01256840|5923019|P1|STARTED|Overall Study||30
2414898|NCT01256788|5923030|P3|NOT COMPLETED|Overall Study||3
2414899|NCT01256788|5923031|P2|NOT COMPLETED|Overall Study||8
2414900|NCT01256788|5923032|P1|NOT COMPLETED|Overall Study||5
2414901|NCT01256788|5923030|P3|COMPLETED|Overall Study||5
2414902|NCT01256788|5923031|P2|COMPLETED|Overall Study||6
2414903|NCT01256788|5923032|P1|COMPLETED|Overall Study||7
2414904|NCT01256788|5923030|P3|STARTED|Overall Study||8
2414905|NCT01256788|5923031|P2|STARTED|Overall Study||14
2414906|NCT01256788|5923032|P1|STARTED|Overall Study||12
2414907|NCT01256684|5923043|P3|NOT COMPLETED|Overall Study||11
2414908|NCT01256684|5923044|P2|NOT COMPLETED|Overall Study||13
2414909|NCT01256684|5923045|P1|NOT COMPLETED|Overall Study||9
2414910|NCT01256684|5923043|P3|COMPLETED|Overall Study||76
2414911|NCT01256684|5923044|P2|COMPLETED|Overall Study||74
2414912|NCT01256684|5923045|P1|COMPLETED|Overall Study||72
2414913|NCT01256684|5923043|P3|ITT Population|Overall Study||81
2414914|NCT01256684|5923044|P2|ITT Population|Overall Study||79
2414915|NCT01256684|5923045|P1|ITT Population|Overall Study||77
2414916|NCT01256684|5923043|P3|Safety Population|Overall Study||87
2414917|NCT01256684|5923044|P2|Safety Population|Overall Study||86
2414918|NCT01256684|5923045|P1|Safety Population|Overall Study||80
2414919|NCT01256684|5923043|P3|STARTED|Overall Study||87
2414920|NCT01256684|5923044|P2|STARTED|Overall Study||87
2414921|NCT01256684|5923045|P1|STARTED|Overall Study||81
2414922|NCT01256671|5923077|P1|NOT COMPLETED|Overall Study||95
2414923|NCT01256671|5923077|P1|COMPLETED|Overall Study||435
2414924|NCT01256671|5923077|P1|Safety Population|Overall Study||521
2414925|NCT01256671|5923077|P1|STARTED|Overall Study||530
2414926|NCT01256658|5923090|P2|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||6372
2414927|NCT01256658|5923091|P1|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||5854
2414928|NCT01256658|5923090|P2|COMPLETED|Period 2 - Follow up Only - No Treatment||0
2414929|NCT01256658|5923091|P1|COMPLETED|Period 2 - Follow up Only - No Treatment||0
2414930|NCT01256658|5923090|P2|Study Termination|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6287
2414931|NCT01256658|5923091|P1|Study Termination|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5777
2414932|NCT01256658|5923090|P2|Death|Period 2 - Follow up Only - No Treatment||8
2414933|NCT01256658|5923091|P1|Death|Period 2 - Follow up Only - No Treatment||6
2414934|NCT01256658|5923090|P2|Lost to Follow up|Period 2 - Follow up Only - No Treatment||77
2414935|NCT01256658|5923091|P1|Lost to Follow up|Period 2 - Follow up Only - No Treatment||71
2414936|NCT01256658|5923090|P2|STARTED|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6372
2414937|NCT01256658|5923091|P1|STARTED|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5854
2414938|NCT01256658|5923090|P2|NOT COMPLETED|Period 1||748
2414939|NCT01256658|5923091|P1|NOT COMPLETED|Period 1||920
2414940|NCT01256658|5923090|P2|COMPLETED|Period 1||6510
2414941|NCT01256658|5923091|P1|COMPLETED|Period 1||5897
2414942|NCT01256658|5923090|P2|STARTED|Period 1||7258
2414943|NCT01256658|5923091|P1|STARTED|Period 1||6817
2414944|NCT01256593|5923141|P1|NOT COMPLETED|Overall Study||214
2414945|NCT01256593|5923141|P1|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|3613
2414946|NCT01256593|5923141|P1|STARTED|Overall Study||3827
2414947|NCT01256567|5923155|P1|NOT COMPLETED|Overall Study||1
2414948|NCT01256567|5923155|P1|COMPLETED|Overall Study||6
2414949|NCT01256567|5923155|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
2414950|NCT01256567|5923155|P1|STARTED|Overall Study||7
2414951|NCT01256502|5923165|P1|NOT COMPLETED|Overall Study||10
2414952|NCT01256502|5923165|P1|COMPLETED|Overall Study||129
2414953|NCT01256502|5923165|P1|STARTED|Overall Study|Implanted with SERI during Stage I breast reconstruction surgery|139
2414954|NCT01256476|5923177|P2|NOT COMPLETED|Overall Study||7
2414955|NCT01256476|5923178|P1|NOT COMPLETED|Overall Study||6
2414956|NCT01256476|5923177|P2|COMPLETED|Overall Study||157
2414957|NCT01256476|5923178|P1|COMPLETED|Overall Study||158
2414958|NCT01256476|5923177|P2|STARTED|Overall Study||164
2414959|NCT01256476|5923178|P1|STARTED|Overall Study||164
2414960|NCT01256450|5923186|P3|NOT COMPLETED|Double-blind Treatment||37
2414961|NCT01256450|5923187|P2|NOT COMPLETED|Double-blind Treatment||28
2414962|NCT01256450|5923188|P1|NOT COMPLETED|Double-blind Treatment||0
2414963|NCT01256450|5923186|P3|COMPLETED|Double-blind Treatment||81
2414964|NCT01256450|5923187|P2|COMPLETED|Double-blind Treatment||89
2414965|NCT01256450|5923188|P1|COMPLETED|Double-blind Treatment||0
2414966|NCT01256450|5923186|P3|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|118
2414967|NCT01256450|5923187|P2|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|117
2414968|NCT01256450|5923188|P1|STARTED|Double-blind Treatment|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
2414969|NCT01256450|5923186|P3|NOT COMPLETED|Open-label Titration||0
2414970|NCT01256450|5923187|P2|NOT COMPLETED|Open-label Titration||0
2414971|NCT01256450|5923188|P1|NOT COMPLETED|Open-label Titration||99
2414972|NCT01256450|5923186|P3|COMPLETED|Open-label Titration||0
2414973|NCT01256450|5923187|P2|COMPLETED|Open-label Titration||0
2414974|NCT01256450|5923188|P1|COMPLETED|Open-label Titration||235
2414975|NCT01256450|5923186|P3|STARTED|Open-label Titration||0
2414976|NCT01256450|5923187|P2|STARTED|Open-label Titration||0
2414977|NCT01256450|5923188|P1|STARTED|Open-label Titration||334
2414978|NCT01256424|5923217|P4|NOT COMPLETED|Overall Study||7
2414979|NCT01256424|5923218|P3|NOT COMPLETED|Overall Study||7
2414980|NCT01256424|5923219|P2|NOT COMPLETED|Overall Study||8
2414981|NCT01256424|5923220|P1|NOT COMPLETED|Overall Study||9
2414982|NCT01256424|5923217|P4|COMPLETED|Overall Study||61
2414983|NCT01256424|5923218|P3|COMPLETED|Overall Study||55
2414984|NCT01256424|5923219|P2|COMPLETED|Overall Study||59
2414985|NCT01256424|5923220|P1|COMPLETED|Overall Study||56
2414986|NCT01256424|5923217|P4|STARTED|Overall Study||68
2414987|NCT01256424|5923218|P3|STARTED|Overall Study||62
2414988|NCT01256424|5923219|P2|STARTED|Overall Study||67
2414989|NCT01256424|5923220|P1|STARTED|Overall Study||65
2414990|NCT01256411|5923246|P6|NOT COMPLETED|Extension by Mono or Combination Therapy||4
2414991|NCT01256411|5923247|P5|NOT COMPLETED|Extension by Mono or Combination Therapy||17
2414992|NCT01256411|5923248|P4|NOT COMPLETED|Extension by Mono or Combination Therapy||0
2414993|NCT01256411|5923249|P3|NOT COMPLETED|Extension by Mono or Combination Therapy||0
2414994|NCT01256411|5923250|P2|NOT COMPLETED|Extension by Mono or Combination Therapy||0
2414995|NCT01256411|5923251|P1|NOT COMPLETED|Extension by Mono or Combination Therapy||0
2414996|NCT01256411|5923246|P6|COMPLETED|Extension by Mono or Combination Therapy||109
2414997|NCT01256411|5923247|P5|COMPLETED|Extension by Mono or Combination Therapy||211
2414998|NCT01256411|5923248|P4|COMPLETED|Extension by Mono or Combination Therapy||0
2414999|NCT01256411|5923249|P3|COMPLETED|Extension by Mono or Combination Therapy||0
2415000|NCT01256411|5923250|P2|COMPLETED|Extension by Mono or Combination Therapy||0
2415001|NCT01256411|5923251|P1|COMPLETED|Extension by Mono or Combination Therapy||0
2415002|NCT01256411|5923246|P6|STARTED|Extension by Mono or Combination Therapy||113
2415003|NCT01256411|5923247|P5|STARTED|Extension by Mono or Combination Therapy||228
2415004|NCT01256411|5923248|P4|STARTED|Extension by Mono or Combination Therapy||0
2415005|NCT01256411|5923249|P3|STARTED|Extension by Mono or Combination Therapy||0
2415006|NCT01256411|5923250|P2|STARTED|Extension by Mono or Combination Therapy||0
2415007|NCT01256411|5923251|P1|STARTED|Extension by Mono or Combination Therapy||0
2415008|NCT01256411|5923246|P6|NOT COMPLETED|Extension by Maximum Treatment||0
2415009|NCT01256411|5923247|P5|NOT COMPLETED|Extension by Maximum Treatment||0
2415010|NCT01256411|5923248|P4|NOT COMPLETED|Extension by Maximum Treatment||0
2415011|NCT01256411|5923249|P3|NOT COMPLETED|Extension by Maximum Treatment||4
2415012|NCT01256411|5923250|P2|NOT COMPLETED|Extension by Maximum Treatment||10
2415013|NCT01256411|5923251|P1|NOT COMPLETED|Extension by Maximum Treatment||7
2415014|NCT01256411|5923246|P6|COMPLETED|Extension by Maximum Treatment||0
2415015|NCT01256411|5923247|P5|COMPLETED|Extension by Maximum Treatment||0
2415016|NCT01256411|5923248|P4|COMPLETED|Extension by Maximum Treatment||4
2415017|NCT01256411|5923249|P3|COMPLETED|Extension by Maximum Treatment||105
2415018|NCT01256411|5923250|P2|COMPLETED|Extension by Maximum Treatment||79
2415019|NCT01256411|5923251|P1|COMPLETED|Extension by Maximum Treatment||132
2415020|NCT01256411|5923246|P6|Down Titrated to 100 mg|Extension by Maximum Treatment||0
2415021|NCT01256411|5923247|P5|Down Titrated to 100 mg|Extension by Maximum Treatment||0
2415022|NCT01256411|5923248|P4|Down Titrated to 100 mg|Extension by Maximum Treatment||0
2415023|NCT01256411|5923249|P3|Down Titrated to 100 mg|Extension by Maximum Treatment||0
2415024|NCT01256411|5923250|P2|Down Titrated to 100 mg|Extension by Maximum Treatment||0
2415025|NCT01256411|5923251|P1|Down Titrated to 100 mg|Extension by Maximum Treatment||12
2415026|NCT01256411|5923246|P6|STARTED|Extension by Maximum Treatment||0
2415027|NCT01256411|5923247|P5|STARTED|Extension by Maximum Treatment||0
2415028|NCT01256411|5923248|P4|STARTED|Extension by Maximum Treatment||4
2415029|NCT01256411|5923249|P3|STARTED|Extension by Maximum Treatment||109
2415030|NCT01256411|5923250|P2|STARTED|Extension by Maximum Treatment||89
2415031|NCT01256411|5923251|P1|STARTED|Extension by Maximum Treatment||139
2415032|NCT01256398|5923275|P1|NOT COMPLETED|Overall Study||1
2415033|NCT01256398|5923275|P1|COMPLETED|Overall Study||65
2415034|NCT01256398|5923275|P1|STARTED|Overall Study||66
2415035|NCT01256385|5923281|P2|NOT COMPLETED|Overall Study||3
2415036|NCT01256385|5923282|P1|NOT COMPLETED|Overall Study||3
2415037|NCT01256385|5923281|P2|COMPLETED|Overall Study||40
2415038|NCT01256385|5923282|P1|COMPLETED|Overall Study||40
2415039|NCT01256385|5923281|P2|Crossover From Arm B to Arm A|Overall Study||15
2415040|NCT01256385|5923282|P1|Crossover From Arm B to Arm A|Overall Study||0
2415041|NCT01256385|5923281|P2|STARTED|Overall Study||43
2415042|NCT01256385|5923282|P1|STARTED|Overall Study||43
2415043|NCT01256294|5923302|P2|NOT COMPLETED|Overall Study||2
2415044|NCT01256294|5923303|P1|NOT COMPLETED|Overall Study||4
2415045|NCT01256294|5923302|P2|COMPLETED|Overall Study||33
2415046|NCT01256294|5923303|P1|COMPLETED|Overall Study||32
2415047|NCT01256294|5923302|P2|STARTED|Overall Study||35
2415048|NCT01256294|5923303|P1|STARTED|Overall Study||36
2415049|NCT01256281|5923319|P1|NOT COMPLETED|Overall Study||0
2415050|NCT01256281|5923319|P1|COMPLETED|Overall Study||2
2415051|NCT01256281|5923319|P1|STARTED|Overall Study||2
2415052|NCT01256190|5923325|P2|NOT COMPLETED|Overall Study||0
2415053|NCT01256190|5923326|P1|NOT COMPLETED|Overall Study||2
2415054|NCT01256190|5923325|P2|COMPLETED|Overall Study||17
2415055|NCT01256190|5923326|P1|COMPLETED|Overall Study||37
2415056|NCT01256190|5923325|P2|STARTED|Overall Study||17
2415057|NCT01256190|5923326|P1|STARTED|Overall Study||39
2415058|NCT01256177|5923342|P2|NOT COMPLETED|Overall Study||37
2415059|NCT01256177|5923343|P1|NOT COMPLETED|Overall Study||50
2415060|NCT01256177|5923342|P2|COMPLETED|Overall Study||111
2415061|NCT01256177|5923343|P1|COMPLETED|Overall Study||98
2415062|NCT01256177|5923342|P2|STARTED|Overall Study||148
2415063|NCT01256177|5923343|P1|STARTED|Overall Study||148
2415064|NCT01256164|5923367|P2|NOT COMPLETED|Overall Study||0
2415065|NCT01256164|5923368|P1|NOT COMPLETED|Overall Study||0
2415066|NCT01256164|5923367|P2|COMPLETED|Overall Study||23
2415067|NCT01256164|5923368|P1|COMPLETED|Overall Study||47
2415068|NCT01256164|5923367|P2|STARTED|Overall Study||23
2415069|NCT01256164|5923368|P1|STARTED|Overall Study||47
2415070|NCT01256086|5923386|P4|NOT COMPLETED|Treatment Day 4||0
2415071|NCT01256086|5923387|P3|NOT COMPLETED|Treatment Day 4||0
2415072|NCT01256086|5923388|P2|NOT COMPLETED|Treatment Day 4||0
2415073|NCT01256086|5923389|P1|NOT COMPLETED|Treatment Day 4||0
2415074|NCT01256086|5923386|P4|COMPLETED|Treatment Day 4||11
2415075|NCT01256086|5923387|P3|COMPLETED|Treatment Day 4||9
2415076|NCT01256086|5923388|P2|COMPLETED|Treatment Day 4||10
2415077|NCT01256086|5923389|P1|COMPLETED|Treatment Day 4||11
2415078|NCT01256086|5923386|P4|STARTED|Treatment Day 4||11
2415079|NCT01256086|5923387|P3|STARTED|Treatment Day 4||9
2415080|NCT01256086|5923388|P2|STARTED|Treatment Day 4||10
2415081|NCT01256086|5923389|P1|STARTED|Treatment Day 4||11
2415082|NCT01256086|5923386|P4|NOT COMPLETED|Treatment Day 3||0
2415083|NCT01256086|5923387|P3|NOT COMPLETED|Treatment Day 3||0
2415084|NCT01256086|5923388|P2|NOT COMPLETED|Treatment Day 3||0
2415085|NCT01256086|5923389|P1|NOT COMPLETED|Treatment Day 3||0
2415086|NCT01256086|5923386|P4|COMPLETED|Treatment Day 3||11
2415087|NCT01256086|5923387|P3|COMPLETED|Treatment Day 3||9
2415088|NCT01256086|5923388|P2|COMPLETED|Treatment Day 3||10
2415089|NCT01256086|5923389|P1|COMPLETED|Treatment Day 3||11
2415090|NCT01256086|5923386|P4|STARTED|Treatment Day 3||11
2415091|NCT01256086|5923387|P3|STARTED|Treatment Day 3||9
2415092|NCT01256086|5923388|P2|STARTED|Treatment Day 3||10
2415093|NCT01256086|5923389|P1|STARTED|Treatment Day 3||11
2415094|NCT01256086|5923386|P4|NOT COMPLETED|Treatment Day 2||0
2415095|NCT01256086|5923387|P3|NOT COMPLETED|Treatment Day 2||0
2415096|NCT01256086|5923388|P2|NOT COMPLETED|Treatment Day 2||0
2415097|NCT01256086|5923389|P1|NOT COMPLETED|Treatment Day 2||0
2415098|NCT01256086|5923386|P4|COMPLETED|Treatment Day 2||11
2415099|NCT01256086|5923387|P3|COMPLETED|Treatment Day 2||9
2415100|NCT01256086|5923388|P2|COMPLETED|Treatment Day 2||10
2415101|NCT01256086|5923389|P1|COMPLETED|Treatment Day 2||11
2415102|NCT01256086|5923386|P4|STARTED|Treatment Day 2||11
2415103|NCT01256086|5923387|P3|STARTED|Treatment Day 2||9
2415104|NCT01256086|5923388|P2|STARTED|Treatment Day 2||10
2415105|NCT01256086|5923389|P1|STARTED|Treatment Day 2||11
2415106|NCT01256086|5923386|P4|NOT COMPLETED|Treatment Day 1||0
2415107|NCT01256086|5923387|P3|NOT COMPLETED|Treatment Day 1||0
2415108|NCT01256086|5923388|P2|NOT COMPLETED|Treatment Day 1||0
2415109|NCT01256086|5923389|P1|NOT COMPLETED|Treatment Day 1||0
2415110|NCT01256086|5923386|P4|COMPLETED|Treatment Day 1||11
2415111|NCT01256086|5923387|P3|COMPLETED|Treatment Day 1||11
2415112|NCT01256086|5923388|P2|COMPLETED|Treatment Day 1||11
2415113|NCT01256086|5923389|P1|COMPLETED|Treatment Day 1||11
2415114|NCT01256086|5923386|P4|STARTED|Treatment Day 1||11
2415115|NCT01256086|5923387|P3|STARTED|Treatment Day 1||11
2415116|NCT01256086|5923388|P2|STARTED|Treatment Day 1||11
2415117|NCT01256086|5923389|P1|STARTED|Treatment Day 1||11
2415118|NCT01256060|5923399|P4|NOT COMPLETED|Overall Study||0
2415119|NCT01256060|5923400|P3|NOT COMPLETED|Overall Study||0
2415120|NCT01256060|5923401|P2|NOT COMPLETED|Overall Study||1
2415121|NCT01256060|5923402|P1|NOT COMPLETED|Overall Study||0
2415122|NCT01256060|5923399|P4|COMPLETED|Overall Study||6
2415123|NCT01256060|5923400|P3|COMPLETED|Overall Study||3
2415124|NCT01256060|5923401|P2|COMPLETED|Overall Study||2
2415125|NCT01256060|5923402|P1|COMPLETED|Overall Study||3
2415126|NCT01256060|5923399|P4|STARTED|Overall Study||6
2415127|NCT01256060|5923400|P3|STARTED|Overall Study||3
2415128|NCT01256060|5923401|P2|STARTED|Overall Study||3
2415129|NCT01256060|5923402|P1|STARTED|Overall Study||3
2415130|NCT01256034|5923411|P2|NOT COMPLETED|Overall Study||25
2415131|NCT01256034|5923412|P1|NOT COMPLETED|Overall Study||25
2415132|NCT01256034|5923411|P2|COMPLETED|Overall Study||0
2415133|NCT01256034|5923412|P1|COMPLETED|Overall Study||0
2415134|NCT01256034|5923411|P2|STARTED|Overall Study||25
2415135|NCT01256034|5923412|P1|STARTED|Overall Study||25
2415136|NCT01256008|5923421|P3|NOT COMPLETED|Overall Study||21
2415137|NCT01256008|5923422|P2|NOT COMPLETED|Overall Study||7
2415138|NCT01256008|5923423|P1|NOT COMPLETED|Overall Study||8
2415139|NCT01256008|5923421|P3|COMPLETED|Overall Study||175
2415140|NCT01256008|5923422|P2|COMPLETED|Overall Study||91
2415141|NCT01256008|5923423|P1|COMPLETED|Overall Study||90
2415142|NCT01256008|5923421|P3|STARTED|Overall Study||196
2415143|NCT01256008|5923422|P2|STARTED|Overall Study||98
2415144|NCT01256008|5923423|P1|STARTED|Overall Study||98
2415145|NCT01255904|5923445|P2|NOT COMPLETED|Overall Study||4
2415146|NCT01255904|5923446|P1|NOT COMPLETED|Overall Study||1
2415147|NCT01255904|5923445|P2|COMPLETED|Overall Study||41
2415148|NCT01255904|5923446|P1|COMPLETED|Overall Study||44
2415149|NCT01255904|5923445|P2|STARTED|Overall Study||45
2415150|NCT01255904|5923446|P1|STARTED|Overall Study||45
2415151|NCT01255787|5923456|P4|NOT COMPLETED|Overall Study||22
2415152|NCT01255787|5923457|P3|NOT COMPLETED|Overall Study||18
2415153|NCT01255787|5923458|P2|NOT COMPLETED|Overall Study||17
2415154|NCT01255787|5923459|P1|NOT COMPLETED|Overall Study||16
2415155|NCT01255787|5923456|P4|COMPLETED|Overall Study||132
2415156|NCT01255787|5923457|P3|COMPLETED|Overall Study||132
2415157|NCT01255787|5923458|P2|COMPLETED|Overall Study||127
2415158|NCT01255787|5923459|P1|COMPLETED|Overall Study||136
2415159|NCT01255787|5923456|P4|Treated|Overall Study||150
2415160|NCT01255787|5923457|P3|Treated|Overall Study||148
2415161|NCT01255787|5923458|P2|Treated|Overall Study||144
2415162|NCT01255787|5923459|P1|Treated|Overall Study||152
2415163|NCT01255787|5923456|P4|STARTED|Overall Study||154
2415164|NCT01255787|5923457|P3|STARTED|Overall Study||150
2415165|NCT01255787|5923458|P2|STARTED|Overall Study||144
2415166|NCT01255787|5923459|P1|STARTED|Overall Study||152
2415167|NCT01255761|5923487|P2|NOT COMPLETED|Overall Study||175
2415168|NCT01255761|5923488|P1|NOT COMPLETED|Overall Study||182
2415169|NCT01255761|5923487|P2|COMPLETED|Overall Study||192
2415170|NCT01255761|5923488|P1|COMPLETED|Overall Study||187
2415171|NCT01255761|5923487|P2|STARTED|Overall Study||367
2415172|NCT01255761|5923488|P1|STARTED|Overall Study||369
2415173|NCT01255722|5923573|P3|NOT COMPLETED|Overall Study||1
2415174|NCT01255722|5923574|P2|NOT COMPLETED|Overall Study||1
2415175|NCT01255722|5923575|P1|NOT COMPLETED|Overall Study||3
2415176|NCT01255722|5923573|P3|COMPLETED|Overall Study||152
2415177|NCT01255722|5923574|P2|COMPLETED|Overall Study||159
2415178|NCT01255722|5923575|P1|COMPLETED|Overall Study||152
2415179|NCT01255722|5923573|P3|STARTED|Overall Study||153
2415180|NCT01255722|5923574|P2|STARTED|Overall Study||160
2415181|NCT01255722|5923575|P1|STARTED|Overall Study||155
2415182|NCT01255631|5923600|P2|NOT COMPLETED|Overall Study||6
2415183|NCT01255631|5923601|P1|NOT COMPLETED|Overall Study||9
2415184|NCT01255631|5923600|P2|COMPLETED|Overall Study|study terminated due to poor enrollment|3
2415185|NCT01255631|5923601|P1|COMPLETED|Overall Study|study terminated due to poor enrollment|4
2415186|NCT01255631|5923600|P2|STARTED|Overall Study||9
2415187|NCT01255631|5923601|P1|STARTED|Overall Study||13
2415188|NCT01255592|5923619|P2|NOT COMPLETED|Overall Study||1
2415189|NCT01255592|5923620|P1|NOT COMPLETED|Overall Study||6
2415190|NCT01255592|5923619|P2|COMPLETED|Overall Study||25
2415191|NCT01255592|5923620|P1|COMPLETED|Overall Study||20
2415192|NCT01255592|5923619|P2|STARTED|Overall Study||26
2415193|NCT01255592|5923620|P1|STARTED|Overall Study||26
2415194|NCT01255449|5923676|P1|NOT COMPLETED|Overall Study||0
2415195|NCT01255449|5923676|P1|COMPLETED|Overall Study||26
2415196|NCT01255449|5923676|P1|STARTED|Overall Study||26
2415197|NCT01255436|5923683|P2|NOT COMPLETED|Overall Study||194
2415198|NCT01255436|5923684|P1|NOT COMPLETED|Overall Study||182
2415199|NCT01255436|5923683|P2|COMPLETED|Overall Study||135
2415200|NCT01255436|5923684|P1|COMPLETED|Overall Study||151
2415201|NCT01255436|5923683|P2|STARTED|Overall Study|350 patients enrolled but 21 excluded because of missing baseline data|329
2415202|NCT01255436|5923684|P1|STARTED|Overall Study|350 patients enrolled but 17 excluded because of missing baseline data.|333
2415203|NCT01255423|5923698|P2|NOT COMPLETED|Overall Study||3
2415204|NCT01255423|5923699|P1|NOT COMPLETED|Overall Study||3
2415205|NCT01255423|5923698|P2|COMPLETED|Overall Study||99
2415206|NCT01255423|5923699|P1|COMPLETED|Overall Study||101
2415207|NCT01255423|5923698|P2|STARTED|Overall Study||102
2415208|NCT01255423|5923699|P1|STARTED|Overall Study||104
2415209|NCT01255306|5923715|P2|NOT COMPLETED|Overall Study||1
2415210|NCT01255306|5923716|P1|NOT COMPLETED|Overall Study||1
2415211|NCT01255306|5923715|P2|COMPLETED|Overall Study||32
2415212|NCT01255306|5923716|P1|COMPLETED|Overall Study||25
2415213|NCT01255306|5923715|P2|STARTED|Overall Study||33
2415214|NCT01255306|5923716|P1|STARTED|Overall Study||26
2415215|NCT01255163|5923727|P2|NOT COMPLETED|Overall Study||5
2415216|NCT01255163|5923728|P1|NOT COMPLETED|Overall Study||4
2415217|NCT01255163|5923727|P2|COMPLETED|Overall Study||9
2415218|NCT01255163|5923728|P1|COMPLETED|Overall Study||9
2415219|NCT01255163|5923727|P2|STARTED|Overall Study||14
2415220|NCT01255163|5923728|P1|STARTED|Overall Study||13
2415221|NCT01255137|5923750|P1|NOT COMPLETED|Overall Study||0
2415222|NCT01255137|5923750|P1|COMPLETED|Overall Study||13
2415223|NCT01255137|5923750|P1|STARTED|Overall Study||13
2415224|NCT01254890|5923757|P2|NOT COMPLETED|Overall Study||10
2415225|NCT01254890|5923758|P1|NOT COMPLETED|Overall Study||1
2415226|NCT01254890|5923757|P2|COMPLETED|Overall Study||47
2415227|NCT01254890|5923758|P1|COMPLETED|Overall Study||2
2415228|NCT01254890|5923757|P2|STARTED|Overall Study||57
2415229|NCT01254890|5923758|P1|STARTED|Overall Study||3
2415230|NCT01254877|5923767|P3|NOT COMPLETED|Overall Study||5
2415231|NCT01254877|5923768|P2|NOT COMPLETED|Overall Study||11
2415232|NCT01254877|5923769|P1|NOT COMPLETED|Overall Study||10
2415233|NCT01254877|5923767|P3|COMPLETED|Overall Study||64
2415234|NCT01254877|5923768|P2|COMPLETED|Overall Study||58
2415235|NCT01254877|5923769|P1|COMPLETED|Overall Study||57
2415236|NCT01254877|5923767|P3|STARTED|Overall Study||69
2415237|NCT01254877|5923768|P2|STARTED|Overall Study||69
2415238|NCT01254877|5923769|P1|STARTED|Overall Study||67
2415239|NCT01254851|5923794|P2|NOT COMPLETED|Overall Study||9
2415240|NCT01254851|5923795|P1|NOT COMPLETED|Overall Study||8
2415241|NCT01254851|5923794|P2|COMPLETED|Overall Study||68
2415242|NCT01254851|5923795|P1|COMPLETED|Overall Study||61
2415243|NCT01254851|5923794|P2|STARTED|Overall Study||77
2415244|NCT01254851|5923795|P1|STARTED|Overall Study||69
2415245|NCT01254760|5923801|P2|NOT COMPLETED|Second Period, 5 Days of Wear||0
2415246|NCT01254760|5923802|P1|NOT COMPLETED|Second Period, 5 Days of Wear||0
2415247|NCT01254760|5923801|P2|COMPLETED|Second Period, 5 Days of Wear||38
2415248|NCT01254760|5923802|P1|COMPLETED|Second Period, 5 Days of Wear||34
2415249|NCT01254760|5923801|P2|STARTED|Second Period, 5 Days of Wear||38
2415250|NCT01254760|5923802|P1|STARTED|Second Period, 5 Days of Wear||34
2415251|NCT01254760|5923801|P2|NOT COMPLETED|First Period, 5 Days of Wear||0
2415252|NCT01254760|5923802|P1|NOT COMPLETED|First Period, 5 Days of Wear||0
2415253|NCT01254760|5923801|P2|COMPLETED|First Period, 5 Days of Wear||38
2415254|NCT01254760|5923802|P1|COMPLETED|First Period, 5 Days of Wear||34
2415255|NCT01254760|5923801|P2|STARTED|First Period, 5 Days of Wear||38
2415256|NCT01254760|5923802|P1|STARTED|First Period, 5 Days of Wear||34
2415257|NCT01254747|5923820|P4|NOT COMPLETED|Overall Study||2
2415258|NCT01254747|5923821|P3|NOT COMPLETED|Overall Study||4
2415259|NCT01254747|5923822|P2|NOT COMPLETED|Overall Study||6
2415260|NCT01254747|5923823|P1|NOT COMPLETED|Overall Study||0
2415261|NCT01254747|5923820|P4|COMPLETED|Overall Study||28
2415262|NCT01254747|5923821|P3|COMPLETED|Overall Study||26
2415263|NCT01254747|5923822|P2|COMPLETED|Overall Study||23
2415264|NCT01254747|5923823|P1|COMPLETED|Overall Study||40
2415265|NCT01254747|5923820|P4|STARTED|Overall Study||30
2415266|NCT01254747|5923821|P3|STARTED|Overall Study||30
2415267|NCT01254747|5923822|P2|STARTED|Overall Study||29
2415268|NCT01254747|5923823|P1|STARTED|Overall Study||40
2415269|NCT01254721|5923863|P2|NOT COMPLETED|Overall Study||22
2415270|NCT01254721|5923864|P1|NOT COMPLETED|Overall Study||15
2415271|NCT01254721|5923863|P2|COMPLETED|Overall Study||42
2415272|NCT01254721|5923864|P1|COMPLETED|Overall Study||52
2415273|NCT01254721|5923863|P2|STARTED|Overall Study|Seroquel XR: 300mg Lithium: 900mg|64
2415274|NCT01254721|5923864|P1|STARTED|Overall Study|Seroquel XR: 300mg|67
2415275|NCT01254669|5923874|P2|NOT COMPLETED|Overall Study||4
2415276|NCT01254669|5923875|P1|NOT COMPLETED|Overall Study||3
2415277|NCT01254669|5923874|P2|COMPLETED|Overall Study||96
2415278|NCT01254669|5923875|P1|COMPLETED|Overall Study||97
2415279|NCT01254669|5923874|P2|STARTED|Overall Study||100
2415280|NCT01254669|5923875|P1|STARTED|Overall Study||100
2415281|NCT01254656|5923886|P3|NOT COMPLETED|Overall Study||18
2415282|NCT01254656|5923887|P2|NOT COMPLETED|Overall Study||43
2415283|NCT01254656|5923888|P1|NOT COMPLETED|Overall Study||47
2415284|NCT01254656|5923886|P3|COMPLETED|Overall Study||0
2415285|NCT01254656|5923887|P2|COMPLETED|Overall Study||0
2415286|NCT01254656|5923888|P1|COMPLETED|Overall Study||0
2415287|NCT01254656|5923886|P3|Treated|Overall Study||18
2415288|NCT01254656|5923887|P2|Treated|Overall Study||43
2415289|NCT01254656|5923888|P1|Treated|Overall Study||47
2415290|NCT01254656|5923886|P3|STARTED|Overall Study||18
2415291|NCT01254656|5923887|P2|STARTED|Overall Study||43
2415292|NCT01254656|5923888|P1|STARTED|Overall Study||47
2415293|NCT01254643|5923914|P1|NOT COMPLETED|Overall Study||1
2415294|NCT01254643|5923914|P1|COMPLETED|Overall Study||99
2415295|NCT01254643|5923914|P1|Vaccination 3|Overall Study||99
2415296|NCT01254643|5923914|P1|Vaccination 2|Overall Study||99
2415297|NCT01254643|5923914|P1|Vaccination 1|Overall Study||100
2415298|NCT01254643|5923914|P1|STARTED|Overall Study||100
2415299|NCT01254630|5923926|P4|NOT COMPLETED|Overall Study||1285
2415300|NCT01254630|5923927|P3|NOT COMPLETED|Overall Study||812
2415301|NCT01254630|5923928|P2|NOT COMPLETED|Overall Study||1288
2415302|NCT01254630|5923929|P1|NOT COMPLETED|Overall Study||802
2415303|NCT01254630|5923926|P4|COMPLETED|Overall Study||0
2415304|NCT01254630|5923927|P3|COMPLETED|Overall Study||552
2415305|NCT01254630|5923928|P2|COMPLETED|Overall Study||0
2415306|NCT01254630|5923929|P1|COMPLETED|Overall Study||546
2415307|NCT01254630|5923926|P4|Received Vaccination 4|Overall Study||1160
2415308|NCT01254630|5923927|P3|Received Vaccination 4|Overall Study||1212
2415309|NCT01254630|5923928|P2|Received Vaccination 4|Overall Study||1145
2415310|NCT01254630|5923929|P1|Received Vaccination 4|Overall Study||1155
2415311|NCT01254630|5923926|P4|Received Vaccination 3|Overall Study||1194
2415312|NCT01254630|5923927|P3|Received Vaccination 3|Overall Study||1247
2415313|NCT01254630|5923928|P2|Received Vaccination 3|Overall Study||1178
2415314|NCT01254630|5923929|P1|Received Vaccination 3|Overall Study||1198
2415315|NCT01254630|5923926|P4|Received Vaccination 2|Overall Study||1226
2415316|NCT01254630|5923927|P3|Received Vaccination 2|Overall Study||1286
2415317|NCT01254630|5923928|P2|Received Vaccination 2|Overall Study||1217
2415318|NCT01254630|5923929|P1|Received Vaccination 2|Overall Study||1255
2415319|NCT01254630|5923926|P4|Received Vaccination 1|Overall Study||1275
2415320|NCT01254630|5923927|P3|Received Vaccination 1|Overall Study||1350
2415321|NCT01254630|5923928|P2|Received Vaccination 1|Overall Study||1277
2415322|NCT01254630|5923929|P1|Received Vaccination 1|Overall Study||1328
2415323|NCT01254630|5923926|P4|STARTED|Overall Study||1285
2415324|NCT01254630|5923927|P3|STARTED|Overall Study||1364
2415325|NCT01254630|5923928|P2|STARTED|Overall Study||1288
2415326|NCT01254630|5923929|P1|STARTED|Overall Study||1348
2415327|NCT01254604|5923949|P2|NOT COMPLETED|Overall Study||9
2415328|NCT01254604|5923950|P1|NOT COMPLETED|Overall Study||8
2415329|NCT01254604|5923949|P2|COMPLETED|Overall Study||86
2415330|NCT01254604|5923950|P1|COMPLETED|Overall Study||87
2415331|NCT01254604|5923949|P2|Treated|Overall Study|"The 1 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|94
2415332|NCT01254604|5923950|P1|Treated|Overall Study|"The 2 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|93
2415333|NCT01254604|5923949|P2|STARTED|Overall Study||95
2415334|NCT01254604|5923950|P1|STARTED|Overall Study||95
2415335|NCT01254565|5923968|P6|NOT COMPLETED|Overall Study||4
2415336|NCT01254565|5923969|P5|NOT COMPLETED|Overall Study||4
2415337|NCT01254565|5923970|P4|NOT COMPLETED|Overall Study||1
2415338|NCT01254565|5923971|P3|NOT COMPLETED|Overall Study||0
2415339|NCT01254565|5923972|P2|NOT COMPLETED|Overall Study||1
2415340|NCT01254565|5923973|P1|NOT COMPLETED|Overall Study||1
2415341|NCT01254565|5923968|P6|COMPLETED|Overall Study||13
2415342|NCT01254565|5923969|P5|COMPLETED|Overall Study||12
2415343|NCT01254565|5923970|P4|COMPLETED|Overall Study||20
2415344|NCT01254565|5923971|P3|COMPLETED|Overall Study||21
2415345|NCT01254565|5923972|P2|COMPLETED|Overall Study||6
2415346|NCT01254565|5923973|P1|COMPLETED|Overall Study||4
2415347|NCT01254565|5923968|P6|Received Treatment|Overall Study||13
2415348|NCT01254565|5923969|P5|Received Treatment|Overall Study||13
2415349|NCT01254565|5923970|P4|Received Treatment|Overall Study||21
2415350|NCT01254565|5923971|P3|Received Treatment|Overall Study||21
2415351|NCT01254565|5923972|P2|Received Treatment|Overall Study||6
2415352|NCT01254565|5923973|P1|Received Treatment|Overall Study||4
2415353|NCT01254565|5923968|P6|STARTED|Overall Study||17
2415354|NCT01254565|5923969|P5|STARTED|Overall Study||16
2415355|NCT01254565|5923970|P4|STARTED|Overall Study||21
2415356|NCT01254565|5923971|P3|STARTED|Overall Study||21
2415357|NCT01254565|5923972|P2|STARTED|Overall Study||7
2415358|NCT01254565|5923973|P1|STARTED|Overall Study||5
2415359|NCT01254552|5924023|P1|NOT COMPLETED|CCTA With Xenetix 350||6
2415360|NCT01254552|5924023|P1|COMPLETED|CCTA With Xenetix 350||322
2415361|NCT01254552|5924023|P1|STARTED|CCTA With Xenetix 350||328
2415362|NCT01254552|5924023|P1|NOT COMPLETED|Delayed-enhanced MRI With Dotarem||20
2415363|NCT01254552|5924023|P1|COMPLETED|Delayed-enhanced MRI With Dotarem||328
2415364|NCT01254552|5924023|P1|STARTED|Delayed-enhanced MRI With Dotarem||348
2415365|NCT01254552|5924023|P1|NOT COMPLETED|Screening Visit||3
2415366|NCT01254552|5924023|P1|COMPLETED|Screening Visit||348
2415367|NCT01254552|5924023|P1|STARTED|Screening Visit||351
2415368|NCT01254422|5924033|P2|NOT COMPLETED|Overall Study||1
2415369|NCT01254422|5924034|P1|NOT COMPLETED|Overall Study||3
2415370|NCT01254422|5924033|P2|COMPLETED|Overall Study||50
2415371|NCT01254422|5924034|P1|COMPLETED|Overall Study||196
2415372|NCT01254422|5924033|P2|STARTED|Overall Study||51
2415373|NCT01254422|5924034|P1|STARTED|Overall Study||199
2415374|NCT01254409|5924062|P4|NOT COMPLETED|Overall Study||0
2415375|NCT01254409|5924063|P3|NOT COMPLETED|Overall Study||0
2415376|NCT01254409|5924064|P2|NOT COMPLETED|Overall Study||1
2415377|NCT01254409|5924065|P1|NOT COMPLETED|Overall Study||0
2415378|NCT01254409|5924062|P4|COMPLETED|Overall Study||4
2415379|NCT01254409|5924063|P3|COMPLETED|Overall Study||5
2415380|NCT01254409|5924064|P2|COMPLETED|Overall Study||5
2415381|NCT01254409|5924065|P1|COMPLETED|Overall Study||6
2415382|NCT01254409|5924062|P4|STARTED|Overall Study||4
2415383|NCT01254409|5924063|P3|STARTED|Overall Study||5
2415384|NCT01254409|5924064|P2|STARTED|Overall Study||6
2415385|NCT01254409|5924065|P1|STARTED|Overall Study||6
2415386|NCT01254396|5924117|P2|NOT COMPLETED|Second Intervention Period||0
2415387|NCT01254396|5924118|P1|NOT COMPLETED|Second Intervention Period||0
2415388|NCT01254396|5924117|P2|COMPLETED|Second Intervention Period||6
2415389|NCT01254396|5924118|P1|COMPLETED|Second Intervention Period||6
2415390|NCT01254396|5924117|P2|STARTED|Second Intervention Period||6
2415391|NCT01254396|5924118|P1|STARTED|Second Intervention Period||6
2415392|NCT01254396|5924117|P2|NOT COMPLETED|Washout Period (at Least 1 Day)||0
2415393|NCT01254396|5924118|P1|NOT COMPLETED|Washout Period (at Least 1 Day)||0
2415394|NCT01254396|5924117|P2|COMPLETED|Washout Period (at Least 1 Day)||6
2415395|NCT01254396|5924118|P1|COMPLETED|Washout Period (at Least 1 Day)||6
2415396|NCT01254396|5924117|P2|STARTED|Washout Period (at Least 1 Day)||6
2415397|NCT01254396|5924118|P1|STARTED|Washout Period (at Least 1 Day)||6
2415398|NCT01254396|5924117|P2|NOT COMPLETED|First Intervention Period||0
2415399|NCT01254396|5924118|P1|NOT COMPLETED|First Intervention Period||0
2415400|NCT01254396|5924117|P2|COMPLETED|First Intervention Period||6
2415401|NCT01254396|5924118|P1|COMPLETED|First Intervention Period||6
2415402|NCT01254396|5924117|P2|STARTED|First Intervention Period||6
2415403|NCT01254396|5924118|P1|STARTED|First Intervention Period||6
2415404|NCT01254344|5924134|P2|NOT COMPLETED|Overall Study||19
2415405|NCT01254344|5924135|P1|NOT COMPLETED|Overall Study||13
2415406|NCT01254344|5924134|P2|COMPLETED|Overall Study||281
2415407|NCT01254344|5924135|P1|COMPLETED|Overall Study||286
2415408|NCT01254344|5924134|P2|Treated|Overall Study||297
2415409|NCT01254344|5924135|P1|Treated|Overall Study||290
2415410|NCT01254344|5924134|P2|STARTED|Overall Study||300
2415411|NCT01254344|5924135|P1|STARTED|Overall Study||299
2415412|NCT01254331|5924143|P1|NOT COMPLETED|Extension Phase||4
2415413|NCT01254331|5924143|P1|COMPLETED|Extension Phase||41
2415414|NCT01254331|5924143|P1|STARTED|Extension Phase|1 participant withdrew consent after completing initial phase and did not enter the extension phase|45
2415415|NCT01254331|5924143|P1|NOT COMPLETED|Initial Phase||5
2415416|NCT01254331|5924143|P1|COMPLETED|Initial Phase||46
2415417|NCT01254331|5924143|P1|STARTED|Initial Phase||51
2415418|NCT01254318|5924161|P1|NOT COMPLETED|Overall Study||52
2415419|NCT01254318|5924161|P1|COMPLETED|Overall Study|Alive at end of study|78
2415420|NCT01254318|5924161|P1|STARTED|Overall Study|Alive at start of study|130
2415421|NCT01254305|5924170|P3|NOT COMPLETED|Overall Study||17
2415422|NCT01254305|5924171|P2|NOT COMPLETED|Overall Study||18
2415423|NCT01254305|5924172|P1|NOT COMPLETED|Overall Study||22
2415424|NCT01254305|5924170|P3|COMPLETED|Overall Study||62
2415425|NCT01254305|5924171|P2|COMPLETED|Overall Study||72
2415426|NCT01254305|5924172|P1|COMPLETED|Overall Study||71
2415427|NCT01254305|5924170|P3|Safety Population|Overall Study||77
2415428|NCT01254305|5924171|P2|Safety Population|Overall Study||85
2415429|NCT01254305|5924172|P1|Safety Population|Overall Study||89
2415430|NCT01254305|5924170|P3|STARTED|Overall Study||79
2415431|NCT01254305|5924171|P2|STARTED|Overall Study||90
2415432|NCT01254305|5924172|P1|STARTED|Overall Study||93
2415433|NCT01254292|5924188|P2|NOT COMPLETED|LCS12 Extension Phase||0
2415434|NCT01254292|5924189|P1|NOT COMPLETED|LCS12 Extension Phase||37
2415435|NCT01254292|5924188|P2|COMPLETED|LCS12 Extension Phase||0
2415436|NCT01254292|5924189|P1|COMPLETED|LCS12 Extension Phase||163
2415437|NCT01254292|5924188|P2|STARTED|LCS12 Extension Phase|Optional Extension Phase was for LCS12 group only.|0
2415438|NCT01254292|5924189|P1|STARTED|LCS12 Extension Phase|A total of 200 participants elected to enter this optional Extension Phase.|200
2415439|NCT01254292|5924188|P2|NOT COMPLETED|Comparative Phase||81
2415440|NCT01254292|5924189|P1|NOT COMPLETED|Comparative Phase||55
2415441|NCT01254292|5924188|P2|COMPLETED|Comparative Phase||204
2415442|NCT01254292|5924189|P1|COMPLETED|Comparative Phase||227
2415443|NCT01254292|5924188|P2|Participants Received Treatment|Comparative Phase|safety population|281
2415444|NCT01254292|5924189|P1|Participants Received Treatment|Comparative Phase|safety population|279
2415445|NCT01254292|5924188|P2|STARTED|Comparative Phase||285
2415446|NCT01254292|5924189|P1|STARTED|Comparative Phase||282
2415447|NCT01254214|5924251|P2|NOT COMPLETED|Overall Study||1
2415448|NCT01254214|5924252|P1|NOT COMPLETED|Overall Study||3
2415449|NCT01254214|5924251|P2|COMPLETED|Overall Study||27
2415450|NCT01254214|5924252|P1|COMPLETED|Overall Study||24
2415451|NCT01254214|5924251|P2|STARTED|Overall Study||28
2415452|NCT01254214|5924252|P1|STARTED|Overall Study||27
2415453|NCT01254188|5924266|P1|NOT COMPLETED|Overall Study||93
2415454|NCT01254188|5924266|P1|COMPLETED|Overall Study||328
2415455|NCT01254188|5924266|P1|STARTED|Overall Study||421
2415456|NCT01254045|5924277|P6|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
2415457|NCT01254045|5924278|P5|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
2415458|NCT01254045|5924279|P4|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
2415459|NCT01254045|5924280|P3|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
2415460|NCT01254045|5924281|P2|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
2415461|NCT01254045|5924282|P1|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
2415462|NCT01254045|5924277|P6|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
2415463|NCT01254045|5924278|P5|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
2415464|NCT01254045|5924279|P4|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
2415465|NCT01254045|5924280|P3|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
2415466|NCT01254045|5924281|P2|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
2415467|NCT01254045|5924282|P1|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
2415468|NCT01254045|5924277|P6|STARTED|Third/Time 3 (1 Day at Week 3)||1
2415469|NCT01254045|5924278|P5|STARTED|Third/Time 3 (1 Day at Week 3)||1
2415470|NCT01254045|5924279|P4|STARTED|Third/Time 3 (1 Day at Week 3)||1
2415471|NCT01254045|5924280|P3|STARTED|Third/Time 3 (1 Day at Week 3)||2
2415472|NCT01254045|5924281|P2|STARTED|Third/Time 3 (1 Day at Week 3)||2
2415473|NCT01254045|5924282|P1|STARTED|Third/Time 3 (1 Day at Week 3)||1
2415474|NCT01254045|5924277|P6|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
2415475|NCT01254045|5924278|P5|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
2415476|NCT01254045|5924279|P4|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
2415477|NCT01254045|5924280|P3|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
2415478|NCT01254045|5924281|P2|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
2415479|NCT01254045|5924282|P1|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
2415480|NCT01254045|5924277|P6|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
2415481|NCT01254045|5924278|P5|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
2415482|NCT01254045|5924279|P4|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
2415483|NCT01254045|5924280|P3|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
2415484|NCT01254045|5924281|P2|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
2415485|NCT01254045|5924282|P1|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
2415486|NCT01254045|5924277|P6|STARTED|Second/Time 2 (1 Day at Week 2)||1
2415487|NCT01254045|5924278|P5|STARTED|Second/Time 2 (1 Day at Week 2)||1
2415488|NCT01254045|5924279|P4|STARTED|Second/Time 2 (1 Day at Week 2)||1
2415489|NCT01254045|5924280|P3|STARTED|Second/Time 2 (1 Day at Week 2)||2
2415490|NCT01254045|5924281|P2|STARTED|Second/Time 2 (1 Day at Week 2)||2
2415491|NCT01254045|5924282|P1|STARTED|Second/Time 2 (1 Day at Week 2)||1
2415492|NCT01254045|5924277|P6|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
2415493|NCT01254045|5924278|P5|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
2415494|NCT01254045|5924279|P4|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
2415495|NCT01254045|5924280|P3|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
2415496|NCT01254045|5924281|P2|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
2415497|NCT01254045|5924282|P1|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||1
2415498|NCT01254045|5924277|P6|COMPLETED|First/Baseline (1 Day at Week 1 )||1
2415499|NCT01254045|5924278|P5|COMPLETED|First/Baseline (1 Day at Week 1 )||1
2415500|NCT01254045|5924279|P4|COMPLETED|First/Baseline (1 Day at Week 1 )||1
2415501|NCT01254045|5924280|P3|COMPLETED|First/Baseline (1 Day at Week 1 )||2
2415502|NCT01254045|5924281|P2|COMPLETED|First/Baseline (1 Day at Week 1 )||2
2415503|NCT01254045|5924282|P1|COMPLETED|First/Baseline (1 Day at Week 1 )||1
2415504|NCT01254045|5924277|P6|STARTED|First/Baseline (1 Day at Week 1 )||1
2415505|NCT01254045|5924278|P5|STARTED|First/Baseline (1 Day at Week 1 )||1
2415506|NCT01254045|5924279|P4|STARTED|First/Baseline (1 Day at Week 1 )||1
2415507|NCT01254045|5924280|P3|STARTED|First/Baseline (1 Day at Week 1 )||2
2415508|NCT01254045|5924281|P2|STARTED|First/Baseline (1 Day at Week 1 )||2
2415509|NCT01254045|5924282|P1|STARTED|First/Baseline (1 Day at Week 1 )|One completed all baseline measures including administration of placebo, but then lost to follow-up.|2
2415510|NCT01254019|5924295|P2|NOT COMPLETED|Overall Study||4
2415511|NCT01254019|5924296|P1|NOT COMPLETED|Overall Study||1
2415512|NCT01254019|5924295|P2|COMPLETED|Overall Study||121
2415513|NCT01254019|5924296|P1|COMPLETED|Overall Study||60
2415514|NCT01254019|5924295|P2|STARTED|Overall Study||125
2415515|NCT01254019|5924296|P1|STARTED|Overall Study||61
2415516|NCT01253980|5924349|P2|NOT COMPLETED|Overall Study||0
2415517|NCT01253980|5924350|P1|NOT COMPLETED|Overall Study||0
2415518|NCT01253980|5924349|P2|COMPLETED|Overall Study||39
2415519|NCT01253980|5924350|P1|COMPLETED|Overall Study||35
2415520|NCT01253980|5924349|P2|STARTED|Overall Study||39
2415521|NCT01253980|5924350|P1|STARTED|Overall Study||35
2415522|NCT01253902|5924359|P3|NOT COMPLETED|Overall Study||4
2415523|NCT01253902|5924360|P2|NOT COMPLETED|Overall Study||2
2415524|NCT01253902|5924361|P1|NOT COMPLETED|Overall Study||5
2415525|NCT01253902|5924359|P3|COMPLETED|Overall Study||51
2415526|NCT01253902|5924360|P2|COMPLETED|Overall Study||51
2415527|NCT01253902|5924361|P1|COMPLETED|Overall Study||51
2415528|NCT01253902|5924359|P3|STARTED|Overall Study||55
2415529|NCT01253902|5924360|P2|STARTED|Overall Study||53
2415530|NCT01253902|5924361|P1|STARTED|Overall Study||56
2415531|NCT01253824|5924377|P2|NOT COMPLETED|Overall Study||0
2415532|NCT01253824|5924378|P1|NOT COMPLETED|Overall Study||0
2415533|NCT01253824|5924377|P2|COMPLETED|Overall Study||7
2415534|NCT01253824|5924378|P1|COMPLETED|Overall Study||7
2415535|NCT01253824|5924377|P2|STARTED|Overall Study||7
2415536|NCT01253824|5924378|P1|STARTED|Overall Study||7
2415537|NCT01253811|5924390|P1|NOT COMPLETED|Overall Study||1
2415538|NCT01253811|5924390|P1|COMPLETED|Overall Study||5
2415539|NCT01253811|5924390|P1|Exposed|Overall Study||6
2415540|NCT01253811|5924390|P1|STARTED|Overall Study||6
2415541|NCT01253642|5924409|P1|NOT COMPLETED|Overall Study||5
2415542|NCT01253642|5924409|P1|COMPLETED|Overall Study||6
2415543|NCT01253642|5924409|P1|STARTED|Overall Study||11
2415544|NCT01253577|5924421|P1|NOT COMPLETED|Overall Study||3
2415545|NCT01253577|5924421|P1|COMPLETED|Overall Study||102
2415546|NCT01253577|5924421|P1|STARTED|Overall Study||105
2415547|NCT01253564|5924429|P1|NOT COMPLETED|Overall Study||24
2415548|NCT01253564|5924429|P1|COMPLETED|Overall Study||0
2415549|NCT01253564|5924429|P1|STARTED|Overall Study||24
2415550|NCT01253525|5924446|P1|NOT COMPLETED|Overall Study||0
2415551|NCT01253525|5924446|P1|COMPLETED|Overall Study||6
2415552|NCT01253525|5924446|P1|Received Any Quantity of Study Drug|Overall Study||6
2415553|NCT01253525|5924446|P1|STARTED|Overall Study||6
2415554|NCT01253460|5924473|P1|NOT COMPLETED|Overall Study||0
2415555|NCT01253460|5924473|P1|COMPLETED|Overall Study||18
2415556|NCT01253460|5924473|P1|STARTED|Overall Study||18
2415557|NCT01253447|5924478|P1|NOT COMPLETED|Overall Study||2
2415558|NCT01253447|5924478|P1|COMPLETED|Overall Study||17
2415559|NCT01253447|5924478|P1|STARTED|Overall Study||19
2415560|NCT01253421|5924488|P5|NOT COMPLETED|Drug+Scanning Visit||1
2415561|NCT01253421|5924489|P4|NOT COMPLETED|Drug+Scanning Visit||0
2415562|NCT01253421|5924490|P3|NOT COMPLETED|Drug+Scanning Visit||0
2415563|NCT01253421|5924491|P2|NOT COMPLETED|Drug+Scanning Visit||0
2415564|NCT01253421|5924492|P1|NOT COMPLETED|Drug+Scanning Visit||0
2415565|NCT01253421|5924488|P5|COMPLETED|Drug+Scanning Visit||14
2415566|NCT01253421|5924489|P4|COMPLETED|Drug+Scanning Visit||16
2415567|NCT01253421|5924490|P3|COMPLETED|Drug+Scanning Visit||14
2415568|NCT01253421|5924491|P2|COMPLETED|Drug+Scanning Visit||15
2415569|NCT01253421|5924492|P1|COMPLETED|Drug+Scanning Visit||0
2415570|NCT01253421|5924488|P5|Received Drug Challenge|Drug+Scanning Visit||15
2415571|NCT01253421|5924489|P4|Received Drug Challenge|Drug+Scanning Visit||16
2415572|NCT01253421|5924490|P3|Received Drug Challenge|Drug+Scanning Visit||14
2415573|NCT01253421|5924491|P2|Received Drug Challenge|Drug+Scanning Visit||15
2415574|NCT01253421|5924492|P1|Received Drug Challenge|Drug+Scanning Visit||0
2415575|NCT01253421|5924488|P5|STARTED|Drug+Scanning Visit||15
2415576|NCT01253421|5924489|P4|STARTED|Drug+Scanning Visit||16
2415577|NCT01253421|5924490|P3|STARTED|Drug+Scanning Visit||14
2415578|NCT01253421|5924491|P2|STARTED|Drug+Scanning Visit||15
2415579|NCT01253421|5924492|P1|STARTED|Drug+Scanning Visit|Arm has no participants once randomization has occurred.|0
2415580|NCT01253421|5924488|P5|NOT COMPLETED|Assessment and Scheduling||0
2415581|NCT01253421|5924489|P4|NOT COMPLETED|Assessment and Scheduling||0
2415582|NCT01253421|5924490|P3|NOT COMPLETED|Assessment and Scheduling||0
2415583|NCT01253421|5924491|P2|NOT COMPLETED|Assessment and Scheduling||0
2415584|NCT01253421|5924492|P1|NOT COMPLETED|Assessment and Scheduling||99
2415585|NCT01253421|5924488|P5|COMPLETED|Assessment and Scheduling||0
2415586|NCT01253421|5924489|P4|COMPLETED|Assessment and Scheduling||0
2415587|NCT01253421|5924490|P3|COMPLETED|Assessment and Scheduling||0
2415588|NCT01253421|5924491|P2|COMPLETED|Assessment and Scheduling||0
2415589|NCT01253421|5924492|P1|COMPLETED|Assessment and Scheduling||60
2415590|NCT01253421|5924488|P5|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
2415591|NCT01253421|5924489|P4|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
2415592|NCT01253421|5924490|P3|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
2415593|NCT01253421|5924491|P2|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
2415594|NCT01253421|5924492|P1|Returned for Drug+Scanning Visit|Assessment and Scheduling||60
2415595|NCT01253421|5924488|P5|Eligible After Screening Visit|Assessment and Scheduling||0
2415596|NCT01253421|5924489|P4|Eligible After Screening Visit|Assessment and Scheduling||0
2415597|NCT01253421|5924490|P3|Eligible After Screening Visit|Assessment and Scheduling||0
2415598|NCT01253421|5924491|P2|Eligible After Screening Visit|Assessment and Scheduling||0
2415599|NCT01253421|5924492|P1|Eligible After Screening Visit|Assessment and Scheduling||85
2415600|NCT01253421|5924488|P5|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
2415601|NCT01253421|5924489|P4|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
2415602|NCT01253421|5924490|P3|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
2415603|NCT01253421|5924491|P2|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
2415604|NCT01253421|5924492|P1|STARTED|Assessment and Scheduling||159
2415605|NCT01253408|5924541|P3|NOT COMPLETED|Overall Study||0
2415606|NCT01253408|5924542|P2|NOT COMPLETED|Overall Study||1
2415607|NCT01253408|5924543|P1|NOT COMPLETED|Overall Study||0
2415608|NCT01253408|5924541|P3|COMPLETED|Overall Study||13
2415609|NCT01253408|5924542|P2|COMPLETED|Overall Study||12
2415610|NCT01253408|5924543|P1|COMPLETED|Overall Study||10
2415611|NCT01253408|5924541|P3|STARTED|Overall Study||13
2415612|NCT01253408|5924542|P2|STARTED|Overall Study||13
2415613|NCT01253408|5924543|P1|STARTED|Overall Study||10
2415614|NCT01253369|5924566|P1|NOT COMPLETED|Overall Study||33
2415615|NCT01253369|5924566|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
2415616|NCT01253369|5924566|P1|Evaluable|Overall Study|Evaluable pts were w/ measurable disease, min 1 cycle of trt rcvd and 1 on-trt disease assessment.|30
2415617|NCT01253369|5924566|P1|STARTED|Overall Study||33
2415618|NCT01253343|5924573|P2|NOT COMPLETED|Overall Study||0
2415619|NCT01253343|5924574|P1|NOT COMPLETED|Overall Study||0
2415620|NCT01253343|5924573|P2|COMPLETED|Overall Study||8
2415621|NCT01253343|5924574|P1|COMPLETED|Overall Study||9
2415622|NCT01253343|5924573|P2|STARTED|Overall Study||8
2415623|NCT01253343|5924574|P1|STARTED|Overall Study||9
2415624|NCT01253317|5924596|P1|NOT COMPLETED|Overall Study||2
2415625|NCT01253317|5924596|P1|COMPLETED|Overall Study||10
2415626|NCT01253317|5924596|P1|STARTED|Overall Study||12
2415627|NCT01253304|5924608|P4|NOT COMPLETED|Overall Study||1
2415628|NCT01253304|5924609|P3|NOT COMPLETED|Overall Study||0
2415629|NCT01253304|5924610|P2|NOT COMPLETED|Overall Study||0
2415630|NCT01253304|5924611|P1|NOT COMPLETED|Overall Study||0
2415631|NCT01253304|5924608|P4|COMPLETED|Overall Study||2
2415632|NCT01253304|5924609|P3|COMPLETED|Overall Study||6
2415633|NCT01253304|5924610|P2|COMPLETED|Overall Study||6
2415634|NCT01253304|5924611|P1|COMPLETED|Overall Study||11
2415635|NCT01253304|5924608|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
2415636|NCT01253304|5924609|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
2415637|NCT01253304|5924610|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
2415638|NCT01253304|5924611|P1|Received at Least 1 Dose of Study Drug|Overall Study||11
2415639|NCT01253304|5924608|P4|STARTED|Overall Study||3
2415640|NCT01253304|5924609|P3|STARTED|Overall Study||6
2415641|NCT01253304|5924610|P2|STARTED|Overall Study||6
2415642|NCT01253304|5924611|P1|STARTED|Overall Study||11
2415643|NCT01253291|5924650|P5|NOT COMPLETED|Overall Study||2
2415644|NCT01253291|5924651|P4|NOT COMPLETED|Overall Study||0
2415645|NCT01253291|5924652|P3|NOT COMPLETED|Overall Study||0
2415646|NCT01253291|5924653|P2|NOT COMPLETED|Overall Study||2
2415647|NCT01253291|5924654|P1|NOT COMPLETED|Overall Study||4
2415648|NCT01253291|5924650|P5|COMPLETED|Overall Study||3
2415649|NCT01253291|5924651|P4|COMPLETED|Overall Study||5
2415650|NCT01253291|5924652|P3|COMPLETED|Overall Study||4
2415651|NCT01253291|5924653|P2|COMPLETED|Overall Study||4
2415652|NCT01253291|5924654|P1|COMPLETED|Overall Study||2
2415653|NCT01253291|5924650|P5|Received Study Drug During BCDL|Overall Study||5
2415654|NCT01253291|5924651|P4|Received Study Drug During BCDL|Overall Study||5
2415655|NCT01253291|5924652|P3|Received Study Drug During BCDL|Overall Study||4
2415656|NCT01253291|5924653|P2|Received Study Drug During BCDL|Overall Study||6
2415657|NCT01253291|5924654|P1|Received Study Drug During BCDL|Overall Study||6
2415658|NCT01253291|5924650|P5|STARTED|Overall Study||5
2415659|NCT01253291|5924651|P4|STARTED|Overall Study||5
2415660|NCT01253291|5924652|P3|STARTED|Overall Study||4
2415661|NCT01253291|5924653|P2|STARTED|Overall Study||6
2415662|NCT01253291|5924654|P1|STARTED|Overall Study||6
2415663|NCT01253265|5924678|P5|NOT COMPLETED|Overall Study||1
2415664|NCT01253265|5924679|P4|NOT COMPLETED|Overall Study||0
2415665|NCT01253265|5924680|P3|NOT COMPLETED|Overall Study||0
2415666|NCT01253265|5924681|P2|NOT COMPLETED|Overall Study||0
2415667|NCT01253265|5924682|P1|NOT COMPLETED|Overall Study||1
2415668|NCT01253265|5924678|P5|COMPLETED|Overall Study||7
2415669|NCT01253265|5924679|P4|COMPLETED|Overall Study||6
2415670|NCT01253265|5924680|P3|COMPLETED|Overall Study||6
2415671|NCT01253265|5924681|P2|COMPLETED|Overall Study||6
2415672|NCT01253265|5924682|P1|COMPLETED|Overall Study||5
2415673|NCT01253265|5924678|P5|STARTED|Overall Study||8
2415674|NCT01253265|5924679|P4|STARTED|Overall Study||6
2415675|NCT01253265|5924680|P3|STARTED|Overall Study||6
2415676|NCT01253265|5924681|P2|STARTED|Overall Study||6
2415677|NCT01253265|5924682|P1|STARTED|Overall Study||6
2415678|NCT01253226|5924731|P5|NOT COMPLETED|Overall Study||2
2415679|NCT01253226|5924732|P4|NOT COMPLETED|Overall Study||1
2415680|NCT01253226|5924733|P3|NOT COMPLETED|Overall Study||1
2415681|NCT01253226|5924734|P2|NOT COMPLETED|Overall Study||1
2415682|NCT01253226|5924735|P1|NOT COMPLETED|Overall Study||0
2415683|NCT01253226|5924731|P5|COMPLETED|Overall Study||6
2415684|NCT01253226|5924732|P4|COMPLETED|Overall Study||5
2415685|NCT01253226|5924733|P3|COMPLETED|Overall Study||5
2415686|NCT01253226|5924734|P2|COMPLETED|Overall Study||5
2415687|NCT01253226|5924735|P1|COMPLETED|Overall Study||6
2415688|NCT01253226|5924731|P5|Received at Least 1 Dose of Study Drug|Overall Study||8
2415689|NCT01253226|5924732|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
2415690|NCT01253226|5924733|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
2415691|NCT01253226|5924734|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
2415692|NCT01253226|5924735|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
2415693|NCT01253226|5924731|P5|STARTED|Overall Study||8
2415694|NCT01253226|5924732|P4|STARTED|Overall Study||6
2415695|NCT01253226|5924733|P3|STARTED|Overall Study||6
2415696|NCT01253226|5924734|P2|STARTED|Overall Study||6
2415697|NCT01253226|5924735|P1|STARTED|Overall Study||6
2415698|NCT01253200|5924795|P5|NOT COMPLETED|Overall Study||5
2415699|NCT01253200|5924796|P4|NOT COMPLETED|Overall Study||5
2415700|NCT01253200|5924797|P3|NOT COMPLETED|Overall Study||2
2415701|NCT01253200|5924798|P2|NOT COMPLETED|Overall Study||19
2415702|NCT01253200|5924799|P1|NOT COMPLETED|Overall Study||21
2415703|NCT01253200|5924795|P5|COMPLETED|Overall Study||0
2415704|NCT01253200|5924796|P4|COMPLETED|Overall Study||12
2415705|NCT01253200|5924797|P3|COMPLETED|Overall Study||28
2415706|NCT01253200|5924798|P2|COMPLETED|Overall Study||106
2415707|NCT01253200|5924799|P1|COMPLETED|Overall Study||104
2415708|NCT01253200|5924795|P5|3 Month Follow-up|Overall Study||0
2415709|NCT01253200|5924796|P4|3 Month Follow-up|Overall Study||12
2415710|NCT01253200|5924797|P3|3 Month Follow-up|Overall Study||28
2415711|NCT01253200|5924798|P2|3 Month Follow-up|Overall Study||106
2415712|NCT01253200|5924799|P1|3 Month Follow-up|Overall Study||104
2415713|NCT01253200|5924795|P5|10 Day Follow-up|Overall Study||0
2415714|NCT01253200|5924796|P4|10 Day Follow-up|Overall Study||12
2415715|NCT01253200|5924797|P3|10 Day Follow-up|Overall Study||28
2415716|NCT01253200|5924798|P2|10 Day Follow-up|Overall Study||111
2415717|NCT01253200|5924799|P1|10 Day Follow-up|Overall Study||106
2415718|NCT01253200|5924795|P5|Procedure|Overall Study||0
2415719|NCT01253200|5924796|P4|Procedure|Overall Study||12
2415720|NCT01253200|5924797|P3|Procedure|Overall Study||28
2415721|NCT01253200|5924798|P2|Procedure|Overall Study||111
2415722|NCT01253200|5924799|P1|Procedure|Overall Study||109
2415723|NCT01253200|5924795|P5|STARTED|Overall Study||5
2415724|NCT01253200|5924796|P4|STARTED|Overall Study||17
2415725|NCT01253200|5924797|P3|STARTED|Overall Study||30
2415726|NCT01253200|5924798|P2|STARTED|Overall Study||125
2415727|NCT01253200|5924799|P1|STARTED|Overall Study||125
2415728|NCT01253187|5924814|P6|NOT COMPLETED|Period 3||0
2415729|NCT01253187|5924815|P5|NOT COMPLETED|Period 3||1
2415730|NCT01253187|5924816|P4|NOT COMPLETED|Period 3||0
2415731|NCT01253187|5924817|P3|NOT COMPLETED|Period 3||0
2415732|NCT01253187|5924818|P2|NOT COMPLETED|Period 3||1
2415733|NCT01253187|5924819|P1|NOT COMPLETED|Period 3||1
2415734|NCT01253187|5924814|P6|COMPLETED|Period 3||6
2415735|NCT01253187|5924815|P5|COMPLETED|Period 3||7
2415736|NCT01253187|5924816|P4|COMPLETED|Period 3||7
2415737|NCT01253187|5924817|P3|COMPLETED|Period 3||7
2415738|NCT01253187|5924818|P2|COMPLETED|Period 3||7
2415739|NCT01253187|5924819|P1|COMPLETED|Period 3||6
2415740|NCT01253187|5924814|P6|STARTED|Period 3||6
2415741|NCT01253187|5924815|P5|STARTED|Period 3||8
2415742|NCT01253187|5924816|P4|STARTED|Period 3||7
2415743|NCT01253187|5924817|P3|STARTED|Period 3||7
2415744|NCT01253187|5924818|P2|STARTED|Period 3||8
2415745|NCT01253187|5924819|P1|STARTED|Period 3||7
2415746|NCT01253187|5924814|P6|NOT COMPLETED|Period 2||0
2415747|NCT01253187|5924815|P5|NOT COMPLETED|Period 2||1
2415748|NCT01253187|5924816|P4|NOT COMPLETED|Period 2||0
2415749|NCT01253187|5924817|P3|NOT COMPLETED|Period 2||0
2415750|NCT01253187|5924818|P2|NOT COMPLETED|Period 2||0
2415751|NCT01253187|5924819|P1|NOT COMPLETED|Period 2||0
2415752|NCT01253187|5924814|P6|COMPLETED|Period 2||6
2415753|NCT01253187|5924815|P5|COMPLETED|Period 2||8
2415754|NCT01253187|5924816|P4|COMPLETED|Period 2||7
2415755|NCT01253187|5924817|P3|COMPLETED|Period 2||7
2415756|NCT01253187|5924818|P2|COMPLETED|Period 2||8
2415757|NCT01253187|5924819|P1|COMPLETED|Period 2||7
2415758|NCT01253187|5924814|P6|STARTED|Period 2||6
2415759|NCT01253187|5924815|P5|STARTED|Period 2||9
2415760|NCT01253187|5924816|P4|STARTED|Period 2||7
2415761|NCT01253187|5924817|P3|STARTED|Period 2||7
2415762|NCT01253187|5924818|P2|STARTED|Period 2||8
2415763|NCT01253187|5924819|P1|STARTED|Period 2||7
2415764|NCT01253187|5924814|P6|NOT COMPLETED|Period 1||0
2415765|NCT01253187|5924815|P5|NOT COMPLETED|Period 1||0
2415766|NCT01253187|5924816|P4|NOT COMPLETED|Period 1||0
2415767|NCT01253187|5924817|P3|NOT COMPLETED|Period 1||0
2415768|NCT01253187|5924818|P2|NOT COMPLETED|Period 1||0
2415769|NCT01253187|5924819|P1|NOT COMPLETED|Period 1||0
2415770|NCT01253187|5924814|P6|COMPLETED|Period 1||6
2415771|NCT01253187|5924815|P5|COMPLETED|Period 1||9
2415772|NCT01253187|5924816|P4|COMPLETED|Period 1||7
2415773|NCT01253187|5924817|P3|COMPLETED|Period 1||7
2415774|NCT01253187|5924818|P2|COMPLETED|Period 1||8
2415775|NCT01253187|5924819|P1|COMPLETED|Period 1||7
2415776|NCT01253187|5924814|P6|STARTED|Period 1||6
2415777|NCT01253187|5924815|P5|STARTED|Period 1||9
2415778|NCT01253187|5924816|P4|STARTED|Period 1||7
2415779|NCT01253187|5924817|P3|STARTED|Period 1||7
2415780|NCT01253187|5924818|P2|STARTED|Period 1||8
2415781|NCT01253187|5924819|P1|STARTED|Period 1||7
2415782|NCT01253174|5924848|P6|NOT COMPLETED|Period 3||0
2415783|NCT01253174|5924849|P5|NOT COMPLETED|Period 3||1
2415784|NCT01253174|5924850|P4|NOT COMPLETED|Period 3||0
2415785|NCT01253174|5924851|P3|NOT COMPLETED|Period 3||1
2415786|NCT01253174|5924852|P2|NOT COMPLETED|Period 3||1
2415787|NCT01253174|5924853|P1|NOT COMPLETED|Period 3||0
2415788|NCT01253174|5924848|P6|COMPLETED|Period 3||7
2415789|NCT01253174|5924849|P5|COMPLETED|Period 3||7
2415790|NCT01253174|5924850|P4|COMPLETED|Period 3||7
2415791|NCT01253174|5924851|P3|COMPLETED|Period 3||6
2415792|NCT01253174|5924852|P2|COMPLETED|Period 3||8
2415793|NCT01253174|5924853|P1|COMPLETED|Period 3||6
2415794|NCT01253174|5924848|P6|STARTED|Period 3||7
2415795|NCT01253174|5924849|P5|STARTED|Period 3||8
2415796|NCT01253174|5924850|P4|STARTED|Period 3||7
2415797|NCT01253174|5924851|P3|STARTED|Period 3||7
2415798|NCT01253174|5924852|P2|STARTED|Period 3||9
2415799|NCT01253174|5924853|P1|STARTED|Period 3||6
2415800|NCT01253174|5924848|P6|NOT COMPLETED|Period 2||0
2415801|NCT01253174|5924849|P5|NOT COMPLETED|Period 2||0
2415802|NCT01253174|5924850|P4|NOT COMPLETED|Period 2||0
2415803|NCT01253174|5924851|P3|NOT COMPLETED|Period 2||1
2415804|NCT01253174|5924852|P2|NOT COMPLETED|Period 2||0
2415805|NCT01253174|5924853|P1|NOT COMPLETED|Period 2||0
2415806|NCT01253174|5924848|P6|COMPLETED|Period 2||7
2415807|NCT01253174|5924849|P5|COMPLETED|Period 2||8
2415808|NCT01253174|5924850|P4|COMPLETED|Period 2||7
2415809|NCT01253174|5924851|P3|COMPLETED|Period 2||7
2415810|NCT01253174|5924852|P2|COMPLETED|Period 2||9
2415811|NCT01253174|5924853|P1|COMPLETED|Period 2||6
2415812|NCT01253174|5924848|P6|STARTED|Period 2||7
2415813|NCT01253174|5924849|P5|STARTED|Period 2||8
2415814|NCT01253174|5924850|P4|STARTED|Period 2||7
2415815|NCT01253174|5924851|P3|STARTED|Period 2||8
2415816|NCT01253174|5924852|P2|STARTED|Period 2||9
2415817|NCT01253174|5924853|P1|STARTED|Period 2||6
2415818|NCT01253174|5924848|P6|NOT COMPLETED|Period 1||0
2415819|NCT01253174|5924849|P5|NOT COMPLETED|Period 1||1
2415820|NCT01253174|5924850|P4|NOT COMPLETED|Period 1||0
2415821|NCT01253174|5924851|P3|NOT COMPLETED|Period 1||1
2415822|NCT01253174|5924852|P2|NOT COMPLETED|Period 1||1
2415823|NCT01253174|5924853|P1|NOT COMPLETED|Period 1||0
2415824|NCT01253174|5924848|P6|COMPLETED|Period 1||7
2415825|NCT01253174|5924849|P5|COMPLETED|Period 1||8
2415826|NCT01253174|5924850|P4|COMPLETED|Period 1||7
2415827|NCT01253174|5924851|P3|COMPLETED|Period 1||8
2415828|NCT01253174|5924852|P2|COMPLETED|Period 1||9
2415829|NCT01253174|5924853|P1|COMPLETED|Period 1||6
2415830|NCT01253174|5924848|P6|STARTED|Period 1||7
2415831|NCT01253174|5924849|P5|STARTED|Period 1||9
2415832|NCT01253174|5924850|P4|STARTED|Period 1||7
2415833|NCT01253174|5924851|P3|STARTED|Period 1||9
2415834|NCT01253174|5924852|P2|STARTED|Period 1||10
2415835|NCT01253174|5924853|P1|STARTED|Period 1||6
2415836|NCT01253148|5924882|P1|NOT COMPLETED|Overall Study||0
2415837|NCT01253148|5924882|P1|COMPLETED|Overall Study||25
2415838|NCT01253148|5924882|P1|STARTED|Overall Study||25
2415839|NCT01253135|5924888|P1|NOT COMPLETED|Amended Protocol||1
2415840|NCT01253135|5924888|P1|COMPLETED|Amended Protocol||24
2415841|NCT01253135|5924888|P1|STARTED|Amended Protocol||25
2415842|NCT01253135|5924888|P1|NOT COMPLETED|Original Protocol||15
2415843|NCT01253135|5924888|P1|COMPLETED|Original Protocol||0
2415844|NCT01253135|5924888|P1|STARTED|Original Protocol||15
2415845|NCT01253070|5924896|P1|NOT COMPLETED|Overall Study||0
2415846|NCT01253070|5924896|P1|COMPLETED|Overall Study||54
2415847|NCT01253070|5924896|P1|STARTED|Overall Study||54
2415848|NCT01253044|5924907|P2|NOT COMPLETED|Overall Study||29
2415849|NCT01253044|5924908|P1|NOT COMPLETED|Overall Study||38
2415850|NCT01253044|5924907|P2|COMPLETED|Overall Study||51
2415851|NCT01253044|5924908|P1|COMPLETED|Overall Study||42
2415852|NCT01253044|5924907|P2|STARTED|Overall Study||80
2415853|NCT01253044|5924908|P1|STARTED|Overall Study||80
2415854|NCT01253018|5924918|P2|NOT COMPLETED|Overall Study||2
2415855|NCT01253018|5924919|P1|NOT COMPLETED|Overall Study||4
2415856|NCT01253018|5924918|P2|COMPLETED|Overall Study||21
2415857|NCT01253018|5924919|P1|COMPLETED|Overall Study||18
2415858|NCT01253018|5924918|P2|STARTED|Overall Study||23
2415859|NCT01253018|5924919|P1|STARTED|Overall Study||22
2415860|NCT01252966|5924933|P2|NOT COMPLETED|Overall Study||13
2415861|NCT01252966|5924934|P1|NOT COMPLETED|Overall Study||23
2415862|NCT01252966|5924933|P2|COMPLETED|Overall Study||92
2415863|NCT01252966|5924934|P1|COMPLETED|Overall Study||85
2415864|NCT01252966|5924933|P2|STARTED|Overall Study||105
2415865|NCT01252966|5924934|P1|STARTED|Overall Study||108
2415866|NCT01252953|5924950|P2|NOT COMPLETED|Overall Study||38
2415867|NCT01252953|5924951|P1|NOT COMPLETED|Overall Study||38
2415868|NCT01252953|5924950|P2|COMPLETED|Overall Study||15186
2415869|NCT01252953|5924951|P1|COMPLETED|Overall Study||15187
2415870|NCT01252953|5924950|P2|STARTED|Overall Study||15224
2415871|NCT01252953|5924951|P1|STARTED|Overall Study||15225
2415872|NCT01252940|5924965|P2|NOT COMPLETED|Extension Phase||3
2415873|NCT01252940|5924966|P1|NOT COMPLETED|Extension Phase||10
2415874|NCT01252940|5924965|P2|COMPLETED|Extension Phase||46
2415875|NCT01252940|5924966|P1|COMPLETED|Extension Phase||100
2415876|NCT01252940|5924965|P2|STARTED|Extension Phase|SBR/Delayed Switch Group: 49 participants completing the main study continued in extension phase.|49
2415877|NCT01252940|5924966|P1|STARTED|Extension Phase|FTC/RPV/TDF group: 110 participants completing the main study continued in extension phase.|110
2415878|NCT01252940|5924965|P2|NOT COMPLETED|Main Study Phase||12
2415879|NCT01252940|5924966|P1|NOT COMPLETED|Main Study Phase||26
2415880|NCT01252940|5924965|P2|COMPLETED|Main Study Phase|Discontinuations after switch: withdrawal by subject, 2; adverse event, 1; protocol violation, 1.|149
2415881|NCT01252940|5924966|P1|COMPLETED|Main Study Phase||295
2415882|NCT01252940|5924965|P2|Completed 24 Weeks|Main Study Phase|152 participants switched regimens at Week 24.|153
2415883|NCT01252940|5924966|P1|Completed 24 Weeks|Main Study Phase||0
2415884|NCT01252940|5924965|P2|STARTED|Main Study Phase||161
2415885|NCT01252940|5924966|P1|STARTED|Main Study Phase||321
2415886|NCT01252810|5924997|P2|NOT COMPLETED|Overall Study||3
2415887|NCT01252810|5924998|P1|NOT COMPLETED|Overall Study||14
2415888|NCT01252810|5924997|P2|COMPLETED|Overall Study||139
2415889|NCT01252810|5924998|P1|COMPLETED|Overall Study||128
2415890|NCT01252810|5924997|P2|STARTED|Overall Study||142
2415891|NCT01252810|5924998|P1|STARTED|Overall Study||142
2415892|NCT01252745|5925011|P3|NOT COMPLETED|Overall Study||0
2415893|NCT01252745|5925012|P2|NOT COMPLETED|Overall Study||0
2415894|NCT01252745|5925013|P1|NOT COMPLETED|Overall Study||0
2415895|NCT01252745|5925011|P3|COMPLETED|Overall Study||7
2415896|NCT01252745|5925012|P2|COMPLETED|Overall Study||7
2415897|NCT01252745|5925013|P1|COMPLETED|Overall Study||8
2415898|NCT01252745|5925011|P3|STARTED|Overall Study||7
2415899|NCT01252745|5925012|P2|STARTED|Overall Study||7
2415900|NCT01252745|5925013|P1|STARTED|Overall Study||8
2415901|NCT01252563|5925027|P1|NOT COMPLETED|Overall Study||432
2415902|NCT01252563|5925027|P1|COMPLETED|Overall Study||13343
2415903|NCT01252563|5925027|P1|STARTED|Overall Study||13775
2415904|NCT01252355|5925067|P3|NOT COMPLETED|Overall Study||179
2415905|NCT01252355|5925068|P2|NOT COMPLETED|Overall Study||178
2415906|NCT01252355|5925069|P1|NOT COMPLETED|Overall Study||177
2415907|NCT01252355|5925067|P3|COMPLETED|Overall Study||0
2415908|NCT01252355|5925068|P2|COMPLETED|Overall Study||0
2415909|NCT01252355|5925069|P1|COMPLETED|Overall Study||0
2415910|NCT01252355|5925067|P3|Treated|Overall Study|One participant received teriflunomide 7 mg.|179
2415911|NCT01252355|5925068|P2|Treated|Overall Study||178
2415912|NCT01252355|5925069|P1|Treated|Overall Study||175
2415913|NCT01252355|5925067|P3|STARTED|Overall Study|Randomized.|179
2415914|NCT01252355|5925068|P2|STARTED|Overall Study|Randomized.|178
2415915|NCT01252355|5925069|P1|STARTED|Overall Study|Randomized.|177
2415916|NCT01252290|5925107|P1|NOT COMPLETED|Overall Study||1
2415917|NCT01252290|5925107|P1|COMPLETED|Overall Study||34
2415918|NCT01252290|5925107|P1|STARTED|Overall Study||35
2415919|NCT01252277|5925115|P1|NOT COMPLETED|Overall Study||2
2415920|NCT01252277|5925115|P1|COMPLETED|Overall Study||34
2415921|NCT01252277|5925115|P1|STARTED|Overall Study||36
2415922|NCT01252251|5925123|P1|NOT COMPLETED|Overall Study||1
2415923|NCT01252251|5925123|P1|COMPLETED|Overall Study||13
2415924|NCT01252251|5925123|P1|STARTED|Overall Study||14
2415925|NCT01252238|5925135|P3|NOT COMPLETED|Overall Study||4
2415926|NCT01252238|5925136|P2|NOT COMPLETED|Overall Study||4
2415927|NCT01252238|5925137|P1|NOT COMPLETED|Overall Study||4
2415928|NCT01252238|5925135|P3|COMPLETED|Overall Study|sponsor terminated study|4
2415929|NCT01252238|5925136|P2|COMPLETED|Overall Study|sponsor terminated study|4
2415930|NCT01252238|5925137|P1|COMPLETED|Overall Study|sponsor terminated study|4
2415931|NCT01252238|5925135|P3|STARTED|Overall Study||8
2415932|NCT01252238|5925136|P2|STARTED|Overall Study||8
2415933|NCT01252238|5925137|P1|STARTED|Overall Study||8
2415934|NCT01252186|5925154|P3|NOT COMPLETED|Overall Study||34
2415935|NCT01252186|5925155|P2|NOT COMPLETED|Overall Study||32
2415936|NCT01252186|5925156|P1|NOT COMPLETED|Overall Study||30
2415937|NCT01252186|5925154|P3|COMPLETED|Overall Study||53
2415938|NCT01252186|5925155|P2|COMPLETED|Overall Study||59
2415939|NCT01252186|5925156|P1|COMPLETED|Overall Study||57
2415940|NCT01252186|5925154|P3|Received Study Drug|Overall Study||80
2415941|NCT01252186|5925155|P2|Received Study Drug|Overall Study||89
2415942|NCT01252186|5925156|P1|Received Study Drug|Overall Study||83
2415943|NCT01252186|5925154|P3|STARTED|Overall Study||87
2415944|NCT01252186|5925155|P2|STARTED|Overall Study||91
2415945|NCT01252186|5925156|P1|STARTED|Overall Study||87
2415946|NCT01252147|5925224|P1|NOT COMPLETED|Overall Study||0
2415947|NCT01252147|5925224|P1|COMPLETED|Overall Study||68
2415948|NCT01252147|5925224|P1|STARTED|Overall Study||68
2415949|NCT01252134|5925229|P6|NOT COMPLETED|Period 3, 8 Hours||0
2415950|NCT01252134|5925230|P5|NOT COMPLETED|Period 3, 8 Hours||0
2415951|NCT01252134|5925231|P4|NOT COMPLETED|Period 3, 8 Hours||0
2415952|NCT01252134|5925232|P3|NOT COMPLETED|Period 3, 8 Hours||0
2415953|NCT01252134|5925233|P2|NOT COMPLETED|Period 3, 8 Hours||0
2415954|NCT01252134|5925234|P1|NOT COMPLETED|Period 3, 8 Hours||0
2415955|NCT01252134|5925229|P6|COMPLETED|Period 3, 8 Hours||4
2415956|NCT01252134|5925230|P5|COMPLETED|Period 3, 8 Hours||3
2415957|NCT01252134|5925231|P4|COMPLETED|Period 3, 8 Hours||5
2415958|NCT01252134|5925232|P3|COMPLETED|Period 3, 8 Hours||2
2415959|NCT01252134|5925233|P2|COMPLETED|Period 3, 8 Hours||3
2415960|NCT01252134|5925234|P1|COMPLETED|Period 3, 8 Hours||3
2415961|NCT01252134|5925229|P6|STARTED|Period 3, 8 Hours||4
2415962|NCT01252134|5925230|P5|STARTED|Period 3, 8 Hours||3
2415963|NCT01252134|5925231|P4|STARTED|Period 3, 8 Hours||5
2415964|NCT01252134|5925232|P3|STARTED|Period 3, 8 Hours||2
2415965|NCT01252134|5925233|P2|STARTED|Period 3, 8 Hours||3
2415966|NCT01252134|5925234|P1|STARTED|Period 3, 8 Hours||3
2415967|NCT01252134|5925229|P6|NOT COMPLETED|Period 2, 8 Hours||0
2415968|NCT01252134|5925230|P5|NOT COMPLETED|Period 2, 8 Hours||0
2415969|NCT01252134|5925231|P4|NOT COMPLETED|Period 2, 8 Hours||0
2415970|NCT01252134|5925232|P3|NOT COMPLETED|Period 2, 8 Hours||0
2415971|NCT01252134|5925233|P2|NOT COMPLETED|Period 2, 8 Hours||0
2415972|NCT01252134|5925234|P1|NOT COMPLETED|Period 2, 8 Hours||0
2415973|NCT01252134|5925229|P6|COMPLETED|Period 2, 8 Hours||4
2415974|NCT01252134|5925230|P5|COMPLETED|Period 2, 8 Hours||3
2415975|NCT01252134|5925231|P4|COMPLETED|Period 2, 8 Hours||5
2415976|NCT01252134|5925232|P3|COMPLETED|Period 2, 8 Hours||2
2415977|NCT01252134|5925233|P2|COMPLETED|Period 2, 8 Hours||3
2415978|NCT01252134|5925234|P1|COMPLETED|Period 2, 8 Hours||3
2415979|NCT01252134|5925229|P6|STARTED|Period 2, 8 Hours||4
2415980|NCT01252134|5925230|P5|STARTED|Period 2, 8 Hours||3
2415981|NCT01252134|5925231|P4|STARTED|Period 2, 8 Hours||5
2415982|NCT01252134|5925232|P3|STARTED|Period 2, 8 Hours||2
2415983|NCT01252134|5925233|P2|STARTED|Period 2, 8 Hours||3
2415984|NCT01252134|5925234|P1|STARTED|Period 2, 8 Hours||3
2415985|NCT01252134|5925229|P6|NOT COMPLETED|Period 1, 8 Hours||0
2415986|NCT01252134|5925230|P5|NOT COMPLETED|Period 1, 8 Hours||0
2415987|NCT01252134|5925231|P4|NOT COMPLETED|Period 1, 8 Hours||0
2415988|NCT01252134|5925232|P3|NOT COMPLETED|Period 1, 8 Hours||1
2415989|NCT01252134|5925233|P2|NOT COMPLETED|Period 1, 8 Hours||1
2415990|NCT01252134|5925234|P1|NOT COMPLETED|Period 1, 8 Hours||0
2415991|NCT01252134|5925229|P6|COMPLETED|Period 1, 8 Hours||4
2415992|NCT01252134|5925230|P5|COMPLETED|Period 1, 8 Hours||3
2415993|NCT01252134|5925231|P4|COMPLETED|Period 1, 8 Hours||5
2415994|NCT01252134|5925232|P3|COMPLETED|Period 1, 8 Hours||2
2415995|NCT01252134|5925233|P2|COMPLETED|Period 1, 8 Hours||3
2415996|NCT01252134|5925234|P1|COMPLETED|Period 1, 8 Hours||3
2415997|NCT01252134|5925229|P6|STARTED|Period 1, 8 Hours||4
2415998|NCT01252134|5925230|P5|STARTED|Period 1, 8 Hours||3
2415999|NCT01252134|5925231|P4|STARTED|Period 1, 8 Hours||5
2416000|NCT01252134|5925232|P3|STARTED|Period 1, 8 Hours||3
2416001|NCT01252134|5925233|P2|STARTED|Period 1, 8 Hours||4
2416002|NCT01252134|5925234|P1|STARTED|Period 1, 8 Hours||3
2416003|NCT01252095|5925253|P2|NOT COMPLETED|Overall Study||0
2416004|NCT01252095|5925254|P1|NOT COMPLETED|Overall Study||1
2416005|NCT01252095|5925253|P2|COMPLETED|Overall Study||1
2416006|NCT01252095|5925254|P1|COMPLETED|Overall Study||2
2416007|NCT01252095|5925253|P2|STARTED|Overall Study||1
2416008|NCT01252095|5925254|P1|STARTED|Overall Study||3
2416009|NCT01251978|5925262|P2|NOT COMPLETED|Overall Study||0
2416010|NCT01251978|5925263|P1|NOT COMPLETED|Overall Study||0
2416011|NCT01251978|5925262|P2|COMPLETED|Overall Study||3
2416012|NCT01251978|5925263|P1|COMPLETED|Overall Study||5
2416013|NCT01251978|5925262|P2|STARTED|Overall Study||3
2416014|NCT01251978|5925263|P1|STARTED|Overall Study||5
2416015|NCT01251965|5925275|P3|NOT COMPLETED|Overall Study||11
2416016|NCT01251965|5925276|P2|NOT COMPLETED|Overall Study||2
2416017|NCT01251965|5925277|P1|NOT COMPLETED|Overall Study||1
2416018|NCT01251965|5925275|P3|COMPLETED|Overall Study||7
2416019|NCT01251965|5925276|P2|COMPLETED|Overall Study||3
2416020|NCT01251965|5925277|P1|COMPLETED|Overall Study||3
2416021|NCT01251965|5925275|P3|STARTED|Overall Study||18
2416022|NCT01251965|5925276|P2|STARTED|Overall Study||5
2416023|NCT01251965|5925277|P1|STARTED|Overall Study||4
2416024|NCT01251952|5925289|P1|NOT COMPLETED|Overall Study||1
2416025|NCT01251952|5925289|P1|COMPLETED|Overall Study||1
2416026|NCT01251952|5925289|P1|STARTED|Overall Study||2
2416027|NCT01251861|5925295|P2|NOT COMPLETED|Overall Study||28
2416028|NCT01251861|5925296|P1|NOT COMPLETED|Overall Study||18
2416029|NCT01251861|5925295|P2|COMPLETED|Overall Study||26
2416030|NCT01251861|5925296|P1|COMPLETED|Overall Study||36
2416031|NCT01251861|5925295|P2|Pts With PSA Response|Overall Study||36
2416032|NCT01251861|5925296|P1|Pts With PSA Response|Overall Study||44
2416033|NCT01251861|5925295|P2|Pts w/ Follow-up PSA Lower Than Baseline|Overall Study||47
2416034|NCT01251861|5925296|P1|Pts w/ Follow-up PSA Lower Than Baseline|Overall Study||49
2416035|NCT01251861|5925295|P2|Pts Who Received Protocol Therapy|Overall Study||53
2416036|NCT01251861|5925296|P1|Pts Who Received Protocol Therapy|Overall Study||50
2416037|NCT01251861|5925295|P2|STARTED|Overall Study||54
2416038|NCT01251861|5925296|P1|STARTED|Overall Study||54
2416039|NCT01251770|5925324|P2|NOT COMPLETED|Overall Study||7
2416040|NCT01251770|5925325|P1|NOT COMPLETED|Overall Study||13
2416041|NCT01251770|5925324|P2|COMPLETED|Overall Study||29
2416042|NCT01251770|5925325|P1|COMPLETED|Overall Study||29
2416043|NCT01251770|5925324|P2|STARTED|Overall Study||36
2416044|NCT01251770|5925325|P1|STARTED|Overall Study||42
2416045|NCT01251757|5925336|P3|NOT COMPLETED|Overall Study||0
2416046|NCT01251757|5925337|P2|NOT COMPLETED|Overall Study||0
2416047|NCT01251757|5925338|P1|NOT COMPLETED|Overall Study||0
2416048|NCT01251757|5925336|P3|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.5) mos, but we computed an adherence score for everyone.|7250
2416049|NCT01251757|5925337|P2|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.4) mos, but we computed an adherence score for everyone.|7247
2416050|NCT01251757|5925338|P1|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.7 (2.3) mos, but we computed an adherence score for everyone.|7255
2416051|NCT01251757|5925336|P3|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7250
2416052|NCT01251757|5925337|P2|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7247
2416053|NCT01251757|5925338|P1|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7255
2416054|NCT01251744|5925369|P2|NOT COMPLETED|Overall Study||0
2416055|NCT01251744|5925370|P1|NOT COMPLETED|Overall Study||1
2416056|NCT01251744|5925369|P2|COMPLETED|Overall Study||78
2416057|NCT01251744|5925370|P1|COMPLETED|Overall Study||76
2416058|NCT01251744|5925369|P2|STARTED|Overall Study||78
2416059|NCT01251744|5925370|P1|STARTED|Overall Study||77
2416060|NCT01251653|5925428|P9|NOT COMPLETED|Overall Study||6
2416061|NCT01251653|5925429|P8|NOT COMPLETED|Overall Study||12
2416062|NCT01251653|5925430|P7|NOT COMPLETED|Overall Study||18
2416063|NCT01251653|5925431|P6|NOT COMPLETED|Overall Study||18
2416064|NCT01251653|5925432|P5|NOT COMPLETED|Overall Study||2
2416065|NCT01251653|5925433|P4|NOT COMPLETED|Overall Study||6
2416066|NCT01251653|5925434|P3|NOT COMPLETED|Overall Study||20
2416067|NCT01251653|5925435|P2|NOT COMPLETED|Overall Study||8
2416068|NCT01251653|5925436|P1|NOT COMPLETED|Overall Study||3
2416069|NCT01251653|5925428|P9|COMPLETED|Overall Study||0
2416070|NCT01251653|5925429|P8|COMPLETED|Overall Study||0
2416071|NCT01251653|5925430|P7|COMPLETED|Overall Study||0
2416072|NCT01251653|5925431|P6|COMPLETED|Overall Study||0
2416073|NCT01251653|5925432|P5|COMPLETED|Overall Study||0
2416074|NCT01251653|5925433|P4|COMPLETED|Overall Study||0
2416075|NCT01251653|5925434|P3|COMPLETED|Overall Study||0
2416076|NCT01251653|5925435|P2|COMPLETED|Overall Study||0
2416077|NCT01251653|5925436|P1|COMPLETED|Overall Study||0
2416078|NCT01251653|5925428|P9|STARTED|Overall Study||6
2416079|NCT01251653|5925429|P8|STARTED|Overall Study||12
2416080|NCT01251653|5925430|P7|STARTED|Overall Study||18
2416081|NCT01251653|5925431|P6|STARTED|Overall Study||18
2416082|NCT01251653|5925432|P5|STARTED|Overall Study||2
2416083|NCT01251653|5925433|P4|STARTED|Overall Study||6
2416084|NCT01251653|5925434|P3|STARTED|Overall Study||20
2416085|NCT01251653|5925435|P2|STARTED|Overall Study||8
2416086|NCT01251653|5925436|P1|STARTED|Overall Study||3
2416087|NCT01251614|5925564|P3|NOT COMPLETED|Overall Study||8
2416088|NCT01251614|5925565|P2|NOT COMPLETED|Overall Study||13
2416089|NCT01251614|5925566|P1|NOT COMPLETED|Overall Study||3
2416090|NCT01251614|5925564|P3|COMPLETED|Overall Study||30
2416091|NCT01251614|5925565|P2|COMPLETED|Overall Study||26
2416092|NCT01251614|5925566|P1|COMPLETED|Overall Study||34
2416093|NCT01251614|5925564|P3|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
2416094|NCT01251614|5925565|P2|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
2416095|NCT01251614|5925566|P1|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
2416096|NCT01251614|5925564|P3|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|19
2416097|NCT01251614|5925565|P2|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|11
2416098|NCT01251614|5925566|P1|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|8
2416099|NCT01251614|5925564|P3|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|23
2416100|NCT01251614|5925565|P2|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|18
2416101|NCT01251614|5925566|P1|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|13
2416102|NCT01251614|5925564|P3|STARTED|Overall Study||38
2416103|NCT01251614|5925565|P2|STARTED|Overall Study||39
2416104|NCT01251614|5925566|P1|STARTED|Overall Study||37
2416105|NCT01251588|5925640|P2|NOT COMPLETED|Overall Study||4
2416106|NCT01251588|5925641|P1|NOT COMPLETED|Overall Study||0
2416107|NCT01251588|5925640|P2|COMPLETED|Overall Study||59
2416108|NCT01251588|5925641|P1|COMPLETED|Overall Study||65
2416109|NCT01251588|5925640|P2|STARTED|Overall Study||63
2416110|NCT01251588|5925641|P1|STARTED|Overall Study||65
2416111|NCT01251575|5925673|P1|NOT COMPLETED|Overall Study||1
2416112|NCT01251575|5925673|P1|COMPLETED|Overall Study||76
2416113|NCT01251575|5925673|P1|STARTED|Overall Study||77
2416114|NCT01251536|5925683|P3|NOT COMPLETED|Overall Study||0
2416115|NCT01251536|5925684|P2|NOT COMPLETED|Overall Study||0
2416116|NCT01251536|5925685|P1|NOT COMPLETED|Overall Study||0
2416117|NCT01251536|5925683|P3|COMPLETED|Overall Study||7
2416118|NCT01251536|5925684|P2|COMPLETED|Overall Study||93
2416119|NCT01251536|5925685|P1|COMPLETED|Overall Study||8
2416120|NCT01251536|5925683|P3|STARTED|Overall Study||7
2416121|NCT01251536|5925684|P2|STARTED|Overall Study||93
2416122|NCT01251536|5925685|P1|STARTED|Overall Study||8
2416123|NCT01251380|5925755|P1|NOT COMPLETED|Overall Study||22
2416124|NCT01251380|5925755|P1|COMPLETED|Overall Study||194
2416125|NCT01251380|5925755|P1|Cycle 4|Overall Study||11
2416126|NCT01251380|5925755|P1|Cycle 3|Overall Study||86
2416127|NCT01251380|5925755|P1|Cycle 2|Overall Study||175
2416128|NCT01251380|5925755|P1|Cycle 1|Overall Study||207
2416129|NCT01251380|5925755|P1|STARTED|Overall Study|Safety population.|216
2416130|NCT01251367|5925779|P1|NOT COMPLETED|Overall Study||76
2416131|NCT01251367|5925779|P1|COMPLETED|Overall Study||269
2416132|NCT01251367|5925779|P1|Cycle 4|Overall Study||139
2416133|NCT01251367|5925779|P1|Cycle 3|Overall Study||224
2416134|NCT01251367|5925779|P1|Cycle 2|Overall Study||297
2416135|NCT01251367|5925779|P1|Cycle 1|Overall Study||345
2416136|NCT01251367|5925779|P1|STARTED|Overall Study||345
2416137|NCT01251354|5925814|P1|NOT COMPLETED|Overall Study||6
2416138|NCT01251354|5925814|P1|COMPLETED|Overall Study||0
2416139|NCT01251354|5925814|P1|STARTED|Overall Study||6
2416140|NCT01251315|5925830|P6|NOT COMPLETED|Overall Study||0
2416141|NCT01251315|5925831|P5|NOT COMPLETED|Overall Study||0
2416142|NCT01251315|5925832|P4|NOT COMPLETED|Overall Study||0
2416143|NCT01251315|5925833|P3|NOT COMPLETED|Overall Study||0
2416144|NCT01251315|5925834|P2|NOT COMPLETED|Overall Study||0
2416145|NCT01251315|5925835|P1|NOT COMPLETED|Overall Study||0
2416146|NCT01251315|5925830|P6|COMPLETED|Overall Study||4
2416147|NCT01251315|5925831|P5|COMPLETED|Overall Study||4
2416148|NCT01251315|5925832|P4|COMPLETED|Overall Study||4
2416149|NCT01251315|5925833|P3|COMPLETED|Overall Study||4
2416150|NCT01251315|5925834|P2|COMPLETED|Overall Study||4
2416151|NCT01251315|5925835|P1|COMPLETED|Overall Study||4
2416152|NCT01251315|5925830|P6|STARTED|Overall Study||4
2416153|NCT01251315|5925831|P5|STARTED|Overall Study||4
2416154|NCT01251315|5925832|P4|STARTED|Overall Study||4
2416155|NCT01251315|5925833|P3|STARTED|Overall Study||4
2416156|NCT01251315|5925834|P2|STARTED|Overall Study||4
2416157|NCT01251315|5925835|P1|STARTED|Overall Study||4
2416158|NCT01251276|5925857|P2|NOT COMPLETED|Overall Study||1
2416159|NCT01251276|5925858|P1|NOT COMPLETED|Overall Study||1
2416160|NCT01251276|5925857|P2|COMPLETED|Overall Study||107
2416161|NCT01251276|5925858|P1|COMPLETED|Overall Study||95
2416162|NCT01251276|5925857|P2|Vaccinated|Overall Study||108
2416163|NCT01251276|5925858|P1|Vaccinated|Overall Study||96
2416164|NCT01251276|5925857|P2|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|108
2416165|NCT01251276|5925858|P1|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|96
2416166|NCT01251146|5925876|P2|NOT COMPLETED|Overall Study||10
2416167|NCT01251146|5925877|P1|NOT COMPLETED|Overall Study||3
2416168|NCT01251146|5925876|P2|COMPLETED|Overall Study||81
2416169|NCT01251146|5925877|P1|COMPLETED|Overall Study||83
2416170|NCT01251146|5925876|P2|STARTED|Overall Study||91
2416171|NCT01251146|5925877|P1|STARTED|Overall Study||86
2416172|NCT01251120|5925899|P2|NOT COMPLETED|Overall Study||1
2416173|NCT01251120|5925900|P1|NOT COMPLETED|Overall Study||0
2416174|NCT01251120|5925899|P2|COMPLETED|Overall Study||0
2416175|NCT01251120|5925900|P1|COMPLETED|Overall Study||1
2416176|NCT01251120|5925899|P2|STARTED|Overall Study||1
2416177|NCT01251120|5925900|P1|STARTED|Overall Study||1
2416178|NCT01251042|5925922|P2|NOT COMPLETED|Overall Study||0
2416179|NCT01251042|5925923|P1|NOT COMPLETED|Overall Study||0
2416180|NCT01251042|5925922|P2|COMPLETED|Overall Study||23
2416181|NCT01251042|5925923|P1|COMPLETED|Overall Study||26
2416182|NCT01251042|5925922|P2|STARTED|Overall Study||23
2416183|NCT01251042|5925923|P1|STARTED|Overall Study||26
2416184|NCT01250990|5925955|P2|NOT COMPLETED|Overall Study||2
2416185|NCT01250990|5925956|P1|NOT COMPLETED|Overall Study||4
2416186|NCT01250990|5925955|P2|COMPLETED|Overall Study||9
2416187|NCT01250990|5925956|P1|COMPLETED|Overall Study||7
2416188|NCT01250990|5925955|P2|STARTED|Overall Study||11
2416189|NCT01250990|5925956|P1|STARTED|Overall Study||11
2416190|NCT01250977|5925964|P2|NOT COMPLETED|Overall Study||2
2416191|NCT01250977|5925965|P1|NOT COMPLETED|Overall Study||0
2416192|NCT01250977|5925964|P2|COMPLETED|Overall Study||12
2416193|NCT01250977|5925965|P1|COMPLETED|Overall Study||6
2416194|NCT01250977|5925964|P2|STARTED|Overall Study||14
2416195|NCT01250977|5925965|P1|STARTED|Overall Study||6
2416196|NCT01250925|5925980|P3|NOT COMPLETED|Overall Study||2
2416197|NCT01250925|5925981|P2|NOT COMPLETED|Overall Study||3
2416198|NCT01250925|5925982|P1|NOT COMPLETED|Overall Study||5
2416199|NCT01250925|5925980|P3|COMPLETED|Overall Study||30
2416200|NCT01250925|5925981|P2|COMPLETED|Overall Study||28
2416201|NCT01250925|5925982|P1|COMPLETED|Overall Study||26
2416202|NCT01250925|5925980|P3|STARTED|Overall Study||32
2416203|NCT01250925|5925981|P2|STARTED|Overall Study||31
2416204|NCT01250925|5925982|P1|STARTED|Overall Study||31
2416205|NCT01250899|5926022|P2|NOT COMPLETED|Overall Study||0
2416206|NCT01250899|5926023|P1|NOT COMPLETED|Overall Study||0
2416207|NCT01250899|5926022|P2|COMPLETED|Overall Study||82
2416208|NCT01250899|5926023|P1|COMPLETED|Overall Study||40
2416209|NCT01250899|5926022|P2|STARTED|Overall Study||82
2416210|NCT01250899|5926023|P1|STARTED|Overall Study||40
2416211|NCT01250873|5926027|P1|NOT COMPLETED|Period 3:LY2216684+Sertraline(Days11-13)||1
2416212|NCT01250873|5926027|P1|COMPLETED|Period 3:LY2216684+Sertraline(Days11-13)||17
2416213|NCT01250873|5926027|P1|STARTED|Period 3:LY2216684+Sertraline(Days11-13)||18
2416214|NCT01250873|5926027|P1|NOT COMPLETED|Period 2: Sertraline (Day 4, 5-10)||0
2416215|NCT01250873|5926027|P1|COMPLETED|Period 2: Sertraline (Day 4, 5-10)||18
2416216|NCT01250873|5926027|P1|STARTED|Period 2: Sertraline (Day 4, 5-10)||18
2416217|NCT01250873|5926027|P1|NOT COMPLETED|Period 1: LY2216684 (Days 1-3)||2
2416218|NCT01250873|5926027|P1|COMPLETED|Period 1: LY2216684 (Days 1-3)||18
2416219|NCT01250873|5926027|P1|STARTED|Period 1: LY2216684 (Days 1-3)||20
2416220|NCT01250834|5926038|P1|NOT COMPLETED|Overall Study||0
2416221|NCT01250834|5926038|P1|COMPLETED|Overall Study||27
2416222|NCT01250834|5926038|P1|STARTED|Overall Study||27
2416223|NCT01250769|5926059|P4|NOT COMPLETED|Overall Study||0
2416224|NCT01250769|5926060|P3|NOT COMPLETED|Overall Study||2
2416225|NCT01250769|5926061|P2|NOT COMPLETED|Overall Study||1
2416226|NCT01250769|5926062|P1|NOT COMPLETED|Overall Study||0
2416227|NCT01250769|5926059|P4|COMPLETED|Overall Study||11
2416228|NCT01250769|5926060|P3|COMPLETED|Overall Study||73
2416229|NCT01250769|5926061|P2|COMPLETED|Overall Study||72
2416230|NCT01250769|5926062|P1|COMPLETED|Overall Study||11
2416231|NCT01250769|5926059|P4|Day 14|Overall Study||11
2416232|NCT01250769|5926060|P3|Day 14|Overall Study||74
2416233|NCT01250769|5926061|P2|Day 14|Overall Study||72
2416234|NCT01250769|5926062|P1|Day 14|Overall Study||11
2416235|NCT01250769|5926059|P4|STARTED|Overall Study||11
2416236|NCT01250769|5926060|P3|STARTED|Overall Study||75
2416237|NCT01250769|5926061|P2|STARTED|Overall Study||73
2416238|NCT01250769|5926062|P1|STARTED|Overall Study||11
2416239|NCT01250756|5926094|P2|NOT COMPLETED|After Toddler Dose||1
2416240|NCT01250756|5926095|P1|NOT COMPLETED|After Toddler Dose||0
2416241|NCT01250756|5926094|P2|COMPLETED|After Toddler Dose||147
2416242|NCT01250756|5926095|P1|COMPLETED|After Toddler Dose||0
2416243|NCT01250756|5926094|P2|STARTED|After Toddler Dose||148
2416244|NCT01250756|5926095|P1|STARTED|After Toddler Dose||0
2416245|NCT01250756|5926094|P2|NOT COMPLETED|Toddler Dose||1
2416246|NCT01250756|5926095|P1|NOT COMPLETED|Toddler Dose||0
2416247|NCT01250756|5926094|P2|COMPLETED|Toddler Dose||148
2416248|NCT01250756|5926095|P1|COMPLETED|Toddler Dose||122
2416249|NCT01250756|5926094|P2|STARTED|Toddler Dose||149
2416250|NCT01250756|5926095|P1|STARTED|Toddler Dose||122
2416251|NCT01250756|5926094|P2|NOT COMPLETED|After Infant Series||4
2416252|NCT01250756|5926095|P1|NOT COMPLETED|After Infant Series||11
2416253|NCT01250756|5926094|P2|COMPLETED|After Infant Series||149
2416254|NCT01250756|5926095|P1|COMPLETED|After Infant Series||122
2416255|NCT01250756|5926094|P2|STARTED|After Infant Series||153
2416256|NCT01250756|5926095|P1|STARTED|After Infant Series||133
2416257|NCT01250756|5926094|P2|NOT COMPLETED|Infant Series||7
2416258|NCT01250756|5926095|P1|NOT COMPLETED|Infant Series||28
2416259|NCT01250756|5926094|P2|COMPLETED|Infant Series||153
2416260|NCT01250756|5926095|P1|COMPLETED|Infant Series||133
2416261|NCT01250756|5926094|P2|Vaccinated Dose 3|Infant Series||155
2416262|NCT01250756|5926095|P1|Vaccinated Dose 3|Infant Series||133
2416263|NCT01250756|5926094|P2|Vaccinated Dose 2|Infant Series||157
2416264|NCT01250756|5926095|P1|Vaccinated Dose 2|Infant Series||147
2416265|NCT01250756|5926094|P2|Vaccinated Dose 1|Infant Series||158
2416266|NCT01250756|5926095|P1|Vaccinated Dose 1|Infant Series||159
2416267|NCT01250756|5926094|P2|STARTED|Infant Series||160
2416268|NCT01250756|5926095|P1|STARTED|Infant Series||161
2416269|NCT01250730|5926148|P3|NOT COMPLETED|Overall Study||0
2416270|NCT01250730|5926149|P2|NOT COMPLETED|Overall Study||0
2416271|NCT01250730|5926150|P1|NOT COMPLETED|Overall Study||0
2416272|NCT01250730|5926148|P3|COMPLETED|Overall Study||6
2416273|NCT01250730|5926149|P2|COMPLETED|Overall Study||6
2416274|NCT01250730|5926150|P1|COMPLETED|Overall Study||6
2416275|NCT01250730|5926148|P3|STARTED|Overall Study||6
2416276|NCT01250730|5926149|P2|STARTED|Overall Study||6
2416277|NCT01250730|5926150|P1|STARTED|Overall Study||6
2416278|NCT01250717|5926206|P1|NOT COMPLETED|Overall Study||0
2416279|NCT01250717|5926206|P1|COMPLETED|Overall Study||28
2416280|NCT01250717|5926206|P1|STARTED|Overall Study||28
2416281|NCT01250509|5926212|P2|NOT COMPLETED|Overall Study||2
2416282|NCT01250509|5926213|P1|NOT COMPLETED|Overall Study||5
2416283|NCT01250509|5926212|P2|COMPLETED|Overall Study||21
2416284|NCT01250509|5926213|P1|COMPLETED|Overall Study||19
2416285|NCT01250509|5926212|P2|STARTED|Overall Study||23
2416286|NCT01250509|5926213|P1|STARTED|Overall Study||24
2416287|NCT01250418|5926227|P2|NOT COMPLETED|Overall Study||1
2416288|NCT01250418|5926228|P1|NOT COMPLETED|Overall Study||1
2416289|NCT01250418|5926227|P2|COMPLETED|Overall Study||15
2416290|NCT01250418|5926228|P1|COMPLETED|Overall Study||8
2416291|NCT01250418|5926227|P2|STARTED|Overall Study||16
2416292|NCT01250418|5926228|P1|STARTED|Overall Study||9
2416293|NCT01250379|5926236|P2|NOT COMPLETED|Overall Study||193
2416294|NCT01250379|5926237|P1|NOT COMPLETED|Overall Study||202
2416295|NCT01250379|5926236|P2|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|54
2416296|NCT01250379|5926237|P1|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|45
2416297|NCT01250379|5926236|P2|STARTED|Overall Study||247
2416298|NCT01250379|5926237|P1|STARTED|Overall Study||247
2416299|NCT01250210|5926298|P3|NOT COMPLETED|Overall Study||8
2416300|NCT01250210|5926299|P2|NOT COMPLETED|Overall Study||4
2416301|NCT01250210|5926300|P1|NOT COMPLETED|Overall Study||4
2416302|NCT01250210|5926298|P3|COMPLETED|Overall Study||25
2416303|NCT01250210|5926299|P2|COMPLETED|Overall Study||41
2416304|NCT01250210|5926300|P1|COMPLETED|Overall Study||41
2416305|NCT01250210|5926298|P3|STARTED|Overall Study||33
2416306|NCT01250210|5926299|P2|STARTED|Overall Study||45
2416307|NCT01250210|5926300|P1|STARTED|Overall Study||45
2416308|NCT01250184|5926314|P3|NOT COMPLETED|Overall Study||0
2416309|NCT01250184|5926315|P2|NOT COMPLETED|Overall Study||0
2416310|NCT01250184|5926316|P1|NOT COMPLETED|Overall Study||0
2416311|NCT01250184|5926314|P3|COMPLETED|Overall Study||43
2416312|NCT01250184|5926315|P2|COMPLETED|Overall Study||41
2416313|NCT01250184|5926316|P1|COMPLETED|Overall Study||43
2416314|NCT01250184|5926314|P3|STARTED|Overall Study||43
2416315|NCT01250184|5926315|P2|STARTED|Overall Study||41
2416316|NCT01250184|5926316|P1|STARTED|Overall Study||43
2416317|NCT01250171|5926342|P3|NOT COMPLETED|Overall Study||0
2416318|NCT01250171|5926343|P2|NOT COMPLETED|Overall Study||0
2416319|NCT01250171|5926344|P1|NOT COMPLETED|Overall Study||1
2416320|NCT01250171|5926342|P3|COMPLETED|Overall Study||24
2416321|NCT01250171|5926343|P2|COMPLETED|Overall Study||22
2416322|NCT01250171|5926344|P1|COMPLETED|Overall Study||25
2416323|NCT01250171|5926342|P3|STARTED|Overall Study||24
2416324|NCT01250171|5926343|P2|STARTED|Overall Study||22
2416325|NCT01250171|5926344|P1|STARTED|Overall Study||26
2416326|NCT01250145|5926375|P2|NOT COMPLETED|Overall Study||5
2416327|NCT01250145|5926376|P1|NOT COMPLETED|Overall Study||2
2416328|NCT01250145|5926375|P2|COMPLETED|Overall Study||205
2416329|NCT01250145|5926376|P1|COMPLETED|Overall Study||39
2416330|NCT01250145|5926375|P2|STARTED|Overall Study||210
2416331|NCT01250145|5926376|P1|STARTED|Overall Study||41
2416332|NCT01250119|5926396|P2|NOT COMPLETED|Treatment Phase||41
2416333|NCT01250119|5926397|P1|NOT COMPLETED|Treatment Phase||0
2416334|NCT01250119|5926396|P2|COMPLETED|Treatment Phase||0
2416335|NCT01250119|5926397|P1|COMPLETED|Treatment Phase||0
2416336|NCT01250119|5926396|P2|STARTED|Treatment Phase|Out of 52 participants with positive EGFR mutation test result, only 41 participants were treated.|41
2416337|NCT01250119|5926397|P1|STARTED|Treatment Phase||0
2416338|NCT01250119|5926396|P2|NOT COMPLETED|Diagnostic Phase||0
2416339|NCT01250119|5926397|P1|NOT COMPLETED|Diagnostic Phase||113
2416340|NCT01250119|5926396|P2|COMPLETED|Diagnostic Phase||0
2416341|NCT01250119|5926397|P1|COMPLETED|Diagnostic Phase|Completed refers to participants with both positive and negative EGFR mutation test result.|575
2416342|NCT01250119|5926396|P2|STARTED|Diagnostic Phase||0
2416343|NCT01250119|5926397|P1|STARTED|Diagnostic Phase||688
2416344|NCT01250054|5926412|P2|NOT COMPLETED|Period 2, One Week of Wear||0
2416345|NCT01250054|5926413|P1|NOT COMPLETED|Period 2, One Week of Wear||1
2416346|NCT01250054|5926412|P2|COMPLETED|Period 2, One Week of Wear||8
2416347|NCT01250054|5926413|P1|COMPLETED|Period 2, One Week of Wear||6
2416348|NCT01250054|5926412|P2|STARTED|Period 2, One Week of Wear||8
2416349|NCT01250054|5926413|P1|STARTED|Period 2, One Week of Wear||7
2416350|NCT01250054|5926412|P2|NOT COMPLETED|Period 1, One Week of Wear||0
2416351|NCT01250054|5926413|P1|NOT COMPLETED|Period 1, One Week of Wear||0
2416352|NCT01250054|5926412|P2|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to noncompliance.|8
2416353|NCT01250054|5926413|P1|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to power availability.|8
2416354|NCT01250054|5926412|P2|STARTED|Period 1, One Week of Wear|One subject did not wear Period 1 lenses due to power availability and proceeded to Period 2 lenses.|8
2416355|NCT01250054|5926413|P1|STARTED|Period 1, One Week of Wear||8
2416356|NCT01250002|5926421|P2|NOT COMPLETED|Overall Study||3
2416357|NCT01250002|5926422|P1|NOT COMPLETED|Overall Study||4
2416358|NCT01250002|5926421|P2|COMPLETED|Overall Study||32
2416359|NCT01250002|5926422|P1|COMPLETED|Overall Study||31
2416360|NCT01250002|5926421|P2|STARTED|Overall Study||35
2416361|NCT01250002|5926422|P1|STARTED|Overall Study||35
2416362|NCT01249872|5926436|P6|NOT COMPLETED|Overall Study||0
2416363|NCT01249872|5926437|P5|NOT COMPLETED|Overall Study||0
2416364|NCT01249872|5926438|P4|NOT COMPLETED|Overall Study||0
2416365|NCT01249872|5926439|P3|NOT COMPLETED|Overall Study||0
2416366|NCT01249872|5926440|P2|NOT COMPLETED|Overall Study||0
2416367|NCT01249872|5926441|P1|NOT COMPLETED|Overall Study||0
2416368|NCT01249872|5926436|P6|COMPLETED|Overall Study||16
2416369|NCT01249872|5926437|P5|COMPLETED|Overall Study||16
2416370|NCT01249872|5926438|P4|COMPLETED|Overall Study||16
2416371|NCT01249872|5926439|P3|COMPLETED|Overall Study||16
2416372|NCT01249872|5926440|P2|COMPLETED|Overall Study||16
2416373|NCT01249872|5926441|P1|COMPLETED|Overall Study||16
2416374|NCT01249872|5926436|P6|STARTED|Overall Study||16
2416375|NCT01249872|5926437|P5|STARTED|Overall Study||16
2416376|NCT01249872|5926438|P4|STARTED|Overall Study||16
2416377|NCT01249872|5926439|P3|STARTED|Overall Study||16
2416378|NCT01249872|5926440|P2|STARTED|Overall Study||16
2416379|NCT01249872|5926441|P1|STARTED|Overall Study||16
2416380|NCT01249833|5926487|P2|NOT COMPLETED|Overall Study||1
2416381|NCT01249833|5926488|P1|NOT COMPLETED|Overall Study||0
2416382|NCT01249833|5926487|P2|COMPLETED|Overall Study||62
2416383|NCT01249833|5926488|P1|COMPLETED|Overall Study||59
2416384|NCT01249833|5926487|P2|STARTED|Overall Study||63
2416385|NCT01249833|5926488|P1|STARTED|Overall Study||59
2416386|NCT01249664|5926502|P2|NOT COMPLETED|Overall Study||0
2416387|NCT01249664|5926503|P1|NOT COMPLETED|Overall Study||6
2416388|NCT01249664|5926502|P2|COMPLETED|Overall Study|Completers of study visits up to week 48|31
2416389|NCT01249664|5926503|P1|COMPLETED|Overall Study|Completers of study visits up to week 48|85
2416390|NCT01249664|5926502|P2|Completed 48 Weeks Treatment|Overall Study||24
2416391|NCT01249664|5926503|P1|Completed 48 Weeks Treatment|Overall Study||78
2416392|NCT01249664|5926502|P2|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|25
2416393|NCT01249664|5926503|P1|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|83
2416394|NCT01249664|5926502|P2|Fulfilled Requirements of FAS Population|Overall Study|FAS population: Basis of efficacy evaluation|31
2416395|NCT01249664|5926503|P1|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) population: Basis of efficacy evaluation|90
2416396|NCT01249664|5926502|P2|Participants Received Treatment|Overall Study|Safety population|31
2416397|NCT01249664|5926503|P1|Participants Received Treatment|Overall Study|Safety population|91
2416398|NCT01249664|5926502|P2|STARTED|Overall Study||31
2416399|NCT01249664|5926503|P1|STARTED|Overall Study||91
2416400|NCT01249651|5926553|P1|NOT COMPLETED|Overall Study||7
2416401|NCT01249651|5926553|P1|COMPLETED|Overall Study|Completed the 8-week treatment period|94
2416402|NCT01249651|5926553|P1|STARTED|Overall Study|Enrolled|101
2416403|NCT01249625|5926562|P2|NOT COMPLETED|Overall Study||0
2416404|NCT01249625|5926563|P1|NOT COMPLETED|Overall Study||0
2416405|NCT01249625|5926562|P2|COMPLETED|Overall Study||1488
2416406|NCT01249625|5926563|P1|COMPLETED|Overall Study||1374
2416407|NCT01249625|5926562|P2|STARTED|Overall Study||1488
2416408|NCT01249625|5926563|P1|STARTED|Overall Study||1374
2416409|NCT01249417|5926582|P3|NOT COMPLETED|Treatment Phase - ITT Population||4
2416410|NCT01249417|5926583|P2|NOT COMPLETED|Treatment Phase - ITT Population||4
2416411|NCT01249417|5926584|P1|NOT COMPLETED|Treatment Phase - ITT Population||1
2416412|NCT01249417|5926582|P3|COMPLETED|Treatment Phase - ITT Population||73
2416413|NCT01249417|5926583|P2|COMPLETED|Treatment Phase - ITT Population||75
2416414|NCT01249417|5926584|P1|COMPLETED|Treatment Phase - ITT Population||78
2416415|NCT01249417|5926582|P3|STARTED|Treatment Phase - ITT Population||77
2416416|NCT01249417|5926583|P2|STARTED|Treatment Phase - ITT Population||79
2416417|NCT01249417|5926584|P1|STARTED|Treatment Phase - ITT Population||79
2416418|NCT01249417|5926582|P3|NOT COMPLETED|Randomised Population||4
2416419|NCT01249417|5926583|P2|NOT COMPLETED|Randomised Population||1
2416420|NCT01249417|5926584|P1|NOT COMPLETED|Randomised Population||1
2416421|NCT01249417|5926582|P3|COMPLETED|Randomised Population||77
2416422|NCT01249417|5926583|P2|COMPLETED|Randomised Population||79
2416423|NCT01249417|5926584|P1|COMPLETED|Randomised Population||79
2416424|NCT01249417|5926582|P3|Treated|Randomised Population||79
2416425|NCT01249417|5926583|P2|Treated|Randomised Population||80
2416426|NCT01249417|5926584|P1|Treated|Randomised Population||80
2416427|NCT01249417|5926582|P3|STARTED|Randomised Population||81
2416428|NCT01249417|5926583|P2|STARTED|Randomised Population||80
2416429|NCT01249417|5926584|P1|STARTED|Randomised Population||80
2416430|NCT01249404|5926601|P3|NOT COMPLETED|Overall Study||7
2416431|NCT01249404|5926602|P2|NOT COMPLETED|Overall Study||8
2416432|NCT01249404|5926603|P1|NOT COMPLETED|Overall Study||7
2416433|NCT01249404|5926601|P3|COMPLETED|Overall Study||125
2416434|NCT01249404|5926602|P2|COMPLETED|Overall Study||121
2416435|NCT01249404|5926603|P1|COMPLETED|Overall Study||120
2416436|NCT01249404|5926601|P3|STARTED|Overall Study||132
2416437|NCT01249404|5926602|P2|STARTED|Overall Study||129
2416438|NCT01249404|5926603|P1|STARTED|Overall Study||127
2416439|NCT01249365|5926680|P1|NOT COMPLETED|Overall Study||1
2416440|NCT01249365|5926680|P1|COMPLETED|Overall Study||198
2416441|NCT01249365|5926680|P1|STARTED|Overall Study||199
2416442|NCT01249274|5926688|P2|NOT COMPLETED|Overall Study||6
2416443|NCT01249274|5926689|P1|NOT COMPLETED|Overall Study||4
2416444|NCT01249274|5926688|P2|COMPLETED|Overall Study||19
2416445|NCT01249274|5926689|P1|COMPLETED|Overall Study||21
2416446|NCT01249274|5926688|P2|Completed Post Trial Visit But Not tx|Overall Study||2
2416447|NCT01249274|5926689|P1|Completed Post Trial Visit But Not tx|Overall Study||1
2416448|NCT01249274|5926688|P2|Completed Treatment & Post Trial Visit|Overall Study||17
2416449|NCT01249274|5926689|P1|Completed Treatment & Post Trial Visit|Overall Study||20
2416450|NCT01249274|5926688|P2|Completed Treatment|Overall Study||19
2416451|NCT01249274|5926689|P1|Completed Treatment|Overall Study||21
2416452|NCT01249274|5926688|P2|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
2416453|NCT01249274|5926689|P1|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
2416454|NCT01249261|5926715|P2|NOT COMPLETED|Overall Study||0
2416455|NCT01249261|5926716|P1|NOT COMPLETED|Overall Study||1
2416456|NCT01249261|5926715|P2|COMPLETED|Overall Study||31
2416457|NCT01249261|5926716|P1|COMPLETED|Overall Study||29
2416458|NCT01249261|5926715|P2|STARTED|Overall Study||31
2416459|NCT01249261|5926716|P1|STARTED|Overall Study||30
2416460|NCT01249157|5926744|P1|NOT COMPLETED|Overall Study||1
2416461|NCT01249157|5926744|P1|COMPLETED|Overall Study|No data displayed because Outcome Measure has zero total participants analyzed.|0
2416462|NCT01249157|5926744|P1|STARTED|Overall Study||1
2416463|NCT01249131|5926748|P6|NOT COMPLETED|Third Intervention||0
2416464|NCT01249131|5926749|P5|NOT COMPLETED|Third Intervention||0
2416465|NCT01249131|5926750|P4|NOT COMPLETED|Third Intervention||0
2416466|NCT01249131|5926751|P3|NOT COMPLETED|Third Intervention||0
2416467|NCT01249131|5926752|P2|NOT COMPLETED|Third Intervention||0
2416468|NCT01249131|5926753|P1|NOT COMPLETED|Third Intervention||0
2416469|NCT01249131|5926748|P6|COMPLETED|Third Intervention||4
2416470|NCT01249131|5926749|P5|COMPLETED|Third Intervention||2
2416471|NCT01249131|5926750|P4|COMPLETED|Third Intervention||3
2416472|NCT01249131|5926751|P3|COMPLETED|Third Intervention||4
2416473|NCT01249131|5926752|P2|COMPLETED|Third Intervention||3
2416474|NCT01249131|5926753|P1|COMPLETED|Third Intervention||3
2416475|NCT01249131|5926748|P6|STARTED|Third Intervention||4
2416476|NCT01249131|5926749|P5|STARTED|Third Intervention||2
2416477|NCT01249131|5926750|P4|STARTED|Third Intervention||3
2416478|NCT01249131|5926751|P3|STARTED|Third Intervention||4
2416479|NCT01249131|5926752|P2|STARTED|Third Intervention||3
2416480|NCT01249131|5926753|P1|STARTED|Third Intervention||3
2416481|NCT01249131|5926748|P6|NOT COMPLETED|Washout Period of 10 Days||0
2416482|NCT01249131|5926749|P5|NOT COMPLETED|Washout Period of 10 Days||0
2416483|NCT01249131|5926750|P4|NOT COMPLETED|Washout Period of 10 Days||0
2416484|NCT01249131|5926751|P3|NOT COMPLETED|Washout Period of 10 Days||0
2416485|NCT01249131|5926752|P2|NOT COMPLETED|Washout Period of 10 Days||0
2416486|NCT01249131|5926753|P1|NOT COMPLETED|Washout Period of 10 Days||0
2416487|NCT01249131|5926748|P6|COMPLETED|Washout Period of 10 Days||4
2416488|NCT01249131|5926749|P5|COMPLETED|Washout Period of 10 Days||2
2416489|NCT01249131|5926750|P4|COMPLETED|Washout Period of 10 Days||3
2416490|NCT01249131|5926751|P3|COMPLETED|Washout Period of 10 Days||4
2416491|NCT01249131|5926752|P2|COMPLETED|Washout Period of 10 Days||3
2416492|NCT01249131|5926753|P1|COMPLETED|Washout Period of 10 Days||3
2416493|NCT01249131|5926748|P6|STARTED|Washout Period of 10 Days||4
2416494|NCT01249131|5926749|P5|STARTED|Washout Period of 10 Days||2
2416495|NCT01249131|5926750|P4|STARTED|Washout Period of 10 Days||3
2416496|NCT01249131|5926751|P3|STARTED|Washout Period of 10 Days||4
2416497|NCT01249131|5926752|P2|STARTED|Washout Period of 10 Days||3
2416498|NCT01249131|5926753|P1|STARTED|Washout Period of 10 Days||3
2416499|NCT01249131|5926748|P6|NOT COMPLETED|Second Intervention||0
2416500|NCT01249131|5926749|P5|NOT COMPLETED|Second Intervention||0
2416501|NCT01249131|5926750|P4|NOT COMPLETED|Second Intervention||0
2416502|NCT01249131|5926751|P3|NOT COMPLETED|Second Intervention||0
2416503|NCT01249131|5926752|P2|NOT COMPLETED|Second Intervention||0
2416504|NCT01249131|5926753|P1|NOT COMPLETED|Second Intervention||0
2416505|NCT01249131|5926748|P6|COMPLETED|Second Intervention||4
2416506|NCT01249131|5926749|P5|COMPLETED|Second Intervention||2
2416507|NCT01249131|5926750|P4|COMPLETED|Second Intervention||3
2416508|NCT01249131|5926751|P3|COMPLETED|Second Intervention||4
2416509|NCT01249131|5926752|P2|COMPLETED|Second Intervention||3
2416510|NCT01249131|5926753|P1|COMPLETED|Second Intervention||3
2416511|NCT01249131|5926748|P6|STARTED|Second Intervention||4
2416512|NCT01249131|5926749|P5|STARTED|Second Intervention||2
2416513|NCT01249131|5926750|P4|STARTED|Second Intervention||3
2416514|NCT01249131|5926751|P3|STARTED|Second Intervention||4
2416515|NCT01249131|5926752|P2|STARTED|Second Intervention||3
2416516|NCT01249131|5926753|P1|STARTED|Second Intervention||3
2416517|NCT01249131|5926748|P6|NOT COMPLETED|Washout Period of 10 Days||0
2416518|NCT01249131|5926749|P5|NOT COMPLETED|Washout Period of 10 Days||1
2416519|NCT01249131|5926750|P4|NOT COMPLETED|Washout Period of 10 Days||0
2416520|NCT01249131|5926751|P3|NOT COMPLETED|Washout Period of 10 Days||0
2416521|NCT01249131|5926752|P2|NOT COMPLETED|Washout Period of 10 Days||0
2416522|NCT01249131|5926753|P1|NOT COMPLETED|Washout Period of 10 Days||0
2416523|NCT01249131|5926748|P6|COMPLETED|Washout Period of 10 Days||4
2416524|NCT01249131|5926749|P5|COMPLETED|Washout Period of 10 Days||2
2416525|NCT01249131|5926750|P4|COMPLETED|Washout Period of 10 Days||3
2416526|NCT01249131|5926751|P3|COMPLETED|Washout Period of 10 Days||4
2416527|NCT01249131|5926752|P2|COMPLETED|Washout Period of 10 Days||3
2416528|NCT01249131|5926753|P1|COMPLETED|Washout Period of 10 Days||3
2416529|NCT01249131|5926748|P6|STARTED|Washout Period of 10 Days||4
2416530|NCT01249131|5926749|P5|STARTED|Washout Period of 10 Days||3
2416531|NCT01249131|5926750|P4|STARTED|Washout Period of 10 Days||3
2416532|NCT01249131|5926751|P3|STARTED|Washout Period of 10 Days||4
2416533|NCT01249131|5926752|P2|STARTED|Washout Period of 10 Days||3
2416534|NCT01249131|5926753|P1|STARTED|Washout Period of 10 Days||3
2416535|NCT01249131|5926748|P6|NOT COMPLETED|First Intervention||0
2416536|NCT01249131|5926749|P5|NOT COMPLETED|First Intervention||0
2416537|NCT01249131|5926750|P4|NOT COMPLETED|First Intervention||0
2416538|NCT01249131|5926751|P3|NOT COMPLETED|First Intervention||0
2416539|NCT01249131|5926752|P2|NOT COMPLETED|First Intervention||0
2416540|NCT01249131|5926753|P1|NOT COMPLETED|First Intervention||0
2416541|NCT01249131|5926748|P6|COMPLETED|First Intervention||4
2416542|NCT01249131|5926749|P5|COMPLETED|First Intervention||3
2416543|NCT01249131|5926750|P4|COMPLETED|First Intervention||3
2416544|NCT01249131|5926751|P3|COMPLETED|First Intervention||4
2416545|NCT01249131|5926752|P2|COMPLETED|First Intervention||3
2416546|NCT01249131|5926753|P1|COMPLETED|First Intervention||3
2416547|NCT01249131|5926748|P6|STARTED|First Intervention||4
2416548|NCT01249131|5926749|P5|STARTED|First Intervention||3
2416549|NCT01249131|5926750|P4|STARTED|First Intervention||3
2416550|NCT01249131|5926751|P3|STARTED|First Intervention||4
2416551|NCT01249131|5926752|P2|STARTED|First Intervention||3
2416552|NCT01249131|5926753|P1|STARTED|First Intervention||3
2416553|NCT01249118|5926773|P3|NOT COMPLETED|Second Washout Period||0
2416554|NCT01249118|5926774|P2|NOT COMPLETED|Second Washout Period||0
2416555|NCT01249118|5926775|P1|NOT COMPLETED|Second Washout Period||0
2416556|NCT01249118|5926773|P3|COMPLETED|Second Washout Period||5
2416557|NCT01249118|5926774|P2|COMPLETED|Second Washout Period||5
2416558|NCT01249118|5926775|P1|COMPLETED|Second Washout Period||2
2416559|NCT01249118|5926773|P3|STARTED|Second Washout Period||5
2416560|NCT01249118|5926774|P2|STARTED|Second Washout Period||5
2416561|NCT01249118|5926775|P1|STARTED|Second Washout Period||2
2416562|NCT01249118|5926773|P3|NOT COMPLETED|Second Intervention Period||0
2416563|NCT01249118|5926774|P2|NOT COMPLETED|Second Intervention Period||0
2416564|NCT01249118|5926775|P1|NOT COMPLETED|Second Intervention Period||0
2416565|NCT01249118|5926773|P3|COMPLETED|Second Intervention Period||5
2416566|NCT01249118|5926774|P2|COMPLETED|Second Intervention Period||5
2416567|NCT01249118|5926775|P1|COMPLETED|Second Intervention Period||2
2416568|NCT01249118|5926773|P3|STARTED|Second Intervention Period||5
2416569|NCT01249118|5926774|P2|STARTED|Second Intervention Period||5
2416570|NCT01249118|5926775|P1|STARTED|Second Intervention Period||2
2416571|NCT01249118|5926773|P3|NOT COMPLETED|First Washout Period||0
2416572|NCT01249118|5926774|P2|NOT COMPLETED|First Washout Period||1
2416573|NCT01249118|5926775|P1|NOT COMPLETED|First Washout Period||0
2416574|NCT01249118|5926773|P3|COMPLETED|First Washout Period||5
2416575|NCT01249118|5926774|P2|COMPLETED|First Washout Period||5
2416576|NCT01249118|5926775|P1|COMPLETED|First Washout Period||2
2416577|NCT01249118|5926773|P3|STARTED|First Washout Period||5
2416578|NCT01249118|5926774|P2|STARTED|First Washout Period||6
2416579|NCT01249118|5926775|P1|STARTED|First Washout Period||2
2416580|NCT01249118|5926773|P3|NOT COMPLETED|First Intervention Period||0
2416581|NCT01249118|5926774|P2|NOT COMPLETED|First Intervention Period||0
2416582|NCT01249118|5926775|P1|NOT COMPLETED|First Intervention Period||0
2416583|NCT01249118|5926773|P3|COMPLETED|First Intervention Period||5
2416584|NCT01249118|5926774|P2|COMPLETED|First Intervention Period||6
2416585|NCT01249118|5926775|P1|COMPLETED|First Intervention Period||2
2416586|NCT01249118|5926773|P3|STARTED|First Intervention Period||5
2416587|NCT01249118|5926774|P2|STARTED|First Intervention Period||6
2416588|NCT01249118|5926775|P1|STARTED|First Intervention Period||2
2416589|NCT01249092|5926809|P1|NOT COMPLETED|Overall Study||2
2416590|NCT01249092|5926809|P1|COMPLETED|Overall Study||18
2416591|NCT01249092|5926809|P1|STARTED|Overall Study||20
2416592|NCT01249027|5926815|P1|NOT COMPLETED|5 Years Clinical Follow up||68
2416593|NCT01249027|5926815|P1|COMPLETED|5 Years Clinical Follow up||2142
2416594|NCT01249027|5926815|P1|STARTED|5 Years Clinical Follow up||2210
2416595|NCT01249027|5926815|P1|NOT COMPLETED|4 Years Clinical Follow up||13
2416596|NCT01249027|5926815|P1|COMPLETED|4 Years Clinical Follow up||2210
2416597|NCT01249027|5926815|P1|STARTED|4 Years Clinical Follow up||2223
2416598|NCT01249027|5926815|P1|NOT COMPLETED|3 Years Clinical Follow up||31
2416599|NCT01249027|5926815|P1|COMPLETED|3 Years Clinical Follow up||2223
2416600|NCT01249027|5926815|P1|STARTED|3 Years Clinical Follow up||2254
2416601|NCT01249027|5926815|P1|NOT COMPLETED|2 Years Clinical Follow up||137
2416602|NCT01249027|5926815|P1|COMPLETED|2 Years Clinical Follow up||2254
2416603|NCT01249027|5926815|P1|STARTED|2 Years Clinical Follow up||2391
2416604|NCT01249027|5926815|P1|NOT COMPLETED|1 Year Clinical Follow up||91
2416605|NCT01249027|5926815|P1|COMPLETED|1 Year Clinical Follow up||2391
2416606|NCT01249027|5926815|P1|STARTED|1 Year Clinical Follow up||2482
2416607|NCT01248962|5926886|P2|NOT COMPLETED|Overall Study||16
2416608|NCT01248962|5926887|P1|NOT COMPLETED|Overall Study||16
2416609|NCT01248962|5926886|P2|COMPLETED|Overall Study||56
2416610|NCT01248962|5926887|P1|COMPLETED|Overall Study||58
2416611|NCT01248962|5926886|P2|STARTED|Overall Study||72
2416612|NCT01248962|5926887|P1|STARTED|Overall Study||74
2416613|NCT01248949|5926903|P5|NOT COMPLETED|Overall Study||4
2416614|NCT01248949|5926904|P4|NOT COMPLETED|Overall Study||10
2416615|NCT01248949|5926905|P3|NOT COMPLETED|Overall Study||37
2416616|NCT01248949|5926906|P2|NOT COMPLETED|Overall Study||13
2416617|NCT01248949|5926907|P1|NOT COMPLETED|Overall Study||33
2416618|NCT01248949|5926903|P5|COMPLETED|Overall Study||3
2416619|NCT01248949|5926904|P4|COMPLETED|Overall Study||3
2416620|NCT01248949|5926905|P3|COMPLETED|Overall Study||1
2416621|NCT01248949|5926906|P2|COMPLETED|Overall Study||3
2416622|NCT01248949|5926907|P1|COMPLETED|Overall Study||9
2416623|NCT01248949|5926903|P5|STARTED|Overall Study||7
2416624|NCT01248949|5926904|P4|STARTED|Overall Study||13
2416625|NCT01248949|5926905|P3|STARTED|Overall Study||38
2416626|NCT01248949|5926906|P2|STARTED|Overall Study||16
2416627|NCT01248949|5926907|P1|STARTED|Overall Study||42
2416628|NCT01248936|5927019|P1|NOT COMPLETED|Overall Study||374
2416629|NCT01248936|5927019|P1|COMPLETED|Overall Study||0
2416630|NCT01248936|5927019|P1|STARTED|Overall Study||374
2416631|NCT01248884|5927032|P3|NOT COMPLETED|Overall Study||1
2416632|NCT01248884|5927033|P2|NOT COMPLETED|Overall Study||3
2416633|NCT01248884|5927034|P1|NOT COMPLETED|Overall Study||2
2416634|NCT01248884|5927032|P3|COMPLETED|Overall Study||238
2416635|NCT01248884|5927033|P2|COMPLETED|Overall Study||239
2416636|NCT01248884|5927034|P1|COMPLETED|Overall Study||238
2416637|NCT01248884|5927032|P3|STARTED|Overall Study||239
2416638|NCT01248884|5927033|P2|STARTED|Overall Study||242
2416639|NCT01248884|5927034|P1|STARTED|Overall Study||240
2416640|NCT01248793|5927092|P2|NOT COMPLETED|Overall Study||6
2416641|NCT01248793|5927093|P1|NOT COMPLETED|Overall Study||4
2416642|NCT01248793|5927092|P2|COMPLETED|Overall Study||102
2416643|NCT01248793|5927093|P1|COMPLETED|Overall Study||101
2416644|NCT01248793|5927092|P2|STARTED|Overall Study||108
2416645|NCT01248793|5927093|P1|STARTED|Overall Study||105
2416646|NCT01248780|5927107|P2|NOT COMPLETED|Overall Study||15
2416647|NCT01248780|5927108|P1|NOT COMPLETED|Overall Study||9
2416648|NCT01248780|5927107|P2|COMPLETED|Overall Study||117
2416649|NCT01248780|5927108|P1|COMPLETED|Overall Study||123
2416650|NCT01248780|5927107|P2|STARTED|Overall Study||132
2416651|NCT01248780|5927108|P1|STARTED|Overall Study||132
2416652|NCT01248728|5927122|P2|NOT COMPLETED|Overall Study||2
2416653|NCT01248728|5927123|P1|NOT COMPLETED|Overall Study||4
2416654|NCT01248728|5927122|P2|COMPLETED|Overall Study||17
2416655|NCT01248728|5927123|P1|COMPLETED|Overall Study||15
2416656|NCT01248728|5927122|P2|STARTED|Overall Study||19
2416657|NCT01248728|5927123|P1|STARTED|Overall Study||19
2416658|NCT01248715|5927139|P2|NOT COMPLETED|Overall Study||510
2416659|NCT01248715|5927140|P1|NOT COMPLETED|Overall Study||501
2416660|NCT01248715|5927139|P2|COMPLETED|Overall Study||41
2416661|NCT01248715|5927140|P1|COMPLETED|Overall Study||55
2416662|NCT01248715|5927139|P2|STARTED|Overall Study||551
2416663|NCT01248715|5927140|P1|STARTED|Overall Study||556
2416664|NCT01248468|5927161|P3|NOT COMPLETED|Overall Study||4
2416665|NCT01248468|5927162|P2|NOT COMPLETED|Overall Study||14
2416666|NCT01248468|5927163|P1|NOT COMPLETED|Overall Study||15
2416667|NCT01248468|5927161|P3|COMPLETED|Overall Study||145
2416668|NCT01248468|5927162|P2|COMPLETED|Overall Study||290
2416669|NCT01248468|5927163|P1|COMPLETED|Overall Study||284
2416670|NCT01248468|5927161|P3|ITT Population|Overall Study||125
2416671|NCT01248468|5927162|P2|ITT Population|Overall Study||261
2416672|NCT01248468|5927163|P1|ITT Population|Overall Study||256
2416673|NCT01248468|5927161|P3|Safety Population|Overall Study||133
2416674|NCT01248468|5927162|P2|Safety Population|Overall Study||271
2416675|NCT01248468|5927163|P1|Safety Population|Overall Study||266
2416676|NCT01248468|5927161|P3|STARTED|Overall Study||149
2416677|NCT01248468|5927162|P2|STARTED|Overall Study||304
2416678|NCT01248468|5927163|P1|STARTED|Overall Study||299
2416679|NCT01248455|5927180|P1|NOT COMPLETED|Overall Study||1
2416680|NCT01248455|5927180|P1|COMPLETED|Overall Study||8
2416681|NCT01248455|5927180|P1|STARTED|Overall Study||9
2416682|NCT01248416|5927188|P3|NOT COMPLETED|Overall Study||1
2416683|NCT01248416|5927189|P2|NOT COMPLETED|Overall Study||0
2416684|NCT01248416|5927190|P1|NOT COMPLETED|Overall Study||4
2416685|NCT01248416|5927188|P3|COMPLETED|Overall Study||25
2416686|NCT01248416|5927189|P2|COMPLETED|Overall Study||25
2416687|NCT01248416|5927190|P1|COMPLETED|Overall Study||21
2416688|NCT01248416|5927188|P3|STARTED|Overall Study||26
2416689|NCT01248416|5927189|P2|STARTED|Overall Study||25
2416690|NCT01248416|5927190|P1|STARTED|Overall Study||25
2416691|NCT01248364|5927225|P4|NOT COMPLETED|Overall Study||0
2416692|NCT01248364|5927226|P3|NOT COMPLETED|Overall Study||0
2416693|NCT01248364|5927227|P2|NOT COMPLETED|Overall Study||1
2416694|NCT01248364|5927228|P1|NOT COMPLETED|Overall Study||0
2416695|NCT01248364|5927225|P4|COMPLETED|Overall Study||12
2416696|NCT01248364|5927226|P3|COMPLETED|Overall Study||13
2416697|NCT01248364|5927227|P2|COMPLETED|Overall Study||33
2416698|NCT01248364|5927228|P1|COMPLETED|Overall Study||32
2416699|NCT01248364|5927225|P4|Completed Chronic Phase:28-day Treatment|Overall Study||0
2416700|NCT01248364|5927226|P3|Completed Chronic Phase:28-day Treatment|Overall Study||13
2416701|NCT01248364|5927227|P2|Completed Chronic Phase:28-day Treatment|Overall Study||33
2416702|NCT01248364|5927228|P1|Completed Chronic Phase:28-day Treatment|Overall Study||32
2416703|NCT01248364|5927225|P4|Completed Acute Phase:Single Dose, Day 1|Overall Study||12
2416704|NCT01248364|5927226|P3|Completed Acute Phase:Single Dose, Day 1|Overall Study||13
2416705|NCT01248364|5927227|P2|Completed Acute Phase:Single Dose, Day 1|Overall Study||34
2416706|NCT01248364|5927228|P1|Completed Acute Phase:Single Dose, Day 1|Overall Study||32
2416707|NCT01248364|5927225|P4|STARTED|Overall Study||12
2416708|NCT01248364|5927226|P3|STARTED|Overall Study||13
2416709|NCT01248364|5927227|P2|STARTED|Overall Study||34
2416710|NCT01248364|5927228|P1|STARTED|Overall Study||32
2416711|NCT01248221|5927276|P2|NOT COMPLETED|Overall Study||0
2416712|NCT01248221|5927277|P1|NOT COMPLETED|Overall Study||0
2416713|NCT01248221|5927276|P2|COMPLETED|Overall Study||15
2416714|NCT01248221|5927277|P1|COMPLETED|Overall Study||15
2416715|NCT01248221|5927276|P2|STARTED|Overall Study||15
2416716|NCT01248221|5927277|P1|STARTED|Overall Study||15
2416717|NCT01248130|5927291|P2|NOT COMPLETED|Overall Study||0
2416718|NCT01248130|5927292|P1|NOT COMPLETED|Overall Study||2
2416719|NCT01248130|5927291|P2|COMPLETED|Overall Study||4
2416720|NCT01248130|5927292|P1|COMPLETED|Overall Study||1
2416721|NCT01248130|5927291|P2|STARTED|Overall Study||4
2416722|NCT01248130|5927292|P1|STARTED|Overall Study||3
2416723|NCT01248065|5927302|P2|NOT COMPLETED|Overall Study||22
2416724|NCT01248065|5927303|P1|NOT COMPLETED|Overall Study||26
2416725|NCT01248065|5927302|P2|COMPLETED|Overall Study|All 201 participants were included in the primary time-to-event analysis.|179
2416726|NCT01248065|5927303|P1|COMPLETED|Overall Study|All 207 participants were included in the primary time-to-event analysis.|181
2416727|NCT01248065|5927302|P2|STARTED|Overall Study||201
2416728|NCT01248065|5927303|P1|STARTED|Overall Study||207
2416729|NCT01248013|5927313|P1|NOT COMPLETED|Overall Study||14
2416730|NCT01248013|5927313|P1|COMPLETED|Overall Study||75
2416731|NCT01248013|5927313|P1|Irritable Bowel Syndrome Hypnotherapy|Overall Study||75
2416732|NCT01248013|5927313|P1|STARTED|Overall Study||89
2416733|NCT01247974|5927319|P2|NOT COMPLETED|Overall Study||19
2416734|NCT01247974|5927320|P1|NOT COMPLETED|Overall Study||26
2416735|NCT01247974|5927319|P2|COMPLETED|Overall Study||203
2416736|NCT01247974|5927320|P1|COMPLETED|Overall Study||191
2416737|NCT01247974|5927319|P2|STARTED|Overall Study||222
2416738|NCT01247974|5927320|P1|STARTED|Overall Study||217
2416739|NCT01247922|5927328|P1|NOT COMPLETED|Overall Study||4
2416740|NCT01247922|5927328|P1|COMPLETED|Overall Study||0
2416741|NCT01247922|5927328|P1|Treated|Overall Study||4
2416742|NCT01247922|5927328|P1|STARTED|Overall Study||4
2416743|NCT01247675|5927338|P4|NOT COMPLETED|Overall Study||0
2416744|NCT01247675|5927339|P3|NOT COMPLETED|Overall Study||0
2416745|NCT01247675|5927340|P2|NOT COMPLETED|Overall Study||2
2416746|NCT01247675|5927341|P1|NOT COMPLETED|Overall Study||2
2416747|NCT01247675|5927338|P4|COMPLETED|Overall Study||8
2416748|NCT01247675|5927339|P3|COMPLETED|Overall Study||9
2416749|NCT01247675|5927340|P2|COMPLETED|Overall Study||8
2416750|NCT01247675|5927341|P1|COMPLETED|Overall Study||8
2416751|NCT01247675|5927338|P4|STARTED|Overall Study||8
2416752|NCT01247675|5927339|P3|STARTED|Overall Study||9
2416753|NCT01247675|5927340|P2|STARTED|Overall Study||10
2416754|NCT01247675|5927341|P1|STARTED|Overall Study||10
2416755|NCT01247571|5927363|P1|NOT COMPLETED|Overall Study||3
2416756|NCT01247571|5927363|P1|COMPLETED|Overall Study||19
2416757|NCT01247571|5927363|P1|STARTED|Overall Study||22
2416758|NCT01247428|5927371|P1|NOT COMPLETED|Overall Study||0
2416759|NCT01247428|5927371|P1|COMPLETED|Overall Study||30
2416760|NCT01247428|5927371|P1|STARTED|Overall Study||30
2416761|NCT01247363|5927392|P1|NOT COMPLETED|Overall Study||0
2416762|NCT01247363|5927392|P1|COMPLETED|Overall Study||20
2416763|NCT01247363|5927392|P1|STARTED|Overall Study||20
2416764|NCT01247350|5927426|P5|NOT COMPLETED|Overall Study||1
2416765|NCT01247350|5927427|P4|NOT COMPLETED|Overall Study||1
2416766|NCT01247350|5927428|P3|NOT COMPLETED|Overall Study||1
2416767|NCT01247350|5927429|P2|NOT COMPLETED|Overall Study||0
2416768|NCT01247350|5927430|P1|NOT COMPLETED|Overall Study||0
2416769|NCT01247350|5927426|P5|COMPLETED|Overall Study||8
2416770|NCT01247350|5927427|P4|COMPLETED|Overall Study||6
2416771|NCT01247350|5927428|P3|COMPLETED|Overall Study||5
2416772|NCT01247350|5927429|P2|COMPLETED|Overall Study||6
2416773|NCT01247350|5927430|P1|COMPLETED|Overall Study||6
2416774|NCT01247350|5927426|P5|Received Multiple Doses of Study Drug|Overall Study||5
2416775|NCT01247350|5927427|P4|Received Multiple Doses of Study Drug|Overall Study||6
2416776|NCT01247350|5927428|P3|Received Multiple Doses of Study Drug|Overall Study||6
2416777|NCT01247350|5927429|P2|Received Multiple Doses of Study Drug|Overall Study||0
2416778|NCT01247350|5927430|P1|Received Multiple Doses of Study Drug|Overall Study||0
2416779|NCT01247350|5927426|P5|STARTED|Overall Study||9
2416780|NCT01247350|5927427|P4|STARTED|Overall Study||7
2416781|NCT01247350|5927428|P3|STARTED|Overall Study||6
2416782|NCT01247350|5927429|P2|STARTED|Overall Study||6
2416783|NCT01247350|5927430|P1|STARTED|Overall Study||6
2416784|NCT01247324|5927488|P2|NOT COMPLETED|Overall Study||44
2416785|NCT01247324|5927489|P1|NOT COMPLETED|Overall Study||71
2416786|NCT01247324|5927488|P2|COMPLETED|Overall Study||366
2416787|NCT01247324|5927489|P1|COMPLETED|Overall Study||340
2416788|NCT01247324|5927488|P2|STARTED|Overall Study||410
2416789|NCT01247324|5927489|P1|STARTED|Overall Study||411
2416790|NCT01247298|5927520|P1|NOT COMPLETED|Overall Study||0
2416791|NCT01247298|5927520|P1|COMPLETED|Overall Study||17
2416792|NCT01247298|5927520|P1|STARTED|Overall Study||17
2416793|NCT01247285|5927530|P2|NOT COMPLETED|Second Intervention||0
2416794|NCT01247285|5927531|P1|NOT COMPLETED|Second Intervention||0
2416795|NCT01247285|5927530|P2|COMPLETED|Second Intervention||13
2416796|NCT01247285|5927531|P1|COMPLETED|Second Intervention||13
2416797|NCT01247285|5927530|P2|STARTED|Second Intervention||13
2416798|NCT01247285|5927531|P1|STARTED|Second Intervention||13
2416799|NCT01247285|5927530|P2|NOT COMPLETED|Washout of 28 Days||0
2416800|NCT01247285|5927531|P1|NOT COMPLETED|Washout of 28 Days||0
2416801|NCT01247285|5927530|P2|COMPLETED|Washout of 28 Days||13
2416802|NCT01247285|5927531|P1|COMPLETED|Washout of 28 Days||13
2416803|NCT01247285|5927530|P2|STARTED|Washout of 28 Days||13
2416804|NCT01247285|5927531|P1|STARTED|Washout of 28 Days||13
2416805|NCT01247285|5927530|P2|NOT COMPLETED|First Intervention||0
2416806|NCT01247285|5927531|P1|NOT COMPLETED|First Intervention||0
2416807|NCT01247285|5927530|P2|COMPLETED|First Intervention||13
2416808|NCT01247285|5927531|P1|COMPLETED|First Intervention||13
2416809|NCT01247285|5927530|P2|STARTED|First Intervention||13
2416810|NCT01247285|5927531|P1|STARTED|First Intervention||13
2416811|NCT01247272|5927549|P2|NOT COMPLETED|Second Intervention||0
2416812|NCT01247272|5927550|P1|NOT COMPLETED|Second Intervention||0
2416813|NCT01247272|5927549|P2|COMPLETED|Second Intervention||13
2416814|NCT01247272|5927550|P1|COMPLETED|Second Intervention||13
2416815|NCT01247272|5927549|P2|STARTED|Second Intervention||13
2416816|NCT01247272|5927550|P1|STARTED|Second Intervention||13
2416817|NCT01247272|5927549|P2|NOT COMPLETED|Washout of 28 Days||0
2416818|NCT01247272|5927550|P1|NOT COMPLETED|Washout of 28 Days||0
2416819|NCT01247272|5927549|P2|COMPLETED|Washout of 28 Days||13
2416820|NCT01247272|5927550|P1|COMPLETED|Washout of 28 Days||13
2416821|NCT01247272|5927549|P2|STARTED|Washout of 28 Days||13
2416822|NCT01247272|5927550|P1|STARTED|Washout of 28 Days||13
2416823|NCT01247272|5927549|P2|NOT COMPLETED|First Intervention||0
2416824|NCT01247272|5927550|P1|NOT COMPLETED|First Intervention||0
2416825|NCT01247272|5927549|P2|COMPLETED|First Intervention||13
2416826|NCT01247272|5927550|P1|COMPLETED|First Intervention||13
2416827|NCT01247272|5927549|P2|STARTED|First Intervention||13
2416828|NCT01247272|5927550|P1|STARTED|First Intervention||13
2416829|NCT01247220|5927568|P2|NOT COMPLETED|Overall Study||0
2416830|NCT01247220|5927569|P1|NOT COMPLETED|Overall Study||0
2416831|NCT01247220|5927568|P2|COMPLETED|Overall Study||6
2416832|NCT01247220|5927569|P1|COMPLETED|Overall Study||6
2416833|NCT01247220|5927568|P2|STARTED|Overall Study||6
2416834|NCT01247220|5927569|P1|STARTED|Overall Study||6
2416835|NCT01247090|5927582|P3|NOT COMPLETED|Overall Study||0
2416836|NCT01247090|5927583|P2|NOT COMPLETED|Overall Study||1
2416837|NCT01247090|5927584|P1|NOT COMPLETED|Overall Study||1
2416838|NCT01247090|5927582|P3|COMPLETED|Overall Study||4
2416839|NCT01247090|5927583|P2|COMPLETED|Overall Study||3
2416840|NCT01247090|5927584|P1|COMPLETED|Overall Study||3
2416841|NCT01247090|5927582|P3|STARTED|Overall Study||4
2416842|NCT01247090|5927583|P2|STARTED|Overall Study||4
2416843|NCT01247090|5927584|P1|STARTED|Overall Study||4
2416844|NCT01247064|5927594|P2|NOT COMPLETED|Overall Study||0
2416845|NCT01247064|5927595|P1|NOT COMPLETED|Overall Study||0
2416846|NCT01247064|5927594|P2|COMPLETED|Overall Study||31
2416847|NCT01247064|5927595|P1|COMPLETED|Overall Study||31
2416848|NCT01247064|5927594|P2|STARTED|Overall Study||31
2416849|NCT01247064|5927595|P1|STARTED|Overall Study||31
2416850|NCT01246999|5927613|P4|NOT COMPLETED|Overall Study||2
2416851|NCT01246999|5927614|P3|NOT COMPLETED|Overall Study||0
2416852|NCT01246999|5927615|P2|NOT COMPLETED|Overall Study||1
2416853|NCT01246999|5927616|P1|NOT COMPLETED|Overall Study||0
2416854|NCT01246999|5927613|P4|COMPLETED|Overall Study||15
2416855|NCT01246999|5927614|P3|COMPLETED|Overall Study||2
2416856|NCT01246999|5927615|P2|COMPLETED|Overall Study||3
2416857|NCT01246999|5927616|P1|COMPLETED|Overall Study||11
2416858|NCT01246999|5927613|P4|STARTED|Overall Study||17
2416859|NCT01246999|5927614|P3|STARTED|Overall Study||2
2416860|NCT01246999|5927615|P2|STARTED|Overall Study||4
2416861|NCT01246999|5927616|P1|STARTED|Overall Study||11
2416862|NCT01246973|5927651|P2|NOT COMPLETED|Overall Study||47
2416863|NCT01246973|5927652|P1|NOT COMPLETED|Overall Study||61
2416864|NCT01246973|5927651|P2|COMPLETED|Overall Study||295
2416865|NCT01246973|5927652|P1|COMPLETED|Overall Study||283
2416866|NCT01246973|5927651|P2|STARTED|Overall Study||342
2416867|NCT01246973|5927652|P1|STARTED|Overall Study||344
2416868|NCT01246960|5927662|P2|NOT COMPLETED|Overall Study||4
2416869|NCT01246960|5927663|P1|NOT COMPLETED|Overall Study||6
2416870|NCT01246960|5927662|P2|COMPLETED|Overall Study||80
2416871|NCT01246960|5927663|P1|COMPLETED|Overall Study||78
2416872|NCT01246960|5927662|P2|Received Any Quantity of Study Drug|Overall Study||80
2416873|NCT01246960|5927663|P1|Received Any Quantity of Study Drug|Overall Study||82
2416874|NCT01246960|5927662|P2|STARTED|Overall Study||84
2416875|NCT01246960|5927663|P1|STARTED|Overall Study||84
2416876|NCT01246895|5927683|P2|NOT COMPLETED|Overall Study||4
2416877|NCT01246895|5927684|P1|NOT COMPLETED|Overall Study||3
2416878|NCT01246895|5927683|P2|COMPLETED|Overall Study||26
2416879|NCT01246895|5927684|P1|COMPLETED|Overall Study||34
2416880|NCT01246895|5927683|P2|STARTED|Overall Study||30
2416881|NCT01246895|5927684|P1|STARTED|Overall Study||37
2416882|NCT01246791|5927698|P1|NOT COMPLETED|Overall Study||0
2416883|NCT01246791|5927698|P1|COMPLETED|Overall Study||12
2416884|NCT01246791|5927698|P1|STARTED|Overall Study||12
2416885|NCT01246713|5927713|P2|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
2416886|NCT01246713|5927714|P1|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
2416887|NCT01246713|5927713|P2|COMPLETED|Second Acetaminophen Dosing (1 Day)||9
2416888|NCT01246713|5927714|P1|COMPLETED|Second Acetaminophen Dosing (1 Day)||6
2416889|NCT01246713|5927713|P2|STARTED|Second Acetaminophen Dosing (1 Day)||9
2416890|NCT01246713|5927714|P1|STARTED|Second Acetaminophen Dosing (1 Day)||6
2416891|NCT01246713|5927713|P2|NOT COMPLETED|Washout (at Least 14 Days)||0
2416892|NCT01246713|5927714|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
2416893|NCT01246713|5927713|P2|COMPLETED|Washout (at Least 14 Days)||9
2416894|NCT01246713|5927714|P1|COMPLETED|Washout (at Least 14 Days)||6
2416895|NCT01246713|5927713|P2|STARTED|Washout (at Least 14 Days)||9
2416896|NCT01246713|5927714|P1|STARTED|Washout (at Least 14 Days)||6
2416897|NCT01246713|5927713|P2|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
2416898|NCT01246713|5927714|P1|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
2416899|NCT01246713|5927713|P2|COMPLETED|First Acetaminophen Dosing (1 Day)||9
2416900|NCT01246713|5927714|P1|COMPLETED|First Acetaminophen Dosing (1 Day)||6
2416901|NCT01246713|5927713|P2|STARTED|First Acetaminophen Dosing (1 Day)||9
2416902|NCT01246713|5927714|P1|STARTED|First Acetaminophen Dosing (1 Day)||6
2416903|NCT01246479|5927720|P1|NOT COMPLETED|Overall Study||5
2416904|NCT01246479|5927720|P1|COMPLETED|Overall Study|primary endpoint at Month 12|18
2416905|NCT01246479|5927720|P1|STARTED|Overall Study||23
2416906|NCT01246401|5927726|P2|NOT COMPLETED|Overall Study||0
2416907|NCT01246401|5927727|P1|NOT COMPLETED|Overall Study||0
2416908|NCT01246401|5927726|P2|COMPLETED|Overall Study||27
2416909|NCT01246401|5927727|P1|COMPLETED|Overall Study||66
2416910|NCT01246401|5927726|P2|STARTED|Overall Study||27
2416911|NCT01246401|5927727|P1|STARTED|Overall Study||66
2416912|NCT01246349|5927753|P2|NOT COMPLETED|Overall Study||0
2416913|NCT01246349|5927754|P1|NOT COMPLETED|Overall Study||0
2416914|NCT01246349|5927753|P2|COMPLETED|Overall Study||20
2416915|NCT01246349|5927754|P1|COMPLETED|Overall Study||20
2416916|NCT01246349|5927753|P2|STARTED|Overall Study||20
2416917|NCT01246349|5927754|P1|STARTED|Overall Study||20
2416918|NCT01246258|5927766|P1|NOT COMPLETED|Overall Study||0
2416919|NCT01246258|5927766|P1|COMPLETED|Overall Study||5
2416920|NCT01246258|5927766|P1|STARTED|Overall Study||5
2416921|NCT01246206|5927771|P1|NOT COMPLETED|Overall Study||1
2416922|NCT01246206|5927771|P1|COMPLETED|Overall Study||20
2416923|NCT01246206|5927771|P1|STARTED|Overall Study||21
2416924|NCT01246076|5927782|P1|NOT COMPLETED|Overall Study||0
2416925|NCT01246076|5927782|P1|COMPLETED|Overall Study||24
2416926|NCT01246076|5927782|P1|STARTED|Overall Study||24
2416927|NCT01246063|5927797|P6|NOT COMPLETED|Overall Study||0
2416928|NCT01246063|5927798|P5|NOT COMPLETED|Overall Study||0
2416929|NCT01246063|5927799|P4|NOT COMPLETED|Overall Study||0
2416930|NCT01246063|5927800|P3|NOT COMPLETED|Overall Study||0
2416931|NCT01246063|5927801|P2|NOT COMPLETED|Overall Study||0
2416932|NCT01246063|5927802|P1|NOT COMPLETED|Overall Study||0
2416933|NCT01246063|5927797|P6|COMPLETED|Overall Study||17
2416934|NCT01246063|5927798|P5|COMPLETED|Overall Study||7
2416935|NCT01246063|5927799|P4|COMPLETED|Overall Study||5
2416936|NCT01246063|5927800|P3|COMPLETED|Overall Study||4
2416937|NCT01246063|5927801|P2|COMPLETED|Overall Study||4
2416938|NCT01246063|5927802|P1|COMPLETED|Overall Study||3
2416939|NCT01246063|5927797|P6|STARTED|Overall Study||17
2416940|NCT01246063|5927798|P5|STARTED|Overall Study||7
2416941|NCT01246063|5927799|P4|STARTED|Overall Study||5
2416942|NCT01246063|5927800|P3|STARTED|Overall Study||4
2416943|NCT01246063|5927801|P2|STARTED|Overall Study||4
2416944|NCT01246063|5927802|P1|STARTED|Overall Study||3
2416945|NCT01246050|5927839|P2|NOT COMPLETED|Overall Study||0
2416946|NCT01246050|5927840|P1|NOT COMPLETED|Overall Study||0
2416947|NCT01246050|5927839|P2|COMPLETED|Overall Study|Control providers were other providers in the same Primary Care Clinic, not enrolled in the study|6
2416948|NCT01246050|5927840|P1|COMPLETED|Overall Study||6
2416949|NCT01246050|5927839|P2|STARTED|Overall Study|Control providers were other providers in the same Primary Care Clinic, not enrolled in the study|6
2416950|NCT01246050|5927840|P1|STARTED|Overall Study||6
2416951|NCT01246011|5927849|P3|NOT COMPLETED|Overall Study||4
2416952|NCT01246011|5927850|P2|NOT COMPLETED|Overall Study||0
2416953|NCT01246011|5927851|P1|NOT COMPLETED|Overall Study||0
2416954|NCT01246011|5927849|P3|COMPLETED|Overall Study||5
2416955|NCT01246011|5927850|P2|COMPLETED|Overall Study||0
2416956|NCT01246011|5927851|P1|COMPLETED|Overall Study||0
2416957|NCT01246011|5927849|P3|STARTED|Overall Study||9
2416958|NCT01246011|5927850|P2|STARTED|Overall Study||0
2416959|NCT01246011|5927851|P1|STARTED|Overall Study||0
2416960|NCT01245972|5927865|P3|NOT COMPLETED|Overall Study||0
2416961|NCT01245972|5927866|P2|NOT COMPLETED|Overall Study||0
2416962|NCT01245972|5927867|P1|NOT COMPLETED|Overall Study||0
2416963|NCT01245972|5927865|P3|COMPLETED|Overall Study||8
2416964|NCT01245972|5927866|P2|COMPLETED|Overall Study||8
2416965|NCT01245972|5927867|P1|COMPLETED|Overall Study||7
2416966|NCT01245972|5927865|P3|STARTED|Overall Study||8
2416967|NCT01245972|5927866|P2|STARTED|Overall Study||8
2416968|NCT01245972|5927867|P1|STARTED|Overall Study||7
2416969|NCT01245764|5927879|P4|NOT COMPLETED|Study Phase B||0
2416970|NCT01245764|5927880|P3|NOT COMPLETED|Study Phase B||0
2416971|NCT01245764|5927881|P2|NOT COMPLETED|Study Phase B||0
2416972|NCT01245764|5927882|P1|NOT COMPLETED|Study Phase B||0
2416973|NCT01245764|5927879|P4|COMPLETED|Study Phase B||17
2416974|NCT01245764|5927880|P3|COMPLETED|Study Phase B||0
2416975|NCT01245764|5927881|P2|COMPLETED|Study Phase B||0
2416976|NCT01245764|5927882|P1|COMPLETED|Study Phase B||0
2416977|NCT01245764|5927879|P4|Completed Vaccinations in Study Phase B|Study Phase B||17
2416978|NCT01245764|5927880|P3|Completed Vaccinations in Study Phase B|Study Phase B||0
2416979|NCT01245764|5927881|P2|Completed Vaccinations in Study Phase B|Study Phase B||0
2416980|NCT01245764|5927882|P1|Completed Vaccinations in Study Phase B|Study Phase B||0
2416981|NCT01245764|5927879|P4|STARTED|Study Phase B||17
2416982|NCT01245764|5927880|P3|STARTED|Study Phase B||0
2416983|NCT01245764|5927881|P2|STARTED|Study Phase B||0
2416984|NCT01245764|5927882|P1|STARTED|Study Phase B||0
2416985|NCT01245764|5927879|P4|NOT COMPLETED|Study Phase A||3
2416986|NCT01245764|5927880|P3|NOT COMPLETED|Study Phase A||10
2416987|NCT01245764|5927881|P2|NOT COMPLETED|Study Phase A||5
2416988|NCT01245764|5927882|P1|NOT COMPLETED|Study Phase A||9
2416989|NCT01245764|5927879|P4|COMPLETED|Study Phase A||17
2416990|NCT01245764|5927880|P3|COMPLETED|Study Phase A||110
2416991|NCT01245764|5927881|P2|COMPLETED|Study Phase A||25
2416992|NCT01245764|5927882|P1|COMPLETED|Study Phase A||71
2416993|NCT01245764|5927879|P4|Completed Vaccinations in Study Phase A|Study Phase A||19
2416994|NCT01245764|5927880|P3|Completed Vaccinations in Study Phase A|Study Phase A||117
2416995|NCT01245764|5927881|P2|Completed Vaccinations in Study Phase A|Study Phase A||28
2416996|NCT01245764|5927882|P1|Completed Vaccinations in Study Phase A|Study Phase A||77
2416997|NCT01245764|5927879|P4|STARTED|Study Phase A||20
2416998|NCT01245764|5927880|P3|STARTED|Study Phase A||120
2416999|NCT01245764|5927881|P2|STARTED|Study Phase A||30
2417000|NCT01245764|5927882|P1|STARTED|Study Phase A||80
2417001|NCT01245751|5927920|P4|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
2417002|NCT01245751|5927921|P3|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
2417003|NCT01245751|5927922|P2|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
2417004|NCT01245751|5927923|P1|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
2417005|NCT01245751|5927920|P4|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
2417006|NCT01245751|5927921|P3|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
2417007|NCT01245751|5927922|P2|COMPLETED|Part 2: Week 156 (3 Year) Visit||139
2417008|NCT01245751|5927923|P1|COMPLETED|Part 2: Week 156 (3 Year) Visit||161
2417009|NCT01245751|5927920|P4|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
2417010|NCT01245751|5927921|P3|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
2417011|NCT01245751|5927922|P2|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|139
2417012|NCT01245751|5927923|P1|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|161
2417013|NCT01245751|5927920|P4|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
2417014|NCT01245751|5927921|P3|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||0
2417015|NCT01245751|5927922|P2|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||5
2417016|NCT01245751|5927923|P1|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
2417017|NCT01245751|5927920|P4|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||98
2417018|NCT01245751|5927921|P3|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||100
2417019|NCT01245751|5927922|P2|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||194
2417020|NCT01245751|5927923|P1|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||199
2417021|NCT01245751|5927920|P4|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
2417022|NCT01245751|5927921|P3|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
2417023|NCT01245751|5927922|P2|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||199
2417024|NCT01245751|5927923|P1|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||201
2417025|NCT01245751|5927920|P4|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
2417026|NCT01245751|5927921|P3|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
2417027|NCT01245751|5927922|P2|STARTED|Part 1: Day 1 to Week 52 (1 Year)||199
2417028|NCT01245751|5927923|P1|STARTED|Part 1: Day 1 to Week 52 (1 Year)||201
2417029|NCT01245738|5927936|P1|NOT COMPLETED|Overall Study||40
2417030|NCT01245738|5927936|P1|COMPLETED|Overall Study||474
2417031|NCT01245738|5927936|P1|STARTED|Overall Study||514
2417032|NCT01245699|5927955|P2|NOT COMPLETED|Overall Study||5
2417033|NCT01245699|5927956|P1|NOT COMPLETED|Overall Study||9
2417034|NCT01245699|5927955|P2|COMPLETED|Overall Study||49
2417035|NCT01245699|5927956|P1|COMPLETED|Overall Study||52
2417036|NCT01245699|5927955|P2|STARTED|Overall Study||54
2417037|NCT01245699|5927956|P1|STARTED|Overall Study||61
2417038|NCT01245647|5927974|P2|NOT COMPLETED|Overall Study||4
2417039|NCT01245647|5927975|P1|NOT COMPLETED|Overall Study||0
2417040|NCT01245647|5927974|P2|COMPLETED|Overall Study||8
2417041|NCT01245647|5927975|P1|COMPLETED|Overall Study||7
2417042|NCT01245647|5927974|P2|STARTED|Overall Study||12
2417043|NCT01245647|5927975|P1|STARTED|Overall Study||7
2417044|NCT01245595|5927991|P2|NOT COMPLETED|Overall Study||0
2417045|NCT01245595|5927992|P1|NOT COMPLETED|Overall Study||0
2417046|NCT01245595|5927991|P2|COMPLETED|Overall Study||72
2417047|NCT01245595|5927992|P1|COMPLETED|Overall Study||72
2417048|NCT01245595|5927991|P2|Completed Full Course of Study Drug|Overall Study||61
2417049|NCT01245595|5927992|P1|Completed Full Course of Study Drug|Overall Study||57
2417050|NCT01245595|5927991|P2|STARTED|Overall Study||72
2417051|NCT01245595|5927992|P1|STARTED|Overall Study||72
2417052|NCT01245439|5927998|P1|NOT COMPLETED|Overall Study||0
2417053|NCT01245439|5927998|P1|COMPLETED|Overall Study||65
2417054|NCT01245439|5927998|P1|STARTED|Overall Study||65
2417055|NCT01245413|5928029|P2|NOT COMPLETED|Athena First,||0
2417056|NCT01245413|5928030|P1|NOT COMPLETED|Athena First,||0
2417057|NCT01245413|5928029|P2|COMPLETED|Athena First,||16
2417058|NCT01245413|5928030|P1|COMPLETED|Athena First,||16
2417059|NCT01245413|5928029|P2|STARTED|Athena First,||16
2417060|NCT01245413|5928030|P1|STARTED|Athena First,||16
2417061|NCT01245413|5928029|P2|NOT COMPLETED|Sensura First,||0
2417062|NCT01245413|5928030|P1|NOT COMPLETED|Sensura First,||0
2417063|NCT01245413|5928029|P2|COMPLETED|Sensura First,||16
2417064|NCT01245413|5928030|P1|COMPLETED|Sensura First,||16
2417065|NCT01245413|5928029|P2|STARTED|Sensura First,||16
2417066|NCT01245413|5928030|P1|STARTED|Sensura First,||16
2417067|NCT01245387|5928036|P1|NOT COMPLETED|Overall Study||813
2417068|NCT01245387|5928036|P1|COMPLETED|Overall Study||188
2417069|NCT01245387|5928036|P1|STARTED|Overall Study||1001
2417070|NCT01245374|5928085|P1|NOT COMPLETED|Overall Study||4
2417071|NCT01245374|5928085|P1|COMPLETED|Overall Study||99
2417072|NCT01245374|5928085|P1|STARTED|Overall Study||103
2417073|NCT01245283|5928108|P3|NOT COMPLETED|Overall Study||11
2417074|NCT01245283|5928109|P2|NOT COMPLETED|Overall Study||11
2417075|NCT01245283|5928110|P1|NOT COMPLETED|Overall Study||14
2417076|NCT01245283|5928108|P3|COMPLETED|Overall Study||19
2417077|NCT01245283|5928109|P2|COMPLETED|Overall Study||17
2417078|NCT01245283|5928110|P1|COMPLETED|Overall Study||18
2417079|NCT01245283|5928108|P3|STARTED|Overall Study||30
2417080|NCT01245283|5928109|P2|STARTED|Overall Study||28
2417081|NCT01245283|5928110|P1|STARTED|Overall Study||32
2417082|NCT01245270|5928144|P2|NOT COMPLETED|Overall Study||0
2417083|NCT01245270|5928145|P1|NOT COMPLETED|Overall Study||0
2417084|NCT01245270|5928144|P2|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
2417085|NCT01245270|5928145|P1|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
2417086|NCT01245270|5928144|P2|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
2417087|NCT01245270|5928145|P1|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
2417088|NCT01245140|5928155|P2|NOT COMPLETED|Overall Study||10
2417089|NCT01245140|5928156|P1|NOT COMPLETED|Overall Study||3
2417090|NCT01245140|5928155|P2|COMPLETED|Overall Study||14
2417091|NCT01245140|5928156|P1|COMPLETED|Overall Study||6
2417092|NCT01245140|5928155|P2|STARTED|Overall Study||24
2417093|NCT01245140|5928156|P1|STARTED|Overall Study||9
2417094|NCT01245101|5928212|P2|NOT COMPLETED|Period 3 (Treatment)||0
2417095|NCT01245101|5928213|P1|NOT COMPLETED|Period 3 (Treatment)||1
2417096|NCT01245101|5928212|P2|COMPLETED|Period 3 (Treatment)||0
2417097|NCT01245101|5928213|P1|COMPLETED|Period 3 (Treatment)||11
2417098|NCT01245101|5928212|P2|STARTED|Period 3 (Treatment)||0
2417099|NCT01245101|5928213|P1|STARTED|Period 3 (Treatment)||12
2417100|NCT01245101|5928212|P2|NOT COMPLETED|Period 2 (Washout)||0
2417101|NCT01245101|5928213|P1|NOT COMPLETED|Period 2 (Washout)||1
2417102|NCT01245101|5928212|P2|COMPLETED|Period 2 (Washout)||0
2417103|NCT01245101|5928213|P1|COMPLETED|Period 2 (Washout)||12
2417104|NCT01245101|5928212|P2|STARTED|Period 2 (Washout)||0
2417105|NCT01245101|5928213|P1|STARTED|Period 2 (Washout)||13
2417106|NCT01245101|5928212|P2|NOT COMPLETED|Period 1 (Treatment)||0
2417107|NCT01245101|5928213|P1|NOT COMPLETED|Period 1 (Treatment)||2
2417108|NCT01245101|5928212|P2|COMPLETED|Period 1 (Treatment)||0
2417109|NCT01245101|5928213|P1|COMPLETED|Period 1 (Treatment)||13
2417110|NCT01245101|5928212|P2|STARTED|Period 1 (Treatment)||0
2417111|NCT01245101|5928213|P1|STARTED|Period 1 (Treatment)||15
2417112|NCT01245062|5928223|P3|NOT COMPLETED|Cross-over Phase||17
2417113|NCT01245062|5928224|P2|NOT COMPLETED|Cross-over Phase||0
2417114|NCT01245062|5928225|P1|NOT COMPLETED|Cross-over Phase||0
2417115|NCT01245062|5928223|P3|COMPLETED|Cross-over Phase||53
2417116|NCT01245062|5928224|P2|COMPLETED|Cross-over Phase||0
2417117|NCT01245062|5928225|P1|COMPLETED|Cross-over Phase||0
2417118|NCT01245062|5928223|P3|STARTED|Cross-over Phase|As of the data cut on December 16, 2016, 70 of 108 participants crossed over from CT to trametinib.|70
2417119|NCT01245062|5928224|P2|STARTED|Cross-over Phase||0
2417120|NCT01245062|5928225|P1|STARTED|Cross-over Phase||0
2417121|NCT01245062|5928223|P3|NOT COMPLETED|Randomization and Crossover Phase||0
2417122|NCT01245062|5928224|P2|NOT COMPLETED|Randomization and Crossover Phase||31
2417123|NCT01245062|5928225|P1|NOT COMPLETED|Randomization and Crossover Phase||41
2417124|NCT01245062|5928223|P3|COMPLETED|Randomization and Crossover Phase||0
2417125|NCT01245062|5928224|P2|COMPLETED|Randomization and Crossover Phase||77
2417126|NCT01245062|5928225|P1|COMPLETED|Randomization and Crossover Phase||173
2417127|NCT01245062|5928223|P3|STARTED|Randomization and Crossover Phase||0
2417128|NCT01245062|5928224|P2|STARTED|Randomization and Crossover Phase||108
2417129|NCT01245062|5928225|P1|STARTED|Randomization and Crossover Phase||214
2417130|NCT01245049|5928263|P2|NOT COMPLETED|Overall Study||4
2417131|NCT01245049|5928264|P1|NOT COMPLETED|Overall Study||1
2417132|NCT01245049|5928263|P2|COMPLETED|Overall Study||126
2417133|NCT01245049|5928264|P1|COMPLETED|Overall Study||254
2417134|NCT01245049|5928263|P2|STARTED|Overall Study||130
2417135|NCT01245049|5928264|P1|STARTED|Overall Study||255
2417136|NCT01244984|5928317|P3|NOT COMPLETED|Overall Study||4
2417137|NCT01244984|5928318|P2|NOT COMPLETED|Overall Study||14
2417138|NCT01244984|5928319|P1|NOT COMPLETED|Overall Study||5
2417139|NCT01244984|5928317|P3|COMPLETED|Overall Study||86
2417140|NCT01244984|5928318|P2|COMPLETED|Overall Study||79
2417141|NCT01244984|5928319|P1|COMPLETED|Overall Study||55
2417142|NCT01244984|5928317|P3|STARTED|Overall Study||90
2417143|NCT01244984|5928318|P2|STARTED|Overall Study||93
2417144|NCT01244984|5928319|P1|STARTED|Overall Study||60
2417145|NCT01244906|5928393|P1|NOT COMPLETED|Overall Study||8
2417146|NCT01244906|5928393|P1|COMPLETED|Overall Study||18
2417147|NCT01244906|5928393|P1|STARTED|Overall Study||26
2417148|NCT01244893|5928402|P2|NOT COMPLETED|Final Visit||0
2417149|NCT01244893|5928403|P1|NOT COMPLETED|Final Visit||0
2417150|NCT01244893|5928402|P2|COMPLETED|Final Visit||21
2417151|NCT01244893|5928403|P1|COMPLETED|Final Visit||21
2417152|NCT01244893|5928402|P2|STARTED|Final Visit||21
2417153|NCT01244893|5928403|P1|STARTED|Final Visit||21
2417154|NCT01244893|5928402|P2|NOT COMPLETED|1-Week Follow Up||0
2417155|NCT01244893|5928403|P1|NOT COMPLETED|1-Week Follow Up||1
2417156|NCT01244893|5928402|P2|COMPLETED|1-Week Follow Up||21
2417157|NCT01244893|5928403|P1|COMPLETED|1-Week Follow Up||21
2417158|NCT01244893|5928402|P2|STARTED|1-Week Follow Up||21
2417159|NCT01244893|5928403|P1|STARTED|1-Week Follow Up||22
2417160|NCT01244893|5928402|P2|NOT COMPLETED|Baseline||1
2417161|NCT01244893|5928403|P1|NOT COMPLETED|Baseline||0
2417162|NCT01244893|5928402|P2|COMPLETED|Baseline||21
2417163|NCT01244893|5928403|P1|COMPLETED|Baseline||22
2417164|NCT01244893|5928402|P2|STARTED|Baseline||22
2417165|NCT01244893|5928403|P1|STARTED|Baseline||22
2417166|NCT01244828|5928415|P1|NOT COMPLETED|Overall Study||78
2417167|NCT01244828|5928415|P1|COMPLETED|Overall Study||79
2417168|NCT01244828|5928415|P1|STARTED|Overall Study|Received study drug|157
2417169|NCT01244815|5928431|P4|NOT COMPLETED|Overall Study||12
2417170|NCT01244815|5928432|P3|NOT COMPLETED|Overall Study||11
2417171|NCT01244815|5928433|P2|NOT COMPLETED|Overall Study||17
2417172|NCT01244815|5928434|P1|NOT COMPLETED|Overall Study||14
2417173|NCT01244815|5928431|P4|COMPLETED|Overall Study||87
2417174|NCT01244815|5928432|P3|COMPLETED|Overall Study||88
2417175|NCT01244815|5928433|P2|COMPLETED|Overall Study||88
2417176|NCT01244815|5928434|P1|COMPLETED|Overall Study||87
2417177|NCT01244815|5928431|P4|Treated|Overall Study||99
2417178|NCT01244815|5928432|P3|Treated|Overall Study||99
2417179|NCT01244815|5928433|P2|Treated|Overall Study||104
2417180|NCT01244815|5928434|P1|Treated|Overall Study||101
2417181|NCT01244815|5928431|P4|STARTED|Overall Study|Randomized|99
2417182|NCT01244815|5928432|P3|STARTED|Overall Study|Randomized|99
2417183|NCT01244815|5928433|P2|STARTED|Overall Study|Randomized|105
2417184|NCT01244815|5928434|P1|STARTED|Overall Study|Randomized|101
2417185|NCT01244724|5928508|P1|NOT COMPLETED|Overall Study||8
2417186|NCT01244724|5928508|P1|COMPLETED|Overall Study||9
2417187|NCT01244724|5928508|P1|Week 2 Visit|Overall Study||15
2417188|NCT01244724|5928508|P1|STARTED|Overall Study|Of these 15 returned for a week 2 visit and are included in the efficacy analysis.|17
2417189|NCT01244711|5928513|P1|NOT COMPLETED|Overall Study||0
2417190|NCT01244711|5928513|P1|COMPLETED|Overall Study||1
2417191|NCT01244711|5928513|P1|STARTED|Overall Study||1
2417192|NCT01244633|5928517|P1|NOT COMPLETED|Overall Study||3
2417193|NCT01244633|5928517|P1|COMPLETED|Overall Study||15
2417194|NCT01244633|5928517|P1|STARTED|Overall Study||18
2417195|NCT01244620|5928521|P4|NOT COMPLETED|Overall Study||4
2417196|NCT01244620|5928522|P3|NOT COMPLETED|Overall Study||4
2417197|NCT01244620|5928523|P2|NOT COMPLETED|Overall Study||4
2417198|NCT01244620|5928524|P1|NOT COMPLETED|Overall Study||4
2417199|NCT01244620|5928521|P4|COMPLETED|Overall Study||0
2417200|NCT01244620|5928522|P3|COMPLETED|Overall Study||0
2417201|NCT01244620|5928523|P2|COMPLETED|Overall Study||0
2417202|NCT01244620|5928524|P1|COMPLETED|Overall Study||0
2417203|NCT01244620|5928521|P4|STARTED|Overall Study||4
2417204|NCT01244620|5928522|P3|STARTED|Overall Study||4
2417205|NCT01244620|5928523|P2|STARTED|Overall Study||4
2417206|NCT01244620|5928524|P1|STARTED|Overall Study||4
2417207|NCT01244529|5928558|P1|NOT COMPLETED|Overall Study||0
2417208|NCT01244529|5928558|P1|COMPLETED|Overall Study||41
2417209|NCT01244529|5928558|P1|STARTED|Overall Study||41
2417210|NCT01244516|5928583|P3|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||2
2417211|NCT01244516|5928584|P2|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||1
2417212|NCT01244516|5928585|P1|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||3
2417213|NCT01244516|5928583|P3|COMPLETED|Period 2 (1-week to 2-week Visit)||168
2417214|NCT01244516|5928584|P2|COMPLETED|Period 2 (1-week to 2-week Visit)||170
2417215|NCT01244516|5928585|P1|COMPLETED|Period 2 (1-week to 2-week Visit)||163
2417216|NCT01244516|5928583|P3|STARTED|Period 2 (1-week to 2-week Visit)||170
2417217|NCT01244516|5928584|P2|STARTED|Period 2 (1-week to 2-week Visit)||171
2417218|NCT01244516|5928585|P1|STARTED|Period 2 (1-week to 2-week Visit)||166
2417219|NCT01244516|5928583|P3|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||3
2417220|NCT01244516|5928584|P2|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||6
2417221|NCT01244516|5928585|P1|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||4
2417222|NCT01244516|5928583|P3|COMPLETED|Period 1 (Baseline to 1-week Visit)||170
2417223|NCT01244516|5928584|P2|COMPLETED|Period 1 (Baseline to 1-week Visit)||171
2417224|NCT01244516|5928585|P1|COMPLETED|Period 1 (Baseline to 1-week Visit)||166
2417225|NCT01244516|5928583|P3|STARTED|Period 1 (Baseline to 1-week Visit)||173
2417226|NCT01244516|5928584|P2|STARTED|Period 1 (Baseline to 1-week Visit)||177
2417227|NCT01244516|5928585|P1|STARTED|Period 1 (Baseline to 1-week Visit)||170
2417228|NCT01244503|5928598|P1|NOT COMPLETED|Overall Study||0
2417229|NCT01244503|5928598|P1|COMPLETED|Overall Study||61
2417230|NCT01244503|5928598|P1|STARTED|Overall Study||61
2417231|NCT01244490|5928606|P3|NOT COMPLETED|Overall Study||23
2417232|NCT01244490|5928607|P2|NOT COMPLETED|Overall Study||24
2417233|NCT01244490|5928608|P1|NOT COMPLETED|Overall Study||19
2417234|NCT01244490|5928606|P3|COMPLETED|Overall Study||89
2417235|NCT01244490|5928607|P2|COMPLETED|Overall Study||91
2417236|NCT01244490|5928608|P1|COMPLETED|Overall Study||92
2417237|NCT01244490|5928606|P3|STARTED|Overall Study||112
2417238|NCT01244490|5928607|P2|STARTED|Overall Study||115
2417239|NCT01244490|5928608|P1|STARTED|Overall Study||111
2417240|NCT01244477|5928663|P2|NOT COMPLETED|Overall Study||3
2417241|NCT01244477|5928664|P1|NOT COMPLETED|Overall Study||20
2417242|NCT01244477|5928663|P2|COMPLETED|Overall Study||20
2417243|NCT01244477|5928664|P1|COMPLETED|Overall Study||18
2417244|NCT01244477|5928663|P2|STARTED|Overall Study||23
2417245|NCT01244477|5928664|P1|STARTED|Overall Study||38
2417246|NCT01244451|5928676|P1|NOT COMPLETED|Overall Study||13
2417247|NCT01244451|5928676|P1|COMPLETED|Overall Study||36
2417248|NCT01244451|5928676|P1|STARTED|Overall Study||49
2417249|NCT01244425|5928685|P2|NOT COMPLETED|Overall Study||3
2417250|NCT01244425|5928686|P1|NOT COMPLETED|Overall Study||3
2417251|NCT01244425|5928685|P2|COMPLETED|Overall Study|Adverse Event: septic shock with multi-organ failure due to liver abscess (death)|32
2417252|NCT01244425|5928686|P1|COMPLETED|Overall Study|Adverse Event: multi-organ failure (death)|32
2417253|NCT01244425|5928685|P2|STARTED|Overall Study||35
2417254|NCT01244425|5928686|P1|STARTED|Overall Study||35
2417255|NCT01244412|5928706|P1|NOT COMPLETED|Overall Study||0
2417256|NCT01244412|5928706|P1|COMPLETED|Overall Study||1
2417257|NCT01244412|5928706|P1|STARTED|Overall Study||1
2417258|NCT01244243|5928710|P1|NOT COMPLETED|Overall Study||0
2417259|NCT01244243|5928710|P1|COMPLETED|Overall Study||41
2417260|NCT01244243|5928710|P1|STARTED|Overall Study||41
2417261|NCT01244126|5928718|P3|NOT COMPLETED|Overall Study||9
2417262|NCT01244126|5928719|P2|NOT COMPLETED|Overall Study||3
2417263|NCT01244126|5928720|P1|NOT COMPLETED|Overall Study||3
2417264|NCT01244126|5928718|P3|COMPLETED|Overall Study||48
2417265|NCT01244126|5928719|P2|COMPLETED|Overall Study||52
2417266|NCT01244126|5928720|P1|COMPLETED|Overall Study||56
2417267|NCT01244126|5928718|P3|STARTED|Overall Study||57
2417268|NCT01244126|5928719|P2|STARTED|Overall Study||55
2417269|NCT01244126|5928720|P1|STARTED|Overall Study||59
2417270|NCT01244061|5928733|P2|NOT COMPLETED|Overall Study||103
2417271|NCT01244061|5928734|P1|NOT COMPLETED|Overall Study||82
2417272|NCT01244061|5928733|P2|COMPLETED|Overall Study||144
2417273|NCT01244061|5928734|P1|COMPLETED|Overall Study||169
2417274|NCT01244061|5928733|P2|STARTED|Overall Study||247
2417275|NCT01244061|5928734|P1|STARTED|Overall Study||251
2417276|NCT01244035|5928746|P6|NOT COMPLETED|Part 1: Period 3||1
2417277|NCT01244035|5928747|P5|NOT COMPLETED|Part 1: Period 3||1
2417278|NCT01244035|5928748|P4|NOT COMPLETED|Part 1: Period 3||0
2417279|NCT01244035|5928749|P3|NOT COMPLETED|Part 1: Period 3||0
2417280|NCT01244035|5928750|P2|NOT COMPLETED|Part 1: Period 3||1
2417281|NCT01244035|5928751|P1|NOT COMPLETED|Part 1: Period 3||0
2417282|NCT01244035|5928746|P6|COMPLETED|Part 1: Period 3||2
2417283|NCT01244035|5928747|P5|COMPLETED|Part 1: Period 3||3
2417284|NCT01244035|5928748|P4|COMPLETED|Part 1: Period 3||5
2417285|NCT01244035|5928749|P3|COMPLETED|Part 1: Period 3||3
2417286|NCT01244035|5928750|P2|COMPLETED|Part 1: Period 3||2
2417287|NCT01244035|5928751|P1|COMPLETED|Part 1: Period 3||4
2417288|NCT01244035|5928746|P6|STARTED|Part 1: Period 3||3
2417289|NCT01244035|5928747|P5|STARTED|Part 1: Period 3||4
2417290|NCT01244035|5928748|P4|STARTED|Part 1: Period 3||5
2417291|NCT01244035|5928749|P3|STARTED|Part 1: Period 3||3
2417292|NCT01244035|5928750|P2|STARTED|Part 1: Period 3||3
2417293|NCT01244035|5928751|P1|STARTED|Part 1: Period 3||4
2417294|NCT01244035|5928746|P6|NOT COMPLETED|Part 1: Period 2||0
2417295|NCT01244035|5928747|P5|NOT COMPLETED|Part 1: Period 2||0
2417296|NCT01244035|5928748|P4|NOT COMPLETED|Part 1: Period 2||0
2417297|NCT01244035|5928749|P3|NOT COMPLETED|Part 1: Period 2||1
2417298|NCT01244035|5928750|P2|NOT COMPLETED|Part 1: Period 2||0
2417299|NCT01244035|5928751|P1|NOT COMPLETED|Part 1: Period 2||0
2417300|NCT01244035|5928746|P6|COMPLETED|Part 1: Period 2||3
2417301|NCT01244035|5928747|P5|COMPLETED|Part 1: Period 2||4
2417302|NCT01244035|5928748|P4|COMPLETED|Part 1: Period 2||5
2417303|NCT01244035|5928749|P3|COMPLETED|Part 1: Period 2||3
2417304|NCT01244035|5928750|P2|COMPLETED|Part 1: Period 2||3
2417305|NCT01244035|5928751|P1|COMPLETED|Part 1: Period 2||4
2417306|NCT01244035|5928746|P6|STARTED|Part 1: Period 2||3
2417307|NCT01244035|5928747|P5|STARTED|Part 1: Period 2||4
2417308|NCT01244035|5928748|P4|STARTED|Part 1: Period 2||5
2417309|NCT01244035|5928749|P3|STARTED|Part 1: Period 2||4
2417310|NCT01244035|5928750|P2|STARTED|Part 1: Period 2||3
2417311|NCT01244035|5928751|P1|STARTED|Part 1: Period 2||4
2417312|NCT01244035|5928746|P6|NOT COMPLETED|Part 1: Period 1||2
2417313|NCT01244035|5928747|P5|NOT COMPLETED|Part 1: Period 1||1
2417314|NCT01244035|5928748|P4|NOT COMPLETED|Part 1: Period 1||0
2417315|NCT01244035|5928749|P3|NOT COMPLETED|Part 1: Period 1||2
2417316|NCT01244035|5928750|P2|NOT COMPLETED|Part 1: Period 1||2
2417317|NCT01244035|5928751|P1|NOT COMPLETED|Part 1: Period 1||1
2417318|NCT01244035|5928746|P6|COMPLETED|Part 1: Period 1||3
2417319|NCT01244035|5928747|P5|COMPLETED|Part 1: Period 1||4
2417320|NCT01244035|5928748|P4|COMPLETED|Part 1: Period 1||5
2417321|NCT01244035|5928749|P3|COMPLETED|Part 1: Period 1||4
2417322|NCT01244035|5928750|P2|COMPLETED|Part 1: Period 1||3
2417323|NCT01244035|5928751|P1|COMPLETED|Part 1: Period 1||4
2417324|NCT01244035|5928746|P6|STARTED|Part 1: Period 1||5
2417325|NCT01244035|5928747|P5|STARTED|Part 1: Period 1||5
2417326|NCT01244035|5928748|P4|STARTED|Part 1: Period 1||5
2417327|NCT01244035|5928749|P3|STARTED|Part 1: Period 1||6
2417328|NCT01244035|5928750|P2|STARTED|Part 1: Period 1||5
2417329|NCT01244035|5928751|P1|STARTED|Part 1: Period 1||5
2417330|NCT01243957|5928779|P1|NOT COMPLETED|Overall Study||0
2417331|NCT01243957|5928779|P1|COMPLETED|Overall Study||20
2417332|NCT01243957|5928779|P1|STARTED|Overall Study||20
2417333|NCT01243944|5928792|P2|NOT COMPLETED|Overall Study||51
2417334|NCT01243944|5928793|P1|NOT COMPLETED|Overall Study||45
2417335|NCT01243944|5928792|P2|COMPLETED|Overall Study|Study evaluation completion is reported for participants that were treated & those never treatment.|61
2417336|NCT01243944|5928793|P1|COMPLETED|Overall Study||65
2417337|NCT01243944|5928792|P2|Followed for Survival|Overall Study||21
2417338|NCT01243944|5928793|P1|Followed for Survival|Overall Study||22
2417339|NCT01243944|5928792|P2|Treated|Overall Study||111
2417340|NCT01243944|5928793|P1|Treated|Overall Study||110
2417341|NCT01243944|5928792|P2|STARTED|Overall Study|One participant withdrew consent 5 days after randomization to BAT & wasn't treated while on study.|112
2417342|NCT01243944|5928793|P1|STARTED|Overall Study||110
2417343|NCT01243892|5928821|P2|NOT COMPLETED|Overall Study||0
2417344|NCT01243892|5928822|P1|NOT COMPLETED|Overall Study||2
2417345|NCT01243892|5928821|P2|COMPLETED|Overall Study||3
2417346|NCT01243892|5928822|P1|COMPLETED|Overall Study||13
2417347|NCT01243892|5928821|P2|STARTED|Overall Study||3
2417348|NCT01243892|5928822|P1|STARTED|Overall Study||15
2417349|NCT01243775|5928832|P1|NOT COMPLETED|Overall Study||2
2417350|NCT01243775|5928832|P1|COMPLETED|Overall Study||31
2417351|NCT01243775|5928832|P1|STARTED|Overall Study||33
2417352|NCT01243762|5928846|P7|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||6
2417353|NCT01243762|5928847|P6|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
2417354|NCT01243762|5928848|P5|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||4
2417610|NCT01241604|5929577|P2|NOT COMPLETED|Study Period||0
2417355|NCT01243762|5928849|P4|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||2
2417356|NCT01243762|5928850|P3|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
2417357|NCT01243762|5928851|P2|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||5
2417358|NCT01243762|5928852|P1|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||1
2417359|NCT01243762|5928846|P7|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
2417360|NCT01243762|5928847|P6|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
2417361|NCT01243762|5928848|P5|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
2417362|NCT01243762|5928849|P4|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
2417363|NCT01243762|5928850|P3|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
2417364|NCT01243762|5928851|P2|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
2417365|NCT01243762|5928852|P1|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
2417366|NCT01243762|5928846|P7|STARTED|Part 2 (Dose Confirmation/Efficacy)|New participants were enrolled in Part 2 of the study that did not participate in Part 1|6
2417367|NCT01243762|5928847|P6|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
2417368|NCT01243762|5928848|P5|STARTED|Part 2 (Dose Confirmation/Efficacy)||4
2417369|NCT01243762|5928849|P4|STARTED|Part 2 (Dose Confirmation/Efficacy)||2
2417370|NCT01243762|5928850|P3|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
2417371|NCT01243762|5928851|P2|STARTED|Part 2 (Dose Confirmation/Efficacy)||5
2417372|NCT01243762|5928852|P1|STARTED|Part 2 (Dose Confirmation/Efficacy)||1
2417373|NCT01243762|5928846|P7|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||0
2417374|NCT01243762|5928847|P6|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
2417375|NCT01243762|5928848|P5|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
2417376|NCT01243762|5928849|P4|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
2417377|NCT01243762|5928850|P3|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
2417378|NCT01243762|5928851|P2|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||8
2417379|NCT01243762|5928852|P1|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
2417380|NCT01243762|5928846|P7|COMPLETED|Part 1 (Dose Escalation/MTD)||0
2417381|NCT01243762|5928847|P6|COMPLETED|Part 1 (Dose Escalation/MTD)||0
2417382|NCT01243762|5928848|P5|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|4
2417383|NCT01243762|5928849|P4|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|2
2417384|NCT01243762|5928850|P3|COMPLETED|Part 1 (Dose Escalation/MTD)||0
2417385|NCT01243762|5928851|P2|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|5
2417386|NCT01243762|5928852|P1|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|1
2417387|NCT01243762|5928846|P7|STARTED|Part 1 (Dose Escalation/MTD)||0
2417388|NCT01243762|5928847|P6|STARTED|Part 1 (Dose Escalation/MTD)||3
2417389|NCT01243762|5928848|P5|STARTED|Part 1 (Dose Escalation/MTD)||10
2417390|NCT01243762|5928849|P4|STARTED|Part 1 (Dose Escalation/MTD)||8
2417391|NCT01243762|5928850|P3|STARTED|Part 1 (Dose Escalation/MTD)||3
2417392|NCT01243762|5928851|P2|STARTED|Part 1 (Dose Escalation/MTD)||13
2417393|NCT01243762|5928852|P1|STARTED|Part 1 (Dose Escalation/MTD)||4
2417394|NCT01243671|5928871|P1|NOT COMPLETED|Overall Study||5
2417395|NCT01243671|5928871|P1|COMPLETED|Overall Study|Completed 136 weeks of treatment.|15
2417396|NCT01243671|5928871|P1|Completed 52 Weeks of Treatment|Overall Study||17
2417397|NCT01243671|5928871|P1|Completed 24 Weeks of Treatment|Overall Study||18
2417398|NCT01243671|5928871|P1|STARTED|Overall Study||20
2417399|NCT01243619|5928884|P1|NOT COMPLETED|Overall Study||0
2417400|NCT01243619|5928884|P1|COMPLETED|Overall Study|Patient enrollment is complete, data analysis is ongoing|5
2417401|NCT01243619|5928884|P1|STARTED|Overall Study||5
2417402|NCT01243580|5928890|P2|NOT COMPLETED|Overall Study||2
2417403|NCT01243580|5928891|P1|NOT COMPLETED|Overall Study||0
2417404|NCT01243580|5928890|P2|COMPLETED|Overall Study||16
2417405|NCT01243580|5928891|P1|COMPLETED|Overall Study||18
2417406|NCT01243580|5928890|P2|STARTED|Overall Study||18
2417407|NCT01243580|5928891|P1|STARTED|Overall Study||18
2417408|NCT01243567|5928920|P2|NOT COMPLETED|Overall Study||0
2417409|NCT01243567|5928921|P1|NOT COMPLETED|Overall Study||1
2417410|NCT01243567|5928920|P2|COMPLETED|Overall Study||38
2417411|NCT01243567|5928921|P1|COMPLETED|Overall Study||42
2417412|NCT01243567|5928920|P2|STARTED|Overall Study||38
2417413|NCT01243567|5928921|P1|STARTED|Overall Study||43
2417414|NCT01243450|5928938|P3|NOT COMPLETED|Overall Study||67
2417415|NCT01243450|5928939|P2|NOT COMPLETED|Overall Study||25
2417416|NCT01243450|5928940|P1|NOT COMPLETED|Overall Study||83
2417417|NCT01243450|5928938|P3|COMPLETED|Overall Study||337
2417418|NCT01243450|5928939|P2|COMPLETED|Overall Study||110
2417419|NCT01243450|5928940|P1|COMPLETED|Overall Study||318
2417420|NCT01243450|5928938|P3|STARTED|Overall Study||404
2417421|NCT01243450|5928939|P2|STARTED|Overall Study||135
2417422|NCT01243450|5928940|P1|STARTED|Overall Study||401
2417423|NCT01243424|5928950|P2|NOT COMPLETED|Discontinuation From Treatment||1182
2417424|NCT01243424|5928951|P1|NOT COMPLETED|Discontinuation From Treatment||1132
2417425|NCT01243424|5928950|P2|COMPLETED|Discontinuation From Treatment||1832
2417426|NCT01243424|5928951|P1|COMPLETED|Discontinuation From Treatment||1896
2417427|NCT01243424|5928950|P2|Treated|Discontinuation From Treatment||3010
2417428|NCT01243424|5928951|P1|Treated|Discontinuation From Treatment||3023
2417429|NCT01243424|5928950|P2|STARTED|Discontinuation From Treatment||3014
2417430|NCT01243424|5928951|P1|STARTED|Discontinuation From Treatment||3028
2417431|NCT01243424|5928950|P2|NOT COMPLETED|Discontinuation From Study (Treated Set)||119
2417432|NCT01243424|5928951|P1|NOT COMPLETED|Discontinuation From Study (Treated Set)||129
2417433|NCT01243424|5928950|P2|COMPLETED|Discontinuation From Study (Treated Set)||2895
2417434|NCT01243424|5928951|P1|COMPLETED|Discontinuation From Study (Treated Set)||2899
2417435|NCT01243424|5928950|P2|Treated|Discontinuation From Study (Treated Set)||3010
2417436|NCT01243424|5928951|P1|Treated|Discontinuation From Study (Treated Set)||3023
2417437|NCT01243424|5928950|P2|Patient Died (Other Cause Than CV Death)|Discontinuation From Study (Treated Set)||146
2417438|NCT01243424|5928951|P1|Patient Died (Other Cause Than CV Death)|Discontinuation From Study (Treated Set)||123
2417439|NCT01243424|5928950|P2|STARTED|Discontinuation From Study (Treated Set)||3014
2417440|NCT01243424|5928951|P1|STARTED|Discontinuation From Study (Treated Set)||3028
2417441|NCT01243411|5928993|P1|NOT COMPLETED|Overall Study||41
2417442|NCT01243411|5928993|P1|COMPLETED|Overall Study||306
2417443|NCT01243411|5928993|P1|STARTED|Overall Study||347
2417447|NCT01243320|5929011|P1|NOT COMPLETED|32ppm Oral Silver (14 Days)||0
2417448|NCT01243320|5929011|P1|COMPLETED|32ppm Oral Silver (14 Days)||24
2417449|NCT01243320|5929011|P1|STARTED|32ppm Oral Silver (14 Days)||24
2417450|NCT01243320|5929011|P1|NOT COMPLETED|Washout (3 Days)||0
2417451|NCT01243320|5929011|P1|COMPLETED|Washout (3 Days)||36
2417452|NCT01243320|5929011|P1|STARTED|Washout (3 Days)||36
2417453|NCT01243320|5929011|P1|NOT COMPLETED|10ppm Oral Silver (14 Days)||0
2417454|NCT01243320|5929011|P1|COMPLETED|10ppm Oral Silver (14 Days)||36
2417455|NCT01243320|5929011|P1|STARTED|10ppm Oral Silver (14 Days)||36
2417456|NCT01243320|5929011|P1|NOT COMPLETED|10ppm Oral Silver (7 Days)||0
2417457|NCT01243320|5929011|P1|COMPLETED|10ppm Oral Silver (7 Days)||36
2417458|NCT01243320|5929011|P1|STARTED|10ppm Oral Silver (7 Days)||36
2417459|NCT01243320|5929011|P1|NOT COMPLETED|10ppm Oral Silver (3 Days)||0
2417460|NCT01243320|5929011|P1|COMPLETED|10ppm Oral Silver (3 Days)||36
2417461|NCT01243320|5929011|P1|STARTED|10ppm Oral Silver (3 Days)||36
2417462|NCT01243294|5929087|P2|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
2417463|NCT01243294|5929088|P1|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
2417464|NCT01243294|5929087|P2|COMPLETED|Second Intervention (10 Days +/- 2 Days)||26
2417465|NCT01243294|5929088|P1|COMPLETED|Second Intervention (10 Days +/- 2 Days)||28
2417466|NCT01243294|5929087|P2|STARTED|Second Intervention (10 Days +/- 2 Days)||26
2417467|NCT01243294|5929088|P1|STARTED|Second Intervention (10 Days +/- 2 Days)||28
2417468|NCT01243294|5929087|P2|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
2417469|NCT01243294|5929088|P1|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
2417470|NCT01243294|5929087|P2|COMPLETED|First Intervention (10 Days +/- 2 Days)||26
2417471|NCT01243294|5929088|P1|COMPLETED|First Intervention (10 Days +/- 2 Days)||28
2417472|NCT01243294|5929087|P2|STARTED|First Intervention (10 Days +/- 2 Days)||26
2417473|NCT01243294|5929088|P1|STARTED|First Intervention (10 Days +/- 2 Days)||28
2417474|NCT01243268|5929104|P1|NOT COMPLETED|Overall Study||64
2417475|NCT01243268|5929104|P1|COMPLETED|Overall Study||610
2417476|NCT01243268|5929104|P1|STARTED|Overall Study||674
2417477|NCT01243242|5929114|P2|NOT COMPLETED|Overall Study||4
2417478|NCT01243242|5929115|P1|NOT COMPLETED|Overall Study||3
2417479|NCT01243242|5929114|P2|COMPLETED|Overall Study||56
2417480|NCT01243242|5929115|P1|COMPLETED|Overall Study||57
2417481|NCT01243242|5929114|P2|STARTED|Overall Study||60
2417482|NCT01243242|5929115|P1|STARTED|Overall Study||60
2417483|NCT01243177|5929129|P2|NOT COMPLETED|Overall Study||178
2417484|NCT01243177|5929130|P1|NOT COMPLETED|Overall Study||178
2417485|NCT01243177|5929129|P2|COMPLETED|Overall Study||264
2417486|NCT01243177|5929130|P1|COMPLETED|Overall Study||266
2417487|NCT01243177|5929129|P2|STARTED|Overall Study||442
2417488|NCT01243177|5929130|P1|STARTED|Overall Study||444
2417489|NCT01243151|5929151|P5|NOT COMPLETED|Overall Study||0
2417490|NCT01243151|5929152|P4|NOT COMPLETED|Overall Study||2
2417491|NCT01243151|5929153|P3|NOT COMPLETED|Overall Study||1
2417492|NCT01243151|5929154|P2|NOT COMPLETED|Overall Study||1
2417493|NCT01243151|5929155|P1|NOT COMPLETED|Overall Study||0
2417494|NCT01243151|5929151|P5|COMPLETED|Overall Study||14
2417495|NCT01243151|5929152|P4|COMPLETED|Overall Study||12
2417496|NCT01243151|5929153|P3|COMPLETED|Overall Study||13
2417497|NCT01243151|5929154|P2|COMPLETED|Overall Study||13
2417498|NCT01243151|5929155|P1|COMPLETED|Overall Study||12
2417499|NCT01243151|5929151|P5|Treated|Overall Study||14
2417500|NCT01243151|5929152|P4|Treated|Overall Study||13
2417501|NCT01243151|5929153|P3|Treated|Overall Study||14
2417502|NCT01243151|5929154|P2|Treated|Overall Study||14
2417503|NCT01243151|5929155|P1|Treated|Overall Study||12
2417504|NCT01243151|5929151|P5|STARTED|Overall Study||14
2417505|NCT01243151|5929152|P4|STARTED|Overall Study||14
2417506|NCT01243151|5929153|P3|STARTED|Overall Study||14
2417507|NCT01243151|5929154|P2|STARTED|Overall Study||14
2417508|NCT01243151|5929155|P1|STARTED|Overall Study||12
2417509|NCT01243112|5929394|P1|NOT COMPLETED|Overall Study||0
2417510|NCT01243112|5929394|P1|COMPLETED|Overall Study||25
2417511|NCT01243112|5929394|P1|STARTED|Overall Study||25
2417512|NCT01242813|5929399|P1|NOT COMPLETED|Overall Study||2
2417513|NCT01242813|5929399|P1|COMPLETED|Overall Study||18
2417514|NCT01242813|5929399|P1|STARTED|Overall Study||20
2417515|NCT01242748|5929421|P2|NOT COMPLETED|Overall Study||14
2417516|NCT01242748|5929422|P1|NOT COMPLETED|Overall Study||38
2417517|NCT01242748|5929421|P2|COMPLETED|Overall Study||80
2417518|NCT01242748|5929422|P1|COMPLETED|Overall Study|These participants were ongoing when the trial was closed by the Sponsor.|156
2417519|NCT01242748|5929421|P2|CS35/CS35A Full Analysis Set (FAS)|Overall Study||282
2417520|NCT01242748|5929422|P1|CS35/CS35A Full Analysis Set (FAS)|Overall Study|Received at least 1 dose of trial drug during CS35+had at least 1 efficacy assessment after dosing.|565
2417521|NCT01242748|5929421|P2|CS35/CS35A Safety Analysis Set|Overall Study||283
2417522|NCT01242748|5929422|P1|CS35/CS35A Safety Analysis Set|Overall Study|Received at least 1 dose of trial drug during the main CS35 trial.|565
2417523|NCT01242748|5929421|P2|STARTED|Overall Study||94
2417524|NCT01242748|5929422|P1|STARTED|Overall Study|Enrolled in CS35A, CS35A Full Analysis Set.|194
2417525|NCT01242527|5929446|P4|NOT COMPLETED|Overall Study||9
2417526|NCT01242527|5929447|P3|NOT COMPLETED|Overall Study||14
2417527|NCT01242527|5929448|P2|NOT COMPLETED|Overall Study||7
2417528|NCT01242527|5929449|P1|NOT COMPLETED|Overall Study||5
2417529|NCT01242527|5929446|P4|COMPLETED|Overall Study||90
2417530|NCT01242527|5929447|P3|COMPLETED|Overall Study||87
2417531|NCT01242527|5929448|P2|COMPLETED|Overall Study||93
2417532|NCT01242527|5929449|P1|COMPLETED|Overall Study||94
2417533|NCT01242527|5929446|P4|STARTED|Overall Study||99
2417534|NCT01242527|5929447|P3|STARTED|Overall Study||101
2417535|NCT01242527|5929448|P2|STARTED|Overall Study||100
2417536|NCT01242527|5929449|P1|STARTED|Overall Study||99
2417537|NCT01242514|5929462|P3|NOT COMPLETED|Overall Study||212
2417538|NCT01242514|5929463|P2|NOT COMPLETED|Overall Study||357
2417539|NCT01242514|5929464|P1|NOT COMPLETED|Overall Study||1343
2417540|NCT01242514|5929462|P3|COMPLETED|Overall Study|Due to project closure.|0
2417541|NCT01242514|5929463|P2|COMPLETED|Overall Study|Due to project closure.|0
2417542|NCT01242514|5929464|P1|COMPLETED|Overall Study|Due to project closure.|0
2417543|NCT01242514|5929462|P3|Enrolled But Did Not Receive Treatment|Overall Study|Adverse event/other|2
2417544|NCT01242514|5929463|P2|Enrolled But Did Not Receive Treatment|Overall Study||0
2417545|NCT01242514|5929464|P1|Enrolled But Did Not Receive Treatment|Overall Study|Other|3
2417546|NCT01242514|5929462|P3|STARTED|Overall Study|Patients who received treatment|212
2417547|NCT01242514|5929463|P2|STARTED|Overall Study|Patients who received treatment|357
2417548|NCT01242514|5929464|P1|STARTED|Overall Study|Patients who received treatment|1343
2417549|NCT01242371|5929483|P2|NOT COMPLETED|Overall Study||5
2417550|NCT01242371|5929484|P1|NOT COMPLETED|Overall Study||2
2417551|NCT01242371|5929483|P2|COMPLETED|Overall Study||27
2417552|NCT01242371|5929484|P1|COMPLETED|Overall Study||31
2417553|NCT01242371|5929483|P2|STARTED|Overall Study||32
2417554|NCT01242371|5929484|P1|STARTED|Overall Study||33
2417555|NCT01242176|5929490|P2|NOT COMPLETED|Second Intervention||0
2417556|NCT01242176|5929491|P1|NOT COMPLETED|Second Intervention||0
2417557|NCT01242176|5929490|P2|COMPLETED|Second Intervention||10
2417558|NCT01242176|5929491|P1|COMPLETED|Second Intervention||11
2417559|NCT01242176|5929490|P2|STARTED|Second Intervention||10
2417560|NCT01242176|5929491|P1|STARTED|Second Intervention||11
2417561|NCT01242176|5929490|P2|NOT COMPLETED|Washout Period of 7 Days||2
2417562|NCT01242176|5929491|P1|NOT COMPLETED|Washout Period of 7 Days||1
2417563|NCT01242176|5929490|P2|COMPLETED|Washout Period of 7 Days||10
2417564|NCT01242176|5929491|P1|COMPLETED|Washout Period of 7 Days||11
2417565|NCT01242176|5929490|P2|STARTED|Washout Period of 7 Days||12
2417566|NCT01242176|5929491|P1|STARTED|Washout Period of 7 Days||12
2417567|NCT01242176|5929490|P2|NOT COMPLETED|First Intervention||0
2417568|NCT01242176|5929491|P1|NOT COMPLETED|First Intervention||0
2417569|NCT01242176|5929490|P2|COMPLETED|First Intervention||12
2417570|NCT01242176|5929491|P1|COMPLETED|First Intervention||12
2417571|NCT01242176|5929490|P2|STARTED|First Intervention||12
2417572|NCT01242176|5929491|P1|STARTED|First Intervention||12
2417573|NCT01242111|5929501|P1|NOT COMPLETED|Overall Study||3
2417574|NCT01242111|5929501|P1|COMPLETED|Overall Study||17
2417575|NCT01242111|5929501|P1|STARTED|Overall Study||20
2417576|NCT01242085|5929513|P3|NOT COMPLETED|Overall Study||0
2417577|NCT01242085|5929514|P2|NOT COMPLETED|Overall Study||7
2417578|NCT01242085|5929515|P1|NOT COMPLETED|Overall Study||8
2417579|NCT01242085|5929513|P3|COMPLETED|Overall Study||1
2417580|NCT01242085|5929514|P2|COMPLETED|Overall Study|7 patients did not receive allocated intervention since 5 had medical problems and 2 withdrew|26
2417581|NCT01242085|5929515|P1|COMPLETED|Overall Study|8 patients did not undergo intervention since 4 had medical problems and 4 withdrew|22
2417582|NCT01242085|5929513|P3|STARTED|Overall Study||1
2417583|NCT01242085|5929514|P2|STARTED|Overall Study||33
2417584|NCT01242085|5929515|P1|STARTED|Overall Study||30
2417585|NCT01242020|5929525|P2|NOT COMPLETED|Overall Study||0
2417586|NCT01242020|5929526|P1|NOT COMPLETED|Overall Study||3
2417587|NCT01242020|5929525|P2|COMPLETED|Overall Study||0
2417588|NCT01242020|5929526|P1|COMPLETED|Overall Study||3
2417589|NCT01242020|5929525|P2|STARTED|Overall Study||0
2417590|NCT01242020|5929526|P1|STARTED|Overall Study||6
2417591|NCT01241916|5929536|P2|NOT COMPLETED|Overall Study||10
2417592|NCT01241916|5929537|P1|NOT COMPLETED|Overall Study||7
2417593|NCT01241916|5929536|P2|COMPLETED|Overall Study||21
2417594|NCT01241916|5929537|P1|COMPLETED|Overall Study||28
2417595|NCT01241916|5929536|P2|STARTED|Overall Study||31
2417596|NCT01241916|5929537|P1|STARTED|Overall Study||35
2417597|NCT01241903|5929547|P2|NOT COMPLETED|Overall Study||0
2417598|NCT01241903|5929548|P1|NOT COMPLETED|Overall Study||1
2417599|NCT01241903|5929547|P2|COMPLETED|Overall Study||27
2417600|NCT01241903|5929548|P1|COMPLETED|Overall Study||26
2417601|NCT01241903|5929547|P2|STARTED|Overall Study||27
2417602|NCT01241903|5929548|P1|STARTED|Overall Study||27
2417603|NCT01241760|5929556|P2|NOT COMPLETED|Overall Study||40
2417604|NCT01241760|5929557|P1|NOT COMPLETED|Overall Study||34
2417605|NCT01241760|5929556|P2|COMPLETED|Overall Study||329
2417606|NCT01241760|5929557|P1|COMPLETED|Overall Study||337
2417607|NCT01241760|5929556|P2|STARTED|Overall Study||369
2417608|NCT01241760|5929557|P1|STARTED|Overall Study||371
2417609|NCT01241604|5929576|P3|NOT COMPLETED|Study Period||0
2417611|NCT01241604|5929578|P1|NOT COMPLETED|Study Period||0
2417612|NCT01241604|5929576|P3|COMPLETED|Study Period||3
2417613|NCT01241604|5929577|P2|COMPLETED|Study Period||5
2417614|NCT01241604|5929578|P1|COMPLETED|Study Period||0
2417615|NCT01241604|5929576|P3|STARTED|Study Period||3
2417616|NCT01241604|5929577|P2|STARTED|Study Period||5
2417617|NCT01241604|5929578|P1|STARTED|Study Period||0
2417618|NCT01241604|5929576|P3|NOT COMPLETED|Screening Period||0
2417619|NCT01241604|5929577|P2|NOT COMPLETED|Screening Period||0
2417620|NCT01241604|5929578|P1|NOT COMPLETED|Screening Period||3
2417621|NCT01241604|5929576|P3|COMPLETED|Screening Period||0
2417622|NCT01241604|5929577|P2|COMPLETED|Screening Period||0
2417623|NCT01241604|5929578|P1|COMPLETED|Screening Period||8
2417624|NCT01241604|5929576|P3|STARTED|Screening Period||0
2417625|NCT01241604|5929577|P2|STARTED|Screening Period||0
2417626|NCT01241604|5929578|P1|STARTED|Screening Period||11
2417627|NCT01241591|5929623|P4|NOT COMPLETED|Overall Study||12
2417628|NCT01241591|5929624|P3|NOT COMPLETED|Overall Study||22
2417629|NCT01241591|5929625|P2|NOT COMPLETED|Overall Study||24
2417630|NCT01241591|5929626|P1|NOT COMPLETED|Overall Study||23
2417631|NCT01241591|5929623|P4|COMPLETED|Overall Study||95
2417632|NCT01241591|5929624|P3|COMPLETED|Overall Study||313
2417633|NCT01241591|5929625|P2|COMPLETED|Overall Study||306
2417634|NCT01241591|5929626|P1|COMPLETED|Overall Study||306
2417635|NCT01241591|5929623|P4|STARTED|Overall Study||107
2417636|NCT01241591|5929624|P3|STARTED|Overall Study||335
2417637|NCT01241591|5929625|P2|STARTED|Overall Study||330
2417638|NCT01241591|5929626|P1|STARTED|Overall Study||329
2417639|NCT01241565|5929816|P1|NOT COMPLETED|Overall Study||0
2417640|NCT01241565|5929816|P1|COMPLETED|Overall Study||50
2417641|NCT01241565|5929816|P1|STARTED|Overall Study||50
2417642|NCT01241552|5929829|P4|NOT COMPLETED|Overall Study||64
2417643|NCT01241552|5929830|P3|NOT COMPLETED|Overall Study||60
2417644|NCT01241552|5929831|P2|NOT COMPLETED|Overall Study||63
2417645|NCT01241552|5929832|P1|NOT COMPLETED|Overall Study||41
2417646|NCT01241552|5929829|P4|COMPLETED|Overall Study||340
2417647|NCT01241552|5929830|P3|COMPLETED|Overall Study||343
2417648|NCT01241552|5929831|P2|COMPLETED|Overall Study||340
2417649|NCT01241552|5929832|P1|COMPLETED|Overall Study||201
2417650|NCT01241552|5929829|P4|Treated|Overall Study||397
2417651|NCT01241552|5929830|P3|Treated|Overall Study||388
2417652|NCT01241552|5929831|P2|Treated|Overall Study||392
2417653|NCT01241552|5929832|P1|Treated|Overall Study||235
2417654|NCT01241552|5929829|P4|STARTED|Overall Study||404
2417655|NCT01241552|5929830|P3|STARTED|Overall Study||403
2417656|NCT01241552|5929831|P2|STARTED|Overall Study||403
2417657|NCT01241552|5929832|P1|STARTED|Overall Study||242
2417658|NCT01241539|5929898|P1|NOT COMPLETED|Period 2||0
2417659|NCT01241539|5929898|P1|COMPLETED|Period 2||7
2417660|NCT01241539|5929898|P1|STARTED|Period 2|After a wash-out phase of at least 6 weeks.|7
2417661|NCT01241539|5929898|P1|NOT COMPLETED|Period 1||0
2417662|NCT01241539|5929898|P1|COMPLETED|Period 1||7
2417663|NCT01241539|5929898|P1|STARTED|Period 1||7
2417664|NCT01241513|5929919|P2|NOT COMPLETED|Overall Study||0
2417665|NCT01241513|5929920|P1|NOT COMPLETED|Overall Study||0
2417666|NCT01241513|5929919|P2|COMPLETED|Overall Study||9
2417667|NCT01241513|5929920|P1|COMPLETED|Overall Study|Study has been completed|10
2417668|NCT01241513|5929919|P2|STARTED|Overall Study||9
2417669|NCT01241513|5929920|P1|STARTED|Overall Study||10
2417670|NCT01241461|5929927|P2|NOT COMPLETED|Overall Study||6
2417671|NCT01241461|5929928|P1|NOT COMPLETED|Overall Study||3
2417672|NCT01241461|5929927|P2|COMPLETED|Overall Study||0
2417673|NCT01241461|5929928|P1|COMPLETED|Overall Study||0
2417674|NCT01241461|5929927|P2|STARTED|Overall Study||6
2417675|NCT01241461|5929928|P1|STARTED|Overall Study||3
2417676|NCT01241448|5929948|P4|NOT COMPLETED|Overall Study||23
2417677|NCT01241448|5929949|P3|NOT COMPLETED|Overall Study||23
2417678|NCT01241448|5929950|P2|NOT COMPLETED|Overall Study||29
2417679|NCT01241448|5929951|P1|NOT COMPLETED|Overall Study||37
2417680|NCT01241448|5929948|P4|COMPLETED|Overall Study||43
2417681|NCT01241448|5929949|P3|COMPLETED|Overall Study||43
2417682|NCT01241448|5929950|P2|COMPLETED|Overall Study||36
2417683|NCT01241448|5929951|P1|COMPLETED|Overall Study||29
2417684|NCT01241448|5929948|P4|ITT With ≥1 Post-Baseline Measure|Overall Study||62
2417685|NCT01241448|5929949|P3|ITT With ≥1 Post-Baseline Measure|Overall Study||64
2417686|NCT01241448|5929950|P2|ITT With ≥1 Post-Baseline Measure|Overall Study||61
2417687|NCT01241448|5929951|P1|ITT With ≥1 Post-Baseline Measure|Overall Study||61
2417688|NCT01241448|5929948|P4|Intent-to-Treat Population (ITT)|Overall Study||64
2417689|NCT01241448|5929949|P3|Intent-to-Treat Population (ITT)|Overall Study||64
2417690|NCT01241448|5929950|P2|Intent-to-Treat Population (ITT)|Overall Study||63
2417691|NCT01241448|5929951|P1|Intent-to-Treat Population (ITT)|Overall Study||63
2417692|NCT01241448|5929948|P4|STARTED|Overall Study||66
2417693|NCT01241448|5929949|P3|STARTED|Overall Study||66
2417694|NCT01241448|5929950|P2|STARTED|Overall Study||65
2417695|NCT01241448|5929951|P1|STARTED|Overall Study||66
2417696|NCT01241435|5930019|P4|NOT COMPLETED|Overall Study||0
2417697|NCT01241435|5930020|P3|NOT COMPLETED|Overall Study||0
2417698|NCT01241435|5930021|P2|NOT COMPLETED|Overall Study||0
2417699|NCT01241435|5930022|P1|NOT COMPLETED|Overall Study||0
2417700|NCT01241435|5930019|P4|COMPLETED|Overall Study||8
2417701|NCT01241435|5930020|P3|COMPLETED|Overall Study||8
2417702|NCT01241435|5930021|P2|COMPLETED|Overall Study||8
2417703|NCT01241435|5930022|P1|COMPLETED|Overall Study||12
2417792|NCT01240863|5930394|P2|NOT COMPLETED|Open-label Titration Period||0
2417704|NCT01241435|5930019|P4|Received at Least 1 Dose of Study Drug|Overall Study||8
2417705|NCT01241435|5930020|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
2417706|NCT01241435|5930021|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
2417707|NCT01241435|5930022|P1|Received at Least 1 Dose of Study Drug|Overall Study||12
2417708|NCT01241435|5930019|P4|STARTED|Overall Study||8
2417709|NCT01241435|5930020|P3|STARTED|Overall Study||8
2417710|NCT01241435|5930021|P2|STARTED|Overall Study||8
2417711|NCT01241435|5930022|P1|STARTED|Overall Study||12
2417712|NCT01241318|5930042|P2|NOT COMPLETED|Overall Study||742
2417713|NCT01241318|5930043|P1|NOT COMPLETED|Overall Study||1179
2417714|NCT01241318|5930042|P2|COMPLETED|Overall Study|Infants|19308
2417715|NCT01241318|5930043|P1|COMPLETED|Overall Study|Infants|18450
2417716|NCT01241318|5930042|P2|Liveborn Infant|Overall Study|Infants|19346
2417717|NCT01241318|5930043|P1|Liveborn Infant|Overall Study|Infants|18510
2417718|NCT01241318|5930042|P2|STARTED|Overall Study|Women enrolled|20050
2417719|NCT01241318|5930043|P1|STARTED|Overall Study|Women enrolled|19629
2417720|NCT01241292|5930056|P2|NOT COMPLETED|Overall Study||3
2417721|NCT01241292|5930057|P1|NOT COMPLETED|Overall Study||3
2417722|NCT01241292|5930056|P2|COMPLETED|Overall Study|completed=treatment on-going|0
2417723|NCT01241292|5930057|P1|COMPLETED|Overall Study|completed=treatment on-going|0
2417724|NCT01241292|5930056|P2|Entered Treatment Period|Overall Study||3
2417725|NCT01241292|5930057|P1|Entered Treatment Period|Overall Study||3
2417726|NCT01241292|5930056|P2|STARTED|Overall Study||3
2417727|NCT01241292|5930057|P1|STARTED|Overall Study||3
2417728|NCT01241279|5930081|P2|NOT COMPLETED|Overall Study||1
2417729|NCT01241279|5930082|P1|NOT COMPLETED|Overall Study||0
2417730|NCT01241279|5930081|P2|COMPLETED|Overall Study||1
2417731|NCT01241279|5930082|P1|COMPLETED|Overall Study||4
2417732|NCT01241279|5930081|P2|STARTED|Overall Study||2
2417733|NCT01241279|5930082|P1|STARTED|Overall Study||4
2417734|NCT01241240|5930092|P2|NOT COMPLETED|Overall Study||9
2417735|NCT01241240|5930093|P1|NOT COMPLETED|Overall Study||8
2417736|NCT01241240|5930092|P2|COMPLETED|Overall Study||89
2417737|NCT01241240|5930093|P1|COMPLETED|Overall Study||86
2417738|NCT01241240|5930092|P2|STARTED|Overall Study||98
2417739|NCT01241240|5930093|P1|STARTED|Overall Study||94
2417740|NCT01240915|5930111|P9|NOT COMPLETED|Overall Study||8
2417741|NCT01240915|5930112|P8|NOT COMPLETED|Overall Study||4
2417742|NCT01240915|5930113|P7|NOT COMPLETED|Overall Study||8
2417743|NCT01240915|5930114|P6|NOT COMPLETED|Overall Study||10
2417744|NCT01240915|5930115|P5|NOT COMPLETED|Overall Study||4
2417745|NCT01240915|5930116|P4|NOT COMPLETED|Overall Study||3
2417746|NCT01240915|5930117|P3|NOT COMPLETED|Overall Study||0
2417747|NCT01240915|5930118|P2|NOT COMPLETED|Overall Study||1
2417748|NCT01240915|5930119|P1|NOT COMPLETED|Overall Study||2
2417749|NCT01240915|5930111|P9|COMPLETED|Overall Study||13
2417750|NCT01240915|5930112|P8|COMPLETED|Overall Study||15
2417751|NCT01240915|5930113|P7|COMPLETED|Overall Study||17
2417752|NCT01240915|5930114|P6|COMPLETED|Overall Study||13
2417753|NCT01240915|5930115|P5|COMPLETED|Overall Study||2
2417754|NCT01240915|5930116|P4|COMPLETED|Overall Study||1
2417755|NCT01240915|5930117|P3|COMPLETED|Overall Study||2
2417756|NCT01240915|5930118|P2|COMPLETED|Overall Study||2
2417757|NCT01240915|5930119|P1|COMPLETED|Overall Study||0
2417758|NCT01240915|5930111|P9|STARTED|Overall Study||21
2417759|NCT01240915|5930112|P8|STARTED|Overall Study||19
2417760|NCT01240915|5930113|P7|STARTED|Overall Study||25
2417761|NCT01240915|5930114|P6|STARTED|Overall Study||23
2417762|NCT01240915|5930115|P5|STARTED|Overall Study||6
2417763|NCT01240915|5930116|P4|STARTED|Overall Study||4
2417764|NCT01240915|5930117|P3|STARTED|Overall Study||2
2417765|NCT01240915|5930118|P2|STARTED|Overall Study||3
2417766|NCT01240915|5930119|P1|STARTED|Overall Study||2
2417767|NCT01240902|5930302|P4|NOT COMPLETED|Overall Study||165
2417768|NCT01240902|5930303|P3|NOT COMPLETED|Overall Study||100
2417769|NCT01240902|5930304|P2|NOT COMPLETED|Overall Study||79
2417770|NCT01240902|5930305|P1|NOT COMPLETED|Overall Study||211
2417771|NCT01240902|5930302|P4|COMPLETED|Overall Study||237
2417772|NCT01240902|5930303|P3|COMPLETED|Overall Study||295
2417773|NCT01240902|5930304|P2|COMPLETED|Overall Study||77
2417774|NCT01240902|5930305|P1|COMPLETED|Overall Study||289
2417775|NCT01240902|5930302|P4|STARTED|Overall Study||402
2417776|NCT01240902|5930303|P3|STARTED|Overall Study||395
2417777|NCT01240902|5930304|P2|STARTED|Overall Study||156
2417778|NCT01240902|5930305|P1|STARTED|Overall Study||500
2417779|NCT01240863|5930393|P3|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||52
2417780|NCT01240863|5930394|P2|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||46
2417781|NCT01240863|5930395|P1|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
2417782|NCT01240863|5930393|P3|COMPLETED|Double-blind Treatment Period (12 Weeks)||94
2417783|NCT01240863|5930394|P2|COMPLETED|Double-blind Treatment Period (12 Weeks)||102
2417784|NCT01240863|5930395|P1|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
2417785|NCT01240863|5930393|P3|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||146
2417786|NCT01240863|5930394|P2|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||147
2417787|NCT01240863|5930395|P1|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||0
2417788|NCT01240863|5930393|P3|STARTED|Double-blind Treatment Period (12 Weeks)||146
2417789|NCT01240863|5930394|P2|STARTED|Double-blind Treatment Period (12 Weeks)||148
2417790|NCT01240863|5930395|P1|STARTED|Double-blind Treatment Period (12 Weeks)||0
2417791|NCT01240863|5930393|P3|NOT COMPLETED|Open-label Titration Period||0
2417793|NCT01240863|5930395|P1|NOT COMPLETED|Open-label Titration Period||97
2417794|NCT01240863|5930393|P3|COMPLETED|Open-label Titration Period||0
2417795|NCT01240863|5930394|P2|COMPLETED|Open-label Titration Period||0
2417796|NCT01240863|5930395|P1|COMPLETED|Open-label Titration Period||294
2417797|NCT01240863|5930393|P3|Safety Analysis Set|Open-label Titration Period||0
2417798|NCT01240863|5930394|P2|Safety Analysis Set|Open-label Titration Period||0
2417799|NCT01240863|5930395|P1|Safety Analysis Set|Open-label Titration Period||389
2417800|NCT01240863|5930393|P3|STARTED|Open-label Titration Period||0
2417801|NCT01240863|5930394|P2|STARTED|Open-label Titration Period||0
2417802|NCT01240863|5930395|P1|STARTED|Open-label Titration Period||391
2417803|NCT01240811|5930457|P3|NOT COMPLETED|Overall Study||1
2417804|NCT01240811|5930458|P2|NOT COMPLETED|Overall Study||1
2417805|NCT01240811|5930459|P1|NOT COMPLETED|Overall Study||0
2417806|NCT01240811|5930457|P3|COMPLETED|Overall Study||16
2417807|NCT01240811|5930458|P2|COMPLETED|Overall Study||16
2417808|NCT01240811|5930459|P1|COMPLETED|Overall Study||8
2417809|NCT01240811|5930457|P3|STARTED|Overall Study||17
2417810|NCT01240811|5930458|P2|STARTED|Overall Study||17
2417811|NCT01240811|5930459|P1|STARTED|Overall Study||8
2417812|NCT01240785|5930475|P2|NOT COMPLETED|Overall Study||3
2417813|NCT01240785|5930476|P1|NOT COMPLETED|Overall Study||1
2417814|NCT01240785|5930475|P2|COMPLETED|Overall Study||107
2417815|NCT01240785|5930476|P1|COMPLETED|Overall Study|110 women completed in the metformin arm and 107 women completed in the insulin arm.|110
2417816|NCT01240785|5930475|P2|STARTED|Overall Study||110
2417817|NCT01240785|5930476|P1|STARTED|Overall Study||111
2417818|NCT01240746|5930507|P3|NOT COMPLETED|Overall Study||243
2417819|NCT01240746|5930508|P2|NOT COMPLETED|Overall Study||48
2417820|NCT01240746|5930509|P1|NOT COMPLETED|Overall Study||59
2417821|NCT01240746|5930507|P3|COMPLETED|Overall Study||2659
2417822|NCT01240746|5930508|P2|COMPLETED|Overall Study||677
2417823|NCT01240746|5930509|P1|COMPLETED|Overall Study||677
2417824|NCT01240746|5930507|P3|STARTED|Overall Study||2902
2417825|NCT01240746|5930508|P2|STARTED|Overall Study||725
2417826|NCT01240746|5930509|P1|STARTED|Overall Study||736
2417827|NCT01240590|5930564|P5|NOT COMPLETED|Phase II||1
2417828|NCT01240590|5930565|P4|NOT COMPLETED|Phase II||2
2417829|NCT01240590|5930566|P3|NOT COMPLETED|Phase II||0
2417830|NCT01240590|5930567|P2|NOT COMPLETED|Phase II||0
2417831|NCT01240590|5930568|P1|NOT COMPLETED|Phase II||0
2417832|NCT01240590|5930564|P5|COMPLETED|Phase II||0
2417833|NCT01240590|5930565|P4|COMPLETED|Phase II||15
2417834|NCT01240590|5930566|P3|COMPLETED|Phase II||0
2417835|NCT01240590|5930567|P2|COMPLETED|Phase II||0
2417836|NCT01240590|5930568|P1|COMPLETED|Phase II||0
2417837|NCT01240590|5930564|P5|STARTED|Phase II||1
2417838|NCT01240590|5930565|P4|STARTED|Phase II||17
2417839|NCT01240590|5930566|P3|STARTED|Phase II||0
2417840|NCT01240590|5930567|P2|STARTED|Phase II||0
2417841|NCT01240590|5930568|P1|STARTED|Phase II||0
2417842|NCT01240590|5930564|P5|NOT COMPLETED|Phase I||0
2417843|NCT01240590|5930565|P4|NOT COMPLETED|Phase I||0
2417844|NCT01240590|5930566|P3|NOT COMPLETED|Phase I||3
2417845|NCT01240590|5930567|P2|NOT COMPLETED|Phase I||0
2417846|NCT01240590|5930568|P1|NOT COMPLETED|Phase I||0
2417847|NCT01240590|5930564|P5|COMPLETED|Phase I||0
2417848|NCT01240590|5930565|P4|COMPLETED|Phase I||0
2417849|NCT01240590|5930566|P3|COMPLETED|Phase I||0
2417850|NCT01240590|5930567|P2|COMPLETED|Phase I||6
2417851|NCT01240590|5930568|P1|COMPLETED|Phase I||0
2417852|NCT01240590|5930564|P5|STARTED|Phase I||0
2417853|NCT01240590|5930565|P4|STARTED|Phase I||0
2417854|NCT01240590|5930566|P3|STARTED|Phase I||3
2417855|NCT01240590|5930567|P2|STARTED|Phase I||6
2417856|NCT01240590|5930568|P1|STARTED|Phase I||0
2417857|NCT01240551|5930596|P2|NOT COMPLETED|Overall Study||3
2417858|NCT01240551|5930597|P1|NOT COMPLETED|Overall Study||4
2417859|NCT01240551|5930596|P2|COMPLETED|Overall Study||27
2417860|NCT01240551|5930597|P1|COMPLETED|Overall Study||26
2417861|NCT01240551|5930596|P2|STARTED|Overall Study||30
2417862|NCT01240551|5930597|P1|STARTED|Overall Study||30
2417863|NCT01240382|5930607|P2|NOT COMPLETED|Overall Study||4
2417864|NCT01240382|5930608|P1|NOT COMPLETED|Overall Study||2
2417865|NCT01240382|5930607|P2|COMPLETED|Overall Study||139
2417866|NCT01240382|5930608|P1|COMPLETED|Overall Study||142
2417867|NCT01240382|5930607|P2|STARTED|Overall Study||143
2417868|NCT01240382|5930608|P1|STARTED|Overall Study||144
2417869|NCT01240356|5930618|P2|NOT COMPLETED|Overall Study||0
2417870|NCT01240356|5930619|P1|NOT COMPLETED|Overall Study||3
2417871|NCT01240356|5930618|P2|COMPLETED|Overall Study||20
2417872|NCT01240356|5930619|P1|COMPLETED|Overall Study||15
2417873|NCT01240356|5930618|P2|STARTED|Overall Study||20
2417874|NCT01240356|5930619|P1|STARTED|Overall Study||18
2417875|NCT01240330|5930630|P1|NOT COMPLETED|Overall Study||0
2417876|NCT01240330|5930630|P1|COMPLETED|Overall Study||33
2417877|NCT01240330|5930630|P1|STARTED|Overall Study||33
2417878|NCT01240304|5930636|P1|NOT COMPLETED|Overall Study||10
2417879|NCT01240304|5930636|P1|COMPLETED|Overall Study||0
2417880|NCT01240304|5930636|P1|STARTED|Overall Study||10
2417881|NCT01240200|5930642|P2|NOT COMPLETED|12-week Crossover Phase - Period 2||0
2417882|NCT01240200|5930643|P1|NOT COMPLETED|12-week Crossover Phase - Period 2||0
2417883|NCT01240200|5930642|P2|COMPLETED|12-week Crossover Phase - Period 2||23
2417884|NCT01240200|5930643|P1|COMPLETED|12-week Crossover Phase - Period 2||23
2417885|NCT01240200|5930642|P2|STARTED|12-week Crossover Phase - Period 2||23
2417886|NCT01240200|5930643|P1|STARTED|12-week Crossover Phase - Period 2||23
2417887|NCT01240200|5930642|P2|NOT COMPLETED|12-week Crossover Phase - Period 1||1
2417888|NCT01240200|5930643|P1|NOT COMPLETED|12-week Crossover Phase - Period 1||2
2417889|NCT01240200|5930642|P2|COMPLETED|12-week Crossover Phase - Period 1||23
2417890|NCT01240200|5930643|P1|COMPLETED|12-week Crossover Phase - Period 1||23
2417891|NCT01240200|5930642|P2|STARTED|12-week Crossover Phase - Period 1||24
2417892|NCT01240200|5930643|P1|STARTED|12-week Crossover Phase - Period 1||25
2417893|NCT01240135|5930661|P2|NOT COMPLETED|Period Two, 14 Days of Wear||2
2417894|NCT01240135|5930662|P1|NOT COMPLETED|Period Two, 14 Days of Wear||1
2417895|NCT01240135|5930661|P2|COMPLETED|Period Two, 14 Days of Wear||43
2417896|NCT01240135|5930662|P1|COMPLETED|Period Two, 14 Days of Wear||43
2417897|NCT01240135|5930661|P2|STARTED|Period Two, 14 Days of Wear||45
2417898|NCT01240135|5930662|P1|STARTED|Period Two, 14 Days of Wear||44
2417899|NCT01240135|5930661|P2|NOT COMPLETED|Period One, 14 Days of Wear||0
2417900|NCT01240135|5930662|P1|NOT COMPLETED|Period One, 14 Days of Wear||0
2417901|NCT01240135|5930661|P2|COMPLETED|Period One, 14 Days of Wear||45
2417902|NCT01240135|5930662|P1|COMPLETED|Period One, 14 Days of Wear||44
2417903|NCT01240135|5930661|P2|STARTED|Period One, 14 Days of Wear||45
2417904|NCT01240135|5930662|P1|STARTED|Period One, 14 Days of Wear||44
2417905|NCT01240122|5930670|P1|NOT COMPLETED|Overall Study||0
2417906|NCT01240122|5930670|P1|COMPLETED|Overall Study||29
2417907|NCT01240122|5930670|P1|STARTED|Overall Study||29
2417908|NCT01239992|5930679|P1|NOT COMPLETED|Overall Study||2
2417909|NCT01239992|5930679|P1|COMPLETED|Overall Study||10
2417910|NCT01239992|5930679|P1|STARTED|Overall Study||12
2417911|NCT01239797|5930688|P2|NOT COMPLETED|Treated Participants||274
2417912|NCT01239797|5930689|P1|NOT COMPLETED|Treated Participants||235
2417913|NCT01239797|5930688|P2|COMPLETED|Treated Participants|Completed = Still on Treatment|43
2417914|NCT01239797|5930689|P1|COMPLETED|Treated Participants|Completed = Still on Treatment|83
2417915|NCT01239797|5930688|P2|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|317
2417916|NCT01239797|5930689|P1|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|318
2417917|NCT01239797|5930688|P2|NOT COMPLETED|Randomized Participants||9
2417918|NCT01239797|5930689|P1|NOT COMPLETED|Randomized Participants||2
2417919|NCT01239797|5930688|P2|COMPLETED|Randomized Participants||316
2417920|NCT01239797|5930689|P1|COMPLETED|Randomized Participants||319
2417921|NCT01239797|5930688|P2|STARTED|Randomized Participants||325
2417922|NCT01239797|5930689|P1|STARTED|Randomized Participants||321
2417923|NCT01239745|5930697|P1|NOT COMPLETED|Overall Study||46
2417924|NCT01239745|5930697|P1|COMPLETED|Overall Study||0
2417925|NCT01239745|5930697|P1|STARTED|Overall Study||46
2417926|NCT01239732|5930708|P1|NOT COMPLETED|Overall Study||1021
2417927|NCT01239732|5930708|P1|COMPLETED|Overall Study||0
2417928|NCT01239732|5930708|P1|STARTED|Overall Study||1021
2417929|NCT01239680|5930721|P2|NOT COMPLETED|Overall Study||0
2417930|NCT01239680|5930722|P1|NOT COMPLETED|Overall Study||2
2417931|NCT01239680|5930721|P2|COMPLETED|Overall Study||2
2417932|NCT01239680|5930722|P1|COMPLETED|Overall Study||1
2417933|NCT01239680|5930721|P2|STARTED|Overall Study||2
2417934|NCT01239680|5930722|P1|STARTED|Overall Study||3
2417935|NCT01239511|5930732|P4|NOT COMPLETED|Overall Study||9
2417936|NCT01239511|5930733|P3|NOT COMPLETED|Overall Study||4
2417937|NCT01239511|5930734|P2|NOT COMPLETED|Overall Study||5
2417938|NCT01239511|5930735|P1|NOT COMPLETED|Overall Study||1
2417939|NCT01239511|5930732|P4|COMPLETED|Overall Study||38
2417940|NCT01239511|5930733|P3|COMPLETED|Overall Study||43
2417941|NCT01239511|5930734|P2|COMPLETED|Overall Study||40
2417942|NCT01239511|5930735|P1|COMPLETED|Overall Study||46
2417943|NCT01239511|5930732|P4|STARTED|Overall Study||47
2417944|NCT01239511|5930733|P3|STARTED|Overall Study||47
2417945|NCT01239511|5930734|P2|STARTED|Overall Study||45
2417946|NCT01239511|5930735|P1|STARTED|Overall Study||47
2417947|NCT01239472|5930747|P2|NOT COMPLETED|Overall Study||3
2417948|NCT01239472|5930748|P1|NOT COMPLETED|Overall Study||5
2417949|NCT01239472|5930747|P2|COMPLETED|Overall Study||12
2417950|NCT01239472|5930748|P1|COMPLETED|Overall Study||10
2417951|NCT01239472|5930747|P2|STARTED|Overall Study||15
2417952|NCT01239472|5930748|P1|STARTED|Overall Study||15
2417953|NCT01239394|5930756|P1|NOT COMPLETED|Overall Study||1
2417954|NCT01239394|5930756|P1|COMPLETED|Overall Study||41
2417955|NCT01239394|5930756|P1|STARTED|Overall Study||42
2417956|NCT01239381|5930763|P1|NOT COMPLETED|Overall Study||2
2417957|NCT01239381|5930763|P1|COMPLETED|Overall Study||90
2417958|NCT01239381|5930763|P1|STARTED|Overall Study||92
2417959|NCT01239368|5930783|P10|NOT COMPLETED|Overall Study||4
2417960|NCT01239368|5930784|P9|NOT COMPLETED|Overall Study||0
2417961|NCT01239368|5930785|P8|NOT COMPLETED|Overall Study||0
2417962|NCT01239368|5930786|P7|NOT COMPLETED|Overall Study||6
2417963|NCT01239368|5930787|P6|NOT COMPLETED|Overall Study||4
2417964|NCT01239368|5930788|P5|NOT COMPLETED|Overall Study||5
2417965|NCT01239368|5930789|P4|NOT COMPLETED|Overall Study||1
2417966|NCT01239368|5930790|P3|NOT COMPLETED|Overall Study||1
2417967|NCT01239368|5930791|P2|NOT COMPLETED|Overall Study||1
2417968|NCT01239368|5930792|P1|NOT COMPLETED|Overall Study||2
2417969|NCT01239368|5930783|P10|COMPLETED|Overall Study||1
2417970|NCT01239368|5930784|P9|COMPLETED|Overall Study||1
2417971|NCT01239368|5930785|P8|COMPLETED|Overall Study||0
2417972|NCT01239368|5930786|P7|COMPLETED|Overall Study||1
2417973|NCT01239368|5930787|P6|COMPLETED|Overall Study||1
2417974|NCT01239368|5930788|P5|COMPLETED|Overall Study||2
2417975|NCT01239368|5930789|P4|COMPLETED|Overall Study||1
2417976|NCT01239368|5930790|P3|COMPLETED|Overall Study||0
2417977|NCT01239368|5930791|P2|COMPLETED|Overall Study||0
2417978|NCT01239368|5930792|P1|COMPLETED|Overall Study||0
2417979|NCT01239368|5930783|P10|STARTED|Overall Study||5
2417980|NCT01239368|5930784|P9|STARTED|Overall Study||1
2417981|NCT01239368|5930785|P8|STARTED|Overall Study||0
2417982|NCT01239368|5930786|P7|STARTED|Overall Study||7
2417983|NCT01239368|5930787|P6|STARTED|Overall Study||5
2417984|NCT01239368|5930788|P5|STARTED|Overall Study||7
2417985|NCT01239368|5930789|P4|STARTED|Overall Study||2
2417986|NCT01239368|5930790|P3|STARTED|Overall Study||1
2417987|NCT01239368|5930791|P2|STARTED|Overall Study||1
2417988|NCT01239368|5930792|P1|STARTED|Overall Study||2
2417989|NCT01239355|5930836|P1|NOT COMPLETED|Overall Study||0
2417990|NCT01239355|5930836|P1|COMPLETED|Overall Study||15
2417991|NCT01239355|5930836|P1|STARTED|Overall Study||15
2417992|NCT01239342|5930844|P2|NOT COMPLETED|Overall Study||6
2417993|NCT01239342|5930845|P1|NOT COMPLETED|Overall Study||3
2417994|NCT01239342|5930844|P2|COMPLETED|Overall Study||8
2417995|NCT01239342|5930845|P1|COMPLETED|Overall Study||26
2417996|NCT01239342|5930844|P2|STARTED|Overall Study||14
2417997|NCT01239342|5930845|P1|STARTED|Overall Study||29
2417998|NCT01239316|5930861|P1|NOT COMPLETED|Overall Study||12
2417999|NCT01239316|5930861|P1|COMPLETED|Overall Study||0
2418000|NCT01239316|5930861|P1|STARTED|Overall Study||12
2418001|NCT01239212|5930869|P1|NOT COMPLETED|Overall Study||0
2418002|NCT01239212|5930869|P1|COMPLETED|Overall Study||7
2418003|NCT01239212|5930869|P1|STARTED|Overall Study||7
2418004|NCT01239121|5930876|P3|NOT COMPLETED|Overall Study||0
2418005|NCT01239121|5930877|P2|NOT COMPLETED|Overall Study||4
2418006|NCT01239121|5930878|P1|NOT COMPLETED|Overall Study||2
2418007|NCT01239121|5930876|P3|COMPLETED|Overall Study||15
2418008|NCT01239121|5930877|P2|COMPLETED|Overall Study||195
2418009|NCT01239121|5930878|P1|COMPLETED|Overall Study||186
2418010|NCT01239121|5930876|P3|STARTED|Overall Study||15
2418011|NCT01239121|5930877|P2|STARTED|Overall Study||199
2418012|NCT01239121|5930878|P1|STARTED|Overall Study||188
2418013|NCT01239056|5930892|P1|NOT COMPLETED|Overall Study||0
2418014|NCT01239056|5930892|P1|COMPLETED|Overall Study||20
2418015|NCT01239056|5930892|P1|STARTED|Overall Study||20
2418016|NCT01239043|5930900|P2|NOT COMPLETED|Overall Study||1
2418017|NCT01239043|5930901|P1|NOT COMPLETED|Overall Study||2
2418018|NCT01239043|5930900|P2|COMPLETED|Overall Study||102
2418019|NCT01239043|5930901|P1|COMPLETED|Overall Study||34
2418020|NCT01239043|5930900|P2|STARTED|Overall Study||103
2418021|NCT01239043|5930901|P1|STARTED|Overall Study|For safety analysis number includes 1 participant randomized to Menactra who received Menomune.|36
2418022|NCT01238991|5930929|P10|NOT COMPLETED|Overall Study||2
2418023|NCT01238991|5930930|P9|NOT COMPLETED|Overall Study||4
2418024|NCT01238991|5930931|P8|NOT COMPLETED|Overall Study||5
2418025|NCT01238991|5930932|P7|NOT COMPLETED|Overall Study||8
2418026|NCT01238991|5930933|P6|NOT COMPLETED|Overall Study||0
2418027|NCT01238991|5930934|P5|NOT COMPLETED|Overall Study||2
2418028|NCT01238991|5930935|P4|NOT COMPLETED|Overall Study||2
2418029|NCT01238991|5930936|P3|NOT COMPLETED|Overall Study||6
2418030|NCT01238991|5930937|P2|NOT COMPLETED|Overall Study||0
2418031|NCT01238991|5930938|P1|NOT COMPLETED|Overall Study||2
2418032|NCT01238991|5930929|P10|COMPLETED|Overall Study||0
2418033|NCT01238991|5930930|P9|COMPLETED|Overall Study||0
2418034|NCT01238991|5930931|P8|COMPLETED|Overall Study||0
2418035|NCT01238991|5930932|P7|COMPLETED|Overall Study||0
2418036|NCT01238991|5930933|P6|COMPLETED|Overall Study||2
2418037|NCT01238991|5930934|P5|COMPLETED|Overall Study||3
2418038|NCT01238991|5930935|P4|COMPLETED|Overall Study||4
2418039|NCT01238991|5930936|P3|COMPLETED|Overall Study||5
2418040|NCT01238991|5930937|P2|COMPLETED|Overall Study||3
2418041|NCT01238991|5930938|P1|COMPLETED|Overall Study||5
2418042|NCT01238991|5930929|P10|Received Treatment|Overall Study||2
2418043|NCT01238991|5930930|P9|Received Treatment|Overall Study||4
2418044|NCT01238991|5930931|P8|Received Treatment|Overall Study||5
2418045|NCT01238991|5930932|P7|Received Treatment|Overall Study||8
2418046|NCT01238991|5930933|P6|Received Treatment|Overall Study||2
2418047|NCT01238991|5930934|P5|Received Treatment|Overall Study||5
2418048|NCT01238991|5930935|P4|Received Treatment|Overall Study||6
2418049|NCT01238991|5930936|P3|Received Treatment|Overall Study||11
2418050|NCT01238991|5930937|P2|Received Treatment|Overall Study||3
2418051|NCT01238991|5930938|P1|Received Treatment|Overall Study||7
2418052|NCT01238991|5930929|P10|STARTED|Overall Study||2
2418053|NCT01238991|5930930|P9|STARTED|Overall Study||4
2418054|NCT01238991|5930931|P8|STARTED|Overall Study||5
2418055|NCT01238991|5930932|P7|STARTED|Overall Study||8
2418056|NCT01238991|5930933|P6|STARTED|Overall Study||2
2418057|NCT01238991|5930934|P5|STARTED|Overall Study||5
2418058|NCT01238991|5930935|P4|STARTED|Overall Study||6
2418059|NCT01238991|5930936|P3|STARTED|Overall Study||11
2418060|NCT01238991|5930937|P2|STARTED|Overall Study||3
2418061|NCT01238991|5930938|P1|STARTED|Overall Study||7
2418062|NCT01238900|5931025|P1|NOT COMPLETED|<12 Months Post Stent Removal||5
2418063|NCT01238900|5931025|P1|COMPLETED|<12 Months Post Stent Removal||18
2418064|NCT01238900|5931025|P1|STARTED|<12 Months Post Stent Removal||23
2418065|NCT01238900|5931025|P1|NOT COMPLETED|6 Months Post Stent Placement||0
2418066|NCT01238900|5931025|P1|COMPLETED|6 Months Post Stent Placement||23
2418067|NCT01238900|5931025|P1|STARTED|6 Months Post Stent Placement||23
2418068|NCT01238861|5931039|P6|NOT COMPLETED|Overall Study||15
2418069|NCT01238861|5931040|P5|NOT COMPLETED|Overall Study||13
2418070|NCT01238861|5931041|P4|NOT COMPLETED|Overall Study||13
2418071|NCT01238861|5931042|P3|NOT COMPLETED|Overall Study||11
2418072|NCT01238861|5931043|P2|NOT COMPLETED|Overall Study||8
2418073|NCT01238861|5931044|P1|NOT COMPLETED|Overall Study||11
2418074|NCT01238861|5931039|P6|COMPLETED|Overall Study||125
2418075|NCT01238861|5931040|P5|COMPLETED|Overall Study||129
2418076|NCT01238861|5931041|P4|COMPLETED|Overall Study||69
2418077|NCT01238861|5931042|P3|COMPLETED|Overall Study||70
2418078|NCT01238861|5931043|P2|COMPLETED|Overall Study||73
2418079|NCT01238861|5931044|P1|COMPLETED|Overall Study||69
2418080|NCT01238861|5931039|P6|STARTED|Overall Study||140
2418081|NCT01238861|5931040|P5|STARTED|Overall Study||142
2418082|NCT01238861|5931041|P4|STARTED|Overall Study||82
2418083|NCT01238861|5931042|P3|STARTED|Overall Study||81
2418084|NCT01238861|5931043|P2|STARTED|Overall Study||81
2418085|NCT01238861|5931044|P1|STARTED|Overall Study||80
2418086|NCT01238848|5931124|P2|NOT COMPLETED|Overall Study||5
2418087|NCT01238848|5931125|P1|NOT COMPLETED|Overall Study||13
2418088|NCT01238848|5931124|P2|COMPLETED|Overall Study||45
2418089|NCT01238848|5931125|P1|COMPLETED|Overall Study||37
2418090|NCT01238848|5931124|P2|STARTED|Overall Study||50
2418091|NCT01238848|5931125|P1|STARTED|Overall Study||50
2418092|NCT01238822|5931133|P1|NOT COMPLETED|Overall Study||3
2418093|NCT01238822|5931133|P1|COMPLETED|Overall Study||93
2418094|NCT01238822|5931133|P1|Received High Dosage|Overall Study||93
2418095|NCT01238822|5931133|P1|Received Medium Dosage|Overall Study||93
2418096|NCT01238822|5931133|P1|Received Low Dosage|Overall Study||93
2418097|NCT01238822|5931133|P1|Received Placebo|Overall Study||93
2418098|NCT01238822|5931133|P1|STARTED|Overall Study||96
2418099|NCT01238640|5931143|P1|NOT COMPLETED|Overall Study||0
2418100|NCT01238640|5931143|P1|COMPLETED|Overall Study||84
2418101|NCT01238640|5931143|P1|STARTED|Overall Study||84
2418102|NCT01238588|5931160|P1|NOT COMPLETED|Overall Study||3
2418103|NCT01238588|5931160|P1|COMPLETED|Overall Study||9
2418104|NCT01238588|5931160|P1|STARTED|Overall Study||12
2418105|NCT01238575|5931173|P2|NOT COMPLETED|Overall Study||4
2418106|NCT01238575|5931174|P1|NOT COMPLETED|Overall Study||4
2418107|NCT01238575|5931173|P2|COMPLETED|Overall Study||28
2418108|NCT01238575|5931174|P1|COMPLETED|Overall Study||26
2418109|NCT01238575|5931173|P2|STARTED|Overall Study||32
2418110|NCT01238575|5931174|P1|STARTED|Overall Study||30
2418111|NCT01238549|5931210|P1|NOT COMPLETED|Overall Study||36
2418112|NCT01238549|5931210|P1|COMPLETED|Overall Study||248
2418113|NCT01238549|5931210|P1|STARTED|Overall Study||284
2418114|NCT01238536|5931229|P2|NOT COMPLETED|Overall Study||50
2418115|NCT01238536|5931230|P1|NOT COMPLETED|Overall Study||47
2418116|NCT01238536|5931229|P2|COMPLETED|Overall Study||150
2418117|NCT01238536|5931230|P1|COMPLETED|Overall Study||153
2418118|NCT01238536|5931229|P2|STARTED|Overall Study||200
2418119|NCT01238536|5931230|P1|STARTED|Overall Study||200
2418120|NCT01238471|5931244|P2|NOT COMPLETED|Overall Study||0
2418121|NCT01238471|5931245|P1|NOT COMPLETED|Overall Study||0
2418122|NCT01238471|5931244|P2|COMPLETED|Overall Study||10
2418123|NCT01238471|5931245|P1|COMPLETED|Overall Study||10
2418124|NCT01238471|5931244|P2|STARTED|Overall Study||10
2418125|NCT01238471|5931245|P1|STARTED|Overall Study||10
2418126|NCT01238341|5931251|P1|NOT COMPLETED|Overall Study||0
2418127|NCT01238341|5931251|P1|COMPLETED|Overall Study||7
2418128|NCT01238341|5931251|P1|STARTED|Overall Study||7
2418129|NCT01238211|5931258|P1|NOT COMPLETED|Overall Study||58
2418130|NCT01238211|5931258|P1|COMPLETED|Overall Study||3
2418131|NCT01238211|5931258|P1|STARTED|Overall Study||61
2418132|NCT01238172|5931264|P2|NOT COMPLETED|Overall Study||24
2418133|NCT01238172|5931265|P1|NOT COMPLETED|Overall Study||11
2418134|NCT01238172|5931264|P2|COMPLETED|Overall Study||217
2418135|NCT01238172|5931265|P1|COMPLETED|Overall Study||226
2418136|NCT01238172|5931264|P2|STARTED|Overall Study||241
2418137|NCT01238172|5931265|P1|STARTED|Overall Study||237
2418138|NCT01237899|5931288|P11|NOT COMPLETED|Second Dosing Period||0
2418139|NCT01237899|5931289|P10|NOT COMPLETED|Second Dosing Period||0
2418140|NCT01237899|5931290|P9|NOT COMPLETED|Second Dosing Period||0
2418141|NCT01237899|5931291|P8|NOT COMPLETED|Second Dosing Period||0
2418142|NCT01237899|5931292|P7|NOT COMPLETED|Second Dosing Period||0
2418143|NCT01237899|5931293|P6|NOT COMPLETED|Second Dosing Period||0
2418144|NCT01237899|5931294|P5|NOT COMPLETED|Second Dosing Period||0
2418145|NCT01237899|5931295|P4|NOT COMPLETED|Second Dosing Period||0
2418146|NCT01237899|5931296|P3|NOT COMPLETED|Second Dosing Period||0
2418147|NCT01237899|5931297|P2|NOT COMPLETED|Second Dosing Period||0
2418148|NCT01237899|5931298|P1|NOT COMPLETED|Second Dosing Period||0
2418149|NCT01237899|5931288|P11|COMPLETED|Second Dosing Period||4
2418150|NCT01237899|5931289|P10|COMPLETED|Second Dosing Period||3
2418151|NCT01237899|5931290|P9|COMPLETED|Second Dosing Period||4
2418152|NCT01237899|5931291|P8|COMPLETED|Second Dosing Period||3
2418153|NCT01237899|5931292|P7|COMPLETED|Second Dosing Period||1
2418154|NCT01237899|5931293|P6|COMPLETED|Second Dosing Period||4
2418155|NCT01237899|5931294|P5|COMPLETED|Second Dosing Period||2
2418156|NCT01237899|5931295|P4|COMPLETED|Second Dosing Period||3
2418157|NCT01237899|5931296|P3|COMPLETED|Second Dosing Period||3
2418158|NCT01237899|5931297|P2|COMPLETED|Second Dosing Period||3
2418159|NCT01237899|5931298|P1|COMPLETED|Second Dosing Period||1
2418160|NCT01237899|5931288|P11|STARTED|Second Dosing Period||4
2418161|NCT01237899|5931289|P10|STARTED|Second Dosing Period||3
2418162|NCT01237899|5931290|P9|STARTED|Second Dosing Period||4
2418163|NCT01237899|5931291|P8|STARTED|Second Dosing Period||3
2418164|NCT01237899|5931292|P7|STARTED|Second Dosing Period||1
2418165|NCT01237899|5931293|P6|STARTED|Second Dosing Period||4
2418166|NCT01237899|5931294|P5|STARTED|Second Dosing Period||2
2418167|NCT01237899|5931295|P4|STARTED|Second Dosing Period||3
2418168|NCT01237899|5931296|P3|STARTED|Second Dosing Period||3
2418169|NCT01237899|5931297|P2|STARTED|Second Dosing Period||3
2418170|NCT01237899|5931298|P1|STARTED|Second Dosing Period||1
2418171|NCT01237899|5931288|P11|NOT COMPLETED|Washout Period of at Least 7 Days||0
2418172|NCT01237899|5931289|P10|NOT COMPLETED|Washout Period of at Least 7 Days||0
2418173|NCT01237899|5931290|P9|NOT COMPLETED|Washout Period of at Least 7 Days||0
2418174|NCT01237899|5931291|P8|NOT COMPLETED|Washout Period of at Least 7 Days||0
2418175|NCT01237899|5931292|P7|NOT COMPLETED|Washout Period of at Least 7 Days||0
2418176|NCT01237899|5931293|P6|NOT COMPLETED|Washout Period of at Least 7 Days||0
2418177|NCT01237899|5931294|P5|NOT COMPLETED|Washout Period of at Least 7 Days||0
2418178|NCT01237899|5931295|P4|NOT COMPLETED|Washout Period of at Least 7 Days||0
2418179|NCT01237899|5931296|P3|NOT COMPLETED|Washout Period of at Least 7 Days||1
2418180|NCT01237899|5931297|P2|NOT COMPLETED|Washout Period of at Least 7 Days||0
2418181|NCT01237899|5931298|P1|NOT COMPLETED|Washout Period of at Least 7 Days||0
2418182|NCT01237899|5931288|P11|COMPLETED|Washout Period of at Least 7 Days||4
2418183|NCT01237899|5931289|P10|COMPLETED|Washout Period of at Least 7 Days||3
2418184|NCT01237899|5931290|P9|COMPLETED|Washout Period of at Least 7 Days||4
2418185|NCT01237899|5931291|P8|COMPLETED|Washout Period of at Least 7 Days||3
2418186|NCT01237899|5931292|P7|COMPLETED|Washout Period of at Least 7 Days||1
2418187|NCT01237899|5931293|P6|COMPLETED|Washout Period of at Least 7 Days||4
2418188|NCT01237899|5931294|P5|COMPLETED|Washout Period of at Least 7 Days||2
2418189|NCT01237899|5931295|P4|COMPLETED|Washout Period of at Least 7 Days||3
2418190|NCT01237899|5931296|P3|COMPLETED|Washout Period of at Least 7 Days||3
2418191|NCT01237899|5931297|P2|COMPLETED|Washout Period of at Least 7 Days||3
2418192|NCT01237899|5931298|P1|COMPLETED|Washout Period of at Least 7 Days||1
2418193|NCT01237899|5931288|P11|STARTED|Washout Period of at Least 7 Days||4
2418194|NCT01237899|5931289|P10|STARTED|Washout Period of at Least 7 Days||3
2418195|NCT01237899|5931290|P9|STARTED|Washout Period of at Least 7 Days||4
2418196|NCT01237899|5931291|P8|STARTED|Washout Period of at Least 7 Days||3
2418197|NCT01237899|5931292|P7|STARTED|Washout Period of at Least 7 Days||1
2418198|NCT01237899|5931293|P6|STARTED|Washout Period of at Least 7 Days||4
2418199|NCT01237899|5931294|P5|STARTED|Washout Period of at Least 7 Days||2
2418200|NCT01237899|5931295|P4|STARTED|Washout Period of at Least 7 Days||3
2418201|NCT01237899|5931296|P3|STARTED|Washout Period of at Least 7 Days||4
2418202|NCT01237899|5931297|P2|STARTED|Washout Period of at Least 7 Days||3
2418203|NCT01237899|5931298|P1|STARTED|Washout Period of at Least 7 Days||1
2418204|NCT01237899|5931288|P11|NOT COMPLETED|First Dosing Period||0
2418205|NCT01237899|5931289|P10|NOT COMPLETED|First Dosing Period||0
2418206|NCT01237899|5931290|P9|NOT COMPLETED|First Dosing Period||0
2418207|NCT01237899|5931291|P8|NOT COMPLETED|First Dosing Period||0
2418208|NCT01237899|5931292|P7|NOT COMPLETED|First Dosing Period||0
2418209|NCT01237899|5931293|P6|NOT COMPLETED|First Dosing Period||0
2418210|NCT01237899|5931294|P5|NOT COMPLETED|First Dosing Period||0
2418211|NCT01237899|5931295|P4|NOT COMPLETED|First Dosing Period||0
2418212|NCT01237899|5931296|P3|NOT COMPLETED|First Dosing Period||0
2418213|NCT01237899|5931297|P2|NOT COMPLETED|First Dosing Period||0
2418214|NCT01237899|5931298|P1|NOT COMPLETED|First Dosing Period||0
2418215|NCT01237899|5931288|P11|COMPLETED|First Dosing Period||4
2418216|NCT01237899|5931289|P10|COMPLETED|First Dosing Period||3
2418217|NCT01237899|5931290|P9|COMPLETED|First Dosing Period||4
2418218|NCT01237899|5931291|P8|COMPLETED|First Dosing Period||3
2418219|NCT01237899|5931292|P7|COMPLETED|First Dosing Period||1
2418220|NCT01237899|5931293|P6|COMPLETED|First Dosing Period||4
2418221|NCT01237899|5931294|P5|COMPLETED|First Dosing Period||2
2418222|NCT01237899|5931295|P4|COMPLETED|First Dosing Period||3
2418223|NCT01237899|5931296|P3|COMPLETED|First Dosing Period||4
2418224|NCT01237899|5931297|P2|COMPLETED|First Dosing Period||3
2418225|NCT01237899|5931298|P1|COMPLETED|First Dosing Period||1
2418226|NCT01237899|5931288|P11|STARTED|First Dosing Period||4
2418227|NCT01237899|5931289|P10|STARTED|First Dosing Period||3
2418228|NCT01237899|5931290|P9|STARTED|First Dosing Period||4
2418229|NCT01237899|5931291|P8|STARTED|First Dosing Period||3
2418230|NCT01237899|5931292|P7|STARTED|First Dosing Period||1
2418231|NCT01237899|5931293|P6|STARTED|First Dosing Period||4
2418232|NCT01237899|5931294|P5|STARTED|First Dosing Period||2
2418233|NCT01237899|5931295|P4|STARTED|First Dosing Period||3
2418234|NCT01237899|5931296|P3|STARTED|First Dosing Period||4
2418235|NCT01237899|5931297|P2|STARTED|First Dosing Period||3
2418236|NCT01237899|5931298|P1|STARTED|First Dosing Period||1
2418237|NCT01237821|5931328|P2|NOT COMPLETED|Overall Study||0
2418238|NCT01237821|5931329|P1|NOT COMPLETED|Overall Study||6
2418239|NCT01237821|5931328|P2|COMPLETED|Overall Study||34
2418240|NCT01237821|5931329|P1|COMPLETED|Overall Study||26
2418241|NCT01237821|5931328|P2|STARTED|Overall Study||34
2418242|NCT01237821|5931329|P1|STARTED|Overall Study||32
2418243|NCT01237678|5931378|P3|NOT COMPLETED|Phase II||50
2418244|NCT01237678|5931379|P2|NOT COMPLETED|Phase II||98
2418245|NCT01237678|5931380|P1|NOT COMPLETED|Phase II||0
2418246|NCT01237678|5931378|P3|COMPLETED|Phase II||0
2418247|NCT01237678|5931379|P2|COMPLETED|Phase II||0
2418248|NCT01237678|5931380|P1|COMPLETED|Phase II||0
2418249|NCT01237678|5931378|P3|Received Intervention|Phase II||47
2418250|NCT01237678|5931379|P2|Received Intervention|Phase II||94
2418251|NCT01237678|5931380|P1|Received Intervention|Phase II||0
2418252|NCT01237678|5931378|P3|STARTED|Phase II|50 subjects were randomized, 47 subjects treated|50
2418253|NCT01237678|5931379|P2|STARTED|Phase II|98 subjects were randomized, 94 subjects treated|98
2418254|NCT01237678|5931380|P1|STARTED|Phase II||0
2418255|NCT01237678|5931378|P3|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
2418256|NCT01237678|5931379|P2|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
2418257|NCT01237678|5931380|P1|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||33
2418258|NCT01237678|5931378|P3|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
2418259|NCT01237678|5931379|P2|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
2418260|NCT01237678|5931380|P1|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
2418261|NCT01237678|5931378|P3|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0
2418262|NCT01237678|5931379|P2|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0
2418263|NCT01237678|5931380|P1|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||33
2418264|NCT01237678|5931378|P3|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0
2418265|NCT01237678|5931379|P2|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0
2418266|NCT01237678|5931380|P1|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||33
2418267|NCT01237613|5931399|P1|NOT COMPLETED|Overall Study||0
2418268|NCT01237613|5931399|P1|COMPLETED|Overall Study||4
2418269|NCT01237613|5931399|P1|STARTED|Overall Study||4
2418270|NCT01237587|5931425|P2|NOT COMPLETED|Taper Phase||10
2418271|NCT01237587|5931426|P1|NOT COMPLETED|Taper Phase||5
2418272|NCT01237587|5931425|P2|COMPLETED|Taper Phase||34
2418273|NCT01237587|5931426|P1|COMPLETED|Taper Phase||31
2418274|NCT01237587|5931425|P2|STARTED|Taper Phase|Participants who discontinued Acute or Extension phase had an option to enter tapering phase.|44
2418275|NCT01237587|5931426|P1|STARTED|Taper Phase|Participants who discontinued Acute or Extension phase had an option to enter tapering phase.|36
2418276|NCT01237587|5931425|P2|NOT COMPLETED|Open Label Treatment (Extension Phase)||25
2418277|NCT01237587|5931426|P1|NOT COMPLETED|Open Label Treatment (Extension Phase)||18
2418278|NCT01237587|5931425|P2|COMPLETED|Open Label Treatment (Extension Phase)||50
2418279|NCT01237587|5931426|P1|COMPLETED|Open Label Treatment (Extension Phase)||56
2418280|NCT01237587|5931425|P2|Received at Least One Dose of Study Drug|Open Label Treatment (Extension Phase)||75
2418281|NCT01237587|5931426|P1|Received at Least One Dose of Study Drug|Open Label Treatment (Extension Phase)||74
2418282|NCT01237587|5931425|P2|STARTED|Open Label Treatment (Extension Phase)||75
2418283|NCT01237587|5931426|P1|STARTED|Open Label Treatment (Extension Phase)||74
2418284|NCT01237587|5931425|P2|NOT COMPLETED|Double Blind Treatment (Acute Phase)||18
2418285|NCT01237587|5931426|P1|NOT COMPLETED|Double Blind Treatment (Acute Phase)||17
2418286|NCT01237587|5931425|P2|COMPLETED|Double Blind Treatment (Acute Phase)||75
2418287|NCT01237587|5931426|P1|COMPLETED|Double Blind Treatment (Acute Phase)||74
2418288|NCT01237587|5931425|P2|Received at Least One Dose of Study Drug|Double Blind Treatment (Acute Phase)||93
2418289|NCT01237587|5931426|P1|Received at Least One Dose of Study Drug|Double Blind Treatment (Acute Phase)||91
2418290|NCT01237587|5931425|P2|STARTED|Double Blind Treatment (Acute Phase)||93
2418291|NCT01237587|5931426|P1|STARTED|Double Blind Treatment (Acute Phase)||91
2418292|NCT01237353|5931473|P1|NOT COMPLETED|Overall Study||0
2418293|NCT01237353|5931473|P1|COMPLETED|Overall Study||6
2418294|NCT01237353|5931473|P1|STARTED|Overall Study||6
2418295|NCT01237340|5931478|P1|NOT COMPLETED|Overall Study||40
2418296|NCT01237340|5931478|P1|COMPLETED|Overall Study||19
2418297|NCT01237340|5931478|P1|STARTED|Overall Study||59
2418298|NCT01237327|5931492|P2|NOT COMPLETED|Overall Study||40
2418299|NCT01237327|5931493|P1|NOT COMPLETED|Overall Study||42
2418300|NCT01237327|5931492|P2|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
2418301|NCT01237327|5931493|P1|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
2418302|NCT01237327|5931492|P2|Continued Treatment in Extension Study|Overall Study||17
2418303|NCT01237327|5931493|P1|Continued Treatment in Extension Study|Overall Study||21
2418304|NCT01237327|5931492|P2|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|2
2418305|NCT01237327|5931493|P1|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|3
2418306|NCT01237327|5931492|P2|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|24
2418307|NCT01237327|5931493|P1|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|22
2418308|NCT01237327|5931492|P2|STARTED|Overall Study||41
2418309|NCT01237327|5931493|P1|STARTED|Overall Study||43
2418310|NCT01237301|5931509|P2|NOT COMPLETED|Overall Study||4
2418311|NCT01237301|5931510|P1|NOT COMPLETED|Overall Study||5
2418312|NCT01237301|5931509|P2|COMPLETED|Overall Study||55
2418313|NCT01237301|5931510|P1|COMPLETED|Overall Study||60
2418314|NCT01237301|5931509|P2|STARTED|Overall Study||59
2418315|NCT01237301|5931510|P1|STARTED|Overall Study||65
2418316|NCT01237223|5931528|P6|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
2418317|NCT01237223|5931529|P5|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||4
2418318|NCT01237223|5931530|P4|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
2418319|NCT01237223|5931531|P3|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
2418320|NCT01237223|5931532|P2|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
2418321|NCT01237223|5931533|P1|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||33
2418322|NCT01237223|5931528|P6|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||154
2418323|NCT01237223|5931529|P5|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||155
2418324|NCT01237223|5931530|P4|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||153
2418325|NCT01237223|5931531|P3|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||143
2418326|NCT01237223|5931532|P2|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||142
2418327|NCT01237223|5931533|P1|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||120
2418328|NCT01237223|5931528|P6|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
2418329|NCT01237223|5931529|P5|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
2418330|NCT01237223|5931530|P4|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
2418331|NCT01237223|5931531|P3|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
2418332|NCT01237223|5931532|P2|STARTED|Double Blind (Treatment Period, 8 Weeks)||157
2418333|NCT01237223|5931533|P1|STARTED|Double Blind (Treatment Period, 8 Weeks)||153
2418334|NCT01237223|5931528|P6|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
2418335|NCT01237223|5931529|P5|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
2418336|NCT01237223|5931530|P4|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
2418337|NCT01237223|5931531|P3|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
2418338|NCT01237223|5931532|P2|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
2418339|NCT01237223|5931533|P1|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||398
2418340|NCT01237223|5931528|P6|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
2418341|NCT01237223|5931529|P5|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
2418342|NCT01237223|5931530|P4|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
2418343|NCT01237223|5931531|P3|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
2418344|NCT01237223|5931532|P2|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
2418345|NCT01237223|5931533|P1|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||944
2418346|NCT01237223|5931528|P6|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
2418347|NCT01237223|5931529|P5|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
2418348|NCT01237223|5931530|P4|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
2418349|NCT01237223|5931531|P3|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
2418350|NCT01237223|5931532|P2|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
2418351|NCT01237223|5931533|P1|STARTED|Single Blind(Run-in Period, 4 Weeks)|All the patients enrolled to single blind period received only placebo treatment.|1342
2418352|NCT01237197|5931574|P2|NOT COMPLETED|Open Label Period||0
2418353|NCT01237197|5931575|P1|NOT COMPLETED|Open Label Period||0
2418354|NCT01237197|5931574|P2|COMPLETED|Open Label Period||10
2418355|NCT01237197|5931575|P1|COMPLETED|Open Label Period||12
2418356|NCT01237197|5931574|P2|STARTED|Open Label Period||10
2418357|NCT01237197|5931575|P1|STARTED|Open Label Period||12
2418358|NCT01237197|5931574|P2|NOT COMPLETED|Randomization Period||3
2418359|NCT01237197|5931575|P1|NOT COMPLETED|Randomization Period||1
2418360|NCT01237197|5931574|P2|COMPLETED|Randomization Period||10
2418361|NCT01237197|5931575|P1|COMPLETED|Randomization Period||12
2418362|NCT01237197|5931574|P2|STARTED|Randomization Period||13
2418363|NCT01237197|5931575|P1|STARTED|Randomization Period||13
2418364|NCT01237080|5931583|P2|NOT COMPLETED|Overall Study||0
2418365|NCT01237080|5931584|P1|NOT COMPLETED|Overall Study||0
2418366|NCT01237080|5931583|P2|COMPLETED|Overall Study||50
2418367|NCT01237080|5931584|P1|COMPLETED|Overall Study||50
2418368|NCT01237080|5931583|P2|STARTED|Overall Study||50
2418369|NCT01237080|5931584|P1|STARTED|Overall Study||50
2418370|NCT01237054|5931592|P1|NOT COMPLETED|Overall Study||1
2418371|NCT01237054|5931592|P1|COMPLETED|Overall Study||30
2418372|NCT01237054|5931592|P1|STARTED|Overall Study||31
2418373|NCT01237041|5931618|P5|NOT COMPLETED|Overall Study||0
2418374|NCT01237041|5931619|P4|NOT COMPLETED|Overall Study||0
2418375|NCT01237041|5931620|P3|NOT COMPLETED|Overall Study||0
2418376|NCT01237041|5931621|P2|NOT COMPLETED|Overall Study||0
2418377|NCT01237041|5931622|P1|NOT COMPLETED|Overall Study||0
2418378|NCT01237041|5931618|P5|COMPLETED|Overall Study||5
2418379|NCT01237041|5931619|P4|COMPLETED|Overall Study||5
2418380|NCT01237041|5931620|P3|COMPLETED|Overall Study||2
2418381|NCT01237041|5931621|P2|COMPLETED|Overall Study||3
2418382|NCT01237041|5931622|P1|COMPLETED|Overall Study||2
2418383|NCT01237041|5931618|P5|STARTED|Overall Study||5
2418384|NCT01237041|5931619|P4|STARTED|Overall Study||5
2418385|NCT01237041|5931620|P3|STARTED|Overall Study||2
2418386|NCT01237041|5931621|P2|STARTED|Overall Study||3
2418387|NCT01237041|5931622|P1|STARTED|Overall Study||2
2418388|NCT01236768|5931646|P2|NOT COMPLETED|Overall Study||61
2418389|NCT01236768|5931647|P1|NOT COMPLETED|Overall Study||89
2418390|NCT01236768|5931646|P2|COMPLETED|Overall Study||145
2418391|NCT01236768|5931647|P1|COMPLETED|Overall Study||112
2418392|NCT01236768|5931646|P2|STARTED|Overall Study||206
2418393|NCT01236768|5931647|P1|STARTED|Overall Study||201
2418394|NCT01236755|5931661|P1|NOT COMPLETED|Orthokeratology Wearing Phase||8
2418395|NCT01236755|5931661|P1|COMPLETED|Orthokeratology Wearing Phase||66
2418396|NCT01236755|5931661|P1|STARTED|Orthokeratology Wearing Phase||74
2418397|NCT01236755|5931661|P1|NOT COMPLETED|Spectacles Wearing Phase||17
2418398|NCT01236755|5931661|P1|COMPLETED|Spectacles Wearing Phase||74
2418399|NCT01236755|5931661|P1|STARTED|Spectacles Wearing Phase||91
2418400|NCT01236742|5931669|P3|NOT COMPLETED|Overall Study||3
2418401|NCT01236742|5931670|P2|NOT COMPLETED|Overall Study||3
2418402|NCT01236742|5931671|P1|NOT COMPLETED|Overall Study||3
2418403|NCT01236742|5931669|P3|COMPLETED|Overall Study||13
2418404|NCT01236742|5931670|P2|COMPLETED|Overall Study||16
2418405|NCT01236742|5931671|P1|COMPLETED|Overall Study||15
2418406|NCT01236742|5931669|P3|STARTED|Overall Study||16
2418407|NCT01236742|5931670|P2|STARTED|Overall Study||19
2418408|NCT01236742|5931671|P1|STARTED|Overall Study||18
2418409|NCT01236534|5931684|P2|NOT COMPLETED|Overall Study||0
2418410|NCT01236534|5931685|P1|NOT COMPLETED|Overall Study||3
2418411|NCT01236534|5931684|P2|COMPLETED|Overall Study||10
2418412|NCT01236534|5931685|P1|COMPLETED|Overall Study|2 subjects stopped treatment due to diarrhea, and 1 stopped treatment due to constipation.|8
2418413|NCT01236534|5931684|P2|STARTED|Overall Study||10
2418414|NCT01236534|5931685|P1|STARTED|Overall Study||11
2418415|NCT01236391|5931693|P1|NOT COMPLETED|Overall Study||16
2418416|NCT01236391|5931693|P1|COMPLETED|Overall Study|Participants who were on treatment or discontinued treatment due to disease progression or death|95
2418417|NCT01236391|5931693|P1|STARTED|Overall Study|Participants who received study treatment|111
2418418|NCT01236365|5931703|P2|NOT COMPLETED|Overall Study||2
2418419|NCT01236365|5931704|P1|NOT COMPLETED|Overall Study||2
2418420|NCT01236365|5931703|P2|COMPLETED|Overall Study||19
2418421|NCT01236365|5931704|P1|COMPLETED|Overall Study||19
2418422|NCT01236365|5931703|P2|STARTED|Overall Study||21
2418423|NCT01236365|5931704|P1|STARTED|Overall Study||21
2418424|NCT01236339|5931728|P2|NOT COMPLETED|Overall Study||13
2418425|NCT01236339|5931729|P1|NOT COMPLETED|Overall Study||11
2418426|NCT01236339|5931728|P2|COMPLETED|Overall Study||0
2418427|NCT01236339|5931729|P1|COMPLETED|Overall Study||2
2418428|NCT01236339|5931728|P2|LVP Crossover to TIPS|Overall Study|ONLY patients failing LVP and meeting crossover according to protocol definition|4
2418429|NCT01236339|5931729|P1|LVP Crossover to TIPS|Overall Study||0
2418430|NCT01236339|5931728|P2|STARTED|Overall Study||13
2418431|NCT01236339|5931729|P1|STARTED|Overall Study||13
2418432|NCT01235923|5931749|P2|NOT COMPLETED|Overall Study||0
2418433|NCT01235923|5931750|P1|NOT COMPLETED|Overall Study||0
2418434|NCT01235923|5931749|P2|COMPLETED|Overall Study||10
2418435|NCT01235923|5931750|P1|COMPLETED|Overall Study||10
2418436|NCT01235923|5931749|P2|STARTED|Overall Study||10
2418437|NCT01235923|5931750|P1|STARTED|Overall Study||10
2418438|NCT01235793|5931758|P1|NOT COMPLETED|Overall Study||6
2418439|NCT01235793|5931758|P1|COMPLETED|Overall Study||5
2418440|NCT01235793|5931758|P1|STARTED|Overall Study||11
2418441|NCT01236573|5931774|P11|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||1
2418442|NCT01236573|5931775|P10|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
2418443|NCT01236573|5931776|P9|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
2418444|NCT01236573|5931777|P8|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
2418445|NCT01236573|5931778|P7|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
2418446|NCT01236573|5931779|P6|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
2418447|NCT01236573|5931780|P5|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
2418448|NCT01236573|5931781|P4|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
2418449|NCT01236573|5931782|P3|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
2418450|NCT01236573|5931783|P2|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
2418451|NCT01236573|5931784|P1|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
2418452|NCT01236573|5931774|P11|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||5
2418453|NCT01236573|5931775|P10|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
2418454|NCT01236573|5931776|P9|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
2418455|NCT01236573|5931777|P8|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
2418456|NCT01236573|5931778|P7|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
2418457|NCT01236573|5931779|P6|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
2418458|NCT01236573|5931780|P5|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
2418459|NCT01236573|5931781|P4|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
2418460|NCT01236573|5931782|P3|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
2418461|NCT01236573|5931783|P2|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
2418462|NCT01236573|5931784|P1|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
2418463|NCT01236573|5931774|P11|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||6
2418464|NCT01236573|5931775|P10|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
2418465|NCT01236573|5931776|P9|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
2418466|NCT01236573|5931777|P8|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
2418467|NCT01236573|5931778|P7|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
2418468|NCT01236573|5931779|P6|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
2418469|NCT01236573|5931780|P5|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
2418470|NCT01236573|5931781|P4|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
2418471|NCT01236573|5931782|P3|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
2418472|NCT01236573|5931783|P2|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
2418473|NCT01236573|5931784|P1|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
2418474|NCT01236573|5931774|P11|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
2418475|NCT01236573|5931775|P10|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
2418476|NCT01236573|5931776|P9|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
2418477|NCT01236573|5931777|P8|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
2418478|NCT01236573|5931778|P7|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
2418479|NCT01236573|5931779|P6|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
2418480|NCT01236573|5931780|P5|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
2418481|NCT01236573|5931781|P4|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
2418482|NCT01236573|5931782|P3|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
2418483|NCT01236573|5931783|P2|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
2418484|NCT01236573|5931784|P1|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
2418485|NCT01236573|5931774|P11|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
2418486|NCT01236573|5931775|P10|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
2418487|NCT01236573|5931776|P9|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
2418488|NCT01236573|5931777|P8|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
2418489|NCT01236573|5931778|P7|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
2418490|NCT01236573|5931779|P6|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||4
2418491|NCT01236573|5931780|P5|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
2418492|NCT01236573|5931781|P4|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
2418493|NCT01236573|5931782|P3|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
2418494|NCT01236573|5931783|P2|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
2418495|NCT01236573|5931784|P1|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
2418496|NCT01236573|5931774|P11|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
2418497|NCT01236573|5931775|P10|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
2418498|NCT01236573|5931776|P9|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
2418499|NCT01236573|5931777|P8|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
2418500|NCT01236573|5931778|P7|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
2418501|NCT01236573|5931779|P6|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
2418502|NCT01236573|5931780|P5|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||1
2418503|NCT01236573|5931781|P4|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
2418504|NCT01236573|5931782|P3|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
2418505|NCT01236573|5931783|P2|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
2418506|NCT01236573|5931784|P1|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
2418507|NCT01236573|5931774|P11|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
2418508|NCT01236573|5931775|P10|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
2418509|NCT01236573|5931776|P9|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
2418510|NCT01236573|5931777|P8|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
2418511|NCT01236573|5931778|P7|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
2418512|NCT01236573|5931779|P6|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
2418513|NCT01236573|5931780|P5|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
2418514|NCT01236573|5931781|P4|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
2418515|NCT01236573|5931782|P3|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
2418516|NCT01236573|5931783|P2|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
2418517|NCT01236573|5931784|P1|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
2418518|NCT01236573|5931774|P11|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
2418519|NCT01236573|5931775|P10|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
2418520|NCT01236573|5931776|P9|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
2418521|NCT01236573|5931777|P8|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
2418522|NCT01236573|5931778|P7|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
2418523|NCT01236573|5931779|P6|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
2418524|NCT01236573|5931780|P5|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
2418525|NCT01236573|5931781|P4|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
2418526|NCT01236573|5931782|P3|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||6
2418527|NCT01236573|5931783|P2|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
2418528|NCT01236573|5931784|P1|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
2418529|NCT01236573|5931774|P11|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
2418530|NCT01236573|5931775|P10|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
2418531|NCT01236573|5931776|P9|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
2418532|NCT01236573|5931777|P8|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
2418533|NCT01236573|5931778|P7|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
2418534|NCT01236573|5931779|P6|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
2418535|NCT01236573|5931780|P5|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
2418536|NCT01236573|5931781|P4|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
2418537|NCT01236573|5931782|P3|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||6
2418538|NCT01236573|5931783|P2|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
2418539|NCT01236573|5931784|P1|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
2418540|NCT01236521|5931822|P2|NOT COMPLETED|Overall Study||25
2418541|NCT01236521|5931823|P1|NOT COMPLETED|Overall Study||21
2418542|NCT01236521|5931822|P2|COMPLETED|Overall Study||105
2418543|NCT01236521|5931823|P1|COMPLETED|Overall Study||110
2418544|NCT01236521|5931822|P2|12-moth Completed|Overall Study||105
2418545|NCT01236521|5931823|P1|12-moth Completed|Overall Study||110
2418546|NCT01236521|5931822|P2|9-month Completed|Overall Study||101
2418547|NCT01236521|5931823|P1|9-month Completed|Overall Study||115
2418548|NCT01236521|5931822|P2|6-month Completed|Overall Study||116
2418549|NCT01236521|5931823|P1|6-month Completed|Overall Study||122
2418550|NCT01236521|5931822|P2|3-month Completed|Overall Study||119
2418551|NCT01236521|5931823|P1|3-month Completed|Overall Study||122
2418552|NCT01236521|5931822|P2|STARTED|Overall Study||130
2418553|NCT01236521|5931823|P1|STARTED|Overall Study||131
2418554|NCT01236378|5931851|P1|NOT COMPLETED|Overall Study||0
2418555|NCT01236378|5931851|P1|COMPLETED|Overall Study||24
2418556|NCT01236378|5931851|P1|STARTED|Overall Study||24
2418557|NCT01236352|5931874|P11|NOT COMPLETED|Overall Study||20
2418558|NCT01236352|5931875|P10|NOT COMPLETED|Overall Study||22
2418559|NCT01236352|5931876|P9|NOT COMPLETED|Overall Study||3
2418560|NCT01236352|5931877|P8|NOT COMPLETED|Overall Study||7
2418561|NCT01236352|5931878|P7|NOT COMPLETED|Overall Study||8
2418562|NCT01236352|5931879|P6|NOT COMPLETED|Overall Study||4
2418563|NCT01236352|5931880|P5|NOT COMPLETED|Overall Study||4
2418564|NCT01236352|5931881|P4|NOT COMPLETED|Overall Study||3
2418565|NCT01236352|5931882|P3|NOT COMPLETED|Overall Study||4
2418566|NCT01236352|5931883|P2|NOT COMPLETED|Overall Study||4
2418567|NCT01236352|5931884|P1|NOT COMPLETED|Overall Study||4
2418568|NCT01236352|5931874|P11|COMPLETED|Overall Study||0
2418569|NCT01236352|5931875|P10|COMPLETED|Overall Study||0
2418570|NCT01236352|5931876|P9|COMPLETED|Overall Study||0
2418571|NCT01236352|5931877|P8|COMPLETED|Overall Study||0
2418572|NCT01236352|5931878|P7|COMPLETED|Overall Study||0
2418573|NCT01236352|5931879|P6|COMPLETED|Overall Study||0
2418574|NCT01236352|5931880|P5|COMPLETED|Overall Study||0
2418575|NCT01236352|5931881|P4|COMPLETED|Overall Study||1
2418576|NCT01236352|5931882|P3|COMPLETED|Overall Study||0
2418577|NCT01236352|5931883|P2|COMPLETED|Overall Study||0
2418578|NCT01236352|5931884|P1|COMPLETED|Overall Study||0
2418579|NCT01236352|5931874|P11|STARTED|Overall Study||20
2418580|NCT01236352|5931875|P10|STARTED|Overall Study||22
2418581|NCT01236352|5931876|P9|STARTED|Overall Study||3
2418582|NCT01236352|5931877|P8|STARTED|Overall Study||7
2418583|NCT01236352|5931878|P7|STARTED|Overall Study||8
2418584|NCT01236352|5931879|P6|STARTED|Overall Study||4
2418585|NCT01236352|5931880|P5|STARTED|Overall Study||4
2418586|NCT01236352|5931881|P4|STARTED|Overall Study||4
2418587|NCT01236352|5931882|P3|STARTED|Overall Study||4
2418588|NCT01236352|5931883|P2|STARTED|Overall Study||4
2418589|NCT01236352|5931884|P1|STARTED|Overall Study||4
2418590|NCT01236326|5932053|P2|NOT COMPLETED|Overall Study||4
2418591|NCT01236326|5932054|P1|NOT COMPLETED|Overall Study||1
2418592|NCT01236326|5932053|P2|COMPLETED|Overall Study||51
2418593|NCT01236326|5932054|P1|COMPLETED|Overall Study||49
2418594|NCT01236326|5932053|P2|STARTED|Overall Study||55
2418595|NCT01236326|5932054|P1|STARTED|Overall Study||50
2418596|NCT01236300|5932068|P1|NOT COMPLETED|Overall Study||0
2418597|NCT01236300|5932068|P1|COMPLETED|Overall Study||66
2418598|NCT01236300|5932068|P1|STARTED|Overall Study||66
2418599|NCT01236196|5932078|P2|NOT COMPLETED|Overall Study||8
2418600|NCT01236196|5932079|P1|NOT COMPLETED|Overall Study||1
2418601|NCT01236196|5932078|P2|COMPLETED|Overall Study||13
2418602|NCT01236196|5932079|P1|COMPLETED|Overall Study||17
2418603|NCT01236196|5932078|P2|STARTED|Overall Study||21
2418604|NCT01236196|5932079|P1|STARTED|Overall Study||18
2418605|NCT01236170|5932091|P1|NOT COMPLETED|Overall Study||15
2418606|NCT01236170|5932091|P1|COMPLETED|Overall Study||482
2418607|NCT01236170|5932091|P1|STARTED|Overall Study||497
2418608|NCT01236118|5932102|P3|NOT COMPLETED|Overall Study||3
2418609|NCT01236118|5932103|P2|NOT COMPLETED|Overall Study||1
2418610|NCT01236118|5932104|P1|NOT COMPLETED|Overall Study||2
2418611|NCT01236118|5932102|P3|COMPLETED|Overall Study||14
2418612|NCT01236118|5932103|P2|COMPLETED|Overall Study||4
2418613|NCT01236118|5932104|P1|COMPLETED|Overall Study||4
2418614|NCT01236118|5932102|P3|STARTED|Overall Study||17
2418615|NCT01236118|5932103|P2|STARTED|Overall Study||5
2418616|NCT01236118|5932104|P1|STARTED|Overall Study||6
2418617|NCT01236105|5932112|P1|NOT COMPLETED|Overall Study||0
2418618|NCT01236105|5932112|P1|COMPLETED|Overall Study||21
2418619|NCT01236105|5932112|P1|STARTED|Overall Study||21
2418620|NCT01236053|5932148|P22|NOT COMPLETED|Overall Study||0
2418621|NCT01236053|5932149|P21|NOT COMPLETED|Overall Study||0
2418622|NCT01236053|5932150|P20|NOT COMPLETED|Overall Study||0
2418623|NCT01236053|5932151|P19|NOT COMPLETED|Overall Study||0
2418624|NCT01236053|5932152|P18|NOT COMPLETED|Overall Study||0
2418625|NCT01236053|5932153|P17|NOT COMPLETED|Overall Study||0
2418626|NCT01236053|5932154|P16|NOT COMPLETED|Overall Study||0
2418627|NCT01236053|5932155|P15|NOT COMPLETED|Overall Study||0
2418628|NCT01236053|5932156|P14|NOT COMPLETED|Overall Study||0
2418629|NCT01236053|5932157|P13|NOT COMPLETED|Overall Study||0
2418630|NCT01236053|5932158|P12|NOT COMPLETED|Overall Study||0
2418631|NCT01236053|5932159|P11|NOT COMPLETED|Overall Study||0
2418632|NCT01236053|5932160|P10|NOT COMPLETED|Overall Study||0
2418633|NCT01236053|5932161|P9|NOT COMPLETED|Overall Study||0
2418634|NCT01236053|5932162|P8|NOT COMPLETED|Overall Study||0
2418635|NCT01236053|5932163|P7|NOT COMPLETED|Overall Study||0
2418636|NCT01236053|5932164|P6|NOT COMPLETED|Overall Study||0
2418637|NCT01236053|5932165|P5|NOT COMPLETED|Overall Study||0
2418638|NCT01236053|5932166|P4|NOT COMPLETED|Overall Study||0
2418639|NCT01236053|5932167|P3|NOT COMPLETED|Overall Study||0
2418640|NCT01236053|5932168|P2|NOT COMPLETED|Overall Study||0
2418641|NCT01236053|5932169|P1|NOT COMPLETED|Overall Study||0
2418642|NCT01236053|5932148|P22|COMPLETED|Overall Study||12167
2418643|NCT01236053|5932149|P21|COMPLETED|Overall Study||1272
2418644|NCT01236053|5932150|P20|COMPLETED|Overall Study||20382
2418645|NCT01236053|5932151|P19|COMPLETED|Overall Study||2155
2418646|NCT01236053|5932152|P18|COMPLETED|Overall Study||380
2418647|NCT01236053|5932153|P17|COMPLETED|Overall Study||38
2418648|NCT01236053|5932154|P16|COMPLETED|Overall Study||43559
2418649|NCT01236053|5932155|P15|COMPLETED|Overall Study||4600
2418650|NCT01236053|5932156|P14|COMPLETED|Overall Study||1396
2418651|NCT01236053|5932157|P13|COMPLETED|Overall Study||148
2418652|NCT01236053|5932158|P12|COMPLETED|Overall Study||188924
2418653|NCT01236053|5932159|P11|COMPLETED|Overall Study||19564
2418654|NCT01236053|5932160|P10|COMPLETED|Overall Study||2935
2418655|NCT01236053|5932161|P9|COMPLETED|Overall Study||300
2418656|NCT01236053|5932162|P8|COMPLETED|Overall Study||102836
2418657|NCT01236053|5932163|P7|COMPLETED|Overall Study||10855
2418658|NCT01236053|5932164|P6|COMPLETED|Overall Study||2067
2418659|NCT01236053|5932165|P5|COMPLETED|Overall Study||212
2418660|NCT01236053|5932166|P4|COMPLETED|Overall Study||17853
2418661|NCT01236053|5932167|P3|COMPLETED|Overall Study||1877
2418662|NCT01236053|5932168|P2|COMPLETED|Overall Study||1710950
2418663|NCT01236053|5932169|P1|COMPLETED|Overall Study||179138
2418664|NCT01236053|5932148|P22|STARTED|Overall Study||12167
2418665|NCT01236053|5932149|P21|STARTED|Overall Study||1272
2418666|NCT01236053|5932150|P20|STARTED|Overall Study||20382
2418667|NCT01236053|5932151|P19|STARTED|Overall Study||2155
2418668|NCT01236053|5932152|P18|STARTED|Overall Study||380
2418669|NCT01236053|5932153|P17|STARTED|Overall Study||38
2418670|NCT01236053|5932154|P16|STARTED|Overall Study||43559
2418671|NCT01236053|5932155|P15|STARTED|Overall Study||4600
2418672|NCT01236053|5932156|P14|STARTED|Overall Study||1396
2418673|NCT01236053|5932157|P13|STARTED|Overall Study||148
2418674|NCT01236053|5932158|P12|STARTED|Overall Study||188924
2418675|NCT01236053|5932159|P11|STARTED|Overall Study||19564
2418676|NCT01236053|5932160|P10|STARTED|Overall Study||2935
2418677|NCT01236053|5932161|P9|STARTED|Overall Study||300
2418678|NCT01236053|5932162|P8|STARTED|Overall Study||102836
2418679|NCT01236053|5932163|P7|STARTED|Overall Study||10855
2418680|NCT01236053|5932164|P6|STARTED|Overall Study||2067
2418681|NCT01236053|5932165|P5|STARTED|Overall Study||212
2418682|NCT01236053|5932166|P4|STARTED|Overall Study||17853
2418683|NCT01236053|5932167|P3|STARTED|Overall Study||1877
2418684|NCT01236053|5932168|P2|STARTED|Overall Study||1710950
2418685|NCT01236053|5932169|P1|STARTED|Overall Study||179138
2418686|NCT01236001|5932305|P2|NOT COMPLETED|Overall Study||22
2418687|NCT01236001|5932306|P1|NOT COMPLETED|Overall Study||18
2418688|NCT01236001|5932305|P2|COMPLETED|Overall Study||65
2418689|NCT01236001|5932306|P1|COMPLETED|Overall Study||87
2418690|NCT01236001|5932305|P2|STARTED|Overall Study||87
2418691|NCT01236001|5932306|P1|STARTED|Overall Study||105
2418692|NCT01235975|5932338|P2|NOT COMPLETED|Overall Study||7
2418693|NCT01235975|5932339|P1|NOT COMPLETED|Overall Study||17
2418694|NCT01235975|5932338|P2|COMPLETED|Overall Study||88
2418695|NCT01235975|5932339|P1|COMPLETED|Overall Study||257
2418696|NCT01235975|5932338|P2|STARTED|Overall Study||95
2418697|NCT01235975|5932339|P1|STARTED|Overall Study||274
2418698|NCT01235949|5932389|P18|NOT COMPLETED|Booster Phase||2
2418699|NCT01235949|5932390|P17|NOT COMPLETED|Booster Phase||0
2418700|NCT01235949|5932391|P16|NOT COMPLETED|Booster Phase||1
2418701|NCT01235949|5932392|P15|NOT COMPLETED|Booster Phase||2
2418702|NCT01235949|5932393|P14|NOT COMPLETED|Booster Phase||0
2418703|NCT01235949|5932394|P13|NOT COMPLETED|Booster Phase||3
2418704|NCT01235949|5932395|P12|NOT COMPLETED|Booster Phase||3
2418705|NCT01235949|5932396|P11|NOT COMPLETED|Booster Phase||2
2418706|NCT01235949|5932397|P10|NOT COMPLETED|Booster Phase||1
2418707|NCT01235949|5932398|P9|NOT COMPLETED|Booster Phase||2
2418708|NCT01235949|5932399|P8|NOT COMPLETED|Booster Phase||1
2418709|NCT01235949|5932400|P7|NOT COMPLETED|Booster Phase||0
2418710|NCT01235949|5932401|P6|NOT COMPLETED|Booster Phase||0
2418711|NCT01235949|5932402|P5|NOT COMPLETED|Booster Phase||0
2418712|NCT01235949|5932403|P4|NOT COMPLETED|Booster Phase||0
2418713|NCT01235949|5932404|P3|NOT COMPLETED|Booster Phase||0
2418714|NCT01235949|5932405|P2|NOT COMPLETED|Booster Phase||0
2418715|NCT01235949|5932406|P1|NOT COMPLETED|Booster Phase||0
2418716|NCT01235949|5932389|P18|COMPLETED|Booster Phase||65
2418717|NCT01235949|5932390|P17|COMPLETED|Booster Phase||68
2418718|NCT01235949|5932391|P16|COMPLETED|Booster Phase||66
2418719|NCT01235949|5932392|P15|COMPLETED|Booster Phase||60
2418720|NCT01235949|5932393|P14|COMPLETED|Booster Phase||65
2418721|NCT01235949|5932394|P13|COMPLETED|Booster Phase||60
2418722|NCT01235949|5932395|P12|COMPLETED|Booster Phase||60
2418723|NCT01235949|5932396|P11|COMPLETED|Booster Phase||61
2418724|NCT01235949|5932397|P10|COMPLETED|Booster Phase||62
2418725|NCT01235949|5932398|P9|COMPLETED|Booster Phase||61
2418726|NCT01235949|5932399|P8|COMPLETED|Booster Phase||59
2418727|NCT01235949|5932400|P7|COMPLETED|Booster Phase||64
2418728|NCT01235949|5932401|P6|COMPLETED|Booster Phase||0
2418729|NCT01235949|5932402|P5|COMPLETED|Booster Phase||0
2418730|NCT01235949|5932403|P4|COMPLETED|Booster Phase||0
2418731|NCT01235949|5932404|P3|COMPLETED|Booster Phase||0
2418732|NCT01235949|5932405|P2|COMPLETED|Booster Phase||0
2418733|NCT01235949|5932406|P1|COMPLETED|Booster Phase||0
2418734|NCT01235949|5932389|P18|STARTED|Booster Phase|subjects from the primary NPARA group continuing in booster phase with different treatment|67
2418735|NCT01235949|5932390|P17|STARTED|Booster Phase|subjects from the primary DPARA group continuing in booster phase with different treatment|68
2418736|NCT01235949|5932391|P16|STARTED|Booster Phase|subjects from the primary IPARA group continuing in booster phase with different treatment|67
2418737|NCT01235949|5932392|P15|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|62
2418738|NCT01235949|5932393|P14|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|65
2418739|NCT01235949|5932394|P13|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|63
2418740|NCT01235949|5932395|P12|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
2418741|NCT01235949|5932396|P11|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
2418742|NCT01235949|5932397|P10|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
2418743|NCT01235949|5932398|P9|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|63
2418744|NCT01235949|5932399|P8|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|60
2418745|NCT01235949|5932400|P7|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|64
2418746|NCT01235949|5932401|P6|STARTED|Booster Phase|subjects re-randomized to NPARA-IPARA Group in booster phase|0
2418747|NCT01235949|5932402|P5|STARTED|Booster Phase|subjects re-randomized to DPARA-IPARA Group in booster phase|0
2418748|NCT01235949|5932403|P4|STARTED|Booster Phase|subjects re-randomized to IPARA-NPARA Group in booster phase|0
2418749|NCT01235949|5932404|P3|STARTED|Booster Phase|re-randomized to diverse treatments (NIBU-IIBU, NIBU-DIBU and NIBU-NIBU Groups) in booster phase|0
2418750|NCT01235949|5932405|P2|STARTED|Booster Phase|re-randomized to diverse treatments (DIBU-IIBU, DIBU-DIBU and DIBU-NIBU Groups) in booster phase|0
2418751|NCT01235949|5932406|P1|STARTED|Booster Phase|re-randomized to diverse treatments (IIBU-IIBU, IIBU-DIBU and IIBU-NIBU Groups) in booster phase|0
2418752|NCT01235949|5932389|P18|NOT COMPLETED|Primary Phase||0
2418753|NCT01235949|5932390|P17|NOT COMPLETED|Primary Phase||0
2418754|NCT01235949|5932391|P16|NOT COMPLETED|Primary Phase||0
2418755|NCT01235949|5932392|P15|NOT COMPLETED|Primary Phase||0
2418756|NCT01235949|5932393|P14|NOT COMPLETED|Primary Phase||0
2418757|NCT01235949|5932394|P13|NOT COMPLETED|Primary Phase||0
2418758|NCT01235949|5932395|P12|NOT COMPLETED|Primary Phase||0
2418759|NCT01235949|5932396|P11|NOT COMPLETED|Primary Phase||0
2418760|NCT01235949|5932397|P10|NOT COMPLETED|Primary Phase||0
2418761|NCT01235949|5932398|P9|NOT COMPLETED|Primary Phase||0
2418762|NCT01235949|5932399|P8|NOT COMPLETED|Primary Phase||0
2418763|NCT01235949|5932400|P7|NOT COMPLETED|Primary Phase||0
2418764|NCT01235949|5932401|P6|NOT COMPLETED|Primary Phase||7
2418765|NCT01235949|5932402|P5|NOT COMPLETED|Primary Phase||1
2418766|NCT01235949|5932403|P4|NOT COMPLETED|Primary Phase||2
2418767|NCT01235949|5932404|P3|NOT COMPLETED|Primary Phase||3
2418768|NCT01235949|5932405|P2|NOT COMPLETED|Primary Phase||3
2418769|NCT01235949|5932406|P1|NOT COMPLETED|Primary Phase||4
2418770|NCT01235949|5932389|P18|COMPLETED|Primary Phase||0
2418771|NCT01235949|5932390|P17|COMPLETED|Primary Phase||0
2418772|NCT01235949|5932391|P16|COMPLETED|Primary Phase||0
2418773|NCT01235949|5932392|P15|COMPLETED|Primary Phase||0
2418774|NCT01235949|5932393|P14|COMPLETED|Primary Phase||0
2418775|NCT01235949|5932394|P13|COMPLETED|Primary Phase||0
2418776|NCT01235949|5932395|P12|COMPLETED|Primary Phase||0
2418777|NCT01235949|5932396|P11|COMPLETED|Primary Phase||0
2418778|NCT01235949|5932397|P10|COMPLETED|Primary Phase||0
2418779|NCT01235949|5932398|P9|COMPLETED|Primary Phase||0
2418780|NCT01235949|5932399|P8|COMPLETED|Primary Phase||0
2418781|NCT01235949|5932400|P7|COMPLETED|Primary Phase||0
2418782|NCT01235949|5932401|P6|COMPLETED|Primary Phase|After Primary Phase completion, all subjects were willing to participate in the Booster Phase|67
2418783|NCT01235949|5932402|P5|COMPLETED|Primary Phase|After Primary Phase completion, 3 subjects were not willing to participate in the Booster Phase|71
2418784|NCT01235949|5932403|P4|COMPLETED|Primary Phase|After Primary Phase completion, 2 subjects were not willing to participate in the Booster Phase|69
2418785|NCT01235949|5932404|P3|COMPLETED|Primary Phase|After Primary Phase completion, 6 subjects were not willing to participate in the Booster Phase|196
2418786|NCT01235949|5932405|P2|COMPLETED|Primary Phase|After Primary Phase completion, 6 subjects were not willing to participate in the Booster Phase|195
2418787|NCT01235949|5932406|P1|COMPLETED|Primary Phase|After Primary Phase completion, 7 subjects were not willing to participate in the Booster Phase|194
2418788|NCT01235949|5932389|P18|STARTED|Primary Phase||0
2418789|NCT01235949|5932390|P17|STARTED|Primary Phase||0
2418790|NCT01235949|5932391|P16|STARTED|Primary Phase||0
2418791|NCT01235949|5932392|P15|STARTED|Primary Phase||0
2418792|NCT01235949|5932393|P14|STARTED|Primary Phase||0
2418793|NCT01235949|5932394|P13|STARTED|Primary Phase||0
2418794|NCT01235949|5932395|P12|STARTED|Primary Phase||0
2418795|NCT01235949|5932396|P11|STARTED|Primary Phase||0
2418796|NCT01235949|5932397|P10|STARTED|Primary Phase||0
2418797|NCT01235949|5932398|P9|STARTED|Primary Phase||0
2418798|NCT01235949|5932399|P8|STARTED|Primary Phase||0
2418799|NCT01235949|5932400|P7|STARTED|Primary Phase||0
2418800|NCT01235949|5932401|P6|STARTED|Primary Phase||74
2418801|NCT01235949|5932402|P5|STARTED|Primary Phase||72
2418802|NCT01235949|5932403|P4|STARTED|Primary Phase||71
2418803|NCT01235949|5932404|P3|STARTED|Primary Phase||199
2418804|NCT01235949|5932405|P2|STARTED|Primary Phase||198
2418805|NCT01235949|5932406|P1|STARTED|Primary Phase||198
2418806|NCT01235910|5932642|P1|NOT COMPLETED|Overall Study||0
2418807|NCT01235910|5932642|P1|COMPLETED|Overall Study||1
2418808|NCT01235910|5932642|P1|STARTED|Overall Study||1
2418809|NCT01235897|5932648|P1|NOT COMPLETED|Overall Study||0
2418810|NCT01235897|5932648|P1|COMPLETED|Overall Study||16
2418811|NCT01235897|5932648|P1|STARTED|Overall Study||16
2418812|NCT01235741|5932656|P3|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||7
2418813|NCT01235741|5932657|P2|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||9
2418814|NCT01235741|5932658|P1|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||0
2418815|NCT01235741|5932656|P3|COMPLETED|Follow-Up Post Treatment up to Month 6|7 participants did not complete the 6 month follow up period|29
2418816|NCT01235741|5932657|P2|COMPLETED|Follow-Up Post Treatment up to Month 6|9 participants did not complete the 6 month follow up period|27
2418817|NCT01235741|5932658|P1|COMPLETED|Follow-Up Post Treatment up to Month 6||0
2418818|NCT01235741|5932656|P3|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with drug (36) were followed up 6 months post treatment.|36
2418819|NCT01235741|5932657|P2|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with placebo (36) were followed up 6 Months post treatment.|36
2418820|NCT01235741|5932658|P1|STARTED|Follow-Up Post Treatment up to Month 6||0
2418821|NCT01235741|5932656|P3|NOT COMPLETED|Randomized to Treatment||36
2418822|NCT01235741|5932657|P2|NOT COMPLETED|Randomized to Treatment||36
2418823|NCT01235741|5932658|P1|NOT COMPLETED|Randomized to Treatment||0
2418824|NCT01235741|5932656|P3|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
2418825|NCT01235741|5932657|P2|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
2418826|NCT01235741|5932658|P1|COMPLETED|Randomized to Treatment||0
2418827|NCT01235741|5932656|P3|STARTED|Randomized to Treatment||36
2418828|NCT01235741|5932657|P2|STARTED|Randomized to Treatment||36
2418829|NCT01235741|5932658|P1|STARTED|Randomized to Treatment||0
2418830|NCT01235741|5932656|P3|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
2418831|NCT01235741|5932657|P2|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
2418832|NCT01235741|5932658|P1|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||141
2418833|NCT01235741|5932656|P3|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
2418834|NCT01235741|5932657|P2|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
2418835|NCT01235741|5932658|P1|COMPLETED|Non-Randomized Low Calorie Diet Lead-In|Study terminated by Sponsor. 72 randomized to treatment at time study halted.|72
2418836|NCT01235741|5932656|P3|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
2418837|NCT01235741|5932657|P2|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
2418838|NCT01235741|5932658|P1|STARTED|Non-Randomized Low Calorie Diet Lead-In|6 Week LCD period. Those who lost >=2% of body weight were randomized to treatment.|213
2418839|NCT01235728|5932685|P8|NOT COMPLETED|Overall Study||0
2418840|NCT01235728|5932686|P7|NOT COMPLETED|Overall Study||0
2418841|NCT01235728|5932687|P6|NOT COMPLETED|Overall Study||0
2418842|NCT01235728|5932688|P5|NOT COMPLETED|Overall Study||0
2418843|NCT01235728|5932689|P4|NOT COMPLETED|Overall Study||1
2418844|NCT01235728|5932690|P3|NOT COMPLETED|Overall Study||0
2418845|NCT01235728|5932691|P2|NOT COMPLETED|Overall Study||0
2418846|NCT01235728|5932692|P1|NOT COMPLETED|Overall Study||0
2418847|NCT01235728|5932685|P8|COMPLETED|Overall Study||3
2418848|NCT01235728|5932686|P7|COMPLETED|Overall Study||3
2418849|NCT01235728|5932687|P6|COMPLETED|Overall Study||3
2418850|NCT01235728|5932688|P5|COMPLETED|Overall Study||3
2418851|NCT01235728|5932689|P4|COMPLETED|Overall Study||2
2418852|NCT01235728|5932690|P3|COMPLETED|Overall Study||3
2418853|NCT01235728|5932691|P2|COMPLETED|Overall Study||3
2418854|NCT01235728|5932692|P1|COMPLETED|Overall Study||3
2418855|NCT01235728|5932685|P8|STARTED|Overall Study||3
2418856|NCT01235728|5932686|P7|STARTED|Overall Study||3
2418857|NCT01235728|5932687|P6|STARTED|Overall Study||3
2418858|NCT01235728|5932688|P5|STARTED|Overall Study||3
2418859|NCT01235728|5932689|P4|STARTED|Overall Study||3
2418860|NCT01235728|5932690|P3|STARTED|Overall Study||3
2418861|NCT01235728|5932691|P2|STARTED|Overall Study||3
2418862|NCT01235728|5932692|P1|STARTED|Overall Study||3
2418863|NCT01235715|5932702|P2|NOT COMPLETED|Overall Study||2
2418864|NCT01235715|5932703|P1|NOT COMPLETED|Overall Study||0
2418865|NCT01235715|5932702|P2|COMPLETED|Overall Study||100
2418866|NCT01235715|5932703|P1|COMPLETED|Overall Study||98
2418867|NCT01235715|5932702|P2|STARTED|Overall Study||102
2418868|NCT01235715|5932703|P1|STARTED|Overall Study||98
2418869|NCT01235689|5932743|P2|NOT COMPLETED|Overall Study||32
2418870|NCT01235689|5932744|P1|NOT COMPLETED|Overall Study||29
2418871|NCT01235689|5932743|P2|COMPLETED|Overall Study||90
2418872|NCT01235689|5932744|P1|COMPLETED|Overall Study||93
2418873|NCT01235689|5932743|P2|Randomized at Week 9|Overall Study||53
2418874|NCT01235689|5932744|P1|Randomized at Week 9|Overall Study||59
2418875|NCT01235689|5932743|P2|Early Randomized (Baseline to Week 9)|Overall Study||69
2418876|NCT01235689|5932744|P1|Early Randomized (Baseline to Week 9)|Overall Study||63
2418877|NCT01235689|5932743|P2|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122
2418878|NCT01235689|5932744|P1|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122
2418879|NCT01235598|5932816|P2|NOT COMPLETED|Overall Study||4
2418880|NCT01235598|5932817|P1|NOT COMPLETED|Overall Study||1
2418881|NCT01235598|5932816|P2|COMPLETED|Overall Study||24
2418882|NCT01235598|5932817|P1|COMPLETED|Overall Study||12
2418883|NCT01235598|5932816|P2|STARTED|Overall Study|One subject was randomized to the CZP Arm but never received an injection (due to pre-treatment AE)|28
2418884|NCT01235598|5932817|P1|STARTED|Overall Study||13
2418885|NCT01235546|5932862|P2|NOT COMPLETED|Overall Study||1
2418886|NCT01235546|5932863|P1|NOT COMPLETED|Overall Study||2
2418887|NCT01235546|5932862|P2|COMPLETED|Overall Study||1018
2418888|NCT01235546|5932863|P1|COMPLETED|Overall Study||992
2418889|NCT01235546|5932862|P2|STARTED|Overall Study||1019
2418890|NCT01235546|5932863|P1|STARTED|Overall Study||994
2418891|NCT01235507|5932887|P1|NOT COMPLETED|Overall Study||2
2418892|NCT01235507|5932887|P1|COMPLETED|Overall Study||69
2418893|NCT01235507|5932887|P1|STARTED|Overall Study||71
2418894|NCT01235442|5932901|P2|NOT COMPLETED|Overall Study||44
2418895|NCT01235442|5932902|P1|NOT COMPLETED|Overall Study||44
2418896|NCT01235442|5932901|P2|COMPLETED|Overall Study||251
2418897|NCT01235442|5932902|P1|COMPLETED|Overall Study||253
2418898|NCT01235442|5932901|P2|STARTED|Overall Study||295
2418899|NCT01235442|5932902|P1|STARTED|Overall Study||297
2418900|NCT01235403|5932920|P1|NOT COMPLETED|Overall Study||26
2418901|NCT01235403|5932920|P1|COMPLETED|Overall Study||74
2418902|NCT01235403|5932920|P1|STARTED|Overall Study||100
2418903|NCT01235377|5932928|P2|NOT COMPLETED|Overall Study||1
2418904|NCT01235377|5932929|P1|NOT COMPLETED|Overall Study||1
2418905|NCT01235377|5932928|P2|COMPLETED|Overall Study||8
2418906|NCT01235377|5932929|P1|COMPLETED|Overall Study||10
2418907|NCT01235377|5932928|P2|STARTED|Overall Study||9
2418908|NCT01235377|5932929|P1|STARTED|Overall Study||11
2418909|NCT01235351|5932937|P2|NOT COMPLETED|Treatment With Different Dose Sequences||0
2418910|NCT01235351|5932938|P1|NOT COMPLETED|Treatment With Different Dose Sequences||0
2418911|NCT01235351|5932937|P2|COMPLETED|Treatment With Different Dose Sequences||82
2418912|NCT01235351|5932938|P1|COMPLETED|Treatment With Different Dose Sequences||233
2418913|NCT01235351|5932937|P2|300 mg First Then 225 mg|Treatment With Different Dose Sequences||41
2418914|NCT01235351|5932938|P1|300 mg First Then 225 mg|Treatment With Different Dose Sequences||0
2418915|NCT01235351|5932937|P2|225 mg First Then 300 mg|Treatment With Different Dose Sequences||41
2418916|NCT01235351|5932938|P1|225 mg First Then 300 mg|Treatment With Different Dose Sequences||0
2418917|NCT01235351|5932937|P2|150 mg First Then 75 mg|Treatment With Different Dose Sequences||0
2418918|NCT01235351|5932938|P1|150 mg First Then 75 mg|Treatment With Different Dose Sequences||117
2418919|NCT01235351|5932937|P2|75 mg First and Then 150 mg|Treatment With Different Dose Sequences||0
2418920|NCT01235351|5932938|P1|75 mg First and Then 150 mg|Treatment With Different Dose Sequences||116
2418921|NCT01235351|5932937|P2|STARTED|Treatment With Different Dose Sequences||82
2418922|NCT01235351|5932938|P1|STARTED|Treatment With Different Dose Sequences||233
2418923|NCT01235351|5932937|P2|NOT COMPLETED|Initial Treatment With 75 mg and 150 mg||4
2418924|NCT01235351|5932938|P1|NOT COMPLETED|Initial Treatment With 75 mg and 150 mg||10
2418925|NCT01235351|5932937|P2|COMPLETED|Initial Treatment With 75 mg and 150 mg||82
2418926|NCT01235351|5932938|P1|COMPLETED|Initial Treatment With 75 mg and 150 mg|4 allocated to initial treatment included in primary analysis|237
2418927|NCT01235351|5932937|P2|STARTED|Initial Treatment With 75 mg and 150 mg||86
2418928|NCT01235351|5932938|P1|STARTED|Initial Treatment With 75 mg and 150 mg||247
2418929|NCT01235338|5932950|P2|NOT COMPLETED|Overall Study||5
2418930|NCT01235338|5932951|P1|NOT COMPLETED|Overall Study||11
2418931|NCT01235338|5932950|P2|COMPLETED|Overall Study||33
2418932|NCT01235338|5932951|P1|COMPLETED|Overall Study||31
2418933|NCT01235338|5932950|P2|STARTED|Overall Study||38
2418934|NCT01235338|5932951|P1|STARTED|Overall Study||42
2418935|NCT01235234|5932996|P3|NOT COMPLETED|Overall Study||1
2418936|NCT01235234|5932997|P2|NOT COMPLETED|Overall Study||2
2418937|NCT01235234|5932998|P1|NOT COMPLETED|Overall Study||2
2418938|NCT01235234|5932996|P3|COMPLETED|Overall Study||80
2418939|NCT01235234|5932997|P2|COMPLETED|Overall Study||76
2418940|NCT01235234|5932998|P1|COMPLETED|Overall Study||75
2418941|NCT01235234|5932996|P3|STARTED|Overall Study||81
2418942|NCT01235234|5932997|P2|STARTED|Overall Study||78
2418943|NCT01235234|5932998|P1|STARTED|Overall Study||77
2418944|NCT01235195|5933006|P2|NOT COMPLETED|Second Intervention||0
2418945|NCT01235195|5933007|P1|NOT COMPLETED|Second Intervention||0
2418946|NCT01235195|5933006|P2|COMPLETED|Second Intervention||15
2418947|NCT01235195|5933007|P1|COMPLETED|Second Intervention||15
2418948|NCT01235195|5933006|P2|STARTED|Second Intervention||15
2418949|NCT01235195|5933007|P1|STARTED|Second Intervention||15
2418950|NCT01235195|5933006|P2|NOT COMPLETED|Washout Period of At Least 8 Days||0
2418951|NCT01235195|5933007|P1|NOT COMPLETED|Washout Period of At Least 8 Days||0
2418952|NCT01235195|5933006|P2|COMPLETED|Washout Period of At Least 8 Days||15
2418953|NCT01235195|5933007|P1|COMPLETED|Washout Period of At Least 8 Days||15
2418954|NCT01235195|5933006|P2|STARTED|Washout Period of At Least 8 Days||15
2418955|NCT01235195|5933007|P1|STARTED|Washout Period of At Least 8 Days||15
2418956|NCT01235195|5933006|P2|NOT COMPLETED|First Intervention||0
2418957|NCT01235195|5933007|P1|NOT COMPLETED|First Intervention||0
2418958|NCT01235195|5933006|P2|COMPLETED|First Intervention||15
2418959|NCT01235195|5933007|P1|COMPLETED|First Intervention||15
2418960|NCT01235195|5933006|P2|STARTED|First Intervention||15
2418961|NCT01235195|5933007|P1|STARTED|First Intervention||15
2418962|NCT01234922|5933027|P4|NOT COMPLETED|Overall Study||0
2418963|NCT01234922|5933028|P3|NOT COMPLETED|Overall Study||0
2418964|NCT01234922|5933029|P2|NOT COMPLETED|Overall Study||0
2418965|NCT01234922|5933030|P1|NOT COMPLETED|Overall Study||0
2418966|NCT01234922|5933027|P4|COMPLETED|Overall Study||2
2418967|NCT01234922|5933028|P3|COMPLETED|Overall Study||2
2418968|NCT01234922|5933029|P2|COMPLETED|Overall Study||1
2418969|NCT01234922|5933030|P1|COMPLETED|Overall Study||1
2418970|NCT01234922|5933027|P4|STARTED|Overall Study||2
2418971|NCT01234922|5933028|P3|STARTED|Overall Study||2
2418972|NCT01234922|5933029|P2|STARTED|Overall Study||1
2418973|NCT01234922|5933030|P1|STARTED|Overall Study||1
2418974|NCT01234883|5933046|P2|NOT COMPLETED|Overall Study||13
2418975|NCT01234883|5933047|P1|NOT COMPLETED|Overall Study||10
2418976|NCT01234883|5933046|P2|COMPLETED|Overall Study||36
2418977|NCT01234883|5933047|P1|COMPLETED|Overall Study||41
2418978|NCT01234883|5933046|P2|STARTED|Overall Study||49
2418979|NCT01234883|5933047|P1|STARTED|Overall Study||51
2418980|NCT01234870|5933053|P1|NOT COMPLETED|Overall Study||0
2418981|NCT01234870|5933053|P1|COMPLETED|Overall Study||40
2418982|NCT01234870|5933053|P1|STARTED|Overall Study||40
2418983|NCT01234831|5933060|P2|NOT COMPLETED|Overall Study||4
2418984|NCT01234831|5933061|P1|NOT COMPLETED|Overall Study||2
2418985|NCT01234831|5933060|P2|COMPLETED|Overall Study||198
2418986|NCT01234831|5933061|P1|COMPLETED|Overall Study||259
2418987|NCT01234831|5933060|P2|STARTED|Overall Study||202
2418988|NCT01234831|5933061|P1|STARTED|Overall Study||261
2418989|NCT01234766|5933073|P1|NOT COMPLETED|Overall Study||4
2418990|NCT01234766|5933073|P1|COMPLETED|Overall Study||35
2418991|NCT01234766|5933073|P1|STARTED|Overall Study||39
2418992|NCT01234714|5933077|P1|NOT COMPLETED|Overall Study||0
2418993|NCT01234714|5933077|P1|COMPLETED|Overall Study||84
2418994|NCT01234714|5933077|P1|STARTED|Overall Study||84
2418995|NCT01234675|5933094|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
2418996|NCT01234675|5933095|P1|NOT COMPLETED|Second Intervention (6 Weeks)||2
2418997|NCT01234675|5933094|P2|COMPLETED|Second Intervention (6 Weeks)||8
2418998|NCT01234675|5933095|P1|COMPLETED|Second Intervention (6 Weeks)||7
2418999|NCT01234675|5933094|P2|STARTED|Second Intervention (6 Weeks)||8
2419000|NCT01234675|5933095|P1|STARTED|Second Intervention (6 Weeks)||9
2419001|NCT01234675|5933094|P2|NOT COMPLETED|First Intervention (6 Weeks)||1
2419002|NCT01234675|5933095|P1|NOT COMPLETED|First Intervention (6 Weeks)||1
2419003|NCT01234675|5933094|P2|COMPLETED|First Intervention (6 Weeks)||8
2419004|NCT01234675|5933095|P1|COMPLETED|First Intervention (6 Weeks)||9
2419005|NCT01234675|5933094|P2|STARTED|First Intervention (6 Weeks)||9
2419006|NCT01234675|5933095|P1|STARTED|First Intervention (6 Weeks)||10
2419007|NCT01234649|5933127|P2|NOT COMPLETED|Overall Study||38
2419008|NCT01234649|5933128|P1|NOT COMPLETED|Overall Study||43
2419009|NCT01234649|5933127|P2|COMPLETED|Overall Study||37
2419010|NCT01234649|5933128|P1|COMPLETED|Overall Study||35
2419011|NCT01234649|5933127|P2|STARTED|Overall Study||75
2419012|NCT01234649|5933128|P1|STARTED|Overall Study||78
2419013|NCT01234467|5933176|P1|NOT COMPLETED|Overall Study||12
2419014|NCT01234467|5933176|P1|COMPLETED|Overall Study||11
2419015|NCT01234467|5933176|P1|STARTED|Overall Study||23
2419016|NCT01234402|5933188|P3|NOT COMPLETED|Overall Study||8
2419017|NCT01234402|5933189|P2|NOT COMPLETED|Overall Study||6
2419018|NCT01234402|5933190|P1|NOT COMPLETED|Overall Study||1
2419019|NCT01234402|5933188|P3|COMPLETED|Overall Study||42
2419020|NCT01234402|5933189|P2|COMPLETED|Overall Study||45
2419021|NCT01234402|5933190|P1|COMPLETED|Overall Study||51
2419022|NCT01234402|5933188|P3|Capecitabine Crossover to Icrucumab|Overall Study||1
2419023|NCT01234402|5933189|P2|Capecitabine Crossover to Icrucumab|Overall Study||0
2419024|NCT01234402|5933190|P1|Capecitabine Crossover to Icrucumab|Overall Study||0
2419025|NCT01234402|5933188|P3|Capecitabine Crossover to Ramucirumab|Overall Study||29
2419026|NCT01234402|5933189|P2|Capecitabine Crossover to Ramucirumab|Overall Study||0
2419027|NCT01234402|5933190|P1|Capecitabine Crossover to Ramucirumab|Overall Study||0
2419028|NCT01234402|5933188|P3|Received at Least One Dose of Study Drug|Overall Study||49
2419029|NCT01234402|5933189|P2|Received at Least One Dose of Study Drug|Overall Study||49
2419030|NCT01234402|5933190|P1|Received at Least One Dose of Study Drug|Overall Study||52
2419031|NCT01234402|5933188|P3|STARTED|Overall Study||50
2419032|NCT01234402|5933189|P2|STARTED|Overall Study||51
2419033|NCT01234402|5933190|P1|STARTED|Overall Study||52
2419034|NCT01234350|5933231|P2|NOT COMPLETED|Overall Study||267
2419035|NCT01234350|5933232|P1|NOT COMPLETED|Overall Study||687
2419036|NCT01234350|5933231|P2|COMPLETED|Overall Study||226
2419037|NCT01234350|5933232|P1|COMPLETED|Overall Study||313
2419038|NCT01234350|5933231|P2|STARTED|Overall Study||493
2419039|NCT01234350|5933232|P1|STARTED|Overall Study||1000
2419040|NCT01234337|5933258|P2|NOT COMPLETED|Overall Study||271
2419041|NCT01234337|5933259|P1|NOT COMPLETED|Overall Study||266
2419042|NCT01234337|5933258|P2|COMPLETED|Overall Study||0
2419043|NCT01234337|5933259|P1|COMPLETED|Overall Study||0
2419044|NCT01234337|5933258|P2|Participants Received Treatment|Overall Study||267
2419045|NCT01234337|5933259|P1|Participants Received Treatment|Overall Study||260
2419046|NCT01234337|5933258|P2|STARTED|Overall Study||271
2419047|NCT01234337|5933259|P1|STARTED|Overall Study||266
2419048|NCT01234207|5933287|P2|NOT COMPLETED|Second Intervention||0
2419049|NCT01234207|5933288|P1|NOT COMPLETED|Second Intervention||0
2419050|NCT01234207|5933287|P2|COMPLETED|Second Intervention||48
2419051|NCT01234207|5933288|P1|COMPLETED|Second Intervention||47
2419052|NCT01234207|5933287|P2|STARTED|Second Intervention||48
2419053|NCT01234207|5933288|P1|STARTED|Second Intervention||47
2419054|NCT01234207|5933287|P2|NOT COMPLETED|1-Week Washout Period||0
2419055|NCT01234207|5933288|P1|NOT COMPLETED|1-Week Washout Period||0
2419056|NCT01234207|5933287|P2|COMPLETED|1-Week Washout Period||48
2419057|NCT01234207|5933288|P1|COMPLETED|1-Week Washout Period||47
2419058|NCT01234207|5933287|P2|STARTED|1-Week Washout Period||48
2419059|NCT01234207|5933288|P1|STARTED|1-Week Washout Period||47
2419060|NCT01234207|5933287|P2|NOT COMPLETED|First Intervention||0
2419061|NCT01234207|5933288|P1|NOT COMPLETED|First Intervention||0
2419062|NCT01234207|5933287|P2|COMPLETED|First Intervention||48
2419063|NCT01234207|5933288|P1|COMPLETED|First Intervention||47
2419064|NCT01234207|5933287|P2|STARTED|First Intervention||48
2419065|NCT01234207|5933288|P1|STARTED|First Intervention||47
2419066|NCT01234103|5933310|P2|NOT COMPLETED|Overall Study||0
2419067|NCT01234103|5933311|P1|NOT COMPLETED|Overall Study||0
2419068|NCT01234103|5933310|P2|COMPLETED|Overall Study||391
2419069|NCT01234103|5933311|P1|COMPLETED|Overall Study||542
2419070|NCT01234103|5933310|P2|STARTED|Overall Study||391
2419071|NCT01234103|5933311|P1|STARTED|Overall Study||542
2419072|NCT01233999|5933319|P1|NOT COMPLETED|Overall Study||2
2419073|NCT01233999|5933319|P1|COMPLETED|Overall Study||8
2419074|NCT01233999|5933319|P1|STARTED|Overall Study||10
2419075|NCT01233921|5933325|P2|NOT COMPLETED|Overall Study||0
2419076|NCT01233921|5933326|P1|NOT COMPLETED|Overall Study||0
2419077|NCT01233921|5933325|P2|COMPLETED|Overall Study||3
2419078|NCT01233921|5933326|P1|COMPLETED|Overall Study||3
2419079|NCT01233921|5933325|P2|STARTED|Overall Study||3
2419080|NCT01233921|5933326|P1|STARTED|Overall Study||3
2419081|NCT01233869|5933338|P4|NOT COMPLETED|Extended Treatment Period (46 Months)||16
2419082|NCT01233869|5933339|P3|NOT COMPLETED|Extended Treatment Period (46 Months)||5
2419083|NCT01233869|5933340|P2|NOT COMPLETED|Extended Treatment Period (46 Months)||3
2419084|NCT01233869|5933341|P1|NOT COMPLETED|Extended Treatment Period (46 Months)||14
2419085|NCT01233869|5933338|P4|COMPLETED|Extended Treatment Period (46 Months)||18
2419086|NCT01233869|5933339|P3|COMPLETED|Extended Treatment Period (46 Months)||17
2419087|NCT01233869|5933340|P2|COMPLETED|Extended Treatment Period (46 Months)||0
2419088|NCT01233869|5933341|P1|COMPLETED|Extended Treatment Period (46 Months)||20
2419089|NCT01233869|5933338|P4|STARTED|Extended Treatment Period (46 Months)||34
2419090|NCT01233869|5933339|P3|STARTED|Extended Treatment Period (46 Months)||22
2419091|NCT01233869|5933340|P2|STARTED|Extended Treatment Period (46 Months)||3
2419092|NCT01233869|5933341|P1|STARTED|Extended Treatment Period (46 Months)||34
2419093|NCT01233869|5933338|P4|NOT COMPLETED|Washout Period 30 Days||0
2419094|NCT01233869|5933339|P3|NOT COMPLETED|Washout Period 30 Days||0
2419095|NCT01233869|5933340|P2|NOT COMPLETED|Washout Period 30 Days||0
2419096|NCT01233869|5933341|P1|NOT COMPLETED|Washout Period 30 Days||0
2419097|NCT01233869|5933338|P4|COMPLETED|Washout Period 30 Days||34
2419098|NCT01233869|5933339|P3|COMPLETED|Washout Period 30 Days||22
2419099|NCT01233869|5933340|P2|COMPLETED|Washout Period 30 Days||3
2419100|NCT01233869|5933341|P1|COMPLETED|Washout Period 30 Days||34
2419101|NCT01233869|5933338|P4|STARTED|Washout Period 30 Days||34
2419102|NCT01233869|5933339|P3|STARTED|Washout Period 30 Days||22
2419103|NCT01233869|5933340|P2|STARTED|Washout Period 30 Days||3
2419104|NCT01233869|5933341|P1|STARTED|Washout Period 30 Days||34
2419105|NCT01233869|5933338|P4|NOT COMPLETED|Initial Treatment Period (24 Months)||22
2419106|NCT01233869|5933339|P3|NOT COMPLETED|Initial Treatment Period (24 Months)||2
2419107|NCT01233869|5933340|P2|NOT COMPLETED|Initial Treatment Period (24 Months)||28
2419108|NCT01233869|5933341|P1|NOT COMPLETED|Initial Treatment Period (24 Months)||24
2419109|NCT01233869|5933338|P4|COMPLETED|Initial Treatment Period (24 Months)||34
2419110|NCT01233869|5933339|P3|COMPLETED|Initial Treatment Period (24 Months)||22
2419111|NCT01233869|5933340|P2|COMPLETED|Initial Treatment Period (24 Months)||3
2419112|NCT01233869|5933341|P1|COMPLETED|Initial Treatment Period (24 Months)||34
2419113|NCT01233869|5933338|P4|STARTED|Initial Treatment Period (24 Months)||56
2419114|NCT01233869|5933339|P3|STARTED|Initial Treatment Period (24 Months)||24
2419115|NCT01233869|5933340|P2|STARTED|Initial Treatment Period (24 Months)||31
2419116|NCT01233869|5933341|P1|STARTED|Initial Treatment Period (24 Months)||58
2419117|NCT01233817|5933427|P1|NOT COMPLETED|Overall Study||3
2419118|NCT01233817|5933427|P1|COMPLETED|Overall Study||9
2419119|NCT01233817|5933427|P1|STARTED|Overall Study||12
2419120|NCT01233726|5933434|P3|NOT COMPLETED|Overall Study||1
2419121|NCT01233726|5933435|P2|NOT COMPLETED|Overall Study||0
2419122|NCT01233726|5933436|P1|NOT COMPLETED|Overall Study||1
2419123|NCT01233726|5933434|P3|COMPLETED|Overall Study||52
2419124|NCT01233726|5933435|P2|COMPLETED|Overall Study||53
2419125|NCT01233726|5933436|P1|COMPLETED|Overall Study||52
2419126|NCT01233726|5933434|P3|STARTED|Overall Study||53
2419127|NCT01233726|5933435|P2|STARTED|Overall Study||53
2419128|NCT01233726|5933436|P1|STARTED|Overall Study||53
2419129|NCT01233687|5933474|P1|NOT COMPLETED|Phase II AMG 102 + Erlotinib||4
2419130|NCT01233687|5933474|P1|COMPLETED|Phase II AMG 102 + Erlotinib||45
2419131|NCT01233687|5933474|P1|Response-Evaluable|Phase II AMG 102 + Erlotinib||45
2419132|NCT01233687|5933474|P1|STARTED|Phase II AMG 102 + Erlotinib|Includes 7 participants from Phase 1 part of study.|49
2419133|NCT01233687|5933474|P1|NOT COMPLETED|Phase I RP2D AMG 102 + Erlotinib||0
2419134|NCT01233687|5933474|P1|COMPLETED|Phase I RP2D AMG 102 + Erlotinib||7
2419135|NCT01233687|5933474|P1|STARTED|Phase I RP2D AMG 102 + Erlotinib||7
2419136|NCT01233609|5933484|P2|NOT COMPLETED|Overall Study||2
2419137|NCT01233609|5933485|P1|NOT COMPLETED|Overall Study||9
2419138|NCT01233609|5933484|P2|COMPLETED|Overall Study||42
2419139|NCT01233609|5933485|P1|COMPLETED|Overall Study||37
2419140|NCT01233609|5933484|P2|STARTED|Overall Study||44
2419141|NCT01233609|5933485|P1|STARTED|Overall Study||46
2419142|NCT01233284|5933509|P5|NOT COMPLETED|Period 4 (4 Weeks)||0
2419143|NCT01233284|5933510|P4|NOT COMPLETED|Period 4 (4 Weeks)||1
2419144|NCT01233284|5933511|P3|NOT COMPLETED|Period 4 (4 Weeks)||0
2419145|NCT01233284|5933512|P2|NOT COMPLETED|Period 4 (4 Weeks)||1
2419146|NCT01233284|5933513|P1|NOT COMPLETED|Period 4 (4 Weeks)||0
2419147|NCT01233284|5933509|P5|COMPLETED|Period 4 (4 Weeks)||1
2419148|NCT01233284|5933510|P4|COMPLETED|Period 4 (4 Weeks)||33
2419149|NCT01233284|5933511|P3|COMPLETED|Period 4 (4 Weeks)||35
2419150|NCT01233284|5933512|P2|COMPLETED|Period 4 (4 Weeks)||36
2419151|NCT01233284|5933513|P1|COMPLETED|Period 4 (4 Weeks)||36
2419152|NCT01233284|5933509|P5|STARTED|Period 4 (4 Weeks)||1
2419153|NCT01233284|5933510|P4|STARTED|Period 4 (4 Weeks)||34
2419154|NCT01233284|5933511|P3|STARTED|Period 4 (4 Weeks)||35
2419155|NCT01233284|5933512|P2|STARTED|Period 4 (4 Weeks)||37
2419156|NCT01233284|5933513|P1|STARTED|Period 4 (4 Weeks)||36
2419157|NCT01233284|5933509|P5|NOT COMPLETED|Period 3 (4 Weeks)||0
2419158|NCT01233284|5933510|P4|NOT COMPLETED|Period 3 (4 Weeks)||1
2419159|NCT01233284|5933511|P3|NOT COMPLETED|Period 3 (4 Weeks)||1
2419160|NCT01233284|5933512|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
2419161|NCT01233284|5933513|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
2419162|NCT01233284|5933509|P5|COMPLETED|Period 3 (4 Weeks)||1
2419163|NCT01233284|5933510|P4|COMPLETED|Period 3 (4 Weeks)||34
2419164|NCT01233284|5933511|P3|COMPLETED|Period 3 (4 Weeks)||35
2419165|NCT01233284|5933512|P2|COMPLETED|Period 3 (4 Weeks)||37
2419166|NCT01233284|5933513|P1|COMPLETED|Period 3 (4 Weeks)||36
2419167|NCT01233284|5933509|P5|STARTED|Period 3 (4 Weeks)||1
2419168|NCT01233284|5933510|P4|STARTED|Period 3 (4 Weeks)||35
2419169|NCT01233284|5933511|P3|STARTED|Period 3 (4 Weeks)||36
2419170|NCT01233284|5933512|P2|STARTED|Period 3 (4 Weeks)||37
2419171|NCT01233284|5933513|P1|STARTED|Period 3 (4 Weeks)||36
2419172|NCT01233284|5933509|P5|NOT COMPLETED|Period 2 (4 Weeks)||0
2419173|NCT01233284|5933510|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
2419174|NCT01233284|5933511|P3|NOT COMPLETED|Period 2 (4 Weeks)||1
2419175|NCT01233284|5933512|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
2419176|NCT01233284|5933513|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
2419177|NCT01233284|5933509|P5|COMPLETED|Period 2 (4 Weeks)||1
2419178|NCT01233284|5933510|P4|COMPLETED|Period 2 (4 Weeks)||35
2419179|NCT01233284|5933511|P3|COMPLETED|Period 2 (4 Weeks)||36
2419180|NCT01233284|5933512|P2|COMPLETED|Period 2 (4 Weeks)||37
2419181|NCT01233284|5933513|P1|COMPLETED|Period 2 (4 Weeks)||36
2419182|NCT01233284|5933509|P5|STARTED|Period 2 (4 Weeks)||1
2419183|NCT01233284|5933510|P4|STARTED|Period 2 (4 Weeks)||35
2419184|NCT01233284|5933511|P3|STARTED|Period 2 (4 Weeks)||37
2419185|NCT01233284|5933512|P2|STARTED|Period 2 (4 Weeks)||37
2419186|NCT01233284|5933513|P1|STARTED|Period 2 (4 Weeks)||36
2419187|NCT01233284|5933509|P5|NOT COMPLETED|Period 1 (4 Weeks)||0
2419188|NCT01233284|5933510|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
2419189|NCT01233284|5933511|P3|NOT COMPLETED|Period 1 (4 Weeks)||1
2419190|NCT01233284|5933512|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
2419191|NCT01233284|5933513|P1|NOT COMPLETED|Period 1 (4 Weeks)||1
2419192|NCT01233284|5933509|P5|COMPLETED|Period 1 (4 Weeks)||1
2419193|NCT01233284|5933510|P4|COMPLETED|Period 1 (4 Weeks)||35
2419194|NCT01233284|5933511|P3|COMPLETED|Period 1 (4 Weeks)||37
2419195|NCT01233284|5933512|P2|COMPLETED|Period 1 (4 Weeks)||37
2419196|NCT01233284|5933513|P1|COMPLETED|Period 1 (4 Weeks)||36
2419197|NCT01233284|5933509|P5|STARTED|Period 1 (4 Weeks)||1
2419198|NCT01233284|5933510|P4|STARTED|Period 1 (4 Weeks)||35
2419199|NCT01233284|5933511|P3|STARTED|Period 1 (4 Weeks)||38
2419200|NCT01233284|5933512|P2|STARTED|Period 1 (4 Weeks)||38
2419201|NCT01233284|5933513|P1|STARTED|Period 1 (4 Weeks)||37
2419202|NCT01233258|5933594|P6|NOT COMPLETED|Second Intervention (6 Months)||0
2419203|NCT01233258|5933595|P5|NOT COMPLETED|Second Intervention (6 Months)||0
2419204|NCT01233258|5933596|P4|NOT COMPLETED|Second Intervention (6 Months)||0
2419205|NCT01233258|5933597|P3|NOT COMPLETED|Second Intervention (6 Months)||0
2419206|NCT01233258|5933598|P2|NOT COMPLETED|Second Intervention (6 Months)||0
2419207|NCT01233258|5933599|P1|NOT COMPLETED|Second Intervention (6 Months)||0
2419208|NCT01233258|5933594|P6|COMPLETED|Second Intervention (6 Months)||15
2419209|NCT01233258|5933595|P5|COMPLETED|Second Intervention (6 Months)||16
2419210|NCT01233258|5933596|P4|COMPLETED|Second Intervention (6 Months)||15
2419211|NCT01233258|5933597|P3|COMPLETED|Second Intervention (6 Months)||13
2419212|NCT01233258|5933598|P2|COMPLETED|Second Intervention (6 Months)||10
2419213|NCT01233258|5933599|P1|COMPLETED|Second Intervention (6 Months)||10
2419214|NCT01233258|5933594|P6|STARTED|Second Intervention (6 Months)||15
2419215|NCT01233258|5933595|P5|STARTED|Second Intervention (6 Months)||16
2419216|NCT01233258|5933596|P4|STARTED|Second Intervention (6 Months)||15
2419217|NCT01233258|5933597|P3|STARTED|Second Intervention (6 Months)||13
2419218|NCT01233258|5933598|P2|STARTED|Second Intervention (6 Months)||10
2419219|NCT01233258|5933599|P1|STARTED|Second Intervention (6 Months)||10
2419220|NCT01233258|5933594|P6|NOT COMPLETED|Washout (2-3 Days)||0
2419221|NCT01233258|5933595|P5|NOT COMPLETED|Washout (2-3 Days)||0
2419222|NCT01233258|5933596|P4|NOT COMPLETED|Washout (2-3 Days)||0
2419223|NCT01233258|5933597|P3|NOT COMPLETED|Washout (2-3 Days)||0
2419224|NCT01233258|5933598|P2|NOT COMPLETED|Washout (2-3 Days)||0
2419225|NCT01233258|5933599|P1|NOT COMPLETED|Washout (2-3 Days)||0
2419226|NCT01233258|5933594|P6|COMPLETED|Washout (2-3 Days)||15
2419227|NCT01233258|5933595|P5|COMPLETED|Washout (2-3 Days)||16
2419228|NCT01233258|5933596|P4|COMPLETED|Washout (2-3 Days)||15
2419229|NCT01233258|5933597|P3|COMPLETED|Washout (2-3 Days)||13
2419230|NCT01233258|5933598|P2|COMPLETED|Washout (2-3 Days)||10
2419231|NCT01233258|5933599|P1|COMPLETED|Washout (2-3 Days)||10
2419232|NCT01233258|5933594|P6|STARTED|Washout (2-3 Days)||15
2419233|NCT01233258|5933595|P5|STARTED|Washout (2-3 Days)||16
2419234|NCT01233258|5933596|P4|STARTED|Washout (2-3 Days)||15
2419235|NCT01233258|5933597|P3|STARTED|Washout (2-3 Days)||13
2419236|NCT01233258|5933598|P2|STARTED|Washout (2-3 Days)||10
2419237|NCT01233258|5933599|P1|STARTED|Washout (2-3 Days)||10
2419238|NCT01233258|5933594|P6|NOT COMPLETED|First Intervention (6 Months)||1
2419239|NCT01233258|5933595|P5|NOT COMPLETED|First Intervention (6 Months)||0
2419240|NCT01233258|5933596|P4|NOT COMPLETED|First Intervention (6 Months)||1
2419241|NCT01233258|5933597|P3|NOT COMPLETED|First Intervention (6 Months)||1
2419242|NCT01233258|5933598|P2|NOT COMPLETED|First Intervention (6 Months)||0
2419243|NCT01233258|5933599|P1|NOT COMPLETED|First Intervention (6 Months)||1
2419244|NCT01233258|5933594|P6|COMPLETED|First Intervention (6 Months)||15
2419245|NCT01233258|5933595|P5|COMPLETED|First Intervention (6 Months)||16
2419246|NCT01233258|5933596|P4|COMPLETED|First Intervention (6 Months)||15
2419247|NCT01233258|5933597|P3|COMPLETED|First Intervention (6 Months)||13
2419248|NCT01233258|5933598|P2|COMPLETED|First Intervention (6 Months)||10
2419249|NCT01233258|5933599|P1|COMPLETED|First Intervention (6 Months)||10
2419250|NCT01233258|5933594|P6|Participants Received Treatment|First Intervention (6 Months)||15
2419251|NCT01233258|5933595|P5|Participants Received Treatment|First Intervention (6 Months)||16
2419252|NCT01233258|5933596|P4|Participants Received Treatment|First Intervention (6 Months)||15
2419253|NCT01233258|5933597|P3|Participants Received Treatment|First Intervention (6 Months)||13
2419254|NCT01233258|5933598|P2|Participants Received Treatment|First Intervention (6 Months)||10
2419255|NCT01233258|5933599|P1|Participants Received Treatment|First Intervention (6 Months)||11
2419256|NCT01233258|5933594|P6|STARTED|First Intervention (6 Months)||16
2419257|NCT01233258|5933595|P5|STARTED|First Intervention (6 Months)||16
2419258|NCT01233258|5933596|P4|STARTED|First Intervention (6 Months)||16
2419259|NCT01233258|5933597|P3|STARTED|First Intervention (6 Months)||14
2419260|NCT01233258|5933598|P2|STARTED|First Intervention (6 Months)||10
2419261|NCT01233258|5933599|P1|STARTED|First Intervention (6 Months)||11
2419262|NCT01233232|5933619|P3|NOT COMPLETED|Overall Study||0
2419263|NCT01233232|5933620|P2|NOT COMPLETED|Overall Study||0
2419264|NCT01233232|5933621|P1|NOT COMPLETED|Overall Study||1
2419265|NCT01233232|5933619|P3|COMPLETED|Overall Study||28
2419266|NCT01233232|5933620|P2|COMPLETED|Overall Study||30
2419267|NCT01233232|5933621|P1|COMPLETED|Overall Study||28
2419268|NCT01233232|5933619|P3|STARTED|Overall Study||28
2419269|NCT01233232|5933620|P2|STARTED|Overall Study||30
2419270|NCT01233232|5933621|P1|STARTED|Overall Study||29
2419271|NCT01233076|5933674|P2|NOT COMPLETED|Period 2, One Week||0
2419272|NCT01233076|5933675|P1|NOT COMPLETED|Period 2, One Week||1
2419273|NCT01233076|5933674|P2|COMPLETED|Period 2, One Week||30
2419274|NCT01233076|5933675|P1|COMPLETED|Period 2, One Week||29
2419275|NCT01233076|5933674|P2|STARTED|Period 2, One Week||30
2419276|NCT01233076|5933675|P1|STARTED|Period 2, One Week||30
2419277|NCT01233076|5933674|P2|NOT COMPLETED|Period 1, One Week||0
2419278|NCT01233076|5933675|P1|NOT COMPLETED|Period 1, One Week||0
2419279|NCT01233076|5933674|P2|COMPLETED|Period 1, One Week||30
2419280|NCT01233076|5933675|P1|COMPLETED|Period 1, One Week||30
2419281|NCT01233076|5933674|P2|STARTED|Period 1, One Week||30
2419282|NCT01233076|5933675|P1|STARTED|Period 1, One Week||30
2419283|NCT01233050|5933683|P2|NOT COMPLETED|Overall Study||6
2419284|NCT01233050|5933684|P1|NOT COMPLETED|Overall Study||8
2419285|NCT01233050|5933683|P2|COMPLETED|Overall Study|6 participants were excluded after treatment administered due to inclusion/exclusion criteria|396
2419286|NCT01233050|5933684|P1|COMPLETED|Overall Study|8 participants were excluded after treatment administered due to inclusion/exclusion criteria|392
2419287|NCT01233050|5933683|P2|STARTED|Overall Study||402
2419288|NCT01233050|5933684|P1|STARTED|Overall Study||400
2419289|NCT01232946|5933703|P3|NOT COMPLETED|Overall Study||2
2419290|NCT01232946|5933704|P2|NOT COMPLETED|Overall Study||1
2419291|NCT01232946|5933705|P1|NOT COMPLETED|Overall Study||0
2419292|NCT01232946|5933703|P3|COMPLETED|Overall Study|2 withdrew after baseline measurements|9
2419293|NCT01232946|5933704|P2|COMPLETED|Overall Study|1 participant died unrelated to study|9
2419294|NCT01232946|5933705|P1|COMPLETED|Overall Study||9
2419295|NCT01232946|5933703|P3|STARTED|Overall Study||11
2419296|NCT01232946|5933704|P2|STARTED|Overall Study||10
2419297|NCT01232946|5933705|P1|STARTED|Overall Study||9
2419298|NCT01232920|5933721|P2|NOT COMPLETED|Overall Study||7
2419299|NCT01232920|5933722|P1|NOT COMPLETED|Overall Study||6
2419300|NCT01232920|5933721|P2|COMPLETED|Overall Study||32
2419301|NCT01232920|5933722|P1|COMPLETED|Overall Study||35
2419302|NCT01232920|5933721|P2|STARTED|Overall Study||39
2419303|NCT01232920|5933722|P1|STARTED|Overall Study||41
2419304|NCT01232894|5933736|P2|NOT COMPLETED|Overall Study||8
2419305|NCT01232894|5933737|P1|NOT COMPLETED|Overall Study||12
2419306|NCT01232894|5933736|P2|COMPLETED|Overall Study||22
2419307|NCT01232894|5933737|P1|COMPLETED|Overall Study||48
2419308|NCT01232894|5933736|P2|Received Study Drug|Overall Study||28
2419309|NCT01232894|5933737|P1|Received Study Drug|Overall Study||59
2419310|NCT01232894|5933736|P2|STARTED|Overall Study||30
2419311|NCT01232894|5933737|P1|STARTED|Overall Study||60
2419312|NCT01232868|5933745|P2|NOT COMPLETED|Overall Study||4
2419313|NCT01232868|5933746|P1|NOT COMPLETED|Overall Study||2
2419314|NCT01232868|5933745|P2|COMPLETED|Overall Study||40
2419315|NCT01232868|5933746|P1|COMPLETED|Overall Study||20
2419316|NCT01232868|5933745|P2|STARTED|Overall Study||44
2419317|NCT01232868|5933746|P1|STARTED|Overall Study||22
2419318|NCT01232829|5933754|P1|NOT COMPLETED|Overall Study||0
2419319|NCT01232829|5933754|P1|COMPLETED|Overall Study||18
2419320|NCT01232829|5933754|P1|STARTED|Overall Study||18
2419321|NCT01232790|5933760|P2|NOT COMPLETED|Second Crossover||2
2419322|NCT01232790|5933761|P1|NOT COMPLETED|Second Crossover||1
2419323|NCT01232790|5933760|P2|COMPLETED|Second Crossover||9
2419324|NCT01232790|5933761|P1|COMPLETED|Second Crossover||10
2419325|NCT01232790|5933760|P2|STARTED|Second Crossover||11
2419326|NCT01232790|5933761|P1|STARTED|Second Crossover||11
2419327|NCT01232790|5933760|P2|NOT COMPLETED|First Crossover||0
2419328|NCT01232790|5933761|P1|NOT COMPLETED|First Crossover||1
2419329|NCT01232790|5933760|P2|COMPLETED|First Crossover||11
2419330|NCT01232790|5933761|P1|COMPLETED|First Crossover||11
2419331|NCT01232790|5933760|P2|STARTED|First Crossover||11
2419332|NCT01232790|5933761|P1|STARTED|First Crossover||12
2419333|NCT01232790|5933760|P2|NOT COMPLETED|Initial Assessment||1
2419334|NCT01232790|5933761|P1|NOT COMPLETED|Initial Assessment||0
2419335|NCT01232790|5933760|P2|COMPLETED|Initial Assessment||11
2419336|NCT01232790|5933761|P1|COMPLETED|Initial Assessment||12
2419337|NCT01232790|5933760|P2|STARTED|Initial Assessment||12
2419338|NCT01232790|5933761|P1|STARTED|Initial Assessment||12
2419339|NCT01232790|5933760|P2|NOT COMPLETED|Randomization||2
2419340|NCT01232790|5933761|P1|NOT COMPLETED|Randomization||2
2419341|NCT01232790|5933760|P2|COMPLETED|Randomization||12
2419342|NCT01232790|5933761|P1|COMPLETED|Randomization||12
2419343|NCT01232790|5933760|P2|STARTED|Randomization||14
2419344|NCT01232790|5933761|P1|STARTED|Randomization||14
2419345|NCT01232738|5933815|P1|NOT COMPLETED|Overall Study||13
2419346|NCT01232738|5933815|P1|COMPLETED|Overall Study||23
2419347|NCT01232738|5933815|P1|STARTED|Overall Study||36
2419348|NCT01232569|5933831|P4|NOT COMPLETED|Open-label Extension Period||27
2419349|NCT01232569|5933832|P3|NOT COMPLETED|Open-label Extension Period||27
2419350|NCT01232569|5933833|P2|NOT COMPLETED|Open-label Extension Period||0
2419351|NCT01232569|5933834|P1|NOT COMPLETED|Open-label Extension Period||0
2419352|NCT01232569|5933831|P4|COMPLETED|Open-label Extension Period||200
2419353|NCT01232569|5933832|P3|COMPLETED|Open-label Extension Period||203
2419354|NCT01232569|5933833|P2|COMPLETED|Open-label Extension Period||0
2419355|NCT01232569|5933834|P1|COMPLETED|Open-label Extension Period||0
2419356|NCT01232569|5933831|P4|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|227
2419357|NCT01232569|5933832|P3|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|230
2419358|NCT01232569|5933833|P2|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
2419359|NCT01232569|5933834|P1|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
2419360|NCT01232569|5933831|P4|NOT COMPLETED|Double-blind Treatment Period||0
2419361|NCT01232569|5933832|P3|NOT COMPLETED|Double-blind Treatment Period||0
2419362|NCT01232569|5933833|P2|NOT COMPLETED|Double-blind Treatment Period||9
2419363|NCT01232569|5933834|P1|NOT COMPLETED|Double-blind Treatment Period||28
2419364|NCT01232569|5933831|P4|COMPLETED|Double-blind Treatment Period||0
2419365|NCT01232569|5933832|P3|COMPLETED|Double-blind Treatment Period||0
2419366|NCT01232569|5933833|P2|COMPLETED|Double-blind Treatment Period||209
2419367|NCT01232569|5933834|P1|COMPLETED|Double-blind Treatment Period||410
2419368|NCT01232569|5933831|P4|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
2419369|NCT01232569|5933832|P3|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
2419370|NCT01232569|5933833|P2|STARTED|Double-blind Treatment Period||218
2419371|NCT01232569|5933834|P1|STARTED|Double-blind Treatment Period||438
2419372|NCT01232556|5933877|P2|NOT COMPLETED|Overall Study||171
2419373|NCT01232556|5933878|P1|NOT COMPLETED|Overall Study||159
2419374|NCT01232556|5933877|P2|COMPLETED|Overall Study||1
2419375|NCT01232556|5933878|P1|COMPLETED|Overall Study||7
2419376|NCT01232556|5933877|P2|Treated|Overall Study||167
2419377|NCT01232556|5933878|P1|Treated|Overall Study|One subject in this arm received rituximab only and was excluded from the safety population.|165
2419378|NCT01232556|5933877|P2|STARTED|Overall Study||172
2419379|NCT01232556|5933878|P1|STARTED|Overall Study||166
2419380|NCT01232504|5933901|P3|NOT COMPLETED|Overall Study||8
2419381|NCT01232504|5933902|P2|NOT COMPLETED|Overall Study||2
2419382|NCT01232504|5933903|P1|NOT COMPLETED|Overall Study||9
2419383|NCT01232504|5933901|P3|COMPLETED|Overall Study||61
2419384|NCT01232504|5933902|P2|COMPLETED|Overall Study||67
2419385|NCT01232504|5933903|P1|COMPLETED|Overall Study||59
2419386|NCT01232504|5933901|P3|STARTED|Overall Study||69
2419387|NCT01232504|5933902|P2|STARTED|Overall Study||69
2419388|NCT01232504|5933903|P1|STARTED|Overall Study||68
2419389|NCT01232491|5933937|P2|NOT COMPLETED|Overall Study||63
2419390|NCT01232491|5933938|P1|NOT COMPLETED|Overall Study||60
2419391|NCT01232491|5933937|P2|COMPLETED|Overall Study||242
2419392|NCT01232491|5933938|P1|COMPLETED|Overall Study||246
2419393|NCT01232491|5933937|P2|Exposed (Safety Analysis Set)|Overall Study|Four subjects withdrew prior to exposure to trial drug.|301
2419394|NCT01232491|5933938|P1|Exposed (Safety Analysis Set)|Overall Study|One subject withdrew prior to exposure to trial drug.|305
2419395|NCT01232491|5933937|P2|STARTED|Overall Study||305
2419396|NCT01232491|5933938|P1|STARTED|Overall Study||306
2419397|NCT01232465|5933958|P2|NOT COMPLETED|Overall Study||0
2419398|NCT01232465|5933959|P1|NOT COMPLETED|Overall Study||0
2419399|NCT01232465|5933958|P2|COMPLETED|Overall Study||402
2419400|NCT01232465|5933959|P1|COMPLETED|Overall Study||337
2419401|NCT01232465|5933958|P2|STARTED|Overall Study||402
2419402|NCT01232465|5933959|P1|STARTED|Overall Study||337
2419403|NCT01232452|5933967|P2|NOT COMPLETED|Overall Study||39
2419404|NCT01232452|5933968|P1|NOT COMPLETED|Overall Study||39
2419405|NCT01232452|5933967|P2|COMPLETED|Overall Study||46
2419406|NCT01232452|5933968|P1|COMPLETED|Overall Study||48
2419407|NCT01232452|5933967|P2|Received at Least One Dose of Study Drug|Overall Study||81
2419408|NCT01232452|5933968|P1|Received at Least One Dose of Study Drug|Overall Study||85
2419409|NCT01232452|5933967|P2|STARTED|Overall Study||85
2419410|NCT01232452|5933968|P1|STARTED|Overall Study||87
2419411|NCT01232296|5933994|P2|NOT COMPLETED|Overall Study||83
2419412|NCT01232296|5933995|P1|NOT COMPLETED|Overall Study||82
2419413|NCT01232296|5933994|P2|COMPLETED|Overall Study||0
2419414|NCT01232296|5933995|P1|COMPLETED|Overall Study||0
2419415|NCT01232296|5933994|P2|Safety Set|Overall Study||83
2419416|NCT01232296|5933995|P1|Safety Set|Overall Study|The Safety Set includes all patients who received at least one dose of study medication|79
2419417|NCT01232296|5933994|P2|Full Analysis Set|Overall Study||83
2419418|NCT01232296|5933995|P1|Full Analysis Set|Overall Study||82
2419419|NCT01232296|5933994|P2|STARTED|Overall Study||83
2419420|NCT01232296|5933995|P1|STARTED|Overall Study||82
2419421|NCT01232283|5934012|P10|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||61
2419422|NCT01232283|5934013|P9|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||108
2419423|NCT01232283|5934014|P8|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
2419424|NCT01232283|5934015|P7|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
2419425|NCT01232283|5934016|P6|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
2419426|NCT01232283|5934017|P5|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
2419427|NCT01232283|5934018|P4|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
2419428|NCT01232283|5934019|P3|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
2419429|NCT01232283|5934020|P2|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
2419430|NCT01232283|5934021|P1|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
2419431|NCT01232283|5934012|P10|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||19
2419432|NCT01232283|5934013|P9|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||29
2419433|NCT01232283|5934014|P8|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
2419434|NCT01232283|5934015|P7|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
2419435|NCT01232283|5934016|P6|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
2419436|NCT01232283|5934017|P5|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
2419437|NCT01232283|5934018|P4|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
2419438|NCT01232283|5934019|P3|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
2419439|NCT01232283|5934020|P2|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
2419440|NCT01232283|5934021|P1|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
2419441|NCT01232283|5934012|P10|STARTED|Long-Term Extension Phase (Weeks 52-260)||80
2419442|NCT01232283|5934013|P9|STARTED|Long-Term Extension Phase (Weeks 52-260)||137
2419443|NCT01232283|5934014|P8|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
2419444|NCT01232283|5934015|P7|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
2419445|NCT01232283|5934016|P6|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
2419446|NCT01232283|5934017|P5|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
2419447|NCT01232283|5934018|P4|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
2419448|NCT01232283|5934019|P3|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
2419449|NCT01232283|5934020|P2|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
2419450|NCT01232283|5934021|P1|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
2419451|NCT01232283|5934012|P10|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
2419452|NCT01232283|5934013|P9|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
2419453|NCT01232283|5934014|P8|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
2419454|NCT01232283|5934015|P7|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||17
2419455|NCT01232283|5934016|P6|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||5
2419456|NCT01232283|5934017|P5|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
2419457|NCT01232283|5934018|P4|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
2419458|NCT01232283|5934019|P3|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
2419459|NCT01232283|5934020|P2|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
2419460|NCT01232283|5934021|P1|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
2419461|NCT01232283|5934012|P10|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
2419462|NCT01232283|5934013|P9|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
2419463|NCT01232283|5934014|P8|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||84
2419464|NCT01232283|5934015|P7|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||41
2419465|NCT01232283|5934016|P6|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||56
2419466|NCT01232283|5934017|P5|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||50
2419467|NCT01232283|5934018|P4|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
2419468|NCT01232283|5934019|P3|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
2419469|NCT01232283|5934020|P2|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
2419470|NCT01232283|5934021|P1|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
2419471|NCT01232283|5934012|P10|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
2419472|NCT01232283|5934013|P9|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
2419473|NCT01232283|5934014|P8|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||17
2419474|NCT01232283|5934015|P7|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||28
2419475|NCT01232283|5934016|P6|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
2419476|NCT01232283|5934017|P5|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
2419477|NCT01232283|5934018|P4|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
2419478|NCT01232283|5934019|P3|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
2419479|NCT01232283|5934020|P2|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
2419480|NCT01232283|5934021|P1|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
2419481|NCT01232283|5934012|P10|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
2419482|NCT01232283|5934013|P9|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
2419483|NCT01232283|5934014|P8|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||96
2419484|NCT01232283|5934015|P7|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||58
2419485|NCT01232283|5934016|P6|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|13 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|61
2419486|NCT01232283|5934017|P5|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|4 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|62
2419487|NCT01232283|5934018|P4|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
2419488|NCT01232283|5934019|P3|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
2419489|NCT01232283|5934020|P2|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
2419490|NCT01232283|5934021|P1|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
2419491|NCT01232283|5934012|P10|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
2419492|NCT01232283|5934013|P9|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
2419493|NCT01232283|5934014|P8|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
2419494|NCT01232283|5934015|P7|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
2419495|NCT01232283|5934016|P6|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
2419496|NCT01232283|5934017|P5|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
2419497|NCT01232283|5934018|P4|NOT COMPLETED|Maintenance Phase (Weeks16-32)||8
2419498|NCT01232283|5934019|P3|NOT COMPLETED|Maintenance Phase (Weeks16-32)||40
2419499|NCT01232283|5934020|P2|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
2419500|NCT01232283|5934021|P1|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
2419501|NCT01232283|5934012|P10|COMPLETED|Maintenance Phase (Weeks16-32)||0
2419502|NCT01232283|5934013|P9|COMPLETED|Maintenance Phase (Weeks16-32)||0
2419503|NCT01232283|5934014|P8|COMPLETED|Maintenance Phase (Weeks16-32)||0
2419504|NCT01232283|5934015|P7|COMPLETED|Maintenance Phase (Weeks16-32)||0
2419505|NCT01232283|5934016|P6|COMPLETED|Maintenance Phase (Weeks16-32)||0
2419506|NCT01232283|5934017|P5|COMPLETED|Maintenance Phase (Weeks16-32)||0
2419507|NCT01232283|5934018|P4|COMPLETED|Maintenance Phase (Weeks16-32)||100
2419508|NCT01232283|5934019|P3|COMPLETED|Maintenance Phase (Weeks16-32)||194
2419509|NCT01232283|5934020|P2|COMPLETED|Maintenance Phase (Weeks16-32)||0
2419510|NCT01232283|5934021|P1|COMPLETED|Maintenance Phase (Weeks16-32)||0
2419511|NCT01232283|5934012|P10|STARTED|Maintenance Phase (Weeks16-32)||0
2419512|NCT01232283|5934013|P9|STARTED|Maintenance Phase (Weeks16-32)||0
2419513|NCT01232283|5934014|P8|STARTED|Maintenance Phase (Weeks16-32)||0
2419514|NCT01232283|5934015|P7|STARTED|Maintenance Phase (Weeks16-32)||0
2419515|NCT01232283|5934016|P6|STARTED|Maintenance Phase (Weeks16-32)||0
2419516|NCT01232283|5934017|P5|STARTED|Maintenance Phase (Weeks16-32)||0
2419517|NCT01232283|5934018|P4|STARTED|Maintenance Phase (Weeks16-32)|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|108
2419518|NCT01232283|5934019|P3|STARTED|Maintenance Phase (Weeks16-32)|5 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|234
2419519|NCT01232283|5934020|P2|STARTED|Maintenance Phase (Weeks16-32)||0
2419520|NCT01232283|5934021|P1|STARTED|Maintenance Phase (Weeks16-32)||0
2419521|NCT01232283|5934012|P10|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
2419522|NCT01232283|5934013|P9|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
2419523|NCT01232283|5934014|P8|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
2419524|NCT01232283|5934015|P7|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
2419525|NCT01232283|5934016|P6|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
2419526|NCT01232283|5934017|P5|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
2419527|NCT01232283|5934018|P4|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
2419528|NCT01232283|5934019|P3|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
2419529|NCT01232283|5934020|P2|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||26
2419530|NCT01232283|5934021|P1|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||36
2419531|NCT01232283|5934012|P10|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
2419532|NCT01232283|5934013|P9|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
2419533|NCT01232283|5934014|P8|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
2419534|NCT01232283|5934015|P7|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
2419535|NCT01232283|5934016|P6|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
2419536|NCT01232283|5934017|P5|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
2419537|NCT01232283|5934018|P4|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
2419538|NCT01232283|5934019|P3|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
2419539|NCT01232283|5934020|P2|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||112
2419540|NCT01232283|5934021|P1|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||239
2419541|NCT01232283|5934012|P10|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
2419542|NCT01232283|5934013|P9|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
2419543|NCT01232283|5934014|P8|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
2419544|NCT01232283|5934015|P7|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
2419545|NCT01232283|5934016|P6|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
2419546|NCT01232283|5934017|P5|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
2419547|NCT01232283|5934018|P4|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
2419548|NCT01232283|5934019|P3|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
2419549|NCT01232283|5934020|P2|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|136
2419550|NCT01232283|5934021|P1|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|272
2419551|NCT01232283|5934012|P10|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
2419552|NCT01232283|5934013|P9|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
2419553|NCT01232283|5934014|P8|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
2419554|NCT01232283|5934015|P7|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
2419555|NCT01232283|5934016|P6|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
2419556|NCT01232283|5934017|P5|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
2419557|NCT01232283|5934018|P4|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
2419558|NCT01232283|5934019|P3|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
2419559|NCT01232283|5934020|P2|STARTED|Placebo Controlled Phase (Weeks 0-16)||138
2419560|NCT01232283|5934021|P1|STARTED|Placebo Controlled Phase (Weeks 0-16)||275
2419561|NCT01232205|5934055|P2|NOT COMPLETED|Overall Study||3
2419562|NCT01232205|5934056|P1|NOT COMPLETED|Overall Study||3
2419563|NCT01232205|5934055|P2|COMPLETED|Overall Study||55
2419564|NCT01232205|5934056|P1|COMPLETED|Overall Study||49
2419565|NCT01232205|5934055|P2|STARTED|Overall Study||58
2419566|NCT01232205|5934056|P1|STARTED|Overall Study||52
2419567|NCT01232127|5934062|P3|NOT COMPLETED|Period 3: Days 18-24||0
2419568|NCT01232127|5934063|P2|NOT COMPLETED|Period 3: Days 18-24||0
2419569|NCT01232127|5934064|P1|NOT COMPLETED|Period 3: Days 18-24||0
2419570|NCT01232127|5934062|P3|COMPLETED|Period 3: Days 18-24||24
2419571|NCT01232127|5934063|P2|COMPLETED|Period 3: Days 18-24||0
2419572|NCT01232127|5934064|P1|COMPLETED|Period 3: Days 18-24||0
2419573|NCT01232127|5934062|P3|STARTED|Period 3: Days 18-24|Participants who received treatment.|24
2419574|NCT01232127|5934063|P2|STARTED|Period 3: Days 18-24||0
2419575|NCT01232127|5934064|P1|STARTED|Period 3: Days 18-24||0
2419576|NCT01232127|5934062|P3|NOT COMPLETED|Period 2: Days 11-17||0
2419577|NCT01232127|5934063|P2|NOT COMPLETED|Period 2: Days 11-17||0
2419578|NCT01232127|5934064|P1|NOT COMPLETED|Period 2: Days 11-17||0
2419579|NCT01232127|5934062|P3|COMPLETED|Period 2: Days 11-17||0
2419580|NCT01232127|5934063|P2|COMPLETED|Period 2: Days 11-17||24
2419581|NCT01232127|5934064|P1|COMPLETED|Period 2: Days 11-17||0
2419582|NCT01232127|5934062|P3|STARTED|Period 2: Days 11-17||0
2419583|NCT01232127|5934063|P2|STARTED|Period 2: Days 11-17|Participants who received treatment.|24
2419584|NCT01232127|5934064|P1|STARTED|Period 2: Days 11-17||0
2419585|NCT01232127|5934062|P3|NOT COMPLETED|Period 1: Days 1-10||0
2419586|NCT01232127|5934063|P2|NOT COMPLETED|Period 1: Days 1-10||0
2419587|NCT01232127|5934064|P1|NOT COMPLETED|Period 1: Days 1-10||1
2419588|NCT01232127|5934062|P3|COMPLETED|Period 1: Days 1-10||0
2419589|NCT01232127|5934063|P2|COMPLETED|Period 1: Days 1-10||0
2419590|NCT01232127|5934064|P1|COMPLETED|Period 1: Days 1-10||24
2419591|NCT01232127|5934062|P3|STARTED|Period 1: Days 1-10||0
2419592|NCT01232127|5934063|P2|STARTED|Period 1: Days 1-10||0
2419593|NCT01232127|5934064|P1|STARTED|Period 1: Days 1-10|Participants who received treatment.|25
2419594|NCT01231984|5934088|P4|NOT COMPLETED|Study Period 2||4
2419595|NCT01231984|5934089|P3|NOT COMPLETED|Study Period 2||0
2419596|NCT01231984|5934090|P2|NOT COMPLETED|Study Period 2||2
2419597|NCT01231984|5934091|P1|NOT COMPLETED|Study Period 2||3
2419598|NCT01231984|5934088|P4|COMPLETED|Study Period 2||56
2419599|NCT01231984|5934089|P3|COMPLETED|Study Period 2||59
2419600|NCT01231984|5934090|P2|COMPLETED|Study Period 2||61
2419601|NCT01231984|5934091|P1|COMPLETED|Study Period 2||54
2419602|NCT01231984|5934088|P4|STARTED|Study Period 2||60
2419603|NCT01231984|5934089|P3|STARTED|Study Period 2||59
2419604|NCT01231984|5934090|P2|STARTED|Study Period 2||63
2419605|NCT01231984|5934091|P1|STARTED|Study Period 2||57
2419606|NCT01231984|5934088|P4|NOT COMPLETED|Study Period 1||9
2419607|NCT01231984|5934089|P3|NOT COMPLETED|Study Period 1||7
2419608|NCT01231984|5934090|P2|NOT COMPLETED|Study Period 1||7
2419609|NCT01231984|5934091|P1|NOT COMPLETED|Study Period 1||12
2419610|NCT01231984|5934088|P4|COMPLETED|Study Period 1||60
2419611|NCT01231984|5934089|P3|COMPLETED|Study Period 1||59
2419612|NCT01231984|5934090|P2|COMPLETED|Study Period 1||63
2419613|NCT01231984|5934091|P1|COMPLETED|Study Period 1||57
2419614|NCT01231984|5934088|P4|STARTED|Study Period 1||69
2419615|NCT01231984|5934089|P3|STARTED|Study Period 1||66
2419616|NCT01231984|5934090|P2|STARTED|Study Period 1||70
2419617|NCT01231984|5934091|P1|STARTED|Study Period 1||69
2419618|NCT01231841|5934112|P1|NOT COMPLETED|Overall Study||0
2419619|NCT01231841|5934112|P1|COMPLETED|Overall Study||20
2419620|NCT01231841|5934112|P1|STARTED|Overall Study||20
2419621|NCT01231750|5934118|P2|NOT COMPLETED|Overall Study||0
2419622|NCT01231750|5934119|P1|NOT COMPLETED|Overall Study||0
2419623|NCT01231750|5934118|P2|COMPLETED|Overall Study||4
2419624|NCT01231750|5934119|P1|COMPLETED|Overall Study||3
2419625|NCT01231750|5934118|P2|STARTED|Overall Study||4
2419626|NCT01231750|5934119|P1|STARTED|Overall Study||3
2419627|NCT01231646|5934137|P2|NOT COMPLETED|Overall Study||0
2419628|NCT01231646|5934138|P1|NOT COMPLETED|Overall Study||0
2419629|NCT01231646|5934137|P2|COMPLETED|Overall Study||10
2419630|NCT01231646|5934138|P1|COMPLETED|Overall Study||28
2419631|NCT01231646|5934137|P2|STARTED|Overall Study||10
2419632|NCT01231646|5934138|P1|STARTED|Overall Study||28
2419633|NCT01231633|5934146|P2|NOT COMPLETED|Overall Study||0
2419634|NCT01231633|5934147|P1|NOT COMPLETED|Overall Study||0
2419635|NCT01231633|5934146|P2|COMPLETED|Overall Study||13
2419636|NCT01231633|5934147|P1|COMPLETED|Overall Study||14
2419637|NCT01231633|5934146|P2|STARTED|Overall Study||13
2419638|NCT01231633|5934147|P1|STARTED|Overall Study||14
2419639|NCT01231620|5934160|P3|NOT COMPLETED|Overall Study||39
2419640|NCT01231620|5934161|P2|NOT COMPLETED|Overall Study||31
2419641|NCT01231620|5934162|P1|NOT COMPLETED|Overall Study||26
2419642|NCT01231620|5934160|P3|COMPLETED|Overall Study||166
2419643|NCT01231620|5934161|P2|COMPLETED|Overall Study||178
2419644|NCT01231620|5934162|P1|COMPLETED|Overall Study||175
2419645|NCT01231620|5934160|P3|STARTED|Overall Study||205
2419646|NCT01231620|5934161|P2|STARTED|Overall Study||209
2419647|NCT01231620|5934162|P1|STARTED|Overall Study||201
2419648|NCT01231607|5934268|P5|NOT COMPLETED|Overall Study||24
2419649|NCT01231607|5934269|P4|NOT COMPLETED|Overall Study||38
2419650|NCT01231607|5934270|P3|NOT COMPLETED|Overall Study||31
2419651|NCT01231607|5934271|P2|NOT COMPLETED|Overall Study||34
2419652|NCT01231607|5934272|P1|NOT COMPLETED|Overall Study||29
2419653|NCT01231607|5934268|P5|COMPLETED|Overall Study||157
2419654|NCT01231607|5934269|P4|COMPLETED|Overall Study||141
2419655|NCT01231607|5934270|P3|COMPLETED|Overall Study||153
2419656|NCT01231607|5934271|P2|COMPLETED|Overall Study||154
2419657|NCT01231607|5934272|P1|COMPLETED|Overall Study||156
2419658|NCT01231607|5934268|P5|STARTED|Overall Study||181
2419659|NCT01231607|5934269|P4|STARTED|Overall Study||179
2419660|NCT01231607|5934270|P3|STARTED|Overall Study||184
2419661|NCT01231607|5934271|P2|STARTED|Overall Study||188
2419662|NCT01231607|5934272|P1|STARTED|Overall Study||185
2419663|NCT01231581|5934364|P2|NOT COMPLETED|Overall Study||80
2419664|NCT01231581|5934365|P1|NOT COMPLETED|Overall Study||80
2419665|NCT01231581|5934364|P2|COMPLETED|Overall Study||0
2419666|NCT01231581|5934365|P1|COMPLETED|Overall Study||0
2419667|NCT01231581|5934364|P2|Ongoing|Overall Study||0
2419668|NCT01231581|5934365|P1|Ongoing|Overall Study|Participant is continuing treatment with trametinib and gemcitabine under roll over study MEK114375.|1
2419669|NCT01231581|5934364|P2|STARTED|Overall Study||80
2419670|NCT01231581|5934365|P1|STARTED|Overall Study||80
2419671|NCT01231555|5934386|P3|NOT COMPLETED|Overall Study||8
2419672|NCT01231555|5934387|P2|NOT COMPLETED|Overall Study||7
2419673|NCT01231555|5934388|P1|NOT COMPLETED|Overall Study||8
2419674|NCT01231555|5934386|P3|COMPLETED|Overall Study||0
2419675|NCT01231555|5934387|P2|COMPLETED|Overall Study||0
2419676|NCT01231555|5934388|P1|COMPLETED|Overall Study||0
2419677|NCT01231555|5934386|P3|STARTED|Overall Study||8
2419678|NCT01231555|5934387|P2|STARTED|Overall Study||7
2419679|NCT01231555|5934388|P1|STARTED|Overall Study||8
2419680|NCT01231516|5934419|P2|NOT COMPLETED|Open-label Phase||26
2419681|NCT01231516|5934420|P1|NOT COMPLETED|Open-label Phase||295
2419682|NCT01231516|5934419|P2|COMPLETED|Open-label Phase||1
2419683|NCT01231516|5934420|P1|COMPLETED|Open-label Phase||0
2419684|NCT01231516|5934419|P2|Ongoing at the Time of Analysis|Open-label Phase||23
2419685|NCT01231516|5934420|P1|Ongoing at the Time of Analysis|Open-label Phase||282
2419686|NCT01231516|5934419|P2|STARTED|Open-label Phase|256 participants completed the Double-blind Phase but did not enter the Open-label Phase.|27
2419687|NCT01231516|5934420|P1|STARTED|Open-label Phase|4 participants completed the Double-blind Phase but did not enter the Open-label Phase.|295
2419688|NCT01231516|5934419|P2|NOT COMPLETED|48 Week Double-blind Phase||79
2419689|NCT01231516|5934420|P1|NOT COMPLETED|48 Week Double-blind Phase||58
2419690|NCT01231516|5934419|P2|COMPLETED|48 Week Double-blind Phase||283
2419691|NCT01231516|5934420|P1|COMPLETED|48 Week Double-blind Phase||299
2419692|NCT01231516|5934419|P2|STARTED|48 Week Double-blind Phase||362
2419693|NCT01231516|5934420|P1|STARTED|48 Week Double-blind Phase||357
2419694|NCT01231503|5934450|P8|NOT COMPLETED|Overall Study||8
2419695|NCT01231503|5934451|P7|NOT COMPLETED|Overall Study||7
2419696|NCT01231503|5934452|P6|NOT COMPLETED|Overall Study||16
2419697|NCT01231503|5934453|P5|NOT COMPLETED|Overall Study||10
2419698|NCT01231503|5934454|P4|NOT COMPLETED|Overall Study||8
2419699|NCT01231503|5934455|P3|NOT COMPLETED|Overall Study||12
2419700|NCT01231503|5934456|P2|NOT COMPLETED|Overall Study||13
2419701|NCT01231503|5934457|P1|NOT COMPLETED|Overall Study||14
2419702|NCT01231503|5934450|P8|COMPLETED|Overall Study||52
2419703|NCT01231503|5934451|P7|COMPLETED|Overall Study||53
2419704|NCT01231503|5934452|P6|COMPLETED|Overall Study||44
2419705|NCT01231503|5934453|P5|COMPLETED|Overall Study||50
2419706|NCT01231503|5934454|P4|COMPLETED|Overall Study||52
2419707|NCT01231503|5934455|P3|COMPLETED|Overall Study||48
2419708|NCT01231503|5934456|P2|COMPLETED|Overall Study||46
2419709|NCT01231503|5934457|P1|COMPLETED|Overall Study||46
2419710|NCT01231503|5934450|P8|STARTED|Overall Study||60
2419711|NCT01231503|5934451|P7|STARTED|Overall Study||60
2419712|NCT01231503|5934452|P6|STARTED|Overall Study||60
2419713|NCT01231503|5934453|P5|STARTED|Overall Study||60
2419714|NCT01231503|5934454|P4|STARTED|Overall Study||60
2419715|NCT01231503|5934455|P3|STARTED|Overall Study||60
2419716|NCT01231503|5934456|P2|STARTED|Overall Study||59
2419717|NCT01231503|5934457|P1|STARTED|Overall Study||60
2419718|NCT01231464|5934697|P2|NOT COMPLETED|Overall Study||7
2419719|NCT01231464|5934698|P1|NOT COMPLETED|Overall Study||5
2419720|NCT01231464|5934697|P2|COMPLETED|Overall Study||176
2419721|NCT01231464|5934698|P1|COMPLETED|Overall Study||177
2419722|NCT01231464|5934697|P2|STARTED|Overall Study||183
2419723|NCT01231464|5934698|P1|STARTED|Overall Study||182
2419724|NCT01231412|5934711|P3|NOT COMPLETED|Overall Study||0
2419725|NCT01231412|5934712|P2|NOT COMPLETED|Overall Study||1
2419726|NCT01231412|5934713|P1|NOT COMPLETED|Overall Study||0
2419727|NCT01231412|5934711|P3|COMPLETED|Overall Study||6
2419728|NCT01231412|5934712|P2|COMPLETED|Overall Study||90
2419729|NCT01231412|5934713|P1|COMPLETED|Overall Study||77
2419730|NCT01231412|5934711|P3|STARTED|Overall Study||6
2419731|NCT01231412|5934712|P2|STARTED|Overall Study||91
2419732|NCT01231412|5934713|P1|STARTED|Overall Study||77
2419733|NCT01231399|5934736|P1|NOT COMPLETED|Overall Study||0
2419734|NCT01231399|5934736|P1|COMPLETED|Overall Study||6
2419735|NCT01231399|5934736|P1|STARTED|Overall Study||6
2419736|NCT01231373|5934747|P4|NOT COMPLETED|Overall Study||1
2419737|NCT01231373|5934748|P3|NOT COMPLETED|Overall Study||0
2419738|NCT01231373|5934749|P2|NOT COMPLETED|Overall Study||1
2419739|NCT01231373|5934750|P1|NOT COMPLETED|Overall Study||3
2419740|NCT01231373|5934747|P4|COMPLETED|Overall Study||57
2419741|NCT01231373|5934748|P3|COMPLETED|Overall Study||60
2419742|NCT01231373|5934749|P2|COMPLETED|Overall Study||57
2419743|NCT01231373|5934750|P1|COMPLETED|Overall Study||56
2419744|NCT01231373|5934747|P4|Patients Receiving Blinded Treatment|Overall Study||58
2419745|NCT01231373|5934748|P3|Patients Receiving Blinded Treatment|Overall Study||60
2419746|NCT01231373|5934749|P2|Patients Receiving Blinded Treatment|Overall Study||57
2419747|NCT01231373|5934750|P1|Patients Receiving Blinded Treatment|Overall Study||57
2419748|NCT01231373|5934747|P4|STARTED|Overall Study||58
2419749|NCT01231373|5934748|P3|STARTED|Overall Study||60
2419750|NCT01231373|5934749|P2|STARTED|Overall Study||58
2419751|NCT01231373|5934750|P1|STARTED|Overall Study||59
2419752|NCT01231334|5934770|P2|NOT COMPLETED|Overall Study||21
2419753|NCT01231334|5934771|P1|NOT COMPLETED|Overall Study||19
2419754|NCT01231334|5934770|P2|COMPLETED|Overall Study||120
2419755|NCT01231334|5934771|P1|COMPLETED|Overall Study||126
2419756|NCT01231334|5934770|P2|STARTED|Overall Study||141
2419757|NCT01231334|5934771|P1|STARTED|Overall Study||145
2419758|NCT01231321|5934789|P1|NOT COMPLETED|Overall Study||5
2419759|NCT01231321|5934789|P1|COMPLETED|Overall Study||95
2419760|NCT01231321|5934789|P1|STARTED|Overall Study||100
2419761|NCT01231230|5934800|P1|NOT COMPLETED|Overall Study||0
2419762|NCT01231230|5934800|P1|COMPLETED|Overall Study||14
2419763|NCT01231230|5934800|P1|Placebo|Overall Study||14
2419764|NCT01231230|5934800|P1|Fluticasone/Salmeterol|Overall Study||14
2419765|NCT01231230|5934800|P1|Salmeterol|Overall Study||14
2419766|NCT01231230|5934800|P1|Fluticasone|Overall Study||14
2419767|NCT01231230|5934800|P1|STARTED|Overall Study||14
2419768|NCT01230931|5934812|P2|NOT COMPLETED|Overall Study||0
2419769|NCT01230931|5934813|P1|NOT COMPLETED|Overall Study||0
2419770|NCT01230931|5934812|P2|COMPLETED|Overall Study||10
2419771|NCT01230931|5934813|P1|COMPLETED|Overall Study||10
2419772|NCT01230931|5934812|P2|STARTED|Overall Study||10
2419773|NCT01230931|5934813|P1|STARTED|Overall Study||10
2419774|NCT01230892|5934837|P2|NOT COMPLETED|Overall Study||1
2419775|NCT01230892|5934838|P1|NOT COMPLETED|Overall Study||3
2419776|NCT01230892|5934837|P2|COMPLETED|Overall Study||13
2419777|NCT01230892|5934838|P1|COMPLETED|Overall Study||12
2419778|NCT01230892|5934837|P2|STARTED|Overall Study||14
2419779|NCT01230892|5934838|P1|STARTED|Overall Study||15
2419780|NCT01230827|5934848|P4|NOT COMPLETED|Overall Study||78
2419781|NCT01230827|5934849|P3|NOT COMPLETED|Overall Study||65
2419782|NCT01230827|5934850|P2|NOT COMPLETED|Overall Study||11
2419783|NCT01230827|5934851|P1|NOT COMPLETED|Overall Study||19
2419784|NCT01230827|5934848|P4|COMPLETED|Overall Study||0
2419785|NCT01230827|5934849|P3|COMPLETED|Overall Study||0
2419786|NCT01230827|5934850|P2|COMPLETED|Overall Study||0
2419787|NCT01230827|5934851|P1|COMPLETED|Overall Study||0
2419788|NCT01230827|5934848|P4|STARTED|Overall Study||78
2419789|NCT01230827|5934849|P3|STARTED|Overall Study||65
2419790|NCT01230827|5934850|P2|STARTED|Overall Study||11
2419791|NCT01230827|5934851|P1|STARTED|Overall Study||19
2419792|NCT01230814|5934867|P2|NOT COMPLETED|Overall Study||4
2419793|NCT01230814|5934868|P1|NOT COMPLETED|Overall Study||13
2419794|NCT01230814|5934867|P2|COMPLETED|Overall Study||112
2419795|NCT01230814|5934868|P1|COMPLETED|Overall Study||105
2419796|NCT01230814|5934867|P2|STARTED|Overall Study||116
2419797|NCT01230814|5934868|P1|STARTED|Overall Study||118
2419798|NCT01230801|5934883|P3|NOT COMPLETED|Overall Study||1
2419799|NCT01230801|5934884|P2|NOT COMPLETED|Overall Study||0
2419800|NCT01230801|5934885|P1|NOT COMPLETED|Overall Study||0
2419801|NCT01230801|5934883|P3|COMPLETED|Overall Study||15
2419802|NCT01230801|5934884|P2|COMPLETED|Overall Study||3
2419803|NCT01230801|5934885|P1|COMPLETED|Overall Study||3
2419804|NCT01230801|5934883|P3|STARTED|Overall Study||16
2419805|NCT01230801|5934884|P2|STARTED|Overall Study||3
2419806|NCT01230801|5934885|P1|STARTED|Overall Study||3
2419807|NCT01230788|5934918|P1|NOT COMPLETED|Overall Study||1
2419808|NCT01230788|5934918|P1|COMPLETED|Overall Study||0
2419809|NCT01230788|5934918|P1|STARTED|Overall Study||1
2419810|NCT01230749|5934930|P4|NOT COMPLETED|Overall Study||2
2419811|NCT01230749|5934931|P3|NOT COMPLETED|Overall Study||2
2419812|NCT01230749|5934932|P2|NOT COMPLETED|Overall Study||2
2419813|NCT01230749|5934933|P1|NOT COMPLETED|Overall Study||0
2419814|NCT01230749|5934930|P4|COMPLETED|Overall Study||20
2419815|NCT01230749|5934931|P3|COMPLETED|Overall Study||21
2419816|NCT01230749|5934932|P2|COMPLETED|Overall Study||20
2419817|NCT01230749|5934933|P1|COMPLETED|Overall Study||22
2419818|NCT01230749|5934930|P4|STARTED|Overall Study||22
2419819|NCT01230749|5934931|P3|STARTED|Overall Study||23
2419820|NCT01230749|5934932|P2|STARTED|Overall Study||22
2419821|NCT01230749|5934933|P1|STARTED|Overall Study||22
2419822|NCT01230710|5934968|P1|NOT COMPLETED|Overall Study||49
2419823|NCT01230710|5934968|P1|COMPLETED|Overall Study||2
2419824|NCT01230710|5934968|P1|STARTED|Overall Study||51
2419825|NCT01230593|5934979|P3|NOT COMPLETED|Overall Study||12
2419826|NCT01230593|5934980|P2|NOT COMPLETED|Overall Study||18
2419827|NCT01230593|5934981|P1|NOT COMPLETED|Overall Study||15
2419828|NCT01230593|5934979|P3|COMPLETED|Overall Study||38
2419829|NCT01230593|5934980|P2|COMPLETED|Overall Study||32
2419830|NCT01230593|5934981|P1|COMPLETED|Overall Study||35
2419831|NCT01230593|5934979|P3|STARTED|Overall Study||50
2419832|NCT01230593|5934980|P2|STARTED|Overall Study||50
2419833|NCT01230593|5934981|P1|STARTED|Overall Study||50
2419834|NCT01230554|5934992|P1|NOT COMPLETED|Overall Study||3
2419835|NCT01230554|5934992|P1|COMPLETED|Overall Study||209
2419836|NCT01230554|5934992|P1|STARTED|Overall Study||212
2419837|NCT01230502|5935002|P3|NOT COMPLETED|Overall Study||0
2419838|NCT01230502|5935003|P2|NOT COMPLETED|Overall Study||0
2419839|NCT01230502|5935004|P1|NOT COMPLETED|Overall Study||0
2419840|NCT01230502|5935002|P3|COMPLETED|Overall Study||0
2419841|NCT01230502|5935003|P2|COMPLETED|Overall Study||0
2419842|NCT01230502|5935004|P1|COMPLETED|Overall Study||9
2419843|NCT01230502|5935002|P3|STARTED|Overall Study||0
2419844|NCT01230502|5935003|P2|STARTED|Overall Study||0
2419845|NCT01230502|5935004|P1|STARTED|Overall Study||9
2419846|NCT01230489|5935015|P1|NOT COMPLETED|Overall Study||5
2419847|NCT01230489|5935015|P1|COMPLETED|Overall Study||8
2419848|NCT01230489|5935015|P1|STARTED|Overall Study||13
2419849|NCT01230424|5935021|P2|NOT COMPLETED|Overall Study||0
2419850|NCT01230424|5935022|P1|NOT COMPLETED|Overall Study||0
2419851|NCT01230424|5935021|P2|COMPLETED|Overall Study||70
2419852|NCT01230424|5935022|P1|COMPLETED|Overall Study||70
2419853|NCT01230424|5935021|P2|STARTED|Overall Study||70
2419854|NCT01230424|5935022|P1|STARTED|Overall Study||70
2419855|NCT01230307|5935050|P2|NOT COMPLETED|Overall Study||2
2419856|NCT01230307|5935051|P1|NOT COMPLETED|Overall Study||0
2419857|NCT01230307|5935050|P2|COMPLETED|Overall Study||4
2419858|NCT01230307|5935051|P1|COMPLETED|Overall Study||6
2419859|NCT01230307|5935050|P2|STARTED|Overall Study||6
2419860|NCT01230307|5935051|P1|STARTED|Overall Study||6
2419861|NCT01230177|5935063|P1|NOT COMPLETED|Overall Study||0
2419862|NCT01230177|5935063|P1|COMPLETED|Overall Study||3
2419863|NCT01230177|5935063|P1|STARTED|Overall Study||3
2419864|NCT01230060|5935071|P1|NOT COMPLETED|Overall Study||1
2419865|NCT01230060|5935071|P1|COMPLETED|Overall Study||121
2419866|NCT01230060|5935071|P1|STARTED|Overall Study||122
2419867|NCT01230021|5935075|P1|NOT COMPLETED|Overall Study||0
2419868|NCT01230021|5935075|P1|COMPLETED|Overall Study||6
2419869|NCT01230021|5935075|P1|STARTED|Overall Study||6
2419870|NCT01229943|5935097|P2|NOT COMPLETED|Overall Study||17
2419871|NCT01229943|5935098|P1|NOT COMPLETED|Overall Study||18
2419872|NCT01229943|5935097|P2|COMPLETED|Overall Study||58
2419873|NCT01229943|5935098|P1|COMPLETED|Overall Study||57
2419874|NCT01229943|5935097|P2|STARTED|Overall Study||75
2419875|NCT01229943|5935098|P1|STARTED|Overall Study||75
2419876|NCT01229891|5935111|P3|NOT COMPLETED|Overall Study||0
2419877|NCT01229891|5935112|P2|NOT COMPLETED|Overall Study||0
2419878|NCT01229891|5935113|P1|NOT COMPLETED|Overall Study||0
2419879|NCT01229891|5935111|P3|COMPLETED|Overall Study||30
2419880|NCT01229891|5935112|P2|COMPLETED|Overall Study||30
2419881|NCT01229891|5935113|P1|COMPLETED|Overall Study||30
2419882|NCT01229891|5935111|P3|STARTED|Overall Study||30
2419883|NCT01229891|5935112|P2|STARTED|Overall Study||30
2419884|NCT01229891|5935113|P1|STARTED|Overall Study||30
2419885|NCT01229735|5935144|P2|NOT COMPLETED|Overall Study||66
2419886|NCT01229735|5935145|P1|NOT COMPLETED|Overall Study||66
2419887|NCT01229735|5935144|P2|COMPLETED|Overall Study||100
2419888|NCT01229735|5935145|P1|COMPLETED|Overall Study||111
2419889|NCT01229735|5935144|P2|STARTED|Overall Study||166
2419890|NCT01229735|5935145|P1|STARTED|Overall Study||177
2419891|NCT01229722|5935161|P2|NOT COMPLETED|Overall Study||4
2419892|NCT01229722|5935162|P1|NOT COMPLETED|Overall Study||0
2419893|NCT01229722|5935161|P2|COMPLETED|Overall Study||30
2419894|NCT01229722|5935162|P1|COMPLETED|Overall Study||36
2419895|NCT01229722|5935161|P2|STARTED|Overall Study||34
2419896|NCT01229722|5935162|P1|STARTED|Overall Study||36
2419897|NCT01229527|5935175|P3|NOT COMPLETED|Overall Study||0
2419898|NCT01229527|5935176|P2|NOT COMPLETED|Overall Study||0
2419899|NCT01229527|5935177|P1|NOT COMPLETED|Overall Study||0
2419900|NCT01229527|5935175|P3|COMPLETED|Overall Study||30
2419901|NCT01229527|5935176|P2|COMPLETED|Overall Study||30
2419902|NCT01229527|5935177|P1|COMPLETED|Overall Study||30
2419903|NCT01229527|5935175|P3|STARTED|Overall Study||30
2419904|NCT01229527|5935176|P2|STARTED|Overall Study||30
2419905|NCT01229527|5935177|P1|STARTED|Overall Study||30
2419906|NCT01229462|5935190|P2|NOT COMPLETED|Overall Study||9
2419907|NCT01229462|5935191|P1|NOT COMPLETED|Overall Study||5
2419908|NCT01229462|5935190|P2|COMPLETED|Overall Study||109
2419909|NCT01229462|5935191|P1|COMPLETED|Overall Study||115
2419910|NCT01229462|5935190|P2|STARTED|Overall Study||118
2419911|NCT01229462|5935191|P1|STARTED|Overall Study||120
2419912|NCT01229449|5935202|P5|NOT COMPLETED|Overall Study||1
2419913|NCT01229449|5935203|P4|NOT COMPLETED|Overall Study||1
2419914|NCT01229449|5935204|P3|NOT COMPLETED|Overall Study||2
2419915|NCT01229449|5935205|P2|NOT COMPLETED|Overall Study||4
2419916|NCT01229449|5935206|P1|NOT COMPLETED|Overall Study||1
2419917|NCT01229449|5935202|P5|COMPLETED|Overall Study||54
2419918|NCT01229449|5935203|P4|COMPLETED|Overall Study||112
2419919|NCT01229449|5935204|P3|COMPLETED|Overall Study||167
2419920|NCT01229449|5935205|P2|COMPLETED|Overall Study||164
2419921|NCT01229449|5935206|P1|COMPLETED|Overall Study||172
2419922|NCT01229449|5935202|P5|STARTED|Overall Study||55
2419923|NCT01229449|5935203|P4|STARTED|Overall Study||113
2419924|NCT01229449|5935204|P3|STARTED|Overall Study||169
2419925|NCT01229449|5935205|P2|STARTED|Overall Study||168
2419926|NCT01229449|5935206|P1|STARTED|Overall Study||173
2419927|NCT01229436|5935263|P1|NOT COMPLETED|Overall Study||5
2419928|NCT01229436|5935263|P1|COMPLETED|Overall Study||249
2419929|NCT01229436|5935263|P1|STARTED|Overall Study||254
2419930|NCT01229423|5935301|P1|NOT COMPLETED|Overall Study||15
2419931|NCT01229423|5935301|P1|COMPLETED|Overall Study||47
2419932|NCT01229423|5935301|P1|STARTED|Overall Study||62
2419933|NCT01229410|5935312|P2|NOT COMPLETED|Overall Study||3
2419934|NCT01229410|5935313|P1|NOT COMPLETED|Overall Study||5
2419935|NCT01229410|5935312|P2|COMPLETED|Overall Study||9
2419936|NCT01229410|5935313|P1|COMPLETED|Overall Study||7
2419937|NCT01229410|5935312|P2|STARTED|Overall Study||12
2419938|NCT01229410|5935313|P1|STARTED|Overall Study||12
2419939|NCT01229397|5935325|P2|NOT COMPLETED|Overall Study||9
2419940|NCT01229397|5935326|P1|NOT COMPLETED|Overall Study||11
2419941|NCT01229397|5935325|P2|COMPLETED|Overall Study||93
2419942|NCT01229397|5935326|P1|COMPLETED|Overall Study||92
2419943|NCT01229397|5935325|P2|STARTED|Overall Study||102
2419944|NCT01229397|5935326|P1|STARTED|Overall Study||103
2419945|NCT01229371|5935344|P4|NOT COMPLETED|Overall Study||0
2419946|NCT01229371|5935345|P3|NOT COMPLETED|Overall Study||0
2419947|NCT01229371|5935346|P2|NOT COMPLETED|Overall Study||1
2419948|NCT01229371|5935347|P1|NOT COMPLETED|Overall Study||0
2419949|NCT01229371|5935344|P4|COMPLETED|Overall Study||110
2419950|NCT01229371|5935345|P3|COMPLETED|Overall Study||110
2419951|NCT01229371|5935346|P2|COMPLETED|Overall Study||110
2419952|NCT01229371|5935347|P1|COMPLETED|Overall Study||109
2419953|NCT01229371|5935344|P4|STARTED|Overall Study||110
2419954|NCT01229371|5935345|P3|STARTED|Overall Study||110
2419955|NCT01229371|5935346|P2|STARTED|Overall Study||111
2419956|NCT01229371|5935347|P1|STARTED|Overall Study||109
2419957|NCT01229267|5935374|P5|NOT COMPLETED|Overall Study||220
2419958|NCT01229267|5935375|P4|NOT COMPLETED|Overall Study||35
2419959|NCT01229267|5935376|P3|NOT COMPLETED|Overall Study||86
2419960|NCT01229267|5935377|P2|NOT COMPLETED|Overall Study||82
2419961|NCT01229267|5935378|P1|NOT COMPLETED|Overall Study||81
2419962|NCT01229267|5935374|P5|COMPLETED|Overall Study||344
2419963|NCT01229267|5935375|P4|COMPLETED|Overall Study||71
2419964|NCT01229267|5935376|P3|COMPLETED|Overall Study||101
2419965|NCT01229267|5935377|P2|COMPLETED|Overall Study||102
2419966|NCT01229267|5935378|P1|COMPLETED|Overall Study||108
2419967|NCT01229267|5935374|P5|Received Vaccination 4|Overall Study||477
2419968|NCT01229267|5935375|P4|Received Vaccination 4|Overall Study||87
2419969|NCT01229267|5935376|P3|Received Vaccination 4|Overall Study||149
2419970|NCT01229267|5935377|P2|Received Vaccination 4|Overall Study||149
2419971|NCT01229267|5935378|P1|Received Vaccination 4|Overall Study||155
2419972|NCT01229267|5935374|P5|Received Vaccination 3|Overall Study||491
2419973|NCT01229267|5935375|P4|Received Vaccination 3|Overall Study||89
2419974|NCT01229267|5935376|P3|Received Vaccination 3|Overall Study||160
2419975|NCT01229267|5935377|P2|Received Vaccination 3|Overall Study||155
2419976|NCT01229267|5935378|P1|Received Vaccination 3|Overall Study||163
2419977|NCT01229267|5935374|P5|Received Vaccination 2|Overall Study||511
2419978|NCT01229267|5935375|P4|Received Vaccination 2|Overall Study||94
2419979|NCT01229267|5935376|P3|Received Vaccination 2|Overall Study||168
2419980|NCT01229267|5935377|P2|Received Vaccination 2|Overall Study||163
2419981|NCT01229267|5935378|P1|Received Vaccination 2|Overall Study||171
2419982|NCT01229267|5935374|P5|Received Vaccination 1|Overall Study||556
2419983|NCT01229267|5935375|P4|Received Vaccination 1|Overall Study||104
2419984|NCT01229267|5935376|P3|Received Vaccination 1|Overall Study||186
2419985|NCT01229267|5935377|P2|Received Vaccination 1|Overall Study||180
2419986|NCT01229267|5935378|P1|Received Vaccination 1|Overall Study||188
2419987|NCT01229267|5935374|P5|STARTED|Overall Study||564
2419988|NCT01229267|5935375|P4|STARTED|Overall Study||106
2419989|NCT01229267|5935376|P3|STARTED|Overall Study||187
2419990|NCT01229267|5935377|P2|STARTED|Overall Study||184
2419991|NCT01229267|5935378|P1|STARTED|Overall Study||189
2419992|NCT01229254|5935397|P3|NOT COMPLETED|Overall Study||12
2419993|NCT01229254|5935398|P2|NOT COMPLETED|Overall Study||16
2419994|NCT01229254|5935399|P1|NOT COMPLETED|Overall Study||15
2419995|NCT01229254|5935397|P3|COMPLETED|Overall Study||61
2419996|NCT01229254|5935398|P2|COMPLETED|Overall Study||58
2419997|NCT01229254|5935399|P1|COMPLETED|Overall Study||27
2419998|NCT01229254|5935397|P3|STARTED|Overall Study||73
2419999|NCT01229254|5935398|P2|STARTED|Overall Study||74
2420000|NCT01229254|5935399|P1|STARTED|Overall Study||42
2420001|NCT01229228|5935413|P5|NOT COMPLETED|Overall Study||1
2420002|NCT01229228|5935414|P4|NOT COMPLETED|Overall Study||0
2420003|NCT01229228|5935415|P3|NOT COMPLETED|Overall Study||1
2420004|NCT01229228|5935416|P2|NOT COMPLETED|Overall Study||0
2420005|NCT01229228|5935417|P1|NOT COMPLETED|Overall Study||1
2420006|NCT01229228|5935413|P5|COMPLETED|Overall Study||50
2420007|NCT01229228|5935414|P4|COMPLETED|Overall Study||51
2420008|NCT01229228|5935415|P3|COMPLETED|Overall Study||49
2420009|NCT01229228|5935416|P2|COMPLETED|Overall Study||51
2420010|NCT01229228|5935417|P1|COMPLETED|Overall Study||50
2420011|NCT01229228|5935413|P5|STARTED|Overall Study||51
2420012|NCT01229228|5935414|P4|STARTED|Overall Study||51
2420013|NCT01229228|5935415|P3|STARTED|Overall Study||50
2420014|NCT01229228|5935416|P2|STARTED|Overall Study||51
2420015|NCT01229228|5935417|P1|STARTED|Overall Study||51
2420016|NCT01229176|5935437|P8|NOT COMPLETED|Overall Study||3
2420017|NCT01229176|5935438|P7|NOT COMPLETED|Overall Study||0
2420018|NCT01229176|5935439|P6|NOT COMPLETED|Overall Study||2
2420019|NCT01229176|5935440|P5|NOT COMPLETED|Overall Study||2
2420020|NCT01229176|5935441|P4|NOT COMPLETED|Overall Study||1
2420021|NCT01229176|5935442|P3|NOT COMPLETED|Overall Study||0
2420022|NCT01229176|5935443|P2|NOT COMPLETED|Overall Study||3
2420023|NCT01229176|5935444|P1|NOT COMPLETED|Overall Study||0
2420024|NCT01229176|5935437|P8|COMPLETED|Overall Study||17
2420025|NCT01229176|5935438|P7|COMPLETED|Overall Study||20
2420026|NCT01229176|5935439|P6|COMPLETED|Overall Study||18
2420027|NCT01229176|5935440|P5|COMPLETED|Overall Study||18
2420028|NCT01229176|5935441|P4|COMPLETED|Overall Study||19
2420029|NCT01229176|5935442|P3|COMPLETED|Overall Study||20
2420030|NCT01229176|5935443|P2|COMPLETED|Overall Study||37
2420031|NCT01229176|5935444|P1|COMPLETED|Overall Study||40
2420032|NCT01229176|5935437|P8|STARTED|Overall Study||20
2420033|NCT01229176|5935438|P7|STARTED|Overall Study||20
2420034|NCT01229176|5935439|P6|STARTED|Overall Study||20
2420035|NCT01229176|5935440|P5|STARTED|Overall Study||20
2420036|NCT01229176|5935441|P4|STARTED|Overall Study||20
2420037|NCT01229176|5935442|P3|STARTED|Overall Study||20
2420038|NCT01229176|5935443|P2|STARTED|Overall Study||40
2420039|NCT01229176|5935444|P1|STARTED|Overall Study||40
2420040|NCT01229150|5935498|P4|NOT COMPLETED|Overall Study||0
2420041|NCT01229150|5935499|P3|NOT COMPLETED|Overall Study||0
2420042|NCT01229150|5935500|P2|NOT COMPLETED|Overall Study||2
2420043|NCT01229150|5935501|P1|NOT COMPLETED|Overall Study||2
2420044|NCT01229150|5935498|P4|COMPLETED|Overall Study||19
2420045|NCT01229150|5935499|P3|COMPLETED|Overall Study||19
2420046|NCT01229150|5935500|P2|COMPLETED|Overall Study||9
2420047|NCT01229150|5935501|P1|COMPLETED|Overall Study||28
2420048|NCT01229150|5935498|P4|STARTED|Overall Study||19
2420049|NCT01229150|5935499|P3|STARTED|Overall Study||19
2420050|NCT01229150|5935500|P2|STARTED|Overall Study||11
2420051|NCT01229150|5935501|P1|STARTED|Overall Study||30
2420052|NCT01229111|5935558|P1|NOT COMPLETED|Overall Study||1
2420053|NCT01229111|5935558|P1|COMPLETED|Overall Study||13
2420054|NCT01229111|5935558|P1|STARTED|Overall Study||14
2420055|NCT01228968|5935566|P1|NOT COMPLETED|Overall Study||0
2420056|NCT01228968|5935566|P1|COMPLETED|Overall Study||9
2420057|NCT01228968|5935566|P1|STARTED|Overall Study||9
2420058|NCT01228929|5935576|P3|NOT COMPLETED|High Temperature Condition||0
2420059|NCT01228929|5935577|P2|NOT COMPLETED|High Temperature Condition||0
2420060|NCT01228929|5935578|P1|NOT COMPLETED|High Temperature Condition||0
2420061|NCT01228929|5935576|P3|COMPLETED|High Temperature Condition||6
2420062|NCT01228929|5935577|P2|COMPLETED|High Temperature Condition||6
2420063|NCT01228929|5935578|P1|COMPLETED|High Temperature Condition||6
2420064|NCT01228929|5935576|P3|STARTED|High Temperature Condition||6
2420065|NCT01228929|5935577|P2|STARTED|High Temperature Condition||6
2420066|NCT01228929|5935578|P1|STARTED|High Temperature Condition||6
2420067|NCT01228929|5935576|P3|NOT COMPLETED|Low Humidity Condition||0
2420068|NCT01228929|5935577|P2|NOT COMPLETED|Low Humidity Condition||0
2420069|NCT01228929|5935578|P1|NOT COMPLETED|Low Humidity Condition||0
2420070|NCT01228929|5935576|P3|COMPLETED|Low Humidity Condition||6
2420071|NCT01228929|5935577|P2|COMPLETED|Low Humidity Condition||6
2420072|NCT01228929|5935578|P1|COMPLETED|Low Humidity Condition||6
2420073|NCT01228929|5935576|P3|STARTED|Low Humidity Condition||6
2420074|NCT01228929|5935577|P2|STARTED|Low Humidity Condition||6
2420075|NCT01228929|5935578|P1|STARTED|Low Humidity Condition||6
2420076|NCT01228929|5935576|P3|NOT COMPLETED|Nominal Condition||0
2420077|NCT01228929|5935577|P2|NOT COMPLETED|Nominal Condition||0
2420078|NCT01228929|5935578|P1|NOT COMPLETED|Nominal Condition||0
2420079|NCT01228929|5935576|P3|COMPLETED|Nominal Condition||6
2420080|NCT01228929|5935577|P2|COMPLETED|Nominal Condition||6
2420081|NCT01228929|5935578|P1|COMPLETED|Nominal Condition||6
2420082|NCT01228929|5935576|P3|STARTED|Nominal Condition||6
2420083|NCT01228929|5935577|P2|STARTED|Nominal Condition||6
2420084|NCT01228929|5935578|P1|STARTED|Nominal Condition||6
2420085|NCT01228903|5935588|P2|NOT COMPLETED|Overall Study||5
2420086|NCT01228903|5935589|P1|NOT COMPLETED|Overall Study||5
2420087|NCT01228903|5935588|P2|COMPLETED|Overall Study||34
2420088|NCT01228903|5935589|P1|COMPLETED|Overall Study||36
2420089|NCT01228903|5935588|P2|STARTED|Overall Study||39
2420090|NCT01228903|5935589|P1|STARTED|Overall Study||41
2420091|NCT01228747|5935607|P2|NOT COMPLETED|Overall Study||45
2420092|NCT01228747|5935608|P1|NOT COMPLETED|Overall Study||65
2420093|NCT01228747|5935607|P2|COMPLETED|Overall Study||81
2420094|NCT01228747|5935608|P1|COMPLETED|Overall Study||60
2420095|NCT01228747|5935607|P2|STARTED|Overall Study||126
2420096|NCT01228747|5935608|P1|STARTED|Overall Study||125
2420097|NCT01228734|5935624|P2|NOT COMPLETED|Overall Study||4
2420098|NCT01228734|5935625|P1|NOT COMPLETED|Overall Study||0
2420099|NCT01228734|5935624|P2|COMPLETED|Overall Study||200
2420100|NCT01228734|5935625|P1|COMPLETED|Overall Study||193
2420101|NCT01228734|5935624|P2|Modified Safety Population|Overall Study||199
2420102|NCT01228734|5935625|P1|Modified Safety Population|Overall Study|One subject was randomized to FOLFOX-4 group but received cetuximab + FOLFOX-4 treatment instead|194
2420103|NCT01228734|5935624|P2|Modified Intent-to-treat Population|Overall Study||200
2420104|NCT01228734|5935625|P1|Modified Intent-to-treat Population|Overall Study||193
2420105|NCT01228734|5935624|P2|STARTED|Overall Study||204
2420106|NCT01228734|5935625|P1|STARTED|Overall Study||193
2420107|NCT01228591|5935639|P2|NOT COMPLETED|Final Visit||0
2420108|NCT01228591|5935640|P1|NOT COMPLETED|Final Visit||0
2420109|NCT01228591|5935639|P2|COMPLETED|Final Visit||16
2420110|NCT01228591|5935640|P1|COMPLETED|Final Visit||17
2420111|NCT01228591|5935639|P2|STARTED|Final Visit||16
2420112|NCT01228591|5935640|P1|STARTED|Final Visit||17
2420113|NCT01228591|5935639|P2|NOT COMPLETED|1-Week Follow-Up||0
2420114|NCT01228591|5935640|P1|NOT COMPLETED|1-Week Follow-Up||0
2420115|NCT01228591|5935639|P2|COMPLETED|1-Week Follow-Up||16
2420116|NCT01228591|5935640|P1|COMPLETED|1-Week Follow-Up||17
2420117|NCT01228591|5935639|P2|STARTED|1-Week Follow-Up||16
2420118|NCT01228591|5935640|P1|STARTED|1-Week Follow-Up||17
2420119|NCT01228591|5935639|P2|NOT COMPLETED|Baseline||2
2420120|NCT01228591|5935640|P1|NOT COMPLETED|Baseline||1
2420121|NCT01228591|5935639|P2|COMPLETED|Baseline||16
2420122|NCT01228591|5935640|P1|COMPLETED|Baseline||17
2420123|NCT01228591|5935639|P2|STARTED|Baseline||18
2420124|NCT01228591|5935640|P1|STARTED|Baseline||18
2420125|NCT01228435|5935658|P2|NOT COMPLETED|Overall Study||0
2420126|NCT01228435|5935659|P1|NOT COMPLETED|Overall Study||0
2420127|NCT01228435|5935658|P2|COMPLETED|Overall Study||2
2420128|NCT01228435|5935659|P1|COMPLETED|Overall Study||1
2420129|NCT01228435|5935658|P2|STARTED|Overall Study||2
2420130|NCT01228435|5935659|P1|STARTED|Overall Study||1
2420131|NCT01228318|5935669|P2|NOT COMPLETED|Overall Study||7
2420132|NCT01228318|5935670|P1|NOT COMPLETED|Overall Study||4
2420133|NCT01228318|5935669|P2|COMPLETED|Overall Study||22
2420134|NCT01228318|5935670|P1|COMPLETED|Overall Study||30
2420135|NCT01228318|5935669|P2|STARTED|Overall Study||29
2420136|NCT01228318|5935670|P1|STARTED|Overall Study||34
2420137|NCT01228175|5935686|P2|NOT COMPLETED|Overall Study||53
2420138|NCT01228175|5935687|P1|NOT COMPLETED|Overall Study||66
2420139|NCT01228175|5935686|P2|COMPLETED|Overall Study||46
2420140|NCT01228175|5935687|P1|COMPLETED|Overall Study||53
2420141|NCT01228175|5935686|P2|STARTED|Overall Study||99
2420142|NCT01228175|5935687|P1|STARTED|Overall Study||119
2420143|NCT01228149|5935695|P2|NOT COMPLETED|Overall Study||4
2420144|NCT01228149|5935696|P1|NOT COMPLETED|Overall Study||5
2420145|NCT01228149|5935695|P2|COMPLETED|Overall Study||26
2420146|NCT01228149|5935696|P1|COMPLETED|Overall Study||27
2420147|NCT01228149|5935695|P2|STARTED|Overall Study||30
2420148|NCT01228149|5935696|P1|STARTED|Overall Study||32
2420149|NCT01228084|5935718|P1|NOT COMPLETED|Overall Study||4
2420150|NCT01228084|5935718|P1|COMPLETED|Overall Study||16
2420151|NCT01228084|5935718|P1|STARTED|Overall Study||20
2420152|NCT01228071|5935729|P1|NOT COMPLETED|Overall Study||2
2420153|NCT01228071|5935729|P1|COMPLETED|Overall Study||32
2420154|NCT01228071|5935729|P1|STARTED|Overall Study||34
2420155|NCT01228019|5935735|P1|NOT COMPLETED|Overall Study||304
2420156|NCT01228019|5935735|P1|COMPLETED|Overall Study||862
2420157|NCT01228019|5935735|P1|STARTED|Overall Study||1166
2420158|NCT01227993|5935750|P1|NOT COMPLETED|Overall Study||0
2420159|NCT01227993|5935750|P1|COMPLETED|Overall Study||3
2420160|NCT01227993|5935750|P1|STARTED|Overall Study||3
2420161|NCT01227980|5935762|P2|NOT COMPLETED|Overall Study||5
2420162|NCT01227980|5935763|P1|NOT COMPLETED|Overall Study||2
2420163|NCT01227980|5935762|P2|COMPLETED|Overall Study||25
2420164|NCT01227980|5935763|P1|COMPLETED|Overall Study|Two subjects did not complete the scripts sessions but completed the remainder of the protocol|38
2420165|NCT01227980|5935762|P2|Measure Drug Level Concentration|Overall Study|No placebo subjects completed this milestone which measured active drug levels|0
2420166|NCT01227980|5935763|P1|Measure Drug Level Concentration|Overall Study||10
2420167|NCT01227980|5935762|P2|Scripts Challenge Sessions|Overall Study||25
2420168|NCT01227980|5935763|P1|Scripts Challenge Sessions|Overall Study||26
2420169|NCT01227980|5935762|P2|STARTED|Overall Study||30
2420170|NCT01227980|5935763|P1|STARTED|Overall Study||40
2420171|NCT01227967|5935801|P2|NOT COMPLETED|Overall Study||13
2420172|NCT01227967|5935802|P1|NOT COMPLETED|Overall Study||16
2420173|NCT01227967|5935801|P2|COMPLETED|Overall Study||303
2420174|NCT01227967|5935802|P1|COMPLETED|Overall Study||298
2420175|NCT01227967|5935801|P2|STARTED|Overall Study||316
2420176|NCT01227967|5935802|P1|STARTED|Overall Study||314
2420177|NCT01227954|5935836|P1|NOT COMPLETED|Overall Study||13
2420178|NCT01227954|5935836|P1|COMPLETED|Overall Study|Eligible subjects available for analysis|100
2420179|NCT01227954|5935836|P1|STARTED|Overall Study||113
2420180|NCT01227928|5935850|P2|NOT COMPLETED|Overall Study||17
2420181|NCT01227928|5935851|P1|NOT COMPLETED|Overall Study||22
2420182|NCT01227928|5935850|P2|COMPLETED|Overall Study||56
2420183|NCT01227928|5935851|P1|COMPLETED|Overall Study||50
2420184|NCT01227928|5935850|P2|STARTED|Overall Study||73
2420185|NCT01227928|5935851|P1|STARTED|Overall Study||72
2420186|NCT01227902|5935889|P4|NOT COMPLETED|Overall Study||10
2420187|NCT01227902|5935890|P3|NOT COMPLETED|Overall Study||19
2420188|NCT01227902|5935891|P2|NOT COMPLETED|Overall Study||13
2420189|NCT01227902|5935892|P1|NOT COMPLETED|Overall Study||18
2420190|NCT01227902|5935889|P4|COMPLETED|Overall Study||42
2420191|NCT01227902|5935890|P3|COMPLETED|Overall Study||25
2420192|NCT01227902|5935891|P2|COMPLETED|Overall Study||38
2420193|NCT01227902|5935892|P1|COMPLETED|Overall Study||38
2420194|NCT01227902|5935889|P4|STARTED|Overall Study||52
2420195|NCT01227902|5935890|P3|STARTED|Overall Study||44
2420196|NCT01227902|5935891|P2|STARTED|Overall Study||51
2420197|NCT01227902|5935892|P1|STARTED|Overall Study||56
2420198|NCT01227889|5935985|P2|NOT COMPLETED|Crossover Phase||37
2420199|NCT01227889|5935986|P1|NOT COMPLETED|Crossover Phase||0
2420200|NCT01227889|5935985|P2|COMPLETED|Crossover Phase||0
2420201|NCT01227889|5935986|P1|COMPLETED|Crossover Phase||0
2420202|NCT01227889|5935985|P2|STARTED|Crossover Phase|As of the data cut on December 18, 2012, 36 of 63 participants crossed over from DTIC to GSK2118436.|37
2420203|NCT01227889|5935986|P1|STARTED|Crossover Phase||0
2420204|NCT01227889|5935985|P2|NOT COMPLETED|Randomized Phase (RP)||63
2420205|NCT01227889|5935986|P1|NOT COMPLETED|Randomized Phase (RP)||187
2420206|NCT01227889|5935985|P2|COMPLETED|Randomized Phase (RP)||0
2420207|NCT01227889|5935986|P1|COMPLETED|Randomized Phase (RP)||0
2420208|NCT01227889|5935985|P2|STARTED|Randomized Phase (RP)||63
2420209|NCT01227889|5935986|P1|STARTED|Randomized Phase (RP)||187
2420210|NCT01227824|5936013|P3|NOT COMPLETED|Open-label Phase: Median of 1267 Days||44
2420211|NCT01227824|5936014|P2|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0
2420212|NCT01227824|5936015|P1|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0
2420213|NCT01227824|5936013|P3|COMPLETED|Open-label Phase: Median of 1267 Days||294
2420214|NCT01227824|5936014|P2|COMPLETED|Open-label Phase: Median of 1267 Days||0
2420215|NCT01227824|5936015|P1|COMPLETED|Open-label Phase: Median of 1267 Days||0
2420216|NCT01227824|5936013|P3|STARTED|Open-label Phase: Median of 1267 Days|338 participants continued into the Open-label phase on completing the Double-blind Phase|338
2420217|NCT01227824|5936014|P2|STARTED|Open-label Phase: Median of 1267 Days||0
2420218|NCT01227824|5936015|P1|STARTED|Open-label Phase: Median of 1267 Days||0
2420219|NCT01227824|5936013|P3|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||0
2420220|NCT01227824|5936014|P2|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||79
2420221|NCT01227824|5936015|P1|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||107
2420222|NCT01227824|5936013|P3|COMPLETED|Double-blind Phase: 96 Weeks Duration||0
2420223|NCT01227824|5936014|P2|COMPLETED|Double-blind Phase: 96 Weeks Duration||332
2420224|NCT01227824|5936015|P1|COMPLETED|Double-blind Phase: 96 Weeks Duration||304
2420225|NCT01227824|5936013|P3|STARTED|Double-blind Phase: 96 Weeks Duration||0
2420226|NCT01227824|5936014|P2|STARTED|Double-blind Phase: 96 Weeks Duration||411
2420227|NCT01227824|5936015|P1|STARTED|Double-blind Phase: 96 Weeks Duration||411
2420228|NCT01227785|5936044|P1|NOT COMPLETED|Overall Study||12
2420229|NCT01227785|5936044|P1|COMPLETED|Overall Study||108
2420230|NCT01227785|5936044|P1|STARTED|Overall Study||120
2420231|NCT01227707|5936110|P1|NOT COMPLETED|Overall Study||24
2420232|NCT01227707|5936110|P1|COMPLETED|Overall Study||19
2420233|NCT01227707|5936110|P1|STARTED|Overall Study||43
2420234|NCT01227681|5936129|P3|NOT COMPLETED|Overall Study||0
2420235|NCT01227681|5936130|P2|NOT COMPLETED|Overall Study||0
2420236|NCT01227681|5936131|P1|NOT COMPLETED|Overall Study||0
2420237|NCT01227681|5936129|P3|COMPLETED|Overall Study||0
2420238|NCT01227681|5936130|P2|COMPLETED|Overall Study||0
2420239|NCT01227681|5936131|P1|COMPLETED|Overall Study||4
2420240|NCT01227681|5936129|P3|STARTED|Overall Study||0
2420241|NCT01227681|5936130|P2|STARTED|Overall Study||0
2420242|NCT01227681|5936131|P1|STARTED|Overall Study||4
2420243|NCT01227668|5936137|P2|NOT COMPLETED|Phase 2 (Randomization Phase)||25
2420244|NCT01227668|5936138|P1|NOT COMPLETED|Phase 2 (Randomization Phase)||19
2420245|NCT01227668|5936137|P2|COMPLETED|Phase 2 (Randomization Phase)||19
2420246|NCT01227668|5936138|P1|COMPLETED|Phase 2 (Randomization Phase)||22
2420247|NCT01227668|5936137|P2|Received Treatment|Phase 2 (Randomization Phase)||43
2420248|NCT01227668|5936138|P1|Received Treatment|Phase 2 (Randomization Phase)||39
2420249|NCT01227668|5936137|P2|STARTED|Phase 2 (Randomization Phase)|Randomized|44
2420250|NCT01227668|5936138|P1|STARTED|Phase 2 (Randomization Phase)|Randomized|41
2420251|NCT01227668|5936137|P2|NOT COMPLETED|Phase 1 (Stabilization Phase)||0
2420252|NCT01227668|5936138|P1|NOT COMPLETED|Phase 1 (Stabilization Phase)||72
2420253|NCT01227668|5936137|P2|COMPLETED|Phase 1 (Stabilization Phase)||0
2420254|NCT01227668|5936138|P1|COMPLETED|Phase 1 (Stabilization Phase)||85
2420255|NCT01227668|5936137|P2|Received Treatment|Phase 1 (Stabilization Phase)||0
2420256|NCT01227668|5936138|P1|Received Treatment|Phase 1 (Stabilization Phase)||155
2420257|NCT01227668|5936137|P2|STARTED|Phase 1 (Stabilization Phase)||0
2420258|NCT01227668|5936138|P1|STARTED|Phase 1 (Stabilization Phase)|Randomized|157
2420259|NCT01227655|5936155|P3|NOT COMPLETED|Overall Study||14
2420260|NCT01227655|5936156|P2|NOT COMPLETED|Overall Study||26
2420261|NCT01227655|5936157|P1|NOT COMPLETED|Overall Study||11
2420262|NCT01227655|5936155|P3|COMPLETED|Overall Study||130
2420263|NCT01227655|5936156|P2|COMPLETED|Overall Study||128
2420264|NCT01227655|5936157|P1|COMPLETED|Overall Study||118
2420265|NCT01227655|5936155|P3|Full Analysis Set|Overall Study||135
2420266|NCT01227655|5936156|P2|Full Analysis Set|Overall Study||147
2420267|NCT01227655|5936157|P1|Full Analysis Set|Overall Study||125
2420268|NCT01227655|5936155|P3|Safety Set|Overall Study||136
2420269|NCT01227655|5936156|P2|Safety Set|Overall Study||150
2420270|NCT01227655|5936157|P1|Safety Set|Overall Study||125
2420271|NCT01227655|5936155|P3|STARTED|Overall Study||144
2420272|NCT01227655|5936156|P2|STARTED|Overall Study||154
2420273|NCT01227655|5936157|P1|STARTED|Overall Study||129
2420274|NCT01227629|5936184|P10|NOT COMPLETED|Overall Study||2
2420275|NCT01227629|5936185|P9|NOT COMPLETED|Overall Study||6
2420276|NCT01227629|5936186|P8|NOT COMPLETED|Overall Study||6
2420277|NCT01227629|5936187|P7|NOT COMPLETED|Overall Study||8
2420278|NCT01227629|5936188|P6|NOT COMPLETED|Overall Study||1
2420279|NCT01227629|5936189|P5|NOT COMPLETED|Overall Study||2
2420280|NCT01227629|5936190|P4|NOT COMPLETED|Overall Study||8
2420281|NCT01227629|5936191|P3|NOT COMPLETED|Overall Study||1
2420282|NCT01227629|5936192|P2|NOT COMPLETED|Overall Study||2
2420283|NCT01227629|5936193|P1|NOT COMPLETED|Overall Study||2
2420284|NCT01227629|5936184|P10|COMPLETED|Overall Study||68
2420285|NCT01227629|5936185|P9|COMPLETED|Overall Study||24
2420286|NCT01227629|5936186|P8|COMPLETED|Overall Study||27
2420287|NCT01227629|5936187|P7|COMPLETED|Overall Study||90
2420288|NCT01227629|5936188|P6|COMPLETED|Overall Study||32
2420289|NCT01227629|5936189|P5|COMPLETED|Overall Study||32
2420290|NCT01227629|5936190|P4|COMPLETED|Overall Study||91
2420291|NCT01227629|5936191|P3|COMPLETED|Overall Study||26
2420292|NCT01227629|5936192|P2|COMPLETED|Overall Study||18
2420293|NCT01227629|5936193|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|56
2420294|NCT01227629|5936184|P10|STARTED|Overall Study||70
2420295|NCT01227629|5936185|P9|STARTED|Overall Study||30
2420296|NCT01227629|5936186|P8|STARTED|Overall Study||33
2420297|NCT01227629|5936187|P7|STARTED|Overall Study||98
2420298|NCT01227629|5936188|P6|STARTED|Overall Study||33
2420299|NCT01227629|5936189|P5|STARTED|Overall Study||34
2420300|NCT01227629|5936190|P4|STARTED|Overall Study||99
2420301|NCT01227629|5936191|P3|STARTED|Overall Study||27
2420302|NCT01227629|5936192|P2|STARTED|Overall Study||20
2420303|NCT01227629|5936193|P1|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|58
2420304|NCT01227616|5936431|P2|NOT COMPLETED|Overall Study||23
2420305|NCT01227616|5936432|P1|NOT COMPLETED|Overall Study||54
2420306|NCT01227616|5936431|P2|COMPLETED|Overall Study||74
2420307|NCT01227616|5936432|P1|COMPLETED|Overall Study||142
2420308|NCT01227616|5936431|P2|STARTED|Overall Study||97
2420309|NCT01227616|5936432|P1|STARTED|Overall Study||196
2420310|NCT01227577|5936442|P1|NOT COMPLETED|Overall Study||35
2420311|NCT01227577|5936442|P1|COMPLETED|Overall Study||93
2420312|NCT01227577|5936442|P1|STARTED|Overall Study||128
2420313|NCT01227564|5936457|P3|NOT COMPLETED|Overall Study||6
2420314|NCT01227564|5936458|P2|NOT COMPLETED|Overall Study||2
2420315|NCT01227564|5936459|P1|NOT COMPLETED|Overall Study||4
2420316|NCT01227564|5936457|P3|COMPLETED|Overall Study|Completed study|15
2420317|NCT01227564|5936458|P2|COMPLETED|Overall Study|Completed study|18
2420318|NCT01227564|5936459|P1|COMPLETED|Overall Study|Completed study|18
2420319|NCT01227564|5936457|P3|Completed Treatment|Overall Study|1 participant stopped treatment due to lack of efficacy, 3 due to no longer willing to participate.|17
2420320|NCT01227564|5936458|P2|Completed Treatment|Overall Study|2 participants discontinued treatment due to no longer willing to participate in study.|18
2420321|NCT01227564|5936459|P1|Completed Treatment|Overall Study|1 participant discontinued treatment due to an adverse event (AE).|21
2420322|NCT01227564|5936457|P3|Treated|Overall Study||21
2420323|NCT01227564|5936458|P2|Treated|Overall Study||20
2420324|NCT01227564|5936459|P1|Treated|Overall Study||22
2420325|NCT01227564|5936457|P3|STARTED|Overall Study||21
2420326|NCT01227564|5936458|P2|STARTED|Overall Study||20
2420327|NCT01227564|5936459|P1|STARTED|Overall Study||22
2420328|NCT01227551|5936590|P1|NOT COMPLETED|Overall Study||34
2420329|NCT01227551|5936590|P1|COMPLETED|Overall Study||23
2420330|NCT01227551|5936590|P1|STARTED|Overall Study||57
2420331|NCT01227512|5936597|P2|NOT COMPLETED|Overall Study||10
2420332|NCT01227512|5936598|P1|NOT COMPLETED|Overall Study||13
2420333|NCT01227512|5936597|P2|COMPLETED|Overall Study||48
2420334|NCT01227512|5936598|P1|COMPLETED|Overall Study||53
2420335|NCT01227512|5936597|P2|STARTED|Overall Study||58
2420336|NCT01227512|5936598|P1|STARTED|Overall Study||66
2420337|NCT01227434|5936620|P2|NOT COMPLETED|Overall Study||0
2420338|NCT01227434|5936621|P1|NOT COMPLETED|Overall Study||0
2420339|NCT01227434|5936620|P2|COMPLETED|Overall Study||16
2420340|NCT01227434|5936621|P1|COMPLETED|Overall Study||6
2420341|NCT01227434|5936620|P2|STARTED|Overall Study||16
2420342|NCT01227434|5936621|P1|STARTED|Overall Study||6
2420343|NCT01227421|5936632|P3|NOT COMPLETED|Overall Study||10
2420344|NCT01227421|5936633|P2|NOT COMPLETED|Overall Study||18
2420345|NCT01227421|5936634|P1|NOT COMPLETED|Overall Study||11
2420346|NCT01227421|5936632|P3|COMPLETED|Overall Study||201
2420347|NCT01227421|5936633|P2|COMPLETED|Overall Study||194
2420348|NCT01227421|5936634|P1|COMPLETED|Overall Study||190
2420349|NCT01227421|5936632|P3|STARTED|Overall Study||211
2420350|NCT01227421|5936633|P2|STARTED|Overall Study||212
2420351|NCT01227421|5936634|P1|STARTED|Overall Study||201
2420352|NCT01227395|5936686|P2|NOT COMPLETED|Overall Study||1
2420353|NCT01227395|5936687|P1|NOT COMPLETED|Overall Study||0
2420354|NCT01227395|5936686|P2|COMPLETED|Overall Study||84
2420355|NCT01227395|5936687|P1|COMPLETED|Overall Study||391
2420356|NCT01227395|5936686|P2|STARTED|Overall Study||85
2420357|NCT01227395|5936687|P1|STARTED|Overall Study||391
2420358|NCT01227382|5936715|P1|NOT COMPLETED|Overall Study||0
2420359|NCT01227382|5936715|P1|COMPLETED|Overall Study||26
2420360|NCT01227382|5936715|P1|STARTED|Overall Study||26
2420361|NCT01227278|5936727|P2|NOT COMPLETED|Overall Study||8
2420362|NCT01227278|5936728|P1|NOT COMPLETED|Overall Study||5
2420363|NCT01227278|5936727|P2|COMPLETED|Overall Study||43
2420364|NCT01227278|5936728|P1|COMPLETED|Overall Study||45
2420365|NCT01227278|5936727|P2|STARTED|Overall Study||51
2420366|NCT01227278|5936728|P1|STARTED|Overall Study||50
2420367|NCT01227265|5936755|P3|NOT COMPLETED|Overall Study||14
2420368|NCT01227265|5936756|P2|NOT COMPLETED|Overall Study||20
2420369|NCT01227265|5936757|P1|NOT COMPLETED|Overall Study||19
2420370|NCT01227265|5936755|P3|COMPLETED|Overall Study||145
2420371|NCT01227265|5936756|P2|COMPLETED|Overall Study||139
2420372|NCT01227265|5936757|P1|COMPLETED|Overall Study||139
2420373|NCT01227265|5936755|P3|Treated|Overall Study||159
2420374|NCT01227265|5936756|P2|Treated|Overall Study||157
2420375|NCT01227265|5936757|P1|Treated|Overall Study||157
2420376|NCT01227265|5936755|P3|STARTED|Overall Study||159
2420377|NCT01227265|5936756|P2|STARTED|Overall Study||159
2420378|NCT01227265|5936757|P1|STARTED|Overall Study||158
2420379|NCT01227252|5936787|P4|NOT COMPLETED|Overall Study||0
2420380|NCT01227252|5936788|P3|NOT COMPLETED|Overall Study||0
2420381|NCT01227252|5936789|P2|NOT COMPLETED|Overall Study||3
2420382|NCT01227252|5936790|P1|NOT COMPLETED|Overall Study||0
2420383|NCT01227252|5936787|P4|COMPLETED|Overall Study||10
2420384|NCT01227252|5936788|P3|COMPLETED|Overall Study||10
2420385|NCT01227252|5936789|P2|COMPLETED|Overall Study||7
2420386|NCT01227252|5936790|P1|COMPLETED|Overall Study||12
2420387|NCT01227252|5936787|P4|Received at Least 1 Dose of Study Drug|Overall Study||10
2420388|NCT01227252|5936788|P3|Received at Least 1 Dose of Study Drug|Overall Study||10
2420389|NCT01227252|5936789|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
2420390|NCT01227252|5936790|P1|Received at Least 1 Dose of Study Drug|Overall Study||12
2420391|NCT01227252|5936787|P4|STARTED|Overall Study||10
2420392|NCT01227252|5936788|P3|STARTED|Overall Study||10
2420393|NCT01227252|5936789|P2|STARTED|Overall Study||10
2420394|NCT01227252|5936790|P1|STARTED|Overall Study||12
2420395|NCT01227057|5936819|P2|NOT COMPLETED|Overall Study||8
2420396|NCT01227057|5936820|P1|NOT COMPLETED|Overall Study||6
2420397|NCT01227057|5936819|P2|COMPLETED|Overall Study||19
2420398|NCT01227057|5936820|P1|COMPLETED|Overall Study||25
2420399|NCT01227057|5936819|P2|STARTED|Overall Study||27
2420400|NCT01227057|5936820|P1|STARTED|Overall Study||31
2420401|NCT01227044|5936832|P2|NOT COMPLETED|Overall Study||9
2420402|NCT01227044|5936833|P1|NOT COMPLETED|Overall Study||6
2420403|NCT01227044|5936832|P2|COMPLETED|Overall Study||17
2420404|NCT01227044|5936833|P1|COMPLETED|Overall Study||19
2420405|NCT01227044|5936832|P2|STARTED|Overall Study||26
2420406|NCT01227044|5936833|P1|STARTED|Overall Study||25
2420407|NCT01227018|5936841|P1|NOT COMPLETED|Overall Study||15
2420408|NCT01227018|5936841|P1|COMPLETED|Overall Study||0
2420409|NCT01227018|5936841|P1|STARTED|Overall Study||15
2420410|NCT01227005|5936851|P2|NOT COMPLETED|Overall Study||1
2420411|NCT01227005|5936852|P1|NOT COMPLETED|Overall Study||5
2420412|NCT01227005|5936851|P2|COMPLETED|Overall Study||51
2420413|NCT01227005|5936852|P1|COMPLETED|Overall Study||50
2420414|NCT01227005|5936851|P2|STARTED|Overall Study||52
2420415|NCT01227005|5936852|P1|STARTED|Overall Study||55
2420416|NCT01226914|5936864|P2|NOT COMPLETED|Overall Study||0
2420417|NCT01226914|5936865|P1|NOT COMPLETED|Overall Study||0
2420418|NCT01226914|5936864|P2|COMPLETED|Overall Study||27
2420419|NCT01226914|5936865|P1|COMPLETED|Overall Study||28
2420420|NCT01226914|5936864|P2|STARTED|Overall Study||27
2420421|NCT01226914|5936865|P1|STARTED|Overall Study||28
2420422|NCT01226745|5936877|P6|NOT COMPLETED|Overall Study||5
2420423|NCT01226745|5936878|P5|NOT COMPLETED|Overall Study||4
2420424|NCT01226745|5936879|P4|NOT COMPLETED|Overall Study||5
2420425|NCT01226745|5936880|P3|NOT COMPLETED|Overall Study||20
2420426|NCT01226745|5936881|P2|NOT COMPLETED|Overall Study||16
2420427|NCT01226745|5936882|P1|NOT COMPLETED|Overall Study||17
2420428|NCT01226745|5936877|P6|COMPLETED|Overall Study||24
2420429|NCT01226745|5936878|P5|COMPLETED|Overall Study||22
2420430|NCT01226745|5936879|P4|COMPLETED|Overall Study||24
2420431|NCT01226745|5936880|P3|COMPLETED|Overall Study||69
2420432|NCT01226745|5936881|P2|COMPLETED|Overall Study||71
2420433|NCT01226745|5936882|P1|COMPLETED|Overall Study||63
2420434|NCT01226745|5936877|P6|STARTED|Overall Study||29
2420435|NCT01226745|5936878|P5|STARTED|Overall Study||26
2420436|NCT01226745|5936879|P4|STARTED|Overall Study||29
2420437|NCT01226745|5936880|P3|STARTED|Overall Study||89
2420438|NCT01226745|5936881|P2|STARTED|Overall Study||87
2420439|NCT01226745|5936882|P1|STARTED|Overall Study||80
2420440|NCT01226732|5936962|P6|NOT COMPLETED|Overall Study||6
2420441|NCT01226732|5936963|P5|NOT COMPLETED|Overall Study||3
2420442|NCT01226732|5936964|P4|NOT COMPLETED|Overall Study||5
2420443|NCT01226732|5936965|P3|NOT COMPLETED|Overall Study||3
2420444|NCT01226732|5936966|P2|NOT COMPLETED|Overall Study||3
2420445|NCT01226732|5936967|P1|NOT COMPLETED|Overall Study||3
2420446|NCT01226732|5936962|P6|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
2420447|NCT01226732|5936963|P5|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
2420448|NCT01226732|5936964|P4|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
2420449|NCT01226732|5936965|P3|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
2420450|NCT01226732|5936966|P2|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
2420451|NCT01226732|5936967|P1|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
2420452|NCT01226732|5936962|P6|STARTED|Overall Study||6
2420453|NCT01226732|5936963|P5|STARTED|Overall Study||3
2420454|NCT01226732|5936964|P4|STARTED|Overall Study||5
2420455|NCT01226732|5936965|P3|STARTED|Overall Study||3
2420456|NCT01226732|5936966|P2|STARTED|Overall Study||3
2420457|NCT01226732|5936967|P1|STARTED|Overall Study||3
2420458|NCT01226719|5936983|P1|NOT COMPLETED|Overall Study||13
2420459|NCT01226719|5936983|P1|COMPLETED|Overall Study|Completed = patient is surgical candidate, underwent resection, received treatment to week 24.|2
2420460|NCT01226719|5936983|P1|STARTED|Overall Study||15
2420461|NCT01226706|5936993|P2|NOT COMPLETED|Overall Study||0
2420462|NCT01226706|5936994|P1|NOT COMPLETED|Overall Study||0
2420463|NCT01226706|5936993|P2|COMPLETED|Overall Study||11
2420464|NCT01226706|5936994|P1|COMPLETED|Overall Study||10
2420465|NCT01226706|5936993|P2|STARTED|Overall Study||11
2420466|NCT01226706|5936994|P1|STARTED|Overall Study||10
2420467|NCT01226511|5937078|P2|NOT COMPLETED|Taper Period||3
2420468|NCT01226511|5937079|P1|NOT COMPLETED|Taper Period||5
2420469|NCT01226511|5937078|P2|COMPLETED|Taper Period||54
2420470|NCT01226511|5937079|P1|COMPLETED|Taper Period||46
2420471|NCT01226511|5937078|P2|STARTED|Taper Period||57
2420472|NCT01226511|5937079|P1|STARTED|Taper Period||51
2420473|NCT01226511|5937078|P2|NOT COMPLETED|Extension Treatment Period||27
2420474|NCT01226511|5937079|P1|NOT COMPLETED|Extension Treatment Period||27
2420475|NCT01226511|5937078|P2|COMPLETED|Extension Treatment Period|Thirty-five (35) participants who completed extension treatment did not enter the taper period.|83
2420476|NCT01226511|5937079|P1|COMPLETED|Extension Treatment Period|Thirty-nine (39) participants who completed extension treatment did not enter the taper period.|81
2420477|NCT01226511|5937078|P2|STARTED|Extension Treatment Period|Twenty-three (23) participants who discontinued extension treatment did not enter the taper period.|110
2420478|NCT01226511|5937079|P1|STARTED|Extension Treatment Period|Nineteen (19) participants who discontinued extension treatment did not enter the taper period.|108
2420479|NCT01226511|5937078|P2|NOT COMPLETED|Acute Treatment Period||31
2420480|NCT01226511|5937079|P1|NOT COMPLETED|Acute Treatment Period||32
2420481|NCT01226511|5937078|P2|COMPLETED|Acute Treatment Period||110
2420482|NCT01226511|5937079|P1|COMPLETED|Acute Treatment Period||108
2420483|NCT01226511|5937078|P2|STARTED|Acute Treatment Period|Twenty-six (26) participants who discontinued acute treatment did not enter the taper period.|141
2420571|NCT01226043|5937238|P2|NOT COMPLETED|4-week Crossover Phase - Period 2||6
2420484|NCT01226511|5937079|P1|STARTED|Acute Treatment Period|Thirty-one (31) participants who discontinued acute treatment did not enter the taper period.|140
2420485|NCT01226485|5937122|P7|NOT COMPLETED|Overall Study||0
2420486|NCT01226485|5937123|P6|NOT COMPLETED|Overall Study||0
2420487|NCT01226485|5937124|P5|NOT COMPLETED|Overall Study||0
2420488|NCT01226485|5937125|P4|NOT COMPLETED|Overall Study||0
2420489|NCT01226485|5937126|P3|NOT COMPLETED|Overall Study||0
2420490|NCT01226485|5937127|P2|NOT COMPLETED|Overall Study||0
2420491|NCT01226485|5937128|P1|NOT COMPLETED|Overall Study||0
2420492|NCT01226485|5937122|P7|COMPLETED|Overall Study||40
2420493|NCT01226485|5937123|P6|COMPLETED|Overall Study||19
2420494|NCT01226485|5937124|P5|COMPLETED|Overall Study||7
2420495|NCT01226485|5937125|P4|COMPLETED|Overall Study||6
2420496|NCT01226485|5937126|P3|COMPLETED|Overall Study||3
2420497|NCT01226485|5937127|P2|COMPLETED|Overall Study||6
2420498|NCT01226485|5937128|P1|COMPLETED|Overall Study||3
2420499|NCT01226485|5937122|P7|Received at Least One Dose of Drug|Overall Study||40
2420500|NCT01226485|5937123|P6|Received at Least One Dose of Drug|Overall Study||19
2420501|NCT01226485|5937124|P5|Received at Least One Dose of Drug|Overall Study||7
2420502|NCT01226485|5937125|P4|Received at Least One Dose of Drug|Overall Study||6
2420503|NCT01226485|5937126|P3|Received at Least One Dose of Drug|Overall Study||3
2420504|NCT01226485|5937127|P2|Received at Least One Dose of Drug|Overall Study||6
2420505|NCT01226485|5937128|P1|Received at Least One Dose of Drug|Overall Study||3
2420506|NCT01226485|5937122|P7|STARTED|Overall Study||40
2420507|NCT01226485|5937123|P6|STARTED|Overall Study||19
2420508|NCT01226485|5937124|P5|STARTED|Overall Study||7
2420509|NCT01226485|5937125|P4|STARTED|Overall Study||6
2420510|NCT01226485|5937126|P3|STARTED|Overall Study||3
2420511|NCT01226485|5937127|P2|STARTED|Overall Study||6
2420512|NCT01226485|5937128|P1|STARTED|Overall Study||3
2420513|NCT01226459|5937179|P2|NOT COMPLETED|Overall Study||32
2420514|NCT01226459|5937180|P1|NOT COMPLETED|Overall Study||21
2420515|NCT01226459|5937179|P2|COMPLETED|Overall Study||171
2420516|NCT01226459|5937180|P1|COMPLETED|Overall Study||180
2420517|NCT01226459|5937179|P2|STARTED|Overall Study||203
2420518|NCT01226459|5937180|P1|STARTED|Overall Study||201
2420519|NCT01226420|5937190|P1|NOT COMPLETED|Overall Study||0
2420520|NCT01226420|5937190|P1|COMPLETED|Overall Study||6
2420521|NCT01226420|5937190|P1|STARTED|Overall Study||6
2420522|NCT01226121|5937198|P3|NOT COMPLETED|Overall Study||1
2420523|NCT01226121|5937199|P2|NOT COMPLETED|Overall Study||0
2420524|NCT01226121|5937200|P1|NOT COMPLETED|Overall Study||2
2420525|NCT01226121|5937198|P3|COMPLETED|Overall Study||12
2420526|NCT01226121|5937199|P2|COMPLETED|Overall Study||11
2420527|NCT01226121|5937200|P1|COMPLETED|Overall Study||11
2420528|NCT01226121|5937198|P3|30 Day Evaluation|Overall Study||13
2420529|NCT01226121|5937199|P2|30 Day Evaluation|Overall Study||11
2420530|NCT01226121|5937200|P1|30 Day Evaluation|Overall Study||12
2420531|NCT01226121|5937198|P3|STARTED|Overall Study||13
2420532|NCT01226121|5937199|P2|STARTED|Overall Study||11
2420533|NCT01226121|5937200|P1|STARTED|Overall Study||13
2420534|NCT01226095|5937211|P1|NOT COMPLETED|Overall Study||1
2420535|NCT01226095|5937211|P1|COMPLETED|Overall Study||518
2420536|NCT01226095|5937211|P1|STARTED|Overall Study||519
2420537|NCT01226043|5937236|P4|NOT COMPLETED|30-week Observational Phase||13
2420538|NCT01226043|5937237|P3|NOT COMPLETED|30-week Observational Phase||6
2420539|NCT01226043|5937238|P2|NOT COMPLETED|30-week Observational Phase||0
2420540|NCT01226043|5937239|P1|NOT COMPLETED|30-week Observational Phase||0
2420541|NCT01226043|5937236|P4|COMPLETED|30-week Observational Phase||140
2420542|NCT01226043|5937237|P3|COMPLETED|30-week Observational Phase||153
2420543|NCT01226043|5937238|P2|COMPLETED|30-week Observational Phase||0
2420544|NCT01226043|5937239|P1|COMPLETED|30-week Observational Phase||0
2420545|NCT01226043|5937236|P4|TREATED|30-week Observational Phase||153
2420546|NCT01226043|5937237|P3|TREATED|30-week Observational Phase||159
2420547|NCT01226043|5937238|P2|TREATED|30-week Observational Phase||0
2420548|NCT01226043|5937239|P1|TREATED|30-week Observational Phase||0
2420549|NCT01226043|5937236|P4|STARTED|30-week Observational Phase||153
2420550|NCT01226043|5937237|P3|STARTED|30-week Observational Phase||159
2420551|NCT01226043|5937238|P2|STARTED|30-week Observational Phase||0
2420552|NCT01226043|5937239|P1|STARTED|30-week Observational Phase||0
2420553|NCT01226043|5937236|P4|NOT COMPLETED|6-week Re-randomization Phase||11
2420554|NCT01226043|5937237|P3|NOT COMPLETED|6-week Re-randomization Phase||7
2420555|NCT01226043|5937238|P2|NOT COMPLETED|6-week Re-randomization Phase||0
2420556|NCT01226043|5937239|P1|NOT COMPLETED|6-week Re-randomization Phase||0
2420557|NCT01226043|5937236|P4|COMPLETED|6-week Re-randomization Phase|3 patients did not enter the observational phase of the study|156
2420558|NCT01226043|5937237|P3|COMPLETED|6-week Re-randomization Phase||159
2420559|NCT01226043|5937238|P2|COMPLETED|6-week Re-randomization Phase||0
2420560|NCT01226043|5937239|P1|COMPLETED|6-week Re-randomization Phase||0
2420561|NCT01226043|5937236|P4|TREATED|6-week Re-randomization Phase||165
2420562|NCT01226043|5937237|P3|TREATED|6-week Re-randomization Phase||165
2420563|NCT01226043|5937238|P2|TREATED|6-week Re-randomization Phase||0
2420564|NCT01226043|5937239|P1|TREATED|6-week Re-randomization Phase||0
2420565|NCT01226043|5937236|P4|STARTED|6-week Re-randomization Phase||167
2420566|NCT01226043|5937237|P3|STARTED|6-week Re-randomization Phase||166
2420567|NCT01226043|5937238|P2|STARTED|6-week Re-randomization Phase||0
2420568|NCT01226043|5937239|P1|STARTED|6-week Re-randomization Phase||0
2420569|NCT01226043|5937236|P4|NOT COMPLETED|4-week Crossover Phase - Period 2||0
2420570|NCT01226043|5937237|P3|NOT COMPLETED|4-week Crossover Phase - Period 2||0
2420572|NCT01226043|5937239|P1|NOT COMPLETED|4-week Crossover Phase - Period 2||4
2420573|NCT01226043|5937236|P4|COMPLETED|4-week Crossover Phase - Period 2||0
2420574|NCT01226043|5937237|P3|COMPLETED|4-week Crossover Phase - Period 2||0
2420575|NCT01226043|5937238|P2|COMPLETED|4-week Crossover Phase - Period 2|22 patients were not re-randomized to the second phase of the study|188
2420576|NCT01226043|5937239|P1|COMPLETED|4-week Crossover Phase - Period 2|28 patients were not re-randomized to the second phase of the study|195
2420577|NCT01226043|5937236|P4|TREATED|4-week Crossover Phase - Period 2||0
2420578|NCT01226043|5937237|P3|TREATED|4-week Crossover Phase - Period 2||0
2420579|NCT01226043|5937238|P2|TREATED|4-week Crossover Phase - Period 2||194
2420580|NCT01226043|5937239|P1|TREATED|4-week Crossover Phase - Period 2||199
2420581|NCT01226043|5937236|P4|STARTED|4-week Crossover Phase - Period 2||0
2420582|NCT01226043|5937237|P3|STARTED|4-week Crossover Phase - Period 2||0
2420583|NCT01226043|5937238|P2|STARTED|4-week Crossover Phase - Period 2||194
2420584|NCT01226043|5937239|P1|STARTED|4-week Crossover Phase - Period 2||199
2420585|NCT01226043|5937236|P4|NOT COMPLETED|4-week Crossover Phase - Period 1||0
2420586|NCT01226043|5937237|P3|NOT COMPLETED|4-week Crossover Phase - Period 1||0
2420587|NCT01226043|5937238|P2|NOT COMPLETED|4-week Crossover Phase - Period 1||9
2420588|NCT01226043|5937239|P1|NOT COMPLETED|4-week Crossover Phase - Period 1||3
2420589|NCT01226043|5937236|P4|COMPLETED|4-week Crossover Phase - Period 1||0
2420590|NCT01226043|5937237|P3|COMPLETED|4-week Crossover Phase - Period 1||0
2420591|NCT01226043|5937238|P2|COMPLETED|4-week Crossover Phase - Period 1||194
2420592|NCT01226043|5937239|P1|COMPLETED|4-week Crossover Phase - Period 1||199
2420593|NCT01226043|5937236|P4|TREATED|4-week Crossover Phase - Period 1||0
2420594|NCT01226043|5937237|P3|TREATED|4-week Crossover Phase - Period 1||0
2420595|NCT01226043|5937238|P2|TREATED|4-week Crossover Phase - Period 1||200
2420596|NCT01226043|5937239|P1|TREATED|4-week Crossover Phase - Period 1||202
2420597|NCT01226043|5937236|P4|STARTED|4-week Crossover Phase - Period 1||0
2420598|NCT01226043|5937237|P3|STARTED|4-week Crossover Phase - Period 1||0
2420599|NCT01226043|5937238|P2|STARTED|4-week Crossover Phase - Period 1||203
2420600|NCT01226043|5937239|P1|STARTED|4-week Crossover Phase - Period 1||202
2420601|NCT01225991|5937277|P1|NOT COMPLETED|Overall Study||6
2420602|NCT01225991|5937277|P1|COMPLETED|Overall Study||12
2420603|NCT01225991|5937277|P1|STARTED|Overall Study||18
2420604|NCT01225952|5937288|P3|NOT COMPLETED|Overall Study||6
2420605|NCT01225952|5937289|P2|NOT COMPLETED|Overall Study||4
2420606|NCT01225952|5937290|P1|NOT COMPLETED|Overall Study||6
2420607|NCT01225952|5937288|P3|COMPLETED|Overall Study||25
2420608|NCT01225952|5937289|P2|COMPLETED|Overall Study||27
2420609|NCT01225952|5937290|P1|COMPLETED|Overall Study||25
2420610|NCT01225952|5937288|P3|STARTED|Overall Study||31
2420611|NCT01225952|5937289|P2|STARTED|Overall Study||31
2420612|NCT01225952|5937290|P1|STARTED|Overall Study||31
2420613|NCT01225926|5937375|P2|NOT COMPLETED|Overall Study||0
2420614|NCT01225926|5937376|P1|NOT COMPLETED|Overall Study||0
2420615|NCT01225926|5937375|P2|COMPLETED|Overall Study||12
2420616|NCT01225926|5937376|P1|COMPLETED|Overall Study||12
2420617|NCT01225926|5937375|P2|STARTED|Overall Study||12
2420618|NCT01225926|5937376|P1|STARTED|Overall Study||12
2420619|NCT01225887|5937382|P1|NOT COMPLETED|Overall Study||5
2420620|NCT01225887|5937382|P1|COMPLETED|Overall Study||32
2420621|NCT01225887|5937382|P1|STARTED|Overall Study||37
2420622|NCT01225835|5937392|P2|NOT COMPLETED|Overall Study||3
2420623|NCT01225835|5937393|P1|NOT COMPLETED|Overall Study||7
2420624|NCT01225835|5937392|P2|COMPLETED|Overall Study|hCG criterion met|59
2420625|NCT01225835|5937393|P1|COMPLETED|Overall Study|hCG criterion met|55
2420626|NCT01225835|5937392|P2|Per Protocol Population|Overall Study||58
2420627|NCT01225835|5937393|P1|Per Protocol Population|Overall Study||48
2420628|NCT01225835|5937392|P2|STARTED|Overall Study||62
2420629|NCT01225835|5937393|P1|STARTED|Overall Study||62
2420630|NCT01225822|5937441|P5|NOT COMPLETED|Overall Study||31
2420631|NCT01225822|5937442|P4|NOT COMPLETED|Overall Study||52
2420632|NCT01225822|5937443|P3|NOT COMPLETED|Overall Study||38
2420633|NCT01225822|5937444|P2|NOT COMPLETED|Overall Study||56
2420634|NCT01225822|5937445|P1|NOT COMPLETED|Overall Study||38
2420635|NCT01225822|5937441|P5|COMPLETED|Overall Study||361
2420636|NCT01225822|5937442|P4|COMPLETED|Overall Study||333
2420637|NCT01225822|5937443|P3|COMPLETED|Overall Study||355
2420638|NCT01225822|5937444|P2|COMPLETED|Overall Study||334
2420639|NCT01225822|5937445|P1|COMPLETED|Overall Study||351
2420640|NCT01225822|5937441|P5|STARTED|Overall Study||392
2420641|NCT01225822|5937442|P4|STARTED|Overall Study||385
2420642|NCT01225822|5937443|P3|STARTED|Overall Study||393
2420643|NCT01225822|5937444|P2|STARTED|Overall Study||390
2420644|NCT01225822|5937445|P1|STARTED|Overall Study||389
2420645|NCT01225731|5937512|P13|NOT COMPLETED|Part 3||7
2420646|NCT01225731|5937513|P12|NOT COMPLETED|Part 3||10
2420647|NCT01225731|5937514|P11|NOT COMPLETED|Part 3||6
2420648|NCT01225731|5937515|P10|NOT COMPLETED|Part 3||0
2420649|NCT01225731|5937516|P9|NOT COMPLETED|Part 3||0
2420650|NCT01225731|5937517|P8|NOT COMPLETED|Part 3||0
2420651|NCT01225731|5937518|P7|NOT COMPLETED|Part 3||0
2420652|NCT01225731|5937519|P6|NOT COMPLETED|Part 3||0
2420653|NCT01225731|5937520|P5|NOT COMPLETED|Part 3||0
2420654|NCT01225731|5937521|P4|NOT COMPLETED|Part 3||0
2420655|NCT01225731|5937522|P3|NOT COMPLETED|Part 3||0
2420656|NCT01225731|5937523|P2|NOT COMPLETED|Part 3||0
2420657|NCT01225731|5937524|P1|NOT COMPLETED|Part 3||0
2420658|NCT01225731|5937512|P13|COMPLETED|Part 3||60
2420659|NCT01225731|5937513|P12|COMPLETED|Part 3||116
2420660|NCT01225731|5937514|P11|COMPLETED|Part 3||80
2420661|NCT01225731|5937515|P10|COMPLETED|Part 3||10
2420662|NCT01225731|5937516|P9|COMPLETED|Part 3||0
2420663|NCT01225731|5937517|P8|COMPLETED|Part 3||0
2420664|NCT01225731|5937518|P7|COMPLETED|Part 3||0
2420665|NCT01225731|5937519|P6|COMPLETED|Part 3||0
2420666|NCT01225731|5937520|P5|COMPLETED|Part 3||0
2420667|NCT01225731|5937521|P4|COMPLETED|Part 3||0
2420668|NCT01225731|5937522|P3|COMPLETED|Part 3||0
2420669|NCT01225731|5937523|P2|COMPLETED|Part 3||0
2420670|NCT01225731|5937524|P1|COMPLETED|Part 3||0
2420671|NCT01225731|5937512|P13|STARTED|Part 3|Not all participants entered follow-up|67
2420672|NCT01225731|5937513|P12|STARTED|Part 3|Not all participants entered follow-up|126
2420673|NCT01225731|5937514|P11|STARTED|Part 3|Not all participants entered follow-up|86
2420674|NCT01225731|5937515|P10|STARTED|Part 3|Not all participants entered follow-up|10
2420675|NCT01225731|5937516|P9|STARTED|Part 3|Participants could enter the follow-up period|0
2420676|NCT01225731|5937517|P8|STARTED|Part 3|Participants could enter the follow-up period|0
2420677|NCT01225731|5937518|P7|STARTED|Part 3|Participants could enter the follow-up period|0
2420678|NCT01225731|5937519|P6|STARTED|Part 3|Participants could enter the follow-up period|0
2420679|NCT01225731|5937520|P5|STARTED|Part 3||0
2420680|NCT01225731|5937521|P4|STARTED|Part 3||0
2420681|NCT01225731|5937522|P3|STARTED|Part 3||0
2420682|NCT01225731|5937523|P2|STARTED|Part 3||0
2420683|NCT01225731|5937524|P1|STARTED|Part 3||0
2420684|NCT01225731|5937512|P13|NOT COMPLETED|Part 2||0
2420685|NCT01225731|5937513|P12|NOT COMPLETED|Part 2||0
2420686|NCT01225731|5937514|P11|NOT COMPLETED|Part 2||0
2420687|NCT01225731|5937515|P10|NOT COMPLETED|Part 2||0
2420688|NCT01225731|5937516|P9|NOT COMPLETED|Part 2||11
2420689|NCT01225731|5937517|P8|NOT COMPLETED|Part 2||25
2420690|NCT01225731|5937518|P7|NOT COMPLETED|Part 2||8
2420691|NCT01225731|5937519|P6|NOT COMPLETED|Part 2||3
2420692|NCT01225731|5937520|P5|NOT COMPLETED|Part 2||0
2420693|NCT01225731|5937521|P4|NOT COMPLETED|Part 2||0
2420694|NCT01225731|5937522|P3|NOT COMPLETED|Part 2||0
2420695|NCT01225731|5937523|P2|NOT COMPLETED|Part 2||0
2420696|NCT01225731|5937524|P1|NOT COMPLETED|Part 2||0
2420697|NCT01225731|5937512|P13|COMPLETED|Part 2||0
2420698|NCT01225731|5937513|P12|COMPLETED|Part 2||0
2420699|NCT01225731|5937514|P11|COMPLETED|Part 2||0
2420700|NCT01225731|5937515|P10|COMPLETED|Part 2||0
2420701|NCT01225731|5937516|P9|COMPLETED|Part 2||68
2420702|NCT01225731|5937517|P8|COMPLETED|Part 2||128
2420703|NCT01225731|5937518|P7|COMPLETED|Part 2||86
2420704|NCT01225731|5937519|P6|COMPLETED|Part 2||10
2420705|NCT01225731|5937520|P5|COMPLETED|Part 2||0
2420706|NCT01225731|5937521|P4|COMPLETED|Part 2||0
2420707|NCT01225731|5937522|P3|COMPLETED|Part 2||0
2420708|NCT01225731|5937523|P2|COMPLETED|Part 2||0
2420709|NCT01225731|5937524|P1|COMPLETED|Part 2||0
2420710|NCT01225731|5937512|P13|STARTED|Part 2||0
2420711|NCT01225731|5937513|P12|STARTED|Part 2||0
2420712|NCT01225731|5937514|P11|STARTED|Part 2||0
2420713|NCT01225731|5937515|P10|STARTED|Part 2||0
2420714|NCT01225731|5937516|P9|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|79
2420715|NCT01225731|5937517|P8|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|153
2420716|NCT01225731|5937518|P7|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|94
2420717|NCT01225731|5937519|P6|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|13
2420718|NCT01225731|5937520|P5|STARTED|Part 2|Participants could progress into Part 2; no placebo was given in Part 2|0
2420719|NCT01225731|5937521|P4|STARTED|Part 2|Participants could progress into Part 2|0
2420720|NCT01225731|5937522|P3|STARTED|Part 2|Participants could progress into Part 2|0
2420721|NCT01225731|5937523|P2|STARTED|Part 2|Participants could progress into Part 2|0
2420722|NCT01225731|5937524|P1|STARTED|Part 2|Participants could progress into Part 2|0
2420723|NCT01225731|5937512|P13|NOT COMPLETED|Part 1||0
2420724|NCT01225731|5937513|P12|NOT COMPLETED|Part 1||0
2420725|NCT01225731|5937514|P11|NOT COMPLETED|Part 1||0
2420726|NCT01225731|5937515|P10|NOT COMPLETED|Part 1||0
2420727|NCT01225731|5937516|P9|NOT COMPLETED|Part 1||0
2420728|NCT01225731|5937517|P8|NOT COMPLETED|Part 1||0
2420729|NCT01225731|5937518|P7|NOT COMPLETED|Part 1||0
2420730|NCT01225731|5937519|P6|NOT COMPLETED|Part 1||0
2420731|NCT01225731|5937520|P5|NOT COMPLETED|Part 1||6
2420732|NCT01225731|5937521|P4|NOT COMPLETED|Part 1||2
2420733|NCT01225731|5937522|P3|NOT COMPLETED|Part 1||1
2420734|NCT01225731|5937523|P2|NOT COMPLETED|Part 1||5
2420735|NCT01225731|5937524|P1|NOT COMPLETED|Part 1||2
2420736|NCT01225731|5937512|P13|COMPLETED|Part 1||0
2420737|NCT01225731|5937513|P12|COMPLETED|Part 1||0
2420738|NCT01225731|5937514|P11|COMPLETED|Part 1||0
2420739|NCT01225731|5937515|P10|COMPLETED|Part 1||0
2420740|NCT01225731|5937516|P9|COMPLETED|Part 1||0
2420741|NCT01225731|5937517|P8|COMPLETED|Part 1||0
2420742|NCT01225731|5937518|P7|COMPLETED|Part 1||0
2420743|NCT01225731|5937519|P6|COMPLETED|Part 1||0
2420744|NCT01225731|5937520|P5|COMPLETED|Part 1||40
2420745|NCT01225731|5937521|P4|COMPLETED|Part 1||84
2420746|NCT01225731|5937522|P3|COMPLETED|Part 1||88
2420747|NCT01225731|5937523|P2|COMPLETED|Part 1||87
2420748|NCT01225731|5937524|P1|COMPLETED|Part 1||40
2420749|NCT01225731|5937512|P13|STARTED|Part 1||0
2420750|NCT01225731|5937513|P12|STARTED|Part 1||0
2420751|NCT01225731|5937514|P11|STARTED|Part 1||0
2420752|NCT01225731|5937515|P10|STARTED|Part 1||0
2420753|NCT01225731|5937516|P9|STARTED|Part 1||0
2420754|NCT01225731|5937517|P8|STARTED|Part 1||0
2420755|NCT01225731|5937518|P7|STARTED|Part 1||0
2420756|NCT01225731|5937519|P6|STARTED|Part 1||0
2420757|NCT01225731|5937520|P5|STARTED|Part 1||46
2420758|NCT01225731|5937521|P4|STARTED|Part 1||86
2420759|NCT01225731|5937522|P3|STARTED|Part 1||89
2420760|NCT01225731|5937523|P2|STARTED|Part 1||92
2420761|NCT01225731|5937524|P1|STARTED|Part 1||42
2420762|NCT01225562|5937619|P3|NOT COMPLETED|Overall Study||53
2420763|NCT01225562|5937620|P2|NOT COMPLETED|Overall Study||56
2420764|NCT01225562|5937621|P1|NOT COMPLETED|Overall Study||55
2420765|NCT01225562|5937619|P3|COMPLETED|Overall Study||7014
2420766|NCT01225562|5937620|P2|COMPLETED|Overall Study||6989
2420767|NCT01225562|5937621|P1|COMPLETED|Overall Study||6995
2420768|NCT01225562|5937619|P3|STARTED|Overall Study||7067
2420769|NCT01225562|5937620|P2|STARTED|Overall Study||7045
2420770|NCT01225562|5937621|P1|STARTED|Overall Study||7050
2420771|NCT01225549|5937638|P10|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
2420772|NCT01225549|5937639|P9|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
2420773|NCT01225549|5937640|P8|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
2420774|NCT01225549|5937641|P7|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
2420775|NCT01225549|5937642|P6|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
2420776|NCT01225549|5937643|P5|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
2420777|NCT01225549|5937644|P4|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
2420778|NCT01225549|5937645|P3|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
2420779|NCT01225549|5937646|P2|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
2420780|NCT01225549|5937647|P1|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
2420781|NCT01225549|5937638|P10|COMPLETED|Period 7 - Fourth Treatment Period||1
2420782|NCT01225549|5937639|P9|COMPLETED|Period 7 - Fourth Treatment Period||4
2420783|NCT01225549|5937640|P8|COMPLETED|Period 7 - Fourth Treatment Period||1
2420784|NCT01225549|5937641|P7|COMPLETED|Period 7 - Fourth Treatment Period||3
2420785|NCT01225549|5937642|P6|COMPLETED|Period 7 - Fourth Treatment Period||1
2420786|NCT01225549|5937643|P5|COMPLETED|Period 7 - Fourth Treatment Period||1
2420787|NCT01225549|5937644|P4|COMPLETED|Period 7 - Fourth Treatment Period||0
2420788|NCT01225549|5937645|P3|COMPLETED|Period 7 - Fourth Treatment Period||3
2420789|NCT01225549|5937646|P2|COMPLETED|Period 7 - Fourth Treatment Period||3
2420790|NCT01225549|5937647|P1|COMPLETED|Period 7 - Fourth Treatment Period||1
2420791|NCT01225549|5937638|P10|STARTED|Period 7 - Fourth Treatment Period||1
2420792|NCT01225549|5937639|P9|STARTED|Period 7 - Fourth Treatment Period||4
2420793|NCT01225549|5937640|P8|STARTED|Period 7 - Fourth Treatment Period||1
2420794|NCT01225549|5937641|P7|STARTED|Period 7 - Fourth Treatment Period||3
2420795|NCT01225549|5937642|P6|STARTED|Period 7 - Fourth Treatment Period||1
2420796|NCT01225549|5937643|P5|STARTED|Period 7 - Fourth Treatment Period||1
2420797|NCT01225549|5937644|P4|STARTED|Period 7 - Fourth Treatment Period||0
2420798|NCT01225549|5937645|P3|STARTED|Period 7 - Fourth Treatment Period||3
2420799|NCT01225549|5937646|P2|STARTED|Period 7 - Fourth Treatment Period||3
2420800|NCT01225549|5937647|P1|STARTED|Period 7 - Fourth Treatment Period||1
2420801|NCT01225549|5937638|P10|NOT COMPLETED|Period 6 - Washout||0
2420802|NCT01225549|5937639|P9|NOT COMPLETED|Period 6 - Washout||0
2420803|NCT01225549|5937640|P8|NOT COMPLETED|Period 6 - Washout||0
2420804|NCT01225549|5937641|P7|NOT COMPLETED|Period 6 - Washout||0
2420805|NCT01225549|5937642|P6|NOT COMPLETED|Period 6 - Washout||0
2420806|NCT01225549|5937643|P5|NOT COMPLETED|Period 6 - Washout||0
2420807|NCT01225549|5937644|P4|NOT COMPLETED|Period 6 - Washout||1
2420808|NCT01225549|5937645|P3|NOT COMPLETED|Period 6 - Washout||0
2420809|NCT01225549|5937646|P2|NOT COMPLETED|Period 6 - Washout||0
2420810|NCT01225549|5937647|P1|NOT COMPLETED|Period 6 - Washout||0
2420811|NCT01225549|5937638|P10|COMPLETED|Period 6 - Washout||1
2420812|NCT01225549|5937639|P9|COMPLETED|Period 6 - Washout||4
2420813|NCT01225549|5937640|P8|COMPLETED|Period 6 - Washout||1
2420814|NCT01225549|5937641|P7|COMPLETED|Period 6 - Washout||3
2420815|NCT01225549|5937642|P6|COMPLETED|Period 6 - Washout||1
2420816|NCT01225549|5937643|P5|COMPLETED|Period 6 - Washout||1
2420817|NCT01225549|5937644|P4|COMPLETED|Period 6 - Washout||0
2420818|NCT01225549|5937645|P3|COMPLETED|Period 6 - Washout||3
2420819|NCT01225549|5937646|P2|COMPLETED|Period 6 - Washout||3
2420820|NCT01225549|5937647|P1|COMPLETED|Period 6 - Washout||1
2420821|NCT01225549|5937638|P10|STARTED|Period 6 - Washout||1
2420822|NCT01225549|5937639|P9|STARTED|Period 6 - Washout||4
2420823|NCT01225549|5937640|P8|STARTED|Period 6 - Washout||1
2420824|NCT01225549|5937641|P7|STARTED|Period 6 - Washout||3
2420825|NCT01225549|5937642|P6|STARTED|Period 6 - Washout||1
2420826|NCT01225549|5937643|P5|STARTED|Period 6 - Washout||1
2420827|NCT01225549|5937644|P4|STARTED|Period 6 - Washout||1
2420828|NCT01225549|5937645|P3|STARTED|Period 6 - Washout||3
2420829|NCT01225549|5937646|P2|STARTED|Period 6 - Washout||3
2420830|NCT01225549|5937647|P1|STARTED|Period 6 - Washout||1
2420831|NCT01225549|5937638|P10|NOT COMPLETED|Period 5 - Third Treatment Period||0
2420832|NCT01225549|5937639|P9|NOT COMPLETED|Period 5 - Third Treatment Period||0
2420833|NCT01225549|5937640|P8|NOT COMPLETED|Period 5 - Third Treatment Period||0
2420834|NCT01225549|5937641|P7|NOT COMPLETED|Period 5 - Third Treatment Period||0
2420835|NCT01225549|5937642|P6|NOT COMPLETED|Period 5 - Third Treatment Period||0
2420836|NCT01225549|5937643|P5|NOT COMPLETED|Period 5 - Third Treatment Period||0
2420837|NCT01225549|5937644|P4|NOT COMPLETED|Period 5 - Third Treatment Period||0
2420838|NCT01225549|5937645|P3|NOT COMPLETED|Period 5 - Third Treatment Period||0
2420839|NCT01225549|5937646|P2|NOT COMPLETED|Period 5 - Third Treatment Period||0
2420840|NCT01225549|5937647|P1|NOT COMPLETED|Period 5 - Third Treatment Period||0
2420841|NCT01225549|5937638|P10|COMPLETED|Period 5 - Third Treatment Period||1
2420842|NCT01225549|5937639|P9|COMPLETED|Period 5 - Third Treatment Period||4
2420843|NCT01225549|5937640|P8|COMPLETED|Period 5 - Third Treatment Period||1
2420844|NCT01225549|5937641|P7|COMPLETED|Period 5 - Third Treatment Period||3
2420845|NCT01225549|5937642|P6|COMPLETED|Period 5 - Third Treatment Period||1
2420846|NCT01225549|5937643|P5|COMPLETED|Period 5 - Third Treatment Period||1
2420847|NCT01225549|5937644|P4|COMPLETED|Period 5 - Third Treatment Period||1
2420848|NCT01225549|5937645|P3|COMPLETED|Period 5 - Third Treatment Period||3
2420849|NCT01225549|5937646|P2|COMPLETED|Period 5 - Third Treatment Period||3
2420850|NCT01225549|5937647|P1|COMPLETED|Period 5 - Third Treatment Period||1
2420851|NCT01225549|5937638|P10|STARTED|Period 5 - Third Treatment Period||1
2420852|NCT01225549|5937639|P9|STARTED|Period 5 - Third Treatment Period||4
2420853|NCT01225549|5937640|P8|STARTED|Period 5 - Third Treatment Period||1
2420854|NCT01225549|5937641|P7|STARTED|Period 5 - Third Treatment Period||3
2420855|NCT01225549|5937642|P6|STARTED|Period 5 - Third Treatment Period||1
2420856|NCT01225549|5937643|P5|STARTED|Period 5 - Third Treatment Period||1
2420857|NCT01225549|5937644|P4|STARTED|Period 5 - Third Treatment Period||1
2420858|NCT01225549|5937645|P3|STARTED|Period 5 - Third Treatment Period||3
2420859|NCT01225549|5937646|P2|STARTED|Period 5 - Third Treatment Period||3
2420860|NCT01225549|5937647|P1|STARTED|Period 5 - Third Treatment Period||1
2420861|NCT01225549|5937638|P10|NOT COMPLETED|Period 4 - Washout||0
2420862|NCT01225549|5937639|P9|NOT COMPLETED|Period 4 - Washout||0
2420863|NCT01225549|5937640|P8|NOT COMPLETED|Period 4 - Washout||0
2420864|NCT01225549|5937641|P7|NOT COMPLETED|Period 4 - Washout||0
2420865|NCT01225549|5937642|P6|NOT COMPLETED|Period 4 - Washout||0
2420866|NCT01225549|5937643|P5|NOT COMPLETED|Period 4 - Washout||0
2420867|NCT01225549|5937644|P4|NOT COMPLETED|Period 4 - Washout||0
2420868|NCT01225549|5937645|P3|NOT COMPLETED|Period 4 - Washout||0
2420869|NCT01225549|5937646|P2|NOT COMPLETED|Period 4 - Washout||1
2420870|NCT01225549|5937647|P1|NOT COMPLETED|Period 4 - Washout||0
2420871|NCT01225549|5937638|P10|COMPLETED|Period 4 - Washout||1
2420872|NCT01225549|5937639|P9|COMPLETED|Period 4 - Washout||4
2420873|NCT01225549|5937640|P8|COMPLETED|Period 4 - Washout||1
2420874|NCT01225549|5937641|P7|COMPLETED|Period 4 - Washout||3
2420875|NCT01225549|5937642|P6|COMPLETED|Period 4 - Washout||1
2420876|NCT01225549|5937643|P5|COMPLETED|Period 4 - Washout||1
2420877|NCT01225549|5937644|P4|COMPLETED|Period 4 - Washout||1
2420878|NCT01225549|5937645|P3|COMPLETED|Period 4 - Washout||3
2420879|NCT01225549|5937646|P2|COMPLETED|Period 4 - Washout||3
2420880|NCT01225549|5937647|P1|COMPLETED|Period 4 - Washout||1
2420881|NCT01225549|5937638|P10|STARTED|Period 4 - Washout||1
2420882|NCT01225549|5937639|P9|STARTED|Period 4 - Washout||4
2420883|NCT01225549|5937640|P8|STARTED|Period 4 - Washout||1
2420884|NCT01225549|5937641|P7|STARTED|Period 4 - Washout||3
2420885|NCT01225549|5937642|P6|STARTED|Period 4 - Washout||1
2420886|NCT01225549|5937643|P5|STARTED|Period 4 - Washout||1
2420887|NCT01225549|5937644|P4|STARTED|Period 4 - Washout||1
2420888|NCT01225549|5937645|P3|STARTED|Period 4 - Washout||3
2420889|NCT01225549|5937646|P2|STARTED|Period 4 - Washout||4
2420890|NCT01225549|5937647|P1|STARTED|Period 4 - Washout||1
2420891|NCT01225549|5937638|P10|NOT COMPLETED|Period 3 - Second Treatment Period||0
2420892|NCT01225549|5937639|P9|NOT COMPLETED|Period 3 - Second Treatment Period||0
2420893|NCT01225549|5937640|P8|NOT COMPLETED|Period 3 - Second Treatment Period||0
2420894|NCT01225549|5937641|P7|NOT COMPLETED|Period 3 - Second Treatment Period||0
2420895|NCT01225549|5937642|P6|NOT COMPLETED|Period 3 - Second Treatment Period||0
2420896|NCT01225549|5937643|P5|NOT COMPLETED|Period 3 - Second Treatment Period||0
2420897|NCT01225549|5937644|P4|NOT COMPLETED|Period 3 - Second Treatment Period||0
2420898|NCT01225549|5937645|P3|NOT COMPLETED|Period 3 - Second Treatment Period||0
2420899|NCT01225549|5937646|P2|NOT COMPLETED|Period 3 - Second Treatment Period||0
2420900|NCT01225549|5937647|P1|NOT COMPLETED|Period 3 - Second Treatment Period||0
2420901|NCT01225549|5937638|P10|COMPLETED|Period 3 - Second Treatment Period||1
2420902|NCT01225549|5937639|P9|COMPLETED|Period 3 - Second Treatment Period||4
2420903|NCT01225549|5937640|P8|COMPLETED|Period 3 - Second Treatment Period||1
2420904|NCT01225549|5937641|P7|COMPLETED|Period 3 - Second Treatment Period||3
2420905|NCT01225549|5937642|P6|COMPLETED|Period 3 - Second Treatment Period||1
2420906|NCT01225549|5937643|P5|COMPLETED|Period 3 - Second Treatment Period||1
2420907|NCT01225549|5937644|P4|COMPLETED|Period 3 - Second Treatment Period||1
2420908|NCT01225549|5937645|P3|COMPLETED|Period 3 - Second Treatment Period||3
2420909|NCT01225549|5937646|P2|COMPLETED|Period 3 - Second Treatment Period||4
2420910|NCT01225549|5937647|P1|COMPLETED|Period 3 - Second Treatment Period||1
2420911|NCT01225549|5937638|P10|STARTED|Period 3 - Second Treatment Period||1
2420912|NCT01225549|5937639|P9|STARTED|Period 3 - Second Treatment Period||4
2420913|NCT01225549|5937640|P8|STARTED|Period 3 - Second Treatment Period||1
2420914|NCT01225549|5937641|P7|STARTED|Period 3 - Second Treatment Period||3
2420915|NCT01225549|5937642|P6|STARTED|Period 3 - Second Treatment Period||1
2420916|NCT01225549|5937643|P5|STARTED|Period 3 - Second Treatment Period||1
2420917|NCT01225549|5937644|P4|STARTED|Period 3 - Second Treatment Period||1
2420918|NCT01225549|5937645|P3|STARTED|Period 3 - Second Treatment Period||3
2420919|NCT01225549|5937646|P2|STARTED|Period 3 - Second Treatment Period||4
2420920|NCT01225549|5937647|P1|STARTED|Period 3 - Second Treatment Period||1
2420921|NCT01225549|5937638|P10|NOT COMPLETED|Period 2 - Washout||0
2420922|NCT01225549|5937639|P9|NOT COMPLETED|Period 2 - Washout||0
2420923|NCT01225549|5937640|P8|NOT COMPLETED|Period 2 - Washout||0
2420924|NCT01225549|5937641|P7|NOT COMPLETED|Period 2 - Washout||0
2420925|NCT01225549|5937642|P6|NOT COMPLETED|Period 2 - Washout||0
2420926|NCT01225549|5937643|P5|NOT COMPLETED|Period 2 - Washout||0
2420927|NCT01225549|5937644|P4|NOT COMPLETED|Period 2 - Washout||0
2420928|NCT01225549|5937645|P3|NOT COMPLETED|Period 2 - Washout||0
2420929|NCT01225549|5937646|P2|NOT COMPLETED|Period 2 - Washout||0
2420930|NCT01225549|5937647|P1|NOT COMPLETED|Period 2 - Washout||0
2420931|NCT01225549|5937638|P10|COMPLETED|Period 2 - Washout||1
2420932|NCT01225549|5937639|P9|COMPLETED|Period 2 - Washout||4
2420933|NCT01225549|5937640|P8|COMPLETED|Period 2 - Washout||1
2420934|NCT01225549|5937641|P7|COMPLETED|Period 2 - Washout||3
2420935|NCT01225549|5937642|P6|COMPLETED|Period 2 - Washout||1
2420936|NCT01225549|5937643|P5|COMPLETED|Period 2 - Washout||1
2420937|NCT01225549|5937644|P4|COMPLETED|Period 2 - Washout||1
2420938|NCT01225549|5937645|P3|COMPLETED|Period 2 - Washout||3
2420939|NCT01225549|5937646|P2|COMPLETED|Period 2 - Washout||4
2420940|NCT01225549|5937647|P1|COMPLETED|Period 2 - Washout||1
2420941|NCT01225549|5937638|P10|STARTED|Period 2 - Washout||1
2420942|NCT01225549|5937639|P9|STARTED|Period 2 - Washout||4
2420943|NCT01225549|5937640|P8|STARTED|Period 2 - Washout||1
2420944|NCT01225549|5937641|P7|STARTED|Period 2 - Washout||3
2420945|NCT01225549|5937642|P6|STARTED|Period 2 - Washout||1
2420946|NCT01225549|5937643|P5|STARTED|Period 2 - Washout||1
2420947|NCT01225549|5937644|P4|STARTED|Period 2 - Washout||1
2420948|NCT01225549|5937645|P3|STARTED|Period 2 - Washout||3
2420949|NCT01225549|5937646|P2|STARTED|Period 2 - Washout||4
2420950|NCT01225549|5937647|P1|STARTED|Period 2 - Washout||1
2420951|NCT01225549|5937638|P10|NOT COMPLETED|Period 1 - First Treatment Period||0
2420952|NCT01225549|5937639|P9|NOT COMPLETED|Period 1 - First Treatment Period||0
2420953|NCT01225549|5937640|P8|NOT COMPLETED|Period 1 - First Treatment Period||0
2420954|NCT01225549|5937641|P7|NOT COMPLETED|Period 1 - First Treatment Period||0
2420955|NCT01225549|5937642|P6|NOT COMPLETED|Period 1 - First Treatment Period||0
2420956|NCT01225549|5937643|P5|NOT COMPLETED|Period 1 - First Treatment Period||0
2420957|NCT01225549|5937644|P4|NOT COMPLETED|Period 1 - First Treatment Period||0
2420958|NCT01225549|5937645|P3|NOT COMPLETED|Period 1 - First Treatment Period||0
2420959|NCT01225549|5937646|P2|NOT COMPLETED|Period 1 - First Treatment Period||0
2420960|NCT01225549|5937647|P1|NOT COMPLETED|Period 1 - First Treatment Period||0
2420961|NCT01225549|5937638|P10|COMPLETED|Period 1 - First Treatment Period||1
2420962|NCT01225549|5937639|P9|COMPLETED|Period 1 - First Treatment Period||4
2420963|NCT01225549|5937640|P8|COMPLETED|Period 1 - First Treatment Period||1
2420964|NCT01225549|5937641|P7|COMPLETED|Period 1 - First Treatment Period||3
2420965|NCT01225549|5937642|P6|COMPLETED|Period 1 - First Treatment Period||1
2420966|NCT01225549|5937643|P5|COMPLETED|Period 1 - First Treatment Period||1
2420967|NCT01225549|5937644|P4|COMPLETED|Period 1 - First Treatment Period||1
2420968|NCT01225549|5937645|P3|COMPLETED|Period 1 - First Treatment Period||3
2420969|NCT01225549|5937646|P2|COMPLETED|Period 1 - First Treatment Period||4
2420970|NCT01225549|5937647|P1|COMPLETED|Period 1 - First Treatment Period||1
2420971|NCT01225549|5937638|P10|STARTED|Period 1 - First Treatment Period||1
2420972|NCT01225549|5937639|P9|STARTED|Period 1 - First Treatment Period||4
2420973|NCT01225549|5937640|P8|STARTED|Period 1 - First Treatment Period||1
2420974|NCT01225549|5937641|P7|STARTED|Period 1 - First Treatment Period||3
2420975|NCT01225549|5937642|P6|STARTED|Period 1 - First Treatment Period||1
2420976|NCT01225549|5937643|P5|STARTED|Period 1 - First Treatment Period||1
2420977|NCT01225549|5937644|P4|STARTED|Period 1 - First Treatment Period||1
2420978|NCT01225549|5937645|P3|STARTED|Period 1 - First Treatment Period||3
2420979|NCT01225549|5937646|P2|STARTED|Period 1 - First Treatment Period||4
2420980|NCT01225549|5937647|P1|STARTED|Period 1 - First Treatment Period||1
2420981|NCT01225354|5937689|P1|NOT COMPLETED|Overall Study||1
2420982|NCT01225354|5937689|P1|COMPLETED|Overall Study||19
2420983|NCT01225354|5937689|P1|STARTED|Overall Study||20
2420984|NCT01225289|5937696|P2|NOT COMPLETED|Overall Study||1
2420985|NCT01225289|5937697|P1|NOT COMPLETED|Overall Study||0
2420986|NCT01225289|5937696|P2|COMPLETED|Overall Study||17
2420987|NCT01225289|5937697|P1|COMPLETED|Overall Study||18
2420988|NCT01225289|5937696|P2|STARTED|Overall Study||18
2420989|NCT01225289|5937697|P1|STARTED|Overall Study||18
2420990|NCT01225263|5937711|P2|NOT COMPLETED|Weeks 13 to 24||1
2420991|NCT01225263|5937712|P1|NOT COMPLETED|Weeks 13 to 24||4
2420992|NCT01225263|5937711|P2|COMPLETED|Weeks 13 to 24||28
2420993|NCT01225263|5937712|P1|COMPLETED|Weeks 13 to 24||24
2420994|NCT01225263|5937711|P2|STARTED|Weeks 13 to 24||29
2420995|NCT01225263|5937712|P1|STARTED|Weeks 13 to 24||28
2420996|NCT01225263|5937711|P2|NOT COMPLETED|Weeks 1 to 12||0
2420997|NCT01225263|5937712|P1|NOT COMPLETED|Weeks 1 to 12||0
2420998|NCT01225263|5937711|P2|COMPLETED|Weeks 1 to 12||29
2420999|NCT01225263|5937712|P1|COMPLETED|Weeks 1 to 12||28
2421000|NCT01225263|5937711|P2|STARTED|Weeks 1 to 12||29
2421001|NCT01225263|5937712|P1|STARTED|Weeks 1 to 12||28
2421002|NCT01225211|5937730|P10|NOT COMPLETED|Overall Study||5
2421003|NCT01225211|5937731|P9|NOT COMPLETED|Overall Study||1
2421004|NCT01225211|5937732|P8|NOT COMPLETED|Overall Study||0
2421005|NCT01225211|5937733|P7|NOT COMPLETED|Overall Study||1
2421006|NCT01225211|5937734|P6|NOT COMPLETED|Overall Study||0
2421007|NCT01225211|5937735|P5|NOT COMPLETED|Overall Study||0
2421008|NCT01225211|5937736|P4|NOT COMPLETED|Overall Study||0
2421009|NCT01225211|5937737|P3|NOT COMPLETED|Overall Study||1
2421010|NCT01225211|5937738|P2|NOT COMPLETED|Overall Study||0
2421011|NCT01225211|5937739|P1|NOT COMPLETED|Overall Study||0
2421012|NCT01225211|5937730|P10|COMPLETED|Overall Study||57
2421013|NCT01225211|5937731|P9|COMPLETED|Overall Study||62
2421014|NCT01225211|5937732|P8|COMPLETED|Overall Study||11
2421015|NCT01225211|5937733|P7|COMPLETED|Overall Study||41
2421016|NCT01225211|5937734|P6|COMPLETED|Overall Study||21
2421017|NCT01225211|5937735|P5|COMPLETED|Overall Study||23
2421018|NCT01225211|5937736|P4|COMPLETED|Overall Study||27
2421019|NCT01225211|5937737|P3|COMPLETED|Overall Study||20
2421020|NCT01225211|5937738|P2|COMPLETED|Overall Study||20
2421021|NCT01225211|5937739|P1|COMPLETED|Overall Study||21
2421022|NCT01225211|5937730|P10|STARTED|Overall Study||62
2421023|NCT01225211|5937731|P9|STARTED|Overall Study||63
2421024|NCT01225211|5937732|P8|STARTED|Overall Study||11
2421025|NCT01225211|5937733|P7|STARTED|Overall Study||42
2421026|NCT01225211|5937734|P6|STARTED|Overall Study||21
2421027|NCT01225211|5937735|P5|STARTED|Overall Study||23
2421028|NCT01225211|5937736|P4|STARTED|Overall Study||27
2421029|NCT01225211|5937737|P3|STARTED|Overall Study||21
2421030|NCT01225211|5937738|P2|STARTED|Overall Study||20
2421031|NCT01225211|5937739|P1|STARTED|Overall Study||21
2421032|NCT01225172|5937842|P2|NOT COMPLETED|Overall Study||1
2421033|NCT01225172|5937843|P1|NOT COMPLETED|Overall Study||6
2421034|NCT01225172|5937842|P2|COMPLETED|Overall Study||6
2421035|NCT01225172|5937843|P1|COMPLETED|Overall Study||46
2421036|NCT01225172|5937842|P2|STARTED|Overall Study||7
2421037|NCT01225172|5937843|P1|STARTED|Overall Study||52
2421038|NCT01225159|5937865|P2|NOT COMPLETED|Overall Study||0
2421039|NCT01225159|5937866|P1|NOT COMPLETED|Overall Study||1
2421040|NCT01225159|5937865|P2|COMPLETED|Overall Study||100
2421041|NCT01225159|5937866|P1|COMPLETED|Overall Study||99
2421042|NCT01225159|5937865|P2|STARTED|Overall Study||100
2421043|NCT01225159|5937866|P1|STARTED|Overall Study||100
2421044|NCT01225146|5937876|P2|NOT COMPLETED|Overall Study||2
2421045|NCT01225146|5937877|P1|NOT COMPLETED|Overall Study||0
2421046|NCT01225146|5937876|P2|COMPLETED|Overall Study||0
2421047|NCT01225146|5937877|P1|COMPLETED|Overall Study||6
2421048|NCT01225146|5937876|P2|STARTED|Overall Study||2
2421049|NCT01225146|5937877|P1|STARTED|Overall Study||6
2421050|NCT01225068|5937895|P2|NOT COMPLETED|Overall Study||1
2421051|NCT01225068|5937896|P1|NOT COMPLETED|Overall Study||4
2421052|NCT01225068|5937895|P2|COMPLETED|Overall Study||19
2421053|NCT01225068|5937896|P1|COMPLETED|Overall Study||16
2421054|NCT01225068|5937895|P2|STARTED|Overall Study||20
2421055|NCT01225068|5937896|P1|STARTED|Overall Study||20
2421056|NCT01225055|5937905|P3|NOT COMPLETED|Overall Study||3
2421057|NCT01225055|5937906|P2|NOT COMPLETED|Overall Study||2
2421058|NCT01225055|5937907|P1|NOT COMPLETED|Overall Study||0
2421059|NCT01225055|5937905|P3|COMPLETED|Overall Study||18
2421060|NCT01225055|5937906|P2|COMPLETED|Overall Study||18
2421061|NCT01225055|5937907|P1|COMPLETED|Overall Study||20
2421062|NCT01225055|5937905|P3|STARTED|Overall Study||21
2421063|NCT01225055|5937906|P2|STARTED|Overall Study||20
2421064|NCT01225055|5937907|P1|STARTED|Overall Study||20
2421065|NCT01225029|5937932|P2|NOT COMPLETED|Overall Study||0
2421066|NCT01225029|5937933|P1|NOT COMPLETED|Overall Study||0
2421067|NCT01225029|5937932|P2|COMPLETED|Overall Study||32
2421068|NCT01225029|5937933|P1|COMPLETED|Overall Study||32
2421069|NCT01225029|5937932|P2|STARTED|Overall Study||32
2421070|NCT01225029|5937933|P1|STARTED|Overall Study||32
2421071|NCT01224925|5937945|P2|NOT COMPLETED|Overall Study||2
2421072|NCT01224925|5937946|P1|NOT COMPLETED|Overall Study||3
2421073|NCT01224925|5937945|P2|COMPLETED|Overall Study||31
2421074|NCT01224925|5937946|P1|COMPLETED|Overall Study||34
2421075|NCT01224925|5937945|P2|STARTED|Overall Study||33
2421076|NCT01224925|5937946|P1|STARTED|Overall Study||37
2421077|NCT01224821|5937954|P1|NOT COMPLETED|Long-Term Follow-Up||11
2421078|NCT01224821|5937954|P1|COMPLETED|Long-Term Follow-Up||0
2421079|NCT01224821|5937954|P1|STARTED|Long-Term Follow-Up|11/47 participants withdrawing from this study enrolled in the LTFU study for continued evaluation.|11
2421080|NCT01224821|5937954|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||46
2421081|NCT01224821|5937954|P1|COMPLETED|Dosimetric and Therapeutic Treatment|This participant completed the study per Protocol Amendment 2.|1
2421082|NCT01224821|5937954|P1|STARTED|Dosimetric and Therapeutic Treatment||47
2421083|NCT01224782|5937973|P1|NOT COMPLETED|Overall Study||264
2421084|NCT01224782|5937973|P1|COMPLETED|Overall Study||730
2421085|NCT01224782|5937973|P1|STARTED|Overall Study||994
2421086|NCT01224678|5937984|P2|NOT COMPLETED|Overall Study||0
2421087|NCT01224678|5937985|P1|NOT COMPLETED|Overall Study||0
2421088|NCT01224678|5937984|P2|COMPLETED|Overall Study||150
2421089|NCT01224678|5937985|P1|COMPLETED|Overall Study||150
2421090|NCT01224678|5937984|P2|STARTED|Overall Study||150
2421091|NCT01224678|5937985|P1|STARTED|Overall Study||150
2421092|NCT01224639|5937999|P8|NOT COMPLETED|Overall Study||2
2421093|NCT01224639|5938000|P7|NOT COMPLETED|Overall Study||1
2421094|NCT01224639|5938001|P6|NOT COMPLETED|Overall Study||0
2421095|NCT01224639|5938002|P5|NOT COMPLETED|Overall Study||2
2421096|NCT01224639|5938003|P4|NOT COMPLETED|Overall Study||0
2421097|NCT01224639|5938004|P3|NOT COMPLETED|Overall Study||0
2421098|NCT01224639|5938005|P2|NOT COMPLETED|Overall Study||0
2421099|NCT01224639|5938006|P1|NOT COMPLETED|Overall Study||0
2421100|NCT01224639|5937999|P8|COMPLETED|Overall Study||3
2421101|NCT01224639|5938000|P7|COMPLETED|Overall Study||17
2421102|NCT01224639|5938001|P6|COMPLETED|Overall Study||4
2421103|NCT01224639|5938002|P5|COMPLETED|Overall Study||19
2421104|NCT01224639|5938003|P4|COMPLETED|Overall Study||3
2421105|NCT01224639|5938004|P3|COMPLETED|Overall Study||21
2421106|NCT01224639|5938005|P2|COMPLETED|Overall Study||5
2421107|NCT01224639|5938006|P1|COMPLETED|Overall Study||19
2421108|NCT01224639|5937999|P8|STARTED|Overall Study||5
2421109|NCT01224639|5938000|P7|STARTED|Overall Study||18
2421110|NCT01224639|5938001|P6|STARTED|Overall Study||4
2421111|NCT01224639|5938002|P5|STARTED|Overall Study||21
2421112|NCT01224639|5938003|P4|STARTED|Overall Study||3
2421113|NCT01224639|5938004|P3|STARTED|Overall Study||21
2421114|NCT01224639|5938005|P2|STARTED|Overall Study||5
2421115|NCT01224639|5938006|P1|STARTED|Overall Study||19
2421116|NCT01224626|5938112|P1|NOT COMPLETED|Overall Study||1
2421117|NCT01224626|5938112|P1|COMPLETED|Overall Study||41
2421118|NCT01224626|5938112|P1|STARTED|Overall Study||42
2421119|NCT01224444|5938118|P1|NOT COMPLETED|Overall Study||0
2421120|NCT01224444|5938118|P1|COMPLETED|Overall Study||269
2421121|NCT01224444|5938118|P1|STARTED|Overall Study||269
2421122|NCT01224431|5938124|P2|NOT COMPLETED|Overall Study||5
2421123|NCT01224431|5938125|P1|NOT COMPLETED|Overall Study||0
2421124|NCT01224431|5938124|P2|COMPLETED|Overall Study||25
2421125|NCT01224431|5938125|P1|COMPLETED|Overall Study||30
2421126|NCT01224431|5938124|P2|STARTED|Overall Study||30
2421127|NCT01224431|5938125|P1|STARTED|Overall Study||30
2421128|NCT01224236|5938135|P2|NOT COMPLETED|Overall Study||1
2421129|NCT01224236|5938136|P1|NOT COMPLETED|Overall Study||1
2421130|NCT01224236|5938135|P2|COMPLETED|Overall Study||73
2421131|NCT01224236|5938136|P1|COMPLETED|Overall Study||75
2421132|NCT01224236|5938135|P2|STARTED|Overall Study||74
2421133|NCT01224236|5938136|P1|STARTED|Overall Study||76
2421134|NCT01224171|5938146|P2|NOT COMPLETED|Overall Study||13
2421135|NCT01224171|5938147|P1|NOT COMPLETED|Overall Study||15
2421136|NCT01224171|5938146|P2|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|196
2421137|NCT01224171|5938147|P1|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|192
2421138|NCT01224171|5938146|P2|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|158
2421139|NCT01224171|5938147|P1|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|157
2421140|NCT01224171|5938146|P2|STARTED|Overall Study||209
2421141|NCT01224171|5938147|P1|STARTED|Overall Study||207
2421142|NCT01224158|5938169|P2|NOT COMPLETED|Overall Study||0
2421143|NCT01224158|5938170|P1|NOT COMPLETED|Overall Study||1
2421144|NCT01224158|5938169|P2|COMPLETED|Overall Study||77
2421145|NCT01224158|5938170|P1|COMPLETED|Overall Study||75
2421146|NCT01224158|5938169|P2|STARTED|Overall Study||77
2421147|NCT01224158|5938170|P1|STARTED|Overall Study||76
2421148|NCT01224015|5938189|P3|NOT COMPLETED|Overall Study||13
2421149|NCT01224015|5938190|P2|NOT COMPLETED|Overall Study||16
2421150|NCT01224015|5938191|P1|NOT COMPLETED|Overall Study||14
2421151|NCT01224015|5938189|P3|COMPLETED|Overall Study||83
2421152|NCT01224015|5938190|P2|COMPLETED|Overall Study||211
2421153|NCT01224015|5938191|P1|COMPLETED|Overall Study||347
2421154|NCT01224015|5938189|P3|STARTED|Overall Study||96
2421155|NCT01224015|5938190|P2|STARTED|Overall Study||227
2421156|NCT01224015|5938191|P1|STARTED|Overall Study||361
2421157|NCT01223963|5938199|P1|NOT COMPLETED|Overall Study||0
2421158|NCT01223963|5938199|P1|COMPLETED|Overall Study||93
2421159|NCT01223963|5938199|P1|STARTED|Overall Study|All subjects treated between May 1 2008 and Dec 31 2009 in selected clinics were to be asked.|93
2421160|NCT01223937|5938206|P2|NOT COMPLETED|Overall Study||18
2421161|NCT01223937|5938207|P1|NOT COMPLETED|Overall Study||17
2421162|NCT01223937|5938206|P2|COMPLETED|Overall Study||119
2421163|NCT01223937|5938207|P1|COMPLETED|Overall Study||114
2421164|NCT01223937|5938206|P2|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|135
2421165|NCT01223937|5938207|P1|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|126
2421166|NCT01223937|5938206|P2|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|133
2421167|NCT01223937|5938207|P1|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|128
2421168|NCT01223937|5938206|P2|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|137
2421169|NCT01223937|5938207|P1|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|131
2421170|NCT01223703|5938231|P2|NOT COMPLETED|Overall Study||0
2421171|NCT01223703|5938232|P1|NOT COMPLETED|Overall Study||0
2421172|NCT01223703|5938231|P2|COMPLETED|Overall Study||66
2421173|NCT01223703|5938232|P1|COMPLETED|Overall Study||67
2421174|NCT01223703|5938231|P2|STARTED|Overall Study||66
2421175|NCT01223703|5938232|P1|STARTED|Overall Study||67
2421176|NCT01223469|5938246|P2|NOT COMPLETED|Overall Study||0
2421177|NCT01223469|5938247|P1|NOT COMPLETED|Overall Study||0
2421178|NCT01223469|5938246|P2|COMPLETED|Overall Study||43
2421179|NCT01223469|5938247|P1|COMPLETED|Overall Study||34
2421180|NCT01223469|5938246|P2|STARTED|Overall Study||43
2421181|NCT01223469|5938247|P1|STARTED|Overall Study||34
2421182|NCT01223404|5938253|P6|NOT COMPLETED|Third Intervention (1 Day)||0
2421183|NCT01223404|5938254|P5|NOT COMPLETED|Third Intervention (1 Day)||0
2421184|NCT01223404|5938255|P4|NOT COMPLETED|Third Intervention (1 Day)||1
2421185|NCT01223404|5938256|P3|NOT COMPLETED|Third Intervention (1 Day)||0
2421186|NCT01223404|5938257|P2|NOT COMPLETED|Third Intervention (1 Day)||0
2421187|NCT01223404|5938258|P1|NOT COMPLETED|Third Intervention (1 Day)||0
2421188|NCT01223404|5938253|P6|COMPLETED|Third Intervention (1 Day)||3
2421189|NCT01223404|5938254|P5|COMPLETED|Third Intervention (1 Day)||2
2421190|NCT01223404|5938255|P4|COMPLETED|Third Intervention (1 Day)||3
2421191|NCT01223404|5938256|P3|COMPLETED|Third Intervention (1 Day)||4
2421192|NCT01223404|5938257|P2|COMPLETED|Third Intervention (1 Day)||3
2421193|NCT01223404|5938258|P1|COMPLETED|Third Intervention (1 Day)||3
2421194|NCT01223404|5938253|P6|STARTED|Third Intervention (1 Day)||3
2421195|NCT01223404|5938254|P5|STARTED|Third Intervention (1 Day)||2
2421196|NCT01223404|5938255|P4|STARTED|Third Intervention (1 Day)||4
2421197|NCT01223404|5938256|P3|STARTED|Third Intervention (1 Day)||4
2421198|NCT01223404|5938257|P2|STARTED|Third Intervention (1 Day)||3
2421199|NCT01223404|5938258|P1|STARTED|Third Intervention (1 Day)||3
2421200|NCT01223404|5938253|P6|NOT COMPLETED|Second Intervention (1 Day)||0
2421201|NCT01223404|5938254|P5|NOT COMPLETED|Second Intervention (1 Day)||0
2421202|NCT01223404|5938255|P4|NOT COMPLETED|Second Intervention (1 Day)||0
2421203|NCT01223404|5938256|P3|NOT COMPLETED|Second Intervention (1 Day)||0
2421204|NCT01223404|5938257|P2|NOT COMPLETED|Second Intervention (1 Day)||0
2421205|NCT01223404|5938258|P1|NOT COMPLETED|Second Intervention (1 Day)||1
2421206|NCT01223404|5938253|P6|COMPLETED|Second Intervention (1 Day)||3
2421207|NCT01223404|5938254|P5|COMPLETED|Second Intervention (1 Day)||2
2421208|NCT01223404|5938255|P4|COMPLETED|Second Intervention (1 Day)||4
2421209|NCT01223404|5938256|P3|COMPLETED|Second Intervention (1 Day)||4
2421210|NCT01223404|5938257|P2|COMPLETED|Second Intervention (1 Day)||3
2421211|NCT01223404|5938258|P1|COMPLETED|Second Intervention (1 Day)||3
2421212|NCT01223404|5938253|P6|STARTED|Second Intervention (1 Day)||3
2421213|NCT01223404|5938254|P5|STARTED|Second Intervention (1 Day)||2
2421214|NCT01223404|5938255|P4|STARTED|Second Intervention (1 Day)||4
2421215|NCT01223404|5938256|P3|STARTED|Second Intervention (1 Day)||4
2421216|NCT01223404|5938257|P2|STARTED|Second Intervention (1 Day)||3
2421217|NCT01223404|5938258|P1|STARTED|Second Intervention (1 Day)||4
2421218|NCT01223404|5938253|P6|NOT COMPLETED|First Intervention (1 Day)||0
2421219|NCT01223404|5938254|P5|NOT COMPLETED|First Intervention (1 Day)||0
2421220|NCT01223404|5938255|P4|NOT COMPLETED|First Intervention (1 Day)||1
2421221|NCT01223404|5938256|P3|NOT COMPLETED|First Intervention (1 Day)||0
2421222|NCT01223404|5938257|P2|NOT COMPLETED|First Intervention (1 Day)||0
2421223|NCT01223404|5938258|P1|NOT COMPLETED|First Intervention (1 Day)||0
2421224|NCT01223404|5938253|P6|COMPLETED|First Intervention (1 Day)||3
2421225|NCT01223404|5938254|P5|COMPLETED|First Intervention (1 Day)||2
2421226|NCT01223404|5938255|P4|COMPLETED|First Intervention (1 Day)||4
2421227|NCT01223404|5938256|P3|COMPLETED|First Intervention (1 Day)||4
2421228|NCT01223404|5938257|P2|COMPLETED|First Intervention (1 Day)||3
2421229|NCT01223404|5938258|P1|COMPLETED|First Intervention (1 Day)||4
2421230|NCT01223404|5938253|P6|STARTED|First Intervention (1 Day)||3
2421231|NCT01223404|5938254|P5|STARTED|First Intervention (1 Day)||2
2421232|NCT01223404|5938255|P4|STARTED|First Intervention (1 Day)||5
2421233|NCT01223404|5938256|P3|STARTED|First Intervention (1 Day)||4
2421234|NCT01223404|5938257|P2|STARTED|First Intervention (1 Day)||3
2421235|NCT01223404|5938258|P1|STARTED|First Intervention (1 Day)||4
2421236|NCT01223378|5938286|P5|NOT COMPLETED|Overall Study||3
2421237|NCT01223378|5938287|P4|NOT COMPLETED|Overall Study||1
2421238|NCT01223378|5938288|P3|NOT COMPLETED|Overall Study||3
2421239|NCT01223378|5938289|P2|NOT COMPLETED|Overall Study||4
2421240|NCT01223378|5938290|P1|NOT COMPLETED|Overall Study||6
2421241|NCT01223378|5938286|P5|COMPLETED|Overall Study||79
2421242|NCT01223378|5938287|P4|COMPLETED|Overall Study||80
2421243|NCT01223378|5938288|P3|COMPLETED|Overall Study||80
2421244|NCT01223378|5938289|P2|COMPLETED|Overall Study||81
2421245|NCT01223378|5938290|P1|COMPLETED|Overall Study||76
2421246|NCT01223378|5938286|P5|STARTED|Overall Study||82
2421247|NCT01223378|5938287|P4|STARTED|Overall Study||81
2421248|NCT01223378|5938288|P3|STARTED|Overall Study||83
2421249|NCT01223378|5938289|P2|STARTED|Overall Study||85
2421250|NCT01223378|5938290|P1|STARTED|Overall Study||82
2421251|NCT01223365|5938322|P1|NOT COMPLETED|Open-label Treatment Period||102
2421252|NCT01223365|5938322|P1|COMPLETED|Open-label Treatment Period||189
2421253|NCT01223365|5938322|P1|STARTED|Open-label Treatment Period||291
2421254|NCT01223365|5938322|P1|NOT COMPLETED|Open-label Titration Period||39
2421255|NCT01223365|5938322|P1|COMPLETED|Open-label Titration Period||291
2421256|NCT01223365|5938322|P1|Achieved Stable Pain Relief|Open-label Titration Period||294
2421257|NCT01223365|5938322|P1|Safety Analysis Set|Open-label Titration Period||329
2421258|NCT01223365|5938322|P1|STARTED|Open-label Titration Period||330
2421259|NCT01223352|5938365|P2|NOT COMPLETED|Overall Study||0
2421260|NCT01223352|5938366|P1|NOT COMPLETED|Overall Study||0
2421261|NCT01223352|5938365|P2|COMPLETED|Overall Study||33
2421262|NCT01223352|5938366|P1|COMPLETED|Overall Study||31
2421263|NCT01223352|5938365|P2|STARTED|Overall Study||33
2421264|NCT01223352|5938366|P1|STARTED|Overall Study||31
2421265|NCT01223235|5938386|P1|NOT COMPLETED|Overall Study||1
2421266|NCT01223235|5938386|P1|COMPLETED|Overall Study||21
2421267|NCT01223235|5938386|P1|STARTED|Overall Study||22
2421268|NCT01223196|5938394|P2|NOT COMPLETED|Overall Study||0
2421269|NCT01223196|5938395|P1|NOT COMPLETED|Overall Study||4
2421270|NCT01223196|5938394|P2|COMPLETED|Overall Study||11
2421271|NCT01223196|5938395|P1|COMPLETED|Overall Study||9
2421272|NCT01223196|5938394|P2|STARTED|Overall Study||11
2421273|NCT01223196|5938395|P1|STARTED|Overall Study||13
2421274|NCT01223183|5938407|P2|NOT COMPLETED|Imaging Day 2||0
2421275|NCT01223183|5938408|P1|NOT COMPLETED|Imaging Day 2||0
2421276|NCT01223183|5938407|P2|COMPLETED|Imaging Day 2||9
2421277|NCT01223183|5938408|P1|COMPLETED|Imaging Day 2||8
2421278|NCT01223183|5938407|P2|STARTED|Imaging Day 2||9
2421279|NCT01223183|5938408|P1|STARTED|Imaging Day 2||8
2421280|NCT01223183|5938407|P2|NOT COMPLETED|Washout Period (5-24 Days)||0
2421281|NCT01223183|5938408|P1|NOT COMPLETED|Washout Period (5-24 Days)||2
2421282|NCT01223183|5938407|P2|COMPLETED|Washout Period (5-24 Days)||9
2421283|NCT01223183|5938408|P1|COMPLETED|Washout Period (5-24 Days)||8
2421284|NCT01223183|5938407|P2|STARTED|Washout Period (5-24 Days)||9
2421285|NCT01223183|5938408|P1|STARTED|Washout Period (5-24 Days)||10
2421286|NCT01223183|5938407|P2|NOT COMPLETED|Imaging Day 1||1
2421287|NCT01223183|5938408|P1|NOT COMPLETED|Imaging Day 1||0
2421288|NCT01223183|5938407|P2|COMPLETED|Imaging Day 1||9
2421289|NCT01223183|5938408|P1|COMPLETED|Imaging Day 1||10
2421290|NCT01223183|5938407|P2|STARTED|Imaging Day 1||10
2421291|NCT01223183|5938408|P1|STARTED|Imaging Day 1||10
2421292|NCT01223027|5938418|P2|NOT COMPLETED|Overall Study||277
2421293|NCT01223027|5938419|P1|NOT COMPLETED|Overall Study||274
2421294|NCT01223027|5938418|P2|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|9
2421295|NCT01223027|5938419|P1|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|10
2421296|NCT01223027|5938418|P2|STARTED|Overall Study||286
2421297|NCT01223027|5938419|P1|STARTED|Overall Study||284
2421298|NCT01223001|5938442|P2|NOT COMPLETED|Overall Study||4
2421299|NCT01223001|5938443|P1|NOT COMPLETED|Overall Study||4
2421300|NCT01223001|5938442|P2|COMPLETED|Overall Study||0
2421301|NCT01223001|5938443|P1|COMPLETED|Overall Study||0
2421302|NCT01223001|5938442|P2|STARTED|Overall Study||4
2421303|NCT01223001|5938443|P1|STARTED|Overall Study||4
2421304|NCT01222884|5938451|P2|NOT COMPLETED|Overall Study||4
2421305|NCT01222884|5938452|P1|NOT COMPLETED|Overall Study||24
2421306|NCT01222884|5938451|P2|COMPLETED|Overall Study||113
2421307|NCT01222884|5938452|P1|COMPLETED|Overall Study||210
2421308|NCT01222884|5938451|P2|STARTED|Overall Study||117
2421309|NCT01222884|5938452|P1|STARTED|Overall Study||234
2421310|NCT01222871|5938462|P2|NOT COMPLETED|Overall Study||0
2421311|NCT01222871|5938463|P1|NOT COMPLETED|Overall Study||0
2421312|NCT01222871|5938462|P2|COMPLETED|Overall Study||0
2421313|NCT01222871|5938463|P1|COMPLETED|Overall Study||0
2421314|NCT01222871|5938462|P2|STARTED|Overall Study||0
2421315|NCT01222871|5938463|P1|STARTED|Overall Study||0
2421316|NCT01222832|5938472|P2|NOT COMPLETED|Overall Study||1
2421317|NCT01222832|5938473|P1|NOT COMPLETED|Overall Study||0
2421318|NCT01222832|5938472|P2|COMPLETED|Overall Study||112
2421319|NCT01222832|5938473|P1|COMPLETED|Overall Study||113
2421320|NCT01222832|5938472|P2|STARTED|Overall Study||113
2421321|NCT01222832|5938473|P1|STARTED|Overall Study||113
2421322|NCT01222715|5938481|P2|NOT COMPLETED|Overall Study||27
2421323|NCT01222715|5938482|P1|NOT COMPLETED|Overall Study||36
2421324|NCT01222715|5938481|P2|COMPLETED|Overall Study||16
2421325|NCT01222715|5938482|P1|COMPLETED|Overall Study||8
2421326|NCT01222715|5938481|P2|STARTED|Overall Study||43
2421327|NCT01222715|5938482|P1|STARTED|Overall Study||44
2421328|NCT01222689|5938492|P1|NOT COMPLETED|Overall Study||0
2421329|NCT01222689|5938492|P1|COMPLETED|Overall Study||46
2421330|NCT01222689|5938492|P1|STARTED|Overall Study||46
2421331|NCT01222585|5938505|P1|NOT COMPLETED|Overall Study||0
2421332|NCT01222585|5938505|P1|COMPLETED|Overall Study||24
2421333|NCT01222585|5938505|P1|STARTED|Overall Study||24
2421334|NCT01222572|5938515|P3|NOT COMPLETED|Overall Study||0
2421335|NCT01222572|5938516|P2|NOT COMPLETED|Overall Study||0
2421336|NCT01222572|5938517|P1|NOT COMPLETED|Overall Study||0
2421337|NCT01222572|5938515|P3|COMPLETED|Overall Study||0
2421338|NCT01222572|5938516|P2|COMPLETED|Overall Study||0
2421339|NCT01222572|5938517|P1|COMPLETED|Overall Study||1
2421340|NCT01222572|5938515|P3|STARTED|Overall Study||0
2421341|NCT01222572|5938516|P2|STARTED|Overall Study||0
2421342|NCT01222572|5938517|P1|STARTED|Overall Study||1
2421343|NCT01222533|5938521|P1|NOT COMPLETED|Overall Study||14
2421344|NCT01222533|5938521|P1|COMPLETED|Overall Study|Completed planned observation time (week 21)|140
2421345|NCT01222533|5938521|P1|Received Tio HH18|Overall Study||146
2421346|NCT01222533|5938521|P1|Received Tio R5|Overall Study||150
2421347|NCT01222533|5938521|P1|Received Tio R2.5|Overall Study||145
2421348|NCT01222533|5938521|P1|Received Tio R1.25|Overall Study||147
2421349|NCT01222533|5938521|P1|Received Placebo|Overall Study||147
2421350|NCT01222533|5938521|P1|STARTED|Overall Study|Entered and treated.|154
2421351|NCT01222520|5938660|P2|NOT COMPLETED|Double-blind Period||2
2421352|NCT01222520|5938661|P1|NOT COMPLETED|Double-blind Period||1
2421353|NCT01222520|5938660|P2|COMPLETED|Double-blind Period||85
2421354|NCT01222520|5938661|P1|COMPLETED|Double-blind Period||86
2421355|NCT01222520|5938660|P2|STARTED|Double-blind Period||87
2421356|NCT01222520|5938661|P1|STARTED|Double-blind Period||87
2421357|NCT01222520|5938660|P2|NOT COMPLETED|Open-label run-in Period||23
2421358|NCT01222520|5938661|P1|NOT COMPLETED|Open-label run-in Period||0
2421359|NCT01222520|5938660|P2|COMPLETED|Open-label run-in Period||174
2421360|NCT01222520|5938661|P1|COMPLETED|Open-label run-in Period||0
2421361|NCT01222520|5938660|P2|STARTED|Open-label run-in Period||197
2421362|NCT01222520|5938661|P1|STARTED|Open-label run-in Period||0
2421363|NCT01222507|5938679|P1|NOT COMPLETED|Overall Study||2
2421364|NCT01222507|5938679|P1|COMPLETED|Overall Study||60
2421365|NCT01222507|5938679|P1|STARTED|Overall Study||62
2421366|NCT01222494|5938686|P3|NOT COMPLETED|Overall Study||4
2421367|NCT01222494|5938687|P2|NOT COMPLETED|Overall Study||4
2421368|NCT01222494|5938688|P1|NOT COMPLETED|Overall Study||1
2421369|NCT01222494|5938686|P3|COMPLETED|Overall Study||17
2421370|NCT01222494|5938687|P2|COMPLETED|Overall Study||15
2421371|NCT01222494|5938688|P1|COMPLETED|Overall Study||6
2421372|NCT01222494|5938686|P3|STARTED|Overall Study||21
2421373|NCT01222494|5938687|P2|STARTED|Overall Study||19
2421374|NCT01222494|5938688|P1|STARTED|Overall Study||7
2421375|NCT01222416|5938707|P2|NOT COMPLETED|Overall Study||0
2421376|NCT01222416|5938708|P1|NOT COMPLETED|Overall Study||20
2421377|NCT01222416|5938707|P2|COMPLETED|Overall Study||0
2421378|NCT01222416|5938708|P1|COMPLETED|Overall Study||30
2421379|NCT01222416|5938707|P2|STARTED|Overall Study||0
2421380|NCT01222416|5938708|P1|STARTED|Overall Study||50
2421381|NCT01222403|5938718|P2|NOT COMPLETED|Overall Study||2
2421382|NCT01222403|5938719|P1|NOT COMPLETED|Overall Study||0
2421383|NCT01222403|5938718|P2|COMPLETED|Overall Study||379
2421384|NCT01222403|5938719|P1|COMPLETED|Overall Study||386
2421385|NCT01222403|5938718|P2|STARTED|Overall Study||381
2421386|NCT01222403|5938719|P1|STARTED|Overall Study||386
2421387|NCT01222390|5938729|P1|NOT COMPLETED|Overall Study||0
2421388|NCT01222390|5938729|P1|COMPLETED|Overall Study||12
2421389|NCT01222390|5938729|P1|STARTED|Overall Study||12
2421390|NCT01222286|5938735|P2|NOT COMPLETED|Overall Study||0
2421391|NCT01222286|5938736|P1|NOT COMPLETED|Overall Study||0
2421392|NCT01222286|5938735|P2|COMPLETED|Overall Study||14
2421393|NCT01222286|5938736|P1|COMPLETED|Overall Study||16
2421394|NCT01222286|5938735|P2|STARTED|Overall Study||14
2421395|NCT01222286|5938736|P1|STARTED|Overall Study||16
2421396|NCT01222273|5938748|P1|NOT COMPLETED|Overall Study||0
2421397|NCT01222273|5938748|P1|COMPLETED|Overall Study||7
2421398|NCT01222273|5938748|P1|STARTED|Overall Study||7
2421399|NCT01222247|5938756|P2|NOT COMPLETED|Overall Study||2
2421400|NCT01222247|5938757|P1|NOT COMPLETED|Overall Study||2
2421401|NCT01222247|5938756|P2|COMPLETED|Overall Study||1400
2421402|NCT01222247|5938757|P1|COMPLETED|Overall Study||1427
2421403|NCT01222247|5938756|P2|Did Not Receive Assigned Medication|Overall Study||5
2421404|NCT01222247|5938757|P1|Did Not Receive Assigned Medication|Overall Study||1
2421405|NCT01222247|5938756|P2|Received 1 Dose|Overall Study||571
2421406|NCT01222247|5938757|P1|Received 1 Dose|Overall Study||568
2421407|NCT01222247|5938756|P2|Received 2 Doses|Overall Study||826
2421408|NCT01222247|5938757|P1|Received 2 Doses|Overall Study||860
2421409|NCT01222247|5938756|P2|STARTED|Overall Study||1402
2421410|NCT01222247|5938757|P1|STARTED|Overall Study||1429
2421411|NCT01222234|5938822|P3|NOT COMPLETED|Overall Study||2
2421412|NCT01222234|5938823|P2|NOT COMPLETED|Overall Study||2
2421413|NCT01222234|5938824|P1|NOT COMPLETED|Overall Study||0
2421414|NCT01222234|5938822|P3|COMPLETED|Overall Study||22
2421415|NCT01222234|5938823|P2|COMPLETED|Overall Study||15
2421416|NCT01222234|5938824|P1|COMPLETED|Overall Study||15
2421417|NCT01222234|5938822|P3|STARTED|Overall Study||24
2421418|NCT01222234|5938823|P2|STARTED|Overall Study||17
2421419|NCT01222234|5938824|P1|STARTED|Overall Study||15
2421420|NCT01222195|5938833|P1|NOT COMPLETED|Overall Study||0
2421421|NCT01222195|5938833|P1|COMPLETED|Overall Study||1
2421422|NCT01222195|5938833|P1|STARTED|Overall Study||1
2421423|NCT01222117|5938848|P11|NOT COMPLETED|Overall Study||0
2421424|NCT01222117|5938849|P10|NOT COMPLETED|Overall Study||2
2421425|NCT01222117|5938850|P9|NOT COMPLETED|Overall Study||3
2421426|NCT01222117|5938851|P8|NOT COMPLETED|Overall Study||0
2421427|NCT01222117|5938852|P7|NOT COMPLETED|Overall Study||0
2421428|NCT01222117|5938853|P6|NOT COMPLETED|Overall Study||1
2421429|NCT01222117|5938854|P5|NOT COMPLETED|Overall Study||1
2421430|NCT01222117|5938855|P4|NOT COMPLETED|Overall Study||1
2421431|NCT01222117|5938856|P3|NOT COMPLETED|Overall Study||0
2421432|NCT01222117|5938857|P2|NOT COMPLETED|Overall Study||1
2421433|NCT01222117|5938858|P1|NOT COMPLETED|Overall Study||3
2421434|NCT01222117|5938848|P11|COMPLETED|Overall Study||6
2421435|NCT01222117|5938849|P10|COMPLETED|Overall Study||17
2421436|NCT01222117|5938850|P9|COMPLETED|Overall Study||20
2421437|NCT01222117|5938851|P8|COMPLETED|Overall Study||12
2421438|NCT01222117|5938852|P7|COMPLETED|Overall Study||13
2421439|NCT01222117|5938853|P6|COMPLETED|Overall Study||9
2421440|NCT01222117|5938854|P5|COMPLETED|Overall Study||8
2421441|NCT01222117|5938855|P4|COMPLETED|Overall Study||19
2421442|NCT01222117|5938856|P3|COMPLETED|Overall Study||22
2421443|NCT01222117|5938857|P2|COMPLETED|Overall Study||19
2421444|NCT01222117|5938858|P1|COMPLETED|Overall Study||17
2421445|NCT01222117|5938848|P11|STARTED|Overall Study||6
2421446|NCT01222117|5938849|P10|STARTED|Overall Study||19
2421447|NCT01222117|5938850|P9|STARTED|Overall Study||23
2421448|NCT01222117|5938851|P8|STARTED|Overall Study||12
2421449|NCT01222117|5938852|P7|STARTED|Overall Study||13
2421450|NCT01222117|5938853|P6|STARTED|Overall Study||10
2421451|NCT01222117|5938854|P5|STARTED|Overall Study||9
2421452|NCT01222117|5938855|P4|STARTED|Overall Study||20
2421453|NCT01222117|5938856|P3|STARTED|Overall Study||22
2421454|NCT01222117|5938857|P2|STARTED|Overall Study||20
2421455|NCT01222117|5938858|P1|STARTED|Overall Study||20
2421456|NCT01222104|5938893|P1|NOT COMPLETED|Overall Study||47
2421457|NCT01222104|5938893|P1|COMPLETED|Overall Study||587
2421458|NCT01222104|5938893|P1|Completed 30-day Visit-No Angio-Seal|Overall Study||90
2421459|NCT01222104|5938893|P1|Completed 30-day Visit-Angio-Seal|Overall Study||497
2421460|NCT01222104|5938893|P1|Successful Deployment and Hemostasis|Overall Study||524
2421461|NCT01222104|5938893|P1|Successful Deployment|Overall Study||529
2421462|NCT01222104|5938893|P1|Angio-Seal Deployment Attempted|Overall Study||534
2421463|NCT01222104|5938893|P1|STARTED|Overall Study||634
2421464|NCT01222091|5938907|P2|NOT COMPLETED|Overall Study||0
2421465|NCT01222091|5938908|P1|NOT COMPLETED|Overall Study||0
2421466|NCT01222091|5938907|P2|COMPLETED|Overall Study||5
2421467|NCT01222091|5938908|P1|COMPLETED|Overall Study||5
2421468|NCT01222091|5938907|P2|STARTED|Overall Study||5
2421469|NCT01222091|5938908|P1|STARTED|Overall Study||5
2421470|NCT01222078|5938916|P1|NOT COMPLETED|Overall Study||1
2421471|NCT01222078|5938916|P1|COMPLETED|Overall Study||0
2421472|NCT01222078|5938916|P1|STARTED|Overall Study||1
2421473|NCT01221948|5938950|P1|NOT COMPLETED|Overall Study||14
2421474|NCT01221948|5938950|P1|COMPLETED|Overall Study||39
2421475|NCT01221948|5938950|P1|STARTED|Overall Study||53
2421476|NCT01221857|5938961|P1|NOT COMPLETED|Overall Study||0
2421477|NCT01221857|5938961|P1|COMPLETED|Overall Study||12
2421478|NCT01221857|5938961|P1|STARTED|Overall Study||12
2421479|NCT01221753|5938969|P1|NOT COMPLETED|Overall Study||1
2421480|NCT01221753|5938969|P1|COMPLETED|Overall Study||6
2421481|NCT01221753|5938969|P1|STARTED|Overall Study||7
2421482|NCT01221727|5938976|P2|NOT COMPLETED|Overall Study||1
2421483|NCT01221727|5938977|P1|NOT COMPLETED|Overall Study||3
2421484|NCT01221727|5938976|P2|COMPLETED|Overall Study||8
2421485|NCT01221727|5938977|P1|COMPLETED|Overall Study||18
2421486|NCT01221727|5938976|P2|Treated|Overall Study|Number of subjects received investigational product|8
2421487|NCT01221727|5938977|P1|Treated|Overall Study|Number of subjects received investigational product|19
2421488|NCT01221727|5938976|P2|STARTED|Overall Study|Number of subjects randomized into the study|9
2421489|NCT01221727|5938977|P1|STARTED|Overall Study|Number of subjects randomized into the study|21
2421490|NCT01221623|5938998|P2|NOT COMPLETED|Overall Study||14
2421491|NCT01221623|5938999|P1|NOT COMPLETED|Overall Study||38
2421492|NCT01221623|5938998|P2|COMPLETED|Overall Study||127
2421493|NCT01221623|5938999|P1|COMPLETED|Overall Study||236
2421494|NCT01221623|5938998|P2|STARTED|Overall Study||141
2421495|NCT01221623|5938999|P1|STARTED|Overall Study||274
2421496|NCT01221597|5939023|P2|NOT COMPLETED|Overall Study||16
2421497|NCT01221597|5939024|P1|NOT COMPLETED|Overall Study||36
2421498|NCT01221597|5939023|P2|COMPLETED|Overall Study||124
2421499|NCT01221597|5939024|P1|COMPLETED|Overall Study||241
2421500|NCT01221597|5939023|P2|STARTED|Overall Study||140
2421501|NCT01221597|5939024|P1|STARTED|Overall Study||277
2421502|NCT01221441|5939048|P2|NOT COMPLETED|Overall Study||12
2421503|NCT01221441|5939049|P1|NOT COMPLETED|Overall Study||22
2421504|NCT01221441|5939048|P2|COMPLETED|Overall Study||23
2421505|NCT01221441|5939049|P1|COMPLETED|Overall Study||45
2421506|NCT01221441|5939048|P2|STARTED|Overall Study||35
2421507|NCT01221441|5939049|P1|STARTED|Overall Study||67
2421508|NCT01221363|5939081|P2|NOT COMPLETED|Overall Study||5
2421509|NCT01221363|5939082|P1|NOT COMPLETED|Overall Study||12
2421510|NCT01221363|5939081|P2|COMPLETED|Overall Study||68
2421511|NCT01221363|5939082|P1|COMPLETED|Overall Study||81
2421512|NCT01221363|5939081|P2|STARTED|Overall Study||73
2421513|NCT01221363|5939082|P1|STARTED|Overall Study||93
2421514|NCT01221350|5939092|P2|NOT COMPLETED|Overall Study||3
2421515|NCT01221350|5939093|P1|NOT COMPLETED|Overall Study||5
2421516|NCT01221350|5939092|P2|COMPLETED|Overall Study||24
2421517|NCT01221350|5939093|P1|COMPLETED|Overall Study||23
2421518|NCT01221350|5939092|P2|Analysis Population|Overall Study||24
2421519|NCT01221350|5939093|P1|Analysis Population|Overall Study||23
2421520|NCT01221350|5939092|P2|Received Intervention|Overall Study||27
2421521|NCT01221350|5939093|P1|Received Intervention|Overall Study||28
2421522|NCT01221350|5939092|P2|STARTED|Overall Study||27
2421523|NCT01221350|5939093|P1|STARTED|Overall Study||28
2421524|NCT01221311|5939135|P2|NOT COMPLETED|Overall Study||0
2421525|NCT01221311|5939136|P1|NOT COMPLETED|Overall Study||0
2421526|NCT01221311|5939135|P2|COMPLETED|Overall Study||55
2421527|NCT01221311|5939136|P1|COMPLETED|Overall Study||57
2421528|NCT01221311|5939135|P2|STARTED|Overall Study||55
2421529|NCT01221311|5939136|P1|STARTED|Overall Study||57
2421530|NCT01221298|5939142|P1|NOT COMPLETED|Overall Study||0
2421531|NCT01221298|5939142|P1|COMPLETED|Overall Study|The number of participants who completed study drug|11
2421532|NCT01221298|5939142|P1|STARTED|Overall Study||11
2421533|NCT01221285|5939152|P1|NOT COMPLETED|Overall Study||1
2421534|NCT01221285|5939152|P1|COMPLETED|Overall Study||10
2421535|NCT01221285|5939152|P1|STARTED|Overall Study||11
2421536|NCT01221272|5939161|P2|NOT COMPLETED|Period 2||2
2421537|NCT01221272|5939162|P1|NOT COMPLETED|Period 2||0
2421538|NCT01221272|5939161|P2|COMPLETED|Period 2||37
2421539|NCT01221272|5939162|P1|COMPLETED|Period 2||39
2421540|NCT01221272|5939161|P2|STARTED|Period 2|1 participant did not complete Period 1, but started and completed Period 2.|39
2421541|NCT01221272|5939162|P1|STARTED|Period 2||39
2421542|NCT01221272|5939161|P2|NOT COMPLETED|Period 1||2
2421543|NCT01221272|5939162|P1|NOT COMPLETED|Period 1||2
2421544|NCT01221272|5939161|P2|COMPLETED|Period 1||38
2421545|NCT01221272|5939162|P1|COMPLETED|Period 1||39
2421546|NCT01221272|5939161|P2|STARTED|Period 1||40
2421547|NCT01221272|5939162|P1|STARTED|Period 1||41
2421548|NCT01221233|5939179|P2|NOT COMPLETED|Overall Study||1
2421549|NCT01221233|5939180|P1|NOT COMPLETED|Overall Study||3
2421550|NCT01221233|5939179|P2|COMPLETED|Overall Study||19
2421551|NCT01221233|5939180|P1|COMPLETED|Overall Study||15
2421552|NCT01221233|5939179|P2|STARTED|Overall Study||20
2421553|NCT01221233|5939180|P1|STARTED|Overall Study||18
2421554|NCT01221181|5939186|P1|NOT COMPLETED|Overall Study||1
2421555|NCT01221181|5939186|P1|COMPLETED|Overall Study||5
2421556|NCT01221181|5939186|P1|STARTED|Overall Study||6
2421557|NCT01221090|5939194|P4|NOT COMPLETED|Overall Study||22
2421558|NCT01221090|5939195|P3|NOT COMPLETED|Overall Study||42
2421559|NCT01221090|5939196|P2|NOT COMPLETED|Overall Study||34
2421560|NCT01221090|5939197|P1|NOT COMPLETED|Overall Study||15
2421561|NCT01221090|5939194|P4|COMPLETED|Overall Study||73
2421562|NCT01221090|5939195|P3|COMPLETED|Overall Study||57
2421563|NCT01221090|5939196|P2|COMPLETED|Overall Study||47
2421564|NCT01221090|5939197|P1|COMPLETED|Overall Study||86
2421565|NCT01221090|5939194|P4|STARTED|Overall Study||95
2421566|NCT01221090|5939195|P3|STARTED|Overall Study||99
2421567|NCT01221090|5939196|P2|STARTED|Overall Study||81
2421568|NCT01221090|5939197|P1|STARTED|Overall Study||101
2421569|NCT01220999|5939228|P5|NOT COMPLETED|Overall Study||0
2421570|NCT01220999|5939229|P4|NOT COMPLETED|Overall Study||0
2421571|NCT01220999|5939230|P3|NOT COMPLETED|Overall Study||1
2421572|NCT01220999|5939231|P2|NOT COMPLETED|Overall Study||0
2421573|NCT01220999|5939232|P1|NOT COMPLETED|Overall Study||0
2421574|NCT01220999|5939228|P5|COMPLETED|Overall Study||5
2421575|NCT01220999|5939229|P4|COMPLETED|Overall Study||3
2421576|NCT01220999|5939230|P3|COMPLETED|Overall Study||4
2421577|NCT01220999|5939231|P2|COMPLETED|Overall Study||4
2421578|NCT01220999|5939232|P1|COMPLETED|Overall Study||2
2421579|NCT01220999|5939228|P5|STARTED|Overall Study||5
2421580|NCT01220999|5939229|P4|STARTED|Overall Study||3
2421581|NCT01220999|5939230|P3|STARTED|Overall Study||5
2421582|NCT01220999|5939231|P2|STARTED|Overall Study||4
2421583|NCT01220999|5939232|P1|STARTED|Overall Study||2
2421584|NCT01220973|5939309|P1|NOT COMPLETED|Overall Study||4
2421585|NCT01220973|5939309|P1|COMPLETED|Overall Study||23
2421586|NCT01220973|5939309|P1|STARTED|Overall Study||27
2421587|NCT01220869|5939313|P1|NOT COMPLETED|Overall Study||6
2421588|NCT01220869|5939313|P1|COMPLETED|Overall Study||104
2421589|NCT01220869|5939313|P1|STARTED|Overall Study||110
2421590|NCT01220739|5939323|P2|NOT COMPLETED|Overall Study||0
2421591|NCT01220739|5939324|P1|NOT COMPLETED|Overall Study||0
2421592|NCT01220739|5939323|P2|COMPLETED|Overall Study||5
2421593|NCT01220739|5939324|P1|COMPLETED|Overall Study||7
2421594|NCT01220739|5939323|P2|STARTED|Overall Study||5
2421595|NCT01220739|5939324|P1|STARTED|Overall Study||7
2421596|NCT01220726|5939334|P2|NOT COMPLETED|Overall Study||2
2421597|NCT01220726|5939335|P1|NOT COMPLETED|Overall Study||0
2421598|NCT01220726|5939334|P2|COMPLETED|Overall Study||13
2421599|NCT01220726|5939335|P1|COMPLETED|Overall Study||15
2421600|NCT01220726|5939334|P2|STARTED|Overall Study||15
2421601|NCT01220726|5939335|P1|STARTED|Overall Study||15
2421602|NCT01220609|5939353|P1|NOT COMPLETED|Overall Study||3
2421603|NCT01220609|5939353|P1|COMPLETED|Overall Study|Eligible and treated patients|23
2421604|NCT01220609|5939353|P1|STARTED|Overall Study||26
2421605|NCT01220557|5939367|P2|NOT COMPLETED|Overall Study||5
2421606|NCT01220557|5939368|P1|NOT COMPLETED|Overall Study||6
2421607|NCT01220557|5939367|P2|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|74
2421608|NCT01220557|5939368|P1|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|75
2421609|NCT01220557|5939367|P2|STARTED|Overall Study||79
2421610|NCT01220557|5939368|P1|STARTED|Overall Study||81
2421611|NCT01220466|5939377|P3|NOT COMPLETED|Overall Study||0
2421612|NCT01220466|5939378|P2|NOT COMPLETED|Overall Study||0
2421613|NCT01220466|5939379|P1|NOT COMPLETED|Overall Study||0
2421614|NCT01220466|5939377|P3|COMPLETED|Overall Study|16 eyes|10
2421615|NCT01220466|5939378|P2|COMPLETED|Overall Study|108 eyes|56
2421616|NCT01220466|5939379|P1|COMPLETED|Overall Study|19 eyes|11
2421617|NCT01220466|5939377|P3|STARTED|Overall Study|16 eyes|10
2421618|NCT01220466|5939378|P2|STARTED|Overall Study|108 eyes|56
2421619|NCT01220466|5939379|P1|STARTED|Overall Study|19 eyes|11
2421620|NCT01220414|5939401|P4|NOT COMPLETED|Overall Study||1
2421621|NCT01220414|5939402|P3|NOT COMPLETED|Overall Study||0
2421622|NCT01220414|5939403|P2|NOT COMPLETED|Overall Study||0
2421623|NCT01220414|5939404|P1|NOT COMPLETED|Overall Study||1
2421624|NCT01220414|5939401|P4|COMPLETED|Overall Study||14
2421625|NCT01220414|5939402|P3|COMPLETED|Overall Study||14
2421626|NCT01220414|5939403|P2|COMPLETED|Overall Study||14
2421627|NCT01220414|5939404|P1|COMPLETED|Overall Study||14
2421628|NCT01220414|5939401|P4|STARTED|Overall Study||15
2421629|NCT01220414|5939402|P3|STARTED|Overall Study||14
2421630|NCT01220414|5939403|P2|STARTED|Overall Study||14
2421631|NCT01220414|5939404|P1|STARTED|Overall Study||15
2421632|NCT01220401|5939411|P1|NOT COMPLETED|Overall Study||3
2421633|NCT01220401|5939411|P1|COMPLETED|Overall Study||18
2421634|NCT01220401|5939411|P1|STARTED|Overall Study||21
2421635|NCT01220297|5939420|P1|NOT COMPLETED|Overall Study||3
2421636|NCT01220297|5939420|P1|COMPLETED|Overall Study||0
2421637|NCT01220297|5939420|P1|STARTED|Overall Study||3
2421638|NCT01220180|5939437|P1|NOT COMPLETED|Overall Study||207
2421639|NCT01220180|5939437|P1|COMPLETED|Overall Study||3968
2421640|NCT01220180|5939437|P1|Treated|Overall Study||4174
2421641|NCT01220180|5939437|P1|STARTED|Overall Study||4175
2421642|NCT01220128|5939467|P7|NOT COMPLETED|Overall Study||5
2421643|NCT01220128|5939468|P6|NOT COMPLETED|Overall Study||0
2421644|NCT01220128|5939469|P5|NOT COMPLETED|Overall Study||0
2421645|NCT01220128|5939470|P4|NOT COMPLETED|Overall Study||0
2421646|NCT01220128|5939471|P3|NOT COMPLETED|Overall Study||3
2421647|NCT01220128|5939472|P2|NOT COMPLETED|Overall Study||1
2421648|NCT01220128|5939473|P1|NOT COMPLETED|Overall Study||4
2421649|NCT01220128|5939467|P7|COMPLETED|Overall Study||3
2421650|NCT01220128|5939468|P6|COMPLETED|Overall Study||4
2421651|NCT01220128|5939469|P5|COMPLETED|Overall Study||11
2421652|NCT01220128|5939470|P4|COMPLETED|Overall Study||6
2421653|NCT01220128|5939471|P3|COMPLETED|Overall Study||6
2421654|NCT01220128|5939472|P2|COMPLETED|Overall Study||6
2421655|NCT01220128|5939473|P1|COMPLETED|Overall Study||11
2421656|NCT01220128|5939467|P7|STARTED|Overall Study||8
2421657|NCT01220128|5939468|P6|STARTED|Overall Study||4
2421658|NCT01220128|5939469|P5|STARTED|Overall Study||11
2421659|NCT01220128|5939470|P4|STARTED|Overall Study||6
2421660|NCT01220128|5939471|P3|STARTED|Overall Study||9
2421661|NCT01220128|5939472|P2|STARTED|Overall Study||7
2421662|NCT01220128|5939473|P1|STARTED|Overall Study||15
2421663|NCT01219985|5939678|P1|NOT COMPLETED|Overall Study||20
2421664|NCT01219985|5939678|P1|COMPLETED|Overall Study||30
2421665|NCT01219985|5939678|P1|STARTED|Overall Study||50
2421666|NCT01219959|5939686|P2|NOT COMPLETED|Overall Study||23
2421667|NCT01219959|5939687|P1|NOT COMPLETED|Overall Study||7
2421668|NCT01219959|5939686|P2|COMPLETED|Overall Study||101
2421669|NCT01219959|5939687|P1|COMPLETED|Overall Study||120
2421670|NCT01219959|5939686|P2|STARTED|Overall Study||124
2421671|NCT01219959|5939687|P1|STARTED|Overall Study||127
2421672|NCT01219933|5939735|P1|NOT COMPLETED|Overall Study||38
2421673|NCT01219933|5939735|P1|COMPLETED|Overall Study||30
2421674|NCT01219933|5939735|P1|STARTED|Overall Study||68
2421675|NCT01219881|5939774|P2|NOT COMPLETED|Overall Study||5
2421676|NCT01219881|5939775|P1|NOT COMPLETED|Overall Study||4
2421677|NCT01219881|5939774|P2|COMPLETED|Overall Study||32
2421678|NCT01219881|5939775|P1|COMPLETED|Overall Study||34
2421679|NCT01219881|5939774|P2|STARTED|Overall Study||37
2421680|NCT01219881|5939775|P1|STARTED|Overall Study||38
2421681|NCT01219855|5939792|P5|NOT COMPLETED|Overall Study||1
2421682|NCT01219855|5939793|P4|NOT COMPLETED|Overall Study||1
2421683|NCT01219855|5939794|P3|NOT COMPLETED|Overall Study||1
2421684|NCT01219855|5939795|P2|NOT COMPLETED|Overall Study||5
2421685|NCT01219855|5939796|P1|NOT COMPLETED|Overall Study||1
2421686|NCT01219855|5939792|P5|COMPLETED|Overall Study||13
2421687|NCT01219855|5939793|P4|COMPLETED|Overall Study||12
2421688|NCT01219855|5939794|P3|COMPLETED|Overall Study||16
2421689|NCT01219855|5939795|P2|COMPLETED|Overall Study||12
2421690|NCT01219855|5939796|P1|COMPLETED|Overall Study||16
2421691|NCT01219855|5939792|P5|STARTED|Overall Study||14
2421692|NCT01219855|5939793|P4|STARTED|Overall Study||13
2421693|NCT01219855|5939794|P3|STARTED|Overall Study||17
2421694|NCT01219855|5939795|P2|STARTED|Overall Study||17
2421695|NCT01219855|5939796|P1|STARTED|Overall Study||17
2421696|NCT01219777|5939832|P1|NOT COMPLETED|Overall Study||0
2421697|NCT01219777|5939832|P1|COMPLETED|Overall Study||9
2421698|NCT01219777|5939832|P1|STARTED|Overall Study||9
2421699|NCT01219738|5939837|P1|NOT COMPLETED|Overall Study||0
2421700|NCT01219738|5939837|P1|COMPLETED|Overall Study||20
2421701|NCT01219738|5939837|P1|Budesonide 720- 4 Times|Overall Study||20
2421702|NCT01219738|5939837|P1|Budesonide 1440|Overall Study||20
2421703|NCT01219738|5939837|P1|Budesonide 720|Overall Study||20
2421704|NCT01219738|5939837|P1|Budesonide 360|Overall Study||20
2421705|NCT01219738|5939837|P1|STARTED|Overall Study||20
2421706|NCT01219673|5939858|P8|NOT COMPLETED|Overall Study||0
2421707|NCT01219673|5939859|P7|NOT COMPLETED|Overall Study||0
2421708|NCT01219673|5939860|P6|NOT COMPLETED|Overall Study||0
2421709|NCT01219673|5939861|P5|NOT COMPLETED|Overall Study||0
2421710|NCT01219673|5939862|P4|NOT COMPLETED|Overall Study||0
2421711|NCT01219673|5939863|P3|NOT COMPLETED|Overall Study||0
2421712|NCT01219673|5939864|P2|NOT COMPLETED|Overall Study||0
2421713|NCT01219673|5939865|P1|NOT COMPLETED|Overall Study||0
2421714|NCT01219673|5939858|P8|COMPLETED|Overall Study||0
2421715|NCT01219673|5939859|P7|COMPLETED|Overall Study||0
2421716|NCT01219673|5939860|P6|COMPLETED|Overall Study||0
2421717|NCT01219673|5939861|P5|COMPLETED|Overall Study||0
2421718|NCT01219673|5939862|P4|COMPLETED|Overall Study||0
2421719|NCT01219673|5939863|P3|COMPLETED|Overall Study||1
2421720|NCT01219673|5939864|P2|COMPLETED|Overall Study||0
2421721|NCT01219673|5939865|P1|COMPLETED|Overall Study||0
2421722|NCT01219673|5939858|P8|STARTED|Overall Study||0
2421723|NCT01219673|5939859|P7|STARTED|Overall Study||0
2421724|NCT01219673|5939860|P6|STARTED|Overall Study||0
2421725|NCT01219673|5939861|P5|STARTED|Overall Study||0
2421726|NCT01219673|5939862|P4|STARTED|Overall Study||0
2421727|NCT01219673|5939863|P3|STARTED|Overall Study||1
2421728|NCT01219673|5939864|P2|STARTED|Overall Study||0
2421729|NCT01219673|5939865|P1|STARTED|Overall Study||0
2421730|NCT01218997|5939885|P2|NOT COMPLETED|Overall Study||41
2421731|NCT01218997|5939886|P1|NOT COMPLETED|Overall Study||245
2421732|NCT01218997|5939885|P2|COMPLETED|Overall Study||24
2421733|NCT01218997|5939886|P1|COMPLETED|Overall Study||126
2421734|NCT01218997|5939885|P2|STARTED|Overall Study||65
2421735|NCT01218997|5939886|P1|STARTED|Overall Study||371
2421736|NCT01218984|5939895|P3|NOT COMPLETED|Overall Study||3
2421737|NCT01218984|5939896|P2|NOT COMPLETED|Overall Study||2
2421738|NCT01218984|5939897|P1|NOT COMPLETED|Overall Study||1
2421739|NCT01218984|5939895|P3|COMPLETED|Overall Study||7
2421740|NCT01218984|5939896|P2|COMPLETED|Overall Study||6
2421741|NCT01218984|5939897|P1|COMPLETED|Overall Study||8
2421742|NCT01218984|5939895|P3|STARTED|Overall Study||10
2421743|NCT01218984|5939896|P2|STARTED|Overall Study||8
2421744|NCT01218984|5939897|P1|STARTED|Overall Study||9
2421745|NCT01218971|5939907|P2|NOT COMPLETED|Overall Study||80
2421746|NCT01218971|5939908|P1|NOT COMPLETED|Overall Study||104
2421747|NCT01218971|5939907|P2|COMPLETED|Overall Study||77
2421748|NCT01218971|5939908|P1|COMPLETED|Overall Study||71
2421749|NCT01218971|5939907|P2|STARTED|Overall Study||157
2421750|NCT01218971|5939908|P1|STARTED|Overall Study||175
2421751|NCT01218958|5939921|P3|NOT COMPLETED|Overall Study||81
2421752|NCT01218958|5939922|P2|NOT COMPLETED|Overall Study||81
2421753|NCT01218958|5939923|P1|NOT COMPLETED|Overall Study||84
2421754|NCT01218958|5939921|P3|COMPLETED|Overall Study||128
2421755|NCT01218958|5939922|P2|COMPLETED|Overall Study||124
2421756|NCT01218958|5939923|P1|COMPLETED|Overall Study||126
2421757|NCT01218958|5939921|P3|STARTED|Overall Study||209
2421758|NCT01218958|5939922|P2|STARTED|Overall Study||205
2421759|NCT01218958|5939923|P1|STARTED|Overall Study||210
2421760|NCT01218867|5939945|P11|NOT COMPLETED|Overall Study||0
2421761|NCT01218867|5939946|P10|NOT COMPLETED|Overall Study||0
2421762|NCT01218867|5939947|P9|NOT COMPLETED|Overall Study||0
2421763|NCT01218867|5939948|P8|NOT COMPLETED|Overall Study||0
2421764|NCT01218867|5939949|P7|NOT COMPLETED|Overall Study||1
2421765|NCT01218867|5939950|P6|NOT COMPLETED|Overall Study||0
2421766|NCT01218867|5939951|P5|NOT COMPLETED|Overall Study||0
2421767|NCT01218867|5939952|P4|NOT COMPLETED|Overall Study||0
2421768|NCT01218867|5939953|P3|NOT COMPLETED|Overall Study||0
2421769|NCT01218867|5939954|P2|NOT COMPLETED|Overall Study||0
2421770|NCT01218867|5939955|P1|NOT COMPLETED|Overall Study||0
2421771|NCT01218867|5939945|P11|COMPLETED|Overall Study||2
2421772|NCT01218867|5939946|P10|COMPLETED|Overall Study||4
2421773|NCT01218867|5939947|P9|COMPLETED|Overall Study||3
2421774|NCT01218867|5939948|P8|COMPLETED|Overall Study||3
2421775|NCT01218867|5939949|P7|COMPLETED|Overall Study||3
2421776|NCT01218867|5939950|P6|COMPLETED|Overall Study||1
2421777|NCT01218867|5939951|P5|COMPLETED|Overall Study||1
2421778|NCT01218867|5939952|P4|COMPLETED|Overall Study||1
2421779|NCT01218867|5939953|P3|COMPLETED|Overall Study||3
2421780|NCT01218867|5939954|P2|COMPLETED|Overall Study||1
2421781|NCT01218867|5939955|P1|COMPLETED|Overall Study||1
2421782|NCT01218867|5939945|P11|STARTED|Overall Study||2
2421783|NCT01218867|5939946|P10|STARTED|Overall Study||4
2421784|NCT01218867|5939947|P9|STARTED|Overall Study||3
2421785|NCT01218867|5939948|P8|STARTED|Overall Study||3
2421786|NCT01218867|5939949|P7|STARTED|Overall Study||4
2421787|NCT01218867|5939950|P6|STARTED|Overall Study||1
2421788|NCT01218867|5939951|P5|STARTED|Overall Study||1
2421789|NCT01218867|5939952|P4|STARTED|Overall Study||1
2421790|NCT01218867|5939953|P3|STARTED|Overall Study||3
2421791|NCT01218867|5939954|P2|STARTED|Overall Study||1
2421792|NCT01218867|5939955|P1|STARTED|Overall Study||1
2421793|NCT01218802|5940003|P2|NOT COMPLETED|Overall Study||18
2421794|NCT01218802|5940004|P1|NOT COMPLETED|Overall Study||10
2421795|NCT01218802|5940003|P2|COMPLETED|Overall Study||57
2421796|NCT01218802|5940004|P1|COMPLETED|Overall Study||62
2421797|NCT01218802|5940003|P2|STARTED|Overall Study||75
2421798|NCT01218802|5940004|P1|STARTED|Overall Study||72
2421799|NCT01218659|5940014|P3|NOT COMPLETED|12-Month OLE||10
2421800|NCT01218659|5940015|P2|NOT COMPLETED|12-Month OLE||0
2421801|NCT01218659|5940016|P1|NOT COMPLETED|12-Month OLE||0
2421802|NCT01218659|5940014|P3|COMPLETED|12-Month OLE||42
2421803|NCT01218659|5940015|P2|COMPLETED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
2421804|NCT01218659|5940016|P1|COMPLETED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
2421805|NCT01218659|5940014|P3|Modified Intent-to-Treat (mITT)|12-Month OLE||46
2421806|NCT01218659|5940015|P2|Modified Intent-to-Treat (mITT)|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
2421807|NCT01218659|5940016|P1|Modified Intent-to-Treat (mITT)|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
2421808|NCT01218659|5940014|P3|Safety Population|12-Month OLE||51
2421809|NCT01218659|5940015|P2|Safety Population|12-Month OLE||0
2421810|NCT01218659|5940016|P1|Safety Population|12-Month OLE||0
2421811|NCT01218659|5940014|P3|STARTED|12-Month OLE|Fifty-two participants completed the 18-mo. randomized treatment period.|52
2421812|NCT01218659|5940015|P2|STARTED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
2421813|NCT01218659|5940016|P1|STARTED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
2421814|NCT01218659|5940014|P3|NOT COMPLETED|18-Month Randomized Period||0
2421815|NCT01218659|5940015|P2|NOT COMPLETED|18-Month Randomized Period||6
2421816|NCT01218659|5940016|P1|NOT COMPLETED|18-Month Randomized Period||2
2421817|NCT01218659|5940014|P3|COMPLETED|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
2421818|NCT01218659|5940015|P2|COMPLETED|18-Month Randomized Period||18
2421819|NCT01218659|5940016|P1|COMPLETED|18-Month Randomized Period||34
2421820|NCT01218659|5940014|P3|Safety Population|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
2421821|NCT01218659|5940015|P2|Safety Population|18-Month Randomized Period||21
2421822|NCT01218659|5940016|P1|Safety Population|18-Month Randomized Period||36
2421823|NCT01218659|5940014|P3|STARTED|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
2421824|NCT01218659|5940015|P2|STARTED|18-Month Randomized Period||24
2421825|NCT01218659|5940016|P1|STARTED|18-Month Randomized Period||36
2421826|NCT01218646|5940031|P4|NOT COMPLETED|Overall Study||1
2421827|NCT01218646|5940032|P3|NOT COMPLETED|Overall Study||2
2421828|NCT01218646|5940033|P2|NOT COMPLETED|Overall Study||0
2421829|NCT01218646|5940034|P1|NOT COMPLETED|Overall Study||1
2421830|NCT01218646|5940031|P4|COMPLETED|Overall Study||63
2421831|NCT01218646|5940032|P3|COMPLETED|Overall Study||223
2421832|NCT01218646|5940033|P2|COMPLETED|Overall Study||225
2421833|NCT01218646|5940034|P1|COMPLETED|Overall Study||224
2421834|NCT01218646|5940031|P4|STARTED|Overall Study||64
2421835|NCT01218646|5940032|P3|STARTED|Overall Study||225
2421836|NCT01218646|5940033|P2|STARTED|Overall Study||225
2421837|NCT01218646|5940034|P1|STARTED|Overall Study||225
2421838|NCT01218594|5940072|P1|NOT COMPLETED|Overall Study||12
2421839|NCT01218594|5940072|P1|COMPLETED|Overall Study||36
2421840|NCT01218594|5940072|P1|STARTED|Overall Study||48
2421841|NCT01218477|5940080|P4|NOT COMPLETED|Overall Study||2
2421842|NCT01218477|5940081|P3|NOT COMPLETED|Overall Study||14
2421843|NCT01218477|5940082|P2|NOT COMPLETED|Overall Study||8
2421844|NCT01218477|5940083|P1|NOT COMPLETED|Overall Study||3
2421845|NCT01218477|5940080|P4|COMPLETED|Overall Study|Still receiving study drug|0
2421846|NCT01218477|5940081|P3|COMPLETED|Overall Study|Still receiving study drug|0
2421847|NCT01218477|5940082|P2|COMPLETED|Overall Study|Still receiving study drug|0
2421848|NCT01218477|5940083|P1|COMPLETED|Overall Study|Still receiving study drug|0
2421849|NCT01218477|5940080|P4|STARTED|Overall Study|Participants who received treatment|2
2421850|NCT01218477|5940081|P3|STARTED|Overall Study|Participants who received treatment|14
2421851|NCT01218477|5940082|P2|STARTED|Overall Study|Participants who received treatment|8
2421852|NCT01218477|5940083|P1|STARTED|Overall Study|Participants who received treatment|3
2421853|NCT01218438|5940100|P1|NOT COMPLETED|Epoch 4||3
2421854|NCT01218438|5940100|P1|COMPLETED|Epoch 4||67
2421855|NCT01218438|5940100|P1|STARTED|Epoch 4||70
2421856|NCT01218438|5940100|P1|NOT COMPLETED|Epoch 3||4
2421857|NCT01218438|5940100|P1|COMPLETED|Epoch 3||70
2421858|NCT01218438|5940100|P1|STARTED|Epoch 3||74
2421859|NCT01218438|5940100|P1|NOT COMPLETED|Epoch 2||0
2421860|NCT01218438|5940100|P1|COMPLETED|Epoch 2||45
2421861|NCT01218438|5940100|P1|STARTED|Epoch 2||45
2421862|NCT01218438|5940100|P1|NOT COMPLETED|Epoch 1||3
2421863|NCT01218438|5940100|P1|COMPLETED|Epoch 1||74
2421864|NCT01218438|5940100|P1|STARTED|Epoch 1||77
2421865|NCT01218399|5940255|P2|NOT COMPLETED|Overall Study||0
2421866|NCT01218399|5940256|P1|NOT COMPLETED|Overall Study||0
2421867|NCT01218399|5940255|P2|COMPLETED|Overall Study||5
2421868|NCT01218399|5940256|P1|COMPLETED|Overall Study||5
2421869|NCT01218399|5940255|P2|STARTED|Overall Study||5
2421870|NCT01218399|5940256|P1|STARTED|Overall Study||5
2421871|NCT01218308|5940266|P2|NOT COMPLETED|Overall Study||120
2421872|NCT01218308|5940267|P1|NOT COMPLETED|Overall Study||103
2421873|NCT01218308|5940266|P2|COMPLETED|Overall Study||2464
2421874|NCT01218308|5940267|P1|COMPLETED|Overall Study||2481
2421875|NCT01218308|5940266|P2|STARTED|Overall Study||2584
2421876|NCT01218308|5940267|P1|STARTED|Overall Study||2584
2421877|NCT01218243|5940311|P2|NOT COMPLETED|Overall Study||14
2421878|NCT01218243|5940312|P1|NOT COMPLETED|Overall Study||9
2421879|NCT01218243|5940311|P2|COMPLETED|Overall Study||36
2421880|NCT01218243|5940312|P1|COMPLETED|Overall Study||41
2421881|NCT01218243|5940311|P2|Treatment Completed|Overall Study||42
2421882|NCT01218243|5940312|P1|Treatment Completed|Overall Study||45
2421883|NCT01218243|5940311|P2|STARTED|Overall Study||50
2421884|NCT01218243|5940312|P1|STARTED|Overall Study||50
2421885|NCT01218204|5940328|P4|NOT COMPLETED|Part B Pooled Treatment Arm||3
2421886|NCT01218204|5940329|P3|NOT COMPLETED|Part B Pooled Treatment Arm||0
2421887|NCT01218204|5940330|P2|NOT COMPLETED|Part B Pooled Treatment Arm||0
2421888|NCT01218204|5940331|P1|NOT COMPLETED|Part B Pooled Treatment Arm||0
2421889|NCT01218204|5940328|P4|COMPLETED|Part B Pooled Treatment Arm||127
2421890|NCT01218204|5940329|P3|COMPLETED|Part B Pooled Treatment Arm||0
2421891|NCT01218204|5940330|P2|COMPLETED|Part B Pooled Treatment Arm||0
2421892|NCT01218204|5940331|P1|COMPLETED|Part B Pooled Treatment Arm||0
2421893|NCT01218204|5940328|P4|STARTED|Part B Pooled Treatment Arm||130
2421894|NCT01218204|5940329|P3|STARTED|Part B Pooled Treatment Arm||0
2421895|NCT01218204|5940330|P2|STARTED|Part B Pooled Treatment Arm||0
2421896|NCT01218204|5940331|P1|STARTED|Part B Pooled Treatment Arm||0
2421897|NCT01218204|5940328|P4|NOT COMPLETED|Part B Run-in||0
2421898|NCT01218204|5940329|P3|NOT COMPLETED|Part B Run-in||6
2421899|NCT01218204|5940330|P2|NOT COMPLETED|Part B Run-in||0
2421900|NCT01218204|5940331|P1|NOT COMPLETED|Part B Run-in||0
2421901|NCT01218204|5940328|P4|COMPLETED|Part B Run-in||0
2421902|NCT01218204|5940329|P3|COMPLETED|Part B Run-in||83
2421903|NCT01218204|5940330|P2|COMPLETED|Part B Run-in||0
2421904|NCT01218204|5940331|P1|COMPLETED|Part B Run-in||0
2421905|NCT01218204|5940328|P4|STARTED|Part B Run-in||0
2421906|NCT01218204|5940329|P3|STARTED|Part B Run-in||89
2421907|NCT01218204|5940330|P2|STARTED|Part B Run-in||0
2421908|NCT01218204|5940331|P1|STARTED|Part B Run-in||0
2421909|NCT01218204|5940328|P4|NOT COMPLETED|Part B Washout||0
2421910|NCT01218204|5940329|P3|NOT COMPLETED|Part B Washout||0
2421911|NCT01218204|5940330|P2|NOT COMPLETED|Part B Washout||145
2421912|NCT01218204|5940331|P1|NOT COMPLETED|Part B Washout||0
2421913|NCT01218204|5940328|P4|COMPLETED|Part B Washout||0
2421914|NCT01218204|5940329|P3|COMPLETED|Part B Washout||0
2421915|NCT01218204|5940330|P2|COMPLETED|Part B Washout||136
2421916|NCT01218204|5940331|P1|COMPLETED|Part B Washout||0
2421917|NCT01218204|5940328|P4|STARTED|Part B Washout||0
2421918|NCT01218204|5940329|P3|STARTED|Part B Washout||0
2421919|NCT01218204|5940330|P2|STARTED|Part B Washout||281
2421920|NCT01218204|5940331|P1|STARTED|Part B Washout||0
2421921|NCT01218204|5940328|P4|NOT COMPLETED|Part A||0
2421922|NCT01218204|5940329|P3|NOT COMPLETED|Part A||0
2421923|NCT01218204|5940330|P2|NOT COMPLETED|Part A||0
2421924|NCT01218204|5940331|P1|NOT COMPLETED|Part A||0
2421925|NCT01218204|5940328|P4|COMPLETED|Part A||0
2421926|NCT01218204|5940329|P3|COMPLETED|Part A||0
2421927|NCT01218204|5940330|P2|COMPLETED|Part A||0
2421928|NCT01218204|5940331|P1|COMPLETED|Part A||6
2421929|NCT01218204|5940328|P4|STARTED|Part A||0
2421930|NCT01218204|5940329|P3|STARTED|Part A||0
2421931|NCT01218204|5940330|P2|STARTED|Part A||0
2421932|NCT01218204|5940331|P1|STARTED|Part A||6
2421933|NCT01218126|5940595|P4|NOT COMPLETED|Overall Study||35
2421934|NCT01218126|5940596|P3|NOT COMPLETED|Overall Study||24
2421935|NCT01218126|5940597|P2|NOT COMPLETED|Overall Study||22
2421936|NCT01218126|5940598|P1|NOT COMPLETED|Overall Study||24
2421937|NCT01218126|5940595|P4|COMPLETED|Overall Study||114
2421938|NCT01218126|5940596|P3|COMPLETED|Overall Study||127
2421939|NCT01218126|5940597|P2|COMPLETED|Overall Study||127
2421940|NCT01218126|5940598|P1|COMPLETED|Overall Study||129
2421941|NCT01218126|5940595|P4|STARTED|Overall Study||149
2421942|NCT01218126|5940596|P3|STARTED|Overall Study||151
2421943|NCT01218126|5940597|P2|STARTED|Overall Study||149
2421944|NCT01218126|5940598|P1|STARTED|Overall Study||153
2421945|NCT01218113|5940639|P3|NOT COMPLETED|Overall Study||6
2421946|NCT01218113|5940640|P2|NOT COMPLETED|Overall Study||1
2421947|NCT01218113|5940641|P1|NOT COMPLETED|Overall Study||5
2421948|NCT01218113|5940639|P3|COMPLETED|Overall Study||58
2421949|NCT01218113|5940640|P2|COMPLETED|Overall Study||63
2421950|NCT01218113|5940641|P1|COMPLETED|Overall Study||57
2421951|NCT01218113|5940639|P3|STARTED|Overall Study||64
2421952|NCT01218113|5940640|P2|STARTED|Overall Study||64
2421953|NCT01218113|5940641|P1|STARTED|Overall Study||62
2421954|NCT01218100|5940822|P4|NOT COMPLETED|Overall Study||34
2421955|NCT01218100|5940823|P3|NOT COMPLETED|Overall Study||27
2421956|NCT01218100|5940824|P2|NOT COMPLETED|Overall Study||25
2421957|NCT01218100|5940825|P1|NOT COMPLETED|Overall Study||24
2421958|NCT01218100|5940822|P4|COMPLETED|Overall Study||156
2421959|NCT01218100|5940823|P3|COMPLETED|Overall Study||162
2421960|NCT01218100|5940824|P2|COMPLETED|Overall Study||165
2421961|NCT01218100|5940825|P1|COMPLETED|Overall Study||71
2421962|NCT01218100|5940822|P4|STARTED|Overall Study||190
2421963|NCT01218100|5940823|P3|STARTED|Overall Study||189
2421964|NCT01218100|5940824|P2|STARTED|Overall Study||190
2421965|NCT01218100|5940825|P1|STARTED|Overall Study||95
2421966|NCT01218087|5940841|P2|NOT COMPLETED|Overall Study||6
2421967|NCT01218087|5940842|P1|NOT COMPLETED|Overall Study||15
2421968|NCT01218087|5940841|P2|COMPLETED|Overall Study||35
2421969|NCT01218087|5940842|P1|COMPLETED|Overall Study||27
2421970|NCT01218087|5940841|P2|STARTED|Overall Study||41
2421971|NCT01218087|5940842|P1|STARTED|Overall Study||42
2421972|NCT01218048|5940850|P1|NOT COMPLETED|Overall Study||0
2421973|NCT01218048|5940850|P1|COMPLETED|Overall Study||40
2421974|NCT01218048|5940850|P1|STARTED|Overall Study||40
2421975|NCT01218009|5940864|P2|NOT COMPLETED|Overall Study||165
2421976|NCT01218009|5940865|P1|NOT COMPLETED|Overall Study||166
2421977|NCT01218009|5940864|P2|COMPLETED|Overall Study||0
2421978|NCT01218009|5940865|P1|COMPLETED|Overall Study||0
2421979|NCT01218009|5940864|P2|STARTED|Overall Study||165
2421980|NCT01218009|5940865|P1|STARTED|Overall Study||166
2421981|NCT01217957|5940888|P5|NOT COMPLETED|Phase 2||1
2421982|NCT01217957|5940889|P4|NOT COMPLETED|Phase 2||0
2421983|NCT01217957|5940890|P3|NOT COMPLETED|Phase 2||0
2421984|NCT01217957|5940891|P2|NOT COMPLETED|Phase 2||0
2421985|NCT01217957|5940892|P1|NOT COMPLETED|Phase 2||0
2421986|NCT01217957|5940888|P5|COMPLETED|Phase 2|Completed=Participants who are ongoing or who have died on study.|49
2421987|NCT01217957|5940889|P4|COMPLETED|Phase 2||0
2421988|NCT01217957|5940890|P3|COMPLETED|Phase 2||0
2421989|NCT01217957|5940891|P2|COMPLETED|Phase 2||0
2421990|NCT01217957|5940892|P1|COMPLETED|Phase 2||0
2421991|NCT01217957|5940888|P5|STARTED|Phase 2||50
2421992|NCT01217957|5940889|P4|STARTED|Phase 2||0
2421993|NCT01217957|5940890|P3|STARTED|Phase 2||0
2421994|NCT01217957|5940891|P2|STARTED|Phase 2||0
2421995|NCT01217957|5940892|P1|STARTED|Phase 2||0
2421996|NCT01217957|5940888|P5|NOT COMPLETED|Phase 1||0
2421997|NCT01217957|5940889|P4|NOT COMPLETED|Phase 1||1
2421998|NCT01217957|5940890|P3|NOT COMPLETED|Phase 1||1
2421999|NCT01217957|5940891|P2|NOT COMPLETED|Phase 1||0
2422000|NCT01217957|5940892|P1|NOT COMPLETED|Phase 1||1
2422001|NCT01217957|5940888|P5|COMPLETED|Phase 1||0
2422002|NCT01217957|5940889|P4|COMPLETED|Phase 1||2
2422003|NCT01217957|5940890|P3|COMPLETED|Phase 1||5
2422004|NCT01217957|5940891|P2|COMPLETED|Phase 1||3
2422005|NCT01217957|5940892|P1|COMPLETED|Phase 1||2
2422006|NCT01217957|5940888|P5|STARTED|Phase 1||0
2422007|NCT01217957|5940889|P4|STARTED|Phase 1||3
2422008|NCT01217957|5940890|P3|STARTED|Phase 1||6
2422009|NCT01217957|5940891|P2|STARTED|Phase 1||3
2422010|NCT01217957|5940892|P1|STARTED|Phase 1||3
2422011|NCT01217944|5940951|P3|NOT COMPLETED|Overall Study||0
2422012|NCT01217944|5940952|P2|NOT COMPLETED|Overall Study||4
2422013|NCT01217944|5940953|P1|NOT COMPLETED|Overall Study||6
2422014|NCT01217944|5940951|P3|COMPLETED|Overall Study||55
2422015|NCT01217944|5940952|P2|COMPLETED|Overall Study||112
2422016|NCT01217944|5940953|P1|COMPLETED|Overall Study||100
2422017|NCT01217944|5940951|P3|Completed 6 Months|Overall Study||55
2422018|NCT01217944|5940952|P2|Completed 6 Months|Overall Study||116
2422019|NCT01217944|5940953|P1|Completed 6 Months|Overall Study||103
2422020|NCT01217944|5940951|P3|Completed 3 Months|Overall Study||55
2422021|NCT01217944|5940952|P2|Completed 3 Months|Overall Study||116
2422022|NCT01217944|5940953|P1|Completed 3 Months|Overall Study||105
2422023|NCT01217944|5940951|P3|STARTED|Overall Study||55
2422024|NCT01217944|5940952|P2|STARTED|Overall Study||116
2422025|NCT01217944|5940953|P1|STARTED|Overall Study||106
2422026|NCT01217892|5940996|P4|NOT COMPLETED|Overall Study||8
2422027|NCT01217892|5940997|P3|NOT COMPLETED|Overall Study||9
2422028|NCT01217892|5940998|P2|NOT COMPLETED|Overall Study||6
2422029|NCT01217892|5940999|P1|NOT COMPLETED|Overall Study||7
2422030|NCT01217892|5940996|P4|COMPLETED|Overall Study||93
2422031|NCT01217892|5940997|P3|COMPLETED|Overall Study||90
2422032|NCT01217892|5940998|P2|COMPLETED|Overall Study||94
2422033|NCT01217892|5940999|P1|COMPLETED|Overall Study||93
2422034|NCT01217892|5940996|P4|STARTED|Overall Study||101
2422035|NCT01217892|5940997|P3|STARTED|Overall Study||99
2422036|NCT01217892|5940998|P2|STARTED|Overall Study||100
2422037|NCT01217892|5940999|P1|STARTED|Overall Study||100
2422038|NCT01217840|5941027|P2|NOT COMPLETED|Overall Study||3
2422039|NCT01217840|5941028|P1|NOT COMPLETED|Overall Study||6
2422040|NCT01217840|5941027|P2|COMPLETED|Overall Study||17
2422041|NCT01217840|5941028|P1|COMPLETED|Overall Study||14
2422042|NCT01217840|5941027|P2|STARTED|Overall Study||20
2422043|NCT01217840|5941028|P1|STARTED|Overall Study||20
2422044|NCT01217827|5941052|P2|NOT COMPLETED|Overall Study||0
2422045|NCT01217827|5941053|P1|NOT COMPLETED|Overall Study||0
2422046|NCT01217827|5941052|P2|COMPLETED|Overall Study||43
2422047|NCT01217827|5941053|P1|COMPLETED|Overall Study||46
2422048|NCT01217827|5941052|P2|STARTED|Overall Study||43
2422049|NCT01217827|5941053|P1|STARTED|Overall Study||46
2422050|NCT01217814|5941062|P3|NOT COMPLETED|Overall Study||1
2422051|NCT01217814|5941063|P2|NOT COMPLETED|Overall Study||1
2422052|NCT01217814|5941064|P1|NOT COMPLETED|Overall Study||1
2422053|NCT01217814|5941062|P3|COMPLETED|Overall Study||6
2422054|NCT01217814|5941063|P2|COMPLETED|Overall Study||4
2422055|NCT01217814|5941064|P1|COMPLETED|Overall Study||3
2422056|NCT01217814|5941062|P3|STARTED|Overall Study||7
2422057|NCT01217814|5941063|P2|STARTED|Overall Study||5
2422058|NCT01217814|5941064|P1|STARTED|Overall Study||4
2422059|NCT01217801|5941090|P2|NOT COMPLETED|Period 2||0
2422060|NCT01217801|5941091|P1|NOT COMPLETED|Period 2||0
2422061|NCT01217801|5941090|P2|COMPLETED|Period 2||22
2422062|NCT01217801|5941091|P1|COMPLETED|Period 2||23
2422063|NCT01217801|5941090|P2|STARTED|Period 2||22
2422064|NCT01217801|5941091|P1|STARTED|Period 2||23
2422065|NCT01217801|5941090|P2|NOT COMPLETED|Period 1||2
2422066|NCT01217801|5941091|P1|NOT COMPLETED|Period 1||1
2422067|NCT01217801|5941090|P2|COMPLETED|Period 1||22
2422068|NCT01217801|5941091|P1|COMPLETED|Period 1||23
2422069|NCT01217801|5941090|P2|STARTED|Period 1||24
2422070|NCT01217801|5941091|P1|STARTED|Period 1||24
2422071|NCT01217749|5941100|P3|NOT COMPLETED|Overall Study||2
2422072|NCT01217749|5941101|P2|NOT COMPLETED|Overall Study||3
2422073|NCT01217749|5941102|P1|NOT COMPLETED|Overall Study||3
2422074|NCT01217749|5941100|P3|COMPLETED|Overall Study||22
2422075|NCT01217749|5941101|P2|COMPLETED|Overall Study||17
2422076|NCT01217749|5941102|P1|COMPLETED|Overall Study||24
2422077|NCT01217749|5941100|P3|STARTED|Overall Study||24
2422078|NCT01217749|5941101|P2|STARTED|Overall Study||20
2422079|NCT01217749|5941102|P1|STARTED|Overall Study||27
2422080|NCT01217606|5941120|P2|NOT COMPLETED|9-Month Masked Extension||11
2422081|NCT01217606|5941121|P1|NOT COMPLETED|9-Month Masked Extension||13
2422082|NCT01217606|5941120|P2|COMPLETED|9-Month Masked Extension||62
2422083|NCT01217606|5941121|P1|COMPLETED|9-Month Masked Extension||54
2422084|NCT01217606|5941120|P2|Not Enrolled in Masked Extension|9-Month Masked Extension||10
2422085|NCT01217606|5941121|P1|Not Enrolled in Masked Extension|9-Month Masked Extension||9
2422086|NCT01217606|5941120|P2|STARTED|9-Month Masked Extension||73
2422087|NCT01217606|5941121|P1|STARTED|9-Month Masked Extension||67
2422088|NCT01217606|5941120|P2|NOT COMPLETED|Initial Treatment Phase||12
2422089|NCT01217606|5941121|P1|NOT COMPLETED|Initial Treatment Phase||14
2422090|NCT01217606|5941120|P2|COMPLETED|Initial Treatment Phase||83
2422091|NCT01217606|5941121|P1|COMPLETED|Initial Treatment Phase||76
2422092|NCT01217606|5941120|P2|STARTED|Initial Treatment Phase||95
2422093|NCT01217606|5941121|P1|STARTED|Initial Treatment Phase||90
2422094|NCT01217515|5941134|P3|NOT COMPLETED|Overall Study||10
2422095|NCT01217515|5941135|P2|NOT COMPLETED|Overall Study||8
2422096|NCT01217515|5941136|P1|NOT COMPLETED|Overall Study||7
2422097|NCT01217515|5941134|P3|COMPLETED|Overall Study||145
2422098|NCT01217515|5941135|P2|COMPLETED|Overall Study||148
2422099|NCT01217515|5941136|P1|COMPLETED|Overall Study||147
2422100|NCT01217515|5941134|P3|STARTED|Overall Study||155
2422101|NCT01217515|5941135|P2|STARTED|Overall Study||156
2422102|NCT01217515|5941136|P1|STARTED|Overall Study||154
2422103|NCT01217476|5941152|P2|NOT COMPLETED|Overall Study||7
2422104|NCT01217476|5941153|P1|NOT COMPLETED|Overall Study||12
2422105|NCT01217476|5941152|P2|COMPLETED|Overall Study||95
2422106|NCT01217476|5941153|P1|COMPLETED|Overall Study||93
2422107|NCT01217476|5941152|P2|STARTED|Overall Study||102
2422108|NCT01217476|5941153|P1|STARTED|Overall Study||105
2422109|NCT01217463|5941163|P2|NOT COMPLETED|Overall Study||8
2422110|NCT01217463|5941164|P1|NOT COMPLETED|Overall Study||13
2422111|NCT01217463|5941163|P2|COMPLETED|Overall Study||94
2422112|NCT01217463|5941164|P1|COMPLETED|Overall Study||86
2422113|NCT01217463|5941163|P2|STARTED|Overall Study||102
2422114|NCT01217463|5941164|P1|STARTED|Overall Study||99
2422115|NCT01217437|5941174|P2|NOT COMPLETED|Overall Study||41
2422116|NCT01217437|5941175|P1|NOT COMPLETED|Overall Study||43
2422117|NCT01217437|5941174|P2|COMPLETED|Overall Study||12
2422118|NCT01217437|5941175|P1|COMPLETED|Overall Study||12
2422119|NCT01217437|5941174|P2|STARTED|Overall Study||53
2422120|NCT01217437|5941175|P1|STARTED|Overall Study||55
2422121|NCT01217411|5941187|P2|NOT COMPLETED|Overall Study||2
2422122|NCT01217411|5941188|P1|NOT COMPLETED|Overall Study||3
2422123|NCT01217411|5941187|P2|COMPLETED|Overall Study||0
2422124|NCT01217411|5941188|P1|COMPLETED|Overall Study||0
2422125|NCT01217411|5941187|P2|20mg|Overall Study||0
2422126|NCT01217411|5941188|P1|20mg|Overall Study||0
2422127|NCT01217411|5941187|P2|10mg|Overall Study||0
2422128|NCT01217411|5941188|P1|10mg|Overall Study||0
2422129|NCT01217411|5941187|P2|5mg|Overall Study||2
2422130|NCT01217411|5941188|P1|5mg|Overall Study||3
2422131|NCT01217411|5941187|P2|STARTED|Overall Study||2
2422132|NCT01217411|5941188|P1|STARTED|Overall Study||3
2422133|NCT01217385|5941196|P1|NOT COMPLETED|Overall Study||26
2422134|NCT01217385|5941196|P1|COMPLETED|Overall Study||34
2422135|NCT01217385|5941196|P1|STARTED|Overall Study||60
2422136|NCT01217307|5941208|P2|NOT COMPLETED|Overall Study||1
2422137|NCT01217307|5941209|P1|NOT COMPLETED|Overall Study||0
2422138|NCT01217307|5941208|P2|COMPLETED|Overall Study||188
2422139|NCT01217307|5941209|P1|COMPLETED|Overall Study||191
2422140|NCT01217307|5941208|P2|STARTED|Overall Study||189
2422141|NCT01217307|5941209|P1|STARTED|Overall Study||191
2422142|NCT01217229|5941215|P1|NOT COMPLETED|Overall Study||0
2422143|NCT01217229|5941215|P1|COMPLETED|Overall Study||20
2422144|NCT01217229|5941215|P1|STARTED|Overall Study||20
2422145|NCT01217112|5941224|P5|NOT COMPLETED|Overall Study||1
2422146|NCT01217112|5941225|P4|NOT COMPLETED|Overall Study||2
2422147|NCT01217112|5941226|P3|NOT COMPLETED|Overall Study||1
2422148|NCT01217112|5941227|P2|NOT COMPLETED|Overall Study||2
2422149|NCT01217112|5941228|P1|NOT COMPLETED|Overall Study||0
2422150|NCT01217112|5941224|P5|COMPLETED|Overall Study||13
2422151|NCT01217112|5941225|P4|COMPLETED|Overall Study||10
2422152|NCT01217112|5941226|P3|COMPLETED|Overall Study||12
2422153|NCT01217112|5941227|P2|COMPLETED|Overall Study||10
2422154|NCT01217112|5941228|P1|COMPLETED|Overall Study||11
2422155|NCT01217112|5941224|P5|STARTED|Overall Study||14
2422156|NCT01217112|5941225|P4|STARTED|Overall Study||12
2422157|NCT01217112|5941226|P3|STARTED|Overall Study||13
2422158|NCT01217112|5941227|P2|STARTED|Overall Study||12
2422159|NCT01217112|5941228|P1|STARTED|Overall Study||11
2422160|NCT01217073|5941461|P8|NOT COMPLETED|Extension Period||20
2422161|NCT01217073|5941462|P7|NOT COMPLETED|Extension Period||91
2422162|NCT01217073|5941463|P6|NOT COMPLETED|Extension Period||0
2422163|NCT01217073|5941464|P5|NOT COMPLETED|Extension Period||0
2422164|NCT01217073|5941465|P4|NOT COMPLETED|Extension Period||0
2422165|NCT01217073|5941466|P3|NOT COMPLETED|Extension Period||0
2422166|NCT01217073|5941467|P2|NOT COMPLETED|Extension Period||0
2422167|NCT01217073|5941468|P1|NOT COMPLETED|Extension Period||0
2422168|NCT01217073|5941461|P8|COMPLETED|Extension Period||60
2422169|NCT01217073|5941462|P7|COMPLETED|Extension Period||314
2422170|NCT01217073|5941463|P6|COMPLETED|Extension Period||0
2422171|NCT01217073|5941464|P5|COMPLETED|Extension Period||0
2422172|NCT01217073|5941465|P4|COMPLETED|Extension Period||0
2422173|NCT01217073|5941466|P3|COMPLETED|Extension Period||0
2422174|NCT01217073|5941467|P2|COMPLETED|Extension Period||0
2422175|NCT01217073|5941468|P1|COMPLETED|Extension Period||0
2422176|NCT01217073|5941461|P8|STARTED|Extension Period||80
2422177|NCT01217073|5941462|P7|STARTED|Extension Period||405
2422178|NCT01217073|5941463|P6|STARTED|Extension Period||0
2422179|NCT01217073|5941464|P5|STARTED|Extension Period||0
2422180|NCT01217073|5941465|P4|STARTED|Extension Period||0
2422181|NCT01217073|5941466|P3|STARTED|Extension Period||0
2422182|NCT01217073|5941467|P2|STARTED|Extension Period||0
2422183|NCT01217073|5941468|P1|STARTED|Extension Period||0
2422184|NCT01217073|5941461|P8|NOT COMPLETED|Base Period||0
2422185|NCT01217073|5941462|P7|NOT COMPLETED|Base Period||0
2422186|NCT01217073|5941463|P6|NOT COMPLETED|Base Period||9
2422187|NCT01217073|5941464|P5|NOT COMPLETED|Base Period||15
2422188|NCT01217073|5941465|P4|NOT COMPLETED|Base Period||2
2422189|NCT01217073|5941466|P3|NOT COMPLETED|Base Period||7
2422190|NCT01217073|5941467|P2|NOT COMPLETED|Base Period||5
2422191|NCT01217073|5941468|P1|NOT COMPLETED|Base Period||7
2422192|NCT01217073|5941461|P8|COMPLETED|Base Period||0
2422193|NCT01217073|5941462|P7|COMPLETED|Base Period||0
2422194|NCT01217073|5941463|P6|COMPLETED|Base Period||105
2422195|NCT01217073|5941464|P5|COMPLETED|Base Period||99
2422196|NCT01217073|5941465|P4|COMPLETED|Base Period||113
2422197|NCT01217073|5941466|P3|COMPLETED|Base Period||107
2422198|NCT01217073|5941467|P2|COMPLETED|Base Period||110
2422199|NCT01217073|5941468|P1|COMPLETED|Base Period||106
2422200|NCT01217073|5941461|P8|STARTED|Base Period||0
2422201|NCT01217073|5941462|P7|STARTED|Base Period||0
2422202|NCT01217073|5941463|P6|STARTED|Base Period||114
2422203|NCT01217073|5941464|P5|STARTED|Base Period||114
2422204|NCT01217073|5941465|P4|STARTED|Base Period||115
2422205|NCT01217073|5941466|P3|STARTED|Base Period||114
2422206|NCT01217073|5941467|P2|STARTED|Base Period||115
2422207|NCT01217073|5941468|P1|STARTED|Base Period||113
2422208|NCT01216943|5941536|P1|NOT COMPLETED|Overall Study||13
2422209|NCT01216943|5941536|P1|COMPLETED|Overall Study||113
2422210|NCT01216943|5941536|P1|STARTED|Overall Study||126
2422211|NCT01216761|5941540|P3|NOT COMPLETED|Overall Study||0
2422212|NCT01216761|5941541|P2|NOT COMPLETED|Overall Study||0
2422213|NCT01216761|5941542|P1|NOT COMPLETED|Overall Study||0
2422214|NCT01216761|5941540|P3|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
2422215|NCT01216761|5941541|P2|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
2422216|NCT01216761|5941542|P1|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
2422217|NCT01216761|5941540|P3|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
2422218|NCT01216761|5941541|P2|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
2422219|NCT01216761|5941542|P1|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
2422220|NCT01216748|5941550|P1|NOT COMPLETED|Overall Study||0
2422221|NCT01216748|5941550|P1|COMPLETED|Overall Study||10
2422222|NCT01216748|5941550|P1|Eucapnic Hyperventilation|Overall Study||10
2422223|NCT01216748|5941550|P1|Hypercapnic Hyperventilation|Overall Study||10
2422224|NCT01216748|5941550|P1|Hypocapnic Hyperventilation|Overall Study||10
2422225|NCT01216748|5941550|P1|Quiet Breathing|Overall Study||10
2422226|NCT01216748|5941550|P1|STARTED|Overall Study||10
2422227|NCT01216735|5941557|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
2422228|NCT01216735|5941558|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
2422229|NCT01216735|5941557|P2|COMPLETED|Second Intervention (3 Weeks)||7
2422230|NCT01216735|5941558|P1|COMPLETED|Second Intervention (3 Weeks)||8
2422231|NCT01216735|5941557|P2|STARTED|Second Intervention (3 Weeks)||7
2422232|NCT01216735|5941558|P1|STARTED|Second Intervention (3 Weeks)||8
2422233|NCT01216735|5941557|P2|NOT COMPLETED|Washout (3 Weeks)||0
2422234|NCT01216735|5941558|P1|NOT COMPLETED|Washout (3 Weeks)||0
2422235|NCT01216735|5941557|P2|COMPLETED|Washout (3 Weeks)||7
2422236|NCT01216735|5941558|P1|COMPLETED|Washout (3 Weeks)||8
2422237|NCT01216735|5941557|P2|STARTED|Washout (3 Weeks)||7
2422238|NCT01216735|5941558|P1|STARTED|Washout (3 Weeks)||8
2422239|NCT01216735|5941557|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
2422240|NCT01216735|5941558|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
2422241|NCT01216735|5941557|P2|COMPLETED|First Intervention (3 Weeks)||7
2422242|NCT01216735|5941558|P1|COMPLETED|First Intervention (3 Weeks)||8
2422243|NCT01216735|5941557|P2|STARTED|First Intervention (3 Weeks)||7
2422244|NCT01216735|5941558|P1|STARTED|First Intervention (3 Weeks)||8
2422245|NCT01216631|5941569|P3|NOT COMPLETED|Overall Study||0
2422246|NCT01216631|5941570|P2|NOT COMPLETED|Overall Study||0
2422247|NCT01216631|5941571|P1|NOT COMPLETED|Overall Study||0
2422248|NCT01216631|5941569|P3|COMPLETED|Overall Study||1
2422249|NCT01216631|5941570|P2|COMPLETED|Overall Study||0
2422250|NCT01216631|5941571|P1|COMPLETED|Overall Study||0
2422251|NCT01216631|5941569|P3|STARTED|Overall Study||1
2422252|NCT01216631|5941570|P2|STARTED|Overall Study||0
2422253|NCT01216631|5941571|P1|STARTED|Overall Study||0
2422254|NCT01216410|5941582|P3|NOT COMPLETED|Overall Study||3
2422255|NCT01216410|5941583|P2|NOT COMPLETED|Overall Study||1
2422256|NCT01216410|5941584|P1|NOT COMPLETED|Overall Study||2
2422257|NCT01216410|5941582|P3|COMPLETED|Overall Study||100
2422258|NCT01216410|5941583|P2|COMPLETED|Overall Study||99
2422259|NCT01216410|5941584|P1|COMPLETED|Overall Study||101
2422260|NCT01216410|5941582|P3|STARTED|Overall Study||103
2422261|NCT01216410|5941583|P2|STARTED|Overall Study||100
2422262|NCT01216410|5941584|P1|STARTED|Overall Study||103
2422263|NCT01216397|5941604|P2|NOT COMPLETED|Period 2||0
2422264|NCT01216397|5941605|P1|NOT COMPLETED|Period 2||0
2422265|NCT01216397|5941604|P2|COMPLETED|Period 2||20
2422266|NCT01216397|5941605|P1|COMPLETED|Period 2||20
2422267|NCT01216397|5941604|P2|STARTED|Period 2||20
2422268|NCT01216397|5941605|P1|STARTED|Period 2||20
2422269|NCT01216397|5941604|P2|NOT COMPLETED|Washout (35 Days)||0
2422270|NCT01216397|5941605|P1|NOT COMPLETED|Washout (35 Days)||0
2422271|NCT01216397|5941604|P2|COMPLETED|Washout (35 Days)||20
2422272|NCT01216397|5941605|P1|COMPLETED|Washout (35 Days)||20
2422273|NCT01216397|5941604|P2|STARTED|Washout (35 Days)||20
2422274|NCT01216397|5941605|P1|STARTED|Washout (35 Days)||20
2422275|NCT01216397|5941604|P2|NOT COMPLETED|Period 1||0
2422276|NCT01216397|5941605|P1|NOT COMPLETED|Period 1||0
2422277|NCT01216397|5941604|P2|COMPLETED|Period 1||20
2422278|NCT01216397|5941605|P1|COMPLETED|Period 1||20
2422279|NCT01216397|5941604|P2|STARTED|Period 1||20
2422280|NCT01216397|5941605|P1|STARTED|Period 1||20
2422281|NCT01216332|5941659|P2|NOT COMPLETED|Overall Study||0
2422282|NCT01216332|5941660|P1|NOT COMPLETED|Overall Study||4
2422283|NCT01216332|5941659|P2|COMPLETED|Overall Study||16
2422284|NCT01216332|5941660|P1|COMPLETED|Overall Study||30
2422285|NCT01216332|5941659|P2|STARTED|Overall Study||16
2422286|NCT01216332|5941660|P1|STARTED|Overall Study||34
2422287|NCT01216319|5941678|P1|NOT COMPLETED|Overall Study||4
2422288|NCT01216319|5941678|P1|COMPLETED|Overall Study||46
2422289|NCT01216319|5941678|P1|STARTED|Overall Study||50
2422290|NCT01216241|5941685|P2|NOT COMPLETED|Overall Study||0
2422291|NCT01216241|5941686|P1|NOT COMPLETED|Overall Study||0
2422292|NCT01216241|5941685|P2|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
2422293|NCT01216241|5941686|P1|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
2422294|NCT01216241|5941685|P2|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
2422295|NCT01216241|5941686|P1|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
2422296|NCT01216176|5941695|P3|NOT COMPLETED|Overall Study||1
2422297|NCT01216176|5941696|P2|NOT COMPLETED|Overall Study||8
2422298|NCT01216176|5941697|P1|NOT COMPLETED|Overall Study||0
2422299|NCT01216176|5941695|P3|COMPLETED|Overall Study||19
2422300|NCT01216176|5941696|P2|COMPLETED|Overall Study||31
2422301|NCT01216176|5941697|P1|COMPLETED|Overall Study||12
2422302|NCT01216176|5941695|P3|STARTED|Overall Study||20
2422303|NCT01216176|5941696|P2|STARTED|Overall Study||39
2422304|NCT01216176|5941697|P1|STARTED|Overall Study||12
2422305|NCT01216163|5941720|P3|NOT COMPLETED|Overall Study||0
2422306|NCT01216163|5941721|P2|NOT COMPLETED|Overall Study||1
2422307|NCT01216163|5941722|P1|NOT COMPLETED|Overall Study||1
2422308|NCT01216163|5941720|P3|COMPLETED|Overall Study||85
2422309|NCT01216163|5941721|P2|COMPLETED|Overall Study||87
2422310|NCT01216163|5941722|P1|COMPLETED|Overall Study||44
2422311|NCT01216163|5941720|P3|STARTED|Overall Study||85
2422312|NCT01216163|5941721|P2|STARTED|Overall Study||88
2422313|NCT01216163|5941722|P1|STARTED|Overall Study||45
2422314|NCT01216072|5941774|P2|NOT COMPLETED|Open-Label Extension Period (3 Months)||14
2422315|NCT01216072|5941775|P1|NOT COMPLETED|Open-Label Extension Period (3 Months)||0
2422316|NCT01216072|5941774|P2|COMPLETED|Open-Label Extension Period (3 Months)||181
2422317|NCT01216072|5941775|P1|COMPLETED|Open-Label Extension Period (3 Months)||0
2422318|NCT01216072|5941774|P2|Safety Set|Open-Label Extension Period (3 Months)||193
2422319|NCT01216072|5941775|P1|Safety Set|Open-Label Extension Period (3 Months)||0
2422320|NCT01216072|5941774|P2|STARTED|Open-Label Extension Period (3 Months)|Only DMT patients, who completed the core study, were eligible for fingolimod.|195
2422321|NCT01216072|5941775|P1|STARTED|Open-Label Extension Period (3 Months)||0
2422322|NCT01216072|5941774|P2|NOT COMPLETED|Open-Label Core Period ( 6 Months)||34
2422323|NCT01216072|5941775|P1|NOT COMPLETED|Open-Label Core Period ( 6 Months)||76
2422324|NCT01216072|5941774|P2|COMPLETED|Open-Label Core Period ( 6 Months)||229
2422325|NCT01216072|5941775|P1|COMPLETED|Open-Label Core Period ( 6 Months)||714
2422326|NCT01216072|5941774|P2|Safety Set|Open-Label Core Period ( 6 Months)||245
2422327|NCT01216072|5941775|P1|Safety Set|Open-Label Core Period ( 6 Months)||783
2422328|NCT01216072|5941774|P2|Full Analysis Set|Open-Label Core Period ( 6 Months)||263
2422329|NCT01216072|5941775|P1|Full Analysis Set|Open-Label Core Period ( 6 Months)|One patient was randomized in error and was not included in FAS.|789
2422330|NCT01216072|5941774|P2|STARTED|Open-Label Core Period ( 6 Months)||263
2422331|NCT01216072|5941775|P1|STARTED|Open-Label Core Period ( 6 Months)||790
2422332|NCT01215981|5941803|P2|NOT COMPLETED|Overall Study||1
2422333|NCT01215981|5941804|P1|NOT COMPLETED|Overall Study||2
2422334|NCT01215981|5941803|P2|COMPLETED|Overall Study||32
2422335|NCT01215981|5941804|P1|COMPLETED|Overall Study||33
2422336|NCT01215981|5941803|P2|STARTED|Overall Study||33
2422337|NCT01215981|5941804|P1|STARTED|Overall Study||35
2422338|NCT01215968|5941814|P2|NOT COMPLETED|Overall Study||7
2422339|NCT01215968|5941815|P1|NOT COMPLETED|Overall Study||2
2422340|NCT01215968|5941814|P2|COMPLETED|Overall Study||18
2422341|NCT01215968|5941815|P1|COMPLETED|Overall Study||11
2422342|NCT01215968|5941814|P2|Received at Least 1 Dose of Study Drug|Overall Study|25 participants received placebo during Week 1.|24
2422343|NCT01215968|5941815|P1|Received at Least 1 Dose of Study Drug|Overall Study||13
2422344|NCT01215968|5941814|P2|STARTED|Overall Study||25
2422345|NCT01215968|5941815|P1|STARTED|Overall Study||13
2422346|NCT01215955|5941835|P4|NOT COMPLETED|Overall Study||53
2422347|NCT01215955|5941836|P3|NOT COMPLETED|Overall Study||48
2422348|NCT01215955|5941837|P2|NOT COMPLETED|Overall Study||53
2422349|NCT01215955|5941838|P1|NOT COMPLETED|Overall Study||45
2422350|NCT01215955|5941835|P4|COMPLETED|Overall Study||241
2422351|NCT01215955|5941836|P3|COMPLETED|Overall Study||244
2422352|NCT01215955|5941837|P2|COMPLETED|Overall Study||210
2422353|NCT01215955|5941838|P1|COMPLETED|Overall Study||223
2422354|NCT01215955|5941835|P4|Received at Least 1 Dose of Study Drug|Overall Study||290
2422355|NCT01215955|5941836|P3|Received at Least 1 Dose of Study Drug|Overall Study||288
2422356|NCT01215955|5941837|P2|Received at Least 1 Dose of Study Drug|Overall Study||261
2422357|NCT01215955|5941838|P1|Received at Least 1 Dose of Study Drug|Overall Study||267
2422358|NCT01215955|5941835|P4|STARTED|Overall Study|Two (2) participants from 1 site were excluded due to quality issues and validity of the data.|294
2422359|NCT01215955|5941836|P3|STARTED|Overall Study|Three (3) participants from 1 site were excluded due to quality issues and validity of data.|292
2422360|NCT01215955|5941837|P2|STARTED|Overall Study||263
2422361|NCT01215955|5941838|P1|STARTED|Overall Study||268
2422362|NCT01215942|5941906|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||146
2422363|NCT01215942|5941907|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||85
2422364|NCT01215942|5941906|P2|COMPLETED|Post-Treatment Follow-Up Period||445
2422365|NCT01215942|5941907|P1|COMPLETED|Post-Treatment Follow-Up Period||283
2422366|NCT01215942|5941906|P2|STARTED|Post-Treatment Follow-Up Period|Not all participants who discontinued treatment entered post-treatment follow-up period.|591
2422367|NCT01215942|5941907|P1|STARTED|Post-Treatment Follow-Up Period|Not all participants who discontinued treatment entered post-treatment follow-up period.|368
2422368|NCT01215942|5941906|P2|NOT COMPLETED|Treatment Period||672
2422369|NCT01215942|5941907|P1|NOT COMPLETED|Treatment Period||414
2422370|NCT01215942|5941906|P2|COMPLETED|Treatment Period||0
2422371|NCT01215942|5941907|P1|COMPLETED|Treatment Period||0
2422372|NCT01215942|5941906|P2|STARTED|Treatment Period|Participants who discontinued treatment were followed in post-treatment follow-up.|672
2422464|NCT01215734|5942147|P1|COMPLETED|Overall Study||29
2422373|NCT01215942|5941907|P1|STARTED|Treatment Period|Participants who discontinued treatment were followed in post-treatment follow-up.|414
2422374|NCT01215929|5942024|P2|NOT COMPLETED|Overall Study||5
2422375|NCT01215929|5942025|P1|NOT COMPLETED|Overall Study||6
2422376|NCT01215929|5942024|P2|COMPLETED|Overall Study||12
2422377|NCT01215929|5942025|P1|COMPLETED|Overall Study||12
2422378|NCT01215929|5942024|P2|STARTED|Overall Study||17
2422379|NCT01215929|5942025|P1|STARTED|Overall Study||18
2422380|NCT01215916|5942040|P9|NOT COMPLETED|Overall Study||2
2422381|NCT01215916|5942041|P8|NOT COMPLETED|Overall Study||3
2422382|NCT01215916|5942042|P7|NOT COMPLETED|Overall Study||9
2422383|NCT01215916|5942043|P6|NOT COMPLETED|Overall Study||4
2422384|NCT01215916|5942044|P5|NOT COMPLETED|Overall Study||6
2422385|NCT01215916|5942045|P4|NOT COMPLETED|Overall Study||6
2422386|NCT01215916|5942046|P3|NOT COMPLETED|Overall Study||3
2422387|NCT01215916|5942047|P2|NOT COMPLETED|Overall Study||5
2422388|NCT01215916|5942048|P1|NOT COMPLETED|Overall Study||1
2422389|NCT01215916|5942040|P9|COMPLETED|Overall Study||0
2422390|NCT01215916|5942041|P8|COMPLETED|Overall Study||0
2422391|NCT01215916|5942042|P7|COMPLETED|Overall Study||0
2422392|NCT01215916|5942043|P6|COMPLETED|Overall Study||0
2422393|NCT01215916|5942044|P5|COMPLETED|Overall Study||0
2422394|NCT01215916|5942045|P4|COMPLETED|Overall Study||0
2422395|NCT01215916|5942046|P3|COMPLETED|Overall Study||0
2422396|NCT01215916|5942047|P2|COMPLETED|Overall Study||0
2422397|NCT01215916|5942048|P1|COMPLETED|Overall Study||0
2422398|NCT01215916|5942040|P9|Received at Least 1 Dose of Either Drug|Overall Study||2
2422399|NCT01215916|5942041|P8|Received at Least 1 Dose of Either Drug|Overall Study||3
2422400|NCT01215916|5942042|P7|Received at Least 1 Dose of Either Drug|Overall Study||9
2422401|NCT01215916|5942043|P6|Received at Least 1 Dose of Either Drug|Overall Study||4
2422402|NCT01215916|5942044|P5|Received at Least 1 Dose of Either Drug|Overall Study||6
2422403|NCT01215916|5942045|P4|Received at Least 1 Dose of Either Drug|Overall Study||6
2422404|NCT01215916|5942046|P3|Received at Least 1 Dose of Either Drug|Overall Study||3
2422405|NCT01215916|5942047|P2|Received at Least 1 Dose of Either Drug|Overall Study||5
2422406|NCT01215916|5942048|P1|Received at Least 1 Dose of Either Drug|Overall Study||1
2422407|NCT01215916|5942040|P9|STARTED|Overall Study||2
2422408|NCT01215916|5942041|P8|STARTED|Overall Study||3
2422409|NCT01215916|5942042|P7|STARTED|Overall Study||9
2422410|NCT01215916|5942043|P6|STARTED|Overall Study||4
2422411|NCT01215916|5942044|P5|STARTED|Overall Study||6
2422412|NCT01215916|5942045|P4|STARTED|Overall Study||6
2422413|NCT01215916|5942046|P3|STARTED|Overall Study||3
2422414|NCT01215916|5942047|P2|STARTED|Overall Study||5
2422415|NCT01215916|5942048|P1|STARTED|Overall Study||1
2422416|NCT01215851|5942082|P6|NOT COMPLETED|Follow up Period||1
2422417|NCT01215851|5942083|P5|NOT COMPLETED|Follow up Period||0
2422418|NCT01215851|5942084|P4|NOT COMPLETED|Follow up Period||0
2422419|NCT01215851|5942085|P3|NOT COMPLETED|Follow up Period||0
2422420|NCT01215851|5942086|P2|NOT COMPLETED|Follow up Period||0
2422421|NCT01215851|5942087|P1|NOT COMPLETED|Follow up Period||0
2422422|NCT01215851|5942082|P6|COMPLETED|Follow up Period||13
2422423|NCT01215851|5942083|P5|COMPLETED|Follow up Period||10
2422424|NCT01215851|5942084|P4|COMPLETED|Follow up Period||12
2422425|NCT01215851|5942085|P3|COMPLETED|Follow up Period||14
2422426|NCT01215851|5942086|P2|COMPLETED|Follow up Period||14
2422427|NCT01215851|5942087|P1|COMPLETED|Follow up Period||14
2422428|NCT01215851|5942082|P6|STARTED|Follow up Period||14
2422429|NCT01215851|5942083|P5|STARTED|Follow up Period||10
2422430|NCT01215851|5942084|P4|STARTED|Follow up Period||12
2422431|NCT01215851|5942085|P3|STARTED|Follow up Period||14
2422432|NCT01215851|5942086|P2|STARTED|Follow up Period||14
2422433|NCT01215851|5942087|P1|STARTED|Follow up Period||14
2422434|NCT01215851|5942082|P6|NOT COMPLETED|Treatment Period||1
2422435|NCT01215851|5942083|P5|NOT COMPLETED|Treatment Period||0
2422436|NCT01215851|5942084|P4|NOT COMPLETED|Treatment Period||3
2422437|NCT01215851|5942085|P3|NOT COMPLETED|Treatment Period||1
2422438|NCT01215851|5942086|P2|NOT COMPLETED|Treatment Period||1
2422439|NCT01215851|5942087|P1|NOT COMPLETED|Treatment Period||1
2422440|NCT01215851|5942082|P6|COMPLETED|Treatment Period||14
2422441|NCT01215851|5942083|P5|COMPLETED|Treatment Period||10
2422442|NCT01215851|5942084|P4|COMPLETED|Treatment Period||12
2422443|NCT01215851|5942085|P3|COMPLETED|Treatment Period||14
2422444|NCT01215851|5942086|P2|COMPLETED|Treatment Period||14
2422445|NCT01215851|5942087|P1|COMPLETED|Treatment Period||14
2422446|NCT01215851|5942082|P6|STARTED|Treatment Period||15
2422447|NCT01215851|5942083|P5|STARTED|Treatment Period||10
2422448|NCT01215851|5942084|P4|STARTED|Treatment Period||15
2422449|NCT01215851|5942085|P3|STARTED|Treatment Period||15
2422450|NCT01215851|5942086|P2|STARTED|Treatment Period||15
2422451|NCT01215851|5942087|P1|STARTED|Treatment Period||15
2422452|NCT01215786|5942128|P3|NOT COMPLETED|Overall Study||0
2422453|NCT01215786|5942129|P2|NOT COMPLETED|Overall Study||0
2422454|NCT01215786|5942130|P1|NOT COMPLETED|Overall Study||0
2422455|NCT01215786|5942128|P3|COMPLETED|Overall Study||10
2422456|NCT01215786|5942129|P2|COMPLETED|Overall Study||19
2422457|NCT01215786|5942130|P1|COMPLETED|Overall Study||21
2422458|NCT01215786|5942128|P3|STARTED|Overall Study||10
2422459|NCT01215786|5942129|P2|STARTED|Overall Study||19
2422460|NCT01215786|5942130|P1|STARTED|Overall Study||21
2422461|NCT01215734|5942146|P2|NOT COMPLETED|Overall Study||1
2422462|NCT01215734|5942147|P1|NOT COMPLETED|Overall Study||0
2422463|NCT01215734|5942146|P2|COMPLETED|Overall Study||14
2422465|NCT01215734|5942146|P2|STARTED|Overall Study||15
2422466|NCT01215734|5942147|P1|STARTED|Overall Study||29
2422467|NCT01215721|5942155|P1|NOT COMPLETED|Overall Study||2
2422468|NCT01215721|5942155|P1|COMPLETED|Overall Study||38
2422469|NCT01215721|5942155|P1|STARTED|Overall Study||40
2422470|NCT01215695|5942161|P2|NOT COMPLETED|Overall Study||0
2422471|NCT01215695|5942162|P1|NOT COMPLETED|Overall Study||0
2422472|NCT01215695|5942161|P2|COMPLETED|Overall Study||70
2422473|NCT01215695|5942162|P1|COMPLETED|Overall Study||70
2422474|NCT01215695|5942161|P2|STARTED|Overall Study||70
2422475|NCT01215695|5942162|P1|STARTED|Overall Study||70
2422476|NCT01215643|5942181|P5|NOT COMPLETED|Overall Study||11
2422477|NCT01215643|5942182|P4|NOT COMPLETED|Overall Study||4
2422478|NCT01215643|5942183|P3|NOT COMPLETED|Overall Study||12
2422479|NCT01215643|5942184|P2|NOT COMPLETED|Overall Study||4
2422480|NCT01215643|5942185|P1|NOT COMPLETED|Overall Study||9
2422481|NCT01215643|5942181|P5|COMPLETED|Overall Study||29
2422482|NCT01215643|5942182|P4|COMPLETED|Overall Study||35
2422483|NCT01215643|5942183|P3|COMPLETED|Overall Study||82
2422484|NCT01215643|5942184|P2|COMPLETED|Overall Study||80
2422485|NCT01215643|5942185|P1|COMPLETED|Overall Study||74
2422486|NCT01215643|5942181|P5|STARTED|Overall Study||40
2422487|NCT01215643|5942182|P4|STARTED|Overall Study||39
2422488|NCT01215643|5942183|P3|STARTED|Overall Study||94
2422489|NCT01215643|5942184|P2|STARTED|Overall Study||84
2422490|NCT01215643|5942185|P1|STARTED|Overall Study||83
2422491|NCT01215513|5942287|P1|NOT COMPLETED|Overall Study||45
2422492|NCT01215513|5942287|P1|COMPLETED|Overall Study||112
2422493|NCT01215513|5942287|P1|CS42A Safety Analysis Set|Overall Study|127 participants were enrolled in the extension study CS42A|127
2422494|NCT01215513|5942287|P1|CS42 and CS42A Full Analysis Set|Overall Study|155 participants received at least 1 dose of degarelix and had at least 1 efficacy assessment|155
2422495|NCT01215513|5942287|P1|CS42 and CS42A Safety Analysis Set|Overall Study|156 participants received at least 1 dose of degarelix|156
2422496|NCT01215513|5942287|P1|STARTED|Overall Study|157 participants were allocated to treatment in CS42 main study (Intent-to-treat analysis set)|157
2422497|NCT01215435|5942296|P2|NOT COMPLETED|Overall Study||16
2422498|NCT01215435|5942297|P1|NOT COMPLETED|Overall Study||19
2422499|NCT01215435|5942296|P2|COMPLETED|Overall Study||107
2422500|NCT01215435|5942297|P1|COMPLETED|Overall Study||103
2422501|NCT01215435|5942296|P2|STARTED|Overall Study||123
2422502|NCT01215435|5942297|P1|STARTED|Overall Study||122
2422503|NCT01215422|5942311|P4|NOT COMPLETED|Overall Study||8
2422504|NCT01215422|5942312|P3|NOT COMPLETED|Overall Study||3
2422505|NCT01215422|5942313|P2|NOT COMPLETED|Overall Study||0
2422506|NCT01215422|5942314|P1|NOT COMPLETED|Overall Study||8
2422507|NCT01215422|5942311|P4|COMPLETED|Overall Study||193
2422508|NCT01215422|5942312|P3|COMPLETED|Overall Study||193
2422509|NCT01215422|5942313|P2|COMPLETED|Overall Study||249
2422510|NCT01215422|5942314|P1|COMPLETED|Overall Study||6
2422511|NCT01215422|5942311|P4|STARTED|Overall Study||201
2422512|NCT01215422|5942312|P3|STARTED|Overall Study||196
2422513|NCT01215422|5942313|P2|STARTED|Overall Study||249
2422514|NCT01215422|5942314|P1|STARTED|Overall Study||14
2422515|NCT01215357|5942336|P1|NOT COMPLETED|Overall Study||12
2422516|NCT01215357|5942336|P1|COMPLETED|Overall Study||22
2422517|NCT01215357|5942336|P1|STARTED|Overall Study||34
2422518|NCT01215344|5942342|P2|NOT COMPLETED|Overall Study||0
2422519|NCT01215344|5942343|P1|NOT COMPLETED|Overall Study||10
2422520|NCT01215344|5942342|P2|COMPLETED|Overall Study||3
2422521|NCT01215344|5942343|P1|COMPLETED|Overall Study||23
2422522|NCT01215344|5942342|P2|STARTED|Overall Study||3
2422523|NCT01215344|5942343|P1|STARTED|Overall Study||33
2422524|NCT01215318|5942353|P2|NOT COMPLETED|Overall Study||0
2422525|NCT01215318|5942354|P1|NOT COMPLETED|Overall Study||0
2422526|NCT01215318|5942353|P2|COMPLETED|Overall Study||24
2422527|NCT01215318|5942354|P1|COMPLETED|Overall Study||20
2422528|NCT01215318|5942353|P2|STARTED|Overall Study||24
2422529|NCT01215318|5942354|P1|STARTED|Overall Study||20
2422530|NCT01215292|5942367|P5|NOT COMPLETED|Overall Study||0
2422531|NCT01215292|5942368|P4|NOT COMPLETED|Overall Study||0
2422532|NCT01215292|5942369|P3|NOT COMPLETED|Overall Study||0
2422533|NCT01215292|5942370|P2|NOT COMPLETED|Overall Study||0
2422534|NCT01215292|5942371|P1|NOT COMPLETED|Overall Study||0
2422535|NCT01215292|5942367|P5|COMPLETED|Overall Study||8
2422536|NCT01215292|5942368|P4|COMPLETED|Overall Study||8
2422537|NCT01215292|5942369|P3|COMPLETED|Overall Study||8
2422538|NCT01215292|5942370|P2|COMPLETED|Overall Study||8
2422539|NCT01215292|5942371|P1|COMPLETED|Overall Study||8
2422540|NCT01215292|5942367|P5|STARTED|Overall Study||8
2422541|NCT01215292|5942368|P4|STARTED|Overall Study||8
2422542|NCT01215292|5942369|P3|STARTED|Overall Study||8
2422543|NCT01215292|5942370|P2|STARTED|Overall Study||8
2422544|NCT01215292|5942371|P1|STARTED|Overall Study||8
2422545|NCT01215279|5942395|P2|NOT COMPLETED|Overall Study||0
2422546|NCT01215279|5942396|P1|NOT COMPLETED|Overall Study||0
2422547|NCT01215279|5942395|P2|COMPLETED|Overall Study||32
2422548|NCT01215279|5942396|P1|COMPLETED|Overall Study||31
2422549|NCT01215279|5942395|P2|STARTED|Overall Study||32
2422550|NCT01215279|5942396|P1|STARTED|Overall Study||31
2422551|NCT01215253|5942462|P2|NOT COMPLETED|Overall Study||63
2422552|NCT01215253|5942463|P1|NOT COMPLETED|Overall Study||86
2422553|NCT01215253|5942462|P2|COMPLETED|Overall Study||439
2422554|NCT01215253|5942463|P1|COMPLETED|Overall Study||424
2422555|NCT01215253|5942462|P2|STARTED|Overall Study||502
2422556|NCT01215253|5942463|P1|STARTED|Overall Study||510
2422557|NCT01215240|5942493|P2|NOT COMPLETED|Overall Study||0
2422558|NCT01215240|5942494|P1|NOT COMPLETED|Overall Study||0
2422559|NCT01215240|5942493|P2|COMPLETED|Overall Study||12
2422560|NCT01215240|5942494|P1|COMPLETED|Overall Study||10
2422561|NCT01215240|5942493|P2|STARTED|Overall Study||12
2422562|NCT01215240|5942494|P1|STARTED|Overall Study||10
2422563|NCT01215227|5942516|P6|NOT COMPLETED|Overall Study||58
2422564|NCT01215227|5942517|P5|NOT COMPLETED|Overall Study||48
2422565|NCT01215227|5942518|P4|NOT COMPLETED|Overall Study||49
2422566|NCT01215227|5942519|P3|NOT COMPLETED|Overall Study||57
2422567|NCT01215227|5942520|P2|NOT COMPLETED|Overall Study||119
2422568|NCT01215227|5942521|P1|NOT COMPLETED|Overall Study||121
2422569|NCT01215227|5942516|P6|COMPLETED|Overall Study||51
2422570|NCT01215227|5942517|P5|COMPLETED|Overall Study||45
2422571|NCT01215227|5942518|P4|COMPLETED|Overall Study||48
2422572|NCT01215227|5942519|P3|COMPLETED|Overall Study||50
2422573|NCT01215227|5942520|P2|COMPLETED|Overall Study||96
2422574|NCT01215227|5942521|P1|COMPLETED|Overall Study||97
2422575|NCT01215227|5942516|P6|Treated|Overall Study||108
2422576|NCT01215227|5942517|P5|Treated|Overall Study||93
2422577|NCT01215227|5942518|P4|Treated|Overall Study||96
2422578|NCT01215227|5942519|P3|Treated|Overall Study||106
2422579|NCT01215227|5942520|P2|Treated|Overall Study||215
2422580|NCT01215227|5942521|P1|Treated|Overall Study||218
2422581|NCT01215227|5942516|P6|STARTED|Overall Study||109
2422582|NCT01215227|5942517|P5|STARTED|Overall Study||93
2422583|NCT01215227|5942518|P4|STARTED|Overall Study||97
2422584|NCT01215227|5942519|P3|STARTED|Overall Study||107
2422585|NCT01215227|5942520|P2|STARTED|Overall Study||215
2422586|NCT01215227|5942521|P1|STARTED|Overall Study||218
2422587|NCT01215188|5942568|P3|NOT COMPLETED|Overall Study||52
2422588|NCT01215188|5942569|P2|NOT COMPLETED|Overall Study||59
2422589|NCT01215188|5942570|P1|NOT COMPLETED|Overall Study||58
2422590|NCT01215188|5942568|P3|COMPLETED|Overall Study||326
2422591|NCT01215188|5942569|P2|COMPLETED|Overall Study||327
2422592|NCT01215188|5942570|P1|COMPLETED|Overall Study||320
2422593|NCT01215188|5942568|P3|STARTED|Overall Study||378
2422594|NCT01215188|5942569|P2|STARTED|Overall Study||386
2422595|NCT01215188|5942570|P1|STARTED|Overall Study||378
2422596|NCT01215175|5942622|P5|NOT COMPLETED|Overall Study||0
2422597|NCT01215175|5942623|P4|NOT COMPLETED|Overall Study||1
2422598|NCT01215175|5942624|P3|NOT COMPLETED|Overall Study||0
2422599|NCT01215175|5942625|P2|NOT COMPLETED|Overall Study||1
2422600|NCT01215175|5942626|P1|NOT COMPLETED|Overall Study||0
2422601|NCT01215175|5942622|P5|COMPLETED|Overall Study||28
2422602|NCT01215175|5942623|P4|COMPLETED|Overall Study||28
2422603|NCT01215175|5942624|P3|COMPLETED|Overall Study||33
2422604|NCT01215175|5942625|P2|COMPLETED|Overall Study||29
2422605|NCT01215175|5942626|P1|COMPLETED|Overall Study||30
2422606|NCT01215175|5942622|P5|Treated|Overall Study||28
2422607|NCT01215175|5942623|P4|Treated|Overall Study||29
2422608|NCT01215175|5942624|P3|Treated|Overall Study||33
2422609|NCT01215175|5942625|P2|Treated|Overall Study||30
2422610|NCT01215175|5942626|P1|Treated|Overall Study||30
2422611|NCT01215175|5942622|P5|STARTED|Overall Study||28
2422612|NCT01215175|5942623|P4|STARTED|Overall Study||29
2422613|NCT01215175|5942624|P3|STARTED|Overall Study||33
2422614|NCT01215175|5942625|P2|STARTED|Overall Study||30
2422615|NCT01215175|5942626|P1|STARTED|Overall Study||30
2422616|NCT01215123|5942668|P1|NOT COMPLETED|Overall Study||0
2422617|NCT01215123|5942668|P1|COMPLETED|Overall Study||28
2422618|NCT01215123|5942668|P1|STARTED|Overall Study||28
2422619|NCT01215110|5942678|P5|NOT COMPLETED|Overall Study||0
2422620|NCT01215110|5942679|P4|NOT COMPLETED|Overall Study||1
2422621|NCT01215110|5942680|P3|NOT COMPLETED|Overall Study||2
2422622|NCT01215110|5942681|P2|NOT COMPLETED|Overall Study||0
2422623|NCT01215110|5942682|P1|NOT COMPLETED|Overall Study||0
2422624|NCT01215110|5942678|P5|COMPLETED|Overall Study||8
2422625|NCT01215110|5942679|P4|COMPLETED|Overall Study||14
2422626|NCT01215110|5942680|P3|COMPLETED|Overall Study||13
2422627|NCT01215110|5942681|P2|COMPLETED|Overall Study||15
2422628|NCT01215110|5942682|P1|COMPLETED|Overall Study||15
2422629|NCT01215110|5942678|P5|STARTED|Overall Study||8
2422630|NCT01215110|5942679|P4|STARTED|Overall Study||15
2422631|NCT01215110|5942680|P3|STARTED|Overall Study||15
2422632|NCT01215110|5942681|P2|STARTED|Overall Study||15
2422633|NCT01215110|5942682|P1|STARTED|Overall Study||15
2422634|NCT01215097|5942743|P2|NOT COMPLETED|Overall Study||14
2422635|NCT01215097|5942744|P1|NOT COMPLETED|Overall Study||12
2422636|NCT01215097|5942743|P2|COMPLETED|Overall Study||191
2422637|NCT01215097|5942744|P1|COMPLETED|Overall Study||88
2422638|NCT01215097|5942743|P2|STARTED|Overall Study|Patients who are randomised and treated with linagliptin.|205
2422639|NCT01215097|5942744|P1|STARTED|Overall Study|Patients who are randomised and treated with placebo. 1 patient was not treated then not included.|100
2422640|NCT01215032|5942776|P1|NOT COMPLETED|Overall Study||20
2422641|NCT01215032|5942776|P1|COMPLETED|Overall Study||1
2422642|NCT01215032|5942776|P1|STARTED|Overall Study||21
2422643|NCT01214980|5942786|P2|NOT COMPLETED|Overall Study||2
2422644|NCT01214980|5942787|P1|NOT COMPLETED|Overall Study||3
2422645|NCT01214980|5942786|P2|COMPLETED|Overall Study||14
2422646|NCT01214980|5942787|P1|COMPLETED|Overall Study||13
2422647|NCT01214980|5942786|P2|STARTED|Overall Study||16
2422648|NCT01214980|5942787|P1|STARTED|Overall Study||16
2422649|NCT01214915|5942801|P1|NOT COMPLETED|Overall Study||11
2422650|NCT01214915|5942801|P1|COMPLETED|Overall Study||42
2422651|NCT01214915|5942801|P1|STARTED|Overall Study||53
2422652|NCT01214850|5942812|P3|NOT COMPLETED|Overall Study||161
2422653|NCT01214850|5942813|P2|NOT COMPLETED|Overall Study||144
2422654|NCT01214850|5942814|P1|NOT COMPLETED|Overall Study||183
2422655|NCT01214850|5942812|P3|COMPLETED|Overall Study||826
2422656|NCT01214850|5942813|P2|COMPLETED|Overall Study||844
2422657|NCT01214850|5942814|P1|COMPLETED|Overall Study||796
2422658|NCT01214850|5942812|P3|STARTED|Overall Study||987
2422659|NCT01214850|5942813|P2|STARTED|Overall Study||988
2422660|NCT01214850|5942814|P1|STARTED|Overall Study||979
2422661|NCT01214837|5942898|P3|NOT COMPLETED|Overall Study||62
2422662|NCT01214837|5942899|P2|NOT COMPLETED|Overall Study||64
2422663|NCT01214837|5942900|P1|NOT COMPLETED|Overall Study||54
2422664|NCT01214837|5942898|P3|COMPLETED|Overall Study||184
2422665|NCT01214837|5942899|P2|COMPLETED|Overall Study||192
2422666|NCT01214837|5942900|P1|COMPLETED|Overall Study||195
2422667|NCT01214837|5942898|P3|STARTED|Overall Study||246
2422668|NCT01214837|5942899|P2|STARTED|Overall Study||256
2422669|NCT01214837|5942900|P1|STARTED|Overall Study||249
2422670|NCT01214824|5942937|P1|NOT COMPLETED|Overall Study||3
2422671|NCT01214824|5942937|P1|COMPLETED|Overall Study||29
2422672|NCT01214824|5942937|P1|STARTED|Overall Study||32
2422673|NCT01214811|5942944|P1|NOT COMPLETED|Overall Study||3
2422674|NCT01214811|5942944|P1|COMPLETED|Overall Study||24
2422675|NCT01214811|5942944|P1|STARTED|Overall Study||27
2422676|NCT01214759|5942948|P1|NOT COMPLETED|Overall Study||48
2422677|NCT01214759|5942948|P1|COMPLETED|Overall Study||55
2422678|NCT01214759|5942948|P1|28 Days nPEP Completion|Overall Study||85
2422679|NCT01214759|5942948|P1|STARTED|Overall Study||103
2422680|NCT01214720|5942956|P2|NOT COMPLETED|Overall Study||68
2422681|NCT01214720|5942957|P1|NOT COMPLETED|Overall Study||85
2422682|NCT01214720|5942956|P2|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|233
2422683|NCT01214720|5942957|P1|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|221
2422684|NCT01214720|5942956|P2|STARTED|Overall Study||301
2422685|NCT01214720|5942957|P1|STARTED|Overall Study||306
2422686|NCT01214668|5942980|P6|NOT COMPLETED|Overall Study||6
2422687|NCT01214668|5942981|P5|NOT COMPLETED|Overall Study||6
2422688|NCT01214668|5942982|P4|NOT COMPLETED|Overall Study||6
2422689|NCT01214668|5942983|P3|NOT COMPLETED|Overall Study||6
2422690|NCT01214668|5942984|P2|NOT COMPLETED|Overall Study||3
2422691|NCT01214668|5942985|P1|NOT COMPLETED|Overall Study||4
2422692|NCT01214668|5942980|P6|COMPLETED|Overall Study||0
2422693|NCT01214668|5942981|P5|COMPLETED|Overall Study||0
2422694|NCT01214668|5942982|P4|COMPLETED|Overall Study||0
2422695|NCT01214668|5942983|P3|COMPLETED|Overall Study||0
2422696|NCT01214668|5942984|P2|COMPLETED|Overall Study||0
2422697|NCT01214668|5942985|P1|COMPLETED|Overall Study||0
2422698|NCT01214668|5942980|P6|Received at Least One Dose of Study Drug|Overall Study||6
2422699|NCT01214668|5942981|P5|Received at Least One Dose of Study Drug|Overall Study||6
2422700|NCT01214668|5942982|P4|Received at Least One Dose of Study Drug|Overall Study||6
2422701|NCT01214668|5942983|P3|Received at Least One Dose of Study Drug|Overall Study||6
2422702|NCT01214668|5942984|P2|Received at Least One Dose of Study Drug|Overall Study||3
2422703|NCT01214668|5942985|P1|Received at Least One Dose of Study Drug|Overall Study||4
2422704|NCT01214668|5942980|P6|STARTED|Overall Study||6
2422705|NCT01214668|5942981|P5|STARTED|Overall Study||6
2422706|NCT01214668|5942982|P4|STARTED|Overall Study||6
2422707|NCT01214668|5942983|P3|STARTED|Overall Study||6
2422708|NCT01214668|5942984|P2|STARTED|Overall Study||3
2422709|NCT01214668|5942985|P1|STARTED|Overall Study||4
2422710|NCT01214655|5943022|P3|NOT COMPLETED|Part C||7
2422711|NCT01214655|5943023|P2|NOT COMPLETED|Part C||0
2422712|NCT01214655|5943024|P1|NOT COMPLETED|Part C||0
2422713|NCT01214655|5943022|P3|COMPLETED|Part C||1
2422714|NCT01214655|5943023|P2|COMPLETED|Part C||0
2422715|NCT01214655|5943024|P1|COMPLETED|Part C||0
2422716|NCT01214655|5943022|P3|Received at Least 1 Dose of 5 mg/m²/Day|Part C||8
2422717|NCT01214655|5943023|P2|Received at Least 1 Dose of 5 mg/m²/Day|Part C||0
2422718|NCT01214655|5943024|P1|Received at Least 1 Dose of 5 mg/m²/Day|Part C||0
2422719|NCT01214655|5943022|P3|STARTED|Part C|Total on Schedule C, dose days 1,2,3|8
2422720|NCT01214655|5943023|P2|STARTED|Part C||0
2422721|NCT01214655|5943024|P1|STARTED|Part C||0
2422722|NCT01214655|5943022|P3|NOT COMPLETED|Part B||0
2422723|NCT01214655|5943023|P2|NOT COMPLETED|Part B||13
2422724|NCT01214655|5943024|P1|NOT COMPLETED|Part B||0
2422725|NCT01214655|5943022|P3|COMPLETED|Part B||0
2422726|NCT01214655|5943023|P2|COMPLETED|Part B||2
2422727|NCT01214655|5943024|P1|COMPLETED|Part B||0
2422728|NCT01214655|5943022|P3|Joined 14 mg/m²/Day|Part B||0
2422729|NCT01214655|5943023|P2|Joined 14 mg/m²/Day|Part B||3
2422730|NCT01214655|5943024|P1|Joined 14 mg/m²/Day|Part B||0
2422731|NCT01214655|5943022|P3|Escalated From 12 to 14 mg/m²/Day|Part B||0
2422732|NCT01214655|5943023|P2|Escalated From 12 to 14 mg/m²/Day|Part B||1
2422733|NCT01214655|5943024|P1|Escalated From 12 to 14 mg/m²/Day|Part B||0
2422734|NCT01214655|5943022|P3|Joined 12 mg/m²/Day|Part B||0
2422735|NCT01214655|5943023|P2|Joined 12 mg/m²/Day|Part B||5
2422736|NCT01214655|5943024|P1|Joined 12 mg/m²/Day|Part B||0
2422737|NCT01214655|5943022|P3|Escalated to 12 mg/m²/Day|Part B||0
2422738|NCT01214655|5943023|P2|Escalated to 12 mg/m²/Day|Part B||2
2422739|NCT01214655|5943024|P1|Escalated to 12 mg/m²/Day|Part B||0
2422740|NCT01214655|5943022|P3|Joined 10 mg/m²/Day Study D|Part B||0
2422741|NCT01214655|5943023|P2|Joined 10 mg/m²/Day Study D|Part B||3
2422742|NCT01214655|5943024|P1|Joined 10 mg/m²/Day Study D|Part B||0
2422743|NCT01214655|5943022|P3|Escalated From 8 to 10 mg/m²/Day|Part B||0
2422744|NCT01214655|5943023|P2|Escalated From 8 to 10 mg/m²/Day|Part B||2
2422745|NCT01214655|5943024|P1|Escalated From 8 to 10 mg/m²/Day|Part B||0
2422746|NCT01214655|5943022|P3|Recieved 8 mg/m²/Day Study Drug|Part B||0
2422747|NCT01214655|5943023|P2|Recieved 8 mg/m²/Day Study Drug|Part B||4
2422748|NCT01214655|5943024|P1|Recieved 8 mg/m²/Day Study Drug|Part B||0
2422749|NCT01214655|5943022|P3|Received at Least 1 Dose of Study Drug|Part B||0
2422750|NCT01214655|5943023|P2|Received at Least 1 Dose of Study Drug|Part B||15
2422751|NCT01214655|5943024|P1|Received at Least 1 Dose of Study Drug|Part B||0
2422752|NCT01214655|5943022|P3|STARTED|Part B||0
2422753|NCT01214655|5943023|P2|STARTED|Part B|Total on Schedule B, dose days 1,5,9|15
2422754|NCT01214655|5943024|P1|STARTED|Part B|Part A participants did not enroll in Part B. Participants in A, B, C are considered Cohorts.|0
2422755|NCT01214655|5943022|P3|NOT COMPLETED|Part A||0
2422756|NCT01214655|5943023|P2|NOT COMPLETED|Part A||0
2422757|NCT01214655|5943024|P1|NOT COMPLETED|Part A||8
2422758|NCT01214655|5943022|P3|COMPLETED|Part A||0
2422759|NCT01214655|5943023|P2|COMPLETED|Part A||0
2422760|NCT01214655|5943024|P1|COMPLETED|Part A||2
2422761|NCT01214655|5943022|P3|Received 6 mg Study Drug|Part A||0
2422762|NCT01214655|5943023|P2|Received 6 mg Study Drug|Part A||0
2422763|NCT01214655|5943024|P1|Received 6 mg Study Drug|Part A||5
2422764|NCT01214655|5943022|P3|Joined 6 mg Group|Part A||0
2422765|NCT01214655|5943023|P2|Joined 6 mg Group|Part A||0
2422766|NCT01214655|5943024|P1|Joined 6 mg Group|Part A||4
2422767|NCT01214655|5943022|P3|Escalated From 5 mg Study Drug|Part A||0
2422768|NCT01214655|5943023|P2|Escalated From 5 mg Study Drug|Part A||0
2422769|NCT01214655|5943024|P1|Escalated From 5 mg Study Drug|Part A||1
2422770|NCT01214655|5943022|P3|Joined 5 mg Study Drug|Part A||0
2422771|NCT01214655|5943023|P2|Joined 5 mg Study Drug|Part A||0
2422772|NCT01214655|5943024|P1|Joined 5 mg Study Drug|Part A||2
2422773|NCT01214655|5943022|P3|Escalated From 4 mg Study Drug|Part A||0
2422774|NCT01214655|5943023|P2|Escalated From 4 mg Study Drug|Part A||0
2422775|NCT01214655|5943024|P1|Escalated From 4 mg Study Drug|Part A||0
2422776|NCT01214655|5943022|P3|Joined 4 mg Group|Part A||0
2422777|NCT01214655|5943023|P2|Joined 4 mg Group|Part A||0
2422778|NCT01214655|5943024|P1|Joined 4 mg Group|Part A||1
2422779|NCT01214655|5943022|P3|Escalated From 2 to 4 mg/m²/Day|Part A||0
2422780|NCT01214655|5943023|P2|Escalated From 2 to 4 mg/m²/Day|Part A||0
2422781|NCT01214655|5943024|P1|Escalated From 2 to 4 mg/m²/Day|Part A||3
2422782|NCT01214655|5943022|P3|Received 2 mg Study Drug|Part A||0
2422783|NCT01214655|5943023|P2|Received 2 mg Study Drug|Part A||0
2422784|NCT01214655|5943024|P1|Received 2 mg Study Drug|Part A||3
2422785|NCT01214655|5943022|P3|STARTED|Part A||0
2422786|NCT01214655|5943023|P2|STARTED|Part A||0
2422787|NCT01214655|5943024|P1|STARTED|Part A|Total on Schedule A, dose days 1,2,3|10
2422788|NCT01214642|5943097|P12|NOT COMPLETED|Overall Study||6
2422789|NCT01214642|5943098|P11|NOT COMPLETED|Overall Study||4
2422790|NCT01214642|5943099|P10|NOT COMPLETED|Overall Study||4
2422791|NCT01214642|5943100|P9|NOT COMPLETED|Overall Study||13
2422792|NCT01214642|5943101|P8|NOT COMPLETED|Overall Study||3
2422793|NCT01214642|5943102|P7|NOT COMPLETED|Overall Study||6
2422794|NCT01214642|5943103|P6|NOT COMPLETED|Overall Study||3
2422795|NCT01214642|5943104|P5|NOT COMPLETED|Overall Study||6
2422796|NCT01214642|5943105|P4|NOT COMPLETED|Overall Study||6
2422797|NCT01214642|5943106|P3|NOT COMPLETED|Overall Study||6
2422798|NCT01214642|5943107|P2|NOT COMPLETED|Overall Study||3
2422799|NCT01214642|5943108|P1|NOT COMPLETED|Overall Study||3
2422800|NCT01214642|5943097|P12|COMPLETED|Overall Study||0
2422801|NCT01214642|5943098|P11|COMPLETED|Overall Study||0
2422802|NCT01214642|5943099|P10|COMPLETED|Overall Study||0
2422803|NCT01214642|5943100|P9|COMPLETED|Overall Study||0
2422804|NCT01214642|5943101|P8|COMPLETED|Overall Study||0
2422805|NCT01214642|5943102|P7|COMPLETED|Overall Study||0
2422806|NCT01214642|5943103|P6|COMPLETED|Overall Study||0
2422807|NCT01214642|5943104|P5|COMPLETED|Overall Study||0
2422808|NCT01214642|5943105|P4|COMPLETED|Overall Study||0
2422809|NCT01214642|5943106|P3|COMPLETED|Overall Study||0
2422810|NCT01214642|5943107|P2|COMPLETED|Overall Study||0
2422811|NCT01214642|5943108|P1|COMPLETED|Overall Study||0
2422812|NCT01214642|5943097|P12|Complete at Least 2 Cycles of Study Drug|Overall Study||5
2422813|NCT01214642|5943098|P11|Complete at Least 2 Cycles of Study Drug|Overall Study||2
2422814|NCT01214642|5943099|P10|Complete at Least 2 Cycles of Study Drug|Overall Study||2
2422815|NCT01214642|5943100|P9|Complete at Least 2 Cycles of Study Drug|Overall Study||12
2422816|NCT01214642|5943101|P8|Complete at Least 2 Cycles of Study Drug|Overall Study||3
2422817|NCT01214642|5943102|P7|Complete at Least 2 Cycles of Study Drug|Overall Study||6
2422818|NCT01214642|5943103|P6|Complete at Least 2 Cycles of Study Drug|Overall Study||1
2422819|NCT01214642|5943104|P5|Complete at Least 2 Cycles of Study Drug|Overall Study||6
2422820|NCT01214642|5943105|P4|Complete at Least 2 Cycles of Study Drug|Overall Study||4
2422821|NCT01214642|5943106|P3|Complete at Least 2 Cycles of Study Drug|Overall Study||5
2422822|NCT01214642|5943107|P2|Complete at Least 2 Cycles of Study Drug|Overall Study||1
2422823|NCT01214642|5943108|P1|Complete at Least 2 Cycles of Study Drug|Overall Study||3
2422824|NCT01214642|5943097|P12|Received at Least 1 Dose of Study Drug|Overall Study||6
2422825|NCT01214642|5943098|P11|Received at Least 1 Dose of Study Drug|Overall Study||4
2422826|NCT01214642|5943099|P10|Received at Least 1 Dose of Study Drug|Overall Study||4
2422827|NCT01214642|5943100|P9|Received at Least 1 Dose of Study Drug|Overall Study||13
2422828|NCT01214642|5943101|P8|Received at Least 1 Dose of Study Drug|Overall Study||3
2422829|NCT01214642|5943102|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
2422830|NCT01214642|5943103|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
2422831|NCT01214642|5943104|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
2422832|NCT01214642|5943105|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
2422833|NCT01214642|5943106|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
2422834|NCT01214642|5943107|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
2422835|NCT01214642|5943108|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
2422836|NCT01214642|5943097|P12|STARTED|Overall Study||6
2422837|NCT01214642|5943098|P11|STARTED|Overall Study||4
2422838|NCT01214642|5943099|P10|STARTED|Overall Study||4
2422839|NCT01214642|5943100|P9|STARTED|Overall Study|All participants who received 12 mg/m2/day on Days 1 and 5 plus PEG in Part A and Part B.|13
2422840|NCT01214642|5943101|P8|STARTED|Overall Study||3
2422841|NCT01214642|5943102|P7|STARTED|Overall Study||6
2422842|NCT01214642|5943103|P6|STARTED|Overall Study||3
2422843|NCT01214642|5943104|P5|STARTED|Overall Study||6
2422844|NCT01214642|5943105|P4|STARTED|Overall Study||6
2422845|NCT01214642|5943106|P3|STARTED|Overall Study||6
2422846|NCT01214642|5943107|P2|STARTED|Overall Study||3
2422847|NCT01214642|5943108|P1|STARTED|Overall Study||3
2422848|NCT01214629|5943188|P11|NOT COMPLETED|Overall Study||2
2422849|NCT01214629|5943189|P10|NOT COMPLETED|Overall Study||7
2422850|NCT01214629|5943190|P9|NOT COMPLETED|Overall Study||1
2422851|NCT01214629|5943191|P8|NOT COMPLETED|Overall Study||1
2422852|NCT01214629|5943192|P7|NOT COMPLETED|Overall Study||1
2422853|NCT01214629|5943193|P6|NOT COMPLETED|Overall Study||4
2422854|NCT01214629|5943194|P5|NOT COMPLETED|Overall Study||2
2422855|NCT01214629|5943195|P4|NOT COMPLETED|Overall Study||2
2422856|NCT01214629|5943196|P3|NOT COMPLETED|Overall Study||0
2422857|NCT01214629|5943197|P2|NOT COMPLETED|Overall Study||1
2422858|NCT01214629|5943198|P1|NOT COMPLETED|Overall Study||1
2422859|NCT01214629|5943188|P11|COMPLETED|Overall Study||1
2422860|NCT01214629|5943189|P10|COMPLETED|Overall Study||11
2422861|NCT01214629|5943190|P9|COMPLETED|Overall Study||2
2422862|NCT01214629|5943191|P8|COMPLETED|Overall Study||2
2422863|NCT01214629|5943192|P7|COMPLETED|Overall Study||4
2422864|NCT01214629|5943193|P6|COMPLETED|Overall Study||9
2422865|NCT01214629|5943194|P5|COMPLETED|Overall Study||1
2422866|NCT01214629|5943195|P4|COMPLETED|Overall Study||1
2422867|NCT01214629|5943196|P3|COMPLETED|Overall Study||1
2422868|NCT01214629|5943197|P2|COMPLETED|Overall Study||0
2422869|NCT01214629|5943198|P1|COMPLETED|Overall Study||0
2422870|NCT01214629|5943188|P11|Received at Least 1 Dose of Study Drug|Overall Study||3
2422871|NCT01214629|5943189|P10|Received at Least 1 Dose of Study Drug|Overall Study||18
2422872|NCT01214629|5943190|P9|Received at Least 1 Dose of Study Drug|Overall Study||3
2422873|NCT01214629|5943191|P8|Received at Least 1 Dose of Study Drug|Overall Study||3
2422874|NCT01214629|5943192|P7|Received at Least 1 Dose of Study Drug|Overall Study||5
2422875|NCT01214629|5943193|P6|Received at Least 1 Dose of Study Drug|Overall Study||13
2422876|NCT01214629|5943194|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
2422877|NCT01214629|5943195|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
2422878|NCT01214629|5943196|P3|Received at Least 1 Dose of Study Drug|Overall Study||1
2422879|NCT01214629|5943197|P2|Received at Least 1 Dose of Study Drug|Overall Study||1
2422880|NCT01214629|5943198|P1|Received at Least 1 Dose of Study Drug|Overall Study||1
2422881|NCT01214629|5943188|P11|STARTED|Overall Study||3
2422882|NCT01214629|5943189|P10|STARTED|Overall Study||18
2422883|NCT01214629|5943190|P9|STARTED|Overall Study||3
2422884|NCT01214629|5943191|P8|STARTED|Overall Study||3
2422885|NCT01214629|5943192|P7|STARTED|Overall Study||5
2422886|NCT01214629|5943193|P6|STARTED|Overall Study||13
2422887|NCT01214629|5943194|P5|STARTED|Overall Study||3
2422888|NCT01214629|5943195|P4|STARTED|Overall Study||3
2422889|NCT01214629|5943196|P3|STARTED|Overall Study||1
2422890|NCT01214629|5943197|P2|STARTED|Overall Study||1
2422891|NCT01214629|5943198|P1|STARTED|Overall Study||1
2422892|NCT01214616|5943263|P4|NOT COMPLETED|Overall Study||6
2422893|NCT01214616|5943264|P3|NOT COMPLETED|Overall Study||3
2422894|NCT01214616|5943265|P2|NOT COMPLETED|Overall Study||5
2422895|NCT01214616|5943266|P1|NOT COMPLETED|Overall Study||3
2422896|NCT01214616|5943263|P4|COMPLETED|Overall Study||0
2422897|NCT01214616|5943264|P3|COMPLETED|Overall Study||0
2422898|NCT01214616|5943265|P2|COMPLETED|Overall Study||0
2422899|NCT01214616|5943266|P1|COMPLETED|Overall Study||0
2422900|NCT01214616|5943263|P4|STARTED|Overall Study|Cohort 3 with afatinib/vinorelbine modification. Skipping vinorelbine allowed and not considered DLT|6
2422901|NCT01214616|5943264|P3|STARTED|Overall Study||3
2422902|NCT01214616|5943265|P2|STARTED|Overall Study||5
2422903|NCT01214616|5943266|P1|STARTED|Overall Study||3
2422904|NCT01214603|5943303|P3|NOT COMPLETED|Overall Study||4
2422905|NCT01214603|5943304|P2|NOT COMPLETED|Overall Study||1
2422906|NCT01214603|5943305|P1|NOT COMPLETED|Overall Study||5
2422907|NCT01214603|5943303|P3|COMPLETED|Overall Study||3
2422908|NCT01214603|5943304|P2|COMPLETED|Overall Study||5
2422909|NCT01214603|5943305|P1|COMPLETED|Overall Study||2
2422910|NCT01214603|5943303|P3|Received at Least 1 Dose of LY2090314|Overall Study||7
2422911|NCT01214603|5943304|P2|Received at Least 1 Dose of LY2090314|Overall Study||6
2422912|NCT01214603|5943305|P1|Received at Least 1 Dose of LY2090314|Overall Study||7
2422913|NCT01214603|5943303|P3|STARTED|Overall Study||7
2422914|NCT01214603|5943304|P2|STARTED|Overall Study||6
2422915|NCT01214603|5943305|P1|STARTED|Overall Study||7
2422916|NCT01214434|5943328|P2|NOT COMPLETED|Overall Study||2
2422917|NCT01214434|5943329|P1|NOT COMPLETED|Overall Study||4
2422918|NCT01214434|5943328|P2|COMPLETED|Overall Study||25
2422919|NCT01214434|5943329|P1|COMPLETED|Overall Study||11
2422920|NCT01214434|5943328|P2|STARTED|Overall Study||27
2422921|NCT01214434|5943329|P1|STARTED|Overall Study||15
2422922|NCT01214395|5943345|P1|NOT COMPLETED|Overall Study||5
2422923|NCT01214395|5943345|P1|COMPLETED|Overall Study||0
2422924|NCT01214395|5943345|P1|STARTED|Overall Study||5
2422925|NCT01214356|5943352|P2|NOT COMPLETED|Overall Study||14
2422926|NCT01214356|5943353|P1|NOT COMPLETED|Overall Study||17
2422927|NCT01214356|5943352|P2|COMPLETED|Overall Study||13
2422928|NCT01214356|5943353|P1|COMPLETED|Overall Study||10
2422929|NCT01214356|5943352|P2|STARTED|Overall Study||27
2422930|NCT01214356|5943353|P1|STARTED|Overall Study||27
2422931|NCT01214330|5943359|P1|NOT COMPLETED|Overall Study||48
2422932|NCT01214330|5943359|P1|COMPLETED|Overall Study||102
2422933|NCT01214330|5943359|P1|STARTED|Overall Study||150
2422934|NCT01214252|5943363|P1|NOT COMPLETED|Overall Study||82
2422935|NCT01214252|5943363|P1|COMPLETED|Overall Study||343
2422936|NCT01214252|5943363|P1|STARTED|Overall Study||425
2422937|NCT01214239|5943371|P2|NOT COMPLETED|Overall Study||18
2422938|NCT01214239|5943372|P1|NOT COMPLETED|Overall Study||12
2422939|NCT01214239|5943371|P2|COMPLETED|Overall Study||182
2422940|NCT01214239|5943372|P1|COMPLETED|Overall Study||87
2422941|NCT01214239|5943371|P2|STARTED|Overall Study|patients who were randomised and treated with placebo. 1 patient was not treated then not included|200
2422942|NCT01214239|5943372|P1|STARTED|Overall Study|patients who were randomised and treated with placebo|99
2422943|NCT01214200|5943404|P1|NOT COMPLETED|Overall Study||11
2422944|NCT01214200|5943404|P1|COMPLETED|Overall Study||9
2422945|NCT01214200|5943404|P1|STARTED|Overall Study||20
2422946|NCT01214187|5943418|P2|NOT COMPLETED|Overall Study||6
2422947|NCT01214187|5943419|P1|NOT COMPLETED|Overall Study||7
2422948|NCT01214187|5943418|P2|COMPLETED|Overall Study||23
2422949|NCT01214187|5943419|P1|COMPLETED|Overall Study||22
2422950|NCT01214187|5943418|P2|STARTED|Overall Study||29
2422951|NCT01214187|5943419|P1|STARTED|Overall Study||29
2422952|NCT01214174|5943436|P3|NOT COMPLETED|Overall Study||1
2422953|NCT01214174|5943437|P2|NOT COMPLETED|Overall Study||0
2422954|NCT01214174|5943438|P1|NOT COMPLETED|Overall Study||0
2422955|NCT01214174|5943436|P3|COMPLETED|Overall Study||13
2422956|NCT01214174|5943437|P2|COMPLETED|Overall Study||16
2422957|NCT01214174|5943438|P1|COMPLETED|Overall Study||13
2422958|NCT01214174|5943436|P3|STARTED|Overall Study||14
2422959|NCT01214174|5943437|P2|STARTED|Overall Study||16
2422960|NCT01214174|5943438|P1|STARTED|Overall Study||13
2422961|NCT01214161|5943448|P2|NOT COMPLETED|Overall Study||0
2422962|NCT01214161|5943449|P1|NOT COMPLETED|Overall Study||0
2422963|NCT01214161|5943448|P2|COMPLETED|Overall Study||100
2422964|NCT01214161|5943449|P1|COMPLETED|Overall Study||100
2422965|NCT01214161|5943448|P2|STARTED|Overall Study||100
2422966|NCT01214161|5943449|P1|STARTED|Overall Study||100
2422967|NCT01214109|5943459|P4|NOT COMPLETED|Overall Study||0
2422968|NCT01214109|5943460|P3|NOT COMPLETED|Overall Study||0
2422969|NCT01214109|5943461|P2|NOT COMPLETED|Overall Study||0
2422970|NCT01214109|5943462|P1|NOT COMPLETED|Overall Study||0
2422971|NCT01214109|5943459|P4|COMPLETED|Overall Study||24
2422972|NCT01214109|5943460|P3|COMPLETED|Overall Study||24
2422973|NCT01214109|5943461|P2|COMPLETED|Overall Study||24
2422974|NCT01214109|5943462|P1|COMPLETED|Overall Study||24
2422975|NCT01214109|5943459|P4|STARTED|Overall Study||24
2422976|NCT01214109|5943460|P3|STARTED|Overall Study||24
2422977|NCT01214109|5943461|P2|STARTED|Overall Study||24
2422978|NCT01214109|5943462|P1|STARTED|Overall Study||24
2422979|NCT01214083|5943554|P3|NOT COMPLETED|Overall Study||10
2422980|NCT01214083|5943555|P2|NOT COMPLETED|Overall Study||10
2422981|NCT01214083|5943556|P1|NOT COMPLETED|Overall Study||12
2422982|NCT01214083|5943554|P3|COMPLETED|Overall Study||21
2422983|NCT01214083|5943555|P2|COMPLETED|Overall Study||23
2422984|NCT01214083|5943556|P1|COMPLETED|Overall Study||19
2422985|NCT01214083|5943554|P3|STARTED|Overall Study||31
2422986|NCT01214083|5943555|P2|STARTED|Overall Study||33
2422987|NCT01214083|5943556|P1|STARTED|Overall Study||31
2422988|NCT01214044|5943588|P1|NOT COMPLETED|Visits 6-11: Escitalopram 20 mg Daily||4
2422989|NCT01214044|5943588|P1|COMPLETED|Visits 6-11: Escitalopram 20 mg Daily||10
2422990|NCT01214044|5943588|P1|STARTED|Visits 6-11: Escitalopram 20 mg Daily||14
2422991|NCT01214044|5943588|P1|NOT COMPLETED|Visits 3-5: Escitalopram 10 mg Daily||3
2422992|NCT01214044|5943588|P1|COMPLETED|Visits 3-5: Escitalopram 10 mg Daily||14
2422993|NCT01214044|5943588|P1|STARTED|Visits 3-5: Escitalopram 10 mg Daily||17
2422994|NCT01214044|5943588|P1|NOT COMPLETED|Visit 2: End Washout & Start Placebo||2
2422995|NCT01214044|5943588|P1|COMPLETED|Visit 2: End Washout & Start Placebo|2 subjects dropped out during the placebo week (between study visits 2 & 3)|17
2422996|NCT01214044|5943588|P1|STARTED|Visit 2: End Washout & Start Placebo||19
2422997|NCT01214044|5943588|P1|NOT COMPLETED|Visit 1: Screening and Consent, Washout||12
2422998|NCT01214044|5943588|P1|COMPLETED|Visit 1: Screening and Consent, Washout||19
2422999|NCT01214044|5943588|P1|STARTED|Visit 1: Screening and Consent, Washout||31
2423000|NCT01213966|5943602|P4|NOT COMPLETED|Overall Study||1
2423001|NCT01213966|5943603|P3|NOT COMPLETED|Overall Study||3
2423002|NCT01213966|5943604|P2|NOT COMPLETED|Overall Study||0
2423003|NCT01213966|5943605|P1|NOT COMPLETED|Overall Study||1
2423004|NCT01213966|5943602|P4|COMPLETED|Overall Study||20
2423005|NCT01213966|5943603|P3|COMPLETED|Overall Study||17
2423006|NCT01213966|5943604|P2|COMPLETED|Overall Study||20
2423007|NCT01213966|5943605|P1|COMPLETED|Overall Study||19
2423008|NCT01213966|5943602|P4|STARTED|Overall Study||21
2423009|NCT01213966|5943603|P3|STARTED|Overall Study||20
2423010|NCT01213966|5943604|P2|STARTED|Overall Study||20
2423011|NCT01213966|5943605|P1|STARTED|Overall Study||20
2423012|NCT01213836|5943617|P2|NOT COMPLETED|Period 2, Second Intervention||0
2423013|NCT01213836|5943618|P1|NOT COMPLETED|Period 2, Second Intervention||0
2423014|NCT01213836|5943617|P2|COMPLETED|Period 2, Second Intervention||29
2423015|NCT01213836|5943618|P1|COMPLETED|Period 2, Second Intervention||31
2423016|NCT01213836|5943617|P2|STARTED|Period 2, Second Intervention||29
2423017|NCT01213836|5943618|P1|STARTED|Period 2, Second Intervention||31
2423018|NCT01213836|5943617|P2|NOT COMPLETED|Period 1, First Intervention||3
2423019|NCT01213836|5943618|P1|NOT COMPLETED|Period 1, First Intervention||3
2423020|NCT01213836|5943617|P2|COMPLETED|Period 1, First Intervention||29
2423021|NCT01213836|5943618|P1|COMPLETED|Period 1, First Intervention||31
2423022|NCT01213836|5943617|P2|STARTED|Period 1, First Intervention||32
2423023|NCT01213836|5943618|P1|STARTED|Period 1, First Intervention||34
2423024|NCT01213823|5943638|P2|NOT COMPLETED|Overall Study||0
2423025|NCT01213823|5943639|P1|NOT COMPLETED|Overall Study||0
2423026|NCT01213823|5943638|P2|COMPLETED|Overall Study||467
2423027|NCT01213823|5943639|P1|COMPLETED|Overall Study||69
2423028|NCT01213823|5943638|P2|STARTED|Overall Study||467
2423029|NCT01213823|5943639|P1|STARTED|Overall Study||69
2423030|NCT01213706|5943645|P1|NOT COMPLETED|WBPA||0
2423031|NCT01213706|5943645|P1|COMPLETED|WBPA||45
2423032|NCT01213706|5943645|P1|STARTED|WBPA||45
2423033|NCT01213706|5943645|P1|NOT COMPLETED|Washout (1 Hour)||0
2423034|NCT01213706|5943645|P1|COMPLETED|Washout (1 Hour)||45
2423035|NCT01213706|5943645|P1|STARTED|Washout (1 Hour)||45
2423036|NCT01213706|5943645|P1|NOT COMPLETED|Sham WBPA||0
2423037|NCT01213706|5943645|P1|COMPLETED|Sham WBPA||45
2423038|NCT01213706|5943645|P1|STARTED|Sham WBPA||45
2423039|NCT01213589|5943654|P3|NOT COMPLETED|Overall Study||8
2423040|NCT01213589|5943655|P2|NOT COMPLETED|Overall Study||5
2423041|NCT01213589|5943656|P1|NOT COMPLETED|Overall Study||13
2423042|NCT01213589|5943654|P3|COMPLETED|Overall Study||18
2423043|NCT01213589|5943655|P2|COMPLETED|Overall Study||19
2423044|NCT01213589|5943656|P1|COMPLETED|Overall Study||37
2423045|NCT01213589|5943654|P3|STARTED|Overall Study||26
2423046|NCT01213589|5943655|P2|STARTED|Overall Study||24
2423047|NCT01213589|5943656|P1|STARTED|Overall Study||50
2423048|NCT01213576|5943686|P4|NOT COMPLETED|Overall Study||4
2423049|NCT01213576|5943687|P3|NOT COMPLETED|Overall Study||5
2423050|NCT01213576|5943688|P2|NOT COMPLETED|Overall Study||4
2423051|NCT01213576|5943689|P1|NOT COMPLETED|Overall Study||3
2423052|NCT01213576|5943686|P4|COMPLETED|Overall Study||13
2423053|NCT01213576|5943687|P3|COMPLETED|Overall Study||13
2423054|NCT01213576|5943688|P2|COMPLETED|Overall Study||13
2423055|NCT01213576|5943689|P1|COMPLETED|Overall Study||15
2423056|NCT01213576|5943686|P4|STARTED|Overall Study||17
2423057|NCT01213576|5943687|P3|STARTED|Overall Study||18
2423058|NCT01213576|5943688|P2|STARTED|Overall Study||17
2423059|NCT01213576|5943689|P1|STARTED|Overall Study||18
2423060|NCT01213472|5943703|P1|NOT COMPLETED|Overall Study||27
2423061|NCT01213472|5943703|P1|COMPLETED|Overall Study||6
2423062|NCT01213472|5943703|P1|STARTED|Overall Study||33
2423063|NCT01213329|5943726|P2|NOT COMPLETED|Phase 2||0
2423064|NCT01213329|5943727|P1|NOT COMPLETED|Phase 2||0
2423065|NCT01213329|5943726|P2|COMPLETED|Phase 2||0
2423066|NCT01213329|5943727|P1|COMPLETED|Phase 2||0
2423067|NCT01213329|5943726|P2|STARTED|Phase 2|No subjects continued into phase 2.This is due to a loss of samples from a processing inconsistency.|0
2423068|NCT01213329|5943727|P1|STARTED|Phase 2|No subjects continued into phase 2.This is due to a loss of samples from a processing inconsistency.|0
2423069|NCT01213329|5943726|P2|NOT COMPLETED|Screening||0
2423070|NCT01213329|5943727|P1|NOT COMPLETED|Screening||0
2423071|NCT01213329|5943726|P2|COMPLETED|Screening||25
2423072|NCT01213329|5943727|P1|COMPLETED|Screening||25
2423073|NCT01213329|5943726|P2|STARTED|Screening||25
2423074|NCT01213329|5943727|P1|STARTED|Screening||25
2423075|NCT01213316|5943733|P1|NOT COMPLETED|Overall Study||0
2423076|NCT01213316|5943733|P1|COMPLETED|Overall Study||451
2423077|NCT01213316|5943733|P1|Initial Cohort|Overall Study|Participants >=18 years of age in the initial cohort|272
2423078|NCT01213316|5943733|P1|Discontinued Treatment Before 48 Weeks|Overall Study||67
2423079|NCT01213316|5943733|P1|Amendment Cohort: Newly Enrolled|Overall Study|Participants >=50 years of age newly enrolled|179
2423080|NCT01213316|5943733|P1|Amendment Cohort: Prolonged Participants|Overall Study|Participants >=50 years of age in the initial cohort who accept an additional 48-week observation|48
2423081|NCT01213316|5943733|P1|STARTED|Overall Study|Participants in the initial and amendment cohorts|451
2423082|NCT01213264|5943752|P3|NOT COMPLETED|Overall Study||6
2423083|NCT01213264|5943753|P2|NOT COMPLETED|Overall Study||2
2423084|NCT01213264|5943754|P1|NOT COMPLETED|Overall Study||2
2423085|NCT01213264|5943752|P3|COMPLETED|Overall Study||321
2423086|NCT01213264|5943753|P2|COMPLETED|Overall Study||175
2423087|NCT01213264|5943754|P1|COMPLETED|Overall Study||153
2423088|NCT01213264|5943752|P3|STARTED|Overall Study||327
2423089|NCT01213264|5943753|P2|STARTED|Overall Study||177
2423090|NCT01213264|5943754|P1|STARTED|Overall Study||155
2423091|NCT01213251|5943774|P3|NOT COMPLETED|Overall Study||11
2423092|NCT01213251|5943775|P2|NOT COMPLETED|Overall Study||4
2423093|NCT01213251|5943776|P1|NOT COMPLETED|Overall Study||6
2423094|NCT01213251|5943774|P3|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
2423181|NCT01212770|5943927|P5|COMPLETED|Long-term Safety Phase (Year 5)||0
2423095|NCT01213251|5943775|P2|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|37
2423096|NCT01213251|5943776|P1|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
2423097|NCT01213251|5943774|P3|STARTED|Overall Study||45
2423098|NCT01213251|5943775|P2|STARTED|Overall Study||41
2423099|NCT01213251|5943776|P1|STARTED|Overall Study||40
2423100|NCT01213199|5943797|P1|NOT COMPLETED|Overall Study||4
2423101|NCT01213199|5943797|P1|COMPLETED|Overall Study||16
2423102|NCT01213199|5943797|P1|STARTED|Overall Study||20
2423103|NCT01213173|5943803|P2|NOT COMPLETED|Overall Study||16
2423104|NCT01213173|5943804|P1|NOT COMPLETED|Overall Study||12
2423105|NCT01213173|5943803|P2|COMPLETED|Overall Study|Patients who completed the study|110
2423106|NCT01213173|5943804|P1|COMPLETED|Overall Study|Patients who completed the study|113
2423107|NCT01213173|5943803|P2|Patients Included in PP Population|Overall Study||89
2423108|NCT01213173|5943804|P1|Patients Included in PP Population|Overall Study||102
2423109|NCT01213173|5943803|P2|Patients Included in ITT Population|Overall Study||115
2423110|NCT01213173|5943804|P1|Patients Included in ITT Population|Overall Study||116
2423111|NCT01213173|5943803|P2|Patients Included in Safety Population|Overall Study||112
2423112|NCT01213173|5943804|P1|Patients Included in Safety Population|Overall Study||139
2423113|NCT01213173|5943803|P2|STARTED|Overall Study|Patients who were randomized and received treatment|126
2423114|NCT01213173|5943804|P1|STARTED|Overall Study|Patients who were randomized and received treatment|125
2423115|NCT01213082|5943837|P3|NOT COMPLETED|Overall Study||5
2423116|NCT01213082|5943838|P2|NOT COMPLETED|Overall Study||7
2423117|NCT01213082|5943839|P1|NOT COMPLETED|Overall Study||6
2423118|NCT01213082|5943837|P3|COMPLETED|Overall Study||6
2423119|NCT01213082|5943838|P2|COMPLETED|Overall Study||4
2423120|NCT01213082|5943839|P1|COMPLETED|Overall Study||6
2423121|NCT01213082|5943837|P3|STARTED|Overall Study||11
2423122|NCT01213082|5943838|P2|STARTED|Overall Study||11
2423123|NCT01213082|5943839|P1|STARTED|Overall Study||12
2423124|NCT01213043|5943852|P2|NOT COMPLETED|Follow-up||0
2423125|NCT01213043|5943853|P1|NOT COMPLETED|Follow-up||0
2423126|NCT01213043|5943852|P2|COMPLETED|Follow-up||15
2423127|NCT01213043|5943853|P1|COMPLETED|Follow-up||15
2423128|NCT01213043|5943852|P2|STARTED|Follow-up||15
2423129|NCT01213043|5943853|P1|STARTED|Follow-up||15
2423130|NCT01213043|5943852|P2|NOT COMPLETED|Treatment Period 2||0
2423131|NCT01213043|5943853|P1|NOT COMPLETED|Treatment Period 2||0
2423132|NCT01213043|5943852|P2|COMPLETED|Treatment Period 2||15
2423133|NCT01213043|5943853|P1|COMPLETED|Treatment Period 2||15
2423134|NCT01213043|5943852|P2|STARTED|Treatment Period 2||15
2423135|NCT01213043|5943853|P1|STARTED|Treatment Period 2||15
2423136|NCT01213043|5943852|P2|NOT COMPLETED|Washout Period||0
2423137|NCT01213043|5943853|P1|NOT COMPLETED|Washout Period||0
2423138|NCT01213043|5943852|P2|COMPLETED|Washout Period||15
2423139|NCT01213043|5943853|P1|COMPLETED|Washout Period||15
2423140|NCT01213043|5943852|P2|STARTED|Washout Period||15
2423141|NCT01213043|5943853|P1|STARTED|Washout Period||15
2423142|NCT01213043|5943852|P2|NOT COMPLETED|Treatment Period 1||0
2423143|NCT01213043|5943853|P1|NOT COMPLETED|Treatment Period 1||0
2423144|NCT01213043|5943852|P2|COMPLETED|Treatment Period 1||15
2423145|NCT01213043|5943853|P1|COMPLETED|Treatment Period 1||15
2423146|NCT01213043|5943852|P2|STARTED|Treatment Period 1||15
2423147|NCT01213043|5943853|P1|STARTED|Treatment Period 1||15
2423148|NCT01212991|5943881|P2|NOT COMPLETED|Overall Study||374
2423149|NCT01212991|5943882|P1|NOT COMPLETED|Overall Study||613
2423150|NCT01212991|5943881|P2|COMPLETED|Overall Study|Indicates participants continuing in long-term follow-up as of 16SEP2013.|471
2423151|NCT01212991|5943882|P1|COMPLETED|Overall Study|Indicates participants continuing in long-term follow-up as of 16SEP2013.|259
2423152|NCT01212991|5943881|P2|STARTED|Overall Study||845
2423153|NCT01212991|5943882|P1|STARTED|Overall Study||872
2423154|NCT01212900|5943902|P2|NOT COMPLETED|Overall Study||7
2423155|NCT01212900|5943903|P1|NOT COMPLETED|Overall Study||12
2423156|NCT01212900|5943902|P2|COMPLETED|Overall Study||107
2423157|NCT01212900|5943903|P1|COMPLETED|Overall Study||104
2423158|NCT01212900|5943902|P2|STARTED|Overall Study||114
2423159|NCT01212900|5943903|P1|STARTED|Overall Study||116
2423160|NCT01212874|5943911|P2|NOT COMPLETED|Overall Study||23
2423161|NCT01212874|5943912|P1|NOT COMPLETED|Overall Study||22
2423162|NCT01212874|5943911|P2|COMPLETED|Overall Study||12
2423163|NCT01212874|5943912|P1|COMPLETED|Overall Study||13
2423164|NCT01212874|5943911|P2|Received Allocated Intervention|Overall Study||12
2423165|NCT01212874|5943912|P1|Received Allocated Intervention|Overall Study||13
2423166|NCT01212874|5943911|P2|STARTED|Overall Study||35
2423167|NCT01212874|5943912|P1|STARTED|Overall Study||35
2423168|NCT01212770|5943923|P9|NOT COMPLETED|Long-term Safety Phase (Year 5)||1
2423169|NCT01212770|5943924|P8|NOT COMPLETED|Long-term Safety Phase (Year 5)||2
2423170|NCT01212770|5943925|P7|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
2423171|NCT01212770|5943926|P6|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
2423172|NCT01212770|5943927|P5|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
2423173|NCT01212770|5943928|P4|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
2423174|NCT01212770|5943929|P3|NOT COMPLETED|Long-term Safety Phase (Year 5)||11
2423175|NCT01212770|5943930|P2|NOT COMPLETED|Long-term Safety Phase (Year 5)||2
2423176|NCT01212770|5943931|P1|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
2423177|NCT01212770|5943923|P9|COMPLETED|Long-term Safety Phase (Year 5)||41
2423178|NCT01212770|5943924|P8|COMPLETED|Long-term Safety Phase (Year 5)||30
2423179|NCT01212770|5943925|P7|COMPLETED|Long-term Safety Phase (Year 5)||0
2423180|NCT01212770|5943926|P6|COMPLETED|Long-term Safety Phase (Year 5)||0
2423182|NCT01212770|5943928|P4|COMPLETED|Long-term Safety Phase (Year 5)||0
2423183|NCT01212770|5943929|P3|COMPLETED|Long-term Safety Phase (Year 5)||72
2423184|NCT01212770|5943930|P2|COMPLETED|Long-term Safety Phase (Year 5)||68
2423185|NCT01212770|5943931|P1|COMPLETED|Long-term Safety Phase (Year 5)||0
2423186|NCT01212770|5943923|P9|STARTED|Long-term Safety Phase (Year 5)||42
2423187|NCT01212770|5943924|P8|STARTED|Long-term Safety Phase (Year 5)||32
2423188|NCT01212770|5943925|P7|STARTED|Long-term Safety Phase (Year 5)||0
2423189|NCT01212770|5943926|P6|STARTED|Long-term Safety Phase (Year 5)||0
2423190|NCT01212770|5943927|P5|STARTED|Long-term Safety Phase (Year 5)||0
2423191|NCT01212770|5943928|P4|STARTED|Long-term Safety Phase (Year 5)||0
2423192|NCT01212770|5943929|P3|STARTED|Long-term Safety Phase (Year 5)||83
2423193|NCT01212770|5943930|P2|STARTED|Long-term Safety Phase (Year 5)|1 participant who completed Year 4 did not continue treatment in Year 5|70
2423194|NCT01212770|5943931|P1|STARTED|Long-term Safety Phase (Year 5)||0
2423195|NCT01212770|5943923|P9|NOT COMPLETED|Long-term Safety Phase (Year 4)||2
2423196|NCT01212770|5943924|P8|NOT COMPLETED|Long-term Safety Phase (Year 4)||3
2423197|NCT01212770|5943925|P7|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
2423198|NCT01212770|5943926|P6|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
2423199|NCT01212770|5943927|P5|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
2423200|NCT01212770|5943928|P4|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
2423201|NCT01212770|5943929|P3|NOT COMPLETED|Long-term Safety Phase (Year 4)||11
2423202|NCT01212770|5943930|P2|NOT COMPLETED|Long-term Safety Phase (Year 4)||6
2423203|NCT01212770|5943931|P1|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
2423204|NCT01212770|5943923|P9|COMPLETED|Long-term Safety Phase (Year 4)||42
2423205|NCT01212770|5943924|P8|COMPLETED|Long-term Safety Phase (Year 4)||32
2423206|NCT01212770|5943925|P7|COMPLETED|Long-term Safety Phase (Year 4)||0
2423207|NCT01212770|5943926|P6|COMPLETED|Long-term Safety Phase (Year 4)||0
2423208|NCT01212770|5943927|P5|COMPLETED|Long-term Safety Phase (Year 4)||0
2423209|NCT01212770|5943928|P4|COMPLETED|Long-term Safety Phase (Year 4)||0
2423210|NCT01212770|5943929|P3|COMPLETED|Long-term Safety Phase (Year 4)||83
2423211|NCT01212770|5943930|P2|COMPLETED|Long-term Safety Phase (Year 4)||71
2423212|NCT01212770|5943931|P1|COMPLETED|Long-term Safety Phase (Year 4)||0
2423213|NCT01212770|5943923|P9|STARTED|Long-term Safety Phase (Year 4)||44
2423214|NCT01212770|5943924|P8|STARTED|Long-term Safety Phase (Year 4)||35
2423215|NCT01212770|5943925|P7|STARTED|Long-term Safety Phase (Year 4)||0
2423216|NCT01212770|5943926|P6|STARTED|Long-term Safety Phase (Year 4)||0
2423217|NCT01212770|5943927|P5|STARTED|Long-term Safety Phase (Year 4)||0
2423218|NCT01212770|5943928|P4|STARTED|Long-term Safety Phase (Year 4)||0
2423219|NCT01212770|5943929|P3|STARTED|Long-term Safety Phase (Year 4)||94
2423220|NCT01212770|5943930|P2|STARTED|Long-term Safety Phase (Year 4)|1 participant was counted in Year 4 but not in year 3 due to late APR dispensing|77
2423221|NCT01212770|5943931|P1|STARTED|Long-term Safety Phase (Year 4)||0
2423222|NCT01212770|5943923|P9|NOT COMPLETED|Long-term Safety Phase (Year 3)||5
2423223|NCT01212770|5943924|P8|NOT COMPLETED|Long-term Safety Phase (Year 3)||7
2423224|NCT01212770|5943925|P7|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
2423225|NCT01212770|5943926|P6|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
2423226|NCT01212770|5943927|P5|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
2423227|NCT01212770|5943928|P4|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
2423228|NCT01212770|5943929|P3|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
2423229|NCT01212770|5943930|P2|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
2423230|NCT01212770|5943931|P1|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
2423231|NCT01212770|5943923|P9|COMPLETED|Long-term Safety Phase (Year 3)||44
2423232|NCT01212770|5943924|P8|COMPLETED|Long-term Safety Phase (Year 3)||35
2423233|NCT01212770|5943925|P7|COMPLETED|Long-term Safety Phase (Year 3)||0
2423234|NCT01212770|5943926|P6|COMPLETED|Long-term Safety Phase (Year 3)||0
2423235|NCT01212770|5943927|P5|COMPLETED|Long-term Safety Phase (Year 3)||0
2423236|NCT01212770|5943928|P4|COMPLETED|Long-term Safety Phase (Year 3)||0
2423237|NCT01212770|5943929|P3|COMPLETED|Long-term Safety Phase (Year 3)||94
2423238|NCT01212770|5943930|P2|COMPLETED|Long-term Safety Phase (Year 3)|1 participant missed due to APR dispensed late|76
2423239|NCT01212770|5943931|P1|COMPLETED|Long-term Safety Phase (Year 3)||0
2423240|NCT01212770|5943923|P9|STARTED|Long-term Safety Phase (Year 3)|Patients from the PBO/APR 30 mg EE and XO are combined;1 patient finished Wk 52;no entry into LTSP|49
2423241|NCT01212770|5943924|P8|STARTED|Long-term Safety Phase (Year 3)|The PBO/APR 20 mg EE and XO participants from week 24-52 are combined within the LTSP.|42
2423242|NCT01212770|5943925|P7|STARTED|Long-term Safety Phase (Year 3)||0
2423243|NCT01212770|5943926|P6|STARTED|Long-term Safety Phase (Year 3)||0
2423244|NCT01212770|5943927|P5|STARTED|Long-term Safety Phase (Year 3)||0
2423245|NCT01212770|5943928|P4|STARTED|Long-term Safety Phase (Year 3)||0
2423246|NCT01212770|5943929|P3|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|105
2423247|NCT01212770|5943930|P2|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|87
2423248|NCT01212770|5943931|P1|STARTED|Long-term Safety Phase (Year 3)||0
2423249|NCT01212770|5943923|P9|NOT COMPLETED|Long-term Safety Phase (Year 2)||14
2423250|NCT01212770|5943924|P8|NOT COMPLETED|Long-term Safety Phase (Year 2)||9
2423251|NCT01212770|5943925|P7|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
2423252|NCT01212770|5943926|P6|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
2423253|NCT01212770|5943927|P5|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
2423254|NCT01212770|5943928|P4|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
2423255|NCT01212770|5943929|P3|NOT COMPLETED|Long-term Safety Phase (Year 2)||15
2423256|NCT01212770|5943930|P2|NOT COMPLETED|Long-term Safety Phase (Year 2)||23
2423257|NCT01212770|5943931|P1|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
2423258|NCT01212770|5943923|P9|COMPLETED|Long-term Safety Phase (Year 2)||50
2423259|NCT01212770|5943924|P8|COMPLETED|Long-term Safety Phase (Year 2)||42
2423260|NCT01212770|5943925|P7|COMPLETED|Long-term Safety Phase (Year 2)||0
2423261|NCT01212770|5943926|P6|COMPLETED|Long-term Safety Phase (Year 2)||0
2423262|NCT01212770|5943927|P5|COMPLETED|Long-term Safety Phase (Year 2)||0
2423263|NCT01212770|5943928|P4|COMPLETED|Long-term Safety Phase (Year 2)||0
2423264|NCT01212770|5943929|P3|COMPLETED|Long-term Safety Phase (Year 2)||106
2423265|NCT01212770|5943930|P2|COMPLETED|Long-term Safety Phase (Year 2)||88
2423266|NCT01212770|5943931|P1|COMPLETED|Long-term Safety Phase (Year 2)||0
2423267|NCT01212770|5943923|P9|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 30 mg EE and XO are combined;3 patients finished Wk 52;no entry into LTSP|64
2423268|NCT01212770|5943924|P8|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 20 mg EE and XO are combined;5 patients finished Wk 52;no entry into LTSP|51
2423269|NCT01212770|5943925|P7|STARTED|Long-term Safety Phase (Year 2)||0
2423270|NCT01212770|5943926|P6|STARTED|Long-term Safety Phase (Year 2)||0
2423271|NCT01212770|5943927|P5|STARTED|Long-term Safety Phase (Year 2)||0
2423272|NCT01212770|5943928|P4|STARTED|Long-term Safety Phase (Year 2)||0
2423273|NCT01212770|5943929|P3|STARTED|Long-term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|121
2423274|NCT01212770|5943930|P2|STARTED|Long-term Safety Phase (Year 2)|9 participants who completed Week 52 did not enter the long-term safety phase (LTSP)|111
2423275|NCT01212770|5943931|P1|STARTED|Long-term Safety Phase (Year 2)||0
2423276|NCT01212770|5943923|P9|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
2423277|NCT01212770|5943924|P8|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
2423278|NCT01212770|5943925|P7|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
2423279|NCT01212770|5943926|P6|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||3
2423280|NCT01212770|5943927|P5|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
2423281|NCT01212770|5943928|P4|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||11
2423282|NCT01212770|5943929|P3|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||12
2423283|NCT01212770|5943930|P2|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||19
2423284|NCT01212770|5943931|P1|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
2423285|NCT01212770|5943923|P9|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
2423286|NCT01212770|5943924|P8|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
2423287|NCT01212770|5943925|P7|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
2423288|NCT01212770|5943926|P6|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||44
2423289|NCT01212770|5943927|P5|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
2423290|NCT01212770|5943928|P4|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||32
2423291|NCT01212770|5943929|P3|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||126
2423292|NCT01212770|5943930|P2|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||120
2423293|NCT01212770|5943931|P1|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
2423294|NCT01212770|5943923|P9|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
2423295|NCT01212770|5943924|P8|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
2423296|NCT01212770|5943925|P7|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
2423297|NCT01212770|5943926|P6|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|47
2423298|NCT01212770|5943927|P5|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
2423299|NCT01212770|5943928|P4|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|43
2423300|NCT01212770|5943929|P3|STARTED|Active Treatment Phase (Weeks 25 - 52)|7 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|138
2423301|NCT01212770|5943930|P2|STARTED|Active Treatment Phase (Weeks 25 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|139
2423302|NCT01212770|5943931|P1|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
2423303|NCT01212770|5943923|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2423304|NCT01212770|5943924|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2423305|NCT01212770|5943925|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2423306|NCT01212770|5943926|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2423307|NCT01212770|5943927|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2423308|NCT01212770|5943928|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2423309|NCT01212770|5943929|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
2423310|NCT01212770|5943930|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
2423311|NCT01212770|5943931|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23
2423312|NCT01212770|5943923|P9|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2423313|NCT01212770|5943924|P8|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2423314|NCT01212770|5943925|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2423315|NCT01212770|5943926|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2423316|NCT01212770|5943927|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2423317|NCT01212770|5943928|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2423318|NCT01212770|5943929|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||145
2423319|NCT01212770|5943930|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||147
2423320|NCT01212770|5943931|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||146
2423321|NCT01212770|5943923|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2423322|NCT01212770|5943924|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2423323|NCT01212770|5943925|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2423324|NCT01212770|5943926|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2423325|NCT01212770|5943927|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2423326|NCT01212770|5943928|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2423327|NCT01212770|5943929|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week 24|53
2423328|NCT01212770|5943930|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||76
2423329|NCT01212770|5943931|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week (Wk) 24|97
2423330|NCT01212770|5943923|P9|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2423331|NCT01212770|5943924|P8|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2423332|NCT01212770|5943925|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2423333|NCT01212770|5943926|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2423334|NCT01212770|5943927|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2423335|NCT01212770|5943928|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2423336|NCT01212770|5943929|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
2423337|NCT01212770|5943930|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||157
2423338|NCT01212770|5943931|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
2423339|NCT01212770|5943923|P9|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
2423340|NCT01212770|5943924|P8|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
2423341|NCT01212770|5943925|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
2423342|NCT01212770|5943926|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
2423343|NCT01212770|5943927|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
2423344|NCT01212770|5943928|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
2423345|NCT01212770|5943929|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||167
2423346|NCT01212770|5943930|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
2423347|NCT01212770|5943931|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
2423348|NCT01212770|5943923|P9|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
2423349|NCT01212770|5943924|P8|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
2423350|NCT01212770|5943925|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
2423351|NCT01212770|5943926|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
2423352|NCT01212770|5943927|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
2423353|NCT01212770|5943928|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
2423354|NCT01212770|5943929|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||167
2423355|NCT01212770|5943930|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
2423356|NCT01212770|5943931|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
2423357|NCT01212757|5944128|P9|NOT COMPLETED|Long-Term Safety Phase (Year 5)||2
2423358|NCT01212757|5944129|P8|NOT COMPLETED|Long-Term Safety Phase (Year 5)||5
2423359|NCT01212757|5944130|P7|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
2423360|NCT01212757|5944131|P6|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
2423361|NCT01212757|5944132|P5|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
2423362|NCT01212757|5944133|P4|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
2423363|NCT01212757|5944134|P3|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8
2423364|NCT01212757|5944135|P2|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8
2423365|NCT01212757|5944136|P1|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
2423366|NCT01212757|5944128|P9|COMPLETED|Long-Term Safety Phase (Year 5)||37
2423367|NCT01212757|5944129|P8|COMPLETED|Long-Term Safety Phase (Year 5)||33
2423368|NCT01212757|5944130|P7|COMPLETED|Long-Term Safety Phase (Year 5)||0
2423369|NCT01212757|5944131|P6|COMPLETED|Long-Term Safety Phase (Year 5)||0
2423370|NCT01212757|5944132|P5|COMPLETED|Long-Term Safety Phase (Year 5)||0
2423371|NCT01212757|5944133|P4|COMPLETED|Long-Term Safety Phase (Year 5)||0
2423372|NCT01212757|5944134|P3|COMPLETED|Long-Term Safety Phase (Year 5)||69
2423373|NCT01212757|5944135|P2|COMPLETED|Long-Term Safety Phase (Year 5)||72
2423374|NCT01212757|5944136|P1|COMPLETED|Long-Term Safety Phase (Year 5)||0
2423375|NCT01212757|5944128|P9|STARTED|Long-Term Safety Phase (Year 5)||39
2423376|NCT01212757|5944129|P8|STARTED|Long-Term Safety Phase (Year 5)|1 participant was only counted in year 5 but not in 4 year due to late APR dispensing|38
2423377|NCT01212757|5944130|P7|STARTED|Long-Term Safety Phase (Year 5)||0
2423378|NCT01212757|5944131|P6|STARTED|Long-Term Safety Phase (Year 5)||0
2423379|NCT01212757|5944132|P5|STARTED|Long-Term Safety Phase (Year 5)||0
2423380|NCT01212757|5944133|P4|STARTED|Long-Term Safety Phase (Year 5)||0
2423381|NCT01212757|5944134|P3|STARTED|Long-Term Safety Phase (Year 5)||77
2423382|NCT01212757|5944135|P2|STARTED|Long-Term Safety Phase (Year 5)||80
2423383|NCT01212757|5944136|P1|STARTED|Long-Term Safety Phase (Year 5)||0
2423384|NCT01212757|5944128|P9|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7
2423385|NCT01212757|5944129|P8|NOT COMPLETED|Long-Term Safety Phase (Year 4)||4
2423386|NCT01212757|5944130|P7|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
2423387|NCT01212757|5944131|P6|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
2423388|NCT01212757|5944132|P5|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
2423389|NCT01212757|5944133|P4|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
2423390|NCT01212757|5944134|P3|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7
2423391|NCT01212757|5944135|P2|NOT COMPLETED|Long-Term Safety Phase (Year 4)||9
2423392|NCT01212757|5944136|P1|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
2423393|NCT01212757|5944128|P9|COMPLETED|Long-Term Safety Phase (Year 4)||39
2423394|NCT01212757|5944129|P8|COMPLETED|Long-Term Safety Phase (Year 4)||37
2423395|NCT01212757|5944130|P7|COMPLETED|Long-Term Safety Phase (Year 4)||0
2423396|NCT01212757|5944131|P6|COMPLETED|Long-Term Safety Phase (Year 4)||0
2423397|NCT01212757|5944132|P5|COMPLETED|Long-Term Safety Phase (Year 4)||0
2423398|NCT01212757|5944133|P4|COMPLETED|Long-Term Safety Phase (Year 4)||0
2423399|NCT01212757|5944134|P3|COMPLETED|Long-Term Safety Phase (Year 4)||77
2423400|NCT01212757|5944135|P2|COMPLETED|Long-Term Safety Phase (Year 4)||80
2423401|NCT01212757|5944136|P1|COMPLETED|Long-Term Safety Phase (Year 4)||0
2423402|NCT01212757|5944128|P9|STARTED|Long-Term Safety Phase (Year 4)||46
2423403|NCT01212757|5944129|P8|STARTED|Long-Term Safety Phase (Year 4)|1 participant who completed Year 3 did not continue treatment in Year 4|41
2423404|NCT01212757|5944130|P7|STARTED|Long-Term Safety Phase (Year 4)||0
2423405|NCT01212757|5944131|P6|STARTED|Long-Term Safety Phase (Year 4)||0
2423406|NCT01212757|5944132|P5|STARTED|Long-Term Safety Phase (Year 4)||0
2423407|NCT01212757|5944133|P4|STARTED|Long-Term Safety Phase (Year 4)||0
2423408|NCT01212757|5944134|P3|STARTED|Long-Term Safety Phase (Year 4)||84
2423409|NCT01212757|5944135|P2|STARTED|Long-Term Safety Phase (Year 4)||89
2423410|NCT01212757|5944136|P1|STARTED|Long-Term Safety Phase (Year 4)||0
2423411|NCT01212757|5944128|P9|NOT COMPLETED|Long-Term Safety Phase (Year 3)||5
2423412|NCT01212757|5944129|P8|NOT COMPLETED|Long-Term Safety Phase (Year 3)||6
2423413|NCT01212757|5944130|P7|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
2423414|NCT01212757|5944131|P6|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
2423415|NCT01212757|5944132|P5|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
2423416|NCT01212757|5944133|P4|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
2423417|NCT01212757|5944134|P3|NOT COMPLETED|Long-Term Safety Phase (Year 3)||11
2423418|NCT01212757|5944135|P2|NOT COMPLETED|Long-Term Safety Phase (Year 3)||18
2423419|NCT01212757|5944136|P1|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
2423420|NCT01212757|5944128|P9|COMPLETED|Long-Term Safety Phase (Year 3)||46
2423421|NCT01212757|5944129|P8|COMPLETED|Long-Term Safety Phase (Year 3)||42
2423422|NCT01212757|5944130|P7|COMPLETED|Long-Term Safety Phase (Year 3)||0
2423423|NCT01212757|5944131|P6|COMPLETED|Long-Term Safety Phase (Year 3)||0
2423424|NCT01212757|5944132|P5|COMPLETED|Long-Term Safety Phase (Year 3)||0
2423425|NCT01212757|5944133|P4|COMPLETED|Long-Term Safety Phase (Year 3)||0
2423426|NCT01212757|5944134|P3|COMPLETED|Long-Term Safety Phase (Year 3)||84
2423427|NCT01212757|5944135|P2|COMPLETED|Long-Term Safety Phase (Year 3)||89
2423428|NCT01212757|5944136|P1|COMPLETED|Long-Term Safety Phase (Year 3)||0
2423429|NCT01212757|5944128|P9|STARTED|Long-Term Safety Phase (Year 3)||51
2423430|NCT01212757|5944129|P8|STARTED|Long-Term Safety Phase (Year 3)||48
2423431|NCT01212757|5944130|P7|STARTED|Long-Term Safety Phase (Year 3)||0
2423432|NCT01212757|5944131|P6|STARTED|Long-Term Safety Phase (Year 3)||0
2423433|NCT01212757|5944132|P5|STARTED|Long-Term Safety Phase (Year 3)||0
2423434|NCT01212757|5944133|P4|STARTED|Long-Term Safety Phase (Year 3)||0
2423435|NCT01212757|5944134|P3|STARTED|Long-Term Safety Phase (Year 3)||95
2423436|NCT01212757|5944135|P2|STARTED|Long-Term Safety Phase (Year 3)||107
2423437|NCT01212757|5944136|P1|STARTED|Long-Term Safety Phase (Year 3)||0
2423438|NCT01212757|5944128|P9|NOT COMPLETED|Long-Term Safety Phase (Year 2)||9
2423439|NCT01212757|5944129|P8|NOT COMPLETED|Long-Term Safety Phase (Year 2)||10
2423440|NCT01212757|5944130|P7|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
2423441|NCT01212757|5944131|P6|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
2423442|NCT01212757|5944132|P5|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
2423443|NCT01212757|5944133|P4|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
2423444|NCT01212757|5944134|P3|NOT COMPLETED|Long-Term Safety Phase (Year 2)||14
2423445|NCT01212757|5944135|P2|NOT COMPLETED|Long-Term Safety Phase (Year 2)||12
2423446|NCT01212757|5944136|P1|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
2423447|NCT01212757|5944128|P9|COMPLETED|Long-Term Safety Phase (Year 2)||51
2423448|NCT01212757|5944129|P8|COMPLETED|Long-Term Safety Phase (Year 2)||48
2423449|NCT01212757|5944130|P7|COMPLETED|Long-Term Safety Phase (Year 2)||0
2423450|NCT01212757|5944131|P6|COMPLETED|Long-Term Safety Phase (Year 2)||0
2423451|NCT01212757|5944132|P5|COMPLETED|Long-Term Safety Phase (Year 2)||0
2423452|NCT01212757|5944133|P4|COMPLETED|Long-Term Safety Phase (Year 2)||0
2423453|NCT01212757|5944134|P3|COMPLETED|Long-Term Safety Phase (Year 2)||95
2423454|NCT01212757|5944135|P2|COMPLETED|Long-Term Safety Phase (Year 2)||107
2423455|NCT01212757|5944136|P1|COMPLETED|Long-Term Safety Phase (Year 2)||0
2423456|NCT01212757|5944128|P9|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 30EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|60
2423457|NCT01212757|5944129|P8|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 20EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|58
2423458|NCT01212757|5944130|P7|STARTED|Long-Term Safety Phase (Year 2)||0
2423459|NCT01212757|5944131|P6|STARTED|Long-Term Safety Phase (Year 2)||0
2423460|NCT01212757|5944132|P5|STARTED|Long-Term Safety Phase (Year 2)||0
2423461|NCT01212757|5944133|P4|STARTED|Long-Term Safety Phase (Year 2)||0
2423462|NCT01212757|5944134|P3|STARTED|Long-Term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|109
2423463|NCT01212757|5944135|P2|STARTED|Long-Term Safety Phase (Year 2)|6 participants who completed Week 52 did not enter the long-term safety phase|119
2423464|NCT01212757|5944136|P1|STARTED|Long-Term Safety Phase (Year 2)||0
2423465|NCT01212757|5944128|P9|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
2423466|NCT01212757|5944129|P8|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
2423467|NCT01212757|5944130|P7|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
2423468|NCT01212757|5944131|P6|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||7
2423469|NCT01212757|5944132|P5|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||2
2423470|NCT01212757|5944133|P4|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||8
2423628|NCT01212107|5944478|P2|COMPLETED|Overall Study||2
2423471|NCT01212757|5944134|P3|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||20
2423472|NCT01212757|5944135|P2|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12
2423473|NCT01212757|5944136|P1|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
2423474|NCT01212757|5944128|P9|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
2423475|NCT01212757|5944129|P8|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
2423476|NCT01212757|5944130|P7|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||28
2423477|NCT01212757|5944131|P6|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||34
2423478|NCT01212757|5944132|P5|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||25
2423479|NCT01212757|5944133|P4|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||35
2423480|NCT01212757|5944134|P3|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||114
2423481|NCT01212757|5944135|P2|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||125
2423482|NCT01212757|5944136|P1|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
2423483|NCT01212757|5944128|P9|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
2423484|NCT01212757|5944129|P8|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
2423485|NCT01212757|5944130|P7|STARTED|Active Treatment Phase (Weeks 24 - 52)||28
2423486|NCT01212757|5944131|P6|STARTED|Active Treatment Phase (Weeks 24 - 52)|2 participants who EE and completed Week 24 did not enter the Week 24-52 active treatment phase|41
2423487|NCT01212757|5944132|P5|STARTED|Active Treatment Phase (Weeks 24 - 52)||27
2423488|NCT01212757|5944133|P4|STARTED|Active Treatment Phase (Weeks 24 - 52)||43
2423489|NCT01212757|5944134|P3|STARTED|Active Treatment Phase (Weeks 24 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|134
2423490|NCT01212757|5944135|P2|STARTED|Active Treatment Phase (Weeks 24 - 52)|6 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|137
2423491|NCT01212757|5944136|P1|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
2423492|NCT01212757|5944128|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2423493|NCT01212757|5944129|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2423494|NCT01212757|5944130|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2423495|NCT01212757|5944131|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2423496|NCT01212757|5944132|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2423497|NCT01212757|5944133|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2423498|NCT01212757|5944134|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||21
2423499|NCT01212757|5944135|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
2423500|NCT01212757|5944136|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||19
2423501|NCT01212757|5944128|P9|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2423502|NCT01212757|5944129|P8|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2423503|NCT01212757|5944130|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2423504|NCT01212757|5944131|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2423505|NCT01212757|5944132|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2423506|NCT01212757|5944133|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
2423507|NCT01212757|5944134|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||142
2423508|NCT01212757|5944135|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||143
2423509|NCT01212757|5944136|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants who completed Week 24 did not enter the active treatment phase|143
2423510|NCT01212757|5944128|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2423511|NCT01212757|5944129|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2423512|NCT01212757|5944130|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2423513|NCT01212757|5944131|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2423514|NCT01212757|5944132|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2423515|NCT01212757|5944133|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2423516|NCT01212757|5944134|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||64
2423517|NCT01212757|5944135|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Three participants who escaped early did not complete Week 24|59
2423518|NCT01212757|5944136|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Two participants who escaped early did not complete Week 24|88
2423519|NCT01212757|5944128|P9|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2423520|NCT01212757|5944129|P8|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2423521|NCT01212757|5944130|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2423522|NCT01212757|5944131|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2423523|NCT01212757|5944132|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2423524|NCT01212757|5944133|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
2423525|NCT01212757|5944134|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||149
2423526|NCT01212757|5944135|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||151
2423527|NCT01212757|5944136|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||148
2423528|NCT01212757|5944128|P9|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
2423529|NCT01212757|5944129|P8|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
2423530|NCT01212757|5944130|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
2423531|NCT01212757|5944131|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
2423532|NCT01212757|5944132|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
2423533|NCT01212757|5944133|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
2423534|NCT01212757|5944134|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||162
2423535|NCT01212757|5944135|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||163
2423536|NCT01212757|5944136|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||159
2423537|NCT01212757|5944128|P9|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
2423538|NCT01212757|5944129|P8|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
2423539|NCT01212757|5944130|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
2423540|NCT01212757|5944131|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
2423541|NCT01212757|5944132|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
2423542|NCT01212757|5944133|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
2423543|NCT01212757|5944134|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
2423544|NCT01212757|5944135|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
2423545|NCT01212757|5944136|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||162
2423546|NCT01212744|5944320|P1|NOT COMPLETED|Overall Study||1
2423547|NCT01212744|5944320|P1|COMPLETED|Overall Study||15
2423548|NCT01212744|5944320|P1|STARTED|Overall Study||16
2423549|NCT01212627|5944333|P1|NOT COMPLETED|Overall Study||0
2423550|NCT01212627|5944333|P1|COMPLETED|Overall Study||12
2423551|NCT01212627|5944333|P1|STARTED|Overall Study||12
2423552|NCT01212588|5944339|P2|NOT COMPLETED|Overall Study||2
2423553|NCT01212588|5944340|P1|NOT COMPLETED|Overall Study||1
2423554|NCT01212588|5944339|P2|COMPLETED|Overall Study||10
2423555|NCT01212588|5944340|P1|COMPLETED|Overall Study||9
2423556|NCT01212588|5944339|P2|STARTED|Overall Study||12
2423557|NCT01212588|5944340|P1|STARTED|Overall Study||10
2423558|NCT01212484|5944374|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
2423559|NCT01212484|5944375|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
2423560|NCT01212484|5944374|P2|COMPLETED|Second Intervention (4 Weeks)||3
2423561|NCT01212484|5944375|P1|COMPLETED|Second Intervention (4 Weeks)||5
2423562|NCT01212484|5944374|P2|STARTED|Second Intervention (4 Weeks)||4
2423563|NCT01212484|5944375|P1|STARTED|Second Intervention (4 Weeks)||5
2423564|NCT01212484|5944374|P2|NOT COMPLETED|First Intervention (4 Weeks)||2
2423565|NCT01212484|5944375|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
2423566|NCT01212484|5944374|P2|COMPLETED|First Intervention (4 Weeks)||4
2423567|NCT01212484|5944375|P1|COMPLETED|First Intervention (4 Weeks)||5
2423568|NCT01212484|5944374|P2|STARTED|First Intervention (4 Weeks)||6
2423569|NCT01212484|5944375|P1|STARTED|First Intervention (4 Weeks)||5
2423570|NCT01212484|5944374|P2|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||0
2423571|NCT01212484|5944375|P1|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||1
2423572|NCT01212484|5944374|P2|COMPLETED|Carbidopa Titration Period (4 Weeks)||6
2423573|NCT01212484|5944375|P1|COMPLETED|Carbidopa Titration Period (4 Weeks)||5
2423574|NCT01212484|5944374|P2|STARTED|Carbidopa Titration Period (4 Weeks)||6
2423575|NCT01212484|5944375|P1|STARTED|Carbidopa Titration Period (4 Weeks)||6
2423576|NCT01212445|5944388|P3|NOT COMPLETED|Overall Study||0
2423577|NCT01212445|5944389|P2|NOT COMPLETED|Overall Study||0
2423578|NCT01212445|5944390|P1|NOT COMPLETED|Overall Study||0
2423579|NCT01212445|5944388|P3|COMPLETED|Overall Study||51
2423580|NCT01212445|5944389|P2|COMPLETED|Overall Study||51
2423581|NCT01212445|5944390|P1|COMPLETED|Overall Study||52
2423582|NCT01212445|5944388|P3|STARTED|Overall Study||51
2423583|NCT01212445|5944389|P2|STARTED|Overall Study||51
2423584|NCT01212445|5944390|P1|STARTED|Overall Study||52
2423585|NCT01212302|5944419|P1|NOT COMPLETED|Overall Study||0
2423586|NCT01212302|5944419|P1|COMPLETED|Overall Study||504
2423587|NCT01212302|5944419|P1|STARTED|Overall Study||504
2423588|NCT01212185|5944425|P2|NOT COMPLETED|Overall Study||1
2423589|NCT01212185|5944426|P1|NOT COMPLETED|Overall Study||2
2423590|NCT01212185|5944425|P2|COMPLETED|Overall Study||7
2423591|NCT01212185|5944426|P1|COMPLETED|Overall Study||4
2423592|NCT01212185|5944425|P2|STARTED|Overall Study||8
2423593|NCT01212185|5944426|P1|STARTED|Overall Study||6
2423594|NCT01212172|5944434|P2|NOT COMPLETED|Overall Study||1
2423595|NCT01212172|5944435|P1|NOT COMPLETED|Overall Study||1
2423596|NCT01212172|5944434|P2|COMPLETED|Overall Study||9
2423597|NCT01212172|5944435|P1|COMPLETED|Overall Study||9
2423598|NCT01212172|5944434|P2|STARTED|Overall Study||10
2423599|NCT01212172|5944435|P1|STARTED|Overall Study||10
2423600|NCT01212159|5944445|P2|NOT COMPLETED|Overall Study||12
2423601|NCT01212159|5944446|P1|NOT COMPLETED|Overall Study||12
2423602|NCT01212159|5944445|P2|COMPLETED|Overall Study||32
2423603|NCT01212159|5944446|P1|COMPLETED|Overall Study||14
2423604|NCT01212159|5944445|P2|STARTED|Overall Study||44
2423605|NCT01212159|5944446|P1|STARTED|Overall Study||26
2423606|NCT01212107|5944468|P12|NOT COMPLETED|Overall Study||32
2423607|NCT01212107|5944469|P11|NOT COMPLETED|Overall Study||1
2423608|NCT01212107|5944470|P10|NOT COMPLETED|Overall Study||2
2423609|NCT01212107|5944471|P9|NOT COMPLETED|Overall Study||2
2423610|NCT01212107|5944472|P8|NOT COMPLETED|Overall Study||1
2423611|NCT01212107|5944473|P7|NOT COMPLETED|Overall Study||0
2423612|NCT01212107|5944474|P6|NOT COMPLETED|Overall Study||1
2423613|NCT01212107|5944475|P5|NOT COMPLETED|Overall Study||1
2423614|NCT01212107|5944476|P4|NOT COMPLETED|Overall Study||0
2423615|NCT01212107|5944477|P3|NOT COMPLETED|Overall Study||3
2423616|NCT01212107|5944478|P2|NOT COMPLETED|Overall Study||1
2423617|NCT01212107|5944479|P1|NOT COMPLETED|Overall Study||1
2423618|NCT01212107|5944468|P12|COMPLETED|Overall Study||26
2423619|NCT01212107|5944469|P11|COMPLETED|Overall Study||2
2423620|NCT01212107|5944470|P10|COMPLETED|Overall Study||1
2423621|NCT01212107|5944471|P9|COMPLETED|Overall Study||1
2423622|NCT01212107|5944472|P8|COMPLETED|Overall Study||2
2423623|NCT01212107|5944473|P7|COMPLETED|Overall Study||3
2423624|NCT01212107|5944474|P6|COMPLETED|Overall Study||2
2423625|NCT01212107|5944475|P5|COMPLETED|Overall Study||2
2423626|NCT01212107|5944476|P4|COMPLETED|Overall Study||3
2423627|NCT01212107|5944477|P3|COMPLETED|Overall Study||3
2423629|NCT01212107|5944479|P1|COMPLETED|Overall Study||2
2423630|NCT01212107|5944468|P12|STARTED|Overall Study||58
2423631|NCT01212107|5944469|P11|STARTED|Overall Study||3
2423632|NCT01212107|5944470|P10|STARTED|Overall Study||3
2423633|NCT01212107|5944471|P9|STARTED|Overall Study||3
2423634|NCT01212107|5944472|P8|STARTED|Overall Study||3
2423635|NCT01212107|5944473|P7|STARTED|Overall Study||3
2423636|NCT01212107|5944474|P6|STARTED|Overall Study||3
2423637|NCT01212107|5944475|P5|STARTED|Overall Study||3
2423638|NCT01212107|5944476|P4|STARTED|Overall Study||3
2423639|NCT01212107|5944477|P3|STARTED|Overall Study||6
2423640|NCT01212107|5944478|P2|STARTED|Overall Study||3
2423641|NCT01212107|5944479|P1|STARTED|Overall Study||3
2423642|NCT01212094|5944545|P3|NOT COMPLETED|Years 2 & 3: Treatment Randomization||11
2423643|NCT01212094|5944546|P2|NOT COMPLETED|Years 2 & 3: Treatment Randomization||4
2423644|NCT01212094|5944547|P1|NOT COMPLETED|Years 2 & 3: Treatment Randomization||0
2423645|NCT01212094|5944545|P3|COMPLETED|Years 2 & 3: Treatment Randomization||7
2423646|NCT01212094|5944546|P2|COMPLETED|Years 2 & 3: Treatment Randomization||5
2423647|NCT01212094|5944547|P1|COMPLETED|Years 2 & 3: Treatment Randomization||0
2423648|NCT01212094|5944545|P3|STARTED|Years 2 & 3: Treatment Randomization||18
2423649|NCT01212094|5944546|P2|STARTED|Years 2 & 3: Treatment Randomization||9
2423650|NCT01212094|5944547|P1|STARTED|Years 2 & 3: Treatment Randomization||0
2423651|NCT01212094|5944545|P3|NOT COMPLETED|Year 1: Baseline Monitoring||0
2423652|NCT01212094|5944546|P2|NOT COMPLETED|Year 1: Baseline Monitoring||0
2423653|NCT01212094|5944547|P1|NOT COMPLETED|Year 1: Baseline Monitoring||16
2423654|NCT01212094|5944545|P3|COMPLETED|Year 1: Baseline Monitoring||0
2423655|NCT01212094|5944546|P2|COMPLETED|Year 1: Baseline Monitoring||0
2423656|NCT01212094|5944547|P1|COMPLETED|Year 1: Baseline Monitoring||27
2423657|NCT01212094|5944545|P3|STARTED|Year 1: Baseline Monitoring||0
2423658|NCT01212094|5944546|P2|STARTED|Year 1: Baseline Monitoring||0
2423659|NCT01212094|5944547|P1|STARTED|Year 1: Baseline Monitoring||43
2423660|NCT01211873|5944581|P3|NOT COMPLETED|Overall Study||2
2423661|NCT01211873|5944582|P2|NOT COMPLETED|Overall Study||2
2423662|NCT01211873|5944583|P1|NOT COMPLETED|Overall Study||5
2423663|NCT01211873|5944581|P3|COMPLETED|Overall Study||36
2423664|NCT01211873|5944582|P2|COMPLETED|Overall Study||117
2423665|NCT01211873|5944583|P1|COMPLETED|Overall Study||240
2423666|NCT01211873|5944581|P3|STARTED|Overall Study||38
2423667|NCT01211873|5944582|P2|STARTED|Overall Study||119
2423668|NCT01211873|5944583|P1|STARTED|Overall Study||245
2423669|NCT01211769|5944606|P4|NOT COMPLETED|Overall Study||11
2423670|NCT01211769|5944607|P3|NOT COMPLETED|Overall Study||8
2423671|NCT01211769|5944608|P2|NOT COMPLETED|Overall Study||10
2423672|NCT01211769|5944609|P1|NOT COMPLETED|Overall Study||9
2423673|NCT01211769|5944606|P4|COMPLETED|Overall Study||9
2423674|NCT01211769|5944607|P3|COMPLETED|Overall Study||12
2423675|NCT01211769|5944608|P2|COMPLETED|Overall Study||10
2423676|NCT01211769|5944609|P1|COMPLETED|Overall Study||11
2423677|NCT01211769|5944606|P4|Participants/Group|Overall Study||20
2423678|NCT01211769|5944607|P3|Participants/Group|Overall Study||20
2423679|NCT01211769|5944608|P2|Participants/Group|Overall Study||20
2423680|NCT01211769|5944609|P1|Participants/Group|Overall Study||20
2423681|NCT01211769|5944606|P4|STARTED|Overall Study||20
2423682|NCT01211769|5944607|P3|STARTED|Overall Study||20
2423683|NCT01211769|5944608|P2|STARTED|Overall Study||20
2423684|NCT01211769|5944609|P1|STARTED|Overall Study||20
2423685|NCT01211756|5944627|P1|NOT COMPLETED|Overall Study||0
2423686|NCT01211756|5944627|P1|COMPLETED|Overall Study||1
2423687|NCT01211756|5944627|P1|STARTED|Overall Study||1
2423688|NCT01211730|5944645|P2|NOT COMPLETED|Overall Study||0
2423689|NCT01211730|5944646|P1|NOT COMPLETED|Overall Study||0
2423690|NCT01211730|5944645|P2|COMPLETED|Overall Study||82
2423691|NCT01211730|5944646|P1|COMPLETED|Overall Study||82
2423692|NCT01211730|5944645|P2|STARTED|Overall Study||82
2423693|NCT01211730|5944646|P1|STARTED|Overall Study||82
2423694|NCT01211665|5944664|P2|NOT COMPLETED|Overall Study||0
2423695|NCT01211665|5944665|P1|NOT COMPLETED|Overall Study||2
2423696|NCT01211665|5944664|P2|COMPLETED|Overall Study|completed treatment with study drug|1
2423697|NCT01211665|5944665|P1|COMPLETED|Overall Study||0
2423698|NCT01211665|5944664|P2|STARTED|Overall Study||1
2423699|NCT01211665|5944665|P1|STARTED|Overall Study||2
2423700|NCT01211613|5944692|P3|NOT COMPLETED|Overall Study||2
2423701|NCT01211613|5944693|P2|NOT COMPLETED|Overall Study||2
2423702|NCT01211613|5944694|P1|NOT COMPLETED|Overall Study||3
2423703|NCT01211613|5944692|P3|COMPLETED|Overall Study||33
2423704|NCT01211613|5944693|P2|COMPLETED|Overall Study||33
2423705|NCT01211613|5944694|P1|COMPLETED|Overall Study||34
2423706|NCT01211613|5944692|P3|STARTED|Overall Study||35
2423707|NCT01211613|5944693|P2|STARTED|Overall Study||35
2423708|NCT01211613|5944694|P1|STARTED|Overall Study||37
2423709|NCT01211600|5944707|P2|NOT COMPLETED|Overall Study||0
2423710|NCT01211600|5944708|P1|NOT COMPLETED|Overall Study||0
2423711|NCT01211600|5944707|P2|COMPLETED|Overall Study||376
2423712|NCT01211600|5944708|P1|COMPLETED|Overall Study||370
2423713|NCT01211600|5944707|P2|STARTED|Overall Study||376
2423714|NCT01211600|5944708|P1|STARTED|Overall Study||370
2423715|NCT01211535|5944740|P2|NOT COMPLETED|Overall Study||1
2423716|NCT01211535|5944741|P1|NOT COMPLETED|Overall Study||0
2423717|NCT01211535|5944740|P2|COMPLETED|Overall Study||51
2423718|NCT01211535|5944741|P1|COMPLETED|Overall Study||52
2423719|NCT01211535|5944740|P2|STARTED|Overall Study||52
2423720|NCT01211535|5944741|P1|STARTED|Overall Study||52
2423721|NCT01211522|5944750|P3|NOT COMPLETED|Overall Study||5
2423722|NCT01211522|5944751|P2|NOT COMPLETED|Overall Study||7
2423723|NCT01211522|5944752|P1|NOT COMPLETED|Overall Study||3
2423724|NCT01211522|5944750|P3|COMPLETED|Overall Study||179
2423725|NCT01211522|5944751|P2|COMPLETED|Overall Study||183
2423726|NCT01211522|5944752|P1|COMPLETED|Overall Study||189
2423727|NCT01211522|5944750|P3|STARTED|Overall Study||184
2423728|NCT01211522|5944751|P2|STARTED|Overall Study||190
2423729|NCT01211522|5944752|P1|STARTED|Overall Study||192
2423730|NCT01211340|5944789|P2|NOT COMPLETED|Overall Study||0
2423731|NCT01211340|5944790|P1|NOT COMPLETED|Overall Study||0
2423732|NCT01211340|5944789|P2|COMPLETED|Overall Study||223
2423733|NCT01211340|5944790|P1|COMPLETED|Overall Study||223
2423734|NCT01211340|5944789|P2|STARTED|Overall Study||223
2423735|NCT01211340|5944790|P1|STARTED|Overall Study||223
2423736|NCT01211197|5944800|P6|NOT COMPLETED|Treatment Period 3 (1 Day)||0
2423737|NCT01211197|5944801|P5|NOT COMPLETED|Treatment Period 3 (1 Day)||0
2423738|NCT01211197|5944802|P4|NOT COMPLETED|Treatment Period 3 (1 Day)||0
2423739|NCT01211197|5944803|P3|NOT COMPLETED|Treatment Period 3 (1 Day)||0
2423740|NCT01211197|5944804|P2|NOT COMPLETED|Treatment Period 3 (1 Day)||0
2423741|NCT01211197|5944805|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
2423742|NCT01211197|5944800|P6|COMPLETED|Treatment Period 3 (1 Day)||2
2423743|NCT01211197|5944801|P5|COMPLETED|Treatment Period 3 (1 Day)||2
2423744|NCT01211197|5944802|P4|COMPLETED|Treatment Period 3 (1 Day)||3
2423745|NCT01211197|5944803|P3|COMPLETED|Treatment Period 3 (1 Day)||2
2423746|NCT01211197|5944804|P2|COMPLETED|Treatment Period 3 (1 Day)||3
2423747|NCT01211197|5944805|P1|COMPLETED|Treatment Period 3 (1 Day)||2
2423748|NCT01211197|5944800|P6|STARTED|Treatment Period 3 (1 Day)||2
2423749|NCT01211197|5944801|P5|STARTED|Treatment Period 3 (1 Day)||2
2423750|NCT01211197|5944802|P4|STARTED|Treatment Period 3 (1 Day)||3
2423751|NCT01211197|5944803|P3|STARTED|Treatment Period 3 (1 Day)||2
2423752|NCT01211197|5944804|P2|STARTED|Treatment Period 3 (1 Day)||3
2423753|NCT01211197|5944805|P1|STARTED|Treatment Period 3 (1 Day)||2
2423754|NCT01211197|5944800|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
2423755|NCT01211197|5944801|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
2423756|NCT01211197|5944802|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
2423757|NCT01211197|5944803|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
2423758|NCT01211197|5944804|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
2423759|NCT01211197|5944805|P1|NOT COMPLETED|Washout Period 2 (7 Days)||1
2423760|NCT01211197|5944800|P6|COMPLETED|Washout Period 2 (7 Days)||2
2423761|NCT01211197|5944801|P5|COMPLETED|Washout Period 2 (7 Days)||2
2423762|NCT01211197|5944802|P4|COMPLETED|Washout Period 2 (7 Days)||3
2423763|NCT01211197|5944803|P3|COMPLETED|Washout Period 2 (7 Days)||2
2423764|NCT01211197|5944804|P2|COMPLETED|Washout Period 2 (7 Days)||3
2423765|NCT01211197|5944805|P1|COMPLETED|Washout Period 2 (7 Days)||2
2423766|NCT01211197|5944800|P6|STARTED|Washout Period 2 (7 Days)||2
2423767|NCT01211197|5944801|P5|STARTED|Washout Period 2 (7 Days)||2
2423768|NCT01211197|5944802|P4|STARTED|Washout Period 2 (7 Days)||3
2423769|NCT01211197|5944803|P3|STARTED|Washout Period 2 (7 Days)||2
2423770|NCT01211197|5944804|P2|STARTED|Washout Period 2 (7 Days)||3
2423771|NCT01211197|5944805|P1|STARTED|Washout Period 2 (7 Days)||3
2423772|NCT01211197|5944800|P6|NOT COMPLETED|Treatment Period 2 (1 Day)||0
2423773|NCT01211197|5944801|P5|NOT COMPLETED|Treatment Period 2 (1 Day)||0
2423774|NCT01211197|5944802|P4|NOT COMPLETED|Treatment Period 2 (1 Day)||0
2423775|NCT01211197|5944803|P3|NOT COMPLETED|Treatment Period 2 (1 Day)||0
2423776|NCT01211197|5944804|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
2423777|NCT01211197|5944805|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
2423778|NCT01211197|5944800|P6|COMPLETED|Treatment Period 2 (1 Day)||2
2423779|NCT01211197|5944801|P5|COMPLETED|Treatment Period 2 (1 Day)||2
2423780|NCT01211197|5944802|P4|COMPLETED|Treatment Period 2 (1 Day)||3
2423781|NCT01211197|5944803|P3|COMPLETED|Treatment Period 2 (1 Day)||2
2423782|NCT01211197|5944804|P2|COMPLETED|Treatment Period 2 (1 Day)||3
2423783|NCT01211197|5944805|P1|COMPLETED|Treatment Period 2 (1 Day)||3
2423784|NCT01211197|5944800|P6|STARTED|Treatment Period 2 (1 Day)||2
2423785|NCT01211197|5944801|P5|STARTED|Treatment Period 2 (1 Day)||2
2423786|NCT01211197|5944802|P4|STARTED|Treatment Period 2 (1 Day)||3
2423787|NCT01211197|5944803|P3|STARTED|Treatment Period 2 (1 Day)||2
2423788|NCT01211197|5944804|P2|STARTED|Treatment Period 2 (1 Day)||3
2423789|NCT01211197|5944805|P1|STARTED|Treatment Period 2 (1 Day)||3
2423790|NCT01211197|5944800|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
2423791|NCT01211197|5944801|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
2423792|NCT01211197|5944802|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
2423793|NCT01211197|5944803|P3|NOT COMPLETED|Washout Period 1 (7 Days)||1
2423794|NCT01211197|5944804|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
2423795|NCT01211197|5944805|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
2423796|NCT01211197|5944800|P6|COMPLETED|Washout Period 1 (7 Days)||2
2423797|NCT01211197|5944801|P5|COMPLETED|Washout Period 1 (7 Days)||2
2423798|NCT01211197|5944802|P4|COMPLETED|Washout Period 1 (7 Days)||3
2423799|NCT01211197|5944803|P3|COMPLETED|Washout Period 1 (7 Days)||2
2423800|NCT01211197|5944804|P2|COMPLETED|Washout Period 1 (7 Days)||3
2423801|NCT01211197|5944805|P1|COMPLETED|Washout Period 1 (7 Days)||3
2423802|NCT01211197|5944800|P6|STARTED|Washout Period 1 (7 Days)||2
2423803|NCT01211197|5944801|P5|STARTED|Washout Period 1 (7 Days)||2
2423804|NCT01211197|5944802|P4|STARTED|Washout Period 1 (7 Days)||3
2423805|NCT01211197|5944803|P3|STARTED|Washout Period 1 (7 Days)||3
2423806|NCT01211197|5944804|P2|STARTED|Washout Period 1 (7 Days)||3
2423807|NCT01211197|5944805|P1|STARTED|Washout Period 1 (7 Days)||3
2423808|NCT01211197|5944800|P6|NOT COMPLETED|Treatment Period 1 (1 Day)||0
2423809|NCT01211197|5944801|P5|NOT COMPLETED|Treatment Period 1 (1 Day)||0
2423810|NCT01211197|5944802|P4|NOT COMPLETED|Treatment Period 1 (1 Day)||0
2423811|NCT01211197|5944803|P3|NOT COMPLETED|Treatment Period 1 (1 Day)||0
2423812|NCT01211197|5944804|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
2423813|NCT01211197|5944805|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
2423814|NCT01211197|5944800|P6|COMPLETED|Treatment Period 1 (1 Day)||2
2423815|NCT01211197|5944801|P5|COMPLETED|Treatment Period 1 (1 Day)||2
2423816|NCT01211197|5944802|P4|COMPLETED|Treatment Period 1 (1 Day)||3
2423817|NCT01211197|5944803|P3|COMPLETED|Treatment Period 1 (1 Day)||3
2423818|NCT01211197|5944804|P2|COMPLETED|Treatment Period 1 (1 Day)||3
2423819|NCT01211197|5944805|P1|COMPLETED|Treatment Period 1 (1 Day)||3
2423820|NCT01211197|5944800|P6|STARTED|Treatment Period 1 (1 Day)||2
2423821|NCT01211197|5944801|P5|STARTED|Treatment Period 1 (1 Day)||2
2423822|NCT01211197|5944802|P4|STARTED|Treatment Period 1 (1 Day)||3
2423823|NCT01211197|5944803|P3|STARTED|Treatment Period 1 (1 Day)||3
2423824|NCT01211197|5944804|P2|STARTED|Treatment Period 1 (1 Day)||3
2423825|NCT01211197|5944805|P1|STARTED|Treatment Period 1 (1 Day)||3
2423826|NCT01211184|5944852|P3|NOT COMPLETED|Overall Study||1
2423827|NCT01211184|5944853|P2|NOT COMPLETED|Overall Study||2
2423828|NCT01211184|5944854|P1|NOT COMPLETED|Overall Study||0
2423829|NCT01211184|5944852|P3|COMPLETED|Overall Study||19
2423830|NCT01211184|5944853|P2|COMPLETED|Overall Study||18
2423831|NCT01211184|5944854|P1|COMPLETED|Overall Study||20
2423832|NCT01211184|5944852|P3|STARTED|Overall Study||20
2423833|NCT01211184|5944853|P2|STARTED|Overall Study||20
2423834|NCT01211184|5944854|P1|STARTED|Overall Study||20
2423835|NCT01211145|5944869|P4|NOT COMPLETED|Overall Study||20
2423836|NCT01211145|5944870|P3|NOT COMPLETED|Overall Study||13
2423837|NCT01211145|5944871|P2|NOT COMPLETED|Overall Study||17
2423838|NCT01211145|5944872|P1|NOT COMPLETED|Overall Study||26
2423839|NCT01211145|5944869|P4|COMPLETED|Overall Study||268
2423840|NCT01211145|5944870|P3|COMPLETED|Overall Study||86
2423841|NCT01211145|5944871|P2|COMPLETED|Overall Study||98
2423842|NCT01211145|5944872|P1|COMPLETED|Overall Study|1 patient was not counted as completed or discontinued due to incomplete information (N=270-1=269).|270
2423843|NCT01211145|5944869|P4|STARTED|Overall Study||288
2423844|NCT01211145|5944870|P3|STARTED|Overall Study||99
2423845|NCT01211145|5944871|P2|STARTED|Overall Study||115
2423846|NCT01211145|5944872|P1|STARTED|Overall Study||296
2423847|NCT01211106|5944904|P2|NOT COMPLETED|Overall Study||11
2423848|NCT01211106|5944905|P1|NOT COMPLETED|Overall Study||13
2423849|NCT01211106|5944904|P2|COMPLETED|Overall Study||77
2423850|NCT01211106|5944905|P1|COMPLETED|Overall Study||82
2423851|NCT01211106|5944904|P2|STARTED|Overall Study||88
2423852|NCT01211106|5944905|P1|STARTED|Overall Study||95
2423853|NCT01210820|5944915|P2|NOT COMPLETED|Overall Study||0
2423854|NCT01210820|5944916|P1|NOT COMPLETED|Overall Study||0
2423855|NCT01210820|5944915|P2|COMPLETED|Overall Study||4
2423856|NCT01210820|5944916|P1|COMPLETED|Overall Study||17
2423857|NCT01210820|5944915|P2|STARTED|Overall Study||4
2423858|NCT01210820|5944916|P1|STARTED|Overall Study||17
2423859|NCT01210807|5944926|P2|NOT COMPLETED|Overall Study||3
2423860|NCT01210807|5944927|P1|NOT COMPLETED|Overall Study||3
2423861|NCT01210807|5944926|P2|COMPLETED|Overall Study||31
2423862|NCT01210807|5944927|P1|COMPLETED|Overall Study||33
2423863|NCT01210807|5944926|P2|STARTED|Overall Study||34
2423864|NCT01210807|5944927|P1|STARTED|Overall Study||36
2423865|NCT01210716|5944935|P2|NOT COMPLETED|Second TPE Procedure||0
2423866|NCT01210716|5944936|P1|NOT COMPLETED|Second TPE Procedure||3
2423867|NCT01210716|5944935|P2|COMPLETED|Second TPE Procedure||15
2423868|NCT01210716|5944936|P1|COMPLETED|Second TPE Procedure||15
2423869|NCT01210716|5944935|P2|STARTED|Second TPE Procedure||15
2423870|NCT01210716|5944936|P1|STARTED|Second TPE Procedure||18
2423871|NCT01210716|5944935|P2|NOT COMPLETED|First TPE Procedure||2
2423872|NCT01210716|5944936|P1|NOT COMPLETED|First TPE Procedure||2
2423873|NCT01210716|5944935|P2|COMPLETED|First TPE Procedure||15
2423874|NCT01210716|5944936|P1|COMPLETED|First TPE Procedure||18
2423875|NCT01210716|5944935|P2|STARTED|First TPE Procedure||17
2423876|NCT01210716|5944936|P1|STARTED|First TPE Procedure||20
2423877|NCT01210690|5944942|P1|NOT COMPLETED|Overall Study||26
2423878|NCT01210690|5944942|P1|COMPLETED|Overall Study||75
2423879|NCT01210690|5944942|P1|STARTED|Overall Study||101
2423880|NCT01210664|5944955|P4|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||1
2423881|NCT01210664|5944956|P3|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
2423882|NCT01210664|5944957|P2|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
2423883|NCT01210664|5944958|P1|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
2423884|NCT01210664|5944955|P4|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||4
2423885|NCT01210664|5944956|P3|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
2423886|NCT01210664|5944957|P2|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
2423887|NCT01210664|5944958|P1|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
2423888|NCT01210664|5944955|P4|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||4
2423889|NCT01210664|5944956|P3|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
2423890|NCT01210664|5944957|P2|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
2423891|NCT01210664|5944958|P1|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
2423892|NCT01210664|5944955|P4|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||5
2423893|NCT01210664|5944956|P3|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
2423894|NCT01210664|5944957|P2|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
2423895|NCT01210664|5944958|P1|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
2423896|NCT01210664|5944955|P4|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
2423897|NCT01210664|5944956|P3|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||2
2423898|NCT01210664|5944957|P2|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
2423899|NCT01210664|5944958|P1|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
2423900|NCT01210664|5944955|P4|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
2423901|NCT01210664|5944956|P3|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||3
2423902|NCT01210664|5944957|P2|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
2423903|NCT01210664|5944958|P1|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
2423904|NCT01210664|5944955|P4|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
2423905|NCT01210664|5944956|P3|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||4
2423906|NCT01210664|5944957|P2|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
2423907|NCT01210664|5944958|P1|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
2423908|NCT01210664|5944955|P4|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
2423909|NCT01210664|5944956|P3|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||5
2423910|NCT01210664|5944957|P2|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
2423911|NCT01210664|5944958|P1|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
2423912|NCT01210664|5944955|P4|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
2423913|NCT01210664|5944956|P3|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
2423914|NCT01210664|5944957|P2|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
2423915|NCT01210664|5944958|P1|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
2423916|NCT01210664|5944955|P4|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
2423917|NCT01210664|5944956|P3|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
2423918|NCT01210664|5944957|P2|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
2423919|NCT01210664|5944958|P1|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
2423920|NCT01210664|5944955|P4|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
2423921|NCT01210664|5944956|P3|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
2423922|NCT01210664|5944957|P2|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
2423923|NCT01210664|5944958|P1|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
2423924|NCT01210664|5944955|P4|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
2423925|NCT01210664|5944956|P3|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
2423926|NCT01210664|5944957|P2|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
2423927|NCT01210664|5944958|P1|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
2423928|NCT01210664|5944955|P4|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
2423929|NCT01210664|5944956|P3|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
2423930|NCT01210664|5944957|P2|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
2423931|NCT01210664|5944958|P1|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
2423932|NCT01210664|5944955|P4|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
2423933|NCT01210664|5944956|P3|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
2423934|NCT01210664|5944957|P2|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
2423935|NCT01210664|5944958|P1|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
2423936|NCT01210664|5944955|P4|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
2423937|NCT01210664|5944956|P3|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
2423938|NCT01210664|5944957|P2|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
2423939|NCT01210664|5944958|P1|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
2423940|NCT01210664|5944955|P4|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
2423941|NCT01210664|5944956|P3|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
2423942|NCT01210664|5944957|P2|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
2423943|NCT01210664|5944958|P1|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
2423944|NCT01210651|5944986|P2|NOT COMPLETED|Overall Study||8
2423945|NCT01210651|5944987|P1|NOT COMPLETED|Overall Study||5
2423946|NCT01210651|5944986|P2|COMPLETED|Overall Study||10
2423947|NCT01210651|5944987|P1|COMPLETED|Overall Study||15
2423948|NCT01210651|5944986|P2|Number Attending 1st Assigned Session|Overall Study||12
2423949|NCT01210651|5944987|P1|Number Attending 1st Assigned Session|Overall Study||18
2423950|NCT01210651|5944986|P2|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|18
2423951|NCT01210651|5944987|P1|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|20
2423952|NCT01210560|5945003|P9|NOT COMPLETED|Intervention 3 (7 Days)||0
2423953|NCT01210560|5945004|P8|NOT COMPLETED|Intervention 3 (7 Days)||0
2423954|NCT01210560|5945005|P7|NOT COMPLETED|Intervention 3 (7 Days)||0
2423955|NCT01210560|5945006|P6|NOT COMPLETED|Intervention 3 (7 Days)||0
2423956|NCT01210560|5945007|P5|NOT COMPLETED|Intervention 3 (7 Days)||0
2423957|NCT01210560|5945008|P4|NOT COMPLETED|Intervention 3 (7 Days)||0
2423958|NCT01210560|5945009|P3|NOT COMPLETED|Intervention 3 (7 Days)||0
2423959|NCT01210560|5945010|P2|NOT COMPLETED|Intervention 3 (7 Days)||0
2423960|NCT01210560|5945011|P1|NOT COMPLETED|Intervention 3 (7 Days)||0
2423961|NCT01210560|5945003|P9|COMPLETED|Intervention 3 (7 Days)||5
2423962|NCT01210560|5945004|P8|COMPLETED|Intervention 3 (7 Days)||4
2423963|NCT01210560|5945005|P7|COMPLETED|Intervention 3 (7 Days)||4
2423964|NCT01210560|5945006|P6|COMPLETED|Intervention 3 (7 Days)||2
2423965|NCT01210560|5945007|P5|COMPLETED|Intervention 3 (7 Days)||2
2423966|NCT01210560|5945008|P4|COMPLETED|Intervention 3 (7 Days)||2
2423967|NCT01210560|5945009|P3|COMPLETED|Intervention 3 (7 Days)||2
2423968|NCT01210560|5945010|P2|COMPLETED|Intervention 3 (7 Days)||2
2423969|NCT01210560|5945011|P1|COMPLETED|Intervention 3 (7 Days)||2
2423970|NCT01210560|5945003|P9|STARTED|Intervention 3 (7 Days)||5
2423971|NCT01210560|5945004|P8|STARTED|Intervention 3 (7 Days)||4
2423972|NCT01210560|5945005|P7|STARTED|Intervention 3 (7 Days)||4
2423973|NCT01210560|5945006|P6|STARTED|Intervention 3 (7 Days)||2
2423974|NCT01210560|5945007|P5|STARTED|Intervention 3 (7 Days)||2
2423975|NCT01210560|5945008|P4|STARTED|Intervention 3 (7 Days)||2
2423976|NCT01210560|5945009|P3|STARTED|Intervention 3 (7 Days)||2
2423977|NCT01210560|5945010|P2|STARTED|Intervention 3 (7 Days)||2
2423978|NCT01210560|5945011|P1|STARTED|Intervention 3 (7 Days)||2
2423979|NCT01210560|5945003|P9|NOT COMPLETED|Intervention 2 (7 Days)||0
2423980|NCT01210560|5945004|P8|NOT COMPLETED|Intervention 2 (7 Days)||0
2423981|NCT01210560|5945005|P7|NOT COMPLETED|Intervention 2 (7 Days)||0
2423982|NCT01210560|5945006|P6|NOT COMPLETED|Intervention 2 (7 Days)||0
2423983|NCT01210560|5945007|P5|NOT COMPLETED|Intervention 2 (7 Days)||0
2423984|NCT01210560|5945008|P4|NOT COMPLETED|Intervention 2 (7 Days)||0
2423985|NCT01210560|5945009|P3|NOT COMPLETED|Intervention 2 (7 Days)||0
2423986|NCT01210560|5945010|P2|NOT COMPLETED|Intervention 2 (7 Days)||0
2423987|NCT01210560|5945011|P1|NOT COMPLETED|Intervention 2 (7 Days)||0
2423988|NCT01210560|5945003|P9|COMPLETED|Intervention 2 (7 Days)||5
2423989|NCT01210560|5945004|P8|COMPLETED|Intervention 2 (7 Days)||4
2423990|NCT01210560|5945005|P7|COMPLETED|Intervention 2 (7 Days)||4
2423991|NCT01210560|5945006|P6|COMPLETED|Intervention 2 (7 Days)||2
2423992|NCT01210560|5945007|P5|COMPLETED|Intervention 2 (7 Days)||2
2423993|NCT01210560|5945008|P4|COMPLETED|Intervention 2 (7 Days)||2
2423994|NCT01210560|5945009|P3|COMPLETED|Intervention 2 (7 Days)||2
2423995|NCT01210560|5945010|P2|COMPLETED|Intervention 2 (7 Days)||2
2423996|NCT01210560|5945011|P1|COMPLETED|Intervention 2 (7 Days)||2
2423997|NCT01210560|5945003|P9|STARTED|Intervention 2 (7 Days)||5
2423998|NCT01210560|5945004|P8|STARTED|Intervention 2 (7 Days)||4
2423999|NCT01210560|5945005|P7|STARTED|Intervention 2 (7 Days)||4
2424000|NCT01210560|5945006|P6|STARTED|Intervention 2 (7 Days)||2
2424001|NCT01210560|5945007|P5|STARTED|Intervention 2 (7 Days)||2
2424002|NCT01210560|5945008|P4|STARTED|Intervention 2 (7 Days)||2
2424003|NCT01210560|5945009|P3|STARTED|Intervention 2 (7 Days)||2
2424004|NCT01210560|5945010|P2|STARTED|Intervention 2 (7 Days)||2
2424005|NCT01210560|5945011|P1|STARTED|Intervention 2 (7 Days)||2
2424006|NCT01210560|5945003|P9|NOT COMPLETED|Intervention 1 (7 Days)||0
2424007|NCT01210560|5945004|P8|NOT COMPLETED|Intervention 1 (7 Days)||0
2424008|NCT01210560|5945005|P7|NOT COMPLETED|Intervention 1 (7 Days)||0
2424009|NCT01210560|5945006|P6|NOT COMPLETED|Intervention 1 (7 Days)||0
2424010|NCT01210560|5945007|P5|NOT COMPLETED|Intervention 1 (7 Days)||0
2424011|NCT01210560|5945008|P4|NOT COMPLETED|Intervention 1 (7 Days)||0
2424012|NCT01210560|5945009|P3|NOT COMPLETED|Intervention 1 (7 Days)||0
2424013|NCT01210560|5945010|P2|NOT COMPLETED|Intervention 1 (7 Days)||0
2424014|NCT01210560|5945011|P1|NOT COMPLETED|Intervention 1 (7 Days)||0
2424015|NCT01210560|5945003|P9|COMPLETED|Intervention 1 (7 Days)||5
2424016|NCT01210560|5945004|P8|COMPLETED|Intervention 1 (7 Days)||4
2424017|NCT01210560|5945005|P7|COMPLETED|Intervention 1 (7 Days)||4
2424018|NCT01210560|5945006|P6|COMPLETED|Intervention 1 (7 Days)||2
2424019|NCT01210560|5945007|P5|COMPLETED|Intervention 1 (7 Days)||2
2424020|NCT01210560|5945008|P4|COMPLETED|Intervention 1 (7 Days)||2
2424021|NCT01210560|5945009|P3|COMPLETED|Intervention 1 (7 Days)||2
2424022|NCT01210560|5945010|P2|COMPLETED|Intervention 1 (7 Days)||2
2424023|NCT01210560|5945011|P1|COMPLETED|Intervention 1 (7 Days)||2
2424024|NCT01210560|5945003|P9|STARTED|Intervention 1 (7 Days)||5
2424025|NCT01210560|5945004|P8|STARTED|Intervention 1 (7 Days)||4
2424026|NCT01210560|5945005|P7|STARTED|Intervention 1 (7 Days)||4
2424027|NCT01210560|5945006|P6|STARTED|Intervention 1 (7 Days)||2
2424028|NCT01210560|5945007|P5|STARTED|Intervention 1 (7 Days)||2
2424029|NCT01210560|5945008|P4|STARTED|Intervention 1 (7 Days)||2
2424030|NCT01210560|5945009|P3|STARTED|Intervention 1 (7 Days)||2
2424031|NCT01210560|5945010|P2|STARTED|Intervention 1 (7 Days)||2
2424032|NCT01210560|5945011|P1|STARTED|Intervention 1 (7 Days)||2
2424033|NCT01210495|5945107|P4|NOT COMPLETED|Overall Study||68
2424034|NCT01210495|5945108|P3|NOT COMPLETED|Overall Study||134
2424035|NCT01210495|5945109|P2|NOT COMPLETED|Overall Study||7
2424036|NCT01210495|5945110|P1|NOT COMPLETED|Overall Study||15
2424037|NCT01210495|5945107|P4|COMPLETED|Overall Study||0
2424038|NCT01210495|5945108|P3|COMPLETED|Overall Study||0
2424039|NCT01210495|5945109|P2|COMPLETED|Overall Study||0
2424040|NCT01210495|5945110|P1|COMPLETED|Overall Study||0
2424041|NCT01210495|5945107|P4|STARTED|Overall Study||68
2424042|NCT01210495|5945108|P3|STARTED|Overall Study||134
2424043|NCT01210495|5945109|P2|STARTED|Overall Study||7
2424044|NCT01210495|5945110|P1|STARTED|Overall Study||15
2424045|NCT01210443|5945172|P1|NOT COMPLETED|Overall Study||2
2424046|NCT01210443|5945172|P1|COMPLETED|Overall Study||0
2424047|NCT01210443|5945172|P1|STARTED|Overall Study||2
2424048|NCT01210352|5945189|P9|NOT COMPLETED|Overall Study||4
2424049|NCT01210352|5945190|P8|NOT COMPLETED|Overall Study||3
2424050|NCT01210352|5945191|P7|NOT COMPLETED|Overall Study||2
2424051|NCT01210352|5945192|P6|NOT COMPLETED|Overall Study||0
2424052|NCT01210352|5945193|P5|NOT COMPLETED|Overall Study||0
2424053|NCT01210352|5945194|P4|NOT COMPLETED|Overall Study||0
2424054|NCT01210352|5945195|P3|NOT COMPLETED|Overall Study||2
2424055|NCT01210352|5945196|P2|NOT COMPLETED|Overall Study||0
2424056|NCT01210352|5945197|P1|NOT COMPLETED|Overall Study||0
2424057|NCT01210352|5945189|P9|COMPLETED|Overall Study||2
2424058|NCT01210352|5945190|P8|COMPLETED|Overall Study||7
2424059|NCT01210352|5945191|P7|COMPLETED|Overall Study||5
2424060|NCT01210352|5945192|P6|COMPLETED|Overall Study||6
2424061|NCT01210352|5945193|P5|COMPLETED|Overall Study||6
2424062|NCT01210352|5945194|P4|COMPLETED|Overall Study||7
2424063|NCT01210352|5945195|P3|COMPLETED|Overall Study||5
2424064|NCT01210352|5945196|P2|COMPLETED|Overall Study||6
2424065|NCT01210352|5945197|P1|COMPLETED|Overall Study||6
2424066|NCT01210352|5945189|P9|STARTED|Overall Study||6
2424067|NCT01210352|5945190|P8|STARTED|Overall Study||10
2424068|NCT01210352|5945191|P7|STARTED|Overall Study||7
2424069|NCT01210352|5945192|P6|STARTED|Overall Study||6
2424070|NCT01210352|5945193|P5|STARTED|Overall Study||6
2424071|NCT01210352|5945194|P4|STARTED|Overall Study||7
2424072|NCT01210352|5945195|P3|STARTED|Overall Study||7
2424073|NCT01210352|5945196|P2|STARTED|Overall Study||6
2424074|NCT01210352|5945197|P1|STARTED|Overall Study||6
2424075|NCT01210222|5945388|P1|NOT COMPLETED|Overall Study||3
2424076|NCT01210222|5945388|P1|COMPLETED|Overall Study||32
2424077|NCT01210222|5945388|P1|STARTED|Overall Study||35
2424078|NCT01210170|5945401|P1|NOT COMPLETED|Overall Study||7
2424079|NCT01210170|5945401|P1|COMPLETED|Overall Study||15
2424080|NCT01210170|5945401|P1|STARTED|Overall Study||22
2424081|NCT01210144|5945424|P2|NOT COMPLETED|Overall Study||0
2424082|NCT01210144|5945425|P1|NOT COMPLETED|Overall Study||3
2424083|NCT01210144|5945424|P2|COMPLETED|Overall Study||11
2424084|NCT01210144|5945425|P1|COMPLETED|Overall Study||10
2424085|NCT01210144|5945424|P2|STARTED|Overall Study||11
2424086|NCT01210144|5945425|P1|STARTED|Overall Study||13
2424087|NCT01210118|5945447|P2|NOT COMPLETED|Overall Study||5
2424088|NCT01210118|5945448|P1|NOT COMPLETED|Overall Study||3
2424089|NCT01210118|5945447|P2|COMPLETED|Overall Study||42
2424090|NCT01210118|5945448|P1|COMPLETED|Overall Study||42
2424091|NCT01210118|5945447|P2|STARTED|Overall Study||47
2424092|NCT01210118|5945448|P1|STARTED|Overall Study||45
2424093|NCT01210079|5945462|P2|NOT COMPLETED|Overall Study||0
2424094|NCT01210079|5945463|P1|NOT COMPLETED|Overall Study||0
2424095|NCT01210079|5945462|P2|COMPLETED|Overall Study||16
2424096|NCT01210079|5945463|P1|COMPLETED|Overall Study||10
2424097|NCT01210079|5945462|P2|STARTED|Overall Study||16
2424098|NCT01210079|5945463|P1|STARTED|Overall Study||10
2424099|NCT01210001|5945472|P3|NOT COMPLETED|Overall Study||12
2424100|NCT01210001|5945473|P2|NOT COMPLETED|Overall Study||11
2424101|NCT01210001|5945474|P1|NOT COMPLETED|Overall Study||19
2424102|NCT01210001|5945472|P3|COMPLETED|Overall Study||156
2424103|NCT01210001|5945473|P2|COMPLETED|Overall Study||154
2424104|NCT01210001|5945474|P1|COMPLETED|Overall Study||147
2424105|NCT01210001|5945472|P3|STARTED|Overall Study||168
2424106|NCT01210001|5945473|P2|STARTED|Overall Study||165
2424107|NCT01210001|5945474|P1|STARTED|Overall Study||166
2424108|NCT01209949|5945494|P1|NOT COMPLETED|Overall Study||3
2424109|NCT01209949|5945494|P1|COMPLETED|Overall Study||27
2424110|NCT01209949|5945494|P1|STARTED|Overall Study||30
2424111|NCT01209832|5945500|P1|NOT COMPLETED|Maintenance Period 2 (M1)||0
2424112|NCT01209832|5945500|P1|COMPLETED|Maintenance Period 2 (M1)||3
2424113|NCT01209832|5945500|P1|STARTED|Maintenance Period 2 (M1)|One participant who completed maintenance period 1 did not enter maintenance period 2.|3
2424114|NCT01209832|5945500|P1|NOT COMPLETED|Maintenance Period 1 (M1)||0
2424115|NCT01209832|5945500|P1|COMPLETED|Maintenance Period 1 (M1)||4
2424116|NCT01209832|5945500|P1|STARTED|Maintenance Period 1 (M1)|Five participants who completed Period 2 did not enroll into Maintenance Period.|4
2424117|NCT01209832|5945500|P1|NOT COMPLETED|Period 2||1
2424118|NCT01209832|5945500|P1|COMPLETED|Period 2||9
2424119|NCT01209832|5945500|P1|STARTED|Period 2||10
2424120|NCT01209832|5945500|P1|NOT COMPLETED|Period 1||1
2424121|NCT01209832|5945500|P1|COMPLETED|Period 1||10
2424122|NCT01209832|5945500|P1|Received At Least 1 Dose of Study Drug|Period 1||10
2424123|NCT01209832|5945500|P1|STARTED|Period 1||11
2424124|NCT01209780|5945519|P5|NOT COMPLETED|Overall Study||5
2424125|NCT01209780|5945520|P4|NOT COMPLETED|Overall Study||10
2424126|NCT01209780|5945521|P3|NOT COMPLETED|Overall Study||4
2424127|NCT01209780|5945522|P2|NOT COMPLETED|Overall Study||18
2424128|NCT01209780|5945523|P1|NOT COMPLETED|Overall Study||26
2424129|NCT01209780|5945519|P5|COMPLETED|Overall Study||407
2424130|NCT01209780|5945520|P4|COMPLETED|Overall Study||807
2424131|NCT01209780|5945521|P3|COMPLETED|Overall Study||44
2424132|NCT01209780|5945522|P2|COMPLETED|Overall Study||467
2424133|NCT01209780|5945523|P1|COMPLETED|Overall Study||1016
2424134|NCT01209780|5945519|P5|STARTED|Overall Study||412
2424135|NCT01209780|5945520|P4|STARTED|Overall Study||817
2424136|NCT01209780|5945521|P3|STARTED|Overall Study||48
2424137|NCT01209780|5945522|P2|STARTED|Overall Study||485
2424138|NCT01209780|5945523|P1|STARTED|Overall Study||1042
2424139|NCT01209767|5945549|P1|NOT COMPLETED|Overall Study||4
2424140|NCT01209767|5945549|P1|COMPLETED|Overall Study||18
2424141|NCT01209767|5945549|P1|STARTED|Overall Study||22
2424142|NCT01209702|5945559|P4|NOT COMPLETED|Overall Study||153
2424143|NCT01209702|5945560|P3|NOT COMPLETED|Overall Study||51
2424144|NCT01209702|5945561|P2|NOT COMPLETED|Overall Study||51
2424145|NCT01209702|5945562|P1|NOT COMPLETED|Overall Study||51
2424146|NCT01209702|5945559|P4|COMPLETED|Overall Study||0
2424147|NCT01209702|5945560|P3|COMPLETED|Overall Study||0
2424148|NCT01209702|5945561|P2|COMPLETED|Overall Study||0
2424149|NCT01209702|5945562|P1|COMPLETED|Overall Study||0
2424150|NCT01209702|5945559|P4|Completed 24 Weeks Treatment|Overall Study||10
2424151|NCT01209702|5945560|P3|Completed 24 Weeks Treatment|Overall Study||3
2424152|NCT01209702|5945561|P2|Completed 24 Weeks Treatment|Overall Study||28
2424153|NCT01209702|5945562|P1|Completed 24 Weeks Treatment|Overall Study||19
2424154|NCT01209702|5945559|P4|Completed 12 Weeks Treatment|Overall Study||59
2424155|NCT01209702|5945560|P3|Completed 12 Weeks Treatment|Overall Study||12
2424156|NCT01209702|5945561|P2|Completed 12 Weeks Treatment|Overall Study||48
2424157|NCT01209702|5945562|P1|Completed 12 Weeks Treatment|Overall Study||50
2424158|NCT01209702|5945559|P4|Escape or Switched to Tocilizumab|Overall Study||0
2424159|NCT01209702|5945560|P3|Escape or Switched to Tocilizumab|Overall Study||6
2424160|NCT01209702|5945561|P2|Escape or Switched to Tocilizumab|Overall Study||0
2424161|NCT01209702|5945562|P1|Escape or Switched to Tocilizumab|Overall Study||51
2424162|NCT01209702|5945559|P4|Treated|Overall Study||152
2424163|NCT01209702|5945560|P3|Treated|Overall Study||51
2424164|NCT01209702|5945561|P2|Treated|Overall Study||51
2424165|NCT01209702|5945562|P1|Treated|Overall Study||51
2424166|NCT01209702|5945559|P4|STARTED|Overall Study||153
2424167|NCT01209702|5945560|P3|STARTED|Overall Study||51
2424168|NCT01209702|5945561|P2|STARTED|Overall Study||51
2424169|NCT01209702|5945562|P1|STARTED|Overall Study||51
2424170|NCT01209689|5945618|P2|NOT COMPLETED|Overall Study||22
2424171|NCT01209689|5945619|P1|NOT COMPLETED|Overall Study||91
2424172|NCT01209689|5945618|P2|COMPLETED|Overall Study||0
2424173|NCT01209689|5945619|P1|COMPLETED|Overall Study||0
2424174|NCT01209689|5945618|P2|STARTED|Overall Study||22
2424175|NCT01209689|5945619|P1|STARTED|Overall Study||91
2424176|NCT01209624|5945625|P1|NOT COMPLETED|Overall Study||326
2424177|NCT01209624|5945625|P1|COMPLETED|Overall Study||576
2424178|NCT01209624|5945625|P1|Per Protocol Population|Overall Study||469
2424179|NCT01209624|5945625|P1|STARTED|Overall Study||902
2424180|NCT01209598|5945658|P2|NOT COMPLETED|Overall Study||0
2424181|NCT01209598|5945659|P1|NOT COMPLETED|Overall Study||1
2424182|NCT01209598|5945658|P2|COMPLETED|Overall Study||60
2424183|NCT01209598|5945659|P1|COMPLETED|Overall Study||29
2424184|NCT01209598|5945658|P2|STARTED|Overall Study||60
2424185|NCT01209598|5945659|P1|STARTED|Overall Study||30
2424186|NCT01209520|5945667|P1|NOT COMPLETED|Overall Study||3
2424187|NCT01209520|5945667|P1|COMPLETED|Overall Study||3
2424188|NCT01209520|5945667|P1|STARTED|Overall Study||6
2424189|NCT01209442|5945672|P1|NOT COMPLETED|Overall Study||0
2424190|NCT01209442|5945672|P1|COMPLETED|Overall Study||30
2424191|NCT01209442|5945672|P1|STARTED|Overall Study||30
2424192|NCT01209286|5945680|P3|NOT COMPLETED|Overall Study||3
2424193|NCT01209286|5945681|P2|NOT COMPLETED|Overall Study||10
2424194|NCT01209286|5945682|P1|NOT COMPLETED|Overall Study||5
2424195|NCT01209286|5945680|P3|COMPLETED|Overall Study||3
2424196|NCT01209286|5945681|P2|COMPLETED|Overall Study||13
2424197|NCT01209286|5945682|P1|COMPLETED|Overall Study||2
2424198|NCT01209286|5945680|P3|STARTED|Overall Study||6
2424199|NCT01209286|5945681|P2|STARTED|Overall Study||23
2424200|NCT01209286|5945682|P1|STARTED|Overall Study||7
2424201|NCT01209260|5945735|P2|NOT COMPLETED|Overall Study||0
2424202|NCT01209260|5945736|P1|NOT COMPLETED|Overall Study||0
2424203|NCT01209260|5945735|P2|COMPLETED|Overall Study||36
2424204|NCT01209260|5945736|P1|COMPLETED|Overall Study||36
2424205|NCT01209260|5945735|P2|STARTED|Overall Study||36
2424206|NCT01209260|5945736|P1|STARTED|Overall Study||36
2424207|NCT01209195|5945750|P6|NOT COMPLETED|Overall Study||0
2424208|NCT01209195|5945751|P5|NOT COMPLETED|Overall Study||0
2424209|NCT01209195|5945752|P4|NOT COMPLETED|Overall Study||0
2424210|NCT01209195|5945753|P3|NOT COMPLETED|Overall Study||0
2424211|NCT01209195|5945754|P2|NOT COMPLETED|Overall Study||0
2424212|NCT01209195|5945755|P1|NOT COMPLETED|Overall Study||0
2424213|NCT01209195|5945750|P6|COMPLETED|Overall Study||13
2424214|NCT01209195|5945751|P5|COMPLETED|Overall Study||6
2424215|NCT01209195|5945752|P4|COMPLETED|Overall Study||6
2424216|NCT01209195|5945753|P3|COMPLETED|Overall Study||6
2424217|NCT01209195|5945754|P2|COMPLETED|Overall Study||3
2424218|NCT01209195|5945755|P1|COMPLETED|Overall Study||7
2424219|NCT01209195|5945750|P6|STARTED|Overall Study||13
2424220|NCT01209195|5945751|P5|STARTED|Overall Study||6
2424221|NCT01209195|5945752|P4|STARTED|Overall Study||6
2424222|NCT01209195|5945753|P3|STARTED|Overall Study||6
2424223|NCT01209195|5945754|P2|STARTED|Overall Study||3
2424224|NCT01209195|5945755|P1|STARTED|Overall Study||7
2424225|NCT01209143|5945791|P2|NOT COMPLETED|Overall Study||20
2424226|NCT01209143|5945792|P1|NOT COMPLETED|Overall Study||19
2424227|NCT01209143|5945791|P2|COMPLETED|Overall Study||8
2424228|NCT01209143|5945792|P1|COMPLETED|Overall Study||5
2424229|NCT01209143|5945791|P2|STARTED|Overall Study||28
2424230|NCT01209143|5945792|P1|STARTED|Overall Study||24
2424231|NCT01209078|5945802|P2|NOT COMPLETED|Overall Study||3
2424232|NCT01209078|5945803|P1|NOT COMPLETED|Overall Study||16
2424233|NCT01209078|5945802|P2|COMPLETED|Overall Study||24
2424234|NCT01209078|5945803|P1|COMPLETED|Overall Study||41
2424235|NCT01209078|5945802|P2|STARTED|Overall Study||27
2424236|NCT01209078|5945803|P1|STARTED|Overall Study||57
2424237|NCT01208961|5945878|P2|NOT COMPLETED|High-Fat Period IV||0
2424238|NCT01208961|5945879|P1|NOT COMPLETED|High-Fat Period IV||0
2424239|NCT01208961|5945878|P2|COMPLETED|High-Fat Period IV||26
2424240|NCT01208961|5945879|P1|COMPLETED|High-Fat Period IV||25
2424241|NCT01208961|5945878|P2|STARTED|High-Fat Period IV||26
2424242|NCT01208961|5945879|P1|STARTED|High-Fat Period IV||25
2424243|NCT01208961|5945878|P2|NOT COMPLETED|High-Fat Period III||0
2424244|NCT01208961|5945879|P1|NOT COMPLETED|High-Fat Period III||1
2424245|NCT01208961|5945878|P2|COMPLETED|High-Fat Period III||26
2424246|NCT01208961|5945879|P1|COMPLETED|High-Fat Period III||25
2424247|NCT01208961|5945878|P2|STARTED|High-Fat Period III||26
2424248|NCT01208961|5945879|P1|STARTED|High-Fat Period III||26
2424249|NCT01208961|5945878|P2|NOT COMPLETED|Low-Fat Period II||0
2424250|NCT01208961|5945879|P1|NOT COMPLETED|Low-Fat Period II||0
2424251|NCT01208961|5945878|P2|COMPLETED|Low-Fat Period II||27
2424252|NCT01208961|5945879|P1|COMPLETED|Low-Fat Period II||26
2424253|NCT01208961|5945878|P2|STARTED|Low-Fat Period II||27
2424254|NCT01208961|5945879|P1|STARTED|Low-Fat Period II||26
2424255|NCT01208961|5945878|P2|NOT COMPLETED|Low-Fat Period I||0
2424256|NCT01208961|5945879|P1|NOT COMPLETED|Low-Fat Period I||0
2424257|NCT01208961|5945878|P2|COMPLETED|Low-Fat Period I||27
2424258|NCT01208961|5945879|P1|COMPLETED|Low-Fat Period I||27
2424259|NCT01208961|5945878|P2|STARTED|Low-Fat Period I||27
2424260|NCT01208961|5945879|P1|STARTED|Low-Fat Period I||27
2424261|NCT01208922|5945890|P2|NOT COMPLETED|Overall Study||10
2424262|NCT01208922|5945891|P1|NOT COMPLETED|Overall Study||11
2424263|NCT01208922|5945890|P2|COMPLETED|Overall Study||405
2424264|NCT01208922|5945891|P1|COMPLETED|Overall Study||409
2424265|NCT01208922|5945890|P2|STARTED|Overall Study||415
2424266|NCT01208922|5945891|P1|STARTED|Overall Study||420
2424267|NCT01208870|5945901|P2|NOT COMPLETED|Overall Study||8
2424268|NCT01208870|5945902|P1|NOT COMPLETED|Overall Study||2
2424269|NCT01208870|5945901|P2|COMPLETED|Overall Study||36
2424270|NCT01208870|5945902|P1|COMPLETED|Overall Study||44
2424271|NCT01208870|5945901|P2|Pilot 2|Overall Study||22
2424272|NCT01208870|5945902|P1|Pilot 2|Overall Study||26
2424273|NCT01208870|5945901|P2|Pilot 1|Overall Study||22
2424274|NCT01208870|5945902|P1|Pilot 1|Overall Study||20
2424275|NCT01208870|5945901|P2|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013.|44
2424276|NCT01208870|5945902|P1|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013|46
2424277|NCT01208415|5945918|P1|NOT COMPLETED|Overall Study||40
2424278|NCT01208415|5945918|P1|COMPLETED|Overall Study||0
2424279|NCT01208415|5945918|P1|6 Months|Overall Study||37
2424280|NCT01208415|5945918|P1|STARTED|Overall Study||40
2424281|NCT01208402|5945924|P2|NOT COMPLETED|Overall Study||0
2424282|NCT01208402|5945925|P1|NOT COMPLETED|Overall Study||1
2424283|NCT01208402|5945924|P2|COMPLETED|Overall Study||28
2424284|NCT01208402|5945925|P1|COMPLETED|Overall Study||30
2424285|NCT01208402|5945924|P2|STARTED|Overall Study||28
2424286|NCT01208402|5945925|P1|STARTED|Overall Study||31
2424287|NCT01208337|5945941|P1|NOT COMPLETED|Overall Study||3
2424288|NCT01208337|5945941|P1|COMPLETED|Overall Study||20
2424289|NCT01208337|5945941|P1|Five-year Follow-up|Overall Study||20
2424290|NCT01208337|5945941|P1|One-year Follow-up|Overall Study||23
2424291|NCT01208337|5945941|P1|STARTED|Overall Study||23
2424292|NCT01208233|5945955|P6|NOT COMPLETED|Overall Study||21
2424293|NCT01208233|5945956|P5|NOT COMPLETED|Overall Study||24
2424294|NCT01208233|5945957|P4|NOT COMPLETED|Overall Study||1
2424295|NCT01208233|5945958|P3|NOT COMPLETED|Overall Study||4
2424296|NCT01208233|5945959|P2|NOT COMPLETED|Overall Study||3
2424297|NCT01208233|5945960|P1|NOT COMPLETED|Overall Study||5
2424298|NCT01208233|5945955|P6|COMPLETED|Overall Study||46
2424299|NCT01208233|5945956|P5|COMPLETED|Overall Study||46
2424300|NCT01208233|5945957|P4|COMPLETED|Overall Study||9
2424301|NCT01208233|5945958|P3|COMPLETED|Overall Study||7
2424302|NCT01208233|5945959|P2|COMPLETED|Overall Study||6
2424303|NCT01208233|5945960|P1|COMPLETED|Overall Study||6
2424304|NCT01208233|5945955|P6|STARTED|Overall Study||67
2424305|NCT01208233|5945956|P5|STARTED|Overall Study||70
2424306|NCT01208233|5945957|P4|STARTED|Overall Study||10
2424307|NCT01208233|5945958|P3|STARTED|Overall Study||11
2424308|NCT01208233|5945959|P2|STARTED|Overall Study||9
2424309|NCT01208233|5945960|P1|STARTED|Overall Study||11
2424310|NCT01208220|5946073|P2|NOT COMPLETED|Overall Study||0
2424311|NCT01208220|5946074|P1|NOT COMPLETED|Overall Study||0
2424312|NCT01208220|5946073|P2|COMPLETED|Overall Study||1
2424313|NCT01208220|5946074|P1|COMPLETED|Overall Study||1
2424314|NCT01208220|5946073|P2|STARTED|Overall Study||1
2424315|NCT01208220|5946074|P1|STARTED|Overall Study||1
2424316|NCT01208207|5946085|P7|NOT COMPLETED|Part II||11
2424317|NCT01208207|5946086|P6|NOT COMPLETED|Part II||16
2424318|NCT01208207|5946087|P5|NOT COMPLETED|Part II||23
2424319|NCT01208207|5946088|P4|NOT COMPLETED|Part II||32
2424320|NCT01208207|5946089|P3|NOT COMPLETED|Part II||0
2424321|NCT01208207|5946090|P2|NOT COMPLETED|Part II||0
2424322|NCT01208207|5946091|P1|NOT COMPLETED|Part II||0
2424323|NCT01208207|5946085|P7|COMPLETED|Part II||131
2424324|NCT01208207|5946086|P6|COMPLETED|Part II||129
2424325|NCT01208207|5946087|P5|COMPLETED|Part II||295
2424326|NCT01208207|5946088|P4|COMPLETED|Part II||282
2424327|NCT01208207|5946089|P3|COMPLETED|Part II||0
2424328|NCT01208207|5946090|P2|COMPLETED|Part II||0
2424329|NCT01208207|5946091|P1|COMPLETED|Part II||0
2424330|NCT01208207|5946085|P7|STARTED|Part II||142
2424331|NCT01208207|5946086|P6|STARTED|Part II||145
2424332|NCT01208207|5946087|P5|STARTED|Part II||318
2424333|NCT01208207|5946088|P4|STARTED|Part II||314
2424334|NCT01208207|5946089|P3|STARTED|Part II||0
2424335|NCT01208207|5946090|P2|STARTED|Part II||0
2424336|NCT01208207|5946091|P1|STARTED|Part II||0
2424337|NCT01208207|5946085|P7|NOT COMPLETED|Part I||0
2424338|NCT01208207|5946086|P6|NOT COMPLETED|Part I||0
2424339|NCT01208207|5946087|P5|NOT COMPLETED|Part I||0
2424340|NCT01208207|5946088|P4|NOT COMPLETED|Part I||0
2424341|NCT01208207|5946089|P3|NOT COMPLETED|Part I||15
2424342|NCT01208207|5946090|P2|NOT COMPLETED|Part I||11
2424343|NCT01208207|5946091|P1|NOT COMPLETED|Part I||70
2424344|NCT01208207|5946085|P7|COMPLETED|Part I||0
2424345|NCT01208207|5946086|P6|COMPLETED|Part I||0
2424346|NCT01208207|5946087|P5|COMPLETED|Part I||0
2424347|NCT01208207|5946088|P4|COMPLETED|Part I||0
2424348|NCT01208207|5946089|P3|COMPLETED|Part I||142
2424349|NCT01208207|5946090|P2|COMPLETED|Part I||145
2424350|NCT01208207|5946091|P1|COMPLETED|Part I||632
2424351|NCT01208207|5946085|P7|STARTED|Part I||0
2424352|NCT01208207|5946086|P6|STARTED|Part I||0
2424353|NCT01208207|5946087|P5|STARTED|Part I||0
2424354|NCT01208207|5946088|P4|STARTED|Part I||0
2424355|NCT01208207|5946089|P3|STARTED|Part I||157
2424356|NCT01208207|5946090|P2|STARTED|Part I||156
2424357|NCT01208207|5946091|P1|STARTED|Part I||702
2424358|NCT01208181|5946118|P5|NOT COMPLETED|Part 2||0
2424359|NCT01208181|5946119|P4|NOT COMPLETED|Part 2||20
2424360|NCT01208181|5946120|P3|NOT COMPLETED|Part 2||16
2424361|NCT01208181|5946121|P2|NOT COMPLETED|Part 2||0
2424362|NCT01208181|5946122|P1|NOT COMPLETED|Part 2||0
2424363|NCT01208181|5946118|P5|COMPLETED|Part 2||0
2424364|NCT01208181|5946119|P4|COMPLETED|Part 2||343
2424365|NCT01208181|5946120|P3|COMPLETED|Part 2||334
2424366|NCT01208181|5946121|P2|COMPLETED|Part 2||0
2424367|NCT01208181|5946122|P1|COMPLETED|Part 2||0
2424368|NCT01208181|5946118|P5|STARTED|Part 2|Per protocol, participants did not receive placebo during Part II of the study|0
2424369|NCT01208181|5946119|P4|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 90 mg in Part II of the study|363
2424370|NCT01208181|5946120|P3|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 60 mg in Part II of the study|350
2424371|NCT01208181|5946121|P2|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
2424372|NCT01208181|5946122|P1|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
2424373|NCT01208181|5946118|P5|NOT COMPLETED|Part 1||22
2424374|NCT01208181|5946119|P4|NOT COMPLETED|Part 1||0
2424375|NCT01208181|5946120|P3|NOT COMPLETED|Part 1||0
2424376|NCT01208181|5946121|P2|NOT COMPLETED|Part 1||55
2424377|NCT01208181|5946122|P1|NOT COMPLETED|Part 1||99
2424378|NCT01208181|5946118|P5|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|96
2424379|NCT01208181|5946119|P4|COMPLETED|Part 1||0
2424380|NCT01208181|5946120|P3|COMPLETED|Part 1||0
2424381|NCT01208181|5946121|P2|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|413
2424382|NCT01208181|5946122|P1|COMPLETED|Part 1|Six participants from this arm did not continue into Part II of the study|719
2424383|NCT01208181|5946118|P5|STARTED|Part 1||118
2424384|NCT01208181|5946119|P4|STARTED|Part 1||0
2424385|NCT01208181|5946120|P3|STARTED|Part 1||0
2424386|NCT01208181|5946121|P2|STARTED|Part 1||468
2424387|NCT01208181|5946122|P1|STARTED|Part 1||818
2424388|NCT01208103|5946151|P1|NOT COMPLETED|Overall Study||2
2424389|NCT01208103|5946151|P1|COMPLETED|Overall Study||28
2424390|NCT01208103|5946151|P1|STARTED|Overall Study||30
2424391|NCT01208038|5946159|P1|NOT COMPLETED|Overall Study||1
2424392|NCT01208038|5946159|P1|COMPLETED|Overall Study|Patient withdrew before commencing study drug|21
2424393|NCT01208038|5946159|P1|STARTED|Overall Study||22
2424394|NCT01207934|5946169|P3|NOT COMPLETED|Overall Study||0
2424395|NCT01207934|5946170|P2|NOT COMPLETED|Overall Study||0
2424396|NCT01207934|5946171|P1|NOT COMPLETED|Overall Study||0
2424397|NCT01207934|5946169|P3|COMPLETED|Overall Study||6
2424398|NCT01207934|5946170|P2|COMPLETED|Overall Study||6
2424399|NCT01207934|5946171|P1|COMPLETED|Overall Study||6
2424400|NCT01207934|5946169|P3|STARTED|Overall Study||6
2424401|NCT01207934|5946170|P2|STARTED|Overall Study||6
2424402|NCT01207934|5946171|P1|STARTED|Overall Study||6
2424403|NCT01207765|5946188|P1|NOT COMPLETED|Overall Study||0
2424404|NCT01207765|5946188|P1|COMPLETED|Overall Study||8
2424405|NCT01207765|5946188|P1|STARTED|Overall Study||8
2424406|NCT01207726|5946196|P2|NOT COMPLETED|Overall Study||0
2424407|NCT01207726|5946197|P1|NOT COMPLETED|Overall Study||0
2424408|NCT01207726|5946196|P2|COMPLETED|Overall Study||6
2424409|NCT01207726|5946197|P1|COMPLETED|Overall Study||7
2424410|NCT01207726|5946196|P2|STARTED|Overall Study||6
2424411|NCT01207726|5946197|P1|STARTED|Overall Study||7
2424412|NCT01207687|5946215|P1|NOT COMPLETED|Overall Study||2
2424413|NCT01207687|5946215|P1|COMPLETED|Overall Study||12
2424414|NCT01207687|5946215|P1|STARTED|Overall Study||14
2424415|NCT01207648|5946245|P1|NOT COMPLETED|Overall Study||0
2424416|NCT01207648|5946245|P1|COMPLETED|Overall Study||307
2424417|NCT01207648|5946245|P1|STARTED|Overall Study||307
2424418|NCT01207596|5946253|P1|NOT COMPLETED|Overall Study||9
2424419|NCT01207596|5946253|P1|COMPLETED|Overall Study||21
2424420|NCT01207596|5946253|P1|STARTED|Overall Study||30
2424421|NCT01207583|5946266|P3|NOT COMPLETED|Overall Study||1
2424422|NCT01207583|5946267|P2|NOT COMPLETED|Overall Study||5
2424423|NCT01207583|5946268|P1|NOT COMPLETED|Overall Study||1
2424424|NCT01207583|5946266|P3|COMPLETED|Overall Study||54
2424425|NCT01207583|5946267|P2|COMPLETED|Overall Study||26
2424426|NCT01207583|5946268|P1|COMPLETED|Overall Study||13
2424427|NCT01207583|5946266|P3|Dose 4|Overall Study||0
2424428|NCT01207583|5946267|P2|Dose 4|Overall Study||0
2424429|NCT01207583|5946268|P1|Dose 4|Overall Study||7
2424430|NCT01207583|5946266|P3|Dose 3|Overall Study||0
2424431|NCT01207583|5946267|P2|Dose 3|Overall Study||27
2424432|NCT01207583|5946268|P1|Dose 3|Overall Study||13
2424433|NCT01207583|5946266|P3|Dose 2|Overall Study||54
2424434|NCT01207583|5946267|P2|Dose 2|Overall Study||29
2424435|NCT01207583|5946268|P1|Dose 2|Overall Study||13
2424436|NCT01207583|5946266|P3|Dose 1|Overall Study||55
2424437|NCT01207583|5946267|P2|Dose 1|Overall Study||31
2424438|NCT01207583|5946268|P1|Dose 1|Overall Study||14
2424439|NCT01207583|5946266|P3|STARTED|Overall Study||55
2424440|NCT01207583|5946267|P2|STARTED|Overall Study||31
2424441|NCT01207583|5946268|P1|STARTED|Overall Study||14
2424442|NCT01207570|5946308|P2|NOT COMPLETED|The Second Stage (After Crossover)||0
2424443|NCT01207570|5946309|P1|NOT COMPLETED|The Second Stage (After Crossover)||0
2424444|NCT01207570|5946308|P2|COMPLETED|The Second Stage (After Crossover)||23
2424445|NCT01207570|5946309|P1|COMPLETED|The Second Stage (After Crossover)||31
2424446|NCT01207570|5946308|P2|STARTED|The Second Stage (After Crossover)||23
2424447|NCT01207570|5946309|P1|STARTED|The Second Stage (After Crossover)||31
2424448|NCT01207570|5946308|P2|NOT COMPLETED|The First Stage (Before Crossover)||0
2424449|NCT01207570|5946309|P1|NOT COMPLETED|The First Stage (Before Crossover)||0
2424450|NCT01207570|5946308|P2|COMPLETED|The First Stage (Before Crossover)||31
2424451|NCT01207570|5946309|P1|COMPLETED|The First Stage (Before Crossover)||23
2424452|NCT01207570|5946308|P2|STARTED|The First Stage (Before Crossover)||31
2424453|NCT01207570|5946309|P1|STARTED|The First Stage (Before Crossover)||23
2424454|NCT01207492|5946321|P1|NOT COMPLETED|Overall Study||15
2424455|NCT01207492|5946321|P1|COMPLETED|Overall Study||2
2424456|NCT01207492|5946321|P1|STARTED|Overall Study||17
2424457|NCT01207466|5946327|P2|NOT COMPLETED|Period 2, One Week of Wear||0
2424458|NCT01207466|5946328|P1|NOT COMPLETED|Period 2, One Week of Wear||0
2424459|NCT01207466|5946327|P2|COMPLETED|Period 2, One Week of Wear||48
2424460|NCT01207466|5946328|P1|COMPLETED|Period 2, One Week of Wear||45
2424461|NCT01207466|5946327|P2|STARTED|Period 2, One Week of Wear||48
2424462|NCT01207466|5946328|P1|STARTED|Period 2, One Week of Wear||45
2424463|NCT01207466|5946327|P2|NOT COMPLETED|Period 1, One Week of Wear||0
2424464|NCT01207466|5946328|P1|NOT COMPLETED|Period 1, One Week of Wear||0
2424465|NCT01207466|5946327|P2|COMPLETED|Period 1, One Week of Wear||48
2424466|NCT01207466|5946328|P1|COMPLETED|Period 1, One Week of Wear|One participant discontinued between Period 1 and Period 2 due to inclusion/exclusion criteria.|46
2424467|NCT01207466|5946327|P2|STARTED|Period 1, One Week of Wear||48
2424468|NCT01207466|5946328|P1|STARTED|Period 1, One Week of Wear||46
2424469|NCT01207453|5946336|P2|NOT COMPLETED|2nd Intervention||2
2424470|NCT01207453|5946337|P1|NOT COMPLETED|2nd Intervention||2
2424471|NCT01207453|5946336|P2|COMPLETED|2nd Intervention||15
2424472|NCT01207453|5946337|P1|COMPLETED|2nd Intervention||17
2424473|NCT01207453|5946336|P2|STARTED|2nd Intervention||17
2424474|NCT01207453|5946337|P1|STARTED|2nd Intervention||19
2424475|NCT01207453|5946336|P2|NOT COMPLETED|Washout||0
2424476|NCT01207453|5946337|P1|NOT COMPLETED|Washout||2
2424477|NCT01207453|5946336|P2|COMPLETED|Washout||17
2424478|NCT01207453|5946337|P1|COMPLETED|Washout||19
2424479|NCT01207453|5946336|P2|STARTED|Washout||17
2424480|NCT01207453|5946337|P1|STARTED|Washout||21
2424481|NCT01207453|5946336|P2|NOT COMPLETED|First Intervention||1
2424482|NCT01207453|5946337|P1|NOT COMPLETED|First Intervention||2
2424483|NCT01207453|5946336|P2|COMPLETED|First Intervention||17
2424484|NCT01207453|5946337|P1|COMPLETED|First Intervention||21
2424485|NCT01207453|5946336|P2|STARTED|First Intervention||18
2424486|NCT01207453|5946337|P1|STARTED|First Intervention||23
2424487|NCT01207440|5946363|P7|NOT COMPLETED|Overall Study||5
2424488|NCT01207440|5946364|P6|NOT COMPLETED|Overall Study||46
2424489|NCT01207440|5946365|P5|NOT COMPLETED|Overall Study||48
2424490|NCT01207440|5946366|P4|NOT COMPLETED|Overall Study||18
2424491|NCT01207440|5946367|P3|NOT COMPLETED|Overall Study||65
2424492|NCT01207440|5946368|P2|NOT COMPLETED|Overall Study||64
2424493|NCT01207440|5946369|P1|NOT COMPLETED|Overall Study||203
2424494|NCT01207440|5946363|P7|COMPLETED|Overall Study||0
2424495|NCT01207440|5946364|P6|COMPLETED|Overall Study||0
2424496|NCT01207440|5946365|P5|COMPLETED|Overall Study||0
2424497|NCT01207440|5946366|P4|COMPLETED|Overall Study||0
2424498|NCT01207440|5946367|P3|COMPLETED|Overall Study||0
2424499|NCT01207440|5946368|P2|COMPLETED|Overall Study||0
2424500|NCT01207440|5946369|P1|COMPLETED|Overall Study||0
2424501|NCT01207440|5946363|P7|STARTED|Overall Study||5
2424502|NCT01207440|5946364|P6|STARTED|Overall Study||46
2424503|NCT01207440|5946365|P5|STARTED|Overall Study||48
2424504|NCT01207440|5946366|P4|STARTED|Overall Study||18
2424505|NCT01207440|5946367|P3|STARTED|Overall Study||65
2424506|NCT01207440|5946368|P2|STARTED|Overall Study||64
2424507|NCT01207440|5946369|P1|STARTED|Overall Study||203
2424508|NCT01207427|5946436|P3|NOT COMPLETED|Run-out Placebo Period||0
2424509|NCT01207427|5946437|P2|NOT COMPLETED|Run-out Placebo Period||0
2424510|NCT01207427|5946438|P1|NOT COMPLETED|Run-out Placebo Period||0
2424511|NCT01207427|5946436|P3|COMPLETED|Run-out Placebo Period||41
2424512|NCT01207427|5946437|P2|COMPLETED|Run-out Placebo Period||43
2424513|NCT01207427|5946438|P1|COMPLETED|Run-out Placebo Period||40
2424514|NCT01207427|5946436|P3|STARTED|Run-out Placebo Period||41
2424515|NCT01207427|5946437|P2|STARTED|Run-out Placebo Period||43
2424516|NCT01207427|5946438|P1|STARTED|Run-out Placebo Period||40
2424517|NCT01207427|5946436|P3|NOT COMPLETED|Double-blind Treatment Period||2
2424518|NCT01207427|5946437|P2|NOT COMPLETED|Double-blind Treatment Period||2
2424519|NCT01207427|5946438|P1|NOT COMPLETED|Double-blind Treatment Period||3
2424520|NCT01207427|5946436|P3|COMPLETED|Double-blind Treatment Period||41
2424521|NCT01207427|5946437|P2|COMPLETED|Double-blind Treatment Period||43
2424522|NCT01207427|5946438|P1|COMPLETED|Double-blind Treatment Period||40
2424523|NCT01207427|5946436|P3|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
2424524|NCT01207427|5946437|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||45
2424525|NCT01207427|5946438|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
2424526|NCT01207427|5946436|P3|STARTED|Double-blind Treatment Period||43
2424527|NCT01207427|5946437|P2|STARTED|Double-blind Treatment Period||45
2424528|NCT01207427|5946438|P1|STARTED|Double-blind Treatment Period||43
2424529|NCT01207427|5946436|P3|NOT COMPLETED|Run-in Placebo Period||0
2424530|NCT01207427|5946437|P2|NOT COMPLETED|Run-in Placebo Period||0
2424531|NCT01207427|5946438|P1|NOT COMPLETED|Run-in Placebo Period||0
2424532|NCT01207427|5946436|P3|COMPLETED|Run-in Placebo Period||43
2424533|NCT01207427|5946437|P2|COMPLETED|Run-in Placebo Period||45
2424534|NCT01207427|5946438|P1|COMPLETED|Run-in Placebo Period||43
2424535|NCT01207427|5946436|P3|STARTED|Run-in Placebo Period||43
2424536|NCT01207427|5946437|P2|STARTED|Run-in Placebo Period||45
2424537|NCT01207427|5946438|P1|STARTED|Run-in Placebo Period||43
2424538|NCT01207414|5946448|P2|NOT COMPLETED|Overall Study||82
2424539|NCT01207414|5946449|P1|NOT COMPLETED|Overall Study||73
2424540|NCT01207414|5946448|P2|COMPLETED|Overall Study||178
2424541|NCT01207414|5946449|P1|COMPLETED|Overall Study||168
2424542|NCT01207414|5946448|P2|Safety Population: Received Study Drug|Overall Study||260
2424543|NCT01207414|5946449|P1|Safety Population: Received Study Drug|Overall Study||240
2424544|NCT01207414|5946448|P2|STARTED|Overall Study||260
2424545|NCT01207414|5946449|P1|STARTED|Overall Study|Includes 1 patient randomized in error.|241
2424546|NCT01207401|5946467|P2|NOT COMPLETED|Overall Study||0
2424547|NCT01207401|5946468|P1|NOT COMPLETED|Overall Study||0
2424548|NCT01207401|5946467|P2|COMPLETED|Overall Study||24
2424549|NCT01207401|5946468|P1|COMPLETED|Overall Study||26
2424550|NCT01207401|5946467|P2|STARTED|Overall Study||24
2424551|NCT01207401|5946468|P1|STARTED|Overall Study||26
2424552|NCT01207388|5946474|P1|NOT COMPLETED|Overall Study||68
2424553|NCT01207388|5946474|P1|COMPLETED|Overall Study||48
2424554|NCT01207388|5946474|P1|STARTED|Overall Study||116
2424555|NCT01207219|5946499|P3|NOT COMPLETED|Overall Study||7
2424556|NCT01207219|5946500|P2|NOT COMPLETED|Overall Study||11
2424557|NCT01207219|5946501|P1|NOT COMPLETED|Overall Study||11
2424558|NCT01207219|5946499|P3|COMPLETED|Overall Study||32
2424559|NCT01207219|5946500|P2|COMPLETED|Overall Study||29
2424560|NCT01207219|5946501|P1|COMPLETED|Overall Study||34
2424561|NCT01207219|5946499|P3|Included in ITT Analysis|Overall Study||38
2424562|NCT01207219|5946500|P2|Included in ITT Analysis|Overall Study||37
2424563|NCT01207219|5946501|P1|Included in ITT Analysis|Overall Study||40
2424564|NCT01207219|5946499|P3|STARTED|Overall Study||39
2424565|NCT01207219|5946500|P2|STARTED|Overall Study||40
2424566|NCT01207219|5946501|P1|STARTED|Overall Study||45
2424567|NCT01207102|5946521|P1|NOT COMPLETED|Overall Study||10
2424568|NCT01207102|5946521|P1|COMPLETED|Overall Study||0
2424569|NCT01207102|5946521|P1|STARTED|Overall Study||10
2424570|NCT01206816|5946533|P7|NOT COMPLETED|Overall Study||6
2424571|NCT01206816|5946534|P6|NOT COMPLETED|Overall Study||19
2424572|NCT01206816|5946535|P5|NOT COMPLETED|Overall Study||3
2424573|NCT01206816|5946536|P4|NOT COMPLETED|Overall Study||3
2424574|NCT01206816|5946537|P3|NOT COMPLETED|Overall Study||20
2424575|NCT01206816|5946538|P2|NOT COMPLETED|Overall Study||3
2424576|NCT01206816|5946539|P1|NOT COMPLETED|Overall Study||3
2424577|NCT01206816|5946533|P7|COMPLETED|Overall Study|1pt dist. due to 'other AE' & 1pt 'other' for vol & since,‘PD’ from aftb.|0
2424578|NCT01206816|5946534|P6|COMPLETED|Overall Study|1pt dist. due to 'PD' for vol & since, ‘Other AE’ from aftb|0
2424579|NCT01206816|5946535|P5|COMPLETED|Overall Study||0
2424580|NCT01206816|5946536|P4|COMPLETED|Overall Study|1pt discontinue (dist.)due to 'PD' for vol.& since, ‘Other AE’ from aftb|0
2424581|NCT01206816|5946537|P3|COMPLETED|Overall Study|1pt dist.due to 'Other AE' for vol& since 'other' from aftb.1pt 'PD' for vol& since,‘DLT’ from aftb|0
2424582|NCT01206816|5946538|P2|COMPLETED|Overall Study||0
2424583|NCT01206816|5946539|P1|COMPLETED|Overall Study||0
2424584|NCT01206816|5946533|P7|STARTED|Overall Study|Started=Treated|6
2424585|NCT01206816|5946534|P6|STARTED|Overall Study|Started=Treated|19
2424586|NCT01206816|5946535|P5|STARTED|Overall Study|Started=Treated|3
2424587|NCT01206816|5946536|P4|STARTED|Overall Study|Started=Treated|3
2424588|NCT01206816|5946537|P3|STARTED|Overall Study|Started=Treated|20
2424589|NCT01206816|5946538|P2|STARTED|Overall Study|Started=Treated|3
2424590|NCT01206816|5946539|P1|STARTED|Overall Study|Started=Treated|3
2424591|NCT01206777|5946585|P1|NOT COMPLETED|Overall Study||2
2424592|NCT01206777|5946585|P1|COMPLETED|Overall Study||50
2424593|NCT01206777|5946585|P1|Discontinued Trial and Deemed Ineligible|Overall Study||2
2424594|NCT01206777|5946585|P1|STARTED|Overall Study||52
2424595|NCT01206764|5946591|P1|NOT COMPLETED|Overall Study||138
2424596|NCT01206764|5946591|P1|COMPLETED|Overall Study||4
2424597|NCT01206764|5946591|P1|STARTED|Overall Study||142
2424598|NCT01206738|5946602|P3|NOT COMPLETED|Overall Study||19
2424599|NCT01206738|5946603|P2|NOT COMPLETED|Overall Study||25
2424600|NCT01206738|5946604|P1|NOT COMPLETED|Overall Study||23
2424601|NCT01206738|5946602|P3|COMPLETED|Overall Study||42
2424602|NCT01206738|5946603|P2|COMPLETED|Overall Study||49
2424603|NCT01206738|5946604|P1|COMPLETED|Overall Study||40
2424604|NCT01206738|5946602|P3|STARTED|Overall Study||61
2424605|NCT01206738|5946603|P2|STARTED|Overall Study||74
2424606|NCT01206738|5946604|P1|STARTED|Overall Study||63
2424607|NCT01206660|5946616|P2|NOT COMPLETED|Overall Study||0
2424608|NCT01206660|5946617|P1|NOT COMPLETED|Overall Study||0
2424609|NCT01206660|5946616|P2|COMPLETED|Overall Study||60
2424610|NCT01206660|5946617|P1|COMPLETED|Overall Study||60
2424611|NCT01206660|5946616|P2|STARTED|Overall Study||60
2424612|NCT01206660|5946617|P1|STARTED|Overall Study||60
2424613|NCT01206608|5946629|P2|NOT COMPLETED|Overall Study||0
2424614|NCT01206608|5946630|P1|NOT COMPLETED|Overall Study||0
2424615|NCT01206608|5946629|P2|COMPLETED|Overall Study||20
2424616|NCT01206608|5946630|P1|COMPLETED|Overall Study||20
2424617|NCT01206608|5946629|P2|STARTED|Overall Study||20
2424618|NCT01206608|5946630|P1|STARTED|Overall Study||20
2424619|NCT01206595|5946638|P2|NOT COMPLETED|Overall Study||0
2424620|NCT01206595|5946639|P1|NOT COMPLETED|Overall Study||0
2424621|NCT01206595|5946638|P2|COMPLETED|Overall Study||20
2424622|NCT01206595|5946639|P1|COMPLETED|Overall Study||38
2424623|NCT01206595|5946638|P2|STARTED|Overall Study||20
2424624|NCT01206595|5946639|P1|STARTED|Overall Study||38
2424625|NCT01206582|5946649|P2|NOT COMPLETED|Overall Study||2
2424626|NCT01206582|5946650|P1|NOT COMPLETED|Overall Study||2
2424627|NCT01206582|5946649|P2|COMPLETED|Overall Study||7
2424628|NCT01206582|5946650|P1|COMPLETED|Overall Study||9
2424629|NCT01206582|5946649|P2|STARTED|Overall Study||9
2424630|NCT01206582|5946650|P1|STARTED|Overall Study||11
2424631|NCT01206517|5946682|P6|NOT COMPLETED|Overall Study||0
2424632|NCT01206517|5946683|P5|NOT COMPLETED|Overall Study||1
2424633|NCT01206517|5946684|P4|NOT COMPLETED|Overall Study||0
2424634|NCT01206517|5946685|P3|NOT COMPLETED|Overall Study||2
2424635|NCT01206517|5946686|P2|NOT COMPLETED|Overall Study||0
2424636|NCT01206517|5946687|P1|NOT COMPLETED|Overall Study||0
2424637|NCT01206517|5946682|P6|COMPLETED|Overall Study||4
2424638|NCT01206517|5946683|P5|COMPLETED|Overall Study||3
2424639|NCT01206517|5946684|P4|COMPLETED|Overall Study||4
2424640|NCT01206517|5946685|P3|COMPLETED|Overall Study||4
2424641|NCT01206517|5946686|P2|COMPLETED|Overall Study||6
2424642|NCT01206517|5946687|P1|COMPLETED|Overall Study||6
2424643|NCT01206517|5946682|P6|STARTED|Overall Study||4
2424644|NCT01206517|5946683|P5|STARTED|Overall Study||4
2424645|NCT01206517|5946684|P4|STARTED|Overall Study||4
2424646|NCT01206517|5946685|P3|STARTED|Overall Study||6
2424647|NCT01206517|5946686|P2|STARTED|Overall Study||6
2424648|NCT01206517|5946687|P1|STARTED|Overall Study||6
2424649|NCT01206478|5946718|P2|NOT COMPLETED|Overall Study||5
2424650|NCT01206478|5946719|P1|NOT COMPLETED|Overall Study||2
2424651|NCT01206478|5946718|P2|COMPLETED|Overall Study||7
2424652|NCT01206478|5946719|P1|COMPLETED|Overall Study||7
2424653|NCT01206478|5946718|P2|STARTED|Overall Study||12
2424654|NCT01206478|5946719|P1|STARTED|Overall Study||9
2424655|NCT01206465|5946727|P5|NOT COMPLETED|Overall Study||0
2424656|NCT01206465|5946728|P4|NOT COMPLETED|Overall Study||0
2424657|NCT01206465|5946729|P3|NOT COMPLETED|Overall Study||0
2424658|NCT01206465|5946730|P2|NOT COMPLETED|Overall Study||0
2424659|NCT01206465|5946731|P1|NOT COMPLETED|Overall Study||0
2424660|NCT01206465|5946727|P5|COMPLETED|Overall Study||6
2424661|NCT01206465|5946728|P4|COMPLETED|Overall Study||6
2424662|NCT01206465|5946729|P3|COMPLETED|Overall Study||6
2424663|NCT01206465|5946730|P2|COMPLETED|Overall Study||6
2424664|NCT01206465|5946731|P1|COMPLETED|Overall Study||3
2424665|NCT01206465|5946727|P5|STARTED|Overall Study||6
2424666|NCT01206465|5946728|P4|STARTED|Overall Study||6
2424667|NCT01206465|5946729|P3|STARTED|Overall Study||6
2424668|NCT01206465|5946730|P2|STARTED|Overall Study||6
2424669|NCT01206465|5946731|P1|STARTED|Overall Study||3
2424670|NCT01206452|5946752|P2|NOT COMPLETED|Overall Study||0
2424671|NCT01206452|5946753|P1|NOT COMPLETED|Overall Study||0
2424672|NCT01206452|5946752|P2|COMPLETED|Overall Study||30
2424673|NCT01206452|5946753|P1|COMPLETED|Overall Study||30
2424674|NCT01206452|5946752|P2|STARTED|Overall Study||30
2424675|NCT01206452|5946753|P1|STARTED|Overall Study||30
2424676|NCT01206439|5946767|P1|NOT COMPLETED|Overall Study||1
2424677|NCT01206439|5946767|P1|COMPLETED|Overall Study||1
2424678|NCT01206439|5946767|P1|STARTED|Overall Study||2
2424679|NCT01206387|5946773|P2|NOT COMPLETED|Overall Study||0
2424680|NCT01206387|5946774|P1|NOT COMPLETED|Overall Study||1
2424681|NCT01206387|5946773|P2|COMPLETED|Overall Study||60
2424682|NCT01206387|5946774|P1|COMPLETED|Overall Study||59
2424683|NCT01206387|5946773|P2|STARTED|Overall Study||60
2424684|NCT01206387|5946774|P1|STARTED|Overall Study||60
2424685|NCT01206322|5946790|P4|NOT COMPLETED|Overall Study||1
2424686|NCT01206322|5946791|P3|NOT COMPLETED|Overall Study||0
2424687|NCT01206322|5946792|P2|NOT COMPLETED|Overall Study||0
2424688|NCT01206322|5946793|P1|NOT COMPLETED|Overall Study||0
2424689|NCT01206322|5946790|P4|COMPLETED|Overall Study||5
2424690|NCT01206322|5946791|P3|COMPLETED|Overall Study||9
2424691|NCT01206322|5946792|P2|COMPLETED|Overall Study||11
2424692|NCT01206322|5946793|P1|COMPLETED|Overall Study||4
2424693|NCT01206322|5946790|P4|STARTED|Overall Study||6
2424694|NCT01206322|5946791|P3|STARTED|Overall Study||9
2424695|NCT01206322|5946792|P2|STARTED|Overall Study||11
2424696|NCT01206322|5946793|P1|STARTED|Overall Study||4
2424697|NCT01206140|5946809|P2|NOT COMPLETED|Overall Study||0
2424698|NCT01206140|5946810|P1|NOT COMPLETED|Overall Study||1
2424699|NCT01206140|5946809|P2|COMPLETED|Overall Study||35
2424700|NCT01206140|5946810|P1|COMPLETED|Overall Study||34
2424701|NCT01206140|5946809|P2|STARTED|Overall Study||35
2424702|NCT01206140|5946810|P1|STARTED|Overall Study||35
2424703|NCT01206101|5946822|P2|NOT COMPLETED|Overall Study||1
2424704|NCT01206101|5946823|P1|NOT COMPLETED|Overall Study||2
2424705|NCT01206101|5946822|P2|COMPLETED|Overall Study||0
2424706|NCT01206101|5946823|P1|COMPLETED|Overall Study||0
2424707|NCT01206101|5946822|P2|STARTED|Overall Study||1
2424708|NCT01206101|5946823|P1|STARTED|Overall Study||2
2424709|NCT01206062|5946841|P2|NOT COMPLETED|Overall Study||0
2424710|NCT01206062|5946842|P1|NOT COMPLETED|Overall Study||0
2424711|NCT01206062|5946841|P2|COMPLETED|Overall Study||4683
2424712|NCT01206062|5946842|P1|COMPLETED|Overall Study||4678
2424713|NCT01206062|5946841|P2|STARTED|Overall Study||4683
2424714|NCT01206062|5946842|P1|STARTED|Overall Study||4678
2424715|NCT01205828|5946854|P1|NOT COMPLETED|Overall Study||0
2424716|NCT01205828|5946854|P1|COMPLETED|Overall Study|Completed the first stage of the study, terminated as pre-planned due to lack of efficacy|16
2424717|NCT01205828|5946854|P1|STARTED|Overall Study||16
2424718|NCT01205776|5946864|P2|NOT COMPLETED|3 Years Follow-up||24
2424719|NCT01205776|5946865|P1|NOT COMPLETED|3 Years Follow-up||16
2424720|NCT01205776|5946864|P2|COMPLETED|3 Years Follow-up||889
2424721|NCT01205776|5946865|P1|COMPLETED|3 Years Follow-up||911
2424722|NCT01205776|5946864|P2|STARTED|3 Years Follow-up||913
2424723|NCT01205776|5946865|P1|STARTED|3 Years Follow-up||927
2424724|NCT01205776|5946864|P2|NOT COMPLETED|2 Years Follow-up||32
2424725|NCT01205776|5946865|P1|NOT COMPLETED|2 Years Follow-up||16
2424726|NCT01205776|5946864|P2|COMPLETED|2 Years Follow-up||913
2424727|NCT01205776|5946865|P1|COMPLETED|2 Years Follow-up||927
2424728|NCT01205776|5946864|P2|STARTED|2 Years Follow-up||945
2424729|NCT01205776|5946865|P1|STARTED|2 Years Follow-up||943
2424730|NCT01205776|5946864|P2|NOT COMPLETED|1 Month Follow-up||12
2424731|NCT01205776|5946865|P1|NOT COMPLETED|1 Month Follow-up||5
2424732|NCT01205776|5946864|P2|COMPLETED|1 Month Follow-up||945
2424733|NCT01205776|5946865|P1|COMPLETED|1 Month Follow-up||943
2424734|NCT01205776|5946864|P2|STARTED|1 Month Follow-up||957
2424735|NCT01205776|5946865|P1|STARTED|1 Month Follow-up||948
2424736|NCT01205685|5947005|P1|NOT COMPLETED|Overall Study||11
2424737|NCT01205685|5947005|P1|COMPLETED|Overall Study||0
2424738|NCT01205685|5947005|P1|STARTED|Overall Study||11
2424739|NCT01205646|5947012|P1|NOT COMPLETED|Overall Study||0
2424740|NCT01205646|5947012|P1|COMPLETED|Overall Study||11
2424741|NCT01205646|5947012|P1|STARTED|Overall Study||11
2424742|NCT01205581|5947025|P6|NOT COMPLETED|Overall Study||0
2424743|NCT01205581|5947026|P5|NOT COMPLETED|Overall Study||0
2424744|NCT01205581|5947027|P4|NOT COMPLETED|Overall Study||0
2424745|NCT01205581|5947028|P3|NOT COMPLETED|Overall Study||0
2424746|NCT01205581|5947029|P2|NOT COMPLETED|Overall Study||0
2424747|NCT01205581|5947030|P1|NOT COMPLETED|Overall Study||1
2424748|NCT01205581|5947025|P6|COMPLETED|Overall Study||20
2424749|NCT01205581|5947026|P5|COMPLETED|Overall Study||20
2424750|NCT01205581|5947027|P4|COMPLETED|Overall Study||9
2424751|NCT01205581|5947028|P3|COMPLETED|Overall Study||8
2424752|NCT01205581|5947029|P2|COMPLETED|Overall Study||13
2424753|NCT01205581|5947030|P1|COMPLETED|Overall Study||13
2424754|NCT01205581|5947025|P6|STARTED|Overall Study||20
2424755|NCT01205581|5947026|P5|STARTED|Overall Study||20
2424756|NCT01205581|5947027|P4|STARTED|Overall Study||9
2424757|NCT01205581|5947028|P3|STARTED|Overall Study||8
2424758|NCT01205581|5947029|P2|STARTED|Overall Study||13
2424759|NCT01205581|5947030|P1|STARTED|Overall Study||14
2424760|NCT01205568|5947094|P2|NOT COMPLETED|Overall Study||0
2424761|NCT01205568|5947095|P1|NOT COMPLETED|Overall Study||0
2424762|NCT01205568|5947094|P2|COMPLETED|Overall Study||47
2424763|NCT01205568|5947095|P1|COMPLETED|Overall Study||65
2424764|NCT01205568|5947094|P2|STARTED|Overall Study|8 patients received only HPB therapy, 39 patients received both CB and HPB therapy.|47
2424765|NCT01205568|5947095|P1|STARTED|Overall Study|26 patients received only CB therapy, 39 patients received both CB and HPB therapy.|65
2424766|NCT01205529|5947100|P1|NOT COMPLETED|Overall Study||55
2424767|NCT01205529|5947100|P1|COMPLETED|Overall Study||106
2424768|NCT01205529|5947100|P1|STARTED|Overall Study||161
2424769|NCT01205503|5947106|P2|NOT COMPLETED|Second Intervention (2nd Cycle)||0
2424770|NCT01205503|5947107|P1|NOT COMPLETED|Second Intervention (2nd Cycle)||0
2424771|NCT01205503|5947106|P2|COMPLETED|Second Intervention (2nd Cycle)||16
2424772|NCT01205503|5947107|P1|COMPLETED|Second Intervention (2nd Cycle)||16
2424773|NCT01205503|5947106|P2|STARTED|Second Intervention (2nd Cycle)||16
2424774|NCT01205503|5947107|P1|STARTED|Second Intervention (2nd Cycle)||16
2424775|NCT01205503|5947106|P2|NOT COMPLETED|First Intervention (1st Cycle)||0
2424776|NCT01205503|5947107|P1|NOT COMPLETED|First Intervention (1st Cycle)||0
2424777|NCT01205503|5947106|P2|COMPLETED|First Intervention (1st Cycle)||16
2424778|NCT01205503|5947107|P1|COMPLETED|First Intervention (1st Cycle)||16
2424779|NCT01205503|5947106|P2|STARTED|First Intervention (1st Cycle)||16
2424780|NCT01205503|5947107|P1|STARTED|First Intervention (1st Cycle)||16
2424781|NCT01205451|5947123|P2|NOT COMPLETED|Overall Study||10
2424782|NCT01205451|5947124|P1|NOT COMPLETED|Overall Study||6
2424783|NCT01205451|5947123|P2|COMPLETED|Overall Study||46
2424784|NCT01205451|5947124|P1|COMPLETED|Overall Study||47
2424785|NCT01205451|5947123|P2|STARTED|Overall Study||56
2424786|NCT01205451|5947124|P1|STARTED|Overall Study||53
2424787|NCT01205438|5947169|P3|NOT COMPLETED|Overall Study||88
2424788|NCT01205438|5947170|P2|NOT COMPLETED|Overall Study||87
2424789|NCT01205438|5947171|P1|NOT COMPLETED|Overall Study||77
2424790|NCT01205438|5947169|P3|COMPLETED|Overall Study||288
2424791|NCT01205438|5947170|P2|COMPLETED|Overall Study||289
2424792|NCT01205438|5947171|P1|COMPLETED|Overall Study||295
2424793|NCT01205438|5947169|P3|Participated in Follow Up|Overall Study||66
2424794|NCT01205438|5947170|P2|Participated in Follow Up|Overall Study||78
2424795|NCT01205438|5947171|P1|Participated in Follow Up|Overall Study||72
2424796|NCT01205438|5947169|P3|Received At Least One Dose of Study Drug|Overall Study||376
2424797|NCT01205438|5947170|P2|Received At Least One Dose of Study Drug|Overall Study||374
2424798|NCT01205438|5947171|P1|Received At Least One Dose of Study Drug|Overall Study||371
2424799|NCT01205438|5947169|P3|STARTED|Overall Study||376
2424800|NCT01205438|5947170|P2|STARTED|Overall Study||376
2424801|NCT01205438|5947171|P1|STARTED|Overall Study||372
2424802|NCT01205399|5947221|P1|NOT COMPLETED|Overall Study||0
2424803|NCT01205399|5947221|P1|COMPLETED|Overall Study||78
2424804|NCT01205399|5947221|P1|STARTED|Overall Study||78
2424805|NCT01205269|5947227|P6|NOT COMPLETED|Period 5 - Third Intervention||0
2424806|NCT01205269|5947228|P5|NOT COMPLETED|Period 5 - Third Intervention||0
2424807|NCT01205269|5947229|P4|NOT COMPLETED|Period 5 - Third Intervention||0
2424808|NCT01205269|5947230|P3|NOT COMPLETED|Period 5 - Third Intervention||0
2424809|NCT01205269|5947231|P2|NOT COMPLETED|Period 5 - Third Intervention||0
2424810|NCT01205269|5947232|P1|NOT COMPLETED|Period 5 - Third Intervention||0
2424811|NCT01205269|5947227|P6|COMPLETED|Period 5 - Third Intervention||5
2424812|NCT01205269|5947228|P5|COMPLETED|Period 5 - Third Intervention||5
2424813|NCT01205269|5947229|P4|COMPLETED|Period 5 - Third Intervention||5
2424814|NCT01205269|5947230|P3|COMPLETED|Period 5 - Third Intervention||4
2424815|NCT01205269|5947231|P2|COMPLETED|Period 5 - Third Intervention||4
2424816|NCT01205269|5947232|P1|COMPLETED|Period 5 - Third Intervention||4
2424817|NCT01205269|5947227|P6|STARTED|Period 5 - Third Intervention||5
2424818|NCT01205269|5947228|P5|STARTED|Period 5 - Third Intervention||5
2424819|NCT01205269|5947229|P4|STARTED|Period 5 - Third Intervention||5
2424820|NCT01205269|5947230|P3|STARTED|Period 5 - Third Intervention||4
2424821|NCT01205269|5947231|P2|STARTED|Period 5 - Third Intervention||4
2424822|NCT01205269|5947232|P1|STARTED|Period 5 - Third Intervention||4
2424823|NCT01205269|5947227|P6|NOT COMPLETED|Period 4 - Washout||0
2424824|NCT01205269|5947228|P5|NOT COMPLETED|Period 4 - Washout||0
2424825|NCT01205269|5947229|P4|NOT COMPLETED|Period 4 - Washout||1
2424826|NCT01205269|5947230|P3|NOT COMPLETED|Period 4 - Washout||0
2424827|NCT01205269|5947231|P2|NOT COMPLETED|Period 4 - Washout||0
2424828|NCT01205269|5947232|P1|NOT COMPLETED|Period 4 - Washout||0
2424829|NCT01205269|5947227|P6|COMPLETED|Period 4 - Washout||5
2424830|NCT01205269|5947228|P5|COMPLETED|Period 4 - Washout||5
2424831|NCT01205269|5947229|P4|COMPLETED|Period 4 - Washout||5
2424832|NCT01205269|5947230|P3|COMPLETED|Period 4 - Washout||4
2424833|NCT01205269|5947231|P2|COMPLETED|Period 4 - Washout||4
2424834|NCT01205269|5947232|P1|COMPLETED|Period 4 - Washout||4
2424835|NCT01205269|5947227|P6|STARTED|Period 4 - Washout||5
2424836|NCT01205269|5947228|P5|STARTED|Period 4 - Washout||5
2424837|NCT01205269|5947229|P4|STARTED|Period 4 - Washout||6
2424838|NCT01205269|5947230|P3|STARTED|Period 4 - Washout||4
2424839|NCT01205269|5947231|P2|STARTED|Period 4 - Washout||4
2424840|NCT01205269|5947232|P1|STARTED|Period 4 - Washout||4
2424841|NCT01205269|5947227|P6|NOT COMPLETED|Period 3 - Second Intervention||0
2424842|NCT01205269|5947228|P5|NOT COMPLETED|Period 3 - Second Intervention||0
2424843|NCT01205269|5947229|P4|NOT COMPLETED|Period 3 - Second Intervention||0
2424844|NCT01205269|5947230|P3|NOT COMPLETED|Period 3 - Second Intervention||0
2424845|NCT01205269|5947231|P2|NOT COMPLETED|Period 3 - Second Intervention||0
2424846|NCT01205269|5947232|P1|NOT COMPLETED|Period 3 - Second Intervention||0
2424847|NCT01205269|5947227|P6|COMPLETED|Period 3 - Second Intervention||5
2424848|NCT01205269|5947228|P5|COMPLETED|Period 3 - Second Intervention||5
2424849|NCT01205269|5947229|P4|COMPLETED|Period 3 - Second Intervention||6
2424850|NCT01205269|5947230|P3|COMPLETED|Period 3 - Second Intervention||4
2424851|NCT01205269|5947231|P2|COMPLETED|Period 3 - Second Intervention||4
2424852|NCT01205269|5947232|P1|COMPLETED|Period 3 - Second Intervention||4
2424853|NCT01205269|5947227|P6|STARTED|Period 3 - Second Intervention||5
2424854|NCT01205269|5947228|P5|STARTED|Period 3 - Second Intervention||5
2424855|NCT01205269|5947229|P4|STARTED|Period 3 - Second Intervention||6
2424856|NCT01205269|5947230|P3|STARTED|Period 3 - Second Intervention||4
2424857|NCT01205269|5947231|P2|STARTED|Period 3 - Second Intervention||4
2424858|NCT01205269|5947232|P1|STARTED|Period 3 - Second Intervention||4
2424859|NCT01205269|5947227|P6|NOT COMPLETED|Period 2 - Washout||0
2424860|NCT01205269|5947228|P5|NOT COMPLETED|Period 2 - Washout||0
2424861|NCT01205269|5947229|P4|NOT COMPLETED|Period 2 - Washout||0
2424862|NCT01205269|5947230|P3|NOT COMPLETED|Period 2 - Washout||0
2424863|NCT01205269|5947231|P2|NOT COMPLETED|Period 2 - Washout||0
2424864|NCT01205269|5947232|P1|NOT COMPLETED|Period 2 - Washout||0
2424865|NCT01205269|5947227|P6|COMPLETED|Period 2 - Washout||5
2424866|NCT01205269|5947228|P5|COMPLETED|Period 2 - Washout||5
2424867|NCT01205269|5947229|P4|COMPLETED|Period 2 - Washout||6
2424868|NCT01205269|5947230|P3|COMPLETED|Period 2 - Washout||4
2424869|NCT01205269|5947231|P2|COMPLETED|Period 2 - Washout||4
2424870|NCT01205269|5947232|P1|COMPLETED|Period 2 - Washout||4
2424871|NCT01205269|5947227|P6|STARTED|Period 2 - Washout||5
2424872|NCT01205269|5947228|P5|STARTED|Period 2 - Washout||5
2424873|NCT01205269|5947229|P4|STARTED|Period 2 - Washout||6
2424874|NCT01205269|5947230|P3|STARTED|Period 2 - Washout||4
2424875|NCT01205269|5947231|P2|STARTED|Period 2 - Washout||4
2424876|NCT01205269|5947232|P1|STARTED|Period 2 - Washout||4
2424877|NCT01205269|5947227|P6|NOT COMPLETED|Period 1 - First Intervention||0
2424878|NCT01205269|5947228|P5|NOT COMPLETED|Period 1 - First Intervention||0
2424879|NCT01205269|5947229|P4|NOT COMPLETED|Period 1 - First Intervention||0
2424880|NCT01205269|5947230|P3|NOT COMPLETED|Period 1 - First Intervention||0
2424881|NCT01205269|5947231|P2|NOT COMPLETED|Period 1 - First Intervention||0
2424882|NCT01205269|5947232|P1|NOT COMPLETED|Period 1 - First Intervention||0
2424883|NCT01205269|5947227|P6|COMPLETED|Period 1 - First Intervention||5
2424884|NCT01205269|5947228|P5|COMPLETED|Period 1 - First Intervention||5
2424885|NCT01205269|5947229|P4|COMPLETED|Period 1 - First Intervention||6
2424886|NCT01205269|5947230|P3|COMPLETED|Period 1 - First Intervention||4
2424887|NCT01205269|5947231|P2|COMPLETED|Period 1 - First Intervention||4
2424888|NCT01205269|5947232|P1|COMPLETED|Period 1 - First Intervention||4
2424889|NCT01205269|5947227|P6|STARTED|Period 1 - First Intervention||5
2424890|NCT01205269|5947228|P5|STARTED|Period 1 - First Intervention||5
2424891|NCT01205269|5947229|P4|STARTED|Period 1 - First Intervention||6
2424892|NCT01205269|5947230|P3|STARTED|Period 1 - First Intervention||4
2424893|NCT01205269|5947231|P2|STARTED|Period 1 - First Intervention||4
2424894|NCT01205269|5947232|P1|STARTED|Period 1 - First Intervention||4
2424895|NCT01205230|5947272|P2|NOT COMPLETED|Overall Study||0
2424896|NCT01205230|5947273|P1|NOT COMPLETED|Overall Study||5
2424897|NCT01205230|5947272|P2|COMPLETED|Overall Study||13
2424898|NCT01205230|5947273|P1|COMPLETED|Overall Study||16
2424899|NCT01205230|5947272|P2|Combination Therapy|Overall Study||13
2424900|NCT01205230|5947273|P1|Combination Therapy|Overall Study||21
2424901|NCT01205230|5947272|P2|STARTED|Overall Study||13
2424902|NCT01205230|5947273|P1|STARTED|Overall Study||21
2424903|NCT01205165|5947316|P1|NOT COMPLETED|Overall Study||2
2424904|NCT01205165|5947316|P1|COMPLETED|Overall Study||102
2424905|NCT01205165|5947316|P1|STARTED|Overall Study||104
2424906|NCT01205152|5947329|P1|NOT COMPLETED|Overall Study||1
2424907|NCT01205152|5947329|P1|COMPLETED|Overall Study||9
2424908|NCT01205152|5947329|P1|STARTED|Overall Study||10
2424909|NCT01205126|5947342|P2|NOT COMPLETED|Maintenance Phase||40
2424910|NCT01205126|5947343|P1|NOT COMPLETED|Maintenance Phase||37
2424911|NCT01205126|5947342|P2|COMPLETED|Maintenance Phase||67
2424912|NCT01205126|5947343|P1|COMPLETED|Maintenance Phase||70
2424913|NCT01205126|5947342|P2|STARTED|Maintenance Phase||107
2424914|NCT01205126|5947343|P1|STARTED|Maintenance Phase||107
2424915|NCT01205126|5947342|P2|NOT COMPLETED|Between Titration & Maintenance Phase||4
2424916|NCT01205126|5947343|P1|NOT COMPLETED|Between Titration & Maintenance Phase||0
2424917|NCT01205126|5947342|P2|COMPLETED|Between Titration & Maintenance Phase||107
2424918|NCT01205126|5947343|P1|COMPLETED|Between Titration & Maintenance Phase||107
2424919|NCT01205126|5947342|P2|STARTED|Between Titration & Maintenance Phase||111
2424920|NCT01205126|5947343|P1|STARTED|Between Titration & Maintenance Phase||107
2424921|NCT01205126|5947342|P2|NOT COMPLETED|Titration Phase||19
2424922|NCT01205126|5947343|P1|NOT COMPLETED|Titration Phase||23
2424923|NCT01205126|5947342|P2|COMPLETED|Titration Phase||111
2424924|NCT01205126|5947343|P1|COMPLETED|Titration Phase||107
2424925|NCT01205126|5947342|P2|STARTED|Titration Phase||130
2424926|NCT01205126|5947343|P1|STARTED|Titration Phase||130
2424927|NCT01205035|5947361|P2|NOT COMPLETED|Overall Study||0
2424928|NCT01205035|5947362|P1|NOT COMPLETED|Overall Study||2
2424929|NCT01205035|5947361|P2|COMPLETED|Overall Study||3
2424930|NCT01205035|5947362|P1|COMPLETED|Overall Study||1
2424931|NCT01205035|5947361|P2|STARTED|Overall Study||3
2424932|NCT01205035|5947362|P1|STARTED|Overall Study||3
2424933|NCT01204918|5947379|P3|NOT COMPLETED|Overall Study||5
2424934|NCT01204918|5947380|P2|NOT COMPLETED|Overall Study||10
2424935|NCT01204918|5947381|P1|NOT COMPLETED|Overall Study||4
2424936|NCT01204918|5947379|P3|COMPLETED|Overall Study||35
2424937|NCT01204918|5947380|P2|COMPLETED|Overall Study||29
2424938|NCT01204918|5947381|P1|COMPLETED|Overall Study||21
2424939|NCT01204918|5947379|P3|Stage 2 End|Overall Study||35
2424940|NCT01204918|5947380|P2|Stage 2 End|Overall Study||29
2424941|NCT01204918|5947381|P1|Stage 2 End|Overall Study||21
2424942|NCT01204918|5947379|P3|Stage 2 Begin|Overall Study||36
2424943|NCT01204918|5947380|P2|Stage 2 Begin|Overall Study||35
2424944|NCT01204918|5947381|P1|Stage 2 Begin|Overall Study||22
2424945|NCT01204918|5947379|P3|Stage 1 End|Overall Study||36
2424946|NCT01204918|5947380|P2|Stage 1 End|Overall Study||35
2424947|NCT01204918|5947381|P1|Stage 1 End|Overall Study||22
2424948|NCT01204918|5947379|P3|Stage 1 Begin|Overall Study||40
2424949|NCT01204918|5947380|P2|Stage 1 Begin|Overall Study||39
2424950|NCT01204918|5947381|P1|Stage 1 Begin|Overall Study||25
2424951|NCT01204918|5947379|P3|STARTED|Overall Study||40
2424952|NCT01204918|5947380|P2|STARTED|Overall Study||39
2424953|NCT01204918|5947381|P1|STARTED|Overall Study||25
2424954|NCT01204905|5947398|P1|NOT COMPLETED|Overall Study||2
2424955|NCT01204905|5947398|P1|COMPLETED|Overall Study||5
2424956|NCT01204905|5947398|P1|STARTED|Overall Study||7
2424957|NCT01204853|5947403|P1|NOT COMPLETED|Overall Study||0
2424958|NCT01204853|5947403|P1|COMPLETED|Overall Study||2
2424959|NCT01204853|5947403|P1|STARTED|Overall Study||2
2424960|NCT01204788|5947415|P2|NOT COMPLETED|Overall Study||3
2424961|NCT01204788|5947416|P1|NOT COMPLETED|Overall Study||1
2424962|NCT01204788|5947415|P2|COMPLETED|Overall Study||0
2424963|NCT01204788|5947416|P1|COMPLETED|Overall Study||0
2424964|NCT01204788|5947415|P2|STARTED|Overall Study||3
2424965|NCT01204788|5947416|P1|STARTED|Overall Study||1
2424966|NCT01204775|5947424|P2|NOT COMPLETED|Overall Study||1
2424967|NCT01204775|5947425|P1|NOT COMPLETED|Overall Study||1
2424968|NCT01204775|5947424|P2|COMPLETED|Overall Study||3
2424969|NCT01204775|5947425|P1|COMPLETED|Overall Study||3
2424970|NCT01204775|5947424|P2|Double-blind Treatment Period|Overall Study||4
2424971|NCT01204775|5947425|P1|Double-blind Treatment Period|Overall Study||4
2424972|NCT01204775|5947424|P2|STARTED|Overall Study||4
2424973|NCT01204775|5947425|P1|STARTED|Overall Study||4
2424974|NCT01204736|5947435|P4|NOT COMPLETED|Overall Study||0
2424975|NCT01204736|5947436|P3|NOT COMPLETED|Overall Study||0
2424976|NCT01204736|5947437|P2|NOT COMPLETED|Overall Study||0
2424977|NCT01204736|5947438|P1|NOT COMPLETED|Overall Study||0
2424978|NCT01204736|5947435|P4|COMPLETED|Overall Study||2
2424979|NCT01204736|5947436|P3|COMPLETED|Overall Study||3
2424980|NCT01204736|5947437|P2|COMPLETED|Overall Study||5
2424981|NCT01204736|5947438|P1|COMPLETED|Overall Study||4
2424982|NCT01204736|5947435|P4|STARTED|Overall Study||2
2424983|NCT01204736|5947436|P3|STARTED|Overall Study||3
2424984|NCT01204736|5947437|P2|STARTED|Overall Study||5
2424985|NCT01204736|5947438|P1|STARTED|Overall Study||4
2424986|NCT01204710|5947450|P2|NOT COMPLETED|Optional Olaratumab Monotherapy||3
2424987|NCT01204710|5947451|P1|NOT COMPLETED|Optional Olaratumab Monotherapy||0
2424988|NCT01204710|5947450|P2|COMPLETED|Optional Olaratumab Monotherapy||16
2424989|NCT01204710|5947451|P1|COMPLETED|Optional Olaratumab Monotherapy||0
2424990|NCT01204710|5947450|P2|STARTED|Optional Olaratumab Monotherapy|Among 43 participants who experienced PD, 19 received olaratumab monotherapy.|19
2424991|NCT01204710|5947451|P1|STARTED|Optional Olaratumab Monotherapy|Olaratumab follow-on treatment was optional for participants in mitoxantrone group only who had PD.|0
2424992|NCT01204710|5947450|P2|NOT COMPLETED|Randomization Treatment||13
2424993|NCT01204710|5947451|P1|NOT COMPLETED|Randomization Treatment||14
2424994|NCT01204710|5947450|P2|COMPLETED|Randomization Treatment||47
2424995|NCT01204710|5947451|P1|COMPLETED|Randomization Treatment||49
2424996|NCT01204710|5947450|P2|Received ≥1 Dose of Study Drug|Randomization Treatment||59
2424997|NCT01204710|5947451|P1|Received ≥1 Dose of Study Drug|Randomization Treatment||62
2424998|NCT01204710|5947450|P2|STARTED|Randomization Treatment||60
2424999|NCT01204710|5947451|P1|STARTED|Randomization Treatment||63
2425000|NCT01204697|5947487|P2|NOT COMPLETED|Overall Study||36
2425001|NCT01204697|5947488|P1|NOT COMPLETED|Overall Study||31
2425002|NCT01204697|5947487|P2|COMPLETED|Overall Study||2
2425003|NCT01204697|5947488|P1|COMPLETED|Overall Study||5
2425004|NCT01204697|5947487|P2|Treated|Overall Study||37
2425005|NCT01204697|5947488|P1|Treated|Overall Study||36
2425006|NCT01204697|5947487|P2|STARTED|Overall Study||38
2425007|NCT01204697|5947488|P1|STARTED|Overall Study||36
2425008|NCT01204671|5947509|P5|NOT COMPLETED|Overall Study||4
2425009|NCT01204671|5947510|P4|NOT COMPLETED|Overall Study||13
2425010|NCT01204671|5947511|P3|NOT COMPLETED|Overall Study||13
2425011|NCT01204671|5947512|P2|NOT COMPLETED|Overall Study||15
2425012|NCT01204671|5947513|P1|NOT COMPLETED|Overall Study||14
2425013|NCT01204671|5947509|P5|COMPLETED|Overall Study||606
2425014|NCT01204671|5947510|P4|COMPLETED|Overall Study||997
2425015|NCT01204671|5947511|P3|COMPLETED|Overall Study||998
2425016|NCT01204671|5947512|P2|COMPLETED|Overall Study||998
2425017|NCT01204671|5947513|P1|COMPLETED|Overall Study||998
2425018|NCT01204671|5947509|P5|STARTED|Overall Study||610
2425019|NCT01204671|5947510|P4|STARTED|Overall Study||1010
2425020|NCT01204671|5947511|P3|STARTED|Overall Study||1011
2425021|NCT01204671|5947512|P2|STARTED|Overall Study||1013
2425022|NCT01204671|5947513|P1|STARTED|Overall Study||1012
2425023|NCT01204658|5947575|P4|NOT COMPLETED|Booster Phase||0
2425024|NCT01204658|5947576|P3|NOT COMPLETED|Booster Phase||0
2425025|NCT01204658|5947577|P2|NOT COMPLETED|Booster Phase||0
2425026|NCT01204658|5947578|P1|NOT COMPLETED|Booster Phase||0
2425027|NCT01204658|5947575|P4|COMPLETED|Booster Phase||140
2425028|NCT01204658|5947576|P3|COMPLETED|Booster Phase||140
2425029|NCT01204658|5947577|P2|COMPLETED|Booster Phase||140
2425030|NCT01204658|5947578|P1|COMPLETED|Booster Phase||144
2425031|NCT01204658|5947575|P4|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
2425032|NCT01204658|5947576|P3|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
2425033|NCT01204658|5947577|P2|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
2425034|NCT01204658|5947578|P1|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|144
2425035|NCT01204658|5947575|P4|NOT COMPLETED|Primary Phase||0
2425036|NCT01204658|5947576|P3|NOT COMPLETED|Primary Phase||1
2425037|NCT01204658|5947577|P2|NOT COMPLETED|Primary Phase||0
2425038|NCT01204658|5947578|P1|NOT COMPLETED|Primary Phase||0
2425039|NCT01204658|5947575|P4|COMPLETED|Primary Phase||142
2425040|NCT01204658|5947576|P3|COMPLETED|Primary Phase||144
2425041|NCT01204658|5947577|P2|COMPLETED|Primary Phase||142
2425042|NCT01204658|5947578|P1|COMPLETED|Primary Phase||146
2425043|NCT01204658|5947575|P4|STARTED|Primary Phase||142
2425044|NCT01204658|5947576|P3|STARTED|Primary Phase||145
2425045|NCT01204658|5947577|P2|STARTED|Primary Phase||142
2425046|NCT01204658|5947578|P1|STARTED|Primary Phase||146
2425047|NCT01204398|5947696|P1|NOT COMPLETED|Overall Study||1
2425048|NCT01204398|5947696|P1|COMPLETED|Overall Study|Completed trial medication.|26
2425049|NCT01204398|5947696|P1|STARTED|Overall Study|Entered and treated.|27
2425050|NCT01204294|5947713|P7|NOT COMPLETED|Overall Study||2
2425051|NCT01204294|5947714|P6|NOT COMPLETED|Overall Study||5
2425052|NCT01204294|5947715|P5|NOT COMPLETED|Overall Study||2
2425053|NCT01204294|5947716|P4|NOT COMPLETED|Overall Study||11
2425054|NCT01204294|5947717|P3|NOT COMPLETED|Overall Study||5
2425055|NCT01204294|5947718|P2|NOT COMPLETED|Overall Study||8
2425056|NCT01204294|5947719|P1|NOT COMPLETED|Overall Study||3
2425057|NCT01204294|5947713|P7|COMPLETED|Overall Study||59
2425058|NCT01204294|5947714|P6|COMPLETED|Overall Study||58
2425059|NCT01204294|5947715|P5|COMPLETED|Overall Study||83
2425060|NCT01204294|5947716|P4|COMPLETED|Overall Study||132
2425061|NCT01204294|5947717|P3|COMPLETED|Overall Study||69
2425062|NCT01204294|5947718|P2|COMPLETED|Overall Study||58
2425063|NCT01204294|5947719|P1|COMPLETED|Overall Study||79
2425064|NCT01204294|5947713|P7|STARTED|Overall Study||61
2425065|NCT01204294|5947714|P6|STARTED|Overall Study||63
2425066|NCT01204294|5947715|P5|STARTED|Overall Study||85
2425067|NCT01204294|5947716|P4|STARTED|Overall Study||143
2425068|NCT01204294|5947717|P3|STARTED|Overall Study||74
2425069|NCT01204294|5947718|P2|STARTED|Overall Study||66
2425070|NCT01204294|5947719|P1|STARTED|Overall Study||82
2425071|NCT01204255|5947742|P1|NOT COMPLETED|Overall Study||1
2425072|NCT01204255|5947742|P1|COMPLETED|Overall Study||10
2425073|NCT01204255|5947742|P1|STARTED|Overall Study||11
2425074|NCT01204203|5947747|P1|NOT COMPLETED|Overall Study||0
2425075|NCT01204203|5947747|P1|COMPLETED|Overall Study||8
2425076|NCT01204203|5947747|P1|STARTED|Overall Study||8
2425077|NCT01203956|5947753|P2|NOT COMPLETED|Second Two-week Period||6
2425078|NCT01203956|5947754|P1|NOT COMPLETED|Second Two-week Period||5
2425079|NCT01203956|5947753|P2|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|7
2425080|NCT01203956|5947754|P1|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|10
2425081|NCT01203956|5947753|P2|Attended Sleep Studies for 14 Nights|Second Two-week Period||13
2425082|NCT01203956|5947754|P1|Attended Sleep Studies for 14 Nights|Second Two-week Period||15
2425083|NCT01203956|5947753|P2|STARTED|Second Two-week Period||13
2425084|NCT01203956|5947754|P1|STARTED|Second Two-week Period||15
2425085|NCT01203956|5947753|P2|NOT COMPLETED|First Two-week Period||0
2425086|NCT01203956|5947754|P1|NOT COMPLETED|First Two-week Period||0
2425087|NCT01203956|5947753|P2|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|13
2425088|NCT01203956|5947754|P1|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|15
2425089|NCT01203956|5947753|P2|STARTED|First Two-week Period||13
2425090|NCT01203956|5947754|P1|STARTED|First Two-week Period||15
2425091|NCT01203930|5947763|P2|NOT COMPLETED|Overall Study||41
2425092|NCT01203930|5947764|P1|NOT COMPLETED|Overall Study||21
2425093|NCT01203930|5947763|P2|COMPLETED|Overall Study||0
2425094|NCT01203930|5947764|P1|COMPLETED|Overall Study|43 participants completed 12 cycles and were then eligible to enroll in the extension study (101-99)|43
2425095|NCT01203930|5947763|P2|STARTED|Overall Study||41
2425096|NCT01203930|5947764|P1|STARTED|Overall Study||64
2425097|NCT01203917|5947786|P1|NOT COMPLETED|Overall Study||36
2425098|NCT01203917|5947786|P1|COMPLETED|Overall Study|Patients on-going study at data cut-off(of which 49 were still on study treatment).|71
2425099|NCT01203917|5947786|P1|STARTED|Overall Study|106 patients were EGFR M+ patients and 1 patient was EGFR M+I|107
2425100|NCT01203878|5947799|P3|NOT COMPLETED|Overall Study||3
2425101|NCT01203878|5947800|P2|NOT COMPLETED|Overall Study||0
2425102|NCT01203878|5947801|P1|NOT COMPLETED|Overall Study||0
2425103|NCT01203878|5947799|P3|COMPLETED|Overall Study||0
2425104|NCT01203878|5947800|P2|COMPLETED|Overall Study||9
2425105|NCT01203878|5947801|P1|COMPLETED|Overall Study||9
2425106|NCT01203878|5947799|P3|STARTED|Overall Study||3
2425107|NCT01203878|5947800|P2|STARTED|Overall Study||9
2425108|NCT01203878|5947801|P1|STARTED|Overall Study||9
2425109|NCT01203852|5947812|P1|NOT COMPLETED|Chlorthalidone 8 Weeks||0
2425110|NCT01203852|5947812|P1|COMPLETED|Chlorthalidone 8 Weeks||328
2425111|NCT01203852|5947812|P1|Continued From Metoprolol|Chlorthalidone 8 Weeks||282
2425112|NCT01203852|5947812|P1|STARTED|Chlorthalidone 8 Weeks|Subjects were allowed to enter the study at Chlorthalidone without completing Metoprolol.|328
2425113|NCT01203852|5947812|P1|NOT COMPLETED|Washout 2 Weeks||46
2425114|NCT01203852|5947812|P1|COMPLETED|Washout 2 Weeks||282
2425115|NCT01203852|5947812|P1|STARTED|Washout 2 Weeks|Some study subjects did not proceed to the washout phase after the first intervention.|328
2425116|NCT01203852|5947812|P1|NOT COMPLETED|Metoprolol 8 Weeks||470
2425117|NCT01203852|5947812|P1|COMPLETED|Metoprolol 8 Weeks||369
2425118|NCT01203852|5947812|P1|STARTED|Metoprolol 8 Weeks|This is the total number of subjects for both groups.|839
2425119|NCT01203826|5947821|P2|NOT COMPLETED|Overall Study||0
2425120|NCT01203826|5947822|P1|NOT COMPLETED|Overall Study||0
2425121|NCT01203826|5947821|P2|COMPLETED|Overall Study||6
2425122|NCT01203826|5947822|P1|COMPLETED|Overall Study||6
2425123|NCT01203826|5947821|P2|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
2425124|NCT01203826|5947822|P1|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
2425125|NCT01203787|5947830|P2|NOT COMPLETED|Overall Study||27
2425126|NCT01203787|5947831|P1|NOT COMPLETED|Overall Study||31
2425127|NCT01203787|5947830|P2|COMPLETED|Overall Study||30
2425128|NCT01203787|5947831|P1|COMPLETED|Overall Study||32
2425129|NCT01203787|5947830|P2|STARTED|Overall Study||57
2425130|NCT01203787|5947831|P1|STARTED|Overall Study||63
2425131|NCT01203644|5947851|P2|NOT COMPLETED|Overall Study||0
2425132|NCT01203644|5947852|P1|NOT COMPLETED|Overall Study||0
2425133|NCT01203644|5947851|P2|COMPLETED|Overall Study||50
2425134|NCT01203644|5947852|P1|COMPLETED|Overall Study||26
2425135|NCT01203644|5947851|P2|STARTED|Overall Study||50
2425136|NCT01203644|5947852|P1|STARTED|Overall Study||26
2425137|NCT01203319|5947864|P3|NOT COMPLETED|Overall Study||5
2425138|NCT01203319|5947865|P2|NOT COMPLETED|Overall Study||9
2425139|NCT01203319|5947866|P1|NOT COMPLETED|Overall Study||6
2425140|NCT01203319|5947864|P3|COMPLETED|Overall Study||217
2425141|NCT01203319|5947865|P2|COMPLETED|Overall Study||426
2425142|NCT01203319|5947866|P1|COMPLETED|Overall Study||428
2425143|NCT01203319|5947864|P3|STARTED|Overall Study||222
2425144|NCT01203319|5947865|P2|STARTED|Overall Study||435
2425145|NCT01203319|5947866|P1|STARTED|Overall Study||434
2425146|NCT01203189|5947883|P3|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
2425147|NCT01203189|5947884|P2|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
2425148|NCT01203189|5947885|P1|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
2425149|NCT01203189|5947883|P3|COMPLETED|Cross Over Period 4 Weeks Treatment||3
2425150|NCT01203189|5947884|P2|COMPLETED|Cross Over Period 4 Weeks Treatment||0
2425151|NCT01203189|5947885|P1|COMPLETED|Cross Over Period 4 Weeks Treatment||0
2425152|NCT01203189|5947883|P3|STARTED|Cross Over Period 4 Weeks Treatment||3
2425153|NCT01203189|5947884|P2|STARTED|Cross Over Period 4 Weeks Treatment||0
2425154|NCT01203189|5947885|P1|STARTED|Cross Over Period 4 Weeks Treatment||0
2425155|NCT01203189|5947883|P3|NOT COMPLETED|First 4 Weeks Treatment||0
2425156|NCT01203189|5947884|P2|NOT COMPLETED|First 4 Weeks Treatment||2
2425157|NCT01203189|5947885|P1|NOT COMPLETED|First 4 Weeks Treatment||2
2425158|NCT01203189|5947883|P3|COMPLETED|First 4 Weeks Treatment||3
2425159|NCT01203189|5947884|P2|COMPLETED|First 4 Weeks Treatment||8
2425160|NCT01203189|5947885|P1|COMPLETED|First 4 Weeks Treatment||8
2425161|NCT01203189|5947883|P3|STARTED|First 4 Weeks Treatment||3
2425162|NCT01203189|5947884|P2|STARTED|First 4 Weeks Treatment||10
2425163|NCT01203189|5947885|P1|STARTED|First 4 Weeks Treatment||10
2425164|NCT01203098|5947902|P3|NOT COMPLETED|Overall Study||11
2425165|NCT01203098|5947903|P2|NOT COMPLETED|Overall Study||4
2425166|NCT01203098|5947904|P1|NOT COMPLETED|Overall Study||6
2425167|NCT01203098|5947902|P3|COMPLETED|Overall Study||78
2425168|NCT01203098|5947903|P2|COMPLETED|Overall Study||82
2425169|NCT01203098|5947904|P1|COMPLETED|Overall Study||83
2425170|NCT01203098|5947902|P3|Safety Analysis Dataset|Overall Study||87
2425171|NCT01203098|5947903|P2|Safety Analysis Dataset|Overall Study||85
2425172|NCT01203098|5947904|P1|Safety Analysis Dataset|Overall Study||89
2425173|NCT01203098|5947902|P3|STARTED|Overall Study||89
2425174|NCT01203098|5947903|P2|STARTED|Overall Study||86
2425175|NCT01203098|5947904|P1|STARTED|Overall Study||89
2425176|NCT01203072|5947920|P5|NOT COMPLETED|Overall Study||6
2425177|NCT01203072|5947921|P4|NOT COMPLETED|Overall Study||6
2425178|NCT01203072|5947922|P3|NOT COMPLETED|Overall Study||3
2425179|NCT01203072|5947923|P2|NOT COMPLETED|Overall Study||6
2425180|NCT01203072|5947924|P1|NOT COMPLETED|Overall Study||10
2425181|NCT01203072|5947920|P5|COMPLETED|Overall Study||96
2425182|NCT01203072|5947921|P4|COMPLETED|Overall Study||100
2425183|NCT01203072|5947922|P3|COMPLETED|Overall Study||101
2425184|NCT01203072|5947923|P2|COMPLETED|Overall Study||100
2425185|NCT01203072|5947924|P1|COMPLETED|Overall Study||95
2425186|NCT01203072|5947920|P5|STARTED|Overall Study||102
2425187|NCT01203072|5947921|P4|STARTED|Overall Study||106
2425188|NCT01203072|5947922|P3|STARTED|Overall Study||104
2425189|NCT01203072|5947923|P2|STARTED|Overall Study||106
2425190|NCT01203072|5947924|P1|STARTED|Overall Study||105
2425191|NCT01203046|5947943|P2|NOT COMPLETED|Overall Study||0
2425192|NCT01203046|5947944|P1|NOT COMPLETED|Overall Study||0
2425193|NCT01203046|5947943|P2|COMPLETED|Overall Study||28
2425194|NCT01203046|5947944|P1|COMPLETED|Overall Study||28
2425195|NCT01203046|5947943|P2|STARTED|Overall Study||28
2425196|NCT01203046|5947944|P1|STARTED|Overall Study||28
2425197|NCT01202994|5947952|P1|NOT COMPLETED|Overall Study||0
2425198|NCT01202994|5947952|P1|COMPLETED|Overall Study||27
2425199|NCT01202994|5947952|P1|STARTED|Overall Study||27
2425200|NCT01202955|5947959|P2|NOT COMPLETED|Period 3: 10 Days||0
2425201|NCT01202955|5947960|P1|NOT COMPLETED|Period 3: 10 Days||0
2425202|NCT01202955|5947959|P2|COMPLETED|Period 3: 10 Days||8
2425203|NCT01202955|5947960|P1|COMPLETED|Period 3: 10 Days||9
2425204|NCT01202955|5947959|P2|STARTED|Period 3: 10 Days||8
2425205|NCT01202955|5947960|P1|STARTED|Period 3: 10 Days||9
2425206|NCT01202955|5947959|P2|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
2425207|NCT01202955|5947960|P1|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
2425208|NCT01202955|5947959|P2|COMPLETED|Period 2: 7 Days (Wash-Out)||8
2425209|NCT01202955|5947960|P1|COMPLETED|Period 2: 7 Days (Wash-Out)||9
2425210|NCT01202955|5947959|P2|STARTED|Period 2: 7 Days (Wash-Out)||8
2425211|NCT01202955|5947960|P1|STARTED|Period 2: 7 Days (Wash-Out)||9
2425212|NCT01202955|5947959|P2|NOT COMPLETED|Period 1: 10 Days||2
2425213|NCT01202955|5947960|P1|NOT COMPLETED|Period 1: 10 Days||0
2425214|NCT01202955|5947959|P2|COMPLETED|Period 1: 10 Days||8
2425215|NCT01202955|5947960|P1|COMPLETED|Period 1: 10 Days||9
2425216|NCT01202955|5947959|P2|STARTED|Period 1: 10 Days||10
2425217|NCT01202955|5947960|P1|STARTED|Period 1: 10 Days||9
2425218|NCT01202903|5947972|P2|NOT COMPLETED|Overall Study||16
2425219|NCT01202903|5947973|P1|NOT COMPLETED|Overall Study||11
2425220|NCT01202903|5947972|P2|COMPLETED|Overall Study||292
2425221|NCT01202903|5947973|P1|COMPLETED|Overall Study||297
2425222|NCT01202903|5947972|P2|Safety Set*|Overall Study||299
2425223|NCT01202903|5947973|P1|Safety Set*|Overall Study||310
2425224|NCT01202903|5947972|P2|Full Analysis Set|Overall Study||302
2425225|NCT01202903|5947973|P1|Full Analysis Set|Overall Study||306
2425226|NCT01202903|5947972|P2|STARTED|Overall Study||308
2425227|NCT01202903|5947973|P1|STARTED|Overall Study||308
2425228|NCT01202877|5948000|P3|NOT COMPLETED|Overall Study||6
2425229|NCT01202877|5948001|P2|NOT COMPLETED|Overall Study||1
2425230|NCT01202877|5948002|P1|NOT COMPLETED|Overall Study||0
2425231|NCT01202877|5948000|P3|COMPLETED|Overall Study||34
2425232|NCT01202877|5948001|P2|COMPLETED|Overall Study||7
2425233|NCT01202877|5948002|P1|COMPLETED|Overall Study||6
2425234|NCT01202877|5948000|P3|STARTED|Overall Study||40
2425235|NCT01202877|5948001|P2|STARTED|Overall Study||8
2425236|NCT01202877|5948002|P1|STARTED|Overall Study||6
2425237|NCT01202773|5948016|P3|NOT COMPLETED|Overall Study||55
2425238|NCT01202773|5948017|P2|NOT COMPLETED|Overall Study||43
2425239|NCT01202773|5948018|P1|NOT COMPLETED|Overall Study||57
2425240|NCT01202773|5948016|P3|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|100
2425241|NCT01202773|5948017|P2|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|105
2425242|NCT01202773|5948018|P1|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|96
2425243|NCT01202773|5948016|P3|Post-Treatment Follow-Up Population|Overall Study||51
2425244|NCT01202773|5948017|P2|Post-Treatment Follow-Up Population|Overall Study||36
2425245|NCT01202773|5948018|P1|Post-Treatment Follow-Up Population|Overall Study||46
2425246|NCT01202773|5948016|P3|Week 16 NR|Overall Study||37
2425247|NCT01202773|5948017|P2|Week 16 NR|Overall Study||33
2425248|NCT01202773|5948018|P1|Week 16 NR|Overall Study||23
2425249|NCT01202773|5948016|P3|Received at Least 1 Dose of Study Drug|Overall Study||154
2425250|NCT01202773|5948017|P2|Received at Least 1 Dose of Study Drug|Overall Study||147
2425251|NCT01202773|5948018|P1|Received at Least 1 Dose of Study Drug|Overall Study||153
2425252|NCT01202773|5948016|P3|STARTED|Overall Study||155
2425253|NCT01202773|5948017|P2|STARTED|Overall Study||148
2425254|NCT01202773|5948018|P1|STARTED|Overall Study||153
2425255|NCT01202760|5948095|P3|NOT COMPLETED|Overall Study||35
2425256|NCT01202760|5948096|P2|NOT COMPLETED|Overall Study||52
2425257|NCT01202760|5948097|P1|NOT COMPLETED|Overall Study||47
2425258|NCT01202760|5948095|P3|COMPLETED|Overall Study||216
2425259|NCT01202760|5948096|P2|COMPLETED|Overall Study||322
2425260|NCT01202760|5948097|P1|COMPLETED|Overall Study||332
2425261|NCT01202760|5948095|P3|Received at Least One Dose of Study Drug|Overall Study||250
2425262|NCT01202760|5948096|P2|Received at Least One Dose of Study Drug|Overall Study||371
2425263|NCT01202760|5948097|P1|Received at Least One Dose of Study Drug|Overall Study||379
2425264|NCT01202760|5948095|P3|STARTED|Overall Study||251
2425265|NCT01202760|5948096|P2|STARTED|Overall Study||374
2425266|NCT01202760|5948097|P1|STARTED|Overall Study||379
2425267|NCT01202747|5948165|P1|NOT COMPLETED|Overall Study||1
2425268|NCT01202747|5948165|P1|COMPLETED|Overall Study|One subject did not return for the 4 Week visit due to inconvenience.|49
2425269|NCT01202747|5948165|P1|STARTED|Overall Study||50
2425270|NCT01202721|5948173|P4|NOT COMPLETED|Overall Study||0
2425271|NCT01202721|5948174|P3|NOT COMPLETED|Overall Study||0
2425272|NCT01202721|5948175|P2|NOT COMPLETED|Overall Study||0
2425273|NCT01202721|5948176|P1|NOT COMPLETED|Overall Study||0
2425274|NCT01202721|5948173|P4|COMPLETED|Overall Study||27
2425275|NCT01202721|5948174|P3|COMPLETED|Overall Study||14
2425276|NCT01202721|5948175|P2|COMPLETED|Overall Study||26
2425277|NCT01202721|5948176|P1|COMPLETED|Overall Study||18
2425278|NCT01202721|5948173|P4|STARTED|Overall Study||27
2425279|NCT01202721|5948174|P3|STARTED|Overall Study||14
2425280|NCT01202721|5948175|P2|STARTED|Overall Study||26
2425281|NCT01202721|5948176|P1|STARTED|Overall Study||18
2425282|NCT01202656|5948192|P2|NOT COMPLETED|CrossoverCycle||0
2425283|NCT01202656|5948193|P1|NOT COMPLETED|CrossoverCycle||0
2425284|NCT01202656|5948192|P2|COMPLETED|CrossoverCycle||14
2425285|NCT01202656|5948193|P1|COMPLETED|CrossoverCycle||18
2425286|NCT01202656|5948192|P2|STARTED|CrossoverCycle|14 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|14
2425287|NCT01202656|5948193|P1|STARTED|CrossoverCycle|16 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|18
2425288|NCT01202656|5948192|P2|NOT COMPLETED|Cycle 1||0
2425289|NCT01202656|5948193|P1|NOT COMPLETED|Cycle 1||0
2425290|NCT01202656|5948192|P2|COMPLETED|Cycle 1||62
2425291|NCT01202656|5948193|P1|COMPLETED|Cycle 1||67
2425292|NCT01202656|5948192|P2|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|62
2425293|NCT01202656|5948193|P1|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|67
2425294|NCT01202643|5948203|P2|NOT COMPLETED|Crossover Cycle||0
2425295|NCT01202643|5948204|P1|NOT COMPLETED|Crossover Cycle||0
2425296|NCT01202643|5948203|P2|COMPLETED|Crossover Cycle||2
2425297|NCT01202643|5948204|P1|COMPLETED|Crossover Cycle||1
2425298|NCT01202643|5948203|P2|STARTED|Crossover Cycle|Three patients became pregnant after Period 1, 1 patient chose not to cycle again|2
2425299|NCT01202643|5948204|P1|STARTED|Crossover Cycle|One patient became pregnant following Period 1, Only one non-pregnant chose to cycle again|1
2425300|NCT01202643|5948203|P2|NOT COMPLETED|Period 1||0
2425301|NCT01202643|5948204|P1|NOT COMPLETED|Period 1||0
2425302|NCT01202643|5948203|P2|COMPLETED|Period 1||6
2425303|NCT01202643|5948204|P1|COMPLETED|Period 1||6
2425304|NCT01202643|5948203|P2|STARTED|Period 1||6
2425305|NCT01202643|5948204|P1|STARTED|Period 1||6
2425306|NCT01202591|5948218|P6|NOT COMPLETED|Overall Study||4
2425307|NCT01202591|5948219|P5|NOT COMPLETED|Overall Study||5
2425308|NCT01202591|5948220|P4|NOT COMPLETED|Overall Study||7
2425309|NCT01202591|5948221|P3|NOT COMPLETED|Overall Study||11
2425310|NCT01202591|5948222|P2|NOT COMPLETED|Overall Study||5
2425311|NCT01202591|5948223|P1|NOT COMPLETED|Overall Study||5
2425312|NCT01202591|5948218|P6|COMPLETED|Overall Study||0
2425313|NCT01202591|5948219|P5|COMPLETED|Overall Study||0
2425314|NCT01202591|5948220|P4|COMPLETED|Overall Study||2
2425315|NCT01202591|5948221|P3|COMPLETED|Overall Study||1
2425316|NCT01202591|5948222|P2|COMPLETED|Overall Study||0
2425317|NCT01202591|5948223|P1|COMPLETED|Overall Study||0
2425318|NCT01202591|5948218|P6|STARTED|Overall Study||4
2425319|NCT01202591|5948219|P5|STARTED|Overall Study||5
2425320|NCT01202591|5948220|P4|STARTED|Overall Study||9
2425321|NCT01202591|5948221|P3|STARTED|Overall Study||12
2425322|NCT01202591|5948222|P2|STARTED|Overall Study||5
2425323|NCT01202591|5948223|P1|STARTED|Overall Study||5
2425324|NCT01202578|5948237|P1|NOT COMPLETED|Overall Study||0
2425325|NCT01202578|5948237|P1|COMPLETED|Overall Study||53
2425326|NCT01202578|5948237|P1|STARTED|Overall Study||53
2425327|NCT01202565|5948244|P1|NOT COMPLETED|Overall Study||67
2425328|NCT01202565|5948244|P1|COMPLETED|Overall Study|Indicates participants who completed the Month 12 visit|439
2425329|NCT01202565|5948244|P1|Full Analysis Set|Overall Study|Participants with a signed informed consent and any available data regarding adalimumab treatment.|501
2425330|NCT01202565|5948244|P1|STARTED|Overall Study||506
2425334|NCT01202279|5948274|P2|NOT COMPLETED|Overall Study||27
2425335|NCT01202279|5948275|P1|NOT COMPLETED|Overall Study||37
2425336|NCT01202279|5948274|P2|COMPLETED|Overall Study||561
2425337|NCT01202279|5948275|P1|COMPLETED|Overall Study||554
2425338|NCT01202279|5948274|P2|STARTED|Overall Study||588
2425339|NCT01202279|5948275|P1|STARTED|Overall Study||591
2425340|NCT01202253|5948283|P1|NOT COMPLETED|Overall Study||0
2425341|NCT01202253|5948283|P1|COMPLETED|Overall Study||50
2425342|NCT01202253|5948283|P1|STARTED|Overall Study||50
2425343|NCT01202227|5948327|P1|NOT COMPLETED|Overall Study||19
2425344|NCT01202227|5948327|P1|COMPLETED|Overall Study||84
2425345|NCT01202227|5948327|P1|STARTED|Overall Study|Treated|103
2425346|NCT01202188|5948351|P5|NOT COMPLETED|Overall Study||45
2425347|NCT01202188|5948352|P4|NOT COMPLETED|Overall Study||42
2425348|NCT01202188|5948353|P3|NOT COMPLETED|Overall Study||53
2425349|NCT01202188|5948354|P2|NOT COMPLETED|Overall Study||56
2425350|NCT01202188|5948355|P1|NOT COMPLETED|Overall Study||38
2425351|NCT01202188|5948351|P5|COMPLETED|Overall Study||189
2425352|NCT01202188|5948352|P4|COMPLETED|Overall Study||441
2425353|NCT01202188|5948353|P3|COMPLETED|Overall Study||422
2425354|NCT01202188|5948354|P2|COMPLETED|Overall Study||421
2425355|NCT01202188|5948355|P1|COMPLETED|Overall Study||437
2425356|NCT01202188|5948351|P5|Safety Set; Received Study Drug|Overall Study||232
2425357|NCT01202188|5948352|P4|Safety Set; Received Study Drug|Overall Study||480
2425358|NCT01202188|5948353|P3|Safety Set; Received Study Drug|Overall Study||473
2425359|NCT01202188|5948354|P2|Safety Set; Received Study Drug|Overall Study||476
2425360|NCT01202188|5948355|P1|Safety Set; Received Study Drug|Overall Study||474
2425361|NCT01202188|5948351|P5|STARTED|Overall Study||234
2425362|NCT01202188|5948352|P4|STARTED|Overall Study||483
2425363|NCT01202188|5948353|P3|STARTED|Overall Study||475
2425364|NCT01202188|5948354|P2|STARTED|Overall Study||477
2425365|NCT01202188|5948355|P1|STARTED|Overall Study||475
2425366|NCT01202175|5948463|P1|NOT COMPLETED|Overall Study||5
2425367|NCT01202175|5948463|P1|COMPLETED|Overall Study||45
2425368|NCT01202175|5948463|P1|Pacebo|Overall Study||25
2425369|NCT01202175|5948463|P1|Nebivolol|Overall Study||25
2425370|NCT01202175|5948463|P1|STARTED|Overall Study||50
2425371|NCT01202162|5948492|P2|NOT COMPLETED|Overall Study||2
2425372|NCT01202162|5948493|P1|NOT COMPLETED|Overall Study||3
2425373|NCT01202162|5948492|P2|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
2425374|NCT01202162|5948493|P1|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
2425375|NCT01202162|5948492|P2|STARTED|Overall Study||42
2425376|NCT01202162|5948493|P1|STARTED|Overall Study||43
2425377|NCT01202110|5948503|P2|NOT COMPLETED|Overall Study||0
2425378|NCT01202110|5948504|P1|NOT COMPLETED|Overall Study||0
2425379|NCT01202110|5948503|P2|COMPLETED|Overall Study||0
2425380|NCT01202110|5948504|P1|COMPLETED|Overall Study||10
2425381|NCT01202110|5948503|P2|STARTED|Overall Study||0
2425382|NCT01202110|5948504|P1|STARTED|Overall Study||10
2425383|NCT01202071|5948508|P4|NOT COMPLETED|Overall Study||0
2425384|NCT01202071|5948509|P3|NOT COMPLETED|Overall Study||0
2425385|NCT01202071|5948510|P2|NOT COMPLETED|Overall Study||0
2425386|NCT01202071|5948511|P1|NOT COMPLETED|Overall Study||0
2425387|NCT01202071|5948508|P4|COMPLETED|Overall Study||6
2425388|NCT01202071|5948509|P3|COMPLETED|Overall Study||6
2425389|NCT01202071|5948510|P2|COMPLETED|Overall Study||6
2425390|NCT01202071|5948511|P1|COMPLETED|Overall Study||6
2425391|NCT01202071|5948508|P4|STARTED|Overall Study||6
2425392|NCT01202071|5948509|P3|STARTED|Overall Study||6
2425393|NCT01202071|5948510|P2|STARTED|Overall Study||6
2425394|NCT01202071|5948511|P1|STARTED|Overall Study||6
2425395|NCT01201967|5948531|P2|NOT COMPLETED|Overall Study||5
2425396|NCT01201967|5948532|P1|NOT COMPLETED|Overall Study||6
2425397|NCT01201967|5948531|P2|COMPLETED|Overall Study||86
2425398|NCT01201967|5948532|P1|COMPLETED|Overall Study||86
2425399|NCT01201967|5948531|P2|STARTED|Overall Study||91
2425400|NCT01201967|5948532|P1|STARTED|Overall Study||92
2425401|NCT01201915|5948557|P3|NOT COMPLETED|Overall Study||6
2425402|NCT01201915|5948558|P2|NOT COMPLETED|Overall Study||11
2425403|NCT01201915|5948559|P1|NOT COMPLETED|Overall Study||8
2425404|NCT01201915|5948557|P3|COMPLETED|Overall Study||19
2425405|NCT01201915|5948558|P2|COMPLETED|Overall Study||14
2425406|NCT01201915|5948559|P1|COMPLETED|Overall Study||16
2425407|NCT01201915|5948557|P3|STARTED|Overall Study||25
2425408|NCT01201915|5948558|P2|STARTED|Overall Study||25
2425409|NCT01201915|5948559|P1|STARTED|Overall Study||24
2425410|NCT01201811|5948570|P1|NOT COMPLETED|Overall Study||19
2425411|NCT01201811|5948570|P1|COMPLETED|Overall Study||25
2425412|NCT01201811|5948570|P1|STARTED|Overall Study||44
2425413|NCT01201798|5948592|P2|NOT COMPLETED|Overall Study||15
2425414|NCT01201798|5948593|P1|NOT COMPLETED|Overall Study||9
2425415|NCT01201798|5948592|P2|COMPLETED|Overall Study||39
2425416|NCT01201798|5948593|P1|COMPLETED|Overall Study||47
2425417|NCT01201798|5948592|P2|STARTED|Overall Study||54
2425418|NCT01201798|5948593|P1|STARTED|Overall Study||56
2425419|NCT01201785|5948617|P1|NOT COMPLETED|Overall Study||16
2425420|NCT01201785|5948617|P1|COMPLETED|Overall Study||20
2425421|NCT01201785|5948617|P1|STARTED|Overall Study||36
2425422|NCT01201772|5948624|P3|NOT COMPLETED|Overall Study||0
2425423|NCT01201772|5948625|P2|NOT COMPLETED|Overall Study||0
2425424|NCT01201772|5948626|P1|NOT COMPLETED|Overall Study||1
2425425|NCT01201772|5948624|P3|COMPLETED|Overall Study||21
2425426|NCT01201772|5948625|P2|COMPLETED|Overall Study||21
2425427|NCT01201772|5948626|P1|COMPLETED|Overall Study||22
2425428|NCT01201772|5948624|P3|STARTED|Overall Study||21
2425429|NCT01201772|5948625|P2|STARTED|Overall Study||21
2425430|NCT01201772|5948626|P1|STARTED|Overall Study||23
2425431|NCT01201759|5948634|P2|NOT COMPLETED|Visit 5||0
2425432|NCT01201759|5948635|P1|NOT COMPLETED|Visit 5||0
2425433|NCT01201759|5948634|P2|COMPLETED|Visit 5||3
2425434|NCT01201759|5948635|P1|COMPLETED|Visit 5||7
2425435|NCT01201759|5948634|P2|STARTED|Visit 5||3
2425436|NCT01201759|5948635|P1|STARTED|Visit 5||7
2425437|NCT01201759|5948634|P2|NOT COMPLETED|Visit 4 Crossover||1
2425438|NCT01201759|5948635|P1|NOT COMPLETED|Visit 4 Crossover||0
2425439|NCT01201759|5948634|P2|COMPLETED|Visit 4 Crossover||3
2425440|NCT01201759|5948635|P1|COMPLETED|Visit 4 Crossover||7
2425441|NCT01201759|5948634|P2|STARTED|Visit 4 Crossover||4
2425442|NCT01201759|5948635|P1|STARTED|Visit 4 Crossover||7
2425443|NCT01201759|5948634|P2|NOT COMPLETED|Visit 3 - Washout||3
2425444|NCT01201759|5948635|P1|NOT COMPLETED|Visit 3 - Washout||1
2425445|NCT01201759|5948634|P2|COMPLETED|Visit 3 - Washout||4
2425446|NCT01201759|5948635|P1|COMPLETED|Visit 3 - Washout||7
2425447|NCT01201759|5948634|P2|STARTED|Visit 3 - Washout||7
2425448|NCT01201759|5948635|P1|STARTED|Visit 3 - Washout||8
2425449|NCT01201759|5948634|P2|NOT COMPLETED|Visit 2||0
2425450|NCT01201759|5948635|P1|NOT COMPLETED|Visit 2||0
2425451|NCT01201759|5948634|P2|COMPLETED|Visit 2||7
2425452|NCT01201759|5948635|P1|COMPLETED|Visit 2||8
2425453|NCT01201759|5948634|P2|STARTED|Visit 2||7
2425454|NCT01201759|5948635|P1|STARTED|Visit 2||8
2425455|NCT01201759|5948634|P2|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||1
2425456|NCT01201759|5948635|P1|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||2
2425457|NCT01201759|5948634|P2|COMPLETED|Visit 1 Wash-in ( Untreated)||7
2425458|NCT01201759|5948635|P1|COMPLETED|Visit 1 Wash-in ( Untreated)||8
2425459|NCT01201759|5948634|P2|STARTED|Visit 1 Wash-in ( Untreated)||8
2425460|NCT01201759|5948635|P1|STARTED|Visit 1 Wash-in ( Untreated)||10
2425461|NCT01201629|5948649|P2|NOT COMPLETED|Overall Study||0
2425462|NCT01201629|5948650|P1|NOT COMPLETED|Overall Study||0
2425463|NCT01201629|5948649|P2|COMPLETED|Overall Study||8
2425464|NCT01201629|5948650|P1|COMPLETED|Overall Study||8
2425465|NCT01201629|5948649|P2|STARTED|Overall Study||8
2425466|NCT01201629|5948650|P1|STARTED|Overall Study||8
2425467|NCT01201486|5948660|P1|NOT COMPLETED|Overall Study||0
2425468|NCT01201486|5948660|P1|COMPLETED|Overall Study||6781
2425469|NCT01201486|5948660|P1|STARTED|Overall Study||6781
2425470|NCT01201356|5948664|P1|NOT COMPLETED|Overall Study||644
2425471|NCT01201356|5948664|P1|COMPLETED|Overall Study||3481
2425472|NCT01201356|5948664|P1|Fingolimod Full Analysis Set|Overall Study||4046
2425473|NCT01201356|5948664|P1|Safety Set|Overall Study||4083
2425474|NCT01201356|5948664|P1|STARTED|Overall Study||4125
2425475|NCT01201343|5948678|P1|NOT COMPLETED|Overall Study||19
2425476|NCT01201343|5948678|P1|COMPLETED|Overall Study||60
2425477|NCT01201343|5948678|P1|Treated|Overall Study||76
2425478|NCT01201343|5948678|P1|STARTED|Overall Study||79
2425479|NCT01201317|5948692|P3|NOT COMPLETED|Overall Study||8
2425480|NCT01201317|5948693|P2|NOT COMPLETED|Overall Study||7
2425481|NCT01201317|5948694|P1|NOT COMPLETED|Overall Study||9
2425482|NCT01201317|5948692|P3|COMPLETED|Overall Study||33
2425483|NCT01201317|5948693|P2|COMPLETED|Overall Study||38
2425484|NCT01201317|5948694|P1|COMPLETED|Overall Study||39
2425485|NCT01201317|5948692|P3|STARTED|Overall Study||41
2425486|NCT01201317|5948693|P2|STARTED|Overall Study||45
2425487|NCT01201317|5948694|P1|STARTED|Overall Study||48
2425488|NCT01201265|5948714|P1|NOT COMPLETED|Overall Study||38
2425489|NCT01201265|5948714|P1|COMPLETED|Overall Study||2
2425490|NCT01201265|5948714|P1|STARTED|Overall Study||40
2425491|NCT01201057|5948730|P4|NOT COMPLETED|Overall Study||4
2425492|NCT01201057|5948731|P3|NOT COMPLETED|Overall Study||5
2425493|NCT01201057|5948732|P2|NOT COMPLETED|Overall Study||4
2425494|NCT01201057|5948733|P1|NOT COMPLETED|Overall Study||2
2425495|NCT01201057|5948730|P4|COMPLETED|Overall Study||29
2425496|NCT01201057|5948731|P3|COMPLETED|Overall Study||27
2425497|NCT01201057|5948732|P2|COMPLETED|Overall Study||29
2425498|NCT01201057|5948733|P1|COMPLETED|Overall Study||32
2425499|NCT01201057|5948730|P4|STARTED|Overall Study||33
2425500|NCT01201057|5948731|P3|STARTED|Overall Study||32
2425501|NCT01201057|5948732|P2|STARTED|Overall Study||33
2425502|NCT01201057|5948733|P1|STARTED|Overall Study||34
2425503|NCT01200992|5948761|P2|NOT COMPLETED|Overall Study||41
2425504|NCT01200992|5948762|P1|NOT COMPLETED|Overall Study||37
2425505|NCT01200992|5948761|P2|COMPLETED|Overall Study||4
2425506|NCT01200992|5948762|P1|COMPLETED|Overall Study||2
2425507|NCT01200992|5948761|P2|STARTED|Overall Study||45
2425508|NCT01200992|5948762|P1|STARTED|Overall Study||39
2425509|NCT01200875|5948770|P1|NOT COMPLETED|Overall Study||0
2425510|NCT01200875|5948770|P1|COMPLETED|Overall Study||25
2425511|NCT01200875|5948770|P1|STARTED|Overall Study||25
2425512|NCT01200810|5948776|P2|NOT COMPLETED|Overall Study||5
2425513|NCT01200810|5948777|P1|NOT COMPLETED|Overall Study||5
2425514|NCT01200810|5948776|P2|COMPLETED|Overall Study||0
2425515|NCT01200810|5948777|P1|COMPLETED|Overall Study||0
2425516|NCT01200810|5948776|P2|STARTED|Overall Study||5
2425517|NCT01200810|5948777|P1|STARTED|Overall Study||5
2425518|NCT01200797|5948797|P1|NOT COMPLETED|Overall Study||19
2425519|NCT01200797|5948797|P1|COMPLETED|Overall Study||0
2425520|NCT01200797|5948797|P1|STARTED|Overall Study||19
2425521|NCT01200758|5948807|P4|NOT COMPLETED|Stage 2||50
2425522|NCT01200758|5948808|P3|NOT COMPLETED|Stage 2||41
2425523|NCT01200758|5948809|P2|NOT COMPLETED|Stage 2||0
2425524|NCT01200758|5948810|P1|NOT COMPLETED|Stage 2||0
2425525|NCT01200758|5948807|P4|COMPLETED|Stage 2|Participants completed treatment period.|92
2425526|NCT01200758|5948808|P3|COMPLETED|Stage 2|Participants completed treatment period.|100
2425527|NCT01200758|5948809|P2|COMPLETED|Stage 2||0
2425528|NCT01200758|5948810|P1|COMPLETED|Stage 2||0
2425529|NCT01200758|5948807|P4|STARTED|Stage 2||142
2425530|NCT01200758|5948808|P3|STARTED|Stage 2||141
2425531|NCT01200758|5948809|P2|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
2425532|NCT01200758|5948810|P1|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
2425533|NCT01200758|5948807|P4|NOT COMPLETED|Stage I||0
2425534|NCT01200758|5948808|P3|NOT COMPLETED|Stage I||0
2425535|NCT01200758|5948809|P2|NOT COMPLETED|Stage I||17
2425536|NCT01200758|5948810|P1|NOT COMPLETED|Stage I||18
2425537|NCT01200758|5948807|P4|COMPLETED|Stage I||0
2425538|NCT01200758|5948808|P3|COMPLETED|Stage I||0
2425539|NCT01200758|5948809|P2|COMPLETED|Stage I|Participants completed treatment period.|46
2425540|NCT01200758|5948810|P1|COMPLETED|Stage I|Participants completed treatment period.|46
2425541|NCT01200758|5948807|P4|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
2425542|NCT01200758|5948808|P3|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
2425543|NCT01200758|5948809|P2|STARTED|Stage I||63
2425544|NCT01200758|5948810|P1|STARTED|Stage I||64
2425545|NCT01200602|5948866|P2|NOT COMPLETED|Overall Study||0
2425546|NCT01200602|5948867|P1|NOT COMPLETED|Overall Study||0
2425547|NCT01200602|5948866|P2|COMPLETED|Overall Study||0
2425548|NCT01200602|5948867|P1|COMPLETED|Overall Study||0
2425549|NCT01200602|5948866|P2|STARTED|Overall Study||0
2425550|NCT01200602|5948867|P1|STARTED|Overall Study||0
2425551|NCT01200589|5948883|P2|NOT COMPLETED|Overall Study||189
2425552|NCT01200589|5948884|P1|NOT COMPLETED|Overall Study||190
2425553|NCT01200589|5948883|P2|COMPLETED|Overall Study||30
2425554|NCT01200589|5948884|P1|COMPLETED|Overall Study||29
2425555|NCT01200589|5948883|P2|Safety Set|Overall Study||218
2425556|NCT01200589|5948884|P1|Safety Set|Overall Study||217
2425557|NCT01200589|5948883|P2|Intent-to-treat (ITT) Analysis Set|Overall Study||219
2425558|NCT01200589|5948884|P1|Intent-to-treat (ITT) Analysis Set|Overall Study||219
2425559|NCT01200589|5948883|P2|STARTED|Overall Study||219
2425560|NCT01200589|5948884|P1|STARTED|Overall Study||219
2425561|NCT01200524|5948911|P3|NOT COMPLETED|Overall Study||4
2425562|NCT01200524|5948912|P2|NOT COMPLETED|Overall Study||1
2425563|NCT01200524|5948913|P1|NOT COMPLETED|Overall Study||2
2425564|NCT01200524|5948911|P3|COMPLETED|Overall Study||40
2425565|NCT01200524|5948912|P2|COMPLETED|Overall Study||47
2425566|NCT01200524|5948913|P1|COMPLETED|Overall Study||39
2425567|NCT01200524|5948911|P3|STARTED|Overall Study||44
2425568|NCT01200524|5948912|P2|STARTED|Overall Study||48
2425569|NCT01200524|5948913|P1|STARTED|Overall Study||41
2425570|NCT01200511|5948933|P1|NOT COMPLETED|Overall Study||5
2425571|NCT01200511|5948933|P1|COMPLETED|Overall Study||44
2425572|NCT01200511|5948933|P1|STARTED|Overall Study||49
2425573|NCT01200498|5948941|P1|NOT COMPLETED|Overall Study||0
2425574|NCT01200498|5948941|P1|COMPLETED|Overall Study||22
2425575|NCT01200498|5948941|P1|STARTED|Overall Study||22
2425576|NCT01200485|5948945|P3|NOT COMPLETED|Cycle 2: Randomization||0
2425577|NCT01200485|5948946|P2|NOT COMPLETED|Cycle 2: Randomization||0
2425578|NCT01200485|5948947|P1|NOT COMPLETED|Cycle 2: Randomization||0
2425579|NCT01200485|5948945|P3|COMPLETED|Cycle 2: Randomization||25
2425580|NCT01200485|5948946|P2|COMPLETED|Cycle 2: Randomization||21
2425581|NCT01200485|5948947|P1|COMPLETED|Cycle 2: Randomization||0
2425582|NCT01200485|5948945|P3|STARTED|Cycle 2: Randomization||25
2425583|NCT01200485|5948946|P2|STARTED|Cycle 2: Randomization|Six not randomized: Methemoglobinemia-1, Kidney failure-2, Chemotherapy changed-2, Not evaluable-1|21
2425584|NCT01200485|5948947|P1|STARTED|Cycle 2: Randomization|Of 55 enrolled on study, 52 participants were treated in Cycle 1, only 46 randomized to Cycle 2|0
2425585|NCT01200485|5948945|P3|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
2425586|NCT01200485|5948946|P2|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
2425587|NCT01200485|5948947|P1|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||3
2425588|NCT01200485|5948945|P3|COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
2425589|NCT01200485|5948946|P2|COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
2425590|NCT01200485|5948947|P1|COMPLETED|Cycle 1: Rasburicase Alone Delivery||52
2425591|NCT01200485|5948945|P3|STARTED|Cycle 1: Rasburicase Alone Delivery||0
2425592|NCT01200485|5948946|P2|STARTED|Cycle 1: Rasburicase Alone Delivery||0
2425593|NCT01200485|5948947|P1|STARTED|Cycle 1: Rasburicase Alone Delivery|Of 55 participants screened, only 52 treated.|55
2425594|NCT01200433|5948958|P2|NOT COMPLETED|Overall Study||0
2425595|NCT01200433|5948959|P1|NOT COMPLETED|Overall Study||0
2425596|NCT01200433|5948958|P2|COMPLETED|Overall Study||23
2425597|NCT01200433|5948959|P1|COMPLETED|Overall Study||21
2425598|NCT01200433|5948958|P2|STARTED|Overall Study||23
2425599|NCT01200433|5948959|P1|STARTED|Overall Study||21
2425600|NCT01200394|5948981|P2|NOT COMPLETED|Overall Study||28
2425601|NCT01200394|5948982|P1|NOT COMPLETED|Overall Study||2
2425602|NCT01200394|5948981|P2|COMPLETED|Overall Study||164
2425603|NCT01200394|5948982|P1|COMPLETED|Overall Study||62
2425604|NCT01200394|5948981|P2|STARTED|Overall Study||192
2425605|NCT01200394|5948982|P1|STARTED|Overall Study||64
2425606|NCT01200368|5949020|P3|NOT COMPLETED|Toddler Dose||1
2425607|NCT01200368|5949021|P2|NOT COMPLETED|Toddler Dose||3
2425608|NCT01200368|5949022|P1|NOT COMPLETED|Toddler Dose||0
2425609|NCT01200368|5949020|P3|COMPLETED|Toddler Dose||168
2425610|NCT01200368|5949021|P2|COMPLETED|Toddler Dose||159
2425611|NCT01200368|5949022|P1|COMPLETED|Toddler Dose||162
2425612|NCT01200368|5949020|P3|STARTED|Toddler Dose||169
2425613|NCT01200368|5949021|P2|STARTED|Toddler Dose||162
2425614|NCT01200368|5949022|P1|STARTED|Toddler Dose||162
2425615|NCT01200368|5949020|P3|NOT COMPLETED|After Infant Series||9
2425616|NCT01200368|5949021|P2|NOT COMPLETED|After Infant Series||16
2425617|NCT01200368|5949022|P1|NOT COMPLETED|After Infant Series||18
2425618|NCT01200368|5949020|P3|COMPLETED|After Infant Series||169
2425619|NCT01200368|5949021|P2|COMPLETED|After Infant Series||162
2425620|NCT01200368|5949022|P1|COMPLETED|After Infant Series||162
2425621|NCT01200368|5949020|P3|STARTED|After Infant Series||178
2425622|NCT01200368|5949021|P2|STARTED|After Infant Series||178
2425623|NCT01200368|5949022|P1|STARTED|After Infant Series||180
2425624|NCT01200368|5949020|P3|NOT COMPLETED|Infant Series||6
2425625|NCT01200368|5949021|P2|NOT COMPLETED|Infant Series||6
2425626|NCT01200368|5949022|P1|NOT COMPLETED|Infant Series||3
2425627|NCT01200368|5949020|P3|COMPLETED|Infant Series||178
2425628|NCT01200368|5949021|P2|COMPLETED|Infant Series||178
2425629|NCT01200368|5949022|P1|COMPLETED|Infant Series||180
2425630|NCT01200368|5949020|P3|Vaccinated Dose 3|Infant Series||182
2425631|NCT01200368|5949021|P2|Vaccinated Dose 3|Infant Series||178
2425632|NCT01200368|5949022|P1|Vaccinated Dose 3|Infant Series||181
2425633|NCT01200368|5949020|P3|Vaccinated Dose 2|Infant Series||183
2425634|NCT01200368|5949021|P2|Vaccinated Dose 2|Infant Series||182
2425635|NCT01200368|5949022|P1|Vaccinated Dose 2|Infant Series||183
2425636|NCT01200368|5949020|P3|Vaccinated Dose 1|Infant Series||183
2425637|NCT01200368|5949021|P2|Vaccinated Dose 1|Infant Series||183
2425638|NCT01200368|5949022|P1|Vaccinated Dose 1|Infant Series||183
2425639|NCT01200368|5949020|P3|STARTED|Infant Series||184
2425640|NCT01200368|5949021|P2|STARTED|Infant Series||184
2425641|NCT01200368|5949022|P1|STARTED|Infant Series||183
2425642|NCT01200355|5949088|P2|NOT COMPLETED|Overall Study||2
2425643|NCT01200355|5949089|P1|NOT COMPLETED|Overall Study||7
2425644|NCT01200355|5949088|P2|COMPLETED|Overall Study||53
2425645|NCT01200355|5949089|P1|COMPLETED|Overall Study||51
2425646|NCT01200355|5949088|P2|STARTED|Overall Study||55
2425647|NCT01200355|5949089|P1|STARTED|Overall Study||58
2425648|NCT01200342|5949103|P1|NOT COMPLETED|Overall Study||1
2425649|NCT01200342|5949103|P1|COMPLETED|Overall Study||6
2425650|NCT01200342|5949103|P1|STARTED|Overall Study||7
2425651|NCT01200329|5949108|P1|NOT COMPLETED|Overall Study||3
2425652|NCT01200329|5949108|P1|COMPLETED|Overall Study||78
2425653|NCT01200329|5949108|P1|STARTED|Overall Study||81
2425654|NCT01200290|5949113|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||2
2425655|NCT01200290|5949113|P1|COMPLETED|Post-Treatment Follow-Up Period||16
2425656|NCT01200290|5949113|P1|STARTED|Post-Treatment Follow-Up Period|Participant who discontinued treatment was included in the post-treatment follow-up period.|18
2425657|NCT01200290|5949113|P1|NOT COMPLETED|Treatment Period||1
2425658|NCT01200290|5949113|P1|COMPLETED|Treatment Period||17
2425659|NCT01200290|5949113|P1|Received at Least 1 Dose of Study Drug|Treatment Period||18
2425660|NCT01200290|5949113|P1|STARTED|Treatment Period||18
2425661|NCT01200238|5949126|P2|NOT COMPLETED|Overall Study||10
2425662|NCT01200238|5949127|P1|NOT COMPLETED|Overall Study||7
2425663|NCT01200238|5949126|P2|COMPLETED|Overall Study||0
2425664|NCT01200238|5949127|P1|COMPLETED|Overall Study||0
2425665|NCT01200238|5949126|P2|STARTED|Overall Study||10
2425666|NCT01200238|5949127|P1|STARTED|Overall Study||7
2425667|NCT01200160|5949145|P1|NOT COMPLETED|Overall Study||62
2425668|NCT01200160|5949145|P1|COMPLETED|Overall Study||66
2425669|NCT01200160|5949145|P1|STARTED|Overall Study||128
2425670|NCT01200069|5949151|P2|NOT COMPLETED|Overall Study||1
2425671|NCT01200069|5949152|P1|NOT COMPLETED|Overall Study||0
2425672|NCT01200069|5949151|P2|COMPLETED|Overall Study||5
2425673|NCT01200069|5949152|P1|COMPLETED|Overall Study||8
2425674|NCT01200069|5949151|P2|STARTED|Overall Study||6
2425675|NCT01200069|5949152|P1|STARTED|Overall Study||8
2425676|NCT01200030|5949207|P3|NOT COMPLETED|Overall Study||0
2425677|NCT01200030|5949208|P2|NOT COMPLETED|Overall Study||0
2425678|NCT01200030|5949209|P1|NOT COMPLETED|Overall Study||0
2425679|NCT01200030|5949207|P3|COMPLETED|Overall Study||12
2425680|NCT01200030|5949208|P2|COMPLETED|Overall Study||13
2425681|NCT01200030|5949209|P1|COMPLETED|Overall Study||12
2425682|NCT01200030|5949207|P3|STARTED|Overall Study||12
2425683|NCT01200030|5949208|P2|STARTED|Overall Study||13
2425684|NCT01200030|5949209|P1|STARTED|Overall Study||12
2425685|NCT01199965|5949222|P2|NOT COMPLETED|Overall Study||0
2425686|NCT01199965|5949223|P1|NOT COMPLETED|Overall Study||1
2425687|NCT01199965|5949222|P2|COMPLETED|Overall Study||24
2425688|NCT01199965|5949223|P1|COMPLETED|Overall Study||22
2425689|NCT01199965|5949222|P2|STARTED|Overall Study||24
2425690|NCT01199965|5949223|P1|STARTED|Overall Study||23
2425691|NCT01199952|5949239|P2|NOT COMPLETED|Overall Study||45
2425692|NCT01199952|5949240|P1|NOT COMPLETED|Overall Study||52
2425693|NCT01199952|5949239|P2|COMPLETED|Overall Study||59
2425694|NCT01199952|5949240|P1|COMPLETED|Overall Study||51
2425695|NCT01199952|5949239|P2|STARTED|Overall Study||104
2425696|NCT01199952|5949240|P1|STARTED|Overall Study||103
2425697|NCT01199939|5949248|P1|NOT COMPLETED|Overall Study||13
2425698|NCT01199939|5949248|P1|COMPLETED|Overall Study||41
2425699|NCT01199939|5949248|P1|STARTED|Overall Study|Number of enrolled participants|54
2425700|NCT01199926|5949267|P2|NOT COMPLETED|Overall Study||4
2425701|NCT01199926|5949268|P1|NOT COMPLETED|Overall Study||7
2425702|NCT01199926|5949267|P2|COMPLETED|Overall Study||13
2425703|NCT01199926|5949268|P1|COMPLETED|Overall Study||10
2425704|NCT01199926|5949267|P2|STARTED|Overall Study||17
2425705|NCT01199926|5949268|P1|STARTED|Overall Study||17
2425706|NCT01199861|5949280|P2|NOT COMPLETED|Overall Study||0
2425707|NCT01199861|5949281|P1|NOT COMPLETED|Overall Study||2
2425708|NCT01199861|5949280|P2|COMPLETED|Overall Study||43
2425709|NCT01199861|5949281|P1|COMPLETED|Overall Study||93
2425710|NCT01199861|5949280|P2|STARTED|Overall Study||43
2425711|NCT01199861|5949281|P1|STARTED|Overall Study||95
2425712|NCT01199822|5949302|P3|NOT COMPLETED|Overall Study||0
2425713|NCT01199822|5949303|P2|NOT COMPLETED|Overall Study||1
2425714|NCT01199822|5949304|P1|NOT COMPLETED|Overall Study||0
2425715|NCT01199822|5949302|P3|COMPLETED|Overall Study||6
2425716|NCT01199822|5949303|P2|COMPLETED|Overall Study||6
2425717|NCT01199822|5949304|P1|COMPLETED|Overall Study||3
2425718|NCT01199822|5949302|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
2425719|NCT01199822|5949303|P2|Received at Least 1 Dose of Study Drug|Overall Study||7
2425720|NCT01199822|5949304|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
2425721|NCT01199822|5949302|P3|STARTED|Overall Study||6
2425722|NCT01199822|5949303|P2|STARTED|Overall Study||7
2425723|NCT01199822|5949304|P1|STARTED|Overall Study||3
2425724|NCT01199744|5949337|P1|NOT COMPLETED|Overall Study||0
2425725|NCT01199744|5949337|P1|COMPLETED|Overall Study||1575
2425726|NCT01199744|5949337|P1|STARTED|Overall Study||1575
2425727|NCT01199731|5949353|P3|NOT COMPLETED|Overall Study||10
2425728|NCT01199731|5949354|P2|NOT COMPLETED|Overall Study||11
2425729|NCT01199731|5949355|P1|NOT COMPLETED|Overall Study||9
2425730|NCT01199731|5949353|P3|COMPLETED|Overall Study||0
2425731|NCT01199731|5949354|P2|COMPLETED|Overall Study||0
2425732|NCT01199731|5949355|P1|COMPLETED|Overall Study||0
2425733|NCT01199731|5949353|P3|STARTED|Overall Study||10
2425734|NCT01199731|5949354|P2|STARTED|Overall Study||11
2425735|NCT01199731|5949355|P1|STARTED|Overall Study||9
2425736|NCT01199705|5949393|P1|NOT COMPLETED|SCIG Treatment (Efficacy)||0
2425737|NCT01199705|5949393|P1|COMPLETED|SCIG Treatment (Efficacy)||24
2425738|NCT01199705|5949393|P1|STARTED|SCIG Treatment (Efficacy)||24
2425739|NCT01199705|5949393|P1|NOT COMPLETED|SCIG Treatment (Wash-in/Wash-out)||1
2425740|NCT01199705|5949393|P1|COMPLETED|SCIG Treatment (Wash-in/Wash-out)||24
2425741|NCT01199705|5949393|P1|STARTED|SCIG Treatment (Wash-in/Wash-out)||25
2425742|NCT01199705|5949393|P1|NOT COMPLETED|IVIG Treatment||0
2425743|NCT01199705|5949393|P1|COMPLETED|IVIG Treatment||25
2425744|NCT01199705|5949393|P1|STARTED|IVIG Treatment||25
2425745|NCT01199601|5949425|P2|NOT COMPLETED|Overall Study||78
2425746|NCT01199601|5949426|P1|NOT COMPLETED|Overall Study||69
2425747|NCT01199601|5949425|P2|COMPLETED|Overall Study||344
2425748|NCT01199601|5949426|P1|COMPLETED|Overall Study||353
2425749|NCT01199601|5949425|P2|STARTED|Overall Study|Intervention Group|422
2425750|NCT01199601|5949426|P1|STARTED|Overall Study|Control Group|422
2425751|NCT01199575|5949436|P1|NOT COMPLETED|Overall Study||5
2425752|NCT01199575|5949436|P1|COMPLETED|Overall Study||25
2425753|NCT01199575|5949436|P1|STARTED|Overall Study||30
2425754|NCT01199471|5949441|P1|NOT COMPLETED|Overall Study||6
2425755|NCT01199471|5949441|P1|COMPLETED|Overall Study||3994
2425756|NCT01199471|5949441|P1|STARTED|Overall Study|3 patients who did not meet ASA Physical Status Class 1 - 3 were excluded from all analyses.|4000
2425757|NCT01199263|5949452|P2|NOT COMPLETED|Overall Study||2
2425758|NCT01199263|5949453|P1|NOT COMPLETED|Overall Study||6
2425759|NCT01199263|5949452|P2|COMPLETED|Overall Study||52
2425760|NCT01199263|5949453|P1|COMPLETED|Overall Study||48
2425761|NCT01199263|5949452|P2|STARTED|Overall Study||54
2425762|NCT01199263|5949453|P1|STARTED|Overall Study||54
2425763|NCT01199237|5949469|P2|NOT COMPLETED|Overall Study||0
2425764|NCT01199237|5949470|P1|NOT COMPLETED|Overall Study||0
2425765|NCT01199237|5949469|P2|COMPLETED|Overall Study||40
2425766|NCT01199237|5949470|P1|COMPLETED|Overall Study||41
2425767|NCT01199237|5949469|P2|STARTED|Overall Study||40
2425768|NCT01199237|5949470|P1|STARTED|Overall Study||41
2425769|NCT01199146|5949484|P1|NOT COMPLETED|Overall Study||3
2425770|NCT01199146|5949484|P1|COMPLETED|Overall Study||39
2425771|NCT01199146|5949484|P1|STARTED|Overall Study||42
2425772|NCT01199042|5949490|P1|NOT COMPLETED|At Home (3 Months)||1
2425773|NCT01199042|5949490|P1|COMPLETED|At Home (3 Months)||26
2425774|NCT01199042|5949490|P1|STARTED|At Home (3 Months)||27
2425775|NCT01199042|5949490|P1|NOT COMPLETED|Sleep Laboratory (3 Nights)||2
2425776|NCT01199042|5949490|P1|COMPLETED|Sleep Laboratory (3 Nights)||27
2425777|NCT01199042|5949490|P1|STARTED|Sleep Laboratory (3 Nights)||29
2425778|NCT01199016|5949499|P1|NOT COMPLETED|Overall Study||77
2425779|NCT01199016|5949499|P1|COMPLETED|Overall Study||162
2425780|NCT01199016|5949499|P1|Treated|Overall Study||236
2425781|NCT01199016|5949499|P1|STARTED|Overall Study||239
2425782|NCT01198977|5949508|P2|NOT COMPLETED|Overall Study||0
2425783|NCT01198977|5949509|P1|NOT COMPLETED|Overall Study||1
2425784|NCT01198977|5949508|P2|COMPLETED|Overall Study||33
2425785|NCT01198977|5949509|P1|COMPLETED|Overall Study||30
2425786|NCT01198977|5949508|P2|STARTED|Overall Study||33
2425787|NCT01198977|5949509|P1|STARTED|Overall Study||31
2425788|NCT01198873|5949521|P2|NOT COMPLETED|Overall Study||32
2425789|NCT01198873|5949522|P1|NOT COMPLETED|Overall Study||37
2425790|NCT01198873|5949521|P2|COMPLETED|Overall Study||3
2425791|NCT01198873|5949522|P1|COMPLETED|Overall Study||4
2425792|NCT01198873|5949521|P2|Evaluable for Efficacy|Overall Study|9 participants discontinued before completing 3-month treatment and were not assessed post-baseline|26
2425793|NCT01198873|5949522|P1|Evaluable for Efficacy|Overall Study|8 participants discontinued before completing 3-month treatment and were not assessed post-baseline|33
2425794|NCT01198873|5949521|P2|Treated|Overall Study||35
2425795|NCT01198873|5949522|P1|Treated|Overall Study||41
2425796|NCT01198873|5949521|P2|STARTED|Overall Study||35
2425797|NCT01198873|5949522|P1|STARTED|Overall Study||41
2425798|NCT01198795|5949536|P1|NOT COMPLETED|Overall Study||82
2425799|NCT01198795|5949536|P1|COMPLETED|Overall Study||80
2425800|NCT01198795|5949536|P1|STARTED|Overall Study||162
2425801|NCT01198769|5949540|P1|NOT COMPLETED|Overall Study||0
2425802|NCT01198769|5949540|P1|COMPLETED|Overall Study||15
2425803|NCT01198769|5949540|P1|STARTED|Overall Study||15
2425804|NCT01198756|5949553|P4|NOT COMPLETED|Overall Study||26
2425805|NCT01198756|5949554|P3|NOT COMPLETED|Overall Study||30
2425806|NCT01198756|5949555|P2|NOT COMPLETED|Overall Study||40
2425807|NCT01198756|5949556|P1|NOT COMPLETED|Overall Study||38
2425808|NCT01198756|5949553|P4|COMPLETED|Overall Study||275
2425809|NCT01198756|5949554|P3|COMPLETED|Overall Study||902
2425810|NCT01198756|5949555|P2|COMPLETED|Overall Study||889
2425811|NCT01198756|5949556|P1|COMPLETED|Overall Study||894
2425812|NCT01198756|5949553|P4|STARTED|Overall Study||301
2425813|NCT01198756|5949554|P3|STARTED|Overall Study||932
2425814|NCT01198756|5949555|P2|STARTED|Overall Study||929
2425815|NCT01198756|5949556|P1|STARTED|Overall Study||932
2425816|NCT01198691|5949654|P2|NOT COMPLETED|6 Week Post-partum Survey||24
2425817|NCT01198691|5949655|P1|NOT COMPLETED|6 Week Post-partum Survey||29
2425818|NCT01198691|5949654|P2|COMPLETED|6 Week Post-partum Survey||26
2425819|NCT01198691|5949655|P1|COMPLETED|6 Week Post-partum Survey||21
2425820|NCT01198691|5949654|P2|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
2425821|NCT01198691|5949655|P1|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
2425822|NCT01198691|5949654|P2|NOT COMPLETED|Survey Prior to Discharge||33
2425823|NCT01198691|5949655|P1|NOT COMPLETED|Survey Prior to Discharge||32
2425824|NCT01198691|5949654|P2|COMPLETED|Survey Prior to Discharge||17
2425825|NCT01198691|5949655|P1|COMPLETED|Survey Prior to Discharge||18
2425826|NCT01198691|5949654|P2|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
2425827|NCT01198691|5949655|P1|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
2425828|NCT01198691|5949654|P2|NOT COMPLETED|Completed VAS Score at Discharge||6
2425829|NCT01198691|5949655|P1|NOT COMPLETED|Completed VAS Score at Discharge||5
2425830|NCT01198691|5949654|P2|COMPLETED|Completed VAS Score at Discharge||44
2425831|NCT01198691|5949655|P1|COMPLETED|Completed VAS Score at Discharge||45
2425832|NCT01198691|5949654|P2|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
2425833|NCT01198691|5949655|P1|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
2425834|NCT01198691|5949654|P2|NOT COMPLETED|Completed VAS Score Postop Day 1||4
2425835|NCT01198691|5949655|P1|NOT COMPLETED|Completed VAS Score Postop Day 1||3
2425836|NCT01198691|5949654|P2|COMPLETED|Completed VAS Score Postop Day 1||46
2425837|NCT01198691|5949655|P1|COMPLETED|Completed VAS Score Postop Day 1||47
2425838|NCT01198691|5949654|P2|STARTED|Completed VAS Score Postop Day 1||50
2425839|NCT01198691|5949655|P1|STARTED|Completed VAS Score Postop Day 1||50
2425840|NCT01198691|5949654|P2|NOT COMPLETED|Completed Surgery -Received Intervention||0
2425841|NCT01198691|5949655|P1|NOT COMPLETED|Completed Surgery -Received Intervention||0
2425842|NCT01198691|5949654|P2|COMPLETED|Completed Surgery -Received Intervention||50
2425843|NCT01198691|5949655|P1|COMPLETED|Completed Surgery -Received Intervention||50
2425844|NCT01198691|5949654|P2|STARTED|Completed Surgery -Received Intervention||50
2425845|NCT01198691|5949655|P1|STARTED|Completed Surgery -Received Intervention||50
2425846|NCT01198600|5949667|P4|NOT COMPLETED|Phase 3: 43 Days of Wear||0
2425847|NCT01198600|5949668|P3|NOT COMPLETED|Phase 3: 43 Days of Wear||0
2425848|NCT01198600|5949669|P2|NOT COMPLETED|Phase 3: 43 Days of Wear||0
2425849|NCT01198600|5949670|P1|NOT COMPLETED|Phase 3: 43 Days of Wear||0
2425850|NCT01198600|5949667|P4|COMPLETED|Phase 3: 43 Days of Wear||38
2425851|NCT01198600|5949668|P3|COMPLETED|Phase 3: 43 Days of Wear||0
2425852|NCT01198600|5949669|P2|COMPLETED|Phase 3: 43 Days of Wear||0
2425853|NCT01198600|5949670|P1|COMPLETED|Phase 3: 43 Days of Wear||0
2425854|NCT01198600|5949667|P4|STARTED|Phase 3: 43 Days of Wear||38
2425855|NCT01198600|5949668|P3|STARTED|Phase 3: 43 Days of Wear||0
2425856|NCT01198600|5949669|P2|STARTED|Phase 3: 43 Days of Wear||0
2425857|NCT01198600|5949670|P1|STARTED|Phase 3: 43 Days of Wear||0
2425858|NCT01198600|5949667|P4|NOT COMPLETED|Phase 2: 56 Days of Wear||0
2425859|NCT01198600|5949668|P3|NOT COMPLETED|Phase 2: 56 Days of Wear||5
2425860|NCT01198600|5949669|P2|NOT COMPLETED|Phase 2: 56 Days of Wear||0
2425861|NCT01198600|5949670|P1|NOT COMPLETED|Phase 2: 56 Days of Wear||0
2425862|NCT01198600|5949667|P4|COMPLETED|Phase 2: 56 Days of Wear||0
2425863|NCT01198600|5949668|P3|COMPLETED|Phase 2: 56 Days of Wear||62
2425864|NCT01198600|5949669|P2|COMPLETED|Phase 2: 56 Days of Wear||0
2425865|NCT01198600|5949670|P1|COMPLETED|Phase 2: 56 Days of Wear||0
2425866|NCT01198600|5949667|P4|STARTED|Phase 2: 56 Days of Wear||0
2425867|NCT01198600|5949668|P3|STARTED|Phase 2: 56 Days of Wear||67
2425868|NCT01198600|5949669|P2|STARTED|Phase 2: 56 Days of Wear||0
2425869|NCT01198600|5949670|P1|STARTED|Phase 2: 56 Days of Wear||0
2425870|NCT01198600|5949667|P4|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
2425871|NCT01198600|5949668|P3|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
2425872|NCT01198600|5949669|P2|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||1
2425873|NCT01198600|5949670|P1|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
2425874|NCT01198600|5949667|P4|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
2425875|NCT01198600|5949668|P3|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
2425876|NCT01198600|5949669|P2|COMPLETED|Phase 1: Period Two, 30 Days of Wear||35
2425877|NCT01198600|5949670|P1|COMPLETED|Phase 1: Period Two, 30 Days of Wear||32
2425878|NCT01198600|5949667|P4|STARTED|Phase 1: Period Two, 30 Days of Wear||0
2425879|NCT01198600|5949668|P3|STARTED|Phase 1: Period Two, 30 Days of Wear||0
2425880|NCT01198600|5949669|P2|STARTED|Phase 1: Period Two, 30 Days of Wear||36
2425881|NCT01198600|5949670|P1|STARTED|Phase 1: Period Two, 30 Days of Wear|One participant discontinued between Period One and Period Two due to unconvenience.|32
2425882|NCT01198600|5949667|P4|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
2425883|NCT01198600|5949668|P3|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
2425884|NCT01198600|5949669|P2|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||1
2425885|NCT01198600|5949670|P1|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||2
2425886|NCT01198600|5949667|P4|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
2425887|NCT01198600|5949668|P3|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
2425888|NCT01198600|5949669|P2|COMPLETED|Phase 1: Period One, 30 Days of Wear||36
2425889|NCT01198600|5949670|P1|COMPLETED|Phase 1: Period One, 30 Days of Wear||33
2425890|NCT01198600|5949667|P4|STARTED|Phase 1: Period One, 30 Days of Wear||0
2425891|NCT01198600|5949668|P3|STARTED|Phase 1: Period One, 30 Days of Wear||0
2425892|NCT01198600|5949669|P2|STARTED|Phase 1: Period One, 30 Days of Wear||37
2425893|NCT01198600|5949670|P1|STARTED|Phase 1: Period One, 30 Days of Wear||35
2425894|NCT01198587|5949696|P4|NOT COMPLETED|Overall Study||0
2425895|NCT01198587|5949697|P3|NOT COMPLETED|Overall Study||9
2425896|NCT01198587|5949698|P2|NOT COMPLETED|Overall Study||0
2425897|NCT01198587|5949699|P1|NOT COMPLETED|Overall Study||8
2425898|NCT01198587|5949696|P4|COMPLETED|Overall Study||5
2425899|NCT01198587|5949697|P3|COMPLETED|Overall Study||21
2425900|NCT01198587|5949698|P2|COMPLETED|Overall Study||5
2425901|NCT01198587|5949699|P1|COMPLETED|Overall Study||23
2425902|NCT01198587|5949696|P4|STARTED|Overall Study||5
2425903|NCT01198587|5949697|P3|STARTED|Overall Study||30
2425904|NCT01198587|5949698|P2|STARTED|Overall Study||5
2425905|NCT01198587|5949699|P1|STARTED|Overall Study||31
2425906|NCT01198574|5949721|P4|NOT COMPLETED|Overall Study||4
2425907|NCT01198574|5949722|P3|NOT COMPLETED|Overall Study||1
2425908|NCT01198574|5949723|P2|NOT COMPLETED|Overall Study||1
2425909|NCT01198574|5949724|P1|NOT COMPLETED|Overall Study||4
2425910|NCT01198574|5949721|P4|COMPLETED|Overall Study||98
2425911|NCT01198574|5949722|P3|COMPLETED|Overall Study||99
2425912|NCT01198574|5949723|P2|COMPLETED|Overall Study||101
2425913|NCT01198574|5949724|P1|COMPLETED|Overall Study||94
2425914|NCT01198574|5949721|P4|STARTED|Overall Study||102
2425915|NCT01198574|5949722|P3|STARTED|Overall Study||100
2425916|NCT01198574|5949723|P2|STARTED|Overall Study||102
2425917|NCT01198574|5949724|P1|STARTED|Overall Study||98
2425918|NCT01198548|5949742|P1|NOT COMPLETED|Overall Study||10
2425919|NCT01198548|5949742|P1|COMPLETED|Overall Study||0
2425920|NCT01198548|5949742|P1|STARTED|Overall Study||10
2425921|NCT01198509|5949757|P6|NOT COMPLETED|Overall Study||0
2425922|NCT01198509|5949758|P5|NOT COMPLETED|Overall Study||0
2425923|NCT01198509|5949759|P4|NOT COMPLETED|Overall Study||0
2425924|NCT01198509|5949760|P3|NOT COMPLETED|Overall Study||0
2425925|NCT01198509|5949761|P2|NOT COMPLETED|Overall Study||0
2425926|NCT01198509|5949762|P1|NOT COMPLETED|Overall Study||1
2425927|NCT01198509|5949757|P6|COMPLETED|Overall Study||58
2425928|NCT01198509|5949758|P5|COMPLETED|Overall Study||20
2425929|NCT01198509|5949759|P4|COMPLETED|Overall Study||66
2425930|NCT01198509|5949760|P3|COMPLETED|Overall Study||19
2425931|NCT01198509|5949761|P2|COMPLETED|Overall Study||10
2425932|NCT01198509|5949762|P1|COMPLETED|Overall Study|Patient declined further participation after enrollment and allocation to treatment group|4
2425933|NCT01198509|5949757|P6|STARTED|Overall Study||58
2425934|NCT01198509|5949758|P5|STARTED|Overall Study||20
2425935|NCT01198509|5949759|P4|STARTED|Overall Study||66
2425936|NCT01198509|5949760|P3|STARTED|Overall Study||19
2425937|NCT01198509|5949761|P2|STARTED|Overall Study||10
2425938|NCT01198509|5949762|P1|STARTED|Overall Study||5
2425939|NCT01198470|5949779|P1|NOT COMPLETED|Overall Study||2
2425940|NCT01198470|5949779|P1|COMPLETED|Overall Study||18
2425941|NCT01198470|5949779|P1|STARTED|Overall Study||20
2425942|NCT01198366|5949792|P6|NOT COMPLETED|Overall Study||13
2425943|NCT01198366|5949793|P5|NOT COMPLETED|Overall Study||15
2425944|NCT01198366|5949794|P4|NOT COMPLETED|Overall Study||5
2425945|NCT01198366|5949795|P3|NOT COMPLETED|Overall Study||8
2425946|NCT01198366|5949796|P2|NOT COMPLETED|Overall Study||7
2425947|NCT01198366|5949797|P1|NOT COMPLETED|Overall Study||12
2425948|NCT01198366|5949792|P6|COMPLETED|Overall Study||128
2425949|NCT01198366|5949793|P5|COMPLETED|Overall Study||125
2425950|NCT01198366|5949794|P4|COMPLETED|Overall Study||47
2425951|NCT01198366|5949795|P3|COMPLETED|Overall Study||43
2425952|NCT01198366|5949796|P2|COMPLETED|Overall Study||44
2425953|NCT01198366|5949797|P1|COMPLETED|Overall Study||40
2425954|NCT01198366|5949792|P6|STARTED|Overall Study||141
2425955|NCT01198366|5949793|P5|STARTED|Overall Study||140
2425956|NCT01198366|5949794|P4|STARTED|Overall Study||52
2425957|NCT01198366|5949795|P3|STARTED|Overall Study||51
2425958|NCT01198366|5949796|P2|STARTED|Overall Study||51
2425959|NCT01198366|5949797|P1|STARTED|Overall Study||52
2425960|NCT01198327|5949835|P1|NOT COMPLETED|Overall Study||10
2425961|NCT01198327|5949835|P1|COMPLETED|Overall Study||56
2425962|NCT01198327|5949835|P1|STARTED|Overall Study||66
2425963|NCT01198275|5949845|P2|NOT COMPLETED|Overall Study||5
2425964|NCT01198275|5949846|P1|NOT COMPLETED|Overall Study||6
2425965|NCT01198275|5949845|P2|COMPLETED|Overall Study||94
2425966|NCT01198275|5949846|P1|COMPLETED|Overall Study||94
2425967|NCT01198275|5949845|P2|STARTED|Overall Study||99
2425968|NCT01198275|5949846|P1|STARTED|Overall Study||100
2425969|NCT01198158|5949854|P2|NOT COMPLETED|Overall Study||0
2425970|NCT01198158|5949855|P1|NOT COMPLETED|Overall Study||0
2425971|NCT01198158|5949854|P2|COMPLETED|Overall Study||36
2425972|NCT01198158|5949855|P1|COMPLETED|Overall Study||41
2425973|NCT01198158|5949854|P2|STARTED|Overall Study||36
2425974|NCT01198158|5949855|P1|STARTED|Overall Study||41
2425975|NCT01198145|5949869|P2|NOT COMPLETED|Overall Study||1
2425976|NCT01198145|5949870|P1|NOT COMPLETED|Overall Study||1
2425977|NCT01198145|5949869|P2|COMPLETED|Overall Study||42
2425978|NCT01198145|5949870|P1|COMPLETED|Overall Study||43
2425979|NCT01198145|5949869|P2|STARTED|Overall Study||43
2425980|NCT01198145|5949870|P1|STARTED|Overall Study||44
2425981|NCT01198132|5949892|P2|NOT COMPLETED|Overall Study||21
2425982|NCT01198132|5949893|P1|NOT COMPLETED|Overall Study||18
2425983|NCT01198132|5949892|P2|COMPLETED|Overall Study||45
2425984|NCT01198132|5949893|P1|COMPLETED|Overall Study||45
2425985|NCT01198132|5949892|P2|STARTED|Overall Study||66
2425986|NCT01198132|5949893|P1|STARTED|Overall Study||63
2425987|NCT01198002|5949920|P3|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||78
2425988|NCT01198002|5949921|P2|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||73
2425989|NCT01198002|5949922|P1|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||69
2425990|NCT01198002|5949920|P3|COMPLETED|Treatment Period 2 (Weeks 52-100)||2
2425991|NCT01198002|5949921|P2|COMPLETED|Treatment Period 2 (Weeks 52-100)||0
2425992|NCT01198002|5949922|P1|COMPLETED|Treatment Period 2 (Weeks 52-100)||1
2425993|NCT01198002|5949920|P3|STARTED|Treatment Period 2 (Weeks 52-100)||80
2425994|NCT01198002|5949921|P2|STARTED|Treatment Period 2 (Weeks 52-100)||73
2425995|NCT01198002|5949922|P1|STARTED|Treatment Period 2 (Weeks 52-100)||70
2425996|NCT01198002|5949920|P3|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||269
2425997|NCT01198002|5949921|P2|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||274
2425998|NCT01198002|5949922|P1|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||275
2425999|NCT01198002|5949920|P3|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|80
2426000|NCT01198002|5949921|P2|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|73
2426001|NCT01198002|5949922|P1|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|70
2426002|NCT01198002|5949920|P3|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||307
2426003|NCT01198002|5949921|P2|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||303
2426004|NCT01198002|5949922|P1|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||293
2426005|NCT01198002|5949920|P3|Week 16 NR|Treatment Period 1 (Weeks 0-52)||90
2426006|NCT01198002|5949921|P2|Week 16 NR|Treatment Period 1 (Weeks 0-52)||62
2426007|NCT01198002|5949922|P1|Week 16 NR|Treatment Period 1 (Weeks 0-52)||58
2426008|NCT01198002|5949920|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||348
2426009|NCT01198002|5949921|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345
2426010|NCT01198002|5949922|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345
2426011|NCT01198002|5949920|P3|STARTED|Treatment Period 1 (Weeks 0-52)||349
2426012|NCT01198002|5949921|P2|STARTED|Treatment Period 1 (Weeks 0-52)||347
2426013|NCT01198002|5949922|P1|STARTED|Treatment Period 1 (Weeks 0-52)||345
2426014|NCT01197911|5950037|P3|NOT COMPLETED|Overall Study||1
2426015|NCT01197911|5950038|P2|NOT COMPLETED|Overall Study||0
2426016|NCT01197911|5950039|P1|NOT COMPLETED|Overall Study||0
2426017|NCT01197911|5950037|P3|COMPLETED|Overall Study||9
2426018|NCT01197911|5950038|P2|COMPLETED|Overall Study||10
2426019|NCT01197911|5950039|P1|COMPLETED|Overall Study||18
2426020|NCT01197911|5950037|P3|STARTED|Overall Study||10
2426021|NCT01197911|5950038|P2|STARTED|Overall Study||10
2426022|NCT01197911|5950039|P1|STARTED|Overall Study||18
2426023|NCT01197898|5950124|P2|NOT COMPLETED|Overall Study||0
2426024|NCT01197898|5950125|P1|NOT COMPLETED|Overall Study||0
2426025|NCT01197898|5950124|P2|COMPLETED|Overall Study||5
2426026|NCT01197898|5950125|P1|COMPLETED|Overall Study||5
2426027|NCT01197898|5950124|P2|STARTED|Overall Study||5
2426028|NCT01197898|5950125|P1|STARTED|Overall Study||5
2426029|NCT01197833|5950134|P3|NOT COMPLETED|Overall Study||0
2426030|NCT01197833|5950135|P2|NOT COMPLETED|Overall Study||0
2426031|NCT01197833|5950136|P1|NOT COMPLETED|Overall Study||0
2426032|NCT01197833|5950134|P3|COMPLETED|Overall Study||40
2426033|NCT01197833|5950135|P2|COMPLETED|Overall Study||39
2426034|NCT01197833|5950136|P1|COMPLETED|Overall Study||38
2426035|NCT01197833|5950134|P3|STARTED|Overall Study||40
2426036|NCT01197833|5950135|P2|STARTED|Overall Study||39
2426037|NCT01197833|5950136|P1|STARTED|Overall Study||38
2426038|NCT01197794|5950154|P7|NOT COMPLETED|Overall Study||21
2426039|NCT01197794|5950155|P6|NOT COMPLETED|Overall Study||19
2426040|NCT01197794|5950156|P5|NOT COMPLETED|Overall Study||14
2426041|NCT01197794|5950157|P4|NOT COMPLETED|Overall Study||12
2426042|NCT01197794|5950158|P3|NOT COMPLETED|Overall Study||13
2426043|NCT01197794|5950159|P2|NOT COMPLETED|Overall Study||15
2426044|NCT01197794|5950160|P1|NOT COMPLETED|Overall Study||16
2426045|NCT01197794|5950154|P7|COMPLETED|Overall Study||142
2426046|NCT01197794|5950155|P6|COMPLETED|Overall Study||144
2426047|NCT01197794|5950156|P5|COMPLETED|Overall Study||149
2426048|NCT01197794|5950157|P4|COMPLETED|Overall Study||152
2426049|NCT01197794|5950158|P3|COMPLETED|Overall Study||153
2426050|NCT01197794|5950159|P2|COMPLETED|Overall Study||146
2426051|NCT01197794|5950160|P1|COMPLETED|Overall Study||148
2426052|NCT01197794|5950154|P7|STARTED|Overall Study|Two participants excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
2426053|NCT01197794|5950155|P6|STARTED|Overall Study||163
2426054|NCT01197794|5950156|P5|STARTED|Overall Study|One participant excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
2426055|NCT01197794|5950157|P4|STARTED|Overall Study||164
2426056|NCT01197794|5950158|P3|STARTED|Overall Study|Two participants did not receive study treatment|166
2426057|NCT01197794|5950159|P2|STARTED|Overall Study|Two participants did not receive study treatment|161
2426058|NCT01197794|5950160|P1|STARTED|Overall Study||164
2426059|NCT01197755|5950242|P3|NOT COMPLETED|Overall Study||54
2426060|NCT01197755|5950243|P2|NOT COMPLETED|Overall Study||43
2426061|NCT01197755|5950244|P1|NOT COMPLETED|Overall Study||38
2426062|NCT01197755|5950242|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|55
2426063|NCT01197755|5950243|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|65
2426064|NCT01197755|5950244|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|67
2426065|NCT01197755|5950242|P3|Randomised But Did Not Receive Treatment|Overall Study|Severe non-compliance to the protocol|1
2426066|NCT01197755|5950243|P2|Randomised But Did Not Receive Treatment|Overall Study||0
2426067|NCT01197755|5950244|P1|Randomised But Did Not Receive Treatment|Overall Study||0
2426068|NCT01197755|5950242|P3|STARTED|Overall Study|Patients who received treatment|109
2426069|NCT01197755|5950243|P2|STARTED|Overall Study|Patients who received treatment|108
2426070|NCT01197755|5950244|P1|STARTED|Overall Study|Patients who received treatment|105
2426071|NCT01197612|5950284|P1|NOT COMPLETED|Overall Study||12
2426072|NCT01197612|5950284|P1|COMPLETED|Overall Study||6
2426073|NCT01197612|5950284|P1|Returned for Week 24|Overall Study||6
2426074|NCT01197612|5950284|P1|Week 3|Overall Study||16
2426075|NCT01197612|5950284|P1|STARTED|Overall Study||18
2426076|NCT01197573|5950299|P4|NOT COMPLETED|Overall Study||0
2426077|NCT01197573|5950300|P3|NOT COMPLETED|Overall Study||0
2426078|NCT01197573|5950301|P2|NOT COMPLETED|Overall Study||0
2426079|NCT01197573|5950302|P1|NOT COMPLETED|Overall Study||0
2426080|NCT01197573|5950299|P4|COMPLETED|Overall Study||12
2426081|NCT01197573|5950300|P3|COMPLETED|Overall Study||12
2426082|NCT01197573|5950301|P2|COMPLETED|Overall Study||46
2426083|NCT01197573|5950302|P1|COMPLETED|Overall Study||33
2426084|NCT01197573|5950299|P4|STARTED|Overall Study||12
2426085|NCT01197573|5950300|P3|STARTED|Overall Study||12
2426086|NCT01197573|5950301|P2|STARTED|Overall Study||46
2426087|NCT01197573|5950302|P1|STARTED|Overall Study||33
2426088|NCT01197560|5950316|P2|NOT COMPLETED|Overall Study||53
2426089|NCT01197560|5950317|P1|NOT COMPLETED|Overall Study||54
2426090|NCT01197560|5950316|P2|COMPLETED|Overall Study||4
2426091|NCT01197560|5950317|P1|COMPLETED|Overall Study||0
2426092|NCT01197560|5950316|P2|Discontinued Treatment After ≥ 6 Cycles|Overall Study||0
2426093|NCT01197560|5950317|P1|Discontinued Treatment After ≥ 6 Cycles|Overall Study||14
2426094|NCT01197560|5950316|P2|Lenalidomide Crossover|Overall Study||29
2426095|NCT01197560|5950317|P1|Lenalidomide Crossover|Overall Study||0
2426096|NCT01197560|5950316|P2|Received ≥ One Dose Study Drug|Overall Study||55
2426097|NCT01197560|5950317|P1|Received ≥ One Dose Study Drug|Overall Study||54
2426098|NCT01197560|5950316|P2|STARTED|Overall Study|This is the intent to treat population|57
2426099|NCT01197560|5950317|P1|STARTED|Overall Study|This is the intent to treat population|54
2426100|NCT01197547|5950355|P1|NOT COMPLETED|Overall Study||22
2426101|NCT01197547|5950355|P1|COMPLETED|Overall Study|992 Intent-To-Treat (ITT) 931 evaluable subjects|992
2426102|NCT01197547|5950355|P1|STARTED|Overall Study||1014
2426103|NCT01197534|5950364|P3|NOT COMPLETED|Overall Study||173
2426104|NCT01197534|5950365|P2|NOT COMPLETED|Overall Study||130
2426105|NCT01197534|5950366|P1|NOT COMPLETED|Overall Study||134
2426106|NCT01197534|5950364|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|129
2426107|NCT01197534|5950365|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|168
2426108|NCT01197534|5950366|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|174
2426109|NCT01197534|5950364|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled / Severe non-compliance to protocol|3
2426110|NCT01197534|5950365|P2|Randomised But Did Not Receive Treatment|Overall Study|Adverse event / Other|2
2426111|NCT01197534|5950366|P1|Randomised But Did Not Receive Treatment|Overall Study||0
2426112|NCT01197534|5950364|P3|STARTED|Overall Study|Patients who received treatment|302
2426113|NCT01197534|5950365|P2|STARTED|Overall Study|Patients who received treatment|298
2426114|NCT01197534|5950366|P1|STARTED|Overall Study|Patients who received treatment|308
2426115|NCT01197521|5950410|P3|NOT COMPLETED|Overall Study||143
2426116|NCT01197521|5950411|P2|NOT COMPLETED|Overall Study||113
2426117|NCT01197521|5950412|P1|NOT COMPLETED|Overall Study||103
2426118|NCT01197521|5950410|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|161
2426119|NCT01197521|5950411|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|191
2426120|NCT01197521|5950412|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|207
2426121|NCT01197521|5950410|P3|Randomised But Did Not Receive Treatment|Overall Study|Adverse event/eligibility criteria not fulfilled|2
2426122|NCT01197521|5950411|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/other|2
2426123|NCT01197521|5950412|P1|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
2426124|NCT01197521|5950410|P3|STARTED|Overall Study|Patients who received treatment|304
2426125|NCT01197521|5950411|P2|STARTED|Overall Study|Patients who received treatment|304
2426126|NCT01197521|5950412|P1|STARTED|Overall Study|Patients who received treatment|310
2426127|NCT01197508|5950457|P4|NOT COMPLETED|Overall Study||16
2426128|NCT01197508|5950458|P3|NOT COMPLETED|Overall Study||49
2426129|NCT01197508|5950459|P2|NOT COMPLETED|Overall Study||30
2426130|NCT01197508|5950460|P1|NOT COMPLETED|Overall Study||23
2426131|NCT01197508|5950457|P4|COMPLETED|Overall Study||158
2426132|NCT01197508|5950458|P3|COMPLETED|Overall Study||125
2426133|NCT01197508|5950459|P2|COMPLETED|Overall Study||144
2426134|NCT01197508|5950460|P1|COMPLETED|Overall Study||151
2426135|NCT01197508|5950457|P4|Received Treatment|Overall Study||174
2426136|NCT01197508|5950458|P3|Received Treatment|Overall Study||171
2426137|NCT01197508|5950459|P2|Received Treatment|Overall Study||174
2426138|NCT01197508|5950460|P1|Received Treatment|Overall Study||174
2426139|NCT01197508|5950457|P4|STARTED|Overall Study||174
2426140|NCT01197508|5950458|P3|STARTED|Overall Study||174
2426141|NCT01197508|5950459|P2|STARTED|Overall Study||174
2426142|NCT01197508|5950460|P1|STARTED|Overall Study||174
2426143|NCT01197495|5950556|P2|NOT COMPLETED|Overall Study||7
2426144|NCT01197495|5950557|P1|NOT COMPLETED|Overall Study||13
2426145|NCT01197495|5950556|P2|COMPLETED|Overall Study||49
2426146|NCT01197495|5950557|P1|COMPLETED|Overall Study||144
2426147|NCT01197495|5950556|P2|STARTED|Overall Study||56
2426148|NCT01197495|5950557|P1|STARTED|Overall Study||157
2426149|NCT01197417|5950570|P2|NOT COMPLETED|Overall Study||18
2426150|NCT01197417|5950571|P1|NOT COMPLETED|Overall Study||8
2426151|NCT01197417|5950570|P2|COMPLETED|Overall Study||86
2426152|NCT01197417|5950571|P1|COMPLETED|Overall Study||96
2426153|NCT01197417|5950570|P2|Received Study Drug|Overall Study||103
2426154|NCT01197417|5950571|P1|Received Study Drug|Overall Study||101
2426155|NCT01197417|5950570|P2|STARTED|Overall Study||104
2426156|NCT01197417|5950571|P1|STARTED|Overall Study||104
2426157|NCT01197378|5950589|P1|NOT COMPLETED|Overall Study||7
2426158|NCT01197378|5950589|P1|COMPLETED|Overall Study||53
2426159|NCT01197378|5950589|P1|Received Treatment|Overall Study||59
2426160|NCT01197378|5950589|P1|STARTED|Overall Study||60
2426161|NCT01197326|5950597|P2|NOT COMPLETED|Overall Study||0
2426162|NCT01197326|5950598|P1|NOT COMPLETED|Overall Study||0
2426163|NCT01197326|5950597|P2|COMPLETED|Overall Study||209
2426164|NCT01197326|5950598|P1|COMPLETED|Overall Study||205
2426165|NCT01197326|5950597|P2|STARTED|Overall Study||209
2426166|NCT01197326|5950598|P1|STARTED|Overall Study||205
2426167|NCT01197300|5950608|P2|NOT COMPLETED|Overall Study||2
2426168|NCT01197300|5950609|P1|NOT COMPLETED|Overall Study||0
2426169|NCT01197300|5950608|P2|COMPLETED|Overall Study||13
2426170|NCT01197300|5950609|P1|COMPLETED|Overall Study||10
2426171|NCT01197300|5950608|P2|STARTED|Overall Study||15
2426172|NCT01197300|5950609|P1|STARTED|Overall Study||10
2426173|NCT01196988|5950641|P4|NOT COMPLETED|Overall Study||1
2426174|NCT01196988|5950642|P3|NOT COMPLETED|Overall Study||25
2426175|NCT01196988|5950643|P2|NOT COMPLETED|Overall Study||32
2426176|NCT01196988|5950644|P1|NOT COMPLETED|Overall Study||24
2426177|NCT01196988|5950641|P4|COMPLETED|Overall Study||276
2426178|NCT01196988|5950642|P3|COMPLETED|Overall Study||886
2426179|NCT01196988|5950643|P2|COMPLETED|Overall Study||880
2426180|NCT01196988|5950644|P1|COMPLETED|Overall Study||891
2426181|NCT01196988|5950641|P4|STARTED|Overall Study||277
2426182|NCT01196988|5950642|P3|STARTED|Overall Study||911
2426183|NCT01196988|5950643|P2|STARTED|Overall Study||912
2426184|NCT01196988|5950644|P1|STARTED|Overall Study||915
2426185|NCT01196975|5950738|P5|NOT COMPLETED|Overall Study||13
2426186|NCT01196975|5950739|P4|NOT COMPLETED|Overall Study||6
2426187|NCT01196975|5950740|P3|NOT COMPLETED|Overall Study||5
2426188|NCT01196975|5950741|P2|NOT COMPLETED|Overall Study||9
2426189|NCT01196975|5950742|P1|NOT COMPLETED|Overall Study||15
2426190|NCT01196975|5950738|P5|COMPLETED|Overall Study||205
2426191|NCT01196975|5950739|P4|COMPLETED|Overall Study||207
2426192|NCT01196975|5950740|P3|COMPLETED|Overall Study||420
2426193|NCT01196975|5950741|P2|COMPLETED|Overall Study||415
2426194|NCT01196975|5950742|P1|COMPLETED|Overall Study||408
2426195|NCT01196975|5950738|P5|STARTED|Overall Study||218
2426196|NCT01196975|5950739|P4|STARTED|Overall Study||213
2426197|NCT01196975|5950740|P3|STARTED|Overall Study||425
2426198|NCT01196975|5950741|P2|STARTED|Overall Study||424
2426199|NCT01196975|5950742|P1|STARTED|Overall Study||423
2426200|NCT01196936|5950876|P2|NOT COMPLETED|Overall Study||17
2426201|NCT01196936|5950877|P1|NOT COMPLETED|Overall Study||11
2426202|NCT01196936|5950876|P2|COMPLETED|Overall Study||21
2426203|NCT01196936|5950877|P1|COMPLETED|Overall Study||23
2426204|NCT01196936|5950876|P2|Year One Post Treatment|Overall Study||28
2426205|NCT01196936|5950877|P1|Year One Post Treatment|Overall Study||27
2426206|NCT01196936|5950876|P2|STARTED|Overall Study||38
2426207|NCT01196936|5950877|P1|STARTED|Overall Study||34
2426208|NCT01196923|5950899|P1|NOT COMPLETED|Overall Study||0
2426209|NCT01196923|5950899|P1|COMPLETED|Overall Study||20
2426210|NCT01196923|5950899|P1|STARTED|Overall Study||20
2426211|NCT01196871|5950909|P6|NOT COMPLETED|Stage 2: Period 2||0
2426212|NCT01196871|5950910|P5|NOT COMPLETED|Stage 2: Period 2||0
2426213|NCT01196871|5950911|P4|NOT COMPLETED|Stage 2: Period 2||0
2426214|NCT01196871|5950912|P3|NOT COMPLETED|Stage 2: Period 2||0
2426215|NCT01196871|5950913|P2|NOT COMPLETED|Stage 2: Period 2||0
2426216|NCT01196871|5950914|P1|NOT COMPLETED|Stage 2: Period 2||0
2426217|NCT01196871|5950909|P6|COMPLETED|Stage 2: Period 2||4
2426218|NCT01196871|5950910|P5|COMPLETED|Stage 2: Period 2||6
2426219|NCT01196871|5950911|P4|COMPLETED|Stage 2: Period 2||1
2426220|NCT01196871|5950912|P3|COMPLETED|Stage 2: Period 2||0
2426221|NCT01196871|5950913|P2|COMPLETED|Stage 2: Period 2||0
2426222|NCT01196871|5950914|P1|COMPLETED|Stage 2: Period 2||0
2426223|NCT01196871|5950909|P6|PK Population|Stage 2: Period 2||4
2426224|NCT01196871|5950910|P5|PK Population|Stage 2: Period 2||6
2426225|NCT01196871|5950911|P4|PK Population|Stage 2: Period 2||1
2426226|NCT01196871|5950912|P3|PK Population|Stage 2: Period 2||0
2426227|NCT01196871|5950913|P2|PK Population|Stage 2: Period 2||0
2426228|NCT01196871|5950914|P1|PK Population|Stage 2: Period 2||0
2426229|NCT01196871|5950909|P6|STARTED|Stage 2: Period 2||4
2426230|NCT01196871|5950910|P5|STARTED|Stage 2: Period 2|One participant switched agalsidase dose from 0.5 mg/kg in Period 1 to 1.0 mg/kg in Period 2|6
2426231|NCT01196871|5950911|P4|STARTED|Stage 2: Period 2|One participant switched agalsidase dose from 0.5 mg/kg in Period 1 to 1.0 mg/kg in Period 2|1
2426232|NCT01196871|5950912|P3|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
2426233|NCT01196871|5950913|P2|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
2426234|NCT01196871|5950914|P1|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
2426235|NCT01196871|5950909|P6|NOT COMPLETED|Stage 2: Period 1||0
2426236|NCT01196871|5950910|P5|NOT COMPLETED|Stage 2: Period 1||0
2426237|NCT01196871|5950911|P4|NOT COMPLETED|Stage 2: Period 1||0
2426238|NCT01196871|5950912|P3|NOT COMPLETED|Stage 2: Period 1||0
2426239|NCT01196871|5950913|P2|NOT COMPLETED|Stage 2: Period 1||0
2426240|NCT01196871|5950914|P1|NOT COMPLETED|Stage 2: Period 1||0
2426241|NCT01196871|5950909|P6|COMPLETED|Stage 2: Period 1||4
2426242|NCT01196871|5950910|P5|COMPLETED|Stage 2: Period 1||5
2426243|NCT01196871|5950911|P4|COMPLETED|Stage 2: Period 1||2
2426244|NCT01196871|5950912|P3|COMPLETED|Stage 2: Period 1||0
2426245|NCT01196871|5950913|P2|COMPLETED|Stage 2: Period 1||0
2426246|NCT01196871|5950914|P1|COMPLETED|Stage 2: Period 1||0
2426247|NCT01196871|5950909|P6|PK Population|Stage 2: Period 1||4
2426248|NCT01196871|5950910|P5|PK Population|Stage 2: Period 1||5
2426249|NCT01196871|5950911|P4|PK Population|Stage 2: Period 1||1
2426250|NCT01196871|5950912|P3|PK Population|Stage 2: Period 1||0
2426251|NCT01196871|5950913|P2|PK Population|Stage 2: Period 1||0
2426252|NCT01196871|5950914|P1|PK Population|Stage 2: Period 1||0
2426253|NCT01196871|5950909|P6|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||4
2426254|NCT01196871|5950910|P5|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||5
2426255|NCT01196871|5950911|P4|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||2
2426256|NCT01196871|5950912|P3|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
2426257|NCT01196871|5950913|P2|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
2426258|NCT01196871|5950914|P1|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
2426259|NCT01196871|5950909|P6|STARTED|Stage 2: Period 1||4
2426260|NCT01196871|5950910|P5|STARTED|Stage 2: Period 1|One participant re-enrolled into Stage 2 after completing Stage 1|5
2426261|NCT01196871|5950911|P4|STARTED|Stage 2: Period 1|Both participants re-enrolled into Stage 2 after completing Stage 1|2
2426262|NCT01196871|5950912|P3|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
2426263|NCT01196871|5950913|P2|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
2426264|NCT01196871|5950914|P1|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
2426265|NCT01196871|5950909|P6|NOT COMPLETED|Stage 1: Period 3||0
2426266|NCT01196871|5950910|P5|NOT COMPLETED|Stage 1: Period 3||0
2426267|NCT01196871|5950911|P4|NOT COMPLETED|Stage 1: Period 3||0
2426268|NCT01196871|5950912|P3|NOT COMPLETED|Stage 1: Period 3||0
2426269|NCT01196871|5950913|P2|NOT COMPLETED|Stage 1: Period 3||0
2426270|NCT01196871|5950914|P1|NOT COMPLETED|Stage 1: Period 3||0
2426271|NCT01196871|5950909|P6|COMPLETED|Stage 1: Period 3||0
2426272|NCT01196871|5950910|P5|COMPLETED|Stage 1: Period 3||0
2426273|NCT01196871|5950911|P4|COMPLETED|Stage 1: Period 3||0
2426274|NCT01196871|5950912|P3|COMPLETED|Stage 1: Period 3||4
2426275|NCT01196871|5950913|P2|COMPLETED|Stage 1: Period 3||3
2426276|NCT01196871|5950914|P1|COMPLETED|Stage 1: Period 3||5
2426277|NCT01196871|5950909|P6|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
2426278|NCT01196871|5950910|P5|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
2426279|NCT01196871|5950911|P4|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
2426280|NCT01196871|5950912|P3|STARTED|Stage 1: Period 3||4
2426281|NCT01196871|5950913|P2|STARTED|Stage 1: Period 3||3
2426282|NCT01196871|5950914|P1|STARTED|Stage 1: Period 3||5
2426283|NCT01196871|5950909|P6|NOT COMPLETED|Stage 1: Period 2||0
2426284|NCT01196871|5950910|P5|NOT COMPLETED|Stage 1: Period 2||0
2426285|NCT01196871|5950911|P4|NOT COMPLETED|Stage 1: Period 2||0
2426286|NCT01196871|5950912|P3|NOT COMPLETED|Stage 1: Period 2||0
2426287|NCT01196871|5950913|P2|NOT COMPLETED|Stage 1: Period 2||0
2426288|NCT01196871|5950914|P1|NOT COMPLETED|Stage 1: Period 2||0
2426289|NCT01196871|5950909|P6|COMPLETED|Stage 1: Period 2||0
2426290|NCT01196871|5950910|P5|COMPLETED|Stage 1: Period 2||0
2426291|NCT01196871|5950911|P4|COMPLETED|Stage 1: Period 2||0
2426292|NCT01196871|5950912|P3|COMPLETED|Stage 1: Period 2||4
2426293|NCT01196871|5950913|P2|COMPLETED|Stage 1: Period 2||3
2426294|NCT01196871|5950914|P1|COMPLETED|Stage 1: Period 2||5
2426295|NCT01196871|5950909|P6|PK Population|Stage 1: Period 2||0
2426296|NCT01196871|5950910|P5|PK Population|Stage 1: Period 2||0
2426297|NCT01196871|5950911|P4|PK Population|Stage 1: Period 2||0
2426298|NCT01196871|5950912|P3|PK Population|Stage 1: Period 2||4
2426299|NCT01196871|5950913|P2|PK Population|Stage 1: Period 2||3
2426300|NCT01196871|5950914|P1|PK Population|Stage 1: Period 2||5
2426301|NCT01196871|5950909|P6|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
2426302|NCT01196871|5950910|P5|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
2426303|NCT01196871|5950911|P4|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
2426304|NCT01196871|5950912|P3|STARTED|Stage 1: Period 2||4
2426305|NCT01196871|5950913|P2|STARTED|Stage 1: Period 2||3
2426306|NCT01196871|5950914|P1|STARTED|Stage 1: Period 2||5
2426307|NCT01196871|5950909|P6|NOT COMPLETED|Stage 1: Period 1||0
2426308|NCT01196871|5950910|P5|NOT COMPLETED|Stage 1: Period 1||0
2426309|NCT01196871|5950911|P4|NOT COMPLETED|Stage 1: Period 1||0
2426310|NCT01196871|5950912|P3|NOT COMPLETED|Stage 1: Period 1||0
2426311|NCT01196871|5950913|P2|NOT COMPLETED|Stage 1: Period 1||0
2426312|NCT01196871|5950914|P1|NOT COMPLETED|Stage 1: Period 1||0
2426313|NCT01196871|5950909|P6|COMPLETED|Stage 1: Period 1||0
2426314|NCT01196871|5950910|P5|COMPLETED|Stage 1: Period 1||0
2426315|NCT01196871|5950911|P4|COMPLETED|Stage 1: Period 1||0
2426316|NCT01196871|5950912|P3|COMPLETED|Stage 1: Period 1||4
2426317|NCT01196871|5950913|P2|COMPLETED|Stage 1: Period 1||3
2426318|NCT01196871|5950914|P1|COMPLETED|Stage 1: Period 1||5
2426319|NCT01196871|5950909|P6|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
2426320|NCT01196871|5950910|P5|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
2426321|NCT01196871|5950911|P4|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
2426322|NCT01196871|5950912|P3|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||4
2426323|NCT01196871|5950913|P2|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||3
2426324|NCT01196871|5950914|P1|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||5
2426325|NCT01196871|5950909|P6|PK Population|Stage 1: Period 1||0
2426326|NCT01196871|5950910|P5|PK Population|Stage 1: Period 1||0
2426327|NCT01196871|5950911|P4|PK Population|Stage 1: Period 1||0
2426328|NCT01196871|5950912|P3|PK Population|Stage 1: Period 1||4
2426329|NCT01196871|5950913|P2|PK Population|Stage 1: Period 1||3
2426330|NCT01196871|5950914|P1|PK Population|Stage 1: Period 1||5
2426331|NCT01196871|5950909|P6|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
2426332|NCT01196871|5950910|P5|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
2426333|NCT01196871|5950911|P4|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
2426334|NCT01196871|5950912|P3|STARTED|Stage 1: Period 1||4
2426335|NCT01196871|5950913|P2|STARTED|Stage 1: Period 1||3
2426336|NCT01196871|5950914|P1|STARTED|Stage 1: Period 1||5
2426337|NCT01196819|5950999|P2|NOT COMPLETED|Overall Study||0
2426338|NCT01196819|5951000|P1|NOT COMPLETED|Overall Study||6
2426339|NCT01196819|5950999|P2|COMPLETED|Overall Study||227
2426340|NCT01196819|5951000|P1|COMPLETED|Overall Study||225
2426341|NCT01196819|5950999|P2|STARTED|Overall Study||227
2426342|NCT01196819|5951000|P1|STARTED|Overall Study||231
2426343|NCT01196793|5951020|P1|NOT COMPLETED|Overall Study||0
2426344|NCT01196793|5951020|P1|COMPLETED|Overall Study||108
2426345|NCT01196793|5951020|P1|STARTED|Overall Study||108
2426346|NCT01196741|5951026|P2|NOT COMPLETED|Overall Study||28
2426347|NCT01196741|5951027|P1|NOT COMPLETED|Overall Study||60
2426348|NCT01196741|5951026|P2|COMPLETED|Overall Study||8
2426349|NCT01196741|5951027|P1|COMPLETED|Overall Study||11
2426350|NCT01196741|5951026|P2|STARTED|Overall Study||36
2426351|NCT01196741|5951027|P1|STARTED|Overall Study||71
2426352|NCT01196533|5951041|P1|NOT COMPLETED|Overall Study||0
2426353|NCT01196533|5951041|P1|COMPLETED|Overall Study||94
2426354|NCT01196533|5951041|P1|STARTED|Overall Study||94
2426355|NCT01196442|5951045|P1|NOT COMPLETED|Overall Study||0
2426356|NCT01196442|5951045|P1|COMPLETED|Overall Study||39
2426357|NCT01196442|5951045|P1|STARTED|Overall Study||39
2426358|NCT01196429|5951057|P2|NOT COMPLETED|Overall Study||0
2426359|NCT01196429|5951058|P1|NOT COMPLETED|Overall Study||3
2426360|NCT01196429|5951057|P2|COMPLETED|Overall Study||45
2426361|NCT01196429|5951058|P1|COMPLETED|Overall Study||42
2426362|NCT01196429|5951057|P2|STARTED|Overall Study||45
2426363|NCT01196429|5951058|P1|STARTED|Overall Study||45
2426364|NCT01196416|5951074|P1|NOT COMPLETED|Overall Study||2
2426365|NCT01196416|5951074|P1|COMPLETED|Overall Study||12
2426366|NCT01196416|5951074|P1|STARTED|Overall Study||14
2426367|NCT01196377|5951092|P4|NOT COMPLETED|Overall Study||0
2426368|NCT01196377|5951093|P3|NOT COMPLETED|Overall Study||0
2426369|NCT01196377|5951094|P2|NOT COMPLETED|Overall Study||0
2426370|NCT01196377|5951095|P1|NOT COMPLETED|Overall Study||0
2426371|NCT01196377|5951092|P4|COMPLETED|Overall Study||4
2426372|NCT01196377|5951093|P3|COMPLETED|Overall Study||4
2426373|NCT01196377|5951094|P2|COMPLETED|Overall Study||4
2426374|NCT01196377|5951095|P1|COMPLETED|Overall Study||4
2426375|NCT01196377|5951092|P4|STARTED|Overall Study||4
2426376|NCT01196377|5951093|P3|STARTED|Overall Study||4
2426377|NCT01196377|5951094|P2|STARTED|Overall Study||4
2426378|NCT01196377|5951095|P1|STARTED|Overall Study||4
2426379|NCT01196104|5951107|P2|NOT COMPLETED|Overall Study||5
2426380|NCT01196104|5951108|P1|NOT COMPLETED|Overall Study||4
2426381|NCT01196104|5951107|P2|COMPLETED|Overall Study||15
2426382|NCT01196104|5951108|P1|COMPLETED|Overall Study||15
2426383|NCT01196104|5951107|P2|STARTED|Overall Study||20
2426384|NCT01196104|5951108|P1|STARTED|Overall Study||19
2426385|NCT01196091|5951151|P3|NOT COMPLETED|Overall Study||104
2426386|NCT01196091|5951152|P2|NOT COMPLETED|Overall Study||98
2426387|NCT01196091|5951153|P1|NOT COMPLETED|Overall Study||88
2426388|NCT01196091|5951151|P3|COMPLETED|Overall Study||284
2426389|NCT01196091|5951152|P2|COMPLETED|Overall Study||291
2426390|NCT01196091|5951153|P1|COMPLETED|Overall Study||299
2426391|NCT01196091|5951151|P3|Follow-Up|Overall Study||128
2426392|NCT01196091|5951152|P2|Follow-Up|Overall Study||105
2426393|NCT01196091|5951153|P1|Follow-Up|Overall Study||103
2426394|NCT01196091|5951151|P3|ITT-Received Drug and Excluded Sites|Overall Study||379
2426395|NCT01196091|5951152|P2|ITT-Received Drug and Excluded Sites|Overall Study||378
2426396|NCT01196091|5951153|P1|ITT-Received Drug and Excluded Sites|Overall Study||381
2426397|NCT01196091|5951151|P3|Received at Least 1 Dose of Study Drug|Overall Study||387
2426398|NCT01196091|5951152|P2|Received at Least 1 Dose of Study Drug|Overall Study||389
2426399|NCT01196091|5951153|P1|Received at Least 1 Dose of Study Drug|Overall Study||386
2426400|NCT01196091|5951151|P3|STARTED|Overall Study||388
2426401|NCT01196091|5951152|P2|STARTED|Overall Study||389
2426402|NCT01196091|5951153|P1|STARTED|Overall Study||387
2426403|NCT01196078|5951205|P2|NOT COMPLETED|Overall Study||37
2426404|NCT01196078|5951206|P1|NOT COMPLETED|Overall Study||33
2426405|NCT01196078|5951205|P2|COMPLETED|Overall Study||20
2426406|NCT01196078|5951206|P1|COMPLETED|Overall Study||24
2426407|NCT01196078|5951205|P2|STARTED|Overall Study||57
2426408|NCT01196078|5951206|P1|STARTED|Overall Study||57
2426409|NCT01196052|5951234|P1|NOT COMPLETED|Overall Study||23
2426410|NCT01196052|5951234|P1|COMPLETED|Overall Study||130
2426411|NCT01196052|5951234|P1|Received Trastuzumab Emtansine|Overall Study||148
2426412|NCT01196052|5951234|P1|STARTED|Overall Study||153
2426413|NCT01196026|5951251|P6|NOT COMPLETED|Overall Study||0
2426414|NCT01196026|5951252|P5|NOT COMPLETED|Overall Study||1
2426415|NCT01196026|5951253|P4|NOT COMPLETED|Overall Study||0
2426416|NCT01196026|5951254|P3|NOT COMPLETED|Overall Study||0
2426417|NCT01196026|5951255|P2|NOT COMPLETED|Overall Study||8
2426418|NCT01196026|5951256|P1|NOT COMPLETED|Overall Study||1
2426419|NCT01196026|5951251|P6|COMPLETED|Overall Study||24
2426420|NCT01196026|5951252|P5|COMPLETED|Overall Study||42
2426421|NCT01196026|5951253|P4|COMPLETED|Overall Study||10
2426422|NCT01196026|5951254|P3|COMPLETED|Overall Study||23
2426423|NCT01196026|5951255|P2|COMPLETED|Overall Study||36
2426424|NCT01196026|5951256|P1|COMPLETED|Overall Study||9
2426425|NCT01196026|5951251|P6|Completed at Day 28|Overall Study||24
2426426|NCT01196026|5951252|P5|Completed at Day 28|Overall Study||42
2426427|NCT01196026|5951253|P4|Completed at Day 28|Overall Study||10
2426428|NCT01196026|5951254|P3|Completed at Day 28|Overall Study||23
2426429|NCT01196026|5951255|P2|Completed at Day 28|Overall Study||41
2426430|NCT01196026|5951256|P1|Completed at Day 28|Overall Study||9
2426431|NCT01196026|5951251|P6|STARTED|Overall Study||24
2426432|NCT01196026|5951252|P5|STARTED|Overall Study||43
2426433|NCT01196026|5951253|P4|STARTED|Overall Study||10
2426434|NCT01196026|5951254|P3|STARTED|Overall Study||23
2426435|NCT01196026|5951255|P2|STARTED|Overall Study||44
2426436|NCT01196026|5951256|P1|STARTED|Overall Study||10
2426437|NCT01195948|5951490|P3|NOT COMPLETED|Overall Study||2
2426438|NCT01195948|5951491|P2|NOT COMPLETED|Overall Study||1
2426439|NCT01195948|5951492|P1|NOT COMPLETED|Overall Study||0
2426440|NCT01195948|5951490|P3|COMPLETED|Overall Study||9
2426441|NCT01195948|5951491|P2|COMPLETED|Overall Study||9
2426442|NCT01195948|5951492|P1|COMPLETED|Overall Study||10
2426443|NCT01195948|5951490|P3|Week 24|Overall Study||10
2426444|NCT01195948|5951491|P2|Week 24|Overall Study||10
2426445|NCT01195948|5951492|P1|Week 24|Overall Study||10
2426446|NCT01195948|5951490|P3|STARTED|Overall Study||11
2426447|NCT01195948|5951491|P2|STARTED|Overall Study||10
2426448|NCT01195948|5951492|P1|STARTED|Overall Study||10
2426449|NCT01195922|5951524|P1|NOT COMPLETED|Overall Study||0
2426450|NCT01195922|5951524|P1|COMPLETED|Overall Study||16
2426451|NCT01195922|5951524|P1|STARTED|Overall Study||16
2426452|NCT01195883|5951532|P2|NOT COMPLETED|Overall Study||26
2426453|NCT01195883|5951533|P1|NOT COMPLETED|Overall Study||19
2426454|NCT01195883|5951532|P2|COMPLETED|Overall Study||523
2426455|NCT01195883|5951533|P1|COMPLETED|Overall Study||534
2426456|NCT01195883|5951532|P2|STARTED|Overall Study||549
2426457|NCT01195883|5951533|P1|STARTED|Overall Study||553
2426458|NCT01195844|5951545|P1|NOT COMPLETED|Overall Study||40
2426459|NCT01195844|5951545|P1|COMPLETED|Overall Study||190
2426460|NCT01195844|5951545|P1|STARTED|Overall Study||230
2426461|NCT01195831|5951562|P2|NOT COMPLETED|Overall Study||10
2426462|NCT01195831|5951563|P1|NOT COMPLETED|Overall Study||8
2426463|NCT01195831|5951562|P2|COMPLETED|Overall Study||114
2426464|NCT01195831|5951563|P1|COMPLETED|Overall Study||112
2426465|NCT01195831|5951562|P2|STARTED|Overall Study||124
2426466|NCT01195831|5951563|P1|STARTED|Overall Study||120
2426467|NCT01195779|5951591|P14|NOT COMPLETED|Overall Study||0
2426468|NCT01195779|5951592|P13|NOT COMPLETED|Overall Study||0
2426469|NCT01195779|5951593|P12|NOT COMPLETED|Overall Study||0
2426470|NCT01195779|5951594|P11|NOT COMPLETED|Overall Study||0
2426471|NCT01195779|5951595|P10|NOT COMPLETED|Overall Study||0
2426472|NCT01195779|5951596|P9|NOT COMPLETED|Overall Study||0
2426473|NCT01195779|5951597|P8|NOT COMPLETED|Overall Study||0
2426474|NCT01195779|5951598|P7|NOT COMPLETED|Overall Study||0
2426475|NCT01195779|5951599|P6|NOT COMPLETED|Overall Study||0
2426476|NCT01195779|5951600|P5|NOT COMPLETED|Overall Study||0
2426477|NCT01195779|5951601|P4|NOT COMPLETED|Overall Study||0
2426478|NCT01195779|5951602|P3|NOT COMPLETED|Overall Study||0
2426479|NCT01195779|5951603|P2|NOT COMPLETED|Overall Study||0
2426480|NCT01195779|5951604|P1|NOT COMPLETED|Overall Study||0
2426481|NCT01195779|5951591|P14|COMPLETED|Overall Study||1
2426482|NCT01195779|5951592|P13|COMPLETED|Overall Study||0
2426483|NCT01195779|5951593|P12|COMPLETED|Overall Study||1
2426484|NCT01195779|5951594|P11|COMPLETED|Overall Study||0
2426485|NCT01195779|5951595|P10|COMPLETED|Overall Study||0
2426486|NCT01195779|5951596|P9|COMPLETED|Overall Study||0
2426487|NCT01195779|5951597|P8|COMPLETED|Overall Study||1
2426488|NCT01195779|5951598|P7|COMPLETED|Overall Study||0
2426489|NCT01195779|5951599|P6|COMPLETED|Overall Study||0
2426490|NCT01195779|5951600|P5|COMPLETED|Overall Study||1
2426491|NCT01195779|5951601|P4|COMPLETED|Overall Study||0
2426492|NCT01195779|5951602|P3|COMPLETED|Overall Study||0
2426493|NCT01195779|5951603|P2|COMPLETED|Overall Study||0
2426494|NCT01195779|5951604|P1|COMPLETED|Overall Study||0
2426495|NCT01195779|5951591|P14|STARTED|Overall Study||1
2426496|NCT01195779|5951592|P13|STARTED|Overall Study||0
2426497|NCT01195779|5951593|P12|STARTED|Overall Study||1
2426498|NCT01195779|5951594|P11|STARTED|Overall Study||0
2426499|NCT01195779|5951595|P10|STARTED|Overall Study||0
2426500|NCT01195779|5951596|P9|STARTED|Overall Study||0
2426501|NCT01195779|5951597|P8|STARTED|Overall Study||1
2426502|NCT01195779|5951598|P7|STARTED|Overall Study||0
2426503|NCT01195779|5951599|P6|STARTED|Overall Study||0
2426504|NCT01195779|5951600|P5|STARTED|Overall Study||1
2426505|NCT01195779|5951601|P4|STARTED|Overall Study||0
2426506|NCT01195779|5951602|P3|STARTED|Overall Study||0
2426507|NCT01195779|5951603|P2|STARTED|Overall Study||0
2426508|NCT01195779|5951604|P1|STARTED|Overall Study||0
2426509|NCT01195701|5951776|P2|NOT COMPLETED|Overall Study||5
2426510|NCT01195701|5951777|P1|NOT COMPLETED|Overall Study||0
2426511|NCT01195701|5951776|P2|COMPLETED|Overall Study||20
2426512|NCT01195701|5951777|P1|COMPLETED|Overall Study||10
2426513|NCT01195701|5951776|P2|STARTED|Overall Study||25
2426514|NCT01195701|5951777|P1|STARTED|Overall Study||10
2426515|NCT01195675|5951803|P1|NOT COMPLETED|Overall Study||3
2426516|NCT01195675|5951803|P1|COMPLETED|Overall Study||27
2426517|NCT01195675|5951803|P1|Received Placebo 2|Overall Study||28
2426518|NCT01195675|5951803|P1|Received Placebo 1|Overall Study||29
2426519|NCT01195675|5951803|P1|Received Moxifloxacin|Overall Study||29
2426520|NCT01195675|5951803|P1|Received Empa 200mg|Overall Study||30
2426521|NCT01195675|5951803|P1|Received Empa 25mg|Overall Study||28
2426522|NCT01195675|5951803|P1|STARTED|Overall Study||30
2426523|NCT01195662|5951836|P3|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||1
2426524|NCT01195662|5951837|P2|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||0
2426525|NCT01195662|5951838|P1|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||3
2426526|NCT01195662|5951836|P3|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||119
2426527|NCT01195662|5951837|P2|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||209
2426528|NCT01195662|5951838|P1|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||200
2426529|NCT01195662|5951836|P3|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in the study and entered the follow up period.|120
2426530|NCT01195662|5951837|P2|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|2 participants completed treatment period but chose not to enter follow up period.|209
2426531|NCT01195662|5951838|P1|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in study and entered Follow-Up.|203
2426532|NCT01195662|5951836|P3|NOT COMPLETED|Double Blind Treatment Period||14
2426533|NCT01195662|5951837|P2|NOT COMPLETED|Double Blind Treatment Period||14
2426534|NCT01195662|5951838|P1|NOT COMPLETED|Double Blind Treatment Period||22
2426535|NCT01195662|5951836|P3|COMPLETED|Double Blind Treatment Period||119
2426536|NCT01195662|5951837|P2|COMPLETED|Double Blind Treatment Period||211
2426537|NCT01195662|5951838|P1|COMPLETED|Double Blind Treatment Period||202
2426538|NCT01195662|5951836|P3|STARTED|Double Blind Treatment Period||133
2426539|NCT01195662|5951837|P2|STARTED|Double Blind Treatment Period||225
2426540|NCT01195662|5951838|P1|STARTED|Double Blind Treatment Period||224
2426541|NCT01195636|5951868|P2|NOT COMPLETED|Second Intervention (3 Weeks)||2
2426542|NCT01195636|5951869|P1|NOT COMPLETED|Second Intervention (3 Weeks)||1
2426543|NCT01195636|5951868|P2|COMPLETED|Second Intervention (3 Weeks)||27
2426544|NCT01195636|5951869|P1|COMPLETED|Second Intervention (3 Weeks)||27
2426545|NCT01195636|5951868|P2|STARTED|Second Intervention (3 Weeks)||29
2426546|NCT01195636|5951869|P1|STARTED|Second Intervention (3 Weeks)||28
2426547|NCT01195636|5951868|P2|NOT COMPLETED|Washout Period (2 Weeks)||3
2426548|NCT01195636|5951869|P1|NOT COMPLETED|Washout Period (2 Weeks)||2
2426549|NCT01195636|5951868|P2|COMPLETED|Washout Period (2 Weeks)||29
2426550|NCT01195636|5951869|P1|COMPLETED|Washout Period (2 Weeks)||28
2426551|NCT01195636|5951868|P2|STARTED|Washout Period (2 Weeks)||32
2426552|NCT01195636|5951869|P1|STARTED|Washout Period (2 Weeks)||30
2426553|NCT01195636|5951868|P2|NOT COMPLETED|First Intervention (3 Weeks)||3
2426554|NCT01195636|5951869|P1|NOT COMPLETED|First Intervention (3 Weeks)||5
2426555|NCT01195636|5951868|P2|COMPLETED|First Intervention (3 Weeks)||32
2426556|NCT01195636|5951869|P1|COMPLETED|First Intervention (3 Weeks)||30
2426557|NCT01195636|5951868|P2|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||35
2426558|NCT01195636|5951869|P1|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||33
2426559|NCT01195636|5951868|P2|STARTED|First Intervention (3 Weeks)||35
2426560|NCT01195636|5951869|P1|STARTED|First Intervention (3 Weeks)||35
2426561|NCT01195623|5951895|P2|NOT COMPLETED|Overall Study||37
2426562|NCT01195623|5951896|P1|NOT COMPLETED|Overall Study||35
2426563|NCT01195623|5951895|P2|COMPLETED|Overall Study|129 legs|108
2426564|NCT01195623|5951896|P1|COMPLETED|Overall Study|127 legs|113
2426565|NCT01195623|5951895|P2|STARTED|Overall Study|177 legs total operated|145
2426566|NCT01195623|5951896|P1|STARTED|Overall Study|166 legs total operated|148
2426567|NCT01195597|5951904|P1|NOT COMPLETED|Overall Study||13
2426568|NCT01195597|5951904|P1|COMPLETED|Overall Study||27
2426569|NCT01195597|5951904|P1|STARTED|Overall Study||40
2426570|NCT01195584|5951912|P3|NOT COMPLETED|Overall Study||0
2426571|NCT01195584|5951913|P2|NOT COMPLETED|Overall Study||0
2426572|NCT01195584|5951914|P1|NOT COMPLETED|Overall Study||0
2426573|NCT01195584|5951912|P3|COMPLETED|Overall Study||27
2426574|NCT01195584|5951913|P2|COMPLETED|Overall Study||25
2426575|NCT01195584|5951914|P1|COMPLETED|Overall Study||20
2426576|NCT01195584|5951912|P3|STARTED|Overall Study||27
2426577|NCT01195584|5951913|P2|STARTED|Overall Study||25
2426578|NCT01195584|5951914|P1|STARTED|Overall Study||20
2426579|NCT01195545|5951925|P1|NOT COMPLETED|Overall Study||4
2426580|NCT01195545|5951925|P1|COMPLETED|Overall Study||16
2426581|NCT01195545|5951925|P1|STARTED|Overall Study||20
2426582|NCT01195467|5951932|P1|NOT COMPLETED|Overall Study||10
2426583|NCT01195467|5951932|P1|COMPLETED|Overall Study||30
2426584|NCT01195467|5951932|P1|STARTED|Overall Study||40
2426585|NCT01195415|5951937|P1|NOT COMPLETED|Overall Study||2
2426586|NCT01195415|5951937|P1|COMPLETED|Overall Study||23
2426587|NCT01195415|5951937|P1|STARTED|Overall Study||25
2426588|NCT01195363|5951946|P2|NOT COMPLETED|Overall Study||9
2426589|NCT01195363|5951947|P1|NOT COMPLETED|Overall Study||11
2426590|NCT01195363|5951946|P2|COMPLETED|Overall Study||4
2426591|NCT01195363|5951947|P1|COMPLETED|Overall Study||4
2426592|NCT01195363|5951946|P2|STARTED|Overall Study||13
2426593|NCT01195363|5951947|P1|STARTED|Overall Study||15
2426594|NCT01195272|5951953|P1|NOT COMPLETED|Overall Study||4
2426595|NCT01195272|5951953|P1|COMPLETED|Overall Study||17
2426596|NCT01195272|5951953|P1|STARTED|Overall Study||21
2426597|NCT01195116|5951972|P2|NOT COMPLETED|Overall Study||0
2426598|NCT01195116|5951973|P1|NOT COMPLETED|Overall Study||0
2426599|NCT01195116|5951972|P2|COMPLETED|Overall Study||20
2426600|NCT01195116|5951973|P1|COMPLETED|Overall Study||21
2426601|NCT01195116|5951972|P2|STARTED|Overall Study||20
2426602|NCT01195116|5951973|P1|STARTED|Overall Study||21
2426603|NCT01195103|5951982|P3|NOT COMPLETED|Overall Study||0
2426604|NCT01195103|5951983|P2|NOT COMPLETED|Overall Study||0
2426605|NCT01195103|5951984|P1|NOT COMPLETED|Overall Study||1
2426606|NCT01195103|5951982|P3|COMPLETED|Overall Study||5
2426607|NCT01195103|5951983|P2|COMPLETED|Overall Study||2
2426608|NCT01195103|5951984|P1|COMPLETED|Overall Study|One patient withdrew after randomization but before received study drug.|5
2426609|NCT01195103|5951982|P3|STARTED|Overall Study||5
2426610|NCT01195103|5951983|P2|STARTED|Overall Study||2
2426611|NCT01195103|5951984|P1|STARTED|Overall Study||6
2426612|NCT01195090|5951994|P2|NOT COMPLETED|Overall Study||8
2426613|NCT01195090|5951995|P1|NOT COMPLETED|Overall Study||6
2426614|NCT01195090|5951994|P2|COMPLETED|Overall Study||52
2426615|NCT01195090|5951995|P1|COMPLETED|Overall Study||54
2426616|NCT01195090|5951994|P2|STARTED|Overall Study||60
2426617|NCT01195090|5951995|P1|STARTED|Overall Study||60
2426618|NCT01195025|5952053|P5|NOT COMPLETED|Third Intervention C||0
2426619|NCT01195025|5952054|P4|NOT COMPLETED|Third Intervention C||0
2426620|NCT01195025|5952055|P3|NOT COMPLETED|Third Intervention C||0
2426621|NCT01195025|5952056|P2|NOT COMPLETED|Third Intervention C||0
2426622|NCT01195025|5952057|P1|NOT COMPLETED|Third Intervention C||0
2426623|NCT01195025|5952053|P5|COMPLETED|Third Intervention C||1
2426624|NCT01195025|5952054|P4|COMPLETED|Third Intervention C||2
2426625|NCT01195025|5952055|P3|COMPLETED|Third Intervention C||2
2426626|NCT01195025|5952056|P2|COMPLETED|Third Intervention C||3
2426627|NCT01195025|5952057|P1|COMPLETED|Third Intervention C||2
2426628|NCT01195025|5952053|P5|STARTED|Third Intervention C||1
2426629|NCT01195025|5952054|P4|STARTED|Third Intervention C||2
2426630|NCT01195025|5952055|P3|STARTED|Third Intervention C||2
2426631|NCT01195025|5952056|P2|STARTED|Third Intervention C||3
2426632|NCT01195025|5952057|P1|STARTED|Third Intervention C||2
2426633|NCT01195025|5952053|P5|NOT COMPLETED|Second Intervention B||0
2426634|NCT01195025|5952054|P4|NOT COMPLETED|Second Intervention B||0
2426635|NCT01195025|5952055|P3|NOT COMPLETED|Second Intervention B||0
2426636|NCT01195025|5952056|P2|NOT COMPLETED|Second Intervention B||0
2426637|NCT01195025|5952057|P1|NOT COMPLETED|Second Intervention B||0
2426638|NCT01195025|5952053|P5|COMPLETED|Second Intervention B||1
2426639|NCT01195025|5952054|P4|COMPLETED|Second Intervention B||2
2426640|NCT01195025|5952055|P3|COMPLETED|Second Intervention B||2
2426641|NCT01195025|5952056|P2|COMPLETED|Second Intervention B||3
2426642|NCT01195025|5952057|P1|COMPLETED|Second Intervention B||2
2426643|NCT01195025|5952053|P5|STARTED|Second Intervention B||1
2426644|NCT01195025|5952054|P4|STARTED|Second Intervention B||2
2426645|NCT01195025|5952055|P3|STARTED|Second Intervention B||2
2426646|NCT01195025|5952056|P2|STARTED|Second Intervention B||3
2426647|NCT01195025|5952057|P1|STARTED|Second Intervention B||2
2426648|NCT01195025|5952053|P5|NOT COMPLETED|First Intervention A||0
2426649|NCT01195025|5952054|P4|NOT COMPLETED|First Intervention A||0
2426650|NCT01195025|5952055|P3|NOT COMPLETED|First Intervention A||0
2426651|NCT01195025|5952056|P2|NOT COMPLETED|First Intervention A||0
2426652|NCT01195025|5952057|P1|NOT COMPLETED|First Intervention A||0
2426653|NCT01195025|5952053|P5|COMPLETED|First Intervention A||1
2426654|NCT01195025|5952054|P4|COMPLETED|First Intervention A||2
2426655|NCT01195025|5952055|P3|COMPLETED|First Intervention A||2
2426656|NCT01195025|5952056|P2|COMPLETED|First Intervention A||3
2426657|NCT01195025|5952057|P1|COMPLETED|First Intervention A||2
2426658|NCT01195025|5952053|P5|STARTED|First Intervention A||1
2426659|NCT01195025|5952054|P4|STARTED|First Intervention A||2
2426660|NCT01195025|5952055|P3|STARTED|First Intervention A||2
2426661|NCT01195025|5952056|P2|STARTED|First Intervention A||3
2426662|NCT01195025|5952057|P1|STARTED|First Intervention A||2
2426663|NCT01194999|5952064|P1|NOT COMPLETED|Overall Study||17
2426664|NCT01194999|5952064|P1|COMPLETED|Overall Study||115
2426665|NCT01194999|5952064|P1|STARTED|Overall Study||132
2426666|NCT01194973|5952068|P1|NOT COMPLETED|26 Week Treatment Period||3
2426667|NCT01194973|5952068|P1|COMPLETED|26 Week Treatment Period||38
2426668|NCT01194973|5952068|P1|STARTED|26 Week Treatment Period||41
2426669|NCT01194973|5952068|P1|NOT COMPLETED|Screening Period||3
2426670|NCT01194973|5952068|P1|COMPLETED|Screening Period||41
2426671|NCT01194973|5952068|P1|STARTED|Screening Period||44
2426672|NCT01194908|5952083|P1|NOT COMPLETED|Overall Study||0
2426673|NCT01194908|5952083|P1|COMPLETED|Overall Study||5
2426674|NCT01194908|5952083|P1|STARTED|Overall Study||5
2426675|NCT01194869|5952088|P1|NOT COMPLETED|Overall Study||4
2426676|NCT01194869|5952088|P1|COMPLETED|Overall Study||21
2426677|NCT01194869|5952088|P1|STARTED|Overall Study||25
2426678|NCT01194856|5952096|P2|NOT COMPLETED|Overall Study||0
2426679|NCT01194856|5952097|P1|NOT COMPLETED|Overall Study||1
2426680|NCT01194856|5952096|P2|COMPLETED|Overall Study||0
2426681|NCT01194856|5952097|P1|COMPLETED|Overall Study||0
2426682|NCT01194856|5952096|P2|STARTED|Overall Study||0
2426683|NCT01194856|5952097|P1|STARTED|Overall Study||1
2426684|NCT01194830|5952119|P2|NOT COMPLETED|Overall Study||27
2426685|NCT01194830|5952120|P1|NOT COMPLETED|Overall Study||36
2426686|NCT01194830|5952119|P2|COMPLETED|Overall Study||83
2426687|NCT01194830|5952120|P1|COMPLETED|Overall Study||88
2426688|NCT01194830|5952119|P2|STARTED|Overall Study||110
2426689|NCT01194830|5952120|P1|STARTED|Overall Study||124
2426690|NCT01194804|5952142|P1|NOT COMPLETED|Overall Study||1
2426691|NCT01194804|5952142|P1|COMPLETED|Overall Study||26
2426692|NCT01194804|5952142|P1|STARTED|Overall Study||27
2426693|NCT01194674|5952150|P1|NOT COMPLETED|Overall Study||0
2426694|NCT01194674|5952150|P1|COMPLETED|Overall Study||2
2426695|NCT01194674|5952150|P1|STARTED|Overall Study||2
2426696|NCT01194570|5952164|P2|NOT COMPLETED|Overall Study||488
2426697|NCT01194570|5952165|P1|NOT COMPLETED|Overall Study||244
2426698|NCT01194570|5952164|P2|COMPLETED|Overall Study||0
2426699|NCT01194570|5952165|P1|COMPLETED|Overall Study|"Reason for discontinuation were provided for Core Treatment Completion."|0
2426700|NCT01194570|5952164|P2|STARTED|Overall Study||488
2426701|NCT01194570|5952165|P1|STARTED|Overall Study||244
2426702|NCT01194531|5952185|P2|NOT COMPLETED|Overall Study||3
2426703|NCT01194531|5952186|P1|NOT COMPLETED|Overall Study||5
2426704|NCT01194531|5952185|P2|COMPLETED|Overall Study||27
2426705|NCT01194531|5952186|P1|COMPLETED|Overall Study||24
2426706|NCT01194531|5952185|P2|STARTED|Overall Study||30
2426707|NCT01194531|5952186|P1|STARTED|Overall Study||29
2426708|NCT01194479|5952194|P4|NOT COMPLETED|Overall Study||0
2426709|NCT01194479|5952195|P3|NOT COMPLETED|Overall Study||0
2426710|NCT01194479|5952196|P2|NOT COMPLETED|Overall Study||0
2426711|NCT01194479|5952197|P1|NOT COMPLETED|Overall Study||0
2426712|NCT01194479|5952194|P4|COMPLETED|Overall Study||5
2426713|NCT01194479|5952195|P3|COMPLETED|Overall Study||2
2426714|NCT01194479|5952196|P2|COMPLETED|Overall Study||4
2426715|NCT01194479|5952197|P1|COMPLETED|Overall Study||3
2426716|NCT01194479|5952194|P4|Cross-over at Second Visit|Overall Study||5
2426717|NCT01194479|5952195|P3|Cross-over at Second Visit|Overall Study||2
2426718|NCT01194479|5952196|P2|Cross-over at Second Visit|Overall Study||4
2426719|NCT01194479|5952197|P1|Cross-over at Second Visit|Overall Study||3
2426720|NCT01194479|5952194|P4|STARTED|Overall Study||5
2426721|NCT01194479|5952195|P3|STARTED|Overall Study||2
2426722|NCT01194479|5952196|P2|STARTED|Overall Study||4
2426723|NCT01194479|5952197|P1|STARTED|Overall Study||3
2426724|NCT01194466|5952219|P3|NOT COMPLETED|Overall Study||0
2426725|NCT01194466|5952220|P2|NOT COMPLETED|Overall Study||0
2426726|NCT01194466|5952221|P1|NOT COMPLETED|Overall Study||0
2426727|NCT01194466|5952219|P3|COMPLETED|Overall Study||13
2426728|NCT01194466|5952220|P2|COMPLETED|Overall Study||14
2426729|NCT01194466|5952221|P1|COMPLETED|Overall Study||14
2426730|NCT01194466|5952219|P3|STARTED|Overall Study||13
2426731|NCT01194466|5952220|P2|STARTED|Overall Study||14
2426732|NCT01194466|5952221|P1|STARTED|Overall Study||14
2426733|NCT01194453|5952231|P2|NOT COMPLETED|Overall Study||17
2426734|NCT01194453|5952232|P1|NOT COMPLETED|Overall Study||17
2426735|NCT01194453|5952231|P2|COMPLETED|Overall Study||127
2426736|NCT01194453|5952232|P1|COMPLETED|Overall Study||127
2426737|NCT01194453|5952231|P2|STARTED|Overall Study||144
2426738|NCT01194453|5952232|P1|STARTED|Overall Study||144
2426739|NCT01194440|5952240|P1|NOT COMPLETED|6-months (2nd Dose)||4
2426740|NCT01194440|5952240|P1|COMPLETED|6-months (2nd Dose)||48
2426741|NCT01194440|5952240|P1|STARTED|6-months (2nd Dose)||52
2426742|NCT01194440|5952240|P1|NOT COMPLETED|Baseline (First Dose)||7
2426743|NCT01194440|5952240|P1|COMPLETED|Baseline (First Dose)||52
2426744|NCT01194440|5952240|P1|STARTED|Baseline (First Dose)||59
2426745|NCT01194427|5952247|P1|NOT COMPLETED|Overall Study||0
2426746|NCT01194427|5952247|P1|COMPLETED|Overall Study||2
2426747|NCT01194427|5952247|P1|STARTED|Overall Study||2
2426748|NCT01194414|5952253|P4|NOT COMPLETED|72 Weeks Open Label Extension||26
2426749|NCT01194414|5952254|P3|NOT COMPLETED|72 Weeks Open Label Extension||8
2426750|NCT01194414|5952255|P2|NOT COMPLETED|72 Weeks Open Label Extension||66
2426751|NCT01194414|5952256|P1|NOT COMPLETED|72 Weeks Open Label Extension||79
2426752|NCT01194414|5952253|P4|COMPLETED|72 Weeks Open Label Extension||160
2426753|NCT01194414|5952254|P3|COMPLETED|72 Weeks Open Label Extension||40
2426754|NCT01194414|5952255|P2|COMPLETED|72 Weeks Open Label Extension||311
2426755|NCT01194414|5952256|P1|COMPLETED|72 Weeks Open Label Extension||445
2426756|NCT01194414|5952253|P4|STARTED|72 Weeks Open Label Extension||186
2426757|NCT01194414|5952254|P3|STARTED|72 Weeks Open Label Extension||48
2426758|NCT01194414|5952255|P2|STARTED|72 Weeks Open Label Extension||377
2426759|NCT01194414|5952256|P1|STARTED|72 Weeks Open Label Extension||524
2426760|NCT01194414|5952253|P4|NOT COMPLETED|24 Weeks Double Blind Period||0
2426761|NCT01194414|5952254|P3|NOT COMPLETED|24 Weeks Double Blind Period||0
2426762|NCT01194414|5952255|P2|NOT COMPLETED|24 Weeks Double Blind Period||67
2426763|NCT01194414|5952256|P1|NOT COMPLETED|24 Weeks Double Blind Period||59
2426764|NCT01194414|5952253|P4|COMPLETED|24 Weeks Double Blind Period||0
2426765|NCT01194414|5952254|P3|COMPLETED|24 Weeks Double Blind Period||0
2426766|NCT01194414|5952255|P2|COMPLETED|24 Weeks Double Blind Period||564
2426767|NCT01194414|5952256|P1|COMPLETED|24 Weeks Double Blind Period||572
2426768|NCT01194414|5952253|P4|Per Protocol Population|24 Weeks Double Blind Period||0
2426769|NCT01194414|5952254|P3|Per Protocol Population|24 Weeks Double Blind Period||0
2426770|NCT01194414|5952255|P2|Per Protocol Population|24 Weeks Double Blind Period||537
2426771|NCT01194414|5952256|P1|Per Protocol Population|24 Weeks Double Blind Period||558
2426772|NCT01194414|5952253|P4|STARTED|24 Weeks Double Blind Period||0
2426773|NCT01194414|5952254|P3|STARTED|24 Weeks Double Blind Period||0
2426774|NCT01194414|5952255|P2|STARTED|24 Weeks Double Blind Period||631
2426775|NCT01194414|5952256|P1|STARTED|24 Weeks Double Blind Period||631
2426776|NCT01194297|5952318|P2|NOT COMPLETED|Overall Study||0
2426777|NCT01194297|5952319|P1|NOT COMPLETED|Overall Study||0
2426778|NCT01194297|5952318|P2|COMPLETED|Overall Study||1
2426779|NCT01194297|5952319|P1|COMPLETED|Overall Study||2
2426780|NCT01194297|5952318|P2|STARTED|Overall Study||1
2426781|NCT01194297|5952319|P1|STARTED|Overall Study||2
2426782|NCT01194258|5952327|P5|NOT COMPLETED|Period 2 (12 Weeks)||2
2426783|NCT01194258|5952328|P4|NOT COMPLETED|Period 2 (12 Weeks)||0
2426784|NCT01194258|5952329|P3|NOT COMPLETED|Period 2 (12 Weeks)||1
2426785|NCT01194258|5952330|P2|NOT COMPLETED|Period 2 (12 Weeks)||2
2426786|NCT01194258|5952331|P1|NOT COMPLETED|Period 2 (12 Weeks)||0
2426787|NCT01194258|5952327|P5|COMPLETED|Period 2 (12 Weeks)||30
2426788|NCT01194258|5952328|P4|COMPLETED|Period 2 (12 Weeks)||29
2426789|NCT01194258|5952329|P3|COMPLETED|Period 2 (12 Weeks)||29
2426790|NCT01194258|5952330|P2|COMPLETED|Period 2 (12 Weeks)||27
2426791|NCT01194258|5952331|P1|COMPLETED|Period 2 (12 Weeks)||0
2426792|NCT01194258|5952327|P5|STARTED|Period 2 (12 Weeks)||32
2426793|NCT01194258|5952328|P4|STARTED|Period 2 (12 Weeks)||29
2426794|NCT01194258|5952329|P3|STARTED|Period 2 (12 Weeks)||30
2426795|NCT01194258|5952330|P2|STARTED|Period 2 (12 Weeks)||29
2426796|NCT01194258|5952331|P1|STARTED|Period 2 (12 Weeks)||0
2426797|NCT01194258|5952327|P5|NOT COMPLETED|Period 1 (12 Weeks)||1
2426798|NCT01194258|5952328|P4|NOT COMPLETED|Period 1 (12 Weeks)||0
2426799|NCT01194258|5952329|P3|NOT COMPLETED|Period 1 (12 Weeks)||0
2426800|NCT01194258|5952330|P2|NOT COMPLETED|Period 1 (12 Weeks)||0
2426801|NCT01194258|5952331|P1|NOT COMPLETED|Period 1 (12 Weeks)||0
2426802|NCT01194258|5952327|P5|COMPLETED|Period 1 (12 Weeks)||32
2426803|NCT01194258|5952328|P4|COMPLETED|Period 1 (12 Weeks)||29
2426804|NCT01194258|5952329|P3|COMPLETED|Period 1 (12 Weeks)||30
2426805|NCT01194258|5952330|P2|COMPLETED|Period 1 (12 Weeks)||29
2426806|NCT01194258|5952331|P1|COMPLETED|Period 1 (12 Weeks)||0
2426807|NCT01194258|5952327|P5|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||33
2426808|NCT01194258|5952328|P4|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
2426809|NCT01194258|5952329|P3|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||30
2426810|NCT01194258|5952330|P2|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
2426811|NCT01194258|5952331|P1|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||0
2426812|NCT01194258|5952327|P5|STARTED|Period 1 (12 Weeks)|After the titration phase, 33 participants were randomized to the Aspart-PH20/Insulin lispro group.|33
2426813|NCT01194258|5952328|P4|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Aspart-PH20 group.|29
2426814|NCT01194258|5952329|P3|STARTED|Period 1 (12 Weeks)|After the titration phase, 30 participants were randomized to the Lispro-PH20/Insulin lispro group.|30
2426815|NCT01194258|5952330|P2|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Lispro-PH20 group.|29
2426816|NCT01194258|5952331|P1|STARTED|Period 1 (12 Weeks)|Participants were randomized to the Insulin lispro or an Analog-PH20 group after titration.|0
2426817|NCT01194258|5952327|P5|NOT COMPLETED|Titration Period||0
2426818|NCT01194258|5952328|P4|NOT COMPLETED|Titration Period||0
2426819|NCT01194258|5952329|P3|NOT COMPLETED|Titration Period||0
2426820|NCT01194258|5952330|P2|NOT COMPLETED|Titration Period||0
2426821|NCT01194258|5952331|P1|NOT COMPLETED|Titration Period||11
2426822|NCT01194258|5952327|P5|COMPLETED|Titration Period||0
2426823|NCT01194258|5952328|P4|COMPLETED|Titration Period||0
2426824|NCT01194258|5952329|P3|COMPLETED|Titration Period||0
2426825|NCT01194258|5952330|P2|COMPLETED|Titration Period||0
2426826|NCT01194258|5952331|P1|COMPLETED|Titration Period||121
2426827|NCT01194258|5952327|P5|STARTED|Titration Period||0
2426828|NCT01194258|5952328|P4|STARTED|Titration Period||0
2426829|NCT01194258|5952329|P3|STARTED|Titration Period||0
2426830|NCT01194258|5952330|P2|STARTED|Titration Period||0
2426831|NCT01194258|5952331|P1|STARTED|Titration Period||132
2426832|NCT01194245|5952355|P5|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
2426833|NCT01194245|5952356|P4|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
2426834|NCT01194245|5952357|P3|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
2426835|NCT01194245|5952358|P2|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
2426836|NCT01194245|5952359|P1|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
2426837|NCT01194245|5952355|P5|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||28
2426838|NCT01194245|5952356|P4|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
2426839|NCT01194245|5952357|P3|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||27
2426840|NCT01194245|5952358|P2|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
2426841|NCT01194245|5952359|P1|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
2426842|NCT01194245|5952355|P5|STARTED|Treatment Period 2 (Weeks 12 to 24)||28
2426843|NCT01194245|5952356|P4|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
2426844|NCT01194245|5952357|P3|STARTED|Treatment Period 2 (Weeks 12 to 24)||27
2426845|NCT01194245|5952358|P2|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
2426846|NCT01194245|5952359|P1|STARTED|Treatment Period 2 (Weeks 12 to 24)||0
2426847|NCT01194245|5952355|P5|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||2
2426848|NCT01194245|5952356|P4|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
2426849|NCT01194245|5952357|P3|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
2426850|NCT01194245|5952358|P2|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
2426851|NCT01194245|5952359|P1|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
2426852|NCT01194245|5952355|P5|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||28
2426853|NCT01194245|5952356|P4|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
2426854|NCT01194245|5952357|P3|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||27
2426855|NCT01194245|5952358|P2|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
2426856|NCT01194245|5952359|P1|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
2426857|NCT01194245|5952355|P5|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
2426858|NCT01194245|5952356|P4|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
2426859|NCT01194245|5952357|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||28
2426860|NCT01194245|5952358|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||29
2426861|NCT01194245|5952359|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||0
2426862|NCT01194245|5952355|P5|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
2426863|NCT01194245|5952356|P4|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
2426864|NCT01194245|5952357|P3|STARTED|Treatment Period 1 (Weeks 0 to 12)||28
2426865|NCT01194245|5952358|P2|STARTED|Treatment Period 1 (Weeks 0 to 12)||29
2426866|NCT01194245|5952359|P1|STARTED|Treatment Period 1 (Weeks 0 to 12)||0
2426867|NCT01194245|5952355|P5|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
2426868|NCT01194245|5952356|P4|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
2426869|NCT01194245|5952357|P3|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
2426870|NCT01194245|5952358|P2|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
2426871|NCT01194245|5952359|P1|NOT COMPLETED|Titration Period (4 to 6 Weeks)||18
2426872|NCT01194245|5952355|P5|COMPLETED|Titration Period (4 to 6 Weeks)||0
2426873|NCT01194245|5952356|P4|COMPLETED|Titration Period (4 to 6 Weeks)||0
2426874|NCT01194245|5952357|P3|COMPLETED|Titration Period (4 to 6 Weeks)||0
2426875|NCT01194245|5952358|P2|COMPLETED|Titration Period (4 to 6 Weeks)||0
2426876|NCT01194245|5952359|P1|COMPLETED|Titration Period (4 to 6 Weeks)|Participants that completed the Titration Period were randomized to Treatment Period 1.|117
2426877|NCT01194245|5952355|P5|STARTED|Titration Period (4 to 6 Weeks)||0
2426878|NCT01194245|5952356|P4|STARTED|Titration Period (4 to 6 Weeks)||0
2426879|NCT01194245|5952357|P3|STARTED|Titration Period (4 to 6 Weeks)||0
2426880|NCT01194245|5952358|P2|STARTED|Titration Period (4 to 6 Weeks)||0
2426881|NCT01194245|5952359|P1|STARTED|Titration Period (4 to 6 Weeks)||135
2426882|NCT01194219|5952380|P10|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||112
2426883|NCT01194219|5952381|P9|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||220
2426884|NCT01194219|5952382|P8|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
2426885|NCT01194219|5952383|P7|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
2426886|NCT01194219|5952384|P6|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
2426887|NCT01194219|5952385|P5|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
2426888|NCT01194219|5952386|P4|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
2426889|NCT01194219|5952387|P3|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
2426890|NCT01194219|5952388|P2|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
2426891|NCT01194219|5952389|P1|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
2426892|NCT01194219|5952380|P10|COMPLETED|Long-Term Extension Weeks 52 to 260||41
2426893|NCT01194219|5952381|P9|COMPLETED|Long-Term Extension Weeks 52 to 260||86
2426894|NCT01194219|5952382|P8|COMPLETED|Long-Term Extension Weeks 52 to 260||0
2426895|NCT01194219|5952383|P7|COMPLETED|Long-Term Extension Weeks 52 to 260||0
2426896|NCT01194219|5952384|P6|COMPLETED|Long-Term Extension Weeks 52 to 260||0
2426897|NCT01194219|5952385|P5|COMPLETED|Long-Term Extension Weeks 52 to 260||0
2426898|NCT01194219|5952386|P4|COMPLETED|Long-Term Extension Weeks 52 to 260||0
2426899|NCT01194219|5952387|P3|COMPLETED|Long-Term Extension Weeks 52 to 260||0
2426900|NCT01194219|5952388|P2|COMPLETED|Long-Term Extension Weeks 52 to 260||0
2426901|NCT01194219|5952389|P1|COMPLETED|Long-Term Extension Weeks 52 to 260||0
2426902|NCT01194219|5952380|P10|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||153
2426903|NCT01194219|5952381|P9|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||304
2426904|NCT01194219|5952382|P8|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
2426905|NCT01194219|5952383|P7|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
2426906|NCT01194219|5952384|P6|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
2426907|NCT01194219|5952385|P5|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
2426908|NCT01194219|5952386|P4|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
2426909|NCT01194219|5952387|P3|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
2426910|NCT01194219|5952388|P2|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
2426911|NCT01194219|5952389|P1|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
2426912|NCT01194219|5952380|P10|STARTED|Long-Term Extension Weeks 52 to 260||153
2426913|NCT01194219|5952381|P9|STARTED|Long-Term Extension Weeks 52 to 260||306
2426914|NCT01194219|5952382|P8|STARTED|Long-Term Extension Weeks 52 to 260||0
2426915|NCT01194219|5952383|P7|STARTED|Long-Term Extension Weeks 52 to 260||0
2426916|NCT01194219|5952384|P6|STARTED|Long-Term Extension Weeks 52 to 260||0
2426917|NCT01194219|5952385|P5|STARTED|Long-Term Extension Weeks 52 to 260||0
2426918|NCT01194219|5952386|P4|STARTED|Long-Term Extension Weeks 52 to 260||0
2426919|NCT01194219|5952387|P3|STARTED|Long-Term Extension Weeks 52 to 260||0
2426920|NCT01194219|5952388|P2|STARTED|Long-Term Extension Weeks 52 to 260||0
2426921|NCT01194219|5952389|P1|STARTED|Long-Term Extension Weeks 52 to 260||0
2426922|NCT01194219|5952380|P10|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
2426923|NCT01194219|5952381|P9|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
2426924|NCT01194219|5952382|P8|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||45
2426925|NCT01194219|5952383|P7|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||61
2426926|NCT01194219|5952384|P6|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4
2426927|NCT01194219|5952385|P5|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4
2426928|NCT01194219|5952386|P4|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
2426929|NCT01194219|5952387|P3|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
2426930|NCT01194219|5952388|P2|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
2426931|NCT01194219|5952389|P1|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
2426932|NCT01194219|5952380|P10|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
2426933|NCT01194219|5952381|P9|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
2426934|NCT01194219|5952382|P8|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|10 participants discontinued after Week 52 but prior to entry into the long term extension study|163
2426935|NCT01194219|5952383|P7|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|18 participants discontinued after Week 52 but prior to entry into the long term extension study|184
2426936|NCT01194219|5952384|P6|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|5 participants discontinued after Week 52 but prior to entry into the long term extension study|73
2426937|NCT01194219|5952385|P5|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|1 participant discontinued after Week 52 but prior to entry into the long term extension study|73
2426938|NCT01194219|5952386|P4|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
2426939|NCT01194219|5952387|P3|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
2426940|NCT01194219|5952388|P2|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
2426941|NCT01194219|5952389|P1|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
2426942|NCT01194219|5952380|P10|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
2426943|NCT01194219|5952381|P9|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
2426944|NCT01194219|5952382|P8|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||91
2426945|NCT01194219|5952383|P7|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||126
2426946|NCT01194219|5952384|P6|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
2426947|NCT01194219|5952385|P5|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
2426948|NCT01194219|5952386|P4|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
2426949|NCT01194219|5952387|P3|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
2426950|NCT01194219|5952388|P2|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
2426951|NCT01194219|5952389|P1|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
2426952|NCT01194219|5952380|P10|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
2426953|NCT01194219|5952381|P9|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
2426954|NCT01194219|5952382|P8|STARTED|Randomized Withdrawal Phase-Weeks 32-52||208
2426955|NCT01194219|5952383|P7|STARTED|Randomized Withdrawal Phase-Weeks 32-52||245
2426956|NCT01194219|5952384|P6|STARTED|Randomized Withdrawal Phase-Weeks 32-52|25 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
2426957|NCT01194219|5952385|P5|STARTED|Randomized Withdrawal Phase-Weeks 32-52|7 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
2426958|NCT01194219|5952386|P4|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
2426959|NCT01194219|5952387|P3|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
2426960|NCT01194219|5952388|P2|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
2426961|NCT01194219|5952389|P1|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
2426962|NCT01194219|5952380|P10|NOT COMPLETED|Maintenance Phase Weeks16-32||0
2426963|NCT01194219|5952381|P9|NOT COMPLETED|Maintenance Phase Weeks16-32||0
2426964|NCT01194219|5952382|P8|NOT COMPLETED|Maintenance Phase Weeks16-32||0
2426965|NCT01194219|5952383|P7|NOT COMPLETED|Maintenance Phase Weeks16-32||0
2426966|NCT01194219|5952384|P6|NOT COMPLETED|Maintenance Phase Weeks16-32||0
2426967|NCT01194219|5952385|P5|NOT COMPLETED|Maintenance Phase Weeks16-32||0
2426968|NCT01194219|5952386|P4|NOT COMPLETED|Maintenance Phase Weeks16-32||30
2426969|NCT01194219|5952387|P3|NOT COMPLETED|Maintenance Phase Weeks16-32||70
2426970|NCT01194219|5952388|P2|NOT COMPLETED|Maintenance Phase Weeks16-32||0
2426971|NCT01194219|5952389|P1|NOT COMPLETED|Maintenance Phase Weeks16-32||0
2426972|NCT01194219|5952380|P10|COMPLETED|Maintenance Phase Weeks16-32||0
2426973|NCT01194219|5952381|P9|COMPLETED|Maintenance Phase Weeks16-32||0
2426974|NCT01194219|5952382|P8|COMPLETED|Maintenance Phase Weeks16-32||0
2426975|NCT01194219|5952383|P7|COMPLETED|Maintenance Phase Weeks16-32||0
2426976|NCT01194219|5952384|P6|COMPLETED|Maintenance Phase Weeks16-32||0
2426977|NCT01194219|5952385|P5|COMPLETED|Maintenance Phase Weeks16-32||0
2426978|NCT01194219|5952386|P4|COMPLETED|Maintenance Phase Weeks16-32||215
2426979|NCT01194219|5952387|P3|COMPLETED|Maintenance Phase Weeks16-32||424
2426980|NCT01194219|5952388|P2|COMPLETED|Maintenance Phase Weeks16-32||0
2426981|NCT01194219|5952389|P1|COMPLETED|Maintenance Phase Weeks16-32||0
2426982|NCT01194219|5952380|P10|Received Apremilast|Maintenance Phase Weeks16-32||0
2426983|NCT01194219|5952381|P9|Received Apremilast|Maintenance Phase Weeks16-32||0
2426984|NCT01194219|5952382|P8|Received Apremilast|Maintenance Phase Weeks16-32||0
2426985|NCT01194219|5952383|P7|Received Apremilast|Maintenance Phase Weeks16-32||0
2426986|NCT01194219|5952384|P6|Received Apremilast|Maintenance Phase Weeks16-32||0
2426987|NCT01194219|5952385|P5|Received Apremilast|Maintenance Phase Weeks16-32||0
2426988|NCT01194219|5952386|P4|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|244
2426989|NCT01194219|5952387|P3|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|493
2426990|NCT01194219|5952388|P2|Received Apremilast|Maintenance Phase Weeks16-32||0
2426991|NCT01194219|5952389|P1|Received Apremilast|Maintenance Phase Weeks16-32||0
2426992|NCT01194219|5952380|P10|STARTED|Maintenance Phase Weeks16-32||0
2426993|NCT01194219|5952381|P9|STARTED|Maintenance Phase Weeks16-32||0
2426994|NCT01194219|5952382|P8|STARTED|Maintenance Phase Weeks16-32||0
2426995|NCT01194219|5952383|P7|STARTED|Maintenance Phase Weeks16-32||0
2426996|NCT01194219|5952384|P6|STARTED|Maintenance Phase Weeks16-32||0
2426997|NCT01194219|5952385|P5|STARTED|Maintenance Phase Weeks16-32||0
2426998|NCT01194219|5952386|P4|STARTED|Maintenance Phase Weeks16-32|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|245
2426999|NCT01194219|5952387|P3|STARTED|Maintenance Phase Weeks16-32|9 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|494
2427000|NCT01194219|5952388|P2|STARTED|Maintenance Phase Weeks16-32||0
2427001|NCT01194219|5952389|P1|STARTED|Maintenance Phase Weeks16-32||0
2427002|NCT01194219|5952380|P10|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
2427003|NCT01194219|5952381|P9|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
2427004|NCT01194219|5952382|P8|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
2427005|NCT01194219|5952383|P7|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
2427006|NCT01194219|5952384|P6|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
2427007|NCT01194219|5952385|P5|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
2427008|NCT01194219|5952386|P4|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
2427009|NCT01194219|5952387|P3|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
2427010|NCT01194219|5952388|P2|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||33
2427011|NCT01194219|5952389|P1|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||59
2427012|NCT01194219|5952380|P10|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
2427013|NCT01194219|5952381|P9|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
2427014|NCT01194219|5952382|P8|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
2427015|NCT01194219|5952383|P7|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
2427016|NCT01194219|5952384|P6|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
2427017|NCT01194219|5952385|P5|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
2427018|NCT01194219|5952386|P4|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
2427019|NCT01194219|5952387|P3|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
2427020|NCT01194219|5952388|P2|COMPLETED|Placebo-Controlled Phase Weeks 0-16||249
2427021|NCT01194219|5952389|P1|COMPLETED|Placebo-Controlled Phase Weeks 0-16||503
2427022|NCT01194219|5952380|P10|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
2427023|NCT01194219|5952381|P9|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
2427024|NCT01194219|5952382|P8|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
2427025|NCT01194219|5952383|P7|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
2427026|NCT01194219|5952384|P6|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
2427027|NCT01194219|5952385|P5|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
2427028|NCT01194219|5952386|P4|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
2427029|NCT01194219|5952387|P3|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
2427030|NCT01194219|5952388|P2|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||282
2427031|NCT01194219|5952389|P1|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||560
2427032|NCT01194219|5952380|P10|STARTED|Placebo-Controlled Phase Weeks 0-16||0
2427033|NCT01194219|5952381|P9|STARTED|Placebo-Controlled Phase Weeks 0-16||0
2427034|NCT01194219|5952382|P8|STARTED|Placebo-Controlled Phase Weeks 0-16||0
2427035|NCT01194219|5952383|P7|STARTED|Placebo-Controlled Phase Weeks 0-16||0
2427036|NCT01194219|5952384|P6|STARTED|Placebo-Controlled Phase Weeks 0-16||0
2427037|NCT01194219|5952385|P5|STARTED|Placebo-Controlled Phase Weeks 0-16||0
2427038|NCT01194219|5952386|P4|STARTED|Placebo-Controlled Phase Weeks 0-16||0
2427039|NCT01194219|5952387|P3|STARTED|Placebo-Controlled Phase Weeks 0-16||0
2427040|NCT01194219|5952388|P2|STARTED|Placebo-Controlled Phase Weeks 0-16||282
2427041|NCT01194219|5952389|P1|STARTED|Placebo-Controlled Phase Weeks 0-16||562
2427042|NCT01194154|5952423|P2|NOT COMPLETED|Overall Study||33
2427043|NCT01194154|5952424|P1|NOT COMPLETED|Overall Study||49
2427044|NCT01194154|5952423|P2|COMPLETED|Overall Study||91
2427045|NCT01194154|5952424|P1|COMPLETED|Overall Study||68
2427046|NCT01194154|5952423|P2|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|117
2427047|NCT01194154|5952424|P1|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|118
2427048|NCT01194154|5952423|P2|Full Analysis Set|Overall Study||120
2427049|NCT01194154|5952424|P1|Full Analysis Set|Overall Study||115
2427050|NCT01194154|5952423|P2|STARTED|Overall Study||124
2427051|NCT01194154|5952424|P1|STARTED|Overall Study||117
2427052|NCT01194089|5952444|P2|NOT COMPLETED|Overall Study||0
2427053|NCT01194089|5952445|P1|NOT COMPLETED|Overall Study||0
2427054|NCT01194089|5952444|P2|COMPLETED|Overall Study||47
2427055|NCT01194089|5952445|P1|COMPLETED|Overall Study||42
2427056|NCT01194089|5952444|P2|STARTED|Overall Study||47
2427057|NCT01194089|5952445|P1|STARTED|Overall Study||42
2427058|NCT01193920|5952465|P10|NOT COMPLETED|Overall Study||7
2427059|NCT01193920|5952466|P9|NOT COMPLETED|Overall Study||5
2427060|NCT01193920|5952467|P8|NOT COMPLETED|Overall Study||4
2427061|NCT01193920|5952468|P7|NOT COMPLETED|Overall Study||6
2427062|NCT01193920|5952469|P6|NOT COMPLETED|Overall Study||4
2427063|NCT01193920|5952470|P5|NOT COMPLETED|Overall Study||6
2427064|NCT01193920|5952471|P4|NOT COMPLETED|Overall Study||4
2427065|NCT01193920|5952472|P3|NOT COMPLETED|Overall Study||6
2427066|NCT01193920|5952473|P2|NOT COMPLETED|Overall Study||0
2427067|NCT01193920|5952474|P1|NOT COMPLETED|Overall Study||3
2427068|NCT01193920|5952465|P10|COMPLETED|Overall Study||74
2427069|NCT01193920|5952466|P9|COMPLETED|Overall Study||71
2427070|NCT01193920|5952467|P8|COMPLETED|Overall Study||76
2427071|NCT01193920|5952468|P7|COMPLETED|Overall Study||74
2427072|NCT01193920|5952469|P6|COMPLETED|Overall Study||76
2427073|NCT01193920|5952470|P5|COMPLETED|Overall Study||74
2427074|NCT01193920|5952471|P4|COMPLETED|Overall Study||76
2427075|NCT01193920|5952472|P3|COMPLETED|Overall Study||74
2427076|NCT01193920|5952473|P2|COMPLETED|Overall Study||20
2427077|NCT01193920|5952474|P1|COMPLETED|Overall Study||37
2427078|NCT01193920|5952465|P10|STARTED|Overall Study||81
2427079|NCT01193920|5952466|P9|STARTED|Overall Study||76
2427080|NCT01193920|5952467|P8|STARTED|Overall Study||80
2427081|NCT01193920|5952468|P7|STARTED|Overall Study||80
2427082|NCT01193920|5952469|P6|STARTED|Overall Study||80
2427083|NCT01193920|5952470|P5|STARTED|Overall Study||80
2427084|NCT01193920|5952471|P4|STARTED|Overall Study||80
2427085|NCT01193920|5952472|P3|STARTED|Overall Study||80
2427086|NCT01193920|5952473|P2|STARTED|Overall Study||20
2427087|NCT01193920|5952474|P1|STARTED|Overall Study||40
2427088|NCT01193907|5952528|P4|NOT COMPLETED|Overall Study||1
2427089|NCT01193907|5952529|P3|NOT COMPLETED|Overall Study||0
2427090|NCT01193907|5952530|P2|NOT COMPLETED|Overall Study||0
2427091|NCT01193907|5952531|P1|NOT COMPLETED|Overall Study||1
2427092|NCT01193907|5952528|P4|COMPLETED|Overall Study||21
2427093|NCT01193907|5952529|P3|COMPLETED|Overall Study||22
2427094|NCT01193907|5952530|P2|COMPLETED|Overall Study||22
2427095|NCT01193907|5952531|P1|COMPLETED|Overall Study||21
2427096|NCT01193907|5952528|P4|STARTED|Overall Study||22
2427097|NCT01193907|5952529|P3|STARTED|Overall Study||22
2427098|NCT01193907|5952530|P2|STARTED|Overall Study||22
2427099|NCT01193907|5952531|P1|STARTED|Overall Study||22
2427100|NCT01193868|5952553|P1|NOT COMPLETED|Overall Study||0
2427101|NCT01193868|5952553|P1|COMPLETED|Overall Study||6
2427102|NCT01193868|5952553|P1|STARTED|Overall Study||6
2427103|NCT01193842|5952570|P5|NOT COMPLETED|Phase II: Randomized Groups||10
2427104|NCT01193842|5952571|P4|NOT COMPLETED|Phase II: Randomized Groups||12
2427105|NCT01193842|5952572|P3|NOT COMPLETED|Phase II: Randomized Groups||0
2427106|NCT01193842|5952573|P2|NOT COMPLETED|Phase II: Randomized Groups||0
2427107|NCT01193842|5952574|P1|NOT COMPLETED|Phase II: Randomized Groups||0
2427108|NCT01193842|5952570|P5|COMPLETED|Phase II: Randomized Groups||36
2427109|NCT01193842|5952571|P4|COMPLETED|Phase II: Randomized Groups||33
2427110|NCT01193842|5952572|P3|COMPLETED|Phase II: Randomized Groups||0
2427111|NCT01193842|5952573|P2|COMPLETED|Phase II: Randomized Groups||0
2427112|NCT01193842|5952574|P1|COMPLETED|Phase II: Randomized Groups||0
2427113|NCT01193842|5952570|P5|STARTED|Phase II: Randomized Groups||46
2427114|NCT01193842|5952571|P4|STARTED|Phase II: Randomized Groups||45
2427115|NCT01193842|5952572|P3|STARTED|Phase II: Randomized Groups||0
2427116|NCT01193842|5952573|P2|STARTED|Phase II: Randomized Groups||0
2427117|NCT01193842|5952574|P1|STARTED|Phase II: Randomized Groups||0
2427118|NCT01193842|5952570|P5|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
2427119|NCT01193842|5952571|P4|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
2427120|NCT01193842|5952572|P3|NOT COMPLETED|Phase I: VR-CHOP, DL 1||1
2427121|NCT01193842|5952573|P2|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
2427122|NCT01193842|5952574|P1|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
2427123|NCT01193842|5952570|P5|COMPLETED|Phase I: VR-CHOP, DL 1||0
2427124|NCT01193842|5952571|P4|COMPLETED|Phase I: VR-CHOP, DL 1||0
2427125|NCT01193842|5952572|P3|COMPLETED|Phase I: VR-CHOP, DL 1||1
2427126|NCT01193842|5952573|P2|COMPLETED|Phase I: VR-CHOP, DL 1||0
2427127|NCT01193842|5952574|P1|COMPLETED|Phase I: VR-CHOP, DL 1||0
2427128|NCT01193842|5952570|P5|STARTED|Phase I: VR-CHOP, DL 1||0
2427129|NCT01193842|5952571|P4|STARTED|Phase I: VR-CHOP, DL 1||0
2427130|NCT01193842|5952572|P3|STARTED|Phase I: VR-CHOP, DL 1||2
2427131|NCT01193842|5952573|P2|STARTED|Phase I: VR-CHOP, DL 1||0
2427132|NCT01193842|5952574|P1|STARTED|Phase I: VR-CHOP, DL 1||0
2427133|NCT01193842|5952570|P5|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
2427134|NCT01193842|5952571|P4|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
2427135|NCT01193842|5952572|P3|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
2427136|NCT01193842|5952573|P2|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
2427137|NCT01193842|5952574|P1|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||1
2427138|NCT01193842|5952570|P5|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
2427139|NCT01193842|5952571|P4|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
2427140|NCT01193842|5952572|P3|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
2427141|NCT01193842|5952573|P2|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
2427142|NCT01193842|5952574|P1|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||3
2427143|NCT01193842|5952570|P5|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
2427144|NCT01193842|5952571|P4|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
2427145|NCT01193842|5952572|P3|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
2427146|NCT01193842|5952573|P2|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
2427147|NCT01193842|5952574|P1|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||4
2427148|NCT01193842|5952570|P5|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
2427149|NCT01193842|5952571|P4|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
2427150|NCT01193842|5952572|P3|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
2427151|NCT01193842|5952573|P2|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||1
2427152|NCT01193842|5952574|P1|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
2427153|NCT01193842|5952570|P5|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
2427154|NCT01193842|5952571|P4|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
2427155|NCT01193842|5952572|P3|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
2427156|NCT01193842|5952573|P2|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||6
2427157|NCT01193842|5952574|P1|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
2427158|NCT01193842|5952570|P5|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
2427159|NCT01193842|5952571|P4|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
2427160|NCT01193842|5952572|P3|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
2427161|NCT01193842|5952573|P2|STARTED|Phase I: VR-DA-EPOCH, DL 2||7
2427162|NCT01193842|5952574|P1|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
2427163|NCT01193842|5952570|P5|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
2427164|NCT01193842|5952571|P4|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
2427165|NCT01193842|5952572|P3|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
2427166|NCT01193842|5952573|P2|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
2427167|NCT01193842|5952574|P1|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
2427168|NCT01193842|5952570|P5|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
2427169|NCT01193842|5952571|P4|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
2427170|NCT01193842|5952572|P3|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
2427171|NCT01193842|5952573|P2|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
2427172|NCT01193842|5952574|P1|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3
2427173|NCT01193842|5952570|P5|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
2427174|NCT01193842|5952571|P4|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
2427175|NCT01193842|5952572|P3|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
2427176|NCT01193842|5952573|P2|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
2427177|NCT01193842|5952574|P1|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3
2427178|NCT01193686|5952609|P2|NOT COMPLETED|Overall Study||1
2427179|NCT01193686|5952610|P1|NOT COMPLETED|Overall Study||7
2427180|NCT01193686|5952609|P2|COMPLETED|Overall Study||8
2427181|NCT01193686|5952610|P1|COMPLETED|Overall Study||8
2427182|NCT01193686|5952609|P2|Completed Visits and Final Assessment|Overall Study||8
2427183|NCT01193686|5952610|P1|Completed Visits and Final Assessment|Overall Study||8
2427184|NCT01193686|5952609|P2|Completed Mentor Training|Overall Study|Not applicable. Recipients were not required to complete training.|0
2427185|NCT01193686|5952610|P1|Completed Mentor Training|Overall Study||9
2427186|NCT01193686|5952609|P2|Completed Baseline Assessment|Overall Study||9
2427187|NCT01193686|5952610|P1|Completed Baseline Assessment|Overall Study||15
2427188|NCT01193686|5952609|P2|STARTED|Overall Study||9
2427189|NCT01193686|5952610|P1|STARTED|Overall Study||15
2427190|NCT01193660|5952627|P3|NOT COMPLETED|Overall Study||2
2427191|NCT01193660|5952628|P2|NOT COMPLETED|Overall Study||3
2427192|NCT01193660|5952629|P1|NOT COMPLETED|Overall Study||4
2427193|NCT01193660|5952627|P3|COMPLETED|Overall Study||32
2427194|NCT01193660|5952628|P2|COMPLETED|Overall Study||33
2427195|NCT01193660|5952629|P1|COMPLETED|Overall Study||31
2427196|NCT01193660|5952627|P3|STARTED|Overall Study||34
2427197|NCT01193660|5952628|P2|STARTED|Overall Study||36
2427198|NCT01193660|5952629|P1|STARTED|Overall Study||35
2427199|NCT01193608|5952673|P6|NOT COMPLETED|Overall Study||2
2427200|NCT01193608|5952674|P5|NOT COMPLETED|Overall Study||5
2427201|NCT01193608|5952675|P4|NOT COMPLETED|Overall Study||3
2427202|NCT01193608|5952676|P3|NOT COMPLETED|Overall Study||2
2427203|NCT01193608|5952677|P2|NOT COMPLETED|Overall Study||2
2427204|NCT01193608|5952678|P1|NOT COMPLETED|Overall Study||0
2427205|NCT01193608|5952673|P6|COMPLETED|Overall Study||17
2427206|NCT01193608|5952674|P5|COMPLETED|Overall Study||19
2427207|NCT01193608|5952675|P4|COMPLETED|Overall Study||14
2427208|NCT01193608|5952676|P3|COMPLETED|Overall Study||14
2427209|NCT01193608|5952677|P2|COMPLETED|Overall Study||4
2427210|NCT01193608|5952678|P1|COMPLETED|Overall Study||6
2427211|NCT01193608|5952673|P6|STARTED|Overall Study||19
2427212|NCT01193608|5952674|P5|STARTED|Overall Study||24
2427213|NCT01193608|5952675|P4|STARTED|Overall Study||17
2427214|NCT01193608|5952676|P3|STARTED|Overall Study||16
2427215|NCT01193608|5952677|P2|STARTED|Overall Study||6
2427216|NCT01193608|5952678|P1|STARTED|Overall Study||6
2427217|NCT01193582|5952915|P4|NOT COMPLETED|12 Month Follow-up||11
2427218|NCT01193582|5952916|P3|NOT COMPLETED|12 Month Follow-up||4
2427219|NCT01193582|5952917|P2|NOT COMPLETED|12 Month Follow-up||0
2427220|NCT01193582|5952918|P1|NOT COMPLETED|12 Month Follow-up||6
2427221|NCT01193582|5952915|P4|COMPLETED|12 Month Follow-up||166
2427222|NCT01193582|5952916|P3|COMPLETED|12 Month Follow-up||113
2427223|NCT01193582|5952917|P2|COMPLETED|12 Month Follow-up||88
2427224|NCT01193582|5952918|P1|COMPLETED|12 Month Follow-up||83
2427225|NCT01193582|5952915|P4|STARTED|12 Month Follow-up||177
2427226|NCT01193582|5952916|P3|STARTED|12 Month Follow-up||117
2427227|NCT01193582|5952917|P2|STARTED|12 Month Follow-up||88
2427228|NCT01193582|5952918|P1|STARTED|12 Month Follow-up||89
2427229|NCT01193582|5952915|P4|NOT COMPLETED|Vaccination Series||3
2427230|NCT01193582|5952916|P3|NOT COMPLETED|Vaccination Series||8
2427231|NCT01193582|5952917|P2|NOT COMPLETED|Vaccination Series||13
2427232|NCT01193582|5952918|P1|NOT COMPLETED|Vaccination Series||11
2427233|NCT01193582|5952915|P4|COMPLETED|Vaccination Series||177
2427234|NCT01193582|5952916|P3|COMPLETED|Vaccination Series||117
2427235|NCT01193582|5952917|P2|COMPLETED|Vaccination Series||88
2427236|NCT01193582|5952918|P1|COMPLETED|Vaccination Series||89
2427237|NCT01193582|5952915|P4|Vaccinated Dose 4|Vaccination Series||0
2427238|NCT01193582|5952916|P3|Vaccinated Dose 4|Vaccination Series||0
2427239|NCT01193582|5952917|P2|Vaccinated Dose 4|Vaccination Series||0
2427240|NCT01193582|5952918|P1|Vaccinated Dose 4|Vaccination Series||90
2427241|NCT01193582|5952915|P4|Vaccinated Dose 3|Vaccination Series||0
2427242|NCT01193582|5952916|P3|Vaccinated Dose 3|Vaccination Series||0
2427243|NCT01193582|5952917|P2|Vaccinated Dose 3|Vaccination Series||89
2427244|NCT01193582|5952918|P1|Vaccinated Dose 3|Vaccination Series||90
2427245|NCT01193582|5952915|P4|Vaccinated Dose 2|Vaccination Series||0
2427246|NCT01193582|5952916|P3|Vaccinated Dose 2|Vaccination Series||118
2427247|NCT01193582|5952917|P2|Vaccinated Dose 2|Vaccination Series||91
2427248|NCT01193582|5952918|P1|Vaccinated Dose 2|Vaccination Series||92
2427249|NCT01193582|5952915|P4|Vaccinated Dose 1|Vaccination Series||180
2427250|NCT01193582|5952916|P3|Vaccinated Dose 1|Vaccination Series||125
2427251|NCT01193582|5952917|P2|Vaccinated Dose 1|Vaccination Series||100
2427252|NCT01193582|5952918|P1|Vaccinated Dose 1|Vaccination Series||100
2427253|NCT01193582|5952915|P4|STARTED|Vaccination Series||180
2427254|NCT01193582|5952916|P3|STARTED|Vaccination Series||125
2427255|NCT01193582|5952917|P2|STARTED|Vaccination Series||101
2427256|NCT01193582|5952918|P1|STARTED|Vaccination Series||100
2427257|NCT01193556|5952948|P2|NOT COMPLETED|Overall Study||25
2427258|NCT01193556|5952949|P1|NOT COMPLETED|Overall Study||26
2427259|NCT01193556|5952948|P2|COMPLETED|Overall Study||0
2427260|NCT01193556|5952949|P1|COMPLETED|Overall Study||0
2427261|NCT01193556|5952948|P2|STARTED|Overall Study||25
2427262|NCT01193556|5952949|P1|STARTED|Overall Study||26
2427263|NCT01193530|5952959|P2|NOT COMPLETED|Overall Study||5
2427264|NCT01193530|5952960|P1|NOT COMPLETED|Overall Study||3
2427265|NCT01193530|5952959|P2|COMPLETED|Overall Study||3
2427266|NCT01193530|5952960|P1|COMPLETED|Overall Study||1
2427267|NCT01193530|5952959|P2|STARTED|Overall Study||8
2427268|NCT01193530|5952960|P1|STARTED|Overall Study||4
2427269|NCT01193348|5952966|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||2
2427270|NCT01193348|5952966|P1|COMPLETED|Post Treatment Period (Patients Who Disc||8
2427271|NCT01193348|5952966|P1|STARTED|Post Treatment Period (Patients Who Disc||10
2427272|NCT01193348|5952966|P1|NOT COMPLETED|Extension Treatment Period||1
2427273|NCT01193348|5952966|P1|COMPLETED|Extension Treatment Period||16
2427274|NCT01193348|5952966|P1|STARTED|Extension Treatment Period||17
2427275|NCT01193348|5952966|P1|NOT COMPLETED|Treatment Period (26 Weeks)||3
2427276|NCT01193348|5952966|P1|COMPLETED|Treatment Period (26 Weeks)||19
2427277|NCT01193348|5952966|P1|STARTED|Treatment Period (26 Weeks)||22
2427278|NCT01193348|5952966|P1|NOT COMPLETED|Screening Period||5
2427279|NCT01193348|5952966|P1|COMPLETED|Screening Period||22
2427280|NCT01193348|5952966|P1|STARTED|Screening Period||27
2427281|NCT01193335|5952986|P2|NOT COMPLETED|2-Year Follow-up||8
2427282|NCT01193335|5952987|P1|NOT COMPLETED|2-Year Follow-up||7
2427283|NCT01193335|5952986|P2|COMPLETED|2-Year Follow-up||80
2427284|NCT01193335|5952987|P1|COMPLETED|2-Year Follow-up||81
2427285|NCT01193335|5952986|P2|STARTED|2-Year Follow-up||88
2427286|NCT01193335|5952987|P1|STARTED|2-Year Follow-up||88
2427287|NCT01193335|5952986|P2|NOT COMPLETED|1-Year Follow-up||9
2427288|NCT01193335|5952987|P1|NOT COMPLETED|1-Year Follow-up||11
2427289|NCT01193335|5952986|P2|COMPLETED|1-Year Follow-up||88
2427290|NCT01193335|5952987|P1|COMPLETED|1-Year Follow-up||88
2427291|NCT01193335|5952986|P2|STARTED|1-Year Follow-up||97
2427292|NCT01193335|5952987|P1|STARTED|1-Year Follow-up||99
2427293|NCT01193335|5952986|P2|NOT COMPLETED|Toddler Dose||0
2427294|NCT01193335|5952987|P1|NOT COMPLETED|Toddler Dose||0
2427295|NCT01193335|5952986|P2|COMPLETED|Toddler Dose||97
2427296|NCT01193335|5952987|P1|COMPLETED|Toddler Dose||99
2427297|NCT01193335|5952986|P2|STARTED|Toddler Dose||97
2427298|NCT01193335|5952987|P1|STARTED|Toddler Dose||99
2427299|NCT01193335|5952986|P2|NOT COMPLETED|After Infant Series||3
2427300|NCT01193335|5952987|P1|NOT COMPLETED|After Infant Series||1
2427301|NCT01193335|5952986|P2|COMPLETED|After Infant Series||97
2427302|NCT01193335|5952987|P1|COMPLETED|After Infant Series||99
2427303|NCT01193335|5952986|P2|STARTED|After Infant Series||100
2427304|NCT01193335|5952987|P1|STARTED|After Infant Series||100
2427305|NCT01193335|5952986|P2|NOT COMPLETED|Infant Series||0
2427306|NCT01193335|5952987|P1|NOT COMPLETED|Infant Series||0
2427307|NCT01193335|5952986|P2|COMPLETED|Infant Series||100
2427308|NCT01193335|5952987|P1|COMPLETED|Infant Series||100
2427309|NCT01193335|5952986|P2|STARTED|Infant Series||100
2427310|NCT01193335|5952987|P1|STARTED|Infant Series||100
2427311|NCT01193283|5953082|P1|NOT COMPLETED|Overall Study||1
2427312|NCT01193283|5953082|P1|COMPLETED|Overall Study||21
2427313|NCT01193283|5953082|P1|STARTED|Overall Study||22
2427314|NCT01193257|5953088|P2|NOT COMPLETED|Overall Study||734
2427315|NCT01193257|5953089|P1|NOT COMPLETED|Overall Study||365
2427316|NCT01193257|5953088|P2|COMPLETED|Overall Study||0
2427317|NCT01193257|5953089|P1|COMPLETED|Overall Study||0
2427318|NCT01193257|5953088|P2|Treated|Overall Study||732
2427319|NCT01193257|5953089|P1|Treated|Overall Study||363
2427320|NCT01193257|5953088|P2|STARTED|Overall Study||734
2427321|NCT01193257|5953089|P1|STARTED|Overall Study||365
2427322|NCT01193244|5953139|P2|NOT COMPLETED|Overall Study||390
2427323|NCT01193244|5953140|P1|NOT COMPLETED|Overall Study||388
2427324|NCT01193244|5953139|P2|COMPLETED|Overall Study||391
2427325|NCT01193244|5953140|P1|COMPLETED|Overall Study||391
2427326|NCT01193244|5953139|P2|Treated|Overall Study|Participants randomized to receive Placebo but crossed-over to receive Orteronel after unblinding.|784
2427327|NCT01193244|5953140|P1|Treated|Overall Study|Participants who continued to receive Placebo after unblinding.|770
2427328|NCT01193244|5953139|P2|STARTED|Overall Study||781
2427329|NCT01193244|5953140|P1|STARTED|Overall Study||779
2427330|NCT01193218|5953195|P8|NOT COMPLETED|12-52 Weeks||4
2427331|NCT01193218|5953196|P7|NOT COMPLETED|12-52 Weeks||3
2427332|NCT01193218|5953197|P6|NOT COMPLETED|12-52 Weeks||5
2427333|NCT01193218|5953198|P5|NOT COMPLETED|12-52 Weeks||4
2427334|NCT01193218|5953199|P4|NOT COMPLETED|12-52 Weeks||3
2427335|NCT01193218|5953200|P3|NOT COMPLETED|12-52 Weeks||4
2427336|NCT01193218|5953201|P2|NOT COMPLETED|12-52 Weeks||0
2427337|NCT01193218|5953202|P1|NOT COMPLETED|12-52 Weeks||5
2427338|NCT01193218|5953195|P8|COMPLETED|12-52 Weeks||49
2427339|NCT01193218|5953196|P7|COMPLETED|12-52 Weeks||51
2427340|NCT01193218|5953197|P6|COMPLETED|12-52 Weeks||101
2427341|NCT01193218|5953198|P5|COMPLETED|12-52 Weeks||104
2427342|NCT01193218|5953199|P4|COMPLETED|12-52 Weeks||50
2427343|NCT01193218|5953200|P3|COMPLETED|12-52 Weeks||50
2427344|NCT01193218|5953201|P2|COMPLETED|12-52 Weeks||50
2427345|NCT01193218|5953202|P1|COMPLETED|12-52 Weeks||45
2427346|NCT01193218|5953195|P8|STARTED|12-52 Weeks||53
2427347|NCT01193218|5953196|P7|STARTED|12-52 Weeks||54
2427348|NCT01193218|5953197|P6|STARTED|12-52 Weeks||106
2427349|NCT01193218|5953198|P5|STARTED|12-52 Weeks||108
2427350|NCT01193218|5953199|P4|STARTED|12-52 Weeks||53
2427351|NCT01193218|5953200|P3|STARTED|12-52 Weeks||54
2427352|NCT01193218|5953201|P2|STARTED|12-52 Weeks||50
2427353|NCT01193218|5953202|P1|STARTED|12-52 Weeks||50
2427354|NCT01193218|5953195|P8|NOT COMPLETED|0-12 Weeks||0
2427355|NCT01193218|5953196|P7|NOT COMPLETED|0-12 Weeks||3
2427356|NCT01193218|5953197|P6|NOT COMPLETED|0-12 Weeks||3
2427357|NCT01193218|5953198|P5|NOT COMPLETED|0-12 Weeks||1
2427358|NCT01193218|5953199|P4|NOT COMPLETED|0-12 Weeks||0
2427359|NCT01193218|5953200|P3|NOT COMPLETED|0-12 Weeks||3
2427360|NCT01193218|5953201|P2|NOT COMPLETED|0-12 Weeks||0
2427361|NCT01193218|5953202|P1|NOT COMPLETED|0-12 Weeks||9
2427362|NCT01193218|5953195|P8|COMPLETED|0-12 Weeks||0
2427363|NCT01193218|5953196|P7|COMPLETED|0-12 Weeks||107
2427364|NCT01193218|5953197|P6|COMPLETED|0-12 Weeks||106
2427365|NCT01193218|5953198|P5|COMPLETED|0-12 Weeks||108
2427366|NCT01193218|5953199|P4|COMPLETED|0-12 Weeks||0
2427367|NCT01193218|5953200|P3|COMPLETED|0-12 Weeks||107
2427368|NCT01193218|5953201|P2|COMPLETED|0-12 Weeks||0
2427369|NCT01193218|5953202|P1|COMPLETED|0-12 Weeks||100
2427370|NCT01193218|5953195|P8|STARTED|0-12 Weeks|It is actually N/A|0
2427371|NCT01193218|5953196|P7|STARTED|0-12 Weeks|It is actually empa 50mg group|110
2427372|NCT01193218|5953197|P6|STARTED|0-12 Weeks||109
2427373|NCT01193218|5953198|P5|STARTED|0-12 Weeks||109
2427374|NCT01193218|5953199|P4|STARTED|0-12 Weeks|It is actually N/A|0
2427375|NCT01193218|5953200|P3|STARTED|0-12 Weeks|It is actually empa 5mg group|110
2427376|NCT01193218|5953201|P2|STARTED|0-12 Weeks|It is actually N/A|0
2427377|NCT01193218|5953202|P1|STARTED|0-12 Weeks|It is actually placebo group|109
2427378|NCT01193153|5953233|P2|NOT COMPLETED|Double Blind Relapse Prevention Period||105
2427379|NCT01193153|5953234|P1|NOT COMPLETED|Double Blind Relapse Prevention Period||64
2427380|NCT01193153|5953233|P2|COMPLETED|Double Blind Relapse Prevention Period||65
2427381|NCT01193153|5953234|P1|COMPLETED|Double Blind Relapse Prevention Period||100
2427382|NCT01193153|5953233|P2|STARTED|Double Blind Relapse Prevention Period||170
2427383|NCT01193153|5953234|P1|STARTED|Double Blind Relapse Prevention Period||164
2427384|NCT01193153|5953233|P2|NOT COMPLETED|Open-label Stabilization Period||0
2427385|NCT01193153|5953234|P1|NOT COMPLETED|Open-label Stabilization Period||98
2427386|NCT01193153|5953233|P2|COMPLETED|Open-label Stabilization Period||0
2427387|NCT01193153|5953234|P1|COMPLETED|Open-label Stabilization Period||334
2427388|NCT01193153|5953233|P2|STARTED|Open-label Stabilization Period||0
2427389|NCT01193153|5953234|P1|STARTED|Open-label Stabilization Period||432
2427390|NCT01193153|5953233|P2|NOT COMPLETED|Open-label Lead in Period||0
2427391|NCT01193153|5953234|P1|NOT COMPLETED|Open-label Lead in Period||235
2427392|NCT01193153|5953233|P2|COMPLETED|Open-label Lead in Period||0
2427393|NCT01193153|5953234|P1|COMPLETED|Open-label Lead in Period||432
2427394|NCT01193153|5953233|P2|STARTED|Open-label Lead in Period||0
2427395|NCT01193153|5953234|P1|STARTED|Open-label Lead in Period||667
2427396|NCT01193127|5953269|P4|NOT COMPLETED|Treated||1
2427397|NCT01193127|5953270|P3|NOT COMPLETED|Treated||0
2427398|NCT01193127|5953271|P2|NOT COMPLETED|Treated||0
2427399|NCT01193127|5953272|P1|NOT COMPLETED|Treated||0
2427400|NCT01193127|5953269|P4|COMPLETED|Treated||55
2427401|NCT01193127|5953270|P3|COMPLETED|Treated||55
2427402|NCT01193127|5953271|P2|COMPLETED|Treated||54
2427403|NCT01193127|5953272|P1|COMPLETED|Treated||57
2427404|NCT01193127|5953269|P4|STARTED|Treated||56
2427405|NCT01193127|5953270|P3|STARTED|Treated||55
2427406|NCT01193127|5953271|P2|STARTED|Treated||54
2427407|NCT01193127|5953272|P1|STARTED|Treated||57
2427408|NCT01193127|5953269|P4|NOT COMPLETED|Randomized||1
2427409|NCT01193127|5953270|P3|NOT COMPLETED|Randomized||0
2427410|NCT01193127|5953271|P2|NOT COMPLETED|Randomized||0
2427411|NCT01193127|5953272|P1|NOT COMPLETED|Randomized||0
2427412|NCT01193127|5953269|P4|COMPLETED|Randomized||56
2427413|NCT01193127|5953270|P3|COMPLETED|Randomized||55
2427414|NCT01193127|5953271|P2|COMPLETED|Randomized||54
2427415|NCT01193127|5953272|P1|COMPLETED|Randomized||57
2427416|NCT01193127|5953269|P4|STARTED|Randomized||57
2427417|NCT01193127|5953270|P3|STARTED|Randomized||55
2427418|NCT01193127|5953271|P2|STARTED|Randomized||54
2427419|NCT01193127|5953272|P1|STARTED|Randomized||57
2427420|NCT01193114|5953576|P2|NOT COMPLETED|Overall Study||0
2427421|NCT01193114|5953577|P1|NOT COMPLETED|Overall Study||0
2427422|NCT01193114|5953576|P2|COMPLETED|Overall Study||30
2427423|NCT01193114|5953577|P1|COMPLETED|Overall Study||30
2427424|NCT01193114|5953576|P2|STARTED|Overall Study||30
2427425|NCT01193114|5953577|P1|STARTED|Overall Study||30
2427426|NCT01193101|5953597|P4|NOT COMPLETED|Overall Study||12
2427427|NCT01193101|5953598|P3|NOT COMPLETED|Overall Study||3
2427428|NCT01193101|5953599|P2|NOT COMPLETED|Overall Study||7
2427429|NCT01193101|5953600|P1|NOT COMPLETED|Overall Study||5
2427430|NCT01193101|5953597|P4|COMPLETED|Overall Study||80
2427431|NCT01193101|5953598|P3|COMPLETED|Overall Study||93
2427432|NCT01193101|5953599|P2|COMPLETED|Overall Study||94
2427433|NCT01193101|5953600|P1|COMPLETED|Overall Study||95
2427434|NCT01193101|5953597|P4|Placebo Withdrawal Set|Overall Study||80
2427435|NCT01193101|5953598|P3|Placebo Withdrawal Set|Overall Study||93
2427436|NCT01193101|5953599|P2|Placebo Withdrawal Set|Overall Study||94
2427437|NCT01193101|5953600|P1|Placebo Withdrawal Set|Overall Study||95
2427438|NCT01193101|5953597|P4|Full Analysis Set|Overall Study||92
2427439|NCT01193101|5953598|P3|Full Analysis Set|Overall Study||96
2427440|NCT01193101|5953599|P2|Full Analysis Set|Overall Study||101
2427441|NCT01193101|5953600|P1|Full Analysis Set|Overall Study||100
2427442|NCT01193101|5953597|P4|STARTED|Overall Study||92
2427443|NCT01193101|5953598|P3|STARTED|Overall Study||96
2427444|NCT01193101|5953599|P2|STARTED|Overall Study||101
2427445|NCT01193101|5953600|P1|STARTED|Overall Study||100
2427446|NCT01193049|5953656|P2|NOT COMPLETED|Period 3 : Double Blind Crossover||0
2427447|NCT01193049|5953657|P1|NOT COMPLETED|Period 3 : Double Blind Crossover||0
2427448|NCT01193049|5953656|P2|COMPLETED|Period 3 : Double Blind Crossover||6
2427449|NCT01193049|5953657|P1|COMPLETED|Period 3 : Double Blind Crossover||5
2427450|NCT01193049|5953656|P2|STARTED|Period 3 : Double Blind Crossover||6
2427451|NCT01193049|5953657|P1|STARTED|Period 3 : Double Blind Crossover||5
2427452|NCT01193049|5953656|P2|NOT COMPLETED|Washout 2 : 21 Day Washout||0
2427453|NCT01193049|5953657|P1|NOT COMPLETED|Washout 2 : 21 Day Washout||0
2427454|NCT01193049|5953656|P2|COMPLETED|Washout 2 : 21 Day Washout||6
2427455|NCT01193049|5953657|P1|COMPLETED|Washout 2 : 21 Day Washout||5
2427456|NCT01193049|5953656|P2|STARTED|Washout 2 : 21 Day Washout||6
2427457|NCT01193049|5953657|P1|STARTED|Washout 2 : 21 Day Washout||5
2427458|NCT01193049|5953656|P2|NOT COMPLETED|Period 2 : Double Blind Crossover||0
2427459|NCT01193049|5953657|P1|NOT COMPLETED|Period 2 : Double Blind Crossover||0
2427460|NCT01193049|5953656|P2|COMPLETED|Period 2 : Double Blind Crossover||6
2427461|NCT01193049|5953657|P1|COMPLETED|Period 2 : Double Blind Crossover||5
2427462|NCT01193049|5953656|P2|STARTED|Period 2 : Double Blind Crossover||6
2427463|NCT01193049|5953657|P1|STARTED|Period 2 : Double Blind Crossover||5
2427464|NCT01193049|5953656|P2|NOT COMPLETED|Washout 1 : 21 Day Washout||0
2427465|NCT01193049|5953657|P1|NOT COMPLETED|Washout 1 : 21 Day Washout||0
2427466|NCT01193049|5953656|P2|COMPLETED|Washout 1 : 21 Day Washout||6
2427467|NCT01193049|5953657|P1|COMPLETED|Washout 1 : 21 Day Washout||5
2427468|NCT01193049|5953656|P2|STARTED|Washout 1 : 21 Day Washout||6
2427469|NCT01193049|5953657|P1|STARTED|Washout 1 : 21 Day Washout||5
2427470|NCT01193049|5953656|P2|NOT COMPLETED|Period 1: Placebo Run-In||0
2427471|NCT01193049|5953657|P1|NOT COMPLETED|Period 1: Placebo Run-In||0
2427472|NCT01193049|5953656|P2|COMPLETED|Period 1: Placebo Run-In||6
2427473|NCT01193049|5953657|P1|COMPLETED|Period 1: Placebo Run-In||5
2427474|NCT01193049|5953656|P2|STARTED|Period 1: Placebo Run-In||6
2427475|NCT01193049|5953657|P1|STARTED|Period 1: Placebo Run-In||5
2427476|NCT01193010|5953689|P2|NOT COMPLETED|Overall Study||0
2427477|NCT01193010|5953690|P1|NOT COMPLETED|Overall Study||3
2427478|NCT01193010|5953689|P2|COMPLETED|Overall Study||20
2427479|NCT01193010|5953690|P1|COMPLETED|Overall Study||17
2427480|NCT01193010|5953689|P2|STARTED|Overall Study||20
2427481|NCT01193010|5953690|P1|STARTED|Overall Study||20
2427482|NCT01192828|5953702|P1|NOT COMPLETED|Overall Study||0
2427483|NCT01192828|5953702|P1|COMPLETED|Overall Study||14
2427484|NCT01192828|5953702|P1|STARTED|Overall Study||14
2427485|NCT01192776|5953721|P4|NOT COMPLETED|Overall Study||20
2427486|NCT01192776|5953722|P3|NOT COMPLETED|Overall Study||21
2427487|NCT01192776|5953723|P2|NOT COMPLETED|Overall Study||21
2427488|NCT01192776|5953724|P1|NOT COMPLETED|Overall Study||11
2427489|NCT01192776|5953721|P4|COMPLETED|Overall Study||63
2427490|NCT01192776|5953722|P3|COMPLETED|Overall Study||75
2427491|NCT01192776|5953723|P2|COMPLETED|Overall Study||69
2427492|NCT01192776|5953724|P1|COMPLETED|Overall Study||84
2427493|NCT01192776|5953721|P4|Died After Discharge|Overall Study||1
2427494|NCT01192776|5953722|P3|Died After Discharge|Overall Study||3
2427495|NCT01192776|5953723|P2|Died After Discharge|Overall Study||2
2427496|NCT01192776|5953724|P1|Died After Discharge|Overall Study||1
2427497|NCT01192776|5953721|P4|Died Prior to Discharge|Overall Study||14
2427498|NCT01192776|5953722|P3|Died Prior to Discharge|Overall Study||15
2427499|NCT01192776|5953723|P2|Died Prior to Discharge|Overall Study||13
2427500|NCT01192776|5953724|P1|Died Prior to Discharge|Overall Study||7
2427501|NCT01192776|5953721|P4|STARTED|Overall Study||83
2427502|NCT01192776|5953722|P3|STARTED|Overall Study||96
2427503|NCT01192776|5953723|P2|STARTED|Overall Study||90
2427504|NCT01192776|5953724|P1|STARTED|Overall Study||95
2427505|NCT01192698|5953780|P2|NOT COMPLETED|Overall Study||0
2427506|NCT01192698|5953781|P1|NOT COMPLETED|Overall Study||0
2427507|NCT01192698|5953780|P2|COMPLETED|Overall Study||5
2427508|NCT01192698|5953781|P1|COMPLETED|Overall Study||10
2427509|NCT01192698|5953780|P2|STARTED|Overall Study||5
2427510|NCT01192698|5953781|P1|STARTED|Overall Study||10
2427511|NCT01192542|5953787|P2|NOT COMPLETED|Period 2||0
2427512|NCT01192542|5953788|P1|NOT COMPLETED|Period 2||0
2427513|NCT01192542|5953787|P2|COMPLETED|Period 2||20
2427514|NCT01192542|5953788|P1|COMPLETED|Period 2||18
2427515|NCT01192542|5953787|P2|STARTED|Period 2||20
2427516|NCT01192542|5953788|P1|STARTED|Period 2||18
2427517|NCT01192542|5953787|P2|NOT COMPLETED|Period 1||0
2427518|NCT01192542|5953788|P1|NOT COMPLETED|Period 1||0
2427519|NCT01192542|5953787|P2|COMPLETED|Period 1||20
2427520|NCT01192542|5953788|P1|COMPLETED|Period 1||18
2427521|NCT01192542|5953787|P2|STARTED|Period 1||20
2427522|NCT01192542|5953788|P1|STARTED|Period 1||18
2427523|NCT01192516|5953802|P3|NOT COMPLETED|Overall Study||8
2427524|NCT01192516|5953803|P2|NOT COMPLETED|Overall Study||17
2427525|NCT01192516|5953804|P1|NOT COMPLETED|Overall Study||20
2427526|NCT01192516|5953802|P3|COMPLETED|Overall Study||55
2427527|NCT01192516|5953803|P2|COMPLETED|Overall Study||49
2427528|NCT01192516|5953804|P1|COMPLETED|Overall Study||46
2427529|NCT01192516|5953802|P3|STARTED|Overall Study|Indicates number of people initially randomized to group|63
2427530|NCT01192516|5953803|P2|STARTED|Overall Study|Indicates number of people initially randomized to group|66
2427531|NCT01192516|5953804|P1|STARTED|Overall Study|Indicates number of people initially randomized to group|66
2427532|NCT01192412|5953838|P2|NOT COMPLETED|Overall Study||2
2427533|NCT01192412|5953839|P1|NOT COMPLETED|Overall Study||4
2427534|NCT01192412|5953838|P2|COMPLETED|Overall Study||488
2427535|NCT01192412|5953839|P1|COMPLETED|Overall Study||493
2427536|NCT01192412|5953838|P2|STARTED|Overall Study||490
2427537|NCT01192412|5953839|P1|STARTED|Overall Study||497
2427538|NCT01192399|5953847|P1|NOT COMPLETED|Overall Study||2
2427539|NCT01192399|5953847|P1|COMPLETED|Overall Study||27
2427540|NCT01192399|5953847|P1|STARTED|Overall Study||29
2427541|NCT01192347|5953857|P1|NOT COMPLETED|Overall Study||12
2427542|NCT01192347|5953857|P1|COMPLETED|Overall Study||163
2427543|NCT01192347|5953857|P1|STARTED|Overall Study||175
2427544|NCT01192295|5953880|P2|NOT COMPLETED|Overall Study||23
2427545|NCT01192295|5953881|P1|NOT COMPLETED|Overall Study||10
2427546|NCT01192295|5953880|P2|COMPLETED|Overall Study||105
2427547|NCT01192295|5953881|P1|COMPLETED|Overall Study||17
2427548|NCT01192295|5953880|P2|STARTED|Overall Study||128
2427549|NCT01192295|5953881|P1|STARTED|Overall Study||27
2427550|NCT01192282|5953898|P1|NOT COMPLETED|Overall Study||0
2427551|NCT01192282|5953898|P1|COMPLETED|Overall Study||156
2427552|NCT01192282|5953898|P1|STARTED|Overall Study||156
2427553|NCT01192204|5953915|P2|NOT COMPLETED|Overall Study||0
2427554|NCT01192204|5953916|P1|NOT COMPLETED|Overall Study||1
2427555|NCT01192204|5953915|P2|COMPLETED|Overall Study||18
2427556|NCT01192204|5953916|P1|COMPLETED|Overall Study||22
2427557|NCT01192204|5953915|P2|STARTED|Overall Study||18
2427558|NCT01192204|5953916|P1|STARTED|Overall Study||23
2427559|NCT01192191|5953928|P2|NOT COMPLETED|Overall Study||21
2427560|NCT01192191|5953929|P1|NOT COMPLETED|Overall Study||11
2427561|NCT01192191|5953928|P2|COMPLETED|Overall Study||106
2427562|NCT01192191|5953929|P1|COMPLETED|Overall Study||49
2427563|NCT01192191|5953928|P2|STARTED|Overall Study||127
2427564|NCT01192191|5953929|P1|STARTED|Overall Study||60
2427565|NCT01192178|5953955|P2|NOT COMPLETED|Overall Study||23
2427566|NCT01192178|5953956|P1|NOT COMPLETED|Overall Study||24
2427567|NCT01192178|5953955|P2|COMPLETED|Overall Study||145
2427568|NCT01192178|5953956|P1|COMPLETED|Overall Study||147
2427569|NCT01192178|5953955|P2|STARTED|Overall Study||168
2427570|NCT01192178|5953956|P1|STARTED|Overall Study||171
2427571|NCT01192152|5953976|P2|NOT COMPLETED|Period 3||0
2427572|NCT01192152|5953977|P1|NOT COMPLETED|Period 3||1
2427573|NCT01192152|5953976|P2|COMPLETED|Period 3||0
2427574|NCT01192152|5953977|P1|COMPLETED|Period 3||14
2427575|NCT01192152|5953976|P2|STARTED|Period 3||0
2427576|NCT01192152|5953977|P1|STARTED|Period 3||15
2427577|NCT01192152|5953976|P2|NOT COMPLETED|Period 2||0
2427578|NCT01192152|5953977|P1|NOT COMPLETED|Period 2||0
2427579|NCT01192152|5953976|P2|COMPLETED|Period 2||14
2427580|NCT01192152|5953977|P1|COMPLETED|Period 2||15
2427581|NCT01192152|5953976|P2|STARTED|Period 2||14
2427582|NCT01192152|5953977|P1|STARTED|Period 2||15
2427583|NCT01192152|5953976|P2|NOT COMPLETED|Period 1||1
2427584|NCT01192152|5953977|P1|NOT COMPLETED|Period 1||0
2427585|NCT01192152|5953976|P2|COMPLETED|Period 1||14
2427586|NCT01192152|5953977|P1|COMPLETED|Period 1||15
2427587|NCT01192152|5953976|P2|STARTED|Period 1||15
2427588|NCT01192152|5953977|P1|STARTED|Period 1||15
2427589|NCT01192139|5954078|P6|NOT COMPLETED|Period 3||0
2427590|NCT01192139|5954079|P5|NOT COMPLETED|Period 3||0
2427591|NCT01192139|5954080|P4|NOT COMPLETED|Period 3||0
2427592|NCT01192139|5954081|P3|NOT COMPLETED|Period 3||0
2427593|NCT01192139|5954082|P2|NOT COMPLETED|Period 3||0
2427594|NCT01192139|5954083|P1|NOT COMPLETED|Period 3||0
2427595|NCT01192139|5954078|P6|COMPLETED|Period 3||5
2427596|NCT01192139|5954079|P5|COMPLETED|Period 3||5
2427597|NCT01192139|5954080|P4|COMPLETED|Period 3||5
2427598|NCT01192139|5954081|P3|COMPLETED|Period 3||5
2427599|NCT01192139|5954082|P2|COMPLETED|Period 3||5
2427600|NCT01192139|5954083|P1|COMPLETED|Period 3||5
2427601|NCT01192139|5954078|P6|STARTED|Period 3||5
2427602|NCT01192139|5954079|P5|STARTED|Period 3||5
2427603|NCT01192139|5954080|P4|STARTED|Period 3||5
2427604|NCT01192139|5954081|P3|STARTED|Period 3||5
2427605|NCT01192139|5954082|P2|STARTED|Period 3||5
2427606|NCT01192139|5954083|P1|STARTED|Period 3||5
2427607|NCT01192139|5954078|P6|NOT COMPLETED|Period 2||0
2427608|NCT01192139|5954079|P5|NOT COMPLETED|Period 2||0
2427609|NCT01192139|5954080|P4|NOT COMPLETED|Period 2||0
2427610|NCT01192139|5954081|P3|NOT COMPLETED|Period 2||0
2427611|NCT01192139|5954082|P2|NOT COMPLETED|Period 2||0
2427612|NCT01192139|5954083|P1|NOT COMPLETED|Period 2||0
2427613|NCT01192139|5954078|P6|COMPLETED|Period 2||5
2427614|NCT01192139|5954079|P5|COMPLETED|Period 2||5
2427615|NCT01192139|5954080|P4|COMPLETED|Period 2||5
2427616|NCT01192139|5954081|P3|COMPLETED|Period 2||5
2427617|NCT01192139|5954082|P2|COMPLETED|Period 2||5
2427618|NCT01192139|5954083|P1|COMPLETED|Period 2||5
2427619|NCT01192139|5954078|P6|STARTED|Period 2||5
2427620|NCT01192139|5954079|P5|STARTED|Period 2||5
2427621|NCT01192139|5954080|P4|STARTED|Period 2||5
2427622|NCT01192139|5954081|P3|STARTED|Period 2||5
2427623|NCT01192139|5954082|P2|STARTED|Period 2||5
2427624|NCT01192139|5954083|P1|STARTED|Period 2||5
2427625|NCT01192139|5954078|P6|NOT COMPLETED|Period 1||0
2427626|NCT01192139|5954079|P5|NOT COMPLETED|Period 1||0
2427627|NCT01192139|5954080|P4|NOT COMPLETED|Period 1||0
2427628|NCT01192139|5954081|P3|NOT COMPLETED|Period 1||0
2427629|NCT01192139|5954082|P2|NOT COMPLETED|Period 1||0
2427630|NCT01192139|5954083|P1|NOT COMPLETED|Period 1||0
2427631|NCT01192139|5954078|P6|COMPLETED|Period 1||5
2427632|NCT01192139|5954079|P5|COMPLETED|Period 1||5
2427633|NCT01192139|5954080|P4|COMPLETED|Period 1||5
2427634|NCT01192139|5954081|P3|COMPLETED|Period 1||5
2427635|NCT01192139|5954082|P2|COMPLETED|Period 1||5
2427636|NCT01192139|5954083|P1|COMPLETED|Period 1||5
2427637|NCT01192139|5954078|P6|STARTED|Period 1||5
2427638|NCT01192139|5954079|P5|STARTED|Period 1||5
2427639|NCT01192139|5954080|P4|STARTED|Period 1||5
2427640|NCT01192139|5954081|P3|STARTED|Period 1||5
2427641|NCT01192139|5954082|P2|STARTED|Period 1||5
2427642|NCT01192139|5954083|P1|STARTED|Period 1||5
2427643|NCT01192126|5954148|P2|NOT COMPLETED|Second Intervention (1 Week)||0
2427644|NCT01192126|5954149|P1|NOT COMPLETED|Second Intervention (1 Week)||0
2427645|NCT01192126|5954148|P2|COMPLETED|Second Intervention (1 Week)||50
2427646|NCT01192126|5954149|P1|COMPLETED|Second Intervention (1 Week)||49
2427647|NCT01192126|5954148|P2|STARTED|Second Intervention (1 Week)||50
2427648|NCT01192126|5954149|P1|STARTED|Second Intervention (1 Week)||49
2427649|NCT01192126|5954148|P2|NOT COMPLETED|First Intervention (1 Week)||1
2427650|NCT01192126|5954149|P1|NOT COMPLETED|First Intervention (1 Week)||2
2427651|NCT01192126|5954148|P2|COMPLETED|First Intervention (1 Week)||50
2427652|NCT01192126|5954149|P1|COMPLETED|First Intervention (1 Week)||49
2427653|NCT01192126|5954148|P2|STARTED|First Intervention (1 Week)||51
2427654|NCT01192126|5954149|P1|STARTED|First Intervention (1 Week)||51
2427655|NCT01192022|5954161|P5|NOT COMPLETED|Overall Study||1
2427656|NCT01192022|5954162|P4|NOT COMPLETED|Overall Study||2
2427657|NCT01192022|5954163|P3|NOT COMPLETED|Overall Study||1
2427658|NCT01192022|5954164|P2|NOT COMPLETED|Overall Study||11
2427659|NCT01192022|5954165|P1|NOT COMPLETED|Overall Study||13
2427660|NCT01192022|5954161|P5|COMPLETED|Overall Study||11
2427661|NCT01192022|5954162|P4|COMPLETED|Overall Study||7
2427662|NCT01192022|5954163|P3|COMPLETED|Overall Study||7
2427663|NCT01192022|5954164|P2|COMPLETED|Overall Study||99
2427664|NCT01192022|5954165|P1|COMPLETED|Overall Study||101
2427665|NCT01192022|5954161|P5|Safety Population-Received Treatment|Overall Study||12
2427666|NCT01192022|5954162|P4|Safety Population-Received Treatment|Overall Study||9
2427667|NCT01192022|5954163|P3|Safety Population-Received Treatment|Overall Study||8
2427668|NCT01192022|5954164|P2|Safety Population-Received Treatment|Overall Study||109
2427669|NCT01192022|5954165|P1|Safety Population-Received Treatment|Overall Study||114
2427670|NCT01192022|5954161|P5|STARTED|Overall Study||12
2427671|NCT01192022|5954162|P4|STARTED|Overall Study||9
2427672|NCT01192022|5954163|P3|STARTED|Overall Study||8
2427673|NCT01192022|5954164|P2|STARTED|Overall Study||110
2427674|NCT01192022|5954165|P1|STARTED|Overall Study||114
2427675|NCT01191944|5954188|P2|NOT COMPLETED|Overall Study||19
2427676|NCT01191944|5954189|P1|NOT COMPLETED|Overall Study||17
2427677|NCT01191944|5954188|P2|COMPLETED|Overall Study|Completed titration/maintenance|220
2427678|NCT01191944|5954189|P1|COMPLETED|Overall Study|Completed titration/maintenance|217
2427679|NCT01191944|5954188|P2|STARTED|Overall Study|Treated titration/maintenance|239
2427680|NCT01191944|5954189|P1|STARTED|Overall Study|Treated titration/maintenance|234
2427681|NCT01191840|5954235|P2|NOT COMPLETED|Overall Study||15
2427682|NCT01191840|5954236|P1|NOT COMPLETED|Overall Study||14
2427683|NCT01191840|5954235|P2|COMPLETED|Overall Study||240
2427684|NCT01191840|5954236|P1|COMPLETED|Overall Study||240
2427685|NCT01191840|5954235|P2|STARTED|Overall Study||255
2427686|NCT01191840|5954236|P1|STARTED|Overall Study||254
2427687|NCT01191827|5954252|P2|NOT COMPLETED|Overall Study||0
2427688|NCT01191827|5954253|P1|NOT COMPLETED|Overall Study||0
2427689|NCT01191827|5954252|P2|COMPLETED|Overall Study||20
2427690|NCT01191827|5954253|P1|COMPLETED|Overall Study||20
2427691|NCT01191827|5954252|P2|STARTED|Overall Study||20
2427692|NCT01191827|5954253|P1|STARTED|Overall Study||20
2427693|NCT01191801|5954261|P2|NOT COMPLETED|Overall Study||337
2427694|NCT01191801|5954262|P1|NOT COMPLETED|Overall Study||316
2427695|NCT01191801|5954261|P2|COMPLETED|Overall Study||18
2427696|NCT01191801|5954262|P1|COMPLETED|Overall Study||40
2427697|NCT01191801|5954261|P2|STARTED|Overall Study||355
2427698|NCT01191801|5954262|P1|STARTED|Overall Study||356
2427699|NCT01191788|5954282|P2|NOT COMPLETED|Overall Study||22
2427700|NCT01191788|5954283|P1|NOT COMPLETED|Overall Study||21
2427701|NCT01191788|5954282|P2|COMPLETED|Overall Study|Completed 3-month followup|137
2427702|NCT01191788|5954283|P1|COMPLETED|Overall Study|Completed 3-month followup|119
2427703|NCT01191788|5954282|P2|STARTED|Overall Study||159
2427704|NCT01191788|5954283|P1|STARTED|Overall Study||140
2427705|NCT01191762|5954293|P2|NOT COMPLETED|Overall Study||0
2427706|NCT01191762|5954294|P1|NOT COMPLETED|Overall Study||1
2427707|NCT01191762|5954293|P2|COMPLETED|Overall Study||15
2427708|NCT01191762|5954294|P1|COMPLETED|Overall Study|One subject dropped out on the 3rd treatment day because of gastrointestinal complaints.|14
2427709|NCT01191762|5954293|P2|STARTED|Overall Study||15
2427710|NCT01191762|5954294|P1|STARTED|Overall Study||15
2427711|NCT01191749|5954300|P1|NOT COMPLETED|Overall Study||0
2427712|NCT01191749|5954300|P1|COMPLETED|Overall Study||7
2427713|NCT01191749|5954300|P1|STARTED|Overall Study||7
2427714|NCT01191736|5954311|P7|NOT COMPLETED|Overall Study||0
2427715|NCT01191736|5954312|P6|NOT COMPLETED|Overall Study||0
2427716|NCT01191736|5954313|P5|NOT COMPLETED|Overall Study||0
2427717|NCT01191736|5954314|P4|NOT COMPLETED|Overall Study||0
2427718|NCT01191736|5954315|P3|NOT COMPLETED|Overall Study||0
2427719|NCT01191736|5954316|P2|NOT COMPLETED|Overall Study||0
2427720|NCT01191736|5954317|P1|NOT COMPLETED|Overall Study||0
2427721|NCT01191736|5954311|P7|COMPLETED|Overall Study||45
2427722|NCT01191736|5954312|P6|COMPLETED|Overall Study||50
2427723|NCT01191736|5954313|P5|COMPLETED|Overall Study||48
2427724|NCT01191736|5954314|P4|COMPLETED|Overall Study||46
2427725|NCT01191736|5954315|P3|COMPLETED|Overall Study||49
2427726|NCT01191736|5954316|P2|COMPLETED|Overall Study||47
2427727|NCT01191736|5954317|P1|COMPLETED|Overall Study||51
2427728|NCT01191736|5954311|P7|STARTED|Overall Study||45
2427729|NCT01191736|5954312|P6|STARTED|Overall Study||50
2427730|NCT01191736|5954313|P5|STARTED|Overall Study||48
2427731|NCT01191736|5954314|P4|STARTED|Overall Study||46
2427732|NCT01191736|5954315|P3|STARTED|Overall Study||49
2427733|NCT01191736|5954316|P2|STARTED|Overall Study||47
2427734|NCT01191736|5954317|P1|STARTED|Overall Study||51
2427735|NCT01191723|5954340|P6|NOT COMPLETED|Overall Study||0
2427736|NCT01191723|5954341|P5|NOT COMPLETED|Overall Study||0
2427737|NCT01191723|5954342|P4|NOT COMPLETED|Overall Study||0
2427738|NCT01191723|5954343|P3|NOT COMPLETED|Overall Study||0
2427739|NCT01191723|5954344|P2|NOT COMPLETED|Overall Study||0
2427740|NCT01191723|5954345|P1|NOT COMPLETED|Overall Study||0
2427741|NCT01191723|5954340|P6|COMPLETED|Overall Study||9
2427742|NCT01191723|5954341|P5|COMPLETED|Overall Study||9
2427743|NCT01191723|5954342|P4|COMPLETED|Overall Study||9
2427744|NCT01191723|5954343|P3|COMPLETED|Overall Study||9
2427745|NCT01191723|5954344|P2|COMPLETED|Overall Study||9
2427746|NCT01191723|5954345|P1|COMPLETED|Overall Study||9
2427747|NCT01191723|5954340|P6|STARTED|Overall Study||9
2427748|NCT01191723|5954341|P5|STARTED|Overall Study||9
2427749|NCT01191723|5954342|P4|STARTED|Overall Study||9
2427750|NCT01191723|5954343|P3|STARTED|Overall Study||9
2427751|NCT01191723|5954344|P2|STARTED|Overall Study||9
2427752|NCT01191723|5954345|P1|STARTED|Overall Study||9
2427753|NCT01191476|5954366|P3|NOT COMPLETED|Overall Study||0
2427754|NCT01191476|5954367|P2|NOT COMPLETED|Overall Study||4
2427755|NCT01191476|5954368|P1|NOT COMPLETED|Overall Study||3
2427756|NCT01191476|5954366|P3|COMPLETED|Overall Study||111
2427757|NCT01191476|5954367|P2|COMPLETED|Overall Study||107
2427758|NCT01191476|5954368|P1|COMPLETED|Overall Study||109
2427759|NCT01191476|5954366|P3|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
2427760|NCT01191476|5954367|P2|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
2427761|NCT01191476|5954368|P1|STARTED|Overall Study||112
2427762|NCT01191411|5954391|P3|NOT COMPLETED|Overall Study||3427
2427763|NCT01191411|5954392|P2|NOT COMPLETED|Overall Study||361
2427764|NCT01191411|5954393|P1|NOT COMPLETED|Overall Study||945
2427765|NCT01191411|5954391|P3|COMPLETED|Overall Study||471
2427766|NCT01191411|5954392|P2|COMPLETED|Overall Study||118
2427767|NCT01191411|5954393|P1|COMPLETED|Overall Study||648
2427768|NCT01191411|5954391|P3|STARTED|Overall Study||3898
2427769|NCT01191411|5954392|P2|STARTED|Overall Study||479
2427770|NCT01191411|5954393|P1|STARTED|Overall Study||1593
2427771|NCT01191398|5954404|P3|NOT COMPLETED|Overall Study||0
2427772|NCT01191398|5954405|P2|NOT COMPLETED|Overall Study||0
2427773|NCT01191398|5954406|P1|NOT COMPLETED|Overall Study||0
2427774|NCT01191398|5954404|P3|COMPLETED|Overall Study||18
2427775|NCT01191398|5954405|P2|COMPLETED|Overall Study||17
2427776|NCT01191398|5954406|P1|COMPLETED|Overall Study||17
2427777|NCT01191398|5954404|P3|STARTED|Overall Study||18
2427778|NCT01191398|5954405|P2|STARTED|Overall Study||17
2427779|NCT01191398|5954406|P1|STARTED|Overall Study||17
2427780|NCT01191333|5954419|P2|NOT COMPLETED|Overall Study||18
2427781|NCT01191333|5954420|P1|NOT COMPLETED|Overall Study||21
2427782|NCT01191333|5954419|P2|COMPLETED|Overall Study||65
2427783|NCT01191333|5954420|P1|COMPLETED|Overall Study||60
2427784|NCT01191333|5954419|P2|STARTED|Overall Study||83
2427785|NCT01191333|5954420|P1|STARTED|Overall Study||81
2427786|NCT01191320|5954439|P3|NOT COMPLETED|Overall Study||7
2427787|NCT01191320|5954440|P2|NOT COMPLETED|Overall Study||6
2427788|NCT01191320|5954441|P1|NOT COMPLETED|Overall Study||7
2427789|NCT01191320|5954439|P3|COMPLETED|Overall Study||31
2427790|NCT01191320|5954440|P2|COMPLETED|Overall Study||32
2427791|NCT01191320|5954441|P1|COMPLETED|Overall Study||36
2427792|NCT01191320|5954439|P3|STARTED|Overall Study||38
2427793|NCT01191320|5954440|P2|STARTED|Overall Study||38
2427794|NCT01191320|5954441|P1|STARTED|Overall Study||43
2427795|NCT01191268|5954452|P3|NOT COMPLETED|Overall Study||52
2427796|NCT01191268|5954453|P2|NOT COMPLETED|Overall Study||55
2427797|NCT01191268|5954454|P1|NOT COMPLETED|Overall Study||58
2427798|NCT01191268|5954452|P3|COMPLETED|Overall Study||244
2427799|NCT01191268|5954453|P2|COMPLETED|Overall Study||238
2427800|NCT01191268|5954454|P1|COMPLETED|Overall Study||237
2427801|NCT01191268|5954452|P3|Received at Least One Dose of Study Drug|Overall Study||296
2427802|NCT01191268|5954453|P2|Received at Least One Dose of Study Drug|Overall Study||293
2427803|NCT01191268|5954454|P1|Received at Least One Dose of Study Drug|Overall Study||295
2427804|NCT01191268|5954452|P3|STARTED|Overall Study||296
2427805|NCT01191268|5954453|P2|STARTED|Overall Study||293
2427806|NCT01191268|5954454|P1|STARTED|Overall Study||295
2427807|NCT01191255|5954551|P4|NOT COMPLETED|Efficacy Assessment Period||6
2427808|NCT01191255|5954552|P3|NOT COMPLETED|Efficacy Assessment Period||26
2427809|NCT01191255|5954553|P2|NOT COMPLETED|Efficacy Assessment Period||0
2427810|NCT01191255|5954554|P1|NOT COMPLETED|Efficacy Assessment Period||0
2427811|NCT01191255|5954551|P4|COMPLETED|Efficacy Assessment Period||90
2427812|NCT01191255|5954552|P3|COMPLETED|Efficacy Assessment Period||70
2427813|NCT01191255|5954553|P2|COMPLETED|Efficacy Assessment Period||0
2427814|NCT01191255|5954554|P1|COMPLETED|Efficacy Assessment Period||0
2427815|NCT01191255|5954551|P4|STARTED|Efficacy Assessment Period||96
2427816|NCT01191255|5954552|P3|STARTED|Efficacy Assessment Period||96
2427817|NCT01191255|5954553|P2|STARTED|Efficacy Assessment Period||0
2427818|NCT01191255|5954554|P1|STARTED|Efficacy Assessment Period||0
2427819|NCT01191255|5954551|P4|NOT COMPLETED|Safety Assessment Period||0
2427820|NCT01191255|5954552|P3|NOT COMPLETED|Safety Assessment Period||0
2427821|NCT01191255|5954553|P2|NOT COMPLETED|Safety Assessment Period||99
2427822|NCT01191255|5954554|P1|NOT COMPLETED|Safety Assessment Period||38
2427823|NCT01191255|5954551|P4|COMPLETED|Safety Assessment Period||0
2427824|NCT01191255|5954552|P3|COMPLETED|Safety Assessment Period||0
2427825|NCT01191255|5954553|P2|COMPLETED|Safety Assessment Period||193
2427826|NCT01191255|5954554|P1|COMPLETED|Safety Assessment Period||111
2427827|NCT01191255|5954551|P4|Safety Population|Safety Assessment Period||0
2427828|NCT01191255|5954552|P3|Safety Population|Safety Assessment Period||0
2427829|NCT01191255|5954553|P2|Safety Population|Safety Assessment Period||289
2427830|NCT01191255|5954554|P1|Safety Population|Safety Assessment Period||149
2427831|NCT01191255|5954551|P4|STARTED|Safety Assessment Period||0
2427832|NCT01191255|5954552|P3|STARTED|Safety Assessment Period||0
2427833|NCT01191255|5954553|P2|STARTED|Safety Assessment Period||292
2427834|NCT01191255|5954554|P1|STARTED|Safety Assessment Period|3 subjects were assigned to receive KRX-0502 but didn't receive a single dose|149
2427835|NCT01191242|5954580|P1|NOT COMPLETED|Overall Study||0
2427836|NCT01191242|5954580|P1|COMPLETED|Overall Study||31
2427837|NCT01191242|5954580|P1|STARTED|Overall Study||31
2427838|NCT01191190|5954595|P1|NOT COMPLETED|Overall Study||1
2427839|NCT01191190|5954595|P1|COMPLETED|Overall Study||20
2427840|NCT01191190|5954595|P1|STARTED|Overall Study||21
2427841|NCT01191086|5954608|P1|NOT COMPLETED|Overall Study||62
2427842|NCT01191086|5954608|P1|COMPLETED|Overall Study||148
2427843|NCT01191086|5954608|P1|STARTED|Overall Study||210
2427844|NCT01191008|5954612|P1|NOT COMPLETED|Overall Study||15
2427845|NCT01191008|5954612|P1|COMPLETED|Overall Study||618
2427846|NCT01191008|5954612|P1|STARTED|Overall Study||633
2427847|NCT01190891|5954620|P2|NOT COMPLETED|Overall Study||0
2427848|NCT01190891|5954621|P1|NOT COMPLETED|Overall Study||6
2427849|NCT01190891|5954620|P2|COMPLETED|Overall Study||52
2427850|NCT01190891|5954621|P1|COMPLETED|Overall Study||46
2427851|NCT01190891|5954620|P2|STARTED|Overall Study||52
2427852|NCT01190891|5954621|P1|STARTED|Overall Study||52
2427853|NCT01190878|5954633|P4|NOT COMPLETED|Overall Study||20
2427854|NCT01190878|5954634|P3|NOT COMPLETED|Overall Study||5
2427855|NCT01190878|5954635|P2|NOT COMPLETED|Overall Study||3
2427856|NCT01190878|5954636|P1|NOT COMPLETED|Overall Study||3
2427857|NCT01190878|5954633|P4|COMPLETED|Overall Study||22
2427858|NCT01190878|5954634|P3|COMPLETED|Overall Study||37
2427859|NCT01190878|5954635|P2|COMPLETED|Overall Study||42
2427860|NCT01190878|5954636|P1|COMPLETED|Overall Study||37
2427861|NCT01190878|5954633|P4|STARTED|Overall Study||42
2427862|NCT01190878|5954634|P3|STARTED|Overall Study||42
2427863|NCT01190878|5954635|P2|STARTED|Overall Study||45
2427864|NCT01190878|5954636|P1|STARTED|Overall Study||40
2427865|NCT01190865|5954646|P1|NOT COMPLETED|Overall Study||3
2427866|NCT01190865|5954646|P1|COMPLETED|Overall Study||25
2427867|NCT01190865|5954646|P1|STARTED|Overall Study||28
2427868|NCT01190839|5954653|P2|NOT COMPLETED|Overall Study||147
2427869|NCT01190839|5954654|P1|NOT COMPLETED|Overall Study||150
2427870|NCT01190839|5954653|P2|COMPLETED|Overall Study||0
2427871|NCT01190839|5954654|P1|COMPLETED|Overall Study||0
2427872|NCT01190839|5954653|P2|Treated|Overall Study||143
2427873|NCT01190839|5954654|P1|Treated|Overall Study||148
2427874|NCT01190839|5954653|P2|STARTED|Overall Study||147
2427875|NCT01190839|5954654|P1|STARTED|Overall Study||150
2427876|NCT01190813|5954668|P2|NOT COMPLETED|Overall Study||4
2427877|NCT01190813|5954669|P1|NOT COMPLETED|Overall Study||4
2427878|NCT01190813|5954668|P2|COMPLETED|Overall Study||45
2427879|NCT01190813|5954669|P1|COMPLETED|Overall Study||86
2427880|NCT01190813|5954668|P2|26-week Visit|Overall Study|0 missed, 0 dropped|45
2427881|NCT01190813|5954669|P1|26-week Visit|Overall Study|0 missed, 0 dropped|86
2427882|NCT01190813|5954668|P2|23-week Phone Call|Overall Study|4 missed, 0 dropped|41
2427883|NCT01190813|5954669|P1|23-week Phone Call|Overall Study|4 missed, 1 dropped|82
2427884|NCT01190813|5954668|P2|18-week Visit (Masked Primary)|Overall Study|1 dropped|45
2427885|NCT01190813|5954669|P1|18-week Visit (Masked Primary)|Overall Study|0 dropped|87
2427886|NCT01190813|5954668|P2|16-week Visit|Overall Study|2 dropped|46
2427887|NCT01190813|5954669|P1|16-week Visit|Overall Study|1 dropped|87
2427888|NCT01190813|5954668|P2|13-week Phone Call|Overall Study|0 dropped, 0 missed|48
2427889|NCT01190813|5954669|P1|13-week Phone Call|Overall Study|6 missed, 0 dropped|82
2427890|NCT01190813|5954668|P2|10-week Visit|Overall Study|0 dropped, 0 missed|48
2427891|NCT01190813|5954669|P1|10-week Visit|Overall Study|0 missed, 0 dropped|88
2427892|NCT01190813|5954668|P2|7-week Phone Call|Overall Study|2 missed, 0 dropped|46
2427893|NCT01190813|5954669|P1|7-week Phone Call|Overall Study|3 missed, 0 dropped|85
2427894|NCT01190813|5954668|P2|4-week Visit|Overall Study|1 missed, 1 dropped|47
2427895|NCT01190813|5954669|P1|4-week Visit|Overall Study|0 missed, 1 dropped|88
2427896|NCT01190813|5954668|P2|2-week Phone Call|Overall Study|1 missed, 0 dropped|48
2427897|NCT01190813|5954669|P1|2-week Phone Call|Overall Study|2 missed, 1 dropped|87
2427898|NCT01190813|5954668|P2|STARTED|Overall Study||49
2427899|NCT01190813|5954669|P1|STARTED|Overall Study||90
2427900|NCT01190566|5954761|P2|NOT COMPLETED|Overall Study||0
2427901|NCT01190566|5954762|P1|NOT COMPLETED|Overall Study||0
2427902|NCT01190566|5954761|P2|COMPLETED|Overall Study||42
2427903|NCT01190566|5954762|P1|COMPLETED|Overall Study||6
2427904|NCT01190566|5954761|P2|STARTED|Overall Study||42
2427905|NCT01190566|5954762|P1|STARTED|Overall Study||6
2427906|NCT01190527|5954783|P1|NOT COMPLETED|Overall Study||0
2427907|NCT01190527|5954783|P1|COMPLETED|Overall Study||42
2427908|NCT01190527|5954783|P1|STARTED|Overall Study||42
2427909|NCT01190514|5954790|P4|NOT COMPLETED|Fourth Intervention (Period 4)||0
2427910|NCT01190514|5954791|P3|NOT COMPLETED|Fourth Intervention (Period 4)||0
2427911|NCT01190514|5954792|P2|NOT COMPLETED|Fourth Intervention (Period 4)||0
2427912|NCT01190514|5954793|P1|NOT COMPLETED|Fourth Intervention (Period 4)||0
2427913|NCT01190514|5954790|P4|COMPLETED|Fourth Intervention (Period 4)||10
2427914|NCT01190514|5954791|P3|COMPLETED|Fourth Intervention (Period 4)||10
2427915|NCT01190514|5954792|P2|COMPLETED|Fourth Intervention (Period 4)||10
2427916|NCT01190514|5954793|P1|COMPLETED|Fourth Intervention (Period 4)||9
2427917|NCT01190514|5954790|P4|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment A|10
2427918|NCT01190514|5954791|P3|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment B|10
2427919|NCT01190514|5954792|P2|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment C|10
2427920|NCT01190514|5954793|P1|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment D|9
2427921|NCT01190514|5954790|P4|NOT COMPLETED|Third Intervention (Period 3)||0
2427922|NCT01190514|5954791|P3|NOT COMPLETED|Third Intervention (Period 3)||0
2427923|NCT01190514|5954792|P2|NOT COMPLETED|Third Intervention (Period 3)||0
2427924|NCT01190514|5954793|P1|NOT COMPLETED|Third Intervention (Period 3)||1
2427925|NCT01190514|5954790|P4|COMPLETED|Third Intervention (Period 3)||10
2427926|NCT01190514|5954791|P3|COMPLETED|Third Intervention (Period 3)||10
2427927|NCT01190514|5954792|P2|COMPLETED|Third Intervention (Period 3)||10
2427928|NCT01190514|5954793|P1|COMPLETED|Third Intervention (Period 3)|Discontinued participant received treatments ABC of sequence ABCD.|9
2427929|NCT01190514|5954790|P4|STARTED|Third Intervention (Period 3)|Period 3 received treatment B|10
2427930|NCT01190514|5954791|P3|STARTED|Third Intervention (Period 3)|Period 3 received treatment A|10
2427931|NCT01190514|5954792|P2|STARTED|Third Intervention (Period 3)|Period 3 received treatment D|10
2427932|NCT01190514|5954793|P1|STARTED|Third Intervention (Period 3)|Period 3 received treatment C|10
2427933|NCT01190514|5954790|P4|NOT COMPLETED|Second Intervention (Period 2)||0
2427934|NCT01190514|5954791|P3|NOT COMPLETED|Second Intervention (Period 2)||0
2427935|NCT01190514|5954792|P2|NOT COMPLETED|Second Intervention (Period 2)||0
2427936|NCT01190514|5954793|P1|NOT COMPLETED|Second Intervention (Period 2)||0
2427937|NCT01190514|5954790|P4|COMPLETED|Second Intervention (Period 2)||10
2427938|NCT01190514|5954791|P3|COMPLETED|Second Intervention (Period 2)||10
2427939|NCT01190514|5954792|P2|COMPLETED|Second Intervention (Period 2)||10
2427940|NCT01190514|5954793|P1|COMPLETED|Second Intervention (Period 2)||10
2427941|NCT01190514|5954790|P4|STARTED|Second Intervention (Period 2)|Period 2 received treatment C|10
2427942|NCT01190514|5954791|P3|STARTED|Second Intervention (Period 2)|Period 2 received treatment D|10
2427943|NCT01190514|5954792|P2|STARTED|Second Intervention (Period 2)|Period 2 received treatment A|10
2427944|NCT01190514|5954793|P1|STARTED|Second Intervention (Period 2)|Period 2 received treatment B|10
2427945|NCT01190514|5954790|P4|NOT COMPLETED|First Intervention (Period 1)||0
2427946|NCT01190514|5954791|P3|NOT COMPLETED|First Intervention (Period 1)||0
2427947|NCT01190514|5954792|P2|NOT COMPLETED|First Intervention (Period 1)||0
2427948|NCT01190514|5954793|P1|NOT COMPLETED|First Intervention (Period 1)||1
2427949|NCT01190514|5954790|P4|COMPLETED|First Intervention (Period 1)||10
2427950|NCT01190514|5954791|P3|COMPLETED|First Intervention (Period 1)||10
2427951|NCT01190514|5954792|P2|COMPLETED|First Intervention (Period 1)||10
2427952|NCT01190514|5954793|P1|COMPLETED|First Intervention (Period 1)|Discontinued participant received treatment A of sequence ABCD.|10
2427953|NCT01190514|5954790|P4|STARTED|First Intervention (Period 1)||10
2427954|NCT01190514|5954791|P3|STARTED|First Intervention (Period 1)||10
2427955|NCT01190514|5954792|P2|STARTED|First Intervention (Period 1)||10
2427956|NCT01190514|5954793|P1|STARTED|First Intervention (Period 1)||11
2427957|NCT01190475|5954826|P3|NOT COMPLETED|Overall Study||1
2427958|NCT01190475|5954827|P2|NOT COMPLETED|Overall Study||0
2427959|NCT01190475|5954828|P1|NOT COMPLETED|Overall Study||0
2427960|NCT01190475|5954826|P3|COMPLETED|Overall Study||1
2427961|NCT01190475|5954827|P2|COMPLETED|Overall Study||2
2427962|NCT01190475|5954828|P1|COMPLETED|Overall Study||2
2427963|NCT01190475|5954826|P3|STARTED|Overall Study||2
2427964|NCT01190475|5954827|P2|STARTED|Overall Study||2
2427965|NCT01190475|5954828|P1|STARTED|Overall Study||2
2427966|NCT01190449|5954838|P2|NOT COMPLETED|Overall Study||4
2427967|NCT01190449|5954839|P1|NOT COMPLETED|Overall Study||0
2427968|NCT01190449|5954838|P2|COMPLETED|Overall Study||32
2427969|NCT01190449|5954839|P1|COMPLETED|Overall Study||15
2427970|NCT01190449|5954838|P2|STARTED|Overall Study||36
2427971|NCT01190449|5954839|P1|STARTED|Overall Study||15
2427972|NCT01190436|5954847|P1|NOT COMPLETED|Overall Study||39
2427973|NCT01190436|5954847|P1|COMPLETED|Overall Study||86
2427974|NCT01190436|5954847|P1|STARTED|Overall Study||125
2427975|NCT01190410|5954863|P2|NOT COMPLETED|Overall Study||9
2427976|NCT01190410|5954864|P1|NOT COMPLETED|Overall Study||1
2427977|NCT01190410|5954863|P2|COMPLETED|Overall Study||3
2427978|NCT01190410|5954864|P1|COMPLETED|Overall Study||3
2427979|NCT01190410|5954863|P2|Re-Induction|Overall Study||2
2427980|NCT01190410|5954864|P1|Re-Induction|Overall Study||0
2427981|NCT01190410|5954863|P2|STARTED|Overall Study||12
2427982|NCT01190410|5954864|P1|STARTED|Overall Study||4
2427983|NCT01190306|5954883|P2|NOT COMPLETED|Overall Study||0
2427984|NCT01190306|5954884|P1|NOT COMPLETED|Overall Study||0
2427985|NCT01190306|5954883|P2|COMPLETED|Overall Study||66
2427986|NCT01190306|5954884|P1|COMPLETED|Overall Study||61
2427987|NCT01190306|5954883|P2|STARTED|Overall Study||66
2427988|NCT01190306|5954884|P1|STARTED|Overall Study||61
2427989|NCT01190267|5954892|P2|NOT COMPLETED|Overall Study||4
2427990|NCT01190267|5954893|P1|NOT COMPLETED|Overall Study||41
2427991|NCT01190267|5954892|P2|COMPLETED|Overall Study||4
2427992|NCT01190267|5954893|P1|COMPLETED|Overall Study||155
2427993|NCT01190267|5954892|P2|STARTED|Overall Study||8
2427994|NCT01190267|5954893|P1|STARTED|Overall Study||196
2427995|NCT01190254|5954904|P3|NOT COMPLETED|Overall Study||22
2427996|NCT01190254|5954905|P2|NOT COMPLETED|Overall Study||17
2427997|NCT01190254|5954906|P1|NOT COMPLETED|Overall Study||21
2427998|NCT01190254|5954904|P3|COMPLETED|Overall Study||84
2427999|NCT01190254|5954905|P2|COMPLETED|Overall Study||81
2428000|NCT01190254|5954906|P1|COMPLETED|Overall Study||81
2428001|NCT01190254|5954904|P3|Treated|Overall Study||106
2428002|NCT01190254|5954905|P2|Treated|Overall Study||98
2428003|NCT01190254|5954906|P1|Treated|Overall Study||102
2428004|NCT01190254|5954904|P3|STARTED|Overall Study||106
2428005|NCT01190254|5954905|P2|STARTED|Overall Study||98
2428006|NCT01190254|5954906|P1|STARTED|Overall Study||102
2428007|NCT01190228|5954971|P3|NOT COMPLETED|Overall Study||0
2428008|NCT01190228|5954972|P2|NOT COMPLETED|Overall Study||0
2428009|NCT01190228|5954973|P1|NOT COMPLETED|Overall Study||5
2428010|NCT01190228|5954971|P3|COMPLETED|Overall Study||59
2428011|NCT01190228|5954972|P2|COMPLETED|Overall Study||46
2428012|NCT01190228|5954973|P1|COMPLETED|Overall Study||344
2428013|NCT01190228|5954971|P3|STARTED|Overall Study||59
2428014|NCT01190228|5954972|P2|STARTED|Overall Study||46
2428015|NCT01190228|5954973|P1|STARTED|Overall Study||349
2428016|NCT01190215|5954996|P2|NOT COMPLETED|Up to Month 6||0
2428017|NCT01190215|5954997|P1|NOT COMPLETED|Up to Month 6||2
2428018|NCT01190215|5954996|P2|COMPLETED|Up to Month 6||39
2428019|NCT01190215|5954997|P1|COMPLETED|Up to Month 6||36
2428020|NCT01190215|5954996|P2|STARTED|Up to Month 6||39
2428021|NCT01190215|5954997|P1|STARTED|Up to Month 6||38
2428022|NCT01190215|5954996|P2|NOT COMPLETED|Up to Day 28||0
2428023|NCT01190215|5954997|P1|NOT COMPLETED|Up to Day 28||0
2428024|NCT01190215|5954996|P2|COMPLETED|Up to Day 28||39
2428025|NCT01190215|5954997|P1|COMPLETED|Up to Day 28||38
2428026|NCT01190215|5954996|P2|STARTED|Up to Day 28||39
2428027|NCT01190215|5954997|P1|STARTED|Up to Day 28||38
2428028|NCT01190189|5955065|P1|NOT COMPLETED|Overall Study||6
2428029|NCT01190189|5955065|P1|COMPLETED|Overall Study||131
2428030|NCT01190189|5955065|P1|STARTED|Overall Study||137
2428031|NCT01190176|5955072|P1|NOT COMPLETED|Overall Study||2
2428032|NCT01190176|5955072|P1|COMPLETED|Overall Study||30
2428033|NCT01190176|5955072|P1|STARTED|Overall Study||32
2428034|NCT01190150|5955093|P2|NOT COMPLETED|Second Treatment||0
2428035|NCT01190150|5955094|P1|NOT COMPLETED|Second Treatment||0
2428036|NCT01190150|5955093|P2|COMPLETED|Second Treatment||7
2428037|NCT01190150|5955094|P1|COMPLETED|Second Treatment||10
2428038|NCT01190150|5955093|P2|STARTED|Second Treatment||7
2428039|NCT01190150|5955094|P1|STARTED|Second Treatment||10
2428040|NCT01190150|5955093|P2|NOT COMPLETED|Washout||2
2428041|NCT01190150|5955094|P1|NOT COMPLETED|Washout||0
2428042|NCT01190150|5955093|P2|COMPLETED|Washout||7
2428043|NCT01190150|5955094|P1|COMPLETED|Washout||10
2428044|NCT01190150|5955093|P2|STARTED|Washout||9
2428045|NCT01190150|5955094|P1|STARTED|Washout||10
2428046|NCT01190150|5955093|P2|NOT COMPLETED|First Treatment||0
2428047|NCT01190150|5955094|P1|NOT COMPLETED|First Treatment||1
2428048|NCT01190150|5955093|P2|COMPLETED|First Treatment||9
2428049|NCT01190150|5955094|P1|COMPLETED|First Treatment||10
2428050|NCT01190150|5955093|P2|STARTED|First Treatment|Randomized, as well as Safety and PK populations|9
2428051|NCT01190150|5955094|P1|STARTED|First Treatment|Randomized, as well as Safety and PK populations|11
2428052|NCT01190124|5955121|P3|NOT COMPLETED|Overall Study||1
2428053|NCT01190124|5955122|P2|NOT COMPLETED|Overall Study||0
2428054|NCT01190124|5955123|P1|NOT COMPLETED|Overall Study||17
2428055|NCT01190124|5955121|P3|COMPLETED|Overall Study||19
2428056|NCT01190124|5955122|P2|COMPLETED|Overall Study||24
2428057|NCT01190124|5955123|P1|COMPLETED|Overall Study||90
2428058|NCT01190124|5955121|P3|STARTED|Overall Study||20
2428059|NCT01190124|5955122|P2|STARTED|Overall Study||24
2428060|NCT01190124|5955123|P1|STARTED|Overall Study||107
2428061|NCT01190098|5955161|P2|NOT COMPLETED|Overall Study||2
2428062|NCT01190098|5955162|P1|NOT COMPLETED|Overall Study||3
2428063|NCT01190098|5955161|P2|COMPLETED|Overall Study||8
2428064|NCT01190098|5955162|P1|COMPLETED|Overall Study||39
2428065|NCT01190098|5955161|P2|STARTED|Overall Study||10
2428066|NCT01190098|5955162|P1|STARTED|Overall Study||42
2428067|NCT01190085|5955185|P3|NOT COMPLETED|Overall Study||0
2428068|NCT01190085|5955186|P2|NOT COMPLETED|Overall Study||0
2428069|NCT01190085|5955187|P1|NOT COMPLETED|Overall Study||0
2428070|NCT01190085|5955185|P3|COMPLETED|Overall Study||18
2428071|NCT01190085|5955186|P2|COMPLETED|Overall Study||14
2428072|NCT01190085|5955187|P1|COMPLETED|Overall Study||13
2428073|NCT01190085|5955185|P3|STARTED|Overall Study||18
2428074|NCT01190085|5955186|P2|STARTED|Overall Study||14
2428075|NCT01190085|5955187|P1|STARTED|Overall Study||13
2428076|NCT01190020|5955203|P2|NOT COMPLETED|Overall Study||0
2428077|NCT01190020|5955204|P1|NOT COMPLETED|Overall Study||7
2428078|NCT01190020|5955203|P2|COMPLETED|Overall Study||12
2428079|NCT01190020|5955204|P1|COMPLETED|Overall Study||22
2428080|NCT01190020|5955203|P2|STARTED|Overall Study||12
2428081|NCT01190020|5955204|P1|STARTED|Overall Study||29
2428082|NCT01190007|5955216|P1|NOT COMPLETED|Overall Study||14
2428083|NCT01190007|5955216|P1|COMPLETED|Overall Study||145
2428084|NCT01190007|5955216|P1|STARTED|Overall Study|Treated|159
2428085|NCT01189890|5955233|P2|NOT COMPLETED|Overall Study||39
2428086|NCT01189890|5955234|P1|NOT COMPLETED|Overall Study||37
2428087|NCT01189890|5955233|P2|COMPLETED|Overall Study||200
2428088|NCT01189890|5955234|P1|COMPLETED|Overall Study||204
2428089|NCT01189890|5955233|P2|STARTED|Overall Study|3 randomized glimepiride participants did not receive study drug.|239
2428090|NCT01189890|5955234|P1|STARTED|Overall Study||241
2428091|NCT01189812|5955256|P2|NOT COMPLETED|Overall Study||8
2428092|NCT01189812|5955257|P1|NOT COMPLETED|Overall Study||8
2428093|NCT01189812|5955256|P2|COMPLETED|Overall Study||32
2428094|NCT01189812|5955257|P1|COMPLETED|Overall Study||32
2428095|NCT01189812|5955256|P2|STARTED|Overall Study||40
2428096|NCT01189812|5955257|P1|STARTED|Overall Study||40
2428097|NCT01189760|5955266|P3|NOT COMPLETED|Overall Study||51
2428098|NCT01189760|5955267|P2|NOT COMPLETED|Overall Study||23
2428099|NCT01189760|5955268|P1|NOT COMPLETED|Overall Study||14
2428100|NCT01189760|5955266|P3|COMPLETED|Overall Study||255
2428101|NCT01189760|5955267|P2|COMPLETED|Overall Study||283
2428102|NCT01189760|5955268|P1|COMPLETED|Overall Study||291
2428103|NCT01189760|5955266|P3|STARTED|Overall Study||306
2428104|NCT01189760|5955267|P2|STARTED|Overall Study||306
2428105|NCT01189760|5955268|P1|STARTED|Overall Study||305
2428106|NCT01189747|5955302|P2|NOT COMPLETED|Overall Study||18
2428107|NCT01189747|5955303|P1|NOT COMPLETED|Overall Study||12
2428108|NCT01189747|5955302|P2|COMPLETED|Overall Study||206
2428109|NCT01189747|5955303|P1|COMPLETED|Overall Study||210
2428110|NCT01189747|5955302|P2|STARTED|Overall Study||224
2428111|NCT01189747|5955303|P1|STARTED|Overall Study||222
2428112|NCT01189617|5955327|P2|NOT COMPLETED|Overall Study||0
2428113|NCT01189617|5955328|P1|NOT COMPLETED|Overall Study||0
2428114|NCT01189617|5955327|P2|COMPLETED|Overall Study||35
2428115|NCT01189617|5955328|P1|COMPLETED|Overall Study||35
2428116|NCT01189617|5955327|P2|STARTED|Overall Study||35
2428117|NCT01189617|5955328|P1|STARTED|Overall Study||35
2428118|NCT01189604|5955341|P7|NOT COMPLETED|Overall Study||1
2428119|NCT01189604|5955342|P6|NOT COMPLETED|Overall Study||1
2428120|NCT01189604|5955343|P5|NOT COMPLETED|Overall Study||2
2428121|NCT01189604|5955344|P4|NOT COMPLETED|Overall Study||0
2428122|NCT01189604|5955345|P3|NOT COMPLETED|Overall Study||0
2428123|NCT01189604|5955346|P2|NOT COMPLETED|Overall Study||1
2428124|NCT01189604|5955347|P1|NOT COMPLETED|Overall Study||1
2428125|NCT01189604|5955341|P7|COMPLETED|Overall Study||9
2428126|NCT01189604|5955342|P6|COMPLETED|Overall Study||10
2428127|NCT01189604|5955343|P5|COMPLETED|Overall Study||18
2428128|NCT01189604|5955344|P4|COMPLETED|Overall Study||20
2428129|NCT01189604|5955345|P3|COMPLETED|Overall Study||20
2428130|NCT01189604|5955346|P2|COMPLETED|Overall Study||20
2428131|NCT01189604|5955347|P1|COMPLETED|Overall Study||20
2428132|NCT01189604|5955341|P7|Administered Study Drug|Overall Study||10
2428133|NCT01189604|5955342|P6|Administered Study Drug|Overall Study||10
2428134|NCT01189604|5955343|P5|Administered Study Drug|Overall Study||20
2428135|NCT01189604|5955344|P4|Administered Study Drug|Overall Study||20
2428136|NCT01189604|5955345|P3|Administered Study Drug|Overall Study||20
2428137|NCT01189604|5955346|P2|Administered Study Drug|Overall Study||20
2428138|NCT01189604|5955347|P1|Administered Study Drug|Overall Study||20
2428139|NCT01189604|5955341|P7|STARTED|Overall Study||10
2428140|NCT01189604|5955342|P6|STARTED|Overall Study||11
2428141|NCT01189604|5955343|P5|STARTED|Overall Study||20
2428142|NCT01189604|5955344|P4|STARTED|Overall Study||20
2428143|NCT01189604|5955345|P3|STARTED|Overall Study||20
2428144|NCT01189604|5955346|P2|STARTED|Overall Study||21
2428145|NCT01189604|5955347|P1|STARTED|Overall Study||21
2428146|NCT01189500|5955391|P1|NOT COMPLETED|Period 2: Coadministration TAMOX+DVS SR||1
2428147|NCT01189500|5955391|P1|COMPLETED|Period 2: Coadministration TAMOX+DVS SR||28
2428148|NCT01189500|5955391|P1|STARTED|Period 2: Coadministration TAMOX+DVS SR||29
2428149|NCT01189500|5955391|P1|NOT COMPLETED|Period 1: TAMOX Alone||1
2428150|NCT01189500|5955391|P1|COMPLETED|Period 1: TAMOX Alone||29
2428151|NCT01189500|5955391|P1|STARTED|Period 1: TAMOX Alone||30
2428152|NCT01189487|5955452|P1|NOT COMPLETED|Overall Study||3
2428153|NCT01189487|5955452|P1|COMPLETED|Overall Study||44
2428154|NCT01189487|5955452|P1|STARTED|Overall Study|Treated participants|47
2428155|NCT01189461|5955460|P1|NOT COMPLETED|Overall Study||34
2428156|NCT01189461|5955460|P1|COMPLETED|Overall Study||12
2428157|NCT01189461|5955460|P1|STARTED|Overall Study||46
2428158|NCT01189435|5955467|P1|NOT COMPLETED|Overall Study||2
2428159|NCT01189435|5955467|P1|COMPLETED|Overall Study||0
2428160|NCT01189435|5955467|P1|STARTED|Overall Study||2
2428161|NCT01189409|5955473|P2|NOT COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||8
2428162|NCT01189409|5955474|P1|NOT COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||6
2428163|NCT01189409|5955473|P2|COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||15
2428164|NCT01189409|5955474|P1|COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||13
2428165|NCT01189409|5955473|P2|STARTED|Second 3 Weeks (Switch to 2nd Treatment)||23
2428166|NCT01189409|5955474|P1|STARTED|Second 3 Weeks (Switch to 2nd Treatment)||19
2428167|NCT01189409|5955473|P2|NOT COMPLETED|First 3 Weeks||10
2428168|NCT01189409|5955474|P1|NOT COMPLETED|First 3 Weeks||18
2428169|NCT01189409|5955473|P2|COMPLETED|First 3 Weeks||23
2428170|NCT01189409|5955474|P1|COMPLETED|First 3 Weeks||19
2428171|NCT01189409|5955473|P2|STARTED|First 3 Weeks||33
2428172|NCT01189409|5955474|P1|STARTED|First 3 Weeks||37
2428173|NCT01189370|5955489|P3|NOT COMPLETED|Dose Level 3||6
2428174|NCT01189370|5955490|P2|NOT COMPLETED|Dose Level 3||0
2428175|NCT01189370|5955491|P1|NOT COMPLETED|Dose Level 3||0
2428176|NCT01189370|5955489|P3|COMPLETED|Dose Level 3||6
2428177|NCT01189370|5955490|P2|COMPLETED|Dose Level 3||0
2428178|NCT01189370|5955491|P1|COMPLETED|Dose Level 3||0
2428179|NCT01189370|5955489|P3|STARTED|Dose Level 3||12
2428180|NCT01189370|5955490|P2|STARTED|Dose Level 3||0
2428181|NCT01189370|5955491|P1|STARTED|Dose Level 3||0
2428182|NCT01189370|5955489|P3|NOT COMPLETED|Dose Level 2||0
2428183|NCT01189370|5955490|P2|NOT COMPLETED|Dose Level 2||4
2428184|NCT01189370|5955491|P1|NOT COMPLETED|Dose Level 2||0
2428185|NCT01189370|5955489|P3|COMPLETED|Dose Level 2||0
2428186|NCT01189370|5955490|P2|COMPLETED|Dose Level 2||12
2428187|NCT01189370|5955491|P1|COMPLETED|Dose Level 2||0
2428188|NCT01189370|5955489|P3|STARTED|Dose Level 2||0
2428189|NCT01189370|5955490|P2|STARTED|Dose Level 2||16
2428190|NCT01189370|5955491|P1|STARTED|Dose Level 2||0
2428191|NCT01189370|5955489|P3|NOT COMPLETED|Dose Level 1||0
2428192|NCT01189370|5955490|P2|NOT COMPLETED|Dose Level 1||0
2428193|NCT01189370|5955491|P1|NOT COMPLETED|Dose Level 1||9
2428194|NCT01189370|5955489|P3|COMPLETED|Dose Level 1||0
2428195|NCT01189370|5955490|P2|COMPLETED|Dose Level 1||0
2428196|NCT01189370|5955491|P1|COMPLETED|Dose Level 1||16
2428197|NCT01189370|5955489|P3|STARTED|Dose Level 1||0
2428198|NCT01189370|5955490|P2|STARTED|Dose Level 1||0
2428199|NCT01189370|5955491|P1|STARTED|Dose Level 1||25
2428200|NCT01189292|5955500|P2|NOT COMPLETED|Per Protocol Analysis||16
2428201|NCT01189292|5955501|P1|NOT COMPLETED|Per Protocol Analysis||11
2428202|NCT01189292|5955500|P2|COMPLETED|Per Protocol Analysis||60
2428203|NCT01189292|5955501|P1|COMPLETED|Per Protocol Analysis||65
2428204|NCT01189292|5955500|P2|STARTED|Per Protocol Analysis||76
2428205|NCT01189292|5955501|P1|STARTED|Per Protocol Analysis||76
2428206|NCT01189292|5955500|P2|NOT COMPLETED|Intention to Treat Analysis||0
2428207|NCT01189292|5955501|P1|NOT COMPLETED|Intention to Treat Analysis||0
2428208|NCT01189292|5955500|P2|COMPLETED|Intention to Treat Analysis||76
2428209|NCT01189292|5955501|P1|COMPLETED|Intention to Treat Analysis||76
2428210|NCT01189292|5955500|P2|STARTED|Intention to Treat Analysis||76
2428211|NCT01189292|5955501|P1|STARTED|Intention to Treat Analysis||76
2428212|NCT01189279|5955522|P3|NOT COMPLETED|Overall Study||1
2428213|NCT01189279|5955523|P2|NOT COMPLETED|Overall Study||0
2428214|NCT01189279|5955524|P1|NOT COMPLETED|Overall Study||1
2428215|NCT01189279|5955522|P3|COMPLETED|Overall Study||13
2428216|NCT01189279|5955523|P2|COMPLETED|Overall Study||14
2428217|NCT01189279|5955524|P1|COMPLETED|Overall Study||13
2428218|NCT01189279|5955522|P3|STARTED|Overall Study||14
2428219|NCT01189279|5955523|P2|STARTED|Overall Study||14
2428220|NCT01189279|5955524|P1|STARTED|Overall Study||14
2428221|NCT01189240|5955544|P3|NOT COMPLETED|Overall Study||0
2428222|NCT01189240|5955545|P2|NOT COMPLETED|Overall Study||0
2428223|NCT01189240|5955546|P1|NOT COMPLETED|Overall Study||0
2428224|NCT01189240|5955544|P3|COMPLETED|Overall Study||3
2428225|NCT01189240|5955545|P2|COMPLETED|Overall Study||6
2428226|NCT01189240|5955546|P1|COMPLETED|Overall Study||4
2428227|NCT01189240|5955544|P3|STARTED|Overall Study||3
2428228|NCT01189240|5955545|P2|STARTED|Overall Study||6
2428229|NCT01189240|5955546|P1|STARTED|Overall Study||4
2428230|NCT01189227|5955567|P2|NOT COMPLETED|Overall Study||3
2428231|NCT01189227|5955568|P1|NOT COMPLETED|Overall Study||6
2428232|NCT01189227|5955567|P2|COMPLETED|Overall Study||0
2428233|NCT01189227|5955568|P1|COMPLETED|Overall Study||0
2428234|NCT01189227|5955567|P2|STARTED|Overall Study||3
2428235|NCT01189227|5955568|P1|STARTED|Overall Study||6
2428236|NCT01189201|5955574|P1|NOT COMPLETED|Overall Study||1
2428237|NCT01189201|5955574|P1|COMPLETED|Overall Study||41
2428238|NCT01189201|5955574|P1|Received Empa/Linagliptin FDC A3(Fasted)|Overall Study||24
2428239|NCT01189201|5955574|P1|Received Empa/Linagliptin FDC A1 (Fed)|Overall Study||18
2428240|NCT01189201|5955574|P1|Rec. Empa/Linagliptin Ind.Tablet(Fasted)|Overall Study||41
2428241|NCT01189201|5955574|P1|Received Empa/Linagliptin FDC A1(Fasted)|Overall Study||42
2428242|NCT01189201|5955574|P1|STARTED|Overall Study||42
2428243|NCT01189136|5955630|P2|NOT COMPLETED|Overall Study||0
2428244|NCT01189136|5955631|P1|NOT COMPLETED|Overall Study||0
2428245|NCT01189136|5955630|P2|COMPLETED|Overall Study||42
2428246|NCT01189136|5955631|P1|COMPLETED|Overall Study||42
2428247|NCT01189136|5955630|P2|STARTED|Overall Study||42
2428248|NCT01189136|5955631|P1|STARTED|Overall Study||42
2428249|NCT01189123|5955645|P2|NOT COMPLETED|Overall Study||6
2428250|NCT01189123|5955646|P1|NOT COMPLETED|Overall Study||2
2428251|NCT01189123|5955645|P2|COMPLETED|Overall Study||47
2428252|NCT01189123|5955646|P1|COMPLETED|Overall Study||50
2428253|NCT01189123|5955645|P2|STARTED|Overall Study||53
2428254|NCT01189123|5955646|P1|STARTED|Overall Study||52
2428255|NCT01189110|5955656|P2|NOT COMPLETED|Overall Study||0
2428256|NCT01189110|5955657|P1|NOT COMPLETED|Overall Study||0
2428257|NCT01189110|5955656|P2|COMPLETED|Overall Study||61
2428258|NCT01189110|5955657|P1|COMPLETED|Overall Study|February, 2011|64
2428259|NCT01189110|5955656|P2|STARTED|Overall Study||61
2428260|NCT01189110|5955657|P1|STARTED|Overall Study|September, 2010|64
2428261|NCT01189071|5955665|P2|NOT COMPLETED|Overall Study||0
2428262|NCT01189071|5955666|P1|NOT COMPLETED|Overall Study||0
2428263|NCT01189071|5955665|P2|COMPLETED|Overall Study||0
2428264|NCT01189071|5955666|P1|COMPLETED|Overall Study||0
2428265|NCT01189071|5955665|P2|STARTED|Overall Study||0
2428266|NCT01189071|5955666|P1|STARTED|Overall Study||0
2428267|NCT01189032|5955677|P3|NOT COMPLETED|Overall Study||6
2428268|NCT01189032|5955678|P2|NOT COMPLETED|Overall Study||7
2428269|NCT01189032|5955679|P1|NOT COMPLETED|Overall Study||5
2428270|NCT01189032|5955677|P3|COMPLETED|Overall Study||90
2428271|NCT01189032|5955678|P2|COMPLETED|Overall Study||89
2428272|NCT01189032|5955679|P1|COMPLETED|Overall Study||89
2428273|NCT01189032|5955677|P3|STARTED|Overall Study||96
2428274|NCT01189032|5955678|P2|STARTED|Overall Study||96
2428275|NCT01189032|5955679|P1|STARTED|Overall Study||94
2428276|NCT01188967|5955689|P2|NOT COMPLETED|Overall Study||4
2428277|NCT01188967|5955690|P1|NOT COMPLETED|Overall Study||5
2428278|NCT01188967|5955689|P2|COMPLETED|Overall Study||4
2428279|NCT01188967|5955690|P1|COMPLETED|Overall Study||5
2428280|NCT01188967|5955689|P2|STARTED|Overall Study||8
2428281|NCT01188967|5955690|P1|STARTED|Overall Study||10
2428282|NCT01188928|5955706|P4|NOT COMPLETED|Overall Study||18
2428283|NCT01188928|5955707|P3|NOT COMPLETED|Overall Study||14
2428284|NCT01188928|5955708|P2|NOT COMPLETED|Overall Study||62
2428285|NCT01188928|5955709|P1|NOT COMPLETED|Overall Study||38
2428286|NCT01188928|5955706|P4|COMPLETED|Overall Study||77
2428287|NCT01188928|5955707|P3|COMPLETED|Overall Study||82
2428288|NCT01188928|5955708|P2|COMPLETED|Overall Study||417
2428289|NCT01188928|5955709|P1|COMPLETED|Overall Study||444
2428290|NCT01188928|5955706|P4|STARTED|Overall Study||95
2428291|NCT01188928|5955707|P3|STARTED|Overall Study||96
2428292|NCT01188928|5955708|P2|STARTED|Overall Study||479
2428293|NCT01188928|5955709|P1|STARTED|Overall Study||482
2428294|NCT01188876|5955731|P1|NOT COMPLETED|Overall Study||0
2428295|NCT01188876|5955731|P1|COMPLETED|Overall Study||50
2428296|NCT01188876|5955731|P1|STARTED|Overall Study||50
2428297|NCT01188811|5955743|P2|NOT COMPLETED|Overall Study||2
2428298|NCT01188811|5955744|P1|NOT COMPLETED|Overall Study||6
2428299|NCT01188811|5955743|P2|COMPLETED|Overall Study||24
2428300|NCT01188811|5955744|P1|COMPLETED|Overall Study||22
2428301|NCT01188811|5955743|P2|STARTED|Overall Study||26
2428302|NCT01188811|5955744|P1|STARTED|Overall Study||28
2428303|NCT01188798|5955756|P2|NOT COMPLETED|Overall Study||3
2428304|NCT01188798|5955757|P1|NOT COMPLETED|Overall Study||2
2428305|NCT01188798|5955756|P2|COMPLETED|Overall Study||1
2428306|NCT01188798|5955757|P1|COMPLETED|Overall Study||0
2428307|NCT01188798|5955756|P2|STARTED|Overall Study||4
2428308|NCT01188798|5955757|P1|STARTED|Overall Study||2
2428309|NCT01188772|5955769|P4|NOT COMPLETED|Overall Study||1
2428310|NCT01188772|5955770|P3|NOT COMPLETED|Overall Study||11
2428311|NCT01188772|5955771|P2|NOT COMPLETED|Overall Study||3
2428312|NCT01188772|5955772|P1|NOT COMPLETED|Overall Study||5
2428313|NCT01188772|5955769|P4|COMPLETED|Overall Study||24
2428314|NCT01188772|5955770|P3|COMPLETED|Overall Study||15
2428315|NCT01188772|5955771|P2|COMPLETED|Overall Study||45
2428316|NCT01188772|5955772|P1|COMPLETED|Overall Study||43
2428317|NCT01188772|5955769|P4|Randomized and Treated|Overall Study||25
2428318|NCT01188772|5955770|P3|Randomized and Treated|Overall Study||26
2428319|NCT01188772|5955771|P2|Randomized and Treated|Overall Study||47
2428320|NCT01188772|5955772|P1|Randomized and Treated|Overall Study||48
2428321|NCT01188772|5955769|P4|STARTED|Overall Study||25
2428322|NCT01188772|5955770|P3|STARTED|Overall Study||26
2428323|NCT01188772|5955771|P2|STARTED|Overall Study||48
2428324|NCT01188772|5955772|P1|STARTED|Overall Study||48
2428325|NCT01188694|5955830|P3|NOT COMPLETED|Overall Study||1
2428326|NCT01188694|5955831|P2|NOT COMPLETED|Overall Study||1
2428327|NCT01188694|5955832|P1|NOT COMPLETED|Overall Study||5
2428328|NCT01188694|5955830|P3|COMPLETED|Overall Study||10
2428329|NCT01188694|5955831|P2|COMPLETED|Overall Study||15
2428330|NCT01188694|5955832|P1|COMPLETED|Overall Study||10
2428331|NCT01188694|5955830|P3|STARTED|Overall Study||11
2428332|NCT01188694|5955831|P2|STARTED|Overall Study||16
2428333|NCT01188694|5955832|P1|STARTED|Overall Study||15
2428334|NCT01188681|5955844|P4|NOT COMPLETED|Overall Study||1
2428335|NCT01188681|5955845|P3|NOT COMPLETED|Overall Study||1
2428336|NCT01188681|5955846|P2|NOT COMPLETED|Overall Study||0
2428337|NCT01188681|5955847|P1|NOT COMPLETED|Overall Study||0
2428338|NCT01188681|5955844|P4|COMPLETED|Overall Study||33
2428339|NCT01188681|5955845|P3|COMPLETED|Overall Study||32
2428340|NCT01188681|5955846|P2|COMPLETED|Overall Study||6
2428341|NCT01188681|5955847|P1|COMPLETED|Overall Study||6
2428342|NCT01188681|5955844|P4|STARTED|Overall Study|34 patients enrolled, 33 patients treated. One patient withdrew consent and was not treated.|34
2428343|NCT01188681|5955845|P3|STARTED|Overall Study|33 patients enrolled, 32 patients treated. One patient had bladder cancer and was not treated.|33
2428344|NCT01188681|5955846|P2|STARTED|Overall Study||6
2428345|NCT01188681|5955847|P1|STARTED|Overall Study||6
2428346|NCT01188668|5955861|P1|NOT COMPLETED|Period 2: Coadministration ARIP + DVS SR||3
2428347|NCT01188668|5955861|P1|COMPLETED|Period 2: Coadministration ARIP + DVS SR||33
2428348|NCT01188668|5955861|P1|STARTED|Period 2: Coadministration ARIP + DVS SR||36
2428349|NCT01188668|5955861|P1|NOT COMPLETED|Period 1: ARIP Alone||2
2428350|NCT01188668|5955861|P1|COMPLETED|Period 1: ARIP Alone||36
2428351|NCT01188668|5955861|P1|STARTED|Period 1: ARIP Alone||38
2428352|NCT01188655|5955894|P1|NOT COMPLETED|Overall Study||13
2428353|NCT01188655|5955894|P1|COMPLETED|Overall Study||76
2428354|NCT01188655|5955894|P1|STARTED|Overall Study||89
2428355|NCT01188603|5955909|P1|NOT COMPLETED|Overall Study||0
2428356|NCT01188603|5955909|P1|COMPLETED|Overall Study||24
2428357|NCT01188603|5955909|P1|STARTED|Overall Study||24
2428358|NCT01188577|5955919|P2|NOT COMPLETED|Visit 2||0
2428359|NCT01188577|5955920|P1|NOT COMPLETED|Visit 2||0
2428360|NCT01188577|5955919|P2|COMPLETED|Visit 2||12
2428361|NCT01188577|5955920|P1|COMPLETED|Visit 2||11
2428362|NCT01188577|5955919|P2|STARTED|Visit 2||12
2428363|NCT01188577|5955920|P1|STARTED|Visit 2||11
2428364|NCT01188577|5955919|P2|NOT COMPLETED|3-14 Day Washout||0
2428365|NCT01188577|5955920|P1|NOT COMPLETED|3-14 Day Washout||0
2428366|NCT01188577|5955919|P2|COMPLETED|3-14 Day Washout||12
2428367|NCT01188577|5955920|P1|COMPLETED|3-14 Day Washout||11
2428368|NCT01188577|5955919|P2|STARTED|3-14 Day Washout||12
2428369|NCT01188577|5955920|P1|STARTED|3-14 Day Washout||11
2428370|NCT01188577|5955919|P2|NOT COMPLETED|Visit 1||0
2428371|NCT01188577|5955920|P1|NOT COMPLETED|Visit 1||0
2428372|NCT01188577|5955919|P2|COMPLETED|Visit 1||12
2428373|NCT01188577|5955920|P1|COMPLETED|Visit 1||11
2428374|NCT01188577|5955919|P2|STARTED|Visit 1||12
2428375|NCT01188577|5955920|P1|STARTED|Visit 1||11
2428376|NCT01188564|5955938|P2|NOT COMPLETED|Open Label Phase||0
2428377|NCT01188564|5955939|P1|NOT COMPLETED|Open Label Phase||0
2428378|NCT01188564|5955938|P2|COMPLETED|Open Label Phase||20
2428379|NCT01188564|5955939|P1|COMPLETED|Open Label Phase||24
2428380|NCT01188564|5955938|P2|STARTED|Open Label Phase|Not all Double Blind Phase participants went on to Open Label Phase|20
2428381|NCT01188564|5955939|P1|STARTED|Open Label Phase|Not all Double-Blind Phase participants went on to Open Label Phase|24
2428382|NCT01188564|5955938|P2|NOT COMPLETED|Double-blind Phase||0
2428383|NCT01188564|5955939|P1|NOT COMPLETED|Double-blind Phase||1
2428384|NCT01188564|5955938|P2|COMPLETED|Double-blind Phase||31
2428385|NCT01188564|5955939|P1|COMPLETED|Double-blind Phase||43
2428386|NCT01188564|5955938|P2|STARTED|Double-blind Phase||31
2428387|NCT01188564|5955939|P1|STARTED|Double-blind Phase||44
2428388|NCT01188551|5955951|P4|NOT COMPLETED|Overall Study||0
2428389|NCT01188551|5955952|P3|NOT COMPLETED|Overall Study||0
2428390|NCT01188551|5955953|P2|NOT COMPLETED|Overall Study||0
2428391|NCT01188551|5955954|P1|NOT COMPLETED|Overall Study||1
2428392|NCT01188551|5955951|P4|COMPLETED|Overall Study||25
2428393|NCT01188551|5955952|P3|COMPLETED|Overall Study||25
2428394|NCT01188551|5955953|P2|COMPLETED|Overall Study||25
2428395|NCT01188551|5955954|P1|COMPLETED|Overall Study||24
2428396|NCT01188551|5955951|P4|STARTED|Overall Study||25
2428397|NCT01188551|5955952|P3|STARTED|Overall Study||25
2428398|NCT01188551|5955953|P2|STARTED|Overall Study||25
2428399|NCT01188551|5955954|P1|STARTED|Overall Study||25
2428400|NCT01188538|5955970|P2|NOT COMPLETED|Overall Study||1
2428401|NCT01188538|5955971|P1|NOT COMPLETED|Overall Study||0
2428402|NCT01188538|5955970|P2|COMPLETED|Overall Study||19
2428403|NCT01188538|5955971|P1|COMPLETED|Overall Study||20
2428404|NCT01188538|5955970|P2|STARTED|Overall Study||20
2428405|NCT01188538|5955971|P1|STARTED|Overall Study||20
2428406|NCT01188499|5955984|P5|NOT COMPLETED|Overall Study||0
2428407|NCT01188499|5955985|P4|NOT COMPLETED|Overall Study||0
2428408|NCT01188499|5955986|P3|NOT COMPLETED|Overall Study||0
2428409|NCT01188499|5955987|P2|NOT COMPLETED|Overall Study||0
2428410|NCT01188499|5955988|P1|NOT COMPLETED|Overall Study||0
2428411|NCT01188499|5955984|P5|COMPLETED|Overall Study||18
2428412|NCT01188499|5955985|P4|COMPLETED|Overall Study||18
2428413|NCT01188499|5955986|P3|COMPLETED|Overall Study||33
2428414|NCT01188499|5955987|P2|COMPLETED|Overall Study||83
2428415|NCT01188499|5955988|P1|COMPLETED|Overall Study||24
2428416|NCT01188499|5955984|P5|STARTED|Overall Study||18
2428417|NCT01188499|5955985|P4|STARTED|Overall Study||18
2428418|NCT01188499|5955986|P3|STARTED|Overall Study||33
2428419|NCT01188499|5955987|P2|STARTED|Overall Study||83
2428420|NCT01188499|5955988|P1|STARTED|Overall Study||24
2428421|NCT01188460|5956007|P2|NOT COMPLETED|Overall Study||0
2428422|NCT01188460|5956008|P1|NOT COMPLETED|Overall Study||0
2428423|NCT01188460|5956007|P2|COMPLETED|Overall Study||23
2428424|NCT01188460|5956008|P1|COMPLETED|Overall Study||25
2428425|NCT01188460|5956007|P2|STARTED|Overall Study||23
2428426|NCT01188460|5956008|P1|STARTED|Overall Study||25
2428427|NCT01188447|5956034|P1|NOT COMPLETED|Overall Study||0
2428428|NCT01188447|5956034|P1|COMPLETED|Overall Study||4034
2428429|NCT01188447|5956034|P1|STARTED|Overall Study||4034
2428430|NCT01188421|5956045|P3|NOT COMPLETED|Overall Study||14
2428431|NCT01188421|5956046|P2|NOT COMPLETED|Overall Study||10
2428432|NCT01188421|5956047|P1|NOT COMPLETED|Overall Study||3
2428433|NCT01188421|5956045|P3|COMPLETED|Overall Study||22
2428434|NCT01188421|5956046|P2|COMPLETED|Overall Study||26
2428435|NCT01188421|5956047|P1|COMPLETED|Overall Study||28
2428436|NCT01188421|5956045|P3|STARTED|Overall Study||36
2428437|NCT01188421|5956046|P2|STARTED|Overall Study||36
2428438|NCT01188421|5956047|P1|STARTED|Overall Study||31
2428439|NCT01188369|5956057|P2|NOT COMPLETED|Overall Study||0
2428440|NCT01188369|5956058|P1|NOT COMPLETED|Overall Study||0
2428441|NCT01188369|5956057|P2|COMPLETED|Overall Study||10
2428442|NCT01188369|5956058|P1|COMPLETED|Overall Study||10
2428443|NCT01188369|5956057|P2|STARTED|Overall Study||10
2428444|NCT01188369|5956058|P1|STARTED|Overall Study||10
2428445|NCT01188343|5956067|P3|NOT COMPLETED|Overall Study||1
2428446|NCT01188343|5956068|P2|NOT COMPLETED|Overall Study||26
2428447|NCT01188343|5956069|P1|NOT COMPLETED|Overall Study||1
2428448|NCT01188343|5956067|P3|COMPLETED|Overall Study||220
2428449|NCT01188343|5956068|P2|COMPLETED|Overall Study||193
2428450|NCT01188343|5956069|P1|COMPLETED|Overall Study||101
2428451|NCT01188343|5956067|P3|STARTED|Overall Study||221
2428452|NCT01188343|5956068|P2|STARTED|Overall Study||219
2428453|NCT01188343|5956069|P1|STARTED|Overall Study||102
2428454|NCT01188226|5956095|P1|NOT COMPLETED|Overall Study||4
2428455|NCT01188226|5956095|P1|COMPLETED|Overall Study||6
2428456|NCT01188226|5956095|P1|STARTED|Overall Study||10
2428457|NCT01188109|5956134|P1|NOT COMPLETED|Overall Study||0
2428458|NCT01188109|5956134|P1|COMPLETED|Overall Study||22
2428459|NCT01188109|5956134|P1|STARTED|Overall Study||22
2428460|NCT01187953|5956141|P2|NOT COMPLETED|Overall Study||21
2428461|NCT01187953|5956142|P1|NOT COMPLETED|Overall Study||15
2428462|NCT01187953|5956141|P2|COMPLETED|Overall Study||254
2428463|NCT01187953|5956142|P1|COMPLETED|Overall Study||253
2428464|NCT01187953|5956141|P2|Dosed|Overall Study||271
2428465|NCT01187953|5956142|P1|Dosed|Overall Study||266
2428466|NCT01187953|5956141|P2|STARTED|Overall Study||275
2428467|NCT01187953|5956142|P1|STARTED|Overall Study||268
2428468|NCT01187914|5956150|P1|NOT COMPLETED|Overall Study||0
2428469|NCT01187914|5956150|P1|COMPLETED|Overall Study||40
2428470|NCT01187914|5956150|P1|STARTED|Overall Study||40
2428471|NCT01187901|5956156|P2|NOT COMPLETED|Overall Study||10
2428472|NCT01187901|5956157|P1|NOT COMPLETED|Overall Study||9
2428473|NCT01187901|5956156|P2|COMPLETED|Overall Study||36
2428474|NCT01187901|5956157|P1|COMPLETED|Overall Study||37
2428475|NCT01187901|5956156|P2|STARTED|Overall Study||46
2428476|NCT01187901|5956157|P1|STARTED|Overall Study||46
2428477|NCT01187771|5956175|P2|NOT COMPLETED|Overall Study||3
2428478|NCT01187771|5956176|P1|NOT COMPLETED|Overall Study||3
2428479|NCT01187771|5956175|P2|COMPLETED|Overall Study||18
2428480|NCT01187771|5956176|P1|COMPLETED|Overall Study||25
2428481|NCT01187771|5956175|P2|STARTED|Overall Study||21
2428482|NCT01187771|5956176|P1|STARTED|Overall Study||28
2428483|NCT01187550|5956198|P2|NOT COMPLETED|Overall Study||1
2428484|NCT01187550|5956199|P1|NOT COMPLETED|Overall Study||14
2428485|NCT01187550|5956198|P2|COMPLETED|Overall Study||29
2428486|NCT01187550|5956199|P1|COMPLETED|Overall Study||169
2428487|NCT01187550|5956198|P2|Treated|Overall Study||30
2428488|NCT01187550|5956199|P1|Treated|Overall Study||175
2428489|NCT01187550|5956198|P2|STARTED|Overall Study||30
2428490|NCT01187550|5956199|P1|STARTED|Overall Study||183
2428491|NCT01187511|5956217|P2|NOT COMPLETED|Overall Study||1
2428492|NCT01187511|5956218|P1|NOT COMPLETED|Overall Study||8
2428493|NCT01187511|5956217|P2|COMPLETED|Overall Study||21
2428494|NCT01187511|5956218|P1|COMPLETED|Overall Study||14
2428495|NCT01187511|5956217|P2|STARTED|Overall Study||22
2428496|NCT01187511|5956218|P1|STARTED|Overall Study||22
2428497|NCT01187498|5956326|P2|NOT COMPLETED|Overall Study||10
2428498|NCT01187498|5956327|P1|NOT COMPLETED|Overall Study||9
2428499|NCT01187498|5956326|P2|COMPLETED|Overall Study||60
2428500|NCT01187498|5956327|P1|COMPLETED|Overall Study||64
2428501|NCT01187498|5956326|P2|STARTED|Overall Study||70
2428502|NCT01187498|5956327|P1|STARTED|Overall Study||73
2428503|NCT01187446|5956355|P2|NOT COMPLETED|Overall Study||1
2428504|NCT01187446|5956356|P1|NOT COMPLETED|Overall Study||0
2428505|NCT01187446|5956355|P2|COMPLETED|Overall Study||13
2428506|NCT01187446|5956356|P1|COMPLETED|Overall Study||14
2428507|NCT01187446|5956355|P2|STARTED|Overall Study||14
2428508|NCT01187446|5956356|P1|STARTED|Overall Study||14
2428509|NCT01187433|5956372|P2|NOT COMPLETED|Overall Study||4
2428510|NCT01187433|5956373|P1|NOT COMPLETED|Overall Study||11
2428511|NCT01187433|5956372|P2|COMPLETED|Overall Study||46
2428512|NCT01187433|5956373|P1|COMPLETED|Overall Study||89
2428513|NCT01187433|5956372|P2|STARTED|Overall Study||50
2428514|NCT01187433|5956373|P1|STARTED|Overall Study||100
2428515|NCT01187407|5956403|P5|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||75
2428516|NCT01187407|5956404|P4|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||29
2428517|NCT01187407|5956405|P3|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
2428518|NCT01187407|5956406|P2|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||36
2428519|NCT01187407|5956407|P1|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
2428520|NCT01187407|5956403|P5|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||626
2428521|NCT01187407|5956404|P4|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||202
2428522|NCT01187407|5956405|P3|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||191
2428523|NCT01187407|5956406|P2|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196
2428524|NCT01187407|5956407|P1|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
2428525|NCT01187407|5956403|P5|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|660
2428526|NCT01187407|5956404|P4|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|220
2428527|NCT01187407|5956405|P3|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|215
2428528|NCT01187407|5956406|P2|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|212
2428529|NCT01187407|5956407|P1|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
2428530|NCT01187407|5956403|P5|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||701
2428531|NCT01187407|5956404|P4|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231
2428532|NCT01187407|5956405|P3|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||226
2428533|NCT01187407|5956406|P2|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||232
2428534|NCT01187407|5956407|P1|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
2428535|NCT01187407|5956403|P5|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
2428536|NCT01187407|5956404|P4|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
2428537|NCT01187407|5956405|P3|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
2428538|NCT01187407|5956406|P2|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
2428539|NCT01187407|5956407|P1|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||90
2428540|NCT01187407|5956403|P5|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
2428541|NCT01187407|5956404|P4|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
2428542|NCT01187407|5956405|P3|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
2428543|NCT01187407|5956406|P2|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
2428544|NCT01187407|5956407|P1|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|1390
2428545|NCT01187407|5956403|P5|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
2428546|NCT01187407|5956404|P4|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
2428547|NCT01187407|5956405|P3|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
2428548|NCT01187407|5956406|P2|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
2428549|NCT01187407|5956407|P1|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|25
2428550|NCT01187407|5956403|P5|STARTED|Confirmation (CF) Phase, 3 Weeks||0
2428551|NCT01187407|5956404|P4|STARTED|Confirmation (CF) Phase, 3 Weeks||0
2428552|NCT01187407|5956405|P3|STARTED|Confirmation (CF) Phase, 3 Weeks||0
2428553|NCT01187407|5956406|P2|STARTED|Confirmation (CF) Phase, 3 Weeks||0
2428554|NCT01187407|5956407|P1|STARTED|Confirmation (CF) Phase, 3 Weeks||1480
2428555|NCT01187381|5956477|P1|NOT COMPLETED|Overall Study||0
2428556|NCT01187381|5956477|P1|COMPLETED|Overall Study|A participant completed study when the trastuzumab treatment was discontinued.|250
2428557|NCT01187381|5956477|P1|STARTED|Overall Study||250
2428558|NCT01187355|5956489|P2|NOT COMPLETED|Overall Study||20
2428559|NCT01187355|5956490|P1|NOT COMPLETED|Overall Study||18
2428560|NCT01187355|5956489|P2|COMPLETED|Overall Study||277
2428561|NCT01187355|5956490|P1|COMPLETED|Overall Study||276
2428562|NCT01187355|5956489|P2|STARTED|Overall Study||297
2428563|NCT01187355|5956490|P1|STARTED|Overall Study||294
2428564|NCT01187329|5956502|P2|NOT COMPLETED|Overall Study||2
2428565|NCT01187329|5956503|P1|NOT COMPLETED|Overall Study||1
2428566|NCT01187329|5956502|P2|COMPLETED|Overall Study||48
2428567|NCT01187329|5956503|P1|COMPLETED|Overall Study||49
2428568|NCT01187329|5956502|P2|STARTED|Overall Study||50
2428569|NCT01187329|5956503|P1|STARTED|Overall Study||50
2428570|NCT01187043|5956520|P5|NOT COMPLETED|Overall Study||2
2428571|NCT01187043|5956521|P4|NOT COMPLETED|Overall Study||0
2428572|NCT01187043|5956522|P3|NOT COMPLETED|Overall Study||4
2428573|NCT01187043|5956523|P2|NOT COMPLETED|Overall Study||0
2428574|NCT01187043|5956524|P1|NOT COMPLETED|Overall Study||1
2428575|NCT01187043|5956520|P5|COMPLETED|Overall Study||10
2428576|NCT01187043|5956521|P4|COMPLETED|Overall Study||12
2428577|NCT01187043|5956522|P3|COMPLETED|Overall Study||8
2428578|NCT01187043|5956523|P2|COMPLETED|Overall Study||10
2428579|NCT01187043|5956524|P1|COMPLETED|Overall Study||11
2428580|NCT01187043|5956520|P5|STARTED|Overall Study||12
2428581|NCT01187043|5956521|P4|STARTED|Overall Study||12
2428582|NCT01187043|5956522|P3|STARTED|Overall Study||12
2428583|NCT01187043|5956523|P2|STARTED|Overall Study||10
2428584|NCT01187043|5956524|P1|STARTED|Overall Study||12
2428585|NCT01187017|5956536|P1|NOT COMPLETED|Overall Study||0
2428586|NCT01187017|5956536|P1|COMPLETED|Overall Study||1
2428587|NCT01187017|5956536|P1|STARTED|Overall Study||1
2428588|NCT01187004|5956542|P2|NOT COMPLETED|Overall Study||0
2428589|NCT01187004|5956543|P1|NOT COMPLETED|Overall Study||0
2428590|NCT01187004|5956542|P2|COMPLETED|Overall Study||144
2428591|NCT01187004|5956543|P1|COMPLETED|Overall Study||20
2428592|NCT01187004|5956542|P2|STARTED|Overall Study||144
2428593|NCT01187004|5956543|P1|STARTED|Overall Study||20
2428594|NCT01186939|5956550|P1|NOT COMPLETED|Overall Study||40
2428595|NCT01186939|5956550|P1|COMPLETED|Overall Study||0
2428596|NCT01186939|5956550|P1|STARTED|Overall Study||40
2428597|NCT01186848|5956554|P1|NOT COMPLETED|Overall Study||8
2428598|NCT01186848|5956554|P1|COMPLETED|Overall Study||22
2428599|NCT01186848|5956554|P1|STARTED|Overall Study||30
2428600|NCT01186809|5956560|P1|NOT COMPLETED|Overall Study||30
2428601|NCT01186809|5956560|P1|COMPLETED|Overall Study||43
2428602|NCT01186809|5956560|P1|STARTED|Overall Study||73
2428603|NCT01186796|5956566|P2|NOT COMPLETED|Overall Study||2
2428604|NCT01186796|5956567|P1|NOT COMPLETED|Overall Study||4
2428605|NCT01186796|5956566|P2|COMPLETED|Overall Study||14
2428606|NCT01186796|5956567|P1|COMPLETED|Overall Study||10
2428607|NCT01186796|5956566|P2|STARTED|Overall Study|1 subject was randomized but withdrew before study interventions.|16
2428608|NCT01186796|5956567|P1|STARTED|Overall Study||14
2428609|NCT01186770|5956585|P4|NOT COMPLETED|Overall Study||58
2428610|NCT01186770|5956586|P3|NOT COMPLETED|Overall Study||52
2428611|NCT01186770|5956587|P2|NOT COMPLETED|Overall Study||46
2428612|NCT01186770|5956588|P1|NOT COMPLETED|Overall Study||41
2428613|NCT01186770|5956585|P4|COMPLETED|Overall Study||143
2428614|NCT01186770|5956586|P3|COMPLETED|Overall Study||148
2428615|NCT01186770|5956587|P2|COMPLETED|Overall Study||156
2428616|NCT01186770|5956588|P1|COMPLETED|Overall Study||160
2428617|NCT01186770|5956585|P4|Intent-to-treat (ITT Population)|Overall Study||201
2428618|NCT01186770|5956586|P3|Intent-to-treat (ITT Population)|Overall Study||200
2428619|NCT01186770|5956587|P2|Intent-to-treat (ITT Population)|Overall Study||201
2428620|NCT01186770|5956588|P1|Intent-to-treat (ITT Population)|Overall Study||201
2428621|NCT01186770|5956585|P4|STARTED|Overall Study||201
2428622|NCT01186770|5956586|P3|STARTED|Overall Study||200
2428623|NCT01186770|5956587|P2|STARTED|Overall Study||202
2428624|NCT01186770|5956588|P1|STARTED|Overall Study||201
2428625|NCT01186744|5956612|P6|NOT COMPLETED|Overall Study||26
2428626|NCT01186744|5956613|P5|NOT COMPLETED|Overall Study||6
2428627|NCT01186744|5956614|P4|NOT COMPLETED|Overall Study||12
2428628|NCT01186744|5956615|P3|NOT COMPLETED|Overall Study||6
2428629|NCT01186744|5956616|P2|NOT COMPLETED|Overall Study||152
2428630|NCT01186744|5956617|P1|NOT COMPLETED|Overall Study||208
2428631|NCT01186744|5956612|P6|COMPLETED|Overall Study||107
2428632|NCT01186744|5956613|P5|COMPLETED|Overall Study||39
2428633|NCT01186744|5956614|P4|COMPLETED|Overall Study||70
2428634|NCT01186744|5956615|P3|COMPLETED|Overall Study||25
2428635|NCT01186744|5956616|P2|COMPLETED|Overall Study||5
2428636|NCT01186744|5956617|P1|COMPLETED|Overall Study||10
2428637|NCT01186744|5956612|P6|STARTED|Overall Study||133
2428638|NCT01186744|5956613|P5|STARTED|Overall Study||45
2428639|NCT01186744|5956614|P4|STARTED|Overall Study||82
2428640|NCT01186744|5956615|P3|STARTED|Overall Study||31
2428641|NCT01186744|5956616|P2|STARTED|Overall Study||157
2428642|NCT01186744|5956617|P1|STARTED|Overall Study||218
2428643|NCT01186705|5957033|P1|NOT COMPLETED|Overall Study||0
2428644|NCT01186705|5957033|P1|COMPLETED|Overall Study||1
2428645|NCT01186705|5957033|P1|STARTED|Overall Study||1
2428646|NCT01186692|5957037|P1|NOT COMPLETED|Overall Study||32
2428647|NCT01186692|5957037|P1|COMPLETED|Overall Study||99
2428648|NCT01186692|5957037|P1|STARTED|Overall Study||131
2428649|NCT01186562|5957047|P2|NOT COMPLETED|Overall Study||2
2428650|NCT01186562|5957048|P1|NOT COMPLETED|Overall Study||4
2428651|NCT01186562|5957047|P2|COMPLETED|Overall Study||27
2428652|NCT01186562|5957048|P1|COMPLETED|Overall Study||50
2428653|NCT01186562|5957047|P2|STARTED|Overall Study||29
2428654|NCT01186562|5957048|P1|STARTED|Overall Study||54
2428655|NCT01186458|5957064|P1|NOT COMPLETED|Overall Study||1
2428656|NCT01186458|5957064|P1|COMPLETED|Overall Study||3
2428657|NCT01186458|5957064|P1|STARTED|Overall Study||4
2428658|NCT01186419|5957073|P2|NOT COMPLETED|Overall Study||9
2428659|NCT01186419|5957074|P1|NOT COMPLETED|Overall Study||7
2428660|NCT01186419|5957073|P2|COMPLETED|Overall Study||18
2428661|NCT01186419|5957074|P1|COMPLETED|Overall Study||17
2428662|NCT01186419|5957073|P2|STARTED|Overall Study||27
2428663|NCT01186419|5957074|P1|STARTED|Overall Study||24
2428664|NCT01186406|5957081|P1|NOT COMPLETED|Overall Study||0
2428665|NCT01186406|5957081|P1|COMPLETED|Overall Study||41
2428666|NCT01186406|5957081|P1|STARTED|Overall Study||41
2428667|NCT01186328|5957088|P3|NOT COMPLETED|Overall Study||0
2428668|NCT01186328|5957089|P2|NOT COMPLETED|Overall Study||0
2428669|NCT01186328|5957090|P1|NOT COMPLETED|Overall Study||1
2428670|NCT01186328|5957088|P3|COMPLETED|Overall Study||0
2428671|NCT01186328|5957089|P2|COMPLETED|Overall Study||0
2428672|NCT01186328|5957090|P1|COMPLETED|Overall Study||5
2428673|NCT01186328|5957088|P3|STARTED|Overall Study||0
2428674|NCT01186328|5957089|P2|STARTED|Overall Study||0
2428675|NCT01186328|5957090|P1|STARTED|Overall Study||6
2428676|NCT01186250|5957098|P2|NOT COMPLETED|Overall Study||0
2428677|NCT01186250|5957099|P1|NOT COMPLETED|Overall Study||1
2428678|NCT01186250|5957098|P2|COMPLETED|Overall Study||9
2428679|NCT01186250|5957099|P1|COMPLETED|Overall Study||8
2428680|NCT01186250|5957098|P2|STARTED|Overall Study||9
2428681|NCT01186250|5957099|P1|STARTED|Overall Study||9
2428682|NCT01185964|5957120|P4|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||5
2428683|NCT01185964|5957121|P3|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
2428684|NCT01185964|5957122|P2|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
2428685|NCT01185964|5957123|P1|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
2428686|NCT01185964|5957120|P4|COMPLETED|Optional Olaratumab Monotherapy on Dox||25
2428687|NCT01185964|5957121|P3|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
2428688|NCT01185964|5957122|P2|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
2428689|NCT01185964|5957123|P1|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
2428690|NCT01185964|5957120|P4|STARTED|Optional Olaratumab Monotherapy on Dox|Participants with disease progression after treatment received olaratumab.|30
2428691|NCT01185964|5957121|P3|STARTED|Optional Olaratumab Monotherapy on Dox||0
2428692|NCT01185964|5957122|P2|STARTED|Optional Olaratumab Monotherapy on Dox||0
2428693|NCT01185964|5957123|P1|STARTED|Optional Olaratumab Monotherapy on Dox||0
2428694|NCT01185964|5957120|P4|NOT COMPLETED|Phase 1b and Phase 2||0
2428695|NCT01185964|5957121|P3|NOT COMPLETED|Phase 1b and Phase 2||9
2428696|NCT01185964|5957122|P2|NOT COMPLETED|Phase 1b and Phase 2||10
2428697|NCT01185964|5957123|P1|NOT COMPLETED|Phase 1b and Phase 2||2
2428698|NCT01185964|5957120|P4|COMPLETED|Phase 1b and Phase 2||0
2428699|NCT01185964|5957121|P3|COMPLETED|Phase 1b and Phase 2||58
2428700|NCT01185964|5957122|P2|COMPLETED|Phase 1b and Phase 2||56
2428701|NCT01185964|5957123|P1|COMPLETED|Phase 1b and Phase 2||13
2428702|NCT01185964|5957120|P4|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||0
2428703|NCT01185964|5957121|P3|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||65
2428704|NCT01185964|5957122|P2|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||64
2428705|NCT01185964|5957123|P1|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||15
2428706|NCT01185964|5957120|P4|STARTED|Phase 1b and Phase 2||0
2428707|NCT01185964|5957121|P3|STARTED|Phase 1b and Phase 2||67
2428708|NCT01185964|5957122|P2|STARTED|Phase 1b and Phase 2||66
2428709|NCT01185964|5957123|P1|STARTED|Phase 1b and Phase 2||15
2428710|NCT01185834|5957149|P1|NOT COMPLETED|Overall Study||14
2428711|NCT01185834|5957149|P1|COMPLETED|Overall Study||104
2428712|NCT01185834|5957149|P1|STARTED|Overall Study||118
2428713|NCT01185821|5957159|P5|NOT COMPLETED|Overall Study||24
2428714|NCT01185821|5957160|P4|NOT COMPLETED|Overall Study||6
2428715|NCT01185821|5957161|P3|NOT COMPLETED|Overall Study||10
2428716|NCT01185821|5957162|P2|NOT COMPLETED|Overall Study||9
2428717|NCT01185821|5957163|P1|NOT COMPLETED|Overall Study||7
2428718|NCT01185821|5957159|P5|COMPLETED|Overall Study||26
2428719|NCT01185821|5957160|P4|COMPLETED|Overall Study||23
2428720|NCT01185821|5957161|P3|COMPLETED|Overall Study||33
2428721|NCT01185821|5957162|P2|COMPLETED|Overall Study||20
2428722|NCT01185821|5957163|P1|COMPLETED|Overall Study||26
2428723|NCT01185821|5957159|P5|Patients on Placebo in Core|Overall Study||2
2428724|NCT01185821|5957160|P4|Patients on Placebo in Core|Overall Study||8
2428725|NCT01185821|5957161|P3|Patients on Placebo in Core|Overall Study||9
2428726|NCT01185821|5957162|P2|Patients on Placebo in Core|Overall Study||7
2428727|NCT01185821|5957163|P1|Patients on Placebo in Core|Overall Study||8
2428728|NCT01185821|5957159|P5|Patients Without Washout|Overall Study||17
2428729|NCT01185821|5957160|P4|Patients Without Washout|Overall Study||0
2428730|NCT01185821|5957161|P3|Patients Without Washout|Overall Study||4
2428731|NCT01185821|5957162|P2|Patients Without Washout|Overall Study||0
2428732|NCT01185821|5957163|P1|Patients Without Washout|Overall Study||0
2428733|NCT01185821|5957159|P5|Patients With Washout|Overall Study||33
2428734|NCT01185821|5957160|P4|Patients With Washout|Overall Study||29
2428735|NCT01185821|5957161|P3|Patients With Washout|Overall Study||39
2428736|NCT01185821|5957162|P2|Patients With Washout|Overall Study||29
2428737|NCT01185821|5957163|P1|Patients With Washout|Overall Study||33
2428738|NCT01185821|5957159|P5|STARTED|Overall Study||50
2428739|NCT01185821|5957160|P4|STARTED|Overall Study||29
2428740|NCT01185821|5957161|P3|STARTED|Overall Study||43
2428741|NCT01185821|5957162|P2|STARTED|Overall Study||29
2428742|NCT01185821|5957163|P1|STARTED|Overall Study||33
2428743|NCT01185782|5957214|P2|NOT COMPLETED|Overall Study||11
2428744|NCT01185782|5957215|P1|NOT COMPLETED|Overall Study||6
2428745|NCT01185782|5957214|P2|COMPLETED|Overall Study||125
2428746|NCT01185782|5957215|P1|COMPLETED|Overall Study||123
2428747|NCT01185782|5957214|P2|Treated|Overall Study||132
2428748|NCT01185782|5957215|P1|Treated|Overall Study||129
2428749|NCT01185782|5957214|P2|STARTED|Overall Study||136
2428750|NCT01185782|5957215|P1|STARTED|Overall Study||129
2428751|NCT01185704|5957243|P2|NOT COMPLETED|Overall Study||8
2428752|NCT01185704|5957244|P1|NOT COMPLETED|Overall Study||13
2428753|NCT01185704|5957243|P2|COMPLETED|Overall Study||60
2428754|NCT01185704|5957244|P1|COMPLETED|Overall Study||55
2428755|NCT01185704|5957243|P2|Treated|Overall Study||65
2428756|NCT01185704|5957244|P1|Treated|Overall Study||65
2428757|NCT01185704|5957243|P2|STARTED|Overall Study||68
2428758|NCT01185704|5957244|P1|STARTED|Overall Study||68
2428759|NCT01185639|5957278|P1|NOT COMPLETED|Overall Study||2
2428760|NCT01185639|5957278|P1|COMPLETED|Overall Study||27
2428761|NCT01185639|5957278|P1|STARTED|Overall Study||29
2428762|NCT01185600|5957288|P2|NOT COMPLETED|Overall Study||45
2428763|NCT01185600|5957289|P1|NOT COMPLETED|Overall Study||32
2428764|NCT01185600|5957288|P2|COMPLETED|Overall Study||59
2428765|NCT01185600|5957289|P1|COMPLETED|Overall Study||41
2428766|NCT01185600|5957288|P2|STARTED|Overall Study||104
2428767|NCT01185600|5957289|P1|STARTED|Overall Study||73
2428768|NCT01185561|5957311|P2|NOT COMPLETED|Overall Study||12
2428769|NCT01185561|5957312|P1|NOT COMPLETED|Overall Study||2
2428770|NCT01185561|5957311|P2|COMPLETED|Overall Study||26
2428771|NCT01185561|5957312|P1|COMPLETED|Overall Study||34
2428772|NCT01185561|5957311|P2|STARTED|Overall Study||38
2428773|NCT01185561|5957312|P1|STARTED|Overall Study||36
2428774|NCT01185548|5957324|P1|NOT COMPLETED|Period 3: Tasisulam and Tolbutamide||0
2428775|NCT01185548|5957324|P1|COMPLETED|Period 3: Tasisulam and Tolbutamide||2
2428776|NCT01185548|5957324|P1|STARTED|Period 3: Tasisulam and Tolbutamide||2
2428777|NCT01185548|5957324|P1|NOT COMPLETED|Period 2: Tasisulam and Tolbutamide||2
2428778|NCT01185548|5957324|P1|COMPLETED|Period 2: Tasisulam and Tolbutamide||2
2428779|NCT01185548|5957324|P1|STARTED|Period 2: Tasisulam and Tolbutamide||4
2428780|NCT01185548|5957324|P1|NOT COMPLETED|Period 1 : Tolbutamide||0
2428781|NCT01185548|5957324|P1|COMPLETED|Period 1 : Tolbutamide||4
2428782|NCT01185548|5957324|P1|STARTED|Period 1 : Tolbutamide||4
2428783|NCT01185522|5957337|P1|NOT COMPLETED|Overall Study||108
2428784|NCT01185522|5957337|P1|COMPLETED|Overall Study||585
2428785|NCT01185522|5957337|P1|STARTED|Overall Study||693
2428786|NCT01185509|5957363|P2|NOT COMPLETED|Overall Study||20
2428787|NCT01185509|5957364|P1|NOT COMPLETED|Overall Study||11
2428788|NCT01185509|5957363|P2|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
2428789|NCT01185509|5957364|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
2428790|NCT01185509|5957363|P2|STARTED|Overall Study||20
2428791|NCT01185509|5957364|P1|STARTED|Overall Study||11
2428792|NCT01185353|5957380|P10|NOT COMPLETED|Part D (Weeks 76 Through 128)||1
2428793|NCT01185353|5957381|P9|NOT COMPLETED|Part D (Weeks 76 Through 128)||7
2428794|NCT01185353|5957382|P8|NOT COMPLETED|Part D (Weeks 76 Through 128)||3
2428795|NCT01185353|5957383|P7|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
2428796|NCT01185353|5957384|P6|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
2428797|NCT01185353|5957385|P5|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
2428798|NCT01185353|5957386|P4|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
2428799|NCT01185353|5957387|P3|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
2428800|NCT01185353|5957388|P2|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
2428801|NCT01185353|5957389|P1|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
2428802|NCT01185353|5957380|P10|COMPLETED|Part D (Weeks 76 Through 128)||17
2428803|NCT01185353|5957381|P9|COMPLETED|Part D (Weeks 76 Through 128)||40
2428804|NCT01185353|5957382|P8|COMPLETED|Part D (Weeks 76 Through 128)||76
2428805|NCT01185353|5957383|P7|COMPLETED|Part D (Weeks 76 Through 128)||0
2428806|NCT01185353|5957384|P6|COMPLETED|Part D (Weeks 76 Through 128)||0
2428807|NCT01185353|5957385|P5|COMPLETED|Part D (Weeks 76 Through 128)||0
2428808|NCT01185353|5957386|P4|COMPLETED|Part D (Weeks 76 Through 128)||0
2428809|NCT01185353|5957387|P3|COMPLETED|Part D (Weeks 76 Through 128)||0
2428810|NCT01185353|5957388|P2|COMPLETED|Part D (Weeks 76 Through 128)||0
2428811|NCT01185353|5957389|P1|COMPLETED|Part D (Weeks 76 Through 128)||0
2428812|NCT01185353|5957380|P10|STARTED|Part D (Weeks 76 Through 128)||18
2428813|NCT01185353|5957381|P9|STARTED|Part D (Weeks 76 Through 128)||47
2428814|NCT01185353|5957382|P8|STARTED|Part D (Weeks 76 Through 128)||79
2428815|NCT01185353|5957383|P7|STARTED|Part D (Weeks 76 Through 128)||0
2428816|NCT01185353|5957384|P6|STARTED|Part D (Weeks 76 Through 128)||0
2428817|NCT01185353|5957385|P5|STARTED|Part D (Weeks 76 Through 128)||0
2428818|NCT01185353|5957386|P4|STARTED|Part D (Weeks 76 Through 128)||0
2428819|NCT01185353|5957387|P3|STARTED|Part D (Weeks 76 Through 128)||0
2428820|NCT01185353|5957388|P2|STARTED|Part D (Weeks 76 Through 128)||0
2428821|NCT01185353|5957389|P1|STARTED|Part D (Weeks 76 Through 128)||0
2428822|NCT01185353|5957380|P10|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
2428823|NCT01185353|5957381|P9|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
2428824|NCT01185353|5957382|P8|NOT COMPLETED|Part C (Weeks 24 Through 76)||16
2428825|NCT01185353|5957383|P7|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
2428826|NCT01185353|5957384|P6|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
2428827|NCT01185353|5957385|P5|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
2428828|NCT01185353|5957386|P4|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
2428829|NCT01185353|5957387|P3|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
2428830|NCT01185353|5957388|P2|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
2428831|NCT01185353|5957389|P1|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
2428832|NCT01185353|5957380|P10|COMPLETED|Part C (Weeks 24 Through 76)||24
2428833|NCT01185353|5957381|P9|COMPLETED|Part C (Weeks 24 Through 76)||53
2428834|NCT01185353|5957382|P8|COMPLETED|Part C (Weeks 24 Through 76)||92
2428835|NCT01185353|5957383|P7|COMPLETED|Part C (Weeks 24 Through 76)||0
2428836|NCT01185353|5957384|P6|COMPLETED|Part C (Weeks 24 Through 76)||0
2428837|NCT01185353|5957385|P5|COMPLETED|Part C (Weeks 24 Through 76)||0
2428838|NCT01185353|5957386|P4|COMPLETED|Part C (Weeks 24 Through 76)||0
2428839|NCT01185353|5957387|P3|COMPLETED|Part C (Weeks 24 Through 76)||0
2428840|NCT01185353|5957388|P2|COMPLETED|Part C (Weeks 24 Through 76)||0
2428841|NCT01185353|5957389|P1|COMPLETED|Part C (Weeks 24 Through 76)||0
2428842|NCT01185353|5957380|P10|STARTED|Part C (Weeks 24 Through 76)||32
2428843|NCT01185353|5957381|P9|STARTED|Part C (Weeks 24 Through 76)||61
2428844|NCT01185353|5957382|P8|STARTED|Part C (Weeks 24 Through 76)||108
2428845|NCT01185353|5957383|P7|STARTED|Part C (Weeks 24 Through 76)||0
2428846|NCT01185353|5957384|P6|STARTED|Part C (Weeks 24 Through 76)||0
2428847|NCT01185353|5957385|P5|STARTED|Part C (Weeks 24 Through 76)||0
2428848|NCT01185353|5957386|P4|STARTED|Part C (Weeks 24 Through 76)||0
2428849|NCT01185353|5957387|P3|STARTED|Part C (Weeks 24 Through 76)||0
2428850|NCT01185353|5957388|P2|STARTED|Part C (Weeks 24 Through 76)||0
2428851|NCT01185353|5957389|P1|STARTED|Part C (Weeks 24 Through 76)||0
2428852|NCT01185353|5957380|P10|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
2428853|NCT01185353|5957381|P9|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
2428854|NCT01185353|5957382|P8|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
2428855|NCT01185353|5957383|P7|NOT COMPLETED|Part B (Weeks 12 Through 24)||6
2428856|NCT01185353|5957384|P6|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
2428857|NCT01185353|5957385|P5|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
2428858|NCT01185353|5957386|P4|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
2428859|NCT01185353|5957387|P3|NOT COMPLETED|Part B (Weeks 12 Through 24)||2
2428860|NCT01185353|5957388|P2|NOT COMPLETED|Part B (Weeks 12 Through 24)||1
2428861|NCT01185353|5957389|P1|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
2428862|NCT01185353|5957380|P10|COMPLETED|Part B (Weeks 12 Through 24)||0
2428863|NCT01185353|5957381|P9|COMPLETED|Part B (Weeks 12 Through 24)||0
2428864|NCT01185353|5957382|P8|COMPLETED|Part B (Weeks 12 Through 24)||0
2428865|NCT01185353|5957383|P7|COMPLETED|Part B (Weeks 12 Through 24)||57
2428866|NCT01185353|5957384|P6|COMPLETED|Part B (Weeks 12 Through 24)||59
2428867|NCT01185353|5957385|P5|COMPLETED|Part B (Weeks 12 Through 24)||0
2428868|NCT01185353|5957386|P4|COMPLETED|Part B (Weeks 12 Through 24)||45
2428869|NCT01185353|5957387|P3|COMPLETED|Part B (Weeks 12 Through 24)||48
2428870|NCT01185353|5957388|P2|COMPLETED|Part B (Weeks 12 Through 24)||50
2428871|NCT01185353|5957389|P1|COMPLETED|Part B (Weeks 12 Through 24)||0
2428872|NCT01185353|5957380|P10|STARTED|Part B (Weeks 12 Through 24)||0
2428873|NCT01185353|5957381|P9|STARTED|Part B (Weeks 12 Through 24)||0
2428874|NCT01185353|5957382|P8|STARTED|Part B (Weeks 12 Through 24)||0
2428875|NCT01185353|5957383|P7|STARTED|Part B (Weeks 12 Through 24)||63
2428876|NCT01185353|5957384|P6|STARTED|Part B (Weeks 12 Through 24)||63
2428877|NCT01185353|5957385|P5|STARTED|Part B (Weeks 12 Through 24)||0
2428878|NCT01185353|5957386|P4|STARTED|Part B (Weeks 12 Through 24)||49
2428879|NCT01185353|5957387|P3|STARTED|Part B (Weeks 12 Through 24)||50
2428880|NCT01185353|5957388|P2|STARTED|Part B (Weeks 12 Through 24)||51
2428881|NCT01185353|5957389|P1|STARTED|Part B (Weeks 12 Through 24)||0
2428882|NCT01185353|5957380|P10|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
2428883|NCT01185353|5957381|P9|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
2428884|NCT01185353|5957382|P8|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
2428885|NCT01185353|5957383|P7|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
2428886|NCT01185353|5957384|P6|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
2428887|NCT01185353|5957385|P5|NOT COMPLETED|Part A (Weeks 0 Through 12)||16
2428888|NCT01185353|5957386|P4|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
2428889|NCT01185353|5957387|P3|NOT COMPLETED|Part A (Weeks 0 Through 12)||2
2428890|NCT01185353|5957388|P2|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
2428891|NCT01185353|5957389|P1|NOT COMPLETED|Part A (Weeks 0 Through 12)||5
2428892|NCT01185353|5957380|P10|COMPLETED|Part A (Weeks 0 Through 12)||0
2428893|NCT01185353|5957381|P9|COMPLETED|Part A (Weeks 0 Through 12)||0
2428894|NCT01185353|5957382|P8|COMPLETED|Part A (Weeks 0 Through 12)||0
2428895|NCT01185353|5957383|P7|COMPLETED|Part A (Weeks 0 Through 12)||0
2428896|NCT01185353|5957384|P6|COMPLETED|Part A (Weeks 0 Through 12)||0
2428897|NCT01185353|5957385|P5|COMPLETED|Part A (Weeks 0 Through 12)||82
2428898|NCT01185353|5957386|P4|COMPLETED|Part A (Weeks 0 Through 12)||49
2428899|NCT01185353|5957387|P3|COMPLETED|Part A (Weeks 0 Through 12)||50
2428900|NCT01185353|5957388|P2|COMPLETED|Part A (Weeks 0 Through 12)||51
2428901|NCT01185353|5957389|P1|COMPLETED|Part A (Weeks 0 Through 12)||44
2428902|NCT01185353|5957380|P10|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
2428903|NCT01185353|5957381|P9|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
2428904|NCT01185353|5957382|P8|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
2428905|NCT01185353|5957383|P7|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
2428906|NCT01185353|5957384|P6|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
2428907|NCT01185353|5957385|P5|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||98
2428908|NCT01185353|5957386|P4|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||50
2428909|NCT01185353|5957387|P3|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
2428910|NCT01185353|5957388|P2|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
2428911|NCT01185353|5957389|P1|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||49
2428912|NCT01185353|5957380|P10|STARTED|Part A (Weeks 0 Through 12)||0
2428913|NCT01185353|5957381|P9|STARTED|Part A (Weeks 0 Through 12)||0
2428914|NCT01185353|5957382|P8|STARTED|Part A (Weeks 0 Through 12)||0
2428915|NCT01185353|5957383|P7|STARTED|Part A (Weeks 0 Through 12)||0
2428916|NCT01185353|5957384|P6|STARTED|Part A (Weeks 0 Through 12)||0
2428917|NCT01185353|5957385|P5|STARTED|Part A (Weeks 0 Through 12)||98
2428918|NCT01185353|5957386|P4|STARTED|Part A (Weeks 0 Through 12)||50
2428919|NCT01185353|5957387|P3|STARTED|Part A (Weeks 0 Through 12)||52
2428920|NCT01185353|5957388|P2|STARTED|Part A (Weeks 0 Through 12)||52
2428921|NCT01185353|5957389|P1|STARTED|Part A (Weeks 0 Through 12)||49
2428922|NCT01185340|5957550|P4|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||61
2428923|NCT01185340|5957551|P3|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33
2428924|NCT01185340|5957552|P2|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
2428925|NCT01185340|5957553|P1|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
2428926|NCT01185340|5957550|P4|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||458
2428927|NCT01185340|5957551|P3|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||186
2428928|NCT01185340|5957552|P2|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||195
2428929|NCT01185340|5957553|P1|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
2428930|NCT01185340|5957550|P4|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|483
2428931|NCT01185340|5957551|P3|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|204
2428932|NCT01185340|5957552|P2|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|206
2428933|NCT01185340|5957553|P1|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
2428934|NCT01185340|5957550|P4|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||519
2428935|NCT01185340|5957551|P3|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||219
2428936|NCT01185340|5957552|P2|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230
2428937|NCT01185340|5957553|P1|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
2428938|NCT01185340|5957550|P4|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
2428939|NCT01185340|5957551|P3|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
2428940|NCT01185340|5957552|P2|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
2428941|NCT01185340|5957553|P1|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88
2428942|NCT01185340|5957550|P4|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
2428943|NCT01185340|5957551|P3|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
2428944|NCT01185340|5957552|P2|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
2428945|NCT01185340|5957553|P1|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|968
2428946|NCT01185340|5957550|P4|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
2428947|NCT01185340|5957551|P3|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
2428948|NCT01185340|5957552|P2|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
2428949|NCT01185340|5957553|P1|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|18
2428950|NCT01185340|5957550|P4|STARTED|Confirmation (CF) Phase, 3 Weeks||0
2428951|NCT01185340|5957551|P3|STARTED|Confirmation (CF) Phase, 3 Weeks||0
2428952|NCT01185340|5957552|P2|STARTED|Confirmation (CF) Phase, 3 Weeks||0
2428953|NCT01185340|5957553|P1|STARTED|Confirmation (CF) Phase, 3 Weeks||1056
2428954|NCT01185301|5957605|P4|NOT COMPLETED|Overall Study||9
2428955|NCT01185301|5957606|P3|NOT COMPLETED|Overall Study||6
2428956|NCT01185301|5957607|P2|NOT COMPLETED|Overall Study||7
2428957|NCT01185301|5957608|P1|NOT COMPLETED|Overall Study||15
2428958|NCT01185301|5957605|P4|COMPLETED|Overall Study||89
2428959|NCT01185301|5957606|P3|COMPLETED|Overall Study||93
2428960|NCT01185301|5957607|P2|COMPLETED|Overall Study||93
2428961|NCT01185301|5957608|P1|COMPLETED|Overall Study||83
2428962|NCT01185301|5957605|P4|STARTED|Overall Study||98
2428963|NCT01185301|5957606|P3|STARTED|Overall Study||99
2428964|NCT01185301|5957607|P2|STARTED|Overall Study||100
2428965|NCT01185301|5957608|P1|STARTED|Overall Study||98
2428966|NCT01185288|5957668|P2|NOT COMPLETED|Overall Study||16
2428967|NCT01185288|5957669|P1|NOT COMPLETED|Overall Study||19
2428968|NCT01185288|5957668|P2|COMPLETED|Overall Study||139
2428969|NCT01185288|5957669|P1|COMPLETED|Overall Study||135
2428970|NCT01185288|5957668|P2|STARTED|Overall Study||155
2428971|NCT01185288|5957669|P1|STARTED|Overall Study||154
2428972|NCT01185249|5957687|P1|NOT COMPLETED|Overall Study||42
2428973|NCT01185249|5957687|P1|COMPLETED|Overall Study|Data was analyzed for patients with three consecutive days of data.|24
2428974|NCT01185249|5957687|P1|STARTED|Overall Study|Total number of patients consented to participate.|66
2428975|NCT01185080|5957695|P3|NOT COMPLETED|Overall Study||1
2428976|NCT01185080|5957696|P2|NOT COMPLETED|Overall Study||1
2428977|NCT01185080|5957697|P1|NOT COMPLETED|Overall Study||1
2428978|NCT01185080|5957695|P3|COMPLETED|Overall Study||16
2428979|NCT01185080|5957696|P2|COMPLETED|Overall Study||15
2428980|NCT01185080|5957697|P1|COMPLETED|Overall Study||49
2428981|NCT01185080|5957695|P3|STARTED|Overall Study||17
2428982|NCT01185080|5957696|P2|STARTED|Overall Study||16
2428983|NCT01185080|5957697|P1|STARTED|Overall Study||50
2428984|NCT01185028|5957744|P1|NOT COMPLETED|Overall Study||4
2428985|NCT01185028|5957744|P1|COMPLETED|Overall Study||4
2428986|NCT01185028|5957744|P1|STARTED|Overall Study||8
2428987|NCT01184989|5957749|P1|NOT COMPLETED|Overall Study||12
2428988|NCT01184989|5957749|P1|COMPLETED|Overall Study||100
2428989|NCT01184989|5957749|P1|STARTED|Overall Study|Treated Patients|112
2428990|NCT01184898|5957755|P1|NOT COMPLETED|Overall Study||0
2428991|NCT01184898|5957755|P1|COMPLETED|Overall Study||36
2428992|NCT01184898|5957755|P1|STARTED|Overall Study||36
2428993|NCT01184885|5957762|P1|NOT COMPLETED|Overall Study||0
2428994|NCT01184885|5957762|P1|COMPLETED|Overall Study||7
2428995|NCT01184885|5957762|P1|STARTED|Overall Study||7
2428996|NCT01184872|5957769|P2|NOT COMPLETED|Overall Study||8
2428997|NCT01184872|5957770|P1|NOT COMPLETED|Overall Study||10
2428998|NCT01184872|5957769|P2|COMPLETED|Overall Study||31
2428999|NCT01184872|5957770|P1|COMPLETED|Overall Study||71
2429000|NCT01184872|5957769|P2|Microbiologically Evaluable Set (MES)|Overall Study||27
2429001|NCT01184872|5957770|P1|Microbiologically Evaluable Set (MES)|Overall Study||65
2429002|NCT01184872|5957769|P2|Clinical Evaluable Set (CES)|Overall Study||30
2429003|NCT01184872|5957770|P1|Clinical Evaluable Set (CES)|Overall Study||73
2429004|NCT01184872|5957769|P2|Safety Set|Overall Study||40
2429005|NCT01184872|5957770|P1|Safety Set|Overall Study|One patient randomized to Daptomycin received Vancomycin.|80
2429006|NCT01184872|5957769|P2|STARTED|Overall Study||39
2429007|NCT01184872|5957770|P1|STARTED|Overall Study|"Started indicates randomized and full analysis set."|81
2429008|NCT01184859|5957789|P5|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
2429009|NCT01184859|5957790|P4|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
2429010|NCT01184859|5957791|P3|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
2429011|NCT01184859|5957792|P2|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
2429012|NCT01184859|5957793|P1|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
2429013|NCT01184859|5957789|P5|COMPLETED|Period 2: Daily Dose for 28 Days||22
2429014|NCT01184859|5957790|P4|COMPLETED|Period 2: Daily Dose for 28 Days||22
2429015|NCT01184859|5957791|P3|COMPLETED|Period 2: Daily Dose for 28 Days||22
2429016|NCT01184859|5957792|P2|COMPLETED|Period 2: Daily Dose for 28 Days||23
2429017|NCT01184859|5957793|P1|COMPLETED|Period 2: Daily Dose for 28 Days||22
2429018|NCT01184859|5957789|P5|STARTED|Period 2: Daily Dose for 28 Days||23
2429019|NCT01184859|5957790|P4|STARTED|Period 2: Daily Dose for 28 Days||22
2429020|NCT01184859|5957791|P3|STARTED|Period 2: Daily Dose for 28 Days||22
2429021|NCT01184859|5957792|P2|STARTED|Period 2: Daily Dose for 28 Days||23
2429022|NCT01184859|5957793|P1|STARTED|Period 2: Daily Dose for 28 Days||23
2429023|NCT01184859|5957789|P5|NOT COMPLETED|Washout Period||0
2429024|NCT01184859|5957790|P4|NOT COMPLETED|Washout Period||0
2429025|NCT01184859|5957791|P3|NOT COMPLETED|Washout Period||0
2429026|NCT01184859|5957792|P2|NOT COMPLETED|Washout Period||0
2429027|NCT01184859|5957793|P1|NOT COMPLETED|Washout Period||0
2429028|NCT01184859|5957789|P5|COMPLETED|Washout Period||23
2429029|NCT01184859|5957790|P4|COMPLETED|Washout Period||22
2429030|NCT01184859|5957791|P3|COMPLETED|Washout Period||22
2429031|NCT01184859|5957792|P2|COMPLETED|Washout Period||23
2429032|NCT01184859|5957793|P1|COMPLETED|Washout Period||23
2429033|NCT01184859|5957789|P5|STARTED|Washout Period||23
2429034|NCT01184859|5957790|P4|STARTED|Washout Period||22
2429035|NCT01184859|5957791|P3|STARTED|Washout Period||22
2429036|NCT01184859|5957792|P2|STARTED|Washout Period||23
2429037|NCT01184859|5957793|P1|STARTED|Washout Period||23
2429038|NCT01184859|5957789|P5|NOT COMPLETED|Period 1: Single Dose||1
2429039|NCT01184859|5957790|P4|NOT COMPLETED|Period 1: Single Dose||0
2429040|NCT01184859|5957791|P3|NOT COMPLETED|Period 1: Single Dose||0
2429041|NCT01184859|5957792|P2|NOT COMPLETED|Period 1: Single Dose||2
2429042|NCT01184859|5957793|P1|NOT COMPLETED|Period 1: Single Dose||0
2429043|NCT01184859|5957789|P5|COMPLETED|Period 1: Single Dose||23
2429044|NCT01184859|5957790|P4|COMPLETED|Period 1: Single Dose||22
2429045|NCT01184859|5957791|P3|COMPLETED|Period 1: Single Dose||22
2429046|NCT01184859|5957792|P2|COMPLETED|Period 1: Single Dose||23
2429047|NCT01184859|5957793|P1|COMPLETED|Period 1: Single Dose||23
2429048|NCT01184859|5957789|P5|Per Protocol (PP)|Period 1: Single Dose|1 additional participant disqualified due to 'other'.|23
2429049|NCT01184859|5957790|P4|Per Protocol (PP)|Period 1: Single Dose||21
2429050|NCT01184859|5957791|P3|Per Protocol (PP)|Period 1: Single Dose||22
2429051|NCT01184859|5957792|P2|Per Protocol (PP)|Period 1: Single Dose||23
2429052|NCT01184859|5957793|P1|Per Protocol (PP)|Period 1: Single Dose||23
2429053|NCT01184859|5957789|P5|Full Analysis Set (FAS)|Period 1: Single Dose||24
2429054|NCT01184859|5957790|P4|Full Analysis Set (FAS)|Period 1: Single Dose|1 participant disqualified due to major entry criteria violation|21
2429055|NCT01184859|5957791|P3|Full Analysis Set (FAS)|Period 1: Single Dose||22
2429056|NCT01184859|5957792|P2|Full Analysis Set (FAS)|Period 1: Single Dose|2 participants disqualified due to no post-baseline primary efficacy data, and/or 'other'.|23
2429057|NCT01184859|5957793|P1|Full Analysis Set (FAS)|Period 1: Single Dose||23
2429058|NCT01184859|5957789|P5|STARTED|Period 1: Single Dose||24
2429059|NCT01184859|5957790|P4|STARTED|Period 1: Single Dose||22
2429060|NCT01184859|5957791|P3|STARTED|Period 1: Single Dose||22
2429061|NCT01184859|5957792|P2|STARTED|Period 1: Single Dose||25
2429062|NCT01184859|5957793|P1|STARTED|Period 1: Single Dose||23
2429063|NCT01184846|5957885|P1|NOT COMPLETED|Overall Study||3
2429064|NCT01184846|5957885|P1|COMPLETED|Overall Study||25
2429065|NCT01184846|5957885|P1|STARTED|Overall Study||28
2429066|NCT01184755|5957906|P3|NOT COMPLETED|Overall Study||6
2429067|NCT01184755|5957907|P2|NOT COMPLETED|Overall Study||11
2429068|NCT01184755|5957908|P1|NOT COMPLETED|Overall Study||25
2429069|NCT01184755|5957906|P3|COMPLETED|Overall Study||56
2429070|NCT01184755|5957907|P2|COMPLETED|Overall Study||54
2429071|NCT01184755|5957908|P1|COMPLETED|Overall Study||101
2429072|NCT01184755|5957906|P3|STARTED|Overall Study||62
2429073|NCT01184755|5957907|P2|STARTED|Overall Study||65
2429074|NCT01184755|5957908|P1|STARTED|Overall Study||126
2429075|NCT01184508|5957918|P2|NOT COMPLETED|Overall Study||15
2429076|NCT01184508|5957919|P1|NOT COMPLETED|Overall Study||16
2429077|NCT01184508|5957918|P2|COMPLETED|Overall Study||27
2429078|NCT01184508|5957919|P1|COMPLETED|Overall Study||29
2429079|NCT01184508|5957918|P2|Received at Least 1 Dose of Study Drug|Overall Study||41
2429080|NCT01184508|5957919|P1|Received at Least 1 Dose of Study Drug|Overall Study||45
2429081|NCT01184508|5957918|P2|STARTED|Overall Study||42
2429082|NCT01184508|5957919|P1|STARTED|Overall Study||45
2429083|NCT01184456|5957946|P2|NOT COMPLETED|Overall Study||0
2429084|NCT01184456|5957947|P1|NOT COMPLETED|Overall Study||0
2429085|NCT01184456|5957946|P2|COMPLETED|Overall Study||0
2429086|NCT01184456|5957947|P1|COMPLETED|Overall Study||0
2429087|NCT01184456|5957946|P2|STARTED|Overall Study||0
2429088|NCT01184456|5957947|P1|STARTED|Overall Study||0
2429089|NCT01184417|5957955|P2|NOT COMPLETED|Overall Study||0
2429090|NCT01184417|5957956|P1|NOT COMPLETED|Overall Study||0
2429091|NCT01184417|5957955|P2|COMPLETED|Overall Study||51
2429092|NCT01184417|5957956|P1|COMPLETED|Overall Study||51
2429093|NCT01184417|5957955|P2|STARTED|Overall Study||51
2429094|NCT01184417|5957956|P1|STARTED|Overall Study||51
2429095|NCT01184326|5957979|P3|NOT COMPLETED|Overall Study||14
2429096|NCT01184326|5957980|P2|NOT COMPLETED|Overall Study||6
2429097|NCT01184326|5957981|P1|NOT COMPLETED|Overall Study||3
2429098|NCT01184326|5957979|P3|COMPLETED|Overall Study||0
2429099|NCT01184326|5957980|P2|COMPLETED|Overall Study||0
2429100|NCT01184326|5957981|P1|COMPLETED|Overall Study||0
2429101|NCT01184326|5957979|P3|STARTED|Overall Study||14
2429102|NCT01184326|5957980|P2|STARTED|Overall Study||6
2429103|NCT01184326|5957981|P1|STARTED|Overall Study||3
2429104|NCT01184118|5957995|P1|NOT COMPLETED|Overall Study||18
2429105|NCT01184118|5957995|P1|COMPLETED|Overall Study||18
2429106|NCT01184118|5957995|P1|FP MDI as Indicated (2 Weeks)|Overall Study||18
2429107|NCT01184118|5957995|P1|FP MDI 880 mcg/Day (2 Weeks)|Overall Study||18
2429108|NCT01184118|5957995|P1|FP MDI 1,760 mcg/Day (16 Weeks)|Overall Study||18
2429109|NCT01184118|5957995|P1|STARTED|Overall Study||36
2429110|NCT01184079|5958003|P2|NOT COMPLETED|Overall Study||2
2429111|NCT01184079|5958004|P1|NOT COMPLETED|Overall Study||14
2429112|NCT01184079|5958003|P2|COMPLETED|Overall Study||107
2429113|NCT01184079|5958004|P1|COMPLETED|Overall Study||97
2429114|NCT01184079|5958003|P2|Final Blood Draw|Overall Study||107
2429115|NCT01184079|5958004|P1|Final Blood Draw|Overall Study||97
2429116|NCT01184079|5958003|P2|Dose 3|Overall Study||107
2429117|NCT01184079|5958004|P1|Dose 3|Overall Study||101
2429118|NCT01184079|5958003|P2|Dose 2|Overall Study||108
2429119|NCT01184079|5958004|P1|Dose 2|Overall Study||110
2429120|NCT01184079|5958003|P2|STARTED|Overall Study||109
2429121|NCT01184079|5958004|P1|STARTED|Overall Study||111
2429122|NCT01184053|5958014|P1|NOT COMPLETED|Overall Study||3
2429123|NCT01184053|5958014|P1|COMPLETED|Overall Study||0
2429124|NCT01184053|5958014|P1|STARTED|Overall Study||3
2429125|NCT01184014|5958023|P2|NOT COMPLETED|Overall Study||6
2429126|NCT01184014|5958024|P1|NOT COMPLETED|Overall Study||5
2429127|NCT01184014|5958023|P2|COMPLETED|Overall Study||31
2429128|NCT01184014|5958024|P1|COMPLETED|Overall Study||30
2429129|NCT01184014|5958023|P2|STARTED|Overall Study||37
2429130|NCT01184014|5958024|P1|STARTED|Overall Study||35
2429131|NCT01183975|5958030|P1|NOT COMPLETED|Overall Study||73
2429132|NCT01183975|5958030|P1|COMPLETED|Overall Study||444
2429133|NCT01183975|5958030|P1|STARTED|Overall Study||517
2429134|NCT01183923|5958035|P2|NOT COMPLETED|Intervention 2 (7 Days)||0
2429135|NCT01183923|5958036|P1|NOT COMPLETED|Intervention 2 (7 Days)||0
2429136|NCT01183923|5958035|P2|COMPLETED|Intervention 2 (7 Days)||0
2429137|NCT01183923|5958036|P1|COMPLETED|Intervention 2 (7 Days)||1
2429138|NCT01183923|5958035|P2|STARTED|Intervention 2 (7 Days)||0
2429139|NCT01183923|5958036|P1|STARTED|Intervention 2 (7 Days)||1
2429140|NCT01183923|5958035|P2|NOT COMPLETED|Washout (14 Days)||0
2429141|NCT01183923|5958036|P1|NOT COMPLETED|Washout (14 Days)||0
2429142|NCT01183923|5958035|P2|COMPLETED|Washout (14 Days)||0
2429143|NCT01183923|5958036|P1|COMPLETED|Washout (14 Days)||1
2429144|NCT01183923|5958035|P2|STARTED|Washout (14 Days)||0
2429145|NCT01183923|5958036|P1|STARTED|Washout (14 Days)||1
2429146|NCT01183923|5958035|P2|NOT COMPLETED|Intervention 1 (7 Days)||0
2429147|NCT01183923|5958036|P1|NOT COMPLETED|Intervention 1 (7 Days)||0
2429148|NCT01183923|5958035|P2|COMPLETED|Intervention 1 (7 Days)||0
2429149|NCT01183923|5958036|P1|COMPLETED|Intervention 1 (7 Days)||1
2429150|NCT01183923|5958035|P2|STARTED|Intervention 1 (7 Days)||0
2429151|NCT01183923|5958036|P1|STARTED|Intervention 1 (7 Days)||1
2429152|NCT01183897|5958041|P1|NOT COMPLETED|Overall Study||0
2429153|NCT01183897|5958041|P1|COMPLETED|Overall Study||31
2429154|NCT01183897|5958041|P1|STARTED|Overall Study||31
2429155|NCT01183884|5958047|P1|NOT COMPLETED|Overall Study||38
2429156|NCT01183884|5958047|P1|COMPLETED|Overall Study||8
2429157|NCT01183884|5958047|P1|STARTED|Overall Study||46
2429158|NCT01183858|5958055|P2|NOT COMPLETED|Overall Study||156
2429159|NCT01183858|5958056|P1|NOT COMPLETED|Overall Study||153
2429160|NCT01183858|5958055|P2|COMPLETED|Overall Study||3
2429161|NCT01183858|5958056|P1|COMPLETED|Overall Study||1
2429162|NCT01183858|5958055|P2|Safety Population|Overall Study||158
2429163|NCT01183858|5958056|P1|Safety Population|Overall Study||154
2429164|NCT01183858|5958055|P2|STARTED|Overall Study||159
2429165|NCT01183858|5958056|P1|STARTED|Overall Study||154
2429166|NCT01183780|5958078|P2|NOT COMPLETED|Overall Study||25
2429167|NCT01183780|5958079|P1|NOT COMPLETED|Overall Study||31
2429168|NCT01183780|5958078|P2|COMPLETED|Overall Study||511
2429169|NCT01183780|5958079|P1|COMPLETED|Overall Study||505
2429170|NCT01183780|5958078|P2|Received at Least 1 Dose of Study Drug|Overall Study||529
2429171|NCT01183780|5958079|P1|Received at Least 1 Dose of Study Drug|Overall Study||528
2429172|NCT01183780|5958078|P2|STARTED|Overall Study||536
2429173|NCT01183780|5958079|P1|STARTED|Overall Study||536
2429174|NCT01183728|5958096|P1|NOT COMPLETED|Overall Study||0
2429175|NCT01183728|5958096|P1|COMPLETED|Overall Study||12
2429176|NCT01183728|5958096|P1|STARTED|Overall Study||12
2429177|NCT01183689|5958104|P3|NOT COMPLETED|Overall Study||0
2429178|NCT01183689|5958105|P2|NOT COMPLETED|Overall Study||0
2429179|NCT01183689|5958106|P1|NOT COMPLETED|Overall Study||0
2429180|NCT01183689|5958104|P3|COMPLETED|Overall Study||197
2429181|NCT01183689|5958105|P2|COMPLETED|Overall Study||200
2429182|NCT01183689|5958106|P1|COMPLETED|Overall Study||202
2429183|NCT01183689|5958104|P3|Year 4 Visit|Overall Study||30
2429184|NCT01183689|5958105|P2|Year 4 Visit|Overall Study||33
2429185|NCT01183689|5958106|P1|Year 4 Visit|Overall Study||38
2429186|NCT01183689|5958104|P3|Year 3 Visit|Overall Study||126
2429187|NCT01183689|5958105|P2|Year 3 Visit|Overall Study||125
2429188|NCT01183689|5958106|P1|Year 3 Visit|Overall Study||139
2429189|NCT01183689|5958104|P3|Year 2 Visit|Overall Study||174
2429190|NCT01183689|5958105|P2|Year 2 Visit|Overall Study||172
2429191|NCT01183689|5958106|P1|Year 2 Visit|Overall Study||178
2429192|NCT01183689|5958104|P3|Year 1 Visit|Overall Study||183
2429193|NCT01183689|5958105|P2|Year 1 Visit|Overall Study||172
2429194|NCT01183689|5958106|P1|Year 1 Visit|Overall Study||187
2429195|NCT01183689|5958104|P3|Month 4 Visit|Overall Study||187
2429196|NCT01183689|5958105|P2|Month 4 Visit|Overall Study||192
2429197|NCT01183689|5958106|P1|Month 4 Visit|Overall Study||197
2429198|NCT01183689|5958104|P3|STARTED|Overall Study||197
2429199|NCT01183689|5958105|P2|STARTED|Overall Study||200
2429200|NCT01183689|5958106|P1|STARTED|Overall Study||202
2429201|NCT01183650|5958176|P2|NOT COMPLETED|Overall Study||0
2429202|NCT01183650|5958177|P1|NOT COMPLETED|Overall Study||0
2429203|NCT01183650|5958176|P2|COMPLETED|Overall Study||12
2429204|NCT01183650|5958177|P1|COMPLETED|Overall Study||12
2429205|NCT01183650|5958176|P2|STARTED|Overall Study||12
2429206|NCT01183650|5958177|P1|STARTED|Overall Study||12
2429207|NCT01183546|5958187|P1|NOT COMPLETED|Overall Study||0
2429208|NCT01183546|5958187|P1|COMPLETED|Overall Study||53
2429209|NCT01183546|5958187|P1|STARTED|Overall Study||53
2429210|NCT01183533|5958194|P1|NOT COMPLETED|Overall Study||0
2429211|NCT01183533|5958194|P1|COMPLETED|Overall Study|- all pre-planned 40 patients received the study medication.|40
2429212|NCT01183533|5958194|P1|STARTED|Overall Study|Between Oct 2010 and Oct 2013.|40
2429213|NCT01183481|5958200|P1|NOT COMPLETED|Overall Study||0
2429214|NCT01183481|5958200|P1|COMPLETED|Overall Study||19
2429215|NCT01183481|5958200|P1|STARTED|Overall Study||19
2429216|NCT01183468|5958212|P4|NOT COMPLETED|Overall Study||0
2429217|NCT01183468|5958213|P3|NOT COMPLETED|Overall Study||0
2429218|NCT01183468|5958214|P2|NOT COMPLETED|Overall Study||2
2429219|NCT01183468|5958215|P1|NOT COMPLETED|Overall Study||3
2429220|NCT01183468|5958212|P4|COMPLETED|Overall Study||0
2429221|NCT01183468|5958213|P3|COMPLETED|Overall Study||0
2429222|NCT01183468|5958214|P2|COMPLETED|Overall Study||7
2429223|NCT01183468|5958215|P1|COMPLETED|Overall Study||5
2429224|NCT01183468|5958212|P4|STARTED|Overall Study||0
2429225|NCT01183468|5958213|P3|STARTED|Overall Study||0
2429226|NCT01183468|5958214|P2|STARTED|Overall Study||9
2429227|NCT01183468|5958215|P1|STARTED|Overall Study||8
2429228|NCT01183429|5958223|P1|NOT COMPLETED|Overall Study||0
2429229|NCT01183429|5958223|P1|COMPLETED|Overall Study||39
2429230|NCT01183429|5958223|P1|STARTED|Overall Study||39
2429231|NCT01183416|5958229|P1|NOT COMPLETED|Overall Study||0
2429232|NCT01183416|5958229|P1|COMPLETED|Overall Study||4
2429233|NCT01183416|5958229|P1|STARTED|Overall Study||4
2429234|NCT01183390|5958237|P2|NOT COMPLETED|Second Intervention||0
2429235|NCT01183390|5958238|P1|NOT COMPLETED|Second Intervention||0
2429236|NCT01183390|5958237|P2|COMPLETED|Second Intervention||10
2429237|NCT01183390|5958238|P1|COMPLETED|Second Intervention||11
2429238|NCT01183390|5958237|P2|STARTED|Second Intervention||10
2429239|NCT01183390|5958238|P1|STARTED|Second Intervention||11
2429240|NCT01183390|5958237|P2|NOT COMPLETED|Washout of 21 Days||0
2429241|NCT01183390|5958238|P1|NOT COMPLETED|Washout of 21 Days||0
2429242|NCT01183390|5958237|P2|COMPLETED|Washout of 21 Days||10
2429243|NCT01183390|5958238|P1|COMPLETED|Washout of 21 Days||11
2429244|NCT01183390|5958237|P2|STARTED|Washout of 21 Days||10
2429245|NCT01183390|5958238|P1|STARTED|Washout of 21 Days||11
2429246|NCT01183390|5958237|P2|NOT COMPLETED|First Intervention||1
2429247|NCT01183390|5958238|P1|NOT COMPLETED|First Intervention||0
2429248|NCT01183390|5958237|P2|COMPLETED|First Intervention||10
2429249|NCT01183390|5958238|P1|COMPLETED|First Intervention||11
2429250|NCT01183390|5958237|P2|STARTED|First Intervention||11
2429251|NCT01183390|5958238|P1|STARTED|First Intervention||11
2429252|NCT01183312|5958248|P2|NOT COMPLETED|Second Intervention Day||0
2429253|NCT01183312|5958249|P1|NOT COMPLETED|Second Intervention Day||0
2429254|NCT01183312|5958248|P2|COMPLETED|Second Intervention Day||5
2429255|NCT01183312|5958249|P1|COMPLETED|Second Intervention Day||5
2429256|NCT01183312|5958248|P2|STARTED|Second Intervention Day||5
2429257|NCT01183312|5958249|P1|STARTED|Second Intervention Day||5
2429258|NCT01183312|5958248|P2|NOT COMPLETED|Washout Period of at Least 1 Week||0
2429259|NCT01183312|5958249|P1|NOT COMPLETED|Washout Period of at Least 1 Week||0
2429260|NCT01183312|5958248|P2|COMPLETED|Washout Period of at Least 1 Week||5
2429261|NCT01183312|5958249|P1|COMPLETED|Washout Period of at Least 1 Week||5
2429262|NCT01183312|5958248|P2|STARTED|Washout Period of at Least 1 Week||5
2429263|NCT01183312|5958249|P1|STARTED|Washout Period of at Least 1 Week||5
2429264|NCT01183312|5958248|P2|NOT COMPLETED|First Intervention Day||0
2429265|NCT01183312|5958249|P1|NOT COMPLETED|First Intervention Day||0
2429266|NCT01183312|5958248|P2|COMPLETED|First Intervention Day||5
2429267|NCT01183312|5958249|P1|COMPLETED|First Intervention Day||5
2429268|NCT01183312|5958248|P2|STARTED|First Intervention Day||5
2429269|NCT01183312|5958249|P1|STARTED|First Intervention Day||5
2429270|NCT01183260|5958271|P2|NOT COMPLETED|Overall Study||2
2429271|NCT01183260|5958272|P1|NOT COMPLETED|Overall Study||4
2429272|NCT01183260|5958271|P2|COMPLETED|Overall Study||9
2429273|NCT01183260|5958272|P1|COMPLETED|Overall Study||10
2429274|NCT01183260|5958271|P2|STARTED|Overall Study||11
2429275|NCT01183260|5958272|P1|STARTED|Overall Study||14
2429276|NCT01183234|5958282|P2|NOT COMPLETED|Second Intervention||0
2429277|NCT01183234|5958283|P1|NOT COMPLETED|Second Intervention||0
2429278|NCT01183234|5958282|P2|COMPLETED|Second Intervention||14
2429279|NCT01183234|5958283|P1|COMPLETED|Second Intervention||13
2429280|NCT01183234|5958282|P2|STARTED|Second Intervention||14
2429281|NCT01183234|5958283|P1|STARTED|Second Intervention||13
2429282|NCT01183234|5958282|P2|NOT COMPLETED|Washout||0
2429283|NCT01183234|5958283|P1|NOT COMPLETED|Washout||0
2429284|NCT01183234|5958282|P2|COMPLETED|Washout||14
2429285|NCT01183234|5958283|P1|COMPLETED|Washout||13
2429286|NCT01183234|5958282|P2|STARTED|Washout||14
2429287|NCT01183234|5958283|P1|STARTED|Washout||13
2429288|NCT01183234|5958282|P2|NOT COMPLETED|First Intervention||0
2429289|NCT01183234|5958283|P1|NOT COMPLETED|First Intervention||1
2429290|NCT01183234|5958282|P2|COMPLETED|First Intervention||14
2429291|NCT01183234|5958283|P1|COMPLETED|First Intervention||13
2429292|NCT01183234|5958282|P2|STARTED|First Intervention||14
2429293|NCT01183234|5958283|P1|STARTED|First Intervention||14
2429294|NCT01183169|5958297|P7|NOT COMPLETED|Post-switch Phase||9
2429295|NCT01183169|5958298|P6|NOT COMPLETED|Post-switch Phase||14
2429296|NCT01183169|5958299|P5|NOT COMPLETED|Post-switch Phase||0
2429297|NCT01183169|5958300|P4|NOT COMPLETED|Post-switch Phase||0
2429298|NCT01183169|5958301|P3|NOT COMPLETED|Post-switch Phase||0
2429299|NCT01183169|5958302|P2|NOT COMPLETED|Post-switch Phase||0
2429300|NCT01183169|5958303|P1|NOT COMPLETED|Post-switch Phase||0
2429301|NCT01183169|5958297|P7|COMPLETED|Post-switch Phase||21
2429302|NCT01183169|5958298|P6|COMPLETED|Post-switch Phase||21
2429303|NCT01183169|5958299|P5|COMPLETED|Post-switch Phase||0
2429304|NCT01183169|5958300|P4|COMPLETED|Post-switch Phase||0
2429305|NCT01183169|5958301|P3|COMPLETED|Post-switch Phase||0
2429306|NCT01183169|5958302|P2|COMPLETED|Post-switch Phase||0
2429307|NCT01183169|5958303|P1|COMPLETED|Post-switch Phase||0
2429308|NCT01183169|5958297|P7|Completed Treatment|Post-switch Phase||13
2429309|NCT01183169|5958298|P6|Completed Treatment|Post-switch Phase||12
2429310|NCT01183169|5958299|P5|Completed Treatment|Post-switch Phase||0
2429311|NCT01183169|5958300|P4|Completed Treatment|Post-switch Phase||0
2429312|NCT01183169|5958301|P3|Completed Treatment|Post-switch Phase||0
2429313|NCT01183169|5958302|P2|Completed Treatment|Post-switch Phase||0
2429314|NCT01183169|5958303|P1|Completed Treatment|Post-switch Phase||0
2429315|NCT01183169|5958297|P7|STARTED|Post-switch Phase|Participants in Treatment C2 who switched to active ALV|30
2429316|NCT01183169|5958298|P6|STARTED|Post-switch Phase|Participants in Treatment C1 who switched to active ALV|35
2429317|NCT01183169|5958299|P5|STARTED|Post-switch Phase|Not a post-switch group|0
2429318|NCT01183169|5958300|P4|STARTED|Post-switch Phase|Not a post-switch group|0
2429319|NCT01183169|5958301|P3|STARTED|Post-switch Phase|Not a post-switch group|0
2429320|NCT01183169|5958302|P2|STARTED|Post-switch Phase|Not a post-switch group|0
2429321|NCT01183169|5958303|P1|STARTED|Post-switch Phase|Not a post-switch group|0
2429322|NCT01183169|5958297|P7|NOT COMPLETED|Main Phase||0
2429323|NCT01183169|5958298|P6|NOT COMPLETED|Main Phase||0
2429324|NCT01183169|5958299|P5|NOT COMPLETED|Main Phase||26
2429325|NCT01183169|5958300|P4|NOT COMPLETED|Main Phase||37
2429326|NCT01183169|5958301|P3|NOT COMPLETED|Main Phase||41
2429327|NCT01183169|5958302|P2|NOT COMPLETED|Main Phase||22
2429328|NCT01183169|5958303|P1|NOT COMPLETED|Main Phase||27
2429329|NCT01183169|5958297|P7|COMPLETED|Main Phase||0
2429330|NCT01183169|5958298|P6|COMPLETED|Main Phase||0
2429331|NCT01183169|5958299|P5|COMPLETED|Main Phase||83
2429332|NCT01183169|5958300|P4|COMPLETED|Main Phase||18
2429333|NCT01183169|5958301|P3|COMPLETED|Main Phase||18
2429334|NCT01183169|5958302|P2|COMPLETED|Main Phase||93
2429335|NCT01183169|5958303|P1|COMPLETED|Main Phase||94
2429336|NCT01183169|5958297|P7|Switched to ALV|Main Phase||0
2429337|NCT01183169|5958298|P6|Switched to ALV|Main Phase||0
2429338|NCT01183169|5958299|P5|Switched to ALV|Main Phase||0
2429339|NCT01183169|5958300|P4|Switched to ALV|Main Phase||30
2429340|NCT01183169|5958301|P3|Switched to ALV|Main Phase||35
2429341|NCT01183169|5958302|P2|Switched to ALV|Main Phase||0
2429342|NCT01183169|5958303|P1|Switched to ALV|Main Phase||0
2429343|NCT01183169|5958297|P7|Completed Treatment|Main Phase||0
2429344|NCT01183169|5958298|P6|Completed Treatment|Main Phase||0
2429345|NCT01183169|5958299|P5|Completed Treatment|Main Phase||77
2429346|NCT01183169|5958300|P4|Completed Treatment|Main Phase||17
2429347|NCT01183169|5958301|P3|Completed Treatment|Main Phase||17
2429348|NCT01183169|5958302|P2|Completed Treatment|Main Phase||78
2429349|NCT01183169|5958303|P1|Completed Treatment|Main Phase||72
2429350|NCT01183169|5958297|P7|STARTED|Main Phase||0
2429351|NCT01183169|5958298|P6|STARTED|Main Phase||0
2429352|NCT01183169|5958299|P5|STARTED|Main Phase||109
2429353|NCT01183169|5958300|P4|STARTED|Main Phase||55
2429354|NCT01183169|5958301|P3|STARTED|Main Phase||59
2429355|NCT01183169|5958302|P2|STARTED|Main Phase||115
2429356|NCT01183169|5958303|P1|STARTED|Main Phase||121
2429357|NCT01183143|5958375|P1|NOT COMPLETED|Overall Study||150
2429358|NCT01183143|5958375|P1|COMPLETED|Overall Study||65
2429359|NCT01183143|5958375|P1|Intention to Treat (ITT) Population|Overall Study|ITT=Subjects who received at least 1 dose of the investigational medicinal product (IMP).|204
2429360|NCT01183143|5958375|P1|STARTED|Overall Study||215
2429361|NCT01183104|5958391|P2|NOT COMPLETED|Overall Study||92
2429362|NCT01183104|5958392|P1|NOT COMPLETED|Overall Study||77
2429363|NCT01183104|5958391|P2|COMPLETED|Overall Study||60
2429364|NCT01183104|5958392|P1|COMPLETED|Overall Study||76
2429365|NCT01183104|5958391|P2|Enrolled in Extension Study|Overall Study||61
2429366|NCT01183104|5958392|P1|Enrolled in Extension Study|Overall Study||80
2429367|NCT01183104|5958391|P2|Completed 52-week Treatment|Overall Study||111
2429368|NCT01183104|5958392|P1|Completed 52-week Treatment|Overall Study||119
2429369|NCT01183104|5958391|P2|Continued Treatment for 12 Weeks|Overall Study||129
2429370|NCT01183104|5958392|P1|Continued Treatment for 12 Weeks|Overall Study||143
2429371|NCT01183104|5958391|P2|Received Study Drug|Overall Study||143
2429372|NCT01183104|5958392|P1|Received Study Drug|Overall Study||148
2429373|NCT01183104|5958391|P2|STARTED|Overall Study||152
2429374|NCT01183104|5958392|P1|STARTED|Overall Study||153
2429375|NCT01183065|5958408|P1|NOT COMPLETED|Overall Study||1
2429376|NCT01183065|5958408|P1|COMPLETED|Overall Study||12
2429377|NCT01183065|5958408|P1|STARTED|Overall Study||13
2429378|NCT01183013|5958419|P7|NOT COMPLETED|Overall Study||37
2429379|NCT01183013|5958420|P6|NOT COMPLETED|Overall Study||45
2429380|NCT01183013|5958421|P5|NOT COMPLETED|Overall Study||36
2429381|NCT01183013|5958422|P4|NOT COMPLETED|Overall Study||30
2429382|NCT01183013|5958423|P3|NOT COMPLETED|Overall Study||41
2429383|NCT01183013|5958424|P2|NOT COMPLETED|Overall Study||39
2429384|NCT01183013|5958425|P1|NOT COMPLETED|Overall Study||45
2429385|NCT01183013|5958419|P7|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|96
2429386|NCT01183013|5958420|P6|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|88
2429387|NCT01183013|5958421|P5|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|90
2429388|NCT01183013|5958422|P4|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|105
2429389|NCT01183013|5958423|P3|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|97
2429390|NCT01183013|5958424|P2|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|101
2429391|NCT01183013|5958425|P1|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|86
2429392|NCT01183013|5958419|P7|STARTED|Overall Study||133
2429393|NCT01183013|5958420|P6|STARTED|Overall Study||133
2429394|NCT01183013|5958421|P5|STARTED|Overall Study||126
2429395|NCT01183013|5958422|P4|STARTED|Overall Study||135
2429396|NCT01183013|5958423|P3|STARTED|Overall Study||138
2429397|NCT01183013|5958424|P2|STARTED|Overall Study||140
2429398|NCT01183013|5958425|P1|STARTED|Overall Study||131
2429399|NCT01182805|5958504|P1|NOT COMPLETED|Overall Study||0
2429400|NCT01182805|5958504|P1|COMPLETED|Overall Study||50
2429401|NCT01182805|5958504|P1|STARTED|Overall Study||50
2429402|NCT01182727|5958513|P1|NOT COMPLETED|Overall Study||0
2429403|NCT01182727|5958513|P1|COMPLETED|Overall Study||10
2429404|NCT01182727|5958513|P1|STARTED|Overall Study||10
2429405|NCT01182675|5958519|P2|NOT COMPLETED|Overall Study||0
2429406|NCT01182675|5958520|P1|NOT COMPLETED|Overall Study||0
2429407|NCT01182675|5958519|P2|COMPLETED|Overall Study||0
2429408|NCT01182675|5958520|P1|COMPLETED|Overall Study||7
2429409|NCT01182675|5958519|P2|STARTED|Overall Study||0
2429410|NCT01182675|5958520|P1|STARTED|Overall Study||7
2429411|NCT01182610|5958536|P1|NOT COMPLETED|Overall Study||0
2429412|NCT01182610|5958536|P1|COMPLETED|Overall Study||1
2429413|NCT01182610|5958536|P1|STARTED|Overall Study||1
2429414|NCT01182493|5958546|P2|NOT COMPLETED|Overall Study||7
2429415|NCT01182493|5958547|P1|NOT COMPLETED|Overall Study||16
2429416|NCT01182493|5958546|P2|COMPLETED|Overall Study||156
2429417|NCT01182493|5958547|P1|COMPLETED|Overall Study||152
2429418|NCT01182493|5958546|P2|STARTED|Overall Study||163
2429419|NCT01182493|5958547|P1|STARTED|Overall Study||168
2429420|NCT01182480|5958565|P1|NOT COMPLETED|Overall Study||0
2429421|NCT01182480|5958565|P1|COMPLETED|Overall Study||47
2429422|NCT01182480|5958565|P1|STARTED|Overall Study||47
2429423|NCT01182441|5958571|P2|NOT COMPLETED|Overall Study||119
2429424|NCT01182441|5958572|P1|NOT COMPLETED|Overall Study||220
2429425|NCT01182441|5958571|P2|COMPLETED|Overall Study||19
2429426|NCT01182441|5958572|P1|COMPLETED|Overall Study||49
2429427|NCT01182441|5958571|P2|STARTED|Overall Study||138
2429428|NCT01182441|5958572|P1|STARTED|Overall Study||269
2429429|NCT01182428|5958583|P2|NOT COMPLETED|Overall Study||1
2429430|NCT01182428|5958584|P1|NOT COMPLETED|Overall Study||11
2429431|NCT01182428|5958583|P2|COMPLETED|Overall Study||150
2429432|NCT01182428|5958584|P1|COMPLETED|Overall Study||293
2429433|NCT01182428|5958583|P2|STARTED|Overall Study||151
2429434|NCT01182428|5958584|P1|STARTED|Overall Study||304
2429435|NCT01182415|5958648|P1|NOT COMPLETED|Overall Study||1
2429436|NCT01182415|5958648|P1|COMPLETED|Overall Study||29
2429437|NCT01182415|5958648|P1|STARTED|Overall Study||30
2429438|NCT01182376|5958657|P2|NOT COMPLETED|Overall Study||5
2429439|NCT01182376|5958658|P1|NOT COMPLETED|Overall Study||11
2429440|NCT01182376|5958657|P2|COMPLETED|Overall Study||13
2429441|NCT01182376|5958658|P1|COMPLETED|Overall Study||4
2429442|NCT01182376|5958657|P2|STARTED|Overall Study||18
2429443|NCT01182376|5958658|P1|STARTED|Overall Study||15
2429444|NCT01182350|5958664|P5|NOT COMPLETED|Overall Study||3
2429445|NCT01182350|5958665|P4|NOT COMPLETED|Overall Study||3
2429446|NCT01182350|5958666|P3|NOT COMPLETED|Overall Study||3
2429447|NCT01182350|5958667|P2|NOT COMPLETED|Overall Study||14
2429448|NCT01182350|5958668|P1|NOT COMPLETED|Overall Study||27
2429449|NCT01182350|5958664|P5|COMPLETED|Overall Study||0
2429450|NCT01182350|5958665|P4|COMPLETED|Overall Study||0
2429451|NCT01182350|5958666|P3|COMPLETED|Overall Study||0
2429452|NCT01182350|5958667|P2|COMPLETED|Overall Study||0
2429453|NCT01182350|5958668|P1|COMPLETED|Overall Study||3
2429454|NCT01182350|5958664|P5|Started Assigned Chemoradiation|Overall Study||0
2429455|NCT01182350|5958665|P4|Started Assigned Chemoradiation|Overall Study||2
2429456|NCT01182350|5958666|P3|Started Assigned Chemoradiation|Overall Study||2
2429457|NCT01182350|5958667|P2|Started Assigned Chemoradiation|Overall Study||14
2429458|NCT01182350|5958668|P1|Started Assigned Chemoradiation|Overall Study||27
2429459|NCT01182350|5958664|P5|Underwent Stereotactic Biopsy|Overall Study||0
2429460|NCT01182350|5958665|P4|Underwent Stereotactic Biopsy|Overall Study||3
2429461|NCT01182350|5958666|P3|Underwent Stereotactic Biopsy|Overall Study||3
2429462|NCT01182350|5958667|P2|Underwent Stereotactic Biopsy|Overall Study||14
2429463|NCT01182350|5958668|P1|Underwent Stereotactic Biopsy|Overall Study||30
2429464|NCT01182350|5958664|P5|STARTED|Overall Study||3
2429465|NCT01182350|5958665|P4|STARTED|Overall Study||3
2429466|NCT01182350|5958666|P3|STARTED|Overall Study||3
2429467|NCT01182350|5958667|P2|STARTED|Overall Study||14
2429468|NCT01182350|5958668|P1|STARTED|Overall Study||30
2429469|NCT01182337|5958690|P2|NOT COMPLETED|Overall Study||2
2429470|NCT01182337|5958691|P1|NOT COMPLETED|Overall Study||3
2429471|NCT01182337|5958690|P2|COMPLETED|Overall Study||7
2429472|NCT01182337|5958691|P1|COMPLETED|Overall Study||19
2429473|NCT01182337|5958690|P2|STARTED|Overall Study||9
2429474|NCT01182337|5958691|P1|STARTED|Overall Study||22
2429475|NCT01182298|5958709|P1|NOT COMPLETED|Overall Study||6
2429476|NCT01182298|5958709|P1|COMPLETED|Overall Study||4
2429477|NCT01182298|5958709|P1|STARTED|Overall Study||10
2429478|NCT01182285|5958713|P3|NOT COMPLETED|Third Intervention Week 11-52||8
2429479|NCT01182285|5958714|P2|NOT COMPLETED|Third Intervention Week 11-52||0
2429480|NCT01182285|5958715|P1|NOT COMPLETED|Third Intervention Week 11-52||0
2429481|NCT01182285|5958713|P3|COMPLETED|Third Intervention Week 11-52||0
2429482|NCT01182285|5958714|P2|COMPLETED|Third Intervention Week 11-52||0
2429483|NCT01182285|5958715|P1|COMPLETED|Third Intervention Week 11-52||0
2429484|NCT01182285|5958713|P3|STARTED|Third Intervention Week 11-52|2 subj. taken off study after completing ph 1: 1 due to a negative uptake scan & one off due to PD.|8
2429485|NCT01182285|5958714|P2|STARTED|Third Intervention Week 11-52||0
2429486|NCT01182285|5958715|P1|STARTED|Third Intervention Week 11-52||0
2429487|NCT01182285|5958713|P3|NOT COMPLETED|Second Intervention Week 11-17||0
2429488|NCT01182285|5958714|P2|NOT COMPLETED|Second Intervention Week 11-17||0
2429489|NCT01182285|5958715|P1|NOT COMPLETED|Second Intervention Week 11-17||0
2429490|NCT01182285|5958713|P3|COMPLETED|Second Intervention Week 11-17||0
2429491|NCT01182285|5958714|P2|COMPLETED|Second Intervention Week 11-17||0
2429492|NCT01182285|5958715|P1|COMPLETED|Second Intervention Week 11-17||0
2429493|NCT01182285|5958713|P3|STARTED|Second Intervention Week 11-17||0
2429494|NCT01182285|5958714|P2|STARTED|Second Intervention Week 11-17||0
2429495|NCT01182285|5958715|P1|STARTED|Second Intervention Week 11-17||0
2429496|NCT01182285|5958713|P3|NOT COMPLETED|First Intervention Week 1-10||0
2429497|NCT01182285|5958714|P2|NOT COMPLETED|First Intervention Week 1-10||0
2429498|NCT01182285|5958715|P1|NOT COMPLETED|First Intervention Week 1-10||3
2429499|NCT01182285|5958713|P3|COMPLETED|First Intervention Week 1-10||0
2429500|NCT01182285|5958714|P2|COMPLETED|First Intervention Week 1-10||0
2429501|NCT01182285|5958715|P1|COMPLETED|First Intervention Week 1-10||10
2429502|NCT01182285|5958713|P3|STARTED|First Intervention Week 1-10||0
2429503|NCT01182285|5958714|P2|STARTED|First Intervention Week 1-10||0
2429504|NCT01182285|5958715|P1|STARTED|First Intervention Week 1-10||13
2429505|NCT01182207|5958725|P2|NOT COMPLETED|Second Intervention||0
2429506|NCT01182207|5958726|P1|NOT COMPLETED|Second Intervention||1
2429507|NCT01182207|5958725|P2|COMPLETED|Second Intervention||14
2429508|NCT01182207|5958726|P1|COMPLETED|Second Intervention||17
2429509|NCT01182207|5958725|P2|STARTED|Second Intervention||14
2429510|NCT01182207|5958726|P1|STARTED|Second Intervention||18
2429511|NCT01182207|5958725|P2|NOT COMPLETED|Washout of 28 Days||0
2429512|NCT01182207|5958726|P1|NOT COMPLETED|Washout of 28 Days||0
2429513|NCT01182207|5958725|P2|COMPLETED|Washout of 28 Days||14
2429514|NCT01182207|5958726|P1|COMPLETED|Washout of 28 Days||18
2429515|NCT01182207|5958725|P2|STARTED|Washout of 28 Days||14
2429516|NCT01182207|5958726|P1|STARTED|Washout of 28 Days||18
2429517|NCT01182207|5958725|P2|NOT COMPLETED|First Intervention||1
2429518|NCT01182207|5958726|P1|NOT COMPLETED|First Intervention||0
2429519|NCT01182207|5958725|P2|COMPLETED|First Intervention||14
2429520|NCT01182207|5958726|P1|COMPLETED|First Intervention||18
2429521|NCT01182207|5958725|P2|STARTED|First Intervention||15
2429522|NCT01182207|5958726|P1|STARTED|First Intervention||18
2429523|NCT01182194|5958744|P2|NOT COMPLETED|Second Intervention||0
2429524|NCT01182194|5958745|P1|NOT COMPLETED|Second Intervention||0
2429525|NCT01182194|5958744|P2|COMPLETED|Second Intervention||16
2429526|NCT01182194|5958745|P1|COMPLETED|Second Intervention||15
2429527|NCT01182194|5958744|P2|STARTED|Second Intervention||16
2429528|NCT01182194|5958745|P1|STARTED|Second Intervention||15
2429529|NCT01182194|5958744|P2|NOT COMPLETED|Washout of 28 Days||0
2429530|NCT01182194|5958745|P1|NOT COMPLETED|Washout of 28 Days||1
2429531|NCT01182194|5958744|P2|COMPLETED|Washout of 28 Days||16
2429532|NCT01182194|5958745|P1|COMPLETED|Washout of 28 Days||15
2429533|NCT01182194|5958744|P2|STARTED|Washout of 28 Days||16
2429534|NCT01182194|5958745|P1|STARTED|Washout of 28 Days||16
2429535|NCT01182194|5958744|P2|NOT COMPLETED|First Intervention||0
2429536|NCT01182194|5958745|P1|NOT COMPLETED|First Intervention||0
2429537|NCT01182194|5958744|P2|COMPLETED|First Intervention||16
2429538|NCT01182194|5958745|P1|COMPLETED|First Intervention||16
2429539|NCT01182194|5958744|P2|STARTED|First Intervention||16
2429540|NCT01182194|5958745|P1|STARTED|First Intervention||16
2429541|NCT01182181|5958763|P2|NOT COMPLETED|Second Intervention||0
2429542|NCT01182181|5958764|P1|NOT COMPLETED|Second Intervention||0
2429543|NCT01182181|5958763|P2|COMPLETED|Second Intervention||10
2429544|NCT01182181|5958764|P1|COMPLETED|Second Intervention||10
2429545|NCT01182181|5958763|P2|STARTED|Second Intervention||10
2429546|NCT01182181|5958764|P1|STARTED|Second Intervention||10
2429547|NCT01182181|5958763|P2|NOT COMPLETED|Washout of 21 Days||1
2429548|NCT01182181|5958764|P1|NOT COMPLETED|Washout of 21 Days||0
2429549|NCT01182181|5958763|P2|COMPLETED|Washout of 21 Days||10
2429550|NCT01182181|5958764|P1|COMPLETED|Washout of 21 Days||10
2429551|NCT01182181|5958763|P2|STARTED|Washout of 21 Days||11
2429552|NCT01182181|5958764|P1|STARTED|Washout of 21 Days||10
2429553|NCT01182181|5958763|P2|NOT COMPLETED|First Intervention||0
2429554|NCT01182181|5958764|P1|NOT COMPLETED|First Intervention||1
2429555|NCT01182181|5958763|P2|COMPLETED|First Intervention||11
2429556|NCT01182181|5958764|P1|COMPLETED|First Intervention||10
2429557|NCT01182181|5958763|P2|STARTED|First Intervention||11
2429558|NCT01182181|5958764|P1|STARTED|First Intervention||11
2429559|NCT01182103|5958774|P2|NOT COMPLETED|Overall Study||0
2429560|NCT01182103|5958775|P1|NOT COMPLETED|Overall Study||0
2429561|NCT01182103|5958774|P2|COMPLETED|Overall Study||62
2429562|NCT01182103|5958775|P1|COMPLETED|Overall Study||48
2429563|NCT01182103|5958774|P2|STARTED|Overall Study||62
2429564|NCT01182103|5958775|P1|STARTED|Overall Study||48
2429565|NCT01181986|5958789|P3|NOT COMPLETED|Phase 2||0
2429566|NCT01181986|5958790|P2|NOT COMPLETED|Phase 2||4
2429567|NCT01181986|5958791|P1|NOT COMPLETED|Phase 2||0
2429568|NCT01181986|5958789|P3|COMPLETED|Phase 2||0
2429569|NCT01181986|5958790|P2|COMPLETED|Phase 2||18
2429570|NCT01181986|5958791|P1|COMPLETED|Phase 2||18
2429571|NCT01181986|5958789|P3|STARTED|Phase 2|N/A for Sub-study 2|0
2429572|NCT01181986|5958790|P2|STARTED|Phase 2||22
2429573|NCT01181986|5958791|P1|STARTED|Phase 2||18
2429574|NCT01181986|5958789|P3|NOT COMPLETED|Phase 1||2
2429575|NCT01181986|5958790|P2|NOT COMPLETED|Phase 1||1
2429576|NCT01181986|5958791|P1|NOT COMPLETED|Phase 1||1
2429577|NCT01181986|5958789|P3|COMPLETED|Phase 1||32
2429578|NCT01181986|5958790|P2|COMPLETED|Phase 1||22
2429579|NCT01181986|5958791|P1|COMPLETED|Phase 1||18
2429580|NCT01181986|5958789|P3|Exendin-9+Exenatide|Phase 1||33
2429581|NCT01181986|5958790|P2|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
2429582|NCT01181986|5958791|P1|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
2429583|NCT01181986|5958789|P3|Saline+Placebo|Phase 1||33
2429584|NCT01181986|5958790|P2|Saline+Placebo|Phase 1|N/A for this arm|0
2429585|NCT01181986|5958791|P1|Saline+Placebo|Phase 1|N/A for this arm|0
2429586|NCT01181986|5958789|P3|Saline+Exenatide|Phase 1||32
2429587|NCT01181986|5958790|P2|Saline+Exenatide|Phase 1|N/A for this arm|0
2429588|NCT01181986|5958791|P1|Saline+Exenatide|Phase 1|N/A for this arm|0
2429589|NCT01181986|5958789|P3|STARTED|Phase 1||34
2429590|NCT01181986|5958790|P2|STARTED|Phase 1||23
2429591|NCT01181986|5958791|P1|STARTED|Phase 1||19
2429592|NCT01181947|5958807|P1|NOT COMPLETED|Overall Study||0
2429593|NCT01181947|5958807|P1|COMPLETED|Overall Study||100
2429594|NCT01181947|5958807|P1|STARTED|Overall Study||100
2429595|NCT01181921|5958812|P1|NOT COMPLETED|Overall Study||1
2429596|NCT01181921|5958812|P1|COMPLETED|Overall Study||0
2429597|NCT01181921|5958812|P1|STARTED|Overall Study||1
2429598|NCT01181895|5958819|P3|NOT COMPLETED|Overall Study||18
2429599|NCT01181895|5958820|P2|NOT COMPLETED|Overall Study||14
2429600|NCT01181895|5958821|P1|NOT COMPLETED|Overall Study||17
2429601|NCT01181895|5958819|P3|COMPLETED|Overall Study||98
2429602|NCT01181895|5958820|P2|COMPLETED|Overall Study||101
2429603|NCT01181895|5958821|P1|COMPLETED|Overall Study||99
2429604|NCT01181895|5958819|P3|STARTED|Overall Study||116
2429605|NCT01181895|5958820|P2|STARTED|Overall Study||115
2429606|NCT01181895|5958821|P1|STARTED|Overall Study||116
2429607|NCT01181804|5958854|P4|NOT COMPLETED|Period 4, Fasted (Part 2)||0
2429608|NCT01181804|5958855|P3|NOT COMPLETED|Period 4, Fasted (Part 2)||1
2429609|NCT01181804|5958856|P2|NOT COMPLETED|Period 4, Fasted (Part 2)||0
2429610|NCT01181804|5958857|P1|NOT COMPLETED|Period 4, Fasted (Part 2)||0
2429611|NCT01181804|5958854|P4|COMPLETED|Period 4, Fasted (Part 2)||58
2429612|NCT01181804|5958855|P3|COMPLETED|Period 4, Fasted (Part 2)||58
2429613|NCT01181804|5958856|P2|COMPLETED|Period 4, Fasted (Part 2)||0
2429614|NCT01181804|5958857|P1|COMPLETED|Period 4, Fasted (Part 2)||0
2429615|NCT01181804|5958854|P4|STARTED|Period 4, Fasted (Part 2)||58
2429616|NCT01181804|5958855|P3|STARTED|Period 4, Fasted (Part 2)||59
2429617|NCT01181804|5958856|P2|STARTED|Period 4, Fasted (Part 2)||0
2429618|NCT01181804|5958857|P1|STARTED|Period 4, Fasted (Part 2)||0
2429619|NCT01181804|5958854|P4|NOT COMPLETED|Period 3, Fasted (Part 2)||0
2429620|NCT01181804|5958855|P3|NOT COMPLETED|Period 3, Fasted (Part 2)||0
2429621|NCT01181804|5958856|P2|NOT COMPLETED|Period 3, Fasted (Part 2)||0
2429622|NCT01181804|5958857|P1|NOT COMPLETED|Period 3, Fasted (Part 2)||0
2429623|NCT01181804|5958854|P4|COMPLETED|Period 3, Fasted (Part 2)||58
2429624|NCT01181804|5958855|P3|COMPLETED|Period 3, Fasted (Part 2)||59
2429625|NCT01181804|5958856|P2|COMPLETED|Period 3, Fasted (Part 2)||0
2429626|NCT01181804|5958857|P1|COMPLETED|Period 3, Fasted (Part 2)||0
2429627|NCT01181804|5958854|P4|STARTED|Period 3, Fasted (Part 2)||58
2429628|NCT01181804|5958855|P3|STARTED|Period 3, Fasted (Part 2)||59
2429629|NCT01181804|5958856|P2|STARTED|Period 3, Fasted (Part 2)||0
2429630|NCT01181804|5958857|P1|STARTED|Period 3, Fasted (Part 2)||0
2429631|NCT01181804|5958854|P4|NOT COMPLETED|Period 2, Fed (Part 1)||0
2429632|NCT01181804|5958855|P3|NOT COMPLETED|Period 2, Fed (Part 1)||0
2429633|NCT01181804|5958856|P2|NOT COMPLETED|Period 2, Fed (Part 1)||0
2429634|NCT01181804|5958857|P1|NOT COMPLETED|Period 2, Fed (Part 1)||0
2429635|NCT01181804|5958854|P4|COMPLETED|Period 2, Fed (Part 1)||0
2429636|NCT01181804|5958855|P3|COMPLETED|Period 2, Fed (Part 1)||0
2429637|NCT01181804|5958856|P2|COMPLETED|Period 2, Fed (Part 1)||30
2429638|NCT01181804|5958857|P1|COMPLETED|Period 2, Fed (Part 1)||30
2429639|NCT01181804|5958854|P4|STARTED|Period 2, Fed (Part 1)||0
2429640|NCT01181804|5958855|P3|STARTED|Period 2, Fed (Part 1)||0
2429641|NCT01181804|5958856|P2|STARTED|Period 2, Fed (Part 1)||30
2429642|NCT01181804|5958857|P1|STARTED|Period 2, Fed (Part 1)||30
2429643|NCT01181804|5958854|P4|NOT COMPLETED|Period 1, Fed (Part 1)||0
2429644|NCT01181804|5958855|P3|NOT COMPLETED|Period 1, Fed (Part 1)||0
2429645|NCT01181804|5958856|P2|NOT COMPLETED|Period 1, Fed (Part 1)||0
2429646|NCT01181804|5958857|P1|NOT COMPLETED|Period 1, Fed (Part 1)||0
2429647|NCT01181804|5958854|P4|COMPLETED|Period 1, Fed (Part 1)||0
2429648|NCT01181804|5958855|P3|COMPLETED|Period 1, Fed (Part 1)||0
2429649|NCT01181804|5958856|P2|COMPLETED|Period 1, Fed (Part 1)||30
2429650|NCT01181804|5958857|P1|COMPLETED|Period 1, Fed (Part 1)||30
2429651|NCT01181804|5958854|P4|STARTED|Period 1, Fed (Part 1)||0
2429652|NCT01181804|5958855|P3|STARTED|Period 1, Fed (Part 1)||0
2429653|NCT01181804|5958856|P2|STARTED|Period 1, Fed (Part 1)||30
2429654|NCT01181804|5958857|P1|STARTED|Period 1, Fed (Part 1)||30
2429655|NCT01181778|5958879|P1|NOT COMPLETED|Overall Study||48
2429656|NCT01181778|5958879|P1|COMPLETED|Overall Study||1871
2429657|NCT01181778|5958879|P1|STARTED|Overall Study||1919
2429658|NCT01181726|5958887|P2|NOT COMPLETED|Second Intervention||0
2429659|NCT01181726|5958888|P1|NOT COMPLETED|Second Intervention||0
2429660|NCT01181726|5958887|P2|COMPLETED|Second Intervention||20
2429661|NCT01181726|5958888|P1|COMPLETED|Second Intervention||19
2429662|NCT01181726|5958887|P2|STARTED|Second Intervention||20
2429663|NCT01181726|5958888|P1|STARTED|Second Intervention||19
2429664|NCT01181726|5958887|P2|NOT COMPLETED|Washout of 28 Days||0
2429665|NCT01181726|5958888|P1|NOT COMPLETED|Washout of 28 Days||0
2429666|NCT01181726|5958887|P2|COMPLETED|Washout of 28 Days||20
2429667|NCT01181726|5958888|P1|COMPLETED|Washout of 28 Days||19
2429668|NCT01181726|5958887|P2|STARTED|Washout of 28 Days||20
2429669|NCT01181726|5958888|P1|STARTED|Washout of 28 Days||19
2429670|NCT01181726|5958887|P2|NOT COMPLETED|First Intervention||0
2429671|NCT01181726|5958888|P1|NOT COMPLETED|First Intervention||1
2429672|NCT01181726|5958887|P2|COMPLETED|First Intervention||20
2429673|NCT01181726|5958888|P1|COMPLETED|First Intervention||19
2429674|NCT01181726|5958887|P2|STARTED|First Intervention||20
2429675|NCT01181726|5958888|P1|STARTED|First Intervention||20
2429676|NCT01181609|5958934|P1|NOT COMPLETED|Overall Study||53
2429677|NCT01181609|5958934|P1|COMPLETED|Overall Study||1
2429678|NCT01181609|5958934|P1|STARTED|Overall Study||54
2429679|NCT01181596|5958945|P1|NOT COMPLETED|Overall Study||0
2429680|NCT01181596|5958945|P1|COMPLETED|Overall Study||31
2429681|NCT01181596|5958945|P1|STARTED|Overall Study||31
2429682|NCT01181531|5958952|P2|NOT COMPLETED|Overall Study||53
2429683|NCT01181531|5958953|P1|NOT COMPLETED|Overall Study||61
2429684|NCT01181531|5958952|P2|COMPLETED|Overall Study||102
2429685|NCT01181531|5958953|P1|COMPLETED|Overall Study||96
2429686|NCT01181531|5958952|P2|Received Investigational Product|Overall Study||153
2429687|NCT01181531|5958953|P1|Received Investigational Product|Overall Study||155
2429688|NCT01181531|5958952|P2|STARTED|Overall Study|Subjects are randomized after washout.|155
2429689|NCT01181531|5958953|P1|STARTED|Overall Study|Subjects are randomized after washout.|157
2429690|NCT01181492|5958966|P3|NOT COMPLETED|Overall Study||0
2429691|NCT01181492|5958967|P2|NOT COMPLETED|Overall Study||0
2429692|NCT01181492|5958968|P1|NOT COMPLETED|Overall Study||0
2429693|NCT01181492|5958966|P3|COMPLETED|Overall Study||7
2429694|NCT01181492|5958967|P2|COMPLETED|Overall Study||66
2429695|NCT01181492|5958968|P1|COMPLETED|Overall Study||103
2429696|NCT01181492|5958966|P3|STARTED|Overall Study||7
2429697|NCT01181492|5958967|P2|STARTED|Overall Study||66
2429698|NCT01181492|5958968|P1|STARTED|Overall Study||103
2429699|NCT01181479|5958984|P3|NOT COMPLETED|Crossover Subjects Recieve AG200-15||99
2429700|NCT01181479|5958985|P2|NOT COMPLETED|Crossover Subjects Recieve AG200-15||0
2429701|NCT01181479|5958986|P1|NOT COMPLETED|Crossover Subjects Recieve AG200-15||0
2429702|NCT01181479|5958984|P3|COMPLETED|Crossover Subjects Recieve AG200-15||150
2429703|NCT01181479|5958985|P2|COMPLETED|Crossover Subjects Recieve AG200-15||0
2429704|NCT01181479|5958986|P1|COMPLETED|Crossover Subjects Recieve AG200-15||0
2429705|NCT01181479|5958984|P3|STARTED|Crossover Subjects Recieve AG200-15|"This column is a subset of the Lessina completers in the Lessina (Cycles 1-6) column."|249
2429706|NCT01181479|5958985|P2|STARTED|Crossover Subjects Recieve AG200-15||0
2429707|NCT01181479|5958986|P1|STARTED|Crossover Subjects Recieve AG200-15||0
2429708|NCT01181479|5958984|P3|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||0
2429709|NCT01181479|5958985|P2|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||126
2429710|NCT01181479|5958986|P1|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||644
2429711|NCT01181479|5958984|P3|COMPLETED|Subjects Receive AG200-15 or Lessina||0
2429712|NCT01181479|5958985|P2|COMPLETED|Subjects Receive AG200-15 or Lessina||249
2429713|NCT01181479|5958986|P1|COMPLETED|Subjects Receive AG200-15 or Lessina||485
2429714|NCT01181479|5958984|P3|STARTED|Subjects Receive AG200-15 or Lessina|"This column is a subset of the Lessina completers in the Lessina (Cycles 1-6) column."|0
2429715|NCT01181479|5958985|P2|STARTED|Subjects Receive AG200-15 or Lessina||375
2429716|NCT01181479|5958986|P1|STARTED|Subjects Receive AG200-15 or Lessina||1129
2429717|NCT01181349|5959001|P1|NOT COMPLETED|Overall Study||0
2429718|NCT01181349|5959001|P1|COMPLETED|Overall Study||350
2429719|NCT01181349|5959001|P1|STARTED|Overall Study||350
2429720|NCT01181323|5959017|P4|NOT COMPLETED|Overall Study||3
2429721|NCT01181323|5959018|P3|NOT COMPLETED|Overall Study||1
2429722|NCT01181323|5959019|P2|NOT COMPLETED|Overall Study||3
2429723|NCT01181323|5959020|P1|NOT COMPLETED|Overall Study||1
2429724|NCT01181323|5959017|P4|COMPLETED|Overall Study||122
2429725|NCT01181323|5959018|P3|COMPLETED|Overall Study||123
2429726|NCT01181323|5959019|P2|COMPLETED|Overall Study||121
2429727|NCT01181323|5959020|P1|COMPLETED|Overall Study||123
2429728|NCT01181323|5959017|P4|STARTED|Overall Study||125
2429729|NCT01181323|5959018|P3|STARTED|Overall Study||124
2429730|NCT01181323|5959019|P2|STARTED|Overall Study||124
2429731|NCT01181323|5959020|P1|STARTED|Overall Study||124
2429732|NCT01181271|5959095|P1|NOT COMPLETED|Allogeneic Transplant||0
2429733|NCT01181271|5959095|P1|COMPLETED|Allogeneic Transplant||29
2429734|NCT01181271|5959095|P1|STARTED|Allogeneic Transplant||29
2429735|NCT01181271|5959095|P1|NOT COMPLETED|Evaluation for Allogeneic Transplant||13
2429736|NCT01181271|5959095|P1|COMPLETED|Evaluation for Allogeneic Transplant||29
2429737|NCT01181271|5959095|P1|STARTED|Evaluation for Allogeneic Transplant||42
2429738|NCT01181271|5959095|P1|NOT COMPLETED|Autologous Transplant||0
2429739|NCT01181271|5959095|P1|COMPLETED|Autologous Transplant||42
2429740|NCT01181271|5959095|P1|STARTED|Autologous Transplant||42
2429741|NCT01181258|5959110|P1|NOT COMPLETED|Overall Study||0
2429742|NCT01181258|5959110|P1|COMPLETED|Overall Study||16
2429743|NCT01181258|5959110|P1|STARTED|Overall Study||16
2429744|NCT01181167|5959119|P2|NOT COMPLETED|Overall Study||32
2429745|NCT01181167|5959120|P1|NOT COMPLETED|Overall Study||23
2429746|NCT01181167|5959119|P2|COMPLETED|Overall Study||271
2429747|NCT01181167|5959120|P1|COMPLETED|Overall Study||284
2429748|NCT01181167|5959119|P2|Efficacy Analysis Population|Overall Study||248
2429749|NCT01181167|5959120|P1|Efficacy Analysis Population|Overall Study||255
2429750|NCT01181167|5959119|P2|STARTED|Overall Study||303
2429751|NCT01181167|5959120|P1|STARTED|Overall Study||307
2429752|NCT01181141|5959130|P2|NOT COMPLETED|Overall Study||4
2429753|NCT01181141|5959131|P1|NOT COMPLETED|Overall Study||12
2429754|NCT01181141|5959130|P2|COMPLETED|Overall Study||26
2429755|NCT01181141|5959131|P1|COMPLETED|Overall Study||50
2429756|NCT01181141|5959130|P2|Safety Analysis Population|Overall Study||29
2429757|NCT01181141|5959131|P1|Safety Analysis Population|Overall Study||59
2429758|NCT01181141|5959130|P2|STARTED|Overall Study||30
2429759|NCT01181141|5959131|P1|STARTED|Overall Study||62
2429760|NCT01181128|5959140|P3|NOT COMPLETED|Overall Study||1
2429761|NCT01181128|5959141|P2|NOT COMPLETED|Overall Study||5
2429762|NCT01181128|5959142|P1|NOT COMPLETED|Overall Study||6
2429763|NCT01181128|5959140|P3|COMPLETED|Overall Study||22
2429764|NCT01181128|5959141|P2|COMPLETED|Overall Study||19
2429765|NCT01181128|5959142|P1|COMPLETED|Overall Study||112
2429766|NCT01181128|5959140|P3|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|0
2429767|NCT01181128|5959141|P2|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|1
2429768|NCT01181128|5959142|P1|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|8
2429769|NCT01181128|5959140|P3|Pharmacokinetic (PK) Subgroup|Overall Study||0
2429770|NCT01181128|5959141|P2|Pharmacokinetic (PK) Subgroup|Overall Study||0
2429771|NCT01181128|5959142|P1|Pharmacokinetic (PK) Subgroup|Overall Study||30
2429772|NCT01181128|5959140|P3|STARTED|Overall Study||23
2429773|NCT01181128|5959141|P2|STARTED|Overall Study||24
2429774|NCT01181128|5959142|P1|STARTED|Overall Study||118
2429775|NCT01181102|5959230|P2|NOT COMPLETED|Overall Study||46
2429776|NCT01181102|5959231|P1|NOT COMPLETED|Overall Study||51
2429777|NCT01181102|5959230|P2|COMPLETED|Overall Study||310
2429778|NCT01181102|5959231|P1|COMPLETED|Overall Study||309
2429779|NCT01181102|5959230|P2|Efficacy Analysis Population|Overall Study||295
2429780|NCT01181102|5959231|P1|Efficacy Analysis Population|Overall Study||299
2429781|NCT01181102|5959230|P2|Safety Analysis Set|Overall Study||349
2429782|NCT01181102|5959231|P1|Safety Analysis Set|Overall Study||354
2429783|NCT01181102|5959230|P2|STARTED|Overall Study||356
2429784|NCT01181102|5959231|P1|STARTED|Overall Study||360
2429785|NCT01181076|5959241|P2|NOT COMPLETED|Overall Study||12
2429786|NCT01181076|5959242|P1|NOT COMPLETED|Overall Study||19
2429787|NCT01181076|5959241|P2|COMPLETED|Overall Study|As determined|48
2429788|NCT01181076|5959242|P1|COMPLETED|Overall Study||40
2429789|NCT01181076|5959241|P2|STARTED|Overall Study||60
2429790|NCT01181076|5959242|P1|STARTED|Overall Study||59
2429791|NCT01181050|5959264|P2|NOT COMPLETED|Overall Study||0
2429792|NCT01181050|5959265|P1|NOT COMPLETED|Overall Study||0
2429793|NCT01181050|5959264|P2|COMPLETED|Overall Study||22
2429794|NCT01181050|5959265|P1|COMPLETED|Overall Study||41
2429795|NCT01181050|5959264|P2|STARTED|Overall Study||22
2429796|NCT01181050|5959265|P1|STARTED|Overall Study||41
2429797|NCT01181011|5959275|P1|NOT COMPLETED|Overall Study||3
2429798|NCT01181011|5959275|P1|COMPLETED|Overall Study||25
2429799|NCT01181011|5959275|P1|Received Amlodipine 5mg|Overall Study||26
2429800|NCT01181011|5959275|P1|Received Telmisartan 80mg,Amlodipine 5mg|Overall Study||27
2429801|NCT01181011|5959275|P1|Received Telmisartan 80mg|Overall Study||27
2429802|NCT01181011|5959275|P1|STARTED|Overall Study||28
2429803|NCT01180998|5959325|P3|NOT COMPLETED|Overall Study||10
2429804|NCT01180998|5959326|P2|NOT COMPLETED|Overall Study||4
2429805|NCT01180998|5959327|P1|NOT COMPLETED|Overall Study||4
2429806|NCT01180998|5959325|P3|COMPLETED|Overall Study||51
2429807|NCT01180998|5959326|P2|COMPLETED|Overall Study||68
2429808|NCT01180998|5959327|P1|COMPLETED|Overall Study||63
2429809|NCT01180998|5959325|P3|STARTED|Overall Study||61
2429810|NCT01180998|5959326|P2|STARTED|Overall Study||72
2429811|NCT01180998|5959327|P1|STARTED|Overall Study||67
2429812|NCT01180985|5959341|P2|NOT COMPLETED|Period 2 (7 +/- 1 Days)||0
2429813|NCT01180985|5959342|P1|NOT COMPLETED|Period 2 (7 +/- 1 Days)||1
2429814|NCT01180985|5959341|P2|COMPLETED|Period 2 (7 +/- 1 Days)||26
2429815|NCT01180985|5959342|P1|COMPLETED|Period 2 (7 +/- 1 Days)||26
2429816|NCT01180985|5959341|P2|STARTED|Period 2 (7 +/- 1 Days)||26
2429817|NCT01180985|5959342|P1|STARTED|Period 2 (7 +/- 1 Days)||27
2429818|NCT01180985|5959341|P2|NOT COMPLETED|Period 1 (7 +/- Days)||0
2429819|NCT01180985|5959342|P1|NOT COMPLETED|Period 1 (7 +/- Days)||0
2429820|NCT01180985|5959341|P2|COMPLETED|Period 1 (7 +/- Days)||26
2429821|NCT01180985|5959342|P1|COMPLETED|Period 1 (7 +/- Days)||27
2429822|NCT01180985|5959341|P2|STARTED|Period 1 (7 +/- Days)||26
2429823|NCT01180985|5959342|P1|STARTED|Period 1 (7 +/- Days)||27
2429824|NCT01180894|5959361|P2|NOT COMPLETED|Overall Study||0
2429825|NCT01180894|5959362|P1|NOT COMPLETED|Overall Study||0
2429826|NCT01180894|5959361|P2|COMPLETED|Overall Study||75
2429827|NCT01180894|5959362|P1|COMPLETED|Overall Study||75
2429828|NCT01180894|5959361|P2|STARTED|Overall Study||75
2429829|NCT01180894|5959362|P1|STARTED|Overall Study||75
2429830|NCT01180790|5959381|P7|NOT COMPLETED|Overall Study||1
2429831|NCT01180790|5959382|P6|NOT COMPLETED|Overall Study||7
2429832|NCT01180790|5959383|P5|NOT COMPLETED|Overall Study||5
2429833|NCT01180790|5959384|P4|NOT COMPLETED|Overall Study||9
2429834|NCT01180790|5959385|P3|NOT COMPLETED|Overall Study||13
2429835|NCT01180790|5959386|P2|NOT COMPLETED|Overall Study||5
2429836|NCT01180790|5959387|P1|NOT COMPLETED|Overall Study||9
2429837|NCT01180790|5959381|P7|COMPLETED|Overall Study||18
2429838|NCT01180790|5959382|P6|COMPLETED|Overall Study||13
2429839|NCT01180790|5959383|P5|COMPLETED|Overall Study||14
2429840|NCT01180790|5959384|P4|COMPLETED|Overall Study||6
2429841|NCT01180790|5959385|P3|COMPLETED|Overall Study||4
2429842|NCT01180790|5959386|P2|COMPLETED|Overall Study||11
2429843|NCT01180790|5959387|P1|COMPLETED|Overall Study||7
2429844|NCT01180790|5959381|P7|STARTED|Overall Study||19
2429845|NCT01180790|5959382|P6|STARTED|Overall Study||20
2429846|NCT01180790|5959383|P5|STARTED|Overall Study||19
2429847|NCT01180790|5959384|P4|STARTED|Overall Study||15
2429848|NCT01180790|5959385|P3|STARTED|Overall Study||17
2429849|NCT01180790|5959386|P2|STARTED|Overall Study||16
2429850|NCT01180790|5959387|P1|STARTED|Overall Study||16
2429851|NCT01180777|5959452|P1|NOT COMPLETED|Overall Study||12
2429852|NCT01180777|5959452|P1|COMPLETED|Overall Study||80
2429853|NCT01180777|5959452|P1|STARTED|Overall Study||92
2429854|NCT01180660|5959466|P2|NOT COMPLETED|Overall Study||0
2429855|NCT01180660|5959467|P1|NOT COMPLETED|Overall Study||1
2429856|NCT01180660|5959466|P2|COMPLETED|Overall Study||26
2429857|NCT01180660|5959467|P1|COMPLETED|Overall Study||24
2429858|NCT01180660|5959466|P2|STARTED|Overall Study||26
2429859|NCT01180660|5959467|P1|STARTED|Overall Study||25
2429860|NCT01180647|5959477|P2|NOT COMPLETED|Overall Study||6
2429861|NCT01180647|5959478|P1|NOT COMPLETED|Overall Study||5
2429862|NCT01180647|5959477|P2|COMPLETED|Overall Study||11
2429863|NCT01180647|5959478|P1|COMPLETED|Overall Study||12
2429864|NCT01180647|5959477|P2|STARTED|Overall Study||17
2429865|NCT01180647|5959478|P1|STARTED|Overall Study||17
2429866|NCT01180478|5959496|P2|NOT COMPLETED|Overall Study||188
2429867|NCT01180478|5959497|P1|NOT COMPLETED|Overall Study||181
2429868|NCT01180478|5959496|P2|COMPLETED|Overall Study||293
2429869|NCT01180478|5959497|P1|COMPLETED|Overall Study||303
2429870|NCT01180478|5959496|P2|STARTED|Overall Study||481
2429871|NCT01180478|5959497|P1|STARTED|Overall Study||484
2429872|NCT01180400|5959513|P2|NOT COMPLETED|Overall Study||27
2429873|NCT01180400|5959514|P1|NOT COMPLETED|Overall Study||25
2429874|NCT01180400|5959513|P2|COMPLETED|Overall Study||121
2429875|NCT01180400|5959514|P1|COMPLETED|Overall Study||122
2429876|NCT01180400|5959513|P2|Received Treatment|Overall Study||146
2429877|NCT01180400|5959514|P1|Received Treatment|Overall Study||147
2429878|NCT01180400|5959513|P2|STARTED|Overall Study||148
2429879|NCT01180400|5959514|P1|STARTED|Overall Study||147
2429880|NCT01180296|5959562|P2|NOT COMPLETED|Overall Study||2
2429881|NCT01180296|5959563|P1|NOT COMPLETED|Overall Study||1
2429882|NCT01180296|5959562|P2|COMPLETED|Overall Study||14
2429883|NCT01180296|5959563|P1|COMPLETED|Overall Study||19
2429884|NCT01180296|5959562|P2|STARTED|Overall Study||16
2429885|NCT01180296|5959563|P1|STARTED|Overall Study||20
2429886|NCT01180244|5959573|P2|NOT COMPLETED|Overall Study||8
2429887|NCT01180244|5959574|P1|NOT COMPLETED|Overall Study||6
2429888|NCT01180244|5959573|P2|COMPLETED|Overall Study|Number of placebo group patients who completed all study visits and are evaluable|38
2429889|NCT01180244|5959574|P1|COMPLETED|Overall Study|Number of active treatment patients who completed all study visits and are evaluable|39
2429890|NCT01180244|5959573|P2|Received Treatment|Overall Study|Number of patients in the placebo group that received at least one sham treatment|45
2429891|NCT01180244|5959574|P1|Received Treatment|Overall Study|Number of patients in the active treatment group that received at least one study treatment|40
2429892|NCT01180244|5959573|P2|STARTED|Overall Study|Number of enrolled patients initially randomized to placebo group|46
2429893|NCT01180244|5959574|P1|STARTED|Overall Study|Number of enrolled patients initially randomized to active treatment group|45
2429894|NCT01180127|5959592|P4|NOT COMPLETED|Overall Study||1
2429895|NCT01180127|5959593|P3|NOT COMPLETED|Overall Study||1
2429896|NCT01180127|5959594|P2|NOT COMPLETED|Overall Study||0
2429897|NCT01180127|5959595|P1|NOT COMPLETED|Overall Study||2
2429898|NCT01180127|5959592|P4|COMPLETED|Overall Study||9
2429899|NCT01180127|5959593|P3|COMPLETED|Overall Study||9
2429900|NCT01180127|5959594|P2|COMPLETED|Overall Study||11
2429901|NCT01180127|5959595|P1|COMPLETED|Overall Study||8
2429902|NCT01180127|5959592|P4|STARTED|Overall Study||10
2429903|NCT01180127|5959593|P3|STARTED|Overall Study||10
2429904|NCT01180127|5959594|P2|STARTED|Overall Study||11
2429905|NCT01180127|5959595|P1|STARTED|Overall Study||10
2429906|NCT01180049|5959619|P2|NOT COMPLETED|Overall Study||48
2429907|NCT01180049|5959620|P1|NOT COMPLETED|Overall Study||53
2429908|NCT01180049|5959619|P2|COMPLETED|Overall Study||0
2429909|NCT01180049|5959620|P1|COMPLETED|Overall Study||0
2429910|NCT01180049|5959619|P2|STARTED|Overall Study||48
2429911|NCT01180049|5959620|P1|STARTED|Overall Study||53
2429912|NCT01180036|5959642|P2|NOT COMPLETED|Overall Study||0
2429913|NCT01180036|5959643|P1|NOT COMPLETED|Overall Study||0
2429914|NCT01180036|5959642|P2|COMPLETED|Overall Study||65
2429915|NCT01180036|5959643|P1|COMPLETED|Overall Study||65
2429916|NCT01180036|5959642|P2|STARTED|Overall Study||65
2429917|NCT01180036|5959643|P1|STARTED|Overall Study||65
2429918|NCT01179984|5959651|P1|NOT COMPLETED|Overall Study||18
2429919|NCT01179984|5959651|P1|COMPLETED|Overall Study||58
2429920|NCT01179984|5959651|P1|STARTED|Overall Study||76
2429921|NCT01179919|5959657|P1|NOT COMPLETED|Overall Study||2
2429922|NCT01179919|5959657|P1|COMPLETED|Overall Study||19
2429923|NCT01179919|5959657|P1|STARTED|Overall Study||21
2429924|NCT01179737|5959666|P4|NOT COMPLETED|Extension||0
2429925|NCT01179737|5959667|P3|NOT COMPLETED|Extension||0
2429926|NCT01179737|5959668|P2|NOT COMPLETED|Extension||0
2429927|NCT01179737|5959669|P1|NOT COMPLETED|Extension||3
2429928|NCT01179737|5959666|P4|COMPLETED|Extension||0
2429929|NCT01179737|5959667|P3|COMPLETED|Extension||0
2429930|NCT01179737|5959668|P2|COMPLETED|Extension||0
2429931|NCT01179737|5959669|P1|COMPLETED|Extension||0
2429932|NCT01179737|5959666|P4|STARTED|Extension||0
2429933|NCT01179737|5959667|P3|STARTED|Extension||0
2429934|NCT01179737|5959668|P2|STARTED|Extension|One patient did not enrol in the extension|0
2429935|NCT01179737|5959669|P1|STARTED|Extension|Two patients did not enrol in the extension|3
2429936|NCT01179737|5959666|P4|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
2429937|NCT01179737|5959667|P3|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
2429938|NCT01179737|5959668|P2|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
2429939|NCT01179737|5959669|P1|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||1
2429940|NCT01179737|5959666|P4|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
2429941|NCT01179737|5959667|P3|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
2429942|NCT01179737|5959668|P2|COMPLETED|Cohort 1 & Cohort 2 Expansion||1
2429943|NCT01179737|5959669|P1|COMPLETED|Cohort 1 & Cohort 2 Expansion||4
2429944|NCT01179737|5959666|P4|STARTED|Cohort 1 & Cohort 2 Expansion||0
2429945|NCT01179737|5959667|P3|STARTED|Cohort 1 & Cohort 2 Expansion||0
2429946|NCT01179737|5959668|P2|STARTED|Cohort 1 & Cohort 2 Expansion||1
2429947|NCT01179737|5959669|P1|STARTED|Cohort 1 & Cohort 2 Expansion|2 participants did not enroll in extension|5
2429948|NCT01179737|5959666|P4|NOT COMPLETED|Cohort 1 & Cohort 2||4
2429949|NCT01179737|5959667|P3|NOT COMPLETED|Cohort 1 & Cohort 2||4
2429950|NCT01179737|5959668|P2|NOT COMPLETED|Cohort 1 & Cohort 2||2
2429951|NCT01179737|5959669|P1|NOT COMPLETED|Cohort 1 & Cohort 2||5
2429952|NCT01179737|5959666|P4|COMPLETED|Cohort 1 & Cohort 2||0
2429953|NCT01179737|5959667|P3|COMPLETED|Cohort 1 & Cohort 2||0
2429954|NCT01179737|5959668|P2|COMPLETED|Cohort 1 & Cohort 2||1
2429955|NCT01179737|5959669|P1|COMPLETED|Cohort 1 & Cohort 2||7
2429956|NCT01179737|5959666|P4|STARTED|Cohort 1 & Cohort 2||4
2429957|NCT01179737|5959667|P3|STARTED|Cohort 1 & Cohort 2||4
2429958|NCT01179737|5959668|P2|STARTED|Cohort 1 & Cohort 2|One patient was missing the end of study evaluation|3
2429959|NCT01179737|5959669|P1|STARTED|Cohort 1 & Cohort 2||12
2429960|NCT01179672|5959680|P2|NOT COMPLETED|Overall Study||26
2429961|NCT01179672|5959681|P1|NOT COMPLETED|Overall Study||30
2429962|NCT01179672|5959680|P2|COMPLETED|Overall Study||176
2429963|NCT01179672|5959681|P1|COMPLETED|Overall Study||173
2429964|NCT01179672|5959680|P2|Entered Taper|Overall Study||177
2429965|NCT01179672|5959681|P1|Entered Taper|Overall Study||181
2429966|NCT01179672|5959680|P2|Received at Least 1 Dose of Study Drug|Overall Study||202
2429967|NCT01179672|5959681|P1|Received at Least 1 Dose of Study Drug|Overall Study||202
2429968|NCT01179672|5959680|P2|STARTED|Overall Study||202
2429969|NCT01179672|5959681|P1|STARTED|Overall Study||203
2429970|NCT01179568|5959711|P4|NOT COMPLETED|Overall Study||20
2429971|NCT01179568|5959712|P3|NOT COMPLETED|Overall Study||23
2429972|NCT01179568|5959713|P2|NOT COMPLETED|Overall Study||38
2429973|NCT01179568|5959714|P1|NOT COMPLETED|Overall Study||28
2429974|NCT01179568|5959711|P4|COMPLETED|Overall Study||76
2429975|NCT01179568|5959712|P3|COMPLETED|Overall Study||76
2429976|NCT01179568|5959713|P2|COMPLETED|Overall Study||61
2429977|NCT01179568|5959714|P1|COMPLETED|Overall Study||73
2429978|NCT01179568|5959711|P4|Completed Week 12 Assessment|Overall Study||75
2429979|NCT01179568|5959712|P3|Completed Week 12 Assessment|Overall Study||76
2429980|NCT01179568|5959713|P2|Completed Week 12 Assessment|Overall Study||69
2429981|NCT01179568|5959714|P1|Completed Week 12 Assessment|Overall Study||69
2429982|NCT01179568|5959711|P4|STARTED|Overall Study||96
2429983|NCT01179568|5959712|P3|STARTED|Overall Study||99
2429984|NCT01179568|5959713|P2|STARTED|Overall Study||99
2429985|NCT01179568|5959714|P1|STARTED|Overall Study||101
2429986|NCT01179516|5959737|P3|NOT COMPLETED|Overall Study||31
2429987|NCT01179516|5959738|P2|NOT COMPLETED|Overall Study||26
2429988|NCT01179516|5959739|P1|NOT COMPLETED|Overall Study||27
2429989|NCT01179516|5959737|P3|COMPLETED|Overall Study||121
2429990|NCT01179516|5959738|P2|COMPLETED|Overall Study||131
2429991|NCT01179516|5959739|P1|COMPLETED|Overall Study||133
2429992|NCT01179516|5959737|P3|Treated|Overall Study||151
2429993|NCT01179516|5959738|P2|Treated|Overall Study||154
2429994|NCT01179516|5959739|P1|Treated|Overall Study||160
2429995|NCT01179516|5959737|P3|STARTED|Overall Study||152
2429996|NCT01179516|5959738|P2|STARTED|Overall Study||157
2429997|NCT01179516|5959739|P1|STARTED|Overall Study||160
2429998|NCT01179490|5959762|P1|NOT COMPLETED|Overall Study||0
2429999|NCT01179490|5959762|P1|COMPLETED|Overall Study||5
2430000|NCT01179490|5959762|P1|STARTED|Overall Study||5
2430001|NCT01179477|5959783|P1|NOT COMPLETED|Overall Study||1087
2430002|NCT01179477|5959783|P1|COMPLETED|Overall Study||843
2430003|NCT01179477|5959783|P1|STARTED|Overall Study||1930
2430004|NCT01179399|5959788|P1|NOT COMPLETED|Overall Study||32
2430005|NCT01179399|5959788|P1|COMPLETED|Overall Study||0
2430006|NCT01179399|5959788|P1|STARTED|Overall Study||32
2430007|NCT01179347|5959794|P2|NOT COMPLETED|Open-label Period (12 Weeks)||16
2430008|NCT01179347|5959795|P1|NOT COMPLETED|Open-label Period (12 Weeks)||15
2430009|NCT01179347|5959794|P2|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|278
2430010|NCT01179347|5959795|P1|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|132
2430011|NCT01179347|5959794|P2|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|294
2430012|NCT01179347|5959795|P1|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|147
2430013|NCT01179347|5959794|P2|NOT COMPLETED|Double-blind Period (12 Weeks)||14
2430014|NCT01179347|5959795|P1|NOT COMPLETED|Double-blind Period (12 Weeks)||8
2430015|NCT01179347|5959794|P2|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|294
2430016|NCT01179347|5959795|P1|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|147
2430017|NCT01179347|5959794|P2|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|308
2430018|NCT01179347|5959795|P1|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|155
2430019|NCT01179334|5959817|P2|NOT COMPLETED|Long-term Extension (LTE) Period||6
2430020|NCT01179334|5959818|P1|NOT COMPLETED|Long-term Extension (LTE) Period||11
2430021|NCT01179334|5959817|P2|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
2430022|NCT01179334|5959818|P1|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
2430023|NCT01179334|5959817|P2|STARTED|Long-term Extension (LTE) Period||6
2430024|NCT01179334|5959818|P1|STARTED|Long-term Extension (LTE) Period||11
2430025|NCT01179334|5959817|P2|NOT COMPLETED|Treatment Period||0
2430026|NCT01179334|5959818|P1|NOT COMPLETED|Treatment Period||1
2430027|NCT01179334|5959817|P2|COMPLETED|Treatment Period||6
2430028|NCT01179334|5959818|P1|COMPLETED|Treatment Period||11
2430029|NCT01179334|5959817|P2|Participants Received Treatment|Treatment Period||6
2430030|NCT01179334|5959818|P1|Participants Received Treatment|Treatment Period||12
2430031|NCT01179334|5959817|P2|STARTED|Treatment Period||6
2430032|NCT01179334|5959818|P1|STARTED|Treatment Period||12
2430033|NCT01179217|5959848|P2|NOT COMPLETED|Overall Study||19
2430034|NCT01179217|5959849|P1|NOT COMPLETED|Overall Study||55
2430035|NCT01179217|5959848|P2|COMPLETED|Overall Study||59
2430036|NCT01179217|5959849|P1|COMPLETED|Overall Study||97
2430037|NCT01179217|5959848|P2|STARTED|Overall Study||78
2430038|NCT01179217|5959849|P1|STARTED|Overall Study||152
2430039|NCT01179191|5959873|P1|NOT COMPLETED|Maintenance Phase (8 Weeks)||117
2430040|NCT01179191|5959873|P1|COMPLETED|Maintenance Phase (8 Weeks)||234
2430041|NCT01179191|5959873|P1|STARTED|Maintenance Phase (8 Weeks)||351
2430132|NCT01178281|5960123|P3|COMPLETED|Overall Study||15
2430042|NCT01179191|5959873|P1|NOT COMPLETED|Titration Phase (up to 6 Weeks)||333
2430043|NCT01179191|5959873|P1|COMPLETED|Titration Phase (up to 6 Weeks)||351
2430044|NCT01179191|5959873|P1|STARTED|Titration Phase (up to 6 Weeks)||684
2430045|NCT01179113|5959892|P2|NOT COMPLETED|Overall Study||0
2430046|NCT01179113|5959893|P1|NOT COMPLETED|Overall Study||0
2430047|NCT01179113|5959892|P2|COMPLETED|Overall Study||16
2430048|NCT01179113|5959893|P1|COMPLETED|Overall Study||17
2430049|NCT01179113|5959892|P2|STARTED|Overall Study||16
2430050|NCT01179113|5959893|P1|STARTED|Overall Study||17
2430051|NCT01179048|5959905|P2|NOT COMPLETED|Overall Study||159
2430052|NCT01179048|5959906|P1|NOT COMPLETED|Overall Study||139
2430053|NCT01179048|5959905|P2|COMPLETED|Overall Study||4513
2430054|NCT01179048|5959906|P1|COMPLETED|Overall Study||4529
2430055|NCT01179048|5959905|P2|STARTED|Overall Study||4672
2430056|NCT01179048|5959906|P1|STARTED|Overall Study||4668
2430057|NCT01178944|5959922|P1|NOT COMPLETED|Overall Study||0
2430058|NCT01178944|5959922|P1|COMPLETED|Overall Study||35
2430059|NCT01178944|5959922|P1|STARTED|Overall Study||35
2430060|NCT01178853|5959933|P2|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||3
2430061|NCT01178853|5959934|P1|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||0
2430062|NCT01178853|5959933|P2|COMPLETED|Period 4 (Warfarin + Study Drug)||19
2430063|NCT01178853|5959934|P1|COMPLETED|Period 4 (Warfarin + Study Drug)||21
2430064|NCT01178853|5959933|P2|STARTED|Period 4 (Warfarin + Study Drug)||22
2430065|NCT01178853|5959934|P1|STARTED|Period 4 (Warfarin + Study Drug)||21
2430066|NCT01178853|5959933|P2|NOT COMPLETED|Period 3 (Warfarin Titration)||0
2430067|NCT01178853|5959934|P1|NOT COMPLETED|Period 3 (Warfarin Titration)||1
2430068|NCT01178853|5959933|P2|COMPLETED|Period 3 (Warfarin Titration)||22
2430069|NCT01178853|5959934|P1|COMPLETED|Period 3 (Warfarin Titration)||21
2430070|NCT01178853|5959933|P2|STARTED|Period 3 (Warfarin Titration)||22
2430071|NCT01178853|5959934|P1|STARTED|Period 3 (Warfarin Titration)||22
2430072|NCT01178853|5959933|P2|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||0
2430073|NCT01178853|5959934|P1|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||1
2430074|NCT01178853|5959933|P2|COMPLETED|Period 2 (Warfarin + Study Drug)||22
2430075|NCT01178853|5959934|P1|COMPLETED|Period 2 (Warfarin + Study Drug)||22
2430076|NCT01178853|5959933|P2|STARTED|Period 2 (Warfarin + Study Drug)||22
2430077|NCT01178853|5959934|P1|STARTED|Period 2 (Warfarin + Study Drug)||23
2430078|NCT01178853|5959933|P2|NOT COMPLETED|Period 1 (Warfarin Titration)||2
2430079|NCT01178853|5959934|P1|NOT COMPLETED|Period 1 (Warfarin Titration)||1
2430080|NCT01178853|5959933|P2|COMPLETED|Period 1 (Warfarin Titration)||22
2430081|NCT01178853|5959934|P1|COMPLETED|Period 1 (Warfarin Titration)||23
2430082|NCT01178853|5959933|P2|STARTED|Period 1 (Warfarin Titration)||24
2430083|NCT01178853|5959934|P1|STARTED|Period 1 (Warfarin Titration)||24
2430084|NCT01178827|5959943|P3|NOT COMPLETED|Overall Study||0
2430085|NCT01178827|5959944|P2|NOT COMPLETED|Overall Study||0
2430086|NCT01178827|5959945|P1|NOT COMPLETED|Overall Study||0
2430087|NCT01178827|5959943|P3|COMPLETED|Overall Study||4
2430088|NCT01178827|5959944|P2|COMPLETED|Overall Study||10
2430089|NCT01178827|5959945|P1|COMPLETED|Overall Study||6
2430090|NCT01178827|5959943|P3|STARTED|Overall Study||4
2430091|NCT01178827|5959944|P2|STARTED|Overall Study||10
2430092|NCT01178827|5959945|P1|STARTED|Overall Study||6
2430093|NCT01178762|5959974|P1|NOT COMPLETED|Overall Study||15
2430094|NCT01178762|5959974|P1|COMPLETED|Overall Study||27
2430095|NCT01178762|5959974|P1|STARTED|Overall Study||42
2430096|NCT01178671|5959980|P2|NOT COMPLETED|Overall Study||15
2430097|NCT01178671|5959981|P1|NOT COMPLETED|Overall Study||12
2430098|NCT01178671|5959980|P2|COMPLETED|Overall Study||3
2430099|NCT01178671|5959981|P1|COMPLETED|Overall Study||6
2430100|NCT01178671|5959980|P2|STARTED|Overall Study||18
2430101|NCT01178671|5959981|P1|STARTED|Overall Study||18
2430102|NCT01178528|5960008|P3|NOT COMPLETED|Overall Study||0
2430103|NCT01178528|5960009|P2|NOT COMPLETED|Overall Study||0
2430104|NCT01178528|5960010|P1|NOT COMPLETED|Overall Study||0
2430105|NCT01178528|5960008|P3|COMPLETED|Overall Study||42
2430106|NCT01178528|5960009|P2|COMPLETED|Overall Study||38
2430107|NCT01178528|5960010|P1|COMPLETED|Overall Study||41
2430108|NCT01178528|5960008|P3|STARTED|Overall Study||42
2430109|NCT01178528|5960009|P2|STARTED|Overall Study||38
2430110|NCT01178528|5960010|P1|STARTED|Overall Study||41
2430111|NCT01178385|5960029|P2|NOT COMPLETED|Overall Study||0
2430112|NCT01178385|5960030|P1|NOT COMPLETED|Overall Study||2
2430113|NCT01178385|5960029|P2|COMPLETED|Overall Study||21
2430114|NCT01178385|5960030|P1|COMPLETED|Overall Study||22
2430115|NCT01178385|5960029|P2|STARTED|Overall Study||21
2430116|NCT01178385|5960030|P1|STARTED|Overall Study||24
2430117|NCT01178333|5960043|P3|NOT COMPLETED|Overall Study||0
2430118|NCT01178333|5960044|P2|NOT COMPLETED|Overall Study||0
2430119|NCT01178333|5960045|P1|NOT COMPLETED|Overall Study||0
2430120|NCT01178333|5960043|P3|COMPLETED|Overall Study||87
2430121|NCT01178333|5960044|P2|COMPLETED|Overall Study||284
2430122|NCT01178333|5960045|P1|COMPLETED|Overall Study||71
2430123|NCT01178333|5960043|P3|STARTED|Overall Study||87
2430124|NCT01178333|5960044|P2|STARTED|Overall Study||284
2430125|NCT01178333|5960045|P1|STARTED|Overall Study||71
2430126|NCT01178294|5960099|P1|NOT COMPLETED|Overall Study||11
2430127|NCT01178294|5960099|P1|COMPLETED|Overall Study||18
2430128|NCT01178294|5960099|P1|STARTED|Overall Study|25 subjects enrolled under OBI-1-301 + 4 subjects enrolled under expanded access OBI-1-301a.|29
2430129|NCT01178281|5960123|P3|NOT COMPLETED|Overall Study||0
2430130|NCT01178281|5960124|P2|NOT COMPLETED|Overall Study||0
2430131|NCT01178281|5960125|P1|NOT COMPLETED|Overall Study||0
2430133|NCT01178281|5960124|P2|COMPLETED|Overall Study||84
2430134|NCT01178281|5960125|P1|COMPLETED|Overall Study||168
2430135|NCT01178281|5960123|P3|Received Study Drug|Overall Study||15
2430136|NCT01178281|5960124|P2|Received Study Drug|Overall Study||83
2430137|NCT01178281|5960125|P1|Received Study Drug|Overall Study||167
2430138|NCT01178281|5960123|P3|STARTED|Overall Study||15
2430139|NCT01178281|5960124|P2|STARTED|Overall Study||84
2430140|NCT01178281|5960125|P1|STARTED|Overall Study||168
2430141|NCT01178268|5960152|P2|NOT COMPLETED|Overall Study||1
2430142|NCT01178268|5960153|P1|NOT COMPLETED|Overall Study||7
2430143|NCT01178268|5960152|P2|COMPLETED|Overall Study||120
2430144|NCT01178268|5960153|P1|COMPLETED|Overall Study||360
2430145|NCT01178268|5960152|P2|STARTED|Overall Study||121
2430146|NCT01178268|5960153|P1|STARTED|Overall Study||367
2430147|NCT01178216|5960370|P1|NOT COMPLETED|Overall Study||2
2430148|NCT01178216|5960370|P1|COMPLETED|Overall Study||39
2430149|NCT01178216|5960370|P1|STARTED|Overall Study||41
2430150|NCT01178138|5960379|P1|NOT COMPLETED|Overall Study||23
2430151|NCT01178138|5960379|P1|COMPLETED|Overall Study||1
2430152|NCT01178138|5960379|P1|Completed 3 Sessions|Overall Study||1
2430153|NCT01178138|5960379|P1|Completed 5 Sessions|Overall Study||1
2430154|NCT01178138|5960379|P1|Completed 6 Sessions|Overall Study||1
2430155|NCT01178138|5960379|P1|STARTED|Overall Study||24
2430156|NCT01178125|5960400|P1|NOT COMPLETED|Overall Study||1178
2430157|NCT01178125|5960400|P1|COMPLETED|Overall Study||1680
2430158|NCT01178125|5960400|P1|Pregnancy ITT (PITT) Population|Overall Study|Participants in the ITT population between the ages of 18 and 35, inclusive.|2401
2430159|NCT01178125|5960400|P1|Intent to Treat (ITT) Population|Overall Study|Completed at least one 28-day cycle of investigational product.|2607
2430160|NCT01178125|5960400|P1|Safety Population|Overall Study|Received at least 1 dose of DR-102.|2765
2430161|NCT01178125|5960400|P1|STARTED|Overall Study|Number enrolled.|2858
2430162|NCT01178099|5960431|P2|NOT COMPLETED|Overall Study||1
2430163|NCT01178099|5960432|P1|NOT COMPLETED|Overall Study||0
2430164|NCT01178099|5960431|P2|COMPLETED|Overall Study||12
2430165|NCT01178099|5960432|P1|COMPLETED|Overall Study||13
2430166|NCT01178099|5960431|P2|STARTED|Overall Study||13
2430167|NCT01178099|5960432|P1|STARTED|Overall Study||13
2430168|NCT01178086|5960472|P1|NOT COMPLETED|Overall Study||332
2430169|NCT01178086|5960472|P1|COMPLETED|Overall Study||349
2430170|NCT01178086|5960472|P1|Effectiveness Analysis Set (EAS)|Overall Study|who received at least 1 dose of rituximab and had data from baseline and at least 1 follow-up visit.|661
2430171|NCT01178086|5960472|P1|STARTED|Overall Study|Safety analysis set: participants who received at least one dose of rituximab.|681
2430172|NCT01178073|5960499|P3|NOT COMPLETED|Overall Study||46
2430173|NCT01178073|5960500|P2|NOT COMPLETED|Overall Study||44
2430174|NCT01178073|5960501|P1|NOT COMPLETED|Overall Study||62
2430175|NCT01178073|5960499|P3|COMPLETED|Overall Study||105
2430176|NCT01178073|5960500|P2|COMPLETED|Overall Study||108
2430177|NCT01178073|5960501|P1|COMPLETED|Overall Study||240
2430178|NCT01178073|5960499|P3|STARTED|Overall Study||151
2430179|NCT01178073|5960500|P2|STARTED|Overall Study||152
2430180|NCT01178073|5960501|P1|STARTED|Overall Study||302
2430181|NCT01177969|5960532|P2|NOT COMPLETED|Overall Study||3
2430182|NCT01177969|5960533|P1|NOT COMPLETED|Overall Study||3
2430183|NCT01177969|5960532|P2|COMPLETED|Overall Study||11
2430184|NCT01177969|5960533|P1|COMPLETED|Overall Study||16
2430185|NCT01177969|5960532|P2|STARTED|Overall Study||14
2430186|NCT01177969|5960533|P1|STARTED|Overall Study||19
2430187|NCT01177956|5960541|P1|NOT COMPLETED|Overall Study||0
2430188|NCT01177956|5960541|P1|COMPLETED|Overall Study||68
2430189|NCT01177956|5960541|P1|STARTED|Overall Study||68
2430190|NCT01177943|5960556|P2|NOT COMPLETED|Second Intervention||0
2430191|NCT01177943|5960557|P1|NOT COMPLETED|Second Intervention||0
2430192|NCT01177943|5960556|P2|COMPLETED|Second Intervention||21
2430193|NCT01177943|5960557|P1|COMPLETED|Second Intervention||19
2430194|NCT01177943|5960556|P2|STARTED|Second Intervention||21
2430195|NCT01177943|5960557|P1|STARTED|Second Intervention||19
2430196|NCT01177943|5960556|P2|NOT COMPLETED|First Intervention||0
2430197|NCT01177943|5960557|P1|NOT COMPLETED|First Intervention||2
2430198|NCT01177943|5960556|P2|COMPLETED|First Intervention||21
2430199|NCT01177943|5960557|P1|COMPLETED|First Intervention||19
2430200|NCT01177943|5960556|P2|STARTED|First Intervention||21
2430201|NCT01177943|5960557|P1|STARTED|First Intervention||21
2430202|NCT01177813|5960570|P5|NOT COMPLETED|Overall Study||9
2430203|NCT01177813|5960571|P4|NOT COMPLETED|Overall Study||17
2430204|NCT01177813|5960572|P3|NOT COMPLETED|Overall Study||20
2430205|NCT01177813|5960573|P2|NOT COMPLETED|Overall Study||18
2430206|NCT01177813|5960574|P1|NOT COMPLETED|Overall Study||41
2430207|NCT01177813|5960570|P5|COMPLETED|Overall Study||78
2430208|NCT01177813|5960571|P4|COMPLETED|Overall Study||206
2430209|NCT01177813|5960572|P3|COMPLETED|Overall Study||204
2430210|NCT01177813|5960573|P2|COMPLETED|Overall Study||206
2430211|NCT01177813|5960574|P1|COMPLETED|Overall Study||187
2430212|NCT01177813|5960570|P5|STARTED|Overall Study||87
2430213|NCT01177813|5960571|P4|STARTED|Overall Study||223
2430214|NCT01177813|5960572|P3|STARTED|Overall Study||224
2430215|NCT01177813|5960573|P2|STARTED|Overall Study||224
2430216|NCT01177813|5960574|P1|STARTED|Overall Study||228
2430217|NCT01177800|5960603|P2|NOT COMPLETED|Overall Study||5
2430218|NCT01177800|5960604|P1|NOT COMPLETED|Overall Study||10
2430219|NCT01177800|5960603|P2|COMPLETED|Overall Study||40
2430220|NCT01177800|5960604|P1|COMPLETED|Overall Study||74
2430221|NCT01177800|5960603|P2|STARTED|Overall Study||45
2430222|NCT01177800|5960604|P1|STARTED|Overall Study||84
2430223|NCT01177735|5960618|P1|NOT COMPLETED|Overall Study||71
2430224|NCT01177735|5960618|P1|COMPLETED|Overall Study||0
2430225|NCT01177735|5960618|P1|STARTED|Overall Study||71
2430226|NCT01177722|5960626|P4|NOT COMPLETED|Overall Study||7
2430227|NCT01177722|5960627|P3|NOT COMPLETED|Overall Study||9
2430228|NCT01177722|5960628|P2|NOT COMPLETED|Overall Study||10
2430229|NCT01177722|5960629|P1|NOT COMPLETED|Overall Study||13
2430230|NCT01177722|5960626|P4|COMPLETED|Overall Study||338
2430231|NCT01177722|5960627|P3|COMPLETED|Overall Study||333
2430232|NCT01177722|5960628|P2|COMPLETED|Overall Study||334
2430233|NCT01177722|5960629|P1|COMPLETED|Overall Study||331
2430234|NCT01177722|5960626|P4|STARTED|Overall Study||345
2430235|NCT01177722|5960627|P3|STARTED|Overall Study||342
2430236|NCT01177722|5960628|P2|STARTED|Overall Study|A randomized participant got Batch A vaccine, analyses was according to actual vaccine administered.|344
2430237|NCT01177722|5960629|P1|STARTED|Overall Study|A Batch B participant got Batch A vaccine data analyses was according to actual vaccine administered|344
2430238|NCT01177709|5960655|P1|NOT COMPLETED|Overall Study||0
2430239|NCT01177709|5960655|P1|COMPLETED|Overall Study||12
2430240|NCT01177709|5960655|P1|STARTED|Overall Study||12
2430241|NCT01177670|5960661|P1|NOT COMPLETED|Overall Study||169
2430242|NCT01177670|5960661|P1|COMPLETED|Overall Study||0
2430243|NCT01177670|5960661|P1|STARTED|Overall Study||169
2430244|NCT01177553|5960668|P2|NOT COMPLETED|Overall Study||0
2430245|NCT01177553|5960669|P1|NOT COMPLETED|Overall Study||1
2430246|NCT01177553|5960668|P2|COMPLETED|Overall Study|data as of March 2009|2
2430247|NCT01177553|5960669|P1|COMPLETED|Overall Study|data as of March 2009|2
2430248|NCT01177553|5960668|P2|STARTED|Overall Study||2
2430249|NCT01177553|5960669|P1|STARTED|Overall Study||3
2430250|NCT01177410|5960678|P3|NOT COMPLETED|Overall Study||5
2430251|NCT01177410|5960679|P2|NOT COMPLETED|Overall Study||7
2430252|NCT01177410|5960680|P1|NOT COMPLETED|Overall Study||1
2430253|NCT01177410|5960678|P3|COMPLETED|Overall Study||45
2430254|NCT01177410|5960679|P2|COMPLETED|Overall Study||40
2430255|NCT01177410|5960680|P1|COMPLETED|Overall Study||50
2430256|NCT01177410|5960678|P3|STARTED|Overall Study||50
2430257|NCT01177410|5960679|P2|STARTED|Overall Study||47
2430258|NCT01177410|5960680|P1|STARTED|Overall Study||51
2430259|NCT01177384|5960693|P2|NOT COMPLETED|Overall Study||26
2430260|NCT01177384|5960694|P1|NOT COMPLETED|Overall Study||14
2430261|NCT01177384|5960693|P2|COMPLETED|Overall Study||164
2430262|NCT01177384|5960694|P1|COMPLETED|Overall Study||177
2430263|NCT01177384|5960693|P2|STARTED|Overall Study|Includes the second randomization of a participant|190
2430264|NCT01177384|5960694|P1|STARTED|Overall Study||191
2430265|NCT01177293|5960706|P2|NOT COMPLETED|Second Intervention Period||0
2430266|NCT01177293|5960707|P1|NOT COMPLETED|Second Intervention Period||0
2430267|NCT01177293|5960706|P2|COMPLETED|Second Intervention Period||6
2430268|NCT01177293|5960707|P1|COMPLETED|Second Intervention Period||7
2430269|NCT01177293|5960706|P2|STARTED|Second Intervention Period||6
2430270|NCT01177293|5960707|P1|STARTED|Second Intervention Period||7
2430271|NCT01177293|5960706|P2|NOT COMPLETED|Washout Period (of 14 Days)||1
2430272|NCT01177293|5960707|P1|NOT COMPLETED|Washout Period (of 14 Days)||0
2430273|NCT01177293|5960706|P2|COMPLETED|Washout Period (of 14 Days)||6
2430274|NCT01177293|5960707|P1|COMPLETED|Washout Period (of 14 Days)||7
2430275|NCT01177293|5960706|P2|STARTED|Washout Period (of 14 Days)||7
2430276|NCT01177293|5960707|P1|STARTED|Washout Period (of 14 Days)||7
2430277|NCT01177293|5960706|P2|NOT COMPLETED|First Intervention Period||0
2430278|NCT01177293|5960707|P1|NOT COMPLETED|First Intervention Period||0
2430279|NCT01177293|5960706|P2|COMPLETED|First Intervention Period||7
2430280|NCT01177293|5960707|P1|COMPLETED|First Intervention Period||7
2430281|NCT01177293|5960706|P2|STARTED|First Intervention Period||7
2430282|NCT01177293|5960707|P1|STARTED|First Intervention Period||7
2430283|NCT01177228|5960725|P4|NOT COMPLETED|Overall Study||0
2430284|NCT01177228|5960726|P3|NOT COMPLETED|Overall Study||0
2430285|NCT01177228|5960727|P2|NOT COMPLETED|Overall Study||2
2430286|NCT01177228|5960728|P1|NOT COMPLETED|Overall Study||1
2430287|NCT01177228|5960725|P4|COMPLETED|Overall Study||11
2430288|NCT01177228|5960726|P3|COMPLETED|Overall Study||14
2430289|NCT01177228|5960727|P2|COMPLETED|Overall Study||11
2430290|NCT01177228|5960728|P1|COMPLETED|Overall Study||8
2430291|NCT01177228|5960725|P4|Received Treatment|Overall Study||11
2430292|NCT01177228|5960726|P3|Received Treatment|Overall Study||14
2430293|NCT01177228|5960727|P2|Received Treatment|Overall Study||12
2430294|NCT01177228|5960728|P1|Received Treatment|Overall Study||9
2430295|NCT01177228|5960725|P4|STARTED|Overall Study||11
2430296|NCT01177228|5960726|P3|STARTED|Overall Study||14
2430297|NCT01177228|5960727|P2|STARTED|Overall Study||13
2430298|NCT01177228|5960728|P1|STARTED|Overall Study||9
2430299|NCT01177189|5960768|P2|NOT COMPLETED|Overall Study||0
2430300|NCT01177189|5960769|P1|NOT COMPLETED|Overall Study||0
2430301|NCT01177189|5960768|P2|COMPLETED|Overall Study||45
2430302|NCT01177189|5960769|P1|COMPLETED|Overall Study||42
2430303|NCT01177189|5960768|P2|STARTED|Overall Study||45
2430304|NCT01177189|5960769|P1|STARTED|Overall Study||42
2430305|NCT01177137|5960782|P3|NOT COMPLETED|Overall Study||2
2430306|NCT01177137|5960783|P2|NOT COMPLETED|Overall Study||10
2430307|NCT01177137|5960784|P1|NOT COMPLETED|Overall Study||10
2430308|NCT01177137|5960782|P3|COMPLETED|Overall Study||47
2430309|NCT01177137|5960783|P2|COMPLETED|Overall Study||41
2430310|NCT01177137|5960784|P1|COMPLETED|Overall Study||41
2430311|NCT01177137|5960782|P3|STARTED|Overall Study||49
2430312|NCT01177137|5960783|P2|STARTED|Overall Study||51
2430313|NCT01177137|5960784|P1|STARTED|Overall Study||51
2430314|NCT01177098|5960851|P2|NOT COMPLETED|Overall Study||12
2430315|NCT01177098|5960852|P1|NOT COMPLETED|Overall Study||9
2430316|NCT01177098|5960851|P2|COMPLETED|Overall Study||271
2430317|NCT01177098|5960852|P1|COMPLETED|Overall Study||269
2430318|NCT01177098|5960851|P2|STARTED|Overall Study||283
2430319|NCT01177098|5960852|P1|STARTED|Overall Study||278
2430320|NCT01177059|5960868|P1|NOT COMPLETED|Overall Study||50
2430321|NCT01177059|5960868|P1|COMPLETED|Overall Study||18
2430322|NCT01177059|5960868|P1|STARTED|Overall Study||68
2430323|NCT01177007|5960874|P1|NOT COMPLETED|Overall Study||38
2430324|NCT01177007|5960874|P1|COMPLETED|Overall Study||12
2430325|NCT01177007|5960874|P1|Completed First Clinical and Imaging|Overall Study||43
2430326|NCT01177007|5960874|P1|Completed First Y90 Treatment|Overall Study||50
2430327|NCT01177007|5960874|P1|STARTED|Overall Study||50
2430328|NCT01176968|5960888|P2|NOT COMPLETED|Overall Study||82
2430329|NCT01176968|5960889|P1|NOT COMPLETED|Overall Study||84
2430330|NCT01176968|5960888|P2|COMPLETED|Overall Study||424
2430331|NCT01176968|5960889|P1|COMPLETED|Overall Study||422
2430332|NCT01176968|5960888|P2|Treated|Overall Study||505
2430333|NCT01176968|5960889|P1|Treated|Overall Study||505
2430334|NCT01176968|5960888|P2|STARTED|Overall Study||506
2430335|NCT01176968|5960889|P1|STARTED|Overall Study||506
2430336|NCT01176955|5960923|P2|NOT COMPLETED|Overall Study||2
2430337|NCT01176955|5960924|P1|NOT COMPLETED|Overall Study||3
2430338|NCT01176955|5960923|P2|COMPLETED|Overall Study||8
2430339|NCT01176955|5960924|P1|COMPLETED|Overall Study||7
2430340|NCT01176955|5960923|P2|STARTED|Overall Study||10
2430341|NCT01176955|5960924|P1|STARTED|Overall Study||10
2430342|NCT01176877|5960935|P1|NOT COMPLETED|Overall Study||9
2430343|NCT01176877|5960935|P1|COMPLETED|Overall Study||31
2430344|NCT01176877|5960935|P1|STARTED|Overall Study||40
2430345|NCT01176773|5960940|P1|NOT COMPLETED|Overall Study||3
2430346|NCT01176773|5960940|P1|COMPLETED|Overall Study||59
2430347|NCT01176773|5960940|P1|STARTED|Overall Study||62
2430348|NCT01176617|5960951|P3|NOT COMPLETED|6 - 12 Months (Randomized)||0
2430349|NCT01176617|5960952|P2|NOT COMPLETED|6 - 12 Months (Randomized)||0
2430350|NCT01176617|5960953|P1|NOT COMPLETED|6 - 12 Months (Randomized)||5
2430351|NCT01176617|5960951|P3|COMPLETED|6 - 12 Months (Randomized)||0
2430352|NCT01176617|5960952|P2|COMPLETED|6 - 12 Months (Randomized)||20
2430353|NCT01176617|5960953|P1|COMPLETED|6 - 12 Months (Randomized)||13
2430354|NCT01176617|5960951|P3|STARTED|6 - 12 Months (Randomized)||0
2430355|NCT01176617|5960952|P2|STARTED|6 - 12 Months (Randomized)||20
2430356|NCT01176617|5960953|P1|STARTED|6 - 12 Months (Randomized)||18
2430357|NCT01176617|5960951|P3|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
2430358|NCT01176617|5960952|P2|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
2430359|NCT01176617|5960953|P1|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
2430360|NCT01176617|5960951|P3|COMPLETED|1 - 6 Months (Ron-randomized)||38
2430361|NCT01176617|5960952|P2|COMPLETED|1 - 6 Months (Ron-randomized)||0
2430362|NCT01176617|5960953|P1|COMPLETED|1 - 6 Months (Ron-randomized)||0
2430363|NCT01176617|5960951|P3|STARTED|1 - 6 Months (Ron-randomized)||38
2430364|NCT01176617|5960952|P2|STARTED|1 - 6 Months (Ron-randomized)||0
2430365|NCT01176617|5960953|P1|STARTED|1 - 6 Months (Ron-randomized)||0
2430366|NCT01176565|5960964|P2|NOT COMPLETED|Overall Study||19
2430367|NCT01176565|5960965|P1|NOT COMPLETED|Overall Study||20
2430368|NCT01176565|5960964|P2|COMPLETED|Overall Study||481
2430369|NCT01176565|5960965|P1|COMPLETED|Overall Study||480
2430370|NCT01176565|5960964|P2|STARTED|Overall Study||500
2430371|NCT01176565|5960965|P1|STARTED|Overall Study||500
2430372|NCT01176513|5960983|P1|NOT COMPLETED|Overall Study||3
2430373|NCT01176513|5960983|P1|COMPLETED|Overall Study||22
2430374|NCT01176513|5960983|P1|STARTED|Overall Study||25
2430375|NCT01176448|5960988|P1|NOT COMPLETED|Overall Study||0
2430376|NCT01176448|5960988|P1|COMPLETED|Overall Study||6
2430377|NCT01176448|5960988|P1|STARTED|Overall Study||6
2430378|NCT01176435|5960999|P3|NOT COMPLETED|Overall Study||0
2430379|NCT01176435|5961000|P2|NOT COMPLETED|Overall Study||0
2430380|NCT01176435|5961001|P1|NOT COMPLETED|Overall Study||0
2430381|NCT01176435|5960999|P3|COMPLETED|Overall Study||15
2430382|NCT01176435|5961000|P2|COMPLETED|Overall Study||15
2430383|NCT01176435|5961001|P1|COMPLETED|Overall Study||15
2430384|NCT01176435|5960999|P3|STARTED|Overall Study||15
2430385|NCT01176435|5961000|P2|STARTED|Overall Study||15
2430386|NCT01176435|5961001|P1|STARTED|Overall Study||15
2430387|NCT01176292|5961011|P2|NOT COMPLETED|Overall Study||9
2430388|NCT01176292|5961012|P1|NOT COMPLETED|Overall Study||5
2430389|NCT01176292|5961011|P2|COMPLETED|Overall Study||62
2430390|NCT01176292|5961012|P1|COMPLETED|Overall Study||66
2430391|NCT01176292|5961011|P2|STARTED|Overall Study||71
2430392|NCT01176292|5961012|P1|STARTED|Overall Study||71
2430393|NCT01176266|5961030|P1|NOT COMPLETED|Overall Study||9
2430394|NCT01176266|5961030|P1|COMPLETED|Overall Study||60
2430395|NCT01176266|5961030|P1|STARTED|Overall Study||69
2430396|NCT01176240|5961054|P2|NOT COMPLETED|Study 306B||17
2430397|NCT01176240|5961055|P1|NOT COMPLETED|Study 306B||26
2430398|NCT01176240|5961054|P2|COMPLETED|Study 306B||68
2430399|NCT01176240|5961055|P1|COMPLETED|Study 306B||63
2430400|NCT01176240|5961054|P2|4 wk of Stable Dosing and Visit 6|Study 306B||73
2430401|NCT01176240|5961055|P1|4 wk of Stable Dosing and Visit 6|Study 306B||67
2430402|NCT01176240|5961054|P2|2 wk of Stable Dosing and Visit 5|Study 306B||75
2430403|NCT01176240|5961055|P1|2 wk of Stable Dosing and Visit 5|Study 306B||68
2430404|NCT01176240|5961054|P2|1 wk of Stable Dosing and Visit 4|Study 306B||78
2430405|NCT01176240|5961055|P1|1 wk of Stable Dosing and Visit 4|Study 306B||69
2430406|NCT01176240|5961054|P2|Took at Least 1 Dose of Study Drug|Study 306B|One randomized patient discontinued before receiving study drug.|84
2430407|NCT01176240|5961055|P1|Took at Least 1 Dose of Study Drug|Study 306B|Two randomized patients discontinued before receiving study drug.|87
2430408|NCT01176240|5961054|P2|STARTED|Study 306B||85
2430409|NCT01176240|5961055|P1|STARTED|Study 306B||89
2430410|NCT01176240|5961054|P2|NOT COMPLETED|Study 306A||3
2430411|NCT01176240|5961055|P1|NOT COMPLETED|Study 306A||3
2430412|NCT01176240|5961054|P2|COMPLETED|Study 306A||24
2430413|NCT01176240|5961055|P1|COMPLETED|Study 306A||21
2430414|NCT01176240|5961054|P2|STARTED|Study 306A||27
2430415|NCT01176240|5961055|P1|STARTED|Study 306A||24
2430416|NCT01176058|5961081|P2|NOT COMPLETED|Overall Study||3
2430417|NCT01176058|5961082|P1|NOT COMPLETED|Overall Study||4
2430418|NCT01176058|5961081|P2|COMPLETED|Overall Study||5
2430419|NCT01176058|5961082|P1|COMPLETED|Overall Study||5
2430420|NCT01176058|5961081|P2|STARTED|Overall Study||8
2430421|NCT01176058|5961082|P1|STARTED|Overall Study||9
2430422|NCT01176032|5961106|P2|NOT COMPLETED|Overall Study||1
2430423|NCT01176032|5961107|P1|NOT COMPLETED|Overall Study||6
2430424|NCT01176032|5961106|P2|COMPLETED|Overall Study||36
2430425|NCT01176032|5961107|P1|COMPLETED|Overall Study||31
2430426|NCT01176032|5961106|P2|Intention-to-treat (ITT) Population|Overall Study||37
2430427|NCT01176032|5961107|P1|Intention-to-treat (ITT) Population|Overall Study||32
2430428|NCT01176032|5961106|P2|STARTED|Overall Study||37
2430429|NCT01176032|5961107|P1|STARTED|Overall Study|"Started indicates randomized and safety population"|37
2430430|NCT01175902|5961167|P2|NOT COMPLETED|Overall Study||0
2430431|NCT01175902|5961168|P1|NOT COMPLETED|Overall Study||0
2430432|NCT01175902|5961167|P2|COMPLETED|Overall Study||22
2430433|NCT01175902|5961168|P1|COMPLETED|Overall Study||22
2430434|NCT01175902|5961167|P2|STARTED|Overall Study||22
2430435|NCT01175902|5961168|P1|STARTED|Overall Study||22
2430436|NCT01175850|5961186|P2|NOT COMPLETED|IN.PACT SFA II Phase||5
2430437|NCT01175850|5961187|P1|NOT COMPLETED|IN.PACT SFA II Phase||12
2430438|NCT01175850|5961186|P2|COMPLETED|IN.PACT SFA II Phase||55
2430439|NCT01175850|5961187|P1|COMPLETED|IN.PACT SFA II Phase||109
2430440|NCT01175850|5961186|P2|STARTED|IN.PACT SFA II Phase||60
2430441|NCT01175850|5961187|P1|STARTED|IN.PACT SFA II Phase||121
2430442|NCT01175850|5961186|P2|NOT COMPLETED|IN.PACT SFA I Phase||2
2430443|NCT01175850|5961187|P1|NOT COMPLETED|IN.PACT SFA I Phase||11
2430444|NCT01175850|5961186|P2|COMPLETED|IN.PACT SFA I Phase||49
2430445|NCT01175850|5961187|P1|COMPLETED|IN.PACT SFA I Phase||88
2430446|NCT01175850|5961186|P2|STARTED|IN.PACT SFA I Phase||51
2430447|NCT01175850|5961187|P1|STARTED|IN.PACT SFA I Phase||99
2430448|NCT01175824|5961231|P2|NOT COMPLETED|Overall Study||22
2430449|NCT01175824|5961232|P1|NOT COMPLETED|Overall Study||16
2430450|NCT01175824|5961231|P2|COMPLETED|Overall Study||220
2430451|NCT01175824|5961232|P1|COMPLETED|Overall Study||220
2430452|NCT01175824|5961231|P2|Received at Least 1 Dose of Study Drug|Overall Study||240
2430453|NCT01175824|5961232|P1|Received at Least 1 Dose of Study Drug|Overall Study||236
2430454|NCT01175824|5961231|P2|STARTED|Overall Study||242
2430455|NCT01175824|5961232|P1|STARTED|Overall Study||236
2430456|NCT01175811|5961266|P2|NOT COMPLETED|Overall Study||14
2430457|NCT01175811|5961267|P1|NOT COMPLETED|Overall Study||16
2430458|NCT01175811|5961266|P2|COMPLETED|Overall Study||189
2430459|NCT01175811|5961267|P1|COMPLETED|Overall Study||183
2430460|NCT01175811|5961266|P2|Received at Least 1 Dose of Study Drug|Overall Study||202
2430461|NCT01175811|5961267|P1|Received at Least 1 Dose of Study Drug|Overall Study||197
2430462|NCT01175811|5961266|P2|STARTED|Overall Study||203
2430463|NCT01175811|5961267|P1|STARTED|Overall Study||199
2430464|NCT01175798|5961293|P2|NOT COMPLETED|Overall Study||21
2430465|NCT01175798|5961294|P1|NOT COMPLETED|Overall Study||7
2430466|NCT01175798|5961293|P2|COMPLETED|Overall Study||41
2430467|NCT01175798|5961294|P1|COMPLETED|Overall Study||27
2430468|NCT01175798|5961293|P2|STARTED|Overall Study||62
2430469|NCT01175798|5961294|P1|STARTED|Overall Study||34
2430470|NCT01175707|5961302|P2|NOT COMPLETED|Overall Study||6
2430471|NCT01175707|5961303|P1|NOT COMPLETED|Overall Study||4
2430472|NCT01175707|5961302|P2|COMPLETED|Overall Study||34
2430473|NCT01175707|5961303|P1|COMPLETED|Overall Study||36
2430474|NCT01175707|5961302|P2|STARTED|Overall Study||40
2430475|NCT01175707|5961303|P1|STARTED|Overall Study||40
2430476|NCT01175668|5961339|P2|NOT COMPLETED|Overall Study||0
2430477|NCT01175668|5961340|P1|NOT COMPLETED|Overall Study||2
2430478|NCT01175668|5961339|P2|COMPLETED|Overall Study||34
2430479|NCT01175668|5961340|P1|COMPLETED|Overall Study||32
2430480|NCT01175668|5961339|P2|STARTED|Overall Study||34
2430481|NCT01175668|5961340|P1|STARTED|Overall Study||34
2430482|NCT01175590|5961350|P2|NOT COMPLETED|Overall Study||10
2430483|NCT01175590|5961351|P1|NOT COMPLETED|Overall Study||12
2430484|NCT01175590|5961350|P2|COMPLETED|Overall Study||161
2430485|NCT01175590|5961351|P1|COMPLETED|Overall Study||335
2430486|NCT01175590|5961350|P2|Safety Population|Overall Study||170
2430487|NCT01175590|5961351|P1|Safety Population|Overall Study||344
2430488|NCT01175590|5961350|P2|Modified Intent to Treat Population|Overall Study||87
2430489|NCT01175590|5961351|P1|Modified Intent to Treat Population|Overall Study||212
2430490|NCT01175590|5961350|P2|STARTED|Overall Study||171
2430491|NCT01175590|5961351|P1|STARTED|Overall Study||347
2430492|NCT01175473|5961385|P2|NOT COMPLETED|Overall Study||2
2430493|NCT01175473|5961386|P1|NOT COMPLETED|Overall Study||2
2430494|NCT01175473|5961385|P2|COMPLETED|Overall Study||69
2430495|NCT01175473|5961386|P1|COMPLETED|Overall Study||75
2430496|NCT01175473|5961385|P2|Pharmacodynamic (PD) Population|Overall Study||68
2430497|NCT01175473|5961386|P1|Pharmacodynamic (PD) Population|Overall Study|All patients who received at least 1 dose; had baseline and at least 1 post-baseline PD assessment.|75
2430498|NCT01175473|5961385|P2|Safety Population|Overall Study||71
2430499|NCT01175473|5961386|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|77
2430500|NCT01175473|5961385|P2|STARTED|Overall Study||71
2430501|NCT01175473|5961386|P1|STARTED|Overall Study|Randomized and treated.|77
2430502|NCT01175434|5961412|P2|NOT COMPLETED|Overall Study||0
2430503|NCT01175434|5961413|P1|NOT COMPLETED|Overall Study||0
2430504|NCT01175434|5961412|P2|COMPLETED|Overall Study||51
2430505|NCT01175434|5961413|P1|COMPLETED|Overall Study||48
2430506|NCT01175434|5961412|P2|STARTED|Overall Study||51
2430507|NCT01175434|5961413|P1|STARTED|Overall Study||48
2430508|NCT01175395|5961419|P1|NOT COMPLETED|Overall Study||0
2430509|NCT01175395|5961419|P1|COMPLETED|Overall Study||10
2430510|NCT01175395|5961419|P1|STARTED|Overall Study||10
2430511|NCT01175382|5961427|P3|NOT COMPLETED|Overall Study||6
2430512|NCT01175382|5961428|P2|NOT COMPLETED|Overall Study||7
2430513|NCT01175382|5961429|P1|NOT COMPLETED|Overall Study||8
2430514|NCT01175382|5961427|P3|COMPLETED|Overall Study||59
2430515|NCT01175382|5961428|P2|COMPLETED|Overall Study||61
2430516|NCT01175382|5961429|P1|COMPLETED|Overall Study||63
2430517|NCT01175382|5961427|P3|STARTED|Overall Study||65
2430518|NCT01175382|5961428|P2|STARTED|Overall Study||68
2430519|NCT01175382|5961429|P1|STARTED|Overall Study||71
2430520|NCT01175369|5961508|P2|NOT COMPLETED|Overall Study||5
2430521|NCT01175369|5961509|P1|NOT COMPLETED|Overall Study||2
2430522|NCT01175369|5961508|P2|COMPLETED|Overall Study||260
2430523|NCT01175369|5961509|P1|COMPLETED|Overall Study||263
2430524|NCT01175369|5961508|P2|STARTED|Overall Study||265
2430525|NCT01175369|5961509|P1|STARTED|Overall Study||265
2430526|NCT01175356|5961515|P1|NOT COMPLETED|Overall Study||81
2430527|NCT01175356|5961515|P1|COMPLETED|Overall Study||18
2430528|NCT01175356|5961515|P1|STARTED|Overall Study||99
2430529|NCT01175343|5961521|P1|NOT COMPLETED|Overall Study||0
2430530|NCT01175343|5961521|P1|COMPLETED|Overall Study||44
2430531|NCT01175343|5961521|P1|STARTED|Overall Study||44
2430532|NCT01175317|5961533|P2|NOT COMPLETED|Overall Study||0
2430533|NCT01175317|5961534|P1|NOT COMPLETED|Overall Study||0
2430534|NCT01175317|5961533|P2|COMPLETED|Overall Study||31
2430535|NCT01175317|5961534|P1|COMPLETED|Overall Study||27
2430536|NCT01175317|5961533|P2|STARTED|Overall Study||31
2430537|NCT01175317|5961534|P1|STARTED|Overall Study||27
2430538|NCT01175226|5961544|P2|NOT COMPLETED|Overall Study||5
2430539|NCT01175226|5961545|P1|NOT COMPLETED|Overall Study||11
2430540|NCT01175226|5961544|P2|COMPLETED|Overall Study||140
2430541|NCT01175226|5961545|P1|COMPLETED|Overall Study||144
2430542|NCT01175226|5961544|P2|STARTED|Overall Study||145
2430543|NCT01175226|5961545|P1|STARTED|Overall Study||155
2430544|NCT01175213|5961555|P2|NOT COMPLETED|Safety Follow-up||0
2430545|NCT01175213|5961556|P1|NOT COMPLETED|Safety Follow-up||1
2430546|NCT01175213|5961555|P2|COMPLETED|Safety Follow-up||3
2430547|NCT01175213|5961556|P1|COMPLETED|Safety Follow-up||47
2430548|NCT01175213|5961555|P2|STARTED|Safety Follow-up||3
2430549|NCT01175213|5961556|P1|STARTED|Safety Follow-up||48
2430550|NCT01175213|5961555|P2|NOT COMPLETED|IGSC, 10%/rHuPH20||0
2430551|NCT01175213|5961556|P1|NOT COMPLETED|IGSC, 10%/rHuPH20||15
2430552|NCT01175213|5961555|P2|COMPLETED|IGSC, 10%/rHuPH20||3
2430553|NCT01175213|5961556|P1|COMPLETED|IGSC, 10%/rHuPH20||48
2430554|NCT01175213|5961555|P2|STARTED|IGSC, 10%/rHuPH20|3 participants treated IV with IGIV,10% without rHuPH20 throughout the study.|3
2430555|NCT01175213|5961556|P1|STARTED|IGSC, 10%/rHuPH20||63
2430556|NCT01175148|5961603|P2|NOT COMPLETED|Overall Study||0
2430557|NCT01175148|5961604|P1|NOT COMPLETED|Overall Study||0
2430558|NCT01175148|5961603|P2|COMPLETED|Overall Study||30
2430559|NCT01175148|5961604|P1|COMPLETED|Overall Study||30
2430560|NCT01175148|5961603|P2|STARTED|Overall Study||30
2430561|NCT01175148|5961604|P1|STARTED|Overall Study||30
2430562|NCT01175135|5961613|P4|NOT COMPLETED|Overall Study||14
2430563|NCT01175135|5961614|P3|NOT COMPLETED|Overall Study||12
2430564|NCT01175135|5961615|P2|NOT COMPLETED|Overall Study||22
2430565|NCT01175135|5961616|P1|NOT COMPLETED|Overall Study||16
2430566|NCT01175135|5961613|P4|COMPLETED|Overall Study||60
2430567|NCT01175135|5961614|P3|COMPLETED|Overall Study||25
2430568|NCT01175135|5961615|P2|COMPLETED|Overall Study||52
2430569|NCT01175135|5961616|P1|COMPLETED|Overall Study||58
2430570|NCT01175135|5961613|P4|Analyzed for Efficacy|Overall Study||73
2430571|NCT01175135|5961614|P3|Analyzed for Efficacy|Overall Study||34
2430572|NCT01175135|5961615|P2|Analyzed for Efficacy|Overall Study||73
2430573|NCT01175135|5961616|P1|Analyzed for Efficacy|Overall Study||74
2430574|NCT01175135|5961613|P4|Treated|Overall Study||74
2430575|NCT01175135|5961614|P3|Treated|Overall Study||36
2430576|NCT01175135|5961615|P2|Treated|Overall Study||74
2430577|NCT01175135|5961616|P1|Treated|Overall Study||74
2430578|NCT01175135|5961613|P4|STARTED|Overall Study||74
2430579|NCT01175135|5961614|P3|STARTED|Overall Study||37
2430580|NCT01175135|5961615|P2|STARTED|Overall Study||74
2430581|NCT01175135|5961616|P1|STARTED|Overall Study||74
2430582|NCT01175083|5961704|P6|NOT COMPLETED|Booster Epoch||0
2430583|NCT01175083|5961705|P5|NOT COMPLETED|Booster Epoch||0
2430584|NCT01175083|5961706|P4|NOT COMPLETED|Booster Epoch||1
2430585|NCT01175083|5961707|P3|NOT COMPLETED|Booster Epoch||1
2430586|NCT01175083|5961708|P2|NOT COMPLETED|Booster Epoch||0
2430587|NCT01175083|5961709|P1|NOT COMPLETED|Booster Epoch||0
2430588|NCT01175083|5961704|P6|COMPLETED|Booster Epoch||0
2430589|NCT01175083|5961705|P5|COMPLETED|Booster Epoch||0
2430590|NCT01175083|5961706|P4|COMPLETED|Booster Epoch||49
2430591|NCT01175083|5961707|P3|COMPLETED|Booster Epoch||49
2430592|NCT01175083|5961708|P2|COMPLETED|Booster Epoch||49
2430593|NCT01175083|5961709|P1|COMPLETED|Booster Epoch||49
2430594|NCT01175083|5961704|P6|STARTED|Booster Epoch|No subjects participated in the Booster Epoch, as no booster dose was planned per protocol.|0
2430595|NCT01175083|5961705|P5|STARTED|Booster Epoch|No subjects participated in the Booster Epoch, as no booster dose was planned per protocol.|0
2430596|NCT01175083|5961706|P4|STARTED|Booster Epoch||50
2430597|NCT01175083|5961707|P3|STARTED|Booster Epoch||50
2430598|NCT01175083|5961708|P2|STARTED|Booster Epoch|One subject died between both Epochs and hence did not participate in the Booster Epoch.|49
2430599|NCT01175083|5961709|P1|STARTED|Booster Epoch|One subject died between both Epochs and hence did not participate in the Booster Epoch.|49
2430600|NCT01175083|5961704|P6|NOT COMPLETED|Primary Epoch||3
2430601|NCT01175083|5961705|P5|NOT COMPLETED|Primary Epoch||0
2430602|NCT01175083|5961706|P4|NOT COMPLETED|Primary Epoch||0
2430603|NCT01175083|5961707|P3|NOT COMPLETED|Primary Epoch||0
2430604|NCT01175083|5961708|P2|NOT COMPLETED|Primary Epoch||0
2430605|NCT01175083|5961709|P1|NOT COMPLETED|Primary Epoch||0
2430606|NCT01175083|5961704|P6|COMPLETED|Primary Epoch||47
2430607|NCT01175083|5961705|P5|COMPLETED|Primary Epoch||50
2430608|NCT01175083|5961706|P4|COMPLETED|Primary Epoch||50
2430609|NCT01175083|5961707|P3|COMPLETED|Primary Epoch||50
2430610|NCT01175083|5961708|P2|COMPLETED|Primary Epoch||50
2430611|NCT01175083|5961709|P1|COMPLETED|Primary Epoch||50
2430612|NCT01175083|5961704|P6|STARTED|Primary Epoch||50
2430613|NCT01175083|5961705|P5|STARTED|Primary Epoch||50
2430614|NCT01175083|5961706|P4|STARTED|Primary Epoch||50
2430615|NCT01175083|5961707|P3|STARTED|Primary Epoch||50
2430616|NCT01175083|5961708|P2|STARTED|Primary Epoch||50
2430617|NCT01175083|5961709|P1|STARTED|Primary Epoch||50
2430618|NCT01175031|5961791|P1|NOT COMPLETED|Overall Study||0
2430619|NCT01175031|5961791|P1|COMPLETED|Overall Study||45
2430620|NCT01175031|5961791|P1|STARTED|Overall Study||45
2430621|NCT01175018|5961801|P2|NOT COMPLETED|Overall Study||1
2430622|NCT01175018|5961802|P1|NOT COMPLETED|Overall Study||3
2430623|NCT01175018|5961801|P2|COMPLETED|Overall Study||14
2430624|NCT01175018|5961802|P1|COMPLETED|Overall Study||12
2430625|NCT01175018|5961801|P2|STARTED|Overall Study||15
2430626|NCT01175018|5961802|P1|STARTED|Overall Study||15
2430627|NCT01175005|5961838|P1|NOT COMPLETED|Overall Study||0
2430628|NCT01175005|5961838|P1|COMPLETED|Overall Study||62
2430629|NCT01175005|5961838|P1|STARTED|Overall Study||62
2430630|NCT01174784|5961843|P1|NOT COMPLETED|Overall Study||0
2430631|NCT01174784|5961843|P1|COMPLETED|Overall Study||88
2430632|NCT01174784|5961843|P1|STARTED|Overall Study||88
2430633|NCT01174576|5961848|P1|NOT COMPLETED|Overall Study||0
2430634|NCT01174576|5961848|P1|COMPLETED|Overall Study||16
2430635|NCT01174576|5961848|P1|STARTED|Overall Study|All participants received all interventions without exception.|16
2430636|NCT01174563|5961889|P1|NOT COMPLETED|Overall Study||60
2430637|NCT01174563|5961889|P1|COMPLETED|Overall Study||0
2430638|NCT01174563|5961889|P1|Safety Set|Overall Study||59
2430639|NCT01174563|5961889|P1|Efficacy Set|Overall Study||59
2430640|NCT01174563|5961889|P1|STARTED|Overall Study||60
2430641|NCT01174550|5961897|P2|NOT COMPLETED|Overall Study||873
2430642|NCT01174550|5961898|P1|NOT COMPLETED|Overall Study||1270
2430643|NCT01174550|5961897|P2|COMPLETED|Overall Study||4123
2430644|NCT01174550|5961898|P1|COMPLETED|Overall Study||3737
2430645|NCT01174550|5961897|P2|STARTED|Overall Study||4996
2430646|NCT01174550|5961898|P1|STARTED|Overall Study||5007
2430647|NCT01174459|5961926|P1|NOT COMPLETED|Overall Study||5
2430648|NCT01174459|5961926|P1|COMPLETED|Overall Study|Case report form (CRF) collected|566
2430649|NCT01174459|5961926|P1|STARTED|Overall Study|Registered patients|571
2430650|NCT01174446|5961931|P4|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
2430651|NCT01174446|5961932|P3|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
2430652|NCT01174446|5961933|P2|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
2430653|NCT01174446|5961934|P1|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
2430654|NCT01174446|5961931|P4|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
2430655|NCT01174446|5961932|P3|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
2430656|NCT01174446|5961933|P2|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
2430657|NCT01174446|5961934|P1|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
2430658|NCT01174446|5961931|P4|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
2430659|NCT01174446|5961932|P3|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
2430660|NCT01174446|5961933|P2|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
2430661|NCT01174446|5961934|P1|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
2430662|NCT01174446|5961931|P4|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
2430663|NCT01174446|5961932|P3|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||2
2430664|NCT01174446|5961933|P2|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
2430665|NCT01174446|5961934|P1|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
2430666|NCT01174446|5961931|P4|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
2430667|NCT01174446|5961932|P3|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||29
2430668|NCT01174446|5961933|P2|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
2430669|NCT01174446|5961934|P1|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
2430670|NCT01174446|5961931|P4|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|14
2430671|NCT01174446|5961932|P3|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|31
2430672|NCT01174446|5961933|P2|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
2430673|NCT01174446|5961934|P1|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
2430674|NCT01174446|5961931|P4|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
2430675|NCT01174446|5961932|P3|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
2430676|NCT01174446|5961933|P2|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
2430677|NCT01174446|5961934|P1|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
2430678|NCT01174446|5961931|P4|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
2430679|NCT01174446|5961932|P3|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
2430680|NCT01174446|5961933|P2|COMPLETED|Part 1 -Pharmacokinetic Crossover||14
2430681|NCT01174446|5961934|P1|COMPLETED|Part 1 -Pharmacokinetic Crossover|BAX326 was mistakenly infused for second PK infusion (ie should have been BeneFIX) for 1 participant|14
2430682|NCT01174446|5961931|P4|STARTED|Part 1 -Pharmacokinetic Crossover||0
2430683|NCT01174446|5961932|P3|STARTED|Part 1 -Pharmacokinetic Crossover||0
2430684|NCT01174446|5961933|P2|STARTED|Part 1 -Pharmacokinetic Crossover||14
2430685|NCT01174446|5961934|P1|STARTED|Part 1 -Pharmacokinetic Crossover||14
2430686|NCT01174368|5962121|P1|NOT COMPLETED|Overall Study||1
2430687|NCT01174368|5962121|P1|COMPLETED|Overall Study||0
2430688|NCT01174368|5962121|P1|STARTED|Overall Study||1
2430689|NCT01174342|5962127|P1|NOT COMPLETED|Overall Study||4
2430690|NCT01174342|5962127|P1|COMPLETED|Overall Study||26
2430691|NCT01174342|5962127|P1|STARTED|Overall Study||30
2430692|NCT01174264|5962134|P3|NOT COMPLETED|Steady-state Pharmacokinetics||2
2430693|NCT01174264|5962135|P2|NOT COMPLETED|Steady-state Pharmacokinetics||0
2430694|NCT01174264|5962136|P1|NOT COMPLETED|Steady-state Pharmacokinetics||6
2430695|NCT01174264|5962134|P3|COMPLETED|Steady-state Pharmacokinetics||27
2430696|NCT01174264|5962135|P2|COMPLETED|Steady-state Pharmacokinetics||0
2430697|NCT01174264|5962136|P1|COMPLETED|Steady-state Pharmacokinetics||25
2430698|NCT01174264|5962134|P3|STARTED|Steady-state Pharmacokinetics|Includes 11 patients from period 1 high-fat arm and 18 patients from period 1 low-fat arm|29
2430699|NCT01174264|5962135|P2|STARTED|Steady-state Pharmacokinetics|Patients in period 2 were randomized to fasting vs. fed state only.|0
2430700|NCT01174264|5962136|P1|STARTED|Steady-state Pharmacokinetics|Includes 22 patients from period 1 fasting arm and 9 patients from period 1 high-fat arm|31
2430701|NCT01174264|5962134|P3|NOT COMPLETED|Single Dose Pharmacokinetics||2
2430702|NCT01174264|5962135|P2|NOT COMPLETED|Single Dose Pharmacokinetics||0
2430703|NCT01174264|5962136|P1|NOT COMPLETED|Single Dose Pharmacokinetics||1
2430704|NCT01174264|5962134|P3|COMPLETED|Single Dose Pharmacokinetics||18
2430705|NCT01174264|5962135|P2|COMPLETED|Single Dose Pharmacokinetics||20
2430706|NCT01174264|5962136|P1|COMPLETED|Single Dose Pharmacokinetics||22
2430707|NCT01174264|5962134|P3|STARTED|Single Dose Pharmacokinetics||20
2430708|NCT01174264|5962135|P2|STARTED|Single Dose Pharmacokinetics||20
2430709|NCT01174264|5962136|P1|STARTED|Single Dose Pharmacokinetics||23
2430710|NCT01174238|5962168|P1|NOT COMPLETED|Overall Study||2
2430711|NCT01174238|5962168|P1|COMPLETED|Overall Study||36
2430712|NCT01174238|5962168|P1|Participants That Underwent FLT-PET Scan|Overall Study||6
2430713|NCT01174238|5962168|P1|STARTED|Overall Study||38
2430714|NCT01174186|5962179|P2|NOT COMPLETED|Overall Study||3
2430715|NCT01174186|5962180|P1|NOT COMPLETED|Overall Study||0
2430716|NCT01174186|5962179|P2|COMPLETED|Overall Study||12
2430717|NCT01174186|5962180|P1|COMPLETED|Overall Study||15
2430718|NCT01174186|5962179|P2|STARTED|Overall Study||15
2430719|NCT01174186|5962180|P1|STARTED|Overall Study|Patients were included over three years|15
2430720|NCT01174173|5962187|P1|NOT COMPLETED|Overall Study||1
2430721|NCT01174173|5962187|P1|COMPLETED|Overall Study||10
2430722|NCT01174173|5962187|P1|STARTED|Overall Study||11
2430723|NCT01174160|5962198|P2|NOT COMPLETED|Overall Study||6
2430724|NCT01174160|5962199|P1|NOT COMPLETED|Overall Study||8
2430725|NCT01174160|5962198|P2|COMPLETED|Overall Study||56
2430726|NCT01174160|5962199|P1|COMPLETED|Overall Study||53
2430727|NCT01174160|5962198|P2|Discontinued Post Dose|Overall Study||0
2430728|NCT01174160|5962199|P1|Discontinued Post Dose|Overall Study||2
2430729|NCT01174160|5962198|P2|Dosed|Overall Study||56
2430730|NCT01174160|5962199|P1|Dosed|Overall Study||55
2430731|NCT01174160|5962198|P2|Discontinued Pre Dose|Overall Study||6
2430732|NCT01174160|5962199|P1|Discontinued Pre Dose|Overall Study||6
2430733|NCT01174160|5962198|P2|STARTED|Overall Study||62
2430734|NCT01174160|5962199|P1|STARTED|Overall Study||61
2430735|NCT01174082|5962207|P2|NOT COMPLETED|Overall Study||0
2430736|NCT01174082|5962208|P1|NOT COMPLETED|Overall Study||0
2430737|NCT01174082|5962207|P2|COMPLETED|Overall Study||1
2430738|NCT01174082|5962208|P1|COMPLETED|Overall Study||1
2430739|NCT01174082|5962207|P2|STARTED|Overall Study||1
2430740|NCT01174082|5962208|P1|STARTED|Overall Study||1
2430741|NCT01174043|5962214|P1|NOT COMPLETED|Overall Study||11
2430742|NCT01174043|5962214|P1|COMPLETED|Overall Study||0
2430743|NCT01174043|5962214|P1|STARTED|Overall Study||11
2430744|NCT01174030|5962225|P5|NOT COMPLETED|Overall Study||1
2430745|NCT01174030|5962226|P4|NOT COMPLETED|Overall Study||2
2430746|NCT01174030|5962227|P3|NOT COMPLETED|Overall Study||2
2430747|NCT01174030|5962228|P2|NOT COMPLETED|Overall Study||2
2430748|NCT01174030|5962229|P1|NOT COMPLETED|Overall Study||2
2430749|NCT01174030|5962225|P5|COMPLETED|Overall Study||52
2430750|NCT01174030|5962226|P4|COMPLETED|Overall Study||53
2430751|NCT01174030|5962227|P3|COMPLETED|Overall Study||52
2430752|NCT01174030|5962228|P2|COMPLETED|Overall Study||52
2430753|NCT01174030|5962229|P1|COMPLETED|Overall Study||51
2430754|NCT01174030|5962225|P5|STARTED|Overall Study||53
2430755|NCT01174030|5962226|P4|STARTED|Overall Study||55
2430756|NCT01174030|5962227|P3|STARTED|Overall Study||54
2430757|NCT01174030|5962228|P2|STARTED|Overall Study||54
2430758|NCT01174030|5962229|P1|STARTED|Overall Study||53
2430759|NCT01174004|5962253|P2|NOT COMPLETED|Overall Study||16
2430760|NCT01174004|5962254|P1|NOT COMPLETED|Overall Study||7
2430761|NCT01174004|5962253|P2|COMPLETED|Overall Study||89
2430762|NCT01174004|5962254|P1|COMPLETED|Overall Study||87
2430763|NCT01174004|5962253|P2|STARTED|Overall Study||105
2430764|NCT01174004|5962254|P1|STARTED|Overall Study||94
2430765|NCT01173874|5962264|P2|NOT COMPLETED|Overall Study||23
2430766|NCT01173874|5962265|P1|NOT COMPLETED|Overall Study||23
2430767|NCT01173874|5962264|P2|COMPLETED|Overall Study||41
2430768|NCT01173874|5962265|P1|COMPLETED|Overall Study||33
2430769|NCT01173874|5962264|P2|STARTED|Overall Study||64
2430770|NCT01173874|5962265|P1|STARTED|Overall Study||56
2430771|NCT01173848|5962279|P2|NOT COMPLETED|Overall Study||8
2430772|NCT01173848|5962280|P1|NOT COMPLETED|Overall Study||4
2430773|NCT01173848|5962279|P2|COMPLETED|Overall Study||3
2430774|NCT01173848|5962280|P1|COMPLETED|Overall Study||4
2430775|NCT01173848|5962279|P2|STARTED|Overall Study||11
2430776|NCT01173848|5962280|P1|STARTED|Overall Study||8
2430777|NCT01173718|5962285|P1|NOT COMPLETED|Overall Study||44
2430778|NCT01173718|5962285|P1|COMPLETED|Overall Study||94
2430779|NCT01173718|5962285|P1|STARTED|Overall Study||138
2430780|NCT01173679|5962294|P1|NOT COMPLETED|Overall Study||1
2430781|NCT01173679|5962294|P1|COMPLETED|Overall Study||9
2430782|NCT01173679|5962294|P1|STARTED|Overall Study||10
2430783|NCT01173653|5962302|P2|NOT COMPLETED|Overall Study||41
2430784|NCT01173653|5962303|P1|NOT COMPLETED|Overall Study||53
2430785|NCT01173653|5962302|P2|COMPLETED|Overall Study||49
2430786|NCT01173653|5962303|P1|COMPLETED|Overall Study||56
2430787|NCT01173653|5962302|P2|STARTED|Overall Study||90
2430788|NCT01173653|5962303|P1|STARTED|Overall Study||109
2430789|NCT01173601|5962313|P5|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||68
2430790|NCT01173601|5962314|P4|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||30
2430791|NCT01173601|5962315|P3|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33
2430792|NCT01173601|5962316|P2|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
2430793|NCT01173601|5962317|P1|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
2430794|NCT01173601|5962313|P5|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||559
2430795|NCT01173601|5962314|P4|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||210
2430796|NCT01173601|5962315|P3|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||197
2430797|NCT01173601|5962316|P2|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196
2430798|NCT01173601|5962317|P1|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
2430799|NCT01173601|5962313|P5|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|586
2430800|NCT01173601|5962314|P4|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|221
2430801|NCT01173601|5962315|P3|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|108
2430802|NCT01173601|5962316|P2|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|100
2430803|NCT01173601|5962317|P1|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
2430804|NCT01173601|5962313|P5|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
2430805|NCT01173601|5962314|P4|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
2430806|NCT01173601|5962315|P3|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|107
2430807|NCT01173601|5962316|P2|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|100
2430808|NCT01173601|5962317|P1|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
2430809|NCT01173601|5962313|P5|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||627
2430810|NCT01173601|5962314|P4|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||240
2430811|NCT01173601|5962315|P3|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230
2430812|NCT01173601|5962316|P2|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231
2430813|NCT01173601|5962317|P1|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
2430814|NCT01173601|5962313|P5|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
2430815|NCT01173601|5962314|P4|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
2430816|NCT01173601|5962315|P3|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
2430817|NCT01173601|5962316|P2|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
2430818|NCT01173601|5962317|P1|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88
2430819|NCT01173601|5962313|P5|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
2430820|NCT01173601|5962314|P4|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
2430821|NCT01173601|5962315|P3|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
2430822|NCT01173601|5962316|P2|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
2430823|NCT01173601|5962317|P1|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the AT Phase.|1328
2430824|NCT01173601|5962313|P5|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
2430825|NCT01173601|5962314|P4|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
2430826|NCT01173601|5962315|P3|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
2430827|NCT01173601|5962316|P2|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
2430828|NCT01173601|5962317|P1|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase had the option to enter the DC phase.|21
2430829|NCT01173601|5962313|P5|STARTED|Confirmation (CF) Phase, 3 Weeks||0
2430830|NCT01173601|5962314|P4|STARTED|Confirmation (CF) Phase, 3 Weeks||0
2430831|NCT01173601|5962315|P3|STARTED|Confirmation (CF) Phase, 3 Weeks||0
2430832|NCT01173601|5962316|P2|STARTED|Confirmation (CF) Phase, 3 Weeks||0
2430833|NCT01173601|5962317|P1|STARTED|Confirmation (CF) Phase, 3 Weeks||1416
2430834|NCT01173523|5962394|P2|NOT COMPLETED|Overall Study||12
2430835|NCT01173523|5962395|P1|NOT COMPLETED|Overall Study||13
2430836|NCT01173523|5962394|P2|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
2430837|NCT01173523|5962395|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
2430838|NCT01173523|5962394|P2|STARTED|Overall Study||12
2430839|NCT01173523|5962395|P1|STARTED|Overall Study||13
2430840|NCT01173471|5962411|P4|NOT COMPLETED|Overall Study||1
2430841|NCT01173471|5962412|P3|NOT COMPLETED|Overall Study||3
2430842|NCT01173471|5962413|P2|NOT COMPLETED|Overall Study||0
2430843|NCT01173471|5962414|P1|NOT COMPLETED|Overall Study||2
2430844|NCT01173471|5962411|P4|COMPLETED|Overall Study|Completed study|18
2430845|NCT01173471|5962412|P3|COMPLETED|Overall Study|Completed study|15
2430846|NCT01173471|5962413|P2|COMPLETED|Overall Study|Completed study|7
2430847|NCT01173471|5962414|P1|COMPLETED|Overall Study|Completed study|4
2430848|NCT01173471|5962411|P4|Completed Treatment|Overall Study||18
2430849|NCT01173471|5962412|P3|Completed Treatment|Overall Study||15
2430850|NCT01173471|5962413|P2|Completed Treatment|Overall Study||7
2430851|NCT01173471|5962414|P1|Completed Treatment|Overall Study||4
2430852|NCT01173471|5962411|P4|Received Treatment|Overall Study||19
2430853|NCT01173471|5962412|P3|Received Treatment|Overall Study||18
2430854|NCT01173471|5962413|P2|Received Treatment|Overall Study||7
2430855|NCT01173471|5962414|P1|Received Treatment|Overall Study||6
2430856|NCT01173471|5962411|P4|STARTED|Overall Study|Randomized|19
2430857|NCT01173471|5962412|P3|STARTED|Overall Study|Randomized|18
2430858|NCT01173471|5962413|P2|STARTED|Overall Study|Randomized|7
2430859|NCT01173471|5962414|P1|STARTED|Overall Study|Randomized|6
2430860|NCT01173211|5962438|P6|NOT COMPLETED|Overall Study||0
2430861|NCT01173211|5962439|P5|NOT COMPLETED|Overall Study||0
2430862|NCT01173211|5962440|P4|NOT COMPLETED|Overall Study||0
2430863|NCT01173211|5962441|P3|NOT COMPLETED|Overall Study||2
2430864|NCT01173211|5962442|P2|NOT COMPLETED|Overall Study||1
2430865|NCT01173211|5962443|P1|NOT COMPLETED|Overall Study||2
2430866|NCT01173211|5962438|P6|COMPLETED|Overall Study||13
2430867|NCT01173211|5962439|P5|COMPLETED|Overall Study||16
2430868|NCT01173211|5962440|P4|COMPLETED|Overall Study||15
2430869|NCT01173211|5962441|P3|COMPLETED|Overall Study||44
2430870|NCT01173211|5962442|P2|COMPLETED|Overall Study||44
2430871|NCT01173211|5962443|P1|COMPLETED|Overall Study||46
2430872|NCT01173211|5962438|P6|STARTED|Overall Study||13
2430873|NCT01173211|5962439|P5|STARTED|Overall Study||16
2430874|NCT01173211|5962440|P4|STARTED|Overall Study||15
2430875|NCT01173211|5962441|P3|STARTED|Overall Study||46
2430876|NCT01173211|5962442|P2|STARTED|Overall Study||45
2430877|NCT01173211|5962443|P1|STARTED|Overall Study||48
2430878|NCT01173120|5962544|P1|NOT COMPLETED|Overall Study||62
2430879|NCT01173120|5962544|P1|COMPLETED|Overall Study||0
2430880|NCT01173120|5962544|P1|Discontinued ACP Substudy and Main Study|Overall Study||5
2430881|NCT01173120|5962544|P1|Switched Back to Main Study|Overall Study||57
2430882|NCT01173120|5962544|P1|STARTED|Overall Study||62
2430883|NCT01173055|5962562|P2|NOT COMPLETED|Period 2 - Day 64 to 112||1
2430884|NCT01173055|5962563|P1|NOT COMPLETED|Period 2 - Day 64 to 112||0
2430885|NCT01173055|5962562|P2|COMPLETED|Period 2 - Day 64 to 112||9
2430886|NCT01173055|5962563|P1|COMPLETED|Period 2 - Day 64 to 112||8
2430887|NCT01173055|5962562|P2|STARTED|Period 2 - Day 64 to 112||10
2430888|NCT01173055|5962563|P1|STARTED|Period 2 - Day 64 to 112||8
2430889|NCT01173055|5962562|P2|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
2430890|NCT01173055|5962563|P1|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
2430891|NCT01173055|5962562|P2|COMPLETED|Placebo Washout Period - Day 50 to 63||10
2430892|NCT01173055|5962563|P1|COMPLETED|Placebo Washout Period - Day 50 to 63||8
2430893|NCT01173055|5962562|P2|STARTED|Placebo Washout Period - Day 50 to 63||10
2430894|NCT01173055|5962563|P1|STARTED|Placebo Washout Period - Day 50 to 63||8
2430895|NCT01173055|5962562|P2|NOT COMPLETED|Period 1 - Day 1 to 49||2
2430896|NCT01173055|5962563|P1|NOT COMPLETED|Period 1 - Day 1 to 49||2
2430897|NCT01173055|5962562|P2|COMPLETED|Period 1 - Day 1 to 49||10
2430898|NCT01173055|5962563|P1|COMPLETED|Period 1 - Day 1 to 49||8
2430899|NCT01173055|5962562|P2|STARTED|Period 1 - Day 1 to 49||12
2430900|NCT01173055|5962563|P1|STARTED|Period 1 - Day 1 to 49||10
2430901|NCT01173029|5962581|P2|NOT COMPLETED|Overall Study||0
2430902|NCT01173029|5962582|P1|NOT COMPLETED|Overall Study||0
2430903|NCT01173029|5962581|P2|COMPLETED|Overall Study||31
2430904|NCT01173029|5962582|P1|COMPLETED|Overall Study||61
2430905|NCT01173029|5962581|P2|STARTED|Overall Study||31
2430906|NCT01173029|5962582|P1|STARTED|Overall Study||61
2430907|NCT01172938|5962602|P9|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||2
2430908|NCT01172938|5962603|P8|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3
2430909|NCT01172938|5962604|P7|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
2430910|NCT01172938|5962605|P6|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
2430911|NCT01172938|5962606|P5|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
2430912|NCT01172938|5962607|P4|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
2430913|NCT01172938|5962608|P3|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||8
2430914|NCT01172938|5962609|P2|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3
2430915|NCT01172938|5962610|P1|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
2430916|NCT01172938|5962602|P9|COMPLETED|Active-Treatment Phase (Weeks 208-260)||32
2430917|NCT01172938|5962603|P8|COMPLETED|Active-Treatment Phase (Weeks 208-260)||29
2430918|NCT01172938|5962604|P7|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
2430919|NCT01172938|5962605|P6|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
2430920|NCT01172938|5962606|P5|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
2430921|NCT01172938|5962607|P4|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
2430922|NCT01172938|5962608|P3|COMPLETED|Active-Treatment Phase (Weeks 208-260)||80
2430923|NCT01172938|5962609|P2|COMPLETED|Active-Treatment Phase (Weeks 208-260)||72
2430924|NCT01172938|5962610|P1|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
2430925|NCT01172938|5962602|P9|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
2430926|NCT01172938|5962603|P8|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||25
2430927|NCT01172938|5962604|P7|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
2430928|NCT01172938|5962605|P6|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
2430929|NCT01172938|5962606|P5|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
2430930|NCT01172938|5962607|P4|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
2430931|NCT01172938|5962608|P3|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
2430932|NCT01172938|5962609|P2|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
2430933|NCT01172938|5962610|P1|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
2430934|NCT01172938|5962602|P9|STARTED|Active-Treatment Phase (Weeks 208-260)||34
2430935|NCT01172938|5962603|P8|STARTED|Active-Treatment Phase (Weeks 208-260)||32
2430936|NCT01172938|5962604|P7|STARTED|Active-Treatment Phase (Weeks 208-260)||0
2430937|NCT01172938|5962605|P6|STARTED|Active-Treatment Phase (Weeks 208-260)||0
2430938|NCT01172938|5962606|P5|STARTED|Active-Treatment Phase (Weeks 208-260)||0
2430939|NCT01172938|5962607|P4|STARTED|Active-Treatment Phase (Weeks 208-260)||0
2430940|NCT01172938|5962608|P3|STARTED|Active-Treatment Phase (Weeks 208-260)||88
2430941|NCT01172938|5962609|P2|STARTED|Active-Treatment Phase (Weeks 208-260)||75
2430942|NCT01172938|5962610|P1|STARTED|Active-Treatment Phase (Weeks 208-260)||0
2430943|NCT01172938|5962602|P9|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||7
2430944|NCT01172938|5962603|P8|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9
2430945|NCT01172938|5962604|P7|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
2430946|NCT01172938|5962605|P6|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
2430947|NCT01172938|5962606|P5|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
2430948|NCT01172938|5962607|P4|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
2430949|NCT01172938|5962608|P3|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||5
2430950|NCT01172938|5962609|P2|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9
2430951|NCT01172938|5962610|P1|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
2430952|NCT01172938|5962602|P9|COMPLETED|Active-Treatment Phase (Weeks 156-208)||34
2430953|NCT01172938|5962603|P8|COMPLETED|Active-Treatment Phase (Weeks 156-208)||32
2430954|NCT01172938|5962604|P7|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
2430955|NCT01172938|5962605|P6|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
2430956|NCT01172938|5962606|P5|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
2430957|NCT01172938|5962607|P4|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
2430958|NCT01172938|5962608|P3|COMPLETED|Active-Treatment Phase (Weeks 156-208)||88
2430959|NCT01172938|5962609|P2|COMPLETED|Active-Treatment Phase (Weeks 156-208)||75
2430960|NCT01172938|5962610|P1|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
2430961|NCT01172938|5962602|P9|STARTED|Active-Treatment Phase (Weeks 156-208)||41
2430962|NCT01172938|5962603|P8|STARTED|Active-Treatment Phase (Weeks 156-208)||41
2430963|NCT01172938|5962604|P7|STARTED|Active-Treatment Phase (Weeks 156-208)||0
2430964|NCT01172938|5962605|P6|STARTED|Active-Treatment Phase (Weeks 156-208)||0
2430965|NCT01172938|5962606|P5|STARTED|Active-Treatment Phase (Weeks 156-208)||0
2430966|NCT01172938|5962607|P4|STARTED|Active-Treatment Phase (Weeks 156-208)||0
2430967|NCT01172938|5962608|P3|STARTED|Active-Treatment Phase (Weeks 156-208)||93
2430968|NCT01172938|5962609|P2|STARTED|Active-Treatment Phase (Weeks 156-208)||84
2430969|NCT01172938|5962610|P1|STARTED|Active-Treatment Phase (Weeks 156-208)||0
2430970|NCT01172938|5962602|P9|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||4
2430971|NCT01172938|5962603|P8|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||5
2430972|NCT01172938|5962604|P7|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
2430973|NCT01172938|5962605|P6|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
2430974|NCT01172938|5962606|P5|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
2430975|NCT01172938|5962607|P4|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
2430976|NCT01172938|5962608|P3|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||7
2430977|NCT01172938|5962609|P2|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||11
2430978|NCT01172938|5962610|P1|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
2430979|NCT01172938|5962602|P9|COMPLETED|Active-Treatment Phase Weeks (104-156)||41
2430980|NCT01172938|5962603|P8|COMPLETED|Active-Treatment Phase Weeks (104-156)||41
2430981|NCT01172938|5962604|P7|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
2430982|NCT01172938|5962605|P6|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
2430983|NCT01172938|5962606|P5|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
2430984|NCT01172938|5962607|P4|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
2430985|NCT01172938|5962608|P3|COMPLETED|Active-Treatment Phase Weeks (104-156)||93
2430986|NCT01172938|5962609|P2|COMPLETED|Active-Treatment Phase Weeks (104-156)||84
2430987|NCT01172938|5962610|P1|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
2430988|NCT01172938|5962602|P9|STARTED|Active-Treatment Phase Weeks (104-156)||45
2430989|NCT01172938|5962603|P8|STARTED|Active-Treatment Phase Weeks (104-156)||46
2430990|NCT01172938|5962604|P7|STARTED|Active-Treatment Phase Weeks (104-156)||0
2430991|NCT01172938|5962605|P6|STARTED|Active-Treatment Phase Weeks (104-156)||0
2430992|NCT01172938|5962606|P5|STARTED|Active-Treatment Phase Weeks (104-156)||0
2430993|NCT01172938|5962607|P4|STARTED|Active-Treatment Phase Weeks (104-156)||0
2430994|NCT01172938|5962608|P3|STARTED|Active-Treatment Phase Weeks (104-156)||100
2430995|NCT01172938|5962609|P2|STARTED|Active-Treatment Phase Weeks (104-156)||95
2430996|NCT01172938|5962610|P1|STARTED|Active-Treatment Phase Weeks (104-156)||0
2430997|NCT01172938|5962602|P9|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||4
2430998|NCT01172938|5962603|P8|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||15
2430999|NCT01172938|5962604|P7|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
2431000|NCT01172938|5962605|P6|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
2431001|NCT01172938|5962606|P5|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
2431002|NCT01172938|5962607|P4|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
2431003|NCT01172938|5962608|P3|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||21
2431004|NCT01172938|5962609|P2|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||23
2431005|NCT01172938|5962610|P1|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
2431006|NCT01172938|5962602|P9|COMPLETED|Active-Treatment Phase (Weeks 52-104)||45
2431007|NCT01172938|5962603|P8|COMPLETED|Active-Treatment Phase (Weeks 52-104)||46
2431008|NCT01172938|5962604|P7|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
2431009|NCT01172938|5962605|P6|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
2431010|NCT01172938|5962606|P5|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
2431011|NCT01172938|5962607|P4|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
2431012|NCT01172938|5962608|P3|COMPLETED|Active-Treatment Phase (Weeks 52-104)||100
2431013|NCT01172938|5962609|P2|COMPLETED|Active-Treatment Phase (Weeks 52-104)||95
2431014|NCT01172938|5962610|P1|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
2431015|NCT01172938|5962602|P9|STARTED|Active-Treatment Phase (Weeks 52-104)||49
2431016|NCT01172938|5962603|P8|STARTED|Active-Treatment Phase (Weeks 52-104)||61
2431017|NCT01172938|5962604|P7|STARTED|Active-Treatment Phase (Weeks 52-104)||0
2431018|NCT01172938|5962605|P6|STARTED|Active-Treatment Phase (Weeks 52-104)||0
2431019|NCT01172938|5962606|P5|STARTED|Active-Treatment Phase (Weeks 52-104)||0
2431020|NCT01172938|5962607|P4|STARTED|Active-Treatment Phase (Weeks 52-104)||0
2431021|NCT01172938|5962608|P3|STARTED|Active-Treatment Phase (Weeks 52-104)|Nine participants who completed Week 52 did not enter the next year of active treatment phase|121
2431022|NCT01172938|5962609|P2|STARTED|Active-Treatment Phase (Weeks 52-104)|Six participants who completed Week 52 did not enter the next year of active treatment phase|118
2431023|NCT01172938|5962610|P1|STARTED|Active-Treatment Phase (Weeks 52-104)||0
2431024|NCT01172938|5962602|P9|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
2431025|NCT01172938|5962603|P8|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
2431026|NCT01172938|5962604|P7|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||2
2431027|NCT01172938|5962605|P6|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15
2431028|NCT01172938|5962606|P5|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||4
2431029|NCT01172938|5962607|P4|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||7
2431030|NCT01172938|5962608|P3|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15
2431031|NCT01172938|5962609|P2|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||12
2431032|NCT01172938|5962610|P1|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
2431033|NCT01172938|5962602|P9|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
2431034|NCT01172938|5962603|P8|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
2431035|NCT01172938|5962604|P7|COMPLETED|Active Treatment Phase (Weeks 25-52)||22
2431036|NCT01172938|5962605|P6|COMPLETED|Active Treatment Phase (Weeks 25-52)||34
2431037|NCT01172938|5962606|P5|COMPLETED|Active Treatment Phase (Weeks 25-52)||19
2431038|NCT01172938|5962607|P4|COMPLETED|Active Treatment Phase (Weeks 25-52)||44
2431039|NCT01172938|5962608|P3|COMPLETED|Active Treatment Phase (Weeks 25-52)||130
2431040|NCT01172938|5962609|P2|COMPLETED|Active Treatment Phase (Weeks 25-52)||124
2431041|NCT01172938|5962610|P1|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
2431042|NCT01172938|5962602|P9|STARTED|Active Treatment Phase (Weeks 25-52)||0
2431043|NCT01172938|5962603|P8|STARTED|Active Treatment Phase (Weeks 25-52)||0
2431044|NCT01172938|5962604|P7|STARTED|Active Treatment Phase (Weeks 25-52)||24
2431045|NCT01172938|5962605|P6|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|49
2431046|NCT01172938|5962606|P5|STARTED|Active Treatment Phase (Weeks 25-52)||23
2431047|NCT01172938|5962607|P4|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|51
2431048|NCT01172938|5962608|P3|STARTED|Active Treatment Phase (Weeks 25-52)|Three participants who completed Week 24 did not enter the active treatment phase|145
2431049|NCT01172938|5962609|P2|STARTED|Active Treatment Phase (Weeks 25-52)|Ten participants who completed Week 24 did not enter the active treatment phase|136
2431050|NCT01172938|5962610|P1|STARTED|Active Treatment Phase (Weeks 25-52)||0
2431051|NCT01172938|5962602|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
2431052|NCT01172938|5962603|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
2431053|NCT01172938|5962604|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
2431054|NCT01172938|5962605|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
2431055|NCT01172938|5962606|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
2431056|NCT01172938|5962607|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
2431057|NCT01172938|5962608|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||20
2431058|NCT01172938|5962609|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||22
2431059|NCT01172938|5962610|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||18
2431060|NCT01172938|5962602|P9|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
2431061|NCT01172938|5962603|P8|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
2431062|NCT01172938|5962604|P7|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
2431063|NCT01172938|5962605|P6|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
2431064|NCT01172938|5962606|P5|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
2431065|NCT01172938|5962607|P4|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
2431066|NCT01172938|5962608|P3|COMPLETED|Placebo-controlled Phase (Week 0-24)||148
2431067|NCT01172938|5962609|P2|COMPLETED|Placebo-controlled Phase (Week 0-24)||146
2431068|NCT01172938|5962610|P1|COMPLETED|Placebo-controlled Phase (Week 0-24)|One participant who completed Week 24 did not enter the active treatment phase|150
2431069|NCT01172938|5962602|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
2431070|NCT01172938|5962603|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
2431071|NCT01172938|5962604|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
2431072|NCT01172938|5962605|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
2431073|NCT01172938|5962606|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
2431074|NCT01172938|5962607|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
2431075|NCT01172938|5962608|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||58
2431076|NCT01172938|5962609|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Six participants who escaped early did not complete Week 24|78
2431077|NCT01172938|5962610|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Five participants who escaped early did not complete Week 24|107
2431078|NCT01172938|5962602|P9|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
2431079|NCT01172938|5962603|P8|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
2431080|NCT01172938|5962604|P7|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
2431081|NCT01172938|5962605|P6|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
2431082|NCT01172938|5962606|P5|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
2431083|NCT01172938|5962607|P4|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
2431084|NCT01172938|5962608|P3|Completed Week 16|Placebo-controlled Phase (Week 0-24)||154
2431085|NCT01172938|5962609|P2|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158
2431086|NCT01172938|5962610|P1|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158
2431087|NCT01172938|5962602|P9|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
2431088|NCT01172938|5962603|P8|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
2431089|NCT01172938|5962604|P7|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
2431090|NCT01172938|5962605|P6|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
2431091|NCT01172938|5962606|P5|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
2431092|NCT01172938|5962607|P4|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
2431093|NCT01172938|5962608|P3|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
2431094|NCT01172938|5962609|P2|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
2431095|NCT01172938|5962610|P1|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
2431096|NCT01172938|5962602|P9|STARTED|Placebo-controlled Phase (Week 0-24)||0
2431097|NCT01172938|5962603|P8|STARTED|Placebo-controlled Phase (Week 0-24)||0
2431098|NCT01172938|5962604|P7|STARTED|Placebo-controlled Phase (Week 0-24)||0
2431099|NCT01172938|5962605|P6|STARTED|Placebo-controlled Phase (Week 0-24)||0
2431100|NCT01172938|5962606|P5|STARTED|Placebo-controlled Phase (Week 0-24)||0
2431101|NCT01172938|5962607|P4|STARTED|Placebo-controlled Phase (Week 0-24)||0
2431102|NCT01172938|5962608|P3|STARTED|Placebo-controlled Phase (Week 0-24)||168
2431103|NCT01172938|5962609|P2|STARTED|Placebo-controlled Phase (Week 0-24)||168
2431104|NCT01172938|5962610|P1|STARTED|Placebo-controlled Phase (Week 0-24)||168
2431105|NCT01172873|5962796|P2|NOT COMPLETED|Overall Study||2
2431106|NCT01172873|5962797|P1|NOT COMPLETED|Overall Study||3
2431107|NCT01172873|5962796|P2|COMPLETED|Overall Study||3
2431108|NCT01172873|5962797|P1|COMPLETED|Overall Study||8
2431109|NCT01172873|5962796|P2|STARTED|Overall Study||5
2431110|NCT01172873|5962797|P1|STARTED|Overall Study||11
2431111|NCT01172847|5962807|P1|NOT COMPLETED|Overall Study||3
2431112|NCT01172847|5962807|P1|COMPLETED|Overall Study||21
2431113|NCT01172847|5962807|P1|Oseltamivir + Rimantadine|Overall Study||21
2431114|NCT01172847|5962807|P1|Rimantadine|Overall Study||22
2431115|NCT01172847|5962807|P1|Oseltamivir|Overall Study||24
2431116|NCT01172847|5962807|P1|STARTED|Overall Study||24
2431117|NCT01172821|5962836|P4|NOT COMPLETED|Overall Study||17
2431118|NCT01172821|5962837|P3|NOT COMPLETED|Overall Study||13
2431119|NCT01172821|5962838|P2|NOT COMPLETED|Overall Study||12
2431120|NCT01172821|5962839|P1|NOT COMPLETED|Overall Study||14
2431121|NCT01172821|5962836|P4|COMPLETED|Overall Study||249
2431122|NCT01172821|5962837|P3|COMPLETED|Overall Study||240
2431123|NCT01172821|5962838|P2|COMPLETED|Overall Study||245
2431124|NCT01172821|5962839|P1|COMPLETED|Overall Study||240
2431125|NCT01172821|5962836|P4|STARTED|Overall Study|Entered and Treated|266
2431126|NCT01172821|5962837|P3|STARTED|Overall Study|Entered and Treated|253
2431127|NCT01172821|5962838|P2|STARTED|Overall Study|Entered and Treated|257
2431128|NCT01172821|5962839|P1|STARTED|Overall Study|Entered and Treated|254
2431129|NCT01172808|5962929|P4|NOT COMPLETED|Overall Study||15
2431130|NCT01172808|5962930|P3|NOT COMPLETED|Overall Study||23
2431131|NCT01172808|5962931|P2|NOT COMPLETED|Overall Study||13
2431132|NCT01172808|5962932|P1|NOT COMPLETED|Overall Study||21
2431133|NCT01172808|5962929|P4|COMPLETED|Overall Study||260
2431134|NCT01172808|5962930|P3|COMPLETED|Overall Study||241
2431135|NCT01172808|5962931|P2|COMPLETED|Overall Study||249
2431136|NCT01172808|5962932|P1|COMPLETED|Overall Study||248
2431137|NCT01172808|5962929|P4|STARTED|Overall Study|Entered and Treated|275
2431138|NCT01172808|5962930|P3|STARTED|Overall Study|Entered and Treated|264
2431139|NCT01172808|5962931|P2|STARTED|Overall Study|Entered and Treated|262
2431140|NCT01172808|5962932|P1|STARTED|Overall Study|Entered and Treated|269
2431141|NCT01172639|5963023|P5|NOT COMPLETED|Overall Study||6
2431142|NCT01172639|5963024|P4|NOT COMPLETED|Overall Study||11
2431143|NCT01172639|5963025|P3|NOT COMPLETED|Overall Study||16
2431144|NCT01172639|5963026|P2|NOT COMPLETED|Overall Study||11
2431145|NCT01172639|5963027|P1|NOT COMPLETED|Overall Study||13
2431146|NCT01172639|5963023|P5|COMPLETED|Overall Study||41
2431147|NCT01172639|5963024|P4|COMPLETED|Overall Study||32
2431148|NCT01172639|5963025|P3|COMPLETED|Overall Study||77
2431149|NCT01172639|5963026|P2|COMPLETED|Overall Study||87
2431150|NCT01172639|5963027|P1|COMPLETED|Overall Study||85
2431151|NCT01172639|5963023|P5|Week 52|Overall Study||45
2431152|NCT01172639|5963024|P4|Week 52|Overall Study||38
2431153|NCT01172639|5963025|P3|Week 52|Overall Study||88
2431154|NCT01172639|5963026|P2|Week 52|Overall Study||89
2431155|NCT01172639|5963027|P1|Week 52|Overall Study||89
2431156|NCT01172639|5963023|P5|Week 16|Overall Study||47
2431157|NCT01172639|5963024|P4|Week 16|Overall Study||39
2431158|NCT01172639|5963025|P3|Week 16|Overall Study||91
2431159|NCT01172639|5963026|P2|Week 16|Overall Study||96
2431160|NCT01172639|5963027|P1|Week 16|Overall Study||94
2431161|NCT01172639|5963023|P5|STARTED|Overall Study||47
2431162|NCT01172639|5963024|P4|STARTED|Overall Study||43
2431163|NCT01172639|5963025|P3|STARTED|Overall Study||93
2431164|NCT01172639|5963026|P2|STARTED|Overall Study||98
2431165|NCT01172639|5963027|P1|STARTED|Overall Study||98
2431166|NCT01172600|5963071|P2|NOT COMPLETED|Overall Study||0
2431167|NCT01172600|5963072|P1|NOT COMPLETED|Overall Study||0
2431168|NCT01172600|5963071|P2|COMPLETED|Overall Study||39
2431169|NCT01172600|5963072|P1|COMPLETED|Overall Study||39
2431170|NCT01172600|5963071|P2|STARTED|Overall Study||39
2431171|NCT01172600|5963072|P1|STARTED|Overall Study||39
2431172|NCT01172535|5963102|P1|NOT COMPLETED|Overall Study||8
2431173|NCT01172535|5963102|P1|COMPLETED|Overall Study||89
2431174|NCT01172535|5963102|P1|STARTED|Overall Study||97
2431175|NCT01172522|5963119|P2|NOT COMPLETED|Overall Study||0
2431176|NCT01172522|5963120|P1|NOT COMPLETED|Overall Study||0
2431177|NCT01172522|5963119|P2|COMPLETED|Overall Study||15
2431178|NCT01172522|5963120|P1|COMPLETED|Overall Study||15
2431179|NCT01172522|5963119|P2|STARTED|Overall Study||15
2431180|NCT01172522|5963120|P1|STARTED|Overall Study||15
2431181|NCT01172418|5963127|P2|NOT COMPLETED|Overall Study||0
2431182|NCT01172418|5963128|P1|NOT COMPLETED|Overall Study||0
2431183|NCT01172418|5963127|P2|COMPLETED|Overall Study||100
2431184|NCT01172418|5963128|P1|COMPLETED|Overall Study||100
2431185|NCT01172418|5963127|P2|STARTED|Overall Study||100
2431186|NCT01172418|5963128|P1|STARTED|Overall Study||100
2431187|NCT01172353|5963144|P2|NOT COMPLETED|Overall Study||0
2431188|NCT01172353|5963145|P1|NOT COMPLETED|Overall Study||0
2431189|NCT01172353|5963144|P2|COMPLETED|Overall Study||151
2431190|NCT01172353|5963145|P1|COMPLETED|Overall Study||150
2431191|NCT01172353|5963144|P2|STARTED|Overall Study||151
2431192|NCT01172353|5963145|P1|STARTED|Overall Study||150
2431193|NCT01172288|5963155|P2|NOT COMPLETED|Overall Study||1
2431194|NCT01172288|5963156|P1|NOT COMPLETED|Overall Study||1
2431195|NCT01172288|5963155|P2|COMPLETED|Overall Study||13
2431196|NCT01172288|5963156|P1|COMPLETED|Overall Study||16
2431197|NCT01172288|5963155|P2|STARTED|Overall Study||14
2431198|NCT01172288|5963156|P1|STARTED|Overall Study||17
2431199|NCT01172275|5963172|P2|NOT COMPLETED|Overall Study||0
2431200|NCT01172275|5963173|P1|NOT COMPLETED|Overall Study||2
2431201|NCT01172275|5963172|P2|COMPLETED|Overall Study||6
2431202|NCT01172275|5963173|P1|COMPLETED|Overall Study||3
2431203|NCT01172275|5963172|P2|STARTED|Overall Study||6
2431204|NCT01172275|5963173|P1|STARTED|Overall Study||5
2431205|NCT01172197|5963183|P2|NOT COMPLETED|Overall Study||0
2431206|NCT01172197|5963184|P1|NOT COMPLETED|Overall Study||0
2431207|NCT01172197|5963183|P2|COMPLETED|Overall Study||7
2431208|NCT01172197|5963184|P1|COMPLETED|Overall Study||7
2431209|NCT01172197|5963183|P2|STARTED|Overall Study||7
2431210|NCT01172197|5963184|P1|STARTED|Overall Study||7
2431211|NCT01172184|5963190|P1|NOT COMPLETED|Overall Study||0
2431212|NCT01172184|5963190|P1|COMPLETED|Overall Study||111
2431213|NCT01172184|5963190|P1|STARTED|Overall Study||111
2431214|NCT01172145|5963198|P2|NOT COMPLETED|Overall Study||0
2431215|NCT01172145|5963199|P1|NOT COMPLETED|Overall Study||0
2431216|NCT01172145|5963198|P2|COMPLETED|Overall Study||11
2431217|NCT01172145|5963199|P1|COMPLETED|Overall Study||11
2431218|NCT01172145|5963198|P2|STARTED|Overall Study||11
2431219|NCT01172145|5963199|P1|STARTED|Overall Study||11
2431220|NCT01172067|5963221|P2|NOT COMPLETED|Overall Study||37
2431221|NCT01172067|5963222|P1|NOT COMPLETED|Overall Study||47
2431222|NCT01172067|5963221|P2|COMPLETED|Overall Study||163
2431223|NCT01172067|5963222|P1|COMPLETED|Overall Study||153
2431224|NCT01172067|5963221|P2|STARTED|Overall Study||200
2431225|NCT01172067|5963222|P1|STARTED|Overall Study||200
2431226|NCT01171989|5963231|P3|NOT COMPLETED|Overall Study||1
2431227|NCT01171989|5963232|P2|NOT COMPLETED|Overall Study||0
2431228|NCT01171989|5963233|P1|NOT COMPLETED|Overall Study||0
2431229|NCT01171989|5963231|P3|COMPLETED|Overall Study||120
2431230|NCT01171989|5963232|P2|COMPLETED|Overall Study||133
2431231|NCT01171989|5963233|P1|COMPLETED|Overall Study||137
2431232|NCT01171989|5963231|P3|STARTED|Overall Study||121
2431233|NCT01171989|5963232|P2|STARTED|Overall Study||133
2431234|NCT01171989|5963233|P1|STARTED|Overall Study||137
2431235|NCT01171976|5963307|P3|NOT COMPLETED|Overall Study||15
2431236|NCT01171976|5963308|P2|NOT COMPLETED|Overall Study||11
2431237|NCT01171976|5963309|P1|NOT COMPLETED|Overall Study||14
2431238|NCT01171976|5963307|P3|COMPLETED|Overall Study||108
2431239|NCT01171976|5963308|P2|COMPLETED|Overall Study||117
2431240|NCT01171976|5963309|P1|COMPLETED|Overall Study||107
2431241|NCT01171976|5963307|P3|Safety Set|Overall Study|Exclude 1 who did not get drug and 4 got laser treatment|118
2431242|NCT01171976|5963308|P2|Safety Set|Overall Study|Exclude 1 who did not get drug and 3 got laser treatment, include 2 from 1st arm with no laser|126
2431243|NCT01171976|5963309|P1|Safety Set|Overall Study|Include 4 from PRN and 3 from TE alone who got laser treatment, exclude 2 with no laser treatment.|126
2431244|NCT01171976|5963307|P3|STARTED|Overall Study||123
2431245|NCT01171976|5963308|P2|STARTED|Overall Study||128
2431246|NCT01171976|5963309|P1|STARTED|Overall Study||121
2431247|NCT01171963|5963346|P2|NOT COMPLETED|Overall Study||168
2431248|NCT01171963|5963347|P1|NOT COMPLETED|Overall Study||148
2431249|NCT01171963|5963346|P2|COMPLETED|Overall Study||1499
2431250|NCT01171963|5963347|P1|COMPLETED|Overall Study||1518
2431251|NCT01171963|5963346|P2|STARTED|Overall Study||1667
2431252|NCT01171963|5963347|P1|STARTED|Overall Study||1666
2431253|NCT01171924|5963405|P2|NOT COMPLETED|Overall Study||23
2431254|NCT01171924|5963406|P1|NOT COMPLETED|Overall Study||23
2431255|NCT01171924|5963405|P2|COMPLETED|Overall Study||0
2431256|NCT01171924|5963406|P1|COMPLETED|Overall Study||0
2431257|NCT01171924|5963405|P2|STARTED|Overall Study||23
2431258|NCT01171924|5963406|P1|STARTED|Overall Study||23
2431259|NCT01171898|5963416|P4|NOT COMPLETED|Overall Study||6
2431260|NCT01171898|5963417|P3|NOT COMPLETED|Overall Study||12
2431261|NCT01171898|5963418|P2|NOT COMPLETED|Overall Study||19
2431262|NCT01171898|5963419|P1|NOT COMPLETED|Overall Study||4
2431263|NCT01171898|5963416|P4|COMPLETED|Overall Study||15
2431264|NCT01171898|5963417|P3|COMPLETED|Overall Study||13
2431265|NCT01171898|5963418|P2|COMPLETED|Overall Study||32
2431266|NCT01171898|5963419|P1|COMPLETED|Overall Study||26
2431267|NCT01171898|5963416|P4|STARTED|Overall Study||21
2431268|NCT01171898|5963417|P3|STARTED|Overall Study||25
2431269|NCT01171898|5963418|P2|STARTED|Overall Study||51
2431270|NCT01171898|5963419|P1|STARTED|Overall Study||30
2431271|NCT01171820|5963443|P2|NOT COMPLETED|Overall Study||6
2431272|NCT01171820|5963444|P1|NOT COMPLETED|Overall Study||6
2431273|NCT01171820|5963443|P2|COMPLETED|Overall Study||212
2431274|NCT01171820|5963444|P1|COMPLETED|Overall Study||100
2431275|NCT01171820|5963443|P2|STARTED|Overall Study||218
2431276|NCT01171820|5963444|P1|STARTED|Overall Study||106
2431277|NCT01171794|5963500|P2|NOT COMPLETED|Overall Study||0
2431278|NCT01171794|5963501|P1|NOT COMPLETED|Overall Study||3
2431279|NCT01171794|5963500|P2|COMPLETED|Overall Study||42
2431280|NCT01171794|5963501|P1|COMPLETED|Overall Study||44
2431281|NCT01171794|5963500|P2|STARTED|Overall Study||42
2431282|NCT01171794|5963501|P1|STARTED|Overall Study||47
2431283|NCT01171690|5963511|P2|NOT COMPLETED|Overall Study||0
2431284|NCT01171690|5963512|P1|NOT COMPLETED|Overall Study||0
2431285|NCT01171690|5963511|P2|COMPLETED|Overall Study||5
2431286|NCT01171690|5963512|P1|COMPLETED|Overall Study||5
2431287|NCT01171690|5963511|P2|STARTED|Overall Study||5
2431288|NCT01171690|5963512|P1|STARTED|Overall Study||5
2431289|NCT01171677|5963522|P2|NOT COMPLETED|Overall Study||3
2431290|NCT01171677|5963523|P1|NOT COMPLETED|Overall Study||6
2431291|NCT01171677|5963522|P2|COMPLETED|Overall Study||12
2431292|NCT01171677|5963523|P1|COMPLETED|Overall Study||11
2431293|NCT01171677|5963522|P2|STARTED|Overall Study||15
2431294|NCT01171677|5963523|P1|STARTED|Overall Study||17
2431295|NCT01171612|5963555|P1|NOT COMPLETED|Overall Study||51
2431296|NCT01171612|5963555|P1|COMPLETED|Overall Study||432
2431297|NCT01171612|5963555|P1|STARTED|Overall Study||483
2431298|NCT01171534|5963565|P2|NOT COMPLETED|Overall Study||3
2431299|NCT01171534|5963566|P1|NOT COMPLETED|Overall Study||0
2431300|NCT01171534|5963565|P2|COMPLETED|Overall Study||4
2431301|NCT01171534|5963566|P1|COMPLETED|Overall Study||0
2431302|NCT01171534|5963565|P2|STARTED|Overall Study||7
2431303|NCT01171534|5963566|P1|STARTED|Overall Study|retrospective arm never performed on study|0
2431304|NCT01171521|5963578|P1|NOT COMPLETED|Overall Study||6
2431305|NCT01171521|5963578|P1|COMPLETED|Overall Study||0
2431306|NCT01171521|5963578|P1|STARTED|Overall Study||6
2431307|NCT01171183|5963585|P2|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||5
2431308|NCT01171183|5963586|P1|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||10
2431309|NCT01171183|5963585|P2|COMPLETED|Outpatient Participation (Weeks 3-10)||4
2431310|NCT01171183|5963586|P1|COMPLETED|Outpatient Participation (Weeks 3-10)||2
2431311|NCT01171183|5963585|P2|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but was discharged due to protocol noncompliance.|9
2431312|NCT01171183|5963586|P1|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but withdrew prior to starting the outpatient phase.|12
2431313|NCT01171183|5963585|P2|NOT COMPLETED|Residential Facility (Weeks 1-2)||6
2431314|NCT01171183|5963586|P1|NOT COMPLETED|Residential Facility (Weeks 1-2)||2
2431315|NCT01171183|5963585|P2|COMPLETED|Residential Facility (Weeks 1-2)||10
2431316|NCT01171183|5963586|P1|COMPLETED|Residential Facility (Weeks 1-2)||13
2431317|NCT01171183|5963585|P2|STARTED|Residential Facility (Weeks 1-2)|Subjects receiving at least one dose of study med. One did not due to BP outside study parameters.|16
2431318|NCT01171183|5963586|P1|STARTED|Residential Facility (Weeks 1-2)|Those who were admitted to the residential facility and received at least one dose of study med.|15
2431319|NCT01171118|5963594|P1|NOT COMPLETED|Overall Study||0
2431320|NCT01171118|5963594|P1|COMPLETED|Overall Study||10
2431321|NCT01171118|5963594|P1|STARTED|Overall Study||10
2431322|NCT01170962|5963607|P3|NOT COMPLETED|Follow up Period||6
2431323|NCT01170962|5963608|P2|NOT COMPLETED|Follow up Period||27
2431324|NCT01170962|5963609|P1|NOT COMPLETED|Follow up Period||39
2431325|NCT01170962|5963607|P3|COMPLETED|Follow up Period||9
2431326|NCT01170962|5963608|P2|COMPLETED|Follow up Period||165
2431327|NCT01170962|5963609|P1|COMPLETED|Follow up Period||159
2431328|NCT01170962|5963607|P3|STARTED|Follow up Period|Out of 17 participants who entered the treatment period, 15 continued in the follow-up period.|15
2431329|NCT01170962|5963608|P2|STARTED|Follow up Period|Out of 199 participants who entered the treatment period, 192 continued in the follow-up period.|192
2431330|NCT01170962|5963609|P1|STARTED|Follow up Period|Out of 203 participants who entered the treatment period, 198 continued in the follow-up period.|198
2431331|NCT01170962|5963607|P3|NOT COMPLETED|Treatment Period||12
2431332|NCT01170962|5963608|P2|NOT COMPLETED|Treatment Period||111
2431333|NCT01170962|5963609|P1|NOT COMPLETED|Treatment Period||127
2431334|NCT01170962|5963607|P3|COMPLETED|Treatment Period||5
2431335|NCT01170962|5963608|P2|COMPLETED|Treatment Period||88
2431336|NCT01170962|5963609|P1|COMPLETED|Treatment Period||76
2431337|NCT01170962|5963607|P3|PDR ­Randomized to 48 Weeks Follow­-up|Treatment Period||0
2431338|NCT01170962|5963608|P2|PDR ­Randomized to 48 Weeks Follow­-up|Treatment Period||36
2431339|NCT01170962|5963609|P1|PDR ­Randomized to 48 Weeks Follow­-up|Treatment Period||28
2431340|NCT01170962|5963607|P3|PDR ­Randomized to 24 Weeks pegIFNα­-2a|Treatment Period||0
2431341|NCT01170962|5963608|P2|PDR ­Randomized to 24 Weeks pegIFNα­-2a|Treatment Period||36
2431342|NCT01170962|5963609|P1|PDR ­Randomized to 24 Weeks pegIFNα­-2a|Treatment Period||30
2431343|NCT01170962|5963607|P3|No PDR|Treatment Period||17
2431344|NCT01170962|5963608|P2|No PDR|Treatment Period||127
2431345|NCT01170962|5963609|P1|No PDR|Treatment Period||145
2431346|NCT01170962|5963607|P3|STARTED|Treatment Period||17
2431347|NCT01170962|5963608|P2|STARTED|Treatment Period||199
2431348|NCT01170962|5963609|P1|STARTED|Treatment Period||203
2431349|NCT01170949|5963655|P2|NOT COMPLETED|Overall Study||4
2431350|NCT01170949|5963656|P1|NOT COMPLETED|Overall Study||7
2431351|NCT01170949|5963655|P2|COMPLETED|Overall Study||22
2431352|NCT01170949|5963656|P1|COMPLETED|Overall Study||43
2431353|NCT01170949|5963655|P2|STARTED|Overall Study||26
2431354|NCT01170949|5963656|P1|STARTED|Overall Study||50
2431355|NCT01170884|5963664|P2|NOT COMPLETED|Overall Study||2
2431356|NCT01170884|5963665|P1|NOT COMPLETED|Overall Study||5
2431357|NCT01170884|5963664|P2|COMPLETED|Overall Study||60
2431358|NCT01170884|5963665|P1|COMPLETED|Overall Study||54
2431359|NCT01170884|5963664|P2|STARTED|Overall Study||62
2431360|NCT01170884|5963665|P1|STARTED|Overall Study||59
2431361|NCT01170754|5963673|P2|NOT COMPLETED|Overall Study||0
2431362|NCT01170754|5963674|P1|NOT COMPLETED|Overall Study||0
2431363|NCT01170754|5963673|P2|COMPLETED|Overall Study||70
2431364|NCT01170754|5963674|P1|COMPLETED|Overall Study||66
2431365|NCT01170754|5963673|P2|STARTED|Overall Study||70
2431366|NCT01170754|5963674|P1|STARTED|Overall Study||66
2431367|NCT01170663|5963704|P2|NOT COMPLETED|Overall Study||20
2431368|NCT01170663|5963705|P1|NOT COMPLETED|Overall Study||14
2431369|NCT01170663|5963704|P2|COMPLETED|Overall Study||315
2431370|NCT01170663|5963705|P1|COMPLETED|Overall Study||316
2431371|NCT01170663|5963704|P2|Received Any Treatment (Safety Pop)|Overall Study||329
2431372|NCT01170663|5963705|P1|Received Any Treatment (Safety Pop)|Overall Study||327
2431373|NCT01170663|5963704|P2|STARTED|Overall Study|Participant was included in the placebo/paclitaxel treatment arm (intent-to-treat (ITT) population).|335
2431374|NCT01170663|5963705|P1|STARTED|Overall Study|Participant was included in ramucirumab (IMC-1121B)/paclitaxel treatment arm (safety population).|330
2431375|NCT01170598|5963733|P1|NOT COMPLETED|Overall Study||6
2431376|NCT01170598|5963733|P1|COMPLETED|Overall Study||29
2431377|NCT01170598|5963733|P1|STARTED|Overall Study||35
2431378|NCT01170546|5963752|P4|NOT COMPLETED|Overall Study||0
2431379|NCT01170546|5963753|P3|NOT COMPLETED|Overall Study||0
2431380|NCT01170546|5963754|P2|NOT COMPLETED|Overall Study||0
2431381|NCT01170546|5963755|P1|NOT COMPLETED|Overall Study||0
2431382|NCT01170546|5963752|P4|COMPLETED|Overall Study||8
2431383|NCT01170546|5963753|P3|COMPLETED|Overall Study||6
2431384|NCT01170546|5963754|P2|COMPLETED|Overall Study||7
2431385|NCT01170546|5963755|P1|COMPLETED|Overall Study||7
2431386|NCT01170546|5963752|P4|STARTED|Overall Study||8
2431387|NCT01170546|5963753|P3|STARTED|Overall Study||6
2431388|NCT01170546|5963754|P2|STARTED|Overall Study||7
2431389|NCT01170546|5963755|P1|STARTED|Overall Study||7
2431390|NCT01170533|5963765|P2|NOT COMPLETED|Pantoprazole Cross-over||0
2431391|NCT01170533|5963766|P1|NOT COMPLETED|Pantoprazole Cross-over||0
2431392|NCT01170533|5963765|P2|COMPLETED|Pantoprazole Cross-over||20
2431393|NCT01170533|5963766|P1|COMPLETED|Pantoprazole Cross-over||0
2431394|NCT01170533|5963765|P2|STARTED|Pantoprazole Cross-over|15 participants continued from omeprazole cross-over; the remaining 5 were new participants|20
2431395|NCT01170533|5963766|P1|STARTED|Pantoprazole Cross-over||0
2431396|NCT01170533|5963765|P2|NOT COMPLETED|Omeprazole Cross-over||0
2431397|NCT01170533|5963766|P1|NOT COMPLETED|Omeprazole Cross-over||0
2431398|NCT01170533|5963765|P2|COMPLETED|Omeprazole Cross-over||0
2431399|NCT01170533|5963766|P1|COMPLETED|Omeprazole Cross-over||20
2431400|NCT01170533|5963765|P2|STARTED|Omeprazole Cross-over||0
2431401|NCT01170533|5963766|P1|STARTED|Omeprazole Cross-over||20
2431402|NCT01170390|5963778|P3|NOT COMPLETED|Randomized Treatment||0
2431403|NCT01170390|5963779|P2|NOT COMPLETED|Randomized Treatment||1
2431404|NCT01170390|5963780|P1|NOT COMPLETED|Randomized Treatment||0
2431405|NCT01170390|5963778|P3|COMPLETED|Randomized Treatment||15
2431406|NCT01170390|5963779|P2|COMPLETED|Randomized Treatment||16
2431407|NCT01170390|5963780|P1|COMPLETED|Randomized Treatment||0
2431408|NCT01170390|5963778|P3|STARTED|Randomized Treatment||15
2431409|NCT01170390|5963779|P2|STARTED|Randomized Treatment||17
2431410|NCT01170390|5963780|P1|STARTED|Randomized Treatment||0
2431411|NCT01170390|5963778|P3|NOT COMPLETED|Oral Contraceptives||0
2431412|NCT01170390|5963779|P2|NOT COMPLETED|Oral Contraceptives||0
2431413|NCT01170390|5963780|P1|NOT COMPLETED|Oral Contraceptives||1
2431414|NCT01170390|5963778|P3|COMPLETED|Oral Contraceptives||0
2431415|NCT01170390|5963779|P2|COMPLETED|Oral Contraceptives||0
2431416|NCT01170390|5963780|P1|COMPLETED|Oral Contraceptives||31
2431417|NCT01170390|5963778|P3|STARTED|Oral Contraceptives||0
2431418|NCT01170390|5963779|P2|STARTED|Oral Contraceptives||0
2431419|NCT01170390|5963780|P1|STARTED|Oral Contraceptives||32
2431420|NCT01170364|5963796|P2|NOT COMPLETED|Overall Study||1
2431421|NCT01170364|5963797|P1|NOT COMPLETED|Overall Study||4
2431422|NCT01170364|5963796|P2|COMPLETED|Overall Study|One participant was unable to begin the second testing period due to scheduling conflicts.|5
2431423|NCT01170364|5963797|P1|COMPLETED|Overall Study||4
2431424|NCT01170364|5963796|P2|STARTED|Overall Study||6
2431425|NCT01170364|5963797|P1|STARTED|Overall Study||8
2431426|NCT01170273|5963805|P2|NOT COMPLETED|Overall Study||9
2431427|NCT01170273|5963806|P1|NOT COMPLETED|Overall Study||8
2431428|NCT01170273|5963805|P2|COMPLETED|Overall Study||57
2431429|NCT01170273|5963806|P1|COMPLETED|Overall Study||56
2431430|NCT01170273|5963805|P2|STARTED|Overall Study||66
2431431|NCT01170273|5963806|P1|STARTED|Overall Study||64
2431432|NCT01170247|5963814|P2|NOT COMPLETED|Overall Study||0
2431433|NCT01170247|5963815|P1|NOT COMPLETED|Overall Study||0
2431434|NCT01170247|5963814|P2|COMPLETED|Overall Study||1
2431435|NCT01170247|5963815|P1|COMPLETED|Overall Study||2
2431436|NCT01170247|5963814|P2|STARTED|Overall Study||1
2431437|NCT01170247|5963815|P1|STARTED|Overall Study||2
2431438|NCT01170221|5963823|P2|NOT COMPLETED|Overall Study||28
2431439|NCT01170221|5963824|P1|NOT COMPLETED|Overall Study||33
2431440|NCT01170221|5963823|P2|COMPLETED|Overall Study||307
2431441|NCT01170221|5963824|P1|COMPLETED|Overall Study||299
2431442|NCT01170221|5963823|P2|STARTED|Overall Study||335
2431443|NCT01170221|5963824|P1|STARTED|Overall Study||332
2431444|NCT01170208|5963847|P3|NOT COMPLETED|Overall Study||2
2431445|NCT01170208|5963848|P2|NOT COMPLETED|Overall Study||0
2431446|NCT01170208|5963849|P1|NOT COMPLETED|Overall Study||6
2431447|NCT01170208|5963847|P3|COMPLETED|Overall Study||4
2431448|NCT01170208|5963848|P2|COMPLETED|Overall Study||20
2431449|NCT01170208|5963849|P1|COMPLETED|Overall Study||14
2431450|NCT01170208|5963847|P3|STARTED|Overall Study||6
2431451|NCT01170208|5963848|P2|STARTED|Overall Study||20
2431452|NCT01170208|5963849|P1|STARTED|Overall Study||20
2431453|NCT01170117|5963868|P2|NOT COMPLETED|Overall Study||20
2431454|NCT01170117|5963869|P1|NOT COMPLETED|Overall Study||30
2431455|NCT01170117|5963868|P2|COMPLETED|Overall Study||55
2431456|NCT01170117|5963869|P1|COMPLETED|Overall Study||47
2431457|NCT01170117|5963868|P2|STARTED|Overall Study||75
2431458|NCT01170117|5963869|P1|STARTED|Overall Study||77
2431459|NCT01170091|5963877|P1|NOT COMPLETED|Overall Study||24
2431460|NCT01170091|5963877|P1|COMPLETED|Overall Study||627
2431461|NCT01170091|5963877|P1|STARTED|Overall Study||651
2431462|NCT01170065|5963887|P3|NOT COMPLETED|Overall Study||26
2431463|NCT01170065|5963888|P2|NOT COMPLETED|Overall Study||92
2431464|NCT01170065|5963889|P1|NOT COMPLETED|Overall Study||28
2431465|NCT01170065|5963887|P3|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow−up visit|9
2431466|NCT01170065|5963888|P2|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow−up visit|34
2431467|NCT01170065|5963889|P1|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow−up visit|9
2431468|NCT01170065|5963887|P3|STARTED|Overall Study||35
2431469|NCT01170065|5963888|P2|STARTED|Overall Study||126
2431470|NCT01170065|5963889|P1|STARTED|Overall Study||37
2431471|NCT01170039|5963920|P2|NOT COMPLETED|Overall Study||6
2431472|NCT01170039|5963921|P1|NOT COMPLETED|Overall Study||8
2431473|NCT01170039|5963920|P2|COMPLETED|Overall Study||33
2431474|NCT01170039|5963921|P1|COMPLETED|Overall Study||29
2431475|NCT01170039|5963920|P2|STARTED|Overall Study||39
2431476|NCT01170039|5963921|P1|STARTED|Overall Study||37
2431477|NCT01169987|5963933|P1|NOT COMPLETED|Overall Study||31
2431478|NCT01169987|5963933|P1|COMPLETED|Overall Study||160
2431479|NCT01169987|5963933|P1|STARTED|Overall Study||191
2431480|NCT01169779|5963999|P2|NOT COMPLETED|Overall Study||17
2431481|NCT01169779|5964000|P1|NOT COMPLETED|Overall Study||11
2431482|NCT01169779|5963999|P2|COMPLETED|Overall Study||179
2431483|NCT01169779|5964000|P1|COMPLETED|Overall Study||184
2431484|NCT01169779|5963999|P2|Subgroup for Standardized Meal Test|Overall Study||121
2431485|NCT01169779|5964000|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|130
2431486|NCT01169779|5963999|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||195
2431487|NCT01169779|5964000|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|193
2431488|NCT01169779|5963999|P2|Treated/Safety Population|Overall Study||196
2431489|NCT01169779|5964000|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|194
2431490|NCT01169779|5963999|P2|STARTED|Overall Study||196
2431491|NCT01169779|5964000|P1|STARTED|Overall Study|Randomized.|195
2431492|NCT01169753|5964026|P2|NOT COMPLETED|Overall Study||1
2431493|NCT01169753|5964027|P1|NOT COMPLETED|Overall Study||0
2431494|NCT01169753|5964026|P2|COMPLETED|Overall Study||0
2431495|NCT01169753|5964027|P1|COMPLETED|Overall Study||0
2431496|NCT01169753|5964026|P2|STARTED|Overall Study||1
2431497|NCT01169753|5964027|P1|STARTED|Overall Study||0
2431498|NCT01169701|5964035|P2|NOT COMPLETED|Overall Study||10
2431499|NCT01169701|5964036|P1|NOT COMPLETED|Overall Study||5
2431500|NCT01169701|5964035|P2|COMPLETED|Overall Study||25
2431501|NCT01169701|5964036|P1|COMPLETED|Overall Study||31
2431502|NCT01169701|5964035|P2|Intent to Treat (ITT) Set|Overall Study||28
2431503|NCT01169701|5964036|P1|Intent to Treat (ITT) Set|Overall Study||32
2431504|NCT01169701|5964035|P2|Safety Set|Overall Study||35
2431505|NCT01169701|5964036|P1|Safety Set|Overall Study||36
2431506|NCT01169701|5964035|P2|STARTED|Overall Study||35
2431507|NCT01169701|5964036|P1|STARTED|Overall Study||36
2431508|NCT01169675|5964073|P5|NOT COMPLETED|Overall Study||6
2431509|NCT01169675|5964074|P4|NOT COMPLETED|Overall Study||17
2431510|NCT01169675|5964075|P3|NOT COMPLETED|Overall Study||7
2431511|NCT01169675|5964076|P2|NOT COMPLETED|Overall Study||3
2431512|NCT01169675|5964077|P1|NOT COMPLETED|Overall Study||20
2431513|NCT01169675|5964073|P5|COMPLETED|Overall Study||0
2431514|NCT01169675|5964074|P4|COMPLETED|Overall Study||0
2431515|NCT01169675|5964075|P3|COMPLETED|Overall Study||0
2431516|NCT01169675|5964076|P2|COMPLETED|Overall Study||0
2431517|NCT01169675|5964077|P1|COMPLETED|Overall Study||0
2431518|NCT01169675|5964073|P5|STARTED|Overall Study||6
2431519|NCT01169675|5964074|P4|STARTED|Overall Study||17
2431520|NCT01169675|5964075|P3|STARTED|Overall Study||7
2431521|NCT01169675|5964076|P2|STARTED|Overall Study||3
2431522|NCT01169675|5964077|P1|STARTED|Overall Study||20
2431523|NCT01169649|5964114|P1|NOT COMPLETED|Overall Study||3
2431524|NCT01169649|5964114|P1|COMPLETED|Overall Study||8
2431525|NCT01169649|5964114|P1|STARTED|Overall Study||11
2431526|NCT01169610|5964118|P1|NOT COMPLETED|Overall Study||0
2431527|NCT01169610|5964118|P1|COMPLETED|Overall Study||1
2431528|NCT01169610|5964118|P1|STARTED|Overall Study||1
2431529|NCT01169558|5964126|P1|NOT COMPLETED|Overall Study||156
2431530|NCT01169558|5964126|P1|COMPLETED|Overall Study||6
2431531|NCT01169558|5964126|P1|STARTED|Overall Study||162
2431532|NCT01169519|5964133|P1|NOT COMPLETED|Overall Study||0
2431533|NCT01169519|5964133|P1|COMPLETED|Overall Study||21
2431534|NCT01169519|5964133|P1|STARTED|Overall Study|This was a pre-post study, All patients receiving a baseline assessment, also received sildenafil.|21
2431535|NCT01169493|5964151|P6|NOT COMPLETED|Period 3 (6 Months)||0
2431536|NCT01169493|5964152|P5|NOT COMPLETED|Period 3 (6 Months)||0
2431537|NCT01169493|5964153|P4|NOT COMPLETED|Period 3 (6 Months)||0
2431538|NCT01169493|5964154|P3|NOT COMPLETED|Period 3 (6 Months)||1
2431539|NCT01169493|5964155|P2|NOT COMPLETED|Period 3 (6 Months)||2
2431540|NCT01169493|5964156|P1|NOT COMPLETED|Period 3 (6 Months)||0
2431541|NCT01169493|5964151|P6|COMPLETED|Period 3 (6 Months)||2
2431542|NCT01169493|5964152|P5|COMPLETED|Period 3 (6 Months)||0
2431543|NCT01169493|5964153|P4|COMPLETED|Period 3 (6 Months)||0
2431544|NCT01169493|5964154|P3|COMPLETED|Period 3 (6 Months)||2
2431545|NCT01169493|5964155|P2|COMPLETED|Period 3 (6 Months)||1
2431546|NCT01169493|5964156|P1|COMPLETED|Period 3 (6 Months)||2
2431547|NCT01169493|5964151|P6|STARTED|Period 3 (6 Months)||2
2431548|NCT01169493|5964152|P5|STARTED|Period 3 (6 Months)||0
2431549|NCT01169493|5964153|P4|STARTED|Period 3 (6 Months)||0
2431550|NCT01169493|5964154|P3|STARTED|Period 3 (6 Months)||3
2431551|NCT01169493|5964155|P2|STARTED|Period 3 (6 Months)||3
2431552|NCT01169493|5964156|P1|STARTED|Period 3 (6 Months)||2
2431553|NCT01169493|5964151|P6|NOT COMPLETED|Period 2 (6 Months)||0
2431554|NCT01169493|5964152|P5|NOT COMPLETED|Period 2 (6 Months)||0
2431555|NCT01169493|5964153|P4|NOT COMPLETED|Period 2 (6 Months)||0
2431556|NCT01169493|5964154|P3|NOT COMPLETED|Period 2 (6 Months)||0
2431557|NCT01169493|5964155|P2|NOT COMPLETED|Period 2 (6 Months)||0
2431558|NCT01169493|5964156|P1|NOT COMPLETED|Period 2 (6 Months)||0
2431559|NCT01169493|5964151|P6|COMPLETED|Period 2 (6 Months)||2
2431560|NCT01169493|5964152|P5|COMPLETED|Period 2 (6 Months)||0
2431561|NCT01169493|5964153|P4|COMPLETED|Period 2 (6 Months)||0
2431562|NCT01169493|5964154|P3|COMPLETED|Period 2 (6 Months)||3
2431563|NCT01169493|5964155|P2|COMPLETED|Period 2 (6 Months)||3
2431564|NCT01169493|5964156|P1|COMPLETED|Period 2 (6 Months)||2
2431565|NCT01169493|5964151|P6|STARTED|Period 2 (6 Months)||2
2431566|NCT01169493|5964152|P5|STARTED|Period 2 (6 Months)||0
2431567|NCT01169493|5964153|P4|STARTED|Period 2 (6 Months)||0
2431568|NCT01169493|5964154|P3|STARTED|Period 2 (6 Months)||3
2431569|NCT01169493|5964155|P2|STARTED|Period 2 (6 Months)||3
2431570|NCT01169493|5964156|P1|STARTED|Period 2 (6 Months)||2
2431571|NCT01169493|5964151|P6|NOT COMPLETED|Period 1 (6 Months)||3
2431572|NCT01169493|5964152|P5|NOT COMPLETED|Period 1 (6 Months)||0
2431573|NCT01169493|5964153|P4|NOT COMPLETED|Period 1 (6 Months)||0
2431574|NCT01169493|5964154|P3|NOT COMPLETED|Period 1 (6 Months)||2
2431575|NCT01169493|5964155|P2|NOT COMPLETED|Period 1 (6 Months)||1
2431576|NCT01169493|5964156|P1|NOT COMPLETED|Period 1 (6 Months)||0
2431577|NCT01169493|5964151|P6|COMPLETED|Period 1 (6 Months)||2
2431578|NCT01169493|5964152|P5|COMPLETED|Period 1 (6 Months)||0
2431579|NCT01169493|5964153|P4|COMPLETED|Period 1 (6 Months)||0
2431580|NCT01169493|5964154|P3|COMPLETED|Period 1 (6 Months)||3
2431581|NCT01169493|5964155|P2|COMPLETED|Period 1 (6 Months)||3
2431582|NCT01169493|5964156|P1|COMPLETED|Period 1 (6 Months)||2
2431583|NCT01169493|5964151|P6|STARTED|Period 1 (6 Months)||5
2431584|NCT01169493|5964152|P5|STARTED|Period 1 (6 Months)||0
2431585|NCT01169493|5964153|P4|STARTED|Period 1 (6 Months)||0
2431586|NCT01169493|5964154|P3|STARTED|Period 1 (6 Months)||5
2431587|NCT01169493|5964155|P2|STARTED|Period 1 (6 Months)||4
2431588|NCT01169493|5964156|P1|STARTED|Period 1 (6 Months)||2
2431589|NCT01169467|5964187|P2|NOT COMPLETED|Overall Study||4
2431590|NCT01169467|5964188|P1|NOT COMPLETED|Overall Study||7
2431591|NCT01169467|5964187|P2|COMPLETED|Overall Study||36
2431592|NCT01169467|5964188|P1|COMPLETED|Overall Study||37
2431593|NCT01169467|5964187|P2|STARTED|Overall Study||40
2431594|NCT01169467|5964188|P1|STARTED|Overall Study||44
2431595|NCT01169350|5964202|P1|NOT COMPLETED|Overall Study||5
2431596|NCT01169350|5964202|P1|COMPLETED|Overall Study||3
2431597|NCT01169350|5964202|P1|STARTED|Overall Study||8
2431598|NCT01169311|5964209|P1|NOT COMPLETED|Overall Study||0
2431599|NCT01169311|5964209|P1|COMPLETED|Overall Study||27
2431600|NCT01169311|5964209|P1|STARTED|Overall Study||27
2431601|NCT01169259|5964225|P4|NOT COMPLETED|Overall Study||0
2431602|NCT01169259|5964226|P3|NOT COMPLETED|Overall Study||0
2431603|NCT01169259|5964227|P2|NOT COMPLETED|Overall Study||0
2431604|NCT01169259|5964228|P1|NOT COMPLETED|Overall Study||0
2431605|NCT01169259|5964225|P4|COMPLETED|Overall Study||6474
2431606|NCT01169259|5964226|P3|COMPLETED|Overall Study||6470
2431607|NCT01169259|5964227|P2|COMPLETED|Overall Study||6464
2431608|NCT01169259|5964228|P1|COMPLETED|Overall Study||6463
2431609|NCT01169259|5964225|P4|STARTED|Overall Study||6474
2431610|NCT01169259|5964226|P3|STARTED|Overall Study||6470
2431611|NCT01169259|5964227|P2|STARTED|Overall Study||6464
2431612|NCT01169259|5964228|P1|STARTED|Overall Study||6463
2431613|NCT01169103|5964332|P2|NOT COMPLETED|Overall Study||4
2431614|NCT01169103|5964333|P1|NOT COMPLETED|Overall Study||6
2431615|NCT01169103|5964332|P2|COMPLETED|Overall Study||7
2431616|NCT01169103|5964333|P1|COMPLETED|Overall Study||5
2431617|NCT01169103|5964332|P2|STARTED|Overall Study||11
2431618|NCT01169103|5964333|P1|STARTED|Overall Study||11
2431619|NCT01169064|5964349|P2|NOT COMPLETED|Overall Study||0
2431620|NCT01169064|5964350|P1|NOT COMPLETED|Overall Study||0
2431621|NCT01169064|5964349|P2|COMPLETED|Overall Study||236
2431622|NCT01169064|5964350|P1|COMPLETED|Overall Study||239
2431623|NCT01169064|5964349|P2|STARTED|Overall Study||236
2431624|NCT01169064|5964350|P1|STARTED|Overall Study||239
2431625|NCT01169038|5964360|P1|NOT COMPLETED|Overall Study||7
2431626|NCT01169038|5964360|P1|COMPLETED|Overall Study||8
2431627|NCT01169038|5964360|P1|STARTED|Overall Study||15
2431628|NCT01168999|5964368|P4|NOT COMPLETED|Overall Study||0
2431629|NCT01168999|5964369|P3|NOT COMPLETED|Overall Study||0
2431630|NCT01168999|5964370|P2|NOT COMPLETED|Overall Study||1
2431631|NCT01168999|5964371|P1|NOT COMPLETED|Overall Study||2
2431632|NCT01168999|5964368|P4|COMPLETED|Overall Study||28
2431633|NCT01168999|5964369|P3|COMPLETED|Overall Study||27
2431634|NCT01168999|5964370|P2|COMPLETED|Overall Study||26
2431635|NCT01168999|5964371|P1|COMPLETED|Overall Study||26
2431636|NCT01168999|5964368|P4|STARTED|Overall Study||28
2431637|NCT01168999|5964369|P3|STARTED|Overall Study||27
2431638|NCT01168999|5964370|P2|STARTED|Overall Study||27
2431639|NCT01168999|5964371|P1|STARTED|Overall Study||28
2431640|NCT01168986|5964416|P3|NOT COMPLETED|Overall Study||0
2431641|NCT01168986|5964417|P2|NOT COMPLETED|Overall Study||1
2431642|NCT01168986|5964418|P1|NOT COMPLETED|Overall Study||2
2431643|NCT01168986|5964416|P3|COMPLETED|Overall Study||21
2431644|NCT01168986|5964417|P2|COMPLETED|Overall Study||20
2431645|NCT01168986|5964418|P1|COMPLETED|Overall Study||18
2431646|NCT01168986|5964416|P3|STARTED|Overall Study||21
2431647|NCT01168986|5964417|P2|STARTED|Overall Study||21
2431648|NCT01168986|5964418|P1|STARTED|Overall Study||20
2431649|NCT01168973|5964437|P2|NOT COMPLETED|Overall Study||611
2431650|NCT01168973|5964438|P1|NOT COMPLETED|Overall Study||613
2431651|NCT01168973|5964437|P2|COMPLETED|Overall Study||14
2431652|NCT01168973|5964438|P1|COMPLETED|Overall Study||15
2431653|NCT01168973|5964437|P2|Received Any Quantity of Any Study Drug|Overall Study|Three participants randomized to placebo and docetaxel received 1 dose of ramucirumab in error.|621
2431654|NCT01168973|5964438|P1|Received Any Quantity of Any Study Drug|Overall Study||624
2431655|NCT01168973|5964437|P2|STARTED|Overall Study||625
2431656|NCT01168973|5964438|P1|STARTED|Overall Study||628
2431657|NCT01168934|5964459|P2|NOT COMPLETED|Second Intervention Period||0
2431658|NCT01168934|5964460|P1|NOT COMPLETED|Second Intervention Period||0
2431659|NCT01168934|5964459|P2|COMPLETED|Second Intervention Period||7
2431660|NCT01168934|5964460|P1|COMPLETED|Second Intervention Period||7
2431661|NCT01168934|5964459|P2|STARTED|Second Intervention Period||7
2431662|NCT01168934|5964460|P1|STARTED|Second Intervention Period||7
2431663|NCT01168934|5964459|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2431664|NCT01168934|5964460|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2431665|NCT01168934|5964459|P2|COMPLETED|Washout Period (at Least 14 Days)||7
2431666|NCT01168934|5964460|P1|COMPLETED|Washout Period (at Least 14 Days)||7
2431667|NCT01168934|5964459|P2|STARTED|Washout Period (at Least 14 Days)||7
2431668|NCT01168934|5964460|P1|STARTED|Washout Period (at Least 14 Days)||7
2431669|NCT01168934|5964459|P2|NOT COMPLETED|First Intervention Period||0
2431670|NCT01168934|5964460|P1|NOT COMPLETED|First Intervention Period||0
2431671|NCT01168934|5964459|P2|COMPLETED|First Intervention Period||7
2431672|NCT01168934|5964460|P1|COMPLETED|First Intervention Period||7
2431673|NCT01168934|5964459|P2|STARTED|First Intervention Period||7
2431674|NCT01168934|5964460|P1|STARTED|First Intervention Period||7
2431675|NCT01168908|5964494|P2|NOT COMPLETED|Open Label||1
2431676|NCT01168908|5964495|P1|NOT COMPLETED|Open Label||1
2431677|NCT01168908|5964494|P2|COMPLETED|Open Label||7
2431678|NCT01168908|5964495|P1|COMPLETED|Open Label||6
2431679|NCT01168908|5964494|P2|STARTED|Open Label||8
2431680|NCT01168908|5964495|P1|STARTED|Open Label||7
2431681|NCT01168908|5964494|P2|NOT COMPLETED|Double Blind, Placebo Controlled||2
2431682|NCT01168908|5964495|P1|NOT COMPLETED|Double Blind, Placebo Controlled||3
2431683|NCT01168908|5964494|P2|COMPLETED|Double Blind, Placebo Controlled||8
2431684|NCT01168908|5964495|P1|COMPLETED|Double Blind, Placebo Controlled||7
2431685|NCT01168908|5964494|P2|STARTED|Double Blind, Placebo Controlled||10
2431686|NCT01168908|5964495|P1|STARTED|Double Blind, Placebo Controlled||10
2431687|NCT01168856|5964513|P2|NOT COMPLETED|Overall Study||343
2431688|NCT01168856|5964514|P1|NOT COMPLETED|Overall Study||18
2431689|NCT01168856|5964513|P2|COMPLETED|Overall Study||215
2431690|NCT01168856|5964514|P1|COMPLETED|Overall Study||158
2431691|NCT01168856|5964513|P2|STARTED|Overall Study||558
2431692|NCT01168856|5964514|P1|STARTED|Overall Study||176
2431693|NCT01168726|5964574|P3|NOT COMPLETED|Overall Study||5
2431694|NCT01168726|5964575|P2|NOT COMPLETED|Overall Study||9
2431695|NCT01168726|5964576|P1|NOT COMPLETED|Overall Study||8
2431696|NCT01168726|5964574|P3|COMPLETED|Overall Study||128
2431697|NCT01168726|5964575|P2|COMPLETED|Overall Study||112
2431698|NCT01168726|5964576|P1|COMPLETED|Overall Study||103
2431699|NCT01168726|5964574|P3|STARTED|Overall Study||133
2431700|NCT01168726|5964575|P2|STARTED|Overall Study||121
2431701|NCT01168726|5964576|P1|STARTED|Overall Study||111
2431702|NCT01168687|5964595|P2|NOT COMPLETED|Overall Study||0
2431703|NCT01168687|5964596|P1|NOT COMPLETED|Overall Study||0
2431704|NCT01168687|5964595|P2|COMPLETED|Overall Study||23
2431705|NCT01168687|5964596|P1|COMPLETED|Overall Study||23
2431706|NCT01168687|5964595|P2|STARTED|Overall Study||23
2431707|NCT01168687|5964596|P1|STARTED|Overall Study||23
2431708|NCT01168674|5964602|P2|NOT COMPLETED|Overall Study||0
2431709|NCT01168674|5964603|P1|NOT COMPLETED|Overall Study||0
2431710|NCT01168674|5964602|P2|COMPLETED|Overall Study||24
2431711|NCT01168674|5964603|P1|COMPLETED|Overall Study||25
2431712|NCT01168674|5964602|P2|STARTED|Overall Study||24
2431713|NCT01168674|5964603|P1|STARTED|Overall Study||25
2431714|NCT01168596|5964612|P2|NOT COMPLETED|Overall Study||1
2431715|NCT01168596|5964613|P1|NOT COMPLETED|Overall Study||3
2431716|NCT01168596|5964612|P2|COMPLETED|Overall Study||13
2431717|NCT01168596|5964613|P1|COMPLETED|Overall Study||13
2431718|NCT01168596|5964612|P2|STARTED|Overall Study||14
2431719|NCT01168596|5964613|P1|STARTED|Overall Study||16
2431720|NCT01168427|5964657|P1|NOT COMPLETED|Overall Study||1
2431721|NCT01168427|5964657|P1|COMPLETED|Overall Study||65
2431722|NCT01168427|5964657|P1|STARTED|Overall Study||66
2431723|NCT01168401|5964673|P11|NOT COMPLETED|Overall Study||0
2431724|NCT01168401|5964674|P10|NOT COMPLETED|Overall Study||0
2431725|NCT01168401|5964675|P9|NOT COMPLETED|Overall Study||0
2431726|NCT01168401|5964676|P8|NOT COMPLETED|Overall Study||0
2431727|NCT01168401|5964677|P7|NOT COMPLETED|Overall Study||0
2431728|NCT01168401|5964678|P6|NOT COMPLETED|Overall Study||0
2431729|NCT01168401|5964679|P5|NOT COMPLETED|Overall Study||0
2431730|NCT01168401|5964680|P4|NOT COMPLETED|Overall Study||2
2431731|NCT01168401|5964681|P3|NOT COMPLETED|Overall Study||2
2431732|NCT01168401|5964682|P2|NOT COMPLETED|Overall Study||1
2431733|NCT01168401|5964683|P1|NOT COMPLETED|Overall Study||1
2431734|NCT01168401|5964673|P11|COMPLETED|Overall Study||8
2431735|NCT01168401|5964674|P10|COMPLETED|Overall Study||8
2431736|NCT01168401|5964675|P9|COMPLETED|Overall Study||9
2431737|NCT01168401|5964676|P8|COMPLETED|Overall Study||10
2431738|NCT01168401|5964677|P7|COMPLETED|Overall Study||10
2431739|NCT01168401|5964678|P6|COMPLETED|Overall Study||9
2431740|NCT01168401|5964679|P5|COMPLETED|Overall Study||9
2431741|NCT01168401|5964680|P4|COMPLETED|Overall Study||7
2431742|NCT01168401|5964681|P3|COMPLETED|Overall Study||8
2431743|NCT01168401|5964682|P2|COMPLETED|Overall Study||9
2431744|NCT01168401|5964683|P1|COMPLETED|Overall Study||9
2431745|NCT01168401|5964673|P11|STARTED|Overall Study||8
2431746|NCT01168401|5964674|P10|STARTED|Overall Study||8
2431747|NCT01168401|5964675|P9|STARTED|Overall Study||9
2431748|NCT01168401|5964676|P8|STARTED|Overall Study||10
2431749|NCT01168401|5964677|P7|STARTED|Overall Study||10
2431750|NCT01168401|5964678|P6|STARTED|Overall Study||9
2431751|NCT01168401|5964679|P5|STARTED|Overall Study||9
2431752|NCT01168401|5964680|P4|STARTED|Overall Study||9
2431753|NCT01168401|5964681|P3|STARTED|Overall Study||10
2431754|NCT01168401|5964682|P2|STARTED|Overall Study||10
2431755|NCT01168401|5964683|P1|STARTED|Overall Study||10
2431756|NCT01168349|5964916|P1|NOT COMPLETED|Overall Study||301
2431757|NCT01168349|5964916|P1|COMPLETED|Overall Study||754
2431758|NCT01168349|5964916|P1|STARTED|Overall Study||1055
2431759|NCT01168232|5965022|P1|NOT COMPLETED|Overall Study||8
2431760|NCT01168232|5965022|P1|COMPLETED|Overall Study|Eligible and treated patients|34
2431761|NCT01168232|5965022|P1|STARTED|Overall Study||42
2431762|NCT01168219|5965029|P1|NOT COMPLETED|Overall Study||5
2431763|NCT01168219|5965029|P1|COMPLETED|Overall Study||63
2431764|NCT01168219|5965029|P1|STARTED|Overall Study||68
2431765|NCT01168024|5965037|P2|NOT COMPLETED|Overall Study||0
2431766|NCT01168024|5965038|P1|NOT COMPLETED|Overall Study||0
2431767|NCT01168024|5965037|P2|COMPLETED|Overall Study||3
2431768|NCT01168024|5965038|P1|COMPLETED|Overall Study||13
2431769|NCT01168024|5965037|P2|STARTED|Overall Study||3
2431770|NCT01168024|5965038|P1|STARTED|Overall Study|13 tx/3 controls. Roll-ins occurred for product training, several more treatment cases than control.|13
2431771|NCT01167907|5965052|P2|NOT COMPLETED|Overall Study||1
2431772|NCT01167907|5965053|P1|NOT COMPLETED|Overall Study||2
2431773|NCT01167907|5965052|P2|COMPLETED|Overall Study||14
2431774|NCT01167907|5965053|P1|COMPLETED|Overall Study||15
2431775|NCT01167907|5965052|P2|STARTED|Overall Study||15
2431776|NCT01167907|5965053|P1|STARTED|Overall Study||17
2431777|NCT01167881|5965071|P2|NOT COMPLETED|Overall Study||191
2431778|NCT01167881|5965072|P1|NOT COMPLETED|Overall Study||159
2431779|NCT01167881|5965071|P2|COMPLETED|Overall Study||589
2431780|NCT01167881|5965072|P1|COMPLETED|Overall Study||610
2431781|NCT01167881|5965071|P2|Completed After 4 Years Treatment|Overall Study||462
2431782|NCT01167881|5965072|P1|Completed After 4 Years Treatment|Overall Study||515
2431783|NCT01167881|5965071|P2|Completed After 2 Years Treatment|Overall Study||127
2431784|NCT01167881|5965072|P1|Completed After 2 Years Treatment|Overall Study||95
2431785|NCT01167881|5965071|P2|STARTED|Overall Study||780
2431786|NCT01167881|5965072|P1|STARTED|Overall Study||769
2431787|NCT01167829|5965096|P1|NOT COMPLETED|Overall Study||0
2431788|NCT01167829|5965096|P1|COMPLETED|Overall Study||12
2431789|NCT01167829|5965096|P1|STARTED|Overall Study||12
2431790|NCT01167712|5965111|P2|NOT COMPLETED|Overall Study||0
2431791|NCT01167712|5965112|P1|NOT COMPLETED|Overall Study||0
2431792|NCT01167712|5965111|P2|COMPLETED|Overall Study||346
2431793|NCT01167712|5965112|P1|COMPLETED|Overall Study||346
2431794|NCT01167712|5965111|P2|STARTED|Overall Study||346
2431795|NCT01167712|5965112|P1|STARTED|Overall Study||346
2431796|NCT01167634|5965126|P4|NOT COMPLETED|Overall Study||4
2431797|NCT01167634|5965127|P3|NOT COMPLETED|Overall Study||3
2431798|NCT01167634|5965128|P2|NOT COMPLETED|Overall Study||4
2431799|NCT01167634|5965129|P1|NOT COMPLETED|Overall Study||2
2431800|NCT01167634|5965126|P4|COMPLETED|Overall Study||29
2431801|NCT01167634|5965127|P3|COMPLETED|Overall Study||30
2431802|NCT01167634|5965128|P2|COMPLETED|Overall Study||29
2431803|NCT01167634|5965129|P1|COMPLETED|Overall Study||31
2431804|NCT01167634|5965126|P4|STARTED|Overall Study||33
2431805|NCT01167634|5965127|P3|STARTED|Overall Study||33
2431806|NCT01167634|5965128|P2|STARTED|Overall Study||33
2431807|NCT01167634|5965129|P1|STARTED|Overall Study||33
2431808|NCT01167608|5965139|P1|NOT COMPLETED|Overall Study||114
2431809|NCT01167608|5965139|P1|COMPLETED|Overall Study||769
2431810|NCT01167608|5965139|P1|STARTED|Overall Study||883
2431811|NCT01167582|5965150|P2|NOT COMPLETED|Overall Study||1
2431812|NCT01167582|5965151|P1|NOT COMPLETED|Overall Study||0
2431813|NCT01167582|5965150|P2|COMPLETED|Overall Study||54
2431814|NCT01167582|5965151|P1|COMPLETED|Overall Study||55
2431815|NCT01167582|5965150|P2|STARTED|Overall Study||55
2431816|NCT01167582|5965151|P1|STARTED|Overall Study||55
2431817|NCT01167504|5965181|P1|NOT COMPLETED|Overall Study||3
2431818|NCT01167504|5965181|P1|COMPLETED|Overall Study||12
2431819|NCT01167504|5965181|P1|STARTED|Overall Study||15
2431820|NCT01167452|5965186|P1|NOT COMPLETED|Overall Study||0
2431821|NCT01167452|5965186|P1|COMPLETED|Overall Study||36
2431822|NCT01167452|5965186|P1|STARTED|Overall Study||36
2431823|NCT01167426|5965191|P1|NOT COMPLETED|Overall Study||10
2431824|NCT01167426|5965191|P1|COMPLETED|Overall Study||138
2431825|NCT01167426|5965191|P1|STARTED|Overall Study||148
2431826|NCT01167257|5965199|P2|NOT COMPLETED|Overall Study||3
2431827|NCT01167257|5965200|P1|NOT COMPLETED|Overall Study||3
2431828|NCT01167257|5965199|P2|COMPLETED|Overall Study||28
2431829|NCT01167257|5965200|P1|COMPLETED|Overall Study||28
2431830|NCT01167257|5965199|P2|STARTED|Overall Study||31
2431831|NCT01167257|5965200|P1|STARTED|Overall Study||31
2431832|NCT01167192|5965222|P1|NOT COMPLETED|Overall Study||4
2431833|NCT01167192|5965222|P1|COMPLETED|Overall Study||6
2431834|NCT01167192|5965222|P1|STARTED|Overall Study||10
2431835|NCT01167179|5965239|P2|NOT COMPLETED|Overall Study||21
2431836|NCT01167179|5965240|P1|NOT COMPLETED|Overall Study||15
2431837|NCT01167179|5965239|P2|COMPLETED|Overall Study||59
2431838|NCT01167179|5965240|P1|COMPLETED|Overall Study||65
2431839|NCT01167179|5965239|P2|STARTED|Overall Study||80
2431840|NCT01167179|5965240|P1|STARTED|Overall Study||80
2431841|NCT01167153|5965250|P2|NOT COMPLETED|Overall Study||33
2431842|NCT01167153|5965251|P1|NOT COMPLETED|Overall Study||18
2431843|NCT01167153|5965250|P2|COMPLETED|Overall Study||249
2431844|NCT01167153|5965251|P1|COMPLETED|Overall Study||264
2431845|NCT01167153|5965250|P2|Intention to Treat (ITT)|Overall Study||268
2431846|NCT01167153|5965251|P1|Intention to Treat (ITT)|Overall Study||272
2431847|NCT01167153|5965250|P2|STARTED|Overall Study||282
2431848|NCT01167153|5965251|P1|STARTED|Overall Study||282
2431849|NCT01167140|5965269|P1|NOT COMPLETED|Overall Study||1
2431850|NCT01167140|5965269|P1|COMPLETED|Overall Study||41
2431851|NCT01167140|5965269|P1|STARTED|Overall Study||42
2431852|NCT01167023|5965277|P3|NOT COMPLETED|Overall Study||2
2431853|NCT01167023|5965278|P2|NOT COMPLETED|Overall Study||3
2431854|NCT01167023|5965279|P1|NOT COMPLETED|Overall Study||0
2431855|NCT01167023|5965277|P3|COMPLETED|Overall Study||39
2431856|NCT01167023|5965278|P2|COMPLETED|Overall Study||18
2431857|NCT01167023|5965279|P1|COMPLETED|Overall Study||0
2431858|NCT01167023|5965277|P3|Received at Least 1 Dose of Study Drug|Overall Study||41
2431859|NCT01167023|5965278|P2|Received at Least 1 Dose of Study Drug|Overall Study||19
2431860|NCT01167023|5965279|P1|Received at Least 1 Dose of Study Drug|Overall Study||0
2431861|NCT01167023|5965277|P3|STARTED|Overall Study||41
2431862|NCT01167023|5965278|P2|STARTED|Overall Study||21
2431863|NCT01167023|5965279|P1|STARTED|Overall Study||0
2431864|NCT01166997|5965299|P2|NOT COMPLETED|Overall Study||0
2431865|NCT01166997|5965300|P1|NOT COMPLETED|Overall Study||2
2431866|NCT01166997|5965299|P2|COMPLETED|Overall Study||30
2431867|NCT01166997|5965300|P1|COMPLETED|Overall Study||27
2431868|NCT01166997|5965299|P2|STARTED|Overall Study||30
2431869|NCT01166997|5965300|P1|STARTED|Overall Study||29
2431870|NCT01166971|5965310|P2|NOT COMPLETED|Overall Study||1
2431871|NCT01166971|5965311|P1|NOT COMPLETED|Overall Study||1
2431872|NCT01166971|5965310|P2|COMPLETED|Overall Study||30
2431873|NCT01166971|5965311|P1|COMPLETED|Overall Study||32
2431874|NCT01166971|5965310|P2|STARTED|Overall Study||31
2431875|NCT01166971|5965311|P1|STARTED|Overall Study||33
2431876|NCT01166958|5965319|P2|NOT COMPLETED|Overall Study||0
2431877|NCT01166958|5965320|P1|NOT COMPLETED|Overall Study||1
2431878|NCT01166958|5965319|P2|COMPLETED|Overall Study||13
2431879|NCT01166958|5965320|P1|COMPLETED|Overall Study||12
2431880|NCT01166958|5965319|P2|STARTED|Overall Study||13
2431881|NCT01166958|5965320|P1|STARTED|Overall Study||13
2431882|NCT01166945|5965336|P2|NOT COMPLETED|Day 30||3
2431883|NCT01166945|5965337|P1|NOT COMPLETED|Day 30||4
2431884|NCT01166945|5965336|P2|COMPLETED|Day 30||37
2431885|NCT01166945|5965337|P1|COMPLETED|Day 30||38
2431886|NCT01166945|5965336|P2|STARTED|Day 30||40
2431887|NCT01166945|5965337|P1|STARTED|Day 30||42
2431888|NCT01166945|5965336|P2|NOT COMPLETED|Day 20||0
2431889|NCT01166945|5965337|P1|NOT COMPLETED|Day 20||0
2431890|NCT01166945|5965336|P2|COMPLETED|Day 20||40
2431891|NCT01166945|5965337|P1|COMPLETED|Day 20||42
2431892|NCT01166945|5965336|P2|STARTED|Day 20||40
2431893|NCT01166945|5965337|P1|STARTED|Day 20||42
2431894|NCT01166945|5965336|P2|NOT COMPLETED|Day 15||1
2431895|NCT01166945|5965337|P1|NOT COMPLETED|Day 15||2
2431896|NCT01166945|5965336|P2|COMPLETED|Day 15||40
2431897|NCT01166945|5965337|P1|COMPLETED|Day 15||42
2431898|NCT01166945|5965336|P2|STARTED|Day 15||41
2431899|NCT01166945|5965337|P1|STARTED|Day 15||44
2431900|NCT01166945|5965336|P2|NOT COMPLETED|Day 10||2
2431901|NCT01166945|5965337|P1|NOT COMPLETED|Day 10||3
2431902|NCT01166945|5965336|P2|COMPLETED|Day 10||41
2431903|NCT01166945|5965337|P1|COMPLETED|Day 10||44
2431904|NCT01166945|5965336|P2|STARTED|Day 10||43
2431905|NCT01166945|5965337|P1|STARTED|Day 10||47
2431906|NCT01166945|5965336|P2|NOT COMPLETED|Day 5||0
2431907|NCT01166945|5965337|P1|NOT COMPLETED|Day 5||0
2431908|NCT01166945|5965336|P2|COMPLETED|Day 5||43
2431909|NCT01166945|5965337|P1|COMPLETED|Day 5||47
2431910|NCT01166945|5965336|P2|STARTED|Day 5||43
2431911|NCT01166945|5965337|P1|STARTED|Day 5||47
2431912|NCT01166945|5965336|P2|NOT COMPLETED|Randomized||4
2431913|NCT01166945|5965337|P1|NOT COMPLETED|Randomized||4
2431914|NCT01166945|5965336|P2|COMPLETED|Randomized||43
2431915|NCT01166945|5965337|P1|COMPLETED|Randomized||47
2431916|NCT01166945|5965336|P2|STARTED|Randomized||47
2431917|NCT01166945|5965337|P1|STARTED|Randomized||51
2431918|NCT01166763|5965345|P1|NOT COMPLETED|Overall Study||3
2431919|NCT01166763|5965345|P1|COMPLETED|Overall Study||27
2431920|NCT01166763|5965345|P1|STARTED|Overall Study||30
2431921|NCT01166750|5965353|P2|NOT COMPLETED|Overall Study||0
2431922|NCT01166750|5965354|P1|NOT COMPLETED|Overall Study||1
2431923|NCT01166750|5965353|P2|COMPLETED|Overall Study||13
2431924|NCT01166750|5965354|P1|COMPLETED|Overall Study||9
2431925|NCT01166750|5965353|P2|STARTED|Overall Study||13
2431926|NCT01166750|5965354|P1|STARTED|Overall Study||10
2431927|NCT01166724|5965362|P2|NOT COMPLETED|Overall Study||5
2431928|NCT01166724|5965363|P1|NOT COMPLETED|Overall Study||7
2431929|NCT01166724|5965362|P2|COMPLETED|Overall Study||0
2431930|NCT01166724|5965363|P1|COMPLETED|Overall Study||0
2431931|NCT01166724|5965362|P2|STARTED|Overall Study||5
2431932|NCT01166724|5965363|P1|STARTED|Overall Study||7
2431933|NCT01166659|5965371|P1|NOT COMPLETED|Overall Study||13
2431934|NCT01166659|5965371|P1|COMPLETED|Overall Study||35
2431935|NCT01166659|5965371|P1|STARTED|Overall Study||48
2431936|NCT01166646|5965380|P2|NOT COMPLETED|Overall Study||1
2431937|NCT01166646|5965381|P1|NOT COMPLETED|Overall Study||1
2431938|NCT01166646|5965380|P2|COMPLETED|Overall Study||21
2431939|NCT01166646|5965381|P1|COMPLETED|Overall Study||20
2431940|NCT01166646|5965380|P2|STARTED|Overall Study||22
2431941|NCT01166646|5965381|P1|STARTED|Overall Study||21
2431942|NCT01166568|5965400|P3|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
2431943|NCT01166568|5965401|P2|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
2431944|NCT01166568|5965402|P1|NOT COMPLETED|Implantation- Nonrandomized & Randomized||14
2431945|NCT01166568|5965400|P3|COMPLETED|Implantation- Nonrandomized & Randomized|(1) Primary eye implanted only subject withdrew consent after implantation of the device.|8
2431946|NCT01166568|5965401|P2|COMPLETED|Implantation- Nonrandomized & Randomized||32
2431947|NCT01166568|5965402|P1|COMPLETED|Implantation- Nonrandomized & Randomized||274
2431948|NCT01166568|5965400|P3|STARTED|Implantation- Nonrandomized & Randomized|15 subjects completed the observation phase and 9 subjects (17 eyes) proceeded with implantation.|9
2431949|NCT01166568|5965401|P2|STARTED|Implantation- Nonrandomized & Randomized||33
2431950|NCT01166568|5965402|P1|STARTED|Implantation- Nonrandomized & Randomized||288
2431951|NCT01166568|5965400|P3|NOT COMPLETED|Deferred Implantation- Randomized||1
2431952|NCT01166568|5965401|P2|NOT COMPLETED|Deferred Implantation- Randomized||0
2431953|NCT01166568|5965402|P1|NOT COMPLETED|Deferred Implantation- Randomized||0
2431954|NCT01166568|5965400|P3|COMPLETED|Deferred Implantation- Randomized|From the randomized sub-study control group (n=16), 1 subject withdrew during the observation phase|15
2431955|NCT01166568|5965401|P2|COMPLETED|Deferred Implantation- Randomized||0
2431956|NCT01166568|5965402|P1|COMPLETED|Deferred Implantation- Randomized||0
2431957|NCT01166568|5965400|P3|STARTED|Deferred Implantation- Randomized||16
2431958|NCT01166568|5965401|P2|STARTED|Deferred Implantation- Randomized||0
2431959|NCT01166568|5965402|P1|STARTED|Deferred Implantation- Randomized||0
2431960|NCT01166438|5965415|P2|NOT COMPLETED|Off Treatment Follow-up Phase||56
2431961|NCT01166438|5965416|P1|NOT COMPLETED|Off Treatment Follow-up Phase||34
2431962|NCT01166438|5965415|P2|COMPLETED|Off Treatment Follow-up Phase||33
2431963|NCT01166438|5965416|P1|COMPLETED|Off Treatment Follow-up Phase||51
2431964|NCT01166438|5965415|P2|STARTED|Off Treatment Follow-up Phase||89
2431965|NCT01166438|5965416|P1|STARTED|Off Treatment Follow-up Phase||85
2431966|NCT01166438|5965415|P2|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9
2431967|NCT01166438|5965416|P1|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9
2431968|NCT01166438|5965415|P2|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|118
2431969|NCT01166438|5965416|P1|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|113
2431970|NCT01166438|5965415|P2|Treated|Double-blind Phase: 1st 6 Months||126
2431971|NCT01166438|5965416|P1|Treated|Double-blind Phase: 1st 6 Months||121
2431972|NCT01166438|5965415|P2|STARTED|Double-blind Phase: 1st 6 Months||127
2431973|NCT01166438|5965416|P1|STARTED|Double-blind Phase: 1st 6 Months||122
2431974|NCT01166347|5965432|P2|NOT COMPLETED|Overall Study||1
2431975|NCT01166347|5965433|P1|NOT COMPLETED|Overall Study||2
2431976|NCT01166347|5965432|P2|COMPLETED|Overall Study||148
2431977|NCT01166347|5965433|P1|COMPLETED|Overall Study||295
2431978|NCT01166347|5965432|P2|STARTED|Overall Study||149
2431979|NCT01166347|5965433|P1|STARTED|Overall Study||297
2431980|NCT01166282|5965465|P3|NOT COMPLETED|Open-label Period||17
2431981|NCT01166282|5965466|P2|NOT COMPLETED|Open-label Period||0
2431982|NCT01166282|5965467|P1|NOT COMPLETED|Open-label Period||0
2431983|NCT01166282|5965465|P3|COMPLETED|Open-label Period||29
2431984|NCT01166282|5965466|P2|COMPLETED|Open-label Period||0
2431985|NCT01166282|5965467|P1|COMPLETED|Open-label Period||0
2431986|NCT01166282|5965465|P3|STARTED|Open-label Period||46
2431987|NCT01166282|5965466|P2|STARTED|Open-label Period||0
2431988|NCT01166282|5965467|P1|STARTED|Open-label Period||0
2431989|NCT01166282|5965465|P3|NOT COMPLETED|Double-blind Period||0
2431990|NCT01166282|5965466|P2|NOT COMPLETED|Double-blind Period||0
2431991|NCT01166282|5965467|P1|NOT COMPLETED|Double-blind Period||0
2431992|NCT01166282|5965465|P3|COMPLETED|Double-blind Period||0
2431993|NCT01166282|5965466|P2|COMPLETED|Double-blind Period||31
2431994|NCT01166282|5965467|P1|COMPLETED|Double-blind Period||15
2431995|NCT01166282|5965465|P3|STARTED|Double-blind Period||0
2431996|NCT01166282|5965466|P2|STARTED|Double-blind Period||31
2431997|NCT01166282|5965467|P1|STARTED|Double-blind Period||15
2431998|NCT01166230|5965491|P2|NOT COMPLETED|Overall Study||16
2431999|NCT01166230|5965492|P1|NOT COMPLETED|Overall Study||19
2432000|NCT01166230|5965491|P2|COMPLETED|Overall Study||255
2432001|NCT01166230|5965492|P1|COMPLETED|Overall Study||261
2432002|NCT01166230|5965491|P2|STARTED|Overall Study||271
2432003|NCT01166230|5965492|P1|STARTED|Overall Study||280
2432004|NCT01166178|5965506|P2|NOT COMPLETED|Overall Study||8
2432005|NCT01166178|5965507|P1|NOT COMPLETED|Overall Study||21
2432006|NCT01166178|5965506|P2|COMPLETED|Overall Study||0
2432007|NCT01166178|5965507|P1|COMPLETED|Overall Study||0
2432008|NCT01166178|5965506|P2|STARTED|Overall Study||8
2432009|NCT01166178|5965507|P1|STARTED|Overall Study||21
2432010|NCT01166139|5965533|P1|NOT COMPLETED|Overall Study||3
2432011|NCT01166139|5965533|P1|COMPLETED|Overall Study||7
2432012|NCT01166139|5965533|P1|STARTED|Overall Study||10
2432013|NCT01166126|5965539|P1|NOT COMPLETED|Overall Study||0
2432014|NCT01166126|5965539|P1|COMPLETED|Overall Study||4
2432015|NCT01166126|5965539|P1|STARTED|Overall Study||4
2432016|NCT01165996|5965546|P1|NOT COMPLETED|Overall Study||2
2432017|NCT01165996|5965546|P1|COMPLETED|Overall Study||23
2432018|NCT01165996|5965546|P1|Maintenance Phase|Overall Study||23
2432019|NCT01165996|5965546|P1|Induction Phase|Overall Study||25
2432020|NCT01165996|5965546|P1|STARTED|Overall Study||25
2432021|NCT01165983|5965558|P2|NOT COMPLETED|Overall Study||7
2432022|NCT01165983|5965559|P1|NOT COMPLETED|Overall Study||5
2432023|NCT01165983|5965558|P2|COMPLETED|Overall Study||42
2432024|NCT01165983|5965559|P1|COMPLETED|Overall Study||46
2432025|NCT01165983|5965558|P2|STARTED|Overall Study||49
2432026|NCT01165983|5965559|P1|STARTED|Overall Study||51
2432027|NCT01165840|5965603|P1|NOT COMPLETED|Overall Study||0
2432028|NCT01165840|5965603|P1|COMPLETED|Overall Study||36
2432029|NCT01165840|5965603|P1|STARTED|Overall Study||36
2432030|NCT01165775|5965607|P1|NOT COMPLETED|Overall Study||2
2432031|NCT01165775|5965607|P1|COMPLETED|Overall Study||15
2432032|NCT01165775|5965607|P1|STARTED|Overall Study||17
2432033|NCT01165684|5965617|P2|NOT COMPLETED|Overall Study||52
2432034|NCT01165684|5965618|P1|NOT COMPLETED|Overall Study||28
2432035|NCT01165684|5965617|P2|COMPLETED|Overall Study||148
2432036|NCT01165684|5965618|P1|COMPLETED|Overall Study||173
2432037|NCT01165684|5965617|P2|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|199
2432038|NCT01165684|5965618|P1|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|198
2432039|NCT01165684|5965617|P2|STARTED|Overall Study||200
2432040|NCT01165684|5965618|P1|STARTED|Overall Study||201
2432041|NCT01165554|5965652|P1|NOT COMPLETED|Overall Study||23
2432042|NCT01165554|5965652|P1|COMPLETED|Overall Study||180
2432043|NCT01165554|5965652|P1|STARTED|Overall Study|This was the number of subjects that started the study.|203
2432044|NCT01165541|5965659|P1|NOT COMPLETED|Quetiapine XR and Mirtazepine||5
2432045|NCT01165541|5965659|P1|COMPLETED|Quetiapine XR and Mirtazepine||11
2432046|NCT01165541|5965659|P1|STARTED|Quetiapine XR and Mirtazepine||16
2432047|NCT01165541|5965659|P1|NOT COMPLETED|Quetiapine XR Monotherapy||4
2432048|NCT01165541|5965659|P1|COMPLETED|Quetiapine XR Monotherapy||16
2432049|NCT01165541|5965659|P1|STARTED|Quetiapine XR Monotherapy||20
2432050|NCT01165450|5965665|P1|NOT COMPLETED|Overall Study||0
2432051|NCT01165450|5965665|P1|COMPLETED|Overall Study||2
2432052|NCT01165450|5965665|P1|STARTED|Overall Study||2
2432053|NCT01165424|5965675|P1|NOT COMPLETED|Overall Study||4
2432054|NCT01165424|5965675|P1|COMPLETED|Overall Study||76
2432055|NCT01165424|5965675|P1|STARTED|Overall Study||80
2432056|NCT01165320|5965682|P3|NOT COMPLETED|Overall Study||0
2432057|NCT01165320|5965683|P2|NOT COMPLETED|Overall Study||4
2432058|NCT01165320|5965684|P1|NOT COMPLETED|Overall Study||3
2432059|NCT01165320|5965682|P3|COMPLETED|Overall Study||0
2432060|NCT01165320|5965683|P2|COMPLETED|Overall Study||4
2432061|NCT01165320|5965684|P1|COMPLETED|Overall Study||9
2432062|NCT01165320|5965682|P3|STARTED|Overall Study|No participants with esophageal candidiasis were identified for inclusion in the study|0
2432063|NCT01165320|5965683|P2|STARTED|Overall Study||8
2432064|NCT01165320|5965684|P1|STARTED|Overall Study||12
2432065|NCT01165307|5965694|P2|NOT COMPLETED|Overall Study||3
2432066|NCT01165307|5965695|P1|NOT COMPLETED|Overall Study||14
2432067|NCT01165307|5965694|P2|COMPLETED|Overall Study||31
2432068|NCT01165307|5965695|P1|COMPLETED|Overall Study||19
2432069|NCT01165307|5965694|P2|STARTED|Overall Study||34
2432070|NCT01165307|5965695|P1|STARTED|Overall Study||33
2432071|NCT01165281|5965725|P2|NOT COMPLETED|Overall Study||51
2432072|NCT01165281|5965726|P1|NOT COMPLETED|Overall Study||58
2432073|NCT01165281|5965725|P2|COMPLETED|Overall Study||121
2432074|NCT01165281|5965726|P1|COMPLETED|Overall Study||110
2432075|NCT01165281|5965725|P2|STARTED|Overall Study||172
2432076|NCT01165281|5965726|P1|STARTED|Overall Study||168
2432077|NCT01165242|5965747|P3|NOT COMPLETED|Overall Study||14
2432078|NCT01165242|5965748|P2|NOT COMPLETED|Overall Study||10
2432079|NCT01165242|5965749|P1|NOT COMPLETED|Overall Study||10
2432080|NCT01165242|5965747|P3|COMPLETED|Overall Study||324
2432081|NCT01165242|5965748|P2|COMPLETED|Overall Study||326
2432082|NCT01165242|5965749|P1|COMPLETED|Overall Study||327
2432083|NCT01165242|5965747|P3|STARTED|Overall Study||338
2432084|NCT01165242|5965748|P2|STARTED|Overall Study||336
2432085|NCT01165242|5965749|P1|STARTED|Overall Study||337
2432086|NCT01165229|5965783|P2|NOT COMPLETED|Overall Study||1189
2432087|NCT01165229|5965784|P1|NOT COMPLETED|Overall Study||1180
2432088|NCT01165229|5965783|P2|COMPLETED|Overall Study||5761
2432089|NCT01165229|5965784|P1|COMPLETED|Overall Study||5770
2432090|NCT01165229|5965783|P2|STARTED|Overall Study||6950
2432091|NCT01165229|5965784|P1|STARTED|Overall Study||6950
2432092|NCT01165216|5965912|P2|NOT COMPLETED|Overall Study||7
2432093|NCT01165216|5965913|P1|NOT COMPLETED|Overall Study||8
2432094|NCT01165216|5965912|P2|COMPLETED|Overall Study|Completed=still on study drug|0
2432095|NCT01165216|5965913|P1|COMPLETED|Overall Study|Completed=still on study drug|0
2432096|NCT01165216|5965912|P2|Received at Least 1 Dose of Ipilimumab|Overall Study||6
2432097|NCT01165216|5965913|P1|Received at Least 1 Dose of Ipilimumab|Overall Study||6
2432098|NCT01165216|5965912|P2|STARTED|Overall Study|Participants who received any study drug|7
2432099|NCT01165216|5965913|P1|STARTED|Overall Study|Participants who received any study drug|8
2432100|NCT01165203|5965935|P2|NOT COMPLETED|Extended Safety Follow-up Phase||4
2432101|NCT01165203|5965936|P1|NOT COMPLETED|Extended Safety Follow-up Phase||7
2432102|NCT01165203|5965935|P2|COMPLETED|Extended Safety Follow-up Phase||45
2432103|NCT01165203|5965936|P1|COMPLETED|Extended Safety Follow-up Phase||67
2432104|NCT01165203|5965935|P2|STARTED|Extended Safety Follow-up Phase||49
2432105|NCT01165203|5965936|P1|STARTED|Extended Safety Follow-up Phase||74
2432106|NCT01165203|5965935|P2|NOT COMPLETED|Active Phase||2
2432107|NCT01165203|5965936|P1|NOT COMPLETED|Active Phase||5
2432108|NCT01165203|5965935|P2|COMPLETED|Active Phase||47
2432109|NCT01165203|5965936|P1|COMPLETED|Active Phase||69
2432110|NCT01165203|5965935|P2|STARTED|Active Phase||49
2432111|NCT01165203|5965936|P1|STARTED|Active Phase||74
2432112|NCT01165177|5966026|P2|NOT COMPLETED|Overall Study||902
2432113|NCT01165177|5966027|P1|NOT COMPLETED|Overall Study||922
2432114|NCT01165177|5966026|P2|COMPLETED|Overall Study||6808
2432115|NCT01165177|5966027|P1|COMPLETED|Overall Study||6773
2432116|NCT01165177|5966026|P2|STARTED|Overall Study||7710
2432117|NCT01165177|5966027|P1|STARTED|Overall Study||7695
2432118|NCT01165138|5966152|P4|NOT COMPLETED|Overall Study||22
2432119|NCT01165138|5966153|P3|NOT COMPLETED|Overall Study||20
2432120|NCT01165138|5966154|P2|NOT COMPLETED|Overall Study||52
2432121|NCT01165138|5966155|P1|NOT COMPLETED|Overall Study||0
2432122|NCT01165138|5966152|P4|COMPLETED|Overall Study||179
2432123|NCT01165138|5966153|P3|COMPLETED|Overall Study||185
2432124|NCT01165138|5966154|P2|COMPLETED|Overall Study||151
2432125|NCT01165138|5966155|P1|COMPLETED|Overall Study||0
2432126|NCT01165138|5966152|P4|STARTED|Overall Study||201
2432127|NCT01165138|5966153|P3|STARTED|Overall Study||205
2432128|NCT01165138|5966154|P2|STARTED|Overall Study||203
2432129|NCT01165138|5966155|P1|STARTED|Overall Study||0
2432130|NCT01165112|5966214|P1|NOT COMPLETED|Overall Study||0
2432131|NCT01165112|5966214|P1|COMPLETED|Overall Study||48
2432132|NCT01165112|5966214|P1|STARTED|Overall Study||48
2432133|NCT01165047|5966221|P1|NOT COMPLETED|Overall Study||0
2432134|NCT01165047|5966221|P1|COMPLETED|Overall Study||10
2432135|NCT01165047|5966221|P1|STARTED|Overall Study||10
2432136|NCT01165021|5966225|P1|NOT COMPLETED|Overall Study||1
2432137|NCT01165021|5966225|P1|COMPLETED|Overall Study||18
2432138|NCT01165021|5966225|P1|3 Cycles of Chemo, Then Surgery|Overall Study||15
2432139|NCT01165021|5966225|P1|≥1 Dose Chemo, Baseline, Cy 3 Assessment|Overall Study||17
2432140|NCT01165021|5966225|P1|≥1 Dose Chemo|Overall Study||19
2432141|NCT01165021|5966225|P1|STARTED|Overall Study||19
2432142|NCT01164956|5966233|P3|NOT COMPLETED|Overall Study||1
2432143|NCT01164956|5966234|P2|NOT COMPLETED|Overall Study||0
2432144|NCT01164956|5966235|P1|NOT COMPLETED|Overall Study||1
2432145|NCT01164956|5966233|P3|COMPLETED|Overall Study||0
2432146|NCT01164956|5966234|P2|COMPLETED|Overall Study||1
2432147|NCT01164956|5966235|P1|COMPLETED|Overall Study||0
2432148|NCT01164956|5966233|P3|Evaluable for pedsFACIT-F Score Change|Overall Study||0
2432149|NCT01164956|5966234|P2|Evaluable for pedsFACIT-F Score Change|Overall Study||1
2432150|NCT01164956|5966235|P1|Evaluable for pedsFACIT-F Score Change|Overall Study||0
2432151|NCT01164956|5966233|P3|STARTED|Overall Study||1
2432152|NCT01164956|5966234|P2|STARTED|Overall Study||1
2432153|NCT01164956|5966235|P1|STARTED|Overall Study||1
2432154|NCT01164891|5966243|P1|NOT COMPLETED|Overall Study||6
2432155|NCT01164891|5966243|P1|COMPLETED|Overall Study||1
2432156|NCT01164891|5966243|P1|STARTED|Overall Study||7
2432157|NCT01164865|5966263|P2|NOT COMPLETED|Overall Study||1
2432158|NCT01164865|5966264|P1|NOT COMPLETED|Overall Study||2
2432159|NCT01164865|5966263|P2|COMPLETED|Overall Study||38
2432160|NCT01164865|5966264|P1|COMPLETED|Overall Study||37
2432161|NCT01164865|5966263|P2|STARTED|Overall Study||39
2432162|NCT01164865|5966264|P1|STARTED|Overall Study||39
2432163|NCT01164722|5966274|P2|NOT COMPLETED|Overall Study||15
2432164|NCT01164722|5966275|P1|NOT COMPLETED|Overall Study||18
2432165|NCT01164722|5966274|P2|COMPLETED|Overall Study||45
2432166|NCT01164722|5966275|P1|COMPLETED|Overall Study||42
2432167|NCT01164722|5966274|P2|STARTED|Overall Study||60
2432168|NCT01164722|5966275|P1|STARTED|Overall Study||60
2432169|NCT01164644|5966291|P2|NOT COMPLETED|Overall Study||1
2432170|NCT01164644|5966292|P1|NOT COMPLETED|Overall Study||3
2432171|NCT01164644|5966291|P2|COMPLETED|Overall Study||13
2432172|NCT01164644|5966292|P1|COMPLETED|Overall Study||9
2432173|NCT01164644|5966291|P2|STARTED|Overall Study||14
2432174|NCT01164644|5966292|P1|STARTED|Overall Study||12
2432175|NCT01164579|5966305|P3|NOT COMPLETED|Overall Study||16
2432176|NCT01164579|5966306|P2|NOT COMPLETED|Overall Study||9
2432177|NCT01164579|5966307|P1|NOT COMPLETED|Overall Study||8
2432178|NCT01164579|5966305|P3|COMPLETED|Overall Study||21
2432179|NCT01164579|5966306|P2|COMPLETED|Overall Study||27
2432180|NCT01164579|5966307|P1|COMPLETED|Overall Study||28
2432181|NCT01164579|5966305|P3|STARTED|Overall Study||37
2432182|NCT01164579|5966306|P2|STARTED|Overall Study||36
2432183|NCT01164579|5966307|P1|STARTED|Overall Study||36
2432184|NCT01164501|5966387|P3|NOT COMPLETED|Overall Study||42
2432185|NCT01164501|5966388|P2|NOT COMPLETED|Overall Study||10
2432186|NCT01164501|5966389|P1|NOT COMPLETED|Overall Study||43
2432187|NCT01164501|5966387|P3|COMPLETED|Overall Study||280
2432188|NCT01164501|5966388|P2|COMPLETED|Overall Study||88
2432189|NCT01164501|5966389|P1|COMPLETED|Overall Study||278
2432190|NCT01164501|5966387|P3|STARTED|Overall Study||322
2432191|NCT01164501|5966388|P2|STARTED|Overall Study||98
2432192|NCT01164501|5966389|P1|STARTED|Overall Study||321
2432193|NCT01164475|5966406|P2|NOT COMPLETED|Overall Study||2
2432194|NCT01164475|5966407|P1|NOT COMPLETED|Overall Study||2
2432195|NCT01164475|5966406|P2|COMPLETED|Overall Study||29
2432196|NCT01164475|5966407|P1|COMPLETED|Overall Study||28
2432197|NCT01164475|5966406|P2|STARTED|Overall Study||31
2432198|NCT01164475|5966407|P1|STARTED|Overall Study||30
2432199|NCT01164137|5966433|P2|NOT COMPLETED|Overall Study||0
2432200|NCT01164137|5966434|P1|NOT COMPLETED|Overall Study||3
2432201|NCT01164137|5966433|P2|COMPLETED|Overall Study||76
2432202|NCT01164137|5966434|P1|COMPLETED|Overall Study||77
2432203|NCT01164137|5966433|P2|STARTED|Overall Study||76
2432204|NCT01164137|5966434|P1|STARTED|Overall Study||80
2432205|NCT01164098|5966450|P2|NOT COMPLETED|Overall Study||0
2432206|NCT01164098|5966451|P1|NOT COMPLETED|Overall Study||0
2432207|NCT01164098|5966450|P2|COMPLETED|Overall Study||15
2432208|NCT01164098|5966451|P1|COMPLETED|Overall Study||15
2432209|NCT01164098|5966450|P2|STARTED|Overall Study||15
2432210|NCT01164098|5966451|P1|STARTED|Overall Study||15
2432211|NCT01164007|5966461|P1|NOT COMPLETED|Overall Study||40
2432212|NCT01164007|5966461|P1|COMPLETED|Overall Study||0
2432213|NCT01164007|5966461|P1|Treated|Overall Study||37
2432214|NCT01164007|5966461|P1|STARTED|Overall Study||40
2432215|NCT01163955|5966477|P2|NOT COMPLETED|Overall Study||4
2432216|NCT01163955|5966478|P1|NOT COMPLETED|Overall Study||0
2432217|NCT01163955|5966477|P2|COMPLETED|Overall Study||26
2432218|NCT01163955|5966478|P1|COMPLETED|Overall Study||26
2432219|NCT01163955|5966477|P2|STARTED|Overall Study||30
2432220|NCT01163955|5966478|P1|STARTED|Overall Study||26
2432221|NCT01163916|5966487|P3|NOT COMPLETED|Overall Study||20
2432222|NCT01163916|5966488|P2|NOT COMPLETED|Overall Study||4
2432223|NCT01163916|5966489|P1|NOT COMPLETED|Overall Study||30
2432224|NCT01163916|5966487|P3|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|71
2432225|NCT01163916|5966488|P2|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|31
2432226|NCT01163916|5966489|P1|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|96
2432227|NCT01163916|5966487|P3|Safety Population|Overall Study||91
2432228|NCT01163916|5966488|P2|Safety Population|Overall Study||35
2432229|NCT01163916|5966489|P1|Safety Population|Overall Study|One patient discontinued prior to receiving treatment with adalimumab due to absence of medication.|125
2432230|NCT01163916|5966487|P3|STARTED|Overall Study||91
2432231|NCT01163916|5966488|P2|STARTED|Overall Study||35
2432232|NCT01163916|5966489|P1|STARTED|Overall Study||126
2432233|NCT01163851|5966527|P2|NOT COMPLETED|Overall Study||1
2432234|NCT01163851|5966528|P1|NOT COMPLETED|Overall Study||1
2432235|NCT01163851|5966527|P2|COMPLETED|Overall Study||11
2432236|NCT01163851|5966528|P1|COMPLETED|Overall Study||12
2432237|NCT01163851|5966527|P2|Treated|Overall Study||12
2432238|NCT01163851|5966528|P1|Treated|Overall Study||12
2432239|NCT01163851|5966527|P2|STARTED|Overall Study||12
2432240|NCT01163851|5966528|P1|STARTED|Overall Study||13
2432241|NCT01163760|5966606|P4|NOT COMPLETED|Period 4 (Follow-up)||0
2432242|NCT01163760|5966607|P3|NOT COMPLETED|Period 4 (Follow-up)||0
2432243|NCT01163760|5966608|P2|NOT COMPLETED|Period 4 (Follow-up)||0
2432244|NCT01163760|5966609|P1|NOT COMPLETED|Period 4 (Follow-up)||0
2432245|NCT01163760|5966606|P4|COMPLETED|Period 4 (Follow-up)||12
2432246|NCT01163760|5966607|P3|COMPLETED|Period 4 (Follow-up)||13
2432247|NCT01163760|5966608|P2|COMPLETED|Period 4 (Follow-up)||13
2432248|NCT01163760|5966609|P1|COMPLETED|Period 4 (Follow-up)||12
2432249|NCT01163760|5966606|P4|STARTED|Period 4 (Follow-up)||12
2432250|NCT01163760|5966607|P3|STARTED|Period 4 (Follow-up)||13
2432251|NCT01163760|5966608|P2|STARTED|Period 4 (Follow-up)||13
2432252|NCT01163760|5966609|P1|STARTED|Period 4 (Follow-up)||12
2432253|NCT01163760|5966606|P4|NOT COMPLETED|Period 3 (Fit)||0
2432254|NCT01163760|5966607|P3|NOT COMPLETED|Period 3 (Fit)||0
2432255|NCT01163760|5966608|P2|NOT COMPLETED|Period 3 (Fit)||0
2432256|NCT01163760|5966609|P1|NOT COMPLETED|Period 3 (Fit)||0
2432257|NCT01163760|5966606|P4|COMPLETED|Period 3 (Fit)||12
2432258|NCT01163760|5966607|P3|COMPLETED|Period 3 (Fit)||13
2432259|NCT01163760|5966608|P2|COMPLETED|Period 3 (Fit)||13
2432260|NCT01163760|5966609|P1|COMPLETED|Period 3 (Fit)||12
2432261|NCT01163760|5966606|P4|STARTED|Period 3 (Fit)||12
2432262|NCT01163760|5966607|P3|STARTED|Period 3 (Fit)||13
2432263|NCT01163760|5966608|P2|STARTED|Period 3 (Fit)||13
2432264|NCT01163760|5966609|P1|STARTED|Period 3 (Fit)||12
2432265|NCT01163760|5966606|P4|NOT COMPLETED|Period 2 (Follow-up)||0
2432266|NCT01163760|5966607|P3|NOT COMPLETED|Period 2 (Follow-up)||0
2432267|NCT01163760|5966608|P2|NOT COMPLETED|Period 2 (Follow-up)||0
2432268|NCT01163760|5966609|P1|NOT COMPLETED|Period 2 (Follow-up)||0
2432269|NCT01163760|5966606|P4|COMPLETED|Period 2 (Follow-up)||12
2432270|NCT01163760|5966607|P3|COMPLETED|Period 2 (Follow-up)||13
2432271|NCT01163760|5966608|P2|COMPLETED|Period 2 (Follow-up)||13
2432272|NCT01163760|5966609|P1|COMPLETED|Period 2 (Follow-up)||12
2432273|NCT01163760|5966606|P4|STARTED|Period 2 (Follow-up)||12
2432274|NCT01163760|5966607|P3|STARTED|Period 2 (Follow-up)||13
2432275|NCT01163760|5966608|P2|STARTED|Period 2 (Follow-up)||13
2432276|NCT01163760|5966609|P1|STARTED|Period 2 (Follow-up)||12
2432277|NCT01163760|5966606|P4|NOT COMPLETED|Period 1 (Fit)||0
2432278|NCT01163760|5966607|P3|NOT COMPLETED|Period 1 (Fit)||0
2432279|NCT01163760|5966608|P2|NOT COMPLETED|Period 1 (Fit)||0
2432280|NCT01163760|5966609|P1|NOT COMPLETED|Period 1 (Fit)||0
2432281|NCT01163760|5966606|P4|COMPLETED|Period 1 (Fit)||12
2432282|NCT01163760|5966607|P3|COMPLETED|Period 1 (Fit)||13
2432283|NCT01163760|5966608|P2|COMPLETED|Period 1 (Fit)||13
2432284|NCT01163760|5966609|P1|COMPLETED|Period 1 (Fit)||12
2432285|NCT01163760|5966606|P4|STARTED|Period 1 (Fit)||12
2432286|NCT01163760|5966607|P3|STARTED|Period 1 (Fit)||13
2432287|NCT01163760|5966608|P2|STARTED|Period 1 (Fit)||13
2432288|NCT01163760|5966609|P1|STARTED|Period 1 (Fit)||12
2432289|NCT01163747|5966623|P2|NOT COMPLETED|Overall Study||11
2432290|NCT01163747|5966624|P1|NOT COMPLETED|Overall Study||6
2432291|NCT01163747|5966623|P2|COMPLETED|Overall Study||49
2432292|NCT01163747|5966624|P1|COMPLETED|Overall Study||25
2432293|NCT01163747|5966623|P2|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|54
2432294|NCT01163747|5966624|P1|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|27
2432295|NCT01163747|5966623|P2|STARTED|Overall Study||60
2432296|NCT01163747|5966624|P1|STARTED|Overall Study||31
2432297|NCT01163721|5966644|P2|NOT COMPLETED|Overall Study||12
2432298|NCT01163721|5966645|P1|NOT COMPLETED|Overall Study||8
2432299|NCT01163721|5966644|P2|COMPLETED|Overall Study||29
2432300|NCT01163721|5966645|P1|COMPLETED|Overall Study||31
2432301|NCT01163721|5966644|P2|STARTED|Overall Study||41
2432302|NCT01163721|5966645|P1|STARTED|Overall Study||39
2432303|NCT01163656|5966657|P2|NOT COMPLETED|Overall Study||3
2432304|NCT01163656|5966658|P1|NOT COMPLETED|Overall Study||3
2432305|NCT01163656|5966657|P2|COMPLETED|Overall Study||30
2432306|NCT01163656|5966658|P1|COMPLETED|Overall Study||30
2432307|NCT01163656|5966657|P2|STARTED|Overall Study||33
2432308|NCT01163656|5966658|P1|STARTED|Overall Study||33
2432309|NCT01163617|5966664|P8|NOT COMPLETED|Phase B (Injection Time), Week 4||0
2432310|NCT01163617|5966665|P7|NOT COMPLETED|Phase B (Injection Time), Week 4||0
2432311|NCT01163617|5966666|P6|NOT COMPLETED|Phase B (Injection Time), Week 4||0
2432312|NCT01163617|5966667|P5|NOT COMPLETED|Phase B (Injection Time), Week 4||0
2432313|NCT01163617|5966668|P4|NOT COMPLETED|Phase B (Injection Time), Week 4||0
2432314|NCT01163617|5966669|P3|NOT COMPLETED|Phase B (Injection Time), Week 4||0
2432315|NCT01163617|5966670|P2|NOT COMPLETED|Phase B (Injection Time), Week 4||0
2432316|NCT01163617|5966671|P1|NOT COMPLETED|Phase B (Injection Time), Week 4||0
2432317|NCT01163617|5966664|P8|COMPLETED|Phase B (Injection Time), Week 4||20
2432318|NCT01163617|5966665|P7|COMPLETED|Phase B (Injection Time), Week 4||16
2432319|NCT01163617|5966666|P6|COMPLETED|Phase B (Injection Time), Week 4||27
2432320|NCT01163617|5966667|P5|COMPLETED|Phase B (Injection Time), Week 4||18
2432321|NCT01163617|5966668|P4|COMPLETED|Phase B (Injection Time), Week 4||0
2432322|NCT01163617|5966669|P3|COMPLETED|Phase B (Injection Time), Week 4||0
2432323|NCT01163617|5966670|P2|COMPLETED|Phase B (Injection Time), Week 4||0
2432324|NCT01163617|5966671|P1|COMPLETED|Phase B (Injection Time), Week 4||0
2432325|NCT01163617|5966664|P8|STARTED|Phase B (Injection Time), Week 4||20
2432326|NCT01163617|5966665|P7|STARTED|Phase B (Injection Time), Week 4||16
2432327|NCT01163617|5966666|P6|STARTED|Phase B (Injection Time), Week 4||27
2432328|NCT01163617|5966667|P5|STARTED|Phase B (Injection Time), Week 4||18
2432329|NCT01163617|5966668|P4|STARTED|Phase B (Injection Time), Week 4||0
2432330|NCT01163617|5966669|P3|STARTED|Phase B (Injection Time), Week 4||0
2432331|NCT01163617|5966670|P2|STARTED|Phase B (Injection Time), Week 4||0
2432332|NCT01163617|5966671|P1|STARTED|Phase B (Injection Time), Week 4||0
2432333|NCT01163617|5966664|P8|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
2432334|NCT01163617|5966665|P7|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
2432335|NCT01163617|5966666|P6|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
2432336|NCT01163617|5966667|P5|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
2432337|NCT01163617|5966668|P4|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
2432338|NCT01163617|5966669|P3|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||1
2432339|NCT01163617|5966670|P2|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||2
2432340|NCT01163617|5966671|P1|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
2432341|NCT01163617|5966664|P8|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
2432342|NCT01163617|5966665|P7|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
2432343|NCT01163617|5966666|P6|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
2432344|NCT01163617|5966667|P5|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
2432345|NCT01163617|5966668|P4|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
2432346|NCT01163617|5966669|P3|COMPLETED|Phase A (User Experience), Weeks 0 and 2||20
2432347|NCT01163617|5966670|P2|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
2432348|NCT01163617|5966671|P1|COMPLETED|Phase A (User Experience), Weeks 0 and 2||19
2432349|NCT01163617|5966664|P8|STARTED|Phase A (User Experience), Weeks 0 and 2||0
2432350|NCT01163617|5966665|P7|STARTED|Phase A (User Experience), Weeks 0 and 2||0
2432351|NCT01163617|5966666|P6|STARTED|Phase A (User Experience), Weeks 0 and 2||0
2432352|NCT01163617|5966667|P5|STARTED|Phase A (User Experience), Weeks 0 and 2||0
2432353|NCT01163617|5966668|P4|STARTED|Phase A (User Experience), Weeks 0 and 2||21
2432354|NCT01163617|5966669|P3|STARTED|Phase A (User Experience), Weeks 0 and 2||21
2432355|NCT01163617|5966670|P2|STARTED|Phase A (User Experience), Weeks 0 and 2||23
2432356|NCT01163617|5966671|P1|STARTED|Phase A (User Experience), Weeks 0 and 2||19
2432357|NCT01163604|5966693|P2|NOT COMPLETED|Overall Study||0
2432358|NCT01163604|5966694|P1|NOT COMPLETED|Overall Study||0
2432359|NCT01163604|5966693|P2|COMPLETED|Overall Study|August 2011|56
2432360|NCT01163604|5966694|P1|COMPLETED|Overall Study|August 2011|58
2432361|NCT01163604|5966693|P2|STARTED|Overall Study|August 2010|56
2432362|NCT01163604|5966694|P1|STARTED|Overall Study|August 2010|58
2432363|NCT01163474|5966700|P1|NOT COMPLETED|Overall Study||16
2432364|NCT01163474|5966700|P1|COMPLETED|Overall Study||24
2432365|NCT01163474|5966700|P1|STARTED|Overall Study||40
2432366|NCT01163461|5966707|P2|NOT COMPLETED|Overall Study||0
2432367|NCT01163461|5966708|P1|NOT COMPLETED|Overall Study||0
2432368|NCT01163461|5966707|P2|COMPLETED|Overall Study||14
2432369|NCT01163461|5966708|P1|COMPLETED|Overall Study||14
2432370|NCT01163461|5966707|P2|STARTED|Overall Study||14
2432371|NCT01163461|5966708|P1|STARTED|Overall Study||14
2432372|NCT01163318|5966712|P1|NOT COMPLETED|Overall Study||268
2432373|NCT01163318|5966712|P1|COMPLETED|Overall Study||284
2432374|NCT01163318|5966712|P1|STARTED|Overall Study||552
2432375|NCT01163292|5966721|P2|NOT COMPLETED|Overall Study||22
2432376|NCT01163292|5966722|P1|NOT COMPLETED|Overall Study||41
2432377|NCT01163292|5966721|P2|COMPLETED|Overall Study||92
2432378|NCT01163292|5966722|P1|COMPLETED|Overall Study||65
2432379|NCT01163292|5966721|P2|STARTED|Overall Study||114
2432380|NCT01163292|5966722|P1|STARTED|Overall Study||106
2432381|NCT01163279|5966738|P2|NOT COMPLETED|Overall Study||0
2432382|NCT01163279|5966739|P1|NOT COMPLETED|Overall Study||2
2432383|NCT01163279|5966738|P2|COMPLETED|Overall Study||9
2432384|NCT01163279|5966739|P1|COMPLETED|Overall Study||8
2432385|NCT01163279|5966738|P2|STARTED|Overall Study||9
2432386|NCT01163279|5966739|P1|STARTED|Overall Study||10
2432387|NCT01163266|5966768|P3|NOT COMPLETED|Overall Study||28
2432388|NCT01163266|5966769|P2|NOT COMPLETED|Overall Study||31
2432389|NCT01163266|5966770|P1|NOT COMPLETED|Overall Study||18
2432390|NCT01163266|5966768|P3|COMPLETED|Overall Study||122
2432391|NCT01163266|5966769|P2|COMPLETED|Overall Study||124
2432392|NCT01163266|5966770|P1|COMPLETED|Overall Study||139
2432393|NCT01163266|5966768|P3|Treated|Overall Study||150
2432394|NCT01163266|5966769|P2|Treated|Overall Study||155
2432395|NCT01163266|5966770|P1|Treated|Overall Study||157
2432396|NCT01163266|5966768|P3|STARTED|Overall Study||150
2432397|NCT01163266|5966769|P2|STARTED|Overall Study||155
2432398|NCT01163266|5966770|P1|STARTED|Overall Study||157
2432399|NCT01163253|5966795|P2|NOT COMPLETED|Overall Study||586
2432400|NCT01163253|5966796|P1|NOT COMPLETED|Overall Study||2281
2432401|NCT01163253|5966795|P2|COMPLETED|Overall Study||0
2432402|NCT01163253|5966796|P1|COMPLETED|Overall Study||0
2432403|NCT01163253|5966795|P2|STARTED|Overall Study||586
2432404|NCT01163253|5966796|P1|STARTED|Overall Study||2281
2432405|NCT01163214|5966958|P2|NOT COMPLETED|Overall Study||0
2432406|NCT01163214|5966959|P1|NOT COMPLETED|Overall Study||0
2432407|NCT01163214|5966958|P2|COMPLETED|Overall Study||81
2432408|NCT01163214|5966959|P1|COMPLETED|Overall Study||79
2432409|NCT01163214|5966958|P2|STARTED|Overall Study||81
2432410|NCT01163214|5966959|P1|STARTED|Overall Study||79
2432411|NCT01163162|5966975|P1|NOT COMPLETED|Overall Study||0
2432412|NCT01163162|5966975|P1|COMPLETED|Overall Study||16
2432413|NCT01163162|5966975|P1|STARTED|Overall Study||16
2432414|NCT01163149|5966984|P3|NOT COMPLETED|Extension Treatment Period||2
2432415|NCT01163149|5966985|P2|NOT COMPLETED|Extension Treatment Period||1
2432416|NCT01163149|5966986|P1|NOT COMPLETED|Extension Treatment Period||2
2432417|NCT01163149|5966984|P3|COMPLETED|Extension Treatment Period||4
2432418|NCT01163149|5966985|P2|COMPLETED|Extension Treatment Period||5
2432419|NCT01163149|5966986|P1|COMPLETED|Extension Treatment Period||5
2432420|NCT01163149|5966984|P3|STARTED|Extension Treatment Period||6
2432421|NCT01163149|5966985|P2|STARTED|Extension Treatment Period||6
2432422|NCT01163149|5966986|P1|STARTED|Extension Treatment Period||7
2432423|NCT01163149|5966984|P3|NOT COMPLETED|Primary Treatment Period||0
2432424|NCT01163149|5966985|P2|NOT COMPLETED|Primary Treatment Period||0
2432425|NCT01163149|5966986|P1|NOT COMPLETED|Primary Treatment Period||0
2432426|NCT01163149|5966984|P3|COMPLETED|Primary Treatment Period||6
2432427|NCT01163149|5966985|P2|COMPLETED|Primary Treatment Period||6
2432428|NCT01163149|5966986|P1|COMPLETED|Primary Treatment Period||7
2432429|NCT01163149|5966984|P3|STARTED|Primary Treatment Period||6
2432430|NCT01163149|5966985|P2|STARTED|Primary Treatment Period||6
2432431|NCT01163149|5966986|P1|STARTED|Primary Treatment Period||7
2432432|NCT01163097|5967031|P3|NOT COMPLETED|Overall Study||0
2432433|NCT01163097|5967032|P2|NOT COMPLETED|Overall Study||0
2432434|NCT01163097|5967033|P1|NOT COMPLETED|Overall Study||6
2432435|NCT01163097|5967031|P3|COMPLETED|Overall Study||8
2432436|NCT01163097|5967032|P2|COMPLETED|Overall Study||16
2432437|NCT01163097|5967033|P1|COMPLETED|Overall Study||14
2432438|NCT01163097|5967031|P3|STARTED|Overall Study||8
2432439|NCT01163097|5967032|P2|STARTED|Overall Study||16
2432440|NCT01163097|5967033|P1|STARTED|Overall Study|15 subjects were successfully titrated and entered the palifermin treatment|20
2432441|NCT01163084|5967085|P2|NOT COMPLETED|Overall Study||0
2432442|NCT01163084|5967086|P1|NOT COMPLETED|Overall Study||0
2432443|NCT01163084|5967085|P2|COMPLETED|Overall Study||5
2432444|NCT01163084|5967086|P1|COMPLETED|Overall Study||4
2432445|NCT01163084|5967085|P2|STARTED|Overall Study||5
2432446|NCT01163084|5967086|P1|STARTED|Overall Study||4
2432447|NCT01163032|5967095|P3|NOT COMPLETED|Open Label Extension Phase||16
2432448|NCT01163032|5967096|P2|NOT COMPLETED|Open Label Extension Phase||0
2432449|NCT01163032|5967097|P1|NOT COMPLETED|Open Label Extension Phase||0
2432450|NCT01163032|5967095|P3|COMPLETED|Open Label Extension Phase||39
2432451|NCT01163032|5967096|P2|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
2432452|NCT01163032|5967097|P1|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
2432453|NCT01163032|5967095|P3|STARTED|Open Label Extension Phase|3 randomized patients rolled into extension (2 randomized to tasimelteon and one to placebo)|55
2432454|NCT01163032|5967096|P2|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
2432455|NCT01163032|5967097|P1|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
2432456|NCT01163032|5967095|P3|NOT COMPLETED|Randomization Phase||0
2432457|NCT01163032|5967096|P2|NOT COMPLETED|Randomization Phase||12
2432458|NCT01163032|5967097|P1|NOT COMPLETED|Randomization Phase||10
2432459|NCT01163032|5967095|P3|COMPLETED|Randomization Phase|Not applicable for Randomized Phase|0
2432460|NCT01163032|5967096|P2|COMPLETED|Randomization Phase||30
2432461|NCT01163032|5967097|P1|COMPLETED|Randomization Phase||32
2432462|NCT01163032|5967095|P3|STARTED|Randomization Phase|Not applicable for Randomized Phase|0
2432463|NCT01163032|5967096|P2|STARTED|Randomization Phase||42
2432464|NCT01163032|5967097|P1|STARTED|Randomization Phase||42
2432465|NCT01162863|5967130|P3|NOT COMPLETED|Overall Study||0
2432466|NCT01162863|5967131|P2|NOT COMPLETED|Overall Study||1
2432467|NCT01162863|5967132|P1|NOT COMPLETED|Overall Study||1
2432468|NCT01162863|5967130|P3|COMPLETED|Overall Study||17
2432469|NCT01162863|5967131|P2|COMPLETED|Overall Study||16
2432470|NCT01162863|5967132|P1|COMPLETED|Overall Study||17
2432471|NCT01162863|5967130|P3|STARTED|Overall Study||17
2432472|NCT01162863|5967131|P2|STARTED|Overall Study||17
2432473|NCT01162863|5967132|P1|STARTED|Overall Study||18
2432474|NCT01162733|5967148|P2|NOT COMPLETED|Overall Study||25
2432475|NCT01162733|5967149|P1|NOT COMPLETED|Overall Study||27
2432476|NCT01162733|5967148|P2|COMPLETED|Overall Study||25
2432477|NCT01162733|5967149|P1|COMPLETED|Overall Study||22
2432478|NCT01162733|5967148|P2|STARTED|Overall Study||50
2432479|NCT01162733|5967149|P1|STARTED|Overall Study||49
2432480|NCT01162551|5967157|P1|NOT COMPLETED|Overall Study||0
2432481|NCT01162551|5967157|P1|COMPLETED|Overall Study||3
2432482|NCT01162551|5967157|P1|STARTED|Overall Study|2 subjects were enrolled but withdrew before receiving any study treatment|3
2432483|NCT01162499|5967162|P2|NOT COMPLETED|Intervention 2 (4 Hours)||0
2432484|NCT01162499|5967163|P1|NOT COMPLETED|Intervention 2 (4 Hours)||0
2432485|NCT01162499|5967162|P2|COMPLETED|Intervention 2 (4 Hours)||3
2432486|NCT01162499|5967163|P1|COMPLETED|Intervention 2 (4 Hours)||3
2432487|NCT01162499|5967162|P2|STARTED|Intervention 2 (4 Hours)||3
2432488|NCT01162499|5967163|P1|STARTED|Intervention 2 (4 Hours)||3
2432489|NCT01162499|5967162|P2|NOT COMPLETED|Intervention 1 (4 Hours)||1
2432490|NCT01162499|5967163|P1|NOT COMPLETED|Intervention 1 (4 Hours)||0
2432491|NCT01162499|5967162|P2|COMPLETED|Intervention 1 (4 Hours)||3
2432492|NCT01162499|5967163|P1|COMPLETED|Intervention 1 (4 Hours)||3
2432493|NCT01162499|5967162|P2|Received Intervention|Intervention 1 (4 Hours)||3
2432494|NCT01162499|5967163|P1|Received Intervention|Intervention 1 (4 Hours)||3
2432495|NCT01162499|5967162|P2|STARTED|Intervention 1 (4 Hours)||4
2432496|NCT01162499|5967163|P1|STARTED|Intervention 1 (4 Hours)||3
2432497|NCT01162486|5967188|P5|NOT COMPLETED|Overall Study||0
2432498|NCT01162486|5967189|P4|NOT COMPLETED|Overall Study||1
2432499|NCT01162486|5967190|P3|NOT COMPLETED|Overall Study||1
2432500|NCT01162486|5967191|P2|NOT COMPLETED|Overall Study||0
2432501|NCT01162486|5967192|P1|NOT COMPLETED|Overall Study||2
2432502|NCT01162486|5967188|P5|COMPLETED|Overall Study||6
2432503|NCT01162486|5967189|P4|COMPLETED|Overall Study||6
2432504|NCT01162486|5967190|P3|COMPLETED|Overall Study||5
2432505|NCT01162486|5967191|P2|COMPLETED|Overall Study||6
2432506|NCT01162486|5967192|P1|COMPLETED|Overall Study||6
2432507|NCT01162486|5967188|P5|Took at Least One Dose Study Drug|Overall Study||6
2432508|NCT01162486|5967189|P4|Took at Least One Dose Study Drug|Overall Study||7
2432509|NCT01162486|5967190|P3|Took at Least One Dose Study Drug|Overall Study||6
2432510|NCT01162486|5967191|P2|Took at Least One Dose Study Drug|Overall Study||6
2432511|NCT01162486|5967192|P1|Took at Least One Dose Study Drug|Overall Study||8
2432512|NCT01162486|5967188|P5|STARTED|Overall Study||6
2432513|NCT01162486|5967189|P4|STARTED|Overall Study||7
2432514|NCT01162486|5967190|P3|STARTED|Overall Study||6
2432515|NCT01162486|5967191|P2|STARTED|Overall Study||6
2432516|NCT01162486|5967192|P1|STARTED|Overall Study||8
2432517|NCT01162473|5967225|P2|NOT COMPLETED|Overall Study||5
2432518|NCT01162473|5967226|P1|NOT COMPLETED|Overall Study||2
2432519|NCT01162473|5967225|P2|COMPLETED|Overall Study||12
2432520|NCT01162473|5967226|P1|COMPLETED|Overall Study||6
2432521|NCT01162473|5967225|P2|STARTED|Overall Study||17
2432522|NCT01162473|5967226|P1|STARTED|Overall Study||8
2432523|NCT01162421|5967234|P2|NOT COMPLETED|Overall Study||13
2432524|NCT01162421|5967235|P1|NOT COMPLETED|Overall Study||8
2432525|NCT01162421|5967234|P2|COMPLETED|Overall Study||27
2432526|NCT01162421|5967235|P1|COMPLETED|Overall Study||29
2432527|NCT01162421|5967234|P2|STARTED|Overall Study||40
2432528|NCT01162421|5967235|P1|STARTED|Overall Study||37
2432529|NCT01162382|5967313|P1|NOT COMPLETED|Overall Study||0
2432530|NCT01162382|5967313|P1|COMPLETED|Overall Study||0
2432531|NCT01162382|5967313|P1|STARTED|Overall Study||0
2432532|NCT01162343|5967318|P1|NOT COMPLETED|Overall Study||92
2432533|NCT01162343|5967318|P1|COMPLETED|Overall Study||406
2432534|NCT01162343|5967318|P1|STARTED|Overall Study||498
2432535|NCT01162317|5967324|P2|NOT COMPLETED|Overall Study||2
2432536|NCT01162317|5967325|P1|NOT COMPLETED|Overall Study||3
2432537|NCT01162317|5967324|P2|COMPLETED|Overall Study||28
2432538|NCT01162317|5967325|P1|COMPLETED|Overall Study||27
2432539|NCT01162317|5967324|P2|STARTED|Overall Study||30
2432540|NCT01162317|5967325|P1|STARTED|Overall Study||30
2432541|NCT01162304|5967333|P1|NOT COMPLETED|Overall Study||11
2432542|NCT01162304|5967333|P1|COMPLETED|Overall Study||7
2432543|NCT01162304|5967333|P1|STARTED|Overall Study||18
2432544|NCT01162135|5967347|P1|NOT COMPLETED|Overall Study||3
2432545|NCT01162135|5967347|P1|COMPLETED|Overall Study||13
2432546|NCT01162135|5967347|P1|STARTED|Overall Study||16
2432547|NCT01162122|5967353|P2|NOT COMPLETED|Overall Study||196
2432548|NCT01162122|5967354|P1|NOT COMPLETED|Overall Study||191
2432549|NCT01162122|5967353|P2|COMPLETED|Overall Study||3356
2432550|NCT01162122|5967354|P1|COMPLETED|Overall Study||3361
2432551|NCT01162122|5967353|P2|Vaccinated|Overall Study||3541
2432552|NCT01162122|5967354|P1|Vaccinated|Overall Study||3541
2432553|NCT01162122|5967353|P2|STARTED|Overall Study||3552
2432554|NCT01162122|5967354|P1|STARTED|Overall Study||3552
2432555|NCT01162096|5967411|P1|NOT COMPLETED|Overall Study||0
2432556|NCT01162096|5967411|P1|COMPLETED|Overall Study||34
2432557|NCT01162096|5967411|P1|STARTED|Overall Study||34
2432558|NCT01162005|5967419|P2|NOT COMPLETED|Overall Study||0
2432559|NCT01162005|5967420|P1|NOT COMPLETED|Overall Study||0
2432560|NCT01162005|5967419|P2|COMPLETED|Overall Study||33
2432561|NCT01162005|5967420|P1|COMPLETED|Overall Study||44
2432562|NCT01162005|5967419|P2|STARTED|Overall Study||33
2432563|NCT01162005|5967420|P1|STARTED|Overall Study||44
2432564|NCT01161862|5967430|P2|NOT COMPLETED|Overall Study||0
2432565|NCT01161862|5967431|P1|NOT COMPLETED|Overall Study||0
2432566|NCT01161862|5967430|P2|COMPLETED|Overall Study||12
2432567|NCT01161862|5967431|P1|COMPLETED|Overall Study||12
2432568|NCT01161862|5967430|P2|STARTED|Overall Study||12
2432569|NCT01161862|5967431|P1|STARTED|Overall Study||12
2432570|NCT01161771|5967451|P1|NOT COMPLETED|Overall Study||0
2432571|NCT01161771|5967451|P1|COMPLETED|Overall Study||32
2432572|NCT01161771|5967451|P1|STARTED|Overall Study||32
2432573|NCT01161628|5967460|P1|NOT COMPLETED|Overall Study||8
2432574|NCT01161628|5967460|P1|COMPLETED|Overall Study||17
2432575|NCT01161628|5967460|P1|STARTED|Overall Study||25
2432576|NCT01161563|5967474|P2|NOT COMPLETED|Overall Study||6
2432577|NCT01161563|5967475|P1|NOT COMPLETED|Overall Study||5
2432578|NCT01161563|5967474|P2|COMPLETED|Overall Study||49
2432579|NCT01161563|5967475|P1|COMPLETED|Overall Study||58
2432580|NCT01161563|5967474|P2|STARTED|Overall Study||55
2432581|NCT01161563|5967475|P1|STARTED|Overall Study||63
2432582|NCT01161537|5967483|P1|NOT COMPLETED|Part B||2
2432583|NCT01161537|5967483|P1|COMPLETED|Part B||7
2432584|NCT01161537|5967483|P1|STARTED|Part B|4 subjects from Part A continued in Part B of the study.|9
2432585|NCT01161537|5967483|P1|NOT COMPLETED|Part A||0
2432586|NCT01161537|5967483|P1|COMPLETED|Part A||8
2432587|NCT01161537|5967483|P1|STARTED|Part A||8
2432588|NCT01161524|5967501|P3|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||24
2432589|NCT01161524|5967502|P2|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||0
2432590|NCT01161524|5967503|P1|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||0
2432591|NCT01161524|5967501|P3|COMPLETED|Extension Phase (Approximately 83 Weeks)||90
2432592|NCT01161524|5967502|P2|COMPLETED|Extension Phase (Approximately 83 Weeks)||0
2432593|NCT01161524|5967503|P1|COMPLETED|Extension Phase (Approximately 83 Weeks)||0
2432594|NCT01161524|5967501|P3|STARTED|Extension Phase (Approximately 83 Weeks)||114
2432595|NCT01161524|5967502|P2|STARTED|Extension Phase (Approximately 83 Weeks)||0
2432596|NCT01161524|5967503|P1|STARTED|Extension Phase (Approximately 83 Weeks)||0
2432597|NCT01161524|5967501|P3|NOT COMPLETED|Core Study (23 Weeks)||0
2432598|NCT01161524|5967502|P2|NOT COMPLETED|Core Study (23 Weeks)||5
2432599|NCT01161524|5967503|P1|NOT COMPLETED|Core Study (23 Weeks)||9
2432600|NCT01161524|5967501|P3|COMPLETED|Core Study (23 Weeks)||0
2432601|NCT01161524|5967502|P2|COMPLETED|Core Study (23 Weeks)||43
2432602|NCT01161524|5967503|P1|COMPLETED|Core Study (23 Weeks)||76
2432603|NCT01161524|5967501|P3|STARTED|Core Study (23 Weeks)||0
2432604|NCT01161524|5967502|P2|STARTED|Core Study (23 Weeks)||48
2432605|NCT01161524|5967503|P1|STARTED|Core Study (23 Weeks)||85
2432606|NCT01161498|5967542|P2|NOT COMPLETED|Overall Study||1
2432607|NCT01161498|5967543|P1|NOT COMPLETED|Overall Study||0
2432608|NCT01161498|5967542|P2|COMPLETED|Overall Study||1
2432609|NCT01161498|5967543|P1|COMPLETED|Overall Study||3
2432610|NCT01161498|5967542|P2|STARTED|Overall Study||2
2432611|NCT01161498|5967543|P1|STARTED|Overall Study||3
2432612|NCT01161472|5967567|P4|NOT COMPLETED|Fourth Intervention Period||0
2432613|NCT01161472|5967568|P3|NOT COMPLETED|Fourth Intervention Period||0
2432614|NCT01161472|5967569|P2|NOT COMPLETED|Fourth Intervention Period||0
2432615|NCT01161472|5967570|P1|NOT COMPLETED|Fourth Intervention Period||0
2432616|NCT01161472|5967567|P4|COMPLETED|Fourth Intervention Period||5
2432617|NCT01161472|5967568|P3|COMPLETED|Fourth Intervention Period||5
2432618|NCT01161472|5967569|P2|COMPLETED|Fourth Intervention Period||5
2432619|NCT01161472|5967570|P1|COMPLETED|Fourth Intervention Period||4
2432620|NCT01161472|5967567|P4|STARTED|Fourth Intervention Period||5
2432621|NCT01161472|5967568|P3|STARTED|Fourth Intervention Period||5
2432622|NCT01161472|5967569|P2|STARTED|Fourth Intervention Period||5
2432623|NCT01161472|5967570|P1|STARTED|Fourth Intervention Period||4
2432624|NCT01161472|5967567|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
2432625|NCT01161472|5967568|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
2432626|NCT01161472|5967569|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
2432627|NCT01161472|5967570|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
2432628|NCT01161472|5967567|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
2432629|NCT01161472|5967568|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
2432630|NCT01161472|5967569|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
2432631|NCT01161472|5967570|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
2432632|NCT01161472|5967567|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
2432633|NCT01161472|5967568|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
2432634|NCT01161472|5967569|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
2432635|NCT01161472|5967570|P1|STARTED|Washout Period (At Least 3 to 6 Days)||4
2432636|NCT01161472|5967567|P4|NOT COMPLETED|Third Intervention Period||0
2432637|NCT01161472|5967568|P3|NOT COMPLETED|Third Intervention Period||0
2432638|NCT01161472|5967569|P2|NOT COMPLETED|Third Intervention Period||0
2432639|NCT01161472|5967570|P1|NOT COMPLETED|Third Intervention Period||0
2432640|NCT01161472|5967567|P4|COMPLETED|Third Intervention Period||5
2432641|NCT01161472|5967568|P3|COMPLETED|Third Intervention Period||5
2432642|NCT01161472|5967569|P2|COMPLETED|Third Intervention Period||5
2432643|NCT01161472|5967570|P1|COMPLETED|Third Intervention Period||4
2432644|NCT01161472|5967567|P4|STARTED|Third Intervention Period||5
2432645|NCT01161472|5967568|P3|STARTED|Third Intervention Period||5
2432646|NCT01161472|5967569|P2|STARTED|Third Intervention Period||5
2432647|NCT01161472|5967570|P1|STARTED|Third Intervention Period||4
2432648|NCT01161472|5967567|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
2432649|NCT01161472|5967568|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
2432650|NCT01161472|5967569|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
2432651|NCT01161472|5967570|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||1
2432652|NCT01161472|5967567|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
2432653|NCT01161472|5967568|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
2432654|NCT01161472|5967569|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
2432655|NCT01161472|5967570|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
2432656|NCT01161472|5967567|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
2432657|NCT01161472|5967568|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
2432658|NCT01161472|5967569|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
2432659|NCT01161472|5967570|P1|STARTED|Washout Period (At Least 3 to 6 Days)||5
2432660|NCT01161472|5967567|P4|NOT COMPLETED|Second Intervention Period||0
2432661|NCT01161472|5967568|P3|NOT COMPLETED|Second Intervention Period||0
2432662|NCT01161472|5967569|P2|NOT COMPLETED|Second Intervention Period||0
2432663|NCT01161472|5967570|P1|NOT COMPLETED|Second Intervention Period||0
2432664|NCT01161472|5967567|P4|COMPLETED|Second Intervention Period||5
2432665|NCT01161472|5967568|P3|COMPLETED|Second Intervention Period||5
2432666|NCT01161472|5967569|P2|COMPLETED|Second Intervention Period||5
2432667|NCT01161472|5967570|P1|COMPLETED|Second Intervention Period||5
2432668|NCT01161472|5967567|P4|STARTED|Second Intervention Period||5
2432669|NCT01161472|5967568|P3|STARTED|Second Intervention Period||5
2432670|NCT01161472|5967569|P2|STARTED|Second Intervention Period||5
2432671|NCT01161472|5967570|P1|STARTED|Second Intervention Period||5
2432672|NCT01161472|5967567|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
2432673|NCT01161472|5967568|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
2432674|NCT01161472|5967569|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
2432675|NCT01161472|5967570|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
2432676|NCT01161472|5967567|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
2432677|NCT01161472|5967568|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
2432678|NCT01161472|5967569|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
2432679|NCT01161472|5967570|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
2432680|NCT01161472|5967567|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
2432681|NCT01161472|5967568|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
2432682|NCT01161472|5967569|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
2432683|NCT01161472|5967570|P1|STARTED|Washout Period (At Least 3 to 6 Days)||5
2432684|NCT01161472|5967567|P4|NOT COMPLETED|First Intervention Period||0
2432685|NCT01161472|5967568|P3|NOT COMPLETED|First Intervention Period||0
2432686|NCT01161472|5967569|P2|NOT COMPLETED|First Intervention Period||0
2432687|NCT01161472|5967570|P1|NOT COMPLETED|First Intervention Period||0
2432688|NCT01161472|5967567|P4|COMPLETED|First Intervention Period||5
2432689|NCT01161472|5967568|P3|COMPLETED|First Intervention Period||5
2432690|NCT01161472|5967569|P2|COMPLETED|First Intervention Period||5
2432691|NCT01161472|5967570|P1|COMPLETED|First Intervention Period||5
2432692|NCT01161472|5967567|P4|Treated|First Intervention Period||5
2432693|NCT01161472|5967568|P3|Treated|First Intervention Period||5
2432694|NCT01161472|5967569|P2|Treated|First Intervention Period||5
2432695|NCT01161472|5967570|P1|Treated|First Intervention Period||5
2432696|NCT01161472|5967567|P4|STARTED|First Intervention Period||5
2432697|NCT01161472|5967568|P3|STARTED|First Intervention Period||5
2432698|NCT01161472|5967569|P2|STARTED|First Intervention Period||5
2432699|NCT01161472|5967570|P1|STARTED|First Intervention Period||5
2432700|NCT01161446|5967626|P2|NOT COMPLETED|Overall Study||15
2432701|NCT01161446|5967627|P1|NOT COMPLETED|Overall Study||18
2432702|NCT01161446|5967626|P2|COMPLETED|Overall Study||99
2432703|NCT01161446|5967627|P1|COMPLETED|Overall Study||98
2432704|NCT01161446|5967626|P2|STARTED|Overall Study||114
2432705|NCT01161446|5967627|P1|STARTED|Overall Study||116
2432706|NCT01161420|5967639|P1|NOT COMPLETED|Withdrawal Study - Withdrawal||0
2432707|NCT01161420|5967639|P1|COMPLETED|Withdrawal Study - Withdrawal||23
2432708|NCT01161420|5967639|P1|STARTED|Withdrawal Study - Withdrawal||23
2432709|NCT01161420|5967639|P1|NOT COMPLETED|Withdrawal Study - Maintenance||0
2432710|NCT01161420|5967639|P1|COMPLETED|Withdrawal Study - Maintenance||23
2432711|NCT01161420|5967639|P1|STARTED|Withdrawal Study - Maintenance||23
2432712|NCT01161420|5967639|P1|NOT COMPLETED|Inspire Therapy||2
2432713|NCT01161420|5967639|P1|COMPLETED|Inspire Therapy||124
2432714|NCT01161420|5967639|P1|STARTED|Inspire Therapy||126
2432715|NCT01161407|5967653|P2|NOT COMPLETED|Overall Study||1
2432716|NCT01161407|5967654|P1|NOT COMPLETED|Overall Study||3
2432717|NCT01161407|5967653|P2|COMPLETED|Overall Study||5
2432718|NCT01161407|5967654|P1|COMPLETED|Overall Study||3
2432719|NCT01161407|5967653|P2|STARTED|Overall Study||6
2432720|NCT01161407|5967654|P1|STARTED|Overall Study||6
2432721|NCT01161329|5967666|P2|NOT COMPLETED|Overall Study||10
2432722|NCT01161329|5967667|P1|NOT COMPLETED|Overall Study||4
2432723|NCT01161329|5967666|P2|COMPLETED|Overall Study||24
2432724|NCT01161329|5967667|P1|COMPLETED|Overall Study||29
2432725|NCT01161329|5967666|P2|STARTED|Overall Study||34
2432726|NCT01161329|5967667|P1|STARTED|Overall Study||33
2432727|NCT01161225|5967678|P3|NOT COMPLETED|Overall Study||2
2432728|NCT01161225|5967679|P2|NOT COMPLETED|Overall Study||9
2432729|NCT01161225|5967680|P1|NOT COMPLETED|Overall Study||14
2432730|NCT01161225|5967678|P3|COMPLETED|Overall Study||12
2432731|NCT01161225|5967679|P2|COMPLETED|Overall Study||44
2432732|NCT01161225|5967680|P1|COMPLETED|Overall Study||45
2432733|NCT01161225|5967678|P3|STARTED|Overall Study||14
2432734|NCT01161225|5967679|P2|STARTED|Overall Study||53
2432735|NCT01161225|5967680|P1|STARTED|Overall Study||59
2432736|NCT01161173|5967709|P1|NOT COMPLETED|Overall Study||347
2432737|NCT01161173|5967709|P1|COMPLETED|Overall Study||0
2432738|NCT01161173|5967709|P1|STARTED|Overall Study||347
2432739|NCT01161160|5967721|P3|NOT COMPLETED|Overall Study||0
2432740|NCT01161160|5967722|P2|NOT COMPLETED|Overall Study||0
2432741|NCT01161160|5967723|P1|NOT COMPLETED|Overall Study||0
2432742|NCT01161160|5967721|P3|COMPLETED|Overall Study||58
2432743|NCT01161160|5967722|P2|COMPLETED|Overall Study||75
2432744|NCT01161160|5967723|P1|COMPLETED|Overall Study||76
2432745|NCT01161160|5967721|P3|STARTED|Overall Study||58
2432746|NCT01161160|5967722|P2|STARTED|Overall Study||75
2432747|NCT01161160|5967723|P1|STARTED|Overall Study||76
2432748|NCT01161121|5967794|P1|NOT COMPLETED|Overall Study||0
2432749|NCT01161121|5967794|P1|COMPLETED|Overall Study||46
2432750|NCT01161121|5967794|P1|STARTED|Overall Study||46
2432751|NCT01160848|5967806|P2|NOT COMPLETED|Overall Study||0
2432752|NCT01160848|5967807|P1|NOT COMPLETED|Overall Study||0
2432753|NCT01160848|5967806|P2|COMPLETED|Overall Study||8
2432754|NCT01160848|5967807|P1|COMPLETED|Overall Study||12
2432755|NCT01160848|5967806|P2|STARTED|Overall Study||8
2432756|NCT01160848|5967807|P1|STARTED|Overall Study||12
2432757|NCT01160822|5967836|P7|NOT COMPLETED|Overall Study||9
2432758|NCT01160822|5967837|P6|NOT COMPLETED|Overall Study||7
2432759|NCT01160822|5967838|P5|NOT COMPLETED|Overall Study||9
2432760|NCT01160822|5967839|P4|NOT COMPLETED|Overall Study||0
2432761|NCT01160822|5967840|P3|NOT COMPLETED|Overall Study||0
2432762|NCT01160822|5967841|P2|NOT COMPLETED|Overall Study||0
2432763|NCT01160822|5967842|P1|NOT COMPLETED|Overall Study||0
2432764|NCT01160822|5967836|P7|COMPLETED|Overall Study||44
2432765|NCT01160822|5967837|P6|COMPLETED|Overall Study||40
2432766|NCT01160822|5967838|P5|COMPLETED|Overall Study||36
2432767|NCT01160822|5967839|P4|COMPLETED|Overall Study||5
2432768|NCT01160822|5967840|P3|COMPLETED|Overall Study||6
2432769|NCT01160822|5967841|P2|COMPLETED|Overall Study||7
2432770|NCT01160822|5967842|P1|COMPLETED|Overall Study||6
2432771|NCT01160822|5967836|P7|STARTED|Overall Study||53
2432772|NCT01160822|5967837|P6|STARTED|Overall Study||47
2432773|NCT01160822|5967838|P5|STARTED|Overall Study||45
2432774|NCT01160822|5967839|P4|STARTED|Overall Study||5
2432775|NCT01160822|5967840|P3|STARTED|Overall Study||6
2432776|NCT01160822|5967841|P2|STARTED|Overall Study||7
2432777|NCT01160822|5967842|P1|STARTED|Overall Study||6
2432778|NCT01160770|5967931|P1|NOT COMPLETED|Overall Study||79
2432779|NCT01160770|5967931|P1|COMPLETED|Overall Study||188
2432780|NCT01160770|5967931|P1|STARTED|Overall Study||267
2432781|NCT01160744|5967944|P4|NOT COMPLETED|Overall Study||4
2432782|NCT01160744|5967945|P3|NOT COMPLETED|Overall Study||7
2432783|NCT01160744|5967946|P2|NOT COMPLETED|Overall Study||5
2432784|NCT01160744|5967947|P1|NOT COMPLETED|Overall Study||11
2432785|NCT01160744|5967944|P4|COMPLETED|Overall Study||67
2432786|NCT01160744|5967945|P3|COMPLETED|Overall Study||62
2432787|NCT01160744|5967946|P2|COMPLETED|Overall Study||64
2432788|NCT01160744|5967947|P1|COMPLETED|Overall Study||60
2432789|NCT01160744|5967944|P4|Received Study Drug|Overall Study||71
2432790|NCT01160744|5967945|P3|Received Study Drug|Overall Study||63
2432791|NCT01160744|5967946|P2|Received Study Drug|Overall Study||67
2432792|NCT01160744|5967947|P1|Received Study Drug|Overall Study||69
2432793|NCT01160744|5967944|P4|STARTED|Overall Study||71
2432794|NCT01160744|5967945|P3|STARTED|Overall Study||69
2432795|NCT01160744|5967946|P2|STARTED|Overall Study||69
2432796|NCT01160744|5967947|P1|STARTED|Overall Study||71
2432797|NCT01160640|5967983|P2|NOT COMPLETED|Overall Study||6
2432798|NCT01160640|5967984|P1|NOT COMPLETED|Overall Study||4
2432799|NCT01160640|5967983|P2|COMPLETED|Overall Study||110
2432800|NCT01160640|5967984|P1|COMPLETED|Overall Study||113
2432801|NCT01160640|5967983|P2|STARTED|Overall Study||116
2432802|NCT01160640|5967984|P1|STARTED|Overall Study||117
2432803|NCT01160614|5968000|P2|NOT COMPLETED|Overall Study||2
2432804|NCT01160614|5968001|P1|NOT COMPLETED|Overall Study||0
2432805|NCT01160614|5968000|P2|COMPLETED|Overall Study||23
2432806|NCT01160614|5968001|P1|COMPLETED|Overall Study||5
2432807|NCT01160614|5968000|P2|STARTED|Overall Study||25
2432808|NCT01160614|5968001|P1|STARTED|Overall Study||5
2432809|NCT01160484|5968049|P1|NOT COMPLETED|Overall Study||18
2432810|NCT01160484|5968049|P1|COMPLETED|Overall Study||22
2432811|NCT01160484|5968049|P1|STARTED|Overall Study||40
2432812|NCT01160458|5968059|P1|NOT COMPLETED|Overall Study||0
2432813|NCT01160458|5968059|P1|COMPLETED|Overall Study||20
2432814|NCT01160458|5968059|P1|STARTED|Overall Study||20
2432815|NCT01160445|5968069|P2|NOT COMPLETED|Overall Study||0
2432816|NCT01160445|5968070|P1|NOT COMPLETED|Overall Study||0
2432817|NCT01160445|5968069|P2|COMPLETED|Overall Study||2
2432818|NCT01160445|5968070|P1|COMPLETED|Overall Study||7
2432819|NCT01160445|5968069|P2|STARTED|Overall Study||2
2432820|NCT01160445|5968070|P1|STARTED|Overall Study||7
2432821|NCT01160380|5968080|P2|NOT COMPLETED|Overall Study||5
2432822|NCT01160380|5968081|P1|NOT COMPLETED|Overall Study||8
2432823|NCT01160380|5968080|P2|COMPLETED|Overall Study||20
2432824|NCT01160380|5968081|P1|COMPLETED|Overall Study||17
2432825|NCT01160380|5968080|P2|STARTED|Overall Study||25
2432826|NCT01160380|5968081|P1|STARTED|Overall Study||25
2432827|NCT01160354|5968102|P3|NOT COMPLETED|Overall Study||1
2432828|NCT01160354|5968103|P2|NOT COMPLETED|Overall Study||1
2432829|NCT01160354|5968104|P1|NOT COMPLETED|Overall Study||0
2432830|NCT01160354|5968102|P3|COMPLETED|Overall Study||14
2432831|NCT01160354|5968103|P2|COMPLETED|Overall Study||3
2432832|NCT01160354|5968104|P1|COMPLETED|Overall Study||3
2432833|NCT01160354|5968102|P3|STARTED|Overall Study||15
2432834|NCT01160354|5968103|P2|STARTED|Overall Study||4
2432835|NCT01160354|5968104|P1|STARTED|Overall Study||3
2432836|NCT01160289|5968123|P6|NOT COMPLETED|Post-Randomization Period||14
2432837|NCT01160289|5968124|P5|NOT COMPLETED|Post-Randomization Period||9
2432838|NCT01160289|5968125|P4|NOT COMPLETED|Post-Randomization Period||21
2432839|NCT01160289|5968126|P3|NOT COMPLETED|Post-Randomization Period||24
2432840|NCT01160289|5968127|P2|NOT COMPLETED|Post-Randomization Period||20
2432841|NCT01160289|5968128|P1|NOT COMPLETED|Post-Randomization Period||0
2432842|NCT01160289|5968123|P6|COMPLETED|Post-Randomization Period||73
2432843|NCT01160289|5968124|P5|COMPLETED|Post-Randomization Period||80
2432844|NCT01160289|5968125|P4|COMPLETED|Post-Randomization Period||31
2432845|NCT01160289|5968126|P3|COMPLETED|Post-Randomization Period||73
2432846|NCT01160289|5968127|P2|COMPLETED|Post-Randomization Period||65
2432847|NCT01160289|5968128|P1|COMPLETED|Post-Randomization Period||0
2432848|NCT01160289|5968123|P6|Received at Least 1 Dose of Study Drug|Post-Randomization Period||87
2432849|NCT01160289|5968124|P5|Received at Least 1 Dose of Study Drug|Post-Randomization Period||89
2432850|NCT01160289|5968125|P4|Received at Least 1 Dose of Study Drug|Post-Randomization Period||52
2432851|NCT01160289|5968126|P3|Received at Least 1 Dose of Study Drug|Post-Randomization Period||97
2432852|NCT01160289|5968127|P2|Received at Least 1 Dose of Study Drug|Post-Randomization Period||85
2432853|NCT01160289|5968128|P1|Received at Least 1 Dose of Study Drug|Post-Randomization Period||0
2432854|NCT01160289|5968123|P6|STARTED|Post-Randomization Period||87
2432855|NCT01160289|5968124|P5|STARTED|Post-Randomization Period||89
2432856|NCT01160289|5968125|P4|STARTED|Post-Randomization Period||52
2432857|NCT01160289|5968126|P3|STARTED|Post-Randomization Period||97
2432858|NCT01160289|5968127|P2|STARTED|Post-Randomization Period||85
2432859|NCT01160289|5968128|P1|STARTED|Post-Randomization Period||0
2432860|NCT01160289|5968123|P6|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
2432861|NCT01160289|5968124|P5|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
2432862|NCT01160289|5968125|P4|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
2432863|NCT01160289|5968126|P3|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
2432864|NCT01160289|5968127|P2|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
2432865|NCT01160289|5968128|P1|NOT COMPLETED|Screening, Washout, and Lead-In Period||484
2432866|NCT01160289|5968123|P6|COMPLETED|Screening, Washout, and Lead-In Period||0
2432867|NCT01160289|5968124|P5|COMPLETED|Screening, Washout, and Lead-In Period||0
2432868|NCT01160289|5968125|P4|COMPLETED|Screening, Washout, and Lead-In Period||0
2432869|NCT01160289|5968126|P3|COMPLETED|Screening, Washout, and Lead-In Period||0
2432870|NCT01160289|5968127|P2|COMPLETED|Screening, Washout, and Lead-In Period||0
2432871|NCT01160289|5968128|P1|COMPLETED|Screening, Washout, and Lead-In Period||410
2432872|NCT01160289|5968123|P6|STARTED|Screening, Washout, and Lead-In Period||0
2432873|NCT01160289|5968124|P5|STARTED|Screening, Washout, and Lead-In Period||0
2432874|NCT01160289|5968125|P4|STARTED|Screening, Washout, and Lead-In Period||0
2432875|NCT01160289|5968126|P3|STARTED|Screening, Washout, and Lead-In Period||0
2432876|NCT01160289|5968127|P2|STARTED|Screening, Washout, and Lead-In Period||0
2432877|NCT01160289|5968128|P1|STARTED|Screening, Washout, and Lead-In Period||894
2432878|NCT01160237|5968189|P3|NOT COMPLETED|Overall Study||0
2432879|NCT01160237|5968190|P2|NOT COMPLETED|Overall Study||0
2432880|NCT01160237|5968191|P1|NOT COMPLETED|Overall Study||0
2432881|NCT01160237|5968189|P3|COMPLETED|Overall Study||0
2432882|NCT01160237|5968190|P2|COMPLETED|Overall Study||3
2432883|NCT01160237|5968191|P1|COMPLETED|Overall Study||4
2432884|NCT01160237|5968189|P3|STARTED|Overall Study||0
2432885|NCT01160237|5968190|P2|STARTED|Overall Study||3
2432886|NCT01160237|5968191|P1|STARTED|Overall Study||4
2432887|NCT01160211|5968217|P3|NOT COMPLETED|Overall Study||87
2432888|NCT01160211|5968218|P2|NOT COMPLETED|Overall Study||87
2432889|NCT01160211|5968219|P1|NOT COMPLETED|Overall Study||99
2432890|NCT01160211|5968217|P3|COMPLETED|Overall Study||30
2432891|NCT01160211|5968218|P2|COMPLETED|Overall Study||31
2432892|NCT01160211|5968219|P1|COMPLETED|Overall Study||21
2432893|NCT01160211|5968217|P3|Ongoing|Overall Study||79
2432894|NCT01160211|5968218|P2|Ongoing|Overall Study||75
2432895|NCT01160211|5968219|P1|Ongoing|Overall Study||90
2432896|NCT01160211|5968217|P3|STARTED|Overall Study||117
2432897|NCT01160211|5968218|P2|STARTED|Overall Study||118
2432898|NCT01160211|5968219|P1|STARTED|Overall Study||120
2432899|NCT01160198|5968252|P3|NOT COMPLETED|Overall Study||1
2432900|NCT01160198|5968253|P2|NOT COMPLETED|Overall Study||3
2432901|NCT01160198|5968254|P1|NOT COMPLETED|Overall Study||2
2432902|NCT01160198|5968252|P3|COMPLETED|Overall Study||89
2432903|NCT01160198|5968253|P2|COMPLETED|Overall Study||88
2432904|NCT01160198|5968254|P1|COMPLETED|Overall Study||87
2432905|NCT01160198|5968252|P3|STARTED|Overall Study||90
2432906|NCT01160198|5968253|P2|STARTED|Overall Study||91
2432907|NCT01160198|5968254|P1|STARTED|Overall Study||89
2432908|NCT01159938|5968276|P5|NOT COMPLETED|Second Study Period||0
2432909|NCT01159938|5968277|P4|NOT COMPLETED|Second Study Period||0
2432910|NCT01159938|5968278|P3|NOT COMPLETED|Second Study Period||0
2432911|NCT01159938|5968279|P2|NOT COMPLETED|Second Study Period||0
2432912|NCT01159938|5968280|P1|NOT COMPLETED|Second Study Period||0
2432913|NCT01159938|5968276|P5|COMPLETED|Second Study Period||12
2432914|NCT01159938|5968277|P4|COMPLETED|Second Study Period||12
2432915|NCT01159938|5968278|P3|COMPLETED|Second Study Period||10
2432916|NCT01159938|5968279|P2|COMPLETED|Second Study Period||11
2432917|NCT01159938|5968280|P1|COMPLETED|Second Study Period||0
2432918|NCT01159938|5968276|P5|STARTED|Second Study Period||12
2432919|NCT01159938|5968277|P4|STARTED|Second Study Period||12
2432920|NCT01159938|5968278|P3|STARTED|Second Study Period||10
2432921|NCT01159938|5968279|P2|STARTED|Second Study Period||11
2432922|NCT01159938|5968280|P1|STARTED|Second Study Period||0
2432923|NCT01159938|5968276|P5|NOT COMPLETED|First Study Period||0
2432924|NCT01159938|5968277|P4|NOT COMPLETED|First Study Period||0
2432925|NCT01159938|5968278|P3|NOT COMPLETED|First Study Period||1
2432926|NCT01159938|5968279|P2|NOT COMPLETED|First Study Period||0
2432927|NCT01159938|5968280|P1|NOT COMPLETED|First Study Period||0
2432928|NCT01159938|5968276|P5|COMPLETED|First Study Period||12
2432929|NCT01159938|5968277|P4|COMPLETED|First Study Period||12
2432930|NCT01159938|5968278|P3|COMPLETED|First Study Period||10
2432931|NCT01159938|5968279|P2|COMPLETED|First Study Period||11
2432932|NCT01159938|5968280|P1|COMPLETED|First Study Period||26
2432933|NCT01159938|5968276|P5|Safety and Efficacy Analysis Population|First Study Period||12
2432934|NCT01159938|5968277|P4|Safety and Efficacy Analysis Population|First Study Period||12
2432935|NCT01159938|5968278|P3|Safety and Efficacy Analysis Population|First Study Period|Microalbuminuria relaxed with protocol amendment. T2DM albuminuria participant included in analyses.|11
2432936|NCT01159938|5968279|P2|Safety and Efficacy Analysis Population|First Study Period||11
2432937|NCT01159938|5968280|P1|Safety and Efficacy Analysis Population|First Study Period|One healthy participant completed study but was excluded from analyses (major protocol violation).|25
2432938|NCT01159938|5968276|P5|Received at Least 1 Dose of Study Drug|First Study Period||12
2432939|NCT01159938|5968277|P4|Received at Least 1 Dose of Study Drug|First Study Period||12
2432940|NCT01159938|5968278|P3|Received at Least 1 Dose of Study Drug|First Study Period||11
2432941|NCT01159938|5968279|P2|Received at Least 1 Dose of Study Drug|First Study Period||11
2432942|NCT01159938|5968280|P1|Received at Least 1 Dose of Study Drug|First Study Period||0
2432943|NCT01159938|5968276|P5|STARTED|First Study Period||12
2432944|NCT01159938|5968277|P4|STARTED|First Study Period||12
2432945|NCT01159938|5968278|P3|STARTED|First Study Period||11
2432946|NCT01159938|5968279|P2|STARTED|First Study Period||11
2432947|NCT01159938|5968280|P1|STARTED|First Study Period||26
2432948|NCT01159912|5968343|P3|NOT COMPLETED|Overall Study||26
2432949|NCT01159912|5968344|P2|NOT COMPLETED|Overall Study||22
2432950|NCT01159912|5968345|P1|NOT COMPLETED|Overall Study||40
2432951|NCT01159912|5968343|P3|COMPLETED|Overall Study||88
2432952|NCT01159912|5968344|P2|COMPLETED|Overall Study||92
2432953|NCT01159912|5968345|P1|COMPLETED|Overall Study||75
2432954|NCT01159912|5968343|P3|STARTED|Overall Study||114
2432955|NCT01159912|5968344|P2|STARTED|Overall Study||114
2432956|NCT01159912|5968345|P1|STARTED|Overall Study||115
2432957|NCT01159769|5968368|P1|NOT COMPLETED|Overall Study||1
2432958|NCT01159769|5968368|P1|COMPLETED|Overall Study||214
2432959|NCT01159769|5968368|P1|STARTED|Overall Study||215
2432960|NCT01159743|5968375|P2|NOT COMPLETED|Overall Study||0
2432961|NCT01159743|5968376|P1|NOT COMPLETED|Overall Study||0
2432962|NCT01159743|5968375|P2|COMPLETED|Overall Study||109
2432963|NCT01159743|5968376|P1|COMPLETED|Overall Study||237
2432964|NCT01159743|5968375|P2|STARTED|Overall Study||109
2432965|NCT01159743|5968376|P1|STARTED|Overall Study||237
2432966|NCT01159691|5968388|P1|NOT COMPLETED|Overall Study||22
2432967|NCT01159691|5968388|P1|COMPLETED|Overall Study|Multiple discontinuation reasons were possible.|54
2432968|NCT01159691|5968388|P1|STARTED|Overall Study||76
2432969|NCT01159665|5968401|P6|NOT COMPLETED|Overall Study||0
2432970|NCT01159665|5968402|P5|NOT COMPLETED|Overall Study||0
2432971|NCT01159665|5968403|P4|NOT COMPLETED|Overall Study||0
2432972|NCT01159665|5968404|P3|NOT COMPLETED|Overall Study||0
2432973|NCT01159665|5968405|P2|NOT COMPLETED|Overall Study||1
2432974|NCT01159665|5968406|P1|NOT COMPLETED|Overall Study||0
2432975|NCT01159665|5968401|P6|COMPLETED|Overall Study||4
2432976|NCT01159665|5968402|P5|COMPLETED|Overall Study||4
2432977|NCT01159665|5968403|P4|COMPLETED|Overall Study||4
2432978|NCT01159665|5968404|P3|COMPLETED|Overall Study||8
2432979|NCT01159665|5968405|P2|COMPLETED|Overall Study||8
2432980|NCT01159665|5968406|P1|COMPLETED|Overall Study||9
2432981|NCT01159665|5968401|P6|STARTED|Overall Study||4
2432982|NCT01159665|5968402|P5|STARTED|Overall Study||4
2432983|NCT01159665|5968403|P4|STARTED|Overall Study||4
2432984|NCT01159665|5968404|P3|STARTED|Overall Study||8
2432985|NCT01159665|5968405|P2|STARTED|Overall Study||9
2432986|NCT01159665|5968406|P1|STARTED|Overall Study||9
2432987|NCT01159600|5968434|P8|NOT COMPLETED|Overall Study||18
2432988|NCT01159600|5968435|P7|NOT COMPLETED|Overall Study||19
2432989|NCT01159600|5968436|P6|NOT COMPLETED|Overall Study||18
2432990|NCT01159600|5968437|P5|NOT COMPLETED|Overall Study||24
2432991|NCT01159600|5968438|P4|NOT COMPLETED|Overall Study||11
2432992|NCT01159600|5968439|P3|NOT COMPLETED|Overall Study||18
2432993|NCT01159600|5968440|P2|NOT COMPLETED|Overall Study||8
2432994|NCT01159600|5968441|P1|NOT COMPLETED|Overall Study||21
2432995|NCT01159600|5968434|P8|COMPLETED|Overall Study||85
2432996|NCT01159600|5968435|P7|COMPLETED|Overall Study||199
2432997|NCT01159600|5968436|P6|COMPLETED|Overall Study||208
2432998|NCT01159600|5968437|P5|COMPLETED|Overall Study||201
2432999|NCT01159600|5968438|P4|COMPLETED|Overall Study||58
2433000|NCT01159600|5968439|P3|COMPLETED|Overall Study||196
2433001|NCT01159600|5968440|P2|COMPLETED|Overall Study||209
2433002|NCT01159600|5968441|P1|COMPLETED|Overall Study||186
2433003|NCT01159600|5968434|P8|STARTED|Overall Study||103
2433004|NCT01159600|5968435|P7|STARTED|Overall Study||218
2433005|NCT01159600|5968436|P6|STARTED|Overall Study||226
2433006|NCT01159600|5968437|P5|STARTED|Overall Study||225
2433007|NCT01159600|5968438|P4|STARTED|Overall Study||69
2433008|NCT01159600|5968439|P3|STARTED|Overall Study||214
2433009|NCT01159600|5968440|P2|STARTED|Overall Study||217
2433010|NCT01159600|5968441|P1|STARTED|Overall Study||207
2433011|NCT01159574|5968483|P1|NOT COMPLETED|Follow Up Phase||20
2433012|NCT01159574|5968483|P1|COMPLETED|Follow Up Phase|Completion defined as those that are no longer in long term follow up due to death.|92
2433013|NCT01159574|5968483|P1|STARTED|Follow Up Phase||112
2433014|NCT01159574|5968483|P1|NOT COMPLETED|Treatment Phase||21
2433015|NCT01159574|5968483|P1|COMPLETED|Treatment Phase||100
2433016|NCT01159574|5968483|P1|STARTED|Treatment Phase||121
2433017|NCT01159535|5968492|P3|NOT COMPLETED|Overall Study||31
2433018|NCT01159535|5968493|P2|NOT COMPLETED|Overall Study||24
2433019|NCT01159535|5968494|P1|NOT COMPLETED|Overall Study||24
2433020|NCT01159535|5968492|P3|COMPLETED|Overall Study||64
2433021|NCT01159535|5968493|P2|COMPLETED|Overall Study||64
2433022|NCT01159535|5968494|P1|COMPLETED|Overall Study||79
2433023|NCT01159535|5968492|P3|STARTED|Overall Study||95
2433024|NCT01159535|5968493|P2|STARTED|Overall Study||88
2433025|NCT01159535|5968494|P1|STARTED|Overall Study||103
2433026|NCT01159431|5968504|P2|NOT COMPLETED|Overall Study||6
2433027|NCT01159431|5968505|P1|NOT COMPLETED|Overall Study||2
2433028|NCT01159431|5968504|P2|COMPLETED|Overall Study||19
2433029|NCT01159431|5968505|P1|COMPLETED|Overall Study||23
2433030|NCT01159431|5968504|P2|STARTED|Overall Study||25
2433031|NCT01159431|5968505|P1|STARTED|Overall Study||25
2433032|NCT01159262|5968524|P3|NOT COMPLETED|Overall Study||0
2433033|NCT01159262|5968525|P2|NOT COMPLETED|Overall Study||0
2433034|NCT01159262|5968526|P1|NOT COMPLETED|Overall Study||0
2433035|NCT01159262|5968524|P3|COMPLETED|Overall Study||8
2433036|NCT01159262|5968525|P2|COMPLETED|Overall Study||14
2433037|NCT01159262|5968526|P1|COMPLETED|Overall Study||14
2433038|NCT01159262|5968524|P3|STARTED|Overall Study||8
2433039|NCT01159262|5968525|P2|STARTED|Overall Study||14
2433040|NCT01159262|5968526|P1|STARTED|Overall Study||14
2433041|NCT01159171|5968558|P1|NOT COMPLETED|Overall Study||50
2433042|NCT01159171|5968558|P1|COMPLETED|Overall Study||0
2433043|NCT01159171|5968558|P1|STARTED|Overall Study||50
2433044|NCT01159067|5968573|P1|NOT COMPLETED|Overall Study||0
2433045|NCT01159067|5968573|P1|COMPLETED|Overall Study||1
2433046|NCT01159067|5968573|P1|STARTED|Overall Study||1
2433047|NCT01159054|5968580|P1|NOT COMPLETED|Overall Study||20
2433048|NCT01159054|5968580|P1|COMPLETED|Overall Study||2
2433049|NCT01159054|5968580|P1|STARTED|Overall Study||22
2433050|NCT01158976|5968594|P2|NOT COMPLETED|Overall Study||4
2433051|NCT01158976|5968595|P1|NOT COMPLETED|Overall Study||9
2433052|NCT01158976|5968594|P2|COMPLETED|Overall Study||17
2433053|NCT01158976|5968595|P1|COMPLETED|Overall Study||34
2433054|NCT01158976|5968594|P2|STARTED|Overall Study||21
2433055|NCT01158976|5968595|P1|STARTED|Overall Study||43
2433056|NCT01158924|5968639|P2|NOT COMPLETED|Overall Study||3
2433057|NCT01158924|5968640|P1|NOT COMPLETED|Overall Study||1
2433058|NCT01158924|5968639|P2|COMPLETED|Overall Study||23
2433059|NCT01158924|5968640|P1|COMPLETED|Overall Study||13
2433060|NCT01158924|5968639|P2|STARTED|Overall Study||26
2433061|NCT01158924|5968640|P1|STARTED|Overall Study||14
2433062|NCT01158885|5968654|P1|NOT COMPLETED|Treatment Course 2||0
2433063|NCT01158885|5968654|P1|COMPLETED|Treatment Course 2||0
2433064|NCT01158885|5968654|P1|STARTED|Treatment Course 2||0
2433065|NCT01158885|5968654|P1|NOT COMPLETED|Treatment Course 1||0
2433066|NCT01158885|5968654|P1|COMPLETED|Treatment Course 1||2
2433067|NCT01158885|5968654|P1|STARTED|Treatment Course 1||2
2433068|NCT01158820|5968662|P2|NOT COMPLETED|Overall Study||0
2433069|NCT01158820|5968663|P1|NOT COMPLETED|Overall Study||0
2433070|NCT01158820|5968662|P2|COMPLETED|Overall Study||25
2433071|NCT01158820|5968663|P1|COMPLETED|Overall Study||25
2433072|NCT01158820|5968662|P2|STARTED|Overall Study||25
2433073|NCT01158820|5968663|P1|STARTED|Overall Study||25
2433074|NCT01158716|5968685|P2|NOT COMPLETED|Overall Study||1
2433075|NCT01158716|5968686|P1|NOT COMPLETED|Overall Study||1
2433076|NCT01158716|5968685|P2|COMPLETED|Overall Study||47
2433077|NCT01158716|5968686|P1|COMPLETED|Overall Study||47
2433078|NCT01158716|5968685|P2|STARTED|Overall Study||48
2433079|NCT01158716|5968686|P1|STARTED|Overall Study||48
2433080|NCT01158703|5968694|P2|NOT COMPLETED|Overall Study||0
2433081|NCT01158703|5968695|P1|NOT COMPLETED|Overall Study||0
2433082|NCT01158703|5968694|P2|COMPLETED|Overall Study||8
2433083|NCT01158703|5968695|P1|COMPLETED|Overall Study||12
2433084|NCT01158703|5968694|P2|STARTED|Overall Study||8
2433085|NCT01158703|5968695|P1|STARTED|Overall Study||12
2433086|NCT01158651|5968711|P1|NOT COMPLETED|Overall Study||1
2433087|NCT01158651|5968711|P1|COMPLETED|Overall Study||22
2433088|NCT01158651|5968711|P1|STARTED|Overall Study||23
2433089|NCT01158573|5968720|P4|NOT COMPLETED|Overall Study||0
2433090|NCT01158573|5968721|P3|NOT COMPLETED|Overall Study||0
2433091|NCT01158573|5968722|P2|NOT COMPLETED|Overall Study||0
2433092|NCT01158573|5968723|P1|NOT COMPLETED|Overall Study||0
2433093|NCT01158573|5968720|P4|COMPLETED|Overall Study||28
2433094|NCT01158573|5968721|P3|COMPLETED|Overall Study||29
2433095|NCT01158573|5968722|P2|COMPLETED|Overall Study||30
2433096|NCT01158573|5968723|P1|COMPLETED|Overall Study|Study completed at 117 subjects.|30
2433097|NCT01158573|5968720|P4|STARTED|Overall Study||28
2433098|NCT01158573|5968721|P3|STARTED|Overall Study||29
2433099|NCT01158573|5968722|P2|STARTED|Overall Study||30
2433100|NCT01158573|5968723|P1|STARTED|Overall Study|Aimed to recruit 160 from July 2010 to May 2013. Each subject studied on one time point only|30
2433101|NCT01158534|5968745|P1|NOT COMPLETED|Overall Study||3
2433102|NCT01158534|5968745|P1|COMPLETED|Overall Study|All three pts that did not complete study had some treatment|14
2433103|NCT01158534|5968745|P1|STARTED|Overall Study||17
2433104|NCT01158521|5968753|P1|NOT COMPLETED|Overall Study||0
2433105|NCT01158521|5968753|P1|COMPLETED|Overall Study||25
2433106|NCT01158521|5968753|P1|STARTED|Overall Study||25
2433107|NCT01158404|5968770|P8|NOT COMPLETED|Overall Study||2
2433108|NCT01158404|5968771|P7|NOT COMPLETED|Overall Study||1
2433109|NCT01158404|5968772|P6|NOT COMPLETED|Overall Study||1
2433110|NCT01158404|5968773|P5|NOT COMPLETED|Overall Study||3
2433111|NCT01158404|5968774|P4|NOT COMPLETED|Overall Study||0
2433112|NCT01158404|5968775|P3|NOT COMPLETED|Overall Study||0
2433113|NCT01158404|5968776|P2|NOT COMPLETED|Overall Study||1
2433114|NCT01158404|5968777|P1|NOT COMPLETED|Overall Study||0
2433115|NCT01158404|5968770|P8|COMPLETED|Overall Study||6
2433116|NCT01158404|5968771|P7|COMPLETED|Overall Study||2
2433117|NCT01158404|5968772|P6|COMPLETED|Overall Study||4
2433118|NCT01158404|5968773|P5|COMPLETED|Overall Study||3
2433119|NCT01158404|5968774|P4|COMPLETED|Overall Study||3
2433120|NCT01158404|5968775|P3|COMPLETED|Overall Study||3
2433121|NCT01158404|5968776|P2|COMPLETED|Overall Study||3
2433122|NCT01158404|5968777|P1|COMPLETED|Overall Study||3
2433123|NCT01158404|5968770|P8|Received at Least 1 Dose of Study Drug|Overall Study||8
2433124|NCT01158404|5968771|P7|Received at Least 1 Dose of Study Drug|Overall Study||3
2433125|NCT01158404|5968772|P6|Received at Least 1 Dose of Study Drug|Overall Study||5
2433126|NCT01158404|5968773|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
2433127|NCT01158404|5968774|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
2433128|NCT01158404|5968775|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
2433129|NCT01158404|5968776|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
2433130|NCT01158404|5968777|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
2433131|NCT01158404|5968770|P8|STARTED|Overall Study||8
2433132|NCT01158404|5968771|P7|STARTED|Overall Study||3
2433133|NCT01158404|5968772|P6|STARTED|Overall Study||5
2433134|NCT01158404|5968773|P5|STARTED|Overall Study||6
2433135|NCT01158404|5968774|P4|STARTED|Overall Study||3
2433136|NCT01158404|5968775|P3|STARTED|Overall Study||3
2433137|NCT01158404|5968776|P2|STARTED|Overall Study||4
2433138|NCT01158404|5968777|P1|STARTED|Overall Study||3
2433139|NCT01158378|5968819|P2|NOT COMPLETED|Overall Study||9
2433140|NCT01158378|5968820|P1|NOT COMPLETED|Overall Study||10
2433141|NCT01158378|5968819|P2|COMPLETED|Overall Study||117
2433142|NCT01158378|5968820|P1|COMPLETED|Overall Study||114
2433143|NCT01158378|5968819|P2|STARTED|Overall Study||126
2433144|NCT01158378|5968820|P1|STARTED|Overall Study||124
2433145|NCT01158261|5968832|P1|NOT COMPLETED|Overall Study||17
2433146|NCT01158261|5968832|P1|COMPLETED|Overall Study||283
2433147|NCT01158261|5968832|P1|STARTED|Overall Study||300
2433148|NCT01158222|5968836|P1|NOT COMPLETED|Overall Study||17
2433149|NCT01158222|5968836|P1|COMPLETED|Overall Study||20
2433150|NCT01158222|5968836|P1|STARTED|Overall Study||37
2433151|NCT01158157|5968842|P1|NOT COMPLETED|Overall Study||0
2433152|NCT01158157|5968842|P1|COMPLETED|Overall Study||25
2433153|NCT01158157|5968842|P1|STARTED|Overall Study|61 subjects screened; 25 subjects were vaccinated; 36 subjects were not eligible.|25
2433154|NCT01158118|5968848|P2|NOT COMPLETED|Overall Study||3
2433155|NCT01158118|5968849|P1|NOT COMPLETED|Overall Study||1
2433156|NCT01158118|5968848|P2|COMPLETED|Overall Study||21
2433157|NCT01158118|5968849|P1|COMPLETED|Overall Study||23
2433158|NCT01158118|5968848|P2|STARTED|Overall Study||24
2433159|NCT01158118|5968849|P1|STARTED|Overall Study||24
2433160|NCT01157897|5968869|P4|NOT COMPLETED|Overall Study||1
2433161|NCT01157897|5968870|P3|NOT COMPLETED|Overall Study||0
2433162|NCT01157897|5968871|P2|NOT COMPLETED|Overall Study||2
2433163|NCT01157897|5968872|P1|NOT COMPLETED|Overall Study||2
2433164|NCT01157897|5968869|P4|COMPLETED|Overall Study||5
2433165|NCT01157897|5968870|P3|COMPLETED|Overall Study||10
2433166|NCT01157897|5968871|P2|COMPLETED|Overall Study||8
2433167|NCT01157897|5968872|P1|COMPLETED|Overall Study||8
2433168|NCT01157897|5968869|P4|STARTED|Overall Study||6
2433169|NCT01157897|5968870|P3|STARTED|Overall Study||10
2433170|NCT01157897|5968871|P2|STARTED|Overall Study||10
2433171|NCT01157897|5968872|P1|STARTED|Overall Study||10
2433172|NCT01157845|5968897|P1|NOT COMPLETED|Overall Study||35
2433173|NCT01157845|5968897|P1|COMPLETED|Overall Study||130
2433174|NCT01157845|5968897|P1|STARTED|Overall Study||165
2433175|NCT01157676|5968904|P2|NOT COMPLETED|Surgery||9
2433176|NCT01157676|5968905|P1|NOT COMPLETED|Surgery||1
2433177|NCT01157676|5968904|P2|COMPLETED|Surgery|advanced disease=2, inadequate visualization=1, inability to tolerate position=1, colonic mass=1.|150
2433178|NCT01157676|5968905|P1|COMPLETED|Surgery||152
2433179|NCT01157676|5968904|P2|STARTED|Surgery||159
2433180|NCT01157676|5968905|P1|STARTED|Surgery||153
2433181|NCT01157676|5968904|P2|NOT COMPLETED|Randomization||17
2433182|NCT01157676|5968905|P1|NOT COMPLETED|Randomization||21
2433183|NCT01157676|5968904|P2|COMPLETED|Randomization||159
2433184|NCT01157676|5968905|P1|COMPLETED|Randomization||153
2433185|NCT01157676|5968904|P2|STARTED|Randomization||176
2433186|NCT01157676|5968905|P1|STARTED|Randomization||174
2433187|NCT01157676|5968904|P2|NOT COMPLETED|Enrollment||0
2433188|NCT01157676|5968905|P1|NOT COMPLETED|Enrollment||0
2433189|NCT01157676|5968904|P2|COMPLETED|Enrollment||176
2433190|NCT01157676|5968905|P1|COMPLETED|Enrollment||174
2433191|NCT01157676|5968904|P2|STARTED|Enrollment||176
2433192|NCT01157676|5968905|P1|STARTED|Enrollment||174
2433193|NCT01157533|5968951|P1|NOT COMPLETED|Overall Study||0
2433194|NCT01157533|5968951|P1|COMPLETED|Overall Study||1
2433195|NCT01157533|5968951|P1|STARTED|Overall Study||1
2433196|NCT01157429|5968957|P2|NOT COMPLETED|Overall Study||4
2433197|NCT01157429|5968958|P1|NOT COMPLETED|Overall Study||4
2433198|NCT01157429|5968957|P2|COMPLETED|Overall Study||8
2433199|NCT01157429|5968958|P1|COMPLETED|Overall Study||8
2433200|NCT01157429|5968957|P2|STARTED|Overall Study||12
2433201|NCT01157429|5968958|P1|STARTED|Overall Study||12
2433202|NCT01157416|5968966|P2|NOT COMPLETED|Overall Study||0
2433203|NCT01157416|5968967|P1|NOT COMPLETED|Overall Study||2
2433204|NCT01157416|5968966|P2|COMPLETED|Overall Study||16
2433205|NCT01157416|5968967|P1|COMPLETED|Overall Study||15
2433206|NCT01157416|5968966|P2|STARTED|Overall Study||16
2433207|NCT01157416|5968967|P1|STARTED|Overall Study||17
2433208|NCT01157377|5968980|P7|NOT COMPLETED|Overall Study||2
2433209|NCT01157377|5968981|P6|NOT COMPLETED|Overall Study||3
2433210|NCT01157377|5968982|P5|NOT COMPLETED|Overall Study||2
2433211|NCT01157377|5968983|P4|NOT COMPLETED|Overall Study||1
2433212|NCT01157377|5968984|P3|NOT COMPLETED|Overall Study||1
2433213|NCT01157377|5968985|P2|NOT COMPLETED|Overall Study||3
2433214|NCT01157377|5968986|P1|NOT COMPLETED|Overall Study||2
2433215|NCT01157377|5968980|P7|COMPLETED|Overall Study||27
2433216|NCT01157377|5968981|P6|COMPLETED|Overall Study||16
2433217|NCT01157377|5968982|P5|COMPLETED|Overall Study||18
2433218|NCT01157377|5968983|P4|COMPLETED|Overall Study||14
2433219|NCT01157377|5968984|P3|COMPLETED|Overall Study||26
2433220|NCT01157377|5968985|P2|COMPLETED|Overall Study||20
2433221|NCT01157377|5968986|P1|COMPLETED|Overall Study||21
2433222|NCT01157377|5968980|P7|STARTED|Overall Study||29
2433223|NCT01157377|5968981|P6|STARTED|Overall Study||19
2433224|NCT01157377|5968982|P5|STARTED|Overall Study||20
2433225|NCT01157377|5968983|P4|STARTED|Overall Study||15
2433226|NCT01157377|5968984|P3|STARTED|Overall Study||27
2433227|NCT01157377|5968985|P2|STARTED|Overall Study||23
2433228|NCT01157377|5968986|P1|STARTED|Overall Study||23
2433229|NCT01157351|5969004|P2|NOT COMPLETED|Overall Study||132
2433230|NCT01157351|5969005|P1|NOT COMPLETED|Overall Study||137
2433231|NCT01157351|5969004|P2|COMPLETED|Overall Study||88
2433232|NCT01157351|5969005|P1|COMPLETED|Overall Study||93
2433233|NCT01157351|5969004|P2|Treated|Overall Study||218
2433234|NCT01157351|5969005|P1|Treated|Overall Study||226
2433235|NCT01157351|5969004|P2|STARTED|Overall Study||220
2433236|NCT01157351|5969005|P1|STARTED|Overall Study||230
2433237|NCT01157234|5969023|P2|NOT COMPLETED|Overall Study||0
2433238|NCT01157234|5969024|P1|NOT COMPLETED|Overall Study||1
2433239|NCT01157234|5969023|P2|COMPLETED|Overall Study||15
2433240|NCT01157234|5969024|P1|COMPLETED|Overall Study||14
2433241|NCT01157234|5969023|P2|STARTED|Overall Study||15
2433242|NCT01157234|5969024|P1|STARTED|Overall Study||15
2433243|NCT01157182|5969056|P2|NOT COMPLETED|Second Intervention||0
2433244|NCT01157182|5969057|P1|NOT COMPLETED|Second Intervention||0
2433245|NCT01157182|5969056|P2|COMPLETED|Second Intervention||18
2433246|NCT01157182|5969057|P1|COMPLETED|Second Intervention||16
2433247|NCT01157182|5969056|P2|STARTED|Second Intervention||18
2433248|NCT01157182|5969057|P1|STARTED|Second Intervention||16
2433249|NCT01157182|5969056|P2|NOT COMPLETED|Washout of 28 Days||0
2433250|NCT01157182|5969057|P1|NOT COMPLETED|Washout of 28 Days||2
2433251|NCT01157182|5969056|P2|COMPLETED|Washout of 28 Days||18
2433252|NCT01157182|5969057|P1|COMPLETED|Washout of 28 Days||16
2433253|NCT01157182|5969056|P2|STARTED|Washout of 28 Days||18
2433254|NCT01157182|5969057|P1|STARTED|Washout of 28 Days||18
2433255|NCT01157182|5969056|P2|NOT COMPLETED|First Intervention||0
2433256|NCT01157182|5969057|P1|NOT COMPLETED|First Intervention||0
2433257|NCT01157182|5969056|P2|COMPLETED|First Intervention||18
2433258|NCT01157182|5969057|P1|COMPLETED|First Intervention||18
2433259|NCT01157182|5969056|P2|STARTED|First Intervention||18
2433260|NCT01157182|5969057|P1|STARTED|First Intervention||18
2433261|NCT01157169|5969105|P2|NOT COMPLETED|Second Intervention||1
2433262|NCT01157169|5969106|P1|NOT COMPLETED|Second Intervention||0
2433263|NCT01157169|5969105|P2|COMPLETED|Second Intervention||17
2433264|NCT01157169|5969106|P1|COMPLETED|Second Intervention||16
2433265|NCT01157169|5969105|P2|STARTED|Second Intervention||18
2433266|NCT01157169|5969106|P1|STARTED|Second Intervention||16
2433267|NCT01157169|5969105|P2|NOT COMPLETED|Washout of 10 Days||0
2433268|NCT01157169|5969106|P1|NOT COMPLETED|Washout of 10 Days||0
2433269|NCT01157169|5969105|P2|COMPLETED|Washout of 10 Days||18
2433270|NCT01157169|5969106|P1|COMPLETED|Washout of 10 Days||16
2433271|NCT01157169|5969105|P2|STARTED|Washout of 10 Days||18
2433272|NCT01157169|5969106|P1|STARTED|Washout of 10 Days||16
2433273|NCT01157169|5969105|P2|NOT COMPLETED|First Intervention||2
2433274|NCT01157169|5969106|P1|NOT COMPLETED|First Intervention||4
2433275|NCT01157169|5969105|P2|COMPLETED|First Intervention||18
2433276|NCT01157169|5969106|P1|COMPLETED|First Intervention||16
2433277|NCT01157169|5969105|P2|STARTED|First Intervention||20
2433278|NCT01157169|5969106|P1|STARTED|First Intervention||20
2433279|NCT01157117|5969125|P3|NOT COMPLETED|Overall Study||15
2433280|NCT01157117|5969126|P2|NOT COMPLETED|Overall Study||11
2433281|NCT01157117|5969127|P1|NOT COMPLETED|Overall Study||9
2433282|NCT01157117|5969125|P3|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|5
2433283|NCT01157117|5969126|P2|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|18
2433284|NCT01157117|5969127|P1|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|19
2433285|NCT01157117|5969125|P3|Completed Final Month 38 Study Visit|Overall Study||3
2433286|NCT01157117|5969126|P2|Completed Final Month 38 Study Visit|Overall Study||18
2433287|NCT01157117|5969127|P1|Completed Final Month 38 Study Visit|Overall Study||19
2433288|NCT01157117|5969125|P3|Completed Month 32 Tolerance OFC|Overall Study||0
2433289|NCT01157117|5969126|P2|Completed Month 32 Tolerance OFC|Overall Study||20
2433290|NCT01157117|5969127|P1|Completed Month 32 Tolerance OFC|Overall Study||24
2433291|NCT01157117|5969125|P3|Discontinued Milk OIT at Month 30|Overall Study||0
2433292|NCT01157117|5969126|P2|Discontinued Milk OIT at Month 30|Overall Study||20
2433293|NCT01157117|5969127|P1|Discontinued Milk OIT at Month 30|Overall Study||24
2433294|NCT01157117|5969125|P3|Completed Month 28 Desensitization OFC|Overall Study||0
2433295|NCT01157117|5969126|P2|Completed Month 28 Desensitization OFC|Overall Study||24
2433296|NCT01157117|5969127|P1|Completed Month 28 Desensitization OFC|Overall Study||26
2433297|NCT01157117|5969125|P3|Unblinded at Month 16|Overall Study||0
2433298|NCT01157117|5969126|P2|Unblinded at Month 16|Overall Study||26
2433299|NCT01157117|5969127|P1|Unblinded at Month 16|Overall Study||26
2433300|NCT01157117|5969125|P3|Reached Milk OIT Maintenance Dosing|Overall Study||0
2433301|NCT01157117|5969126|P2|Reached Milk OIT Maintenance Dosing|Overall Study||26
2433302|NCT01157117|5969127|P1|Reached Milk OIT Maintenance Dosing|Overall Study||26
2433303|NCT01157117|5969125|P3|Began Milk OIT Dosing at Month 4|Overall Study||0
2433304|NCT01157117|5969126|P2|Began Milk OIT Dosing at Month 4|Overall Study||28
2433305|NCT01157117|5969127|P1|Began Milk OIT Dosing at Month 4|Overall Study||27
2433306|NCT01157117|5969125|P3|Began Omalizumab or Placebo Dosing|Overall Study||0
2433307|NCT01157117|5969126|P2|Began Omalizumab or Placebo Dosing|Overall Study||28
2433308|NCT01157117|5969127|P1|Began Omalizumab or Placebo Dosing|Overall Study||27
2433309|NCT01157117|5969125|P3|STARTED|Overall Study||20
2433310|NCT01157117|5969126|P2|STARTED|Overall Study||29
2433311|NCT01157117|5969127|P1|STARTED|Overall Study||28
2433312|NCT01157078|5969168|P2|NOT COMPLETED|Overall Study||36
2433313|NCT01157078|5969169|P1|NOT COMPLETED|Overall Study||35
2433314|NCT01157078|5969168|P2|COMPLETED|Overall Study||124
2433315|NCT01157078|5969169|P1|COMPLETED|Overall Study||124
2433316|NCT01157078|5969168|P2|Received Treatment|Overall Study||159
2433317|NCT01157078|5969169|P1|Received Treatment|Overall Study||157
2433318|NCT01157078|5969168|P2|STARTED|Overall Study||160
2433319|NCT01157078|5969169|P1|STARTED|Overall Study||159
2433320|NCT01157065|5969219|P2|NOT COMPLETED|Overall Study||1
2433321|NCT01157065|5969220|P1|NOT COMPLETED|Overall Study||0
2433322|NCT01157065|5969219|P2|COMPLETED|Overall Study||10
2433323|NCT01157065|5969220|P1|COMPLETED|Overall Study||38
2433324|NCT01157065|5969219|P2|STARTED|Overall Study||11
2433325|NCT01157065|5969220|P1|STARTED|Overall Study||38
2433326|NCT01156987|5969230|P2|NOT COMPLETED|Overall Study||11
2433327|NCT01156987|5969231|P1|NOT COMPLETED|Overall Study||0
2433328|NCT01156987|5969230|P2|COMPLETED|Overall Study||12
2433329|NCT01156987|5969231|P1|COMPLETED|Overall Study||8
2433330|NCT01156987|5969230|P2|STARTED|Overall Study||23
2433331|NCT01156987|5969231|P1|STARTED|Overall Study||8
2433332|NCT01156844|5969241|P4|NOT COMPLETED|Overall Study||6
2433333|NCT01156844|5969242|P3|NOT COMPLETED|Overall Study||6
2433334|NCT01156844|5969243|P2|NOT COMPLETED|Overall Study||2
2433335|NCT01156844|5969244|P1|NOT COMPLETED|Overall Study||2
2433336|NCT01156844|5969241|P4|COMPLETED|Overall Study||41
2433337|NCT01156844|5969242|P3|COMPLETED|Overall Study||42
2433338|NCT01156844|5969243|P2|COMPLETED|Overall Study||46
2433339|NCT01156844|5969244|P1|COMPLETED|Overall Study||46
2433340|NCT01156844|5969241|P4|PD & Safety Sets: Received Study Drug|Overall Study||46
2433341|NCT01156844|5969242|P3|PD & Safety Sets: Received Study Drug|Overall Study||48
2433342|NCT01156844|5969243|P2|PD & Safety Sets: Received Study Drug|Overall Study||47
2433343|NCT01156844|5969244|P1|PD & Safety Sets: Received Study Drug|Overall Study|PD=Pharmacodynamic|48
2433344|NCT01156844|5969241|P4|STARTED|Overall Study||47
2433345|NCT01156844|5969242|P3|STARTED|Overall Study||48
2433346|NCT01156844|5969243|P2|STARTED|Overall Study||48
2433347|NCT01156844|5969244|P1|STARTED|Overall Study|Randomized participants.|48
2433348|NCT01156805|5969265|P2|NOT COMPLETED|Overall Study||56
2433349|NCT01156805|5969266|P1|NOT COMPLETED|Overall Study||56
2433350|NCT01156805|5969265|P2|COMPLETED|Overall Study||216
2433351|NCT01156805|5969266|P1|COMPLETED|Overall Study||181
2433352|NCT01156805|5969265|P2|STARTED|Overall Study||272
2433353|NCT01156805|5969266|P1|STARTED|Overall Study||237
2433354|NCT01156792|5969278|P1|NOT COMPLETED|Overall Study||69
2433355|NCT01156792|5969278|P1|COMPLETED|Overall Study||93
2433356|NCT01156792|5969278|P1|STARTED|Overall Study||162
2433357|NCT01156714|5969346|P3|NOT COMPLETED|Overall Study||3
2433358|NCT01156714|5969347|P2|NOT COMPLETED|Overall Study||4
2433359|NCT01156714|5969348|P1|NOT COMPLETED|Overall Study||9
2433360|NCT01156714|5969346|P3|COMPLETED|Overall Study||17
2433361|NCT01156714|5969347|P2|COMPLETED|Overall Study||15
2433362|NCT01156714|5969348|P1|COMPLETED|Overall Study||11
2433363|NCT01156714|5969346|P3|STARTED|Overall Study||20
2433364|NCT01156714|5969347|P2|STARTED|Overall Study||19
2433365|NCT01156714|5969348|P1|STARTED|Overall Study||20
2433366|NCT01156701|5969371|P4|NOT COMPLETED|Overall Study||0
2433367|NCT01156701|5969372|P3|NOT COMPLETED|Overall Study||0
2433368|NCT01156701|5969373|P2|NOT COMPLETED|Overall Study||0
2433369|NCT01156701|5969374|P1|NOT COMPLETED|Overall Study||0
2433370|NCT01156701|5969371|P4|COMPLETED|Overall Study||6725
2433371|NCT01156701|5969372|P3|COMPLETED|Overall Study||163716
2433372|NCT01156701|5969373|P2|COMPLETED|Overall Study||1007
2433373|NCT01156701|5969374|P1|COMPLETED|Overall Study||257
2433374|NCT01156701|5969371|P4|STARTED|Overall Study||6725
2433375|NCT01156701|5969372|P3|STARTED|Overall Study||163716
2433376|NCT01156701|5969373|P2|STARTED|Overall Study||1007
2433377|NCT01156701|5969374|P1|STARTED|Overall Study||257
2433378|NCT01156675|5969411|P3|NOT COMPLETED|Overall Study||2
2433379|NCT01156675|5969412|P2|NOT COMPLETED|Overall Study||25
2433380|NCT01156675|5969413|P1|NOT COMPLETED|Overall Study||34
2433381|NCT01156675|5969411|P3|COMPLETED|Overall Study||0
2433382|NCT01156675|5969412|P2|COMPLETED|Overall Study||81
2433383|NCT01156675|5969413|P1|COMPLETED|Overall Study||73
2433384|NCT01156675|5969411|P3|STARTED|Overall Study||2
2433385|NCT01156675|5969412|P2|STARTED|Overall Study||106
2433386|NCT01156675|5969413|P1|STARTED|Overall Study||107
2433387|NCT01156597|5969447|P2|NOT COMPLETED|Overall Study||1
2433388|NCT01156597|5969448|P1|NOT COMPLETED|Overall Study||3
2433389|NCT01156597|5969447|P2|COMPLETED|Overall Study||13
2433390|NCT01156597|5969448|P1|COMPLETED|Overall Study||13
2433391|NCT01156597|5969447|P2|STARTED|Overall Study||14
2433392|NCT01156597|5969448|P1|STARTED|Overall Study||16
2433393|NCT01156571|5969460|P2|NOT COMPLETED|Overall Study||19
2433394|NCT01156571|5969461|P1|NOT COMPLETED|Overall Study||17
2433395|NCT01156571|5969460|P2|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5545
2433396|NCT01156571|5969461|P1|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5564
2433397|NCT01156571|5969460|P2|STARTED|Overall Study|ITT: defined as all patients randomized.|5564
2433398|NCT01156571|5969461|P1|STARTED|Overall Study|ITT: defined as all patients randomized.|5581
2433399|NCT01156532|5969471|P1|NOT COMPLETED|Overall Study||2
2433400|NCT01156532|5969471|P1|COMPLETED|Overall Study||28
2433401|NCT01156532|5969471|P1|STARTED|Overall Study||30
2433402|NCT01156480|5969483|P2|NOT COMPLETED|Overall Study||1
2433403|NCT01156480|5969484|P1|NOT COMPLETED|Overall Study||0
2433404|NCT01156480|5969483|P2|COMPLETED|Overall Study||1
2433405|NCT01156480|5969484|P1|COMPLETED|Overall Study||0
2433406|NCT01156480|5969483|P2|STARTED|Overall Study||2
2433407|NCT01156480|5969484|P1|STARTED|Overall Study||0
2433408|NCT01156376|5969513|P3|NOT COMPLETED|Overall Study||4
2433409|NCT01156376|5969514|P2|NOT COMPLETED|Overall Study||0
2433410|NCT01156376|5969515|P1|NOT COMPLETED|Overall Study||1
2433411|NCT01156376|5969513|P3|COMPLETED|Overall Study||23
2433412|NCT01156376|5969514|P2|COMPLETED|Overall Study||26
2433413|NCT01156376|5969515|P1|COMPLETED|Overall Study||26
2433414|NCT01156376|5969513|P3|STARTED|Overall Study||27
2433415|NCT01156376|5969514|P2|STARTED|Overall Study||26
2433416|NCT01156376|5969515|P1|STARTED|Overall Study||27
2433417|NCT01156363|5969736|P1|NOT COMPLETED|Overall Study||22
2433418|NCT01156363|5969736|P1|COMPLETED|Overall Study||64
2433419|NCT01156363|5969736|P1|STARTED|Overall Study||86
2433420|NCT01156311|5969758|P4|NOT COMPLETED|6-month Add-on Therapy Period||10
2433421|NCT01156311|5969759|P3|NOT COMPLETED|6-month Add-on Therapy Period||12
2433422|NCT01156311|5969760|P2|NOT COMPLETED|6-month Add-on Therapy Period||0
2433423|NCT01156311|5969761|P1|NOT COMPLETED|6-month Add-on Therapy Period||0
2433424|NCT01156311|5969758|P4|COMPLETED|6-month Add-on Therapy Period||37
2433425|NCT01156311|5969759|P3|COMPLETED|6-month Add-on Therapy Period||45
2433426|NCT01156311|5969760|P2|COMPLETED|6-month Add-on Therapy Period||0
2433427|NCT01156311|5969761|P1|COMPLETED|6-month Add-on Therapy Period||0
2433428|NCT01156311|5969758|P4|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||38
2433429|NCT01156311|5969759|P3|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||45
2433430|NCT01156311|5969760|P2|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
2433431|NCT01156311|5969761|P1|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
2433432|NCT01156311|5969758|P4|STARTED|6-month Add-on Therapy Period||47
2433433|NCT01156311|5969759|P3|STARTED|6-month Add-on Therapy Period||57
2433434|NCT01156311|5969760|P2|STARTED|6-month Add-on Therapy Period||0
2433435|NCT01156311|5969761|P1|STARTED|6-month Add-on Therapy Period||0
2433436|NCT01156311|5969758|P4|NOT COMPLETED|2-Month Monotherapy Period||0
2433437|NCT01156311|5969759|P3|NOT COMPLETED|2-Month Monotherapy Period||0
2433438|NCT01156311|5969760|P2|NOT COMPLETED|2-Month Monotherapy Period||2
2433439|NCT01156311|5969761|P1|NOT COMPLETED|2-Month Monotherapy Period||2
2433440|NCT01156311|5969758|P4|COMPLETED|2-Month Monotherapy Period||0
2433441|NCT01156311|5969759|P3|COMPLETED|2-Month Monotherapy Period||0
2433442|NCT01156311|5969760|P2|COMPLETED|2-Month Monotherapy Period||47
2433443|NCT01156311|5969761|P1|COMPLETED|2-Month Monotherapy Period||57
2433444|NCT01156311|5969758|P4|STARTED|2-Month Monotherapy Period||0
2433445|NCT01156311|5969759|P3|STARTED|2-Month Monotherapy Period||0
2433446|NCT01156311|5969760|P2|STARTED|2-Month Monotherapy Period||49
2433447|NCT01156311|5969761|P1|STARTED|2-Month Monotherapy Period||59
2433448|NCT01156142|5969785|P2|NOT COMPLETED|Overall Study||7
2433449|NCT01156142|5969786|P1|NOT COMPLETED|Overall Study||8
2433450|NCT01156142|5969785|P2|COMPLETED|Overall Study||71
2433451|NCT01156142|5969786|P1|COMPLETED|Overall Study||69
2433452|NCT01156142|5969785|P2|STARTED|Overall Study||78
2433453|NCT01156142|5969786|P1|STARTED|Overall Study||77
2433454|NCT01156116|5969804|P2|NOT COMPLETED|Overall Study||1
2433455|NCT01156116|5969805|P1|NOT COMPLETED|Overall Study||5
2433456|NCT01156116|5969804|P2|COMPLETED|Overall Study||12
2433457|NCT01156116|5969805|P1|COMPLETED|Overall Study||21
2433458|NCT01156116|5969804|P2|STARTED|Overall Study||13
2433459|NCT01156116|5969805|P1|STARTED|Overall Study||26
2433460|NCT01156051|5969819|P2|NOT COMPLETED|Overall Study||1
2433461|NCT01156051|5969820|P1|NOT COMPLETED|Overall Study||1
2433462|NCT01156051|5969819|P2|COMPLETED|Overall Study||16
2433463|NCT01156051|5969820|P1|COMPLETED|Overall Study||11
2433464|NCT01156051|5969819|P2|STARTED|Overall Study||17
2433465|NCT01156051|5969820|P1|STARTED|Overall Study||12
2433466|NCT01156012|5969834|P2|NOT COMPLETED|Overall Study||3
2433467|NCT01156012|5969835|P1|NOT COMPLETED|Overall Study||7
2433468|NCT01156012|5969834|P2|COMPLETED|Overall Study||186
2433469|NCT01156012|5969835|P1|COMPLETED|Overall Study||206
2433470|NCT01156012|5969834|P2|STARTED|Overall Study||189
2433471|NCT01156012|5969835|P1|STARTED|Overall Study||213
2433472|NCT01155999|5969843|P2|NOT COMPLETED|Overall Study||4
2433473|NCT01155999|5969844|P1|NOT COMPLETED|Overall Study||7
2433474|NCT01155999|5969843|P2|COMPLETED|Overall Study||136
2433475|NCT01155999|5969844|P1|COMPLETED|Overall Study||139
2433476|NCT01155999|5969843|P2|STARTED|Overall Study||140
2433477|NCT01155999|5969844|P1|STARTED|Overall Study||146
2433478|NCT01155869|5969852|P2|NOT COMPLETED|Overall Study||1
2433479|NCT01155869|5969853|P1|NOT COMPLETED|Overall Study||3
2433480|NCT01155869|5969852|P2|COMPLETED|Overall Study||3
2433481|NCT01155869|5969853|P1|COMPLETED|Overall Study||0
2433482|NCT01155869|5969852|P2|STARTED|Overall Study||4
2433483|NCT01155869|5969853|P1|STARTED|Overall Study||3
2433484|NCT01155830|5969864|P3|NOT COMPLETED|Overall Study||0
2433485|NCT01155830|5969865|P2|NOT COMPLETED|Overall Study||0
2433486|NCT01155830|5969866|P1|NOT COMPLETED|Overall Study||0
2433487|NCT01155830|5969864|P3|COMPLETED|Overall Study||21
2433488|NCT01155830|5969865|P2|COMPLETED|Overall Study||0
2433489|NCT01155830|5969866|P1|COMPLETED|Overall Study||0
2433490|NCT01155830|5969864|P3|STARTED|Overall Study||21
2433491|NCT01155830|5969865|P2|STARTED|Overall Study||0
2433492|NCT01155830|5969866|P1|STARTED|Overall Study||0
2433493|NCT01155778|5969880|P3|NOT COMPLETED|Overall Study||0
2433494|NCT01155778|5969881|P2|NOT COMPLETED|Overall Study||0
2433495|NCT01155778|5969882|P1|NOT COMPLETED|Overall Study||0
2433496|NCT01155778|5969880|P3|COMPLETED|Overall Study||4
2433497|NCT01155778|5969881|P2|COMPLETED|Overall Study||4
2433498|NCT01155778|5969882|P1|COMPLETED|Overall Study||4
2433499|NCT01155778|5969880|P3|STARTED|Overall Study||4
2433500|NCT01155778|5969881|P2|STARTED|Overall Study||4
2433501|NCT01155778|5969882|P1|STARTED|Overall Study||4
2433502|NCT01155726|5969962|P4|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
2433503|NCT01155726|5969963|P3|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
2433504|NCT01155726|5969964|P2|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
2433505|NCT01155726|5969965|P1|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
2433506|NCT01155726|5969962|P4|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||25
2433507|NCT01155726|5969963|P3|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||28
2433508|NCT01155726|5969964|P2|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||20
2433509|NCT01155726|5969965|P1|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||23
2433510|NCT01155726|5969962|P4|STARTED|Period 2, 3 Days (Unmask) or (Partial)||25
2433511|NCT01155726|5969963|P3|STARTED|Period 2, 3 Days (Unmask) or (Partial)||28
2433512|NCT01155726|5969964|P2|STARTED|Period 2, 3 Days (Unmask) or (Partial)||20
2433513|NCT01155726|5969965|P1|STARTED|Period 2, 3 Days (Unmask) or (Partial)||23
2433514|NCT01155726|5969962|P4|NOT COMPLETED|Period 1, 3 Days (Masked)||0
2433515|NCT01155726|5969963|P3|NOT COMPLETED|Period 1, 3 Days (Masked)||2
2433516|NCT01155726|5969964|P2|NOT COMPLETED|Period 1, 3 Days (Masked)||0
2433517|NCT01155726|5969965|P1|NOT COMPLETED|Period 1, 3 Days (Masked)||1
2433518|NCT01155726|5969962|P4|COMPLETED|Period 1, 3 Days (Masked)||25
2433519|NCT01155726|5969963|P3|COMPLETED|Period 1, 3 Days (Masked)||28
2433520|NCT01155726|5969964|P2|COMPLETED|Period 1, 3 Days (Masked)||20
2433521|NCT01155726|5969965|P1|COMPLETED|Period 1, 3 Days (Masked)||23
2433522|NCT01155726|5969962|P4|STARTED|Period 1, 3 Days (Masked)||25
2433523|NCT01155726|5969963|P3|STARTED|Period 1, 3 Days (Masked)||30
2433524|NCT01155726|5969964|P2|STARTED|Period 1, 3 Days (Masked)||20
2433525|NCT01155726|5969965|P1|STARTED|Period 1, 3 Days (Masked)||24
2433526|NCT01155661|5969987|P1|NOT COMPLETED|Overall Study||280
2433527|NCT01155661|5969987|P1|COMPLETED|Overall Study||328
2433528|NCT01155661|5969987|P1|STARTED|Overall Study||608
2433529|NCT01155570|5970013|P1|NOT COMPLETED|Overall Study||142
2433530|NCT01155570|5970013|P1|COMPLETED|Overall Study||592
2433531|NCT01155570|5970013|P1|Efficacy Analysis Population|Overall Study|5 received Humira off-label, 21 did not receive Humira after the first administration|708
2433532|NCT01155570|5970013|P1|STARTED|Overall Study|Safety Analysis Population|734
2433533|NCT01155531|5970047|P4|NOT COMPLETED|Overall Study||1
2433534|NCT01155531|5970048|P3|NOT COMPLETED|Overall Study||2
2433535|NCT01155531|5970049|P2|NOT COMPLETED|Overall Study||0
2433536|NCT01155531|5970050|P1|NOT COMPLETED|Overall Study||1
2433537|NCT01155531|5970047|P4|COMPLETED|Overall Study||9
2433538|NCT01155531|5970048|P3|COMPLETED|Overall Study||8
2433539|NCT01155531|5970049|P2|COMPLETED|Overall Study||10
2433540|NCT01155531|5970050|P1|COMPLETED|Overall Study||9
2433541|NCT01155531|5970047|P4|STARTED|Overall Study||10
2433542|NCT01155531|5970048|P3|STARTED|Overall Study||10
2433543|NCT01155531|5970049|P2|STARTED|Overall Study||10
2433544|NCT01155531|5970050|P1|STARTED|Overall Study||10
2433545|NCT01155518|5970074|P6|NOT COMPLETED|Overall Study||0
2433546|NCT01155518|5970075|P5|NOT COMPLETED|Overall Study||0
2433547|NCT01155518|5970076|P4|NOT COMPLETED|Overall Study||0
2433548|NCT01155518|5970077|P3|NOT COMPLETED|Overall Study||0
2433549|NCT01155518|5970078|P2|NOT COMPLETED|Overall Study||1
2433550|NCT01155518|5970079|P1|NOT COMPLETED|Overall Study||0
2433551|NCT01155518|5970074|P6|COMPLETED|Overall Study||2
2433552|NCT01155518|5970075|P5|COMPLETED|Overall Study||1
2433553|NCT01155518|5970076|P4|COMPLETED|Overall Study||0
2433554|NCT01155518|5970077|P3|COMPLETED|Overall Study||0
2433555|NCT01155518|5970078|P2|COMPLETED|Overall Study|never started the study|0
2433556|NCT01155518|5970079|P1|COMPLETED|Overall Study||1
2433557|NCT01155518|5970074|P6|STARTED|Overall Study||2
2433558|NCT01155518|5970075|P5|STARTED|Overall Study||1
2433559|NCT01155518|5970076|P4|STARTED|Overall Study||0
2433560|NCT01155518|5970077|P3|STARTED|Overall Study||0
2433561|NCT01155518|5970078|P2|STARTED|Overall Study||1
2433562|NCT01155518|5970079|P1|STARTED|Overall Study||1
2433563|NCT01155479|5970098|P5|NOT COMPLETED|Part II||55
2433564|NCT01155479|5970099|P4|NOT COMPLETED|Part II||50
2433565|NCT01155479|5970100|P3|NOT COMPLETED|Part II||58
2433566|NCT01155479|5970101|P2|NOT COMPLETED|Part II||61
2433567|NCT01155479|5970102|P1|NOT COMPLETED|Part II||59
2433568|NCT01155479|5970098|P5|COMPLETED|Part II||126
2433569|NCT01155479|5970099|P4|COMPLETED|Part II||127
2433570|NCT01155479|5970100|P3|COMPLETED|Part II||109
2433571|NCT01155479|5970101|P2|COMPLETED|Part II||116
2433572|NCT01155479|5970102|P1|COMPLETED|Part II||107
2433573|NCT01155479|5970098|P5|STARTED|Part II||181
2433574|NCT01155479|5970099|P4|STARTED|Part II||177
2433575|NCT01155479|5970100|P3|STARTED|Part II||167
2433576|NCT01155479|5970101|P2|STARTED|Part II||177
2433577|NCT01155479|5970102|P1|STARTED|Part II||166
2433578|NCT01155479|5970098|P5|NOT COMPLETED|Part I||23
2433579|NCT01155479|5970099|P4|NOT COMPLETED|Part I||27
2433580|NCT01155479|5970100|P3|NOT COMPLETED|Part I||39
2433581|NCT01155479|5970101|P2|NOT COMPLETED|Part I||27
2433582|NCT01155479|5970102|P1|NOT COMPLETED|Part I||38
2433583|NCT01155479|5970098|P5|COMPLETED|Part I||181
2433584|NCT01155479|5970099|P4|COMPLETED|Part I||177
2433585|NCT01155479|5970100|P3|COMPLETED|Part I||167
2433586|NCT01155479|5970101|P2|COMPLETED|Part I||177
2433587|NCT01155479|5970102|P1|COMPLETED|Part I||166
2433588|NCT01155479|5970098|P5|Treated|Part I||203
2433589|NCT01155479|5970099|P4|Treated|Part I||198
2433590|NCT01155479|5970100|P3|Treated|Part I||204
2433591|NCT01155479|5970101|P2|Treated|Part I||202
2433592|NCT01155479|5970102|P1|Treated|Part I||200
2433593|NCT01155479|5970098|P5|STARTED|Part I||204
2433594|NCT01155479|5970099|P4|STARTED|Part I||204
2433595|NCT01155479|5970100|P3|STARTED|Part I||206
2433596|NCT01155479|5970101|P2|STARTED|Part I||204
2433597|NCT01155479|5970102|P1|STARTED|Part I||204
2433598|NCT01155466|5970154|P5|NOT COMPLETED|Overall Study||27
2433599|NCT01155466|5970155|P4|NOT COMPLETED|Overall Study||21
2433600|NCT01155466|5970156|P3|NOT COMPLETED|Overall Study||20
2433601|NCT01155466|5970157|P2|NOT COMPLETED|Overall Study||25
2433602|NCT01155466|5970158|P1|NOT COMPLETED|Overall Study||22
2433603|NCT01155466|5970154|P5|COMPLETED|Overall Study|Completed treatment phase|129
2433604|NCT01155466|5970155|P4|COMPLETED|Overall Study|Completed treatment phase|134
2433605|NCT01155466|5970156|P3|COMPLETED|Overall Study|Completed treatment phase|136
2433606|NCT01155466|5970157|P2|COMPLETED|Overall Study|Completed treatment phase|130
2433607|NCT01155466|5970158|P1|COMPLETED|Overall Study|Completed treatment phase|134
2433608|NCT01155466|5970154|P5|Treated|Overall Study||154
2433609|NCT01155466|5970155|P4|Treated|Overall Study||155
2433610|NCT01155466|5970156|P3|Treated|Overall Study||153
2433611|NCT01155466|5970157|P2|Treated|Overall Study||153
2433612|NCT01155466|5970158|P1|Treated|Overall Study||154
2433613|NCT01155466|5970154|P5|STARTED|Overall Study||156
2433614|NCT01155466|5970155|P4|STARTED|Overall Study||155
2433615|NCT01155466|5970156|P3|STARTED|Overall Study||156
2433616|NCT01155466|5970157|P2|STARTED|Overall Study||155
2433617|NCT01155466|5970158|P1|STARTED|Overall Study||156
2433618|NCT01155388|5970212|P2|NOT COMPLETED|Overall Study||0
2433619|NCT01155388|5970213|P1|NOT COMPLETED|Overall Study||1
2433620|NCT01155388|5970212|P2|COMPLETED|Overall Study||6
2433621|NCT01155388|5970213|P1|COMPLETED|Overall Study||7
2433622|NCT01155388|5970212|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
2433623|NCT01155388|5970213|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
2433624|NCT01155388|5970212|P2|STARTED|Overall Study||6
2433625|NCT01155388|5970213|P1|STARTED|Overall Study||8
2433626|NCT01155375|5970223|P2|NOT COMPLETED|Overall Study||0
2433627|NCT01155375|5970224|P1|NOT COMPLETED|Overall Study||1
2433628|NCT01155375|5970223|P2|COMPLETED|Overall Study||6
2433629|NCT01155375|5970224|P1|COMPLETED|Overall Study||7
2433630|NCT01155375|5970223|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
2433631|NCT01155375|5970224|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
2433632|NCT01155375|5970223|P2|STARTED|Overall Study||6
2433633|NCT01155375|5970224|P1|STARTED|Overall Study||8
2433634|NCT01155336|5970234|P2|NOT COMPLETED|Overall Study||0
2433635|NCT01155336|5970235|P1|NOT COMPLETED|Overall Study||0
2433636|NCT01155336|5970234|P2|COMPLETED|Overall Study|We did not complete the study.|4
2433637|NCT01155336|5970235|P1|COMPLETED|Overall Study|We did not complete the study.|0
2433638|NCT01155336|5970234|P2|STARTED|Overall Study|We did not complete the study.|4
2433639|NCT01155336|5970235|P1|STARTED|Overall Study|We did not complete the study.|0
2433640|NCT01155323|5970243|P2|NOT COMPLETED|Second Intervention||1
2433641|NCT01155323|5970244|P1|NOT COMPLETED|Second Intervention||1
2433642|NCT01155323|5970243|P2|COMPLETED|Second Intervention||56
2433643|NCT01155323|5970244|P1|COMPLETED|Second Intervention||58
2433644|NCT01155323|5970243|P2|STARTED|Second Intervention||57
2433645|NCT01155323|5970244|P1|STARTED|Second Intervention||59
2433646|NCT01155323|5970243|P2|NOT COMPLETED|First Intervention||1
2433647|NCT01155323|5970244|P1|NOT COMPLETED|First Intervention||1
2433648|NCT01155323|5970243|P2|COMPLETED|First Intervention||57
2433649|NCT01155323|5970244|P1|COMPLETED|First Intervention||59
2433650|NCT01155323|5970243|P2|STARTED|First Intervention||58
2433651|NCT01155323|5970244|P1|STARTED|First Intervention||60
2433652|NCT01155284|5970262|P2|NOT COMPLETED|Overall Study||5
2433653|NCT01155284|5970263|P1|NOT COMPLETED|Overall Study||7
2433654|NCT01155284|5970262|P2|COMPLETED|Overall Study||18
2433655|NCT01155284|5970263|P1|COMPLETED|Overall Study||40
2433656|NCT01155284|5970262|P2|STARTED|Overall Study||23
2433657|NCT01155284|5970263|P1|STARTED|Overall Study||47
2433658|NCT01155219|5970273|P2|NOT COMPLETED|Overall Study||3
2433659|NCT01155219|5970274|P1|NOT COMPLETED|Overall Study||4
2433660|NCT01155219|5970273|P2|COMPLETED|Overall Study||70
2433661|NCT01155219|5970274|P1|COMPLETED|Overall Study||73
2433662|NCT01155219|5970273|P2|STARTED|Overall Study||73
2433663|NCT01155219|5970274|P1|STARTED|Overall Study||77
2433664|NCT01155193|5970284|P4|NOT COMPLETED|Overall Study||91
2433665|NCT01155193|5970285|P3|NOT COMPLETED|Overall Study||12
2433666|NCT01155193|5970286|P2|NOT COMPLETED|Overall Study||13
2433667|NCT01155193|5970287|P1|NOT COMPLETED|Overall Study||238
2433668|NCT01155193|5970284|P4|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|13711
2433669|NCT01155193|5970285|P3|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|2248
2433670|NCT01155193|5970286|P2|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|3805
2433671|NCT01155193|5970287|P1|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|10686
2433672|NCT01155193|5970284|P4|STARTED|Overall Study||13802
2433673|NCT01155193|5970285|P3|STARTED|Overall Study||2260
2433674|NCT01155193|5970286|P2|STARTED|Overall Study||3818
2433675|NCT01155193|5970287|P1|STARTED|Overall Study||10924
2433676|NCT01155180|5970314|P2|NOT COMPLETED|Overall Study||0
2433677|NCT01155180|5970315|P1|NOT COMPLETED|Overall Study||0
2433678|NCT01155180|5970314|P2|COMPLETED|Overall Study||6
2433679|NCT01155180|5970315|P1|COMPLETED|Overall Study||18
2433680|NCT01155180|5970314|P2|STARTED|Overall Study||6
2433681|NCT01155180|5970315|P1|STARTED|Overall Study||18
2433682|NCT01155167|5970323|P2|NOT COMPLETED|Overall Study||0
2433683|NCT01155167|5970324|P1|NOT COMPLETED|Overall Study||3
2433684|NCT01155167|5970323|P2|COMPLETED|Overall Study||43
2433685|NCT01155167|5970324|P1|COMPLETED|Overall Study||40
2433686|NCT01155167|5970323|P2|STARTED|Overall Study||43
2433687|NCT01155167|5970324|P1|STARTED|Overall Study||43
2433688|NCT01155154|5970337|P3|NOT COMPLETED|Overall Study||0
2433689|NCT01155154|5970338|P2|NOT COMPLETED|Overall Study||0
2433690|NCT01155154|5970339|P1|NOT COMPLETED|Overall Study||0
2433691|NCT01155154|5970337|P3|COMPLETED|Overall Study||24
2433692|NCT01155154|5970338|P2|COMPLETED|Overall Study||24
2433693|NCT01155154|5970339|P1|COMPLETED|Overall Study||25
2433694|NCT01155154|5970337|P3|STARTED|Overall Study||24
2433695|NCT01155154|5970338|P2|STARTED|Overall Study||24
2433696|NCT01155154|5970339|P1|STARTED|Overall Study||25
2433697|NCT01155141|5970347|P1|NOT COMPLETED|Overall Study||2
2433698|NCT01155141|5970347|P1|COMPLETED|Overall Study||14
2433699|NCT01155141|5970347|P1|STARTED|Overall Study||16
2433700|NCT01155063|5970359|P1|NOT COMPLETED|Overall Study||89
2433701|NCT01155063|5970359|P1|COMPLETED|Overall Study||0
2433702|NCT01155063|5970359|P1|STARTED|Overall Study||89
2433703|NCT01155024|5970369|P2|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||6
2433704|NCT01155024|5970370|P1|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||0
2433705|NCT01155024|5970369|P2|COMPLETED|Direct Manufactured Socket 3 Month Trial||4
2433706|NCT01155024|5970370|P1|COMPLETED|Direct Manufactured Socket 3 Month Trial||0
2433707|NCT01155024|5970369|P2|STARTED|Direct Manufactured Socket 3 Month Trial||10
2433708|NCT01155024|5970370|P1|STARTED|Direct Manufactured Socket 3 Month Trial||0
2433709|NCT01155024|5970369|P2|NOT COMPLETED|Second Socket Intervention Fitting||0
2433710|NCT01155024|5970370|P1|NOT COMPLETED|Second Socket Intervention Fitting||0
2433711|NCT01155024|5970369|P2|COMPLETED|Second Socket Intervention Fitting||5
2433712|NCT01155024|5970370|P1|COMPLETED|Second Socket Intervention Fitting||5
2433713|NCT01155024|5970369|P2|STARTED|Second Socket Intervention Fitting||5
2433714|NCT01155024|5970370|P1|STARTED|Second Socket Intervention Fitting||5
2433715|NCT01155024|5970369|P2|NOT COMPLETED|First Socket Intervention Fitting||0
2433716|NCT01155024|5970370|P1|NOT COMPLETED|First Socket Intervention Fitting||0
2433717|NCT01155024|5970369|P2|COMPLETED|First Socket Intervention Fitting||5
2433718|NCT01155024|5970370|P1|COMPLETED|First Socket Intervention Fitting||5
2433719|NCT01155024|5970369|P2|STARTED|First Socket Intervention Fitting||5
2433720|NCT01155024|5970370|P1|STARTED|First Socket Intervention Fitting||5
2433721|NCT01155011|5970380|P2|NOT COMPLETED|6 to 12 Months||10
2433722|NCT01155011|5970381|P1|NOT COMPLETED|6 to 12 Months||9
2433723|NCT01155011|5970380|P2|COMPLETED|6 to 12 Months||121
2433724|NCT01155011|5970381|P1|COMPLETED|6 to 12 Months||120
2433725|NCT01155011|5970380|P2|STARTED|6 to 12 Months||131
2433726|NCT01155011|5970381|P1|STARTED|6 to 12 Months||129
2433727|NCT01155011|5970380|P2|NOT COMPLETED|Baseline to 6 Months||25
2433728|NCT01155011|5970381|P1|NOT COMPLETED|Baseline to 6 Months||22
2433729|NCT01155011|5970380|P2|COMPLETED|Baseline to 6 Months||131
2433730|NCT01155011|5970381|P1|COMPLETED|Baseline to 6 Months||129
2433731|NCT01155011|5970380|P2|STARTED|Baseline to 6 Months||156
2433732|NCT01155011|5970381|P1|STARTED|Baseline to 6 Months||151
2433733|NCT01154985|5970394|P3|NOT COMPLETED|Overall Study||18
2433734|NCT01154985|5970395|P2|NOT COMPLETED|Overall Study||27
2433735|NCT01154985|5970396|P1|NOT COMPLETED|Overall Study||17
2433736|NCT01154985|5970394|P3|COMPLETED|Overall Study||68
2433737|NCT01154985|5970395|P2|COMPLETED|Overall Study||55
2433738|NCT01154985|5970396|P1|COMPLETED|Overall Study||58
2433739|NCT01154985|5970394|P3|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|64
2433740|NCT01154985|5970395|P2|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
2433741|NCT01154985|5970396|P1|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
2433742|NCT01154985|5970394|P3|Valid Biopsy -Baseline and Month 12.5|Overall Study||68
2433743|NCT01154985|5970395|P2|Valid Biopsy -Baseline and Month 12.5|Overall Study||62
2433744|NCT01154985|5970396|P1|Valid Biopsy -Baseline and Month 12.5|Overall Study||60
2433745|NCT01154985|5970394|P3|Full Analysis Set|Overall Study|Received at least one dose of study medication|86
2433746|NCT01154985|5970395|P2|Full Analysis Set|Overall Study|Received at least one dose of study medication|82
2433747|NCT01154985|5970396|P1|Full Analysis Set|Overall Study|Received at least one dose of study medication|75
2433748|NCT01154985|5970394|P3|STARTED|Overall Study|Randomized|86
2433749|NCT01154985|5970395|P2|STARTED|Overall Study|Randomized|82
2433750|NCT01154985|5970396|P1|STARTED|Overall Study|Randomized|75
2433751|NCT01154816|5970422|P12|NOT COMPLETED|Overall Study||4
2433752|NCT01154816|5970423|P11|NOT COMPLETED|Overall Study||11
2433753|NCT01154816|5970424|P10|NOT COMPLETED|Overall Study||10
2433754|NCT01154816|5970425|P9|NOT COMPLETED|Overall Study||9
2433755|NCT01154816|5970426|P8|NOT COMPLETED|Overall Study||7
2433756|NCT01154816|5970427|P7|NOT COMPLETED|Overall Study||6
2433757|NCT01154816|5970428|P6|NOT COMPLETED|Overall Study||8
2433758|NCT01154816|5970429|P5|NOT COMPLETED|Overall Study||10
2433759|NCT01154816|5970430|P4|NOT COMPLETED|Overall Study||10
2433760|NCT01154816|5970431|P3|NOT COMPLETED|Overall Study||10
2433761|NCT01154816|5970432|P2|NOT COMPLETED|Overall Study||10
2433762|NCT01154816|5970433|P1|NOT COMPLETED|Overall Study||20
2433763|NCT01154816|5970422|P12|COMPLETED|Overall Study||0
2433764|NCT01154816|5970423|P11|COMPLETED|Overall Study||0
2433765|NCT01154816|5970424|P10|COMPLETED|Overall Study||0
2433766|NCT01154816|5970425|P9|COMPLETED|Overall Study||1
2433767|NCT01154816|5970426|P8|COMPLETED|Overall Study||0
2433768|NCT01154816|5970427|P7|COMPLETED|Overall Study||0
2433769|NCT01154816|5970428|P6|COMPLETED|Overall Study||0
2433770|NCT01154816|5970429|P5|COMPLETED|Overall Study||0
2433771|NCT01154816|5970430|P4|COMPLETED|Overall Study||0
2433772|NCT01154816|5970431|P3|COMPLETED|Overall Study||0
2433773|NCT01154816|5970432|P2|COMPLETED|Overall Study||2
2433774|NCT01154816|5970433|P1|COMPLETED|Overall Study||0
2433775|NCT01154816|5970422|P12|STARTED|Overall Study||4
2433776|NCT01154816|5970423|P11|STARTED|Overall Study||11
2433777|NCT01154816|5970424|P10|STARTED|Overall Study||10
2433778|NCT01154816|5970425|P9|STARTED|Overall Study||10
2433779|NCT01154816|5970426|P8|STARTED|Overall Study||7
2433780|NCT01154816|5970427|P7|STARTED|Overall Study||6
2433781|NCT01154816|5970428|P6|STARTED|Overall Study||8
2433782|NCT01154816|5970429|P5|STARTED|Overall Study||10
2433783|NCT01154816|5970430|P4|STARTED|Overall Study||10
2433784|NCT01154816|5970431|P3|STARTED|Overall Study||10
2433785|NCT01154816|5970432|P2|STARTED|Overall Study||12
2433786|NCT01154816|5970433|P1|STARTED|Overall Study||20
2433787|NCT01154751|5970466|P1|NOT COMPLETED|3-year Follow-up||49
2433788|NCT01154751|5970466|P1|COMPLETED|3-year Follow-up||34
2433789|NCT01154751|5970466|P1|STARTED|3-year Follow-up||83
2433790|NCT01154751|5970466|P1|NOT COMPLETED|2-year Follow-up||10
2433791|NCT01154751|5970466|P1|COMPLETED|2-year Follow-up||83
2433792|NCT01154751|5970466|P1|STARTED|2-year Follow-up||93
2433793|NCT01154751|5970466|P1|NOT COMPLETED|1-year Follow-up||5
2433794|NCT01154751|5970466|P1|COMPLETED|1-year Follow-up||93
2433795|NCT01154751|5970466|P1|STARTED|1-year Follow-up||98
2433796|NCT01154751|5970466|P1|NOT COMPLETED|6-month Follow-up||11
2433797|NCT01154751|5970466|P1|COMPLETED|6-month Follow-up||98
2433798|NCT01154751|5970466|P1|STARTED|6-month Follow-up||109
2433799|NCT01154699|5970491|P2|NOT COMPLETED|Second Intervention||0
2433800|NCT01154699|5970492|P1|NOT COMPLETED|Second Intervention||0
2433801|NCT01154699|5970491|P2|COMPLETED|Second Intervention||8
2433802|NCT01154699|5970492|P1|COMPLETED|Second Intervention||13
2433803|NCT01154699|5970491|P2|Subjects With Asthma + OSA|Second Intervention||2
2433804|NCT01154699|5970492|P1|Subjects With Asthma + OSA|Second Intervention||6
2433805|NCT01154699|5970491|P2|Subjects With Asthma Only|Second Intervention||6
2433806|NCT01154699|5970492|P1|Subjects With Asthma Only|Second Intervention||7
2433807|NCT01154699|5970491|P2|STARTED|Second Intervention||8
2433808|NCT01154699|5970492|P1|STARTED|Second Intervention||13
2433809|NCT01154699|5970491|P2|NOT COMPLETED|Washout Period (4 Weeks)||0
2433810|NCT01154699|5970492|P1|NOT COMPLETED|Washout Period (4 Weeks)||0
2433811|NCT01154699|5970491|P2|COMPLETED|Washout Period (4 Weeks)||8
2433812|NCT01154699|5970492|P1|COMPLETED|Washout Period (4 Weeks)||13
2433813|NCT01154699|5970491|P2|Subjects With Asthma + OSA|Washout Period (4 Weeks)||2
2433814|NCT01154699|5970492|P1|Subjects With Asthma + OSA|Washout Period (4 Weeks)||6
2433815|NCT01154699|5970491|P2|Subjects With Asthma Only|Washout Period (4 Weeks)||6
2433816|NCT01154699|5970492|P1|Subjects With Asthma Only|Washout Period (4 Weeks)||7
2433817|NCT01154699|5970491|P2|STARTED|Washout Period (4 Weeks)||8
2433818|NCT01154699|5970492|P1|STARTED|Washout Period (4 Weeks)||13
2433819|NCT01154699|5970491|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
2433820|NCT01154699|5970492|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
2433821|NCT01154699|5970491|P2|COMPLETED|First Intervention (4 Weeks)||8
2433822|NCT01154699|5970492|P1|COMPLETED|First Intervention (4 Weeks)||13
2433823|NCT01154699|5970491|P2|Subjects With Asthma + OSA|First Intervention (4 Weeks)||2
2433824|NCT01154699|5970492|P1|Subjects With Asthma + OSA|First Intervention (4 Weeks)||6
2433825|NCT01154699|5970491|P2|Subjects With Asthma Only|First Intervention (4 Weeks)||6
2433826|NCT01154699|5970492|P1|Subjects With Asthma Only|First Intervention (4 Weeks)||7
2433827|NCT01154699|5970491|P2|STARTED|First Intervention (4 Weeks)||8
2433828|NCT01154699|5970492|P1|STARTED|First Intervention (4 Weeks)||13
2433829|NCT01154673|5970510|P2|NOT COMPLETED|Overall Study||0
2433830|NCT01154673|5970511|P1|NOT COMPLETED|Overall Study||2
2433831|NCT01154673|5970510|P2|COMPLETED|Overall Study||16
2433832|NCT01154673|5970511|P1|COMPLETED|Overall Study||14
2433833|NCT01154673|5970510|P2|STARTED|Overall Study||16
2433834|NCT01154673|5970511|P1|STARTED|Overall Study||16
2433835|NCT01154634|5970521|P4|NOT COMPLETED|Period 7 - Fourth Intervention||0
2433836|NCT01154634|5970522|P3|NOT COMPLETED|Period 7 - Fourth Intervention||0
2433837|NCT01154634|5970523|P2|NOT COMPLETED|Period 7 - Fourth Intervention||0
2433838|NCT01154634|5970524|P1|NOT COMPLETED|Period 7 - Fourth Intervention||0
2433839|NCT01154634|5970521|P4|COMPLETED|Period 7 - Fourth Intervention||5
2433840|NCT01154634|5970522|P3|COMPLETED|Period 7 - Fourth Intervention||4
2433841|NCT01154634|5970523|P2|COMPLETED|Period 7 - Fourth Intervention||7
2433842|NCT01154634|5970524|P1|COMPLETED|Period 7 - Fourth Intervention||4
2433843|NCT01154634|5970521|P4|STARTED|Period 7 - Fourth Intervention||5
2433844|NCT01154634|5970522|P3|STARTED|Period 7 - Fourth Intervention||4
2433845|NCT01154634|5970523|P2|STARTED|Period 7 - Fourth Intervention||7
2433846|NCT01154634|5970524|P1|STARTED|Period 7 - Fourth Intervention||4
2433847|NCT01154634|5970521|P4|NOT COMPLETED|Period 6 - Washout||0
2433848|NCT01154634|5970522|P3|NOT COMPLETED|Period 6 - Washout||0
2433849|NCT01154634|5970523|P2|NOT COMPLETED|Period 6 - Washout||0
2433850|NCT01154634|5970524|P1|NOT COMPLETED|Period 6 - Washout||0
2433851|NCT01154634|5970521|P4|COMPLETED|Period 6 - Washout||5
2433852|NCT01154634|5970522|P3|COMPLETED|Period 6 - Washout||4
2433853|NCT01154634|5970523|P2|COMPLETED|Period 6 - Washout||7
2433854|NCT01154634|5970524|P1|COMPLETED|Period 6 - Washout||4
2433855|NCT01154634|5970521|P4|STARTED|Period 6 - Washout||5
2433856|NCT01154634|5970522|P3|STARTED|Period 6 - Washout||4
2433857|NCT01154634|5970523|P2|STARTED|Period 6 - Washout||7
2433858|NCT01154634|5970524|P1|STARTED|Period 6 - Washout||4
2433859|NCT01154634|5970521|P4|NOT COMPLETED|Period 5 - Third Intervention||0
2433860|NCT01154634|5970522|P3|NOT COMPLETED|Period 5 - Third Intervention||0
2433861|NCT01154634|5970523|P2|NOT COMPLETED|Period 5 - Third Intervention||0
2433862|NCT01154634|5970524|P1|NOT COMPLETED|Period 5 - Third Intervention||0
2433863|NCT01154634|5970521|P4|COMPLETED|Period 5 - Third Intervention||5
2433864|NCT01154634|5970522|P3|COMPLETED|Period 5 - Third Intervention||4
2433865|NCT01154634|5970523|P2|COMPLETED|Period 5 - Third Intervention||7
2433866|NCT01154634|5970524|P1|COMPLETED|Period 5 - Third Intervention||4
2433867|NCT01154634|5970521|P4|STARTED|Period 5 - Third Intervention||5
2433868|NCT01154634|5970522|P3|STARTED|Period 5 - Third Intervention||4
2433869|NCT01154634|5970523|P2|STARTED|Period 5 - Third Intervention||7
2433870|NCT01154634|5970524|P1|STARTED|Period 5 - Third Intervention||4
2433871|NCT01154634|5970521|P4|NOT COMPLETED|Period 4 - Washout||0
2433872|NCT01154634|5970522|P3|NOT COMPLETED|Period 4 - Washout||0
2433873|NCT01154634|5970523|P2|NOT COMPLETED|Period 4 - Washout||0
2433874|NCT01154634|5970524|P1|NOT COMPLETED|Period 4 - Washout||0
2433875|NCT01154634|5970521|P4|COMPLETED|Period 4 - Washout||5
2433876|NCT01154634|5970522|P3|COMPLETED|Period 4 - Washout||4
2433877|NCT01154634|5970523|P2|COMPLETED|Period 4 - Washout||7
2433878|NCT01154634|5970524|P1|COMPLETED|Period 4 - Washout||4
2433879|NCT01154634|5970521|P4|STARTED|Period 4 - Washout||5
2433880|NCT01154634|5970522|P3|STARTED|Period 4 - Washout||4
2433881|NCT01154634|5970523|P2|STARTED|Period 4 - Washout||7
2433882|NCT01154634|5970524|P1|STARTED|Period 4 - Washout||4
2433883|NCT01154634|5970521|P4|NOT COMPLETED|Period 3- Second Intervention||0
2433884|NCT01154634|5970522|P3|NOT COMPLETED|Period 3- Second Intervention||0
2433885|NCT01154634|5970523|P2|NOT COMPLETED|Period 3- Second Intervention||0
2433886|NCT01154634|5970524|P1|NOT COMPLETED|Period 3- Second Intervention||0
2433887|NCT01154634|5970521|P4|COMPLETED|Period 3- Second Intervention||5
2433888|NCT01154634|5970522|P3|COMPLETED|Period 3- Second Intervention||4
2433889|NCT01154634|5970523|P2|COMPLETED|Period 3- Second Intervention||7
2433890|NCT01154634|5970524|P1|COMPLETED|Period 3- Second Intervention||4
2433891|NCT01154634|5970521|P4|STARTED|Period 3- Second Intervention||5
2433892|NCT01154634|5970522|P3|STARTED|Period 3- Second Intervention||4
2433893|NCT01154634|5970523|P2|STARTED|Period 3- Second Intervention||7
2433894|NCT01154634|5970524|P1|STARTED|Period 3- Second Intervention||4
2433895|NCT01154634|5970521|P4|NOT COMPLETED|Period 2 - Washout||0
2433896|NCT01154634|5970522|P3|NOT COMPLETED|Period 2 - Washout||0
2433897|NCT01154634|5970523|P2|NOT COMPLETED|Period 2 - Washout||0
2433898|NCT01154634|5970524|P1|NOT COMPLETED|Period 2 - Washout||0
2433899|NCT01154634|5970521|P4|COMPLETED|Period 2 - Washout||5
2433900|NCT01154634|5970522|P3|COMPLETED|Period 2 - Washout||4
2433901|NCT01154634|5970523|P2|COMPLETED|Period 2 - Washout||7
2433902|NCT01154634|5970524|P1|COMPLETED|Period 2 - Washout||4
2433903|NCT01154634|5970521|P4|STARTED|Period 2 - Washout||5
2433904|NCT01154634|5970522|P3|STARTED|Period 2 - Washout||4
2433905|NCT01154634|5970523|P2|STARTED|Period 2 - Washout||7
2433906|NCT01154634|5970524|P1|STARTED|Period 2 - Washout||4
2433907|NCT01154634|5970521|P4|NOT COMPLETED|Period 1 - First Intervention||0
2433908|NCT01154634|5970522|P3|NOT COMPLETED|Period 1 - First Intervention||0
2433909|NCT01154634|5970523|P2|NOT COMPLETED|Period 1 - First Intervention||0
2433910|NCT01154634|5970524|P1|NOT COMPLETED|Period 1 - First Intervention||0
2433911|NCT01154634|5970521|P4|COMPLETED|Period 1 - First Intervention||5
2433912|NCT01154634|5970522|P3|COMPLETED|Period 1 - First Intervention||4
2433913|NCT01154634|5970523|P2|COMPLETED|Period 1 - First Intervention||7
2433914|NCT01154634|5970524|P1|COMPLETED|Period 1 - First Intervention||4
2433915|NCT01154634|5970521|P4|STARTED|Period 1 - First Intervention||5
2433916|NCT01154634|5970522|P3|STARTED|Period 1 - First Intervention||4
2433917|NCT01154634|5970523|P2|STARTED|Period 1 - First Intervention||7
2433918|NCT01154634|5970524|P1|STARTED|Period 1 - First Intervention||4
2433919|NCT01154452|5970566|P4|NOT COMPLETED|Phase II||6
2433920|NCT01154452|5970567|P3|NOT COMPLETED|Phase II||5
2433921|NCT01154452|5970568|P2|NOT COMPLETED|Phase II||0
2433922|NCT01154452|5970569|P1|NOT COMPLETED|Phase II||0
2433923|NCT01154452|5970566|P4|COMPLETED|Phase II||27
2433924|NCT01154452|5970567|P3|COMPLETED|Phase II||30
2433925|NCT01154452|5970568|P2|COMPLETED|Phase II||0
2433926|NCT01154452|5970569|P1|COMPLETED|Phase II||0
2433927|NCT01154452|5970566|P4|STARTED|Phase II||33
2433928|NCT01154452|5970567|P3|STARTED|Phase II||35
2433929|NCT01154452|5970568|P2|STARTED|Phase II||0
2433930|NCT01154452|5970569|P1|STARTED|Phase II||0
2433931|NCT01154452|5970566|P4|NOT COMPLETED|Phase Ib||0
2433932|NCT01154452|5970567|P3|NOT COMPLETED|Phase Ib||0
2433933|NCT01154452|5970568|P2|NOT COMPLETED|Phase Ib||1
2433934|NCT01154452|5970569|P1|NOT COMPLETED|Phase Ib||3
2433935|NCT01154452|5970566|P4|COMPLETED|Phase Ib||0
2433936|NCT01154452|5970567|P3|COMPLETED|Phase Ib||0
2433937|NCT01154452|5970568|P2|COMPLETED|Phase Ib||3
2433938|NCT01154452|5970569|P1|COMPLETED|Phase Ib||3
2433939|NCT01154452|5970566|P4|STARTED|Phase Ib||0
2433940|NCT01154452|5970567|P3|STARTED|Phase Ib||0
2433941|NCT01154452|5970568|P2|STARTED|Phase Ib||4
2433942|NCT01154452|5970569|P1|STARTED|Phase Ib||6
2433943|NCT01154335|5970585|P3|NOT COMPLETED|Overall Study||5
2433944|NCT01154335|5970586|P2|NOT COMPLETED|Overall Study||6
2433945|NCT01154335|5970587|P1|NOT COMPLETED|Overall Study||7
2433946|NCT01154335|5970585|P3|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
2433947|NCT01154335|5970586|P2|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
2433948|NCT01154335|5970587|P1|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
2433949|NCT01154335|5970585|P3|STARTED|Overall Study||5
2433950|NCT01154335|5970586|P2|STARTED|Overall Study||6
2433951|NCT01154335|5970587|P1|STARTED|Overall Study||7
2433952|NCT01154322|5970594|P1|NOT COMPLETED|Overall Study||2
2433953|NCT01154322|5970594|P1|COMPLETED|Overall Study||14
2433954|NCT01154322|5970594|P1|STARTED|Overall Study||16
2433955|NCT01154296|5970601|P2|NOT COMPLETED|6-month Follow-up||328
2433956|NCT01154296|5970602|P1|NOT COMPLETED|6-month Follow-up||328
2433957|NCT01154296|5970601|P2|COMPLETED|6-month Follow-up||2179
2433958|NCT01154296|5970602|P1|COMPLETED|6-month Follow-up||2177
2433959|NCT01154296|5970601|P2|STARTED|6-month Follow-up||2507
2433960|NCT01154296|5970602|P1|STARTED|6-month Follow-up||2505
2433961|NCT01154296|5970601|P2|NOT COMPLETED|Randomization and Intervention||2
2433962|NCT01154296|5970602|P1|NOT COMPLETED|Randomization and Intervention||5
2433963|NCT01154296|5970601|P2|COMPLETED|Randomization and Intervention||2505
2433964|NCT01154296|5970602|P1|COMPLETED|Randomization and Intervention||2500
2433965|NCT01154296|5970601|P2|STARTED|Randomization and Intervention||2507
2433966|NCT01154296|5970602|P1|STARTED|Randomization and Intervention||2505
2433967|NCT01154283|5970620|P2|NOT COMPLETED|7-12 Weeks||1
2433968|NCT01154283|5970621|P1|NOT COMPLETED|7-12 Weeks||1
2433969|NCT01154283|5970620|P2|COMPLETED|7-12 Weeks||10
2433970|NCT01154283|5970621|P1|COMPLETED|7-12 Weeks||6
2433971|NCT01154283|5970620|P2|STARTED|7-12 Weeks||11
2433972|NCT01154283|5970621|P1|STARTED|7-12 Weeks||7
2433973|NCT01154283|5970620|P2|NOT COMPLETED|0-6 Weeks||3
2433974|NCT01154283|5970621|P1|NOT COMPLETED|0-6 Weeks||7
2433975|NCT01154283|5970620|P2|COMPLETED|0-6 Weeks||11
2433976|NCT01154283|5970621|P1|COMPLETED|0-6 Weeks||7
2433977|NCT01154283|5970620|P2|STARTED|0-6 Weeks||14
2433978|NCT01154283|5970621|P1|STARTED|0-6 Weeks||14
2433979|NCT01154231|5970633|P1|NOT COMPLETED|Overall Study||2
2433980|NCT01154231|5970633|P1|COMPLETED|Overall Study||312
2433981|NCT01154231|5970633|P1|STARTED|Overall Study||314
2433982|NCT01154218|5970639|P4|NOT COMPLETED|Fourth Intervention Period||0
2433983|NCT01154218|5970640|P3|NOT COMPLETED|Fourth Intervention Period||0
2433984|NCT01154218|5970641|P2|NOT COMPLETED|Fourth Intervention Period||0
2433985|NCT01154218|5970642|P1|NOT COMPLETED|Fourth Intervention Period||1
2433986|NCT01154218|5970639|P4|COMPLETED|Fourth Intervention Period||8
2433987|NCT01154218|5970640|P3|COMPLETED|Fourth Intervention Period||9
2433988|NCT01154218|5970641|P2|COMPLETED|Fourth Intervention Period||8
2433989|NCT01154218|5970642|P1|COMPLETED|Fourth Intervention Period||8
2433990|NCT01154218|5970639|P4|STARTED|Fourth Intervention Period||8
2433991|NCT01154218|5970640|P3|STARTED|Fourth Intervention Period||9
2433992|NCT01154218|5970641|P2|STARTED|Fourth Intervention Period||8
2433993|NCT01154218|5970642|P1|STARTED|Fourth Intervention Period||9
2433994|NCT01154218|5970639|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||1
2433995|NCT01154218|5970640|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2433996|NCT01154218|5970641|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2433997|NCT01154218|5970642|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2433998|NCT01154218|5970639|P4|COMPLETED|Washout Period (at Least 14 Days)||8
2433999|NCT01154218|5970640|P3|COMPLETED|Washout Period (at Least 14 Days)||9
2434000|NCT01154218|5970641|P2|COMPLETED|Washout Period (at Least 14 Days)||8
2434001|NCT01154218|5970642|P1|COMPLETED|Washout Period (at Least 14 Days)||9
2434002|NCT01154218|5970639|P4|STARTED|Washout Period (at Least 14 Days)||9
2434003|NCT01154218|5970640|P3|STARTED|Washout Period (at Least 14 Days)||9
2434004|NCT01154218|5970641|P2|STARTED|Washout Period (at Least 14 Days)||8
2434005|NCT01154218|5970642|P1|STARTED|Washout Period (at Least 14 Days)||9
2434006|NCT01154218|5970639|P4|NOT COMPLETED|Third Intervention Period||0
2434007|NCT01154218|5970640|P3|NOT COMPLETED|Third Intervention Period||0
2434008|NCT01154218|5970641|P2|NOT COMPLETED|Third Intervention Period||1
2434009|NCT01154218|5970642|P1|NOT COMPLETED|Third Intervention Period||0
2434010|NCT01154218|5970639|P4|COMPLETED|Third Intervention Period||9
2434011|NCT01154218|5970640|P3|COMPLETED|Third Intervention Period||9
2434012|NCT01154218|5970641|P2|COMPLETED|Third Intervention Period||8
2434013|NCT01154218|5970642|P1|COMPLETED|Third Intervention Period||9
2434014|NCT01154218|5970639|P4|STARTED|Third Intervention Period||9
2434015|NCT01154218|5970640|P3|STARTED|Third Intervention Period||9
2434016|NCT01154218|5970641|P2|STARTED|Third Intervention Period||9
2434017|NCT01154218|5970642|P1|STARTED|Third Intervention Period||9
2434018|NCT01154218|5970639|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2434019|NCT01154218|5970640|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2434020|NCT01154218|5970641|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2434021|NCT01154218|5970642|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2434022|NCT01154218|5970639|P4|COMPLETED|Washout Period (at Least 14 Days)||9
2434023|NCT01154218|5970640|P3|COMPLETED|Washout Period (at Least 14 Days)||9
2434024|NCT01154218|5970641|P2|COMPLETED|Washout Period (at Least 14 Days)||9
2434025|NCT01154218|5970642|P1|COMPLETED|Washout Period (at Least 14 Days)||9
2434026|NCT01154218|5970639|P4|STARTED|Washout Period (at Least 14 Days)||9
2434027|NCT01154218|5970640|P3|STARTED|Washout Period (at Least 14 Days)||9
2434028|NCT01154218|5970641|P2|STARTED|Washout Period (at Least 14 Days)||9
2434029|NCT01154218|5970642|P1|STARTED|Washout Period (at Least 14 Days)||9
2434030|NCT01154218|5970639|P4|NOT COMPLETED|Second Intervention Period||0
2434031|NCT01154218|5970640|P3|NOT COMPLETED|Second Intervention Period||0
2434032|NCT01154218|5970641|P2|NOT COMPLETED|Second Intervention Period||0
2434033|NCT01154218|5970642|P1|NOT COMPLETED|Second Intervention Period||0
2434034|NCT01154218|5970639|P4|COMPLETED|Second Intervention Period||9
2434035|NCT01154218|5970640|P3|COMPLETED|Second Intervention Period||9
2434036|NCT01154218|5970641|P2|COMPLETED|Second Intervention Period||9
2434037|NCT01154218|5970642|P1|COMPLETED|Second Intervention Period||9
2434038|NCT01154218|5970639|P4|STARTED|Second Intervention Period||9
2434039|NCT01154218|5970640|P3|STARTED|Second Intervention Period||9
2434040|NCT01154218|5970641|P2|STARTED|Second Intervention Period||9
2434041|NCT01154218|5970642|P1|STARTED|Second Intervention Period||9
2434042|NCT01154218|5970639|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2434043|NCT01154218|5970640|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2434044|NCT01154218|5970641|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2434045|NCT01154218|5970642|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2434046|NCT01154218|5970639|P4|COMPLETED|Washout Period (at Least 14 Days)||9
2434047|NCT01154218|5970640|P3|COMPLETED|Washout Period (at Least 14 Days)||9
2434048|NCT01154218|5970641|P2|COMPLETED|Washout Period (at Least 14 Days)||9
2434049|NCT01154218|5970642|P1|COMPLETED|Washout Period (at Least 14 Days)||9
2434050|NCT01154218|5970639|P4|STARTED|Washout Period (at Least 14 Days)||9
2434051|NCT01154218|5970640|P3|STARTED|Washout Period (at Least 14 Days)||9
2434052|NCT01154218|5970641|P2|STARTED|Washout Period (at Least 14 Days)||9
2434053|NCT01154218|5970642|P1|STARTED|Washout Period (at Least 14 Days)||9
2434054|NCT01154218|5970639|P4|NOT COMPLETED|First Intervention Period||0
2434055|NCT01154218|5970640|P3|NOT COMPLETED|First Intervention Period||0
2434056|NCT01154218|5970641|P2|NOT COMPLETED|First Intervention Period||0
2434057|NCT01154218|5970642|P1|NOT COMPLETED|First Intervention Period||0
2434058|NCT01154218|5970639|P4|COMPLETED|First Intervention Period||9
2434059|NCT01154218|5970640|P3|COMPLETED|First Intervention Period||9
2434060|NCT01154218|5970641|P2|COMPLETED|First Intervention Period||9
2434061|NCT01154218|5970642|P1|COMPLETED|First Intervention Period||9
2434062|NCT01154218|5970639|P4|STARTED|First Intervention Period||9
2434063|NCT01154218|5970640|P3|STARTED|First Intervention Period||9
2434064|NCT01154218|5970641|P2|STARTED|First Intervention Period||9
2434065|NCT01154218|5970642|P1|STARTED|First Intervention Period||9
2434066|NCT01154192|5970695|P3|NOT COMPLETED|Overall Study||0
2434067|NCT01154192|5970696|P2|NOT COMPLETED|Overall Study||0
2434068|NCT01154192|5970697|P1|NOT COMPLETED|Overall Study||0
2434069|NCT01154192|5970695|P3|COMPLETED|Overall Study||0
2434070|NCT01154192|5970696|P2|COMPLETED|Overall Study||10
2434071|NCT01154192|5970697|P1|COMPLETED|Overall Study||14
2434072|NCT01154192|5970695|P3|STARTED|Overall Study||0
2434073|NCT01154192|5970696|P2|STARTED|Overall Study||10
2434074|NCT01154192|5970697|P1|STARTED|Overall Study||14
2434075|NCT01154166|5970716|P2|NOT COMPLETED|Overall Study||12
2434076|NCT01154166|5970717|P1|NOT COMPLETED|Overall Study||34
2434077|NCT01154166|5970716|P2|COMPLETED|Overall Study||163
2434078|NCT01154166|5970717|P1|COMPLETED|Overall Study||135
2434079|NCT01154166|5970716|P2|STARTED|Overall Study||175
2434080|NCT01154166|5970717|P1|STARTED|Overall Study||169
2434081|NCT01154153|5970749|P2|NOT COMPLETED|Overall Study||3
2434082|NCT01154153|5970750|P1|NOT COMPLETED|Overall Study||5
2434083|NCT01154153|5970749|P2|COMPLETED|Overall Study||66
2434084|NCT01154153|5970750|P1|COMPLETED|Overall Study||66
2434085|NCT01154153|5970749|P2|STARTED|Overall Study||69
2434086|NCT01154153|5970750|P1|STARTED|Overall Study||71
2434087|NCT01154140|5970768|P2|NOT COMPLETED|Overall Study||102
2434088|NCT01154140|5970769|P1|NOT COMPLETED|Overall Study||91
2434089|NCT01154140|5970768|P2|COMPLETED|Overall Study||69
2434090|NCT01154140|5970769|P1|COMPLETED|Overall Study||81
2434091|NCT01154140|5970768|P2|Treated|Overall Study||169
2434092|NCT01154140|5970769|P1|Treated|Overall Study||171
2434093|NCT01154140|5970768|P2|STARTED|Overall Study||171
2434094|NCT01154140|5970769|P1|STARTED|Overall Study||172
2434095|NCT01154127|5970822|P2|NOT COMPLETED|Period 2 (21 Days)||1
2434096|NCT01154127|5970823|P1|NOT COMPLETED|Period 2 (21 Days)||0
2434097|NCT01154127|5970822|P2|COMPLETED|Period 2 (21 Days)||46
2434098|NCT01154127|5970823|P1|COMPLETED|Period 2 (21 Days)||49
2434099|NCT01154127|5970822|P2|STARTED|Period 2 (21 Days)||47
2434100|NCT01154127|5970823|P1|STARTED|Period 2 (21 Days)||49
2434101|NCT01154127|5970822|P2|NOT COMPLETED|Washout (14 - 28 Days)||0
2434102|NCT01154127|5970823|P1|NOT COMPLETED|Washout (14 - 28 Days)||3
2434103|NCT01154127|5970822|P2|COMPLETED|Washout (14 - 28 Days)||47
2434104|NCT01154127|5970823|P1|COMPLETED|Washout (14 - 28 Days)||49
2434105|NCT01154127|5970822|P2|STARTED|Washout (14 - 28 Days)||47
2434106|NCT01154127|5970823|P1|STARTED|Washout (14 - 28 Days)||52
2434107|NCT01154127|5970822|P2|NOT COMPLETED|Period 1 (21 Days)||6
2434108|NCT01154127|5970823|P1|NOT COMPLETED|Period 1 (21 Days)||3
2434109|NCT01154127|5970822|P2|COMPLETED|Period 1 (21 Days)||47
2434110|NCT01154127|5970823|P1|COMPLETED|Period 1 (21 Days)||52
2434111|NCT01154127|5970822|P2|STARTED|Period 1 (21 Days)||53
2434112|NCT01154127|5970823|P1|STARTED|Period 1 (21 Days)||55
2434113|NCT01154101|5970850|P5|NOT COMPLETED|Overall Study||1
2434114|NCT01154101|5970851|P4|NOT COMPLETED|Overall Study||2
2434115|NCT01154101|5970852|P3|NOT COMPLETED|Overall Study||3
2434116|NCT01154101|5970853|P2|NOT COMPLETED|Overall Study||4
2434117|NCT01154101|5970854|P1|NOT COMPLETED|Overall Study||0
2434118|NCT01154101|5970850|P5|COMPLETED|Overall Study||0
2434119|NCT01154101|5970851|P4|COMPLETED|Overall Study||9
2434120|NCT01154101|5970852|P3|COMPLETED|Overall Study||9
2434121|NCT01154101|5970853|P2|COMPLETED|Overall Study||5
2434122|NCT01154101|5970854|P1|COMPLETED|Overall Study||7
2434123|NCT01154101|5970850|P5|STARTED|Overall Study||1
2434124|NCT01154101|5970851|P4|STARTED|Overall Study||11
2434125|NCT01154101|5970852|P3|STARTED|Overall Study||12
2434126|NCT01154101|5970853|P2|STARTED|Overall Study||9
2434127|NCT01154101|5970854|P1|STARTED|Overall Study||7
2434128|NCT01154088|5970909|P3|NOT COMPLETED|Overall Study||7
2434129|NCT01154088|5970910|P2|NOT COMPLETED|Overall Study||6
2434130|NCT01154088|5970911|P1|NOT COMPLETED|Overall Study||4
2434131|NCT01154088|5970909|P3|COMPLETED|Overall Study||383
2434132|NCT01154088|5970910|P2|COMPLETED|Overall Study||384
2434133|NCT01154088|5970911|P1|COMPLETED|Overall Study||386
2434134|NCT01154088|5970909|P3|STARTED|Overall Study||390
2434135|NCT01154088|5970910|P2|STARTED|Overall Study||390
2434136|NCT01154088|5970911|P1|STARTED|Overall Study||390
2434137|NCT01154036|5970951|P8|NOT COMPLETED|Phase II||6
2434138|NCT01154036|5970952|P7|NOT COMPLETED|Phase II||9
2434139|NCT01154036|5970953|P6|NOT COMPLETED|Phase II||5
2434140|NCT01154036|5970954|P5|NOT COMPLETED|Phase II||8
2434141|NCT01154036|5970955|P4|NOT COMPLETED|Phase II||1
2434142|NCT01154036|5970956|P3|NOT COMPLETED|Phase II||0
2434143|NCT01154036|5970957|P2|NOT COMPLETED|Phase II||0
2434144|NCT01154036|5970958|P1|NOT COMPLETED|Phase II||0
2434145|NCT01154036|5970951|P8|COMPLETED|Phase II||200
2434146|NCT01154036|5970952|P7|COMPLETED|Phase II||225
2434147|NCT01154036|5970953|P6|COMPLETED|Phase II||121
2434148|NCT01154036|5970954|P5|COMPLETED|Phase II||116
2434149|NCT01154036|5970955|P4|COMPLETED|Phase II||27
2434150|NCT01154036|5970956|P3|COMPLETED|Phase II||0
2434151|NCT01154036|5970957|P2|COMPLETED|Phase II||0
2434152|NCT01154036|5970958|P1|COMPLETED|Phase II||0
2434153|NCT01154036|5970951|P8|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|206
2434154|NCT01154036|5970952|P7|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|234
2434155|NCT01154036|5970953|P6|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|126
2434156|NCT01154036|5970954|P5|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|124
2434157|NCT01154036|5970955|P4|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|28
2434158|NCT01154036|5970956|P3|STARTED|Phase II||0
2434159|NCT01154036|5970957|P2|STARTED|Phase II||0
2434160|NCT01154036|5970958|P1|STARTED|Phase II||0
2434161|NCT01154036|5970951|P8|NOT COMPLETED|Phase I||0
2434162|NCT01154036|5970952|P7|NOT COMPLETED|Phase I||0
2434163|NCT01154036|5970953|P6|NOT COMPLETED|Phase I||0
2434164|NCT01154036|5970954|P5|NOT COMPLETED|Phase I||0
2434165|NCT01154036|5970955|P4|NOT COMPLETED|Phase I||0
2434166|NCT01154036|5970956|P3|NOT COMPLETED|Phase I||56
2434167|NCT01154036|5970957|P2|NOT COMPLETED|Phase I||28
2434168|NCT01154036|5970958|P1|NOT COMPLETED|Phase I||3
2434169|NCT01154036|5970951|P8|COMPLETED|Phase I||0
2434170|NCT01154036|5970952|P7|COMPLETED|Phase I||0
2434171|NCT01154036|5970953|P6|COMPLETED|Phase I||0
2434172|NCT01154036|5970954|P5|COMPLETED|Phase I||0
2434173|NCT01154036|5970955|P4|COMPLETED|Phase I||0
2434174|NCT01154036|5970956|P3|COMPLETED|Phase I|Not all completers were eligible for Phase II|888
2434175|NCT01154036|5970957|P2|COMPLETED|Phase I|Not all completers were eligible for Phase II|455
2434176|NCT01154036|5970958|P1|COMPLETED|Phase I|Not all completers were eligible for Phase II|117
2434177|NCT01154036|5970951|P8|STARTED|Phase I||0
2434178|NCT01154036|5970952|P7|STARTED|Phase I||0
2434179|NCT01154036|5970953|P6|STARTED|Phase I||0
2434180|NCT01154036|5970954|P5|STARTED|Phase I||0
2434181|NCT01154036|5970955|P4|STARTED|Phase I||0
2434182|NCT01154036|5970956|P3|STARTED|Phase I||944
2434183|NCT01154036|5970957|P2|STARTED|Phase I||483
2434184|NCT01154036|5970958|P1|STARTED|Phase I||120
2434185|NCT01154010|5971082|P2|NOT COMPLETED|Overall Study||1
2434186|NCT01154010|5971083|P1|NOT COMPLETED|Overall Study||0
2434187|NCT01154010|5971082|P2|COMPLETED|Overall Study||8
2434188|NCT01154010|5971083|P1|COMPLETED|Overall Study||9
2434189|NCT01154010|5971082|P2|STARTED|Overall Study||9
2434190|NCT01154010|5971083|P1|STARTED|Overall Study||9
2434191|NCT01153984|5971089|P1|NOT COMPLETED|Overall Study||2
2434192|NCT01153984|5971089|P1|COMPLETED|Overall Study||21
2434193|NCT01153984|5971089|P1|STARTED|Overall Study||23
2434194|NCT01153971|5971100|P1|NOT COMPLETED|Follow-up (Months 17-40 of Study)||4
2434195|NCT01153971|5971100|P1|COMPLETED|Follow-up (Months 17-40 of Study)||37
2434196|NCT01153971|5971100|P1|STARTED|Follow-up (Months 17-40 of Study)||41
2434197|NCT01153971|5971100|P1|NOT COMPLETED|Maintenance Phase (Months 8-16 of Study)||3
2434198|NCT01153971|5971100|P1|COMPLETED|Maintenance Phase (Months 8-16 of Study)||41
2434199|NCT01153971|5971100|P1|STARTED|Maintenance Phase (Months 8-16 of Study)||44
2434200|NCT01153971|5971100|P1|NOT COMPLETED|Induction Phase (Months 1 to 7 of Study)||3
2434201|NCT01153971|5971100|P1|COMPLETED|Induction Phase (Months 1 to 7 of Study)||44
2434202|NCT01153971|5971100|P1|STARTED|Induction Phase (Months 1 to 7 of Study)||47
2434203|NCT01153958|5971123|P2|NOT COMPLETED|Overall Study||32
2434204|NCT01153958|5971124|P1|NOT COMPLETED|Overall Study||36
2434205|NCT01153958|5971123|P2|COMPLETED|Overall Study||35
2434206|NCT01153958|5971124|P1|COMPLETED|Overall Study||30
2434207|NCT01153958|5971123|P2|STARTED|Overall Study||67
2434208|NCT01153958|5971124|P1|STARTED|Overall Study||66
2434209|NCT01153893|5971142|P2|NOT COMPLETED|Overall Study||0
2434210|NCT01153893|5971143|P1|NOT COMPLETED|Overall Study||1
2434211|NCT01153893|5971142|P2|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 3.|36
2434212|NCT01153893|5971143|P1|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 1.|67
2434213|NCT01153893|5971142|P2|STARTED|Overall Study||36
2434214|NCT01153893|5971143|P1|STARTED|Overall Study|Issues with the informed consent obtained from one child led to related data not used in this report|68
2434215|NCT01153841|5971169|P2|NOT COMPLETED|Overall Study||0
2434216|NCT01153841|5971170|P1|NOT COMPLETED|Overall Study||6
2434217|NCT01153841|5971169|P2|COMPLETED|Overall Study||99
2434218|NCT01153841|5971170|P1|COMPLETED|Overall Study||193
2434219|NCT01153841|5971169|P2|STARTED|Overall Study||99
2434220|NCT01153841|5971170|P1|STARTED|Overall Study||199
2434221|NCT01153815|5971186|P2|NOT COMPLETED|Overall Study||5
2434222|NCT01153815|5971187|P1|NOT COMPLETED|Overall Study||9
2434223|NCT01153815|5971186|P2|COMPLETED|Overall Study||82
2434224|NCT01153815|5971187|P1|COMPLETED|Overall Study||74
2434225|NCT01153815|5971186|P2|STARTED|Overall Study||87
2434226|NCT01153815|5971187|P1|STARTED|Overall Study||83
2434227|NCT01153763|5971209|P1|NOT COMPLETED|Overall Study||21
2434228|NCT01153763|5971209|P1|COMPLETED|Overall Study||71
2434229|NCT01153763|5971209|P1|STARTED|Overall Study||92
2434230|NCT01153724|5971225|P1|NOT COMPLETED|Treatment Period 2||2
2434231|NCT01153724|5971225|P1|COMPLETED|Treatment Period 2||32
2434232|NCT01153724|5971225|P1|STARTED|Treatment Period 2||34
2434233|NCT01153724|5971225|P1|NOT COMPLETED|Treatment Period 1||1
2434234|NCT01153724|5971225|P1|COMPLETED|Treatment Period 1||34
2434235|NCT01153724|5971225|P1|STARTED|Treatment Period 1||35
2434236|NCT01153711|5971245|P1|NOT COMPLETED|Overall Study||0
2434237|NCT01153711|5971245|P1|COMPLETED|Overall Study||32
2434238|NCT01153711|5971245|P1|STARTED|Overall Study||32
2434239|NCT01153698|5971265|P1|NOT COMPLETED|Overall Study||29
2434240|NCT01153698|5971265|P1|COMPLETED|Overall Study|Completed Pradaxa treatment.|139
2434241|NCT01153698|5971265|P1|STARTED|Overall Study|Entered and treated.|168
2434242|NCT01153685|5971281|P2|NOT COMPLETED|Overall Study||0
2434243|NCT01153685|5971282|P1|NOT COMPLETED|Overall Study||0
2434244|NCT01153685|5971281|P2|COMPLETED|Overall Study||70
2434245|NCT01153685|5971282|P1|COMPLETED|Overall Study||50
2434246|NCT01153685|5971281|P2|STARTED|Overall Study||70
2434247|NCT01153685|5971282|P1|STARTED|Overall Study||50
2434248|NCT01153672|5971306|P1|NOT COMPLETED|Overall Study||2
2434249|NCT01153672|5971306|P1|COMPLETED|Overall Study||6
2434250|NCT01153672|5971306|P1|STARTED|Overall Study||8
2434251|NCT01153633|5971316|P2|NOT COMPLETED|Overall Study||4
2434252|NCT01153633|5971317|P1|NOT COMPLETED|Overall Study||4
2434253|NCT01153633|5971316|P2|COMPLETED|Overall Study||13
2434254|NCT01153633|5971317|P1|COMPLETED|Overall Study||13
2434255|NCT01153633|5971316|P2|STARTED|Overall Study||17
2434256|NCT01153633|5971317|P1|STARTED|Overall Study||17
2434257|NCT01153620|5971335|P2|NOT COMPLETED|Overall Study||0
2434258|NCT01153620|5971336|P1|NOT COMPLETED|Overall Study||0
2434259|NCT01153620|5971335|P2|COMPLETED|Overall Study|30 patients (31 wounds)|30
2434260|NCT01153620|5971336|P1|COMPLETED|Overall Study||30
2434261|NCT01153620|5971335|P2|STARTED|Overall Study|30 patients (31 wounds)|30
2434262|NCT01153620|5971336|P1|STARTED|Overall Study||30
2434263|NCT01153581|5971342|P1|NOT COMPLETED|Overall Study||0
2434264|NCT01153581|5971342|P1|COMPLETED|Overall Study||109
2434265|NCT01153581|5971342|P1|STARTED|Overall Study||109
2434266|NCT01153516|5971354|P2|NOT COMPLETED|Overall Study||0
2434267|NCT01153516|5971355|P1|NOT COMPLETED|Overall Study||2
2434268|NCT01153516|5971354|P2|COMPLETED|Overall Study||10
2434269|NCT01153516|5971355|P1|COMPLETED|Overall Study||10
2434270|NCT01153516|5971354|P2|STARTED|Overall Study||10
2434271|NCT01153516|5971355|P1|STARTED|Overall Study||12
2434272|NCT01153503|5971368|P3|NOT COMPLETED|Overall Study||0
2434273|NCT01153503|5971369|P2|NOT COMPLETED|Overall Study||1
2434274|NCT01153503|5971370|P1|NOT COMPLETED|Overall Study||0
2434275|NCT01153503|5971368|P3|COMPLETED|Overall Study||25
2434276|NCT01153503|5971369|P2|COMPLETED|Overall Study||24
2434277|NCT01153503|5971370|P1|COMPLETED|Overall Study||25
2434278|NCT01153503|5971368|P3|STARTED|Overall Study||25
2434279|NCT01153503|5971369|P2|STARTED|Overall Study||25
2434280|NCT01153503|5971370|P1|STARTED|Overall Study||25
2434281|NCT01153425|5971380|P2|NOT COMPLETED|Overall Study||3
2434282|NCT01153425|5971381|P1|NOT COMPLETED|Overall Study||3
2434283|NCT01153425|5971380|P2|COMPLETED|Overall Study||14
2434284|NCT01153425|5971381|P1|COMPLETED|Overall Study||13
2434285|NCT01153425|5971380|P2|STARTED|Overall Study||17
2434286|NCT01153425|5971381|P1|STARTED|Overall Study||16
2434287|NCT01153347|5971393|P4|NOT COMPLETED|Overall Study||32
2434288|NCT01153347|5971394|P3|NOT COMPLETED|Overall Study||50
2434289|NCT01153347|5971395|P2|NOT COMPLETED|Overall Study||44
2434290|NCT01153347|5971396|P1|NOT COMPLETED|Overall Study||33
2434291|NCT01153347|5971393|P4|COMPLETED|Overall Study||129
2434292|NCT01153347|5971394|P3|COMPLETED|Overall Study||110
2434293|NCT01153347|5971395|P2|COMPLETED|Overall Study||116
2434294|NCT01153347|5971396|P1|COMPLETED|Overall Study||127
2434295|NCT01153347|5971393|P4|Received Treatment|Overall Study||160
2434296|NCT01153347|5971394|P3|Received Treatment|Overall Study||158
2434297|NCT01153347|5971395|P2|Received Treatment|Overall Study||158
2434298|NCT01153347|5971396|P1|Received Treatment|Overall Study||160
2434299|NCT01153347|5971393|P4|STARTED|Overall Study||161
2434300|NCT01153347|5971394|P3|STARTED|Overall Study||160
2434301|NCT01153347|5971395|P2|STARTED|Overall Study||160
2434302|NCT01153347|5971396|P1|STARTED|Overall Study||160
2434303|NCT01153321|5971496|P2|NOT COMPLETED|Overall Study||3
2434304|NCT01153321|5971497|P1|NOT COMPLETED|Overall Study||1
2434305|NCT01153321|5971496|P2|COMPLETED|Overall Study||19
2434306|NCT01153321|5971497|P1|COMPLETED|Overall Study||21
2434307|NCT01153321|5971496|P2|STARTED|Overall Study||22
2434308|NCT01153321|5971497|P1|STARTED|Overall Study||22
2434309|NCT01153269|5971609|P1|NOT COMPLETED|Overall Study||2
2434310|NCT01153269|5971609|P1|COMPLETED|Overall Study||31
2434311|NCT01153269|5971609|P1|Participants Analyzed|Overall Study||33
2434312|NCT01153269|5971609|P1|STARTED|Overall Study||33
2434313|NCT01153009|5971672|P4|NOT COMPLETED|Overall Study||37
2434314|NCT01153009|5971673|P3|NOT COMPLETED|Overall Study||41
2434315|NCT01153009|5971674|P2|NOT COMPLETED|Overall Study||34
2434316|NCT01153009|5971675|P1|NOT COMPLETED|Overall Study||32
2434317|NCT01153009|5971672|P4|COMPLETED|Overall Study||115
2434318|NCT01153009|5971673|P3|COMPLETED|Overall Study||113
2434319|NCT01153009|5971674|P2|COMPLETED|Overall Study||113
2434320|NCT01153009|5971675|P1|COMPLETED|Overall Study||129
2434321|NCT01153009|5971672|P4|Treated|Overall Study||150
2434322|NCT01153009|5971673|P3|Treated|Overall Study||154
2434323|NCT01153009|5971674|P2|Treated|Overall Study||147
2434324|NCT01153009|5971675|P1|Treated|Overall Study||159
2434325|NCT01153009|5971672|P4|STARTED|Overall Study||152
2434326|NCT01153009|5971673|P3|STARTED|Overall Study||154
2434327|NCT01153009|5971674|P2|STARTED|Overall Study||147
2434328|NCT01153009|5971675|P1|STARTED|Overall Study||161
2434329|NCT01152996|5971705|P1|NOT COMPLETED|Overall Study||537
2434330|NCT01152996|5971705|P1|COMPLETED|Overall Study||538
2434331|NCT01152996|5971705|P1|Treated|Overall Study||1073
2434332|NCT01152996|5971705|P1|STARTED|Overall Study||1075
2434333|NCT01152814|5971718|P1|NOT COMPLETED|Overall Study||2
2434334|NCT01152814|5971718|P1|COMPLETED|Overall Study||62
2434335|NCT01152814|5971718|P1|STARTED|Overall Study||64
2434336|NCT01152788|5971727|P2|NOT COMPLETED|Overall Study||4
2434337|NCT01152788|5971728|P1|NOT COMPLETED|Overall Study||0
2434338|NCT01152788|5971727|P2|COMPLETED|Overall Study||28
2434339|NCT01152788|5971728|P1|COMPLETED|Overall Study||32
2434340|NCT01152788|5971727|P2|STARTED|Overall Study||32
2434341|NCT01152788|5971728|P1|STARTED|Overall Study||32
2434342|NCT01152697|5971740|P1|NOT COMPLETED|Overall Study||19
2434343|NCT01152697|5971740|P1|COMPLETED|Overall Study||11
2434344|NCT01152697|5971740|P1|STARTED|Overall Study||30
2434345|NCT01152580|5971765|P2|NOT COMPLETED|Overall Study||1
2434346|NCT01152580|5971766|P1|NOT COMPLETED|Overall Study||0
2434347|NCT01152580|5971765|P2|COMPLETED|Overall Study||13
2434348|NCT01152580|5971766|P1|COMPLETED|Overall Study||5
2434349|NCT01152580|5971765|P2|STARTED|Overall Study||14
2434350|NCT01152580|5971766|P1|STARTED|Overall Study||5
2434351|NCT01152554|5971788|P2|NOT COMPLETED|Overall Study||111
2434352|NCT01152554|5971789|P1|NOT COMPLETED|Overall Study||334
2434353|NCT01152554|5971788|P2|COMPLETED|Overall Study||92
2434354|NCT01152554|5971789|P1|COMPLETED|Overall Study||276
2434355|NCT01152554|5971788|P2|Received Treatment|Overall Study||201
2434356|NCT01152554|5971789|P1|Received Treatment|Overall Study||607
2434357|NCT01152554|5971788|P2|STARTED|Overall Study||203
2434358|NCT01152554|5971789|P1|STARTED|Overall Study||610
2434359|NCT01152450|5971811|P6|NOT COMPLETED|Period 3 (4 Weeks)||0
2434360|NCT01152450|5971812|P5|NOT COMPLETED|Period 3 (4 Weeks)||0
2434361|NCT01152450|5971813|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
2434362|NCT01152450|5971814|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
2434363|NCT01152450|5971815|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
2434364|NCT01152450|5971816|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
2434365|NCT01152450|5971811|P6|COMPLETED|Period 3 (4 Weeks)||12
2434366|NCT01152450|5971812|P5|COMPLETED|Period 3 (4 Weeks)||16
2434367|NCT01152450|5971813|P4|COMPLETED|Period 3 (4 Weeks)||15
2434368|NCT01152450|5971814|P3|COMPLETED|Period 3 (4 Weeks)||16
2434369|NCT01152450|5971815|P2|COMPLETED|Period 3 (4 Weeks)||15
2434370|NCT01152450|5971816|P1|COMPLETED|Period 3 (4 Weeks)||15
2434371|NCT01152450|5971811|P6|STARTED|Period 3 (4 Weeks)||12
2434372|NCT01152450|5971812|P5|STARTED|Period 3 (4 Weeks)||16
2434373|NCT01152450|5971813|P4|STARTED|Period 3 (4 Weeks)||15
2434374|NCT01152450|5971814|P3|STARTED|Period 3 (4 Weeks)||16
2434375|NCT01152450|5971815|P2|STARTED|Period 3 (4 Weeks)||15
2434376|NCT01152450|5971816|P1|STARTED|Period 3 (4 Weeks)||15
2434377|NCT01152450|5971811|P6|NOT COMPLETED|Period 2 (4 Weeks)||0
2434378|NCT01152450|5971812|P5|NOT COMPLETED|Period 2 (4 Weeks)||0
2434379|NCT01152450|5971813|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
2434380|NCT01152450|5971814|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
2434381|NCT01152450|5971815|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
2434382|NCT01152450|5971816|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
2434383|NCT01152450|5971811|P6|COMPLETED|Period 2 (4 Weeks)||12
2434384|NCT01152450|5971812|P5|COMPLETED|Period 2 (4 Weeks)||16
2434385|NCT01152450|5971813|P4|COMPLETED|Period 2 (4 Weeks)||15
2434386|NCT01152450|5971814|P3|COMPLETED|Period 2 (4 Weeks)||16
2434387|NCT01152450|5971815|P2|COMPLETED|Period 2 (4 Weeks)||15
2434388|NCT01152450|5971816|P1|COMPLETED|Period 2 (4 Weeks)||15
2434389|NCT01152450|5971811|P6|STARTED|Period 2 (4 Weeks)||12
2434390|NCT01152450|5971812|P5|STARTED|Period 2 (4 Weeks)||16
2434391|NCT01152450|5971813|P4|STARTED|Period 2 (4 Weeks)||15
2434392|NCT01152450|5971814|P3|STARTED|Period 2 (4 Weeks)||16
2434393|NCT01152450|5971815|P2|STARTED|Period 2 (4 Weeks)||15
2434394|NCT01152450|5971816|P1|STARTED|Period 2 (4 Weeks)||15
2434395|NCT01152450|5971811|P6|NOT COMPLETED|Period 1 (4 Weeks)||1
2434396|NCT01152450|5971812|P5|NOT COMPLETED|Period 1 (4 Weeks)||2
2434397|NCT01152450|5971813|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
2434398|NCT01152450|5971814|P3|NOT COMPLETED|Period 1 (4 Weeks)||1
2434399|NCT01152450|5971815|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
2434400|NCT01152450|5971816|P1|NOT COMPLETED|Period 1 (4 Weeks)||0
2434401|NCT01152450|5971811|P6|COMPLETED|Period 1 (4 Weeks)||12
2434402|NCT01152450|5971812|P5|COMPLETED|Period 1 (4 Weeks)||16
2434403|NCT01152450|5971813|P4|COMPLETED|Period 1 (4 Weeks)||15
2434404|NCT01152450|5971814|P3|COMPLETED|Period 1 (4 Weeks)||16
2434405|NCT01152450|5971815|P2|COMPLETED|Period 1 (4 Weeks)||15
2434406|NCT01152450|5971816|P1|COMPLETED|Period 1 (4 Weeks)||15
2434407|NCT01152450|5971811|P6|STARTED|Period 1 (4 Weeks)||13
2434408|NCT01152450|5971812|P5|STARTED|Period 1 (4 Weeks)||18
2434409|NCT01152450|5971813|P4|STARTED|Period 1 (4 Weeks)||15
2434410|NCT01152450|5971814|P3|STARTED|Period 1 (4 Weeks)||17
2434411|NCT01152450|5971815|P2|STARTED|Period 1 (4 Weeks)||16
2434412|NCT01152450|5971816|P1|STARTED|Period 1 (4 Weeks)||15
2434413|NCT01152437|5971887|P3|NOT COMPLETED|Overall Study||43
2434414|NCT01152437|5971888|P2|NOT COMPLETED|Overall Study||15
2434415|NCT01152437|5971889|P1|NOT COMPLETED|Overall Study||36
2434416|NCT01152437|5971887|P3|COMPLETED|Overall Study||0
2434417|NCT01152437|5971888|P2|COMPLETED|Overall Study||0
2434418|NCT01152437|5971889|P1|COMPLETED|Overall Study||0
2434419|NCT01152437|5971887|P3|STARTED|Overall Study|entered|43
2434420|NCT01152437|5971888|P2|STARTED|Overall Study|randomised|15
2434421|NCT01152437|5971889|P1|STARTED|Overall Study|randomised|36
2434422|NCT01152385|5971909|P4|NOT COMPLETED|Overall Study||5
2434423|NCT01152385|5971910|P3|NOT COMPLETED|Overall Study||5
2434424|NCT01152385|5971911|P2|NOT COMPLETED|Overall Study||6
2434425|NCT01152385|5971912|P1|NOT COMPLETED|Overall Study||9
2434426|NCT01152385|5971909|P4|COMPLETED|Overall Study||50
2434427|NCT01152385|5971910|P3|COMPLETED|Overall Study||51
2434428|NCT01152385|5971911|P2|COMPLETED|Overall Study||52
2434429|NCT01152385|5971912|P1|COMPLETED|Overall Study||46
2434430|NCT01152385|5971909|P4|STARTED|Overall Study||55
2434431|NCT01152385|5971910|P3|STARTED|Overall Study||56
2434432|NCT01152385|5971911|P2|STARTED|Overall Study||58
2434433|NCT01152385|5971912|P1|STARTED|Overall Study||55
2434434|NCT01152359|5971952|P2|NOT COMPLETED|Overall Study||22
2434435|NCT01152359|5971953|P1|NOT COMPLETED|Overall Study||24
2434436|NCT01152359|5971952|P2|COMPLETED|Overall Study||80
2434437|NCT01152359|5971953|P1|COMPLETED|Overall Study||81
2434438|NCT01152359|5971952|P2|STARTED|Overall Study||102
2434439|NCT01152359|5971953|P1|STARTED|Overall Study||105
2434440|NCT01152307|5971965|P2|NOT COMPLETED|Overall Study||0
2434441|NCT01152307|5971966|P1|NOT COMPLETED|Overall Study||0
2434442|NCT01152307|5971965|P2|COMPLETED|Overall Study||214
2434443|NCT01152307|5971966|P1|COMPLETED|Overall Study||191
2434444|NCT01152307|5971965|P2|STARTED|Overall Study||214
2434445|NCT01152307|5971966|P1|STARTED|Overall Study||191
2434446|NCT01152294|5971974|P2|NOT COMPLETED|Overall Study||0
2434447|NCT01152294|5971975|P1|NOT COMPLETED|Overall Study||0
2434448|NCT01152294|5971974|P2|COMPLETED|Overall Study||188
2434449|NCT01152294|5971975|P1|COMPLETED|Overall Study||213
2434450|NCT01152294|5971974|P2|STARTED|Overall Study||188
2434451|NCT01152294|5971975|P1|STARTED|Overall Study||213
2434452|NCT01152190|5971983|P2|NOT COMPLETED|Overall Study||8
2434453|NCT01152190|5971984|P1|NOT COMPLETED|Overall Study||5
2434454|NCT01152190|5971983|P2|COMPLETED|Overall Study||39
2434455|NCT01152190|5971984|P1|COMPLETED|Overall Study||45
2434456|NCT01152190|5971983|P2|Received at Least 1 Dose of Study Drug|Overall Study||47
2434457|NCT01152190|5971984|P1|Received at Least 1 Dose of Study Drug|Overall Study||50
2434458|NCT01152190|5971983|P2|STARTED|Overall Study||47
2434459|NCT01152190|5971984|P1|STARTED|Overall Study||50
2434460|NCT01152112|5971998|P2|NOT COMPLETED|Overall Study||0
2434461|NCT01152112|5971999|P1|NOT COMPLETED|Overall Study||0
2434462|NCT01152112|5971998|P2|COMPLETED|Overall Study||32
2434463|NCT01152112|5971999|P1|COMPLETED|Overall Study||42
2434464|NCT01152112|5971998|P2|STARTED|Overall Study||32
2434465|NCT01152112|5971999|P1|STARTED|Overall Study||42
2434466|NCT01152021|5972007|P2|NOT COMPLETED|Overall Study||6
2434467|NCT01152021|5972008|P1|NOT COMPLETED|Overall Study||6
2434468|NCT01152021|5972007|P2|COMPLETED|Overall Study||1
2434469|NCT01152021|5972008|P1|COMPLETED|Overall Study||2
2434470|NCT01152021|5972007|P2|STARTED|Overall Study||7
2434471|NCT01152021|5972008|P1|STARTED|Overall Study||8
2434472|NCT01151904|5972016|P1|NOT COMPLETED|Overall Study||0
2434473|NCT01151904|5972016|P1|COMPLETED|Overall Study||17
2434474|NCT01151904|5972016|P1|STARTED|Overall Study||17
2434475|NCT01151852|5972024|P2|NOT COMPLETED|Overall Study||0
2434476|NCT01151852|5972025|P1|NOT COMPLETED|Overall Study||0
2434477|NCT01151852|5972024|P2|COMPLETED|Overall Study||40
2434478|NCT01151852|5972025|P1|COMPLETED|Overall Study||41
2434479|NCT01151852|5972024|P2|STARTED|Overall Study||40
2434480|NCT01151852|5972025|P1|STARTED|Overall Study||41
2434481|NCT01151761|5972041|P1|NOT COMPLETED|Overall Study||0
2434482|NCT01151761|5972041|P1|COMPLETED|Overall Study||2
2434483|NCT01151761|5972041|P1|STARTED|Overall Study||2
2434484|NCT01151618|5972052|P1|NOT COMPLETED|Overall Study||9
2434485|NCT01151618|5972052|P1|COMPLETED|Overall Study||13
2434486|NCT01151618|5972052|P1|STARTED|Overall Study||22
2434487|NCT01151579|5972060|P2|NOT COMPLETED|Overall Study||7
2434488|NCT01151579|5972061|P1|NOT COMPLETED|Overall Study||12
2434489|NCT01151579|5972060|P2|COMPLETED|Overall Study||24
2434490|NCT01151579|5972061|P1|COMPLETED|Overall Study||46
2434491|NCT01151579|5972060|P2|STARTED|Overall Study||31
2434492|NCT01151579|5972061|P1|STARTED|Overall Study||58
2434493|NCT01151553|5972071|P1|NOT COMPLETED|Overall Study||0
2434494|NCT01151553|5972071|P1|COMPLETED|Overall Study||5
2434495|NCT01151553|5972071|P1|STARTED|Overall Study||5
2434496|NCT01151540|5972075|P1|NOT COMPLETED|Overall Study||13
2434497|NCT01151540|5972075|P1|COMPLETED|Overall Study||41
2434498|NCT01151540|5972075|P1|STARTED|Overall Study||54
2434499|NCT01151449|5972084|P1|NOT COMPLETED|Overall Study||0
2434500|NCT01151449|5972084|P1|COMPLETED|Overall Study||6
2434501|NCT01151449|5972084|P1|STARTED|Overall Study||6
2434502|NCT01151436|5972092|P1|NOT COMPLETED|Overall Study||1
2434503|NCT01151436|5972092|P1|COMPLETED|Overall Study||76
2434504|NCT01151436|5972092|P1|STARTED|Overall Study||77
2434505|NCT01151423|5972124|P2|NOT COMPLETED|Overall Study||18
2434506|NCT01151423|5972125|P1|NOT COMPLETED|Overall Study||16
2434507|NCT01151423|5972124|P2|COMPLETED|Overall Study||21
2434508|NCT01151423|5972125|P1|COMPLETED|Overall Study||20
2434509|NCT01151423|5972124|P2|Received Study Drug|Overall Study||37
2434510|NCT01151423|5972125|P1|Received Study Drug|Overall Study||35
2434511|NCT01151423|5972124|P2|STARTED|Overall Study||39
2434512|NCT01151423|5972125|P1|STARTED|Overall Study||36
2434513|NCT01151410|5972173|P2|NOT COMPLETED|Overall Study||15
2434514|NCT01151410|5972174|P1|NOT COMPLETED|Overall Study||11
2434515|NCT01151410|5972173|P2|COMPLETED|Overall Study||89
2434516|NCT01151410|5972174|P1|COMPLETED|Overall Study||93
2434517|NCT01151410|5972173|P2|Safety Set (SAF)|Overall Study|Number of patients in SAF differed due to kit dispensing error in 1 patient at Visit 12|103
2434518|NCT01151410|5972174|P1|Safety Set (SAF)|Overall Study||105
2434519|NCT01151410|5972173|P2|STARTED|Overall Study||104
2434520|NCT01151410|5972174|P1|STARTED|Overall Study||104
2434521|NCT01151371|5972187|P3|NOT COMPLETED|Overall Study||7
2434522|NCT01151371|5972188|P2|NOT COMPLETED|Overall Study||1
2434523|NCT01151371|5972189|P1|NOT COMPLETED|Overall Study||5
2434524|NCT01151371|5972187|P3|COMPLETED|Overall Study||146
2434525|NCT01151371|5972188|P2|COMPLETED|Overall Study||149
2434526|NCT01151371|5972189|P1|COMPLETED|Overall Study||144
2434527|NCT01151371|5972187|P3|STARTED|Overall Study||153
2434528|NCT01151371|5972188|P2|STARTED|Overall Study||150
2434529|NCT01151371|5972189|P1|STARTED|Overall Study||149
2434530|NCT01151345|5972218|P2|NOT COMPLETED|Second Intervention Period||0
2434531|NCT01151345|5972219|P1|NOT COMPLETED|Second Intervention Period||0
2434532|NCT01151345|5972218|P2|COMPLETED|Second Intervention Period||12
2434533|NCT01151345|5972219|P1|COMPLETED|Second Intervention Period||13
2434534|NCT01151345|5972218|P2|STARTED|Second Intervention Period||12
2434535|NCT01151345|5972219|P1|STARTED|Second Intervention Period||13
2434536|NCT01151345|5972218|P2|NOT COMPLETED|Wash-out Period (7 Days)||0
2434537|NCT01151345|5972219|P1|NOT COMPLETED|Wash-out Period (7 Days)||0
2434538|NCT01151345|5972218|P2|COMPLETED|Wash-out Period (7 Days)||12
2434539|NCT01151345|5972219|P1|COMPLETED|Wash-out Period (7 Days)||13
2434540|NCT01151345|5972218|P2|STARTED|Wash-out Period (7 Days)||12
2434541|NCT01151345|5972219|P1|STARTED|Wash-out Period (7 Days)||13
2434542|NCT01151345|5972218|P2|NOT COMPLETED|First Intervention Period||1
2434543|NCT01151345|5972219|P1|NOT COMPLETED|First Intervention Period||0
2434544|NCT01151345|5972218|P2|COMPLETED|First Intervention Period||12
2434545|NCT01151345|5972219|P1|COMPLETED|First Intervention Period||13
2434546|NCT01151345|5972218|P2|Treated|First Intervention Period||12
2434547|NCT01151345|5972219|P1|Treated|First Intervention Period||13
2434548|NCT01151345|5972218|P2|STARTED|First Intervention Period||13
2434549|NCT01151345|5972219|P1|STARTED|First Intervention Period||13
2434550|NCT01151280|5972233|P1|NOT COMPLETED|Overall Study||4
2434551|NCT01151280|5972233|P1|COMPLETED|Overall Study||6
2434552|NCT01151280|5972233|P1|STARTED|Overall Study||10
2434553|NCT01151215|5972246|P3|NOT COMPLETED|Overall Study||19
2434554|NCT01151215|5972247|P2|NOT COMPLETED|Overall Study||23
2434555|NCT01151215|5972248|P1|NOT COMPLETED|Overall Study||20
2434556|NCT01151215|5972246|P3|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|102
2434557|NCT01151215|5972247|P2|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|95
2434558|NCT01151215|5972248|P1|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|100
2434559|NCT01151215|5972246|P3|STARTED|Overall Study||121
2434560|NCT01151215|5972247|P2|STARTED|Overall Study||118
2434561|NCT01151215|5972248|P1|STARTED|Overall Study||120
2434562|NCT01151189|5972261|P2|NOT COMPLETED|Overall Study||10
2434563|NCT01151189|5972262|P1|NOT COMPLETED|Overall Study||15
2434564|NCT01151189|5972261|P2|COMPLETED|Overall Study||314
2434565|NCT01151189|5972262|P1|COMPLETED|Overall Study||311
2434566|NCT01151189|5972261|P2|Received Vaccine|Overall Study||324
2434567|NCT01151189|5972262|P1|Received Vaccine|Overall Study||325
2434568|NCT01151189|5972261|P2|STARTED|Overall Study||324
2434569|NCT01151189|5972262|P1|STARTED|Overall Study||326
2434570|NCT01151137|5972286|P2|NOT COMPLETED|Overall Study||28
2434571|NCT01151137|5972287|P1|NOT COMPLETED|Overall Study||16
2434572|NCT01151137|5972286|P2|COMPLETED|Overall Study||1591
2434573|NCT01151137|5972287|P1|COMPLETED|Overall Study||1601
2434574|NCT01151137|5972286|P2|Discontinued Treatment|Overall Study||342
2434575|NCT01151137|5972287|P1|Discontinued Treatment|Overall Study||171
2434576|NCT01151137|5972286|P2|Treated|Overall Study||1613
2434577|NCT01151137|5972287|P1|Treated|Overall Study|One participant randomized to the placebo group received Dronedarone for 7 days by mistake|1610
2434578|NCT01151137|5972286|P2|STARTED|Overall Study||1619
2434579|NCT01151137|5972287|P1|STARTED|Overall Study||1617
2434580|NCT01151098|5972305|P1|NOT COMPLETED|Overall Study||117
2434581|NCT01151098|5972305|P1|COMPLETED|Overall Study||72
2434582|NCT01151098|5972305|P1|STARTED|Overall Study|Extension Safety Population|189
2434583|NCT01151085|5972309|P1|NOT COMPLETED|Overall Study||56
2434584|NCT01151085|5972309|P1|COMPLETED|Overall Study||946
2434585|NCT01151085|5972309|P1|STARTED|Overall Study||1002
2434586|NCT01151046|5972327|P2|NOT COMPLETED|Overall Study||0
2434587|NCT01151046|5972328|P1|NOT COMPLETED|Overall Study||3
2434588|NCT01151046|5972327|P2|COMPLETED|Overall Study||59
2434589|NCT01151046|5972328|P1|COMPLETED|Overall Study||56
2434590|NCT01151046|5972327|P2|STARTED|Overall Study||59
2434591|NCT01151046|5972328|P1|STARTED|Overall Study||59
2434592|NCT01151020|5972340|P1|NOT COMPLETED|Overall Study||110
2434593|NCT01151020|5972340|P1|COMPLETED|Overall Study||0
2434594|NCT01151020|5972340|P1|12-month|Overall Study||99
2434595|NCT01151020|5972340|P1|30-day|Overall Study||110
2434596|NCT01151020|5972340|P1|STARTED|Overall Study||110
2434597|NCT01150981|5972347|P2|NOT COMPLETED|Overall Study||2
2434598|NCT01150981|5972348|P1|NOT COMPLETED|Overall Study||4
2434599|NCT01150981|5972347|P2|COMPLETED|Overall Study||13
2434600|NCT01150981|5972348|P1|COMPLETED|Overall Study||16
2434601|NCT01150981|5972347|P2|STARTED|Overall Study||15
2434602|NCT01150981|5972348|P1|STARTED|Overall Study||20
2434603|NCT01150903|5972358|P2|NOT COMPLETED|Overall Study||0
2434604|NCT01150903|5972359|P1|NOT COMPLETED|Overall Study||0
2434605|NCT01150903|5972358|P2|COMPLETED|Overall Study||74124
2434606|NCT01150903|5972359|P1|COMPLETED|Overall Study||24708
2434607|NCT01150903|5972358|P2|STARTED|Overall Study||74124
2434608|NCT01150903|5972359|P1|STARTED|Overall Study||24708
2434609|NCT01150760|5972375|P2|NOT COMPLETED|Overall Study||0
2434610|NCT01150760|5972376|P1|NOT COMPLETED|Overall Study||0
2434611|NCT01150760|5972375|P2|COMPLETED|Overall Study||3525
2434612|NCT01150760|5972376|P1|COMPLETED|Overall Study||3525
2434613|NCT01150760|5972375|P2|STARTED|Overall Study||3525
2434614|NCT01150760|5972376|P1|STARTED|Overall Study||3525
2434615|NCT01150500|5972408|P1|NOT COMPLETED|Overall Study||65
2434616|NCT01150500|5972408|P1|COMPLETED|Overall Study||0
2434617|NCT01150500|5972408|P1|STARTED|Overall Study||65
2434618|NCT01150474|5972419|P2|NOT COMPLETED|Overall Study||3
2434619|NCT01150474|5972420|P1|NOT COMPLETED|Overall Study||10
2434620|NCT01150474|5972419|P2|COMPLETED|Overall Study||49
2434621|NCT01150474|5972420|P1|COMPLETED|Overall Study||41
2434622|NCT01150474|5972419|P2|STARTED|Overall Study||52
2434623|NCT01150474|5972420|P1|STARTED|Overall Study||51
2434624|NCT01150461|5972444|P2|NOT COMPLETED|Overall Study||0
2434625|NCT01150461|5972445|P1|NOT COMPLETED|Overall Study||0
2434626|NCT01150461|5972444|P2|COMPLETED|Overall Study||9
2434627|NCT01150461|5972445|P1|COMPLETED|Overall Study||11
2434628|NCT01150461|5972444|P2|STARTED|Overall Study||9
2434629|NCT01150461|5972445|P1|STARTED|Overall Study||11
2434630|NCT01150409|5972455|P2|NOT COMPLETED|Overall Study||0
2434631|NCT01150409|5972456|P1|NOT COMPLETED|Overall Study||0
2434632|NCT01150409|5972455|P2|COMPLETED|Overall Study||0
2434633|NCT01150409|5972456|P1|COMPLETED|Overall Study||11
2434634|NCT01150409|5972455|P2|STARTED|Overall Study||0
2434635|NCT01150409|5972456|P1|STARTED|Overall Study||11
2434636|NCT01150357|5972465|P3|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||2
2434637|NCT01150357|5972466|P2|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||0
2434638|NCT01150357|5972467|P1|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||3
2434639|NCT01150357|5972465|P3|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||100
2434640|NCT01150357|5972466|P2|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||51
2434641|NCT01150357|5972467|P1|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||104
2434642|NCT01150357|5972465|P3|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||51
2434643|NCT01150357|5972466|P2|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||21
2434644|NCT01150357|5972467|P1|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||54
2434645|NCT01150357|5972465|P3|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||52
2434646|NCT01150357|5972466|P2|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||21
2434647|NCT01150357|5972467|P1|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||57
2434648|NCT01150357|5972465|P3|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||49
2434649|NCT01150357|5972466|P2|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
2434650|NCT01150357|5972467|P1|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
2434651|NCT01150357|5972465|P3|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
2434652|NCT01150357|5972466|P2|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
2434653|NCT01150357|5972467|P1|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
2434654|NCT01150357|5972465|P3|STARTED|Placebo-controlled Withdrawal (Phase 2)||102
2434655|NCT01150357|5972466|P2|STARTED|Placebo-controlled Withdrawal (Phase 2)||51
2434656|NCT01150357|5972467|P1|STARTED|Placebo-controlled Withdrawal (Phase 2)||107
2434657|NCT01150357|5972465|P3|NOT COMPLETED|Dose Response Phase (Phase 1)||3
2434658|NCT01150357|5972466|P2|NOT COMPLETED|Dose Response Phase (Phase 1)||3
2434659|NCT01150357|5972467|P1|NOT COMPLETED|Dose Response Phase (Phase 1)||1
2434660|NCT01150357|5972465|P3|COMPLETED|Dose Response Phase (Phase 1)||102
2434661|NCT01150357|5972466|P2|COMPLETED|Dose Response Phase (Phase 1)||51
2434662|NCT01150357|5972467|P1|COMPLETED|Dose Response Phase (Phase 1)||107
2434663|NCT01150357|5972465|P3|STARTED|Dose Response Phase (Phase 1)||105
2434664|NCT01150357|5972466|P2|STARTED|Dose Response Phase (Phase 1)||54
2434665|NCT01150357|5972467|P1|STARTED|Dose Response Phase (Phase 1)||108
2434666|NCT01150123|5972547|P18|NOT COMPLETED|Overall Study||1
2434667|NCT01150123|5972548|P17|NOT COMPLETED|Overall Study||0
2434668|NCT01150123|5972549|P16|NOT COMPLETED|Overall Study||1
2434669|NCT01150123|5972550|P15|NOT COMPLETED|Overall Study||0
2434670|NCT01150123|5972551|P14|NOT COMPLETED|Overall Study||0
2434671|NCT01150123|5972552|P13|NOT COMPLETED|Overall Study||3
2434672|NCT01150123|5972553|P12|NOT COMPLETED|Overall Study||1
2434673|NCT01150123|5972554|P11|NOT COMPLETED|Overall Study||2
2434674|NCT01150123|5972555|P10|NOT COMPLETED|Overall Study||1
2434675|NCT01150123|5972556|P9|NOT COMPLETED|Overall Study||5
2434676|NCT01150123|5972557|P8|NOT COMPLETED|Overall Study||3
2434677|NCT01150123|5972558|P7|NOT COMPLETED|Overall Study||0
2434678|NCT01150123|5972559|P6|NOT COMPLETED|Overall Study||6
2434679|NCT01150123|5972560|P5|NOT COMPLETED|Overall Study||3
2434680|NCT01150123|5972561|P4|NOT COMPLETED|Overall Study||3
2434681|NCT01150123|5972562|P3|NOT COMPLETED|Overall Study||4
2434682|NCT01150123|5972563|P2|NOT COMPLETED|Overall Study||2
2434683|NCT01150123|5972564|P1|NOT COMPLETED|Overall Study||3
2434684|NCT01150123|5972547|P18|COMPLETED|Overall Study||19
2434685|NCT01150123|5972548|P17|COMPLETED|Overall Study||40
2434686|NCT01150123|5972549|P16|COMPLETED|Overall Study||39
2434687|NCT01150123|5972550|P15|COMPLETED|Overall Study||40
2434688|NCT01150123|5972551|P14|COMPLETED|Overall Study||40
2434689|NCT01150123|5972552|P13|COMPLETED|Overall Study||37
2434690|NCT01150123|5972553|P12|COMPLETED|Overall Study||39
2434691|NCT01150123|5972554|P11|COMPLETED|Overall Study||38
2434692|NCT01150123|5972555|P10|COMPLETED|Overall Study||39
2434693|NCT01150123|5972556|P9|COMPLETED|Overall Study||15
2434694|NCT01150123|5972557|P8|COMPLETED|Overall Study||37
2434695|NCT01150123|5972558|P7|COMPLETED|Overall Study||39
2434696|NCT01150123|5972559|P6|COMPLETED|Overall Study||34
2434697|NCT01150123|5972560|P5|COMPLETED|Overall Study||37
2434698|NCT01150123|5972561|P4|COMPLETED|Overall Study||37
2434699|NCT01150123|5972562|P3|COMPLETED|Overall Study||35
2434700|NCT01150123|5972563|P2|COMPLETED|Overall Study||38
2434701|NCT01150123|5972564|P1|COMPLETED|Overall Study||37
2434702|NCT01150123|5972547|P18|STARTED|Overall Study||20
2434703|NCT01150123|5972548|P17|STARTED|Overall Study||40
2434704|NCT01150123|5972549|P16|STARTED|Overall Study||40
2434705|NCT01150123|5972550|P15|STARTED|Overall Study||40
2434706|NCT01150123|5972551|P14|STARTED|Overall Study||40
2434707|NCT01150123|5972552|P13|STARTED|Overall Study||40
2434708|NCT01150123|5972553|P12|STARTED|Overall Study||40
2434709|NCT01150123|5972554|P11|STARTED|Overall Study||40
2434710|NCT01150123|5972555|P10|STARTED|Overall Study||40
2434711|NCT01150123|5972556|P9|STARTED|Overall Study||20
2434712|NCT01150123|5972557|P8|STARTED|Overall Study||40
2434713|NCT01150123|5972558|P7|STARTED|Overall Study||39
2434714|NCT01150123|5972559|P6|STARTED|Overall Study||40
2434715|NCT01150123|5972560|P5|STARTED|Overall Study||40
2434716|NCT01150123|5972561|P4|STARTED|Overall Study||40
2434717|NCT01150123|5972562|P3|STARTED|Overall Study||39
2434718|NCT01150123|5972563|P2|STARTED|Overall Study||40
2434719|NCT01150123|5972564|P1|STARTED|Overall Study||40
2434720|NCT01150097|5972740|P3|NOT COMPLETED|Months 24 to 48 Post-transplantation||0
2434721|NCT01150097|5972741|P2|NOT COMPLETED|Months 24 to 48 Post-transplantation||4
2434722|NCT01150097|5972742|P1|NOT COMPLETED|Months 24 to 48 Post-transplantation||11
2434723|NCT01150097|5972740|P3|COMPLETED|Months 24 to 48 Post-transplantation||0
2434724|NCT01150097|5972741|P2|COMPLETED|Months 24 to 48 Post-transplantation||47
2434725|NCT01150097|5972742|P1|COMPLETED|Months 24 to 48 Post-transplantation||95
2434726|NCT01150097|5972740|P3|STARTED|Months 24 to 48 Post-transplantation||0
2434727|NCT01150097|5972741|P2|STARTED|Months 24 to 48 Post-transplantation||51
2434728|NCT01150097|5972742|P1|STARTED|Months 24 to 48 Post-transplantation||106
2434729|NCT01150097|5972740|P3|NOT COMPLETED|Months 24 to 36 Post-transplantation||8
2434730|NCT01150097|5972741|P2|NOT COMPLETED|Months 24 to 36 Post-transplantation||2
2434731|NCT01150097|5972742|P1|NOT COMPLETED|Months 24 to 36 Post-transplantation||10
2434732|NCT01150097|5972740|P3|COMPLETED|Months 24 to 36 Post-transplantation||117
2434733|NCT01150097|5972741|P2|COMPLETED|Months 24 to 36 Post-transplantation||49
2434734|NCT01150097|5972742|P1|COMPLETED|Months 24 to 36 Post-transplantation||96
2434735|NCT01150097|5972740|P3|STARTED|Months 24 to 36 Post-transplantation||125
2434736|NCT01150097|5972741|P2|STARTED|Months 24 to 36 Post-transplantation||51
2434737|NCT01150097|5972742|P1|STARTED|Months 24 to 36 Post-transplantation||106
2434738|NCT01149876|5972769|P4|NOT COMPLETED|Overall Study||0
2434739|NCT01149876|5972770|P3|NOT COMPLETED|Overall Study||1
2434740|NCT01149876|5972771|P2|NOT COMPLETED|Overall Study||0
2434741|NCT01149876|5972772|P1|NOT COMPLETED|Overall Study||1
2434742|NCT01149876|5972769|P4|COMPLETED|Overall Study||18
2434743|NCT01149876|5972770|P3|COMPLETED|Overall Study||20
2434744|NCT01149876|5972771|P2|COMPLETED|Overall Study||20
2434745|NCT01149876|5972772|P1|COMPLETED|Overall Study||20
2434746|NCT01149876|5972769|P4|STARTED|Overall Study||18
2434747|NCT01149876|5972770|P3|STARTED|Overall Study||21
2434748|NCT01149876|5972771|P2|STARTED|Overall Study||20
2434749|NCT01149876|5972772|P1|STARTED|Overall Study||21
2434750|NCT01149863|5972786|P1|NOT COMPLETED|Overall Study||3
2434751|NCT01149863|5972786|P1|COMPLETED|Overall Study||31
2434752|NCT01149863|5972786|P1|STARTED|Overall Study||34
2434753|NCT01149785|5972791|P2|NOT COMPLETED|Second Intervention||0
2434754|NCT01149785|5972792|P1|NOT COMPLETED|Second Intervention||0
2434755|NCT01149785|5972791|P2|COMPLETED|Second Intervention||15
2434756|NCT01149785|5972792|P1|COMPLETED|Second Intervention||0
2434757|NCT01149785|5972791|P2|STARTED|Second Intervention||15
2434758|NCT01149785|5972792|P1|STARTED|Second Intervention||0
2434759|NCT01149785|5972791|P2|NOT COMPLETED|Washout Period of at Least 14 Days||0
2434760|NCT01149785|5972792|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
2434761|NCT01149785|5972791|P2|COMPLETED|Washout Period of at Least 14 Days||0
2434762|NCT01149785|5972792|P1|COMPLETED|Washout Period of at Least 14 Days||15
2434763|NCT01149785|5972791|P2|STARTED|Washout Period of at Least 14 Days||0
2434764|NCT01149785|5972792|P1|STARTED|Washout Period of at Least 14 Days||15
2434765|NCT01149785|5972791|P2|NOT COMPLETED|First Intervention||0
2434766|NCT01149785|5972792|P1|NOT COMPLETED|First Intervention||0
2434767|NCT01149785|5972791|P2|COMPLETED|First Intervention||0
2434768|NCT01149785|5972792|P1|COMPLETED|First Intervention||15
2434769|NCT01149785|5972791|P2|STARTED|First Intervention||0
2434770|NCT01149785|5972792|P1|STARTED|First Intervention||15
2434771|NCT01149772|5972826|P2|NOT COMPLETED|Overall Study||21
2434772|NCT01149772|5972827|P1|NOT COMPLETED|Overall Study||48
2434773|NCT01149772|5972826|P2|COMPLETED|Overall Study||101
2434774|NCT01149772|5972827|P1|COMPLETED|Overall Study||132
2434775|NCT01149772|5972826|P2|STARTED|Overall Study||122
2434776|NCT01149772|5972827|P1|STARTED|Overall Study||180
2434777|NCT01149759|5972843|P1|NOT COMPLETED|Overall Study||0
2434778|NCT01149759|5972843|P1|COMPLETED|Overall Study||9
2434779|NCT01149759|5972843|P1|STARTED|Overall Study||9
2434780|NCT01149733|5972850|P2|NOT COMPLETED|Overall Study||0
2434781|NCT01149733|5972851|P1|NOT COMPLETED|Overall Study||0
2434782|NCT01149733|5972850|P2|COMPLETED|Overall Study||16
2434783|NCT01149733|5972851|P1|COMPLETED|Overall Study||16
2434784|NCT01149733|5972850|P2|STARTED|Overall Study||16
2434785|NCT01149733|5972851|P1|STARTED|Overall Study||16
2434786|NCT01149655|5972863|P4|NOT COMPLETED|Period 3-DB Maintenance Phase||42
2434787|NCT01149655|5972864|P3|NOT COMPLETED|Period 3-DB Maintenance Phase||83
2434788|NCT01149655|5972865|P2|NOT COMPLETED|Period 3-DB Maintenance Phase||0
2434789|NCT01149655|5972866|P1|NOT COMPLETED|Period 3-DB Maintenance Phase||0
2434790|NCT01149655|5972863|P4|COMPLETED|Period 3-DB Maintenance Phase||6
2434791|NCT01149655|5972864|P3|COMPLETED|Period 3-DB Maintenance Phase||15
2434792|NCT01149655|5972865|P2|COMPLETED|Period 3-DB Maintenance Phase||0
2434793|NCT01149655|5972866|P1|COMPLETED|Period 3-DB Maintenance Phase||0
2434794|NCT01149655|5972863|P4|STARTED|Period 3-DB Maintenance Phase||48
2434795|NCT01149655|5972864|P3|STARTED|Period 3-DB Maintenance Phase||98
2434796|NCT01149655|5972865|P2|STARTED|Period 3-DB Maintenance Phase||0
2434797|NCT01149655|5972866|P1|STARTED|Period 3-DB Maintenance Phase||0
2434798|NCT01149655|5972863|P4|NOT COMPLETED|Period 2-Stabilization Phase||0
2434799|NCT01149655|5972864|P3|NOT COMPLETED|Period 2-Stabilization Phase||0
2434800|NCT01149655|5972865|P2|NOT COMPLETED|Period 2-Stabilization Phase||37
2434801|NCT01149655|5972866|P1|NOT COMPLETED|Period 2-Stabilization Phase||0
2434802|NCT01149655|5972863|P4|COMPLETED|Period 2-Stabilization Phase||0
2434803|NCT01149655|5972864|P3|COMPLETED|Period 2-Stabilization Phase||0
2434804|NCT01149655|5972865|P2|COMPLETED|Period 2-Stabilization Phase||146
2434805|NCT01149655|5972866|P1|COMPLETED|Period 2-Stabilization Phase||0
2434806|NCT01149655|5972863|P4|STARTED|Period 2-Stabilization Phase||0
2434807|NCT01149655|5972864|P3|STARTED|Period 2-Stabilization Phase||0
2434808|NCT01149655|5972865|P2|STARTED|Period 2-Stabilization Phase||183
2434809|NCT01149655|5972866|P1|STARTED|Period 2-Stabilization Phase||0
2434810|NCT01149655|5972863|P4|NOT COMPLETED|Period 1 - Conversion Phase||0
2434811|NCT01149655|5972864|P3|NOT COMPLETED|Period 1 - Conversion Phase||0
2434812|NCT01149655|5972865|P2|NOT COMPLETED|Period 1 - Conversion Phase||0
2434813|NCT01149655|5972866|P1|NOT COMPLETED|Period 1 - Conversion Phase||18
2434814|NCT01149655|5972863|P4|COMPLETED|Period 1 - Conversion Phase||0
2434815|NCT01149655|5972864|P3|COMPLETED|Period 1 - Conversion Phase||0
2434816|NCT01149655|5972865|P2|COMPLETED|Period 1 - Conversion Phase||0
2434817|NCT01149655|5972866|P1|COMPLETED|Period 1 - Conversion Phase||168
2434818|NCT01149655|5972863|P4|STARTED|Period 1 - Conversion Phase||0
2434819|NCT01149655|5972864|P3|STARTED|Period 1 - Conversion Phase||0
2434820|NCT01149655|5972865|P2|STARTED|Period 1 - Conversion Phase||0
2434821|NCT01149655|5972866|P1|STARTED|Period 1 - Conversion Phase||186
2434822|NCT01149616|5972896|P2|NOT COMPLETED|Overall Study||0
2434823|NCT01149616|5972897|P1|NOT COMPLETED|Overall Study||0
2434824|NCT01149616|5972896|P2|COMPLETED|Overall Study||41
2434825|NCT01149616|5972897|P1|COMPLETED|Overall Study||41
2434826|NCT01149616|5972896|P2|STARTED|Overall Study||41
2434827|NCT01149616|5972897|P1|STARTED|Overall Study||41
2434828|NCT01149538|5972909|P2|NOT COMPLETED|Overall Study||4
2434829|NCT01149538|5972910|P1|NOT COMPLETED|Overall Study||5
2434830|NCT01149538|5972909|P2|COMPLETED|Overall Study||25
2434831|NCT01149538|5972910|P1|COMPLETED|Overall Study||26
2434832|NCT01149538|5972909|P2|STARTED|Overall Study||29
2434833|NCT01149538|5972910|P1|STARTED|Overall Study||31
2434834|NCT01149512|5972924|P1|NOT COMPLETED|Overall Study||0
2434835|NCT01149512|5972924|P1|COMPLETED|Overall Study||178
2434836|NCT01149512|5972924|P1|STARTED|Overall Study||178
2434837|NCT01149486|5972931|P2|NOT COMPLETED|Second Intervention||0
2434838|NCT01149486|5972932|P1|NOT COMPLETED|Second Intervention||0
2434839|NCT01149486|5972931|P2|COMPLETED|Second Intervention||9
2434840|NCT01149486|5972932|P1|COMPLETED|Second Intervention||10
2434841|NCT01149486|5972931|P2|STARTED|Second Intervention||9
2434842|NCT01149486|5972932|P1|STARTED|Second Intervention||10
2434843|NCT01149486|5972931|P2|NOT COMPLETED|Washout of 7 Days||0
2434844|NCT01149486|5972932|P1|NOT COMPLETED|Washout of 7 Days||0
2434845|NCT01149486|5972931|P2|COMPLETED|Washout of 7 Days||9
2434846|NCT01149486|5972932|P1|COMPLETED|Washout of 7 Days||10
2434847|NCT01149486|5972931|P2|STARTED|Washout of 7 Days||9
2434848|NCT01149486|5972932|P1|STARTED|Washout of 7 Days||10
2434849|NCT01149486|5972931|P2|NOT COMPLETED|First Intervention||1
2434850|NCT01149486|5972932|P1|NOT COMPLETED|First Intervention||0
2434851|NCT01149486|5972931|P2|COMPLETED|First Intervention||9
2434852|NCT01149486|5972932|P1|COMPLETED|First Intervention||10
2434853|NCT01149486|5972931|P2|STARTED|First Intervention||10
2434854|NCT01149486|5972932|P1|STARTED|First Intervention||10
2434855|NCT01149473|5972956|P2|NOT COMPLETED|Second Intervention||0
2434856|NCT01149473|5972957|P1|NOT COMPLETED|Second Intervention||0
2434857|NCT01149473|5972956|P2|COMPLETED|Second Intervention||38
2434858|NCT01149473|5972957|P1|COMPLETED|Second Intervention||38
2434859|NCT01149473|5972956|P2|STARTED|Second Intervention||38
2434860|NCT01149473|5972957|P1|STARTED|Second Intervention||38
2434861|NCT01149473|5972956|P2|NOT COMPLETED|Washout of 7 Days||1
2434862|NCT01149473|5972957|P1|NOT COMPLETED|Washout of 7 Days||1
2434863|NCT01149473|5972956|P2|COMPLETED|Washout of 7 Days||38
2434864|NCT01149473|5972957|P1|COMPLETED|Washout of 7 Days||38
2434865|NCT01149473|5972956|P2|STARTED|Washout of 7 Days||39
2434866|NCT01149473|5972957|P1|STARTED|Washout of 7 Days||39
2434867|NCT01149473|5972956|P2|NOT COMPLETED|First Intervention||1
2434868|NCT01149473|5972957|P1|NOT COMPLETED|First Intervention||1
2434869|NCT01149473|5972956|P2|COMPLETED|First Intervention||39
2434870|NCT01149473|5972957|P1|COMPLETED|First Intervention||39
2434871|NCT01149473|5972956|P2|STARTED|First Intervention||40
2434872|NCT01149473|5972957|P1|STARTED|First Intervention||40
2434873|NCT01149460|5972975|P2|NOT COMPLETED|Overall Study||2
2434874|NCT01149460|5972976|P1|NOT COMPLETED|Overall Study||0
2434875|NCT01149460|5972975|P2|COMPLETED|Overall Study||16
2434876|NCT01149460|5972976|P1|COMPLETED|Overall Study||18
2434877|NCT01149460|5972975|P2|STARTED|Overall Study||18
2434878|NCT01149460|5972976|P1|STARTED|Overall Study||18
2434879|NCT01149434|5972994|P2|NOT COMPLETED|Overall Study||5
2434880|NCT01149434|5972995|P1|NOT COMPLETED|Overall Study||0
2434881|NCT01149434|5972994|P2|COMPLETED|Overall Study||10
2434882|NCT01149434|5972995|P1|COMPLETED|Overall Study||4
2434883|NCT01149434|5972994|P2|STARTED|Overall Study||15
2434884|NCT01149434|5972995|P1|STARTED|Overall Study||4
2434885|NCT01149421|5973009|P3|NOT COMPLETED|Overall Study||44
2434886|NCT01149421|5973010|P2|NOT COMPLETED|Overall Study||29
2434887|NCT01149421|5973011|P1|NOT COMPLETED|Overall Study||52
2434888|NCT01149421|5973009|P3|COMPLETED|Overall Study||206
2434889|NCT01149421|5973010|P2|COMPLETED|Overall Study||225
2434890|NCT01149421|5973011|P1|COMPLETED|Overall Study||199
2434891|NCT01149421|5973009|P3|Received at Least One Dose of Study Drug|Overall Study||250
2434892|NCT01149421|5973010|P2|Received at Least One Dose of Study Drug|Overall Study||254
2434987|NCT01148745|5973478|P1|NOT COMPLETED|Overall Study||0
2434893|NCT01149421|5973011|P1|Received at Least One Dose of Study Drug|Overall Study||251
2434894|NCT01149421|5973009|P3|STARTED|Overall Study||250
2434895|NCT01149421|5973010|P2|STARTED|Overall Study||254
2434896|NCT01149421|5973011|P1|STARTED|Overall Study||251
2434897|NCT01149369|5973092|P2|NOT COMPLETED|Overall Study||3
2434898|NCT01149369|5973093|P1|NOT COMPLETED|Overall Study||6
2434899|NCT01149369|5973092|P2|COMPLETED|Overall Study||60
2434900|NCT01149369|5973093|P1|COMPLETED|Overall Study||57
2434901|NCT01149369|5973092|P2|STARTED|Overall Study||63
2434902|NCT01149369|5973093|P1|STARTED|Overall Study||63
2434903|NCT01149343|5973261|P4|NOT COMPLETED|Overall Study||40
2434904|NCT01149343|5973262|P3|NOT COMPLETED|Overall Study||22
2434905|NCT01149343|5973263|P2|NOT COMPLETED|Overall Study||24
2434906|NCT01149343|5973264|P1|NOT COMPLETED|Overall Study||20
2434907|NCT01149343|5973261|P4|COMPLETED|Overall Study||0
2434908|NCT01149343|5973262|P3|COMPLETED|Overall Study||0
2434909|NCT01149343|5973263|P2|COMPLETED|Overall Study||0
2434910|NCT01149343|5973264|P1|COMPLETED|Overall Study||0
2434911|NCT01149343|5973261|P4|STARTED|Overall Study||40
2434912|NCT01149343|5973262|P3|STARTED|Overall Study||22
2434913|NCT01149343|5973263|P2|STARTED|Overall Study||24
2434914|NCT01149343|5973264|P1|STARTED|Overall Study||20
2434915|NCT01149148|5973349|P2|NOT COMPLETED|Overall Study||2
2434916|NCT01149148|5973350|P1|NOT COMPLETED|Overall Study||2
2434917|NCT01149148|5973349|P2|COMPLETED|Overall Study||11
2434918|NCT01149148|5973350|P1|COMPLETED|Overall Study||10
2434919|NCT01149148|5973349|P2|STARTED|Overall Study||13
2434920|NCT01149148|5973350|P1|STARTED|Overall Study||12
2434921|NCT01149057|5973358|P1|NOT COMPLETED|Overall Study||57
2434922|NCT01149057|5973358|P1|COMPLETED|Overall Study||88
2434923|NCT01149057|5973358|P1|STARTED|Overall Study||145
2434924|NCT01148979|5973385|P2|NOT COMPLETED|Overall Study||1
2434925|NCT01148979|5973386|P1|NOT COMPLETED|Overall Study||0
2434926|NCT01148979|5973385|P2|COMPLETED|Overall Study||15
2434927|NCT01148979|5973386|P1|COMPLETED|Overall Study||13
2434928|NCT01148979|5973385|P2|STARTED|Overall Study||16
2434929|NCT01148979|5973386|P1|STARTED|Overall Study||13
2434930|NCT01148940|5973394|P3|NOT COMPLETED|Overall Study||0
2434931|NCT01148940|5973395|P2|NOT COMPLETED|Overall Study||0
2434932|NCT01148940|5973396|P1|NOT COMPLETED|Overall Study||0
2434933|NCT01148940|5973394|P3|COMPLETED|Overall Study||0
2434934|NCT01148940|5973395|P2|COMPLETED|Overall Study||27
2434935|NCT01148940|5973396|P1|COMPLETED|Overall Study||7
2434936|NCT01148940|5973394|P3|STARTED|Overall Study||0
2434937|NCT01148940|5973395|P2|STARTED|Overall Study||27
2434938|NCT01148940|5973396|P1|STARTED|Overall Study||7
2434939|NCT01148862|5973404|P2|NOT COMPLETED|Second Intervention||2
2434940|NCT01148862|5973405|P1|NOT COMPLETED|Second Intervention||0
2434941|NCT01148862|5973404|P2|COMPLETED|Second Intervention||23
2434942|NCT01148862|5973405|P1|COMPLETED|Second Intervention||25
2434943|NCT01148862|5973404|P2|STARTED|Second Intervention||25
2434944|NCT01148862|5973405|P1|STARTED|Second Intervention||25
2434945|NCT01148862|5973404|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
2434946|NCT01148862|5973405|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
2434947|NCT01148862|5973404|P2|COMPLETED|Washout Period of 2 Weeks||25
2434948|NCT01148862|5973405|P1|COMPLETED|Washout Period of 2 Weeks||25
2434949|NCT01148862|5973404|P2|STARTED|Washout Period of 2 Weeks||25
2434950|NCT01148862|5973405|P1|STARTED|Washout Period of 2 Weeks||25
2434951|NCT01148862|5973404|P2|NOT COMPLETED|First Intervention||0
2434952|NCT01148862|5973405|P1|NOT COMPLETED|First Intervention||0
2434953|NCT01148862|5973404|P2|COMPLETED|First Intervention||25
2434954|NCT01148862|5973405|P1|COMPLETED|First Intervention||25
2434955|NCT01148862|5973404|P2|STARTED|First Intervention||25
2434956|NCT01148862|5973405|P1|STARTED|First Intervention||25
2434957|NCT01148836|5973415|P2|NOT COMPLETED|Overall Study||2
2434958|NCT01148836|5973416|P1|NOT COMPLETED|Overall Study||1
2434959|NCT01148836|5973415|P2|COMPLETED|Overall Study||8
2434960|NCT01148836|5973416|P1|COMPLETED|Overall Study|Enrollment completed|7
2434961|NCT01148836|5973415|P2|STARTED|Overall Study||10
2434962|NCT01148836|5973416|P1|STARTED|Overall Study|Enrollment completed|8
2434963|NCT01148810|5973437|P2|NOT COMPLETED|Overall Study||5
2434964|NCT01148810|5973438|P1|NOT COMPLETED|Overall Study||1
2434965|NCT01148810|5973437|P2|COMPLETED|Overall Study||5
2434966|NCT01148810|5973438|P1|COMPLETED|Overall Study||7
2434967|NCT01148810|5973437|P2|STARTED|Overall Study||10
2434968|NCT01148810|5973438|P1|STARTED|Overall Study||8
2434969|NCT01148771|5973465|P2|NOT COMPLETED|Second Intervention||0
2434970|NCT01148771|5973466|P1|NOT COMPLETED|Second Intervention||0
2434971|NCT01148771|5973465|P2|COMPLETED|Second Intervention||5
2434972|NCT01148771|5973466|P1|COMPLETED|Second Intervention||6
2434973|NCT01148771|5973465|P2|STARTED|Second Intervention||5
2434974|NCT01148771|5973466|P1|STARTED|Second Intervention||6
2434975|NCT01148771|5973465|P2|NOT COMPLETED|Washout Period||1
2434976|NCT01148771|5973466|P1|NOT COMPLETED|Washout Period||0
2434977|NCT01148771|5973465|P2|COMPLETED|Washout Period||5
2434978|NCT01148771|5973466|P1|COMPLETED|Washout Period||6
2434979|NCT01148771|5973465|P2|STARTED|Washout Period||6
2434980|NCT01148771|5973466|P1|STARTED|Washout Period||6
2434981|NCT01148771|5973465|P2|NOT COMPLETED|First Intervention||0
2434982|NCT01148771|5973466|P1|NOT COMPLETED|First Intervention||0
2434983|NCT01148771|5973465|P2|COMPLETED|First Intervention||6
2434984|NCT01148771|5973466|P1|COMPLETED|First Intervention||6
2434985|NCT01148771|5973465|P2|STARTED|First Intervention||6
2434986|NCT01148771|5973466|P1|STARTED|First Intervention||6
2434988|NCT01148745|5973478|P1|COMPLETED|Overall Study||15
2434989|NCT01148745|5973478|P1|STARTED|Overall Study||15
2434990|NCT01148693|5973486|P2|NOT COMPLETED|Overall Study||10
2434991|NCT01148693|5973487|P1|NOT COMPLETED|Overall Study||13
2434992|NCT01148693|5973486|P2|COMPLETED|Overall Study||57
2434993|NCT01148693|5973487|P1|COMPLETED|Overall Study||57
2434994|NCT01148693|5973486|P2|STARTED|Overall Study||67
2434995|NCT01148693|5973487|P1|STARTED|Overall Study||70
2434996|NCT01148563|5973495|P2|NOT COMPLETED|Overall Study||30
2434997|NCT01148563|5973496|P1|NOT COMPLETED|Overall Study||29
2434998|NCT01148563|5973495|P2|COMPLETED|Overall Study||37
2434999|NCT01148563|5973496|P1|COMPLETED|Overall Study||40
2435000|NCT01148563|5973495|P2|STARTED|Overall Study||67
2435001|NCT01148563|5973496|P1|STARTED|Overall Study||69
2435002|NCT01148537|5973507|P3|NOT COMPLETED|Overall Study||3
2435003|NCT01148537|5973508|P2|NOT COMPLETED|Overall Study||0
2435004|NCT01148537|5973509|P1|NOT COMPLETED|Overall Study||3
2435005|NCT01148537|5973507|P3|COMPLETED|Overall Study||41
2435006|NCT01148537|5973508|P2|COMPLETED|Overall Study||44
2435007|NCT01148537|5973509|P1|COMPLETED|Overall Study||41
2435008|NCT01148537|5973507|P3|STARTED|Overall Study||44
2435009|NCT01148537|5973508|P2|STARTED|Overall Study||44
2435010|NCT01148537|5973509|P1|STARTED|Overall Study||44
2435011|NCT01148524|5973539|P9|NOT COMPLETED|Overall Study||0
2435012|NCT01148524|5973540|P8|NOT COMPLETED|Overall Study||0
2435013|NCT01148524|5973541|P7|NOT COMPLETED|Overall Study||0
2435014|NCT01148524|5973542|P6|NOT COMPLETED|Overall Study||0
2435015|NCT01148524|5973543|P5|NOT COMPLETED|Overall Study||0
2435016|NCT01148524|5973544|P4|NOT COMPLETED|Overall Study||0
2435017|NCT01148524|5973545|P3|NOT COMPLETED|Overall Study||0
2435018|NCT01148524|5973546|P2|NOT COMPLETED|Overall Study||0
2435019|NCT01148524|5973547|P1|NOT COMPLETED|Overall Study||0
2435020|NCT01148524|5973539|P9|COMPLETED|Overall Study||151
2435021|NCT01148524|5973540|P8|COMPLETED|Overall Study||51
2435022|NCT01148524|5973541|P7|COMPLETED|Overall Study||153
2435023|NCT01148524|5973542|P6|COMPLETED|Overall Study||106
2435024|NCT01148524|5973543|P5|COMPLETED|Overall Study||57
2435025|NCT01148524|5973544|P4|COMPLETED|Overall Study||102
2435026|NCT01148524|5973545|P3|COMPLETED|Overall Study||53
2435027|NCT01148524|5973546|P2|COMPLETED|Overall Study||95
2435028|NCT01148524|5973547|P1|COMPLETED|Overall Study||49
2435029|NCT01148524|5973539|P9|STARTED|Overall Study||151
2435030|NCT01148524|5973540|P8|STARTED|Overall Study||51
2435031|NCT01148524|5973541|P7|STARTED|Overall Study||153
2435032|NCT01148524|5973542|P6|STARTED|Overall Study||106
2435033|NCT01148524|5973543|P5|STARTED|Overall Study||57
2435034|NCT01148524|5973544|P4|STARTED|Overall Study||102
2435035|NCT01148524|5973545|P3|STARTED|Overall Study||53
2435036|NCT01148524|5973546|P2|STARTED|Overall Study||95
2435037|NCT01148524|5973547|P1|STARTED|Overall Study||49
2435038|NCT01148511|5973595|P3|NOT COMPLETED|Randomized||6
2435039|NCT01148511|5973596|P2|NOT COMPLETED|Randomized||10
2435040|NCT01148511|5973597|P1|NOT COMPLETED|Randomized||0
2435041|NCT01148511|5973595|P3|COMPLETED|Randomized||39
2435042|NCT01148511|5973596|P2|COMPLETED|Randomized||38
2435043|NCT01148511|5973597|P1|COMPLETED|Randomized||0
2435044|NCT01148511|5973595|P3|STARTED|Randomized||45
2435045|NCT01148511|5973596|P2|STARTED|Randomized||48
2435046|NCT01148511|5973597|P1|STARTED|Randomized|All patients were randomized into the Treat and Extend and the Treat and Observe treatment groups.|0
2435047|NCT01148511|5973595|P3|NOT COMPLETED|Exposed to Study Drug||0
2435048|NCT01148511|5973596|P2|NOT COMPLETED|Exposed to Study Drug||0
2435049|NCT01148511|5973597|P1|NOT COMPLETED|Exposed to Study Drug||6
2435050|NCT01148511|5973595|P3|COMPLETED|Exposed to Study Drug||0
2435051|NCT01148511|5973596|P2|COMPLETED|Exposed to Study Drug||0
2435052|NCT01148511|5973597|P1|COMPLETED|Exposed to Study Drug||93
2435053|NCT01148511|5973595|P3|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
2435054|NCT01148511|5973596|P2|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
2435055|NCT01148511|5973597|P1|STARTED|Exposed to Study Drug||99
2435056|NCT01148459|5973618|P2|NOT COMPLETED|Overall Study||11
2435057|NCT01148459|5973619|P1|NOT COMPLETED|Overall Study||12
2435058|NCT01148459|5973618|P2|COMPLETED|Overall Study||90
2435059|NCT01148459|5973619|P1|COMPLETED|Overall Study||87
2435060|NCT01148459|5973618|P2|STARTED|Overall Study||101
2435061|NCT01148459|5973619|P1|STARTED|Overall Study||99
2435062|NCT01148420|5973661|P1|NOT COMPLETED|Overall Study||0
2435063|NCT01148420|5973661|P1|COMPLETED|Overall Study||48
2435064|NCT01148420|5973661|P1|STARTED|Overall Study||48
2435065|NCT01148225|5973667|P1|NOT COMPLETED|Overall Study||185
2435066|NCT01148225|5973667|P1|COMPLETED|Overall Study||239
2435067|NCT01148225|5973667|P1|STARTED|Overall Study||424
2435068|NCT01148056|5973705|P1|NOT COMPLETED|Overall Study||0
2435069|NCT01148056|5973705|P1|COMPLETED|Overall Study||2
2435070|NCT01148056|5973705|P1|STARTED|Overall Study||2
2435071|NCT01148017|5973718|P4|NOT COMPLETED|Overall Study||0
2435072|NCT01148017|5973719|P3|NOT COMPLETED|Overall Study||0
2435073|NCT01148017|5973720|P2|NOT COMPLETED|Overall Study||34
2435074|NCT01148017|5973721|P1|NOT COMPLETED|Overall Study||80
2435075|NCT01148017|5973718|P4|COMPLETED|Overall Study||45
2435076|NCT01148017|5973719|P3|COMPLETED|Overall Study||53
2435077|NCT01148017|5973720|P2|COMPLETED|Overall Study||87
2435078|NCT01148017|5973721|P1|COMPLETED|Overall Study||134
2435079|NCT01148017|5973718|P4|STARTED|Overall Study||45
2435080|NCT01148017|5973719|P3|STARTED|Overall Study||53
2435081|NCT01148017|5973720|P2|STARTED|Overall Study||121
2435082|NCT01148017|5973721|P1|STARTED|Overall Study||214
2435083|NCT01147926|5973760|P2|NOT COMPLETED|Overall Study||29
2435084|NCT01147926|5973761|P1|NOT COMPLETED|Overall Study||27
2435085|NCT01147926|5973760|P2|COMPLETED|Overall Study||158
2435086|NCT01147926|5973761|P1|COMPLETED|Overall Study||160
2435087|NCT01147926|5973760|P2|STARTED|Overall Study||187
2435088|NCT01147926|5973761|P1|STARTED|Overall Study||187
2435089|NCT01147900|5973796|P3|NOT COMPLETED|At Year 10||0
2435090|NCT01147900|5973797|P2|NOT COMPLETED|At Year 10||1
2435091|NCT01147900|5973798|P1|NOT COMPLETED|At Year 10||0
2435092|NCT01147900|5973796|P3|COMPLETED|At Year 10||62
2435093|NCT01147900|5973797|P2|COMPLETED|At Year 10||59
2435094|NCT01147900|5973798|P1|COMPLETED|At Year 10||55
2435095|NCT01147900|5973796|P3|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled.|62
2435096|NCT01147900|5973797|P2|STARTED|At Year 10||60
2435097|NCT01147900|5973798|P1|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled|55
2435098|NCT01147900|5973796|P3|NOT COMPLETED|At Year 8.5||0
2435099|NCT01147900|5973797|P2|NOT COMPLETED|At Year 8.5||0
2435100|NCT01147900|5973798|P1|NOT COMPLETED|At Year 8.5||0
2435101|NCT01147900|5973796|P3|COMPLETED|At Year 8.5||66
2435102|NCT01147900|5973797|P2|COMPLETED|At Year 8.5||60
2435103|NCT01147900|5973798|P1|COMPLETED|At Year 8.5||54
2435104|NCT01147900|5973796|P3|STARTED|At Year 8.5||66
2435105|NCT01147900|5973797|P2|STARTED|At Year 8.5||60
2435106|NCT01147900|5973798|P1|STARTED|At Year 8.5||54
2435107|NCT01147874|5973857|P1|NOT COMPLETED|Overall Study||67
2435108|NCT01147874|5973857|P1|COMPLETED|Overall Study||946
2435109|NCT01147874|5973857|P1|STARTED|Overall Study||1013
2435110|NCT01147848|5973865|P3|NOT COMPLETED|Randomized Phase||46
2435111|NCT01147848|5973866|P2|NOT COMPLETED|Randomized Phase||45
2435112|NCT01147848|5973867|P1|NOT COMPLETED|Randomized Phase||0
2435113|NCT01147848|5973865|P3|COMPLETED|Randomized Phase||357
2435114|NCT01147848|5973866|P2|COMPLETED|Randomized Phase||358
2435115|NCT01147848|5973867|P1|COMPLETED|Randomized Phase||0
2435116|NCT01147848|5973865|P3|STARTED|Randomized Phase||403
2435117|NCT01147848|5973866|P2|STARTED|Randomized Phase||403
2435118|NCT01147848|5973867|P1|STARTED|Randomized Phase||0
2435119|NCT01147848|5973865|P3|NOT COMPLETED|Run-in Period||0
2435120|NCT01147848|5973866|P2|NOT COMPLETED|Run-in Period||0
2435121|NCT01147848|5973867|P1|NOT COMPLETED|Run-in Period||758
2435122|NCT01147848|5973865|P3|COMPLETED|Run-in Period||0
2435123|NCT01147848|5973866|P2|COMPLETED|Run-in Period||0
2435124|NCT01147848|5973867|P1|COMPLETED|Run-in Period||806
2435125|NCT01147848|5973865|P3|STARTED|Run-in Period||0
2435126|NCT01147848|5973866|P2|STARTED|Run-in Period||0
2435127|NCT01147848|5973867|P1|STARTED|Run-in Period||1564
2435128|NCT01147822|5973899|P2|NOT COMPLETED|Overall Study||179
2435129|NCT01147822|5973900|P1|NOT COMPLETED|Overall Study||188
2435130|NCT01147822|5973899|P2|COMPLETED|Overall Study||0
2435131|NCT01147822|5973900|P1|COMPLETED|Overall Study||0
2435132|NCT01147822|5973899|P2|Not Completed/Ongoing|Overall Study||102
2435133|NCT01147822|5973900|P1|Not Completed/Ongoing|Overall Study||111
2435134|NCT01147822|5973899|P2|STARTED|Overall Study||179
2435135|NCT01147822|5973900|P1|STARTED|Overall Study||188
2435136|NCT01147809|5973920|P6|NOT COMPLETED|Phase II (168 Days)||33
2435137|NCT01147809|5973921|P5|NOT COMPLETED|Phase II (168 Days)||16
2435138|NCT01147809|5973922|P4|NOT COMPLETED|Phase II (168 Days)||0
2435139|NCT01147809|5973923|P3|NOT COMPLETED|Phase II (168 Days)||0
2435140|NCT01147809|5973924|P2|NOT COMPLETED|Phase II (168 Days)||0
2435141|NCT01147809|5973925|P1|NOT COMPLETED|Phase II (168 Days)||0
2435142|NCT01147809|5973920|P6|COMPLETED|Phase II (168 Days)||19
2435143|NCT01147809|5973921|P5|COMPLETED|Phase II (168 Days)||7
2435144|NCT01147809|5973922|P4|COMPLETED|Phase II (168 Days)||0
2435145|NCT01147809|5973923|P3|COMPLETED|Phase II (168 Days)||0
2435146|NCT01147809|5973924|P2|COMPLETED|Phase II (168 Days)||0
2435147|NCT01147809|5973925|P1|COMPLETED|Phase II (168 Days)||0
2435148|NCT01147809|5973920|P6|Ongoing|Phase II (168 Days)||0
2435149|NCT01147809|5973921|P5|Ongoing|Phase II (168 Days)||1
2435150|NCT01147809|5973922|P4|Ongoing|Phase II (168 Days)||0
2435151|NCT01147809|5973923|P3|Ongoing|Phase II (168 Days)||0
2435152|NCT01147809|5973924|P2|Ongoing|Phase II (168 Days)||0
2435153|NCT01147809|5973925|P1|Ongoing|Phase II (168 Days)||0
2435154|NCT01147809|5973920|P6|STARTED|Phase II (168 Days)||52
2435155|NCT01147809|5973921|P5|STARTED|Phase II (168 Days)||23
2435156|NCT01147809|5973922|P4|STARTED|Phase II (168 Days)||0
2435157|NCT01147809|5973923|P3|STARTED|Phase II (168 Days)||0
2435158|NCT01147809|5973924|P2|STARTED|Phase II (168 Days)||0
2435159|NCT01147809|5973925|P1|STARTED|Phase II (168 Days)||0
2435160|NCT01147809|5973920|P6|NOT COMPLETED|Phase I (168 Days)||0
2435161|NCT01147809|5973921|P5|NOT COMPLETED|Phase I (168 Days)||0
2435162|NCT01147809|5973922|P4|NOT COMPLETED|Phase I (168 Days)||5
2435163|NCT01147809|5973923|P3|NOT COMPLETED|Phase I (168 Days)||2
2435164|NCT01147809|5973924|P2|NOT COMPLETED|Phase I (168 Days)||1
2435165|NCT01147809|5973925|P1|NOT COMPLETED|Phase I (168 Days)||1
2435166|NCT01147809|5973920|P6|COMPLETED|Phase I (168 Days)||0
2435167|NCT01147809|5973921|P5|COMPLETED|Phase I (168 Days)||0
2435168|NCT01147809|5973922|P4|COMPLETED|Phase I (168 Days)||5
2435169|NCT01147809|5973923|P3|COMPLETED|Phase I (168 Days)||2
2435170|NCT01147809|5973924|P2|COMPLETED|Phase I (168 Days)||8
2435171|NCT01147809|5973925|P1|COMPLETED|Phase I (168 Days)||2
2435172|NCT01147809|5973920|P6|STARTED|Phase I (168 Days)||0
2435173|NCT01147809|5973921|P5|STARTED|Phase I (168 Days)||0
2435174|NCT01147809|5973922|P4|STARTED|Phase I (168 Days)||10
2435175|NCT01147809|5973923|P3|STARTED|Phase I (168 Days)||4
2435176|NCT01147809|5973924|P2|STARTED|Phase I (168 Days)||9
2435177|NCT01147809|5973925|P1|STARTED|Phase I (168 Days)||3
2435178|NCT01147744|5974046|P7|NOT COMPLETED|Overall Study||19
2435179|NCT01147744|5974047|P6|NOT COMPLETED|Overall Study||20
2435180|NCT01147744|5974048|P5|NOT COMPLETED|Overall Study||25
2435181|NCT01147744|5974049|P4|NOT COMPLETED|Overall Study||18
2435182|NCT01147744|5974050|P3|NOT COMPLETED|Overall Study||18
2435183|NCT01147744|5974051|P2|NOT COMPLETED|Overall Study||23
2435184|NCT01147744|5974052|P1|NOT COMPLETED|Overall Study||29
2435185|NCT01147744|5974046|P7|COMPLETED|Overall Study||78
2435186|NCT01147744|5974047|P6|COMPLETED|Overall Study||83
2435187|NCT01147744|5974048|P5|COMPLETED|Overall Study||76
2435188|NCT01147744|5974049|P4|COMPLETED|Overall Study||82
2435189|NCT01147744|5974050|P3|COMPLETED|Overall Study||82
2435190|NCT01147744|5974051|P2|COMPLETED|Overall Study||76
2435191|NCT01147744|5974052|P1|COMPLETED|Overall Study||71
2435192|NCT01147744|5974046|P7|STARTED|Overall Study||97
2435193|NCT01147744|5974047|P6|STARTED|Overall Study||103
2435194|NCT01147744|5974048|P5|STARTED|Overall Study||101
2435195|NCT01147744|5974049|P4|STARTED|Overall Study||100
2435196|NCT01147744|5974050|P3|STARTED|Overall Study||100
2435197|NCT01147744|5974051|P2|STARTED|Overall Study||99
2435198|NCT01147744|5974052|P1|STARTED|Overall Study||100
2435199|NCT01147653|5974147|P2|NOT COMPLETED|Year 2||3
2435200|NCT01147653|5974148|P1|NOT COMPLETED|Year 2||2
2435201|NCT01147653|5974147|P2|COMPLETED|Year 2||28
2435202|NCT01147653|5974148|P1|COMPLETED|Year 2||30
2435203|NCT01147653|5974147|P2|STARTED|Year 2||31
2435204|NCT01147653|5974148|P1|STARTED|Year 2||32
2435205|NCT01147653|5974147|P2|NOT COMPLETED|Year 1||0
2435206|NCT01147653|5974148|P1|NOT COMPLETED|Year 1||0
2435207|NCT01147653|5974147|P2|COMPLETED|Year 1||31
2435208|NCT01147653|5974148|P1|COMPLETED|Year 1||32
2435209|NCT01147653|5974147|P2|STARTED|Year 1||31
2435210|NCT01147653|5974148|P1|STARTED|Year 1||32
2435211|NCT01147640|5974209|P2|NOT COMPLETED|Overall Study||1
2435212|NCT01147640|5974210|P1|NOT COMPLETED|Overall Study||5
2435213|NCT01147640|5974209|P2|COMPLETED|Overall Study||38
2435214|NCT01147640|5974210|P1|COMPLETED|Overall Study||78
2435215|NCT01147640|5974209|P2|STARTED|Overall Study||39
2435216|NCT01147640|5974210|P1|STARTED|Overall Study||83
2435217|NCT01147627|5974221|P3|NOT COMPLETED|Overall Study||18
2435218|NCT01147627|5974222|P2|NOT COMPLETED|Overall Study||24
2435219|NCT01147627|5974223|P1|NOT COMPLETED|Overall Study||32
2435220|NCT01147627|5974221|P3|COMPLETED|Overall Study||118
2435221|NCT01147627|5974222|P2|COMPLETED|Overall Study||114
2435222|NCT01147627|5974223|P1|COMPLETED|Overall Study||110
2435223|NCT01147627|5974221|P3|STARTED|Overall Study||136
2435224|NCT01147627|5974222|P2|STARTED|Overall Study||138
2435225|NCT01147627|5974223|P1|STARTED|Overall Study||142
2435226|NCT01147601|5974233|P2|NOT COMPLETED|Overall Study||0
2435227|NCT01147601|5974234|P1|NOT COMPLETED|Overall Study||3
2435228|NCT01147601|5974233|P2|COMPLETED|Overall Study||1
2435229|NCT01147601|5974234|P1|COMPLETED|Overall Study||2
2435230|NCT01147601|5974233|P2|STARTED|Overall Study||1
2435231|NCT01147601|5974234|P1|STARTED|Overall Study||5
2435232|NCT01147497|5974242|P2|NOT COMPLETED|Overall Study||0
2435233|NCT01147497|5974243|P1|NOT COMPLETED|Overall Study||2
2435234|NCT01147497|5974242|P2|COMPLETED|Overall Study||36
2435235|NCT01147497|5974243|P1|COMPLETED|Overall Study||35
2435236|NCT01147497|5974242|P2|STARTED|Overall Study||36
2435237|NCT01147497|5974243|P1|STARTED|Overall Study||37
2435238|NCT01147471|5974263|P2|NOT COMPLETED|6 Month Follow Up||2
2435239|NCT01147471|5974264|P1|NOT COMPLETED|6 Month Follow Up||4
2435240|NCT01147471|5974263|P2|COMPLETED|6 Month Follow Up||4
2435241|NCT01147471|5974264|P1|COMPLETED|6 Month Follow Up||8
2435242|NCT01147471|5974263|P2|STARTED|6 Month Follow Up||6
2435243|NCT01147471|5974264|P1|STARTED|6 Month Follow Up||12
2435244|NCT01147471|5974263|P2|NOT COMPLETED|3 Month Follow Up||2
2435245|NCT01147471|5974264|P1|NOT COMPLETED|3 Month Follow Up||1
2435246|NCT01147471|5974263|P2|COMPLETED|3 Month Follow Up||6
2435247|NCT01147471|5974264|P1|COMPLETED|3 Month Follow Up||12
2435248|NCT01147471|5974263|P2|STARTED|3 Month Follow Up||8
2435249|NCT01147471|5974264|P1|STARTED|3 Month Follow Up||13
2435250|NCT01147471|5974263|P2|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||3
2435251|NCT01147471|5974264|P1|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||0
2435252|NCT01147471|5974263|P2|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||8
2435253|NCT01147471|5974264|P1|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||13
2435254|NCT01147471|5974263|P2|STARTED|Post-discharge Follow Up (Approx 2 Wks)||11
2435255|NCT01147471|5974264|P1|STARTED|Post-discharge Follow Up (Approx 2 Wks)||13
2435256|NCT01147471|5974263|P2|NOT COMPLETED|Through Initial Hospital Discharge||0
2435257|NCT01147471|5974264|P1|NOT COMPLETED|Through Initial Hospital Discharge||0
2435258|NCT01147471|5974263|P2|COMPLETED|Through Initial Hospital Discharge||11
2435259|NCT01147471|5974264|P1|COMPLETED|Through Initial Hospital Discharge||13
2435260|NCT01147471|5974263|P2|STARTED|Through Initial Hospital Discharge||11
2435261|NCT01147471|5974264|P1|STARTED|Through Initial Hospital Discharge||13
2435262|NCT01147458|5974278|P4|NOT COMPLETED|Second Intervention||4
2435263|NCT01147458|5974279|P3|NOT COMPLETED|Second Intervention||8
2435264|NCT01147458|5974280|P2|NOT COMPLETED|Second Intervention||7
2435265|NCT01147458|5974281|P1|NOT COMPLETED|Second Intervention||9
2435266|NCT01147458|5974278|P4|COMPLETED|Second Intervention||30
2435267|NCT01147458|5974279|P3|COMPLETED|Second Intervention||27
2435268|NCT01147458|5974280|P2|COMPLETED|Second Intervention||24
2435269|NCT01147458|5974281|P1|COMPLETED|Second Intervention||25
2435270|NCT01147458|5974278|P4|STARTED|Second Intervention||34
2435271|NCT01147458|5974279|P3|STARTED|Second Intervention||35
2435272|NCT01147458|5974280|P2|STARTED|Second Intervention||31
2435273|NCT01147458|5974281|P1|STARTED|Second Intervention||34
2435274|NCT01147458|5974278|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
2435275|NCT01147458|5974279|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
2435276|NCT01147458|5974280|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
2435277|NCT01147458|5974281|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
2435278|NCT01147458|5974278|P4|COMPLETED|Washout Period of 2 Weeks||34
2435279|NCT01147458|5974279|P3|COMPLETED|Washout Period of 2 Weeks||35
2435280|NCT01147458|5974280|P2|COMPLETED|Washout Period of 2 Weeks||31
2435281|NCT01147458|5974281|P1|COMPLETED|Washout Period of 2 Weeks||34
2435282|NCT01147458|5974278|P4|STARTED|Washout Period of 2 Weeks||34
2435283|NCT01147458|5974279|P3|STARTED|Washout Period of 2 Weeks||35
2435284|NCT01147458|5974280|P2|STARTED|Washout Period of 2 Weeks||31
2435285|NCT01147458|5974281|P1|STARTED|Washout Period of 2 Weeks||34
2435286|NCT01147458|5974278|P4|NOT COMPLETED|First Intervention||14
2435287|NCT01147458|5974279|P3|NOT COMPLETED|First Intervention||12
2435288|NCT01147458|5974280|P2|NOT COMPLETED|First Intervention||16
2435289|NCT01147458|5974281|P1|NOT COMPLETED|First Intervention||14
2435290|NCT01147458|5974278|P4|COMPLETED|First Intervention||34
2435291|NCT01147458|5974279|P3|COMPLETED|First Intervention||35
2435292|NCT01147458|5974280|P2|COMPLETED|First Intervention||31
2435293|NCT01147458|5974281|P1|COMPLETED|First Intervention||34
2435294|NCT01147458|5974278|P4|STARTED|First Intervention||48
2435295|NCT01147458|5974279|P3|STARTED|First Intervention||47
2435296|NCT01147458|5974280|P2|STARTED|First Intervention||47
2435297|NCT01147458|5974281|P1|STARTED|First Intervention||48
2435298|NCT01147406|5974335|P6|NOT COMPLETED|Overall Study||0
2435299|NCT01147406|5974336|P5|NOT COMPLETED|Overall Study||0
2435300|NCT01147406|5974337|P4|NOT COMPLETED|Overall Study||0
2435301|NCT01147406|5974338|P3|NOT COMPLETED|Overall Study||0
2435302|NCT01147406|5974339|P2|NOT COMPLETED|Overall Study||0
2435303|NCT01147406|5974340|P1|NOT COMPLETED|Overall Study||0
2435304|NCT01147406|5974335|P6|COMPLETED|Overall Study||10
2435305|NCT01147406|5974336|P5|COMPLETED|Overall Study||6
2435306|NCT01147406|5974337|P4|COMPLETED|Overall Study||6
2435307|NCT01147406|5974338|P3|COMPLETED|Overall Study||1
2435308|NCT01147406|5974339|P2|COMPLETED|Overall Study||12
2435309|NCT01147406|5974340|P1|COMPLETED|Overall Study||6
2435310|NCT01147406|5974335|P6|STARTED|Overall Study||10
2435311|NCT01147406|5974336|P5|STARTED|Overall Study||6
2435312|NCT01147406|5974337|P4|STARTED|Overall Study||6
2435313|NCT01147406|5974338|P3|STARTED|Overall Study||1
2435314|NCT01147406|5974339|P2|STARTED|Overall Study||12
2435315|NCT01147406|5974340|P1|STARTED|Overall Study||6
2435316|NCT01147393|5974360|P1|NOT COMPLETED|Dose Level -1||1
2435317|NCT01147393|5974360|P1|COMPLETED|Dose Level -1||0
2435318|NCT01147393|5974360|P1|STARTED|Dose Level -1||1
2435319|NCT01147393|5974360|P1|NOT COMPLETED|Dose Level 1||2
2435320|NCT01147393|5974360|P1|COMPLETED|Dose Level 1||1
2435321|NCT01147393|5974360|P1|STARTED|Dose Level 1||3
2435322|NCT01147380|5974370|P2|NOT COMPLETED|Overall Study||0
2435323|NCT01147380|5974371|P1|NOT COMPLETED|Overall Study||0
2435324|NCT01147380|5974370|P2|COMPLETED|Overall Study||12
2435325|NCT01147380|5974371|P1|COMPLETED|Overall Study||6
2435326|NCT01147380|5974370|P2|STARTED|Overall Study||12
2435327|NCT01147380|5974371|P1|STARTED|Overall Study||6
2435328|NCT01147341|5974381|P2|NOT COMPLETED|Open Label Period||0
2435329|NCT01147341|5974382|P1|NOT COMPLETED|Open Label Period||4
2435330|NCT01147341|5974381|P2|COMPLETED|Open Label Period||8
2435331|NCT01147341|5974382|P1|COMPLETED|Open Label Period||22
2435332|NCT01147341|5974381|P2|STARTED|Open Label Period||8
2435333|NCT01147341|5974382|P1|STARTED|Open Label Period||26
2435334|NCT01147341|5974381|P2|NOT COMPLETED|Double Blind Period||2
2435335|NCT01147341|5974382|P1|NOT COMPLETED|Double Blind Period||1
2435336|NCT01147341|5974381|P2|COMPLETED|Double Blind Period||8
2435337|NCT01147341|5974382|P1|COMPLETED|Double Blind Period||26
2435338|NCT01147341|5974381|P2|STARTED|Double Blind Period||10
2435339|NCT01147341|5974382|P1|STARTED|Double Blind Period||27
2435340|NCT01147302|5974412|P2|NOT COMPLETED|Overall Study||0
2435341|NCT01147302|5974413|P1|NOT COMPLETED|Overall Study||0
2435342|NCT01147302|5974412|P2|COMPLETED|Overall Study||9
2435343|NCT01147302|5974413|P1|COMPLETED|Overall Study||9
2435344|NCT01147302|5974412|P2|STARTED|Overall Study||9
2435345|NCT01147302|5974413|P1|STARTED|Overall Study||9
2435346|NCT01147250|5974445|P2|NOT COMPLETED|Overall Study||105
2435347|NCT01147250|5974446|P1|NOT COMPLETED|Overall Study||110
2435348|NCT01147250|5974445|P2|COMPLETED|Overall Study||2929
2435349|NCT01147250|5974446|P1|COMPLETED|Overall Study||2924
2435350|NCT01147250|5974445|P2|Treated|Overall Study||3031
2435351|NCT01147250|5974446|P1|Treated|Overall Study||3032
2435352|NCT01147250|5974445|P2|STARTED|Overall Study||3034
2435353|NCT01147250|5974446|P1|STARTED|Overall Study||3034
2435354|NCT01147172|5974458|P1|NOT COMPLETED|Overall Study||4
2435355|NCT01147172|5974458|P1|COMPLETED|Overall Study||96
2435356|NCT01147172|5974458|P1|STARTED|Overall Study||100
2435357|NCT01147068|5974476|P7|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
2435358|NCT01147068|5974477|P6|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
2435434|NCT01147055|5974512|P2|COMPLETED|First Intervention Period||0
2435359|NCT01147068|5974478|P5|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
2435360|NCT01147068|5974479|P4|NOT COMPLETED|Subjects That Completed Safety Follow-up||2
2435361|NCT01147068|5974480|P3|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
2435362|NCT01147068|5974481|P2|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
2435363|NCT01147068|5974482|P1|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
2435364|NCT01147068|5974476|P7|COMPLETED|Subjects That Completed Safety Follow-up||54
2435365|NCT01147068|5974477|P6|COMPLETED|Subjects That Completed Safety Follow-up||52
2435366|NCT01147068|5974478|P5|COMPLETED|Subjects That Completed Safety Follow-up||56
2435367|NCT01147068|5974479|P4|COMPLETED|Subjects That Completed Safety Follow-up||54
2435368|NCT01147068|5974480|P3|COMPLETED|Subjects That Completed Safety Follow-up||55
2435369|NCT01147068|5974481|P2|COMPLETED|Subjects That Completed Safety Follow-up||56
2435370|NCT01147068|5974482|P1|COMPLETED|Subjects That Completed Safety Follow-up||59
2435371|NCT01147068|5974476|P7|STARTED|Subjects That Completed Safety Follow-up||55
2435372|NCT01147068|5974477|P6|STARTED|Subjects That Completed Safety Follow-up|One subject was lost to follow up and one subject did not complete the study.|53
2435373|NCT01147068|5974478|P5|STARTED|Subjects That Completed Safety Follow-up|Data for one subject is unknown.|56
2435374|NCT01147068|5974479|P4|STARTED|Subjects That Completed Safety Follow-up||56
2435375|NCT01147068|5974480|P3|STARTED|Subjects That Completed Safety Follow-up|Data on three subjects is unknown.|55
2435376|NCT01147068|5974481|P2|STARTED|Subjects That Completed Safety Follow-up|One subject was ineligible, one subject did not complete the study, and the other data is unknown.|57
2435377|NCT01147068|5974482|P1|STARTED|Subjects That Completed Safety Follow-up|Participants were eligible for follow-up regardless of number of doses received.|60
2435378|NCT01147068|5974476|P7|NOT COMPLETED|Subjects That Received 2nd Dose||0
2435379|NCT01147068|5974477|P6|NOT COMPLETED|Subjects That Received 2nd Dose||2
2435380|NCT01147068|5974478|P5|NOT COMPLETED|Subjects That Received 2nd Dose||1
2435381|NCT01147068|5974479|P4|NOT COMPLETED|Subjects That Received 2nd Dose||0
2435382|NCT01147068|5974480|P3|NOT COMPLETED|Subjects That Received 2nd Dose||3
2435383|NCT01147068|5974481|P2|NOT COMPLETED|Subjects That Received 2nd Dose||5
2435384|NCT01147068|5974482|P1|NOT COMPLETED|Subjects That Received 2nd Dose||1
2435385|NCT01147068|5974476|P7|COMPLETED|Subjects That Received 2nd Dose||55
2435386|NCT01147068|5974477|P6|COMPLETED|Subjects That Received 2nd Dose||51
2435387|NCT01147068|5974478|P5|COMPLETED|Subjects That Received 2nd Dose||55
2435388|NCT01147068|5974479|P4|COMPLETED|Subjects That Received 2nd Dose||56
2435389|NCT01147068|5974480|P3|COMPLETED|Subjects That Received 2nd Dose||52
2435390|NCT01147068|5974481|P2|COMPLETED|Subjects That Received 2nd Dose||52
2435391|NCT01147068|5974482|P1|COMPLETED|Subjects That Received 2nd Dose||59
2435392|NCT01147068|5974476|P7|STARTED|Subjects That Received 2nd Dose||55
2435393|NCT01147068|5974477|P6|STARTED|Subjects That Received 2nd Dose||53
2435394|NCT01147068|5974478|P5|STARTED|Subjects That Received 2nd Dose||56
2435395|NCT01147068|5974479|P4|STARTED|Subjects That Received 2nd Dose||56
2435396|NCT01147068|5974480|P3|STARTED|Subjects That Received 2nd Dose||55
2435397|NCT01147068|5974481|P2|STARTED|Subjects That Received 2nd Dose||57
2435398|NCT01147068|5974482|P1|STARTED|Subjects That Received 2nd Dose||60
2435399|NCT01147068|5974476|P7|NOT COMPLETED|Subjects That Received 1st Dose||0
2435400|NCT01147068|5974477|P6|NOT COMPLETED|Subjects That Received 1st Dose||0
2435401|NCT01147068|5974478|P5|NOT COMPLETED|Subjects That Received 1st Dose||0
2435402|NCT01147068|5974479|P4|NOT COMPLETED|Subjects That Received 1st Dose||0
2435403|NCT01147068|5974480|P3|NOT COMPLETED|Subjects That Received 1st Dose||0
2435404|NCT01147068|5974481|P2|NOT COMPLETED|Subjects That Received 1st Dose||0
2435405|NCT01147068|5974482|P1|NOT COMPLETED|Subjects That Received 1st Dose||0
2435406|NCT01147068|5974476|P7|COMPLETED|Subjects That Received 1st Dose||55
2435407|NCT01147068|5974477|P6|COMPLETED|Subjects That Received 1st Dose||53
2435408|NCT01147068|5974478|P5|COMPLETED|Subjects That Received 1st Dose||56
2435409|NCT01147068|5974479|P4|COMPLETED|Subjects That Received 1st Dose||56
2435410|NCT01147068|5974480|P3|COMPLETED|Subjects That Received 1st Dose||55
2435411|NCT01147068|5974481|P2|COMPLETED|Subjects That Received 1st Dose||57
2435412|NCT01147068|5974482|P1|COMPLETED|Subjects That Received 1st Dose||60
2435413|NCT01147068|5974476|P7|STARTED|Subjects That Received 1st Dose||55
2435414|NCT01147068|5974477|P6|STARTED|Subjects That Received 1st Dose||53
2435415|NCT01147068|5974478|P5|STARTED|Subjects That Received 1st Dose||56
2435416|NCT01147068|5974479|P4|STARTED|Subjects That Received 1st Dose||56
2435417|NCT01147068|5974480|P3|STARTED|Subjects That Received 1st Dose||55
2435418|NCT01147068|5974481|P2|STARTED|Subjects That Received 1st Dose||57
2435419|NCT01147068|5974482|P1|STARTED|Subjects That Received 1st Dose||60
2435420|NCT01147055|5974512|P2|NOT COMPLETED|Second Intervention Period||0
2435421|NCT01147055|5974513|P1|NOT COMPLETED|Second Intervention Period||0
2435422|NCT01147055|5974512|P2|COMPLETED|Second Intervention Period||14
2435423|NCT01147055|5974513|P1|COMPLETED|Second Intervention Period||0
2435424|NCT01147055|5974512|P2|STARTED|Second Intervention Period||14
2435425|NCT01147055|5974513|P1|STARTED|Second Intervention Period||0
2435426|NCT01147055|5974512|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2435427|NCT01147055|5974513|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2435428|NCT01147055|5974512|P2|COMPLETED|Washout Period (at Least 14 Days)||0
2435429|NCT01147055|5974513|P1|COMPLETED|Washout Period (at Least 14 Days)||14
2435430|NCT01147055|5974512|P2|STARTED|Washout Period (at Least 14 Days)||0
2435431|NCT01147055|5974513|P1|STARTED|Washout Period (at Least 14 Days)||14
2435432|NCT01147055|5974512|P2|NOT COMPLETED|First Intervention Period||0
2435433|NCT01147055|5974513|P1|NOT COMPLETED|First Intervention Period||1
2435435|NCT01147055|5974513|P1|COMPLETED|First Intervention Period||14
2435436|NCT01147055|5974512|P2|STARTED|First Intervention Period||0
2435437|NCT01147055|5974513|P1|STARTED|First Intervention Period||15
2435438|NCT01147042|5974547|P2|NOT COMPLETED|Overall Study||0
2435439|NCT01147042|5974548|P1|NOT COMPLETED|Overall Study||0
2435440|NCT01147042|5974547|P2|COMPLETED|Overall Study||0
2435441|NCT01147042|5974548|P1|COMPLETED|Overall Study||2
2435442|NCT01147042|5974547|P2|STARTED|Overall Study||0
2435443|NCT01147042|5974548|P1|STARTED|Overall Study||2
2435444|NCT01146951|5974555|P2|NOT COMPLETED|Overall Study||1
2435445|NCT01146951|5974556|P1|NOT COMPLETED|Overall Study||4
2435446|NCT01146951|5974555|P2|COMPLETED|Overall Study||29
2435447|NCT01146951|5974556|P1|COMPLETED|Overall Study||25
2435448|NCT01146951|5974555|P2|STARTED|Overall Study||30
2435449|NCT01146951|5974556|P1|STARTED|Overall Study||29
2435450|NCT01146912|5974577|P8|NOT COMPLETED|Overall Study||0
2435451|NCT01146912|5974578|P7|NOT COMPLETED|Overall Study||56
2435452|NCT01146912|5974579|P6|NOT COMPLETED|Overall Study||61
2435453|NCT01146912|5974580|P5|NOT COMPLETED|Overall Study||41
2435454|NCT01146912|5974581|P4|NOT COMPLETED|Overall Study||17
2435455|NCT01146912|5974582|P3|NOT COMPLETED|Overall Study||17
2435456|NCT01146912|5974583|P2|NOT COMPLETED|Overall Study||822
2435457|NCT01146912|5974584|P1|NOT COMPLETED|Overall Study||817
2435458|NCT01146912|5974577|P8|COMPLETED|Overall Study|Parents are considered subjects but outcomes are on child level|14675
2435459|NCT01146912|5974578|P7|COMPLETED|Overall Study||1764
2435460|NCT01146912|5974579|P6|COMPLETED|Overall Study||1760
2435461|NCT01146912|5974580|P5|COMPLETED|Overall Study||1780
2435462|NCT01146912|5974581|P4|COMPLETED|Overall Study||577
2435463|NCT01146912|5974582|P3|COMPLETED|Overall Study||576
2435464|NCT01146912|5974583|P2|COMPLETED|Overall Study||3784
2435465|NCT01146912|5974584|P1|COMPLETED|Overall Study||3790
2435466|NCT01146912|5974577|P8|STARTED|Overall Study||14675
2435467|NCT01146912|5974578|P7|STARTED|Overall Study||1820
2435468|NCT01146912|5974579|P6|STARTED|Overall Study||1821
2435469|NCT01146912|5974580|P5|STARTED|Overall Study||1821
2435470|NCT01146912|5974581|P4|STARTED|Overall Study||594
2435471|NCT01146912|5974582|P3|STARTED|Overall Study||593
2435472|NCT01146912|5974583|P2|STARTED|Overall Study||4606
2435473|NCT01146912|5974584|P1|STARTED|Overall Study||4607
2435474|NCT01146873|5974606|P2|NOT COMPLETED|Overall Study||6
2435475|NCT01146873|5974607|P1|NOT COMPLETED|Overall Study||0
2435476|NCT01146873|5974606|P2|COMPLETED|Overall Study||144
2435477|NCT01146873|5974607|P1|COMPLETED|Overall Study||148
2435478|NCT01146873|5974606|P2|STARTED|Overall Study||150
2435479|NCT01146873|5974607|P1|STARTED|Overall Study||148
2435480|NCT01146860|5974623|P2|NOT COMPLETED|Overall Study||1
2435481|NCT01146860|5974624|P1|NOT COMPLETED|Overall Study||0
2435482|NCT01146860|5974623|P2|COMPLETED|Overall Study||191
2435483|NCT01146860|5974624|P1|COMPLETED|Overall Study||194
2435484|NCT01146860|5974623|P2|STARTED|Overall Study||192
2435485|NCT01146860|5974624|P1|STARTED|Overall Study||194
2435486|NCT01146834|5974643|P5|NOT COMPLETED|Overall Study||0
2435487|NCT01146834|5974644|P4|NOT COMPLETED|Overall Study||0
2435488|NCT01146834|5974645|P3|NOT COMPLETED|Overall Study||2
2435489|NCT01146834|5974646|P2|NOT COMPLETED|Overall Study||0
2435490|NCT01146834|5974647|P1|NOT COMPLETED|Overall Study||3
2435491|NCT01146834|5974643|P5|COMPLETED|Overall Study||0
2435492|NCT01146834|5974644|P4|COMPLETED|Overall Study||0
2435493|NCT01146834|5974645|P3|COMPLETED|Overall Study||21
2435494|NCT01146834|5974646|P2|COMPLETED|Overall Study||4
2435495|NCT01146834|5974647|P1|COMPLETED|Overall Study||17
2435496|NCT01146834|5974643|P5|STARTED|Overall Study||0
2435497|NCT01146834|5974644|P4|STARTED|Overall Study||0
2435498|NCT01146834|5974645|P3|STARTED|Overall Study||23
2435499|NCT01146834|5974646|P2|STARTED|Overall Study||4
2435500|NCT01146834|5974647|P1|STARTED|Overall Study||20
2435501|NCT01146808|5974669|P1|NOT COMPLETED|Overall Study||0
2435502|NCT01146808|5974669|P1|COMPLETED|Overall Study||16
2435503|NCT01146808|5974669|P1|STARTED|Overall Study||16
2435504|NCT01146782|5974675|P1|NOT COMPLETED|Primary Endpoint Cohort||6
2435505|NCT01146782|5974675|P1|COMPLETED|Primary Endpoint Cohort|57 Subjects in the Primary Endpoint Cohort completed the 28 day study|57
2435506|NCT01146782|5974675|P1|STARTED|Primary Endpoint Cohort|63 Subjects in the Primary Endpoint Cohort|63
2435507|NCT01146782|5974675|P1|NOT COMPLETED|Safety Cohort||83
2435508|NCT01146782|5974675|P1|COMPLETED|Safety Cohort||63
2435509|NCT01146782|5974675|P1|STARTED|Safety Cohort||146
2435510|NCT01146782|5974675|P1|NOT COMPLETED|Screening Cohort||221
2435511|NCT01146782|5974675|P1|COMPLETED|Screening Cohort||146
2435512|NCT01146782|5974675|P1|STARTED|Screening Cohort||367
2435513|NCT01146704|5974684|P2|NOT COMPLETED|Overall Study||0
2435514|NCT01146704|5974685|P1|NOT COMPLETED|Overall Study||0
2435515|NCT01146704|5974684|P2|COMPLETED|Overall Study||15
2435516|NCT01146704|5974685|P1|COMPLETED|Overall Study||16
2435517|NCT01146704|5974684|P2|STARTED|Overall Study||15
2435518|NCT01146704|5974685|P1|STARTED|Overall Study||16
2435519|NCT01146665|5974693|P2|NOT COMPLETED|Overall Study||16
2435520|NCT01146665|5974694|P1|NOT COMPLETED|Overall Study||10
2435521|NCT01146665|5974693|P2|COMPLETED|Overall Study||10
2435522|NCT01146665|5974694|P1|COMPLETED|Overall Study||8
2435523|NCT01146665|5974693|P2|3-month Post-ED Discharge (Follow-up)|Overall Study||10
2435524|NCT01146665|5974694|P1|3-month Post-ED Discharge (Follow-up)|Overall Study||8
2435525|NCT01146665|5974693|P2|1-month Post-ED Discharge (Follow-up)|Overall Study||12
2435526|NCT01146665|5974694|P1|1-month Post-ED Discharge (Follow-up)|Overall Study||9
2435527|NCT01146665|5974693|P2|STARTED|Overall Study||26
2435528|NCT01146665|5974694|P1|STARTED|Overall Study||18
2435529|NCT01146613|5974726|P2|NOT COMPLETED|Overall Study||12
2435530|NCT01146613|5974727|P1|NOT COMPLETED|Overall Study||7
2435531|NCT01146613|5974726|P2|COMPLETED|Overall Study||89
2435532|NCT01146613|5974727|P1|COMPLETED|Overall Study||92
2435533|NCT01146613|5974726|P2|STARTED|Overall Study||101
2435534|NCT01146613|5974727|P1|STARTED|Overall Study||99
2435535|NCT01146600|5974735|P2|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
2435536|NCT01146600|5974736|P1|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
2435537|NCT01146600|5974735|P2|COMPLETED|Period 2 (Weeks 4 & 5)||10
2435538|NCT01146600|5974736|P1|COMPLETED|Period 2 (Weeks 4 & 5)||10
2435539|NCT01146600|5974735|P2|STARTED|Period 2 (Weeks 4 & 5)||10
2435540|NCT01146600|5974736|P1|STARTED|Period 2 (Weeks 4 & 5)||10
2435541|NCT01146600|5974735|P2|NOT COMPLETED|Washout (Week 3)||0
2435542|NCT01146600|5974736|P1|NOT COMPLETED|Washout (Week 3)||0
2435543|NCT01146600|5974735|P2|COMPLETED|Washout (Week 3)||10
2435544|NCT01146600|5974736|P1|COMPLETED|Washout (Week 3)||10
2435545|NCT01146600|5974735|P2|STARTED|Washout (Week 3)||10
2435546|NCT01146600|5974736|P1|STARTED|Washout (Week 3)||10
2435547|NCT01146600|5974735|P2|NOT COMPLETED|Period 1 (Weeks 1 & 2)||0
2435548|NCT01146600|5974736|P1|NOT COMPLETED|Period 1 (Weeks 1 & 2)||3
2435549|NCT01146600|5974735|P2|COMPLETED|Period 1 (Weeks 1 & 2)||10
2435550|NCT01146600|5974736|P1|COMPLETED|Period 1 (Weeks 1 & 2)||10
2435551|NCT01146600|5974735|P2|STARTED|Period 1 (Weeks 1 & 2)||10
2435552|NCT01146600|5974736|P1|STARTED|Period 1 (Weeks 1 & 2)||13
2435553|NCT01146496|5974763|P2|NOT COMPLETED|Overall Study||0
2435554|NCT01146496|5974764|P1|NOT COMPLETED|Overall Study||0
2435555|NCT01146496|5974763|P2|COMPLETED|Overall Study||109693
2435556|NCT01146496|5974764|P1|COMPLETED|Overall Study||114168
2435557|NCT01146496|5974763|P2|STARTED|Overall Study||109693
2435558|NCT01146496|5974764|P1|STARTED|Overall Study||114168
2435559|NCT01146457|5974785|P5|NOT COMPLETED|Overall Study||0
2435560|NCT01146457|5974786|P4|NOT COMPLETED|Overall Study||0
2435561|NCT01146457|5974787|P3|NOT COMPLETED|Overall Study||1
2435562|NCT01146457|5974788|P2|NOT COMPLETED|Overall Study||0
2435563|NCT01146457|5974789|P1|NOT COMPLETED|Overall Study||0
2435564|NCT01146457|5974785|P5|COMPLETED|Overall Study||13
2435565|NCT01146457|5974786|P4|COMPLETED|Overall Study||13
2435566|NCT01146457|5974787|P3|COMPLETED|Overall Study||20
2435567|NCT01146457|5974788|P2|COMPLETED|Overall Study||17
2435568|NCT01146457|5974789|P1|COMPLETED|Overall Study||19
2435569|NCT01146457|5974785|P5|STARTED|Overall Study||13
2435570|NCT01146457|5974786|P4|STARTED|Overall Study||13
2435571|NCT01146457|5974787|P3|STARTED|Overall Study||21
2435572|NCT01146457|5974788|P2|STARTED|Overall Study||17
2435573|NCT01146457|5974789|P1|STARTED|Overall Study||19
2435574|NCT01146418|5974803|P4|NOT COMPLETED|Live-Born Infant Follow Up||5
2435575|NCT01146418|5974804|P3|NOT COMPLETED|Live-Born Infant Follow Up||6
2435576|NCT01146418|5974805|P2|NOT COMPLETED|Live-Born Infant Follow Up||0
2435577|NCT01146418|5974806|P1|NOT COMPLETED|Live-Born Infant Follow Up||0
2435578|NCT01146418|5974803|P4|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|51
2435579|NCT01146418|5974804|P3|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|55
2435580|NCT01146418|5974805|P2|COMPLETED|Live-Born Infant Follow Up||0
2435581|NCT01146418|5974806|P1|COMPLETED|Live-Born Infant Follow Up||0
2435582|NCT01146418|5974803|P4|STARTED|Live-Born Infant Follow Up||56
2435583|NCT01146418|5974804|P3|STARTED|Live-Born Infant Follow Up||61
2435584|NCT01146418|5974805|P2|STARTED|Live-Born Infant Follow Up||0
2435585|NCT01146418|5974806|P1|STARTED|Live-Born Infant Follow Up||0
2435586|NCT01146418|5974803|P4|NOT COMPLETED|Women/Expectant Mother Follow Up||0
2435587|NCT01146418|5974804|P3|NOT COMPLETED|Women/Expectant Mother Follow Up||0
2435588|NCT01146418|5974805|P2|NOT COMPLETED|Women/Expectant Mother Follow Up||40
2435589|NCT01146418|5974806|P1|NOT COMPLETED|Women/Expectant Mother Follow Up||44
2435590|NCT01146418|5974803|P4|COMPLETED|Women/Expectant Mother Follow Up||0
2435591|NCT01146418|5974804|P3|COMPLETED|Women/Expectant Mother Follow Up||0
2435592|NCT01146418|5974805|P2|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|110
2435593|NCT01146418|5974806|P1|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|113
2435594|NCT01146418|5974803|P4|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
2435595|NCT01146418|5974804|P3|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
2435596|NCT01146418|5974805|P2|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|50
2435597|NCT01146418|5974806|P1|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|52
2435598|NCT01146418|5974803|P4|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
2435599|NCT01146418|5974804|P3|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
2435600|NCT01146418|5974805|P2|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||147
2435601|NCT01146418|5974806|P1|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||151
2435602|NCT01146418|5974803|P4|STARTED|Women/Expectant Mother Follow Up||0
2435603|NCT01146418|5974804|P3|STARTED|Women/Expectant Mother Follow Up||0
2435604|NCT01146418|5974805|P2|STARTED|Women/Expectant Mother Follow Up|Participants from base study P06029 with at least one embryo thawed for use in FTET cycle.|150
2435605|NCT01146418|5974806|P1|STARTED|Women/Expectant Mother Follow Up|Participants from Base Study P06029 with at least one embryo thawed for use in FTET cycle.|157
2435606|NCT01146418|5974803|P4|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
2435607|NCT01146418|5974804|P3|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
2435608|NCT01146418|5974805|P2|NOT COMPLETED|Base Study P06029 (NCT01144416)||49
2435609|NCT01146418|5974806|P1|NOT COMPLETED|Base Study P06029 (NCT01144416)||62
2435610|NCT01146418|5974803|P4|COMPLETED|Base Study P06029 (NCT01144416)||0
2435611|NCT01146418|5974804|P3|COMPLETED|Base Study P06029 (NCT01144416)||0
2435612|NCT01146418|5974805|P2|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|647
2435613|NCT01146418|5974806|P1|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|632
2435614|NCT01146418|5974803|P4|STARTED|Base Study P06029 (NCT01144416)||0
2435615|NCT01146418|5974804|P3|STARTED|Base Study P06029 (NCT01144416)||0
2435616|NCT01146418|5974805|P2|STARTED|Base Study P06029 (NCT01144416)||696
2435617|NCT01146418|5974806|P1|STARTED|Base Study P06029 (NCT01144416)||694
2435618|NCT01146379|5974822|P4|NOT COMPLETED|Overall Study||1
2435619|NCT01146379|5974823|P3|NOT COMPLETED|Overall Study||0
2435620|NCT01146379|5974824|P2|NOT COMPLETED|Overall Study||1
2435621|NCT01146379|5974825|P1|NOT COMPLETED|Overall Study||1
2435622|NCT01146379|5974822|P4|COMPLETED|Overall Study||20
2435623|NCT01146379|5974823|P3|COMPLETED|Overall Study||21
2435624|NCT01146379|5974824|P2|COMPLETED|Overall Study||21
2435625|NCT01146379|5974825|P1|COMPLETED|Overall Study||20
2435626|NCT01146379|5974822|P4|STARTED|Overall Study||21
2435627|NCT01146379|5974823|P3|STARTED|Overall Study||21
2435628|NCT01146379|5974824|P2|STARTED|Overall Study||22
2435629|NCT01146379|5974825|P1|STARTED|Overall Study||21
2435630|NCT01146288|5974837|P2|NOT COMPLETED|Second Intervention (1 Day)||0
2435631|NCT01146288|5974838|P1|NOT COMPLETED|Second Intervention (1 Day)||0
2435632|NCT01146288|5974837|P2|COMPLETED|Second Intervention (1 Day)||5
2435633|NCT01146288|5974838|P1|COMPLETED|Second Intervention (1 Day)||7
2435634|NCT01146288|5974837|P2|STARTED|Second Intervention (1 Day)||5
2435635|NCT01146288|5974838|P1|STARTED|Second Intervention (1 Day)||7
2435636|NCT01146288|5974837|P2|NOT COMPLETED|First Intervention(1 Day)||1
2435637|NCT01146288|5974838|P1|NOT COMPLETED|First Intervention(1 Day)||0
2435638|NCT01146288|5974837|P2|COMPLETED|First Intervention(1 Day)||5
2435639|NCT01146288|5974838|P1|COMPLETED|First Intervention(1 Day)||7
2435640|NCT01146288|5974837|P2|STARTED|First Intervention(1 Day)||6
2435641|NCT01146288|5974838|P1|STARTED|First Intervention(1 Day)||7
2435642|NCT01146275|5974847|P1|NOT COMPLETED|Overall Study||0
2435643|NCT01146275|5974847|P1|COMPLETED|Overall Study||6
2435644|NCT01146275|5974847|P1|STARTED|Overall Study||6
2435645|NCT01146054|5974852|P1|NOT COMPLETED|Overall Study||10
2435646|NCT01146054|5974852|P1|COMPLETED|Overall Study||49
2435647|NCT01146054|5974852|P1|STARTED|Overall Study||59
2435648|NCT01145898|5974862|P2|NOT COMPLETED|3-year Treatment||16
2435649|NCT01145898|5974863|P1|NOT COMPLETED|3-year Treatment||3
2435650|NCT01145898|5974862|P2|COMPLETED|3-year Treatment||28
2435651|NCT01145898|5974863|P1|COMPLETED|3-year Treatment||9
2435652|NCT01145898|5974862|P2|STARTED|3-year Treatment||44
2435653|NCT01145898|5974863|P1|STARTED|3-year Treatment||12
2435654|NCT01145898|5974862|P2|NOT COMPLETED|6-month Treatment||0
2435655|NCT01145898|5974863|P1|NOT COMPLETED|6-month Treatment||0
2435656|NCT01145898|5974862|P2|COMPLETED|6-month Treatment||44
2435657|NCT01145898|5974863|P1|COMPLETED|6-month Treatment||12
2435658|NCT01145898|5974862|P2|STARTED|6-month Treatment||44
2435659|NCT01145898|5974863|P1|STARTED|6-month Treatment||12
2435660|NCT01145885|5974894|P1|NOT COMPLETED|Overall Study||7
2435661|NCT01145885|5974894|P1|COMPLETED|Overall Study||0
2435662|NCT01145885|5974894|P1|STARTED|Overall Study||7
2435663|NCT01145755|5974929|P3|NOT COMPLETED|Overall Study||25
2435664|NCT01145755|5974930|P2|NOT COMPLETED|Overall Study||28
2435665|NCT01145755|5974931|P1|NOT COMPLETED|Overall Study||20
2435666|NCT01145755|5974929|P3|COMPLETED|Overall Study||19
2435667|NCT01145755|5974930|P2|COMPLETED|Overall Study||19
2435668|NCT01145755|5974931|P1|COMPLETED|Overall Study||20
2435669|NCT01145755|5974929|P3|STARTED|Overall Study||44
2435670|NCT01145755|5974930|P2|STARTED|Overall Study||47
2435671|NCT01145755|5974931|P1|STARTED|Overall Study||40
2435672|NCT01145638|5974947|P2|NOT COMPLETED|Overall Study||57
2435673|NCT01145638|5974948|P1|NOT COMPLETED|Overall Study||90
2435674|NCT01145638|5974947|P2|COMPLETED|Overall Study||62
2435675|NCT01145638|5974948|P1|COMPLETED|Overall Study||141
2435676|NCT01145638|5974947|P2|STARTED|Overall Study||119
2435677|NCT01145638|5974948|P1|STARTED|Overall Study||231
2435678|NCT01145625|5974958|P2|NOT COMPLETED|Overall Study||31
2435679|NCT01145625|5974959|P1|NOT COMPLETED|Overall Study||24
2435680|NCT01145625|5974958|P2|COMPLETED|Overall Study||130
2435681|NCT01145625|5974959|P1|COMPLETED|Overall Study||137
2435682|NCT01145625|5974958|P2|STARTED|Overall Study||161
2435683|NCT01145625|5974959|P1|STARTED|Overall Study||161
2435684|NCT01145560|5974972|P3|NOT COMPLETED|Overall Study||2
2435685|NCT01145560|5974973|P2|NOT COMPLETED|Overall Study||4
2435686|NCT01145560|5974974|P1|NOT COMPLETED|Overall Study||4
2435687|NCT01145560|5974972|P3|COMPLETED|Overall Study|27 patients died during the study. Death was not a reason for treatment or study discontinuation.|98
2435688|NCT01145560|5974973|P2|COMPLETED|Overall Study|33 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
2435689|NCT01145560|5974974|P1|COMPLETED|Overall Study|20 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
2435690|NCT01145560|5974972|P3|Completed Treatment|Overall Study|7 patients died during the treatment period without completing the full course of treatment.|78
2435691|NCT01145560|5974973|P2|Completed Treatment|Overall Study|8 patients died during the treatment period without completing the full course of treatment.|85
2435692|NCT01145560|5974974|P1|Completed Treatment|Overall Study|9 patients died during the treatment period without completing the full course of treatment.|69
2435693|NCT01145560|5974972|P3|Received Treatment|Overall Study||99
2435694|NCT01145560|5974973|P2|Received Treatment|Overall Study||98
2435695|NCT01145560|5974974|P1|Received Treatment|Overall Study||99
2435696|NCT01145560|5974972|P3|STARTED|Overall Study||100
2435697|NCT01145560|5974973|P2|STARTED|Overall Study||100
2435698|NCT01145560|5974974|P1|STARTED|Overall Study||100
2435699|NCT01145547|5974991|P2|NOT COMPLETED|Overall Study||0
2435700|NCT01145547|5974992|P1|NOT COMPLETED|Overall Study||0
2435701|NCT01145547|5974991|P2|COMPLETED|Overall Study||3
2435702|NCT01145547|5974992|P1|COMPLETED|Overall Study||4
2435703|NCT01145547|5974991|P2|STARTED|Overall Study||3
2435704|NCT01145547|5974992|P1|STARTED|Overall Study||4
2435705|NCT01145508|5975000|P2|NOT COMPLETED|Overall Study||2
2435706|NCT01145508|5975001|P1|NOT COMPLETED|Overall Study||5
2435707|NCT01145508|5975000|P2|COMPLETED|Overall Study||1
2435708|NCT01145508|5975001|P1|COMPLETED|Overall Study||2
2435709|NCT01145508|5975000|P2|Treated|Overall Study||2
2435710|NCT01145508|5975001|P1|Treated|Overall Study||6
2435711|NCT01145508|5975000|P2|STARTED|Overall Study||3
2435712|NCT01145508|5975001|P1|STARTED|Overall Study||7
2435713|NCT01145495|5975007|P1|NOT COMPLETED|Overall Study||12
2435714|NCT01145495|5975007|P1|COMPLETED|Overall Study||51
2435715|NCT01145495|5975007|P1|STARTED|Overall Study||63
2435716|NCT01145482|5975013|P2|NOT COMPLETED|Second Intervention (1 Day)||0
2435717|NCT01145482|5975014|P1|NOT COMPLETED|Second Intervention (1 Day)||0
2435718|NCT01145482|5975013|P2|COMPLETED|Second Intervention (1 Day)||6
2435719|NCT01145482|5975014|P1|COMPLETED|Second Intervention (1 Day)||5
2435720|NCT01145482|5975013|P2|STARTED|Second Intervention (1 Day)||6
2435721|NCT01145482|5975014|P1|STARTED|Second Intervention (1 Day)||5
2435722|NCT01145482|5975013|P2|NOT COMPLETED|First Intervention (1 Day)||1
2435723|NCT01145482|5975014|P1|NOT COMPLETED|First Intervention (1 Day)||0
2435724|NCT01145482|5975013|P2|COMPLETED|First Intervention (1 Day)||5
2435725|NCT01145482|5975014|P1|COMPLETED|First Intervention (1 Day)||6
2435726|NCT01145482|5975013|P2|STARTED|First Intervention (1 Day)||6
2435727|NCT01145482|5975014|P1|STARTED|First Intervention (1 Day)||6
2435728|NCT01145417|5975024|P2|NOT COMPLETED|Overall Study||47
2435729|NCT01145417|5975025|P1|NOT COMPLETED|Overall Study||41
2435730|NCT01145417|5975024|P2|COMPLETED|Overall Study||62
2435731|NCT01145417|5975025|P1|COMPLETED|Overall Study||67
2435732|NCT01145417|5975024|P2|STARTED|Overall Study||109
2435733|NCT01145417|5975025|P1|STARTED|Overall Study||108
2435734|NCT01145391|5975049|P2|NOT COMPLETED|Overall Study||0
2435735|NCT01145391|5975050|P1|NOT COMPLETED|Overall Study||0
2435736|NCT01145391|5975049|P2|COMPLETED|Overall Study||298
2435737|NCT01145391|5975050|P1|COMPLETED|Overall Study||293
2435738|NCT01145391|5975049|P2|9 Months Post-randomization|Overall Study||298
2435739|NCT01145391|5975050|P1|9 Months Post-randomization|Overall Study||293
2435740|NCT01145391|5975049|P2|STARTED|Overall Study||298
2435741|NCT01145391|5975050|P1|STARTED|Overall Study||293
2435742|NCT01145352|5975058|P1|NOT COMPLETED|Overall Study||11
2435743|NCT01145352|5975058|P1|COMPLETED|Overall Study||102
2435744|NCT01145352|5975058|P1|STARTED|Overall Study||113
2435745|NCT01145222|5975070|P4|NOT COMPLETED|Overall Study||1
2435746|NCT01145222|5975071|P3|NOT COMPLETED|Overall Study||1
2435747|NCT01145222|5975072|P2|NOT COMPLETED|Overall Study||0
2435748|NCT01145222|5975073|P1|NOT COMPLETED|Overall Study||0
2435749|NCT01145222|5975070|P4|COMPLETED|Overall Study||40
2435750|NCT01145222|5975071|P3|COMPLETED|Overall Study||40
2435751|NCT01145222|5975072|P2|COMPLETED|Overall Study||40
2435752|NCT01145222|5975073|P1|COMPLETED|Overall Study||40
2435753|NCT01145222|5975070|P4|Intention to Treat (ITT) Population|Overall Study||40
2435754|NCT01145222|5975071|P3|Intention to Treat (ITT) Population|Overall Study||40
2435755|NCT01145222|5975072|P2|Intention to Treat (ITT) Population|Overall Study||40
2435756|NCT01145222|5975073|P1|Intention to Treat (ITT) Population|Overall Study||40
2435757|NCT01145222|5975070|P4|Safety Population|Overall Study||41
2435758|NCT01145222|5975071|P3|Safety Population|Overall Study||40
2435759|NCT01145222|5975072|P2|Safety Population|Overall Study||40
2435760|NCT01145222|5975073|P1|Safety Population|Overall Study||40
2435761|NCT01145222|5975070|P4|STARTED|Overall Study||41
2435762|NCT01145222|5975071|P3|STARTED|Overall Study||41
2435763|NCT01145222|5975072|P2|STARTED|Overall Study||40
2435764|NCT01145222|5975073|P1|STARTED|Overall Study||40
2435765|NCT01145209|5975093|P2|NOT COMPLETED|Overall Study||1
2435766|NCT01145209|5975094|P1|NOT COMPLETED|Overall Study||3
2435767|NCT01145209|5975093|P2|COMPLETED|Overall Study||18
2435768|NCT01145209|5975094|P1|COMPLETED|Overall Study||10
2435769|NCT01145209|5975093|P2|STARTED|Overall Study||19
2435770|NCT01145209|5975094|P1|STARTED|Overall Study||13
2435771|NCT01145183|5975104|P4|NOT COMPLETED|Overall Study||0
2435772|NCT01145183|5975105|P3|NOT COMPLETED|Overall Study||0
2435773|NCT01145183|5975106|P2|NOT COMPLETED|Overall Study||0
2435774|NCT01145183|5975107|P1|NOT COMPLETED|Overall Study||0
2435775|NCT01145183|5975104|P4|COMPLETED|Overall Study||10
2435776|NCT01145183|5975105|P3|COMPLETED|Overall Study||19
2435777|NCT01145183|5975106|P2|COMPLETED|Overall Study||26
2435778|NCT01145183|5975107|P1|COMPLETED|Overall Study||21
2435779|NCT01145183|5975104|P4|STARTED|Overall Study||10
2435780|NCT01145183|5975105|P3|STARTED|Overall Study||19
2435781|NCT01145183|5975106|P2|STARTED|Overall Study||26
2435782|NCT01145183|5975107|P1|STARTED|Overall Study||21
2435783|NCT01145066|5975120|P3|NOT COMPLETED|Overall Study||4
2435784|NCT01145066|5975121|P2|NOT COMPLETED|Overall Study||4
2435785|NCT01145066|5975122|P1|NOT COMPLETED|Overall Study||4
2435786|NCT01145066|5975120|P3|COMPLETED|Overall Study||21
2435787|NCT01145066|5975121|P2|COMPLETED|Overall Study||16
2435788|NCT01145066|5975122|P1|COMPLETED|Overall Study||22
2435789|NCT01145066|5975120|P3|STARTED|Overall Study||25
2435790|NCT01145066|5975121|P2|STARTED|Overall Study||20
2435791|NCT01145066|5975122|P1|STARTED|Overall Study||26
2435792|NCT01145053|5975190|P1|NOT COMPLETED|Overall Study||93
2435793|NCT01145053|5975190|P1|COMPLETED|Overall Study||248
2435794|NCT01145053|5975190|P1|STARTED|Overall Study||341
2435795|NCT01145001|5975204|P4|NOT COMPLETED|Overall Study||6
2435796|NCT01145001|5975205|P3|NOT COMPLETED|Overall Study||5
2435797|NCT01145001|5975206|P2|NOT COMPLETED|Overall Study||6
2435798|NCT01145001|5975207|P1|NOT COMPLETED|Overall Study||8
2435799|NCT01145001|5975204|P4|COMPLETED|Overall Study||31
2435800|NCT01145001|5975205|P3|COMPLETED|Overall Study||39
2435801|NCT01145001|5975206|P2|COMPLETED|Overall Study||31
2435802|NCT01145001|5975207|P1|COMPLETED|Overall Study||28
2435803|NCT01145001|5975204|P4|STARTED|Overall Study||37
2435804|NCT01145001|5975205|P3|STARTED|Overall Study||44
2435805|NCT01145001|5975206|P2|STARTED|Overall Study||37
2435806|NCT01145001|5975207|P1|STARTED|Overall Study||36
2435807|NCT01144949|5975223|P2|NOT COMPLETED|Overall Study||14
2435808|NCT01144949|5975224|P1|NOT COMPLETED|Overall Study||11
2435809|NCT01144949|5975223|P2|COMPLETED|Overall Study||106
2435810|NCT01144949|5975224|P1|COMPLETED|Overall Study||108
2435811|NCT01144949|5975223|P2|STARTED|Overall Study||120
2435812|NCT01144949|5975224|P1|STARTED|Overall Study||119
2435813|NCT01144715|5975242|P2|NOT COMPLETED|Overall Study||3
2435814|NCT01144715|5975243|P1|NOT COMPLETED|Overall Study||4
2435815|NCT01144715|5975242|P2|COMPLETED|Overall Study||45
2435816|NCT01144715|5975243|P1|COMPLETED|Overall Study||47
2435817|NCT01144715|5975242|P2|STARTED|Overall Study||48
2435818|NCT01144715|5975243|P1|STARTED|Overall Study||51
2435819|NCT01144663|5975259|P4|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||1
2435820|NCT01144663|5975260|P3|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||7
2435821|NCT01144663|5975261|P2|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||9
2435822|NCT01144663|5975262|P1|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||5
2435823|NCT01144663|5975259|P4|COMPLETED|Extended Safety Follow-Up (ESFU)||505
2435824|NCT01144663|5975260|P3|COMPLETED|Extended Safety Follow-Up (ESFU)||496
2435825|NCT01144663|5975261|P2|COMPLETED|Extended Safety Follow-Up (ESFU)||502
2435826|NCT01144663|5975262|P1|COMPLETED|Extended Safety Follow-Up (ESFU)||492
2435827|NCT01144663|5975259|P4|STARTED|Extended Safety Follow-Up (ESFU)||506
2435828|NCT01144663|5975260|P3|STARTED|Extended Safety Follow-Up (ESFU)||503
2435829|NCT01144663|5975261|P2|STARTED|Extended Safety Follow-Up (ESFU)||511
2435830|NCT01144663|5975262|P1|STARTED|Extended Safety Follow-Up (ESFU)||497
2435831|NCT01144663|5975259|P4|NOT COMPLETED|Booster Vaccination Phase||1
2435832|NCT01144663|5975260|P3|NOT COMPLETED|Booster Vaccination Phase||5
2435833|NCT01144663|5975261|P2|NOT COMPLETED|Booster Vaccination Phase||2
2435834|NCT01144663|5975262|P1|NOT COMPLETED|Booster Vaccination Phase||3
2435835|NCT01144663|5975259|P4|COMPLETED|Booster Vaccination Phase||505
2435836|NCT01144663|5975260|P3|COMPLETED|Booster Vaccination Phase||498
2435837|NCT01144663|5975261|P2|COMPLETED|Booster Vaccination Phase||509
2435838|NCT01144663|5975262|P1|COMPLETED|Booster Vaccination Phase||494
2435839|NCT01144663|5975259|P4|STARTED|Booster Vaccination Phase||506
2435840|NCT01144663|5975260|P3|STARTED|Booster Vaccination Phase||503
2435841|NCT01144663|5975261|P2|STARTED|Booster Vaccination Phase||511
2435842|NCT01144663|5975262|P1|STARTED|Booster Vaccination Phase||497
2435843|NCT01144663|5975259|P4|NOT COMPLETED|Primary Vaccination Phase||18
2435844|NCT01144663|5975260|P3|NOT COMPLETED|Primary Vaccination Phase||8
2435845|NCT01144663|5975261|P2|NOT COMPLETED|Primary Vaccination Phase||7
2435846|NCT01144663|5975262|P1|NOT COMPLETED|Primary Vaccination Phase||20
2435847|NCT01144663|5975259|P4|COMPLETED|Primary Vaccination Phase||509
2435848|NCT01144663|5975260|P3|COMPLETED|Primary Vaccination Phase||508
2435849|NCT01144663|5975261|P2|COMPLETED|Primary Vaccination Phase||517
2435850|NCT01144663|5975262|P1|COMPLETED|Primary Vaccination Phase||508
2435851|NCT01144663|5975259|P4|STARTED|Primary Vaccination Phase||527
2435852|NCT01144663|5975260|P3|STARTED|Primary Vaccination Phase||516
2435853|NCT01144663|5975261|P2|STARTED|Primary Vaccination Phase||524
2435854|NCT01144663|5975262|P1|STARTED|Primary Vaccination Phase||528
2435855|NCT01144637|5975466|P4|NOT COMPLETED|Overall Study||56
2435856|NCT01144637|5975467|P3|NOT COMPLETED|Overall Study||60
2435857|NCT01144637|5975468|P2|NOT COMPLETED|Overall Study||76
2435858|NCT01144637|5975469|P1|NOT COMPLETED|Overall Study||74
2435859|NCT01144637|5975466|P4|COMPLETED|Overall Study||946
2435860|NCT01144637|5975467|P3|COMPLETED|Overall Study||939
2435861|NCT01144637|5975468|P2|COMPLETED|Overall Study||929
2435862|NCT01144637|5975469|P1|COMPLETED|Overall Study||925
2435863|NCT01144637|5975466|P4|STARTED|Overall Study||1002
2435864|NCT01144637|5975467|P3|STARTED|Overall Study||999
2435865|NCT01144637|5975468|P2|STARTED|Overall Study||1005
2435866|NCT01144637|5975469|P1|STARTED|Overall Study||999
2435867|NCT01144624|5975526|P3|NOT COMPLETED|Overall Study||0
2435868|NCT01144624|5975527|P2|NOT COMPLETED|Overall Study||0
2435869|NCT01144624|5975528|P1|NOT COMPLETED|Overall Study||0
2435870|NCT01144624|5975526|P3|COMPLETED|Overall Study|Two patients died during the study. Death was not a reason for treatment or study discontinuation.|6
2435871|NCT01144624|5975527|P2|COMPLETED|Overall Study||7
2435948|NCT01144377|5975633|P1|STARTED|12 Week Safety Follow-up Period||26
2435872|NCT01144624|5975528|P1|COMPLETED|Overall Study|One patient died during the study. Death was not a reason for treatment or study discontinuation.|7
2435873|NCT01144624|5975526|P3|Completed Treatment|Overall Study|Two patients died during the dosing period. Death was not a reason for treatment discontinuation.|6
2435874|NCT01144624|5975527|P2|Completed Treatment|Overall Study||7
2435875|NCT01144624|5975528|P1|Completed Treatment|Overall Study|One patient died after completing the full course of study treatment.|7
2435876|NCT01144624|5975526|P3|Received Treatment|Overall Study||6
2435877|NCT01144624|5975527|P2|Received Treatment|Overall Study||7
2435878|NCT01144624|5975528|P1|Received Treatment|Overall Study||7
2435879|NCT01144624|5975526|P3|STARTED|Overall Study||6
2435880|NCT01144624|5975527|P2|STARTED|Overall Study||7
2435881|NCT01144624|5975528|P1|STARTED|Overall Study||7
2435882|NCT01144598|5975542|P1|NOT COMPLETED|Overall Study||0
2435883|NCT01144598|5975542|P1|COMPLETED|Overall Study||356
2435884|NCT01144598|5975542|P1|Analysis Population|Overall Study||356
2435885|NCT01144598|5975542|P1|STARTED|Overall Study||356
2435886|NCT01144494|5975560|P2|NOT COMPLETED|Overall Study||4
2435887|NCT01144494|5975561|P1|NOT COMPLETED|Overall Study||0
2435888|NCT01144494|5975560|P2|COMPLETED|Overall Study||14
2435889|NCT01144494|5975561|P1|COMPLETED|Overall Study||15
2435890|NCT01144494|5975560|P2|STARTED|Overall Study||18
2435891|NCT01144494|5975561|P1|STARTED|Overall Study||15
2435892|NCT01144455|5975580|P3|NOT COMPLETED|Overall Study||36
2435893|NCT01144455|5975581|P2|NOT COMPLETED|Overall Study||42
2435894|NCT01144455|5975582|P1|NOT COMPLETED|Overall Study||50
2435895|NCT01144455|5975580|P3|COMPLETED|Overall Study||38
2435896|NCT01144455|5975581|P2|COMPLETED|Overall Study||29
2435897|NCT01144455|5975582|P1|COMPLETED|Overall Study||19
2435898|NCT01144455|5975580|P3|STARTED|Overall Study||74
2435899|NCT01144455|5975581|P2|STARTED|Overall Study||71
2435900|NCT01144455|5975582|P1|STARTED|Overall Study||69
2435901|NCT01144442|5975590|P1|NOT COMPLETED|Overall Study||0
2435902|NCT01144442|5975590|P1|COMPLETED|Overall Study||10
2435903|NCT01144442|5975590|P1|STARTED|Overall Study||10
2435904|NCT01144416|5975600|P2|NOT COMPLETED|Pregnancy Follow-up Period||10
2435905|NCT01144416|5975601|P1|NOT COMPLETED|Pregnancy Follow-up Period||8
2435906|NCT01144416|5975600|P2|COMPLETED|Pregnancy Follow-up Period||157
2435907|NCT01144416|5975601|P1|COMPLETED|Pregnancy Follow-up Period||146
2435908|NCT01144416|5975600|P2|STARTED|Pregnancy Follow-up Period|Participants received daily injections of 300 IU recFSH in Intervention Period and became pregnant.|167
2435909|NCT01144416|5975601|P1|STARTED|Pregnancy Follow-up Period|Participants received 150 ug SCH 900962 in Intervention Period and became pregnant.|154
2435910|NCT01144416|5975600|P2|NOT COMPLETED|Intervention Period||49
2435911|NCT01144416|5975601|P1|NOT COMPLETED|Intervention Period||62
2435912|NCT01144416|5975600|P2|COMPLETED|Intervention Period||647
2435913|NCT01144416|5975601|P1|COMPLETED|Intervention Period||632
2435914|NCT01144416|5975600|P2|STARTED|Intervention Period||696
2435915|NCT01144416|5975601|P1|STARTED|Intervention Period||694
2435916|NCT01144403|5975617|P1|NOT COMPLETED|Overall Study||5
2435917|NCT01144403|5975617|P1|COMPLETED|Overall Study||3
2435918|NCT01144403|5975617|P1|STARTED|Overall Study||8
2435919|NCT01144377|5975629|P5|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||2
2435920|NCT01144377|5975630|P4|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0
2435921|NCT01144377|5975631|P3|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0
2435922|NCT01144377|5975632|P2|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1
2435923|NCT01144377|5975633|P1|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1
2435924|NCT01144377|5975629|P5|COMPLETED|Optional 40 Week Safety Follow-up Period||21
2435925|NCT01144377|5975630|P4|COMPLETED|Optional 40 Week Safety Follow-up Period||3
2435926|NCT01144377|5975631|P3|COMPLETED|Optional 40 Week Safety Follow-up Period||23
2435927|NCT01144377|5975632|P2|COMPLETED|Optional 40 Week Safety Follow-up Period||24
2435928|NCT01144377|5975633|P1|COMPLETED|Optional 40 Week Safety Follow-up Period||21
2435929|NCT01144377|5975629|P5|STARTED|Optional 40 Week Safety Follow-up Period||23
2435930|NCT01144377|5975630|P4|STARTED|Optional 40 Week Safety Follow-up Period||3
2435931|NCT01144377|5975631|P3|STARTED|Optional 40 Week Safety Follow-up Period||23
2435932|NCT01144377|5975632|P2|STARTED|Optional 40 Week Safety Follow-up Period||25
2435933|NCT01144377|5975633|P1|STARTED|Optional 40 Week Safety Follow-up Period||22
2435934|NCT01144377|5975629|P5|NOT COMPLETED|12 Week Safety Follow-up Period||0
2435935|NCT01144377|5975630|P4|NOT COMPLETED|12 Week Safety Follow-up Period||0
2435936|NCT01144377|5975631|P3|NOT COMPLETED|12 Week Safety Follow-up Period||0
2435937|NCT01144377|5975632|P2|NOT COMPLETED|12 Week Safety Follow-up Period||0
2435938|NCT01144377|5975633|P1|NOT COMPLETED|12 Week Safety Follow-up Period||0
2435939|NCT01144377|5975629|P5|COMPLETED|12 Week Safety Follow-up Period|Of the 34 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|34
2435940|NCT01144377|5975630|P4|COMPLETED|12 Week Safety Follow-up Period|Of the 22 participants who completed this Period, 3 continued to the Optional 40 Week follow-up.|22
2435941|NCT01144377|5975631|P3|COMPLETED|12 Week Safety Follow-up Period|Of the 25 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|25
2435942|NCT01144377|5975632|P2|COMPLETED|12 Week Safety Follow-up Period|Of the 29 participants who completed this Period, 25 continued to the Optional 40 Week follow-up.|29
2435943|NCT01144377|5975633|P1|COMPLETED|12 Week Safety Follow-up Period|Of the 26 participants who completed this Period, 22 continued to the Optional 40 Week follow-up.|26
2435944|NCT01144377|5975629|P5|STARTED|12 Week Safety Follow-up Period||34
2435945|NCT01144377|5975630|P4|STARTED|12 Week Safety Follow-up Period||22
2435946|NCT01144377|5975631|P3|STARTED|12 Week Safety Follow-up Period||25
2435947|NCT01144377|5975632|P2|STARTED|12 Week Safety Follow-up Period||29
2435949|NCT01144377|5975629|P5|NOT COMPLETED|52 Week Treatment Period||3
2435950|NCT01144377|5975630|P4|NOT COMPLETED|52 Week Treatment Period||4
2435951|NCT01144377|5975631|P3|NOT COMPLETED|52 Week Treatment Period||5
2435952|NCT01144377|5975632|P2|NOT COMPLETED|52 Week Treatment Period||1
2435953|NCT01144377|5975633|P1|NOT COMPLETED|52 Week Treatment Period||5
2435954|NCT01144377|5975629|P5|COMPLETED|52 Week Treatment Period||34
2435955|NCT01144377|5975630|P4|COMPLETED|52 Week Treatment Period||22
2435956|NCT01144377|5975631|P3|COMPLETED|52 Week Treatment Period||25
2435957|NCT01144377|5975632|P2|COMPLETED|52 Week Treatment Period||29
2435958|NCT01144377|5975633|P1|COMPLETED|52 Week Treatment Period||26
2435959|NCT01144377|5975629|P5|Received at Least One Dose of Study Drug|52 Week Treatment Period||37
2435960|NCT01144377|5975630|P4|Received at Least One Dose of Study Drug|52 Week Treatment Period||25
2435961|NCT01144377|5975631|P3|Received at Least One Dose of Study Drug|52 Week Treatment Period||30
2435962|NCT01144377|5975632|P2|Received at Least One Dose of Study Drug|52 Week Treatment Period||30
2435963|NCT01144377|5975633|P1|Received at Least One Dose of Study Drug|52 Week Treatment Period||31
2435964|NCT01144377|5975629|P5|STARTED|52 Week Treatment Period||37
2435965|NCT01144377|5975630|P4|STARTED|52 Week Treatment Period||26
2435966|NCT01144377|5975631|P3|STARTED|52 Week Treatment Period||30
2435967|NCT01144377|5975632|P2|STARTED|52 Week Treatment Period||30
2435968|NCT01144377|5975633|P1|STARTED|52 Week Treatment Period||31
2435969|NCT01144364|5975682|P3|NOT COMPLETED|Follow-Up/Maintenance Phase||41
2435970|NCT01144364|5975683|P2|NOT COMPLETED|Follow-Up/Maintenance Phase||35
2435971|NCT01144364|5975684|P1|NOT COMPLETED|Follow-Up/Maintenance Phase||0
2435972|NCT01144364|5975682|P3|COMPLETED|Follow-Up/Maintenance Phase||60
2435973|NCT01144364|5975683|P2|COMPLETED|Follow-Up/Maintenance Phase||66
2435974|NCT01144364|5975684|P1|COMPLETED|Follow-Up/Maintenance Phase||0
2435975|NCT01144364|5975682|P3|STARTED|Follow-Up/Maintenance Phase||101
2435976|NCT01144364|5975683|P2|STARTED|Follow-Up/Maintenance Phase||101
2435977|NCT01144364|5975684|P1|STARTED|Follow-Up/Maintenance Phase||0
2435978|NCT01144364|5975682|P3|NOT COMPLETED|Induction Phase||0
2435979|NCT01144364|5975683|P2|NOT COMPLETED|Induction Phase||0
2435980|NCT01144364|5975684|P1|NOT COMPLETED|Induction Phase||32
2435981|NCT01144364|5975682|P3|COMPLETED|Induction Phase||0
2435982|NCT01144364|5975683|P2|COMPLETED|Induction Phase||0
2435983|NCT01144364|5975684|P1|COMPLETED|Induction Phase||202
2435984|NCT01144364|5975682|P3|STARTED|Induction Phase||0
2435985|NCT01144364|5975683|P2|STARTED|Induction Phase||0
2435986|NCT01144364|5975684|P1|STARTED|Induction Phase||234
2435987|NCT01144338|5975710|P2|NOT COMPLETED|Overall Study||262
2435988|NCT01144338|5975711|P1|NOT COMPLETED|Overall Study||303
2435989|NCT01144338|5975710|P2|COMPLETED|Overall Study||7094
2435990|NCT01144338|5975711|P1|COMPLETED|Overall Study||7093
2435991|NCT01144338|5975710|P2|STARTED|Overall Study||7356
2435992|NCT01144338|5975711|P1|STARTED|Overall Study||7396
2435993|NCT01144299|5975733|P2|NOT COMPLETED|Overall Study||0
2435994|NCT01144299|5975734|P1|NOT COMPLETED|Overall Study||2
2435995|NCT01144299|5975733|P2|COMPLETED|Overall Study||54
2435996|NCT01144299|5975734|P1|COMPLETED|Overall Study||58
2435997|NCT01144299|5975733|P2|STARTED|Overall Study||54
2435998|NCT01144299|5975734|P1|STARTED|Overall Study||60
2435999|NCT01144286|5975760|P4|NOT COMPLETED|Overall Study||0
2436000|NCT01144286|5975761|P3|NOT COMPLETED|Overall Study||0
2436001|NCT01144286|5975762|P2|NOT COMPLETED|Overall Study||0
2436002|NCT01144286|5975763|P1|NOT COMPLETED|Overall Study||0
2436003|NCT01144286|5975760|P4|COMPLETED|Overall Study||56
2436004|NCT01144286|5975761|P3|COMPLETED|Overall Study||58
2436005|NCT01144286|5975762|P2|COMPLETED|Overall Study||58
2436006|NCT01144286|5975763|P1|COMPLETED|Overall Study||57
2436007|NCT01144286|5975760|P4|STARTED|Overall Study||56
2436008|NCT01144286|5975761|P3|STARTED|Overall Study||58
2436009|NCT01144286|5975762|P2|STARTED|Overall Study||58
2436010|NCT01144286|5975763|P1|STARTED|Overall Study||57
2436011|NCT01144182|5975779|P2|NOT COMPLETED|Overall Study||21
2436012|NCT01144182|5975780|P1|NOT COMPLETED|Overall Study||17
2436013|NCT01144182|5975779|P2|COMPLETED|Overall Study||47
2436014|NCT01144182|5975780|P1|COMPLETED|Overall Study||51
2436015|NCT01144182|5975779|P2|STARTED|Overall Study||68
2436016|NCT01144182|5975780|P1|STARTED|Overall Study||68
2436017|NCT01144143|5975813|P3|NOT COMPLETED|Overall Study||0
2436018|NCT01144143|5975814|P2|NOT COMPLETED|Overall Study||0
2436019|NCT01144143|5975815|P1|NOT COMPLETED|Overall Study||0
2436020|NCT01144143|5975813|P3|COMPLETED|Overall Study||4
2436021|NCT01144143|5975814|P2|COMPLETED|Overall Study||4
2436022|NCT01144143|5975815|P1|COMPLETED|Overall Study||8
2436023|NCT01144143|5975813|P3|STARTED|Overall Study||4
2436024|NCT01144143|5975814|P2|STARTED|Overall Study||4
2436025|NCT01144143|5975815|P1|STARTED|Overall Study||8
2436026|NCT01144052|5975840|P2|NOT COMPLETED|Overall Study||1
2436027|NCT01144052|5975841|P1|NOT COMPLETED|Overall Study||1
2436028|NCT01144052|5975840|P2|COMPLETED|Overall Study||8
2436029|NCT01144052|5975841|P1|COMPLETED|Overall Study||9
2436030|NCT01144052|5975840|P2|STARTED|Overall Study||9
2436031|NCT01144052|5975841|P1|STARTED|Overall Study||10
2436032|NCT01144026|5975863|P2|NOT COMPLETED|Overall Study||0
2436033|NCT01144026|5975864|P1|NOT COMPLETED|Overall Study||0
2436034|NCT01144026|5975863|P2|COMPLETED|Overall Study||5
2436035|NCT01144026|5975864|P1|COMPLETED|Overall Study||10
2436036|NCT01144026|5975863|P2|STARTED|Overall Study||5
2436037|NCT01144026|5975864|P1|STARTED|Overall Study||10
2436038|NCT01143896|5975872|P2|NOT COMPLETED|Overall Study||25
2436039|NCT01143896|5975873|P1|NOT COMPLETED|Overall Study||42
2436040|NCT01143896|5975872|P2|COMPLETED|Overall Study||128
2436041|NCT01143896|5975873|P1|COMPLETED|Overall Study||114
2436042|NCT01143896|5975872|P2|STARTED|Overall Study||153
2436043|NCT01143896|5975873|P1|STARTED|Overall Study||156
2436044|NCT01143883|5975891|P2|NOT COMPLETED|Overall Study||0
2436045|NCT01143883|5975892|P1|NOT COMPLETED|Overall Study||0
2436046|NCT01143883|5975891|P2|COMPLETED|Overall Study||55
2436047|NCT01143883|5975892|P1|COMPLETED|Overall Study||55
2436048|NCT01143883|5975891|P2|STARTED|Overall Study||55
2436049|NCT01143883|5975892|P1|STARTED|Overall Study||55
2436050|NCT01143870|5975901|P3|NOT COMPLETED|Overall Study||0
2436051|NCT01143870|5975902|P2|NOT COMPLETED|Overall Study||0
2436052|NCT01143870|5975903|P1|NOT COMPLETED|Overall Study||0
2436053|NCT01143870|5975901|P3|COMPLETED|Overall Study||61
2436054|NCT01143870|5975902|P2|COMPLETED|Overall Study||58
2436055|NCT01143870|5975903|P1|COMPLETED|Overall Study||58
2436056|NCT01143870|5975901|P3|A1C Imputed|Overall Study||30
2436057|NCT01143870|5975902|P2|A1C Imputed|Overall Study||29
2436058|NCT01143870|5975903|P1|A1C Imputed|Overall Study||31
2436059|NCT01143870|5975901|P3|Had Available 6-month A1C|Overall Study||31
2436060|NCT01143870|5975902|P2|Had Available 6-month A1C|Overall Study||29
2436061|NCT01143870|5975903|P1|Had Available 6-month A1C|Overall Study||27
2436062|NCT01143870|5975901|P3|Post-intervention Survey|Overall Study||61
2436063|NCT01143870|5975902|P2|Post-intervention Survey|Overall Study||50
2436064|NCT01143870|5975903|P1|Post-intervention Survey|Overall Study||53
2436065|NCT01143870|5975901|P3|STARTED|Overall Study||61
2436066|NCT01143870|5975902|P2|STARTED|Overall Study||58
2436067|NCT01143870|5975903|P1|STARTED|Overall Study||58
2436068|NCT01143818|5975911|P1|NOT COMPLETED|Overall Study||250
2436069|NCT01143818|5975911|P1|COMPLETED|Overall Study||799
2436070|NCT01143818|5975911|P1|STARTED|Overall Study|A total of 1053 participants were enrolled but only 1049 received study drug.|1049
2436071|NCT01143792|5975921|P3|NOT COMPLETED|Overall Study||0
2436072|NCT01143792|5975922|P2|NOT COMPLETED|Overall Study||0
2436073|NCT01143792|5975923|P1|NOT COMPLETED|Overall Study||0
2436074|NCT01143792|5975921|P3|COMPLETED|Overall Study||91
2436075|NCT01143792|5975922|P2|COMPLETED|Overall Study||86
2436076|NCT01143792|5975923|P1|COMPLETED|Overall Study||93
2436077|NCT01143792|5975921|P3|STARTED|Overall Study||91
2436078|NCT01143792|5975922|P2|STARTED|Overall Study||86
2436079|NCT01143792|5975923|P1|STARTED|Overall Study||93
2436080|NCT01143766|5975957|P2|NOT COMPLETED|Overall Study||0
2436081|NCT01143766|5975958|P1|NOT COMPLETED|Overall Study||0
2436082|NCT01143766|5975957|P2|COMPLETED|Overall Study||31
2436083|NCT01143766|5975958|P1|COMPLETED|Overall Study||25
2436084|NCT01143766|5975957|P2|STARTED|Overall Study||31
2436085|NCT01143766|5975958|P1|STARTED|Overall Study||25
2436086|NCT01143727|5975974|P2|NOT COMPLETED|Overall Study||0
2436087|NCT01143727|5975975|P1|NOT COMPLETED|Overall Study||0
2436088|NCT01143727|5975974|P2|COMPLETED|Overall Study||8
2436089|NCT01143727|5975975|P1|COMPLETED|Overall Study||9
2436090|NCT01143727|5975974|P2|STARTED|Overall Study||8
2436091|NCT01143727|5975975|P1|STARTED|Overall Study||9
2436092|NCT01143714|5975985|P2|NOT COMPLETED|Overall Study||3
2436093|NCT01143714|5975986|P1|NOT COMPLETED|Overall Study||7
2436094|NCT01143714|5975985|P2|COMPLETED|Overall Study||25
2436095|NCT01143714|5975986|P1|COMPLETED|Overall Study||22
2436096|NCT01143714|5975985|P2|STARTED|Overall Study||28
2436097|NCT01143714|5975986|P1|STARTED|Overall Study||29
2436098|NCT01143701|5975996|P2|NOT COMPLETED|Overall Study||32
2436099|NCT01143701|5975997|P1|NOT COMPLETED|Overall Study||23
2436100|NCT01143701|5975996|P2|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|287
2436101|NCT01143701|5975997|P1|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|235
2436102|NCT01143701|5975996|P2|STARTED|Overall Study||319
2436103|NCT01143701|5975997|P1|STARTED|Overall Study||258
2436104|NCT01143688|5976005|P1|NOT COMPLETED|Overall Study||0
2436105|NCT01143688|5976005|P1|COMPLETED|Overall Study||39
2436106|NCT01143688|5976005|P1|STARTED|Overall Study||39
2436107|NCT01143649|5976024|P6|NOT COMPLETED|Overall Study||2
2436108|NCT01143649|5976025|P5|NOT COMPLETED|Overall Study||1
2436109|NCT01143649|5976026|P4|NOT COMPLETED|Overall Study||0
2436110|NCT01143649|5976027|P3|NOT COMPLETED|Overall Study||0
2436111|NCT01143649|5976028|P2|NOT COMPLETED|Overall Study||0
2436112|NCT01143649|5976029|P1|NOT COMPLETED|Overall Study||0
2436113|NCT01143649|5976024|P6|COMPLETED|Overall Study||3
2436114|NCT01143649|5976025|P5|COMPLETED|Overall Study||4
2436115|NCT01143649|5976026|P4|COMPLETED|Overall Study||10
2436116|NCT01143649|5976027|P3|COMPLETED|Overall Study||10
2436117|NCT01143649|5976028|P2|COMPLETED|Overall Study||7
2436118|NCT01143649|5976029|P1|COMPLETED|Overall Study||7
2436119|NCT01143649|5976024|P6|STARTED|Overall Study||5
2436120|NCT01143649|5976025|P5|STARTED|Overall Study||5
2436121|NCT01143649|5976026|P4|STARTED|Overall Study||10
2436122|NCT01143649|5976027|P3|STARTED|Overall Study||10
2436123|NCT01143649|5976028|P2|STARTED|Overall Study||7
2436124|NCT01143649|5976029|P1|STARTED|Overall Study||7
2436125|NCT01143636|5976046|P4|NOT COMPLETED|Overall Study||0
2436126|NCT01143636|5976047|P3|NOT COMPLETED|Overall Study||0
2436127|NCT01143636|5976048|P2|NOT COMPLETED|Overall Study||1
2436128|NCT01143636|5976049|P1|NOT COMPLETED|Overall Study||1
2436129|NCT01143636|5976046|P4|COMPLETED|Overall Study||7
2436130|NCT01143636|5976047|P3|COMPLETED|Overall Study||8
2436131|NCT01143636|5976048|P2|COMPLETED|Overall Study||4
2436132|NCT01143636|5976049|P1|COMPLETED|Overall Study||5
2436133|NCT01143636|5976046|P4|STARTED|Overall Study||7
2436134|NCT01143636|5976047|P3|STARTED|Overall Study||8
2436135|NCT01143636|5976048|P2|STARTED|Overall Study||5
2436136|NCT01143636|5976049|P1|STARTED|Overall Study||6
2436137|NCT01143610|5976079|P2|NOT COMPLETED|Overall Study||0
2436138|NCT01143610|5976080|P1|NOT COMPLETED|Overall Study||0
2436139|NCT01143610|5976079|P2|COMPLETED|Overall Study||8
2436140|NCT01143610|5976080|P1|COMPLETED|Overall Study||7
2436141|NCT01143610|5976079|P2|STARTED|Overall Study||8
2436142|NCT01143610|5976080|P1|STARTED|Overall Study||7
2436143|NCT01143402|5976091|P3|NOT COMPLETED|Overall Study||1
2436144|NCT01143402|5976092|P2|NOT COMPLETED|Overall Study||1
2436145|NCT01143402|5976093|P1|NOT COMPLETED|Overall Study||1
2436146|NCT01143402|5976091|P3|COMPLETED|Overall Study||18
2436147|NCT01143402|5976092|P2|COMPLETED|Overall Study||49
2436148|NCT01143402|5976093|P1|COMPLETED|Overall Study||50
2436149|NCT01143402|5976091|P3|STARTED|Overall Study||19
2436150|NCT01143402|5976092|P2|STARTED|Overall Study||50
2436151|NCT01143402|5976093|P1|STARTED|Overall Study||51
2436152|NCT01143389|5976104|P2|NOT COMPLETED|Overall Study||25
2436153|NCT01143389|5976105|P1|NOT COMPLETED|Overall Study||26
2436154|NCT01143389|5976104|P2|COMPLETED|Overall Study||232
2436155|NCT01143389|5976105|P1|COMPLETED|Overall Study||227
2436156|NCT01143389|5976104|P2|STARTED|Overall Study||257
2436157|NCT01143389|5976105|P1|STARTED|Overall Study||253
2436158|NCT01143337|5976119|P3|NOT COMPLETED|Overall Study||12
2436159|NCT01143337|5976120|P2|NOT COMPLETED|Overall Study||11
2436160|NCT01143337|5976121|P1|NOT COMPLETED|Overall Study||10
2436161|NCT01143337|5976119|P3|COMPLETED|Overall Study|Frequency of this arm AE was higher than assumption before study initiation.|1
2436162|NCT01143337|5976120|P2|COMPLETED|Overall Study||39
2436163|NCT01143337|5976121|P1|COMPLETED|Overall Study||39
2436164|NCT01143337|5976119|P3|STARTED|Overall Study||13
2436165|NCT01143337|5976120|P2|STARTED|Overall Study||50
2436166|NCT01143337|5976121|P1|STARTED|Overall Study||49
2436167|NCT01143324|5976135|P1|NOT COMPLETED|Overall Study||19
2436168|NCT01143324|5976135|P1|COMPLETED|Overall Study||233
2436169|NCT01143324|5976135|P1|STARTED|Overall Study||252
2436170|NCT01143272|5976153|P2|NOT COMPLETED|Overall Study||0
2436171|NCT01143272|5976154|P1|NOT COMPLETED|Overall Study||0
2436172|NCT01143272|5976153|P2|COMPLETED|Overall Study||231
2436173|NCT01143272|5976154|P1|COMPLETED|Overall Study||246
2436174|NCT01143272|5976153|P2|STARTED|Overall Study||231
2436175|NCT01143272|5976154|P1|STARTED|Overall Study||246
2436176|NCT01143259|5976174|P2|NOT COMPLETED|Overall Study||20
2436177|NCT01143259|5976175|P1|NOT COMPLETED|Overall Study||23
2436178|NCT01143259|5976174|P2|COMPLETED|Overall Study||118
2436179|NCT01143259|5976175|P1|COMPLETED|Overall Study||113
2436180|NCT01143259|5976174|P2|STARTED|Overall Study||138
2436181|NCT01143259|5976175|P1|STARTED|Overall Study||136
2436182|NCT01143207|5976183|P1|NOT COMPLETED|Overall Study||2
2436183|NCT01143207|5976183|P1|COMPLETED|Overall Study||24
2436184|NCT01143207|5976183|P1|STARTED|Overall Study||26
2436185|NCT01143142|5976194|P2|NOT COMPLETED|Overall Study||0
2436186|NCT01143142|5976195|P1|NOT COMPLETED|Overall Study||0
2436187|NCT01143142|5976194|P2|COMPLETED|Overall Study||34
2436188|NCT01143142|5976195|P1|COMPLETED|Overall Study||36
2436189|NCT01143142|5976194|P2|STARTED|Overall Study||34
2436190|NCT01143142|5976195|P1|STARTED|Overall Study||36
2436191|NCT01143090|5976203|P1|NOT COMPLETED|Overall Study||51
2436192|NCT01143090|5976203|P1|COMPLETED|Overall Study||98
2436193|NCT01143090|5976203|P1|STARTED|Overall Study||149
2436194|NCT01143077|5976210|P3|NOT COMPLETED|Overall Study||15
2436195|NCT01143077|5976211|P2|NOT COMPLETED|Overall Study||15
2436196|NCT01143077|5976212|P1|NOT COMPLETED|Overall Study||16
2436197|NCT01143077|5976210|P3|COMPLETED|Overall Study||67
2436198|NCT01143077|5976211|P2|COMPLETED|Overall Study||73
2436199|NCT01143077|5976212|P1|COMPLETED|Overall Study||58
2436200|NCT01143077|5976210|P3|STARTED|Overall Study||82
2436201|NCT01143077|5976211|P2|STARTED|Overall Study||88
2436202|NCT01143077|5976212|P1|STARTED|Overall Study||74
2436203|NCT01143051|5976229|P6|NOT COMPLETED|Visit 3||0
2436204|NCT01143051|5976230|P5|NOT COMPLETED|Visit 3||0
2436205|NCT01143051|5976231|P4|NOT COMPLETED|Visit 3||0
2436206|NCT01143051|5976232|P3|NOT COMPLETED|Visit 3||0
2436207|NCT01143051|5976233|P2|NOT COMPLETED|Visit 3||0
2436208|NCT01143051|5976234|P1|NOT COMPLETED|Visit 3||0
2436209|NCT01143051|5976229|P6|COMPLETED|Visit 3||3
2436210|NCT01143051|5976230|P5|COMPLETED|Visit 3||4
2436211|NCT01143051|5976231|P4|COMPLETED|Visit 3||4
2436212|NCT01143051|5976232|P3|COMPLETED|Visit 3||3
2436213|NCT01143051|5976233|P2|COMPLETED|Visit 3||4
2436214|NCT01143051|5976234|P1|COMPLETED|Visit 3||4
2436215|NCT01143051|5976229|P6|STARTED|Visit 3||3
2436216|NCT01143051|5976230|P5|STARTED|Visit 3||4
2436217|NCT01143051|5976231|P4|STARTED|Visit 3||4
2436218|NCT01143051|5976232|P3|STARTED|Visit 3||3
2436219|NCT01143051|5976233|P2|STARTED|Visit 3||4
2436220|NCT01143051|5976234|P1|STARTED|Visit 3||4
2436221|NCT01143051|5976229|P6|NOT COMPLETED|3-14 Day Washout||1
2436222|NCT01143051|5976230|P5|NOT COMPLETED|3-14 Day Washout||0
2436223|NCT01143051|5976231|P4|NOT COMPLETED|3-14 Day Washout||0
2436224|NCT01143051|5976232|P3|NOT COMPLETED|3-14 Day Washout||0
2436225|NCT01143051|5976233|P2|NOT COMPLETED|3-14 Day Washout||0
2436226|NCT01143051|5976234|P1|NOT COMPLETED|3-14 Day Washout||0
2436227|NCT01143051|5976229|P6|COMPLETED|3-14 Day Washout||3
2436228|NCT01143051|5976230|P5|COMPLETED|3-14 Day Washout||4
2436229|NCT01143051|5976231|P4|COMPLETED|3-14 Day Washout||4
2436230|NCT01143051|5976232|P3|COMPLETED|3-14 Day Washout||3
2436231|NCT01143051|5976233|P2|COMPLETED|3-14 Day Washout||4
2436232|NCT01143051|5976234|P1|COMPLETED|3-14 Day Washout||4
2436233|NCT01143051|5976229|P6|STARTED|3-14 Day Washout||4
2436234|NCT01143051|5976230|P5|STARTED|3-14 Day Washout||4
2436235|NCT01143051|5976231|P4|STARTED|3-14 Day Washout||4
2436236|NCT01143051|5976232|P3|STARTED|3-14 Day Washout||3
2436237|NCT01143051|5976233|P2|STARTED|3-14 Day Washout||4
2436238|NCT01143051|5976234|P1|STARTED|3-14 Day Washout||4
2436239|NCT01143051|5976229|P6|NOT COMPLETED|Visit 2||0
2436240|NCT01143051|5976230|P5|NOT COMPLETED|Visit 2||0
2436241|NCT01143051|5976231|P4|NOT COMPLETED|Visit 2||0
2436242|NCT01143051|5976232|P3|NOT COMPLETED|Visit 2||0
2436243|NCT01143051|5976233|P2|NOT COMPLETED|Visit 2||0
2436244|NCT01143051|5976234|P1|NOT COMPLETED|Visit 2||0
2436245|NCT01143051|5976229|P6|COMPLETED|Visit 2||4
2436246|NCT01143051|5976230|P5|COMPLETED|Visit 2||4
2436247|NCT01143051|5976231|P4|COMPLETED|Visit 2||4
2436248|NCT01143051|5976232|P3|COMPLETED|Visit 2||3
2436249|NCT01143051|5976233|P2|COMPLETED|Visit 2||4
2436250|NCT01143051|5976234|P1|COMPLETED|Visit 2||4
2436251|NCT01143051|5976229|P6|STARTED|Visit 2||4
2436252|NCT01143051|5976230|P5|STARTED|Visit 2||4
2436253|NCT01143051|5976231|P4|STARTED|Visit 2||4
2436254|NCT01143051|5976232|P3|STARTED|Visit 2||3
2436255|NCT01143051|5976233|P2|STARTED|Visit 2||4
2436256|NCT01143051|5976234|P1|STARTED|Visit 2||4
2436257|NCT01143051|5976229|P6|NOT COMPLETED|3-14 Day Washout||0
2436258|NCT01143051|5976230|P5|NOT COMPLETED|3-14 Day Washout||0
2436259|NCT01143051|5976231|P4|NOT COMPLETED|3-14 Day Washout||0
2436260|NCT01143051|5976232|P3|NOT COMPLETED|3-14 Day Washout||1
2436261|NCT01143051|5976233|P2|NOT COMPLETED|3-14 Day Washout||0
2436262|NCT01143051|5976234|P1|NOT COMPLETED|3-14 Day Washout||0
2436263|NCT01143051|5976229|P6|COMPLETED|3-14 Day Washout||4
2436264|NCT01143051|5976230|P5|COMPLETED|3-14 Day Washout||4
2436265|NCT01143051|5976231|P4|COMPLETED|3-14 Day Washout||4
2436266|NCT01143051|5976232|P3|COMPLETED|3-14 Day Washout||3
2436267|NCT01143051|5976233|P2|COMPLETED|3-14 Day Washout||4
2436268|NCT01143051|5976234|P1|COMPLETED|3-14 Day Washout||4
2436269|NCT01143051|5976229|P6|STARTED|3-14 Day Washout||4
2436270|NCT01143051|5976230|P5|STARTED|3-14 Day Washout||4
2436271|NCT01143051|5976231|P4|STARTED|3-14 Day Washout||4
2436272|NCT01143051|5976232|P3|STARTED|3-14 Day Washout||4
2436273|NCT01143051|5976233|P2|STARTED|3-14 Day Washout||4
2436274|NCT01143051|5976234|P1|STARTED|3-14 Day Washout||4
2436275|NCT01143051|5976229|P6|NOT COMPLETED|Visit 1||0
2436276|NCT01143051|5976230|P5|NOT COMPLETED|Visit 1||0
2436277|NCT01143051|5976231|P4|NOT COMPLETED|Visit 1||0
2436278|NCT01143051|5976232|P3|NOT COMPLETED|Visit 1||0
2436279|NCT01143051|5976233|P2|NOT COMPLETED|Visit 1||0
2436280|NCT01143051|5976234|P1|NOT COMPLETED|Visit 1||0
2436281|NCT01143051|5976229|P6|COMPLETED|Visit 1||4
2436282|NCT01143051|5976230|P5|COMPLETED|Visit 1||4
2436283|NCT01143051|5976231|P4|COMPLETED|Visit 1||4
2436284|NCT01143051|5976232|P3|COMPLETED|Visit 1||4
2436285|NCT01143051|5976233|P2|COMPLETED|Visit 1||4
2436286|NCT01143051|5976234|P1|COMPLETED|Visit 1||4
2436287|NCT01143051|5976229|P6|STARTED|Visit 1||4
2436288|NCT01143051|5976230|P5|STARTED|Visit 1||4
2436289|NCT01143051|5976231|P4|STARTED|Visit 1||4
2436290|NCT01143051|5976232|P3|STARTED|Visit 1||4
2436291|NCT01143051|5976233|P2|STARTED|Visit 1||4
2436292|NCT01143051|5976234|P1|STARTED|Visit 1||4
2436293|NCT01143038|5976283|P1|NOT COMPLETED|Overall Study||16
2436294|NCT01143038|5976283|P1|COMPLETED|Overall Study|Defined as completion of romiplostim treatment|59
2436295|NCT01143038|5976283|P1|STARTED|Overall Study||75
2436296|NCT01142947|5976291|P1|NOT COMPLETED|Overall Study||118
2436297|NCT01142947|5976291|P1|COMPLETED|Overall Study||244
2436298|NCT01142947|5976291|P1|STARTED|Overall Study||362
2436299|NCT01142908|5976297|P2|NOT COMPLETED|Overall Study||22
2436300|NCT01142908|5976298|P1|NOT COMPLETED|Overall Study||32
2436301|NCT01142908|5976297|P2|COMPLETED|Overall Study||191
2436302|NCT01142908|5976298|P1|COMPLETED|Overall Study||183
2436303|NCT01142908|5976297|P2|6 Month f/u|Overall Study||196
2436304|NCT01142908|5976298|P1|6 Month f/u|Overall Study||188
2436305|NCT01142908|5976297|P2|STARTED|Overall Study||213
2436306|NCT01142908|5976298|P1|STARTED|Overall Study||215
2436307|NCT01142791|5976344|P2|NOT COMPLETED|Overall Study||6
2436308|NCT01142791|5976345|P1|NOT COMPLETED|Overall Study||7
2436309|NCT01142791|5976344|P2|COMPLETED|Overall Study||0
2436310|NCT01142791|5976345|P1|COMPLETED|Overall Study||108
2436311|NCT01142791|5976344|P2|Safety|Overall Study|Safety data only was reported for 6 participants receiving only 1 sonication.|6
2436312|NCT01142791|5976345|P1|Safety|Overall Study||115
2436313|NCT01142791|5976344|P2|STARTED|Overall Study|6 participants receiving only 1 sonication were included only in adverse events reporting.|6
2436314|NCT01142791|5976345|P1|STARTED|Overall Study||115
2436315|NCT01142726|5976352|P3|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||3
2436316|NCT01142726|5976353|P2|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||2
2436317|NCT01142726|5976354|P1|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||1
2436318|NCT01142726|5976352|P3|COMPLETED|Re-Exposure Phase: Months 24 up to 30||40
2436319|NCT01142726|5976353|P2|COMPLETED|Re-Exposure Phase: Months 24 up to 30||46
2436320|NCT01142726|5976354|P1|COMPLETED|Re-Exposure Phase: Months 24 up to 30||54
2436321|NCT01142726|5976352|P3|STARTED|Re-Exposure Phase: Months 24 up to 30||43
2436322|NCT01142726|5976353|P2|STARTED|Re-Exposure Phase: Months 24 up to 30||48
2436323|NCT01142726|5976354|P1|STARTED|Re-Exposure Phase: Months 24 up to 30||55
2436324|NCT01142726|5976352|P3|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||58
2436325|NCT01142726|5976353|P2|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||56
2436326|NCT01142726|5976354|P1|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||70
2436327|NCT01142726|5976352|P3|COMPLETED|Withdrawal Phase: Months 12 up to 24||17
2436328|NCT01142726|5976353|P2|COMPLETED|Withdrawal Phase: Months 12 up to 24||10
2436329|NCT01142726|5976354|P1|COMPLETED|Withdrawal Phase: Months 12 up to 24||14
2436330|NCT01142726|5976352|P3|STARTED|Withdrawal Phase: Months 12 up to 24||75
2436331|NCT01142726|5976353|P2|STARTED|Withdrawal Phase: Months 12 up to 24||66
2436332|NCT01142726|5976354|P1|STARTED|Withdrawal Phase: Months 12 up to 24||84
2436333|NCT01142726|5976352|P3|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||20
2436334|NCT01142726|5976353|P2|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||25
2436335|NCT01142726|5976354|P1|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||16
2436336|NCT01142726|5976352|P3|COMPLETED|Treatment Phase: Day 1 Through Month 12||96
2436337|NCT01142726|5976353|P2|COMPLETED|Treatment Phase: Day 1 Through Month 12||91
2436338|NCT01142726|5976354|P1|COMPLETED|Treatment Phase: Day 1 Through Month 12||103
2436339|NCT01142726|5976352|P3|STARTED|Treatment Phase: Day 1 Through Month 12||116
2436340|NCT01142726|5976353|P2|STARTED|Treatment Phase: Day 1 Through Month 12||116
2436341|NCT01142726|5976354|P1|STARTED|Treatment Phase: Day 1 Through Month 12||119
2436342|NCT01142661|5976417|P1|NOT COMPLETED|Overall Study||4
2436343|NCT01142661|5976417|P1|COMPLETED|Overall Study||5
2436344|NCT01142661|5976417|P1|STARTED|Overall Study||9
2436345|NCT01142596|5976424|P2|NOT COMPLETED|Overall Study||86
2436346|NCT01142596|5976425|P1|NOT COMPLETED|Overall Study||29
2436347|NCT01142596|5976424|P2|COMPLETED|Overall Study||71
2436348|NCT01142596|5976425|P1|COMPLETED|Overall Study||15
2436349|NCT01142596|5976424|P2|STARTED|Overall Study||157
2436350|NCT01142596|5976425|P1|STARTED|Overall Study||44
2436351|NCT01142466|5976477|P2|NOT COMPLETED|Overall Study||2
2436352|NCT01142466|5976478|P1|NOT COMPLETED|Overall Study||3
2436353|NCT01142466|5976477|P2|COMPLETED|Overall Study||13
2436354|NCT01142466|5976478|P1|COMPLETED|Overall Study||12
2436355|NCT01142466|5976477|P2|STARTED|Overall Study||15
2436356|NCT01142466|5976478|P1|STARTED|Overall Study||15
2436357|NCT01142388|5976498|P2|NOT COMPLETED|Overall Study||47
2436358|NCT01142388|5976499|P1|NOT COMPLETED|Overall Study||47
2436359|NCT01142388|5976498|P2|COMPLETED|Overall Study||0
2436360|NCT01142388|5976499|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|0
2436361|NCT01142388|5976498|P2|Treated|Overall Study||44
2436362|NCT01142388|5976499|P1|Treated|Overall Study||40
2436363|NCT01142388|5976498|P2|Eligible|Overall Study||44
2436364|NCT01142388|5976499|P1|Eligible|Overall Study||43
2436365|NCT01142388|5976498|P2|STARTED|Overall Study||47
2436366|NCT01142388|5976499|P1|STARTED|Overall Study||47
2436367|NCT01142336|5976511|P2|NOT COMPLETED|Overall Study||2
2436368|NCT01142336|5976512|P1|NOT COMPLETED|Overall Study||1
2436369|NCT01142336|5976511|P2|COMPLETED|Overall Study||21
2436370|NCT01142336|5976512|P1|COMPLETED|Overall Study||25
2436371|NCT01142336|5976511|P2|STARTED|Overall Study||23
2436372|NCT01142336|5976512|P1|STARTED|Overall Study||26
2436373|NCT01142323|5976522|P1|NOT COMPLETED|Overall Study||0
2436374|NCT01142323|5976522|P1|COMPLETED|Overall Study||8
2436375|NCT01142323|5976522|P1|STARTED|Overall Study||8
2436376|NCT01142310|5976530|P2|NOT COMPLETED|Overall Study||12
2436377|NCT01142310|5976531|P1|NOT COMPLETED|Overall Study||9
2436378|NCT01142310|5976530|P2|COMPLETED|Overall Study||16
2436379|NCT01142310|5976531|P1|COMPLETED|Overall Study||17
2436380|NCT01142310|5976530|P2|STARTED|Overall Study||28
2436381|NCT01142310|5976531|P1|STARTED|Overall Study||26
2436382|NCT01142297|5976537|P1|NOT COMPLETED|Overall Study||6
2436383|NCT01142297|5976537|P1|COMPLETED|Overall Study||18
2436384|NCT01142297|5976537|P1|STARTED|Overall Study||24
2436385|NCT01142232|5976549|P5|NOT COMPLETED|Overall Study||34
2436386|NCT01142232|5976550|P4|NOT COMPLETED|Overall Study||5
2436387|NCT01142232|5976551|P3|NOT COMPLETED|Overall Study||3
2436388|NCT01142232|5976552|P2|NOT COMPLETED|Overall Study||4
2436389|NCT01142232|5976553|P1|NOT COMPLETED|Overall Study||3
2436390|NCT01142232|5976549|P5|COMPLETED|Overall Study||10
2436391|NCT01142232|5976550|P4|COMPLETED|Overall Study||1
2436392|NCT01142232|5976551|P3|COMPLETED|Overall Study||0
2436393|NCT01142232|5976552|P2|COMPLETED|Overall Study||0
2436394|NCT01142232|5976553|P1|COMPLETED|Overall Study||0
2436395|NCT01142232|5976549|P5|STARTED|Overall Study||44
2436396|NCT01142232|5976550|P4|STARTED|Overall Study||6
2436397|NCT01142232|5976551|P3|STARTED|Overall Study||3
2436398|NCT01142232|5976552|P2|STARTED|Overall Study||4
2436399|NCT01142232|5976553|P1|STARTED|Overall Study||3
2436400|NCT01142193|5976568|P2|NOT COMPLETED|Overall Study||11
2436401|NCT01142193|5976569|P1|NOT COMPLETED|Overall Study||21
2436402|NCT01142193|5976568|P2|COMPLETED|Overall Study||114
2436403|NCT01142193|5976569|P1|COMPLETED|Overall Study||103
2436404|NCT01142193|5976568|P2|STARTED|Overall Study||125
2436405|NCT01142193|5976569|P1|STARTED|Overall Study||124
2436406|NCT01142128|5976597|P1|NOT COMPLETED|Overall Study||4
2436407|NCT01142128|5976597|P1|COMPLETED|Overall Study||4
2436408|NCT01142128|5976597|P1|Viokase 16 Plus Placebo to Nexium|Overall Study||0
2436409|NCT01142128|5976597|P1|Viokase 16 Plus Nexium|Overall Study||2
2436410|NCT01142128|5976597|P1|Placebo to Nexium, Alone|Overall Study||3
2436411|NCT01142128|5976597|P1|Nexium Alone|Overall Study||3
2436412|NCT01142128|5976597|P1|STARTED|Overall Study||8
2436413|NCT01142115|5976607|P2|NOT COMPLETED|Second Intervention||0
2436414|NCT01142115|5976608|P1|NOT COMPLETED|Second Intervention||0
2436415|NCT01142115|5976607|P2|COMPLETED|Second Intervention||19
2436416|NCT01142115|5976608|P1|COMPLETED|Second Intervention||19
2436417|NCT01142115|5976607|P2|STARTED|Second Intervention||19
2436418|NCT01142115|5976608|P1|STARTED|Second Intervention||19
2436419|NCT01142115|5976607|P2|NOT COMPLETED|First Intervention||1
2436420|NCT01142115|5976608|P1|NOT COMPLETED|First Intervention||2
2436421|NCT01142115|5976607|P2|COMPLETED|First Intervention||19
2436422|NCT01142115|5976608|P1|COMPLETED|First Intervention||19
2436423|NCT01142115|5976607|P2|STARTED|First Intervention||20
2436424|NCT01142115|5976608|P1|STARTED|First Intervention||21
2436425|NCT01142089|5976625|P2|NOT COMPLETED|Overall Study||21
2436426|NCT01142089|5976626|P1|NOT COMPLETED|Overall Study||12
2436427|NCT01142089|5976625|P2|COMPLETED|Overall Study||178
2436428|NCT01142089|5976626|P1|COMPLETED|Overall Study||53
2436429|NCT01142089|5976625|P2|STARTED|Overall Study||199
2436430|NCT01142089|5976626|P1|STARTED|Overall Study||65
2436431|NCT01141907|5976636|P2|NOT COMPLETED|Overall Study||0
2436432|NCT01141907|5976637|P1|NOT COMPLETED|Overall Study||0
2436433|NCT01141907|5976636|P2|COMPLETED|Overall Study||5
2436434|NCT01141907|5976637|P1|COMPLETED|Overall Study||6
2436435|NCT01141907|5976636|P2|STARTED|Overall Study||5
2436436|NCT01141907|5976637|P1|STARTED|Overall Study||6
2436437|NCT01141725|5976643|P3|NOT COMPLETED|Overall Study||0
2436438|NCT01141725|5976644|P2|NOT COMPLETED|Overall Study||0
2436439|NCT01141725|5976645|P1|NOT COMPLETED|Overall Study||0
2436440|NCT01141725|5976643|P3|COMPLETED|Overall Study||3
2436441|NCT01141725|5976644|P2|COMPLETED|Overall Study||33
2436442|NCT01141725|5976645|P1|COMPLETED|Overall Study||3
2436443|NCT01141725|5976643|P3|STARTED|Overall Study||3
2436444|NCT01141725|5976644|P2|STARTED|Overall Study||33
2436445|NCT01141725|5976645|P1|STARTED|Overall Study||3
2436446|NCT01141712|5976657|P1|NOT COMPLETED|Overall Study||3
2436447|NCT01141712|5976657|P1|COMPLETED|Overall Study||40
2436448|NCT01141712|5976657|P1|STARTED|Overall Study||43
2436449|NCT01141660|5976678|P2|NOT COMPLETED|Overall Study||12
2436450|NCT01141660|5976679|P1|NOT COMPLETED|Overall Study||0
2436451|NCT01141660|5976678|P2|COMPLETED|Overall Study||48
2436452|NCT01141660|5976679|P1|COMPLETED|Overall Study||71
2436453|NCT01141660|5976678|P2|STARTED|Overall Study||60
2436454|NCT01141660|5976679|P1|STARTED|Overall Study||71
2436455|NCT01141647|5976687|P1|NOT COMPLETED|Overall Study||46
2436456|NCT01141647|5976687|P1|COMPLETED|Overall Study||167
2436457|NCT01141647|5976687|P1|STARTED|Overall Study||213
2436458|NCT01141608|5976702|P2|NOT COMPLETED|Overall Study||0
2436459|NCT01141608|5976703|P1|NOT COMPLETED|Overall Study||0
2436460|NCT01141608|5976702|P2|COMPLETED|Overall Study||150
2436461|NCT01141608|5976703|P1|COMPLETED|Overall Study||152
2436462|NCT01141608|5976702|P2|STARTED|Overall Study||150
2436463|NCT01141608|5976703|P1|STARTED|Overall Study||152
2436464|NCT01141595|5976709|P1|NOT COMPLETED|Overall Study||2
2436465|NCT01141595|5976709|P1|COMPLETED|Overall Study||8
2436466|NCT01141595|5976709|P1|STARTED|Overall Study||10
2436467|NCT01141569|5976713|P1|NOT COMPLETED|Overall Study||0
2436468|NCT01141569|5976713|P1|COMPLETED|Overall Study||12
2436469|NCT01141569|5976713|P1|STARTED|Overall Study||12
2436470|NCT01141491|5976724|P2|NOT COMPLETED|Overall Study||47
2436471|NCT01141491|5976725|P1|NOT COMPLETED|Overall Study||48
2436472|NCT01141491|5976724|P2|COMPLETED|Overall Study||21
2436473|NCT01141491|5976725|P1|COMPLETED|Overall Study||20
2436474|NCT01141491|5976724|P2|STARTED|Overall Study||68
2436475|NCT01141491|5976725|P1|STARTED|Overall Study||68
2436476|NCT01141374|5976734|P3|NOT COMPLETED|Overall Study||0
2436477|NCT01141374|5976735|P2|NOT COMPLETED|Overall Study||0
2436478|NCT01141374|5976736|P1|NOT COMPLETED|Overall Study||0
2436479|NCT01141374|5976734|P3|COMPLETED|Overall Study||22
2436480|NCT01141374|5976735|P2|COMPLETED|Overall Study||27
2436481|NCT01141374|5976736|P1|COMPLETED|Overall Study||26
2436482|NCT01141374|5976734|P3|STARTED|Overall Study||22
2436483|NCT01141374|5976735|P2|STARTED|Overall Study||27
2436484|NCT01141374|5976736|P1|STARTED|Overall Study||26
2436485|NCT01141283|5976747|P1|NOT COMPLETED|Overall Study||88
2436486|NCT01141283|5976747|P1|COMPLETED|Overall Study||202
2436487|NCT01141283|5976747|P1|STARTED|Overall Study||290
2436488|NCT01141205|5976753|P2|NOT COMPLETED|Overall Study||2
2436489|NCT01141205|5976754|P1|NOT COMPLETED|Overall Study||3
2436490|NCT01141205|5976753|P2|COMPLETED|Overall Study||3
2436491|NCT01141205|5976754|P1|COMPLETED|Overall Study||15
2436492|NCT01141205|5976753|P2|STARTED|Overall Study||5
2436493|NCT01141205|5976754|P1|STARTED|Overall Study||18
2436494|NCT01141049|5976768|P2|NOT COMPLETED|Overall Study||8
2436495|NCT01141049|5976769|P1|NOT COMPLETED|Overall Study||5
2436496|NCT01141049|5976768|P2|COMPLETED|Overall Study||13
2436497|NCT01141049|5976769|P1|COMPLETED|Overall Study||14
2436498|NCT01141049|5976768|P2|STARTED|Overall Study||21
2436499|NCT01141049|5976769|P1|STARTED|Overall Study||19
2436500|NCT01140906|5976781|P4|NOT COMPLETED|Overall Study||16
2436501|NCT01140906|5976782|P3|NOT COMPLETED|Overall Study||26
2436502|NCT01140906|5976783|P2|NOT COMPLETED|Overall Study||34
2436503|NCT01140906|5976784|P1|NOT COMPLETED|Overall Study||25
2436504|NCT01140906|5976781|P4|COMPLETED|Overall Study||131
2436505|NCT01140906|5976782|P3|COMPLETED|Overall Study||125
2436506|NCT01140906|5976783|P2|COMPLETED|Overall Study||117
2436507|NCT01140906|5976784|P1|COMPLETED|Overall Study||133
2436508|NCT01140906|5976781|P4|STARTED|Overall Study||147
2436509|NCT01140906|5976782|P3|STARTED|Overall Study||151
2436510|NCT01140906|5976783|P2|STARTED|Overall Study||151
2436511|NCT01140906|5976784|P1|STARTED|Overall Study||158
2436512|NCT01140880|5976824|P2|NOT COMPLETED|Overall Study||44
2436513|NCT01140880|5976825|P1|NOT COMPLETED|Overall Study||14
2436514|NCT01140880|5976824|P2|COMPLETED|Overall Study||56
2436515|NCT01140880|5976825|P1|COMPLETED|Overall Study||56
2436516|NCT01140880|5976824|P2|STARTED|Overall Study||100
2436517|NCT01140880|5976825|P1|STARTED|Overall Study||70
2436518|NCT01140867|5976837|P1|NOT COMPLETED|Overall Study||33
2436519|NCT01140867|5976837|P1|COMPLETED|Overall Study||88
2436520|NCT01140867|5976837|P1|STARTED|Overall Study||121
2436521|NCT01140815|5976846|P2|NOT COMPLETED|Overall Study||0
2436522|NCT01140815|5976847|P1|NOT COMPLETED|Overall Study||0
2436523|NCT01140815|5976846|P2|COMPLETED|Overall Study||25
2436524|NCT01140815|5976847|P1|COMPLETED|Overall Study||25
2436525|NCT01140815|5976846|P2|STARTED|Overall Study||25
2436526|NCT01140815|5976847|P1|STARTED|Overall Study||25
2436527|NCT01140646|5976877|P1|NOT COMPLETED|Overall Study||9
2436528|NCT01140646|5976877|P1|COMPLETED|Overall Study||34
2436529|NCT01140646|5976877|P1|STARTED|Overall Study||43
2436530|NCT01140503|5976885|P1|NOT COMPLETED|Overall Study||1
2436531|NCT01140503|5976885|P1|COMPLETED|Overall Study||4
2436532|NCT01140503|5976885|P1|STARTED|Overall Study||5
2436533|NCT01140477|5976893|P2|NOT COMPLETED|Overall Study||6
2436534|NCT01140477|5976894|P1|NOT COMPLETED|Overall Study||8
2436535|NCT01140477|5976893|P2|COMPLETED|Overall Study||70
2436536|NCT01140477|5976894|P1|COMPLETED|Overall Study||145
2436537|NCT01140477|5976893|P2|STARTED|Overall Study||76
2436538|NCT01140477|5976894|P1|STARTED|Overall Study||153
2436539|NCT01140360|5976903|P1|NOT COMPLETED|Overall Study||6
2436540|NCT01140360|5976903|P1|COMPLETED|Overall Study||15
2436541|NCT01140360|5976903|P1|STARTED|Overall Study||21
2436542|NCT01140347|5976909|P2|NOT COMPLETED|Overall Study||14
2436543|NCT01140347|5976910|P1|NOT COMPLETED|Overall Study||18
2436544|NCT01140347|5976909|P2|COMPLETED|Overall Study||268
2436545|NCT01140347|5976910|P1|COMPLETED|Overall Study||265
2436546|NCT01140347|5976909|P2|Received at Least 1 Dose of Study Drug|Overall Study||276
2436547|NCT01140347|5976910|P1|Received at Least 1 Dose of Study Drug|Overall Study||277
2436548|NCT01140347|5976909|P2|STARTED|Overall Study||282
2436549|NCT01140347|5976910|P1|STARTED|Overall Study||283
2436550|NCT01140295|5976935|P2|NOT COMPLETED|Overall Study||2
2436551|NCT01140295|5976936|P1|NOT COMPLETED|Overall Study||1
2436552|NCT01140295|5976935|P2|COMPLETED|Overall Study||14
2436553|NCT01140295|5976936|P1|COMPLETED|Overall Study||16
2436554|NCT01140295|5976935|P2|STARTED|Overall Study||16
2436555|NCT01140295|5976936|P1|STARTED|Overall Study||17
2436556|NCT01140191|5976944|P1|NOT COMPLETED|Overall Study||0
2436557|NCT01140191|5976944|P1|COMPLETED|Overall Study||1
2436558|NCT01140191|5976944|P1|STARTED|Overall Study||1
2436559|NCT01140061|5976963|P10|NOT COMPLETED|Extension||1
2436560|NCT01140061|5976964|P9|NOT COMPLETED|Extension||0
2436561|NCT01140061|5976965|P8|NOT COMPLETED|Extension||0
2436562|NCT01140061|5976966|P7|NOT COMPLETED|Extension||0
2436563|NCT01140061|5976967|P6|NOT COMPLETED|Extension||0
2436564|NCT01140061|5976968|P5|NOT COMPLETED|Extension||0
2436565|NCT01140061|5976969|P4|NOT COMPLETED|Extension||0
2436566|NCT01140061|5976970|P3|NOT COMPLETED|Extension||0
2436567|NCT01140061|5976971|P2|NOT COMPLETED|Extension||0
2436568|NCT01140061|5976972|P1|NOT COMPLETED|Extension||0
2436569|NCT01140061|5976963|P10|COMPLETED|Extension||1
2436570|NCT01140061|5976964|P9|COMPLETED|Extension||7
2436571|NCT01140061|5976965|P8|COMPLETED|Extension||0
2436572|NCT01140061|5976966|P7|COMPLETED|Extension||0
2436573|NCT01140061|5976967|P6|COMPLETED|Extension||0
2436574|NCT01140061|5976968|P5|COMPLETED|Extension||0
2436575|NCT01140061|5976969|P4|COMPLETED|Extension||0
2436576|NCT01140061|5976970|P3|COMPLETED|Extension||0
2436577|NCT01140061|5976971|P2|COMPLETED|Extension||0
2436578|NCT01140061|5976972|P1|COMPLETED|Extension||0
2436579|NCT01140061|5976963|P10|STARTED|Extension||2
2436580|NCT01140061|5976964|P9|STARTED|Extension||7
2436581|NCT01140061|5976965|P8|STARTED|Extension||0
2436582|NCT01140061|5976966|P7|STARTED|Extension||0
2436583|NCT01140061|5976967|P6|STARTED|Extension||0
2436584|NCT01140061|5976968|P5|STARTED|Extension||0
2436585|NCT01140061|5976969|P4|STARTED|Extension||0
2436586|NCT01140061|5976970|P3|STARTED|Extension||0
2436587|NCT01140061|5976971|P2|STARTED|Extension||0
2436588|NCT01140061|5976972|P1|STARTED|Extension||0
2436589|NCT01140061|5976963|P10|NOT COMPLETED|Part III||0
2436590|NCT01140061|5976964|P9|NOT COMPLETED|Part III||0
2436591|NCT01140061|5976965|P8|NOT COMPLETED|Part III||0
2436592|NCT01140061|5976966|P7|NOT COMPLETED|Part III||0
2436593|NCT01140061|5976967|P6|NOT COMPLETED|Part III||0
2436594|NCT01140061|5976968|P5|NOT COMPLETED|Part III||0
2436595|NCT01140061|5976969|P4|NOT COMPLETED|Part III||0
2436596|NCT01140061|5976970|P3|NOT COMPLETED|Part III||0
2436597|NCT01140061|5976971|P2|NOT COMPLETED|Part III||0
2436598|NCT01140061|5976972|P1|NOT COMPLETED|Part III||0
2436599|NCT01140061|5976963|P10|COMPLETED|Part III||2
2436600|NCT01140061|5976964|P9|COMPLETED|Part III||7
2436601|NCT01140061|5976965|P8|COMPLETED|Part III||0
2436602|NCT01140061|5976966|P7|COMPLETED|Part III||0
2436603|NCT01140061|5976967|P6|COMPLETED|Part III||0
2436604|NCT01140061|5976968|P5|COMPLETED|Part III||0
2436605|NCT01140061|5976969|P4|COMPLETED|Part III||0
2436606|NCT01140061|5976970|P3|COMPLETED|Part III||0
2436607|NCT01140061|5976971|P2|COMPLETED|Part III||0
2436608|NCT01140061|5976972|P1|COMPLETED|Part III||0
2436609|NCT01140061|5976963|P10|STARTED|Part III|Includes 1 replacement participant|2
2436610|NCT01140061|5976964|P9|STARTED|Part III||7
2436611|NCT01140061|5976965|P8|STARTED|Part III||0
2436612|NCT01140061|5976966|P7|STARTED|Part III||0
2436613|NCT01140061|5976967|P6|STARTED|Part III||0
2436614|NCT01140061|5976968|P5|STARTED|Part III||0
2436615|NCT01140061|5976969|P4|STARTED|Part III||0
2436616|NCT01140061|5976970|P3|STARTED|Part III||0
2436617|NCT01140061|5976971|P2|STARTED|Part III||0
2436618|NCT01140061|5976972|P1|STARTED|Part III||0
2436619|NCT01140061|5976963|P10|NOT COMPLETED|Part II||0
2436620|NCT01140061|5976964|P9|NOT COMPLETED|Part II||0
2436621|NCT01140061|5976965|P8|NOT COMPLETED|Part II||0
2436622|NCT01140061|5976966|P7|NOT COMPLETED|Part II||0
2436623|NCT01140061|5976967|P6|NOT COMPLETED|Part II||0
2436624|NCT01140061|5976968|P5|NOT COMPLETED|Part II||0
2436625|NCT01140061|5976969|P4|NOT COMPLETED|Part II||0
2436626|NCT01140061|5976970|P3|NOT COMPLETED|Part II||0
2436627|NCT01140061|5976971|P2|NOT COMPLETED|Part II||0
2436628|NCT01140061|5976972|P1|NOT COMPLETED|Part II||0
2436629|NCT01140061|5976963|P10|COMPLETED|Part II||0
2436630|NCT01140061|5976964|P9|COMPLETED|Part II||0
2436631|NCT01140061|5976965|P8|COMPLETED|Part II||2
2436632|NCT01140061|5976966|P7|COMPLETED|Part II||6
2436633|NCT01140061|5976967|P6|COMPLETED|Part II||2
2436634|NCT01140061|5976968|P5|COMPLETED|Part II||6
2436635|NCT01140061|5976969|P4|COMPLETED|Part II||2
2436636|NCT01140061|5976970|P3|COMPLETED|Part II||6
2436637|NCT01140061|5976971|P2|COMPLETED|Part II||0
2436638|NCT01140061|5976972|P1|COMPLETED|Part II||0
2436639|NCT01140061|5976963|P10|STARTED|Part II||0
2436640|NCT01140061|5976964|P9|STARTED|Part II||0
2436641|NCT01140061|5976965|P8|STARTED|Part II||2
2436642|NCT01140061|5976966|P7|STARTED|Part II||6
2436643|NCT01140061|5976967|P6|STARTED|Part II||2
2436644|NCT01140061|5976968|P5|STARTED|Part II||6
2436645|NCT01140061|5976969|P4|STARTED|Part II||2
2436646|NCT01140061|5976970|P3|STARTED|Part II||6
2436647|NCT01140061|5976971|P2|STARTED|Part II||0
2436648|NCT01140061|5976972|P1|STARTED|Part II||0
2436649|NCT01140061|5976963|P10|NOT COMPLETED|Part I||0
2436650|NCT01140061|5976964|P9|NOT COMPLETED|Part I||0
2436651|NCT01140061|5976965|P8|NOT COMPLETED|Part I||0
2436652|NCT01140061|5976966|P7|NOT COMPLETED|Part I||0
2436653|NCT01140061|5976967|P6|NOT COMPLETED|Part I||0
2436654|NCT01140061|5976968|P5|NOT COMPLETED|Part I||0
2436655|NCT01140061|5976969|P4|NOT COMPLETED|Part I||0
2436656|NCT01140061|5976970|P3|NOT COMPLETED|Part I||0
2436657|NCT01140061|5976971|P2|NOT COMPLETED|Part I||0
2436658|NCT01140061|5976972|P1|NOT COMPLETED|Part I||1
2436659|NCT01140061|5976963|P10|COMPLETED|Part I||0
2436660|NCT01140061|5976964|P9|COMPLETED|Part I||0
2436661|NCT01140061|5976965|P8|COMPLETED|Part I||0
2436662|NCT01140061|5976966|P7|COMPLETED|Part I||0
2436663|NCT01140061|5976967|P6|COMPLETED|Part I||0
2436664|NCT01140061|5976968|P5|COMPLETED|Part I||0
2436665|NCT01140061|5976969|P4|COMPLETED|Part I||0
2436666|NCT01140061|5976970|P3|COMPLETED|Part I||0
2436667|NCT01140061|5976971|P2|COMPLETED|Part I||2
2436668|NCT01140061|5976972|P1|COMPLETED|Part I||6
2436669|NCT01140061|5976963|P10|STARTED|Part I||0
2436670|NCT01140061|5976964|P9|STARTED|Part I||0
2436671|NCT01140061|5976965|P8|STARTED|Part I||0
2436672|NCT01140061|5976966|P7|STARTED|Part I||0
2436673|NCT01140061|5976967|P6|STARTED|Part I||0
2436674|NCT01140061|5976968|P5|STARTED|Part I||0
2436675|NCT01140061|5976969|P4|STARTED|Part I||0
2436676|NCT01140061|5976970|P3|STARTED|Part I||0
2436677|NCT01140061|5976971|P2|STARTED|Part I||2
2436678|NCT01140061|5976972|P1|STARTED|Part I|Includes 1 replacement participant|7
2436679|NCT01140048|5976999|P1|NOT COMPLETED|Overall Study||45
2436680|NCT01140048|5976999|P1|COMPLETED|Overall Study||298
2436681|NCT01140048|5976999|P1|STARTED|Overall Study||343
2436682|NCT01139996|5977007|P2|NOT COMPLETED|Overall Study||0
2436683|NCT01139996|5977008|P1|NOT COMPLETED|Overall Study||0
2436684|NCT01139996|5977007|P2|COMPLETED|Overall Study||11
2436685|NCT01139996|5977008|P1|COMPLETED|Overall Study||11
2436686|NCT01139996|5977007|P2|STARTED|Overall Study||11
2436687|NCT01139996|5977008|P1|STARTED|Overall Study||11
2436688|NCT01139879|5977014|P1|NOT COMPLETED|Overall Study||0
2436689|NCT01139879|5977014|P1|COMPLETED|Overall Study||10
2436690|NCT01139879|5977014|P1|STARTED|Overall Study||10
2436691|NCT01139814|5977020|P1|NOT COMPLETED|Overall Study||0
2436692|NCT01139814|5977020|P1|COMPLETED|Overall Study||181
2436693|NCT01139814|5977020|P1|STARTED|Overall Study||181
2436694|NCT01139801|5977027|P2|NOT COMPLETED|Overall Study||0
2436695|NCT01139801|5977028|P1|NOT COMPLETED|Overall Study||0
2436696|NCT01139801|5977027|P2|COMPLETED|Overall Study||25
2436697|NCT01139801|5977028|P1|COMPLETED|Overall Study||25
2436698|NCT01139801|5977027|P2|STARTED|Overall Study||25
2436699|NCT01139801|5977028|P1|STARTED|Overall Study||25
2436700|NCT01139775|5977039|P3|NOT COMPLETED|Overall Study||6
2436701|NCT01139775|5977040|P2|NOT COMPLETED|Overall Study||13
2436702|NCT01139775|5977041|P1|NOT COMPLETED|Overall Study||1
2436703|NCT01139775|5977039|P3|COMPLETED|Overall Study||17
2436704|NCT01139775|5977040|P2|COMPLETED|Overall Study||26
2436705|NCT01139775|5977041|P1|COMPLETED|Overall Study||13
2436706|NCT01139775|5977039|P3|Received at Least 1 Dose of Study Drug|Overall Study||22
2436707|NCT01139775|5977040|P2|Received at Least 1 Dose of Study Drug|Overall Study||39
2436708|NCT01139775|5977041|P1|Received at Least 1 Dose of Study Drug|Overall Study||14
2436709|NCT01139775|5977039|P3|STARTED|Overall Study||23
2436710|NCT01139775|5977040|P2|STARTED|Overall Study||39
2436711|NCT01139775|5977041|P1|STARTED|Overall Study||14
2436712|NCT01139762|5977073|P3|NOT COMPLETED|Double-Blind Randomized Active Treatment||64
2436713|NCT01139762|5977074|P2|NOT COMPLETED|Double-Blind Randomized Active Treatment||40
2436714|NCT01139762|5977075|P1|NOT COMPLETED|Double-Blind Randomized Active Treatment||0
2436715|NCT01139762|5977073|P3|COMPLETED|Double-Blind Randomized Active Treatment||286
2436716|NCT01139762|5977074|P2|COMPLETED|Double-Blind Randomized Active Treatment||306
2436717|NCT01139762|5977075|P1|COMPLETED|Double-Blind Randomized Active Treatment||0
2436718|NCT01139762|5977073|P3|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||350
2436719|NCT01139762|5977074|P2|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||345
2436720|NCT01139762|5977075|P1|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||0
2436721|NCT01139762|5977073|P3|STARTED|Double-Blind Randomized Active Treatment||350
2436722|NCT01139762|5977074|P2|STARTED|Double-Blind Randomized Active Treatment||346
2436723|NCT01139762|5977075|P1|STARTED|Double-Blind Randomized Active Treatment||0
2436724|NCT01139762|5977073|P3|NOT COMPLETED|Washout and Placebo Lead-In Period||0
2436725|NCT01139762|5977074|P2|NOT COMPLETED|Washout and Placebo Lead-In Period||0
2436726|NCT01139762|5977075|P1|NOT COMPLETED|Washout and Placebo Lead-In Period||374
2436727|NCT01139762|5977073|P3|COMPLETED|Washout and Placebo Lead-In Period||0
2436728|NCT01139762|5977074|P2|COMPLETED|Washout and Placebo Lead-In Period||0
2436729|NCT01139762|5977075|P1|COMPLETED|Washout and Placebo Lead-In Period||696
2436730|NCT01139762|5977073|P3|STARTED|Washout and Placebo Lead-In Period||0
2436731|NCT01139762|5977074|P2|STARTED|Washout and Placebo Lead-In Period||0
2436732|NCT01139762|5977075|P1|STARTED|Washout and Placebo Lead-In Period||1070
2436733|NCT01139658|5977110|P2|NOT COMPLETED|Overall Study||113
2436734|NCT01139658|5977111|P1|NOT COMPLETED|Overall Study||56
2436735|NCT01139658|5977110|P2|COMPLETED|Overall Study||816
2436736|NCT01139658|5977111|P1|COMPLETED|Overall Study||691
2436737|NCT01139658|5977110|P2|STARTED|Overall Study||929
2436738|NCT01139658|5977111|P1|STARTED|Overall Study||747
2436739|NCT01139580|5977149|P2|NOT COMPLETED|Overall Study||18
2436740|NCT01139580|5977150|P1|NOT COMPLETED|Overall Study||23
2436741|NCT01139580|5977149|P2|COMPLETED|Overall Study||164
2436742|NCT01139580|5977150|P1|COMPLETED|Overall Study||158
2436743|NCT01139580|5977149|P2|STARTED|Overall Study||182
2436744|NCT01139580|5977150|P1|STARTED|Overall Study||181
2436745|NCT01139515|5977166|P4|NOT COMPLETED|Fourth Intervention Period||0
2436746|NCT01139515|5977167|P3|NOT COMPLETED|Fourth Intervention Period||0
2436747|NCT01139515|5977168|P2|NOT COMPLETED|Fourth Intervention Period||0
2436748|NCT01139515|5977169|P1|NOT COMPLETED|Fourth Intervention Period||0
2436749|NCT01139515|5977166|P4|COMPLETED|Fourth Intervention Period||4
2436750|NCT01139515|5977167|P3|COMPLETED|Fourth Intervention Period||4
2436751|NCT01139515|5977168|P2|COMPLETED|Fourth Intervention Period||4
2436752|NCT01139515|5977169|P1|COMPLETED|Fourth Intervention Period||4
2436753|NCT01139515|5977166|P4|STARTED|Fourth Intervention Period||4
2436754|NCT01139515|5977167|P3|STARTED|Fourth Intervention Period||4
2436755|NCT01139515|5977168|P2|STARTED|Fourth Intervention Period||4
2436756|NCT01139515|5977169|P1|STARTED|Fourth Intervention Period||4
2436757|NCT01139515|5977166|P4|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
2436758|NCT01139515|5977167|P3|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
2436759|NCT01139515|5977168|P2|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
2436760|NCT01139515|5977169|P1|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
2436761|NCT01139515|5977166|P4|COMPLETED|Washout Period 3 (46 Hrs)||4
2436762|NCT01139515|5977167|P3|COMPLETED|Washout Period 3 (46 Hrs)||4
2436763|NCT01139515|5977168|P2|COMPLETED|Washout Period 3 (46 Hrs)||4
2436764|NCT01139515|5977169|P1|COMPLETED|Washout Period 3 (46 Hrs)||4
2436765|NCT01139515|5977166|P4|STARTED|Washout Period 3 (46 Hrs)||4
2436766|NCT01139515|5977167|P3|STARTED|Washout Period 3 (46 Hrs)||4
2436767|NCT01139515|5977168|P2|STARTED|Washout Period 3 (46 Hrs)||4
2436768|NCT01139515|5977169|P1|STARTED|Washout Period 3 (46 Hrs)||4
2436769|NCT01139515|5977166|P4|NOT COMPLETED|Third Intervention Period||0
2436770|NCT01139515|5977167|P3|NOT COMPLETED|Third Intervention Period||0
2436771|NCT01139515|5977168|P2|NOT COMPLETED|Third Intervention Period||0
2436772|NCT01139515|5977169|P1|NOT COMPLETED|Third Intervention Period||0
2436773|NCT01139515|5977166|P4|COMPLETED|Third Intervention Period||4
2436774|NCT01139515|5977167|P3|COMPLETED|Third Intervention Period||4
2436775|NCT01139515|5977168|P2|COMPLETED|Third Intervention Period||4
2436776|NCT01139515|5977169|P1|COMPLETED|Third Intervention Period||4
2436777|NCT01139515|5977166|P4|STARTED|Third Intervention Period||4
2436778|NCT01139515|5977167|P3|STARTED|Third Intervention Period||4
2436779|NCT01139515|5977168|P2|STARTED|Third Intervention Period||4
2436780|NCT01139515|5977169|P1|STARTED|Third Intervention Period||4
2436781|NCT01139515|5977166|P4|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
2436782|NCT01139515|5977167|P3|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
2436783|NCT01139515|5977168|P2|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
2436784|NCT01139515|5977169|P1|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
2436785|NCT01139515|5977166|P4|COMPLETED|Washout Period 2 (46 Hrs)||4
2436786|NCT01139515|5977167|P3|COMPLETED|Washout Period 2 (46 Hrs)||4
2436787|NCT01139515|5977168|P2|COMPLETED|Washout Period 2 (46 Hrs)||4
2436788|NCT01139515|5977169|P1|COMPLETED|Washout Period 2 (46 Hrs)||4
2436789|NCT01139515|5977166|P4|STARTED|Washout Period 2 (46 Hrs)||4
2436790|NCT01139515|5977167|P3|STARTED|Washout Period 2 (46 Hrs)||4
2436791|NCT01139515|5977168|P2|STARTED|Washout Period 2 (46 Hrs)||4
2436792|NCT01139515|5977169|P1|STARTED|Washout Period 2 (46 Hrs)||4
2436793|NCT01139515|5977166|P4|NOT COMPLETED|Second Intervention Period||0
2436794|NCT01139515|5977167|P3|NOT COMPLETED|Second Intervention Period||0
2436795|NCT01139515|5977168|P2|NOT COMPLETED|Second Intervention Period||0
2436796|NCT01139515|5977169|P1|NOT COMPLETED|Second Intervention Period||0
2436797|NCT01139515|5977166|P4|COMPLETED|Second Intervention Period||4
2436798|NCT01139515|5977167|P3|COMPLETED|Second Intervention Period||4
2436799|NCT01139515|5977168|P2|COMPLETED|Second Intervention Period||4
2436800|NCT01139515|5977169|P1|COMPLETED|Second Intervention Period||4
2436801|NCT01139515|5977166|P4|STARTED|Second Intervention Period||4
2436802|NCT01139515|5977167|P3|STARTED|Second Intervention Period||4
2436803|NCT01139515|5977168|P2|STARTED|Second Intervention Period||4
2436804|NCT01139515|5977169|P1|STARTED|Second Intervention Period||4
2436805|NCT01139515|5977166|P4|NOT COMPLETED|Washout Period I (46hrs)||0
2436806|NCT01139515|5977167|P3|NOT COMPLETED|Washout Period I (46hrs)||0
2436807|NCT01139515|5977168|P2|NOT COMPLETED|Washout Period I (46hrs)||0
2436808|NCT01139515|5977169|P1|NOT COMPLETED|Washout Period I (46hrs)||0
2436809|NCT01139515|5977166|P4|COMPLETED|Washout Period I (46hrs)||4
2436810|NCT01139515|5977167|P3|COMPLETED|Washout Period I (46hrs)||4
2436811|NCT01139515|5977168|P2|COMPLETED|Washout Period I (46hrs)||4
2436812|NCT01139515|5977169|P1|COMPLETED|Washout Period I (46hrs)||4
2436813|NCT01139515|5977166|P4|STARTED|Washout Period I (46hrs)||4
2436814|NCT01139515|5977167|P3|STARTED|Washout Period I (46hrs)||4
2436815|NCT01139515|5977168|P2|STARTED|Washout Period I (46hrs)||4
2436816|NCT01139515|5977169|P1|STARTED|Washout Period I (46hrs)||4
2436817|NCT01139515|5977166|P4|NOT COMPLETED|First Intervention Period||0
2436818|NCT01139515|5977167|P3|NOT COMPLETED|First Intervention Period||0
2436819|NCT01139515|5977168|P2|NOT COMPLETED|First Intervention Period||0
2436820|NCT01139515|5977169|P1|NOT COMPLETED|First Intervention Period||0
2436821|NCT01139515|5977166|P4|COMPLETED|First Intervention Period||4
2436822|NCT01139515|5977167|P3|COMPLETED|First Intervention Period||4
2436823|NCT01139515|5977168|P2|COMPLETED|First Intervention Period||4
2436824|NCT01139515|5977169|P1|COMPLETED|First Intervention Period||4
2436825|NCT01139515|5977166|P4|STARTED|First Intervention Period||4
2436826|NCT01139515|5977167|P3|STARTED|First Intervention Period||4
2436827|NCT01139515|5977168|P2|STARTED|First Intervention Period||4
2436828|NCT01139515|5977169|P1|STARTED|First Intervention Period||4
2436829|NCT01139450|5977198|P3|NOT COMPLETED|Overall Study||38
2436830|NCT01139450|5977199|P2|NOT COMPLETED|Overall Study||25
2436831|NCT01139450|5977200|P1|NOT COMPLETED|Overall Study||27
2436832|NCT01139450|5977198|P3|COMPLETED|Overall Study||262
2436833|NCT01139450|5977199|P2|COMPLETED|Overall Study||272
2436834|NCT01139450|5977200|P1|COMPLETED|Overall Study||275
2436835|NCT01139450|5977198|P3|STARTED|Overall Study||300
2436836|NCT01139450|5977199|P2|STARTED|Overall Study||297
2436837|NCT01139450|5977200|P1|STARTED|Overall Study||302
2436838|NCT01139411|5977210|P2|NOT COMPLETED|Overall Study||4
2436839|NCT01139411|5977211|P1|NOT COMPLETED|Overall Study||2
2436840|NCT01139411|5977210|P2|COMPLETED|Overall Study||19
2436841|NCT01139411|5977211|P1|COMPLETED|Overall Study||24
2436842|NCT01139411|5977210|P2|STARTED|Overall Study||23
2436843|NCT01139411|5977211|P1|STARTED|Overall Study||26
2436844|NCT01139294|5977231|P2|NOT COMPLETED|Overall Study||0
2436845|NCT01139294|5977232|P1|NOT COMPLETED|Overall Study||0
2436846|NCT01139294|5977231|P2|COMPLETED|Overall Study||0
2436847|NCT01139294|5977232|P1|COMPLETED|Overall Study||0
2436848|NCT01139294|5977231|P2|STARTED|Overall Study||0
2436849|NCT01139294|5977232|P1|STARTED|Overall Study||0
2436850|NCT01139190|5977242|P2|NOT COMPLETED|Overall Study||1
2436851|NCT01139190|5977243|P1|NOT COMPLETED|Overall Study||0
2436852|NCT01139190|5977242|P2|COMPLETED|Overall Study||38
2436853|NCT01139190|5977243|P1|COMPLETED|Overall Study||38
2436854|NCT01139190|5977242|P2|STARTED|Overall Study||39
2436855|NCT01139190|5977243|P1|STARTED|Overall Study||38
2436856|NCT01139164|5977252|P3|NOT COMPLETED|Overall Study||0
2436857|NCT01139164|5977253|P2|NOT COMPLETED|Overall Study||2
2436858|NCT01139164|5977254|P1|NOT COMPLETED|Overall Study||0
2436859|NCT01139164|5977252|P3|COMPLETED|Overall Study||7
2436860|NCT01139164|5977253|P2|COMPLETED|Overall Study||65
2436861|NCT01139164|5977254|P1|COMPLETED|Overall Study||4
2436862|NCT01139164|5977252|P3|STARTED|Overall Study||7
2436863|NCT01139164|5977253|P2|STARTED|Overall Study||67
2436864|NCT01139164|5977254|P1|STARTED|Overall Study||4
2436865|NCT01139125|5977268|P1|NOT COMPLETED|Overall Study||1
2436866|NCT01139125|5977268|P1|COMPLETED|Overall Study||2
2436867|NCT01139125|5977268|P1|STARTED|Overall Study||3
2436868|NCT01139047|5977272|P1|NOT COMPLETED|Overall Study||1
2436869|NCT01139047|5977272|P1|COMPLETED|Overall Study||76
2436870|NCT01139047|5977272|P1|STARTED|Overall Study||77
2436871|NCT01139021|5977287|P6|NOT COMPLETED|Overall Study||0
2436872|NCT01139021|5977288|P5|NOT COMPLETED|Overall Study||9
2436873|NCT01139021|5977289|P4|NOT COMPLETED|Overall Study||1
2436874|NCT01139021|5977290|P3|NOT COMPLETED|Overall Study||0
2436875|NCT01139021|5977291|P2|NOT COMPLETED|Overall Study||0
2436876|NCT01139021|5977292|P1|NOT COMPLETED|Overall Study||1
2436877|NCT01139021|5977287|P6|COMPLETED|Overall Study||1
2436878|NCT01139021|5977288|P5|COMPLETED|Overall Study||107
2436879|NCT01139021|5977289|P4|COMPLETED|Overall Study||18
2436880|NCT01139021|5977290|P3|COMPLETED|Overall Study||67
2436881|NCT01139021|5977291|P2|COMPLETED|Overall Study||153
2436882|NCT01139021|5977292|P1|COMPLETED|Overall Study||151
2436883|NCT01139021|5977287|P6|STARTED|Overall Study||1
2436884|NCT01139021|5977288|P5|STARTED|Overall Study||116
2436885|NCT01139021|5977289|P4|STARTED|Overall Study||19
2436886|NCT01139021|5977290|P3|STARTED|Overall Study||67
2436887|NCT01139021|5977291|P2|STARTED|Overall Study||153
2436888|NCT01139021|5977292|P1|STARTED|Overall Study||152
2436889|NCT01139008|5977328|P1|NOT COMPLETED|Overall Study||6
2436890|NCT01139008|5977328|P1|COMPLETED|Overall Study||74
2436891|NCT01139008|5977328|P1|STARTED|Overall Study||80
2436892|NCT01138995|5977339|P2|NOT COMPLETED|Overall Study||25
2436893|NCT01138995|5977340|P1|NOT COMPLETED|Overall Study||10
2436894|NCT01138995|5977339|P2|COMPLETED|Overall Study||74
2436895|NCT01138995|5977340|P1|COMPLETED|Overall Study||88
2436896|NCT01138995|5977339|P2|STARTED|Overall Study||99
2436897|NCT01138995|5977340|P1|STARTED|Overall Study||98
2436898|NCT01138969|5977352|P2|NOT COMPLETED|Overall Study||0
2436899|NCT01138969|5977353|P1|NOT COMPLETED|Overall Study||0
2436900|NCT01138969|5977352|P2|COMPLETED|Overall Study||82
2436901|NCT01138969|5977353|P1|COMPLETED|Overall Study||83
2436902|NCT01138969|5977352|P2|STARTED|Overall Study||82
2436903|NCT01138969|5977353|P1|STARTED|Overall Study||83
2436904|NCT01138917|5977361|P1|NOT COMPLETED|Overall Study||24
2436905|NCT01138917|5977361|P1|COMPLETED|Overall Study||77
2436906|NCT01138917|5977361|P1|STARTED|Overall Study||101
2436907|NCT01138826|5977375|P6|NOT COMPLETED|Third Intervention Period||0
2436908|NCT01138826|5977376|P5|NOT COMPLETED|Third Intervention Period||0
2436909|NCT01138826|5977377|P4|NOT COMPLETED|Third Intervention Period||0
2436910|NCT01138826|5977378|P3|NOT COMPLETED|Third Intervention Period||0
2436911|NCT01138826|5977379|P2|NOT COMPLETED|Third Intervention Period||0
2436912|NCT01138826|5977380|P1|NOT COMPLETED|Third Intervention Period||0
2436913|NCT01138826|5977375|P6|COMPLETED|Third Intervention Period||3
2436914|NCT01138826|5977376|P5|COMPLETED|Third Intervention Period||2
2436915|NCT01138826|5977377|P4|COMPLETED|Third Intervention Period||3
2436916|NCT01138826|5977378|P3|COMPLETED|Third Intervention Period||3
2436917|NCT01138826|5977379|P2|COMPLETED|Third Intervention Period||2
2436918|NCT01138826|5977380|P1|COMPLETED|Third Intervention Period||2
2436919|NCT01138826|5977375|P6|STARTED|Third Intervention Period||3
2436920|NCT01138826|5977376|P5|STARTED|Third Intervention Period||2
2436921|NCT01138826|5977377|P4|STARTED|Third Intervention Period||3
2436922|NCT01138826|5977378|P3|STARTED|Third Intervention Period||3
2436923|NCT01138826|5977379|P2|STARTED|Third Intervention Period||2
2436924|NCT01138826|5977380|P1|STARTED|Third Intervention Period||2
2436925|NCT01138826|5977375|P6|NOT COMPLETED|Washout Period II (of 16 Days)||0
2436926|NCT01138826|5977376|P5|NOT COMPLETED|Washout Period II (of 16 Days)||0
2436927|NCT01138826|5977377|P4|NOT COMPLETED|Washout Period II (of 16 Days)||0
2436928|NCT01138826|5977378|P3|NOT COMPLETED|Washout Period II (of 16 Days)||0
2436929|NCT01138826|5977379|P2|NOT COMPLETED|Washout Period II (of 16 Days)||0
2436930|NCT01138826|5977380|P1|NOT COMPLETED|Washout Period II (of 16 Days)||0
2436931|NCT01138826|5977375|P6|COMPLETED|Washout Period II (of 16 Days)||3
2436932|NCT01138826|5977376|P5|COMPLETED|Washout Period II (of 16 Days)||2
2436933|NCT01138826|5977377|P4|COMPLETED|Washout Period II (of 16 Days)||3
2436934|NCT01138826|5977378|P3|COMPLETED|Washout Period II (of 16 Days)||3
2436935|NCT01138826|5977379|P2|COMPLETED|Washout Period II (of 16 Days)||2
2436936|NCT01138826|5977380|P1|COMPLETED|Washout Period II (of 16 Days)||2
2436937|NCT01138826|5977375|P6|STARTED|Washout Period II (of 16 Days)||3
2436938|NCT01138826|5977376|P5|STARTED|Washout Period II (of 16 Days)||2
2436939|NCT01138826|5977377|P4|STARTED|Washout Period II (of 16 Days)||3
2436940|NCT01138826|5977378|P3|STARTED|Washout Period II (of 16 Days)||3
2436941|NCT01138826|5977379|P2|STARTED|Washout Period II (of 16 Days)||2
2436942|NCT01138826|5977380|P1|STARTED|Washout Period II (of 16 Days)||2
2436943|NCT01138826|5977375|P6|NOT COMPLETED|Second Intervention Period||0
2436944|NCT01138826|5977376|P5|NOT COMPLETED|Second Intervention Period||0
2436945|NCT01138826|5977377|P4|NOT COMPLETED|Second Intervention Period||0
2436946|NCT01138826|5977378|P3|NOT COMPLETED|Second Intervention Period||0
2436947|NCT01138826|5977379|P2|NOT COMPLETED|Second Intervention Period||0
2436948|NCT01138826|5977380|P1|NOT COMPLETED|Second Intervention Period||0
2436949|NCT01138826|5977375|P6|COMPLETED|Second Intervention Period||3
2436950|NCT01138826|5977376|P5|COMPLETED|Second Intervention Period||2
2436951|NCT01138826|5977377|P4|COMPLETED|Second Intervention Period||3
2436952|NCT01138826|5977378|P3|COMPLETED|Second Intervention Period||3
2436953|NCT01138826|5977379|P2|COMPLETED|Second Intervention Period||2
2436954|NCT01138826|5977380|P1|COMPLETED|Second Intervention Period||2
2436955|NCT01138826|5977375|P6|STARTED|Second Intervention Period||3
2436956|NCT01138826|5977376|P5|STARTED|Second Intervention Period||2
2436957|NCT01138826|5977377|P4|STARTED|Second Intervention Period||3
2436958|NCT01138826|5977378|P3|STARTED|Second Intervention Period||3
2436959|NCT01138826|5977379|P2|STARTED|Second Intervention Period||2
2436960|NCT01138826|5977380|P1|STARTED|Second Intervention Period||2
2436961|NCT01138826|5977375|P6|NOT COMPLETED|Washout Period I (of 16 Days)||0
2436962|NCT01138826|5977376|P5|NOT COMPLETED|Washout Period I (of 16 Days)||1
2436963|NCT01138826|5977377|P4|NOT COMPLETED|Washout Period I (of 16 Days)||0
2436964|NCT01138826|5977378|P3|NOT COMPLETED|Washout Period I (of 16 Days)||0
2436965|NCT01138826|5977379|P2|NOT COMPLETED|Washout Period I (of 16 Days)||1
2436966|NCT01138826|5977380|P1|NOT COMPLETED|Washout Period I (of 16 Days)||1
2436967|NCT01138826|5977375|P6|COMPLETED|Washout Period I (of 16 Days)||3
2436968|NCT01138826|5977376|P5|COMPLETED|Washout Period I (of 16 Days)||2
2436969|NCT01138826|5977377|P4|COMPLETED|Washout Period I (of 16 Days)||3
2436970|NCT01138826|5977378|P3|COMPLETED|Washout Period I (of 16 Days)||3
2436971|NCT01138826|5977379|P2|COMPLETED|Washout Period I (of 16 Days)||2
2436972|NCT01138826|5977380|P1|COMPLETED|Washout Period I (of 16 Days)||2
2436973|NCT01138826|5977375|P6|STARTED|Washout Period I (of 16 Days)||3
2436974|NCT01138826|5977376|P5|STARTED|Washout Period I (of 16 Days)||3
2436975|NCT01138826|5977377|P4|STARTED|Washout Period I (of 16 Days)||3
2436976|NCT01138826|5977378|P3|STARTED|Washout Period I (of 16 Days)||3
2436977|NCT01138826|5977379|P2|STARTED|Washout Period I (of 16 Days)||3
2436978|NCT01138826|5977380|P1|STARTED|Washout Period I (of 16 Days)||3
2436979|NCT01138826|5977375|P6|NOT COMPLETED|First Intervention Period||0
2436980|NCT01138826|5977376|P5|NOT COMPLETED|First Intervention Period||0
2436981|NCT01138826|5977377|P4|NOT COMPLETED|First Intervention Period||0
2436982|NCT01138826|5977378|P3|NOT COMPLETED|First Intervention Period||0
2436983|NCT01138826|5977379|P2|NOT COMPLETED|First Intervention Period||0
2436984|NCT01138826|5977380|P1|NOT COMPLETED|First Intervention Period||0
2436985|NCT01138826|5977375|P6|COMPLETED|First Intervention Period||3
2436986|NCT01138826|5977376|P5|COMPLETED|First Intervention Period||3
2436987|NCT01138826|5977377|P4|COMPLETED|First Intervention Period||3
2436988|NCT01138826|5977378|P3|COMPLETED|First Intervention Period||3
2436989|NCT01138826|5977379|P2|COMPLETED|First Intervention Period||3
2436990|NCT01138826|5977380|P1|COMPLETED|First Intervention Period||3
2436991|NCT01138826|5977375|P6|STARTED|First Intervention Period||3
2436992|NCT01138826|5977376|P5|STARTED|First Intervention Period||3
2436993|NCT01138826|5977377|P4|STARTED|First Intervention Period||3
2436994|NCT01138826|5977378|P3|STARTED|First Intervention Period||3
2436995|NCT01138826|5977379|P2|STARTED|First Intervention Period||3
2436996|NCT01138826|5977380|P1|STARTED|First Intervention Period||3
2436997|NCT01138735|5977402|P2|NOT COMPLETED|Overall Study||17
2436998|NCT01138735|5977403|P1|NOT COMPLETED|Overall Study||8
2436999|NCT01138735|5977402|P2|COMPLETED|Overall Study||126
2437000|NCT01138735|5977403|P1|COMPLETED|Overall Study||134
2437001|NCT01138735|5977402|P2|STARTED|Overall Study||143
2437002|NCT01138735|5977403|P1|STARTED|Overall Study||142
2437003|NCT01138657|5977417|P2|NOT COMPLETED|Overall Study||18
2437004|NCT01138657|5977418|P1|NOT COMPLETED|Overall Study||8
2437005|NCT01138657|5977417|P2|COMPLETED|Overall Study||101
2437006|NCT01138657|5977418|P1|COMPLETED|Overall Study||112
2437007|NCT01138657|5977417|P2|Enrolled in Japan Sub-study|Overall Study||8
2437008|NCT01138657|5977418|P1|Enrolled in Japan Sub-study|Overall Study||8
2437009|NCT01138657|5977417|P2|Enrolled in Main Study|Overall Study||111
2437010|NCT01138657|5977418|P1|Enrolled in Main Study|Overall Study||112
2437011|NCT01138657|5977417|P2|STARTED|Overall Study||119
2437012|NCT01138657|5977418|P1|STARTED|Overall Study||120
2437013|NCT01138514|5977465|P3|NOT COMPLETED|Overall Study||93
2437014|NCT01138514|5977466|P2|NOT COMPLETED|Overall Study||53
2437015|NCT01138514|5977467|P1|NOT COMPLETED|Overall Study||48
2437016|NCT01138514|5977465|P3|COMPLETED|Overall Study||424
2437017|NCT01138514|5977466|P2|COMPLETED|Overall Study||463
2437018|NCT01138514|5977467|P1|COMPLETED|Overall Study||474
2437019|NCT01138514|5977465|P3|STARTED|Overall Study||517
2437020|NCT01138514|5977466|P2|STARTED|Overall Study||516
2437021|NCT01138514|5977467|P1|STARTED|Overall Study||522
2437022|NCT01138501|5977481|P1|NOT COMPLETED|Overall Study||5
2437023|NCT01138501|5977481|P1|COMPLETED|Overall Study||60
2437024|NCT01138501|5977481|P1|Exposed|Overall Study||63
2437025|NCT01138501|5977481|P1|STARTED|Overall Study|Two subjects withdrew consent after being enrolled but before receiving any trial product.|65
2437026|NCT01138475|5977489|P3|NOT COMPLETED|Overall Study||0
2437027|NCT01138475|5977490|P2|NOT COMPLETED|Overall Study||0
2437028|NCT01138475|5977491|P1|NOT COMPLETED|Overall Study||0
2437029|NCT01138475|5977489|P3|COMPLETED|Overall Study||17
2437030|NCT01138475|5977490|P2|COMPLETED|Overall Study||16
2437031|NCT01138475|5977491|P1|COMPLETED|Overall Study||16
2437032|NCT01138475|5977489|P3|STARTED|Overall Study||17
2437033|NCT01138475|5977490|P2|STARTED|Overall Study||16
2437034|NCT01138475|5977491|P1|STARTED|Overall Study||16
2437035|NCT01138150|5977525|P2|NOT COMPLETED|Overall Study||1
2437036|NCT01138150|5977526|P1|NOT COMPLETED|Overall Study||1
2437037|NCT01138150|5977525|P2|COMPLETED|Overall Study||17
2437038|NCT01138150|5977526|P1|COMPLETED|Overall Study||17
2437039|NCT01138150|5977525|P2|STARTED|Overall Study||18
2437040|NCT01138150|5977526|P1|STARTED|Overall Study||18
2437041|NCT01138124|5977582|P4|NOT COMPLETED|Overall Study||0
2437042|NCT01138124|5977583|P3|NOT COMPLETED|Overall Study||0
2437043|NCT01138124|5977584|P2|NOT COMPLETED|Overall Study||0
2437044|NCT01138124|5977585|P1|NOT COMPLETED|Overall Study||0
2437045|NCT01138124|5977582|P4|COMPLETED|Overall Study||19046
2437046|NCT01138124|5977583|P3|COMPLETED|Overall Study||1981
2437047|NCT01138124|5977584|P2|COMPLETED|Overall Study||30026
2437048|NCT01138124|5977585|P1|COMPLETED|Overall Study||3149
2437049|NCT01138124|5977582|P4|STARTED|Overall Study||19046
2437050|NCT01138124|5977583|P3|STARTED|Overall Study||1981
2437051|NCT01138124|5977584|P2|STARTED|Overall Study||30026
2437052|NCT01138124|5977585|P1|STARTED|Overall Study||3149
2437053|NCT01138111|5977607|P1|NOT COMPLETED|Overall Study||9
2437054|NCT01138111|5977607|P1|COMPLETED|Overall Study||36
2437055|NCT01138111|5977607|P1|STARTED|Overall Study||45
2437056|NCT01138098|5977638|P2|NOT COMPLETED|Overall Study||0
2437057|NCT01138098|5977639|P1|NOT COMPLETED|Overall Study||0
2437058|NCT01138098|5977638|P2|COMPLETED|Overall Study||90
2437059|NCT01138098|5977639|P1|COMPLETED|Overall Study||95
2437060|NCT01138098|5977638|P2|STARTED|Overall Study||90
2437061|NCT01138098|5977639|P1|STARTED|Overall Study||95
2437062|NCT01138046|5977661|P1|NOT COMPLETED|Overall Study||6
2437063|NCT01138046|5977661|P1|COMPLETED|Overall Study||6
2437064|NCT01138046|5977661|P1|STARTED|Overall Study||12
2437065|NCT01138007|5977681|P3|NOT COMPLETED|Overall Study||48
2437066|NCT01138007|5977682|P2|NOT COMPLETED|Overall Study||30
2437067|NCT01138007|5977683|P1|NOT COMPLETED|Overall Study||22
2437068|NCT01138007|5977681|P3|COMPLETED|Overall Study||144
2437069|NCT01138007|5977682|P2|COMPLETED|Overall Study||160
2437070|NCT01138007|5977683|P1|COMPLETED|Overall Study||165
2437071|NCT01138007|5977681|P3|STARTED|Overall Study||192
2437072|NCT01138007|5977682|P2|STARTED|Overall Study||190
2437073|NCT01138007|5977683|P1|STARTED|Overall Study||187
2437074|NCT01137890|5977717|P2|NOT COMPLETED|Overall Study||3
2437075|NCT01137890|5977718|P1|NOT COMPLETED|Overall Study||6
2437076|NCT01137890|5977717|P2|COMPLETED|Overall Study||2
2437077|NCT01137890|5977718|P1|COMPLETED|Overall Study||8
2437078|NCT01137890|5977717|P2|STARTED|Overall Study||5
2437079|NCT01137890|5977718|P1|STARTED|Overall Study||14
2437080|NCT01137812|5977790|P2|NOT COMPLETED|Overall Study||168
2437081|NCT01137812|5977791|P1|NOT COMPLETED|Overall Study||123
2437082|NCT01137812|5977790|P2|COMPLETED|Overall Study||210
2437083|NCT01137812|5977791|P1|COMPLETED|Overall Study||254
2437084|NCT01137812|5977790|P2|STARTED|Overall Study||378
2437085|NCT01137812|5977791|P1|STARTED|Overall Study||377
2437086|NCT01137786|5977811|P2|NOT COMPLETED|Overall Study||3
2437087|NCT01137786|5977812|P1|NOT COMPLETED|Overall Study||1
2437088|NCT01137786|5977811|P2|COMPLETED|Overall Study||21
2437089|NCT01137786|5977812|P1|COMPLETED|Overall Study||24
2437090|NCT01137786|5977811|P2|STARTED|Overall Study||24
2437091|NCT01137786|5977812|P1|STARTED|Overall Study||25
2437092|NCT01137773|5977822|P2|NOT COMPLETED|Overall Study||3
2437093|NCT01137773|5977823|P1|NOT COMPLETED|Overall Study||9
2437094|NCT01137773|5977822|P2|COMPLETED|Overall Study||20
2437095|NCT01137773|5977823|P1|COMPLETED|Overall Study||24
2437096|NCT01137773|5977822|P2|STARTED|Overall Study||23
2437097|NCT01137773|5977823|P1|STARTED|Overall Study||33
2437098|NCT01137682|5977834|P3|NOT COMPLETED|Overall Study||34
2437099|NCT01137682|5977835|P2|NOT COMPLETED|Overall Study||40
2437100|NCT01137682|5977836|P1|NOT COMPLETED|Overall Study||37
2437101|NCT01137682|5977834|P3|COMPLETED|Overall Study||34
2437102|NCT01137682|5977835|P2|COMPLETED|Overall Study||25
2437103|NCT01137682|5977836|P1|COMPLETED|Overall Study||28
2437104|NCT01137682|5977834|P3|Safety Set - Extension|Overall Study|1 patient did not receive study treatment|62
2437105|NCT01137682|5977835|P2|Safety Set - Extension|Overall Study||54
2437106|NCT01137682|5977836|P1|Safety Set - Extension|Overall Study||57
2437107|NCT01137682|5977834|P3|Safety Set - CORE|Overall Study|2 patients never received drug.|66
2437108|NCT01137682|5977835|P2|Safety Set - CORE|Overall Study|2 patients never received drug. 1 patient had no post baseline safety assement.|62
2437109|NCT01137682|5977836|P1|Safety Set - CORE|Overall Study|2 patients never received drug.|63
2437110|NCT01137682|5977834|P3|Continuing Into Extension|Overall Study||63
2437111|NCT01137682|5977835|P2|Continuing Into Extension|Overall Study||54
2437112|NCT01137682|5977836|P1|Continuing Into Extension|Overall Study||57
2437113|NCT01137682|5977834|P3|Not Continuing Into Extension|Overall Study||2
2437114|NCT01137682|5977835|P2|Not Continuing Into Extension|Overall Study||3
2437115|NCT01137682|5977836|P1|Not Continuing Into Extension|Overall Study||2
2437116|NCT01137682|5977834|P3|Completed 24-Week Core Phase|Overall Study||65
2437117|NCT01137682|5977835|P2|Completed 24-Week Core Phase|Overall Study||57
2437118|NCT01137682|5977836|P1|Completed 24-Week Core Phase|Overall Study||59
2437119|NCT01137682|5977834|P3|Treated|Overall Study||67
2437120|NCT01137682|5977835|P2|Treated|Overall Study||63
2437121|NCT01137682|5977836|P1|Treated|Overall Study||63
2437122|NCT01137682|5977834|P3|Not Treated|Overall Study||1
2437123|NCT01137682|5977835|P2|Not Treated|Overall Study||2
2437124|NCT01137682|5977836|P1|Not Treated|Overall Study||2
2437125|NCT01137682|5977834|P3|STARTED|Overall Study||68
2437126|NCT01137682|5977835|P2|STARTED|Overall Study||65
2437127|NCT01137682|5977836|P1|STARTED|Overall Study||65
2437128|NCT01137604|5977886|P4|NOT COMPLETED|Overall Study||11
2437129|NCT01137604|5977887|P3|NOT COMPLETED|Overall Study||13
2437130|NCT01137604|5977888|P2|NOT COMPLETED|Overall Study||10
2437131|NCT01137604|5977889|P1|NOT COMPLETED|Overall Study||2
2437132|NCT01137604|5977886|P4|COMPLETED|Overall Study||21
2437133|NCT01137604|5977887|P3|COMPLETED|Overall Study||26
2437134|NCT01137604|5977888|P2|COMPLETED|Overall Study||32
2437135|NCT01137604|5977889|P1|COMPLETED|Overall Study|Participants with disease progression and treatment ongoing at data cutoff (19 Mar 2013)|36
2437136|NCT01137604|5977886|P4|Treatment Ongoing at Data Cutoff|Overall Study||0
2437137|NCT01137604|5977887|P3|Treatment Ongoing at Data Cutoff|Overall Study||1
2437138|NCT01137604|5977888|P2|Treatment Ongoing at Data Cutoff|Overall Study||3
2437139|NCT01137604|5977889|P1|Treatment Ongoing at Data Cutoff|Overall Study||2
2437140|NCT01137604|5977886|P4|Disease Progression|Overall Study||21
2437141|NCT01137604|5977887|P3|Disease Progression|Overall Study||25
2437142|NCT01137604|5977888|P2|Disease Progression|Overall Study||29
2437143|NCT01137604|5977889|P1|Disease Progression|Overall Study||34
2437144|NCT01137604|5977886|P4|STARTED|Overall Study||32
2437145|NCT01137604|5977887|P3|STARTED|Overall Study||39
2437146|NCT01137604|5977888|P2|STARTED|Overall Study||42
2437147|NCT01137604|5977889|P1|STARTED|Overall Study|39 participants were randomized but 1 participant died prior to receiving treatment.|38
2437148|NCT01137578|5977923|P3|NOT COMPLETED|Overall Study||6
2437149|NCT01137578|5977924|P2|NOT COMPLETED|Overall Study||2
2437150|NCT01137578|5977925|P1|NOT COMPLETED|Overall Study||16
2437151|NCT01137578|5977923|P3|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|37
2437152|NCT01137578|5977924|P2|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|12
2437153|NCT01137578|5977925|P1|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|61
2437154|NCT01137578|5977923|P3|STARTED|Overall Study||43
2437155|NCT01137578|5977924|P2|STARTED|Overall Study||14
2437156|NCT01137578|5977925|P1|STARTED|Overall Study||77
2437157|NCT01137539|5977965|P1|NOT COMPLETED|Overall Study||0
2437158|NCT01137539|5977965|P1|COMPLETED|Overall Study||50
2437159|NCT01137539|5977965|P1|STARTED|Overall Study||50
2437160|NCT01137474|5977974|P4|NOT COMPLETED|Overall Study||21
2437161|NCT01137474|5977975|P3|NOT COMPLETED|Overall Study||7
2437162|NCT01137474|5977976|P2|NOT COMPLETED|Overall Study||12
2437163|NCT01137474|5977977|P1|NOT COMPLETED|Overall Study||24
2437164|NCT01137474|5977974|P4|COMPLETED|Overall Study||281
2437165|NCT01137474|5977975|P3|COMPLETED|Overall Study||158
2437166|NCT01137474|5977976|P2|COMPLETED|Overall Study||154
2437167|NCT01137474|5977977|P1|COMPLETED|Overall Study||287
2437168|NCT01137474|5977974|P4|Received Treatment|Overall Study||302
2437169|NCT01137474|5977975|P3|Received Treatment|Overall Study||165
2437170|NCT01137474|5977976|P2|Received Treatment|Overall Study||166
2437171|NCT01137474|5977977|P1|Received Treatment|Overall Study||311
2437172|NCT01137474|5977974|P4|STARTED|Overall Study||302
2437173|NCT01137474|5977975|P3|STARTED|Overall Study||165
2437174|NCT01137474|5977976|P2|STARTED|Overall Study||166
2437175|NCT01137474|5977977|P1|STARTED|Overall Study||311
2437176|NCT01137435|5977995|P1|NOT COMPLETED|Overall Study||28
2437177|NCT01137435|5977995|P1|COMPLETED|Overall Study||659
2437178|NCT01137435|5977995|P1|STARTED|Overall Study||687
2437179|NCT01137396|5978004|P2|NOT COMPLETED|Overall Study||2
2437180|NCT01137396|5978005|P1|NOT COMPLETED|Overall Study||8
2437181|NCT01137396|5978004|P2|COMPLETED|Overall Study||25
2437182|NCT01137396|5978005|P1|COMPLETED|Overall Study||22
2437183|NCT01137396|5978004|P2|STARTED|Overall Study||27
2437184|NCT01137396|5978005|P1|STARTED|Overall Study||30
2437185|NCT01137370|5978015|P2|NOT COMPLETED|Overall Study||0
2437186|NCT01137370|5978016|P1|NOT COMPLETED|Overall Study||0
2437187|NCT01137370|5978015|P2|COMPLETED|Overall Study||87
2437188|NCT01137370|5978016|P1|COMPLETED|Overall Study||116
2437189|NCT01137370|5978015|P2|STARTED|Overall Study||87
2437190|NCT01137370|5978016|P1|STARTED|Overall Study||116
2437191|NCT01137292|5978022|P1|NOT COMPLETED|Overall Study||54
2437192|NCT01137292|5978022|P1|COMPLETED|Overall Study||123
2437193|NCT01137292|5978022|P1|STARTED|Overall Study||177
2437194|NCT01137110|5978031|P2|NOT COMPLETED|Overall Study||0
2437195|NCT01137110|5978032|P1|NOT COMPLETED|Overall Study||1
2437196|NCT01137110|5978031|P2|COMPLETED|Overall Study||49
2437197|NCT01137110|5978032|P1|COMPLETED|Overall Study||34
2437198|NCT01137110|5978031|P2|STARTED|Overall Study||49
2437199|NCT01137110|5978032|P1|STARTED|Overall Study||35
2437200|NCT01137071|5978038|P1|NOT COMPLETED|Overall Study||14
2437201|NCT01137071|5978038|P1|COMPLETED|Overall Study|Of the eligible patients|15
2437202|NCT01137071|5978038|P1|STARTED|Overall Study|all patients considered eligible were included on the study|29
2437203|NCT01137032|5978099|P1|NOT COMPLETED|Overall Study||0
2437204|NCT01137032|5978099|P1|COMPLETED|Overall Study||19
2437205|NCT01137032|5978099|P1|STARTED|Overall Study||19
2437206|NCT01137006|5978112|P7|NOT COMPLETED|Overall Study||0
2437207|NCT01137006|5978113|P6|NOT COMPLETED|Overall Study||0
2437208|NCT01137006|5978114|P5|NOT COMPLETED|Overall Study||0
2437209|NCT01137006|5978115|P4|NOT COMPLETED|Overall Study||0
2437210|NCT01137006|5978116|P3|NOT COMPLETED|Overall Study||0
2437211|NCT01137006|5978117|P2|NOT COMPLETED|Overall Study||0
2437212|NCT01137006|5978118|P1|NOT COMPLETED|Overall Study||0
2437213|NCT01137006|5978112|P7|COMPLETED|Overall Study||3
2437214|NCT01137006|5978113|P6|COMPLETED|Overall Study||4
2437215|NCT01137006|5978114|P5|COMPLETED|Overall Study||3
2437216|NCT01137006|5978115|P4|COMPLETED|Overall Study||3
2437217|NCT01137006|5978116|P3|COMPLETED|Overall Study||8
2437218|NCT01137006|5978117|P2|COMPLETED|Overall Study||3
2437219|NCT01137006|5978118|P1|COMPLETED|Overall Study||3
2437220|NCT01137006|5978112|P7|Completed at Least 1 Treatment Cycle|Overall Study||3
2437221|NCT01137006|5978113|P6|Completed at Least 1 Treatment Cycle|Overall Study||4
2437222|NCT01137006|5978114|P5|Completed at Least 1 Treatment Cycle|Overall Study||3
2437223|NCT01137006|5978115|P4|Completed at Least 1 Treatment Cycle|Overall Study||3
2437224|NCT01137006|5978116|P3|Completed at Least 1 Treatment Cycle|Overall Study||8
2437225|NCT01137006|5978117|P2|Completed at Least 1 Treatment Cycle|Overall Study||3
2437226|NCT01137006|5978118|P1|Completed at Least 1 Treatment Cycle|Overall Study||3
2437227|NCT01137006|5978112|P7|STARTED|Overall Study||3
2437228|NCT01137006|5978113|P6|STARTED|Overall Study||4
2437229|NCT01137006|5978114|P5|STARTED|Overall Study||3
2437230|NCT01137006|5978115|P4|STARTED|Overall Study||3
2437231|NCT01137006|5978116|P3|STARTED|Overall Study||8
2437232|NCT01137006|5978117|P2|STARTED|Overall Study||3
2437233|NCT01137006|5978118|P1|STARTED|Overall Study||3
2437234|NCT01136967|5978194|P2|NOT COMPLETED|Overall Study||27
2437235|NCT01136967|5978195|P1|NOT COMPLETED|Overall Study||24
2437236|NCT01136967|5978194|P2|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (15 April 2013)|62
2437414|NCT01136174|5978609|P3|NOT COMPLETED|Overall Study||0
2437237|NCT01136967|5978195|P1|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (18 January 2012)|69
2437238|NCT01136967|5978194|P2|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (15 April 2013)|6
2437239|NCT01136967|5978195|P1|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (18 January 2012)|14
2437240|NCT01136967|5978194|P2|Disease Progression|Overall Study||56
2437241|NCT01136967|5978195|P1|Disease Progression|Overall Study||55
2437242|NCT01136967|5978194|P2|STARTED|Overall Study||89
2437243|NCT01136967|5978195|P1|STARTED|Overall Study||93
2437244|NCT01136954|5978217|P2|NOT COMPLETED|Overall Study||21
2437245|NCT01136954|5978218|P1|NOT COMPLETED|Overall Study||24
2437246|NCT01136954|5978217|P2|COMPLETED|Overall Study||51
2437247|NCT01136954|5978218|P1|COMPLETED|Overall Study||48
2437248|NCT01136954|5978217|P2|STARTED|Overall Study||72
2437249|NCT01136954|5978218|P1|STARTED|Overall Study||72
2437250|NCT01136915|5978232|P2|NOT COMPLETED|Overall Study||1
2437251|NCT01136915|5978233|P1|NOT COMPLETED|Overall Study||2
2437252|NCT01136915|5978232|P2|COMPLETED|Overall Study||6
2437253|NCT01136915|5978233|P1|COMPLETED|Overall Study||6
2437254|NCT01136915|5978232|P2|STARTED|Overall Study||7
2437255|NCT01136915|5978233|P1|STARTED|Overall Study||8
2437256|NCT01136876|5978243|P2|NOT COMPLETED|Overall Study||6
2437257|NCT01136876|5978244|P1|NOT COMPLETED|Overall Study||3
2437258|NCT01136876|5978243|P2|COMPLETED|Overall Study||23
2437259|NCT01136876|5978244|P1|COMPLETED|Overall Study||25
2437260|NCT01136876|5978243|P2|STARTED|Overall Study||29
2437261|NCT01136876|5978244|P1|STARTED|Overall Study||28
2437262|NCT01136798|5978254|P2|NOT COMPLETED|Overall Study||0
2437263|NCT01136798|5978255|P1|NOT COMPLETED|Overall Study||0
2437264|NCT01136798|5978254|P2|COMPLETED|Overall Study||8
2437265|NCT01136798|5978255|P1|COMPLETED|Overall Study||10
2437266|NCT01136798|5978254|P2|STARTED|Overall Study||8
2437267|NCT01136798|5978255|P1|STARTED|Overall Study||10
2437268|NCT01136785|5978273|P2|NOT COMPLETED|Overall Study||1
2437269|NCT01136785|5978274|P1|NOT COMPLETED|Overall Study||2
2437270|NCT01136785|5978273|P2|COMPLETED|Overall Study||6
2437271|NCT01136785|5978274|P1|COMPLETED|Overall Study||13
2437272|NCT01136785|5978273|P2|STARTED|Overall Study||7
2437273|NCT01136785|5978274|P1|STARTED|Overall Study||15
2437274|NCT01136772|5978289|P2|NOT COMPLETED|Overall Study||110
2437275|NCT01136772|5978290|P1|NOT COMPLETED|Overall Study||116
2437276|NCT01136772|5978289|P2|COMPLETED|Overall Study||44
2437277|NCT01136772|5978290|P1|COMPLETED|Overall Study||41
2437278|NCT01136772|5978289|P2|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
2437279|NCT01136772|5978290|P1|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
2437280|NCT01136772|5978289|P2|STARTED|Overall Study||154
2437281|NCT01136772|5978290|P1|STARTED|Overall Study||157
2437282|NCT01136746|5978300|P2|NOT COMPLETED|Overall Study||3
2437283|NCT01136746|5978301|P1|NOT COMPLETED|Overall Study||3
2437284|NCT01136746|5978300|P2|COMPLETED|Overall Study||4
2437285|NCT01136746|5978301|P1|COMPLETED|Overall Study||6
2437286|NCT01136746|5978300|P2|STARTED|Overall Study||7
2437287|NCT01136746|5978301|P1|STARTED|Overall Study||9
2437288|NCT01136733|5978368|P7|NOT COMPLETED|Phase 2||50
2437289|NCT01136733|5978369|P6|NOT COMPLETED|Phase 2||52
2437290|NCT01136733|5978370|P5|NOT COMPLETED|Phase 2||51
2437291|NCT01136733|5978371|P4|NOT COMPLETED|Phase 2||0
2437292|NCT01136733|5978372|P3|NOT COMPLETED|Phase 2||0
2437293|NCT01136733|5978373|P2|NOT COMPLETED|Phase 2||0
2437294|NCT01136733|5978374|P1|NOT COMPLETED|Phase 2||0
2437295|NCT01136733|5978368|P7|COMPLETED|Phase 2||0
2437296|NCT01136733|5978369|P6|COMPLETED|Phase 2||0
2437297|NCT01136733|5978370|P5|COMPLETED|Phase 2||0
2437298|NCT01136733|5978371|P4|COMPLETED|Phase 2||0
2437299|NCT01136733|5978372|P3|COMPLETED|Phase 2||0
2437300|NCT01136733|5978373|P2|COMPLETED|Phase 2||0
2437301|NCT01136733|5978374|P1|COMPLETED|Phase 2||0
2437302|NCT01136733|5978368|P7|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|50
2437303|NCT01136733|5978369|P6|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|52
2437304|NCT01136733|5978370|P5|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|51
2437305|NCT01136733|5978371|P4|STARTED|Phase 2||0
2437306|NCT01136733|5978372|P3|STARTED|Phase 2||0
2437307|NCT01136733|5978373|P2|STARTED|Phase 2||0
2437308|NCT01136733|5978374|P1|STARTED|Phase 2||0
2437309|NCT01136733|5978368|P7|NOT COMPLETED|Phase 1b||0
2437310|NCT01136733|5978369|P6|NOT COMPLETED|Phase 1b||0
2437311|NCT01136733|5978370|P5|NOT COMPLETED|Phase 1b||0
2437312|NCT01136733|5978371|P4|NOT COMPLETED|Phase 1b||0
2437313|NCT01136733|5978372|P3|NOT COMPLETED|Phase 1b||2
2437314|NCT01136733|5978373|P2|NOT COMPLETED|Phase 1b||5
2437315|NCT01136733|5978374|P1|NOT COMPLETED|Phase 1b||1
2437316|NCT01136733|5978368|P7|COMPLETED|Phase 1b||0
2437317|NCT01136733|5978369|P6|COMPLETED|Phase 1b||0
2437318|NCT01136733|5978370|P5|COMPLETED|Phase 1b||0
2437319|NCT01136733|5978371|P4|COMPLETED|Phase 1b||0
2437320|NCT01136733|5978372|P3|COMPLETED|Phase 1b||0
2437321|NCT01136733|5978373|P2|COMPLETED|Phase 1b||6
2437322|NCT01136733|5978374|P1|COMPLETED|Phase 1b||6
2437323|NCT01136733|5978368|P7|STARTED|Phase 1b||0
2437324|NCT01136733|5978369|P6|STARTED|Phase 1b||0
2437325|NCT01136733|5978370|P5|STARTED|Phase 1b||0
2437326|NCT01136733|5978371|P4|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|0
2437415|NCT01136174|5978610|P2|NOT COMPLETED|Overall Study||0
2437327|NCT01136733|5978372|P3|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|2
2437328|NCT01136733|5978373|P2|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|11
2437329|NCT01136733|5978374|P1|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|7
2437330|NCT01136655|5978457|P1|NOT COMPLETED|Washout After BUD 160/ Foradil (7 Days)||0
2437331|NCT01136655|5978457|P1|COMPLETED|Washout After BUD 160/ Foradil (7 Days)||50
2437332|NCT01136655|5978457|P1|STARTED|Washout After BUD 160/ Foradil (7 Days)||50
2437333|NCT01136655|5978457|P1|NOT COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||0
2437334|NCT01136655|5978457|P1|COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||50
2437335|NCT01136655|5978457|P1|STARTED|BUD 160/ Foradil 12.0 (1 Dose)||50
2437336|NCT01136655|5978457|P1|NOT COMPLETED|Washout After BUD 160 (7 Days)||0
2437337|NCT01136655|5978457|P1|COMPLETED|Washout After BUD 160 (7 Days)||51
2437338|NCT01136655|5978457|P1|STARTED|Washout After BUD 160 (7 Days)||51
2437339|NCT01136655|5978457|P1|NOT COMPLETED|BUD 160 (1 Dose)||0
2437340|NCT01136655|5978457|P1|COMPLETED|BUD 160 (1 Dose)||51
2437341|NCT01136655|5978457|P1|STARTED|BUD 160 (1 Dose)||51
2437342|NCT01136655|5978457|P1|NOT COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||2
2437343|NCT01136655|5978457|P1|COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||51
2437344|NCT01136655|5978457|P1|STARTED|Washout After BUD 160/FM 9.0 (7 Days)||53
2437345|NCT01136655|5978457|P1|NOT COMPLETED|BUD 160/FM 9.0 (1 Dose)||0
2437346|NCT01136655|5978457|P1|COMPLETED|BUD 160/FM 9.0 (1 Dose)||53
2437347|NCT01136655|5978457|P1|STARTED|BUD 160/FM 9.0 (1 Dose)||53
2437348|NCT01136655|5978457|P1|NOT COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||1
2437349|NCT01136655|5978457|P1|COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||52
2437350|NCT01136655|5978457|P1|STARTED|Washout After BUD 160/FM 4.5 (7 Days)||53
2437351|NCT01136655|5978457|P1|NOT COMPLETED|BUD 160/FM 4.5 (1 Dose)||0
2437352|NCT01136655|5978457|P1|COMPLETED|BUD 160/FM 4.5 (1 Dose)||53
2437353|NCT01136655|5978457|P1|STARTED|BUD 160/FM 4.5 (1 Dose)||53
2437354|NCT01136655|5978457|P1|NOT COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||1
2437355|NCT01136655|5978457|P1|COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||53
2437356|NCT01136655|5978457|P1|STARTED|Washout After BUD 160/FM 2.25 (7 Days)||54
2437357|NCT01136655|5978457|P1|NOT COMPLETED|BUD 160/FM 2.25 (1 Dose)||0
2437358|NCT01136655|5978457|P1|COMPLETED|BUD 160/FM 2.25 (1 Dose)||54
2437359|NCT01136655|5978457|P1|STARTED|BUD 160/FM 2.25 (1 Dose)||54
2437360|NCT01136486|5978483|P1|NOT COMPLETED|Overall Study||0
2437361|NCT01136486|5978483|P1|COMPLETED|Overall Study||56
2437362|NCT01136486|5978483|P1|STARTED|Overall Study||56
2437363|NCT01136408|5978490|P3|NOT COMPLETED|Overall Study||5
2437364|NCT01136408|5978491|P2|NOT COMPLETED|Overall Study||9
2437365|NCT01136408|5978492|P1|NOT COMPLETED|Overall Study||5
2437366|NCT01136408|5978490|P3|COMPLETED|Overall Study||57
2437367|NCT01136408|5978491|P2|COMPLETED|Overall Study||49
2437368|NCT01136408|5978492|P1|COMPLETED|Overall Study||41
2437369|NCT01136408|5978490|P3|STARTED|Overall Study||62
2437370|NCT01136408|5978491|P2|STARTED|Overall Study||58
2437371|NCT01136408|5978492|P1|STARTED|Overall Study||46
2437372|NCT01136382|5978549|P2|NOT COMPLETED|Overall Study||31
2437373|NCT01136382|5978550|P1|NOT COMPLETED|Overall Study||60
2437374|NCT01136382|5978549|P2|COMPLETED|Overall Study||121
2437375|NCT01136382|5978550|P1|COMPLETED|Overall Study||92
2437376|NCT01136382|5978549|P2|STARTED|Overall Study||152
2437377|NCT01136382|5978550|P1|STARTED|Overall Study||152
2437378|NCT01136356|5978576|P2|NOT COMPLETED|Second 18-day Withdrawal||1
2437379|NCT01136356|5978577|P1|NOT COMPLETED|Second 18-day Withdrawal||0
2437380|NCT01136356|5978576|P2|COMPLETED|Second 18-day Withdrawal||5
2437381|NCT01136356|5978577|P1|COMPLETED|Second 18-day Withdrawal||2
2437382|NCT01136356|5978576|P2|STARTED|Second 18-day Withdrawal||6
2437383|NCT01136356|5978577|P1|STARTED|Second 18-day Withdrawal||2
2437384|NCT01136356|5978576|P2|NOT COMPLETED|Second Intervention||0
2437385|NCT01136356|5978577|P1|NOT COMPLETED|Second Intervention||0
2437386|NCT01136356|5978576|P2|COMPLETED|Second Intervention||6
2437387|NCT01136356|5978577|P1|COMPLETED|Second Intervention||2
2437388|NCT01136356|5978576|P2|STARTED|Second Intervention||6
2437389|NCT01136356|5978577|P1|STARTED|Second Intervention||2
2437390|NCT01136356|5978576|P2|NOT COMPLETED|First 18-day Withdrawal||0
2437391|NCT01136356|5978577|P1|NOT COMPLETED|First 18-day Withdrawal||4
2437392|NCT01136356|5978576|P2|COMPLETED|First 18-day Withdrawal||6
2437393|NCT01136356|5978577|P1|COMPLETED|First 18-day Withdrawal||2
2437394|NCT01136356|5978576|P2|STARTED|First 18-day Withdrawal||6
2437395|NCT01136356|5978577|P1|STARTED|First 18-day Withdrawal||6
2437396|NCT01136356|5978576|P2|NOT COMPLETED|First Intervention||0
2437397|NCT01136356|5978577|P1|NOT COMPLETED|First Intervention||0
2437398|NCT01136356|5978576|P2|COMPLETED|First Intervention||6
2437399|NCT01136356|5978577|P1|COMPLETED|First Intervention||6
2437400|NCT01136356|5978576|P2|STARTED|First Intervention||6
2437401|NCT01136356|5978577|P1|STARTED|First Intervention||6
2437402|NCT01136291|5978588|P2|NOT COMPLETED|Overall Study||1
2437403|NCT01136291|5978589|P1|NOT COMPLETED|Overall Study||1
2437404|NCT01136291|5978588|P2|COMPLETED|Overall Study||41
2437405|NCT01136291|5978589|P1|COMPLETED|Overall Study||39
2437406|NCT01136291|5978588|P2|Follow|Overall Study||42
2437407|NCT01136291|5978589|P1|Follow|Overall Study||40
2437408|NCT01136291|5978588|P2|STARTED|Overall Study||42
2437409|NCT01136291|5978589|P1|STARTED|Overall Study||40
2437410|NCT01136226|5978599|P1|NOT COMPLETED|Overall Study||13
2437411|NCT01136226|5978599|P1|COMPLETED|Overall Study||29
2437412|NCT01136226|5978599|P1|STARTED|Overall Study||42
2437413|NCT01136174|5978608|P4|NOT COMPLETED|Overall Study||4
2437416|NCT01136174|5978611|P1|NOT COMPLETED|Overall Study||0
2437417|NCT01136174|5978608|P4|COMPLETED|Overall Study||20
2437418|NCT01136174|5978609|P3|COMPLETED|Overall Study||8
2437419|NCT01136174|5978610|P2|COMPLETED|Overall Study||6
2437420|NCT01136174|5978611|P1|COMPLETED|Overall Study||12
2437421|NCT01136174|5978608|P4|STARTED|Overall Study||24
2437422|NCT01136174|5978609|P3|STARTED|Overall Study||8
2437423|NCT01136174|5978610|P2|STARTED|Overall Study||6
2437424|NCT01136174|5978611|P1|STARTED|Overall Study||12
2437425|NCT01135992|5978691|P1|NOT COMPLETED|Overall Study||21
2437426|NCT01135992|5978691|P1|COMPLETED|Overall Study||122
2437427|NCT01135992|5978691|P1|Full Analysis Set|Overall Study||129
2437428|NCT01135992|5978691|P1|Exposed|Overall Study|One subject was withdrawn before being exposed.|142
2437429|NCT01135992|5978691|P1|STARTED|Overall Study||143
2437430|NCT01135914|5978703|P3|NOT COMPLETED|Overall Study||22
2437431|NCT01135914|5978704|P2|NOT COMPLETED|Overall Study||5
2437432|NCT01135914|5978705|P1|NOT COMPLETED|Overall Study||4
2437433|NCT01135914|5978703|P3|COMPLETED|Overall Study||59
2437434|NCT01135914|5978704|P2|COMPLETED|Overall Study||75
2437435|NCT01135914|5978705|P1|COMPLETED|Overall Study||74
2437436|NCT01135914|5978703|P3|Safety Population|Overall Study||74
2437437|NCT01135914|5978704|P2|Safety Population|Overall Study||75
2437438|NCT01135914|5978705|P1|Safety Population|Overall Study||73
2437439|NCT01135914|5978703|P3|Intent to Treat (ITT) Population|Overall Study||72
2437440|NCT01135914|5978704|P2|Intent to Treat (ITT) Population|Overall Study||75
2437441|NCT01135914|5978705|P1|Intent to Treat (ITT) Population|Overall Study||73
2437442|NCT01135914|5978703|P3|STARTED|Overall Study||81
2437443|NCT01135914|5978704|P2|STARTED|Overall Study||80
2437444|NCT01135914|5978705|P1|STARTED|Overall Study||78
2437445|NCT01135537|5978734|P1|NOT COMPLETED|Overall Study||13
2437446|NCT01135537|5978734|P1|COMPLETED|Overall Study||17
2437447|NCT01135537|5978734|P1|STARTED|Overall Study||30
2437448|NCT01135524|5978738|P1|NOT COMPLETED|Overall Study||196
2437449|NCT01135524|5978738|P1|COMPLETED|Overall Study||0
2437450|NCT01135524|5978738|P1|STARTED|Overall Study||196
2437451|NCT01135511|5978751|P9|NOT COMPLETED|Overall Study||1
2437452|NCT01135511|5978752|P8|NOT COMPLETED|Overall Study||1
2437453|NCT01135511|5978753|P7|NOT COMPLETED|Overall Study||1
2437454|NCT01135511|5978754|P6|NOT COMPLETED|Overall Study||1
2437455|NCT01135511|5978755|P5|NOT COMPLETED|Overall Study||1
2437456|NCT01135511|5978756|P4|NOT COMPLETED|Overall Study||3
2437457|NCT01135511|5978757|P3|NOT COMPLETED|Overall Study||8
2437458|NCT01135511|5978758|P2|NOT COMPLETED|Overall Study||3
2437459|NCT01135511|5978759|P1|NOT COMPLETED|Overall Study||0
2437460|NCT01135511|5978751|P9|COMPLETED|Overall Study||20
2437461|NCT01135511|5978752|P8|COMPLETED|Overall Study||20
2437462|NCT01135511|5978753|P7|COMPLETED|Overall Study||18
2437463|NCT01135511|5978754|P6|COMPLETED|Overall Study||20
2437464|NCT01135511|5978755|P5|COMPLETED|Overall Study||38
2437465|NCT01135511|5978756|P4|COMPLETED|Overall Study||37
2437466|NCT01135511|5978757|P3|COMPLETED|Overall Study||33
2437467|NCT01135511|5978758|P2|COMPLETED|Overall Study||39
2437468|NCT01135511|5978759|P1|COMPLETED|Overall Study||41
2437469|NCT01135511|5978751|P9|STARTED|Overall Study||21
2437470|NCT01135511|5978752|P8|STARTED|Overall Study||21
2437471|NCT01135511|5978753|P7|STARTED|Overall Study||19
2437472|NCT01135511|5978754|P6|STARTED|Overall Study||21
2437473|NCT01135511|5978755|P5|STARTED|Overall Study||39
2437474|NCT01135511|5978756|P4|STARTED|Overall Study||40
2437475|NCT01135511|5978757|P3|STARTED|Overall Study||41
2437476|NCT01135511|5978758|P2|STARTED|Overall Study||42
2437477|NCT01135511|5978759|P1|STARTED|Overall Study||41
2437478|NCT01135498|5979041|P1|NOT COMPLETED|Overall Study||90
2437479|NCT01135498|5979041|P1|COMPLETED|Overall Study||0
2437480|NCT01135498|5979041|P1|STARTED|Overall Study||90
2437481|NCT01135420|5979052|P2|NOT COMPLETED|Overall Study||32
2437482|NCT01135420|5979053|P1|NOT COMPLETED|Overall Study||44
2437483|NCT01135420|5979052|P2|COMPLETED|Overall Study||175
2437484|NCT01135420|5979053|P1|COMPLETED|Overall Study||155
2437485|NCT01135420|5979052|P2|STARTED|Overall Study||207
2437486|NCT01135420|5979053|P1|STARTED|Overall Study||199
2437487|NCT01135381|5979063|P4|NOT COMPLETED|Overall Study||1
2437488|NCT01135381|5979064|P3|NOT COMPLETED|Overall Study||4
2437489|NCT01135381|5979065|P2|NOT COMPLETED|Overall Study||7
2437490|NCT01135381|5979066|P1|NOT COMPLETED|Overall Study||21
2437491|NCT01135381|5979063|P4|COMPLETED|Overall Study||67
2437492|NCT01135381|5979064|P3|COMPLETED|Overall Study||65
2437493|NCT01135381|5979065|P2|COMPLETED|Overall Study||178
2437494|NCT01135381|5979066|P1|COMPLETED|Overall Study||168
2437495|NCT01135381|5979063|P4|STARTED|Overall Study||68
2437496|NCT01135381|5979064|P3|STARTED|Overall Study||69
2437497|NCT01135381|5979065|P2|STARTED|Overall Study||185
2437498|NCT01135381|5979066|P1|STARTED|Overall Study||189
2437499|NCT01135368|5979084|P1|NOT COMPLETED|Overall Study||251
2437500|NCT01135368|5979084|P1|COMPLETED|Overall Study||255
2437501|NCT01135368|5979084|P1|STARTED|Overall Study||506
2437502|NCT01135329|5979200|P1|NOT COMPLETED|Overall Study||0
2437503|NCT01135329|5979200|P1|COMPLETED|Overall Study||15
2437504|NCT01135329|5979200|P1|STARTED|Overall Study||15
2437505|NCT01135186|5979211|P1|NOT COMPLETED|Overall Study||0
2437506|NCT01135186|5979211|P1|COMPLETED|Overall Study||9
2437507|NCT01135186|5979211|P1|STARTED|Overall Study||9
2437508|NCT01135134|5979220|P2|NOT COMPLETED|Overall Study||1
2437509|NCT01135134|5979221|P1|NOT COMPLETED|Overall Study||2
2437510|NCT01135134|5979220|P2|COMPLETED|Overall Study||112
2437511|NCT01135134|5979221|P1|COMPLETED|Overall Study||218
2437512|NCT01135134|5979220|P2|STARTED|Overall Study||113
2437513|NCT01135134|5979221|P1|STARTED|Overall Study||220
2437514|NCT01135069|5979232|P3|NOT COMPLETED|Overall Study||10
2437515|NCT01135069|5979233|P2|NOT COMPLETED|Overall Study||32
2437516|NCT01135069|5979234|P1|NOT COMPLETED|Overall Study||36
2437517|NCT01135069|5979232|P3|COMPLETED|Overall Study||56
2437518|NCT01135069|5979233|P2|COMPLETED|Overall Study||177
2437519|NCT01135069|5979234|P1|COMPLETED|Overall Study||169
2437520|NCT01135069|5979232|P3|STARTED|Overall Study||66
2437521|NCT01135069|5979233|P2|STARTED|Overall Study||209
2437522|NCT01135069|5979234|P1|STARTED|Overall Study||205
2437523|NCT01135017|5979244|P2|NOT COMPLETED|Overall Study||12
2437524|NCT01135017|5979245|P1|NOT COMPLETED|Overall Study||6
2437525|NCT01135017|5979244|P2|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|45
2437526|NCT01135017|5979245|P1|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|49
2437527|NCT01135017|5979244|P2|Evaluable for Efficacy|Overall Study|Two participants did not have interrogation of the pacemaker after randomization|55
2437528|NCT01135017|5979245|P1|Evaluable for Efficacy|Overall Study||55
2437529|NCT01135017|5979244|P2|Treated|Overall Study||57
2437530|NCT01135017|5979245|P1|Treated|Overall Study||55
2437531|NCT01135017|5979244|P2|STARTED|Overall Study||57
2437532|NCT01135017|5979245|P1|STARTED|Overall Study||55
2437533|NCT01134952|5979261|P1|NOT COMPLETED|Overall Study||0
2437534|NCT01134952|5979261|P1|COMPLETED|Overall Study||11
2437535|NCT01134952|5979261|P1|STARTED|Overall Study||11
2437536|NCT01134939|5979283|P8|NOT COMPLETED|Overall Study||0
2437537|NCT01134939|5979284|P7|NOT COMPLETED|Overall Study||9
2437538|NCT01134939|5979285|P6|NOT COMPLETED|Overall Study||9
2437539|NCT01134939|5979286|P5|NOT COMPLETED|Overall Study||10
2437540|NCT01134939|5979287|P4|NOT COMPLETED|Overall Study||14
2437541|NCT01134939|5979288|P3|NOT COMPLETED|Overall Study||10
2437542|NCT01134939|5979289|P2|NOT COMPLETED|Overall Study||18
2437543|NCT01134939|5979290|P1|NOT COMPLETED|Overall Study||17
2437544|NCT01134939|5979283|P8|COMPLETED|Overall Study||1
2437545|NCT01134939|5979284|P7|COMPLETED|Overall Study||10
2437546|NCT01134939|5979285|P6|COMPLETED|Overall Study||5
2437547|NCT01134939|5979286|P5|COMPLETED|Overall Study||23
2437548|NCT01134939|5979287|P4|COMPLETED|Overall Study||32
2437549|NCT01134939|5979288|P3|COMPLETED|Overall Study||41
2437550|NCT01134939|5979289|P2|COMPLETED|Overall Study||24
2437551|NCT01134939|5979290|P1|COMPLETED|Overall Study||42
2437552|NCT01134939|5979283|P8|STARTED|Overall Study||1
2437553|NCT01134939|5979284|P7|STARTED|Overall Study||19
2437554|NCT01134939|5979285|P6|STARTED|Overall Study||14
2437555|NCT01134939|5979286|P5|STARTED|Overall Study||33
2437556|NCT01134939|5979287|P4|STARTED|Overall Study||46
2437557|NCT01134939|5979288|P3|STARTED|Overall Study||51
2437558|NCT01134939|5979289|P2|STARTED|Overall Study||42
2437559|NCT01134939|5979290|P1|STARTED|Overall Study||59
2437560|NCT01134900|5979402|P2|NOT COMPLETED|Overall Study||0
2437561|NCT01134900|5979403|P1|NOT COMPLETED|Overall Study||0
2437562|NCT01134900|5979402|P2|COMPLETED|Overall Study||196
2437563|NCT01134900|5979403|P1|COMPLETED|Overall Study||200
2437564|NCT01134900|5979402|P2|STARTED|Overall Study||196
2437565|NCT01134900|5979403|P1|STARTED|Overall Study||200
2437566|NCT01134887|5979415|P4|NOT COMPLETED|Overall Study||0
2437567|NCT01134887|5979416|P3|NOT COMPLETED|Overall Study||0
2437568|NCT01134887|5979417|P2|NOT COMPLETED|Overall Study||4
2437569|NCT01134887|5979418|P1|NOT COMPLETED|Overall Study||0
2437570|NCT01134887|5979415|P4|COMPLETED|Overall Study||5
2437571|NCT01134887|5979416|P3|COMPLETED|Overall Study||5
2437572|NCT01134887|5979417|P2|COMPLETED|Overall Study|Four patients in the Veteran-Control arm did not have two clinic visits videotaped and left study.|7
2437573|NCT01134887|5979418|P1|COMPLETED|Overall Study||9
2437574|NCT01134887|5979415|P4|STARTED|Overall Study||5
2437575|NCT01134887|5979416|P3|STARTED|Overall Study||5
2437576|NCT01134887|5979417|P2|STARTED|Overall Study||11
2437577|NCT01134887|5979418|P1|STARTED|Overall Study||9
2437578|NCT01134783|5979428|P2|NOT COMPLETED|Overall Study||37
2437579|NCT01134783|5979429|P1|NOT COMPLETED|Overall Study||36
2437580|NCT01134783|5979428|P2|COMPLETED|Overall Study||180
2437581|NCT01134783|5979429|P1|COMPLETED|Overall Study||188
2437582|NCT01134783|5979428|P2|STARTED|Overall Study||217
2437583|NCT01134783|5979429|P1|STARTED|Overall Study||224
2437584|NCT01134731|5979448|P3|NOT COMPLETED|Overall Study||8
2437585|NCT01134731|5979449|P2|NOT COMPLETED|Overall Study||11
2437586|NCT01134731|5979450|P1|NOT COMPLETED|Overall Study||13
2437587|NCT01134731|5979448|P3|COMPLETED|Overall Study||2
2437588|NCT01134731|5979449|P2|COMPLETED|Overall Study||10
2437589|NCT01134731|5979450|P1|COMPLETED|Overall Study||10
2437590|NCT01134731|5979448|P3|STARTED|Overall Study||10
2437591|NCT01134731|5979449|P2|STARTED|Overall Study||21
2437592|NCT01134731|5979450|P1|STARTED|Overall Study||23
2437593|NCT01134705|5979463|P2|NOT COMPLETED|Overall Study||22
2437594|NCT01134705|5979464|P1|NOT COMPLETED|Overall Study||15
2437595|NCT01134705|5979463|P2|COMPLETED|Overall Study||216
2437596|NCT01134705|5979464|P1|COMPLETED|Overall Study||221
2437597|NCT01134705|5979463|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|234
2437598|NCT01134705|5979464|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|232
2437599|NCT01134705|5979463|P2|STARTED|Overall Study||238
2437600|NCT01134705|5979464|P1|STARTED|Overall Study||236
2437601|NCT01134627|5979476|P2|NOT COMPLETED|Overall Study||67
2437602|NCT01134627|5979477|P1|NOT COMPLETED|Overall Study||69
2437603|NCT01134627|5979476|P2|COMPLETED|Overall Study||88
2437604|NCT01134627|5979477|P1|COMPLETED|Overall Study||80
2437605|NCT01134627|5979476|P2|STARTED|Overall Study|Number of participants treated.|155
2437606|NCT01134627|5979477|P1|STARTED|Overall Study|Number of participants treated.|149
2437607|NCT01134614|5979507|P2|NOT COMPLETED|Overall Study||122
2437608|NCT01134614|5979508|P1|NOT COMPLETED|Overall Study||123
2437609|NCT01134614|5979507|P2|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicities|0
2437610|NCT01134614|5979508|P1|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicity.|0
2437611|NCT01134614|5979507|P2|Treated and Toxicity Assessed|Overall Study||120
2437612|NCT01134614|5979508|P1|Treated and Toxicity Assessed|Overall Study||118
2437613|NCT01134614|5979507|P2|Treated|Overall Study||121
2437614|NCT01134614|5979508|P1|Treated|Overall Study||119
2437615|NCT01134614|5979507|P2|STARTED|Overall Study||122
2437616|NCT01134614|5979508|P1|STARTED|Overall Study||123
2437617|NCT01134575|5979521|P3|NOT COMPLETED|Overall Study||0
2437618|NCT01134575|5979522|P2|NOT COMPLETED|Overall Study||0
2437619|NCT01134575|5979523|P1|NOT COMPLETED|Overall Study||0
2437620|NCT01134575|5979521|P3|COMPLETED|Overall Study||42
2437621|NCT01134575|5979522|P2|COMPLETED|Overall Study||45
2437622|NCT01134575|5979523|P1|COMPLETED|Overall Study||3
2437623|NCT01134575|5979521|P3|STARTED|Overall Study||42
2437624|NCT01134575|5979522|P2|STARTED|Overall Study||45
2437625|NCT01134575|5979523|P1|STARTED|Overall Study||3
2437626|NCT01134562|5979536|P5|NOT COMPLETED|Overall Study||0
2437627|NCT01134562|5979537|P4|NOT COMPLETED|Overall Study||0
2437628|NCT01134562|5979538|P3|NOT COMPLETED|Overall Study||0
2437629|NCT01134562|5979539|P2|NOT COMPLETED|Overall Study||1
2437630|NCT01134562|5979540|P1|NOT COMPLETED|Overall Study||0
2437631|NCT01134562|5979536|P5|COMPLETED|Overall Study||8
2437632|NCT01134562|5979537|P4|COMPLETED|Overall Study||8
2437633|NCT01134562|5979538|P3|COMPLETED|Overall Study||4
2437634|NCT01134562|5979539|P2|COMPLETED|Overall Study||3
2437635|NCT01134562|5979540|P1|COMPLETED|Overall Study||4
2437636|NCT01134562|5979536|P5|STARTED|Overall Study||8
2437637|NCT01134562|5979537|P4|STARTED|Overall Study||8
2437638|NCT01134562|5979538|P3|STARTED|Overall Study||4
2437639|NCT01134562|5979539|P2|STARTED|Overall Study||4
2437640|NCT01134562|5979540|P1|STARTED|Overall Study||4
2437641|NCT01134549|5979609|P5|NOT COMPLETED|Overall Study||0
2437642|NCT01134549|5979610|P4|NOT COMPLETED|Overall Study||0
2437643|NCT01134549|5979611|P3|NOT COMPLETED|Overall Study||0
2437644|NCT01134549|5979612|P2|NOT COMPLETED|Overall Study||0
2437645|NCT01134549|5979613|P1|NOT COMPLETED|Overall Study||0
2437646|NCT01134549|5979609|P5|COMPLETED|Overall Study||6
2437647|NCT01134549|5979610|P4|COMPLETED|Overall Study||6
2437648|NCT01134549|5979611|P3|COMPLETED|Overall Study||6
2437649|NCT01134549|5979612|P2|COMPLETED|Overall Study||6
2437650|NCT01134549|5979613|P1|COMPLETED|Overall Study||8
2437651|NCT01134549|5979609|P5|STARTED|Overall Study||6
2437652|NCT01134549|5979610|P4|STARTED|Overall Study||6
2437653|NCT01134549|5979611|P3|STARTED|Overall Study||6
2437654|NCT01134549|5979612|P2|STARTED|Overall Study||6
2437655|NCT01134549|5979613|P1|STARTED|Overall Study||8
2437656|NCT01134510|5979699|P2|NOT COMPLETED|Overall Study||1
2437657|NCT01134510|5979700|P1|NOT COMPLETED|Overall Study||0
2437658|NCT01134510|5979699|P2|COMPLETED|Overall Study||9
2437659|NCT01134510|5979700|P1|COMPLETED|Overall Study||10
2437660|NCT01134510|5979699|P2|Month 3|Overall Study||9
2437661|NCT01134510|5979700|P1|Month 3|Overall Study||10
2437662|NCT01134510|5979699|P2|Month 1|Overall Study||10
2437663|NCT01134510|5979700|P1|Month 1|Overall Study||10
2437664|NCT01134510|5979699|P2|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
2437665|NCT01134510|5979700|P1|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
2437666|NCT01134510|5979699|P2|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
2437667|NCT01134510|5979700|P1|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
2437668|NCT01134510|5979699|P2|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
2437669|NCT01134510|5979700|P1|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
2437670|NCT01134510|5979699|P2|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
2437671|NCT01134510|5979700|P1|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
2437672|NCT01134510|5979699|P2|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
2437673|NCT01134510|5979700|P1|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
2437674|NCT01134510|5979699|P2|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
2437675|NCT01134510|5979700|P1|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
2437676|NCT01134510|5979699|P2|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
2437677|NCT01134510|5979700|P1|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
2437678|NCT01134510|5979699|P2|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
2437679|NCT01134510|5979700|P1|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
2437680|NCT01134393|5979712|P1|NOT COMPLETED|Overall Study||52
2437681|NCT01134393|5979712|P1|COMPLETED|Overall Study|Completed trial medication.|449
2437682|NCT01134393|5979712|P1|STARTED|Overall Study|Entered and treated.|501
2437683|NCT01134328|5979730|P4|NOT COMPLETED|Overall Study||4
2437684|NCT01134328|5979731|P3|NOT COMPLETED|Overall Study||3
2437685|NCT01134328|5979732|P2|NOT COMPLETED|Overall Study||3
2437686|NCT01134328|5979733|P1|NOT COMPLETED|Overall Study||2
2437687|NCT01134328|5979730|P4|COMPLETED|Overall Study||17
2437688|NCT01134328|5979731|P3|COMPLETED|Overall Study||17
2437689|NCT01134328|5979732|P2|COMPLETED|Overall Study||18
2437690|NCT01134328|5979733|P1|COMPLETED|Overall Study||19
2437691|NCT01134328|5979730|P4|STARTED|Overall Study||21
2437692|NCT01134328|5979731|P3|STARTED|Overall Study||20
2437693|NCT01134328|5979732|P2|STARTED|Overall Study||21
2437694|NCT01134328|5979733|P1|STARTED|Overall Study||21
2437695|NCT01134315|5979833|P2|NOT COMPLETED|Overall Study||19
2437696|NCT01134315|5979834|P1|NOT COMPLETED|Overall Study||9
2437697|NCT01134315|5979833|P2|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|21
2437698|NCT01134315|5979834|P1|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|12
2437699|NCT01134315|5979833|P2|STARTED|Overall Study||40
2437700|NCT01134315|5979834|P1|STARTED|Overall Study||21
2437701|NCT01134276|5979856|P2|NOT COMPLETED|Overall Study||0
2437702|NCT01134276|5979857|P1|NOT COMPLETED|Overall Study||0
2437703|NCT01134276|5979856|P2|COMPLETED|Overall Study||107
2437704|NCT01134276|5979857|P1|COMPLETED|Overall Study||104
2437705|NCT01134276|5979856|P2|STARTED|Overall Study||107
2437706|NCT01134276|5979857|P1|STARTED|Overall Study||104
2437707|NCT01134263|5979872|P5|NOT COMPLETED|Overall Study||9
2437708|NCT01134263|5979873|P4|NOT COMPLETED|Overall Study||19
2437709|NCT01134263|5979874|P3|NOT COMPLETED|Overall Study||29
2437710|NCT01134263|5979875|P2|NOT COMPLETED|Overall Study||20
2437711|NCT01134263|5979876|P1|NOT COMPLETED|Overall Study||24
2437712|NCT01134263|5979872|P5|COMPLETED|Overall Study||48
2437713|NCT01134263|5979873|P4|COMPLETED|Overall Study||149
2437714|NCT01134263|5979874|P3|COMPLETED|Overall Study||134
2437715|NCT01134263|5979875|P2|COMPLETED|Overall Study||143
2437716|NCT01134263|5979876|P1|COMPLETED|Overall Study||140
2437717|NCT01134263|5979872|P5|Safety Population|Overall Study||57
2437718|NCT01134263|5979873|P4|Safety Population|Overall Study||167
2437719|NCT01134263|5979874|P3|Safety Population|Overall Study|1 participant randomized to the Phase III Lot 2 group, received Phase III Lot 3 vaccination.|164
2437720|NCT01134263|5979875|P2|Safety Population|Overall Study||161
2437721|NCT01134263|5979876|P1|Safety Population|Overall Study||163
2437722|NCT01134263|5979872|P5|Received Vaccination 3|Overall Study||49
2437723|NCT01134263|5979873|P4|Received Vaccination 3|Overall Study||151
2437724|NCT01134263|5979874|P3|Received Vaccination 3|Overall Study||134
2437725|NCT01134263|5979875|P2|Received Vaccination 3|Overall Study||145
2437726|NCT01134263|5979876|P1|Received Vaccination 3|Overall Study||140
2437727|NCT01134263|5979872|P5|Received Vaccination 2|Overall Study||53
2437728|NCT01134263|5979873|P4|Received Vaccination 2|Overall Study||154
2437729|NCT01134263|5979874|P3|Received Vaccination 2|Overall Study||139
2437730|NCT01134263|5979875|P2|Received Vaccination 2|Overall Study||152
2437731|NCT01134263|5979876|P1|Received Vaccination 2|Overall Study||151
2437732|NCT01134263|5979872|P5|Received Vaccination 1|Overall Study||57
2437733|NCT01134263|5979873|P4|Received Vaccination 1|Overall Study||167
2437734|NCT01134263|5979874|P3|Received Vaccination 1|Overall Study||163
2437735|NCT01134263|5979875|P2|Received Vaccination 1|Overall Study||162
2437736|NCT01134263|5979876|P1|Received Vaccination 1|Overall Study||163
2437737|NCT01134263|5979872|P5|STARTED|Overall Study||57
2437738|NCT01134263|5979873|P4|STARTED|Overall Study||168
2437739|NCT01134263|5979874|P3|STARTED|Overall Study||163
2437740|NCT01134263|5979875|P2|STARTED|Overall Study||163
2437741|NCT01134263|5979876|P1|STARTED|Overall Study||164
2437742|NCT01134198|5979900|P2|NOT COMPLETED|Phase 2||4
2437743|NCT01134198|5979901|P1|NOT COMPLETED|Phase 2||0
2437744|NCT01134198|5979900|P2|COMPLETED|Phase 2||7
2437745|NCT01134198|5979901|P1|COMPLETED|Phase 2||9
2437746|NCT01134198|5979900|P2|STARTED|Phase 2||11
2437747|NCT01134198|5979901|P1|STARTED|Phase 2||9
2437748|NCT01134198|5979900|P2|NOT COMPLETED|Phase 1||2
2437749|NCT01134198|5979901|P1|NOT COMPLETED|Phase 1||7
2437750|NCT01134198|5979900|P2|COMPLETED|Phase 1||11
2437751|NCT01134198|5979901|P1|COMPLETED|Phase 1||9
2437752|NCT01134198|5979900|P2|STARTED|Phase 1||13
2437753|NCT01134198|5979901|P1|STARTED|Phase 1||16
2437754|NCT01134107|5979909|P2|NOT COMPLETED|Period 2-Second Treatment Intervention||0
2437755|NCT01134107|5979910|P1|NOT COMPLETED|Period 2-Second Treatment Intervention||4
2437756|NCT01134107|5979909|P2|COMPLETED|Period 2-Second Treatment Intervention||61
2437757|NCT01134107|5979910|P1|COMPLETED|Period 2-Second Treatment Intervention||57
2437758|NCT01134107|5979909|P2|STARTED|Period 2-Second Treatment Intervention||61
2437759|NCT01134107|5979910|P1|STARTED|Period 2-Second Treatment Intervention||61
2437760|NCT01134107|5979909|P2|NOT COMPLETED|Period 1-First Treatment Intervention||5
2437761|NCT01134107|5979910|P1|NOT COMPLETED|Period 1-First Treatment Intervention||6
2437762|NCT01134107|5979909|P2|COMPLETED|Period 1-First Treatment Intervention||61
2437763|NCT01134107|5979910|P1|COMPLETED|Period 1-First Treatment Intervention||61
2437764|NCT01134107|5979909|P2|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
2437765|NCT01134107|5979910|P1|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
2437766|NCT01134107|5979909|P2|STARTED|Period 1-First Treatment Intervention||66
2437767|NCT01134107|5979910|P1|STARTED|Period 1-First Treatment Intervention||67
2437768|NCT01134081|5979942|P1|NOT COMPLETED|Overall Study||0
2437769|NCT01134081|5979942|P1|COMPLETED|Overall Study||44
2437770|NCT01134081|5979942|P1|STARTED|Overall Study||44
2437771|NCT01134055|5979957|P7|NOT COMPLETED|Overall Study||11
2437772|NCT01134055|5979958|P6|NOT COMPLETED|Overall Study||7
2437773|NCT01134055|5979959|P5|NOT COMPLETED|Overall Study||6
2437774|NCT01134055|5979960|P4|NOT COMPLETED|Overall Study||6
2437775|NCT01134055|5979961|P3|NOT COMPLETED|Overall Study||3
2437776|NCT01134055|5979962|P2|NOT COMPLETED|Overall Study||6
2437777|NCT01134055|5979963|P1|NOT COMPLETED|Overall Study||8
2437778|NCT01134055|5979957|P7|COMPLETED|Overall Study||62
2437779|NCT01134055|5979958|P6|COMPLETED|Overall Study||65
2437780|NCT01134055|5979959|P5|COMPLETED|Overall Study||67
2437781|NCT01134055|5979960|P4|COMPLETED|Overall Study||67
2437782|NCT01134055|5979961|P3|COMPLETED|Overall Study||71
2437783|NCT01134055|5979962|P2|COMPLETED|Overall Study||66
2437784|NCT01134055|5979963|P1|COMPLETED|Overall Study||65
2437785|NCT01134055|5979957|P7|STARTED|Overall Study||73
2437786|NCT01134055|5979958|P6|STARTED|Overall Study||72
2437787|NCT01134055|5979959|P5|STARTED|Overall Study||73
2437788|NCT01134055|5979960|P4|STARTED|Overall Study||73
2437789|NCT01134055|5979961|P3|STARTED|Overall Study||74
2437790|NCT01134055|5979962|P2|STARTED|Overall Study||72
2437791|NCT01134055|5979963|P1|STARTED|Overall Study||73
2437792|NCT01134042|5980097|P3|NOT COMPLETED|Overall Study||34
2437793|NCT01134042|5980098|P2|NOT COMPLETED|Overall Study||28
2437794|NCT01134042|5980099|P1|NOT COMPLETED|Overall Study||48
2437795|NCT01134042|5980097|P3|COMPLETED|Overall Study||161
2437796|NCT01134042|5980098|P2|COMPLETED|Overall Study||169
2437797|NCT01134042|5980099|P1|COMPLETED|Overall Study||146
2437798|NCT01134042|5980097|P3|STARTED|Overall Study||195
2437799|NCT01134042|5980098|P2|STARTED|Overall Study||197
2437800|NCT01134042|5980099|P1|STARTED|Overall Study||194
2437801|NCT01134016|5980137|P1|NOT COMPLETED|Overall Study||3
2437802|NCT01134016|5980137|P1|COMPLETED|Overall Study||10
2437803|NCT01134016|5980137|P1|STARTED|Overall Study||13
2437804|NCT01133977|5980175|P5|NOT COMPLETED|Overall Study||38
2437805|NCT01133977|5980176|P4|NOT COMPLETED|Overall Study||39
2437806|NCT01133977|5980177|P3|NOT COMPLETED|Overall Study||6
2437807|NCT01133977|5980178|P2|NOT COMPLETED|Overall Study||7
2437808|NCT01133977|5980179|P1|NOT COMPLETED|Overall Study||3
2437809|NCT01133977|5980175|P5|COMPLETED|Overall Study||1
2437810|NCT01133977|5980176|P4|COMPLETED|Overall Study||3
2437811|NCT01133977|5980177|P3|COMPLETED|Overall Study||0
2437812|NCT01133977|5980178|P2|COMPLETED|Overall Study||0
2437813|NCT01133977|5980179|P1|COMPLETED|Overall Study||0
2437814|NCT01133977|5980175|P5|STARTED|Overall Study|Treated|39
2437815|NCT01133977|5980176|P4|STARTED|Overall Study|Treated|42
2437816|NCT01133977|5980177|P3|STARTED|Overall Study|Treated|6
2437817|NCT01133977|5980178|P2|STARTED|Overall Study|Treated|7
2437818|NCT01133977|5980179|P1|STARTED|Overall Study|Treated|3
2437819|NCT01133860|5980196|P1|NOT COMPLETED|Overall Study||0
2437820|NCT01133860|5980196|P1|COMPLETED|Overall Study||12
2437821|NCT01133860|5980196|P1|STARTED|Overall Study||12
2437822|NCT01133847|5980206|P3|NOT COMPLETED|Follow-Up Phase||7
2437823|NCT01133847|5980207|P2|NOT COMPLETED|Follow-Up Phase||3
2437824|NCT01133847|5980208|P1|NOT COMPLETED|Follow-Up Phase||1
2437825|NCT01133847|5980206|P3|COMPLETED|Follow-Up Phase||60
2437826|NCT01133847|5980207|P2|COMPLETED|Follow-Up Phase||70
2437827|NCT01133847|5980208|P1|COMPLETED|Follow-Up Phase||72
2437828|NCT01133847|5980206|P3|STARTED|Follow-Up Phase||67
2437829|NCT01133847|5980207|P2|STARTED|Follow-Up Phase||73
2437830|NCT01133847|5980208|P1|STARTED|Follow-Up Phase||73
2437831|NCT01133847|5980206|P3|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||3
2437832|NCT01133847|5980207|P2|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||1
2437833|NCT01133847|5980208|P1|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||5
2437834|NCT01133847|5980206|P3|COMPLETED|Active Treatment Phase (Weeks 1-16)||67
2437835|NCT01133847|5980207|P2|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
2437836|NCT01133847|5980208|P1|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
2437837|NCT01133847|5980206|P3|STARTED|Active Treatment Phase (Weeks 1-16)||70
2437838|NCT01133847|5980207|P2|STARTED|Active Treatment Phase (Weeks 1-16)||74
2437839|NCT01133847|5980208|P1|STARTED|Active Treatment Phase (Weeks 1-16)||78
2437840|NCT01133821|5980248|P2|NOT COMPLETED|Overall Study||19
2437841|NCT01133821|5980249|P1|NOT COMPLETED|Overall Study||18
2437842|NCT01133821|5980248|P2|COMPLETED|Overall Study||28
2437843|NCT01133821|5980249|P1|COMPLETED|Overall Study||27
2437844|NCT01133821|5980248|P2|STARTED|Overall Study||47
2437845|NCT01133821|5980249|P1|STARTED|Overall Study||45
2437846|NCT01133756|5980260|P3|NOT COMPLETED|Overall Study||2
2437847|NCT01133756|5980261|P2|NOT COMPLETED|Overall Study||3
2437848|NCT01133756|5980262|P1|NOT COMPLETED|Overall Study||2
2437849|NCT01133756|5980260|P3|COMPLETED|Overall Study||0
2437850|NCT01133756|5980261|P2|COMPLETED|Overall Study||0
2437851|NCT01133756|5980262|P1|COMPLETED|Overall Study||0
2437852|NCT01133756|5980260|P3|Completed 6 Cycles|Overall Study||0
2437853|NCT01133756|5980261|P2|Completed 6 Cycles|Overall Study||0
2437854|NCT01133756|5980262|P1|Completed 6 Cycles|Overall Study|One participant completed 6 cycles and remained in the study until 18 Sep 2012.|1
2437855|NCT01133756|5980260|P3|STARTED|Overall Study||2
2437856|NCT01133756|5980261|P2|STARTED|Overall Study||3
2437857|NCT01133756|5980262|P1|STARTED|Overall Study||2
2437858|NCT01133704|5980278|P2|NOT COMPLETED|Overall Study||26
2437859|NCT01133704|5980279|P1|NOT COMPLETED|Overall Study||49
2437860|NCT01133704|5980278|P2|COMPLETED|Overall Study|(including 3 year follow-up)|7
2437861|NCT01133704|5980279|P1|COMPLETED|Overall Study|(including 3 year follow-up)|16
2437862|NCT01133704|5980278|P2|STARTED|Overall Study||33
2437863|NCT01133704|5980279|P1|STARTED|Overall Study||65
2437864|NCT01133665|5980287|P1|NOT COMPLETED|Overall Study||2
2437865|NCT01133665|5980287|P1|COMPLETED|Overall Study||40
2437866|NCT01133665|5980287|P1|STARTED|Overall Study||42
2437867|NCT01133639|5980330|P2|NOT COMPLETED|Overall Study||0
2437868|NCT01133639|5980331|P1|NOT COMPLETED|Overall Study||0
2437869|NCT01133639|5980330|P2|COMPLETED|Overall Study|18 total subjects were enrolled,study was terminated prematurely and data was not analyzed|0
2437870|NCT01133639|5980331|P1|COMPLETED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
2437871|NCT01133639|5980330|P2|STARTED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
2437872|NCT01133639|5980331|P1|STARTED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
2437873|NCT01133626|5980347|P3|NOT COMPLETED|Overall Study||2
2437874|NCT01133626|5980348|P2|NOT COMPLETED|Overall Study||5
2437875|NCT01133626|5980349|P1|NOT COMPLETED|Overall Study||1
2437876|NCT01133626|5980347|P3|COMPLETED|Overall Study||9
2437877|NCT01133626|5980348|P2|COMPLETED|Overall Study||41
2437878|NCT01133626|5980349|P1|COMPLETED|Overall Study||49
2437879|NCT01133626|5980347|P3|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|9
2437880|NCT01133626|5980348|P2|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|41
2437881|NCT01133626|5980349|P1|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|48
2437882|NCT01133626|5980347|P3|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|11
2437883|NCT01133626|5980348|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|46
2437884|NCT01133626|5980349|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|50
2437885|NCT01133626|5980347|P3|STARTED|Overall Study||11
2437886|NCT01133626|5980348|P2|STARTED|Overall Study||46
2437887|NCT01133626|5980349|P1|STARTED|Overall Study||50
2437888|NCT01133522|5980367|P10|NOT COMPLETED|Overall Study||0
2437889|NCT01133522|5980368|P9|NOT COMPLETED|Overall Study||0
2437890|NCT01133522|5980369|P8|NOT COMPLETED|Overall Study||0
2437891|NCT01133522|5980370|P7|NOT COMPLETED|Overall Study||0
2437892|NCT01133522|5980371|P6|NOT COMPLETED|Overall Study||0
2437893|NCT01133522|5980372|P5|NOT COMPLETED|Overall Study||1
2437894|NCT01133522|5980373|P4|NOT COMPLETED|Overall Study||1
2437895|NCT01133522|5980374|P3|NOT COMPLETED|Overall Study||0
2437896|NCT01133522|5980375|P2|NOT COMPLETED|Overall Study||1
2437897|NCT01133522|5980376|P1|NOT COMPLETED|Overall Study||0
2437898|NCT01133522|5980367|P10|COMPLETED|Overall Study||4
2437899|NCT01133522|5980368|P9|COMPLETED|Overall Study||2
2437900|NCT01133522|5980369|P8|COMPLETED|Overall Study||9
2437901|NCT01133522|5980370|P7|COMPLETED|Overall Study||2
2437902|NCT01133522|5980371|P6|COMPLETED|Overall Study||6
2437903|NCT01133522|5980372|P5|COMPLETED|Overall Study||6
2437904|NCT01133522|5980373|P4|COMPLETED|Overall Study||6
2437905|NCT01133522|5980374|P3|COMPLETED|Overall Study||6
2437906|NCT01133522|5980375|P2|COMPLETED|Overall Study||6
2437907|NCT01133522|5980376|P1|COMPLETED|Overall Study||10
2437908|NCT01133522|5980367|P10|Received Treatment|Overall Study||4
2437909|NCT01133522|5980368|P9|Received Treatment|Overall Study||2
2437910|NCT01133522|5980369|P8|Received Treatment|Overall Study||9
2437911|NCT01133522|5980370|P7|Received Treatment|Overall Study||2
2437912|NCT01133522|5980371|P6|Received Treatment|Overall Study||6
2437913|NCT01133522|5980372|P5|Received Treatment|Overall Study||6
2437914|NCT01133522|5980373|P4|Received Treatment|Overall Study||6
2437915|NCT01133522|5980374|P3|Received Treatment|Overall Study||6
2437916|NCT01133522|5980375|P2|Received Treatment|Overall Study||6
2437917|NCT01133522|5980376|P1|Received Treatment|Overall Study||10
2437918|NCT01133522|5980367|P10|STARTED|Overall Study||4
2437919|NCT01133522|5980368|P9|STARTED|Overall Study||2
2437920|NCT01133522|5980369|P8|STARTED|Overall Study||9
2437921|NCT01133522|5980370|P7|STARTED|Overall Study||2
2437922|NCT01133522|5980371|P6|STARTED|Overall Study||6
2437923|NCT01133522|5980372|P5|STARTED|Overall Study||7
2437924|NCT01133522|5980373|P4|STARTED|Overall Study||7
2437925|NCT01133522|5980374|P3|STARTED|Overall Study||6
2437926|NCT01133522|5980375|P2|STARTED|Overall Study||7
2437927|NCT01133522|5980376|P1|STARTED|Overall Study||10
2437928|NCT01133418|5980444|P2|NOT COMPLETED|Overall Study||6
2437929|NCT01133418|5980445|P1|NOT COMPLETED|Overall Study||5
2437930|NCT01133418|5980444|P2|COMPLETED|Overall Study||32
2437931|NCT01133418|5980445|P1|COMPLETED|Overall Study||29
2437932|NCT01133418|5980444|P2|STARTED|Overall Study||38
2437933|NCT01133418|5980445|P1|STARTED|Overall Study||34
2437934|NCT01133405|5980467|P10|NOT COMPLETED|Period 3||0
2437935|NCT01133405|5980468|P9|NOT COMPLETED|Period 3||0
2437936|NCT01133405|5980469|P8|NOT COMPLETED|Period 3||0
2437937|NCT01133405|5980470|P7|NOT COMPLETED|Period 3||0
2437938|NCT01133405|5980471|P6|NOT COMPLETED|Period 3||0
2437939|NCT01133405|5980472|P5|NOT COMPLETED|Period 3||0
2437940|NCT01133405|5980473|P4|NOT COMPLETED|Period 3||0
2437941|NCT01133405|5980474|P3|NOT COMPLETED|Period 3||0
2437942|NCT01133405|5980475|P2|NOT COMPLETED|Period 3||0
2437943|NCT01133405|5980476|P1|NOT COMPLETED|Period 3||0
2437944|NCT01133405|5980467|P10|COMPLETED|Period 3||0
2437945|NCT01133405|5980468|P9|COMPLETED|Period 3||0
2437946|NCT01133405|5980469|P8|COMPLETED|Period 3||0
2437947|NCT01133405|5980470|P7|COMPLETED|Period 3||0
2437948|NCT01133405|5980471|P6|COMPLETED|Period 3||2
2437949|NCT01133405|5980472|P5|COMPLETED|Period 3||3
2437950|NCT01133405|5980473|P4|COMPLETED|Period 3||2
2437951|NCT01133405|5980474|P3|COMPLETED|Period 3||4
2437952|NCT01133405|5980475|P2|COMPLETED|Period 3||4
2437953|NCT01133405|5980476|P1|COMPLETED|Period 3||2
2437954|NCT01133405|5980467|P10|Received at Least 1 Dose of Study Drug|Period 3||0
2437955|NCT01133405|5980468|P9|Received at Least 1 Dose of Study Drug|Period 3||0
2437956|NCT01133405|5980469|P8|Received at Least 1 Dose of Study Drug|Period 3||0
2437957|NCT01133405|5980470|P7|Received at Least 1 Dose of Study Drug|Period 3||0
2437958|NCT01133405|5980471|P6|Received at Least 1 Dose of Study Drug|Period 3||2
2437959|NCT01133405|5980472|P5|Received at Least 1 Dose of Study Drug|Period 3||3
2437960|NCT01133405|5980473|P4|Received at Least 1 Dose of Study Drug|Period 3||2
2437961|NCT01133405|5980474|P3|Received at Least 1 Dose of Study Drug|Period 3||4
2437962|NCT01133405|5980475|P2|Received at Least 1 Dose of Study Drug|Period 3||4
2437963|NCT01133405|5980476|P1|Received at Least 1 Dose of Study Drug|Period 3||2
2437964|NCT01133405|5980467|P10|STARTED|Period 3||0
2437965|NCT01133405|5980468|P9|STARTED|Period 3||0
2437966|NCT01133405|5980469|P8|STARTED|Period 3||0
2437967|NCT01133405|5980470|P7|STARTED|Period 3||0
2437968|NCT01133405|5980471|P6|STARTED|Period 3||2
2437969|NCT01133405|5980472|P5|STARTED|Period 3||3
2437970|NCT01133405|5980473|P4|STARTED|Period 3||2
2437971|NCT01133405|5980474|P3|STARTED|Period 3|One participant started and received 35 mg LY2886721 only in period 3.|4
2437972|NCT01133405|5980475|P2|STARTED|Period 3|One participant started and received placebo only in period 3.|4
2437973|NCT01133405|5980476|P1|STARTED|Period 3||2
2437974|NCT01133405|5980467|P10|NOT COMPLETED|Period 2||0
2437975|NCT01133405|5980468|P9|NOT COMPLETED|Period 2||0
2437976|NCT01133405|5980469|P8|NOT COMPLETED|Period 2||0
2437977|NCT01133405|5980470|P7|NOT COMPLETED|Period 2||0
2437978|NCT01133405|5980471|P6|NOT COMPLETED|Period 2||2
2437979|NCT01133405|5980472|P5|NOT COMPLETED|Period 2||0
2437980|NCT01133405|5980473|P4|NOT COMPLETED|Period 2||1
2437981|NCT01133405|5980474|P3|NOT COMPLETED|Period 2||1
2437982|NCT01133405|5980475|P2|NOT COMPLETED|Period 2||1
2437983|NCT01133405|5980476|P1|NOT COMPLETED|Period 2||0
2437984|NCT01133405|5980467|P10|COMPLETED|Period 2||0
2437985|NCT01133405|5980468|P9|COMPLETED|Period 2||0
2437986|NCT01133405|5980469|P8|COMPLETED|Period 2||0
2437987|NCT01133405|5980470|P7|COMPLETED|Period 2||0
2437988|NCT01133405|5980471|P6|COMPLETED|Period 2||2
2437989|NCT01133405|5980472|P5|COMPLETED|Period 2||3
2437990|NCT01133405|5980473|P4|COMPLETED|Period 2||2
2437991|NCT01133405|5980474|P3|COMPLETED|Period 2||3
2437992|NCT01133405|5980475|P2|COMPLETED|Period 2||3
2437993|NCT01133405|5980476|P1|COMPLETED|Period 2||2
2437994|NCT01133405|5980467|P10|Received at Least 1 Dose of Study Drug|Period 2||0
2437995|NCT01133405|5980468|P9|Received at Least 1 Dose of Study Drug|Period 2||0
2437996|NCT01133405|5980469|P8|Received at Least 1 Dose of Study Drug|Period 2||0
2437997|NCT01133405|5980470|P7|Received at Least 1 Dose of Study Drug|Period 2||0
2437998|NCT01133405|5980471|P6|Received at Least 1 Dose of Study Drug|Period 2||4
2437999|NCT01133405|5980472|P5|Received at Least 1 Dose of Study Drug|Period 2||3
2438000|NCT01133405|5980473|P4|Received at Least 1 Dose of Study Drug|Period 2||3
2438001|NCT01133405|5980474|P3|Received at Least 1 Dose of Study Drug|Period 2||4
2438002|NCT01133405|5980475|P2|Received at Least 1 Dose of Study Drug|Period 2||4
2438003|NCT01133405|5980476|P1|Received at Least 1 Dose of Study Drug|Period 2||2
2438004|NCT01133405|5980467|P10|STARTED|Period 2|Cohort D was planned only for single period.|0
2438005|NCT01133405|5980468|P9|STARTED|Period 2|Cohort D was planned only for single period.|0
2438006|NCT01133405|5980469|P8|STARTED|Period 2|Cohort C was planned only for single period.|0
2438007|NCT01133405|5980470|P7|STARTED|Period 2|Cohort C was planned only for single period.|0
2438008|NCT01133405|5980471|P6|STARTED|Period 2|One participant started and received 25 mg LY2886721 only in period 2.|4
2438009|NCT01133405|5980472|P5|STARTED|Period 2||3
2438010|NCT01133405|5980473|P4|STARTED|Period 2|Two participants started and received 25 mg LY2886721 only in period 2.|3
2438011|NCT01133405|5980474|P3|STARTED|Period 2||4
2438012|NCT01133405|5980475|P2|STARTED|Period 2|One participant started and received 15 mg LY2886721 only in period 2.|4
2438013|NCT01133405|5980476|P1|STARTED|Period 2||2
2438014|NCT01133405|5980467|P10|NOT COMPLETED|Period 1||0
2438015|NCT01133405|5980468|P9|NOT COMPLETED|Period 1||0
2438016|NCT01133405|5980469|P8|NOT COMPLETED|Period 1||0
2438017|NCT01133405|5980470|P7|NOT COMPLETED|Period 1||1
2438018|NCT01133405|5980471|P6|NOT COMPLETED|Period 1||2
2438019|NCT01133405|5980472|P5|NOT COMPLETED|Period 1||0
2438020|NCT01133405|5980473|P4|NOT COMPLETED|Period 1||4
2438021|NCT01133405|5980474|P3|NOT COMPLETED|Period 1||1
2438022|NCT01133405|5980475|P2|NOT COMPLETED|Period 1||3
2438023|NCT01133405|5980476|P1|NOT COMPLETED|Period 1||1
2438024|NCT01133405|5980467|P10|COMPLETED|Period 1||2
2438025|NCT01133405|5980468|P9|COMPLETED|Period 1||4
2438026|NCT01133405|5980469|P8|COMPLETED|Period 1||2
2438027|NCT01133405|5980470|P7|COMPLETED|Period 1||4
2438028|NCT01133405|5980471|P6|COMPLETED|Period 1||3
2438029|NCT01133405|5980472|P5|COMPLETED|Period 1||3
2438030|NCT01133405|5980473|P4|COMPLETED|Period 1||1
2438031|NCT01133405|5980474|P3|COMPLETED|Period 1||4
2438032|NCT01133405|5980475|P2|COMPLETED|Period 1||3
2438033|NCT01133405|5980476|P1|COMPLETED|Period 1||2
2438034|NCT01133405|5980467|P10|Received at Least 1 Dose of Drug|Period 1||2
2438035|NCT01133405|5980468|P9|Received at Least 1 Dose of Drug|Period 1||4
2438036|NCT01133405|5980469|P8|Received at Least 1 Dose of Drug|Period 1||2
2438037|NCT01133405|5980470|P7|Received at Least 1 Dose of Drug|Period 1||4
2438038|NCT01133405|5980471|P6|Received at Least 1 Dose of Drug|Period 1||4
2438039|NCT01133405|5980472|P5|Received at Least 1 Dose of Drug|Period 1||3
2438040|NCT01133405|5980473|P4|Received at Least 1 Dose of Drug|Period 1||3
2438041|NCT01133405|5980474|P3|Received at Least 1 Dose of Drug|Period 1||4
2438042|NCT01133405|5980475|P2|Received at Least 1 Dose of Drug|Period 1||4
2438043|NCT01133405|5980476|P1|Received at Least 1 Dose of Drug|Period 1||2
2438044|NCT01133405|5980467|P10|Safety Analysis Population|Period 1||2
2438045|NCT01133405|5980468|P9|Safety Analysis Population|Period 1||4
2438046|NCT01133405|5980469|P8|Safety Analysis Population|Period 1||2
2438047|NCT01133405|5980470|P7|Safety Analysis Population|Period 1||5
2438048|NCT01133405|5980471|P6|Safety Analysis Population|Period 1||5
2438049|NCT01133405|5980472|P5|Safety Analysis Population|Period 1||3
2438050|NCT01133405|5980473|P4|Safety Analysis Population|Period 1||5
2438051|NCT01133405|5980474|P3|Safety Analysis Population|Period 1||5
2438052|NCT01133405|5980475|P2|Safety Analysis Population|Period 1||6
2438053|NCT01133405|5980476|P1|Safety Analysis Population|Period 1|One discontinued from study after randomization but before any study procedures.|2
2438054|NCT01133405|5980467|P10|STARTED|Period 1||2
2438055|NCT01133405|5980468|P9|STARTED|Period 1||4
2438056|NCT01133405|5980469|P8|STARTED|Period 1||2
2438057|NCT01133405|5980470|P7|STARTED|Period 1||5
2438058|NCT01133405|5980471|P6|STARTED|Period 1||5
2438059|NCT01133405|5980472|P5|STARTED|Period 1||3
2438060|NCT01133405|5980473|P4|STARTED|Period 1||5
2438061|NCT01133405|5980474|P3|STARTED|Period 1||5
2438062|NCT01133405|5980475|P2|STARTED|Period 1||6
2438063|NCT01133405|5980476|P1|STARTED|Period 1||3
2438064|NCT01133392|5980527|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
2438065|NCT01133392|5980528|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
2438066|NCT01133392|5980527|P2|COMPLETED|Fourth Intervention (1 Day)||16
2438067|NCT01133392|5980528|P1|COMPLETED|Fourth Intervention (1 Day)||20
2438068|NCT01133392|5980527|P2|STARTED|Fourth Intervention (1 Day)||16
2438069|NCT01133392|5980528|P1|STARTED|Fourth Intervention (1 Day)||20
2438070|NCT01133392|5980527|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
2438071|NCT01133392|5980528|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
2438072|NCT01133392|5980527|P2|COMPLETED|Interval Between Dosing (4-7 Days)||16
2438073|NCT01133392|5980528|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
2438074|NCT01133392|5980527|P2|STARTED|Interval Between Dosing (4-7 Days)||17
2438075|NCT01133392|5980528|P1|STARTED|Interval Between Dosing (4-7 Days)||20
2438076|NCT01133392|5980527|P2|NOT COMPLETED|Third Intervention (1 Day)||0
2438077|NCT01133392|5980528|P1|NOT COMPLETED|Third Intervention (1 Day)||0
2438078|NCT01133392|5980527|P2|COMPLETED|Third Intervention (1 Day)||17
2438079|NCT01133392|5980528|P1|COMPLETED|Third Intervention (1 Day)||20
2438080|NCT01133392|5980527|P2|STARTED|Third Intervention (1 Day)||17
2438081|NCT01133392|5980528|P1|STARTED|Third Intervention (1 Day)||20
2438082|NCT01133392|5980527|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
2438083|NCT01133392|5980528|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
2438084|NCT01133392|5980527|P2|COMPLETED|Interval Between Dosing (4-7 Days)||17
2438085|NCT01133392|5980528|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
2438086|NCT01133392|5980527|P2|STARTED|Interval Between Dosing (4-7 Days)||17
2438087|NCT01133392|5980528|P1|STARTED|Interval Between Dosing (4-7 Days)||20
2438088|NCT01133392|5980527|P2|NOT COMPLETED|Second Intervention (1 Day)||0
2438089|NCT01133392|5980528|P1|NOT COMPLETED|Second Intervention (1 Day)||0
2438090|NCT01133392|5980527|P2|COMPLETED|Second Intervention (1 Day)||17
2438091|NCT01133392|5980528|P1|COMPLETED|Second Intervention (1 Day)||20
2438092|NCT01133392|5980527|P2|STARTED|Second Intervention (1 Day)||17
2438093|NCT01133392|5980528|P1|STARTED|Second Intervention (1 Day)||20
2438094|NCT01133392|5980527|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
2438095|NCT01133392|5980528|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
2438096|NCT01133392|5980527|P2|COMPLETED|Interval Between Dosing (4-7 Days)||17
2438097|NCT01133392|5980528|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
2438098|NCT01133392|5980527|P2|STARTED|Interval Between Dosing (4-7 Days)||18
2438099|NCT01133392|5980528|P1|STARTED|Interval Between Dosing (4-7 Days)||20
2438100|NCT01133392|5980527|P2|NOT COMPLETED|First Intervention (1 Day )||0
2438101|NCT01133392|5980528|P1|NOT COMPLETED|First Intervention (1 Day )||0
2438102|NCT01133392|5980527|P2|COMPLETED|First Intervention (1 Day )||18
2438103|NCT01133392|5980528|P1|COMPLETED|First Intervention (1 Day )||20
2438104|NCT01133392|5980527|P2|STARTED|First Intervention (1 Day )||18
2438105|NCT01133392|5980528|P1|STARTED|First Intervention (1 Day )||20
2438106|NCT01133379|5980545|P3|NOT COMPLETED|Overall Study||2
2438107|NCT01133379|5980546|P2|NOT COMPLETED|Overall Study||2
2438108|NCT01133379|5980547|P1|NOT COMPLETED|Overall Study||1
2438109|NCT01133379|5980545|P3|COMPLETED|Overall Study||56
2438110|NCT01133379|5980546|P2|COMPLETED|Overall Study||56
2438111|NCT01133379|5980547|P1|COMPLETED|Overall Study||57
2438112|NCT01133379|5980545|P3|STARTED|Overall Study||58
2438113|NCT01133379|5980546|P2|STARTED|Overall Study||58
2438114|NCT01133379|5980547|P1|STARTED|Overall Study||58
2438115|NCT01133288|5980600|P1|NOT COMPLETED|Intervention Allocation||2
2438116|NCT01133288|5980600|P1|COMPLETED|Intervention Allocation||0
2438117|NCT01133288|5980600|P1|STARTED|Intervention Allocation||2
2438118|NCT01133288|5980600|P1|NOT COMPLETED|Eligibility Assessment||5
2438119|NCT01133288|5980600|P1|COMPLETED|Eligibility Assessment||2
2438120|NCT01133288|5980600|P1|STARTED|Eligibility Assessment||7
2438121|NCT01133275|5980605|P1|NOT COMPLETED|Overall Study||2
2438122|NCT01133275|5980605|P1|COMPLETED|Overall Study||26
2438123|NCT01133275|5980605|P1|STARTED|Overall Study||28
2438124|NCT01133171|5980613|P3|NOT COMPLETED|Overall Study||0
2438125|NCT01133171|5980614|P2|NOT COMPLETED|Overall Study||2
2438126|NCT01133171|5980615|P1|NOT COMPLETED|Overall Study||1
2438127|NCT01133171|5980613|P3|COMPLETED|Overall Study||25
2438128|NCT01133171|5980614|P2|COMPLETED|Overall Study||25
2438129|NCT01133171|5980615|P1|COMPLETED|Overall Study||24
2438130|NCT01133171|5980613|P3|STARTED|Overall Study||25
2438131|NCT01133171|5980614|P2|STARTED|Overall Study||27
2438132|NCT01133171|5980615|P1|STARTED|Overall Study||25
2438133|NCT01133158|5980625|P1|NOT COMPLETED|Overall Study||17
2438134|NCT01133158|5980625|P1|COMPLETED|Overall Study||43
2438135|NCT01133158|5980625|P1|STARTED|Overall Study||60
2438136|NCT01133067|5980631|P1|NOT COMPLETED|Overall Study||139
2438137|NCT01133067|5980631|P1|COMPLETED|Overall Study||61
2438138|NCT01133067|5980631|P1|STARTED|Overall Study||200
2438139|NCT01132846|5980639|P3|NOT COMPLETED|Overall Study||11
2438140|NCT01132846|5980640|P2|NOT COMPLETED|Overall Study||18
2438141|NCT01132846|5980641|P1|NOT COMPLETED|Overall Study||16
2438142|NCT01132846|5980639|P3|COMPLETED|Overall Study||108
2438143|NCT01132846|5980640|P2|COMPLETED|Overall Study||101
2438144|NCT01132846|5980641|P1|COMPLETED|Overall Study||106
2438145|NCT01132846|5980639|P3|STARTED|Overall Study||119
2438146|NCT01132846|5980640|P2|STARTED|Overall Study||119
2438147|NCT01132846|5980641|P1|STARTED|Overall Study||122
2438148|NCT01132820|5980691|P1|NOT COMPLETED|Overall Study||5
2438149|NCT01132820|5980691|P1|COMPLETED|Overall Study||48
2438150|NCT01132820|5980691|P1|STARTED|Overall Study||53
2438151|NCT01132755|5980700|P1|NOT COMPLETED|Overall Study||42
2438152|NCT01132755|5980700|P1|COMPLETED|Overall Study||70
2438153|NCT01132755|5980700|P1|STARTED|Overall Study||112
2438154|NCT01132690|5980707|P2|NOT COMPLETED|Overall Study||0
2438155|NCT01132690|5980708|P1|NOT COMPLETED|Overall Study||0
2438156|NCT01132690|5980707|P2|COMPLETED|Overall Study||5
2438157|NCT01132690|5980708|P1|COMPLETED|Overall Study||6
2438158|NCT01132690|5980707|P2|STARTED|Overall Study||5
2438159|NCT01132690|5980708|P1|STARTED|Overall Study||6
2438160|NCT01132664|5980729|P5|NOT COMPLETED|BM Cohort||6
2438161|NCT01132664|5980730|P4|NOT COMPLETED|BM Cohort||3
2438162|NCT01132664|5980731|P3|NOT COMPLETED|BM Cohort||0
2438163|NCT01132664|5980732|P2|NOT COMPLETED|BM Cohort||0
2438164|NCT01132664|5980733|P1|NOT COMPLETED|BM Cohort||0
2438165|NCT01132664|5980729|P5|COMPLETED|BM Cohort||0
2438166|NCT01132664|5980730|P4|COMPLETED|BM Cohort||0
2438167|NCT01132664|5980731|P3|COMPLETED|BM Cohort||0
2438168|NCT01132664|5980732|P2|COMPLETED|BM Cohort||0
2438169|NCT01132664|5980733|P1|COMPLETED|BM Cohort||0
2438170|NCT01132664|5980729|P5|STARTED|BM Cohort||6
2438171|NCT01132664|5980730|P4|STARTED|BM Cohort||3
2438172|NCT01132664|5980731|P3|STARTED|BM Cohort||0
2438173|NCT01132664|5980732|P2|STARTED|BM Cohort||0
2438174|NCT01132664|5980733|P1|STARTED|BM Cohort||0
2438175|NCT01132664|5980729|P5|NOT COMPLETED|Phase ll||0
2438176|NCT01132664|5980730|P4|NOT COMPLETED|Phase ll||0
2438177|NCT01132664|5980731|P3|NOT COMPLETED|Phase ll||50
2438178|NCT01132664|5980732|P2|NOT COMPLETED|Phase ll||0
2438179|NCT01132664|5980733|P1|NOT COMPLETED|Phase ll||0
2438180|NCT01132664|5980729|P5|COMPLETED|Phase ll||0
2438181|NCT01132664|5980730|P4|COMPLETED|Phase ll||0
2438182|NCT01132664|5980731|P3|COMPLETED|Phase ll||0
2438183|NCT01132664|5980732|P2|COMPLETED|Phase ll||0
2438184|NCT01132664|5980733|P1|COMPLETED|Phase ll||0
2438185|NCT01132664|5980729|P5|STARTED|Phase ll||0
2438186|NCT01132664|5980730|P4|STARTED|Phase ll||0
2438187|NCT01132664|5980731|P3|STARTED|Phase ll|Of the 50 patients, 8 were from phase lb & were eligible for inclusion in Phase II|50
2438188|NCT01132664|5980732|P2|STARTED|Phase ll||0
2438189|NCT01132664|5980733|P1|STARTED|Phase ll||0
2438190|NCT01132664|5980729|P5|NOT COMPLETED|Phase lb||0
2438191|NCT01132664|5980730|P4|NOT COMPLETED|Phase lb||0
2438192|NCT01132664|5980731|P3|NOT COMPLETED|Phase lb||0
2438193|NCT01132664|5980732|P2|NOT COMPLETED|Phase lb||12
2438194|NCT01132664|5980733|P1|NOT COMPLETED|Phase lb||5
2438195|NCT01132664|5980729|P5|COMPLETED|Phase lb||0
2438196|NCT01132664|5980730|P4|COMPLETED|Phase lb||0
2438197|NCT01132664|5980731|P3|COMPLETED|Phase lb||0
2438198|NCT01132664|5980732|P2|COMPLETED|Phase lb||0
2438199|NCT01132664|5980733|P1|COMPLETED|Phase lb||0
2438200|NCT01132664|5980729|P5|STARTED|Phase lb||0
2438201|NCT01132664|5980730|P4|STARTED|Phase lb||0
2438202|NCT01132664|5980731|P3|STARTED|Phase lb||0
2438203|NCT01132664|5980732|P2|STARTED|Phase lb||12
2438204|NCT01132664|5980733|P1|STARTED|Phase lb||5
2438205|NCT01132651|5980767|P2|NOT COMPLETED|Overall Study||1
2438206|NCT01132651|5980768|P1|NOT COMPLETED|Overall Study||1
2438207|NCT01132651|5980767|P2|COMPLETED|Overall Study||4
2438208|NCT01132651|5980768|P1|COMPLETED|Overall Study||3
2438209|NCT01132651|5980767|P2|STARTED|Overall Study||5
2438210|NCT01132651|5980768|P1|STARTED|Overall Study||4
2438211|NCT01132612|5980779|P3|NOT COMPLETED|Overall Study||170
2438212|NCT01132612|5980780|P2|NOT COMPLETED|Overall Study||35
2438213|NCT01132612|5980781|P1|NOT COMPLETED|Overall Study||40
2438214|NCT01132612|5980779|P3|COMPLETED|Overall Study||17
2438215|NCT01132612|5980780|P2|COMPLETED|Overall Study||7
2438216|NCT01132612|5980781|P1|COMPLETED|Overall Study||6
2438217|NCT01132612|5980779|P3|STARTED|Overall Study||187
2438218|NCT01132612|5980780|P2|STARTED|Overall Study||42
2438219|NCT01132612|5980781|P1|STARTED|Overall Study||46
2438220|NCT01132547|5980797|P2|NOT COMPLETED|Overall Study||1
2438221|NCT01132547|5980798|P1|NOT COMPLETED|Overall Study||4
2438222|NCT01132547|5980797|P2|COMPLETED|Overall Study||12
2438223|NCT01132547|5980798|P1|COMPLETED|Overall Study||5
2438224|NCT01132547|5980797|P2|STARTED|Overall Study||13
2438225|NCT01132547|5980798|P1|STARTED|Overall Study||9
2438226|NCT01132508|5980808|P1|NOT COMPLETED|Overall Study||9
2438227|NCT01132508|5980808|P1|COMPLETED|Overall Study||24
2438228|NCT01132508|5980808|P1|104 Weeks|Overall Study||27
2438229|NCT01132508|5980808|P1|78 Weeks|Overall Study||28
2438230|NCT01132508|5980808|P1|52 Weeks|Overall Study||30
2438231|NCT01132508|5980808|P1|26 Weeks|Overall Study||33
2438232|NCT01132508|5980808|P1|12 Weeks|Overall Study||33
2438233|NCT01132508|5980808|P1|6 Weeks|Overall Study||33
2438234|NCT01132508|5980808|P1|Treated at Baseline|Overall Study||33
2438235|NCT01132508|5980808|P1|STARTED|Overall Study||33
2438236|NCT01132495|5980868|P4|NOT COMPLETED|Overall Study||12
2438237|NCT01132495|5980869|P3|NOT COMPLETED|Overall Study||20
2438238|NCT01132495|5980870|P2|NOT COMPLETED|Overall Study||38
2438239|NCT01132495|5980871|P1|NOT COMPLETED|Overall Study||40
2438240|NCT01132495|5980868|P4|COMPLETED|Overall Study||104
2438241|NCT01132495|5980869|P3|COMPLETED|Overall Study||146
2438242|NCT01132495|5980870|P2|COMPLETED|Overall Study||403
2438243|NCT01132495|5980871|P1|COMPLETED|Overall Study||407
2438244|NCT01132495|5980868|P4|STARTED|Overall Study||116
2438245|NCT01132495|5980869|P3|STARTED|Overall Study||166
2438246|NCT01132495|5980870|P2|STARTED|Overall Study||441
2438247|NCT01132495|5980871|P1|STARTED|Overall Study||447
2438248|NCT01132482|5980884|P2|NOT COMPLETED|Overall Study||0
2438249|NCT01132482|5980885|P1|NOT COMPLETED|Overall Study||1
2438250|NCT01132482|5980884|P2|COMPLETED|Overall Study||6
2438251|NCT01132482|5980885|P1|COMPLETED|Overall Study||12
2438252|NCT01132482|5980884|P2|STARTED|Overall Study||6
2438253|NCT01132482|5980885|P1|STARTED|Overall Study||13
2438254|NCT01132378|5980903|P1|NOT COMPLETED|Overall Study||0
2438255|NCT01132378|5980903|P1|COMPLETED|Overall Study||40
2438256|NCT01132378|5980903|P1|STARTED|Overall Study||40
2438257|NCT01132326|5980908|P1|NOT COMPLETED|Overall Study||218
2438258|NCT01132326|5980908|P1|COMPLETED|Overall Study||132
2438259|NCT01132326|5980908|P1|STARTED|Overall Study||350
2438260|NCT01132313|5980924|P12|NOT COMPLETED|Overall Study||0
2438261|NCT01132313|5980925|P11|NOT COMPLETED|Overall Study||1
2438262|NCT01132313|5980926|P10|NOT COMPLETED|Overall Study||20
2438263|NCT01132313|5980927|P9|NOT COMPLETED|Overall Study||21
2438264|NCT01132313|5980928|P8|NOT COMPLETED|Overall Study||8
2438265|NCT01132313|5980929|P7|NOT COMPLETED|Overall Study||30
2438266|NCT01132313|5980930|P6|NOT COMPLETED|Overall Study||25
2438267|NCT01132313|5980931|P5|NOT COMPLETED|Overall Study||45
2438268|NCT01132313|5980932|P4|NOT COMPLETED|Overall Study||32
2438269|NCT01132313|5980933|P3|NOT COMPLETED|Overall Study||20
2438270|NCT01132313|5980934|P2|NOT COMPLETED|Overall Study||0
2438271|NCT01132313|5980935|P1|NOT COMPLETED|Overall Study||3
2438272|NCT01132313|5980924|P12|COMPLETED|Overall Study||2
2438273|NCT01132313|5980925|P11|COMPLETED|Overall Study||0
2438274|NCT01132313|5980926|P10|COMPLETED|Overall Study||5
2438275|NCT01132313|5980927|P9|COMPLETED|Overall Study||5
2438276|NCT01132313|5980928|P8|COMPLETED|Overall Study||24
2438277|NCT01132313|5980929|P7|COMPLETED|Overall Study||19
2438278|NCT01132313|5980930|P6|COMPLETED|Overall Study||54
2438279|NCT01132313|5980931|P5|COMPLETED|Overall Study||34
2438280|NCT01132313|5980932|P4|COMPLETED|Overall Study||48
2438281|NCT01132313|5980933|P3|COMPLETED|Overall Study||61
2438282|NCT01132313|5980934|P2|COMPLETED|Overall Study||17
2438283|NCT01132313|5980935|P1|COMPLETED|Overall Study||14
2438284|NCT01132313|5980924|P12|STARTED|Overall Study||2
2438285|NCT01132313|5980925|P11|STARTED|Overall Study||1
2438286|NCT01132313|5980926|P10|STARTED|Overall Study||25
2438287|NCT01132313|5980927|P9|STARTED|Overall Study||26
2438288|NCT01132313|5980928|P8|STARTED|Overall Study||32
2438289|NCT01132313|5980929|P7|STARTED|Overall Study||49
2438290|NCT01132313|5980930|P6|STARTED|Overall Study||79
2438291|NCT01132313|5980931|P5|STARTED|Overall Study||79
2438292|NCT01132313|5980932|P4|STARTED|Overall Study||80
2438293|NCT01132313|5980933|P3|STARTED|Overall Study||81
2438294|NCT01132313|5980934|P2|STARTED|Overall Study||17
2438295|NCT01132313|5980935|P1|STARTED|Overall Study||17
2438296|NCT01132144|5980992|P2|NOT COMPLETED|Overall Study||0
2438297|NCT01132144|5980993|P1|NOT COMPLETED|Overall Study||0
2438298|NCT01132144|5980992|P2|COMPLETED|Overall Study||79
2438299|NCT01132144|5980993|P1|COMPLETED|Overall Study||79
2438300|NCT01132144|5980992|P2|STARTED|Overall Study||79
2438301|NCT01132144|5980993|P1|STARTED|Overall Study||79
2438302|NCT01132118|5981015|P2|NOT COMPLETED|Second Intervention (8 Weeks)||1
2438303|NCT01132118|5981016|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
2438304|NCT01132118|5981015|P2|COMPLETED|Second Intervention (8 Weeks)||11
2438305|NCT01132118|5981016|P1|COMPLETED|Second Intervention (8 Weeks)||12
2438306|NCT01132118|5981015|P2|STARTED|Second Intervention (8 Weeks)||12
2438307|NCT01132118|5981016|P1|STARTED|Second Intervention (8 Weeks)||12
2438308|NCT01132118|5981015|P2|NOT COMPLETED|First Intervention (8 Weeks)||3
2438309|NCT01132118|5981016|P1|NOT COMPLETED|First Intervention (8 Weeks)||3
2438310|NCT01132118|5981015|P2|COMPLETED|First Intervention (8 Weeks)||12
2438311|NCT01132118|5981016|P1|COMPLETED|First Intervention (8 Weeks)||12
2438312|NCT01132118|5981015|P2|STARTED|First Intervention (8 Weeks)||15
2438313|NCT01132118|5981016|P1|STARTED|First Intervention (8 Weeks)||15
2438314|NCT01131884|5981036|P2|NOT COMPLETED|Overall Study||0
2438315|NCT01131884|5981037|P1|NOT COMPLETED|Overall Study||0
2438316|NCT01131884|5981036|P2|COMPLETED|Overall Study||0
2438317|NCT01131884|5981037|P1|COMPLETED|Overall Study||1
2438318|NCT01131884|5981036|P2|STARTED|Overall Study||0
2438319|NCT01131884|5981037|P1|STARTED|Overall Study||1
2438320|NCT01131676|5981046|P3|NOT COMPLETED|Discontinuation From Study (Treated Set)||63
2438321|NCT01131676|5981047|P2|NOT COMPLETED|Discontinuation From Study (Treated Set)||81
2438322|NCT01131676|5981048|P1|NOT COMPLETED|Discontinuation From Study (Treated Set)||67
2438323|NCT01131676|5981046|P3|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2279
2438324|NCT01131676|5981047|P2|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2264
2438325|NCT01131676|5981048|P1|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2266
2438326|NCT01131676|5981046|P3|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2327
2438327|NCT01131676|5981047|P2|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2324
2438328|NCT01131676|5981048|P1|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2316
2438329|NCT01131676|5981046|P3|STARTED|Discontinuation From Study (Treated Set)||2342
2438330|NCT01131676|5981047|P2|STARTED|Discontinuation From Study (Treated Set)||2345
2438331|NCT01131676|5981048|P1|STARTED|Discontinuation From Study (Treated Set)||2333
2438332|NCT01131676|5981046|P3|NOT COMPLETED|Discontinuation From Treatment||544
2438333|NCT01131676|5981047|P2|NOT COMPLETED|Discontinuation From Treatment||557
2438334|NCT01131676|5981048|P1|NOT COMPLETED|Discontinuation From Treatment||687
2438335|NCT01131676|5981046|P3|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1800
2438336|NCT01131676|5981047|P2|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1790
2438337|NCT01131676|5981048|P1|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1650
2438338|NCT01131676|5981046|P3|STARTED|Discontinuation From Treatment|Randomised|2344
2438339|NCT01131676|5981047|P2|STARTED|Discontinuation From Treatment|Randomised|2347
2438340|NCT01131676|5981048|P1|STARTED|Discontinuation From Treatment|Randomised|2337
2438341|NCT01131585|5981083|P2|NOT COMPLETED|Overall Study||43
2438342|NCT01131585|5981084|P1|NOT COMPLETED|Overall Study||85
2438343|NCT01131585|5981083|P2|COMPLETED|Overall Study||0
2438344|NCT01131585|5981084|P1|COMPLETED|Overall Study||0
2438345|NCT01131585|5981083|P2|STARTED|Overall Study||43
2438346|NCT01131585|5981084|P1|STARTED|Overall Study||85
2438347|NCT01131520|5981092|P2|NOT COMPLETED|Overall Study||4
2438348|NCT01131520|5981093|P1|NOT COMPLETED|Overall Study||1
2438349|NCT01131520|5981092|P2|COMPLETED|Overall Study||176
2438350|NCT01131520|5981093|P1|COMPLETED|Overall Study||179
2438351|NCT01131520|5981092|P2|STARTED|Overall Study||180
2438352|NCT01131520|5981093|P1|STARTED|Overall Study||180
2438353|NCT01131507|5981115|P1|NOT COMPLETED|Overall Study||3
2438354|NCT01131507|5981115|P1|COMPLETED|Overall Study||12
2438355|NCT01131507|5981115|P1|STARTED|Overall Study||15
2438356|NCT01131494|5981120|P1|NOT COMPLETED|Overall Study||2
2438357|NCT01131494|5981120|P1|COMPLETED|Overall Study||15
2438358|NCT01131494|5981120|P1|STARTED|Overall Study||17
2438359|NCT01131455|5981130|P3|NOT COMPLETED|Overall Study||0
2438360|NCT01131455|5981131|P2|NOT COMPLETED|Overall Study||4
2438361|NCT01131455|5981132|P1|NOT COMPLETED|Overall Study||6
2438362|NCT01131455|5981130|P3|COMPLETED|Overall Study||0
2438363|NCT01131455|5981131|P2|COMPLETED|Overall Study||0
2438364|NCT01131455|5981132|P1|COMPLETED|Overall Study||0
2438365|NCT01131455|5981130|P3|STARTED|Overall Study||0
2438366|NCT01131455|5981131|P2|STARTED|Overall Study||4
2438367|NCT01131455|5981132|P1|STARTED|Overall Study||6
2438368|NCT01131312|5981143|P3|NOT COMPLETED|Overall Study||351
2438369|NCT01131312|5981144|P2|NOT COMPLETED|Overall Study||229
2438370|NCT01131312|5981145|P1|NOT COMPLETED|Overall Study||425
2438371|NCT01131312|5981143|P3|COMPLETED|Overall Study||1485
2438372|NCT01131312|5981144|P2|COMPLETED|Overall Study||1156
2438373|NCT01131312|5981145|P1|COMPLETED|Overall Study||1414
2438374|NCT01131312|5981143|P3|STARTED|Overall Study||1836
2438375|NCT01131312|5981144|P2|STARTED|Overall Study||1385
2438376|NCT01131312|5981145|P1|STARTED|Overall Study||1839
2438377|NCT01131299|5981156|P2|NOT COMPLETED|Overall Study||7
2438378|NCT01131299|5981157|P1|NOT COMPLETED|Overall Study||4
2438379|NCT01131299|5981156|P2|COMPLETED|Overall Study||37
2438380|NCT01131299|5981157|P1|COMPLETED|Overall Study||38
2438381|NCT01131299|5981156|P2|STARTED|Overall Study||44
2438382|NCT01131299|5981157|P1|STARTED|Overall Study||42
2438383|NCT01131260|5981170|P2|NOT COMPLETED|Overall Study||47
2438384|NCT01131260|5981171|P1|NOT COMPLETED|Overall Study||44
2438385|NCT01131260|5981170|P2|COMPLETED|Overall Study||5529
2438386|NCT01131260|5981171|P1|COMPLETED|Overall Study||5488
2438387|NCT01131260|5981170|P2|STARTED|Overall Study||5576
2438388|NCT01131260|5981171|P1|STARTED|Overall Study||5532
2438389|NCT01131182|5981219|P2|NOT COMPLETED|Overall Study||16
2438390|NCT01131182|5981220|P1|NOT COMPLETED|Overall Study||16
2438391|NCT01131182|5981219|P2|COMPLETED|Overall Study||521
2438392|NCT01131182|5981220|P1|COMPLETED|Overall Study||513
2438393|NCT01131182|5981219|P2|STARTED|Overall Study||537
2438394|NCT01131182|5981220|P1|STARTED|Overall Study||529
2438395|NCT01131130|5981228|P1|NOT COMPLETED|Period 3- Crossover||1
2438396|NCT01131130|5981228|P1|COMPLETED|Period 3- Crossover||116
2438397|NCT01131130|5981228|P1|STARTED|Period 3- Crossover||117
2438398|NCT01131130|5981228|P1|NOT COMPLETED|Period 2 - Crossover||0
2438399|NCT01131130|5981228|P1|COMPLETED|Period 2 - Crossover||117
2438400|NCT01131130|5981228|P1|STARTED|Period 2 - Crossover||117
2438401|NCT01131130|5981228|P1|NOT COMPLETED|Period 1 - Baseline||1
2438402|NCT01131130|5981228|P1|COMPLETED|Period 1 - Baseline|Participant was discontinued 1 day following dispensing and not reported in result tables|117
2438403|NCT01131130|5981228|P1|STARTED|Period 1 - Baseline||118
2438404|NCT01131104|5981241|P1|NOT COMPLETED|Overall Study||13
2438405|NCT01131104|5981241|P1|COMPLETED|Overall Study||332
2438406|NCT01131104|5981241|P1|12-Month Analysis Set|Overall Study||26
2438407|NCT01131104|5981241|P1|42-Day Analysis Set|Overall Study||28
2438408|NCT01131104|5981241|P1|30-Day Analysis Set|Overall Study||24
2438409|NCT01131104|5981241|P1|Adjudication-Confirmed NAION Set|Overall Study||279
2438410|NCT01131104|5981241|P1|Study Set|Overall Study||344
2438411|NCT01131104|5981241|P1|STARTED|Overall Study||345
2438412|NCT01131078|5981248|P3|NOT COMPLETED|Overall Study||102
2438413|NCT01131078|5981249|P2|NOT COMPLETED|Overall Study||101
2438414|NCT01131078|5981250|P1|NOT COMPLETED|Overall Study||101
2438415|NCT01131078|5981248|P3|COMPLETED|Overall Study||1
2438416|NCT01131078|5981249|P2|COMPLETED|Overall Study||1
2438417|NCT01131078|5981250|P1|COMPLETED|Overall Study||0
2438418|NCT01131078|5981248|P3|STARTED|Overall Study||103
2438419|NCT01131078|5981249|P2|STARTED|Overall Study||102
2438420|NCT01131078|5981250|P1|STARTED|Overall Study||101
2438421|NCT01131065|5981306|P1|NOT COMPLETED|Overall Study||0
2438422|NCT01131065|5981306|P1|COMPLETED|Overall Study||15
2438423|NCT01131065|5981306|P1|STARTED|Overall Study||15
2438424|NCT01131052|5981314|P2|NOT COMPLETED|Overall Study||0
2438425|NCT01131052|5981315|P1|NOT COMPLETED|Overall Study||0
2438426|NCT01131052|5981314|P2|COMPLETED|Overall Study||75
2438427|NCT01131052|5981315|P1|COMPLETED|Overall Study||75
2438428|NCT01131052|5981314|P2|STARTED|Overall Study||75
2438429|NCT01131052|5981315|P1|STARTED|Overall Study||75
2438430|NCT01130974|5981337|P2|NOT COMPLETED|Overall Study||13
2438431|NCT01130974|5981338|P1|NOT COMPLETED|Overall Study||15
2438432|NCT01130974|5981337|P2|COMPLETED|Overall Study||87
2438433|NCT01130974|5981338|P1|COMPLETED|Overall Study||85
2438434|NCT01130974|5981337|P2|STARTED|Overall Study||100
2438435|NCT01130974|5981338|P1|STARTED|Overall Study||100
2438436|NCT01130896|5981358|P1|NOT COMPLETED|Overall Study||0
2438437|NCT01130896|5981358|P1|COMPLETED|Overall Study||1509
2438438|NCT01130896|5981358|P1|STARTED|Overall Study||1509
2438439|NCT01130883|5981364|P1|NOT COMPLETED|Overall Study||10
2438440|NCT01130883|5981364|P1|COMPLETED|Overall Study||3120
2438441|NCT01130883|5981364|P1|Participants Analyzed|Overall Study||3128
2438442|NCT01130883|5981364|P1|STARTED|Overall Study||3130
2438443|NCT01130844|5981381|P3|NOT COMPLETED|Overall Study||0
2438444|NCT01130844|5981382|P2|NOT COMPLETED|Overall Study||0
2438445|NCT01130844|5981383|P1|NOT COMPLETED|Overall Study||0
2438446|NCT01130844|5981381|P3|COMPLETED|Overall Study||9
2438447|NCT01130844|5981382|P2|COMPLETED|Overall Study||22
2438448|NCT01130844|5981383|P1|COMPLETED|Overall Study||21
2438449|NCT01130844|5981381|P3|STARTED|Overall Study||9
2438450|NCT01130844|5981382|P2|STARTED|Overall Study||22
2438451|NCT01130844|5981383|P1|STARTED|Overall Study||21
2438452|NCT01130831|5981421|P1|NOT COMPLETED|Overall Study||14
2438453|NCT01130831|5981421|P1|COMPLETED|Overall Study||52
2438454|NCT01130831|5981421|P1|STARTED|Overall Study||66
2438455|NCT01130740|5981449|P2|NOT COMPLETED|Overall Study||15
2438456|NCT01130740|5981450|P1|NOT COMPLETED|Overall Study||12
2438457|NCT01130740|5981449|P2|COMPLETED|Overall Study||136
2438458|NCT01130740|5981450|P1|COMPLETED|Overall Study||137
2438459|NCT01130740|5981449|P2|STARTED|Overall Study||151
2438460|NCT01130740|5981450|P1|STARTED|Overall Study||149
2438461|NCT01130597|5981460|P1|NOT COMPLETED|Overall Study||7
2438462|NCT01130597|5981460|P1|COMPLETED|Overall Study||56
2438463|NCT01130597|5981460|P1|STARTED|Overall Study||63
2438464|NCT01130532|5981485|P4|NOT COMPLETED|Period IV (Weeks 13-16)||10
2438465|NCT01130532|5981486|P3|NOT COMPLETED|Period IV (Weeks 13-16)||0
2438466|NCT01130532|5981487|P2|NOT COMPLETED|Period IV (Weeks 13-16)||0
2438467|NCT01130532|5981488|P1|NOT COMPLETED|Period IV (Weeks 13-16)||0
2438468|NCT01130532|5981485|P4|COMPLETED|Period IV (Weeks 13-16)||552
2438469|NCT01130532|5981486|P3|COMPLETED|Period IV (Weeks 13-16)||0
2438470|NCT01130532|5981487|P2|COMPLETED|Period IV (Weeks 13-16)||0
2438471|NCT01130532|5981488|P1|COMPLETED|Period IV (Weeks 13-16)||0
2438472|NCT01130532|5981485|P4|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||546
2438473|NCT01130532|5981486|P3|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
2438474|NCT01130532|5981487|P2|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
2438475|NCT01130532|5981488|P1|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
2438476|NCT01130532|5981485|P4|STARTED|Period IV (Weeks 13-16)|Three participants who completed Period III chose not to continue into Period IV.|562
2438477|NCT01130532|5981486|P3|STARTED|Period IV (Weeks 13-16)||0
2438478|NCT01130532|5981487|P2|STARTED|Period IV (Weeks 13-16)||0
2438479|NCT01130532|5981488|P1|STARTED|Period IV (Weeks 13-16)||0
2438480|NCT01130532|5981485|P4|NOT COMPLETED|Period III (Weeks 0-12)||0
2438481|NCT01130532|5981486|P3|NOT COMPLETED|Period III (Weeks 0-12)||19
2438482|NCT01130532|5981487|P2|NOT COMPLETED|Period III (Weeks 0-12)||18
2438483|NCT01130532|5981488|P1|NOT COMPLETED|Period III (Weeks 0-12)||21
2438484|NCT01130532|5981485|P4|COMPLETED|Period III (Weeks 0-12)||0
2438485|NCT01130532|5981486|P3|COMPLETED|Period III (Weeks 0-12)||190
2438486|NCT01130532|5981487|P2|COMPLETED|Period III (Weeks 0-12)||189
2438487|NCT01130532|5981488|P1|COMPLETED|Period III (Weeks 0-12)||186
2438488|NCT01130532|5981485|P4|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||0
2438660|NCT01129960|5981680|P1|COMPLETED|Overall Study||54
2438489|NCT01130532|5981486|P3|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||207
2438490|NCT01130532|5981487|P2|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
2438491|NCT01130532|5981488|P1|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
2438492|NCT01130532|5981485|P4|STARTED|Period III (Weeks 0-12)||0
2438493|NCT01130532|5981486|P3|STARTED|Period III (Weeks 0-12)||209
2438494|NCT01130532|5981487|P2|STARTED|Period III (Weeks 0-12)||207
2438495|NCT01130532|5981488|P1|STARTED|Period III (Weeks 0-12)||207
2438496|NCT01130493|5981533|P3|NOT COMPLETED|Part 2: OLE||5
2438497|NCT01130493|5981534|P2|NOT COMPLETED|Part 2: OLE||3
2438498|NCT01130493|5981535|P1|NOT COMPLETED|Part 2: OLE||0
2438499|NCT01130493|5981533|P3|COMPLETED|Part 2: OLE||30
2438500|NCT01130493|5981534|P2|COMPLETED|Part 2: OLE||36
2438501|NCT01130493|5981535|P1|COMPLETED|Part 2: OLE||0
2438502|NCT01130493|5981533|P3|STARTED|Part 2: OLE|No subjects received CLE during OLE|35
2438503|NCT01130493|5981534|P2|STARTED|Part 2: OLE|All subjects received IPX066 during OLE|39
2438504|NCT01130493|5981535|P1|STARTED|Part 2: OLE||0
2438505|NCT01130493|5981533|P3|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||2
2438506|NCT01130493|5981534|P2|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
2438507|NCT01130493|5981535|P1|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
2438508|NCT01130493|5981533|P3|COMPLETED|Part 1: Double-blind Treatment Period 2||39
2438509|NCT01130493|5981534|P2|COMPLETED|Part 1: Double-blind Treatment Period 2||45
2438510|NCT01130493|5981535|P1|COMPLETED|Part 1: Double-blind Treatment Period 2||0
2438511|NCT01130493|5981533|P3|STARTED|Part 1: Double-blind Treatment Period 2||41
2438512|NCT01130493|5981534|P2|STARTED|Part 1: Double-blind Treatment Period 2||45
2438513|NCT01130493|5981535|P1|STARTED|Part 1: Double-blind Treatment Period 2||0
2438514|NCT01130493|5981533|P3|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||2
2438515|NCT01130493|5981534|P2|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||1
2438516|NCT01130493|5981535|P1|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||0
2438517|NCT01130493|5981533|P3|COMPLETED|Part 1: Open-Label IPX066 Washout||41
2438518|NCT01130493|5981534|P2|COMPLETED|Part 1: Open-Label IPX066 Washout||45
2438519|NCT01130493|5981535|P1|COMPLETED|Part 1: Open-Label IPX066 Washout||0
2438520|NCT01130493|5981533|P3|STARTED|Part 1: Open-Label IPX066 Washout||43
2438521|NCT01130493|5981534|P2|STARTED|Part 1: Open-Label IPX066 Washout||46
2438522|NCT01130493|5981535|P1|STARTED|Part 1: Open-Label IPX066 Washout||0
2438523|NCT01130493|5981533|P3|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
2438524|NCT01130493|5981534|P2|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||2
2438525|NCT01130493|5981535|P1|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
2438526|NCT01130493|5981533|P3|COMPLETED|Part 1: Double-blind Treatment Period 1||43
2438527|NCT01130493|5981534|P2|COMPLETED|Part 1: Double-blind Treatment Period 1||46
2438528|NCT01130493|5981535|P1|COMPLETED|Part 1: Double-blind Treatment Period 1||0
2438529|NCT01130493|5981533|P3|STARTED|Part 1: Double-blind Treatment Period 1|43 were randomized to CLE-IPX066 double-blind treatment sequence|43
2438530|NCT01130493|5981534|P2|STARTED|Part 1: Double-blind Treatment Period 1|48 were randomized to IPX066-CLE double-blind treatment sequence|48
2438531|NCT01130493|5981535|P1|STARTED|Part 1: Double-blind Treatment Period 1|91 subjects completed IPX066 dose conversion and were then randomized to the two treatment sequences|0
2438532|NCT01130493|5981533|P3|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
2438533|NCT01130493|5981534|P2|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
2438534|NCT01130493|5981535|P1|NOT COMPLETED|Open-label Dose Conversion to IPX066||19
2438535|NCT01130493|5981533|P3|COMPLETED|Open-label Dose Conversion to IPX066||0
2438536|NCT01130493|5981534|P2|COMPLETED|Open-label Dose Conversion to IPX066||0
2438537|NCT01130493|5981535|P1|COMPLETED|Open-label Dose Conversion to IPX066||91
2438538|NCT01130493|5981533|P3|STARTED|Open-label Dose Conversion to IPX066||0
2438539|NCT01130493|5981534|P2|STARTED|Open-label Dose Conversion to IPX066||0
2438540|NCT01130493|5981535|P1|STARTED|Open-label Dose Conversion to IPX066|During the open-label dose conversion to IPX066, all subjects received IPX066|110
2438541|NCT01130337|5981552|P1|NOT COMPLETED|Overall Study||14
2438542|NCT01130337|5981552|P1|COMPLETED|Overall Study||22
2438543|NCT01130337|5981552|P1|STARTED|Overall Study||36
2438544|NCT01130272|5981564|P5|NOT COMPLETED|Overall Study||52
2438545|NCT01130272|5981565|P4|NOT COMPLETED|Overall Study||68
2438546|NCT01130272|5981566|P3|NOT COMPLETED|Overall Study||48
2438547|NCT01130272|5981567|P2|NOT COMPLETED|Overall Study||42
2438548|NCT01130272|5981568|P1|NOT COMPLETED|Overall Study||59
2438549|NCT01130272|5981564|P5|COMPLETED|Overall Study||117
2438550|NCT01130272|5981565|P4|COMPLETED|Overall Study||103
2438551|NCT01130272|5981566|P3|COMPLETED|Overall Study||121
2438552|NCT01130272|5981567|P2|COMPLETED|Overall Study||131
2438553|NCT01130272|5981568|P1|COMPLETED|Overall Study||48
2438554|NCT01130272|5981564|P5|Safety Analysis Set: Highest Dose Level|Overall Study|159 total represents 2 patients out to 25 mg arm; 1 patient out to 5 mg arm.|159
2438555|NCT01130272|5981565|P4|Safety Analysis Set: Highest Dose Level|Overall Study|172 total represents 1 patient in from 5 mg; 3 patients in from 25 mg;1 patient in from 100 mg arms.|172
2438556|NCT01130272|5981566|P3|Safety Analysis Set: Highest Dose Level|Overall Study|165 total represents 1 patient out to 200 mg arm.|165
2438557|NCT01130272|5981567|P2|Safety Analysis Set: Highest Dose Level|Overall Study|170 total represents 2 patients in from Placebo arm; 3 patients out to 200 mg arm.|170
2438558|NCT01130272|5981568|P1|Safety Analysis Set: Highest Dose Level|Overall Study|105 total represents 1 patient in from Placebo arm; 1 patient out to 200 mg arm.|105
2438559|NCT01130272|5981564|P5|Safety Analysis Set: as Randomized|Overall Study||162
2438560|NCT01130272|5981565|P4|Safety Analysis Set: as Randomized|Overall Study||167
2438561|NCT01130272|5981566|P3|Safety Analysis Set: as Randomized|Overall Study||166
2438562|NCT01130272|5981567|P2|Safety Analysis Set: as Randomized|Overall Study||171
2438563|NCT01130272|5981568|P1|Safety Analysis Set: as Randomized|Overall Study||105
2438564|NCT01130272|5981564|P5|STARTED|Overall Study||169
2438565|NCT01130272|5981565|P4|STARTED|Overall Study||171
2438566|NCT01130272|5981566|P3|STARTED|Overall Study||169
2438567|NCT01130272|5981567|P2|STARTED|Overall Study||173
2438568|NCT01130272|5981568|P1|STARTED|Overall Study||107
2438569|NCT01130168|5981605|P6|NOT COMPLETED|Period 3||0
2438570|NCT01130168|5981606|P5|NOT COMPLETED|Period 3||0
2438571|NCT01130168|5981607|P4|NOT COMPLETED|Period 3||0
2438572|NCT01130168|5981608|P3|NOT COMPLETED|Period 3||0
2438573|NCT01130168|5981609|P2|NOT COMPLETED|Period 3||0
2438574|NCT01130168|5981610|P1|NOT COMPLETED|Period 3||0
2438575|NCT01130168|5981605|P6|COMPLETED|Period 3||6
2438576|NCT01130168|5981606|P5|COMPLETED|Period 3||5
2438577|NCT01130168|5981607|P4|COMPLETED|Period 3||5
2438578|NCT01130168|5981608|P3|COMPLETED|Period 3||5
2438579|NCT01130168|5981609|P2|COMPLETED|Period 3||6
2438580|NCT01130168|5981610|P1|COMPLETED|Period 3||6
2438581|NCT01130168|5981605|P6|STARTED|Period 3||6
2438582|NCT01130168|5981606|P5|STARTED|Period 3||5
2438583|NCT01130168|5981607|P4|STARTED|Period 3||5
2438584|NCT01130168|5981608|P3|STARTED|Period 3||5
2438585|NCT01130168|5981609|P2|STARTED|Period 3||6
2438586|NCT01130168|5981610|P1|STARTED|Period 3||6
2438587|NCT01130168|5981605|P6|NOT COMPLETED|Period 2||0
2438588|NCT01130168|5981606|P5|NOT COMPLETED|Period 2||0
2438589|NCT01130168|5981607|P4|NOT COMPLETED|Period 2||0
2438590|NCT01130168|5981608|P3|NOT COMPLETED|Period 2||0
2438591|NCT01130168|5981609|P2|NOT COMPLETED|Period 2||0
2438592|NCT01130168|5981610|P1|NOT COMPLETED|Period 2||0
2438593|NCT01130168|5981605|P6|COMPLETED|Period 2||6
2438594|NCT01130168|5981606|P5|COMPLETED|Period 2||5
2438595|NCT01130168|5981607|P4|COMPLETED|Period 2||5
2438596|NCT01130168|5981608|P3|COMPLETED|Period 2||5
2438597|NCT01130168|5981609|P2|COMPLETED|Period 2||6
2438598|NCT01130168|5981610|P1|COMPLETED|Period 2||6
2438599|NCT01130168|5981605|P6|STARTED|Period 2||6
2438600|NCT01130168|5981606|P5|STARTED|Period 2||5
2438601|NCT01130168|5981607|P4|STARTED|Period 2||5
2438602|NCT01130168|5981608|P3|STARTED|Period 2||5
2438603|NCT01130168|5981609|P2|STARTED|Period 2||6
2438604|NCT01130168|5981610|P1|STARTED|Period 2||6
2438605|NCT01130168|5981605|P6|NOT COMPLETED|Period 1||0
2438606|NCT01130168|5981606|P5|NOT COMPLETED|Period 1||0
2438607|NCT01130168|5981607|P4|NOT COMPLETED|Period 1||3
2438608|NCT01130168|5981608|P3|NOT COMPLETED|Period 1||1
2438609|NCT01130168|5981609|P2|NOT COMPLETED|Period 1||1
2438610|NCT01130168|5981610|P1|NOT COMPLETED|Period 1||0
2438611|NCT01130168|5981605|P6|COMPLETED|Period 1||6
2438612|NCT01130168|5981606|P5|COMPLETED|Period 1||5
2438613|NCT01130168|5981607|P4|COMPLETED|Period 1||5
2438614|NCT01130168|5981608|P3|COMPLETED|Period 1||5
2438615|NCT01130168|5981609|P2|COMPLETED|Period 1||6
2438616|NCT01130168|5981610|P1|COMPLETED|Period 1||6
2438617|NCT01130168|5981605|P6|STARTED|Period 1||6
2438618|NCT01130168|5981606|P5|STARTED|Period 1||5
2438619|NCT01130168|5981607|P4|STARTED|Period 1||8
2438620|NCT01130168|5981608|P3|STARTED|Period 1||6
2438621|NCT01130168|5981609|P2|STARTED|Period 1||7
2438622|NCT01130168|5981610|P1|STARTED|Period 1||6
2438623|NCT01130103|5981647|P2|NOT COMPLETED|Maintenance Treatment||2
2438624|NCT01130103|5981648|P1|NOT COMPLETED|Maintenance Treatment||2
2438625|NCT01130103|5981647|P2|COMPLETED|Maintenance Treatment||11
2438626|NCT01130103|5981648|P1|COMPLETED|Maintenance Treatment||11
2438627|NCT01130103|5981647|P2|STARTED|Maintenance Treatment||13
2438628|NCT01130103|5981648|P1|STARTED|Maintenance Treatment||13
2438629|NCT01130103|5981647|P2|NOT COMPLETED|Randomized Treatment||5
2438630|NCT01130103|5981648|P1|NOT COMPLETED|Randomized Treatment||6
2438631|NCT01130103|5981647|P2|COMPLETED|Randomized Treatment||13
2438632|NCT01130103|5981648|P1|COMPLETED|Randomized Treatment||13
2438633|NCT01130103|5981647|P2|STARTED|Randomized Treatment||18
2438634|NCT01130103|5981648|P1|STARTED|Randomized Treatment||19
2438635|NCT01130051|5981662|P2|NOT COMPLETED|Period 2||0
2438636|NCT01130051|5981663|P1|NOT COMPLETED|Period 2||0
2438637|NCT01130051|5981662|P2|COMPLETED|Period 2||6
2438638|NCT01130051|5981663|P1|COMPLETED|Period 2||7
2438639|NCT01130051|5981662|P2|STARTED|Period 2||6
2438640|NCT01130051|5981663|P1|STARTED|Period 2||7
2438641|NCT01130051|5981662|P2|NOT COMPLETED|Washout Period of 14 Days||2
2438642|NCT01130051|5981663|P1|NOT COMPLETED|Washout Period of 14 Days||1
2438643|NCT01130051|5981662|P2|COMPLETED|Washout Period of 14 Days||6
2438644|NCT01130051|5981663|P1|COMPLETED|Washout Period of 14 Days||7
2438645|NCT01130051|5981662|P2|STARTED|Washout Period of 14 Days||8
2438646|NCT01130051|5981663|P1|STARTED|Washout Period of 14 Days||8
2438647|NCT01130051|5981662|P2|NOT COMPLETED|Period 1||0
2438648|NCT01130051|5981663|P1|NOT COMPLETED|Period 1||0
2438649|NCT01130051|5981662|P2|COMPLETED|Period 1||8
2438650|NCT01130051|5981663|P1|COMPLETED|Period 1||8
2438651|NCT01130051|5981662|P2|STARTED|Period 1||8
2438652|NCT01130051|5981663|P1|STARTED|Period 1||8
2438653|NCT01129960|5981677|P4|NOT COMPLETED|Overall Study||13
2438654|NCT01129960|5981678|P3|NOT COMPLETED|Overall Study||26
2438655|NCT01129960|5981679|P2|NOT COMPLETED|Overall Study||22
2438656|NCT01129960|5981680|P1|NOT COMPLETED|Overall Study||30
2438657|NCT01129960|5981677|P4|COMPLETED|Overall Study||70
2438658|NCT01129960|5981678|P3|COMPLETED|Overall Study||56
2438659|NCT01129960|5981679|P2|COMPLETED|Overall Study||61
2438661|NCT01129960|5981677|P4|Full Analysis Set (FAS|Overall Study||71
2438662|NCT01129960|5981678|P3|Full Analysis Set (FAS|Overall Study||68
2438663|NCT01129960|5981679|P2|Full Analysis Set (FAS|Overall Study||67
2438664|NCT01129960|5981680|P1|Full Analysis Set (FAS|Overall Study||71
2438665|NCT01129960|5981677|P4|Per-Protocol|Overall Study||55
2438666|NCT01129960|5981678|P3|Per-Protocol|Overall Study||49
2438667|NCT01129960|5981679|P2|Per-Protocol|Overall Study||52
2438668|NCT01129960|5981680|P1|Per-Protocol|Overall Study||34
2438669|NCT01129960|5981677|P4|Intent-to-Treat|Overall Study||83
2438670|NCT01129960|5981678|P3|Intent-to-Treat|Overall Study||82
2438671|NCT01129960|5981679|P2|Intent-to-Treat|Overall Study||83
2438672|NCT01129960|5981680|P1|Intent-to-Treat|Overall Study||84
2438673|NCT01129960|5981677|P4|Safety|Overall Study||82
2438674|NCT01129960|5981678|P3|Safety|Overall Study|One subject was randomized to placebo, but was dispensed in error with an ESL 800 mg kit at DB Visit|83
2438675|NCT01129960|5981679|P2|Safety|Overall Study||83
2438676|NCT01129960|5981680|P1|Safety|Overall Study||84
2438677|NCT01129960|5981677|P4|STARTED|Overall Study||83
2438678|NCT01129960|5981678|P3|STARTED|Overall Study||82
2438679|NCT01129960|5981679|P2|STARTED|Overall Study||83
2438680|NCT01129960|5981680|P1|STARTED|Overall Study||84
2438681|NCT01129921|5981692|P2|NOT COMPLETED|After Sham Cross-over to Mild, One Year||7
2438682|NCT01129921|5981693|P1|NOT COMPLETED|After Sham Cross-over to Mild, One Year||2
2438683|NCT01129921|5981692|P2|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis prior to x-over. After x-over 13 reported Year 1.|13
2438684|NCT01129921|5981693|P1|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis. Eighteen reported Year 1 outcomes.|18
2438685|NCT01129921|5981692|P2|STARTED|After Sham Cross-over to Mild, One Year||20
2438686|NCT01129921|5981693|P1|STARTED|After Sham Cross-over to Mild, One Year||20
2438687|NCT01129921|5981692|P2|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
2438688|NCT01129921|5981693|P1|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
2438689|NCT01129921|5981692|P2|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
2438690|NCT01129921|5981693|P1|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
2438691|NCT01129921|5981692|P2|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
2438692|NCT01129921|5981693|P1|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
2438693|NCT01129882|5981703|P1|NOT COMPLETED|Overall Study||278
2438694|NCT01129882|5981703|P1|COMPLETED|Overall Study||431
2438695|NCT01129882|5981703|P1|Received at Least 1 Dose of Study Drug|Overall Study||709
2438696|NCT01129882|5981703|P1|STARTED|Overall Study||709
2438697|NCT01129778|5981708|P1|NOT COMPLETED|Overall Study||7
2438698|NCT01129778|5981708|P1|COMPLETED|Overall Study||15
2438699|NCT01129778|5981708|P1|STARTED|Overall Study||22
2438700|NCT01129765|5981713|P1|NOT COMPLETED|Overall Study||0
2438701|NCT01129765|5981713|P1|COMPLETED|Overall Study||30
2438702|NCT01129765|5981713|P1|STARTED|Overall Study||30
2438703|NCT01129622|5981722|P1|NOT COMPLETED|Overall Study||2
2438704|NCT01129622|5981722|P1|COMPLETED|Overall Study||14
2438705|NCT01129622|5981722|P1|STARTED|Overall Study||16
2438706|NCT01129609|5981727|P1|NOT COMPLETED|Overall Study||2
2438707|NCT01129609|5981727|P1|COMPLETED|Overall Study||18
2438708|NCT01129609|5981727|P1|STARTED|Overall Study||20
2438709|NCT01129583|5981733|P2|NOT COMPLETED|Overall Study||2
2438710|NCT01129583|5981734|P1|NOT COMPLETED|Overall Study||3
2438711|NCT01129583|5981733|P2|COMPLETED|Overall Study||7
2438712|NCT01129583|5981734|P1|COMPLETED|Overall Study||6
2438713|NCT01129583|5981733|P2|STARTED|Overall Study||9
2438714|NCT01129583|5981734|P1|STARTED|Overall Study||9
2438715|NCT01129557|5981747|P3|NOT COMPLETED|Overall Study||4
2438716|NCT01129557|5981748|P2|NOT COMPLETED|Overall Study||5
2438717|NCT01129557|5981749|P1|NOT COMPLETED|Overall Study||4
2438718|NCT01129557|5981747|P3|COMPLETED|Overall Study||10
2438719|NCT01129557|5981748|P2|COMPLETED|Overall Study||12
2438720|NCT01129557|5981749|P1|COMPLETED|Overall Study||11
2438721|NCT01129557|5981747|P3|STARTED|Overall Study||14
2438722|NCT01129557|5981748|P2|STARTED|Overall Study||17
2438723|NCT01129557|5981749|P1|STARTED|Overall Study||15
2438724|NCT01129531|5981820|P3|NOT COMPLETED|Treatment Cycle 2||5
2438725|NCT01129531|5981821|P2|NOT COMPLETED|Treatment Cycle 2||3
2438726|NCT01129531|5981822|P1|NOT COMPLETED|Treatment Cycle 2||6
2438727|NCT01129531|5981820|P3|COMPLETED|Treatment Cycle 2||74
2438728|NCT01129531|5981821|P2|COMPLETED|Treatment Cycle 2||92
2438729|NCT01129531|5981822|P1|COMPLETED|Treatment Cycle 2||88
2438730|NCT01129531|5981820|P3|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|79
2438731|NCT01129531|5981821|P2|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|95
2438732|NCT01129531|5981822|P1|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|94
2438733|NCT01129531|5981820|P3|NOT COMPLETED|Treatment Cycle 1||16
2438734|NCT01129531|5981821|P2|NOT COMPLETED|Treatment Cycle 1||6
2438735|NCT01129531|5981822|P1|NOT COMPLETED|Treatment Cycle 1||4
2438736|NCT01129531|5981820|P3|COMPLETED|Treatment Cycle 1||110
2438737|NCT01129531|5981821|P2|COMPLETED|Treatment Cycle 1||78
2438738|NCT01129531|5981822|P1|COMPLETED|Treatment Cycle 1||80
2438739|NCT01129531|5981820|P3|STARTED|Treatment Cycle 1||126
2438740|NCT01129531|5981821|P2|STARTED|Treatment Cycle 1||84
2438741|NCT01129531|5981822|P1|STARTED|Treatment Cycle 1||84
2438752|NCT01129336|5981857|P2|NOT COMPLETED|Overall Study||16
2438753|NCT01129336|5981858|P1|NOT COMPLETED|Overall Study||12
2438754|NCT01129336|5981857|P2|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|13
2438755|NCT01129336|5981858|P1|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|3
2438756|NCT01129336|5981857|P2|Completed Treatment|Overall Study||3
2438757|NCT01129336|5981858|P1|Completed Treatment|Overall Study||1
2438758|NCT01129336|5981857|P2|STARTED|Overall Study||29
2438759|NCT01129336|5981858|P1|STARTED|Overall Study||15
2438760|NCT01129284|5981873|P3|NOT COMPLETED|Overall Study||1
2438761|NCT01129284|5981874|P2|NOT COMPLETED|Overall Study||0
2438762|NCT01129284|5981875|P1|NOT COMPLETED|Overall Study||2
2438763|NCT01129284|5981873|P3|COMPLETED|Overall Study||4
2438764|NCT01129284|5981874|P2|COMPLETED|Overall Study||5
2438765|NCT01129284|5981875|P1|COMPLETED|Overall Study||3
2438766|NCT01129284|5981873|P3|STARTED|Overall Study||5
2438767|NCT01129284|5981874|P2|STARTED|Overall Study||5
2438768|NCT01129284|5981875|P1|STARTED|Overall Study||5
2438769|NCT01129245|5981888|P2|NOT COMPLETED|Treatment Cycle 2||0
2438770|NCT01129245|5981889|P1|NOT COMPLETED|Treatment Cycle 2||0
2438771|NCT01129245|5981888|P2|COMPLETED|Treatment Cycle 2||10
2438772|NCT01129245|5981889|P1|COMPLETED|Treatment Cycle 2||10
2438773|NCT01129245|5981888|P2|STARTED|Treatment Cycle 2||10
2438774|NCT01129245|5981889|P1|STARTED|Treatment Cycle 2||10
2438775|NCT01129245|5981888|P2|NOT COMPLETED|Washout Cycle||0
2438776|NCT01129245|5981889|P1|NOT COMPLETED|Washout Cycle||0
2438777|NCT01129245|5981888|P2|COMPLETED|Washout Cycle||10
2438778|NCT01129245|5981889|P1|COMPLETED|Washout Cycle||10
2438779|NCT01129245|5981888|P2|STARTED|Washout Cycle||10
2438780|NCT01129245|5981889|P1|STARTED|Washout Cycle||10
2438781|NCT01129245|5981888|P2|NOT COMPLETED|Treatment Cycle 1||0
2438782|NCT01129245|5981889|P1|NOT COMPLETED|Treatment Cycle 1||0
2438783|NCT01129245|5981888|P2|COMPLETED|Treatment Cycle 1||10
2438784|NCT01129245|5981889|P1|COMPLETED|Treatment Cycle 1||10
2438785|NCT01129245|5981888|P2|STARTED|Treatment Cycle 1||10
2438786|NCT01129245|5981889|P1|STARTED|Treatment Cycle 1||10
2438787|NCT01129245|5981888|P2|NOT COMPLETED|Control Cycle (no Celecoxib or Placebo)||0
2438788|NCT01129245|5981889|P1|NOT COMPLETED|Control Cycle (no Celecoxib or Placebo)||0
2438789|NCT01129245|5981888|P2|COMPLETED|Control Cycle (no Celecoxib or Placebo)||10
2438790|NCT01129245|5981889|P1|COMPLETED|Control Cycle (no Celecoxib or Placebo)||10
2438791|NCT01129245|5981888|P2|STARTED|Control Cycle (no Celecoxib or Placebo)||10
2438792|NCT01129245|5981889|P1|STARTED|Control Cycle (no Celecoxib or Placebo)||10
2438793|NCT01129206|5981903|P1|NOT COMPLETED|Overall Study||0
2438794|NCT01129206|5981903|P1|COMPLETED|Overall Study||6
2438795|NCT01129206|5981903|P1|STARTED|Overall Study||6
2438796|NCT01129141|5981913|P2|NOT COMPLETED|Overall Study||13
2438797|NCT01129141|5981914|P1|NOT COMPLETED|Overall Study||15
2438798|NCT01129141|5981913|P2|COMPLETED|Overall Study||91
2438799|NCT01129141|5981914|P1|COMPLETED|Overall Study||86
2438800|NCT01129141|5981913|P2|STARTED|Overall Study||104
2438801|NCT01129141|5981914|P1|STARTED|Overall Study||101
2438802|NCT01129128|5981923|P3|NOT COMPLETED|Overall Study||4
2438803|NCT01129128|5981924|P2|NOT COMPLETED|Overall Study||4
2438804|NCT01129128|5981925|P1|NOT COMPLETED|Overall Study||3
2438805|NCT01129128|5981923|P3|COMPLETED|Overall Study||19
2438806|NCT01129128|5981924|P2|COMPLETED|Overall Study||18
2438807|NCT01129128|5981925|P1|COMPLETED|Overall Study||19
2438808|NCT01129128|5981923|P3|STARTED|Overall Study||23
2438809|NCT01129128|5981924|P2|STARTED|Overall Study||22
2438810|NCT01129128|5981925|P1|STARTED|Overall Study||22
2438811|NCT01129115|5981949|P4|NOT COMPLETED|Overall Study||9
2438812|NCT01129115|5981950|P3|NOT COMPLETED|Overall Study||6
2438813|NCT01129115|5981951|P2|NOT COMPLETED|Overall Study||7
2438814|NCT01129115|5981952|P1|NOT COMPLETED|Overall Study||2
2438815|NCT01129115|5981949|P4|COMPLETED|Overall Study||15
2438816|NCT01129115|5981950|P3|COMPLETED|Overall Study||21
2438817|NCT01129115|5981951|P2|COMPLETED|Overall Study||18
2438818|NCT01129115|5981952|P1|COMPLETED|Overall Study||23
2438819|NCT01129115|5981949|P4|STARTED|Overall Study||24
2438820|NCT01129115|5981950|P3|STARTED|Overall Study||27
2438821|NCT01129115|5981951|P2|STARTED|Overall Study||25
2438822|NCT01129115|5981952|P1|STARTED|Overall Study||25
2438823|NCT01129102|5981989|P3|NOT COMPLETED|Overall Study||7
2438824|NCT01129102|5981990|P2|NOT COMPLETED|Overall Study||6
2438825|NCT01129102|5981991|P1|NOT COMPLETED|Overall Study||8
2438826|NCT01129102|5981989|P3|COMPLETED|Overall Study||48
2438827|NCT01129102|5981990|P2|COMPLETED|Overall Study||44
2438828|NCT01129102|5981991|P1|COMPLETED|Overall Study||102
2438829|NCT01129102|5981989|P3|STARTED|Overall Study||55
2438830|NCT01129102|5981990|P2|STARTED|Overall Study||50
2438831|NCT01129102|5981991|P1|STARTED|Overall Study||110
2438832|NCT01129011|5982002|P2|NOT COMPLETED|Overall Study||57
2438833|NCT01129011|5982003|P1|NOT COMPLETED|Overall Study||59
2438834|NCT01129011|5982002|P2|COMPLETED|Overall Study||153
2438835|NCT01129011|5982003|P1|COMPLETED|Overall Study||151
2438836|NCT01129011|5982002|P2|STARTED|Overall Study|Safety, Intent-to-Treat population|210
2438837|NCT01129011|5982003|P1|STARTED|Overall Study|Safety, Intent-to-Treat population|210
2438838|NCT01128972|5982025|P5|NOT COMPLETED|Period V||0
2438839|NCT01128972|5982026|P4|NOT COMPLETED|Period V||0
2438840|NCT01128972|5982027|P3|NOT COMPLETED|Period V||0
2438841|NCT01128972|5982028|P2|NOT COMPLETED|Period V||0
2438842|NCT01128972|5982029|P1|NOT COMPLETED|Period V||0
2438843|NCT01128972|5982025|P5|COMPLETED|Period V||7
2438844|NCT01128972|5982026|P4|COMPLETED|Period V||7
2438845|NCT01128972|5982027|P3|COMPLETED|Period V||7
2438846|NCT01128972|5982028|P2|COMPLETED|Period V||7
2438847|NCT01128972|5982029|P1|COMPLETED|Period V||8
2438848|NCT01128972|5982025|P5|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
2438849|NCT01128972|5982026|P4|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
2438850|NCT01128972|5982027|P3|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
2438851|NCT01128972|5982028|P2|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
2438852|NCT01128972|5982029|P1|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|8
2438853|NCT01128972|5982025|P5|NOT COMPLETED|Period IV||0
2438854|NCT01128972|5982026|P4|NOT COMPLETED|Period IV||0
2438855|NCT01128972|5982027|P3|NOT COMPLETED|Period IV||0
2438856|NCT01128972|5982028|P2|NOT COMPLETED|Period IV||0
2438857|NCT01128972|5982029|P1|NOT COMPLETED|Period IV||0
2438858|NCT01128972|5982025|P5|COMPLETED|Period IV||7
2438859|NCT01128972|5982026|P4|COMPLETED|Period IV||7
2438860|NCT01128972|5982027|P3|COMPLETED|Period IV||7
2438861|NCT01128972|5982028|P2|COMPLETED|Period IV||8
2438862|NCT01128972|5982029|P1|COMPLETED|Period IV||7
2438863|NCT01128972|5982025|P5|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
2438864|NCT01128972|5982026|P4|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
2438865|NCT01128972|5982027|P3|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
2438866|NCT01128972|5982028|P2|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|8
2438867|NCT01128972|5982029|P1|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
2438868|NCT01128972|5982025|P5|NOT COMPLETED|Period III||0
2438869|NCT01128972|5982026|P4|NOT COMPLETED|Period III||0
2438870|NCT01128972|5982027|P3|NOT COMPLETED|Period III||0
2438871|NCT01128972|5982028|P2|NOT COMPLETED|Period III||0
2438872|NCT01128972|5982029|P1|NOT COMPLETED|Period III||0
2438873|NCT01128972|5982025|P5|COMPLETED|Period III||7
2438874|NCT01128972|5982026|P4|COMPLETED|Period III||7
2438875|NCT01128972|5982027|P3|COMPLETED|Period III||8
2438876|NCT01128972|5982028|P2|COMPLETED|Period III||7
2438877|NCT01128972|5982029|P1|COMPLETED|Period III||7
2438878|NCT01128972|5982025|P5|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
2438879|NCT01128972|5982026|P4|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
2438880|NCT01128972|5982027|P3|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|8
2438881|NCT01128972|5982028|P2|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
2438882|NCT01128972|5982029|P1|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
2438883|NCT01128972|5982025|P5|NOT COMPLETED|Period II||0
2438884|NCT01128972|5982026|P4|NOT COMPLETED|Period II||0
2438885|NCT01128972|5982027|P3|NOT COMPLETED|Period II||0
2438886|NCT01128972|5982028|P2|NOT COMPLETED|Period II||0
2438887|NCT01128972|5982029|P1|NOT COMPLETED|Period II||0
2438888|NCT01128972|5982025|P5|COMPLETED|Period II||7
2438889|NCT01128972|5982026|P4|COMPLETED|Period II||8
2438890|NCT01128972|5982027|P3|COMPLETED|Period II||7
2438891|NCT01128972|5982028|P2|COMPLETED|Period II||7
2438892|NCT01128972|5982029|P1|COMPLETED|Period II||7
2438893|NCT01128972|5982025|P5|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
2438894|NCT01128972|5982026|P4|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|8
2438895|NCT01128972|5982027|P3|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
2438896|NCT01128972|5982028|P2|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
2438897|NCT01128972|5982029|P1|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
2438898|NCT01128972|5982025|P5|NOT COMPLETED|Period I||0
2438899|NCT01128972|5982026|P4|NOT COMPLETED|Period I||0
2438900|NCT01128972|5982027|P3|NOT COMPLETED|Period I||0
2438901|NCT01128972|5982028|P2|NOT COMPLETED|Period I||0
2438902|NCT01128972|5982029|P1|NOT COMPLETED|Period I||0
2438903|NCT01128972|5982025|P5|COMPLETED|Period I||8
2438904|NCT01128972|5982026|P4|COMPLETED|Period I||7
2438905|NCT01128972|5982027|P3|COMPLETED|Period I||7
2438906|NCT01128972|5982028|P2|COMPLETED|Period I||7
2438907|NCT01128972|5982029|P1|COMPLETED|Period I||7
2438908|NCT01128972|5982025|P5|STARTED|Period I||8
2438909|NCT01128972|5982026|P4|STARTED|Period I||7
2438910|NCT01128972|5982027|P3|STARTED|Period I||7
2438911|NCT01128972|5982028|P2|STARTED|Period I||7
2438912|NCT01128972|5982029|P1|STARTED|Period I||7
2438913|NCT01128959|5982058|P1|NOT COMPLETED|Treatment Period||4
2438914|NCT01128959|5982058|P1|COMPLETED|Treatment Period||101
2438915|NCT01128959|5982058|P1|STARTED|Treatment Period||105
2438916|NCT01128959|5982058|P1|NOT COMPLETED|Lead in Period||3
2438917|NCT01128959|5982058|P1|COMPLETED|Lead in Period||105
2438918|NCT01128959|5982058|P1|STARTED|Lead in Period||108
2438919|NCT01128946|5982064|P4|NOT COMPLETED|Period IV||0
2438920|NCT01128946|5982065|P3|NOT COMPLETED|Period IV||0
2438921|NCT01128946|5982066|P2|NOT COMPLETED|Period IV||0
2438922|NCT01128946|5982067|P1|NOT COMPLETED|Period IV||0
2438923|NCT01128946|5982064|P4|COMPLETED|Period IV||19
2438924|NCT01128946|5982065|P3|COMPLETED|Period IV||19
2438925|NCT01128946|5982066|P2|COMPLETED|Period IV||20
2438926|NCT01128946|5982067|P1|COMPLETED|Period IV||19
2438927|NCT01128946|5982064|P4|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
2438928|NCT01128946|5982065|P3|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
2438929|NCT01128946|5982066|P2|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|20
2438930|NCT01128946|5982067|P1|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
2438931|NCT01128946|5982064|P4|NOT COMPLETED|Period III||0
2438932|NCT01128946|5982065|P3|NOT COMPLETED|Period III||0
2438933|NCT01128946|5982066|P2|NOT COMPLETED|Period III||0
2438934|NCT01128946|5982067|P1|NOT COMPLETED|Period III||1
2438935|NCT01128946|5982064|P4|COMPLETED|Period III||19
2438936|NCT01128946|5982065|P3|COMPLETED|Period III||20
2438937|NCT01128946|5982066|P2|COMPLETED|Period III||19
2438938|NCT01128946|5982067|P1|COMPLETED|Period III||19
2438939|NCT01128946|5982064|P4|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
2438940|NCT01128946|5982065|P3|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
2438941|NCT01128946|5982066|P2|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
2438942|NCT01128946|5982067|P1|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
2438943|NCT01128946|5982064|P4|NOT COMPLETED|Period II||1
2438944|NCT01128946|5982065|P3|NOT COMPLETED|Period II||0
2438945|NCT01128946|5982066|P2|NOT COMPLETED|Period II||1
2438946|NCT01128946|5982067|P1|NOT COMPLETED|Period II||0
2438947|NCT01128946|5982064|P4|COMPLETED|Period II||19
2438948|NCT01128946|5982065|P3|COMPLETED|Period II||20
2438949|NCT01128946|5982066|P2|COMPLETED|Period II||19
2438950|NCT01128946|5982067|P1|COMPLETED|Period II||20
2438951|NCT01128946|5982064|P4|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
2438952|NCT01128946|5982065|P3|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
2438953|NCT01128946|5982066|P2|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
2438954|NCT01128946|5982067|P1|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
2438955|NCT01128946|5982064|P4|NOT COMPLETED|Period I||1
2438956|NCT01128946|5982065|P3|NOT COMPLETED|Period I||1
2438957|NCT01128946|5982066|P2|NOT COMPLETED|Period I||1
2438958|NCT01128946|5982067|P1|NOT COMPLETED|Period I||0
2438959|NCT01128946|5982064|P4|COMPLETED|Period I||20
2438960|NCT01128946|5982065|P3|COMPLETED|Period I||20
2438961|NCT01128946|5982066|P2|COMPLETED|Period I||20
2438962|NCT01128946|5982067|P1|COMPLETED|Period I||20
2438963|NCT01128946|5982064|P4|STARTED|Period I||21
2438964|NCT01128946|5982065|P3|STARTED|Period I||21
2438965|NCT01128946|5982066|P2|STARTED|Period I||21
2438966|NCT01128946|5982067|P1|STARTED|Period I||20
2438967|NCT01128894|5982085|P2|NOT COMPLETED|Overall Study||68
2438968|NCT01128894|5982086|P1|NOT COMPLETED|Overall Study||58
2438969|NCT01128894|5982085|P2|COMPLETED|Overall Study||340
2438970|NCT01128894|5982086|P1|COMPLETED|Overall Study||346
2438971|NCT01128894|5982085|P2|STARTED|Overall Study||408
2438972|NCT01128894|5982086|P1|STARTED|Overall Study||404
2438973|NCT01128842|5982104|P1|NOT COMPLETED|Overall Study||7
2438974|NCT01128842|5982104|P1|COMPLETED|Overall Study||0
2438975|NCT01128842|5982104|P1|STARTED|Overall Study||7
2438976|NCT01128829|5982114|P2|NOT COMPLETED|Overall Study||0
2438977|NCT01128829|5982115|P1|NOT COMPLETED|Overall Study||0
2438978|NCT01128829|5982114|P2|COMPLETED|Overall Study||11
2438979|NCT01128829|5982115|P1|COMPLETED|Overall Study||6
2438980|NCT01128829|5982114|P2|STARTED|Overall Study||11
2438981|NCT01128829|5982115|P1|STARTED|Overall Study||6
2438982|NCT01128738|5982121|P2|NOT COMPLETED|Second TP||3
2438983|NCT01128738|5982122|P1|NOT COMPLETED|Second TP||0
2438984|NCT01128738|5982121|P2|COMPLETED|Second TP||63
2438985|NCT01128738|5982122|P1|COMPLETED|Second TP||34
2438986|NCT01128738|5982121|P2|STARTED|Second TP|Only participants who received a second treatment entered this phase.|66
2438987|NCT01128738|5982122|P1|STARTED|Second TP|Only participants who received a second treatment entered this phase.|34
2438988|NCT01128738|5982121|P2|NOT COMPLETED|First Treatment Phase (TP)||1
2438989|NCT01128738|5982122|P1|NOT COMPLETED|First Treatment Phase (TP)||4
2438990|NCT01128738|5982121|P2|COMPLETED|First Treatment Phase (TP)||73
2438991|NCT01128738|5982122|P1|COMPLETED|First Treatment Phase (TP)||74
2438992|NCT01128738|5982121|P2|STARTED|First Treatment Phase (TP)||74
2438993|NCT01128738|5982122|P1|STARTED|First Treatment Phase (TP)||78
2438994|NCT01128621|5982247|P2|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||2
2439085|NCT01128595|5982372|P1|COMPLETED|Treatment Period 1||7
2438995|NCT01128621|5982248|P1|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
2438996|NCT01128621|5982247|P2|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||65
2438997|NCT01128621|5982248|P1|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
2438998|NCT01128621|5982247|P2|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||67
2438999|NCT01128621|5982248|P1|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
2439000|NCT01128621|5982247|P2|NOT COMPLETED|Part A: GSK1292263 300 mg||0
2439001|NCT01128621|5982248|P1|NOT COMPLETED|Part A: GSK1292263 300 mg||0
2439002|NCT01128621|5982247|P2|COMPLETED|Part A: GSK1292263 300 mg||0
2439003|NCT01128621|5982248|P1|COMPLETED|Part A: GSK1292263 300 mg||6
2439004|NCT01128621|5982247|P2|STARTED|Part A: GSK1292263 300 mg||0
2439005|NCT01128621|5982248|P1|STARTED|Part A: GSK1292263 300 mg||6
2439006|NCT01128595|5982369|P4|NOT COMPLETED|Treatment Period 4||0
2439007|NCT01128595|5982370|P3|NOT COMPLETED|Treatment Period 4||0
2439008|NCT01128595|5982371|P2|NOT COMPLETED|Treatment Period 4||0
2439009|NCT01128595|5982372|P1|NOT COMPLETED|Treatment Period 4||0
2439010|NCT01128595|5982369|P4|COMPLETED|Treatment Period 4||7
2439011|NCT01128595|5982370|P3|COMPLETED|Treatment Period 4||7
2439012|NCT01128595|5982371|P2|COMPLETED|Treatment Period 4||5
2439013|NCT01128595|5982372|P1|COMPLETED|Treatment Period 4||7
2439014|NCT01128595|5982369|P4|STARTED|Treatment Period 4||7
2439015|NCT01128595|5982370|P3|STARTED|Treatment Period 4||7
2439016|NCT01128595|5982371|P2|STARTED|Treatment Period 4||5
2439017|NCT01128595|5982372|P1|STARTED|Treatment Period 4||7
2439018|NCT01128595|5982369|P4|NOT COMPLETED|Washout Period 3||0
2439019|NCT01128595|5982370|P3|NOT COMPLETED|Washout Period 3||0
2439020|NCT01128595|5982371|P2|NOT COMPLETED|Washout Period 3||0
2439021|NCT01128595|5982372|P1|NOT COMPLETED|Washout Period 3||0
2439022|NCT01128595|5982369|P4|COMPLETED|Washout Period 3||7
2439023|NCT01128595|5982370|P3|COMPLETED|Washout Period 3||7
2439024|NCT01128595|5982371|P2|COMPLETED|Washout Period 3||5
2439025|NCT01128595|5982372|P1|COMPLETED|Washout Period 3||7
2439026|NCT01128595|5982369|P4|STARTED|Washout Period 3||7
2439027|NCT01128595|5982370|P3|STARTED|Washout Period 3||7
2439028|NCT01128595|5982371|P2|STARTED|Washout Period 3||5
2439029|NCT01128595|5982372|P1|STARTED|Washout Period 3||7
2439030|NCT01128595|5982369|P4|NOT COMPLETED|Treatment Period 3||0
2439031|NCT01128595|5982370|P3|NOT COMPLETED|Treatment Period 3||0
2439032|NCT01128595|5982371|P2|NOT COMPLETED|Treatment Period 3||1
2439033|NCT01128595|5982372|P1|NOT COMPLETED|Treatment Period 3||0
2439034|NCT01128595|5982369|P4|COMPLETED|Treatment Period 3||7
2439035|NCT01128595|5982370|P3|COMPLETED|Treatment Period 3||7
2439036|NCT01128595|5982371|P2|COMPLETED|Treatment Period 3||5
2439037|NCT01128595|5982372|P1|COMPLETED|Treatment Period 3||7
2439038|NCT01128595|5982369|P4|STARTED|Treatment Period 3||7
2439039|NCT01128595|5982370|P3|STARTED|Treatment Period 3||7
2439040|NCT01128595|5982371|P2|STARTED|Treatment Period 3||6
2439041|NCT01128595|5982372|P1|STARTED|Treatment Period 3||7
2439042|NCT01128595|5982369|P4|NOT COMPLETED|Washout Period 2||0
2439043|NCT01128595|5982370|P3|NOT COMPLETED|Washout Period 2||0
2439044|NCT01128595|5982371|P2|NOT COMPLETED|Washout Period 2||0
2439045|NCT01128595|5982372|P1|NOT COMPLETED|Washout Period 2||0
2439046|NCT01128595|5982369|P4|COMPLETED|Washout Period 2||7
2439047|NCT01128595|5982370|P3|COMPLETED|Washout Period 2||7
2439048|NCT01128595|5982371|P2|COMPLETED|Washout Period 2||6
2439049|NCT01128595|5982372|P1|COMPLETED|Washout Period 2||7
2439050|NCT01128595|5982369|P4|STARTED|Washout Period 2||7
2439051|NCT01128595|5982370|P3|STARTED|Washout Period 2||7
2439052|NCT01128595|5982371|P2|STARTED|Washout Period 2||6
2439053|NCT01128595|5982372|P1|STARTED|Washout Period 2||7
2439054|NCT01128595|5982369|P4|NOT COMPLETED|Treatment Period 2||0
2439055|NCT01128595|5982370|P3|NOT COMPLETED|Treatment Period 2||0
2439056|NCT01128595|5982371|P2|NOT COMPLETED|Treatment Period 2||0
2439057|NCT01128595|5982372|P1|NOT COMPLETED|Treatment Period 2||0
2439058|NCT01128595|5982369|P4|COMPLETED|Treatment Period 2||7
2439059|NCT01128595|5982370|P3|COMPLETED|Treatment Period 2||7
2439060|NCT01128595|5982371|P2|COMPLETED|Treatment Period 2||6
2439061|NCT01128595|5982372|P1|COMPLETED|Treatment Period 2||7
2439062|NCT01128595|5982369|P4|STARTED|Treatment Period 2||7
2439063|NCT01128595|5982370|P3|STARTED|Treatment Period 2||7
2439064|NCT01128595|5982371|P2|STARTED|Treatment Period 2||6
2439065|NCT01128595|5982372|P1|STARTED|Treatment Period 2||7
2439066|NCT01128595|5982369|P4|NOT COMPLETED|Washout Period 1||0
2439067|NCT01128595|5982370|P3|NOT COMPLETED|Washout Period 1||0
2439068|NCT01128595|5982371|P2|NOT COMPLETED|Washout Period 1||0
2439069|NCT01128595|5982372|P1|NOT COMPLETED|Washout Period 1||0
2439070|NCT01128595|5982369|P4|COMPLETED|Washout Period 1||7
2439071|NCT01128595|5982370|P3|COMPLETED|Washout Period 1||7
2439072|NCT01128595|5982371|P2|COMPLETED|Washout Period 1||6
2439073|NCT01128595|5982372|P1|COMPLETED|Washout Period 1||7
2439074|NCT01128595|5982369|P4|STARTED|Washout Period 1||7
2439075|NCT01128595|5982370|P3|STARTED|Washout Period 1||7
2439076|NCT01128595|5982371|P2|STARTED|Washout Period 1||6
2439077|NCT01128595|5982372|P1|STARTED|Washout Period 1||7
2439078|NCT01128595|5982369|P4|NOT COMPLETED|Treatment Period 1||0
2439079|NCT01128595|5982370|P3|NOT COMPLETED|Treatment Period 1||0
2439080|NCT01128595|5982371|P2|NOT COMPLETED|Treatment Period 1||0
2439081|NCT01128595|5982372|P1|NOT COMPLETED|Treatment Period 1||0
2439082|NCT01128595|5982369|P4|COMPLETED|Treatment Period 1||7
2439083|NCT01128595|5982370|P3|COMPLETED|Treatment Period 1||7
2439084|NCT01128595|5982371|P2|COMPLETED|Treatment Period 1||6
2439086|NCT01128595|5982369|P4|STARTED|Treatment Period 1||7
2439087|NCT01128595|5982370|P3|STARTED|Treatment Period 1||7
2439088|NCT01128595|5982371|P2|STARTED|Treatment Period 1||6
2439089|NCT01128595|5982372|P1|STARTED|Treatment Period 1||7
2439090|NCT01128569|5982402|P6|NOT COMPLETED|Treatment Period 3||0
2439091|NCT01128569|5982403|P5|NOT COMPLETED|Treatment Period 3||0
2439092|NCT01128569|5982404|P4|NOT COMPLETED|Treatment Period 3||0
2439093|NCT01128569|5982405|P3|NOT COMPLETED|Treatment Period 3||0
2439094|NCT01128569|5982406|P2|NOT COMPLETED|Treatment Period 3||0
2439095|NCT01128569|5982407|P1|NOT COMPLETED|Treatment Period 3||0
2439096|NCT01128569|5982402|P6|COMPLETED|Treatment Period 3||9
2439097|NCT01128569|5982403|P5|COMPLETED|Treatment Period 3||9
2439098|NCT01128569|5982404|P4|COMPLETED|Treatment Period 3||8
2439099|NCT01128569|5982405|P3|COMPLETED|Treatment Period 3||8
2439100|NCT01128569|5982406|P2|COMPLETED|Treatment Period 3||7
2439101|NCT01128569|5982407|P1|COMPLETED|Treatment Period 3||9
2439102|NCT01128569|5982402|P6|STARTED|Treatment Period 3||9
2439103|NCT01128569|5982403|P5|STARTED|Treatment Period 3||9
2439104|NCT01128569|5982404|P4|STARTED|Treatment Period 3||8
2439105|NCT01128569|5982405|P3|STARTED|Treatment Period 3||8
2439106|NCT01128569|5982406|P2|STARTED|Treatment Period 3||7
2439107|NCT01128569|5982407|P1|STARTED|Treatment Period 3||9
2439108|NCT01128569|5982402|P6|NOT COMPLETED|Washout Period 2||0
2439109|NCT01128569|5982403|P5|NOT COMPLETED|Washout Period 2||0
2439110|NCT01128569|5982404|P4|NOT COMPLETED|Washout Period 2||0
2439111|NCT01128569|5982405|P3|NOT COMPLETED|Washout Period 2||0
2439112|NCT01128569|5982406|P2|NOT COMPLETED|Washout Period 2||0
2439113|NCT01128569|5982407|P1|NOT COMPLETED|Washout Period 2||0
2439114|NCT01128569|5982402|P6|COMPLETED|Washout Period 2||9
2439115|NCT01128569|5982403|P5|COMPLETED|Washout Period 2||9
2439116|NCT01128569|5982404|P4|COMPLETED|Washout Period 2||8
2439117|NCT01128569|5982405|P3|COMPLETED|Washout Period 2||8
2439118|NCT01128569|5982406|P2|COMPLETED|Washout Period 2||7
2439119|NCT01128569|5982407|P1|COMPLETED|Washout Period 2||9
2439120|NCT01128569|5982402|P6|STARTED|Washout Period 2||9
2439121|NCT01128569|5982403|P5|STARTED|Washout Period 2||9
2439122|NCT01128569|5982404|P4|STARTED|Washout Period 2||8
2439123|NCT01128569|5982405|P3|STARTED|Washout Period 2||8
2439124|NCT01128569|5982406|P2|STARTED|Washout Period 2||7
2439125|NCT01128569|5982407|P1|STARTED|Washout Period 2||9
2439126|NCT01128569|5982402|P6|NOT COMPLETED|Treatment Period 2||0
2439127|NCT01128569|5982403|P5|NOT COMPLETED|Treatment Period 2||0
2439128|NCT01128569|5982404|P4|NOT COMPLETED|Treatment Period 2||0
2439129|NCT01128569|5982405|P3|NOT COMPLETED|Treatment Period 2||0
2439130|NCT01128569|5982406|P2|NOT COMPLETED|Treatment Period 2||1
2439131|NCT01128569|5982407|P1|NOT COMPLETED|Treatment Period 2||0
2439132|NCT01128569|5982402|P6|COMPLETED|Treatment Period 2||9
2439133|NCT01128569|5982403|P5|COMPLETED|Treatment Period 2||9
2439134|NCT01128569|5982404|P4|COMPLETED|Treatment Period 2||8
2439135|NCT01128569|5982405|P3|COMPLETED|Treatment Period 2||8
2439136|NCT01128569|5982406|P2|COMPLETED|Treatment Period 2||7
2439137|NCT01128569|5982407|P1|COMPLETED|Treatment Period 2||9
2439138|NCT01128569|5982402|P6|STARTED|Treatment Period 2||9
2439139|NCT01128569|5982403|P5|STARTED|Treatment Period 2||9
2439140|NCT01128569|5982404|P4|STARTED|Treatment Period 2||8
2439141|NCT01128569|5982405|P3|STARTED|Treatment Period 2||8
2439142|NCT01128569|5982406|P2|STARTED|Treatment Period 2||8
2439143|NCT01128569|5982407|P1|STARTED|Treatment Period 2||9
2439144|NCT01128569|5982402|P6|NOT COMPLETED|Washout Period 1||0
2439145|NCT01128569|5982403|P5|NOT COMPLETED|Washout Period 1||0
2439146|NCT01128569|5982404|P4|NOT COMPLETED|Washout Period 1||0
2439147|NCT01128569|5982405|P3|NOT COMPLETED|Washout Period 1||1
2439148|NCT01128569|5982406|P2|NOT COMPLETED|Washout Period 1||0
2439149|NCT01128569|5982407|P1|NOT COMPLETED|Washout Period 1||0
2439150|NCT01128569|5982402|P6|COMPLETED|Washout Period 1||9
2439151|NCT01128569|5982403|P5|COMPLETED|Washout Period 1||9
2439152|NCT01128569|5982404|P4|COMPLETED|Washout Period 1||8
2439153|NCT01128569|5982405|P3|COMPLETED|Washout Period 1||8
2439154|NCT01128569|5982406|P2|COMPLETED|Washout Period 1||8
2439155|NCT01128569|5982407|P1|COMPLETED|Washout Period 1||9
2439156|NCT01128569|5982402|P6|STARTED|Washout Period 1||9
2439157|NCT01128569|5982403|P5|STARTED|Washout Period 1||9
2439158|NCT01128569|5982404|P4|STARTED|Washout Period 1||8
2439159|NCT01128569|5982405|P3|STARTED|Washout Period 1||9
2439160|NCT01128569|5982406|P2|STARTED|Washout Period 1||8
2439161|NCT01128569|5982407|P1|STARTED|Washout Period 1||9
2439162|NCT01128569|5982402|P6|NOT COMPLETED|Treatment Period 1||0
2439163|NCT01128569|5982403|P5|NOT COMPLETED|Treatment Period 1||0
2439164|NCT01128569|5982404|P4|NOT COMPLETED|Treatment Period 1||0
2439165|NCT01128569|5982405|P3|NOT COMPLETED|Treatment Period 1||0
2439166|NCT01128569|5982406|P2|NOT COMPLETED|Treatment Period 1||0
2439167|NCT01128569|5982407|P1|NOT COMPLETED|Treatment Period 1||0
2439168|NCT01128569|5982402|P6|COMPLETED|Treatment Period 1||9
2439169|NCT01128569|5982403|P5|COMPLETED|Treatment Period 1||9
2439170|NCT01128569|5982404|P4|COMPLETED|Treatment Period 1||8
2439171|NCT01128569|5982405|P3|COMPLETED|Treatment Period 1||9
2439172|NCT01128569|5982406|P2|COMPLETED|Treatment Period 1||8
2439173|NCT01128569|5982407|P1|COMPLETED|Treatment Period 1||9
2439174|NCT01128569|5982402|P6|STARTED|Treatment Period 1||9
2439175|NCT01128569|5982403|P5|STARTED|Treatment Period 1||9
2439176|NCT01128569|5982404|P4|STARTED|Treatment Period 1||8
2439177|NCT01128569|5982405|P3|STARTED|Treatment Period 1||9
2439178|NCT01128569|5982406|P2|STARTED|Treatment Period 1||8
2439179|NCT01128569|5982407|P1|STARTED|Treatment Period 1||9
2439180|NCT01128543|5982424|P1|NOT COMPLETED|Overall Study||4
2439181|NCT01128543|5982424|P1|COMPLETED|Overall Study||25
2439182|NCT01128543|5982424|P1|STARTED|Overall Study||29
2439183|NCT01128426|5982430|P1|NOT COMPLETED|Overall Study||0
2439184|NCT01128426|5982430|P1|COMPLETED|Overall Study||53902
2439185|NCT01128426|5982430|P1|STARTED|Overall Study||53902
2439186|NCT01128413|5982450|P2|NOT COMPLETED|Overall Study||1
2439187|NCT01128413|5982451|P1|NOT COMPLETED|Overall Study||4
2439188|NCT01128413|5982450|P2|COMPLETED|Overall Study||10
2439189|NCT01128413|5982451|P1|COMPLETED|Overall Study||7
2439190|NCT01128413|5982450|P2|STARTED|Overall Study||11
2439191|NCT01128413|5982451|P1|STARTED|Overall Study||11
2439192|NCT01128400|5982460|P3|NOT COMPLETED|Overall Study||16
2439193|NCT01128400|5982461|P2|NOT COMPLETED|Overall Study||1
2439194|NCT01128400|5982462|P1|NOT COMPLETED|Overall Study||2
2439195|NCT01128400|5982460|P3|COMPLETED|Overall Study||7
2439196|NCT01128400|5982461|P2|COMPLETED|Overall Study||8
2439197|NCT01128400|5982462|P1|COMPLETED|Overall Study||6
2439198|NCT01128400|5982460|P3|STARTED|Overall Study||23
2439199|NCT01128400|5982461|P2|STARTED|Overall Study||9
2439200|NCT01128400|5982462|P1|STARTED|Overall Study||8
2439201|NCT01128387|5982475|P2|NOT COMPLETED|Overall Study||1
2439202|NCT01128387|5982476|P1|NOT COMPLETED|Overall Study||0
2439203|NCT01128387|5982475|P2|COMPLETED|Overall Study||5
2439204|NCT01128387|5982476|P1|COMPLETED|Overall Study||5
2439205|NCT01128387|5982475|P2|STARTED|Overall Study||6
2439206|NCT01128387|5982476|P1|STARTED|Overall Study||5
2439207|NCT01128361|5982486|P2|NOT COMPLETED|Overall Study||3
2439208|NCT01128361|5982487|P1|NOT COMPLETED|Overall Study||5
2439209|NCT01128361|5982486|P2|COMPLETED|Overall Study||34
2439210|NCT01128361|5982487|P1|COMPLETED|Overall Study||34
2439211|NCT01128361|5982486|P2|STARTED|Overall Study||37
2439212|NCT01128361|5982487|P1|STARTED|Overall Study||39
2439213|NCT01128296|5982499|P6|NOT COMPLETED|Overall Study||5
2439214|NCT01128296|5982500|P5|NOT COMPLETED|Overall Study||0
2439215|NCT01128296|5982501|P4|NOT COMPLETED|Overall Study||0
2439216|NCT01128296|5982502|P3|NOT COMPLETED|Overall Study||0
2439217|NCT01128296|5982503|P2|NOT COMPLETED|Overall Study||0
2439218|NCT01128296|5982504|P1|NOT COMPLETED|Overall Study||0
2439219|NCT01128296|5982499|P6|COMPLETED|Overall Study||21
2439220|NCT01128296|5982500|P5|COMPLETED|Overall Study||1
2439221|NCT01128296|5982501|P4|COMPLETED|Overall Study||1
2439222|NCT01128296|5982502|P3|COMPLETED|Overall Study||1
2439223|NCT01128296|5982503|P2|COMPLETED|Overall Study||1
2439224|NCT01128296|5982504|P1|COMPLETED|Overall Study||1
2439225|NCT01128296|5982499|P6|STARTED|Overall Study||26
2439226|NCT01128296|5982500|P5|STARTED|Overall Study||1
2439227|NCT01128296|5982501|P4|STARTED|Overall Study||1
2439228|NCT01128296|5982502|P3|STARTED|Overall Study||1
2439229|NCT01128296|5982503|P2|STARTED|Overall Study||1
2439230|NCT01128296|5982504|P1|STARTED|Overall Study||1
2439231|NCT01128270|5982522|P1|NOT COMPLETED|Therapeutic Chloral Hydrate (2B)||0
2439232|NCT01128270|5982522|P1|COMPLETED|Therapeutic Chloral Hydrate (2B)||8
2439233|NCT01128270|5982522|P1|STARTED|Therapeutic Chloral Hydrate (2B)||8
2439234|NCT01128270|5982522|P1|NOT COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||0
2439235|NCT01128270|5982522|P1|COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||8
2439236|NCT01128270|5982522|P1|STARTED|Therapeutic Chloral Hydrate and DCA (2A)||8
2439237|NCT01128270|5982522|P1|NOT COMPLETED|Environmental Chloral Hydrate (1B)||0
2439238|NCT01128270|5982522|P1|COMPLETED|Environmental Chloral Hydrate (1B)||8
2439239|NCT01128270|5982522|P1|STARTED|Environmental Chloral Hydrate (1B)|Per the suggestion from Heather, periods are not in chronological order, but defined by treatment.|8
2439240|NCT01128270|5982522|P1|NOT COMPLETED|Environment Chloral Hydrate and DCA (1A)||0
2439241|NCT01128270|5982522|P1|COMPLETED|Environment Chloral Hydrate and DCA (1A)||7
2439242|NCT01128270|5982522|P1|STARTED|Environment Chloral Hydrate and DCA (1A)||7
2439243|NCT01128244|5982535|P1|NOT COMPLETED|Overall Study||3
2439244|NCT01128244|5982535|P1|COMPLETED|Overall Study||10
2439245|NCT01128244|5982535|P1|STARTED|Overall Study||13
2439246|NCT01128192|5982545|P3|NOT COMPLETED|Overall Study||0
2439247|NCT01128192|5982546|P2|NOT COMPLETED|Overall Study||0
2439248|NCT01128192|5982547|P1|NOT COMPLETED|Overall Study||0
2439249|NCT01128192|5982545|P3|COMPLETED|Overall Study||7
2439250|NCT01128192|5982546|P2|COMPLETED|Overall Study||19
2439251|NCT01128192|5982547|P1|COMPLETED|Overall Study||19
2439252|NCT01128192|5982545|P3|STARTED|Overall Study||7
2439253|NCT01128192|5982546|P2|STARTED|Overall Study||19
2439254|NCT01128192|5982547|P1|STARTED|Overall Study||19
2439255|NCT01128179|5982576|P2|NOT COMPLETED|Overall Study||0
2439256|NCT01128179|5982577|P1|NOT COMPLETED|Overall Study||2
2439257|NCT01128179|5982576|P2|COMPLETED|Overall Study||12
2439258|NCT01128179|5982577|P1|COMPLETED|Overall Study||21
2439259|NCT01128179|5982576|P2|STARTED|Overall Study||12
2439260|NCT01128179|5982577|P1|STARTED|Overall Study||23
2439261|NCT01128153|5982597|P2|NOT COMPLETED|Overall Study||15
2439262|NCT01128153|5982598|P1|NOT COMPLETED|Overall Study||16
2439263|NCT01128153|5982597|P2|COMPLETED|Overall Study|Completed 24 weeks|113
2439264|NCT01128153|5982598|P1|COMPLETED|Overall Study|Completed 24 weeks|113
2439265|NCT01128153|5982597|P2|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|128
2439266|NCT01128153|5982598|P1|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|127
2439267|NCT01128153|5982597|P2|STARTED|Overall Study|Randomised|128
2439268|NCT01128153|5982598|P1|STARTED|Overall Study|Randomised|129
2439269|NCT01128114|5982614|P1|NOT COMPLETED|Overall Study||8
2439270|NCT01128114|5982614|P1|COMPLETED|Overall Study||24
2439271|NCT01128114|5982614|P1|STARTED|Overall Study||32
2439272|NCT01128049|5982621|P3|NOT COMPLETED|Overall Study||0
2439273|NCT01128049|5982622|P2|NOT COMPLETED|Overall Study||0
2439274|NCT01128049|5982623|P1|NOT COMPLETED|Overall Study||0
2439275|NCT01128049|5982621|P3|COMPLETED|Overall Study||5
2439276|NCT01128049|5982622|P2|COMPLETED|Overall Study||5
2439277|NCT01128049|5982623|P1|COMPLETED|Overall Study||5
2439278|NCT01128049|5982621|P3|STARTED|Overall Study||5
2439279|NCT01128049|5982622|P2|STARTED|Overall Study||5
2439280|NCT01128049|5982623|P1|STARTED|Overall Study||5
2439281|NCT01127763|5982631|P1|NOT COMPLETED|Overall Study||5
2439282|NCT01127763|5982631|P1|COMPLETED|Overall Study|Patients off study due to disease progression were considered to have completed the study.|20
2439283|NCT01127763|5982631|P1|STARTED|Overall Study||25
2439284|NCT01127737|5982642|P2|NOT COMPLETED|Overall Study||0
2439285|NCT01127737|5982643|P1|NOT COMPLETED|Overall Study||0
2439286|NCT01127737|5982642|P2|COMPLETED|Overall Study||38
2439287|NCT01127737|5982643|P1|COMPLETED|Overall Study||37
2439288|NCT01127737|5982642|P2|STARTED|Overall Study||38
2439289|NCT01127737|5982643|P1|STARTED|Overall Study||37
2439290|NCT01127659|5982655|P6|NOT COMPLETED|Overall Study||0
2439291|NCT01127659|5982656|P5|NOT COMPLETED|Overall Study||0
2439292|NCT01127659|5982657|P4|NOT COMPLETED|Overall Study||4
2439293|NCT01127659|5982658|P3|NOT COMPLETED|Overall Study||2
2439294|NCT01127659|5982659|P2|NOT COMPLETED|Overall Study||8
2439295|NCT01127659|5982660|P1|NOT COMPLETED|Overall Study||2
2439296|NCT01127659|5982655|P6|COMPLETED|Overall Study||21
2439297|NCT01127659|5982656|P5|COMPLETED|Overall Study||50
2439298|NCT01127659|5982657|P4|COMPLETED|Overall Study||6
2439299|NCT01127659|5982658|P3|COMPLETED|Overall Study||10
2439300|NCT01127659|5982659|P2|COMPLETED|Overall Study||14
2439301|NCT01127659|5982660|P1|COMPLETED|Overall Study||20
2439302|NCT01127659|5982655|P6|STARTED|Overall Study||21
2439303|NCT01127659|5982656|P5|STARTED|Overall Study||50
2439304|NCT01127659|5982657|P4|STARTED|Overall Study||10
2439305|NCT01127659|5982658|P3|STARTED|Overall Study||12
2439306|NCT01127659|5982659|P2|STARTED|Overall Study||22
2439307|NCT01127659|5982660|P1|STARTED|Overall Study||22
2439308|NCT01127646|5982676|P2|NOT COMPLETED|Overall Study||1
2439309|NCT01127646|5982677|P1|NOT COMPLETED|Overall Study||1
2439310|NCT01127646|5982676|P2|COMPLETED|Overall Study||7
2439311|NCT01127646|5982677|P1|COMPLETED|Overall Study||14
2439312|NCT01127646|5982676|P2|STARTED|Overall Study||8
2439313|NCT01127646|5982677|P1|STARTED|Overall Study||15
2439314|NCT01127633|5982711|P2|NOT COMPLETED|Overall Study||673
2439315|NCT01127633|5982712|P1|NOT COMPLETED|Overall Study||653
2439316|NCT01127633|5982711|P2|COMPLETED|Overall Study||61
2439317|NCT01127633|5982712|P1|COMPLETED|Overall Study||70
2439318|NCT01127633|5982711|P2|Received at Least 1 Dose of Study Drug|Overall Study||734
2439319|NCT01127633|5982712|P1|Received at Least 1 Dose of Study Drug|Overall Study||723
2439320|NCT01127633|5982711|P2|STARTED|Overall Study||734
2439321|NCT01127633|5982712|P1|STARTED|Overall Study||723
2439322|NCT01127607|5982744|P2|NOT COMPLETED|Phase II (Between Subjects)||2
2439323|NCT01127607|5982745|P1|NOT COMPLETED|Phase II (Between Subjects)||1
2439324|NCT01127607|5982744|P2|COMPLETED|Phase II (Between Subjects)||11
2439325|NCT01127607|5982745|P1|COMPLETED|Phase II (Between Subjects)||13
2439326|NCT01127607|5982744|P2|STARTED|Phase II (Between Subjects)||13
2439327|NCT01127607|5982745|P1|STARTED|Phase II (Between Subjects)||14
2439328|NCT01127607|5982744|P2|NOT COMPLETED|Phase I (Within Subjects)||0
2439329|NCT01127607|5982745|P1|NOT COMPLETED|Phase I (Within Subjects)||0
2439330|NCT01127607|5982744|P2|COMPLETED|Phase I (Within Subjects)||13
2439331|NCT01127607|5982745|P1|COMPLETED|Phase I (Within Subjects)||14
2439332|NCT01127607|5982744|P2|STARTED|Phase I (Within Subjects)||13
2439333|NCT01127607|5982745|P1|STARTED|Phase I (Within Subjects)||14
2439334|NCT01127581|5982818|P2|NOT COMPLETED|Overall Study||0
2439335|NCT01127581|5982819|P1|NOT COMPLETED|Overall Study||0
2439336|NCT01127581|5982818|P2|COMPLETED|Overall Study||680
2439337|NCT01127581|5982819|P1|COMPLETED|Overall Study||678
2439338|NCT01127581|5982818|P2|STARTED|Overall Study||680
2439339|NCT01127581|5982819|P1|STARTED|Overall Study||678
2439340|NCT01127503|5982847|P2|NOT COMPLETED|Overall Study||0
2439341|NCT01127503|5982848|P1|NOT COMPLETED|Overall Study||0
2439342|NCT01127503|5982847|P2|COMPLETED|Overall Study||1
2439343|NCT01127503|5982848|P1|COMPLETED|Overall Study||1
2439344|NCT01127503|5982847|P2|STARTED|Overall Study||1
2439345|NCT01127503|5982848|P1|STARTED|Overall Study||1
2439346|NCT01127438|5982862|P6|NOT COMPLETED|Overall Study||0
2439347|NCT01127438|5982863|P5|NOT COMPLETED|Overall Study||0
2439348|NCT01127438|5982864|P4|NOT COMPLETED|Overall Study||0
2439349|NCT01127438|5982865|P3|NOT COMPLETED|Overall Study||0
2439350|NCT01127438|5982866|P2|NOT COMPLETED|Overall Study||0
2439351|NCT01127438|5982867|P1|NOT COMPLETED|Overall Study||0
2439352|NCT01127438|5982862|P6|COMPLETED|Overall Study||25
2439353|NCT01127438|5982863|P5|COMPLETED|Overall Study||28
2439354|NCT01127438|5982864|P4|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|24
2439355|NCT01127438|5982865|P3|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|26
2439356|NCT01127438|5982866|P2|COMPLETED|Overall Study||25
2439357|NCT01127438|5982867|P1|COMPLETED|Overall Study||25
2439358|NCT01127438|5982862|P6|STARTED|Overall Study||25
2439359|NCT01127438|5982863|P5|STARTED|Overall Study||28
2439360|NCT01127438|5982864|P4|STARTED|Overall Study||24
2439361|NCT01127438|5982865|P3|STARTED|Overall Study||26
2439362|NCT01127438|5982866|P2|STARTED|Overall Study||25
2439363|NCT01127438|5982867|P1|STARTED|Overall Study||25
2439364|NCT01127321|5982894|P5|NOT COMPLETED|Overall Study||0
2439365|NCT01127321|5982895|P4|NOT COMPLETED|Overall Study||0
2439366|NCT01127321|5982896|P3|NOT COMPLETED|Overall Study||0
2439367|NCT01127321|5982897|P2|NOT COMPLETED|Overall Study||0
2439368|NCT01127321|5982898|P1|NOT COMPLETED|Overall Study||0
2439369|NCT01127321|5982894|P5|COMPLETED|Overall Study||5
2439370|NCT01127321|5982895|P4|COMPLETED|Overall Study||7
2439371|NCT01127321|5982896|P3|COMPLETED|Overall Study||1
2439372|NCT01127321|5982897|P2|COMPLETED|Overall Study||1
2439373|NCT01127321|5982898|P1|COMPLETED|Overall Study||3
2439374|NCT01127321|5982894|P5|STARTED|Overall Study||5
2439375|NCT01127321|5982895|P4|STARTED|Overall Study||7
2439376|NCT01127321|5982896|P3|STARTED|Overall Study||1
2439377|NCT01127321|5982897|P2|STARTED|Overall Study||1
2439378|NCT01127321|5982898|P1|STARTED|Overall Study||3
2439379|NCT01127256|5982922|P2|NOT COMPLETED|Overall Study||39
2439380|NCT01127256|5982923|P1|NOT COMPLETED|Overall Study||39
2439381|NCT01127256|5982922|P2|COMPLETED|Overall Study||65
2439382|NCT01127256|5982923|P1|COMPLETED|Overall Study||57
2439383|NCT01127256|5982922|P2|STARTED|Overall Study||104
2439384|NCT01127256|5982923|P1|STARTED|Overall Study||96
2439385|NCT01127165|5982935|P2|NOT COMPLETED|Overall Study||19
2439386|NCT01127165|5982936|P1|NOT COMPLETED|Overall Study||16
2439387|NCT01127165|5982935|P2|COMPLETED|Overall Study||41
2439388|NCT01127165|5982936|P1|COMPLETED|Overall Study||49
2439389|NCT01127165|5982935|P2|STARTED|Overall Study||60
2439390|NCT01127165|5982936|P1|STARTED|Overall Study||65
2439391|NCT01127139|5982948|P1|NOT COMPLETED|Overall Study||57
2439392|NCT01127139|5982948|P1|COMPLETED|Overall Study||3771
2439393|NCT01127139|5982948|P1|Number of Participants Analyzed|Overall Study||3828
2439394|NCT01127139|5982948|P1|STARTED|Overall Study||3828
2439395|NCT01127087|5982965|P2|NOT COMPLETED|Overall Study||0
2439396|NCT01127087|5982966|P1|NOT COMPLETED|Overall Study||0
2439397|NCT01127087|5982965|P2|COMPLETED|Overall Study||2
2439398|NCT01127087|5982966|P1|COMPLETED|Overall Study||8
2439399|NCT01127087|5982965|P2|STARTED|Overall Study||2
2439400|NCT01127087|5982966|P1|STARTED|Overall Study||8
2439401|NCT01127061|5982976|P2|NOT COMPLETED|Overall Study||13
2439402|NCT01127061|5982977|P1|NOT COMPLETED|Overall Study||10
2439403|NCT01127061|5982976|P2|COMPLETED|Overall Study||56
2439404|NCT01127061|5982977|P1|COMPLETED|Overall Study||57
2439405|NCT01127061|5982976|P2|STARTED|Overall Study||69
2439406|NCT01127061|5982977|P1|STARTED|Overall Study||67
2439407|NCT01126957|5983007|P1|NOT COMPLETED|Overall Study||0
2439408|NCT01126957|5983007|P1|COMPLETED|Overall Study||103
2439409|NCT01126957|5983007|P1|STARTED|Overall Study||103
2439410|NCT01126879|5983014|P2|NOT COMPLETED|Overall Study||2
2439411|NCT01126879|5983015|P1|NOT COMPLETED|Overall Study||5
2439412|NCT01126879|5983014|P2|COMPLETED|Overall Study||2
2439413|NCT01126879|5983015|P1|COMPLETED|Overall Study||3
2439414|NCT01126879|5983014|P2|Completed 3 Months Genistein/Placebo|Overall Study||2
2439415|NCT01126879|5983015|P1|Completed 3 Months Genistein/Placebo|Overall Study||4
2439416|NCT01126879|5983014|P2|Prostatectomy or Radiation|Overall Study||4
2439417|NCT01126879|5983015|P1|Prostatectomy or Radiation|Overall Study||8
2439418|NCT01126879|5983014|P2|Started 3 Months of Genistein/Placebo|Overall Study||4
2439419|NCT01126879|5983015|P1|Started 3 Months of Genistein/Placebo|Overall Study||8
2439420|NCT01126879|5983014|P2|STARTED|Overall Study||4
2439421|NCT01126879|5983015|P1|STARTED|Overall Study||8
2439422|NCT01126801|5983029|P2|NOT COMPLETED|Overall Study||0
2439423|NCT01126801|5983030|P1|NOT COMPLETED|Overall Study||0
2439424|NCT01126801|5983029|P2|COMPLETED|Overall Study||1
2439425|NCT01126801|5983030|P1|COMPLETED|Overall Study||1
2439426|NCT01126801|5983029|P2|STARTED|Overall Study||1
2439427|NCT01126801|5983030|P1|STARTED|Overall Study||1
2439428|NCT01126723|5983040|P2|NOT COMPLETED|Overall Study||3
2439429|NCT01126723|5983041|P1|NOT COMPLETED|Overall Study||6
2439430|NCT01126723|5983040|P2|COMPLETED|Overall Study||28
2439431|NCT01126723|5983041|P1|COMPLETED|Overall Study||29
2439432|NCT01126723|5983040|P2|STARTED|Overall Study||31
2439433|NCT01126723|5983041|P1|STARTED|Overall Study||35
2439434|NCT01126671|5983049|P2|NOT COMPLETED|Overall Study||1
2439435|NCT01126671|5983050|P1|NOT COMPLETED|Overall Study||2
2439436|NCT01126671|5983049|P2|COMPLETED|Overall Study||29
2439437|NCT01126671|5983050|P1|COMPLETED|Overall Study||24
2439438|NCT01126671|5983049|P2|STARTED|Overall Study||30
2439439|NCT01126671|5983050|P1|STARTED|Overall Study||26
2439440|NCT01126619|5983062|P1|NOT COMPLETED|Overall Study||17
2439441|NCT01126619|5983062|P1|COMPLETED|Overall Study|The completed population was used for all effectiveness analyses.|86
2439442|NCT01126619|5983062|P1|STARTED|Overall Study||103
2439443|NCT01126593|5983077|P3|NOT COMPLETED|Overall Study||2
2439444|NCT01126593|5983078|P2|NOT COMPLETED|Overall Study||2
2439445|NCT01126593|5983079|P1|NOT COMPLETED|Overall Study||4
2439446|NCT01126593|5983077|P3|COMPLETED|Overall Study||32
2439447|NCT01126593|5983078|P2|COMPLETED|Overall Study||27
2439448|NCT01126593|5983079|P1|COMPLETED|Overall Study||29
2439449|NCT01126593|5983077|P3|STARTED|Overall Study||34
2439450|NCT01126593|5983078|P2|STARTED|Overall Study||29
2439451|NCT01126593|5983079|P1|STARTED|Overall Study||33
2439452|NCT01126580|5983090|P3|NOT COMPLETED|Overall Study||55
2439453|NCT01126580|5983091|P2|NOT COMPLETED|Overall Study||52
2439454|NCT01126580|5983092|P1|NOT COMPLETED|Overall Study||49
2439455|NCT01126580|5983090|P3|COMPLETED|Overall Study||213
2439456|NCT01126580|5983091|P2|COMPLETED|Overall Study||218
2439457|NCT01126580|5983092|P1|COMPLETED|Overall Study||220
2439458|NCT01126580|5983090|P3|Completed 26 Weeks|Overall Study||226
2439459|NCT01126580|5983091|P2|Completed 26 Weeks|Overall Study||242
2439460|NCT01126580|5983092|P1|Completed 26 Weeks|Overall Study||233
2439461|NCT01126580|5983090|P3|Received at Least 1 Dose of Study Drug|Overall Study||268
2439462|NCT01126580|5983091|P2|Received at Least 1 Dose of Study Drug|Overall Study||270
2439463|NCT01126580|5983092|P1|Received at Least 1 Dose of Study Drug|Overall Study||269
2439464|NCT01126580|5983090|P3|STARTED|Overall Study||268
2439465|NCT01126580|5983091|P2|STARTED|Overall Study||270
2439466|NCT01126580|5983092|P1|STARTED|Overall Study||269
2439467|NCT01126541|5983187|P3|NOT COMPLETED|Overall Study||26
2439468|NCT01126541|5983188|P2|NOT COMPLETED|Overall Study||12
2439469|NCT01126541|5983189|P1|NOT COMPLETED|Overall Study||10
2439470|NCT01126541|5983187|P3|COMPLETED|Overall Study||55
2439471|NCT01126541|5983188|P2|COMPLETED|Overall Study||61
2439472|NCT01126541|5983189|P1|COMPLETED|Overall Study||60
2439473|NCT01126541|5983187|P3|STARTED|Overall Study||81
2439474|NCT01126541|5983188|P2|STARTED|Overall Study||73
2439475|NCT01126541|5983189|P1|STARTED|Overall Study||70
2439476|NCT01126437|5983273|P3|NOT COMPLETED|Overall Study||1313
2439477|NCT01126437|5983274|P2|NOT COMPLETED|Overall Study||1330
2439478|NCT01126437|5983275|P1|NOT COMPLETED|Overall Study||1341
2439479|NCT01126437|5983273|P3|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
2439480|NCT01126437|5983274|P2|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4399
2439481|NCT01126437|5983275|P1|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
2439482|NCT01126437|5983273|P3|STARTED|Overall Study||5713
2439483|NCT01126437|5983274|P2|STARTED|Overall Study||5729
2439484|NCT01126437|5983275|P1|STARTED|Overall Study||5741
2439485|NCT01126424|5983313|P6|NOT COMPLETED|Overall Study||0
2439486|NCT01126424|5983314|P5|NOT COMPLETED|Overall Study||2
2439487|NCT01126424|5983315|P4|NOT COMPLETED|Overall Study||3
2439488|NCT01126424|5983316|P3|NOT COMPLETED|Overall Study||1
2439489|NCT01126424|5983317|P2|NOT COMPLETED|Overall Study||0
2439490|NCT01126424|5983318|P1|NOT COMPLETED|Overall Study||0
2439491|NCT01126424|5983313|P6|COMPLETED|Overall Study||4
2439492|NCT01126424|5983314|P5|COMPLETED|Overall Study||2
2439493|NCT01126424|5983315|P4|COMPLETED|Overall Study||3
2439494|NCT01126424|5983316|P3|COMPLETED|Overall Study||4
2439495|NCT01126424|5983317|P2|COMPLETED|Overall Study||4
2439496|NCT01126424|5983318|P1|COMPLETED|Overall Study||3
2439497|NCT01126424|5983313|P6|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
2439498|NCT01126424|5983314|P5|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
2439499|NCT01126424|5983315|P4|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
2439500|NCT01126424|5983316|P3|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
2439501|NCT01126424|5983317|P2|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
2439502|NCT01126424|5983318|P1|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|3
2439503|NCT01126424|5983313|P6|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
2439504|NCT01126424|5983314|P5|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
2439505|NCT01126424|5983315|P4|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|6
2439506|NCT01126424|5983316|P3|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|5
2439507|NCT01126424|5983317|P2|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
2439508|NCT01126424|5983318|P1|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|3
2439509|NCT01126359|5983341|P2|NOT COMPLETED|Second Intervention (20-minutes)||0
2439510|NCT01126359|5983342|P1|NOT COMPLETED|Second Intervention (20-minutes)||0
2439511|NCT01126359|5983341|P2|COMPLETED|Second Intervention (20-minutes)||5
2439512|NCT01126359|5983342|P1|COMPLETED|Second Intervention (20-minutes)||5
2439513|NCT01126359|5983341|P2|STARTED|Second Intervention (20-minutes)||5
2439514|NCT01126359|5983342|P1|STARTED|Second Intervention (20-minutes)||5
2439515|NCT01126359|5983341|P2|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
2439516|NCT01126359|5983342|P1|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
2439517|NCT01126359|5983341|P2|COMPLETED|Dressing Replacement/Healing (48-hours)||5
2439518|NCT01126359|5983342|P1|COMPLETED|Dressing Replacement/Healing (48-hours)||5
2439519|NCT01126359|5983341|P2|STARTED|Dressing Replacement/Healing (48-hours)||5
2439520|NCT01126359|5983342|P1|STARTED|Dressing Replacement/Healing (48-hours)||5
2439521|NCT01126359|5983341|P2|NOT COMPLETED|First Intervention (20-minutes)||1
2439522|NCT01126359|5983342|P1|NOT COMPLETED|First Intervention (20-minutes)||0
2439523|NCT01126359|5983341|P2|COMPLETED|First Intervention (20-minutes)||5
2439524|NCT01126359|5983342|P1|COMPLETED|First Intervention (20-minutes)||5
2439525|NCT01126359|5983341|P2|STARTED|First Intervention (20-minutes)||6
2439526|NCT01126359|5983342|P1|STARTED|First Intervention (20-minutes)||5
2439527|NCT01126268|5983354|P1|NOT COMPLETED|Overall Study||1
2439528|NCT01126268|5983354|P1|COMPLETED|Overall Study||37
2439529|NCT01126268|5983354|P1|STARTED|Overall Study||38
2439530|NCT01126099|5983378|P2|NOT COMPLETED|Open-label Extension||1
2439531|NCT01126099|5983379|P1|NOT COMPLETED|Open-label Extension||1
2439532|NCT01126099|5983378|P2|COMPLETED|Open-label Extension||6
2439533|NCT01126099|5983379|P1|COMPLETED|Open-label Extension||4
2439534|NCT01126099|5983378|P2|STARTED|Open-label Extension||7
2439535|NCT01126099|5983379|P1|STARTED|Open-label Extension|2 in the Prazosin arm of the Double Blind Phase elected not to enter the Open-Label extension|5
2439536|NCT01126099|5983378|P2|NOT COMPLETED|Double Blind Phase||2
2439537|NCT01126099|5983379|P1|NOT COMPLETED|Double Blind Phase||4
2439538|NCT01126099|5983378|P2|COMPLETED|Double Blind Phase||7
2439539|NCT01126099|5983379|P1|COMPLETED|Double Blind Phase||7
2439540|NCT01126099|5983378|P2|STARTED|Double Blind Phase||9
2439541|NCT01126099|5983379|P1|STARTED|Double Blind Phase||11
2439542|NCT01126060|5983393|P2|NOT COMPLETED|Overall Study||2
2439543|NCT01126060|5983394|P1|NOT COMPLETED|Overall Study||0
2439544|NCT01126060|5983393|P2|COMPLETED|Overall Study||38
2439545|NCT01126060|5983394|P1|COMPLETED|Overall Study||40
2439546|NCT01126060|5983393|P2|STARTED|Overall Study||40
2439547|NCT01126060|5983394|P1|STARTED|Overall Study||40
2439548|NCT01125930|5983402|P2|NOT COMPLETED|Overall Study||10
2439549|NCT01125930|5983403|P1|NOT COMPLETED|Overall Study||1
2439550|NCT01125930|5983402|P2|COMPLETED|Overall Study||36
2439551|NCT01125930|5983403|P1|COMPLETED|Overall Study||21
2439552|NCT01125930|5983402|P2|STARTED|Overall Study||46
2439553|NCT01125930|5983403|P1|STARTED|Overall Study||22
2439554|NCT01125917|5983557|P1|NOT COMPLETED|Overall Study||339
2439555|NCT01125917|5983557|P1|COMPLETED|Overall Study||15
2439556|NCT01125917|5983557|P1|STARTED|Overall Study||354
2439557|NCT01125813|5983561|P1|NOT COMPLETED|Overall Study||6
2439558|NCT01125813|5983561|P1|COMPLETED|Overall Study||30
2439559|NCT01125813|5983561|P1|STARTED|Overall Study||36
2439560|NCT01125800|5983571|P5|NOT COMPLETED|Phase II||11
2439561|NCT01125800|5983572|P4|NOT COMPLETED|Phase II||1
2439562|NCT01125800|5983573|P3|NOT COMPLETED|Phase II||0
2439563|NCT01125800|5983574|P2|NOT COMPLETED|Phase II||0
2439564|NCT01125800|5983575|P1|NOT COMPLETED|Phase II||0
2439565|NCT01125800|5983571|P5|COMPLETED|Phase II||5
2439566|NCT01125800|5983572|P4|COMPLETED|Phase II||0
2439567|NCT01125800|5983573|P3|COMPLETED|Phase II||0
2439568|NCT01125800|5983574|P2|COMPLETED|Phase II||0
2439569|NCT01125800|5983575|P1|COMPLETED|Phase II||0
2439570|NCT01125800|5983571|P5|STARTED|Phase II|Additional participants were enrolled to this treatment in this period.|16
2439571|NCT01125800|5983572|P4|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|1
2439572|NCT01125800|5983573|P3|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
2439573|NCT01125800|5983574|P2|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
2439574|NCT01125800|5983575|P1|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
2439575|NCT01125800|5983571|P5|NOT COMPLETED|Phase I||0
2439576|NCT01125800|5983572|P4|NOT COMPLETED|Phase I||11
2439577|NCT01125800|5983573|P3|NOT COMPLETED|Phase I||4
2439578|NCT01125800|5983574|P2|NOT COMPLETED|Phase I||9
2439579|NCT01125800|5983575|P1|NOT COMPLETED|Phase I||8
2439580|NCT01125800|5983571|P5|COMPLETED|Phase I||0
2439581|NCT01125800|5983572|P4|COMPLETED|Phase I||10
2439582|NCT01125800|5983573|P3|COMPLETED|Phase I||7
2439583|NCT01125800|5983574|P2|COMPLETED|Phase I||7
2439584|NCT01125800|5983575|P1|COMPLETED|Phase I||3
2439585|NCT01125800|5983571|P5|STARTED|Phase I|None of participants were enrolled to this treatment in this period.|0
2439586|NCT01125800|5983572|P4|STARTED|Phase I||21
2439587|NCT01125800|5983573|P3|STARTED|Phase I||11
2439588|NCT01125800|5983574|P2|STARTED|Phase I||16
2439589|NCT01125800|5983575|P1|STARTED|Phase I||11
2439590|NCT01125774|5983614|P4|NOT COMPLETED|Overall Study||3
2439591|NCT01125774|5983615|P3|NOT COMPLETED|Overall Study||9
2439592|NCT01125774|5983616|P2|NOT COMPLETED|Overall Study||554
2439593|NCT01125774|5983617|P1|NOT COMPLETED|Overall Study||1125
2439594|NCT01125774|5983614|P4|COMPLETED|Overall Study|Completed study at least once|3
2439595|NCT01125774|5983615|P3|COMPLETED|Overall Study|"Completed study at least once while treated with telcagepant (otherwise counted Not Completed)"|13
2439596|NCT01125774|5983616|P2|COMPLETED|Overall Study||948
2439597|NCT01125774|5983617|P1|COMPLETED|Overall Study||1893
2439598|NCT01125774|5983614|P4|Treated|Overall Study||5
2439599|NCT01125774|5983615|P3|Treated|Overall Study|Received telcagepant|21
2439600|NCT01125774|5983616|P2|Treated|Overall Study|1 mistakenly took telcagepant and is included with telcagepant group for adverse event analysis|1322
2439601|NCT01125774|5983617|P1|Treated|Overall Study||2638
2439602|NCT01125774|5983614|P4|STARTED|Overall Study|Unique participants randomized|6
2439603|NCT01125774|5983615|P3|STARTED|Overall Study|Unique participants randomized|22
2439604|NCT01125774|5983616|P2|STARTED|Overall Study|Randomized|1502
2439605|NCT01125774|5983617|P1|STARTED|Overall Study|Randomized|3018
2439606|NCT01125748|5983641|P2|NOT COMPLETED|Overall Study||14
2439607|NCT01125748|5983642|P1|NOT COMPLETED|Overall Study||10
2439608|NCT01125748|5983641|P2|COMPLETED|Overall Study||74
2439609|NCT01125748|5983642|P1|COMPLETED|Overall Study||78
2439610|NCT01125748|5983641|P2|STARTED|Overall Study||88
2439611|NCT01125748|5983642|P1|STARTED|Overall Study||88
2439612|NCT01125722|5983652|P2|NOT COMPLETED|Overall Study||1
2439613|NCT01125722|5983653|P1|NOT COMPLETED|Overall Study||3
2439614|NCT01125722|5983652|P2|COMPLETED|Overall Study||36
2439615|NCT01125722|5983653|P1|COMPLETED|Overall Study||34
2439616|NCT01125722|5983652|P2|STARTED|Overall Study||37
2439617|NCT01125722|5983653|P1|STARTED|Overall Study||37
2439618|NCT01125605|5983667|P1|NOT COMPLETED|Overall Study||0
2439619|NCT01125605|5983667|P1|COMPLETED|Overall Study||325
2439620|NCT01125605|5983667|P1|Safety|Overall Study|1 patient was only analysed for safety|326
2439621|NCT01125605|5983667|P1|STARTED|Overall Study|started = had baseline values|325
2439622|NCT01125566|5983700|P3|NOT COMPLETED|Patients Who Switched From AV to TV||73
2439623|NCT01125566|5983701|P2|NOT COMPLETED|Patients Who Switched From AV to TV||0
2439624|NCT01125566|5983702|P1|NOT COMPLETED|Patients Who Switched From AV to TV||0
2439625|NCT01125566|5983700|P3|COMPLETED|Patients Who Switched From AV to TV||2
2439626|NCT01125566|5983701|P2|COMPLETED|Patients Who Switched From AV to TV||0
2439627|NCT01125566|5983702|P1|COMPLETED|Patients Who Switched From AV to TV||0
2439628|NCT01125566|5983700|P3|STARTED|Patients Who Switched From AV to TV||75
2439629|NCT01125566|5983701|P2|STARTED|Patients Who Switched From AV to TV||0
2439630|NCT01125566|5983702|P1|STARTED|Patients Who Switched From AV to TV||0
2439631|NCT01125566|5983700|P3|NOT COMPLETED|Patients Before the Switch (26Apr2013)||0
2439632|NCT01125566|5983701|P2|NOT COMPLETED|Patients Before the Switch (26Apr2013)||169
2439633|NCT01125566|5983702|P1|NOT COMPLETED|Patients Before the Switch (26Apr2013)||265
2439634|NCT01125566|5983700|P3|COMPLETED|Patients Before the Switch (26Apr2013)||0
2439635|NCT01125566|5983701|P2|COMPLETED|Patients Before the Switch (26Apr2013)||0
2439636|NCT01125566|5983702|P1|COMPLETED|Patients Before the Switch (26Apr2013)||74
2439637|NCT01125566|5983700|P3|Treated|Patients Before the Switch (26Apr2013)||0
2439638|NCT01125566|5983701|P2|Treated|Patients Before the Switch (26Apr2013)||169
2439639|NCT01125566|5983702|P1|Treated|Patients Before the Switch (26Apr2013)||337
2439640|NCT01125566|5983700|P3|STARTED|Patients Before the Switch (26Apr2013)||0
2439641|NCT01125566|5983701|P2|STARTED|Patients Before the Switch (26Apr2013)||169
2439642|NCT01125566|5983702|P1|STARTED|Patients Before the Switch (26Apr2013)||339
2439643|NCT01125514|5983715|P1|NOT COMPLETED|Treatment Period2(Day9-Day27) and Day 28||4
2439644|NCT01125514|5983715|P1|COMPLETED|Treatment Period2(Day9-Day27) and Day 28||28
2439645|NCT01125514|5983715|P1|STARTED|Treatment Period2(Day9-Day27) and Day 28||32
2439646|NCT01125514|5983715|P1|NOT COMPLETED|Treatment Period 2 (Day 8 - Day 17)||3
2439647|NCT01125514|5983715|P1|COMPLETED|Treatment Period 2 (Day 8 - Day 17)||32
2439648|NCT01125514|5983715|P1|Pharmacodynamics (PD) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
2439649|NCT01125514|5983715|P1|Pharmacokinetic (PK) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
2439650|NCT01125514|5983715|P1|STARTED|Treatment Period 2 (Day 8 - Day 17)||35
2439651|NCT01125514|5983715|P1|NOT COMPLETED|Treatment Period 1 (Day 1 - Day 7)||2
2439652|NCT01125514|5983715|P1|COMPLETED|Treatment Period 1 (Day 1 - Day 7)||35
2439653|NCT01125514|5983715|P1|STARTED|Treatment Period 1 (Day 1 - Day 7)|Randomized and safety population|37
2439654|NCT01125202|5983789|P2|NOT COMPLETED|Overall Study||7
2439655|NCT01125202|5983790|P1|NOT COMPLETED|Overall Study||12
2439656|NCT01125202|5983789|P2|COMPLETED|Overall Study||79
2439657|NCT01125202|5983790|P1|COMPLETED|Overall Study||81
2439658|NCT01125202|5983789|P2|STARTED|Overall Study||86
2439659|NCT01125202|5983790|P1|STARTED|Overall Study||93
2439660|NCT01125189|5983815|P3|NOT COMPLETED|Follow up Period||16
2439661|NCT01125189|5983816|P2|NOT COMPLETED|Follow up Period||15
2439662|NCT01125189|5983817|P1|NOT COMPLETED|Follow up Period||20
2439663|NCT01125189|5983815|P3|COMPLETED|Follow up Period||58
2439664|NCT01125189|5983816|P2|COMPLETED|Follow up Period||138
2439665|NCT01125189|5983817|P1|COMPLETED|Follow up Period||132
2439666|NCT01125189|5983815|P3|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|74
2439667|NCT01125189|5983816|P2|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|153
2439668|NCT01125189|5983817|P1|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|152
2439669|NCT01125189|5983815|P3|NOT COMPLETED|Treatment Period||41
2439670|NCT01125189|5983816|P2|NOT COMPLETED|Treatment Period||35
2439671|NCT01125189|5983817|P1|NOT COMPLETED|Treatment Period||31
2439672|NCT01125189|5983815|P3|COMPLETED|Treatment Period||37
2439673|NCT01125189|5983816|P2|COMPLETED|Treatment Period||123
2439674|NCT01125189|5983817|P1|COMPLETED|Treatment Period||128
2439675|NCT01125189|5983815|P3|STARTED|Treatment Period||78
2439676|NCT01125189|5983816|P2|STARTED|Treatment Period||158
2439677|NCT01125189|5983817|P1|STARTED|Treatment Period||159
2439678|NCT01125176|5983843|P1|NOT COMPLETED|Post-treatment Follow-up Phase||11
2439679|NCT01125176|5983843|P1|COMPLETED|Post-treatment Follow-up Phase||2
2439680|NCT01125176|5983843|P1|STARTED|Post-treatment Follow-up Phase||13
2439681|NCT01125176|5983843|P1|NOT COMPLETED|Treatment Phase||1
2439682|NCT01125176|5983843|P1|COMPLETED|Treatment Phase||13
2439683|NCT01125176|5983843|P1|STARTED|Treatment Phase||14
2439684|NCT01125163|5983849|P2|NOT COMPLETED|Overall Study||0
2439685|NCT01125163|5983850|P1|NOT COMPLETED|Overall Study||0
2439686|NCT01125163|5983849|P2|COMPLETED|Overall Study||74
2439687|NCT01125163|5983850|P1|COMPLETED|Overall Study||76
2439688|NCT01125163|5983849|P2|STARTED|Overall Study||74
2439689|NCT01125163|5983850|P1|STARTED|Overall Study||76
2439690|NCT01125098|5983860|P2|NOT COMPLETED|Overall Study||0
2439691|NCT01125098|5983861|P1|NOT COMPLETED|Overall Study||3
2439692|NCT01125098|5983860|P2|COMPLETED|Overall Study||90
2439693|NCT01125098|5983861|P1|COMPLETED|Overall Study||88
2439694|NCT01125098|5983860|P2|STARTED|Overall Study||90
2439695|NCT01125098|5983861|P1|STARTED|Overall Study||91
2439696|NCT01124955|5983869|P2|NOT COMPLETED|Overall Study||0
2439697|NCT01124955|5983870|P1|NOT COMPLETED|Overall Study||0
2439698|NCT01124955|5983869|P2|COMPLETED|Overall Study||40
2439699|NCT01124955|5983870|P1|COMPLETED|Overall Study||40
2439700|NCT01124955|5983869|P2|STARTED|Overall Study||40
2439701|NCT01124955|5983870|P1|STARTED|Overall Study||40
2439702|NCT01124916|5983886|P2|NOT COMPLETED|Overall Study||2
2439703|NCT01124916|5983887|P1|NOT COMPLETED|Overall Study||3
2439704|NCT01124916|5983886|P2|COMPLETED|Overall Study||38
2439705|NCT01124916|5983887|P1|COMPLETED|Overall Study||35
2439706|NCT01124916|5983886|P2|STARTED|Overall Study||40
2439707|NCT01124916|5983887|P1|STARTED|Overall Study||38
2439708|NCT01124864|5983901|P6|NOT COMPLETED|Overall Study||3
2439709|NCT01124864|5983902|P5|NOT COMPLETED|Overall Study||30
2439710|NCT01124864|5983903|P4|NOT COMPLETED|Overall Study||21
2439711|NCT01124864|5983904|P3|NOT COMPLETED|Overall Study||34
2439712|NCT01124864|5983905|P2|NOT COMPLETED|Overall Study||35
2439713|NCT01124864|5983906|P1|NOT COMPLETED|Overall Study||28
2439714|NCT01124864|5983901|P6|COMPLETED|Overall Study||0
2439715|NCT01124864|5983902|P5|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
2439716|NCT01124864|5983903|P4|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
2439717|NCT01124864|5983904|P3|COMPLETED|Overall Study||0
2439718|NCT01124864|5983905|P2|COMPLETED|Overall Study||0
2439719|NCT01124864|5983906|P1|COMPLETED|Overall Study||0
2439720|NCT01124864|5983901|P6|STARTED|Overall Study||3
2439721|NCT01124864|5983902|P5|STARTED|Overall Study||31
2439722|NCT01124864|5983903|P4|STARTED|Overall Study||22
2439723|NCT01124864|5983904|P3|STARTED|Overall Study||34
2439724|NCT01124864|5983905|P2|STARTED|Overall Study||35
2439725|NCT01124864|5983906|P1|STARTED|Overall Study||28
2439726|NCT01124838|5983940|P2|NOT COMPLETED|Overall Study||15
2439727|NCT01124838|5983941|P1|NOT COMPLETED|Overall Study||18
2439728|NCT01124838|5983940|P2|COMPLETED|Overall Study||116
2439729|NCT01124838|5983941|P1|COMPLETED|Overall Study||112
2439730|NCT01124838|5983940|P2|Enrolled in Japan Sub-study|Overall Study||16
2439731|NCT01124838|5983941|P1|Enrolled in Japan Sub-study|Overall Study||16
2439732|NCT01124838|5983940|P2|Enrolled in Main Study|Overall Study||115
2439733|NCT01124838|5983941|P1|Enrolled in Main Study|Overall Study||114
2439734|NCT01124838|5983940|P2|STARTED|Overall Study||131
2439735|NCT01124838|5983941|P1|STARTED|Overall Study||130
2439736|NCT01124786|5983987|P2|NOT COMPLETED|Overall Study||5
2439737|NCT01124786|5983988|P1|NOT COMPLETED|Overall Study||4
2439738|NCT01124786|5983987|P2|COMPLETED|Overall Study||180
2439739|NCT01124786|5983988|P1|COMPLETED|Overall Study||178
2439740|NCT01124786|5983987|P2|Tumor Evaluable Population|Overall Study||180
2439741|NCT01124786|5983988|P1|Tumor Evaluable Population|Overall Study|All pts with measurable/evaluable tumor at baseline per RECIST and have received ≥ one dose of drug|178
2439742|NCT01124786|5983987|P2|Safety Population|Overall Study||181
2439743|NCT01124786|5983988|P1|Safety Population|Overall Study|All pts who received at least one dose of study drug|179
2439744|NCT01124786|5983987|P2|Intent-to-Treat (ITT) Population|Overall Study||185
2439745|NCT01124786|5983988|P1|Intent-to-Treat (ITT) Population|Overall Study|All randomized patients (pts)|182
2439746|NCT01124786|5983987|P2|STARTED|Overall Study||185
2439747|NCT01124786|5983988|P1|STARTED|Overall Study||182
2439748|NCT01124734|5984008|P1|NOT COMPLETED|Overall Study||17
2439749|NCT01124734|5984008|P1|COMPLETED|Overall Study|Closed to accrual|0
2439750|NCT01124734|5984008|P1|Initiation of Course 1 Cycle 2|Overall Study||17
2439751|NCT01124734|5984008|P1|Completion of Course 1 Cycle 1|Overall Study|All 17 participants successfully completed Course 1 Cycle 1|17
2439752|NCT01124734|5984008|P1|STARTED|Overall Study||17
2439753|NCT01124643|5984019|P1|NOT COMPLETED|Overall Study||1
2439754|NCT01124643|5984019|P1|COMPLETED|Overall Study||34
2439755|NCT01124643|5984019|P1|STARTED|Overall Study||35
2439756|NCT01124617|5984033|P2|NOT COMPLETED|Overall Study||6
2439757|NCT01124617|5984034|P1|NOT COMPLETED|Overall Study||19
2439758|NCT01124617|5984033|P2|COMPLETED|Overall Study||25
2439759|NCT01124617|5984034|P1|COMPLETED|Overall Study||41
2439760|NCT01124617|5984033|P2|STARTED|Overall Study||31
2439761|NCT01124617|5984034|P1|STARTED|Overall Study||60
2439762|NCT01124604|5984066|P2|NOT COMPLETED|Overall Study||2
2439763|NCT01124604|5984067|P1|NOT COMPLETED|Overall Study||15
2439764|NCT01124604|5984066|P2|COMPLETED|Overall Study||29
2439765|NCT01124604|5984067|P1|COMPLETED|Overall Study||45
2439766|NCT01124604|5984066|P2|STARTED|Overall Study||31
2439767|NCT01124604|5984067|P1|STARTED|Overall Study||60
2439768|NCT01124448|5984106|P2|NOT COMPLETED|Overall Study||3
2439769|NCT01124448|5984107|P1|NOT COMPLETED|Overall Study||2
2439770|NCT01124448|5984106|P2|COMPLETED|Overall Study||12
2439771|NCT01124448|5984107|P1|COMPLETED|Overall Study||23
2439772|NCT01124448|5984106|P2|STARTED|Overall Study||15
2439773|NCT01124448|5984107|P1|STARTED|Overall Study||25
2439774|NCT01124422|5984115|P3|NOT COMPLETED|4-Week Double-blind Treatment Phase||9
2439775|NCT01124422|5984116|P2|NOT COMPLETED|4-Week Double-blind Treatment Phase||11
2439776|NCT01124422|5984117|P1|NOT COMPLETED|4-Week Double-blind Treatment Phase||0
2439777|NCT01124422|5984115|P3|COMPLETED|4-Week Double-blind Treatment Phase||115
2439778|NCT01124422|5984116|P2|COMPLETED|4-Week Double-blind Treatment Phase||120
2439779|NCT01124422|5984117|P1|COMPLETED|4-Week Double-blind Treatment Phase||0
2439780|NCT01124422|5984115|P3|STARTED|4-Week Double-blind Treatment Phase||124
2439781|NCT01124422|5984116|P2|STARTED|4-Week Double-blind Treatment Phase||131
2439782|NCT01124422|5984117|P1|STARTED|4-Week Double-blind Treatment Phase||0
2439783|NCT01124422|5984115|P3|NOT COMPLETED|4-Week Open-label Run-in Phase||0
2439784|NCT01124422|5984116|P2|NOT COMPLETED|4-Week Open-label Run-in Phase||0
2439785|NCT01124422|5984117|P1|NOT COMPLETED|4-Week Open-label Run-in Phase||83
2439786|NCT01124422|5984115|P3|COMPLETED|4-Week Open-label Run-in Phase||0
2439787|NCT01124422|5984116|P2|COMPLETED|4-Week Open-label Run-in Phase||0
2439788|NCT01124422|5984117|P1|COMPLETED|4-Week Open-label Run-in Phase||255
2439789|NCT01124422|5984115|P3|STARTED|4-Week Open-label Run-in Phase||0
2439790|NCT01124422|5984116|P2|STARTED|4-Week Open-label Run-in Phase||0
2439791|NCT01124422|5984117|P1|STARTED|4-Week Open-label Run-in Phase||338
2439792|NCT01124370|5984159|P1|NOT COMPLETED|Overall Study||20
2439793|NCT01124370|5984159|P1|COMPLETED|Overall Study|Completed 2 year post-implant follow-up|37
2439794|NCT01124370|5984159|P1|3 Month Visit|Overall Study|Defines evaluable population|47
2439795|NCT01124370|5984159|P1|Therapy Initiated|Overall Study||48
2439796|NCT01124370|5984159|P1|Successfully Implanted|Overall Study||50
2439797|NCT01124370|5984159|P1|STARTED|Overall Study|Underwent implant attempt|57
2439798|NCT01124305|5984171|P2|NOT COMPLETED|Overall Study||10
2439799|NCT01124305|5984172|P1|NOT COMPLETED|Overall Study||8
2439800|NCT01124305|5984171|P2|COMPLETED|Overall Study||26
2439801|NCT01124305|5984172|P1|COMPLETED|Overall Study||26
2439802|NCT01124305|5984171|P2|STARTED|Overall Study||36
2439803|NCT01124305|5984172|P1|STARTED|Overall Study||34
2439804|NCT01124292|5984187|P3|NOT COMPLETED|Overall Study||10
2439805|NCT01124292|5984188|P2|NOT COMPLETED|Overall Study||15
2439806|NCT01124292|5984189|P1|NOT COMPLETED|Overall Study||2
2439807|NCT01124292|5984187|P3|COMPLETED|Overall Study||11
2439808|NCT01124292|5984188|P2|COMPLETED|Overall Study||9
2439809|NCT01124292|5984189|P1|COMPLETED|Overall Study||14
2439810|NCT01124292|5984187|P3|STARTED|Overall Study||21
2439811|NCT01124292|5984188|P2|STARTED|Overall Study||24
2439812|NCT01124292|5984189|P1|STARTED|Overall Study||16
2439813|NCT01124188|5984247|P2|NOT COMPLETED|Overall Study||6
2439814|NCT01124188|5984248|P1|NOT COMPLETED|Overall Study||8
2439815|NCT01124188|5984247|P2|COMPLETED|Overall Study||65
2439816|NCT01124188|5984248|P1|COMPLETED|Overall Study||60
2439817|NCT01124188|5984247|P2|STARTED|Overall Study||71
2439818|NCT01124188|5984248|P1|STARTED|Overall Study||68
2439819|NCT01124175|5984260|P2|NOT COMPLETED|Second Intervention||0
2439820|NCT01124175|5984261|P1|NOT COMPLETED|Second Intervention||0
2439821|NCT01124175|5984260|P2|COMPLETED|Second Intervention||38
2439822|NCT01124175|5984261|P1|COMPLETED|Second Intervention||40
2439823|NCT01124175|5984260|P2|STARTED|Second Intervention||38
2439824|NCT01124175|5984261|P1|STARTED|Second Intervention||40
2439825|NCT01124175|5984260|P2|NOT COMPLETED|Washout of 7 Days||2
2439826|NCT01124175|5984261|P1|NOT COMPLETED|Washout of 7 Days||0
2439827|NCT01124175|5984260|P2|COMPLETED|Washout of 7 Days||38
2439828|NCT01124175|5984261|P1|COMPLETED|Washout of 7 Days||40
2439829|NCT01124175|5984260|P2|STARTED|Washout of 7 Days||40
2439830|NCT01124175|5984261|P1|STARTED|Washout of 7 Days||40
2439831|NCT01124175|5984260|P2|NOT COMPLETED|First Intervention||0
2439832|NCT01124175|5984261|P1|NOT COMPLETED|First Intervention||0
2439833|NCT01124175|5984260|P2|COMPLETED|First Intervention||40
2439834|NCT01124175|5984261|P1|COMPLETED|First Intervention||40
2439835|NCT01124175|5984260|P2|STARTED|First Intervention||40
2439836|NCT01124175|5984261|P1|STARTED|First Intervention||40
2439837|NCT01124162|5984279|P2|NOT COMPLETED|Second Intervention||0
2439838|NCT01124162|5984280|P1|NOT COMPLETED|Second Intervention||0
2439839|NCT01124162|5984279|P2|COMPLETED|Second Intervention||40
2439840|NCT01124162|5984280|P1|COMPLETED|Second Intervention||37
2439841|NCT01124162|5984279|P2|STARTED|Second Intervention||40
2439842|NCT01124162|5984280|P1|STARTED|Second Intervention||37
2439843|NCT01124162|5984279|P2|NOT COMPLETED|Washout of 7 Days||0
2439844|NCT01124162|5984280|P1|NOT COMPLETED|Washout of 7 Days||1
2439845|NCT01124162|5984279|P2|COMPLETED|Washout of 7 Days||40
2439846|NCT01124162|5984280|P1|COMPLETED|Washout of 7 Days||37
2439847|NCT01124162|5984279|P2|STARTED|Washout of 7 Days||40
2439848|NCT01124162|5984280|P1|STARTED|Washout of 7 Days||38
2439849|NCT01124162|5984279|P2|NOT COMPLETED|First Intervention||0
2439850|NCT01124162|5984280|P1|NOT COMPLETED|First Intervention||2
2439851|NCT01124162|5984279|P2|COMPLETED|First Intervention||40
2439852|NCT01124162|5984280|P1|COMPLETED|First Intervention||38
2439853|NCT01124162|5984279|P2|STARTED|First Intervention||40
2439854|NCT01124162|5984280|P1|STARTED|First Intervention||40
2439855|NCT01124149|5984296|P1|NOT COMPLETED|Maintenance Phase||96
2439856|NCT01124149|5984296|P1|COMPLETED|Maintenance Phase||373
2439857|NCT01124149|5984296|P1|STARTED|Maintenance Phase||469
2439858|NCT01124149|5984296|P1|NOT COMPLETED|Acute Phase||83
2439859|NCT01124149|5984296|P1|COMPLETED|Acute Phase||639
2439860|NCT01124149|5984296|P1|STARTED|Acute Phase||722
2439861|NCT01124097|5984316|P4|NOT COMPLETED|Overall Study||14
2439862|NCT01124097|5984317|P3|NOT COMPLETED|Overall Study||20
2439863|NCT01124097|5984318|P2|NOT COMPLETED|Overall Study||22
2439864|NCT01124097|5984319|P1|NOT COMPLETED|Overall Study||34
2439865|NCT01124097|5984316|P4|COMPLETED|Overall Study||46
2439866|NCT01124097|5984317|P3|COMPLETED|Overall Study||40
2439867|NCT01124097|5984318|P2|COMPLETED|Overall Study||38
2439868|NCT01124097|5984319|P1|COMPLETED|Overall Study||26
2439869|NCT01124097|5984316|P4|Efficacy Population|Overall Study||51
2439870|NCT01124097|5984317|P3|Efficacy Population|Overall Study||53
2439871|NCT01124097|5984318|P2|Efficacy Population|Overall Study||53
2439872|NCT01124097|5984319|P1|Efficacy Population|Overall Study||52
2439873|NCT01124097|5984316|P4|Safety Population|Overall Study||60
2439874|NCT01124097|5984317|P3|Safety Population|Overall Study||60
2439875|NCT01124097|5984318|P2|Safety Population|Overall Study||60
2439876|NCT01124097|5984319|P1|Safety Population|Overall Study||60
2439877|NCT01124097|5984316|P4|STARTED|Overall Study||60
2439878|NCT01124097|5984317|P3|STARTED|Overall Study||60
2439879|NCT01124097|5984318|P2|STARTED|Overall Study||60
2439880|NCT01124097|5984319|P1|STARTED|Overall Study||60
2439881|NCT01124045|5984331|P2|NOT COMPLETED|Overall Study||3
2439882|NCT01124045|5984332|P1|NOT COMPLETED|Overall Study||0
2439883|NCT01124045|5984331|P2|COMPLETED|Overall Study||37
2439884|NCT01124045|5984332|P1|COMPLETED|Overall Study||39
2439885|NCT01124045|5984331|P2|STARTED|Overall Study||40
2439886|NCT01124045|5984332|P1|STARTED|Overall Study||39
2439887|NCT01124006|5984365|P3|NOT COMPLETED|Overall Study||2
2439888|NCT01124006|5984366|P2|NOT COMPLETED|Overall Study||2
2439889|NCT01124006|5984367|P1|NOT COMPLETED|Overall Study||3
2439890|NCT01124006|5984365|P3|COMPLETED|Overall Study||2
2439891|NCT01124006|5984366|P2|COMPLETED|Overall Study||8
2439892|NCT01124006|5984367|P1|COMPLETED|Overall Study||7
2439893|NCT01124006|5984365|P3|STARTED|Overall Study||4
2439894|NCT01124006|5984366|P2|STARTED|Overall Study||10
2439895|NCT01124006|5984367|P1|STARTED|Overall Study||10
2439896|NCT01123980|5984395|P2|NOT COMPLETED|Overall Study||24
2439897|NCT01123980|5984396|P1|NOT COMPLETED|Overall Study||19
2439898|NCT01123980|5984395|P2|COMPLETED|Overall Study||236
2439899|NCT01123980|5984396|P1|COMPLETED|Overall Study||242
2439900|NCT01123980|5984395|P2|STARTED|Overall Study||260
2439901|NCT01123980|5984396|P1|STARTED|Overall Study||261
2439902|NCT01123941|5984416|P2|NOT COMPLETED|Overall Study||1
2439903|NCT01123941|5984417|P1|NOT COMPLETED|Overall Study||2
2439904|NCT01123941|5984416|P2|COMPLETED|Overall Study||24
2439905|NCT01123941|5984417|P1|COMPLETED|Overall Study||23
2439906|NCT01123941|5984416|P2|STARTED|Overall Study||25
2439907|NCT01123941|5984417|P1|STARTED|Overall Study||25
2439908|NCT01123928|5984431|P2|NOT COMPLETED|Overall Study||0
2439909|NCT01123928|5984432|P1|NOT COMPLETED|Overall Study||0
2439910|NCT01123928|5984431|P2|COMPLETED|Overall Study||222
2439911|NCT01123928|5984432|P1|COMPLETED|Overall Study||212
2439912|NCT01123928|5984431|P2|STARTED|Overall Study||222
2439913|NCT01123928|5984432|P1|STARTED|Overall Study||212
2439914|NCT01123889|5984452|P2|NOT COMPLETED|Overall Study||1
2439915|NCT01123889|5984453|P1|NOT COMPLETED|Overall Study||3
2439916|NCT01123889|5984452|P2|COMPLETED|Overall Study||6
2439917|NCT01123889|5984453|P1|COMPLETED|Overall Study||2
2439918|NCT01123889|5984452|P2|STARTED|Overall Study||7
2439919|NCT01123889|5984453|P1|STARTED|Overall Study||5
2439920|NCT01123850|5984463|P1|NOT COMPLETED|Overall Study||45
2439921|NCT01123850|5984463|P1|COMPLETED|Overall Study||0
2439922|NCT01123850|5984463|P1|STARTED|Overall Study||45
2439923|NCT01123655|5984470|P3|NOT COMPLETED|Overall Study||1
2439924|NCT01123655|5984471|P2|NOT COMPLETED|Overall Study||1
2439925|NCT01123655|5984472|P1|NOT COMPLETED|Overall Study||1
2439926|NCT01123655|5984470|P3|COMPLETED|Overall Study||7
2439927|NCT01123655|5984471|P2|COMPLETED|Overall Study||3
2439928|NCT01123655|5984472|P1|COMPLETED|Overall Study||9
2439929|NCT01123655|5984470|P3|STARTED|Overall Study||8
2439930|NCT01123655|5984471|P2|STARTED|Overall Study||4
2439931|NCT01123655|5984472|P1|STARTED|Overall Study||10
2439932|NCT01123642|5984544|P1|NOT COMPLETED|Overall Study||68
2439933|NCT01123642|5984544|P1|COMPLETED|Overall Study||277
2439934|NCT01123642|5984544|P1|STARTED|Overall Study||345
2439935|NCT01123512|5984553|P2|NOT COMPLETED|Overall Study||21
2439936|NCT01123512|5984554|P1|NOT COMPLETED|Overall Study||26
2439937|NCT01123512|5984553|P2|COMPLETED|Overall Study||126
2439938|NCT01123512|5984554|P1|COMPLETED|Overall Study||127
2439939|NCT01123512|5984553|P2|STARTED|Overall Study||147
2439940|NCT01123512|5984554|P1|STARTED|Overall Study||153
2439941|NCT01123395|5984560|P2|NOT COMPLETED|Period 2||0
2439942|NCT01123395|5984561|P1|NOT COMPLETED|Period 2||0
2439943|NCT01123395|5984560|P2|COMPLETED|Period 2||7
2439944|NCT01123395|5984561|P1|COMPLETED|Period 2||8
2439945|NCT01123395|5984560|P2|STARTED|Period 2||7
2439946|NCT01123395|5984561|P1|STARTED|Period 2||8
2439947|NCT01123395|5984560|P2|NOT COMPLETED|Washout Period of 14 Days||1
2439948|NCT01123395|5984561|P1|NOT COMPLETED|Washout Period of 14 Days||0
2439949|NCT01123395|5984560|P2|COMPLETED|Washout Period of 14 Days||7
2439950|NCT01123395|5984561|P1|COMPLETED|Washout Period of 14 Days||8
2439951|NCT01123395|5984560|P2|STARTED|Washout Period of 14 Days||8
2439952|NCT01123395|5984561|P1|STARTED|Washout Period of 14 Days||8
2439953|NCT01123395|5984560|P2|NOT COMPLETED|Period 1||0
2439954|NCT01123395|5984561|P1|NOT COMPLETED|Period 1||0
2439955|NCT01123395|5984560|P2|COMPLETED|Period 1||8
2439956|NCT01123395|5984561|P1|COMPLETED|Period 1||8
2439957|NCT01123395|5984560|P2|STARTED|Period 1||8
2439958|NCT01123395|5984561|P1|STARTED|Period 1||8
2439959|NCT01123382|5984573|P2|NOT COMPLETED|Overall Study||6
2439960|NCT01123382|5984574|P1|NOT COMPLETED|Overall Study||2
2439961|NCT01123382|5984573|P2|COMPLETED|Overall Study||6
2439962|NCT01123382|5984574|P1|COMPLETED|Overall Study||11
2439963|NCT01123382|5984573|P2|Received Intervention|Overall Study||10
2439964|NCT01123382|5984574|P1|Received Intervention|Overall Study||12
2439965|NCT01123382|5984573|P2|STARTED|Overall Study||12
2439966|NCT01123382|5984574|P1|STARTED|Overall Study||13
2439967|NCT01123356|5984596|P1|NOT COMPLETED|Overall Study||7
2439968|NCT01123356|5984596|P1|COMPLETED|Overall Study||14
2439969|NCT01123356|5984596|P1|STARTED|Overall Study||21
2439970|NCT01123200|5984604|P1|NOT COMPLETED|Overall Study||1
2439971|NCT01123200|5984604|P1|COMPLETED|Overall Study||0
2439972|NCT01123200|5984604|P1|STARTED|Overall Study||1
2439973|NCT01123161|5984611|P2|NOT COMPLETED|Overall Study||0
2439974|NCT01123161|5984612|P1|NOT COMPLETED|Overall Study||2
2439975|NCT01123161|5984611|P2|COMPLETED|Overall Study||63
2439976|NCT01123161|5984612|P1|COMPLETED|Overall Study||55
2439977|NCT01123161|5984611|P2|STARTED|Overall Study||63
2439978|NCT01123161|5984612|P1|STARTED|Overall Study||57
2439979|NCT01123148|5984630|P1|NOT COMPLETED|Overall Study||2
2439980|NCT01123148|5984630|P1|COMPLETED|Overall Study||12
2439981|NCT01123148|5984630|P1|BCI Calibration >50% Accuracy|Overall Study||13
2439982|NCT01123148|5984630|P1|STARTED|Overall Study||14
2439983|NCT01123083|5984636|P2|NOT COMPLETED|Overall Study||15
2439984|NCT01123083|5984637|P1|NOT COMPLETED|Overall Study||11
2439985|NCT01123083|5984636|P2|COMPLETED|Overall Study||103
2439986|NCT01123083|5984637|P1|COMPLETED|Overall Study||50
2439987|NCT01123083|5984636|P2|STARTED|Overall Study||118
2439988|NCT01123083|5984637|P1|STARTED|Overall Study||61
2439989|NCT01122927|5984661|P2|NOT COMPLETED|Period 2- Open-label Treatment Phase||312
2439990|NCT01122927|5984662|P1|NOT COMPLETED|Period 2- Open-label Treatment Phase||0
2439991|NCT01122927|5984661|P2|COMPLETED|Period 2- Open-label Treatment Phase|De novo participants who completed Month 24 visit or rolled over from study NCT01149655.|198
2439992|NCT01122927|5984662|P1|COMPLETED|Period 2- Open-label Treatment Phase||0
2439993|NCT01122927|5984661|P2|STARTED|Period 2- Open-label Treatment Phase|362 were de novo participants and 148 had rolled over from study NCT01149655.|510
2439994|NCT01122927|5984662|P1|STARTED|Period 2- Open-label Treatment Phase||0
2439995|NCT01122927|5984661|P2|NOT COMPLETED|Period 1 - Conversion Phase||0
2439996|NCT01122927|5984662|P1|NOT COMPLETED|Period 1 - Conversion Phase||14
2439997|NCT01122927|5984661|P2|COMPLETED|Period 1 - Conversion Phase||0
2439998|NCT01122927|5984662|P1|COMPLETED|Period 1 - Conversion Phase||283
2439999|NCT01122927|5984661|P2|STARTED|Period 1 - Conversion Phase||0
2440000|NCT01122927|5984662|P1|STARTED|Period 1 - Conversion Phase||297
2440001|NCT01122901|5984695|P2|NOT COMPLETED|Overall Study||0
2440002|NCT01122901|5984696|P1|NOT COMPLETED|Overall Study||0
2440003|NCT01122901|5984695|P2|COMPLETED|Overall Study||7
2440004|NCT01122901|5984696|P1|COMPLETED|Overall Study||40
2440005|NCT01122901|5984695|P2|STARTED|Overall Study||7
2440006|NCT01122901|5984696|P1|STARTED|Overall Study||40
2440007|NCT01122862|5984714|P3|NOT COMPLETED|Period 3||0
2440008|NCT01122862|5984715|P2|NOT COMPLETED|Period 3||0
2440009|NCT01122862|5984716|P1|NOT COMPLETED|Period 3||0
2440010|NCT01122862|5984714|P3|COMPLETED|Period 3||8
2440011|NCT01122862|5984715|P2|COMPLETED|Period 3||7
2440012|NCT01122862|5984716|P1|COMPLETED|Period 3||6
2440013|NCT01122862|5984714|P3|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|8
2440014|NCT01122862|5984715|P2|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|7
2440015|NCT01122862|5984716|P1|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|6
2440016|NCT01122862|5984714|P3|NOT COMPLETED|Period 2||1
2440017|NCT01122862|5984715|P2|NOT COMPLETED|Period 2||0
2440018|NCT01122862|5984716|P1|NOT COMPLETED|Period 2||0
2440019|NCT01122862|5984714|P3|COMPLETED|Period 2||6
2440020|NCT01122862|5984715|P2|COMPLETED|Period 2||7
2440021|NCT01122862|5984716|P1|COMPLETED|Period 2||8
2440022|NCT01122862|5984714|P3|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
2440023|NCT01122862|5984715|P2|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
2440024|NCT01122862|5984716|P1|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|8
2440025|NCT01122862|5984714|P3|NOT COMPLETED|Period 1||0
2440026|NCT01122862|5984715|P2|NOT COMPLETED|Period 1||1
2440027|NCT01122862|5984716|P1|NOT COMPLETED|Period 1||0
2440028|NCT01122862|5984714|P3|COMPLETED|Period 1||7
2440029|NCT01122862|5984715|P2|COMPLETED|Period 1||7
2440030|NCT01122862|5984716|P1|COMPLETED|Period 1||8
2440031|NCT01122862|5984714|P3|STARTED|Period 1||7
2440032|NCT01122862|5984715|P2|STARTED|Period 1||8
2440033|NCT01122862|5984716|P1|STARTED|Period 1||8
2440034|NCT01122849|5984737|P3|NOT COMPLETED|Overall Study||0
2440035|NCT01122849|5984738|P2|NOT COMPLETED|Overall Study||0
2440036|NCT01122849|5984739|P1|NOT COMPLETED|Overall Study||0
2440037|NCT01122849|5984737|P3|COMPLETED|Overall Study||20
2440038|NCT01122849|5984738|P2|COMPLETED|Overall Study||21
2440039|NCT01122849|5984739|P1|COMPLETED|Overall Study||20
2440040|NCT01122849|5984737|P3|STARTED|Overall Study||20
2440041|NCT01122849|5984738|P2|STARTED|Overall Study||21
2440042|NCT01122849|5984739|P1|STARTED|Overall Study||20
2440043|NCT01122680|5984822|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
2440044|NCT01122680|5984823|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
2440045|NCT01122680|5984824|P2|NOT COMPLETED|Period 3 (4 Weeks)||1
2440046|NCT01122680|5984825|P1|NOT COMPLETED|Period 3 (4 Weeks)||1
2440047|NCT01122680|5984822|P4|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|23
2440048|NCT01122680|5984823|P3|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|26
2440049|NCT01122680|5984824|P2|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
2440050|NCT01122680|5984825|P1|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
2440051|NCT01122680|5984822|P4|STARTED|Period 3 (4 Weeks)|Entered this study period.|23
2440052|NCT01122680|5984823|P3|STARTED|Period 3 (4 Weeks)|Entered this study period.|26
2440053|NCT01122680|5984824|P2|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
2440054|NCT01122680|5984825|P1|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
2440055|NCT01122680|5984822|P4|NOT COMPLETED|Period 2 (4 Weeks)||1
2440056|NCT01122680|5984823|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
2440057|NCT01122680|5984824|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
2440058|NCT01122680|5984825|P1|NOT COMPLETED|Period 2 (4 Weeks)||1
2440059|NCT01122680|5984822|P4|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|23
2440060|NCT01122680|5984823|P3|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|26
2440061|NCT01122680|5984824|P2|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
2440062|NCT01122680|5984825|P1|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
2440063|NCT01122680|5984822|P4|STARTED|Period 2 (4 Weeks)|Entered this study period.|24
2440064|NCT01122680|5984823|P3|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
2440065|NCT01122680|5984824|P2|STARTED|Period 2 (4 Weeks)|Entered this study period.|25
2440066|NCT01122680|5984825|P1|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
2440067|NCT01122680|5984822|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
2440068|NCT01122680|5984823|P3|NOT COMPLETED|Period 1 (4 Weeks)||0
2440069|NCT01122680|5984824|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
2440070|NCT01122680|5984825|P1|NOT COMPLETED|Period 1 (4 Weeks)||3
2440071|NCT01122680|5984822|P4|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|24
2440072|NCT01122680|5984823|P3|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
2440073|NCT01122680|5984824|P2|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|25
2440074|NCT01122680|5984825|P1|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
2440075|NCT01122680|5984822|P4|STARTED|Period 1 (4 Weeks)|Entered this study period.|24
2440076|NCT01122680|5984823|P3|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
2440077|NCT01122680|5984824|P2|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
2440078|NCT01122680|5984825|P1|STARTED|Period 1 (4 Weeks)|Entered this study period.|29
2440079|NCT01122576|5984890|P3|NOT COMPLETED|Post-Cataract Surgery||2
2440080|NCT01122576|5984891|P2|NOT COMPLETED|Post-Cataract Surgery||0
2440081|NCT01122576|5984892|P1|NOT COMPLETED|Post-Cataract Surgery||0
2440082|NCT01122576|5984890|P3|COMPLETED|Post-Cataract Surgery||22
2440083|NCT01122576|5984891|P2|COMPLETED|Post-Cataract Surgery||25
2440084|NCT01122576|5984892|P1|COMPLETED|Post-Cataract Surgery||26
2440085|NCT01122576|5984890|P3|STARTED|Post-Cataract Surgery||24
2440086|NCT01122576|5984891|P2|STARTED|Post-Cataract Surgery||25
2440087|NCT01122576|5984892|P1|STARTED|Post-Cataract Surgery||26
2440088|NCT01122576|5984890|P3|NOT COMPLETED|Pre-Cataract Surgery||2
2440089|NCT01122576|5984891|P2|NOT COMPLETED|Pre-Cataract Surgery||1
2440090|NCT01122576|5984892|P1|NOT COMPLETED|Pre-Cataract Surgery||0
2440091|NCT01122576|5984890|P3|COMPLETED|Pre-Cataract Surgery||24
2440092|NCT01122576|5984891|P2|COMPLETED|Pre-Cataract Surgery||25
2440093|NCT01122576|5984892|P1|COMPLETED|Pre-Cataract Surgery||26
2440094|NCT01122576|5984890|P3|STARTED|Pre-Cataract Surgery||26
2440095|NCT01122576|5984891|P2|STARTED|Pre-Cataract Surgery||26
2440096|NCT01122576|5984892|P1|STARTED|Pre-Cataract Surgery||26
2440097|NCT01122511|5985031|P2|NOT COMPLETED|Overall Study||2
2440098|NCT01122511|5985032|P1|NOT COMPLETED|Overall Study||2
2440099|NCT01122511|5985031|P2|COMPLETED|Overall Study||0
2440100|NCT01122511|5985032|P1|COMPLETED|Overall Study||0
2440101|NCT01122511|5985031|P2|STARTED|Overall Study||2
2440102|NCT01122511|5985032|P1|STARTED|Overall Study||2
2440103|NCT01122446|5985046|P2|NOT COMPLETED|Overall Study||0
2440104|NCT01122446|5985047|P1|NOT COMPLETED|Overall Study||0
2440105|NCT01122446|5985046|P2|COMPLETED|Overall Study||25
2440106|NCT01122446|5985047|P1|COMPLETED|Overall Study||25
2440107|NCT01122446|5985046|P2|STARTED|Overall Study||25
2440108|NCT01122446|5985047|P1|STARTED|Overall Study||25
2440109|NCT01122394|5985073|P2|NOT COMPLETED|Overall Study||4
2440110|NCT01122394|5985074|P1|NOT COMPLETED|Overall Study||3
2440111|NCT01122394|5985073|P2|COMPLETED|Overall Study||70
2440112|NCT01122394|5985074|P1|COMPLETED|Overall Study||63
2440113|NCT01122394|5985073|P2|STARTED|Overall Study||74
2440114|NCT01122394|5985074|P1|STARTED|Overall Study||66
2440115|NCT01122381|5985090|P2|NOT COMPLETED|Overall Study||1
2440116|NCT01122381|5985091|P1|NOT COMPLETED|Overall Study||0
2440117|NCT01122381|5985090|P2|COMPLETED|Overall Study||0
2440118|NCT01122381|5985091|P1|COMPLETED|Overall Study|Subject never took the drug per review of ESX levels after unblinding|1
2440119|NCT01122381|5985090|P2|STARTED|Overall Study||1
2440120|NCT01122381|5985091|P1|STARTED|Overall Study||1
2440121|NCT01122264|5985100|P3|NOT COMPLETED|Overall Study||47
2440122|NCT01122264|5985101|P2|NOT COMPLETED|Overall Study||29
2440123|NCT01122264|5985102|P1|NOT COMPLETED|Overall Study||32
2440124|NCT01122264|5985100|P3|COMPLETED|Overall Study||214
2440125|NCT01122264|5985101|P2|COMPLETED|Overall Study||228
2440126|NCT01122264|5985102|P1|COMPLETED|Overall Study||220
2440127|NCT01122264|5985100|P3|Received at Least 1 Dose of Study Drug|Overall Study||260
2440128|NCT01122264|5985101|P2|Received at Least 1 Dose of Study Drug|Overall Study||257
2440129|NCT01122264|5985102|P1|Received at Least 1 Dose of Study Drug|Overall Study||250
2440130|NCT01122264|5985100|P3|STARTED|Overall Study||261
2440131|NCT01122264|5985101|P2|STARTED|Overall Study||257
2440132|NCT01122264|5985102|P1|STARTED|Overall Study||252
2440133|NCT01122238|5985175|P16|NOT COMPLETED|Overall Study||0
2440134|NCT01122238|5985176|P15|NOT COMPLETED|Overall Study||0
2440135|NCT01122238|5985177|P14|NOT COMPLETED|Overall Study||1
2440136|NCT01122238|5985178|P13|NOT COMPLETED|Overall Study||2
2440137|NCT01122238|5985179|P12|NOT COMPLETED|Overall Study||2
2440138|NCT01122238|5985180|P11|NOT COMPLETED|Overall Study||0
2440139|NCT01122238|5985181|P10|NOT COMPLETED|Overall Study||1
2440140|NCT01122238|5985182|P9|NOT COMPLETED|Overall Study||1
2440141|NCT01122238|5985183|P8|NOT COMPLETED|Overall Study||0
2440142|NCT01122238|5985184|P7|NOT COMPLETED|Overall Study||1
2440143|NCT01122238|5985185|P6|NOT COMPLETED|Overall Study||1
2440144|NCT01122238|5985186|P5|NOT COMPLETED|Overall Study||0
2440145|NCT01122238|5985187|P4|NOT COMPLETED|Overall Study||0
2440146|NCT01122238|5985188|P3|NOT COMPLETED|Overall Study||5
2440147|NCT01122238|5985189|P2|NOT COMPLETED|Overall Study||1
2440148|NCT01122238|5985190|P1|NOT COMPLETED|Overall Study||2
2440149|NCT01122238|5985175|P16|COMPLETED|Overall Study||31
2440150|NCT01122238|5985176|P15|COMPLETED|Overall Study||28
2440151|NCT01122238|5985177|P14|COMPLETED|Overall Study||31
2440152|NCT01122238|5985178|P13|COMPLETED|Overall Study||28
2440153|NCT01122238|5985179|P12|COMPLETED|Overall Study||31
2440154|NCT01122238|5985180|P11|COMPLETED|Overall Study||32
2440155|NCT01122238|5985181|P10|COMPLETED|Overall Study||33
2440156|NCT01122238|5985182|P9|COMPLETED|Overall Study||31
2440157|NCT01122238|5985183|P8|COMPLETED|Overall Study||32
2440158|NCT01122238|5985184|P7|COMPLETED|Overall Study||34
2440159|NCT01122238|5985185|P6|COMPLETED|Overall Study||31
2440160|NCT01122238|5985186|P5|COMPLETED|Overall Study||33
2440161|NCT01122238|5985187|P4|COMPLETED|Overall Study||33
2440162|NCT01122238|5985188|P3|COMPLETED|Overall Study||28
2440163|NCT01122238|5985189|P2|COMPLETED|Overall Study||36
2440164|NCT01122238|5985190|P1|COMPLETED|Overall Study||28
2440165|NCT01122238|5985175|P16|STARTED|Overall Study||31
2440166|NCT01122238|5985176|P15|STARTED|Overall Study||28
2440167|NCT01122238|5985177|P14|STARTED|Overall Study||32
2440168|NCT01122238|5985178|P13|STARTED|Overall Study||30
2440169|NCT01122238|5985179|P12|STARTED|Overall Study||33
2440170|NCT01122238|5985180|P11|STARTED|Overall Study||32
2440171|NCT01122238|5985181|P10|STARTED|Overall Study||34
2440172|NCT01122238|5985182|P9|STARTED|Overall Study||32
2440173|NCT01122238|5985183|P8|STARTED|Overall Study||32
2440174|NCT01122238|5985184|P7|STARTED|Overall Study||35
2440175|NCT01122238|5985185|P6|STARTED|Overall Study||32
2440176|NCT01122238|5985186|P5|STARTED|Overall Study||33
2440177|NCT01122238|5985187|P4|STARTED|Overall Study||33
2440178|NCT01122238|5985188|P3|STARTED|Overall Study||33
2440179|NCT01122238|5985189|P2|STARTED|Overall Study||37
2440180|NCT01122238|5985190|P1|STARTED|Overall Study||30
2440181|NCT01122173|5985212|P1|NOT COMPLETED|Overall Study||9
2440182|NCT01122173|5985212|P1|COMPLETED|Overall Study||141
2440183|NCT01122173|5985212|P1|STARTED|Overall Study||150
2440184|NCT01122160|5985219|P2|NOT COMPLETED|Second Intervention (7 Days)||0
2440185|NCT01122160|5985220|P1|NOT COMPLETED|Second Intervention (7 Days)||0
2440186|NCT01122160|5985219|P2|COMPLETED|Second Intervention (7 Days)||5
2440187|NCT01122160|5985220|P1|COMPLETED|Second Intervention (7 Days)||6
2440188|NCT01122160|5985219|P2|STARTED|Second Intervention (7 Days)||5
2440189|NCT01122160|5985220|P1|STARTED|Second Intervention (7 Days)||6
2440190|NCT01122160|5985219|P2|NOT COMPLETED|Washout (7-14 Days)||0
2440191|NCT01122160|5985220|P1|NOT COMPLETED|Washout (7-14 Days)||0
2440192|NCT01122160|5985219|P2|COMPLETED|Washout (7-14 Days)||5
2440193|NCT01122160|5985220|P1|COMPLETED|Washout (7-14 Days)||6
2440194|NCT01122160|5985219|P2|STARTED|Washout (7-14 Days)||5
2440195|NCT01122160|5985220|P1|STARTED|Washout (7-14 Days)||6
2440196|NCT01122160|5985219|P2|NOT COMPLETED|First Intervention (7 Days)||0
2440197|NCT01122160|5985220|P1|NOT COMPLETED|First Intervention (7 Days)||0
2440198|NCT01122160|5985219|P2|COMPLETED|First Intervention (7 Days)||5
2440199|NCT01122160|5985220|P1|COMPLETED|First Intervention (7 Days)||6
2440200|NCT01122160|5985219|P2|STARTED|First Intervention (7 Days)||5
2440201|NCT01122160|5985220|P1|STARTED|First Intervention (7 Days)||6
2440202|NCT01122108|5985226|P2|NOT COMPLETED|Overall Study||0
2440203|NCT01122108|5985227|P1|NOT COMPLETED|Overall Study||0
2440204|NCT01122108|5985226|P2|COMPLETED|Overall Study||21
2440205|NCT01122108|5985227|P1|COMPLETED|Overall Study||21
2440206|NCT01122108|5985226|P2|STARTED|Overall Study||21
2440207|NCT01122108|5985227|P1|STARTED|Overall Study||21
2440208|NCT01122030|5985243|P7|NOT COMPLETED|Overall Study||0
2440209|NCT01122030|5985244|P6|NOT COMPLETED|Overall Study||0
2440210|NCT01122030|5985245|P5|NOT COMPLETED|Overall Study||0
2440211|NCT01122030|5985246|P4|NOT COMPLETED|Overall Study||0
2440212|NCT01122030|5985247|P3|NOT COMPLETED|Overall Study||0
2440213|NCT01122030|5985248|P2|NOT COMPLETED|Overall Study||0
2440214|NCT01122030|5985249|P1|NOT COMPLETED|Overall Study||0
2440215|NCT01122030|5985243|P7|COMPLETED|Overall Study||9
2440216|NCT01122030|5985244|P6|COMPLETED|Overall Study||9
2440217|NCT01122030|5985245|P5|COMPLETED|Overall Study||9
2440218|NCT01122030|5985246|P4|COMPLETED|Overall Study||9
2440219|NCT01122030|5985247|P3|COMPLETED|Overall Study||9
2440220|NCT01122030|5985248|P2|COMPLETED|Overall Study||9
2440221|NCT01122030|5985249|P1|COMPLETED|Overall Study||18
2440222|NCT01122030|5985243|P7|Received Treatment|Overall Study||9
2440223|NCT01122030|5985244|P6|Received Treatment|Overall Study||9
2440224|NCT01122030|5985245|P5|Received Treatment|Overall Study||9
2440225|NCT01122030|5985246|P4|Received Treatment|Overall Study||9
2440226|NCT01122030|5985247|P3|Received Treatment|Overall Study||9
2440227|NCT01122030|5985248|P2|Received Treatment|Overall Study||9
2440228|NCT01122030|5985249|P1|Received Treatment|Overall Study||18
2440229|NCT01122030|5985243|P7|STARTED|Overall Study||9
2440230|NCT01122030|5985244|P6|STARTED|Overall Study||9
2440231|NCT01122030|5985245|P5|STARTED|Overall Study||9
2440232|NCT01122030|5985246|P4|STARTED|Overall Study||9
2440233|NCT01122030|5985247|P3|STARTED|Overall Study||9
2440234|NCT01122030|5985248|P2|STARTED|Overall Study||9
2440235|NCT01122030|5985249|P1|STARTED|Overall Study||18
2440236|NCT01121991|5985435|P1|NOT COMPLETED|Overall Study||6
2440237|NCT01121991|5985435|P1|COMPLETED|Overall Study||46
2440238|NCT01121991|5985435|P1|STARTED|Overall Study|Number of participants treated|52
2440239|NCT01121939|5985446|P1|NOT COMPLETED|Overall Study||43
2440240|NCT01121939|5985446|P1|COMPLETED|Overall Study|Patients remained on-study until disease progression or unacceptable toxicity occurred.|0
2440241|NCT01121939|5985446|P1|STARTED|Overall Study||43
2440242|NCT01121926|5985460|P2|NOT COMPLETED|Second Intervention Period||0
2440243|NCT01121926|5985461|P1|NOT COMPLETED|Second Intervention Period||0
2440244|NCT01121926|5985460|P2|COMPLETED|Second Intervention Period||13
2440245|NCT01121926|5985461|P1|COMPLETED|Second Intervention Period||14
2440246|NCT01121926|5985460|P2|STARTED|Second Intervention Period||13
2440247|NCT01121926|5985461|P1|STARTED|Second Intervention Period||14
2440248|NCT01121926|5985460|P2|NOT COMPLETED|Washout Period||2
2440249|NCT01121926|5985461|P1|NOT COMPLETED|Washout Period||0
2440250|NCT01121926|5985460|P2|COMPLETED|Washout Period||13
2440251|NCT01121926|5985461|P1|COMPLETED|Washout Period||14
2440252|NCT01121926|5985460|P2|STARTED|Washout Period||15
2440253|NCT01121926|5985461|P1|STARTED|Washout Period||14
2440254|NCT01121926|5985460|P2|NOT COMPLETED|First Intervention Period||0
2440255|NCT01121926|5985461|P1|NOT COMPLETED|First Intervention Period||1
2440256|NCT01121926|5985460|P2|COMPLETED|First Intervention Period||15
2440257|NCT01121926|5985461|P1|COMPLETED|First Intervention Period||14
2440258|NCT01121926|5985460|P2|STARTED|First Intervention Period||15
2440259|NCT01121926|5985461|P1|STARTED|First Intervention Period||15
2440260|NCT01121913|5985479|P4|NOT COMPLETED|Fourth Intervention Period||0
2440261|NCT01121913|5985480|P3|NOT COMPLETED|Fourth Intervention Period||0
2440262|NCT01121913|5985481|P2|NOT COMPLETED|Fourth Intervention Period||0
2440263|NCT01121913|5985482|P1|NOT COMPLETED|Fourth Intervention Period||0
2440264|NCT01121913|5985479|P4|COMPLETED|Fourth Intervention Period||6
2440265|NCT01121913|5985480|P3|COMPLETED|Fourth Intervention Period||3
2440266|NCT01121913|5985481|P2|COMPLETED|Fourth Intervention Period||6
2440267|NCT01121913|5985482|P1|COMPLETED|Fourth Intervention Period||4
2440268|NCT01121913|5985479|P4|STARTED|Fourth Intervention Period||6
2440269|NCT01121913|5985480|P3|STARTED|Fourth Intervention Period||3
2440270|NCT01121913|5985481|P2|STARTED|Fourth Intervention Period||6
2440271|NCT01121913|5985482|P1|STARTED|Fourth Intervention Period||4
2440272|NCT01121913|5985479|P4|NOT COMPLETED|Third Washout Period||0
2440273|NCT01121913|5985480|P3|NOT COMPLETED|Third Washout Period||0
2440274|NCT01121913|5985481|P2|NOT COMPLETED|Third Washout Period||0
2440275|NCT01121913|5985482|P1|NOT COMPLETED|Third Washout Period||1
2440276|NCT01121913|5985479|P4|COMPLETED|Third Washout Period||6
2440277|NCT01121913|5985480|P3|COMPLETED|Third Washout Period||3
2440278|NCT01121913|5985481|P2|COMPLETED|Third Washout Period||6
2440279|NCT01121913|5985482|P1|COMPLETED|Third Washout Period||4
2440280|NCT01121913|5985479|P4|STARTED|Third Washout Period||6
2440281|NCT01121913|5985480|P3|STARTED|Third Washout Period||3
2440282|NCT01121913|5985481|P2|STARTED|Third Washout Period||6
2440283|NCT01121913|5985482|P1|STARTED|Third Washout Period||5
2440284|NCT01121913|5985479|P4|NOT COMPLETED|Third Intervention Period||0
2440285|NCT01121913|5985480|P3|NOT COMPLETED|Third Intervention Period||0
2440286|NCT01121913|5985481|P2|NOT COMPLETED|Third Intervention Period||0
2440287|NCT01121913|5985482|P1|NOT COMPLETED|Third Intervention Period||0
2440288|NCT01121913|5985479|P4|COMPLETED|Third Intervention Period||6
2440289|NCT01121913|5985480|P3|COMPLETED|Third Intervention Period||3
2440290|NCT01121913|5985481|P2|COMPLETED|Third Intervention Period||6
2440291|NCT01121913|5985482|P1|COMPLETED|Third Intervention Period||5
2440292|NCT01121913|5985479|P4|STARTED|Third Intervention Period||6
2440293|NCT01121913|5985480|P3|STARTED|Third Intervention Period||3
2440294|NCT01121913|5985481|P2|STARTED|Third Intervention Period||6
2440295|NCT01121913|5985482|P1|STARTED|Third Intervention Period||5
2440296|NCT01121913|5985479|P4|NOT COMPLETED|Second Washout Period||0
2440297|NCT01121913|5985480|P3|NOT COMPLETED|Second Washout Period||1
2440298|NCT01121913|5985481|P2|NOT COMPLETED|Second Washout Period||0
2440299|NCT01121913|5985482|P1|NOT COMPLETED|Second Washout Period||0
2440300|NCT01121913|5985479|P4|COMPLETED|Second Washout Period||6
2440301|NCT01121913|5985480|P3|COMPLETED|Second Washout Period||3
2440302|NCT01121913|5985481|P2|COMPLETED|Second Washout Period||6
2440303|NCT01121913|5985482|P1|COMPLETED|Second Washout Period||5
2440304|NCT01121913|5985479|P4|STARTED|Second Washout Period||6
2440305|NCT01121913|5985480|P3|STARTED|Second Washout Period||4
2440306|NCT01121913|5985481|P2|STARTED|Second Washout Period||6
2440307|NCT01121913|5985482|P1|STARTED|Second Washout Period||5
2440308|NCT01121913|5985479|P4|NOT COMPLETED|Second Intervention Period||0
2440309|NCT01121913|5985480|P3|NOT COMPLETED|Second Intervention Period||1
2440310|NCT01121913|5985481|P2|NOT COMPLETED|Second Intervention Period||0
2440311|NCT01121913|5985482|P1|NOT COMPLETED|Second Intervention Period||0
2440312|NCT01121913|5985479|P4|COMPLETED|Second Intervention Period||6
2440313|NCT01121913|5985480|P3|COMPLETED|Second Intervention Period||4
2440314|NCT01121913|5985481|P2|COMPLETED|Second Intervention Period||6
2440315|NCT01121913|5985482|P1|COMPLETED|Second Intervention Period||5
2440316|NCT01121913|5985479|P4|STARTED|Second Intervention Period||6
2440317|NCT01121913|5985480|P3|STARTED|Second Intervention Period||5
2440318|NCT01121913|5985481|P2|STARTED|Second Intervention Period||6
2440319|NCT01121913|5985482|P1|STARTED|Second Intervention Period||5
2440320|NCT01121913|5985479|P4|NOT COMPLETED|First Washout Period||0
2440321|NCT01121913|5985480|P3|NOT COMPLETED|First Washout Period||0
2440322|NCT01121913|5985481|P2|NOT COMPLETED|First Washout Period||0
2440323|NCT01121913|5985482|P1|NOT COMPLETED|First Washout Period||1
2440324|NCT01121913|5985479|P4|COMPLETED|First Washout Period||6
2440325|NCT01121913|5985480|P3|COMPLETED|First Washout Period||5
2440326|NCT01121913|5985481|P2|COMPLETED|First Washout Period||6
2440327|NCT01121913|5985482|P1|COMPLETED|First Washout Period||5
2440328|NCT01121913|5985479|P4|STARTED|First Washout Period||6
2440329|NCT01121913|5985480|P3|STARTED|First Washout Period||5
2440330|NCT01121913|5985481|P2|STARTED|First Washout Period||6
2440331|NCT01121913|5985482|P1|STARTED|First Washout Period||6
2440332|NCT01121913|5985479|P4|NOT COMPLETED|First Intervention Period||0
2440333|NCT01121913|5985480|P3|NOT COMPLETED|First Intervention Period||1
2440334|NCT01121913|5985481|P2|NOT COMPLETED|First Intervention Period||0
2440335|NCT01121913|5985482|P1|NOT COMPLETED|First Intervention Period||0
2440336|NCT01121913|5985479|P4|COMPLETED|First Intervention Period||6
2440337|NCT01121913|5985480|P3|COMPLETED|First Intervention Period||5
2440338|NCT01121913|5985481|P2|COMPLETED|First Intervention Period||6
2440339|NCT01121913|5985482|P1|COMPLETED|First Intervention Period||6
2440340|NCT01121913|5985479|P4|STARTED|First Intervention Period||6
2440341|NCT01121913|5985480|P3|STARTED|First Intervention Period||6
2440342|NCT01121913|5985481|P2|STARTED|First Intervention Period||6
2440343|NCT01121913|5985482|P1|STARTED|First Intervention Period||6
2440344|NCT01121900|5985512|P2|NOT COMPLETED|Second Intervention Period||0
2440345|NCT01121900|5985513|P1|NOT COMPLETED|Second Intervention Period||0
2440346|NCT01121900|5985512|P2|COMPLETED|Second Intervention Period||11
2440347|NCT01121900|5985513|P1|COMPLETED|Second Intervention Period||12
2440348|NCT01121900|5985512|P2|STARTED|Second Intervention Period||11
2440349|NCT01121900|5985513|P1|STARTED|Second Intervention Period||12
2440350|NCT01121900|5985512|P2|NOT COMPLETED|Washout Period of 7 Days||1
2440351|NCT01121900|5985513|P1|NOT COMPLETED|Washout Period of 7 Days||0
2440352|NCT01121900|5985512|P2|COMPLETED|Washout Period of 7 Days||11
2440353|NCT01121900|5985513|P1|COMPLETED|Washout Period of 7 Days||12
2440354|NCT01121900|5985512|P2|STARTED|Washout Period of 7 Days||12
2440355|NCT01121900|5985513|P1|STARTED|Washout Period of 7 Days||12
2440356|NCT01121900|5985512|P2|NOT COMPLETED|First Intervention Period||1
2440357|NCT01121900|5985513|P1|NOT COMPLETED|First Intervention Period||1
2440358|NCT01121900|5985512|P2|COMPLETED|First Intervention Period||12
2440359|NCT01121900|5985513|P1|COMPLETED|First Intervention Period||12
2440360|NCT01121900|5985512|P2|STARTED|First Intervention Period||13
2440361|NCT01121900|5985513|P1|STARTED|First Intervention Period||13
2440362|NCT01121757|5985533|P2|NOT COMPLETED|Combination||1
2440363|NCT01121757|5985534|P1|NOT COMPLETED|Combination||2
2440364|NCT01121757|5985533|P2|COMPLETED|Combination||0
2440365|NCT01121757|5985534|P1|COMPLETED|Combination||0
2440366|NCT01121757|5985533|P2|STARTED|Combination||1
2440367|NCT01121757|5985534|P1|STARTED|Combination|2 subjects did not start combination drug. 1 elected surgery 1 had a complete response after drug 2.|2
2440368|NCT01121757|5985533|P2|NOT COMPLETED|Second Drug||0
2440369|NCT01121757|5985534|P1|NOT COMPLETED|Second Drug||0
2440370|NCT01121757|5985533|P2|COMPLETED|Second Drug||1
2440371|NCT01121757|5985534|P1|COMPLETED|Second Drug||4
2440372|NCT01121757|5985533|P2|STARTED|Second Drug||1
2440373|NCT01121757|5985534|P1|STARTED|Second Drug|1 subject did not start drug 2 due to disease progression|4
2440374|NCT01121757|5985533|P2|NOT COMPLETED|First Drug||2
2440375|NCT01121757|5985534|P1|NOT COMPLETED|First Drug||1
2440376|NCT01121757|5985533|P2|COMPLETED|First Drug|Completed a minimum of 4 cycles of Lenalidomide|1
2440377|NCT01121757|5985534|P1|COMPLETED|First Drug|Completed a minimum of 4 cycles of Azacitidine.|5
2440378|NCT01121757|5985533|P2|STARTED|First Drug||3
2440379|NCT01121757|5985534|P1|STARTED|First Drug||6
2440380|NCT01121666|5985550|P2|NOT COMPLETED|Overall Study||10
2440381|NCT01121666|5985551|P1|NOT COMPLETED|Overall Study||29
2440382|NCT01121666|5985550|P2|COMPLETED|Overall Study||113
2440383|NCT01121666|5985551|P1|COMPLETED|Overall Study||220
2440384|NCT01121666|5985550|P2|STARTED|Overall Study||123
2440385|NCT01121666|5985551|P1|STARTED|Overall Study||249
2440386|NCT01121575|5985607|P6|NOT COMPLETED|Overall Study||12
2440387|NCT01121575|5985608|P5|NOT COMPLETED|Overall Study||25
2440388|NCT01121575|5985609|P4|NOT COMPLETED|Overall Study||6
2440389|NCT01121575|5985610|P3|NOT COMPLETED|Overall Study||7
2440390|NCT01121575|5985611|P2|NOT COMPLETED|Overall Study||6
2440391|NCT01121575|5985612|P1|NOT COMPLETED|Overall Study||14
2440392|NCT01121575|5985607|P6|COMPLETED|Overall Study||0
2440393|NCT01121575|5985608|P5|COMPLETED|Overall Study||0
2440394|NCT01121575|5985609|P4|COMPLETED|Overall Study||0
2440395|NCT01121575|5985610|P3|COMPLETED|Overall Study||0
2440396|NCT01121575|5985611|P2|COMPLETED|Overall Study||0
2440397|NCT01121575|5985612|P1|COMPLETED|Overall Study||0
2440398|NCT01121575|5985607|P6|Treated|Overall Study||12
2440399|NCT01121575|5985608|P5|Treated|Overall Study||25
2440400|NCT01121575|5985609|P4|Treated|Overall Study||6
2440401|NCT01121575|5985610|P3|Treated|Overall Study||7
2440402|NCT01121575|5985611|P2|Treated|Overall Study||6
2440403|NCT01121575|5985612|P1|Treated|Overall Study||14
2440404|NCT01121575|5985607|P6|STARTED|Overall Study||12
2440405|NCT01121575|5985608|P5|STARTED|Overall Study||25
2440406|NCT01121575|5985609|P4|STARTED|Overall Study||6
2440407|NCT01121575|5985610|P3|STARTED|Overall Study||7
2440408|NCT01121575|5985611|P2|STARTED|Overall Study||6
2440409|NCT01121575|5985612|P1|STARTED|Overall Study||14
2440410|NCT01121562|5985736|P1|NOT COMPLETED|Overall Study||12
2440411|NCT01121562|5985736|P1|COMPLETED|Overall Study||0
2440412|NCT01121562|5985736|P1|STARTED|Overall Study||12
2440413|NCT01121549|5985745|P1|NOT COMPLETED|Overall Study||347
2440414|NCT01121549|5985745|P1|COMPLETED|Overall Study||31
2440415|NCT01121549|5985745|P1|STARTED|Overall Study||378
2440416|NCT01121536|5985756|P1|NOT COMPLETED|Overall Study||361
2440417|NCT01121536|5985756|P1|COMPLETED|Overall Study|One participant 'completed' early due to study closeout.|506
2440418|NCT01121536|5985756|P1|Full Analysis Population|Overall Study|Treated participants who had at least 1 post-baseline efficacy assessment.|859
2440419|NCT01121536|5985756|P1|Safety Population|Overall Study|Participants treated|863
2440420|NCT01121536|5985756|P1|STARTED|Overall Study||867
2440421|NCT01121484|5985777|P2|NOT COMPLETED|Overall Study||43
2440422|NCT01121484|5985778|P1|NOT COMPLETED|Overall Study||33
2440423|NCT01121484|5985777|P2|COMPLETED|Overall Study||178
2440424|NCT01121484|5985778|P1|COMPLETED|Overall Study||185
2440425|NCT01121484|5985777|P2|Treated|Overall Study||217
2440426|NCT01121484|5985778|P1|Treated|Overall Study||217
2440427|NCT01121484|5985777|P2|STARTED|Overall Study||221
2440428|NCT01121484|5985778|P1|STARTED|Overall Study||218
2440429|NCT01121406|5985796|P2|NOT COMPLETED|Overall Study||55
2440430|NCT01121406|5985797|P1|NOT COMPLETED|Overall Study||55
2440431|NCT01121406|5985796|P2|COMPLETED|Overall Study||0
2440432|NCT01121406|5985797|P1|COMPLETED|Overall Study||0
2440433|NCT01121406|5985796|P2|STARTED|Overall Study|24 patients switched to Volasertib (BI 6727) due to disease progression or occurrence of toxicity|55
2440434|NCT01121406|5985797|P1|STARTED|Overall Study||55
2440435|NCT01121393|5985847|P2|NOT COMPLETED|Overall Study||84
2440436|NCT01121393|5985848|P1|NOT COMPLETED|Overall Study||242
2440437|NCT01121393|5985847|P2|COMPLETED|Overall Study|Completed 6 courses of chemotherapy|38
2440438|NCT01121393|5985848|P1|COMPLETED|Overall Study|At the time of data cut-off for last-patient out (07 December 2017)|0
2440439|NCT01121393|5985847|P2|Treated|Overall Study|Treated|113
2440440|NCT01121393|5985848|P1|Treated|Overall Study|Treated|239
2440441|NCT01121393|5985847|P2|STARTED|Overall Study|Randomised|122
2440442|NCT01121393|5985848|P1|STARTED|Overall Study|Randomised|242
2440443|NCT01121263|5985893|P2|NOT COMPLETED|Overall Study||15
2440444|NCT01121263|5985894|P1|NOT COMPLETED|Overall Study||25
2440445|NCT01121263|5985893|P2|COMPLETED|Overall Study||83
2440446|NCT01121263|5985894|P1|COMPLETED|Overall Study||175
2440447|NCT01121263|5985893|P2|STARTED|Overall Study||98
2440448|NCT01121263|5985894|P1|STARTED|Overall Study||200
2440449|NCT01121250|5985905|P3|NOT COMPLETED|Overall Study||1
2440450|NCT01121250|5985906|P2|NOT COMPLETED|Overall Study||0
2440451|NCT01121250|5985907|P1|NOT COMPLETED|Overall Study||0
2440452|NCT01121250|5985905|P3|COMPLETED|Overall Study||75
2440453|NCT01121250|5985906|P2|COMPLETED|Overall Study||76
2440454|NCT01121250|5985907|P1|COMPLETED|Overall Study||76
2440455|NCT01121250|5985905|P3|STARTED|Overall Study||76
2440456|NCT01121250|5985906|P2|STARTED|Overall Study||76
2440457|NCT01121250|5985907|P1|STARTED|Overall Study||76
2440458|NCT01121224|5985923|P2|NOT COMPLETED|Overall Study||17
2440459|NCT01121224|5985924|P1|NOT COMPLETED|Overall Study||25
2440460|NCT01121224|5985923|P2|COMPLETED|Overall Study||275
2440461|NCT01121224|5985924|P1|COMPLETED|Overall Study||280
2440462|NCT01121224|5985923|P2|STARTED|Overall Study||292
2440463|NCT01121224|5985924|P1|STARTED|Overall Study||305
2440464|NCT01121211|5985974|P2|NOT COMPLETED|Overall Study||12
2440465|NCT01121211|5985975|P1|NOT COMPLETED|Overall Study||11
2440466|NCT01121211|5985974|P2|COMPLETED|Overall Study||35
2440467|NCT01121211|5985975|P1|COMPLETED|Overall Study||32
2440468|NCT01121211|5985974|P2|STARTED|Overall Study||47
2440469|NCT01121211|5985975|P1|STARTED|Overall Study||43
2440470|NCT01121185|5985985|P2|NOT COMPLETED|Overall Study||1
2440471|NCT01121185|5985986|P1|NOT COMPLETED|Overall Study||1
2440472|NCT01121185|5985985|P2|COMPLETED|Overall Study||5
2440473|NCT01121185|5985986|P1|COMPLETED|Overall Study||6
2440474|NCT01121185|5985985|P2|Transplanted|Overall Study||5
2440475|NCT01121185|5985986|P1|Transplanted|Overall Study|One subject initiated the first study infusion, but transplant surgery was subsequently cancelled.|6
2440476|NCT01121185|5985985|P2|Infused|Overall Study|Excluded medical condition identified in one subject after randomization but before study infusion.|5
2440477|NCT01121185|5985986|P1|Infused|Overall Study||7
2440478|NCT01121185|5985985|P2|STARTED|Overall Study||6
2440479|NCT01121185|5985986|P1|STARTED|Overall Study||7
2440480|NCT01121172|5986010|P2|NOT COMPLETED|Overall Study||0
2440481|NCT01121172|5986011|P1|NOT COMPLETED|Overall Study||0
2440482|NCT01121172|5986010|P2|COMPLETED|Overall Study||90
2440483|NCT01121172|5986011|P1|COMPLETED|Overall Study||90
2440484|NCT01121172|5986010|P2|STARTED|Overall Study||90
2440485|NCT01121172|5986011|P1|STARTED|Overall Study||90
2440486|NCT01121146|5986020|P2|NOT COMPLETED|Overall Study||42
2440487|NCT01121146|5986021|P1|NOT COMPLETED|Overall Study||26
2440488|NCT01121146|5986020|P2|COMPLETED|Overall Study|The 72 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|72
2440489|NCT01121146|5986021|P1|COMPLETED|Overall Study|The 90 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|90
2440490|NCT01121146|5986020|P2|STARTED|Overall Study||114
2440491|NCT01121146|5986021|P1|STARTED|Overall Study||116
2440492|NCT01120990|5986035|P1|NOT COMPLETED|Overall Study||0
2440493|NCT01120990|5986035|P1|COMPLETED|Overall Study||51
2440494|NCT01120990|5986035|P1|STARTED|Overall Study||51
2440495|NCT01120899|5986042|P1|NOT COMPLETED|Overall Study||3
2440496|NCT01120899|5986042|P1|COMPLETED|Overall Study||3
2440497|NCT01120899|5986042|P1|Month 18|Overall Study||3
2440498|NCT01120899|5986042|P1|Month 12|Overall Study||3
2440499|NCT01120899|5986042|P1|Month 6|Overall Study||5
2440500|NCT01120899|5986042|P1|STARTED|Overall Study||6
2440501|NCT01120834|5986062|P1|NOT COMPLETED|Overall Study||0
2440502|NCT01120834|5986062|P1|COMPLETED|Overall Study||18
2440503|NCT01120834|5986062|P1|STARTED|Overall Study||18
2440504|NCT01120808|5986066|P1|NOT COMPLETED|Overall Study||46
2440505|NCT01120808|5986066|P1|COMPLETED|Overall Study||90
2440506|NCT01120808|5986066|P1|STARTED|Overall Study||136
2440507|NCT01120782|5986070|P1|NOT COMPLETED|Overall Study||11
2440508|NCT01120782|5986070|P1|COMPLETED|Overall Study||34
2440509|NCT01120782|5986070|P1|STARTED|Overall Study||45
2440510|NCT01120756|5986076|P2|NOT COMPLETED|Overall Study||1
2440511|NCT01120756|5986077|P1|NOT COMPLETED|Overall Study||1
2440512|NCT01120756|5986076|P2|COMPLETED|Overall Study||13
2440513|NCT01120756|5986077|P1|COMPLETED|Overall Study||20
2440514|NCT01120756|5986076|P2|STARTED|Overall Study||14
2440515|NCT01120756|5986077|P1|STARTED|Overall Study||21
2440516|NCT01120717|5986087|P2|NOT COMPLETED|Overall Study||24
2440517|NCT01120717|5986088|P1|NOT COMPLETED|Overall Study||32
2440518|NCT01120717|5986087|P2|COMPLETED|Overall Study||89
2440519|NCT01120717|5986088|P1|COMPLETED|Overall Study||194
2440520|NCT01120717|5986087|P2|Safety Population: Received Study Drug|Overall Study||113
2440521|NCT01120717|5986088|P1|Safety Population: Received Study Drug|Overall Study||225
2440522|NCT01120717|5986087|P2|STARTED|Overall Study||113
2440523|NCT01120717|5986088|P1|STARTED|Overall Study||226
2440524|NCT01120704|5986136|P32|NOT COMPLETED|Overall Study||1
2440525|NCT01120704|5986137|P31|NOT COMPLETED|Overall Study||2
2440526|NCT01120704|5986138|P30|NOT COMPLETED|Overall Study||3
2440527|NCT01120704|5986139|P29|NOT COMPLETED|Overall Study||5
2440528|NCT01120704|5986140|P28|NOT COMPLETED|Overall Study||2
2440529|NCT01120704|5986141|P27|NOT COMPLETED|Overall Study||3
2440530|NCT01120704|5986142|P26|NOT COMPLETED|Overall Study||0
2440531|NCT01120704|5986143|P25|NOT COMPLETED|Overall Study||2
2440532|NCT01120704|5986144|P24|NOT COMPLETED|Overall Study||3
2440533|NCT01120704|5986145|P23|NOT COMPLETED|Overall Study||4
2440534|NCT01120704|5986146|P22|NOT COMPLETED|Overall Study||0
2440535|NCT01120704|5986147|P21|NOT COMPLETED|Overall Study||3
2440536|NCT01120704|5986148|P20|NOT COMPLETED|Overall Study||3
2440537|NCT01120704|5986149|P19|NOT COMPLETED|Overall Study||2
2440538|NCT01120704|5986150|P18|NOT COMPLETED|Overall Study||0
2440539|NCT01120704|5986151|P17|NOT COMPLETED|Overall Study||1
2440540|NCT01120704|5986152|P16|NOT COMPLETED|Overall Study||2
2440541|NCT01120704|5986153|P15|NOT COMPLETED|Overall Study||1
2440542|NCT01120704|5986154|P14|NOT COMPLETED|Overall Study||4
2440543|NCT01120704|5986155|P13|NOT COMPLETED|Overall Study||3
2440544|NCT01120704|5986156|P12|NOT COMPLETED|Overall Study||2
2440545|NCT01120704|5986157|P11|NOT COMPLETED|Overall Study||1
2440546|NCT01120704|5986158|P10|NOT COMPLETED|Overall Study||1
2440547|NCT01120704|5986159|P9|NOT COMPLETED|Overall Study||3
2440548|NCT01120704|5986160|P8|NOT COMPLETED|Overall Study||2
2440549|NCT01120704|5986161|P7|NOT COMPLETED|Overall Study||3
2440550|NCT01120704|5986162|P6|NOT COMPLETED|Overall Study||1
2440551|NCT01120704|5986163|P5|NOT COMPLETED|Overall Study||2
2440552|NCT01120704|5986164|P4|NOT COMPLETED|Overall Study||4
2440553|NCT01120704|5986165|P3|NOT COMPLETED|Overall Study||1
2440554|NCT01120704|5986166|P2|NOT COMPLETED|Overall Study||4
2440555|NCT01120704|5986167|P1|NOT COMPLETED|Overall Study||3
2440556|NCT01120704|5986136|P32|COMPLETED|Overall Study||17
2440557|NCT01120704|5986137|P31|COMPLETED|Overall Study||12
2440558|NCT01120704|5986138|P30|COMPLETED|Overall Study||12
2440559|NCT01120704|5986139|P29|COMPLETED|Overall Study||14
2440560|NCT01120704|5986140|P28|COMPLETED|Overall Study||16
2440561|NCT01120704|5986141|P27|COMPLETED|Overall Study||15
2440562|NCT01120704|5986142|P26|COMPLETED|Overall Study||14
2440563|NCT01120704|5986143|P25|COMPLETED|Overall Study||16
2440564|NCT01120704|5986144|P24|COMPLETED|Overall Study||13
2440565|NCT01120704|5986145|P23|COMPLETED|Overall Study||17
2440566|NCT01120704|5986146|P22|COMPLETED|Overall Study||16
2440567|NCT01120704|5986147|P21|COMPLETED|Overall Study||14
2440568|NCT01120704|5986148|P20|COMPLETED|Overall Study||15
2440569|NCT01120704|5986149|P19|COMPLETED|Overall Study||15
2440570|NCT01120704|5986150|P18|COMPLETED|Overall Study||16
2440571|NCT01120704|5986151|P17|COMPLETED|Overall Study||13
2440572|NCT01120704|5986152|P16|COMPLETED|Overall Study||16
2440573|NCT01120704|5986153|P15|COMPLETED|Overall Study||17
2440574|NCT01120704|5986154|P14|COMPLETED|Overall Study||15
2440575|NCT01120704|5986155|P13|COMPLETED|Overall Study||14
2440576|NCT01120704|5986156|P12|COMPLETED|Overall Study||14
2440577|NCT01120704|5986157|P11|COMPLETED|Overall Study||16
2440578|NCT01120704|5986158|P10|COMPLETED|Overall Study||19
2440579|NCT01120704|5986159|P9|COMPLETED|Overall Study||19
2440580|NCT01120704|5986160|P8|COMPLETED|Overall Study||13
2440581|NCT01120704|5986161|P7|COMPLETED|Overall Study||12
2440582|NCT01120704|5986162|P6|COMPLETED|Overall Study||18
2440583|NCT01120704|5986163|P5|COMPLETED|Overall Study||14
2440584|NCT01120704|5986164|P4|COMPLETED|Overall Study||15
2440585|NCT01120704|5986165|P3|COMPLETED|Overall Study||13
2440586|NCT01120704|5986166|P2|COMPLETED|Overall Study||13
2440587|NCT01120704|5986167|P1|COMPLETED|Overall Study||10
2440588|NCT01120704|5986136|P32|STARTED|Overall Study||18
2440589|NCT01120704|5986137|P31|STARTED|Overall Study||14
2440590|NCT01120704|5986138|P30|STARTED|Overall Study||15
2440591|NCT01120704|5986139|P29|STARTED|Overall Study||19
2440592|NCT01120704|5986140|P28|STARTED|Overall Study||18
2440593|NCT01120704|5986141|P27|STARTED|Overall Study||18
2440594|NCT01120704|5986142|P26|STARTED|Overall Study||14
2440595|NCT01120704|5986143|P25|STARTED|Overall Study||18
2440596|NCT01120704|5986144|P24|STARTED|Overall Study||16
2440597|NCT01120704|5986145|P23|STARTED|Overall Study||21
2440598|NCT01120704|5986146|P22|STARTED|Overall Study||16
2440599|NCT01120704|5986147|P21|STARTED|Overall Study||17
2440600|NCT01120704|5986148|P20|STARTED|Overall Study||18
2440601|NCT01120704|5986149|P19|STARTED|Overall Study||17
2440602|NCT01120704|5986150|P18|STARTED|Overall Study||16
2440603|NCT01120704|5986151|P17|STARTED|Overall Study||14
2440604|NCT01120704|5986152|P16|STARTED|Overall Study||18
2440605|NCT01120704|5986153|P15|STARTED|Overall Study||18
2440606|NCT01120704|5986154|P14|STARTED|Overall Study||19
2440607|NCT01120704|5986155|P13|STARTED|Overall Study||17
2440608|NCT01120704|5986156|P12|STARTED|Overall Study||16
2440609|NCT01120704|5986157|P11|STARTED|Overall Study||17
2440610|NCT01120704|5986158|P10|STARTED|Overall Study||20
2440611|NCT01120704|5986159|P9|STARTED|Overall Study||22
2440612|NCT01120704|5986160|P8|STARTED|Overall Study||15
2440613|NCT01120704|5986161|P7|STARTED|Overall Study||15
2440614|NCT01120704|5986162|P6|STARTED|Overall Study||19
2440615|NCT01120704|5986163|P5|STARTED|Overall Study||16
2440616|NCT01120704|5986164|P4|STARTED|Overall Study||19
2440617|NCT01120704|5986165|P3|STARTED|Overall Study||14
2440618|NCT01120704|5986166|P2|STARTED|Overall Study||17
2440619|NCT01120704|5986167|P1|STARTED|Overall Study||13
2440620|NCT01120691|5986194|P3|NOT COMPLETED|Overall Study||183
2440621|NCT01120691|5986195|P2|NOT COMPLETED|Overall Study||203
2440622|NCT01120691|5986196|P1|NOT COMPLETED|Overall Study||171
2440623|NCT01120691|5986194|P3|COMPLETED|Overall Study||559
2440624|NCT01120691|5986195|P2|COMPLETED|Overall Study||538
2440625|NCT01120691|5986196|P1|COMPLETED|Overall Study||570
2440626|NCT01120691|5986194|P3|Modified Full Analysis Set (mFAS)|Overall Study||737
2440627|NCT01120691|5986195|P2|Modified Full Analysis Set (mFAS)|Overall Study||739
2440628|NCT01120691|5986196|P1|Modified Full Analysis Set (mFAS)|Overall Study||729
2440629|NCT01120691|5986194|P3|Modified Safety Set (mSAF)|Overall Study||737
2440630|NCT01120691|5986195|P2|Modified Safety Set (mSAF)|Overall Study||740
2440631|NCT01120691|5986196|P1|Modified Safety Set (mSAF)|Overall Study||729
2440632|NCT01120691|5986194|P3|Safety Set (SAF)|Overall Study||739
2440633|NCT01120691|5986195|P2|Safety Set (SAF)|Overall Study||740
2440634|NCT01120691|5986196|P1|Safety Set (SAF)|Overall Study||736
2440635|NCT01120691|5986194|P3|Full Analysis Set (FAS)|Overall Study||739
2440636|NCT01120691|5986195|P2|Full Analysis Set (FAS)|Overall Study||739
2440637|NCT01120691|5986196|P1|Full Analysis Set (FAS)|Overall Study||736
2440638|NCT01120691|5986194|P3|STARTED|Overall Study||742
2440639|NCT01120691|5986195|P2|STARTED|Overall Study||741
2440640|NCT01120691|5986196|P1|STARTED|Overall Study||741
2440641|NCT01120639|5986242|P4|NOT COMPLETED|Overall Study||0
2440642|NCT01120639|5986243|P3|NOT COMPLETED|Overall Study||0
2440643|NCT01120639|5986244|P2|NOT COMPLETED|Overall Study||0
2440644|NCT01120639|5986245|P1|NOT COMPLETED|Overall Study||0
2440645|NCT01120639|5986242|P4|COMPLETED|Overall Study||12
2440646|NCT01120639|5986243|P3|COMPLETED|Overall Study||6
2440647|NCT01120639|5986244|P2|COMPLETED|Overall Study||6
2440648|NCT01120639|5986245|P1|COMPLETED|Overall Study||6
2440649|NCT01120639|5986242|P4|STARTED|Overall Study||12
2440650|NCT01120639|5986243|P3|STARTED|Overall Study||6
2440651|NCT01120639|5986244|P2|STARTED|Overall Study||6
2440652|NCT01120639|5986245|P1|STARTED|Overall Study||6
2440653|NCT01120626|5986293|P2|NOT COMPLETED|Overall Study||0
2440654|NCT01120626|5986294|P1|NOT COMPLETED|Overall Study||1
2440655|NCT01120626|5986293|P2|COMPLETED|Overall Study||22
2440656|NCT01120626|5986294|P1|COMPLETED|Overall Study||19
2440657|NCT01120626|5986293|P2|STARTED|Overall Study||22
2440658|NCT01120626|5986294|P1|STARTED|Overall Study||20
2440659|NCT01120600|5986304|P2|NOT COMPLETED|Overall Study||32
2440660|NCT01120600|5986305|P1|NOT COMPLETED|Overall Study||19
2440661|NCT01120600|5986304|P2|COMPLETED|Overall Study||115
2440662|NCT01120600|5986305|P1|COMPLETED|Overall Study||128
2440663|NCT01120600|5986304|P2|Treated|Overall Study||146
2440664|NCT01120600|5986305|P1|Treated|Overall Study||146
2440665|NCT01120600|5986304|P2|STARTED|Overall Study||147
2440666|NCT01120600|5986305|P1|STARTED|Overall Study||147
2440667|NCT01120405|5986331|P2|NOT COMPLETED|Overall Study||33
2440668|NCT01120405|5986332|P1|NOT COMPLETED|Overall Study||27
2440669|NCT01120405|5986331|P2|COMPLETED|Overall Study||269
2440670|NCT01120405|5986332|P1|COMPLETED|Overall Study||271
2440671|NCT01120405|5986331|P2|STARTED|Overall Study||302
2440672|NCT01120405|5986332|P1|STARTED|Overall Study||298
2440673|NCT01120379|5986360|P1|NOT COMPLETED|Four Year Timepoint||368
2440674|NCT01120379|5986360|P1|COMPLETED|Four Year Timepoint||3923
2440675|NCT01120379|5986360|P1|STARTED|Four Year Timepoint||4291
2440676|NCT01120379|5986360|P1|NOT COMPLETED|Three Year Timepoint||214
2440677|NCT01120379|5986360|P1|COMPLETED|Three Year Timepoint||4291
2440678|NCT01120379|5986360|P1|STARTED|Three Year Timepoint||4505
2440679|NCT01120379|5986360|P1|NOT COMPLETED|Two Year Timepoint||237
2440680|NCT01120379|5986360|P1|COMPLETED|Two Year Timepoint||4505
2440681|NCT01120379|5986360|P1|STARTED|Two Year Timepoint||4742
2440682|NCT01120379|5986360|P1|NOT COMPLETED|One Year Timepoint||278
2440683|NCT01120379|5986360|P1|COMPLETED|One Year Timepoint||4742
2440684|NCT01120379|5986360|P1|STARTED|One Year Timepoint||5020
2440685|NCT01120275|5986396|P1|NOT COMPLETED|Overall Study||36
2440686|NCT01120275|5986396|P1|COMPLETED|Overall Study||0
2440687|NCT01120275|5986396|P1|Eligible and Treated|Overall Study||32
2440688|NCT01120275|5986396|P1|STARTED|Overall Study||36
2440689|NCT01120236|5986405|P2|NOT COMPLETED|Overall Study||1
2440690|NCT01120236|5986406|P1|NOT COMPLETED|Overall Study||0
2440691|NCT01120236|5986405|P2|COMPLETED|Overall Study||105
2440692|NCT01120236|5986406|P1|COMPLETED|Overall Study||105
2440693|NCT01120236|5986405|P2|Ineligble|Overall Study|Patient ineligible due to no demonstable radiographic metastasis and is excluded from all analyses.|1
2440694|NCT01120236|5986406|P1|Ineligble|Overall Study||0
2440695|NCT01120236|5986405|P2|STARTED|Overall Study||106
2440696|NCT01120236|5986406|P1|STARTED|Overall Study||105
2440697|NCT01120223|5986433|P1|NOT COMPLETED|Overall Study||4
2440698|NCT01120223|5986433|P1|COMPLETED|Overall Study||74
2440699|NCT01120223|5986433|P1|STARTED|Overall Study||78
2440700|NCT01120210|5986463|P2|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
2440701|NCT01120210|5986464|P1|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
2440702|NCT01120210|5986463|P2|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
2440703|NCT01120210|5986464|P1|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
2440704|NCT01120210|5986463|P2|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
2440705|NCT01120210|5986464|P1|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
2440706|NCT01120210|5986463|P2|NOT COMPLETED|MAIN INFUSION||1
2440707|NCT01120210|5986464|P1|NOT COMPLETED|MAIN INFUSION||1
2440708|NCT01120210|5986463|P2|COMPLETED|MAIN INFUSION||45
2440709|NCT01120210|5986464|P1|COMPLETED|MAIN INFUSION||15
2440710|NCT01120210|5986463|P2|STARTED|MAIN INFUSION||46
2440711|NCT01120210|5986464|P1|STARTED|MAIN INFUSION||16
2440712|NCT01120197|5986496|P2|NOT COMPLETED|Overall Study||10
2440713|NCT01120197|5986497|P1|NOT COMPLETED|Overall Study||9
2440714|NCT01120197|5986496|P2|COMPLETED|Overall Study||32
2440715|NCT01120197|5986497|P1|COMPLETED|Overall Study||38
2440716|NCT01120197|5986496|P2|STARTED|Overall Study||42
2440717|NCT01120197|5986497|P1|STARTED|Overall Study||47
2440718|NCT01120184|5986514|P3|NOT COMPLETED|Overall Study||363
2440719|NCT01120184|5986515|P2|NOT COMPLETED|Overall Study||367
2440720|NCT01120184|5986516|P1|NOT COMPLETED|Overall Study||365
2440721|NCT01120184|5986514|P3|COMPLETED|Overall Study||0
2440722|NCT01120184|5986515|P2|COMPLETED|Overall Study||0
2440723|NCT01120184|5986516|P1|COMPLETED|Overall Study||0
2440724|NCT01120184|5986514|P3|Treated|Overall Study||360
2440725|NCT01120184|5986515|P2|Treated|Overall Study||365
2440726|NCT01120184|5986516|P1|Treated|Overall Study||355
2440727|NCT01120184|5986514|P3|STARTED|Overall Study||363
2440728|NCT01120184|5986515|P2|STARTED|Overall Study||367
2440729|NCT01120184|5986516|P1|STARTED|Overall Study||365
2440730|NCT01120093|5986638|P5|NOT COMPLETED|Treatment Period 5||0
2440731|NCT01120093|5986639|P4|NOT COMPLETED|Treatment Period 5||1
2440732|NCT01120093|5986640|P3|NOT COMPLETED|Treatment Period 5||0
2440733|NCT01120093|5986641|P2|NOT COMPLETED|Treatment Period 5||1
2440734|NCT01120093|5986642|P1|NOT COMPLETED|Treatment Period 5||0
2440735|NCT01120093|5986638|P5|COMPLETED|Treatment Period 5||13
2440736|NCT01120093|5986639|P4|COMPLETED|Treatment Period 5||11
2440737|NCT01120093|5986640|P3|COMPLETED|Treatment Period 5||15
2440738|NCT01120093|5986641|P2|COMPLETED|Treatment Period 5||12
2440739|NCT01120093|5986642|P1|COMPLETED|Treatment Period 5||17
2440740|NCT01120093|5986638|P5|STARTED|Treatment Period 5||13
2440741|NCT01120093|5986639|P4|STARTED|Treatment Period 5||12
2440742|NCT01120093|5986640|P3|STARTED|Treatment Period 5||15
2440743|NCT01120093|5986641|P2|STARTED|Treatment Period 5||13
2440744|NCT01120093|5986642|P1|STARTED|Treatment Period 5||17
2440745|NCT01120093|5986638|P5|NOT COMPLETED|Treatment Period 4||0
2440746|NCT01120093|5986639|P4|NOT COMPLETED|Treatment Period 4||0
2440747|NCT01120093|5986640|P3|NOT COMPLETED|Treatment Period 4||0
2440748|NCT01120093|5986641|P2|NOT COMPLETED|Treatment Period 4||0
2440749|NCT01120093|5986642|P1|NOT COMPLETED|Treatment Period 4||1
2440750|NCT01120093|5986638|P5|COMPLETED|Treatment Period 4||13
2440751|NCT01120093|5986639|P4|COMPLETED|Treatment Period 4||12
2440752|NCT01120093|5986640|P3|COMPLETED|Treatment Period 4||15
2440753|NCT01120093|5986641|P2|COMPLETED|Treatment Period 4||13
2440754|NCT01120093|5986642|P1|COMPLETED|Treatment Period 4||17
2440755|NCT01120093|5986638|P5|STARTED|Treatment Period 4||13
2440756|NCT01120093|5986639|P4|STARTED|Treatment Period 4||12
2440757|NCT01120093|5986640|P3|STARTED|Treatment Period 4||15
2440758|NCT01120093|5986641|P2|STARTED|Treatment Period 4||13
2440759|NCT01120093|5986642|P1|STARTED|Treatment Period 4||18
2440760|NCT01120093|5986638|P5|NOT COMPLETED|Treatment Period 3||1
2440761|NCT01120093|5986639|P4|NOT COMPLETED|Treatment Period 3||1
2440762|NCT01120093|5986640|P3|NOT COMPLETED|Treatment Period 3||1
2440763|NCT01120093|5986641|P2|NOT COMPLETED|Treatment Period 3||0
2440764|NCT01120093|5986642|P1|NOT COMPLETED|Treatment Period 3||0
2440765|NCT01120093|5986638|P5|COMPLETED|Treatment Period 3||13
2440766|NCT01120093|5986639|P4|COMPLETED|Treatment Period 3||12
2440767|NCT01120093|5986640|P3|COMPLETED|Treatment Period 3||15
2440768|NCT01120093|5986641|P2|COMPLETED|Treatment Period 3||13
2440769|NCT01120093|5986642|P1|COMPLETED|Treatment Period 3||18
2440770|NCT01120093|5986638|P5|STARTED|Treatment Period 3||14
2440771|NCT01120093|5986639|P4|STARTED|Treatment Period 3||13
2440772|NCT01120093|5986640|P3|STARTED|Treatment Period 3||16
2440773|NCT01120093|5986641|P2|STARTED|Treatment Period 3||13
2440774|NCT01120093|5986642|P1|STARTED|Treatment Period 3||18
2440775|NCT01120093|5986638|P5|NOT COMPLETED|Treatment Period 2||1
2440776|NCT01120093|5986639|P4|NOT COMPLETED|Treatment Period 2||1
2440777|NCT01120093|5986640|P3|NOT COMPLETED|Treatment Period 2||0
2440778|NCT01120093|5986641|P2|NOT COMPLETED|Treatment Period 2||0
2440779|NCT01120093|5986642|P1|NOT COMPLETED|Treatment Period 2||0
2440780|NCT01120093|5986638|P5|COMPLETED|Treatment Period 2||14
2440781|NCT01120093|5986639|P4|COMPLETED|Treatment Period 2||13
2440782|NCT01120093|5986640|P3|COMPLETED|Treatment Period 2||16
2440783|NCT01120093|5986641|P2|COMPLETED|Treatment Period 2||13
2440784|NCT01120093|5986642|P1|COMPLETED|Treatment Period 2||18
2440785|NCT01120093|5986638|P5|STARTED|Treatment Period 2||15
2440786|NCT01120093|5986639|P4|STARTED|Treatment Period 2||14
2440787|NCT01120093|5986640|P3|STARTED|Treatment Period 2||16
2440788|NCT01120093|5986641|P2|STARTED|Treatment Period 2||13
2440789|NCT01120093|5986642|P1|STARTED|Treatment Period 2||18
2440790|NCT01120093|5986638|P5|NOT COMPLETED|Treatment Period 1||1
2440791|NCT01120093|5986639|P4|NOT COMPLETED|Treatment Period 1||0
2440792|NCT01120093|5986640|P3|NOT COMPLETED|Treatment Period 1||1
2440793|NCT01120093|5986641|P2|NOT COMPLETED|Treatment Period 1||1
2440794|NCT01120093|5986642|P1|NOT COMPLETED|Treatment Period 1||0
2440795|NCT01120093|5986638|P5|COMPLETED|Treatment Period 1||15
2440796|NCT01120093|5986639|P4|COMPLETED|Treatment Period 1||14
2440797|NCT01120093|5986640|P3|COMPLETED|Treatment Period 1||16
2440798|NCT01120093|5986641|P2|COMPLETED|Treatment Period 1||13
2440799|NCT01120093|5986642|P1|COMPLETED|Treatment Period 1||18
2440800|NCT01120093|5986638|P5|STARTED|Treatment Period 1||16
2440801|NCT01120093|5986639|P4|STARTED|Treatment Period 1||14
2440802|NCT01120093|5986640|P3|STARTED|Treatment Period 1||17
2440803|NCT01120093|5986641|P2|STARTED|Treatment Period 1||14
2440804|NCT01120093|5986642|P1|STARTED|Treatment Period 1||18
2440805|NCT01120067|5986671|P2|NOT COMPLETED|Overall Study||1
2440806|NCT01120067|5986672|P1|NOT COMPLETED|Overall Study||5
2440807|NCT01120067|5986671|P2|COMPLETED|Overall Study||10
2440808|NCT01120067|5986672|P1|COMPLETED|Overall Study||7
2440809|NCT01120067|5986671|P2|STARTED|Overall Study||11
2440810|NCT01120067|5986672|P1|STARTED|Overall Study||12
2440811|NCT01120028|5986682|P4|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
2440812|NCT01120028|5986683|P3|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
2440813|NCT01120028|5986684|P2|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
2440814|NCT01120028|5986685|P1|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
2440815|NCT01120028|5986682|P4|COMPLETED|Period 2: Tacrolimus or Sirolimus||197
2440816|NCT01120028|5986683|P3|COMPLETED|Period 2: Tacrolimus or Sirolimus||197
2440817|NCT01120028|5986684|P2|COMPLETED|Period 2: Tacrolimus or Sirolimus||0
2440818|NCT01120028|5986685|P1|COMPLETED|Period 2: Tacrolimus or Sirolimus||0
2440819|NCT01120028|5986682|P4|STARTED|Period 2: Tacrolimus or Sirolimus||197
2440820|NCT01120028|5986683|P3|STARTED|Period 2: Tacrolimus or Sirolimus||197
2440821|NCT01120028|5986684|P2|STARTED|Period 2: Tacrolimus or Sirolimus||0
2440822|NCT01120028|5986685|P1|STARTED|Period 2: Tacrolimus or Sirolimus||0
2440823|NCT01120028|5986682|P4|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
2440824|NCT01120028|5986683|P3|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
2440825|NCT01120028|5986684|P2|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||23
2440826|NCT01120028|5986685|P1|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||14
2440827|NCT01120028|5986682|P4|COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
2440828|NCT01120028|5986683|P3|COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
2440829|NCT01120028|5986684|P2|COMPLETED|Period 1: Alemtuzumab or Basiliximab||403
2440830|NCT01120028|5986685|P1|COMPLETED|Period 1: Alemtuzumab or Basiliximab||412
2440831|NCT01120028|5986682|P4|STARTED|Period 1: Alemtuzumab or Basiliximab||0
2440832|NCT01120028|5986683|P3|STARTED|Period 1: Alemtuzumab or Basiliximab||0
2440833|NCT01120028|5986684|P2|STARTED|Period 1: Alemtuzumab or Basiliximab||426
2440834|NCT01120028|5986685|P1|STARTED|Period 1: Alemtuzumab or Basiliximab||426
2440835|NCT01119963|5986709|P2|NOT COMPLETED|Overall Study||1
2440836|NCT01119963|5986710|P1|NOT COMPLETED|Overall Study||1
2440837|NCT01119963|5986709|P2|COMPLETED|Overall Study||77
2440838|NCT01119963|5986710|P1|COMPLETED|Overall Study||73
2440839|NCT01119963|5986709|P2|STARTED|Overall Study||78
2440840|NCT01119963|5986710|P1|STARTED|Overall Study||74
2440841|NCT01119950|5986720|P1|NOT COMPLETED|Overall Study||47
2440842|NCT01119950|5986720|P1|COMPLETED|Overall Study|These participants completed both periods 1 and 2|341
2440843|NCT01119950|5986720|P1|Placebo|Overall Study|3 randomized participants did not receive study drug, 82 completed treatment, 5 discontinued.|94
2440844|NCT01119950|5986720|P1|NVA237 50 ug b.i.d.|Overall Study|6 randomized and 1 misrandomized patients did not receive study drug, 82 completed, 5 discontinued.|94
2440845|NCT01119950|5986720|P1|NVA237 100 ug q.d.|Overall Study|2 randomized participants did not receive study drug, 92 completed treatment, 4 discontinued.|98
2440846|NCT01119950|5986720|P1|NVA237 25 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 7 discontinued.|100
2440847|NCT01119950|5986720|P1|NVA237 50 ug q.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 3 discontinued.|96
2440848|NCT01119950|5986720|P1|NVA237 12.5 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 93 completed treatment, 2 discontinued.|99
2440849|NCT01119950|5986720|P1|NVA237 25 ug q.d.|Overall Study|3 randomized participants did not receive study drug, 91 completed treatment, 5 discontinued.|99
2440850|NCT01119950|5986720|P1|NVA237 12.5 ug q.d.|Overall Study|5 randomized and 2 misrandomized patients did not receive study drug, 80 completed, 9 discontinued.|96
2440851|NCT01119950|5986720|P1|STARTED|Overall Study|These participants were randomized to 2 different treatment sequences during period 1 and 2.|388
2440852|NCT01119937|5986967|P2|NOT COMPLETED|Overall Study||7
2440853|NCT01119937|5986968|P1|NOT COMPLETED|Overall Study||19
2440854|NCT01119937|5986967|P2|COMPLETED|Overall Study||33
2440855|NCT01119937|5986968|P1|COMPLETED|Overall Study||104
2440856|NCT01119937|5986967|P2|STARTED|Overall Study||40
2440857|NCT01119937|5986968|P1|STARTED|Overall Study||123
2440858|NCT01119898|5986996|P2|NOT COMPLETED|Overall Study||12
2440859|NCT01119898|5986997|P1|NOT COMPLETED|Overall Study||8
2440860|NCT01119898|5986996|P2|COMPLETED|Overall Study||117
2440861|NCT01119898|5986997|P1|COMPLETED|Overall Study||123
2440862|NCT01119898|5986996|P2|Received Study Drug (mITT)|Overall Study||129
2440863|NCT01119898|5986997|P1|Received Study Drug (mITT)|Overall Study||130
2440864|NCT01119898|5986996|P2|STARTED|Overall Study||129
2440865|NCT01119898|5986997|P1|STARTED|Overall Study||131
2440866|NCT01119859|5987023|P2|NOT COMPLETED|Overall Study||30
2440867|NCT01119859|5987024|P1|NOT COMPLETED|Overall Study||24
2440868|NCT01119859|5987023|P2|COMPLETED|Overall Study||133
2440869|NCT01119859|5987024|P1|COMPLETED|Overall Study||139
2440870|NCT01119859|5987023|P2|STARTED|Overall Study||163
2440871|NCT01119859|5987024|P1|STARTED|Overall Study||163
2440872|NCT01119846|5987043|P3|NOT COMPLETED|Overall Study||11
2440873|NCT01119846|5987044|P2|NOT COMPLETED|Overall Study||0
2440874|NCT01119846|5987045|P1|NOT COMPLETED|Overall Study||2
2440875|NCT01119846|5987043|P3|COMPLETED|Overall Study||72
2440876|NCT01119846|5987044|P2|COMPLETED|Overall Study||4
2440877|NCT01119846|5987045|P1|COMPLETED|Overall Study||11
2440878|NCT01119846|5987043|P3|STARTED|Overall Study||83
2440879|NCT01119846|5987044|P2|STARTED|Overall Study||4
2440880|NCT01119846|5987045|P1|STARTED|Overall Study||13
2440881|NCT01119794|5987253|P1|NOT COMPLETED|Overall Study||0
2440882|NCT01119794|5987253|P1|COMPLETED|Overall Study||10
2440883|NCT01119794|5987253|P1|STARTED|Overall Study||10
2440884|NCT01119768|5987259|P2|NOT COMPLETED|Follow-up||2
2440885|NCT01119768|5987260|P1|NOT COMPLETED|Follow-up||1
2440886|NCT01119768|5987259|P2|COMPLETED|Follow-up||122
2440887|NCT01119768|5987260|P1|COMPLETED|Follow-up||135
2440888|NCT01119768|5987259|P2|STARTED|Follow-up||124
2440889|NCT01119768|5987260|P1|STARTED|Follow-up||136
2440890|NCT01119768|5987259|P2|NOT COMPLETED|Treatment Period||25
2440891|NCT01119768|5987260|P1|NOT COMPLETED|Treatment Period||18
2440892|NCT01119768|5987259|P2|COMPLETED|Treatment Period||126
2440893|NCT01119768|5987260|P1|COMPLETED|Treatment Period||136
2440894|NCT01119768|5987259|P2|STARTED|Treatment Period||151
2440895|NCT01119768|5987260|P1|STARTED|Treatment Period||154
2440896|NCT01119755|5987282|P1|NOT COMPLETED|Overall Study||0
2440897|NCT01119755|5987282|P1|COMPLETED|Overall Study||80
2440898|NCT01119755|5987282|P1|STARTED|Overall Study||80
2440899|NCT01119716|5987293|P1|NOT COMPLETED|Overall Study||0
2440900|NCT01119716|5987293|P1|COMPLETED|Overall Study||4658
2440901|NCT01119716|5987293|P1|STARTED|Overall Study||4658
2440902|NCT01119703|5987316|P2|NOT COMPLETED|Overall Study||1
2440903|NCT01119703|5987317|P1|NOT COMPLETED|Overall Study||0
2440904|NCT01119703|5987316|P2|COMPLETED|Overall Study||143
2440905|NCT01119703|5987317|P1|COMPLETED|Overall Study||30
2440906|NCT01119703|5987316|P2|STARTED|Overall Study||144
2440907|NCT01119703|5987317|P1|STARTED|Overall Study||30
2440908|NCT01119625|5987331|P2|NOT COMPLETED|Overall Study||4
2440909|NCT01119625|5987332|P1|NOT COMPLETED|Overall Study||3
2440910|NCT01119625|5987331|P2|COMPLETED|Overall Study||116
2440911|NCT01119625|5987332|P1|COMPLETED|Overall Study||115
2440912|NCT01119625|5987331|P2|STARTED|Overall Study||120
2440913|NCT01119625|5987332|P1|STARTED|Overall Study||118
2440914|NCT01119456|5987380|P8|NOT COMPLETED|Overall Study||0
2440915|NCT01119456|5987381|P7|NOT COMPLETED|Overall Study||0
2440916|NCT01119456|5987382|P6|NOT COMPLETED|Overall Study||0
2440917|NCT01119456|5987383|P5|NOT COMPLETED|Overall Study||0
2440918|NCT01119456|5987384|P4|NOT COMPLETED|Overall Study||0
2440919|NCT01119456|5987385|P3|NOT COMPLETED|Overall Study||0
2440920|NCT01119456|5987386|P2|NOT COMPLETED|Overall Study||0
2440921|NCT01119456|5987387|P1|NOT COMPLETED|Overall Study||0
2440922|NCT01119456|5987380|P8|COMPLETED|Overall Study||3
2440923|NCT01119456|5987381|P7|COMPLETED|Overall Study||3
2440924|NCT01119456|5987382|P6|COMPLETED|Overall Study||3
2440925|NCT01119456|5987383|P5|COMPLETED|Overall Study||4
2440926|NCT01119456|5987384|P4|COMPLETED|Overall Study||13
2440927|NCT01119456|5987385|P3|COMPLETED|Overall Study||3
2440928|NCT01119456|5987386|P2|COMPLETED|Overall Study||3
2440929|NCT01119456|5987387|P1|COMPLETED|Overall Study||7
2440930|NCT01119456|5987380|P8|Received at Least 1 Dose of Study Drug|Overall Study||3
2440931|NCT01119456|5987381|P7|Received at Least 1 Dose of Study Drug|Overall Study||3
2440932|NCT01119456|5987382|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
2440933|NCT01119456|5987383|P5|Received at Least 1 Dose of Study Drug|Overall Study||4
2440934|NCT01119456|5987384|P4|Received at Least 1 Dose of Study Drug|Overall Study||13
2440935|NCT01119456|5987385|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
2440936|NCT01119456|5987386|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
2440937|NCT01119456|5987387|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
2440938|NCT01119456|5987380|P8|STARTED|Overall Study||3
2440939|NCT01119456|5987381|P7|STARTED|Overall Study||3
2440940|NCT01119456|5987382|P6|STARTED|Overall Study||3
2440941|NCT01119456|5987383|P5|STARTED|Overall Study||4
2440942|NCT01119456|5987384|P4|STARTED|Overall Study||13
2440943|NCT01119456|5987385|P3|STARTED|Overall Study||3
2440944|NCT01119456|5987386|P2|STARTED|Overall Study||3
2440945|NCT01119456|5987387|P1|STARTED|Overall Study||7
2440946|NCT01119443|5987448|P2|NOT COMPLETED|End of Study (All Patients)||0
2440947|NCT01119443|5987449|P1|NOT COMPLETED|End of Study (All Patients)||0
2440948|NCT01119443|5987448|P2|COMPLETED|End of Study (All Patients)||14
2440949|NCT01119443|5987449|P1|COMPLETED|End of Study (All Patients)||14
2440950|NCT01119443|5987448|P2|STARTED|End of Study (All Patients)||14
2440951|NCT01119443|5987449|P1|STARTED|End of Study (All Patients)||14
2440952|NCT01119443|5987448|P2|NOT COMPLETED|Down-titration Period (1 Day)||0
2440953|NCT01119443|5987449|P1|NOT COMPLETED|Down-titration Period (1 Day)||0
2440954|NCT01119443|5987448|P2|COMPLETED|Down-titration Period (1 Day)||13
2440955|NCT01119443|5987449|P1|COMPLETED|Down-titration Period (1 Day)||14
2440956|NCT01119443|5987448|P2|STARTED|Down-titration Period (1 Day)||13
2440957|NCT01119443|5987449|P1|STARTED|Down-titration Period (1 Day)||14
2440958|NCT01119443|5987448|P2|NOT COMPLETED|Crossover Period 4 (5 Days)||0
2440959|NCT01119443|5987449|P1|NOT COMPLETED|Crossover Period 4 (5 Days)||0
2440960|NCT01119443|5987448|P2|COMPLETED|Crossover Period 4 (5 Days)||13
2440961|NCT01119443|5987449|P1|COMPLETED|Crossover Period 4 (5 Days)||14
2440962|NCT01119443|5987448|P2|STARTED|Crossover Period 4 (5 Days)||13
2440963|NCT01119443|5987449|P1|STARTED|Crossover Period 4 (5 Days)||14
2440964|NCT01119443|5987448|P2|NOT COMPLETED|Crossover Period 3 (5 Days)||0
2440965|NCT01119443|5987449|P1|NOT COMPLETED|Crossover Period 3 (5 Days)||0
2440966|NCT01119443|5987448|P2|COMPLETED|Crossover Period 3 (5 Days)||13
2440967|NCT01119443|5987449|P1|COMPLETED|Crossover Period 3 (5 Days)||14
2440968|NCT01119443|5987448|P2|STARTED|Crossover Period 3 (5 Days)||13
2440969|NCT01119443|5987449|P1|STARTED|Crossover Period 3 (5 Days)||14
2440970|NCT01119443|5987448|P2|NOT COMPLETED|Crossover Period 2 (5 Days)||0
2440971|NCT01119443|5987449|P1|NOT COMPLETED|Crossover Period 2 (5 Days)||0
2440972|NCT01119443|5987448|P2|COMPLETED|Crossover Period 2 (5 Days)||13
2440973|NCT01119443|5987449|P1|COMPLETED|Crossover Period 2 (5 Days)||14
2440974|NCT01119443|5987448|P2|STARTED|Crossover Period 2 (5 Days)||13
2440975|NCT01119443|5987449|P1|STARTED|Crossover Period 2 (5 Days)||14
2440976|NCT01119443|5987448|P2|NOT COMPLETED|Crossover Period 1 (5 Days)||1
2440977|NCT01119443|5987449|P1|NOT COMPLETED|Crossover Period 1 (5 Days)||0
2440978|NCT01119443|5987448|P2|COMPLETED|Crossover Period 1 (5 Days)||13
2440979|NCT01119443|5987449|P1|COMPLETED|Crossover Period 1 (5 Days)||14
2440980|NCT01119443|5987448|P2|STARTED|Crossover Period 1 (5 Days)||14
2440981|NCT01119443|5987449|P1|STARTED|Crossover Period 1 (5 Days)||14
2440982|NCT01119443|5987448|P2|NOT COMPLETED|Up-titration Period (10 Days)||0
2440983|NCT01119443|5987449|P1|NOT COMPLETED|Up-titration Period (10 Days)||0
2440984|NCT01119443|5987448|P2|COMPLETED|Up-titration Period (10 Days)||14
2440985|NCT01119443|5987449|P1|COMPLETED|Up-titration Period (10 Days)||14
2440986|NCT01119443|5987448|P2|STARTED|Up-titration Period (10 Days)||14
2440987|NCT01119443|5987449|P1|STARTED|Up-titration Period (10 Days)||14
2440988|NCT01119287|5987492|P6|NOT COMPLETED|Overall Study||0
2440989|NCT01119287|5987493|P5|NOT COMPLETED|Overall Study||1
2440990|NCT01119287|5987494|P4|NOT COMPLETED|Overall Study||2
2440991|NCT01119287|5987495|P3|NOT COMPLETED|Overall Study||2
2440992|NCT01119287|5987496|P2|NOT COMPLETED|Overall Study||0
2440993|NCT01119287|5987497|P1|NOT COMPLETED|Overall Study||0
2440994|NCT01119287|5987492|P6|COMPLETED|Overall Study||32
2440995|NCT01119287|5987493|P5|COMPLETED|Overall Study||30
2440996|NCT01119287|5987494|P4|COMPLETED|Overall Study||29
2440997|NCT01119287|5987495|P3|COMPLETED|Overall Study||24
2440998|NCT01119287|5987496|P2|COMPLETED|Overall Study||24
2440999|NCT01119287|5987497|P1|COMPLETED|Overall Study||26
2441000|NCT01119287|5987492|P6|STARTED|Overall Study||32
2441001|NCT01119287|5987493|P5|STARTED|Overall Study||31
2441002|NCT01119287|5987494|P4|STARTED|Overall Study||31
2441003|NCT01119287|5987495|P3|STARTED|Overall Study||26
2441004|NCT01119287|5987496|P2|STARTED|Overall Study||24
2441005|NCT01119287|5987497|P1|STARTED|Overall Study||26
2441006|NCT01119248|5987510|P1|NOT COMPLETED|Overall Study||5
2441007|NCT01119248|5987510|P1|COMPLETED|Overall Study||115
2441008|NCT01119248|5987510|P1|STARTED|Overall Study||120
2441009|NCT01119222|5987516|P4|NOT COMPLETED|Overall Study||0
2441010|NCT01119222|5987517|P3|NOT COMPLETED|Overall Study||0
2441011|NCT01119222|5987518|P2|NOT COMPLETED|Overall Study||0
2441012|NCT01119222|5987519|P1|NOT COMPLETED|Overall Study||0
2441013|NCT01119222|5987516|P4|COMPLETED|Overall Study||4
2441014|NCT01119222|5987517|P3|COMPLETED|Overall Study||5
2441015|NCT01119222|5987518|P2|COMPLETED|Overall Study||5
2441016|NCT01119222|5987519|P1|COMPLETED|Overall Study||5
2441017|NCT01119222|5987516|P4|STARTED|Overall Study||4
2441018|NCT01119222|5987517|P3|STARTED|Overall Study||5
2441019|NCT01119222|5987518|P2|STARTED|Overall Study||5
2441020|NCT01119222|5987519|P1|STARTED|Overall Study||5
2441021|NCT01119131|5987560|P3|NOT COMPLETED|Overall Study||6
2441022|NCT01119131|5987561|P2|NOT COMPLETED|Overall Study||1
2441023|NCT01119131|5987562|P1|NOT COMPLETED|Overall Study||2
2441024|NCT01119131|5987560|P3|COMPLETED|Overall Study||24
2441025|NCT01119131|5987561|P2|COMPLETED|Overall Study||27
2441026|NCT01119131|5987562|P1|COMPLETED|Overall Study||8
2441027|NCT01119131|5987560|P3|STARTED|Overall Study||30
2441028|NCT01119131|5987561|P2|STARTED|Overall Study||28
2441029|NCT01119131|5987562|P1|STARTED|Overall Study||10
2441030|NCT01119118|5987591|P1|NOT COMPLETED|Overall Study||1
2441031|NCT01119118|5987591|P1|COMPLETED|Overall Study||5
2441032|NCT01119118|5987591|P1|STARTED|Overall Study||6
2441033|NCT01119040|5987599|P1|NOT COMPLETED|Overall Study||1
2441034|NCT01119040|5987599|P1|COMPLETED|Overall Study||0
2441035|NCT01119040|5987599|P1|STARTED|Overall Study||1
2441036|NCT01119001|5987603|P1|NOT COMPLETED|Overall Study||2
2441037|NCT01119001|5987603|P1|COMPLETED|Overall Study||11
2441038|NCT01119001|5987603|P1|STARTED|Overall Study||13
2441039|NCT01118988|5987612|P3|NOT COMPLETED|Overall Study||4
2441040|NCT01118988|5987613|P2|NOT COMPLETED|Overall Study||1
2441041|NCT01118988|5987614|P1|NOT COMPLETED|Overall Study||5
2441042|NCT01118988|5987612|P3|COMPLETED|Overall Study||3
2441043|NCT01118988|5987613|P2|COMPLETED|Overall Study||3
2441044|NCT01118988|5987614|P1|COMPLETED|Overall Study||11
2441045|NCT01118988|5987612|P3|STARTED|Overall Study||7
2441046|NCT01118988|5987613|P2|STARTED|Overall Study||4
2441047|NCT01118988|5987614|P1|STARTED|Overall Study||16
2441048|NCT01118975|5987647|P2|NOT COMPLETED|Overall Study||1
2441049|NCT01118975|5987648|P1|NOT COMPLETED|Overall Study||0
2441050|NCT01118975|5987647|P2|COMPLETED|Overall Study||2
2441051|NCT01118975|5987648|P1|COMPLETED|Overall Study||9
2441052|NCT01118975|5987647|P2|STARTED|Overall Study||3
2441053|NCT01118975|5987648|P1|STARTED|Overall Study||9
2441054|NCT01118962|5987654|P1|NOT COMPLETED|Overall Study||10
2441055|NCT01118962|5987654|P1|COMPLETED|Overall Study||29
2441056|NCT01118962|5987654|P1|STARTED|Overall Study||39
2441057|NCT01118949|5987659|P1|NOT COMPLETED|Overall Study||9
2441058|NCT01118949|5987659|P1|COMPLETED|Overall Study||40
2441059|NCT01118949|5987659|P1|STARTED|Overall Study||49
2441060|NCT01118845|5987668|P1|NOT COMPLETED|Overall Study||42
2441061|NCT01118845|5987668|P1|COMPLETED|Overall Study||17
2441062|NCT01118845|5987668|P1|STARTED|Overall Study||59
2441063|NCT01118780|5987689|P2|NOT COMPLETED|Overall Study||35
2441064|NCT01118780|5987690|P1|NOT COMPLETED|Overall Study||36
2441065|NCT01118780|5987689|P2|COMPLETED|Overall Study||105
2441066|NCT01118780|5987690|P1|COMPLETED|Overall Study||115
2441067|NCT01118780|5987689|P2|STARTED|Overall Study||140
2441068|NCT01118780|5987690|P1|STARTED|Overall Study||151
2441069|NCT01118741|5987739|P2|NOT COMPLETED|Overall Study||0
2441070|NCT01118741|5987740|P1|NOT COMPLETED|Overall Study||0
2441071|NCT01118741|5987739|P2|COMPLETED|Overall Study||10
2441072|NCT01118741|5987740|P1|COMPLETED|Overall Study||9
2441073|NCT01118741|5987739|P2|STARTED|Overall Study||10
2441074|NCT01118741|5987740|P1|STARTED|Overall Study||9
2441075|NCT01118728|5987748|P1|NOT COMPLETED|Overall Study||223
2441076|NCT01118728|5987748|P1|COMPLETED|Overall Study||0
2441077|NCT01118728|5987748|P1|STARTED|Overall Study||223
2441078|NCT01118663|5987755|P2|NOT COMPLETED|Overall Study||2
2441079|NCT01118663|5987756|P1|NOT COMPLETED|Overall Study||2
2441080|NCT01118663|5987755|P2|COMPLETED|Overall Study||8
2441081|NCT01118663|5987756|P1|COMPLETED|Overall Study||5
2441082|NCT01118663|5987755|P2|STARTED|Overall Study||10
2441083|NCT01118663|5987756|P1|STARTED|Overall Study||7
2441084|NCT01118624|5987770|P1|NOT COMPLETED|Overall Study||22
2441085|NCT01118624|5987770|P1|COMPLETED|Overall Study||0
2441086|NCT01118624|5987770|P1|STARTED|Overall Study||22
2441087|NCT01118455|5987779|P2|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
2441088|NCT01118455|5987780|P1|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
2441089|NCT01118455|5987779|P2|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||69
2441090|NCT01118455|5987780|P1|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||65
2441091|NCT01118455|5987779|P2|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||69
2441092|NCT01118455|5987780|P1|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||65
2441093|NCT01118455|5987779|P2|NOT COMPLETED|Baseline [Visits 1 & 2]||0
2441094|NCT01118455|5987780|P1|NOT COMPLETED|Baseline [Visits 1 & 2]||1
2441095|NCT01118455|5987779|P2|COMPLETED|Baseline [Visits 1 & 2]||69
2441096|NCT01118455|5987780|P1|COMPLETED|Baseline [Visits 1 & 2]||65
2441097|NCT01118455|5987779|P2|Actual Patients Treated|Baseline [Visits 1 & 2]||69
2441098|NCT01118455|5987780|P1|Actual Patients Treated|Baseline [Visits 1 & 2]||65
2441099|NCT01118455|5987779|P2|STARTED|Baseline [Visits 1 & 2]||69
2441100|NCT01118455|5987780|P1|STARTED|Baseline [Visits 1 & 2]||66
2441101|NCT01118377|5987808|P1|NOT COMPLETED|Overall Study||42
2441102|NCT01118377|5987808|P1|COMPLETED|Overall Study||3
2441103|NCT01118377|5987808|P1|STARTED|Overall Study||45
2441104|NCT01118351|5987814|P1|NOT COMPLETED|Overall Study||4
2441105|NCT01118351|5987814|P1|COMPLETED|Overall Study||15
2441106|NCT01118351|5987814|P1|STARTED|Overall Study||19
2441107|NCT01118325|5987825|P3|NOT COMPLETED|Overall Study||1
2441108|NCT01118325|5987826|P2|NOT COMPLETED|Overall Study||0
2441109|NCT01118325|5987827|P1|NOT COMPLETED|Overall Study||1
2441110|NCT01118325|5987825|P3|COMPLETED|Overall Study||45
2441111|NCT01118325|5987826|P2|COMPLETED|Overall Study||43
2441112|NCT01118325|5987827|P1|COMPLETED|Overall Study||49
2441113|NCT01118325|5987825|P3|STARTED|Overall Study||46
2441114|NCT01118325|5987826|P2|STARTED|Overall Study||43
2441115|NCT01118325|5987827|P1|STARTED|Overall Study||50
2441116|NCT01118312|5987873|P2|NOT COMPLETED|Overall Study||35
2441117|NCT01118312|5987874|P1|NOT COMPLETED|Overall Study||34
2441118|NCT01118312|5987873|P2|COMPLETED|Overall Study||164
2441119|NCT01118312|5987874|P1|COMPLETED|Overall Study||155
2441120|NCT01118312|5987873|P2|STARTED|Overall Study||199
2441121|NCT01118312|5987874|P1|STARTED|Overall Study||189
2441122|NCT01118273|5987888|P6|NOT COMPLETED|Overall Study||0
2441123|NCT01118273|5987889|P5|NOT COMPLETED|Overall Study||0
2441124|NCT01118273|5987890|P4|NOT COMPLETED|Overall Study||0
2441125|NCT01118273|5987891|P3|NOT COMPLETED|Overall Study||0
2441126|NCT01118273|5987892|P2|NOT COMPLETED|Overall Study||0
2441127|NCT01118273|5987893|P1|NOT COMPLETED|Overall Study||0
2441128|NCT01118273|5987888|P6|COMPLETED|Overall Study||27
2441129|NCT01118273|5987889|P5|COMPLETED|Overall Study||27
2441130|NCT01118273|5987890|P4|COMPLETED|Overall Study||27
2441131|NCT01118273|5987891|P3|COMPLETED|Overall Study||27
2441132|NCT01118273|5987892|P2|COMPLETED|Overall Study||27
2441133|NCT01118273|5987893|P1|COMPLETED|Overall Study||27
2441134|NCT01118273|5987888|P6|STARTED|Overall Study||27
2441135|NCT01118273|5987889|P5|STARTED|Overall Study||27
2441136|NCT01118273|5987890|P4|STARTED|Overall Study||27
2441137|NCT01118273|5987891|P3|STARTED|Overall Study||27
2441138|NCT01118273|5987892|P2|STARTED|Overall Study||27
2441139|NCT01118273|5987893|P1|STARTED|Overall Study||27
2441140|NCT01118221|5988059|P2|NOT COMPLETED|Overall Study||1
2441141|NCT01118221|5988060|P1|NOT COMPLETED|Overall Study||3
2441142|NCT01118221|5988059|P2|COMPLETED|Overall Study||10
2441143|NCT01118221|5988060|P1|COMPLETED|Overall Study||11
2441144|NCT01118221|5988059|P2|STARTED|Overall Study||11
2441145|NCT01118221|5988060|P1|STARTED|Overall Study||14
2441146|NCT01118143|5988072|P2|NOT COMPLETED|Overall Study||5
2441147|NCT01118143|5988073|P1|NOT COMPLETED|Overall Study||2
2441148|NCT01118143|5988072|P2|COMPLETED|Overall Study||64
2441149|NCT01118143|5988073|P1|COMPLETED|Overall Study||62
2441150|NCT01118143|5988072|P2|STARTED|Overall Study||69
2441151|NCT01118143|5988073|P1|STARTED|Overall Study||64
2441152|NCT01118117|5988083|P2|NOT COMPLETED|Overall Study||0
2441153|NCT01118117|5988084|P1|NOT COMPLETED|Overall Study||21
2441154|NCT01118117|5988083|P2|COMPLETED|Overall Study||15
2441155|NCT01118117|5988084|P1|COMPLETED|Overall Study||240
2441156|NCT01118117|5988083|P2|STARTED|Overall Study||15
2441157|NCT01118117|5988084|P1|STARTED|Overall Study||261
2441158|NCT01118091|5988105|P2|NOT COMPLETED|Overall Study||0
2441159|NCT01118091|5988106|P1|NOT COMPLETED|Overall Study||0
2441160|NCT01118091|5988105|P2|COMPLETED|Overall Study||5
2441161|NCT01118091|5988106|P1|COMPLETED|Overall Study|Continued from above: These 2 pts are only represented in Arm 1 (and not Arm 2).|7
2441162|NCT01118091|5988105|P2|STARTED|Overall Study||5
2441163|NCT01118091|5988106|P1|STARTED|Overall Study|2pts were randomized to Arm 2, were not able to grow cell product, were treated with Arm 1 regimen.|7
2441164|NCT01118052|5988116|P1|NOT COMPLETED|Overall Study||2
2441165|NCT01118052|5988116|P1|COMPLETED|Overall Study||20
2441166|NCT01118052|5988116|P1|STARTED|Overall Study||22
2441167|NCT01118013|5988129|P1|NOT COMPLETED|Overall Study||0
2441168|NCT01118013|5988129|P1|COMPLETED|Overall Study||6
2441169|NCT01118013|5988129|P1|STARTED|Overall Study||6
2441170|NCT01117987|5988139|P2|NOT COMPLETED|Overall Study||74
2441171|NCT01117987|5988140|P1|NOT COMPLETED|Overall Study||61
2441172|NCT01117987|5988139|P2|COMPLETED|Overall Study||4
2441173|NCT01117987|5988140|P1|COMPLETED|Overall Study||5
2441174|NCT01117987|5988139|P2|STARTED|Overall Study||78
2441175|NCT01117987|5988140|P1|STARTED|Overall Study||66
2441176|NCT01117948|5988152|P2|NOT COMPLETED|Open Label||47
2441177|NCT01117948|5988153|P1|NOT COMPLETED|Open Label||52
2441178|NCT01117948|5988152|P2|COMPLETED|Open Label||51
2441179|NCT01117948|5988153|P1|COMPLETED|Open Label||41
2441180|NCT01117948|5988152|P2|STARTED|Open Label||98
2441181|NCT01117948|5988153|P1|STARTED|Open Label||93
2441182|NCT01117948|5988152|P2|NOT COMPLETED|Double Blind||10
2441183|NCT01117948|5988153|P1|NOT COMPLETED|Double Blind||18
2441184|NCT01117948|5988152|P2|COMPLETED|Double Blind||98
2441185|NCT01117948|5988153|P1|COMPLETED|Double Blind||93
2441186|NCT01117948|5988152|P2|STARTED|Double Blind||108
2441187|NCT01117948|5988153|P1|STARTED|Double Blind||111
2441188|NCT01117870|5988161|P2|NOT COMPLETED|Overall Study||0
2441189|NCT01117870|5988162|P1|NOT COMPLETED|Overall Study||1
2441190|NCT01117870|5988161|P2|COMPLETED|Overall Study||16
2441191|NCT01117870|5988162|P1|COMPLETED|Overall Study|One did not receive the allocated intervention; (degenerate spine/inability to place needle).|14
2441192|NCT01117870|5988161|P2|STARTED|Overall Study||16
2441193|NCT01117870|5988162|P1|STARTED|Overall Study||15
2441194|NCT01117857|5988176|P1|NOT COMPLETED|Overall Study||9
2441195|NCT01117857|5988176|P1|COMPLETED|Overall Study||13
2441196|NCT01117857|5988176|P1|STARTED|Overall Study||22
2441197|NCT01117766|5988184|P2|NOT COMPLETED|Second Intervention||5
2441198|NCT01117766|5988185|P1|NOT COMPLETED|Second Intervention||2
2441199|NCT01117766|5988184|P2|COMPLETED|Second Intervention||9
2441200|NCT01117766|5988185|P1|COMPLETED|Second Intervention||11
2441201|NCT01117766|5988184|P2|STARTED|Second Intervention||14
2441202|NCT01117766|5988185|P1|STARTED|Second Intervention||13
2441203|NCT01117766|5988184|P2|NOT COMPLETED|Washout Period||2
2441204|NCT01117766|5988185|P1|NOT COMPLETED|Washout Period||0
2441205|NCT01117766|5988184|P2|COMPLETED|Washout Period||14
2441206|NCT01117766|5988185|P1|COMPLETED|Washout Period||13
2441207|NCT01117766|5988184|P2|STARTED|Washout Period||16
2441208|NCT01117766|5988185|P1|STARTED|Washout Period||13
2441209|NCT01117766|5988184|P2|NOT COMPLETED|First Intervention||1
2441210|NCT01117766|5988185|P1|NOT COMPLETED|First Intervention||1
2441211|NCT01117766|5988184|P2|COMPLETED|First Intervention||16
2441212|NCT01117766|5988185|P1|COMPLETED|First Intervention||13
2441213|NCT01117766|5988184|P2|Received Treatment|First Intervention||17
2441214|NCT01117766|5988185|P1|Received Treatment|First Intervention||14
2441215|NCT01117766|5988184|P2|STARTED|First Intervention||17
2441216|NCT01117766|5988185|P1|STARTED|First Intervention||14
2441217|NCT01117727|5988209|P1|NOT COMPLETED|Overall Study||0
2441218|NCT01117727|5988209|P1|COMPLETED|Overall Study||1
2441219|NCT01117727|5988209|P1|STARTED|Overall Study||1
2441220|NCT01117623|5988222|P8|NOT COMPLETED|Overall Study||26
2441221|NCT01117623|5988223|P7|NOT COMPLETED|Overall Study||6
2441222|NCT01117623|5988224|P6|NOT COMPLETED|Overall Study||16
2441223|NCT01117623|5988225|P5|NOT COMPLETED|Overall Study||10
2441224|NCT01117623|5988226|P4|NOT COMPLETED|Overall Study||6
2441225|NCT01117623|5988227|P3|NOT COMPLETED|Overall Study||11
2441226|NCT01117623|5988228|P2|NOT COMPLETED|Overall Study||8
2441227|NCT01117623|5988229|P1|NOT COMPLETED|Overall Study||3
2441228|NCT01117623|5988222|P8|COMPLETED|Overall Study||0
2441229|NCT01117623|5988223|P7|COMPLETED|Overall Study||0
2441230|NCT01117623|5988224|P6|COMPLETED|Overall Study||0
2441231|NCT01117623|5988225|P5|COMPLETED|Overall Study||0
2441232|NCT01117623|5988226|P4|COMPLETED|Overall Study||0
2441233|NCT01117623|5988227|P3|COMPLETED|Overall Study||0
2441234|NCT01117623|5988228|P2|COMPLETED|Overall Study||0
2441235|NCT01117623|5988229|P1|COMPLETED|Overall Study||0
2441236|NCT01117623|5988222|P8|PK Population|Overall Study||24
2441237|NCT01117623|5988223|P7|PK Population|Overall Study||6
2441238|NCT01117623|5988224|P6|PK Population|Overall Study||14
2441239|NCT01117623|5988225|P5|PK Population|Overall Study||10
2441240|NCT01117623|5988226|P4|PK Population|Overall Study||6
2441241|NCT01117623|5988227|P3|PK Population|Overall Study||10
2441242|NCT01117623|5988228|P2|PK Population|Overall Study||8
2441243|NCT01117623|5988229|P1|PK Population|Overall Study||3
2441244|NCT01117623|5988222|P8|ITT Efficacy Analysis Population|Overall Study||22
2441245|NCT01117623|5988223|P7|ITT Efficacy Analysis Population|Overall Study||6
2441246|NCT01117623|5988224|P6|ITT Efficacy Analysis Population|Overall Study||16
2441247|NCT01117623|5988225|P5|ITT Efficacy Analysis Population|Overall Study||10
2441248|NCT01117623|5988226|P4|ITT Efficacy Analysis Population|Overall Study||5
2441249|NCT01117623|5988227|P3|ITT Efficacy Analysis Population|Overall Study||11
2441250|NCT01117623|5988228|P2|ITT Efficacy Analysis Population|Overall Study||8
2441251|NCT01117623|5988229|P1|ITT Efficacy Analysis Population|Overall Study||3
2441252|NCT01117623|5988222|P8|STARTED|Overall Study||26
2441253|NCT01117623|5988223|P7|STARTED|Overall Study||6
2441254|NCT01117623|5988224|P6|STARTED|Overall Study||16
2441255|NCT01117623|5988225|P5|STARTED|Overall Study||10
2441256|NCT01117623|5988226|P4|STARTED|Overall Study||6
2441257|NCT01117623|5988227|P3|STARTED|Overall Study||11
2441258|NCT01117623|5988228|P2|STARTED|Overall Study||8
2441259|NCT01117623|5988229|P1|STARTED|Overall Study||3
2441260|NCT01117480|5988381|P1|NOT COMPLETED|Overall Study||28
2441261|NCT01117480|5988381|P1|COMPLETED|Overall Study||985
2441262|NCT01117480|5988381|P1|STARTED|Overall Study||1013
2441263|NCT01117454|5988389|P2|NOT COMPLETED|Overall Study||1
2441264|NCT01117454|5988390|P1|NOT COMPLETED|Overall Study||0
2441265|NCT01117454|5988389|P2|COMPLETED|Overall Study||7
2441266|NCT01117454|5988390|P1|COMPLETED|Overall Study||6
2441267|NCT01117454|5988389|P2|STARTED|Overall Study||8
2441268|NCT01117454|5988390|P1|STARTED|Overall Study||6
2441269|NCT01117428|5988402|P6|NOT COMPLETED|Overall Study||20
2441270|NCT01117428|5988403|P5|NOT COMPLETED|Overall Study||17
2441271|NCT01117428|5988404|P4|NOT COMPLETED|Overall Study||12
2441272|NCT01117428|5988405|P3|NOT COMPLETED|Overall Study||13
2441273|NCT01117428|5988406|P2|NOT COMPLETED|Overall Study||29
2441274|NCT01117428|5988407|P1|NOT COMPLETED|Overall Study||20
2441275|NCT01117428|5988402|P6|COMPLETED|Overall Study||0
2441276|NCT01117428|5988403|P5|COMPLETED|Overall Study||0
2441277|NCT01117428|5988404|P4|COMPLETED|Overall Study||0
2441278|NCT01117428|5988405|P3|COMPLETED|Overall Study||0
2441279|NCT01117428|5988406|P2|COMPLETED|Overall Study||0
2441280|NCT01117428|5988407|P1|COMPLETED|Overall Study||0
2441281|NCT01117428|5988402|P6|STARTED|Overall Study||20
2441282|NCT01117428|5988403|P5|STARTED|Overall Study||17
2441283|NCT01117428|5988404|P4|STARTED|Overall Study||12
2441284|NCT01117428|5988405|P3|STARTED|Overall Study||13
2441285|NCT01117428|5988406|P2|STARTED|Overall Study||29
2441286|NCT01117428|5988407|P1|STARTED|Overall Study|"0.4 mg/kg=1~0.75 mg/kg=1~1.5 mg/kg=3~3 mg/kg=3~6 mg/kg=3~9 mg/kg=6~12 mg/kg=3"|20
2441287|NCT01117350|5988441|P2|NOT COMPLETED|Extension Period||63
2441288|NCT01117350|5988442|P1|NOT COMPLETED|Extension Period||0
2441289|NCT01117350|5988441|P2|COMPLETED|Extension Period||147
2441290|NCT01117350|5988442|P1|COMPLETED|Extension Period||0
2441291|NCT01117350|5988441|P2|mITT Population (Extension)|Extension Period|mITT (extension): treated patients with at least 1 efficacy value both at entry and during extension|154
2441292|NCT01117350|5988442|P1|mITT Population (Extension)|Extension Period||0
2441293|NCT01117350|5988441|P2|TREATED = Safety Population (Extension)|Extension Period|Safety population (extension): treated with insulin glargine during the extension period|160
2441294|NCT01117350|5988442|P1|TREATED = Safety Population (Extension)|Extension Period||0
2441295|NCT01117350|5988441|P2|STARTED|Extension Period|STARTED: patients having completed the comparative period and eligible for the extension period|210
2441296|NCT01117350|5988442|P1|STARTED|Extension Period||0
2441297|NCT01117350|5988441|P2|NOT COMPLETED|Comparative Period||75
2441298|NCT01117350|5988442|P1|NOT COMPLETED|Comparative Period||42
2441299|NCT01117350|5988441|P2|COMPLETED|Comparative Period||414
2441300|NCT01117350|5988442|P1|COMPLETED|Comparative Period||447
2441301|NCT01117350|5988441|P2|mITT Population|Comparative Period||470
2441302|NCT01117350|5988442|P1|mITT Population|Comparative Period|modified Intent-To-Treat population: treated patients with at least one efficacy post-baseline value|474
2441303|NCT01117350|5988441|P2|TREATED = Safety Population|Comparative Period||481
2441304|NCT01117350|5988442|P1|TREATED = Safety Population|Comparative Period|Safety population: all randomized and treated patients (received at least one dose)|484
2441305|NCT01117350|5988441|P2|STARTED|Comparative Period||489
2441306|NCT01117350|5988442|P1|STARTED|Comparative Period|STARTED: randomized|489
2441307|NCT01117337|5988474|P2|NOT COMPLETED|Overall Study||0
2441308|NCT01117337|5988475|P1|NOT COMPLETED|Overall Study||4
2441309|NCT01117337|5988474|P2|COMPLETED|Overall Study||52
2441310|NCT01117337|5988475|P1|COMPLETED|Overall Study|48 completed one year follow-up. 4 lost to follow-up.|48
2441311|NCT01117337|5988474|P2|Underwent Surgery|Overall Study||52
2441312|NCT01117337|5988475|P1|Underwent Surgery|Overall Study|52 patients underwent surgery|52
2441313|NCT01117337|5988474|P2|STARTED|Overall Study||52
2441314|NCT01117337|5988475|P1|STARTED|Overall Study|52 pateints on inguinal hernia were randomized to mesh fixation group|52
2441315|NCT01117311|5988485|P2|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
2441316|NCT01117311|5988486|P1|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
2441317|NCT01117311|5988485|P2|COMPLETED|Second Intervention - Mixed Meal 3||4
2441318|NCT01117311|5988486|P1|COMPLETED|Second Intervention - Mixed Meal 3||3
2441319|NCT01117311|5988485|P2|STARTED|Second Intervention - Mixed Meal 3||4
2441320|NCT01117311|5988486|P1|STARTED|Second Intervention - Mixed Meal 3||3
2441321|NCT01117311|5988485|P2|NOT COMPLETED|First Intervention - Mixed Meal 2||0
2441322|NCT01117311|5988486|P1|NOT COMPLETED|First Intervention - Mixed Meal 2||0
2441323|NCT01117311|5988485|P2|COMPLETED|First Intervention - Mixed Meal 2||4
2441324|NCT01117311|5988486|P1|COMPLETED|First Intervention - Mixed Meal 2||3
2441325|NCT01117311|5988485|P2|STARTED|First Intervention - Mixed Meal 2||4
2441326|NCT01117311|5988486|P1|STARTED|First Intervention - Mixed Meal 2||3
2441327|NCT01117311|5988485|P2|NOT COMPLETED|Lead-in Mixed Meal 1||0
2441328|NCT01117311|5988486|P1|NOT COMPLETED|Lead-in Mixed Meal 1||0
2441329|NCT01117311|5988485|P2|COMPLETED|Lead-in Mixed Meal 1||4
2441330|NCT01117311|5988486|P1|COMPLETED|Lead-in Mixed Meal 1||3
2441331|NCT01117311|5988485|P2|STARTED|Lead-in Mixed Meal 1||4
2441332|NCT01117311|5988486|P1|STARTED|Lead-in Mixed Meal 1||3
2441333|NCT01117181|5988496|P2|NOT COMPLETED|Overall Study||2
2441334|NCT01117181|5988497|P1|NOT COMPLETED|Overall Study||1
2441335|NCT01117181|5988496|P2|COMPLETED|Overall Study||29
2441336|NCT01117181|5988497|P1|COMPLETED|Overall Study||28
2441337|NCT01117181|5988496|P2|STARTED|Overall Study||31
2441338|NCT01117181|5988497|P1|STARTED|Overall Study||29
2441339|NCT01117090|5988517|P1|NOT COMPLETED|Overall Study||0
2441340|NCT01117090|5988517|P1|COMPLETED|Overall Study||47
2441341|NCT01117090|5988517|P1|STARTED|Overall Study||47
2441342|NCT01117051|5988530|P2|NOT COMPLETED|Overall Study||11
2441343|NCT01117051|5988531|P1|NOT COMPLETED|Overall Study||13
2441344|NCT01117051|5988530|P2|COMPLETED|Overall Study||77
2441345|NCT01117051|5988531|P1|COMPLETED|Overall Study||73
2441346|NCT01117051|5988530|P2|STARTED|Overall Study||88
2441347|NCT01117051|5988531|P1|STARTED|Overall Study||86
2441348|NCT01117012|5988541|P2|NOT COMPLETED|Overall Study||5
2441349|NCT01117012|5988542|P1|NOT COMPLETED|Overall Study||8
2441350|NCT01117012|5988541|P2|COMPLETED|Overall Study||98
2441351|NCT01117012|5988542|P1|COMPLETED|Overall Study||81
2441352|NCT01117012|5988541|P2|STARTED|Overall Study||103
2441353|NCT01117012|5988542|P1|STARTED|Overall Study||89
2441354|NCT01116986|5988590|P32|NOT COMPLETED|Overall Study||3
2441355|NCT01116986|5988591|P31|NOT COMPLETED|Overall Study||1
2441356|NCT01116986|5988592|P30|NOT COMPLETED|Overall Study||0
2441357|NCT01116986|5988593|P29|NOT COMPLETED|Overall Study||0
2441358|NCT01116986|5988594|P28|NOT COMPLETED|Overall Study||1
2441359|NCT01116986|5988595|P27|NOT COMPLETED|Overall Study||4
2441360|NCT01116986|5988596|P26|NOT COMPLETED|Overall Study||0
2441361|NCT01116986|5988597|P25|NOT COMPLETED|Overall Study||3
2441362|NCT01116986|5988598|P24|NOT COMPLETED|Overall Study||2
2441363|NCT01116986|5988599|P23|NOT COMPLETED|Overall Study||4
2441364|NCT01116986|5988600|P22|NOT COMPLETED|Overall Study||2
2441365|NCT01116986|5988601|P21|NOT COMPLETED|Overall Study||2
2441366|NCT01116986|5988602|P20|NOT COMPLETED|Overall Study||2
2441367|NCT01116986|5988603|P19|NOT COMPLETED|Overall Study||3
2441368|NCT01116986|5988604|P18|NOT COMPLETED|Overall Study||5
2441369|NCT01116986|5988605|P17|NOT COMPLETED|Overall Study||3
2441370|NCT01116986|5988606|P16|NOT COMPLETED|Overall Study||6
2441371|NCT01116986|5988607|P15|NOT COMPLETED|Overall Study||0
2441372|NCT01116986|5988608|P14|NOT COMPLETED|Overall Study||3
2441373|NCT01116986|5988609|P13|NOT COMPLETED|Overall Study||1
2441374|NCT01116986|5988610|P12|NOT COMPLETED|Overall Study||0
2441375|NCT01116986|5988611|P11|NOT COMPLETED|Overall Study||1
2441376|NCT01116986|5988612|P10|NOT COMPLETED|Overall Study||4
2441377|NCT01116986|5988613|P9|NOT COMPLETED|Overall Study||1
2441378|NCT01116986|5988614|P8|NOT COMPLETED|Overall Study||2
2441379|NCT01116986|5988615|P7|NOT COMPLETED|Overall Study||2
2441380|NCT01116986|5988616|P6|NOT COMPLETED|Overall Study||2
2441381|NCT01116986|5988617|P5|NOT COMPLETED|Overall Study||4
2441382|NCT01116986|5988618|P4|NOT COMPLETED|Overall Study||2
2441383|NCT01116986|5988619|P3|NOT COMPLETED|Overall Study||2
2441384|NCT01116986|5988620|P2|NOT COMPLETED|Overall Study||3
2441385|NCT01116986|5988621|P1|NOT COMPLETED|Overall Study||2
2441386|NCT01116986|5988590|P32|COMPLETED|Overall Study||14
2441387|NCT01116986|5988591|P31|COMPLETED|Overall Study||16
2441388|NCT01116986|5988592|P30|COMPLETED|Overall Study||17
2441389|NCT01116986|5988593|P29|COMPLETED|Overall Study||17
2441390|NCT01116986|5988594|P28|COMPLETED|Overall Study||18
2441391|NCT01116986|5988595|P27|COMPLETED|Overall Study||14
2441392|NCT01116986|5988596|P26|COMPLETED|Overall Study||19
2441393|NCT01116986|5988597|P25|COMPLETED|Overall Study||15
2441394|NCT01116986|5988598|P24|COMPLETED|Overall Study||19
2441395|NCT01116986|5988599|P23|COMPLETED|Overall Study||19
2441396|NCT01116986|5988600|P22|COMPLETED|Overall Study||18
2441397|NCT01116986|5988601|P21|COMPLETED|Overall Study||22
2441398|NCT01116986|5988602|P20|COMPLETED|Overall Study||13
2441399|NCT01116986|5988603|P19|COMPLETED|Overall Study||20
2441400|NCT01116986|5988604|P18|COMPLETED|Overall Study||19
2441401|NCT01116986|5988605|P17|COMPLETED|Overall Study||13
2441402|NCT01116986|5988606|P16|COMPLETED|Overall Study||15
2441403|NCT01116986|5988607|P15|COMPLETED|Overall Study||17
2441404|NCT01116986|5988608|P14|COMPLETED|Overall Study||16
2441405|NCT01116986|5988609|P13|COMPLETED|Overall Study||16
2441406|NCT01116986|5988610|P12|COMPLETED|Overall Study||20
2441407|NCT01116986|5988611|P11|COMPLETED|Overall Study||18
2441408|NCT01116986|5988612|P10|COMPLETED|Overall Study||19
2441409|NCT01116986|5988613|P9|COMPLETED|Overall Study||19
2441410|NCT01116986|5988614|P8|COMPLETED|Overall Study||20
2441411|NCT01116986|5988615|P7|COMPLETED|Overall Study||20
2441412|NCT01116986|5988616|P6|COMPLETED|Overall Study||20
2441413|NCT01116986|5988617|P5|COMPLETED|Overall Study||20
2441414|NCT01116986|5988618|P4|COMPLETED|Overall Study||20
2441415|NCT01116986|5988619|P3|COMPLETED|Overall Study||16
2441416|NCT01116986|5988620|P2|COMPLETED|Overall Study||16
2441417|NCT01116986|5988621|P1|COMPLETED|Overall Study||22
2441418|NCT01116986|5988590|P32|STARTED|Overall Study||17
2441419|NCT01116986|5988591|P31|STARTED|Overall Study||17
2441420|NCT01116986|5988592|P30|STARTED|Overall Study||17
2441421|NCT01116986|5988593|P29|STARTED|Overall Study||17
2441422|NCT01116986|5988594|P28|STARTED|Overall Study||19
2441423|NCT01116986|5988595|P27|STARTED|Overall Study||18
2441424|NCT01116986|5988596|P26|STARTED|Overall Study||19
2441425|NCT01116986|5988597|P25|STARTED|Overall Study||18
2441426|NCT01116986|5988598|P24|STARTED|Overall Study||21
2441427|NCT01116986|5988599|P23|STARTED|Overall Study||23
2441428|NCT01116986|5988600|P22|STARTED|Overall Study||20
2441429|NCT01116986|5988601|P21|STARTED|Overall Study||24
2441430|NCT01116986|5988602|P20|STARTED|Overall Study||15
2441431|NCT01116986|5988603|P19|STARTED|Overall Study||23
2441432|NCT01116986|5988604|P18|STARTED|Overall Study||24
2441433|NCT01116986|5988605|P17|STARTED|Overall Study||16
2441434|NCT01116986|5988606|P16|STARTED|Overall Study||21
2441435|NCT01116986|5988607|P15|STARTED|Overall Study||17
2441436|NCT01116986|5988608|P14|STARTED|Overall Study||19
2441437|NCT01116986|5988609|P13|STARTED|Overall Study||17
2441438|NCT01116986|5988610|P12|STARTED|Overall Study||20
2441439|NCT01116986|5988611|P11|STARTED|Overall Study||19
2441440|NCT01116986|5988612|P10|STARTED|Overall Study||23
2441441|NCT01116986|5988613|P9|STARTED|Overall Study||20
2441442|NCT01116986|5988614|P8|STARTED|Overall Study||22
2441443|NCT01116986|5988615|P7|STARTED|Overall Study||22
2441444|NCT01116986|5988616|P6|STARTED|Overall Study||22
2441445|NCT01116986|5988617|P5|STARTED|Overall Study||24
2441446|NCT01116986|5988618|P4|STARTED|Overall Study||22
2441447|NCT01116986|5988619|P3|STARTED|Overall Study||18
2441448|NCT01116986|5988620|P2|STARTED|Overall Study||19
2441449|NCT01116986|5988621|P1|STARTED|Overall Study||24
2441450|NCT01116934|5988655|P2|NOT COMPLETED|Overall Study||0
2441451|NCT01116934|5988656|P1|NOT COMPLETED|Overall Study||0
2441452|NCT01116934|5988655|P2|COMPLETED|Overall Study||9
2441453|NCT01116934|5988656|P1|COMPLETED|Overall Study||8
2441454|NCT01116934|5988655|P2|STARTED|Overall Study||9
2441455|NCT01116934|5988656|P1|STARTED|Overall Study||8
2441456|NCT01116921|5988664|P2|NOT COMPLETED|Overall Study||0
2441457|NCT01116921|5988665|P1|NOT COMPLETED|Overall Study||0
2441458|NCT01116921|5988664|P2|COMPLETED|Overall Study||50
2441459|NCT01116921|5988665|P1|COMPLETED|Overall Study||53
2441460|NCT01116921|5988664|P2|STARTED|Overall Study||50
2441461|NCT01116921|5988665|P1|STARTED|Overall Study||53
2441462|NCT01116895|5988685|P4|NOT COMPLETED|Overall Study||3
2441463|NCT01116895|5988686|P3|NOT COMPLETED|Overall Study||4
2441464|NCT01116895|5988687|P2|NOT COMPLETED|Overall Study||7
2441465|NCT01116895|5988688|P1|NOT COMPLETED|Overall Study||4
2441466|NCT01116895|5988685|P4|COMPLETED|Overall Study||11
2441467|NCT01116895|5988686|P3|COMPLETED|Overall Study||14
2441468|NCT01116895|5988687|P2|COMPLETED|Overall Study||8
2441469|NCT01116895|5988688|P1|COMPLETED|Overall Study||12
2441470|NCT01116895|5988685|P4|STARTED|Overall Study||14
2441471|NCT01116895|5988686|P3|STARTED|Overall Study||18
2441472|NCT01116895|5988687|P2|STARTED|Overall Study||15
2441473|NCT01116895|5988688|P1|STARTED|Overall Study||16
2441474|NCT01116882|5988716|P2|NOT COMPLETED|12-month||99
2441475|NCT01116882|5988717|P1|NOT COMPLETED|12-month||267
2441476|NCT01116882|5988716|P2|COMPLETED|12-month||787
2441477|NCT01116882|5988717|P1|COMPLETED|12-month||2439
2441478|NCT01116882|5988716|P2|STARTED|12-month||886
2441479|NCT01116882|5988717|P1|STARTED|12-month||2706
2441480|NCT01116882|5988716|P2|NOT COMPLETED|30-day||31
2441481|NCT01116882|5988717|P1|NOT COMPLETED|30-day||68
2441482|NCT01116882|5988716|P2|COMPLETED|30-day||886
2441483|NCT01116882|5988717|P1|COMPLETED|30-day||2706
2441484|NCT01116882|5988716|P2|STARTED|30-day||917
2441485|NCT01116882|5988717|P1|STARTED|30-day||2774
2441486|NCT01116687|5988755|P1|NOT COMPLETED|Overall Study||4
2441487|NCT01116687|5988755|P1|COMPLETED|Overall Study||33
2441488|NCT01116687|5988755|P1|STARTED|Overall Study||37
2441489|NCT01116661|5988762|P1|NOT COMPLETED|Overall Study||2
2441490|NCT01116661|5988762|P1|COMPLETED|Overall Study||197
2441491|NCT01116661|5988762|P1|STARTED|Overall Study||199
2441492|NCT01116544|5988769|P2|NOT COMPLETED|Overall Study||1
2441493|NCT01116544|5988770|P1|NOT COMPLETED|Overall Study||2
2441494|NCT01116544|5988769|P2|COMPLETED|Overall Study||22
2441495|NCT01116544|5988770|P1|COMPLETED|Overall Study||21
2441496|NCT01116544|5988769|P2|STARTED|Overall Study||23
2441497|NCT01116544|5988770|P1|STARTED|Overall Study||23
2441498|NCT01116466|5988786|P1|NOT COMPLETED|Overall Study||0
2441499|NCT01116466|5988786|P1|COMPLETED|Overall Study||5
2441500|NCT01116466|5988786|P1|STARTED|Overall Study||5
2441501|NCT01116427|5988796|P2|NOT COMPLETED|Extension Phase||2
2441502|NCT01116427|5988797|P1|NOT COMPLETED|Extension Phase||9
2441503|NCT01116427|5988796|P2|COMPLETED|Extension Phase||18
2441504|NCT01116427|5988797|P1|COMPLETED|Extension Phase||29
2441505|NCT01116427|5988796|P2|STARTED|Extension Phase||20
2441506|NCT01116427|5988797|P1|STARTED|Extension Phase|One participant that completed core phase did not meet eligibility for Extension Phase|38
2441507|NCT01116427|5988796|P2|NOT COMPLETED|Core Phase||1
2441508|NCT01116427|5988797|P1|NOT COMPLETED|Core Phase||5
2441509|NCT01116427|5988796|P2|COMPLETED|Core Phase||20
2441510|NCT01116427|5988797|P1|COMPLETED|Core Phase||39
2441511|NCT01116427|5988796|P2|STARTED|Core Phase||21
2441512|NCT01116427|5988797|P1|STARTED|Core Phase||44
2441513|NCT01116401|5988833|P1|NOT COMPLETED|Overall Study||0
2441514|NCT01116401|5988833|P1|COMPLETED|Overall Study||29
2441515|NCT01116401|5988833|P1|STARTED|Overall Study||29
2441516|NCT01116232|5988838|P1|NOT COMPLETED|Overall Study||4
2441517|NCT01116232|5988838|P1|COMPLETED|Overall Study||0
2441518|NCT01116232|5988838|P1|STARTED|Overall Study||4
2441519|NCT01116102|5988857|P8|NOT COMPLETED|Overall Study||0
2441520|NCT01116102|5988858|P7|NOT COMPLETED|Overall Study||0
2441521|NCT01116102|5988859|P6|NOT COMPLETED|Overall Study||0
2441522|NCT01116102|5988860|P5|NOT COMPLETED|Overall Study||0
2441523|NCT01116102|5988861|P4|NOT COMPLETED|Overall Study||0
2441524|NCT01116102|5988862|P3|NOT COMPLETED|Overall Study||0
2441525|NCT01116102|5988863|P2|NOT COMPLETED|Overall Study||0
2441526|NCT01116102|5988864|P1|NOT COMPLETED|Overall Study||0
2441527|NCT01116102|5988857|P8|COMPLETED|Overall Study||3
2441528|NCT01116102|5988858|P7|COMPLETED|Overall Study||2
2441529|NCT01116102|5988859|P6|COMPLETED|Overall Study||2
2441530|NCT01116102|5988860|P5|COMPLETED|Overall Study||2
2441531|NCT01116102|5988861|P4|COMPLETED|Overall Study||3
2441532|NCT01116102|5988862|P3|COMPLETED|Overall Study||3
2441533|NCT01116102|5988863|P2|COMPLETED|Overall Study||3
2441534|NCT01116102|5988864|P1|COMPLETED|Overall Study||2
2441535|NCT01116102|5988857|P8|STARTED|Overall Study||3
2441536|NCT01116102|5988858|P7|STARTED|Overall Study||2
2441537|NCT01116102|5988859|P6|STARTED|Overall Study||2
2441538|NCT01116102|5988860|P5|STARTED|Overall Study||2
2441539|NCT01116102|5988861|P4|STARTED|Overall Study||3
2441540|NCT01116102|5988862|P3|STARTED|Overall Study||3
2441541|NCT01116102|5988863|P2|STARTED|Overall Study||3
2441542|NCT01116102|5988864|P1|STARTED|Overall Study||2
2441543|NCT01116037|5988906|P1|NOT COMPLETED|Overall Study||25
2441544|NCT01116037|5988906|P1|COMPLETED|Overall Study||1
2441545|NCT01116037|5988906|P1|STARTED|Overall Study||26
2441546|NCT01116024|5988911|P1|NOT COMPLETED|Overall Study||52
2441547|NCT01116024|5988911|P1|COMPLETED|Overall Study|Patient Enrollment stop date|96
2441548|NCT01116024|5988911|P1|STARTED|Overall Study|148 subjects left operating room with the device implanted and were included in the analysis.|148
2441549|NCT01115998|5988952|P2|NOT COMPLETED|Overall Study||6
2441550|NCT01115998|5988953|P1|NOT COMPLETED|Overall Study||6
2441551|NCT01115998|5988952|P2|COMPLETED|Overall Study||11
2441552|NCT01115998|5988953|P1|COMPLETED|Overall Study||11
2441553|NCT01115998|5988952|P2|STARTED|Overall Study||17
2441554|NCT01115998|5988953|P1|STARTED|Overall Study||17
2441555|NCT01115933|5988963|P1|NOT COMPLETED|Overall Study||1
2441556|NCT01115933|5988963|P1|COMPLETED|Overall Study||64
2441557|NCT01115933|5988963|P1|STARTED|Overall Study||65
2441558|NCT01115855|5989060|P2|NOT COMPLETED|Overall Study||36
2441559|NCT01115855|5989061|P1|NOT COMPLETED|Overall Study||36
2441560|NCT01115855|5989060|P2|COMPLETED|Overall Study||74
2441561|NCT01115855|5989061|P1|COMPLETED|Overall Study||75
2441562|NCT01115855|5989060|P2|STARTED|Overall Study||110
2441563|NCT01115855|5989061|P1|STARTED|Overall Study||111
2441564|NCT01115803|5989116|P7|NOT COMPLETED|Overall Study||2
2441565|NCT01115803|5989117|P6|NOT COMPLETED|Overall Study||0
2441566|NCT01115803|5989118|P5|NOT COMPLETED|Overall Study||0
2441567|NCT01115803|5989119|P4|NOT COMPLETED|Overall Study||0
2441568|NCT01115803|5989120|P3|NOT COMPLETED|Overall Study||1
2441569|NCT01115803|5989121|P2|NOT COMPLETED|Overall Study||0
2441570|NCT01115803|5989122|P1|NOT COMPLETED|Overall Study||0
2441571|NCT01115803|5989116|P7|COMPLETED|Overall Study||4
2441572|NCT01115803|5989117|P6|COMPLETED|Overall Study||3
2441573|NCT01115803|5989118|P5|COMPLETED|Overall Study||3
2441574|NCT01115803|5989119|P4|COMPLETED|Overall Study||5
2441575|NCT01115803|5989120|P3|COMPLETED|Overall Study||2
2441576|NCT01115803|5989121|P2|COMPLETED|Overall Study||5
2441577|NCT01115803|5989122|P1|COMPLETED|Overall Study||4
2441578|NCT01115803|5989116|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
2441579|NCT01115803|5989117|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
2441580|NCT01115803|5989118|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
2441581|NCT01115803|5989119|P4|Received at Least 1 Dose of Study Drug|Overall Study||5
2441582|NCT01115803|5989120|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
2441583|NCT01115803|5989121|P2|Received at Least 1 Dose of Study Drug|Overall Study||5
2441584|NCT01115803|5989122|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
2441585|NCT01115803|5989116|P7|STARTED|Overall Study||6
2441586|NCT01115803|5989117|P6|STARTED|Overall Study||3
2441587|NCT01115803|5989118|P5|STARTED|Overall Study||3
2441588|NCT01115803|5989119|P4|STARTED|Overall Study||5
2441589|NCT01115803|5989120|P3|STARTED|Overall Study||3
2441590|NCT01115803|5989121|P2|STARTED|Overall Study||5
2441591|NCT01115803|5989122|P1|STARTED|Overall Study||4
2441592|NCT01115738|5989185|P3|NOT COMPLETED|Overall Study||27
2441593|NCT01115738|5989186|P2|NOT COMPLETED|Overall Study||21
2441594|NCT01115738|5989187|P1|NOT COMPLETED|Overall Study||25
2441595|NCT01115738|5989185|P3|COMPLETED|Overall Study||62
2441596|NCT01115738|5989186|P2|COMPLETED|Overall Study||62
2441597|NCT01115738|5989187|P1|COMPLETED|Overall Study||85
2441598|NCT01115738|5989185|P3|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|50
2441599|NCT01115738|5989186|P2|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|47
2441600|NCT01115738|5989187|P1|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|52
2441601|NCT01115738|5989185|P3|Received Any Treatment|Overall Study||88
2441602|NCT01115738|5989186|P2|Received Any Treatment|Overall Study||79
2441603|NCT01115738|5989187|P1|Received Any Treatment|Overall Study||109
2441604|NCT01115738|5989185|P3|STARTED|Overall Study||89
2441605|NCT01115738|5989186|P2|STARTED|Overall Study||83
2441606|NCT01115738|5989187|P1|STARTED|Overall Study||110
2441607|NCT01115699|5989221|P1|NOT COMPLETED|Overall Study||0
2441608|NCT01115699|5989221|P1|COMPLETED|Overall Study||2
2441609|NCT01115699|5989221|P1|STARTED|Overall Study||2
2441610|NCT01115673|5989229|P3|NOT COMPLETED|Overall Study||0
2441611|NCT01115673|5989230|P2|NOT COMPLETED|Overall Study||0
2441612|NCT01115673|5989231|P1|NOT COMPLETED|Overall Study||0
2441613|NCT01115673|5989229|P3|COMPLETED|Overall Study||60
2441614|NCT01115673|5989230|P2|COMPLETED|Overall Study||241
2441615|NCT01115673|5989231|P1|COMPLETED|Overall Study||239
2441616|NCT01115673|5989229|P3|STARTED|Overall Study||60
2441617|NCT01115673|5989230|P2|STARTED|Overall Study||241
2441618|NCT01115673|5989231|P1|STARTED|Overall Study||239
2441619|NCT01115660|5989367|P2|NOT COMPLETED|Overall Study||0
2441620|NCT01115660|5989368|P1|NOT COMPLETED|Overall Study||1
2441621|NCT01115660|5989367|P2|COMPLETED|Overall Study||10
2441622|NCT01115660|5989368|P1|COMPLETED|Overall Study||19
2441623|NCT01115660|5989367|P2|STARTED|Overall Study||10
2441624|NCT01115660|5989368|P1|STARTED|Overall Study||20
2441625|NCT01115582|5989376|P1|NOT COMPLETED|Overall Study||0
2441626|NCT01115582|5989376|P1|COMPLETED|Overall Study||16
2441627|NCT01115582|5989376|P1|STARTED|Overall Study||16
2441628|NCT01115569|5989385|P2|NOT COMPLETED|Maintenance Phase||139
2441629|NCT01115569|5989386|P1|NOT COMPLETED|Maintenance Phase||0
2441630|NCT01115569|5989385|P2|COMPLETED|Maintenance Phase||285
2441631|NCT01115569|5989386|P1|COMPLETED|Maintenance Phase||0
2441632|NCT01115569|5989385|P2|STARTED|Maintenance Phase||424
2441633|NCT01115569|5989386|P1|STARTED|Maintenance Phase||0
2441634|NCT01115569|5989385|P2|NOT COMPLETED|Conversion/Titration Phase||0
2441635|NCT01115569|5989386|P1|NOT COMPLETED|Conversion/Titration Phase||214
2441636|NCT01115569|5989385|P2|COMPLETED|Conversion/Titration Phase||0
2441637|NCT01115569|5989386|P1|COMPLETED|Conversion/Titration Phase||424
2441638|NCT01115569|5989385|P2|STARTED|Conversion/Titration Phase||0
2441639|NCT01115569|5989386|P1|STARTED|Conversion/Titration Phase||638
2441640|NCT01115556|5989393|P2|NOT COMPLETED|Overall Study||0
2441641|NCT01115556|5989394|P1|NOT COMPLETED|Overall Study||0
2441642|NCT01115556|5989393|P2|COMPLETED|Overall Study||2
2441643|NCT01115556|5989394|P1|COMPLETED|Overall Study||7
2441644|NCT01115556|5989393|P2|STARTED|Overall Study||2
2441645|NCT01115556|5989394|P1|STARTED|Overall Study||7
2441646|NCT01115517|5989404|P2|NOT COMPLETED|Overall Study||5
2441647|NCT01115517|5989405|P1|NOT COMPLETED|Overall Study||4
2441648|NCT01115517|5989404|P2|COMPLETED|Overall Study||16
2441649|NCT01115517|5989405|P1|COMPLETED|Overall Study||14
2441650|NCT01115517|5989404|P2|STARTED|Overall Study||21
2441651|NCT01115517|5989405|P1|STARTED|Overall Study||18
2441652|NCT01115491|5989415|P1|NOT COMPLETED|Overall Study||30
2441653|NCT01115491|5989415|P1|COMPLETED|Overall Study||2
2441654|NCT01115491|5989415|P1|STARTED|Overall Study||32
2441655|NCT01115452|5989424|P1|NOT COMPLETED|Overall Study||0
2441656|NCT01115452|5989424|P1|COMPLETED|Overall Study||32
2441657|NCT01115452|5989424|P1|STARTED|Overall Study||32
2441658|NCT01115244|5989476|P2|NOT COMPLETED|Overall Study||0
2441659|NCT01115244|5989477|P1|NOT COMPLETED|Overall Study||0
2441660|NCT01115244|5989476|P2|COMPLETED|Overall Study||0
2441661|NCT01115244|5989477|P1|COMPLETED|Overall Study||0
2441662|NCT01115244|5989476|P2|STARTED|Overall Study||0
2441663|NCT01115244|5989477|P1|STARTED|Overall Study||0
2441664|NCT01115231|5989489|P2|NOT COMPLETED|Overall Study||0
2441665|NCT01115231|5989490|P1|NOT COMPLETED|Overall Study||0
2441666|NCT01115231|5989489|P2|COMPLETED|Overall Study||90
2441667|NCT01115231|5989490|P1|COMPLETED|Overall Study||133
2441668|NCT01115231|5989489|P2|STARTED|Overall Study||90
2441669|NCT01115231|5989490|P1|STARTED|Overall Study||133
2441670|NCT01115166|5989502|P1|NOT COMPLETED|Overall Study||0
2441671|NCT01115166|5989502|P1|COMPLETED|Overall Study||10
2441672|NCT01115166|5989502|P1|STARTED|Overall Study||10
2441673|NCT01115101|5989510|P2|NOT COMPLETED|Overall Study||0
2441674|NCT01115101|5989511|P1|NOT COMPLETED|Overall Study||0
2441675|NCT01115101|5989510|P2|COMPLETED|Overall Study||126
2441676|NCT01115101|5989511|P1|COMPLETED|Overall Study||113
2441677|NCT01115101|5989510|P2|STARTED|Overall Study||126
2441678|NCT01115101|5989511|P1|STARTED|Overall Study||113
2441679|NCT01114997|5989520|P3|NOT COMPLETED|Overall Study||0
2441680|NCT01114997|5989521|P2|NOT COMPLETED|Overall Study||0
2441681|NCT01114997|5989522|P1|NOT COMPLETED|Overall Study||0
2441682|NCT01114997|5989520|P3|COMPLETED|Overall Study||11
2441683|NCT01114997|5989521|P2|COMPLETED|Overall Study||10
2441684|NCT01114997|5989522|P1|COMPLETED|Overall Study||11
2441685|NCT01114997|5989520|P3|STARTED|Overall Study||11
2441686|NCT01114997|5989521|P2|STARTED|Overall Study||10
2441687|NCT01114997|5989522|P1|STARTED|Overall Study||11
2441697|NCT01114945|5989580|P4|NOT COMPLETED|Overall Study||0
2441698|NCT01114945|5989581|P3|NOT COMPLETED|Overall Study||0
2441699|NCT01114945|5989582|P2|NOT COMPLETED|Overall Study||0
2441700|NCT01114945|5989583|P1|NOT COMPLETED|Overall Study||0
2441701|NCT01114945|5989580|P4|COMPLETED|Overall Study||31
2441702|NCT01114945|5989581|P3|COMPLETED|Overall Study||30
2441703|NCT01114945|5989582|P2|COMPLETED|Overall Study||30
2441704|NCT01114945|5989583|P1|COMPLETED|Overall Study||30
2441705|NCT01114945|5989580|P4|STARTED|Overall Study||31
2441706|NCT01114945|5989581|P3|STARTED|Overall Study||30
2441707|NCT01114945|5989582|P2|STARTED|Overall Study||30
2441708|NCT01114945|5989583|P1|STARTED|Overall Study||30
2441709|NCT01114893|5989610|P5|NOT COMPLETED|Overall Study||0
2441710|NCT01114893|5989611|P4|NOT COMPLETED|Overall Study||0
2441711|NCT01114893|5989612|P3|NOT COMPLETED|Overall Study||0
2441712|NCT01114893|5989613|P2|NOT COMPLETED|Overall Study||0
2441713|NCT01114893|5989614|P1|NOT COMPLETED|Overall Study||0
2441714|NCT01114893|5989610|P5|COMPLETED|Overall Study||12
2441715|NCT01114893|5989611|P4|COMPLETED|Overall Study||13
2441716|NCT01114893|5989612|P3|COMPLETED|Overall Study||14
2441717|NCT01114893|5989613|P2|COMPLETED|Overall Study||14
2441718|NCT01114893|5989614|P1|COMPLETED|Overall Study||14
2441719|NCT01114893|5989610|P5|STARTED|Overall Study||12
2441720|NCT01114893|5989611|P4|STARTED|Overall Study||13
2441721|NCT01114893|5989612|P3|STARTED|Overall Study||14
2441722|NCT01114893|5989613|P2|STARTED|Overall Study||14
2441723|NCT01114893|5989614|P1|STARTED|Overall Study||14
2441724|NCT01114880|5989633|P2|NOT COMPLETED|Period 2 (Week 12 to Week 24)||2
2441725|NCT01114880|5989634|P1|NOT COMPLETED|Period 2 (Week 12 to Week 24)||3
2441726|NCT01114880|5989633|P2|COMPLETED|Period 2 (Week 12 to Week 24)||111
2441727|NCT01114880|5989634|P1|COMPLETED|Period 2 (Week 12 to Week 24)||221
2441728|NCT01114880|5989633|P2|STARTED|Period 2 (Week 12 to Week 24)||113
2441729|NCT01114880|5989634|P1|STARTED|Period 2 (Week 12 to Week 24)||224
2441730|NCT01114880|5989633|P2|NOT COMPLETED|Period 1 (Week 0 to Week 12)||2
2441731|NCT01114880|5989634|P1|NOT COMPLETED|Period 1 (Week 0 to Week 12)||5
2441732|NCT01114880|5989633|P2|COMPLETED|Period 1 (Week 0 to Week 12)||113
2441733|NCT01114880|5989634|P1|COMPLETED|Period 1 (Week 0 to Week 12)||224
2441734|NCT01114880|5989633|P2|STARTED|Period 1 (Week 0 to Week 12)||115
2441735|NCT01114880|5989634|P1|STARTED|Period 1 (Week 0 to Week 12)||229
2441736|NCT01114828|5989686|P2|NOT COMPLETED|Overall Study||4
2441737|NCT01114828|5989687|P1|NOT COMPLETED|Overall Study||3
2441738|NCT01114828|5989686|P2|COMPLETED|Overall Study||17
2441739|NCT01114828|5989687|P1|COMPLETED|Overall Study||16
2441740|NCT01114828|5989686|P2|STARTED|Overall Study||21
2441741|NCT01114828|5989687|P1|STARTED|Overall Study||19
2441742|NCT01114737|5989697|P2|NOT COMPLETED|Open-Label Treatment Period||2
2441743|NCT01114737|5989698|P1|NOT COMPLETED|Open-Label Treatment Period||5
2441744|NCT01114737|5989697|P2|COMPLETED|Open-Label Treatment Period||95
2441745|NCT01114737|5989698|P1|COMPLETED|Open-Label Treatment Period||100
2441746|NCT01114737|5989697|P2|STARTED|Open-Label Treatment Period|Two subjects did not receive a single dose of the study drug|97
2441747|NCT01114737|5989698|P1|STARTED|Open-Label Treatment Period|One subject did not receive a single dose of the study drug|105
2441748|NCT01114737|5989697|P2|NOT COMPLETED|Randomized Treatment Period||1
2441749|NCT01114737|5989698|P1|NOT COMPLETED|Randomized Treatment Period||3
2441750|NCT01114737|5989697|P2|COMPLETED|Randomized Treatment Period||97
2441751|NCT01114737|5989698|P1|COMPLETED|Randomized Treatment Period||105
2441752|NCT01114737|5989697|P2|STARTED|Randomized Treatment Period||98
2441753|NCT01114737|5989698|P1|STARTED|Randomized Treatment Period||108
2441754|NCT01114724|5989746|P1|NOT COMPLETED|Overall Study||10
2441755|NCT01114724|5989746|P1|COMPLETED|Overall Study||40
2441756|NCT01114724|5989746|P1|STARTED|Overall Study||50
2441757|NCT01114672|5989766|P2|NOT COMPLETED|Overall Study||2
2441758|NCT01114672|5989767|P1|NOT COMPLETED|Overall Study||4
2441759|NCT01114672|5989766|P2|COMPLETED|Overall Study||23
2441760|NCT01114672|5989767|P1|COMPLETED|Overall Study||21
2441761|NCT01114672|5989766|P2|STARTED|Overall Study||25
2441762|NCT01114672|5989767|P1|STARTED|Overall Study||25
2441763|NCT01114646|5989775|P2|NOT COMPLETED|Overall Study||2
2441764|NCT01114646|5989776|P1|NOT COMPLETED|Overall Study||3
2441765|NCT01114646|5989775|P2|COMPLETED|Overall Study||62
2441766|NCT01114646|5989776|P1|COMPLETED|Overall Study||63
2441767|NCT01114646|5989775|P2|STARTED|Overall Study||64
2441768|NCT01114646|5989776|P1|STARTED|Overall Study||66
2441769|NCT01114620|5989782|P1|NOT COMPLETED|Overall Study||0
2441770|NCT01114620|5989782|P1|COMPLETED|Overall Study||50
2441771|NCT01114620|5989782|P1|STARTED|Overall Study||50
2441772|NCT01114581|5989815|P2|NOT COMPLETED|Overall Study||0
2441773|NCT01114581|5989816|P1|NOT COMPLETED|Overall Study||0
2441774|NCT01114581|5989815|P2|COMPLETED|Overall Study||19
2441775|NCT01114581|5989816|P1|COMPLETED|Overall Study||19
2441776|NCT01114581|5989815|P2|STARTED|Overall Study||19
2441777|NCT01114581|5989816|P1|STARTED|Overall Study||19
2441778|NCT01114555|5989826|P1|NOT COMPLETED|Overall Study||0
2441779|NCT01114555|5989826|P1|COMPLETED|Overall Study||34
2441780|NCT01114555|5989826|P1|STARTED|Overall Study||34
2441781|NCT01114529|5989836|P3|NOT COMPLETED|Completed Study Phase at Month 24||14
2441782|NCT01114529|5989837|P2|NOT COMPLETED|Completed Study Phase at Month 24||16
2441783|NCT01114529|5989838|P1|NOT COMPLETED|Completed Study Phase at Month 24||40
2441784|NCT01114529|5989836|P3|COMPLETED|Completed Study Phase at Month 24|at month 24|111
2441785|NCT01114529|5989837|P2|COMPLETED|Completed Study Phase at Month 24|at month 24|215
2441786|NCT01114529|5989838|P1|COMPLETED|Completed Study Phase at Month 24|at month 24|313
2441787|NCT01114529|5989836|P3|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|125
2441788|NCT01114529|5989837|P2|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|231
2441789|NCT01114529|5989838|P1|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|353
2441790|NCT01114529|5989836|P3|NOT COMPLETED|Completed Study Medication at Month 24||32
2441791|NCT01114529|5989837|P2|NOT COMPLETED|Completed Study Medication at Month 24||41
2441792|NCT01114529|5989838|P1|NOT COMPLETED|Completed Study Medication at Month 24||124
2441793|NCT01114529|5989836|P3|COMPLETED|Completed Study Medication at Month 24|completed at month 24|93
2441794|NCT01114529|5989837|P2|COMPLETED|Completed Study Medication at Month 24|completed at month 24|190
2441795|NCT01114529|5989838|P1|COMPLETED|Completed Study Medication at Month 24|completed at month 24|229
2441796|NCT01114529|5989836|P3|STARTED|Completed Study Medication at Month 24|Randomized set-125 Full analysis set -125 Safety analysis set -121***|125
2441797|NCT01114529|5989837|P2|STARTED|Completed Study Medication at Month 24|Randomized set -231 Full analysis set -231 Safety analysis set -238**|231
2441798|NCT01114529|5989838|P1|STARTED|Completed Study Medication at Month 24|Randomized set - 360 Full analysis set - 353 Safety analysis set -346*|353
2441799|NCT01114516|5989857|P2|NOT COMPLETED|Overall Study||1
2441800|NCT01114516|5989858|P1|NOT COMPLETED|Overall Study||2
2441801|NCT01114516|5989857|P2|COMPLETED|Overall Study||26
2441802|NCT01114516|5989858|P1|COMPLETED|Overall Study||24
2441803|NCT01114516|5989857|P2|STARTED|Overall Study||27
2441804|NCT01114516|5989858|P1|STARTED|Overall Study||26
2441805|NCT01114503|5989872|P1|NOT COMPLETED|Overall Study||0
2441806|NCT01114503|5989872|P1|COMPLETED|Overall Study||2
2441807|NCT01114503|5989872|P1|STARTED|Overall Study||2
2441808|NCT01114438|5989893|P1|NOT COMPLETED|Overall Study||14
2441809|NCT01114438|5989893|P1|COMPLETED|Overall Study||31
2441810|NCT01114438|5989893|P1|STARTED|Overall Study||45
2441811|NCT01114373|5989903|P2|NOT COMPLETED|Intervention 2 (4 Weeks)||1
2441812|NCT01114373|5989904|P1|NOT COMPLETED|Intervention 2 (4 Weeks)||0
2441813|NCT01114373|5989903|P2|COMPLETED|Intervention 2 (4 Weeks)||18
2441814|NCT01114373|5989904|P1|COMPLETED|Intervention 2 (4 Weeks)||18
2441815|NCT01114373|5989903|P2|STARTED|Intervention 2 (4 Weeks)||19
2441816|NCT01114373|5989904|P1|STARTED|Intervention 2 (4 Weeks)||18
2441817|NCT01114373|5989903|P2|NOT COMPLETED|Intervention 1 (4 Weeks)||0
2441818|NCT01114373|5989904|P1|NOT COMPLETED|Intervention 1 (4 Weeks)||3
2441819|NCT01114373|5989903|P2|COMPLETED|Intervention 1 (4 Weeks)||19
2441820|NCT01114373|5989904|P1|COMPLETED|Intervention 1 (4 Weeks)||18
2441821|NCT01114373|5989903|P2|STARTED|Intervention 1 (4 Weeks)||19
2441822|NCT01114373|5989904|P1|STARTED|Intervention 1 (4 Weeks)||21
2441823|NCT01114360|5989936|P2|NOT COMPLETED|Intervention 2 (4 Weeks)||0
2441824|NCT01114360|5989937|P1|NOT COMPLETED|Intervention 2 (4 Weeks)||0
2441825|NCT01114360|5989936|P2|COMPLETED|Intervention 2 (4 Weeks)||18
2441826|NCT01114360|5989937|P1|COMPLETED|Intervention 2 (4 Weeks)||18
2441827|NCT01114360|5989936|P2|STARTED|Intervention 2 (4 Weeks)||18
2441828|NCT01114360|5989937|P1|STARTED|Intervention 2 (4 Weeks)||18
2441829|NCT01114360|5989936|P2|NOT COMPLETED|Intervention 1 (4 Weeks)||1
2441830|NCT01114360|5989937|P1|NOT COMPLETED|Intervention 1 (4 Weeks)||0
2441831|NCT01114360|5989936|P2|COMPLETED|Intervention 1 (4 Weeks)||18
2441832|NCT01114360|5989937|P1|COMPLETED|Intervention 1 (4 Weeks)||18
2441833|NCT01114360|5989936|P2|STARTED|Intervention 1 (4 Weeks)||19
2441834|NCT01114360|5989937|P1|STARTED|Intervention 1 (4 Weeks)||18
2441835|NCT01114334|5989975|P2|NOT COMPLETED|Overall Study||22
2441836|NCT01114334|5989976|P1|NOT COMPLETED|Overall Study||21
2441837|NCT01114334|5989975|P2|COMPLETED|Overall Study||58
2441838|NCT01114334|5989976|P1|COMPLETED|Overall Study||67
2441839|NCT01114334|5989975|P2|STARTED|Overall Study||80
2441840|NCT01114334|5989976|P1|STARTED|Overall Study||88
2441841|NCT01114217|5989988|P2|NOT COMPLETED|Overall Study||98
2441842|NCT01114217|5989989|P1|NOT COMPLETED|Overall Study||75
2441843|NCT01114217|5989988|P2|COMPLETED|Overall Study||199
2441844|NCT01114217|5989989|P1|COMPLETED|Overall Study|Two participants lacked study completion data: one site stopped communicating during the study.|262
2441845|NCT01114217|5989988|P2|Received at Least 1 Dose of Ferumoxytol|Overall Study||0
2441846|NCT01114217|5989989|P1|Received at Least 1 Dose of Ferumoxytol|Overall Study||337
2441847|NCT01114217|5989988|P2|STARTED|Overall Study||297
2441848|NCT01114217|5989989|P1|STARTED|Overall Study||337
2441849|NCT01114204|5990001|P2|NOT COMPLETED|Overall Study||8
2441850|NCT01114204|5990002|P1|NOT COMPLETED|Overall Study||21
2441851|NCT01114204|5990001|P2|COMPLETED|Overall Study||191
2441852|NCT01114204|5990002|P1|COMPLETED|Overall Study||385
2441853|NCT01114204|5990001|P2|Received at Least 1 Dose of Study Drug|Overall Study||199
2441854|NCT01114204|5990002|P1|Received at Least 1 Dose of Study Drug|Overall Study||406
2441855|NCT01114204|5990001|P2|STARTED|Overall Study||199
2441856|NCT01114204|5990002|P1|STARTED|Overall Study||406
2441857|NCT01114139|5990020|P2|NOT COMPLETED|Overall Study||16
2441858|NCT01114139|5990021|P1|NOT COMPLETED|Overall Study||40
2441859|NCT01114139|5990020|P2|COMPLETED|Overall Study||187
2441860|NCT01114139|5990021|P1|COMPLETED|Overall Study||569
2441861|NCT01114139|5990020|P2|Received at Least 1 Dose of Study Drug|Overall Study||200
2441862|NCT01114139|5990021|P1|Received at Least 1 Dose of Study Drug|Overall Study||608
2441863|NCT01114139|5990020|P2|STARTED|Overall Study||203
2441864|NCT01114139|5990021|P1|STARTED|Overall Study||609
2441865|NCT01113931|5990039|P2|NOT COMPLETED|Overall Study||17
2441866|NCT01113931|5990040|P1|NOT COMPLETED|Overall Study||19
2441867|NCT01113931|5990039|P2|COMPLETED|Overall Study||231
2441868|NCT01113931|5990040|P1|COMPLETED|Overall Study||228
2441869|NCT01113931|5990039|P2|mITT Population|Overall Study||190
2441870|NCT01113931|5990040|P1|mITT Population|Overall Study||188
2441871|NCT01113931|5990039|P2|Safety Population|Overall Study||248
2441872|NCT01113931|5990040|P1|Safety Population|Overall Study|1 subject did not take any study medication|246
2441873|NCT01113931|5990039|P2|STARTED|Overall Study||248
2441874|NCT01113931|5990040|P1|STARTED|Overall Study||247
2441875|NCT01113879|5990054|P2|NOT COMPLETED|Period 2: Block 2||0
2441876|NCT01113879|5990055|P1|NOT COMPLETED|Period 2: Block 2||0
2441877|NCT01113879|5990054|P2|COMPLETED|Period 2: Block 2||2
2441878|NCT01113879|5990055|P1|COMPLETED|Period 2: Block 2||5
2441879|NCT01113879|5990054|P2|STARTED|Period 2: Block 2||2
2441880|NCT01113879|5990055|P1|STARTED|Period 2: Block 2||5
2441881|NCT01113879|5990054|P2|NOT COMPLETED|Period 1: Block 1||0
2441882|NCT01113879|5990055|P1|NOT COMPLETED|Period 1: Block 1||2
2441883|NCT01113879|5990054|P2|COMPLETED|Period 1: Block 1||2
2441884|NCT01113879|5990055|P1|COMPLETED|Period 1: Block 1||5
2441885|NCT01113879|5990054|P2|STARTED|Period 1: Block 1||2
2441886|NCT01113879|5990055|P1|STARTED|Period 1: Block 1||7
2441887|NCT01113801|5990067|P4|NOT COMPLETED|Overall Study||41
2441888|NCT01113801|5990068|P3|NOT COMPLETED|Overall Study||37
2441889|NCT01113801|5990069|P2|NOT COMPLETED|Overall Study||40
2441890|NCT01113801|5990070|P1|NOT COMPLETED|Overall Study||41
2441891|NCT01113801|5990067|P4|COMPLETED|Overall Study||65
2441892|NCT01113801|5990068|P3|COMPLETED|Overall Study||66
2441893|NCT01113801|5990069|P2|COMPLETED|Overall Study||65
2441894|NCT01113801|5990070|P1|COMPLETED|Overall Study||62
2441895|NCT01113801|5990067|P4|Received at Least One Dose of Drug|Overall Study||105
2441896|NCT01113801|5990068|P3|Received at Least One Dose of Drug|Overall Study||103
2441897|NCT01113801|5990069|P2|Received at Least One Dose of Drug|Overall Study||105
2441898|NCT01113801|5990070|P1|Received at Least One Dose of Drug|Overall Study||103
2441899|NCT01113801|5990067|P4|STARTED|Overall Study||106
2441900|NCT01113801|5990068|P3|STARTED|Overall Study||103
2441901|NCT01113801|5990069|P2|STARTED|Overall Study||105
2441902|NCT01113801|5990070|P1|STARTED|Overall Study||103
2441903|NCT01113749|5990098|P2|NOT COMPLETED|Overall Study||2
2441904|NCT01113749|5990099|P1|NOT COMPLETED|Overall Study||1
2441905|NCT01113749|5990098|P2|COMPLETED|Overall Study||127
2441906|NCT01113749|5990099|P1|COMPLETED|Overall Study||126
2441907|NCT01113749|5990098|P2|STARTED|Overall Study||129
2441908|NCT01113749|5990099|P1|STARTED|Overall Study||127
2441909|NCT01113723|5990111|P2|NOT COMPLETED|Overall Study||0
2441910|NCT01113723|5990112|P1|NOT COMPLETED|Overall Study||0
2441911|NCT01113723|5990111|P2|COMPLETED|Overall Study||70
2441912|NCT01113723|5990112|P1|COMPLETED|Overall Study||70
2441913|NCT01113723|5990111|P2|STARTED|Overall Study||70
2441914|NCT01113723|5990112|P1|STARTED|Overall Study||70
2441915|NCT01113710|5990122|P1|NOT COMPLETED|Overall Study||269
2441916|NCT01113710|5990122|P1|COMPLETED|Overall Study|"Discontinued reasons for Other are listed in the Participant Flow."|418
2441917|NCT01113710|5990122|P1|STARTED|Overall Study|See Additional Study Description for further information regarding withdrawal due to Adverse Event.|687
2441918|NCT01113632|5990133|P2|NOT COMPLETED|Overall Study||25
2441919|NCT01113632|5990134|P1|NOT COMPLETED|Overall Study||31
2441920|NCT01113632|5990133|P2|COMPLETED|Overall Study||19
2441921|NCT01113632|5990134|P1|COMPLETED|Overall Study||2
2441922|NCT01113632|5990133|P2|STARTED|Overall Study||44
2441923|NCT01113632|5990134|P1|STARTED|Overall Study||33
2441924|NCT01113580|5990150|P2|NOT COMPLETED|Overall Study||0
2441925|NCT01113580|5990151|P1|NOT COMPLETED|Overall Study||1
2441926|NCT01113580|5990150|P2|COMPLETED|Overall Study||60
2441927|NCT01113580|5990151|P1|COMPLETED|Overall Study||59
2441928|NCT01113580|5990150|P2|STARTED|Overall Study||60
2441929|NCT01113580|5990151|P1|STARTED|Overall Study||60
2441930|NCT01113541|5990165|P1|NOT COMPLETED|Overall Study||13
2441931|NCT01113541|5990165|P1|COMPLETED|Overall Study||0
2441932|NCT01113541|5990165|P1|STARTED|Overall Study||13
2441933|NCT01113463|5990198|P1|NOT COMPLETED|Overall Study||5
2441934|NCT01113463|5990198|P1|COMPLETED|Overall Study||12
2441935|NCT01113463|5990198|P1|STARTED|Overall Study||17
2441936|NCT01113398|5990203|P1|NOT COMPLETED|Overall Study||0
2441937|NCT01113398|5990203|P1|COMPLETED|Overall Study|Completed= Discontinued study drug due to disease progression, death, toxicity or any other reason|36
2441938|NCT01113398|5990203|P1|STARTED|Overall Study||36
2441939|NCT01113385|5990210|P1|NOT COMPLETED|Overall Study||0
2441940|NCT01113385|5990210|P1|COMPLETED|Overall Study||7
2441941|NCT01113385|5990210|P1|STARTED|Overall Study||7
2441942|NCT01113008|5990217|P2|NOT COMPLETED|Overall Study||0
2441943|NCT01113008|5990218|P1|NOT COMPLETED|Overall Study||0
2441944|NCT01113008|5990217|P2|COMPLETED|Overall Study||133
2441945|NCT01113008|5990218|P1|COMPLETED|Overall Study||133
2441946|NCT01113008|5990217|P2|STARTED|Overall Study||133
2441947|NCT01113008|5990218|P1|STARTED|Overall Study||133
2441948|NCT01112982|5990228|P1|NOT COMPLETED|Overall Study||2
2441949|NCT01112982|5990228|P1|COMPLETED|Overall Study||72
2441950|NCT01112982|5990228|P1|STARTED|Overall Study||74
2441951|NCT01112917|5990240|P2|NOT COMPLETED|Overall Study||15
2441952|NCT01112917|5990241|P1|NOT COMPLETED|Overall Study||7
2441953|NCT01112917|5990240|P2|COMPLETED|Overall Study||38
2441954|NCT01112917|5990241|P1|COMPLETED|Overall Study||89
2441955|NCT01112917|5990240|P2|STARTED|Overall Study||53
2441956|NCT01112917|5990241|P1|STARTED|Overall Study||96
2441957|NCT01112865|5990246|P2|NOT COMPLETED|Second Intervention||0
2441958|NCT01112865|5990247|P1|NOT COMPLETED|Second Intervention||0
2441959|NCT01112865|5990246|P2|COMPLETED|Second Intervention||61
2441960|NCT01112865|5990247|P1|COMPLETED|Second Intervention||59
2441961|NCT01112865|5990246|P2|STARTED|Second Intervention||61
2441962|NCT01112865|5990247|P1|STARTED|Second Intervention||59
2441963|NCT01112865|5990246|P2|NOT COMPLETED|First Intervention||0
2441964|NCT01112865|5990247|P1|NOT COMPLETED|First Intervention||0
2441965|NCT01112865|5990246|P2|COMPLETED|First Intervention||61
2441966|NCT01112865|5990247|P1|COMPLETED|First Intervention||59
2441967|NCT01112865|5990246|P2|STARTED|First Intervention||61
2441968|NCT01112865|5990247|P1|STARTED|First Intervention||59
2441969|NCT01112735|5990259|P2|NOT COMPLETED|Overall Study||0
2441970|NCT01112735|5990260|P1|NOT COMPLETED|Overall Study||0
2441971|NCT01112735|5990259|P2|COMPLETED|Overall Study||20
2441972|NCT01112735|5990260|P1|COMPLETED|Overall Study||20
2441973|NCT01112735|5990259|P2|STARTED|Overall Study||20
2441974|NCT01112735|5990260|P1|STARTED|Overall Study||20
2441975|NCT01112696|5990284|P1|NOT COMPLETED|Overall Study||2
2441976|NCT01112696|5990284|P1|COMPLETED|Overall Study||98
2441977|NCT01112696|5990284|P1|STARTED|Overall Study||100
2441978|NCT01112683|5990291|P2|NOT COMPLETED|Overall Study||1
2441979|NCT01112683|5990292|P1|NOT COMPLETED|Overall Study||1
2441980|NCT01112683|5990291|P2|COMPLETED|Overall Study||19
2441981|NCT01112683|5990292|P1|COMPLETED|Overall Study||18
2441982|NCT01112683|5990291|P2|STARTED|Overall Study||20
2441983|NCT01112683|5990292|P1|STARTED|Overall Study||19
2441984|NCT01112670|5990302|P6|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
2441985|NCT01112670|5990303|P5|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
2441986|NCT01112670|5990304|P4|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
2441987|NCT01112670|5990305|P3|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
2441988|NCT01112670|5990306|P2|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
2441989|NCT01112670|5990307|P1|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
2441990|NCT01112670|5990302|P6|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||5
2441991|NCT01112670|5990303|P5|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
2441992|NCT01112670|5990304|P4|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||4
2441993|NCT01112670|5990305|P3|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
2441994|NCT01112670|5990306|P2|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||3
2441995|NCT01112670|5990307|P1|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
2441996|NCT01112670|5990302|P6|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||5
2441997|NCT01112670|5990303|P5|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
2441998|NCT01112670|5990304|P4|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||4
2441999|NCT01112670|5990305|P3|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
2442000|NCT01112670|5990306|P2|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||3
2442001|NCT01112670|5990307|P1|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
2442002|NCT01112670|5990302|P6|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
2442003|NCT01112670|5990303|P5|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
2442004|NCT01112670|5990304|P4|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
2442005|NCT01112670|5990305|P3|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
2442006|NCT01112670|5990306|P2|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
2442007|NCT01112670|5990307|P1|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
2442008|NCT01112670|5990302|P6|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
2442009|NCT01112670|5990303|P5|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||5
2442010|NCT01112670|5990304|P4|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
2442011|NCT01112670|5990305|P3|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||6
2442012|NCT01112670|5990306|P2|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
2442013|NCT01112670|5990307|P1|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||7
2442014|NCT01112670|5990302|P6|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
2442015|NCT01112670|5990303|P5|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||6
2442016|NCT01112670|5990304|P4|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
2442017|NCT01112670|5990305|P3|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||7
2442018|NCT01112670|5990306|P2|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
2442019|NCT01112670|5990307|P1|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||8
2442020|NCT01112579|5990345|P2|NOT COMPLETED|Overall Study||3
2442021|NCT01112579|5990346|P1|NOT COMPLETED|Overall Study||1
2442022|NCT01112579|5990345|P2|COMPLETED|Overall Study||21
2442023|NCT01112579|5990346|P1|COMPLETED|Overall Study||41
2442024|NCT01112579|5990345|P2|STARTED|Overall Study||24
2442025|NCT01112579|5990346|P1|STARTED|Overall Study||42
2442026|NCT01112514|5990356|P1|NOT COMPLETED|Overall Study||1
2442027|NCT01112514|5990356|P1|COMPLETED|Overall Study||3
2442028|NCT01112514|5990356|P1|STARTED|Overall Study||4
2442029|NCT01112358|5990362|P2|NOT COMPLETED|Overall Study||0
2442030|NCT01112358|5990363|P1|NOT COMPLETED|Overall Study||0
2442031|NCT01112358|5990362|P2|COMPLETED|Overall Study||33
2442032|NCT01112358|5990363|P1|COMPLETED|Overall Study||25
2442033|NCT01112358|5990362|P2|STARTED|Overall Study||33
2442034|NCT01112358|5990363|P1|STARTED|Overall Study||25
2442035|NCT01112267|5990401|P2|NOT COMPLETED|Overall Study||18
2442036|NCT01112267|5990402|P1|NOT COMPLETED|Overall Study||34
2442037|NCT01112267|5990401|P2|COMPLETED|Overall Study||104
2442038|NCT01112267|5990402|P1|COMPLETED|Overall Study||92
2442039|NCT01112267|5990401|P2|Treated|Overall Study||120
2442040|NCT01112267|5990402|P1|Treated|Overall Study||125
2442041|NCT01112267|5990401|P2|STARTED|Overall Study||122
2442042|NCT01112267|5990402|P1|STARTED|Overall Study||126
2442043|NCT01112241|5990420|P1|NOT COMPLETED|Overall Study||0
2442044|NCT01112241|5990420|P1|COMPLETED|Overall Study||17
2442045|NCT01112241|5990420|P1|STARTED|Overall Study||17
2442046|NCT01112059|5990435|P2|NOT COMPLETED|Overall Study||0
2442047|NCT01112059|5990436|P1|NOT COMPLETED|Overall Study||1
2442048|NCT01112059|5990435|P2|COMPLETED|Overall Study||20
2442049|NCT01112059|5990436|P1|COMPLETED|Overall Study||19
2442050|NCT01112059|5990435|P2|STARTED|Overall Study||20
2442051|NCT01112059|5990436|P1|STARTED|Overall Study||20
2442052|NCT01111851|5990450|P2|NOT COMPLETED|Overall Study||0
2442053|NCT01111851|5990451|P1|NOT COMPLETED|Overall Study||2
2442054|NCT01111851|5990450|P2|COMPLETED|Overall Study||8
2442055|NCT01111851|5990451|P1|COMPLETED|Overall Study||6
2442056|NCT01111851|5990450|P2|STARTED|Overall Study||8
2442057|NCT01111851|5990451|P1|STARTED|Overall Study||8
2442058|NCT01111838|5990463|P1|NOT COMPLETED|Overall Study||7
2442059|NCT01111838|5990463|P1|COMPLETED|Overall Study||15
2442060|NCT01111838|5990463|P1|STARTED|Overall Study||22
2442061|NCT01111825|5990471|P4|NOT COMPLETED|Overall Study||21
2442062|NCT01111825|5990472|P3|NOT COMPLETED|Overall Study||8
2442063|NCT01111825|5990473|P2|NOT COMPLETED|Overall Study||1
2442064|NCT01111825|5990474|P1|NOT COMPLETED|Overall Study||3
2442065|NCT01111825|5990471|P4|COMPLETED|Overall Study||27
2442066|NCT01111825|5990472|P3|COMPLETED|Overall Study||29
2442067|NCT01111825|5990473|P2|COMPLETED|Overall Study||5
2442068|NCT01111825|5990474|P1|COMPLETED|Overall Study||5
2442069|NCT01111825|5990471|P4|STARTED|Overall Study||48
2442070|NCT01111825|5990472|P3|STARTED|Overall Study||37
2442071|NCT01111825|5990473|P2|STARTED|Overall Study||6
2442072|NCT01111825|5990474|P1|STARTED|Overall Study||8
2442073|NCT01111604|5990496|P3|NOT COMPLETED|Overall Study||3
2442074|NCT01111604|5990497|P2|NOT COMPLETED|Overall Study||0
2442075|NCT01111604|5990498|P1|NOT COMPLETED|Overall Study||8
2442076|NCT01111604|5990496|P3|COMPLETED|Overall Study||49
2442077|NCT01111604|5990497|P2|COMPLETED|Overall Study||52
2442078|NCT01111604|5990498|P1|COMPLETED|Overall Study||46
2442079|NCT01111604|5990496|P3|Received at Least One Dose of Study Drug|Overall Study||52
2442080|NCT01111604|5990497|P2|Received at Least One Dose of Study Drug|Overall Study||52
2442081|NCT01111604|5990498|P1|Received at Least One Dose of Study Drug|Overall Study||49
2442082|NCT01111604|5990496|P3|STARTED|Overall Study||52
2442083|NCT01111604|5990497|P2|STARTED|Overall Study||52
2442084|NCT01111604|5990498|P1|STARTED|Overall Study||54
2442085|NCT01111526|5990536|P3|NOT COMPLETED|Overall Study||2
2442086|NCT01111526|5990537|P2|NOT COMPLETED|Overall Study||1
2442087|NCT01111526|5990538|P1|NOT COMPLETED|Overall Study||0
2442088|NCT01111526|5990536|P3|COMPLETED|Overall Study||8
2442089|NCT01111526|5990537|P2|COMPLETED|Overall Study||7
2442090|NCT01111526|5990538|P1|COMPLETED|Overall Study||4
2442091|NCT01111526|5990536|P3|STARTED|Overall Study||10
2442092|NCT01111526|5990537|P2|STARTED|Overall Study||8
2442093|NCT01111526|5990538|P1|STARTED|Overall Study||4
2442094|NCT01111461|5990550|P1|NOT COMPLETED|Overall Study||51
2442095|NCT01111461|5990550|P1|COMPLETED|Overall Study|On treatment at data cut-off or on treatment until disease progression|82
2442096|NCT01111461|5990550|P1|STARTED|Overall Study||133
2442097|NCT01111370|5990563|P1|NOT COMPLETED|Overall Study||2
2442098|NCT01111370|5990563|P1|COMPLETED|Overall Study||58
2442099|NCT01111370|5990563|P1|STARTED|Overall Study||60
2442100|NCT01111331|5990567|P2|NOT COMPLETED|Overall Study||0
2442101|NCT01111331|5990568|P1|NOT COMPLETED|Overall Study||0
2442102|NCT01111331|5990567|P2|COMPLETED|Overall Study||9
2442103|NCT01111331|5990568|P1|COMPLETED|Overall Study||9
2442104|NCT01111331|5990567|P2|STARTED|Overall Study||9
2442105|NCT01111331|5990568|P1|STARTED|Overall Study||9
2442106|NCT01111318|5990650|P4|NOT COMPLETED|Overall Study||0
2442107|NCT01111318|5990651|P3|NOT COMPLETED|Overall Study||0
2442108|NCT01111318|5990652|P2|NOT COMPLETED|Overall Study||0
2442109|NCT01111318|5990653|P1|NOT COMPLETED|Overall Study||0
2442110|NCT01111318|5990650|P4|COMPLETED|Overall Study||8
2442111|NCT01111318|5990651|P3|COMPLETED|Overall Study||8
2442112|NCT01111318|5990652|P2|COMPLETED|Overall Study||8
2442113|NCT01111318|5990653|P1|COMPLETED|Overall Study||12
2442114|NCT01111318|5990650|P4|STARTED|Overall Study||8
2442115|NCT01111318|5990651|P3|STARTED|Overall Study||8
2442116|NCT01111318|5990652|P2|STARTED|Overall Study||8
2442117|NCT01111318|5990653|P1|STARTED|Overall Study||12
2442118|NCT01111305|5990717|P2|NOT COMPLETED|Overall Study||0
2442119|NCT01111305|5990718|P1|NOT COMPLETED|Overall Study||0
2442120|NCT01111305|5990717|P2|COMPLETED|Overall Study||4
2442121|NCT01111305|5990718|P1|COMPLETED|Overall Study||4
2442122|NCT01111305|5990717|P2|STARTED|Overall Study||4
2442123|NCT01111305|5990718|P1|STARTED|Overall Study||4
2442124|NCT01111292|5990730|P2|NOT COMPLETED|Follow-Up||0
2442125|NCT01111292|5990731|P1|NOT COMPLETED|Follow-Up||0
2442126|NCT01111292|5990730|P2|COMPLETED|Follow-Up||1
2442127|NCT01111292|5990731|P1|COMPLETED|Follow-Up||2
2442128|NCT01111292|5990730|P2|STARTED|Follow-Up||1
2442129|NCT01111292|5990731|P1|STARTED|Follow-Up||2
2442130|NCT01111292|5990730|P2|NOT COMPLETED|Post Treatment Biopsy||0
2442131|NCT01111292|5990731|P1|NOT COMPLETED|Post Treatment Biopsy||0
2442132|NCT01111292|5990730|P2|COMPLETED|Post Treatment Biopsy||1
2442133|NCT01111292|5990731|P1|COMPLETED|Post Treatment Biopsy||2
2442134|NCT01111292|5990730|P2|STARTED|Post Treatment Biopsy||1
2442135|NCT01111292|5990731|P1|STARTED|Post Treatment Biopsy||2
2442136|NCT01111292|5990730|P2|NOT COMPLETED|Treatment||1
2442137|NCT01111292|5990731|P1|NOT COMPLETED|Treatment||1
2442138|NCT01111292|5990730|P2|COMPLETED|Treatment||1
2442139|NCT01111292|5990731|P1|COMPLETED|Treatment||2
2442140|NCT01111292|5990730|P2|STARTED|Treatment||2
2442141|NCT01111292|5990731|P1|STARTED|Treatment||3
2442142|NCT01111292|5990730|P2|NOT COMPLETED|Randomization||0
2442143|NCT01111292|5990731|P1|NOT COMPLETED|Randomization||0
2442144|NCT01111292|5990730|P2|COMPLETED|Randomization||2
2442145|NCT01111292|5990731|P1|COMPLETED|Randomization||3
2442146|NCT01111292|5990730|P2|STARTED|Randomization||2
2442147|NCT01111292|5990731|P1|STARTED|Randomization||3
2442148|NCT01111240|5990737|P1|NOT COMPLETED|Overall Study||1066
2442149|NCT01111240|5990737|P1|COMPLETED|Overall Study||3569
2442150|NCT01111240|5990737|P1|STARTED|Overall Study||4635
2442151|NCT01111162|5990759|P1|NOT COMPLETED|Overall Study||0
2442152|NCT01111162|5990759|P1|COMPLETED|Overall Study||120
2442153|NCT01111162|5990759|P1|STARTED|Overall Study||120
2442154|NCT01111149|5990767|P3|NOT COMPLETED|Overall Study||4
2442155|NCT01111149|5990768|P2|NOT COMPLETED|Overall Study||1
2442156|NCT01111149|5990769|P1|NOT COMPLETED|Overall Study||2
2442157|NCT01111149|5990767|P3|COMPLETED|Overall Study||5
2442158|NCT01111149|5990768|P2|COMPLETED|Overall Study||5
2442159|NCT01111149|5990769|P1|COMPLETED|Overall Study||7
2442160|NCT01111149|5990767|P3|STARTED|Overall Study||9
2442161|NCT01111149|5990768|P2|STARTED|Overall Study||6
2442162|NCT01111149|5990769|P1|STARTED|Overall Study||9
2442163|NCT01111123|5990845|P2|NOT COMPLETED|Maintenance Phase||2
2442164|NCT01111123|5990846|P1|NOT COMPLETED|Maintenance Phase||0
2442165|NCT01111123|5990845|P2|COMPLETED|Maintenance Phase||18
2442166|NCT01111123|5990846|P1|COMPLETED|Maintenance Phase||21
2442167|NCT01111123|5990845|P2|STARTED|Maintenance Phase||20
2442168|NCT01111123|5990846|P1|STARTED|Maintenance Phase||21
2442169|NCT01111123|5990845|P2|NOT COMPLETED|Open- Label Phase||0
2442170|NCT01111123|5990846|P1|NOT COMPLETED|Open- Label Phase||14
2442171|NCT01111123|5990845|P2|COMPLETED|Open- Label Phase||0
2442172|NCT01111123|5990846|P1|COMPLETED|Open- Label Phase||41
2442173|NCT01111123|5990845|P2|STARTED|Open- Label Phase||0
2442174|NCT01111123|5990846|P1|STARTED|Open- Label Phase||55
2442175|NCT01111110|5990856|P2|NOT COMPLETED|Overall Study||0
2442176|NCT01111110|5990857|P1|NOT COMPLETED|Overall Study||0
2442177|NCT01111110|5990856|P2|COMPLETED|Overall Study||4
2442178|NCT01111110|5990857|P1|COMPLETED|Overall Study||3
2442179|NCT01111110|5990856|P2|STARTED|Overall Study||4
2442180|NCT01111110|5990857|P1|STARTED|Overall Study||3
2442181|NCT01111019|5990867|P1|NOT COMPLETED|Overall Study||3
2442182|NCT01111019|5990867|P1|COMPLETED|Overall Study||16
2442183|NCT01111019|5990867|P1|STARTED|Overall Study||19
2442184|NCT01110967|5990886|P1|NOT COMPLETED|Overall Study||9
2442185|NCT01110967|5990886|P1|COMPLETED|Overall Study||31
2442186|NCT01110967|5990886|P1|12 Months Follow up|Overall Study||31
2442187|NCT01110967|5990886|P1|6 Months Follow up|Overall Study||24
2442188|NCT01110967|5990886|P1|3 Months Follow up|Overall Study||28
2442189|NCT01110967|5990886|P1|1 Month Follow up|Overall Study||26
2442190|NCT01110967|5990886|P1|Surgery|Overall Study||40
2442191|NCT01110967|5990886|P1|STARTED|Overall Study||40
2442192|NCT01110915|5990899|P2|NOT COMPLETED|Overall Study||2
2442193|NCT01110915|5990900|P1|NOT COMPLETED|Overall Study||10
2442194|NCT01110915|5990899|P2|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|84
2442195|NCT01110915|5990900|P1|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|167
2442196|NCT01110915|5990899|P2|STARTED|Overall Study|Subjects being randomized to the Control group.|86
2442197|NCT01110915|5990900|P1|STARTED|Overall Study|Subjects being randomized to the MRI group.|177
2442198|NCT01110707|5990917|P2|NOT COMPLETED|Overall Study||3
2442199|NCT01110707|5990918|P1|NOT COMPLETED|Overall Study||0
2442200|NCT01110707|5990917|P2|COMPLETED|Overall Study||65
2442201|NCT01110707|5990918|P1|COMPLETED|Overall Study||63
2442202|NCT01110707|5990917|P2|STARTED|Overall Study||68
2442203|NCT01110707|5990918|P1|STARTED|Overall Study||63
2442204|NCT01110681|5990940|P1|NOT COMPLETED|Overall Study||32
2442205|NCT01110681|5990940|P1|COMPLETED|Overall Study||83
2442206|NCT01110681|5990940|P1|STARTED|Overall Study||115
2442207|NCT01110499|5990956|P8|NOT COMPLETED|Overall Study||0
2442208|NCT01110499|5990957|P7|NOT COMPLETED|Overall Study||0
2442209|NCT01110499|5990958|P6|NOT COMPLETED|Overall Study||0
2442210|NCT01110499|5990959|P5|NOT COMPLETED|Overall Study||0
2442211|NCT01110499|5990960|P4|NOT COMPLETED|Overall Study||0
2442212|NCT01110499|5990961|P3|NOT COMPLETED|Overall Study||0
2442213|NCT01110499|5990962|P2|NOT COMPLETED|Overall Study||0
2442214|NCT01110499|5990963|P1|NOT COMPLETED|Overall Study||0
2442215|NCT01110499|5990956|P8|COMPLETED|Overall Study||40
2442216|NCT01110499|5990957|P7|COMPLETED|Overall Study||39
2442217|NCT01110499|5990958|P6|COMPLETED|Overall Study||14
2442218|NCT01110499|5990959|P5|COMPLETED|Overall Study||14
2442219|NCT01110499|5990960|P4|COMPLETED|Overall Study||14
2442220|NCT01110499|5990961|P3|COMPLETED|Overall Study||14
2442221|NCT01110499|5990962|P2|COMPLETED|Overall Study||14
2442222|NCT01110499|5990963|P1|COMPLETED|Overall Study||14
2442223|NCT01110499|5990956|P8|STARTED|Overall Study||40
2442224|NCT01110499|5990957|P7|STARTED|Overall Study||39
2442225|NCT01110499|5990958|P6|STARTED|Overall Study||14
2442226|NCT01110499|5990959|P5|STARTED|Overall Study||14
2442227|NCT01110499|5990960|P4|STARTED|Overall Study||14
2442228|NCT01110499|5990961|P3|STARTED|Overall Study||14
2442229|NCT01110499|5990962|P2|STARTED|Overall Study||14
2442230|NCT01110499|5990963|P1|STARTED|Overall Study||14
2442231|NCT01110421|5990985|P2|NOT COMPLETED|Overall Study||0
2442232|NCT01110421|5990986|P1|NOT COMPLETED|Overall Study||0
2442233|NCT01110421|5990985|P2|COMPLETED|Overall Study||2
2442234|NCT01110421|5990986|P1|COMPLETED|Overall Study|Includes 1 participant who discontinued study drug due to an adverse event of empyema on Days 9-13.|5
2442235|NCT01110421|5990985|P2|STARTED|Overall Study||2
2442236|NCT01110421|5990986|P1|STARTED|Overall Study||5
2442237|NCT01110408|5991006|P2|NOT COMPLETED|Overall Study||0
2442238|NCT01110408|5991007|P1|NOT COMPLETED|Overall Study||1
2442239|NCT01110408|5991006|P2|COMPLETED|Overall Study||10
2442240|NCT01110408|5991007|P1|COMPLETED|Overall Study||30
2442241|NCT01110408|5991006|P2|STARTED|Overall Study||10
2442242|NCT01110408|5991007|P1|STARTED|Overall Study||31
2442243|NCT01110382|5991027|P2|NOT COMPLETED|Overall Study||2
2442244|NCT01110382|5991028|P1|NOT COMPLETED|Overall Study||0
2442245|NCT01110382|5991027|P2|COMPLETED|Overall Study||8
2442246|NCT01110382|5991028|P1|COMPLETED|Overall Study||31
2442247|NCT01110382|5991027|P2|STARTED|Overall Study||10
2442248|NCT01110382|5991028|P1|STARTED|Overall Study||31
2442249|NCT01110330|5991049|P3|NOT COMPLETED|Overall Study||26
2442250|NCT01110330|5991050|P2|NOT COMPLETED|Overall Study||23
2442251|NCT01110330|5991051|P1|NOT COMPLETED|Overall Study||15
2442252|NCT01110330|5991049|P3|COMPLETED|Overall Study||208
2442253|NCT01110330|5991050|P2|COMPLETED|Overall Study||207
2442254|NCT01110330|5991051|P1|COMPLETED|Overall Study||104
2442255|NCT01110330|5991049|P3|Positive Baseline Culture Set|Overall Study||114
2442256|NCT01110330|5991050|P2|Positive Baseline Culture Set|Overall Study||111
2442257|NCT01110330|5991051|P1|Positive Baseline Culture Set|Overall Study||56
2442258|NCT01110330|5991049|P3|STARTED|Overall Study||234
2442259|NCT01110330|5991050|P2|STARTED|Overall Study||230
2442260|NCT01110330|5991051|P1|STARTED|Overall Study||119
2442261|NCT01110252|5991062|P1|NOT COMPLETED|Post-procedure (Stem Cells Infusion)||0
2442262|NCT01110252|5991062|P1|COMPLETED|Post-procedure (Stem Cells Infusion)||4
2442263|NCT01110252|5991062|P1|STARTED|Post-procedure (Stem Cells Infusion)||4
2442264|NCT01110252|5991062|P1|NOT COMPLETED|Pre-procedure (Stem Cells Infusion)||0
2442265|NCT01110252|5991062|P1|COMPLETED|Pre-procedure (Stem Cells Infusion)||4
2442266|NCT01110252|5991062|P1|STARTED|Pre-procedure (Stem Cells Infusion)||4
2442267|NCT01110239|5991079|P4|NOT COMPLETED|10 Min Ischemia||0
2442268|NCT01110239|5991080|P3|NOT COMPLETED|10 Min Ischemia||0
2442269|NCT01110239|5991081|P2|NOT COMPLETED|10 Min Ischemia||0
2442270|NCT01110239|5991082|P1|NOT COMPLETED|10 Min Ischemia||0
2442271|NCT01110239|5991079|P4|COMPLETED|10 Min Ischemia||6
2442272|NCT01110239|5991080|P3|COMPLETED|10 Min Ischemia||0
2442273|NCT01110239|5991081|P2|COMPLETED|10 Min Ischemia||0
2442274|NCT01110239|5991082|P1|COMPLETED|10 Min Ischemia||0
2442275|NCT01110239|5991079|P4|STARTED|10 Min Ischemia||6
2442276|NCT01110239|5991080|P3|STARTED|10 Min Ischemia||0
2442277|NCT01110239|5991081|P2|STARTED|10 Min Ischemia||0
2442278|NCT01110239|5991082|P1|STARTED|10 Min Ischemia||0
2442279|NCT01110239|5991079|P4|NOT COMPLETED|7.5 Min Ischemia||0
2442280|NCT01110239|5991080|P3|NOT COMPLETED|7.5 Min Ischemia||1
2442281|NCT01110239|5991081|P2|NOT COMPLETED|7.5 Min Ischemia||0
2442282|NCT01110239|5991082|P1|NOT COMPLETED|7.5 Min Ischemia||0
2442283|NCT01110239|5991079|P4|COMPLETED|7.5 Min Ischemia||0
2442284|NCT01110239|5991080|P3|COMPLETED|7.5 Min Ischemia||6
2442285|NCT01110239|5991081|P2|COMPLETED|7.5 Min Ischemia||0
2442286|NCT01110239|5991082|P1|COMPLETED|7.5 Min Ischemia||0
2442287|NCT01110239|5991079|P4|STARTED|7.5 Min Ischemia||0
2442288|NCT01110239|5991080|P3|STARTED|7.5 Min Ischemia||7
2442289|NCT01110239|5991081|P2|STARTED|7.5 Min Ischemia||0
2442290|NCT01110239|5991082|P1|STARTED|7.5 Min Ischemia||0
2442291|NCT01110239|5991079|P4|NOT COMPLETED|5 Min Ischemia||0
2442292|NCT01110239|5991080|P3|NOT COMPLETED|5 Min Ischemia||0
2442293|NCT01110239|5991081|P2|NOT COMPLETED|5 Min Ischemia||14
2442294|NCT01110239|5991082|P1|NOT COMPLETED|5 Min Ischemia||0
2442295|NCT01110239|5991079|P4|COMPLETED|5 Min Ischemia||0
2442296|NCT01110239|5991080|P3|COMPLETED|5 Min Ischemia||0
2442297|NCT01110239|5991081|P2|COMPLETED|5 Min Ischemia||0
2442298|NCT01110239|5991082|P1|COMPLETED|5 Min Ischemia||0
2442299|NCT01110239|5991079|P4|STARTED|5 Min Ischemia||0
2442300|NCT01110239|5991080|P3|STARTED|5 Min Ischemia||0
2442301|NCT01110239|5991081|P2|STARTED|5 Min Ischemia||14
2442302|NCT01110239|5991082|P1|STARTED|5 Min Ischemia||0
2442303|NCT01110239|5991079|P4|NOT COMPLETED|Sham Preconditioning||0
2442304|NCT01110239|5991080|P3|NOT COMPLETED|Sham Preconditioning||1
2442305|NCT01110239|5991081|P2|NOT COMPLETED|Sham Preconditioning||0
2442306|NCT01110239|5991082|P1|NOT COMPLETED|Sham Preconditioning||0
2442307|NCT01110239|5991079|P4|COMPLETED|Sham Preconditioning||6
2442308|NCT01110239|5991080|P3|COMPLETED|Sham Preconditioning||6
2442309|NCT01110239|5991081|P2|COMPLETED|Sham Preconditioning||14
2442310|NCT01110239|5991082|P1|COMPLETED|Sham Preconditioning||7
2442311|NCT01110239|5991079|P4|STARTED|Sham Preconditioning||6
2442312|NCT01110239|5991080|P3|STARTED|Sham Preconditioning||7
2442313|NCT01110239|5991081|P2|STARTED|Sham Preconditioning||14
2442314|NCT01110239|5991082|P1|STARTED|Sham Preconditioning||7
2442315|NCT01110200|5991098|P2|NOT COMPLETED|Overall Study||121
2442316|NCT01110200|5991099|P1|NOT COMPLETED|Overall Study||106
2442317|NCT01110200|5991098|P2|COMPLETED|Overall Study||204
2442318|NCT01110200|5991099|P1|COMPLETED|Overall Study||208
2442319|NCT01110200|5991098|P2|STARTED|Overall Study||325
2442320|NCT01110200|5991099|P1|STARTED|Overall Study||314
2442321|NCT01110187|5991115|P2|NOT COMPLETED|Overall Study||0
2442322|NCT01110187|5991116|P1|NOT COMPLETED|Overall Study||0
2442323|NCT01110187|5991115|P2|COMPLETED|Overall Study|completed 7 day treatment|4
2442324|NCT01110187|5991116|P1|COMPLETED|Overall Study|completed 7 day treatment|7
2442325|NCT01110187|5991115|P2|STARTED|Overall Study||4
2442326|NCT01110187|5991116|P1|STARTED|Overall Study||7
2442327|NCT01110174|5991124|P1|NOT COMPLETED|Overall Study||0
2442328|NCT01110174|5991124|P1|COMPLETED|Overall Study||8
2442329|NCT01110174|5991124|P1|STARTED|Overall Study||8
2442330|NCT01110135|5991129|P1|NOT COMPLETED|Overall Study||9
2442331|NCT01110135|5991129|P1|COMPLETED|Overall Study||34
2442332|NCT01110135|5991129|P1|STARTED|Overall Study||43
2442333|NCT01110005|5991135|P2|NOT COMPLETED|Overall Study||5
2442334|NCT01110005|5991136|P1|NOT COMPLETED|Overall Study||4
2442335|NCT01110005|5991135|P2|COMPLETED|Overall Study||156
2442336|NCT01110005|5991136|P1|COMPLETED|Overall Study||153
2442337|NCT01110005|5991135|P2|STARTED|Overall Study||161
2442338|NCT01110005|5991136|P1|STARTED|Overall Study||157
2442339|NCT01109992|5991148|P2|NOT COMPLETED|Overall Study||2
2442340|NCT01109992|5991149|P1|NOT COMPLETED|Overall Study||0
2442341|NCT01109992|5991148|P2|COMPLETED|Overall Study||30
2442342|NCT01109992|5991149|P1|COMPLETED|Overall Study||11
2442343|NCT01109992|5991148|P2|Subjects Enrolled|Overall Study||32
2442344|NCT01109992|5991149|P1|Subjects Enrolled|Overall Study||11
2442345|NCT01109992|5991148|P2|STARTED|Overall Study||32
2442346|NCT01109992|5991149|P1|STARTED|Overall Study||11
2442347|NCT01109979|5991163|P2|NOT COMPLETED|Overall Study||1
2442348|NCT01109979|5991164|P1|NOT COMPLETED|Overall Study||2
2442349|NCT01109979|5991163|P2|COMPLETED|Overall Study||11
2442350|NCT01109979|5991164|P1|COMPLETED|Overall Study||10
2442351|NCT01109979|5991163|P2|STARTED|Overall Study||12
2442352|NCT01109979|5991164|P1|STARTED|Overall Study||12
2442353|NCT01109849|5991172|P5|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
2442354|NCT01109849|5991173|P4|NOT COMPLETED|Adaptive Randomization: Weight Recovery||3
2442355|NCT01109849|5991174|P3|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
2442356|NCT01109849|5991175|P2|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
2442357|NCT01109849|5991176|P1|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
2442358|NCT01109849|5991172|P5|COMPLETED|Adaptive Randomization: Weight Recovery||24
2442359|NCT01109849|5991173|P4|COMPLETED|Adaptive Randomization: Weight Recovery||20
2442360|NCT01109849|5991174|P3|COMPLETED|Adaptive Randomization: Weight Recovery||23
2442361|NCT01109849|5991175|P2|COMPLETED|Adaptive Randomization: Weight Recovery||0
2442362|NCT01109849|5991176|P1|COMPLETED|Adaptive Randomization: Weight Recovery||0
2442363|NCT01109849|5991172|P5|STARTED|Adaptive Randomization: Weight Recovery||25
2442364|NCT01109849|5991173|P4|STARTED|Adaptive Randomization: Weight Recovery||23
2442365|NCT01109849|5991174|P3|STARTED|Adaptive Randomization: Weight Recovery||24
2442366|NCT01109849|5991175|P2|STARTED|Adaptive Randomization: Weight Recovery||0
2442367|NCT01109849|5991176|P1|STARTED|Adaptive Randomization: Weight Recovery||0
2442368|NCT01109849|5991172|P5|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
2442369|NCT01109849|5991173|P4|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
2442370|NCT01109849|5991174|P3|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
2442371|NCT01109849|5991175|P2|NOT COMPLETED|Initial Randomization: ADHD Treatment||49
2442372|NCT01109849|5991176|P1|NOT COMPLETED|Initial Randomization: ADHD Treatment||18
2442373|NCT01109849|5991172|P5|COMPLETED|Initial Randomization: ADHD Treatment||0
2442374|NCT01109849|5991173|P4|COMPLETED|Initial Randomization: ADHD Treatment||0
2442375|NCT01109849|5991174|P3|COMPLETED|Initial Randomization: ADHD Treatment||0
2442376|NCT01109849|5991175|P2|COMPLETED|Initial Randomization: ADHD Treatment||131
2442377|NCT01109849|5991176|P1|COMPLETED|Initial Randomization: ADHD Treatment||32
2442378|NCT01109849|5991172|P5|STARTED|Initial Randomization: ADHD Treatment||0
2442379|NCT01109849|5991173|P4|STARTED|Initial Randomization: ADHD Treatment||0
2442380|NCT01109849|5991174|P3|STARTED|Initial Randomization: ADHD Treatment||0
2442381|NCT01109849|5991175|P2|STARTED|Initial Randomization: ADHD Treatment||180
2442382|NCT01109849|5991176|P1|STARTED|Initial Randomization: ADHD Treatment||50
2442383|NCT01109602|5991228|P3|NOT COMPLETED|Overall Study||1
2442384|NCT01109602|5991229|P2|NOT COMPLETED|Overall Study||2
2442385|NCT01109602|5991230|P1|NOT COMPLETED|Overall Study||1
2442386|NCT01109602|5991228|P3|COMPLETED|Overall Study||9
2442387|NCT01109602|5991229|P2|COMPLETED|Overall Study||21
2442388|NCT01109602|5991230|P1|COMPLETED|Overall Study||13
2442389|NCT01109602|5991228|P3|STARTED|Overall Study||10
2442390|NCT01109602|5991229|P2|STARTED|Overall Study||23
2442391|NCT01109602|5991230|P1|STARTED|Overall Study||14
2442392|NCT01109576|5991241|P1|NOT COMPLETED|Overall Study||1
2442393|NCT01109576|5991241|P1|COMPLETED|Overall Study||12
2442394|NCT01109576|5991241|P1|STARTED|Overall Study||13
2442395|NCT01109524|5991245|P1|NOT COMPLETED|Overall Study||57
2442396|NCT01109524|5991245|P1|COMPLETED|Overall Study||3
2442397|NCT01109524|5991245|P1|STARTED|Overall Study||60
2442398|NCT01109381|5991255|P1|NOT COMPLETED|Overall Study||2
2442399|NCT01109381|5991255|P1|COMPLETED|Overall Study||31
2442400|NCT01109381|5991255|P1|STARTED|Overall Study||33
2442401|NCT01109316|5991267|P6|NOT COMPLETED|Study Period 3||0
2442402|NCT01109316|5991268|P5|NOT COMPLETED|Study Period 3||2
2442403|NCT01109316|5991269|P4|NOT COMPLETED|Study Period 3||0
2442404|NCT01109316|5991270|P3|NOT COMPLETED|Study Period 3||0
2442405|NCT01109316|5991271|P2|NOT COMPLETED|Study Period 3||0
2442406|NCT01109316|5991272|P1|NOT COMPLETED|Study Period 3||1
2442407|NCT01109316|5991267|P6|COMPLETED|Study Period 3||19
2442408|NCT01109316|5991268|P5|COMPLETED|Study Period 3||18
2442409|NCT01109316|5991269|P4|COMPLETED|Study Period 3||20
2442410|NCT01109316|5991270|P3|COMPLETED|Study Period 3||18
2442411|NCT01109316|5991271|P2|COMPLETED|Study Period 3||21
2442412|NCT01109316|5991272|P1|COMPLETED|Study Period 3||20
2442413|NCT01109316|5991267|P6|STARTED|Study Period 3||19
2442414|NCT01109316|5991268|P5|STARTED|Study Period 3||20
2442415|NCT01109316|5991269|P4|STARTED|Study Period 3||20
2442416|NCT01109316|5991270|P3|STARTED|Study Period 3||18
2442417|NCT01109316|5991271|P2|STARTED|Study Period 3||21
2442418|NCT01109316|5991272|P1|STARTED|Study Period 3||21
2442419|NCT01109316|5991267|P6|NOT COMPLETED|Study Period 2||1
2442420|NCT01109316|5991268|P5|NOT COMPLETED|Study Period 2||0
2442421|NCT01109316|5991269|P4|NOT COMPLETED|Study Period 2||1
2442422|NCT01109316|5991270|P3|NOT COMPLETED|Study Period 2||1
2442423|NCT01109316|5991271|P2|NOT COMPLETED|Study Period 2||1
2442424|NCT01109316|5991272|P1|NOT COMPLETED|Study Period 2||1
2442425|NCT01109316|5991267|P6|COMPLETED|Study Period 2||19
2442426|NCT01109316|5991268|P5|COMPLETED|Study Period 2||20
2442427|NCT01109316|5991269|P4|COMPLETED|Study Period 2||20
2442428|NCT01109316|5991270|P3|COMPLETED|Study Period 2||18
2442429|NCT01109316|5991271|P2|COMPLETED|Study Period 2||21
2442430|NCT01109316|5991272|P1|COMPLETED|Study Period 2||21
2442431|NCT01109316|5991267|P6|STARTED|Study Period 2||20
2442432|NCT01109316|5991268|P5|STARTED|Study Period 2||20
2442433|NCT01109316|5991269|P4|STARTED|Study Period 2||21
2442434|NCT01109316|5991270|P3|STARTED|Study Period 2||19
2442435|NCT01109316|5991271|P2|STARTED|Study Period 2||22
2442436|NCT01109316|5991272|P1|STARTED|Study Period 2||22
2442437|NCT01109316|5991267|P6|NOT COMPLETED|Study Period 1||2
2442438|NCT01109316|5991268|P5|NOT COMPLETED|Study Period 1||2
2442439|NCT01109316|5991269|P4|NOT COMPLETED|Study Period 1||1
2442440|NCT01109316|5991270|P3|NOT COMPLETED|Study Period 1||3
2442441|NCT01109316|5991271|P2|NOT COMPLETED|Study Period 1||0
2442442|NCT01109316|5991272|P1|NOT COMPLETED|Study Period 1||0
2442443|NCT01109316|5991267|P6|COMPLETED|Study Period 1||20
2442444|NCT01109316|5991268|P5|COMPLETED|Study Period 1||20
2442445|NCT01109316|5991269|P4|COMPLETED|Study Period 1||21
2442446|NCT01109316|5991270|P3|COMPLETED|Study Period 1||19
2442447|NCT01109316|5991271|P2|COMPLETED|Study Period 1||22
2442448|NCT01109316|5991272|P1|COMPLETED|Study Period 1||22
2442449|NCT01109316|5991267|P6|Received at Least One Dose of Study Drug|Study Period 1||20
2442450|NCT01109316|5991268|P5|Received at Least One Dose of Study Drug|Study Period 1||22
2442451|NCT01109316|5991269|P4|Received at Least One Dose of Study Drug|Study Period 1||22
2442452|NCT01109316|5991270|P3|Received at Least One Dose of Study Drug|Study Period 1||22
2442453|NCT01109316|5991271|P2|Received at Least One Dose of Study Drug|Study Period 1||22
2442454|NCT01109316|5991272|P1|Received at Least One Dose of Study Drug|Study Period 1||22
2442455|NCT01109316|5991267|P6|STARTED|Study Period 1||22
2442456|NCT01109316|5991268|P5|STARTED|Study Period 1||22
2442457|NCT01109316|5991269|P4|STARTED|Study Period 1||22
2442458|NCT01109316|5991270|P3|STARTED|Study Period 1||22
2442459|NCT01109316|5991271|P2|STARTED|Study Period 1||22
2442460|NCT01109316|5991272|P1|STARTED|Study Period 1||22
2442461|NCT01109173|5991320|P4|NOT COMPLETED|Overall Study||93
2442462|NCT01109173|5991321|P3|NOT COMPLETED|Overall Study||101
2442463|NCT01109173|5991322|P2|NOT COMPLETED|Overall Study||86
2442464|NCT01109173|5991323|P1|NOT COMPLETED|Overall Study||88
2442465|NCT01109173|5991320|P4|COMPLETED|Overall Study||120
2442466|NCT01109173|5991321|P3|COMPLETED|Overall Study||110
2442467|NCT01109173|5991322|P2|COMPLETED|Overall Study||759
2442468|NCT01109173|5991323|P1|COMPLETED|Overall Study||763
2442469|NCT01109173|5991320|P4|STARTED|Overall Study||213
2442470|NCT01109173|5991321|P3|STARTED|Overall Study||211
2442471|NCT01109173|5991322|P2|STARTED|Overall Study||845
2442472|NCT01109173|5991323|P1|STARTED|Overall Study||851
2442473|NCT01109147|5991340|P3|NOT COMPLETED|Overall Study||10
2442474|NCT01109147|5991341|P2|NOT COMPLETED|Overall Study||3
2442475|NCT01109147|5991342|P1|NOT COMPLETED|Overall Study||2
2442476|NCT01109147|5991340|P3|COMPLETED|Overall Study|10 have been excluded of the results|26
2442477|NCT01109147|5991341|P2|COMPLETED|Overall Study|3 have been excluded of the results|11
2442478|NCT01109147|5991342|P1|COMPLETED|Overall Study|2 have been excluded of the results|15
2442479|NCT01109147|5991340|P3|STARTED|Overall Study||36
2442480|NCT01109147|5991341|P2|STARTED|Overall Study||14
2442481|NCT01109147|5991342|P1|STARTED|Overall Study||17
2442482|NCT01109108|5991352|P2|NOT COMPLETED|Overall Study||0
2442483|NCT01109108|5991353|P1|NOT COMPLETED|Overall Study||0
2442484|NCT01109108|5991352|P2|COMPLETED|Overall Study||4755
2442485|NCT01109108|5991353|P1|COMPLETED|Overall Study||4035
2442486|NCT01109108|5991352|P2|STARTED|Overall Study||4755
2442487|NCT01109108|5991353|P1|STARTED|Overall Study||4035
2442488|NCT01109056|5991361|P2|NOT COMPLETED|Overall Study||5
2442489|NCT01109056|5991362|P1|NOT COMPLETED|Overall Study||7
2442490|NCT01109056|5991361|P2|COMPLETED|Overall Study||53
2442491|NCT01109056|5991362|P1|COMPLETED|Overall Study||50
2442492|NCT01109056|5991361|P2|STARTED|Overall Study||58
2442493|NCT01109056|5991362|P1|STARTED|Overall Study||57
2442494|NCT01109004|5991375|P3|NOT COMPLETED|Overall Study||0
2442495|NCT01109004|5991376|P2|NOT COMPLETED|Overall Study||0
2442496|NCT01109004|5991377|P1|NOT COMPLETED|Overall Study||0
2442497|NCT01109004|5991375|P3|COMPLETED|Overall Study||257
2442498|NCT01109004|5991376|P2|COMPLETED|Overall Study||254
2442499|NCT01109004|5991377|P1|COMPLETED|Overall Study||247
2442500|NCT01109004|5991375|P3|STARTED|Overall Study||257
2442501|NCT01109004|5991376|P2|STARTED|Overall Study||254
2442502|NCT01109004|5991377|P1|STARTED|Overall Study||247
2442503|NCT01108835|5991414|P2|NOT COMPLETED|Overall Study||21
2442504|NCT01108835|5991415|P1|NOT COMPLETED|Overall Study||17
2442505|NCT01108835|5991414|P2|COMPLETED|Overall Study||69
2442506|NCT01108835|5991415|P1|COMPLETED|Overall Study||73
2442507|NCT01108835|5991414|P2|STARTED|Overall Study||90
2442508|NCT01108835|5991415|P1|STARTED|Overall Study||90
2442509|NCT01108809|5991429|P1|NOT COMPLETED|Overall Study||4
2442510|NCT01108809|5991429|P1|COMPLETED|Overall Study||291
2442511|NCT01108809|5991429|P1|STARTED|Overall Study||295
2442512|NCT01108796|5991446|P2|NOT COMPLETED|Overall Study||7
2442513|NCT01108796|5991447|P1|NOT COMPLETED|Overall Study||7
2442514|NCT01108796|5991446|P2|COMPLETED|Overall Study||1060
2442515|NCT01108796|5991447|P1|COMPLETED|Overall Study||767
2442516|NCT01108796|5991446|P2|STARTED|Overall Study||1067
2442517|NCT01108796|5991447|P1|STARTED|Overall Study||774
2442518|NCT01108757|5991481|P2|NOT COMPLETED|Overall Study||0
2442519|NCT01108757|5991482|P1|NOT COMPLETED|Overall Study||0
2442520|NCT01108757|5991481|P2|COMPLETED|Overall Study||26
2442521|NCT01108757|5991482|P1|COMPLETED|Overall Study||26
2442522|NCT01108757|5991481|P2|STARTED|Overall Study||26
2442523|NCT01108757|5991482|P1|STARTED|Overall Study||26
2442524|NCT01108731|5991490|P2|NOT COMPLETED|Overall Study||4
2442525|NCT01108731|5991491|P1|NOT COMPLETED|Overall Study||4
2442526|NCT01108731|5991490|P2|COMPLETED|Overall Study||13
2442527|NCT01108731|5991491|P1|COMPLETED|Overall Study||13
2442528|NCT01108731|5991490|P2|STARTED|Overall Study||17
2442529|NCT01108731|5991491|P1|STARTED|Overall Study||17
2442530|NCT01108718|5991503|P2|NOT COMPLETED|Received Second Intervention (2 Months)||0
2442531|NCT01108718|5991504|P1|NOT COMPLETED|Received Second Intervention (2 Months)||1
2442532|NCT01108718|5991503|P2|COMPLETED|Received Second Intervention (2 Months)||7
2442533|NCT01108718|5991504|P1|COMPLETED|Received Second Intervention (2 Months)||4
2442534|NCT01108718|5991503|P2|STARTED|Received Second Intervention (2 Months)||7
2442535|NCT01108718|5991504|P1|STARTED|Received Second Intervention (2 Months)|Used control mattress was delivered to participant at crossover causing her to withdraw.|5
2442536|NCT01108718|5991503|P2|NOT COMPLETED|Received First Intervention (2 Months)||0
2442537|NCT01108718|5991504|P1|NOT COMPLETED|Received First Intervention (2 Months)||0
2442538|NCT01108718|5991503|P2|COMPLETED|Received First Intervention (2 Months)||7
2442539|NCT01108718|5991504|P1|COMPLETED|Received First Intervention (2 Months)||5
2442540|NCT01108718|5991503|P2|STARTED|Received First Intervention (2 Months)||7
2442541|NCT01108718|5991504|P1|STARTED|Received First Intervention (2 Months)||5
2442542|NCT01108523|5991509|P1|NOT COMPLETED|Overall Study||4
2442543|NCT01108523|5991509|P1|COMPLETED|Overall Study||3
2442544|NCT01108523|5991509|P1|STARTED|Overall Study||7
2442545|NCT01108510|5991516|P2|NOT COMPLETED|Overall Study||268
2442546|NCT01108510|5991517|P1|NOT COMPLETED|Overall Study||279
2442547|NCT01108510|5991516|P2|COMPLETED|Overall Study||81
2442548|NCT01108510|5991517|P1|COMPLETED|Overall Study||70
2442549|NCT01108510|5991516|P2|STARTED|Overall Study||349
2442550|NCT01108510|5991517|P1|STARTED|Overall Study||349
2442551|NCT01108458|5991537|P1|NOT COMPLETED|Overall Study||1
2442552|NCT01108458|5991537|P1|COMPLETED|Overall Study||0
2442553|NCT01108458|5991537|P1|STARTED|Overall Study||1
2442554|NCT01108445|5991548|P2|NOT COMPLETED|Overall Study||49
2442555|NCT01108445|5991549|P1|NOT COMPLETED|Overall Study||56
2442556|NCT01108445|5991548|P2|COMPLETED|Overall Study||2
2442557|NCT01108445|5991549|P1|COMPLETED|Overall Study||1
2442558|NCT01108445|5991548|P2|STARTED|Overall Study||51
2442559|NCT01108445|5991549|P1|STARTED|Overall Study||57
2442560|NCT01108406|5991583|P1|NOT COMPLETED|Overall Study||0
2442561|NCT01108406|5991583|P1|COMPLETED|Overall Study||22
2442562|NCT01108406|5991583|P1|STARTED|Overall Study||22
2442563|NCT01108341|5991589|P1|NOT COMPLETED|Overall Study||5
2442564|NCT01108341|5991589|P1|COMPLETED|Overall Study||45
2442565|NCT01108341|5991589|P1|Safety Set (Enrolled and Treated)|Overall Study||49
2442566|NCT01108341|5991589|P1|STARTED|Overall Study||50
2442567|NCT01108263|5991596|P2|NOT COMPLETED|Overall Study||1
2442568|NCT01108263|5991597|P1|NOT COMPLETED|Overall Study||0
2442569|NCT01108263|5991596|P2|COMPLETED|Overall Study||2
2442570|NCT01108263|5991597|P1|COMPLETED|Overall Study||2
2442571|NCT01108263|5991596|P2|STARTED|Overall Study||3
2442572|NCT01108263|5991597|P1|STARTED|Overall Study||2
2442573|NCT01108237|5991607|P2|NOT COMPLETED|Overall Study||17
2442574|NCT01108237|5991608|P1|NOT COMPLETED|Overall Study||9
2442575|NCT01108237|5991607|P2|COMPLETED|Overall Study||84
2442576|NCT01108237|5991608|P1|COMPLETED|Overall Study|66 subjects underwent surgery per the protocol, however, only 64 met the primary end point.|64
2442577|NCT01108237|5991607|P2|STARTED|Overall Study||101
2442578|NCT01108237|5991608|P1|STARTED|Overall Study|78 subjects were consented with intent to treat, however, 73 had surgery.|73
2442579|NCT01108185|5991614|P1|NOT COMPLETED|Overall Study||27
2442580|NCT01108185|5991614|P1|COMPLETED|Overall Study||3154
2442581|NCT01108185|5991614|P1|Per Protocol Population|Overall Study||3181
2442582|NCT01108185|5991614|P1|STARTED|Overall Study||3181
2442583|NCT01108094|5991631|P4|NOT COMPLETED|Overall Study||0
2442584|NCT01108094|5991632|P3|NOT COMPLETED|Overall Study||0
2442585|NCT01108094|5991633|P2|NOT COMPLETED|Overall Study||0
2442586|NCT01108094|5991634|P1|NOT COMPLETED|Overall Study||3
2442587|NCT01108094|5991631|P4|COMPLETED|Overall Study||10
2442588|NCT01108094|5991632|P3|COMPLETED|Overall Study||4
2442589|NCT01108094|5991633|P2|COMPLETED|Overall Study||3
2442590|NCT01108094|5991634|P1|COMPLETED|Overall Study||9
2442591|NCT01108094|5991631|P4|STARTED|Overall Study||10
2442592|NCT01108094|5991632|P3|STARTED|Overall Study||4
2442593|NCT01108094|5991633|P2|STARTED|Overall Study||3
2442594|NCT01108094|5991634|P1|STARTED|Overall Study||12
2442595|NCT01108081|5991659|P4|NOT COMPLETED|Overall Study||4
2442596|NCT01108081|5991660|P3|NOT COMPLETED|Overall Study||0
2442597|NCT01108081|5991661|P2|NOT COMPLETED|Overall Study||2
2442598|NCT01108081|5991662|P1|NOT COMPLETED|Overall Study||2
2442599|NCT01108081|5991659|P4|COMPLETED|Overall Study||39
2442600|NCT01108081|5991660|P3|COMPLETED|Overall Study||38
2442601|NCT01108081|5991661|P2|COMPLETED|Overall Study||40
2442602|NCT01108081|5991662|P1|COMPLETED|Overall Study||44
2442603|NCT01108081|5991659|P4|STARTED|Overall Study||43
2442604|NCT01108081|5991660|P3|STARTED|Overall Study||38
2442605|NCT01108081|5991661|P2|STARTED|Overall Study||42
2442606|NCT01108081|5991662|P1|STARTED|Overall Study||46
2442607|NCT01108068|5991678|P2|NOT COMPLETED|Overall Study||0
2442608|NCT01108068|5991679|P1|NOT COMPLETED|Overall Study||6
2442609|NCT01108068|5991678|P2|COMPLETED|Overall Study||16
2442610|NCT01108068|5991679|P1|COMPLETED|Overall Study|Only 5 individuals were recruited into the Lithium treatment arm|4
2442611|NCT01108068|5991678|P2|STARTED|Overall Study||16
2442612|NCT01108068|5991679|P1|STARTED|Overall Study||10
2442613|NCT01108055|5991686|P1|NOT COMPLETED|Overall Study||15
2442614|NCT01108055|5991686|P1|COMPLETED|Overall Study||28
2442615|NCT01108055|5991686|P1|Eligible and Started Treatment|Overall Study||32
2442616|NCT01108055|5991686|P1|STARTED|Overall Study||43
2442617|NCT01108003|5991696|P2|NOT COMPLETED|Overall Study||0
2442618|NCT01108003|5991697|P1|NOT COMPLETED|Overall Study||0
2442619|NCT01108003|5991696|P2|COMPLETED|Overall Study||3
2442620|NCT01108003|5991697|P1|COMPLETED|Overall Study||4
2442621|NCT01108003|5991696|P2|STARTED|Overall Study||3
2442622|NCT01108003|5991697|P1|STARTED|Overall Study||4
2442623|NCT01107964|5991707|P2|NOT COMPLETED|Overall Study||1
2442624|NCT01107964|5991708|P1|NOT COMPLETED|Overall Study||1
2442625|NCT01107964|5991707|P2|COMPLETED|Overall Study||13
2442626|NCT01107964|5991708|P1|COMPLETED|Overall Study||12
2442627|NCT01107964|5991707|P2|STARTED|Overall Study||14
2442628|NCT01107964|5991708|P1|STARTED|Overall Study||13
2442629|NCT01107925|5991724|P6|NOT COMPLETED|Period 3||0
2442630|NCT01107925|5991725|P5|NOT COMPLETED|Period 3||0
2442631|NCT01107925|5991726|P4|NOT COMPLETED|Period 3||0
2442632|NCT01107925|5991727|P3|NOT COMPLETED|Period 3||0
2442633|NCT01107925|5991728|P2|NOT COMPLETED|Period 3||0
2442634|NCT01107925|5991729|P1|NOT COMPLETED|Period 3||0
2442635|NCT01107925|5991724|P6|COMPLETED|Period 3||20
2442636|NCT01107925|5991725|P5|COMPLETED|Period 3||0
2442637|NCT01107925|5991726|P4|COMPLETED|Period 3||16
2442638|NCT01107925|5991727|P3|COMPLETED|Period 3||15
2442639|NCT01107925|5991728|P2|COMPLETED|Period 3||17
2442640|NCT01107925|5991729|P1|COMPLETED|Period 3||0
2442641|NCT01107925|5991724|P6|Took at Least 1 Dose of Study Drug|Period 3||20
2442642|NCT01107925|5991725|P5|Took at Least 1 Dose of Study Drug|Period 3||0
2442643|NCT01107925|5991726|P4|Took at Least 1 Dose of Study Drug|Period 3||16
2442644|NCT01107925|5991727|P3|Took at Least 1 Dose of Study Drug|Period 3||15
2442645|NCT01107925|5991728|P2|Took at Least 1 Dose of Study Drug|Period 3||17
2442646|NCT01107925|5991729|P1|Took at Least 1 Dose of Study Drug|Period 3||0
2442647|NCT01107925|5991724|P6|STARTED|Period 3|5 mg prasugrel (Period 2, HBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|20
2442648|NCT01107925|5991725|P5|STARTED|Period 3||0
2442649|NCT01107925|5991726|P4|STARTED|Period 3|75 mg clopidogrel (Period 2, HBW treatment sequence) crossed over to 5 mg prasugrel (Period 3).|16
2442650|NCT01107925|5991727|P3|STARTED|Period 3|10 mg prasugrel (Period 2, LBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|15
2442651|NCT01107925|5991728|P2|STARTED|Period 3|75 mg clopidogrel (Period 2, LBW treatment sequence) crossed over to 10 mg prasugrel (Period 3).|17
2442652|NCT01107925|5991729|P1|STARTED|Period 3||0
2442653|NCT01107925|5991724|P6|NOT COMPLETED|Period 2||1
2442654|NCT01107925|5991725|P5|NOT COMPLETED|Period 2||0
2442655|NCT01107925|5991726|P4|NOT COMPLETED|Period 2||0
2442656|NCT01107925|5991727|P3|NOT COMPLETED|Period 2||0
2442657|NCT01107925|5991728|P2|NOT COMPLETED|Period 2||1
2442658|NCT01107925|5991729|P1|NOT COMPLETED|Period 2||0
2442659|NCT01107925|5991724|P6|COMPLETED|Period 2||16
2442660|NCT01107925|5991725|P5|COMPLETED|Period 2||0
2442661|NCT01107925|5991726|P4|COMPLETED|Period 2||20
2442662|NCT01107925|5991727|P3|COMPLETED|Period 2||17
2442663|NCT01107925|5991728|P2|COMPLETED|Period 2||15
2442664|NCT01107925|5991729|P1|COMPLETED|Period 2||0
2442665|NCT01107925|5991724|P6|Took at Least 1 Dose of Study Drug|Period 2||17
2442666|NCT01107925|5991725|P5|Took at Least 1 Dose of Study Drug|Period 2||0
2442667|NCT01107925|5991726|P4|Took at Least 1 Dose of Study Drug|Period 2||20
2442668|NCT01107925|5991727|P3|Took at Least 1 Dose of Study Drug|Period 2||17
2442669|NCT01107925|5991728|P2|Took at Least 1 Dose of Study Drug|Period 2||16
2442670|NCT01107925|5991729|P1|Took at Least 1 Dose of Study Drug|Period 2||0
2442671|NCT01107925|5991724|P6|STARTED|Period 2||17
2442672|NCT01107925|5991725|P5|STARTED|Period 2|10 mg prasugrel (Period 1, HBW treatment) switched to 5 mg prasugrel or 75 mg clopidogrel (Period 2)|0
2442673|NCT01107925|5991726|P4|STARTED|Period 2||20
2442674|NCT01107925|5991727|P3|STARTED|Period 2||17
2442675|NCT01107925|5991728|P2|STARTED|Period 2||16
2442676|NCT01107925|5991729|P1|STARTED|Period 2|5 mg prasugrel (Period 1, LBW treatment) switched to 10 mg prasugrel or 75 mg clopidogrel (Period 2)|0
2442677|NCT01107925|5991724|P6|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
2442678|NCT01107925|5991725|P5|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
2442679|NCT01107925|5991726|P4|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
2442680|NCT01107925|5991727|P3|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
2442681|NCT01107925|5991728|P2|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
2442682|NCT01107925|5991729|P1|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
2442683|NCT01107925|5991724|P6|COMPLETED|Period 1-Randomization up Through Day 12||0
2442684|NCT01107925|5991725|P5|COMPLETED|Period 1-Randomization up Through Day 12||37
2442685|NCT01107925|5991726|P4|COMPLETED|Period 1-Randomization up Through Day 12||0
2442686|NCT01107925|5991727|P3|COMPLETED|Period 1-Randomization up Through Day 12||0
2442687|NCT01107925|5991728|P2|COMPLETED|Period 1-Randomization up Through Day 12||0
2442688|NCT01107925|5991729|P1|COMPLETED|Period 1-Randomization up Through Day 12||33
2442689|NCT01107925|5991724|P6|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
2442690|NCT01107925|5991725|P5|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||38
2442691|NCT01107925|5991726|P4|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
2442692|NCT01107925|5991727|P3|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
2442693|NCT01107925|5991728|P2|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
2442694|NCT01107925|5991729|P1|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||34
2442695|NCT01107925|5991724|P6|STARTED|Period 1-Randomization up Through Day 12||0
2442696|NCT01107925|5991725|P5|STARTED|Period 1-Randomization up Through Day 12||38
2442697|NCT01107925|5991726|P4|STARTED|Period 1-Randomization up Through Day 12||0
2442698|NCT01107925|5991727|P3|STARTED|Period 1-Randomization up Through Day 12||0
2442699|NCT01107925|5991728|P2|STARTED|Period 1-Randomization up Through Day 12||0
2442700|NCT01107925|5991729|P1|STARTED|Period 1-Randomization up Through Day 12||34
2442701|NCT01107912|5991767|P6|NOT COMPLETED|Period 3||0
2442702|NCT01107912|5991768|P5|NOT COMPLETED|Period 3||0
2442703|NCT01107912|5991769|P4|NOT COMPLETED|Period 3||1
2442704|NCT01107912|5991770|P3|NOT COMPLETED|Period 3||1
2442705|NCT01107912|5991771|P2|NOT COMPLETED|Period 3||1
2442706|NCT01107912|5991772|P1|NOT COMPLETED|Period 3||0
2442707|NCT01107912|5991767|P6|COMPLETED|Period 3||41
2442708|NCT01107912|5991768|P5|COMPLETED|Period 3||0
2442709|NCT01107912|5991769|P4|COMPLETED|Period 3||37
2442710|NCT01107912|5991770|P3|COMPLETED|Period 3||35
2442711|NCT01107912|5991771|P2|COMPLETED|Period 3||34
2442712|NCT01107912|5991772|P1|COMPLETED|Period 3||0
2442713|NCT01107912|5991767|P6|STARTED|Period 3|Participants who received 5 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|41
2442714|NCT01107912|5991768|P5|STARTED|Period 3||0
2442715|NCT01107912|5991769|P4|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 5 mg prasugrel in Period 3|38
2442716|NCT01107912|5991770|P3|STARTED|Period 3|Participants who received 10 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|36
2442717|NCT01107912|5991771|P2|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 10 mg prasugrel in Period 3|35
2442718|NCT01107912|5991772|P1|STARTED|Period 3||0
2442719|NCT01107912|5991767|P6|NOT COMPLETED|Period 2||0
2442720|NCT01107912|5991768|P5|NOT COMPLETED|Period 2||0
2442721|NCT01107912|5991769|P4|NOT COMPLETED|Period 2||0
2442722|NCT01107912|5991770|P3|NOT COMPLETED|Period 2||1
2442723|NCT01107912|5991771|P2|NOT COMPLETED|Period 2||0
2442724|NCT01107912|5991772|P1|NOT COMPLETED|Period 2||0
2442725|NCT01107912|5991767|P6|COMPLETED|Period 2||38
2442726|NCT01107912|5991768|P5|COMPLETED|Period 2||0
2442727|NCT01107912|5991769|P4|COMPLETED|Period 2||41
2442728|NCT01107912|5991770|P3|COMPLETED|Period 2||35
2442729|NCT01107912|5991771|P2|COMPLETED|Period 2||36
2442730|NCT01107912|5991772|P1|COMPLETED|Period 2||0
2442731|NCT01107912|5991767|P6|STARTED|Period 2||38
2442732|NCT01107912|5991768|P5|STARTED|Period 2|Participants switched to either 5 mg prasugrel or 75 mg clopidogrel in Period 2.|0
2442733|NCT01107912|5991769|P4|STARTED|Period 2||41
2442734|NCT01107912|5991770|P3|STARTED|Period 2||36
2442735|NCT01107912|5991771|P2|STARTED|Period 2||36
2442736|NCT01107912|5991772|P1|STARTED|Period 2|Participants switched to either 10 mg prasugrel or 75 mg clopidogrel in Period 2.|0
2442737|NCT01107912|5991767|P6|NOT COMPLETED|Period 1||0
2442738|NCT01107912|5991768|P5|NOT COMPLETED|Period 1||3
2442739|NCT01107912|5991769|P4|NOT COMPLETED|Period 1||0
2442740|NCT01107912|5991770|P3|NOT COMPLETED|Period 1||0
2442741|NCT01107912|5991771|P2|NOT COMPLETED|Period 1||0
2442742|NCT01107912|5991772|P1|NOT COMPLETED|Period 1||1
2442743|NCT01107912|5991767|P6|COMPLETED|Period 1||0
2442744|NCT01107912|5991768|P5|COMPLETED|Period 1||79
2442745|NCT01107912|5991769|P4|COMPLETED|Period 1||0
2442746|NCT01107912|5991770|P3|COMPLETED|Period 1||0
2442747|NCT01107912|5991771|P2|COMPLETED|Period 1||0
2442748|NCT01107912|5991772|P1|COMPLETED|Period 1||72
2442749|NCT01107912|5991767|P6|Received at Least 1 Dose of Study Drug|Period 1||0
2442750|NCT01107912|5991768|P5|Received at Least 1 Dose of Study Drug|Period 1||82
2442751|NCT01107912|5991769|P4|Received at Least 1 Dose of Study Drug|Period 1||0
2442752|NCT01107912|5991770|P3|Received at Least 1 Dose of Study Drug|Period 1||0
2442753|NCT01107912|5991771|P2|Received at Least 1 Dose of Study Drug|Period 1||0
2442754|NCT01107912|5991772|P1|Received at Least 1 Dose of Study Drug|Period 1||73
2442755|NCT01107912|5991767|P6|STARTED|Period 1||0
2442756|NCT01107912|5991768|P5|STARTED|Period 1||82
2442757|NCT01107912|5991769|P4|STARTED|Period 1||0
2442758|NCT01107912|5991770|P3|STARTED|Period 1||0
2442759|NCT01107912|5991771|P2|STARTED|Period 1||0
2442760|NCT01107912|5991772|P1|STARTED|Period 1||73
2442761|NCT01107899|5991809|P3|NOT COMPLETED|Overall Study||4
2442762|NCT01107899|5991810|P2|NOT COMPLETED|Overall Study||0
2442763|NCT01107899|5991811|P1|NOT COMPLETED|Overall Study||5
2442764|NCT01107899|5991809|P3|COMPLETED|Overall Study||5
2442765|NCT01107899|5991810|P2|COMPLETED|Overall Study||10
2442766|NCT01107899|5991811|P1|COMPLETED|Overall Study||5
2442767|NCT01107899|5991809|P3|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|4
2442768|NCT01107899|5991810|P2|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|10
2442769|NCT01107899|5991811|P1|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|5
2442770|NCT01107899|5991809|P3|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|6
2442771|NCT01107899|5991810|P2|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|10
2442772|NCT01107899|5991811|P1|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|5
2442773|NCT01107899|5991809|P3|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|6
2442774|NCT01107899|5991810|P2|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|10
2442775|NCT01107899|5991811|P1|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|5
2442776|NCT01107899|5991809|P3|Received at Least One Dose of Study Drug|Overall Study||8
2442777|NCT01107899|5991810|P2|Received at Least One Dose of Study Drug|Overall Study||10
2442778|NCT01107899|5991811|P1|Received at Least One Dose of Study Drug|Overall Study||10
2442779|NCT01107899|5991809|P3|STARTED|Overall Study||9
2442780|NCT01107899|5991810|P2|STARTED|Overall Study||10
2442781|NCT01107899|5991811|P1|STARTED|Overall Study||10
2442782|NCT01107886|5991857|P2|NOT COMPLETED|Overall Study||214
2442783|NCT01107886|5991858|P1|NOT COMPLETED|Overall Study||202
2442784|NCT01107886|5991857|P2|COMPLETED|Overall Study|Completed subjects|7998
2442785|NCT01107886|5991858|P1|COMPLETED|Overall Study|Completed subjects|8078
2442786|NCT01107886|5991857|P2|STARTED|Overall Study|Randomized subjects|8212
2442787|NCT01107886|5991858|P1|STARTED|Overall Study|Randomized subjects|8280
2442788|NCT01107834|5991870|P2|NOT COMPLETED|Overall Study||0
2442789|NCT01107834|5991871|P1|NOT COMPLETED|Overall Study||0
2442790|NCT01107834|5991870|P2|COMPLETED|Overall Study||30
2442791|NCT01107834|5991871|P1|COMPLETED|Overall Study||30
2442792|NCT01107834|5991870|P2|STARTED|Overall Study||30
2442793|NCT01107834|5991871|P1|STARTED|Overall Study||30
2442794|NCT01107795|5991887|P1|NOT COMPLETED|Overall Study||0
2442795|NCT01107795|5991887|P1|COMPLETED|Overall Study||41
2442796|NCT01107795|5991887|P1|STARTED|Overall Study||41
2442797|NCT01107743|5991891|P1|NOT COMPLETED|Overall Study||46
2442798|NCT01107743|5991891|P1|COMPLETED|Overall Study||1245
2442799|NCT01107743|5991891|P1|STARTED|Overall Study||1291
2442800|NCT01107730|5991980|P3|NOT COMPLETED|Overall Study||0
2442801|NCT01107730|5991981|P2|NOT COMPLETED|Overall Study||0
2442802|NCT01107730|5991982|P1|NOT COMPLETED|Overall Study||0
2442803|NCT01107730|5991980|P3|COMPLETED|Overall Study||11
2442804|NCT01107730|5991981|P2|COMPLETED|Overall Study||11
2442805|NCT01107730|5991982|P1|COMPLETED|Overall Study||11
2442806|NCT01107730|5991980|P3|STARTED|Overall Study||11
2442807|NCT01107730|5991981|P2|STARTED|Overall Study||11
2442808|NCT01107730|5991982|P1|STARTED|Overall Study||11
2442809|NCT01107665|5991990|P1|NOT COMPLETED|Overall Study||49
2442810|NCT01107665|5991990|P1|COMPLETED|Overall Study||11
2442811|NCT01107665|5991990|P1|STARTED|Overall Study||60
2442812|NCT01107535|5992005|P1|NOT COMPLETED|Overall Study||5
2442813|NCT01107535|5992005|P1|COMPLETED|Overall Study||77
2442814|NCT01107535|5992005|P1|Number of Participants Analyzed|Overall Study||82
2442815|NCT01107535|5992005|P1|STARTED|Overall Study||82
2442816|NCT01107457|5992018|P6|NOT COMPLETED|Part B and C||120
2442817|NCT01107457|5992019|P5|NOT COMPLETED|Part B and C||0
2442818|NCT01107457|5992020|P4|NOT COMPLETED|Part B and C||0
2442819|NCT01107457|5992021|P3|NOT COMPLETED|Part B and C||0
2442820|NCT01107457|5992022|P2|NOT COMPLETED|Part B and C||0
2442821|NCT01107457|5992023|P1|NOT COMPLETED|Part B and C||0
2442822|NCT01107457|5992018|P6|COMPLETED|Part B and C|No participants completed the study as Part C was stopped.|0
2442823|NCT01107457|5992019|P5|COMPLETED|Part B and C||0
2442824|NCT01107457|5992020|P4|COMPLETED|Part B and C||0
2442825|NCT01107457|5992021|P3|COMPLETED|Part B and C||0
2442826|NCT01107457|5992022|P2|COMPLETED|Part B and C||0
2442827|NCT01107457|5992023|P1|COMPLETED|Part B and C||0
2442828|NCT01107457|5992018|P6|Post Treatment Safety Visits|Part B and C|Only participants with neutropenia entered the post treatment safety visits.|6
2442829|NCT01107457|5992019|P5|Post Treatment Safety Visits|Part B and C||0
2442830|NCT01107457|5992020|P4|Post Treatment Safety Visits|Part B and C||0
2442831|NCT01107457|5992021|P3|Post Treatment Safety Visits|Part B and C||0
2442832|NCT01107457|5992022|P2|Post Treatment Safety Visits|Part B and C||0
2442833|NCT01107457|5992023|P1|Post Treatment Safety Visits|Part B and C||0
2442834|NCT01107457|5992018|P6|Completed Part C|Part B and C|Part C was stopped once ixekizumab became available through marketing authorization.|0
2442835|NCT01107457|5992019|P5|Completed Part C|Part B and C||0
2442836|NCT01107457|5992020|P4|Completed Part C|Part B and C||0
2442837|NCT01107457|5992021|P3|Completed Part C|Part B and C||0
2442838|NCT01107457|5992022|P2|Completed Part C|Part B and C||0
2442839|NCT01107457|5992023|P1|Completed Part C|Part B and C||0
2442840|NCT01107457|5992018|P6|Completed Part B (Week 240)|Part B and C||74
2442841|NCT01107457|5992019|P5|Completed Part B (Week 240)|Part B and C||0
2442842|NCT01107457|5992020|P4|Completed Part B (Week 240)|Part B and C||0
2442843|NCT01107457|5992021|P3|Completed Part B (Week 240)|Part B and C||0
2442844|NCT01107457|5992022|P2|Completed Part B (Week 240)|Part B and C||0
2442845|NCT01107457|5992023|P1|Completed Part B (Week 240)|Part B and C||0
2442846|NCT01107457|5992018|P6|STARTED|Part B and C|80 and 120 mg ixekizumab were administered during Part B and C.|120
2442847|NCT01107457|5992019|P5|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
2442848|NCT01107457|5992020|P4|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
2442849|NCT01107457|5992021|P3|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
2442850|NCT01107457|5992022|P2|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
2442851|NCT01107457|5992023|P1|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
2442852|NCT01107457|5992018|P6|NOT COMPLETED|Part A||0
2442853|NCT01107457|5992019|P5|NOT COMPLETED|Part A||1
2442854|NCT01107457|5992020|P4|NOT COMPLETED|Part A||3
2442855|NCT01107457|5992021|P3|NOT COMPLETED|Part A||1
2442856|NCT01107457|5992022|P2|NOT COMPLETED|Part A||7
2442857|NCT01107457|5992023|P1|NOT COMPLETED|Part A||5
2442858|NCT01107457|5992018|P6|COMPLETED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
2442859|NCT01107457|5992019|P5|COMPLETED|Part A||27
2442860|NCT01107457|5992020|P4|COMPLETED|Part A||26
2442861|NCT01107457|5992021|P3|COMPLETED|Part A||29
2442862|NCT01107457|5992022|P2|COMPLETED|Part A||21
2442863|NCT01107457|5992023|P1|COMPLETED|Part A||22
2442864|NCT01107457|5992018|P6|Received at Least 1 Dose of Study Drug|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
2442865|NCT01107457|5992019|P5|Received at Least 1 Dose of Study Drug|Part A||28
2442866|NCT01107457|5992020|P4|Received at Least 1 Dose of Study Drug|Part A||29
2442867|NCT01107457|5992021|P3|Received at Least 1 Dose of Study Drug|Part A||30
2442868|NCT01107457|5992022|P2|Received at Least 1 Dose of Study Drug|Part A||28
2442869|NCT01107457|5992023|P1|Received at Least 1 Dose of Study Drug|Part A||27
2442870|NCT01107457|5992018|P6|STARTED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
2442871|NCT01107457|5992019|P5|STARTED|Part A||28
2442872|NCT01107457|5992020|P4|STARTED|Part A||29
2442873|NCT01107457|5992021|P3|STARTED|Part A||30
2442874|NCT01107457|5992022|P2|STARTED|Part A||28
2442875|NCT01107457|5992023|P1|STARTED|Part A||27
2442876|NCT01107444|5992151|P2|NOT COMPLETED|Overall Study||13
2442877|NCT01107444|5992152|P1|NOT COMPLETED|Overall Study||8
2442878|NCT01107444|5992151|P2|COMPLETED|Overall Study||47
2442879|NCT01107444|5992152|P1|COMPLETED|Overall Study||112
2442880|NCT01107444|5992151|P2|Received At Least 1 Dose of Study Drug|Overall Study||48
2442881|NCT01107444|5992152|P1|Received At Least 1 Dose of Study Drug|Overall Study||114
2442882|NCT01107444|5992151|P2|STARTED|Overall Study||60
2442883|NCT01107444|5992152|P1|STARTED|Overall Study||120
2442884|NCT01107418|5992186|P1|NOT COMPLETED|Overall Study||52
2442885|NCT01107418|5992186|P1|COMPLETED|Overall Study||0
2442886|NCT01107418|5992186|P1|STARTED|Overall Study||52
2442887|NCT01107405|5992259|P5|NOT COMPLETED|Overall Study||3
2442888|NCT01107405|5992260|P4|NOT COMPLETED|Overall Study||3
2442889|NCT01107405|5992261|P3|NOT COMPLETED|Overall Study||2
2442890|NCT01107405|5992262|P2|NOT COMPLETED|Overall Study||1
2442891|NCT01107405|5992263|P1|NOT COMPLETED|Overall Study||2
2442892|NCT01107405|5992259|P5|COMPLETED|Overall Study||17
2442893|NCT01107405|5992260|P4|COMPLETED|Overall Study||17
2442894|NCT01107405|5992261|P3|COMPLETED|Overall Study||18
2442895|NCT01107405|5992262|P2|COMPLETED|Overall Study||19
2442896|NCT01107405|5992263|P1|COMPLETED|Overall Study||19
2442897|NCT01107405|5992259|P5|STARTED|Overall Study||20
2442898|NCT01107405|5992260|P4|STARTED|Overall Study||20
2442899|NCT01107405|5992261|P3|STARTED|Overall Study||20
2442900|NCT01107405|5992262|P2|STARTED|Overall Study||20
2442901|NCT01107405|5992263|P1|STARTED|Overall Study||21
2442902|NCT01107392|5992302|P2|NOT COMPLETED|Overall Study||3
2442903|NCT01107392|5992303|P1|NOT COMPLETED|Overall Study||5
2442904|NCT01107392|5992302|P2|COMPLETED|Overall Study||154
2442905|NCT01107392|5992303|P1|COMPLETED|Overall Study||153
2442906|NCT01107392|5992302|P2|STARTED|Overall Study||157
2442907|NCT01107392|5992303|P1|STARTED|Overall Study||158
2442908|NCT01107379|5992315|P1|NOT COMPLETED|Overall Study||21
2442909|NCT01107379|5992315|P1|COMPLETED|Overall Study||182
2442910|NCT01107379|5992315|P1|STARTED|Overall Study||203
2442911|NCT01107353|5992326|P2|NOT COMPLETED|Overall Study||0
2442912|NCT01107353|5992327|P1|NOT COMPLETED|Overall Study||1
2442913|NCT01107353|5992326|P2|COMPLETED|Overall Study||20
2442914|NCT01107353|5992327|P1|COMPLETED|Overall Study||19
2442915|NCT01107353|5992326|P2|STARTED|Overall Study||20
2442916|NCT01107353|5992327|P1|STARTED|Overall Study||20
2442917|NCT01107197|5992335|P2|NOT COMPLETED|Overall Study||23
2442918|NCT01107197|5992336|P1|NOT COMPLETED|Overall Study||20
2442919|NCT01107197|5992335|P2|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 64 patients )|78
2442920|NCT01107197|5992336|P1|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 67 patients )|79
2442921|NCT01107197|5992335|P2|STARTED|Overall Study||101
2442922|NCT01107197|5992336|P1|STARTED|Overall Study||99
2442923|NCT01107015|5992358|P4|NOT COMPLETED|Overall Study||18
2442924|NCT01107015|5992359|P3|NOT COMPLETED|Overall Study||11
2442925|NCT01107015|5992360|P2|NOT COMPLETED|Overall Study||15
2442926|NCT01107015|5992361|P1|NOT COMPLETED|Overall Study||6
2442927|NCT01107015|5992358|P4|COMPLETED|Overall Study||62
2442928|NCT01107015|5992359|P3|COMPLETED|Overall Study||22
2442929|NCT01107015|5992360|P2|COMPLETED|Overall Study||23
2442930|NCT01107015|5992361|P1|COMPLETED|Overall Study||56
2442931|NCT01107015|5992358|P4|STARTED|Overall Study||80
2442932|NCT01107015|5992359|P3|STARTED|Overall Study||33
2442933|NCT01107015|5992360|P2|STARTED|Overall Study||38
2442934|NCT01107015|5992361|P1|STARTED|Overall Study||62
2442935|NCT01106976|5992371|P1|NOT COMPLETED|Overall Study||8
2442936|NCT01106976|5992371|P1|COMPLETED|Overall Study||59
2442937|NCT01106976|5992371|P1|STARTED|Overall Study||67
2442938|NCT01106950|5992375|P1|NOT COMPLETED|Overall Study||0
2442939|NCT01106950|5992375|P1|COMPLETED|Overall Study||15
2442940|NCT01106950|5992375|P1|STARTED|Overall Study||15
2442941|NCT01106911|5992385|P1|NOT COMPLETED|Overall Study||5
2442942|NCT01106911|5992385|P1|COMPLETED|Overall Study||1080
2442943|NCT01106911|5992385|P1|STARTED|Overall Study||1085
2442944|NCT01106898|5992389|P1|NOT COMPLETED|Overall Study||6
2442945|NCT01106898|5992389|P1|COMPLETED|Overall Study||94
2442946|NCT01106898|5992389|P1|STARTED|Overall Study||100
2442947|NCT01106859|5992393|P1|NOT COMPLETED|Overall Study||0
2442948|NCT01106859|5992393|P1|COMPLETED|Overall Study||40
2442949|NCT01106859|5992393|P1|STARTED|Overall Study|Intent to treat population and safety population are the same (40 participants)|40
2442950|NCT01106846|5992434|P2|NOT COMPLETED|Overall Study||1
2442951|NCT01106846|5992435|P1|NOT COMPLETED|Overall Study||0
2442952|NCT01106846|5992434|P2|COMPLETED|Overall Study||9
2442953|NCT01106846|5992435|P1|COMPLETED|Overall Study||12
2442954|NCT01106846|5992434|P2|STARTED|Overall Study||10
2442955|NCT01106846|5992435|P1|STARTED|Overall Study||12
2442956|NCT01106833|5992443|P2|NOT COMPLETED|Overall Study||0
2442957|NCT01106833|5992444|P1|NOT COMPLETED|Overall Study||0
2442958|NCT01106833|5992443|P2|COMPLETED|Overall Study||77
2442959|NCT01106833|5992444|P1|COMPLETED|Overall Study||74
2442960|NCT01106833|5992443|P2|STARTED|Overall Study||77
2442961|NCT01106833|5992444|P1|STARTED|Overall Study||74
2442962|NCT01106690|5992485|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
2442963|NCT01106690|5992486|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
2442964|NCT01106690|5992487|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
2442965|NCT01106690|5992485|P3|COMPLETED|Extension Period: Week 26 to Week 52||89
2442966|NCT01106690|5992486|P2|COMPLETED|Extension Period: Week 26 to Week 52||96
2442967|NCT01106690|5992487|P1|COMPLETED|Extension Period: Week 26 to Week 52||78
2442968|NCT01106690|5992485|P3|STARTED|Extension Period: Week 26 to Week 52|5 pts completed core but did not exter ext: lost to f/u(1), not spec(2), AE(1), eGFR criteria(1).|96
2442969|NCT01106690|5992486|P2|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|103
2442970|NCT01106690|5992487|P1|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|90
2442971|NCT01106690|5992485|P3|NOT COMPLETED|Core Period: Baseline to Week 26||13
2442972|NCT01106690|5992486|P2|NOT COMPLETED|Core Period: Baseline to Week 26||9
2442973|NCT01106690|5992487|P1|NOT COMPLETED|Core Period: Baseline to Week 26||24
2442974|NCT01106690|5992485|P3|COMPLETED|Core Period: Baseline to Week 26||101
2442975|NCT01106690|5992486|P2|COMPLETED|Core Period: Baseline to Week 26||104
2442976|NCT01106690|5992487|P1|COMPLETED|Core Period: Baseline to Week 26||91
2442977|NCT01106690|5992485|P3|STARTED|Core Period: Baseline to Week 26||114
2442978|NCT01106690|5992486|P2|STARTED|Core Period: Baseline to Week 26||113
2442979|NCT01106690|5992487|P1|STARTED|Core Period: Baseline to Week 26||115
2442980|NCT01106677|5992523|P4|NOT COMPLETED|Extension Period: Week 26 to Week 52||28
2442981|NCT01106677|5992524|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||22
2442982|NCT01106677|5992525|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
2442983|NCT01106677|5992526|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||15
2442984|NCT01106677|5992523|P4|COMPLETED|Extension Period: Week 26 to Week 52||285
2442985|NCT01106677|5992524|P3|COMPLETED|Extension Period: Week 26 to Week 52||299
2442986|NCT01106677|5992525|P2|COMPLETED|Extension Period: Week 26 to Week 52||298
2442987|NCT01106677|5992526|P1|COMPLETED|Extension Period: Week 26 to Week 52||138
2442988|NCT01106677|5992523|P4|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(3), physician decision(2), lost to f/u(1).|313
2442989|NCT01106677|5992524|P3|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: not specified(1), withdrawal by subject(1).|321
2442990|NCT01106677|5992525|P2|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(5), withdrawal by subject(1).|316
2442991|NCT01106677|5992526|P1|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: protcol violation(1), lost to f/u(1).|153
2442992|NCT01106677|5992523|P4|NOT COMPLETED|Core Period: Baseline to Week 26||47
2442993|NCT01106677|5992524|P3|NOT COMPLETED|Core Period: Baseline to Week 26||44
2442994|NCT01106677|5992525|P2|NOT COMPLETED|Core Period: Baseline to Week 26||46
2442995|NCT01106677|5992526|P1|NOT COMPLETED|Core Period: Baseline to Week 26||28
2442996|NCT01106677|5992523|P4|COMPLETED|Core Period: Baseline to Week 26||319
2442997|NCT01106677|5992524|P3|COMPLETED|Core Period: Baseline to Week 26||323
2442998|NCT01106677|5992525|P2|COMPLETED|Core Period: Baseline to Week 26||322
2442999|NCT01106677|5992526|P1|COMPLETED|Core Period: Baseline to Week 26||155
2443000|NCT01106677|5992523|P4|STARTED|Core Period: Baseline to Week 26||366
2443001|NCT01106677|5992524|P3|STARTED|Core Period: Baseline to Week 26||367
2443002|NCT01106677|5992525|P2|STARTED|Core Period: Baseline to Week 26||368
2443003|NCT01106677|5992526|P1|STARTED|Core Period: Baseline to Week 26||183
2443004|NCT01106651|5992589|P3|NOT COMPLETED|Overall Study||58
2443005|NCT01106651|5992590|P2|NOT COMPLETED|Overall Study||57
2443006|NCT01106651|5992591|P1|NOT COMPLETED|Overall Study||79
2443007|NCT01106651|5992589|P3|COMPLETED|Overall Study||178
2443008|NCT01106651|5992590|P2|COMPLETED|Overall Study||184
2443009|NCT01106651|5992591|P1|COMPLETED|Overall Study||158
2443010|NCT01106651|5992589|P3|STARTED|Overall Study||236
2443011|NCT01106651|5992590|P2|STARTED|Overall Study||241
2443012|NCT01106651|5992591|P1|STARTED|Overall Study||237
2443013|NCT01106625|5992644|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||17
2443014|NCT01106625|5992645|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
2443015|NCT01106625|5992646|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||29
2443016|NCT01106625|5992644|P3|COMPLETED|Extension Period: Week 26 to Week 52||111
2443017|NCT01106625|5992645|P2|COMPLETED|Extension Period: Week 26 to Week 52||109
2443018|NCT01106625|5992646|P1|COMPLETED|Extension Period: Week 26 to Week 52||90
2443019|NCT01106625|5992644|P3|STARTED|Extension Period: Week 26 to Week 52|1 pt discontinued last day of core: withdrawal by subject (1).|128
2443020|NCT01106625|5992645|P2|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued last day of core: adverse event (1), not specified (1).|127
2443021|NCT01106625|5992646|P1|STARTED|Extension Period: Week 26 to Week 52|4 pts discontinued last day of core: physician decision (1), noncompliance (1), not specified (2).|119
2443022|NCT01106625|5992644|P3|NOT COMPLETED|Core Period: Baseline to Week 26||27
2443023|NCT01106625|5992645|P2|NOT COMPLETED|Core Period: Baseline to Week 26||28
2443024|NCT01106625|5992646|P1|NOT COMPLETED|Core Period: Baseline to Week 26||33
2443025|NCT01106625|5992644|P3|COMPLETED|Core Period: Baseline to Week 26||129
2443026|NCT01106625|5992645|P2|COMPLETED|Core Period: Baseline to Week 26||129
2443027|NCT01106625|5992646|P1|COMPLETED|Core Period: Baseline to Week 26||123
2443028|NCT01106625|5992644|P3|STARTED|Core Period: Baseline to Week 26||156
2443029|NCT01106625|5992645|P2|STARTED|Core Period: Baseline to Week 26||157
2443030|NCT01106625|5992646|P1|STARTED|Core Period: Baseline to Week 26||156
2443031|NCT01106586|5992677|P2|NOT COMPLETED|Overall Study||285
2443032|NCT01106586|5992678|P1|NOT COMPLETED|Overall Study||285
2443033|NCT01106586|5992677|P2|COMPLETED|Overall Study||70
2443034|NCT01106586|5992678|P1|COMPLETED|Overall Study||68
2443035|NCT01106586|5992677|P2|STARTED|Overall Study||355
2443036|NCT01106586|5992678|P1|STARTED|Overall Study||353
2443037|NCT01106534|5992696|P1|NOT COMPLETED|Overall Study||37
2443038|NCT01106534|5992696|P1|COMPLETED|Overall Study||2960
2443039|NCT01106534|5992696|P1|STARTED|Overall Study||2997
2443040|NCT01106456|5992719|P2|NOT COMPLETED|Overall Study||124
2443041|NCT01106456|5992720|P1|NOT COMPLETED|Overall Study||103
2443042|NCT01106456|5992719|P2|COMPLETED|Overall Study||96
2443043|NCT01106456|5992720|P1|COMPLETED|Overall Study||140
2443044|NCT01106456|5992719|P2|STARTED|Overall Study||220
2443045|NCT01106456|5992720|P1|STARTED|Overall Study||243
2443046|NCT01106430|5992728|P2|NOT COMPLETED|Overall Study||33
2443047|NCT01106430|5992729|P1|NOT COMPLETED|Overall Study||33
2443048|NCT01106430|5992728|P2|COMPLETED|Overall Study||101
2443049|NCT01106430|5992729|P1|COMPLETED|Overall Study||100
2443050|NCT01106430|5992728|P2|STARTED|Overall Study||134
2443051|NCT01106430|5992729|P1|STARTED|Overall Study||133
2443052|NCT01106404|5992751|P2|NOT COMPLETED|Period II (Second 6 Weeks)||0
2443053|NCT01106404|5992752|P1|NOT COMPLETED|Period II (Second 6 Weeks)||0
2443054|NCT01106404|5992751|P2|COMPLETED|Period II (Second 6 Weeks)||38
2443055|NCT01106404|5992752|P1|COMPLETED|Period II (Second 6 Weeks)||33
2443056|NCT01106404|5992751|P2|STARTED|Period II (Second 6 Weeks)||38
2443057|NCT01106404|5992752|P1|STARTED|Period II (Second 6 Weeks)||33
2443058|NCT01106404|5992751|P2|NOT COMPLETED|Period I (First 6 Weeks)||2
2443059|NCT01106404|5992752|P1|NOT COMPLETED|Period I (First 6 Weeks)||3
2443060|NCT01106404|5992751|P2|COMPLETED|Period I (First 6 Weeks)||38
2443061|NCT01106404|5992752|P1|COMPLETED|Period I (First 6 Weeks)||33
2443062|NCT01106404|5992751|P2|STARTED|Period I (First 6 Weeks)||40
2443063|NCT01106404|5992752|P1|STARTED|Period I (First 6 Weeks)||36
2443064|NCT01106391|5992765|P1|NOT COMPLETED|Overall Study||0
2443065|NCT01106391|5992765|P1|COMPLETED|Overall Study||60
2443066|NCT01106391|5992765|P1|STARTED|Overall Study||60
2443067|NCT01106352|5992775|P5|NOT COMPLETED|Overall Study||8
2443068|NCT01106352|5992776|P4|NOT COMPLETED|Overall Study||13
2443069|NCT01106352|5992777|P3|NOT COMPLETED|Overall Study||2
2443070|NCT01106352|5992778|P2|NOT COMPLETED|Overall Study||0
2443071|NCT01106352|5992779|P1|NOT COMPLETED|Overall Study||1
2443072|NCT01106352|5992775|P5|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|9
2443073|NCT01106352|5992776|P4|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|23
2443074|NCT01106352|5992777|P3|COMPLETED|Overall Study||5
2443075|NCT01106352|5992778|P2|COMPLETED|Overall Study||3
2443076|NCT01106352|5992779|P1|COMPLETED|Overall Study||6
2443077|NCT01106352|5992775|P5|Completed Safety Cohort|Overall Study||9
2443078|NCT01106352|5992776|P4|Completed Safety Cohort|Overall Study||23
2443079|NCT01106352|5992777|P3|Completed Safety Cohort|Overall Study||0
2443080|NCT01106352|5992778|P2|Completed Safety Cohort|Overall Study||0
2443081|NCT01106352|5992779|P1|Completed Safety Cohort|Overall Study||0
2443082|NCT01106352|5992775|P5|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|13
2443083|NCT01106352|5992776|P4|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|33
2443084|NCT01106352|5992777|P3|Treated Safety Cohort|Overall Study||0
2443085|NCT01106352|5992778|P2|Treated Safety Cohort|Overall Study||0
2443086|NCT01106352|5992779|P1|Treated Safety Cohort|Overall Study||0
2443087|NCT01106352|5992775|P5|Started Safety Cohort|Overall Study||17
2443088|NCT01106352|5992776|P4|Started Safety Cohort|Overall Study||36
2443089|NCT01106352|5992777|P3|Started Safety Cohort|Overall Study||0
2443090|NCT01106352|5992778|P2|Started Safety Cohort|Overall Study||0
2443091|NCT01106352|5992779|P1|Started Safety Cohort|Overall Study||0
2443092|NCT01106352|5992775|P5|Completed Dose Escalation|Overall Study||0
2443093|NCT01106352|5992776|P4|Completed Dose Escalation|Overall Study||0
2443094|NCT01106352|5992777|P3|Completed Dose Escalation|Overall Study||5
2443095|NCT01106352|5992778|P2|Completed Dose Escalation|Overall Study||3
2443096|NCT01106352|5992779|P1|Completed Dose Escalation|Overall Study||6
2443097|NCT01106352|5992775|P5|Started Dose Escalation|Overall Study||0
2443098|NCT01106352|5992776|P4|Started Dose Escalation|Overall Study||0
2443099|NCT01106352|5992777|P3|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
2443100|NCT01106352|5992778|P2|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|3
2443101|NCT01106352|5992779|P1|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
2443102|NCT01106352|5992775|P5|STARTED|Overall Study||17
2443103|NCT01106352|5992776|P4|STARTED|Overall Study||36
2443104|NCT01106352|5992777|P3|STARTED|Overall Study||7
2443105|NCT01106352|5992778|P2|STARTED|Overall Study||3
2443106|NCT01106352|5992779|P1|STARTED|Overall Study||7
2443107|NCT01106326|5992865|P1|NOT COMPLETED|Overall Study||2
2443108|NCT01106326|5992865|P1|COMPLETED|Overall Study||28
2443109|NCT01106326|5992865|P1|STARTED|Overall Study||30
2443110|NCT01106287|5992875|P4|NOT COMPLETED|Overall Study||0
2443111|NCT01106287|5992876|P3|NOT COMPLETED|Overall Study||0
2443112|NCT01106287|5992877|P2|NOT COMPLETED|Overall Study||0
2443113|NCT01106287|5992878|P1|NOT COMPLETED|Overall Study||1
2443114|NCT01106287|5992875|P4|COMPLETED|Overall Study||3
2443115|NCT01106287|5992876|P3|COMPLETED|Overall Study||3
2443116|NCT01106287|5992877|P2|COMPLETED|Overall Study||3
2443117|NCT01106287|5992878|P1|COMPLETED|Overall Study||3
2443118|NCT01106287|5992875|P4|STARTED|Overall Study||3
2443119|NCT01106287|5992876|P3|STARTED|Overall Study||3
2443120|NCT01106287|5992877|P2|STARTED|Overall Study||3
2443121|NCT01106287|5992878|P1|STARTED|Overall Study|One participant that discontinued the study due to a pre-treatment adverse event was replaced.|4
2443122|NCT01106248|5992898|P1|NOT COMPLETED|Overall Study||3
2443123|NCT01106248|5992898|P1|COMPLETED|Overall Study||23
2443124|NCT01106248|5992898|P1|STARTED|Overall Study||26
2443125|NCT01106157|5992906|P2|NOT COMPLETED|Overall Study||0
2443126|NCT01106157|5992907|P1|NOT COMPLETED|Overall Study||1
2443127|NCT01106157|5992906|P2|COMPLETED|Overall Study||8
2443128|NCT01106157|5992907|P1|COMPLETED|Overall Study||16
2443129|NCT01106157|5992906|P2|STARTED|Overall Study||8
2443130|NCT01106157|5992907|P1|STARTED|Overall Study||17
2443131|NCT01106092|5992935|P4|NOT COMPLETED|Overall Study||1
2443132|NCT01106092|5992936|P3|NOT COMPLETED|Overall Study||0
2443133|NCT01106092|5992937|P2|NOT COMPLETED|Overall Study||0
2443134|NCT01106092|5992938|P1|NOT COMPLETED|Overall Study||0
2443135|NCT01106092|5992935|P4|COMPLETED|Overall Study||77
2443136|NCT01106092|5992936|P3|COMPLETED|Overall Study||78
2443137|NCT01106092|5992937|P2|COMPLETED|Overall Study||78
2443138|NCT01106092|5992938|P1|COMPLETED|Overall Study||78
2443139|NCT01106092|5992935|P4|STARTED|Overall Study||78
2443140|NCT01106092|5992936|P3|STARTED|Overall Study||78
2443141|NCT01106092|5992937|P2|STARTED|Overall Study||78
2443142|NCT01106092|5992938|P1|STARTED|Overall Study||78
2443143|NCT01106040|5993016|P1|NOT COMPLETED|Overall Study||11
2443144|NCT01106040|5993016|P1|COMPLETED|Overall Study||152
2443145|NCT01106040|5993016|P1|STARTED|Overall Study||163
2443146|NCT01106027|5993021|P1|NOT COMPLETED|Overall Study||1
2443147|NCT01106027|5993021|P1|COMPLETED|Overall Study||1
2443148|NCT01106027|5993021|P1|STARTED|Overall Study||2
2443149|NCT01106014|5993027|P2|NOT COMPLETED|Overall Study||330
2443150|NCT01106014|5993028|P1|NOT COMPLETED|Overall Study||285
2443151|NCT01106014|5993027|P2|COMPLETED|Overall Study||252
2443152|NCT01106014|5993028|P1|COMPLETED|Overall Study||289
2443153|NCT01106014|5993027|P2|STARTED|Overall Study||582
2443154|NCT01106014|5993028|P1|STARTED|Overall Study||574
2443155|NCT01105975|5993048|P10|NOT COMPLETED|Overall Study||9
2443156|NCT01105975|5993049|P9|NOT COMPLETED|Overall Study||6
2443157|NCT01105975|5993050|P8|NOT COMPLETED|Overall Study||7
2443158|NCT01105975|5993051|P7|NOT COMPLETED|Overall Study||8
2443159|NCT01105975|5993052|P6|NOT COMPLETED|Overall Study||5
2443160|NCT01105975|5993053|P5|NOT COMPLETED|Overall Study||6
2443161|NCT01105975|5993054|P4|NOT COMPLETED|Overall Study||2
2443162|NCT01105975|5993055|P3|NOT COMPLETED|Overall Study||10
2443163|NCT01105975|5993056|P2|NOT COMPLETED|Overall Study||5
2443164|NCT01105975|5993057|P1|NOT COMPLETED|Overall Study||5
2443165|NCT01105975|5993048|P10|COMPLETED|Overall Study||32
2443166|NCT01105975|5993049|P9|COMPLETED|Overall Study||34
2443167|NCT01105975|5993050|P8|COMPLETED|Overall Study||33
2443168|NCT01105975|5993051|P7|COMPLETED|Overall Study||34
2443169|NCT01105975|5993052|P6|COMPLETED|Overall Study||30
2443170|NCT01105975|5993053|P5|COMPLETED|Overall Study||35
2443171|NCT01105975|5993054|P4|COMPLETED|Overall Study||36
2443172|NCT01105975|5993055|P3|COMPLETED|Overall Study||32
2443173|NCT01105975|5993056|P2|COMPLETED|Overall Study||34
2443174|NCT01105975|5993057|P1|COMPLETED|Overall Study||35
2443175|NCT01105975|5993048|P10|Took at Least One Dose of Study Drug|Overall Study||41
2443176|NCT01105975|5993049|P9|Took at Least One Dose of Study Drug|Overall Study||39
2443177|NCT01105975|5993050|P8|Took at Least One Dose of Study Drug|Overall Study||40
2443178|NCT01105975|5993051|P7|Took at Least One Dose of Study Drug|Overall Study||41
2443179|NCT01105975|5993052|P6|Took at Least One Dose of Study Drug|Overall Study||35
2443180|NCT01105975|5993053|P5|Took at Least One Dose of Study Drug|Overall Study||41
2443181|NCT01105975|5993054|P4|Took at Least One Dose of Study Drug|Overall Study||38
2443182|NCT01105975|5993055|P3|Took at Least One Dose of Study Drug|Overall Study||40
2443183|NCT01105975|5993056|P2|Took at Least One Dose of Study Drug|Overall Study||38
2443184|NCT01105975|5993057|P1|Took at Least One Dose of Study Drug|Overall Study||40
2443185|NCT01105975|5993048|P10|STARTED|Overall Study||41
2443186|NCT01105975|5993049|P9|STARTED|Overall Study||40
2443187|NCT01105975|5993050|P8|STARTED|Overall Study||40
2443188|NCT01105975|5993051|P7|STARTED|Overall Study||42
2443189|NCT01105975|5993052|P6|STARTED|Overall Study||35
2443190|NCT01105975|5993053|P5|STARTED|Overall Study||41
2443191|NCT01105975|5993054|P4|STARTED|Overall Study||38
2443192|NCT01105975|5993055|P3|STARTED|Overall Study||42
2443193|NCT01105975|5993056|P2|STARTED|Overall Study||39
2443194|NCT01105975|5993057|P1|STARTED|Overall Study||40
2443195|NCT01105936|5993205|P4|NOT COMPLETED|Period 3||0
2443196|NCT01105936|5993206|P3|NOT COMPLETED|Period 3||0
2443197|NCT01105936|5993207|P2|NOT COMPLETED|Period 3||2
2443198|NCT01105936|5993208|P1|NOT COMPLETED|Period 3||0
2443199|NCT01105936|5993205|P4|COMPLETED|Period 3||7
2443200|NCT01105936|5993206|P3|COMPLETED|Period 3||7
2443201|NCT01105936|5993207|P2|COMPLETED|Period 3||6
2443202|NCT01105936|5993208|P1|COMPLETED|Period 3||7
2443203|NCT01105936|5993205|P4|STARTED|Period 3||7
2443204|NCT01105936|5993206|P3|STARTED|Period 3||7
2443205|NCT01105936|5993207|P2|STARTED|Period 3||8
2443206|NCT01105936|5993208|P1|STARTED|Period 3||7
2443207|NCT01105936|5993205|P4|NOT COMPLETED|Wash-out Period 2||0
2443208|NCT01105936|5993206|P3|NOT COMPLETED|Wash-out Period 2||0
2443209|NCT01105936|5993207|P2|NOT COMPLETED|Wash-out Period 2||0
2443210|NCT01105936|5993208|P1|NOT COMPLETED|Wash-out Period 2||0
2443211|NCT01105936|5993205|P4|COMPLETED|Wash-out Period 2||7
2443212|NCT01105936|5993206|P3|COMPLETED|Wash-out Period 2||7
2443213|NCT01105936|5993207|P2|COMPLETED|Wash-out Period 2||8
2443214|NCT01105936|5993208|P1|COMPLETED|Wash-out Period 2||7
2443215|NCT01105936|5993205|P4|STARTED|Wash-out Period 2||7
2443216|NCT01105936|5993206|P3|STARTED|Wash-out Period 2||7
2443217|NCT01105936|5993207|P2|STARTED|Wash-out Period 2||8
2443218|NCT01105936|5993208|P1|STARTED|Wash-out Period 2||7
2443219|NCT01105936|5993205|P4|NOT COMPLETED|Period 2||0
2443220|NCT01105936|5993206|P3|NOT COMPLETED|Period 2||0
2443221|NCT01105936|5993207|P2|NOT COMPLETED|Period 2||0
2443222|NCT01105936|5993208|P1|NOT COMPLETED|Period 2||1
2443223|NCT01105936|5993205|P4|COMPLETED|Period 2||7
2443224|NCT01105936|5993206|P3|COMPLETED|Period 2||7
2443225|NCT01105936|5993207|P2|COMPLETED|Period 2||8
2443226|NCT01105936|5993208|P1|COMPLETED|Period 2||7
2443227|NCT01105936|5993205|P4|STARTED|Period 2||7
2443228|NCT01105936|5993206|P3|STARTED|Period 2||7
2443229|NCT01105936|5993207|P2|STARTED|Period 2||8
2443230|NCT01105936|5993208|P1|STARTED|Period 2||8
2443231|NCT01105936|5993205|P4|NOT COMPLETED|Wash-out Period 1||0
2443232|NCT01105936|5993206|P3|NOT COMPLETED|Wash-out Period 1||0
2443233|NCT01105936|5993207|P2|NOT COMPLETED|Wash-out Period 1||0
2443234|NCT01105936|5993208|P1|NOT COMPLETED|Wash-out Period 1||0
2443235|NCT01105936|5993205|P4|COMPLETED|Wash-out Period 1||7
2443236|NCT01105936|5993206|P3|COMPLETED|Wash-out Period 1||7
2443237|NCT01105936|5993207|P2|COMPLETED|Wash-out Period 1||8
2443238|NCT01105936|5993208|P1|COMPLETED|Wash-out Period 1||8
2443239|NCT01105936|5993205|P4|STARTED|Wash-out Period 1||7
2443240|NCT01105936|5993206|P3|STARTED|Wash-out Period 1||7
2443241|NCT01105936|5993207|P2|STARTED|Wash-out Period 1||8
2443242|NCT01105936|5993208|P1|STARTED|Wash-out Period 1||8
2443243|NCT01105936|5993205|P4|NOT COMPLETED|Period 1||1
2443244|NCT01105936|5993206|P3|NOT COMPLETED|Period 1||0
2443245|NCT01105936|5993207|P2|NOT COMPLETED|Period 1||0
2443246|NCT01105936|5993208|P1|NOT COMPLETED|Period 1||0
2443247|NCT01105936|5993205|P4|COMPLETED|Period 1||7
2443248|NCT01105936|5993206|P3|COMPLETED|Period 1||7
2443249|NCT01105936|5993207|P2|COMPLETED|Period 1||8
2443250|NCT01105936|5993208|P1|COMPLETED|Period 1||8
2443251|NCT01105936|5993205|P4|STARTED|Period 1||8
2443252|NCT01105936|5993206|P3|STARTED|Period 1||7
2443253|NCT01105936|5993207|P2|STARTED|Period 1||8
2443254|NCT01105936|5993208|P1|STARTED|Period 1||8
2443255|NCT01105767|5993237|P3|NOT COMPLETED|Overall Study||1184
2443256|NCT01105767|5993238|P2|NOT COMPLETED|Overall Study||1614
2443257|NCT01105767|5993239|P1|NOT COMPLETED|Overall Study||1160
2443258|NCT01105767|5993237|P3|COMPLETED|Overall Study||8846
2443259|NCT01105767|5993238|P2|COMPLETED|Overall Study||9250
2443260|NCT01105767|5993239|P1|COMPLETED|Overall Study||8155
2443261|NCT01105767|5993237|P3|STARTED|Overall Study||10030
2443262|NCT01105767|5993238|P2|STARTED|Overall Study||10864
2443263|NCT01105767|5993239|P1|STARTED|Overall Study||9315
2443264|NCT01105754|5993252|P2|NOT COMPLETED|Overall Study||12
2443265|NCT01105754|5993253|P1|NOT COMPLETED|Overall Study||15
2443266|NCT01105754|5993252|P2|COMPLETED|Overall Study||307
2443267|NCT01105754|5993253|P1|COMPLETED|Overall Study||304
2443268|NCT01105754|5993252|P2|STARTED|Overall Study||319
2443269|NCT01105754|5993253|P1|STARTED|Overall Study||319
2443270|NCT01105702|5993261|P1|NOT COMPLETED|Overall Study||18
2443271|NCT01105702|5993261|P1|COMPLETED|Overall Study||10
2443272|NCT01105702|5993261|P1|STARTED|Overall Study||28
2443273|NCT01105650|5993271|P4|NOT COMPLETED|Overall Study||0
2443274|NCT01105650|5993272|P3|NOT COMPLETED|Overall Study||0
2443275|NCT01105650|5993273|P2|NOT COMPLETED|Overall Study||0
2443276|NCT01105650|5993274|P1|NOT COMPLETED|Overall Study||0
2443277|NCT01105650|5993271|P4|COMPLETED|Overall Study||0
2443278|NCT01105650|5993272|P3|COMPLETED|Overall Study||7
2443279|NCT01105650|5993273|P2|COMPLETED|Overall Study||3
2443280|NCT01105650|5993274|P1|COMPLETED|Overall Study||3
2443281|NCT01105650|5993271|P4|STARTED|Overall Study|Arm 3 was determined to be successful, thus eliminating the need to test Arm 4.|0
2443282|NCT01105650|5993272|P3|STARTED|Overall Study||7
2443283|NCT01105650|5993273|P2|STARTED|Overall Study||3
2443284|NCT01105650|5993274|P1|STARTED|Overall Study||3
2443285|NCT01105533|5993291|P9|NOT COMPLETED|Overall Study||12
2443286|NCT01105533|5993292|P8|NOT COMPLETED|Overall Study||4
2443287|NCT01105533|5993293|P7|NOT COMPLETED|Overall Study||8
2443288|NCT01105533|5993294|P6|NOT COMPLETED|Overall Study||7
2443289|NCT01105533|5993295|P5|NOT COMPLETED|Overall Study||7
2443290|NCT01105533|5993296|P4|NOT COMPLETED|Overall Study||3
2443291|NCT01105533|5993297|P3|NOT COMPLETED|Overall Study||3
2443292|NCT01105533|5993298|P2|NOT COMPLETED|Overall Study||1
2443293|NCT01105533|5993299|P1|NOT COMPLETED|Overall Study||1
2443294|NCT01105533|5993291|P9|COMPLETED|Overall Study||0
2443295|NCT01105533|5993292|P8|COMPLETED|Overall Study||0
2443296|NCT01105533|5993293|P7|COMPLETED|Overall Study||0
2443297|NCT01105533|5993294|P6|COMPLETED|Overall Study||0
2443298|NCT01105533|5993295|P5|COMPLETED|Overall Study||0
2443299|NCT01105533|5993296|P4|COMPLETED|Overall Study||0
2443300|NCT01105533|5993297|P3|COMPLETED|Overall Study||0
2443301|NCT01105533|5993298|P2|COMPLETED|Overall Study||0
2443302|NCT01105533|5993299|P1|COMPLETED|Overall Study||0
2443303|NCT01105533|5993291|P9|STARTED|Overall Study||12
2443304|NCT01105533|5993292|P8|STARTED|Overall Study||4
2443305|NCT01105533|5993293|P7|STARTED|Overall Study||8
2443306|NCT01105533|5993294|P6|STARTED|Overall Study||7
2443307|NCT01105533|5993295|P5|STARTED|Overall Study||7
2443308|NCT01105533|5993296|P4|STARTED|Overall Study||3
2443309|NCT01105533|5993297|P3|STARTED|Overall Study||3
2443310|NCT01105533|5993298|P2|STARTED|Overall Study||1
2443311|NCT01105533|5993299|P1|STARTED|Overall Study||1
2443312|NCT01105377|5993389|P2|NOT COMPLETED|Overall Study||1
2443313|NCT01105377|5993390|P1|NOT COMPLETED|Overall Study||0
2443314|NCT01105377|5993389|P2|COMPLETED|Overall Study||22
2443315|NCT01105377|5993390|P1|COMPLETED|Overall Study||24
2443316|NCT01105377|5993389|P2|STARTED|Overall Study||23
2443317|NCT01105377|5993390|P1|STARTED|Overall Study||24
2443318|NCT01105312|5993401|P3|NOT COMPLETED|Overall Study||0
2443319|NCT01105312|5993402|P2|NOT COMPLETED|Overall Study||0
2443320|NCT01105312|5993403|P1|NOT COMPLETED|Overall Study||3
2443321|NCT01105312|5993401|P3|COMPLETED|Overall Study||6
2443322|NCT01105312|5993402|P2|COMPLETED|Overall Study||6
2443323|NCT01105312|5993403|P1|COMPLETED|Overall Study||13
2443324|NCT01105312|5993401|P3|STARTED|Overall Study||6
2443325|NCT01105312|5993402|P2|STARTED|Overall Study||6
2443326|NCT01105312|5993403|P1|STARTED|Overall Study||16
2443327|NCT01105247|5993421|P2|NOT COMPLETED|Overall Study||0
2443328|NCT01105247|5993422|P1|NOT COMPLETED|Overall Study||37
2443329|NCT01105247|5993421|P2|COMPLETED|Overall Study||16
2443330|NCT01105247|5993422|P1|COMPLETED|Overall Study||79
2443331|NCT01105247|5993421|P2|STARTED|Overall Study||16
2443332|NCT01105247|5993422|P1|STARTED|Overall Study||116
2443333|NCT01105130|5993438|P3|NOT COMPLETED|Overall Study||10
2443334|NCT01105130|5993439|P2|NOT COMPLETED|Overall Study||11
2443335|NCT01105130|5993440|P1|NOT COMPLETED|Overall Study||10
2443336|NCT01105130|5993438|P3|COMPLETED|Overall Study||37
2443337|NCT01105130|5993439|P2|COMPLETED|Overall Study||34
2443338|NCT01105130|5993440|P1|COMPLETED|Overall Study||38
2443339|NCT01105130|5993438|P3|STARTED|Overall Study||47
2443340|NCT01105130|5993439|P2|STARTED|Overall Study||45
2443341|NCT01105130|5993440|P1|STARTED|Overall Study||48
2443342|NCT01105117|5993459|P2|NOT COMPLETED|Overall Study||0
2443343|NCT01105117|5993460|P1|NOT COMPLETED|Overall Study||0
2443344|NCT01105117|5993459|P2|COMPLETED|Overall Study||1
2443345|NCT01105117|5993460|P1|COMPLETED|Overall Study||1
2443346|NCT01105117|5993459|P2|STARTED|Overall Study||1
2443347|NCT01105117|5993460|P1|STARTED|Overall Study||1
2443348|NCT01105091|5993470|P2|NOT COMPLETED|Overall Study||0
2443349|NCT01105091|5993471|P1|NOT COMPLETED|Overall Study||2
2443350|NCT01105091|5993470|P2|COMPLETED|Overall Study||10
2443351|NCT01105091|5993471|P1|COMPLETED|Overall Study||18
2443352|NCT01105091|5993470|P2|STARTED|Overall Study||10
2443353|NCT01105091|5993471|P1|STARTED|Overall Study||20
2443354|NCT01105065|5993495|P1|NOT COMPLETED|Overall Study||6
2443355|NCT01105065|5993495|P1|COMPLETED|Overall Study||17
2443356|NCT01105065|5993495|P1|STARTED|Overall Study||23
2443357|NCT01104870|5993504|P3|NOT COMPLETED|Overall Study||2
2443358|NCT01104870|5993505|P2|NOT COMPLETED|Overall Study||1
2443359|NCT01104870|5993506|P1|NOT COMPLETED|Overall Study||1
2443360|NCT01104870|5993504|P3|COMPLETED|Overall Study||18
2443361|NCT01104870|5993505|P2|COMPLETED|Overall Study||18
2443362|NCT01104870|5993506|P1|COMPLETED|Overall Study||10
2443363|NCT01104870|5993504|P3|STARTED|Overall Study||20
2443364|NCT01104870|5993505|P2|STARTED|Overall Study||19
2443365|NCT01104870|5993506|P1|STARTED|Overall Study||11
2443366|NCT01104792|5993535|P1|NOT COMPLETED|Overall Study||526
2443367|NCT01104792|5993535|P1|COMPLETED|Overall Study||226
2443368|NCT01104792|5993535|P1|STARTED|Overall Study||752
2443369|NCT01104779|5993543|P3|NOT COMPLETED|Overall Study||62
2443370|NCT01104779|5993544|P2|NOT COMPLETED|Overall Study||55
2443371|NCT01104779|5993545|P1|NOT COMPLETED|Overall Study||59
2443372|NCT01104779|5993543|P3|COMPLETED|Overall Study||86
2443373|NCT01104779|5993544|P2|COMPLETED|Overall Study||96
2443374|NCT01104779|5993545|P1|COMPLETED|Overall Study||88
2443375|NCT01104779|5993543|P3|STARTED|Overall Study||148
2443376|NCT01104779|5993544|P2|STARTED|Overall Study||151
2443377|NCT01104779|5993545|P1|STARTED|Overall Study||147
2443378|NCT01104766|5993560|P4|NOT COMPLETED|Overall Study||38
2443379|NCT01104766|5993561|P3|NOT COMPLETED|Overall Study||60
2443380|NCT01104766|5993562|P2|NOT COMPLETED|Overall Study||51
2443381|NCT01104766|5993563|P1|NOT COMPLETED|Overall Study||58
2443382|NCT01104766|5993560|P4|COMPLETED|Overall Study||114
2443383|NCT01104766|5993561|P3|COMPLETED|Overall Study||97
2443384|NCT01104766|5993562|P2|COMPLETED|Overall Study||104
2443385|NCT01104766|5993563|P1|COMPLETED|Overall Study||95
2443386|NCT01104766|5993560|P4|STARTED|Overall Study||152
2443387|NCT01104766|5993561|P3|STARTED|Overall Study||157
2443388|NCT01104766|5993562|P2|STARTED|Overall Study||155
2443389|NCT01104766|5993563|P1|STARTED|Overall Study||153
2443390|NCT01104701|5993581|P4|NOT COMPLETED|Overall Study||2
2443391|NCT01104701|5993582|P3|NOT COMPLETED|Overall Study||2
2443392|NCT01104701|5993583|P2|NOT COMPLETED|Overall Study||3
2443393|NCT01104701|5993584|P1|NOT COMPLETED|Overall Study||0
2443394|NCT01104701|5993581|P4|COMPLETED|Overall Study||28
2443395|NCT01104701|5993582|P3|COMPLETED|Overall Study||29
2443396|NCT01104701|5993583|P2|COMPLETED|Overall Study||27
2443397|NCT01104701|5993584|P1|COMPLETED|Overall Study||30
2443398|NCT01104701|5993581|P4|STARTED|Overall Study||30
2443399|NCT01104701|5993582|P3|STARTED|Overall Study||31
2443400|NCT01104701|5993583|P2|STARTED|Overall Study||30
2443401|NCT01104701|5993584|P1|STARTED|Overall Study||30
2443402|NCT01104662|5993646|P8|NOT COMPLETED|Overall Study||0
2443403|NCT01104662|5993647|P7|NOT COMPLETED|Overall Study||0
2443404|NCT01104662|5993648|P6|NOT COMPLETED|Overall Study||4
2443405|NCT01104662|5993649|P5|NOT COMPLETED|Overall Study||1
2443406|NCT01104662|5993650|P4|NOT COMPLETED|Overall Study||1
2443407|NCT01104662|5993651|P3|NOT COMPLETED|Overall Study||1
2443408|NCT01104662|5993652|P2|NOT COMPLETED|Overall Study||10
2443409|NCT01104662|5993653|P1|NOT COMPLETED|Overall Study||10
2443410|NCT01104662|5993646|P8|COMPLETED|Overall Study||6
2443411|NCT01104662|5993647|P7|COMPLETED|Overall Study||5
2443412|NCT01104662|5993648|P6|COMPLETED|Overall Study||12
2443413|NCT01104662|5993649|P5|COMPLETED|Overall Study||14
2443414|NCT01104662|5993650|P4|COMPLETED|Overall Study||3
2443415|NCT01104662|5993651|P3|COMPLETED|Overall Study||4
2443416|NCT01104662|5993652|P2|COMPLETED|Overall Study||11
2443417|NCT01104662|5993653|P1|COMPLETED|Overall Study||10
2443418|NCT01104662|5993646|P8|Received at Least 1 Dose of Study Drug|Overall Study||6
2443419|NCT01104662|5993647|P7|Received at Least 1 Dose of Study Drug|Overall Study||5
2443420|NCT01104662|5993648|P6|Received at Least 1 Dose of Study Drug|Overall Study||15
2443421|NCT01104662|5993649|P5|Received at Least 1 Dose of Study Drug|Overall Study||15
2443422|NCT01104662|5993650|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
2443423|NCT01104662|5993651|P3|Received at Least 1 Dose of Study Drug|Overall Study||4
2443424|NCT01104662|5993652|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
2443425|NCT01104662|5993653|P1|Received at Least 1 Dose of Study Drug|Overall Study||17
2443426|NCT01104662|5993646|P8|STARTED|Overall Study||6
2443427|NCT01104662|5993647|P7|STARTED|Overall Study||5
2443428|NCT01104662|5993648|P6|STARTED|Overall Study||16
2443429|NCT01104662|5993649|P5|STARTED|Overall Study||15
2443430|NCT01104662|5993650|P4|STARTED|Overall Study||4
2443431|NCT01104662|5993651|P3|STARTED|Overall Study||5
2443432|NCT01104662|5993652|P2|STARTED|Overall Study||21
2443433|NCT01104662|5993653|P1|STARTED|Overall Study||20
2443434|NCT01104636|5993679|P1|NOT COMPLETED|Overall Study||178
2443435|NCT01104636|5993679|P1|COMPLETED|Overall Study||999
2443436|NCT01104636|5993679|P1|STARTED|Overall Study||1177
2443437|NCT01104584|5993684|P1|NOT COMPLETED|Overall Study||23
2443438|NCT01104584|5993684|P1|COMPLETED|Overall Study|study course completed|437
2443439|NCT01104584|5993684|P1|Fulfilled Requirements of FAS Population|Overall Study||397
2443440|NCT01104584|5993684|P1|Received Treatment|Overall Study|treatment started|439
2443441|NCT01104584|5993684|P1|STARTED|Overall Study|screened and enrolled|460
2443442|NCT01104558|5993754|P1|NOT COMPLETED|Overall Study||17
2443443|NCT01104558|5993754|P1|COMPLETED|Overall Study||83
2443444|NCT01104558|5993754|P1|STARTED|Overall Study||100
2443445|NCT01104545|5993798|P3|NOT COMPLETED|Overall Study||2
2443446|NCT01104545|5993799|P2|NOT COMPLETED|Overall Study||1
2443447|NCT01104545|5993800|P1|NOT COMPLETED|Overall Study||0
2443448|NCT01104545|5993798|P3|COMPLETED|Overall Study|Participants discontinued after receiving MK-3614 0.75 mg (Period 1)and placebo (Period 2)|6
2443449|NCT01104545|5993799|P2|COMPLETED|Overall Study|Participant discontinued after receiving 0.75 mg MK-3614 in Period 1|7
2443450|NCT01104545|5993800|P1|COMPLETED|Overall Study||8
2443451|NCT01104545|5993798|P3|STARTED|Overall Study|1 participant received 0.50 mg of MK-3614 or placebo in Periods 3 and 4 instead of planned 0.75 mg|8
2443452|NCT01104545|5993799|P2|STARTED|Overall Study||8
2443453|NCT01104545|5993800|P1|STARTED|Overall Study||8
2443454|NCT01104493|5993957|P2|NOT COMPLETED|Overall Study||2
2443455|NCT01104493|5993958|P1|NOT COMPLETED|Overall Study||0
2443456|NCT01104493|5993957|P2|COMPLETED|Overall Study||58
2443457|NCT01104493|5993958|P1|COMPLETED|Overall Study||240
2443458|NCT01104493|5993957|P2|STARTED|Overall Study||60
2443459|NCT01104493|5993958|P1|STARTED|Overall Study||240
2443460|NCT01104415|5993976|P2|NOT COMPLETED|Extension Period||11
2443461|NCT01104415|5993977|P1|NOT COMPLETED|Extension Period||0
2443462|NCT01104415|5993976|P2|COMPLETED|Extension Period||0
2443463|NCT01104415|5993977|P1|COMPLETED|Extension Period||0
2443464|NCT01104415|5993976|P2|STARTED|Extension Period|Out of 14 participants who completed Core Phase, 3 were not eligible to enter the Extension Period.|11
2443465|NCT01104415|5993977|P1|STARTED|Extension Period||0
2443466|NCT01104415|5993976|P2|NOT COMPLETED|Core Phase||0
2443467|NCT01104415|5993977|P1|NOT COMPLETED|Core Phase||1
2443468|NCT01104415|5993976|P2|COMPLETED|Core Phase||0
2443469|NCT01104415|5993977|P1|COMPLETED|Core Phase||14
2443470|NCT01104415|5993976|P2|STARTED|Core Phase||0
2443471|NCT01104415|5993977|P1|STARTED|Core Phase||15
2443472|NCT01104402|5994002|P2|NOT COMPLETED|Overall Study||33
2443473|NCT01104402|5994003|P1|NOT COMPLETED|Overall Study||21
2443474|NCT01104402|5994002|P2|COMPLETED|Overall Study||102
2443475|NCT01104402|5994003|P1|COMPLETED|Overall Study||111
2443476|NCT01104402|5994002|P2|STARTED|Overall Study||135
2443477|NCT01104402|5994003|P1|STARTED|Overall Study||132
2443478|NCT01104376|5994021|P1|NOT COMPLETED|Overall Study||28
2443479|NCT01104376|5994021|P1|COMPLETED|Overall Study||61
2443480|NCT01104376|5994021|P1|STARTED|Overall Study||89
2443481|NCT01104311|5994027|P2|NOT COMPLETED|Overall Study||12
2443482|NCT01104311|5994028|P1|NOT COMPLETED|Overall Study||10
2443483|NCT01104311|5994027|P2|COMPLETED|Overall Study||54
2443484|NCT01104311|5994028|P1|COMPLETED|Overall Study||56
2443485|NCT01104311|5994027|P2|STARTED|Overall Study||66
2443486|NCT01104311|5994028|P1|STARTED|Overall Study||66
2443487|NCT01104285|5994048|P2|NOT COMPLETED|Overall Study||0
2443488|NCT01104285|5994049|P1|NOT COMPLETED|Overall Study||0
2443489|NCT01104285|5994048|P2|COMPLETED|Overall Study||86
2443490|NCT01104285|5994049|P1|COMPLETED|Overall Study||112
2443491|NCT01104285|5994048|P2|STARTED|Overall Study||86
2443492|NCT01104285|5994049|P1|STARTED|Overall Study||112
2443493|NCT01104246|5994055|P1|NOT COMPLETED|Overall Study||5
2443494|NCT01104246|5994055|P1|COMPLETED|Overall Study||35
2443495|NCT01104246|5994055|P1|Baseline Characteristics Measured|Overall Study||35
2443496|NCT01104246|5994055|P1|STARTED|Overall Study||40
2443497|NCT01104207|5994061|P2|NOT COMPLETED|Overall Study||3
2443498|NCT01104207|5994062|P1|NOT COMPLETED|Overall Study||3
2443499|NCT01104207|5994061|P2|COMPLETED|Overall Study||32
2443500|NCT01104207|5994062|P1|COMPLETED|Overall Study||32
2443501|NCT01104207|5994061|P2|STARTED|Overall Study||35
2443502|NCT01104207|5994062|P1|STARTED|Overall Study||35
2443503|NCT01104155|5994070|P2|NOT COMPLETED|Overall Study||18
2443504|NCT01104155|5994071|P1|NOT COMPLETED|Overall Study||25
2443505|NCT01104155|5994070|P2|COMPLETED|Overall Study||42
2443506|NCT01104155|5994071|P1|COMPLETED|Overall Study||38
2443507|NCT01104155|5994070|P2|STARTED|Overall Study||60
2443508|NCT01104155|5994071|P1|STARTED|Overall Study||63
2443509|NCT01104116|5994085|P1|NOT COMPLETED|Overall Study||0
2443510|NCT01104116|5994085|P1|COMPLETED|Overall Study||1
2443511|NCT01104116|5994085|P1|STARTED|Overall Study||1
2443512|NCT01104103|5994092|P2|NOT COMPLETED|Overall Study||0
2443513|NCT01104103|5994093|P1|NOT COMPLETED|Overall Study||0
2443514|NCT01104103|5994092|P2|COMPLETED|Overall Study||224
2443515|NCT01104103|5994093|P1|COMPLETED|Overall Study||243
2443516|NCT01104103|5994092|P2|STARTED|Overall Study||224
2443517|NCT01104103|5994093|P1|STARTED|Overall Study||243
2443518|NCT01103973|5994103|P2|NOT COMPLETED|Overall Study||0
2443519|NCT01103973|5994104|P1|NOT COMPLETED|Overall Study||0
2443520|NCT01103973|5994103|P2|COMPLETED|Overall Study||46
2443521|NCT01103973|5994104|P1|COMPLETED|Overall Study||51
2443522|NCT01103973|5994103|P2|STARTED|Overall Study||46
2443523|NCT01103973|5994104|P1|STARTED|Overall Study||51
2443524|NCT01103960|5994114|P2|NOT COMPLETED|Overall Study||2
2443525|NCT01103960|5994115|P1|NOT COMPLETED|Overall Study||5
2443526|NCT01103960|5994114|P2|COMPLETED|Overall Study|Completed study medication.|158
2443527|NCT01103960|5994115|P1|COMPLETED|Overall Study|Completed study medication.|159
2443528|NCT01103960|5994114|P2|STARTED|Overall Study|Randomised and treated.|160
2443529|NCT01103960|5994115|P1|STARTED|Overall Study|Randomised and treated.|164
2443530|NCT01103934|5994141|P2|NOT COMPLETED|Overall Study||0
2443531|NCT01103934|5994142|P1|NOT COMPLETED|Overall Study||0
2443532|NCT01103934|5994141|P2|COMPLETED|Overall Study||18
2443533|NCT01103934|5994142|P1|COMPLETED|Overall Study||17
2443534|NCT01103934|5994141|P2|STARTED|Overall Study||18
2443535|NCT01103934|5994142|P1|STARTED|Overall Study||17
2443536|NCT01103778|5994150|P1|NOT COMPLETED|Overall Study||3
2443537|NCT01103778|5994150|P1|COMPLETED|Overall Study||8
2443538|NCT01103778|5994150|P1|STARTED|Overall Study||11
2443539|NCT01103713|5994157|P1|NOT COMPLETED|Overall Study||13
2443540|NCT01103713|5994157|P1|COMPLETED|Overall Study||155
2443541|NCT01103713|5994157|P1|STARTED|Overall Study||168
2443542|NCT01103505|5994185|P2|NOT COMPLETED|Overall Study||20
2443543|NCT01103505|5994186|P1|NOT COMPLETED|Overall Study||24
2443544|NCT01103505|5994185|P2|COMPLETED|Overall Study||737
2443545|NCT01103505|5994186|P1|COMPLETED|Overall Study||739
2443546|NCT01103505|5994185|P2|STARTED|Overall Study||757
2443547|NCT01103505|5994186|P1|STARTED|Overall Study||763
2443548|NCT01103492|5994200|P1|NOT COMPLETED|Overall Study||0
2443549|NCT01103492|5994200|P1|COMPLETED|Overall Study||1
2443550|NCT01103492|5994200|P1|STARTED|Overall Study||1
2443551|NCT01103479|5994207|P3|NOT COMPLETED|Overall Study||14
2443552|NCT01103479|5994208|P2|NOT COMPLETED|Overall Study||9
2443553|NCT01103479|5994209|P1|NOT COMPLETED|Overall Study||5
2443554|NCT01103479|5994207|P3|COMPLETED|Overall Study||174
2443555|NCT01103479|5994208|P2|COMPLETED|Overall Study||201
2443556|NCT01103479|5994209|P1|COMPLETED|Overall Study||163
2443557|NCT01103479|5994207|P3|STARTED|Overall Study||188
2443558|NCT01103479|5994208|P2|STARTED|Overall Study||210
2443559|NCT01103479|5994209|P1|STARTED|Overall Study||168
2443560|NCT01103466|5994222|P3|NOT COMPLETED|Third Period (14 +/- 3 Days)||1
2443561|NCT01103466|5994223|P2|NOT COMPLETED|Third Period (14 +/- 3 Days)||0
2443562|NCT01103466|5994224|P1|NOT COMPLETED|Third Period (14 +/- 3 Days)||2
2443563|NCT01103466|5994222|P3|COMPLETED|Third Period (14 +/- 3 Days)||13
2443564|NCT01103466|5994223|P2|COMPLETED|Third Period (14 +/- 3 Days)||8
2443565|NCT01103466|5994224|P1|COMPLETED|Third Period (14 +/- 3 Days)||6
2443566|NCT01103466|5994222|P3|STARTED|Third Period (14 +/- 3 Days)||14
2443567|NCT01103466|5994223|P2|STARTED|Third Period (14 +/- 3 Days)||8
2443568|NCT01103466|5994224|P1|STARTED|Third Period (14 +/- 3 Days)||8
2443569|NCT01103466|5994222|P3|NOT COMPLETED|Second Period (14 +/- 3 Days)||1
2443570|NCT01103466|5994223|P2|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
2443571|NCT01103466|5994224|P1|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
2443572|NCT01103466|5994222|P3|COMPLETED|Second Period (14 +/- 3 Days)||6
2443573|NCT01103466|5994223|P2|COMPLETED|Second Period (14 +/- 3 Days)||11
2443574|NCT01103466|5994224|P1|COMPLETED|Second Period (14 +/- 3 Days)||13
2443575|NCT01103466|5994222|P3|STARTED|Second Period (14 +/- 3 Days)||7
2443576|NCT01103466|5994223|P2|STARTED|Second Period (14 +/- 3 Days)||13
2443577|NCT01103466|5994224|P1|STARTED|Second Period (14 +/- 3 Days)||15
2443578|NCT01103466|5994222|P3|NOT COMPLETED|First Period (14 +/- 3 Days)||0
2443579|NCT01103466|5994223|P2|NOT COMPLETED|First Period (14 +/- 3 Days)||0
2443580|NCT01103466|5994224|P1|NOT COMPLETED|First Period (14 +/- 3 Days)||2
2443581|NCT01103466|5994222|P3|COMPLETED|First Period (14 +/- 3 Days)||13
2443582|NCT01103466|5994223|P2|COMPLETED|First Period (14 +/- 3 Days)||12
2443583|NCT01103466|5994224|P1|COMPLETED|First Period (14 +/- 3 Days)||10
2443584|NCT01103466|5994222|P3|STARTED|First Period (14 +/- 3 Days)||13
2443585|NCT01103466|5994223|P2|STARTED|First Period (14 +/- 3 Days)||12
2443586|NCT01103466|5994224|P1|STARTED|First Period (14 +/- 3 Days)||12
2443587|NCT01103440|5994234|P2|NOT COMPLETED|Overall Study||0
2443588|NCT01103440|5994235|P1|NOT COMPLETED|Overall Study||0
2443589|NCT01103440|5994234|P2|COMPLETED|Overall Study||18
2443590|NCT01103440|5994235|P1|COMPLETED|Overall Study||18
2443591|NCT01103440|5994234|P2|STARTED|Overall Study||18
2443592|NCT01103440|5994235|P1|STARTED|Overall Study||18
2443593|NCT01103414|5994248|P5|NOT COMPLETED|Overall Study||15
2443594|NCT01103414|5994249|P4|NOT COMPLETED|Overall Study||7
2443595|NCT01103414|5994250|P3|NOT COMPLETED|Overall Study||15
2443596|NCT01103414|5994251|P2|NOT COMPLETED|Overall Study||9
2443597|NCT01103414|5994252|P1|NOT COMPLETED|Overall Study||13
2443598|NCT01103414|5994248|P5|COMPLETED|Overall Study||56
2443599|NCT01103414|5994249|P4|COMPLETED|Overall Study||64
2443600|NCT01103414|5994250|P3|COMPLETED|Overall Study||56
2443601|NCT01103414|5994251|P2|COMPLETED|Overall Study||62
2443602|NCT01103414|5994252|P1|COMPLETED|Overall Study||59
2443603|NCT01103414|5994248|P5|STARTED|Overall Study||71
2443604|NCT01103414|5994249|P4|STARTED|Overall Study||71
2443605|NCT01103414|5994250|P3|STARTED|Overall Study||71
2443606|NCT01103414|5994251|P2|STARTED|Overall Study||71
2443607|NCT01103414|5994252|P1|STARTED|Overall Study||72
2443608|NCT01103362|5994314|P1|NOT COMPLETED|Overall Study||596
2443609|NCT01103362|5994314|P1|COMPLETED|Overall Study||0
2443610|NCT01103362|5994314|P1|STARTED|Overall Study||596
2443611|NCT01103323|5994320|P2|NOT COMPLETED|Switched From Placebo to Regorafenib||1
2443612|NCT01103323|5994321|P1|NOT COMPLETED|Switched From Placebo to Regorafenib||0
2443613|NCT01103323|5994320|P2|COMPLETED|Switched From Placebo to Regorafenib||3
2443614|NCT01103323|5994321|P1|COMPLETED|Switched From Placebo to Regorafenib||0
2443615|NCT01103323|5994320|P2|STARTED|Switched From Placebo to Regorafenib|Participants in the placebo+BSC group switched to Regorafenib treatment after unblinding.|4
2443616|NCT01103323|5994321|P1|STARTED|Switched From Placebo to Regorafenib||0
2443617|NCT01103323|5994320|P2|NOT COMPLETED|Without/Before Drug Switch||18
2443618|NCT01103323|5994321|P1|NOT COMPLETED|Without/Before Drug Switch||76
2443619|NCT01103323|5994320|P2|COMPLETED|Without/Before Drug Switch||237
2443620|NCT01103323|5994321|P1|COMPLETED|Without/Before Drug Switch||429
2443621|NCT01103323|5994320|P2|Participants Received Treatment|Without/Before Drug Switch||253
2443622|NCT01103323|5994321|P1|Participants Received Treatment|Without/Before Drug Switch||500
2443623|NCT01103323|5994320|P2|STARTED|Without/Before Drug Switch||255
2443624|NCT01103323|5994321|P1|STARTED|Without/Before Drug Switch||505
2443625|NCT01103284|5994338|P2|NOT COMPLETED|Overall Study||44
2443626|NCT01103284|5994339|P1|NOT COMPLETED|Overall Study||42
2443627|NCT01103284|5994338|P2|COMPLETED|Overall Study||195
2443628|NCT01103284|5994339|P1|COMPLETED|Overall Study||194
2443629|NCT01103284|5994338|P2|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS)|235
2443630|NCT01103284|5994339|P1|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS) population|233
2443631|NCT01103284|5994338|P2|Treated|Overall Study||238
2443632|NCT01103284|5994339|P1|Treated|Overall Study||236
2443633|NCT01103284|5994338|P2|STARTED|Overall Study||239
2443634|NCT01103284|5994339|P1|STARTED|Overall Study||236
2443635|NCT01103271|5994355|P2|NOT COMPLETED|Overall Study||4
2443636|NCT01103271|5994356|P1|NOT COMPLETED|Overall Study||1
2443637|NCT01103271|5994355|P2|COMPLETED|Overall Study||5
2443638|NCT01103271|5994356|P1|COMPLETED|Overall Study||10
2443639|NCT01103271|5994355|P2|STARTED|Overall Study||9
2443640|NCT01103271|5994356|P1|STARTED|Overall Study||11
2443641|NCT01103245|5994367|P4|NOT COMPLETED|Overall Study||0
2443642|NCT01103245|5994368|P3|NOT COMPLETED|Overall Study||4
2443643|NCT01103245|5994369|P2|NOT COMPLETED|Overall Study||2
2443644|NCT01103245|5994370|P1|NOT COMPLETED|Overall Study||3
2443645|NCT01103245|5994367|P4|COMPLETED|Overall Study||6
2443646|NCT01103245|5994368|P3|COMPLETED|Overall Study||8
2443647|NCT01103245|5994369|P2|COMPLETED|Overall Study||5
2443648|NCT01103245|5994370|P1|COMPLETED|Overall Study||10
2443649|NCT01103245|5994367|P4|STARTED|Overall Study||6
2443650|NCT01103245|5994368|P3|STARTED|Overall Study||12
2443651|NCT01103245|5994369|P2|STARTED|Overall Study||7
2443652|NCT01103245|5994370|P1|STARTED|Overall Study||13
2443653|NCT01103232|5994386|P2|NOT COMPLETED|Overall Study||2
2443654|NCT01103232|5994387|P1|NOT COMPLETED|Overall Study||1
2443655|NCT01103232|5994386|P2|COMPLETED|Overall Study||11
2443656|NCT01103232|5994387|P1|COMPLETED|Overall Study||12
2443657|NCT01103232|5994386|P2|STARTED|Overall Study||13
2443658|NCT01103232|5994387|P1|STARTED|Overall Study||13
2443659|NCT01103180|5994395|P2|NOT COMPLETED|Overall Study||21
2443660|NCT01103180|5994396|P1|NOT COMPLETED|Overall Study||22
2443661|NCT01103180|5994395|P2|COMPLETED|Overall Study||14
2443662|NCT01103180|5994396|P1|COMPLETED|Overall Study||13
2443663|NCT01103180|5994395|P2|STARTED|Overall Study||35
2443664|NCT01103180|5994396|P1|STARTED|Overall Study||35
2443665|NCT01103141|5994406|P2|NOT COMPLETED|Overall Study||2
2443666|NCT01103141|5994407|P1|NOT COMPLETED|Overall Study||2
2443667|NCT01103141|5994406|P2|COMPLETED|Overall Study||74
2443668|NCT01103141|5994407|P1|COMPLETED|Overall Study||65
2443669|NCT01103141|5994406|P2|STARTED|Overall Study||76
2443670|NCT01103141|5994407|P1|STARTED|Overall Study||67
2443671|NCT01103063|5994415|P2|NOT COMPLETED|Overall Study||421
2443672|NCT01103063|5994416|P1|NOT COMPLETED|Overall Study||477
2443673|NCT01103063|5994415|P2|COMPLETED|Overall Study||1024
2443674|NCT01103063|5994416|P1|COMPLETED|Overall Study||969
2443675|NCT01103063|5994415|P2|STARTED|Overall Study||1445
2443676|NCT01103063|5994416|P1|STARTED|Overall Study||1446
2443677|NCT01102972|5994484|P2|NOT COMPLETED|Overall Study||14
2443678|NCT01102972|5994485|P1|NOT COMPLETED|Overall Study||29
2443679|NCT01102972|5994484|P2|COMPLETED|Overall Study|These participants completed Study Week 48.|83
2443680|NCT01102972|5994485|P1|COMPLETED|Overall Study|These participants completed Study Week 48.|170
2443681|NCT01102972|5994484|P2|Completed Week 24|Overall Study||88
2443682|NCT01102972|5994485|P1|Completed Week 24|Overall Study||180
2443683|NCT01102972|5994484|P2|STARTED|Overall Study|297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn’t “start” the study.|97
2443684|NCT01102972|5994485|P1|STARTED|Overall Study|297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn’t “start” the study.|199
2443685|NCT01102894|5994537|P1|NOT COMPLETED|Overall Study||0
2443686|NCT01102894|5994537|P1|COMPLETED|Overall Study||10
2443687|NCT01102894|5994537|P1|STARTED|Overall Study||10
2443688|NCT01102803|5994549|P2|NOT COMPLETED|Post to Follow-Up||3
2443689|NCT01102803|5994550|P1|NOT COMPLETED|Post to Follow-Up||1
2443690|NCT01102803|5994549|P2|COMPLETED|Post to Follow-Up||12
2443691|NCT01102803|5994550|P1|COMPLETED|Post to Follow-Up||10
2443692|NCT01102803|5994549|P2|STARTED|Post to Follow-Up||15
2443693|NCT01102803|5994550|P1|STARTED|Post to Follow-Up||11
2443694|NCT01102803|5994549|P2|NOT COMPLETED|Baseline to Post-Treatment||0
2443695|NCT01102803|5994550|P1|NOT COMPLETED|Baseline to Post-Treatment||3
2443696|NCT01102803|5994549|P2|COMPLETED|Baseline to Post-Treatment||15
2443697|NCT01102803|5994550|P1|COMPLETED|Baseline to Post-Treatment||11
2443698|NCT01102803|5994549|P2|STARTED|Baseline to Post-Treatment||15
2443699|NCT01102803|5994550|P1|STARTED|Baseline to Post-Treatment||14
2443700|NCT01102777|5994564|P2|NOT COMPLETED|Overall Study||16
2443701|NCT01102777|5994565|P1|NOT COMPLETED|Overall Study||9
2443702|NCT01102777|5994564|P2|COMPLETED|Overall Study||139
2443703|NCT01102777|5994565|P1|COMPLETED|Overall Study||75
2443704|NCT01102777|5994564|P2|STARTED|Overall Study||155
2443705|NCT01102777|5994565|P1|STARTED|Overall Study||84
2443706|NCT01102764|5994591|P2|NOT COMPLETED|Overall Study||13
2443707|NCT01102764|5994592|P1|NOT COMPLETED|Overall Study||21
2443708|NCT01102764|5994591|P2|COMPLETED|Overall Study||55
2443709|NCT01102764|5994592|P1|COMPLETED|Overall Study||43
2443710|NCT01102764|5994591|P2|STARTED|Overall Study||68
2443711|NCT01102764|5994592|P1|STARTED|Overall Study||64
2443712|NCT01102491|5994620|P2|NOT COMPLETED|Overall Study||12
2443713|NCT01102491|5994621|P1|NOT COMPLETED|Overall Study||11
2443714|NCT01102491|5994620|P2|COMPLETED|Overall Study|12 patients were excluded|59
2443715|NCT01102491|5994621|P1|COMPLETED|Overall Study|11 patient excluded|60
2443716|NCT01102491|5994620|P2|STARTED|Overall Study||71
2443717|NCT01102491|5994621|P1|STARTED|Overall Study||71
2443718|NCT01102413|5994629|P2|NOT COMPLETED|Overall Study||12
2443719|NCT01102413|5994630|P1|NOT COMPLETED|Overall Study||25
2443720|NCT01102413|5994629|P2|COMPLETED|Overall Study||106
2443721|NCT01102413|5994630|P1|COMPLETED|Overall Study||208
2443722|NCT01102413|5994629|P2|STARTED|Overall Study||118
2443723|NCT01102413|5994630|P1|STARTED|Overall Study||233
2443724|NCT01102374|5994640|P2|NOT COMPLETED|Overall Study||19
2443725|NCT01102374|5994641|P1|NOT COMPLETED|Overall Study||16
2443726|NCT01102374|5994640|P2|COMPLETED|Overall Study||33
2443727|NCT01102374|5994641|P1|COMPLETED|Overall Study||39
2443728|NCT01102374|5994640|P2|STARTED|Overall Study||52
2443729|NCT01102374|5994641|P1|STARTED|Overall Study||55
2443730|NCT01102270|5994675|P2|NOT COMPLETED|Overall Study||0
2443731|NCT01102270|5994676|P1|NOT COMPLETED|Overall Study||0
2443732|NCT01102270|5994675|P2|COMPLETED|Overall Study||9
2443733|NCT01102270|5994676|P1|COMPLETED|Overall Study||8
2443734|NCT01102270|5994675|P2|STARTED|Overall Study||9
2443735|NCT01102270|5994676|P1|STARTED|Overall Study||8
2443736|NCT01102257|5994690|P2|NOT COMPLETED|Overall Study||0
2443737|NCT01102257|5994691|P1|NOT COMPLETED|Overall Study||2
2443738|NCT01102257|5994690|P2|COMPLETED|Overall Study||9
2443739|NCT01102257|5994691|P1|COMPLETED|Overall Study|2 withdrew from the study d/t adverse events. 1 had shortness of breath and the other had chest pain|7
2443740|NCT01102257|5994690|P2|STARTED|Overall Study||9
2443741|NCT01102257|5994691|P1|STARTED|Overall Study||9
2443742|NCT01102218|5994699|P2|NOT COMPLETED|Overall Study||10
2443743|NCT01102218|5994700|P1|NOT COMPLETED|Overall Study||11
2443744|NCT01102218|5994699|P2|COMPLETED|Overall Study||14
2443745|NCT01102218|5994700|P1|COMPLETED|Overall Study||13
2443746|NCT01102218|5994699|P2|STARTED|Overall Study||24
2443747|NCT01102218|5994700|P1|STARTED|Overall Study||24
2443748|NCT01102140|5994708|P2|NOT COMPLETED|Overall Study||2
2443749|NCT01102140|5994709|P1|NOT COMPLETED|Overall Study||3
2443750|NCT01102140|5994708|P2|COMPLETED|Overall Study||5
2443751|NCT01102140|5994709|P1|COMPLETED|Overall Study||10
2443752|NCT01102140|5994708|P2|STARTED|Overall Study||7
2443753|NCT01102140|5994709|P1|STARTED|Overall Study||13
2443754|NCT01101971|5994721|P1|NOT COMPLETED|Overall Study||0
2443755|NCT01101971|5994721|P1|COMPLETED|Overall Study||45
2443756|NCT01101971|5994721|P1|STARTED|Overall Study||45
2443757|NCT01101958|5994727|P2|NOT COMPLETED|Overall Study||5
2443758|NCT01101958|5994728|P1|NOT COMPLETED|Overall Study||11
2443759|NCT01101958|5994727|P2|COMPLETED|Overall Study||29
2443760|NCT01101958|5994728|P1|COMPLETED|Overall Study||51
2443761|NCT01101958|5994727|P2|STARTED|Overall Study||34
2443762|NCT01101958|5994728|P1|STARTED|Overall Study||62
2443763|NCT01101880|5994734|P1|NOT COMPLETED|Overall Study||0
2443764|NCT01101880|5994734|P1|COMPLETED|Overall Study||50
2443765|NCT01101880|5994734|P1|STARTED|Overall Study||50
2443766|NCT01101867|5994745|P2|NOT COMPLETED|Overall Study||4
2443767|NCT01101867|5994746|P1|NOT COMPLETED|Overall Study||1
2443768|NCT01101867|5994745|P2|COMPLETED|Overall Study||59
2443769|NCT01101867|5994746|P1|COMPLETED|Overall Study||62
2443770|NCT01101867|5994745|P2|STARTED|Overall Study||63
2443771|NCT01101867|5994746|P1|STARTED|Overall Study||63
2443772|NCT01101841|5994764|P2|NOT COMPLETED|Overall Study||67
2443773|NCT01101841|5994765|P1|NOT COMPLETED|Overall Study||50
2443774|NCT01101841|5994764|P2|COMPLETED|Overall Study||218
2443775|NCT01101841|5994765|P1|COMPLETED|Overall Study||235
2443776|NCT01101841|5994764|P2|STARTED|Overall Study||285
2443777|NCT01101841|5994765|P1|STARTED|Overall Study||285
2443778|NCT01101542|5994803|P1|NOT COMPLETED|Year 6 Surveillance Period||991
2443779|NCT01101542|5994803|P1|COMPLETED|Year 6 Surveillance Period||2100
2443780|NCT01101542|5994803|P1|STARTED|Year 6 Surveillance Period||3091
2443781|NCT01101542|5994803|P1|NOT COMPLETED|Year 5 Surveillance Period||141
2443782|NCT01101542|5994803|P1|COMPLETED|Year 5 Surveillance Period||668
2443783|NCT01101542|5994803|P1|STARTED|Year 5 Surveillance Period||809
2443784|NCT01101542|5994803|P1|NOT COMPLETED|Year 4 Surveillance Period||287
2443785|NCT01101542|5994803|P1|COMPLETED|Year 4 Surveillance Period||282
2443786|NCT01101542|5994803|P1|STARTED|Year 4 Surveillance Period||569
2443787|NCT01101542|5994803|P1|NOT COMPLETED|Year 3 Surveillance Period||11
2443788|NCT01101542|5994803|P1|COMPLETED|Year 3 Surveillance Period||94
2443789|NCT01101542|5994803|P1|STARTED|Year 3 Surveillance Period||105
2443790|NCT01101477|5994819|P3|NOT COMPLETED|Overall Study||1
2443791|NCT01101477|5994820|P2|NOT COMPLETED|Overall Study||3
2443792|NCT01101477|5994821|P1|NOT COMPLETED|Overall Study||5
2443793|NCT01101477|5994819|P3|COMPLETED|Overall Study||45
2443794|NCT01101477|5994820|P2|COMPLETED|Overall Study||46
2443795|NCT01101477|5994821|P1|COMPLETED|Overall Study||44
2443796|NCT01101477|5994819|P3|STARTED|Overall Study||46
2443797|NCT01101477|5994820|P2|STARTED|Overall Study||49
2443798|NCT01101477|5994821|P1|STARTED|Overall Study||49
2443799|NCT01101464|5994831|P2|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
2443800|NCT01101464|5994832|P1|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
2443801|NCT01101464|5994831|P2|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
2443802|NCT01101464|5994832|P1|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
2443803|NCT01101464|5994831|P2|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
2443804|NCT01101464|5994832|P1|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
2443805|NCT01101464|5994831|P2|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
2443806|NCT01101464|5994832|P1|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
2443807|NCT01101464|5994831|P2|COMPLETED|Day 1 Through AM Dose of Day 5||4
2443808|NCT01101464|5994832|P1|COMPLETED|Day 1 Through AM Dose of Day 5||4
2443809|NCT01101464|5994831|P2|STARTED|Day 1 Through AM Dose of Day 5||4
2443810|NCT01101464|5994832|P1|STARTED|Day 1 Through AM Dose of Day 5||4
2443811|NCT01101321|5994842|P2|NOT COMPLETED|Period 2||0
2443812|NCT01101321|5994843|P1|NOT COMPLETED|Period 2||0
2443813|NCT01101321|5994842|P2|COMPLETED|Period 2||24
2443814|NCT01101321|5994843|P1|COMPLETED|Period 2||26
2443815|NCT01101321|5994842|P2|STARTED|Period 2||24
2443816|NCT01101321|5994843|P1|STARTED|Period 2||26
2443817|NCT01101321|5994842|P2|NOT COMPLETED|Period 1||4
2443818|NCT01101321|5994843|P1|NOT COMPLETED|Period 1||4
2443819|NCT01101321|5994842|P2|COMPLETED|Period 1||24
2443820|NCT01101321|5994843|P1|COMPLETED|Period 1||26
2443821|NCT01101321|5994842|P2|STARTED|Period 1||28
2443822|NCT01101321|5994843|P1|STARTED|Period 1||30
2443823|NCT01101308|5994853|P2|NOT COMPLETED|Period 2||0
2443824|NCT01101308|5994854|P1|NOT COMPLETED|Period 2||0
2443825|NCT01101308|5994853|P2|COMPLETED|Period 2||27
2443826|NCT01101308|5994854|P1|COMPLETED|Period 2||24
2443827|NCT01101308|5994853|P2|STARTED|Period 2||27
2443828|NCT01101308|5994854|P1|STARTED|Period 2||24
2443829|NCT01101308|5994853|P2|NOT COMPLETED|Period 1||1
2443830|NCT01101308|5994854|P1|NOT COMPLETED|Period 1||3
2443831|NCT01101308|5994853|P2|COMPLETED|Period 1||27
2443832|NCT01101308|5994854|P1|COMPLETED|Period 1||24
2443833|NCT01101308|5994853|P2|STARTED|Period 1||28
2443834|NCT01101308|5994854|P1|STARTED|Period 1||27
2443835|NCT01101191|5994865|P2|NOT COMPLETED|Period 2||0
2443836|NCT01101191|5994866|P1|NOT COMPLETED|Period 2||0
2443837|NCT01101191|5994865|P2|COMPLETED|Period 2||40
2443838|NCT01101191|5994866|P1|COMPLETED|Period 2||40
2443839|NCT01101191|5994865|P2|STARTED|Period 2||40
2443840|NCT01101191|5994866|P1|STARTED|Period 2||40
2443841|NCT01101191|5994865|P2|NOT COMPLETED|Period 1||2
2443842|NCT01101191|5994866|P1|NOT COMPLETED|Period 1||2
2443843|NCT01101191|5994865|P2|COMPLETED|Period 1||40
2443844|NCT01101191|5994866|P1|COMPLETED|Period 1||40
2443845|NCT01101191|5994865|P2|STARTED|Period 1||42
2443846|NCT01101191|5994866|P1|STARTED|Period 1||42
2443847|NCT01101178|5994877|P2|NOT COMPLETED|Period 2||1
2443848|NCT01101178|5994878|P1|NOT COMPLETED|Period 2||0
2443849|NCT01101178|5994877|P2|COMPLETED|Period 2||34
2443850|NCT01101178|5994878|P1|COMPLETED|Period 2||36
2443851|NCT01101178|5994877|P2|STARTED|Period 2||35
2443852|NCT01101178|5994878|P1|STARTED|Period 2||36
2443853|NCT01101178|5994877|P2|NOT COMPLETED|Period 1||4
2443854|NCT01101178|5994878|P1|NOT COMPLETED|Period 1||4
2443855|NCT01101178|5994877|P2|COMPLETED|Period 1||35
2443856|NCT01101178|5994878|P1|COMPLETED|Period 1||36
2443857|NCT01101178|5994877|P2|STARTED|Period 1||39
2443858|NCT01101178|5994878|P1|STARTED|Period 1||40
2443859|NCT01101165|5994889|P2|NOT COMPLETED|Period 2||1
2443860|NCT01101165|5994890|P1|NOT COMPLETED|Period 2||4
2443861|NCT01101165|5994889|P2|COMPLETED|Period 2||39
2443862|NCT01101165|5994890|P1|COMPLETED|Period 2||41
2443863|NCT01101165|5994889|P2|STARTED|Period 2||40
2443864|NCT01101165|5994890|P1|STARTED|Period 2||45
2443865|NCT01101165|5994889|P2|NOT COMPLETED|Period 1||5
2443866|NCT01101165|5994890|P1|NOT COMPLETED|Period 1||2
2443867|NCT01101165|5994889|P2|COMPLETED|Period 1||40
2443868|NCT01101165|5994890|P1|COMPLETED|Period 1||45
2443869|NCT01101165|5994889|P2|STARTED|Period 1||45
2443870|NCT01101165|5994890|P1|STARTED|Period 1||47
2443871|NCT01101100|5994900|P1|NOT COMPLETED|Overall Study||55
2443872|NCT01101100|5994900|P1|COMPLETED|Overall Study||126
2443873|NCT01101100|5994900|P1|STARTED|Overall Study||181
2443874|NCT01101061|5994911|P6|NOT COMPLETED|Overall Study||0
2443875|NCT01101061|5994912|P5|NOT COMPLETED|Overall Study||0
2443876|NCT01101061|5994913|P4|NOT COMPLETED|Overall Study||0
2443877|NCT01101061|5994914|P3|NOT COMPLETED|Overall Study||1
2443878|NCT01101061|5994915|P2|NOT COMPLETED|Overall Study||0
2443879|NCT01101061|5994916|P1|NOT COMPLETED|Overall Study||0
2443880|NCT01101061|5994911|P6|COMPLETED|Overall Study||4
2443881|NCT01101061|5994912|P5|COMPLETED|Overall Study||2
2443882|NCT01101061|5994913|P4|COMPLETED|Overall Study||6
2443883|NCT01101061|5994914|P3|COMPLETED|Overall Study||6
2443884|NCT01101061|5994915|P2|COMPLETED|Overall Study||6
2443885|NCT01101061|5994916|P1|COMPLETED|Overall Study||6
2443886|NCT01101061|5994911|P6|Received Study Drug|Overall Study||4
2443887|NCT01101061|5994912|P5|Received Study Drug|Overall Study||2
2443888|NCT01101061|5994913|P4|Received Study Drug|Overall Study||6
2443889|NCT01101061|5994914|P3|Received Study Drug|Overall Study||6
2443890|NCT01101061|5994915|P2|Received Study Drug|Overall Study||6
2443891|NCT01101061|5994916|P1|Received Study Drug|Overall Study||6
2443892|NCT01101061|5994911|P6|STARTED|Overall Study||4
2443893|NCT01101061|5994912|P5|STARTED|Overall Study||2
2443894|NCT01101061|5994913|P4|STARTED|Overall Study||6
2443895|NCT01101061|5994914|P3|STARTED|Overall Study||7
2443896|NCT01101061|5994915|P2|STARTED|Overall Study||6
2443897|NCT01101061|5994916|P1|STARTED|Overall Study||6
2443898|NCT01101035|5994996|P2|NOT COMPLETED|Overall Study||1391
2443899|NCT01101035|5994997|P1|NOT COMPLETED|Overall Study||1397
2443900|NCT01101035|5994996|P2|COMPLETED|Overall Study||1706
2443901|NCT01101035|5994997|P1|COMPLETED|Overall Study||1704
2443902|NCT01101035|5994996|P2|STARTED|Overall Study||3097
2443903|NCT01101035|5994997|P1|STARTED|Overall Study||3101
2443904|NCT01101022|5995017|P2|NOT COMPLETED|Overall Study||27
2443905|NCT01101022|5995018|P1|NOT COMPLETED|Overall Study||17
2443906|NCT01101022|5995017|P2|COMPLETED|Overall Study||53
2443907|NCT01101022|5995018|P1|COMPLETED|Overall Study||62
2443908|NCT01101022|5995017|P2|STARTED|Overall Study||80
2443909|NCT01101022|5995018|P1|STARTED|Overall Study||79
2443910|NCT01100944|5995052|P3|NOT COMPLETED|Expansion Phase - Phase 2||0
2443911|NCT01100944|5995053|P2|NOT COMPLETED|Expansion Phase - Phase 2||0
2443912|NCT01100944|5995054|P1|NOT COMPLETED|Expansion Phase - Phase 2||0
2443913|NCT01100944|5995052|P3|COMPLETED|Expansion Phase - Phase 2||18
2443914|NCT01100944|5995053|P2|COMPLETED|Expansion Phase - Phase 2||0
2443915|NCT01100944|5995054|P1|COMPLETED|Expansion Phase - Phase 2||0
2443916|NCT01100944|5995052|P3|STARTED|Expansion Phase - Phase 2||18
2443917|NCT01100944|5995053|P2|STARTED|Expansion Phase - Phase 2||0
2443918|NCT01100944|5995054|P1|STARTED|Expansion Phase - Phase 2||0
2443919|NCT01100944|5995052|P3|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
2443920|NCT01100944|5995053|P2|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||2
2443921|NCT01100944|5995054|P1|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
2443922|NCT01100944|5995052|P3|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
2443923|NCT01100944|5995053|P2|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
2443924|NCT01100944|5995054|P1|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
2443925|NCT01100944|5995052|P3|STARTED|Dose Escalation Phase 1 Dose Level 2||0
2443926|NCT01100944|5995053|P2|STARTED|Dose Escalation Phase 1 Dose Level 2||2
2443927|NCT01100944|5995054|P1|STARTED|Dose Escalation Phase 1 Dose Level 2||0
2443928|NCT01100944|5995052|P3|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
2443929|NCT01100944|5995053|P2|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
2443930|NCT01100944|5995054|P1|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||4
2443931|NCT01100944|5995052|P3|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
2443932|NCT01100944|5995053|P2|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
2443933|NCT01100944|5995054|P1|COMPLETED|Dose Escalation Phase 1 Dose Level 1||2
2443934|NCT01100944|5995052|P3|STARTED|Dose Escalation Phase 1 Dose Level 1||0
2443935|NCT01100944|5995053|P2|STARTED|Dose Escalation Phase 1 Dose Level 1||0
2443936|NCT01100944|5995054|P1|STARTED|Dose Escalation Phase 1 Dose Level 1||6
2443937|NCT01100931|5995101|P2|NOT COMPLETED|Phase II||0
2443938|NCT01100931|5995102|P1|NOT COMPLETED|Phase II||0
2443939|NCT01100931|5995101|P2|COMPLETED|Phase II||19
2443940|NCT01100931|5995102|P1|COMPLETED|Phase II||0
2443941|NCT01100931|5995101|P2|STARTED|Phase II||19
2443942|NCT01100931|5995102|P1|STARTED|Phase II||0
2443943|NCT01100931|5995101|P2|NOT COMPLETED|Phase I||0
2443944|NCT01100931|5995102|P1|NOT COMPLETED|Phase I||0
2443945|NCT01100931|5995101|P2|COMPLETED|Phase I||0
2443946|NCT01100931|5995102|P1|COMPLETED|Phase I||22
2443947|NCT01100931|5995101|P2|STARTED|Phase I||0
2443948|NCT01100931|5995102|P1|STARTED|Phase I||22
2443949|NCT01100853|5995112|P2|NOT COMPLETED|Overall Study||23
2443950|NCT01100853|5995113|P1|NOT COMPLETED|Overall Study||27
2443951|NCT01100853|5995112|P2|COMPLETED|Overall Study||26
2443952|NCT01100853|5995113|P1|COMPLETED|Overall Study||24
2443953|NCT01100853|5995112|P2|STARTED|Overall Study||49
2443954|NCT01100853|5995113|P1|STARTED|Overall Study||51
2443955|NCT01100762|5995129|P1|NOT COMPLETED|Overall Study||0
2443956|NCT01100762|5995129|P1|COMPLETED|Overall Study||10
2443957|NCT01100762|5995129|P1|STARTED|Overall Study||10
2443958|NCT01100723|5995150|P1|NOT COMPLETED|Overall Study||14
2443959|NCT01100723|5995150|P1|COMPLETED|Overall Study|78 subjects had laboratory data at the 12 month analysis and were compared to their baseline data.|78
2443960|NCT01100723|5995150|P1|6 Month Analysis|Overall Study|85 subjects had laboratory data at the 6 month analysis and were compared to their baseline data.|85
2443961|NCT01100723|5995150|P1|STARTED|Overall Study||92
2443962|NCT01100658|5995159|P1|NOT COMPLETED|Overall Study||1
2443963|NCT01100658|5995159|P1|COMPLETED|Overall Study||0
2443964|NCT01100658|5995159|P1|STARTED|Overall Study||1
2443965|NCT01100606|5995164|P2|NOT COMPLETED|Second Treatment Period||0
2443966|NCT01100606|5995165|P1|NOT COMPLETED|Second Treatment Period||0
2443967|NCT01100606|5995164|P2|COMPLETED|Second Treatment Period|Due to difficulty with syringe nurser, 1 participant completed study using apple sauce|7
2443968|NCT01100606|5995165|P1|COMPLETED|Second Treatment Period|Due to intolerance to apple sauce & apple juice,1 participant completed study with banana-based food|8
2443969|NCT01100606|5995164|P2|STARTED|Second Treatment Period||7
2443970|NCT01100606|5995165|P1|STARTED|Second Treatment Period||8
2443971|NCT01100606|5995164|P2|NOT COMPLETED|First Treatment Period||0
2443972|NCT01100606|5995165|P1|NOT COMPLETED|First Treatment Period||0
2443973|NCT01100606|5995164|P2|COMPLETED|First Treatment Period||7
2443974|NCT01100606|5995165|P1|COMPLETED|First Treatment Period|Due to difficulty with syringe nurser,1 participant completed study with apple sauce,not apple juice|8
2443975|NCT01100606|5995164|P2|STARTED|First Treatment Period||7
2443976|NCT01100606|5995165|P1|STARTED|First Treatment Period||8
2443977|NCT01100567|5995191|P2|NOT COMPLETED|Overall Study||16
2443978|NCT01100567|5995192|P1|NOT COMPLETED|Overall Study||12
2443979|NCT01100567|5995191|P2|COMPLETED|Overall Study||35
2443980|NCT01100567|5995192|P1|COMPLETED|Overall Study||38
2443981|NCT01100567|5995191|P2|STARTED|Overall Study||51
2443982|NCT01100567|5995192|P1|STARTED|Overall Study||50
2443983|NCT01100528|5995200|P1|NOT COMPLETED|Overall Study||3
2443984|NCT01100528|5995200|P1|COMPLETED|Overall Study||35
2443985|NCT01100528|5995200|P1|STARTED|Overall Study||38
2443986|NCT01100502|5995208|P2|NOT COMPLETED|Long-Term Follow-up||139
2443987|NCT01100502|5995209|P1|NOT COMPLETED|Long-Term Follow-up||137
2443988|NCT01100502|5995208|P2|COMPLETED|Long-Term Follow-up|Completed follow-up due to death|25
2443989|NCT01100502|5995209|P1|COMPLETED|Long-Term Follow-up|Completed follow-up due to death|28
2443990|NCT01100502|5995208|P2|STARTED|Long-Term Follow-up|All participants were to be followed after treatment|164
2443991|NCT01100502|5995209|P1|STARTED|Long-Term Follow-up|All participants were to be followed after treatment|165
2443992|NCT01100502|5995208|P2|NOT COMPLETED|Treatment Period||83
2443993|NCT01100502|5995209|P1|NOT COMPLETED|Treatment Period||87
2443994|NCT01100502|5995208|P2|COMPLETED|Treatment Period||81
2443995|NCT01100502|5995209|P1|COMPLETED|Treatment Period||78
2443996|NCT01100502|5995208|P2|STARTED|Treatment Period||164
2443997|NCT01100502|5995209|P1|STARTED|Treatment Period||165
2443998|NCT01100437|5995219|P3|NOT COMPLETED|Treatment 2||0
2443999|NCT01100437|5995220|P2|NOT COMPLETED|Treatment 2||0
2444000|NCT01100437|5995221|P1|NOT COMPLETED|Treatment 2||0
2444001|NCT01100437|5995219|P3|COMPLETED|Treatment 2||0
2444002|NCT01100437|5995220|P2|COMPLETED|Treatment 2||2
2444003|NCT01100437|5995221|P1|COMPLETED|Treatment 2||4
2444004|NCT01100437|5995219|P3|STARTED|Treatment 2||0
2444005|NCT01100437|5995220|P2|STARTED|Treatment 2||2
2444006|NCT01100437|5995221|P1|STARTED|Treatment 2||4
2444007|NCT01100437|5995219|P3|NOT COMPLETED|Washout (4 Days)||0
2444008|NCT01100437|5995220|P2|NOT COMPLETED|Washout (4 Days)||0
2444009|NCT01100437|5995221|P1|NOT COMPLETED|Washout (4 Days)||0
2444010|NCT01100437|5995219|P3|COMPLETED|Washout (4 Days)||0
2444011|NCT01100437|5995220|P2|COMPLETED|Washout (4 Days)||2
2444012|NCT01100437|5995221|P1|COMPLETED|Washout (4 Days)||4
2444013|NCT01100437|5995219|P3|STARTED|Washout (4 Days)||0
2444014|NCT01100437|5995220|P2|STARTED|Washout (4 Days)||2
2444015|NCT01100437|5995221|P1|STARTED|Washout (4 Days)||4
2444016|NCT01100437|5995219|P3|NOT COMPLETED|Treatment 1||0
2444017|NCT01100437|5995220|P2|NOT COMPLETED|Treatment 1||0
2444018|NCT01100437|5995221|P1|NOT COMPLETED|Treatment 1||0
2444019|NCT01100437|5995219|P3|COMPLETED|Treatment 1||0
2444020|NCT01100437|5995220|P2|COMPLETED|Treatment 1||2
2444021|NCT01100437|5995221|P1|COMPLETED|Treatment 1||4
2444022|NCT01100437|5995219|P3|STARTED|Treatment 1||0
2444023|NCT01100437|5995220|P2|STARTED|Treatment 1||2
2444024|NCT01100437|5995221|P1|STARTED|Treatment 1||4
2444025|NCT01100437|5995219|P3|NOT COMPLETED|Maintenance||2
2444026|NCT01100437|5995220|P2|NOT COMPLETED|Maintenance||0
2444027|NCT01100437|5995221|P1|NOT COMPLETED|Maintenance||0
2444028|NCT01100437|5995219|P3|COMPLETED|Maintenance||0
2444029|NCT01100437|5995220|P2|COMPLETED|Maintenance||2
2444030|NCT01100437|5995221|P1|COMPLETED|Maintenance||4
2444031|NCT01100437|5995219|P3|STARTED|Maintenance||2
2444032|NCT01100437|5995220|P2|STARTED|Maintenance||2
2444033|NCT01100437|5995221|P1|STARTED|Maintenance||4
2444034|NCT01100437|5995219|P3|NOT COMPLETED|Titration/Stabilization||6
2444035|NCT01100437|5995220|P2|NOT COMPLETED|Titration/Stabilization||0
2444036|NCT01100437|5995221|P1|NOT COMPLETED|Titration/Stabilization||0
2444037|NCT01100437|5995219|P3|COMPLETED|Titration/Stabilization||2
2444038|NCT01100437|5995220|P2|COMPLETED|Titration/Stabilization||2
2444039|NCT01100437|5995221|P1|COMPLETED|Titration/Stabilization||4
2444040|NCT01100437|5995219|P3|STARTED|Titration/Stabilization||8
2444041|NCT01100437|5995220|P2|STARTED|Titration/Stabilization||2
2444042|NCT01100437|5995221|P1|STARTED|Titration/Stabilization||4
2444043|NCT01100437|5995219|P3|NOT COMPLETED|Screening||0
2444044|NCT01100437|5995220|P2|NOT COMPLETED|Screening||0
2444045|NCT01100437|5995221|P1|NOT COMPLETED|Screening||0
2444046|NCT01100437|5995219|P3|COMPLETED|Screening||8
2444047|NCT01100437|5995220|P2|COMPLETED|Screening||2
2444048|NCT01100437|5995221|P1|COMPLETED|Screening||4
2444049|NCT01100437|5995219|P3|STARTED|Screening||8
2444050|NCT01100437|5995220|P2|STARTED|Screening||2
2444051|NCT01100437|5995221|P1|STARTED|Screening||4
2444052|NCT01100320|5995258|P2|NOT COMPLETED|Period 2||1
2444053|NCT01100320|5995259|P1|NOT COMPLETED|Period 2||1
2444054|NCT01100320|5995258|P2|COMPLETED|Period 2||37
2444055|NCT01100320|5995259|P1|COMPLETED|Period 2||37
2444056|NCT01100320|5995258|P2|STARTED|Period 2||38
2444057|NCT01100320|5995259|P1|STARTED|Period 2||38
2444058|NCT01100320|5995258|P2|NOT COMPLETED|Period 1||7
2444059|NCT01100320|5995259|P1|NOT COMPLETED|Period 1||5
2444060|NCT01100320|5995258|P2|COMPLETED|Period 1||38
2444061|NCT01100320|5995259|P1|COMPLETED|Period 1||38
2444062|NCT01100320|5995258|P2|STARTED|Period 1||45
2444063|NCT01100320|5995259|P1|STARTED|Period 1||43
2444064|NCT01100307|5995271|P2|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||13
2444065|NCT01100307|5995272|P1|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||6
2444066|NCT01100307|5995271|P2|COMPLETED|Open Phase (Week 24 up to Week 54)||99
2444067|NCT01100307|5995272|P1|COMPLETED|Open Phase (Week 24 up to Week 54)||110
2444068|NCT01100307|5995271|P2|STARTED|Open Phase (Week 24 up to Week 54)|Four participants did not enter to the open phase after completing the double masked phase.|112
2444069|NCT01100307|5995272|P1|STARTED|Open Phase (Week 24 up to Week 54)|One participant discontinued from the study due to adverse event before study drug administration.|116
2444070|NCT01100307|5995271|P2|NOT COMPLETED|Double Masked Phase (Up to Week 24)||4
2444071|NCT01100307|5995272|P1|NOT COMPLETED|Double Masked Phase (Up to Week 24)||6
2444072|NCT01100307|5995271|P2|COMPLETED|Double Masked Phase (Up to Week 24)||116
2444073|NCT01100307|5995272|P1|COMPLETED|Double Masked Phase (Up to Week 24)||117
2444074|NCT01100307|5995271|P2|STARTED|Double Masked Phase (Up to Week 24)||120
2444075|NCT01100307|5995272|P1|STARTED|Double Masked Phase (Up to Week 24)||123
2444076|NCT01100268|5995314|P1|NOT COMPLETED|Overall Study||0
2444077|NCT01100268|5995314|P1|COMPLETED|Overall Study||4
2444078|NCT01100268|5995314|P1|STARTED|Overall Study||4
2444079|NCT01100255|5995321|P2|NOT COMPLETED|Overall Study||0
2444080|NCT01100255|5995322|P1|NOT COMPLETED|Overall Study||0
2444081|NCT01100255|5995321|P2|COMPLETED|Overall Study||7
2444082|NCT01100255|5995322|P1|COMPLETED|Overall Study||8
2444083|NCT01100255|5995321|P2|STARTED|Overall Study||7
2444084|NCT01100255|5995322|P1|STARTED|Overall Study||8
2444085|NCT01100242|5995328|P1|NOT COMPLETED|Overall Study||0
2444086|NCT01100242|5995328|P1|COMPLETED|Overall Study||17
2444087|NCT01100242|5995328|P1|STARTED|Overall Study||17
2444088|NCT01100112|5995334|P1|NOT COMPLETED|Overall Study||8
2444089|NCT01100112|5995334|P1|COMPLETED|Overall Study||52
2444090|NCT01100112|5995334|P1|STARTED|Overall Study||60
2444091|NCT01100086|5995341|P2|NOT COMPLETED|Period 2||0
2444092|NCT01100086|5995342|P1|NOT COMPLETED|Period 2||0
2444093|NCT01100086|5995341|P2|COMPLETED|Period 2||41
2444094|NCT01100086|5995342|P1|COMPLETED|Period 2||42
2444095|NCT01100086|5995341|P2|STARTED|Period 2||41
2444096|NCT01100086|5995342|P1|STARTED|Period 2||42
2444097|NCT01100086|5995341|P2|NOT COMPLETED|Period 1||0
2444098|NCT01100086|5995342|P1|NOT COMPLETED|Period 1||1
2444099|NCT01100086|5995341|P2|COMPLETED|Period 1||41
2444100|NCT01100086|5995342|P1|COMPLETED|Period 1||42
2444101|NCT01100086|5995341|P2|STARTED|Period 1||41
2444102|NCT01100086|5995342|P1|STARTED|Period 1||43
2444103|NCT01100073|5995352|P1|NOT COMPLETED|Overall Study||100
2444104|NCT01100073|5995352|P1|COMPLETED|Overall Study|End of study (Visit 3)|1599
2444105|NCT01100073|5995352|P1|STARTED|Overall Study|Baseline (Visit 1)|1699
2444106|NCT01100034|5995367|P1|NOT COMPLETED|Overall Study||43
2444107|NCT01100034|5995367|P1|COMPLETED|Overall Study||29
2444108|NCT01100034|5995367|P1|STARTED|Overall Study||72
2444109|NCT01099969|5995380|P4|NOT COMPLETED|Overall Study||0
2444110|NCT01099969|5995381|P3|NOT COMPLETED|Overall Study||0
2444111|NCT01099969|5995382|P2|NOT COMPLETED|Overall Study||0
2444112|NCT01099969|5995383|P1|NOT COMPLETED|Overall Study||0
2444113|NCT01099969|5995380|P4|COMPLETED|Overall Study||15
2444114|NCT01099969|5995381|P3|COMPLETED|Overall Study||15
2444115|NCT01099969|5995382|P2|COMPLETED|Overall Study||15
2444116|NCT01099969|5995383|P1|COMPLETED|Overall Study||15
2444117|NCT01099969|5995380|P4|STARTED|Overall Study||15
2444118|NCT01099969|5995381|P3|STARTED|Overall Study||15
2444119|NCT01099969|5995382|P2|STARTED|Overall Study||15
2444120|NCT01099969|5995383|P1|STARTED|Overall Study||15
2444121|NCT01099917|5995405|P1|NOT COMPLETED|Overall Study||27
2444122|NCT01099917|5995405|P1|COMPLETED|Overall Study||18
2444123|NCT01099917|5995405|P1|STARTED|Overall Study||45
2444124|NCT01099774|5995411|P2|NOT COMPLETED|Overall Study||6
2444125|NCT01099774|5995412|P1|NOT COMPLETED|Overall Study||6
2444126|NCT01099774|5995411|P2|COMPLETED|Overall Study||289
2444127|NCT01099774|5995412|P1|COMPLETED|Overall Study||296
2444128|NCT01099774|5995411|P2|STARTED|Overall Study||295
2444129|NCT01099774|5995412|P1|STARTED|Overall Study||302
2444130|NCT01099761|5995428|P4|NOT COMPLETED|Overall Study||0
2444131|NCT01099761|5995429|P3|NOT COMPLETED|Overall Study||0
2444132|NCT01099761|5995430|P2|NOT COMPLETED|Overall Study||0
2444133|NCT01099761|5995431|P1|NOT COMPLETED|Overall Study||0
2444134|NCT01099761|5995428|P4|COMPLETED|Overall Study||6
2444135|NCT01099761|5995429|P3|COMPLETED|Overall Study||0
2444136|NCT01099761|5995430|P2|COMPLETED|Overall Study||9
2444137|NCT01099761|5995431|P1|COMPLETED|Overall Study||9
2444138|NCT01099761|5995428|P4|STARTED|Overall Study||6
2444139|NCT01099761|5995429|P3|STARTED|Overall Study|Study terminated prior to enrolling cohort 3|0
2444140|NCT01099761|5995430|P2|STARTED|Overall Study||9
2444141|NCT01099761|5995431|P1|STARTED|Overall Study||9
2444142|NCT01099709|5995467|P2|NOT COMPLETED|Period 2||0
2444143|NCT01099709|5995468|P1|NOT COMPLETED|Period 2||0
2444144|NCT01099709|5995467|P2|COMPLETED|Period 2||41
2444145|NCT01099709|5995468|P1|COMPLETED|Period 2||41
2444146|NCT01099709|5995467|P2|STARTED|Period 2||41
2444147|NCT01099709|5995468|P1|STARTED|Period 2||41
2444148|NCT01099709|5995467|P2|NOT COMPLETED|Period 1||2
2444149|NCT01099709|5995468|P1|NOT COMPLETED|Period 1||1
2444150|NCT01099709|5995467|P2|COMPLETED|Period 1||41
2444151|NCT01099709|5995468|P1|COMPLETED|Period 1||41
2444152|NCT01099709|5995467|P2|STARTED|Period 1||43
2444153|NCT01099709|5995468|P1|STARTED|Period 1||42
2444154|NCT01099618|5995481|P3|NOT COMPLETED|Overall Study||0
2444155|NCT01099618|5995482|P2|NOT COMPLETED|Overall Study||0
2444156|NCT01099618|5995483|P1|NOT COMPLETED|Overall Study||0
2444157|NCT01099618|5995481|P3|COMPLETED|Overall Study||15
2444158|NCT01099618|5995482|P2|COMPLETED|Overall Study||16
2444159|NCT01099618|5995483|P1|COMPLETED|Overall Study||17
2444160|NCT01099618|5995481|P3|STARTED|Overall Study||15
2444161|NCT01099618|5995482|P2|STARTED|Overall Study||16
2444162|NCT01099618|5995483|P1|STARTED|Overall Study||17
2444163|NCT01099579|5995494|P3|NOT COMPLETED|Stage 2 (ATV Capsule)||6
2444164|NCT01099579|5995495|P2|NOT COMPLETED|Stage 2 (ATV Capsule)||5
2444165|NCT01099579|5995496|P1|NOT COMPLETED|Stage 2 (ATV Capsule)||6
2444166|NCT01099579|5995494|P3|COMPLETED|Stage 2 (ATV Capsule)||9
2444167|NCT01099579|5995495|P2|COMPLETED|Stage 2 (ATV Capsule)||9
2444168|NCT01099579|5995496|P1|COMPLETED|Stage 2 (ATV Capsule)||10
2444169|NCT01099579|5995494|P3|STARTED|Stage 2 (ATV Capsule)||15
2444170|NCT01099579|5995495|P2|STARTED|Stage 2 (ATV Capsule)||14
2444171|NCT01099579|5995496|P1|STARTED|Stage 2 (ATV Capsule)||16
2444172|NCT01099579|5995494|P3|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||1
2444173|NCT01099579|5995495|P2|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||5
2444174|NCT01099579|5995496|P1|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||4
2444175|NCT01099579|5995494|P3|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|15
2444176|NCT01099579|5995495|P2|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|14
2444177|NCT01099579|5995496|P1|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|17
2444178|NCT01099579|5995494|P3|STARTED|Stage 1 (ATV Powder Formulation)||16
2444179|NCT01099579|5995495|P2|STARTED|Stage 1 (ATV Powder Formulation)||19
2444180|NCT01099579|5995496|P1|STARTED|Stage 1 (ATV Powder Formulation)||21
2444181|NCT01099475|5995552|P2|NOT COMPLETED|Overall Study||0
2444182|NCT01099475|5995553|P1|NOT COMPLETED|Overall Study||0
2444183|NCT01099475|5995552|P2|COMPLETED|Overall Study||10
2444184|NCT01099475|5995553|P1|COMPLETED|Overall Study||10
2444185|NCT01099475|5995552|P2|STARTED|Overall Study||10
2444186|NCT01099475|5995553|P1|STARTED|Overall Study||10
2444187|NCT01099449|5995568|P3|NOT COMPLETED|Overall Study||0
2444188|NCT01099449|5995569|P2|NOT COMPLETED|Overall Study||0
2444189|NCT01099449|5995570|P1|NOT COMPLETED|Overall Study||0
2444190|NCT01099449|5995568|P3|COMPLETED|Overall Study||116
2444191|NCT01099449|5995569|P2|COMPLETED|Overall Study||119
2444192|NCT01099449|5995570|P1|COMPLETED|Overall Study||118
2444193|NCT01099449|5995568|P3|STARTED|Overall Study||116
2444194|NCT01099449|5995569|P2|STARTED|Overall Study||119
2444195|NCT01099449|5995570|P1|STARTED|Overall Study||118
2444196|NCT01099397|5995605|P1|NOT COMPLETED|Overall Study||13
2444197|NCT01099397|5995605|P1|COMPLETED|Overall Study||26
2444198|NCT01099397|5995605|P1|STARTED|Overall Study||39
2444199|NCT01099358|5995610|P4|NOT COMPLETED|Overall Study||4
2444200|NCT01099358|5995611|P3|NOT COMPLETED|Overall Study||8
2444201|NCT01099358|5995612|P2|NOT COMPLETED|Overall Study||1
2444202|NCT01099358|5995613|P1|NOT COMPLETED|Overall Study||3
2444203|NCT01099358|5995610|P4|COMPLETED|Overall Study||12
2444204|NCT01099358|5995611|P3|COMPLETED|Overall Study||13
2444205|NCT01099358|5995612|P2|COMPLETED|Overall Study||5
2444206|NCT01099358|5995613|P1|COMPLETED|Overall Study||1
2444207|NCT01099358|5995610|P4|Received at Least One Dose of Study Drug|Overall Study||15
2444208|NCT01099358|5995611|P3|Received at Least One Dose of Study Drug|Overall Study||20
2444209|NCT01099358|5995612|P2|Received at Least One Dose of Study Drug|Overall Study||6
2444210|NCT01099358|5995613|P1|Received at Least One Dose of Study Drug|Overall Study||3
2444211|NCT01099358|5995610|P4|STARTED|Overall Study||16
2444212|NCT01099358|5995611|P3|STARTED|Overall Study||21
2444213|NCT01099358|5995612|P2|STARTED|Overall Study||6
2444214|NCT01099358|5995613|P1|STARTED|Overall Study||4
2444215|NCT01099267|5995632|P1|NOT COMPLETED|MDS-009 Extension Follow-up||0
2444216|NCT01099267|5995632|P1|COMPLETED|MDS-009 Extension Follow-up||54
2444217|NCT01099267|5995632|P1|Other Source of Follow-up Info Used|MDS-009 Extension Follow-up|Social Security Death Index, public records, verbal reports from health providers and next of kin.|21
2444218|NCT01099267|5995632|P1|Informed Consent Given|MDS-009 Extension Follow-up||33
2444219|NCT01099267|5995632|P1|STARTED|MDS-009 Extension Follow-up|Participants from MDS-003 (including some who did not complete) at sites participating in MDS-009.|54
2444220|NCT01099267|5995632|P1|NOT COMPLETED|MDS-003 Study||124
2444221|NCT01099267|5995632|P1|COMPLETED|MDS-003 Study||24
2444222|NCT01099267|5995632|P1|STARTED|MDS-003 Study|This information duplicates results in NCT00065156.|148
2444223|NCT01099215|5995642|P2|NOT COMPLETED|Overall Study||1
2444224|NCT01099215|5995643|P1|NOT COMPLETED|Overall Study||1
2444225|NCT01099215|5995642|P2|COMPLETED|Overall Study||9
2444226|NCT01099215|5995643|P1|COMPLETED|Overall Study||10
2444227|NCT01099215|5995642|P2|STARTED|Overall Study||10
2444228|NCT01099215|5995643|P1|STARTED|Overall Study||11
2444229|NCT01099202|5995681|P2|NOT COMPLETED|Overall Study||0
2444230|NCT01099202|5995682|P1|NOT COMPLETED|Overall Study||0
2444231|NCT01099202|5995681|P2|COMPLETED|Overall Study||54
2444232|NCT01099202|5995682|P1|COMPLETED|Overall Study||55
2444233|NCT01099202|5995681|P2|STARTED|Overall Study||54
2444234|NCT01099202|5995682|P1|STARTED|Overall Study||55
2444235|NCT01099111|5995695|P5|NOT COMPLETED|Overall Study||0
2444236|NCT01099111|5995696|P4|NOT COMPLETED|Overall Study||0
2444237|NCT01099111|5995697|P3|NOT COMPLETED|Overall Study||0
2444238|NCT01099111|5995698|P2|NOT COMPLETED|Overall Study||0
2444239|NCT01099111|5995699|P1|NOT COMPLETED|Overall Study||0
2444240|NCT01099111|5995695|P5|COMPLETED|Overall Study|6 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
2444241|NCT01099111|5995696|P4|COMPLETED|Overall Study||29
2444242|NCT01099111|5995697|P3|COMPLETED|Overall Study|2 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|46
2444243|NCT01099111|5995698|P2|COMPLETED|Overall Study|3 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
2444244|NCT01099111|5995699|P1|COMPLETED|Overall Study|5 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
2444245|NCT01099111|5995695|P5|STARTED|Overall Study||50
2444246|NCT01099111|5995696|P4|STARTED|Overall Study||29
2444247|NCT01099111|5995697|P3|STARTED|Overall Study||46
2444248|NCT01099111|5995698|P2|STARTED|Overall Study||50
2444249|NCT01099111|5995699|P1|STARTED|Overall Study||50
2444250|NCT01098851|5995713|P2|NOT COMPLETED|Overall Study||0
2444251|NCT01098851|5995714|P1|NOT COMPLETED|Overall Study||1
2444252|NCT01098851|5995713|P2|COMPLETED|Overall Study||10
2444253|NCT01098851|5995714|P1|COMPLETED|Overall Study||10
2444254|NCT01098851|5995713|P2|STARTED|Overall Study||10
2444255|NCT01098851|5995714|P1|STARTED|Overall Study||11
2444256|NCT01098812|5995725|P3|NOT COMPLETED|Overall Study||1
2444257|NCT01098812|5995726|P2|NOT COMPLETED|Overall Study||1
2444258|NCT01098812|5995727|P1|NOT COMPLETED|Overall Study||2
2444259|NCT01098812|5995725|P3|COMPLETED|Overall Study||71
2444260|NCT01098812|5995726|P2|COMPLETED|Overall Study||101
2444261|NCT01098812|5995727|P1|COMPLETED|Overall Study||93
2444262|NCT01098812|5995725|P3|STARTED|Overall Study||72
2444263|NCT01098812|5995726|P2|STARTED|Overall Study||102
2444264|NCT01098812|5995727|P1|STARTED|Overall Study||95
2444265|NCT01098747|5995741|P4|NOT COMPLETED|Overall Study||0
2444266|NCT01098747|5995742|P3|NOT COMPLETED|Overall Study||0
2444267|NCT01098747|5995743|P2|NOT COMPLETED|Overall Study||0
2444268|NCT01098747|5995744|P1|NOT COMPLETED|Overall Study||0
2444269|NCT01098747|5995741|P4|COMPLETED|Overall Study||87
2444270|NCT01098747|5995742|P3|COMPLETED|Overall Study||86
2444271|NCT01098747|5995743|P2|COMPLETED|Overall Study||95
2444272|NCT01098747|5995744|P1|COMPLETED|Overall Study||48
2444273|NCT01098747|5995741|P4|STARTED|Overall Study||87
2444274|NCT01098747|5995742|P3|STARTED|Overall Study||86
2444275|NCT01098747|5995743|P2|STARTED|Overall Study||95
2444276|NCT01098747|5995744|P1|STARTED|Overall Study||48
2444277|NCT01098578|5995794|P1|NOT COMPLETED|Overall Study||0
2444278|NCT01098578|5995794|P1|COMPLETED|Overall Study||20
2444279|NCT01098578|5995794|P1|STARTED|Overall Study||20
2444280|NCT01098539|5995803|P2|NOT COMPLETED|Overall Study||68
2444281|NCT01098539|5995804|P1|NOT COMPLETED|Overall Study||51
2444282|NCT01098539|5995803|P2|COMPLETED|Overall Study||178
2444283|NCT01098539|5995804|P1|COMPLETED|Overall Study||198
2444284|NCT01098539|5995803|P2|STARTED|Overall Study||246
2444285|NCT01098539|5995804|P1|STARTED|Overall Study||249
2444286|NCT01098500|5995840|P1|NOT COMPLETED|Overall Study||0
2444287|NCT01098500|5995840|P1|COMPLETED|Overall Study||3800
2444288|NCT01098500|5995840|P1|STARTED|Overall Study||3800
2444289|NCT01098487|5995855|P1|NOT COMPLETED|Overall Study||44
2444290|NCT01098487|5995855|P1|COMPLETED|Overall Study||118
2444291|NCT01098487|5995855|P1|STARTED|Overall Study||162
2444292|NCT01098474|5995873|P6|NOT COMPLETED|Follow Up Phase||5
2444293|NCT01098474|5995874|P5|NOT COMPLETED|Follow Up Phase||2
2444294|NCT01098474|5995875|P4|NOT COMPLETED|Follow Up Phase||2
2444295|NCT01098474|5995876|P3|NOT COMPLETED|Follow Up Phase||0
2444296|NCT01098474|5995877|P2|NOT COMPLETED|Follow Up Phase||0
2444297|NCT01098474|5995878|P1|NOT COMPLETED|Follow Up Phase||0
2444298|NCT01098474|5995873|P6|COMPLETED|Follow Up Phase||44
2444299|NCT01098474|5995874|P5|COMPLETED|Follow Up Phase||50
2444300|NCT01098474|5995875|P4|COMPLETED|Follow Up Phase||47
2444301|NCT01098474|5995876|P3|COMPLETED|Follow Up Phase||45
2444302|NCT01098474|5995877|P2|COMPLETED|Follow Up Phase||49
2444303|NCT01098474|5995878|P1|COMPLETED|Follow Up Phase||48
2444304|NCT01098474|5995873|P6|STARTED|Follow Up Phase||49
2444305|NCT01098474|5995874|P5|STARTED|Follow Up Phase||52
2444306|NCT01098474|5995875|P4|STARTED|Follow Up Phase||49
2444307|NCT01098474|5995876|P3|STARTED|Follow Up Phase||45
2444308|NCT01098474|5995877|P2|STARTED|Follow Up Phase||49
2444309|NCT01098474|5995878|P1|STARTED|Follow Up Phase||48
2444310|NCT01098474|5995873|P6|NOT COMPLETED|Active Phase||0
2444311|NCT01098474|5995874|P5|NOT COMPLETED|Active Phase||0
2444312|NCT01098474|5995875|P4|NOT COMPLETED|Active Phase||0
2444313|NCT01098474|5995876|P3|NOT COMPLETED|Active Phase||5
2444314|NCT01098474|5995877|P2|NOT COMPLETED|Active Phase||1
2444315|NCT01098474|5995878|P1|NOT COMPLETED|Active Phase||2
2444316|NCT01098474|5995873|P6|COMPLETED|Active Phase||49
2444317|NCT01098474|5995874|P5|COMPLETED|Active Phase||52
2444318|NCT01098474|5995875|P4|COMPLETED|Active Phase||49
2444319|NCT01098474|5995876|P3|COMPLETED|Active Phase||45
2444320|NCT01098474|5995877|P2|COMPLETED|Active Phase||49
2444321|NCT01098474|5995878|P1|COMPLETED|Active Phase||48
2444322|NCT01098474|5995873|P6|STARTED|Active Phase||49
2444323|NCT01098474|5995874|P5|STARTED|Active Phase||52
2444324|NCT01098474|5995875|P4|STARTED|Active Phase||49
2444325|NCT01098474|5995876|P3|STARTED|Active Phase||50
2444326|NCT01098474|5995877|P2|STARTED|Active Phase||50
2444327|NCT01098474|5995878|P1|STARTED|Active Phase||50
2444328|NCT01098461|5996112|P4|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
2444329|NCT01098461|5996113|P3|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||1
2444330|NCT01098461|5996114|P2|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||3
2444331|NCT01098461|5996115|P1|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
2444332|NCT01098461|5996112|P4|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
2444333|NCT01098461|5996113|P3|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
2444334|NCT01098461|5996114|P2|COMPLETED|Follow-up (FU) Period (8 Weeks)||49
2444335|NCT01098461|5996115|P1|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
2444336|NCT01098461|5996112|P4|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
2444337|NCT01098461|5996113|P3|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|53
2444338|NCT01098461|5996114|P2|STARTED|Follow-up (FU) Period (8 Weeks)||52
2444339|NCT01098461|5996115|P1|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
2444340|NCT01098461|5996112|P4|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||3
2444341|NCT01098461|5996113|P3|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||1
2444342|NCT01098461|5996114|P2|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||7
2444343|NCT01098461|5996115|P1|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||12
2444344|NCT01098461|5996112|P4|COMPLETED|Treatment Period (TP) (16 Weeks)||50
2444345|NCT01098461|5996113|P3|COMPLETED|Treatment Period (TP) (16 Weeks)||53
2444346|NCT01098461|5996114|P2|COMPLETED|Treatment Period (TP) (16 Weeks)||45
2444347|NCT01098461|5996115|P1|COMPLETED|Treatment Period (TP) (16 Weeks)||41
2444348|NCT01098461|5996112|P4|STARTED|Treatment Period (TP) (16 Weeks)||53
2444349|NCT01098461|5996113|P3|STARTED|Treatment Period (TP) (16 Weeks)||54
2444350|NCT01098461|5996114|P2|STARTED|Treatment Period (TP) (16 Weeks)||52
2444351|NCT01098461|5996115|P1|STARTED|Treatment Period (TP) (16 Weeks)||53
2444352|NCT01098318|5996148|P3|NOT COMPLETED|Overall Study||3
2444353|NCT01098318|5996149|P2|NOT COMPLETED|Overall Study||7
2444354|NCT01098318|5996150|P1|NOT COMPLETED|Overall Study||3
2444355|NCT01098318|5996148|P3|COMPLETED|Overall Study||15
2444356|NCT01098318|5996149|P2|COMPLETED|Overall Study||12
2444357|NCT01098318|5996150|P1|COMPLETED|Overall Study||17
2444358|NCT01098318|5996148|P3|STARTED|Overall Study||18
2444359|NCT01098318|5996149|P2|STARTED|Overall Study||19
2444360|NCT01098318|5996150|P1|STARTED|Overall Study||20
2444361|NCT01098305|5996175|P2|NOT COMPLETED|Overall Study||33
2444362|NCT01098305|5996176|P1|NOT COMPLETED|Overall Study||31
2444363|NCT01098305|5996175|P2|COMPLETED|Overall Study||85
2444364|NCT01098305|5996176|P1|COMPLETED|Overall Study||88
2444365|NCT01098305|5996175|P2|STARTED|Overall Study||118
2444366|NCT01098305|5996176|P1|STARTED|Overall Study||119
2444367|NCT01098266|5996186|P2|NOT COMPLETED|Overall Study||7
2444368|NCT01098266|5996187|P1|NOT COMPLETED|Overall Study||7
2444369|NCT01098266|5996186|P2|COMPLETED|Overall Study||193
2444370|NCT01098266|5996187|P1|COMPLETED|Overall Study||193
2444371|NCT01098266|5996186|P2|STARTED|Overall Study||200
2444372|NCT01098266|5996187|P1|STARTED|Overall Study||200
2444373|NCT01098253|5996207|P2|NOT COMPLETED|Overall Study||0
2444374|NCT01098253|5996208|P1|NOT COMPLETED|Overall Study||2
2444375|NCT01098253|5996207|P2|COMPLETED|Overall Study||88
2444376|NCT01098253|5996208|P1|COMPLETED|Overall Study||92
2444377|NCT01098253|5996207|P2|STARTED|Overall Study||88
2444378|NCT01098253|5996208|P1|STARTED|Overall Study||94
2444379|NCT01098240|5996216|P3|NOT COMPLETED|Double-Blind Phase||22
2444380|NCT01098240|5996217|P2|NOT COMPLETED|Double-Blind Phase||17
2444381|NCT01098240|5996218|P1|NOT COMPLETED|Double-Blind Phase||0
2444382|NCT01098240|5996216|P3|COMPLETED|Double-Blind Phase||63
2444383|NCT01098240|5996217|P2|COMPLETED|Double-Blind Phase||60
2444384|NCT01098240|5996218|P1|COMPLETED|Double-Blind Phase||0
2444385|NCT01098240|5996216|P3|STARTED|Double-Blind Phase||85
2444386|NCT01098240|5996217|P2|STARTED|Double-Blind Phase||77
2444387|NCT01098240|5996218|P1|STARTED|Double-Blind Phase||0
2444388|NCT01098240|5996216|P3|NOT COMPLETED|Open-Label Phase||0
2444389|NCT01098240|5996217|P2|NOT COMPLETED|Open-Label Phase||0
2444390|NCT01098240|5996218|P1|NOT COMPLETED|Open-Label Phase||135
2444391|NCT01098240|5996216|P3|COMPLETED|Open-Label Phase||0
2444392|NCT01098240|5996217|P2|COMPLETED|Open-Label Phase||0
2444393|NCT01098240|5996218|P1|COMPLETED|Open-Label Phase||162
2444394|NCT01098240|5996216|P3|STARTED|Open-Label Phase||0
2444395|NCT01098240|5996217|P2|STARTED|Open-Label Phase||0
2444396|NCT01098240|5996218|P1|STARTED|Open-Label Phase||297
2444397|NCT01098162|5996248|P1|NOT COMPLETED|Overall Study||112
2444398|NCT01098162|5996248|P1|COMPLETED|Overall Study||461
2444399|NCT01098162|5996248|P1|STARTED|Overall Study||573
2444400|NCT01098110|5996260|P3|NOT COMPLETED|Overall Study||94
2444401|NCT01098110|5996261|P2|NOT COMPLETED|Overall Study||73
2444402|NCT01098110|5996262|P1|NOT COMPLETED|Overall Study||62
2444403|NCT01098110|5996260|P3|COMPLETED|Overall Study||80
2444404|NCT01098110|5996261|P2|COMPLETED|Overall Study||109
2444405|NCT01098110|5996262|P1|COMPLETED|Overall Study||114
2444406|NCT01098110|5996260|P3|Treated|Overall Study|Received at least one dose of trial medication|174
2444407|NCT01098110|5996261|P2|Treated|Overall Study|Received at least one dose of trial medication|181
2444408|NCT01098110|5996262|P1|Treated|Overall Study|Received at least one dose of trial medication|175
2444409|NCT01098110|5996260|P3|STARTED|Overall Study|Randomized participants|174
2444410|NCT01098110|5996261|P2|STARTED|Overall Study|Randomized participants|182
2444411|NCT01098110|5996262|P1|STARTED|Overall Study|Randomized participants|176
2444412|NCT01098097|5996303|P1|NOT COMPLETED|Overall Study||82
2444413|NCT01098097|5996303|P1|COMPLETED|Overall Study|Participants completing the study received at least 12 weeks of treatment|881
2444414|NCT01098097|5996303|P1|STARTED|Overall Study||963
2444415|NCT01098071|5996312|P1|NOT COMPLETED|Overall Study||15
2444416|NCT01098071|5996312|P1|COMPLETED|Overall Study||19
2444417|NCT01098071|5996312|P1|STARTED|Overall Study||34
2444418|NCT01098032|5996325|P2|NOT COMPLETED|Overall Study||1
2444419|NCT01098032|5996326|P1|NOT COMPLETED|Overall Study||1
2444420|NCT01098032|5996325|P2|COMPLETED|Overall Study||146
2444421|NCT01098032|5996326|P1|COMPLETED|Overall Study||146
2444422|NCT01098032|5996325|P2|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
2444423|NCT01098032|5996326|P1|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
2444436|NCT01097915|5996416|P3|NOT COMPLETED|Overall Study||30
2444437|NCT01097915|5996417|P2|NOT COMPLETED|Overall Study||42
2444438|NCT01097915|5996418|P1|NOT COMPLETED|Overall Study||23
2444439|NCT01097915|5996416|P3|COMPLETED|Overall Study||20
2444440|NCT01097915|5996417|P2|COMPLETED|Overall Study||28
2444441|NCT01097915|5996418|P1|COMPLETED|Overall Study||27
2444442|NCT01097915|5996416|P3|STARTED|Overall Study||50
2444443|NCT01097915|5996417|P2|STARTED|Overall Study||70
2444444|NCT01097915|5996418|P1|STARTED|Overall Study||50
2444445|NCT01097863|5996443|P3|NOT COMPLETED|Overall Study||2
2444446|NCT01097863|5996444|P2|NOT COMPLETED|Overall Study||0
2444447|NCT01097863|5996445|P1|NOT COMPLETED|Overall Study||1
2444448|NCT01097863|5996443|P3|COMPLETED|Overall Study||89
2444449|NCT01097863|5996444|P2|COMPLETED|Overall Study||98
2444450|NCT01097863|5996445|P1|COMPLETED|Overall Study||89
2444451|NCT01097863|5996443|P3|STARTED|Overall Study||91
2444452|NCT01097863|5996444|P2|STARTED|Overall Study||98
2444453|NCT01097863|5996445|P1|STARTED|Overall Study||90
2444454|NCT01097785|5996455|P2|NOT COMPLETED|Cycle 3 (30 Days)||0
2444455|NCT01097785|5996456|P1|NOT COMPLETED|Cycle 3 (30 Days)||0
2444456|NCT01097785|5996455|P2|COMPLETED|Cycle 3 (30 Days)||6
2444457|NCT01097785|5996456|P1|COMPLETED|Cycle 3 (30 Days)||6
2444458|NCT01097785|5996455|P2|STARTED|Cycle 3 (30 Days)||6
2444459|NCT01097785|5996456|P1|STARTED|Cycle 3 (30 Days)||6
2444460|NCT01097785|5996455|P2|NOT COMPLETED|Washout (2 Weeks)||0
2444461|NCT01097785|5996456|P1|NOT COMPLETED|Washout (2 Weeks)||0
2444462|NCT01097785|5996455|P2|COMPLETED|Washout (2 Weeks)||6
2444463|NCT01097785|5996456|P1|COMPLETED|Washout (2 Weeks)||6
2444464|NCT01097785|5996455|P2|STARTED|Washout (2 Weeks)||6
2444465|NCT01097785|5996456|P1|STARTED|Washout (2 Weeks)||6
2444466|NCT01097785|5996455|P2|NOT COMPLETED|Cycle 1 (30 Days)||0
2444467|NCT01097785|5996456|P1|NOT COMPLETED|Cycle 1 (30 Days)||0
2444468|NCT01097785|5996455|P2|COMPLETED|Cycle 1 (30 Days)||6
2444469|NCT01097785|5996456|P1|COMPLETED|Cycle 1 (30 Days)||6
2444470|NCT01097785|5996455|P2|STARTED|Cycle 1 (30 Days)||6
2444471|NCT01097785|5996456|P1|STARTED|Cycle 1 (30 Days)||6
2444472|NCT01097707|5996469|P5|NOT COMPLETED|Overall Study||50
2444473|NCT01097707|5996470|P4|NOT COMPLETED|Overall Study||44
2444474|NCT01097707|5996471|P3|NOT COMPLETED|Overall Study||45
2444475|NCT01097707|5996472|P2|NOT COMPLETED|Overall Study||43
2444476|NCT01097707|5996473|P1|NOT COMPLETED|Overall Study||44
2444477|NCT01097707|5996469|P5|COMPLETED|Overall Study||35
2444478|NCT01097707|5996470|P4|COMPLETED|Overall Study||40
2444479|NCT01097707|5996471|P3|COMPLETED|Overall Study||37
2444480|NCT01097707|5996472|P2|COMPLETED|Overall Study||37
2444481|NCT01097707|5996473|P1|COMPLETED|Overall Study||39
2444482|NCT01097707|5996469|P5|STARTED|Overall Study||85
2444483|NCT01097707|5996470|P4|STARTED|Overall Study||84
2444484|NCT01097707|5996471|P3|STARTED|Overall Study||82
2444485|NCT01097707|5996472|P2|STARTED|Overall Study||80
2444486|NCT01097707|5996473|P1|STARTED|Overall Study||83
2444487|NCT01097694|5996522|P2|NOT COMPLETED|Overall Study||4
2444488|NCT01097694|5996523|P1|NOT COMPLETED|Overall Study||8
2444489|NCT01097694|5996522|P2|COMPLETED|Overall Study||26
2444490|NCT01097694|5996523|P1|COMPLETED|Overall Study||24
2444491|NCT01097694|5996522|P2|STARTED|Overall Study||30
2444492|NCT01097694|5996523|P1|STARTED|Overall Study||32
2444493|NCT01097668|5996585|P2|NOT COMPLETED|Overall Study||2
2444494|NCT01097668|5996586|P1|NOT COMPLETED|Overall Study||2
2444495|NCT01097668|5996585|P2|COMPLETED|Overall Study||20
2444496|NCT01097668|5996586|P1|COMPLETED|Overall Study||19
2444497|NCT01097668|5996585|P2|Week 48|Overall Study||20
2444498|NCT01097668|5996586|P1|Week 48|Overall Study||19
2444499|NCT01097668|5996585|P2|Week 20|Overall Study|Patient evaluability time point = week 20|22
2444500|NCT01097668|5996586|P1|Week 20|Overall Study|Patient evaluability time point = week 20|21
2444501|NCT01097668|5996585|P2|STARTED|Overall Study||22
2444502|NCT01097668|5996586|P1|STARTED|Overall Study||21
2444503|NCT01097655|5996596|P1|NOT COMPLETED|Overall Study||10
2444504|NCT01097655|5996596|P1|COMPLETED|Overall Study|participants included for analysis|3039
2444505|NCT01097655|5996596|P1|STARTED|Overall Study||3049
2444506|NCT01097629|5996606|P8|NOT COMPLETED|DB RO Phase||1
2444507|NCT01097629|5996607|P7|NOT COMPLETED|DB RO Phase||3
2444508|NCT01097629|5996608|P6|NOT COMPLETED|DB RO Phase||1
2444509|NCT01097629|5996609|P5|NOT COMPLETED|DB RO Phase||0
2444510|NCT01097629|5996610|P4|NOT COMPLETED|DB RO Phase||1
2444511|NCT01097629|5996611|P3|NOT COMPLETED|DB RO Phase||0
2444512|NCT01097629|5996612|P2|NOT COMPLETED|DB RO Phase||0
2444513|NCT01097629|5996613|P1|NOT COMPLETED|DB RO Phase||0
2444514|NCT01097629|5996606|P8|COMPLETED|DB RO Phase||326
2444515|NCT01097629|5996607|P7|COMPLETED|DB RO Phase||168
2444516|NCT01097629|5996608|P6|COMPLETED|DB RO Phase||172
2444517|NCT01097629|5996609|P5|COMPLETED|DB RO Phase||108
2444518|NCT01097629|5996610|P4|COMPLETED|DB RO Phase||96
2444519|NCT01097629|5996611|P3|COMPLETED|DB RO Phase||0
2444520|NCT01097629|5996612|P2|COMPLETED|DB RO Phase||0
2444521|NCT01097629|5996613|P1|COMPLETED|DB RO Phase||0
2444522|NCT01097629|5996606|P8|STARTED|DB RO Phase||327
2444523|NCT01097629|5996607|P7|STARTED|DB RO Phase||171
2444524|NCT01097629|5996608|P6|STARTED|DB RO Phase||173
2444525|NCT01097629|5996609|P5|STARTED|DB RO Phase||108
2444526|NCT01097629|5996610|P4|STARTED|DB RO Phase||97
2444527|NCT01097629|5996611|P3|STARTED|DB RO Phase||0
2444528|NCT01097629|5996612|P2|STARTED|DB RO Phase||0
2444529|NCT01097629|5996613|P1|STARTED|DB RO Phase||0
2444530|NCT01097629|5996606|P8|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
2444531|NCT01097629|5996607|P7|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
2444532|NCT01097629|5996608|P6|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
2444533|NCT01097629|5996609|P5|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
2444534|NCT01097629|5996610|P4|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
2444535|NCT01097629|5996611|P3|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||57
2444536|NCT01097629|5996612|P2|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||46
2444537|NCT01097629|5996613|P1|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||35
2444538|NCT01097629|5996606|P8|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
2444539|NCT01097629|5996607|P7|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
2444540|NCT01097629|5996608|P6|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
2444541|NCT01097629|5996609|P5|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
2444542|NCT01097629|5996610|P4|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
2444543|NCT01097629|5996611|P3|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|3 did not continue into RO|330
2444544|NCT01097629|5996612|P2|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|2 did not continue into RO|346
2444545|NCT01097629|5996613|P1|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||205
2444546|NCT01097629|5996606|P8|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
2444547|NCT01097629|5996607|P7|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
2444548|NCT01097629|5996608|P6|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
2444549|NCT01097629|5996609|P5|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
2444550|NCT01097629|5996610|P4|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
2444551|NCT01097629|5996611|P3|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
2444552|NCT01097629|5996612|P2|Treated|Double-Blind (DB) Treatment (TRT) Phase||387
2444553|NCT01097629|5996613|P1|Treated|Double-Blind (DB) Treatment (TRT) Phase||239
2444554|NCT01097629|5996606|P8|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
2444555|NCT01097629|5996607|P7|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
2444556|NCT01097629|5996608|P6|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
2444557|NCT01097629|5996609|P5|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
2444558|NCT01097629|5996610|P4|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
2444559|NCT01097629|5996611|P3|STARTED|Double-Blind (DB) Treatment (TRT) Phase||387
2444560|NCT01097629|5996612|P2|STARTED|Double-Blind (DB) Treatment (TRT) Phase||392
2444561|NCT01097629|5996613|P1|STARTED|Double-Blind (DB) Treatment (TRT) Phase||240
2444562|NCT01097616|5996664|P8|NOT COMPLETED|DB RO Phase||1
2444563|NCT01097616|5996665|P7|NOT COMPLETED|DB RO Phase||1
2444564|NCT01097616|5996666|P6|NOT COMPLETED|DB RO Phase||2
2444565|NCT01097616|5996667|P5|NOT COMPLETED|DB RO Phase||1
2444566|NCT01097616|5996668|P4|NOT COMPLETED|DB RO Phase||1
2444567|NCT01097616|5996669|P3|NOT COMPLETED|DB RO Phase||0
2444568|NCT01097616|5996670|P2|NOT COMPLETED|DB RO Phase||0
2444569|NCT01097616|5996671|P1|NOT COMPLETED|DB RO Phase||0
2444570|NCT01097616|5996664|P8|COMPLETED|DB RO Phase||326
2444571|NCT01097616|5996665|P7|COMPLETED|DB RO Phase||161
2444572|NCT01097616|5996666|P6|COMPLETED|DB RO Phase||159
2444573|NCT01097616|5996667|P5|COMPLETED|DB RO Phase||111
2444574|NCT01097616|5996668|P4|COMPLETED|DB RO Phase||100
2444575|NCT01097616|5996669|P3|COMPLETED|DB RO Phase||0
2444576|NCT01097616|5996670|P2|COMPLETED|DB RO Phase||0
2444577|NCT01097616|5996671|P1|COMPLETED|DB RO Phase||0
2444578|NCT01097616|5996664|P8|STARTED|DB RO Phase||327
2444579|NCT01097616|5996665|P7|STARTED|DB RO Phase||162
2444580|NCT01097616|5996666|P6|STARTED|DB RO Phase|1 entered RO but was not treated during RO|161
2444581|NCT01097616|5996667|P5|STARTED|DB RO Phase|1 was randomized to this group but actually received suvorexant LD during RO|112
2444582|NCT01097616|5996668|P4|STARTED|DB RO Phase||101
2444583|NCT01097616|5996669|P3|STARTED|DB RO Phase||0
2444584|NCT01097616|5996670|P2|STARTED|DB RO Phase||0
2444585|NCT01097616|5996671|P1|STARTED|DB RO Phase||0
2444586|NCT01097616|5996664|P8|NOT COMPLETED|Optional DB EXT Phase||0
2444587|NCT01097616|5996665|P7|NOT COMPLETED|Optional DB EXT Phase||0
2444588|NCT01097616|5996666|P6|NOT COMPLETED|Optional DB EXT Phase||0
2444589|NCT01097616|5996667|P5|NOT COMPLETED|Optional DB EXT Phase||0
2444590|NCT01097616|5996668|P4|NOT COMPLETED|Optional DB EXT Phase||0
2444591|NCT01097616|5996669|P3|NOT COMPLETED|Optional DB EXT Phase||10
2444592|NCT01097616|5996670|P2|NOT COMPLETED|Optional DB EXT Phase||21
2444593|NCT01097616|5996671|P1|NOT COMPLETED|Optional DB EXT Phase||15
2444594|NCT01097616|5996664|P8|COMPLETED|Optional DB EXT Phase||0
2444595|NCT01097616|5996665|P7|COMPLETED|Optional DB EXT Phase||0
2444596|NCT01097616|5996666|P6|COMPLETED|Optional DB EXT Phase||0
2444597|NCT01097616|5996667|P5|COMPLETED|Optional DB EXT Phase||0
2444598|NCT01097616|5996668|P4|COMPLETED|Optional DB EXT Phase||0
2444599|NCT01097616|5996669|P3|COMPLETED|Optional DB EXT Phase|All 141 continued into RO|141
2444600|NCT01097616|5996670|P2|COMPLETED|Optional DB EXT Phase|All 151 continued into RO|151
2444601|NCT01097616|5996671|P1|COMPLETED|Optional DB EXT Phase|All 85 continued into RO|85
2444602|NCT01097616|5996664|P8|STARTED|Optional DB EXT Phase||0
2444603|NCT01097616|5996665|P7|STARTED|Optional DB EXT Phase||0
2444604|NCT01097616|5996666|P6|STARTED|Optional DB EXT Phase||0
2444605|NCT01097616|5996667|P5|STARTED|Optional DB EXT Phase||0
2444606|NCT01097616|5996668|P4|STARTED|Optional DB EXT Phase||0
2444607|NCT01097616|5996669|P3|STARTED|Optional DB EXT Phase||151
2444608|NCT01097616|5996670|P2|STARTED|Optional DB EXT Phase||172
2444609|NCT01097616|5996671|P1|STARTED|Optional DB EXT Phase||100
2444610|NCT01097616|5996664|P8|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
2444611|NCT01097616|5996665|P7|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
2444612|NCT01097616|5996666|P6|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
2444613|NCT01097616|5996667|P5|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
2444614|NCT01097616|5996668|P4|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
2444615|NCT01097616|5996669|P3|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||44
2444616|NCT01097616|5996670|P2|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||38
2444617|NCT01097616|5996671|P1|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||24
2444618|NCT01097616|5996664|P8|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
2444619|NCT01097616|5996665|P7|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
2444620|NCT01097616|5996666|P6|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
2444621|NCT01097616|5996667|P5|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
2444622|NCT01097616|5996668|P4|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
2444623|NCT01097616|5996669|P3|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|151 continued into EXT, 186 continued directly into RO, 4 did not continue into either Phase|341
2444624|NCT01097616|5996670|P2|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|172 continued into EXT, 172 continued directly into RO, 1 did not continue into either Phase|345
2444625|NCT01097616|5996671|P1|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|100 continued into EXT, 128 continued directly into RO, 2 did not continue into either Phase|230
2444626|NCT01097616|5996664|P8|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
2444627|NCT01097616|5996665|P7|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
2444628|NCT01097616|5996666|P6|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
2444629|NCT01097616|5996667|P5|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
2444630|NCT01097616|5996668|P4|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
2444631|NCT01097616|5996669|P3|Treated|Double-Blind (DB) Treatment (TRT) Phase||384
2444632|NCT01097616|5996670|P2|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
2444633|NCT01097616|5996671|P1|Treated|Double-Blind (DB) Treatment (TRT) Phase||254
2444634|NCT01097616|5996664|P8|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
2444635|NCT01097616|5996665|P7|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
2444636|NCT01097616|5996666|P6|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
2444637|NCT01097616|5996667|P5|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
2444638|NCT01097616|5996668|P4|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
2444639|NCT01097616|5996669|P3|STARTED|Double-Blind (DB) Treatment (TRT) Phase||385
2444640|NCT01097616|5996670|P2|STARTED|Double-Blind (DB) Treatment (TRT) Phase||383
2444641|NCT01097616|5996671|P1|STARTED|Double-Blind (DB) Treatment (TRT) Phase||254
2444642|NCT01097460|5996742|P1|NOT COMPLETED|Overall Study||0
2444643|NCT01097460|5996742|P1|COMPLETED|Overall Study||16
2444644|NCT01097460|5996742|P1|STARTED|Overall Study||16
2444645|NCT01097421|5996746|P1|NOT COMPLETED|Overall Study||14
2444646|NCT01097421|5996746|P1|COMPLETED|Overall Study||314
2444647|NCT01097421|5996746|P1|STARTED|Overall Study||328
2444648|NCT01097343|5996756|P2|NOT COMPLETED|Second Intervention- 30 Days||0
2444649|NCT01097343|5996757|P1|NOT COMPLETED|Second Intervention- 30 Days||0
2444650|NCT01097343|5996756|P2|COMPLETED|Second Intervention- 30 Days||25
2444651|NCT01097343|5996757|P1|COMPLETED|Second Intervention- 30 Days||25
2444652|NCT01097343|5996756|P2|STARTED|Second Intervention- 30 Days||25
2444653|NCT01097343|5996757|P1|STARTED|Second Intervention- 30 Days||25
2444654|NCT01097343|5996756|P2|NOT COMPLETED|First Intervention- 30 Days||0
2444655|NCT01097343|5996757|P1|NOT COMPLETED|First Intervention- 30 Days||0
2444656|NCT01097343|5996756|P2|COMPLETED|First Intervention- 30 Days||25
2444657|NCT01097343|5996757|P1|COMPLETED|First Intervention- 30 Days||25
2444658|NCT01097343|5996756|P2|STARTED|First Intervention- 30 Days||25
2444659|NCT01097343|5996757|P1|STARTED|First Intervention- 30 Days||25
2444660|NCT01097330|5996765|P2|NOT COMPLETED|Overall Study||5
2444661|NCT01097330|5996766|P1|NOT COMPLETED|Overall Study||7
2444662|NCT01097330|5996765|P2|COMPLETED|Overall Study||0
2444663|NCT01097330|5996766|P1|COMPLETED|Overall Study||0
2444664|NCT01097330|5996765|P2|STARTED|Overall Study||5
2444665|NCT01097330|5996766|P1|STARTED|Overall Study||7
2444666|NCT01097304|5996776|P1|NOT COMPLETED|Overall Study||7
2444667|NCT01097304|5996776|P1|COMPLETED|Overall Study||29
2444668|NCT01097304|5996776|P1|STARTED|Overall Study||36
2444669|NCT01097057|5996783|P1|NOT COMPLETED|Overall Study||3
2444670|NCT01097057|5996783|P1|COMPLETED|Overall Study||17
2444671|NCT01097057|5996783|P1|STARTED|Overall Study||20
2444672|NCT01097044|5996792|P2|NOT COMPLETED|Overall Study||5
2444673|NCT01097044|5996793|P1|NOT COMPLETED|Overall Study||5
2444674|NCT01097044|5996792|P2|COMPLETED|Overall Study||33
2444675|NCT01097044|5996793|P1|COMPLETED|Overall Study||34
2444676|NCT01097044|5996792|P2|STARTED|Overall Study||38
2444677|NCT01097044|5996793|P1|STARTED|Overall Study||39
2444678|NCT01097005|5996811|P1|NOT COMPLETED|Overall Study||365
2444679|NCT01097005|5996811|P1|COMPLETED|Overall Study||101
2444680|NCT01097005|5996811|P1|Analysis of CGI|Overall Study|number of participants who were measured for Clinical Global Improvement (CGI)|249
2444681|NCT01097005|5996811|P1|Analysis of Bacilli Negative Conversion|Overall Study|number of participants who were analysed for bacilli negative conversion|285
2444682|NCT01097005|5996811|P1|Analysis of NTM Lung Disease|Overall Study|number of participants who contributed to the Baseline data|340
2444683|NCT01097005|5996811|P1|Analysis of Safety|Overall Study|number of participants who could be measured for Adverse Events|441
2444684|NCT01097005|5996811|P1|STARTED|Overall Study|number of participants who were enrolled for this study.|466
2444685|NCT01096992|5996822|P5|NOT COMPLETED|Overall Study||0
2444686|NCT01096992|5996823|P4|NOT COMPLETED|Overall Study||0
2444687|NCT01096992|5996824|P3|NOT COMPLETED|Overall Study||0
2444688|NCT01096992|5996825|P2|NOT COMPLETED|Overall Study||0
2444689|NCT01096992|5996826|P1|NOT COMPLETED|Overall Study||0
2444690|NCT01096992|5996822|P5|COMPLETED|Overall Study||30
2444691|NCT01096992|5996823|P4|COMPLETED|Overall Study||6
2444692|NCT01096992|5996824|P3|COMPLETED|Overall Study||6
2444693|NCT01096992|5996825|P2|COMPLETED|Overall Study||3
2444694|NCT01096992|5996826|P1|COMPLETED|Overall Study||6
2444695|NCT01096992|5996822|P5|STARTED|Overall Study||30
2444696|NCT01096992|5996823|P4|STARTED|Overall Study||6
2444697|NCT01096992|5996824|P3|STARTED|Overall Study||6
2444698|NCT01096992|5996825|P2|STARTED|Overall Study||3
2444699|NCT01096992|5996826|P1|STARTED|Overall Study||6
2444700|NCT01096875|5996841|P2|NOT COMPLETED|Overall Study||1
2444701|NCT01096875|5996842|P1|NOT COMPLETED|Overall Study||0
2444702|NCT01096875|5996841|P2|COMPLETED|Overall Study||29
2444703|NCT01096875|5996842|P1|COMPLETED|Overall Study||30
2444704|NCT01096875|5996841|P2|STARTED|Overall Study||30
2444705|NCT01096875|5996842|P1|STARTED|Overall Study||30
2444706|NCT01096849|5996857|P3|NOT COMPLETED|Overall Study||6
2444707|NCT01096849|5996858|P2|NOT COMPLETED|Overall Study||12
2444708|NCT01096849|5996859|P1|NOT COMPLETED|Overall Study||2
2444709|NCT01096849|5996857|P3|COMPLETED|Overall Study||41
2444710|NCT01096849|5996858|P2|COMPLETED|Overall Study||64
2444711|NCT01096849|5996859|P1|COMPLETED|Overall Study||20
2444712|NCT01096849|5996857|P3|STARTED|Overall Study||47
2444713|NCT01096849|5996858|P2|STARTED|Overall Study||76
2444714|NCT01096849|5996859|P1|STARTED|Overall Study||22
2444715|NCT01096823|5996914|P2|NOT COMPLETED|Overall Study||1
2444716|NCT01096823|5996915|P1|NOT COMPLETED|Overall Study||3
2444717|NCT01096823|5996914|P2|COMPLETED|Overall Study||15
2444718|NCT01096823|5996915|P1|COMPLETED|Overall Study||11
2444719|NCT01096823|5996914|P2|STARTED|Overall Study||16
2444720|NCT01096823|5996915|P1|STARTED|Overall Study||14
2444721|NCT01096810|5996927|P1|NOT COMPLETED|Overall Study||0
2444722|NCT01096810|5996927|P1|COMPLETED|Overall Study||20
2444723|NCT01096810|5996927|P1|STARTED|Overall Study||20
2444724|NCT01096784|5996935|P2|NOT COMPLETED|Overall Study||14
2444725|NCT01096784|5996936|P1|NOT COMPLETED|Overall Study||15
2444726|NCT01096784|5996935|P2|COMPLETED|Overall Study||46
2444727|NCT01096784|5996936|P1|COMPLETED|Overall Study||46
2444728|NCT01096784|5996935|P2|STARTED|Overall Study||60
2444729|NCT01096784|5996936|P1|STARTED|Overall Study||61
2444730|NCT01096771|5996970|P2|NOT COMPLETED|Overall Study||0
2444731|NCT01096771|5996971|P1|NOT COMPLETED|Overall Study||0
2444732|NCT01096771|5996970|P2|COMPLETED|Overall Study||7
2444733|NCT01096771|5996971|P1|COMPLETED|Overall Study||7
2444734|NCT01096771|5996970|P2|STARTED|Overall Study||7
2444735|NCT01096771|5996971|P1|STARTED|Overall Study||7
2444736|NCT01096680|5997000|P5|NOT COMPLETED|Overall Study||0
2444737|NCT01096680|5997001|P4|NOT COMPLETED|Overall Study||0
2444738|NCT01096680|5997002|P3|NOT COMPLETED|Overall Study||0
2444739|NCT01096680|5997003|P2|NOT COMPLETED|Overall Study||0
2444740|NCT01096680|5997004|P1|NOT COMPLETED|Overall Study||0
2444741|NCT01096680|5997000|P5|COMPLETED|Overall Study||27
2444742|NCT01096680|5997001|P4|COMPLETED|Overall Study||27
2444743|NCT01096680|5997002|P3|COMPLETED|Overall Study||27
2444744|NCT01096680|5997003|P2|COMPLETED|Overall Study||27
2444745|NCT01096680|5997004|P1|COMPLETED|Overall Study||27
2444746|NCT01096680|5997000|P5|STARTED|Overall Study||27
2444747|NCT01096680|5997001|P4|STARTED|Overall Study||27
2444748|NCT01096680|5997002|P3|STARTED|Overall Study||27
2444749|NCT01096680|5997003|P2|STARTED|Overall Study||27
2444750|NCT01096680|5997004|P1|STARTED|Overall Study||27
2444751|NCT01096667|5997041|P5|NOT COMPLETED|Overall Study||0
2444752|NCT01096667|5997042|P4|NOT COMPLETED|Overall Study||3
2444753|NCT01096667|5997043|P3|NOT COMPLETED|Overall Study||2
2444754|NCT01096667|5997044|P2|NOT COMPLETED|Overall Study||2
2444755|NCT01096667|5997045|P1|NOT COMPLETED|Overall Study||3
2444756|NCT01096667|5997041|P5|COMPLETED|Overall Study||39
2444757|NCT01096667|5997042|P4|COMPLETED|Overall Study||36
2444758|NCT01096667|5997043|P3|COMPLETED|Overall Study||36
2444759|NCT01096667|5997044|P2|COMPLETED|Overall Study||37
2444760|NCT01096667|5997045|P1|COMPLETED|Overall Study||36
2444761|NCT01096667|5997041|P5|Treated|Overall Study||39
2444762|NCT01096667|5997042|P4|Treated|Overall Study||39
2444763|NCT01096667|5997043|P3|Treated|Overall Study||38
2444764|NCT01096667|5997044|P2|Treated|Overall Study||39
2444765|NCT01096667|5997045|P1|Treated|Overall Study||38
2444766|NCT01096667|5997041|P5|STARTED|Overall Study||39
2444767|NCT01096667|5997042|P4|STARTED|Overall Study||39
2444768|NCT01096667|5997043|P3|STARTED|Overall Study||38
2444769|NCT01096667|5997044|P2|STARTED|Overall Study||39
2444770|NCT01096667|5997045|P1|STARTED|Overall Study||39
2444771|NCT01096589|5997187|P4|NOT COMPLETED|Overall Study||3
2444772|NCT01096589|5997188|P3|NOT COMPLETED|Overall Study||4
2444773|NCT01096589|5997189|P2|NOT COMPLETED|Overall Study||2
2444774|NCT01096589|5997190|P1|NOT COMPLETED|Overall Study||4
2444775|NCT01096589|5997187|P4|COMPLETED|Overall Study||15
2444776|NCT01096589|5997188|P3|COMPLETED|Overall Study||18
2444777|NCT01096589|5997189|P2|COMPLETED|Overall Study||18
2444778|NCT01096589|5997190|P1|COMPLETED|Overall Study||18
2444779|NCT01096589|5997187|P4|STARTED|Overall Study||18
2444780|NCT01096589|5997188|P3|STARTED|Overall Study||22
2444781|NCT01096589|5997189|P2|STARTED|Overall Study||20
2444782|NCT01096589|5997190|P1|STARTED|Overall Study||22
2444789|NCT01096446|5997215|P2|NOT COMPLETED|Overall Study||0
2444790|NCT01096446|5997216|P1|NOT COMPLETED|Overall Study||3
2444791|NCT01096446|5997215|P2|COMPLETED|Overall Study||10
2444792|NCT01096446|5997216|P1|COMPLETED|Overall Study|One infant was SGA; one infant had a congenital anomaly; and one discontinued medical management|9
2444793|NCT01096446|5997215|P2|STARTED|Overall Study||10
2444794|NCT01096446|5997216|P1|STARTED|Overall Study||12
2444795|NCT01096342|5997221|P1|NOT COMPLETED|Overall Study||1
2444796|NCT01096342|5997221|P1|COMPLETED|Overall Study||15
2444797|NCT01096342|5997221|P1|STARTED|Overall Study||16
2444798|NCT01096316|5997229|P2|NOT COMPLETED|Overall Study||9
2444799|NCT01096316|5997230|P1|NOT COMPLETED|Overall Study||15
2444800|NCT01096316|5997229|P2|COMPLETED|Overall Study||94
2444801|NCT01096316|5997230|P1|COMPLETED|Overall Study||87
2444802|NCT01096316|5997229|P2|STARTED|Overall Study||103
2444803|NCT01096316|5997230|P1|STARTED|Overall Study||102
2444804|NCT01096186|5997240|P1|NOT COMPLETED|Overall Study||50
2444805|NCT01096186|5997240|P1|COMPLETED|Overall Study||567
2444806|NCT01096186|5997240|P1|STARTED|Overall Study||617
2444807|NCT01096160|5997256|P10|NOT COMPLETED|Overall Study||1
2444808|NCT01096160|5997257|P9|NOT COMPLETED|Overall Study||2
2444809|NCT01096160|5997258|P8|NOT COMPLETED|Overall Study||0
2444810|NCT01096160|5997259|P7|NOT COMPLETED|Overall Study||2
2444811|NCT01096160|5997260|P6|NOT COMPLETED|Overall Study||0
2444812|NCT01096160|5997261|P5|NOT COMPLETED|Overall Study||1
2444813|NCT01096160|5997262|P4|NOT COMPLETED|Overall Study||0
2444814|NCT01096160|5997263|P3|NOT COMPLETED|Overall Study||1
2444815|NCT01096160|5997264|P2|NOT COMPLETED|Overall Study||0
2444816|NCT01096160|5997265|P1|NOT COMPLETED|Overall Study||0
2444817|NCT01096160|5997256|P10|COMPLETED|Overall Study||1
2444818|NCT01096160|5997257|P9|COMPLETED|Overall Study||4
2444819|NCT01096160|5997258|P8|COMPLETED|Overall Study||2
2444820|NCT01096160|5997259|P7|COMPLETED|Overall Study||4
2444821|NCT01096160|5997260|P6|COMPLETED|Overall Study||2
2444822|NCT01096160|5997261|P5|COMPLETED|Overall Study||5
2444823|NCT01096160|5997262|P4|COMPLETED|Overall Study||2
2444824|NCT01096160|5997263|P3|COMPLETED|Overall Study||5
2444825|NCT01096160|5997264|P2|COMPLETED|Overall Study||2
2444826|NCT01096160|5997265|P1|COMPLETED|Overall Study||6
2444827|NCT01096160|5997256|P10|STARTED|Overall Study||2
2444828|NCT01096160|5997257|P9|STARTED|Overall Study||6
2444829|NCT01096160|5997258|P8|STARTED|Overall Study||2
2444830|NCT01096160|5997259|P7|STARTED|Overall Study||6
2444831|NCT01096160|5997260|P6|STARTED|Overall Study||2
2444832|NCT01096160|5997261|P5|STARTED|Overall Study||6
2444833|NCT01096160|5997262|P4|STARTED|Overall Study||2
2444834|NCT01096160|5997263|P3|STARTED|Overall Study||6
2444835|NCT01096160|5997264|P2|STARTED|Overall Study||2
2444836|NCT01096160|5997265|P1|STARTED|Overall Study||6
2444837|NCT01096056|5997323|P2|NOT COMPLETED|Overall Study||1
2444838|NCT01096056|5997324|P1|NOT COMPLETED|Overall Study||0
2444839|NCT01096056|5997323|P2|COMPLETED|Overall Study||19
2444840|NCT01096056|5997324|P1|COMPLETED|Overall Study||20
2444841|NCT01096056|5997323|P2|Completed at Day 42|Overall Study||20
2444842|NCT01096056|5997324|P1|Completed at Day 42|Overall Study||20
2444843|NCT01096056|5997323|P2|STARTED|Overall Study||20
2444844|NCT01096056|5997324|P1|STARTED|Overall Study||20
2444845|NCT01096017|5997356|P2|NOT COMPLETED|Treatment Period 2||1
2444846|NCT01096017|5997357|P1|NOT COMPLETED|Treatment Period 2||1
2444847|NCT01096017|5997356|P2|COMPLETED|Treatment Period 2||11
2444848|NCT01096017|5997357|P1|COMPLETED|Treatment Period 2||11
2444849|NCT01096017|5997356|P2|STARTED|Treatment Period 2||12
2444850|NCT01096017|5997357|P1|STARTED|Treatment Period 2||12
2444851|NCT01096017|5997356|P2|NOT COMPLETED|Washout 1 - 14 Days||0
2444852|NCT01096017|5997357|P1|NOT COMPLETED|Washout 1 - 14 Days||0
2444853|NCT01096017|5997356|P2|COMPLETED|Washout 1 - 14 Days||12
2444854|NCT01096017|5997357|P1|COMPLETED|Washout 1 - 14 Days||12
2444855|NCT01096017|5997356|P2|STARTED|Washout 1 - 14 Days||12
2444856|NCT01096017|5997357|P1|STARTED|Washout 1 - 14 Days||12
2444857|NCT01096017|5997356|P2|NOT COMPLETED|Treatment Period 1||0
2444858|NCT01096017|5997357|P1|NOT COMPLETED|Treatment Period 1||0
2444859|NCT01096017|5997356|P2|COMPLETED|Treatment Period 1||12
2444860|NCT01096017|5997357|P1|COMPLETED|Treatment Period 1||12
2444861|NCT01096017|5997356|P2|STARTED|Treatment Period 1||12
2444862|NCT01096017|5997357|P1|STARTED|Treatment Period 1||12
2444863|NCT01095978|5997385|P1|NOT COMPLETED|Overall Study||3
2444864|NCT01095978|5997385|P1|COMPLETED|Overall Study||2819
2444865|NCT01095978|5997385|P1|STARTED|Overall Study||2822
2444866|NCT01095887|5997412|P1|NOT COMPLETED|Overall Study||0
2444867|NCT01095887|5997412|P1|COMPLETED|Overall Study||6
2444868|NCT01095887|5997412|P1|STARTED|Overall Study||6
2444869|NCT01095835|5997419|P3|NOT COMPLETED|Overall Study||8
2444870|NCT01095835|5997420|P2|NOT COMPLETED|Overall Study||12
2444871|NCT01095835|5997421|P1|NOT COMPLETED|Overall Study||10
2444872|NCT01095835|5997419|P3|COMPLETED|Overall Study||17
2444873|NCT01095835|5997420|P2|COMPLETED|Overall Study||40
2444874|NCT01095835|5997421|P1|COMPLETED|Overall Study||41
2444875|NCT01095835|5997419|P3|STARTED|Overall Study||25
2444876|NCT01095835|5997420|P2|STARTED|Overall Study||52
2444877|NCT01095835|5997421|P1|STARTED|Overall Study||51
2444878|NCT01095796|5997459|P2|NOT COMPLETED|Overall Study||289
2444879|NCT01095796|5997460|P1|NOT COMPLETED|Overall Study||295
2444880|NCT01095796|5997459|P2|COMPLETED|Overall Study||65
2444881|NCT01095796|5997460|P1|COMPLETED|Overall Study||58
2444882|NCT01095796|5997459|P2|STARTED|Overall Study||354
2444883|NCT01095796|5997460|P1|STARTED|Overall Study||353
2444884|NCT01095757|5997478|P1|NOT COMPLETED|Overall Study||0
2444885|NCT01095757|5997478|P1|COMPLETED|Overall Study||45
2444886|NCT01095757|5997478|P1|STARTED|Overall Study||45
2444887|NCT01095666|5997490|P3|NOT COMPLETED|Overall Study||7
2444888|NCT01095666|5997491|P2|NOT COMPLETED|Overall Study||11
2444889|NCT01095666|5997492|P1|NOT COMPLETED|Overall Study||17
2444890|NCT01095666|5997490|P3|COMPLETED|Overall Study||145
2444891|NCT01095666|5997491|P2|COMPLETED|Overall Study||136
2444892|NCT01095666|5997492|P1|COMPLETED|Overall Study||128
2444893|NCT01095666|5997490|P3|STARTED|Overall Study||152
2444894|NCT01095666|5997491|P2|STARTED|Overall Study||147
2444895|NCT01095666|5997492|P1|STARTED|Overall Study||145
2444896|NCT01095653|5997515|P3|NOT COMPLETED|Overall Study||16
2444897|NCT01095653|5997516|P2|NOT COMPLETED|Overall Study||15
2444898|NCT01095653|5997517|P1|NOT COMPLETED|Overall Study||19
2444899|NCT01095653|5997515|P3|COMPLETED|Overall Study||117
2444900|NCT01095653|5997516|P2|COMPLETED|Overall Study||113
2444901|NCT01095653|5997517|P1|COMPLETED|Overall Study||113
2444902|NCT01095653|5997515|P3|STARTED|Overall Study||133
2444903|NCT01095653|5997516|P2|STARTED|Overall Study||128
2444904|NCT01095653|5997517|P1|STARTED|Overall Study||132
2444905|NCT01095510|5997540|P4|NOT COMPLETED|Overall Study||0
2444906|NCT01095510|5997541|P3|NOT COMPLETED|Overall Study||0
2444907|NCT01095510|5997542|P2|NOT COMPLETED|Overall Study||0
2444908|NCT01095510|5997543|P1|NOT COMPLETED|Overall Study||0
2444909|NCT01095510|5997540|P4|COMPLETED|Overall Study||3
2444910|NCT01095510|5997541|P3|COMPLETED|Overall Study||3
2444911|NCT01095510|5997542|P2|COMPLETED|Overall Study||0
2444912|NCT01095510|5997543|P1|COMPLETED|Overall Study||3
2444913|NCT01095510|5997540|P4|STARTED|Overall Study||3
2444914|NCT01095510|5997541|P3|STARTED|Overall Study||3
2444915|NCT01095510|5997542|P2|STARTED|Overall Study||0
2444916|NCT01095510|5997543|P1|STARTED|Overall Study||3
2444917|NCT01095497|5997562|P2|NOT COMPLETED|Subcutaneous CINRYZE||0
2444918|NCT01095497|5997563|P1|NOT COMPLETED|Subcutaneous CINRYZE||1
2444919|NCT01095497|5997562|P2|COMPLETED|Subcutaneous CINRYZE||12
2444920|NCT01095497|5997563|P1|COMPLETED|Subcutaneous CINRYZE||12
2444921|NCT01095497|5997562|P2|STARTED|Subcutaneous CINRYZE||12
2444922|NCT01095497|5997563|P1|STARTED|Subcutaneous CINRYZE||13
2444923|NCT01095497|5997562|P2|NOT COMPLETED|Intravenous CINRYZE||0
2444924|NCT01095497|5997563|P1|NOT COMPLETED|Intravenous CINRYZE||1
2444925|NCT01095497|5997562|P2|COMPLETED|Intravenous CINRYZE||12
2444926|NCT01095497|5997563|P1|COMPLETED|Intravenous CINRYZE||13
2444927|NCT01095497|5997562|P2|STARTED|Intravenous CINRYZE||12
2444928|NCT01095497|5997563|P1|STARTED|Intravenous CINRYZE||14
2444929|NCT01095250|5997575|P4|NOT COMPLETED|Overall Study||5
2444930|NCT01095250|5997576|P3|NOT COMPLETED|Overall Study||8
2444931|NCT01095250|5997577|P2|NOT COMPLETED|Overall Study||10
2444932|NCT01095250|5997578|P1|NOT COMPLETED|Overall Study||8
2444933|NCT01095250|5997575|P4|COMPLETED|Overall Study||0
2444934|NCT01095250|5997576|P3|COMPLETED|Overall Study||0
2444935|NCT01095250|5997577|P2|COMPLETED|Overall Study||0
2444936|NCT01095250|5997578|P1|COMPLETED|Overall Study||0
2444937|NCT01095250|5997575|P4|STARTED|Overall Study||5
2444938|NCT01095250|5997576|P3|STARTED|Overall Study||8
2444939|NCT01095250|5997577|P2|STARTED|Overall Study||10
2444940|NCT01095250|5997578|P1|STARTED|Overall Study||8
2444941|NCT01095094|5997608|P1|NOT COMPLETED|Overall Study||3
2444942|NCT01095094|5997608|P1|COMPLETED|Overall Study||16
2444943|NCT01095094|5997608|P1|STARTED|Overall Study||19
2444944|NCT01095003|5997615|P2|NOT COMPLETED|Overall Study||386
2444945|NCT01095003|5997616|P1|NOT COMPLETED|Overall Study||384
2444946|NCT01095003|5997615|P2|COMPLETED|Overall Study||0
2444947|NCT01095003|5997616|P1|COMPLETED|Overall Study||0
2444948|NCT01095003|5997615|P2|STARTED|Overall Study||386
2444949|NCT01095003|5997616|P1|STARTED|Overall Study||384
2444950|NCT01094886|5997630|P1|NOT COMPLETED|Overall Study||7
2444951|NCT01094886|5997630|P1|COMPLETED|Overall Study||46
2444952|NCT01094886|5997630|P1|STARTED|Overall Study||53
2444953|NCT01094808|5997640|P3|NOT COMPLETED|Overall Study||0
2444954|NCT01094808|5997641|P2|NOT COMPLETED|Overall Study||1
2444955|NCT01094808|5997642|P1|NOT COMPLETED|Overall Study||1
2444956|NCT01094808|5997640|P3|COMPLETED|Overall Study||21
2444957|NCT01094808|5997641|P2|COMPLETED|Overall Study||19
2444958|NCT01094808|5997642|P1|COMPLETED|Overall Study||20
2444959|NCT01094808|5997640|P3|STARTED|Overall Study||21
2444960|NCT01094808|5997641|P2|STARTED|Overall Study||20
2444961|NCT01094808|5997642|P1|STARTED|Overall Study||21
2444980|NCT01094743|5997732|P1|NOT COMPLETED|Period 2||0
2444981|NCT01094743|5997732|P1|COMPLETED|Period 2||50
2444982|NCT01094743|5997732|P1|STARTED|Period 2||50
2444983|NCT01094743|5997732|P1|NOT COMPLETED|Period 1||2
2444984|NCT01094743|5997732|P1|COMPLETED|Period 1||50
2444985|NCT01094743|5997732|P1|STARTED|Period 1||52
2444986|NCT01094730|5997749|P2|NOT COMPLETED|Period 2 (14 Days)||2
2444987|NCT01094730|5997750|P1|NOT COMPLETED|Period 2 (14 Days)||3
2444988|NCT01094730|5997749|P2|COMPLETED|Period 2 (14 Days)||84
2444989|NCT01094730|5997750|P1|COMPLETED|Period 2 (14 Days)||87
2444990|NCT01094730|5997749|P2|STARTED|Period 2 (14 Days)||86
2444991|NCT01094730|5997750|P1|STARTED|Period 2 (14 Days)||90
2444992|NCT01094730|5997749|P2|NOT COMPLETED|Period 1 (14 Days)||2
2444993|NCT01094730|5997750|P1|NOT COMPLETED|Period 1 (14 Days)||2
2444994|NCT01094730|5997749|P2|COMPLETED|Period 1 (14 Days)||86
2444995|NCT01094730|5997750|P1|COMPLETED|Period 1 (14 Days)||90
2444996|NCT01094730|5997749|P2|STARTED|Period 1 (14 Days)||88
2444997|NCT01094730|5997750|P1|STARTED|Period 1 (14 Days)||92
2444998|NCT01094717|5997763|P2|NOT COMPLETED|Overall Study||0
2444999|NCT01094717|5997764|P1|NOT COMPLETED|Overall Study||0
2445000|NCT01094717|5997763|P2|COMPLETED|Overall Study||10
2445001|NCT01094717|5997764|P1|COMPLETED|Overall Study||3
2445002|NCT01094717|5997763|P2|STARTED|Overall Study||10
2445003|NCT01094717|5997764|P1|STARTED|Overall Study||3
2445004|NCT01094704|5997782|P2|NOT COMPLETED|Overall Study||0
2445005|NCT01094704|5997783|P1|NOT COMPLETED|Overall Study||0
2445006|NCT01094704|5997782|P2|COMPLETED|Overall Study||8
2445007|NCT01094704|5997783|P1|COMPLETED|Overall Study||8
2445008|NCT01094704|5997782|P2|STARTED|Overall Study||8
2445009|NCT01094704|5997783|P1|STARTED|Overall Study||8
2445010|NCT01094574|5997795|P6|NOT COMPLETED|Overall Study||0
2445011|NCT01094574|5997796|P5|NOT COMPLETED|Overall Study||0
2445012|NCT01094574|5997797|P4|NOT COMPLETED|Overall Study||0
2445013|NCT01094574|5997798|P3|NOT COMPLETED|Overall Study||0
2445014|NCT01094574|5997799|P2|NOT COMPLETED|Overall Study||0
2445015|NCT01094574|5997800|P1|NOT COMPLETED|Overall Study||0
2445016|NCT01094574|5997795|P6|COMPLETED|Overall Study||2
2445017|NCT01094574|5997796|P5|COMPLETED|Overall Study||2
2445018|NCT01094574|5997797|P4|COMPLETED|Overall Study||2
2445019|NCT01094574|5997798|P3|COMPLETED|Overall Study||2
2445020|NCT01094574|5997799|P2|COMPLETED|Overall Study||1
2445021|NCT01094574|5997800|P1|COMPLETED|Overall Study||1
2445022|NCT01094574|5997795|P6|STARTED|Overall Study||2
2445023|NCT01094574|5997796|P5|STARTED|Overall Study||2
2445024|NCT01094574|5997797|P4|STARTED|Overall Study||2
2445025|NCT01094574|5997798|P3|STARTED|Overall Study||2
2445026|NCT01094574|5997799|P2|STARTED|Overall Study||1
2445027|NCT01094574|5997800|P1|STARTED|Overall Study||1
2445028|NCT01094561|5997847|P1|NOT COMPLETED|Overall Study||6
2445029|NCT01094561|5997847|P1|COMPLETED|Overall Study||17
2445030|NCT01094561|5997847|P1|STARTED|Overall Study||23
2445031|NCT01094548|5997854|P2|NOT COMPLETED|Overall Study||0
2445032|NCT01094548|5997855|P1|NOT COMPLETED|Overall Study||0
2445033|NCT01094548|5997854|P2|COMPLETED|Overall Study||17
2445034|NCT01094548|5997855|P1|COMPLETED|Overall Study||17
2445035|NCT01094548|5997854|P2|STARTED|Overall Study||17
2445036|NCT01094548|5997855|P1|STARTED|Overall Study||17
2445037|NCT01094522|5997875|P2|NOT COMPLETED|Overall Study||0
2445038|NCT01094522|5997876|P1|NOT COMPLETED|Overall Study||0
2445039|NCT01094522|5997875|P2|COMPLETED|Overall Study||20
2445040|NCT01094522|5997876|P1|COMPLETED|Overall Study||20
2445041|NCT01094522|5997875|P2|STARTED|Overall Study||20
2445042|NCT01094522|5997876|P1|STARTED|Overall Study||20
2445043|NCT01094301|5997886|P1|NOT COMPLETED|Implant Stage||8
2445044|NCT01094301|5997886|P1|COMPLETED|Implant Stage||5
2445045|NCT01094301|5997886|P1|Subjects Who Received SPR IPG|Implant Stage||5
2445046|NCT01094301|5997886|P1|Met Criteria for Implant Stage|Implant Stage||7
2445047|NCT01094301|5997886|P1|STARTED|Implant Stage||13
2445048|NCT01094301|5997886|P1|NOT COMPLETED|Trial Stage||1
2445049|NCT01094301|5997886|P1|COMPLETED|Trial Stage||27
2445050|NCT01094301|5997886|P1|Subjects Who Received Smartpatch Lead|Trial Stage||28
2445051|NCT01094301|5997886|P1|STARTED|Trial Stage||28
2445052|NCT01094288|5997916|P8|NOT COMPLETED|Overall Study||2
2445053|NCT01094288|5997917|P7|NOT COMPLETED|Overall Study||0
2445054|NCT01094288|5997918|P6|NOT COMPLETED|Overall Study||0
2445055|NCT01094288|5997919|P5|NOT COMPLETED|Overall Study||0
2445056|NCT01094288|5997920|P4|NOT COMPLETED|Overall Study||2
2445057|NCT01094288|5997921|P3|NOT COMPLETED|Overall Study||4
2445058|NCT01094288|5997922|P2|NOT COMPLETED|Overall Study||10
2445059|NCT01094288|5997923|P1|NOT COMPLETED|Overall Study||2
2445060|NCT01094288|5997916|P8|COMPLETED|Overall Study||2
2445061|NCT01094288|5997917|P7|COMPLETED|Overall Study||2
2445062|NCT01094288|5997918|P6|COMPLETED|Overall Study||4
2445063|NCT01094288|5997919|P5|COMPLETED|Overall Study||2
2445064|NCT01094288|5997920|P4|COMPLETED|Overall Study||1
2445065|NCT01094288|5997921|P3|COMPLETED|Overall Study||1
2445066|NCT01094288|5997922|P2|COMPLETED|Overall Study||5
2445067|NCT01094288|5997923|P1|COMPLETED|Overall Study|Completed=Completed Treatment|4
2445068|NCT01094288|5997916|P8|STARTED|Overall Study||4
2445069|NCT01094288|5997917|P7|STARTED|Overall Study||2
2445070|NCT01094288|5997918|P6|STARTED|Overall Study||4
2445071|NCT01094288|5997919|P5|STARTED|Overall Study||2
2445072|NCT01094288|5997920|P4|STARTED|Overall Study||3
2445073|NCT01094288|5997921|P3|STARTED|Overall Study||5
2445074|NCT01094288|5997922|P2|STARTED|Overall Study||15
2445075|NCT01094288|5997923|P1|STARTED|Overall Study||6
2445076|NCT01094184|5998035|P2|NOT COMPLETED|Overall Study||11
2445077|NCT01094184|5998036|P1|NOT COMPLETED|Overall Study||35
2445078|NCT01094184|5998035|P2|COMPLETED|Overall Study||2
2445079|NCT01094184|5998036|P1|COMPLETED|Overall Study||1
2445080|NCT01094184|5998035|P2|STARTED|Overall Study||13
2445081|NCT01094184|5998036|P1|STARTED|Overall Study||36
2445082|NCT01094171|5998270|P1|NOT COMPLETED|Overall Study||10
2445083|NCT01094171|5998270|P1|COMPLETED|Overall Study||390
2445084|NCT01094171|5998270|P1|STARTED|Overall Study||400
2445085|NCT01094119|5998279|P2|NOT COMPLETED|Overall Study||4
2445086|NCT01094119|5998280|P1|NOT COMPLETED|Overall Study||2
2445087|NCT01094119|5998279|P2|COMPLETED|Overall Study||32
2445088|NCT01094119|5998280|P1|COMPLETED|Overall Study||32
2445089|NCT01094119|5998279|P2|STARTED|Overall Study||36
2445090|NCT01094119|5998280|P1|STARTED|Overall Study||34
2445091|NCT01093976|5998288|P1|NOT COMPLETED|Overall Study||0
2445092|NCT01093976|5998288|P1|COMPLETED|Overall Study||14
2445093|NCT01093976|5998288|P1|STARTED|Overall Study||14
2445094|NCT01093885|5998292|P1|NOT COMPLETED|Overall Study||5
2445095|NCT01093885|5998292|P1|COMPLETED|Overall Study||10
2445096|NCT01093885|5998292|P1|STARTED|Overall Study||15
2445097|NCT01093846|5998300|P3|NOT COMPLETED|Overall Study||21
2445098|NCT01093846|5998301|P2|NOT COMPLETED|Overall Study||18
2445099|NCT01093846|5998302|P1|NOT COMPLETED|Overall Study||19
2445100|NCT01093846|5998300|P3|COMPLETED|Overall Study||1
2445101|NCT01093846|5998301|P2|COMPLETED|Overall Study||0
2445102|NCT01093846|5998302|P1|COMPLETED|Overall Study||0
2445103|NCT01093846|5998300|P3|STARTED|Overall Study||22
2445104|NCT01093846|5998301|P2|STARTED|Overall Study||18
2445105|NCT01093846|5998302|P1|STARTED|Overall Study||19
2445106|NCT01093794|5998308|P4|NOT COMPLETED|Treatment Period 4||0
2445107|NCT01093794|5998309|P3|NOT COMPLETED|Treatment Period 4||0
2445108|NCT01093794|5998310|P2|NOT COMPLETED|Treatment Period 4||0
2445109|NCT01093794|5998311|P1|NOT COMPLETED|Treatment Period 4||0
2445110|NCT01093794|5998308|P4|COMPLETED|Treatment Period 4||7
2445111|NCT01093794|5998309|P3|COMPLETED|Treatment Period 4||6
2445112|NCT01093794|5998310|P2|COMPLETED|Treatment Period 4||7
2445113|NCT01093794|5998311|P1|COMPLETED|Treatment Period 4||7
2445114|NCT01093794|5998308|P4|STARTED|Treatment Period 4||7
2445115|NCT01093794|5998309|P3|STARTED|Treatment Period 4||6
2445116|NCT01093794|5998310|P2|STARTED|Treatment Period 4||7
2445117|NCT01093794|5998311|P1|STARTED|Treatment Period 4||7
2445118|NCT01093794|5998308|P4|NOT COMPLETED|Treatment Period 3||0
2445119|NCT01093794|5998309|P3|NOT COMPLETED|Treatment Period 3||0
2445120|NCT01093794|5998310|P2|NOT COMPLETED|Treatment Period 3||0
2445121|NCT01093794|5998311|P1|NOT COMPLETED|Treatment Period 3||0
2445122|NCT01093794|5998308|P4|COMPLETED|Treatment Period 3||7
2445123|NCT01093794|5998309|P3|COMPLETED|Treatment Period 3||6
2445124|NCT01093794|5998310|P2|COMPLETED|Treatment Period 3||7
2445125|NCT01093794|5998311|P1|COMPLETED|Treatment Period 3||7
2445126|NCT01093794|5998308|P4|STARTED|Treatment Period 3||7
2445127|NCT01093794|5998309|P3|STARTED|Treatment Period 3||6
2445128|NCT01093794|5998310|P2|STARTED|Treatment Period 3||7
2445129|NCT01093794|5998311|P1|STARTED|Treatment Period 3||7
2445130|NCT01093794|5998308|P4|NOT COMPLETED|Treatment Period 2||0
2445131|NCT01093794|5998309|P3|NOT COMPLETED|Treatment Period 2||0
2445132|NCT01093794|5998310|P2|NOT COMPLETED|Treatment Period 2||0
2445133|NCT01093794|5998311|P1|NOT COMPLETED|Treatment Period 2||0
2445134|NCT01093794|5998308|P4|COMPLETED|Treatment Period 2||7
2445135|NCT01093794|5998309|P3|COMPLETED|Treatment Period 2||6
2445136|NCT01093794|5998310|P2|COMPLETED|Treatment Period 2||7
2445137|NCT01093794|5998311|P1|COMPLETED|Treatment Period 2||7
2445138|NCT01093794|5998308|P4|STARTED|Treatment Period 2||7
2445139|NCT01093794|5998309|P3|STARTED|Treatment Period 2|After period 1, one participant was discontinued by the investigator due to a protocol deviation.|6
2445140|NCT01093794|5998310|P2|STARTED|Treatment Period 2||7
2445141|NCT01093794|5998311|P1|STARTED|Treatment Period 2||7
2445142|NCT01093794|5998308|P4|NOT COMPLETED|Treatment Period 1||0
2445143|NCT01093794|5998309|P3|NOT COMPLETED|Treatment Period 1||0
2445144|NCT01093794|5998310|P2|NOT COMPLETED|Treatment Period 1||0
2445145|NCT01093794|5998311|P1|NOT COMPLETED|Treatment Period 1||0
2445146|NCT01093794|5998308|P4|COMPLETED|Treatment Period 1||7
2445147|NCT01093794|5998309|P3|COMPLETED|Treatment Period 1||7
2445148|NCT01093794|5998310|P2|COMPLETED|Treatment Period 1||7
2445149|NCT01093794|5998311|P1|COMPLETED|Treatment Period 1||7
2445150|NCT01093794|5998308|P4|STARTED|Treatment Period 1||7
2445151|NCT01093794|5998309|P3|STARTED|Treatment Period 1||7
2445152|NCT01093794|5998310|P2|STARTED|Treatment Period 1||7
2445153|NCT01093794|5998311|P1|STARTED|Treatment Period 1||7
2445154|NCT01093755|5998327|P2|NOT COMPLETED|Overall Study||4
2445155|NCT01093755|5998328|P1|NOT COMPLETED|Overall Study||3
2445156|NCT01093755|5998327|P2|COMPLETED|Overall Study||10
2445157|NCT01093755|5998328|P1|COMPLETED|Overall Study||13
2445158|NCT01093755|5998327|P2|STARTED|Overall Study||14
2445159|NCT01093755|5998328|P1|STARTED|Overall Study||16
2445160|NCT01093690|5998338|P2|NOT COMPLETED|Overall Study||0
2445161|NCT01093690|5998339|P1|NOT COMPLETED|Overall Study||0
2445162|NCT01093690|5998338|P2|COMPLETED|Overall Study||79
2445163|NCT01093690|5998339|P1|COMPLETED|Overall Study||83
2445164|NCT01093690|5998338|P2|STARTED|Overall Study||79
2445165|NCT01093690|5998339|P1|STARTED|Overall Study||83
2445166|NCT01093651|5998347|P2|NOT COMPLETED|Overall Study||0
2445167|NCT01093651|5998348|P1|NOT COMPLETED|Overall Study||0
2445168|NCT01093651|5998347|P2|COMPLETED|Overall Study||10
2445169|NCT01093651|5998348|P1|COMPLETED|Overall Study||10
2445170|NCT01093651|5998347|P2|STARTED|Overall Study||10
2445171|NCT01093651|5998348|P1|STARTED|Overall Study||10
2445172|NCT01093625|5998368|P2|NOT COMPLETED|1-Year Visit||3
2445173|NCT01093625|5998369|P1|NOT COMPLETED|1-Year Visit||5
2445174|NCT01093625|5998368|P2|COMPLETED|1-Year Visit||37
2445175|NCT01093625|5998369|P1|COMPLETED|1-Year Visit||29
2445176|NCT01093625|5998368|P2|STARTED|1-Year Visit||40
2445177|NCT01093625|5998369|P1|STARTED|1-Year Visit||34
2445178|NCT01093625|5998368|P2|NOT COMPLETED|6-Month Visit||9
2445179|NCT01093625|5998369|P1|NOT COMPLETED|6-Month Visit||8
2445180|NCT01093625|5998368|P2|COMPLETED|6-Month Visit||40
2445181|NCT01093625|5998369|P1|COMPLETED|6-Month Visit||34
2445182|NCT01093625|5998368|P2|STARTED|6-Month Visit||49
2445183|NCT01093625|5998369|P1|STARTED|6-Month Visit||42
2445184|NCT01093625|5998368|P2|NOT COMPLETED|3-Month Visit||0
2445185|NCT01093625|5998369|P1|NOT COMPLETED|3-Month Visit||2
2445186|NCT01093625|5998368|P2|COMPLETED|3-Month Visit||49
2445187|NCT01093625|5998369|P1|COMPLETED|3-Month Visit||42
2445188|NCT01093625|5998368|P2|STARTED|3-Month Visit||49
2445189|NCT01093625|5998369|P1|STARTED|3-Month Visit||44
2445190|NCT01093625|5998368|P2|NOT COMPLETED|1-Month Visit||0
2445191|NCT01093625|5998369|P1|NOT COMPLETED|1-Month Visit||2
2445192|NCT01093625|5998368|P2|COMPLETED|1-Month Visit||49
2445193|NCT01093625|5998369|P1|COMPLETED|1-Month Visit||44
2445194|NCT01093625|5998368|P2|STARTED|1-Month Visit||49
2445195|NCT01093625|5998369|P1|STARTED|1-Month Visit||46
2445196|NCT01093625|5998368|P2|NOT COMPLETED|2-Week Visit||0
2445197|NCT01093625|5998369|P1|NOT COMPLETED|2-Week Visit||1
2445198|NCT01093625|5998368|P2|COMPLETED|2-Week Visit||49
2445199|NCT01093625|5998369|P1|COMPLETED|2-Week Visit||46
2445200|NCT01093625|5998368|P2|STARTED|2-Week Visit||49
2445201|NCT01093625|5998369|P1|STARTED|2-Week Visit||47
2445202|NCT01093625|5998368|P2|NOT COMPLETED|Baseline and Dispensed||0
2445203|NCT01093625|5998369|P1|NOT COMPLETED|Baseline and Dispensed||2
2445204|NCT01093625|5998368|P2|COMPLETED|Baseline and Dispensed||49
2445205|NCT01093625|5998369|P1|COMPLETED|Baseline and Dispensed||47
2445206|NCT01093625|5998368|P2|STARTED|Baseline and Dispensed||49
2445207|NCT01093625|5998369|P1|STARTED|Baseline and Dispensed||49
2445208|NCT01093599|5998389|P2|NOT COMPLETED|Overall Study||46
2445209|NCT01093599|5998390|P1|NOT COMPLETED|Overall Study||32
2445210|NCT01093599|5998389|P2|COMPLETED|Overall Study||59
2445211|NCT01093599|5998390|P1|COMPLETED|Overall Study||59
2445212|NCT01093599|5998389|P2|STARTED|Overall Study||105
2445213|NCT01093599|5998390|P1|STARTED|Overall Study||91
2445214|NCT01093586|5998396|P1|NOT COMPLETED|Overall Study||3
2445215|NCT01093586|5998396|P1|COMPLETED|Overall Study||11
2445216|NCT01093586|5998396|P1|STARTED|Overall Study||14
2445217|NCT01093534|5998417|P3|NOT COMPLETED|Overall Study||9
2445218|NCT01093534|5998418|P2|NOT COMPLETED|Overall Study||16
2445219|NCT01093534|5998419|P1|NOT COMPLETED|Overall Study||10
2445220|NCT01093534|5998417|P3|COMPLETED|Overall Study||169
2445221|NCT01093534|5998418|P2|COMPLETED|Overall Study||167
2445222|NCT01093534|5998419|P1|COMPLETED|Overall Study||176
2445223|NCT01093534|5998417|P3|Received Study Treatment|Overall Study||175
2445224|NCT01093534|5998418|P2|Received Study Treatment|Overall Study||182
2445225|NCT01093534|5998419|P1|Received Study Treatment|Overall Study||186
2445226|NCT01093534|5998417|P3|STARTED|Overall Study||178
2445227|NCT01093534|5998418|P2|STARTED|Overall Study||183
2445228|NCT01093534|5998419|P1|STARTED|Overall Study||186
2445229|NCT01093521|5998524|P1|NOT COMPLETED|Overall Study||0
2445230|NCT01093521|5998524|P1|COMPLETED|Overall Study||20
2445231|NCT01093521|5998524|P1|STARTED|Overall Study||20
2445232|NCT01093482|5998539|P1|NOT COMPLETED|Overall Study||0
2445233|NCT01093482|5998539|P1|COMPLETED|Overall Study||8151
2445234|NCT01093482|5998539|P1|STARTED|Overall Study||8151
2445235|NCT01093469|5998546|P3|NOT COMPLETED|Overall Study||1
2445236|NCT01093469|5998547|P2|NOT COMPLETED|Overall Study||0
2445237|NCT01093469|5998548|P1|NOT COMPLETED|Overall Study||0
2445238|NCT01093469|5998546|P3|COMPLETED|Overall Study||12
2445239|NCT01093469|5998547|P2|COMPLETED|Overall Study||13
2445240|NCT01093469|5998548|P1|COMPLETED|Overall Study||13
2445241|NCT01093469|5998546|P3|STARTED|Overall Study||13
2445242|NCT01093469|5998547|P2|STARTED|Overall Study||13
2445243|NCT01093469|5998548|P1|STARTED|Overall Study||13
2445244|NCT01093417|5998558|P2|NOT COMPLETED|Overall Study||1
2445245|NCT01093417|5998559|P1|NOT COMPLETED|Overall Study||0
2445246|NCT01093417|5998558|P2|COMPLETED|Overall Study||29
2445247|NCT01093417|5998559|P1|COMPLETED|Overall Study||15
2445248|NCT01093417|5998558|P2|STARTED|Overall Study||30
2445249|NCT01093417|5998559|P1|STARTED|Overall Study||15
2445250|NCT01093222|5998567|P1|NOT COMPLETED|Overall Study||40
2445251|NCT01093222|5998567|P1|COMPLETED|Overall Study||0
2445252|NCT01093222|5998567|P1|Eligible and Began Protocol Therapy|Overall Study||34
2445253|NCT01093222|5998567|P1|STARTED|Overall Study||40
2445254|NCT01093183|5998574|P2|NOT COMPLETED|Overall Study||2
2445255|NCT01093183|5998575|P1|NOT COMPLETED|Overall Study||1
2445256|NCT01093183|5998574|P2|COMPLETED|Overall Study||4
2445257|NCT01093183|5998575|P1|COMPLETED|Overall Study||18
2445258|NCT01093183|5998574|P2|STARTED|Overall Study||6
2445259|NCT01093183|5998575|P1|STARTED|Overall Study||19
2445260|NCT01093027|5998585|P2|NOT COMPLETED|Visit 2||0
2445261|NCT01093027|5998586|P1|NOT COMPLETED|Visit 2||0
2445262|NCT01093027|5998585|P2|COMPLETED|Visit 2||10
2445263|NCT01093027|5998586|P1|COMPLETED|Visit 2||10
2445264|NCT01093027|5998585|P2|STARTED|Visit 2||10
2445265|NCT01093027|5998586|P1|STARTED|Visit 2||10
2445266|NCT01093027|5998585|P2|NOT COMPLETED|Visit 1||0
2445267|NCT01093027|5998586|P1|NOT COMPLETED|Visit 1||0
2445268|NCT01093027|5998585|P2|COMPLETED|Visit 1||10
2445269|NCT01093027|5998586|P1|COMPLETED|Visit 1||10
2445270|NCT01093027|5998585|P2|STARTED|Visit 1||10
2445271|NCT01093027|5998586|P1|STARTED|Visit 1||10
2445272|NCT01093014|5998597|P3|NOT COMPLETED|Overall Study||0
2445273|NCT01093014|5998598|P2|NOT COMPLETED|Overall Study||0
2445274|NCT01093014|5998599|P1|NOT COMPLETED|Overall Study||0
2445275|NCT01093014|5998597|P3|COMPLETED|Overall Study||12
2445276|NCT01093014|5998598|P2|COMPLETED|Overall Study||9
2445277|NCT01093014|5998599|P1|COMPLETED|Overall Study||12
2445278|NCT01093014|5998597|P3|STARTED|Overall Study||12
2445279|NCT01093014|5998598|P2|STARTED|Overall Study||9
2445280|NCT01093014|5998599|P1|STARTED|Overall Study||12
2445281|NCT01092923|5998618|P2|NOT COMPLETED|Overall Study||0
2445282|NCT01092923|5998619|P1|NOT COMPLETED|Overall Study||0
2445283|NCT01092923|5998618|P2|COMPLETED|Overall Study||10
2445284|NCT01092923|5998619|P1|COMPLETED|Overall Study||10
2445285|NCT01092923|5998618|P2|STARTED|Overall Study||10
2445286|NCT01092923|5998619|P1|STARTED|Overall Study||10
2445287|NCT01092910|5998628|P1|NOT COMPLETED|Overall Study||5
2445288|NCT01092910|5998628|P1|COMPLETED|Overall Study||52
2445289|NCT01092910|5998628|P1|10 Month Follow-up|Overall Study||52
2445290|NCT01092910|5998628|P1|4 Month Follow-up|Overall Study||54
2445291|NCT01092910|5998628|P1|STARTED|Overall Study||57
2445292|NCT01092832|5998643|P2|NOT COMPLETED|Overall Study||0
2445293|NCT01092832|5998644|P1|NOT COMPLETED|Overall Study||1
2445294|NCT01092832|5998643|P2|COMPLETED|Overall Study||8
2445295|NCT01092832|5998644|P1|COMPLETED|Overall Study||13
2445296|NCT01092832|5998643|P2|STARTED|Overall Study||8
2445297|NCT01092832|5998644|P1|STARTED|Overall Study||14
2445298|NCT01092780|5998656|P4|NOT COMPLETED|Treatment Period 4||0
2445299|NCT01092780|5998657|P3|NOT COMPLETED|Treatment Period 4||0
2445300|NCT01092780|5998658|P2|NOT COMPLETED|Treatment Period 4||0
2445301|NCT01092780|5998659|P1|NOT COMPLETED|Treatment Period 4||0
2445302|NCT01092780|5998656|P4|COMPLETED|Treatment Period 4||13
2445303|NCT01092780|5998657|P3|COMPLETED|Treatment Period 4||13
2445304|NCT01092780|5998658|P2|COMPLETED|Treatment Period 4||13
2445305|NCT01092780|5998659|P1|COMPLETED|Treatment Period 4||13
2445306|NCT01092780|5998656|P4|STARTED|Treatment Period 4||13
2445307|NCT01092780|5998657|P3|STARTED|Treatment Period 4||13
2445308|NCT01092780|5998658|P2|STARTED|Treatment Period 4||13
2445309|NCT01092780|5998659|P1|STARTED|Treatment Period 4||13
2445310|NCT01092780|5998656|P4|NOT COMPLETED|Washout Period 3||0
2445311|NCT01092780|5998657|P3|NOT COMPLETED|Washout Period 3||0
2445312|NCT01092780|5998658|P2|NOT COMPLETED|Washout Period 3||0
2445313|NCT01092780|5998659|P1|NOT COMPLETED|Washout Period 3||0
2445314|NCT01092780|5998656|P4|COMPLETED|Washout Period 3||13
2445315|NCT01092780|5998657|P3|COMPLETED|Washout Period 3||13
2445316|NCT01092780|5998658|P2|COMPLETED|Washout Period 3||13
2445317|NCT01092780|5998659|P1|COMPLETED|Washout Period 3||13
2445318|NCT01092780|5998656|P4|STARTED|Washout Period 3||13
2445319|NCT01092780|5998657|P3|STARTED|Washout Period 3||13
2445320|NCT01092780|5998658|P2|STARTED|Washout Period 3||13
2445321|NCT01092780|5998659|P1|STARTED|Washout Period 3||13
2445322|NCT01092780|5998656|P4|NOT COMPLETED|Treatment Period 3||0
2445323|NCT01092780|5998657|P3|NOT COMPLETED|Treatment Period 3||0
2445324|NCT01092780|5998658|P2|NOT COMPLETED|Treatment Period 3||0
2445325|NCT01092780|5998659|P1|NOT COMPLETED|Treatment Period 3||0
2445326|NCT01092780|5998656|P4|COMPLETED|Treatment Period 3||13
2445327|NCT01092780|5998657|P3|COMPLETED|Treatment Period 3||13
2445328|NCT01092780|5998658|P2|COMPLETED|Treatment Period 3||13
2445329|NCT01092780|5998659|P1|COMPLETED|Treatment Period 3||13
2445330|NCT01092780|5998656|P4|STARTED|Treatment Period 3||13
2445331|NCT01092780|5998657|P3|STARTED|Treatment Period 3||13
2445332|NCT01092780|5998658|P2|STARTED|Treatment Period 3||13
2445333|NCT01092780|5998659|P1|STARTED|Treatment Period 3||13
2445334|NCT01092780|5998656|P4|NOT COMPLETED|Washout Period 2||0
2445335|NCT01092780|5998657|P3|NOT COMPLETED|Washout Period 2||1
2445336|NCT01092780|5998658|P2|NOT COMPLETED|Washout Period 2||1
2445337|NCT01092780|5998659|P1|NOT COMPLETED|Washout Period 2||0
2445338|NCT01092780|5998656|P4|COMPLETED|Washout Period 2||13
2445339|NCT01092780|5998657|P3|COMPLETED|Washout Period 2||13
2445340|NCT01092780|5998658|P2|COMPLETED|Washout Period 2||13
2445341|NCT01092780|5998659|P1|COMPLETED|Washout Period 2||13
2445342|NCT01092780|5998656|P4|STARTED|Washout Period 2||13
2445343|NCT01092780|5998657|P3|STARTED|Washout Period 2||14
2445344|NCT01092780|5998658|P2|STARTED|Washout Period 2||14
2445345|NCT01092780|5998659|P1|STARTED|Washout Period 2||13
2445346|NCT01092780|5998656|P4|NOT COMPLETED|Treatment Period 2||0
2445347|NCT01092780|5998657|P3|NOT COMPLETED|Treatment Period 2||0
2445348|NCT01092780|5998658|P2|NOT COMPLETED|Treatment Period 2||0
2445349|NCT01092780|5998659|P1|NOT COMPLETED|Treatment Period 2||0
2445350|NCT01092780|5998656|P4|COMPLETED|Treatment Period 2||13
2445351|NCT01092780|5998657|P3|COMPLETED|Treatment Period 2||14
2445352|NCT01092780|5998658|P2|COMPLETED|Treatment Period 2||14
2445353|NCT01092780|5998659|P1|COMPLETED|Treatment Period 2||13
2445354|NCT01092780|5998656|P4|STARTED|Treatment Period 2||13
2445355|NCT01092780|5998657|P3|STARTED|Treatment Period 2||14
2445356|NCT01092780|5998658|P2|STARTED|Treatment Period 2||14
2445357|NCT01092780|5998659|P1|STARTED|Treatment Period 2||13
2445358|NCT01092780|5998656|P4|NOT COMPLETED|Washout Period 1||0
2445359|NCT01092780|5998657|P3|NOT COMPLETED|Washout Period 1||0
2445360|NCT01092780|5998658|P2|NOT COMPLETED|Washout Period 1||1
2445361|NCT01092780|5998659|P1|NOT COMPLETED|Washout Period 1||1
2445362|NCT01092780|5998656|P4|COMPLETED|Washout Period 1||13
2445363|NCT01092780|5998657|P3|COMPLETED|Washout Period 1||14
2445364|NCT01092780|5998658|P2|COMPLETED|Washout Period 1||14
2445365|NCT01092780|5998659|P1|COMPLETED|Washout Period 1||13
2445366|NCT01092780|5998656|P4|STARTED|Washout Period 1||13
2445367|NCT01092780|5998657|P3|STARTED|Washout Period 1||14
2445368|NCT01092780|5998658|P2|STARTED|Washout Period 1||15
2445369|NCT01092780|5998659|P1|STARTED|Washout Period 1||14
2445370|NCT01092780|5998656|P4|NOT COMPLETED|Treatment Period 1||0
2445371|NCT01092780|5998657|P3|NOT COMPLETED|Treatment Period 1||0
2445372|NCT01092780|5998658|P2|NOT COMPLETED|Treatment Period 1||0
2445373|NCT01092780|5998659|P1|NOT COMPLETED|Treatment Period 1||0
2445374|NCT01092780|5998656|P4|COMPLETED|Treatment Period 1||13
2445375|NCT01092780|5998657|P3|COMPLETED|Treatment Period 1||14
2445376|NCT01092780|5998658|P2|COMPLETED|Treatment Period 1||15
2445377|NCT01092780|5998659|P1|COMPLETED|Treatment Period 1||14
2445378|NCT01092780|5998656|P4|STARTED|Treatment Period 1||13
2445379|NCT01092780|5998657|P3|STARTED|Treatment Period 1||14
2445380|NCT01092780|5998658|P2|STARTED|Treatment Period 1||15
2445381|NCT01092780|5998659|P1|STARTED|Treatment Period 1||14
2445382|NCT01092767|5998689|P1|NOT COMPLETED|Overall Study||5
2445383|NCT01092767|5998689|P1|COMPLETED|Overall Study||45
2445384|NCT01092767|5998689|P1|STARTED|Overall Study||50
2445385|NCT01092728|5998695|P2|NOT COMPLETED|Overall Study||14
2445386|NCT01092728|5998696|P1|NOT COMPLETED|Overall Study||4
2445387|NCT01092728|5998695|P2|COMPLETED|Overall Study||0
2445388|NCT01092728|5998696|P1|COMPLETED|Overall Study||0
2445389|NCT01092728|5998695|P2|STARTED|Overall Study||14
2445390|NCT01092728|5998696|P1|STARTED|Overall Study||4
2445391|NCT01092702|5998704|P1|NOT COMPLETED|Overall Study||9
2445392|NCT01092702|5998704|P1|COMPLETED|Overall Study||23
2445393|NCT01092702|5998704|P1|STARTED|Overall Study||32
2445394|NCT01092676|5998710|P2|NOT COMPLETED|Overall Study||0
2445395|NCT01092676|5998711|P1|NOT COMPLETED|Overall Study||0
2445396|NCT01092676|5998710|P2|COMPLETED|Overall Study||49
2445397|NCT01092676|5998711|P1|COMPLETED|Overall Study||50
2445398|NCT01092676|5998710|P2|STARTED|Overall Study||49
2445399|NCT01092676|5998711|P1|STARTED|Overall Study||50
2445400|NCT01092663|5998721|P2|NOT COMPLETED|Overall Study||4
2445401|NCT01092663|5998722|P1|NOT COMPLETED|Overall Study||7
2445402|NCT01092663|5998721|P2|COMPLETED|Overall Study||26
2445403|NCT01092663|5998722|P1|COMPLETED|Overall Study||24
2445404|NCT01092663|5998721|P2|STARTED|Overall Study||30
2445405|NCT01092663|5998722|P1|STARTED|Overall Study||31
2445406|NCT01092637|5998770|P2|NOT COMPLETED|Overall Study||49
2445407|NCT01092637|5998771|P1|NOT COMPLETED|Overall Study||47
2445408|NCT01092637|5998770|P2|COMPLETED|Overall Study||86
2445409|NCT01092637|5998771|P1|COMPLETED|Overall Study||98
2445410|NCT01092637|5998770|P2|STARTED|Overall Study||135
2445411|NCT01092637|5998771|P1|STARTED|Overall Study||145
2445412|NCT01092559|5998781|P1|NOT COMPLETED|Overall Study||0
2445413|NCT01092559|5998781|P1|COMPLETED|Overall Study||10
2445414|NCT01092559|5998781|P1|STARTED|Overall Study||10
2445415|NCT01092546|5998786|P1|NOT COMPLETED|Overall Study||4
2445416|NCT01092546|5998786|P1|COMPLETED|Overall Study||12
2445417|NCT01092546|5998786|P1|STARTED|Overall Study||16
2445418|NCT01092507|5998793|P2|NOT COMPLETED|Overall Study||0
2445419|NCT01092507|5998794|P1|NOT COMPLETED|Overall Study||2
2445420|NCT01092507|5998793|P2|COMPLETED|Overall Study||150
2445421|NCT01092507|5998794|P1|COMPLETED|Overall Study||147
2445422|NCT01092507|5998793|P2|STARTED|Overall Study||150
2445423|NCT01092507|5998794|P1|STARTED|Overall Study||149
2445424|NCT01092442|5998814|P2|NOT COMPLETED|Overall Study||0
2445425|NCT01092442|5998815|P1|NOT COMPLETED|Overall Study||0
2445426|NCT01092442|5998814|P2|COMPLETED|Overall Study||60
2445427|NCT01092442|5998815|P1|COMPLETED|Overall Study||80
2445428|NCT01092442|5998814|P2|STARTED|Overall Study||60
2445429|NCT01092442|5998815|P1|STARTED|Overall Study||80
2445430|NCT01092416|5998829|P1|NOT COMPLETED|12-Month Follow-up||25
2445431|NCT01092416|5998829|P1|COMPLETED|12-Month Follow-up||413
2445432|NCT01092416|5998829|P1|STARTED|12-Month Follow-up||438
2445433|NCT01092416|5998829|P1|NOT COMPLETED|30-Day Follow-up||10
2445434|NCT01092416|5998829|P1|COMPLETED|30-Day Follow-up||430
2445435|NCT01092416|5998829|P1|STARTED|30-Day Follow-up||440
2445436|NCT01092416|5998829|P1|NOT COMPLETED|Enrollment||3
2445437|NCT01092416|5998829|P1|COMPLETED|Enrollment||440
2445438|NCT01092416|5998829|P1|STARTED|Enrollment||443
2445439|NCT01092364|5998841|P3|NOT COMPLETED|Overall Study||18
2445440|NCT01092364|5998842|P2|NOT COMPLETED|Overall Study||16
2445441|NCT01092364|5998843|P1|NOT COMPLETED|Overall Study||18
2445442|NCT01092364|5998841|P3|COMPLETED|Overall Study||105
2445443|NCT01092364|5998842|P2|COMPLETED|Overall Study||104
2445444|NCT01092364|5998843|P1|COMPLETED|Overall Study||104
2445445|NCT01092364|5998841|P3|STARTED|Overall Study||123
2445446|NCT01092364|5998842|P2|STARTED|Overall Study||120
2445447|NCT01092364|5998843|P1|STARTED|Overall Study||122
2445448|NCT01092338|5998853|P2|NOT COMPLETED|Overall Study||1
2445449|NCT01092338|5998854|P1|NOT COMPLETED|Overall Study||1
2445450|NCT01092338|5998853|P2|COMPLETED|Overall Study||21
2445451|NCT01092338|5998854|P1|COMPLETED|Overall Study||21
2445452|NCT01092338|5998853|P2|STARTED|Overall Study||22
2445453|NCT01092338|5998854|P1|STARTED|Overall Study||22
2445454|NCT01092195|5998865|P3|NOT COMPLETED|Overall Study||0
2445455|NCT01092195|5998866|P2|NOT COMPLETED|Overall Study||0
2445456|NCT01092195|5998867|P1|NOT COMPLETED|Overall Study||0
2445457|NCT01092195|5998865|P3|COMPLETED|Overall Study||20
2445458|NCT01092195|5998866|P2|COMPLETED|Overall Study||21
2445459|NCT01092195|5998867|P1|COMPLETED|Overall Study||23
2445460|NCT01092195|5998865|P3|STARTED|Overall Study||20
2445461|NCT01092195|5998866|P2|STARTED|Overall Study||21
2445462|NCT01092195|5998867|P1|STARTED|Overall Study||23
2445463|NCT01091974|5998879|P4|NOT COMPLETED|Overall Study||7
2445464|NCT01091974|5998880|P3|NOT COMPLETED|Overall Study||6
2445465|NCT01091974|5998881|P2|NOT COMPLETED|Overall Study||5
2445466|NCT01091974|5998882|P1|NOT COMPLETED|Overall Study||5
2445467|NCT01091974|5998879|P4|COMPLETED|Overall Study||17
2445468|NCT01091974|5998880|P3|COMPLETED|Overall Study||19
2445469|NCT01091974|5998881|P2|COMPLETED|Overall Study||18
2445470|NCT01091974|5998882|P1|COMPLETED|Overall Study||19
2445471|NCT01091974|5998879|P4|STARTED|Overall Study||24
2445472|NCT01091974|5998880|P3|STARTED|Overall Study||25
2445473|NCT01091974|5998881|P2|STARTED|Overall Study||23
2445474|NCT01091974|5998882|P1|STARTED|Overall Study||24
2445475|NCT01091948|5998898|P2|NOT COMPLETED|Overall Study||0
2445476|NCT01091948|5998899|P1|NOT COMPLETED|Overall Study||0
2445477|NCT01091948|5998898|P2|COMPLETED|Overall Study||38
2445478|NCT01091948|5998899|P1|COMPLETED|Overall Study||37
2445479|NCT01091948|5998898|P2|STARTED|Overall Study||38
2445480|NCT01091948|5998899|P1|STARTED|Overall Study||37
2445481|NCT01091675|5998917|P1|NOT COMPLETED|Overall Study||34
2445482|NCT01091675|5998917|P1|COMPLETED|Overall Study||23
2445483|NCT01091675|5998917|P1|STARTED|Overall Study|7 patients leave the study due to hypertension, 27 patients withdrew due to lack of efficacy|57
2445484|NCT01091662|5998923|P2|NOT COMPLETED|Overall Study||34
2445485|NCT01091662|5998924|P1|NOT COMPLETED|Overall Study||17
2445486|NCT01091662|5998923|P2|COMPLETED|Overall Study||80
2445487|NCT01091662|5998924|P1|COMPLETED|Overall Study||41
2445488|NCT01091662|5998923|P2|STARTED|Overall Study||114
2445489|NCT01091662|5998924|P1|STARTED|Overall Study||58
2445490|NCT01091519|5998962|P2|NOT COMPLETED|Overall Study||73
2445491|NCT01091519|5998963|P1|NOT COMPLETED|Overall Study||55
2445492|NCT01091519|5998962|P2|COMPLETED|Overall Study||362
2445493|NCT01091519|5998963|P1|COMPLETED|Overall Study||291
2445494|NCT01091519|5998962|P2|Treated|Overall Study||431
2445495|NCT01091519|5998963|P1|Treated|Overall Study||342
2445496|NCT01091519|5998962|P2|STARTED|Overall Study||435
2445497|NCT01091519|5998963|P1|STARTED|Overall Study||346
2445498|NCT01091454|5998975|P1|NOT COMPLETED|Overall Study||1
2445499|NCT01091454|5998975|P1|COMPLETED|Overall Study||47
2445500|NCT01091454|5998975|P1|STARTED|Overall Study||48
2445501|NCT01091428|5998988|P4|NOT COMPLETED|Phase 2||69
2445502|NCT01091428|5998989|P3|NOT COMPLETED|Phase 2||73
2445503|NCT01091428|5998990|P2|NOT COMPLETED|Phase 2||0
2445504|NCT01091428|5998991|P1|NOT COMPLETED|Phase 2||0
2445505|NCT01091428|5998988|P4|COMPLETED|Phase 2||0
2445506|NCT01091428|5998989|P3|COMPLETED|Phase 2||0
2445507|NCT01091428|5998990|P2|COMPLETED|Phase 2||0
2445508|NCT01091428|5998991|P1|COMPLETED|Phase 2||0
2445509|NCT01091428|5998988|P4|STARTED|Phase 2||69
2445510|NCT01091428|5998989|P3|STARTED|Phase 2||73
2445511|NCT01091428|5998990|P2|STARTED|Phase 2||0
2445512|NCT01091428|5998991|P1|STARTED|Phase 2||0
2445513|NCT01091428|5998988|P4|NOT COMPLETED|Phase 1||0
2445514|NCT01091428|5998989|P3|NOT COMPLETED|Phase 1||0
2445515|NCT01091428|5998990|P2|NOT COMPLETED|Phase 1||11
2445516|NCT01091428|5998991|P1|NOT COMPLETED|Phase 1||38
2445517|NCT01091428|5998988|P4|COMPLETED|Phase 1||0
2445518|NCT01091428|5998989|P3|COMPLETED|Phase 1||0
2445519|NCT01091428|5998990|P2|COMPLETED|Phase 1||0
2445520|NCT01091428|5998991|P1|COMPLETED|Phase 1|Completed = participants who completed the treatment.|0
2445521|NCT01091428|5998988|P4|STARTED|Phase 1||0
2445522|NCT01091428|5998989|P3|STARTED|Phase 1||0
2445523|NCT01091428|5998990|P2|STARTED|Phase 1||11
2445524|NCT01091428|5998991|P1|STARTED|Phase 1||38
2445525|NCT01091363|5999094|P2|NOT COMPLETED|Overall Study||17
2445526|NCT01091363|5999095|P1|NOT COMPLETED|Overall Study||13
2445527|NCT01091363|5999094|P2|COMPLETED|Overall Study||37
2445528|NCT01091363|5999095|P1|COMPLETED|Overall Study||42
2445529|NCT01091363|5999094|P2|STARTED|Overall Study||54
2445530|NCT01091363|5999095|P1|STARTED|Overall Study||55
2445531|NCT01091259|5999105|P1|NOT COMPLETED|Overall Study||5
2445532|NCT01091259|5999105|P1|COMPLETED|Overall Study|Number of patients who had at least 2 cycles of treatments|24
2445533|NCT01091259|5999105|P1|STARTED|Overall Study||29
2445534|NCT01091246|5999116|P3|NOT COMPLETED|Overall Study||13
2445535|NCT01091246|5999117|P2|NOT COMPLETED|Overall Study||16
2445536|NCT01091246|5999118|P1|NOT COMPLETED|Overall Study||35
2445537|NCT01091246|5999116|P3|COMPLETED|Overall Study||450
2445538|NCT01091246|5999117|P2|COMPLETED|Overall Study||448
2445539|NCT01091246|5999118|P1|COMPLETED|Overall Study||1350
2445540|NCT01091246|5999116|P3|STARTED|Overall Study||463
2445541|NCT01091246|5999117|P2|STARTED|Overall Study||464
2445542|NCT01091246|5999118|P1|STARTED|Overall Study||1385
2445543|NCT01091168|5999194|P2|NOT COMPLETED|Overall Study||296
2445544|NCT01091168|5999195|P1|NOT COMPLETED|Overall Study||298
2445545|NCT01091168|5999194|P2|COMPLETED|Overall Study||0
2445546|NCT01091168|5999195|P1|COMPLETED|Overall Study||0
2445547|NCT01091168|5999194|P2|STARTED|Overall Study||296
2445548|NCT01091168|5999195|P1|STARTED|Overall Study||298
2445549|NCT01091155|5999205|P1|NOT COMPLETED|Overall Study||9
2445550|NCT01091155|5999205|P1|COMPLETED|Overall Study||279
2445551|NCT01091155|5999205|P1|STARTED|Overall Study||288
2445552|NCT01091116|5999214|P5|NOT COMPLETED|Overall Study||11
2445553|NCT01091116|5999215|P4|NOT COMPLETED|Overall Study||4
2445554|NCT01091116|5999216|P3|NOT COMPLETED|Overall Study||11
2445555|NCT01091116|5999217|P2|NOT COMPLETED|Overall Study||8
2445556|NCT01091116|5999218|P1|NOT COMPLETED|Overall Study||6
2445557|NCT01091116|5999214|P5|COMPLETED|Overall Study||73
2445558|NCT01091116|5999215|P4|COMPLETED|Overall Study||80
2445559|NCT01091116|5999216|P3|COMPLETED|Overall Study||73
2445560|NCT01091116|5999217|P2|COMPLETED|Overall Study||80
2445561|NCT01091116|5999218|P1|COMPLETED|Overall Study||77
2445562|NCT01091116|5999214|P5|STARTED|Overall Study||84
2445563|NCT01091116|5999215|P4|STARTED|Overall Study||84
2445564|NCT01091116|5999216|P3|STARTED|Overall Study||84
2445565|NCT01091116|5999217|P2|STARTED|Overall Study||88
2445566|NCT01091116|5999218|P1|STARTED|Overall Study||83
2445567|NCT01091103|5999270|P1|NOT COMPLETED|Overall Study||4
2445568|NCT01091103|5999270|P1|COMPLETED|Overall Study|Patients on study drug and completed Week 9 visit assessments.|56
2445569|NCT01091103|5999270|P1|STARTED|Overall Study||60
2445570|NCT01090973|5999290|P1|NOT COMPLETED|Overall Study||1
2445571|NCT01090973|5999290|P1|COMPLETED|Overall Study||0
2445572|NCT01090973|5999290|P1|STARTED|Overall Study||1
2445573|NCT01090765|5999306|P6|NOT COMPLETED|Overall Study||1
2445574|NCT01090765|5999307|P5|NOT COMPLETED|Overall Study||2
2445575|NCT01090765|5999308|P4|NOT COMPLETED|Overall Study||1
2445576|NCT01090765|5999309|P3|NOT COMPLETED|Overall Study||0
2445577|NCT01090765|5999310|P2|NOT COMPLETED|Overall Study||0
2445578|NCT01090765|5999311|P1|NOT COMPLETED|Overall Study||0
2445579|NCT01090765|5999306|P6|COMPLETED|Overall Study||3
2445580|NCT01090765|5999307|P5|COMPLETED|Overall Study||4
2445581|NCT01090765|5999308|P4|COMPLETED|Overall Study||1
2445582|NCT01090765|5999309|P3|COMPLETED|Overall Study||3
2445583|NCT01090765|5999310|P2|COMPLETED|Overall Study||3
2445584|NCT01090765|5999311|P1|COMPLETED|Overall Study||3
2445585|NCT01090765|5999306|P6|STARTED|Overall Study||4
2445586|NCT01090765|5999307|P5|STARTED|Overall Study||6
2445587|NCT01090765|5999308|P4|STARTED|Overall Study||2
2445588|NCT01090765|5999309|P3|STARTED|Overall Study||3
2445589|NCT01090765|5999310|P2|STARTED|Overall Study||3
2445590|NCT01090765|5999311|P1|STARTED|Overall Study||3
2445591|NCT01090752|5999346|P2|NOT COMPLETED|Overall Study||0
2445592|NCT01090752|5999347|P1|NOT COMPLETED|Overall Study||0
2445593|NCT01090752|5999346|P2|COMPLETED|Overall Study||8
2445594|NCT01090752|5999347|P1|COMPLETED|Overall Study||8
2445595|NCT01090752|5999346|P2|STARTED|Overall Study||8
2445596|NCT01090752|5999347|P1|STARTED|Overall Study||8
2445597|NCT01090739|5999357|P1|NOT COMPLETED|36 Month Follow-up||23
2445598|NCT01090739|5999357|P1|COMPLETED|36 Month Follow-up||115
2445599|NCT01090739|5999357|P1|STARTED|36 Month Follow-up||138
2445600|NCT01090739|5999357|P1|NOT COMPLETED|24 Month Follow-up||9
2445601|NCT01090739|5999357|P1|COMPLETED|24 Month Follow-up||138
2445602|NCT01090739|5999357|P1|STARTED|24 Month Follow-up||147
2445603|NCT01090739|5999357|P1|NOT COMPLETED|12 Month Follow-up||5
2445604|NCT01090739|5999357|P1|COMPLETED|12 Month Follow-up||147
2445605|NCT01090739|5999357|P1|STARTED|12 Month Follow-up||152
2445606|NCT01090739|5999357|P1|NOT COMPLETED|Enrollment||55
2445607|NCT01090739|5999357|P1|COMPLETED|Enrollment||152
2445608|NCT01090739|5999357|P1|STARTED|Enrollment|Subject enrollment = signed informed consent form|207
2445609|NCT01090492|5999382|P8|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
2445610|NCT01090492|5999383|P7|NOT COMPLETED|Second Intervention Period (4 Weeks)||9
2445611|NCT01090492|5999384|P6|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
2445612|NCT01090492|5999385|P5|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
2445613|NCT01090492|5999386|P4|NOT COMPLETED|Second Intervention Period (4 Weeks)||0
2445614|NCT01090492|5999387|P3|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
2445615|NCT01090492|5999388|P2|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
2445616|NCT01090492|5999389|P1|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
2445617|NCT01090492|5999382|P8|COMPLETED|Second Intervention Period (4 Weeks)||25
2445618|NCT01090492|5999383|P7|COMPLETED|Second Intervention Period (4 Weeks)||22
2445619|NCT01090492|5999384|P6|COMPLETED|Second Intervention Period (4 Weeks)||29
2445620|NCT01090492|5999385|P5|COMPLETED|Second Intervention Period (4 Weeks)||27
2445621|NCT01090492|5999386|P4|COMPLETED|Second Intervention Period (4 Weeks)||22
2445622|NCT01090492|5999387|P3|COMPLETED|Second Intervention Period (4 Weeks)||24
2445623|NCT01090492|5999388|P2|COMPLETED|Second Intervention Period (4 Weeks)||22
2445624|NCT01090492|5999389|P1|COMPLETED|Second Intervention Period (4 Weeks)||25
2445625|NCT01090492|5999382|P8|STARTED|Second Intervention Period (4 Weeks)||27
2445626|NCT01090492|5999383|P7|STARTED|Second Intervention Period (4 Weeks)||31
2445627|NCT01090492|5999384|P6|STARTED|Second Intervention Period (4 Weeks)||30
2445628|NCT01090492|5999385|P5|STARTED|Second Intervention Period (4 Weeks)||29
2445629|NCT01090492|5999386|P4|STARTED|Second Intervention Period (4 Weeks)||22
2445630|NCT01090492|5999387|P3|STARTED|Second Intervention Period (4 Weeks)||26
2445631|NCT01090492|5999388|P2|STARTED|Second Intervention Period (4 Weeks)||24
2445632|NCT01090492|5999389|P1|STARTED|Second Intervention Period (4 Weeks)||26
2445633|NCT01090492|5999382|P8|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
2445634|NCT01090492|5999383|P7|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
2445635|NCT01090492|5999384|P6|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
2445636|NCT01090492|5999385|P5|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
2445637|NCT01090492|5999386|P4|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
2445638|NCT01090492|5999387|P3|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
2445639|NCT01090492|5999388|P2|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
2445640|NCT01090492|5999389|P1|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
2445641|NCT01090492|5999382|P8|COMPLETED|Placebo Washout Period ( 2 Weeks)||27
2445642|NCT01090492|5999383|P7|COMPLETED|Placebo Washout Period ( 2 Weeks)||31
2445643|NCT01090492|5999384|P6|COMPLETED|Placebo Washout Period ( 2 Weeks)||30
2445644|NCT01090492|5999385|P5|COMPLETED|Placebo Washout Period ( 2 Weeks)||29
2445645|NCT01090492|5999386|P4|COMPLETED|Placebo Washout Period ( 2 Weeks)||22
2445646|NCT01090492|5999387|P3|COMPLETED|Placebo Washout Period ( 2 Weeks)||26
2445647|NCT01090492|5999388|P2|COMPLETED|Placebo Washout Period ( 2 Weeks)||24
2445648|NCT01090492|5999389|P1|COMPLETED|Placebo Washout Period ( 2 Weeks)||26
2445649|NCT01090492|5999382|P8|STARTED|Placebo Washout Period ( 2 Weeks)||27
2445650|NCT01090492|5999383|P7|STARTED|Placebo Washout Period ( 2 Weeks)||31
2445651|NCT01090492|5999384|P6|STARTED|Placebo Washout Period ( 2 Weeks)||30
2445652|NCT01090492|5999385|P5|STARTED|Placebo Washout Period ( 2 Weeks)||29
2445653|NCT01090492|5999386|P4|STARTED|Placebo Washout Period ( 2 Weeks)||22
2445654|NCT01090492|5999387|P3|STARTED|Placebo Washout Period ( 2 Weeks)||26
2445655|NCT01090492|5999388|P2|STARTED|Placebo Washout Period ( 2 Weeks)||24
2445656|NCT01090492|5999389|P1|STARTED|Placebo Washout Period ( 2 Weeks)||26
2445657|NCT01090492|5999382|P8|NOT COMPLETED|First Intervention Period (4 Weeks)||6
2445658|NCT01090492|5999383|P7|NOT COMPLETED|First Intervention Period (4 Weeks)||1
2445659|NCT01090492|5999384|P6|NOT COMPLETED|First Intervention Period (4 Weeks)||2
2445660|NCT01090492|5999385|P5|NOT COMPLETED|First Intervention Period (4 Weeks)||4
2445661|NCT01090492|5999386|P4|NOT COMPLETED|First Intervention Period (4 Weeks)||6
2445662|NCT01090492|5999387|P3|NOT COMPLETED|First Intervention Period (4 Weeks)||3
2445663|NCT01090492|5999388|P2|NOT COMPLETED|First Intervention Period (4 Weeks)||5
2445664|NCT01090492|5999389|P1|NOT COMPLETED|First Intervention Period (4 Weeks)||1
2445665|NCT01090492|5999382|P8|COMPLETED|First Intervention Period (4 Weeks)||27
2445666|NCT01090492|5999383|P7|COMPLETED|First Intervention Period (4 Weeks)||31
2445667|NCT01090492|5999384|P6|COMPLETED|First Intervention Period (4 Weeks)||30
2445668|NCT01090492|5999385|P5|COMPLETED|First Intervention Period (4 Weeks)||29
2445669|NCT01090492|5999386|P4|COMPLETED|First Intervention Period (4 Weeks)||22
2445670|NCT01090492|5999387|P3|COMPLETED|First Intervention Period (4 Weeks)||26
2445671|NCT01090492|5999388|P2|COMPLETED|First Intervention Period (4 Weeks)||24
2445672|NCT01090492|5999389|P1|COMPLETED|First Intervention Period (4 Weeks)||26
2445673|NCT01090492|5999382|P8|STARTED|First Intervention Period (4 Weeks)||33
2445674|NCT01090492|5999383|P7|STARTED|First Intervention Period (4 Weeks)||32
2445675|NCT01090492|5999384|P6|STARTED|First Intervention Period (4 Weeks)||32
2445676|NCT01090492|5999385|P5|STARTED|First Intervention Period (4 Weeks)||33
2445677|NCT01090492|5999386|P4|STARTED|First Intervention Period (4 Weeks)||28
2445678|NCT01090492|5999387|P3|STARTED|First Intervention Period (4 Weeks)||29
2445679|NCT01090492|5999388|P2|STARTED|First Intervention Period (4 Weeks)||29
2445680|NCT01090492|5999389|P1|STARTED|First Intervention Period (4 Weeks)||27
2445681|NCT01090479|5999448|P2|NOT COMPLETED|Overall Study||0
2445682|NCT01090479|5999449|P1|NOT COMPLETED|Overall Study||0
2445683|NCT01090479|5999448|P2|COMPLETED|Overall Study||50
2445684|NCT01090479|5999449|P1|COMPLETED|Overall Study||50
2445685|NCT01090479|5999448|P2|STARTED|Overall Study||50
2445686|NCT01090479|5999449|P1|STARTED|Overall Study||50
2445687|NCT01090453|5999457|P2|NOT COMPLETED|Overall Study||14
2445688|NCT01090453|5999458|P1|NOT COMPLETED|Overall Study||13
2445689|NCT01090453|5999457|P2|COMPLETED|Overall Study||228
2445690|NCT01090453|5999458|P1|COMPLETED|Overall Study||225
2445691|NCT01090453|5999457|P2|STARTED|Overall Study||242
2445692|NCT01090453|5999458|P1|STARTED|Overall Study||238
2445693|NCT01090427|5999509|P7|NOT COMPLETED|After Controlled Period||2
2445694|NCT01090427|5999510|P6|NOT COMPLETED|After Controlled Period||5
2445695|NCT01090427|5999511|P5|NOT COMPLETED|After Controlled Period||0
2445696|NCT01090427|5999512|P4|NOT COMPLETED|After Controlled Period||2
2445697|NCT01090427|5999513|P3|NOT COMPLETED|After Controlled Period||0
2445698|NCT01090427|5999514|P2|NOT COMPLETED|After Controlled Period||0
2445699|NCT01090427|5999515|P1|NOT COMPLETED|After Controlled Period||0
2445700|NCT01090427|5999509|P7|COMPLETED|After Controlled Period||34
2445701|NCT01090427|5999510|P6|COMPLETED|After Controlled Period||32
2445702|NCT01090427|5999511|P5|COMPLETED|After Controlled Period||18
2445703|NCT01090427|5999512|P4|COMPLETED|After Controlled Period||17
2445704|NCT01090427|5999513|P3|COMPLETED|After Controlled Period||0
2445705|NCT01090427|5999514|P2|COMPLETED|After Controlled Period||0
2445706|NCT01090427|5999515|P1|COMPLETED|After Controlled Period||0
2445707|NCT01090427|5999509|P7|STARTED|After Controlled Period||36
2445708|NCT01090427|5999510|P6|STARTED|After Controlled Period||37
2445709|NCT01090427|5999511|P5|STARTED|After Controlled Period||18
2445710|NCT01090427|5999512|P4|STARTED|After Controlled Period||19
2445711|NCT01090427|5999513|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
2445712|NCT01090427|5999514|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
2445713|NCT01090427|5999515|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
2445714|NCT01090427|5999509|P7|NOT COMPLETED|Controlled Period||0
2445715|NCT01090427|5999510|P6|NOT COMPLETED|Controlled Period||0
2445716|NCT01090427|5999511|P5|NOT COMPLETED|Controlled Period||0
2445717|NCT01090427|5999512|P4|NOT COMPLETED|Controlled Period||0
2445718|NCT01090427|5999513|P3|NOT COMPLETED|Controlled Period||0
2445719|NCT01090427|5999514|P2|NOT COMPLETED|Controlled Period||0
2445720|NCT01090427|5999515|P1|NOT COMPLETED|Controlled Period||0
2445721|NCT01090427|5999509|P7|COMPLETED|Controlled Period||0
2445722|NCT01090427|5999510|P6|COMPLETED|Controlled Period||0
2445723|NCT01090427|5999511|P5|COMPLETED|Controlled Period||0
2445724|NCT01090427|5999512|P4|COMPLETED|Controlled Period||0
2445725|NCT01090427|5999513|P3|COMPLETED|Controlled Period||36
2445726|NCT01090427|5999514|P2|COMPLETED|Controlled Period||37
2445727|NCT01090427|5999515|P1|COMPLETED|Controlled Period||37
2445728|NCT01090427|5999509|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
2445729|NCT01090427|5999510|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
2445730|NCT01090427|5999511|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
2445731|NCT01090427|5999512|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
2445732|NCT01090427|5999513|P3|STARTED|Controlled Period||36
2445733|NCT01090427|5999514|P2|STARTED|Controlled Period||37
2445734|NCT01090427|5999515|P1|STARTED|Controlled Period||37
2445735|NCT01090414|5999552|P4|NOT COMPLETED|Study 101-99||5
2445736|NCT01090414|5999553|P3|NOT COMPLETED|Study 101-99||41
2445737|NCT01090414|5999554|P2|NOT COMPLETED|Study 101-99||108
2445738|NCT01090414|5999555|P1|NOT COMPLETED|Study 101-99||48
2445739|NCT01090414|5999552|P4|COMPLETED|Study 101-99||0
2445740|NCT01090414|5999553|P3|COMPLETED|Study 101-99||0
2445741|NCT01090414|5999554|P2|COMPLETED|Study 101-99||0
2445742|NCT01090414|5999555|P1|COMPLETED|Study 101-99||0
2445743|NCT01090414|5999552|P4|STARTED|Study 101-99||5
2445744|NCT01090414|5999553|P3|STARTED|Study 101-99|43 participants completed the parent study, but only 41 participants enrolled into Study 101-99.|41
2445745|NCT01090414|5999554|P2|STARTED|Study 101-99|114 participants completed the parent study, but only 108 participants enrolled into Study 101-99.|108
2445746|NCT01090414|5999555|P1|STARTED|Study 101-99|50 participants completed the parent study, but only 48 participants enrolled into Study 101-99.|48
2445747|NCT01090414|5999552|P4|NOT COMPLETED|Parent Studies||13
2445748|NCT01090414|5999553|P3|NOT COMPLETED|Parent Studies||21
2445749|NCT01090414|5999554|P2|NOT COMPLETED|Parent Studies||127
2445750|NCT01090414|5999555|P1|NOT COMPLETED|Parent Studies||141
2445751|NCT01090414|5999552|P4|COMPLETED|Parent Studies||5
2445752|NCT01090414|5999553|P3|COMPLETED|Parent Studies||43
2445753|NCT01090414|5999554|P2|COMPLETED|Parent Studies||114
2445754|NCT01090414|5999555|P1|COMPLETED|Parent Studies||50
2445755|NCT01090414|5999552|P4|STARTED|Parent Studies||18
2445756|NCT01090414|5999553|P3|STARTED|Parent Studies||64
2445757|NCT01090414|5999554|P2|STARTED|Parent Studies||241
2445758|NCT01090414|5999555|P1|STARTED|Parent Studies||191
2445759|NCT01090323|5999622|P2|NOT COMPLETED|Overall Study||34
2445760|NCT01090323|5999623|P1|NOT COMPLETED|Overall Study||89
2445761|NCT01090323|5999622|P2|COMPLETED|Overall Study||19
2445762|NCT01090323|5999623|P1|COMPLETED|Overall Study||43
2445763|NCT01090323|5999622|P2|STARTED|Overall Study||53
2445764|NCT01090323|5999623|P1|STARTED|Overall Study||132
2445765|NCT01090310|5999635|P4|NOT COMPLETED|Extension Study||20
2445766|NCT01090310|5999636|P3|NOT COMPLETED|Extension Study||15
2445767|NCT01090310|5999637|P2|NOT COMPLETED|Extension Study||16
2445768|NCT01090310|5999638|P1|NOT COMPLETED|Extension Study||14
2445769|NCT01090310|5999635|P4|COMPLETED|Extension Study||1
2445770|NCT01090310|5999636|P3|COMPLETED|Extension Study||1
2445771|NCT01090310|5999637|P2|COMPLETED|Extension Study||0
2445772|NCT01090310|5999638|P1|COMPLETED|Extension Study||3
2445773|NCT01090310|5999635|P4|STARTED|Extension Study||21
2445774|NCT01090310|5999636|P3|STARTED|Extension Study||16
2445775|NCT01090310|5999637|P2|STARTED|Extension Study||16
2445776|NCT01090310|5999638|P1|STARTED|Extension Study||17
2445777|NCT01090310|5999635|P4|NOT COMPLETED|Core Study||7
2445778|NCT01090310|5999636|P3|NOT COMPLETED|Core Study||7
2445779|NCT01090310|5999637|P2|NOT COMPLETED|Core Study||11
2445780|NCT01090310|5999638|P1|NOT COMPLETED|Core Study||8
2445781|NCT01090310|5999635|P4|COMPLETED|Core Study||27
2445782|NCT01090310|5999636|P3|COMPLETED|Core Study||24
2445783|NCT01090310|5999637|P2|COMPLETED|Core Study||20
2445784|NCT01090310|5999638|P1|COMPLETED|Core Study||21
2445785|NCT01090310|5999635|P4|STARTED|Core Study||34
2445786|NCT01090310|5999636|P3|STARTED|Core Study||31
2445787|NCT01090310|5999637|P2|STARTED|Core Study||31
2445788|NCT01090310|5999638|P1|STARTED|Core Study||29
2445789|NCT01090180|5999666|P2|NOT COMPLETED|Overall Study||8
2445790|NCT01090180|5999667|P1|NOT COMPLETED|Overall Study||11
2445791|NCT01090180|5999666|P2|COMPLETED|Overall Study||21
2445792|NCT01090180|5999667|P1|COMPLETED|Overall Study||22
2445793|NCT01090180|5999666|P2|STARTED|Overall Study||29
2445794|NCT01090180|5999667|P1|STARTED|Overall Study||33
2445795|NCT01090102|5999677|P2|NOT COMPLETED|Second 12 Weeks||1
2445796|NCT01090102|5999678|P1|NOT COMPLETED|Second 12 Weeks||0
2445797|NCT01090102|5999677|P2|COMPLETED|Second 12 Weeks||15
2445798|NCT01090102|5999678|P1|COMPLETED|Second 12 Weeks||11
2445799|NCT01090102|5999677|P2|STARTED|Second 12 Weeks||16
2445800|NCT01090102|5999678|P1|STARTED|Second 12 Weeks||11
2445801|NCT01090102|5999677|P2|NOT COMPLETED|First 12 Weeks||2
2445802|NCT01090102|5999678|P1|NOT COMPLETED|First 12 Weeks||4
2445803|NCT01090102|5999677|P2|COMPLETED|First 12 Weeks||16
2445804|NCT01090102|5999678|P1|COMPLETED|First 12 Weeks||11
2445805|NCT01090102|5999677|P2|STARTED|First 12 Weeks||18
2445806|NCT01090102|5999678|P1|STARTED|First 12 Weeks||15
2445807|NCT01090076|5999688|P2|NOT COMPLETED|Overall Study||2
2445808|NCT01090076|5999689|P1|NOT COMPLETED|Overall Study||1
2445809|NCT01090076|5999688|P2|COMPLETED|Overall Study||12
2445810|NCT01090076|5999689|P1|COMPLETED|Overall Study||11
2445811|NCT01090076|5999688|P2|STARTED|Overall Study||14
2445812|NCT01090076|5999689|P1|STARTED|Overall Study||12
2445813|NCT01090063|5999699|P1|NOT COMPLETED|Treatment||4
2445814|NCT01090063|5999699|P1|COMPLETED|Treatment||20
2445815|NCT01090063|5999699|P1|STARTED|Treatment||24
2445816|NCT01090063|5999699|P1|NOT COMPLETED|Screen||4
2445817|NCT01090063|5999699|P1|COMPLETED|Screen||24
2445818|NCT01090063|5999699|P1|STARTED|Screen||28
2445819|NCT01090050|5999715|P2|NOT COMPLETED|Overall Study||7
2445820|NCT01090050|5999716|P1|NOT COMPLETED|Overall Study||1
2445821|NCT01090050|5999715|P2|COMPLETED|Overall Study||5
2445822|NCT01090050|5999716|P1|COMPLETED|Overall Study||15
2445823|NCT01090050|5999715|P2|STARTED|Overall Study||12
2445824|NCT01090050|5999716|P1|STARTED|Overall Study||16
2445825|NCT01090011|5999736|P1|NOT COMPLETED|Overall Study||171
2445826|NCT01090011|5999736|P1|COMPLETED|Overall Study||0
2445827|NCT01090011|5999736|P1|STARTED|Overall Study||171
2445828|NCT01089751|5999806|P2|NOT COMPLETED|Overall Study||27
2445829|NCT01089751|5999807|P1|NOT COMPLETED|Overall Study||34
2445830|NCT01089751|5999806|P2|COMPLETED|Overall Study||132
2445831|NCT01089751|5999807|P1|COMPLETED|Overall Study||129
2445832|NCT01089751|5999806|P2|STARTED|Overall Study||159
2445833|NCT01089751|5999807|P1|STARTED|Overall Study||163
2445834|NCT01089647|5999829|P2|NOT COMPLETED|Overall Study||4
2445835|NCT01089647|5999830|P1|NOT COMPLETED|Overall Study||4
2445836|NCT01089647|5999829|P2|COMPLETED|Overall Study||13
2445837|NCT01089647|5999830|P1|COMPLETED|Overall Study||13
2445838|NCT01089647|5999829|P2|STARTED|Overall Study||17
2445839|NCT01089647|5999830|P1|STARTED|Overall Study||17
2445840|NCT01089608|5999838|P2|NOT COMPLETED|Overall Study||6
2445841|NCT01089608|5999839|P1|NOT COMPLETED|Overall Study||0
2445842|NCT01089608|5999838|P2|COMPLETED|Overall Study||44
2445843|NCT01089608|5999839|P1|COMPLETED|Overall Study||43
2445844|NCT01089608|5999838|P2|STARTED|Overall Study||50
2445845|NCT01089608|5999839|P1|STARTED|Overall Study||43
2445846|NCT01089595|5999847|P2|NOT COMPLETED|Overall Study||0
2445847|NCT01089595|5999848|P1|NOT COMPLETED|Overall Study||0
2445848|NCT01089595|5999847|P2|COMPLETED|Overall Study||3
2445849|NCT01089595|5999848|P1|COMPLETED|Overall Study||2
2445850|NCT01089595|5999847|P2|STARTED|Overall Study||3
2445851|NCT01089595|5999848|P1|STARTED|Overall Study||2
2445852|NCT01089582|5999856|P1|NOT COMPLETED|Overall Study||30
2445853|NCT01089582|5999856|P1|COMPLETED|Overall Study|1 subject died during the study; 1 subject died following permanent discontinuation from the study.|573
2445854|NCT01089582|5999856|P1|STARTED|Overall Study||603
2445855|NCT01089569|5999869|P3|NOT COMPLETED|Overall Study||4
2445856|NCT01089569|5999870|P2|NOT COMPLETED|Overall Study||3
2445857|NCT01089569|5999871|P1|NOT COMPLETED|Overall Study||4
2445858|NCT01089569|5999869|P3|COMPLETED|Overall Study||16
2445859|NCT01089569|5999870|P2|COMPLETED|Overall Study||17
2445860|NCT01089569|5999871|P1|COMPLETED|Overall Study||16
2445861|NCT01089569|5999869|P3|STARTED|Overall Study||20
2445862|NCT01089569|5999870|P2|STARTED|Overall Study||20
2445863|NCT01089569|5999871|P1|STARTED|Overall Study||20
2445864|NCT01089556|5999899|P6|NOT COMPLETED|Study Period III (Weeks 9-16)||7
2445865|NCT01089556|5999900|P5|NOT COMPLETED|Study Period III (Weeks 9-16)||12
2445866|NCT01089556|5999901|P4|NOT COMPLETED|Study Period III (Weeks 9-16)||9
2445867|NCT01089556|5999902|P3|NOT COMPLETED|Study Period III (Weeks 9-16)||14
2445868|NCT01089556|5999903|P2|NOT COMPLETED|Study Period III (Weeks 9-16)||0
2445869|NCT01089556|5999904|P1|NOT COMPLETED|Study Period III (Weeks 9-16)||0
2445870|NCT01089556|5999899|P6|COMPLETED|Study Period III (Weeks 9-16)||92
2445871|NCT01089556|5999900|P5|COMPLETED|Study Period III (Weeks 9-16)||83
2445872|NCT01089556|5999901|P4|COMPLETED|Study Period III (Weeks 9-16)||66
2445873|NCT01089556|5999902|P3|COMPLETED|Study Period III (Weeks 9-16)||60
2445874|NCT01089556|5999903|P2|COMPLETED|Study Period III (Weeks 9-16)||0
2445875|NCT01089556|5999904|P1|COMPLETED|Study Period III (Weeks 9-16)||0
2445876|NCT01089556|5999899|P6|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|97
2445877|NCT01089556|5999900|P5|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|94
2445878|NCT01089556|5999901|P4|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|75
2445879|NCT01089556|5999902|P3|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|73
2445880|NCT01089556|5999903|P2|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
2445881|NCT01089556|5999904|P1|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
2445882|NCT01089556|5999899|P6|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 1 responders entered SPIII|99
2445883|NCT01089556|5999900|P5|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|95
2445884|NCT01089556|5999901|P4|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 3 responders entered SPIII|75
2445885|NCT01089556|5999902|P3|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|74
2445886|NCT01089556|5999903|P2|STARTED|Study Period III (Weeks 9-16)||0
2445887|NCT01089556|5999904|P1|STARTED|Study Period III (Weeks 9-16)||0
2445888|NCT01089556|5999899|P6|NOT COMPLETED|Study Period II (Weeks 1-8)||0
2445889|NCT01089556|5999900|P5|NOT COMPLETED|Study Period II (Weeks 1-8)||0
2445890|NCT01089556|5999901|P4|NOT COMPLETED|Study Period II (Weeks 1-8)||0
2445891|NCT01089556|5999902|P3|NOT COMPLETED|Study Period II (Weeks 1-8)||0
2445892|NCT01089556|5999903|P2|NOT COMPLETED|Study Period II (Weeks 1-8)||74
2445893|NCT01089556|5999904|P1|NOT COMPLETED|Study Period II (Weeks 1-8)||71
2445894|NCT01089556|5999899|P6|COMPLETED|Study Period II (Weeks 1-8)||0
2445895|NCT01089556|5999900|P5|COMPLETED|Study Period II (Weeks 1-8)||0
2445896|NCT01089556|5999901|P4|COMPLETED|Study Period II (Weeks 1-8)||0
2445897|NCT01089556|5999902|P3|COMPLETED|Study Period II (Weeks 1-8)||0
2445898|NCT01089556|5999903|P2|COMPLETED|Study Period II (Weeks 1-8)||333
2445899|NCT01089556|5999904|P1|COMPLETED|Study Period II (Weeks 1-8)||333
2445900|NCT01089556|5999899|P6|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
2445901|NCT01089556|5999900|P5|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
2445902|NCT01089556|5999901|P4|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
2445903|NCT01089556|5999902|P3|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
2445904|NCT01089556|5999903|P2|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||205
2445905|NCT01089556|5999904|P1|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||158
2445906|NCT01089556|5999899|P6|Safety Population|Study Period II (Weeks 1-8)||0
2445907|NCT01089556|5999900|P5|Safety Population|Study Period II (Weeks 1-8)||0
2445908|NCT01089556|5999901|P4|Safety Population|Study Period II (Weeks 1-8)||0
2445909|NCT01089556|5999902|P3|Safety Population|Study Period II (Weeks 1-8)||0
2445910|NCT01089556|5999903|P2|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|403
2445911|NCT01089556|5999904|P1|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|401
2445912|NCT01089556|5999899|P6|STARTED|Study Period II (Weeks 1-8)||0
2445913|NCT01089556|5999900|P5|STARTED|Study Period II (Weeks 1-8)||0
2445914|NCT01089556|5999901|P4|STARTED|Study Period II (Weeks 1-8)||0
2445915|NCT01089556|5999902|P3|STARTED|Study Period II (Weeks 1-8)||0
2445916|NCT01089556|5999903|P2|STARTED|Study Period II (Weeks 1-8)||407
2445917|NCT01089556|5999904|P1|STARTED|Study Period II (Weeks 1-8)||404
2445918|NCT01089543|5999978|P4|NOT COMPLETED|Overall Study||2
2445919|NCT01089543|5999979|P3|NOT COMPLETED|Overall Study||3
2445920|NCT01089543|5999980|P2|NOT COMPLETED|Overall Study||4
2445921|NCT01089543|5999981|P1|NOT COMPLETED|Overall Study||3
2445922|NCT01089543|5999978|P4|COMPLETED|Overall Study||83
2445923|NCT01089543|5999979|P3|COMPLETED|Overall Study||81
2445924|NCT01089543|5999980|P2|COMPLETED|Overall Study||81
2445925|NCT01089543|5999981|P1|COMPLETED|Overall Study||81
2445926|NCT01089543|5999978|P4|STARTED|Overall Study||85
2445927|NCT01089543|5999979|P3|STARTED|Overall Study||84
2445928|NCT01089543|5999980|P2|STARTED|Overall Study||85
2445929|NCT01089543|5999981|P1|STARTED|Overall Study||84
2445930|NCT01089517|5999998|P3|NOT COMPLETED|Overall Study||5
2445931|NCT01089517|5999999|P2|NOT COMPLETED|Overall Study||5
2445932|NCT01089517|6000000|P1|NOT COMPLETED|Overall Study||4
2445933|NCT01089517|5999998|P3|COMPLETED|Overall Study||147
2445934|NCT01089517|5999999|P2|COMPLETED|Overall Study||144
2445935|NCT01089517|6000000|P1|COMPLETED|Overall Study||144
2445936|NCT01089517|5999998|P3|STARTED|Overall Study||152
2445937|NCT01089517|5999999|P2|STARTED|Overall Study||149
2445938|NCT01089517|6000000|P1|STARTED|Overall Study||148
2445939|NCT01089504|6000016|P2|NOT COMPLETED|Overall Study||1
2445940|NCT01089504|6000017|P1|NOT COMPLETED|Overall Study||3
2445941|NCT01089504|6000016|P2|COMPLETED|Overall Study||4
2445942|NCT01089504|6000017|P1|COMPLETED|Overall Study||5
2445943|NCT01089504|6000016|P2|STARTED|Overall Study||5
2445944|NCT01089504|6000017|P1|STARTED|Overall Study||8
2445945|NCT01089413|6000030|P1|NOT COMPLETED|Overall Study||201
2445946|NCT01089413|6000030|P1|COMPLETED|Overall Study||0
2445947|NCT01089413|6000030|P1|Received Bevacizumab in First Line|Overall Study||199
2445948|NCT01089413|6000030|P1|STARTED|Overall Study||201
2445949|NCT01089361|6000049|P2|NOT COMPLETED|Overall Study||0
2445950|NCT01089361|6000050|P1|NOT COMPLETED|Overall Study||1
2445951|NCT01089361|6000049|P2|COMPLETED|Overall Study||10
2445952|NCT01089361|6000050|P1|COMPLETED|Overall Study||8
2445953|NCT01089361|6000049|P2|STARTED|Overall Study||10
2445954|NCT01089361|6000050|P1|STARTED|Overall Study||9
2445955|NCT01089231|6000072|P4|NOT COMPLETED|Overall Study||1
2445956|NCT01089231|6000073|P3|NOT COMPLETED|Overall Study||2
2445957|NCT01089231|6000074|P2|NOT COMPLETED|Overall Study||2
2445958|NCT01089231|6000075|P1|NOT COMPLETED|Overall Study||4
2445959|NCT01089231|6000072|P4|COMPLETED|Overall Study|1 subject excluded (low RNA yield)|9
2445960|NCT01089231|6000073|P3|COMPLETED|Overall Study|2 subject excluded (1 use of not allowed drugs; 1 low RNA yield)|8
2445961|NCT01089231|6000074|P2|COMPLETED|Overall Study|2 subjects excluded (1 highly elevated TG and TC data; 1 elevated inflammation (CRP level))|8
2445962|NCT01089231|6000075|P1|COMPLETED|Overall Study|4 subjects excluded (2 alcohol use / TG level changes; 1 use of not allowed drugs; 1 low RNA yield)|6
2445963|NCT01089231|6000072|P4|STARTED|Overall Study||10
2445964|NCT01089231|6000073|P3|STARTED|Overall Study||10
2445965|NCT01089231|6000074|P2|STARTED|Overall Study||10
2445966|NCT01089231|6000075|P1|STARTED|Overall Study||10
2445967|NCT01089127|6000099|P6|NOT COMPLETED|Overall Study||3
2445968|NCT01089127|6000100|P5|NOT COMPLETED|Overall Study||2
2445969|NCT01089127|6000101|P4|NOT COMPLETED|Overall Study||1
2445970|NCT01089127|6000102|P3|NOT COMPLETED|Overall Study||2
2445971|NCT01089127|6000103|P2|NOT COMPLETED|Overall Study||5
2445972|NCT01089127|6000104|P1|NOT COMPLETED|Overall Study||8
2445973|NCT01089127|6000099|P6|COMPLETED|Overall Study||88
2445974|NCT01089127|6000100|P5|COMPLETED|Overall Study||90
2445975|NCT01089127|6000101|P4|COMPLETED|Overall Study||91
2445976|NCT01089127|6000102|P3|COMPLETED|Overall Study||92
2445977|NCT01089127|6000103|P2|COMPLETED|Overall Study||86
2445978|NCT01089127|6000104|P1|COMPLETED|Overall Study||84
2445979|NCT01089127|6000099|P6|Exposed to Study Drug|Overall Study||91
2445980|NCT01089127|6000100|P5|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|91
2445981|NCT01089127|6000101|P4|Exposed to Study Drug|Overall Study||92
2445982|NCT01089127|6000102|P3|Exposed to Study Drug|Overall Study||94
2445983|NCT01089127|6000103|P2|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|90
2445984|NCT01089127|6000104|P1|Exposed to Study Drug|Overall Study|3 randomized patients in this group were not exposed to study treatment.|89
2445985|NCT01089127|6000099|P6|STARTED|Overall Study||91
2445986|NCT01089127|6000100|P5|STARTED|Overall Study||92
2445987|NCT01089127|6000101|P4|STARTED|Overall Study||92
2445988|NCT01089127|6000102|P3|STARTED|Overall Study||94
2445989|NCT01089127|6000103|P2|STARTED|Overall Study||91
2445990|NCT01089127|6000104|P1|STARTED|Overall Study||92
2445991|NCT01089062|6000130|P6|NOT COMPLETED|Follow-up Visit (Final Visit)||0
2445992|NCT01089062|6000131|P5|NOT COMPLETED|Follow-up Visit (Final Visit)||0
2445993|NCT01089062|6000132|P4|NOT COMPLETED|Follow-up Visit (Final Visit)||0
2445994|NCT01089062|6000133|P3|NOT COMPLETED|Follow-up Visit (Final Visit)||0
2445995|NCT01089062|6000134|P2|NOT COMPLETED|Follow-up Visit (Final Visit)||0
2445996|NCT01089062|6000135|P1|NOT COMPLETED|Follow-up Visit (Final Visit)||0
2445997|NCT01089062|6000130|P6|COMPLETED|Follow-up Visit (Final Visit)||3
2445998|NCT01089062|6000131|P5|COMPLETED|Follow-up Visit (Final Visit)||3
2445999|NCT01089062|6000132|P4|COMPLETED|Follow-up Visit (Final Visit)||3
2446000|NCT01089062|6000133|P3|COMPLETED|Follow-up Visit (Final Visit)||3
2446001|NCT01089062|6000134|P2|COMPLETED|Follow-up Visit (Final Visit)||3
2446002|NCT01089062|6000135|P1|COMPLETED|Follow-up Visit (Final Visit)||3
2446003|NCT01089062|6000130|P6|STARTED|Follow-up Visit (Final Visit)||3
2446004|NCT01089062|6000131|P5|STARTED|Follow-up Visit (Final Visit)||3
2446005|NCT01089062|6000132|P4|STARTED|Follow-up Visit (Final Visit)||3
2446006|NCT01089062|6000133|P3|STARTED|Follow-up Visit (Final Visit)||3
2446007|NCT01089062|6000134|P2|STARTED|Follow-up Visit (Final Visit)||3
2446008|NCT01089062|6000135|P1|STARTED|Follow-up Visit (Final Visit)||3
2446009|NCT01089062|6000130|P6|NOT COMPLETED|Visit 4||0
2446010|NCT01089062|6000131|P5|NOT COMPLETED|Visit 4||0
2446011|NCT01089062|6000132|P4|NOT COMPLETED|Visit 4||0
2446012|NCT01089062|6000133|P3|NOT COMPLETED|Visit 4||0
2446013|NCT01089062|6000134|P2|NOT COMPLETED|Visit 4||0
2446014|NCT01089062|6000135|P1|NOT COMPLETED|Visit 4||0
2446015|NCT01089062|6000130|P6|COMPLETED|Visit 4||3
2446016|NCT01089062|6000131|P5|COMPLETED|Visit 4||3
2446017|NCT01089062|6000132|P4|COMPLETED|Visit 4||3
2446018|NCT01089062|6000133|P3|COMPLETED|Visit 4||3
2446019|NCT01089062|6000134|P2|COMPLETED|Visit 4||3
2446020|NCT01089062|6000135|P1|COMPLETED|Visit 4||3
2446021|NCT01089062|6000130|P6|STARTED|Visit 4||3
2446022|NCT01089062|6000131|P5|STARTED|Visit 4||3
2446023|NCT01089062|6000132|P4|STARTED|Visit 4||3
2446024|NCT01089062|6000133|P3|STARTED|Visit 4||3
2446025|NCT01089062|6000134|P2|STARTED|Visit 4||3
2446026|NCT01089062|6000135|P1|STARTED|Visit 4||3
2446027|NCT01089062|6000130|P6|NOT COMPLETED|Visit 3||0
2446028|NCT01089062|6000131|P5|NOT COMPLETED|Visit 3||0
2446029|NCT01089062|6000132|P4|NOT COMPLETED|Visit 3||1
2446030|NCT01089062|6000133|P3|NOT COMPLETED|Visit 3||0
2446031|NCT01089062|6000134|P2|NOT COMPLETED|Visit 3||0
2446032|NCT01089062|6000135|P1|NOT COMPLETED|Visit 3||0
2446033|NCT01089062|6000130|P6|COMPLETED|Visit 3||3
2446034|NCT01089062|6000131|P5|COMPLETED|Visit 3||3
2446035|NCT01089062|6000132|P4|COMPLETED|Visit 3||3
2446036|NCT01089062|6000133|P3|COMPLETED|Visit 3||3
2446037|NCT01089062|6000134|P2|COMPLETED|Visit 3||3
2446038|NCT01089062|6000135|P1|COMPLETED|Visit 3||3
2446039|NCT01089062|6000130|P6|STARTED|Visit 3||3
2446040|NCT01089062|6000131|P5|STARTED|Visit 3||3
2446041|NCT01089062|6000132|P4|STARTED|Visit 3||4
2446042|NCT01089062|6000133|P3|STARTED|Visit 3||3
2446043|NCT01089062|6000134|P2|STARTED|Visit 3||3
2446044|NCT01089062|6000135|P1|STARTED|Visit 3||3
2446045|NCT01089062|6000130|P6|NOT COMPLETED|Visit 2 (Randomization)||1
2446046|NCT01089062|6000131|P5|NOT COMPLETED|Visit 2 (Randomization)||1
2446047|NCT01089062|6000132|P4|NOT COMPLETED|Visit 2 (Randomization)||0
2446048|NCT01089062|6000133|P3|NOT COMPLETED|Visit 2 (Randomization)||1
2446049|NCT01089062|6000134|P2|NOT COMPLETED|Visit 2 (Randomization)||1
2446050|NCT01089062|6000135|P1|NOT COMPLETED|Visit 2 (Randomization)||1
2446051|NCT01089062|6000130|P6|COMPLETED|Visit 2 (Randomization)||3
2446052|NCT01089062|6000131|P5|COMPLETED|Visit 2 (Randomization)||3
2446053|NCT01089062|6000132|P4|COMPLETED|Visit 2 (Randomization)||4
2446054|NCT01089062|6000133|P3|COMPLETED|Visit 2 (Randomization)||3
2446055|NCT01089062|6000134|P2|COMPLETED|Visit 2 (Randomization)||3
2446056|NCT01089062|6000135|P1|COMPLETED|Visit 2 (Randomization)||3
2446057|NCT01089062|6000130|P6|STARTED|Visit 2 (Randomization)||4
2446058|NCT01089062|6000131|P5|STARTED|Visit 2 (Randomization)||4
2446059|NCT01089062|6000132|P4|STARTED|Visit 2 (Randomization)||4
2446060|NCT01089062|6000133|P3|STARTED|Visit 2 (Randomization)||4
2446061|NCT01089062|6000134|P2|STARTED|Visit 2 (Randomization)||4
2446062|NCT01089062|6000135|P1|STARTED|Visit 2 (Randomization)||4
2446063|NCT01089023|6000158|P1|NOT COMPLETED|Overall Study||7
2446064|NCT01089023|6000158|P1|COMPLETED|Overall Study||88
2446065|NCT01089023|6000158|P1|STARTED|Overall Study||95
2446066|NCT01088997|6000172|P2|NOT COMPLETED|Overall Study||3
2446067|NCT01088997|6000173|P1|NOT COMPLETED|Overall Study||3
2446068|NCT01088997|6000172|P2|COMPLETED|Overall Study||2
2446069|NCT01088997|6000173|P1|COMPLETED|Overall Study||4
2446070|NCT01088997|6000172|P2|STARTED|Overall Study||5
2446071|NCT01088997|6000173|P1|STARTED|Overall Study||7
2446072|NCT01088984|6000184|P2|NOT COMPLETED|Phase 2||32
2446073|NCT01088984|6000185|P1|NOT COMPLETED|Phase 2||0
2446074|NCT01088984|6000184|P2|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
2446075|NCT01088984|6000185|P1|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
2446076|NCT01088984|6000184|P2|STARTED|Phase 2||32
2446077|NCT01088984|6000185|P1|STARTED|Phase 2||0
2446078|NCT01088984|6000184|P2|NOT COMPLETED|Phase 1||6
2446079|NCT01088984|6000185|P1|NOT COMPLETED|Phase 1||5
2446080|NCT01088984|6000184|P2|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
2446081|NCT01088984|6000185|P1|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
2446082|NCT01088984|6000184|P2|STARTED|Phase 1||6
2446083|NCT01088984|6000185|P1|STARTED|Phase 1||5
2446084|NCT01088815|6000203|P1|NOT COMPLETED|Overall Study||0
2446085|NCT01088815|6000203|P1|COMPLETED|Overall Study||72
2446086|NCT01088815|6000203|P1|STARTED|Overall Study||72
2446087|NCT01088711|6000216|P4|NOT COMPLETED|Overall Study||0
2446088|NCT01088711|6000217|P3|NOT COMPLETED|Overall Study||0
2446089|NCT01088711|6000218|P2|NOT COMPLETED|Overall Study||0
2446090|NCT01088711|6000219|P1|NOT COMPLETED|Overall Study||0
2446091|NCT01088711|6000216|P4|COMPLETED|Overall Study||2
2446092|NCT01088711|6000217|P3|COMPLETED|Overall Study||6
2446093|NCT01088711|6000218|P2|COMPLETED|Overall Study||6
2446094|NCT01088711|6000219|P1|COMPLETED|Overall Study||18
2446095|NCT01088711|6000216|P4|STARTED|Overall Study||2
2446096|NCT01088711|6000217|P3|STARTED|Overall Study||6
2446097|NCT01088711|6000218|P2|STARTED|Overall Study||6
2446098|NCT01088711|6000219|P1|STARTED|Overall Study||18
2446099|NCT01088672|6000243|P1|NOT COMPLETED|Overall Study||0
2446100|NCT01088672|6000243|P1|COMPLETED|Overall Study||60
2446101|NCT01088672|6000243|P1|STARTED|Overall Study||60
2446102|NCT01088646|6000249|P1|NOT COMPLETED|Overall Study||0
2446103|NCT01088646|6000249|P1|COMPLETED|Overall Study||25
2446104|NCT01088646|6000249|P1|STARTED|Overall Study||25
2446105|NCT01088529|6000255|P2|NOT COMPLETED|Overall Study||1
2446106|NCT01088529|6000256|P1|NOT COMPLETED|Overall Study||0
2446107|NCT01088529|6000255|P2|COMPLETED|Overall Study||21
2446108|NCT01088529|6000256|P1|COMPLETED|Overall Study||44
2446109|NCT01088529|6000255|P2|Received Treatment|Overall Study||21
2446110|NCT01088529|6000256|P1|Received Treatment|Overall Study||44
2446111|NCT01088529|6000255|P2|STARTED|Overall Study||22
2446112|NCT01088529|6000256|P1|STARTED|Overall Study||44
2446113|NCT01088503|6000269|P3|NOT COMPLETED|Overall Study||17
2446114|NCT01088503|6000270|P2|NOT COMPLETED|Overall Study||685
2446115|NCT01088503|6000271|P1|NOT COMPLETED|Overall Study||182
2446116|NCT01088503|6000269|P3|COMPLETED|Overall Study||241
2446117|NCT01088503|6000270|P2|COMPLETED|Overall Study||8161
2446118|NCT01088503|6000271|P1|COMPLETED|Overall Study||2941
2446119|NCT01088503|6000269|P3|STARTED|Overall Study||258
2446120|NCT01088503|6000270|P2|STARTED|Overall Study||8846
2446121|NCT01088503|6000271|P1|STARTED|Overall Study||3123
2446122|NCT01088464|6000295|P3|NOT COMPLETED|Overall Study||0
2446123|NCT01088464|6000296|P2|NOT COMPLETED|Overall Study||0
2446124|NCT01088464|6000297|P1|NOT COMPLETED|Overall Study||0
2446125|NCT01088464|6000295|P3|COMPLETED|Overall Study||6
2446126|NCT01088464|6000296|P2|COMPLETED|Overall Study||6
2446127|NCT01088464|6000297|P1|COMPLETED|Overall Study||3
2446128|NCT01088464|6000295|P3|Received Any Quantity of Study Drug|Overall Study||6
2446129|NCT01088464|6000296|P2|Received Any Quantity of Study Drug|Overall Study||6
2446130|NCT01088464|6000297|P1|Received Any Quantity of Study Drug|Overall Study||3
2446131|NCT01088464|6000295|P3|STARTED|Overall Study||6
2446132|NCT01088464|6000296|P2|STARTED|Overall Study||6
2446133|NCT01088464|6000297|P1|STARTED|Overall Study||3
2446134|NCT01088438|6000349|P2|NOT COMPLETED|Overall Study||36
2446135|NCT01088438|6000350|P1|NOT COMPLETED|Overall Study||29
2446136|NCT01088438|6000349|P2|COMPLETED|Overall Study||59
2446137|NCT01088438|6000350|P1|COMPLETED|Overall Study||65
2446138|NCT01088438|6000349|P2|STARTED|Overall Study||95
2446139|NCT01088438|6000350|P1|STARTED|Overall Study||94
2446140|NCT01088412|6000363|P3|NOT COMPLETED|Overall Study||72
2446141|NCT01088412|6000364|P2|NOT COMPLETED|Overall Study||436
2446142|NCT01088412|6000365|P1|NOT COMPLETED|Overall Study||18017
2446143|NCT01088412|6000363|P3|COMPLETED|Overall Study||5
2446144|NCT01088412|6000364|P2|COMPLETED|Overall Study||21
2446145|NCT01088412|6000365|P1|COMPLETED|Overall Study||4294
2446146|NCT01088412|6000363|P3|SME+ >= 1 FU and Previous Cancer|Overall Study||0
2446147|NCT01088412|6000364|P2|SME+ >= 1 FU and Previous Cancer|Overall Study||114
2446148|NCT01088412|6000365|P1|SME+ >= 1 FU and Previous Cancer|Overall Study||622
2446149|NCT01088412|6000363|P3|SME+ >= 1 FU and No Previous Cancer|Overall Study||0
2446150|NCT01088412|6000364|P2|SME+ >= 1 FU and No Previous Cancer|Overall Study||192
2446151|NCT01088412|6000365|P1|SME+ >= 1 FU and No Previous Cancer|Overall Study||20556
2446152|NCT01088412|6000363|P3|SME+ >= 1 FU and Unknown Arm|Overall Study||40
2446153|NCT01088412|6000364|P2|SME+ >= 1 FU and Unknown Arm|Overall Study||306
2446154|NCT01088412|6000365|P1|SME+ >= 1 FU and Unknown Arm|Overall Study||21177
2446155|NCT01088412|6000363|P3|SME With at Least 1 Follow Up (FU)|Overall Study||0
2446156|NCT01088412|6000364|P2|SME With at Least 1 Follow Up (FU)|Overall Study||306
2446157|NCT01088412|6000365|P1|SME With at Least 1 Follow Up (FU)|Overall Study||21178
2446158|NCT01088412|6000363|P3|Safety Modified Evaluable (SME)|Overall Study||0
2446159|NCT01088412|6000364|P2|Safety Modified Evaluable (SME)|Overall Study||456
2446160|NCT01088412|6000365|P1|Safety Modified Evaluable (SME)|Overall Study||22294
2446161|NCT01088412|6000363|P3|STARTED|Overall Study||77
2446162|NCT01088412|6000364|P2|STARTED|Overall Study||457
2446163|NCT01088412|6000365|P1|STARTED|Overall Study||22311
2446164|NCT01088399|6000384|P3|NOT COMPLETED|Overall Study||281
2446165|NCT01088399|6000385|P2|NOT COMPLETED|Overall Study||1347
2446166|NCT01088399|6000386|P1|NOT COMPLETED|Overall Study||7121
2446167|NCT01088399|6000384|P3|COMPLETED|Overall Study||21
2446168|NCT01088399|6000385|P2|COMPLETED|Overall Study||308
2446169|NCT01088399|6000386|P1|COMPLETED|Overall Study||1595
2446170|NCT01088399|6000384|P3|STARTED|Overall Study||302
2446171|NCT01088399|6000385|P2|STARTED|Overall Study||1655
2446172|NCT01088399|6000386|P1|STARTED|Overall Study||8716
2446173|NCT01088295|6000409|P1|NOT COMPLETED|Overall Study||1
2446174|NCT01088295|6000409|P1|COMPLETED|Overall Study||35
2446175|NCT01088295|6000409|P1|STARTED|Overall Study||36
2446176|NCT01088243|6000415|P2|NOT COMPLETED|Overall Study||0
2446177|NCT01088243|6000416|P1|NOT COMPLETED|Overall Study||1
2446178|NCT01088243|6000415|P2|COMPLETED|Overall Study||5
2446179|NCT01088243|6000416|P1|COMPLETED|Overall Study||12
2446180|NCT01088243|6000415|P2|STARTED|Overall Study||5
2446181|NCT01088243|6000416|P1|STARTED|Overall Study||13
2446182|NCT01087996|6000434|P2|NOT COMPLETED|Overall Study||0
2446183|NCT01087996|6000435|P1|NOT COMPLETED|Overall Study||0
2446184|NCT01087996|6000434|P2|COMPLETED|Overall Study||15
2446185|NCT01087996|6000435|P1|COMPLETED|Overall Study||15
2446186|NCT01087996|6000434|P2|STARTED|Overall Study||15
2446187|NCT01087996|6000435|P1|STARTED|Overall Study||15
2446188|NCT01087970|6000457|P1|NOT COMPLETED|Overall Study||2
2446189|NCT01087970|6000457|P1|COMPLETED|Overall Study||67
2446190|NCT01087970|6000457|P1|Received Carboplatin|Overall Study||63
2446191|NCT01087970|6000457|P1|Efficacy Population|Overall Study|All treated participants excluding those from a noncompliant study site.|58
2446192|NCT01087970|6000457|P1|Completed 6 Cycles|Overall Study||69
2446193|NCT01087970|6000457|P1|Received ≥1 Dose of Any Study Drug|Overall Study||69
2446194|NCT01087970|6000457|P1|STARTED|Overall Study||69
2446195|NCT01087957|6000469|P2|NOT COMPLETED|Overall Study||55
2446196|NCT01087957|6000470|P1|NOT COMPLETED|Overall Study||41
2446197|NCT01087957|6000469|P2|COMPLETED|Overall Study||187
2446198|NCT01087957|6000470|P1|COMPLETED|Overall Study||212
2446199|NCT01087957|6000469|P2|STARTED|Overall Study||242
2446200|NCT01087957|6000470|P1|STARTED|Overall Study||253
2446201|NCT01087944|6000496|P2|NOT COMPLETED|Period 2 (Week 4-6)||2
2446202|NCT01087944|6000497|P1|NOT COMPLETED|Period 2 (Week 4-6)||0
2446203|NCT01087944|6000496|P2|COMPLETED|Period 2 (Week 4-6)||28
2446204|NCT01087944|6000497|P1|COMPLETED|Period 2 (Week 4-6)||29
2446205|NCT01087944|6000496|P2|STARTED|Period 2 (Week 4-6)||30
2446206|NCT01087944|6000497|P1|STARTED|Period 2 (Week 4-6)||29
2446207|NCT01087944|6000496|P2|NOT COMPLETED|Period 1 (Week 1-3)||0
2446208|NCT01087944|6000497|P1|NOT COMPLETED|Period 1 (Week 1-3)||1
2446209|NCT01087944|6000496|P2|COMPLETED|Period 1 (Week 1-3)||30
2446210|NCT01087944|6000497|P1|COMPLETED|Period 1 (Week 1-3)||29
2446211|NCT01087944|6000496|P2|STARTED|Period 1 (Week 1-3)||30
2446212|NCT01087944|6000497|P1|STARTED|Period 1 (Week 1-3)||30
2446213|NCT01087931|6000527|P2|NOT COMPLETED|Overall Study||0
2446214|NCT01087931|6000528|P1|NOT COMPLETED|Overall Study||0
2446215|NCT01087931|6000527|P2|COMPLETED|Overall Study||20
2446216|NCT01087931|6000528|P1|COMPLETED|Overall Study||20
2446217|NCT01087931|6000527|P2|Final Follow up|Overall Study||17
2446218|NCT01087931|6000528|P1|Final Follow up|Overall Study||19
2446219|NCT01087931|6000527|P2|1st Follow up|Overall Study||19
2446220|NCT01087931|6000528|P1|1st Follow up|Overall Study||20
2446221|NCT01087931|6000527|P2|STARTED|Overall Study||20
2446222|NCT01087931|6000528|P1|STARTED|Overall Study||20
2446223|NCT01087918|6000542|P2|NOT COMPLETED|Overall Study||0
2446224|NCT01087918|6000543|P1|NOT COMPLETED|Overall Study||0
2446225|NCT01087918|6000542|P2|COMPLETED|Overall Study||4
2446226|NCT01087918|6000543|P1|COMPLETED|Overall Study||5
2446227|NCT01087918|6000542|P2|STARTED|Overall Study||4
2446228|NCT01087918|6000543|P1|STARTED|Overall Study||5
2446229|NCT01087905|6000577|P8|NOT COMPLETED|Overall Study||29
2446230|NCT01087905|6000578|P7|NOT COMPLETED|Overall Study||23
2446231|NCT01087905|6000579|P6|NOT COMPLETED|Overall Study||28
2446232|NCT01087905|6000580|P5|NOT COMPLETED|Overall Study||31
2446233|NCT01087905|6000581|P4|NOT COMPLETED|Overall Study||36
2446234|NCT01087905|6000582|P3|NOT COMPLETED|Overall Study||22
2446235|NCT01087905|6000583|P2|NOT COMPLETED|Overall Study||32
2446236|NCT01087905|6000584|P1|NOT COMPLETED|Overall Study||29
2446237|NCT01087905|6000577|P8|COMPLETED|Overall Study||98
2446238|NCT01087905|6000578|P7|COMPLETED|Overall Study||98
2446239|NCT01087905|6000579|P6|COMPLETED|Overall Study||99
2446240|NCT01087905|6000580|P5|COMPLETED|Overall Study||91
2446241|NCT01087905|6000581|P4|COMPLETED|Overall Study||86
2446242|NCT01087905|6000582|P3|COMPLETED|Overall Study||101
2446243|NCT01087905|6000583|P2|COMPLETED|Overall Study||94
2446244|NCT01087905|6000584|P1|COMPLETED|Overall Study||90
2446245|NCT01087905|6000577|P8|STARTED|Overall Study||127
2446246|NCT01087905|6000578|P7|STARTED|Overall Study||121
2446247|NCT01087905|6000579|P6|STARTED|Overall Study||127
2446248|NCT01087905|6000580|P5|STARTED|Overall Study||122
2446249|NCT01087905|6000581|P4|STARTED|Overall Study||122
2446250|NCT01087905|6000582|P3|STARTED|Overall Study||123
2446251|NCT01087905|6000583|P2|STARTED|Overall Study||126
2446252|NCT01087905|6000584|P1|STARTED|Overall Study||119
2446253|NCT01087814|6000606|P2|NOT COMPLETED|Second Intervention (5 Days)||0
2446254|NCT01087814|6000607|P1|NOT COMPLETED|Second Intervention (5 Days)||1
2446255|NCT01087814|6000606|P2|COMPLETED|Second Intervention (5 Days)||6
2446256|NCT01087814|6000607|P1|COMPLETED|Second Intervention (5 Days)||4
2446257|NCT01087814|6000606|P2|STARTED|Second Intervention (5 Days)||6
2446258|NCT01087814|6000607|P1|STARTED|Second Intervention (5 Days)||5
2446259|NCT01087814|6000606|P2|NOT COMPLETED|First Intervention (5 Days)||1
2446260|NCT01087814|6000607|P1|NOT COMPLETED|First Intervention (5 Days)||3
2446261|NCT01087814|6000606|P2|COMPLETED|First Intervention (5 Days)||6
2446262|NCT01087814|6000607|P1|COMPLETED|First Intervention (5 Days)||5
2446263|NCT01087814|6000606|P2|STARTED|First Intervention (5 Days)||7
2446264|NCT01087814|6000607|P1|STARTED|First Intervention (5 Days)||8
2446265|NCT01087801|6000615|P2|NOT COMPLETED|Overall Study||5
2446266|NCT01087801|6000616|P1|NOT COMPLETED|Overall Study||4
2446267|NCT01087801|6000615|P2|COMPLETED|Overall Study||29
2446268|NCT01087801|6000616|P1|COMPLETED|Overall Study||26
2446269|NCT01087801|6000615|P2|STARTED|Overall Study||34
2446270|NCT01087801|6000616|P1|STARTED|Overall Study||30
2446271|NCT01087788|6000625|P3|NOT COMPLETED|Open-Label Period (OL-P)||28
2446272|NCT01087788|6000626|P2|NOT COMPLETED|Open-Label Period (OL-P)||24
2446273|NCT01087788|6000627|P1|NOT COMPLETED|Open-Label Period (OL-P)||30
2446274|NCT01087788|6000625|P3|COMPLETED|Open-Label Period (OL-P)||86
2446275|NCT01087788|6000626|P2|COMPLETED|Open-Label Period (OL-P)||97
2446276|NCT01087788|6000627|P1|COMPLETED|Open-Label Period (OL-P)||81
2446277|NCT01087788|6000625|P3|STARTED|Open-Label Period (OL-P)||114
2446278|NCT01087788|6000626|P2|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|121
2446279|NCT01087788|6000627|P1|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|111
2446280|NCT01087788|6000625|P3|NOT COMPLETED|24-weeks Dose-blind Period||6
2446281|NCT01087788|6000626|P2|NOT COMPLETED|24-weeks Dose-blind Period||5
2446282|NCT01087788|6000627|P1|NOT COMPLETED|24-weeks Dose-blind Period||7
2446283|NCT01087788|6000625|P3|COMPLETED|24-weeks Dose-blind Period||114
2446284|NCT01087788|6000626|P2|COMPLETED|24-weeks Dose-blind Period||123
2446285|NCT01087788|6000627|P1|COMPLETED|24-weeks Dose-blind Period||113
2446286|NCT01087788|6000625|P3|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
2446287|NCT01087788|6000626|P2|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
2446288|NCT01087788|6000627|P1|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 400mg Q2W at week 16 (29 subjects) and at week 24 (31 subjects)|60
2446289|NCT01087788|6000625|P3|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
2446290|NCT01087788|6000626|P2|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
2446291|NCT01087788|6000627|P1|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 200mg Q2W at week 16 (30 subjects) and at week 24 (30 subjects)|60
2446292|NCT01087788|6000625|P3|STARTED|24-weeks Dose-blind Period||120
2446293|NCT01087788|6000626|P2|STARTED|24-weeks Dose-blind Period||128
2446294|NCT01087788|6000627|P1|STARTED|24-weeks Dose-blind Period||120
2446295|NCT01087788|6000625|P3|NOT COMPLETED|24-weeks Double-blind Period||15
2446296|NCT01087788|6000626|P2|NOT COMPLETED|24-weeks Double-blind Period||10
2446297|NCT01087788|6000627|P1|NOT COMPLETED|24-weeks Double-blind Period||16
2446298|NCT01087788|6000625|P3|COMPLETED|24-weeks Double-blind Period||120
2446299|NCT01087788|6000626|P2|COMPLETED|24-weeks Double-blind Period||128
2446300|NCT01087788|6000627|P1|COMPLETED|24-weeks Double-blind Period||120
2446301|NCT01087788|6000625|P3|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
2446302|NCT01087788|6000626|P2|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
2446303|NCT01087788|6000627|P1|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|29 subjects left the Placebo group and were re-randomized to CZP 400 mg Q4W on Week 16.|29
2446304|NCT01087788|6000625|P3|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
2446305|NCT01087788|6000626|P2|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
2446306|NCT01087788|6000627|P1|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|30 subjects left the Placebo group and were re-randomized to CZP 200 mg Q2W on Week 16.|30
2446307|NCT01087788|6000625|P3|STARTED|24-weeks Double-blind Period||135
2446308|NCT01087788|6000626|P2|STARTED|24-weeks Double-blind Period||138
2446309|NCT01087788|6000627|P1|STARTED|24-weeks Double-blind Period||136
2446310|NCT01087775|6000654|P1|NOT COMPLETED|Overall Study||2
2446311|NCT01087775|6000654|P1|COMPLETED|Overall Study|2 subjects were found to be ineligible for the study|23
2446312|NCT01087775|6000654|P1|STARTED|Overall Study||25
2446313|NCT01087762|6000662|P5|NOT COMPLETED|Open-Label Period (Weeks 48-204)||57
2446314|NCT01087762|6000663|P4|NOT COMPLETED|Open-Label Period (Weeks 48-204)||59
2446315|NCT01087762|6000664|P3|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
2446316|NCT01087762|6000665|P2|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
2446317|NCT01087762|6000666|P1|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
2446318|NCT01087762|6000662|P5|COMPLETED|Open-Label Period (Weeks 48-204)||100
2446319|NCT01087762|6000663|P4|COMPLETED|Open-Label Period (Weeks 48-204)||99
2446320|NCT01087762|6000664|P3|COMPLETED|Open-Label Period (Weeks 48-204)||0
2446321|NCT01087762|6000665|P2|COMPLETED|Open-Label Period (Weeks 48-204)||0
2446322|NCT01087762|6000666|P1|COMPLETED|Open-Label Period (Weeks 48-204)||0
2446323|NCT01087762|6000662|P5|STARTED|Open-Label Period (Weeks 48-204)||157
2446324|NCT01087762|6000663|P4|STARTED|Open-Label Period (Weeks 48-204)||158
2446325|NCT01087762|6000664|P3|STARTED|Open-Label Period (Weeks 48-204)||0
2446326|NCT01087762|6000665|P2|STARTED|Open-Label Period (Weeks 48-204)||0
2446327|NCT01087762|6000666|P1|STARTED|Open-Label Period (Weeks 48-204)||0
2446328|NCT01087762|6000662|P5|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
2446329|NCT01087762|6000663|P4|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
2446330|NCT01087762|6000664|P3|NOT COMPLETED|Double Blind Period (Weeks 0-24)||9
2446331|NCT01087762|6000665|P2|NOT COMPLETED|Double Blind Period (Weeks 0-24)||6
2446332|NCT01087762|6000666|P1|NOT COMPLETED|Double Blind Period (Weeks 0-24)||12
2446333|NCT01087762|6000662|P5|COMPLETED|Double Blind Period (Weeks 0-24)||0
2446334|NCT01087762|6000663|P4|COMPLETED|Double Blind Period (Weeks 0-24)||0
2446335|NCT01087762|6000664|P3|COMPLETED|Double Blind Period (Weeks 0-24)||98
2446336|NCT01087762|6000665|P2|COMPLETED|Double Blind Period (Weeks 0-24)||105
2446337|NCT01087762|6000666|P1|COMPLETED|Double Blind Period (Weeks 0-24)||95
2446338|NCT01087762|6000662|P5|STARTED|Double Blind Period (Weeks 0-24)||0
2446339|NCT01087762|6000663|P4|STARTED|Double Blind Period (Weeks 0-24)||0
2446340|NCT01087762|6000664|P3|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
2446341|NCT01087762|6000665|P2|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|111
2446342|NCT01087762|6000666|P1|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
2446343|NCT01087736|6000714|P2|NOT COMPLETED|Overall Study||2
2446344|NCT01087736|6000715|P1|NOT COMPLETED|Overall Study||1
2446345|NCT01087736|6000714|P2|COMPLETED|Overall Study||14
2446346|NCT01087736|6000715|P1|COMPLETED|Overall Study||13
2446347|NCT01087736|6000714|P2|STARTED|Overall Study||16
2446348|NCT01087736|6000715|P1|STARTED|Overall Study||14
2446349|NCT01087723|6000725|P2|NOT COMPLETED|Overall Study||20
2446350|NCT01087723|6000726|P1|NOT COMPLETED|Overall Study||14
2446351|NCT01087723|6000725|P2|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1089
2446352|NCT01087723|6000726|P1|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1075
2446353|NCT01087723|6000725|P2|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1094
2446354|NCT01087723|6000726|P1|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1099
2446355|NCT01087723|6000725|P2|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1109
2446356|NCT01087723|6000726|P1|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1089
2446357|NCT01087541|6000750|P2|NOT COMPLETED|Overall Study||0
2446358|NCT01087541|6000751|P1|NOT COMPLETED|Overall Study||0
2446359|NCT01087541|6000750|P2|COMPLETED|Overall Study||3523
2446360|NCT01087541|6000751|P1|COMPLETED|Overall Study||3307
2446361|NCT01087541|6000750|P2|STARTED|Overall Study||3523
2446362|NCT01087541|6000751|P1|STARTED|Overall Study||3307
2446363|NCT01087528|6000767|P1|NOT COMPLETED|Overall Study||7
2446364|NCT01087528|6000767|P1|COMPLETED|Overall Study|withdrawn from the study prior to any procedure|44
2446365|NCT01087528|6000767|P1|STARTED|Overall Study||51
2446366|NCT01087502|6000773|P2|NOT COMPLETED|Up to Final Analysis (Week 52)||23
2446367|NCT01087502|6000774|P1|NOT COMPLETED|Up to Final Analysis (Week 52)||33
2446368|NCT01087502|6000773|P2|COMPLETED|Up to Final Analysis (Week 52)||95
2446369|NCT01087502|6000774|P1|COMPLETED|Up to Final Analysis (Week 52)||90
2446370|NCT01087502|6000773|P2|STARTED|Up to Final Analysis (Week 52)||118
2446371|NCT01087502|6000774|P1|STARTED|Up to Final Analysis (Week 52)||123
2446372|NCT01087502|6000773|P2|NOT COMPLETED|Up to Interim Analysis (Week 12)||8
2446373|NCT01087502|6000774|P1|NOT COMPLETED|Up to Interim Analysis (Week 12)||9
2446374|NCT01087502|6000773|P2|COMPLETED|Up to Interim Analysis (Week 12)||110
2446375|NCT01087502|6000774|P1|COMPLETED|Up to Interim Analysis (Week 12)||114
2446376|NCT01087502|6000773|P2|STARTED|Up to Interim Analysis (Week 12)||118
2446377|NCT01087502|6000774|P1|STARTED|Up to Interim Analysis (Week 12)||123
2446378|NCT01087489|6000793|P2|NOT COMPLETED|Overall Study||3
2446379|NCT01087489|6000794|P1|NOT COMPLETED|Overall Study||0
2446380|NCT01087489|6000793|P2|COMPLETED|Overall Study||31
2446381|NCT01087489|6000794|P1|COMPLETED|Overall Study||19
2446382|NCT01087489|6000793|P2|STARTED|Overall Study||34
2446383|NCT01087489|6000794|P1|STARTED|Overall Study||19
2446384|NCT01086969|6000807|P3|NOT COMPLETED|Overall Study||0
2446385|NCT01086969|6000808|P2|NOT COMPLETED|Overall Study||2
2446386|NCT01086969|6000809|P1|NOT COMPLETED|Overall Study||1
2446387|NCT01086969|6000807|P3|COMPLETED|Overall Study||100
2446388|NCT01086969|6000808|P2|COMPLETED|Overall Study||98
2446389|NCT01086969|6000809|P1|COMPLETED|Overall Study||99
2446390|NCT01086969|6000807|P3|STARTED|Overall Study||100
2446391|NCT01086969|6000808|P2|STARTED|Overall Study||100
2446392|NCT01086969|6000809|P1|STARTED|Overall Study||100
2446393|NCT01086852|6000826|P1|NOT COMPLETED|Overall Study||0
2446394|NCT01086852|6000826|P1|COMPLETED|Overall Study||4
2446395|NCT01086852|6000826|P1|STARTED|Overall Study||4
2446396|NCT01086761|6000842|P6|NOT COMPLETED|Overall Study||0
2446397|NCT01086761|6000843|P5|NOT COMPLETED|Overall Study||0
2446398|NCT01086761|6000844|P4|NOT COMPLETED|Overall Study||0
2446399|NCT01086761|6000845|P3|NOT COMPLETED|Overall Study||0
2446400|NCT01086761|6000846|P2|NOT COMPLETED|Overall Study||0
2446401|NCT01086761|6000847|P1|NOT COMPLETED|Overall Study||0
2446402|NCT01086761|6000842|P6|COMPLETED|Overall Study||0
2446403|NCT01086761|6000843|P5|COMPLETED|Overall Study||4
2446404|NCT01086761|6000844|P4|COMPLETED|Overall Study||6
2446405|NCT01086761|6000845|P3|COMPLETED|Overall Study||6
2446406|NCT01086761|6000846|P2|COMPLETED|Overall Study||7
2446407|NCT01086761|6000847|P1|COMPLETED|Overall Study||9
2446408|NCT01086761|6000842|P6|STARTED|Overall Study||0
2446409|NCT01086761|6000843|P5|STARTED|Overall Study||4
2446410|NCT01086761|6000844|P4|STARTED|Overall Study||6
2446411|NCT01086761|6000845|P3|STARTED|Overall Study||6
2446412|NCT01086761|6000846|P2|STARTED|Overall Study||7
2446413|NCT01086761|6000847|P1|STARTED|Overall Study||9
2446414|NCT01086605|6000887|P2|NOT COMPLETED|Overall Study||0
2446415|NCT01086605|6000888|P1|NOT COMPLETED|Overall Study||0
2446416|NCT01086605|6000887|P2|COMPLETED|Overall Study||22
2446417|NCT01086605|6000888|P1|COMPLETED|Overall Study||24
2446418|NCT01086605|6000887|P2|STARTED|Overall Study||22
2446419|NCT01086605|6000888|P1|STARTED|Overall Study||24
2446420|NCT01086475|6000905|P2|NOT COMPLETED|Overall Study||0
2446421|NCT01086475|6000906|P1|NOT COMPLETED|Overall Study||0
2446422|NCT01086475|6000905|P2|COMPLETED|Overall Study||33
2446423|NCT01086475|6000906|P1|COMPLETED|Overall Study||34
2446424|NCT01086475|6000905|P2|STARTED|Overall Study||33
2446425|NCT01086475|6000906|P1|STARTED|Overall Study||34
2446426|NCT01086423|6000919|P3|NOT COMPLETED|Overall Study||9
2446427|NCT01086423|6000920|P2|NOT COMPLETED|Overall Study||3
2446428|NCT01086423|6000921|P1|NOT COMPLETED|Overall Study||10
2446429|NCT01086423|6000919|P3|COMPLETED|Overall Study||321
2446430|NCT01086423|6000920|P2|COMPLETED|Overall Study||321
2446431|NCT01086423|6000921|P1|COMPLETED|Overall Study||320
2446432|NCT01086423|6000919|P3|STARTED|Overall Study||330
2446433|NCT01086423|6000920|P2|STARTED|Overall Study||324
2446434|NCT01086423|6000921|P1|STARTED|Overall Study||330
2446435|NCT01086410|6000966|P4|NOT COMPLETED|Overall Study||2
2446436|NCT01086410|6000967|P3|NOT COMPLETED|Overall Study||1
2446437|NCT01086410|6000968|P2|NOT COMPLETED|Overall Study||2
2446438|NCT01086410|6000969|P1|NOT COMPLETED|Overall Study||3
2446439|NCT01086410|6000966|P4|COMPLETED|Overall Study||13
2446440|NCT01086410|6000967|P3|COMPLETED|Overall Study||55
2446441|NCT01086410|6000968|P2|COMPLETED|Overall Study||54
2446442|NCT01086410|6000969|P1|COMPLETED|Overall Study||55
2446443|NCT01086410|6000966|P4|STARTED|Overall Study||15
2446444|NCT01086410|6000967|P3|STARTED|Overall Study||56
2446445|NCT01086410|6000968|P2|STARTED|Overall Study||56
2446446|NCT01086410|6000969|P1|STARTED|Overall Study||58
2446447|NCT01086384|6001065|P3|NOT COMPLETED|Treatment Period||124
2446448|NCT01086384|6001066|P2|NOT COMPLETED|Treatment Period||148
2446449|NCT01086384|6001067|P1|NOT COMPLETED|Treatment Period||0
2446450|NCT01086384|6001065|P3|COMPLETED|Treatment Period||885
2446451|NCT01086384|6001066|P2|COMPLETED|Treatment Period||863
2446452|NCT01086384|6001067|P1|COMPLETED|Treatment Period||0
2446453|NCT01086384|6001065|P3|STARTED|Treatment Period||1009
2446454|NCT01086384|6001066|P2|STARTED|Treatment Period||1011
2446455|NCT01086384|6001067|P1|STARTED|Treatment Period||0
2446456|NCT01086384|6001065|P3|NOT COMPLETED|2-week Run-in Period||0
2446457|NCT01086384|6001066|P2|NOT COMPLETED|2-week Run-in Period||0
2446458|NCT01086384|6001067|P1|NOT COMPLETED|2-week Run-in Period||163
2446459|NCT01086384|6001065|P3|COMPLETED|2-week Run-in Period||0
2446460|NCT01086384|6001066|P2|COMPLETED|2-week Run-in Period||0
2446461|NCT01086384|6001067|P1|COMPLETED|2-week Run-in Period||2020
2446462|NCT01086384|6001065|P3|STARTED|2-week Run-in Period||0
2446463|NCT01086384|6001066|P2|STARTED|2-week Run-in Period||0
2446464|NCT01086384|6001067|P1|STARTED|2-week Run-in Period||2183
2446465|NCT01086358|6001077|P2|NOT COMPLETED|Second Intervention||4
2446466|NCT01086358|6001078|P1|NOT COMPLETED|Second Intervention||4
2446467|NCT01086358|6001077|P2|COMPLETED|Second Intervention||20
2446468|NCT01086358|6001078|P1|COMPLETED|Second Intervention||17
2446469|NCT01086358|6001077|P2|STARTED|Second Intervention||24
2446470|NCT01086358|6001078|P1|STARTED|Second Intervention||21
2446471|NCT01086358|6001077|P2|NOT COMPLETED|First Intervention||5
2446472|NCT01086358|6001078|P1|NOT COMPLETED|First Intervention||9
2446473|NCT01086358|6001077|P2|COMPLETED|First Intervention||24
2446474|NCT01086358|6001078|P1|COMPLETED|First Intervention||21
2446475|NCT01086358|6001077|P2|STARTED|First Intervention|30 subjects enrolled, 1 withdrew before randomization|29
2446476|NCT01086358|6001078|P1|STARTED|First Intervention|30 subjects enrolled.|30
2446477|NCT01086228|6001090|P1|NOT COMPLETED|5-year Follow-up||652
2446478|NCT01086228|6001090|P1|COMPLETED|5-year Follow-up||1012
2446479|NCT01086228|6001090|P1|STARTED|5-year Follow-up||1664
2446480|NCT01086228|6001090|P1|NOT COMPLETED|4-year Follow-up||103
2446481|NCT01086228|6001090|P1|COMPLETED|4-year Follow-up||1664
2446482|NCT01086228|6001090|P1|STARTED|4-year Follow-up||1767
2446483|NCT01086228|6001090|P1|NOT COMPLETED|3-year Follow-up||67
2446484|NCT01086228|6001090|P1|COMPLETED|3-year Follow-up||1767
2446485|NCT01086228|6001090|P1|STARTED|3-year Follow-up||1834
2446486|NCT01086228|6001090|P1|NOT COMPLETED|2-year Follow-up||60
2446487|NCT01086228|6001090|P1|COMPLETED|2-year Follow-up||1834
2446488|NCT01086228|6001090|P1|STARTED|2-year Follow-up||1894
2446489|NCT01086228|6001090|P1|NOT COMPLETED|1-year Follow-up||44
2446490|NCT01086228|6001090|P1|COMPLETED|1-year Follow-up||1894
2446491|NCT01086228|6001090|P1|STARTED|1-year Follow-up||1938
2446492|NCT01086228|6001090|P1|NOT COMPLETED|8 Month Follow-up||71
2446493|NCT01086228|6001090|P1|COMPLETED|8 Month Follow-up||1938
2446494|NCT01086228|6001090|P1|STARTED|8 Month Follow-up|Analysis population|2009
2446495|NCT01086215|6001148|P4|NOT COMPLETED|Overall Study||3
2446496|NCT01086215|6001149|P3|NOT COMPLETED|Overall Study||26
2446497|NCT01086215|6001150|P2|NOT COMPLETED|Overall Study||47
2446498|NCT01086215|6001151|P1|NOT COMPLETED|Overall Study||36
2446499|NCT01086215|6001148|P4|COMPLETED|Overall Study||11
2446500|NCT01086215|6001149|P3|COMPLETED|Overall Study||47
2446501|NCT01086215|6001150|P2|COMPLETED|Overall Study||154
2446502|NCT01086215|6001151|P1|COMPLETED|Overall Study||176
2446503|NCT01086215|6001148|P4|12 Month Follow Up|Overall Study|0 LTF; 1 Death|11
2446504|NCT01086215|6001149|P3|12 Month Follow Up|Overall Study|9 LTF; 4 Deaths|47
2446505|NCT01086215|6001150|P2|12 Month Follow Up|Overall Study|16 LTF; 2 Deaths|154
2446506|NCT01086215|6001151|P1|12 Month Follow Up|Overall Study|10 LTF; 6 Deaths|176
2446507|NCT01086215|6001148|P4|6 Month Follow Up|Overall Study|1 LTF; 0 Deaths|12
2446508|NCT01086215|6001149|P3|6 Month Follow Up|Overall Study|4 LTF; 0 Deaths|60
2446509|NCT01086215|6001150|P2|6 Month Follow Up|Overall Study|13 LTF; 2 Deaths|172
2446510|NCT01086215|6001151|P1|6 Month Follow Up|Overall Study|5 LTF; 4 Deaths|192
2446511|NCT01086215|6001148|P4|3 Month Follow Up|Overall Study|1 LTF; 0 Deaths|13
2446512|NCT01086215|6001149|P3|3 Month Follow Up|Overall Study|5 LTF; 4 Deaths|64
2446513|NCT01086215|6001150|P2|3 Month Follow Up|Overall Study|10 LTF; 4 Deaths|187
2446514|NCT01086215|6001151|P1|3 Month Follow Up|Overall Study|7 LTF; 4 Deaths|201
2446515|NCT01086215|6001148|P4|STARTED|Overall Study||14
2446516|NCT01086215|6001149|P3|STARTED|Overall Study||73
2446517|NCT01086215|6001150|P2|STARTED|Overall Study||201
2446518|NCT01086215|6001151|P1|STARTED|Overall Study||212
2446519|NCT01086033|6001169|P1|NOT COMPLETED|Overall Study||304
2446520|NCT01086033|6001169|P1|COMPLETED|Overall Study||262
2446521|NCT01086033|6001169|P1|STARTED|Overall Study||566
2446522|NCT01085968|6001183|P2|NOT COMPLETED|Overall Study||4
2446523|NCT01085968|6001184|P1|NOT COMPLETED|Overall Study||10
2446524|NCT01085968|6001183|P2|COMPLETED|Overall Study||21
2446525|NCT01085968|6001184|P1|COMPLETED|Overall Study||19
2446526|NCT01085968|6001183|P2|STARTED|Overall Study||25
2446527|NCT01085968|6001184|P1|STARTED|Overall Study||29
2446528|NCT01085903|6001200|P3|NOT COMPLETED|Overall Study||0
2446529|NCT01085903|6001201|P2|NOT COMPLETED|Overall Study||0
2446530|NCT01085903|6001202|P1|NOT COMPLETED|Overall Study||0
2446531|NCT01085903|6001200|P3|COMPLETED|Overall Study||3
2446532|NCT01085903|6001201|P2|COMPLETED|Overall Study||4
2446533|NCT01085903|6001202|P1|COMPLETED|Overall Study||21
2446534|NCT01085903|6001200|P3|STARTED|Overall Study||3
2446535|NCT01085903|6001201|P2|STARTED|Overall Study||4
2446536|NCT01085903|6001202|P1|STARTED|Overall Study||21
2446537|NCT01085825|6001228|P2|NOT COMPLETED|Overall Study||1
2446538|NCT01085825|6001229|P1|NOT COMPLETED|Overall Study||1
2446539|NCT01085825|6001228|P2|COMPLETED|Overall Study||247
2446540|NCT01085825|6001229|P1|COMPLETED|Overall Study||251
2446541|NCT01085825|6001228|P2|STARTED|Overall Study||248
2446542|NCT01085825|6001229|P1|STARTED|Overall Study|1st participant enrolled|252
2446543|NCT01085812|6001235|P2|NOT COMPLETED|Double-blind Intent-to-treat Population||56
2446544|NCT01085812|6001236|P1|NOT COMPLETED|Double-blind Intent-to-treat Population||20
2446545|NCT01085812|6001235|P2|COMPLETED|Double-blind Intent-to-treat Population||174
2446546|NCT01085812|6001236|P1|COMPLETED|Double-blind Intent-to-treat Population||92
2446547|NCT01085812|6001235|P2|STARTED|Double-blind Intent-to-treat Population||230
2446548|NCT01085812|6001236|P1|STARTED|Double-blind Intent-to-treat Population||112
2446549|NCT01085812|6001235|P2|NOT COMPLETED|Double-Blind Period||58
2446550|NCT01085812|6001236|P1|NOT COMPLETED|Double-Blind Period||21
2446551|NCT01085812|6001235|P2|COMPLETED|Double-Blind Period||177
2446552|NCT01085812|6001236|P1|COMPLETED|Double-Blind Period||92
2446553|NCT01085812|6001235|P2|STARTED|Double-Blind Period||235
2446554|NCT01085812|6001236|P1|STARTED|Double-Blind Period||113
2446555|NCT01085812|6001235|P2|NOT COMPLETED|Open-Label Period||240
2446556|NCT01085812|6001236|P1|NOT COMPLETED|Open-Label Period||0
2446557|NCT01085812|6001235|P2|COMPLETED|Open-Label Period||494
2446558|NCT01085812|6001236|P1|COMPLETED|Open-Label Period||0
2446559|NCT01085812|6001235|P2|STARTED|Open-Label Period||734
2446560|NCT01085812|6001236|P1|STARTED|Open-Label Period||0
2446561|NCT01085786|6001245|P2|NOT COMPLETED|Overall Study||0
2446562|NCT01085786|6001246|P1|NOT COMPLETED|Overall Study||0
2446563|NCT01085786|6001245|P2|COMPLETED|Overall Study||117
2446564|NCT01085786|6001246|P1|COMPLETED|Overall Study||123
2446565|NCT01085786|6001245|P2|STARTED|Overall Study||117
2446566|NCT01085786|6001246|P1|STARTED|Overall Study||123
2446567|NCT01085760|6001256|P4|NOT COMPLETED|Overall Study||3
2446568|NCT01085760|6001257|P3|NOT COMPLETED|Overall Study||2
2446569|NCT01085760|6001258|P2|NOT COMPLETED|Overall Study||1
2446570|NCT01085760|6001259|P1|NOT COMPLETED|Overall Study||1
2446571|NCT01085760|6001256|P4|COMPLETED|Overall Study||6
2446572|NCT01085760|6001257|P3|COMPLETED|Overall Study||7
2446573|NCT01085760|6001258|P2|COMPLETED|Overall Study||8
2446574|NCT01085760|6001259|P1|COMPLETED|Overall Study||7
2446575|NCT01085760|6001256|P4|STARTED|Overall Study||9
2446576|NCT01085760|6001257|P3|STARTED|Overall Study||9
2446577|NCT01085760|6001258|P2|STARTED|Overall Study||9
2446578|NCT01085760|6001259|P1|STARTED|Overall Study||8
2446579|NCT01085734|6001283|P2|NOT COMPLETED|Overall Study||4
2446580|NCT01085734|6001284|P1|NOT COMPLETED|Overall Study||1
2446581|NCT01085734|6001283|P2|COMPLETED|Overall Study||11
2446582|NCT01085734|6001284|P1|COMPLETED|Overall Study||14
2446583|NCT01085734|6001283|P2|STARTED|Overall Study||15
2446584|NCT01085734|6001284|P1|STARTED|Overall Study||15
2446585|NCT01085682|6001296|P2|NOT COMPLETED|Overall Study||25
2446586|NCT01085682|6001297|P1|NOT COMPLETED|Overall Study||25
2446587|NCT01085682|6001296|P2|COMPLETED|Overall Study||3
2446588|NCT01085682|6001297|P1|COMPLETED|Overall Study||6
2446589|NCT01085682|6001296|P2|STARTED|Overall Study||28
2446590|NCT01085682|6001297|P1|STARTED|Overall Study||31
2446591|NCT01085643|6001303|P1|NOT COMPLETED|Overall Study||0
2446592|NCT01085643|6001303|P1|COMPLETED|Overall Study||4
2446593|NCT01085643|6001303|P1|STARTED|Overall Study||4
2446594|NCT01085630|6001314|P2|NOT COMPLETED|Overall Study||0
2446595|NCT01085630|6001315|P1|NOT COMPLETED|Overall Study||4
2446596|NCT01085630|6001314|P2|COMPLETED|Overall Study||27
2446597|NCT01085630|6001315|P1|COMPLETED|Overall Study||22
2446598|NCT01085630|6001314|P2|STARTED|Overall Study||27
2446599|NCT01085630|6001315|P1|STARTED|Overall Study||26
2446600|NCT01085591|6001328|P3|NOT COMPLETED|Overall Study||7
2446601|NCT01085591|6001329|P2|NOT COMPLETED|Overall Study||6
2446602|NCT01085591|6001330|P1|NOT COMPLETED|Overall Study||3
2446603|NCT01085591|6001328|P3|COMPLETED|Overall Study||63
2446604|NCT01085591|6001329|P2|COMPLETED|Overall Study||65
2446605|NCT01085591|6001330|P1|COMPLETED|Overall Study||66
2446606|NCT01085591|6001328|P3|Received at Least 1 Dose of Study Drug|Overall Study||70
2446607|NCT01085591|6001329|P2|Received at Least 1 Dose of Study Drug|Overall Study||69
2446608|NCT01085591|6001330|P1|Received at Least 1 Dose of Study Drug|Overall Study||68
2446609|NCT01085591|6001328|P3|STARTED|Overall Study||70
2446610|NCT01085591|6001329|P2|STARTED|Overall Study||71
2446611|NCT01085591|6001330|P1|STARTED|Overall Study||69
2446612|NCT01085539|6001353|P1|NOT COMPLETED|100Sat Secs-100 Second Alarm Evaluation||0
2446613|NCT01085539|6001353|P1|COMPLETED|100Sat Secs-100 Second Alarm Evaluation||50
2446614|NCT01085539|6001353|P1|STARTED|100Sat Secs-100 Second Alarm Evaluation||50
2446615|NCT01085539|6001353|P1|NOT COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||0
2446616|NCT01085539|6001353|P1|COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||50
2446617|NCT01085539|6001353|P1|STARTED|50 Sat Secs--50 Second Alarm Evaluation||50
2446618|NCT01085539|6001353|P1|NOT COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||0
2446619|NCT01085539|6001353|P1|COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||50
2446620|NCT01085539|6001353|P1|STARTED|25 Sat Secs--25 Second Alarm Evaluation||50
2446621|NCT01085539|6001353|P1|NOT COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||0
2446622|NCT01085539|6001353|P1|COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||50
2446623|NCT01085539|6001353|P1|STARTED|10 Sat Secs--10 Second Alarm Evaluation||50
2446624|NCT01085539|6001353|P1|NOT COMPLETED|Sat Secs Off--No Alarm Evaluation||0
2446625|NCT01085539|6001353|P1|COMPLETED|Sat Secs Off--No Alarm Evaluation||50
2446626|NCT01085539|6001353|P1|STARTED|Sat Secs Off--No Alarm Evaluation||50
2446627|NCT01085513|6001359|P2|NOT COMPLETED|Overall Study||0
2446628|NCT01085513|6001360|P1|NOT COMPLETED|Overall Study||0
2446629|NCT01085513|6001359|P2|COMPLETED|Overall Study||68
2446630|NCT01085513|6001360|P1|COMPLETED|Overall Study|recruitment was premature terminated|75
2446631|NCT01085513|6001359|P2|STARTED|Overall Study||68
2446632|NCT01085513|6001360|P1|STARTED|Overall Study||75
2446633|NCT01085500|6001368|P2|NOT COMPLETED|Overall Study||0
2446634|NCT01085500|6001369|P1|NOT COMPLETED|Overall Study||0
2446635|NCT01085500|6001368|P2|COMPLETED|Overall Study||24
2446636|NCT01085500|6001369|P1|COMPLETED|Overall Study||26
2446637|NCT01085500|6001368|P2|STARTED|Overall Study||24
2446638|NCT01085500|6001369|P1|STARTED|Overall Study||26
2446639|NCT01085357|6001381|P2|NOT COMPLETED|Overall Study||6
2446640|NCT01085357|6001382|P1|NOT COMPLETED|Overall Study||19
2446641|NCT01085357|6001381|P2|COMPLETED|Overall Study||125
2446642|NCT01085357|6001382|P1|COMPLETED|Overall Study||355
2446643|NCT01085357|6001381|P2|STARTED|Overall Study||131
2446644|NCT01085357|6001382|P1|STARTED|Overall Study||374
2446645|NCT01085344|6001392|P1|NOT COMPLETED|Overall Study||6
2446646|NCT01085344|6001392|P1|COMPLETED|Overall Study||50
2446647|NCT01085344|6001392|P1|STARTED|Overall Study||56
2446648|NCT01085331|6001404|P2|NOT COMPLETED|Overall Study||0
2446649|NCT01085331|6001405|P1|NOT COMPLETED|Overall Study||0
2446650|NCT01085331|6001404|P2|COMPLETED|Overall Study||6
2446651|NCT01085331|6001405|P1|COMPLETED|Overall Study||10
2446652|NCT01085331|6001404|P2|STARTED|Overall Study||6
2446653|NCT01085331|6001405|P1|STARTED|Overall Study||10
2446654|NCT01085318|6001444|P2|NOT COMPLETED|Overall Study||0
2446655|NCT01085318|6001445|P1|NOT COMPLETED|Overall Study||2
2446656|NCT01085318|6001444|P2|COMPLETED|Overall Study||15
2446657|NCT01085318|6001445|P1|COMPLETED|Overall Study||21
2446658|NCT01085318|6001444|P2|STARTED|Overall Study||15
2446659|NCT01085318|6001445|P1|STARTED|Overall Study||23
2446660|NCT01085214|6001455|P1|NOT COMPLETED|Overall Study||1
2446661|NCT01085214|6001455|P1|COMPLETED|Overall Study||36
2446662|NCT01085214|6001455|P1|STARTED|Overall Study||37
2446663|NCT01085201|6001467|P5|NOT COMPLETED|Overall Study||0
2446664|NCT01085201|6001468|P4|NOT COMPLETED|Overall Study||0
2446665|NCT01085201|6001469|P3|NOT COMPLETED|Overall Study||2
2446666|NCT01085201|6001470|P2|NOT COMPLETED|Overall Study||1
2446667|NCT01085201|6001471|P1|NOT COMPLETED|Overall Study||3
2446668|NCT01085201|6001467|P5|COMPLETED|Overall Study||3
2446669|NCT01085201|6001468|P4|COMPLETED|Overall Study||6
2446670|NCT01085201|6001469|P3|COMPLETED|Overall Study||3
2446671|NCT01085201|6001470|P2|COMPLETED|Overall Study||6
2446672|NCT01085201|6001471|P1|COMPLETED|Overall Study||15
2446673|NCT01085201|6001467|P5|STARTED|Overall Study||3
2446674|NCT01085201|6001468|P4|STARTED|Overall Study||6
2446675|NCT01085201|6001469|P3|STARTED|Overall Study||5
2446676|NCT01085201|6001470|P2|STARTED|Overall Study||7
2446677|NCT01085201|6001471|P1|STARTED|Overall Study||18
2446678|NCT01085136|6001493|P3|NOT COMPLETED|Part B||26
2446679|NCT01085136|6001494|P2|NOT COMPLETED|Part B||51
2446680|NCT01085136|6001495|P1|NOT COMPLETED|Part B||0
2446681|NCT01085136|6001493|P3|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|42
2446682|NCT01085136|6001494|P2|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|87
2446683|NCT01085136|6001495|P1|COMPLETED|Part B|Afatinib monotherapy not administered in Part B|0
2446684|NCT01085136|6001493|P3|STARTED|Part B||68
2446685|NCT01085136|6001494|P2|STARTED|Part B||138
2446686|NCT01085136|6001495|P1|STARTED|Part B|Afatinib monotherapy not administered in Part B|0
2446687|NCT01085136|6001493|P3|NOT COMPLETED|Part A||0
2446688|NCT01085136|6001494|P2|NOT COMPLETED|Part A||0
2446689|NCT01085136|6001495|P1|NOT COMPLETED|Part A||323
2446690|NCT01085136|6001493|P3|COMPLETED|Part A||0
2446691|NCT01085136|6001494|P2|COMPLETED|Part A||0
2446692|NCT01085136|6001495|P1|COMPLETED|Part A|Randomized to Part B & completed trial as per protocol, had PD, clinical progression.|831
2446693|NCT01085136|6001493|P3|Randomized to Part B|Part A||0
2446694|NCT01085136|6001494|P2|Randomized to Part B|Part A||0
2446695|NCT01085136|6001495|P1|Randomized to Part B|Part A|Discontinued Part A -Randomized to Part B|206
2446696|NCT01085136|6001493|P3|STARTED|Part A||0
2446697|NCT01085136|6001494|P2|STARTED|Part A|Only Afatinib monotherapy administered in Part A|0
2446698|NCT01085136|6001495|P1|STARTED|Part A||1154
2446699|NCT01085045|6001511|P1|NOT COMPLETED|Part B||15
2446700|NCT01085045|6001511|P1|COMPLETED|Part B||89
2446701|NCT01085045|6001511|P1|GP MDI 36 µg (PT001)|Part B||0
2446702|NCT01085045|6001511|P1|Foradil 12 µg|Part B||41
2446703|NCT01085045|6001511|P1|Placebo MDI|Part B||47
2446704|NCT01085045|6001511|P1|FF MDI 7.2 µg (PT005)|Part B||43
2446705|NCT01085045|6001511|P1|FF MDI 9.6 µg (PT005)|Part B||43
2446706|NCT01085045|6001511|P1|Spiriva 18 µg|Part B||0
2446707|NCT01085045|6001511|P1|GFF MDI 36/9.6 µg|Part B||0
2446708|NCT01085045|6001511|P1|GFF MDI 72/9.6mcg (PT003)|Part B||0
2446709|NCT01085045|6001511|P1|STARTED|Part B||104
2446710|NCT01085045|6001511|P1|NOT COMPLETED|Part A||18
2446711|NCT01085045|6001511|P1|COMPLETED|Part A||104
2446712|NCT01085045|6001511|P1|Foradil 12 µg|Part A||14
2446713|NCT01085045|6001511|P1|Placebo MDI|Part A||5
2446714|NCT01085045|6001511|P1|FF MDI 7.2 µg (PT005)|Part A||21
2446715|NCT01085045|6001511|P1|FF MDI 9.6 µg (PT005)|Part A||20
2446716|NCT01085045|6001511|P1|Spiriva 18 µg|Part A||58
2446717|NCT01085045|6001511|P1|GP MDI 36 µg (PT001)|Part A||40
2446718|NCT01085045|6001511|P1|GFF MDI 36/9.6 µg (PT003)|Part A||42
2446719|NCT01085045|6001511|P1|GFF MDI 72/9.6mcg|Part A||40
2446720|NCT01085045|6001511|P1|STARTED|Part A||122
2446721|NCT01085006|6001613|P2|NOT COMPLETED|Overall Study||0
2446722|NCT01085006|6001614|P1|NOT COMPLETED|Overall Study||0
2446723|NCT01085006|6001613|P2|COMPLETED|Overall Study||50
2446724|NCT01085006|6001614|P1|COMPLETED|Overall Study||50
2446725|NCT01085006|6001613|P2|STARTED|Overall Study||50
2446726|NCT01085006|6001614|P1|STARTED|Overall Study||50
2446727|NCT01084759|6001620|P1|NOT COMPLETED|Overall Study||2
2446728|NCT01084759|6001620|P1|COMPLETED|Overall Study||14
2446729|NCT01084759|6001620|P1|STARTED|Overall Study||16
2446730|NCT01084707|6001626|P1|NOT COMPLETED|Overall Study||6
2446731|NCT01084707|6001626|P1|COMPLETED|Overall Study||34
2446732|NCT01084707|6001626|P1|STARTED|Overall Study||40
2446733|NCT01084694|6001662|P2|NOT COMPLETED|Overall Study||20
2446734|NCT01084694|6001663|P1|NOT COMPLETED|Overall Study||6
2446735|NCT01084694|6001662|P2|COMPLETED|Overall Study||30
2446736|NCT01084694|6001663|P1|COMPLETED|Overall Study||44
2446737|NCT01084694|6001662|P2|STARTED|Overall Study||50
2446738|NCT01084694|6001663|P1|STARTED|Overall Study||50
2446739|NCT01084668|6001679|P1|NOT COMPLETED|Overall Study||9
2446740|NCT01084668|6001679|P1|COMPLETED|Overall Study||33
2446741|NCT01084668|6001679|P1|STARTED|Overall Study|Three participants who took Humira prior to study entry have been excluded from the database.|42
2446742|NCT01084655|6001691|P3|NOT COMPLETED|Overall Study||19
2446743|NCT01084655|6001692|P2|NOT COMPLETED|Overall Study||6
2446744|NCT01084655|6001693|P1|NOT COMPLETED|Overall Study||6
2446745|NCT01084655|6001691|P3|COMPLETED|Overall Study||5
2446746|NCT01084655|6001692|P2|COMPLETED|Overall Study||2
2446747|NCT01084655|6001693|P1|COMPLETED|Overall Study||0
2446748|NCT01084655|6001691|P3|Treated|Overall Study||23
2446749|NCT01084655|6001692|P2|Treated|Overall Study||8
2446750|NCT01084655|6001693|P1|Treated|Overall Study||6
2446751|NCT01084655|6001691|P3|STARTED|Overall Study||24
2446752|NCT01084655|6001692|P2|STARTED|Overall Study||8
2446753|NCT01084655|6001693|P1|STARTED|Overall Study||6
2446754|NCT01084603|6001728|P1|NOT COMPLETED|Oral Nicotine 4||0
2446755|NCT01084603|6001728|P1|COMPLETED|Oral Nicotine 4||39
2446756|NCT01084603|6001728|P1|STARTED|Oral Nicotine 4||39
2446757|NCT01084603|6001728|P1|NOT COMPLETED|Washout Period 4||1
2446758|NCT01084603|6001728|P1|COMPLETED|Washout Period 4||39
2446759|NCT01084603|6001728|P1|STARTED|Washout Period 4||40
2446760|NCT01084603|6001728|P1|NOT COMPLETED|Oral Nicotine 2||0
2446761|NCT01084603|6001728|P1|COMPLETED|Oral Nicotine 2||40
2446762|NCT01084603|6001728|P1|STARTED|Oral Nicotine 2||40
2446763|NCT01084603|6001728|P1|NOT COMPLETED|Washout Period 3||0
2446764|NCT01084603|6001728|P1|COMPLETED|Washout Period 3||40
2446765|NCT01084603|6001728|P1|STARTED|Washout Period 3||40
2446766|NCT01084603|6001728|P1|NOT COMPLETED|Oral Nicotine 1||1
2446767|NCT01084603|6001728|P1|COMPLETED|Oral Nicotine 1||40
2446768|NCT01084603|6001728|P1|STARTED|Oral Nicotine 1||41
2446769|NCT01084603|6001728|P1|NOT COMPLETED|Washout Period 2||0
2446770|NCT01084603|6001728|P1|COMPLETED|Washout Period 2||41
2446771|NCT01084603|6001728|P1|STARTED|Washout Period 2||41
2446772|NCT01084603|6001728|P1|NOT COMPLETED|Nicorette® Gum||1
2446773|NCT01084603|6001728|P1|COMPLETED|Nicorette® Gum||41
2446774|NCT01084603|6001728|P1|STARTED|Nicorette® Gum||42
2446775|NCT01084603|6001728|P1|NOT COMPLETED|Washout Period 1||0
2446776|NCT01084603|6001728|P1|COMPLETED|Washout Period 1||42
2446777|NCT01084603|6001728|P1|STARTED|Washout Period 1||42
2446778|NCT01084603|6001728|P1|NOT COMPLETED|NiQuitinTM Lozenge||1
2446779|NCT01084603|6001728|P1|COMPLETED|NiQuitinTM Lozenge||42
2446780|NCT01084603|6001728|P1|STARTED|NiQuitinTM Lozenge||43
2446781|NCT01084603|6001728|P1|NOT COMPLETED|Baseline||2
2446782|NCT01084603|6001728|P1|COMPLETED|Baseline||43
2446783|NCT01084603|6001728|P1|STARTED|Baseline||45
2446784|NCT01084551|6001764|P3|NOT COMPLETED|Overall Study||8
2446785|NCT01084551|6001765|P2|NOT COMPLETED|Overall Study||14
2446786|NCT01084551|6001766|P1|NOT COMPLETED|Overall Study||9
2446787|NCT01084551|6001764|P3|COMPLETED|Overall Study||86
2446788|NCT01084551|6001765|P2|COMPLETED|Overall Study||81
2446789|NCT01084551|6001766|P1|COMPLETED|Overall Study||86
2446790|NCT01084551|6001764|P3|STARTED|Overall Study||94
2446791|NCT01084551|6001765|P2|STARTED|Overall Study||95
2446792|NCT01084551|6001766|P1|STARTED|Overall Study||95
2446793|NCT01084538|6001804|P1|NOT COMPLETED|Overall Study||68
2446794|NCT01084538|6001804|P1|COMPLETED|Overall Study||113
2446795|NCT01084538|6001804|P1|STARTED|Overall Study||181
2446796|NCT01084499|6001813|P2|NOT COMPLETED|Overall Study||0
2446797|NCT01084499|6001814|P1|NOT COMPLETED|Overall Study||0
2446798|NCT01084499|6001813|P2|COMPLETED|Overall Study|Second Intervention (Sequence 2) : Femara (1 Day)|13
2446799|NCT01084499|6001814|P1|COMPLETED|Overall Study|Second Intervention (Sequence 1) : Peratra (1 Day)|13
2446800|NCT01084499|6001813|P2|Washout (5 Weeks)|Overall Study||13
2446801|NCT01084499|6001814|P1|Washout (5 Weeks)|Overall Study||13
2446802|NCT01084499|6001813|P2|STARTED|Overall Study|First Intervention (Sequence 2) : Peratra (1 Day)|13
2446803|NCT01084499|6001814|P1|STARTED|Overall Study|First Intervention (Sequence 1) : Femara (1 Day)|13
2446804|NCT01084278|6001827|P5|NOT COMPLETED|Overall Study||0
2446805|NCT01084278|6001828|P4|NOT COMPLETED|Overall Study||0
2446806|NCT01084278|6001829|P3|NOT COMPLETED|Overall Study||0
2446807|NCT01084278|6001830|P2|NOT COMPLETED|Overall Study||0
2446808|NCT01084278|6001831|P1|NOT COMPLETED|Overall Study||0
2446809|NCT01084278|6001827|P5|COMPLETED|Overall Study||8
2446810|NCT01084278|6001828|P4|COMPLETED|Overall Study||8
2446811|NCT01084278|6001829|P3|COMPLETED|Overall Study||8
2446812|NCT01084278|6001830|P2|COMPLETED|Overall Study||8
2446813|NCT01084278|6001831|P1|COMPLETED|Overall Study||8
2446814|NCT01084278|6001827|P5|STARTED|Overall Study||8
2446815|NCT01084278|6001828|P4|STARTED|Overall Study||8
2446816|NCT01084278|6001829|P3|STARTED|Overall Study||8
2446817|NCT01084278|6001830|P2|STARTED|Overall Study||8
2446818|NCT01084278|6001831|P1|STARTED|Overall Study||8
2446819|NCT01084265|6001912|P1|NOT COMPLETED|Overall Study||0
2446820|NCT01084265|6001912|P1|COMPLETED|Overall Study||31
2446821|NCT01084265|6001912|P1|STARTED|Overall Study||31
2446822|NCT01084239|6001926|P2|NOT COMPLETED|28-Day Follow-up||9
2446823|NCT01084239|6001927|P1|NOT COMPLETED|28-Day Follow-up||4
2446824|NCT01084239|6001926|P2|COMPLETED|28-Day Follow-up||490
2446825|NCT01084239|6001927|P1|COMPLETED|28-Day Follow-up||497
2446826|NCT01084239|6001926|P2|STARTED|28-Day Follow-up||499
2446827|NCT01084239|6001927|P1|STARTED|28-Day Follow-up|All 501 patients enrolled were evaluated for follow-up at 28 days.|501
2446828|NCT01084239|6001926|P2|NOT COMPLETED|Randomization - Index Hospitalization||0
2446829|NCT01084239|6001927|P1|NOT COMPLETED|Randomization - Index Hospitalization||0
2446830|NCT01084239|6001926|P2|COMPLETED|Randomization - Index Hospitalization||499
2446831|NCT01084239|6001927|P1|COMPLETED|Randomization - Index Hospitalization||501
2446832|NCT01084239|6001926|P2|STARTED|Randomization - Index Hospitalization||499
2446833|NCT01084239|6001927|P1|STARTED|Randomization - Index Hospitalization||501
2446834|NCT01084174|6001945|P2|NOT COMPLETED|Overall Study||4
2446835|NCT01084174|6001946|P1|NOT COMPLETED|Overall Study||1
2446836|NCT01084174|6001945|P2|COMPLETED|Overall Study||7
2446837|NCT01084174|6001946|P1|COMPLETED|Overall Study||9
2446838|NCT01084174|6001945|P2|STARTED|Overall Study||11
2446839|NCT01084174|6001946|P1|STARTED|Overall Study||10
2446840|NCT01084148|6001966|P2|NOT COMPLETED|Overall Study||16
2446841|NCT01084148|6001967|P1|NOT COMPLETED|Overall Study||30
2446842|NCT01084148|6001966|P2|COMPLETED|Overall Study||102
2446843|NCT01084148|6001967|P1|COMPLETED|Overall Study||88
2446844|NCT01084148|6001966|P2|Treated Patients|Overall Study|Patients who received test product at least once|117
2446845|NCT01084148|6001967|P1|Treated Patients|Overall Study||118
2446846|NCT01084148|6001966|P2|STARTED|Overall Study|Among those 118 patients randomized into V0034 CR 01B vehicle arm, one patient not treated.|118
2446847|NCT01084148|6001967|P1|STARTED|Overall Study||118
2446848|NCT01084135|6001979|P2|NOT COMPLETED|20 Week||1
2446849|NCT01084135|6001980|P1|NOT COMPLETED|20 Week||0
2446850|NCT01084135|6001979|P2|COMPLETED|20 Week||10
2446851|NCT01084135|6001980|P1|COMPLETED|20 Week||12
2446852|NCT01084135|6001979|P2|STARTED|20 Week||11
2446853|NCT01084135|6001980|P1|STARTED|20 Week||12
2446854|NCT01084135|6001979|P2|NOT COMPLETED|12 Week||0
2446855|NCT01084135|6001980|P1|NOT COMPLETED|12 Week||0
2446856|NCT01084135|6001979|P2|COMPLETED|12 Week||4
2446857|NCT01084135|6001980|P1|COMPLETED|12 Week||4
2446858|NCT01084135|6001979|P2|STARTED|12 Week||4
2446859|NCT01084135|6001980|P1|STARTED|12 Week||4
2446860|NCT01084083|6001990|P1|NOT COMPLETED|Overall Study||12
2446861|NCT01084083|6001990|P1|COMPLETED|Overall Study||78
2446862|NCT01084083|6001990|P1|CR and Treated With 5400 cGy IMRT|Overall Study|This is the primary study population for the primary endpoint (24-month PFS).|44
2446863|NCT01084083|6001990|P1|CR to Induction Therapy|Overall Study||56
2446864|NCT01084083|6001990|P1|Eligible and Treated|Overall Study|This is the eligible and treated patients for secondary efficacy endpoints|80
2446865|NCT01084083|6001990|P1|Eligible|Overall Study||81
2446866|NCT01084083|6001990|P1|Treated|Overall Study|This is the all treated patients for toxicity analysis|89
2446867|NCT01084083|6001990|P1|STARTED|Overall Study||90
2446868|NCT01084005|6001998|P2|NOT COMPLETED|Overall Study||16
2446869|NCT01084005|6001999|P1|NOT COMPLETED|Overall Study||5
2446870|NCT01084005|6001998|P2|COMPLETED|Overall Study||146
2446871|NCT01084005|6001999|P1|COMPLETED|Overall Study||74
2446872|NCT01084005|6001998|P2|STARTED|Overall Study||162
2446873|NCT01084005|6001999|P1|STARTED|Overall Study||79
2446874|NCT01083979|6002027|P1|NOT COMPLETED|Overall Study||0
2446875|NCT01083979|6002027|P1|COMPLETED|Overall Study||1
2446876|NCT01083979|6002027|P1|STARTED|Overall Study||1
2446877|NCT01083901|6002035|P3|NOT COMPLETED|Overall Study||2
2446878|NCT01083901|6002036|P2|NOT COMPLETED|Overall Study||2
2446879|NCT01083901|6002037|P1|NOT COMPLETED|Overall Study||1
2446880|NCT01083901|6002035|P3|COMPLETED|Overall Study||11
2446881|NCT01083901|6002036|P2|COMPLETED|Overall Study||6
2446882|NCT01083901|6002037|P1|COMPLETED|Overall Study||12
2446883|NCT01083901|6002035|P3|STARTED|Overall Study||13
2446884|NCT01083901|6002036|P2|STARTED|Overall Study||8
2446885|NCT01083901|6002037|P1|STARTED|Overall Study||13
2446886|NCT01083849|6002056|P2|NOT COMPLETED|Overall Study||111
2446887|NCT01083849|6002057|P1|NOT COMPLETED|Overall Study||60
2446888|NCT01083849|6002056|P2|COMPLETED|Overall Study||527
2446889|NCT01083849|6002057|P1|COMPLETED|Overall Study||61
2446890|NCT01083849|6002056|P2|STARTED|Overall Study||638
2446891|NCT01083849|6002057|P1|STARTED|Overall Study||121
2446892|NCT01083810|6002080|P3|NOT COMPLETED|Overall Study||20
2446893|NCT01083810|6002081|P2|NOT COMPLETED|Overall Study||45
2446894|NCT01083810|6002082|P1|NOT COMPLETED|Overall Study||65
2446895|NCT01083810|6002080|P3|COMPLETED|Overall Study||35
2446896|NCT01083810|6002081|P2|COMPLETED|Overall Study||47
2446897|NCT01083810|6002082|P1|COMPLETED|Overall Study||72
2446898|NCT01083810|6002080|P3|STARTED|Overall Study||55
2446899|NCT01083810|6002081|P2|STARTED|Overall Study||92
2446900|NCT01083810|6002082|P1|STARTED|Overall Study||137
2446901|NCT01083771|6002103|P1|NOT COMPLETED|Overall Study||5
2446902|NCT01083771|6002103|P1|COMPLETED|Overall Study||16
2446903|NCT01083771|6002103|P1|STARTED|Overall Study||21
2446904|NCT01083758|6002108|P1|NOT COMPLETED|Overall Study||2
2446905|NCT01083758|6002108|P1|COMPLETED|Overall Study||29
2446906|NCT01083758|6002108|P1|STARTED|Overall Study||31
2446907|NCT01083732|6002142|P3|NOT COMPLETED|Overall Study||0
2446908|NCT01083732|6002143|P2|NOT COMPLETED|Overall Study||0
2446909|NCT01083732|6002144|P1|NOT COMPLETED|Overall Study||0
2446910|NCT01083732|6002142|P3|COMPLETED|Overall Study||3
2446911|NCT01083732|6002143|P2|COMPLETED|Overall Study||9
2446912|NCT01083732|6002144|P1|COMPLETED|Overall Study||6
2446913|NCT01083732|6002142|P3|STARTED|Overall Study||3
2446914|NCT01083732|6002143|P2|STARTED|Overall Study||9
2446915|NCT01083732|6002144|P1|STARTED|Overall Study||6
2446916|NCT01083706|6002195|P1|NOT COMPLETED|Overall Study||0
2446917|NCT01083706|6002195|P1|COMPLETED|Overall Study||39
2446918|NCT01083706|6002195|P1|STARTED|Overall Study||39
2446919|NCT01083693|6002204|P3|NOT COMPLETED|Overall Study||7
2446920|NCT01083693|6002205|P2|NOT COMPLETED|Overall Study||6
2446921|NCT01083693|6002206|P1|NOT COMPLETED|Overall Study||20
2446922|NCT01083693|6002204|P3|COMPLETED|Overall Study||33
2446923|NCT01083693|6002205|P2|COMPLETED|Overall Study||22
2446924|NCT01083693|6002206|P1|COMPLETED|Overall Study||73
2446925|NCT01083693|6002204|P3|STARTED|Overall Study||40
2446926|NCT01083693|6002205|P2|STARTED|Overall Study||28
2446927|NCT01083693|6002206|P1|STARTED|Overall Study||93
2446928|NCT01083680|6002241|P1|NOT COMPLETED|Overall Study||3844
2446929|NCT01083680|6002241|P1|COMPLETED|Overall Study||263
2446930|NCT01083680|6002241|P1|Full Analysis Set (FAS), Efficacy|Overall Study||1621
2446931|NCT01083680|6002241|P1|STARTED|Overall Study||4107
2446932|NCT01083667|6002250|P1|NOT COMPLETED|Overall Study||10
2446933|NCT01083667|6002250|P1|COMPLETED|Overall Study|22 completed to visit 9, the last visit on study.|22
2446934|NCT01083667|6002250|P1|STARTED|Overall Study|enrolled|32
2446935|NCT01083654|6002257|P2|NOT COMPLETED|Overall Study||0
2446936|NCT01083654|6002258|P1|NOT COMPLETED|Overall Study||0
2446937|NCT01083654|6002257|P2|COMPLETED|Overall Study||50
2446938|NCT01083654|6002258|P1|COMPLETED|Overall Study||53
2446939|NCT01083654|6002257|P2|STARTED|Overall Study||50
2446940|NCT01083654|6002258|P1|STARTED|Overall Study||53
2446941|NCT01083641|6002264|P1|NOT COMPLETED|Overall Study||2
2446942|NCT01083641|6002264|P1|COMPLETED|Overall Study||15
2446943|NCT01083641|6002264|P1|STARTED|Overall Study||17
2446944|NCT01083628|6002273|P2|NOT COMPLETED|Overall Study||0
2446945|NCT01083628|6002274|P1|NOT COMPLETED|Overall Study||0
2446946|NCT01083628|6002273|P2|COMPLETED|Overall Study||40
2446947|NCT01083628|6002274|P1|COMPLETED|Overall Study||45
2446948|NCT01083628|6002273|P2|STARTED|Overall Study||40
2446949|NCT01083628|6002274|P1|STARTED|Overall Study||45
2446950|NCT01083602|6002284|P1|NOT COMPLETED|Overall Study||55
2446951|NCT01083602|6002284|P1|COMPLETED|Overall Study||0
2446952|NCT01083602|6002284|P1|STARTED|Overall Study||55
2446953|NCT01083576|6002295|P2|NOT COMPLETED|Overall Study||1
2446954|NCT01083576|6002296|P1|NOT COMPLETED|Overall Study||6
2446955|NCT01083576|6002295|P2|COMPLETED|Overall Study||14
2446956|NCT01083576|6002296|P1|COMPLETED|Overall Study||9
2446957|NCT01083576|6002295|P2|STARTED|Overall Study||15
2446958|NCT01083576|6002296|P1|STARTED|Overall Study||15
2446959|NCT01083485|6002326|P2|NOT COMPLETED|Overall Study||3
2446960|NCT01083485|6002327|P1|NOT COMPLETED|Overall Study||7
2446961|NCT01083485|6002326|P2|COMPLETED|Overall Study||64
2446962|NCT01083485|6002327|P1|COMPLETED|Overall Study||63
2446963|NCT01083485|6002326|P2|STARTED|Overall Study||67
2446964|NCT01083485|6002327|P1|STARTED|Overall Study||70
2446965|NCT01083472|6002337|P2|NOT COMPLETED|Overall Study||0
2446966|NCT01083472|6002338|P1|NOT COMPLETED|Overall Study||0
2446967|NCT01083472|6002337|P2|COMPLETED|Overall Study||19
2446968|NCT01083472|6002338|P1|COMPLETED|Overall Study||18
2446969|NCT01083472|6002337|P2|STARTED|Overall Study||19
2446970|NCT01083472|6002338|P1|STARTED|Overall Study||18
2446971|NCT01083368|6002346|P4|NOT COMPLETED|Phase II - Efficacy/Safety||0
2446972|NCT01083368|6002347|P3|NOT COMPLETED|Phase II - Efficacy/Safety||0
2446973|NCT01083368|6002348|P2|NOT COMPLETED|Phase II - Efficacy/Safety||0
2446974|NCT01083368|6002349|P1|NOT COMPLETED|Phase II - Efficacy/Safety||0
2446975|NCT01083368|6002346|P4|COMPLETED|Phase II - Efficacy/Safety|14 plus 6 participants from previous period|20
2446976|NCT01083368|6002347|P3|COMPLETED|Phase II - Efficacy/Safety||0
2446977|NCT01083368|6002348|P2|COMPLETED|Phase II - Efficacy/Safety||0
2446978|NCT01083368|6002349|P1|COMPLETED|Phase II - Efficacy/Safety||0
2446979|NCT01083368|6002346|P4|STARTED|Phase II - Efficacy/Safety||20
2446980|NCT01083368|6002347|P3|STARTED|Phase II - Efficacy/Safety||0
2446981|NCT01083368|6002348|P2|STARTED|Phase II - Efficacy/Safety||0
2446982|NCT01083368|6002349|P1|STARTED|Phase II - Efficacy/Safety||0
2446983|NCT01083368|6002346|P4|NOT COMPLETED|Dose Escalation Weeks 5-9||0
2446984|NCT01083368|6002347|P3|NOT COMPLETED|Dose Escalation Weeks 5-9||0
2446985|NCT01083368|6002348|P2|NOT COMPLETED|Dose Escalation Weeks 5-9||0
2446986|NCT01083368|6002349|P1|NOT COMPLETED|Dose Escalation Weeks 5-9||0
2446987|NCT01083368|6002346|P4|COMPLETED|Dose Escalation Weeks 5-9|3 participants on dose level 1 moved to dose level 2, 3 more new participants joined.|6
2446988|NCT01083368|6002347|P3|COMPLETED|Dose Escalation Weeks 5-9||1
2446989|NCT01083368|6002348|P2|COMPLETED|Dose Escalation Weeks 5-9||0
2446990|NCT01083368|6002349|P1|COMPLETED|Dose Escalation Weeks 5-9||0
2446991|NCT01083368|6002346|P4|STARTED|Dose Escalation Weeks 5-9||6
2446992|NCT01083368|6002347|P3|STARTED|Dose Escalation Weeks 5-9|Participant on DL1 did not move to dose level 2 because of disease progression.|1
2446993|NCT01083368|6002348|P2|STARTED|Dose Escalation Weeks 5-9||0
2446994|NCT01083368|6002349|P1|STARTED|Dose Escalation Weeks 5-9||0
2446995|NCT01083368|6002346|P4|NOT COMPLETED|Dose Escalation Weeks 1-4||0
2446996|NCT01083368|6002347|P3|NOT COMPLETED|Dose Escalation Weeks 1-4||0
2446997|NCT01083368|6002348|P2|NOT COMPLETED|Dose Escalation Weeks 1-4||0
2446998|NCT01083368|6002349|P1|NOT COMPLETED|Dose Escalation Weeks 1-4||0
2446999|NCT01083368|6002346|P4|COMPLETED|Dose Escalation Weeks 1-4||0
2447000|NCT01083368|6002347|P3|COMPLETED|Dose Escalation Weeks 1-4||4
2447001|NCT01083368|6002348|P2|COMPLETED|Dose Escalation Weeks 1-4||0
2447002|NCT01083368|6002349|P1|COMPLETED|Dose Escalation Weeks 1-4||0
2447003|NCT01083368|6002346|P4|Disease Progression|Dose Escalation Weeks 1-4||0
2447004|NCT01083368|6002347|P3|Disease Progression|Dose Escalation Weeks 1-4||1
2447005|NCT01083368|6002348|P2|Disease Progression|Dose Escalation Weeks 1-4||0
2447006|NCT01083368|6002349|P1|Disease Progression|Dose Escalation Weeks 1-4||0
2447007|NCT01083368|6002346|P4|STARTED|Dose Escalation Weeks 1-4||0
2447008|NCT01083368|6002347|P3|STARTED|Dose Escalation Weeks 1-4||4
2447009|NCT01083368|6002348|P2|STARTED|Dose Escalation Weeks 1-4||0
2447010|NCT01083368|6002349|P1|STARTED|Dose Escalation Weeks 1-4||0
2447011|NCT01083316|6002359|P1|NOT COMPLETED|Overall Study||3
2447012|NCT01083316|6002359|P1|COMPLETED|Overall Study||32
2447013|NCT01083316|6002359|P1|STARTED|Overall Study||35
2447014|NCT01083199|6002366|P1|NOT COMPLETED|Overall Study||0
2447015|NCT01083199|6002366|P1|COMPLETED|Overall Study||10
2447016|NCT01083199|6002366|P1|STARTED|Overall Study||10
2447017|NCT01083186|6002371|P1|NOT COMPLETED|Overall Study||94
2447018|NCT01083186|6002371|P1|COMPLETED|Overall Study||406
2447019|NCT01083186|6002371|P1|STARTED|Overall Study||500
2447020|NCT01083173|6002412|P2|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||377
2447021|NCT01083173|6002413|P1|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||0
2447022|NCT01083173|6002412|P2|COMPLETED|Long-term Surveillance: Effectiveness Gr||102
2447023|NCT01083173|6002413|P1|COMPLETED|Long-term Surveillance: Effectiveness Gr||0
2447024|NCT01083173|6002412|P2|STARTED|Long-term Surveillance: Effectiveness Gr||479
2447025|NCT01083173|6002413|P1|STARTED|Long-term Surveillance: Effectiveness Gr||0
2447026|NCT01083173|6002412|P2|NOT COMPLETED|Long-term Surveillance: Safety Group||116
2447027|NCT01083173|6002413|P1|NOT COMPLETED|Long-term Surveillance: Safety Group||0
2447028|NCT01083173|6002412|P2|COMPLETED|Long-term Surveillance: Safety Group||479
2447029|NCT01083173|6002413|P1|COMPLETED|Long-term Surveillance: Safety Group||0
2447030|NCT01083173|6002412|P2|STARTED|Long-term Surveillance: Safety Group||595
2447031|NCT01083173|6002413|P1|STARTED|Long-term Surveillance: Safety Group||0
2447032|NCT01083173|6002412|P2|NOT COMPLETED|Main Surveillance: Effectiveness Group||0
2447033|NCT01083173|6002413|P1|NOT COMPLETED|Main Surveillance: Effectiveness Group||382
2447034|NCT01083173|6002412|P2|COMPLETED|Main Surveillance: Effectiveness Group||0
2447035|NCT01083173|6002413|P1|COMPLETED|Main Surveillance: Effectiveness Group||198
2447036|NCT01083173|6002412|P2|STARTED|Main Surveillance: Effectiveness Group||0
2447037|NCT01083173|6002413|P1|STARTED|Main Surveillance: Effectiveness Group||580
2447038|NCT01083173|6002412|P2|NOT COMPLETED|Main Surveillance: Safety Group||0
2447039|NCT01083173|6002413|P1|NOT COMPLETED|Main Surveillance: Safety Group||15
2447040|NCT01083173|6002412|P2|COMPLETED|Main Surveillance: Safety Group||0
2447041|NCT01083173|6002413|P1|COMPLETED|Main Surveillance: Safety Group||580
2447042|NCT01083173|6002412|P2|STARTED|Main Surveillance: Safety Group||0
2447043|NCT01083173|6002413|P1|STARTED|Main Surveillance: Safety Group||595
2447044|NCT01083160|6002431|P1|NOT COMPLETED|Overall Study||1
2447045|NCT01083160|6002431|P1|COMPLETED|Overall Study||81
2447046|NCT01083160|6002431|P1|Evaluable Population|Overall Study||71
2447047|NCT01083160|6002431|P1|STARTED|Overall Study||82
2447048|NCT01083121|6002438|P1|NOT COMPLETED|Overall Study||81
2447049|NCT01083121|6002438|P1|COMPLETED|Overall Study|Participants included in the analysis|1698
2447050|NCT01083121|6002438|P1|STARTED|Overall Study|Participants who were enrolled in the study|1779
2447051|NCT01082965|6002448|P2|NOT COMPLETED|Overall Study||2
2447052|NCT01082965|6002449|P1|NOT COMPLETED|Overall Study||1
2447053|NCT01082965|6002448|P2|COMPLETED|Overall Study||6
2447054|NCT01082965|6002449|P1|COMPLETED|Overall Study||9
2447055|NCT01082965|6002448|P2|STARTED|Overall Study||8
2447056|NCT01082965|6002449|P1|STARTED|Overall Study||10
2447057|NCT01082952|6002469|P2|NOT COMPLETED|Overall Study||0
2447058|NCT01082952|6002470|P1|NOT COMPLETED|Overall Study||0
2447059|NCT01082952|6002469|P2|COMPLETED|Overall Study||6
2447060|NCT01082952|6002470|P1|COMPLETED|Overall Study||6
2447061|NCT01082952|6002469|P2|STARTED|Overall Study||6
2447062|NCT01082952|6002470|P1|STARTED|Overall Study||6
2447063|NCT01082939|6002478|P1|NOT COMPLETED|Overall Study||0
2447064|NCT01082939|6002478|P1|COMPLETED|Overall Study||80
2447065|NCT01082939|6002478|P1|STARTED|Overall Study||80
2447066|NCT01082874|6002486|P4|NOT COMPLETED|Overall Study||13
2447067|NCT01082874|6002487|P3|NOT COMPLETED|Overall Study||11
2447068|NCT01082874|6002488|P2|NOT COMPLETED|Overall Study||12
2447069|NCT01082874|6002489|P1|NOT COMPLETED|Overall Study||11
2447070|NCT01082874|6002486|P4|COMPLETED|Overall Study||2489
2447071|NCT01082874|6002487|P3|COMPLETED|Overall Study||2488
2447072|NCT01082874|6002488|P2|COMPLETED|Overall Study||2498
2447073|NCT01082874|6002489|P1|COMPLETED|Overall Study||2488
2447074|NCT01082874|6002486|P4|STARTED|Overall Study||2502
2447075|NCT01082874|6002487|P3|STARTED|Overall Study||2499
2447076|NCT01082874|6002488|P2|STARTED|Overall Study||2510
2447077|NCT01082874|6002489|P1|STARTED|Overall Study||2499
2447078|NCT01082640|6002502|P3|NOT COMPLETED|Overall Study||8
2447079|NCT01082640|6002503|P2|NOT COMPLETED|Overall Study||15
2447080|NCT01082640|6002504|P1|NOT COMPLETED|Overall Study||17
2447081|NCT01082640|6002502|P3|COMPLETED|Overall Study||24
2447082|NCT01082640|6002503|P2|COMPLETED|Overall Study||17
2447083|NCT01082640|6002504|P1|COMPLETED|Overall Study||15
2447084|NCT01082640|6002502|P3|STARTED|Overall Study||32
2447085|NCT01082640|6002503|P2|STARTED|Overall Study||32
2447086|NCT01082640|6002504|P1|STARTED|Overall Study||32
2447087|NCT01082614|6002526|P2|NOT COMPLETED|Overall Study||5
2447088|NCT01082614|6002527|P1|NOT COMPLETED|Overall Study||3
2447089|NCT01082614|6002526|P2|COMPLETED|Overall Study||18
2447090|NCT01082614|6002527|P1|COMPLETED|Overall Study||20
2447091|NCT01082614|6002526|P2|STARTED|Overall Study||23
2447092|NCT01082614|6002527|P1|STARTED|Overall Study||23
2447093|NCT01082588|6002539|P2|NOT COMPLETED|Overall Study||5
2447094|NCT01082588|6002540|P1|NOT COMPLETED|Overall Study||6
2447095|NCT01082588|6002539|P2|COMPLETED|Overall Study||25
2447096|NCT01082588|6002540|P1|COMPLETED|Overall Study||24
2447097|NCT01082588|6002539|P2|STARTED|Overall Study||30
2447098|NCT01082588|6002540|P1|STARTED|Overall Study||30
2447099|NCT01082575|6002558|P1|NOT COMPLETED|Overall Study||0
2447100|NCT01082575|6002558|P1|COMPLETED|Overall Study||100
2447101|NCT01082575|6002558|P1|STARTED|Overall Study||100
2447102|NCT01082380|6002563|P1|NOT COMPLETED|Overall Study||0
2447103|NCT01082380|6002563|P1|COMPLETED|Overall Study||6
2447104|NCT01082380|6002563|P1|STARTED|Overall Study||6
2447105|NCT01082367|6002598|P2|NOT COMPLETED|Follow-up (F-U) Period||1
2447106|NCT01082367|6002599|P1|NOT COMPLETED|Follow-up (F-U) Period||2
2447107|NCT01082367|6002598|P2|COMPLETED|Follow-up (F-U) Period||9
2447108|NCT01082367|6002599|P1|COMPLETED|Follow-up (F-U) Period||17
2447109|NCT01082367|6002598|P2|Treated in F-U|Follow-up (F-U) Period||5
2447110|NCT01082367|6002599|P1|Treated in F-U|Follow-up (F-U) Period||5
2447111|NCT01082367|6002598|P2|STARTED|Follow-up (F-U) Period||10
2447112|NCT01082367|6002599|P1|STARTED|Follow-up (F-U) Period||19
2447113|NCT01082367|6002598|P2|NOT COMPLETED|Double-blind Period||13
2447114|NCT01082367|6002599|P1|NOT COMPLETED|Double-blind Period||5
2447115|NCT01082367|6002598|P2|COMPLETED|Double-blind Period||12
2447116|NCT01082367|6002599|P1|COMPLETED|Double-blind Period||21
2447117|NCT01082367|6002598|P2|Stage 4:no tx for Patients Not in co|Double-blind Period||0
2447118|NCT01082367|6002599|P1|Stage 4:no tx for Patients Not in co|Double-blind Period||0
2447119|NCT01082367|6002598|P2|Stage 3: Cross-over (co) tx|Double-blind Period||6
2447120|NCT01082367|6002599|P1|Stage 3: Cross-over (co) tx|Double-blind Period||13
2447121|NCT01082367|6002598|P2|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||0
2447122|NCT01082367|6002599|P1|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||9
2447123|NCT01082367|6002598|P2|Entered OL TOBI|Double-blind Period||18
2447124|NCT01082367|6002599|P1|Entered OL TOBI|Double-blind Period||4
2447125|NCT01082367|6002598|P2|Stage 2:no tx|Double-blind Period||0
2447126|NCT01082367|6002599|P1|Stage 2:no tx|Double-blind Period||0
2447127|NCT01082367|6002598|P2|Stage 1:1st Treatment (tx) Cycle|Double-blind Period|1 participant discontinued after cycle 1 due to an SAE|25
2447128|NCT01082367|6002599|P1|Stage 1:1st Treatment (tx) Cycle|Double-blind Period||26
2447129|NCT01082367|6002598|P2|STARTED|Double-blind Period||25
2447130|NCT01082367|6002599|P1|STARTED|Double-blind Period||26
2447131|NCT01082328|6002613|P1|NOT COMPLETED|Overall Study||1
2447132|NCT01082328|6002613|P1|COMPLETED|Overall Study||58
2447133|NCT01082328|6002613|P1|STARTED|Overall Study||59
2447134|NCT01082211|6002622|P1|NOT COMPLETED|Overall Study||7
2447135|NCT01082211|6002622|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
2447136|NCT01082211|6002622|P1|All Eligible Patients|Overall Study||58
2447137|NCT01082211|6002622|P1|Has Baseline/36-Month MD QOL Data|Overall Study||27
2447138|NCT01082211|6002622|P1|Has Baseline/36-month PT QOL Data|Overall Study||32
2447139|NCT01082211|6002622|P1|Has Baseline/12-Month MD QOL Data|Overall Study||35
2447140|NCT01082211|6002622|P1|Has Baseline/12-month PT QOL Data|Overall Study||36
2447141|NCT01082211|6002622|P1|Has Baseline MD QOL Data|Overall Study||44
2447142|NCT01082211|6002622|P1|Has Baseline PT QOL Data|Overall Study||46
2447143|NCT01082211|6002622|P1|STARTED|Overall Study||65
2447144|NCT01082159|6002640|P1|NOT COMPLETED|Overall Study||9
2447145|NCT01082159|6002640|P1|COMPLETED|Overall Study||46
2447146|NCT01082159|6002640|P1|STARTED|Overall Study||55
2447147|NCT01082081|6002649|P3|NOT COMPLETED|Overall Study||2
2447148|NCT01082081|6002650|P2|NOT COMPLETED|Overall Study||1
2447149|NCT01082081|6002651|P1|NOT COMPLETED|Overall Study||0
2447150|NCT01082081|6002649|P3|COMPLETED|Overall Study||58
2447151|NCT01082081|6002650|P2|COMPLETED|Overall Study||118
2447152|NCT01082081|6002651|P1|COMPLETED|Overall Study||121
2447153|NCT01082081|6002649|P3|STARTED|Overall Study||60
2447154|NCT01082081|6002650|P2|STARTED|Overall Study||119
2447155|NCT01082081|6002651|P1|STARTED|Overall Study||121
2447156|NCT01081951|6002703|P2|NOT COMPLETED|Overall Study||55
2447157|NCT01081951|6002704|P1|NOT COMPLETED|Overall Study||56
2447158|NCT01081951|6002703|P2|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off), either on-treatment or in survival follow-up|26
2447159|NCT01081951|6002704|P1|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off),either on-treatment or in survival follow-up|25
2447160|NCT01081951|6002703|P2|Ongoing Study Treatment at Data Cut-off|Overall Study||0
2447161|NCT01081951|6002704|P1|Ongoing Study Treatment at Data Cut-off|Overall Study||11
2447162|NCT01081951|6002703|P2|Entered Maintenance Phase|Overall Study||55
2447163|NCT01081951|6002704|P1|Entered Maintenance Phase|Overall Study||66
2447164|NCT01081951|6002703|P2|Received Study Treatment|Overall Study||75
2447165|NCT01081951|6002704|P1|Received Study Treatment|Overall Study||81
2447166|NCT01081951|6002703|P2|STARTED|Overall Study||81
2447167|NCT01081951|6002704|P1|STARTED|Overall Study||81
2447168|NCT01081912|6002714|P3|NOT COMPLETED|Maintenance Treatment||92
2447169|NCT01081912|6002715|P2|NOT COMPLETED|Maintenance Treatment||27
2447170|NCT01081912|6002716|P1|NOT COMPLETED|Maintenance Treatment||0
2447171|NCT01081912|6002714|P3|COMPLETED|Maintenance Treatment||59
2447172|NCT01081912|6002715|P2|COMPLETED|Maintenance Treatment||124
2447173|NCT01081912|6002716|P1|COMPLETED|Maintenance Treatment||0
2447174|NCT01081912|6002714|P3|STARTED|Maintenance Treatment||151
2447175|NCT01081912|6002715|P2|STARTED|Maintenance Treatment||151
2447176|NCT01081912|6002716|P1|STARTED|Maintenance Treatment||0
2447177|NCT01081912|6002714|P3|NOT COMPLETED|Conversion/Titration||0
2447178|NCT01081912|6002715|P2|NOT COMPLETED|Conversion/Titration||0
2447179|NCT01081912|6002716|P1|NOT COMPLETED|Conversion/Titration||208
2447180|NCT01081912|6002714|P3|COMPLETED|Conversion/Titration||0
2447181|NCT01081912|6002715|P2|COMPLETED|Conversion/Titration||0
2447182|NCT01081912|6002716|P1|COMPLETED|Conversion/Titration||302
2447183|NCT01081912|6002714|P3|STARTED|Conversion/Titration||0
2447184|NCT01081912|6002715|P2|STARTED|Conversion/Titration||0
2447185|NCT01081912|6002716|P1|STARTED|Conversion/Titration||510
2447186|NCT01081886|6002725|P2|NOT COMPLETED|Overall Study||13
2447187|NCT01081886|6002726|P1|NOT COMPLETED|Overall Study||11
2447188|NCT01081886|6002725|P2|COMPLETED|Overall Study||0
2447189|NCT01081886|6002726|P1|COMPLETED|Overall Study||0
2447190|NCT01081886|6002725|P2|STARTED|Overall Study||13
2447191|NCT01081886|6002726|P1|STARTED|Overall Study||11
2447192|NCT01081873|6002734|P1|NOT COMPLETED|Overall Study||298
2447193|NCT01081873|6002734|P1|COMPLETED|Overall Study||2416
2447194|NCT01081873|6002734|P1|STARTED|Overall Study|3 patients were excluded from this and all analyses due to no available data from Baseline.|2714
2447195|NCT01081834|6002806|P5|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
2447196|NCT01081834|6002807|P4|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
2447197|NCT01081834|6002808|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
2447198|NCT01081834|6002809|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
2447199|NCT01081834|6002810|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||20
2447200|NCT01081834|6002806|P5|COMPLETED|Extension Period: Week 26 to Week 52||0
2447283|NCT01081262|6003064|P3|NOT COMPLETED|Overall Study||0
2447201|NCT01081834|6002807|P4|COMPLETED|Extension Period: Week 26 to Week 52||0
2447202|NCT01081834|6002808|P3|COMPLETED|Extension Period: Week 26 to Week 52||165
2447203|NCT01081834|6002809|P2|COMPLETED|Extension Period: Week 26 to Week 52||152
2447204|NCT01081834|6002810|P1|COMPLETED|Extension Period: Week 26 to Week 52||135
2447205|NCT01081834|6002806|P5|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
2447206|NCT01081834|6002807|P4|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
2447207|NCT01081834|6002808|P3|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued last day of core: AE (1), lost f/u (1), PV (1), NS (1), physician decision (1).|170
2447208|NCT01081834|6002809|P2|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued on last day of core: adverse event (AE) (1), protocol violation (PV) (1).|170
2447209|NCT01081834|6002810|P1|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued on last day of core: lack of efficacy on rescue (2), not specified (NS) (3).|155
2447210|NCT01081834|6002806|P5|NOT COMPLETED|Core Period: Baseline to Week 26||4
2447211|NCT01081834|6002807|P4|NOT COMPLETED|Core Period: Baseline to Week 26||7
2447212|NCT01081834|6002808|P3|NOT COMPLETED|Core Period: Baseline to Week 26||22
2447213|NCT01081834|6002809|P2|NOT COMPLETED|Core Period: Baseline to Week 26||23
2447214|NCT01081834|6002810|P1|NOT COMPLETED|Core Period: Baseline to Week 26||32
2447215|NCT01081834|6002806|P5|COMPLETED|Core Period: Baseline to Week 26||40
2447216|NCT01081834|6002807|P4|COMPLETED|Core Period: Baseline to Week 26||40
2447217|NCT01081834|6002808|P3|COMPLETED|Core Period: Baseline to Week 26||175
2447218|NCT01081834|6002809|P2|COMPLETED|Core Period: Baseline to Week 26||172
2447219|NCT01081834|6002810|P1|COMPLETED|Core Period: Baseline to Week 26||160
2447220|NCT01081834|6002806|P5|STARTED|Core Period: Baseline to Week 26||44
2447221|NCT01081834|6002807|P4|STARTED|Core Period: Baseline to Week 26||47
2447222|NCT01081834|6002808|P3|STARTED|Core Period: Baseline to Week 26||197
2447223|NCT01081834|6002809|P2|STARTED|Core Period: Baseline to Week 26||195
2447224|NCT01081834|6002810|P1|STARTED|Core Period: Baseline to Week 26||192
2447225|NCT01081795|6002871|P3|NOT COMPLETED|Overall Study||30
2447226|NCT01081795|6002872|P2|NOT COMPLETED|Overall Study||35
2447227|NCT01081795|6002873|P1|NOT COMPLETED|Overall Study||33
2447228|NCT01081795|6002871|P3|COMPLETED|Overall Study||97
2447229|NCT01081795|6002872|P2|COMPLETED|Overall Study||95
2447230|NCT01081795|6002873|P1|COMPLETED|Overall Study||97
2447231|NCT01081795|6002871|P3|STARTED|Overall Study||127
2447232|NCT01081795|6002872|P2|STARTED|Overall Study||130
2447233|NCT01081795|6002873|P1|STARTED|Overall Study||130
2447234|NCT01081769|6002910|P2|NOT COMPLETED|CORE Intent-To-Treat||97
2447235|NCT01081769|6002911|P1|NOT COMPLETED|CORE Intent-To-Treat||80
2447236|NCT01081769|6002910|P2|COMPLETED|CORE Intent-To-Treat||266
2447237|NCT01081769|6002911|P1|COMPLETED|CORE Intent-To-Treat||272
2447238|NCT01081769|6002910|P2|STARTED|CORE Intent-To-Treat||363
2447239|NCT01081769|6002911|P1|STARTED|CORE Intent-To-Treat||352
2447240|NCT01081769|6002910|P2|NOT COMPLETED|Whole Intent-to-Treat||25
2447241|NCT01081769|6002911|P1|NOT COMPLETED|Whole Intent-to-Treat||24
2447242|NCT01081769|6002910|P2|COMPLETED|Whole Intent-to-Treat||363
2447243|NCT01081769|6002911|P1|COMPLETED|Whole Intent-to-Treat||352
2447244|NCT01081769|6002910|P2|STARTED|Whole Intent-to-Treat||388
2447245|NCT01081769|6002911|P1|STARTED|Whole Intent-to-Treat||376
2447246|NCT01081678|6002949|P4|NOT COMPLETED|Overall Study||29
2447247|NCT01081678|6002950|P3|NOT COMPLETED|Overall Study||31
2447248|NCT01081678|6002951|P2|NOT COMPLETED|Overall Study||16
2447249|NCT01081678|6002952|P1|NOT COMPLETED|Overall Study||27
2447250|NCT01081678|6002949|P4|COMPLETED|Overall Study||61
2447251|NCT01081678|6002950|P3|COMPLETED|Overall Study||62
2447252|NCT01081678|6002951|P2|COMPLETED|Overall Study||44
2447253|NCT01081678|6002952|P1|COMPLETED|Overall Study||62
2447254|NCT01081678|6002949|P4|Completed 24 Weeks of Study|Overall Study||68
2447255|NCT01081678|6002950|P3|Completed 24 Weeks of Study|Overall Study||72
2447256|NCT01081678|6002951|P2|Completed 24 Weeks of Study|Overall Study||50
2447257|NCT01081678|6002952|P1|Completed 24 Weeks of Study|Overall Study||73
2447258|NCT01081678|6002949|P4|Received Study Drug|Overall Study||89
2447259|NCT01081678|6002950|P3|Received Study Drug|Overall Study||89
2447260|NCT01081678|6002951|P2|Received Study Drug|Overall Study||60
2447261|NCT01081678|6002952|P1|Received Study Drug|Overall Study||87
2447262|NCT01081678|6002949|P4|STARTED|Overall Study||90
2447263|NCT01081678|6002950|P3|STARTED|Overall Study||93
2447264|NCT01081678|6002951|P2|STARTED|Overall Study||60
2447265|NCT01081678|6002952|P1|STARTED|Overall Study||89
2447266|NCT01081665|6002982|P1|NOT COMPLETED|Overall Study||95
2447267|NCT01081665|6002982|P1|COMPLETED|Overall Study||142
2447268|NCT01081665|6002982|P1|Evaluable Population|Overall Study|Participants with baseline and at least 2 post-baseline parathormone measurements at 24 months.|212
2447269|NCT01081665|6002982|P1|Full Analysis Set|Overall Study||237
2447270|NCT01081665|6002982|P1|STARTED|Overall Study||237
2447271|NCT01081626|6002994|P2|NOT COMPLETED|Overall Study||61
2447272|NCT01081626|6002995|P1|NOT COMPLETED|Overall Study||60
2447273|NCT01081626|6002994|P2|COMPLETED|Overall Study||94
2447274|NCT01081626|6002995|P1|COMPLETED|Overall Study||95
2447275|NCT01081626|6002994|P2|Assessed for Efficacy|Overall Study||125
2447276|NCT01081626|6002995|P1|Assessed for Efficacy|Overall Study||122
2447277|NCT01081626|6002994|P2|STARTED|Overall Study||155
2447278|NCT01081626|6002995|P1|STARTED|Overall Study||155
2447279|NCT01081301|6003021|P1|NOT COMPLETED|Overall Study||14
2447280|NCT01081301|6003021|P1|COMPLETED|Overall Study||22
2447281|NCT01081301|6003021|P1|STARTED|Overall Study||36
2447282|NCT01081262|6003063|P4|NOT COMPLETED|Overall Study||0
2447284|NCT01081262|6003065|P2|NOT COMPLETED|Overall Study||0
2447285|NCT01081262|6003066|P1|NOT COMPLETED|Overall Study||0
2447286|NCT01081262|6003063|P4|COMPLETED|Overall Study||11
2447287|NCT01081262|6003064|P3|COMPLETED|Overall Study||13
2447288|NCT01081262|6003065|P2|COMPLETED|Overall Study||13
2447289|NCT01081262|6003066|P1|COMPLETED|Overall Study||13
2447290|NCT01081262|6003063|P4|STARTED|Overall Study||11
2447291|NCT01081262|6003064|P3|STARTED|Overall Study||13
2447292|NCT01081262|6003065|P2|STARTED|Overall Study||13
2447293|NCT01081262|6003066|P1|STARTED|Overall Study||13
2447294|NCT01081249|6003096|P2|NOT COMPLETED|Overall Study||1
2447295|NCT01081249|6003097|P1|NOT COMPLETED|Overall Study||0
2447296|NCT01081249|6003096|P2|COMPLETED|Overall Study||6
2447297|NCT01081249|6003097|P1|COMPLETED|Overall Study||11
2447298|NCT01081249|6003096|P2|Second Psychotherapy Appointment (1 Day)|Overall Study||6
2447299|NCT01081249|6003097|P1|Second Psychotherapy Appointment (1 Day)|Overall Study||11
2447300|NCT01081249|6003096|P2|Washout (5-10 Days)|Overall Study||6
2447301|NCT01081249|6003097|P1|Washout (5-10 Days)|Overall Study||11
2447302|NCT01081249|6003096|P2|First Psychotherapy Appointment (1 Day)|Overall Study||6
2447303|NCT01081249|6003097|P1|First Psychotherapy Appointment (1 Day)|Overall Study||11
2447304|NCT01081249|6003096|P2|STARTED|Overall Study||7
2447305|NCT01081249|6003097|P1|STARTED|Overall Study||11
2447306|NCT01081145|6003103|P2|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||106
2447307|NCT01081145|6003104|P1|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||81
2447308|NCT01081145|6003103|P2|COMPLETED|Double-Blind Randomized-Withdrawal Phase||53
2447309|NCT01081145|6003104|P1|COMPLETED|Double-Blind Randomized-Withdrawal Phase||76
2447310|NCT01081145|6003103|P2|STARTED|Double-Blind Randomized-Withdrawal Phase||159
2447311|NCT01081145|6003104|P1|STARTED|Double-Blind Randomized-Withdrawal Phase||157
2447312|NCT01081145|6003103|P2|NOT COMPLETED|Open-Label Phase||0
2447313|NCT01081145|6003104|P1|NOT COMPLETED|Open-Label Phase||212
2447314|NCT01081145|6003103|P2|COMPLETED|Open-Label Phase||0
2447315|NCT01081145|6003104|P1|COMPLETED|Open-Label Phase||316
2447316|NCT01081145|6003103|P2|STARTED|Open-Label Phase||0
2447317|NCT01081145|6003104|P1|STARTED|Open-Label Phase||528
2447318|NCT01081132|6003132|P2|NOT COMPLETED|Overall Study||52
2447319|NCT01081132|6003133|P1|NOT COMPLETED|Overall Study||55
2447320|NCT01081132|6003132|P2|COMPLETED|Overall Study||105
2447321|NCT01081132|6003133|P1|COMPLETED|Overall Study||102
2447322|NCT01081132|6003132|P2|STARTED|Overall Study||157
2447323|NCT01081132|6003133|P1|STARTED|Overall Study||157
2447324|NCT01081041|6003174|P3|NOT COMPLETED|Overall Study||2
2447325|NCT01081041|6003175|P2|NOT COMPLETED|Overall Study||4
2447326|NCT01081041|6003176|P1|NOT COMPLETED|Overall Study||0
2447327|NCT01081041|6003174|P3|COMPLETED|Overall Study||71
2447328|NCT01081041|6003175|P2|COMPLETED|Overall Study||77
2447329|NCT01081041|6003176|P1|COMPLETED|Overall Study||33
2447330|NCT01081041|6003174|P3|Received at Least 1 Dose of Study Drug|Overall Study||71
2447331|NCT01081041|6003175|P2|Received at Least 1 Dose of Study Drug|Overall Study||77
2447332|NCT01081041|6003176|P1|Received at Least 1 Dose of Study Drug|Overall Study||33
2447333|NCT01081041|6003174|P3|STARTED|Overall Study||73
2447334|NCT01081041|6003175|P2|STARTED|Overall Study||81
2447335|NCT01081041|6003176|P1|STARTED|Overall Study||33
2447336|NCT01080976|6003206|P2|NOT COMPLETED|Overall Study||0
2447337|NCT01080976|6003207|P1|NOT COMPLETED|Overall Study||0
2447338|NCT01080976|6003206|P2|COMPLETED|Overall Study||5
2447339|NCT01080976|6003207|P1|COMPLETED|Overall Study||5
2447340|NCT01080976|6003206|P2|STARTED|Overall Study||5
2447341|NCT01080976|6003207|P1|STARTED|Overall Study||5
2447342|NCT01080807|6003217|P2|NOT COMPLETED|Overall Study||23
2447343|NCT01080807|6003218|P1|NOT COMPLETED|Overall Study||35
2447344|NCT01080807|6003217|P2|COMPLETED|Overall Study||167
2447345|NCT01080807|6003218|P1|COMPLETED|Overall Study||158
2447346|NCT01080807|6003217|P2|STARTED|Overall Study|Three patients randomly assigned to the placebo treatment group did not receive study drug.|190
2447347|NCT01080807|6003218|P1|STARTED|Overall Study|Nine patients randomly assigned to the armodafinil treatment group did not receive study drug.|193
2447348|NCT01080794|6003276|P4|NOT COMPLETED|Overall Study||2
2447349|NCT01080794|6003277|P3|NOT COMPLETED|Overall Study||2
2447350|NCT01080794|6003278|P2|NOT COMPLETED|Overall Study||2
2447351|NCT01080794|6003279|P1|NOT COMPLETED|Overall Study||5
2447352|NCT01080794|6003276|P4|COMPLETED|Overall Study||13
2447353|NCT01080794|6003277|P3|COMPLETED|Overall Study||10
2447354|NCT01080794|6003278|P2|COMPLETED|Overall Study||12
2447355|NCT01080794|6003279|P1|COMPLETED|Overall Study||15
2447356|NCT01080794|6003276|P4|STARTED|Overall Study||15
2447357|NCT01080794|6003277|P3|STARTED|Overall Study||12
2447358|NCT01080794|6003278|P2|STARTED|Overall Study||14
2447359|NCT01080794|6003279|P1|STARTED|Overall Study||20
2447360|NCT01080768|6003327|P2|NOT COMPLETED|Overall Study||1
2447361|NCT01080768|6003328|P1|NOT COMPLETED|Overall Study||2
2447362|NCT01080768|6003327|P2|COMPLETED|Overall Study||16
2447363|NCT01080768|6003328|P1|COMPLETED|Overall Study||12
2447364|NCT01080768|6003327|P2|STARTED|Overall Study||17
2447365|NCT01080768|6003328|P1|STARTED|Overall Study||14
2447366|NCT01080716|6003338|P4|NOT COMPLETED|Part 2||0
2447367|NCT01080716|6003339|P3|NOT COMPLETED|Part 2||0
2447368|NCT01080716|6003340|P2|NOT COMPLETED|Part 2||0
2447369|NCT01080716|6003341|P1|NOT COMPLETED|Part 2||0
2447370|NCT01080716|6003338|P4|COMPLETED|Part 2||10
2447371|NCT01080716|6003339|P3|COMPLETED|Part 2||10
2447372|NCT01080716|6003340|P2|COMPLETED|Part 2||0
2447373|NCT01080716|6003341|P1|COMPLETED|Part 2||0
2447374|NCT01080716|6003338|P4|STARTED|Part 2||10
2447375|NCT01080716|6003339|P3|STARTED|Part 2||10
2447376|NCT01080716|6003340|P2|STARTED|Part 2||0
2447377|NCT01080716|6003341|P1|STARTED|Part 2||0
2447378|NCT01080716|6003338|P4|NOT COMPLETED|Part 1||0
2447379|NCT01080716|6003339|P3|NOT COMPLETED|Part 1||0
2447380|NCT01080716|6003340|P2|NOT COMPLETED|Part 1||0
2447381|NCT01080716|6003341|P1|NOT COMPLETED|Part 1||1
2447382|NCT01080716|6003338|P4|COMPLETED|Part 1||0
2447383|NCT01080716|6003339|P3|COMPLETED|Part 1||0
2447384|NCT01080716|6003340|P2|COMPLETED|Part 1||6
2447385|NCT01080716|6003341|P1|COMPLETED|Part 1||13
2447386|NCT01080716|6003338|P4|STARTED|Part 1||0
2447387|NCT01080716|6003339|P3|STARTED|Part 1||0
2447388|NCT01080716|6003340|P2|STARTED|Part 1||6
2447389|NCT01080716|6003341|P1|STARTED|Part 1||14
2447390|NCT01080677|6003358|P3|NOT COMPLETED|Overall Study||0
2447391|NCT01080677|6003359|P2|NOT COMPLETED|Overall Study||0
2447392|NCT01080677|6003360|P1|NOT COMPLETED|Overall Study||0
2447393|NCT01080677|6003358|P3|COMPLETED|Overall Study||20
2447394|NCT01080677|6003359|P2|COMPLETED|Overall Study||20
2447395|NCT01080677|6003360|P1|COMPLETED|Overall Study||20
2447396|NCT01080677|6003358|P3|STARTED|Overall Study||20
2447397|NCT01080677|6003359|P2|STARTED|Overall Study||20
2447398|NCT01080677|6003360|P1|STARTED|Overall Study||20
2447399|NCT01080625|6003380|P3|NOT COMPLETED|Overall Study||1
2447400|NCT01080625|6003381|P2|NOT COMPLETED|Overall Study||2
2447401|NCT01080625|6003382|P1|NOT COMPLETED|Overall Study||0
2447402|NCT01080625|6003380|P3|COMPLETED|Overall Study||31
2447403|NCT01080625|6003381|P2|COMPLETED|Overall Study||31
2447404|NCT01080625|6003382|P1|COMPLETED|Overall Study||31
2447405|NCT01080625|6003380|P3|STARTED|Overall Study||32
2447406|NCT01080625|6003381|P2|STARTED|Overall Study||33
2447407|NCT01080625|6003382|P1|STARTED|Overall Study||31
2447408|NCT01080391|6003392|P2|NOT COMPLETED|Overall Study||4
2447409|NCT01080391|6003393|P1|NOT COMPLETED|Overall Study||7
2447410|NCT01080391|6003392|P2|COMPLETED|Overall Study||392
2447411|NCT01080391|6003393|P1|COMPLETED|Overall Study||389
2447412|NCT01080391|6003392|P2|Treated|Overall Study||392
2447413|NCT01080391|6003393|P1|Treated|Overall Study||389
2447414|NCT01080391|6003392|P2|STARTED|Overall Study||396
2447415|NCT01080391|6003393|P1|STARTED|Overall Study||396
2447416|NCT01080326|6003411|P1|NOT COMPLETED|Overall Study||4
2447417|NCT01080326|6003411|P1|COMPLETED|Overall Study||3
2447418|NCT01080326|6003411|P1|STARTED|Overall Study||7
2447419|NCT01080300|6003417|P2|NOT COMPLETED|Overall Study||104
2447420|NCT01080300|6003418|P1|NOT COMPLETED|Overall Study||94
2447421|NCT01080300|6003417|P2|COMPLETED|Overall Study||191
2447422|NCT01080300|6003418|P1|COMPLETED|Overall Study||206
2447423|NCT01080300|6003417|P2|STARTED|Overall Study|298 subjects were randomized, but only 295 received study treatment.|295
2447424|NCT01080300|6003418|P1|STARTED|Overall Study|302 subjects were randomized, but only 300 received study treatment.|300
2447425|NCT01080261|6003426|P1|NOT COMPLETED|Overall Study||0
2447426|NCT01080261|6003426|P1|COMPLETED|Overall Study||60
2447427|NCT01080261|6003426|P1|STARTED|Overall Study||60
2447428|NCT01080248|6003441|P1|NOT COMPLETED|Overall Study||0
2447429|NCT01080248|6003441|P1|COMPLETED|Overall Study||2
2447430|NCT01080248|6003441|P1|STARTED|Overall Study||2
2447431|NCT01080209|6003455|P7|NOT COMPLETED|Overall Study||7
2447432|NCT01080209|6003456|P6|NOT COMPLETED|Overall Study||0
2447433|NCT01080209|6003457|P5|NOT COMPLETED|Overall Study||0
2447434|NCT01080209|6003458|P4|NOT COMPLETED|Overall Study||5
2447435|NCT01080209|6003459|P3|NOT COMPLETED|Overall Study||5
2447436|NCT01080209|6003460|P2|NOT COMPLETED|Overall Study||11
2447437|NCT01080209|6003461|P1|NOT COMPLETED|Overall Study||6
2447438|NCT01080209|6003455|P7|COMPLETED|Overall Study||44
2447439|NCT01080209|6003456|P6|COMPLETED|Overall Study||2
2447440|NCT01080209|6003457|P5|COMPLETED|Overall Study||6
2447441|NCT01080209|6003458|P4|COMPLETED|Overall Study||37
2447442|NCT01080209|6003459|P3|COMPLETED|Overall Study||28
2447443|NCT01080209|6003460|P2|COMPLETED|Overall Study||42
2447444|NCT01080209|6003461|P1|COMPLETED|Overall Study||22
2447445|NCT01080209|6003455|P7|STARTED|Overall Study||51
2447446|NCT01080209|6003456|P6|STARTED|Overall Study||2
2447447|NCT01080209|6003457|P5|STARTED|Overall Study||6
2447448|NCT01080209|6003458|P4|STARTED|Overall Study||42
2447449|NCT01080209|6003459|P3|STARTED|Overall Study||33
2447450|NCT01080209|6003460|P2|STARTED|Overall Study||53
2447451|NCT01080209|6003461|P1|STARTED|Overall Study||28
2447452|NCT01080196|6003486|P2|NOT COMPLETED|Overall Study||0
2447453|NCT01080196|6003487|P1|NOT COMPLETED|Overall Study||0
2447454|NCT01080196|6003486|P2|COMPLETED|Overall Study||66
2447455|NCT01080196|6003487|P1|COMPLETED|Overall Study||68
2447456|NCT01080196|6003486|P2|STARTED|Overall Study||66
2447457|NCT01080196|6003487|P1|STARTED|Overall Study||68
2447458|NCT01080131|6003503|P2|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||11
2447459|NCT01080131|6003504|P1|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||8
2447460|NCT01080131|6003503|P2|COMPLETED|Extension Study 2 (25-72 Weeks)||54
2447461|NCT01080131|6003504|P1|COMPLETED|Extension Study 2 (25-72 Weeks)||64
2447462|NCT01080131|6003503|P2|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|41
2447463|NCT01080131|6003504|P1|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab at any time during the 72 weeks|62
2447464|NCT01080131|6003503|P2|STARTED|Extension Study 2 (25-72 Weeks)||65
2447465|NCT01080131|6003504|P1|STARTED|Extension Study 2 (25-72 Weeks)||72
2447466|NCT01080131|6003503|P2|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||4
2447467|NCT01080131|6003504|P1|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||6
2447468|NCT01080131|6003503|P2|COMPLETED|Extension Study 1 (12 -24 Weeks)||72
2447469|NCT01080131|6003504|P1|COMPLETED|Extension Study 1 (12 -24 Weeks)||78
2447470|NCT01080131|6003503|P2|STARTED|Extension Study 1 (12 -24 Weeks)||76
2447471|NCT01080131|6003504|P1|STARTED|Extension Study 1 (12 -24 Weeks)||84
2447472|NCT01080131|6003503|P2|NOT COMPLETED|Core Study (0- 12 Weeks)||11
2447473|NCT01080131|6003504|P1|NOT COMPLETED|Core Study (0- 12 Weeks)||13
2447474|NCT01080131|6003503|P2|COMPLETED|Core Study (0- 12 Weeks)||103
2447475|NCT01080131|6003504|P1|COMPLETED|Core Study (0- 12 Weeks)||99
2447476|NCT01080131|6003503|P2|STARTED|Core Study (0- 12 Weeks)||114
2447477|NCT01080131|6003504|P1|STARTED|Core Study (0- 12 Weeks)||112
2447478|NCT01080118|6003583|P4|NOT COMPLETED|Overall Study||0
2447479|NCT01080118|6003584|P3|NOT COMPLETED|Overall Study||0
2447480|NCT01080118|6003585|P2|NOT COMPLETED|Overall Study||0
2447481|NCT01080118|6003586|P1|NOT COMPLETED|Overall Study||0
2447482|NCT01080118|6003583|P4|COMPLETED|Overall Study||30
2447483|NCT01080118|6003584|P3|COMPLETED|Overall Study||30
2447484|NCT01080118|6003585|P2|COMPLETED|Overall Study||15
2447485|NCT01080118|6003586|P1|COMPLETED|Overall Study||15
2447486|NCT01080118|6003583|P4|STARTED|Overall Study||30
2447487|NCT01080118|6003584|P3|STARTED|Overall Study||30
2447488|NCT01080118|6003585|P2|STARTED|Overall Study||15
2447489|NCT01080118|6003586|P1|STARTED|Overall Study||15
2447490|NCT01079988|6003599|P5|NOT COMPLETED|Overall Study||1
2447491|NCT01079988|6003600|P4|NOT COMPLETED|Overall Study||3
2447492|NCT01079988|6003601|P3|NOT COMPLETED|Overall Study||0
2447493|NCT01079988|6003602|P2|NOT COMPLETED|Overall Study||0
2447494|NCT01079988|6003603|P1|NOT COMPLETED|Overall Study||1
2447495|NCT01079988|6003599|P5|COMPLETED|Overall Study||1
2447496|NCT01079988|6003600|P4|COMPLETED|Overall Study||17
2447497|NCT01079988|6003601|P3|COMPLETED|Overall Study||8
2447498|NCT01079988|6003602|P2|COMPLETED|Overall Study||1
2447499|NCT01079988|6003603|P1|COMPLETED|Overall Study||9
2447500|NCT01079988|6003599|P5|STARTED|Overall Study||2
2447501|NCT01079988|6003600|P4|STARTED|Overall Study||20
2447502|NCT01079988|6003601|P3|STARTED|Overall Study||8
2447503|NCT01079988|6003602|P2|STARTED|Overall Study||1
2447504|NCT01079988|6003603|P1|STARTED|Overall Study||10
2447505|NCT01079962|6003622|P2|NOT COMPLETED|Overall Study||15
2447506|NCT01079962|6003623|P1|NOT COMPLETED|Overall Study||15
2447507|NCT01079962|6003622|P2|COMPLETED|Overall Study||89
2447508|NCT01079962|6003623|P1|COMPLETED|Overall Study||90
2447509|NCT01079962|6003622|P2|STARTED|Overall Study||104
2447510|NCT01079962|6003623|P1|STARTED|Overall Study||105
2447511|NCT01079949|6003651|P2|NOT COMPLETED|Overall Study||13
2447512|NCT01079949|6003652|P1|NOT COMPLETED|Overall Study||15
2447513|NCT01079949|6003651|P2|COMPLETED|Overall Study||34
2447514|NCT01079949|6003652|P1|COMPLETED|Overall Study||31
2447515|NCT01079949|6003651|P2|STARTED|Overall Study||47
2447516|NCT01079949|6003652|P1|STARTED|Overall Study||46
2447517|NCT01079936|6003698|P5|NOT COMPLETED|Phase II||1
2447518|NCT01079936|6003699|P4|NOT COMPLETED|Phase II||0
2447519|NCT01079936|6003700|P3|NOT COMPLETED|Phase II||1
2447520|NCT01079936|6003701|P2|NOT COMPLETED|Phase II||0
2447521|NCT01079936|6003702|P1|NOT COMPLETED|Phase II||0
2447522|NCT01079936|6003698|P5|COMPLETED|Phase II||25
2447523|NCT01079936|6003699|P4|COMPLETED|Phase II||24
2447524|NCT01079936|6003700|P3|COMPLETED|Phase II||5
2447525|NCT01079936|6003701|P2|COMPLETED|Phase II||3
2447526|NCT01079936|6003702|P1|COMPLETED|Phase II||0
2447527|NCT01079936|6003698|P5|STARTED|Phase II||26
2447528|NCT01079936|6003699|P4|STARTED|Phase II||24
2447529|NCT01079936|6003700|P3|STARTED|Phase II||6
2447530|NCT01079936|6003701|P2|STARTED|Phase II||3
2447531|NCT01079936|6003702|P1|STARTED|Phase II||0
2447532|NCT01079936|6003698|P5|NOT COMPLETED|Phase I: MTD||0
2447533|NCT01079936|6003699|P4|NOT COMPLETED|Phase I: MTD||0
2447534|NCT01079936|6003700|P3|NOT COMPLETED|Phase I: MTD||0
2447535|NCT01079936|6003701|P2|NOT COMPLETED|Phase I: MTD||0
2447536|NCT01079936|6003702|P1|NOT COMPLETED|Phase I: MTD||4
2447537|NCT01079936|6003698|P5|COMPLETED|Phase I: MTD||0
2447538|NCT01079936|6003699|P4|COMPLETED|Phase I: MTD||0
2447539|NCT01079936|6003700|P3|COMPLETED|Phase I: MTD||0
2447540|NCT01079936|6003701|P2|COMPLETED|Phase I: MTD||0
2447541|NCT01079936|6003702|P1|COMPLETED|Phase I: MTD|The 12 Phase I participants were randomized across 4 dose arms for Phase II.|12
2447542|NCT01079936|6003698|P5|STARTED|Phase I: MTD||0
2447543|NCT01079936|6003699|P4|STARTED|Phase I: MTD||0
2447544|NCT01079936|6003700|P3|STARTED|Phase I: MTD||0
2447545|NCT01079936|6003701|P2|STARTED|Phase I: MTD||0
2447546|NCT01079936|6003702|P1|STARTED|Phase I: MTD||16
2447547|NCT01079832|6003721|P1|NOT COMPLETED|Overall Study||1
2447548|NCT01079832|6003721|P1|COMPLETED|Overall Study||49
2447549|NCT01079832|6003721|P1|STARTED|Overall Study||50
2447550|NCT01079806|6003731|P2|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||15
2447551|NCT01079806|6003732|P1|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||19
2447552|NCT01079806|6003731|P2|COMPLETED|Long-term Follow-up: Day 1-End of Study||43
2447553|NCT01079806|6003732|P1|COMPLETED|Long-term Follow-up: Day 1-End of Study||92
2447554|NCT01079806|6003731|P2|STARTED|Long-term Follow-up: Day 1-End of Study||58
2447555|NCT01079806|6003732|P1|STARTED|Long-term Follow-up: Day 1-End of Study||111
2447556|NCT01079806|6003731|P2|NOT COMPLETED|Day 1 to Week 96||7
2447557|NCT01079806|6003732|P1|NOT COMPLETED|Day 1 to Week 96||7
2447558|NCT01079806|6003731|P2|COMPLETED|Day 1 to Week 96||53
2447559|NCT01079806|6003732|P1|COMPLETED|Day 1 to Week 96||113
2447560|NCT01079806|6003731|P2|Primary Endpoint Cohort|Day 1 to Week 96||41
2447561|NCT01079806|6003732|P1|Primary Endpoint Cohort|Day 1 to Week 96||82
2447562|NCT01079806|6003731|P2|Received Treatment|Day 1 to Week 96||60
2447563|NCT01079806|6003732|P1|Received Treatment|Day 1 to Week 96||120
2447564|NCT01079806|6003731|P2|STARTED|Day 1 to Week 96||60
2447565|NCT01079806|6003732|P1|STARTED|Day 1 to Week 96||120
2447566|NCT01079741|6003767|P5|NOT COMPLETED|Phase 2 (Weeks 37-48)||3
2447567|NCT01079741|6003768|P4|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
2447568|NCT01079741|6003769|P3|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
2447569|NCT01079741|6003770|P2|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
2447570|NCT01079741|6003771|P1|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
2447571|NCT01079741|6003767|P5|COMPLETED|Phase 2 (Weeks 37-48)||9
2447572|NCT01079741|6003768|P4|COMPLETED|Phase 2 (Weeks 37-48)||12
2447573|NCT01079741|6003769|P3|COMPLETED|Phase 2 (Weeks 37-48)||0
2447574|NCT01079741|6003770|P2|COMPLETED|Phase 2 (Weeks 37-48)||0
2447575|NCT01079741|6003771|P1|COMPLETED|Phase 2 (Weeks 37-48)||0
2447576|NCT01079741|6003767|P5|STARTED|Phase 2 (Weeks 37-48)||12
2447577|NCT01079741|6003768|P4|STARTED|Phase 2 (Weeks 37-48)||12
2447578|NCT01079741|6003769|P3|STARTED|Phase 2 (Weeks 37-48)||0
2447579|NCT01079741|6003770|P2|STARTED|Phase 2 (Weeks 37-48)||0
2447580|NCT01079741|6003771|P1|STARTED|Phase 2 (Weeks 37-48)||0
2447581|NCT01079741|6003767|P5|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
2447582|NCT01079741|6003768|P4|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
2447583|NCT01079741|6003769|P3|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||3
2447584|NCT01079741|6003770|P2|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
2447585|NCT01079741|6003771|P1|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
2447586|NCT01079741|6003767|P5|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
2447587|NCT01079741|6003768|P4|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
2447588|NCT01079741|6003769|P3|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
2447589|NCT01079741|6003770|P2|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
2447590|NCT01079741|6003771|P1|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
2447591|NCT01079741|6003767|P5|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
2447592|NCT01079741|6003768|P4|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
2447593|NCT01079741|6003769|P3|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||3
2447594|NCT01079741|6003770|P2|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
2447595|NCT01079741|6003771|P1|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
2447596|NCT01079741|6003767|P5|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
2447597|NCT01079741|6003768|P4|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
2447598|NCT01079741|6003769|P3|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
2447599|NCT01079741|6003770|P2|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||1
2447600|NCT01079741|6003771|P1|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
2447601|NCT01079741|6003767|P5|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
2447602|NCT01079741|6003768|P4|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
2447603|NCT01079741|6003769|P3|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
2447604|NCT01079741|6003770|P2|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||3
2447605|NCT01079741|6003771|P1|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
2447606|NCT01079741|6003767|P5|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
2447607|NCT01079741|6003768|P4|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
2447608|NCT01079741|6003769|P3|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
2447609|NCT01079741|6003770|P2|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||4
2447610|NCT01079741|6003771|P1|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
2447611|NCT01079741|6003767|P5|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
2447612|NCT01079741|6003768|P4|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
2447613|NCT01079741|6003769|P3|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
2447614|NCT01079741|6003770|P2|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
2447615|NCT01079741|6003771|P1|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
2447616|NCT01079741|6003767|P5|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
2447617|NCT01079741|6003768|P4|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
2447618|NCT01079741|6003769|P3|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
2447619|NCT01079741|6003770|P2|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
2447620|NCT01079741|6003771|P1|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||3
2447621|NCT01079741|6003767|P5|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
2447622|NCT01079741|6003768|P4|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
2447623|NCT01079741|6003769|P3|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
2447624|NCT01079741|6003770|P2|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
2447625|NCT01079741|6003771|P1|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||3
2447626|NCT01079598|6003785|P1|NOT COMPLETED|Overall Study||0
2447627|NCT01079598|6003785|P1|COMPLETED|Overall Study||8
2447628|NCT01079598|6003785|P1|STARTED|Overall Study||8
2447629|NCT01079390|6003795|P3|NOT COMPLETED|Overall Study||4
2447630|NCT01079390|6003796|P2|NOT COMPLETED|Overall Study||5
2447631|NCT01079390|6003797|P1|NOT COMPLETED|Overall Study||5
2447632|NCT01079390|6003795|P3|COMPLETED|Overall Study||10
2447633|NCT01079390|6003796|P2|COMPLETED|Overall Study||10
2447634|NCT01079390|6003797|P1|COMPLETED|Overall Study||10
2447635|NCT01079390|6003795|P3|STARTED|Overall Study||14
2447636|NCT01079390|6003796|P2|STARTED|Overall Study||15
2447637|NCT01079390|6003797|P1|STARTED|Overall Study||15
2447638|NCT01079299|6003809|P2|NOT COMPLETED|Overall Study||0
2447639|NCT01079299|6003810|P1|NOT COMPLETED|Overall Study||0
2447640|NCT01079299|6003809|P2|COMPLETED|Overall Study||25
2447641|NCT01079299|6003810|P1|COMPLETED|Overall Study||27
2447642|NCT01079299|6003809|P2|STARTED|Overall Study||25
2447643|NCT01079299|6003810|P1|STARTED|Overall Study||27
2447644|NCT01079234|6003819|P4|NOT COMPLETED|Extension: Week 27 to 52||16
2447645|NCT01079234|6003820|P3|NOT COMPLETED|Extension: Week 27 to 52||11
2447646|NCT01079234|6003821|P2|NOT COMPLETED|Extension: Week 27 to 52||0
2447647|NCT01079234|6003822|P1|NOT COMPLETED|Extension: Week 27 to 52||0
2447648|NCT01079234|6003819|P4|COMPLETED|Extension: Week 27 to 52||223
2447649|NCT01079234|6003820|P3|COMPLETED|Extension: Week 27 to 52||122
2447650|NCT01079234|6003821|P2|COMPLETED|Extension: Week 27 to 52||0
2447651|NCT01079234|6003822|P1|COMPLETED|Extension: Week 27 to 52||0
2447652|NCT01079234|6003819|P4|STARTED|Extension: Week 27 to 52|Thirty eight subjects did not continue into extension trial.|239
2447653|NCT01079234|6003820|P3|STARTED|Extension: Week 27 to 52|Nineteen subjects from main trial did not continue into extension trial|133
2447654|NCT01079234|6003821|P2|STARTED|Extension: Week 27 to 52||0
2447655|NCT01079234|6003822|P1|STARTED|Extension: Week 27 to 52||0
2447656|NCT01079234|6003819|P4|NOT COMPLETED|Main: Week 0 to 26||0
2447657|NCT01079234|6003820|P3|NOT COMPLETED|Main: Week 0 to 26||12
2447658|NCT01079234|6003821|P2|NOT COMPLETED|Main: Week 0 to 26||26
2447659|NCT01079234|6003822|P1|NOT COMPLETED|Main: Week 0 to 26||26
2447660|NCT01079234|6003819|P4|COMPLETED|Main: Week 0 to 26||0
2447661|NCT01079234|6003820|P3|COMPLETED|Main: Week 0 to 26||152
2447662|NCT01079234|6003821|P2|COMPLETED|Main: Week 0 to 26||139
2447663|NCT01079234|6003822|P1|COMPLETED|Main: Week 0 to 26||138
2447664|NCT01079234|6003819|P4|Exposed|Main: Week 0 to 26||0
2447665|NCT01079234|6003820|P3|Exposed|Main: Week 0 to 26|Three subjects withdrew prior to exposure to trial drug.|161
2447666|NCT01079234|6003821|P2|Exposed|Main: Week 0 to 26||165
2447667|NCT01079234|6003822|P1|Exposed|Main: Week 0 to 26||164
2447668|NCT01079234|6003819|P4|STARTED|Main: Week 0 to 26||0
2447669|NCT01079234|6003820|P3|STARTED|Main: Week 0 to 26||164
2447670|NCT01079234|6003821|P2|STARTED|Main: Week 0 to 26||165
2447671|NCT01079234|6003822|P1|STARTED|Main: Week 0 to 26||164
2447672|NCT01079195|6003840|P1|NOT COMPLETED|Overall Study||1431
2447673|NCT01079195|6003840|P1|COMPLETED|Overall Study||14442
2447674|NCT01079195|6003840|P1|STARTED|Overall Study||15873
2447675|NCT01079182|6003846|P1|NOT COMPLETED|Overall Study||2719
2447676|NCT01079182|6003846|P1|COMPLETED|Overall Study||1962
2447677|NCT01079182|6003846|P1|STARTED|Overall Study||4681
2447678|NCT01079143|6003877|P4|NOT COMPLETED|Overall Study||5
2447679|NCT01079143|6003878|P3|NOT COMPLETED|Overall Study||5
2447680|NCT01079143|6003879|P2|NOT COMPLETED|Overall Study||17
2447681|NCT01079143|6003880|P1|NOT COMPLETED|Overall Study||9
2447682|NCT01079143|6003877|P4|COMPLETED|Overall Study||54
2447683|NCT01079143|6003878|P3|COMPLETED|Overall Study||34
2447684|NCT01079143|6003879|P2|COMPLETED|Overall Study||43
2447685|NCT01079143|6003880|P1|COMPLETED|Overall Study||27
2447686|NCT01079143|6003877|P4|M3 and M12 Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
2447687|NCT01079143|6003878|P3|M3 and M12 Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
2447688|NCT01079143|6003879|P2|M3 and M12 Biopsies|Overall Study||43
2447689|NCT01079143|6003880|P1|M3 and M12 Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
2447690|NCT01079143|6003877|P4|Month 12 (M12) Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
2447691|NCT01079143|6003878|P3|Month 12 (M12) Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
2447692|NCT01079143|6003879|P2|Month 12 (M12) Biopsies|Overall Study||43
2447693|NCT01079143|6003880|P1|Month 12 (M12) Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
2447694|NCT01079143|6003877|P4|Month 3 (M3) Biopsies|Overall Study||59
2447695|NCT01079143|6003878|P3|Month 3 (M3) Biopsies|Overall Study||39
2447696|NCT01079143|6003879|P2|Month 3 (M3) Biopsies|Overall Study|1 patient was excluded due to an IF/TA Grade of III at the M3 Biopsy|59
2447697|NCT01079143|6003880|P1|Month 3 (M3) Biopsies|Overall Study||36
2447698|NCT01079143|6003877|P4|Exposed|Overall Study||59
2447699|NCT01079143|6003878|P3|Exposed|Overall Study||39
2447700|NCT01079143|6003879|P2|Exposed|Overall Study||60
2447701|NCT01079143|6003880|P1|Exposed|Overall Study||36
2447702|NCT01079143|6003877|P4|STARTED|Overall Study||59
2447703|NCT01079143|6003878|P3|STARTED|Overall Study||39
2447704|NCT01079143|6003879|P2|STARTED|Overall Study||60
2447705|NCT01079143|6003880|P1|STARTED|Overall Study||36
2447706|NCT01079130|6003954|P6|NOT COMPLETED|Overall Study||5
2447707|NCT01079130|6003955|P5|NOT COMPLETED|Overall Study||8
2447708|NCT01079130|6003956|P4|NOT COMPLETED|Overall Study||5
2447709|NCT01079130|6003957|P3|NOT COMPLETED|Overall Study||1
2447710|NCT01079130|6003958|P2|NOT COMPLETED|Overall Study||7
2447711|NCT01079130|6003959|P1|NOT COMPLETED|Overall Study||2
2447712|NCT01079130|6003954|P6|COMPLETED|Overall Study||80
2447713|NCT01079130|6003955|P5|COMPLETED|Overall Study||78
2447714|NCT01079130|6003956|P4|COMPLETED|Overall Study||81
2447715|NCT01079130|6003957|P3|COMPLETED|Overall Study||83
2447716|NCT01079130|6003958|P2|COMPLETED|Overall Study||78
2447717|NCT01079130|6003959|P1|COMPLETED|Overall Study||83
2447718|NCT01079130|6003954|P6|Full Analysis Set (FAS)|Overall Study||84
2447719|NCT01079130|6003955|P5|Full Analysis Set (FAS)|Overall Study||84
2447720|NCT01079130|6003956|P4|Full Analysis Set (FAS)|Overall Study||85
2447721|NCT01079130|6003957|P3|Full Analysis Set (FAS)|Overall Study||83
2447808|NCT01078623|6004122|P16|NOT COMPLETED|Treatment Period 4||1
2447722|NCT01079130|6003958|P2|Full Analysis Set (FAS)|Overall Study|2 patients (1 in 37.5 µg;1 in 75 µg group) randomized more than once and were excluded from the FAS.|80
2447723|NCT01079130|6003959|P1|Full Analysis Set (FAS)|Overall Study||84
2447724|NCT01079130|6003954|P6|Safety Set: Received Study Drug|Overall Study||84
2447725|NCT01079130|6003955|P5|Safety Set: Received Study Drug|Overall Study||84
2447726|NCT01079130|6003956|P4|Safety Set: Received Study Drug|Overall Study||85
2447727|NCT01079130|6003957|P3|Safety Set: Received Study Drug|Overall Study||84
2447728|NCT01079130|6003958|P2|Safety Set: Received Study Drug|Overall Study||81
2447729|NCT01079130|6003959|P1|Safety Set: Received Study Drug|Overall Study||84
2447730|NCT01079130|6003954|P6|STARTED|Overall Study||85
2447731|NCT01079130|6003955|P5|STARTED|Overall Study||86
2447732|NCT01079130|6003956|P4|STARTED|Overall Study||86
2447733|NCT01079130|6003957|P3|STARTED|Overall Study||84
2447734|NCT01079130|6003958|P2|STARTED|Overall Study||85
2447735|NCT01079130|6003959|P1|STARTED|Overall Study||85
2447736|NCT01078974|6003979|P1|NOT COMPLETED|Overall Study||3
2447737|NCT01078974|6003979|P1|COMPLETED|Overall Study||4
2447738|NCT01078974|6003979|P1|STARTED|Overall Study||7
2447739|NCT01078922|6003984|P1|NOT COMPLETED|Overall Study||1
2447740|NCT01078922|6003984|P1|COMPLETED|Overall Study||10
2447741|NCT01078922|6003984|P1|STARTED|Overall Study||11
2447742|NCT01078909|6003994|P5|NOT COMPLETED|Overall Study||2
2447743|NCT01078909|6003995|P4|NOT COMPLETED|Overall Study||1
2447744|NCT01078909|6003996|P3|NOT COMPLETED|Overall Study||1
2447745|NCT01078909|6003997|P2|NOT COMPLETED|Overall Study||4
2447746|NCT01078909|6003998|P1|NOT COMPLETED|Overall Study||2
2447747|NCT01078909|6003994|P5|COMPLETED|Overall Study||23
2447748|NCT01078909|6003995|P4|COMPLETED|Overall Study||24
2447749|NCT01078909|6003996|P3|COMPLETED|Overall Study||24
2447750|NCT01078909|6003997|P2|COMPLETED|Overall Study||21
2447751|NCT01078909|6003998|P1|COMPLETED|Overall Study||23
2447752|NCT01078909|6003994|P5|STARTED|Overall Study||25
2447753|NCT01078909|6003995|P4|STARTED|Overall Study||25
2447754|NCT01078909|6003996|P3|STARTED|Overall Study||25
2447755|NCT01078909|6003997|P2|STARTED|Overall Study||25
2447756|NCT01078909|6003998|P1|STARTED|Overall Study||25
2447757|NCT01078844|6004020|P1|NOT COMPLETED|Overall Study||4
2447758|NCT01078844|6004020|P1|COMPLETED|Overall Study||0
2447759|NCT01078844|6004020|P1|STARTED|Overall Study||4
2447760|NCT01078805|6004025|P1|NOT COMPLETED|Overall Study||2050
2447761|NCT01078805|6004025|P1|COMPLETED|Overall Study||2117
2447762|NCT01078805|6004025|P1|Modified Intent-To-Treat|Overall Study|≥1 dose of study drug (SD) and didn't discontinue SD more than 3 consecutive months during treatment|3720
2447763|NCT01078805|6004025|P1|Took at Least 1 Dose of Study Drug|Overall Study||4085
2447764|NCT01078805|6004025|P1|STARTED|Overall Study||4167
2447765|NCT01078753|6004039|P2|NOT COMPLETED|Treatment Period II||0
2447766|NCT01078753|6004040|P1|NOT COMPLETED|Treatment Period II||0
2447767|NCT01078753|6004039|P2|COMPLETED|Treatment Period II||44
2447768|NCT01078753|6004040|P1|COMPLETED|Treatment Period II||45
2447769|NCT01078753|6004039|P2|Full Analysis Set|Treatment Period II||44
2447770|NCT01078753|6004040|P1|Full Analysis Set|Treatment Period II|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
2447771|NCT01078753|6004039|P2|STARTED|Treatment Period II||44
2447772|NCT01078753|6004040|P1|STARTED|Treatment Period II|Desmopressin 120 µg - 4 participants Desmopressin 240 µg - 41 participants|45
2447773|NCT01078753|6004039|P2|NOT COMPLETED|Treatment Period I||0
2447774|NCT01078753|6004040|P1|NOT COMPLETED|Treatment Period I||0
2447775|NCT01078753|6004039|P2|COMPLETED|Treatment Period I||44
2447776|NCT01078753|6004040|P1|COMPLETED|Treatment Period I||45
2447777|NCT01078753|6004039|P2|Full Analysis Set|Treatment Period I||44
2447778|NCT01078753|6004040|P1|Full Analysis Set|Treatment Period I|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
2447779|NCT01078753|6004039|P2|STARTED|Treatment Period I||44
2447780|NCT01078753|6004040|P1|STARTED|Treatment Period I||45
2447781|NCT01078675|6004052|P2|NOT COMPLETED|Overall Study||6
2447782|NCT01078675|6004053|P1|NOT COMPLETED|Overall Study||68
2447783|NCT01078675|6004052|P2|COMPLETED|Overall Study|Healthy siblings did not participate in investigational product administration.|59
2447784|NCT01078675|6004053|P1|COMPLETED|Overall Study||182
2447785|NCT01078675|6004052|P2|Patients Treated|Overall Study||0
2447786|NCT01078675|6004053|P1|Patients Treated|Overall Study||198
2447787|NCT01078675|6004052|P2|STARTED|Overall Study||65
2447788|NCT01078675|6004053|P1|STARTED|Overall Study||250
2447789|NCT01078662|6004075|P5|NOT COMPLETED|Overall Study||11
2447790|NCT01078662|6004076|P4|NOT COMPLETED|Overall Study||7
2447791|NCT01078662|6004077|P3|NOT COMPLETED|Overall Study||21
2447792|NCT01078662|6004078|P2|NOT COMPLETED|Overall Study||168
2447793|NCT01078662|6004079|P1|NOT COMPLETED|Overall Study||58
2447794|NCT01078662|6004075|P5|COMPLETED|Overall Study||1
2447795|NCT01078662|6004076|P4|COMPLETED|Overall Study||1
2447796|NCT01078662|6004077|P3|COMPLETED|Overall Study||2
2447797|NCT01078662|6004078|P2|COMPLETED|Overall Study||25
2447798|NCT01078662|6004079|P1|COMPLETED|Overall Study||4
2447799|NCT01078662|6004075|P5|STARTED|Overall Study||12
2447800|NCT01078662|6004076|P4|STARTED|Overall Study||8
2447801|NCT01078662|6004077|P3|STARTED|Overall Study||23
2447802|NCT01078662|6004078|P2|STARTED|Overall Study||193
2447803|NCT01078662|6004079|P1|STARTED|Overall Study||62
2447804|NCT01078623|6004118|P20|NOT COMPLETED|Treatment Period 4||0
2447805|NCT01078623|6004119|P19|NOT COMPLETED|Treatment Period 4||0
2447806|NCT01078623|6004120|P18|NOT COMPLETED|Treatment Period 4||0
2447807|NCT01078623|6004121|P17|NOT COMPLETED|Treatment Period 4||0
2447809|NCT01078623|6004123|P15|NOT COMPLETED|Treatment Period 4||0
2447810|NCT01078623|6004124|P14|NOT COMPLETED|Treatment Period 4||0
2447811|NCT01078623|6004125|P13|NOT COMPLETED|Treatment Period 4||0
2447812|NCT01078623|6004126|P12|NOT COMPLETED|Treatment Period 4||0
2447813|NCT01078623|6004127|P11|NOT COMPLETED|Treatment Period 4||0
2447814|NCT01078623|6004128|P10|NOT COMPLETED|Treatment Period 4||0
2447815|NCT01078623|6004129|P9|NOT COMPLETED|Treatment Period 4||0
2447816|NCT01078623|6004130|P8|NOT COMPLETED|Treatment Period 4||0
2447817|NCT01078623|6004131|P7|NOT COMPLETED|Treatment Period 4||0
2447818|NCT01078623|6004132|P6|NOT COMPLETED|Treatment Period 4||0
2447819|NCT01078623|6004133|P5|NOT COMPLETED|Treatment Period 4||0
2447820|NCT01078623|6004134|P4|NOT COMPLETED|Treatment Period 4||0
2447821|NCT01078623|6004135|P3|NOT COMPLETED|Treatment Period 4||1
2447822|NCT01078623|6004136|P2|NOT COMPLETED|Treatment Period 4||0
2447823|NCT01078623|6004137|P1|NOT COMPLETED|Treatment Period 4||0
2447824|NCT01078623|6004118|P20|COMPLETED|Treatment Period 4||7
2447825|NCT01078623|6004119|P19|COMPLETED|Treatment Period 4||6
2447826|NCT01078623|6004120|P18|COMPLETED|Treatment Period 4||7
2447827|NCT01078623|6004121|P17|COMPLETED|Treatment Period 4||7
2447828|NCT01078623|6004122|P16|COMPLETED|Treatment Period 4||6
2447829|NCT01078623|6004123|P15|COMPLETED|Treatment Period 4||7
2447830|NCT01078623|6004124|P14|COMPLETED|Treatment Period 4||6
2447831|NCT01078623|6004125|P13|COMPLETED|Treatment Period 4||7
2447832|NCT01078623|6004126|P12|COMPLETED|Treatment Period 4||7
2447833|NCT01078623|6004127|P11|COMPLETED|Treatment Period 4||6
2447834|NCT01078623|6004128|P10|COMPLETED|Treatment Period 4||6
2447835|NCT01078623|6004129|P9|COMPLETED|Treatment Period 4||5
2447836|NCT01078623|6004130|P8|COMPLETED|Treatment Period 4||6
2447837|NCT01078623|6004131|P7|COMPLETED|Treatment Period 4||5
2447838|NCT01078623|6004132|P6|COMPLETED|Treatment Period 4||4
2447839|NCT01078623|6004133|P5|COMPLETED|Treatment Period 4||6
2447840|NCT01078623|6004134|P4|COMPLETED|Treatment Period 4||6
2447841|NCT01078623|6004135|P3|COMPLETED|Treatment Period 4||5
2447842|NCT01078623|6004136|P2|COMPLETED|Treatment Period 4||5
2447843|NCT01078623|6004137|P1|COMPLETED|Treatment Period 4||5
2447844|NCT01078623|6004118|P20|STARTED|Treatment Period 4||7
2447845|NCT01078623|6004119|P19|STARTED|Treatment Period 4||6
2447846|NCT01078623|6004120|P18|STARTED|Treatment Period 4||7
2447847|NCT01078623|6004121|P17|STARTED|Treatment Period 4||7
2447848|NCT01078623|6004122|P16|STARTED|Treatment Period 4||7
2447849|NCT01078623|6004123|P15|STARTED|Treatment Period 4||7
2447850|NCT01078623|6004124|P14|STARTED|Treatment Period 4||6
2447851|NCT01078623|6004125|P13|STARTED|Treatment Period 4||7
2447852|NCT01078623|6004126|P12|STARTED|Treatment Period 4||7
2447853|NCT01078623|6004127|P11|STARTED|Treatment Period 4||6
2447854|NCT01078623|6004128|P10|STARTED|Treatment Period 4||6
2447855|NCT01078623|6004129|P9|STARTED|Treatment Period 4||5
2447856|NCT01078623|6004130|P8|STARTED|Treatment Period 4||6
2447857|NCT01078623|6004131|P7|STARTED|Treatment Period 4||5
2447858|NCT01078623|6004132|P6|STARTED|Treatment Period 4||4
2447859|NCT01078623|6004133|P5|STARTED|Treatment Period 4||6
2447860|NCT01078623|6004134|P4|STARTED|Treatment Period 4||6
2447861|NCT01078623|6004135|P3|STARTED|Treatment Period 4||6
2447862|NCT01078623|6004136|P2|STARTED|Treatment Period 4||5
2447863|NCT01078623|6004137|P1|STARTED|Treatment Period 4||5
2447864|NCT01078623|6004118|P20|NOT COMPLETED|Treatment Period 3||0
2447865|NCT01078623|6004119|P19|NOT COMPLETED|Treatment Period 3||0
2447866|NCT01078623|6004120|P18|NOT COMPLETED|Treatment Period 3||0
2447867|NCT01078623|6004121|P17|NOT COMPLETED|Treatment Period 3||0
2447868|NCT01078623|6004122|P16|NOT COMPLETED|Treatment Period 3||0
2447869|NCT01078623|6004123|P15|NOT COMPLETED|Treatment Period 3||0
2447870|NCT01078623|6004124|P14|NOT COMPLETED|Treatment Period 3||1
2447871|NCT01078623|6004125|P13|NOT COMPLETED|Treatment Period 3||0
2447872|NCT01078623|6004126|P12|NOT COMPLETED|Treatment Period 3||0
2447873|NCT01078623|6004127|P11|NOT COMPLETED|Treatment Period 3||0
2447874|NCT01078623|6004128|P10|NOT COMPLETED|Treatment Period 3||0
2447875|NCT01078623|6004129|P9|NOT COMPLETED|Treatment Period 3||0
2447876|NCT01078623|6004130|P8|NOT COMPLETED|Treatment Period 3||0
2447877|NCT01078623|6004131|P7|NOT COMPLETED|Treatment Period 3||0
2447878|NCT01078623|6004132|P6|NOT COMPLETED|Treatment Period 3||0
2447879|NCT01078623|6004133|P5|NOT COMPLETED|Treatment Period 3||1
2447880|NCT01078623|6004134|P4|NOT COMPLETED|Treatment Period 3||0
2447881|NCT01078623|6004135|P3|NOT COMPLETED|Treatment Period 3||0
2447882|NCT01078623|6004136|P2|NOT COMPLETED|Treatment Period 3||0
2447883|NCT01078623|6004137|P1|NOT COMPLETED|Treatment Period 3||0
2447884|NCT01078623|6004118|P20|COMPLETED|Treatment Period 3||7
2447885|NCT01078623|6004119|P19|COMPLETED|Treatment Period 3||6
2447886|NCT01078623|6004120|P18|COMPLETED|Treatment Period 3||7
2447887|NCT01078623|6004121|P17|COMPLETED|Treatment Period 3||7
2447888|NCT01078623|6004122|P16|COMPLETED|Treatment Period 3||7
2447889|NCT01078623|6004123|P15|COMPLETED|Treatment Period 3||7
2447890|NCT01078623|6004124|P14|COMPLETED|Treatment Period 3||6
2447891|NCT01078623|6004125|P13|COMPLETED|Treatment Period 3||7
2447892|NCT01078623|6004126|P12|COMPLETED|Treatment Period 3||7
2447893|NCT01078623|6004127|P11|COMPLETED|Treatment Period 3||6
2447894|NCT01078623|6004128|P10|COMPLETED|Treatment Period 3||6
2447895|NCT01078623|6004129|P9|COMPLETED|Treatment Period 3||5
2447896|NCT01078623|6004130|P8|COMPLETED|Treatment Period 3||6
2447897|NCT01078623|6004131|P7|COMPLETED|Treatment Period 3||5
2447898|NCT01078623|6004132|P6|COMPLETED|Treatment Period 3||4
2447899|NCT01078623|6004133|P5|COMPLETED|Treatment Period 3||6
2447900|NCT01078623|6004134|P4|COMPLETED|Treatment Period 3||6
2447901|NCT01078623|6004135|P3|COMPLETED|Treatment Period 3||6
2447902|NCT01078623|6004136|P2|COMPLETED|Treatment Period 3||5
2447903|NCT01078623|6004137|P1|COMPLETED|Treatment Period 3||5
2447904|NCT01078623|6004118|P20|STARTED|Treatment Period 3||7
2447905|NCT01078623|6004119|P19|STARTED|Treatment Period 3||6
2447906|NCT01078623|6004120|P18|STARTED|Treatment Period 3||7
2447907|NCT01078623|6004121|P17|STARTED|Treatment Period 3||7
2447908|NCT01078623|6004122|P16|STARTED|Treatment Period 3||7
2447909|NCT01078623|6004123|P15|STARTED|Treatment Period 3||7
2447910|NCT01078623|6004124|P14|STARTED|Treatment Period 3||7
2447911|NCT01078623|6004125|P13|STARTED|Treatment Period 3||7
2447912|NCT01078623|6004126|P12|STARTED|Treatment Period 3||7
2447913|NCT01078623|6004127|P11|STARTED|Treatment Period 3||6
2447914|NCT01078623|6004128|P10|STARTED|Treatment Period 3||6
2447915|NCT01078623|6004129|P9|STARTED|Treatment Period 3||5
2447916|NCT01078623|6004130|P8|STARTED|Treatment Period 3||6
2447917|NCT01078623|6004131|P7|STARTED|Treatment Period 3||5
2447918|NCT01078623|6004132|P6|STARTED|Treatment Period 3||4
2447919|NCT01078623|6004133|P5|STARTED|Treatment Period 3||7
2447920|NCT01078623|6004134|P4|STARTED|Treatment Period 3||6
2447921|NCT01078623|6004135|P3|STARTED|Treatment Period 3||6
2447922|NCT01078623|6004136|P2|STARTED|Treatment Period 3||5
2447923|NCT01078623|6004137|P1|STARTED|Treatment Period 3||5
2447924|NCT01078623|6004118|P20|NOT COMPLETED|Treatment Period 2||0
2447925|NCT01078623|6004119|P19|NOT COMPLETED|Treatment Period 2||1
2447926|NCT01078623|6004120|P18|NOT COMPLETED|Treatment Period 2||0
2447927|NCT01078623|6004121|P17|NOT COMPLETED|Treatment Period 2||0
2447928|NCT01078623|6004122|P16|NOT COMPLETED|Treatment Period 2||0
2447929|NCT01078623|6004123|P15|NOT COMPLETED|Treatment Period 2||0
2447930|NCT01078623|6004124|P14|NOT COMPLETED|Treatment Period 2||0
2447931|NCT01078623|6004125|P13|NOT COMPLETED|Treatment Period 2||0
2447932|NCT01078623|6004126|P12|NOT COMPLETED|Treatment Period 2||0
2447933|NCT01078623|6004127|P11|NOT COMPLETED|Treatment Period 2||0
2447934|NCT01078623|6004128|P10|NOT COMPLETED|Treatment Period 2||0
2447935|NCT01078623|6004129|P9|NOT COMPLETED|Treatment Period 2||0
2447936|NCT01078623|6004130|P8|NOT COMPLETED|Treatment Period 2||0
2447937|NCT01078623|6004131|P7|NOT COMPLETED|Treatment Period 2||1
2447938|NCT01078623|6004132|P6|NOT COMPLETED|Treatment Period 2||1
2447939|NCT01078623|6004133|P5|NOT COMPLETED|Treatment Period 2||0
2447940|NCT01078623|6004134|P4|NOT COMPLETED|Treatment Period 2||0
2447941|NCT01078623|6004135|P3|NOT COMPLETED|Treatment Period 2||0
2447942|NCT01078623|6004136|P2|NOT COMPLETED|Treatment Period 2||0
2447943|NCT01078623|6004137|P1|NOT COMPLETED|Treatment Period 2||0
2447944|NCT01078623|6004118|P20|COMPLETED|Treatment Period 2||7
2447945|NCT01078623|6004119|P19|COMPLETED|Treatment Period 2||6
2447946|NCT01078623|6004120|P18|COMPLETED|Treatment Period 2||7
2447947|NCT01078623|6004121|P17|COMPLETED|Treatment Period 2||7
2447948|NCT01078623|6004122|P16|COMPLETED|Treatment Period 2||7
2447949|NCT01078623|6004123|P15|COMPLETED|Treatment Period 2||7
2447950|NCT01078623|6004124|P14|COMPLETED|Treatment Period 2||7
2447951|NCT01078623|6004125|P13|COMPLETED|Treatment Period 2||7
2447952|NCT01078623|6004126|P12|COMPLETED|Treatment Period 2||7
2447953|NCT01078623|6004127|P11|COMPLETED|Treatment Period 2||6
2447954|NCT01078623|6004128|P10|COMPLETED|Treatment Period 2||6
2447955|NCT01078623|6004129|P9|COMPLETED|Treatment Period 2||5
2447956|NCT01078623|6004130|P8|COMPLETED|Treatment Period 2||6
2447957|NCT01078623|6004131|P7|COMPLETED|Treatment Period 2||5
2447958|NCT01078623|6004132|P6|COMPLETED|Treatment Period 2||4
2447959|NCT01078623|6004133|P5|COMPLETED|Treatment Period 2||7
2447960|NCT01078623|6004134|P4|COMPLETED|Treatment Period 2||6
2447961|NCT01078623|6004135|P3|COMPLETED|Treatment Period 2||6
2447962|NCT01078623|6004136|P2|COMPLETED|Treatment Period 2||5
2447963|NCT01078623|6004137|P1|COMPLETED|Treatment Period 2||5
2447964|NCT01078623|6004118|P20|STARTED|Treatment Period 2||7
2447965|NCT01078623|6004119|P19|STARTED|Treatment Period 2||7
2447966|NCT01078623|6004120|P18|STARTED|Treatment Period 2||7
2447967|NCT01078623|6004121|P17|STARTED|Treatment Period 2||7
2447968|NCT01078623|6004122|P16|STARTED|Treatment Period 2||7
2447969|NCT01078623|6004123|P15|STARTED|Treatment Period 2||7
2447970|NCT01078623|6004124|P14|STARTED|Treatment Period 2||7
2447971|NCT01078623|6004125|P13|STARTED|Treatment Period 2||7
2447972|NCT01078623|6004126|P12|STARTED|Treatment Period 2||7
2447973|NCT01078623|6004127|P11|STARTED|Treatment Period 2||6
2447974|NCT01078623|6004128|P10|STARTED|Treatment Period 2||6
2447975|NCT01078623|6004129|P9|STARTED|Treatment Period 2||5
2447976|NCT01078623|6004130|P8|STARTED|Treatment Period 2||6
2447977|NCT01078623|6004131|P7|STARTED|Treatment Period 2||6
2447978|NCT01078623|6004132|P6|STARTED|Treatment Period 2||5
2447979|NCT01078623|6004133|P5|STARTED|Treatment Period 2||7
2447980|NCT01078623|6004134|P4|STARTED|Treatment Period 2||6
2447981|NCT01078623|6004135|P3|STARTED|Treatment Period 2||6
2447982|NCT01078623|6004136|P2|STARTED|Treatment Period 2||5
2447983|NCT01078623|6004137|P1|STARTED|Treatment Period 2||5
2447984|NCT01078623|6004118|P20|NOT COMPLETED|Treatment Period 1||0
2447985|NCT01078623|6004119|P19|NOT COMPLETED|Treatment Period 1||0
2447986|NCT01078623|6004120|P18|NOT COMPLETED|Treatment Period 1||0
2447987|NCT01078623|6004121|P17|NOT COMPLETED|Treatment Period 1||0
2447988|NCT01078623|6004122|P16|NOT COMPLETED|Treatment Period 1||0
2447989|NCT01078623|6004123|P15|NOT COMPLETED|Treatment Period 1||0
2447990|NCT01078623|6004124|P14|NOT COMPLETED|Treatment Period 1||0
2447991|NCT01078623|6004125|P13|NOT COMPLETED|Treatment Period 1||0
2447992|NCT01078623|6004126|P12|NOT COMPLETED|Treatment Period 1||0
2447993|NCT01078623|6004127|P11|NOT COMPLETED|Treatment Period 1||1
2447994|NCT01078623|6004128|P10|NOT COMPLETED|Treatment Period 1||1
2447995|NCT01078623|6004129|P9|NOT COMPLETED|Treatment Period 1||1
2447996|NCT01078623|6004130|P8|NOT COMPLETED|Treatment Period 1||1
2447997|NCT01078623|6004131|P7|NOT COMPLETED|Treatment Period 1||1
2447998|NCT01078623|6004132|P6|NOT COMPLETED|Treatment Period 1||1
2447999|NCT01078623|6004133|P5|NOT COMPLETED|Treatment Period 1||0
2448000|NCT01078623|6004134|P4|NOT COMPLETED|Treatment Period 1||0
2448001|NCT01078623|6004135|P3|NOT COMPLETED|Treatment Period 1||1
2448002|NCT01078623|6004136|P2|NOT COMPLETED|Treatment Period 1||1
2448003|NCT01078623|6004137|P1|NOT COMPLETED|Treatment Period 1||1
2448004|NCT01078623|6004118|P20|COMPLETED|Treatment Period 1||7
2448005|NCT01078623|6004119|P19|COMPLETED|Treatment Period 1||7
2448006|NCT01078623|6004120|P18|COMPLETED|Treatment Period 1||7
2448007|NCT01078623|6004121|P17|COMPLETED|Treatment Period 1||7
2448008|NCT01078623|6004122|P16|COMPLETED|Treatment Period 1||7
2448009|NCT01078623|6004123|P15|COMPLETED|Treatment Period 1||7
2448010|NCT01078623|6004124|P14|COMPLETED|Treatment Period 1||7
2448011|NCT01078623|6004125|P13|COMPLETED|Treatment Period 1||7
2448012|NCT01078623|6004126|P12|COMPLETED|Treatment Period 1||7
2448013|NCT01078623|6004127|P11|COMPLETED|Treatment Period 1||6
2448014|NCT01078623|6004128|P10|COMPLETED|Treatment Period 1||6
2448015|NCT01078623|6004129|P9|COMPLETED|Treatment Period 1||5
2448016|NCT01078623|6004130|P8|COMPLETED|Treatment Period 1||6
2448017|NCT01078623|6004131|P7|COMPLETED|Treatment Period 1||6
2448018|NCT01078623|6004132|P6|COMPLETED|Treatment Period 1||5
2448019|NCT01078623|6004133|P5|COMPLETED|Treatment Period 1||7
2448020|NCT01078623|6004134|P4|COMPLETED|Treatment Period 1||6
2448021|NCT01078623|6004135|P3|COMPLETED|Treatment Period 1||6
2448022|NCT01078623|6004136|P2|COMPLETED|Treatment Period 1||5
2448023|NCT01078623|6004137|P1|COMPLETED|Treatment Period 1||5
2448024|NCT01078623|6004118|P20|STARTED|Treatment Period 1||7
2448025|NCT01078623|6004119|P19|STARTED|Treatment Period 1||7
2448026|NCT01078623|6004120|P18|STARTED|Treatment Period 1||7
2448027|NCT01078623|6004121|P17|STARTED|Treatment Period 1||7
2448028|NCT01078623|6004122|P16|STARTED|Treatment Period 1||7
2448029|NCT01078623|6004123|P15|STARTED|Treatment Period 1||7
2448030|NCT01078623|6004124|P14|STARTED|Treatment Period 1||7
2448031|NCT01078623|6004125|P13|STARTED|Treatment Period 1||7
2448032|NCT01078623|6004126|P12|STARTED|Treatment Period 1||7
2448033|NCT01078623|6004127|P11|STARTED|Treatment Period 1||7
2448034|NCT01078623|6004128|P10|STARTED|Treatment Period 1||7
2448035|NCT01078623|6004129|P9|STARTED|Treatment Period 1||6
2448036|NCT01078623|6004130|P8|STARTED|Treatment Period 1||7
2448037|NCT01078623|6004131|P7|STARTED|Treatment Period 1||7
2448038|NCT01078623|6004132|P6|STARTED|Treatment Period 1||6
2448039|NCT01078623|6004133|P5|STARTED|Treatment Period 1||7
2448040|NCT01078623|6004134|P4|STARTED|Treatment Period 1||6
2448041|NCT01078623|6004135|P3|STARTED|Treatment Period 1||7
2448042|NCT01078623|6004136|P2|STARTED|Treatment Period 1||6
2448043|NCT01078623|6004137|P1|STARTED|Treatment Period 1||6
2448044|NCT01078584|6004159|P1|NOT COMPLETED|Overall Study||3010
2448045|NCT01078584|6004159|P1|COMPLETED|Overall Study||4983
2448046|NCT01078584|6004159|P1|Participants Conducted Visit 4(12-month)|Overall Study||4983
2448047|NCT01078584|6004159|P1|Participants Conducted Visit 3 (6-month)|Overall Study||5833
2448048|NCT01078584|6004159|P1|Participants Conducted Visit 2 (3-month)|Overall Study||7125
2448049|NCT01078584|6004159|P1|STARTED|Overall Study||7993
2448050|NCT01078571|6004240|P1|NOT COMPLETED|Overall Study||115
2448051|NCT01078571|6004240|P1|COMPLETED|Overall Study||590
2448052|NCT01078571|6004240|P1|Intent-to-treat (ITT) Population|Overall Study||591
2448053|NCT01078571|6004240|P1|Safety Population|Overall Study||675
2448054|NCT01078571|6004240|P1|STARTED|Overall Study||705
2448055|NCT01078558|6004259|P3|NOT COMPLETED|Overall Study||1361
2448056|NCT01078558|6004260|P2|NOT COMPLETED|Overall Study||755
2448057|NCT01078558|6004261|P1|NOT COMPLETED|Overall Study||2018
2448058|NCT01078558|6004259|P3|COMPLETED|Overall Study||596
2448059|NCT01078558|6004260|P2|COMPLETED|Overall Study||372
2448060|NCT01078558|6004261|P1|COMPLETED|Overall Study||818
2448061|NCT01078558|6004259|P3|Oligoarticular PsA|Overall Study||0
2448062|NCT01078558|6004260|P2|Oligoarticular PsA|Overall Study||197
2448063|NCT01078558|6004261|P1|Oligoarticular PsA|Overall Study||0
2448064|NCT01078558|6004259|P3|STARTED|Overall Study||1957
2448065|NCT01078558|6004260|P2|STARTED|Overall Study||1127
2448066|NCT01078558|6004261|P1|STARTED|Overall Study||2836
2448067|NCT01078545|6004291|P1|NOT COMPLETED|Overall Study||26
2448068|NCT01078545|6004291|P1|COMPLETED|Overall Study||703
2448069|NCT01078545|6004291|P1|Per Protocol Population|Overall Study||661
2448070|NCT01078545|6004291|P1|Intent-to-treat Population|Overall Study||729
2448071|NCT01078545|6004291|P1|STARTED|Overall Study||729
2448072|NCT01078454|6004301|P2|NOT COMPLETED|Overall Study||2
2448073|NCT01078454|6004302|P1|NOT COMPLETED|Overall Study||1
2448074|NCT01078454|6004301|P2|COMPLETED|Overall Study||3
2448075|NCT01078454|6004302|P1|COMPLETED|Overall Study||5
2448076|NCT01078454|6004301|P2|STARTED|Overall Study||5
2448077|NCT01078454|6004302|P1|STARTED|Overall Study||6
2448078|NCT01078441|6004308|P1|NOT COMPLETED|Overall Study||1
2448079|NCT01078441|6004308|P1|COMPLETED|Overall Study||1
2448080|NCT01078441|6004308|P1|STARTED|Overall Study||2
2448081|NCT01078402|6004315|P3|NOT COMPLETED|Overall Study||68
2448082|NCT01078402|6004316|P2|NOT COMPLETED|Overall Study||29
2448083|NCT01078402|6004317|P1|NOT COMPLETED|Overall Study||107
2448084|NCT01078402|6004315|P3|COMPLETED|Overall Study||166
2448085|NCT01078402|6004316|P2|COMPLETED|Overall Study||95
2448086|NCT01078402|6004317|P1|COMPLETED|Overall Study||324
2448087|NCT01078402|6004315|P3|STARTED|Overall Study||234
2448088|NCT01078402|6004316|P2|STARTED|Overall Study||124
2448089|NCT01078402|6004317|P1|STARTED|Overall Study||431
2448090|NCT01078389|6004348|P2|NOT COMPLETED|Overall Study||67
2448091|NCT01078389|6004349|P1|NOT COMPLETED|Overall Study||64
2448092|NCT01078389|6004348|P2|COMPLETED|Overall Study||90
2448093|NCT01078389|6004349|P1|COMPLETED|Overall Study||93
2448094|NCT01078389|6004348|P2|STARTED|Overall Study||157
2448095|NCT01078389|6004349|P1|STARTED|Overall Study||157
2448096|NCT01078376|6004367|P4|NOT COMPLETED|Overall Study||0
2448097|NCT01078376|6004368|P3|NOT COMPLETED|Overall Study||0
2448098|NCT01078376|6004369|P2|NOT COMPLETED|Overall Study||0
2448099|NCT01078376|6004370|P1|NOT COMPLETED|Overall Study||0
2448100|NCT01078376|6004367|P4|COMPLETED|Overall Study||3
2448101|NCT01078376|6004368|P3|COMPLETED|Overall Study||8
2448102|NCT01078376|6004369|P2|COMPLETED|Overall Study||9
2448103|NCT01078376|6004370|P1|COMPLETED|Overall Study||9
2448104|NCT01078376|6004367|P4|STARTED|Overall Study||3
2448105|NCT01078376|6004368|P3|STARTED|Overall Study||8
2448106|NCT01078376|6004369|P2|STARTED|Overall Study||9
2448107|NCT01078376|6004370|P1|STARTED|Overall Study||9
2448108|NCT01078363|6004491|P2|NOT COMPLETED|Overall Study||0
2448109|NCT01078363|6004492|P1|NOT COMPLETED|Overall Study||0
2448110|NCT01078363|6004491|P2|COMPLETED|Overall Study||49
2448111|NCT01078363|6004492|P1|COMPLETED|Overall Study||47
2448112|NCT01078363|6004491|P2|STARTED|Overall Study||49
2448113|NCT01078363|6004492|P1|STARTED|Overall Study||47
2448114|NCT01078298|6004510|P2|NOT COMPLETED|Overall Study||90
2448115|NCT01078298|6004511|P1|NOT COMPLETED|Overall Study||81
2448116|NCT01078298|6004510|P2|COMPLETED|Overall Study||179
2448117|NCT01078298|6004511|P1|COMPLETED|Overall Study||175
2448118|NCT01078298|6004510|P2|STARTED|Overall Study||269
2448119|NCT01078298|6004511|P1|STARTED|Overall Study||256
2448120|NCT01078246|6004544|P7|NOT COMPLETED|Overall Study||0
2448121|NCT01078246|6004545|P6|NOT COMPLETED|Overall Study||0
2448122|NCT01078246|6004546|P5|NOT COMPLETED|Overall Study||0
2448123|NCT01078246|6004547|P4|NOT COMPLETED|Overall Study||0
2448124|NCT01078246|6004548|P3|NOT COMPLETED|Overall Study||0
2448125|NCT01078246|6004549|P2|NOT COMPLETED|Overall Study||0
2448126|NCT01078246|6004550|P1|NOT COMPLETED|Overall Study||0
2448127|NCT01078246|6004544|P7|COMPLETED|Overall Study||22
2448128|NCT01078246|6004545|P6|COMPLETED|Overall Study||231
2448129|NCT01078246|6004546|P5|COMPLETED|Overall Study||3310
2448130|NCT01078246|6004547|P4|COMPLETED|Overall Study||152
2448131|NCT01078246|6004548|P3|COMPLETED|Overall Study||1963
2448132|NCT01078246|6004549|P2|COMPLETED|Overall Study||405
2448133|NCT01078246|6004550|P1|COMPLETED|Overall Study||1041
2448134|NCT01078246|6004544|P7|STARTED|Overall Study||22
2448135|NCT01078246|6004545|P6|STARTED|Overall Study||231
2448136|NCT01078246|6004546|P5|STARTED|Overall Study||3310
2448137|NCT01078246|6004547|P4|STARTED|Overall Study||152
2448138|NCT01078246|6004548|P3|STARTED|Overall Study||1963
2448139|NCT01078246|6004549|P2|STARTED|Overall Study||405
2448140|NCT01078246|6004550|P1|STARTED|Overall Study||1041
2448141|NCT01078233|6004582|P6|NOT COMPLETED|Overall Study||0
2448142|NCT01078233|6004583|P5|NOT COMPLETED|Overall Study||0
2448143|NCT01078233|6004584|P4|NOT COMPLETED|Overall Study||0
2448144|NCT01078233|6004585|P3|NOT COMPLETED|Overall Study||0
2448145|NCT01078233|6004586|P2|NOT COMPLETED|Overall Study||0
2448146|NCT01078233|6004587|P1|NOT COMPLETED|Overall Study||0
2448147|NCT01078233|6004582|P6|COMPLETED|Overall Study||154
2448148|NCT01078233|6004583|P5|COMPLETED|Overall Study||3199
2448149|NCT01078233|6004584|P4|COMPLETED|Overall Study||631
2448150|NCT01078233|6004585|P3|COMPLETED|Overall Study||1681
2448151|NCT01078233|6004586|P2|COMPLETED|Overall Study||296
2448152|NCT01078233|6004587|P1|COMPLETED|Overall Study||656
2448153|NCT01078233|6004582|P6|STARTED|Overall Study||154
2448154|NCT01078233|6004583|P5|STARTED|Overall Study||3199
2448155|NCT01078233|6004584|P4|STARTED|Overall Study||631
2448156|NCT01078233|6004585|P3|STARTED|Overall Study||1681
2448157|NCT01078233|6004586|P2|STARTED|Overall Study||296
2448158|NCT01078233|6004587|P1|STARTED|Overall Study||656
2448159|NCT01078220|6004604|P1|NOT COMPLETED|Overall Study||0
2448160|NCT01078220|6004604|P1|COMPLETED|Overall Study||189629
2448161|NCT01078220|6004604|P1|STARTED|Overall Study||189629
2448162|NCT01078207|6004614|P1|NOT COMPLETED|Overall Study||0
2448163|NCT01078207|6004614|P1|COMPLETED|Overall Study||100
2448164|NCT01078207|6004614|P1|STARTED|Overall Study||100
2448165|NCT01078168|6004621|P2|NOT COMPLETED|Overall Study||1
2448166|NCT01078168|6004622|P1|NOT COMPLETED|Overall Study||0
2448167|NCT01078168|6004621|P2|COMPLETED|Overall Study||10
2448168|NCT01078168|6004622|P1|COMPLETED|Overall Study||11
2448169|NCT01078168|6004621|P2|STARTED|Overall Study||11
2448170|NCT01078168|6004622|P1|STARTED|Overall Study||11
2448171|NCT01078155|6004628|P1|NOT COMPLETED|Overall Study||44
2448172|NCT01078155|6004628|P1|COMPLETED|Overall Study||87
2448173|NCT01078155|6004628|P1|STARTED|Overall Study||131
2448174|NCT01078116|6004644|P1|NOT COMPLETED|Overall Study||48
2448175|NCT01078116|6004644|P1|COMPLETED|Overall Study||76
2448176|NCT01078116|6004644|P1|STARTED|Overall Study|121 participants were included in analysis (3 were excluded due to missing case report form data).|124
2448177|NCT01078090|6004652|P1|NOT COMPLETED|Overall Study||4593
2448178|NCT01078090|6004652|P1|COMPLETED|Overall Study||1152
2448179|NCT01078090|6004652|P1|STARTED|Overall Study||5745
2448180|NCT01077973|6004696|P3|NOT COMPLETED|Overall Study||0
2448181|NCT01077973|6004697|P2|NOT COMPLETED|Overall Study||0
2448182|NCT01077973|6004698|P1|NOT COMPLETED|Overall Study||0
2448183|NCT01077973|6004696|P3|COMPLETED|Overall Study||80
2448184|NCT01077973|6004697|P2|COMPLETED|Overall Study||79
2448185|NCT01077973|6004698|P1|COMPLETED|Overall Study||41
2448186|NCT01077973|6004696|P3|STARTED|Overall Study||80
2448187|NCT01077973|6004697|P2|STARTED|Overall Study||79
2448188|NCT01077973|6004698|P1|STARTED|Overall Study||41
2448189|NCT01077960|6004746|P1|NOT COMPLETED|Overall Study||16
2448190|NCT01077960|6004746|P1|COMPLETED|Overall Study|Modified Intent To Treat (ITT) Population|110
2448191|NCT01077960|6004746|P1|STARTED|Overall Study|130 subjects consented to participate, 129 enrolled in the study, and 126 received study drug|126
2448192|NCT01077921|6004757|P2|NOT COMPLETED|Second Intervention||1
2448193|NCT01077921|6004758|P1|NOT COMPLETED|Second Intervention||0
2448194|NCT01077921|6004757|P2|COMPLETED|Second Intervention||9
2448195|NCT01077921|6004758|P1|COMPLETED|Second Intervention||13
2448196|NCT01077921|6004757|P2|STARTED|Second Intervention||10
2448197|NCT01077921|6004758|P1|STARTED|Second Intervention||13
2448198|NCT01077921|6004757|P2|NOT COMPLETED|Washout||2
2448199|NCT01077921|6004758|P1|NOT COMPLETED|Washout||0
2448200|NCT01077921|6004757|P2|COMPLETED|Washout||10
2448201|NCT01077921|6004758|P1|COMPLETED|Washout||13
2448202|NCT01077921|6004757|P2|STARTED|Washout||12
2448203|NCT01077921|6004758|P1|STARTED|Washout||13
2448204|NCT01077921|6004757|P2|NOT COMPLETED|First Intervention||1
2448205|NCT01077921|6004758|P1|NOT COMPLETED|First Intervention||1
2448206|NCT01077921|6004757|P2|COMPLETED|First Intervention||12
2448207|NCT01077921|6004758|P1|COMPLETED|First Intervention||13
2448208|NCT01077921|6004757|P2|STARTED|First Intervention||13
2448209|NCT01077921|6004758|P1|STARTED|First Intervention||14
2448210|NCT01077856|6004791|P3|NOT COMPLETED|Overall Study||0
2448211|NCT01077856|6004792|P2|NOT COMPLETED|Overall Study||0
2448212|NCT01077856|6004793|P1|NOT COMPLETED|Overall Study||0
2448213|NCT01077856|6004791|P3|COMPLETED|Overall Study||15713
2448214|NCT01077856|6004792|P2|COMPLETED|Overall Study||16604
2448215|NCT01077856|6004793|P1|COMPLETED|Overall Study||22199
2448216|NCT01077856|6004791|P3|STARTED|Overall Study||15713
2448217|NCT01077856|6004792|P2|STARTED|Overall Study||16604
2448218|NCT01077856|6004793|P1|STARTED|Overall Study||22199
2448219|NCT01077830|6004974|P2|NOT COMPLETED|Overall Study||0
2448220|NCT01077830|6004975|P1|NOT COMPLETED|Overall Study||0
2448221|NCT01077830|6004974|P2|COMPLETED|Overall Study||682
2448222|NCT01077830|6004975|P1|COMPLETED|Overall Study||677
2448223|NCT01077830|6004974|P2|STARTED|Overall Study||682
2448224|NCT01077830|6004975|P1|STARTED|Overall Study||677
2448225|NCT01077817|6004985|P1|NOT COMPLETED|Overall Study||0
2448226|NCT01077817|6004985|P1|COMPLETED|Overall Study||684815
2448227|NCT01077817|6004985|P1|STARTED|Overall Study|STARTED and COMPLETED is the number of participants meeting incl./excl. criteria in the GPRD.|684815
2448228|NCT01077804|6004996|P1|NOT COMPLETED|Overall Study||199
2448229|NCT01077804|6004996|P1|COMPLETED|Overall Study||7386
2448230|NCT01077804|6004996|P1|STARTED|Overall Study||7585
2448231|NCT01077739|6005005|P2|NOT COMPLETED|Overall Study||10
2448232|NCT01077739|6005006|P1|NOT COMPLETED|Overall Study||5
2448233|NCT01077739|6005005|P2|COMPLETED|Overall Study||40
2448234|NCT01077739|6005006|P1|COMPLETED|Overall Study||20
2448235|NCT01077739|6005005|P2|STARTED|Overall Study||50
2448236|NCT01077739|6005006|P1|STARTED|Overall Study||25
2448237|NCT01077713|6005020|P2|NOT COMPLETED|Overall Study||36
2448238|NCT01077713|6005021|P1|NOT COMPLETED|Overall Study||36
2448239|NCT01077713|6005020|P2|COMPLETED|Overall Study||6
2448240|NCT01077713|6005021|P1|COMPLETED|Overall Study||8
2448241|NCT01077713|6005020|P2|STARTED|Overall Study||42
2448242|NCT01077713|6005021|P1|STARTED|Overall Study||44
2448243|NCT01077622|6005045|P1|NOT COMPLETED|Overall Study||3
2448244|NCT01077622|6005045|P1|COMPLETED|Overall Study||7
2448245|NCT01077622|6005045|P1|STARTED|Overall Study||10
2448246|NCT01077596|6005103|P12|NOT COMPLETED|Overall Study||0
2448247|NCT01077596|6005104|P11|NOT COMPLETED|Overall Study||0
2448248|NCT01077596|6005105|P10|NOT COMPLETED|Overall Study||0
2448249|NCT01077596|6005106|P9|NOT COMPLETED|Overall Study||0
2448250|NCT01077596|6005107|P8|NOT COMPLETED|Overall Study||0
2448251|NCT01077596|6005108|P7|NOT COMPLETED|Overall Study||0
2448252|NCT01077596|6005109|P6|NOT COMPLETED|Overall Study||0
2448253|NCT01077596|6005110|P5|NOT COMPLETED|Overall Study||0
2448254|NCT01077596|6005111|P4|NOT COMPLETED|Overall Study||0
2448255|NCT01077596|6005112|P3|NOT COMPLETED|Overall Study||0
2448256|NCT01077596|6005113|P2|NOT COMPLETED|Overall Study||0
2448257|NCT01077596|6005114|P1|NOT COMPLETED|Overall Study||0
2448258|NCT01077596|6005103|P12|COMPLETED|Overall Study||22150
2448259|NCT01077596|6005104|P11|COMPLETED|Overall Study||2215
2448260|NCT01077596|6005105|P10|COMPLETED|Overall Study||28420
2448261|NCT01077596|6005106|P9|COMPLETED|Overall Study||2842
2448262|NCT01077596|6005107|P8|COMPLETED|Overall Study||837
2448263|NCT01077596|6005108|P7|COMPLETED|Overall Study||308
2448264|NCT01077596|6005109|P6|COMPLETED|Overall Study||882
2448265|NCT01077596|6005110|P5|COMPLETED|Overall Study||294
2448266|NCT01077596|6005111|P4|COMPLETED|Overall Study||1370
2448267|NCT01077596|6005112|P3|COMPLETED|Overall Study||457
2448268|NCT01077596|6005113|P2|COMPLETED|Overall Study||1050
2448269|NCT01077596|6005114|P1|COMPLETED|Overall Study||350
2448270|NCT01077596|6005103|P12|STARTED|Overall Study||22150
2448271|NCT01077596|6005104|P11|STARTED|Overall Study||2215
2448272|NCT01077596|6005105|P10|STARTED|Overall Study||28420
2448273|NCT01077596|6005106|P9|STARTED|Overall Study||2842
2448274|NCT01077596|6005107|P8|STARTED|Overall Study||837
2448275|NCT01077596|6005108|P7|STARTED|Overall Study||308
2448276|NCT01077596|6005109|P6|STARTED|Overall Study||882
2448277|NCT01077596|6005110|P5|STARTED|Overall Study||294
2448278|NCT01077596|6005111|P4|STARTED|Overall Study||1370
2448279|NCT01077596|6005112|P3|STARTED|Overall Study||457
2448280|NCT01077596|6005113|P2|STARTED|Overall Study||1050
2448281|NCT01077596|6005114|P1|STARTED|Overall Study||350
2448282|NCT01077544|6005165|P2|NOT COMPLETED|Overall Study||5
2448283|NCT01077544|6005166|P1|NOT COMPLETED|Overall Study||3
2448284|NCT01077544|6005165|P2|COMPLETED|Overall Study||2
2448285|NCT01077544|6005166|P1|COMPLETED|Overall Study||5
2448286|NCT01077544|6005165|P2|STARTED|Overall Study||7
2448287|NCT01077544|6005166|P1|STARTED|Overall Study||8
2448288|NCT01077401|6005194|P2|NOT COMPLETED|Overall Study||21
2448289|NCT01077401|6005195|P1|NOT COMPLETED|Overall Study||18
2448290|NCT01077401|6005194|P2|COMPLETED|Overall Study||54
2448291|NCT01077401|6005195|P1|COMPLETED|Overall Study||59
2448292|NCT01077401|6005194|P2|STARTED|Overall Study||75
2448293|NCT01077401|6005195|P1|STARTED|Overall Study||77
2448294|NCT01077375|6005207|P2|NOT COMPLETED|Overall Study||35
2448295|NCT01077375|6005208|P1|NOT COMPLETED|Overall Study||10
2448296|NCT01077375|6005207|P2|COMPLETED|Overall Study||51
2448297|NCT01077375|6005208|P1|COMPLETED|Overall Study||11
2448298|NCT01077375|6005207|P2|STARTED|Overall Study|One randomized patient not taking study drug was excluded from the Double-blind Safety Population.|86
2448299|NCT01077375|6005208|P1|STARTED|Overall Study||21
2448300|NCT01077362|6005219|P3|NOT COMPLETED|Overall Study||24
2448301|NCT01077362|6005220|P2|NOT COMPLETED|Overall Study||19
2448302|NCT01077362|6005221|P1|NOT COMPLETED|Overall Study||31
2448303|NCT01077362|6005219|P3|COMPLETED|Overall Study||81
2448304|NCT01077362|6005220|P2|COMPLETED|Overall Study||84
2448305|NCT01077362|6005221|P1|COMPLETED|Overall Study||73
2448306|NCT01077362|6005219|P3|STARTED|Overall Study||105
2448307|NCT01077362|6005220|P2|STARTED|Overall Study||103
2448308|NCT01077362|6005221|P1|STARTED|Overall Study||104
2448309|NCT01077323|6005257|P3|NOT COMPLETED|Overall Study||11912089
2448310|NCT01077323|6005258|P2|NOT COMPLETED|Overall Study||386263
2448311|NCT01077323|6005259|P1|NOT COMPLETED|Overall Study||11378
2448312|NCT01077323|6005257|P3|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|103511
2448313|NCT01077323|6005258|P2|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|234536
2448314|NCT01077323|6005259|P1|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|25719
2448315|NCT01077323|6005257|P3|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|12015600
2448316|NCT01077323|6005258|P2|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|620799
2448317|NCT01077323|6005259|P1|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|37097
2448318|NCT01077310|6005278|P2|NOT COMPLETED|Overall Study||0
2448319|NCT01077310|6005279|P1|NOT COMPLETED|Overall Study||0
2448320|NCT01077310|6005278|P2|COMPLETED|Overall Study||33
2448321|NCT01077310|6005279|P1|COMPLETED|Overall Study||67
2448322|NCT01077310|6005278|P2|STARTED|Overall Study||33
2448323|NCT01077310|6005279|P1|STARTED|Overall Study||67
2448324|NCT01077284|6005302|P3|NOT COMPLETED|Overall Study||3
2448325|NCT01077284|6005303|P2|NOT COMPLETED|Overall Study||5
2448326|NCT01077284|6005304|P1|NOT COMPLETED|Overall Study||5
2448327|NCT01077284|6005302|P3|COMPLETED|Overall Study||30
2448328|NCT01077284|6005303|P2|COMPLETED|Overall Study||28
2448329|NCT01077284|6005304|P1|COMPLETED|Overall Study||28
2448330|NCT01077284|6005302|P3|STARTED|Overall Study||33
2448331|NCT01077284|6005303|P2|STARTED|Overall Study||33
2448332|NCT01077284|6005304|P1|STARTED|Overall Study||33
2448333|NCT01077271|6005325|P1|NOT COMPLETED|Overall Study||22
2448334|NCT01077271|6005325|P1|COMPLETED|Overall Study||102
2448335|NCT01077271|6005325|P1|Number of Participants Analyzed|Overall Study||120
2448336|NCT01077271|6005325|P1|Participants Treated With Palivizumab|Overall Study||120
2448337|NCT01077271|6005325|P1|STARTED|Overall Study||124
2448338|NCT01077258|6005363|P1|NOT COMPLETED|Overall Study||2568
2448339|NCT01077258|6005363|P1|COMPLETED|Overall Study||1640
2448340|NCT01077258|6005363|P1|STARTED|Overall Study||4208
2448341|NCT01077193|6005399|P1|NOT COMPLETED|Overall Study||44
2448342|NCT01077193|6005399|P1|COMPLETED|Overall Study||0
2448343|NCT01077193|6005399|P1|STARTED|Overall Study||44
2448344|NCT01077154|6005405|P2|NOT COMPLETED|Overall Study||2228
2448345|NCT01077154|6005406|P1|NOT COMPLETED|Overall Study||2226
2448346|NCT01077154|6005405|P2|COMPLETED|Overall Study||28
2448347|NCT01077154|6005406|P1|COMPLETED|Overall Study||27
2448348|NCT01077154|6005405|P2|Received Study Drug|Overall Study||2230
2448349|NCT01077154|6005406|P1|Received Study Drug|Overall Study||2229
2448350|NCT01077154|6005405|P2|STARTED|Overall Study||2256
2448351|NCT01077154|6005406|P1|STARTED|Overall Study||2253
2448352|NCT01077128|6005420|P1|NOT COMPLETED|Overall Study||67
2448353|NCT01077128|6005420|P1|COMPLETED|Overall Study||433
2448354|NCT01077128|6005420|P1|STARTED|Overall Study||500
2448355|NCT01077076|6005478|P6|NOT COMPLETED|Third Intervention||1
2448356|NCT01077076|6005479|P5|NOT COMPLETED|Third Intervention||0
2448357|NCT01077076|6005480|P4|NOT COMPLETED|Third Intervention||0
2448358|NCT01077076|6005481|P3|NOT COMPLETED|Third Intervention||0
2448359|NCT01077076|6005482|P2|NOT COMPLETED|Third Intervention||0
2448360|NCT01077076|6005483|P1|NOT COMPLETED|Third Intervention||0
2448361|NCT01077076|6005478|P6|COMPLETED|Third Intervention||4
2448362|NCT01077076|6005479|P5|COMPLETED|Third Intervention||5
2448363|NCT01077076|6005480|P4|COMPLETED|Third Intervention||5
2448364|NCT01077076|6005481|P3|COMPLETED|Third Intervention||5
2448365|NCT01077076|6005482|P2|COMPLETED|Third Intervention||5
2448366|NCT01077076|6005483|P1|COMPLETED|Third Intervention||4
2448367|NCT01077076|6005478|P6|STARTED|Third Intervention||5
2448368|NCT01077076|6005479|P5|STARTED|Third Intervention||5
2448369|NCT01077076|6005480|P4|STARTED|Third Intervention||5
2448370|NCT01077076|6005481|P3|STARTED|Third Intervention||5
2448371|NCT01077076|6005482|P2|STARTED|Third Intervention||5
2448372|NCT01077076|6005483|P1|STARTED|Third Intervention||4
2448373|NCT01077076|6005478|P6|NOT COMPLETED|Washout Period of 2 Weeks||0
2448374|NCT01077076|6005479|P5|NOT COMPLETED|Washout Period of 2 Weeks||0
2448375|NCT01077076|6005480|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
2448376|NCT01077076|6005481|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
2448377|NCT01077076|6005482|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
2448378|NCT01077076|6005483|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
2448379|NCT01077076|6005478|P6|COMPLETED|Washout Period of 2 Weeks||5
2448380|NCT01077076|6005479|P5|COMPLETED|Washout Period of 2 Weeks||5
2448381|NCT01077076|6005480|P4|COMPLETED|Washout Period of 2 Weeks||5
2448382|NCT01077076|6005481|P3|COMPLETED|Washout Period of 2 Weeks||5
2448383|NCT01077076|6005482|P2|COMPLETED|Washout Period of 2 Weeks||5
2448384|NCT01077076|6005483|P1|COMPLETED|Washout Period of 2 Weeks||4
2448385|NCT01077076|6005478|P6|STARTED|Washout Period of 2 Weeks||5
2448386|NCT01077076|6005479|P5|STARTED|Washout Period of 2 Weeks||5
2448387|NCT01077076|6005480|P4|STARTED|Washout Period of 2 Weeks||5
2448388|NCT01077076|6005481|P3|STARTED|Washout Period of 2 Weeks||5
2448389|NCT01077076|6005482|P2|STARTED|Washout Period of 2 Weeks||5
2448390|NCT01077076|6005483|P1|STARTED|Washout Period of 2 Weeks||4
2448391|NCT01077076|6005478|P6|NOT COMPLETED|Second Intervention||0
2448392|NCT01077076|6005479|P5|NOT COMPLETED|Second Intervention||0
2448393|NCT01077076|6005480|P4|NOT COMPLETED|Second Intervention||0
2448394|NCT01077076|6005481|P3|NOT COMPLETED|Second Intervention||0
2448395|NCT01077076|6005482|P2|NOT COMPLETED|Second Intervention||0
2448396|NCT01077076|6005483|P1|NOT COMPLETED|Second Intervention||0
2448397|NCT01077076|6005478|P6|COMPLETED|Second Intervention||5
2448398|NCT01077076|6005479|P5|COMPLETED|Second Intervention||5
2448399|NCT01077076|6005480|P4|COMPLETED|Second Intervention||5
2448400|NCT01077076|6005481|P3|COMPLETED|Second Intervention||5
2448401|NCT01077076|6005482|P2|COMPLETED|Second Intervention||5
2448402|NCT01077076|6005483|P1|COMPLETED|Second Intervention||4
2448403|NCT01077076|6005478|P6|STARTED|Second Intervention||5
2448404|NCT01077076|6005479|P5|STARTED|Second Intervention||5
2448405|NCT01077076|6005480|P4|STARTED|Second Intervention||5
2448406|NCT01077076|6005481|P3|STARTED|Second Intervention||5
2448407|NCT01077076|6005482|P2|STARTED|Second Intervention||5
2448408|NCT01077076|6005483|P1|STARTED|Second Intervention||4
2448409|NCT01077076|6005478|P6|NOT COMPLETED|Washout Period of 2 Weeks||0
2448410|NCT01077076|6005479|P5|NOT COMPLETED|Washout Period of 2 Weeks||0
2448411|NCT01077076|6005480|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
2448412|NCT01077076|6005481|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
2448413|NCT01077076|6005482|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
2448414|NCT01077076|6005483|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
2448415|NCT01077076|6005478|P6|COMPLETED|Washout Period of 2 Weeks||5
2448416|NCT01077076|6005479|P5|COMPLETED|Washout Period of 2 Weeks||5
2448417|NCT01077076|6005480|P4|COMPLETED|Washout Period of 2 Weeks||5
2448418|NCT01077076|6005481|P3|COMPLETED|Washout Period of 2 Weeks||5
2448419|NCT01077076|6005482|P2|COMPLETED|Washout Period of 2 Weeks||5
2448420|NCT01077076|6005483|P1|COMPLETED|Washout Period of 2 Weeks||4
2448421|NCT01077076|6005478|P6|STARTED|Washout Period of 2 Weeks||5
2448422|NCT01077076|6005479|P5|STARTED|Washout Period of 2 Weeks||5
2448423|NCT01077076|6005480|P4|STARTED|Washout Period of 2 Weeks||5
2448424|NCT01077076|6005481|P3|STARTED|Washout Period of 2 Weeks||5
2448425|NCT01077076|6005482|P2|STARTED|Washout Period of 2 Weeks||5
2448426|NCT01077076|6005483|P1|STARTED|Washout Period of 2 Weeks||4
2448427|NCT01077076|6005478|P6|NOT COMPLETED|First Intervention||0
2448428|NCT01077076|6005479|P5|NOT COMPLETED|First Intervention||0
2448429|NCT01077076|6005480|P4|NOT COMPLETED|First Intervention||0
2448430|NCT01077076|6005481|P3|NOT COMPLETED|First Intervention||0
2448431|NCT01077076|6005482|P2|NOT COMPLETED|First Intervention||0
2448432|NCT01077076|6005483|P1|NOT COMPLETED|First Intervention||1
2448433|NCT01077076|6005478|P6|COMPLETED|First Intervention||5
2448434|NCT01077076|6005479|P5|COMPLETED|First Intervention||5
2448435|NCT01077076|6005480|P4|COMPLETED|First Intervention||5
2448436|NCT01077076|6005481|P3|COMPLETED|First Intervention||5
2448437|NCT01077076|6005482|P2|COMPLETED|First Intervention||5
2448438|NCT01077076|6005483|P1|COMPLETED|First Intervention||4
2448439|NCT01077076|6005478|P6|STARTED|First Intervention||5
2448440|NCT01077076|6005479|P5|STARTED|First Intervention||5
2448441|NCT01077076|6005480|P4|STARTED|First Intervention||5
2448442|NCT01077076|6005481|P3|STARTED|First Intervention||5
2448443|NCT01077076|6005482|P2|STARTED|First Intervention||5
2448444|NCT01077076|6005483|P1|STARTED|First Intervention||5
2448445|NCT01077063|6005493|P2|NOT COMPLETED|Overall Study||3
2448446|NCT01077063|6005494|P1|NOT COMPLETED|Overall Study||4
2448447|NCT01077063|6005493|P2|COMPLETED|Overall Study||0
2448448|NCT01077063|6005494|P1|COMPLETED|Overall Study||0
2448449|NCT01077063|6005493|P2|STARTED|Overall Study||3
2448450|NCT01077063|6005494|P1|STARTED|Overall Study||4
2448451|NCT01077050|6005500|P1|NOT COMPLETED|Overall Study||9
2448452|NCT01077050|6005500|P1|COMPLETED|Overall Study||1942
2448453|NCT01077050|6005500|P1|STARTED|Overall Study||1951
2448454|NCT01077024|6005506|P2|NOT COMPLETED|Overall Study||28
2448455|NCT01077024|6005507|P1|NOT COMPLETED|Overall Study||31
2448456|NCT01077024|6005506|P2|COMPLETED|Overall Study||243
2448457|NCT01077024|6005507|P1|COMPLETED|Overall Study||236
2448458|NCT01077024|6005506|P2|STARTED|Overall Study||271
2448459|NCT01077024|6005507|P1|STARTED|Overall Study||267
2448460|NCT01076985|6005525|P1|NOT COMPLETED|Overall Study||0
2448461|NCT01076985|6005525|P1|COMPLETED|Overall Study||24
2448462|NCT01076985|6005525|P1|STARTED|Overall Study||24
2448463|NCT01076972|6005531|P1|NOT COMPLETED|Overall Study||0
2448464|NCT01076972|6005531|P1|COMPLETED|Overall Study||1184
2448465|NCT01076972|6005531|P1|STARTED|Overall Study||1184
2448466|NCT01076959|6005546|P1|NOT COMPLETED|Overall Study||2250
2448467|NCT01076959|6005546|P1|COMPLETED|Overall Study||5490
2448468|NCT01076959|6005546|P1|STARTED|Overall Study||7740
2448469|NCT01076686|6005567|P4|NOT COMPLETED|Overall Study||0
2448470|NCT01076686|6005568|P3|NOT COMPLETED|Overall Study||0
2448471|NCT01076686|6005569|P2|NOT COMPLETED|Overall Study||0
2448472|NCT01076686|6005570|P1|NOT COMPLETED|Overall Study||0
2448473|NCT01076686|6005567|P4|COMPLETED|Overall Study||31
2448474|NCT01076686|6005568|P3|COMPLETED|Overall Study||32
2448475|NCT01076686|6005569|P2|COMPLETED|Overall Study||14
2448476|NCT01076686|6005570|P1|COMPLETED|Overall Study||17
2448477|NCT01076686|6005567|P4|STARTED|Overall Study||31
2448478|NCT01076686|6005568|P3|STARTED|Overall Study||32
2448479|NCT01076686|6005569|P2|STARTED|Overall Study||14
2448480|NCT01076686|6005570|P1|STARTED|Overall Study||17
2448481|NCT01076647|6005582|P2|NOT COMPLETED|Overall Study||25
2448482|NCT01076647|6005583|P1|NOT COMPLETED|Overall Study||25
2448483|NCT01076647|6005582|P2|COMPLETED|Overall Study||209
2448484|NCT01076647|6005583|P1|COMPLETED|Overall Study||208
2448485|NCT01076647|6005582|P2|STARTED|Overall Study||234
2448486|NCT01076647|6005583|P1|STARTED|Overall Study||233
2448487|NCT01076543|6005597|P6|NOT COMPLETED|Overall Study||0
2448488|NCT01076543|6005598|P5|NOT COMPLETED|Overall Study||0
2448489|NCT01076543|6005599|P4|NOT COMPLETED|Overall Study||0
2448490|NCT01076543|6005600|P3|NOT COMPLETED|Overall Study||0
2448491|NCT01076543|6005601|P2|NOT COMPLETED|Overall Study||0
2448492|NCT01076543|6005602|P1|NOT COMPLETED|Overall Study||2
2448493|NCT01076543|6005597|P6|COMPLETED|Overall Study||39
2448494|NCT01076543|6005598|P5|COMPLETED|Overall Study||15
2448495|NCT01076543|6005599|P4|COMPLETED|Overall Study||39
2448496|NCT01076543|6005600|P3|COMPLETED|Overall Study||6
2448497|NCT01076543|6005601|P2|COMPLETED|Overall Study||3
2448498|NCT01076543|6005602|P1|COMPLETED|Overall Study||6
2448499|NCT01076543|6005597|P6|STARTED|Overall Study||39
2448500|NCT01076543|6005598|P5|STARTED|Overall Study||15
2448501|NCT01076543|6005599|P4|STARTED|Overall Study||39
2448502|NCT01076543|6005600|P3|STARTED|Overall Study||6
2448503|NCT01076543|6005601|P2|STARTED|Overall Study||3
2448504|NCT01076543|6005602|P1|STARTED|Overall Study||8
2448505|NCT01076504|6005640|P1|NOT COMPLETED|Overall Study||80
2448506|NCT01076504|6005640|P1|COMPLETED|Overall Study|Patients remained on study until disease progression or withdrawal for any other reason|0
2448507|NCT01076504|6005640|P1|STARTED|Overall Study||80
2448508|NCT01076452|6005650|P2|NOT COMPLETED|Overall Study||14
2448509|NCT01076452|6005651|P1|NOT COMPLETED|Overall Study||24
2448510|NCT01076452|6005650|P2|COMPLETED|Overall Study||138
2448511|NCT01076452|6005651|P1|COMPLETED|Overall Study||123
2448512|NCT01076452|6005650|P2|STARTED|Overall Study||152
2448513|NCT01076452|6005651|P1|STARTED|Overall Study||147
2448514|NCT01076400|6005663|P3|NOT COMPLETED|Overall Study||0
2448515|NCT01076400|6005664|P2|NOT COMPLETED|Overall Study||0
2448516|NCT01076400|6005665|P1|NOT COMPLETED|Overall Study||7
2448517|NCT01076400|6005663|P3|COMPLETED|Overall Study||0
2448518|NCT01076400|6005664|P2|COMPLETED|Overall Study||0
2448519|NCT01076400|6005665|P1|COMPLETED|Overall Study||0
2448520|NCT01076400|6005663|P3|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0
2448521|NCT01076400|6005664|P2|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0
2448522|NCT01076400|6005665|P1|STARTED|Overall Study||7
2448523|NCT01076361|6005671|P1|NOT COMPLETED|Overall Study||21
2448524|NCT01076361|6005671|P1|COMPLETED|Overall Study|Follow-up data was not available for 21 participants (22 leads)|349
2448525|NCT01076361|6005671|P1|STARTED|Overall Study|631 leads were implanted in 370 patients. 22 leads in 21 patients were excluded from analysis.|370
2448526|NCT01076348|6005675|P1|NOT COMPLETED|Overall Study||22
2448527|NCT01076348|6005675|P1|COMPLETED|Overall Study||51
2448528|NCT01076348|6005675|P1|STARTED|Overall Study||73
2448529|NCT01076335|6005679|P1|NOT COMPLETED|Overall Study||4
2448530|NCT01076335|6005679|P1|COMPLETED|Overall Study||36
2448531|NCT01076335|6005679|P1|STARTED|Overall Study||40
2448532|NCT01076296|6005683|P8|NOT COMPLETED|Overall Study||0
2448533|NCT01076296|6005684|P7|NOT COMPLETED|Overall Study||0
2448534|NCT01076296|6005685|P6|NOT COMPLETED|Overall Study||0
2448535|NCT01076296|6005686|P5|NOT COMPLETED|Overall Study||0
2448536|NCT01076296|6005687|P4|NOT COMPLETED|Overall Study||0
2448537|NCT01076296|6005688|P3|NOT COMPLETED|Overall Study||0
2448538|NCT01076296|6005689|P2|NOT COMPLETED|Overall Study||0
2448539|NCT01076296|6005690|P1|NOT COMPLETED|Overall Study||0
2448540|NCT01076296|6005683|P8|COMPLETED|Overall Study||199
2448541|NCT01076296|6005684|P7|COMPLETED|Overall Study||51
2448542|NCT01076296|6005685|P6|COMPLETED|Overall Study||191
2448543|NCT01076296|6005686|P5|COMPLETED|Overall Study||59
2448544|NCT01076296|6005687|P4|COMPLETED|Overall Study||199
2448545|NCT01076296|6005688|P3|COMPLETED|Overall Study||51
2448546|NCT01076296|6005689|P2|COMPLETED|Overall Study||196
2448547|NCT01076296|6005690|P1|COMPLETED|Overall Study||54
2448548|NCT01076296|6005683|P8|STARTED|Overall Study||199
2448549|NCT01076296|6005684|P7|STARTED|Overall Study||51
2448550|NCT01076296|6005685|P6|STARTED|Overall Study||191
2448551|NCT01076296|6005686|P5|STARTED|Overall Study||59
2448552|NCT01076296|6005687|P4|STARTED|Overall Study||199
2448553|NCT01076296|6005688|P3|STARTED|Overall Study||51
2448554|NCT01076296|6005689|P2|STARTED|Overall Study||196
2448555|NCT01076296|6005690|P1|STARTED|Overall Study||54
2448556|NCT01076283|6005710|P2|NOT COMPLETED|Overall Study||0
2448557|NCT01076283|6005711|P1|NOT COMPLETED|Overall Study||1
2448558|NCT01076283|6005710|P2|COMPLETED|Overall Study||7
2448559|NCT01076283|6005711|P1|COMPLETED|Overall Study||6
2448560|NCT01076283|6005710|P2|STARTED|Overall Study||7
2448561|NCT01076283|6005711|P1|STARTED|Overall Study||7
2448562|NCT01076270|6005719|P1|NOT COMPLETED|Overall Study||0
2448563|NCT01076270|6005719|P1|COMPLETED|Overall Study||1
2448564|NCT01076270|6005719|P1|STARTED|Overall Study||1
2448565|NCT01076244|6005724|P1|NOT COMPLETED|Overall Study||4
2448566|NCT01076244|6005724|P1|COMPLETED|Overall Study||42
2448567|NCT01076244|6005724|P1|STARTED|Overall Study||46
2448568|NCT01076205|6005731|P1|NOT COMPLETED|Overall Study||6019
2448569|NCT01076205|6005731|P1|COMPLETED|Overall Study||1210
2448570|NCT01076205|6005731|P1|STARTED|Overall Study||7229
2448571|NCT01076192|6005784|P1|NOT COMPLETED|Overall Study||197
2448572|NCT01076192|6005784|P1|COMPLETED|Overall Study||350
2448573|NCT01076192|6005784|P1|STARTED|Overall Study||547
2448574|NCT01076179|6005799|P1|NOT COMPLETED|Overall Study||1
2448575|NCT01076179|6005799|P1|COMPLETED|Overall Study||501
2448576|NCT01076179|6005799|P1|STARTED|Overall Study||502
2448577|NCT01076166|6005822|P1|NOT COMPLETED|Overall Study||9
2448578|NCT01076166|6005822|P1|COMPLETED|Overall Study||328
2448579|NCT01076166|6005822|P1|STARTED|Overall Study||337
2448580|NCT01076153|6005829|P1|NOT COMPLETED|Overall Study||11
2448581|NCT01076153|6005829|P1|COMPLETED|Overall Study||749
2448582|NCT01076153|6005829|P1|STARTED|Overall Study||760
2448583|NCT01076088|6005843|P6|NOT COMPLETED|Overall Study||23
2448584|NCT01076088|6005844|P5|NOT COMPLETED|Overall Study||16
2448585|NCT01076088|6005845|P4|NOT COMPLETED|Overall Study||15
2448586|NCT01076088|6005846|P3|NOT COMPLETED|Overall Study||17
2448587|NCT01076088|6005847|P2|NOT COMPLETED|Overall Study||18
2448588|NCT01076088|6005848|P1|NOT COMPLETED|Overall Study||11
2448589|NCT01076088|6005843|P6|COMPLETED|Overall Study||104
2448590|NCT01076088|6005844|P5|COMPLETED|Overall Study||104
2448591|NCT01076088|6005845|P4|COMPLETED|Overall Study||109
2448592|NCT01076088|6005846|P3|COMPLETED|Overall Study||109
2448593|NCT01076088|6005847|P2|COMPLETED|Overall Study||107
2448594|NCT01076088|6005848|P1|COMPLETED|Overall Study||111
2448595|NCT01076088|6005843|P6|STARTED|Overall Study||127
2448596|NCT01076088|6005844|P5|STARTED|Overall Study||120
2448597|NCT01076088|6005845|P4|STARTED|Overall Study||124
2448598|NCT01076088|6005846|P3|STARTED|Overall Study||126
2448599|NCT01076088|6005847|P2|STARTED|Overall Study||125
2448600|NCT01076088|6005848|P1|STARTED|Overall Study||122
2448601|NCT01076075|6005876|P2|NOT COMPLETED|Overall Study||47
2448602|NCT01076075|6005877|P1|NOT COMPLETED|Overall Study||41
2448603|NCT01076075|6005876|P2|COMPLETED|Overall Study||167
2448604|NCT01076075|6005877|P1|COMPLETED|Overall Study||172
2448605|NCT01076075|6005876|P2|Completed Phase A|Overall Study||189
2448606|NCT01076075|6005877|P1|Completed Phase A|Overall Study||199
2448607|NCT01076075|6005876|P2|STARTED|Overall Study|2 participants were excluded from safety and efficacy analyses due to one site's non-compliance|214
2448608|NCT01076075|6005877|P1|STARTED|Overall Study|3 participants were excluded from safety and efficacy analyses due to one site's non-compliance|213
2448609|NCT01076036|6005891|P1|NOT COMPLETED|Overall Study||2
2448610|NCT01076036|6005891|P1|COMPLETED|Overall Study||8
2448611|NCT01076036|6005891|P1|Complete CorPath Procedures|Overall Study||8
2448612|NCT01076036|6005891|P1|# of Procedures|Overall Study||8
2448613|NCT01076036|6005891|P1|STARTED|Overall Study||10
2448614|NCT01075984|6005901|P5|NOT COMPLETED|Follow-up Phase||47
2448615|NCT01075984|6005902|P4|NOT COMPLETED|Follow-up Phase||2
2448616|NCT01075984|6005903|P3|NOT COMPLETED|Follow-up Phase||1
2448617|NCT01075984|6005904|P2|NOT COMPLETED|Follow-up Phase||0
2448618|NCT01075984|6005905|P1|NOT COMPLETED|Follow-up Phase||0
2448619|NCT01075984|6005901|P5|COMPLETED|Follow-up Phase||165
2448620|NCT01075984|6005902|P4|COMPLETED|Follow-up Phase||19
2448621|NCT01075984|6005903|P3|COMPLETED|Follow-up Phase||19
2448622|NCT01075984|6005904|P2|COMPLETED|Follow-up Phase||10
2448623|NCT01075984|6005905|P1|COMPLETED|Follow-up Phase||10
2448624|NCT01075984|6005901|P5|STARTED|Follow-up Phase|One participant withdrew consent before the start of the follow-up phase.|212
2448625|NCT01075984|6005902|P4|STARTED|Follow-up Phase|Three participants did not start the follow-up phase: one died and two were lost to follow-up.|21
2448626|NCT01075984|6005903|P3|STARTED|Follow-up Phase|One participant did not start the follow-up phase for reasons unrelated to study procedures.|20
2448627|NCT01075984|6005904|P2|STARTED|Follow-up Phase||10
2448628|NCT01075984|6005905|P1|STARTED|Follow-up Phase||10
2448629|NCT01075984|6005901|P5|NOT COMPLETED|Treatment Phase||60
2448630|NCT01075984|6005902|P4|NOT COMPLETED|Treatment Phase||7
2448631|NCT01075984|6005903|P3|NOT COMPLETED|Treatment Phase||7
2448632|NCT01075984|6005904|P2|NOT COMPLETED|Treatment Phase||1
2448633|NCT01075984|6005905|P1|NOT COMPLETED|Treatment Phase||0
2448634|NCT01075984|6005901|P5|COMPLETED|Treatment Phase||153
2448635|NCT01075984|6005902|P4|COMPLETED|Treatment Phase||17
2448636|NCT01075984|6005903|P3|COMPLETED|Treatment Phase||14
2448637|NCT01075984|6005904|P2|COMPLETED|Treatment Phase||10
2448638|NCT01075984|6005905|P1|COMPLETED|Treatment Phase||10
2448639|NCT01075984|6005901|P5|STARTED|Treatment Phase||213
2448640|NCT01075984|6005902|P4|STARTED|Treatment Phase||24
2448641|NCT01075984|6005903|P3|STARTED|Treatment Phase||21
2448642|NCT01075984|6005904|P2|STARTED|Treatment Phase||11
2448643|NCT01075984|6005905|P1|STARTED|Treatment Phase||10
2448644|NCT01075971|6005959|P1|NOT COMPLETED|Overall Study||0
2448645|NCT01075971|6005959|P1|COMPLETED|Overall Study||52
2448646|NCT01075971|6005959|P1|STARTED|Overall Study||52
2448647|NCT01075958|6005963|P1|NOT COMPLETED|Overall Study||44
2448648|NCT01075958|6005963|P1|COMPLETED|Overall Study||239
2448649|NCT01075958|6005963|P1|STARTED|Overall Study||283
2448650|NCT01075815|6005979|P2|NOT COMPLETED|Overall Study||4
2448651|NCT01075815|6005980|P1|NOT COMPLETED|Overall Study||10
2448652|NCT01075815|6005979|P2|COMPLETED|Overall Study||31
2448653|NCT01075815|6005980|P1|COMPLETED|Overall Study||30
2448654|NCT01075815|6005979|P2|STARTED|Overall Study|Number of participants treated.|35
2448655|NCT01075815|6005980|P1|STARTED|Overall Study|Number of participants treated.|40
2448656|NCT01075763|6006018|P2|NOT COMPLETED|Overall Study||4
2448657|NCT01075763|6006019|P1|NOT COMPLETED|Overall Study||4
2448658|NCT01075763|6006018|P2|COMPLETED|Overall Study||15
2448659|NCT01075763|6006019|P1|COMPLETED|Overall Study||19
2448660|NCT01075763|6006018|P2|STARTED|Overall Study||19
2448661|NCT01075763|6006019|P1|STARTED|Overall Study||23
2448662|NCT01075685|6006043|P2|NOT COMPLETED|Overall Study||226
2448663|NCT01075685|6006044|P1|NOT COMPLETED|Overall Study||592
2448664|NCT01075685|6006043|P2|COMPLETED|Overall Study||188
2448665|NCT01075685|6006044|P1|COMPLETED|Overall Study||151
2448666|NCT01075685|6006043|P2|Completed Baseline Measures|Overall Study||263
2448667|NCT01075685|6006044|P1|Completed Baseline Measures|Overall Study||225
2448668|NCT01075685|6006043|P2|Met Inclusion Criteria|Overall Study||413
2448669|NCT01075685|6006044|P1|Met Inclusion Criteria|Overall Study||734
2448670|NCT01075685|6006043|P2|STARTED|Overall Study||414
2448671|NCT01075685|6006044|P1|STARTED|Overall Study||743
2448672|NCT01075646|6006060|P4|NOT COMPLETED|Overall Study||2
2448673|NCT01075646|6006061|P3|NOT COMPLETED|Overall Study||1
2448674|NCT01075646|6006062|P2|NOT COMPLETED|Overall Study||3
2448675|NCT01075646|6006063|P1|NOT COMPLETED|Overall Study||4
2448676|NCT01075646|6006060|P4|COMPLETED|Overall Study||44
2448677|NCT01075646|6006061|P3|COMPLETED|Overall Study||52
2448678|NCT01075646|6006062|P2|COMPLETED|Overall Study||31
2448679|NCT01075646|6006063|P1|COMPLETED|Overall Study||29
2448680|NCT01075646|6006060|P4|STARTED|Overall Study||46
2448681|NCT01075646|6006061|P3|STARTED|Overall Study||53
2448682|NCT01075646|6006062|P2|STARTED|Overall Study||34
2448683|NCT01075646|6006063|P1|STARTED|Overall Study||33
2448684|NCT01075412|6006095|P2|NOT COMPLETED|Overall Study||1
2448685|NCT01075412|6006096|P1|NOT COMPLETED|Overall Study||0
2448686|NCT01075412|6006095|P2|COMPLETED|Overall Study||1
2448687|NCT01075412|6006096|P1|COMPLETED|Overall Study||4
2448688|NCT01075412|6006095|P2|STARTED|Overall Study||2
2448689|NCT01075412|6006096|P1|STARTED|Overall Study||4
2448690|NCT01075399|6006106|P1|NOT COMPLETED|Overall Study||8
2448691|NCT01075399|6006106|P1|COMPLETED|Overall Study|42 of 50 patients received at least one dose and 39 of 50 patients completed two pre-treatment scan|42
2448692|NCT01075399|6006106|P1|STARTED|Overall Study|A total of 50 patients were enrolled into the study.|50
2448693|NCT01075347|6006112|P2|NOT COMPLETED|Overall Study||0
2448694|NCT01075347|6006113|P1|NOT COMPLETED|Overall Study||0
2448695|NCT01075347|6006112|P2|COMPLETED|Overall Study||83
2448696|NCT01075347|6006113|P1|COMPLETED|Overall Study||82
2448697|NCT01075347|6006112|P2|STARTED|Overall Study||83
2448698|NCT01075347|6006113|P1|STARTED|Overall Study||82
2448699|NCT01075282|6006124|P3|NOT COMPLETED|Overall Study||27
2448700|NCT01075282|6006125|P2|NOT COMPLETED|Overall Study||29
2448701|NCT01075282|6006126|P1|NOT COMPLETED|Overall Study||31
2448702|NCT01075282|6006124|P3|COMPLETED|Overall Study||238
2448703|NCT01075282|6006125|P2|COMPLETED|Overall Study||243
2448704|NCT01075282|6006126|P1|COMPLETED|Overall Study||242
2448705|NCT01075282|6006124|P3|Received at Least One Dose of Study Drug|Overall Study||262
2448706|NCT01075282|6006125|P2|Received at Least One Dose of Study Drug|Overall Study||272
2448707|NCT01075282|6006126|P1|Received at Least One Dose of Study Drug|Overall Study||273
2448708|NCT01075282|6006124|P3|STARTED|Overall Study|Of 265 participants randomized to Insulin Glargine, 3 chose not to take study drug.|265
2448709|NCT01075282|6006125|P2|STARTED|Overall Study||272
2448710|NCT01075282|6006126|P1|STARTED|Overall Study||273
2448711|NCT01075256|6006209|P3|NOT COMPLETED|Overall Study||0
2448712|NCT01075256|6006210|P2|NOT COMPLETED|Overall Study||0
2448713|NCT01075256|6006211|P1|NOT COMPLETED|Overall Study||1
2448714|NCT01075256|6006209|P3|COMPLETED|Overall Study||65
2448715|NCT01075256|6006210|P2|COMPLETED|Overall Study||66
2448716|NCT01075256|6006211|P1|COMPLETED|Overall Study||63
2448717|NCT01075256|6006209|P3|STARTED|Overall Study||65
2448718|NCT01075256|6006210|P2|STARTED|Overall Study||66
2448719|NCT01075256|6006211|P1|STARTED|Overall Study||64
2448720|NCT01075243|6006243|P3|NOT COMPLETED|Overall Study||0
2448721|NCT01075243|6006244|P2|NOT COMPLETED|Overall Study||3
2448722|NCT01075243|6006245|P1|NOT COMPLETED|Overall Study||6
2448723|NCT01075243|6006243|P3|COMPLETED|Overall Study||80
2448724|NCT01075243|6006244|P2|COMPLETED|Overall Study||155
2448725|NCT01075243|6006245|P1|COMPLETED|Overall Study||157
2448726|NCT01075243|6006243|P3|STARTED|Overall Study||80
2448727|NCT01075243|6006244|P2|STARTED|Overall Study||158
2448728|NCT01075243|6006245|P1|STARTED|Overall Study||163
2448729|NCT01075217|6006297|P2|NOT COMPLETED|Overall Study||1
2448730|NCT01075217|6006298|P1|NOT COMPLETED|Overall Study||2
2448731|NCT01075217|6006297|P2|COMPLETED|Overall Study||84
2448732|NCT01075217|6006298|P1|COMPLETED|Overall Study||82
2448733|NCT01075217|6006297|P2|STARTED|Overall Study|86 patients randomized to receive Visipaque; 1 of the patients did not meet entry requirements|85
2448734|NCT01075217|6006298|P1|STARTED|Overall Study|88 patients randomized to receive Isovue; 4 of the patients did not meet entry requirements|84
2448735|NCT01075204|6006314|P1|NOT COMPLETED|Overall Study||0
2448736|NCT01075204|6006314|P1|COMPLETED|Overall Study||335
2448737|NCT01075204|6006314|P1|STARTED|Overall Study||335
2448738|NCT01075191|6006331|P1|NOT COMPLETED|Overall Study||18
2448739|NCT01075191|6006331|P1|COMPLETED|Overall Study||42
2448740|NCT01075191|6006331|P1|Discontinued Year 3|Overall Study||5
2448741|NCT01075191|6006331|P1|Discontinued Year 2|Overall Study||6
2448742|NCT01075191|6006331|P1|Discontinued Year 1|Overall Study||7
2448743|NCT01075191|6006331|P1|STARTED|Overall Study|65 participants were enrolled; 5 protocol violations were excluded from all analyses except safety.|60
2448744|NCT01075178|6006342|P2|NOT COMPLETED|Subject Chart Review||9
2448745|NCT01075178|6006343|P1|NOT COMPLETED|Subject Chart Review||9
2448746|NCT01075178|6006342|P2|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
2448747|NCT01075178|6006343|P1|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
2448748|NCT01075178|6006342|P2|STARTED|Subject Chart Review|subjects matched|1018
2448749|NCT01075178|6006343|P1|STARTED|Subject Chart Review|subjects matched|1018
2448750|NCT01075178|6006342|P2|NOT COMPLETED|Subject Matching||403
2448751|NCT01075178|6006343|P1|NOT COMPLETED|Subject Matching||130
2448752|NCT01075178|6006342|P2|COMPLETED|Subject Matching|subjects matched|1018
2448753|NCT01075178|6006343|P1|COMPLETED|Subject Matching|subjects matched|1018
2448754|NCT01075178|6006342|P2|STARTED|Subject Matching|eligible for matching|1421
2448755|NCT01075178|6006343|P1|STARTED|Subject Matching|eligible for matching|1148
2448756|NCT01075152|6006357|P2|NOT COMPLETED|Overall Study||0
2448757|NCT01075152|6006358|P1|NOT COMPLETED|Overall Study||1
2448758|NCT01075152|6006357|P2|COMPLETED|Overall Study||89
2448759|NCT01075152|6006358|P1|COMPLETED|Overall Study||87
2448760|NCT01075152|6006357|P2|STARTED|Overall Study|randomized|89
2448761|NCT01075152|6006358|P1|STARTED|Overall Study|randomized|88
2448762|NCT01075100|6006384|P2|NOT COMPLETED|Overall Study||53
2448763|NCT01075100|6006385|P1|NOT COMPLETED|Overall Study||49
2448764|NCT01075100|6006384|P2|COMPLETED|Overall Study||1
2448765|NCT01075100|6006385|P1|COMPLETED|Overall Study||0
2448766|NCT01075100|6006384|P2|STARTED|Overall Study||54
2448767|NCT01075100|6006385|P1|STARTED|Overall Study||49
2448768|NCT01075087|6006403|P2|NOT COMPLETED|Overall Study||0
2448769|NCT01075087|6006404|P1|NOT COMPLETED|Overall Study||0
2448770|NCT01075087|6006403|P2|COMPLETED|Overall Study||10
2448771|NCT01075087|6006404|P1|COMPLETED|Overall Study||9
2448772|NCT01075087|6006403|P2|STARTED|Overall Study||10
2448773|NCT01075087|6006404|P1|STARTED|Overall Study||9
2448774|NCT01075074|6006415|P3|NOT COMPLETED|Overall Study||2
2448775|NCT01075074|6006416|P2|NOT COMPLETED|Overall Study||2
2448776|NCT01075074|6006417|P1|NOT COMPLETED|Overall Study||1
2448777|NCT01075074|6006415|P3|COMPLETED|Overall Study||23
2448778|NCT01075074|6006416|P2|COMPLETED|Overall Study||23
2448779|NCT01075074|6006417|P1|COMPLETED|Overall Study||24
2448780|NCT01075074|6006415|P3|STARTED|Overall Study||25
2448781|NCT01075074|6006416|P2|STARTED|Overall Study||25
2448782|NCT01075074|6006417|P1|STARTED|Overall Study||25
2448783|NCT01074944|6006434|P5|NOT COMPLETED|Extended Treatment (up to 42 Months)||5
2448784|NCT01074944|6006435|P4|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
2448785|NCT01074944|6006436|P3|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
2448786|NCT01074944|6006437|P2|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
2448787|NCT01074944|6006438|P1|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
2448788|NCT01074944|6006434|P5|COMPLETED|Extended Treatment (up to 42 Months)||20
2448789|NCT01074944|6006435|P4|COMPLETED|Extended Treatment (up to 42 Months)||0
2448790|NCT01074944|6006436|P3|COMPLETED|Extended Treatment (up to 42 Months)||0
2448791|NCT01074944|6006437|P2|COMPLETED|Extended Treatment (up to 42 Months)||0
2448792|NCT01074944|6006438|P1|COMPLETED|Extended Treatment (up to 42 Months)||0
2448793|NCT01074944|6006434|P5|STARTED|Extended Treatment (up to 42 Months)|Participants who were failed to meet the randomization criteria during the lead-in period.|25
2448794|NCT01074944|6006435|P4|STARTED|Extended Treatment (up to 42 Months)||0
2448795|NCT01074944|6006436|P3|STARTED|Extended Treatment (up to 42 Months)||0
2448796|NCT01074944|6006437|P2|STARTED|Extended Treatment (up to 42 Months)||0
2448797|NCT01074944|6006438|P1|STARTED|Extended Treatment (up to 42 Months)||0
2448798|NCT01074944|6006434|P5|NOT COMPLETED|Long Term Treatment||0
2448799|NCT01074944|6006435|P4|NOT COMPLETED|Long Term Treatment||26
2448800|NCT01074944|6006436|P3|NOT COMPLETED|Long Term Treatment||0
2448801|NCT01074944|6006437|P2|NOT COMPLETED|Long Term Treatment||0
2448802|NCT01074944|6006438|P1|NOT COMPLETED|Long Term Treatment||0
2448803|NCT01074944|6006434|P5|COMPLETED|Long Term Treatment||0
2448804|NCT01074944|6006435|P4|COMPLETED|Long Term Treatment||95
2448805|NCT01074944|6006436|P3|COMPLETED|Long Term Treatment||0
2448806|NCT01074944|6006437|P2|COMPLETED|Long Term Treatment||0
2448807|NCT01074944|6006438|P1|COMPLETED|Long Term Treatment||0
2448808|NCT01074944|6006434|P5|STARTED|Long Term Treatment||0
2448809|NCT01074944|6006435|P4|STARTED|Long Term Treatment|Participants who completed PAP (114) including those who considered as treatment failure in PAP (7).|121
2448810|NCT01074944|6006436|P3|STARTED|Long Term Treatment||0
2448811|NCT01074944|6006437|P2|STARTED|Long Term Treatment||0
2448812|NCT01074944|6006438|P1|STARTED|Long Term Treatment||0
2448813|NCT01074944|6006434|P5|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
2448814|NCT01074944|6006435|P4|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
2448815|NCT01074944|6006436|P3|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||6
2448816|NCT01074944|6006437|P2|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||11
2448817|NCT01074944|6006438|P1|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
2448818|NCT01074944|6006434|P5|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
2448819|NCT01074944|6006435|P4|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
2448820|NCT01074944|6006436|P3|COMPLETED|Primary Analysis Period (up to 52 Weeks)||60
2448821|NCT01074944|6006437|P2|COMPLETED|Primary Analysis Period (up to 52 Weeks)||54
2448822|NCT01074944|6006438|P1|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
2448823|NCT01074944|6006434|P5|STARTED|Primary Analysis Period (up to 52 Weeks)||0
2448824|NCT01074944|6006435|P4|STARTED|Primary Analysis Period (up to 52 Weeks)||0
2448825|NCT01074944|6006436|P3|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|66
2448826|NCT01074944|6006437|P2|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|65
2448827|NCT01074944|6006438|P1|STARTED|Primary Analysis Period (up to 52 Weeks)||0
2448828|NCT01074944|6006434|P5|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
2448829|NCT01074944|6006435|P4|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
2448830|NCT01074944|6006436|P3|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
2448831|NCT01074944|6006437|P2|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
2448832|NCT01074944|6006438|P1|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||13
2448833|NCT01074944|6006434|P5|COMPLETED|Lead-in Period (up to 78 Weeks)||0
2448834|NCT01074944|6006435|P4|COMPLETED|Lead-in Period (up to 78 Weeks)||0
2448835|NCT01074944|6006436|P3|COMPLETED|Lead-in Period (up to 78 Weeks)||0
2448836|NCT01074944|6006437|P2|COMPLETED|Lead-in Period (up to 78 Weeks)||0
2448837|NCT01074944|6006438|P1|COMPLETED|Lead-in Period (up to 78 Weeks)||157
2448838|NCT01074944|6006434|P5|STARTED|Lead-in Period (up to 78 Weeks)||0
2448839|NCT01074944|6006435|P4|STARTED|Lead-in Period (up to 78 Weeks)||0
2448840|NCT01074944|6006436|P3|STARTED|Lead-in Period (up to 78 Weeks)||0
2448841|NCT01074944|6006437|P2|STARTED|Lead-in Period (up to 78 Weeks)||0
2448842|NCT01074944|6006438|P1|STARTED|Lead-in Period (up to 78 Weeks)|LIP conducted to assess randomization criteria of all participants in single reporting arm.|170
2448843|NCT01074931|6006492|P1|NOT COMPLETED|Overall Study||6
2448844|NCT01074931|6006492|P1|COMPLETED|Overall Study||92
2448845|NCT01074931|6006492|P1|STARTED|Overall Study||98
2448846|NCT01074658|6006504|P1|NOT COMPLETED|Overall Study||19
2448847|NCT01074658|6006504|P1|COMPLETED|Overall Study||996
2448848|NCT01074658|6006504|P1|Attempted Implant|Overall Study||996
2448849|NCT01074658|6006504|P1|STARTED|Overall Study||1015
2448850|NCT01074554|6006512|P2|NOT COMPLETED|Overall Study||4
2448851|NCT01074554|6006513|P1|NOT COMPLETED|Overall Study||3
2448852|NCT01074554|6006512|P2|COMPLETED|Overall Study||11
2448853|NCT01074554|6006513|P1|COMPLETED|Overall Study||11
2448854|NCT01074554|6006512|P2|STARTED|Overall Study||15
2448855|NCT01074554|6006513|P1|STARTED|Overall Study||14
2448856|NCT01074502|6006523|P1|NOT COMPLETED|Overall Study||1
2448857|NCT01074502|6006523|P1|COMPLETED|Overall Study||2
2448858|NCT01074502|6006523|P1|STARTED|Overall Study||3
2448859|NCT01074463|6006534|P2|NOT COMPLETED|Second Intervention||0
2448860|NCT01074463|6006535|P1|NOT COMPLETED|Second Intervention||0
2448861|NCT01074463|6006534|P2|COMPLETED|Second Intervention||12
2448862|NCT01074463|6006535|P1|COMPLETED|Second Intervention||12
2448863|NCT01074463|6006534|P2|STARTED|Second Intervention||12
2448864|NCT01074463|6006535|P1|STARTED|Second Intervention||12
2448865|NCT01074463|6006534|P2|NOT COMPLETED|Washout of 7 Days||0
2448866|NCT01074463|6006535|P1|NOT COMPLETED|Washout of 7 Days||0
2448867|NCT01074463|6006534|P2|COMPLETED|Washout of 7 Days||12
2448868|NCT01074463|6006535|P1|COMPLETED|Washout of 7 Days||12
2448869|NCT01074463|6006534|P2|STARTED|Washout of 7 Days||12
2448870|NCT01074463|6006535|P1|STARTED|Washout of 7 Days||12
2448871|NCT01074463|6006534|P2|NOT COMPLETED|First Intervention||0
2448872|NCT01074463|6006535|P1|NOT COMPLETED|First Intervention||0
2448873|NCT01074463|6006534|P2|COMPLETED|First Intervention||12
2448874|NCT01074463|6006535|P1|COMPLETED|First Intervention||12
2448875|NCT01074463|6006534|P2|STARTED|First Intervention||12
2448876|NCT01074463|6006535|P1|STARTED|First Intervention||12
2448877|NCT01074450|6006547|P2|NOT COMPLETED|Second Intervention||1
2448878|NCT01074450|6006548|P1|NOT COMPLETED|Second Intervention||1
2448879|NCT01074450|6006547|P2|COMPLETED|Second Intervention|Influenze Symptoms Present at Check in.|9
2448880|NCT01074450|6006548|P1|COMPLETED|Second Intervention|Positive Drug Screen at Check in.|11
2448881|NCT01074450|6006547|P2|STARTED|Second Intervention||10
2448882|NCT01074450|6006548|P1|STARTED|Second Intervention||12
2448883|NCT01074450|6006547|P2|NOT COMPLETED|Washout of 7 Days||0
2448884|NCT01074450|6006548|P1|NOT COMPLETED|Washout of 7 Days||0
2448885|NCT01074450|6006547|P2|COMPLETED|Washout of 7 Days||10
2448886|NCT01074450|6006548|P1|COMPLETED|Washout of 7 Days||12
2448887|NCT01074450|6006547|P2|STARTED|Washout of 7 Days||10
2448888|NCT01074450|6006548|P1|STARTED|Washout of 7 Days||12
2448889|NCT01074450|6006547|P2|NOT COMPLETED|First Intervention||2
2448890|NCT01074450|6006548|P1|NOT COMPLETED|First Intervention||0
2448891|NCT01074450|6006547|P2|COMPLETED|First Intervention||10
2448892|NCT01074450|6006548|P1|COMPLETED|First Intervention||12
2448893|NCT01074450|6006547|P2|STARTED|First Intervention||12
2448894|NCT01074450|6006548|P1|STARTED|First Intervention||12
2448895|NCT01074437|6006560|P2|NOT COMPLETED|Overall Study||0
2448896|NCT01074437|6006561|P1|NOT COMPLETED|Overall Study||0
2448897|NCT01074437|6006560|P2|COMPLETED|Overall Study||5
2448898|NCT01074437|6006561|P1|COMPLETED|Overall Study||4
2448899|NCT01074437|6006560|P2|STARTED|Overall Study||5
2448900|NCT01074437|6006561|P1|STARTED|Overall Study||4
2448901|NCT01074307|6006577|P2|NOT COMPLETED|Overall Study||12
2448902|NCT01074307|6006578|P1|NOT COMPLETED|Overall Study||22
2448903|NCT01074307|6006577|P2|COMPLETED|Overall Study||102
2448904|NCT01074307|6006578|P1|COMPLETED|Overall Study||44
2448905|NCT01074307|6006577|P2|STARTED|Overall Study||114
2448906|NCT01074307|6006578|P1|STARTED|Overall Study||66
2448907|NCT01074268|6006600|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||7
2448908|NCT01074268|6006601|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||6
2448909|NCT01074268|6006600|P2|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||115
2448910|NCT01074268|6006601|P1|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||242
2448911|NCT01074268|6006600|P2|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Sixteen subjects from main trial did not continue into the extension|122
2448912|NCT01074268|6006601|P1|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Thirty five subjects from main trial did not continue into the extension|248
2448913|NCT01074268|6006600|P2|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||15
2448914|NCT01074268|6006601|P1|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||20
2448915|NCT01074268|6006600|P2|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||138
2448916|NCT01074268|6006601|P1|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||283
2448917|NCT01074268|6006600|P2|Exposed|Main: Week 0 to 26 (NN1250-3585)|One subject withdrew prior to exposure to trial drugs|152
2448918|NCT01074268|6006601|P1|Exposed|Main: Week 0 to 26 (NN1250-3585)|Two subjects withdrew prior to exposure to trial drugs|301
2448919|NCT01074268|6006600|P2|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)||153
2448920|NCT01074268|6006601|P1|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)|One subject was withdrawn because the subject was randomised in error (screening failure)|302
2448921|NCT01074268|6006600|P2|STARTED|Main: Week 0 to 26 (NN1250-3585)||153
2448922|NCT01074268|6006601|P1|STARTED|Main: Week 0 to 26 (NN1250-3585)||303
2448923|NCT01074255|6006627|P1|NOT COMPLETED|Overall Study||2
2448924|NCT01074255|6006627|P1|COMPLETED|Overall Study||3139
2448925|NCT01074255|6006627|P1|Treated|Overall Study||3139
2448926|NCT01074255|6006627|P1|STARTED|Overall Study||3141
2448927|NCT01074242|6006631|P1|NOT COMPLETED|Overall Study||403
2448928|NCT01074242|6006631|P1|COMPLETED|Overall Study||3395
2448929|NCT01074242|6006631|P1|Received at Least 1 Dose of Vaccine|Overall Study||3395
2448930|NCT01074242|6006631|P1|STARTED|Overall Study||3798
2448931|NCT01074229|6006639|P3|NOT COMPLETED|Overall Study||4
2448932|NCT01074229|6006640|P2|NOT COMPLETED|Overall Study||3
2448933|NCT01074229|6006641|P1|NOT COMPLETED|Overall Study||2
2448934|NCT01074229|6006639|P3|COMPLETED|Overall Study||21
2448935|NCT01074229|6006640|P2|COMPLETED|Overall Study||22
2448936|NCT01074229|6006641|P1|COMPLETED|Overall Study||23
2448937|NCT01074229|6006639|P3|STARTED|Overall Study||25
2448938|NCT01074229|6006640|P2|STARTED|Overall Study||25
2448939|NCT01074229|6006641|P1|STARTED|Overall Study||25
2448940|NCT01074216|6006652|P1|NOT COMPLETED|Overall Study||13
2448941|NCT01074216|6006652|P1|COMPLETED|Overall Study||41
2448942|NCT01074216|6006652|P1|STARTED|Overall Study||54
2448943|NCT01074177|6006656|P1|NOT COMPLETED|Overall Study||0
2448944|NCT01074177|6006656|P1|COMPLETED|Overall Study||24
2448945|NCT01074177|6006656|P1|STARTED|Overall Study||24
2448946|NCT01074164|6006665|P2|NOT COMPLETED|Overall Study||1
2448947|NCT01074164|6006666|P1|NOT COMPLETED|Overall Study||3
2448948|NCT01074164|6006665|P2|COMPLETED|Overall Study||7
2448949|NCT01074164|6006666|P1|COMPLETED|Overall Study||4
2448950|NCT01074164|6006665|P2|STARTED|Overall Study||8
2448951|NCT01074164|6006666|P1|STARTED|Overall Study||7
2448952|NCT01074125|6006687|P3|NOT COMPLETED|Overall Study||12
2448953|NCT01074125|6006688|P2|NOT COMPLETED|Overall Study||5
2448954|NCT01074125|6006689|P1|NOT COMPLETED|Overall Study||12
2448955|NCT01074125|6006687|P3|COMPLETED|Overall Study||36
2448956|NCT01074125|6006688|P2|COMPLETED|Overall Study||47
2448957|NCT01074125|6006689|P1|COMPLETED|Overall Study||39
2448958|NCT01074125|6006687|P3|STARTED|Overall Study||48
2448959|NCT01074125|6006688|P2|STARTED|Overall Study||52
2448960|NCT01074125|6006689|P1|STARTED|Overall Study||51
2448961|NCT01074099|6006705|P2|NOT COMPLETED|Overall Study||0
2448962|NCT01074099|6006706|P1|NOT COMPLETED|Overall Study||0
2448963|NCT01074099|6006705|P2|COMPLETED|Overall Study||3
2448964|NCT01074099|6006706|P1|COMPLETED|Overall Study||2
2448965|NCT01074099|6006705|P2|STARTED|Overall Study||3
2448966|NCT01074099|6006706|P1|STARTED|Overall Study||2
2448967|NCT01074047|6006716|P2|NOT COMPLETED|Extension Phase||0
2448968|NCT01074047|6006717|P1|NOT COMPLETED|Extension Phase||22
2448969|NCT01074047|6006716|P2|COMPLETED|Extension Phase||0
2448970|NCT01074047|6006717|P1|COMPLETED|Extension Phase||0
2448971|NCT01074047|6006716|P2|Safety Population|Extension Phase||0
2448972|NCT01074047|6006717|P1|Safety Population|Extension Phase|Participants who enrolled in the extension phase|22
2448973|NCT01074047|6006716|P2|STARTED|Extension Phase||0
2448974|NCT01074047|6006717|P1|STARTED|Extension Phase|2 participants did not enroll in the extension period.|22
2448975|NCT01074047|6006716|P2|NOT COMPLETED|Survival Follow-Up Phase||136
2448976|NCT01074047|6006717|P1|NOT COMPLETED|Survival Follow-Up Phase||124
2448977|NCT01074047|6006716|P2|COMPLETED|Survival Follow-Up Phase||27
2448978|NCT01074047|6006717|P1|COMPLETED|Survival Follow-Up Phase||16
2448979|NCT01074047|6006716|P2|STARTED|Survival Follow-Up Phase||163
2448980|NCT01074047|6006717|P1|STARTED|Survival Follow-Up Phase||140
2448981|NCT01074047|6006716|P2|NOT COMPLETED|Treatment Phase||234
2448982|NCT01074047|6006717|P1|NOT COMPLETED|Treatment Phase||217
2448983|NCT01074047|6006716|P2|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|13
2448984|NCT01074047|6006717|P1|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|24
2448985|NCT01074047|6006716|P2|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|191
2448986|NCT01074047|6006717|P1|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|179
2448987|NCT01074047|6006716|P2|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|235
2448988|NCT01074047|6006717|P1|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|236
2448989|NCT01074047|6006716|P2|Treated Population|Treatment Phase|7 patients not treated with any drug regimen|240
2448990|NCT01074047|6006717|P1|Treated Population|Treatment Phase|5 patients not treated with any drug regimen|236
2448991|NCT01074047|6006716|P2|STARTED|Treatment Phase||247
2448992|NCT01074047|6006717|P1|STARTED|Treatment Phase||241
2448993|NCT01074034|6006791|P1|NOT COMPLETED|Overall Study||6
2448994|NCT01074034|6006791|P1|COMPLETED|Overall Study||205
2448995|NCT01074034|6006791|P1|STARTED|Overall Study||211
2448996|NCT01074008|6006805|P9|NOT COMPLETED|Overall Study||4
2448997|NCT01074008|6006806|P8|NOT COMPLETED|Overall Study||0
2448998|NCT01074008|6006807|P7|NOT COMPLETED|Overall Study||1
2448999|NCT01074008|6006808|P6|NOT COMPLETED|Overall Study||0
2449000|NCT01074008|6006809|P5|NOT COMPLETED|Overall Study||2
2449001|NCT01074008|6006810|P4|NOT COMPLETED|Overall Study||1
2449002|NCT01074008|6006811|P3|NOT COMPLETED|Overall Study||2
2449003|NCT01074008|6006812|P2|NOT COMPLETED|Overall Study||3
2449004|NCT01074008|6006813|P1|NOT COMPLETED|Overall Study||1
2449005|NCT01074008|6006805|P9|COMPLETED|Overall Study||7
2449006|NCT01074008|6006806|P8|COMPLETED|Overall Study||8
2449007|NCT01074008|6006807|P7|COMPLETED|Overall Study||7
2449008|NCT01074008|6006808|P6|COMPLETED|Overall Study||7
2449009|NCT01074008|6006809|P5|COMPLETED|Overall Study||6
2449010|NCT01074008|6006810|P4|COMPLETED|Overall Study||7
2449011|NCT01074008|6006811|P3|COMPLETED|Overall Study||6
2449012|NCT01074008|6006812|P2|COMPLETED|Overall Study||5
2449013|NCT01074008|6006813|P1|COMPLETED|Overall Study||7
2449014|NCT01074008|6006805|P9|Completed Direct-acting Antiviral Agent|Overall Study||5
2449015|NCT01074008|6006806|P8|Completed Direct-acting Antiviral Agent|Overall Study||7
2449016|NCT01074008|6006807|P7|Completed Direct-acting Antiviral Agent|Overall Study||8
2449017|NCT01074008|6006808|P6|Completed Direct-acting Antiviral Agent|Overall Study||5
2449018|NCT01074008|6006809|P5|Completed Direct-acting Antiviral Agent|Overall Study||8
2449019|NCT01074008|6006810|P4|Completed Direct-acting Antiviral Agent|Overall Study||8
2449020|NCT01074008|6006811|P3|Completed Direct-acting Antiviral Agent|Overall Study||7
2449021|NCT01074008|6006812|P2|Completed Direct-acting Antiviral Agent|Overall Study||7
2449022|NCT01074008|6006813|P1|Completed Direct-acting Antiviral Agent|Overall Study||8
2449023|NCT01074008|6006805|P9|STARTED|Overall Study||11
2449024|NCT01074008|6006806|P8|STARTED|Overall Study||8
2449025|NCT01074008|6006807|P7|STARTED|Overall Study||8
2449026|NCT01074008|6006808|P6|STARTED|Overall Study||7
2449027|NCT01074008|6006809|P5|STARTED|Overall Study||8
2449028|NCT01074008|6006810|P4|STARTED|Overall Study||8
2449029|NCT01074008|6006811|P3|STARTED|Overall Study||8
2449030|NCT01074008|6006812|P2|STARTED|Overall Study||8
2449031|NCT01074008|6006813|P1|STARTED|Overall Study||8
2449032|NCT01073943|6006923|P2|NOT COMPLETED|Overall Study||8
2449033|NCT01073943|6006924|P1|NOT COMPLETED|Overall Study||13
2449034|NCT01073943|6006923|P2|COMPLETED|Overall Study||295
2449035|NCT01073943|6006924|P1|COMPLETED|Overall Study||287
2449036|NCT01073943|6006923|P2|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|300
2449037|NCT01073943|6006924|P1|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|294
2449038|NCT01073943|6006923|P2|Safety Population (Treated)|Overall Study||302
2449039|NCT01073943|6006924|P1|Safety Population (Treated)|Overall Study||296
2449040|NCT01073943|6006923|P2|STARTED|Overall Study||303
2449041|NCT01073943|6006924|P1|STARTED|Overall Study||300
2449042|NCT01073930|6006950|P2|NOT COMPLETED|Overall Study||6
2449043|NCT01073930|6006951|P1|NOT COMPLETED|Overall Study||3
2449044|NCT01073930|6006950|P2|COMPLETED|Overall Study||295
2449045|NCT01073930|6006951|P1|COMPLETED|Overall Study||304
2449046|NCT01073930|6006950|P2|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|297
2449047|NCT01073930|6006951|P1|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|304
2449048|NCT01073930|6006950|P2|Safety Population (Treated)|Overall Study||298
2449049|NCT01073930|6006951|P1|Safety Population (Treated)|Overall Study||305
2449050|NCT01073930|6006950|P2|STARTED|Overall Study||301
2449051|NCT01073930|6006951|P1|STARTED|Overall Study||307
2449052|NCT01073865|6006975|P2|NOT COMPLETED|Overall Study||39
2449053|NCT01073865|6006976|P1|NOT COMPLETED|Overall Study||28
2449054|NCT01073865|6006975|P2|COMPLETED|Overall Study|Number of patients completed the study|74
2449055|NCT01073865|6006976|P1|COMPLETED|Overall Study|Number of patients completed the study|81
2449056|NCT01073865|6006975|P2|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|113
2449057|NCT01073865|6006976|P1|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|108
2449058|NCT01073865|6006975|P2|STARTED|Overall Study|Number of patients randomised|113
2449059|NCT01073865|6006976|P1|STARTED|Overall Study|Number of patients randomised|109
2449060|NCT01073657|6006988|P2|NOT COMPLETED|Overall Study||0
2449061|NCT01073657|6006989|P1|NOT COMPLETED|Overall Study||0
2449062|NCT01073657|6006988|P2|COMPLETED|Overall Study||16
2449063|NCT01073657|6006989|P1|COMPLETED|Overall Study||17
2449064|NCT01073657|6006988|P2|STARTED|Overall Study||16
2449065|NCT01073657|6006989|P1|STARTED|Overall Study||17
2449066|NCT01073631|6006995|P1|NOT COMPLETED|Overall Study||169
2449067|NCT01073631|6006995|P1|COMPLETED|Overall Study||374
2449068|NCT01073631|6006995|P1|STARTED|Overall Study||543
2449069|NCT01073618|6007000|P1|NOT COMPLETED|Overall Study||307
2449070|NCT01073618|6007000|P1|COMPLETED|Overall Study||385
2449071|NCT01073618|6007000|P1|STARTED|Overall Study||692
2449072|NCT01073605|6007008|P3|NOT COMPLETED|Overall Study||61
2449073|NCT01073605|6007009|P2|NOT COMPLETED|Overall Study||67
2449074|NCT01073605|6007010|P1|NOT COMPLETED|Overall Study||62
2449075|NCT01073605|6007008|P3|COMPLETED|Overall Study|Corresponds to follow-up until final height|8
2449076|NCT01073605|6007009|P2|COMPLETED|Overall Study|Corresponds to follow-up until final height|4
2449077|NCT01073605|6007010|P1|COMPLETED|Overall Study|Corresponds to follow-up until final height|6
2449078|NCT01073605|6007008|P3|Received Treatment|Overall Study||68
2449079|NCT01073605|6007009|P2|Received Treatment|Overall Study||70
2449080|NCT01073605|6007010|P1|Received Treatment|Overall Study||68
2449081|NCT01073605|6007008|P3|STARTED|Overall Study||69
2449082|NCT01073605|6007009|P2|STARTED|Overall Study||71
2449083|NCT01073605|6007010|P1|STARTED|Overall Study||68
2449084|NCT01073566|6007056|P2|NOT COMPLETED|Period 2 (6 Weeks)||0
2449085|NCT01073566|6007057|P1|NOT COMPLETED|Period 2 (6 Weeks)||1
2449086|NCT01073566|6007056|P2|COMPLETED|Period 2 (6 Weeks)||19
2449087|NCT01073566|6007057|P1|COMPLETED|Period 2 (6 Weeks)||18
2449088|NCT01073566|6007056|P2|STARTED|Period 2 (6 Weeks)||19
2449089|NCT01073566|6007057|P1|STARTED|Period 2 (6 Weeks)||19
2449090|NCT01073566|6007056|P2|NOT COMPLETED|Period 1 (6 Weeks)||0
2449091|NCT01073566|6007057|P1|NOT COMPLETED|Period 1 (6 Weeks)||0
2449092|NCT01073566|6007056|P2|COMPLETED|Period 1 (6 Weeks)||19
2449093|NCT01073566|6007057|P1|COMPLETED|Period 1 (6 Weeks)||19
2449094|NCT01073566|6007056|P2|STARTED|Period 1 (6 Weeks)||19
2449095|NCT01073566|6007057|P1|STARTED|Period 1 (6 Weeks)||19
2449096|NCT01073462|6007069|P1|NOT COMPLETED|Overall Study||41
2449097|NCT01073462|6007069|P1|COMPLETED|Overall Study||26
2449098|NCT01073462|6007069|P1|STARTED|Overall Study||67
2449099|NCT01073449|6007080|P1|NOT COMPLETED|Overall Study||0
2449100|NCT01073449|6007080|P1|COMPLETED|Overall Study||3362
2449101|NCT01073449|6007080|P1|STARTED|Overall Study||3362
2449102|NCT01073293|6007088|P2|NOT COMPLETED|Overall Study||11
2449103|NCT01073293|6007089|P1|NOT COMPLETED|Overall Study||5
2449104|NCT01073293|6007088|P2|COMPLETED|Overall Study||517
2449105|NCT01073293|6007089|P1|COMPLETED|Overall Study||521
2449106|NCT01073293|6007088|P2|STARTED|Overall Study||528
2449107|NCT01073293|6007089|P1|STARTED|Overall Study||526
2449108|NCT01073267|6007111|P1|NOT COMPLETED|Overall Study||3
2449109|NCT01073267|6007111|P1|COMPLETED|Overall Study||1
2449110|NCT01073267|6007111|P1|STARTED|Overall Study||4
2449111|NCT01073163|6007115|P1|NOT COMPLETED|Overall Study||3
2449112|NCT01073163|6007115|P1|COMPLETED|Overall Study|Patients completed study|51
2449113|NCT01073163|6007115|P1|Treated With >=6 Cycles|Overall Study||49
2449114|NCT01073163|6007115|P1|Treated With <6 Cycles|Overall Study||4
2449115|NCT01073163|6007115|P1|Enrolled But Not Treated|Overall Study||1
2449116|NCT01073163|6007115|P1|STARTED|Overall Study||54
2449117|NCT01072929|6007138|P3|NOT COMPLETED|Overall Study||9
2449118|NCT01072929|6007139|P2|NOT COMPLETED|Overall Study||51
2449119|NCT01072929|6007140|P1|NOT COMPLETED|Overall Study||44
2449120|NCT01072929|6007138|P3|COMPLETED|Overall Study||24
2449121|NCT01072929|6007139|P2|COMPLETED|Overall Study||150
2449122|NCT01072929|6007140|P1|COMPLETED|Overall Study||155
2449123|NCT01072929|6007138|P3|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|31
2449124|NCT01072929|6007139|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
2449125|NCT01072929|6007140|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
2449126|NCT01072929|6007138|P3|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|32
2449127|NCT01072929|6007139|P2|Safety Population|Overall Study|Treated participants. Three participants were randomized but not treated.|198
2449128|NCT01072929|6007140|P1|Safety Population|Overall Study|Treated participants|199
2449129|NCT01072929|6007138|P3|STARTED|Overall Study||33
2449130|NCT01072929|6007139|P2|STARTED|Overall Study||201
2449131|NCT01072929|6007140|P1|STARTED|Overall Study||199
2449132|NCT01072877|6007219|P5|NOT COMPLETED|Overall Study||0
2449133|NCT01072877|6007220|P4|NOT COMPLETED|Overall Study||2
2449134|NCT01072877|6007221|P3|NOT COMPLETED|Overall Study||0
2449135|NCT01072877|6007222|P2|NOT COMPLETED|Overall Study||1
2449136|NCT01072877|6007223|P1|NOT COMPLETED|Overall Study||1
2449137|NCT01072877|6007219|P5|COMPLETED|Overall Study||63
2449138|NCT01072877|6007220|P4|COMPLETED|Overall Study||50
2449139|NCT01072877|6007221|P3|COMPLETED|Overall Study||51
2449140|NCT01072877|6007222|P2|COMPLETED|Overall Study||56
2449141|NCT01072877|6007223|P1|COMPLETED|Overall Study||55
2449142|NCT01072877|6007219|P5|STARTED|Overall Study||63
2449143|NCT01072877|6007220|P4|STARTED|Overall Study||52
2449144|NCT01072877|6007221|P3|STARTED|Overall Study||51
2449145|NCT01072877|6007222|P2|STARTED|Overall Study||57
2449146|NCT01072877|6007223|P1|STARTED|Overall Study||56
2449147|NCT01072773|6007245|P1|NOT COMPLETED|Overall Study||0
2449148|NCT01072773|6007245|P1|COMPLETED|Overall Study||2
2449149|NCT01072773|6007245|P1|STARTED|Overall Study||2
2449150|NCT01072669|6007256|P2|NOT COMPLETED|Overall Study||0
2449151|NCT01072669|6007257|P1|NOT COMPLETED|Overall Study||0
2449152|NCT01072669|6007256|P2|COMPLETED|Overall Study||5
2449153|NCT01072669|6007257|P1|COMPLETED|Overall Study||15
2449154|NCT01072669|6007256|P2|STARTED|Overall Study||5
2449155|NCT01072669|6007257|P1|STARTED|Overall Study||15
2449156|NCT01072656|6007265|P2|NOT COMPLETED|Second Intervention||0
2449157|NCT01072656|6007266|P1|NOT COMPLETED|Second Intervention||0
2449158|NCT01072656|6007265|P2|COMPLETED|Second Intervention||4
2449159|NCT01072656|6007266|P1|COMPLETED|Second Intervention||5
2449160|NCT01072656|6007265|P2|STARTED|Second Intervention||4
2449161|NCT01072656|6007266|P1|STARTED|Second Intervention||5
2449162|NCT01072656|6007265|P2|NOT COMPLETED|First Intervention||0
2449163|NCT01072656|6007266|P1|NOT COMPLETED|First Intervention||0
2449164|NCT01072656|6007265|P2|COMPLETED|First Intervention||4
2449165|NCT01072656|6007266|P1|COMPLETED|First Intervention||5
2449166|NCT01072656|6007265|P2|STARTED|First Intervention||4
2449167|NCT01072656|6007266|P1|STARTED|First Intervention||5
2449168|NCT01072643|6007276|P1|NOT COMPLETED|Overall Study||0
2449169|NCT01072643|6007276|P1|COMPLETED|Overall Study||4
2449170|NCT01072643|6007276|P1|STARTED|Overall Study||4
2449171|NCT01072630|6007302|P3|NOT COMPLETED|Overall Study||13
2449172|NCT01072630|6007303|P2|NOT COMPLETED|Overall Study||60
2449173|NCT01072630|6007304|P1|NOT COMPLETED|Overall Study||55
2449174|NCT01072630|6007302|P3|COMPLETED|Overall Study||17
2449175|NCT01072630|6007303|P2|COMPLETED|Overall Study||172
2449176|NCT01072630|6007304|P1|COMPLETED|Overall Study||175
2449177|NCT01072630|6007302|P3|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|28
2449178|NCT01072630|6007303|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|230
2449179|NCT01072630|6007304|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|224
2449180|NCT01072630|6007302|P3|Safety Population|Overall Study|Treated participants.|30
2449181|NCT01072630|6007303|P2|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|231
2449182|NCT01072630|6007304|P1|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|229
2449183|NCT01072630|6007302|P3|STARTED|Overall Study||30
2449184|NCT01072630|6007303|P2|STARTED|Overall Study||232
2449185|NCT01072630|6007304|P1|STARTED|Overall Study||230
2449186|NCT01072617|6007378|P1|NOT COMPLETED|Overall Study||0
2449187|NCT01072617|6007378|P1|COMPLETED|Overall Study||8
2449188|NCT01072617|6007378|P1|STARTED|Overall Study||8
2449189|NCT01072539|6007385|P1|NOT COMPLETED|Overall Study||3
2449190|NCT01072539|6007385|P1|COMPLETED|Overall Study|Refer to the Safety Analysis Set. Data for completion were not collected.|3169
2449191|NCT01072539|6007385|P1|STARTED|Overall Study||3172
2449192|NCT01072526|6007393|P2|NOT COMPLETED|Overall Study||0
2449193|NCT01072526|6007394|P1|NOT COMPLETED|Overall Study||0
2449194|NCT01072526|6007393|P2|COMPLETED|Overall Study||0
2449195|NCT01072526|6007394|P1|COMPLETED|Overall Study|Study completed in September 2008(recruited 6 patients total of 20 anticipated)|6
2449196|NCT01072526|6007393|P2|STARTED|Overall Study||0
2449197|NCT01072526|6007394|P1|STARTED|Overall Study|Study started in December 2007 (recruited 6 patients total of 20 anticipated)|6
2449198|NCT01072500|6007409|P2|NOT COMPLETED|Overall Study||14
2449199|NCT01072500|6007410|P1|NOT COMPLETED|Overall Study||24
2449200|NCT01072500|6007409|P2|COMPLETED|Overall Study||803
2449201|NCT01072500|6007410|P1|COMPLETED|Overall Study||794
2449202|NCT01072500|6007409|P2|STARTED|Overall Study||817
2449203|NCT01072500|6007410|P1|STARTED|Overall Study||818
2449204|NCT01072448|6007420|P2|NOT COMPLETED|Overall Study||30
2449205|NCT01072448|6007421|P1|NOT COMPLETED|Overall Study||19
2449206|NCT01072448|6007420|P2|COMPLETED|Overall Study||130
2449207|NCT01072448|6007421|P1|COMPLETED|Overall Study||144
2449208|NCT01072448|6007420|P2|STARTED|Overall Study||160
2449209|NCT01072448|6007421|P1|STARTED|Overall Study||163
2449210|NCT01072409|6007429|P1|NOT COMPLETED|Overall Study||7
2449211|NCT01072409|6007429|P1|COMPLETED|Overall Study||38
2449212|NCT01072409|6007429|P1|STARTED|Overall Study||45
2449213|NCT01072396|6007435|P2|NOT COMPLETED|Period Two||3
2449214|NCT01072396|6007436|P1|NOT COMPLETED|Period Two||1
2449215|NCT01072396|6007435|P2|COMPLETED|Period Two||57
2449216|NCT01072396|6007436|P1|COMPLETED|Period Two||57
2449217|NCT01072396|6007435|P2|STARTED|Period Two||60
2449218|NCT01072396|6007436|P1|STARTED|Period Two||58
2449219|NCT01072396|6007435|P2|NOT COMPLETED|Washout Period||1
2449220|NCT01072396|6007436|P1|NOT COMPLETED|Washout Period||0
2449221|NCT01072396|6007435|P2|COMPLETED|Washout Period||60
2449222|NCT01072396|6007436|P1|COMPLETED|Washout Period||58
2449223|NCT01072396|6007435|P2|STARTED|Washout Period||61
2449224|NCT01072396|6007436|P1|STARTED|Washout Period||58
2449225|NCT01072396|6007435|P2|NOT COMPLETED|Period One||2
2449226|NCT01072396|6007436|P1|NOT COMPLETED|Period One||5
2449227|NCT01072396|6007435|P2|COMPLETED|Period One||61
2449228|NCT01072396|6007436|P1|COMPLETED|Period One||58
2449229|NCT01072396|6007435|P2|STARTED|Period One||63
2449230|NCT01072396|6007436|P1|STARTED|Period One||63
2449231|NCT01072357|6007448|P2|NOT COMPLETED|Overall Study||1
2449232|NCT01072357|6007449|P1|NOT COMPLETED|Overall Study||0
2449233|NCT01072357|6007448|P2|COMPLETED|Overall Study||14
2449234|NCT01072357|6007449|P1|COMPLETED|Overall Study||15
2449235|NCT01072357|6007448|P2|STARTED|Overall Study||15
2449236|NCT01072357|6007449|P1|STARTED|Overall Study||15
2449237|NCT01072344|6007459|P2|NOT COMPLETED|Overall Study||18
2449238|NCT01072344|6007460|P1|NOT COMPLETED|Overall Study||11
2449239|NCT01072344|6007459|P2|COMPLETED|Overall Study||29
2449240|NCT01072344|6007460|P1|COMPLETED|Overall Study||35
2449241|NCT01072344|6007459|P2|STARTED|Overall Study||47
2449242|NCT01072344|6007460|P1|STARTED|Overall Study||46
2449243|NCT01072331|6007477|P3|NOT COMPLETED|Overall Study||0
2449244|NCT01072331|6007478|P2|NOT COMPLETED|Overall Study||0
2449245|NCT01072331|6007479|P1|NOT COMPLETED|Overall Study||0
2449246|NCT01072331|6007477|P3|COMPLETED|Overall Study||32
2449247|NCT01072331|6007478|P2|COMPLETED|Overall Study||33
2449248|NCT01072331|6007479|P1|COMPLETED|Overall Study||34
2449249|NCT01072331|6007477|P3|STARTED|Overall Study||32
2449250|NCT01072331|6007478|P2|STARTED|Overall Study||33
2449251|NCT01072331|6007479|P1|STARTED|Overall Study||34
2449252|NCT01072201|6007498|P2|NOT COMPLETED|Overall Study||1
2449253|NCT01072201|6007499|P1|NOT COMPLETED|Overall Study||0
2449254|NCT01072201|6007498|P2|COMPLETED|Overall Study||29
2449255|NCT01072201|6007499|P1|COMPLETED|Overall Study||30
2449256|NCT01072201|6007498|P2|STARTED|Overall Study||30
2449257|NCT01072201|6007499|P1|STARTED|Overall Study||30
2449258|NCT01072188|6007511|P2|NOT COMPLETED|Overall Study||0
2449259|NCT01072188|6007512|P1|NOT COMPLETED|Overall Study||0
2449260|NCT01072188|6007511|P2|COMPLETED|Overall Study||23
2449261|NCT01072188|6007512|P1|COMPLETED|Overall Study||22
2449262|NCT01072188|6007511|P2|STARTED|Overall Study||23
2449263|NCT01072188|6007512|P1|STARTED|Overall Study||22
2449264|NCT01072175|6007532|P13|NOT COMPLETED|Part D (HPMC Capsules)||39
2449265|NCT01072175|6007533|P12|NOT COMPLETED|Part D (HPMC Capsules)||43
2449266|NCT01072175|6007534|P11|NOT COMPLETED|Part D (HPMC Capsules)||16
2449267|NCT01072175|6007535|P10|NOT COMPLETED|Part D (HPMC Capsules)||12
2449268|NCT01072175|6007536|P9|NOT COMPLETED|Part D (HPMC Capsules)||0
2449269|NCT01072175|6007537|P8|NOT COMPLETED|Part D (HPMC Capsules)||0
2449270|NCT01072175|6007538|P7|NOT COMPLETED|Part D (HPMC Capsules)||0
2449271|NCT01072175|6007539|P6|NOT COMPLETED|Part D (HPMC Capsules)||0
2449272|NCT01072175|6007540|P5|NOT COMPLETED|Part D (HPMC Capsules)||0
2449273|NCT01072175|6007541|P4|NOT COMPLETED|Part D (HPMC Capsules)||0
2449274|NCT01072175|6007542|P3|NOT COMPLETED|Part D (HPMC Capsules)||0
2449275|NCT01072175|6007543|P2|NOT COMPLETED|Part D (HPMC Capsules)||0
2449276|NCT01072175|6007544|P1|NOT COMPLETED|Part D (HPMC Capsules)||0
2449277|NCT01072175|6007532|P13|COMPLETED|Part D (HPMC Capsules)||0
2449278|NCT01072175|6007533|P12|COMPLETED|Part D (HPMC Capsules)||0
2449279|NCT01072175|6007534|P11|COMPLETED|Part D (HPMC Capsules)||0
2449280|NCT01072175|6007535|P10|COMPLETED|Part D (HPMC Capsules)||0
2449281|NCT01072175|6007536|P9|COMPLETED|Part D (HPMC Capsules)||0
2449282|NCT01072175|6007537|P8|COMPLETED|Part D (HPMC Capsules)||0
2449283|NCT01072175|6007538|P7|COMPLETED|Part D (HPMC Capsules)||0
2449284|NCT01072175|6007539|P6|COMPLETED|Part D (HPMC Capsules)||0
2449285|NCT01072175|6007540|P5|COMPLETED|Part D (HPMC Capsules)||0
2449286|NCT01072175|6007541|P4|COMPLETED|Part D (HPMC Capsules)||0
2449287|NCT01072175|6007542|P3|COMPLETED|Part D (HPMC Capsules)||0
2449288|NCT01072175|6007543|P2|COMPLETED|Part D (HPMC Capsules)||0
2449289|NCT01072175|6007544|P1|COMPLETED|Part D (HPMC Capsules)||0
2449290|NCT01072175|6007532|P13|STARTED|Part D (HPMC Capsules)||39
2449291|NCT01072175|6007533|P12|STARTED|Part D (HPMC Capsules)||43
2449292|NCT01072175|6007534|P11|STARTED|Part D (HPMC Capsules)||16
2449293|NCT01072175|6007535|P10|STARTED|Part D (HPMC Capsules)||12
2449294|NCT01072175|6007536|P9|STARTED|Part D (HPMC Capsules)||0
2449295|NCT01072175|6007537|P8|STARTED|Part D (HPMC Capsules)||0
2449296|NCT01072175|6007538|P7|STARTED|Part D (HPMC Capsules)||0
2449297|NCT01072175|6007539|P6|STARTED|Part D (HPMC Capsules)||0
2449298|NCT01072175|6007540|P5|STARTED|Part D (HPMC Capsules)||0
2449299|NCT01072175|6007541|P4|STARTED|Part D (HPMC Capsules)||0
2449300|NCT01072175|6007542|P3|STARTED|Part D (HPMC Capsules)||0
2449301|NCT01072175|6007543|P2|STARTED|Part D (HPMC Capsules)||0
2449302|NCT01072175|6007544|P1|STARTED|Part D (HPMC Capsules)||0
2449303|NCT01072175|6007532|P13|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
2449304|NCT01072175|6007533|P12|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
2449305|NCT01072175|6007534|P11|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
2449306|NCT01072175|6007535|P10|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
2449307|NCT01072175|6007536|P9|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||45
2449308|NCT01072175|6007537|P8|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
2449309|NCT01072175|6007538|P7|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
2449310|NCT01072175|6007539|P6|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
2449311|NCT01072175|6007540|P5|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
2449312|NCT01072175|6007541|P4|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
2449313|NCT01072175|6007542|P3|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
2449314|NCT01072175|6007543|P2|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
2449315|NCT01072175|6007544|P1|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
2449316|NCT01072175|6007532|P13|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
2449317|NCT01072175|6007533|P12|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
2449318|NCT01072175|6007534|P11|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
2449319|NCT01072175|6007535|P10|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
2449320|NCT01072175|6007536|P9|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
2449321|NCT01072175|6007537|P8|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
2449322|NCT01072175|6007538|P7|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
2449323|NCT01072175|6007539|P6|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
2449324|NCT01072175|6007540|P5|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
2449325|NCT01072175|6007541|P4|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
2449326|NCT01072175|6007542|P3|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
2449327|NCT01072175|6007543|P2|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
2449328|NCT01072175|6007544|P1|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
2449329|NCT01072175|6007532|P13|STARTED|Part C (Phase II: Crossover Phase [CP])||0
2449330|NCT01072175|6007533|P12|STARTED|Part C (Phase II: Crossover Phase [CP])||0
2449331|NCT01072175|6007534|P11|STARTED|Part C (Phase II: Crossover Phase [CP])||0
2449332|NCT01072175|6007535|P10|STARTED|Part C (Phase II: Crossover Phase [CP])||0
2449333|NCT01072175|6007536|P9|STARTED|Part C (Phase II: Crossover Phase [CP])||45
2449334|NCT01072175|6007537|P8|STARTED|Part C (Phase II: Crossover Phase [CP])||0
2449335|NCT01072175|6007538|P7|STARTED|Part C (Phase II: Crossover Phase [CP])||0
2449336|NCT01072175|6007539|P6|STARTED|Part C (Phase II: Crossover Phase [CP])||0
2449337|NCT01072175|6007540|P5|STARTED|Part C (Phase II: Crossover Phase [CP])||0
2449338|NCT01072175|6007541|P4|STARTED|Part C (Phase II: Crossover Phase [CP])||0
2449339|NCT01072175|6007542|P3|STARTED|Part C (Phase II: Crossover Phase [CP])||0
2449340|NCT01072175|6007543|P2|STARTED|Part C (Phase II: Crossover Phase [CP])||0
2449341|NCT01072175|6007544|P1|STARTED|Part C (Phase II: Crossover Phase [CP])||0
2449342|NCT01072175|6007532|P13|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
2449343|NCT01072175|6007533|P12|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
2449344|NCT01072175|6007534|P11|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
2449345|NCT01072175|6007535|P10|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
2449346|NCT01072175|6007536|P9|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
2449347|NCT01072175|6007537|P8|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
2449348|NCT01072175|6007538|P7|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
2449349|NCT01072175|6007539|P6|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
2449350|NCT01072175|6007540|P5|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
2449351|NCT01072175|6007541|P4|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
2449352|NCT01072175|6007542|P3|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
2449353|NCT01072175|6007543|P2|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
2449354|NCT01072175|6007544|P1|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
2449355|NCT01072175|6007532|P13|COMPLETED|Part C (Phase II: Randomized Phase)||0
2449356|NCT01072175|6007533|P12|COMPLETED|Part C (Phase II: Randomized Phase)||0
2449357|NCT01072175|6007534|P11|COMPLETED|Part C (Phase II: Randomized Phase)||0
2449358|NCT01072175|6007535|P10|COMPLETED|Part C (Phase II: Randomized Phase)||0
2449359|NCT01072175|6007536|P9|COMPLETED|Part C (Phase II: Randomized Phase)||0
2449360|NCT01072175|6007537|P8|COMPLETED|Part C (Phase II: Randomized Phase)||0
2449361|NCT01072175|6007538|P7|COMPLETED|Part C (Phase II: Randomized Phase)||0
2449362|NCT01072175|6007539|P6|COMPLETED|Part C (Phase II: Randomized Phase)||0
2449363|NCT01072175|6007540|P5|COMPLETED|Part C (Phase II: Randomized Phase)||0
2449364|NCT01072175|6007541|P4|COMPLETED|Part C (Phase II: Randomized Phase)||0
2449365|NCT01072175|6007542|P3|COMPLETED|Part C (Phase II: Randomized Phase)||0
2449366|NCT01072175|6007543|P2|COMPLETED|Part C (Phase II: Randomized Phase)||0
2449367|NCT01072175|6007544|P1|COMPLETED|Part C (Phase II: Randomized Phase)||0
2449368|NCT01072175|6007532|P13|STARTED|Part C (Phase II: Randomized Phase)||0
2449369|NCT01072175|6007533|P12|STARTED|Part C (Phase II: Randomized Phase)||0
2449370|NCT01072175|6007534|P11|STARTED|Part C (Phase II: Randomized Phase)||0
2449371|NCT01072175|6007535|P10|STARTED|Part C (Phase II: Randomized Phase)||0
2449372|NCT01072175|6007536|P9|STARTED|Part C (Phase II: Randomized Phase)||0
2449373|NCT01072175|6007537|P8|STARTED|Part C (Phase II: Randomized Phase)||54
2449374|NCT01072175|6007538|P7|STARTED|Part C (Phase II: Randomized Phase)||54
2449375|NCT01072175|6007539|P6|STARTED|Part C (Phase II: Randomized Phase)||54
2449376|NCT01072175|6007540|P5|STARTED|Part C (Phase II: Randomized Phase)||0
2449377|NCT01072175|6007541|P4|STARTED|Part C (Phase II: Randomized Phase)||0
2449378|NCT01072175|6007542|P3|STARTED|Part C (Phase II: Randomized Phase)||0
2449379|NCT01072175|6007543|P2|STARTED|Part C (Phase II: Randomized Phase)||0
2449380|NCT01072175|6007544|P1|STARTED|Part C (Phase II: Randomized Phase)||0
2449381|NCT01072175|6007532|P13|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
2449382|NCT01072175|6007533|P12|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
2449383|NCT01072175|6007534|P11|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
2449384|NCT01072175|6007535|P10|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
2449385|NCT01072175|6007536|P9|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
2449386|NCT01072175|6007537|P8|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
2449387|NCT01072175|6007538|P7|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
2449388|NCT01072175|6007539|P6|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
2449389|NCT01072175|6007540|P5|NOT COMPLETED|Part B (Dose Escalation and Expansion)||94
2449390|NCT01072175|6007541|P4|NOT COMPLETED|Part B (Dose Escalation and Expansion)||27
2449391|NCT01072175|6007542|P3|NOT COMPLETED|Part B (Dose Escalation and Expansion)||23
2449392|NCT01072175|6007543|P2|NOT COMPLETED|Part B (Dose Escalation and Expansion)||6
2449393|NCT01072175|6007544|P1|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
2449394|NCT01072175|6007532|P13|COMPLETED|Part B (Dose Escalation and Expansion)||0
2449395|NCT01072175|6007533|P12|COMPLETED|Part B (Dose Escalation and Expansion)||0
2449396|NCT01072175|6007534|P11|COMPLETED|Part B (Dose Escalation and Expansion)||0
2449397|NCT01072175|6007535|P10|COMPLETED|Part B (Dose Escalation and Expansion)||0
2449398|NCT01072175|6007536|P9|COMPLETED|Part B (Dose Escalation and Expansion)||0
2449399|NCT01072175|6007537|P8|COMPLETED|Part B (Dose Escalation and Expansion)||0
2449400|NCT01072175|6007538|P7|COMPLETED|Part B (Dose Escalation and Expansion)||0
2449401|NCT01072175|6007539|P6|COMPLETED|Part B (Dose Escalation and Expansion)||0
2449402|NCT01072175|6007540|P5|COMPLETED|Part B (Dose Escalation and Expansion)||0
2449403|NCT01072175|6007541|P4|COMPLETED|Part B (Dose Escalation and Expansion)||0
2449404|NCT01072175|6007542|P3|COMPLETED|Part B (Dose Escalation and Expansion)||0
2449405|NCT01072175|6007543|P2|COMPLETED|Part B (Dose Escalation and Expansion)||0
2449406|NCT01072175|6007544|P1|COMPLETED|Part B (Dose Escalation and Expansion)||0
2449407|NCT01072175|6007532|P13|STARTED|Part B (Dose Escalation and Expansion)||0
2449408|NCT01072175|6007533|P12|STARTED|Part B (Dose Escalation and Expansion)||0
2449409|NCT01072175|6007534|P11|STARTED|Part B (Dose Escalation and Expansion)||0
2449410|NCT01072175|6007535|P10|STARTED|Part B (Dose Escalation and Expansion)||0
2449411|NCT01072175|6007536|P9|STARTED|Part B (Dose Escalation and Expansion)||0
2449412|NCT01072175|6007537|P8|STARTED|Part B (Dose Escalation and Expansion)||0
2449413|NCT01072175|6007538|P7|STARTED|Part B (Dose Escalation and Expansion)||0
2449414|NCT01072175|6007539|P6|STARTED|Part B (Dose Escalation and Expansion)||0
2449415|NCT01072175|6007540|P5|STARTED|Part B (Dose Escalation and Expansion)||94
2449416|NCT01072175|6007541|P4|STARTED|Part B (Dose Escalation and Expansion)||27
2449417|NCT01072175|6007542|P3|STARTED|Part B (Dose Escalation and Expansion)||23
2449418|NCT01072175|6007543|P2|STARTED|Part B (Dose Escalation and Expansion)||6
2449419|NCT01072175|6007544|P1|STARTED|Part B (Dose Escalation and Expansion)||0
2449420|NCT01072175|6007532|P13|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
2449421|NCT01072175|6007533|P12|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
2449422|NCT01072175|6007534|P11|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
2449423|NCT01072175|6007535|P10|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
2449424|NCT01072175|6007536|P9|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
2449425|NCT01072175|6007537|P8|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
2449426|NCT01072175|6007538|P7|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
2449427|NCT01072175|6007539|P6|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
2449428|NCT01072175|6007540|P5|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
2449429|NCT01072175|6007541|P4|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
2449430|NCT01072175|6007542|P3|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
2449431|NCT01072175|6007543|P2|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
2449432|NCT01072175|6007544|P1|NOT COMPLETED|Part A (Drug-Drug Interaction)||8
2449433|NCT01072175|6007532|P13|COMPLETED|Part A (Drug-Drug Interaction)||0
2449434|NCT01072175|6007533|P12|COMPLETED|Part A (Drug-Drug Interaction)||0
2449435|NCT01072175|6007534|P11|COMPLETED|Part A (Drug-Drug Interaction)||0
2449436|NCT01072175|6007535|P10|COMPLETED|Part A (Drug-Drug Interaction)||0
2449437|NCT01072175|6007536|P9|COMPLETED|Part A (Drug-Drug Interaction)||0
2449438|NCT01072175|6007537|P8|COMPLETED|Part A (Drug-Drug Interaction)||0
2449439|NCT01072175|6007538|P7|COMPLETED|Part A (Drug-Drug Interaction)||0
2449440|NCT01072175|6007539|P6|COMPLETED|Part A (Drug-Drug Interaction)||0
2449441|NCT01072175|6007540|P5|COMPLETED|Part A (Drug-Drug Interaction)||0
2449442|NCT01072175|6007541|P4|COMPLETED|Part A (Drug-Drug Interaction)||0
2449443|NCT01072175|6007542|P3|COMPLETED|Part A (Drug-Drug Interaction)||0
2449444|NCT01072175|6007543|P2|COMPLETED|Part A (Drug-Drug Interaction)||0
2449445|NCT01072175|6007544|P1|COMPLETED|Part A (Drug-Drug Interaction)||0
2449446|NCT01072175|6007532|P13|STARTED|Part A (Drug-Drug Interaction)||0
2449447|NCT01072175|6007533|P12|STARTED|Part A (Drug-Drug Interaction)||0
2449448|NCT01072175|6007534|P11|STARTED|Part A (Drug-Drug Interaction)||0
2449449|NCT01072175|6007535|P10|STARTED|Part A (Drug-Drug Interaction)||0
2449450|NCT01072175|6007536|P9|STARTED|Part A (Drug-Drug Interaction)||0
2449451|NCT01072175|6007537|P8|STARTED|Part A (Drug-Drug Interaction)||0
2449452|NCT01072175|6007538|P7|STARTED|Part A (Drug-Drug Interaction)||0
2449453|NCT01072175|6007539|P6|STARTED|Part A (Drug-Drug Interaction)||0
2449454|NCT01072175|6007540|P5|STARTED|Part A (Drug-Drug Interaction)||0
2449455|NCT01072175|6007541|P4|STARTED|Part A (Drug-Drug Interaction)||0
2449456|NCT01072175|6007542|P3|STARTED|Part A (Drug-Drug Interaction)||0
2449457|NCT01072175|6007543|P2|STARTED|Part A (Drug-Drug Interaction)||0
2449458|NCT01072175|6007544|P1|STARTED|Part A (Drug-Drug Interaction)||8
2449459|NCT01072149|6007753|P18|NOT COMPLETED|Treatment Period 3 (28 Days)||0
2449460|NCT01072149|6007754|P17|NOT COMPLETED|Treatment Period 3 (28 Days)||0
2449461|NCT01072149|6007755|P16|NOT COMPLETED|Treatment Period 3 (28 Days)||0
2449462|NCT01072149|6007756|P15|NOT COMPLETED|Treatment Period 3 (28 Days)||0
2449463|NCT01072149|6007757|P14|NOT COMPLETED|Treatment Period 3 (28 Days)||1
2449464|NCT01072149|6007758|P13|NOT COMPLETED|Treatment Period 3 (28 Days)||0
2449465|NCT01072149|6007759|P12|NOT COMPLETED|Treatment Period 3 (28 Days)||0
2449466|NCT01072149|6007760|P11|NOT COMPLETED|Treatment Period 3 (28 Days)||0
2449467|NCT01072149|6007761|P10|NOT COMPLETED|Treatment Period 3 (28 Days)||0
2449468|NCT01072149|6007762|P9|NOT COMPLETED|Treatment Period 3 (28 Days)||0
2449469|NCT01072149|6007763|P8|NOT COMPLETED|Treatment Period 3 (28 Days)||0
2449470|NCT01072149|6007764|P7|NOT COMPLETED|Treatment Period 3 (28 Days)||0
2449471|NCT01072149|6007765|P6|NOT COMPLETED|Treatment Period 3 (28 Days)||0
2449472|NCT01072149|6007766|P5|NOT COMPLETED|Treatment Period 3 (28 Days)||0
2449473|NCT01072149|6007767|P4|NOT COMPLETED|Treatment Period 3 (28 Days)||0
2449474|NCT01072149|6007768|P3|NOT COMPLETED|Treatment Period 3 (28 Days)||1
2449475|NCT01072149|6007769|P2|NOT COMPLETED|Treatment Period 3 (28 Days)||0
2449476|NCT01072149|6007770|P1|NOT COMPLETED|Treatment Period 3 (28 Days)||0
2449477|NCT01072149|6007753|P18|COMPLETED|Treatment Period 3 (28 Days)||2
2449478|NCT01072149|6007754|P17|COMPLETED|Treatment Period 3 (28 Days)||3
2449479|NCT01072149|6007755|P16|COMPLETED|Treatment Period 3 (28 Days)||1
2449480|NCT01072149|6007756|P15|COMPLETED|Treatment Period 3 (28 Days)||3
2449481|NCT01072149|6007757|P14|COMPLETED|Treatment Period 3 (28 Days)||2
2449482|NCT01072149|6007758|P13|COMPLETED|Treatment Period 3 (28 Days)||2
2449483|NCT01072149|6007759|P12|COMPLETED|Treatment Period 3 (28 Days)||3
2449484|NCT01072149|6007760|P11|COMPLETED|Treatment Period 3 (28 Days)||2
2449485|NCT01072149|6007761|P10|COMPLETED|Treatment Period 3 (28 Days)||3
2449486|NCT01072149|6007762|P9|COMPLETED|Treatment Period 3 (28 Days)||3
2449487|NCT01072149|6007763|P8|COMPLETED|Treatment Period 3 (28 Days)||2
2449488|NCT01072149|6007764|P7|COMPLETED|Treatment Period 3 (28 Days)||3
2449489|NCT01072149|6007765|P6|COMPLETED|Treatment Period 3 (28 Days)||3
2449490|NCT01072149|6007766|P5|COMPLETED|Treatment Period 3 (28 Days)||3
2449491|NCT01072149|6007767|P4|COMPLETED|Treatment Period 3 (28 Days)||3
2449492|NCT01072149|6007768|P3|COMPLETED|Treatment Period 3 (28 Days)||0
2449493|NCT01072149|6007769|P2|COMPLETED|Treatment Period 3 (28 Days)||2
2449494|NCT01072149|6007770|P1|COMPLETED|Treatment Period 3 (28 Days)||2
2449495|NCT01072149|6007753|P18|STARTED|Treatment Period 3 (28 Days)||2
2449496|NCT01072149|6007754|P17|STARTED|Treatment Period 3 (28 Days)||3
2449497|NCT01072149|6007755|P16|STARTED|Treatment Period 3 (28 Days)||1
2449498|NCT01072149|6007756|P15|STARTED|Treatment Period 3 (28 Days)||3
2449499|NCT01072149|6007757|P14|STARTED|Treatment Period 3 (28 Days)||3
2449500|NCT01072149|6007758|P13|STARTED|Treatment Period 3 (28 Days)||2
2449501|NCT01072149|6007759|P12|STARTED|Treatment Period 3 (28 Days)||3
2449502|NCT01072149|6007760|P11|STARTED|Treatment Period 3 (28 Days)||2
2449503|NCT01072149|6007761|P10|STARTED|Treatment Period 3 (28 Days)||3
2449504|NCT01072149|6007762|P9|STARTED|Treatment Period 3 (28 Days)||3
2449505|NCT01072149|6007763|P8|STARTED|Treatment Period 3 (28 Days)||2
2449506|NCT01072149|6007764|P7|STARTED|Treatment Period 3 (28 Days)||3
2449507|NCT01072149|6007765|P6|STARTED|Treatment Period 3 (28 Days)||3
2449508|NCT01072149|6007766|P5|STARTED|Treatment Period 3 (28 Days)||3
2449509|NCT01072149|6007767|P4|STARTED|Treatment Period 3 (28 Days)||3
2449510|NCT01072149|6007768|P3|STARTED|Treatment Period 3 (28 Days)||1
2449511|NCT01072149|6007769|P2|STARTED|Treatment Period 3 (28 Days)||2
2449512|NCT01072149|6007770|P1|STARTED|Treatment Period 3 (28 Days)||2
2449513|NCT01072149|6007753|P18|NOT COMPLETED|Washout Period 2 (14 Days)||0
2449514|NCT01072149|6007754|P17|NOT COMPLETED|Washout Period 2 (14 Days)||0
2449515|NCT01072149|6007755|P16|NOT COMPLETED|Washout Period 2 (14 Days)||2
2449516|NCT01072149|6007756|P15|NOT COMPLETED|Washout Period 2 (14 Days)||0
2449517|NCT01072149|6007757|P14|NOT COMPLETED|Washout Period 2 (14 Days)||0
2449518|NCT01072149|6007758|P13|NOT COMPLETED|Washout Period 2 (14 Days)||1
2449519|NCT01072149|6007759|P12|NOT COMPLETED|Washout Period 2 (14 Days)||0
2449520|NCT01072149|6007760|P11|NOT COMPLETED|Washout Period 2 (14 Days)||0
2449521|NCT01072149|6007761|P10|NOT COMPLETED|Washout Period 2 (14 Days)||0
2449522|NCT01072149|6007762|P9|NOT COMPLETED|Washout Period 2 (14 Days)||0
2449523|NCT01072149|6007763|P8|NOT COMPLETED|Washout Period 2 (14 Days)||0
2449524|NCT01072149|6007764|P7|NOT COMPLETED|Washout Period 2 (14 Days)||0
2449525|NCT01072149|6007765|P6|NOT COMPLETED|Washout Period 2 (14 Days)||0
2449526|NCT01072149|6007766|P5|NOT COMPLETED|Washout Period 2 (14 Days)||0
2449527|NCT01072149|6007767|P4|NOT COMPLETED|Washout Period 2 (14 Days)||0
2449528|NCT01072149|6007768|P3|NOT COMPLETED|Washout Period 2 (14 Days)||0
2449529|NCT01072149|6007769|P2|NOT COMPLETED|Washout Period 2 (14 Days)||0
2449530|NCT01072149|6007770|P1|NOT COMPLETED|Washout Period 2 (14 Days)||1
2449531|NCT01072149|6007753|P18|COMPLETED|Washout Period 2 (14 Days)||2
2449532|NCT01072149|6007754|P17|COMPLETED|Washout Period 2 (14 Days)||3
2449533|NCT01072149|6007755|P16|COMPLETED|Washout Period 2 (14 Days)||1
2449534|NCT01072149|6007756|P15|COMPLETED|Washout Period 2 (14 Days)||3
2449535|NCT01072149|6007757|P14|COMPLETED|Washout Period 2 (14 Days)||3
2449536|NCT01072149|6007758|P13|COMPLETED|Washout Period 2 (14 Days)||2
2449537|NCT01072149|6007759|P12|COMPLETED|Washout Period 2 (14 Days)||3
2449538|NCT01072149|6007760|P11|COMPLETED|Washout Period 2 (14 Days)||2
2449539|NCT01072149|6007761|P10|COMPLETED|Washout Period 2 (14 Days)||3
2449540|NCT01072149|6007762|P9|COMPLETED|Washout Period 2 (14 Days)||3
2449541|NCT01072149|6007763|P8|COMPLETED|Washout Period 2 (14 Days)||2
2449542|NCT01072149|6007764|P7|COMPLETED|Washout Period 2 (14 Days)||3
2449543|NCT01072149|6007765|P6|COMPLETED|Washout Period 2 (14 Days)||3
2449544|NCT01072149|6007766|P5|COMPLETED|Washout Period 2 (14 Days)||3
2449545|NCT01072149|6007767|P4|COMPLETED|Washout Period 2 (14 Days)||3
2449546|NCT01072149|6007768|P3|COMPLETED|Washout Period 2 (14 Days)||1
2449547|NCT01072149|6007769|P2|COMPLETED|Washout Period 2 (14 Days)||2
2449548|NCT01072149|6007770|P1|COMPLETED|Washout Period 2 (14 Days)||2
2449549|NCT01072149|6007753|P18|STARTED|Washout Period 2 (14 Days)||2
2449550|NCT01072149|6007754|P17|STARTED|Washout Period 2 (14 Days)||3
2449551|NCT01072149|6007755|P16|STARTED|Washout Period 2 (14 Days)||3
2449552|NCT01072149|6007756|P15|STARTED|Washout Period 2 (14 Days)||3
2449553|NCT01072149|6007757|P14|STARTED|Washout Period 2 (14 Days)||3
2449554|NCT01072149|6007758|P13|STARTED|Washout Period 2 (14 Days)||3
2449555|NCT01072149|6007759|P12|STARTED|Washout Period 2 (14 Days)||3
2449556|NCT01072149|6007760|P11|STARTED|Washout Period 2 (14 Days)||2
2449557|NCT01072149|6007761|P10|STARTED|Washout Period 2 (14 Days)||3
2449558|NCT01072149|6007762|P9|STARTED|Washout Period 2 (14 Days)||3
2449559|NCT01072149|6007763|P8|STARTED|Washout Period 2 (14 Days)||2
2449560|NCT01072149|6007764|P7|STARTED|Washout Period 2 (14 Days)||3
2449561|NCT01072149|6007765|P6|STARTED|Washout Period 2 (14 Days)||3
2449562|NCT01072149|6007766|P5|STARTED|Washout Period 2 (14 Days)||3
2449563|NCT01072149|6007767|P4|STARTED|Washout Period 2 (14 Days)||3
2449564|NCT01072149|6007768|P3|STARTED|Washout Period 2 (14 Days)||1
2449565|NCT01072149|6007769|P2|STARTED|Washout Period 2 (14 Days)||2
2449566|NCT01072149|6007770|P1|STARTED|Washout Period 2 (14 Days)||3
2449567|NCT01072149|6007753|P18|NOT COMPLETED|Treatment Period 2 (28 Days)||0
2449568|NCT01072149|6007754|P17|NOT COMPLETED|Treatment Period 2 (28 Days)||0
2449569|NCT01072149|6007755|P16|NOT COMPLETED|Treatment Period 2 (28 Days)||0
2449570|NCT01072149|6007756|P15|NOT COMPLETED|Treatment Period 2 (28 Days)||0
2449571|NCT01072149|6007757|P14|NOT COMPLETED|Treatment Period 2 (28 Days)||0
2449572|NCT01072149|6007758|P13|NOT COMPLETED|Treatment Period 2 (28 Days)||0
2449573|NCT01072149|6007759|P12|NOT COMPLETED|Treatment Period 2 (28 Days)||0
2449574|NCT01072149|6007760|P11|NOT COMPLETED|Treatment Period 2 (28 Days)||0
2449575|NCT01072149|6007761|P10|NOT COMPLETED|Treatment Period 2 (28 Days)||0
2449576|NCT01072149|6007762|P9|NOT COMPLETED|Treatment Period 2 (28 Days)||0
2449577|NCT01072149|6007763|P8|NOT COMPLETED|Treatment Period 2 (28 Days)||1
2449578|NCT01072149|6007764|P7|NOT COMPLETED|Treatment Period 2 (28 Days)||0
2449579|NCT01072149|6007765|P6|NOT COMPLETED|Treatment Period 2 (28 Days)||0
2449580|NCT01072149|6007766|P5|NOT COMPLETED|Treatment Period 2 (28 Days)||0
2449581|NCT01072149|6007767|P4|NOT COMPLETED|Treatment Period 2 (28 Days)||0
2449582|NCT01072149|6007768|P3|NOT COMPLETED|Treatment Period 2 (28 Days)||1
2449583|NCT01072149|6007769|P2|NOT COMPLETED|Treatment Period 2 (28 Days)||1
2449584|NCT01072149|6007770|P1|NOT COMPLETED|Treatment Period 2 (28 Days)||0
2449585|NCT01072149|6007753|P18|COMPLETED|Treatment Period 2 (28 Days)||2
2449586|NCT01072149|6007754|P17|COMPLETED|Treatment Period 2 (28 Days)||3
2449587|NCT01072149|6007755|P16|COMPLETED|Treatment Period 2 (28 Days)||3
2449588|NCT01072149|6007756|P15|COMPLETED|Treatment Period 2 (28 Days)||3
2449589|NCT01072149|6007757|P14|COMPLETED|Treatment Period 2 (28 Days)||3
2449590|NCT01072149|6007758|P13|COMPLETED|Treatment Period 2 (28 Days)||3
2449591|NCT01072149|6007759|P12|COMPLETED|Treatment Period 2 (28 Days)||3
2449592|NCT01072149|6007760|P11|COMPLETED|Treatment Period 2 (28 Days)||2
2449593|NCT01072149|6007761|P10|COMPLETED|Treatment Period 2 (28 Days)||3
2449594|NCT01072149|6007762|P9|COMPLETED|Treatment Period 2 (28 Days)||3
2449595|NCT01072149|6007763|P8|COMPLETED|Treatment Period 2 (28 Days)||2
2449596|NCT01072149|6007764|P7|COMPLETED|Treatment Period 2 (28 Days)||3
2449597|NCT01072149|6007765|P6|COMPLETED|Treatment Period 2 (28 Days)||3
2449598|NCT01072149|6007766|P5|COMPLETED|Treatment Period 2 (28 Days)||3
2449599|NCT01072149|6007767|P4|COMPLETED|Treatment Period 2 (28 Days)||3
2449600|NCT01072149|6007768|P3|COMPLETED|Treatment Period 2 (28 Days)||1
2449601|NCT01072149|6007769|P2|COMPLETED|Treatment Period 2 (28 Days)||2
2449602|NCT01072149|6007770|P1|COMPLETED|Treatment Period 2 (28 Days)||3
2449603|NCT01072149|6007753|P18|STARTED|Treatment Period 2 (28 Days)||2
2449604|NCT01072149|6007754|P17|STARTED|Treatment Period 2 (28 Days)||3
2449605|NCT01072149|6007755|P16|STARTED|Treatment Period 2 (28 Days)||3
2449606|NCT01072149|6007756|P15|STARTED|Treatment Period 2 (28 Days)||3
2449607|NCT01072149|6007757|P14|STARTED|Treatment Period 2 (28 Days)||3
2449608|NCT01072149|6007758|P13|STARTED|Treatment Period 2 (28 Days)||3
2449609|NCT01072149|6007759|P12|STARTED|Treatment Period 2 (28 Days)||3
2449610|NCT01072149|6007760|P11|STARTED|Treatment Period 2 (28 Days)||2
2449611|NCT01072149|6007761|P10|STARTED|Treatment Period 2 (28 Days)||3
2449612|NCT01072149|6007762|P9|STARTED|Treatment Period 2 (28 Days)||3
2449613|NCT01072149|6007763|P8|STARTED|Treatment Period 2 (28 Days)||3
2449614|NCT01072149|6007764|P7|STARTED|Treatment Period 2 (28 Days)||3
2449615|NCT01072149|6007765|P6|STARTED|Treatment Period 2 (28 Days)||3
2449616|NCT01072149|6007766|P5|STARTED|Treatment Period 2 (28 Days)||3
2449617|NCT01072149|6007767|P4|STARTED|Treatment Period 2 (28 Days)||3
2449618|NCT01072149|6007768|P3|STARTED|Treatment Period 2 (28 Days)||2
2449619|NCT01072149|6007769|P2|STARTED|Treatment Period 2 (28 Days)||3
2449620|NCT01072149|6007770|P1|STARTED|Treatment Period 2 (28 Days)||3
2449621|NCT01072149|6007753|P18|NOT COMPLETED|Washout Period 1 (14 Days)||0
2449622|NCT01072149|6007754|P17|NOT COMPLETED|Washout Period 1 (14 Days)||0
2449623|NCT01072149|6007755|P16|NOT COMPLETED|Washout Period 1 (14 Days)||0
2449624|NCT01072149|6007756|P15|NOT COMPLETED|Washout Period 1 (14 Days)||0
2449625|NCT01072149|6007757|P14|NOT COMPLETED|Washout Period 1 (14 Days)||0
2449626|NCT01072149|6007758|P13|NOT COMPLETED|Washout Period 1 (14 Days)||0
2449627|NCT01072149|6007759|P12|NOT COMPLETED|Washout Period 1 (14 Days)||0
2449628|NCT01072149|6007760|P11|NOT COMPLETED|Washout Period 1 (14 Days)||0
2449629|NCT01072149|6007761|P10|NOT COMPLETED|Washout Period 1 (14 Days)||0
2449630|NCT01072149|6007762|P9|NOT COMPLETED|Washout Period 1 (14 Days)||0
2449631|NCT01072149|6007763|P8|NOT COMPLETED|Washout Period 1 (14 Days)||0
2449632|NCT01072149|6007764|P7|NOT COMPLETED|Washout Period 1 (14 Days)||0
2449633|NCT01072149|6007765|P6|NOT COMPLETED|Washout Period 1 (14 Days)||0
2449634|NCT01072149|6007766|P5|NOT COMPLETED|Washout Period 1 (14 Days)||0
2449635|NCT01072149|6007767|P4|NOT COMPLETED|Washout Period 1 (14 Days)||0
2449636|NCT01072149|6007768|P3|NOT COMPLETED|Washout Period 1 (14 Days)||0
2449637|NCT01072149|6007769|P2|NOT COMPLETED|Washout Period 1 (14 Days)||0
2449638|NCT01072149|6007770|P1|NOT COMPLETED|Washout Period 1 (14 Days)||0
2449639|NCT01072149|6007753|P18|COMPLETED|Washout Period 1 (14 Days)||2
2449640|NCT01072149|6007754|P17|COMPLETED|Washout Period 1 (14 Days)||3
2449641|NCT01072149|6007755|P16|COMPLETED|Washout Period 1 (14 Days)||3
2449642|NCT01072149|6007756|P15|COMPLETED|Washout Period 1 (14 Days)||3
2449643|NCT01072149|6007757|P14|COMPLETED|Washout Period 1 (14 Days)||3
2449644|NCT01072149|6007758|P13|COMPLETED|Washout Period 1 (14 Days)||3
2449645|NCT01072149|6007759|P12|COMPLETED|Washout Period 1 (14 Days)||3
2449646|NCT01072149|6007760|P11|COMPLETED|Washout Period 1 (14 Days)||2
2449647|NCT01072149|6007761|P10|COMPLETED|Washout Period 1 (14 Days)||3
2449648|NCT01072149|6007762|P9|COMPLETED|Washout Period 1 (14 Days)||3
2449649|NCT01072149|6007763|P8|COMPLETED|Washout Period 1 (14 Days)||3
2449650|NCT01072149|6007764|P7|COMPLETED|Washout Period 1 (14 Days)||3
2449651|NCT01072149|6007765|P6|COMPLETED|Washout Period 1 (14 Days)||3
2449652|NCT01072149|6007766|P5|COMPLETED|Washout Period 1 (14 Days)||3
2449653|NCT01072149|6007767|P4|COMPLETED|Washout Period 1 (14 Days)||3
2449654|NCT01072149|6007768|P3|COMPLETED|Washout Period 1 (14 Days)||2
2449655|NCT01072149|6007769|P2|COMPLETED|Washout Period 1 (14 Days)||3
2449656|NCT01072149|6007770|P1|COMPLETED|Washout Period 1 (14 Days)||3
2449657|NCT01072149|6007753|P18|STARTED|Washout Period 1 (14 Days)||2
2449658|NCT01072149|6007754|P17|STARTED|Washout Period 1 (14 Days)||3
2449659|NCT01072149|6007755|P16|STARTED|Washout Period 1 (14 Days)||3
2449660|NCT01072149|6007756|P15|STARTED|Washout Period 1 (14 Days)||3
2449661|NCT01072149|6007757|P14|STARTED|Washout Period 1 (14 Days)||3
2449662|NCT01072149|6007758|P13|STARTED|Washout Period 1 (14 Days)||3
2449663|NCT01072149|6007759|P12|STARTED|Washout Period 1 (14 Days)||3
2449664|NCT01072149|6007760|P11|STARTED|Washout Period 1 (14 Days)||2
2449665|NCT01072149|6007761|P10|STARTED|Washout Period 1 (14 Days)||3
2449666|NCT01072149|6007762|P9|STARTED|Washout Period 1 (14 Days)||3
2449667|NCT01072149|6007763|P8|STARTED|Washout Period 1 (14 Days)||3
2449668|NCT01072149|6007764|P7|STARTED|Washout Period 1 (14 Days)||3
2449669|NCT01072149|6007765|P6|STARTED|Washout Period 1 (14 Days)||3
2449670|NCT01072149|6007766|P5|STARTED|Washout Period 1 (14 Days)||3
2449671|NCT01072149|6007767|P4|STARTED|Washout Period 1 (14 Days)||3
2449672|NCT01072149|6007768|P3|STARTED|Washout Period 1 (14 Days)||2
2449673|NCT01072149|6007769|P2|STARTED|Washout Period 1 (14 Days)||3
2449674|NCT01072149|6007770|P1|STARTED|Washout Period 1 (14 Days)||3
2449675|NCT01072149|6007753|P18|NOT COMPLETED|Treatment Period 1 (28 Days)||1
2449676|NCT01072149|6007754|P17|NOT COMPLETED|Treatment Period 1 (28 Days)||0
2449677|NCT01072149|6007755|P16|NOT COMPLETED|Treatment Period 1 (28 Days)||0
2449678|NCT01072149|6007756|P15|NOT COMPLETED|Treatment Period 1 (28 Days)||0
2449679|NCT01072149|6007757|P14|NOT COMPLETED|Treatment Period 1 (28 Days)||0
2449680|NCT01072149|6007758|P13|NOT COMPLETED|Treatment Period 1 (28 Days)||0
2449681|NCT01072149|6007759|P12|NOT COMPLETED|Treatment Period 1 (28 Days)||0
2449682|NCT01072149|6007760|P11|NOT COMPLETED|Treatment Period 1 (28 Days)||1
2449683|NCT01072149|6007761|P10|NOT COMPLETED|Treatment Period 1 (28 Days)||0
2449684|NCT01072149|6007762|P9|NOT COMPLETED|Treatment Period 1 (28 Days)||0
2449685|NCT01072149|6007763|P8|NOT COMPLETED|Treatment Period 1 (28 Days)||0
2449686|NCT01072149|6007764|P7|NOT COMPLETED|Treatment Period 1 (28 Days)||0
2449687|NCT01072149|6007765|P6|NOT COMPLETED|Treatment Period 1 (28 Days)||0
2449688|NCT01072149|6007766|P5|NOT COMPLETED|Treatment Period 1 (28 Days)||0
2449689|NCT01072149|6007767|P4|NOT COMPLETED|Treatment Period 1 (28 Days)||0
2449690|NCT01072149|6007768|P3|NOT COMPLETED|Treatment Period 1 (28 Days)||1
2449691|NCT01072149|6007769|P2|NOT COMPLETED|Treatment Period 1 (28 Days)||0
2449692|NCT01072149|6007770|P1|NOT COMPLETED|Treatment Period 1 (28 Days)||0
2449693|NCT01072149|6007753|P18|COMPLETED|Treatment Period 1 (28 Days)||2
2449694|NCT01072149|6007754|P17|COMPLETED|Treatment Period 1 (28 Days)||3
2449695|NCT01072149|6007755|P16|COMPLETED|Treatment Period 1 (28 Days)||3
2449696|NCT01072149|6007756|P15|COMPLETED|Treatment Period 1 (28 Days)||3
2449697|NCT01072149|6007757|P14|COMPLETED|Treatment Period 1 (28 Days)||3
2449698|NCT01072149|6007758|P13|COMPLETED|Treatment Period 1 (28 Days)||3
2449699|NCT01072149|6007759|P12|COMPLETED|Treatment Period 1 (28 Days)||3
2449700|NCT01072149|6007760|P11|COMPLETED|Treatment Period 1 (28 Days)||2
2449701|NCT01072149|6007761|P10|COMPLETED|Treatment Period 1 (28 Days)||3
2449702|NCT01072149|6007762|P9|COMPLETED|Treatment Period 1 (28 Days)||3
2449703|NCT01072149|6007763|P8|COMPLETED|Treatment Period 1 (28 Days)||3
2449704|NCT01072149|6007764|P7|COMPLETED|Treatment Period 1 (28 Days)||3
2449705|NCT01072149|6007765|P6|COMPLETED|Treatment Period 1 (28 Days)||3
2449706|NCT01072149|6007766|P5|COMPLETED|Treatment Period 1 (28 Days)||3
2449707|NCT01072149|6007767|P4|COMPLETED|Treatment Period 1 (28 Days)||3
2449708|NCT01072149|6007768|P3|COMPLETED|Treatment Period 1 (28 Days)||2
2449709|NCT01072149|6007769|P2|COMPLETED|Treatment Period 1 (28 Days)||3
2449710|NCT01072149|6007770|P1|COMPLETED|Treatment Period 1 (28 Days)||3
2449711|NCT01072149|6007753|P18|STARTED|Treatment Period 1 (28 Days)||3
2449712|NCT01072149|6007754|P17|STARTED|Treatment Period 1 (28 Days)||3
2449713|NCT01072149|6007755|P16|STARTED|Treatment Period 1 (28 Days)||3
2449714|NCT01072149|6007756|P15|STARTED|Treatment Period 1 (28 Days)||3
2449715|NCT01072149|6007757|P14|STARTED|Treatment Period 1 (28 Days)||3
2449716|NCT01072149|6007758|P13|STARTED|Treatment Period 1 (28 Days)||3
2449717|NCT01072149|6007759|P12|STARTED|Treatment Period 1 (28 Days)||3
2449718|NCT01072149|6007760|P11|STARTED|Treatment Period 1 (28 Days)||3
2449719|NCT01072149|6007761|P10|STARTED|Treatment Period 1 (28 Days)||3
2449720|NCT01072149|6007762|P9|STARTED|Treatment Period 1 (28 Days)||3
2449721|NCT01072149|6007763|P8|STARTED|Treatment Period 1 (28 Days)||3
2449722|NCT01072149|6007764|P7|STARTED|Treatment Period 1 (28 Days)||3
2449723|NCT01072149|6007765|P6|STARTED|Treatment Period 1 (28 Days)||3
2449724|NCT01072149|6007766|P5|STARTED|Treatment Period 1 (28 Days)||3
2449725|NCT01072149|6007767|P4|STARTED|Treatment Period 1 (28 Days)||3
2449726|NCT01072149|6007768|P3|STARTED|Treatment Period 1 (28 Days)||3
2449727|NCT01072149|6007769|P2|STARTED|Treatment Period 1 (28 Days)||3
2449728|NCT01072149|6007770|P1|STARTED|Treatment Period 1 (28 Days)||3
2449729|NCT01072136|6007790|P2|NOT COMPLETED|Overall Study||31
2449730|NCT01072136|6007791|P1|NOT COMPLETED|Overall Study||23
2449731|NCT01072136|6007790|P2|COMPLETED|Overall Study||12
2449732|NCT01072136|6007791|P1|COMPLETED|Overall Study||21
2449733|NCT01072136|6007790|P2|Met All Enrollment Criteria|Overall Study||25
2449734|NCT01072136|6007791|P1|Met All Enrollment Criteria|Overall Study|Some eligibility test results were not available until after randomization.|30
2449735|NCT01072136|6007790|P2|STARTED|Overall Study||43
2449736|NCT01072136|6007791|P1|STARTED|Overall Study||44
2449737|NCT01072032|6007815|P2|NOT COMPLETED|Overall Study||9
2449738|NCT01072032|6007816|P1|NOT COMPLETED|Overall Study||8
2449739|NCT01072032|6007815|P2|COMPLETED|Overall Study||5
2449740|NCT01072032|6007816|P1|COMPLETED|Overall Study||5
2449741|NCT01072032|6007815|P2|STARTED|Overall Study||14
2449742|NCT01072032|6007816|P1|STARTED|Overall Study||13
2449743|NCT01072006|6007830|P4|NOT COMPLETED|Overall Study||0
2449744|NCT01072006|6007831|P3|NOT COMPLETED|Overall Study||0
2449745|NCT01072006|6007832|P2|NOT COMPLETED|Overall Study||0
2449746|NCT01072006|6007833|P1|NOT COMPLETED|Overall Study||0
2449747|NCT01072006|6007830|P4|COMPLETED|Overall Study||11
2449748|NCT01072006|6007831|P3|COMPLETED|Overall Study||0
2449749|NCT01072006|6007832|P2|COMPLETED|Overall Study||5
2449750|NCT01072006|6007833|P1|COMPLETED|Overall Study||14
2449751|NCT01072006|6007830|P4|STARTED|Overall Study||11
2449752|NCT01072006|6007831|P3|STARTED|Overall Study||0
2449753|NCT01072006|6007832|P2|STARTED|Overall Study||5
2449754|NCT01072006|6007833|P1|STARTED|Overall Study||14
2449755|NCT01071993|6007852|P2|NOT COMPLETED|Overall Study||0
2449756|NCT01071993|6007853|P1|NOT COMPLETED|Overall Study||0
2449757|NCT01071993|6007852|P2|COMPLETED|Overall Study||0
2449758|NCT01071993|6007853|P1|COMPLETED|Overall Study||0
2449759|NCT01071993|6007852|P2|STARTED|Overall Study||0
2449760|NCT01071993|6007853|P1|STARTED|Overall Study||0
2449761|NCT01071954|6007859|P1|NOT COMPLETED|Overall Study||27
2449762|NCT01071954|6007859|P1|COMPLETED|Overall Study||39
2449763|NCT01071954|6007859|P1|Received Treatment|Overall Study||65
2449764|NCT01071954|6007859|P1|STARTED|Overall Study||66
2449765|NCT01071915|6007868|P1|NOT COMPLETED|Overall Study||9
2449766|NCT01071915|6007868|P1|COMPLETED|Overall Study||148
2449767|NCT01071915|6007868|P1|Safety Analysis Set|Overall Study||156
2449768|NCT01071915|6007868|P1|Full Analysis Set (FAS)|Overall Study||155
2449769|NCT01071915|6007868|P1|STARTED|Overall Study|Intention to Treat Analysis Set|157
2449770|NCT01071798|6007878|P1|NOT COMPLETED|Subpopulation Who Received Two Cycles||15
2449771|NCT01071798|6007878|P1|COMPLETED|Subpopulation Who Received Two Cycles||805
2449772|NCT01071798|6007878|P1|Baseline and Safety Analysis Set|Subpopulation Who Received Two Cycles||820
2449773|NCT01071798|6007878|P1|STARTED|Subpopulation Who Received Two Cycles||820
2449774|NCT01071798|6007878|P1|NOT COMPLETED|Participants Who Received One Cycle||65
2449775|NCT01071798|6007878|P1|COMPLETED|Participants Who Received One Cycle||1588
2449776|NCT01071798|6007878|P1|Baseline and Safety Analysis Set|Participants Who Received One Cycle||1653
2449777|NCT01071798|6007878|P1|STARTED|Participants Who Received One Cycle||1653
2449778|NCT01071538|6007898|P1|NOT COMPLETED|Overall Study||2
2449779|NCT01071538|6007898|P1|COMPLETED|Overall Study||13
2449780|NCT01071538|6007898|P1|STARTED|Overall Study||15
2449781|NCT01071512|6007908|P1|NOT COMPLETED|Overall Study||5
2449782|NCT01071512|6007908|P1|COMPLETED|Overall Study||15
2449783|NCT01071512|6007908|P1|STARTED|Overall Study||20
2449784|NCT01071395|6007918|P2|NOT COMPLETED|Overall Study||2
2449785|NCT01071395|6007919|P1|NOT COMPLETED|Overall Study||5
2449786|NCT01071395|6007918|P2|COMPLETED|Overall Study||30
2449787|NCT01071395|6007919|P1|COMPLETED|Overall Study||31
2449788|NCT01071395|6007918|P2|STARTED|Overall Study||32
2449789|NCT01071395|6007919|P1|STARTED|Overall Study||36
2449790|NCT01071356|6007927|P2|NOT COMPLETED|Overall Study||9
2449791|NCT01071356|6007928|P1|NOT COMPLETED|Overall Study||7
2449792|NCT01071356|6007927|P2|COMPLETED|Overall Study||97
2449793|NCT01071356|6007928|P1|COMPLETED|Overall Study||104
2449794|NCT01071356|6007927|P2|STARTED|Overall Study||106
2449795|NCT01071356|6007928|P1|STARTED|Overall Study||111
2449796|NCT01071317|6007938|P2|NOT COMPLETED|Overall Study||2
2449797|NCT01071317|6007939|P1|NOT COMPLETED|Overall Study||2
2449798|NCT01071317|6007938|P2|COMPLETED|Overall Study||23
2449799|NCT01071317|6007939|P1|COMPLETED|Overall Study||23
2449800|NCT01071317|6007938|P2|STARTED|Overall Study||25
2449801|NCT01071317|6007939|P1|STARTED|Overall Study||25
2449802|NCT01071278|6007951|P1|NOT COMPLETED|Overall Study||713
2449803|NCT01071278|6007951|P1|COMPLETED|Overall Study||1677
2449804|NCT01071278|6007951|P1|STARTED|Overall Study||2390
2449805|NCT01071252|6007962|P5|NOT COMPLETED|Overall Study||11
2449806|NCT01071252|6007963|P4|NOT COMPLETED|Overall Study||7
2449807|NCT01071252|6007964|P3|NOT COMPLETED|Overall Study||4
2449808|NCT01071252|6007965|P2|NOT COMPLETED|Overall Study||10
2449809|NCT01071252|6007966|P1|NOT COMPLETED|Overall Study||15
2449810|NCT01071252|6007962|P5|COMPLETED|Overall Study||11
2449811|NCT01071252|6007963|P4|COMPLETED|Overall Study||20
2449812|NCT01071252|6007964|P3|COMPLETED|Overall Study||17
2449813|NCT01071252|6007965|P2|COMPLETED|Overall Study||16
2449814|NCT01071252|6007966|P1|COMPLETED|Overall Study||14
2449815|NCT01071252|6007962|P5|STARTED|Overall Study||22
2449816|NCT01071252|6007963|P4|STARTED|Overall Study||27
2449817|NCT01071252|6007964|P3|STARTED|Overall Study||21
2449818|NCT01071252|6007965|P2|STARTED|Overall Study||26
2449819|NCT01071252|6007966|P1|STARTED|Overall Study||29
2449820|NCT01071200|6007994|P2|NOT COMPLETED|Overall Study||3
2449821|NCT01071200|6007995|P1|NOT COMPLETED|Overall Study||7
2449822|NCT01071200|6007994|P2|COMPLETED|Overall Study||63
2449823|NCT01071200|6007995|P1|COMPLETED|Overall Study||60
2449824|NCT01071200|6007994|P2|STARTED|Overall Study||66
2449825|NCT01071200|6007995|P1|STARTED|Overall Study||67
2449826|NCT01071096|6008027|P2|NOT COMPLETED|Second Intervention (90 Days)||0
2449827|NCT01071096|6008028|P1|NOT COMPLETED|Second Intervention (90 Days)||0
2449828|NCT01071096|6008027|P2|COMPLETED|Second Intervention (90 Days)||10
2449829|NCT01071096|6008028|P1|COMPLETED|Second Intervention (90 Days)||9
2449830|NCT01071096|6008027|P2|STARTED|Second Intervention (90 Days)||10
2449831|NCT01071096|6008028|P1|STARTED|Second Intervention (90 Days)||9
2449832|NCT01071096|6008027|P2|NOT COMPLETED|Washout Period (30 Days)||0
2449833|NCT01071096|6008028|P1|NOT COMPLETED|Washout Period (30 Days)||0
2449834|NCT01071096|6008027|P2|COMPLETED|Washout Period (30 Days)||10
2449835|NCT01071096|6008028|P1|COMPLETED|Washout Period (30 Days)||9
2449836|NCT01071096|6008027|P2|STARTED|Washout Period (30 Days)||10
2449837|NCT01071096|6008028|P1|STARTED|Washout Period (30 Days)||9
2449838|NCT01071096|6008027|P2|NOT COMPLETED|First Intervention (90 Days)||0
2449839|NCT01071096|6008028|P1|NOT COMPLETED|First Intervention (90 Days)||1
2449840|NCT01071096|6008027|P2|COMPLETED|First Intervention (90 Days)||10
2449841|NCT01071096|6008028|P1|COMPLETED|First Intervention (90 Days)||9
2449842|NCT01071096|6008027|P2|STARTED|First Intervention (90 Days)||10
2449843|NCT01071096|6008028|P1|STARTED|First Intervention (90 Days)||10
2449844|NCT01071083|6008052|P5|NOT COMPLETED|Overall Study||8
2449845|NCT01071083|6008053|P4|NOT COMPLETED|Overall Study||2
2449846|NCT01071083|6008054|P3|NOT COMPLETED|Overall Study||5
2449847|NCT01071083|6008055|P2|NOT COMPLETED|Overall Study||2
2449848|NCT01071083|6008056|P1|NOT COMPLETED|Overall Study||7
2449849|NCT01071083|6008052|P5|COMPLETED|Overall Study||46
2449850|NCT01071083|6008053|P4|COMPLETED|Overall Study||15
2449851|NCT01071083|6008054|P3|COMPLETED|Overall Study||12
2449852|NCT01071083|6008055|P2|COMPLETED|Overall Study||43
2449853|NCT01071083|6008056|P1|COMPLETED|Overall Study||35
2449854|NCT01071083|6008052|P5|STARTED|Overall Study||54
2449855|NCT01071083|6008053|P4|STARTED|Overall Study||17
2449856|NCT01071083|6008054|P3|STARTED|Overall Study||17
2449857|NCT01071083|6008055|P2|STARTED|Overall Study||45
2449858|NCT01071083|6008056|P1|STARTED|Overall Study||42
2449859|NCT01071070|6008075|P2|NOT COMPLETED|Overall Study||3
2449860|NCT01071070|6008076|P1|NOT COMPLETED|Overall Study||4
2449861|NCT01071070|6008075|P2|COMPLETED|Overall Study||105
2449862|NCT01071070|6008076|P1|COMPLETED|Overall Study||104
2449863|NCT01071070|6008075|P2|STARTED|Overall Study||108
2449864|NCT01071070|6008076|P1|STARTED|Overall Study||108
2449865|NCT01071044|6008100|P2|NOT COMPLETED|Overall Study||0
2449866|NCT01071044|6008101|P1|NOT COMPLETED|Overall Study||2
2449867|NCT01071044|6008100|P2|COMPLETED|Overall Study||11
2449868|NCT01071044|6008101|P1|COMPLETED|Overall Study||13
2449869|NCT01071044|6008100|P2|STARTED|Overall Study||11
2449870|NCT01071044|6008101|P1|STARTED|Overall Study||15
2449871|NCT01070979|6008122|P3|NOT COMPLETED|Overall Study||13
2449872|NCT01070979|6008123|P2|NOT COMPLETED|Overall Study||12
2449873|NCT01070979|6008124|P1|NOT COMPLETED|Overall Study||11
2449874|NCT01070979|6008122|P3|COMPLETED|Overall Study||72
2449875|NCT01070979|6008123|P2|COMPLETED|Overall Study||73
2449876|NCT01070979|6008124|P1|COMPLETED|Overall Study||68
2449877|NCT01070979|6008122|P3|STARTED|Overall Study||85
2449878|NCT01070979|6008123|P2|STARTED|Overall Study||85
2449879|NCT01070979|6008124|P1|STARTED|Overall Study||79
2449880|NCT01070966|6008150|P1|NOT COMPLETED|Participants for Efficacy Evaluation||82
2449881|NCT01070966|6008150|P1|COMPLETED|Participants for Efficacy Evaluation||1929
2449882|NCT01070966|6008150|P1|STARTED|Participants for Efficacy Evaluation||2011
2449883|NCT01070966|6008150|P1|NOT COMPLETED|Participants for Safety Evaluation||78
2449884|NCT01070966|6008150|P1|COMPLETED|Participants for Safety Evaluation||2011
2449885|NCT01070966|6008150|P1|STARTED|Participants for Safety Evaluation||2089
2449886|NCT01070953|6008161|P1|NOT COMPLETED|Participants for Efficacy Evaluation||227
2449887|NCT01070953|6008161|P1|COMPLETED|Participants for Efficacy Evaluation||3309
2449888|NCT01070953|6008161|P1|STARTED|Participants for Efficacy Evaluation||3536
2449889|NCT01070953|6008161|P1|NOT COMPLETED|Participants for Safety Evaluation||931
2449890|NCT01070953|6008161|P1|COMPLETED|Participants for Safety Evaluation||3536
2449891|NCT01070953|6008161|P1|STARTED|Participants for Safety Evaluation||4467
2449892|NCT01070888|6008174|P2|NOT COMPLETED|Second Intervention (14 Days)||0
2449893|NCT01070888|6008175|P1|NOT COMPLETED|Second Intervention (14 Days)||0
2449894|NCT01070888|6008174|P2|COMPLETED|Second Intervention (14 Days)||2
2449895|NCT01070888|6008175|P1|COMPLETED|Second Intervention (14 Days)||1
2449896|NCT01070888|6008174|P2|STARTED|Second Intervention (14 Days)||2
2449897|NCT01070888|6008175|P1|STARTED|Second Intervention (14 Days)||1
2449898|NCT01070888|6008174|P2|NOT COMPLETED|Washout (14 Days)||0
2449899|NCT01070888|6008175|P1|NOT COMPLETED|Washout (14 Days)||1
2449900|NCT01070888|6008174|P2|COMPLETED|Washout (14 Days)||2
2449901|NCT01070888|6008175|P1|COMPLETED|Washout (14 Days)||1
2449902|NCT01070888|6008174|P2|STARTED|Washout (14 Days)||2
2449903|NCT01070888|6008175|P1|STARTED|Washout (14 Days)||2
2449904|NCT01070888|6008174|P2|NOT COMPLETED|First Intervention (14 Days)||2
2449905|NCT01070888|6008175|P1|NOT COMPLETED|First Intervention (14 Days)||0
2449906|NCT01070888|6008174|P2|COMPLETED|First Intervention (14 Days)||2
2449907|NCT01070888|6008175|P1|COMPLETED|First Intervention (14 Days)||2
2449908|NCT01070888|6008174|P2|STARTED|First Intervention (14 Days)||4
2449909|NCT01070888|6008175|P1|STARTED|First Intervention (14 Days)||2
2449910|NCT01070810|6008183|P2|NOT COMPLETED|Overall Study||0
2449911|NCT01070810|6008184|P1|NOT COMPLETED|Overall Study||0
2449912|NCT01070810|6008183|P2|COMPLETED|Overall Study||43
2449913|NCT01070810|6008184|P1|COMPLETED|Overall Study||45
2449914|NCT01070810|6008183|P2|STARTED|Overall Study||43
2449915|NCT01070810|6008184|P1|STARTED|Overall Study||45
2449916|NCT01070784|6008200|P2|NOT COMPLETED|Overall Study||18
2449917|NCT01070784|6008201|P1|NOT COMPLETED|Overall Study||20
2449918|NCT01070784|6008200|P2|COMPLETED|Overall Study||112
2449919|NCT01070784|6008201|P1|COMPLETED|Overall Study||110
2449920|NCT01070784|6008200|P2|STARTED|Overall Study||130
2449921|NCT01070784|6008201|P1|STARTED|Overall Study||130
2449922|NCT01070771|6008289|P1|NOT COMPLETED|Overall Study||3
2449923|NCT01070771|6008289|P1|COMPLETED|Overall Study|August 2012|200
2449924|NCT01070771|6008289|P1|STARTED|Overall Study|September 2008|203
2449925|NCT01070693|6008296|P2|NOT COMPLETED|Overall Study||39
2449926|NCT01070693|6008297|P1|NOT COMPLETED|Overall Study||28
2449927|NCT01070693|6008296|P2|COMPLETED|Overall Study||110
2449928|NCT01070693|6008297|P1|COMPLETED|Overall Study||122
2449929|NCT01070693|6008296|P2|STARTED|Overall Study||149
2449930|NCT01070693|6008297|P1|STARTED|Overall Study||150
2449931|NCT01070550|6008309|P6|NOT COMPLETED|Overall Study||7
2449932|NCT01070550|6008310|P5|NOT COMPLETED|Overall Study||1
2449933|NCT01070550|6008311|P4|NOT COMPLETED|Overall Study||77
2449934|NCT01070550|6008312|P3|NOT COMPLETED|Overall Study||216
2449935|NCT01070550|6008313|P2|NOT COMPLETED|Overall Study||62
2449936|NCT01070550|6008314|P1|NOT COMPLETED|Overall Study||1285
2449937|NCT01070550|6008309|P6|COMPLETED|Overall Study||35
2449938|NCT01070550|6008310|P5|COMPLETED|Overall Study||20
2449939|NCT01070550|6008311|P4|COMPLETED|Overall Study||124
2449940|NCT01070550|6008312|P3|COMPLETED|Overall Study||528
2449941|NCT01070550|6008313|P2|COMPLETED|Overall Study||254
2449942|NCT01070550|6008314|P1|COMPLETED|Overall Study||2071
2449943|NCT01070550|6008309|P6|STARTED|Overall Study||42
2449944|NCT01070550|6008310|P5|STARTED|Overall Study||21
2449945|NCT01070550|6008311|P4|STARTED|Overall Study||201
2449946|NCT01070550|6008312|P3|STARTED|Overall Study||744
2449947|NCT01070550|6008313|P2|STARTED|Overall Study||316
2449948|NCT01070550|6008314|P1|STARTED|Overall Study||3356
2449949|NCT01070394|6008454|P1|NOT COMPLETED|Overall Study||7
2449950|NCT01070394|6008454|P1|COMPLETED|Overall Study||33
2449951|NCT01070394|6008454|P1|STARTED|Overall Study||40
2449952|NCT01070381|6008465|P2|NOT COMPLETED|Period 2, 1 Week of Wear||1
2449953|NCT01070381|6008466|P1|NOT COMPLETED|Period 2, 1 Week of Wear||1
2449954|NCT01070381|6008465|P2|COMPLETED|Period 2, 1 Week of Wear||106
2449955|NCT01070381|6008466|P1|COMPLETED|Period 2, 1 Week of Wear||108
2449956|NCT01070381|6008465|P2|STARTED|Period 2, 1 Week of Wear||107
2449957|NCT01070381|6008466|P1|STARTED|Period 2, 1 Week of Wear||109
2449958|NCT01070381|6008465|P2|NOT COMPLETED|Period 1, 1 Week of Wear||0
2449959|NCT01070381|6008466|P1|NOT COMPLETED|Period 1, 1 Week of Wear||0
2449960|NCT01070381|6008465|P2|COMPLETED|Period 1, 1 Week of Wear||107
2449961|NCT01070381|6008466|P1|COMPLETED|Period 1, 1 Week of Wear|One subject could not continue into Period 2 due to product unavailability.|109
2449962|NCT01070381|6008465|P2|STARTED|Period 1, 1 Week of Wear||107
2449963|NCT01070381|6008466|P1|STARTED|Period 1, 1 Week of Wear|One subject could not be dispensed into Period 1 product. Subject started Period 2 wear.|109
2449964|NCT01070329|6008474|P2|NOT COMPLETED|Overall Study||49
2449965|NCT01070329|6008475|P1|NOT COMPLETED|Overall Study||52
2449966|NCT01070329|6008474|P2|COMPLETED|Overall Study||217
2449967|NCT01070329|6008475|P1|COMPLETED|Overall Study||209
2449968|NCT01070329|6008474|P2|STARTED|Overall Study||266
2449969|NCT01070329|6008475|P1|STARTED|Overall Study||261
2449970|NCT01070316|6008507|P1|NOT COMPLETED|Extension Phase||4
2449971|NCT01070316|6008507|P1|COMPLETED|Extension Phase||14
2449972|NCT01070316|6008507|P1|STARTED|Extension Phase|Two participants did not qualify for Extension Phase as defined by protocol|18
2449973|NCT01070316|6008507|P1|NOT COMPLETED|Main Phase||0
2449974|NCT01070316|6008507|P1|COMPLETED|Main Phase||20
2449975|NCT01070316|6008507|P1|STARTED|Main Phase||20
2449976|NCT01070303|6008514|P1|NOT COMPLETED|Overall Study||89
2449977|NCT01070303|6008514|P1|COMPLETED|Overall Study||88
2449978|NCT01070303|6008514|P1|STARTED|Overall Study||177
2449979|NCT01070173|6008573|P3|NOT COMPLETED|Overall Study||0
2449980|NCT01070173|6008574|P2|NOT COMPLETED|Overall Study||0
2449981|NCT01070173|6008575|P1|NOT COMPLETED|Overall Study||0
2449982|NCT01070173|6008573|P3|COMPLETED|Overall Study||11
2449983|NCT01070173|6008574|P2|COMPLETED|Overall Study||8
2449984|NCT01070173|6008575|P1|COMPLETED|Overall Study||33
2449985|NCT01070173|6008573|P3|STARTED|Overall Study||11
2449986|NCT01070173|6008574|P2|STARTED|Overall Study||8
2449987|NCT01070173|6008575|P1|STARTED|Overall Study||33
2449988|NCT01070095|6008586|P2|NOT COMPLETED|Intervention Period||0
2449989|NCT01070095|6008587|P1|NOT COMPLETED|Intervention Period||0
2449990|NCT01070095|6008586|P2|COMPLETED|Intervention Period||890
2449991|NCT01070095|6008587|P1|COMPLETED|Intervention Period||18
2449992|NCT01070095|6008586|P2|STARTED|Intervention Period||890
2449993|NCT01070095|6008587|P1|STARTED|Intervention Period||18
2449994|NCT01070095|6008586|P2|NOT COMPLETED|Baseline Period||0
2449995|NCT01070095|6008587|P1|NOT COMPLETED|Baseline Period||1
2449996|NCT01070095|6008586|P2|COMPLETED|Baseline Period||830
2449997|NCT01070095|6008587|P1|COMPLETED|Baseline Period||18
2449998|NCT01070095|6008586|P2|STARTED|Baseline Period||830
2449999|NCT01070095|6008587|P1|STARTED|Baseline Period||19
2450000|NCT01070043|6008609|P3|NOT COMPLETED|Double-Blind Treatment||2
2450001|NCT01070043|6008610|P2|NOT COMPLETED|Double-Blind Treatment||0
2450002|NCT01070043|6008611|P1|NOT COMPLETED|Double-Blind Treatment||0
2450003|NCT01070043|6008609|P3|COMPLETED|Double-Blind Treatment||19
2450004|NCT01070043|6008610|P2|COMPLETED|Double-Blind Treatment||21
2450005|NCT01070043|6008611|P1|COMPLETED|Double-Blind Treatment||0
2450006|NCT01070043|6008609|P3|STARTED|Double-Blind Treatment||21
2450007|NCT01070043|6008610|P2|STARTED|Double-Blind Treatment||21
2450008|NCT01070043|6008611|P1|STARTED|Double-Blind Treatment||0
2450009|NCT01070043|6008609|P3|NOT COMPLETED|Run-In Phase||0
2450010|NCT01070043|6008610|P2|NOT COMPLETED|Run-In Phase||0
2450011|NCT01070043|6008611|P1|NOT COMPLETED|Run-In Phase||18
2450012|NCT01070043|6008609|P3|COMPLETED|Run-In Phase||0
2450013|NCT01070043|6008610|P2|COMPLETED|Run-In Phase||0
2450014|NCT01070043|6008611|P1|COMPLETED|Run-In Phase||42
2450015|NCT01070043|6008609|P3|STARTED|Run-In Phase|This monotherapy (Valsartan 160 mg) treatment arm is used only for double-blind phase.|0
2450016|NCT01070043|6008610|P2|STARTED|Run-In Phase|This combination therapy arm is used only for double-blind phase.|0
2450017|NCT01070043|6008611|P1|STARTED|Run-In Phase||60
2450018|NCT01069939|6008627|P2|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||32
2450019|NCT01069939|6008628|P1|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||31
2450020|NCT01069939|6008627|P2|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
2450021|NCT01069939|6008628|P1|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
2450022|NCT01069939|6008627|P2|STARTED|At Data Cut Off Date (26 Feb 2011)||214
2450023|NCT01069939|6008628|P1|STARTED|At Data Cut Off Date (26 Feb 2011)||213
2450024|NCT01069939|6008627|P2|NOT COMPLETED|Randomised and Included in the Analyses||77
2450025|NCT01069939|6008628|P1|NOT COMPLETED|Randomised and Included in the Analyses||49
2450026|NCT01069939|6008627|P2|COMPLETED|Randomised and Included in the Analyses||137
2450027|NCT01069939|6008628|P1|COMPLETED|Randomised and Included in the Analyses||164
2450028|NCT01069939|6008627|P2|STARTED|Randomised and Included in the Analyses||214
2450029|NCT01069939|6008628|P1|STARTED|Randomised and Included in the Analyses||213
2450030|NCT01069900|6008654|P2|NOT COMPLETED|Overall Study||4
2450031|NCT01069900|6008655|P1|NOT COMPLETED|Overall Study||18
2450032|NCT01069900|6008654|P2|COMPLETED|Overall Study||149
2450033|NCT01069900|6008655|P1|COMPLETED|Overall Study||287
2450034|NCT01069900|6008654|P2|Treated|Overall Study||150
2450035|NCT01069900|6008655|P1|Treated|Overall Study||301
2450036|NCT01069900|6008654|P2|STARTED|Overall Study||153
2450037|NCT01069900|6008655|P1|STARTED|Overall Study||305
2450038|NCT01069861|6008699|P1|NOT COMPLETED|Overall Study||3
2450039|NCT01069861|6008699|P1|COMPLETED|Overall Study||1
2450040|NCT01069861|6008699|P1|STARTED|Overall Study||4
2450041|NCT01069627|6008712|P1|NOT COMPLETED|Overall Study||20
2450042|NCT01069627|6008712|P1|COMPLETED|Overall Study||0
2450043|NCT01069627|6008712|P1|STARTED|Overall Study||20
2450044|NCT01069562|6008735|P2|NOT COMPLETED|Overall Study||0
2450045|NCT01069562|6008736|P1|NOT COMPLETED|Overall Study||0
2450046|NCT01069562|6008735|P2|COMPLETED|Overall Study||20
2450047|NCT01069562|6008736|P1|COMPLETED|Overall Study||20
2450048|NCT01069562|6008735|P2|STARTED|Overall Study||20
2450049|NCT01069562|6008736|P1|STARTED|Overall Study||20
2450050|NCT01069523|6008762|P2|NOT COMPLETED|Overall Study||7
2450051|NCT01069523|6008763|P1|NOT COMPLETED|Overall Study||4
2450052|NCT01069523|6008762|P2|COMPLETED|Overall Study||9
2450053|NCT01069523|6008763|P1|COMPLETED|Overall Study||9
2450054|NCT01069523|6008762|P2|STARTED|Overall Study||16
2450055|NCT01069523|6008763|P1|STARTED|Overall Study||13
2450056|NCT01069510|6008773|P2|NOT COMPLETED|Overall Study||0
2450057|NCT01069510|6008774|P1|NOT COMPLETED|Overall Study||0
2450058|NCT01069510|6008773|P2|COMPLETED|Overall Study||7
2450059|NCT01069510|6008774|P1|COMPLETED|Overall Study||8
2450060|NCT01069510|6008773|P2|STARTED|Overall Study||7
2450061|NCT01069510|6008774|P1|STARTED|Overall Study||8
2450062|NCT01069484|6008786|P2|NOT COMPLETED|Overall Study||3
2450063|NCT01069484|6008787|P1|NOT COMPLETED|Overall Study||12
2450064|NCT01069484|6008786|P2|COMPLETED|Overall Study|27 in the stratum with major levator ani muscle defects and 58 in the stratum without such defects.|85
2450065|NCT01069484|6008787|P1|COMPLETED|Overall Study|24 in the stratum with major levator ani muscle defects and 51 in the stratum without such defects.|75
2450066|NCT01069484|6008786|P2|STARTED|Overall Study|28 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|88
2450067|NCT01069484|6008787|P1|STARTED|Overall Study|27 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|87
2450068|NCT01069419|6008795|P1|NOT COMPLETED|Overall Study||715
2450069|NCT01069419|6008795|P1|COMPLETED|Overall Study||402
2450070|NCT01069419|6008795|P1|Full Analysis Set|Overall Study||851
2450071|NCT01069419|6008795|P1|Safety Set|Overall Study||1111
2450072|NCT01069419|6008795|P1|STARTED|Overall Study||1117
2450073|NCT01069354|6008802|P1|NOT COMPLETED|Overall Study||1
2450074|NCT01069354|6008802|P1|COMPLETED|Overall Study|One subject's treatment fold not injected due to adverse event during control fold injection|101
2450075|NCT01069354|6008802|P1|STARTED|Overall Study||102
2450076|NCT01069341|6008824|P1|NOT COMPLETED|Overall Study||1
2450077|NCT01069341|6008824|P1|COMPLETED|Overall Study||3
2450078|NCT01069341|6008824|P1|STARTED|Overall Study||4
2450079|NCT01069315|6008839|P4|NOT COMPLETED|Overall Study||7
2450080|NCT01069315|6008840|P3|NOT COMPLETED|Overall Study||5
2450081|NCT01069315|6008841|P2|NOT COMPLETED|Overall Study||6
2450082|NCT01069315|6008842|P1|NOT COMPLETED|Overall Study||4
2450083|NCT01069315|6008839|P4|COMPLETED|Overall Study||19
2450084|NCT01069315|6008840|P3|COMPLETED|Overall Study||23
2450085|NCT01069315|6008841|P2|COMPLETED|Overall Study||24
2450086|NCT01069315|6008842|P1|COMPLETED|Overall Study||23
2450087|NCT01069315|6008839|P4|STARTED|Overall Study||26
2450088|NCT01069315|6008840|P3|STARTED|Overall Study||28
2450089|NCT01069315|6008841|P2|STARTED|Overall Study||30
2450090|NCT01069315|6008842|P1|STARTED|Overall Study||27
2450091|NCT01069289|6008866|P2|NOT COMPLETED|Overall Study||56
2450092|NCT01069289|6008867|P1|NOT COMPLETED|Overall Study||42
2450093|NCT01069289|6008866|P2|COMPLETED|Overall Study||601
2450094|NCT01069289|6008867|P1|COMPLETED|Overall Study||594
2450095|NCT01069289|6008866|P2|STARTED|Overall Study||657
2450096|NCT01069289|6008867|P1|STARTED|Overall Study||636
2450097|NCT01069185|6008907|P2|NOT COMPLETED|Overall Study||0
2450098|NCT01069185|6008908|P1|NOT COMPLETED|Overall Study||0
2450099|NCT01069185|6008907|P2|COMPLETED|Overall Study||45
2450100|NCT01069185|6008908|P1|COMPLETED|Overall Study||47
2450101|NCT01069185|6008907|P2|STARTED|Overall Study||45
2450102|NCT01069185|6008908|P1|STARTED|Overall Study||47
2450103|NCT01069172|6008916|P2|NOT COMPLETED|Overall Study||0
2450104|NCT01069172|6008917|P1|NOT COMPLETED|Overall Study||1
2450105|NCT01069172|6008916|P2|COMPLETED|Overall Study|30 eyes|30
2450106|NCT01069172|6008917|P1|COMPLETED|Overall Study|29 eyes|29
2450107|NCT01069172|6008916|P2|STARTED|Overall Study|30 eyes|30
2450108|NCT01069172|6008917|P1|STARTED|Overall Study|30 eyes|30
2450109|NCT01069120|6008927|P1|NOT COMPLETED|Overall Study||27
2450110|NCT01069120|6008927|P1|COMPLETED|Overall Study||0
2450111|NCT01069120|6008927|P1|STARTED|Overall Study||27
2450112|NCT01069003|6008936|P3|NOT COMPLETED|Overall Study||475
2450113|NCT01069003|6008937|P2|NOT COMPLETED|Overall Study||54
2450114|NCT01069003|6008938|P1|NOT COMPLETED|Overall Study||46
2450115|NCT01069003|6008936|P3|COMPLETED|Overall Study||976
2450116|NCT01069003|6008937|P2|COMPLETED|Overall Study||358
2450117|NCT01069003|6008938|P1|COMPLETED|Overall Study||353
2450118|NCT01069003|6008936|P3|STARTED|Overall Study||1451
2450119|NCT01069003|6008937|P2|STARTED|Overall Study||412
2450120|NCT01069003|6008938|P1|STARTED|Overall Study||399
2450121|NCT01068964|6008954|P2|NOT COMPLETED|Overall Study||10
2450122|NCT01068964|6008955|P1|NOT COMPLETED|Overall Study||8
2450123|NCT01068964|6008954|P2|COMPLETED|Overall Study||104
2450124|NCT01068964|6008955|P1|COMPLETED|Overall Study||113
2450125|NCT01068964|6008954|P2|STARTED|Overall Study||114
2450126|NCT01068964|6008955|P1|STARTED|Overall Study||121
2450127|NCT01068912|6008964|P3|NOT COMPLETED|Overall Study||15
2450128|NCT01068912|6008965|P2|NOT COMPLETED|Overall Study||22
2450129|NCT01068912|6008966|P1|NOT COMPLETED|Overall Study||11
2450130|NCT01068912|6008964|P3|COMPLETED|Overall Study||186
2450131|NCT01068912|6008965|P2|COMPLETED|Overall Study||173
2450132|NCT01068912|6008966|P1|COMPLETED|Overall Study||123
2450133|NCT01068912|6008964|P3|STARTED|Overall Study||201
2450134|NCT01068912|6008965|P2|STARTED|Overall Study||195
2450135|NCT01068912|6008966|P1|STARTED|Overall Study||134
2450136|NCT01068860|6008984|P10|NOT COMPLETED|Overall Study||4
2450137|NCT01068860|6008985|P9|NOT COMPLETED|Overall Study||0
2450138|NCT01068860|6008986|P8|NOT COMPLETED|Overall Study||0
2450139|NCT01068860|6008987|P7|NOT COMPLETED|Overall Study||0
2450140|NCT01068860|6008988|P6|NOT COMPLETED|Overall Study||2
2450141|NCT01068860|6008989|P5|NOT COMPLETED|Overall Study||0
2450142|NCT01068860|6008990|P4|NOT COMPLETED|Overall Study||1
2450143|NCT01068860|6008991|P3|NOT COMPLETED|Overall Study||0
2450144|NCT01068860|6008992|P2|NOT COMPLETED|Overall Study||1
2450145|NCT01068860|6008993|P1|NOT COMPLETED|Overall Study||0
2450146|NCT01068860|6008984|P10|COMPLETED|Overall Study||23
2450147|NCT01068860|6008985|P9|COMPLETED|Overall Study||28
2450148|NCT01068860|6008986|P8|COMPLETED|Overall Study||15
2450149|NCT01068860|6008987|P7|COMPLETED|Overall Study||28
2450150|NCT01068860|6008988|P6|COMPLETED|Overall Study||14
2450151|NCT01068860|6008989|P5|COMPLETED|Overall Study||32
2450152|NCT01068860|6008990|P4|COMPLETED|Overall Study||16
2450153|NCT01068860|6008991|P3|COMPLETED|Overall Study||33
2450154|NCT01068860|6008992|P2|COMPLETED|Overall Study||16
2450155|NCT01068860|6008993|P1|COMPLETED|Overall Study||33
2450156|NCT01068860|6008984|P10|STARTED|Overall Study||27
2450157|NCT01068860|6008985|P9|STARTED|Overall Study||28
2450158|NCT01068860|6008986|P8|STARTED|Overall Study||15
2450159|NCT01068860|6008987|P7|STARTED|Overall Study||28
2450160|NCT01068860|6008988|P6|STARTED|Overall Study||16
2450161|NCT01068860|6008989|P5|STARTED|Overall Study||32
2450162|NCT01068860|6008990|P4|STARTED|Overall Study||17
2450163|NCT01068860|6008991|P3|STARTED|Overall Study||33
2450164|NCT01068860|6008992|P2|STARTED|Overall Study||17
2450165|NCT01068860|6008993|P1|STARTED|Overall Study||33
2450166|NCT01068821|6009167|P2|NOT COMPLETED|Overall Study||0
2450167|NCT01068821|6009168|P1|NOT COMPLETED|Overall Study||1
2450168|NCT01068821|6009167|P2|COMPLETED|Overall Study||29
2450169|NCT01068821|6009168|P1|COMPLETED|Overall Study|1 patient had slide measured, but her patient ID not listed; couldn't do postoperative followup.|30
2450170|NCT01068821|6009167|P2|STARTED|Overall Study||29
2450171|NCT01068821|6009168|P1|STARTED|Overall Study||31
2450172|NCT01068769|6009176|P1|NOT COMPLETED|Overall Study||1
2450173|NCT01068769|6009176|P1|COMPLETED|Overall Study||33
2450174|NCT01068769|6009176|P1|STARTED|Overall Study||34
2450175|NCT01068743|6009181|P4|NOT COMPLETED|Period 4||0
2450176|NCT01068743|6009182|P3|NOT COMPLETED|Period 4||0
2450177|NCT01068743|6009183|P2|NOT COMPLETED|Period 4||0
2450178|NCT01068743|6009184|P1|NOT COMPLETED|Period 4||0
2450179|NCT01068743|6009181|P4|COMPLETED|Period 4||6
2450180|NCT01068743|6009182|P3|COMPLETED|Period 4||6
2450181|NCT01068743|6009183|P2|COMPLETED|Period 4||5
2450182|NCT01068743|6009184|P1|COMPLETED|Period 4||6
2450183|NCT01068743|6009181|P4|STARTED|Period 4||6
2450184|NCT01068743|6009182|P3|STARTED|Period 4||6
2450185|NCT01068743|6009183|P2|STARTED|Period 4||5
2450186|NCT01068743|6009184|P1|STARTED|Period 4||6
2450187|NCT01068743|6009181|P4|NOT COMPLETED|Period 3||0
2450188|NCT01068743|6009182|P3|NOT COMPLETED|Period 3||0
2450189|NCT01068743|6009183|P2|NOT COMPLETED|Period 3||1
2450190|NCT01068743|6009184|P1|NOT COMPLETED|Period 3||0
2450191|NCT01068743|6009181|P4|COMPLETED|Period 3||6
2450192|NCT01068743|6009182|P3|COMPLETED|Period 3||6
2450193|NCT01068743|6009183|P2|COMPLETED|Period 3||5
2450194|NCT01068743|6009184|P1|COMPLETED|Period 3||6
2450195|NCT01068743|6009181|P4|STARTED|Period 3||6
2450196|NCT01068743|6009182|P3|STARTED|Period 3||6
2450197|NCT01068743|6009183|P2|STARTED|Period 3||6
2450198|NCT01068743|6009184|P1|STARTED|Period 3||6
2450199|NCT01068743|6009181|P4|NOT COMPLETED|Period 2||0
2450200|NCT01068743|6009182|P3|NOT COMPLETED|Period 2||0
2450201|NCT01068743|6009183|P2|NOT COMPLETED|Period 2||0
2450202|NCT01068743|6009184|P1|NOT COMPLETED|Period 2||0
2450203|NCT01068743|6009181|P4|COMPLETED|Period 2||6
2450204|NCT01068743|6009182|P3|COMPLETED|Period 2||6
2450205|NCT01068743|6009183|P2|COMPLETED|Period 2||6
2450206|NCT01068743|6009184|P1|COMPLETED|Period 2||6
2450207|NCT01068743|6009181|P4|STARTED|Period 2||6
2450208|NCT01068743|6009182|P3|STARTED|Period 2||6
2450209|NCT01068743|6009183|P2|STARTED|Period 2||6
2450210|NCT01068743|6009184|P1|STARTED|Period 2||6
2450211|NCT01068743|6009181|P4|NOT COMPLETED|Period 1||0
2450212|NCT01068743|6009182|P3|NOT COMPLETED|Period 1||0
2450213|NCT01068743|6009183|P2|NOT COMPLETED|Period 1||0
2450214|NCT01068743|6009184|P1|NOT COMPLETED|Period 1||0
2450215|NCT01068743|6009181|P4|COMPLETED|Period 1||6
2450216|NCT01068743|6009182|P3|COMPLETED|Period 1||6
2450217|NCT01068743|6009183|P2|COMPLETED|Period 1||6
2450218|NCT01068743|6009184|P1|COMPLETED|Period 1||6
2450219|NCT01068743|6009181|P4|STARTED|Period 1||6
2450220|NCT01068743|6009182|P3|STARTED|Period 1||6
2450221|NCT01068743|6009183|P2|STARTED|Period 1||6
2450222|NCT01068743|6009184|P1|STARTED|Period 1||6
2450223|NCT01068730|6009258|P4|NOT COMPLETED|Period 4||0
2450224|NCT01068730|6009259|P3|NOT COMPLETED|Period 4||0
2450225|NCT01068730|6009260|P2|NOT COMPLETED|Period 4||1
2450226|NCT01068730|6009261|P1|NOT COMPLETED|Period 4||0
2450227|NCT01068730|6009258|P4|COMPLETED|Period 4||7
2450228|NCT01068730|6009259|P3|COMPLETED|Period 4||7
2450229|NCT01068730|6009260|P2|COMPLETED|Period 4||6
2450230|NCT01068730|6009261|P1|COMPLETED|Period 4||6
2450231|NCT01068730|6009258|P4|STARTED|Period 4||7
2450232|NCT01068730|6009259|P3|STARTED|Period 4||7
2450233|NCT01068730|6009260|P2|STARTED|Period 4||7
2450234|NCT01068730|6009261|P1|STARTED|Period 4||6
2450235|NCT01068730|6009258|P4|NOT COMPLETED|Period 3||0
2450236|NCT01068730|6009259|P3|NOT COMPLETED|Period 3||0
2450237|NCT01068730|6009260|P2|NOT COMPLETED|Period 3||0
2450238|NCT01068730|6009261|P1|NOT COMPLETED|Period 3||1
2450239|NCT01068730|6009258|P4|COMPLETED|Period 3||7
2450240|NCT01068730|6009259|P3|COMPLETED|Period 3||7
2450241|NCT01068730|6009260|P2|COMPLETED|Period 3||7
2450242|NCT01068730|6009261|P1|COMPLETED|Period 3||6
2450243|NCT01068730|6009258|P4|STARTED|Period 3||7
2450244|NCT01068730|6009259|P3|STARTED|Period 3||7
2450245|NCT01068730|6009260|P2|STARTED|Period 3||7
2450246|NCT01068730|6009261|P1|STARTED|Period 3||7
2450247|NCT01068730|6009258|P4|NOT COMPLETED|Period 2||0
2450248|NCT01068730|6009259|P3|NOT COMPLETED|Period 2||0
2450249|NCT01068730|6009260|P2|NOT COMPLETED|Period 2||0
2450250|NCT01068730|6009261|P1|NOT COMPLETED|Period 2||0
2450251|NCT01068730|6009258|P4|COMPLETED|Period 2||7
2450252|NCT01068730|6009259|P3|COMPLETED|Period 2||7
2450253|NCT01068730|6009260|P2|COMPLETED|Period 2||7
2450254|NCT01068730|6009261|P1|COMPLETED|Period 2||7
2450255|NCT01068730|6009258|P4|STARTED|Period 2||7
2450256|NCT01068730|6009259|P3|STARTED|Period 2||7
2450257|NCT01068730|6009260|P2|STARTED|Period 2||7
2450258|NCT01068730|6009261|P1|STARTED|Period 2||7
2450259|NCT01068730|6009258|P4|NOT COMPLETED|Period 1||0
2450260|NCT01068730|6009259|P3|NOT COMPLETED|Period 1||0
2450261|NCT01068730|6009260|P2|NOT COMPLETED|Period 1||0
2450262|NCT01068730|6009261|P1|NOT COMPLETED|Period 1||0
2450263|NCT01068730|6009258|P4|COMPLETED|Period 1||7
2450264|NCT01068730|6009259|P3|COMPLETED|Period 1||7
2450265|NCT01068730|6009260|P2|COMPLETED|Period 1||7
2450266|NCT01068730|6009261|P1|COMPLETED|Period 1||7
2450267|NCT01068730|6009258|P4|STARTED|Period 1||7
2450268|NCT01068730|6009259|P3|STARTED|Period 1||7
2450269|NCT01068730|6009260|P2|STARTED|Period 1||7
2450270|NCT01068730|6009261|P1|STARTED|Period 1||7
2450271|NCT01068717|6009315|P4|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
2450272|NCT01068717|6009316|P3|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
2450273|NCT01068717|6009317|P2|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
2450274|NCT01068717|6009318|P1|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
2450275|NCT01068717|6009315|P4|COMPLETED|Period 4: Treatment Schedule Phase 4||7
2450276|NCT01068717|6009316|P3|COMPLETED|Period 4: Treatment Schedule Phase 4||7
2450277|NCT01068717|6009317|P2|COMPLETED|Period 4: Treatment Schedule Phase 4||6
2450278|NCT01068717|6009318|P1|COMPLETED|Period 4: Treatment Schedule Phase 4||7
2450279|NCT01068717|6009315|P4|STARTED|Period 4: Treatment Schedule Phase 4||7
2450280|NCT01068717|6009316|P3|STARTED|Period 4: Treatment Schedule Phase 4||7
2450281|NCT01068717|6009317|P2|STARTED|Period 4: Treatment Schedule Phase 4||6
2450282|NCT01068717|6009318|P1|STARTED|Period 4: Treatment Schedule Phase 4|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
2450283|NCT01068717|6009315|P4|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
2450284|NCT01068717|6009316|P3|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
2450285|NCT01068717|6009317|P2|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
2450286|NCT01068717|6009318|P1|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
2450287|NCT01068717|6009315|P4|COMPLETED|Period 3: Treatment Schedule Phase 3||7
2450288|NCT01068717|6009316|P3|COMPLETED|Period 3: Treatment Schedule Phase 3||7
2450289|NCT01068717|6009317|P2|COMPLETED|Period 3: Treatment Schedule Phase 3||6
2450290|NCT01068717|6009318|P1|COMPLETED|Period 3: Treatment Schedule Phase 3||7
2450291|NCT01068717|6009315|P4|STARTED|Period 3: Treatment Schedule Phase 3||7
2450292|NCT01068717|6009316|P3|STARTED|Period 3: Treatment Schedule Phase 3||7
2450293|NCT01068717|6009317|P2|STARTED|Period 3: Treatment Schedule Phase 3||6
2450294|NCT01068717|6009318|P1|STARTED|Period 3: Treatment Schedule Phase 3|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
2450295|NCT01068717|6009315|P4|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
2450296|NCT01068717|6009316|P3|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
2450297|NCT01068717|6009317|P2|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
2450298|NCT01068717|6009318|P1|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
2450299|NCT01068717|6009315|P4|COMPLETED|Period 2: Treatment Schedule Phase 2||7
2450300|NCT01068717|6009316|P3|COMPLETED|Period 2: Treatment Schedule Phase 2||7
2450301|NCT01068717|6009317|P2|COMPLETED|Period 2: Treatment Schedule Phase 2||6
2450302|NCT01068717|6009318|P1|COMPLETED|Period 2: Treatment Schedule Phase 2||6
2450303|NCT01068717|6009315|P4|STARTED|Period 2: Treatment Schedule Phase 2||7
2450304|NCT01068717|6009316|P3|STARTED|Period 2: Treatment Schedule Phase 2||7
2450305|NCT01068717|6009317|P2|STARTED|Period 2: Treatment Schedule Phase 2||6
2450306|NCT01068717|6009318|P1|STARTED|Period 2: Treatment Schedule Phase 2||6
2450307|NCT01068717|6009315|P4|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
2450308|NCT01068717|6009316|P3|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
2450309|NCT01068717|6009317|P2|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
2450310|NCT01068717|6009318|P1|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||1
2450311|NCT01068717|6009315|P4|COMPLETED|Period 1: Treatment Schedule Phase 1||7
2450312|NCT01068717|6009316|P3|COMPLETED|Period 1: Treatment Schedule Phase 1||7
2450313|NCT01068717|6009317|P2|COMPLETED|Period 1: Treatment Schedule Phase 1||6
2450314|NCT01068717|6009318|P1|COMPLETED|Period 1: Treatment Schedule Phase 1|Patient who withdrew returned for Treatment Periods 3 and 4.|6
2450315|NCT01068717|6009315|P4|STARTED|Period 1: Treatment Schedule Phase 1||7
2450316|NCT01068717|6009316|P3|STARTED|Period 1: Treatment Schedule Phase 1||7
2450317|NCT01068717|6009317|P2|STARTED|Period 1: Treatment Schedule Phase 1||6
2450318|NCT01068717|6009318|P1|STARTED|Period 1: Treatment Schedule Phase 1||7
2450319|NCT01068678|6009374|P2|NOT COMPLETED|Overall Study||24
2450320|NCT01068678|6009375|P1|NOT COMPLETED|Overall Study||38
2450321|NCT01068678|6009374|P2|COMPLETED|Overall Study||206
2450322|NCT01068678|6009375|P1|COMPLETED|Overall Study||192
2450323|NCT01068678|6009374|P2|Exposed|Overall Study|one subject withdrew prior to exposure to trial product|229
2450324|NCT01068678|6009375|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial product.|227
2450325|NCT01068678|6009374|P2|STARTED|Overall Study||230
2450326|NCT01068678|6009375|P1|STARTED|Overall Study||230
2450327|NCT01068665|6009385|P2|NOT COMPLETED|Overall Study||29
2450328|NCT01068665|6009386|P1|NOT COMPLETED|Overall Study||30
2450329|NCT01068665|6009385|P2|COMPLETED|Overall Study||201
2450330|NCT01068665|6009386|P1|COMPLETED|Overall Study||200
2450331|NCT01068665|6009385|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|228
2450332|NCT01068665|6009386|P1|Exposed|Overall Study||228
2450333|NCT01068665|6009385|P2|Full Analysis Set|Overall Study|One subject was withdrawn because the subject was randomised in error.|229
2450334|NCT01068665|6009386|P1|Full Analysis Set|Overall Study|Two subjects were withdrawn because the subjects were randomised in error.|228
2450335|NCT01068665|6009385|P2|STARTED|Overall Study||230
2450336|NCT01068665|6009386|P1|STARTED|Overall Study||230
2450337|NCT01068652|6009396|P2|NOT COMPLETED|Overall Study||15
2450338|NCT01068652|6009397|P1|NOT COMPLETED|Overall Study||18
2450339|NCT01068652|6009396|P2|COMPLETED|Overall Study||188
2450340|NCT01068652|6009397|P1|COMPLETED|Overall Study||182
2450341|NCT01068652|6009396|P2|STARTED|Overall Study||203
2450342|NCT01068652|6009397|P1|STARTED|Overall Study||200
2450343|NCT01068626|6009437|P2|NOT COMPLETED|Overall Study||2
2450344|NCT01068626|6009438|P1|NOT COMPLETED|Overall Study||3
2450345|NCT01068626|6009437|P2|COMPLETED|Overall Study||27
2450346|NCT01068626|6009438|P1|COMPLETED|Overall Study||27
2450347|NCT01068626|6009437|P2|STARTED|Overall Study||29
2450348|NCT01068626|6009438|P1|STARTED|Overall Study||30
2450349|NCT01068600|6009456|P2|NOT COMPLETED|Overall Study||17
2450350|NCT01068600|6009457|P1|NOT COMPLETED|Overall Study||11
2450351|NCT01068600|6009456|P2|COMPLETED|Overall Study||142
2450352|NCT01068600|6009457|P1|COMPLETED|Overall Study||148
2450353|NCT01068600|6009456|P2|STARTED|Overall Study||159
2450354|NCT01068600|6009457|P1|STARTED|Overall Study||159
2450355|NCT01068548|6009467|P2|NOT COMPLETED|Overall Study||0
2450356|NCT01068548|6009468|P1|NOT COMPLETED|Overall Study||0
2450357|NCT01068548|6009467|P2|COMPLETED|Overall Study||63
2450358|NCT01068548|6009468|P1|COMPLETED|Overall Study||66
2450359|NCT01068548|6009467|P2|STARTED|Overall Study||63
2450360|NCT01068548|6009468|P1|STARTED|Overall Study||66
2450361|NCT01068509|6009479|P3|NOT COMPLETED|Overall Study||21
2450362|NCT01068509|6009480|P2|NOT COMPLETED|Overall Study||22
2450363|NCT01068509|6009481|P1|NOT COMPLETED|Overall Study||6
2450364|NCT01068509|6009479|P3|COMPLETED|Overall Study||6
2450365|NCT01068509|6009480|P2|COMPLETED|Overall Study||7
2450366|NCT01068509|6009481|P1|COMPLETED|Overall Study||1
2450367|NCT01068509|6009479|P3|STARTED|Overall Study||27
2450368|NCT01068509|6009480|P2|STARTED|Overall Study||29
2450369|NCT01068509|6009481|P1|STARTED|Overall Study||7
2450370|NCT01068418|6009494|P1|NOT COMPLETED|Overall Study||12
2450371|NCT01068418|6009494|P1|COMPLETED|Overall Study|14 participants completed all study procedures.|14
2450372|NCT01068418|6009494|P1|Medication Washout|Overall Study|9 participants were disempaneled during the medication washout phase due to noncompliance or high BP|17
2450373|NCT01068418|6009494|P1|STARTED|Overall Study|26 participants found to be eligible|26
2450374|NCT01068262|6009503|P4|NOT COMPLETED|Overall Study||0
2450375|NCT01068262|6009504|P3|NOT COMPLETED|Overall Study||1
2450376|NCT01068262|6009505|P2|NOT COMPLETED|Overall Study||1
2450377|NCT01068262|6009506|P1|NOT COMPLETED|Overall Study||3
2450378|NCT01068262|6009503|P4|COMPLETED|Overall Study||2
2450379|NCT01068262|6009504|P3|COMPLETED|Overall Study||9
2450380|NCT01068262|6009505|P2|COMPLETED|Overall Study||8
2450381|NCT01068262|6009506|P1|COMPLETED|Overall Study||20
2450382|NCT01068262|6009503|P4|STARTED|Overall Study||2
2450383|NCT01068262|6009504|P3|STARTED|Overall Study||10
2450384|NCT01068262|6009505|P2|STARTED|Overall Study||9
2450385|NCT01068262|6009506|P1|STARTED|Overall Study||23
2450386|NCT01068158|6009536|P2|NOT COMPLETED|Overall Study||4
2450387|NCT01068158|6009537|P1|NOT COMPLETED|Overall Study||8
2450388|NCT01068158|6009536|P2|COMPLETED|Overall Study||198
2450389|NCT01068158|6009537|P1|COMPLETED|Overall Study||161
2450390|NCT01068158|6009536|P2|STARTED|Overall Study||202
2450391|NCT01068158|6009537|P1|STARTED|Overall Study||169
2450392|NCT01067976|6009549|P1|NOT COMPLETED|Overall Study||22
2450393|NCT01067976|6009549|P1|COMPLETED|Overall Study|study course completed|424
2450394|NCT01067976|6009549|P1|Fulfilled Requirements of FAS Population|Overall Study||390
2450395|NCT01067976|6009549|P1|Received Treatment|Overall Study|treatment started|426
2450396|NCT01067976|6009549|P1|STARTED|Overall Study|screened and enrolled|446
2450397|NCT01067846|6009610|P2|NOT COMPLETED|Overall Study||19
2450398|NCT01067846|6009611|P1|NOT COMPLETED|Overall Study||19
2450399|NCT01067846|6009610|P2|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|11
2450400|NCT01067846|6009611|P1|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|10
2450401|NCT01067846|6009610|P2|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
2450402|NCT01067846|6009611|P1|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
2450403|NCT01067846|6009610|P2|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|30
2450404|NCT01067846|6009611|P1|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|29
2450405|NCT01067781|6009623|P4|NOT COMPLETED|180 to Day 720||89
2450406|NCT01067781|6009624|P3|NOT COMPLETED|180 to Day 720||89
2450407|NCT01067781|6009625|P2|NOT COMPLETED|180 to Day 720||164
2450408|NCT01067781|6009626|P1|NOT COMPLETED|180 to Day 720||170
2450409|NCT01067781|6009623|P4|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
2450410|NCT01067781|6009624|P3|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
2450411|NCT01067781|6009625|P2|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|4
2450412|NCT01067781|6009626|P1|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|3
2450413|NCT01067781|6009623|P4|STARTED|180 to Day 720||89
2450414|NCT01067781|6009624|P3|STARTED|180 to Day 720||89
2450415|NCT01067781|6009625|P2|STARTED|180 to Day 720||168
2450416|NCT01067781|6009626|P1|STARTED|180 to Day 720||173
2450417|NCT01067781|6009623|P4|NOT COMPLETED|Up to Day 180||12
2450418|NCT01067781|6009624|P3|NOT COMPLETED|Up to Day 180||8
2450419|NCT01067781|6009625|P2|NOT COMPLETED|Up to Day 180||31
2450420|NCT01067781|6009626|P1|NOT COMPLETED|Up to Day 180||30
2450421|NCT01067781|6009623|P4|COMPLETED|Up to Day 180||89
2450422|NCT01067781|6009624|P3|COMPLETED|Up to Day 180||89
2450423|NCT01067781|6009625|P2|COMPLETED|Up to Day 180||168
2450424|NCT01067781|6009626|P1|COMPLETED|Up to Day 180||173
2450425|NCT01067781|6009623|P4|STARTED|Up to Day 180||101
2450426|NCT01067781|6009624|P3|STARTED|Up to Day 180||97
2450427|NCT01067781|6009625|P2|STARTED|Up to Day 180||199
2450428|NCT01067781|6009626|P1|STARTED|Up to Day 180||203
2450429|NCT01067768|6009648|P2|NOT COMPLETED|Overall Study||0
2450430|NCT01067768|6009649|P1|NOT COMPLETED|Overall Study||0
2450431|NCT01067768|6009648|P2|COMPLETED|Overall Study||605
2450432|NCT01067768|6009649|P1|COMPLETED|Overall Study||604
2450433|NCT01067768|6009648|P2|STARTED|Overall Study||605
2450434|NCT01067768|6009649|P1|STARTED|Overall Study||604
2450435|NCT01067716|6009660|P3|NOT COMPLETED|Overall Study||0
2450436|NCT01067716|6009661|P2|NOT COMPLETED|Overall Study||0
2450437|NCT01067716|6009662|P1|NOT COMPLETED|Overall Study||0
2450438|NCT01067716|6009660|P3|COMPLETED|Overall Study|15 eyes|9
2450439|NCT01067716|6009661|P2|COMPLETED|Overall Study|25 eyes|13
2450440|NCT01067716|6009662|P1|COMPLETED|Overall Study|110 eyes|57
2450441|NCT01067716|6009660|P3|STARTED|Overall Study|15 eyes|9
2450442|NCT01067716|6009661|P2|STARTED|Overall Study|25 eyes|13
2450443|NCT01067716|6009662|P1|STARTED|Overall Study|110 eyes|57
2450444|NCT01067521|6009681|P2|NOT COMPLETED|Open-Label Period||158
2450445|NCT01067521|6009682|P1|NOT COMPLETED|Open-Label Period||254
2450446|NCT01067521|6009681|P2|COMPLETED|Open-Label Period||261
2450447|NCT01067521|6009682|P1|COMPLETED|Open-Label Period||580
2450448|NCT01067521|6009681|P2|STARTED|Open-Label Period|Some participants did not continue into the open-label period.|419
2450449|NCT01067521|6009682|P1|STARTED|Open-Label Period|Some participants did not continue into the open-label period.|834
2450450|NCT01067521|6009681|P2|NOT COMPLETED|Double-Blind Placebo-Controlled Period||31
2450451|NCT01067521|6009682|P1|NOT COMPLETED|Double-Blind Placebo-Controlled Period||84
2450452|NCT01067521|6009681|P2|COMPLETED|Double-Blind Placebo-Controlled Period||430
2450453|NCT01067521|6009682|P1|COMPLETED|Double-Blind Placebo-Controlled Period||859
2450454|NCT01067521|6009681|P2|STARTED|Double-Blind Placebo-Controlled Period||461
2450455|NCT01067521|6009682|P1|STARTED|Double-Blind Placebo-Controlled Period||943
2450456|NCT01067508|6009708|P2|NOT COMPLETED|Overall Study||2
2450457|NCT01067508|6009709|P1|NOT COMPLETED|Overall Study||0
2450458|NCT01067508|6009708|P2|COMPLETED|Overall Study||7
2450459|NCT01067508|6009709|P1|COMPLETED|Overall Study||10
2450460|NCT01067508|6009708|P2|STARTED|Overall Study||9
2450461|NCT01067508|6009709|P1|STARTED|Overall Study||10
2450462|NCT01067456|6009717|P2|NOT COMPLETED|Overall Study||0
2450463|NCT01067456|6009718|P1|NOT COMPLETED|Overall Study||0
2450464|NCT01067456|6009717|P2|COMPLETED|Overall Study||29
2450465|NCT01067456|6009718|P1|COMPLETED|Overall Study||30
2450466|NCT01067456|6009717|P2|STARTED|Overall Study||29
2450467|NCT01067456|6009718|P1|STARTED|Overall Study||30
2450468|NCT01067352|6009731|P3|NOT COMPLETED|Overall Study||1
2450469|NCT01067352|6009732|P2|NOT COMPLETED|Overall Study||3
2450470|NCT01067352|6009733|P1|NOT COMPLETED|Overall Study||1
2450471|NCT01067352|6009731|P3|COMPLETED|Overall Study||9
2450472|NCT01067352|6009732|P2|COMPLETED|Overall Study||3
2450473|NCT01067352|6009733|P1|COMPLETED|Overall Study||8
2450474|NCT01067352|6009731|P3|STARTED|Overall Study||10
2450475|NCT01067352|6009732|P2|STARTED|Overall Study||6
2450476|NCT01067352|6009733|P1|STARTED|Overall Study||9
2450477|NCT01067339|6009749|P2|NOT COMPLETED|Overall Study||5
2450478|NCT01067339|6009750|P1|NOT COMPLETED|Overall Study||6
2450479|NCT01067339|6009749|P2|COMPLETED|Overall Study||29
2450480|NCT01067339|6009750|P1|COMPLETED|Overall Study||25
2450481|NCT01067339|6009749|P2|STARTED|Overall Study||34
2450482|NCT01067339|6009750|P1|STARTED|Overall Study||31
2450483|NCT01067326|6009760|P2|NOT COMPLETED|Overall Study||3
2450484|NCT01067326|6009761|P1|NOT COMPLETED|Overall Study||2
2450485|NCT01067326|6009760|P2|COMPLETED|Overall Study||5
2450486|NCT01067326|6009761|P1|COMPLETED|Overall Study||12
2450487|NCT01067326|6009760|P2|STARTED|Overall Study||8
2450488|NCT01067326|6009761|P1|STARTED|Overall Study||14
2450489|NCT01067144|6009775|P2|NOT COMPLETED|Follow-up||56
2450490|NCT01067144|6009776|P1|NOT COMPLETED|Follow-up||59
2450491|NCT01067144|6009775|P2|COMPLETED|Follow-up||152
2450492|NCT01067144|6009776|P1|COMPLETED|Follow-up||144
2450493|NCT01067144|6009775|P2|Intention-to-Treat Analysis Set|Follow-up||208
2450494|NCT01067144|6009776|P1|Intention-to-Treat Analysis Set|Follow-up||202
2450495|NCT01067144|6009775|P2|STARTED|Follow-up||208
2450496|NCT01067144|6009776|P1|STARTED|Follow-up||203
2450497|NCT01067144|6009775|P2|NOT COMPLETED|Treatment||7
2450498|NCT01067144|6009776|P1|NOT COMPLETED|Treatment||4
2450499|NCT01067144|6009775|P2|COMPLETED|Treatment||208
2450500|NCT01067144|6009776|P1|COMPLETED|Treatment||203
2450501|NCT01067144|6009775|P2|STARTED|Treatment||215
2450502|NCT01067144|6009776|P1|STARTED|Treatment||207
2450503|NCT01067105|6009792|P1|NOT COMPLETED|Overall Study||141
2450504|NCT01067105|6009792|P1|COMPLETED|Overall Study||683
2450505|NCT01067105|6009792|P1|STARTED|Overall Study||824
2450506|NCT01066923|6009813|P4|NOT COMPLETED|Overall Study||8
2450507|NCT01066923|6009814|P3|NOT COMPLETED|Overall Study||8
2450508|NCT01066923|6009815|P2|NOT COMPLETED|Overall Study||3
2450509|NCT01066923|6009816|P1|NOT COMPLETED|Overall Study||3
2450510|NCT01066923|6009813|P4|COMPLETED|Overall Study||23
2450511|NCT01066923|6009814|P3|COMPLETED|Overall Study||25
2450512|NCT01066923|6009815|P2|COMPLETED|Overall Study||29
2450513|NCT01066923|6009816|P1|COMPLETED|Overall Study||25
2450514|NCT01066923|6009813|P4|Retinal Imaging|Overall Study||0
2450515|NCT01066923|6009814|P3|Retinal Imaging|Overall Study||0
2450516|NCT01066923|6009815|P2|Retinal Imaging|Overall Study||0
2450517|NCT01066923|6009816|P1|Retinal Imaging|Overall Study||0
2450518|NCT01066923|6009813|P4|Activation of Coagulation|Overall Study||0
2450519|NCT01066923|6009814|P3|Activation of Coagulation|Overall Study||0
2450520|NCT01066923|6009815|P2|Activation of Coagulation|Overall Study||0
2450521|NCT01066923|6009816|P1|Activation of Coagulation|Overall Study||0
2450522|NCT01066923|6009813|P4|Vascular Function|Overall Study||13
2450523|NCT01066923|6009814|P3|Vascular Function|Overall Study||12
2450524|NCT01066923|6009815|P2|Vascular Function|Overall Study||14
2450525|NCT01066923|6009816|P1|Vascular Function|Overall Study||13
2450526|NCT01066923|6009813|P4|Platelet Closure Time|Overall Study||23
2450527|NCT01066923|6009814|P3|Platelet Closure Time|Overall Study||25
2450528|NCT01066923|6009815|P2|Platelet Closure Time|Overall Study||29
2450529|NCT01066923|6009816|P1|Platelet Closure Time|Overall Study||25
2450530|NCT01066923|6009813|P4|STARTED|Overall Study||31
2450531|NCT01066923|6009814|P3|STARTED|Overall Study||33
2450532|NCT01066923|6009815|P2|STARTED|Overall Study||32
2450533|NCT01066923|6009816|P1|STARTED|Overall Study||28
2450534|NCT01066897|6009840|P2|NOT COMPLETED|Overall Study||0
2450535|NCT01066897|6009841|P1|NOT COMPLETED|Overall Study||2
2450536|NCT01066897|6009840|P2|COMPLETED|Overall Study||9
2450537|NCT01066897|6009841|P1|COMPLETED|Overall Study||5
2450538|NCT01066897|6009840|P2|STARTED|Overall Study||9
2450539|NCT01066897|6009841|P1|STARTED|Overall Study||7
2450540|NCT01066871|6009855|P4|NOT COMPLETED|Overall Study||5
2450541|NCT01066871|6009856|P3|NOT COMPLETED|Overall Study||6
2450542|NCT01066871|6009857|P2|NOT COMPLETED|Overall Study||5
2450543|NCT01066871|6009858|P1|NOT COMPLETED|Overall Study||4
2450544|NCT01066871|6009855|P4|COMPLETED|Overall Study||13
2450545|NCT01066871|6009856|P3|COMPLETED|Overall Study||12
2450546|NCT01066871|6009857|P2|COMPLETED|Overall Study||13
2450547|NCT01066871|6009858|P1|COMPLETED|Overall Study||16
2450548|NCT01066871|6009855|P4|STARTED|Overall Study||18
2450549|NCT01066871|6009856|P3|STARTED|Overall Study||18
2450550|NCT01066871|6009857|P2|STARTED|Overall Study||18
2450551|NCT01066871|6009858|P1|STARTED|Overall Study||20
2450552|NCT01066819|6009922|P6|NOT COMPLETED|Overall Study||6
2450553|NCT01066819|6009923|P5|NOT COMPLETED|Overall Study||4
2450554|NCT01066819|6009924|P4|NOT COMPLETED|Overall Study||17
2450555|NCT01066819|6009925|P3|NOT COMPLETED|Overall Study||146
2450556|NCT01066819|6009926|P2|NOT COMPLETED|Overall Study||171
2450557|NCT01066819|6009927|P1|NOT COMPLETED|Overall Study||689
2450558|NCT01066819|6009922|P6|COMPLETED|Overall Study||7
2450559|NCT01066819|6009923|P5|COMPLETED|Overall Study||3
2450560|NCT01066819|6009924|P4|COMPLETED|Overall Study||8
2450561|NCT01066819|6009925|P3|COMPLETED|Overall Study||111
2450562|NCT01066819|6009926|P2|COMPLETED|Overall Study||177
2450563|NCT01066819|6009927|P1|COMPLETED|Overall Study||317
2450564|NCT01066819|6009922|P6|STARTED|Overall Study||13
2450565|NCT01066819|6009923|P5|STARTED|Overall Study||7
2450566|NCT01066819|6009924|P4|STARTED|Overall Study||25
2450567|NCT01066819|6009925|P3|STARTED|Overall Study||257
2450568|NCT01066819|6009926|P2|STARTED|Overall Study||348
2450569|NCT01066819|6009927|P1|STARTED|Overall Study||1006
2450570|NCT01066793|6010068|P6|NOT COMPLETED|Overall Study||1
2450571|NCT01066793|6010069|P5|NOT COMPLETED|Overall Study||0
2450572|NCT01066793|6010070|P4|NOT COMPLETED|Overall Study||49
2450573|NCT01066793|6010071|P3|NOT COMPLETED|Overall Study||115
2450574|NCT01066793|6010072|P2|NOT COMPLETED|Overall Study||77
2450575|NCT01066793|6010073|P1|NOT COMPLETED|Overall Study||374
2450576|NCT01066793|6010068|P6|COMPLETED|Overall Study||4
2450577|NCT01066793|6010069|P5|COMPLETED|Overall Study||11
2450578|NCT01066793|6010070|P4|COMPLETED|Overall Study||94
2450579|NCT01066793|6010071|P3|COMPLETED|Overall Study||369
2450580|NCT01066793|6010072|P2|COMPLETED|Overall Study||495
2450581|NCT01066793|6010073|P1|COMPLETED|Overall Study||754
2450582|NCT01066793|6010068|P6|STARTED|Overall Study||5
2450583|NCT01066793|6010069|P5|STARTED|Overall Study||11
2450584|NCT01066793|6010070|P4|STARTED|Overall Study||143
2450585|NCT01066793|6010071|P3|STARTED|Overall Study||484
2450586|NCT01066793|6010072|P2|STARTED|Overall Study||572
2450587|NCT01066793|6010073|P1|STARTED|Overall Study||1128
2450588|NCT01066780|6010213|P2|NOT COMPLETED|Overall Study||1
2450589|NCT01066780|6010214|P1|NOT COMPLETED|Overall Study||1
2450590|NCT01066780|6010213|P2|COMPLETED|Overall Study||23
2450591|NCT01066780|6010214|P1|COMPLETED|Overall Study||23
2450592|NCT01066780|6010213|P2|STARTED|Overall Study||24
2450593|NCT01066780|6010214|P1|STARTED|Overall Study||24
2450594|NCT01066624|6010221|P3|NOT COMPLETED|Overall Study||0
2450595|NCT01066624|6010222|P2|NOT COMPLETED|Overall Study||0
2450596|NCT01066624|6010223|P1|NOT COMPLETED|Overall Study||0
2450597|NCT01066624|6010221|P3|COMPLETED|Overall Study||39
2450598|NCT01066624|6010222|P2|COMPLETED|Overall Study||40
2450599|NCT01066624|6010223|P1|COMPLETED|Overall Study||38
2450600|NCT01066624|6010221|P3|STARTED|Overall Study||39
2450601|NCT01066624|6010222|P2|STARTED|Overall Study||40
2450602|NCT01066624|6010223|P1|STARTED|Overall Study||38
2450603|NCT01066585|6010233|P2|NOT COMPLETED|Overall Study||3
2450604|NCT01066585|6010234|P1|NOT COMPLETED|Overall Study||1
2450605|NCT01066585|6010233|P2|COMPLETED|Overall Study||196
2450606|NCT01066585|6010234|P1|COMPLETED|Overall Study||210
2450607|NCT01066585|6010233|P2|STARTED|Overall Study||199
2450608|NCT01066585|6010234|P1|STARTED|Overall Study||211
2450609|NCT01066546|6010246|P1|NOT COMPLETED|Overall Study||5
2450610|NCT01066546|6010246|P1|COMPLETED|Overall Study||0
2450611|NCT01066546|6010246|P1|STARTED|Overall Study||5
2450612|NCT01066520|6010260|P3|NOT COMPLETED|Overall Study||0
2450613|NCT01066520|6010261|P2|NOT COMPLETED|Overall Study||0
2450614|NCT01066520|6010262|P1|NOT COMPLETED|Overall Study||0
2450615|NCT01066520|6010260|P3|COMPLETED|Overall Study||137
2450616|NCT01066520|6010261|P2|COMPLETED|Overall Study||140
2450617|NCT01066520|6010262|P1|COMPLETED|Overall Study||143
2450618|NCT01066520|6010260|P3|STARTED|Overall Study||137
2450619|NCT01066520|6010261|P2|STARTED|Overall Study||140
2450620|NCT01066520|6010262|P1|STARTED|Overall Study||143
2450621|NCT01066156|6010276|P1|NOT COMPLETED|Overall Study||10
2450622|NCT01066156|6010276|P1|COMPLETED|Overall Study||24
2450623|NCT01066156|6010276|P1|STARTED|Overall Study||34
2450624|NCT01066143|6010280|P1|NOT COMPLETED|Overall Study||8
2450625|NCT01066143|6010280|P1|COMPLETED|Overall Study||0
2450626|NCT01066143|6010280|P1|STARTED|Overall Study||8
2450627|NCT01066104|6010286|P2|NOT COMPLETED|Overall Study||1
2450628|NCT01066104|6010287|P1|NOT COMPLETED|Overall Study||2
2450629|NCT01066104|6010286|P2|COMPLETED|Overall Study||12
2450630|NCT01066104|6010287|P1|COMPLETED|Overall Study||12
2450631|NCT01066104|6010286|P2|STARTED|Overall Study||13
2450632|NCT01066104|6010287|P1|STARTED|Overall Study||14
2450633|NCT01066052|6010297|P2|NOT COMPLETED|Overall Study||0
2450634|NCT01066052|6010298|P1|NOT COMPLETED|Overall Study||3
2450635|NCT01066052|6010297|P2|COMPLETED|Overall Study||51
2450636|NCT01066052|6010298|P1|COMPLETED|Overall Study||61
2450637|NCT01066052|6010297|P2|Treated|Overall Study||0
2450638|NCT01066052|6010298|P1|Treated|Overall Study||61
2450639|NCT01066052|6010297|P2|STARTED|Overall Study||51
2450640|NCT01066052|6010298|P1|STARTED|Overall Study||64
2450641|NCT01066039|6010309|P1|NOT COMPLETED|Overall Study||44
2450642|NCT01066039|6010309|P1|COMPLETED|Overall Study||158
2450643|NCT01066039|6010309|P1|Treated|Overall Study||200
2450644|NCT01066039|6010309|P1|STARTED|Overall Study||202
2450645|NCT01066000|6010322|P1|NOT COMPLETED|Overall Study||9
2450646|NCT01066000|6010322|P1|COMPLETED|Overall Study||24
2450647|NCT01066000|6010322|P1|STARTED|Overall Study||33
2450648|NCT01065844|6010333|P1|NOT COMPLETED|Overall Study||5
2450649|NCT01065844|6010333|P1|COMPLETED|Overall Study||10
2450650|NCT01065844|6010333|P1|STARTED|Overall Study||15
2450651|NCT01065818|6010337|P1|NOT COMPLETED|Overall Study||2
2450652|NCT01065818|6010337|P1|COMPLETED|Overall Study||4
2450653|NCT01065818|6010337|P1|STARTED|Overall Study||6
2450654|NCT01065779|6010341|P1|NOT COMPLETED|Overall Study||82
2450655|NCT01065779|6010341|P1|COMPLETED|Overall Study||798
2450656|NCT01065779|6010341|P1|STARTED|Overall Study||880
2450657|NCT01065766|6010352|P1|NOT COMPLETED|Overall Study||32
2450658|NCT01065766|6010352|P1|COMPLETED|Overall Study||4033
2450659|NCT01065766|6010352|P1|STARTED|Overall Study||4065
2450660|NCT01065714|6010364|P1|NOT COMPLETED|Overall Study||0
2450661|NCT01065714|6010364|P1|COMPLETED|Overall Study||20
2450662|NCT01065714|6010364|P1|STARTED|Overall Study|"This was a split body Study. All participants used both Hydrogel and Eucerin"|20
2450663|NCT01065597|6010371|P1|NOT COMPLETED|Overall Study||1
2450664|NCT01065597|6010371|P1|COMPLETED|Overall Study||12
2450665|NCT01065597|6010371|P1|STARTED|Overall Study||13
2450666|NCT01065571|6010380|P2|NOT COMPLETED|Overall Study||0
2450667|NCT01065571|6010381|P1|NOT COMPLETED|Overall Study||3
2450668|NCT01065571|6010380|P2|COMPLETED|Overall Study||5
2450669|NCT01065571|6010381|P1|COMPLETED|Overall Study||7
2450670|NCT01065571|6010380|P2|STARTED|Overall Study||5
2450671|NCT01065571|6010381|P1|STARTED|Overall Study||10
2450672|NCT01065558|6010391|P1|NOT COMPLETED|Overall Study||0
2450673|NCT01065558|6010391|P1|COMPLETED|Overall Study||5
2450674|NCT01065558|6010391|P1|STARTED|Overall Study||5
2450675|NCT01065506|6010398|P2|NOT COMPLETED|Overall Study||38
2450676|NCT01065506|6010399|P1|NOT COMPLETED|Overall Study||32
2450677|NCT01065506|6010398|P2|COMPLETED|Overall Study||34
2450678|NCT01065506|6010399|P1|COMPLETED|Overall Study||32
2450679|NCT01065506|6010398|P2|4-Month Follow-Up|Overall Study||34
2450680|NCT01065506|6010399|P1|4-Month Follow-Up|Overall Study||35
2450681|NCT01065506|6010398|P2|End of Treatment|Overall Study||37
2450682|NCT01065506|6010399|P1|End of Treatment|Overall Study||44
2450683|NCT01065506|6010398|P2|STARTED|Overall Study||72
2450684|NCT01065506|6010399|P1|STARTED|Overall Study||64
2450685|NCT01065480|6010407|P2|NOT COMPLETED|Overall Study||0
2450686|NCT01065480|6010408|P1|NOT COMPLETED|Overall Study||0
2450687|NCT01065480|6010407|P2|COMPLETED|Overall Study||43
2450688|NCT01065480|6010408|P1|COMPLETED|Overall Study||48
2450689|NCT01065480|6010407|P2|STARTED|Overall Study||43
2450690|NCT01065480|6010408|P1|STARTED|Overall Study||48
2450719|NCT01065428|6010533|P2|NOT COMPLETED|Overall Study||0
2450720|NCT01065428|6010534|P1|NOT COMPLETED|Overall Study||0
2450721|NCT01065428|6010533|P2|COMPLETED|Overall Study||35
2450722|NCT01065428|6010534|P1|COMPLETED|Overall Study||17
2450723|NCT01065428|6010533|P2|STARTED|Overall Study||35
2450724|NCT01065428|6010534|P1|STARTED|Overall Study||17
2450725|NCT01065350|6010544|P2|NOT COMPLETED|Overall Study||1
2450726|NCT01065350|6010545|P1|NOT COMPLETED|Overall Study||0
2450727|NCT01065350|6010544|P2|COMPLETED|Overall Study||41
2450728|NCT01065350|6010545|P1|COMPLETED|Overall Study||43
2450729|NCT01065350|6010544|P2|STARTED|Overall Study||42
2450730|NCT01065350|6010545|P1|STARTED|Overall Study||43
2450731|NCT01065051|6010579|P2|NOT COMPLETED|Overall Study||0
2450732|NCT01065051|6010580|P1|NOT COMPLETED|Overall Study||0
2450733|NCT01065051|6010579|P2|COMPLETED|Overall Study||0
2450734|NCT01065051|6010580|P1|COMPLETED|Overall Study||1
2450735|NCT01065051|6010579|P2|STARTED|Overall Study||0
2450736|NCT01065051|6010580|P1|STARTED|Overall Study||1
2450737|NCT01064947|6010606|P1|NOT COMPLETED|Overall Study||41
2450738|NCT01064947|6010606|P1|COMPLETED|Overall Study||29
2450739|NCT01064947|6010606|P1|STARTED|Overall Study||70
2450740|NCT01064882|6010617|P3|NOT COMPLETED|Overall Study||2
2450741|NCT01064882|6010618|P2|NOT COMPLETED|Overall Study||2
2450742|NCT01064882|6010619|P1|NOT COMPLETED|Overall Study||2
2450743|NCT01064882|6010617|P3|COMPLETED|Overall Study||32
2450744|NCT01064882|6010618|P2|COMPLETED|Overall Study||32
2450745|NCT01064882|6010619|P1|COMPLETED|Overall Study||34
2450746|NCT01064882|6010617|P3|STARTED|Overall Study||34
2450747|NCT01064882|6010618|P2|STARTED|Overall Study||34
2450748|NCT01064882|6010619|P1|STARTED|Overall Study||36
2450749|NCT01064856|6010647|P4|NOT COMPLETED|Open-label (OL) Period||20
2450750|NCT01064856|6010648|P3|NOT COMPLETED|Open-label (OL) Period||26
2450751|NCT01064856|6010649|P2|NOT COMPLETED|Open-label (OL) Period||0
2450752|NCT01064856|6010650|P1|NOT COMPLETED|Open-label (OL) Period||0
2450753|NCT01064856|6010647|P4|COMPLETED|Open-label (OL) Period||61
2450754|NCT01064856|6010648|P3|COMPLETED|Open-label (OL) Period||56
2450755|NCT01064856|6010649|P2|COMPLETED|Open-label (OL) Period||0
2450756|NCT01064856|6010650|P1|COMPLETED|Open-label (OL) Period||0
2450757|NCT01064856|6010647|P4|STARTED|Open-label (OL) Period||81
2450758|NCT01064856|6010648|P3|STARTED|Open-label (OL) Period||82
2450759|NCT01064856|6010649|P2|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
2450760|NCT01064856|6010650|P1|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
2450761|NCT01064856|6010647|P4|NOT COMPLETED|Double-blind (DB) Period||0
2450762|NCT01064856|6010648|P3|NOT COMPLETED|Double-blind (DB) Period||0
2450763|NCT01064856|6010649|P2|NOT COMPLETED|Double-blind (DB) Period||0
2450764|NCT01064856|6010650|P1|NOT COMPLETED|Double-blind (DB) Period||2
2450765|NCT01064856|6010647|P4|COMPLETED|Double-blind (DB) Period||0
2450766|NCT01064856|6010648|P3|COMPLETED|Double-blind (DB) Period||0
2450767|NCT01064856|6010649|P2|COMPLETED|Double-blind (DB) Period||81
2450768|NCT01064856|6010650|P1|COMPLETED|Double-blind (DB) Period||82
2450769|NCT01064856|6010647|P4|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
2450770|NCT01064856|6010648|P3|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
2450771|NCT01064856|6010649|P2|STARTED|Double-blind (DB) Period||81
2450772|NCT01064856|6010650|P1|STARTED|Double-blind (DB) Period||84
2450773|NCT01064830|6010683|P2|NOT COMPLETED|Overall Study||4
2450774|NCT01064830|6010684|P1|NOT COMPLETED|Overall Study||2
2450775|NCT01064830|6010683|P2|COMPLETED|Overall Study||7
2450776|NCT01064830|6010684|P1|COMPLETED|Overall Study||8
2450777|NCT01064830|6010683|P2|STARTED|Overall Study||11
2450778|NCT01064830|6010684|P1|STARTED|Overall Study||10
2450779|NCT01064817|6010694|P2|NOT COMPLETED|Study Completion||0
2450780|NCT01064817|6010695|P1|NOT COMPLETED|Study Completion||2
2450781|NCT01064817|6010694|P2|COMPLETED|Study Completion||62
2450782|NCT01064817|6010695|P1|COMPLETED|Study Completion||60
2450783|NCT01064817|6010694|P2|STARTED|Study Completion||62
2450784|NCT01064817|6010695|P1|STARTED|Study Completion||62
2450785|NCT01064817|6010694|P2|NOT COMPLETED|All Study Treatment Days 1-9||0
2450786|NCT01064817|6010695|P1|NOT COMPLETED|All Study Treatment Days 1-9||0
2450787|NCT01064817|6010694|P2|COMPLETED|All Study Treatment Days 1-9||62
2450788|NCT01064817|6010695|P1|COMPLETED|All Study Treatment Days 1-9||62
2450789|NCT01064817|6010694|P2|STARTED|All Study Treatment Days 1-9||62
2450790|NCT01064817|6010695|P1|STARTED|All Study Treatment Days 1-9||62
2450791|NCT01064739|6010707|P1|NOT COMPLETED|Fixed Sodium Diet + Fava Beans||1
2450792|NCT01064739|6010707|P1|COMPLETED|Fixed Sodium Diet + Fava Beans|1 participant withdrew with blood in his urine on the fava bean study day.|13
2450793|NCT01064739|6010707|P1|STARTED|Fixed Sodium Diet + Fava Beans||14
2450794|NCT01064739|6010707|P1|NOT COMPLETED|Fixed Sodium Study Diet||0
2450795|NCT01064739|6010707|P1|COMPLETED|Fixed Sodium Study Diet||14
2450796|NCT01064739|6010707|P1|STARTED|Fixed Sodium Study Diet|14 participants consumed the fixed-sodium study diet prior to the fava bean supplement study day.|14
2450797|NCT01064713|6010765|P2|NOT COMPLETED|Overall Study||0
2450798|NCT01064713|6010766|P1|NOT COMPLETED|Overall Study||0
2450799|NCT01064713|6010765|P2|COMPLETED|Overall Study||4
2450800|NCT01064713|6010766|P1|COMPLETED|Overall Study||13
2450801|NCT01064713|6010765|P2|STARTED|Overall Study||4
2450802|NCT01064713|6010766|P1|STARTED|Overall Study||13
2450803|NCT01064687|6010778|P4|NOT COMPLETED|Overall Study||17
2450804|NCT01064687|6010779|P3|NOT COMPLETED|Overall Study||41
2450805|NCT01064687|6010780|P2|NOT COMPLETED|Overall Study||26
2450806|NCT01064687|6010781|P1|NOT COMPLETED|Overall Study||34
2450807|NCT01064687|6010778|P4|COMPLETED|Overall Study||124
2450808|NCT01064687|6010779|P3|COMPLETED|Overall Study||237
2450809|NCT01064687|6010780|P2|COMPLETED|Overall Study||254
2450810|NCT01064687|6010781|P1|COMPLETED|Overall Study||245
2450811|NCT01064687|6010778|P4|Completed 26 Weeks|Overall Study||124
2450812|NCT01064687|6010779|P3|Completed 26 Weeks|Overall Study||252
2450813|NCT01064687|6010780|P2|Completed 26 Weeks|Overall Study||263
2450814|NCT01064687|6010781|P1|Completed 26 Weeks|Overall Study||260
2450815|NCT01064687|6010778|P4|Received at Least 1 Dose of Study Drug|Overall Study||141
2450816|NCT01064687|6010779|P3|Received at Least 1 Dose of Study Drug|Overall Study||276
2450817|NCT01064687|6010780|P2|Received at Least 1 Dose of Study Drug|Overall Study||280
2450818|NCT01064687|6010781|P1|Received at Least 1 Dose of Study Drug|Overall Study||279
2450819|NCT01064687|6010778|P4|STARTED|Overall Study||141
2450820|NCT01064687|6010779|P3|STARTED|Overall Study|Of 278 participants randomized to Exenatide, 2 chose not to take study drug.|278
2450821|NCT01064687|6010780|P2|STARTED|Overall Study||280
2450822|NCT01064687|6010781|P1|STARTED|Overall Study||279
2450859|NCT01064622|6010990|P2|NOT COMPLETED|Crossover of Arm I||0
2450860|NCT01064622|6010991|P1|NOT COMPLETED|Crossover of Arm I||0
2450861|NCT01064622|6010990|P2|COMPLETED|Crossover of Arm I||0
2450862|NCT01064622|6010991|P1|COMPLETED|Crossover of Arm I||22
2450863|NCT01064622|6010990|P2|STARTED|Crossover of Arm I||0
2450864|NCT01064622|6010991|P1|STARTED|Crossover of Arm I|Among 53 patients, 45 had disease progression; however 23 elected not to crossover to vismodegib.|22
2450865|NCT01064622|6010990|P2|NOT COMPLETED|Randomized Phase II||3
2450866|NCT01064622|6010991|P1|NOT COMPLETED|Randomized Phase II||2
2450867|NCT01064622|6010990|P2|COMPLETED|Randomized Phase II||53
2450868|NCT01064622|6010991|P1|COMPLETED|Randomized Phase II||53
2450869|NCT01064622|6010990|P2|STARTED|Randomized Phase II||56
2450870|NCT01064622|6010991|P1|STARTED|Randomized Phase II||55
2450871|NCT01064622|6010990|P2|NOT COMPLETED|Lead-in Phase I||0
2450872|NCT01064622|6010991|P1|NOT COMPLETED|Lead-in Phase I||0
2450873|NCT01064622|6010990|P2|COMPLETED|Lead-in Phase I||7
2450874|NCT01064622|6010991|P1|COMPLETED|Lead-in Phase I||0
2450875|NCT01064622|6010990|P2|STARTED|Lead-in Phase I||7
2450876|NCT01064622|6010991|P1|STARTED|Lead-in Phase I||0
2450877|NCT01064414|6011015|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
2450878|NCT01064414|6011016|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
2450879|NCT01064414|6011017|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
2450880|NCT01064414|6011015|P3|COMPLETED|Extension Period: Week 26 to Week 52||76
2450881|NCT01064414|6011016|P2|COMPLETED|Extension Period: Week 26 to Week 52||67
2450882|NCT01064414|6011017|P1|COMPLETED|Extension Period: Week 26 to Week 52||64
2450883|NCT01064414|6011015|P3|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|81
2450884|NCT01064414|6011016|P2|STARTED|Extension Period: Week 26 to Week 52|3 pts completed core but did not enter ext. Reason: other (not specified) (3).|72
2450885|NCT01064414|6011017|P1|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|76
2450886|NCT01064414|6011015|P3|NOT COMPLETED|Core Period: Baseline to Week 26||7
2450887|NCT01064414|6011016|P2|NOT COMPLETED|Core Period: Baseline to Week 26||15
2450888|NCT01064414|6011017|P1|NOT COMPLETED|Core Period: Baseline to Week 26||13
2450889|NCT01064414|6011015|P3|COMPLETED|Core Period: Baseline to Week 26||82
2450890|NCT01064414|6011016|P2|COMPLETED|Core Period: Baseline to Week 26||75
2450891|NCT01064414|6011017|P1|COMPLETED|Core Period: Baseline to Week 26||77
2450892|NCT01064414|6011015|P3|STARTED|Core Period: Baseline to Week 26||89
2450893|NCT01064414|6011016|P2|STARTED|Core Period: Baseline to Week 26||90
2450894|NCT01064414|6011017|P1|STARTED|Core Period: Baseline to Week 26||90
2450895|NCT01064401|6011036|P2|NOT COMPLETED|Overall Study||195
2450896|NCT01064401|6011037|P1|NOT COMPLETED|Overall Study||228
2450897|NCT01064401|6011036|P2|COMPLETED|Overall Study||724
2450898|NCT01064401|6011037|P1|COMPLETED|Overall Study||694
2450899|NCT01064401|6011036|P2|STARTED|Overall Study||919
2450900|NCT01064401|6011037|P1|STARTED|Overall Study||922
2450901|NCT01064362|6011053|P2|NOT COMPLETED|Overall Study||0
2450902|NCT01064362|6011054|P1|NOT COMPLETED|Overall Study||0
2450903|NCT01064362|6011053|P2|COMPLETED|Overall Study||11883
2450904|NCT01064362|6011054|P1|COMPLETED|Overall Study||1559
2450905|NCT01064362|6011053|P2|STARTED|Overall Study||11883
2450906|NCT01064362|6011054|P1|STARTED|Overall Study||1559
2450907|NCT01064323|6011062|P1|NOT COMPLETED|Overall Study||0
2450908|NCT01064323|6011062|P1|COMPLETED|Overall Study||10
2450909|NCT01064323|6011062|P1|STARTED|Overall Study||10
2450910|NCT01064310|6011086|P3|NOT COMPLETED|Open Label Pazopinib||84
2450911|NCT01064310|6011087|P2|NOT COMPLETED|Open Label Pazopinib||0
2450912|NCT01064310|6011088|P1|NOT COMPLETED|Open Label Pazopinib||0
2450913|NCT01064310|6011086|P3|COMPLETED|Open Label Pazopinib||0
2450914|NCT01064310|6011087|P2|COMPLETED|Open Label Pazopinib||0
2450915|NCT01064310|6011088|P1|COMPLETED|Open Label Pazopinib||0
2450916|NCT01064310|6011086|P3|STARTED|Open Label Pazopinib||84
2450917|NCT01064310|6011087|P2|STARTED|Open Label Pazopinib||0
2450918|NCT01064310|6011088|P1|STARTED|Open Label Pazopinib||0
2450919|NCT01064310|6011086|P3|NOT COMPLETED|Period 2||0
2450920|NCT01064310|6011087|P2|NOT COMPLETED|Period 2||6
2450921|NCT01064310|6011088|P1|NOT COMPLETED|Period 2||4
2450922|NCT01064310|6011086|P3|COMPLETED|Period 2||0
2450923|NCT01064310|6011087|P2|COMPLETED|Period 2||62
2450924|NCT01064310|6011088|P1|COMPLETED|Period 2||64
2450925|NCT01064310|6011086|P3|STARTED|Period 2||0
2450926|NCT01064310|6011087|P2|STARTED|Period 2||68
2450927|NCT01064310|6011088|P1|STARTED|Period 2||68
2450928|NCT01064310|6011086|P3|NOT COMPLETED|Period 1||0
2450929|NCT01064310|6011087|P2|NOT COMPLETED|Period 1||18
2450930|NCT01064310|6011088|P1|NOT COMPLETED|Period 1||14
2450931|NCT01064310|6011086|P3|COMPLETED|Period 1||0
2450932|NCT01064310|6011087|P2|COMPLETED|Period 1||68
2450933|NCT01064310|6011088|P1|COMPLETED|Period 1||68
2450934|NCT01064310|6011086|P3|STARTED|Period 1||0
2450935|NCT01064310|6011087|P2|STARTED|Period 1||86
2450936|NCT01064310|6011088|P1|STARTED|Period 1||82
2450937|NCT01064297|6011118|P3|NOT COMPLETED|Overall Study||133
2450938|NCT01064297|6011119|P2|NOT COMPLETED|Overall Study||48
2450939|NCT01064297|6011120|P1|NOT COMPLETED|Overall Study||791
2450940|NCT01064297|6011118|P3|COMPLETED|Overall Study||497
2450941|NCT01064297|6011119|P2|COMPLETED|Overall Study||171
2450942|NCT01064297|6011120|P1|COMPLETED|Overall Study||1776
2450943|NCT01064297|6011118|P3|STARTED|Overall Study||630
2450944|NCT01064297|6011119|P2|STARTED|Overall Study||219
2450945|NCT01064297|6011120|P1|STARTED|Overall Study||2567
2450946|NCT01064284|6011166|P2|NOT COMPLETED|Overall Study||17
2450947|NCT01064284|6011167|P1|NOT COMPLETED|Overall Study||18
2450948|NCT01064284|6011166|P2|COMPLETED|Overall Study||109
2450949|NCT01064284|6011167|P1|COMPLETED|Overall Study||107
2450950|NCT01064284|6011166|P2|STARTED|Overall Study|Taking into account the analyzed patients only|126
2450951|NCT01064284|6011167|P1|STARTED|Overall Study|Taking into account the analyzed patients only|125
2450952|NCT01064167|6011189|P2|NOT COMPLETED|Overall Study||15
2450953|NCT01064167|6011190|P1|NOT COMPLETED|Overall Study||14
2450954|NCT01064167|6011189|P2|COMPLETED|Overall Study||115
2450955|NCT01064167|6011190|P1|COMPLETED|Overall Study||116
2450956|NCT01064167|6011189|P2|STARTED|Overall Study||130
2450957|NCT01064167|6011190|P1|STARTED|Overall Study||130
2450958|NCT01064076|6011198|P1|NOT COMPLETED|Overall Study||18
2450959|NCT01064076|6011198|P1|COMPLETED|Overall Study|303 subjects completed a minimum of 180 days of follow up|303
2450960|NCT01064076|6011198|P1|STARTED|Overall Study|321 subjects underwent an implant procedure for the S-ICD System|321
2450961|NCT01063972|6011205|P2|NOT COMPLETED|Overall Study||12
2450962|NCT01063972|6011206|P1|NOT COMPLETED|Overall Study||14
2450963|NCT01063972|6011205|P2|COMPLETED|Overall Study|Participants who were deceased or incarcerated were excluded.|284
2450964|NCT01063972|6011206|P1|COMPLETED|Overall Study|Participants who were deceased or incarcerated were excluded.|296
2450965|NCT01063972|6011205|P2|STARTED|Overall Study||296
2450966|NCT01063972|6011206|P1|STARTED|Overall Study||310
2450967|NCT01063907|6011222|P2|NOT COMPLETED|Overall Study||0
2450968|NCT01063907|6011223|P1|NOT COMPLETED|Overall Study||0
2450969|NCT01063907|6011222|P2|COMPLETED|Overall Study||80
2450970|NCT01063907|6011223|P1|COMPLETED|Overall Study||15
2450971|NCT01063907|6011222|P2|STARTED|Overall Study||80
2450972|NCT01063907|6011223|P1|STARTED|Overall Study||15
2450973|NCT01063881|6011256|P3|NOT COMPLETED|Overall Study||1
2450974|NCT01063881|6011257|P2|NOT COMPLETED|Overall Study||11
2450975|NCT01063881|6011258|P1|NOT COMPLETED|Overall Study||55
2450976|NCT01063881|6011256|P3|COMPLETED|Overall Study||12
2450977|NCT01063881|6011257|P2|COMPLETED|Overall Study||114
2450978|NCT01063881|6011258|P1|COMPLETED|Overall Study||92
2450979|NCT01063881|6011256|P3|STARTED|Overall Study||13
2450980|NCT01063881|6011257|P2|STARTED|Overall Study||125
2450981|NCT01063881|6011258|P1|STARTED|Overall Study||147
2450982|NCT01063868|6011282|P2|NOT COMPLETED|Overall Study||12
2450983|NCT01063868|6011283|P1|NOT COMPLETED|Overall Study||35
2450984|NCT01063868|6011282|P2|COMPLETED|Overall Study||0
2450985|NCT01063868|6011283|P1|COMPLETED|Overall Study||0
2450986|NCT01063868|6011282|P2|STARTED|Overall Study||12
2450987|NCT01063868|6011283|P1|STARTED|Overall Study||35
2450988|NCT01063855|6011291|P2|NOT COMPLETED|Overall Study||29
2450989|NCT01063855|6011292|P1|NOT COMPLETED|Overall Study||37
2450990|NCT01063855|6011291|P2|COMPLETED|Overall Study||221
2450991|NCT01063855|6011292|P1|COMPLETED|Overall Study||208
2450992|NCT01063855|6011291|P2|STARTED|Overall Study||250
2450993|NCT01063855|6011292|P1|STARTED|Overall Study||245
2450994|NCT01063829|6011318|P4|NOT COMPLETED|Overall Study||21
2450995|NCT01063829|6011319|P3|NOT COMPLETED|Overall Study||10
2450996|NCT01063829|6011320|P2|NOT COMPLETED|Overall Study||10
2450997|NCT01063829|6011321|P1|NOT COMPLETED|Overall Study||16
2450998|NCT01063829|6011318|P4|COMPLETED|Overall Study|Non-completers considered as failure; FAS|12
2450999|NCT01063829|6011319|P3|COMPLETED|Overall Study|Non-completers considered as failure; FAS|24
2451000|NCT01063829|6011320|P2|COMPLETED|Overall Study|Non-completers considered as failure; FAS|21
2451001|NCT01063829|6011321|P1|COMPLETED|Overall Study|Non-completers considered as failure; FAS|17
2451002|NCT01063829|6011318|P4|STARTED|Overall Study||33
2451003|NCT01063829|6011319|P3|STARTED|Overall Study||34
2451004|NCT01063829|6011320|P2|STARTED|Overall Study||31
2451005|NCT01063829|6011321|P1|STARTED|Overall Study||33
2451006|NCT01063764|6011339|P1|NOT COMPLETED|2nd Period (Week 22 to the End of Study)||20
2451007|NCT01063764|6011339|P1|COMPLETED|2nd Period (Week 22 to the End of Study)||35
2451008|NCT01063764|6011339|P1|STARTED|2nd Period (Week 22 to the End of Study)|7 subjects who completed Period 1 did not enter the Second Period.|55
2451009|NCT01063764|6011339|P1|NOT COMPLETED|1st Period (From Week 8 to Week 22)||11
2451010|NCT01063764|6011339|P1|COMPLETED|1st Period (From Week 8 to Week 22)|62 subjects completed the First Period, but 7 of these subjects did not enter the Second Period.|62
2451011|NCT01063764|6011339|P1|STARTED|1st Period (From Week 8 to Week 22)||73
2451012|NCT01063712|6011353|P1|NOT COMPLETED|Overall Study||0
2451013|NCT01063712|6011353|P1|COMPLETED|Overall Study||29
2451014|NCT01063712|6011353|P1|STARTED|Overall Study||29
2451015|NCT01063595|6011358|P2|NOT COMPLETED|Second Intervention||0
2451016|NCT01063595|6011359|P1|NOT COMPLETED|Second Intervention||0
2451017|NCT01063595|6011358|P2|COMPLETED|Second Intervention||24
2451018|NCT01063595|6011359|P1|COMPLETED|Second Intervention||29
2451019|NCT01063595|6011358|P2|STARTED|Second Intervention||24
2451020|NCT01063595|6011359|P1|STARTED|Second Intervention||29
2451021|NCT01063595|6011358|P2|NOT COMPLETED|First Intervention||5
2451022|NCT01063595|6011359|P1|NOT COMPLETED|First Intervention||2
2451023|NCT01063595|6011358|P2|COMPLETED|First Intervention||24
2451024|NCT01063595|6011359|P1|COMPLETED|First Intervention||29
2451025|NCT01063595|6011358|P2|STARTED|First Intervention||29
2451026|NCT01063595|6011359|P1|STARTED|First Intervention||31
2451027|NCT01063595|6011358|P2|NOT COMPLETED|Enrolled in Study and Randomized||2
2451028|NCT01063595|6011359|P1|NOT COMPLETED|Enrolled in Study and Randomized||1
2451029|NCT01063595|6011358|P2|COMPLETED|Enrolled in Study and Randomized||29
2451030|NCT01063595|6011359|P1|COMPLETED|Enrolled in Study and Randomized||31
2451031|NCT01063595|6011358|P2|Received Treatment|Enrolled in Study and Randomized||29
2451032|NCT01063595|6011359|P1|Received Treatment|Enrolled in Study and Randomized||31
2451033|NCT01063595|6011358|P2|STARTED|Enrolled in Study and Randomized||31
2451034|NCT01063595|6011359|P1|STARTED|Enrolled in Study and Randomized||32
2451043|NCT01063348|6011412|P2|NOT COMPLETED|Overall Study||10
2451044|NCT01063348|6011413|P1|NOT COMPLETED|Overall Study||3
2451045|NCT01063348|6011412|P2|COMPLETED|Overall Study||21
2451046|NCT01063348|6011413|P1|COMPLETED|Overall Study||32
2451047|NCT01063348|6011412|P2|STARTED|Overall Study||31
2451048|NCT01063348|6011413|P1|STARTED|Overall Study||35
2451049|NCT01063283|6011423|P3|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
2451050|NCT01063283|6011424|P2|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
2451051|NCT01063283|6011425|P1|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
2451052|NCT01063283|6011423|P3|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||11
2451053|NCT01063283|6011424|P2|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||6
2451145|NCT01062399|6011659|P4|NOT COMPLETED|Overall Study||6
2451054|NCT01063283|6011425|P1|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
2451055|NCT01063283|6011423|P3|STARTED|Randomized Phase (Cycle 2 and Beyond)||11
2451056|NCT01063283|6011424|P2|STARTED|Randomized Phase (Cycle 2 and Beyond)||6
2451057|NCT01063283|6011425|P1|STARTED|Randomized Phase (Cycle 2 and Beyond)||0
2451058|NCT01063283|6011423|P3|NOT COMPLETED|Cycle 1||0
2451059|NCT01063283|6011424|P2|NOT COMPLETED|Cycle 1||0
2451060|NCT01063283|6011425|P1|NOT COMPLETED|Cycle 1||3
2451061|NCT01063283|6011423|P3|COMPLETED|Cycle 1||0
2451062|NCT01063283|6011424|P2|COMPLETED|Cycle 1||0
2451063|NCT01063283|6011425|P1|COMPLETED|Cycle 1||17
2451064|NCT01063283|6011423|P3|STARTED|Cycle 1||0
2451065|NCT01063283|6011424|P2|STARTED|Cycle 1||0
2451066|NCT01063283|6011425|P1|STARTED|Cycle 1||20
2451067|NCT01063153|6011439|P2|NOT COMPLETED|Overall Study||12
2451068|NCT01063153|6011440|P1|NOT COMPLETED|Overall Study||2
2451069|NCT01063153|6011439|P2|COMPLETED|Overall Study||26
2451070|NCT01063153|6011440|P1|COMPLETED|Overall Study||31
2451071|NCT01063153|6011439|P2|STARTED|Overall Study||38
2451072|NCT01063153|6011440|P1|STARTED|Overall Study||33
2451073|NCT01063075|6011450|P4|NOT COMPLETED|Overall Study||1
2451074|NCT01063075|6011451|P3|NOT COMPLETED|Overall Study||5
2451075|NCT01063075|6011452|P2|NOT COMPLETED|Overall Study||2
2451076|NCT01063075|6011453|P1|NOT COMPLETED|Overall Study||1
2451077|NCT01063075|6011450|P4|COMPLETED|Overall Study||14
2451078|NCT01063075|6011451|P3|COMPLETED|Overall Study||9
2451079|NCT01063075|6011452|P2|COMPLETED|Overall Study||1
2451080|NCT01063075|6011453|P1|COMPLETED|Overall Study||1
2451081|NCT01063075|6011450|P4|STARTED|Overall Study||15
2451082|NCT01063075|6011451|P3|STARTED|Overall Study||14
2451083|NCT01063075|6011452|P2|STARTED|Overall Study||3
2451084|NCT01063075|6011453|P1|STARTED|Overall Study||2
2451085|NCT01063062|6011471|P2|NOT COMPLETED|Overall Study||12
2451086|NCT01063062|6011472|P1|NOT COMPLETED|Overall Study||8
2451087|NCT01063062|6011471|P2|COMPLETED|Overall Study||65
2451088|NCT01063062|6011472|P1|COMPLETED|Overall Study||22
2451089|NCT01063062|6011471|P2|Received Study Drug|Overall Study||76
2451090|NCT01063062|6011472|P1|Received Study Drug|Overall Study||29
2451091|NCT01063062|6011471|P2|STARTED|Overall Study||77
2451092|NCT01063062|6011472|P1|STARTED|Overall Study||30
2451093|NCT01063049|6011513|P3|NOT COMPLETED|Overall Study||0
2451094|NCT01063049|6011514|P2|NOT COMPLETED|Overall Study||0
2451095|NCT01063049|6011515|P1|NOT COMPLETED|Overall Study||0
2451096|NCT01063049|6011513|P3|COMPLETED|Overall Study||200
2451097|NCT01063049|6011514|P2|COMPLETED|Overall Study||200
2451098|NCT01063049|6011515|P1|COMPLETED|Overall Study||200
2451099|NCT01063049|6011513|P3|STARTED|Overall Study||200
2451100|NCT01063049|6011514|P2|STARTED|Overall Study||200
2451101|NCT01063049|6011515|P1|STARTED|Overall Study||200
2451102|NCT01063036|6011526|P1|NOT COMPLETED|Post Dosing Follow-up Through 24 Weeks||39
2451103|NCT01063036|6011526|P1|COMPLETED|Post Dosing Follow-up Through 24 Weeks||46
2451104|NCT01063036|6011526|P1|STARTED|Post Dosing Follow-up Through 24 Weeks|2 included did not complete treatment; 3 completed treatment but not included (lost to follow-up).|85
2451105|NCT01063036|6011526|P1|NOT COMPLETED|Participants Treated With Study Drug||6
2451106|NCT01063036|6011526|P1|COMPLETED|Participants Treated With Study Drug||86
2451107|NCT01063036|6011526|P1|STARTED|Participants Treated With Study Drug||92
2451108|NCT01062971|6011542|P2|NOT COMPLETED|Overall Study||7
2451109|NCT01062971|6011543|P1|NOT COMPLETED|Overall Study||4
2451110|NCT01062971|6011542|P2|COMPLETED|Overall Study||56
2451111|NCT01062971|6011543|P1|COMPLETED|Overall Study||56
2451112|NCT01062971|6011542|P2|STARTED|Overall Study||63
2451113|NCT01062971|6011543|P1|STARTED|Overall Study||60
2451114|NCT01062893|6011553|P2|NOT COMPLETED|Overall Study||13
2451115|NCT01062893|6011554|P1|NOT COMPLETED|Overall Study||14
2451116|NCT01062893|6011553|P2|COMPLETED|Overall Study||28
2451117|NCT01062893|6011554|P1|COMPLETED|Overall Study||27
2451118|NCT01062893|6011553|P2|STARTED|Overall Study||41
2451119|NCT01062893|6011554|P1|STARTED|Overall Study||41
2451120|NCT01062841|6011582|P2|NOT COMPLETED|Overall Study||53
2451121|NCT01062841|6011583|P1|NOT COMPLETED|Overall Study||49
2451122|NCT01062841|6011582|P2|COMPLETED|Overall Study||162
2451123|NCT01062841|6011583|P1|COMPLETED|Overall Study||154
2451124|NCT01062841|6011582|P2|STARTED|Overall Study||215
2451125|NCT01062841|6011583|P1|STARTED|Overall Study||203
2451126|NCT01062763|6011613|P2|NOT COMPLETED|Overall Study||4
2451127|NCT01062763|6011614|P1|NOT COMPLETED|Overall Study||3
2451128|NCT01062763|6011613|P2|COMPLETED|Overall Study||57
2451129|NCT01062763|6011614|P1|COMPLETED|Overall Study||55
2451130|NCT01062763|6011613|P2|STARTED|Overall Study||61
2451131|NCT01062763|6011614|P1|STARTED|Overall Study|119 randomized.|58
2451132|NCT01062568|6011626|P2|NOT COMPLETED|Overall Study||0
2451133|NCT01062568|6011627|P1|NOT COMPLETED|Overall Study||0
2451134|NCT01062568|6011626|P2|COMPLETED|Overall Study||40
2451135|NCT01062568|6011627|P1|COMPLETED|Overall Study||10
2451136|NCT01062568|6011626|P2|STARTED|Overall Study||40
2451137|NCT01062568|6011627|P1|STARTED|Overall Study||10
2451138|NCT01062425|6011640|P2|NOT COMPLETED|Overall Study||6
2451139|NCT01062425|6011641|P1|NOT COMPLETED|Overall Study||3
2451140|NCT01062425|6011640|P2|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|97
2451141|NCT01062425|6011641|P1|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|52
2451142|NCT01062425|6011640|P2|STARTED|Overall Study||103
2451143|NCT01062425|6011641|P1|STARTED|Overall Study||55
2451144|NCT01062399|6011658|P5|NOT COMPLETED|Overall Study||4
2451146|NCT01062399|6011660|P3|NOT COMPLETED|Overall Study||0
2451147|NCT01062399|6011661|P2|NOT COMPLETED|Overall Study||1
2451148|NCT01062399|6011662|P1|NOT COMPLETED|Overall Study||0
2451149|NCT01062399|6011658|P5|COMPLETED|Overall Study||88
2451150|NCT01062399|6011659|P4|COMPLETED|Overall Study||83
2451151|NCT01062399|6011660|P3|COMPLETED|Overall Study||8
2451152|NCT01062399|6011661|P2|COMPLETED|Overall Study||9
2451153|NCT01062399|6011662|P1|COMPLETED|Overall Study|Subjects with data available for the primary analyses are considered to have completed the study.|8
2451154|NCT01062399|6011658|P5|STARTED|Overall Study||92
2451155|NCT01062399|6011659|P4|STARTED|Overall Study||89
2451156|NCT01062399|6011660|P3|STARTED|Overall Study||8
2451157|NCT01062399|6011661|P2|STARTED|Overall Study||10
2451158|NCT01062399|6011662|P1|STARTED|Overall Study||8
2451159|NCT01062308|6011683|P2|NOT COMPLETED|Overall Study||10
2451160|NCT01062308|6011684|P1|NOT COMPLETED|Overall Study||16
2451161|NCT01062308|6011683|P2|COMPLETED|Overall Study||72
2451162|NCT01062308|6011684|P1|COMPLETED|Overall Study||64
2451163|NCT01062308|6011683|P2|STARTED|Overall Study||82
2451164|NCT01062308|6011684|P1|STARTED|Overall Study||80
2451165|NCT01062269|6011692|P1|NOT COMPLETED|Overall Study||0
2451166|NCT01062269|6011692|P1|COMPLETED|Overall Study||42
2451167|NCT01062269|6011692|P1|STARTED|Overall Study||42
2451168|NCT01062256|6011706|P3|NOT COMPLETED|Overall Study||4
2451169|NCT01062256|6011707|P2|NOT COMPLETED|Overall Study||7
2451170|NCT01062256|6011708|P1|NOT COMPLETED|Overall Study||3
2451171|NCT01062256|6011706|P3|COMPLETED|Overall Study||103
2451172|NCT01062256|6011707|P2|COMPLETED|Overall Study||96
2451173|NCT01062256|6011708|P1|COMPLETED|Overall Study||52
2451174|NCT01062256|6011706|P3|STARTED|Overall Study||107
2451175|NCT01062256|6011707|P2|STARTED|Overall Study||103
2451176|NCT01062256|6011708|P1|STARTED|Overall Study||55
2451177|NCT01062230|6011731|P1|NOT COMPLETED|Overall Study||0
2451178|NCT01062230|6011731|P1|COMPLETED|Overall Study||6
2451179|NCT01062230|6011731|P1|STARTED|Overall Study||6
2451180|NCT01062165|6011735|P1|NOT COMPLETED|Overall Study||0
2451181|NCT01062165|6011735|P1|COMPLETED|Overall Study||18
2451182|NCT01062165|6011735|P1|STARTED|Overall Study||18
2451183|NCT01062113|6011742|P3|NOT COMPLETED|Overall Study||31
2451184|NCT01062113|6011743|P2|NOT COMPLETED|Overall Study||22
2451185|NCT01062113|6011744|P1|NOT COMPLETED|Overall Study||40
2451186|NCT01062113|6011742|P3|COMPLETED|Overall Study||27
2451187|NCT01062113|6011743|P2|COMPLETED|Overall Study||42
2451188|NCT01062113|6011744|P1|COMPLETED|Overall Study||93
2451189|NCT01062113|6011742|P3|STARTED|Overall Study||58
2451190|NCT01062113|6011743|P2|STARTED|Overall Study||64
2451191|NCT01062113|6011744|P1|STARTED|Overall Study||133
2451192|NCT01062074|6011757|P1|NOT COMPLETED|Overall Study||0
2451193|NCT01062074|6011757|P1|COMPLETED|Overall Study||3605
2451194|NCT01062074|6011757|P1|STARTED|Overall Study||3605
2451195|NCT01062061|6011762|P1|NOT COMPLETED|Overall Study||27
2451196|NCT01062061|6011762|P1|COMPLETED|Overall Study||727
2451197|NCT01062061|6011762|P1|STARTED|Overall Study||754
2451198|NCT01062009|6011780|P4|NOT COMPLETED|Overall Study||0
2451199|NCT01062009|6011781|P3|NOT COMPLETED|Overall Study||0
2451200|NCT01062009|6011782|P2|NOT COMPLETED|Overall Study||0
2451201|NCT01062009|6011783|P1|NOT COMPLETED|Overall Study||1
2451202|NCT01062009|6011780|P4|COMPLETED|Overall Study||6
2451203|NCT01062009|6011781|P3|COMPLETED|Overall Study||6
2451204|NCT01062009|6011782|P2|COMPLETED|Overall Study||6
2451205|NCT01062009|6011783|P1|COMPLETED|Overall Study||6
2451206|NCT01062009|6011780|P4|STARTED|Overall Study||6
2451207|NCT01062009|6011781|P3|STARTED|Overall Study||6
2451208|NCT01062009|6011782|P2|STARTED|Overall Study||6
2451209|NCT01062009|6011783|P1|STARTED|Overall Study||7
2451210|NCT01061866|6011801|P1|NOT COMPLETED|Overall Study||2
2451211|NCT01061866|6011801|P1|COMPLETED|Overall Study||5
2451212|NCT01061866|6011801|P1|STARTED|Overall Study||7
2451213|NCT01061775|6011805|P1|NOT COMPLETED|Overall Study||3
2451214|NCT01061775|6011805|P1|COMPLETED|Overall Study||16
2451215|NCT01061775|6011805|P1|STARTED|Overall Study||19
2451216|NCT01061736|6011822|P10|NOT COMPLETED|Overall Study||74
2451217|NCT01061736|6011823|P9|NOT COMPLETED|Overall Study||97
2451218|NCT01061736|6011824|P8|NOT COMPLETED|Overall Study||94
2451219|NCT01061736|6011825|P7|NOT COMPLETED|Overall Study||84
2451220|NCT01061736|6011826|P6|NOT COMPLETED|Overall Study||3
2451221|NCT01061736|6011827|P5|NOT COMPLETED|Overall Study||7
2451222|NCT01061736|6011828|P4|NOT COMPLETED|Overall Study||3
2451223|NCT01061736|6011829|P3|NOT COMPLETED|Overall Study||6
2451224|NCT01061736|6011830|P2|NOT COMPLETED|Overall Study||4
2451225|NCT01061736|6011831|P1|NOT COMPLETED|Overall Study||13
2451226|NCT01061736|6011822|P10|COMPLETED|Overall Study||354
2451227|NCT01061736|6011823|P9|COMPLETED|Overall Study||330
2451228|NCT01061736|6011824|P8|COMPLETED|Overall Study||336
2451229|NCT01061736|6011825|P7|COMPLETED|Overall Study||0
2451230|NCT01061736|6011826|P6|COMPLETED|Overall Study||49
2451231|NCT01061736|6011827|P5|COMPLETED|Overall Study||45
2451232|NCT01061736|6011828|P4|COMPLETED|Overall Study||48
2451233|NCT01061736|6011829|P3|COMPLETED|Overall Study||45
2451234|NCT01061736|6011830|P2|COMPLETED|Overall Study||46
2451235|NCT01061736|6011831|P1|COMPLETED|Overall Study||37
2451236|NCT01061736|6011822|P10|Rescued|Overall Study|Included both participants who completed and did not complete the study.|168
2451237|NCT01061736|6011823|P9|Rescued|Overall Study|Included both participants who completed and did not complete the study.|55
2451238|NCT01061736|6011824|P8|Rescued|Overall Study|Included both participants who completed and did not complete the study.|61
2451239|NCT01061736|6011825|P7|Rescued|Overall Study||0
2451240|NCT01061736|6011826|P6|Rescued|Overall Study||0
2451241|NCT01061736|6011827|P5|Rescued|Overall Study||0
2451242|NCT01061736|6011828|P4|Rescued|Overall Study||0
2451243|NCT01061736|6011829|P3|Rescued|Overall Study||0
2451244|NCT01061736|6011830|P2|Rescued|Overall Study||0
2451245|NCT01061736|6011831|P1|Rescued|Overall Study||0
2451246|NCT01061736|6011822|P10|Treated|Overall Study||428
2451247|NCT01061736|6011823|P9|Treated|Overall Study||426
2451248|NCT01061736|6011824|P8|Treated|Overall Study||428
2451249|NCT01061736|6011825|P7|Treated|Overall Study||84
2451250|NCT01061736|6011826|P6|Treated|Overall Study||52
2451251|NCT01061736|6011827|P5|Treated|Overall Study||51
2451252|NCT01061736|6011828|P4|Treated|Overall Study||51
2451253|NCT01061736|6011829|P3|Treated|Overall Study||51
2451254|NCT01061736|6011830|P2|Treated|Overall Study||50
2451255|NCT01061736|6011831|P1|Treated|Overall Study||50
2451256|NCT01061736|6011822|P10|STARTED|Overall Study||428
2451257|NCT01061736|6011823|P9|STARTED|Overall Study||427
2451258|NCT01061736|6011824|P8|STARTED|Overall Study||430
2451259|NCT01061736|6011825|P7|STARTED|Overall Study||84
2451260|NCT01061736|6011826|P6|STARTED|Overall Study||52
2451261|NCT01061736|6011827|P5|STARTED|Overall Study||52
2451262|NCT01061736|6011828|P4|STARTED|Overall Study||51
2451263|NCT01061736|6011829|P3|STARTED|Overall Study||51
2451264|NCT01061736|6011830|P2|STARTED|Overall Study||50
2451265|NCT01061736|6011831|P1|STARTED|Overall Study||50
2451266|NCT01061723|6011870|P6|NOT COMPLETED|Overall Study||9
2451267|NCT01061723|6011871|P5|NOT COMPLETED|Overall Study||3
2451268|NCT01061723|6011872|P4|NOT COMPLETED|Overall Study||8
2451269|NCT01061723|6011873|P3|NOT COMPLETED|Overall Study||10
2451270|NCT01061723|6011874|P2|NOT COMPLETED|Overall Study||6
2451271|NCT01061723|6011875|P1|NOT COMPLETED|Overall Study||4
2451272|NCT01061723|6011870|P6|COMPLETED|Overall Study||41
2451273|NCT01061723|6011871|P5|COMPLETED|Overall Study||47
2451274|NCT01061723|6011872|P4|COMPLETED|Overall Study||44
2451275|NCT01061723|6011873|P3|COMPLETED|Overall Study||40
2451276|NCT01061723|6011874|P2|COMPLETED|Overall Study||43
2451277|NCT01061723|6011875|P1|COMPLETED|Overall Study||46
2451278|NCT01061723|6011870|P6|Treated|Overall Study||49
2451279|NCT01061723|6011871|P5|Treated|Overall Study||50
2451280|NCT01061723|6011872|P4|Treated|Overall Study||52
2451281|NCT01061723|6011873|P3|Treated|Overall Study||50
2451282|NCT01061723|6011874|P2|Treated|Overall Study||49
2451283|NCT01061723|6011875|P1|Treated|Overall Study||50
2451284|NCT01061723|6011870|P6|STARTED|Overall Study||50
2451285|NCT01061723|6011871|P5|STARTED|Overall Study||50
2451286|NCT01061723|6011872|P4|STARTED|Overall Study||52
2451287|NCT01061723|6011873|P3|STARTED|Overall Study||50
2451288|NCT01061723|6011874|P2|STARTED|Overall Study||49
2451289|NCT01061723|6011875|P1|STARTED|Overall Study||50
2451290|NCT01061710|6011955|P1|NOT COMPLETED|Overall Study||14
2451291|NCT01061710|6011955|P1|COMPLETED|Overall Study||6
2451292|NCT01061710|6011955|P1|STARTED|Overall Study||20
2451293|NCT01061671|6011965|P2|NOT COMPLETED|Overall Study||55
2451294|NCT01061671|6011966|P1|NOT COMPLETED|Overall Study||47
2451295|NCT01061671|6011965|P2|COMPLETED|Overall Study||397
2451296|NCT01061671|6011966|P1|COMPLETED|Overall Study||386
2451297|NCT01061671|6011965|P2|STARTED|Overall Study||452
2451298|NCT01061671|6011966|P1|STARTED|Overall Study||433
2451299|NCT01061606|6011978|P1|NOT COMPLETED|Overall Study||8
2451300|NCT01061606|6011978|P1|COMPLETED|Overall Study||0
2451301|NCT01061606|6011978|P1|STARTED|Overall Study||8
2451302|NCT01061567|6011987|P1|NOT COMPLETED|Overall Study||76
2451303|NCT01061567|6011987|P1|COMPLETED|Overall Study||1738
2451304|NCT01061567|6011987|P1|STARTED|Overall Study||1814
2451305|NCT01061528|6011998|P2|NOT COMPLETED|Overall Study||2
2451306|NCT01061528|6011999|P1|NOT COMPLETED|Overall Study||3
2451307|NCT01061528|6011998|P2|COMPLETED|Overall Study||52
2451308|NCT01061528|6011999|P1|COMPLETED|Overall Study||59
2451309|NCT01061528|6011998|P2|STARTED|Overall Study||54
2451310|NCT01061528|6011999|P1|STARTED|Overall Study||62
2451311|NCT01061476|6012005|P1|NOT COMPLETED|Overall Study||0
2451312|NCT01061476|6012005|P1|COMPLETED|Overall Study||12
2451313|NCT01061476|6012005|P1|STARTED|Overall Study||12
2451314|NCT01061385|6012011|P2|NOT COMPLETED|Overall Study||1
2451315|NCT01061385|6012012|P1|NOT COMPLETED|Overall Study||1
2451316|NCT01061385|6012011|P2|COMPLETED|Overall Study||8
2451317|NCT01061385|6012012|P1|COMPLETED|Overall Study||20
2451318|NCT01061385|6012011|P2|STARTED|Overall Study||9
2451319|NCT01061385|6012012|P1|STARTED|Overall Study||21
2451320|NCT01061359|6012020|P1|NOT COMPLETED|Overall Study||1302
2451321|NCT01061359|6012020|P1|COMPLETED|Overall Study|Completed 5 years of follow-up: 668 Disease free and 2 Relapsed|670
2451322|NCT01061359|6012020|P1|STARTED|Overall Study||1972
2451323|NCT01061333|6012026|P2|NOT COMPLETED|Period 7: Mometasone||0
2451324|NCT01061333|6012027|P1|NOT COMPLETED|Period 7: Mometasone||0
2451325|NCT01061333|6012026|P2|COMPLETED|Period 7: Mometasone||7
2451326|NCT01061333|6012027|P1|COMPLETED|Period 7: Mometasone||8
2451327|NCT01061333|6012026|P2|STARTED|Period 7: Mometasone||7
2451328|NCT01061333|6012027|P1|STARTED|Period 7: Mometasone||8
2451329|NCT01061333|6012026|P2|NOT COMPLETED|Period 6: 20-day Washout||0
2451330|NCT01061333|6012027|P1|NOT COMPLETED|Period 6: 20-day Washout||0
2451331|NCT01061333|6012026|P2|COMPLETED|Period 6: 20-day Washout||7
2451332|NCT01061333|6012027|P1|COMPLETED|Period 6: 20-day Washout||8
2451333|NCT01061333|6012026|P2|STARTED|Period 6: 20-day Washout||7
2451334|NCT01061333|6012027|P1|STARTED|Period 6: 20-day Washout||8
2451335|NCT01061333|6012026|P2|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
2451336|NCT01061333|6012027|P1|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
2451337|NCT01061333|6012026|P2|COMPLETED|Period 5: Nedocromil-Montelukast X-over||7
2451338|NCT01061333|6012027|P1|COMPLETED|Period 5: Nedocromil-Montelukast X-over||8
2451339|NCT01061333|6012026|P2|STARTED|Period 5: Nedocromil-Montelukast X-over||7
2451340|NCT01061333|6012027|P1|STARTED|Period 5: Nedocromil-Montelukast X-over||8
2451341|NCT01061333|6012026|P2|NOT COMPLETED|Period 4: 20-day Washout||1
2451342|NCT01061333|6012027|P1|NOT COMPLETED|Period 4: 20-day Washout||0
2451343|NCT01061333|6012026|P2|COMPLETED|Period 4: 20-day Washout||7
2451344|NCT01061333|6012027|P1|COMPLETED|Period 4: 20-day Washout||8
2451345|NCT01061333|6012026|P2|STARTED|Period 4: 20-day Washout||8
2451346|NCT01061333|6012027|P1|STARTED|Period 4: 20-day Washout||8
2451347|NCT01061333|6012026|P2|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
2451348|NCT01061333|6012027|P1|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
2451349|NCT01061333|6012026|P2|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
2451350|NCT01061333|6012027|P1|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
2451351|NCT01061333|6012026|P2|STARTED|Period 3: Nedocromil-Montelukast X-over||8
2451352|NCT01061333|6012027|P1|STARTED|Period 3: Nedocromil-Montelukast X-over||8
2451353|NCT01061333|6012026|P2|NOT COMPLETED|Period 2: 20-day Washout||0
2451354|NCT01061333|6012027|P1|NOT COMPLETED|Period 2: 20-day Washout||0
2451355|NCT01061333|6012026|P2|COMPLETED|Period 2: 20-day Washout||8
2451356|NCT01061333|6012027|P1|COMPLETED|Period 2: 20-day Washout||8
2451357|NCT01061333|6012026|P2|STARTED|Period 2: 20-day Washout||8
2451358|NCT01061333|6012027|P1|STARTED|Period 2: 20-day Washout||8
2451359|NCT01061333|6012026|P2|NOT COMPLETED|Period 1: Placebo Run-in||0
2451360|NCT01061333|6012027|P1|NOT COMPLETED|Period 1: Placebo Run-in||0
2451361|NCT01061333|6012026|P2|COMPLETED|Period 1: Placebo Run-in||8
2451362|NCT01061333|6012027|P1|COMPLETED|Period 1: Placebo Run-in||8
2451363|NCT01061333|6012026|P2|STARTED|Period 1: Placebo Run-in||8
2451364|NCT01061333|6012027|P1|STARTED|Period 1: Placebo Run-in||8
2451365|NCT01061177|6012065|P1|NOT COMPLETED|Overall Study||208
2451366|NCT01061177|6012065|P1|COMPLETED|Overall Study||881
2451367|NCT01061177|6012065|P1|ITT_CyR (Ph+ Patients Only)|Overall Study||983
2451368|NCT01061177|6012065|P1|ITT_MR (b2a2 &/or b3a2 +ve Pts Only)|Overall Study||1056
2451369|NCT01061177|6012065|P1|STARTED|Overall Study||1089
2451370|NCT01061151|6012088|P4|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||20
2451371|NCT01061151|6012089|P3|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||77
2451372|NCT01061151|6012090|P2|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||138
2451373|NCT01061151|6012091|P1|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||152
2451374|NCT01061151|6012088|P4|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||55
2451375|NCT01061151|6012089|P3|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||345
2451376|NCT01061151|6012090|P2|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||548
2451377|NCT01061151|6012091|P1|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||542
2451378|NCT01061151|6012088|P4|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||75
2451379|NCT01061151|6012089|P3|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||421
2451380|NCT01061151|6012090|P2|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||684
2451381|NCT01061151|6012091|P1|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||694
2451382|NCT01061151|6012088|P4|STARTED|Protocol Version 3.0: 10/2012-10/2014||75
2451383|NCT01061151|6012089|P3|STARTED|Protocol Version 3.0: 10/2012-10/2014||422
2451384|NCT01061151|6012090|P2|STARTED|Protocol Version 3.0: 10/2012-10/2014||686
2451385|NCT01061151|6012091|P1|STARTED|Protocol Version 3.0: 10/2012-10/2014||694
2451386|NCT01061151|6012088|P4|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||28
2451387|NCT01061151|6012089|P3|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||9
2451388|NCT01061151|6012090|P2|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||241
2451389|NCT01061151|6012091|P1|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||232
2451390|NCT01061151|6012088|P4|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||101
2451391|NCT01061151|6012089|P3|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||16
2451392|NCT01061151|6012090|P2|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||620
2451393|NCT01061151|6012091|P1|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||623
2451394|NCT01061151|6012088|P4|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||129
2451395|NCT01061151|6012089|P3|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||24
2451396|NCT01061151|6012090|P2|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||861
2451397|NCT01061151|6012091|P1|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||853
2451398|NCT01061151|6012088|P4|STARTED|Protocol Version 2.0: 04/2011-09/2012||129
2451399|NCT01061151|6012089|P3|STARTED|Protocol Version 2.0: 04/2011-09/2012||25
2451400|NCT01061151|6012090|P2|STARTED|Protocol Version 2.0: 04/2011-09/2012||861
2451401|NCT01061151|6012091|P1|STARTED|Protocol Version 2.0: 04/2011-09/2012||855
2451402|NCT01061034|6012143|P1|NOT COMPLETED|Aspirin Plus Omeprazole||0
2451403|NCT01061034|6012143|P1|COMPLETED|Aspirin Plus Omeprazole||9
2451404|NCT01061034|6012143|P1|STARTED|Aspirin Plus Omeprazole||9
2451405|NCT01061034|6012143|P1|NOT COMPLETED|Aspirin||0
2451406|NCT01061034|6012143|P1|COMPLETED|Aspirin||9
2451407|NCT01061034|6012143|P1|STARTED|Aspirin||9
2451408|NCT01061008|6012150|P2|NOT COMPLETED|Overall Study||6
2451409|NCT01061008|6012151|P1|NOT COMPLETED|Overall Study||6
2451410|NCT01061008|6012150|P2|COMPLETED|Overall Study||9
2451411|NCT01061008|6012151|P1|COMPLETED|Overall Study||10
2451412|NCT01061008|6012150|P2|STARTED|Overall Study||15
2451413|NCT01061008|6012151|P1|STARTED|Overall Study||16
2451414|NCT01060670|6012159|P2|NOT COMPLETED|Follow up Phase||35
2451415|NCT01060670|6012160|P1|NOT COMPLETED|Follow up Phase||22
2451416|NCT01060670|6012159|P2|COMPLETED|Follow up Phase||82
2451417|NCT01060670|6012160|P1|COMPLETED|Follow up Phase||106
2451418|NCT01060670|6012159|P2|Withdrew From Follow up Phase|Follow up Phase||35
2451419|NCT01060670|6012160|P1|Withdrew From Follow up Phase|Follow up Phase||22
2451420|NCT01060670|6012159|P2|Recurrence|Follow up Phase||9
2451421|NCT01060670|6012160|P1|Recurrence|Follow up Phase||14
2451422|NCT01060670|6012159|P2|STARTED|Follow up Phase||117
2451423|NCT01060670|6012160|P1|STARTED|Follow up Phase||128
2451424|NCT01060670|6012159|P2|NOT COMPLETED|Treatment Phase||36
2451425|NCT01060670|6012160|P1|NOT COMPLETED|Treatment Phase||26
2451426|NCT01060670|6012159|P2|COMPLETED|Treatment Phase||117
2451427|NCT01060670|6012160|P1|COMPLETED|Treatment Phase||128
2451428|NCT01060670|6012159|P2|Withdrew From Treatment|Treatment Phase||36
2451429|NCT01060670|6012160|P1|Withdrew From Treatment|Treatment Phase||26
2451430|NCT01060670|6012159|P2|Did Not Heal by Treatment Visit 17|Treatment Phase||68
2451431|NCT01060670|6012160|P1|Did Not Heal by Treatment Visit 17|Treatment Phase||49
2451432|NCT01060670|6012159|P2|Healed at End of Treatment Phase|Treatment Phase||49
2451433|NCT01060670|6012160|P1|Healed at End of Treatment Phase|Treatment Phase||79
2451434|NCT01060670|6012159|P2|STARTED|Treatment Phase||153
2451435|NCT01060670|6012160|P1|STARTED|Treatment Phase||154
2451436|NCT01060670|6012159|P2|NOT COMPLETED|Run In||238
2451437|NCT01060670|6012160|P1|NOT COMPLETED|Run In||0
2451438|NCT01060670|6012159|P2|COMPLETED|Run In||307
2451439|NCT01060670|6012160|P1|COMPLETED|Run In||0
2451440|NCT01060670|6012159|P2|STARTED|Run In||545
2451441|NCT01060670|6012160|P1|STARTED|Run In||0
2451442|NCT01060592|6012180|P2|NOT COMPLETED|12m||18
2451443|NCT01060592|6012181|P1|NOT COMPLETED|12m||0
2451444|NCT01060592|6012180|P2|COMPLETED|12m|Historic data was not available at 12m for 18 of the historic controls|31
2451445|NCT01060592|6012181|P1|COMPLETED|12m||35
2451446|NCT01060592|6012180|P2|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|49
2451447|NCT01060592|6012181|P1|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|35
2451448|NCT01060592|6012180|P2|NOT COMPLETED|4-6w||10
2451449|NCT01060592|6012181|P1|NOT COMPLETED|4-6w||12
2451450|NCT01060592|6012180|P2|COMPLETED|4-6w||39
2451451|NCT01060592|6012181|P1|COMPLETED|4-6w||23
2451452|NCT01060592|6012180|P2|STARTED|4-6w||49
2451453|NCT01060592|6012181|P1|STARTED|4-6w||35
2451454|NCT01060553|6012195|P2|NOT COMPLETED|Overall Study||10
2451455|NCT01060553|6012196|P1|NOT COMPLETED|Overall Study||9
2451456|NCT01060553|6012195|P2|COMPLETED|Overall Study||5
2451457|NCT01060553|6012196|P1|COMPLETED|Overall Study|5 subjects completed more than half the sessions and midpoint outcome measures were obtained|6
2451458|NCT01060553|6012195|P2|STARTED|Overall Study||15
2451459|NCT01060553|6012196|P1|STARTED|Overall Study||15
2451460|NCT01060540|6012203|P2|NOT COMPLETED|Overall Study||65
2451461|NCT01060540|6012204|P1|NOT COMPLETED|Overall Study||64
2451462|NCT01060540|6012203|P2|COMPLETED|Overall Study||233
2451463|NCT01060540|6012204|P1|COMPLETED|Overall Study||239
2451464|NCT01060540|6012203|P2|STARTED|Overall Study||298
2451465|NCT01060540|6012204|P1|STARTED|Overall Study||303
2451466|NCT01060384|6012218|P5|NOT COMPLETED|Overall Study||2
2451467|NCT01060384|6012219|P4|NOT COMPLETED|Overall Study||0
2451468|NCT01060384|6012220|P3|NOT COMPLETED|Overall Study||0
2451469|NCT01060384|6012221|P2|NOT COMPLETED|Overall Study||1
2451470|NCT01060384|6012222|P1|NOT COMPLETED|Overall Study||0
2451471|NCT01060384|6012218|P5|COMPLETED|Overall Study||34
2451472|NCT01060384|6012219|P4|COMPLETED|Overall Study||0
2451473|NCT01060384|6012220|P3|COMPLETED|Overall Study||0
2451474|NCT01060384|6012221|P2|COMPLETED|Overall Study||3
2451475|NCT01060384|6012222|P1|COMPLETED|Overall Study||6
2451476|NCT01060384|6012218|P5|STARTED|Overall Study||36
2451477|NCT01060384|6012219|P4|STARTED|Overall Study||0
2451478|NCT01060384|6012220|P3|STARTED|Overall Study||0
2451479|NCT01060384|6012221|P2|STARTED|Overall Study||4
2451480|NCT01060384|6012222|P1|STARTED|Overall Study||6
2451481|NCT01060150|6012231|P1|NOT COMPLETED|Overall Study||23
2451482|NCT01060150|6012231|P1|COMPLETED|Overall Study||92
2451483|NCT01060150|6012231|P1|Treated|Overall Study||113
2451484|NCT01060150|6012231|P1|STARTED|Overall Study||115
2451485|NCT01060124|6012246|P1|NOT COMPLETED|Overall Study||37
2451486|NCT01060124|6012246|P1|COMPLETED|Overall Study||66
2451487|NCT01060124|6012246|P1|STARTED|Overall Study||103
2451488|NCT01060111|6012257|P3|NOT COMPLETED|Overall Study||35
2451489|NCT01060111|6012258|P2|NOT COMPLETED|Overall Study||23
2451490|NCT01060111|6012259|P1|NOT COMPLETED|Overall Study||27
2451491|NCT01060111|6012257|P3|COMPLETED|Overall Study||45
2451492|NCT01060111|6012258|P2|COMPLETED|Overall Study||61
2451493|NCT01060111|6012259|P1|COMPLETED|Overall Study||54
2451494|NCT01060111|6012257|P3|Treated|Overall Study||79
2451495|NCT01060111|6012258|P2|Treated|Overall Study||83
2451496|NCT01060111|6012259|P1|Treated|Overall Study||81
2451497|NCT01060111|6012257|P3|STARTED|Overall Study||80
2451498|NCT01060111|6012258|P2|STARTED|Overall Study||84
2451499|NCT01060111|6012259|P1|STARTED|Overall Study||81
2451500|NCT01060098|6012279|P3|NOT COMPLETED|Overall Study||0
2451501|NCT01060098|6012280|P2|NOT COMPLETED|Overall Study||0
2451502|NCT01060098|6012281|P1|NOT COMPLETED|Overall Study||0
2451503|NCT01060098|6012279|P3|COMPLETED|Overall Study||8
2451504|NCT01060098|6012280|P2|COMPLETED|Overall Study||15
2451505|NCT01060098|6012281|P1|COMPLETED|Overall Study||25
2451506|NCT01060098|6012279|P3|STARTED|Overall Study||8
2451507|NCT01060098|6012280|P2|STARTED|Overall Study||15
2451508|NCT01060098|6012281|P1|STARTED|Overall Study||25
2451509|NCT01060072|6012291|P2|NOT COMPLETED|Overall Study||5
2451510|NCT01060072|6012292|P1|NOT COMPLETED|Overall Study||2
2451511|NCT01060072|6012291|P2|COMPLETED|Overall Study||196
2451512|NCT01060072|6012292|P1|COMPLETED|Overall Study||204
2451513|NCT01060072|6012291|P2|STARTED|Overall Study||201
2451514|NCT01060072|6012292|P1|STARTED|Overall Study||206
2451515|NCT01060059|6012308|P2|NOT COMPLETED|Overall Study||67
2451516|NCT01060059|6012309|P1|NOT COMPLETED|Overall Study||67
2451517|NCT01060059|6012308|P2|COMPLETED|Overall Study||371
2451518|NCT01060059|6012309|P1|COMPLETED|Overall Study||377
2451519|NCT01060059|6012308|P2|STARTED|Overall Study||438
2451520|NCT01060059|6012309|P1|STARTED|Overall Study||444
2451521|NCT01060020|6012359|P1|NOT COMPLETED|Overall Study||0
2451522|NCT01060020|6012359|P1|COMPLETED|Overall Study||20
2451523|NCT01060020|6012359|P1|STARTED|Overall Study||20
2451524|NCT01060007|6012367|P1|NOT COMPLETED|Overall Study||4
2451525|NCT01060007|6012367|P1|COMPLETED|Overall Study||76
2451526|NCT01060007|6012367|P1|STARTED|Overall Study||80
2451527|NCT01059994|6012385|P4|NOT COMPLETED|Overall Study||1
2451528|NCT01059994|6012386|P3|NOT COMPLETED|Overall Study||0
2451529|NCT01059994|6012387|P2|NOT COMPLETED|Overall Study||0
2451530|NCT01059994|6012388|P1|NOT COMPLETED|Overall Study||0
2451531|NCT01059994|6012385|P4|COMPLETED|Overall Study||3
2451532|NCT01059994|6012386|P3|COMPLETED|Overall Study||3
2451533|NCT01059994|6012387|P2|COMPLETED|Overall Study||2
2451534|NCT01059994|6012388|P1|COMPLETED|Overall Study||3
2451535|NCT01059994|6012385|P4|STARTED|Overall Study||4
2451536|NCT01059994|6012386|P3|STARTED|Overall Study||3
2451537|NCT01059994|6012387|P2|STARTED|Overall Study||2
2451538|NCT01059994|6012388|P1|STARTED|Overall Study||3
2451539|NCT01059929|6012404|P2|NOT COMPLETED|Overall Study||0
2451540|NCT01059929|6012405|P1|NOT COMPLETED|Overall Study||0
2451541|NCT01059929|6012404|P2|COMPLETED|Overall Study||21
2451542|NCT01059929|6012405|P1|COMPLETED|Overall Study||20
2451543|NCT01059929|6012404|P2|STARTED|Overall Study||21
2451544|NCT01059929|6012405|P1|STARTED|Overall Study||20
2451545|NCT01059903|6012435|P2|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
2451546|NCT01059903|6012436|P1|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
2451547|NCT01059903|6012435|P2|COMPLETED|Period 3: Second Intervention- 24 Hours||24
2451548|NCT01059903|6012436|P1|COMPLETED|Period 3: Second Intervention- 24 Hours||24
2451549|NCT01059903|6012435|P2|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Two subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|22
2451550|NCT01059903|6012436|P1|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Six subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|18
2451551|NCT01059903|6012435|P2|STARTED|Period 3: Second Intervention- 24 Hours||24
2451552|NCT01059903|6012436|P1|STARTED|Period 3: Second Intervention- 24 Hours||24
2451553|NCT01059903|6012435|P2|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
2451554|NCT01059903|6012436|P1|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
2451555|NCT01059903|6012435|P2|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
2451556|NCT01059903|6012436|P1|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
2451557|NCT01059903|6012435|P2|STARTED|Period 2: Washout Period (>= 5 Days)||24
2451558|NCT01059903|6012436|P1|STARTED|Period 2: Washout Period (>= 5 Days)||24
2451559|NCT01059903|6012435|P2|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
2451560|NCT01059903|6012436|P1|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
2451561|NCT01059903|6012435|P2|COMPLETED|Period 1: First Intervention- 24 Hours||24
2451562|NCT01059903|6012436|P1|COMPLETED|Period 1: First Intervention- 24 Hours||24
2451563|NCT01059903|6012435|P2|STARTED|Period 1: First Intervention- 24 Hours||25
2451564|NCT01059903|6012436|P1|STARTED|Period 1: First Intervention- 24 Hours||25
2451565|NCT01059877|6012472|P2|NOT COMPLETED|Overall Study||2
2451566|NCT01059877|6012473|P1|NOT COMPLETED|Overall Study||0
2451567|NCT01059877|6012472|P2|COMPLETED|Overall Study||3
2451568|NCT01059877|6012473|P1|COMPLETED|Overall Study||6
2451569|NCT01059877|6012472|P2|STARTED|Overall Study||5
2451570|NCT01059877|6012473|P1|STARTED|Overall Study||6
2451571|NCT01059864|6012479|P3|NOT COMPLETED|Double-Blind Treatment Phase||3
2451572|NCT01059864|6012480|P2|NOT COMPLETED|Double-Blind Treatment Phase||3
2451573|NCT01059864|6012481|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
2451574|NCT01059864|6012479|P3|COMPLETED|Double-Blind Treatment Phase||45
2451575|NCT01059864|6012480|P2|COMPLETED|Double-Blind Treatment Phase||47
2451576|NCT01059864|6012481|P1|COMPLETED|Double-Blind Treatment Phase||0
2451577|NCT01059864|6012479|P3|Treated|Double-Blind Treatment Phase||47
2451578|NCT01059864|6012480|P2|Treated|Double-Blind Treatment Phase||50
2451579|NCT01059864|6012481|P1|Treated|Double-Blind Treatment Phase||0
2451580|NCT01059864|6012479|P3|STARTED|Double-Blind Treatment Phase||48
2451581|NCT01059864|6012480|P2|STARTED|Double-Blind Treatment Phase||50
2451582|NCT01059864|6012481|P1|STARTED|Double-Blind Treatment Phase||0
2451583|NCT01059864|6012479|P3|NOT COMPLETED|Open-Label Run-In Phase||0
2451584|NCT01059864|6012480|P2|NOT COMPLETED|Open-Label Run-In Phase||0
2451585|NCT01059864|6012481|P1|NOT COMPLETED|Open-Label Run-In Phase||13
2451586|NCT01059864|6012479|P3|COMPLETED|Open-Label Run-In Phase||0
2451587|NCT01059864|6012480|P2|COMPLETED|Open-Label Run-In Phase||0
2451588|NCT01059864|6012481|P1|COMPLETED|Open-Label Run-In Phase||98
2451589|NCT01059864|6012479|P3|STARTED|Open-Label Run-In Phase||0
2451590|NCT01059864|6012480|P2|STARTED|Open-Label Run-In Phase||0
2451591|NCT01059864|6012481|P1|STARTED|Open-Label Run-In Phase||111
2451592|NCT01059851|6012530|P6|NOT COMPLETED|Overall Study||0
2451593|NCT01059851|6012531|P5|NOT COMPLETED|Overall Study||0
2451594|NCT01059851|6012532|P4|NOT COMPLETED|Overall Study||0
2451595|NCT01059851|6012533|P3|NOT COMPLETED|Overall Study||0
2451596|NCT01059851|6012534|P2|NOT COMPLETED|Overall Study||0
2451597|NCT01059851|6012535|P1|NOT COMPLETED|Overall Study||0
2451598|NCT01059851|6012530|P6|COMPLETED|Overall Study||0
2451599|NCT01059851|6012531|P5|COMPLETED|Overall Study||0
2451600|NCT01059851|6012532|P4|COMPLETED|Overall Study||0
2451601|NCT01059851|6012533|P3|COMPLETED|Overall Study||0
2451602|NCT01059851|6012534|P2|COMPLETED|Overall Study||8
2451603|NCT01059851|6012535|P1|COMPLETED|Overall Study||8
2451604|NCT01059851|6012530|P6|STARTED|Overall Study||0
2451605|NCT01059851|6012531|P5|STARTED|Overall Study||0
2451606|NCT01059851|6012532|P4|STARTED|Overall Study||0
2451607|NCT01059851|6012533|P3|STARTED|Overall Study||0
2451608|NCT01059851|6012534|P2|STARTED|Overall Study||8
2451609|NCT01059851|6012535|P1|STARTED|Overall Study||8
2451610|NCT01059825|6012555|P7|NOT COMPLETED|Treatment Period||0
2451611|NCT01059825|6012556|P6|NOT COMPLETED|Treatment Period||3
2451612|NCT01059825|6012557|P5|NOT COMPLETED|Treatment Period||8
2451613|NCT01059825|6012558|P4|NOT COMPLETED|Treatment Period||11
2451614|NCT01059825|6012559|P3|NOT COMPLETED|Treatment Period||6
2451615|NCT01059825|6012560|P2|NOT COMPLETED|Treatment Period||4
2451616|NCT01059825|6012561|P1|NOT COMPLETED|Treatment Period||10
2451617|NCT01059825|6012555|P7|COMPLETED|Treatment Period||0
2451618|NCT01059825|6012556|P6|COMPLETED|Treatment Period||52
2451619|NCT01059825|6012557|P5|COMPLETED|Treatment Period||47
2451620|NCT01059825|6012558|P4|COMPLETED|Treatment Period||44
2451621|NCT01059825|6012559|P3|COMPLETED|Treatment Period||49
2451622|NCT01059825|6012560|P2|COMPLETED|Treatment Period||50
2451623|NCT01059825|6012561|P1|COMPLETED|Treatment Period||44
2451624|NCT01059825|6012555|P7|STARTED|Treatment Period|Participants who completed run-in were randomized to 1 of 6 treatment groups.|0
2451625|NCT01059825|6012556|P6|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
2451626|NCT01059825|6012557|P5|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
2451627|NCT01059825|6012558|P4|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
2451628|NCT01059825|6012559|P3|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
2451629|NCT01059825|6012560|P2|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
2451630|NCT01059825|6012561|P1|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
2451631|NCT01059825|6012555|P7|NOT COMPLETED|Enrolled, Run-in Period||47
2451632|NCT01059825|6012556|P6|NOT COMPLETED|Enrolled, Run-in Period||0
2451633|NCT01059825|6012557|P5|NOT COMPLETED|Enrolled, Run-in Period||0
2451634|NCT01059825|6012558|P4|NOT COMPLETED|Enrolled, Run-in Period||0
2451635|NCT01059825|6012559|P3|NOT COMPLETED|Enrolled, Run-in Period||0
2451636|NCT01059825|6012560|P2|NOT COMPLETED|Enrolled, Run-in Period||0
2451637|NCT01059825|6012561|P1|NOT COMPLETED|Enrolled, Run-in Period||0
2451638|NCT01059825|6012555|P7|COMPLETED|Enrolled, Run-in Period||328
2451639|NCT01059825|6012556|P6|COMPLETED|Enrolled, Run-in Period||0
2451640|NCT01059825|6012557|P5|COMPLETED|Enrolled, Run-in Period||0
2451641|NCT01059825|6012558|P4|COMPLETED|Enrolled, Run-in Period||0
2451642|NCT01059825|6012559|P3|COMPLETED|Enrolled, Run-in Period||0
2451643|NCT01059825|6012560|P2|COMPLETED|Enrolled, Run-in Period||0
2451644|NCT01059825|6012561|P1|COMPLETED|Enrolled, Run-in Period||0
2451645|NCT01059825|6012555|P7|STARTED|Enrolled, Run-in Period||375
2451646|NCT01059825|6012556|P6|STARTED|Enrolled, Run-in Period||0
2451647|NCT01059825|6012557|P5|STARTED|Enrolled, Run-in Period||0
2451648|NCT01059825|6012558|P4|STARTED|Enrolled, Run-in Period||0
2451649|NCT01059825|6012559|P3|STARTED|Enrolled, Run-in Period||0
2451650|NCT01059825|6012560|P2|STARTED|Enrolled, Run-in Period||0
2451651|NCT01059825|6012561|P1|STARTED|Enrolled, Run-in Period||0
2451652|NCT01059812|6012748|P2|NOT COMPLETED|Overall Study||16
2451653|NCT01059812|6012749|P1|NOT COMPLETED|Overall Study||37
2451654|NCT01059812|6012748|P2|COMPLETED|Overall Study||126
2451655|NCT01059812|6012749|P1|COMPLETED|Overall Study||245
2451656|NCT01059812|6012748|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|141
2451657|NCT01059812|6012749|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|279
2451658|NCT01059812|6012748|P2|STARTED|Overall Study||142
2451659|NCT01059812|6012749|P1|STARTED|Overall Study||282
2451660|NCT01059799|6012765|P2|NOT COMPLETED|Overall Study||10
2451661|NCT01059799|6012766|P1|NOT COMPLETED|Overall Study||31
2451662|NCT01059799|6012765|P2|COMPLETED|Overall Study||136
2451663|NCT01059799|6012766|P1|COMPLETED|Overall Study||258
2451664|NCT01059799|6012765|P2|Exposed|Overall Study||146
2451665|NCT01059799|6012766|P1|Exposed|Overall Study|Five subjects withdrew before exposure to trial drug|284
2451666|NCT01059799|6012765|P2|STARTED|Overall Study||146
2451667|NCT01059799|6012766|P1|STARTED|Overall Study||289
2451668|NCT01059773|6012780|P2|NOT COMPLETED|Overall Study||24
2451669|NCT01059773|6012781|P1|NOT COMPLETED|Overall Study||20
2451670|NCT01059773|6012780|P2|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|221
2451759|NCT01059435|6013246|P8|STARTED|Overall Study||4
2451671|NCT01059773|6012781|P1|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|224
2451672|NCT01059773|6012780|P2|STARTED|Overall Study||245
2451673|NCT01059773|6012781|P1|STARTED|Overall Study||244
2451674|NCT01059760|6012813|P2|NOT COMPLETED|Overall Study||0
2451675|NCT01059760|6012814|P1|NOT COMPLETED|Overall Study||0
2451676|NCT01059760|6012813|P2|COMPLETED|Overall Study||14
2451677|NCT01059760|6012814|P1|COMPLETED|Overall Study||16
2451678|NCT01059760|6012813|P2|STARTED|Overall Study||14
2451679|NCT01059760|6012814|P1|STARTED|Overall Study||16
2451680|NCT01059643|6012920|P1|NOT COMPLETED|Overall Study||6
2451681|NCT01059643|6012920|P1|COMPLETED|Overall Study||97
2451682|NCT01059643|6012920|P1|Received at Least 1 Dose of Study Drug|Overall Study||103
2451683|NCT01059643|6012920|P1|STARTED|Overall Study||103
2451684|NCT01059630|6012935|P2|NOT COMPLETED|Overall Study||103
2451685|NCT01059630|6012936|P1|NOT COMPLETED|Overall Study||127
2451686|NCT01059630|6012935|P2|COMPLETED|Overall Study||101
2451687|NCT01059630|6012936|P1|COMPLETED|Overall Study||82
2451688|NCT01059630|6012935|P2|STARTED|Overall Study||204
2451689|NCT01059630|6012936|P1|STARTED|Overall Study||209
2451690|NCT01059617|6013010|P4|NOT COMPLETED|Overall Study||6
2451691|NCT01059617|6013011|P3|NOT COMPLETED|Overall Study||8
2451692|NCT01059617|6013012|P2|NOT COMPLETED|Overall Study||1
2451693|NCT01059617|6013013|P1|NOT COMPLETED|Overall Study||7
2451694|NCT01059617|6013010|P4|COMPLETED|Overall Study||27
2451695|NCT01059617|6013011|P3|COMPLETED|Overall Study||25
2451696|NCT01059617|6013012|P2|COMPLETED|Overall Study||33
2451697|NCT01059617|6013013|P1|COMPLETED|Overall Study||26
2451698|NCT01059617|6013010|P4|STARTED|Overall Study||33
2451699|NCT01059617|6013011|P3|STARTED|Overall Study||33
2451700|NCT01059617|6013012|P2|STARTED|Overall Study||34
2451701|NCT01059617|6013013|P1|STARTED|Overall Study||33
2451702|NCT01059565|6013183|P2|NOT COMPLETED|24-Week Open-Label Phase||3
2451703|NCT01059565|6013184|P1|NOT COMPLETED|24-Week Open-Label Phase||5
2451704|NCT01059565|6013183|P2|COMPLETED|24-Week Open-Label Phase||42
2451705|NCT01059565|6013184|P1|COMPLETED|24-Week Open-Label Phase||34
2451706|NCT01059565|6013183|P2|STARTED|24-Week Open-Label Phase||45
2451707|NCT01059565|6013184|P1|STARTED|24-Week Open-Label Phase||39
2451708|NCT01059565|6013183|P2|NOT COMPLETED|24-Week Randomized Phase||7
2451709|NCT01059565|6013184|P1|NOT COMPLETED|24-Week Randomized Phase||10
2451710|NCT01059565|6013183|P2|COMPLETED|24-Week Randomized Phase||45
2451711|NCT01059565|6013184|P1|COMPLETED|24-Week Randomized Phase||39
2451712|NCT01059565|6013183|P2|Randomized and Treated|24-Week Randomized Phase||52
2451713|NCT01059565|6013184|P1|Randomized and Treated|24-Week Randomized Phase||48
2451714|NCT01059565|6013183|P2|STARTED|24-Week Randomized Phase||52
2451715|NCT01059565|6013184|P1|STARTED|24-Week Randomized Phase||49
2451716|NCT01059539|6013218|P1|NOT COMPLETED|Overall Study||271
2451717|NCT01059539|6013218|P1|COMPLETED|Overall Study||132
2451718|NCT01059539|6013218|P1|STARTED|Overall Study||403
2451719|NCT01059526|6013225|P2|NOT COMPLETED|Overall Study||22
2451720|NCT01059526|6013226|P1|NOT COMPLETED|Overall Study||30
2451721|NCT01059526|6013225|P2|COMPLETED|Overall Study||18
2451722|NCT01059526|6013226|P1|COMPLETED|Overall Study||11
2451723|NCT01059526|6013225|P2|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|23
2451724|NCT01059526|6013226|P1|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|21
2451725|NCT01059526|6013225|P2|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|40
2451726|NCT01059526|6013226|P1|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|41
2451727|NCT01059435|6013244|P10|NOT COMPLETED|Overall Study||0
2451728|NCT01059435|6013245|P9|NOT COMPLETED|Overall Study||0
2451729|NCT01059435|6013246|P8|NOT COMPLETED|Overall Study||0
2451730|NCT01059435|6013247|P7|NOT COMPLETED|Overall Study||0
2451731|NCT01059435|6013248|P6|NOT COMPLETED|Overall Study||0
2451732|NCT01059435|6013249|P5|NOT COMPLETED|Overall Study||0
2451733|NCT01059435|6013250|P4|NOT COMPLETED|Overall Study||0
2451734|NCT01059435|6013251|P3|NOT COMPLETED|Overall Study||2
2451735|NCT01059435|6013252|P2|NOT COMPLETED|Overall Study||0
2451736|NCT01059435|6013253|P1|NOT COMPLETED|Overall Study||0
2451737|NCT01059435|6013244|P10|COMPLETED|Overall Study||6
2451738|NCT01059435|6013245|P9|COMPLETED|Overall Study||6
2451739|NCT01059435|6013246|P8|COMPLETED|Overall Study||4
2451740|NCT01059435|6013247|P7|COMPLETED|Overall Study||6
2451741|NCT01059435|6013248|P6|COMPLETED|Overall Study||9
2451742|NCT01059435|6013249|P5|COMPLETED|Overall Study||6
2451743|NCT01059435|6013250|P4|COMPLETED|Overall Study||9
2451744|NCT01059435|6013251|P3|COMPLETED|Overall Study||6
2451745|NCT01059435|6013252|P2|COMPLETED|Overall Study||6
2451746|NCT01059435|6013253|P1|COMPLETED|Overall Study||14
2451747|NCT01059435|6013244|P10|Received Study Drug|Overall Study||6
2451748|NCT01059435|6013245|P9|Received Study Drug|Overall Study||6
2451749|NCT01059435|6013246|P8|Received Study Drug|Overall Study||4
2451750|NCT01059435|6013247|P7|Received Study Drug|Overall Study||6
2451751|NCT01059435|6013248|P6|Received Study Drug|Overall Study||9
2451752|NCT01059435|6013249|P5|Received Study Drug|Overall Study||6
2451753|NCT01059435|6013250|P4|Received Study Drug|Overall Study||9
2451754|NCT01059435|6013251|P3|Received Study Drug|Overall Study||6
2451755|NCT01059435|6013252|P2|Received Study Drug|Overall Study||6
2451756|NCT01059435|6013253|P1|Received Study Drug|Overall Study||14
2451757|NCT01059435|6013244|P10|STARTED|Overall Study||6
2451758|NCT01059435|6013245|P9|STARTED|Overall Study||6
2451760|NCT01059435|6013247|P7|STARTED|Overall Study||6
2451761|NCT01059435|6013248|P6|STARTED|Overall Study||9
2451762|NCT01059435|6013249|P5|STARTED|Overall Study||6
2451763|NCT01059435|6013250|P4|STARTED|Overall Study||9
2451764|NCT01059435|6013251|P3|STARTED|Overall Study||8
2451765|NCT01059435|6013252|P2|STARTED|Overall Study||6
2451766|NCT01059435|6013253|P1|STARTED|Overall Study||14
2451767|NCT01059357|6013561|P1|NOT COMPLETED|Overall Study||4
2451768|NCT01059357|6013561|P1|COMPLETED|Overall Study||54
2451769|NCT01059357|6013561|P1|STARTED|Overall Study||58
2451770|NCT01059344|6013572|P2|NOT COMPLETED|Overall Study||46
2451771|NCT01059344|6013573|P1|NOT COMPLETED|Overall Study||22
2451772|NCT01059344|6013572|P2|COMPLETED|Overall Study||95
2451773|NCT01059344|6013573|P1|COMPLETED|Overall Study||118
2451774|NCT01059344|6013572|P2|STARTED|Overall Study||141
2451775|NCT01059344|6013573|P1|STARTED|Overall Study||140
2451776|NCT01059305|6013591|P1|NOT COMPLETED|Overall Study||0
2451777|NCT01059305|6013591|P1|COMPLETED|Overall Study||10
2451778|NCT01059305|6013591|P1|STARTED|Overall Study||10
2451779|NCT01059175|6013597|P2|NOT COMPLETED|Overall Study||20
2451780|NCT01059175|6013598|P1|NOT COMPLETED|Overall Study||21
2451781|NCT01059175|6013597|P2|COMPLETED|Overall Study|17 patients deceased 3 patients were prematurely exited|21
2451782|NCT01059175|6013598|P1|COMPLETED|Overall Study|17 patients deceased 4 additional patients were prematurely exited|22
2451783|NCT01059175|6013597|P2|STARTED|Overall Study||41
2451784|NCT01059175|6013598|P1|STARTED|Overall Study||43
2451785|NCT01059071|6013620|P4|NOT COMPLETED|Overall Study||6
2451786|NCT01059071|6013621|P3|NOT COMPLETED|Overall Study||2
2451787|NCT01059071|6013622|P2|NOT COMPLETED|Overall Study||4
2451788|NCT01059071|6013623|P1|NOT COMPLETED|Overall Study||2
2451789|NCT01059071|6013620|P4|COMPLETED|Overall Study||3
2451790|NCT01059071|6013621|P3|COMPLETED|Overall Study||1
2451791|NCT01059071|6013622|P2|COMPLETED|Overall Study||1
2451792|NCT01059071|6013623|P1|COMPLETED|Overall Study||2
2451793|NCT01059071|6013620|P4|STARTED|Overall Study||9
2451794|NCT01059071|6013621|P3|STARTED|Overall Study||3
2451795|NCT01059071|6013622|P2|STARTED|Overall Study||5
2451796|NCT01059071|6013623|P1|STARTED|Overall Study||4
2451797|NCT01058993|6013635|P1|NOT COMPLETED|Overall Study||0
2451798|NCT01058993|6013635|P1|COMPLETED|Overall Study||6
2451799|NCT01058993|6013635|P1|STARTED|Overall Study||6
2451800|NCT01058941|6013641|P2|NOT COMPLETED|Overall Study||11
2451801|NCT01058941|6013642|P1|NOT COMPLETED|Overall Study||9
2451802|NCT01058941|6013641|P2|COMPLETED|Overall Study||22
2451803|NCT01058941|6013642|P1|COMPLETED|Overall Study||25
2451804|NCT01058941|6013641|P2|STARTED|Overall Study||33
2451805|NCT01058941|6013642|P1|STARTED|Overall Study||34
2451806|NCT01058863|6013650|P1|NOT COMPLETED|Overall Study||4
2451807|NCT01058863|6013650|P1|COMPLETED|Overall Study||68
2451808|NCT01058863|6013650|P1|Treated With Placebo Inhaler|Overall Study||69
2451809|NCT01058863|6013650|P1|Treated With ProAir® HFA 180 mcg|Overall Study||68
2451810|NCT01058863|6013650|P1|Treated With ProAir® HFA 90 mcg|Overall Study||70
2451811|NCT01058863|6013650|P1|Treated With Albuterol Spiromax® 180 mcg|Overall Study||68
2451812|NCT01058863|6013650|P1|Treated With Albuterol Spiromax® 90 mcg|Overall Study||68
2451813|NCT01058863|6013650|P1|Safety and ITT Populations|Overall Study|One patient was randomized in error and never received the study drug.|71
2451814|NCT01058863|6013650|P1|STARTED|Overall Study||72
2451815|NCT01058668|6013671|P3|NOT COMPLETED|Safety Follow-up||7
2451816|NCT01058668|6013672|P2|NOT COMPLETED|Safety Follow-up||0
2451817|NCT01058668|6013673|P1|NOT COMPLETED|Safety Follow-up||5
2451818|NCT01058668|6013671|P3|COMPLETED|Safety Follow-up||141
2451819|NCT01058668|6013672|P2|COMPLETED|Safety Follow-up||146
2451820|NCT01058668|6013673|P1|COMPLETED|Safety Follow-up||139
2451821|NCT01058668|6013671|P3|STARTED|Safety Follow-up||148
2451822|NCT01058668|6013672|P2|STARTED|Safety Follow-up||146
2451823|NCT01058668|6013673|P1|STARTED|Safety Follow-up|Not all participants entered the Safety-Follow-up|144
2451824|NCT01058668|6013671|P3|NOT COMPLETED|Double-blind Treatment Phase||50
2451825|NCT01058668|6013672|P2|NOT COMPLETED|Double-blind Treatment Phase||38
2451826|NCT01058668|6013673|P1|NOT COMPLETED|Double-blind Treatment Phase||39
2451827|NCT01058668|6013671|P3|COMPLETED|Double-blind Treatment Phase||119
2451828|NCT01058668|6013672|P2|COMPLETED|Double-blind Treatment Phase||129
2451829|NCT01058668|6013673|P1|COMPLETED|Double-blind Treatment Phase||122
2451830|NCT01058668|6013671|P3|STARTED|Double-blind Treatment Phase||169
2451831|NCT01058668|6013672|P2|STARTED|Double-blind Treatment Phase||167
2451832|NCT01058668|6013673|P1|STARTED|Double-blind Treatment Phase||161
2451833|NCT01058655|6013688|P4|NOT COMPLETED|Overall Study||42
2451834|NCT01058655|6013689|P3|NOT COMPLETED|Overall Study||8
2451835|NCT01058655|6013690|P2|NOT COMPLETED|Overall Study||3
2451836|NCT01058655|6013691|P1|NOT COMPLETED|Overall Study||3
2451837|NCT01058655|6013688|P4|COMPLETED|Overall Study||0
2451838|NCT01058655|6013689|P3|COMPLETED|Overall Study||0
2451839|NCT01058655|6013690|P2|COMPLETED|Overall Study||0
2451840|NCT01058655|6013691|P1|COMPLETED|Overall Study||0
2451841|NCT01058655|6013688|P4|Evaluable|Overall Study||40
2451842|NCT01058655|6013689|P3|Evaluable|Overall Study||6
2451843|NCT01058655|6013690|P2|Evaluable|Overall Study||3
2451844|NCT01058655|6013691|P1|Evaluable|Overall Study||3
2451845|NCT01058655|6013688|P4|STARTED|Overall Study||42
2451846|NCT01058655|6013689|P3|STARTED|Overall Study||8
2451847|NCT01058655|6013690|P2|STARTED|Overall Study||3
2451848|NCT01058655|6013691|P1|STARTED|Overall Study||3
2451849|NCT01058642|6013709|P4|NOT COMPLETED|Treatment Period 2||0
2451850|NCT01058642|6013710|P3|NOT COMPLETED|Treatment Period 2||0
2451851|NCT01058642|6013711|P2|NOT COMPLETED|Treatment Period 2||0
2451852|NCT01058642|6013712|P1|NOT COMPLETED|Treatment Period 2||0
2451853|NCT01058642|6013709|P4|COMPLETED|Treatment Period 2||7
2451854|NCT01058642|6013710|P3|COMPLETED|Treatment Period 2||9
2451855|NCT01058642|6013711|P2|COMPLETED|Treatment Period 2||11
2451856|NCT01058642|6013712|P1|COMPLETED|Treatment Period 2||7
2451857|NCT01058642|6013709|P4|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
2451858|NCT01058642|6013710|P3|Received at Least 1 Dose of Study Drug|Treatment Period 2||9
2451859|NCT01058642|6013711|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||11
2451860|NCT01058642|6013712|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
2451861|NCT01058642|6013709|P4|STARTED|Treatment Period 2||7
2451862|NCT01058642|6013710|P3|STARTED|Treatment Period 2||9
2451863|NCT01058642|6013711|P2|STARTED|Treatment Period 2||11
2451864|NCT01058642|6013712|P1|STARTED|Treatment Period 2||7
2451865|NCT01058642|6013709|P4|NOT COMPLETED|Washout Period||0
2451866|NCT01058642|6013710|P3|NOT COMPLETED|Washout Period||0
2451867|NCT01058642|6013711|P2|NOT COMPLETED|Washout Period||0
2451868|NCT01058642|6013712|P1|NOT COMPLETED|Washout Period||0
2451869|NCT01058642|6013709|P4|COMPLETED|Washout Period||7
2451870|NCT01058642|6013710|P3|COMPLETED|Washout Period||9
2451871|NCT01058642|6013711|P2|COMPLETED|Washout Period||11
2451872|NCT01058642|6013712|P1|COMPLETED|Washout Period||7
2451873|NCT01058642|6013709|P4|STARTED|Washout Period||7
2451874|NCT01058642|6013710|P3|STARTED|Washout Period||9
2451875|NCT01058642|6013711|P2|STARTED|Washout Period||11
2451876|NCT01058642|6013712|P1|STARTED|Washout Period||7
2451877|NCT01058642|6013709|P4|NOT COMPLETED|Treatment Period 1||2
2451878|NCT01058642|6013710|P3|NOT COMPLETED|Treatment Period 1||2
2451879|NCT01058642|6013711|P2|NOT COMPLETED|Treatment Period 1||1
2451880|NCT01058642|6013712|P1|NOT COMPLETED|Treatment Period 1||2
2451881|NCT01058642|6013709|P4|COMPLETED|Treatment Period 1||7
2451882|NCT01058642|6013710|P3|COMPLETED|Treatment Period 1||9
2451883|NCT01058642|6013711|P2|COMPLETED|Treatment Period 1||11
2451884|NCT01058642|6013712|P1|COMPLETED|Treatment Period 1||7
2451885|NCT01058642|6013709|P4|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
2451886|NCT01058642|6013710|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1||11
2451887|NCT01058642|6013711|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||12
2451888|NCT01058642|6013712|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
2451889|NCT01058642|6013709|P4|STARTED|Treatment Period 1||9
2451890|NCT01058642|6013710|P3|STARTED|Treatment Period 1||11
2451891|NCT01058642|6013711|P2|STARTED|Treatment Period 1||12
2451892|NCT01058642|6013712|P1|STARTED|Treatment Period 1||9
2451893|NCT01058421|6013722|P2|NOT COMPLETED|6 Month Outcomes||26
2451894|NCT01058421|6013723|P1|NOT COMPLETED|6 Month Outcomes||19
2451895|NCT01058421|6013722|P2|COMPLETED|6 Month Outcomes||24
2451896|NCT01058421|6013723|P1|COMPLETED|6 Month Outcomes||27
2451897|NCT01058421|6013722|P2|STARTED|6 Month Outcomes|61 (subjects started Period 1) minus 11 (deceased subjects in Periods 1 & 2) = 50 started Period 3.|50
2451898|NCT01058421|6013723|P1|STARTED|6 Month Outcomes|55 (subjects started Period 1) minus 13 (deceased subjects in Periods 1 & 2) = 46 started Period 3.|46
2451899|NCT01058421|6013722|P2|NOT COMPLETED|3 Month Outcomes||26
2451900|NCT01058421|6013723|P1|NOT COMPLETED|3 Month Outcomes||20
2451901|NCT01058421|6013722|P2|COMPLETED|3 Month Outcomes||29
2451902|NCT01058421|6013723|P1|COMPLETED|3 Month Outcomes||29
2451903|NCT01058421|6013722|P2|STARTED|3 Month Outcomes|61 (Subjects started Period 1) minus 6 (deceased subjects during Period 1) = 55 started Period 2.|55
2451904|NCT01058421|6013723|P1|STARTED|3 Month Outcomes|59 (Subjects started Period 1) minus 10 (deceased subjects during Period 1) = 49 started Period 2.|49
2451905|NCT01058421|6013722|P2|NOT COMPLETED|1 Month Outcomes||42
2451906|NCT01058421|6013723|P1|NOT COMPLETED|1 Month Outcomes||39
2451907|NCT01058421|6013722|P2|COMPLETED|1 Month Outcomes||19
2451908|NCT01058421|6013723|P1|COMPLETED|1 Month Outcomes||20
2451909|NCT01058421|6013722|P2|STARTED|1 Month Outcomes||61
2451910|NCT01058421|6013723|P1|STARTED|1 Month Outcomes||59
2451911|NCT01058395|6013747|P2|NOT COMPLETED|Overall Study||1
2451912|NCT01058395|6013748|P1|NOT COMPLETED|Overall Study||3
2451913|NCT01058395|6013747|P2|COMPLETED|Overall Study|One died after enrollment. The patient died in the first 48 hours.|7
2451914|NCT01058395|6013748|P1|COMPLETED|Overall Study|Two died, and one was lost to followup.|4
2451915|NCT01058395|6013747|P2|STARTED|Overall Study||8
2451916|NCT01058395|6013748|P1|STARTED|Overall Study||7
2451917|NCT01058356|6013757|P1|NOT COMPLETED|Overall Study||42
2451918|NCT01058356|6013757|P1|COMPLETED|Overall Study||172
2451919|NCT01058356|6013757|P1|STARTED|Overall Study||214
2451920|NCT01058304|6013764|P2|NOT COMPLETED|Overall Study||33
2451921|NCT01058304|6013765|P1|NOT COMPLETED|Overall Study||27
2451922|NCT01058304|6013764|P2|COMPLETED|Overall Study||128
2451923|NCT01058304|6013765|P1|COMPLETED|Overall Study||132
2451924|NCT01058304|6013764|P2|STARTED|Overall Study||161
2451925|NCT01058304|6013765|P1|STARTED|Overall Study||159
2451926|NCT01058265|6013775|P2|NOT COMPLETED|Overall Study||12
2451927|NCT01058265|6013776|P1|NOT COMPLETED|Overall Study||11
2451928|NCT01058265|6013775|P2|COMPLETED|Overall Study||13
2451929|NCT01058265|6013776|P1|COMPLETED|Overall Study||11
2451930|NCT01058265|6013775|P2|STARTED|Overall Study||25
2451931|NCT01058265|6013776|P1|STARTED|Overall Study||22
2451932|NCT01058239|6013784|P1|NOT COMPLETED|Overall Study||0
2451933|NCT01058239|6013784|P1|COMPLETED|Overall Study||7
2451934|NCT01058239|6013784|P1|STARTED|Overall Study||7
2451935|NCT01058096|6013795|P2|NOT COMPLETED|Safety Follow-up||4
2451936|NCT01058096|6013796|P1|NOT COMPLETED|Safety Follow-up||4
2451937|NCT01058096|6013795|P2|COMPLETED|Safety Follow-up||130
2451938|NCT01058096|6013796|P1|COMPLETED|Safety Follow-up||129
2451939|NCT01058096|6013795|P2|STARTED|Safety Follow-up||134
2451940|NCT01058096|6013796|P1|STARTED|Safety Follow-up|Not all participants continued to Safety Follow-up.|133
2451941|NCT01058096|6013795|P2|NOT COMPLETED|Double-blind Treatment Phase||50
2451942|NCT01058096|6013796|P1|NOT COMPLETED|Double-blind Treatment Phase||48
2451943|NCT01058096|6013795|P2|COMPLETED|Double-blind Treatment Phase||108
2451944|NCT01058096|6013796|P1|COMPLETED|Double-blind Treatment Phase||106
2451945|NCT01058096|6013795|P2|STARTED|Double-blind Treatment Phase||158
2451946|NCT01058096|6013796|P1|STARTED|Double-blind Treatment Phase||154
2451947|NCT01058070|6013804|P1|NOT COMPLETED|Overall Study||11
2451948|NCT01058070|6013804|P1|COMPLETED|Overall Study||33
2451949|NCT01058070|6013804|P1|STARTED|Overall Study||44
2451950|NCT01058005|6013812|P3|NOT COMPLETED|Overall Study||20
2451951|NCT01058005|6013813|P2|NOT COMPLETED|Overall Study||25
2451952|NCT01058005|6013814|P1|NOT COMPLETED|Overall Study||38
2451953|NCT01058005|6013812|P3|COMPLETED|Overall Study||1
2451954|NCT01058005|6013813|P2|COMPLETED|Overall Study||0
2451955|NCT01058005|6013814|P1|COMPLETED|Overall Study||0
2451956|NCT01058005|6013812|P3|Dosed With Study Treatment|Overall Study||17
2451957|NCT01058005|6013813|P2|Dosed With Study Treatment|Overall Study||22
2451958|NCT01058005|6013814|P1|Dosed With Study Treatment|Overall Study||36
2451959|NCT01058005|6013812|P3|STARTED|Overall Study||21
2451960|NCT01058005|6013813|P2|STARTED|Overall Study||25
2451961|NCT01058005|6013814|P1|STARTED|Overall Study||38
2451962|NCT01057901|6013824|P2|NOT COMPLETED|Overall Study||246
2451963|NCT01057901|6013825|P1|NOT COMPLETED|Overall Study||260
2451964|NCT01057901|6013824|P2|COMPLETED|Overall Study||126
2451965|NCT01057901|6013825|P1|COMPLETED|Overall Study||116
2451966|NCT01057901|6013824|P2|STARTED|Overall Study||372
2451967|NCT01057901|6013825|P1|STARTED|Overall Study||376
2451968|NCT01057888|6013836|P3|NOT COMPLETED|Overall Study||0
2451969|NCT01057888|6013837|P2|NOT COMPLETED|Overall Study||0
2451970|NCT01057888|6013838|P1|NOT COMPLETED|Overall Study||0
2451971|NCT01057888|6013836|P3|COMPLETED|Overall Study||2494
2451972|NCT01057888|6013837|P2|COMPLETED|Overall Study||2406
2451973|NCT01057888|6013838|P1|COMPLETED|Overall Study||2504
2451974|NCT01057888|6013836|P3|STARTED|Overall Study||2494
2451975|NCT01057888|6013837|P2|STARTED|Overall Study||2406
2451976|NCT01057888|6013838|P1|STARTED|Overall Study||2504
2451977|NCT01057862|6013849|P2|NOT COMPLETED|Overall Study||2
2451978|NCT01057862|6013850|P1|NOT COMPLETED|Overall Study||1
2451979|NCT01057862|6013849|P2|COMPLETED|Overall Study||2
2451980|NCT01057862|6013850|P1|COMPLETED|Overall Study||4
2451981|NCT01057862|6013849|P2|STARTED|Overall Study||4
2451982|NCT01057862|6013850|P1|STARTED|Overall Study||5
2451983|NCT01057810|6013860|P2|NOT COMPLETED|Overall Study||398
2451984|NCT01057810|6013861|P1|NOT COMPLETED|Overall Study||198
2451985|NCT01057810|6013860|P2|COMPLETED|Overall Study||1
2451986|NCT01057810|6013861|P1|COMPLETED|Overall Study||1
2451987|NCT01057810|6013860|P2|STARTED|Overall Study||399
2451988|NCT01057810|6013861|P1|STARTED|Overall Study||199
2451989|NCT01057693|6013877|P3|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||36
2451990|NCT01057693|6013878|P2|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||22
2451991|NCT01057693|6013879|P1|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
2451992|NCT01057693|6013877|P3|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||113
2451993|NCT01057693|6013878|P2|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||125
2451994|NCT01057693|6013879|P1|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
2451995|NCT01057693|6013877|P3|Treated|Double-Blind Phase (Week 7 to Week 19)||147
2451996|NCT01057693|6013878|P2|Treated|Double-Blind Phase (Week 7 to Week 19)||147
2451997|NCT01057693|6013879|P1|Treated|Double-Blind Phase (Week 7 to Week 19)||0
2451998|NCT01057693|6013877|P3|STARTED|Double-Blind Phase (Week 7 to Week 19)||149
2451999|NCT01057693|6013878|P2|STARTED|Double-Blind Phase (Week 7 to Week 19)||147
2452000|NCT01057693|6013879|P1|STARTED|Double-Blind Phase (Week 7 to Week 19)||0
2452001|NCT01057693|6013877|P3|NOT COMPLETED|Between Single-Blind and Double-Blind||0
2452002|NCT01057693|6013878|P2|NOT COMPLETED|Between Single-Blind and Double-Blind||0
2452003|NCT01057693|6013879|P1|NOT COMPLETED|Between Single-Blind and Double-Blind||270
2452004|NCT01057693|6013877|P3|COMPLETED|Between Single-Blind and Double-Blind||0
2452005|NCT01057693|6013878|P2|COMPLETED|Between Single-Blind and Double-Blind||0
2452006|NCT01057693|6013879|P1|COMPLETED|Between Single-Blind and Double-Blind||296
2452007|NCT01057693|6013877|P3|STARTED|Between Single-Blind and Double-Blind||0
2452008|NCT01057693|6013878|P2|STARTED|Between Single-Blind and Double-Blind||0
2452009|NCT01057693|6013879|P1|STARTED|Between Single-Blind and Double-Blind||566
2452010|NCT01057693|6013877|P3|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
2452011|NCT01057693|6013878|P2|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
2452012|NCT01057693|6013879|P1|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||99
2452013|NCT01057693|6013877|P3|COMPLETED|Single-Blind Phase (Up to Week 6)||0
2452014|NCT01057693|6013878|P2|COMPLETED|Single-Blind Phase (Up to Week 6)||0
2452015|NCT01057693|6013879|P1|COMPLETED|Single-Blind Phase (Up to Week 6)||566
2452016|NCT01057693|6013877|P3|STARTED|Single-Blind Phase (Up to Week 6)||0
2452017|NCT01057693|6013878|P2|STARTED|Single-Blind Phase (Up to Week 6)||0
2452018|NCT01057693|6013879|P1|STARTED|Single-Blind Phase (Up to Week 6)||665
2452019|NCT01057589|6013925|P1|NOT COMPLETED|Overall Study||66
2452020|NCT01057589|6013925|P1|COMPLETED|Overall Study||0
2452021|NCT01057589|6013925|P1|STARTED|Overall Study||66
2452022|NCT01057433|6013934|P1|NOT COMPLETED|Overall Study||1
2452023|NCT01057433|6013934|P1|COMPLETED|Overall Study||23
2452024|NCT01057433|6013934|P1|STARTED|Overall Study||24
2452025|NCT01057394|6013938|P2|NOT COMPLETED|Overall Study||2
2452026|NCT01057394|6013939|P1|NOT COMPLETED|Overall Study||0
2452027|NCT01057394|6013938|P2|COMPLETED|Overall Study|19 treated participants|19
2452028|NCT01057394|6013939|P1|COMPLETED|Overall Study||0
2452029|NCT01057394|6013938|P2|STARTED|Overall Study|21 enrolled participants|21
2452030|NCT01057394|6013939|P1|STARTED|Overall Study||0
2452034|NCT01057251|6013949|P2|NOT COMPLETED|Overall Study||29
2452035|NCT01057251|6013950|P1|NOT COMPLETED|Overall Study||28
2452036|NCT01057251|6013949|P2|COMPLETED|Overall Study||114
2452037|NCT01057251|6013950|P1|COMPLETED|Overall Study||262
2452038|NCT01057251|6013949|P2|STARTED|Overall Study|The safety population is 142, as one patient was randomized, but never received study drug.|143
2452039|NCT01057251|6013950|P1|STARTED|Overall Study||290
2452040|NCT01057225|6013958|P6|NOT COMPLETED|Overall Study||0
2452041|NCT01057225|6013959|P5|NOT COMPLETED|Overall Study||0
2452042|NCT01057225|6013960|P4|NOT COMPLETED|Overall Study||0
2452043|NCT01057225|6013961|P3|NOT COMPLETED|Overall Study||0
2452044|NCT01057225|6013962|P2|NOT COMPLETED|Overall Study||0
2452045|NCT01057225|6013963|P1|NOT COMPLETED|Overall Study||0
2452046|NCT01057225|6013958|P6|COMPLETED|Overall Study||23
2452047|NCT01057225|6013959|P5|COMPLETED|Overall Study||22
2452048|NCT01057225|6013960|P4|COMPLETED|Overall Study||7
2452049|NCT01057225|6013961|P3|COMPLETED|Overall Study||6
2452050|NCT01057225|6013962|P2|COMPLETED|Overall Study||3
2452051|NCT01057225|6013963|P1|COMPLETED|Overall Study||3
2452052|NCT01057225|6013958|P6|STARTED|Overall Study||23
2452053|NCT01057225|6013959|P5|STARTED|Overall Study||22
2452054|NCT01057225|6013960|P4|STARTED|Overall Study||7
2452055|NCT01057225|6013961|P3|STARTED|Overall Study||6
2452056|NCT01057225|6013962|P2|STARTED|Overall Study||3
2452057|NCT01057225|6013963|P1|STARTED|Overall Study||3
2452058|NCT01057121|6013985|P5|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
2452059|NCT01057121|6013986|P4|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
2452060|NCT01057121|6013987|P3|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
2452061|NCT01057121|6013988|P2|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
2452062|NCT01057121|6013989|P1|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
2452063|NCT01057121|6013985|P5|COMPLETED|Phase II: 25 mg/Day Lenalidomide||23
2452064|NCT01057121|6013986|P4|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
2452065|NCT01057121|6013987|P3|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
2452066|NCT01057121|6013988|P2|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
2452067|NCT01057121|6013989|P1|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
2452068|NCT01057121|6013985|P5|STARTED|Phase II: 25 mg/Day Lenalidomide||23
2452069|NCT01057121|6013986|P4|STARTED|Phase II: 25 mg/Day Lenalidomide||0
2452070|NCT01057121|6013987|P3|STARTED|Phase II: 25 mg/Day Lenalidomide||0
2452071|NCT01057121|6013988|P2|STARTED|Phase II: 25 mg/Day Lenalidomide||0
2452072|NCT01057121|6013989|P1|STARTED|Phase II: 25 mg/Day Lenalidomide||0
2452073|NCT01057121|6013985|P5|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
2452074|NCT01057121|6013986|P4|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
2452075|NCT01057121|6013987|P3|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
2452076|NCT01057121|6013988|P2|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
2452077|NCT01057121|6013989|P1|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
2452078|NCT01057121|6013985|P5|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
2452079|NCT01057121|6013986|P4|COMPLETED|Phase I: 25 mg/Day Lenalidomide||6
2452080|NCT01057121|6013987|P3|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
2452081|NCT01057121|6013988|P2|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
2452082|NCT01057121|6013989|P1|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
2452083|NCT01057121|6013985|P5|STARTED|Phase I: 25 mg/Day Lenalidomide||0
2452084|NCT01057121|6013986|P4|STARTED|Phase I: 25 mg/Day Lenalidomide||6
2452085|NCT01057121|6013987|P3|STARTED|Phase I: 25 mg/Day Lenalidomide||0
2452086|NCT01057121|6013988|P2|STARTED|Phase I: 25 mg/Day Lenalidomide||0
2452087|NCT01057121|6013989|P1|STARTED|Phase I: 25 mg/Day Lenalidomide||0
2452088|NCT01057121|6013985|P5|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
2452089|NCT01057121|6013986|P4|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
2452090|NCT01057121|6013987|P3|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
2452091|NCT01057121|6013988|P2|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
2452092|NCT01057121|6013989|P1|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
2452093|NCT01057121|6013985|P5|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
2452094|NCT01057121|6013986|P4|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
2452095|NCT01057121|6013987|P3|COMPLETED|Phase I: 20 mg/Day Lenalidomide||3
2452096|NCT01057121|6013988|P2|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
2452097|NCT01057121|6013989|P1|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
2452098|NCT01057121|6013985|P5|STARTED|Phase I: 20 mg/Day Lenalidomide||0
2452099|NCT01057121|6013986|P4|STARTED|Phase I: 20 mg/Day Lenalidomide||0
2452100|NCT01057121|6013987|P3|STARTED|Phase I: 20 mg/Day Lenalidomide||3
2452101|NCT01057121|6013988|P2|STARTED|Phase I: 20 mg/Day Lenalidomide||0
2452102|NCT01057121|6013989|P1|STARTED|Phase I: 20 mg/Day Lenalidomide||0
2452103|NCT01057121|6013985|P5|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
2452104|NCT01057121|6013986|P4|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
2452105|NCT01057121|6013987|P3|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
2452106|NCT01057121|6013988|P2|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
2452107|NCT01057121|6013989|P1|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
2452108|NCT01057121|6013985|P5|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
2452109|NCT01057121|6013986|P4|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
2452110|NCT01057121|6013987|P3|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
2452111|NCT01057121|6013988|P2|COMPLETED|Phase I: 15 mg/Day Lenolidomide||3
2452112|NCT01057121|6013989|P1|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
2452113|NCT01057121|6013985|P5|STARTED|Phase I: 15 mg/Day Lenolidomide||0
2452114|NCT01057121|6013986|P4|STARTED|Phase I: 15 mg/Day Lenolidomide||0
2452115|NCT01057121|6013987|P3|STARTED|Phase I: 15 mg/Day Lenolidomide||0
2452116|NCT01057121|6013988|P2|STARTED|Phase I: 15 mg/Day Lenolidomide||3
2452117|NCT01057121|6013989|P1|STARTED|Phase I: 15 mg/Day Lenolidomide||0
2452118|NCT01057121|6013985|P5|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
2452119|NCT01057121|6013986|P4|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
2452120|NCT01057121|6013987|P3|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
2452121|NCT01057121|6013988|P2|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
2452122|NCT01057121|6013989|P1|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
2452123|NCT01057121|6013985|P5|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
2452124|NCT01057121|6013986|P4|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
2452125|NCT01057121|6013987|P3|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
2452126|NCT01057121|6013988|P2|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
2452127|NCT01057121|6013989|P1|COMPLETED|Phase I: 10 mg/Day Lenalidomide||3
2452128|NCT01057121|6013985|P5|STARTED|Phase I: 10 mg/Day Lenalidomide||0
2452129|NCT01057121|6013986|P4|STARTED|Phase I: 10 mg/Day Lenalidomide||0
2452130|NCT01057121|6013987|P3|STARTED|Phase I: 10 mg/Day Lenalidomide||0
2452131|NCT01057121|6013988|P2|STARTED|Phase I: 10 mg/Day Lenalidomide||0
2452132|NCT01057121|6013989|P1|STARTED|Phase I: 10 mg/Day Lenalidomide||3
2452136|NCT01056913|6014022|P1|NOT COMPLETED|Overall Study||0
2452137|NCT01056913|6014022|P1|COMPLETED|Overall Study||62
2452138|NCT01056913|6014022|P1|STARTED|Overall Study||62
2452139|NCT01056822|6014028|P2|NOT COMPLETED|Overall Study||7
2452140|NCT01056822|6014029|P1|NOT COMPLETED|Overall Study||8
2452141|NCT01056822|6014028|P2|COMPLETED|Overall Study||35
2452142|NCT01056822|6014029|P1|COMPLETED|Overall Study||39
2452143|NCT01056822|6014028|P2|Safety (SAF) Population: NO|Overall Study||2
2452144|NCT01056822|6014029|P1|Safety (SAF) Population: NO|Overall Study||1
2452145|NCT01056822|6014028|P2|Safety (SAF) Population: YES|Overall Study||40
2452146|NCT01056822|6014029|P1|Safety (SAF) Population: YES|Overall Study||46
2452147|NCT01056822|6014028|P2|Per-protocol (PP) Population: NO|Overall Study||17
2452148|NCT01056822|6014029|P1|Per-protocol (PP) Population: NO|Overall Study||18
2452149|NCT01056822|6014028|P2|Per-protocol (PP) Population: YES|Overall Study||25
2452150|NCT01056822|6014029|P1|Per-protocol (PP) Population: YES|Overall Study||29
2452151|NCT01056822|6014028|P2|Intention-to-treat (ITT) Population: NO|Overall Study||4
2452152|NCT01056822|6014029|P1|Intention-to-treat (ITT) Population: NO|Overall Study||4
2452153|NCT01056822|6014028|P2|Intention-to-treat (ITT) Population: YES|Overall Study||38
2452154|NCT01056822|6014029|P1|Intention-to-treat (ITT) Population: YES|Overall Study||43
2452155|NCT01056822|6014028|P2|STARTED|Overall Study||42
2452156|NCT01056822|6014029|P1|STARTED|Overall Study||47
2452157|NCT01056718|6014078|P1|NOT COMPLETED|Overall Study||3
2452158|NCT01056718|6014078|P1|COMPLETED|Overall Study||50
2452159|NCT01056718|6014078|P1|STARTED|Overall Study||53
2452160|NCT01056653|6014111|P3|NOT COMPLETED|Overall Study||2
2452161|NCT01056653|6014112|P2|NOT COMPLETED|Overall Study||0
2452162|NCT01056653|6014113|P1|NOT COMPLETED|Overall Study||0
2452163|NCT01056653|6014111|P3|COMPLETED|Overall Study|2 were lost to follow-up because one mother left the country and one father was too busy.|42
2452164|NCT01056653|6014112|P2|COMPLETED|Overall Study||23
2452165|NCT01056653|6014113|P1|COMPLETED|Overall Study||46
2452166|NCT01056653|6014111|P3|STARTED|Overall Study||44
2452167|NCT01056653|6014112|P2|STARTED|Overall Study||23
2452168|NCT01056653|6014113|P1|STARTED|Overall Study||46
2452169|NCT01056640|6014129|P2|NOT COMPLETED|Overall Study||12
2452170|NCT01056640|6014130|P1|NOT COMPLETED|Overall Study||26
2452171|NCT01056640|6014129|P2|COMPLETED|Overall Study||91
2452172|NCT01056640|6014130|P1|COMPLETED|Overall Study||76
2452173|NCT01056640|6014129|P2|STARTED|Overall Study||103
2452174|NCT01056640|6014130|P1|STARTED|Overall Study||102
2452175|NCT01056601|6014136|P1|NOT COMPLETED|Overall Study||0
2452176|NCT01056601|6014136|P1|COMPLETED|Overall Study||7
2452177|NCT01056601|6014136|P1|STARTED|Overall Study||7
2452178|NCT01056523|6014142|P7|NOT COMPLETED|Overall Study||1
2452179|NCT01056523|6014143|P6|NOT COMPLETED|Overall Study||0
2452180|NCT01056523|6014144|P5|NOT COMPLETED|Overall Study||0
2452181|NCT01056523|6014145|P4|NOT COMPLETED|Overall Study||3
2452182|NCT01056523|6014146|P3|NOT COMPLETED|Overall Study||2
2452183|NCT01056523|6014147|P2|NOT COMPLETED|Overall Study||0
2452184|NCT01056523|6014148|P1|NOT COMPLETED|Overall Study||1
2452185|NCT01056523|6014142|P7|COMPLETED|Overall Study||4
2452186|NCT01056523|6014143|P6|COMPLETED|Overall Study||3
2452187|NCT01056523|6014144|P5|COMPLETED|Overall Study||3
2452188|NCT01056523|6014145|P4|COMPLETED|Overall Study||3
2452189|NCT01056523|6014146|P3|COMPLETED|Overall Study||3
2452190|NCT01056523|6014147|P2|COMPLETED|Overall Study||3
2452191|NCT01056523|6014148|P1|COMPLETED|Overall Study||3
2452192|NCT01056523|6014142|P7|STARTED|Overall Study||5
2452193|NCT01056523|6014143|P6|STARTED|Overall Study||3
2452194|NCT01056523|6014144|P5|STARTED|Overall Study||3
2452195|NCT01056523|6014145|P4|STARTED|Overall Study||6
2452196|NCT01056523|6014146|P3|STARTED|Overall Study||5
2452197|NCT01056523|6014147|P2|STARTED|Overall Study||3
2452198|NCT01056523|6014148|P1|STARTED|Overall Study||4
2452199|NCT01056510|6014158|P2|NOT COMPLETED|Overall Study||64
2452200|NCT01056510|6014159|P1|NOT COMPLETED|Overall Study||54
2452201|NCT01056510|6014158|P2|COMPLETED|Overall Study||115
2452202|NCT01056510|6014159|P1|COMPLETED|Overall Study||124
2452203|NCT01056510|6014158|P2|STARTED|Overall Study||179
2452204|NCT01056510|6014159|P1|STARTED|Overall Study||178
2452205|NCT01056484|6014205|P2|NOT COMPLETED|Follow up - Non-randomized||2
2452206|NCT01056484|6014206|P1|NOT COMPLETED|Follow up - Non-randomized||0
2452207|NCT01056484|6014205|P2|COMPLETED|Follow up - Non-randomized||56
2452208|NCT01056484|6014206|P1|COMPLETED|Follow up - Non-randomized||57
2452209|NCT01056484|6014205|P2|STARTED|Follow up - Non-randomized|Out of the enrolled control subjects (N=59), 58 completed Period 1 and entered into Period 2.|58
2452210|NCT01056484|6014206|P1|STARTED|Follow up - Non-randomized|Out of the enrolled experimental subjects (N=64), 57 completed Period 1 and entered into Period 2.|57
2452211|NCT01056484|6014205|P2|NOT COMPLETED|Randomized Controlled Trial||1
2452212|NCT01056484|6014206|P1|NOT COMPLETED|Randomized Controlled Trial||7
2452213|NCT01056484|6014205|P2|COMPLETED|Randomized Controlled Trial||58
2452214|NCT01056484|6014206|P1|COMPLETED|Randomized Controlled Trial||57
2452215|NCT01056484|6014205|P2|STARTED|Randomized Controlled Trial||59
2452216|NCT01056484|6014206|P1|STARTED|Randomized Controlled Trial||64
2452217|NCT01056380|6014222|P2|NOT COMPLETED|Overall Study||3
2452218|NCT01056380|6014223|P1|NOT COMPLETED|Overall Study||2
2452219|NCT01056380|6014222|P2|COMPLETED|Overall Study||39
2452220|NCT01056380|6014223|P1|COMPLETED|Overall Study||35
2452221|NCT01056380|6014222|P2|STARTED|Overall Study||42
2452222|NCT01056380|6014223|P1|STARTED|Overall Study||37
2452223|NCT01056341|6014250|P5|NOT COMPLETED|Overall Study||14
2452224|NCT01056341|6014251|P4|NOT COMPLETED|Overall Study||36
2452225|NCT01056341|6014252|P3|NOT COMPLETED|Overall Study||15
2452226|NCT01056341|6014253|P2|NOT COMPLETED|Overall Study||36
2452227|NCT01056341|6014254|P1|NOT COMPLETED|Overall Study||36
2452228|NCT01056341|6014250|P5|COMPLETED|Overall Study||88
2452229|NCT01056341|6014251|P4|COMPLETED|Overall Study||65
2452230|NCT01056341|6014252|P3|COMPLETED|Overall Study||88
2452231|NCT01056341|6014253|P2|COMPLETED|Overall Study||63
2452232|NCT01056341|6014254|P1|COMPLETED|Overall Study||19
2452233|NCT01056341|6014250|P5|Interim Analysis|Overall Study||43
2452234|NCT01056341|6014251|P4|Interim Analysis|Overall Study||40
2452235|NCT01056341|6014252|P3|Interim Analysis|Overall Study||41
2452236|NCT01056341|6014253|P2|Interim Analysis|Overall Study||41
2452237|NCT01056341|6014254|P1|Interim Analysis|Overall Study||25
2452238|NCT01056341|6014250|P5|STARTED|Overall Study||102
2452239|NCT01056341|6014251|P4|STARTED|Overall Study||101
2452240|NCT01056341|6014252|P3|STARTED|Overall Study||103
2452241|NCT01056341|6014253|P2|STARTED|Overall Study||99
2452242|NCT01056341|6014254|P1|STARTED|Overall Study||55
2452243|NCT01056328|6014275|P2|NOT COMPLETED|Overall Study||16
2452244|NCT01056328|6014276|P1|NOT COMPLETED|Overall Study||17
2452245|NCT01056328|6014275|P2|COMPLETED|Overall Study||144
2452246|NCT01056328|6014276|P1|COMPLETED|Overall Study||147
2452247|NCT01056328|6014275|P2|STARTED|Overall Study||160
2452248|NCT01056328|6014276|P1|STARTED|Overall Study||164
2452249|NCT01056315|6014292|P2|NOT COMPLETED|Overall Study||11
2452250|NCT01056315|6014293|P1|NOT COMPLETED|Overall Study||14
2452251|NCT01056315|6014292|P2|COMPLETED|Overall Study||12
2452252|NCT01056315|6014293|P1|COMPLETED|Overall Study||13
2452253|NCT01056315|6014292|P2|STARTED|Overall Study||23
2452254|NCT01056315|6014293|P1|STARTED|Overall Study||27
2452255|NCT01056289|6014327|P4|NOT COMPLETED|Double-blind Phase||10
2452256|NCT01056289|6014328|P3|NOT COMPLETED|Double-blind Phase||13
2452257|NCT01056289|6014329|P2|NOT COMPLETED|Double-blind Phase||4
2452258|NCT01056289|6014330|P1|NOT COMPLETED|Double-blind Phase||0
2452259|NCT01056289|6014327|P4|COMPLETED|Double-blind Phase||138
2452260|NCT01056289|6014328|P3|COMPLETED|Double-blind Phase||127
2452261|NCT01056289|6014329|P2|COMPLETED|Double-blind Phase||69
2452262|NCT01056289|6014330|P1|COMPLETED|Double-blind Phase||0
2452263|NCT01056289|6014327|P4|STARTED|Double-blind Phase||148
2452264|NCT01056289|6014328|P3|STARTED|Double-blind Phase||140
2452265|NCT01056289|6014329|P2|STARTED|Double-blind Phase||73
2452266|NCT01056289|6014330|P1|STARTED|Double-blind Phase||0
2452267|NCT01056289|6014327|P4|NOT COMPLETED|Open-label Phase||0
2452268|NCT01056289|6014328|P3|NOT COMPLETED|Open-label Phase||0
2452269|NCT01056289|6014329|P2|NOT COMPLETED|Open-label Phase||0
2452270|NCT01056289|6014330|P1|NOT COMPLETED|Open-label Phase||119
2452271|NCT01056289|6014327|P4|COMPLETED|Open-label Phase||0
2452272|NCT01056289|6014328|P3|COMPLETED|Open-label Phase||0
2452273|NCT01056289|6014329|P2|COMPLETED|Open-label Phase||0
2452274|NCT01056289|6014330|P1|COMPLETED|Open-label Phase|Participants transitioned to Double-blind phase|361
2452275|NCT01056289|6014327|P4|STARTED|Open-label Phase||0
2452276|NCT01056289|6014328|P3|STARTED|Open-label Phase||0
2452277|NCT01056289|6014329|P2|STARTED|Open-label Phase||0
2452278|NCT01056289|6014330|P1|STARTED|Open-label Phase||480
2452279|NCT01056276|6014347|P2|NOT COMPLETED|Maintenance Therapy||28
2452280|NCT01056276|6014348|P1|NOT COMPLETED|Maintenance Therapy||0
2452281|NCT01056276|6014347|P2|COMPLETED|Maintenance Therapy|14 patients are continuing maintenance therapy.|0
2452282|NCT01056276|6014348|P1|COMPLETED|Maintenance Therapy||0
2452283|NCT01056276|6014347|P2|STARTED|Maintenance Therapy|5 patients completed 8 cycles but did not have maintenance therapy.|28
2452284|NCT01056276|6014348|P1|STARTED|Maintenance Therapy|Original regimen did not include maintenance therapy.|0
2452285|NCT01056276|6014347|P2|NOT COMPLETED|Treatment Period-Cycles 1-8||8
2452286|NCT01056276|6014348|P1|NOT COMPLETED|Treatment Period-Cycles 1-8||13
2452287|NCT01056276|6014347|P2|COMPLETED|Treatment Period-Cycles 1-8||33
2452288|NCT01056276|6014348|P1|COMPLETED|Treatment Period-Cycles 1-8||5
2452289|NCT01056276|6014347|P2|STARTED|Treatment Period-Cycles 1-8||41
2452290|NCT01056276|6014348|P1|STARTED|Treatment Period-Cycles 1-8||18
2452291|NCT01056263|6014362|P1|NOT COMPLETED|Overall Study||52
2452292|NCT01056263|6014362|P1|COMPLETED|Overall Study||0
2452293|NCT01056263|6014362|P1|STARTED|Overall Study||52
2452294|NCT01056198|6014368|P2|NOT COMPLETED|Overall Study||0
2452295|NCT01056198|6014369|P1|NOT COMPLETED|Overall Study||0
2452296|NCT01056198|6014368|P2|COMPLETED|Overall Study||24
2452297|NCT01056198|6014369|P1|COMPLETED|Overall Study||24
2452298|NCT01056198|6014368|P2|STARTED|Overall Study||24
2452299|NCT01056198|6014369|P1|STARTED|Overall Study||24
2452300|NCT01056107|6014385|P4|NOT COMPLETED|Overall Study||0
2452301|NCT01056107|6014386|P3|NOT COMPLETED|Overall Study||3
2452302|NCT01056107|6014387|P2|NOT COMPLETED|Overall Study||1
2452303|NCT01056107|6014388|P1|NOT COMPLETED|Overall Study||0
2452304|NCT01056107|6014385|P4|COMPLETED|Overall Study||12
2452305|NCT01056107|6014386|P3|COMPLETED|Overall Study||9
2452306|NCT01056107|6014387|P2|COMPLETED|Overall Study||10
2452307|NCT01056107|6014388|P1|COMPLETED|Overall Study||11
2452308|NCT01056107|6014385|P4|STARTED|Overall Study||12
2452309|NCT01056107|6014386|P3|STARTED|Overall Study||12
2452310|NCT01056107|6014387|P2|STARTED|Overall Study||11
2452311|NCT01056107|6014388|P1|STARTED|Overall Study||11
2452312|NCT01056016|6014436|P2|NOT COMPLETED|Overall Study||1
2452313|NCT01056016|6014437|P1|NOT COMPLETED|Overall Study||2
2452314|NCT01056016|6014436|P2|COMPLETED|Overall Study||26
2452315|NCT01056016|6014437|P1|COMPLETED|Overall Study||20
2452316|NCT01056016|6014436|P2|STARTED|Overall Study|27 pediatricians were at 4 practices; practices were unit of randomization|27
2452317|NCT01056016|6014437|P1|STARTED|Overall Study|22 pediatricians were at 4 practices; practices were unit of randomization|22
2452318|NCT01055886|6014445|P2|NOT COMPLETED|Overall Study||11
2452319|NCT01055886|6014446|P1|NOT COMPLETED|Overall Study||5
2452320|NCT01055886|6014445|P2|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|21
2452321|NCT01055886|6014446|P1|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|28
2452322|NCT01055886|6014445|P2|Reached Pre-quit Period|Overall Study|1 lost to contact|31
2452323|NCT01055886|6014446|P1|Reached Pre-quit Period|Overall Study|2 withdrawals, 1 lost to contact|30
2452324|NCT01055886|6014445|P2|STARTED|Overall Study||32
2452325|NCT01055886|6014446|P1|STARTED|Overall Study||33
2452326|NCT01055834|6014458|P2|NOT COMPLETED|Treatment Period III||0
2452327|NCT01055834|6014459|P1|NOT COMPLETED|Treatment Period III||0
2452328|NCT01055834|6014458|P2|COMPLETED|Treatment Period III||14
2452329|NCT01055834|6014459|P1|COMPLETED|Treatment Period III||0
2452330|NCT01055834|6014458|P2|STARTED|Treatment Period III|14 of 21 participants in Group B who were treated in Period II participated in Period III.|14
2452331|NCT01055834|6014459|P1|STARTED|Treatment Period III|Participants from Group A did not continue into Period III.|0
2452332|NCT01055834|6014458|P2|NOT COMPLETED|Treatment Period II||0
2452333|NCT01055834|6014459|P1|NOT COMPLETED|Treatment Period II||0
2452334|NCT01055834|6014458|P2|COMPLETED|Treatment Period II||21
2452335|NCT01055834|6014459|P1|COMPLETED|Treatment Period II||20
2452336|NCT01055834|6014458|P2|STARTED|Treatment Period II||21
2452337|NCT01055834|6014459|P1|STARTED|Treatment Period II||20
2452338|NCT01055834|6014458|P2|NOT COMPLETED|Treatment Period I||0
2452339|NCT01055834|6014459|P1|NOT COMPLETED|Treatment Period I||1
2452340|NCT01055834|6014458|P2|COMPLETED|Treatment Period I||21
2452341|NCT01055834|6014459|P1|COMPLETED|Treatment Period I||20
2452342|NCT01055834|6014458|P2|STARTED|Treatment Period I||21
2452343|NCT01055834|6014459|P1|STARTED|Treatment Period I||21
2452344|NCT01055782|6014473|P2|NOT COMPLETED|Overall Study||0
2452345|NCT01055782|6014474|P1|NOT COMPLETED|Overall Study||0
2452346|NCT01055782|6014473|P2|COMPLETED|Overall Study||449
2452347|NCT01055782|6014474|P1|COMPLETED|Overall Study||555
2452348|NCT01055782|6014473|P2|STARTED|Overall Study||449
2452349|NCT01055782|6014474|P1|STARTED|Overall Study||555
2452350|NCT01055769|6014482|P2|NOT COMPLETED|Second Intervention||0
2452351|NCT01055769|6014483|P1|NOT COMPLETED|Second Intervention||0
2452352|NCT01055769|6014482|P2|COMPLETED|Second Intervention||10
2452353|NCT01055769|6014483|P1|COMPLETED|Second Intervention||10
2452354|NCT01055769|6014482|P2|STARTED|Second Intervention||10
2452355|NCT01055769|6014483|P1|STARTED|Second Intervention||10
2452356|NCT01055769|6014482|P2|NOT COMPLETED|Washout Period of Atleast 4 Days||0
2452357|NCT01055769|6014483|P1|NOT COMPLETED|Washout Period of Atleast 4 Days||0
2452358|NCT01055769|6014482|P2|COMPLETED|Washout Period of Atleast 4 Days||10
2452359|NCT01055769|6014483|P1|COMPLETED|Washout Period of Atleast 4 Days||10
2452360|NCT01055769|6014482|P2|STARTED|Washout Period of Atleast 4 Days||10
2452361|NCT01055769|6014483|P1|STARTED|Washout Period of Atleast 4 Days||10
2452362|NCT01055769|6014482|P2|NOT COMPLETED|First Intervention||0
2452363|NCT01055769|6014483|P1|NOT COMPLETED|First Intervention||0
2452364|NCT01055769|6014482|P2|COMPLETED|First Intervention||10
2452365|NCT01055769|6014483|P1|COMPLETED|First Intervention||10
2452366|NCT01055769|6014482|P2|STARTED|First Intervention||10
2452367|NCT01055769|6014483|P1|STARTED|First Intervention||10
2452368|NCT01055704|6014501|P4|NOT COMPLETED|Overall Study||0
2452369|NCT01055704|6014502|P3|NOT COMPLETED|Overall Study||0
2452370|NCT01055704|6014503|P2|NOT COMPLETED|Overall Study||0
2452371|NCT01055704|6014504|P1|NOT COMPLETED|Overall Study||0
2452372|NCT01055704|6014501|P4|COMPLETED|Overall Study||8
2452373|NCT01055704|6014502|P3|COMPLETED|Overall Study||16
2452374|NCT01055704|6014503|P2|COMPLETED|Overall Study||8
2452375|NCT01055704|6014504|P1|COMPLETED|Overall Study||16
2452376|NCT01055704|6014501|P4|STARTED|Overall Study||8
2452377|NCT01055704|6014502|P3|STARTED|Overall Study||16
2452378|NCT01055704|6014503|P2|STARTED|Overall Study||8
2452379|NCT01055704|6014504|P1|STARTED|Overall Study||16
2452380|NCT01055639|6014544|P2|NOT COMPLETED|Overall Study||29
2452381|NCT01055639|6014545|P1|NOT COMPLETED|Overall Study||21
2452382|NCT01055639|6014544|P2|COMPLETED|Overall Study||31
2452383|NCT01055639|6014545|P1|COMPLETED|Overall Study||45
2452384|NCT01055639|6014544|P2|STARTED|Overall Study||60
2452385|NCT01055639|6014545|P1|STARTED|Overall Study||66
2452386|NCT01055613|6014569|P2|NOT COMPLETED|Overall Study||4
2452387|NCT01055613|6014570|P1|NOT COMPLETED|Overall Study||9
2452388|NCT01055613|6014569|P2|COMPLETED|Overall Study||96
2452389|NCT01055613|6014570|P1|COMPLETED|Overall Study||191
2452390|NCT01055613|6014569|P2|STARTED|Overall Study||100
2452391|NCT01055613|6014570|P1|STARTED|Overall Study||200
2452392|NCT01055496|6014580|P2|NOT COMPLETED|Overall Study||30
2452393|NCT01055496|6014581|P1|NOT COMPLETED|Overall Study||15
2452394|NCT01055496|6014580|P2|COMPLETED|Overall Study||25
2452395|NCT01055496|6014581|P1|COMPLETED|Overall Study||33
2452396|NCT01055496|6014580|P2|STARTED|Overall Study||55
2452397|NCT01055496|6014581|P1|STARTED|Overall Study||48
2452398|NCT01055457|6014638|P10|NOT COMPLETED|Overall Study||1
2452399|NCT01055457|6014639|P9|NOT COMPLETED|Overall Study||0
2452400|NCT01055457|6014640|P8|NOT COMPLETED|Overall Study||1
2452401|NCT01055457|6014641|P7|NOT COMPLETED|Overall Study||1
2452402|NCT01055457|6014642|P6|NOT COMPLETED|Overall Study||3
2452403|NCT01055457|6014643|P5|NOT COMPLETED|Overall Study||3
2452404|NCT01055457|6014644|P4|NOT COMPLETED|Overall Study||3
2452405|NCT01055457|6014645|P3|NOT COMPLETED|Overall Study||2
2452406|NCT01055457|6014646|P2|NOT COMPLETED|Overall Study||1
2452407|NCT01055457|6014647|P1|NOT COMPLETED|Overall Study||1
2452408|NCT01055457|6014638|P10|COMPLETED|Overall Study||19
2452409|NCT01055457|6014639|P9|COMPLETED|Overall Study||20
2452410|NCT01055457|6014640|P8|COMPLETED|Overall Study||18
2452411|NCT01055457|6014641|P7|COMPLETED|Overall Study||18
2452412|NCT01055457|6014642|P6|COMPLETED|Overall Study||15
2452413|NCT01055457|6014643|P5|COMPLETED|Overall Study||38
2452414|NCT01055457|6014644|P4|COMPLETED|Overall Study||37
2452415|NCT01055457|6014645|P3|COMPLETED|Overall Study||36
2452416|NCT01055457|6014646|P2|COMPLETED|Overall Study||39
2452417|NCT01055457|6014647|P1|COMPLETED|Overall Study||39
2452418|NCT01055457|6014638|P10|STARTED|Overall Study||20
2452419|NCT01055457|6014639|P9|STARTED|Overall Study||20
2452420|NCT01055457|6014640|P8|STARTED|Overall Study||19
2452421|NCT01055457|6014641|P7|STARTED|Overall Study||19
2452422|NCT01055457|6014642|P6|STARTED|Overall Study||18
2452423|NCT01055457|6014643|P5|STARTED|Overall Study||41
2452424|NCT01055457|6014644|P4|STARTED|Overall Study||40
2452425|NCT01055457|6014645|P3|STARTED|Overall Study||38
2452426|NCT01055457|6014646|P2|STARTED|Overall Study||40
2452427|NCT01055457|6014647|P1|STARTED|Overall Study||40
2452428|NCT01055314|6014681|P2|NOT COMPLETED|Overall Study||38
2452429|NCT01055314|6014682|P1|NOT COMPLETED|Overall Study||45
2452430|NCT01055314|6014681|P2|COMPLETED|Overall Study||37
2452431|NCT01055314|6014682|P1|COMPLETED|Overall Study||55
2452432|NCT01055314|6014681|P2|STARTED|Overall Study||75
2452433|NCT01055314|6014682|P1|STARTED|Overall Study||100
2452434|NCT01055262|6014694|P1|NOT COMPLETED|Overall Study||9
2452435|NCT01055262|6014694|P1|COMPLETED|Overall Study||160
2452436|NCT01055262|6014694|P1|STARTED|Overall Study||169
2452437|NCT01055223|6014705|P1|NOT COMPLETED|Overall Study||0
2452438|NCT01055223|6014705|P1|COMPLETED|Overall Study||98483
2452439|NCT01055223|6014705|P1|STARTED|Overall Study||98483
2452440|NCT01055197|6014735|P2|NOT COMPLETED|Overall Study||2
2452441|NCT01055197|6014736|P1|NOT COMPLETED|Overall Study||9
2452442|NCT01055197|6014735|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
2452443|NCT01055197|6014736|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|42
2452444|NCT01055197|6014735|P2|STARTED|Overall Study||46
2452445|NCT01055197|6014736|P1|STARTED|Overall Study||51
2452446|NCT01055184|6014750|P1|NOT COMPLETED|Overall Study||0
2452447|NCT01055184|6014750|P1|COMPLETED|Overall Study||34
2452448|NCT01055184|6014750|P1|STARTED|Overall Study||34
2452449|NCT01055171|6014756|P2|NOT COMPLETED|Overall Study||7
2452450|NCT01055171|6014757|P1|NOT COMPLETED|Overall Study||11
2452451|NCT01055171|6014756|P2|COMPLETED|Overall Study|Received the sugar pill and completed all visits including the one-week follow-up.|21
2452452|NCT01055171|6014757|P1|COMPLETED|Overall Study|Received the medication and completed all visits including the one-week follow-up.|18
2452453|NCT01055171|6014756|P2|Test Procedure Completion|Overall Study|Received the placebo and completed the first test session.|23
2452454|NCT01055171|6014757|P1|Test Procedure Completion|Overall Study|Received the medication and completed the first test session.|21
2452455|NCT01055171|6014756|P2|Retrieval Completion|Overall Study|Received the sugar pill and completed the retrieval session.|24
2452456|NCT01055171|6014757|P1|Retrieval Completion|Overall Study|Received the medication and completed the retrieval session.|25
2452457|NCT01055171|6014756|P2|STARTED|Overall Study|Randomized to receive placebo.|28
2452458|NCT01055171|6014757|P1|STARTED|Overall Study|Randomized to receive medication.|29
2452459|NCT01055132|6014771|P2|NOT COMPLETED|Period 2 (5-9 Days)||1
2452460|NCT01055132|6014772|P1|NOT COMPLETED|Period 2 (5-9 Days)||0
2452461|NCT01055132|6014771|P2|COMPLETED|Period 2 (5-9 Days)||32
2452462|NCT01055132|6014772|P1|COMPLETED|Period 2 (5-9 Days)||35
2452463|NCT01055132|6014771|P2|STARTED|Period 2 (5-9 Days)||33
2452464|NCT01055132|6014772|P1|STARTED|Period 2 (5-9 Days)||35
2452465|NCT01055132|6014771|P2|NOT COMPLETED|Period 1 (5-9 Days)||0
2452466|NCT01055132|6014772|P1|NOT COMPLETED|Period 1 (5-9 Days)||1
2452467|NCT01055132|6014771|P2|COMPLETED|Period 1 (5-9 Days)||33
2452468|NCT01055132|6014772|P1|COMPLETED|Period 1 (5-9 Days)||35
2452469|NCT01055132|6014771|P2|STARTED|Period 1 (5-9 Days)||33
2452470|NCT01055132|6014772|P1|STARTED|Period 1 (5-9 Days)||36
2452471|NCT01055028|6014785|P2|NOT COMPLETED|Treatment Cycles 4 to 6||0
2452472|NCT01055028|6014786|P1|NOT COMPLETED|Treatment Cycles 4 to 6||0
2452473|NCT01055028|6014785|P2|COMPLETED|Treatment Cycles 4 to 6||2
2452474|NCT01055028|6014786|P1|COMPLETED|Treatment Cycles 4 to 6||6
2452475|NCT01055028|6014785|P2|STARTED|Treatment Cycles 4 to 6||2
2452476|NCT01055028|6014786|P1|STARTED|Treatment Cycles 4 to 6||6
2452477|NCT01055028|6014785|P2|NOT COMPLETED|Inter-treatment Period||3
2452478|NCT01055028|6014786|P1|NOT COMPLETED|Inter-treatment Period||0
2452479|NCT01055028|6014785|P2|COMPLETED|Inter-treatment Period||2
2452480|NCT01055028|6014786|P1|COMPLETED|Inter-treatment Period||6
2452481|NCT01055028|6014785|P2|STARTED|Inter-treatment Period||5
2452482|NCT01055028|6014786|P1|STARTED|Inter-treatment Period||6
2452483|NCT01055028|6014785|P2|NOT COMPLETED|Treatment Cycles 1 to 3||3
2452484|NCT01055028|6014786|P1|NOT COMPLETED|Treatment Cycles 1 to 3||2
2452485|NCT01055028|6014785|P2|COMPLETED|Treatment Cycles 1 to 3||5
2452486|NCT01055028|6014786|P1|COMPLETED|Treatment Cycles 1 to 3||6
2452487|NCT01055028|6014785|P2|STARTED|Treatment Cycles 1 to 3||8
2452488|NCT01055028|6014786|P1|STARTED|Treatment Cycles 1 to 3||8
2452489|NCT01055028|6014785|P2|NOT COMPLETED|Screening||1
2452490|NCT01055028|6014786|P1|NOT COMPLETED|Screening||1
2452491|NCT01055028|6014785|P2|COMPLETED|Screening||8
2452492|NCT01055028|6014786|P1|COMPLETED|Screening||8
2452493|NCT01055028|6014785|P2|STARTED|Screening||9
2452494|NCT01055028|6014786|P1|STARTED|Screening||9
2452495|NCT01054976|6014800|P1|NOT COMPLETED|Overall Study||35
2452496|NCT01054976|6014800|P1|COMPLETED|Overall Study||57
2452497|NCT01054976|6014800|P1|STARTED|Overall Study||92
2452498|NCT01054911|6014808|P1|NOT COMPLETED|Overall Study||0
2452499|NCT01054911|6014808|P1|COMPLETED|Overall Study||5
2452500|NCT01054911|6014808|P1|STARTED|Overall Study||5
2452501|NCT01054885|6014821|P7|NOT COMPLETED|24-week, Double-blind Treatment Period||47
2452502|NCT01054885|6014822|P6|NOT COMPLETED|24-week, Double-blind Treatment Period||60
2452503|NCT01054885|6014823|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||42
2452504|NCT01054885|6014824|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||43
2452505|NCT01054885|6014825|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||49
2452506|NCT01054885|6014826|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||59
2452507|NCT01054885|6014827|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
2452508|NCT01054885|6014821|P7|COMPLETED|24-week, Double-blind Treatment Period||158
2452509|NCT01054885|6014822|P6|COMPLETED|24-week, Double-blind Treatment Period||144
2452510|NCT01054885|6014823|P5|COMPLETED|24-week, Double-blind Treatment Period||161
2452511|NCT01054885|6014824|P4|COMPLETED|24-week, Double-blind Treatment Period||160
2452512|NCT01054885|6014825|P3|COMPLETED|24-week, Double-blind Treatment Period||155
2452513|NCT01054885|6014826|P2|COMPLETED|24-week, Double-blind Treatment Period||146
2452514|NCT01054885|6014827|P1|COMPLETED|24-week, Double-blind Treatment Period||0
2452515|NCT01054885|6014821|P7|STARTED|24-week, Double-blind Treatment Period||205
2452516|NCT01054885|6014822|P6|STARTED|24-week, Double-blind Treatment Period||204
2452517|NCT01054885|6014823|P5|STARTED|24-week, Double-blind Treatment Period||203
2452518|NCT01054885|6014824|P4|STARTED|24-week, Double-blind Treatment Period||203
2452519|NCT01054885|6014825|P3|STARTED|24-week, Double-blind Treatment Period||204
2452520|NCT01054885|6014826|P2|STARTED|24-week, Double-blind Treatment Period||205
2452521|NCT01054885|6014827|P1|STARTED|24-week, Double-blind Treatment Period||0
2452522|NCT01054885|6014821|P7|NOT COMPLETED|2-week, Single-blind Run-In Period||0
2452523|NCT01054885|6014822|P6|NOT COMPLETED|2-week, Single-blind Run-In Period||0
2452524|NCT01054885|6014823|P5|NOT COMPLETED|2-week, Single-blind Run-In Period||0
2452525|NCT01054885|6014824|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
2452526|NCT01054885|6014825|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
2452527|NCT01054885|6014826|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
2452528|NCT01054885|6014827|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||351
2452529|NCT01054885|6014821|P7|COMPLETED|2-week, Single-blind Run-In Period||0
2452530|NCT01054885|6014822|P6|COMPLETED|2-week, Single-blind Run-In Period||0
2452531|NCT01054885|6014823|P5|COMPLETED|2-week, Single-blind Run-In Period||0
2452532|NCT01054885|6014824|P4|COMPLETED|2-week, Single-blind Run-In Period||0
2452533|NCT01054885|6014825|P3|COMPLETED|2-week, Single-blind Run-In Period||0
2452534|NCT01054885|6014826|P2|COMPLETED|2-week, Single-blind Run-In Period||0
2452535|NCT01054885|6014827|P1|COMPLETED|2-week, Single-blind Run-In Period||1226
2452536|NCT01054885|6014821|P7|STARTED|2-week, Single-blind Run-In Period||0
2452537|NCT01054885|6014822|P6|STARTED|2-week, Single-blind Run-In Period||0
2452538|NCT01054885|6014823|P5|STARTED|2-week, Single-blind Run-In Period||0
2452539|NCT01054885|6014824|P4|STARTED|2-week, Single-blind Run-In Period||0
2452540|NCT01054885|6014825|P3|STARTED|2-week, Single-blind Run-In Period||0
2452541|NCT01054885|6014826|P2|STARTED|2-week, Single-blind Run-In Period||0
2452542|NCT01054885|6014827|P1|STARTED|2-week, Single-blind Run-In Period||1577
2452543|NCT01054846|6014867|P2|NOT COMPLETED|Overall Study||17
2452544|NCT01054846|6014868|P1|NOT COMPLETED|Overall Study||76
2452545|NCT01054846|6014867|P2|COMPLETED|Overall Study||51
2452546|NCT01054846|6014868|P1|COMPLETED|Overall Study||246
2452547|NCT01054846|6014867|P2|STARTED|Overall Study||68
2452548|NCT01054846|6014868|P1|STARTED|Overall Study||322
2452549|NCT01054820|6014875|P1|NOT COMPLETED|Overall Study||2
2452550|NCT01054820|6014875|P1|COMPLETED|Overall Study||121
2452551|NCT01054820|6014875|P1|STARTED|Overall Study||123
2452552|NCT01054742|6014889|P1|NOT COMPLETED|Overall Study||0
2452553|NCT01054742|6014889|P1|COMPLETED|Overall Study||2
2452554|NCT01054742|6014889|P1|STARTED|Overall Study||2
2452555|NCT01054729|6014897|P4|NOT COMPLETED|Overall Study||3
2452556|NCT01054729|6014898|P3|NOT COMPLETED|Overall Study||6
2452557|NCT01054729|6014899|P2|NOT COMPLETED|Overall Study||5
2452558|NCT01054729|6014900|P1|NOT COMPLETED|Overall Study||4
2452559|NCT01054729|6014897|P4|COMPLETED|Overall Study||11
2452560|NCT01054729|6014898|P3|COMPLETED|Overall Study||9
2452561|NCT01054729|6014899|P2|COMPLETED|Overall Study||14
2452562|NCT01054729|6014900|P1|COMPLETED|Overall Study||12
2452563|NCT01054729|6014897|P4|Randomized and Treated|Overall Study||14
2452564|NCT01054729|6014898|P3|Randomized and Treated|Overall Study||15
2452565|NCT01054729|6014899|P2|Randomized and Treated|Overall Study||18
2452566|NCT01054729|6014900|P1|Randomized and Treated|Overall Study||16
2452567|NCT01054729|6014897|P4|STARTED|Overall Study||14
2452568|NCT01054729|6014898|P3|STARTED|Overall Study||15
2452569|NCT01054729|6014899|P2|STARTED|Overall Study||19
2452570|NCT01054729|6014900|P1|STARTED|Overall Study||16
2452571|NCT01054703|6014961|P1|NOT COMPLETED|Overall Study||0
2452572|NCT01054703|6014961|P1|COMPLETED|Overall Study||14
2452573|NCT01054703|6014961|P1|STARTED|Overall Study||14
2452574|NCT01054625|6014968|P3|NOT COMPLETED|Overall Study||1
2452575|NCT01054625|6014969|P2|NOT COMPLETED|Overall Study||3
2452576|NCT01054625|6014970|P1|NOT COMPLETED|Overall Study||2
2452577|NCT01054625|6014968|P3|COMPLETED|Overall Study||9
2452578|NCT01054625|6014969|P2|COMPLETED|Overall Study||9
2452579|NCT01054625|6014970|P1|COMPLETED|Overall Study||6
2452580|NCT01054625|6014968|P3|STARTED|Overall Study||10
2452581|NCT01054625|6014969|P2|STARTED|Overall Study||12
2452582|NCT01054625|6014970|P1|STARTED|Overall Study|A total of 31 patients were enrolled, 1 patient died before receiving any zalutumumab|8
2452583|NCT01054599|6014998|P2|NOT COMPLETED|Overall Study||7
2452584|NCT01054599|6014999|P1|NOT COMPLETED|Overall Study||4
2452585|NCT01054599|6014998|P2|COMPLETED|Overall Study||9
2452586|NCT01054599|6014999|P1|COMPLETED|Overall Study||9
2452587|NCT01054599|6014998|P2|STARTED|Overall Study||16
2452588|NCT01054599|6014999|P1|STARTED|Overall Study||13
2452589|NCT01054586|6015011|P4|NOT COMPLETED|Overall Study||0
2452590|NCT01054586|6015012|P3|NOT COMPLETED|Overall Study||0
2452591|NCT01054586|6015013|P2|NOT COMPLETED|Overall Study||0
2452592|NCT01054586|6015014|P1|NOT COMPLETED|Overall Study||0
2452593|NCT01054586|6015011|P4|COMPLETED|Overall Study||101
2452594|NCT01054586|6015012|P3|COMPLETED|Overall Study||8
2452595|NCT01054586|6015013|P2|COMPLETED|Overall Study||15
2452596|NCT01054586|6015014|P1|COMPLETED|Overall Study||43
2452597|NCT01054586|6015011|P4|STARTED|Overall Study||101
2452598|NCT01054586|6015012|P3|STARTED|Overall Study||8
2452599|NCT01054586|6015013|P2|STARTED|Overall Study||15
2452600|NCT01054586|6015014|P1|STARTED|Overall Study||43
2452601|NCT01054573|6015106|P4|NOT COMPLETED|Overall Study||2
2452602|NCT01054573|6015107|P3|NOT COMPLETED|Overall Study||3
2452603|NCT01054573|6015108|P2|NOT COMPLETED|Overall Study||4
2452604|NCT01054573|6015109|P1|NOT COMPLETED|Overall Study||1
2452605|NCT01054573|6015106|P4|COMPLETED|Overall Study||25
2452606|NCT01054573|6015107|P3|COMPLETED|Overall Study||19
2452607|NCT01054573|6015108|P2|COMPLETED|Overall Study||28
2452608|NCT01054573|6015109|P1|COMPLETED|Overall Study||8
2452609|NCT01054573|6015106|P4|STARTED|Overall Study||27
2452610|NCT01054573|6015107|P3|STARTED|Overall Study||22
2452611|NCT01054573|6015108|P2|STARTED|Overall Study||32
2452612|NCT01054573|6015109|P1|STARTED|Overall Study||9
2452613|NCT01054560|6015155|P2|NOT COMPLETED|Overall Study||28
2452614|NCT01054560|6015156|P1|NOT COMPLETED|Overall Study||13
2452615|NCT01054560|6015155|P2|COMPLETED|Overall Study||27
2452616|NCT01054560|6015156|P1|COMPLETED|Overall Study||45
2452617|NCT01054560|6015155|P2|STARTED|Overall Study||55
2452618|NCT01054560|6015156|P1|STARTED|Overall Study||58
2452619|NCT01054404|6015180|P2|NOT COMPLETED|Overall Study||0
2452620|NCT01054404|6015181|P1|NOT COMPLETED|Overall Study||0
2452621|NCT01054404|6015180|P2|COMPLETED|Overall Study||13
2452622|NCT01054404|6015181|P1|COMPLETED|Overall Study||10
2452623|NCT01054404|6015180|P2|STARTED|Overall Study||13
2452624|NCT01054404|6015181|P1|STARTED|Overall Study||10
2452625|NCT01054339|6015190|P3|NOT COMPLETED|Overall Study||0
2452626|NCT01054339|6015191|P2|NOT COMPLETED|Overall Study||0
2452627|NCT01054339|6015192|P1|NOT COMPLETED|Overall Study||0
2452628|NCT01054339|6015190|P3|COMPLETED|Overall Study||3
2452629|NCT01054339|6015191|P2|COMPLETED|Overall Study||3
2452630|NCT01054339|6015192|P1|COMPLETED|Overall Study||3
2452631|NCT01054339|6015190|P3|STARTED|Overall Study||3
2452632|NCT01054339|6015191|P2|STARTED|Overall Study||3
2452633|NCT01054339|6015192|P1|STARTED|Overall Study||3
2452634|NCT01054300|6015208|P4|NOT COMPLETED|Period 2||0
2452635|NCT01054300|6015209|P3|NOT COMPLETED|Period 2||1
2452636|NCT01054300|6015210|P2|NOT COMPLETED|Period 2||0
2452637|NCT01054300|6015211|P1|NOT COMPLETED|Period 2||0
2452638|NCT01054300|6015208|P4|COMPLETED|Period 2||13
2452639|NCT01054300|6015209|P3|COMPLETED|Period 2||12
2452640|NCT01054300|6015210|P2|COMPLETED|Period 2||13
2452641|NCT01054300|6015211|P1|COMPLETED|Period 2||12
2452642|NCT01054300|6015208|P4|STARTED|Period 2||13
2452643|NCT01054300|6015209|P3|STARTED|Period 2||13
2452644|NCT01054300|6015210|P2|STARTED|Period 2||13
2452645|NCT01054300|6015211|P1|STARTED|Period 2||12
2452646|NCT01054300|6015208|P4|NOT COMPLETED|Period 1||0
2452647|NCT01054300|6015209|P3|NOT COMPLETED|Period 1||0
2452648|NCT01054300|6015210|P2|NOT COMPLETED|Period 1||0
2452649|NCT01054300|6015211|P1|NOT COMPLETED|Period 1||1
2452650|NCT01054300|6015208|P4|COMPLETED|Period 1||13
2452651|NCT01054300|6015209|P3|COMPLETED|Period 1||13
2452652|NCT01054300|6015210|P2|COMPLETED|Period 1||13
2452653|NCT01054300|6015211|P1|COMPLETED|Period 1|Discontinuation occurred prior to Period 2 dose.|12
2452654|NCT01054300|6015208|P4|STARTED|Period 1||13
2452655|NCT01054300|6015209|P3|STARTED|Period 1||13
2452656|NCT01054300|6015210|P2|STARTED|Period 1||13
2452657|NCT01054300|6015211|P1|STARTED|Period 1||13
2452658|NCT01054222|6015261|P1|NOT COMPLETED|Overall Study||11
2452659|NCT01054222|6015261|P1|COMPLETED|Overall Study||20
2452660|NCT01054222|6015261|P1|STARTED|Overall Study||31
2452661|NCT01054209|6015282|P2|NOT COMPLETED|Overall Study||0
2452662|NCT01054209|6015283|P1|NOT COMPLETED|Overall Study||0
2452663|NCT01054209|6015282|P2|COMPLETED|Overall Study||58
2452664|NCT01054209|6015283|P1|COMPLETED|Overall Study||58
2452665|NCT01054209|6015282|P2|STARTED|Overall Study||58
2452666|NCT01054209|6015283|P1|STARTED|Overall Study||58
2452667|NCT01054183|6015291|P2|NOT COMPLETED|Overall Study||0
2452668|NCT01054183|6015292|P1|NOT COMPLETED|Overall Study||0
2452669|NCT01054183|6015291|P2|COMPLETED|Overall Study||12
2452670|NCT01054183|6015292|P1|COMPLETED|Overall Study||10
2452671|NCT01054183|6015291|P2|STARTED|Overall Study||12
2452672|NCT01054183|6015292|P1|STARTED|Overall Study||10
2452673|NCT01054170|6015302|P2|NOT COMPLETED|Overall Study||6
2452674|NCT01054170|6015303|P1|NOT COMPLETED|Overall Study||4
2452675|NCT01054170|6015302|P2|COMPLETED|Overall Study||21
2452676|NCT01054170|6015303|P1|COMPLETED|Overall Study||21
2452677|NCT01054170|6015302|P2|STARTED|Overall Study||27
2452678|NCT01054170|6015303|P1|STARTED|Overall Study||25
2452679|NCT01054079|6015355|P1|NOT COMPLETED|Overall Study||0
2452680|NCT01054079|6015355|P1|COMPLETED|Overall Study|while all 20 patients received at least some of the intervention, some did not get proper PSA tests.|20
2452681|NCT01054079|6015355|P1|# Recieved Proper PSA Testing|Overall Study||10
2452682|NCT01054079|6015355|P1|STARTED|Overall Study||20
2452683|NCT01053988|6015368|P6|NOT COMPLETED|24-week, Double-blind Treatment Period||55
2452684|NCT01053988|6015369|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||59
2452685|NCT01053988|6015370|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||63
2452686|NCT01053988|6015371|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||61
2452687|NCT01053988|6015372|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||69
2452688|NCT01053988|6015373|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
2452689|NCT01053988|6015368|P6|COMPLETED|24-week, Double-blind Treatment Period||151
2452690|NCT01053988|6015369|P5|COMPLETED|24-week, Double-blind Treatment Period||147
2452691|NCT01053988|6015370|P4|COMPLETED|24-week, Double-blind Treatment Period||142
2452692|NCT01053988|6015371|P3|COMPLETED|24-week, Double-blind Treatment Period||145
2452693|NCT01053988|6015372|P2|COMPLETED|24-week, Double-blind Treatment Period||138
2452694|NCT01053988|6015373|P1|COMPLETED|24-week, Double-blind Treatment Period||0
2452695|NCT01053988|6015368|P6|STARTED|24-week, Double-blind Treatment Period||206
2452696|NCT01053988|6015369|P5|STARTED|24-week, Double-blind Treatment Period||206
2452697|NCT01053988|6015370|P4|STARTED|24-week, Double-blind Treatment Period||205
2452698|NCT01053988|6015371|P3|STARTED|24-week, Double-blind Treatment Period||206
2452699|NCT01053988|6015372|P2|STARTED|24-week, Double-blind Treatment Period||207
2452700|NCT01053988|6015373|P1|STARTED|24-week, Double-blind Treatment Period||0
2452701|NCT01053988|6015368|P6|NOT COMPLETED|2-week, Single-blind Run-In Period||0
2452702|NCT01053988|6015369|P5|NOT COMPLETED|2-week, Single-blind Run-In Period||0
2452703|NCT01053988|6015370|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
2452704|NCT01053988|6015371|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
2452705|NCT01053988|6015372|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
2452706|NCT01053988|6015373|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||360
2452707|NCT01053988|6015368|P6|COMPLETED|2-week, Single-blind Run-In Period||0
2452708|NCT01053988|6015369|P5|COMPLETED|2-week, Single-blind Run-In Period||0
2452709|NCT01053988|6015370|P4|COMPLETED|2-week, Single-blind Run-In Period||0
2452710|NCT01053988|6015371|P3|COMPLETED|2-week, Single-blind Run-In Period||0
2452711|NCT01053988|6015372|P2|COMPLETED|2-week, Single-blind Run-In Period||0
2452712|NCT01053988|6015373|P1|COMPLETED|2-week, Single-blind Run-In Period||1030
2452713|NCT01053988|6015368|P6|STARTED|2-week, Single-blind Run-In Period||0
2452714|NCT01053988|6015369|P5|STARTED|2-week, Single-blind Run-In Period||0
2452715|NCT01053988|6015370|P4|STARTED|2-week, Single-blind Run-In Period||0
2452716|NCT01053988|6015371|P3|STARTED|2-week, Single-blind Run-In Period||0
2452717|NCT01053988|6015372|P2|STARTED|2-week, Single-blind Run-In Period||0
2452718|NCT01053988|6015373|P1|STARTED|2-week, Single-blind Run-In Period||1390
2452719|NCT01053962|6015410|P5|NOT COMPLETED|Follow-up Period||0
2452720|NCT01053962|6015411|P4|NOT COMPLETED|Follow-up Period||0
2452721|NCT01053962|6015412|P3|NOT COMPLETED|Follow-up Period||0
2452722|NCT01053962|6015413|P2|NOT COMPLETED|Follow-up Period||0
2452723|NCT01053962|6015414|P1|NOT COMPLETED|Follow-up Period||0
2452724|NCT01053962|6015410|P5|COMPLETED|Follow-up Period||17
2452725|NCT01053962|6015411|P4|COMPLETED|Follow-up Period||15
2452726|NCT01053962|6015412|P3|COMPLETED|Follow-up Period||15
2452727|NCT01053962|6015413|P2|COMPLETED|Follow-up Period||14
2452728|NCT01053962|6015414|P1|COMPLETED|Follow-up Period||13
2452729|NCT01053962|6015410|P5|STARTED|Follow-up Period||17
2452730|NCT01053962|6015411|P4|STARTED|Follow-up Period||15
2452731|NCT01053962|6015412|P3|STARTED|Follow-up Period||15
2452732|NCT01053962|6015413|P2|STARTED|Follow-up Period||14
2452733|NCT01053962|6015414|P1|STARTED|Follow-up Period||13
2452734|NCT01053962|6015410|P5|NOT COMPLETED|Treatment Period||3
2452735|NCT01053962|6015411|P4|NOT COMPLETED|Treatment Period||0
2452736|NCT01053962|6015412|P3|NOT COMPLETED|Treatment Period||0
2452737|NCT01053962|6015413|P2|NOT COMPLETED|Treatment Period||0
2452738|NCT01053962|6015414|P1|NOT COMPLETED|Treatment Period||1
2452739|NCT01053962|6015410|P5|COMPLETED|Treatment Period||17
2452740|NCT01053962|6015411|P4|COMPLETED|Treatment Period||15
2452741|NCT01053962|6015412|P3|COMPLETED|Treatment Period||15
2452742|NCT01053962|6015413|P2|COMPLETED|Treatment Period||14
2452743|NCT01053962|6015414|P1|COMPLETED|Treatment Period||13
2452744|NCT01053962|6015410|P5|STARTED|Treatment Period||20
2452745|NCT01053962|6015411|P4|STARTED|Treatment Period||15
2452746|NCT01053962|6015412|P3|STARTED|Treatment Period||15
2452747|NCT01053962|6015413|P2|STARTED|Treatment Period||14
2452748|NCT01053962|6015414|P1|STARTED|Treatment Period||14
2452749|NCT01053962|6015410|P5|NOT COMPLETED|Pretreatment Period||2
2452750|NCT01053962|6015411|P4|NOT COMPLETED|Pretreatment Period||2
2452751|NCT01053962|6015412|P3|NOT COMPLETED|Pretreatment Period||1
2452752|NCT01053962|6015413|P2|NOT COMPLETED|Pretreatment Period||1
2452753|NCT01053962|6015414|P1|NOT COMPLETED|Pretreatment Period||0
2452754|NCT01053962|6015410|P5|COMPLETED|Pretreatment Period||20
2452755|NCT01053962|6015411|P4|COMPLETED|Pretreatment Period||15
2452756|NCT01053962|6015412|P3|COMPLETED|Pretreatment Period||15
2452757|NCT01053962|6015413|P2|COMPLETED|Pretreatment Period||14
2452758|NCT01053962|6015414|P1|COMPLETED|Pretreatment Period||14
2452759|NCT01053962|6015410|P5|STARTED|Pretreatment Period||22
2452760|NCT01053962|6015411|P4|STARTED|Pretreatment Period||17
2452761|NCT01053962|6015412|P3|STARTED|Pretreatment Period||16
2452762|NCT01053962|6015413|P2|STARTED|Pretreatment Period||15
2452763|NCT01053962|6015414|P1|STARTED|Pretreatment Period||14
2452764|NCT01053897|6015446|P1|NOT COMPLETED|Overall Study||0
2452765|NCT01053897|6015446|P1|COMPLETED|Overall Study||5
2452766|NCT01053897|6015446|P1|STARTED|Overall Study||5
2452767|NCT01053819|6015458|P1|NOT COMPLETED|Overall Study||0
2452768|NCT01053819|6015458|P1|COMPLETED|Overall Study||6
2452769|NCT01053819|6015458|P1|STARTED|Overall Study||6
2452770|NCT01053741|6015465|P2|NOT COMPLETED|2nd Study Intervention||1
2452771|NCT01053741|6015466|P1|NOT COMPLETED|2nd Study Intervention||0
2452772|NCT01053741|6015465|P2|COMPLETED|2nd Study Intervention||5
2452773|NCT01053741|6015466|P1|COMPLETED|2nd Study Intervention||5
2452774|NCT01053741|6015465|P2|STARTED|2nd Study Intervention||6
2452775|NCT01053741|6015466|P1|STARTED|2nd Study Intervention||5
2452776|NCT01053741|6015465|P2|NOT COMPLETED|14 Day Washout||0
2452777|NCT01053741|6015466|P1|NOT COMPLETED|14 Day Washout||0
2452778|NCT01053741|6015465|P2|COMPLETED|14 Day Washout||6
2452779|NCT01053741|6015466|P1|COMPLETED|14 Day Washout||5
2452780|NCT01053741|6015465|P2|STARTED|14 Day Washout||6
2452781|NCT01053741|6015466|P1|STARTED|14 Day Washout||5
2452782|NCT01053741|6015465|P2|NOT COMPLETED|1st Intervention||0
2452783|NCT01053741|6015466|P1|NOT COMPLETED|1st Intervention||0
2452784|NCT01053741|6015465|P2|COMPLETED|1st Intervention||6
2452785|NCT01053741|6015466|P1|COMPLETED|1st Intervention||5
2452786|NCT01053741|6015465|P2|STARTED|1st Intervention||6
2452787|NCT01053741|6015466|P1|STARTED|1st Intervention||5
2452788|NCT01053663|6015475|P1|NOT COMPLETED|Overall Study||6
2452789|NCT01053663|6015475|P1|COMPLETED|Overall Study||3
2452790|NCT01053663|6015475|P1|STARTED|Overall Study||9
2452791|NCT01053507|6015518|P2|NOT COMPLETED|Overall Study||1
2452792|NCT01053507|6015519|P1|NOT COMPLETED|Overall Study||3
2452793|NCT01053507|6015518|P2|COMPLETED|Overall Study||11
2452794|NCT01053507|6015519|P1|COMPLETED|Overall Study||8
2452795|NCT01053507|6015518|P2|STARTED|Overall Study||12
2452796|NCT01053507|6015519|P1|STARTED|Overall Study||11
2452797|NCT01053429|6015533|P1|NOT COMPLETED|Overall Study||373
2452798|NCT01053429|6015533|P1|COMPLETED|Overall Study||3018
2452799|NCT01053429|6015533|P1|STARTED|Overall Study||3391
2452800|NCT01053312|6015542|P1|NOT COMPLETED|Overall Study||0
2452801|NCT01053312|6015542|P1|COMPLETED|Overall Study||7
2452802|NCT01053312|6015542|P1|STARTED|Overall Study||7
2452803|NCT01053247|6015563|P3|NOT COMPLETED|Overall Study||28
2452804|NCT01053247|6015564|P2|NOT COMPLETED|Overall Study||19
2452805|NCT01053247|6015565|P1|NOT COMPLETED|Overall Study||20
2452806|NCT01053247|6015563|P3|COMPLETED|Overall Study||236
2452807|NCT01053247|6015564|P2|COMPLETED|Overall Study||241
2452808|NCT01053247|6015565|P1|COMPLETED|Overall Study||249
2452809|NCT01053247|6015563|P3|STARTED|Overall Study||264
2452810|NCT01053247|6015564|P2|STARTED|Overall Study||260
2452811|NCT01053247|6015565|P1|STARTED|Overall Study||269
2452812|NCT01053221|6015575|P2|NOT COMPLETED|Overall Study||9
2452813|NCT01053221|6015576|P1|NOT COMPLETED|Overall Study||5
2452814|NCT01053221|6015575|P2|COMPLETED|Overall Study||0
2452815|NCT01053221|6015576|P1|COMPLETED|Overall Study||0
2452816|NCT01053221|6015575|P2|STARTED|Overall Study||9
2452817|NCT01053221|6015576|P1|STARTED|Overall Study||5
2452818|NCT01053156|6015592|P2|NOT COMPLETED|Second Intervention (Week 13-24)||5
2452819|NCT01053156|6015593|P1|NOT COMPLETED|Second Intervention (Week 13-24)||2
2452820|NCT01053156|6015592|P2|COMPLETED|Second Intervention (Week 13-24)||22
2452821|NCT01053156|6015593|P1|COMPLETED|Second Intervention (Week 13-24)||26
2452822|NCT01053156|6015592|P2|STARTED|Second Intervention (Week 13-24)||27
2452823|NCT01053156|6015593|P1|STARTED|Second Intervention (Week 13-24)||28
2452824|NCT01053156|6015592|P2|NOT COMPLETED|First Intervention (Week 1-12)||6
2452825|NCT01053156|6015593|P1|NOT COMPLETED|First Intervention (Week 1-12)||5
2452826|NCT01053156|6015592|P2|COMPLETED|First Intervention (Week 1-12)||27
2452827|NCT01053156|6015593|P1|COMPLETED|First Intervention (Week 1-12)||28
2452828|NCT01053156|6015592|P2|STARTED|First Intervention (Week 1-12)||33
2452829|NCT01053156|6015593|P1|STARTED|First Intervention (Week 1-12)||33
2452830|NCT01053078|6015631|P2|NOT COMPLETED|Overall Study||3
2452831|NCT01053078|6015632|P1|NOT COMPLETED|Overall Study||4
2452832|NCT01053078|6015631|P2|COMPLETED|Overall Study||12
2452833|NCT01053078|6015632|P1|COMPLETED|Overall Study||10
2452834|NCT01053078|6015631|P2|STARTED|Overall Study||15
2452835|NCT01053078|6015632|P1|STARTED|Overall Study||14
2452836|NCT01053000|6015640|P2|NOT COMPLETED|Overall Study||0
2452837|NCT01053000|6015641|P1|NOT COMPLETED|Overall Study||0
2452838|NCT01053000|6015640|P2|COMPLETED|Overall Study||5
2452839|NCT01053000|6015641|P1|COMPLETED|Overall Study||5
2452840|NCT01053000|6015640|P2|STARTED|Overall Study||5
2452841|NCT01053000|6015641|P1|STARTED|Overall Study||5
2452842|NCT01052948|6015651|P4|NOT COMPLETED|Overall Study||0
2452843|NCT01052948|6015652|P3|NOT COMPLETED|Overall Study||0
2452844|NCT01052948|6015653|P2|NOT COMPLETED|Overall Study||0
2452845|NCT01052948|6015654|P1|NOT COMPLETED|Overall Study||0
2452846|NCT01052948|6015651|P4|COMPLETED|Overall Study||29311
2452847|NCT01052948|6015652|P3|COMPLETED|Overall Study||15147
2452848|NCT01052948|6015653|P2|COMPLETED|Overall Study||14669
2452849|NCT01052948|6015654|P1|COMPLETED|Overall Study||27812
2452850|NCT01052948|6015651|P4|STARTED|Overall Study||29311
2452851|NCT01052948|6015652|P3|STARTED|Overall Study||15147
2452852|NCT01052948|6015653|P2|STARTED|Overall Study||14669
2452853|NCT01052948|6015654|P1|STARTED|Overall Study||27812
2452854|NCT01052844|6015678|P2|NOT COMPLETED|Overall Study||1
2452855|NCT01052844|6015679|P1|NOT COMPLETED|Overall Study||0
2452856|NCT01052844|6015678|P2|COMPLETED|Overall Study||39
2452857|NCT01052844|6015679|P1|COMPLETED|Overall Study||40
2452858|NCT01052844|6015678|P2|STARTED|Overall Study||40
2452859|NCT01052844|6015679|P1|STARTED|Overall Study||40
2452860|NCT01052831|6015689|P2|NOT COMPLETED|Overall Study||1
2452861|NCT01052831|6015690|P1|NOT COMPLETED|Overall Study||4
2452862|NCT01052831|6015689|P2|COMPLETED|Overall Study||23
2452863|NCT01052831|6015690|P1|COMPLETED|Overall Study||22
2452864|NCT01052831|6015689|P2|STARTED|Overall Study||24
2452865|NCT01052831|6015690|P1|STARTED|Overall Study||26
2452866|NCT01052779|6015700|P2|NOT COMPLETED|Overall Study||9
2452867|NCT01052779|6015701|P1|NOT COMPLETED|Overall Study||5
2452868|NCT01052779|6015700|P2|COMPLETED|Overall Study||73
2452869|NCT01052779|6015701|P1|COMPLETED|Overall Study||75
2452870|NCT01052779|6015700|P2|Received at Least 1 Dose of Study Drug|Overall Study||81
2452871|NCT01052779|6015701|P1|Received at Least 1 Dose of Study Drug|Overall Study||80
2452872|NCT01052779|6015700|P2|STARTED|Overall Study||82
2452873|NCT01052779|6015701|P1|STARTED|Overall Study||80
2452874|NCT01052714|6015711|P3|NOT COMPLETED|Overall Study||2
2452875|NCT01052714|6015712|P2|NOT COMPLETED|Overall Study||29
2452876|NCT01052714|6015713|P1|NOT COMPLETED|Overall Study||25
2452877|NCT01052714|6015711|P3|COMPLETED|Overall Study||15
2452878|NCT01052714|6015712|P2|COMPLETED|Overall Study||33
2452879|NCT01052714|6015713|P1|COMPLETED|Overall Study||17
2452880|NCT01052714|6015711|P3|STARTED|Overall Study||17
2452881|NCT01052714|6015712|P2|STARTED|Overall Study||62
2452882|NCT01052714|6015713|P1|STARTED|Overall Study||42
2452883|NCT01052701|6015755|P2|NOT COMPLETED|Overall Study||0
2452884|NCT01052701|6015756|P1|NOT COMPLETED|Overall Study||0
2452885|NCT01052701|6015755|P2|COMPLETED|Overall Study||12
2452886|NCT01052701|6015756|P1|COMPLETED|Overall Study||14
2452887|NCT01052701|6015755|P2|STARTED|Overall Study||12
2452888|NCT01052701|6015756|P1|STARTED|Overall Study||14
2452889|NCT01052662|6015767|P3|NOT COMPLETED|Overall Study||22
2452890|NCT01052662|6015768|P2|NOT COMPLETED|Overall Study||22
2452891|NCT01052662|6015769|P1|NOT COMPLETED|Overall Study||22
2452892|NCT01052662|6015767|P3|COMPLETED|Overall Study||10
2452893|NCT01052662|6015768|P2|COMPLETED|Overall Study||5
2452894|NCT01052662|6015769|P1|COMPLETED|Overall Study||6
2452895|NCT01052662|6015767|P3|Discontinuation Phase|Overall Study||10
2452896|NCT01052662|6015768|P2|Discontinuation Phase|Overall Study||5
2452897|NCT01052662|6015769|P1|Discontinuation Phase|Overall Study||6
2452898|NCT01052662|6015767|P3|Stabilization Phase|Overall Study||26
2452899|NCT01052662|6015768|P2|Stabilization Phase|Overall Study||21
2452900|NCT01052662|6015769|P1|Stabilization Phase|Overall Study||21
2452996|NCT01051986|6015996|P1|STARTED|Overall Study||112
2452901|NCT01052662|6015767|P3|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|32
2452902|NCT01052662|6015768|P2|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|27
2452903|NCT01052662|6015769|P1|STARTED|Overall Study|1 subject excluded from Intent-to-treat sample for final analysis due to pharmacy issue.|28
2452904|NCT01052545|6015785|P2|NOT COMPLETED|Overall Study||0
2452905|NCT01052545|6015786|P1|NOT COMPLETED|Overall Study||0
2452906|NCT01052545|6015785|P2|COMPLETED|Overall Study||731
2452907|NCT01052545|6015786|P1|COMPLETED|Overall Study||867
2452908|NCT01052545|6015785|P2|STARTED|Overall Study||731
2452909|NCT01052545|6015786|P1|STARTED|Overall Study||867
2452910|NCT01052480|6015810|P2|NOT COMPLETED|Overall Study||17
2452911|NCT01052480|6015811|P1|NOT COMPLETED|Overall Study||8
2452912|NCT01052480|6015810|P2|COMPLETED|Overall Study||32
2452913|NCT01052480|6015811|P1|COMPLETED|Overall Study||41
2452914|NCT01052480|6015810|P2|STARTED|Overall Study||49
2452915|NCT01052480|6015811|P1|STARTED|Overall Study||49
2452916|NCT01052428|6015861|P2|NOT COMPLETED|Overall Study||1
2452917|NCT01052428|6015862|P1|NOT COMPLETED|Overall Study||1
2452918|NCT01052428|6015861|P2|COMPLETED|Overall Study||18
2452919|NCT01052428|6015862|P1|COMPLETED|Overall Study||18
2452920|NCT01052428|6015861|P2|STARTED|Overall Study||19
2452921|NCT01052428|6015862|P1|STARTED|Overall Study||19
2452922|NCT01052272|6015884|P4|NOT COMPLETED|Overall Study||7
2452923|NCT01052272|6015885|P3|NOT COMPLETED|Overall Study||8
2452924|NCT01052272|6015886|P2|NOT COMPLETED|Overall Study||7
2452925|NCT01052272|6015887|P1|NOT COMPLETED|Overall Study||5
2452926|NCT01052272|6015884|P4|COMPLETED|Overall Study||11
2452927|NCT01052272|6015885|P3|COMPLETED|Overall Study||10
2452928|NCT01052272|6015886|P2|COMPLETED|Overall Study||11
2452929|NCT01052272|6015887|P1|COMPLETED|Overall Study||13
2452930|NCT01052272|6015884|P4|STARTED|Overall Study||18
2452931|NCT01052272|6015885|P3|STARTED|Overall Study||18
2452932|NCT01052272|6015886|P2|STARTED|Overall Study||18
2452933|NCT01052272|6015887|P1|STARTED|Overall Study||18
2452934|NCT01052207|6015923|P2|NOT COMPLETED|Overall Study||0
2452935|NCT01052207|6015924|P1|NOT COMPLETED|Overall Study||0
2452936|NCT01052207|6015923|P2|COMPLETED|Overall Study||42
2452937|NCT01052207|6015924|P1|COMPLETED|Overall Study||60
2452938|NCT01052207|6015923|P2|STARTED|Overall Study||42
2452939|NCT01052207|6015924|P1|STARTED|Overall Study||60
2452940|NCT01052116|6015932|P2|NOT COMPLETED|Overall Study||27
2452941|NCT01052116|6015933|P1|NOT COMPLETED|Overall Study||14
2452942|NCT01052116|6015932|P2|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|166
2452943|NCT01052116|6015933|P1|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|179
2452944|NCT01052116|6015932|P2|STARTED|Overall Study||193
2452945|NCT01052116|6015933|P1|STARTED|Overall Study||193
2452946|NCT01052077|6015941|P4|NOT COMPLETED|Phase A+||21
2452947|NCT01052077|6015942|P3|NOT COMPLETED|Phase A+||0
2452948|NCT01052077|6015943|P2|NOT COMPLETED|Phase A+||0
2452949|NCT01052077|6015944|P1|NOT COMPLETED|Phase A+||0
2452950|NCT01052077|6015941|P4|COMPLETED|Phase A+||230
2452951|NCT01052077|6015942|P3|COMPLETED|Phase A+||0
2452952|NCT01052077|6015943|P2|COMPLETED|Phase A+||0
2452953|NCT01052077|6015944|P1|COMPLETED|Phase A+||0
2452954|NCT01052077|6015941|P4|STARTED|Phase A+||251
2452955|NCT01052077|6015942|P3|STARTED|Phase A+||0
2452956|NCT01052077|6015943|P2|STARTED|Phase A+||0
2452957|NCT01052077|6015944|P1|STARTED|Phase A+||0
2452958|NCT01052077|6015941|P4|NOT COMPLETED|Phase B||0
2452959|NCT01052077|6015942|P3|NOT COMPLETED|Phase B||16
2452960|NCT01052077|6015943|P2|NOT COMPLETED|Phase B||18
2452961|NCT01052077|6015944|P1|NOT COMPLETED|Phase B||0
2452962|NCT01052077|6015941|P4|COMPLETED|Phase B||0
2452963|NCT01052077|6015942|P3|COMPLETED|Phase B||171
2452964|NCT01052077|6015943|P2|COMPLETED|Phase B||167
2452965|NCT01052077|6015944|P1|COMPLETED|Phase B||0
2452966|NCT01052077|6015941|P4|STARTED|Phase B||0
2452967|NCT01052077|6015942|P3|STARTED|Phase B||187
2452968|NCT01052077|6015943|P2|STARTED|Phase B||185
2452969|NCT01052077|6015944|P1|STARTED|Phase B||0
2452970|NCT01052077|6015941|P4|NOT COMPLETED|Phase A||0
2452971|NCT01052077|6015942|P3|NOT COMPLETED|Phase A||0
2452972|NCT01052077|6015943|P2|NOT COMPLETED|Phase A||0
2452973|NCT01052077|6015944|P1|NOT COMPLETED|Phase A||146
2452974|NCT01052077|6015941|P4|COMPLETED|Phase A||0
2452975|NCT01052077|6015942|P3|COMPLETED|Phase A||0
2452976|NCT01052077|6015943|P2|COMPLETED|Phase A||0
2452977|NCT01052077|6015944|P1|COMPLETED|Phase A||623
2452978|NCT01052077|6015941|P4|STARTED|Phase A||0
2452979|NCT01052077|6015942|P3|STARTED|Phase A||0
2452980|NCT01052077|6015943|P2|STARTED|Phase A||0
2452981|NCT01052077|6015944|P1|STARTED|Phase A||769
2452982|NCT01052038|6015971|P3|NOT COMPLETED|Overall Study||4
2452983|NCT01052038|6015972|P2|NOT COMPLETED|Overall Study||6
2452984|NCT01052038|6015973|P1|NOT COMPLETED|Overall Study||4
2452985|NCT01052038|6015971|P3|COMPLETED|Overall Study||36
2452986|NCT01052038|6015972|P2|COMPLETED|Overall Study||34
2452987|NCT01052038|6015973|P1|COMPLETED|Overall Study||36
2452988|NCT01052038|6015971|P3|STARTED|Overall Study||40
2452989|NCT01052038|6015972|P2|STARTED|Overall Study||40
2452990|NCT01052038|6015973|P1|STARTED|Overall Study||40
2452991|NCT01051986|6015995|P2|NOT COMPLETED|Overall Study||4
2452992|NCT01051986|6015996|P1|NOT COMPLETED|Overall Study||5
2452993|NCT01051986|6015995|P2|COMPLETED|Overall Study||108
2452994|NCT01051986|6015996|P1|COMPLETED|Overall Study||107
2452995|NCT01051986|6015995|P2|STARTED|Overall Study||112
2452997|NCT01051921|6016010|P1|NOT COMPLETED|Overall Study||30
2452998|NCT01051921|6016010|P1|COMPLETED|Overall Study||37
2452999|NCT01051921|6016010|P1|STARTED|Overall Study||67
2453000|NCT01051856|6016017|P2|NOT COMPLETED|Overall Study||0
2453001|NCT01051856|6016018|P1|NOT COMPLETED|Overall Study||1
2453002|NCT01051856|6016017|P2|COMPLETED|Overall Study||35
2453003|NCT01051856|6016018|P1|COMPLETED|Overall Study||32
2453004|NCT01051856|6016017|P2|STARTED|Overall Study||35
2453005|NCT01051856|6016018|P1|STARTED|Overall Study||33
2453006|NCT01051817|6016028|P2|NOT COMPLETED|Overall Study||9
2453007|NCT01051817|6016029|P1|NOT COMPLETED|Overall Study||3
2453008|NCT01051817|6016028|P2|COMPLETED|Overall Study||26
2453009|NCT01051817|6016029|P1|COMPLETED|Overall Study||35
2453010|NCT01051817|6016028|P2|STARTED|Overall Study||35
2453011|NCT01051817|6016029|P1|STARTED|Overall Study||38
2453012|NCT01051791|6016039|P1|NOT COMPLETED|Overall Study||4
2453013|NCT01051791|6016039|P1|COMPLETED|Overall Study||9
2453014|NCT01051791|6016039|P1|STARTED|Overall Study||13
2453015|NCT01051778|6016048|P2|NOT COMPLETED|Overall Study||0
2453016|NCT01051778|6016049|P1|NOT COMPLETED|Overall Study||0
2453017|NCT01051778|6016048|P2|COMPLETED|Overall Study|November 2009|30
2453018|NCT01051778|6016049|P1|COMPLETED|Overall Study|November 2009|30
2453019|NCT01051778|6016048|P2|STARTED|Overall Study|June 2006|30
2453020|NCT01051778|6016049|P1|STARTED|Overall Study|June 2006|30
2453021|NCT01051739|6016057|P2|NOT COMPLETED|Overall Study||13
2453022|NCT01051739|6016058|P1|NOT COMPLETED|Overall Study||28
2453023|NCT01051739|6016057|P2|COMPLETED|Overall Study||47
2453024|NCT01051739|6016058|P1|COMPLETED|Overall Study||92
2453025|NCT01051739|6016057|P2|STARTED|Overall Study||60
2453026|NCT01051739|6016058|P1|STARTED|Overall Study||120
2453027|NCT01051596|6016064|P1|NOT COMPLETED|Overall Study||0
2453028|NCT01051596|6016064|P1|COMPLETED|Overall Study||75
2453029|NCT01051596|6016064|P1|STARTED|Overall Study||75
2453030|NCT01051570|6016071|P1|NOT COMPLETED|Overall Study||0
2453031|NCT01051570|6016071|P1|COMPLETED|Overall Study||26
2453032|NCT01051570|6016071|P1|STARTED|Overall Study||26
2453033|NCT01051557|6016082|P7|NOT COMPLETED|Overall Study||6
2453034|NCT01051557|6016083|P6|NOT COMPLETED|Overall Study||6
2453035|NCT01051557|6016084|P5|NOT COMPLETED|Overall Study||7
2453036|NCT01051557|6016085|P4|NOT COMPLETED|Overall Study||3
2453037|NCT01051557|6016086|P3|NOT COMPLETED|Overall Study||6
2453038|NCT01051557|6016087|P2|NOT COMPLETED|Overall Study||3
2453039|NCT01051557|6016088|P1|NOT COMPLETED|Overall Study||4
2453040|NCT01051557|6016082|P7|COMPLETED|Overall Study||0
2453041|NCT01051557|6016083|P6|COMPLETED|Overall Study||0
2453042|NCT01051557|6016084|P5|COMPLETED|Overall Study||1
2453043|NCT01051557|6016085|P4|COMPLETED|Overall Study||0
2453044|NCT01051557|6016086|P3|COMPLETED|Overall Study||0
2453045|NCT01051557|6016087|P2|COMPLETED|Overall Study||0
2453046|NCT01051557|6016088|P1|COMPLETED|Overall Study||0
2453047|NCT01051557|6016082|P7|STARTED|Overall Study||6
2453048|NCT01051557|6016083|P6|STARTED|Overall Study||6
2453049|NCT01051557|6016084|P5|STARTED|Overall Study||8
2453050|NCT01051557|6016085|P4|STARTED|Overall Study||3
2453051|NCT01051557|6016086|P3|STARTED|Overall Study||6
2453052|NCT01051557|6016087|P2|STARTED|Overall Study||3
2453053|NCT01051557|6016088|P1|STARTED|Overall Study||4
2453054|NCT01051518|6016107|P1|NOT COMPLETED|Overall Study||73
2453055|NCT01051518|6016107|P1|COMPLETED|Overall Study||53
2453056|NCT01051518|6016107|P1|STARTED|Overall Study||126
2453057|NCT01051466|6016119|P2|NOT COMPLETED|Overall Study||5
2453058|NCT01051466|6016120|P1|NOT COMPLETED|Overall Study||8
2453059|NCT01051466|6016119|P2|COMPLETED|Overall Study||23
2453060|NCT01051466|6016120|P1|COMPLETED|Overall Study||24
2453061|NCT01051466|6016119|P2|STARTED|Overall Study||28
2453062|NCT01051466|6016120|P1|STARTED|Overall Study||32
2453063|NCT01051440|6016154|P2|NOT COMPLETED|Overall Study||0
2453064|NCT01051440|6016155|P1|NOT COMPLETED|Overall Study||0
2453065|NCT01051440|6016154|P2|COMPLETED|Overall Study||1
2453066|NCT01051440|6016155|P1|COMPLETED|Overall Study||1
2453067|NCT01051440|6016154|P2|STARTED|Overall Study||1
2453068|NCT01051440|6016155|P1|STARTED|Overall Study||1
2453069|NCT01051349|6016165|P1|NOT COMPLETED|Overall Study||173
2453070|NCT01051349|6016165|P1|COMPLETED|Overall Study||237
2453071|NCT01051349|6016165|P1|STARTED|Overall Study||410
2453072|NCT01051323|6016194|P1|NOT COMPLETED|Overall Study||539
2453073|NCT01051323|6016194|P1|COMPLETED|Overall Study||1041
2453074|NCT01051323|6016194|P1|Received at Least One Dose|Overall Study||1547
2453075|NCT01051323|6016194|P1|STARTED|Overall Study||1580
2453076|NCT01051310|6016216|P1|NOT COMPLETED|Overall Study||5
2453077|NCT01051310|6016216|P1|COMPLETED|Overall Study||13
2453078|NCT01051310|6016216|P1|STARTED|Overall Study||18
2453079|NCT01051063|6016223|P2|NOT COMPLETED|Overall Study||4
2453080|NCT01051063|6016224|P1|NOT COMPLETED|Overall Study||10
2453081|NCT01051063|6016223|P2|COMPLETED|Overall Study||1
2453082|NCT01051063|6016224|P1|COMPLETED|Overall Study||2
2453083|NCT01051063|6016223|P2|STARTED|Overall Study||5
2453084|NCT01051063|6016224|P1|STARTED|Overall Study||12
2453085|NCT01050998|6016244|P5|NOT COMPLETED|Overall Study||14
2453086|NCT01050998|6016245|P4|NOT COMPLETED|Overall Study||3
2453087|NCT01050998|6016246|P3|NOT COMPLETED|Overall Study||3
2453088|NCT01050998|6016247|P2|NOT COMPLETED|Overall Study||2
2453089|NCT01050998|6016248|P1|NOT COMPLETED|Overall Study||4
2453090|NCT01050998|6016244|P5|COMPLETED|Overall Study||82
2453091|NCT01050998|6016245|P4|COMPLETED|Overall Study||45
2453092|NCT01050998|6016246|P3|COMPLETED|Overall Study||46
2453093|NCT01050998|6016247|P2|COMPLETED|Overall Study||47
2453094|NCT01050998|6016248|P1|COMPLETED|Overall Study||44
2453095|NCT01050998|6016244|P5|STARTED|Overall Study||96
2453096|NCT01050998|6016245|P4|STARTED|Overall Study||48
2453097|NCT01050998|6016246|P3|STARTED|Overall Study||49
2453098|NCT01050998|6016247|P2|STARTED|Overall Study||49
2453099|NCT01050998|6016248|P1|STARTED|Overall Study||48
2453100|NCT01050946|6016572|P1|NOT COMPLETED|Overall Study||0
2453101|NCT01050946|6016572|P1|COMPLETED|Overall Study|Patient signed consent 2/3/2011. Patient had their transplant 2/15/2011. Patient died 9/2/2011|1
2453102|NCT01050946|6016572|P1|STARTED|Overall Study||1
2453103|NCT01050816|6016582|P1|NOT COMPLETED|Overall Study||4
2453104|NCT01050816|6016582|P1|COMPLETED|Overall Study||26
2453105|NCT01050816|6016582|P1|STARTED|Overall Study||30
2453106|NCT01050790|6016588|P1|NOT COMPLETED|Overall Study||1
2453107|NCT01050790|6016588|P1|COMPLETED|Overall Study||16
2453108|NCT01050790|6016588|P1|STARTED|Overall Study||17
2453109|NCT01050764|6016598|P1|NOT COMPLETED|Overall Study||3
2453110|NCT01050764|6016598|P1|COMPLETED|Overall Study||7
2453111|NCT01050764|6016598|P1|Received Infusion of T-con Cells|Overall Study||7
2453112|NCT01050764|6016598|P1|Received Infusion of T-reg Cells|Overall Study||7
2453113|NCT01050764|6016598|P1|Received HSCT Graft|Overall Study||8
2453114|NCT01050764|6016598|P1|STARTED|Overall Study||10
2453115|NCT01050673|6016609|P2|NOT COMPLETED|Overall Study||5
2453116|NCT01050673|6016610|P1|NOT COMPLETED|Overall Study||4
2453117|NCT01050673|6016609|P2|COMPLETED|Overall Study||14
2453118|NCT01050673|6016610|P1|COMPLETED|Overall Study||17
2453119|NCT01050673|6016609|P2|STARTED|Overall Study||19
2453120|NCT01050673|6016610|P1|STARTED|Overall Study||21
2453121|NCT01050660|6016634|P2|NOT COMPLETED|Overall Study||0
2453122|NCT01050660|6016635|P1|NOT COMPLETED|Overall Study||0
2453123|NCT01050660|6016634|P2|COMPLETED|Overall Study||69
2453124|NCT01050660|6016635|P1|COMPLETED|Overall Study||67
2453125|NCT01050660|6016634|P2|STARTED|Overall Study||69
2453126|NCT01050660|6016635|P1|STARTED|Overall Study||67
2453127|NCT01050647|6016661|P2|NOT COMPLETED|Overall Study||0
2453128|NCT01050647|6016662|P1|NOT COMPLETED|Overall Study||0
2453129|NCT01050647|6016661|P2|COMPLETED|Overall Study||11
2453130|NCT01050647|6016662|P1|COMPLETED|Overall Study||10
2453131|NCT01050647|6016661|P2|STARTED|Overall Study||11
2453132|NCT01050647|6016662|P1|STARTED|Overall Study||10
2453133|NCT01050634|6016678|P1|NOT COMPLETED|Overall Study||128
2453134|NCT01050634|6016678|P1|COMPLETED|Overall Study||852
2453135|NCT01050634|6016678|P1|Received Treatment|Overall Study||924
2453136|NCT01050634|6016678|P1|STARTED|Overall Study||980
2453137|NCT01050582|6016688|P2|NOT COMPLETED|Overall Study||0
2453138|NCT01050582|6016689|P1|NOT COMPLETED|Overall Study||0
2453139|NCT01050582|6016688|P2|COMPLETED|Overall Study||51
2453140|NCT01050582|6016689|P1|COMPLETED|Overall Study||133
2453141|NCT01050582|6016688|P2|STARTED|Overall Study||51
2453142|NCT01050582|6016689|P1|STARTED|Overall Study||133
2453143|NCT01050569|6016702|P3|NOT COMPLETED|Overall Study||33
2453144|NCT01050569|6016703|P2|NOT COMPLETED|Overall Study||24
2453145|NCT01050569|6016704|P1|NOT COMPLETED|Overall Study||38
2453146|NCT01050569|6016702|P3|COMPLETED|Overall Study||47
2453147|NCT01050569|6016703|P2|COMPLETED|Overall Study||52
2453148|NCT01050569|6016704|P1|COMPLETED|Overall Study||41
2453149|NCT01050569|6016702|P3|STARTED|Overall Study||80
2453150|NCT01050569|6016703|P2|STARTED|Overall Study||76
2453151|NCT01050569|6016704|P1|STARTED|Overall Study||79
2453152|NCT01050543|6016723|P2|NOT COMPLETED|Overall Study||4
2453153|NCT01050543|6016724|P1|NOT COMPLETED|Overall Study||4
2453154|NCT01050543|6016723|P2|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
2453155|NCT01050543|6016724|P1|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
2453156|NCT01050543|6016723|P2|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
2453157|NCT01050543|6016724|P1|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
2453158|NCT01050530|6016732|P2|NOT COMPLETED|Overall Study||10
2453159|NCT01050530|6016733|P1|NOT COMPLETED|Overall Study||8
2453160|NCT01050530|6016732|P2|COMPLETED|Overall Study||70
2453161|NCT01050530|6016733|P1|COMPLETED|Overall Study||74
2453162|NCT01050530|6016732|P2|STARTED|Overall Study||80
2453163|NCT01050530|6016733|P1|STARTED|Overall Study||82
2453164|NCT01050257|6016744|P3|NOT COMPLETED|Overall Study||7
2453165|NCT01050257|6016745|P2|NOT COMPLETED|Overall Study||13
2453166|NCT01050257|6016746|P1|NOT COMPLETED|Overall Study||11
2453167|NCT01050257|6016744|P3|COMPLETED|Overall Study||8
2453168|NCT01050257|6016745|P2|COMPLETED|Overall Study||40
2453169|NCT01050257|6016746|P1|COMPLETED|Overall Study|Completed 5 days of treatment either IV or Oral|39
2453170|NCT01050257|6016744|P3|Switched to Oral Treatment|Overall Study||3
2453171|NCT01050257|6016745|P2|Switched to Oral Treatment|Overall Study||31
2453172|NCT01050257|6016746|P1|Switched to Oral Treatment|Overall Study||28
2453173|NCT01050257|6016744|P3|Intent-to-treat Infected Confirmed|Overall Study||10
2453174|NCT01050257|6016745|P2|Intent-to-treat Infected Confirmed|Overall Study||32
2453175|NCT01050257|6016746|P1|Intent-to-treat Infected Confirmed|Overall Study||30
2453176|NCT01050257|6016744|P3|Safety Population: Actual Dose Received|Overall Study||14
2453177|NCT01050257|6016745|P2|Safety Population: Actual Dose Received|Overall Study|One participant randomized to 100 mg actually received the 200 mg doses.|51
2453178|NCT01050257|6016746|P1|Safety Population: Actual Dose Received|Overall Study||48
2453179|NCT01050257|6016744|P3|Received Treatment|Overall Study||14
2453180|NCT01050257|6016745|P2|Received Treatment|Overall Study||50
2453181|NCT01050257|6016746|P1|Received Treatment|Overall Study||49
2453182|NCT01050257|6016744|P3|STARTED|Overall Study||15
2453183|NCT01050257|6016745|P2|STARTED|Overall Study||53
2453184|NCT01050257|6016746|P1|STARTED|Overall Study||50
2453185|NCT01050218|6016781|P1|NOT COMPLETED|Overall Study||95
2453186|NCT01050218|6016781|P1|COMPLETED|Overall Study||142
2453187|NCT01050218|6016781|P1|STARTED|Overall Study||237
2453188|NCT01050205|6016787|P2|NOT COMPLETED|Overall Study||4
2453189|NCT01050205|6016788|P1|NOT COMPLETED|Overall Study||11
2453190|NCT01050205|6016787|P2|COMPLETED|Overall Study||71
2453191|NCT01050205|6016788|P1|COMPLETED|Overall Study||137
2453192|NCT01050205|6016787|P2|STARTED|Overall Study||75
2453193|NCT01050205|6016788|P1|STARTED|Overall Study||148
2453194|NCT01050153|6016818|P2|NOT COMPLETED|Overall Study||0
2453195|NCT01050153|6016819|P1|NOT COMPLETED|Overall Study||0
2453196|NCT01050153|6016818|P2|COMPLETED|Overall Study||25
2453197|NCT01050153|6016819|P1|COMPLETED|Overall Study||25
2453198|NCT01050153|6016818|P2|STARTED|Overall Study||25
2453199|NCT01050153|6016819|P1|STARTED|Overall Study||25
2453200|NCT01050062|6016845|P2|NOT COMPLETED|Overall Study||112
2453201|NCT01050062|6016846|P1|NOT COMPLETED|Overall Study||271
2453202|NCT01050062|6016845|P2|COMPLETED|Overall Study||243
2453203|NCT01050062|6016846|P1|COMPLETED|Overall Study||799
2453204|NCT01050062|6016845|P2|STARTED|Overall Study||355
2453205|NCT01050062|6016846|P1|STARTED|Overall Study||1070
2453206|NCT01049984|6016868|P2|NOT COMPLETED|Overall Study||19
2453207|NCT01049984|6016869|P1|NOT COMPLETED|Overall Study||19
2453208|NCT01049984|6016868|P2|COMPLETED|Overall Study||146
2453209|NCT01049984|6016869|P1|COMPLETED|Overall Study||144
2453210|NCT01049984|6016868|P2|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|162
2453211|NCT01049984|6016869|P1|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|159
2453212|NCT01049984|6016868|P2|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|164
2453213|NCT01049984|6016869|P1|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|162
2453214|NCT01049984|6016868|P2|STARTED|Overall Study||165
2453215|NCT01049984|6016869|P1|STARTED|Overall Study||163
2453216|NCT01049945|6016887|P6|NOT COMPLETED|Overall Study||0
2453217|NCT01049945|6016888|P5|NOT COMPLETED|Overall Study||0
2453218|NCT01049945|6016889|P4|NOT COMPLETED|Overall Study||0
2453219|NCT01049945|6016890|P3|NOT COMPLETED|Overall Study||0
2453220|NCT01049945|6016891|P2|NOT COMPLETED|Overall Study||0
2453221|NCT01049945|6016892|P1|NOT COMPLETED|Overall Study||0
2453222|NCT01049945|6016887|P6|COMPLETED|Overall Study||49
2453223|NCT01049945|6016888|P5|COMPLETED|Overall Study||3
2453224|NCT01049945|6016889|P4|COMPLETED|Overall Study||6
2453225|NCT01049945|6016890|P3|COMPLETED|Overall Study||3
2453226|NCT01049945|6016891|P2|COMPLETED|Overall Study||6
2453227|NCT01049945|6016892|P1|COMPLETED|Overall Study||3
2453228|NCT01049945|6016887|P6|STARTED|Overall Study||49
2453229|NCT01049945|6016888|P5|STARTED|Overall Study||3
2453230|NCT01049945|6016889|P4|STARTED|Overall Study||6
2453231|NCT01049945|6016890|P3|STARTED|Overall Study||3
2453232|NCT01049945|6016891|P2|STARTED|Overall Study||6
2453233|NCT01049945|6016892|P1|STARTED|Overall Study||3
2453234|NCT01049802|6016912|P2|NOT COMPLETED|Overall Study||0
2453235|NCT01049802|6016913|P1|NOT COMPLETED|Overall Study||0
2453236|NCT01049802|6016912|P2|COMPLETED|Overall Study||10
2453237|NCT01049802|6016913|P1|COMPLETED|Overall Study||20
2453238|NCT01049802|6016912|P2|STARTED|Overall Study||10
2453239|NCT01049802|6016913|P1|STARTED|Overall Study||20
2453240|NCT01049776|6016927|P1|NOT COMPLETED|Overall Study||20
2453241|NCT01049776|6016927|P1|COMPLETED|Overall Study||12
2453242|NCT01049776|6016927|P1|STARTED|Overall Study||32
2453243|NCT01049581|6016933|P2|NOT COMPLETED|Overall Study||1
2453244|NCT01049581|6016934|P1|NOT COMPLETED|Overall Study||2
2453245|NCT01049581|6016933|P2|COMPLETED|Overall Study||13
2453246|NCT01049581|6016934|P1|COMPLETED|Overall Study||11
2453247|NCT01049581|6016933|P2|STARTED|Overall Study||14
2453248|NCT01049581|6016934|P1|STARTED|Overall Study||13
2453249|NCT01049503|6016949|P6|NOT COMPLETED|Overall Study||8
2453250|NCT01049503|6016950|P5|NOT COMPLETED|Overall Study||27
2453251|NCT01049503|6016951|P4|NOT COMPLETED|Overall Study||26
2453252|NCT01049503|6016952|P3|NOT COMPLETED|Overall Study||24
2453253|NCT01049503|6016953|P2|NOT COMPLETED|Overall Study||12
2453254|NCT01049503|6016954|P1|NOT COMPLETED|Overall Study||11
2453255|NCT01049503|6016949|P6|COMPLETED|Overall Study||40
2453256|NCT01049503|6016950|P5|COMPLETED|Overall Study||29
2453257|NCT01049503|6016951|P4|COMPLETED|Overall Study||29
2453258|NCT01049503|6016952|P3|COMPLETED|Overall Study||32
2453259|NCT01049503|6016953|P2|COMPLETED|Overall Study||36
2453260|NCT01049503|6016954|P1|COMPLETED|Overall Study||41
2453261|NCT01049503|6016949|P6|STARTED|Overall Study||48
2453262|NCT01049503|6016950|P5|STARTED|Overall Study||56
2453263|NCT01049503|6016951|P4|STARTED|Overall Study||55
2453264|NCT01049503|6016952|P3|STARTED|Overall Study||56
2453265|NCT01049503|6016953|P2|STARTED|Overall Study||48
2453266|NCT01049503|6016954|P1|STARTED|Overall Study||52
2453267|NCT01049412|6016985|P2|NOT COMPLETED|Period II||3
2453268|NCT01049412|6016986|P1|NOT COMPLETED|Period II||4
2453269|NCT01049412|6016985|P2|COMPLETED|Period II||52
2453270|NCT01049412|6016986|P1|COMPLETED|Period II||58
2453271|NCT01049412|6016985|P2|STARTED|Period II||55
2453272|NCT01049412|6016986|P1|STARTED|Period II||62
2453273|NCT01049412|6016985|P2|NOT COMPLETED|Period I||13
2453274|NCT01049412|6016986|P1|NOT COMPLETED|Period I||8
2453275|NCT01049412|6016985|P2|COMPLETED|Period I||55
2453276|NCT01049412|6016986|P1|COMPLETED|Period I||62
2453277|NCT01049412|6016985|P2|Took at Least One Dose of Study Drug|Period I||68
2453278|NCT01049412|6016986|P1|Took at Least One Dose of Study Drug|Period I||69
2453279|NCT01049412|6016985|P2|STARTED|Period I||68
2453280|NCT01049412|6016986|P1|STARTED|Period I||70
2453281|NCT01049373|6017015|P2|NOT COMPLETED|Overall Study||44
2453282|NCT01049373|6017016|P1|NOT COMPLETED|Overall Study||39
2453283|NCT01049373|6017015|P2|COMPLETED|Overall Study||65
2453284|NCT01049373|6017016|P1|COMPLETED|Overall Study||73
2453285|NCT01049373|6017015|P2|STARTED|Overall Study||109
2453286|NCT01049373|6017016|P1|STARTED|Overall Study||112
2453287|NCT01049360|6017030|P20|NOT COMPLETED|Period 4||0
2453288|NCT01049360|6017031|P19|NOT COMPLETED|Period 4||0
2453289|NCT01049360|6017032|P18|NOT COMPLETED|Period 4||1
2453290|NCT01049360|6017033|P17|NOT COMPLETED|Period 4||0
2453291|NCT01049360|6017034|P16|NOT COMPLETED|Period 4||0
2453292|NCT01049360|6017035|P15|NOT COMPLETED|Period 4||0
2453293|NCT01049360|6017036|P14|NOT COMPLETED|Period 4||0
2453294|NCT01049360|6017037|P13|NOT COMPLETED|Period 4||0
2453295|NCT01049360|6017038|P12|NOT COMPLETED|Period 4||0
2453296|NCT01049360|6017039|P11|NOT COMPLETED|Period 4||0
2453297|NCT01049360|6017040|P10|NOT COMPLETED|Period 4||0
2453298|NCT01049360|6017041|P9|NOT COMPLETED|Period 4||0
2453299|NCT01049360|6017042|P8|NOT COMPLETED|Period 4||0
2453300|NCT01049360|6017043|P7|NOT COMPLETED|Period 4||0
2453301|NCT01049360|6017044|P6|NOT COMPLETED|Period 4||0
2453302|NCT01049360|6017045|P5|NOT COMPLETED|Period 4||0
2453303|NCT01049360|6017046|P4|NOT COMPLETED|Period 4||1
2453304|NCT01049360|6017047|P3|NOT COMPLETED|Period 4||0
2453305|NCT01049360|6017048|P2|NOT COMPLETED|Period 4||0
2453306|NCT01049360|6017049|P1|NOT COMPLETED|Period 4||0
2453307|NCT01049360|6017030|P20|COMPLETED|Period 4||5
2453308|NCT01049360|6017031|P19|COMPLETED|Period 4||5
2453309|NCT01049360|6017032|P18|COMPLETED|Period 4||5
2453310|NCT01049360|6017033|P17|COMPLETED|Period 4||5
2453311|NCT01049360|6017034|P16|COMPLETED|Period 4||6
2453312|NCT01049360|6017035|P15|COMPLETED|Period 4||5
2453313|NCT01049360|6017036|P14|COMPLETED|Period 4||6
2453314|NCT01049360|6017037|P13|COMPLETED|Period 4||4
2453315|NCT01049360|6017038|P12|COMPLETED|Period 4||6
2453316|NCT01049360|6017039|P11|COMPLETED|Period 4||5
2453317|NCT01049360|6017040|P10|COMPLETED|Period 4||6
2453318|NCT01049360|6017041|P9|COMPLETED|Period 4||4
2453319|NCT01049360|6017042|P8|COMPLETED|Period 4||4
2453320|NCT01049360|6017043|P7|COMPLETED|Period 4||6
2453321|NCT01049360|6017044|P6|COMPLETED|Period 4||5
2453322|NCT01049360|6017045|P5|COMPLETED|Period 4||7
2453323|NCT01049360|6017046|P4|COMPLETED|Period 4||3
2453324|NCT01049360|6017047|P3|COMPLETED|Period 4||7
2453325|NCT01049360|6017048|P2|COMPLETED|Period 4||4
2453326|NCT01049360|6017049|P1|COMPLETED|Period 4||6
2453327|NCT01049360|6017030|P20|STARTED|Period 4||5
2453328|NCT01049360|6017031|P19|STARTED|Period 4||5
2453329|NCT01049360|6017032|P18|STARTED|Period 4||6
2453330|NCT01049360|6017033|P17|STARTED|Period 4||5
2453331|NCT01049360|6017034|P16|STARTED|Period 4||6
2453332|NCT01049360|6017035|P15|STARTED|Period 4||5
2453333|NCT01049360|6017036|P14|STARTED|Period 4||6
2453334|NCT01049360|6017037|P13|STARTED|Period 4||4
2453335|NCT01049360|6017038|P12|STARTED|Period 4||6
2453336|NCT01049360|6017039|P11|STARTED|Period 4||5
2453337|NCT01049360|6017040|P10|STARTED|Period 4||6
2453338|NCT01049360|6017041|P9|STARTED|Period 4||4
2453339|NCT01049360|6017042|P8|STARTED|Period 4||4
2453340|NCT01049360|6017043|P7|STARTED|Period 4||6
2453341|NCT01049360|6017044|P6|STARTED|Period 4||5
2453342|NCT01049360|6017045|P5|STARTED|Period 4||7
2453343|NCT01049360|6017046|P4|STARTED|Period 4||4
2453344|NCT01049360|6017047|P3|STARTED|Period 4||7
2453345|NCT01049360|6017048|P2|STARTED|Period 4||4
2453346|NCT01049360|6017049|P1|STARTED|Period 4||6
2453347|NCT01049360|6017030|P20|NOT COMPLETED|Period 3||0
2453348|NCT01049360|6017031|P19|NOT COMPLETED|Period 3||0
2453349|NCT01049360|6017032|P18|NOT COMPLETED|Period 3||0
2453350|NCT01049360|6017033|P17|NOT COMPLETED|Period 3||0
2453351|NCT01049360|6017034|P16|NOT COMPLETED|Period 3||0
2453352|NCT01049360|6017035|P15|NOT COMPLETED|Period 3||0
2453353|NCT01049360|6017036|P14|NOT COMPLETED|Period 3||0
2453354|NCT01049360|6017037|P13|NOT COMPLETED|Period 3||0
2453355|NCT01049360|6017038|P12|NOT COMPLETED|Period 3||0
2453356|NCT01049360|6017039|P11|NOT COMPLETED|Period 3||0
2453357|NCT01049360|6017040|P10|NOT COMPLETED|Period 3||0
2453358|NCT01049360|6017041|P9|NOT COMPLETED|Period 3||0
2453359|NCT01049360|6017042|P8|NOT COMPLETED|Period 3||0
2453360|NCT01049360|6017043|P7|NOT COMPLETED|Period 3||0
2453361|NCT01049360|6017044|P6|NOT COMPLETED|Period 3||0
2453362|NCT01049360|6017045|P5|NOT COMPLETED|Period 3||0
2453363|NCT01049360|6017046|P4|NOT COMPLETED|Period 3||0
2453364|NCT01049360|6017047|P3|NOT COMPLETED|Period 3||0
2453365|NCT01049360|6017048|P2|NOT COMPLETED|Period 3||0
2453366|NCT01049360|6017049|P1|NOT COMPLETED|Period 3||0
2453367|NCT01049360|6017030|P20|COMPLETED|Period 3||5
2453368|NCT01049360|6017031|P19|COMPLETED|Period 3||5
2453369|NCT01049360|6017032|P18|COMPLETED|Period 3||6
2453370|NCT01049360|6017033|P17|COMPLETED|Period 3||5
2453371|NCT01049360|6017034|P16|COMPLETED|Period 3||6
2453372|NCT01049360|6017035|P15|COMPLETED|Period 3||5
2453373|NCT01049360|6017036|P14|COMPLETED|Period 3||6
2453374|NCT01049360|6017037|P13|COMPLETED|Period 3||4
2453375|NCT01049360|6017038|P12|COMPLETED|Period 3||6
2453376|NCT01049360|6017039|P11|COMPLETED|Period 3||5
2453377|NCT01049360|6017040|P10|COMPLETED|Period 3||6
2453378|NCT01049360|6017041|P9|COMPLETED|Period 3||4
2453379|NCT01049360|6017042|P8|COMPLETED|Period 3||4
2453380|NCT01049360|6017043|P7|COMPLETED|Period 3||6
2453381|NCT01049360|6017044|P6|COMPLETED|Period 3||5
2453382|NCT01049360|6017045|P5|COMPLETED|Period 3||7
2453383|NCT01049360|6017046|P4|COMPLETED|Period 3||4
2453384|NCT01049360|6017047|P3|COMPLETED|Period 3||7
2453385|NCT01049360|6017048|P2|COMPLETED|Period 3||4
2453386|NCT01049360|6017049|P1|COMPLETED|Period 3||6
2453387|NCT01049360|6017030|P20|STARTED|Period 3||5
2453388|NCT01049360|6017031|P19|STARTED|Period 3||5
2453389|NCT01049360|6017032|P18|STARTED|Period 3||6
2453390|NCT01049360|6017033|P17|STARTED|Period 3||5
2453391|NCT01049360|6017034|P16|STARTED|Period 3||6
2453392|NCT01049360|6017035|P15|STARTED|Period 3||5
2453393|NCT01049360|6017036|P14|STARTED|Period 3||6
2453394|NCT01049360|6017037|P13|STARTED|Period 3||4
2453395|NCT01049360|6017038|P12|STARTED|Period 3||6
2453396|NCT01049360|6017039|P11|STARTED|Period 3||5
2453397|NCT01049360|6017040|P10|STARTED|Period 3||6
2453398|NCT01049360|6017041|P9|STARTED|Period 3||4
2453399|NCT01049360|6017042|P8|STARTED|Period 3||4
2453400|NCT01049360|6017043|P7|STARTED|Period 3||6
2453401|NCT01049360|6017044|P6|STARTED|Period 3||5
2453402|NCT01049360|6017045|P5|STARTED|Period 3||7
2453403|NCT01049360|6017046|P4|STARTED|Period 3||4
2453404|NCT01049360|6017047|P3|STARTED|Period 3||7
2453405|NCT01049360|6017048|P2|STARTED|Period 3||4
2453406|NCT01049360|6017049|P1|STARTED|Period 3||6
2453407|NCT01049360|6017030|P20|NOT COMPLETED|Period 2||2
2453408|NCT01049360|6017031|P19|NOT COMPLETED|Period 2||0
2453409|NCT01049360|6017032|P18|NOT COMPLETED|Period 2||0
2453410|NCT01049360|6017033|P17|NOT COMPLETED|Period 2||0
2453411|NCT01049360|6017034|P16|NOT COMPLETED|Period 2||1
2453412|NCT01049360|6017035|P15|NOT COMPLETED|Period 2||2
2453413|NCT01049360|6017036|P14|NOT COMPLETED|Period 2||0
2453414|NCT01049360|6017037|P13|NOT COMPLETED|Period 2||0
2453415|NCT01049360|6017038|P12|NOT COMPLETED|Period 2||0
2453416|NCT01049360|6017039|P11|NOT COMPLETED|Period 2||0
2453417|NCT01049360|6017040|P10|NOT COMPLETED|Period 2||0
2453418|NCT01049360|6017041|P9|NOT COMPLETED|Period 2||1
2453419|NCT01049360|6017042|P8|NOT COMPLETED|Period 2||0
2453420|NCT01049360|6017043|P7|NOT COMPLETED|Period 2||0
2453421|NCT01049360|6017044|P6|NOT COMPLETED|Period 2||1
2453422|NCT01049360|6017045|P5|NOT COMPLETED|Period 2||0
2453423|NCT01049360|6017046|P4|NOT COMPLETED|Period 2||2
2453424|NCT01049360|6017047|P3|NOT COMPLETED|Period 2||0
2453425|NCT01049360|6017048|P2|NOT COMPLETED|Period 2||1
2453426|NCT01049360|6017049|P1|NOT COMPLETED|Period 2||0
2453427|NCT01049360|6017030|P20|COMPLETED|Period 2||5
2453428|NCT01049360|6017031|P19|COMPLETED|Period 2||5
2453429|NCT01049360|6017032|P18|COMPLETED|Period 2||6
2453430|NCT01049360|6017033|P17|COMPLETED|Period 2||5
2453431|NCT01049360|6017034|P16|COMPLETED|Period 2||6
2453432|NCT01049360|6017035|P15|COMPLETED|Period 2||5
2453433|NCT01049360|6017036|P14|COMPLETED|Period 2||6
2453434|NCT01049360|6017037|P13|COMPLETED|Period 2||4
2453435|NCT01049360|6017038|P12|COMPLETED|Period 2||6
2453436|NCT01049360|6017039|P11|COMPLETED|Period 2||5
2453437|NCT01049360|6017040|P10|COMPLETED|Period 2||6
2453438|NCT01049360|6017041|P9|COMPLETED|Period 2||4
2453439|NCT01049360|6017042|P8|COMPLETED|Period 2||4
2453440|NCT01049360|6017043|P7|COMPLETED|Period 2||6
2453441|NCT01049360|6017044|P6|COMPLETED|Period 2||5
2453442|NCT01049360|6017045|P5|COMPLETED|Period 2||7
2453443|NCT01049360|6017046|P4|COMPLETED|Period 2||4
2453444|NCT01049360|6017047|P3|COMPLETED|Period 2||7
2453445|NCT01049360|6017048|P2|COMPLETED|Period 2||4
2453446|NCT01049360|6017049|P1|COMPLETED|Period 2||6
2453447|NCT01049360|6017030|P20|STARTED|Period 2||7
2453448|NCT01049360|6017031|P19|STARTED|Period 2||5
2453449|NCT01049360|6017032|P18|STARTED|Period 2||6
2453450|NCT01049360|6017033|P17|STARTED|Period 2||5
2453451|NCT01049360|6017034|P16|STARTED|Period 2||7
2453452|NCT01049360|6017035|P15|STARTED|Period 2||7
2453453|NCT01049360|6017036|P14|STARTED|Period 2||6
2453454|NCT01049360|6017037|P13|STARTED|Period 2||4
2453455|NCT01049360|6017038|P12|STARTED|Period 2||6
2453456|NCT01049360|6017039|P11|STARTED|Period 2||5
2453457|NCT01049360|6017040|P10|STARTED|Period 2||6
2453458|NCT01049360|6017041|P9|STARTED|Period 2||5
2453459|NCT01049360|6017042|P8|STARTED|Period 2||4
2453460|NCT01049360|6017043|P7|STARTED|Period 2||6
2453461|NCT01049360|6017044|P6|STARTED|Period 2||6
2453462|NCT01049360|6017045|P5|STARTED|Period 2||7
2453463|NCT01049360|6017046|P4|STARTED|Period 2||6
2453464|NCT01049360|6017047|P3|STARTED|Period 2||7
2453465|NCT01049360|6017048|P2|STARTED|Period 2||5
2453466|NCT01049360|6017049|P1|STARTED|Period 2||6
2453467|NCT01049360|6017030|P20|NOT COMPLETED|Period 1||0
2453468|NCT01049360|6017031|P19|NOT COMPLETED|Period 1||1
2453469|NCT01049360|6017032|P18|NOT COMPLETED|Period 1||0
2453470|NCT01049360|6017033|P17|NOT COMPLETED|Period 1||1
2453471|NCT01049360|6017034|P16|NOT COMPLETED|Period 1||0
2453472|NCT01049360|6017035|P15|NOT COMPLETED|Period 1||0
2453473|NCT01049360|6017036|P14|NOT COMPLETED|Period 1||1
2453474|NCT01049360|6017037|P13|NOT COMPLETED|Period 1||2
2453475|NCT01049360|6017038|P12|NOT COMPLETED|Period 1||0
2453476|NCT01049360|6017039|P11|NOT COMPLETED|Period 1||1
2453477|NCT01049360|6017040|P10|NOT COMPLETED|Period 1||0
2453478|NCT01049360|6017041|P9|NOT COMPLETED|Period 1||2
2453479|NCT01049360|6017042|P8|NOT COMPLETED|Period 1||2
2453480|NCT01049360|6017043|P7|NOT COMPLETED|Period 1||0
2453481|NCT01049360|6017044|P6|NOT COMPLETED|Period 1||0
2453482|NCT01049360|6017045|P5|NOT COMPLETED|Period 1||0
2453483|NCT01049360|6017046|P4|NOT COMPLETED|Period 1||1
2453484|NCT01049360|6017047|P3|NOT COMPLETED|Period 1||0
2453485|NCT01049360|6017048|P2|NOT COMPLETED|Period 1||1
2453486|NCT01049360|6017049|P1|NOT COMPLETED|Period 1||0
2453487|NCT01049360|6017030|P20|COMPLETED|Period 1||7
2453488|NCT01049360|6017031|P19|COMPLETED|Period 1||5
2453489|NCT01049360|6017032|P18|COMPLETED|Period 1||6
2453490|NCT01049360|6017033|P17|COMPLETED|Period 1||5
2453491|NCT01049360|6017034|P16|COMPLETED|Period 1||7
2453492|NCT01049360|6017035|P15|COMPLETED|Period 1||7
2453493|NCT01049360|6017036|P14|COMPLETED|Period 1||6
2453494|NCT01049360|6017037|P13|COMPLETED|Period 1||4
2453495|NCT01049360|6017038|P12|COMPLETED|Period 1||6
2453496|NCT01049360|6017039|P11|COMPLETED|Period 1||5
2453497|NCT01049360|6017040|P10|COMPLETED|Period 1||6
2453498|NCT01049360|6017041|P9|COMPLETED|Period 1||5
2453499|NCT01049360|6017042|P8|COMPLETED|Period 1||4
2453500|NCT01049360|6017043|P7|COMPLETED|Period 1||6
2453501|NCT01049360|6017044|P6|COMPLETED|Period 1||6
2453502|NCT01049360|6017045|P5|COMPLETED|Period 1||7
2453503|NCT01049360|6017046|P4|COMPLETED|Period 1||6
2453504|NCT01049360|6017047|P3|COMPLETED|Period 1||7
2453505|NCT01049360|6017048|P2|COMPLETED|Period 1||5
2453506|NCT01049360|6017049|P1|COMPLETED|Period 1||6
2453507|NCT01049360|6017030|P20|STARTED|Period 1||7
2453508|NCT01049360|6017031|P19|STARTED|Period 1||6
2453509|NCT01049360|6017032|P18|STARTED|Period 1||6
2453510|NCT01049360|6017033|P17|STARTED|Period 1||6
2453511|NCT01049360|6017034|P16|STARTED|Period 1||7
2453512|NCT01049360|6017035|P15|STARTED|Period 1||7
2453513|NCT01049360|6017036|P14|STARTED|Period 1||7
2453514|NCT01049360|6017037|P13|STARTED|Period 1||6
2453515|NCT01049360|6017038|P12|STARTED|Period 1||6
2453516|NCT01049360|6017039|P11|STARTED|Period 1||6
2453517|NCT01049360|6017040|P10|STARTED|Period 1||6
2453518|NCT01049360|6017041|P9|STARTED|Period 1||7
2453519|NCT01049360|6017042|P8|STARTED|Period 1||6
2453520|NCT01049360|6017043|P7|STARTED|Period 1||6
2453521|NCT01049360|6017044|P6|STARTED|Period 1||6
2453522|NCT01049360|6017045|P5|STARTED|Period 1||7
2453523|NCT01049360|6017046|P4|STARTED|Period 1||7
2453524|NCT01049360|6017047|P3|STARTED|Period 1||7
2453525|NCT01049360|6017048|P2|STARTED|Period 1||6
2453526|NCT01049360|6017049|P1|STARTED|Period 1||6
2453527|NCT01049334|6017073|P2|NOT COMPLETED|Overall Study||7
2453528|NCT01049334|6017074|P1|NOT COMPLETED|Overall Study||9
2453529|NCT01049334|6017073|P2|COMPLETED|Overall Study||95
2453530|NCT01049334|6017074|P1|COMPLETED|Overall Study||93
2453531|NCT01049334|6017073|P2|STARTED|Overall Study||102
2453532|NCT01049334|6017074|P1|STARTED|Overall Study||102
2453533|NCT01049308|6017110|P1|NOT COMPLETED|Pill Counts||83
2453534|NCT01049308|6017110|P1|COMPLETED|Pill Counts||168
2453535|NCT01049308|6017110|P1|STARTED|Pill Counts||251
2453536|NCT01049308|6017110|P1|NOT COMPLETED|Evaluation of Cognitive Impairment||0
2453537|NCT01049308|6017110|P1|COMPLETED|Evaluation of Cognitive Impairment||251
2453538|NCT01049308|6017110|P1|STARTED|Evaluation of Cognitive Impairment||251
2453539|NCT01049243|6017117|P1|NOT COMPLETED|Overall Study||2
2453540|NCT01049243|6017117|P1|COMPLETED|Overall Study||18
2453541|NCT01049243|6017117|P1|STARTED|Overall Study||20
2453542|NCT01049217|6017124|P2|NOT COMPLETED|Overall Study||63
2453543|NCT01049217|6017125|P1|NOT COMPLETED|Overall Study||56
2453544|NCT01049217|6017124|P2|COMPLETED|Overall Study||131
2453545|NCT01049217|6017125|P1|COMPLETED|Overall Study||127
2453546|NCT01049217|6017124|P2|Treated|Overall Study||192
2453547|NCT01049217|6017125|P1|Treated|Overall Study||183
2453548|NCT01049217|6017124|P2|STARTED|Overall Study||194
2453549|NCT01049217|6017125|P1|STARTED|Overall Study||183
2453550|NCT01049009|6017197|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
2453551|NCT01049009|6017198|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
2453552|NCT01049009|6017197|P2|COMPLETED|Treatment Period 2 (12 Weeks)||8
2453553|NCT01049009|6017198|P1|COMPLETED|Treatment Period 2 (12 Weeks)||11
2453554|NCT01049009|6017197|P2|STARTED|Treatment Period 2 (12 Weeks)||18
2453555|NCT01049009|6017198|P1|STARTED|Treatment Period 2 (12 Weeks)||21
2453556|NCT01049009|6017197|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
2453557|NCT01049009|6017198|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
2453558|NCT01049009|6017197|P2|COMPLETED|Treatment Period 1 (12 Weeks)||18
2453559|NCT01049009|6017198|P1|COMPLETED|Treatment Period 1 (12 Weeks)||21
2453560|NCT01049009|6017197|P2|STARTED|Treatment Period 1 (12 Weeks)||21
2453561|NCT01049009|6017198|P1|STARTED|Treatment Period 1 (12 Weeks)||23
2453562|NCT01048944|6017210|P4|NOT COMPLETED|Overall Study||2
2453563|NCT01048944|6017211|P3|NOT COMPLETED|Overall Study||10
2453564|NCT01048944|6017212|P2|NOT COMPLETED|Overall Study||10
2453565|NCT01048944|6017213|P1|NOT COMPLETED|Overall Study||8
2453566|NCT01048944|6017210|P4|COMPLETED|Overall Study||19
2453567|NCT01048944|6017211|P3|COMPLETED|Overall Study||25
2453568|NCT01048944|6017212|P2|COMPLETED|Overall Study||28
2453569|NCT01048944|6017213|P1|COMPLETED|Overall Study||24
2453570|NCT01048944|6017210|P4|STARTED|Overall Study||21
2453571|NCT01048944|6017211|P3|STARTED|Overall Study||35
2453572|NCT01048944|6017212|P2|STARTED|Overall Study||38
2453573|NCT01048944|6017213|P1|STARTED|Overall Study||32
2453574|NCT01048879|6017230|P3|NOT COMPLETED|Overall Study||0
2453575|NCT01048879|6017231|P2|NOT COMPLETED|Overall Study||0
2453576|NCT01048879|6017232|P1|NOT COMPLETED|Overall Study||0
2453577|NCT01048879|6017230|P3|COMPLETED|Overall Study||5
2453578|NCT01048879|6017231|P2|COMPLETED|Overall Study||9
2453579|NCT01048879|6017232|P1|COMPLETED|Overall Study||1
2453580|NCT01048879|6017230|P3|STARTED|Overall Study||5
2453581|NCT01048879|6017231|P2|STARTED|Overall Study||9
2453582|NCT01048879|6017232|P1|STARTED|Overall Study||1
2453583|NCT01048866|6017245|P2|NOT COMPLETED|Overall Study||5
2453584|NCT01048866|6017246|P1|NOT COMPLETED|Overall Study||4
2453585|NCT01048866|6017245|P2|COMPLETED|Overall Study||92
2453586|NCT01048866|6017246|P1|COMPLETED|Overall Study||97
2453587|NCT01048866|6017245|P2|STARTED|Overall Study||97
2453588|NCT01048866|6017246|P1|STARTED|Overall Study||101
2453589|NCT01048788|6017291|P3|NOT COMPLETED|Overall Study||2
2453590|NCT01048788|6017292|P2|NOT COMPLETED|Overall Study||2
2453591|NCT01048788|6017293|P1|NOT COMPLETED|Overall Study||5
2453592|NCT01048788|6017291|P3|COMPLETED|Overall Study||11
2453593|NCT01048788|6017292|P2|COMPLETED|Overall Study||28
2453594|NCT01048788|6017293|P1|COMPLETED|Overall Study||3
2453595|NCT01048788|6017291|P3|STARTED|Overall Study||13
2453596|NCT01048788|6017292|P2|STARTED|Overall Study||30
2453597|NCT01048788|6017293|P1|STARTED|Overall Study||8
2453598|NCT01048723|6017301|P1|NOT COMPLETED|Overall Study||0
2453599|NCT01048723|6017301|P1|COMPLETED|Overall Study||2
2453600|NCT01048723|6017301|P1|STARTED|Overall Study||2
2453601|NCT01048697|6017308|P1|NOT COMPLETED|Overall Study||0
2453602|NCT01048697|6017308|P1|COMPLETED|Overall Study||18
2453603|NCT01048697|6017308|P1|STARTED|Overall Study||18
2453604|NCT01048671|6017315|P3|NOT COMPLETED|Overall Study||1
2453605|NCT01048671|6017316|P2|NOT COMPLETED|Overall Study||1
2453606|NCT01048671|6017317|P1|NOT COMPLETED|Overall Study||0
2453607|NCT01048671|6017315|P3|COMPLETED|Overall Study||151
2453608|NCT01048671|6017316|P2|COMPLETED|Overall Study||263
2453609|NCT01048671|6017317|P1|COMPLETED|Overall Study||66
2453610|NCT01048671|6017315|P3|STARTED|Overall Study||152
2453611|NCT01048671|6017316|P2|STARTED|Overall Study||264
2453612|NCT01048671|6017317|P1|STARTED|Overall Study||66
2453613|NCT01048658|6017340|P2|NOT COMPLETED|Overall Study||0
2453614|NCT01048658|6017341|P1|NOT COMPLETED|Overall Study||0
2453615|NCT01048658|6017340|P2|COMPLETED|Overall Study||80
2453616|NCT01048658|6017341|P1|COMPLETED|Overall Study||80
2453617|NCT01048658|6017340|P2|STARTED|Overall Study||80
2453618|NCT01048658|6017341|P1|STARTED|Overall Study||80
2453619|NCT01048606|6017359|P4|NOT COMPLETED|Overall Study||5
2453620|NCT01048606|6017360|P3|NOT COMPLETED|Overall Study||10
2453621|NCT01048606|6017361|P2|NOT COMPLETED|Overall Study||7
2453622|NCT01048606|6017362|P1|NOT COMPLETED|Overall Study||12
2453623|NCT01048606|6017359|P4|COMPLETED|Overall Study||5
2453624|NCT01048606|6017360|P3|COMPLETED|Overall Study||16
2453625|NCT01048606|6017361|P2|COMPLETED|Overall Study||8
2453626|NCT01048606|6017362|P1|COMPLETED|Overall Study||16
2453627|NCT01048606|6017359|P4|STARTED|Overall Study||10
2453628|NCT01048606|6017360|P3|STARTED|Overall Study||26
2453629|NCT01048606|6017361|P2|STARTED|Overall Study||15
2453630|NCT01048606|6017362|P1|STARTED|Overall Study||28
2453631|NCT01048593|6017375|P3|NOT COMPLETED|Overall Study||0
2453632|NCT01048593|6017376|P2|NOT COMPLETED|Overall Study||0
2453633|NCT01048593|6017377|P1|NOT COMPLETED|Overall Study||0
2453634|NCT01048593|6017375|P3|COMPLETED|Overall Study||1
2453635|NCT01048593|6017376|P2|COMPLETED|Overall Study||2
2453636|NCT01048593|6017377|P1|COMPLETED|Overall Study||3
2453637|NCT01048593|6017375|P3|STARTED|Overall Study||1
2453638|NCT01048593|6017376|P2|STARTED|Overall Study||2
2453639|NCT01048593|6017377|P1|STARTED|Overall Study||3
2453640|NCT01048541|6017397|P2|NOT COMPLETED|Overall Study||0
2453641|NCT01048541|6017398|P1|NOT COMPLETED|Overall Study||1
2453642|NCT01048541|6017397|P2|COMPLETED|Overall Study||19
2453643|NCT01048541|6017398|P1|COMPLETED|Overall Study||17
2453644|NCT01048541|6017397|P2|STARTED|Overall Study||19
2453645|NCT01048541|6017398|P1|STARTED|Overall Study||18
2453646|NCT01048502|6017408|P4|NOT COMPLETED|Overall Study||4
2453647|NCT01048502|6017409|P3|NOT COMPLETED|Overall Study||5
2453648|NCT01048502|6017410|P2|NOT COMPLETED|Overall Study||7
2453649|NCT01048502|6017411|P1|NOT COMPLETED|Overall Study||4
2453650|NCT01048502|6017408|P4|COMPLETED|Overall Study||21
2453651|NCT01048502|6017409|P3|COMPLETED|Overall Study||23
2453652|NCT01048502|6017410|P2|COMPLETED|Overall Study||16
2453653|NCT01048502|6017411|P1|COMPLETED|Overall Study||20
2453654|NCT01048502|6017408|P4|STARTED|Overall Study||25
2453655|NCT01048502|6017409|P3|STARTED|Overall Study||28
2453656|NCT01048502|6017410|P2|STARTED|Overall Study||23
2453657|NCT01048502|6017411|P1|STARTED|Overall Study||24
2453658|NCT01048424|6017424|P2|NOT COMPLETED|Overall Study||0
2453659|NCT01048424|6017425|P1|NOT COMPLETED|Overall Study||2
2453660|NCT01048424|6017424|P2|COMPLETED|Overall Study||10
2453661|NCT01048424|6017425|P1|COMPLETED|Overall Study||8
2453662|NCT01048424|6017424|P2|STARTED|Overall Study||10
2453663|NCT01048424|6017425|P1|STARTED|Overall Study||10
2453664|NCT01048333|6017447|P6|NOT COMPLETED|Treatment Period 3||0
2453665|NCT01048333|6017448|P5|NOT COMPLETED|Treatment Period 3||0
2453666|NCT01048333|6017449|P4|NOT COMPLETED|Treatment Period 3||0
2453667|NCT01048333|6017450|P3|NOT COMPLETED|Treatment Period 3||0
2453668|NCT01048333|6017451|P2|NOT COMPLETED|Treatment Period 3||0
2453669|NCT01048333|6017452|P1|NOT COMPLETED|Treatment Period 3||0
2453670|NCT01048333|6017447|P6|COMPLETED|Treatment Period 3||18
2453671|NCT01048333|6017448|P5|COMPLETED|Treatment Period 3||17
2453672|NCT01048333|6017449|P4|COMPLETED|Treatment Period 3||18
2453673|NCT01048333|6017450|P3|COMPLETED|Treatment Period 3||16
2453674|NCT01048333|6017451|P2|COMPLETED|Treatment Period 3||18
2453675|NCT01048333|6017452|P1|COMPLETED|Treatment Period 3||21
2453676|NCT01048333|6017447|P6|STARTED|Treatment Period 3||18
2453677|NCT01048333|6017448|P5|STARTED|Treatment Period 3||17
2453678|NCT01048333|6017449|P4|STARTED|Treatment Period 3||18
2453679|NCT01048333|6017450|P3|STARTED|Treatment Period 3||16
2453680|NCT01048333|6017451|P2|STARTED|Treatment Period 3||18
2453681|NCT01048333|6017452|P1|STARTED|Treatment Period 3||21
2453682|NCT01048333|6017447|P6|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
2453683|NCT01048333|6017448|P5|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
2453684|NCT01048333|6017449|P4|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
2453685|NCT01048333|6017450|P3|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
2453686|NCT01048333|6017451|P2|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||1
2453687|NCT01048333|6017452|P1|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
2453688|NCT01048333|6017447|P6|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
2453689|NCT01048333|6017448|P5|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||17
2453690|NCT01048333|6017449|P4|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
2453691|NCT01048333|6017450|P3|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||16
2453692|NCT01048333|6017451|P2|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
2453693|NCT01048333|6017452|P1|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||21
2453694|NCT01048333|6017447|P6|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
2453695|NCT01048333|6017448|P5|STARTED|Wash-Out Period 2 of 2 - 7 Days||17
2453696|NCT01048333|6017449|P4|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
2453697|NCT01048333|6017450|P3|STARTED|Wash-Out Period 2 of 2 - 7 Days||16
2453698|NCT01048333|6017451|P2|STARTED|Wash-Out Period 2 of 2 - 7 Days||19
2453699|NCT01048333|6017452|P1|STARTED|Wash-Out Period 2 of 2 - 7 Days||21
2453700|NCT01048333|6017447|P6|NOT COMPLETED|Treatment Period 2||0
2453701|NCT01048333|6017448|P5|NOT COMPLETED|Treatment Period 2||0
2453702|NCT01048333|6017449|P4|NOT COMPLETED|Treatment Period 2||0
2453703|NCT01048333|6017450|P3|NOT COMPLETED|Treatment Period 2||0
2453704|NCT01048333|6017451|P2|NOT COMPLETED|Treatment Period 2||0
2453705|NCT01048333|6017452|P1|NOT COMPLETED|Treatment Period 2||0
2453706|NCT01048333|6017447|P6|COMPLETED|Treatment Period 2||18
2453707|NCT01048333|6017448|P5|COMPLETED|Treatment Period 2||17
2453708|NCT01048333|6017449|P4|COMPLETED|Treatment Period 2||18
2453709|NCT01048333|6017450|P3|COMPLETED|Treatment Period 2||16
2453710|NCT01048333|6017451|P2|COMPLETED|Treatment Period 2||19
2453711|NCT01048333|6017452|P1|COMPLETED|Treatment Period 2||21
2453712|NCT01048333|6017447|P6|STARTED|Treatment Period 2||18
2453713|NCT01048333|6017448|P5|STARTED|Treatment Period 2||17
2453714|NCT01048333|6017449|P4|STARTED|Treatment Period 2||18
2453715|NCT01048333|6017450|P3|STARTED|Treatment Period 2||16
2453716|NCT01048333|6017451|P2|STARTED|Treatment Period 2||19
2453717|NCT01048333|6017452|P1|STARTED|Treatment Period 2||21
2453718|NCT01048333|6017447|P6|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
2453719|NCT01048333|6017448|P5|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
2453720|NCT01048333|6017449|P4|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
2453721|NCT01048333|6017450|P3|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
2453722|NCT01048333|6017451|P2|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
2453723|NCT01048333|6017452|P1|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
2453724|NCT01048333|6017447|P6|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
2453725|NCT01048333|6017448|P5|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||17
2453726|NCT01048333|6017449|P4|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
2453727|NCT01048333|6017450|P3|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||16
2453728|NCT01048333|6017451|P2|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||19
2453729|NCT01048333|6017452|P1|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||21
2453730|NCT01048333|6017447|P6|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
2453731|NCT01048333|6017448|P5|STARTED|Wash-Out Period 1 of 2 - 7 Days||17
2453732|NCT01048333|6017449|P4|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
2453733|NCT01048333|6017450|P3|STARTED|Wash-Out Period 1 of 2 - 7 Days||16
2453734|NCT01048333|6017451|P2|STARTED|Wash-Out Period 1 of 2 - 7 Days||19
2453735|NCT01048333|6017452|P1|STARTED|Wash-Out Period 1 of 2 - 7 Days||21
2453736|NCT01048333|6017447|P6|NOT COMPLETED|Treatment Period 1||0
2453737|NCT01048333|6017448|P5|NOT COMPLETED|Treatment Period 1||0
2453738|NCT01048333|6017449|P4|NOT COMPLETED|Treatment Period 1||0
2453739|NCT01048333|6017450|P3|NOT COMPLETED|Treatment Period 1||0
2453740|NCT01048333|6017451|P2|NOT COMPLETED|Treatment Period 1||0
2453741|NCT01048333|6017452|P1|NOT COMPLETED|Treatment Period 1||0
2453742|NCT01048333|6017447|P6|COMPLETED|Treatment Period 1||18
2453743|NCT01048333|6017448|P5|COMPLETED|Treatment Period 1||17
2453744|NCT01048333|6017449|P4|COMPLETED|Treatment Period 1||18
2453745|NCT01048333|6017450|P3|COMPLETED|Treatment Period 1||16
2453746|NCT01048333|6017451|P2|COMPLETED|Treatment Period 1||19
2453747|NCT01048333|6017452|P1|COMPLETED|Treatment Period 1||21
2453748|NCT01048333|6017447|P6|STARTED|Treatment Period 1||18
2453749|NCT01048333|6017448|P5|STARTED|Treatment Period 1||17
2453750|NCT01048333|6017449|P4|STARTED|Treatment Period 1||18
2453751|NCT01048333|6017450|P3|STARTED|Treatment Period 1||16
2453752|NCT01048333|6017451|P2|STARTED|Treatment Period 1||19
2453753|NCT01048333|6017452|P1|STARTED|Treatment Period 1||21
2453754|NCT01048242|6017474|P2|NOT COMPLETED|Overall Study||2
2453755|NCT01048242|6017475|P1|NOT COMPLETED|Overall Study||4
2453756|NCT01048242|6017474|P2|COMPLETED|Overall Study||13
2453757|NCT01048242|6017475|P1|COMPLETED|Overall Study||8
2453758|NCT01048242|6017474|P2|STARTED|Overall Study||15
2453759|NCT01048242|6017475|P1|STARTED|Overall Study||12
2453760|NCT01048125|6017483|P2|NOT COMPLETED|Overall Study||0
2453761|NCT01048125|6017484|P1|NOT COMPLETED|Overall Study||0
2453762|NCT01048125|6017483|P2|COMPLETED|Overall Study||0
2453763|NCT01048125|6017484|P1|COMPLETED|Overall Study||0
2453764|NCT01048125|6017483|P2|STARTED|Overall Study||0
2453765|NCT01048125|6017484|P1|STARTED|Overall Study||0
2453766|NCT01048099|6017490|P1|NOT COMPLETED|Treatment Per Protocol||14
2453767|NCT01048099|6017490|P1|COMPLETED|Treatment Per Protocol|Patients continued treatment until disease progression or coming off-study for any other reason|0
2453768|NCT01048099|6017490|P1|STARTED|Treatment Per Protocol||14
2453769|NCT01048099|6017490|P1|NOT COMPLETED|Pts w/ HER2 Overexpression/Activation||10
2453770|NCT01048099|6017490|P1|COMPLETED|Pts w/ HER2 Overexpression/Activation|Patients who proceeded to treatment|14
2453771|NCT01048099|6017490|P1|STARTED|Pts w/ HER2 Overexpression/Activation|Patients with detected HER2 activation and/or overexpression|24
2453772|NCT01048099|6017490|P1|NOT COMPLETED|Patients Evaluated by PRO Onc Assay||202
2453773|NCT01048099|6017490|P1|COMPLETED|Patients Evaluated by PRO Onc Assay|Patients evaluated by PRO Onc Assay with HER2 overexpression/activation detected|24
2453774|NCT01048099|6017490|P1|STARTED|Patients Evaluated by PRO Onc Assay|Patients with CTCs who were evaluated by PRO Onc Assay|226
2453775|NCT01048099|6017490|P1|NOT COMPLETED|Patients Enrolled and Blood Collected||57
2453776|NCT01048099|6017490|P1|COMPLETED|Patients Enrolled and Blood Collected|Patients with circulating tumor cells (CTCs)|226
2453777|NCT01048099|6017490|P1|STARTED|Patients Enrolled and Blood Collected|Patients enrolled|283
2453778|NCT01047839|6017501|P3|NOT COMPLETED|Overall Study||6
2453779|NCT01047839|6017502|P2|NOT COMPLETED|Overall Study||0
2453780|NCT01047839|6017503|P1|NOT COMPLETED|Overall Study||2
2453781|NCT01047839|6017501|P3|COMPLETED|Overall Study||53
2453782|NCT01047839|6017502|P2|COMPLETED|Overall Study||29
2453783|NCT01047839|6017503|P1|COMPLETED|Overall Study||10
2453784|NCT01047839|6017501|P3|STARTED|Overall Study||59
2453785|NCT01047839|6017502|P2|STARTED|Overall Study||29
2453786|NCT01047839|6017503|P1|STARTED|Overall Study||12
2453787|NCT01047709|6017511|P2|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
2453788|NCT01047709|6017512|P1|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
2453789|NCT01047709|6017511|P2|COMPLETED|Control/Positioning ad Lib (1 Night)||9
2453790|NCT01047709|6017512|P1|COMPLETED|Control/Positioning ad Lib (1 Night)||9
2453791|NCT01047709|6017511|P2|STARTED|Control/Positioning ad Lib (1 Night)||9
2453792|NCT01047709|6017512|P1|STARTED|Control/Positioning ad Lib (1 Night)||9
2453793|NCT01047709|6017511|P2|NOT COMPLETED|Positional Therapy (1 Night)||0
2453794|NCT01047709|6017512|P1|NOT COMPLETED|Positional Therapy (1 Night)||0
2453795|NCT01047709|6017511|P2|COMPLETED|Positional Therapy (1 Night)||9
2453796|NCT01047709|6017512|P1|COMPLETED|Positional Therapy (1 Night)||9
2453797|NCT01047709|6017511|P2|STARTED|Positional Therapy (1 Night)||9
2453798|NCT01047709|6017512|P1|STARTED|Positional Therapy (1 Night)||9
2453799|NCT01047553|6017520|P2|NOT COMPLETED|Overall Study||9
2453800|NCT01047553|6017521|P1|NOT COMPLETED|Overall Study||17
2453801|NCT01047553|6017520|P2|COMPLETED|Overall Study||117
2453802|NCT01047553|6017521|P1|COMPLETED|Overall Study||108
2453803|NCT01047553|6017520|P2|STARTED|Overall Study||126
2453804|NCT01047553|6017521|P1|STARTED|Overall Study||125
2453805|NCT01047527|6017606|P3|NOT COMPLETED|Overall Study||65
2453806|NCT01047527|6017607|P2|NOT COMPLETED|Overall Study||61
2453807|NCT01047527|6017608|P1|NOT COMPLETED|Overall Study||85
2453808|NCT01047527|6017606|P3|COMPLETED|Overall Study||107
2453809|NCT01047527|6017607|P2|COMPLETED|Overall Study||112
2453810|NCT01047527|6017608|P1|COMPLETED|Overall Study||95
2453811|NCT01047527|6017606|P3|24 Weeks|Overall Study||119
2453812|NCT01047527|6017607|P2|24 Weeks|Overall Study||123
2453813|NCT01047527|6017608|P1|24 Weeks|Overall Study||111
2453814|NCT01047527|6017606|P3|8 Weeks|Overall Study||138
2453815|NCT01047527|6017607|P2|8 Weeks|Overall Study||142
2453816|NCT01047527|6017608|P1|8 Weeks|Overall Study||148
2453817|NCT01047527|6017606|P3|STARTED|Overall Study||172
2453818|NCT01047527|6017607|P2|STARTED|Overall Study||173
2453819|NCT01047527|6017608|P1|STARTED|Overall Study||180
2453820|NCT01047475|6017619|P2|NOT COMPLETED|Overall Study||7
2453821|NCT01047475|6017620|P1|NOT COMPLETED|Overall Study||5
2453822|NCT01047475|6017619|P2|COMPLETED|Overall Study||31
2453823|NCT01047475|6017620|P1|COMPLETED|Overall Study||29
2453824|NCT01047475|6017619|P2|STARTED|Overall Study||38
2453825|NCT01047475|6017620|P1|STARTED|Overall Study||34
2453826|NCT01047436|6017628|P2|NOT COMPLETED|Overall Study||0
2453827|NCT01047436|6017629|P1|NOT COMPLETED|Overall Study||1
2453828|NCT01047436|6017628|P2|COMPLETED|Overall Study||15
2453829|NCT01047436|6017629|P1|COMPLETED|Overall Study||15
2453830|NCT01047436|6017628|P2|STARTED|Overall Study||15
2453831|NCT01047436|6017629|P1|STARTED|Overall Study||16
2453832|NCT01047358|6017645|P1|NOT COMPLETED|Overall Study||0
2453833|NCT01047358|6017645|P1|COMPLETED|Overall Study|At least one safety assessment (Safety Population)|206
2453834|NCT01047358|6017645|P1|STARTED|Overall Study||206
2453835|NCT01047345|6017654|P3|NOT COMPLETED|Extension||6
2453836|NCT01047345|6017655|P2|NOT COMPLETED|Extension||0
2453837|NCT01047345|6017656|P1|NOT COMPLETED|Extension||0
2453838|NCT01047345|6017654|P3|COMPLETED|Extension||96
2453839|NCT01047345|6017655|P2|COMPLETED|Extension||0
2453840|NCT01047345|6017656|P1|COMPLETED|Extension||0
2453841|NCT01047345|6017654|P3|Vaccination 6|Extension|1 participant received 6th vaccination outside the context of study but completed the study.|95
2453842|NCT01047345|6017655|P2|Vaccination 6|Extension||0
2453843|NCT01047345|6017656|P1|Vaccination 6|Extension||0
2453844|NCT01047345|6017654|P3|Vaccination 5|Extension||99
2453845|NCT01047345|6017655|P2|Vaccination 5|Extension||0
2453846|NCT01047345|6017656|P1|Vaccination 5|Extension||0
2453847|NCT01047345|6017654|P3|Vaccination 4|Extension||102
2453848|NCT01047345|6017655|P2|Vaccination 4|Extension||0
2453849|NCT01047345|6017656|P1|Vaccination 4|Extension||0
2453850|NCT01047345|6017654|P3|STARTED|Extension|Not all eligible participants elected to participate in extension|102
2453851|NCT01047345|6017655|P2|STARTED|Extension||0
2453852|NCT01047345|6017656|P1|STARTED|Extension||0
2453853|NCT01047345|6017654|P3|NOT COMPLETED|Base Study||0
2453854|NCT01047345|6017655|P2|NOT COMPLETED|Base Study||6
2453855|NCT01047345|6017656|P1|NOT COMPLETED|Base Study||22
2453856|NCT01047345|6017654|P3|COMPLETED|Base Study||0
2453857|NCT01047345|6017655|P2|COMPLETED|Base Study||300
2453858|NCT01047345|6017656|P1|COMPLETED|Base Study|Includes 1 participant for whom completion status is unknown|596
2453859|NCT01047345|6017654|P3|Vaccination 3|Base Study||0
2453860|NCT01047345|6017655|P2|Vaccination 3|Base Study||300
2453861|NCT01047345|6017656|P1|Vaccination 3|Base Study||597
2453862|NCT01047345|6017654|P3|Vaccination 2|Base Study||0
2453863|NCT01047345|6017655|P2|Vaccination 2|Base Study||304
2453864|NCT01047345|6017656|P1|Vaccination 2|Base Study||604
2453865|NCT01047345|6017654|P3|Vaccination 1|Base Study||0
2453866|NCT01047345|6017655|P2|Vaccination 1|Base Study||306
2453867|NCT01047345|6017656|P1|Vaccination 1|Base Study||615
2453868|NCT01047345|6017654|P3|STARTED|Base Study||0
2453869|NCT01047345|6017655|P2|STARTED|Base Study||306
2453870|NCT01047345|6017656|P1|STARTED|Base Study||618
2453871|NCT01047332|6017678|P2|NOT COMPLETED|Overall Study||64
2453872|NCT01047332|6017679|P1|NOT COMPLETED|Overall Study||57
2453873|NCT01047332|6017678|P2|COMPLETED|Overall Study|Alive at final follow-up|4
2453874|NCT01047332|6017679|P1|COMPLETED|Overall Study|Alive at final follow-up|4
2453875|NCT01047332|6017678|P2|STARTED|Overall Study||68
2453876|NCT01047332|6017679|P1|STARTED|Overall Study||61
2453877|NCT01047319|6017694|P3|NOT COMPLETED|Overall Study||352
2453878|NCT01047319|6017695|P2|NOT COMPLETED|Overall Study||350
2453879|NCT01047319|6017696|P1|NOT COMPLETED|Overall Study||345
2453880|NCT01047319|6017694|P3|COMPLETED|Overall Study||0
2453881|NCT01047319|6017695|P2|COMPLETED|Overall Study||0
2453882|NCT01047319|6017696|P1|COMPLETED|Overall Study||0
2453883|NCT01047319|6017694|P3|STARTED|Overall Study||352
2453884|NCT01047319|6017695|P2|STARTED|Overall Study||350
2453885|NCT01047319|6017696|P1|STARTED|Overall Study||345
2453886|NCT01047306|6017718|P2|NOT COMPLETED|Overall Study||0
2453887|NCT01047306|6017719|P1|NOT COMPLETED|Overall Study||3
2453888|NCT01047306|6017718|P2|COMPLETED|Overall Study||6
2453889|NCT01047306|6017719|P1|COMPLETED|Overall Study||16
2453890|NCT01047306|6017718|P2|Discontinued From the Study|Overall Study||0
2453891|NCT01047306|6017719|P1|Discontinued From the Study|Overall Study||3
2453892|NCT01047306|6017718|P2|STARTED|Overall Study||6
2453893|NCT01047306|6017719|P1|STARTED|Overall Study||19
2453894|NCT01047293|6017793|P4|NOT COMPLETED|Overall Study||0
2453895|NCT01047293|6017794|P3|NOT COMPLETED|Overall Study||0
2453896|NCT01047293|6017795|P2|NOT COMPLETED|Overall Study||1
2453897|NCT01047293|6017796|P1|NOT COMPLETED|Overall Study||1
2453898|NCT01047293|6017793|P4|COMPLETED|Overall Study||26
2453899|NCT01047293|6017794|P3|COMPLETED|Overall Study||9
2453900|NCT01047293|6017795|P2|COMPLETED|Overall Study||7
2453901|NCT01047293|6017796|P1|COMPLETED|Overall Study||3
2453902|NCT01047293|6017793|P4|STARTED|Overall Study||26
2453903|NCT01047293|6017794|P3|STARTED|Overall Study||9
2453904|NCT01047293|6017795|P2|STARTED|Overall Study||8
2453905|NCT01047293|6017796|P1|STARTED|Overall Study||4
2453906|NCT01047241|6017803|P1|NOT COMPLETED|Overall Study||0
2453907|NCT01047241|6017803|P1|COMPLETED|Overall Study||50
2453908|NCT01047241|6017803|P1|STARTED|Overall Study||50
2453909|NCT01047189|6017814|P2|NOT COMPLETED|Overall Study||0
2453910|NCT01047189|6017815|P1|NOT COMPLETED|Overall Study||4
2453911|NCT01047189|6017814|P2|COMPLETED|Overall Study||13
2453912|NCT01047189|6017815|P1|COMPLETED|Overall Study||9
2453913|NCT01047189|6017814|P2|STARTED|Overall Study||13
2453914|NCT01047189|6017815|P1|STARTED|Overall Study||13
2453915|NCT01047007|6017827|P4|NOT COMPLETED|Overall Study||0
2453916|NCT01047007|6017828|P3|NOT COMPLETED|Overall Study||2
2453917|NCT01047007|6017829|P2|NOT COMPLETED|Overall Study||6
2453918|NCT01047007|6017830|P1|NOT COMPLETED|Overall Study||2
2453919|NCT01047007|6017827|P4|COMPLETED|Overall Study||0
2453920|NCT01047007|6017828|P3|COMPLETED|Overall Study||0
2453921|NCT01047007|6017829|P2|COMPLETED|Overall Study||0
2453922|NCT01047007|6017830|P1|COMPLETED|Overall Study||1
2453923|NCT01047007|6017827|P4|Treated|Overall Study||0
2453924|NCT01047007|6017828|P3|Treated|Overall Study||2
2453925|NCT01047007|6017829|P2|Treated|Overall Study||6
2453926|NCT01047007|6017830|P1|Treated|Overall Study||3
2453927|NCT01047007|6017827|P4|STARTED|Overall Study||0
2453928|NCT01047007|6017828|P3|STARTED|Overall Study||2
2453929|NCT01047007|6017829|P2|STARTED|Overall Study||6
2453930|NCT01047007|6017830|P1|STARTED|Overall Study||3
2453931|NCT01046903|6017841|P1|NOT COMPLETED|Overall Study||28
2453932|NCT01046903|6017841|P1|COMPLETED|Overall Study||475
2453933|NCT01046903|6017841|P1|STARTED|Overall Study||503
2453934|NCT01046877|6017854|P1|NOT COMPLETED|Overall Study||18
2453935|NCT01046877|6017854|P1|COMPLETED|Overall Study||7
2454022|NCT01046253|6017947|P1|STARTED|Second Washout of 7 Days||25
2453936|NCT01046877|6017854|P1|Completed Study Late|Overall Study|One completed (evidencing extrusions) at 23.5 mos. Missed 9 mo visit. Exam not possible at 12 mo.|1
2453937|NCT01046877|6017854|P1|Completed on Schedule|Overall Study|Final visit = the earlier of 24 months post-procedure or 12 months after extrusion.|6
2453938|NCT01046877|6017854|P1|STARTED|Overall Study||25
2453939|NCT01046695|6017870|P2|NOT COMPLETED|Overall Study||2
2453940|NCT01046695|6017871|P1|NOT COMPLETED|Overall Study||0
2453941|NCT01046695|6017870|P2|COMPLETED|Overall Study||20
2453942|NCT01046695|6017871|P1|COMPLETED|Overall Study||20
2453943|NCT01046695|6017870|P2|STARTED|Overall Study||22
2453944|NCT01046695|6017871|P1|STARTED|Overall Study||20
2453945|NCT01046682|6017883|P2|NOT COMPLETED|Overall Study||0
2453946|NCT01046682|6017884|P1|NOT COMPLETED|Overall Study||2
2453947|NCT01046682|6017883|P2|COMPLETED|Overall Study||20
2453948|NCT01046682|6017884|P1|COMPLETED|Overall Study||18
2453949|NCT01046682|6017883|P2|STARTED|Overall Study||20
2453950|NCT01046682|6017884|P1|STARTED|Overall Study||20
2453951|NCT01046669|6017892|P2|NOT COMPLETED|Overall Study||1
2453952|NCT01046669|6017893|P1|NOT COMPLETED|Overall Study||0
2453953|NCT01046669|6017892|P2|COMPLETED|Overall Study||223
2453954|NCT01046669|6017893|P1|COMPLETED|Overall Study||226
2453955|NCT01046669|6017892|P2|STARTED|Overall Study||224
2453956|NCT01046669|6017893|P1|STARTED|Overall Study||226
2453957|NCT01046643|6017901|P4|NOT COMPLETED|Second Period Treatment or Placebo||0
2453958|NCT01046643|6017902|P3|NOT COMPLETED|Second Period Treatment or Placebo||0
2453959|NCT01046643|6017903|P2|NOT COMPLETED|Second Period Treatment or Placebo||0
2453960|NCT01046643|6017904|P1|NOT COMPLETED|Second Period Treatment or Placebo||0
2453961|NCT01046643|6017901|P4|COMPLETED|Second Period Treatment or Placebo||7
2453962|NCT01046643|6017902|P3|COMPLETED|Second Period Treatment or Placebo||7
2453963|NCT01046643|6017903|P2|COMPLETED|Second Period Treatment or Placebo||6
2453964|NCT01046643|6017904|P1|COMPLETED|Second Period Treatment or Placebo||9
2453965|NCT01046643|6017901|P4|STARTED|Second Period Treatment or Placebo||7
2453966|NCT01046643|6017902|P3|STARTED|Second Period Treatment or Placebo||7
2453967|NCT01046643|6017903|P2|STARTED|Second Period Treatment or Placebo||6
2453968|NCT01046643|6017904|P1|STARTED|Second Period Treatment or Placebo||9
2453969|NCT01046643|6017901|P4|NOT COMPLETED|Washout Period||0
2453970|NCT01046643|6017902|P3|NOT COMPLETED|Washout Period||0
2453971|NCT01046643|6017903|P2|NOT COMPLETED|Washout Period||0
2453972|NCT01046643|6017904|P1|NOT COMPLETED|Washout Period||0
2453973|NCT01046643|6017901|P4|COMPLETED|Washout Period||7
2453974|NCT01046643|6017902|P3|COMPLETED|Washout Period||7
2453975|NCT01046643|6017903|P2|COMPLETED|Washout Period||6
2453976|NCT01046643|6017904|P1|COMPLETED|Washout Period||9
2453977|NCT01046643|6017901|P4|STARTED|Washout Period||7
2453978|NCT01046643|6017902|P3|STARTED|Washout Period||7
2453979|NCT01046643|6017903|P2|STARTED|Washout Period||6
2453980|NCT01046643|6017904|P1|STARTED|Washout Period||9
2453981|NCT01046643|6017901|P4|NOT COMPLETED|First Period Treatment or Placebo||0
2453982|NCT01046643|6017902|P3|NOT COMPLETED|First Period Treatment or Placebo||0
2453983|NCT01046643|6017903|P2|NOT COMPLETED|First Period Treatment or Placebo||1
2453984|NCT01046643|6017904|P1|NOT COMPLETED|First Period Treatment or Placebo||0
2453985|NCT01046643|6017901|P4|COMPLETED|First Period Treatment or Placebo||7
2453986|NCT01046643|6017902|P3|COMPLETED|First Period Treatment or Placebo||7
2453987|NCT01046643|6017903|P2|COMPLETED|First Period Treatment or Placebo||6
2453988|NCT01046643|6017904|P1|COMPLETED|First Period Treatment or Placebo||9
2453989|NCT01046643|6017901|P4|STARTED|First Period Treatment or Placebo||7
2453990|NCT01046643|6017902|P3|STARTED|First Period Treatment or Placebo||7
2453991|NCT01046643|6017903|P2|STARTED|First Period Treatment or Placebo||7
2453992|NCT01046643|6017904|P1|STARTED|First Period Treatment or Placebo||9
2453993|NCT01046565|6017926|P1|NOT COMPLETED|Overall Study||9
2453994|NCT01046565|6017926|P1|COMPLETED|Overall Study||66
2453995|NCT01046565|6017926|P1|STARTED|Overall Study||75
2453996|NCT01046396|6017935|P1|NOT COMPLETED|Overall Study||5
2453997|NCT01046396|6017935|P1|COMPLETED|Overall Study||64
2453998|NCT01046396|6017935|P1|STARTED|Overall Study||69
2453999|NCT01046253|6017946|P2|NOT COMPLETED|Fourth Intervention||0
2454000|NCT01046253|6017947|P1|NOT COMPLETED|Fourth Intervention||0
2454001|NCT01046253|6017946|P2|COMPLETED|Fourth Intervention||23
2454002|NCT01046253|6017947|P1|COMPLETED|Fourth Intervention||25
2454003|NCT01046253|6017946|P2|STARTED|Fourth Intervention||23
2454004|NCT01046253|6017947|P1|STARTED|Fourth Intervention||25
2454005|NCT01046253|6017946|P2|NOT COMPLETED|Third Washout of 7 Days||0
2454006|NCT01046253|6017947|P1|NOT COMPLETED|Third Washout of 7 Days||0
2454007|NCT01046253|6017946|P2|COMPLETED|Third Washout of 7 Days||23
2454008|NCT01046253|6017947|P1|COMPLETED|Third Washout of 7 Days||25
2454009|NCT01046253|6017946|P2|STARTED|Third Washout of 7 Days||23
2454010|NCT01046253|6017947|P1|STARTED|Third Washout of 7 Days||25
2454011|NCT01046253|6017946|P2|NOT COMPLETED|Third Intervention||0
2454012|NCT01046253|6017947|P1|NOT COMPLETED|Third Intervention||0
2454013|NCT01046253|6017946|P2|COMPLETED|Third Intervention||23
2454014|NCT01046253|6017947|P1|COMPLETED|Third Intervention||25
2454015|NCT01046253|6017946|P2|STARTED|Third Intervention||23
2454016|NCT01046253|6017947|P1|STARTED|Third Intervention||25
2454017|NCT01046253|6017946|P2|NOT COMPLETED|Second Washout of 7 Days||0
2454018|NCT01046253|6017947|P1|NOT COMPLETED|Second Washout of 7 Days||0
2454019|NCT01046253|6017946|P2|COMPLETED|Second Washout of 7 Days||23
2454020|NCT01046253|6017947|P1|COMPLETED|Second Washout of 7 Days||25
2454021|NCT01046253|6017946|P2|STARTED|Second Washout of 7 Days||23
2454023|NCT01046253|6017946|P2|NOT COMPLETED|Second Intervention||2
2454024|NCT01046253|6017947|P1|NOT COMPLETED|Second Intervention||0
2454025|NCT01046253|6017946|P2|COMPLETED|Second Intervention||23
2454026|NCT01046253|6017947|P1|COMPLETED|Second Intervention||25
2454027|NCT01046253|6017946|P2|STARTED|Second Intervention||25
2454028|NCT01046253|6017947|P1|STARTED|Second Intervention||25
2454029|NCT01046253|6017946|P2|NOT COMPLETED|First Washout of 7 Days||0
2454030|NCT01046253|6017947|P1|NOT COMPLETED|First Washout of 7 Days||0
2454031|NCT01046253|6017946|P2|COMPLETED|First Washout of 7 Days||25
2454032|NCT01046253|6017947|P1|COMPLETED|First Washout of 7 Days||25
2454033|NCT01046253|6017946|P2|STARTED|First Washout of 7 Days||25
2454034|NCT01046253|6017947|P1|STARTED|First Washout of 7 Days||25
2454035|NCT01046253|6017946|P2|NOT COMPLETED|First Intervention||0
2454036|NCT01046253|6017947|P1|NOT COMPLETED|First Intervention||0
2454037|NCT01046253|6017946|P2|COMPLETED|First Intervention||25
2454038|NCT01046253|6017947|P1|COMPLETED|First Intervention||25
2454039|NCT01046253|6017946|P2|STARTED|First Intervention||25
2454040|NCT01046253|6017947|P1|STARTED|First Intervention||25
2454041|NCT01046136|6017959|P2|NOT COMPLETED|Overall Study||8
2454042|NCT01046136|6017960|P1|NOT COMPLETED|Overall Study||4
2454043|NCT01046136|6017959|P2|COMPLETED|Overall Study||182
2454044|NCT01046136|6017960|P1|COMPLETED|Overall Study||184
2454045|NCT01046136|6017959|P2|STARTED|Overall Study||190
2454046|NCT01046136|6017960|P1|STARTED|Overall Study||188
2454047|NCT01046110|6017972|P2|NOT COMPLETED|Overall Study||55
2454048|NCT01046110|6017973|P1|NOT COMPLETED|Overall Study||55
2454049|NCT01046110|6017972|P2|COMPLETED|Overall Study||174
2454050|NCT01046110|6017973|P1|COMPLETED|Overall Study||174
2454051|NCT01046110|6017972|P2|Exposed|Overall Study|1 subject was randomised in error|228
2454052|NCT01046110|6017973|P1|Exposed|Overall Study|2 subjects were randomised in error and 1 subject did not want to take insulin|226
2454053|NCT01046110|6017972|P2|STARTED|Overall Study||229
2454054|NCT01046110|6017973|P1|STARTED|Overall Study||229
2454055|NCT01046084|6017983|P2|NOT COMPLETED|Fourth Intervention||0
2454056|NCT01046084|6017984|P1|NOT COMPLETED|Fourth Intervention||0
2454057|NCT01046084|6017983|P2|COMPLETED|Fourth Intervention||25
2454058|NCT01046084|6017984|P1|COMPLETED|Fourth Intervention||23
2454059|NCT01046084|6017983|P2|STARTED|Fourth Intervention||25
2454060|NCT01046084|6017984|P1|STARTED|Fourth Intervention||23
2454061|NCT01046084|6017983|P2|NOT COMPLETED|Third Washout of 7 Days||0
2454062|NCT01046084|6017984|P1|NOT COMPLETED|Third Washout of 7 Days||2
2454063|NCT01046084|6017983|P2|COMPLETED|Third Washout of 7 Days||25
2454064|NCT01046084|6017984|P1|COMPLETED|Third Washout of 7 Days||23
2454065|NCT01046084|6017983|P2|STARTED|Third Washout of 7 Days||25
2454066|NCT01046084|6017984|P1|STARTED|Third Washout of 7 Days||25
2454067|NCT01046084|6017983|P2|NOT COMPLETED|Third Intervention||0
2454068|NCT01046084|6017984|P1|NOT COMPLETED|Third Intervention||0
2454069|NCT01046084|6017983|P2|COMPLETED|Third Intervention||25
2454070|NCT01046084|6017984|P1|COMPLETED|Third Intervention||25
2454071|NCT01046084|6017983|P2|STARTED|Third Intervention||25
2454072|NCT01046084|6017984|P1|STARTED|Third Intervention||25
2454073|NCT01046084|6017983|P2|NOT COMPLETED|Second Washout of 7 Days||0
2454074|NCT01046084|6017984|P1|NOT COMPLETED|Second Washout of 7 Days||0
2454075|NCT01046084|6017983|P2|COMPLETED|Second Washout of 7 Days||25
2454076|NCT01046084|6017984|P1|COMPLETED|Second Washout of 7 Days||25
2454077|NCT01046084|6017983|P2|STARTED|Second Washout of 7 Days||25
2454078|NCT01046084|6017984|P1|STARTED|Second Washout of 7 Days||25
2454079|NCT01046084|6017983|P2|NOT COMPLETED|Second Intervention||0
2454080|NCT01046084|6017984|P1|NOT COMPLETED|Second Intervention||0
2454081|NCT01046084|6017983|P2|COMPLETED|Second Intervention||25
2454082|NCT01046084|6017984|P1|COMPLETED|Second Intervention||25
2454083|NCT01046084|6017983|P2|STARTED|Second Intervention||25
2454084|NCT01046084|6017984|P1|STARTED|Second Intervention||25
2454085|NCT01046084|6017983|P2|NOT COMPLETED|First Washout of 7 Days||0
2454086|NCT01046084|6017984|P1|NOT COMPLETED|First Washout of 7 Days||0
2454087|NCT01046084|6017983|P2|COMPLETED|First Washout of 7 Days||25
2454088|NCT01046084|6017984|P1|COMPLETED|First Washout of 7 Days||25
2454089|NCT01046084|6017983|P2|STARTED|First Washout of 7 Days||25
2454090|NCT01046084|6017984|P1|STARTED|First Washout of 7 Days||25
2454091|NCT01046084|6017983|P2|NOT COMPLETED|First Intervention||0
2454092|NCT01046084|6017984|P1|NOT COMPLETED|First Intervention||0
2454093|NCT01046084|6017983|P2|COMPLETED|First Intervention||25
2454094|NCT01046084|6017984|P1|COMPLETED|First Intervention||25
2454095|NCT01046084|6017983|P2|STARTED|First Intervention||25
2454096|NCT01046084|6017984|P1|STARTED|First Intervention||25
2454097|NCT01045993|6017998|P4|NOT COMPLETED|Overall Study||0
2454098|NCT01045993|6017999|P3|NOT COMPLETED|Overall Study||0
2454099|NCT01045993|6018000|P2|NOT COMPLETED|Overall Study||1
2454100|NCT01045993|6018001|P1|NOT COMPLETED|Overall Study||0
2454101|NCT01045993|6017998|P4|COMPLETED|Overall Study||25
2454102|NCT01045993|6017999|P3|COMPLETED|Overall Study||5
2454103|NCT01045993|6018000|P2|COMPLETED|Overall Study||4
2454104|NCT01045993|6018001|P1|COMPLETED|Overall Study||26
2454105|NCT01045993|6017998|P4|STARTED|Overall Study||25
2454106|NCT01045993|6017999|P3|STARTED|Overall Study||5
2454107|NCT01045993|6018000|P2|STARTED|Overall Study||5
2454108|NCT01045993|6018001|P1|STARTED|Overall Study||26
2454109|NCT01045967|6018077|P2|NOT COMPLETED|Second Intervention||1
2454110|NCT01045967|6018078|P1|NOT COMPLETED|Second Intervention||0
2454111|NCT01045967|6018077|P2|COMPLETED|Second Intervention||27
2454112|NCT01045967|6018078|P1|COMPLETED|Second Intervention||28
2454113|NCT01045967|6018077|P2|STARTED|Second Intervention|Subject was dropped prior to dosing in Period II due to positive drug screen.|28
2454114|NCT01045967|6018078|P1|STARTED|Second Intervention||28
2454115|NCT01045967|6018077|P2|NOT COMPLETED|Washout of 7 Days||0
2454116|NCT01045967|6018078|P1|NOT COMPLETED|Washout of 7 Days||0
2454117|NCT01045967|6018077|P2|COMPLETED|Washout of 7 Days||28
2454118|NCT01045967|6018078|P1|COMPLETED|Washout of 7 Days||28
2454119|NCT01045967|6018077|P2|STARTED|Washout of 7 Days||28
2454120|NCT01045967|6018078|P1|STARTED|Washout of 7 Days||28
2454121|NCT01045967|6018077|P2|NOT COMPLETED|First Intervention||0
2454122|NCT01045967|6018078|P1|NOT COMPLETED|First Intervention||0
2454123|NCT01045967|6018077|P2|COMPLETED|First Intervention||28
2454124|NCT01045967|6018078|P1|COMPLETED|First Intervention||28
2454125|NCT01045967|6018077|P2|STARTED|First Intervention||28
2454126|NCT01045967|6018078|P1|STARTED|First Intervention||28
2454127|NCT01045798|6018090|P2|NOT COMPLETED|Overall Study||4
2454128|NCT01045798|6018091|P1|NOT COMPLETED|Overall Study||2
2454129|NCT01045798|6018090|P2|COMPLETED|Overall Study||5
2454130|NCT01045798|6018091|P1|COMPLETED|Overall Study||4
2454131|NCT01045798|6018090|P2|STARTED|Overall Study||9
2454132|NCT01045798|6018091|P1|STARTED|Overall Study||6
2454133|NCT01045707|6018099|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||12
2454134|NCT01045707|6018100|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||13
2454135|NCT01045707|6018099|P2|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||209
2454136|NCT01045707|6018100|P1|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||179
2454137|NCT01045707|6018099|P2|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Eleven subjects from main trial did not continue into the extension|221
2454138|NCT01045707|6018100|P1|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Twenty seven subjects from main trial did not continue into the extension|192
2454139|NCT01045707|6018099|P2|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||32
2454140|NCT01045707|6018100|P1|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||47
2454141|NCT01045707|6018099|P2|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||232
2454142|NCT01045707|6018100|P1|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||219
2454143|NCT01045707|6018099|P2|Exposed|Main: Week 0 to 26 (NN5401-3590)|Three subjects withdrew prior to exposure to trial drug|261
2454144|NCT01045707|6018100|P1|Exposed|Main: Week 0 to 26 (NN5401-3590)|One subject withdrew prior to exposure to trial drug|265
2454145|NCT01045707|6018099|P2|STARTED|Main: Week 0 to 26 (NN5401-3590)||264
2454146|NCT01045707|6018100|P1|STARTED|Main: Week 0 to 26 (NN5401-3590)||266
2454147|NCT01045694|6018116|P1|NOT COMPLETED|Overall Study||2
2454148|NCT01045694|6018116|P1|COMPLETED|Overall Study||6
2454149|NCT01045694|6018116|P1|STARTED|Overall Study||8
2454150|NCT01045551|6018122|P1|NOT COMPLETED|Overall Study||0
2454151|NCT01045551|6018122|P1|COMPLETED|Overall Study||10
2454152|NCT01045551|6018122|P1|STARTED|Overall Study||10
2454153|NCT01045460|6018132|P2|NOT COMPLETED|Overall Study||3
2454154|NCT01045460|6018133|P1|NOT COMPLETED|Overall Study||6
2454155|NCT01045460|6018132|P2|COMPLETED|Overall Study||15
2454156|NCT01045460|6018133|P1|COMPLETED|Overall Study||11
2454157|NCT01045460|6018132|P2|STARTED|Overall Study||18
2454158|NCT01045460|6018133|P1|STARTED|Overall Study||17
2454159|NCT01045447|6018145|P2|NOT COMPLETED|Overall Study||28
2454160|NCT01045447|6018146|P1|NOT COMPLETED|Overall Study||36
2454161|NCT01045447|6018145|P2|COMPLETED|Overall Study||205
2454162|NCT01045447|6018146|P1|COMPLETED|Overall Study||196
2454163|NCT01045447|6018145|P2|Exposed|Overall Study||233
2454164|NCT01045447|6018146|P1|Exposed|Overall Study|Two subjects withdrew prior to exposure to trial drug|230
2454165|NCT01045447|6018145|P2|STARTED|Overall Study||233
2454166|NCT01045447|6018146|P1|STARTED|Overall Study||232
2454167|NCT01045421|6018160|P11|NOT COMPLETED|Phase 2||2
2454168|NCT01045421|6018161|P10|NOT COMPLETED|Phase 2||3
2454169|NCT01045421|6018162|P9|NOT COMPLETED|Phase 2||2
2454170|NCT01045421|6018163|P8|NOT COMPLETED|Phase 2||5
2454171|NCT01045421|6018164|P7|NOT COMPLETED|Phase 2||0
2454172|NCT01045421|6018165|P6|NOT COMPLETED|Phase 2||0
2454173|NCT01045421|6018166|P5|NOT COMPLETED|Phase 2||0
2454174|NCT01045421|6018167|P4|NOT COMPLETED|Phase 2||0
2454175|NCT01045421|6018168|P3|NOT COMPLETED|Phase 2||0
2454176|NCT01045421|6018169|P2|NOT COMPLETED|Phase 2||0
2454177|NCT01045421|6018170|P1|NOT COMPLETED|Phase 2||0
2454178|NCT01045421|6018160|P11|COMPLETED|Phase 2||58
2454179|NCT01045421|6018161|P10|COMPLETED|Phase 2||23
2454180|NCT01045421|6018162|P9|COMPLETED|Phase 2||53
2454181|NCT01045421|6018163|P8|COMPLETED|Phase 2||50
2454182|NCT01045421|6018164|P7|COMPLETED|Phase 2||53
2454183|NCT01045421|6018165|P6|COMPLETED|Phase 2||0
2454184|NCT01045421|6018166|P5|COMPLETED|Phase 2||0
2454185|NCT01045421|6018167|P4|COMPLETED|Phase 2||0
2454186|NCT01045421|6018168|P3|COMPLETED|Phase 2||0
2454187|NCT01045421|6018169|P2|COMPLETED|Phase 2||0
2454188|NCT01045421|6018170|P1|COMPLETED|Phase 2||0
2454189|NCT01045421|6018160|P11|STARTED|Phase 2||60
2454190|NCT01045421|6018161|P10|STARTED|Phase 2||26
2454191|NCT01045421|6018162|P9|STARTED|Phase 2||55
2454192|NCT01045421|6018163|P8|STARTED|Phase 2||55
2454193|NCT01045421|6018164|P7|STARTED|Phase 2||53
2454194|NCT01045421|6018165|P6|STARTED|Phase 2||0
2454195|NCT01045421|6018166|P5|STARTED|Phase 2||0
2454196|NCT01045421|6018167|P4|STARTED|Phase 2||0
2454197|NCT01045421|6018168|P3|STARTED|Phase 2||0
2454198|NCT01045421|6018169|P2|STARTED|Phase 2||0
2454199|NCT01045421|6018170|P1|STARTED|Phase 2||0
2454200|NCT01045421|6018160|P11|NOT COMPLETED|Phase 1||0
2454201|NCT01045421|6018161|P10|NOT COMPLETED|Phase 1||0
2454202|NCT01045421|6018162|P9|NOT COMPLETED|Phase 1||0
2454203|NCT01045421|6018163|P8|NOT COMPLETED|Phase 1||0
2454204|NCT01045421|6018164|P7|NOT COMPLETED|Phase 1||0
2454205|NCT01045421|6018165|P6|NOT COMPLETED|Phase 1||0
2454206|NCT01045421|6018166|P5|NOT COMPLETED|Phase 1||1
2454207|NCT01045421|6018167|P4|NOT COMPLETED|Phase 1||1
2454208|NCT01045421|6018168|P3|NOT COMPLETED|Phase 1||0
2454209|NCT01045421|6018169|P2|NOT COMPLETED|Phase 1||0
2454210|NCT01045421|6018170|P1|NOT COMPLETED|Phase 1||0
2454211|NCT01045421|6018160|P11|COMPLETED|Phase 1||0
2454212|NCT01045421|6018161|P10|COMPLETED|Phase 1||0
2454213|NCT01045421|6018162|P9|COMPLETED|Phase 1||0
2454214|NCT01045421|6018163|P8|COMPLETED|Phase 1||0
2454215|NCT01045421|6018164|P7|COMPLETED|Phase 1||0
2454216|NCT01045421|6018165|P6|COMPLETED|Phase 1||1
2454217|NCT01045421|6018166|P5|COMPLETED|Phase 1||2
2454218|NCT01045421|6018167|P4|COMPLETED|Phase 1||11
2454219|NCT01045421|6018168|P3|COMPLETED|Phase 1||4
2454220|NCT01045421|6018169|P2|COMPLETED|Phase 1||3
2454221|NCT01045421|6018170|P1|COMPLETED|Phase 1||1
2454222|NCT01045421|6018160|P11|STARTED|Phase 1||0
2454223|NCT01045421|6018161|P10|STARTED|Phase 1||0
2454224|NCT01045421|6018162|P9|STARTED|Phase 1||0
2454225|NCT01045421|6018163|P8|STARTED|Phase 1||0
2454226|NCT01045421|6018164|P7|STARTED|Phase 1||0
2454227|NCT01045421|6018165|P6|STARTED|Phase 1||1
2454228|NCT01045421|6018166|P5|STARTED|Phase 1||3
2454229|NCT01045421|6018167|P4|STARTED|Phase 1||12
2454230|NCT01045421|6018168|P3|STARTED|Phase 1||4
2454231|NCT01045421|6018169|P2|STARTED|Phase 1||3
2454232|NCT01045421|6018170|P1|STARTED|Phase 1||1
2454233|NCT01045265|6018250|P1|NOT COMPLETED|Overall Study||0
2454234|NCT01045265|6018250|P1|COMPLETED|Overall Study||16
2454235|NCT01045265|6018250|P1|STARTED|Overall Study||16
2454236|NCT01045187|6018257|P1|NOT COMPLETED|Overall Study||0
2454237|NCT01045187|6018257|P1|COMPLETED|Overall Study||15
2454238|NCT01045187|6018257|P1|STARTED|Overall Study||15
2454239|NCT01045161|6018264|P3|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||32
2454240|NCT01045161|6018265|P2|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
2454241|NCT01045161|6018266|P1|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
2454242|NCT01045161|6018264|P3|COMPLETED|Part B - 40 Additional Weeks Open Label||115
2454243|NCT01045161|6018265|P2|COMPLETED|Part B - 40 Additional Weeks Open Label||118
2454244|NCT01045161|6018266|P1|COMPLETED|Part B - 40 Additional Weeks Open Label||111
2454245|NCT01045161|6018264|P3|STARTED|Part B - 40 Additional Weeks Open Label||147
2454246|NCT01045161|6018265|P2|STARTED|Part B - 40 Additional Weeks Open Label||154
2454247|NCT01045161|6018266|P1|STARTED|Part B - 40 Additional Weeks Open Label||147
2454248|NCT01045161|6018264|P3|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||30
2454249|NCT01045161|6018265|P2|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||29
2454250|NCT01045161|6018266|P1|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||31
2454251|NCT01045161|6018264|P3|COMPLETED|Part A - 12 Weeks Double Blind Treatment||148
2454252|NCT01045161|6018265|P2|COMPLETED|Part A - 12 Weeks Double Blind Treatment||155
2454253|NCT01045161|6018266|P1|COMPLETED|Part A - 12 Weeks Double Blind Treatment||151
2454254|NCT01045161|6018264|P3|STARTED|Part A - 12 Weeks Double Blind Treatment||178
2454255|NCT01045161|6018265|P2|STARTED|Part A - 12 Weeks Double Blind Treatment||184
2454256|NCT01045161|6018266|P1|STARTED|Part A - 12 Weeks Double Blind Treatment||182
2454257|NCT01045135|6018286|P1|NOT COMPLETED|Overall Study||26
2454258|NCT01045135|6018286|P1|COMPLETED|Overall Study||274
2454259|NCT01045135|6018286|P1|STARTED|Overall Study||300
2454260|NCT01045122|6018293|P2|NOT COMPLETED|Propofol Then Dexmedetomidine||0
2454261|NCT01045122|6018294|P1|NOT COMPLETED|Propofol Then Dexmedetomidine||0
2454262|NCT01045122|6018293|P2|COMPLETED|Propofol Then Dexmedetomidine||6
2454263|NCT01045122|6018294|P1|COMPLETED|Propofol Then Dexmedetomidine||5
2454264|NCT01045122|6018293|P2|STARTED|Propofol Then Dexmedetomidine||6
2454265|NCT01045122|6018294|P1|STARTED|Propofol Then Dexmedetomidine||5
2454266|NCT01045122|6018293|P2|NOT COMPLETED|Dexmedetomidine Then Propofol||0
2454267|NCT01045122|6018294|P1|NOT COMPLETED|Dexmedetomidine Then Propofol||0
2454268|NCT01045122|6018293|P2|COMPLETED|Dexmedetomidine Then Propofol||6
2454269|NCT01045122|6018294|P1|COMPLETED|Dexmedetomidine Then Propofol||5
2454270|NCT01045122|6018293|P2|STARTED|Dexmedetomidine Then Propofol||6
2454271|NCT01045122|6018294|P1|STARTED|Dexmedetomidine Then Propofol||5
2454272|NCT01045096|6018303|P3|NOT COMPLETED|Overall Study||0
2454273|NCT01045096|6018304|P2|NOT COMPLETED|Overall Study||0
2454274|NCT01045096|6018305|P1|NOT COMPLETED|Overall Study||3
2454275|NCT01045096|6018303|P3|COMPLETED|Overall Study||12
2454276|NCT01045096|6018304|P2|COMPLETED|Overall Study||12
2454277|NCT01045096|6018305|P1|COMPLETED|Overall Study||9
2454278|NCT01045096|6018303|P3|Pharmacokinetic Set|Overall Study||11
2454279|NCT01045096|6018304|P2|Pharmacokinetic Set|Overall Study||11
2454280|NCT01045096|6018305|P1|Pharmacokinetic Set|Overall Study|All patients with at least one estimable PK parameter for dexlansoprazole on Day 7.|9
2454281|NCT01045096|6018303|P3|STARTED|Overall Study||12
2454282|NCT01045096|6018304|P2|STARTED|Overall Study||12
2454283|NCT01045096|6018305|P1|STARTED|Overall Study||12
2454284|NCT01045057|6018331|P1|NOT COMPLETED|Overall Study||0
2454285|NCT01045057|6018331|P1|COMPLETED|Overall Study||27
2454286|NCT01045057|6018331|P1|STARTED|Overall Study||27
2454287|NCT01045031|6018340|P2|NOT COMPLETED|Overall Study||6
2454288|NCT01045031|6018341|P1|NOT COMPLETED|Overall Study||9
2454289|NCT01045031|6018340|P2|COMPLETED|Overall Study||50
2454290|NCT01045031|6018341|P1|COMPLETED|Overall Study||49
2454291|NCT01045031|6018340|P2|STARTED|Overall Study||56
2454292|NCT01045031|6018341|P1|STARTED|Overall Study||58
2454293|NCT01044966|6018351|P1|NOT COMPLETED|Consolidation Phase||10
2454294|NCT01044966|6018351|P1|COMPLETED|Consolidation Phase||2
2454295|NCT01044966|6018351|P1|STARTED|Consolidation Phase||12
2454296|NCT01044966|6018351|P1|NOT COMPLETED|Induction Phase||0
2454297|NCT01044966|6018351|P1|COMPLETED|Induction Phase||12
2454298|NCT01044966|6018351|P1|STARTED|Induction Phase||12
2454299|NCT01044862|6018362|P3|NOT COMPLETED|Overall Study||52
2454300|NCT01044862|6018363|P2|NOT COMPLETED|Overall Study||49
2454301|NCT01044862|6018364|P1|NOT COMPLETED|Overall Study||53
2454302|NCT01044862|6018362|P3|COMPLETED|Overall Study||249
2454303|NCT01044862|6018363|P2|COMPLETED|Overall Study||251
2454304|NCT01044862|6018364|P1|COMPLETED|Overall Study||246
2454305|NCT01044862|6018362|P3|STARTED|Overall Study||301
2454306|NCT01044862|6018363|P2|STARTED|Overall Study||300
2454307|NCT01044862|6018364|P1|STARTED|Overall Study||299
2454308|NCT01044771|6018381|P1|NOT COMPLETED|Overall Study||0
2454309|NCT01044771|6018381|P1|COMPLETED|Overall Study||20
2454310|NCT01044771|6018381|P1|STARTED|Overall Study||20
2454311|NCT01044758|6018393|P7|NOT COMPLETED|Overall Study||10
2454312|NCT01044758|6018394|P6|NOT COMPLETED|Overall Study||3
2454313|NCT01044758|6018395|P5|NOT COMPLETED|Overall Study||2
2454314|NCT01044758|6018396|P4|NOT COMPLETED|Overall Study||2
2454315|NCT01044758|6018397|P3|NOT COMPLETED|Overall Study||4
2454316|NCT01044758|6018398|P2|NOT COMPLETED|Overall Study||0
2454317|NCT01044758|6018399|P1|NOT COMPLETED|Overall Study||4
2454318|NCT01044758|6018393|P7|COMPLETED|Overall Study||17
2454319|NCT01044758|6018394|P6|COMPLETED|Overall Study||8
2454320|NCT01044758|6018395|P5|COMPLETED|Overall Study||9
2454321|NCT01044758|6018396|P4|COMPLETED|Overall Study||10
2454322|NCT01044758|6018397|P3|COMPLETED|Overall Study||7
2454323|NCT01044758|6018398|P2|COMPLETED|Overall Study||12
2454324|NCT01044758|6018399|P1|COMPLETED|Overall Study||8
2454325|NCT01044758|6018393|P7|STARTED|Overall Study||27
2454326|NCT01044758|6018394|P6|STARTED|Overall Study||11
2454327|NCT01044758|6018395|P5|STARTED|Overall Study||11
2454328|NCT01044758|6018396|P4|STARTED|Overall Study||12
2454329|NCT01044758|6018397|P3|STARTED|Overall Study||11
2454330|NCT01044758|6018398|P2|STARTED|Overall Study||12
2454331|NCT01044758|6018399|P1|STARTED|Overall Study||12
2454332|NCT01044745|6018422|P1|NOT COMPLETED|Overall Study||2
2454333|NCT01044745|6018422|P1|COMPLETED|Overall Study||18
2454334|NCT01044745|6018422|P1|STARTED|Overall Study||20
2454335|NCT01044732|6018431|P2|NOT COMPLETED|Overall Study||50
2454336|NCT01044732|6018432|P1|NOT COMPLETED|Overall Study||49
2454337|NCT01044732|6018431|P2|COMPLETED|Overall Study||176
2454338|NCT01044732|6018432|P1|COMPLETED|Overall Study||173
2454339|NCT01044732|6018431|P2|STARTED|Overall Study||226
2454340|NCT01044732|6018432|P1|STARTED|Overall Study||222
2454341|NCT01044706|6018442|P2|NOT COMPLETED|Overall Study||0
2454342|NCT01044706|6018443|P1|NOT COMPLETED|Overall Study||0
2454343|NCT01044706|6018442|P2|COMPLETED|Overall Study||30
2454344|NCT01044706|6018443|P1|COMPLETED|Overall Study||30
2454345|NCT01044706|6018442|P2|STARTED|Overall Study||30
2454346|NCT01044706|6018443|P1|STARTED|Overall Study||30
2454347|NCT01044693|6018451|P16|NOT COMPLETED|Overall Study||0
2454348|NCT01044693|6018452|P15|NOT COMPLETED|Overall Study||0
2454349|NCT01044693|6018453|P14|NOT COMPLETED|Overall Study||0
2454350|NCT01044693|6018454|P13|NOT COMPLETED|Overall Study||0
2454351|NCT01044693|6018455|P12|NOT COMPLETED|Overall Study||0
2454352|NCT01044693|6018456|P11|NOT COMPLETED|Overall Study||0
2454353|NCT01044693|6018457|P10|NOT COMPLETED|Overall Study||0
2454354|NCT01044693|6018458|P9|NOT COMPLETED|Overall Study||0
2454355|NCT01044693|6018459|P8|NOT COMPLETED|Overall Study||0
2454356|NCT01044693|6018460|P7|NOT COMPLETED|Overall Study||0
2454357|NCT01044693|6018461|P6|NOT COMPLETED|Overall Study||0
2454358|NCT01044693|6018462|P5|NOT COMPLETED|Overall Study||0
2454359|NCT01044693|6018463|P4|NOT COMPLETED|Overall Study||0
2454360|NCT01044693|6018464|P3|NOT COMPLETED|Overall Study||0
2454361|NCT01044693|6018465|P2|NOT COMPLETED|Overall Study||0
2454362|NCT01044693|6018466|P1|NOT COMPLETED|Overall Study||0
2454363|NCT01044693|6018451|P16|COMPLETED|Overall Study||1
2454364|NCT01044693|6018452|P15|COMPLETED|Overall Study||1
2454365|NCT01044693|6018453|P14|COMPLETED|Overall Study||1
2454366|NCT01044693|6018454|P13|COMPLETED|Overall Study||2
2454367|NCT01044693|6018455|P12|COMPLETED|Overall Study||1
2454368|NCT01044693|6018456|P11|COMPLETED|Overall Study||1
2454369|NCT01044693|6018457|P10|COMPLETED|Overall Study||1
2454370|NCT01044693|6018458|P9|COMPLETED|Overall Study||1
2454371|NCT01044693|6018459|P8|COMPLETED|Overall Study||1
2454372|NCT01044693|6018460|P7|COMPLETED|Overall Study||1
2454373|NCT01044693|6018461|P6|COMPLETED|Overall Study||2
2454374|NCT01044693|6018462|P5|COMPLETED|Overall Study||1
2454375|NCT01044693|6018463|P4|COMPLETED|Overall Study||1
2454376|NCT01044693|6018464|P3|COMPLETED|Overall Study||1
2454377|NCT01044693|6018465|P2|COMPLETED|Overall Study||1
2454378|NCT01044693|6018466|P1|COMPLETED|Overall Study||3
2454379|NCT01044693|6018451|P16|STARTED|Overall Study||1
2454380|NCT01044693|6018452|P15|STARTED|Overall Study||1
2454381|NCT01044693|6018453|P14|STARTED|Overall Study||1
2454382|NCT01044693|6018454|P13|STARTED|Overall Study||2
2454383|NCT01044693|6018455|P12|STARTED|Overall Study||1
2454384|NCT01044693|6018456|P11|STARTED|Overall Study||1
2454385|NCT01044693|6018457|P10|STARTED|Overall Study||1
2454386|NCT01044693|6018458|P9|STARTED|Overall Study||1
2454387|NCT01044693|6018459|P8|STARTED|Overall Study||1
2454388|NCT01044693|6018460|P7|STARTED|Overall Study||1
2454389|NCT01044693|6018461|P6|STARTED|Overall Study||2
2454390|NCT01044693|6018462|P5|STARTED|Overall Study||1
2454391|NCT01044693|6018463|P4|STARTED|Overall Study||1
2454392|NCT01044693|6018464|P3|STARTED|Overall Study||1
2454393|NCT01044693|6018465|P2|STARTED|Overall Study||1
2454394|NCT01044693|6018466|P1|STARTED|Overall Study||3
2454395|NCT01044589|6018490|P2|NOT COMPLETED|Overall Study||5
2454396|NCT01044589|6018491|P1|NOT COMPLETED|Overall Study||3
2454397|NCT01044589|6018490|P2|COMPLETED|Overall Study||2
2454398|NCT01044589|6018491|P1|COMPLETED|Overall Study||3
2454399|NCT01044589|6018490|P2|STARTED|Overall Study||7
2454400|NCT01044589|6018491|P1|STARTED|Overall Study||6
2454401|NCT01044537|6018506|P7|NOT COMPLETED|Overall Study||0
2454402|NCT01044537|6018507|P6|NOT COMPLETED|Overall Study||0
2454403|NCT01044537|6018508|P5|NOT COMPLETED|Overall Study||0
2454404|NCT01044537|6018509|P4|NOT COMPLETED|Overall Study||0
2454405|NCT01044537|6018510|P3|NOT COMPLETED|Overall Study||0
2454406|NCT01044537|6018511|P2|NOT COMPLETED|Overall Study||0
2454407|NCT01044537|6018512|P1|NOT COMPLETED|Overall Study||0
2454408|NCT01044537|6018506|P7|COMPLETED|Overall Study||16
2454409|NCT01044537|6018507|P6|COMPLETED|Overall Study||5
2454410|NCT01044537|6018508|P5|COMPLETED|Overall Study||5
2454411|NCT01044537|6018509|P4|COMPLETED|Overall Study||6
2454412|NCT01044537|6018510|P3|COMPLETED|Overall Study||6
2454413|NCT01044537|6018511|P2|COMPLETED|Overall Study||6
2454414|NCT01044537|6018512|P1|COMPLETED|Overall Study||6
2454415|NCT01044537|6018506|P7|STARTED|Overall Study||16
2454416|NCT01044537|6018507|P6|STARTED|Overall Study||5
2454417|NCT01044537|6018508|P5|STARTED|Overall Study||5
2454418|NCT01044537|6018509|P4|STARTED|Overall Study||6
2454419|NCT01044537|6018510|P3|STARTED|Overall Study||6
2454420|NCT01044537|6018511|P2|STARTED|Overall Study||6
2454421|NCT01044537|6018512|P1|STARTED|Overall Study||6
2454422|NCT01044498|6018621|P2|NOT COMPLETED|Overall Study||2
2454423|NCT01044498|6018622|P1|NOT COMPLETED|Overall Study||3
2454424|NCT01044498|6018621|P2|COMPLETED|Overall Study||21
2454425|NCT01044498|6018622|P1|COMPLETED|Overall Study||20
2454426|NCT01044498|6018621|P2|STARTED|Overall Study||23
2454427|NCT01044498|6018622|P1|STARTED|Overall Study||23
2454428|NCT01044459|6018648|P2|NOT COMPLETED|Overall Study||131
2454429|NCT01044459|6018649|P1|NOT COMPLETED|Overall Study||133
2454430|NCT01044459|6018648|P2|COMPLETED|Overall Study||162
2454431|NCT01044459|6018649|P1|COMPLETED|Overall Study||179
2454432|NCT01044459|6018648|P2|STARTED|Overall Study||293
2454433|NCT01044459|6018649|P1|STARTED|Overall Study||312
2454434|NCT01044303|6018657|P1|NOT COMPLETED|Overall Study||2
2454435|NCT01044303|6018657|P1|COMPLETED|Overall Study||30
2454436|NCT01044303|6018657|P1|STARTED|Overall Study||32
2454437|NCT01044290|6018667|P3|NOT COMPLETED|Follow-Up 2||2
2454438|NCT01044290|6018668|P2|NOT COMPLETED|Follow-Up 2||2
2454439|NCT01044290|6018669|P1|NOT COMPLETED|Follow-Up 2||0
2454440|NCT01044290|6018667|P3|COMPLETED|Follow-Up 2||69
2454441|NCT01044290|6018668|P2|COMPLETED|Follow-Up 2||67
2454442|NCT01044290|6018669|P1|COMPLETED|Follow-Up 2||70
2454443|NCT01044290|6018667|P3|Completed F2 Interview|Follow-Up 2||64
2454444|NCT01044290|6018668|P2|Completed F2 Interview|Follow-Up 2||57
2454445|NCT01044290|6018669|P1|Completed F2 Interview|Follow-Up 2||64
2454446|NCT01044290|6018667|P3|STARTED|Follow-Up 2||71
2454447|NCT01044290|6018668|P2|STARTED|Follow-Up 2||69
2454448|NCT01044290|6018669|P1|STARTED|Follow-Up 2||70
2454449|NCT01044290|6018667|P3|NOT COMPLETED|Follow-up 1||1
2454450|NCT01044290|6018668|P2|NOT COMPLETED|Follow-up 1||5
2454451|NCT01044290|6018669|P1|NOT COMPLETED|Follow-up 1||5
2454452|NCT01044290|6018667|P3|COMPLETED|Follow-up 1||71
2454453|NCT01044290|6018668|P2|COMPLETED|Follow-up 1||69
2454454|NCT01044290|6018669|P1|COMPLETED|Follow-up 1||70
2454455|NCT01044290|6018667|P3|Completed F1 Interview|Follow-up 1||61
2454456|NCT01044290|6018668|P2|Completed F1 Interview|Follow-up 1||60
2454457|NCT01044290|6018669|P1|Completed F1 Interview|Follow-up 1||61
2454458|NCT01044290|6018667|P3|STARTED|Follow-up 1||72
2454459|NCT01044290|6018668|P2|STARTED|Follow-up 1||74
2454460|NCT01044290|6018669|P1|STARTED|Follow-up 1||75
2454461|NCT01044290|6018667|P3|NOT COMPLETED|Randomization||0
2454462|NCT01044290|6018668|P2|NOT COMPLETED|Randomization||0
2454463|NCT01044290|6018669|P1|NOT COMPLETED|Randomization||0
2454464|NCT01044290|6018667|P3|COMPLETED|Randomization||72
2454465|NCT01044290|6018668|P2|COMPLETED|Randomization||74
2454466|NCT01044290|6018669|P1|COMPLETED|Randomization||75
2454467|NCT01044290|6018667|P3|Randomized|Randomization||72
2454468|NCT01044290|6018668|P2|Randomized|Randomization||74
2454469|NCT01044290|6018669|P1|Randomized|Randomization||75
2454470|NCT01044290|6018667|P3|STARTED|Randomization||72
2454471|NCT01044290|6018668|P2|STARTED|Randomization||74
2454472|NCT01044290|6018669|P1|STARTED|Randomization||75
2454473|NCT01044264|6018695|P3|NOT COMPLETED|Overall Study||92
2454474|NCT01044264|6018696|P2|NOT COMPLETED|Overall Study||94
2454475|NCT01044264|6018697|P1|NOT COMPLETED|Overall Study||90
2454476|NCT01044264|6018695|P3|COMPLETED|Overall Study||108
2454477|NCT01044264|6018696|P2|COMPLETED|Overall Study||108
2454478|NCT01044264|6018697|P1|COMPLETED|Overall Study||110
2454479|NCT01044264|6018695|P3|STARTED|Overall Study||200
2454480|NCT01044264|6018696|P2|STARTED|Overall Study||202
2454481|NCT01044264|6018697|P1|STARTED|Overall Study||200
2454482|NCT01044212|6018707|P2|NOT COMPLETED|Overall Study||7
2454483|NCT01044212|6018708|P1|NOT COMPLETED|Overall Study||5
2454484|NCT01044212|6018707|P2|COMPLETED|Overall Study||30
2454485|NCT01044212|6018708|P1|COMPLETED|Overall Study||30
2454486|NCT01044212|6018707|P2|STARTED|Overall Study||37
2454487|NCT01044212|6018708|P1|STARTED|Overall Study||35
2454488|NCT01044056|6018721|P3|NOT COMPLETED|Overall Study||0
2454489|NCT01044056|6018722|P2|NOT COMPLETED|Overall Study||0
2454490|NCT01044056|6018723|P1|NOT COMPLETED|Overall Study||0
2454491|NCT01044056|6018721|P3|COMPLETED|Overall Study||8
2454492|NCT01044056|6018722|P2|COMPLETED|Overall Study||8
2454493|NCT01044056|6018723|P1|COMPLETED|Overall Study||8
2454494|NCT01044056|6018721|P3|STARTED|Overall Study||8
2454495|NCT01044056|6018722|P2|STARTED|Overall Study||8
2454496|NCT01044056|6018723|P1|STARTED|Overall Study||8
2454497|NCT01044030|6018742|P2|NOT COMPLETED|Overall Study||20
2454498|NCT01044030|6018743|P1|NOT COMPLETED|Overall Study||19
2454499|NCT01044030|6018742|P2|COMPLETED|Overall Study||146
2454500|NCT01044030|6018743|P1|COMPLETED|Overall Study||141
2454501|NCT01044030|6018742|P2|STARTED|Overall Study||166
2454502|NCT01044030|6018743|P1|STARTED|Overall Study||160
2454503|NCT01043939|6018757|P2|NOT COMPLETED|Second Intervention||0
2454504|NCT01043939|6018758|P1|NOT COMPLETED|Second Intervention||0
2454505|NCT01043939|6018757|P2|COMPLETED|Second Intervention||12
2454506|NCT01043939|6018758|P1|COMPLETED|Second Intervention||12
2454507|NCT01043939|6018757|P2|STARTED|Second Intervention||12
2454508|NCT01043939|6018758|P1|STARTED|Second Intervention||12
2454509|NCT01043939|6018757|P2|NOT COMPLETED|Washout Period||0
2454510|NCT01043939|6018758|P1|NOT COMPLETED|Washout Period||0
2454511|NCT01043939|6018757|P2|COMPLETED|Washout Period||12
2454512|NCT01043939|6018758|P1|COMPLETED|Washout Period||12
2454513|NCT01043939|6018757|P2|STARTED|Washout Period||12
2454514|NCT01043939|6018758|P1|STARTED|Washout Period||12
2454515|NCT01043939|6018757|P2|NOT COMPLETED|First Intervention||0
2454516|NCT01043939|6018758|P1|NOT COMPLETED|First Intervention||0
2454517|NCT01043939|6018757|P2|COMPLETED|First Intervention||12
2454518|NCT01043939|6018758|P1|COMPLETED|First Intervention||12
2454519|NCT01043939|6018757|P2|STARTED|First Intervention||12
2454520|NCT01043939|6018758|P1|STARTED|First Intervention||12
2454521|NCT01043926|6018772|P4|NOT COMPLETED|Overall Study||0
2454522|NCT01043926|6018773|P3|NOT COMPLETED|Overall Study||0
2454523|NCT01043926|6018774|P2|NOT COMPLETED|Overall Study||0
2454524|NCT01043926|6018775|P1|NOT COMPLETED|Overall Study||0
2454525|NCT01043926|6018772|P4|COMPLETED|Overall Study||0
2454526|NCT01043926|6018773|P3|COMPLETED|Overall Study||0
2454527|NCT01043926|6018774|P2|COMPLETED|Overall Study||8
2454528|NCT01043926|6018775|P1|COMPLETED|Overall Study||8
2454529|NCT01043926|6018772|P4|STARTED|Overall Study||0
2454530|NCT01043926|6018773|P3|STARTED|Overall Study||0
2454531|NCT01043926|6018774|P2|STARTED|Overall Study||8
2454532|NCT01043926|6018775|P1|STARTED|Overall Study||8
2454533|NCT01043874|6018789|P1|NOT COMPLETED|Overall Study||6
2454534|NCT01043874|6018789|P1|COMPLETED|Overall Study||39
2454535|NCT01043874|6018789|P1|STARTED|Overall Study||45
2454536|NCT01043705|6018799|P3|NOT COMPLETED|Overall Study||80
2454537|NCT01043705|6018800|P2|NOT COMPLETED|Overall Study||131
2454538|NCT01043705|6018801|P1|NOT COMPLETED|Overall Study||107
2454539|NCT01043705|6018799|P3|COMPLETED|Overall Study||498
2454540|NCT01043705|6018800|P2|COMPLETED|Overall Study||447
2454541|NCT01043705|6018801|P1|COMPLETED|Overall Study||352
2454542|NCT01043705|6018799|P3|STARTED|Overall Study||578
2454543|NCT01043705|6018800|P2|STARTED|Overall Study||578
2454544|NCT01043705|6018801|P1|STARTED|Overall Study||459
2454545|NCT01043653|6018811|P1|NOT COMPLETED|Overall Study||64
2454546|NCT01043653|6018811|P1|COMPLETED|Overall Study||186
2454547|NCT01043653|6018811|P1|STARTED|Overall Study||250
2454548|NCT01043640|6018816|P1|NOT COMPLETED|Overall Study||0
2454549|NCT01043640|6018816|P1|COMPLETED|Overall Study||46
2454550|NCT01043640|6018816|P1|STARTED|Overall Study||46
2454551|NCT01043562|6018831|P1|NOT COMPLETED|Overall Study||0
2454552|NCT01043562|6018831|P1|COMPLETED|Overall Study||20
2454553|NCT01043562|6018831|P1|STARTED|Overall Study||20
2454554|NCT01043523|6018838|P1|NOT COMPLETED|Overall Study||0
2454555|NCT01043523|6018838|P1|COMPLETED|Overall Study||52
2454556|NCT01043523|6018838|P1|Participants With Unenhanced Images|Overall Study||51
2454557|NCT01043523|6018838|P1|STARTED|Overall Study||52
2454558|NCT01043432|6018867|P4|NOT COMPLETED|Overall Study||0
2454559|NCT01043432|6018868|P3|NOT COMPLETED|Overall Study||0
2454560|NCT01043432|6018869|P2|NOT COMPLETED|Overall Study||0
2454561|NCT01043432|6018870|P1|NOT COMPLETED|Overall Study||0
2454562|NCT01043432|6018867|P4|COMPLETED|Overall Study||48
2454563|NCT01043432|6018868|P3|COMPLETED|Overall Study||12
2454564|NCT01043432|6018869|P2|COMPLETED|Overall Study||51
2454565|NCT01043432|6018870|P1|COMPLETED|Overall Study||22
2454566|NCT01043432|6018867|P4|STARTED|Overall Study||48
2454567|NCT01043432|6018868|P3|STARTED|Overall Study||12
2454568|NCT01043432|6018869|P2|STARTED|Overall Study||51
2454569|NCT01043432|6018870|P1|STARTED|Overall Study||22
2454570|NCT01043393|6018879|P2|NOT COMPLETED|Overall Study||0
2454571|NCT01043393|6018880|P1|NOT COMPLETED|Overall Study||0
2454572|NCT01043393|6018879|P2|COMPLETED|Overall Study||12
2454573|NCT01043393|6018880|P1|COMPLETED|Overall Study||12
2454574|NCT01043393|6018879|P2|STARTED|Overall Study||12
2454575|NCT01043393|6018880|P1|STARTED|Overall Study||12
2454576|NCT01043185|6018890|P10|NOT COMPLETED|Period 7 - Fourth Intervention||0
2454577|NCT01043185|6018891|P9|NOT COMPLETED|Period 7 - Fourth Intervention||0
2454578|NCT01043185|6018892|P8|NOT COMPLETED|Period 7 - Fourth Intervention||0
2454579|NCT01043185|6018893|P7|NOT COMPLETED|Period 7 - Fourth Intervention||0
2454580|NCT01043185|6018894|P6|NOT COMPLETED|Period 7 - Fourth Intervention||0
2454581|NCT01043185|6018895|P5|NOT COMPLETED|Period 7 - Fourth Intervention||0
2454582|NCT01043185|6018896|P4|NOT COMPLETED|Period 7 - Fourth Intervention||0
2454583|NCT01043185|6018897|P3|NOT COMPLETED|Period 7 - Fourth Intervention||0
2454584|NCT01043185|6018898|P2|NOT COMPLETED|Period 7 - Fourth Intervention||0
2454585|NCT01043185|6018899|P1|NOT COMPLETED|Period 7 - Fourth Intervention||0
2454586|NCT01043185|6018890|P10|COMPLETED|Period 7 - Fourth Intervention||3
2454587|NCT01043185|6018891|P9|COMPLETED|Period 7 - Fourth Intervention||2
2454588|NCT01043185|6018892|P8|COMPLETED|Period 7 - Fourth Intervention||3
2454589|NCT01043185|6018893|P7|COMPLETED|Period 7 - Fourth Intervention||3
2454590|NCT01043185|6018894|P6|COMPLETED|Period 7 - Fourth Intervention||3
2454591|NCT01043185|6018895|P5|COMPLETED|Period 7 - Fourth Intervention||2
2454592|NCT01043185|6018896|P4|COMPLETED|Period 7 - Fourth Intervention||2
2454593|NCT01043185|6018897|P3|COMPLETED|Period 7 - Fourth Intervention||3
2454594|NCT01043185|6018898|P2|COMPLETED|Period 7 - Fourth Intervention||2
2454595|NCT01043185|6018899|P1|COMPLETED|Period 7 - Fourth Intervention||3
2454596|NCT01043185|6018890|P10|STARTED|Period 7 - Fourth Intervention||3
2454597|NCT01043185|6018891|P9|STARTED|Period 7 - Fourth Intervention||2
2454598|NCT01043185|6018892|P8|STARTED|Period 7 - Fourth Intervention||3
2454599|NCT01043185|6018893|P7|STARTED|Period 7 - Fourth Intervention||3
2454600|NCT01043185|6018894|P6|STARTED|Period 7 - Fourth Intervention||3
2454601|NCT01043185|6018895|P5|STARTED|Period 7 - Fourth Intervention||2
2454602|NCT01043185|6018896|P4|STARTED|Period 7 - Fourth Intervention||2
2454603|NCT01043185|6018897|P3|STARTED|Period 7 - Fourth Intervention||3
2454604|NCT01043185|6018898|P2|STARTED|Period 7 - Fourth Intervention||2
2454605|NCT01043185|6018899|P1|STARTED|Period 7 - Fourth Intervention||3
2454606|NCT01043185|6018890|P10|NOT COMPLETED|Period 6 - Third Washout Period||0
2454607|NCT01043185|6018891|P9|NOT COMPLETED|Period 6 - Third Washout Period||1
2454608|NCT01043185|6018892|P8|NOT COMPLETED|Period 6 - Third Washout Period||0
2454609|NCT01043185|6018893|P7|NOT COMPLETED|Period 6 - Third Washout Period||0
2454610|NCT01043185|6018894|P6|NOT COMPLETED|Period 6 - Third Washout Period||0
2454611|NCT01043185|6018895|P5|NOT COMPLETED|Period 6 - Third Washout Period||0
2454612|NCT01043185|6018896|P4|NOT COMPLETED|Period 6 - Third Washout Period||0
2454613|NCT01043185|6018897|P3|NOT COMPLETED|Period 6 - Third Washout Period||0
2454614|NCT01043185|6018898|P2|NOT COMPLETED|Period 6 - Third Washout Period||0
2454615|NCT01043185|6018899|P1|NOT COMPLETED|Period 6 - Third Washout Period||0
2454616|NCT01043185|6018890|P10|COMPLETED|Period 6 - Third Washout Period||3
2454617|NCT01043185|6018891|P9|COMPLETED|Period 6 - Third Washout Period||2
2454618|NCT01043185|6018892|P8|COMPLETED|Period 6 - Third Washout Period||3
2454619|NCT01043185|6018893|P7|COMPLETED|Period 6 - Third Washout Period||3
2454620|NCT01043185|6018894|P6|COMPLETED|Period 6 - Third Washout Period||3
2454621|NCT01043185|6018895|P5|COMPLETED|Period 6 - Third Washout Period||2
2454622|NCT01043185|6018896|P4|COMPLETED|Period 6 - Third Washout Period||2
2454623|NCT01043185|6018897|P3|COMPLETED|Period 6 - Third Washout Period||3
2454624|NCT01043185|6018898|P2|COMPLETED|Period 6 - Third Washout Period||2
2454625|NCT01043185|6018899|P1|COMPLETED|Period 6 - Third Washout Period||3
2454626|NCT01043185|6018890|P10|STARTED|Period 6 - Third Washout Period||3
2454627|NCT01043185|6018891|P9|STARTED|Period 6 - Third Washout Period||3
2454628|NCT01043185|6018892|P8|STARTED|Period 6 - Third Washout Period||3
2454629|NCT01043185|6018893|P7|STARTED|Period 6 - Third Washout Period||3
2454630|NCT01043185|6018894|P6|STARTED|Period 6 - Third Washout Period||3
2454631|NCT01043185|6018895|P5|STARTED|Period 6 - Third Washout Period||2
2454632|NCT01043185|6018896|P4|STARTED|Period 6 - Third Washout Period||2
2454633|NCT01043185|6018897|P3|STARTED|Period 6 - Third Washout Period||3
2454634|NCT01043185|6018898|P2|STARTED|Period 6 - Third Washout Period||2
2454635|NCT01043185|6018899|P1|STARTED|Period 6 - Third Washout Period||3
2454636|NCT01043185|6018890|P10|NOT COMPLETED|Period 5 - Third Intervention||0
2454637|NCT01043185|6018891|P9|NOT COMPLETED|Period 5 - Third Intervention||0
2454638|NCT01043185|6018892|P8|NOT COMPLETED|Period 5 - Third Intervention||0
2454639|NCT01043185|6018893|P7|NOT COMPLETED|Period 5 - Third Intervention||0
2454640|NCT01043185|6018894|P6|NOT COMPLETED|Period 5 - Third Intervention||0
2454641|NCT01043185|6018895|P5|NOT COMPLETED|Period 5 - Third Intervention||0
2454642|NCT01043185|6018896|P4|NOT COMPLETED|Period 5 - Third Intervention||0
2454643|NCT01043185|6018897|P3|NOT COMPLETED|Period 5 - Third Intervention||0
2454644|NCT01043185|6018898|P2|NOT COMPLETED|Period 5 - Third Intervention||0
2454645|NCT01043185|6018899|P1|NOT COMPLETED|Period 5 - Third Intervention||0
2454646|NCT01043185|6018890|P10|COMPLETED|Period 5 - Third Intervention||3
2454647|NCT01043185|6018891|P9|COMPLETED|Period 5 - Third Intervention||3
2454648|NCT01043185|6018892|P8|COMPLETED|Period 5 - Third Intervention||3
2454649|NCT01043185|6018893|P7|COMPLETED|Period 5 - Third Intervention||3
2454650|NCT01043185|6018894|P6|COMPLETED|Period 5 - Third Intervention||3
2454651|NCT01043185|6018895|P5|COMPLETED|Period 5 - Third Intervention||2
2454652|NCT01043185|6018896|P4|COMPLETED|Period 5 - Third Intervention||2
2454653|NCT01043185|6018897|P3|COMPLETED|Period 5 - Third Intervention||3
2454654|NCT01043185|6018898|P2|COMPLETED|Period 5 - Third Intervention||2
2454655|NCT01043185|6018899|P1|COMPLETED|Period 5 - Third Intervention||3
2454656|NCT01043185|6018890|P10|STARTED|Period 5 - Third Intervention||3
2454657|NCT01043185|6018891|P9|STARTED|Period 5 - Third Intervention||3
2454658|NCT01043185|6018892|P8|STARTED|Period 5 - Third Intervention||3
2454659|NCT01043185|6018893|P7|STARTED|Period 5 - Third Intervention||3
2454660|NCT01043185|6018894|P6|STARTED|Period 5 - Third Intervention||3
2454661|NCT01043185|6018895|P5|STARTED|Period 5 - Third Intervention||2
2454662|NCT01043185|6018896|P4|STARTED|Period 5 - Third Intervention||2
2454663|NCT01043185|6018897|P3|STARTED|Period 5 - Third Intervention||3
2454664|NCT01043185|6018898|P2|STARTED|Period 5 - Third Intervention||2
2454665|NCT01043185|6018899|P1|STARTED|Period 5 - Third Intervention||3
2454666|NCT01043185|6018890|P10|NOT COMPLETED|Period 4 - Second Washout Period||0
2454667|NCT01043185|6018891|P9|NOT COMPLETED|Period 4 - Second Washout Period||0
2454668|NCT01043185|6018892|P8|NOT COMPLETED|Period 4 - Second Washout Period||0
2454669|NCT01043185|6018893|P7|NOT COMPLETED|Period 4 - Second Washout Period||0
2454670|NCT01043185|6018894|P6|NOT COMPLETED|Period 4 - Second Washout Period||0
2454671|NCT01043185|6018895|P5|NOT COMPLETED|Period 4 - Second Washout Period||0
2454672|NCT01043185|6018896|P4|NOT COMPLETED|Period 4 - Second Washout Period||0
2454673|NCT01043185|6018897|P3|NOT COMPLETED|Period 4 - Second Washout Period||0
2454674|NCT01043185|6018898|P2|NOT COMPLETED|Period 4 - Second Washout Period||0
2454675|NCT01043185|6018899|P1|NOT COMPLETED|Period 4 - Second Washout Period||0
2454676|NCT01043185|6018890|P10|COMPLETED|Period 4 - Second Washout Period||3
2454677|NCT01043185|6018891|P9|COMPLETED|Period 4 - Second Washout Period||3
2454678|NCT01043185|6018892|P8|COMPLETED|Period 4 - Second Washout Period||3
2454679|NCT01043185|6018893|P7|COMPLETED|Period 4 - Second Washout Period||3
2454680|NCT01043185|6018894|P6|COMPLETED|Period 4 - Second Washout Period||3
2454681|NCT01043185|6018895|P5|COMPLETED|Period 4 - Second Washout Period||2
2454682|NCT01043185|6018896|P4|COMPLETED|Period 4 - Second Washout Period||2
2454683|NCT01043185|6018897|P3|COMPLETED|Period 4 - Second Washout Period||3
2454684|NCT01043185|6018898|P2|COMPLETED|Period 4 - Second Washout Period||2
2454685|NCT01043185|6018899|P1|COMPLETED|Period 4 - Second Washout Period||3
2454686|NCT01043185|6018890|P10|STARTED|Period 4 - Second Washout Period||3
2454687|NCT01043185|6018891|P9|STARTED|Period 4 - Second Washout Period||3
2454688|NCT01043185|6018892|P8|STARTED|Period 4 - Second Washout Period||3
2454689|NCT01043185|6018893|P7|STARTED|Period 4 - Second Washout Period||3
2454690|NCT01043185|6018894|P6|STARTED|Period 4 - Second Washout Period||3
2454691|NCT01043185|6018895|P5|STARTED|Period 4 - Second Washout Period||2
2454692|NCT01043185|6018896|P4|STARTED|Period 4 - Second Washout Period||2
2454693|NCT01043185|6018897|P3|STARTED|Period 4 - Second Washout Period||3
2454694|NCT01043185|6018898|P2|STARTED|Period 4 - Second Washout Period||2
2454695|NCT01043185|6018899|P1|STARTED|Period 4 - Second Washout Period||3
2454696|NCT01043185|6018890|P10|NOT COMPLETED|Period 3 - Second Intervention||0
2454697|NCT01043185|6018891|P9|NOT COMPLETED|Period 3 - Second Intervention||0
2454698|NCT01043185|6018892|P8|NOT COMPLETED|Period 3 - Second Intervention||0
2454699|NCT01043185|6018893|P7|NOT COMPLETED|Period 3 - Second Intervention||0
2454700|NCT01043185|6018894|P6|NOT COMPLETED|Period 3 - Second Intervention||0
2454701|NCT01043185|6018895|P5|NOT COMPLETED|Period 3 - Second Intervention||0
2454702|NCT01043185|6018896|P4|NOT COMPLETED|Period 3 - Second Intervention||0
2454703|NCT01043185|6018897|P3|NOT COMPLETED|Period 3 - Second Intervention||0
2454704|NCT01043185|6018898|P2|NOT COMPLETED|Period 3 - Second Intervention||0
2454705|NCT01043185|6018899|P1|NOT COMPLETED|Period 3 - Second Intervention||0
2454706|NCT01043185|6018890|P10|COMPLETED|Period 3 - Second Intervention||3
2454707|NCT01043185|6018891|P9|COMPLETED|Period 3 - Second Intervention||3
2454708|NCT01043185|6018892|P8|COMPLETED|Period 3 - Second Intervention||3
2454709|NCT01043185|6018893|P7|COMPLETED|Period 3 - Second Intervention||3
2454710|NCT01043185|6018894|P6|COMPLETED|Period 3 - Second Intervention||3
2454711|NCT01043185|6018895|P5|COMPLETED|Period 3 - Second Intervention||2
2454712|NCT01043185|6018896|P4|COMPLETED|Period 3 - Second Intervention||2
2454713|NCT01043185|6018897|P3|COMPLETED|Period 3 - Second Intervention||3
2454714|NCT01043185|6018898|P2|COMPLETED|Period 3 - Second Intervention||2
2454715|NCT01043185|6018899|P1|COMPLETED|Period 3 - Second Intervention||3
2454716|NCT01043185|6018890|P10|STARTED|Period 3 - Second Intervention||3
2454717|NCT01043185|6018891|P9|STARTED|Period 3 - Second Intervention||3
2454718|NCT01043185|6018892|P8|STARTED|Period 3 - Second Intervention||3
2454719|NCT01043185|6018893|P7|STARTED|Period 3 - Second Intervention||3
2454720|NCT01043185|6018894|P6|STARTED|Period 3 - Second Intervention||3
2454721|NCT01043185|6018895|P5|STARTED|Period 3 - Second Intervention||2
2454722|NCT01043185|6018896|P4|STARTED|Period 3 - Second Intervention||2
2454723|NCT01043185|6018897|P3|STARTED|Period 3 - Second Intervention||3
2454724|NCT01043185|6018898|P2|STARTED|Period 3 - Second Intervention||2
2454725|NCT01043185|6018899|P1|STARTED|Period 3 - Second Intervention||3
2454726|NCT01043185|6018890|P10|NOT COMPLETED|Period 2 - First Washout Period||0
2454727|NCT01043185|6018891|P9|NOT COMPLETED|Period 2 - First Washout Period||0
2454728|NCT01043185|6018892|P8|NOT COMPLETED|Period 2 - First Washout Period||0
2454729|NCT01043185|6018893|P7|NOT COMPLETED|Period 2 - First Washout Period||0
2454730|NCT01043185|6018894|P6|NOT COMPLETED|Period 2 - First Washout Period||0
2454731|NCT01043185|6018895|P5|NOT COMPLETED|Period 2 - First Washout Period||0
2454732|NCT01043185|6018896|P4|NOT COMPLETED|Period 2 - First Washout Period||0
2454733|NCT01043185|6018897|P3|NOT COMPLETED|Period 2 - First Washout Period||0
2454734|NCT01043185|6018898|P2|NOT COMPLETED|Period 2 - First Washout Period||0
2454735|NCT01043185|6018899|P1|NOT COMPLETED|Period 2 - First Washout Period||0
2454736|NCT01043185|6018890|P10|COMPLETED|Period 2 - First Washout Period||3
2454737|NCT01043185|6018891|P9|COMPLETED|Period 2 - First Washout Period||3
2454738|NCT01043185|6018892|P8|COMPLETED|Period 2 - First Washout Period||3
2454739|NCT01043185|6018893|P7|COMPLETED|Period 2 - First Washout Period||3
2454740|NCT01043185|6018894|P6|COMPLETED|Period 2 - First Washout Period||3
2454741|NCT01043185|6018895|P5|COMPLETED|Period 2 - First Washout Period||2
2454742|NCT01043185|6018896|P4|COMPLETED|Period 2 - First Washout Period||2
2454743|NCT01043185|6018897|P3|COMPLETED|Period 2 - First Washout Period||3
2454744|NCT01043185|6018898|P2|COMPLETED|Period 2 - First Washout Period||2
2454745|NCT01043185|6018899|P1|COMPLETED|Period 2 - First Washout Period||3
2454746|NCT01043185|6018890|P10|STARTED|Period 2 - First Washout Period||3
2454747|NCT01043185|6018891|P9|STARTED|Period 2 - First Washout Period||3
2454748|NCT01043185|6018892|P8|STARTED|Period 2 - First Washout Period||3
2454749|NCT01043185|6018893|P7|STARTED|Period 2 - First Washout Period||3
2454750|NCT01043185|6018894|P6|STARTED|Period 2 - First Washout Period||3
2454751|NCT01043185|6018895|P5|STARTED|Period 2 - First Washout Period||2
2454752|NCT01043185|6018896|P4|STARTED|Period 2 - First Washout Period||2
2454753|NCT01043185|6018897|P3|STARTED|Period 2 - First Washout Period||3
2454754|NCT01043185|6018898|P2|STARTED|Period 2 - First Washout Period||2
2454755|NCT01043185|6018899|P1|STARTED|Period 2 - First Washout Period||3
2454756|NCT01043185|6018890|P10|NOT COMPLETED|Period 1 - First Intervention||0
2454757|NCT01043185|6018891|P9|NOT COMPLETED|Period 1 - First Intervention||0
2454758|NCT01043185|6018892|P8|NOT COMPLETED|Period 1 - First Intervention||0
2454759|NCT01043185|6018893|P7|NOT COMPLETED|Period 1 - First Intervention||0
2454760|NCT01043185|6018894|P6|NOT COMPLETED|Period 1 - First Intervention||0
2454761|NCT01043185|6018895|P5|NOT COMPLETED|Period 1 - First Intervention||0
2454762|NCT01043185|6018896|P4|NOT COMPLETED|Period 1 - First Intervention||0
2454763|NCT01043185|6018897|P3|NOT COMPLETED|Period 1 - First Intervention||0
2454764|NCT01043185|6018898|P2|NOT COMPLETED|Period 1 - First Intervention||0
2454765|NCT01043185|6018899|P1|NOT COMPLETED|Period 1 - First Intervention||0
2454766|NCT01043185|6018890|P10|COMPLETED|Period 1 - First Intervention||3
2454767|NCT01043185|6018891|P9|COMPLETED|Period 1 - First Intervention||3
2454768|NCT01043185|6018892|P8|COMPLETED|Period 1 - First Intervention||3
2454769|NCT01043185|6018893|P7|COMPLETED|Period 1 - First Intervention||3
2454770|NCT01043185|6018894|P6|COMPLETED|Period 1 - First Intervention||3
2454771|NCT01043185|6018895|P5|COMPLETED|Period 1 - First Intervention||2
2454772|NCT01043185|6018896|P4|COMPLETED|Period 1 - First Intervention||2
2454773|NCT01043185|6018897|P3|COMPLETED|Period 1 - First Intervention||3
2454774|NCT01043185|6018898|P2|COMPLETED|Period 1 - First Intervention||2
2454775|NCT01043185|6018899|P1|COMPLETED|Period 1 - First Intervention||3
2454776|NCT01043185|6018890|P10|STARTED|Period 1 - First Intervention||3
2454777|NCT01043185|6018891|P9|STARTED|Period 1 - First Intervention||3
2454778|NCT01043185|6018892|P8|STARTED|Period 1 - First Intervention||3
2454779|NCT01043185|6018893|P7|STARTED|Period 1 - First Intervention||3
2454780|NCT01043185|6018894|P6|STARTED|Period 1 - First Intervention||3
2454781|NCT01043185|6018895|P5|STARTED|Period 1 - First Intervention||2
2454782|NCT01043185|6018896|P4|STARTED|Period 1 - First Intervention||2
2454783|NCT01043185|6018897|P3|STARTED|Period 1 - First Intervention||3
2454784|NCT01043185|6018898|P2|STARTED|Period 1 - First Intervention||2
2454785|NCT01043185|6018899|P1|STARTED|Period 1 - First Intervention||3
2454786|NCT01043146|6018932|P6|NOT COMPLETED|Overall Study||0
2454787|NCT01043146|6018933|P5|NOT COMPLETED|Overall Study||0
2454788|NCT01043146|6018934|P4|NOT COMPLETED|Overall Study||0
2454789|NCT01043146|6018935|P3|NOT COMPLETED|Overall Study||0
2454790|NCT01043146|6018936|P2|NOT COMPLETED|Overall Study||0
2454791|NCT01043146|6018937|P1|NOT COMPLETED|Overall Study||0
2454792|NCT01043146|6018932|P6|COMPLETED|Overall Study||8
2454793|NCT01043146|6018933|P5|COMPLETED|Overall Study||8
2454794|NCT01043146|6018934|P4|COMPLETED|Overall Study||8
2454795|NCT01043146|6018935|P3|COMPLETED|Overall Study||8
2454796|NCT01043146|6018936|P2|COMPLETED|Overall Study||8
2454797|NCT01043146|6018937|P1|COMPLETED|Overall Study||10
2454798|NCT01043146|6018932|P6|STARTED|Overall Study||8
2454799|NCT01043146|6018933|P5|STARTED|Overall Study||8
2454800|NCT01043146|6018934|P4|STARTED|Overall Study||8
2454801|NCT01043146|6018935|P3|STARTED|Overall Study||8
2454802|NCT01043146|6018936|P2|STARTED|Overall Study||8
2454803|NCT01043146|6018937|P1|STARTED|Overall Study||10
2454804|NCT01043133|6018953|P2|NOT COMPLETED|Overall Study||2
2454805|NCT01043133|6018954|P1|NOT COMPLETED|Overall Study||1
2454806|NCT01043133|6018953|P2|COMPLETED|Overall Study||78
2454807|NCT01043133|6018954|P1|COMPLETED|Overall Study||74
2454808|NCT01043133|6018953|P2|STARTED|Overall Study||80
2454809|NCT01043133|6018954|P1|STARTED|Overall Study||75
2454810|NCT01043094|6018964|P2|NOT COMPLETED|Overall Study||0
2454811|NCT01043094|6018965|P1|NOT COMPLETED|Overall Study||0
2454812|NCT01043094|6018964|P2|COMPLETED|Overall Study||8
2454813|NCT01043094|6018965|P1|COMPLETED|Overall Study||8
2454814|NCT01043094|6018964|P2|STARTED|Overall Study||8
2454815|NCT01043094|6018965|P1|STARTED|Overall Study||8
2454816|NCT01042977|6018975|P2|NOT COMPLETED|Overall Study||55
2454817|NCT01042977|6018976|P1|NOT COMPLETED|Overall Study||41
2454818|NCT01042977|6018975|P2|COMPLETED|Overall Study||428
2454819|NCT01042977|6018976|P1|COMPLETED|Overall Study||441
2454820|NCT01042977|6018975|P2|STARTED|Overall Study|Of the 483 participants only 482 were included in the full analysis set.|483
2454821|NCT01042977|6018976|P1|STARTED|Overall Study|Of 482 part. 480 were included in full analysis set. Thereof, 1 part. treated but not randomized.|482
2454822|NCT01042938|6018996|P2|NOT COMPLETED|Overall Study||2
2454823|NCT01042938|6018997|P1|NOT COMPLETED|Overall Study||3
2454824|NCT01042938|6018996|P2|COMPLETED|Overall Study||16
2454825|NCT01042938|6018997|P1|COMPLETED|Overall Study||14
2454826|NCT01042938|6018996|P2|STARTED|Overall Study|1 withdrew before radiation; 1 non-compliance.|18
2454827|NCT01042938|6018997|P1|STARTED|Overall Study|1 withdrew before radiation; 1 ineligible due to other clinical trial; 1 non-compliance.|17
2454828|NCT01042795|6019009|P1|NOT COMPLETED|Follow up - 22 Months After Drug Start||2
2454829|NCT01042795|6019009|P1|COMPLETED|Follow up - 22 Months After Drug Start||0
2454830|NCT01042795|6019009|P1|STARTED|Follow up - 22 Months After Drug Start||2
2454831|NCT01042795|6019009|P1|NOT COMPLETED|Dosing Period - 16 Weeks of Daily Doses||5
2454832|NCT01042795|6019009|P1|COMPLETED|Dosing Period - 16 Weeks of Daily Doses||2
2454833|NCT01042795|6019009|P1|STARTED|Dosing Period - 16 Weeks of Daily Doses||7
2454834|NCT01042678|6019016|P6|NOT COMPLETED|Overall Study||0
2454835|NCT01042678|6019017|P5|NOT COMPLETED|Overall Study||0
2454836|NCT01042678|6019018|P4|NOT COMPLETED|Overall Study||0
2454837|NCT01042678|6019019|P3|NOT COMPLETED|Overall Study||0
2454838|NCT01042678|6019020|P2|NOT COMPLETED|Overall Study||0
2454839|NCT01042678|6019021|P1|NOT COMPLETED|Overall Study||1
2454840|NCT01042678|6019016|P6|COMPLETED|Overall Study||0
2454841|NCT01042678|6019017|P5|COMPLETED|Overall Study||0
2454842|NCT01042678|6019018|P4|COMPLETED|Overall Study||0
2454843|NCT01042678|6019019|P3|COMPLETED|Overall Study||6
2454844|NCT01042678|6019020|P2|COMPLETED|Overall Study||6
2454845|NCT01042678|6019021|P1|COMPLETED|Overall Study||5
2454846|NCT01042678|6019016|P6|STARTED|Overall Study||0
2454847|NCT01042678|6019017|P5|STARTED|Overall Study||0
2454848|NCT01042678|6019018|P4|STARTED|Overall Study||0
2454849|NCT01042678|6019019|P3|STARTED|Overall Study||6
2454850|NCT01042678|6019020|P2|STARTED|Overall Study||6
2454851|NCT01042678|6019021|P1|STARTED|Overall Study||6
2454852|NCT01042613|6019046|P2|NOT COMPLETED|Overall Study||0
2454853|NCT01042613|6019047|P1|NOT COMPLETED|Overall Study||0
2454854|NCT01042613|6019046|P2|COMPLETED|Overall Study||74
2454855|NCT01042613|6019047|P1|COMPLETED|Overall Study||72
2454856|NCT01042613|6019046|P2|STARTED|Overall Study||74
2454857|NCT01042613|6019047|P1|STARTED|Overall Study||72
2454858|NCT01042600|6019059|P2|NOT COMPLETED|Overall Study||0
2454859|NCT01042600|6019060|P1|NOT COMPLETED|Overall Study||1
2454860|NCT01042600|6019059|P2|COMPLETED|Overall Study||30
2454861|NCT01042600|6019060|P1|COMPLETED|Overall Study||30
2454862|NCT01042600|6019059|P2|STARTED|Overall Study||30
2454863|NCT01042600|6019060|P1|STARTED|Overall Study||31
2454864|NCT01042535|6019080|P1|NOT COMPLETED|Overall Study||8
2454865|NCT01042535|6019080|P1|COMPLETED|Overall Study||36
2454866|NCT01042535|6019080|P1|STARTED|Overall Study||44
2454867|NCT01042509|6019088|P1|NOT COMPLETED|Overall Study||0
2454868|NCT01042509|6019088|P1|COMPLETED|Overall Study||15
2454869|NCT01042509|6019088|P1|STARTED|Overall Study||15
2454870|NCT01042496|6019095|P2|NOT COMPLETED|Overall Study||0
2454871|NCT01042496|6019096|P1|NOT COMPLETED|Overall Study||0
2454872|NCT01042496|6019095|P2|COMPLETED|Overall Study||33
2454873|NCT01042496|6019096|P1|COMPLETED|Overall Study||29
2454874|NCT01042496|6019095|P2|STARTED|Overall Study||33
2454875|NCT01042496|6019096|P1|STARTED|Overall Study||29
2454876|NCT01042392|6019114|P4|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
2454877|NCT01042392|6019115|P3|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||4
2454878|NCT01042392|6019116|P2|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
2454879|NCT01042392|6019117|P1|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||2
2454880|NCT01042392|6019114|P4|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||121
2454881|NCT01042392|6019115|P3|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||115
2454882|NCT01042392|6019116|P2|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||117
2454883|NCT01042392|6019117|P1|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||127
2454884|NCT01042392|6019114|P4|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||82
2454885|NCT01042392|6019115|P3|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||93
2454886|NCT01042392|6019116|P2|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||73
2454887|NCT01042392|6019117|P1|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)|PPMD excluded patients violated protocol instructions for period 3 (duration and treatment intake)|98
2454888|NCT01042392|6019114|P4|STARTED|Period III (Unblinded,Controlled, 1 Day)||122
2454889|NCT01042392|6019115|P3|STARTED|Period III (Unblinded,Controlled, 1 Day)||119
2454890|NCT01042392|6019116|P2|STARTED|Period III (Unblinded,Controlled, 1 Day)||118
2454891|NCT01042392|6019117|P1|STARTED|Period III (Unblinded,Controlled, 1 Day)||129
2454892|NCT01042392|6019114|P4|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
2454893|NCT01042392|6019115|P3|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||8
2454894|NCT01042392|6019116|P2|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
2454895|NCT01042392|6019117|P1|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||10
2454896|NCT01042392|6019114|P4|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
2454897|NCT01042392|6019115|P3|COMPLETED|Period II(Randomized,Double Blinded,8wk)||241
2454898|NCT01042392|6019116|P2|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
2454899|NCT01042392|6019117|P1|COMPLETED|Period II(Randomized,Double Blinded,8wk)||247
2454900|NCT01042392|6019114|P4|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
2454901|NCT01042392|6019115|P3|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||222
2454902|NCT01042392|6019116|P2|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
2454903|NCT01042392|6019117|P1|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)|ITT excluded patients from centers where 90% of BP measurements were rounded to 5 or 0|222
2454904|NCT01042392|6019114|P4|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
2454905|NCT01042392|6019115|P3|STARTED|Period II(Randomized,Double Blinded,8wk)||249
2454906|NCT01042392|6019116|P2|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
2454907|NCT01042392|6019117|P1|STARTED|Period II(Randomized,Double Blinded,8wk)||257
2454908|NCT01042366|6019146|P3|NOT COMPLETED|Overall Study||0
2454909|NCT01042366|6019147|P2|NOT COMPLETED|Overall Study||0
2454910|NCT01042366|6019148|P1|NOT COMPLETED|Overall Study||0
2454911|NCT01042366|6019146|P3|COMPLETED|Overall Study||4
2454912|NCT01042366|6019147|P2|COMPLETED|Overall Study||6
2454913|NCT01042366|6019148|P1|COMPLETED|Overall Study||5
2454914|NCT01042366|6019146|P3|STARTED|Overall Study||4
2454915|NCT01042366|6019147|P2|STARTED|Overall Study||6
2454916|NCT01042366|6019148|P1|STARTED|Overall Study||5
2454917|NCT01042288|6019157|P1|NOT COMPLETED|Overall Study||69
2454918|NCT01042288|6019157|P1|COMPLETED|Overall Study|Patients remained on maintenance until disease progression, toxicity or other reason to come off|0
2454919|NCT01042288|6019157|P1|Maintenance|Overall Study||27
2454920|NCT01042288|6019157|P1|STARTED|Overall Study||69
2454921|NCT01042236|6019165|P6|NOT COMPLETED|Treatment Period 3||0
2454922|NCT01042236|6019166|P5|NOT COMPLETED|Treatment Period 3||0
2454923|NCT01042236|6019167|P4|NOT COMPLETED|Treatment Period 3||2
2454924|NCT01042236|6019168|P3|NOT COMPLETED|Treatment Period 3||0
2454925|NCT01042236|6019169|P2|NOT COMPLETED|Treatment Period 3||0
2454926|NCT01042236|6019170|P1|NOT COMPLETED|Treatment Period 3||0
2454927|NCT01042236|6019165|P6|COMPLETED|Treatment Period 3||3
2454928|NCT01042236|6019166|P5|COMPLETED|Treatment Period 3||3
2454929|NCT01042236|6019167|P4|COMPLETED|Treatment Period 3||3
2454930|NCT01042236|6019168|P3|COMPLETED|Treatment Period 3||3
2454931|NCT01042236|6019169|P2|COMPLETED|Treatment Period 3||3
2454932|NCT01042236|6019170|P1|COMPLETED|Treatment Period 3||3
2454933|NCT01042236|6019165|P6|STARTED|Treatment Period 3||3
2454934|NCT01042236|6019166|P5|STARTED|Treatment Period 3||3
2454935|NCT01042236|6019167|P4|STARTED|Treatment Period 3||5
2454936|NCT01042236|6019168|P3|STARTED|Treatment Period 3||3
2454937|NCT01042236|6019169|P2|STARTED|Treatment Period 3||3
2454938|NCT01042236|6019170|P1|STARTED|Treatment Period 3||3
2454939|NCT01042236|6019165|P6|NOT COMPLETED|Treatment Period 2||0
2454940|NCT01042236|6019166|P5|NOT COMPLETED|Treatment Period 2||0
2454941|NCT01042236|6019167|P4|NOT COMPLETED|Treatment Period 2||0
2454942|NCT01042236|6019168|P3|NOT COMPLETED|Treatment Period 2||0
2454943|NCT01042236|6019169|P2|NOT COMPLETED|Treatment Period 2||0
2454944|NCT01042236|6019170|P1|NOT COMPLETED|Treatment Period 2||0
2454945|NCT01042236|6019165|P6|COMPLETED|Treatment Period 2||3
2454946|NCT01042236|6019166|P5|COMPLETED|Treatment Period 2||3
2454947|NCT01042236|6019167|P4|COMPLETED|Treatment Period 2||5
2454948|NCT01042236|6019168|P3|COMPLETED|Treatment Period 2||3
2454949|NCT01042236|6019169|P2|COMPLETED|Treatment Period 2||3
2454950|NCT01042236|6019170|P1|COMPLETED|Treatment Period 2||3
2454951|NCT01042236|6019165|P6|STARTED|Treatment Period 2||3
2454952|NCT01042236|6019166|P5|STARTED|Treatment Period 2||3
2454953|NCT01042236|6019167|P4|STARTED|Treatment Period 2||5
2454954|NCT01042236|6019168|P3|STARTED|Treatment Period 2||3
2454955|NCT01042236|6019169|P2|STARTED|Treatment Period 2||3
2454956|NCT01042236|6019170|P1|STARTED|Treatment Period 2||3
2454957|NCT01042236|6019165|P6|NOT COMPLETED|Treatment Period 1||0
2454958|NCT01042236|6019166|P5|NOT COMPLETED|Treatment Period 1||1
2454959|NCT01042236|6019167|P4|NOT COMPLETED|Treatment Period 1||0
2454960|NCT01042236|6019168|P3|NOT COMPLETED|Treatment Period 1||0
2454961|NCT01042236|6019169|P2|NOT COMPLETED|Treatment Period 1||1
2454962|NCT01042236|6019170|P1|NOT COMPLETED|Treatment Period 1||0
2454963|NCT01042236|6019165|P6|COMPLETED|Treatment Period 1||3
2454964|NCT01042236|6019166|P5|COMPLETED|Treatment Period 1||3
2454965|NCT01042236|6019167|P4|COMPLETED|Treatment Period 1||5
2454966|NCT01042236|6019168|P3|COMPLETED|Treatment Period 1||3
2454967|NCT01042236|6019169|P2|COMPLETED|Treatment Period 1||3
2454968|NCT01042236|6019170|P1|COMPLETED|Treatment Period 1||3
2454969|NCT01042236|6019165|P6|STARTED|Treatment Period 1||3
2454970|NCT01042236|6019166|P5|STARTED|Treatment Period 1||4
2454971|NCT01042236|6019167|P4|STARTED|Treatment Period 1||5
2454972|NCT01042236|6019168|P3|STARTED|Treatment Period 1||3
2454973|NCT01042236|6019169|P2|STARTED|Treatment Period 1||4
2454974|NCT01042236|6019170|P1|STARTED|Treatment Period 1||3
2454975|NCT01042158|6019207|P1|NOT COMPLETED|Overall Study||1
2454976|NCT01042158|6019207|P1|COMPLETED|Overall Study||24
2454977|NCT01042158|6019207|P1|STARTED|Overall Study||25
2454978|NCT01042145|6019216|P2|NOT COMPLETED|Overall Study||1
2454979|NCT01042145|6019217|P1|NOT COMPLETED|Overall Study||1
2454980|NCT01042145|6019216|P2|COMPLETED|Overall Study||45
2454981|NCT01042145|6019217|P1|COMPLETED|Overall Study||40
2454982|NCT01042145|6019216|P2|STARTED|Overall Study||46
2454983|NCT01042145|6019217|P1|STARTED|Overall Study||41
2454984|NCT01042093|6019237|P4|NOT COMPLETED|Overall Study||4
2454985|NCT01042093|6019238|P3|NOT COMPLETED|Overall Study||2
2454986|NCT01042093|6019239|P2|NOT COMPLETED|Overall Study||2
2454987|NCT01042093|6019240|P1|NOT COMPLETED|Overall Study||2
2454988|NCT01042093|6019237|P4|COMPLETED|Overall Study||36
2454989|NCT01042093|6019238|P3|COMPLETED|Overall Study||38
2454990|NCT01042093|6019239|P2|COMPLETED|Overall Study||38
2454991|NCT01042093|6019240|P1|COMPLETED|Overall Study||38
2454992|NCT01042093|6019237|P4|STARTED|Overall Study||40
2454993|NCT01042093|6019238|P3|STARTED|Overall Study||40
2454994|NCT01042093|6019239|P2|STARTED|Overall Study||40
2454995|NCT01042093|6019240|P1|STARTED|Overall Study||40
2454996|NCT01041976|6019260|P2|NOT COMPLETED|Overall Study||4
2454997|NCT01041976|6019261|P1|NOT COMPLETED|Overall Study||5
2454998|NCT01041976|6019260|P2|COMPLETED|Overall Study||38
2454999|NCT01041976|6019261|P1|COMPLETED|Overall Study||37
2455000|NCT01041976|6019260|P2|18 Month Follow-up|Overall Study||38
2455001|NCT01041976|6019261|P1|18 Month Follow-up|Overall Study||37
2455002|NCT01041976|6019260|P2|12 Month Follow-up|Overall Study||38
2455003|NCT01041976|6019261|P1|12 Month Follow-up|Overall Study||37
2455004|NCT01041976|6019260|P2|6 Month Follow-up|Overall Study||41
2455005|NCT01041976|6019261|P1|6 Month Follow-up|Overall Study||39
2455006|NCT01041976|6019260|P2|STARTED|Overall Study||42
2455007|NCT01041976|6019261|P1|STARTED|Overall Study||42
2455008|NCT01041859|6019271|P3|NOT COMPLETED|Double-Blind Maintenance||45
2455009|NCT01041859|6019272|P2|NOT COMPLETED|Double-Blind Maintenance||46
2455010|NCT01041859|6019273|P1|NOT COMPLETED|Double-Blind Maintenance||0
2455011|NCT01041859|6019271|P3|COMPLETED|Double-Blind Maintenance||107
2455012|NCT01041859|6019272|P2|COMPLETED|Double-Blind Maintenance||120
2455013|NCT01041859|6019273|P1|COMPLETED|Double-Blind Maintenance||0
2455014|NCT01041859|6019271|P3|STARTED|Double-Blind Maintenance|152 randomized, all were treated.|152
2455015|NCT01041859|6019272|P2|STARTED|Double-Blind Maintenance|168 were randomized, 2 were not treated (1 randomized in error, 1 withdrew consent).|166
2455016|NCT01041859|6019273|P1|STARTED|Double-Blind Maintenance||0
2455017|NCT01041859|6019271|P3|NOT COMPLETED|Open-Label Titration||0
2455018|NCT01041859|6019272|P2|NOT COMPLETED|Open-Label Titration||0
2455019|NCT01041859|6019273|P1|NOT COMPLETED|Open-Label Titration||101
2455020|NCT01041859|6019271|P3|COMPLETED|Open-Label Titration||0
2455021|NCT01041859|6019272|P2|COMPLETED|Open-Label Titration||0
2455022|NCT01041859|6019273|P1|COMPLETED|Open-Label Titration|Of 358 completed subjects, 320 were randomized to the Double-Blind Maintenance Period.|358
2455023|NCT01041859|6019271|P3|STARTED|Open-Label Titration||0
2455024|NCT01041859|6019272|P2|STARTED|Open-Label Titration||0
2455025|NCT01041859|6019273|P1|STARTED|Open-Label Titration|Of 460 total enrollment, one subject enrolled twice; this subject's second enrollment is excluded.|459
2455026|NCT01041781|6019290|P2|NOT COMPLETED|Overall Study||0
2455027|NCT01041781|6019291|P1|NOT COMPLETED|Overall Study||0
2455028|NCT01041781|6019290|P2|COMPLETED|Overall Study||158
2455029|NCT01041781|6019291|P1|COMPLETED|Overall Study||154
2455030|NCT01041781|6019290|P2|STARTED|Overall Study||158
2455031|NCT01041781|6019291|P1|STARTED|Overall Study||154
2455032|NCT01041638|6019309|P1|NOT COMPLETED|Overall Study||27
2455033|NCT01041638|6019309|P1|COMPLETED|Overall Study||78
2455034|NCT01041638|6019309|P1|STARTED|Overall Study||105
2455035|NCT01041573|6019319|P4|NOT COMPLETED|Overall Study||2
2455036|NCT01041573|6019320|P3|NOT COMPLETED|Overall Study||7
2455037|NCT01041573|6019321|P2|NOT COMPLETED|Overall Study||13
2455038|NCT01041573|6019322|P1|NOT COMPLETED|Overall Study||5
2455039|NCT01041573|6019319|P4|COMPLETED|Overall Study||62
2455040|NCT01041573|6019320|P3|COMPLETED|Overall Study||387
2455041|NCT01041573|6019321|P2|COMPLETED|Overall Study||858
2455042|NCT01041573|6019322|P1|COMPLETED|Overall Study||535
2455043|NCT01041573|6019319|P4|STARTED|Overall Study||64
2455044|NCT01041573|6019320|P3|STARTED|Overall Study||394
2455045|NCT01041573|6019321|P2|STARTED|Overall Study||871
2455046|NCT01041573|6019322|P1|STARTED|Overall Study||540
2455047|NCT01041521|6019334|P2|NOT COMPLETED|Overall Study||16
2455048|NCT01041521|6019335|P1|NOT COMPLETED|Overall Study||17
2455049|NCT01041521|6019334|P2|COMPLETED|Overall Study||40
2455050|NCT01041521|6019335|P1|COMPLETED|Overall Study||44
2455051|NCT01041521|6019334|P2|STARTED|Overall Study||56
2455052|NCT01041521|6019335|P1|STARTED|Overall Study||61
2455053|NCT01041417|6019345|P2|NOT COMPLETED|Overall Study||3
2455054|NCT01041417|6019346|P1|NOT COMPLETED|Overall Study||7
2455055|NCT01041417|6019345|P2|COMPLETED|Overall Study||76
2455056|NCT01041417|6019346|P1|COMPLETED|Overall Study||73
2455057|NCT01041417|6019345|P2|STARTED|Overall Study||79
2455058|NCT01041417|6019346|P1|STARTED|Overall Study||80
2455059|NCT01041404|6019384|P2|NOT COMPLETED|Overall Study||294
2455060|NCT01041404|6019385|P1|NOT COMPLETED|Overall Study||290
2455061|NCT01041404|6019384|P2|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
2455062|NCT01041404|6019385|P1|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
2455063|NCT01041404|6019384|P2|Alive in Follow-up|Overall Study||41
2455064|NCT01041404|6019385|P1|Alive in Follow-up|Overall Study||40
2455065|NCT01041404|6019384|P2|Lost to Follow-up|Overall Study||10
2455066|NCT01041404|6019385|P1|Lost to Follow-up|Overall Study||12
2455067|NCT01041404|6019384|P2|Died in Follow-up|Overall Study||200
2455068|NCT01041404|6019385|P1|Died in Follow-up|Overall Study||199
2455069|NCT01041404|6019384|P2|Entered Follow-Up|Overall Study||251
2455070|NCT01041404|6019385|P1|Entered Follow-Up|Overall Study||251
2455071|NCT01041404|6019384|P2|STARTED|Overall Study||294
2455072|NCT01041404|6019385|P1|STARTED|Overall Study||290
2455073|NCT01041287|6019426|P2|NOT COMPLETED|Treatment Period 2 (3 Months)||5
2455074|NCT01041287|6019427|P1|NOT COMPLETED|Treatment Period 2 (3 Months)||3
2455075|NCT01041287|6019426|P2|COMPLETED|Treatment Period 2 (3 Months)||14
2455076|NCT01041287|6019427|P1|COMPLETED|Treatment Period 2 (3 Months)||16
2455077|NCT01041287|6019426|P2|STARTED|Treatment Period 2 (3 Months)||19
2455078|NCT01041287|6019427|P1|STARTED|Treatment Period 2 (3 Months)||19
2455079|NCT01041287|6019426|P2|NOT COMPLETED|Treatment Period 1 (3 Months)||0
2455080|NCT01041287|6019427|P1|NOT COMPLETED|Treatment Period 1 (3 Months)||0
2455081|NCT01041287|6019426|P2|COMPLETED|Treatment Period 1 (3 Months)||19
2455082|NCT01041287|6019427|P1|COMPLETED|Treatment Period 1 (3 Months)||19
2455083|NCT01041287|6019426|P2|STARTED|Treatment Period 1 (3 Months)||19
2455084|NCT01041287|6019427|P1|STARTED|Treatment Period 1 (3 Months)||19
2455085|NCT01041274|6019439|P2|NOT COMPLETED|Overall Study||21
2455086|NCT01041274|6019440|P1|NOT COMPLETED|Overall Study||23
2455087|NCT01041274|6019439|P2|COMPLETED|Overall Study||25
2455088|NCT01041274|6019440|P1|COMPLETED|Overall Study||26
2455089|NCT01041274|6019439|P2|STARTED|Overall Study||46
2455090|NCT01041274|6019440|P1|STARTED|Overall Study||49
2455091|NCT01041209|6019456|P2|NOT COMPLETED|Overall Study||0
2455092|NCT01041209|6019457|P1|NOT COMPLETED|Overall Study||0
2455093|NCT01041209|6019456|P2|COMPLETED|Overall Study||60
2455094|NCT01041209|6019457|P1|COMPLETED|Overall Study||60
2455095|NCT01041209|6019456|P2|STARTED|Overall Study||60
2455096|NCT01041209|6019457|P1|STARTED|Overall Study||60
2455097|NCT01040871|6019467|P2|NOT COMPLETED|Overall Study||7
2455098|NCT01040871|6019468|P1|NOT COMPLETED|Overall Study||13
2455099|NCT01040871|6019467|P2|COMPLETED|Overall Study||73
2455100|NCT01040871|6019468|P1|COMPLETED|Overall Study||71
2455101|NCT01040871|6019467|P2|STARTED|Overall Study|Intent to Treat, Randomized|80
2455102|NCT01040871|6019468|P1|STARTED|Overall Study|Intent to Treat, Randomized|84
2455103|NCT01040858|6019488|P2|NOT COMPLETED|Overall Study||0
2455104|NCT01040858|6019489|P1|NOT COMPLETED|Overall Study||9
2455105|NCT01040858|6019488|P2|COMPLETED|Overall Study||69
2455106|NCT01040858|6019489|P1|COMPLETED|Overall Study||50
2455107|NCT01040858|6019488|P2|STARTED|Overall Study||69
2455108|NCT01040858|6019489|P1|STARTED|Overall Study||59
2455109|NCT01040845|6019519|P2|NOT COMPLETED|Overall Study||1
2455110|NCT01040845|6019520|P1|NOT COMPLETED|Overall Study||2
2455111|NCT01040845|6019519|P2|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1)|14
2455112|NCT01040845|6019520|P1|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1); dropped by physician due to positive drug screen (1)|13
2455113|NCT01040845|6019519|P2|STARTED|Overall Study||15
2455114|NCT01040845|6019520|P1|STARTED|Overall Study||15
2455115|NCT01040832|6019535|P2|NOT COMPLETED|Overall Study||37
2455116|NCT01040832|6019536|P1|NOT COMPLETED|Overall Study||46
2455117|NCT01040832|6019535|P2|COMPLETED|Overall Study||16
2455118|NCT01040832|6019536|P1|COMPLETED|Overall Study||8
2455119|NCT01040832|6019535|P2|STARTED|Overall Study||53
2455120|NCT01040832|6019536|P1|STARTED|Overall Study|One participant was treated with study drug 'Cetuximab Plus EMD 1201081' but was not randomized|54
2455121|NCT01040819|6019552|P2|NOT COMPLETED|Overall Study||0
2455122|NCT01040819|6019553|P1|NOT COMPLETED|Overall Study||0
2455123|NCT01040819|6019552|P2|COMPLETED|Overall Study||12
2455124|NCT01040819|6019553|P1|COMPLETED|Overall Study||13
2455125|NCT01040819|6019552|P2|STARTED|Overall Study||12
2455126|NCT01040819|6019553|P1|STARTED|Overall Study||13
2455127|NCT01040793|6019559|P6|NOT COMPLETED|Overall Study||1
2455128|NCT01040793|6019560|P5|NOT COMPLETED|Overall Study||4
2455129|NCT01040793|6019561|P4|NOT COMPLETED|Overall Study||4
2455130|NCT01040793|6019562|P3|NOT COMPLETED|Overall Study||3
2455131|NCT01040793|6019563|P2|NOT COMPLETED|Overall Study||5
2455132|NCT01040793|6019564|P1|NOT COMPLETED|Overall Study||6
2455133|NCT01040793|6019559|P6|COMPLETED|Overall Study||26
2455134|NCT01040793|6019560|P5|COMPLETED|Overall Study||22
2455135|NCT01040793|6019561|P4|COMPLETED|Overall Study||22
2455136|NCT01040793|6019562|P3|COMPLETED|Overall Study||23
2455137|NCT01040793|6019563|P2|COMPLETED|Overall Study||21
2455138|NCT01040793|6019564|P1|COMPLETED|Overall Study||20
2455139|NCT01040793|6019559|P6|STARTED|Overall Study||27
2455140|NCT01040793|6019560|P5|STARTED|Overall Study||26
2455141|NCT01040793|6019561|P4|STARTED|Overall Study||26
2455142|NCT01040793|6019562|P3|STARTED|Overall Study||26
2455143|NCT01040793|6019563|P2|STARTED|Overall Study||26
2455144|NCT01040793|6019564|P1|STARTED|Overall Study|Entered and treated|26
2455145|NCT01040780|6019643|P2|NOT COMPLETED|Overall Study||3
2455146|NCT01040780|6019644|P1|NOT COMPLETED|Overall Study||1
2455147|NCT01040780|6019643|P2|COMPLETED|Overall Study||196
2455148|NCT01040780|6019644|P1|COMPLETED|Overall Study||199
2455149|NCT01040780|6019643|P2|STARTED|Overall Study||199
2455150|NCT01040780|6019644|P1|STARTED|Overall Study||200
2455151|NCT01040728|6019658|P4|NOT COMPLETED|Overall Study||6
2455152|NCT01040728|6019659|P3|NOT COMPLETED|Overall Study||1
2455153|NCT01040728|6019660|P2|NOT COMPLETED|Overall Study||11
2455154|NCT01040728|6019661|P1|NOT COMPLETED|Overall Study||4
2455155|NCT01040728|6019658|P4|COMPLETED|Overall Study||24
2455156|NCT01040728|6019659|P3|COMPLETED|Overall Study||30
2455157|NCT01040728|6019660|P2|COMPLETED|Overall Study||19
2455158|NCT01040728|6019661|P1|COMPLETED|Overall Study||27
2455159|NCT01040728|6019658|P4|STARTED|Overall Study||30
2455160|NCT01040728|6019659|P3|STARTED|Overall Study||31
2455161|NCT01040728|6019660|P2|STARTED|Overall Study||30
2455162|NCT01040728|6019661|P1|STARTED|Overall Study||31
2455163|NCT01040689|6019731|P4|NOT COMPLETED|Overall Study||4
2455164|NCT01040689|6019732|P3|NOT COMPLETED|Overall Study||4
2455165|NCT01040689|6019733|P2|NOT COMPLETED|Overall Study||2
2455166|NCT01040689|6019734|P1|NOT COMPLETED|Overall Study||3
2455167|NCT01040689|6019731|P4|COMPLETED|Overall Study||23
2455168|NCT01040689|6019732|P3|COMPLETED|Overall Study||23
2455169|NCT01040689|6019733|P2|COMPLETED|Overall Study||25
2455170|NCT01040689|6019734|P1|COMPLETED|Overall Study||24
2455171|NCT01040689|6019731|P4|STARTED|Overall Study||27
2455172|NCT01040689|6019732|P3|STARTED|Overall Study||27
2455173|NCT01040689|6019733|P2|STARTED|Overall Study||27
2455174|NCT01040689|6019734|P1|STARTED|Overall Study||27
2455175|NCT01040624|6019806|P2|NOT COMPLETED|Overall Study||0
2455176|NCT01040624|6019807|P1|NOT COMPLETED|Overall Study||0
2455177|NCT01040624|6019806|P2|COMPLETED|Overall Study||19
2455178|NCT01040624|6019807|P1|COMPLETED|Overall Study||58
2455179|NCT01040624|6019806|P2|STARTED|Overall Study||19
2455180|NCT01040624|6019807|P1|STARTED|Overall Study||58
2455181|NCT01040403|6019813|P1|NOT COMPLETED|Overall Study||20
2455182|NCT01040403|6019813|P1|COMPLETED|Overall Study|All treatment periods|213
2455183|NCT01040403|6019813|P1|Completed T+O 5/10|Overall Study||107
2455184|NCT01040403|6019813|P1|Completed T+O 2.5/10|Overall Study||110
2455185|NCT01040403|6019813|P1|Completed T+O 1.25/10|Overall Study||106
2455186|NCT01040403|6019813|P1|Completed Olo 10|Overall Study||109
2455187|NCT01040403|6019813|P1|Completed T+O 5/5|Overall Study||106
2455188|NCT01040403|6019813|P1|Completed T+O 2.5/5|Overall Study||111
2455189|NCT01040403|6019813|P1|Completed T+O 1.25/5|Overall Study||105
2455190|NCT01040403|6019813|P1|Completed Olo 5|Overall Study||106
2455191|NCT01040403|6019813|P1|STARTED|Overall Study||233
2455192|NCT01040351|6020001|P2|NOT COMPLETED|Overall Study||2
2455193|NCT01040351|6020002|P1|NOT COMPLETED|Overall Study||1
2455194|NCT01040351|6020001|P2|COMPLETED|Overall Study|May 2010|53
2455195|NCT01040351|6020002|P1|COMPLETED|Overall Study|May 2010|54
2455196|NCT01040351|6020001|P2|STARTED|Overall Study|October 2006|55
2455197|NCT01040351|6020002|P1|STARTED|Overall Study|October 2006|55
2455198|NCT01040260|6020012|P2|NOT COMPLETED|Overall Study||11
2455199|NCT01040260|6020013|P1|NOT COMPLETED|Overall Study||15
2455200|NCT01040260|6020012|P2|COMPLETED|Overall Study||39
2455201|NCT01040260|6020013|P1|COMPLETED|Overall Study||38
2455202|NCT01040260|6020012|P2|STARTED|Overall Study||50
2455203|NCT01040260|6020013|P1|STARTED|Overall Study||53
2455204|NCT01040208|6020022|P3|NOT COMPLETED|Overall Study||3
2455205|NCT01040208|6020023|P2|NOT COMPLETED|Overall Study||13
2455206|NCT01040208|6020024|P1|NOT COMPLETED|Overall Study||6
2455207|NCT01040208|6020022|P3|COMPLETED|Overall Study||35
2455208|NCT01040208|6020023|P2|COMPLETED|Overall Study||15
2455209|NCT01040208|6020024|P1|COMPLETED|Overall Study||39
2455210|NCT01040208|6020022|P3|STARTED|Overall Study||38
2455211|NCT01040208|6020023|P2|STARTED|Overall Study||28
2455212|NCT01040208|6020024|P1|STARTED|Overall Study||45
2455213|NCT01040169|6020040|P2|NOT COMPLETED|Overall Study||8
2455214|NCT01040169|6020041|P1|NOT COMPLETED|Overall Study||3
2455215|NCT01040169|6020040|P2|COMPLETED|Overall Study||36
2455216|NCT01040169|6020041|P1|COMPLETED|Overall Study||32
2455217|NCT01040169|6020040|P2|STARTED|Overall Study||44
2455218|NCT01040169|6020041|P1|STARTED|Overall Study||35
2455219|NCT01040130|6020049|P6|NOT COMPLETED|Overall Study||4
2455220|NCT01040130|6020050|P5|NOT COMPLETED|Overall Study||0
2455221|NCT01040130|6020051|P4|NOT COMPLETED|Overall Study||5
2455222|NCT01040130|6020052|P3|NOT COMPLETED|Overall Study||2
2455223|NCT01040130|6020053|P2|NOT COMPLETED|Overall Study||3
2455224|NCT01040130|6020054|P1|NOT COMPLETED|Overall Study||3
2455225|NCT01040130|6020049|P6|COMPLETED|Overall Study||22
2455226|NCT01040130|6020050|P5|COMPLETED|Overall Study||25
2455227|NCT01040130|6020051|P4|COMPLETED|Overall Study||20
2455228|NCT01040130|6020052|P3|COMPLETED|Overall Study||23
2455229|NCT01040130|6020053|P2|COMPLETED|Overall Study||22
2455230|NCT01040130|6020054|P1|COMPLETED|Overall Study|Number of patients who did not discontinue from the trial.|22
2455231|NCT01040130|6020049|P6|STARTED|Overall Study||26
2455232|NCT01040130|6020050|P5|STARTED|Overall Study||25
2455233|NCT01040130|6020051|P4|STARTED|Overall Study||25
2455234|NCT01040130|6020052|P3|STARTED|Overall Study||25
2455235|NCT01040130|6020053|P2|STARTED|Overall Study||25
2455236|NCT01040130|6020054|P1|STARTED|Overall Study|Number of patients entered and treated|25
2455237|NCT01040052|6020131|P1|NOT COMPLETED|Overall Study||0
2455238|NCT01040052|6020131|P1|COMPLETED|Overall Study||30
2455239|NCT01040052|6020131|P1|STARTED|Overall Study||30
2455240|NCT01039792|6020137|P2|NOT COMPLETED|Overall Study||1
2455241|NCT01039792|6020138|P1|NOT COMPLETED|Overall Study||6
2455242|NCT01039792|6020137|P2|COMPLETED|Overall Study||27
2455243|NCT01039792|6020138|P1|COMPLETED|Overall Study||23
2455244|NCT01039792|6020137|P2|STARTED|Overall Study||28
2455245|NCT01039792|6020138|P1|STARTED|Overall Study||29
2455246|NCT01039688|6020147|P3|NOT COMPLETED|Overall Study||80
2455247|NCT01039688|6020148|P2|NOT COMPLETED|Overall Study||111
2455248|NCT01039688|6020149|P1|NOT COMPLETED|Overall Study||107
2455249|NCT01039688|6020147|P3|COMPLETED|Overall Study||106
2455250|NCT01039688|6020148|P2|COMPLETED|Overall Study||286
2455251|NCT01039688|6020149|P1|COMPLETED|Overall Study||266
2455252|NCT01039688|6020147|P3|STARTED|Overall Study||186
2455253|NCT01039688|6020148|P2|STARTED|Overall Study||397
2455254|NCT01039688|6020149|P1|STARTED|Overall Study||373
2455255|NCT01039675|6020420|P2|NOT COMPLETED|Overall Study||7
2455256|NCT01039675|6020421|P1|NOT COMPLETED|Overall Study||0
2455257|NCT01039675|6020420|P2|COMPLETED|Overall Study||35
2455258|NCT01039675|6020421|P1|COMPLETED|Overall Study||9
2455259|NCT01039675|6020420|P2|STARTED|Overall Study||42
2455260|NCT01039675|6020421|P1|STARTED|Overall Study||9
2455261|NCT01039584|6020434|P3|NOT COMPLETED|Overall Study||57
2455262|NCT01039584|6020435|P2|NOT COMPLETED|Overall Study||97
2455263|NCT01039584|6020436|P1|NOT COMPLETED|Overall Study||103
2455264|NCT01039584|6020434|P3|COMPLETED|Overall Study||65
2455265|NCT01039584|6020435|P2|COMPLETED|Overall Study||146
2455266|NCT01039584|6020436|P1|COMPLETED|Overall Study||143
2455267|NCT01039584|6020434|P3|STARTED|Overall Study||122
2455268|NCT01039584|6020435|P2|STARTED|Overall Study||243
2455269|NCT01039584|6020436|P1|STARTED|Overall Study||246
2455270|NCT01039519|6020450|P1|NOT COMPLETED|Survival Follow-up||27
2455271|NCT01039519|6020450|P1|COMPLETED|Survival Follow-up||0
2455272|NCT01039519|6020450|P1|STARTED|Survival Follow-up||27
2455273|NCT01039519|6020450|P1|NOT COMPLETED|Treatment||27
2455274|NCT01039519|6020450|P1|COMPLETED|Treatment|Reason not completed represents reason for terminating treatment.|0
2455275|NCT01039519|6020450|P1|STARTED|Treatment||27
2455276|NCT01039467|6020461|P2|NOT COMPLETED|Overall Study||49
2455277|NCT01039467|6020462|P1|NOT COMPLETED|Overall Study||40
2455278|NCT01039467|6020461|P2|COMPLETED|Overall Study||140
2455279|NCT01039467|6020462|P1|COMPLETED|Overall Study||156
2455280|NCT01039467|6020461|P2|STARTED|Overall Study||189
2455281|NCT01039467|6020462|P1|STARTED|Overall Study||196
2455282|NCT01039428|6020486|P2|NOT COMPLETED|Overall Study||0
2455283|NCT01039428|6020487|P1|NOT COMPLETED|Overall Study||2
2455284|NCT01039428|6020486|P2|COMPLETED|Overall Study||28
2455285|NCT01039428|6020487|P1|COMPLETED|Overall Study||33
2455286|NCT01039428|6020486|P2|STARTED|Overall Study||28
2455287|NCT01039428|6020487|P1|STARTED|Overall Study||35
2455288|NCT01039376|6020511|P2|NOT COMPLETED|Overall Study||126
2455289|NCT01039376|6020512|P1|NOT COMPLETED|Overall Study||130
2455290|NCT01039376|6020511|P2|COMPLETED|Overall Study||114
2455291|NCT01039376|6020512|P1|COMPLETED|Overall Study||110
2455292|NCT01039376|6020511|P2|STARTED|Overall Study||240
2455293|NCT01039376|6020512|P1|STARTED|Overall Study||240
2455294|NCT01039207|6020571|P1|NOT COMPLETED|Overall Study||0
2455295|NCT01039207|6020571|P1|COMPLETED|Overall Study||31
2455296|NCT01039207|6020571|P1|STARTED|Overall Study||31
2455297|NCT01038921|6020581|P2|NOT COMPLETED|Overall Study||0
2455298|NCT01038921|6020582|P1|NOT COMPLETED|Overall Study||2
2455299|NCT01038921|6020581|P2|COMPLETED|Overall Study||20
2455300|NCT01038921|6020582|P1|COMPLETED|Overall Study|2 subjects withdrew|17
2455301|NCT01038921|6020581|P2|STARTED|Overall Study|20 subjects received placebo first (10 weeks), washout (6 weeks), melatonin second ( 10 weeks)|20
2455302|NCT01038921|6020582|P1|STARTED|Overall Study|19 subjects received melatonin first(10 weeks), washout (6 weeks), placebo second (10 weeks)|19
2455303|NCT01038869|6020588|P1|NOT COMPLETED|Overall Study||7
2455304|NCT01038869|6020588|P1|COMPLETED|Overall Study||13
2455305|NCT01038869|6020588|P1|STARTED|Overall Study||20
2455306|NCT01038856|6020596|P1|NOT COMPLETED|Overall Study||2
2455307|NCT01038856|6020596|P1|COMPLETED|Overall Study||3
2455308|NCT01038856|6020596|P1|STARTED|Overall Study||5
2455309|NCT01038752|6020605|P2|NOT COMPLETED|Overall Study||5
2455310|NCT01038752|6020606|P1|NOT COMPLETED|Overall Study||5
2455311|NCT01038752|6020605|P2|COMPLETED|Overall Study||1
2455312|NCT01038752|6020606|P1|COMPLETED|Overall Study||3
2455313|NCT01038752|6020605|P2|STARTED|Overall Study||6
2455314|NCT01038752|6020606|P1|STARTED|Overall Study||8
2455315|NCT01038713|6020629|P3|NOT COMPLETED|Overall Study||1
2455316|NCT01038713|6020630|P2|NOT COMPLETED|Overall Study||3
2455317|NCT01038713|6020631|P1|NOT COMPLETED|Overall Study||5
2455318|NCT01038713|6020629|P3|COMPLETED|Overall Study||16
2455319|NCT01038713|6020630|P2|COMPLETED|Overall Study||17
2455320|NCT01038713|6020631|P1|COMPLETED|Overall Study||21
2455321|NCT01038713|6020629|P3|STARTED|Overall Study||17
2455322|NCT01038713|6020630|P2|STARTED|Overall Study||20
2455323|NCT01038713|6020631|P1|STARTED|Overall Study||26
2455324|NCT01038635|6020660|P9|NOT COMPLETED|Overall Study||2
2455325|NCT01038635|6020661|P8|NOT COMPLETED|Overall Study||5
2455326|NCT01038635|6020662|P7|NOT COMPLETED|Overall Study||2
2455327|NCT01038635|6020663|P6|NOT COMPLETED|Overall Study||0
2455328|NCT01038635|6020664|P5|NOT COMPLETED|Overall Study||1
2455329|NCT01038635|6020665|P4|NOT COMPLETED|Overall Study||0
2455330|NCT01038635|6020666|P3|NOT COMPLETED|Overall Study||0
2455331|NCT01038635|6020667|P2|NOT COMPLETED|Overall Study||0
2455332|NCT01038635|6020668|P1|NOT COMPLETED|Overall Study||2
2455333|NCT01038635|6020660|P9|COMPLETED|Overall Study||38
2455334|NCT01038635|6020661|P8|COMPLETED|Overall Study||15
2455335|NCT01038635|6020662|P7|COMPLETED|Overall Study||5
2455336|NCT01038635|6020663|P6|COMPLETED|Overall Study||3
2455337|NCT01038635|6020664|P5|COMPLETED|Overall Study||3
2455338|NCT01038635|6020665|P4|COMPLETED|Overall Study||3
2455339|NCT01038635|6020666|P3|COMPLETED|Overall Study||3
2455340|NCT01038635|6020667|P2|COMPLETED|Overall Study||3
2455341|NCT01038635|6020668|P1|COMPLETED|Overall Study||3
2455342|NCT01038635|6020660|P9|STARTED|Overall Study||40
2455343|NCT01038635|6020661|P8|STARTED|Overall Study||20
2455344|NCT01038635|6020662|P7|STARTED|Overall Study||7
2455345|NCT01038635|6020663|P6|STARTED|Overall Study||3
2455346|NCT01038635|6020664|P5|STARTED|Overall Study||4
2455347|NCT01038635|6020665|P4|STARTED|Overall Study||3
2455348|NCT01038635|6020666|P3|STARTED|Overall Study||3
2455349|NCT01038635|6020667|P2|STARTED|Overall Study||3
2455350|NCT01038635|6020668|P1|STARTED|Overall Study||5
2455351|NCT01038609|6020694|P5|NOT COMPLETED|Overall Study||1
2455352|NCT01038609|6020695|P4|NOT COMPLETED|Overall Study||1
2455353|NCT01038609|6020696|P3|NOT COMPLETED|Overall Study||1
2455354|NCT01038609|6020697|P2|NOT COMPLETED|Overall Study||1
2455355|NCT01038609|6020698|P1|NOT COMPLETED|Overall Study||1
2455356|NCT01038609|6020694|P5|COMPLETED|Overall Study||50
2455357|NCT01038609|6020695|P4|COMPLETED|Overall Study||47
2455358|NCT01038609|6020696|P3|COMPLETED|Overall Study||48
2455359|NCT01038609|6020697|P2|COMPLETED|Overall Study||51
2455360|NCT01038609|6020698|P1|COMPLETED|Overall Study||49
2455361|NCT01038609|6020694|P5|STARTED|Overall Study||51
2455362|NCT01038609|6020695|P4|STARTED|Overall Study||48
2455363|NCT01038609|6020696|P3|STARTED|Overall Study||49
2455364|NCT01038609|6020697|P2|STARTED|Overall Study||52
2455365|NCT01038609|6020698|P1|STARTED|Overall Study||50
2455366|NCT01038557|6020743|P3|NOT COMPLETED|Overall Study||0
2455367|NCT01038557|6020744|P2|NOT COMPLETED|Overall Study||0
2455368|NCT01038557|6020745|P1|NOT COMPLETED|Overall Study||0
2455369|NCT01038557|6020743|P3|COMPLETED|Overall Study||86
2455370|NCT01038557|6020744|P2|COMPLETED|Overall Study||86
2455371|NCT01038557|6020745|P1|COMPLETED|Overall Study||82
2455372|NCT01038557|6020743|P3|STARTED|Overall Study||86
2455373|NCT01038557|6020744|P2|STARTED|Overall Study||86
2455374|NCT01038557|6020745|P1|STARTED|Overall Study||82
2455375|NCT01038336|6020783|P3|NOT COMPLETED|Overall Study||0
2455376|NCT01038336|6020784|P2|NOT COMPLETED|Overall Study||0
2455377|NCT01038336|6020785|P1|NOT COMPLETED|Overall Study||0
2455378|NCT01038336|6020783|P3|COMPLETED|Overall Study||44
2455379|NCT01038336|6020784|P2|COMPLETED|Overall Study||42
2455380|NCT01038336|6020785|P1|COMPLETED|Overall Study||43
2455381|NCT01038336|6020783|P3|STARTED|Overall Study||44
2455382|NCT01038336|6020784|P2|STARTED|Overall Study||42
2455383|NCT01038336|6020785|P1|STARTED|Overall Study||43
2455384|NCT01038323|6020817|P3|NOT COMPLETED|Overall Study||4
2455385|NCT01038323|6020818|P2|NOT COMPLETED|Overall Study||2
2455386|NCT01038323|6020819|P1|NOT COMPLETED|Overall Study||3
2455387|NCT01038323|6020817|P3|COMPLETED|Overall Study||15
2455388|NCT01038323|6020818|P2|COMPLETED|Overall Study||17
2455389|NCT01038323|6020819|P1|COMPLETED|Overall Study||17
2455390|NCT01038323|6020817|P3|STARTED|Overall Study||19
2455391|NCT01038323|6020818|P2|STARTED|Overall Study||19
2455392|NCT01038323|6020819|P1|STARTED|Overall Study||20
2455393|NCT01038128|6020833|P1|NOT COMPLETED|Overall Study||4
2455394|NCT01038128|6020833|P1|COMPLETED|Overall Study||1
2455395|NCT01038128|6020833|P1|Baseline Visit|Overall Study||3
2455396|NCT01038128|6020833|P1|STARTED|Overall Study||5
2455397|NCT01037881|6020848|P7|NOT COMPLETED|Overall Study||2
2455398|NCT01037881|6020849|P6|NOT COMPLETED|Overall Study||3
2455399|NCT01037881|6020850|P5|NOT COMPLETED|Overall Study||3
2455400|NCT01037881|6020851|P4|NOT COMPLETED|Overall Study||1
2455401|NCT01037881|6020852|P3|NOT COMPLETED|Overall Study||3
2455402|NCT01037881|6020853|P2|NOT COMPLETED|Overall Study||2
2455403|NCT01037881|6020854|P1|NOT COMPLETED|Overall Study||6
2455404|NCT01037881|6020848|P7|COMPLETED|Overall Study||23
2455405|NCT01037881|6020849|P6|COMPLETED|Overall Study||27
2455406|NCT01037881|6020850|P5|COMPLETED|Overall Study||26
2455407|NCT01037881|6020851|P4|COMPLETED|Overall Study||24
2455408|NCT01037881|6020852|P3|COMPLETED|Overall Study||22
2455409|NCT01037881|6020853|P2|COMPLETED|Overall Study||22
2455410|NCT01037881|6020854|P1|COMPLETED|Overall Study||19
2455411|NCT01037881|6020848|P7|STARTED|Overall Study||25
2455412|NCT01037881|6020849|P6|STARTED|Overall Study||30
2455413|NCT01037881|6020850|P5|STARTED|Overall Study||29
2455414|NCT01037881|6020851|P4|STARTED|Overall Study||25
2455415|NCT01037881|6020852|P3|STARTED|Overall Study||25
2455416|NCT01037881|6020853|P2|STARTED|Overall Study||24
2455417|NCT01037881|6020854|P1|STARTED|Overall Study||25
2455418|NCT01037452|6020916|P4|NOT COMPLETED|Overall Study||0
2455419|NCT01037452|6020917|P3|NOT COMPLETED|Overall Study||0
2455420|NCT01037452|6020918|P2|NOT COMPLETED|Overall Study||0
2455421|NCT01037452|6020919|P1|NOT COMPLETED|Overall Study||0
2455422|NCT01037452|6020916|P4|COMPLETED|Overall Study||30
2455423|NCT01037452|6020917|P3|COMPLETED|Overall Study||30
2455424|NCT01037452|6020918|P2|COMPLETED|Overall Study||30
2455425|NCT01037452|6020919|P1|COMPLETED|Overall Study||30
2455426|NCT01037452|6020916|P4|STARTED|Overall Study||30
2455427|NCT01037452|6020917|P3|STARTED|Overall Study||30
2455428|NCT01037452|6020918|P2|STARTED|Overall Study||30
2455429|NCT01037452|6020919|P1|STARTED|Overall Study||30
2455430|NCT01037309|6020947|P9|NOT COMPLETED|Intravenous Period 7 - 9||0
2455431|NCT01037309|6020948|P8|NOT COMPLETED|Intravenous Period 7 - 9||0
2455432|NCT01037309|6020949|P7|NOT COMPLETED|Intravenous Period 7 - 9||0
2455433|NCT01037309|6020950|P6|NOT COMPLETED|Intravenous Period 7 - 9||0
2455434|NCT01037309|6020951|P5|NOT COMPLETED|Intravenous Period 7 - 9||0
2455435|NCT01037309|6020952|P4|NOT COMPLETED|Intravenous Period 7 - 9||0
2455436|NCT01037309|6020953|P3|NOT COMPLETED|Intravenous Period 7 - 9||0
2455437|NCT01037309|6020954|P2|NOT COMPLETED|Intravenous Period 7 - 9||0
2455438|NCT01037309|6020955|P1|NOT COMPLETED|Intravenous Period 7 - 9||0
2455439|NCT01037309|6020947|P9|COMPLETED|Intravenous Period 7 - 9||3
2455440|NCT01037309|6020948|P8|COMPLETED|Intravenous Period 7 - 9||3
2455441|NCT01037309|6020949|P7|COMPLETED|Intravenous Period 7 - 9||3
2455442|NCT01037309|6020950|P6|COMPLETED|Intravenous Period 7 - 9||0
2455443|NCT01037309|6020951|P5|COMPLETED|Intravenous Period 7 - 9||0
2455444|NCT01037309|6020952|P4|COMPLETED|Intravenous Period 7 - 9||0
2455445|NCT01037309|6020953|P3|COMPLETED|Intravenous Period 7 - 9||0
2455446|NCT01037309|6020954|P2|COMPLETED|Intravenous Period 7 - 9||0
2455447|NCT01037309|6020955|P1|COMPLETED|Intravenous Period 7 - 9||0
2455448|NCT01037309|6020947|P9|STARTED|Intravenous Period 7 - 9||3
2455449|NCT01037309|6020948|P8|STARTED|Intravenous Period 7 - 9||3
2455450|NCT01037309|6020949|P7|STARTED|Intravenous Period 7 - 9||3
2455451|NCT01037309|6020950|P6|STARTED|Intravenous Period 7 - 9||0
2455452|NCT01037309|6020951|P5|STARTED|Intravenous Period 7 - 9||0
2455453|NCT01037309|6020952|P4|STARTED|Intravenous Period 7 - 9||0
2455454|NCT01037309|6020953|P3|STARTED|Intravenous Period 7 - 9||0
2455455|NCT01037309|6020954|P2|STARTED|Intravenous Period 7 - 9||0
2455456|NCT01037309|6020955|P1|STARTED|Intravenous Period 7 - 9||0
2455457|NCT01037309|6020947|P9|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
2455458|NCT01037309|6020948|P8|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
2455459|NCT01037309|6020949|P7|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
2455460|NCT01037309|6020950|P6|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
2455461|NCT01037309|6020951|P5|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
2455462|NCT01037309|6020952|P4|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
2455463|NCT01037309|6020953|P3|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
2455464|NCT01037309|6020954|P2|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
2455465|NCT01037309|6020955|P1|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
2455466|NCT01037309|6020947|P9|COMPLETED|Subcutaneous Cohort 1 - 6||0
2455467|NCT01037309|6020948|P8|COMPLETED|Subcutaneous Cohort 1 - 6||0
2455468|NCT01037309|6020949|P7|COMPLETED|Subcutaneous Cohort 1 - 6||0
2455469|NCT01037309|6020950|P6|COMPLETED|Subcutaneous Cohort 1 - 6||3
2455470|NCT01037309|6020951|P5|COMPLETED|Subcutaneous Cohort 1 - 6||3
2455471|NCT01037309|6020952|P4|COMPLETED|Subcutaneous Cohort 1 - 6||3
2455472|NCT01037309|6020953|P3|COMPLETED|Subcutaneous Cohort 1 - 6||3
2455473|NCT01037309|6020954|P2|COMPLETED|Subcutaneous Cohort 1 - 6||3
2455474|NCT01037309|6020955|P1|COMPLETED|Subcutaneous Cohort 1 - 6||3
2455475|NCT01037309|6020947|P9|STARTED|Subcutaneous Cohort 1 - 6||0
2455476|NCT01037309|6020948|P8|STARTED|Subcutaneous Cohort 1 - 6||0
2455477|NCT01037309|6020949|P7|STARTED|Subcutaneous Cohort 1 - 6||0
2455478|NCT01037309|6020950|P6|STARTED|Subcutaneous Cohort 1 - 6||3
2455479|NCT01037309|6020951|P5|STARTED|Subcutaneous Cohort 1 - 6||3
2455480|NCT01037309|6020952|P4|STARTED|Subcutaneous Cohort 1 - 6||3
2455481|NCT01037309|6020953|P3|STARTED|Subcutaneous Cohort 1 - 6||3
2455482|NCT01037309|6020954|P2|STARTED|Subcutaneous Cohort 1 - 6||3
2455483|NCT01037309|6020955|P1|STARTED|Subcutaneous Cohort 1 - 6||3
2455484|NCT01037244|6020997|P4|NOT COMPLETED|Overall Study||14
2455485|NCT01037244|6020998|P3|NOT COMPLETED|Overall Study||14
2455486|NCT01037244|6020999|P2|NOT COMPLETED|Overall Study||14
2455487|NCT01037244|6021000|P1|NOT COMPLETED|Overall Study||13
2455488|NCT01037244|6020997|P4|COMPLETED|Overall Study||140
2455489|NCT01037244|6020998|P3|COMPLETED|Overall Study||144
2455490|NCT01037244|6020999|P2|COMPLETED|Overall Study||138
2455491|NCT01037244|6021000|P1|COMPLETED|Overall Study||141
2455492|NCT01037244|6020997|P4|Safety Population|Overall Study||152
2455493|NCT01037244|6020998|P3|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|159
2455494|NCT01037244|6020999|P2|Safety Population|Overall Study||150
2455495|NCT01037244|6021000|P1|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|155
2455496|NCT01037244|6020997|P4|mITT (Modified Intent-to-Treat)|Overall Study||153
2455497|NCT01037244|6020998|P3|mITT (Modified Intent-to-Treat)|Overall Study||154
2455498|NCT01037244|6020999|P2|mITT (Modified Intent-to-Treat)|Overall Study||148
2455499|NCT01037244|6021000|P1|mITT (Modified Intent-to-Treat)|Overall Study||150
2455500|NCT01037244|6020997|P4|STARTED|Overall Study||154
2455501|NCT01037244|6020998|P3|STARTED|Overall Study||158
2455502|NCT01037244|6020999|P2|STARTED|Overall Study||152
2455503|NCT01037244|6021000|P1|STARTED|Overall Study||154
2455504|NCT01037218|6021062|P4|NOT COMPLETED|Overall Study||16
2455505|NCT01037218|6021063|P3|NOT COMPLETED|Overall Study||21
2455506|NCT01037218|6021064|P2|NOT COMPLETED|Overall Study||21
2455507|NCT01037218|6021065|P1|NOT COMPLETED|Overall Study||16
2455508|NCT01037218|6021062|P4|COMPLETED|Overall Study||134
2455509|NCT01037218|6021063|P3|COMPLETED|Overall Study||134
2455510|NCT01037218|6021064|P2|COMPLETED|Overall Study||128
2455511|NCT01037218|6021065|P1|COMPLETED|Overall Study||131
2455512|NCT01037218|6021062|P4|mITT Population|Overall Study||141
2455513|NCT01037218|6021063|P3|mITT Population|Overall Study||147
2455514|NCT01037218|6021064|P2|mITT Population|Overall Study||140
2455515|NCT01037218|6021065|P1|mITT Population|Overall Study||141
2455516|NCT01037218|6021062|P4|Safety Population|Overall Study||150
2455517|NCT01037218|6021063|P3|Safety Population|Overall Study||154
2455518|NCT01037218|6021064|P2|Safety Population|Overall Study||148
2455519|NCT01037218|6021065|P1|Safety Population|Overall Study||147
2455520|NCT01037218|6021062|P4|STARTED|Overall Study||150
2455521|NCT01037218|6021063|P3|STARTED|Overall Study||155
2455522|NCT01037218|6021064|P2|STARTED|Overall Study||149
2455523|NCT01037218|6021065|P1|STARTED|Overall Study||147
2455524|NCT01037192|6021125|P2|NOT COMPLETED|Overall Study||0
2455525|NCT01037192|6021126|P1|NOT COMPLETED|Overall Study||0
2455526|NCT01037192|6021125|P2|COMPLETED|Overall Study||1
2455527|NCT01037192|6021126|P1|COMPLETED|Overall Study||3
2455528|NCT01037192|6021125|P2|STARTED|Overall Study||1
2455529|NCT01037192|6021126|P1|STARTED|Overall Study||3
2455530|NCT01037127|6021136|P2|NOT COMPLETED|Overall Study||21
2455531|NCT01037127|6021137|P1|NOT COMPLETED|Overall Study||5
2455532|NCT01037127|6021136|P2|COMPLETED|Overall Study||36
2455533|NCT01037127|6021137|P1|COMPLETED|Overall Study||35
2455534|NCT01037127|6021136|P2|STARTED|Overall Study||57
2455535|NCT01037127|6021137|P1|STARTED|Overall Study||40
2455536|NCT01037114|6021169|P1|NOT COMPLETED|Year 20||1
2455537|NCT01037114|6021169|P1|COMPLETED|Year 20|One subject returned at Y20 but did not do lab test because subject met a study exclusion criteria.|44
2455538|NCT01037114|6021169|P1|STARTED|Year 20||45
2455539|NCT01037114|6021169|P1|NOT COMPLETED|Year 19||0
2455540|NCT01037114|6021169|P1|COMPLETED|Year 19||45
2455541|NCT01037114|6021169|P1|STARTED|Year 19||45
2455542|NCT01037114|6021169|P1|NOT COMPLETED|Year 18||0
2455543|NCT01037114|6021169|P1|COMPLETED|Year 18||44
2455544|NCT01037114|6021169|P1|STARTED|Year 18||44
2455545|NCT01037114|6021169|P1|NOT COMPLETED|Year 17||0
2455546|NCT01037114|6021169|P1|COMPLETED|Year 17||48
2455547|NCT01037114|6021169|P1|STARTED|Year 17||48
2455548|NCT01037114|6021169|P1|NOT COMPLETED|Year 16||0
2455549|NCT01037114|6021169|P1|COMPLETED|Year 16||49
2455550|NCT01037114|6021169|P1|STARTED|Year 16||49
2455551|NCT01037088|6021182|P1|NOT COMPLETED|Overall Study||3
2455552|NCT01037088|6021182|P1|COMPLETED|Overall Study||36
2455553|NCT01037088|6021182|P1|Received Placebo|Overall Study||38
2455554|NCT01037088|6021182|P1|Received 1.29% THC|Overall Study||37
2455555|NCT01037088|6021182|P1|Received 3.53% THC|Overall Study||36
2455556|NCT01037088|6021182|P1|STARTED|Overall Study||39
2455557|NCT01036802|6021195|P2|NOT COMPLETED|Overall Study||0
2455558|NCT01036802|6021196|P1|NOT COMPLETED|Overall Study||0
2455559|NCT01036802|6021195|P2|COMPLETED|Overall Study|Patient was taken off study after 7 months as she required hip replacement surgery.|1
2455560|NCT01036802|6021196|P1|COMPLETED|Overall Study||2
2455561|NCT01036802|6021195|P2|STARTED|Overall Study||1
2455562|NCT01036802|6021196|P1|STARTED|Overall Study||2
2455563|NCT01036763|6021214|P1|NOT COMPLETED|Overall Study||93
2455564|NCT01036763|6021214|P1|COMPLETED|Overall Study||1171
2455565|NCT01036763|6021214|P1|STARTED|Overall Study||1264
2455566|NCT01036724|6021226|P2|NOT COMPLETED|Overall Study||8
2455567|NCT01036724|6021227|P1|NOT COMPLETED|Overall Study||6
2455568|NCT01036724|6021226|P2|COMPLETED|Overall Study||47
2455569|NCT01036724|6021227|P1|COMPLETED|Overall Study||46
2455570|NCT01036724|6021226|P2|STARTED|Overall Study||55
2455571|NCT01036724|6021227|P1|STARTED|Overall Study||52
2455572|NCT01036529|6021237|P2|NOT COMPLETED|Overall Study||15
2455573|NCT01036529|6021238|P1|NOT COMPLETED|Overall Study||13
2455574|NCT01036529|6021237|P2|COMPLETED|Overall Study||0
2455575|NCT01036529|6021238|P1|COMPLETED|Overall Study||0
2455576|NCT01036529|6021237|P2|Crossover to Other Group|Overall Study||1
2455577|NCT01036529|6021238|P1|Crossover to Other Group|Overall Study||1
2455578|NCT01036529|6021237|P2|Requested Crossover|Overall Study||2
2455579|NCT01036529|6021238|P1|Requested Crossover|Overall Study||1
2455580|NCT01036529|6021237|P2|12 Month Follow-up|Overall Study||3
2455581|NCT01036529|6021238|P1|12 Month Follow-up|Overall Study||4
2455582|NCT01036529|6021237|P2|6 Month Follow-up|Overall Study||7
2455583|NCT01036529|6021238|P1|6 Month Follow-up|Overall Study||6
2455584|NCT01036529|6021237|P2|3 Month Follow-up|Overall Study||9
2455585|NCT01036529|6021238|P1|3 Month Follow-up|Overall Study||7
2455586|NCT01036529|6021237|P2|Index Procedure|Overall Study|Index Procedure: Surgery|11
2455587|NCT01036529|6021238|P1|Index Procedure|Overall Study|Index Procedure: Trial Stimulation|10
2455588|NCT01036529|6021237|P2|Baseline Visit|Overall Study||13
2455589|NCT01036529|6021238|P1|Baseline Visit|Overall Study||10
2455590|NCT01036529|6021237|P2|STARTED|Overall Study||15
2455591|NCT01036529|6021238|P1|STARTED|Overall Study||13
2455592|NCT01036490|6021246|P2|NOT COMPLETED|Overall Study||0
2455593|NCT01036490|6021247|P1|NOT COMPLETED|Overall Study||4
2455594|NCT01036490|6021246|P2|COMPLETED|Overall Study||18
2455595|NCT01036490|6021247|P1|COMPLETED|Overall Study||14
2455596|NCT01036490|6021246|P2|STARTED|Overall Study||18
2455597|NCT01036490|6021247|P1|STARTED|Overall Study||18
2455598|NCT01036438|6021265|P2|NOT COMPLETED|Overall Study||10
2455599|NCT01036438|6021266|P1|NOT COMPLETED|Overall Study||10
2455600|NCT01036438|6021265|P2|COMPLETED|Overall Study||90
2455601|NCT01036438|6021266|P1|COMPLETED|Overall Study||91
2455602|NCT01036438|6021265|P2|STARTED|Overall Study||100
2455603|NCT01036438|6021266|P1|STARTED|Overall Study||101
2455604|NCT01036321|6021274|P2|NOT COMPLETED|Overall Study||4
2455605|NCT01036321|6021275|P1|NOT COMPLETED|Overall Study||5
2455606|NCT01036321|6021274|P2|COMPLETED|Overall Study||31
2455607|NCT01036321|6021275|P1|COMPLETED|Overall Study||31
2455608|NCT01036321|6021274|P2|STARTED|Overall Study||35
2455609|NCT01036321|6021275|P1|STARTED|Overall Study||36
2455610|NCT01036165|6021299|P1|NOT COMPLETED|Overall Study||15
2455611|NCT01036165|6021299|P1|COMPLETED|Overall Study||88
2455612|NCT01036165|6021299|P1|STARTED|Overall Study||103
2455613|NCT01036022|6021310|P6|NOT COMPLETED|Overall Study||3
2455614|NCT01036022|6021311|P5|NOT COMPLETED|Overall Study||3
2455615|NCT01036022|6021312|P4|NOT COMPLETED|Overall Study||2
2455616|NCT01036022|6021313|P3|NOT COMPLETED|Overall Study||4
2455617|NCT01036022|6021314|P2|NOT COMPLETED|Overall Study||4
2455618|NCT01036022|6021315|P1|NOT COMPLETED|Overall Study||2
2455619|NCT01036022|6021310|P6|COMPLETED|Overall Study||13
2455620|NCT01036022|6021311|P5|COMPLETED|Overall Study||9
2455621|NCT01036022|6021312|P4|COMPLETED|Overall Study||10
2455622|NCT01036022|6021313|P3|COMPLETED|Overall Study||8
2455623|NCT01036022|6021314|P2|COMPLETED|Overall Study||7
2455624|NCT01036022|6021315|P1|COMPLETED|Overall Study||13
2455625|NCT01036022|6021310|P6|STARTED|Overall Study||16
2455626|NCT01036022|6021311|P5|STARTED|Overall Study||12
2455627|NCT01036022|6021312|P4|STARTED|Overall Study||12
2455628|NCT01036022|6021313|P3|STARTED|Overall Study||12
2455629|NCT01036022|6021314|P2|STARTED|Overall Study||11
2455630|NCT01036022|6021315|P1|STARTED|Overall Study||15
2455631|NCT01036009|6021417|P2|NOT COMPLETED|Overall Study||0
2455632|NCT01036009|6021418|P1|NOT COMPLETED|Overall Study||0
2455633|NCT01036009|6021417|P2|COMPLETED|Overall Study||26
2455634|NCT01036009|6021418|P1|COMPLETED|Overall Study||17
2455635|NCT01036009|6021417|P2|STARTED|Overall Study||26
2455636|NCT01036009|6021418|P1|STARTED|Overall Study||17
2455637|NCT01035944|6021436|P4|NOT COMPLETED|Overall Study||0
2455638|NCT01035944|6021437|P3|NOT COMPLETED|Overall Study||1
2455639|NCT01035944|6021438|P2|NOT COMPLETED|Overall Study||1
2455640|NCT01035944|6021439|P1|NOT COMPLETED|Overall Study||3
2455641|NCT01035944|6021436|P4|COMPLETED|Overall Study||4
2455642|NCT01035944|6021437|P3|COMPLETED|Overall Study||4
2455643|NCT01035944|6021438|P2|COMPLETED|Overall Study||13
2455644|NCT01035944|6021439|P1|COMPLETED|Overall Study||11
2455645|NCT01035944|6021436|P4|STARTED|Overall Study||4
2455646|NCT01035944|6021437|P3|STARTED|Overall Study||5
2455647|NCT01035944|6021438|P2|STARTED|Overall Study||14
2455648|NCT01035944|6021439|P1|STARTED|Overall Study||14
2455649|NCT01035905|6021451|P2|NOT COMPLETED|Overall Study||1
2455650|NCT01035905|6021452|P1|NOT COMPLETED|Overall Study||1
2455651|NCT01035905|6021451|P2|COMPLETED|Overall Study||30
2455652|NCT01035905|6021452|P1|COMPLETED|Overall Study||31
2455653|NCT01035905|6021451|P2|STARTED|Overall Study||31
2455654|NCT01035905|6021452|P1|STARTED|Overall Study||32
2455655|NCT01035788|6021460|P2|NOT COMPLETED|Overall Study||14
2455656|NCT01035788|6021461|P1|NOT COMPLETED|Overall Study||6
2455657|NCT01035788|6021460|P2|COMPLETED|Overall Study||9
2455658|NCT01035788|6021461|P1|COMPLETED|Overall Study||17
2455659|NCT01035788|6021460|P2|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
2455660|NCT01035788|6021461|P1|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
2455661|NCT01035749|6021471|P4|NOT COMPLETED|Overall Study||0
2455662|NCT01035749|6021472|P3|NOT COMPLETED|Overall Study||0
2455663|NCT01035749|6021473|P2|NOT COMPLETED|Overall Study||0
2455664|NCT01035749|6021474|P1|NOT COMPLETED|Overall Study||0
2455665|NCT01035749|6021471|P4|COMPLETED|Overall Study||110
2455666|NCT01035749|6021472|P3|COMPLETED|Overall Study||68
2455667|NCT01035749|6021473|P2|COMPLETED|Overall Study||66
2455668|NCT01035749|6021474|P1|COMPLETED|Overall Study||66
2455669|NCT01035749|6021471|P4|STARTED|Overall Study||110
2455670|NCT01035749|6021472|P3|STARTED|Overall Study||68
2455671|NCT01035749|6021473|P2|STARTED|Overall Study||66
2455672|NCT01035749|6021474|P1|STARTED|Overall Study||66
2455673|NCT01035658|6021596|P4|NOT COMPLETED|Overall Study||0
2455674|NCT01035658|6021597|P3|NOT COMPLETED|Overall Study||0
2455675|NCT01035658|6021598|P2|NOT COMPLETED|Overall Study||0
2455676|NCT01035658|6021599|P1|NOT COMPLETED|Overall Study||0
2455677|NCT01035658|6021596|P4|COMPLETED|Overall Study||6
2455678|NCT01035658|6021597|P3|COMPLETED|Overall Study||3
2455679|NCT01035658|6021598|P2|COMPLETED|Overall Study||8
2455680|NCT01035658|6021599|P1|COMPLETED|Overall Study||5
2455681|NCT01035658|6021596|P4|STARTED|Overall Study||6
2455682|NCT01035658|6021597|P3|STARTED|Overall Study||3
2455683|NCT01035658|6021598|P2|STARTED|Overall Study||8
2455684|NCT01035658|6021599|P1|STARTED|Overall Study||5
2455685|NCT01035606|6021625|P3|NOT COMPLETED|Overall Study||4
2455686|NCT01035606|6021626|P2|NOT COMPLETED|Overall Study||3
2455687|NCT01035606|6021627|P1|NOT COMPLETED|Overall Study||3
2455688|NCT01035606|6021625|P3|COMPLETED|Overall Study||7
2455689|NCT01035606|6021626|P2|COMPLETED|Overall Study||16
2455690|NCT01035606|6021627|P1|COMPLETED|Overall Study||16
2455691|NCT01035606|6021625|P3|STARTED|Overall Study||11
2455692|NCT01035606|6021626|P2|STARTED|Overall Study||19
2455693|NCT01035606|6021627|P1|STARTED|Overall Study||19
2455694|NCT01035463|6021643|P6|NOT COMPLETED|Overall Study||18
2455695|NCT01035463|6021644|P5|NOT COMPLETED|Overall Study||6
2455696|NCT01035463|6021645|P4|NOT COMPLETED|Overall Study||2
2455697|NCT01035463|6021646|P3|NOT COMPLETED|Overall Study||5
2455698|NCT01035463|6021647|P2|NOT COMPLETED|Overall Study||2
2455699|NCT01035463|6021648|P1|NOT COMPLETED|Overall Study||0
2455700|NCT01035463|6021643|P6|COMPLETED|Overall Study||15
2455701|NCT01035463|6021644|P5|COMPLETED|Overall Study||1
2455702|NCT01035463|6021645|P4|COMPLETED|Overall Study||2
2455703|NCT01035463|6021646|P3|COMPLETED|Overall Study||1
2455704|NCT01035463|6021647|P2|COMPLETED|Overall Study||1
2455705|NCT01035463|6021648|P1|COMPLETED|Overall Study||6
2455706|NCT01035463|6021643|P6|STARTED|Overall Study||33
2455707|NCT01035463|6021644|P5|STARTED|Overall Study||7
2455708|NCT01035463|6021645|P4|STARTED|Overall Study||4
2455709|NCT01035463|6021646|P3|STARTED|Overall Study||6
2455710|NCT01035463|6021647|P2|STARTED|Overall Study||3
2455711|NCT01035463|6021648|P1|STARTED|Overall Study||6
2455712|NCT01035346|6021659|P2|NOT COMPLETED|Overall Study||0
2455713|NCT01035346|6021660|P1|NOT COMPLETED|Overall Study||0
2455714|NCT01035346|6021659|P2|COMPLETED|Overall Study||9
2455715|NCT01035346|6021660|P1|COMPLETED|Overall Study||7
2455716|NCT01035346|6021659|P2|STARTED|Overall Study||9
2455717|NCT01035346|6021660|P1|STARTED|Overall Study||7
2455718|NCT01035333|6021678|P1|NOT COMPLETED|Overall Study||10
2455719|NCT01035333|6021678|P1|COMPLETED|Overall Study||9
2455720|NCT01035333|6021678|P1|STARTED|Overall Study||19
2455721|NCT01035255|6021685|P2|NOT COMPLETED|Overall Study||862
2455722|NCT01035255|6021686|P1|NOT COMPLETED|Overall Study||741
2455723|NCT01035255|6021685|P2|COMPLETED|Overall Study||3371
2455724|NCT01035255|6021686|P1|COMPLETED|Overall Study||3468
2455725|NCT01035255|6021685|P2|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4212
2455726|NCT01035255|6021686|P1|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4187
2455727|NCT01035255|6021685|P2|Mis-randomized|Overall Study||2
2455728|NCT01035255|6021686|P1|Mis-randomized|Overall Study||4
2455729|NCT01035255|6021685|P2|GCP Violations|Overall Study||19
2455730|NCT01035255|6021686|P1|GCP Violations|Overall Study||18
2455731|NCT01035255|6021685|P2|STARTED|Overall Study||4233
2455732|NCT01035255|6021686|P1|STARTED|Overall Study||4209
2455733|NCT01035229|6021704|P2|NOT COMPLETED|Overall Study||184
2455734|NCT01035229|6021705|P1|NOT COMPLETED|Overall Study||362
2455735|NCT01035229|6021704|P2|COMPLETED|Overall Study||0
2455736|NCT01035229|6021705|P1|COMPLETED|Overall Study||0
2455737|NCT01035229|6021704|P2|STARTED|Overall Study||184
2455738|NCT01035229|6021705|P1|STARTED|Overall Study||362
2455739|NCT01035151|6021725|P2|NOT COMPLETED|Overall Study||15
2455740|NCT01035151|6021726|P1|NOT COMPLETED|Overall Study||21
2455741|NCT01035151|6021725|P2|COMPLETED|Overall Study||185
2455742|NCT01035151|6021726|P1|COMPLETED|Overall Study||188
2455743|NCT01035151|6021725|P2|STARTED|Overall Study||200
2455744|NCT01035151|6021726|P1|STARTED|Overall Study||209
2455745|NCT01035138|6021735|P3|NOT COMPLETED|Overall Study||47
2455746|NCT01035138|6021736|P2|NOT COMPLETED|Overall Study||60
2455747|NCT01035138|6021737|P1|NOT COMPLETED|Overall Study||73
2455748|NCT01035138|6021735|P3|COMPLETED|Overall Study||0
2455749|NCT01035138|6021736|P2|COMPLETED|Overall Study||0
2455750|NCT01035138|6021737|P1|COMPLETED|Overall Study||0
2455751|NCT01035138|6021735|P3|STARTED|Overall Study||47
2455752|NCT01035138|6021736|P2|STARTED|Overall Study||60
2455753|NCT01035138|6021737|P1|STARTED|Overall Study||73
2455754|NCT01035060|6021793|P2|NOT COMPLETED|Overall Study||14
2455755|NCT01035060|6021794|P1|NOT COMPLETED|Overall Study||24
2455756|NCT01035060|6021793|P2|COMPLETED|Overall Study||15
2455757|NCT01035060|6021794|P1|COMPLETED|Overall Study||15
2455758|NCT01035060|6021793|P2|STARTED|Overall Study||29
2455759|NCT01035060|6021794|P1|STARTED|Overall Study||39
2455760|NCT01035047|6021802|P2|NOT COMPLETED|Overall Study||0
2455761|NCT01035047|6021803|P1|NOT COMPLETED|Overall Study||0
2455762|NCT01035047|6021802|P2|COMPLETED|Overall Study||53
2455763|NCT01035047|6021803|P1|COMPLETED|Overall Study||52
2455764|NCT01035047|6021802|P2|STARTED|Overall Study||53
2455765|NCT01035047|6021803|P1|STARTED|Overall Study||52
2455766|NCT01034709|6021819|P2|NOT COMPLETED|Overall Study||16
2455767|NCT01034709|6021820|P1|NOT COMPLETED|Overall Study||9
2455768|NCT01034709|6021819|P2|COMPLETED|Overall Study||42
2455769|NCT01034709|6021820|P1|COMPLETED|Overall Study||44
2455770|NCT01034709|6021819|P2|STARTED|Overall Study||58
2455771|NCT01034709|6021820|P1|STARTED|Overall Study||53
2455772|NCT01034657|6021826|P3|NOT COMPLETED|Randomized Phase||1
2455773|NCT01034657|6021827|P2|NOT COMPLETED|Randomized Phase||6
2455774|NCT01034657|6021828|P1|NOT COMPLETED|Randomized Phase||5
2455775|NCT01034657|6021826|P3|COMPLETED|Randomized Phase||0
2455776|NCT01034657|6021827|P2|COMPLETED|Randomized Phase||0
2455777|NCT01034657|6021828|P1|COMPLETED|Randomized Phase||1
2455778|NCT01034657|6021826|P3|STARTED|Randomized Phase||1
2455779|NCT01034657|6021827|P2|STARTED|Randomized Phase||6
2455780|NCT01034657|6021828|P1|STARTED|Randomized Phase||6
2455781|NCT01034657|6021826|P3|NOT COMPLETED|Core Phase||0
2455782|NCT01034657|6021827|P2|NOT COMPLETED|Core Phase||0
2455783|NCT01034657|6021828|P1|NOT COMPLETED|Core Phase||14
2455784|NCT01034657|6021826|P3|COMPLETED|Core Phase||0
2455785|NCT01034657|6021827|P2|COMPLETED|Core Phase||0
2455786|NCT01034657|6021828|P1|COMPLETED|Core Phase||20
2455787|NCT01034657|6021826|P3|STARTED|Core Phase||0
2455788|NCT01034657|6021827|P2|STARTED|Core Phase||0
2455789|NCT01034657|6021828|P1|STARTED|Core Phase||34
2455790|NCT01034631|6021869|P3|NOT COMPLETED|Phase II||2
2455791|NCT01034631|6021870|P2|NOT COMPLETED|Phase II||1
2455792|NCT01034631|6021871|P1|NOT COMPLETED|Phase II||0
2455793|NCT01034631|6021869|P3|COMPLETED|Phase II||67
2455794|NCT01034631|6021870|P2|COMPLETED|Phase II||69
2455795|NCT01034631|6021871|P1|COMPLETED|Phase II||0
2455796|NCT01034631|6021869|P3|STARTED|Phase II||69
2455797|NCT01034631|6021870|P2|STARTED|Phase II||70
2455798|NCT01034631|6021871|P1|STARTED|Phase II|No Phase I Participants were enrolled during this time period.|0
2455799|NCT01034631|6021869|P3|NOT COMPLETED|Phase I||0
2455800|NCT01034631|6021870|P2|NOT COMPLETED|Phase I||0
2455801|NCT01034631|6021871|P1|NOT COMPLETED|Phase I||3
2455802|NCT01034631|6021869|P3|COMPLETED|Phase I||0
2455803|NCT01034631|6021870|P2|COMPLETED|Phase I||0
2455804|NCT01034631|6021871|P1|COMPLETED|Phase I||12
2455805|NCT01034631|6021869|P3|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
2455806|NCT01034631|6021870|P2|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
2455807|NCT01034631|6021871|P1|STARTED|Phase I||15
2455808|NCT01034592|6021890|P1|NOT COMPLETED|Overall Study||0
2455809|NCT01034592|6021890|P1|COMPLETED|Overall Study||2
2455810|NCT01034592|6021890|P1|STARTED|Overall Study||2
2455811|NCT01034579|6021902|P2|NOT COMPLETED|Overall Study||0
2455812|NCT01034579|6021903|P1|NOT COMPLETED|Overall Study||0
2455813|NCT01034579|6021902|P2|COMPLETED|Overall Study||166
2455814|NCT01034579|6021903|P1|COMPLETED|Overall Study||158
2455815|NCT01034579|6021902|P2|STARTED|Overall Study||166
2455816|NCT01034579|6021903|P1|STARTED|Overall Study||158
2455817|NCT01034553|6021917|P6|NOT COMPLETED|Overall Study||0
2455818|NCT01034553|6021918|P5|NOT COMPLETED|Overall Study||0
2455819|NCT01034553|6021919|P4|NOT COMPLETED|Overall Study||0
2455820|NCT01034553|6021920|P3|NOT COMPLETED|Overall Study||0
2455821|NCT01034553|6021921|P2|NOT COMPLETED|Overall Study||0
2455822|NCT01034553|6021922|P1|NOT COMPLETED|Overall Study||0
2455823|NCT01034553|6021917|P6|COMPLETED|Overall Study||7
2455824|NCT01034553|6021918|P5|COMPLETED|Overall Study||6
2455825|NCT01034553|6021919|P4|COMPLETED|Overall Study||3
2455826|NCT01034553|6021920|P3|COMPLETED|Overall Study||3
2455827|NCT01034553|6021921|P2|COMPLETED|Overall Study||4
2455828|NCT01034553|6021922|P1|COMPLETED|Overall Study||3
2455829|NCT01034553|6021917|P6|STARTED|Overall Study||7
2455830|NCT01034553|6021918|P5|STARTED|Overall Study||6
2455831|NCT01034553|6021919|P4|STARTED|Overall Study||3
2455832|NCT01034553|6021920|P3|STARTED|Overall Study||3
2455833|NCT01034553|6021921|P2|STARTED|Overall Study||4
2455834|NCT01034553|6021922|P1|STARTED|Overall Study||3
2455835|NCT01034540|6021938|P2|NOT COMPLETED|Overall Study||1
2455836|NCT01034540|6021939|P1|NOT COMPLETED|Overall Study||0
2455837|NCT01034540|6021938|P2|COMPLETED|Overall Study||11
2455838|NCT01034540|6021939|P1|COMPLETED|Overall Study||11
2455839|NCT01034540|6021938|P2|Completed 1st Treatment Intervention|Overall Study||11
2455840|NCT01034540|6021939|P1|Completed 1st Treatment Intervention|Overall Study||11
2455841|NCT01034540|6021938|P2|STARTED|Overall Study||12
2455842|NCT01034540|6021939|P1|STARTED|Overall Study||11
2455843|NCT01034527|6021949|P2|NOT COMPLETED|Overall Study||0
2455844|NCT01034527|6021950|P1|NOT COMPLETED|Overall Study||0
2455845|NCT01034527|6021949|P2|COMPLETED|Overall Study||216
2455846|NCT01034527|6021950|P1|COMPLETED|Overall Study||307
2455847|NCT01034527|6021949|P2|STARTED|Overall Study||216
2455848|NCT01034527|6021950|P1|STARTED|Overall Study||307
2455849|NCT01034462|6021958|P2|NOT COMPLETED|Overall Study||54
2455850|NCT01034462|6021959|P1|NOT COMPLETED|Overall Study||45
2455851|NCT01034462|6021958|P2|COMPLETED|Overall Study||163
2455852|NCT01034462|6021959|P1|COMPLETED|Overall Study||172
2455853|NCT01034462|6021958|P2|STARTED|Overall Study||217
2455854|NCT01034462|6021959|P1|STARTED|Overall Study||217
2455855|NCT01034397|6021969|P2|NOT COMPLETED|Overall Study||2
2455856|NCT01034397|6021970|P1|NOT COMPLETED|Overall Study||7
2455857|NCT01034397|6021969|P2|COMPLETED|Overall Study||17
2455858|NCT01034397|6021970|P1|COMPLETED|Overall Study||28
2455859|NCT01034397|6021969|P2|STARTED|Overall Study||19
2455860|NCT01034397|6021970|P1|STARTED|Overall Study||35
2455861|NCT01034358|6022119|P1|NOT COMPLETED|Overall Study||2
2455862|NCT01034358|6022119|P1|COMPLETED|Overall Study|One patient was found after enrollment to have already received one prior dose of the HPV vaccine.|13
2455863|NCT01034358|6022119|P1|STARTED|Overall Study||15
2455864|NCT01034306|6022125|P2|NOT COMPLETED|Overall Study||3
2455865|NCT01034306|6022126|P1|NOT COMPLETED|Overall Study||5
2455866|NCT01034306|6022125|P2|COMPLETED|Overall Study||34
2455867|NCT01034306|6022126|P1|COMPLETED|Overall Study||37
2455868|NCT01034306|6022125|P2|STARTED|Overall Study||37
2455869|NCT01034306|6022126|P1|STARTED|Overall Study||42
2455870|NCT01034176|6022134|P2|NOT COMPLETED|Overall Study||2
2455871|NCT01034176|6022135|P1|NOT COMPLETED|Overall Study||2
2455872|NCT01034176|6022134|P2|COMPLETED|Overall Study||19
2455873|NCT01034176|6022135|P1|COMPLETED|Overall Study||20
2455874|NCT01034176|6022134|P2|STARTED|Overall Study||21
2455875|NCT01034176|6022135|P1|STARTED|Overall Study||22
2455876|NCT01034163|6022145|P2|NOT COMPLETED|Overall Study||14
2455877|NCT01034163|6022146|P1|NOT COMPLETED|Overall Study||27
2455878|NCT01034163|6022145|P2|COMPLETED|Overall Study||0
2455879|NCT01034163|6022146|P1|COMPLETED|Overall Study||0
2455880|NCT01034163|6022145|P2|In Open Label Phase After Unblinding|Overall Study||0
2455881|NCT01034163|6022146|P1|In Open Label Phase After Unblinding|Overall Study||5
2455882|NCT01034163|6022145|P2|Safety Set|Overall Study||12
2455883|NCT01034163|6022146|P1|Safety Set|Overall Study||26
2455884|NCT01034163|6022145|P2|Untreated (Not in Safety Set)|Overall Study||2
2455885|NCT01034163|6022146|P1|Untreated (Not in Safety Set)|Overall Study||1
2455886|NCT01034163|6022145|P2|STARTED|Overall Study||14
2455887|NCT01034163|6022146|P1|STARTED|Overall Study||27
2455888|NCT01034137|6022155|P3|NOT COMPLETED|Overall Study||30
2455889|NCT01034137|6022156|P2|NOT COMPLETED|Overall Study||22
2455890|NCT01034137|6022157|P1|NOT COMPLETED|Overall Study||28
2455891|NCT01034137|6022155|P3|COMPLETED|Overall Study||78
2455892|NCT01034137|6022156|P2|COMPLETED|Overall Study||81
2455893|NCT01034137|6022157|P1|COMPLETED|Overall Study||78
2455894|NCT01034137|6022155|P3|STARTED|Overall Study||108
2455895|NCT01034137|6022156|P2|STARTED|Overall Study||103
2455896|NCT01034137|6022157|P1|STARTED|Overall Study||106
2455897|NCT01034111|6022288|P1|NOT COMPLETED|Overall Study||0
2455898|NCT01034111|6022288|P1|COMPLETED|Overall Study||30
2455899|NCT01034111|6022288|P1|STARTED|Overall Study||30
2455900|NCT01033942|6022296|P3|NOT COMPLETED|Overall Study||1
2455901|NCT01033942|6022297|P2|NOT COMPLETED|Overall Study||4
2455902|NCT01033942|6022298|P1|NOT COMPLETED|Overall Study||2
2455903|NCT01033942|6022296|P3|COMPLETED|Overall Study||18
2455904|NCT01033942|6022297|P2|COMPLETED|Overall Study||15
2455905|NCT01033942|6022298|P1|COMPLETED|Overall Study||18
2455906|NCT01033942|6022296|P3|STARTED|Overall Study||19
2455907|NCT01033942|6022297|P2|STARTED|Overall Study||19
2455908|NCT01033942|6022298|P1|STARTED|Overall Study||20
2455909|NCT01033864|6022570|P2|NOT COMPLETED|Overall Study||0
2455910|NCT01033864|6022571|P1|NOT COMPLETED|Overall Study||0
2455911|NCT01033864|6022570|P2|COMPLETED|Overall Study||11
2455912|NCT01033864|6022571|P1|COMPLETED|Overall Study||12
2455913|NCT01033864|6022570|P2|STARTED|Overall Study||11
2455914|NCT01033864|6022571|P1|STARTED|Overall Study||12
2455915|NCT01033851|6022596|P2|NOT COMPLETED|Overall Study||7
2455916|NCT01033851|6022597|P1|NOT COMPLETED|Overall Study||3
2455917|NCT01033851|6022596|P2|COMPLETED|Overall Study||34
2455918|NCT01033851|6022597|P1|COMPLETED|Overall Study||45
2455919|NCT01033851|6022596|P2|STARTED|Overall Study||41
2455920|NCT01033851|6022597|P1|STARTED|Overall Study||48
2455921|NCT01033825|6022612|P7|NOT COMPLETED|Overall Study||0
2455922|NCT01033825|6022613|P6|NOT COMPLETED|Overall Study||0
2455923|NCT01033825|6022614|P5|NOT COMPLETED|Overall Study||2
2455924|NCT01033825|6022615|P4|NOT COMPLETED|Overall Study||2
2455925|NCT01033825|6022616|P3|NOT COMPLETED|Overall Study||2
2455926|NCT01033825|6022617|P2|NOT COMPLETED|Overall Study||3
2455927|NCT01033825|6022618|P1|NOT COMPLETED|Overall Study||3
2455928|NCT01033825|6022612|P7|COMPLETED|Overall Study||18
2455929|NCT01033825|6022613|P6|COMPLETED|Overall Study||18
2455930|NCT01033825|6022614|P5|COMPLETED|Overall Study||56
2455931|NCT01033825|6022615|P4|COMPLETED|Overall Study||46
2455932|NCT01033825|6022616|P3|COMPLETED|Overall Study||55
2455933|NCT01033825|6022617|P2|COMPLETED|Overall Study||57
2455934|NCT01033825|6022618|P1|COMPLETED|Overall Study||48
2455935|NCT01033825|6022612|P7|STARTED|Overall Study||18
2455936|NCT01033825|6022613|P6|STARTED|Overall Study||18
2455937|NCT01033825|6022614|P5|STARTED|Overall Study||58
2455938|NCT01033825|6022615|P4|STARTED|Overall Study||48
2455939|NCT01033825|6022616|P3|STARTED|Overall Study||57
2455940|NCT01033825|6022617|P2|STARTED|Overall Study||60
2455941|NCT01033825|6022618|P1|STARTED|Overall Study||51
2455942|NCT01033747|6022839|P2|NOT COMPLETED|Overall Study||15
2455943|NCT01033747|6022840|P1|NOT COMPLETED|Overall Study||37
2455944|NCT01033747|6022839|P2|COMPLETED|Overall Study||4
2455945|NCT01033747|6022840|P1|COMPLETED|Overall Study||14
2455946|NCT01033747|6022839|P2|STARTED|Overall Study||19
2455947|NCT01033747|6022840|P1|STARTED|Overall Study||51
2455948|NCT01033734|6022848|P1|NOT COMPLETED|Overall Study||1
2455949|NCT01033734|6022848|P1|COMPLETED|Overall Study||7
2455950|NCT01033734|6022848|P1|STARTED|Overall Study||8
2455951|NCT01033565|6022900|P1|NOT COMPLETED|Overall Study||0
2455952|NCT01033565|6022900|P1|COMPLETED|Overall Study||1
2455953|NCT01033565|6022900|P1|STARTED|Overall Study||1
2455954|NCT01033487|6022904|P10|NOT COMPLETED|Fifth Intervention Period||0
2455955|NCT01033487|6022905|P9|NOT COMPLETED|Fifth Intervention Period||0
2455956|NCT01033487|6022906|P8|NOT COMPLETED|Fifth Intervention Period||0
2455957|NCT01033487|6022907|P7|NOT COMPLETED|Fifth Intervention Period||0
2455958|NCT01033487|6022908|P6|NOT COMPLETED|Fifth Intervention Period||0
2455959|NCT01033487|6022909|P5|NOT COMPLETED|Fifth Intervention Period||0
2455960|NCT01033487|6022910|P4|NOT COMPLETED|Fifth Intervention Period||0
2455961|NCT01033487|6022911|P3|NOT COMPLETED|Fifth Intervention Period||0
2455962|NCT01033487|6022912|P2|NOT COMPLETED|Fifth Intervention Period||0
2455963|NCT01033487|6022913|P1|NOT COMPLETED|Fifth Intervention Period||0
2455964|NCT01033487|6022904|P10|COMPLETED|Fifth Intervention Period||2
2455965|NCT01033487|6022905|P9|COMPLETED|Fifth Intervention Period||1
2455966|NCT01033487|6022906|P8|COMPLETED|Fifth Intervention Period||3
2455967|NCT01033487|6022907|P7|COMPLETED|Fifth Intervention Period||2
2455968|NCT01033487|6022908|P6|COMPLETED|Fifth Intervention Period||2
2455969|NCT01033487|6022909|P5|COMPLETED|Fifth Intervention Period||2
2455970|NCT01033487|6022910|P4|COMPLETED|Fifth Intervention Period||2
2455971|NCT01033487|6022911|P3|COMPLETED|Fifth Intervention Period||2
2455972|NCT01033487|6022912|P2|COMPLETED|Fifth Intervention Period||3
2455973|NCT01033487|6022913|P1|COMPLETED|Fifth Intervention Period||2
2455974|NCT01033487|6022904|P10|STARTED|Fifth Intervention Period||2
2455975|NCT01033487|6022905|P9|STARTED|Fifth Intervention Period||1
2455976|NCT01033487|6022906|P8|STARTED|Fifth Intervention Period||3
2455977|NCT01033487|6022907|P7|STARTED|Fifth Intervention Period||2
2455978|NCT01033487|6022908|P6|STARTED|Fifth Intervention Period||2
2455979|NCT01033487|6022909|P5|STARTED|Fifth Intervention Period||2
2455980|NCT01033487|6022910|P4|STARTED|Fifth Intervention Period||2
2455981|NCT01033487|6022911|P3|STARTED|Fifth Intervention Period||2
2455982|NCT01033487|6022912|P2|STARTED|Fifth Intervention Period||3
2455983|NCT01033487|6022913|P1|STARTED|Fifth Intervention Period||2
2455984|NCT01033487|6022904|P10|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
2455985|NCT01033487|6022905|P9|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
2455986|NCT01033487|6022906|P8|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
2455987|NCT01033487|6022907|P7|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
2455988|NCT01033487|6022908|P6|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
2455989|NCT01033487|6022909|P5|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
2455990|NCT01033487|6022910|P4|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
2455991|NCT01033487|6022911|P3|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
2455992|NCT01033487|6022912|P2|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
2455993|NCT01033487|6022913|P1|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
2455994|NCT01033487|6022904|P10|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
2455995|NCT01033487|6022905|P9|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||1
2455996|NCT01033487|6022906|P8|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
2455997|NCT01033487|6022907|P7|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
2455998|NCT01033487|6022908|P6|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
2455999|NCT01033487|6022909|P5|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
2456000|NCT01033487|6022910|P4|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
2456001|NCT01033487|6022911|P3|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
2456002|NCT01033487|6022912|P2|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
2456003|NCT01033487|6022913|P1|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
2456004|NCT01033487|6022904|P10|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
2456005|NCT01033487|6022905|P9|STARTED|Between Period 4 and 5 (At Least 7 Days)||1
2456006|NCT01033487|6022906|P8|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
2456007|NCT01033487|6022907|P7|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
2456008|NCT01033487|6022908|P6|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
2456009|NCT01033487|6022909|P5|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
2456010|NCT01033487|6022910|P4|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
2456011|NCT01033487|6022911|P3|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
2456012|NCT01033487|6022912|P2|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
2456013|NCT01033487|6022913|P1|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
2456014|NCT01033487|6022904|P10|NOT COMPLETED|Fourth Intervention Period||0
2456015|NCT01033487|6022905|P9|NOT COMPLETED|Fourth Intervention Period||1
2456016|NCT01033487|6022906|P8|NOT COMPLETED|Fourth Intervention Period||0
2456017|NCT01033487|6022907|P7|NOT COMPLETED|Fourth Intervention Period||0
2456018|NCT01033487|6022908|P6|NOT COMPLETED|Fourth Intervention Period||0
2456019|NCT01033487|6022909|P5|NOT COMPLETED|Fourth Intervention Period||0
2456020|NCT01033487|6022910|P4|NOT COMPLETED|Fourth Intervention Period||0
2456021|NCT01033487|6022911|P3|NOT COMPLETED|Fourth Intervention Period||0
2456022|NCT01033487|6022912|P2|NOT COMPLETED|Fourth Intervention Period||0
2456023|NCT01033487|6022913|P1|NOT COMPLETED|Fourth Intervention Period||0
2456024|NCT01033487|6022904|P10|COMPLETED|Fourth Intervention Period||2
2456025|NCT01033487|6022905|P9|COMPLETED|Fourth Intervention Period||1
2456026|NCT01033487|6022906|P8|COMPLETED|Fourth Intervention Period||3
2456027|NCT01033487|6022907|P7|COMPLETED|Fourth Intervention Period||2
2456028|NCT01033487|6022908|P6|COMPLETED|Fourth Intervention Period||2
2456029|NCT01033487|6022909|P5|COMPLETED|Fourth Intervention Period||2
2456030|NCT01033487|6022910|P4|COMPLETED|Fourth Intervention Period||2
2456031|NCT01033487|6022911|P3|COMPLETED|Fourth Intervention Period||2
2456032|NCT01033487|6022912|P2|COMPLETED|Fourth Intervention Period||3
2456033|NCT01033487|6022913|P1|COMPLETED|Fourth Intervention Period||2
2456034|NCT01033487|6022904|P10|STARTED|Fourth Intervention Period||2
2456035|NCT01033487|6022905|P9|STARTED|Fourth Intervention Period||2
2456036|NCT01033487|6022906|P8|STARTED|Fourth Intervention Period||3
2456037|NCT01033487|6022907|P7|STARTED|Fourth Intervention Period||2
2456038|NCT01033487|6022908|P6|STARTED|Fourth Intervention Period||2
2456039|NCT01033487|6022909|P5|STARTED|Fourth Intervention Period||2
2456040|NCT01033487|6022910|P4|STARTED|Fourth Intervention Period||2
2456041|NCT01033487|6022911|P3|STARTED|Fourth Intervention Period||2
2456042|NCT01033487|6022912|P2|STARTED|Fourth Intervention Period||3
2456043|NCT01033487|6022913|P1|STARTED|Fourth Intervention Period||2
2456044|NCT01033487|6022904|P10|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
2456045|NCT01033487|6022905|P9|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
2456046|NCT01033487|6022906|P8|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
2456047|NCT01033487|6022907|P7|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
2456048|NCT01033487|6022908|P6|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
2456049|NCT01033487|6022909|P5|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
2456050|NCT01033487|6022910|P4|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
2456051|NCT01033487|6022911|P3|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
2456052|NCT01033487|6022912|P2|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
2456053|NCT01033487|6022913|P1|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
2456054|NCT01033487|6022904|P10|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
2456055|NCT01033487|6022905|P9|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
2456056|NCT01033487|6022906|P8|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
2456057|NCT01033487|6022907|P7|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
2456058|NCT01033487|6022908|P6|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
2456059|NCT01033487|6022909|P5|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
2456060|NCT01033487|6022910|P4|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
2456061|NCT01033487|6022911|P3|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
2456062|NCT01033487|6022912|P2|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
2456063|NCT01033487|6022913|P1|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
2456064|NCT01033487|6022904|P10|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
2456065|NCT01033487|6022905|P9|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
2456066|NCT01033487|6022906|P8|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
2456067|NCT01033487|6022907|P7|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
2456068|NCT01033487|6022908|P6|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
2456069|NCT01033487|6022909|P5|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
2456070|NCT01033487|6022910|P4|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
2456071|NCT01033487|6022911|P3|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
2456072|NCT01033487|6022912|P2|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
2456073|NCT01033487|6022913|P1|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
2456074|NCT01033487|6022904|P10|NOT COMPLETED|Third Intervention Period||0
2456075|NCT01033487|6022905|P9|NOT COMPLETED|Third Intervention Period||0
2456076|NCT01033487|6022906|P8|NOT COMPLETED|Third Intervention Period||0
2456077|NCT01033487|6022907|P7|NOT COMPLETED|Third Intervention Period||0
2456078|NCT01033487|6022908|P6|NOT COMPLETED|Third Intervention Period||0
2456079|NCT01033487|6022909|P5|NOT COMPLETED|Third Intervention Period||0
2456080|NCT01033487|6022910|P4|NOT COMPLETED|Third Intervention Period||0
2456081|NCT01033487|6022911|P3|NOT COMPLETED|Third Intervention Period||0
2456082|NCT01033487|6022912|P2|NOT COMPLETED|Third Intervention Period||0
2456083|NCT01033487|6022913|P1|NOT COMPLETED|Third Intervention Period||0
2456084|NCT01033487|6022904|P10|COMPLETED|Third Intervention Period||2
2456085|NCT01033487|6022905|P9|COMPLETED|Third Intervention Period||2
2456086|NCT01033487|6022906|P8|COMPLETED|Third Intervention Period||3
2456087|NCT01033487|6022907|P7|COMPLETED|Third Intervention Period||2
2456088|NCT01033487|6022908|P6|COMPLETED|Third Intervention Period||2
2456089|NCT01033487|6022909|P5|COMPLETED|Third Intervention Period||2
2456090|NCT01033487|6022910|P4|COMPLETED|Third Intervention Period||2
2456091|NCT01033487|6022911|P3|COMPLETED|Third Intervention Period||2
2456092|NCT01033487|6022912|P2|COMPLETED|Third Intervention Period||3
2456093|NCT01033487|6022913|P1|COMPLETED|Third Intervention Period||2
2456094|NCT01033487|6022904|P10|STARTED|Third Intervention Period||2
2456095|NCT01033487|6022905|P9|STARTED|Third Intervention Period||2
2456096|NCT01033487|6022906|P8|STARTED|Third Intervention Period||3
2456097|NCT01033487|6022907|P7|STARTED|Third Intervention Period||2
2456098|NCT01033487|6022908|P6|STARTED|Third Intervention Period||2
2456099|NCT01033487|6022909|P5|STARTED|Third Intervention Period||2
2456100|NCT01033487|6022910|P4|STARTED|Third Intervention Period||2
2456101|NCT01033487|6022911|P3|STARTED|Third Intervention Period||2
2456102|NCT01033487|6022912|P2|STARTED|Third Intervention Period||3
2456103|NCT01033487|6022913|P1|STARTED|Third Intervention Period||2
2456104|NCT01033487|6022904|P10|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
2456105|NCT01033487|6022905|P9|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
2456106|NCT01033487|6022906|P8|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
2456107|NCT01033487|6022907|P7|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
2456108|NCT01033487|6022908|P6|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
2456109|NCT01033487|6022909|P5|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
2456110|NCT01033487|6022910|P4|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
2456111|NCT01033487|6022911|P3|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
2456112|NCT01033487|6022912|P2|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
2456113|NCT01033487|6022913|P1|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
2456114|NCT01033487|6022904|P10|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
2456115|NCT01033487|6022905|P9|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
2456116|NCT01033487|6022906|P8|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
2456117|NCT01033487|6022907|P7|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
2456118|NCT01033487|6022908|P6|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
2456119|NCT01033487|6022909|P5|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
2456120|NCT01033487|6022910|P4|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
2456121|NCT01033487|6022911|P3|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
2456122|NCT01033487|6022912|P2|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
2456123|NCT01033487|6022913|P1|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
2456124|NCT01033487|6022904|P10|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
2456125|NCT01033487|6022905|P9|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
2456126|NCT01033487|6022906|P8|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
2456127|NCT01033487|6022907|P7|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
2456128|NCT01033487|6022908|P6|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
2456129|NCT01033487|6022909|P5|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
2456130|NCT01033487|6022910|P4|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
2456131|NCT01033487|6022911|P3|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
2456132|NCT01033487|6022912|P2|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
2456133|NCT01033487|6022913|P1|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
2456134|NCT01033487|6022904|P10|NOT COMPLETED|Second Intervention Period||0
2456135|NCT01033487|6022905|P9|NOT COMPLETED|Second Intervention Period||0
2456136|NCT01033487|6022906|P8|NOT COMPLETED|Second Intervention Period||0
2456137|NCT01033487|6022907|P7|NOT COMPLETED|Second Intervention Period||0
2456138|NCT01033487|6022908|P6|NOT COMPLETED|Second Intervention Period||0
2456139|NCT01033487|6022909|P5|NOT COMPLETED|Second Intervention Period||0
2456140|NCT01033487|6022910|P4|NOT COMPLETED|Second Intervention Period||0
2456141|NCT01033487|6022911|P3|NOT COMPLETED|Second Intervention Period||0
2456142|NCT01033487|6022912|P2|NOT COMPLETED|Second Intervention Period||0
2456143|NCT01033487|6022913|P1|NOT COMPLETED|Second Intervention Period||0
2456144|NCT01033487|6022904|P10|COMPLETED|Second Intervention Period||2
2456145|NCT01033487|6022905|P9|COMPLETED|Second Intervention Period||2
2456146|NCT01033487|6022906|P8|COMPLETED|Second Intervention Period||3
2456147|NCT01033487|6022907|P7|COMPLETED|Second Intervention Period||2
2456148|NCT01033487|6022908|P6|COMPLETED|Second Intervention Period||2
2456149|NCT01033487|6022909|P5|COMPLETED|Second Intervention Period||2
2456150|NCT01033487|6022910|P4|COMPLETED|Second Intervention Period||2
2456151|NCT01033487|6022911|P3|COMPLETED|Second Intervention Period||2
2456152|NCT01033487|6022912|P2|COMPLETED|Second Intervention Period||3
2456153|NCT01033487|6022913|P1|COMPLETED|Second Intervention Period||2
2456154|NCT01033487|6022904|P10|STARTED|Second Intervention Period||2
2456155|NCT01033487|6022905|P9|STARTED|Second Intervention Period||2
2456156|NCT01033487|6022906|P8|STARTED|Second Intervention Period||3
2456157|NCT01033487|6022907|P7|STARTED|Second Intervention Period||2
2456158|NCT01033487|6022908|P6|STARTED|Second Intervention Period||2
2456159|NCT01033487|6022909|P5|STARTED|Second Intervention Period||2
2456160|NCT01033487|6022910|P4|STARTED|Second Intervention Period||2
2456161|NCT01033487|6022911|P3|STARTED|Second Intervention Period||2
2456162|NCT01033487|6022912|P2|STARTED|Second Intervention Period||3
2456163|NCT01033487|6022913|P1|STARTED|Second Intervention Period||2
2456164|NCT01033487|6022904|P10|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
2456165|NCT01033487|6022905|P9|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
2456166|NCT01033487|6022906|P8|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
2456167|NCT01033487|6022907|P7|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
2456168|NCT01033487|6022908|P6|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
2456169|NCT01033487|6022909|P5|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
2456170|NCT01033487|6022910|P4|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
2456171|NCT01033487|6022911|P3|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
2456172|NCT01033487|6022912|P2|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
2456173|NCT01033487|6022913|P1|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
2456174|NCT01033487|6022904|P10|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
2456175|NCT01033487|6022905|P9|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
2456176|NCT01033487|6022906|P8|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
2456177|NCT01033487|6022907|P7|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
2456178|NCT01033487|6022908|P6|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
2456179|NCT01033487|6022909|P5|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
2456180|NCT01033487|6022910|P4|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
2456181|NCT01033487|6022911|P3|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
2456182|NCT01033487|6022912|P2|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
2456183|NCT01033487|6022913|P1|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
2456184|NCT01033487|6022904|P10|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
2456185|NCT01033487|6022905|P9|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
2456186|NCT01033487|6022906|P8|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
2456187|NCT01033487|6022907|P7|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
2456188|NCT01033487|6022908|P6|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
2456189|NCT01033487|6022909|P5|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
2456190|NCT01033487|6022910|P4|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
2456191|NCT01033487|6022911|P3|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
2456192|NCT01033487|6022912|P2|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
2456193|NCT01033487|6022913|P1|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
2456194|NCT01033487|6022904|P10|NOT COMPLETED|First Intervention Period||0
2456195|NCT01033487|6022905|P9|NOT COMPLETED|First Intervention Period||0
2456196|NCT01033487|6022906|P8|NOT COMPLETED|First Intervention Period||0
2456197|NCT01033487|6022907|P7|NOT COMPLETED|First Intervention Period||0
2456198|NCT01033487|6022908|P6|NOT COMPLETED|First Intervention Period||0
2456199|NCT01033487|6022909|P5|NOT COMPLETED|First Intervention Period||0
2456200|NCT01033487|6022910|P4|NOT COMPLETED|First Intervention Period||0
2456201|NCT01033487|6022911|P3|NOT COMPLETED|First Intervention Period||0
2456202|NCT01033487|6022912|P2|NOT COMPLETED|First Intervention Period||0
2456203|NCT01033487|6022913|P1|NOT COMPLETED|First Intervention Period||0
2456204|NCT01033487|6022904|P10|COMPLETED|First Intervention Period||2
2456205|NCT01033487|6022905|P9|COMPLETED|First Intervention Period||2
2456206|NCT01033487|6022906|P8|COMPLETED|First Intervention Period||3
2456207|NCT01033487|6022907|P7|COMPLETED|First Intervention Period||2
2456208|NCT01033487|6022908|P6|COMPLETED|First Intervention Period||2
2456209|NCT01033487|6022909|P5|COMPLETED|First Intervention Period||2
2456210|NCT01033487|6022910|P4|COMPLETED|First Intervention Period||2
2456211|NCT01033487|6022911|P3|COMPLETED|First Intervention Period||2
2456212|NCT01033487|6022912|P2|COMPLETED|First Intervention Period||3
2456213|NCT01033487|6022913|P1|COMPLETED|First Intervention Period||2
2456214|NCT01033487|6022904|P10|STARTED|First Intervention Period||2
2456215|NCT01033487|6022905|P9|STARTED|First Intervention Period||2
2456216|NCT01033487|6022906|P8|STARTED|First Intervention Period||3
2456217|NCT01033487|6022907|P7|STARTED|First Intervention Period||2
2456218|NCT01033487|6022908|P6|STARTED|First Intervention Period||2
2456219|NCT01033487|6022909|P5|STARTED|First Intervention Period||2
2456220|NCT01033487|6022910|P4|STARTED|First Intervention Period||2
2456221|NCT01033487|6022911|P3|STARTED|First Intervention Period||2
2456222|NCT01033487|6022912|P2|STARTED|First Intervention Period||3
2456223|NCT01033487|6022913|P1|STARTED|First Intervention Period||2
2456224|NCT01033448|6022967|P1|NOT COMPLETED|Overall Study||12
2456225|NCT01033448|6022967|P1|COMPLETED|Overall Study||47
2456226|NCT01033448|6022967|P1|STARTED|Overall Study||59
2456227|NCT01033422|6022978|P3|NOT COMPLETED|Overall Study||1
2456228|NCT01033422|6022979|P2|NOT COMPLETED|Overall Study||4
2456229|NCT01033422|6022980|P1|NOT COMPLETED|Overall Study||1
2456230|NCT01033422|6022978|P3|COMPLETED|Overall Study||22
2456231|NCT01033422|6022979|P2|COMPLETED|Overall Study||28
2456232|NCT01033422|6022980|P1|COMPLETED|Overall Study||33
2456233|NCT01033422|6022978|P3|STARTED|Overall Study||23
2456234|NCT01033422|6022979|P2|STARTED|Overall Study||32
2456235|NCT01033422|6022980|P1|STARTED|Overall Study||34
2456236|NCT01033383|6022992|P4|NOT COMPLETED|Overall Study||0
2456237|NCT01033383|6022993|P3|NOT COMPLETED|Overall Study||0
2456238|NCT01033383|6022994|P2|NOT COMPLETED|Overall Study||0
2456239|NCT01033383|6022995|P1|NOT COMPLETED|Overall Study||0
2456240|NCT01033383|6022992|P4|COMPLETED|Overall Study||20
2456241|NCT01033383|6022993|P3|COMPLETED|Overall Study||20
2456242|NCT01033383|6022994|P2|COMPLETED|Overall Study||20
2456243|NCT01033383|6022995|P1|COMPLETED|Overall Study||20
2456244|NCT01033383|6022992|P4|STARTED|Overall Study||20
2456245|NCT01033383|6022993|P3|STARTED|Overall Study||20
2456246|NCT01033383|6022994|P2|STARTED|Overall Study||20
2456247|NCT01033383|6022995|P1|STARTED|Overall Study||20
2456248|NCT01033227|6023015|P2|NOT COMPLETED|Overall Study||0
2456249|NCT01033227|6023016|P1|NOT COMPLETED|Overall Study||0
2456250|NCT01033227|6023015|P2|COMPLETED|Overall Study||2
2456251|NCT01033227|6023016|P1|COMPLETED|Overall Study||3
2456252|NCT01033227|6023015|P2|STARTED|Overall Study||2
2456253|NCT01033227|6023016|P1|STARTED|Overall Study||3
2456254|NCT01033136|6023026|P2|NOT COMPLETED|Follow-Up (3 Month)||2
2456255|NCT01033136|6023027|P1|NOT COMPLETED|Follow-Up (3 Month)||2
2456256|NCT01033136|6023026|P2|COMPLETED|Follow-Up (3 Month)||13
2456257|NCT01033136|6023027|P1|COMPLETED|Follow-Up (3 Month)||14
2456258|NCT01033136|6023026|P2|STARTED|Follow-Up (3 Month)||15
2456259|NCT01033136|6023027|P1|STARTED|Follow-Up (3 Month)||16
2456260|NCT01033136|6023026|P2|NOT COMPLETED|Post-Treatment (1 Week)||11
2456261|NCT01033136|6023027|P1|NOT COMPLETED|Post-Treatment (1 Week)||14
2456262|NCT01033136|6023026|P2|COMPLETED|Post-Treatment (1 Week)||15
2456263|NCT01033136|6023027|P1|COMPLETED|Post-Treatment (1 Week)||16
2456264|NCT01033136|6023026|P2|STARTED|Post-Treatment (1 Week)||26
2456265|NCT01033136|6023027|P1|STARTED|Post-Treatment (1 Week)||30
2456266|NCT01033136|6023026|P2|NOT COMPLETED|Baseline Assessment||6
2456267|NCT01033136|6023027|P1|NOT COMPLETED|Baseline Assessment||6
2456268|NCT01033136|6023026|P2|COMPLETED|Baseline Assessment||26
2456269|NCT01033136|6023027|P1|COMPLETED|Baseline Assessment||30
2456270|NCT01033136|6023026|P2|STARTED|Baseline Assessment||32
2456271|NCT01033136|6023027|P1|STARTED|Baseline Assessment||36
2456272|NCT01033071|6023038|P3|NOT COMPLETED|Overall Study||47
2456273|NCT01033071|6023039|P2|NOT COMPLETED|Overall Study||77
2456274|NCT01033071|6023040|P1|NOT COMPLETED|Overall Study||55
2456275|NCT01033071|6023038|P3|COMPLETED|Overall Study||317
2456276|NCT01033071|6023039|P2|COMPLETED|Overall Study||275
2456277|NCT01033071|6023040|P1|COMPLETED|Overall Study||300
2456278|NCT01033071|6023038|P3|STARTED|Overall Study||364
2456279|NCT01033071|6023039|P2|STARTED|Overall Study||352
2456280|NCT01033071|6023040|P1|STARTED|Overall Study||355
2456281|NCT01033032|6023099|P4|NOT COMPLETED|Phase II||0
2456282|NCT01033032|6023100|P3|NOT COMPLETED|Phase II||66
2456283|NCT01033032|6023101|P2|NOT COMPLETED|Phase II||0
2456284|NCT01033032|6023102|P1|NOT COMPLETED|Phase II||0
2456285|NCT01033032|6023099|P4|COMPLETED|Phase II||0
2456286|NCT01033032|6023100|P3|COMPLETED|Phase II|Patients continued recieving treatment until disease progression or unacceptable toxicity|0
2456287|NCT01033032|6023101|P2|COMPLETED|Phase II||0
2456288|NCT01033032|6023102|P1|COMPLETED|Phase II||0
2456289|NCT01033032|6023099|P4|STARTED|Phase II||0
2456290|NCT01033032|6023100|P3|STARTED|Phase II|Includes patients treated at MTD during Phase I (3 patients); 63 additional patients enrolled|66
2456291|NCT01033032|6023101|P2|STARTED|Phase II||0
2456292|NCT01033032|6023102|P1|STARTED|Phase II||0
2456293|NCT01033032|6023099|P4|NOT COMPLETED|Phase I||6
2456294|NCT01033032|6023100|P3|NOT COMPLETED|Phase I||0
2456295|NCT01033032|6023101|P2|NOT COMPLETED|Phase I||3
2456296|NCT01033032|6023102|P1|NOT COMPLETED|Phase I||3
2456297|NCT01033032|6023099|P4|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
2456298|NCT01033032|6023100|P3|COMPLETED|Phase I||3
2456299|NCT01033032|6023101|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
2456300|NCT01033032|6023102|P1|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
2456301|NCT01033032|6023099|P4|STARTED|Phase I||6
2456302|NCT01033032|6023100|P3|STARTED|Phase I||3
2456303|NCT01033032|6023101|P2|STARTED|Phase I||3
2456304|NCT01033032|6023102|P1|STARTED|Phase I||3
2456305|NCT01033019|6023111|P2|NOT COMPLETED|Overall Study||0
2456306|NCT01033019|6023112|P1|NOT COMPLETED|Overall Study||1
2456307|NCT01033019|6023111|P2|COMPLETED|Overall Study||8
2456308|NCT01033019|6023112|P1|COMPLETED|Overall Study||15
2456309|NCT01033019|6023111|P2|STARTED|Overall Study||8
2456310|NCT01033019|6023112|P1|STARTED|Overall Study||16
2456311|NCT01032993|6023121|P2|NOT COMPLETED|Overall Study||0
2456312|NCT01032993|6023122|P1|NOT COMPLETED|Overall Study||0
2456313|NCT01032993|6023121|P2|COMPLETED|Overall Study||20
2456314|NCT01032993|6023122|P1|COMPLETED|Overall Study||19
2456315|NCT01032993|6023121|P2|STARTED|Overall Study||20
2456316|NCT01032993|6023122|P1|STARTED|Overall Study||19
2456317|NCT01032928|6023134|P1|NOT COMPLETED|Overall Study||0
2456318|NCT01032928|6023134|P1|COMPLETED|Overall Study||30
2456319|NCT01032928|6023134|P1|STARTED|Overall Study||30
2456320|NCT01032915|6023150|P4|NOT COMPLETED|Overall Study||7
2456321|NCT01032915|6023151|P3|NOT COMPLETED|Overall Study||7
2456322|NCT01032915|6023152|P2|NOT COMPLETED|Overall Study||11
2456323|NCT01032915|6023153|P1|NOT COMPLETED|Overall Study||8
2456324|NCT01032915|6023150|P4|COMPLETED|Overall Study||27
2456325|NCT01032915|6023151|P3|COMPLETED|Overall Study||24
2456326|NCT01032915|6023152|P2|COMPLETED|Overall Study||20
2456327|NCT01032915|6023153|P1|COMPLETED|Overall Study||21
2456328|NCT01032915|6023150|P4|STARTED|Overall Study||34
2456329|NCT01032915|6023151|P3|STARTED|Overall Study||31
2456330|NCT01032915|6023152|P2|STARTED|Overall Study||31
2456331|NCT01032915|6023153|P1|STARTED|Overall Study||29
2456332|NCT01032889|6023178|P3|NOT COMPLETED|Overall Study||3
2456333|NCT01032889|6023179|P2|NOT COMPLETED|Overall Study||15
2456334|NCT01032889|6023180|P1|NOT COMPLETED|Overall Study||8
2456335|NCT01032889|6023178|P3|COMPLETED|Overall Study||42
2456336|NCT01032889|6023179|P2|COMPLETED|Overall Study||28
2456337|NCT01032889|6023180|P1|COMPLETED|Overall Study||33
2456338|NCT01032889|6023178|P3|Received Treatment|Overall Study||45
2456339|NCT01032889|6023179|P2|Received Treatment|Overall Study||43
2456340|NCT01032889|6023180|P1|Received Treatment|Overall Study||41
2456341|NCT01032889|6023178|P3|STARTED|Overall Study||45
2456342|NCT01032889|6023179|P2|STARTED|Overall Study||43
2456343|NCT01032889|6023180|P1|STARTED|Overall Study||41
2456344|NCT01032850|6023200|P1|NOT COMPLETED|Overall Study||2
2456345|NCT01032850|6023200|P1|COMPLETED|Overall Study||13
2456346|NCT01032850|6023200|P1|STARTED|Overall Study||15
2456347|NCT01032837|6023211|P4|NOT COMPLETED|Overall Study||3
2456348|NCT01032837|6023212|P3|NOT COMPLETED|Overall Study||1
2456349|NCT01032837|6023213|P2|NOT COMPLETED|Overall Study||3
2456350|NCT01032837|6023214|P1|NOT COMPLETED|Overall Study||0
2456351|NCT01032837|6023211|P4|COMPLETED|Overall Study|Represents patients who completed treatment.|22
2456352|NCT01032837|6023212|P3|COMPLETED|Overall Study|Represents patients who completed treatment.|24
2456353|NCT01032837|6023213|P2|COMPLETED|Overall Study|Represents patients who completed treatment.|23
2456354|NCT01032837|6023214|P1|COMPLETED|Overall Study|Represents patients who completed treatment.|26
2456355|NCT01032837|6023211|P4|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|24
2456356|NCT01032837|6023212|P3|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|25
2456357|NCT01032837|6023213|P2|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
2456358|NCT01032837|6023214|P1|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
2456359|NCT01032837|6023211|P4|STARTED|Overall Study||25
2456360|NCT01032837|6023212|P3|STARTED|Overall Study||25
2456361|NCT01032837|6023213|P2|STARTED|Overall Study||26
2456362|NCT01032837|6023214|P1|STARTED|Overall Study||26
2456363|NCT01032759|6023262|P2|NOT COMPLETED|Overall Study||3
2456364|NCT01032759|6023263|P1|NOT COMPLETED|Overall Study||1
2456365|NCT01032759|6023262|P2|COMPLETED|Overall Study||28
2456366|NCT01032759|6023263|P1|COMPLETED|Overall Study||31
2456367|NCT01032759|6023262|P2|Completed 48 Hour Assessment|Overall Study||28
2456368|NCT01032759|6023263|P1|Completed 48 Hour Assessment|Overall Study||31
2456369|NCT01032759|6023262|P2|Completed 24 Hour Assessment|Overall Study||30
2456370|NCT01032759|6023263|P1|Completed 24 Hour Assessment|Overall Study||32
2456371|NCT01032759|6023262|P2|STARTED|Overall Study||31
2456372|NCT01032759|6023263|P1|STARTED|Overall Study||32
2456373|NCT01032733|6023283|P2|NOT COMPLETED|Overall Study||1
2456374|NCT01032733|6023284|P1|NOT COMPLETED|Overall Study||1
2456375|NCT01032733|6023283|P2|COMPLETED|Overall Study||16
2456376|NCT01032733|6023284|P1|COMPLETED|Overall Study||16
2456377|NCT01032733|6023283|P2|STARTED|Overall Study||17
2456378|NCT01032733|6023284|P1|STARTED|Overall Study||17
2456379|NCT01032694|6023300|P2|NOT COMPLETED|Overall Study||0
2456380|NCT01032694|6023301|P1|NOT COMPLETED|Overall Study||0
2456381|NCT01032694|6023300|P2|COMPLETED|Overall Study||10
2456382|NCT01032694|6023301|P1|COMPLETED|Overall Study||20
2456383|NCT01032694|6023300|P2|STARTED|Overall Study||10
2456384|NCT01032694|6023301|P1|STARTED|Overall Study||20
2456385|NCT01032629|6023314|P3|NOT COMPLETED|Overall Study||88
2456386|NCT01032629|6023315|P2|NOT COMPLETED|Overall Study||101
2456387|NCT01032629|6023316|P1|NOT COMPLETED|Overall Study||145
2456388|NCT01032629|6023314|P3|COMPLETED|Overall Study|Participants who died on trial were considered completed|1355
2456389|NCT01032629|6023315|P2|COMPLETED|Overall Study|Participants who died on trial were considered completed|1344
2456390|NCT01032629|6023316|P1|COMPLETED|Overall Study|Participants who died on trial were considered completed|1297
2456391|NCT01032629|6023314|P3|Treated|Overall Study||1441
2456392|NCT01032629|6023315|P2|Treated|Overall Study||1445
2456393|NCT01032629|6023316|P1|Treated|Overall Study||1441
2456394|NCT01032629|6023314|P3|STARTED|Overall Study||1443
2456395|NCT01032629|6023315|P2|STARTED|Overall Study||1445
2456396|NCT01032629|6023316|P1|STARTED|Overall Study||1442
2456397|NCT01032603|6023363|P2|NOT COMPLETED|Overall Study||19
2456398|NCT01032603|6023364|P1|NOT COMPLETED|Overall Study||15
2456399|NCT01032603|6023363|P2|COMPLETED|Overall Study||77
2456400|NCT01032603|6023364|P1|COMPLETED|Overall Study||86
2456401|NCT01032603|6023363|P2|STARTED|Overall Study||96
2456402|NCT01032603|6023364|P1|STARTED|Overall Study||101
2456403|NCT01032538|6023420|P1|NOT COMPLETED|Overall Study||0
2456404|NCT01032538|6023420|P1|COMPLETED|Overall Study|Knees|99
2456405|NCT01032538|6023420|P1|STARTED|Overall Study|Knees|99
2456406|NCT01032382|6023428|P2|NOT COMPLETED|Overall Study||5
2456407|NCT01032382|6023429|P1|NOT COMPLETED|Overall Study||5
2456408|NCT01032382|6023428|P2|COMPLETED|Overall Study||9
2456409|NCT01032382|6023429|P1|COMPLETED|Overall Study||11
2456410|NCT01032382|6023428|P2|STARTED|Overall Study||14
2456411|NCT01032382|6023429|P1|STARTED|Overall Study||16
2456412|NCT01032330|6023459|P4|NOT COMPLETED|Overall Study||14
2456413|NCT01032330|6023460|P3|NOT COMPLETED|Overall Study||10
2456414|NCT01032330|6023461|P2|NOT COMPLETED|Overall Study||24
2456415|NCT01032330|6023462|P1|NOT COMPLETED|Overall Study||18
2456416|NCT01032330|6023459|P4|COMPLETED|Overall Study||90
2456417|NCT01032330|6023460|P3|COMPLETED|Overall Study||87
2456418|NCT01032330|6023461|P2|COMPLETED|Overall Study||151
2456419|NCT01032330|6023462|P1|COMPLETED|Overall Study||165
2456420|NCT01032330|6023459|P4|STARTED|Overall Study||104
2456421|NCT01032330|6023460|P3|STARTED|Overall Study||97
2456422|NCT01032330|6023461|P2|STARTED|Overall Study||175
2456423|NCT01032330|6023462|P1|STARTED|Overall Study||183
2456424|NCT01032291|6023517|P3|NOT COMPLETED|Proof of Concept||3
2456425|NCT01032291|6023518|P2|NOT COMPLETED|Proof of Concept||8
2456426|NCT01032291|6023519|P1|NOT COMPLETED|Proof of Concept||0
2456427|NCT01032291|6023517|P3|COMPLETED|Proof of Concept|Participants with disease progression|18
2456428|NCT01032291|6023518|P2|COMPLETED|Proof of Concept|Participants with disease progression|14
2456429|NCT01032291|6023519|P1|COMPLETED|Proof of Concept||0
2456430|NCT01032291|6023517|P3|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
2456431|NCT01032291|6023518|P2|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
2456432|NCT01032291|6023519|P1|Intent to Treat and Safety Populations|Proof of Concept||0
2456433|NCT01032291|6023517|P3|STARTED|Proof of Concept||21
2456434|NCT01032291|6023518|P2|STARTED|Proof of Concept||22
2456435|NCT01032291|6023519|P1|STARTED|Proof of Concept||0
2456436|NCT01032291|6023517|P3|NOT COMPLETED|Safety Lead-in||0
2456437|NCT01032291|6023518|P2|NOT COMPLETED|Safety Lead-in||0
2456438|NCT01032291|6023519|P1|NOT COMPLETED|Safety Lead-in||2
2456439|NCT01032291|6023517|P3|COMPLETED|Safety Lead-in||0
2456440|NCT01032291|6023518|P2|COMPLETED|Safety Lead-in||0
2456441|NCT01032291|6023519|P1|COMPLETED|Safety Lead-in|Participants with disease progression|6
2456442|NCT01032291|6023517|P3|STARTED|Safety Lead-in||0
2456443|NCT01032291|6023518|P2|STARTED|Safety Lead-in||0
2456444|NCT01032291|6023519|P1|STARTED|Safety Lead-in||8
2456445|NCT01032265|6023545|P2|NOT COMPLETED|Overall Study||17
2456446|NCT01032265|6023546|P1|NOT COMPLETED|Overall Study||13
2456447|NCT01032265|6023545|P2|COMPLETED|Overall Study||107
2456448|NCT01032265|6023546|P1|COMPLETED|Overall Study||113
2456449|NCT01032265|6023545|P2|STARTED|Overall Study||124
2456450|NCT01032265|6023546|P1|STARTED|Overall Study||126
2456451|NCT01032239|6023566|P2|NOT COMPLETED|Overall Study||5
2456452|NCT01032239|6023567|P1|NOT COMPLETED|Overall Study||7
2456453|NCT01032239|6023566|P2|COMPLETED|Overall Study||24
2456454|NCT01032239|6023567|P1|COMPLETED|Overall Study||24
2456455|NCT01032239|6023566|P2|Implant|Overall Study||0
2456456|NCT01032239|6023567|P1|Implant|Overall Study|implanted|25
2456457|NCT01032239|6023566|P2|STARTED|Overall Study|randomized to BMT arm|29
2456458|NCT01032239|6023567|P1|STARTED|Overall Study|randomized to ITB arm|31
2456459|NCT01032200|6023597|P2|NOT COMPLETED|Overall Study||7
2456460|NCT01032200|6023598|P1|NOT COMPLETED|Overall Study||4
2456461|NCT01032200|6023597|P2|COMPLETED|Overall Study||21
2456462|NCT01032200|6023598|P1|COMPLETED|Overall Study||22
2456463|NCT01032200|6023597|P2|STARTED|Overall Study||28
2456464|NCT01032200|6023598|P1|STARTED|Overall Study||26
2456465|NCT01032174|6023614|P2|NOT COMPLETED|Overall Study||1
2456466|NCT01032174|6023615|P1|NOT COMPLETED|Overall Study||0
2456467|NCT01032174|6023614|P2|COMPLETED|Overall Study||59
2456468|NCT01032174|6023615|P1|COMPLETED|Overall Study||63
2456469|NCT01032174|6023614|P2|STARTED|Overall Study||60
2456470|NCT01032174|6023615|P1|STARTED|Overall Study||63
2456471|NCT01032135|6023630|P7|NOT COMPLETED|8 Week Randomization||18
2456472|NCT01032135|6023631|P6|NOT COMPLETED|8 Week Randomization||17
2456473|NCT01032135|6023632|P5|NOT COMPLETED|8 Week Randomization||9
2456474|NCT01032135|6023633|P4|NOT COMPLETED|8 Week Randomization||11
2456475|NCT01032135|6023634|P3|NOT COMPLETED|8 Week Randomization||0
2456476|NCT01032135|6023635|P2|NOT COMPLETED|8 Week Randomization||0
2456477|NCT01032135|6023636|P1|NOT COMPLETED|8 Week Randomization||26
2456478|NCT01032135|6023630|P7|COMPLETED|8 Week Randomization||36
2456479|NCT01032135|6023631|P6|COMPLETED|8 Week Randomization||31
2456480|NCT01032135|6023632|P5|COMPLETED|8 Week Randomization||34
2456481|NCT01032135|6023633|P4|COMPLETED|8 Week Randomization||30
2456482|NCT01032135|6023634|P3|COMPLETED|8 Week Randomization||0
2456483|NCT01032135|6023635|P2|COMPLETED|8 Week Randomization||0
2456484|NCT01032135|6023636|P1|COMPLETED|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|201
2456485|NCT01032135|6023630|P7|12 Week Follow up|8 Week Randomization||41
2456486|NCT01032135|6023631|P6|12 Week Follow up|8 Week Randomization||36
2456487|NCT01032135|6023632|P5|12 Week Follow up|8 Week Randomization||38
2456488|NCT01032135|6023633|P4|12 Week Follow up|8 Week Randomization||34
2456489|NCT01032135|6023634|P3|12 Week Follow up|8 Week Randomization||0
2456490|NCT01032135|6023635|P2|12 Week Follow up|8 Week Randomization||0
2456491|NCT01032135|6023636|P1|12 Week Follow up|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|217
2456492|NCT01032135|6023630|P7|STARTED|8 Week Randomization||54
2456493|NCT01032135|6023631|P6|STARTED|8 Week Randomization||48
2456494|NCT01032135|6023632|P5|STARTED|8 Week Randomization||43
2456495|NCT01032135|6023633|P4|STARTED|8 Week Randomization||41
2456496|NCT01032135|6023634|P3|STARTED|8 Week Randomization||0
2456497|NCT01032135|6023635|P2|STARTED|8 Week Randomization||0
2456498|NCT01032135|6023636|P1|STARTED|8 Week Randomization||227
2456499|NCT01032135|6023630|P7|NOT COMPLETED|2 Week Randomization||0
2456500|NCT01032135|6023631|P6|NOT COMPLETED|2 Week Randomization||0
2456501|NCT01032135|6023632|P5|NOT COMPLETED|2 Week Randomization||0
2456502|NCT01032135|6023633|P4|NOT COMPLETED|2 Week Randomization||0
2456503|NCT01032135|6023634|P3|NOT COMPLETED|2 Week Randomization||0
2456504|NCT01032135|6023635|P2|NOT COMPLETED|2 Week Randomization||0
2456505|NCT01032135|6023636|P1|NOT COMPLETED|2 Week Randomization||0
2456506|NCT01032135|6023630|P7|COMPLETED|2 Week Randomization||0
2456507|NCT01032135|6023631|P6|COMPLETED|2 Week Randomization||0
2456508|NCT01032135|6023632|P5|COMPLETED|2 Week Randomization||0
2456509|NCT01032135|6023633|P4|COMPLETED|2 Week Randomization||0
2456510|NCT01032135|6023634|P3|COMPLETED|2 Week Randomization||96
2456511|NCT01032135|6023635|P2|COMPLETED|2 Week Randomization||93
2456512|NCT01032135|6023636|P1|COMPLETED|2 Week Randomization||311
2456513|NCT01032135|6023630|P7|STARTED|2 Week Randomization||0
2456514|NCT01032135|6023631|P6|STARTED|2 Week Randomization||0
2456515|NCT01032135|6023632|P5|STARTED|2 Week Randomization||0
2456516|NCT01032135|6023633|P4|STARTED|2 Week Randomization||0
2456517|NCT01032135|6023634|P3|STARTED|2 Week Randomization||96
2456518|NCT01032135|6023635|P2|STARTED|2 Week Randomization||93
2456519|NCT01032135|6023636|P1|STARTED|2 Week Randomization||311
2456520|NCT01032070|6023855|P2|NOT COMPLETED|Overall Study||12
2456521|NCT01032070|6023856|P1|NOT COMPLETED|Overall Study||13
2456522|NCT01032070|6023855|P2|COMPLETED|Overall Study||0
2456523|NCT01032070|6023856|P1|COMPLETED|Overall Study||0
2456524|NCT01032070|6023855|P2|STARTED|Overall Study||12
2456525|NCT01032070|6023856|P1|STARTED|Overall Study||13
2456526|NCT01032044|6023885|P2|NOT COMPLETED|Overall Study||20
2456527|NCT01032044|6023886|P1|NOT COMPLETED|Overall Study||25
2456528|NCT01032044|6023885|P2|COMPLETED|Overall Study||62
2456529|NCT01032044|6023886|P1|COMPLETED|Overall Study||57
2456530|NCT01032044|6023885|P2|Procedure|Overall Study||75
2456531|NCT01032044|6023886|P1|Procedure|Overall Study||74
2456532|NCT01032044|6023885|P2|STARTED|Overall Study||82
2456533|NCT01032044|6023886|P1|STARTED|Overall Study||82
2456534|NCT01032018|6023894|P2|NOT COMPLETED|Overall Study||6
2456535|NCT01032018|6023895|P1|NOT COMPLETED|Overall Study||6
2456536|NCT01032018|6023894|P2|COMPLETED|Overall Study||67
2456537|NCT01032018|6023895|P1|COMPLETED|Overall Study||71
2456538|NCT01032018|6023894|P2|STARTED|Overall Study||73
2456539|NCT01032018|6023895|P1|STARTED|Overall Study||77
2456540|NCT01031979|6023905|P2|NOT COMPLETED|Overall Study||4
2456541|NCT01031979|6023906|P1|NOT COMPLETED|Overall Study||5
2456542|NCT01031979|6023905|P2|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|8
2456543|NCT01031979|6023906|P1|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|9
2456544|NCT01031979|6023905|P2|Completed Primary Outcome Measure|Overall Study||12
2456545|NCT01031979|6023906|P1|Completed Primary Outcome Measure|Overall Study||12
2456546|NCT01031979|6023905|P2|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|12
2456547|NCT01031979|6023906|P1|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|14
2456548|NCT01031953|6023918|P1|NOT COMPLETED|Overall Study||0
2456549|NCT01031953|6023918|P1|COMPLETED|Overall Study||11
2456550|NCT01031953|6023918|P1|STARTED|Overall Study||11
2456551|NCT01031914|6023929|P1|NOT COMPLETED|Overall Study||0
2456552|NCT01031914|6023929|P1|COMPLETED|Overall Study||36
2456553|NCT01031914|6023929|P1|STARTED|Overall Study||36
2456554|NCT01031836|6023939|P6|NOT COMPLETED|Stage II||1
2456555|NCT01031836|6023940|P5|NOT COMPLETED|Stage II||2
2456556|NCT01031836|6023941|P4|NOT COMPLETED|Stage II||3
2456557|NCT01031836|6023942|P3|NOT COMPLETED|Stage II||2
2456558|NCT01031836|6023943|P2|NOT COMPLETED|Stage II||0
2456559|NCT01031836|6023944|P1|NOT COMPLETED|Stage II||2
2456560|NCT01031836|6023939|P6|COMPLETED|Stage II||3
2456561|NCT01031836|6023940|P5|COMPLETED|Stage II||3
2456562|NCT01031836|6023941|P4|COMPLETED|Stage II||1
2456563|NCT01031836|6023942|P3|COMPLETED|Stage II||2
2456564|NCT01031836|6023943|P2|COMPLETED|Stage II||1
2456565|NCT01031836|6023944|P1|COMPLETED|Stage II||1
2456566|NCT01031836|6023939|P6|STARTED|Stage II||4
2456567|NCT01031836|6023940|P5|STARTED|Stage II||5
2456568|NCT01031836|6023941|P4|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|4
2456569|NCT01031836|6023942|P3|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|4
2456570|NCT01031836|6023943|P2|STARTED|Stage II|2 patient who completed the study treatment in Stage I did not register in Stage II.|1
2456571|NCT01031836|6023944|P1|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|3
2456572|NCT01031836|6023939|P6|NOT COMPLETED|Stage I||1
2456573|NCT01031836|6023940|P5|NOT COMPLETED|Stage I||0
2456574|NCT01031836|6023941|P4|NOT COMPLETED|Stage I||0
2456575|NCT01031836|6023942|P3|NOT COMPLETED|Stage I||0
2456576|NCT01031836|6023943|P2|NOT COMPLETED|Stage I||2
2456577|NCT01031836|6023944|P1|NOT COMPLETED|Stage I||1
2456578|NCT01031836|6023939|P6|COMPLETED|Stage I||4
2456579|NCT01031836|6023940|P5|COMPLETED|Stage I||5
2456580|NCT01031836|6023941|P4|COMPLETED|Stage I||5
2456581|NCT01031836|6023942|P3|COMPLETED|Stage I||5
2456582|NCT01031836|6023943|P2|COMPLETED|Stage I||3
2456583|NCT01031836|6023944|P1|COMPLETED|Stage I||4
2456584|NCT01031836|6023939|P6|STARTED|Stage I||5
2456585|NCT01031836|6023940|P5|STARTED|Stage I||5
2456586|NCT01031836|6023941|P4|STARTED|Stage I||5
2456587|NCT01031836|6023942|P3|STARTED|Stage I||5
2456588|NCT01031836|6023943|P2|STARTED|Stage I||5
2456589|NCT01031836|6023944|P1|STARTED|Stage I||5
2456590|NCT01031810|6023994|P1|NOT COMPLETED|Overall Study||4
2456591|NCT01031810|6023994|P1|COMPLETED|Overall Study||9
2456592|NCT01031810|6023994|P1|STARTED|Overall Study||13
2456593|NCT01031706|6024005|P2|NOT COMPLETED|Overall Study||1
2456594|NCT01031706|6024006|P1|NOT COMPLETED|Overall Study||2
2456595|NCT01031706|6024005|P2|COMPLETED|Overall Study||8
2456596|NCT01031706|6024006|P1|COMPLETED|Overall Study||12
2456597|NCT01031706|6024005|P2|STARTED|Overall Study||9
2456598|NCT01031706|6024006|P1|STARTED|Overall Study||14
2456599|NCT01031680|6024016|P2|NOT COMPLETED|Overall Study||58
2456600|NCT01031680|6024017|P1|NOT COMPLETED|Overall Study||57
2456601|NCT01031680|6024016|P2|COMPLETED|Overall Study||404
2456602|NCT01031680|6024017|P1|COMPLETED|Overall Study||403
2456603|NCT01031680|6024016|P2|STARTED|Overall Study|Of the 462 randomized participants only 459 were included in the full analysis set.|462
2456604|NCT01031680|6024017|P1|STARTED|Overall Study|Of the 460 randomized participants only 455 were included in the full analysis set.|460
2456605|NCT01031628|6024037|P4|NOT COMPLETED|Overall Study||0
2456606|NCT01031628|6024038|P3|NOT COMPLETED|Overall Study||3
2456607|NCT01031628|6024039|P2|NOT COMPLETED|Overall Study||1
2456608|NCT01031628|6024040|P1|NOT COMPLETED|Overall Study||0
2456609|NCT01031628|6024037|P4|COMPLETED|Overall Study||0
2456610|NCT01031628|6024038|P3|COMPLETED|Overall Study||0
2456611|NCT01031628|6024039|P2|COMPLETED|Overall Study||0
2456612|NCT01031628|6024040|P1|COMPLETED|Overall Study||0
2456613|NCT01031628|6024037|P4|STARTED|Overall Study||0
2456614|NCT01031628|6024038|P3|STARTED|Overall Study||3
2456615|NCT01031628|6024039|P2|STARTED|Overall Study||1
2456616|NCT01031628|6024040|P1|STARTED|Overall Study||0
2456617|NCT01031550|6024052|P2|NOT COMPLETED|Overall Study||0
2456618|NCT01031550|6024053|P1|NOT COMPLETED|Overall Study||0
2456619|NCT01031550|6024052|P2|COMPLETED|Overall Study||3
2456620|NCT01031550|6024053|P1|COMPLETED|Overall Study||5
2456621|NCT01031550|6024052|P2|STARTED|Overall Study||3
2456622|NCT01031550|6024053|P1|STARTED|Overall Study||5
2456623|NCT01031537|6024065|P1|NOT COMPLETED|Overall Study||32
2456624|NCT01031537|6024065|P1|COMPLETED|Overall Study||34
2456625|NCT01031537|6024065|P1|STARTED|Overall Study||66
2456626|NCT01031498|6024073|P3|NOT COMPLETED|Overall Study||2
2456627|NCT01031498|6024074|P2|NOT COMPLETED|Overall Study||3
2456628|NCT01031498|6024075|P1|NOT COMPLETED|Overall Study||2
2456629|NCT01031498|6024073|P3|COMPLETED|Overall Study||48
2456630|NCT01031498|6024074|P2|COMPLETED|Overall Study||48
2456631|NCT01031498|6024075|P1|COMPLETED|Overall Study||47
2456632|NCT01031498|6024073|P3|STARTED|Overall Study|2 patients were not evaluable in arm 3.|50
2456633|NCT01031498|6024074|P2|STARTED|Overall Study|3 patients were not evaluable in arm 2|51
2456634|NCT01031498|6024075|P1|STARTED|Overall Study|2 patients were not evaluable in arm 1.|49
2456635|NCT01031446|6024083|P1|NOT COMPLETED|Overall Study||55
2456636|NCT01031446|6024083|P1|COMPLETED|Overall Study||0
2456637|NCT01031446|6024083|P1|STARTED|Overall Study||55
2456638|NCT01031420|6024092|P1|NOT COMPLETED|Overall Study||10
2456639|NCT01031420|6024092|P1|COMPLETED|Overall Study||44
2456640|NCT01031420|6024092|P1|STARTED|Overall Study||54
2456641|NCT01031381|6024097|P1|NOT COMPLETED|Overall Study||9
2456642|NCT01031381|6024097|P1|COMPLETED|Overall Study||50
2456643|NCT01031381|6024097|P1|STARTED|Overall Study||59
2456644|NCT01031134|6024104|P2|NOT COMPLETED|Overall Study||10
2456645|NCT01031134|6024105|P1|NOT COMPLETED|Overall Study||11
2456646|NCT01031134|6024104|P2|COMPLETED|Overall Study||78
2456647|NCT01031134|6024105|P1|COMPLETED|Overall Study||103
2456648|NCT01031134|6024104|P2|STARTED|Overall Study||88
2456649|NCT01031134|6024105|P1|STARTED|Overall Study||114
2456650|NCT01031095|6024115|P2|NOT COMPLETED|Overall Study||0
2456651|NCT01031095|6024116|P1|NOT COMPLETED|Overall Study||0
2456652|NCT01031095|6024115|P2|COMPLETED|Overall Study||100
2456653|NCT01031095|6024116|P1|COMPLETED|Overall Study||100
2456654|NCT01031095|6024115|P2|STARTED|Overall Study||100
2456655|NCT01031095|6024116|P1|STARTED|Overall Study||100
2456656|NCT01031069|6024126|P4|NOT COMPLETED|Overall Study||34
2456657|NCT01031069|6024127|P3|NOT COMPLETED|Overall Study||41
2456658|NCT01031069|6024128|P2|NOT COMPLETED|Overall Study||11
2456659|NCT01031069|6024129|P1|NOT COMPLETED|Overall Study||12
2456660|NCT01031069|6024126|P4|COMPLETED|Overall Study||111
2456661|NCT01031069|6024127|P3|COMPLETED|Overall Study||103
2456662|NCT01031069|6024128|P2|COMPLETED|Overall Study||117
2456663|NCT01031069|6024129|P1|COMPLETED|Overall Study||117
2456664|NCT01031069|6024126|P4|STARTED|Overall Study||145
2456665|NCT01031069|6024127|P3|STARTED|Overall Study||144
2456666|NCT01031069|6024128|P2|STARTED|Overall Study||128
2456667|NCT01031069|6024129|P1|STARTED|Overall Study||129
2456668|NCT01031043|6024225|P1|NOT COMPLETED|Overall Study||1
2456669|NCT01031043|6024225|P1|COMPLETED|Overall Study||4
2456670|NCT01031043|6024225|P1|STARTED|Overall Study||5
2456671|NCT01031004|6024231|P2|NOT COMPLETED|Overall Study||1
2456672|NCT01031004|6024232|P1|NOT COMPLETED|Overall Study||1
2456673|NCT01031004|6024231|P2|COMPLETED|Overall Study||24
2456674|NCT01031004|6024232|P1|COMPLETED|Overall Study||24
2456675|NCT01031004|6024231|P2|STARTED|Overall Study||25
2456676|NCT01031004|6024232|P1|STARTED|Overall Study||25
2456677|NCT01030965|6024276|P4|NOT COMPLETED|Overall Study||7
2456678|NCT01030965|6024277|P3|NOT COMPLETED|Overall Study||4
2456679|NCT01030965|6024278|P2|NOT COMPLETED|Overall Study||6
2456680|NCT01030965|6024279|P1|NOT COMPLETED|Overall Study||4
2456681|NCT01030965|6024276|P4|COMPLETED|Overall Study||64
2456682|NCT01030965|6024277|P3|COMPLETED|Overall Study||68
2456683|NCT01030965|6024278|P2|COMPLETED|Overall Study||65
2456684|NCT01030965|6024279|P1|COMPLETED|Overall Study||67
2456685|NCT01030965|6024276|P4|STARTED|Overall Study||71
2456686|NCT01030965|6024277|P3|STARTED|Overall Study||72
2456687|NCT01030965|6024278|P2|STARTED|Overall Study||71
2456688|NCT01030965|6024279|P1|STARTED|Overall Study||71
2456689|NCT01030952|6024299|P2|NOT COMPLETED|Overall Study||3
2456690|NCT01030952|6024300|P1|NOT COMPLETED|Overall Study||2
2456691|NCT01030952|6024299|P2|COMPLETED|Overall Study||49
2456692|NCT01030952|6024300|P1|COMPLETED|Overall Study||49
2456693|NCT01030952|6024299|P2|STARTED|Overall Study||52
2456694|NCT01030952|6024300|P1|STARTED|Overall Study||51
2456695|NCT01030822|6024337|P3|NOT COMPLETED|Overall Study||26
2456696|NCT01030822|6024338|P2|NOT COMPLETED|Overall Study||24
2456697|NCT01030822|6024339|P1|NOT COMPLETED|Overall Study||31
2456698|NCT01030822|6024337|P3|COMPLETED|Overall Study||61
2456699|NCT01030822|6024338|P2|COMPLETED|Overall Study||71
2456700|NCT01030822|6024339|P1|COMPLETED|Overall Study||69
2456701|NCT01030822|6024337|P3|STARTED|Overall Study||87
2456702|NCT01030822|6024338|P2|STARTED|Overall Study||95
2456703|NCT01030822|6024339|P1|STARTED|Overall Study||100
2456704|NCT01030783|6024388|P2|NOT COMPLETED|Overall Study||26
2456705|NCT01030783|6024389|P1|NOT COMPLETED|Overall Study||49
2456706|NCT01030783|6024388|P2|COMPLETED|Overall Study||231
2456707|NCT01030783|6024389|P1|COMPLETED|Overall Study||211
2456708|NCT01030783|6024388|P2|STARTED|Overall Study||257
2456709|NCT01030783|6024389|P1|STARTED|Overall Study||260
2456710|NCT01030757|6024406|P1|NOT COMPLETED|Overall Study||0
2456711|NCT01030757|6024406|P1|COMPLETED|Overall Study||2
2456712|NCT01030757|6024406|P1|STARTED|Overall Study||2
2456713|NCT01030718|6024414|P3|NOT COMPLETED|Study CA180-036 Only||5
2456714|NCT01030718|6024415|P2|NOT COMPLETED|Study CA180-036 Only||7
2456715|NCT01030718|6024416|P1|NOT COMPLETED|Study CA180-036 Only||3
2456716|NCT01030718|6024414|P3|COMPLETED|Study CA180-036 Only||1
2456717|NCT01030718|6024415|P2|COMPLETED|Study CA180-036 Only||2
2456718|NCT01030718|6024416|P1|COMPLETED|Study CA180-036 Only||26
2456719|NCT01030718|6024414|P3|STARTED|Study CA180-036 Only||6
2456720|NCT01030718|6024415|P2|STARTED|Study CA180-036 Only||9
2456721|NCT01030718|6024416|P1|STARTED|Study CA180-036 Only||29
2456722|NCT01030718|6024414|P3|NOT COMPLETED|Studies CA180-031 and -036 Combined||12
2456723|NCT01030718|6024415|P2|NOT COMPLETED|Studies CA180-031 and -036 Combined||9
2456724|NCT01030718|6024416|P1|NOT COMPLETED|Studies CA180-031 and -036 Combined||4
2456725|NCT01030718|6024414|P3|COMPLETED|Studies CA180-031 and -036 Combined||1
2456726|NCT01030718|6024415|P2|COMPLETED|Studies CA180-031 and -036 Combined||2
2456727|NCT01030718|6024416|P1|COMPLETED|Studies CA180-031 and -036 Combined||26
2456728|NCT01030718|6024414|P3|STARTED|Studies CA180-031 and -036 Combined||13
2456729|NCT01030718|6024415|P2|STARTED|Studies CA180-031 and -036 Combined||11
2456730|NCT01030718|6024416|P1|STARTED|Studies CA180-031 and -036 Combined||30
2456731|NCT01030666|6024477|P2|NOT COMPLETED|Overall Study||2
2456732|NCT01030666|6024478|P1|NOT COMPLETED|Overall Study||3
2456733|NCT01030666|6024477|P2|COMPLETED|Overall Study||31
2456734|NCT01030666|6024478|P1|COMPLETED|Overall Study||25
2456735|NCT01030666|6024477|P2|STARTED|Overall Study||33
2456736|NCT01030666|6024478|P1|STARTED|Overall Study||28
2456737|NCT01030653|6024488|P2|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
2456738|NCT01030653|6024489|P1|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
2456739|NCT01030653|6024488|P2|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
2456740|NCT01030653|6024489|P1|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
2456741|NCT01030653|6024488|P2|STARTED|Loading Dose & 2nd Maintenance Regimen||4
2456742|NCT01030653|6024489|P1|STARTED|Loading Dose & 2nd Maintenance Regimen||4
2456743|NCT01030653|6024488|P2|NOT COMPLETED|7-Day Washout Period||0
2456744|NCT01030653|6024489|P1|NOT COMPLETED|7-Day Washout Period||0
2456745|NCT01030653|6024488|P2|COMPLETED|7-Day Washout Period||4
2456746|NCT01030653|6024489|P1|COMPLETED|7-Day Washout Period||4
2456747|NCT01030653|6024488|P2|STARTED|7-Day Washout Period||4
2456748|NCT01030653|6024489|P1|STARTED|7-Day Washout Period||4
2456749|NCT01030653|6024488|P2|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
2456750|NCT01030653|6024489|P1|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
2456751|NCT01030653|6024488|P2|COMPLETED|Loading Dose & First Maintenance Regimen||4
2456752|NCT01030653|6024489|P1|COMPLETED|Loading Dose & First Maintenance Regimen||4
2456753|NCT01030653|6024488|P2|STARTED|Loading Dose & First Maintenance Regimen||4
2456754|NCT01030653|6024489|P1|STARTED|Loading Dose & First Maintenance Regimen||4
2456755|NCT01030536|6024503|P5|NOT COMPLETED|Overall Study||1
2456756|NCT01030536|6024504|P4|NOT COMPLETED|Overall Study||3
2456757|NCT01030536|6024505|P3|NOT COMPLETED|Overall Study||6
2456758|NCT01030536|6024506|P2|NOT COMPLETED|Overall Study||6
2456759|NCT01030536|6024507|P1|NOT COMPLETED|Overall Study||7
2456760|NCT01030536|6024503|P5|COMPLETED|Overall Study||0
2456761|NCT01030536|6024504|P4|COMPLETED|Overall Study||0
2456762|NCT01030536|6024505|P3|COMPLETED|Overall Study||0
2456763|NCT01030536|6024506|P2|COMPLETED|Overall Study||0
2456764|NCT01030536|6024507|P1|COMPLETED|Overall Study||0
2456765|NCT01030536|6024503|P5|STARTED|Overall Study||1
2456766|NCT01030536|6024504|P4|STARTED|Overall Study||3
2456767|NCT01030536|6024505|P3|STARTED|Overall Study||6
2456768|NCT01030536|6024506|P2|STARTED|Overall Study||6
2456769|NCT01030536|6024507|P1|STARTED|Overall Study||7
2456770|NCT01030458|6024612|P2|NOT COMPLETED|Overall Study||32
2456771|NCT01030458|6024613|P1|NOT COMPLETED|Overall Study||27
2456772|NCT01030458|6024612|P2|COMPLETED|Overall Study||57
2456773|NCT01030458|6024613|P1|COMPLETED|Overall Study||67
2456774|NCT01030458|6024612|P2|STARTED|Overall Study||89
2456775|NCT01030458|6024613|P1|STARTED|Overall Study||94
2456776|NCT01030406|6024630|P5|NOT COMPLETED|Overall Study||0
2456777|NCT01030406|6024631|P4|NOT COMPLETED|Overall Study||1
2456778|NCT01030406|6024632|P3|NOT COMPLETED|Overall Study||1
2456779|NCT01030406|6024633|P2|NOT COMPLETED|Overall Study||0
2456780|NCT01030406|6024634|P1|NOT COMPLETED|Overall Study||0
2456781|NCT01030406|6024630|P5|COMPLETED|Overall Study||9
2456782|NCT01030406|6024631|P4|COMPLETED|Overall Study||9
2456783|NCT01030406|6024632|P3|COMPLETED|Overall Study||9
2456784|NCT01030406|6024633|P2|COMPLETED|Overall Study||10
2456785|NCT01030406|6024634|P1|COMPLETED|Overall Study||10
2456786|NCT01030406|6024630|P5|STARTED|Overall Study||9
2456787|NCT01030406|6024631|P4|STARTED|Overall Study||10
2456788|NCT01030406|6024632|P3|STARTED|Overall Study||10
2456789|NCT01030406|6024633|P2|STARTED|Overall Study||10
2456790|NCT01030406|6024634|P1|STARTED|Overall Study||10
2456791|NCT01030341|6024646|P1|NOT COMPLETED|Overall Study||3
2456792|NCT01030341|6024646|P1|COMPLETED|Overall Study|42 participants completed the study|42
2456793|NCT01030341|6024646|P1|STARTED|Overall Study|45 participants met all enrollment criteria by completing the screening and run-in phases|45
2456794|NCT01030289|6024651|P2|NOT COMPLETED|Overall Study||0
2456795|NCT01030289|6024652|P1|NOT COMPLETED|Overall Study||0
2456796|NCT01030289|6024651|P2|COMPLETED|Overall Study||10
2456797|NCT01030289|6024652|P1|COMPLETED|Overall Study||9
2456798|NCT01030289|6024651|P2|STARTED|Overall Study||10
2456799|NCT01030289|6024652|P1|STARTED|Overall Study||9
2456800|NCT01030133|6024669|P2|NOT COMPLETED|Overall Study||2
2456801|NCT01030133|6024670|P1|NOT COMPLETED|Overall Study||2
2456802|NCT01030133|6024669|P2|COMPLETED|Overall Study||12
2456803|NCT01030133|6024670|P1|COMPLETED|Overall Study||12
2456804|NCT01030133|6024669|P2|STARTED|Overall Study||14
2456805|NCT01030133|6024670|P1|STARTED|Overall Study||14
2456806|NCT01029925|6024682|P1|NOT COMPLETED|Completion of Cycle 2 (56 Days)||1
2456807|NCT01029925|6024682|P1|COMPLETED|Completion of Cycle 2 (56 Days)||2
2456808|NCT01029925|6024682|P1|STARTED|Completion of Cycle 2 (56 Days)||3
2456809|NCT01029925|6024682|P1|NOT COMPLETED|Completion of Cycle 1 (28 Days)||4
2456810|NCT01029925|6024682|P1|COMPLETED|Completion of Cycle 1 (28 Days)||3
2456811|NCT01029925|6024682|P1|STARTED|Completion of Cycle 1 (28 Days)||7
2456812|NCT01029912|6024688|P2|NOT COMPLETED|Overall Study||0
2456813|NCT01029912|6024689|P1|NOT COMPLETED|Overall Study||2
2456814|NCT01029912|6024688|P2|COMPLETED|Overall Study||12
2456815|NCT01029912|6024689|P1|COMPLETED|Overall Study||12
2456816|NCT01029912|6024688|P2|STARTED|Overall Study||12
2456817|NCT01029912|6024689|P1|STARTED|Overall Study||14
2456818|NCT01029886|6024701|P2|NOT COMPLETED|Overall Study||60
2456819|NCT01029886|6024702|P1|NOT COMPLETED|Overall Study||61
2456820|NCT01029886|6024701|P2|COMPLETED|Overall Study||391
2456821|NCT01029886|6024702|P1|COMPLETED|Overall Study||400
2456822|NCT01029886|6024701|P2|Intent to Treat (ITT)|Overall Study||450
2456823|NCT01029886|6024702|P1|Intent to Treat (ITT)|Overall Study||461
2456824|NCT01029886|6024701|P2|STARTED|Overall Study||451
2456825|NCT01029886|6024702|P1|STARTED|Overall Study||461
2456826|NCT01029795|6024730|P2|NOT COMPLETED|Overall Study||22
2456827|NCT01029795|6024731|P1|NOT COMPLETED|Overall Study||16
2456828|NCT01029795|6024730|P2|COMPLETED|Overall Study||0
2456829|NCT01029795|6024731|P1|COMPLETED|Overall Study||0
2456830|NCT01029795|6024730|P2|STARTED|Overall Study||22
2456831|NCT01029795|6024731|P1|STARTED|Overall Study||16
2456832|NCT01029782|6024785|P2|NOT COMPLETED|Overall Study||8
2456833|NCT01029782|6024786|P1|NOT COMPLETED|Overall Study||3
2456834|NCT01029782|6024785|P2|COMPLETED|Overall Study||96
2456835|NCT01029782|6024786|P1|COMPLETED|Overall Study||99
2456836|NCT01029782|6024785|P2|STARTED|Overall Study||104
2456837|NCT01029782|6024786|P1|STARTED|Overall Study||102
2456838|NCT01029730|6024792|P1|NOT COMPLETED|Maintenance Therapy||23
2456839|NCT01029730|6024792|P1|COMPLETED|Maintenance Therapy||14
2456840|NCT01029730|6024792|P1|STARTED|Maintenance Therapy|Two patients complete study treatment but declined subsequent maintenance therapy|37
2456841|NCT01029730|6024792|P1|NOT COMPLETED|Combination Therapy||16
2456842|NCT01029730|6024792|P1|COMPLETED|Combination Therapy|Patients remained on-study until completing 6 cycles or coming off-treatment for any other reason|39
2456843|NCT01029730|6024792|P1|STARTED|Combination Therapy||55
2456844|NCT01029704|6024804|P5|NOT COMPLETED|Overall Study||0
2456845|NCT01029704|6024805|P4|NOT COMPLETED|Overall Study||0
2456846|NCT01029704|6024806|P3|NOT COMPLETED|Overall Study||0
2456847|NCT01029704|6024807|P2|NOT COMPLETED|Overall Study||0
2456848|NCT01029704|6024808|P1|NOT COMPLETED|Overall Study||0
2456849|NCT01029704|6024804|P5|COMPLETED|Overall Study||26
2456850|NCT01029704|6024805|P4|COMPLETED|Overall Study||28
2456851|NCT01029704|6024806|P3|COMPLETED|Overall Study||23
2456852|NCT01029704|6024807|P2|COMPLETED|Overall Study||24
2456853|NCT01029704|6024808|P1|COMPLETED|Overall Study||28
2456854|NCT01029704|6024804|P5|STARTED|Overall Study||26
2456855|NCT01029704|6024805|P4|STARTED|Overall Study||28
2456856|NCT01029704|6024806|P3|STARTED|Overall Study||23
2456857|NCT01029704|6024807|P2|STARTED|Overall Study||24
2456858|NCT01029704|6024808|P1|STARTED|Overall Study||28
2456859|NCT01029691|6024838|P3|NOT COMPLETED|Continued APAP to Delivery||1
2456860|NCT01029691|6024839|P2|NOT COMPLETED|Continued APAP to Delivery||0
2456861|NCT01029691|6024840|P1|NOT COMPLETED|Continued APAP to Delivery||0
2456862|NCT01029691|6024838|P3|COMPLETED|Continued APAP to Delivery||76
2456863|NCT01029691|6024839|P2|COMPLETED|Continued APAP to Delivery||16
2456864|NCT01029691|6024840|P1|COMPLETED|Continued APAP to Delivery||20
2456865|NCT01029691|6024838|P3|STARTED|Continued APAP to Delivery||77
2456866|NCT01029691|6024839|P2|STARTED|Continued APAP to Delivery||16
2456867|NCT01029691|6024840|P1|STARTED|Continued APAP to Delivery||20
2456868|NCT01029691|6024838|P3|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
2456869|NCT01029691|6024839|P2|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||11
2456870|NCT01029691|6024840|P1|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
2456871|NCT01029691|6024838|P3|COMPLETED|APAP Initiation to Week 1 or Delivery||77
2456872|NCT01029691|6024839|P2|COMPLETED|APAP Initiation to Week 1 or Delivery||16
2456873|NCT01029691|6024840|P1|COMPLETED|APAP Initiation to Week 1 or Delivery||20
2456874|NCT01029691|6024838|P3|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||77
2456875|NCT01029691|6024839|P2|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||16
2456876|NCT01029691|6024840|P1|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||20
2456877|NCT01029691|6024838|P3|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||77
2456878|NCT01029691|6024839|P2|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||23
2456879|NCT01029691|6024840|P1|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||20
2456880|NCT01029691|6024838|P3|STARTED|APAP Initiation to Week 1 or Delivery||77
2456881|NCT01029691|6024839|P2|STARTED|APAP Initiation to Week 1 or Delivery|4 delivered before APAP initiation 7 elected not to have APAP following baseline study|27
2456882|NCT01029691|6024840|P1|STARTED|APAP Initiation to Week 1 or Delivery||20
2456883|NCT01029652|6024865|P2|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||3
2456884|NCT01029652|6024866|P1|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||1
2456885|NCT01029652|6024865|P2|COMPLETED|Extension Study 2 (25-72 Weeks)||63
2456886|NCT01029652|6024866|P1|COMPLETED|Extension Study 2 (25-72 Weeks)||68
2456887|NCT01029652|6024865|P2|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|39
2456888|NCT01029652|6024866|P1|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab over 72 weeks study duration overall|69
2456889|NCT01029652|6024865|P2|STARTED|Extension Study 2 (25-72 Weeks)||66
2456890|NCT01029652|6024866|P1|STARTED|Extension Study 2 (25-72 Weeks)||69
2456891|NCT01029652|6024865|P2|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||5
2456892|NCT01029652|6024866|P1|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||3
2456893|NCT01029652|6024865|P2|COMPLETED|Extension Study 1 (12-24 Weeks)||80
2456894|NCT01029652|6024866|P1|COMPLETED|Extension Study 1 (12-24 Weeks)||87
2456895|NCT01029652|6024865|P2|STARTED|Extension Study 1 (12-24 Weeks)||85
2456896|NCT01029652|6024866|P1|STARTED|Extension Study 1 (12-24 Weeks)||90
2456897|NCT01029652|6024865|P2|NOT COMPLETED|Core Study (0-12 Weeks)||10
2456898|NCT01029652|6024866|P1|NOT COMPLETED|Core Study (0-12 Weeks)||6
2456899|NCT01029652|6024865|P2|COMPLETED|Core Study (0-12 Weeks)||105
2456900|NCT01029652|6024866|P1|COMPLETED|Core Study (0-12 Weeks)||109
2456901|NCT01029652|6024865|P2|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||115
2456902|NCT01029652|6024866|P1|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||113
2456903|NCT01029652|6024865|P2|STARTED|Core Study (0-12 Weeks)||115
2456904|NCT01029652|6024866|P1|STARTED|Core Study (0-12 Weeks)||115
2456905|NCT01029535|6024944|P1|NOT COMPLETED|Overall Study||31
2456906|NCT01029535|6024944|P1|COMPLETED|Overall Study||72
2456907|NCT01029535|6024944|P1|STARTED|Overall Study||103
2456908|NCT01029405|6024973|P4|NOT COMPLETED|Overall Study||5
2456909|NCT01029405|6024974|P3|NOT COMPLETED|Overall Study||4
2456910|NCT01029405|6024975|P2|NOT COMPLETED|Overall Study||3
2456911|NCT01029405|6024976|P1|NOT COMPLETED|Overall Study||2
2456912|NCT01029405|6024973|P4|COMPLETED|Overall Study||32
2456913|NCT01029405|6024974|P3|COMPLETED|Overall Study||31
2456914|NCT01029405|6024975|P2|COMPLETED|Overall Study||34
2456915|NCT01029405|6024976|P1|COMPLETED|Overall Study||34
2456916|NCT01029405|6024973|P4|STARTED|Overall Study||37
2456917|NCT01029405|6024974|P3|STARTED|Overall Study||35
2456918|NCT01029405|6024975|P2|STARTED|Overall Study||37
2456919|NCT01029405|6024976|P1|STARTED|Overall Study||36
2456920|NCT01029392|6024988|P2|NOT COMPLETED|Overall Study||11
2456921|NCT01029392|6024989|P1|NOT COMPLETED|Overall Study||20
2456922|NCT01029392|6024988|P2|COMPLETED|Overall Study||27
2456923|NCT01029392|6024989|P1|COMPLETED|Overall Study||17
2456924|NCT01029392|6024988|P2|STARTED|Overall Study||38
2456925|NCT01029392|6024989|P1|STARTED|Overall Study||37
2456926|NCT01029366|6024999|P2|NOT COMPLETED|Overall Study||2
2456927|NCT01029366|6025000|P1|NOT COMPLETED|Overall Study||4
2456928|NCT01029366|6024999|P2|COMPLETED|Overall Study||6
2456929|NCT01029366|6025000|P1|COMPLETED|Overall Study||14
2456930|NCT01029366|6024999|P2|STARTED|Overall Study||8
2456931|NCT01029366|6025000|P1|STARTED|Overall Study||18
2456932|NCT01029340|6025012|P6|NOT COMPLETED|Part C Follow up Period||0
2456933|NCT01029340|6025013|P5|NOT COMPLETED|Part C Follow up Period||0
2456934|NCT01029340|6025014|P4|NOT COMPLETED|Part C Follow up Period||0
2456935|NCT01029340|6025015|P3|NOT COMPLETED|Part C Follow up Period||0
2456936|NCT01029340|6025016|P2|NOT COMPLETED|Part C Follow up Period||0
2456937|NCT01029340|6025017|P1|NOT COMPLETED|Part C Follow up Period||0
2456938|NCT01029340|6025012|P6|COMPLETED|Part C Follow up Period||0
2456939|NCT01029340|6025013|P5|COMPLETED|Part C Follow up Period||5
2456940|NCT01029340|6025014|P4|COMPLETED|Part C Follow up Period||0
2456941|NCT01029340|6025015|P3|COMPLETED|Part C Follow up Period||0
2456942|NCT01029340|6025016|P2|COMPLETED|Part C Follow up Period||0
2456943|NCT01029340|6025017|P1|COMPLETED|Part C Follow up Period||0
2456944|NCT01029340|6025012|P6|STARTED|Part C Follow up Period||0
2456945|NCT01029340|6025013|P5|STARTED|Part C Follow up Period||5
2456946|NCT01029340|6025014|P4|STARTED|Part C Follow up Period||0
2456947|NCT01029340|6025015|P3|STARTED|Part C Follow up Period||0
2456948|NCT01029340|6025016|P2|STARTED|Part C Follow up Period||0
2456949|NCT01029340|6025017|P1|STARTED|Part C Follow up Period||0
2456950|NCT01029340|6025012|P6|NOT COMPLETED|Part C Treatment Period||0
2456951|NCT01029340|6025013|P5|NOT COMPLETED|Part C Treatment Period||0
2456952|NCT01029340|6025014|P4|NOT COMPLETED|Part C Treatment Period||0
2456953|NCT01029340|6025015|P3|NOT COMPLETED|Part C Treatment Period||0
2456954|NCT01029340|6025016|P2|NOT COMPLETED|Part C Treatment Period||0
2456955|NCT01029340|6025017|P1|NOT COMPLETED|Part C Treatment Period||0
2456956|NCT01029340|6025012|P6|COMPLETED|Part C Treatment Period||0
2456957|NCT01029340|6025013|P5|COMPLETED|Part C Treatment Period||5
2456958|NCT01029340|6025014|P4|COMPLETED|Part C Treatment Period||0
2456959|NCT01029340|6025015|P3|COMPLETED|Part C Treatment Period||0
2456960|NCT01029340|6025016|P2|COMPLETED|Part C Treatment Period||0
2456961|NCT01029340|6025017|P1|COMPLETED|Part C Treatment Period||0
2456962|NCT01029340|6025012|P6|Participants Received Treatment|Part C Treatment Period||0
2456963|NCT01029340|6025013|P5|Participants Received Treatment|Part C Treatment Period||5
2456964|NCT01029340|6025014|P4|Participants Received Treatment|Part C Treatment Period||0
2456965|NCT01029340|6025015|P3|Participants Received Treatment|Part C Treatment Period||0
2456966|NCT01029340|6025016|P2|Participants Received Treatment|Part C Treatment Period||0
2456967|NCT01029340|6025017|P1|Participants Received Treatment|Part C Treatment Period||0
2456968|NCT01029340|6025012|P6|STARTED|Part C Treatment Period||0
2456969|NCT01029340|6025013|P5|STARTED|Part C Treatment Period||5
2456970|NCT01029340|6025014|P4|STARTED|Part C Treatment Period||0
2456971|NCT01029340|6025015|P3|STARTED|Part C Treatment Period||0
2456972|NCT01029340|6025016|P2|STARTED|Part C Treatment Period||0
2456973|NCT01029340|6025017|P1|STARTED|Part C Treatment Period||0
2456974|NCT01029340|6025012|P6|NOT COMPLETED|Extension Period||12
2456975|NCT01029340|6025013|P5|NOT COMPLETED|Extension Period||0
2456976|NCT01029340|6025014|P4|NOT COMPLETED|Extension Period||0
2456977|NCT01029340|6025015|P3|NOT COMPLETED|Extension Period||0
2456978|NCT01029340|6025016|P2|NOT COMPLETED|Extension Period||0
2456979|NCT01029340|6025017|P1|NOT COMPLETED|Extension Period||0
2456980|NCT01029340|6025012|P6|COMPLETED|Extension Period||43
2456981|NCT01029340|6025013|P5|COMPLETED|Extension Period||0
2456982|NCT01029340|6025014|P4|COMPLETED|Extension Period||0
2456983|NCT01029340|6025015|P3|COMPLETED|Extension Period||0
2456984|NCT01029340|6025016|P2|COMPLETED|Extension Period||0
2456985|NCT01029340|6025017|P1|COMPLETED|Extension Period||0
2456986|NCT01029340|6025012|P6|STARTED|Extension Period||55
2456987|NCT01029340|6025013|P5|STARTED|Extension Period||0
2456988|NCT01029340|6025014|P4|STARTED|Extension Period||0
2456989|NCT01029340|6025015|P3|STARTED|Extension Period||0
2456990|NCT01029340|6025016|P2|STARTED|Extension Period||0
2456991|NCT01029340|6025017|P1|STARTED|Extension Period||0
2456992|NCT01029340|6025012|P6|NOT COMPLETED|Part B Follow up Period||0
2456993|NCT01029340|6025013|P5|NOT COMPLETED|Part B Follow up Period||0
2456994|NCT01029340|6025014|P4|NOT COMPLETED|Part B Follow up Period||0
2456995|NCT01029340|6025015|P3|NOT COMPLETED|Part B Follow up Period||0
2456996|NCT01029340|6025016|P2|NOT COMPLETED|Part B Follow up Period||0
2456997|NCT01029340|6025017|P1|NOT COMPLETED|Part B Follow up Period||0
2456998|NCT01029340|6025012|P6|COMPLETED|Part B Follow up Period||0
2456999|NCT01029340|6025013|P5|COMPLETED|Part B Follow up Period||0
2457000|NCT01029340|6025014|P4|COMPLETED|Part B Follow up Period||32
2457001|NCT01029340|6025015|P3|COMPLETED|Part B Follow up Period||29
2457002|NCT01029340|6025016|P2|COMPLETED|Part B Follow up Period||0
2457003|NCT01029340|6025017|P1|COMPLETED|Part B Follow up Period||0
2457004|NCT01029340|6025012|P6|STARTED|Part B Follow up Period||0
2457005|NCT01029340|6025013|P5|STARTED|Part B Follow up Period||0
2457006|NCT01029340|6025014|P4|STARTED|Part B Follow up Period||32
2457007|NCT01029340|6025015|P3|STARTED|Part B Follow up Period||29
2457008|NCT01029340|6025016|P2|STARTED|Part B Follow up Period||0
2457009|NCT01029340|6025017|P1|STARTED|Part B Follow up Period||0
2457010|NCT01029340|6025012|P6|NOT COMPLETED|Part B Treatment Period||0
2457011|NCT01029340|6025013|P5|NOT COMPLETED|Part B Treatment Period||0
2457012|NCT01029340|6025014|P4|NOT COMPLETED|Part B Treatment Period||0
2457013|NCT01029340|6025015|P3|NOT COMPLETED|Part B Treatment Period||2
2457014|NCT01029340|6025016|P2|NOT COMPLETED|Part B Treatment Period||0
2457015|NCT01029340|6025017|P1|NOT COMPLETED|Part B Treatment Period||0
2457016|NCT01029340|6025012|P6|COMPLETED|Part B Treatment Period||0
2457017|NCT01029340|6025013|P5|COMPLETED|Part B Treatment Period||0
2457018|NCT01029340|6025014|P4|COMPLETED|Part B Treatment Period||32
2457019|NCT01029340|6025015|P3|COMPLETED|Part B Treatment Period||29
2457020|NCT01029340|6025016|P2|COMPLETED|Part B Treatment Period||0
2457021|NCT01029340|6025017|P1|COMPLETED|Part B Treatment Period||0
2457022|NCT01029340|6025012|P6|Participants Received Treatment|Part B Treatment Period||0
2457023|NCT01029340|6025013|P5|Participants Received Treatment|Part B Treatment Period||0
2457024|NCT01029340|6025014|P4|Participants Received Treatment|Part B Treatment Period||32
2457025|NCT01029340|6025015|P3|Participants Received Treatment|Part B Treatment Period||30
2457026|NCT01029340|6025016|P2|Participants Received Treatment|Part B Treatment Period||0
2457027|NCT01029340|6025017|P1|Participants Received Treatment|Part B Treatment Period||0
2457028|NCT01029340|6025012|P6|STARTED|Part B Treatment Period||0
2457029|NCT01029340|6025013|P5|STARTED|Part B Treatment Period||0
2457030|NCT01029340|6025014|P4|STARTED|Part B Treatment Period|Enrolled 7 participants from Arm 1 and 4 participants from Arm 2|32
2457031|NCT01029340|6025015|P3|STARTED|Part B Treatment Period|Enrolled 4 participants from Arm 1 and 7 participants from Arm 2|31
2457032|NCT01029340|6025016|P2|STARTED|Part B Treatment Period||0
2457033|NCT01029340|6025017|P1|STARTED|Part B Treatment Period||0
2457034|NCT01029340|6025012|P6|NOT COMPLETED|Part A Follow up Period||0
2457035|NCT01029340|6025013|P5|NOT COMPLETED|Part A Follow up Period||0
2457036|NCT01029340|6025014|P4|NOT COMPLETED|Part A Follow up Period||0
2457037|NCT01029340|6025015|P3|NOT COMPLETED|Part A Follow up Period||0
2457038|NCT01029340|6025016|P2|NOT COMPLETED|Part A Follow up Period||0
2457039|NCT01029340|6025017|P1|NOT COMPLETED|Part A Follow up Period||0
2457040|NCT01029340|6025012|P6|COMPLETED|Part A Follow up Period||0
2457041|NCT01029340|6025013|P5|COMPLETED|Part A Follow up Period||0
2457042|NCT01029340|6025014|P4|COMPLETED|Part A Follow up Period||0
2457043|NCT01029340|6025015|P3|COMPLETED|Part A Follow up Period||0
2457044|NCT01029340|6025016|P2|COMPLETED|Part A Follow up Period||14
2457045|NCT01029340|6025017|P1|COMPLETED|Part A Follow up Period||14
2457046|NCT01029340|6025012|P6|STARTED|Part A Follow up Period||0
2457047|NCT01029340|6025013|P5|STARTED|Part A Follow up Period||0
2457048|NCT01029340|6025014|P4|STARTED|Part A Follow up Period||0
2457049|NCT01029340|6025015|P3|STARTED|Part A Follow up Period||0
2457050|NCT01029340|6025016|P2|STARTED|Part A Follow up Period||14
2457051|NCT01029340|6025017|P1|STARTED|Part A Follow up Period||14
2457052|NCT01029340|6025012|P6|NOT COMPLETED|Part A Treatment Period||0
2457053|NCT01029340|6025013|P5|NOT COMPLETED|Part A Treatment Period||0
2457054|NCT01029340|6025014|P4|NOT COMPLETED|Part A Treatment Period||0
2457055|NCT01029340|6025015|P3|NOT COMPLETED|Part A Treatment Period||0
2457056|NCT01029340|6025016|P2|NOT COMPLETED|Part A Treatment Period||0
2457057|NCT01029340|6025017|P1|NOT COMPLETED|Part A Treatment Period||0
2457058|NCT01029340|6025012|P6|COMPLETED|Part A Treatment Period||0
2457059|NCT01029340|6025013|P5|COMPLETED|Part A Treatment Period||0
2457060|NCT01029340|6025014|P4|COMPLETED|Part A Treatment Period||0
2457061|NCT01029340|6025015|P3|COMPLETED|Part A Treatment Period||0
2457062|NCT01029340|6025016|P2|COMPLETED|Part A Treatment Period||14
2457063|NCT01029340|6025017|P1|COMPLETED|Part A Treatment Period||14
2457064|NCT01029340|6025012|P6|Safety Population|Part A Treatment Period||0
2457065|NCT01029340|6025013|P5|Safety Population|Part A Treatment Period||0
2457066|NCT01029340|6025014|P4|Safety Population|Part A Treatment Period||0
2457067|NCT01029340|6025015|P3|Safety Population|Part A Treatment Period||0
2457068|NCT01029340|6025016|P2|Safety Population|Part A Treatment Period||14
2457069|NCT01029340|6025017|P1|Safety Population|Part A Treatment Period|One excluded because receiving Kogenate FS twice.|13
2457070|NCT01029340|6025012|P6|Participants Received Treatment|Part A Treatment Period||0
2457071|NCT01029340|6025013|P5|Participants Received Treatment|Part A Treatment Period||0
2457072|NCT01029340|6025014|P4|Participants Received Treatment|Part A Treatment Period||0
2457073|NCT01029340|6025015|P3|Participants Received Treatment|Part A Treatment Period||0
2457074|NCT01029340|6025016|P2|Participants Received Treatment|Part A Treatment Period||14
2457075|NCT01029340|6025017|P1|Participants Received Treatment|Part A Treatment Period||14
2457076|NCT01029340|6025012|P6|STARTED|Part A Treatment Period||0
2457077|NCT01029340|6025013|P5|STARTED|Part A Treatment Period||0
2457078|NCT01029340|6025014|P4|STARTED|Part A Treatment Period||0
2457079|NCT01029340|6025015|P3|STARTED|Part A Treatment Period||0
2457080|NCT01029340|6025016|P2|STARTED|Part A Treatment Period||14
2457081|NCT01029340|6025017|P1|STARTED|Part A Treatment Period||14
2457082|NCT01029262|6025048|P2|NOT COMPLETED|Overall Study||160
2457083|NCT01029262|6025049|P1|NOT COMPLETED|Overall Study||79
2457084|NCT01029262|6025048|P2|COMPLETED|Overall Study||0
2457085|NCT01029262|6025049|P1|COMPLETED|Overall Study||0
2457086|NCT01029262|6025048|P2|STARTED|Overall Study||160
2457087|NCT01029262|6025049|P1|STARTED|Overall Study||79
2457088|NCT01029054|6025111|P3|NOT COMPLETED|Phase II||0
2457089|NCT01029054|6025112|P2|NOT COMPLETED|Phase II||0
2457090|NCT01029054|6025113|P1|NOT COMPLETED|Phase II||0
2457091|NCT01029054|6025111|P3|COMPLETED|Phase II||18
2457092|NCT01029054|6025112|P2|COMPLETED|Phase II||0
2457093|NCT01029054|6025113|P1|COMPLETED|Phase II||0
2457094|NCT01029054|6025111|P3|STARTED|Phase II|35 participants were enrolled in Ph I. 18 additional participants were enrolled in Ph II at the MTD.|18
2457095|NCT01029054|6025112|P2|STARTED|Phase II||0
2457096|NCT01029054|6025113|P1|STARTED|Phase II||0
2457097|NCT01029054|6025111|P3|NOT COMPLETED|Phase I||0
2457098|NCT01029054|6025112|P2|NOT COMPLETED|Phase I||0
2457099|NCT01029054|6025113|P1|NOT COMPLETED|Phase I||0
2457100|NCT01029054|6025111|P3|COMPLETED|Phase I||18
2457101|NCT01029054|6025112|P2|COMPLETED|Phase I||13
2457102|NCT01029054|6025113|P1|COMPLETED|Phase I||4
2457103|NCT01029054|6025111|P3|STARTED|Phase I||18
2457104|NCT01029054|6025112|P2|STARTED|Phase I||13
2457105|NCT01029054|6025113|P1|STARTED|Phase I||4
2457106|NCT01028937|6025119|P1|NOT COMPLETED|Overall Study||0
2457107|NCT01028937|6025119|P1|COMPLETED|Overall Study||6
2457108|NCT01028937|6025119|P1|STARTED|Overall Study||6
2457109|NCT01028911|6025126|P2|NOT COMPLETED|Overall Study||0
2457110|NCT01028911|6025127|P1|NOT COMPLETED|Overall Study||0
2457111|NCT01028911|6025126|P2|COMPLETED|Overall Study||2
2457112|NCT01028911|6025127|P1|COMPLETED|Overall Study||7
2457113|NCT01028911|6025126|P2|STARTED|Overall Study||2
2457114|NCT01028911|6025127|P1|STARTED|Overall Study||7
2457115|NCT01028820|6025192|P1|NOT COMPLETED|Overall Study||1
2457116|NCT01028820|6025192|P1|COMPLETED|Overall Study||12
2457117|NCT01028820|6025192|P1|STARTED|Overall Study||13
2457118|NCT01028677|6025201|P2|NOT COMPLETED|Overall Study||1
2457119|NCT01028677|6025202|P1|NOT COMPLETED|Overall Study||2
2457120|NCT01028677|6025201|P2|COMPLETED|Overall Study||6
2457121|NCT01028677|6025202|P1|COMPLETED|Overall Study||8
2457122|NCT01028677|6025201|P2|STARTED|Overall Study||7
2457123|NCT01028677|6025202|P1|STARTED|Overall Study||10
2457124|NCT01028651|6025218|P1|NOT COMPLETED|Overall Study||3
2457125|NCT01028651|6025218|P1|COMPLETED|Overall Study||10
2457126|NCT01028651|6025218|P1|STARTED|Overall Study||13
2457127|NCT01028560|6025241|P2|NOT COMPLETED|Overall Study||18
2457128|NCT01028560|6025242|P1|NOT COMPLETED|Overall Study||10
2457129|NCT01028560|6025241|P2|COMPLETED|Overall Study||13
2457130|NCT01028560|6025242|P1|COMPLETED|Overall Study||17
2457131|NCT01028560|6025241|P2|Started Study Protocol|Overall Study||27
2457132|NCT01028560|6025242|P1|Started Study Protocol|Overall Study||23
2457133|NCT01028560|6025241|P2|STARTED|Overall Study|4 of 31 withdrew consent immediately after randomization and are excluded from outcome analysis|31
2457134|NCT01028560|6025242|P1|STARTED|Overall Study|4 of 27 withdrew consent immediately after randomization and are excluded from outcome analysis|27
2457135|NCT01028391|6025256|P2|NOT COMPLETED|Overall Study||11
2457136|NCT01028391|6025257|P1|NOT COMPLETED|Overall Study||14
2457137|NCT01028391|6025256|P2|COMPLETED|Overall Study||142
2457138|NCT01028391|6025257|P1|COMPLETED|Overall Study||150
2457139|NCT01028391|6025256|P2|STARTED|Overall Study||153
2457140|NCT01028391|6025257|P1|STARTED|Overall Study||164
2457141|NCT01028378|6025265|P1|NOT COMPLETED|Overall Study||17
2457142|NCT01028378|6025265|P1|COMPLETED|Overall Study|195 participants (230 eyes) with myopia|195
2457143|NCT01028378|6025265|P1|STARTED|Overall Study|212 participants (249 eyes) with myopia|212
2457144|NCT01028352|6025277|P1|NOT COMPLETED|Overall Study||6
2457145|NCT01028352|6025277|P1|COMPLETED|Overall Study||29
2457146|NCT01028352|6025277|P1|STARTED|Overall Study||35
2457147|NCT01028300|6025282|P1|NOT COMPLETED|Overall Study||4
2457148|NCT01028300|6025282|P1|COMPLETED|Overall Study||0
2457149|NCT01028300|6025282|P1|STARTED|Overall Study||4
2457150|NCT01028222|6025291|P2|NOT COMPLETED|Overall Study||13
2457151|NCT01028222|6025292|P1|NOT COMPLETED|Overall Study||38
2457152|NCT01028222|6025291|P2|COMPLETED|Overall Study||0
2457153|NCT01028222|6025292|P1|COMPLETED|Overall Study||4
2457154|NCT01028222|6025291|P2|Cross Over From DTIC to Nilotinib|Overall Study||10
2457155|NCT01028222|6025292|P1|Cross Over From DTIC to Nilotinib|Overall Study||0
2457156|NCT01028222|6025291|P2|STARTED|Overall Study||13
2457157|NCT01028222|6025292|P1|STARTED|Overall Study||42
2457158|NCT01028131|6025317|P4|NOT COMPLETED|Overall Study||4
2457159|NCT01028131|6025318|P3|NOT COMPLETED|Overall Study||6
2457160|NCT01028131|6025319|P2|NOT COMPLETED|Overall Study||3
2457161|NCT01028131|6025320|P1|NOT COMPLETED|Overall Study||3
2457162|NCT01028131|6025317|P4|COMPLETED|Overall Study||26
2457163|NCT01028131|6025318|P3|COMPLETED|Overall Study||22
2457164|NCT01028131|6025319|P2|COMPLETED|Overall Study||23
2457165|NCT01028131|6025320|P1|COMPLETED|Overall Study||23
2457166|NCT01028131|6025317|P4|Completed Intervention/Control Session|Overall Study||30
2457167|NCT01028131|6025318|P3|Completed Intervention/Control Session|Overall Study||28
2457168|NCT01028131|6025319|P2|Completed Intervention/Control Session|Overall Study||26
2457169|NCT01028131|6025320|P1|Completed Intervention/Control Session|Overall Study||26
2457170|NCT01028131|6025317|P4|STARTED|Overall Study||30
2457171|NCT01028131|6025318|P3|STARTED|Overall Study||28
2457172|NCT01028131|6025319|P2|STARTED|Overall Study||26
2457173|NCT01028131|6025320|P1|STARTED|Overall Study||26
2457174|NCT01028053|6025334|P1|NOT COMPLETED|Overall Study||133
2457175|NCT01028053|6025334|P1|COMPLETED|Overall Study||232
2457176|NCT01028053|6025334|P1|STARTED|Overall Study||365
2457177|NCT01028027|6025342|P2|NOT COMPLETED|Overall Study||13
2457178|NCT01028027|6025343|P1|NOT COMPLETED|Overall Study||16
2457179|NCT01028027|6025342|P2|COMPLETED|Overall Study||164
2457180|NCT01028027|6025343|P1|COMPLETED|Overall Study||164
2457181|NCT01028027|6025342|P2|STARTED|Overall Study||177
2457182|NCT01028027|6025343|P1|STARTED|Overall Study||180
2457183|NCT01028014|6025365|P6|NOT COMPLETED|Overall Study||2
2457184|NCT01028014|6025366|P5|NOT COMPLETED|Overall Study||1
2457185|NCT01028014|6025367|P4|NOT COMPLETED|Overall Study||1
2457186|NCT01028014|6025368|P3|NOT COMPLETED|Overall Study||0
2457187|NCT01028014|6025369|P2|NOT COMPLETED|Overall Study||2
2457188|NCT01028014|6025370|P1|NOT COMPLETED|Overall Study||1
2457189|NCT01028014|6025365|P6|COMPLETED|Overall Study||4
2457190|NCT01028014|6025366|P5|COMPLETED|Overall Study||9
2457191|NCT01028014|6025367|P4|COMPLETED|Overall Study||9
2457192|NCT01028014|6025368|P3|COMPLETED|Overall Study||10
2457193|NCT01028014|6025369|P2|COMPLETED|Overall Study||8
2457194|NCT01028014|6025370|P1|COMPLETED|Overall Study||9
2457195|NCT01028014|6025365|P6|STARTED|Overall Study||6
2457196|NCT01028014|6025366|P5|STARTED|Overall Study||10
2457197|NCT01028014|6025367|P4|STARTED|Overall Study||10
2457198|NCT01028014|6025368|P3|STARTED|Overall Study||10
2457199|NCT01028014|6025369|P2|STARTED|Overall Study||10
2457200|NCT01028014|6025370|P1|STARTED|Overall Study||10
2457201|NCT01027910|6025398|P2|NOT COMPLETED|Overall Study||0
2457202|NCT01027910|6025399|P1|NOT COMPLETED|Overall Study||0
2457203|NCT01027910|6025398|P2|COMPLETED|Overall Study||14
2457204|NCT01027910|6025399|P1|COMPLETED|Overall Study||6
2457205|NCT01027910|6025398|P2|STARTED|Overall Study||14
2457206|NCT01027910|6025399|P1|STARTED|Overall Study||6
2457207|NCT01027897|6025411|P1|NOT COMPLETED|Overall Study||2
2457208|NCT01027897|6025411|P1|COMPLETED|Overall Study||28
2457209|NCT01027897|6025411|P1|STARTED|Overall Study||30
2457210|NCT01027884|6025419|P2|NOT COMPLETED|Overall Study||7
2457211|NCT01027884|6025420|P1|NOT COMPLETED|Overall Study||4
2457212|NCT01027884|6025419|P2|COMPLETED|Overall Study||25
2457213|NCT01027884|6025420|P1|COMPLETED|Overall Study||30
2457214|NCT01027884|6025419|P2|STARTED|Overall Study||32
2457215|NCT01027884|6025420|P1|STARTED|Overall Study||34
2457216|NCT01027871|6025437|P3|NOT COMPLETED|Overall Study||7
2457217|NCT01027871|6025438|P2|NOT COMPLETED|Overall Study||13
2457218|NCT01027871|6025439|P1|NOT COMPLETED|Overall Study||2
2457219|NCT01027871|6025437|P3|COMPLETED|Overall Study||91
2457220|NCT01027871|6025438|P2|COMPLETED|Overall Study||85
2457221|NCT01027871|6025439|P1|COMPLETED|Overall Study||91
2457222|NCT01027871|6025437|P3|Received at Least One Dose of Study Drug|Overall Study||97
2457223|NCT01027871|6025438|P2|Received at Least One Dose of Study Drug|Overall Study||98
2457224|NCT01027871|6025439|P1|Received at Least One Dose of Study Drug|Overall Study||93
2457225|NCT01027871|6025437|P3|STARTED|Overall Study||98
2457226|NCT01027871|6025438|P2|STARTED|Overall Study||98
2457227|NCT01027871|6025439|P1|STARTED|Overall Study||93
2457228|NCT01027845|6025498|P4|NOT COMPLETED|Booster Vaccination Phase||0
2457229|NCT01027845|6025499|P3|NOT COMPLETED|Booster Vaccination Phase||0
2457230|NCT01027845|6025500|P2|NOT COMPLETED|Booster Vaccination Phase||0
2457231|NCT01027845|6025501|P1|NOT COMPLETED|Booster Vaccination Phase||2
2457232|NCT01027845|6025498|P4|COMPLETED|Booster Vaccination Phase||1
2457233|NCT01027845|6025499|P3|COMPLETED|Booster Vaccination Phase||119
2457234|NCT01027845|6025500|P2|COMPLETED|Booster Vaccination Phase||0
2457235|NCT01027845|6025501|P1|COMPLETED|Booster Vaccination Phase||226
2457236|NCT01027845|6025498|P4|STARTED|Booster Vaccination Phase||1
2457237|NCT01027845|6025499|P3|STARTED|Booster Vaccination Phase||119
2457238|NCT01027845|6025500|P2|STARTED|Booster Vaccination Phase|Subjects from this group were assigned to DTPa+Prevenar&DTPa-No Prevenar Groups in the booster phase|0
2457239|NCT01027845|6025501|P1|STARTED|Booster Vaccination Phase||228
2457240|NCT01027845|6025498|P4|NOT COMPLETED|Primary Vaccination Phase||0
2457241|NCT01027845|6025499|P3|NOT COMPLETED|Primary Vaccination Phase||0
2457242|NCT01027845|6025500|P2|NOT COMPLETED|Primary Vaccination Phase||1
2457243|NCT01027845|6025501|P1|NOT COMPLETED|Primary Vaccination Phase||4
2457244|NCT01027845|6025498|P4|COMPLETED|Primary Vaccination Phase||0
2457245|NCT01027845|6025499|P3|COMPLETED|Primary Vaccination Phase||0
2457246|NCT01027845|6025500|P2|COMPLETED|Primary Vaccination Phase||122
2457247|NCT01027845|6025501|P1|COMPLETED|Primary Vaccination Phase||233
2457248|NCT01027845|6025498|P4|STARTED|Primary Vaccination Phase|Subjects were not yet assigned to this group at the time of the primary vaccination|0
2457249|NCT01027845|6025499|P3|STARTED|Primary Vaccination Phase|Subjects were not yet assigned to this group at the time of the primary vaccination|0
2457250|NCT01027845|6025500|P2|STARTED|Primary Vaccination Phase||123
2457251|NCT01027845|6025501|P1|STARTED|Primary Vaccination Phase||237
2457252|NCT01027819|6025553|P2|NOT COMPLETED|Overall Study||0
2457253|NCT01027819|6025554|P1|NOT COMPLETED|Overall Study||0
2457254|NCT01027819|6025553|P2|COMPLETED|Overall Study||40
2457255|NCT01027819|6025554|P1|COMPLETED|Overall Study||40
2457256|NCT01027819|6025553|P2|STARTED|Overall Study||40
2457257|NCT01027819|6025554|P1|STARTED|Overall Study||40
2457258|NCT01027806|6025562|P2|NOT COMPLETED|Overall Study||3
2457259|NCT01027806|6025563|P1|NOT COMPLETED|Overall Study||4
2457260|NCT01027806|6025562|P2|COMPLETED|Overall Study||29
2457261|NCT01027806|6025563|P1|COMPLETED|Overall Study||28
2457262|NCT01027806|6025562|P2|STARTED|Overall Study||32
2457263|NCT01027806|6025563|P1|STARTED|Overall Study||32
2457264|NCT01027780|6025571|P2|NOT COMPLETED|Overall Study||1
2457265|NCT01027780|6025572|P1|NOT COMPLETED|Overall Study||0
2457266|NCT01027780|6025571|P2|COMPLETED|Overall Study||102
2457267|NCT01027780|6025572|P1|COMPLETED|Overall Study||105
2457268|NCT01027780|6025571|P2|STARTED|Overall Study||103
2457269|NCT01027780|6025572|P1|STARTED|Overall Study||105
2457270|NCT01027754|6025584|P2|NOT COMPLETED|Overall Study||8
2457271|NCT01027754|6025585|P1|NOT COMPLETED|Overall Study||2
2457272|NCT01027754|6025584|P2|COMPLETED|Overall Study||47
2457273|NCT01027754|6025585|P1|COMPLETED|Overall Study||55
2457274|NCT01027754|6025584|P2|STARTED|Overall Study||55
2457275|NCT01027754|6025585|P1|STARTED|Overall Study||57
2457276|NCT01027702|6025619|P7|NOT COMPLETED|Overall Study||1
2457277|NCT01027702|6025620|P6|NOT COMPLETED|Overall Study||0
2457278|NCT01027702|6025621|P5|NOT COMPLETED|Overall Study||1
2457279|NCT01027702|6025622|P4|NOT COMPLETED|Overall Study||4
2457280|NCT01027702|6025623|P3|NOT COMPLETED|Overall Study||1
2457281|NCT01027702|6025624|P2|NOT COMPLETED|Overall Study||2
2457282|NCT01027702|6025625|P1|NOT COMPLETED|Overall Study||1
2457283|NCT01027702|6025619|P7|COMPLETED|Overall Study||1
2457284|NCT01027702|6025620|P6|COMPLETED|Overall Study||1
2457285|NCT01027702|6025621|P5|COMPLETED|Overall Study||9
2457286|NCT01027702|6025622|P4|COMPLETED|Overall Study||10
2457287|NCT01027702|6025623|P3|COMPLETED|Overall Study||2
2457288|NCT01027702|6025624|P2|COMPLETED|Overall Study||2
2457289|NCT01027702|6025625|P1|COMPLETED|Overall Study||3
2457290|NCT01027702|6025619|P7|STARTED|Overall Study||2
2457291|NCT01027702|6025620|P6|STARTED|Overall Study||1
2457292|NCT01027702|6025621|P5|STARTED|Overall Study||10
2457293|NCT01027702|6025622|P4|STARTED|Overall Study||14
2457294|NCT01027702|6025623|P3|STARTED|Overall Study||3
2457295|NCT01027702|6025624|P2|STARTED|Overall Study||4
2457296|NCT01027702|6025625|P1|STARTED|Overall Study||4
2457297|NCT01027650|6025651|P8|NOT COMPLETED|Overall Study||0
2457298|NCT01027650|6025652|P7|NOT COMPLETED|Overall Study||1
2457299|NCT01027650|6025653|P6|NOT COMPLETED|Overall Study||2
2457300|NCT01027650|6025654|P5|NOT COMPLETED|Overall Study||2
2457301|NCT01027650|6025655|P4|NOT COMPLETED|Overall Study||0
2457302|NCT01027650|6025656|P3|NOT COMPLETED|Overall Study||0
2457303|NCT01027650|6025657|P2|NOT COMPLETED|Overall Study||0
2457304|NCT01027650|6025658|P1|NOT COMPLETED|Overall Study||0
2457305|NCT01027650|6025651|P8|COMPLETED|Overall Study||24
2457306|NCT01027650|6025652|P7|COMPLETED|Overall Study||24
2457307|NCT01027650|6025653|P6|COMPLETED|Overall Study||24
2457308|NCT01027650|6025654|P5|COMPLETED|Overall Study||23
2457309|NCT01027650|6025655|P4|COMPLETED|Overall Study||3
2457310|NCT01027650|6025656|P3|COMPLETED|Overall Study||6
2457311|NCT01027650|6025657|P2|COMPLETED|Overall Study||6
2457312|NCT01027650|6025658|P1|COMPLETED|Overall Study||6
2457313|NCT01027650|6025651|P8|STARTED|Overall Study||24
2457314|NCT01027650|6025652|P7|STARTED|Overall Study||25
2457315|NCT01027650|6025653|P6|STARTED|Overall Study||26
2457316|NCT01027650|6025654|P5|STARTED|Overall Study||25
2457317|NCT01027650|6025655|P4|STARTED|Overall Study||3
2457318|NCT01027650|6025656|P3|STARTED|Overall Study||6
2457319|NCT01027650|6025657|P2|STARTED|Overall Study||6
2457320|NCT01027650|6025658|P1|STARTED|Overall Study||6
2457321|NCT01027598|6025702|P2|NOT COMPLETED|Overall Study||67
2457322|NCT01027598|6025703|P1|NOT COMPLETED|Overall Study||134
2457323|NCT01027598|6025702|P2|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
2457324|NCT01027598|6025703|P1|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
2457325|NCT01027598|6025702|P2|STARTED|Overall Study||67
2457326|NCT01027598|6025703|P1|STARTED|Overall Study|One patient was enrolled but not treated|134
2457327|NCT01027559|6025716|P3|NOT COMPLETED|Overall Study||9
2457328|NCT01027559|6025717|P2|NOT COMPLETED|Overall Study||8
2457329|NCT01027559|6025718|P1|NOT COMPLETED|Overall Study||6
2457330|NCT01027559|6025716|P3|COMPLETED|Overall Study||22
2457331|NCT01027559|6025717|P2|COMPLETED|Overall Study||26
2457332|NCT01027559|6025718|P1|COMPLETED|Overall Study||20
2457333|NCT01027559|6025716|P3|STARTED|Overall Study||31
2457334|NCT01027559|6025717|P2|STARTED|Overall Study||34
2457335|NCT01027559|6025718|P1|STARTED|Overall Study||26
2457336|NCT01027468|6025728|P1|NOT COMPLETED|Overall Study||0
2457337|NCT01027468|6025728|P1|COMPLETED|Overall Study||160
2457338|NCT01027468|6025728|P1|STARTED|Overall Study||160
2457339|NCT01027416|6025736|P2|NOT COMPLETED|Overall Study||5
2457340|NCT01027416|6025737|P1|NOT COMPLETED|Overall Study||1
2457341|NCT01027416|6025736|P2|COMPLETED|Overall Study||23
2457342|NCT01027416|6025737|P1|COMPLETED|Overall Study||30
2457343|NCT01027416|6025736|P2|STARTED|Overall Study||28
2457344|NCT01027416|6025737|P1|STARTED|Overall Study||31
2457345|NCT01027364|6025749|P4|NOT COMPLETED|Overall Study||1
2457346|NCT01027364|6025750|P3|NOT COMPLETED|Overall Study||1
2457347|NCT01027364|6025751|P2|NOT COMPLETED|Overall Study||2
2457348|NCT01027364|6025752|P1|NOT COMPLETED|Overall Study||4
2457349|NCT01027364|6025749|P4|COMPLETED|Overall Study|11 participants total completed Arm 4 (3: compl. Arm 4 only; 7: cont. to Arm 1; 1: cont. to Arm 3)|3
2457350|NCT01027364|6025750|P3|COMPLETED|Overall Study||26
2457351|NCT01027364|6025751|P2|COMPLETED|Overall Study||27
2457352|NCT01027364|6025752|P1|COMPLETED|Overall Study||59
2457353|NCT01027364|6025749|P4|Started Arm 4 Then Joined Another Arm|Overall Study||0
2457354|NCT01027364|6025750|P3|Started Arm 4 Then Joined Another Arm|Overall Study||0
2457355|NCT01027364|6025751|P2|Started Arm 4 Then Joined Another Arm|Overall Study||0
2457356|NCT01027364|6025752|P1|Started Arm 4 Then Joined Another Arm|Overall Study||2
2457357|NCT01027364|6025749|P4|Joined Arm 4 for Surgery Then Returned|Overall Study||0
2457358|NCT01027364|6025750|P3|Joined Arm 4 for Surgery Then Returned|Overall Study||1
2457359|NCT01027364|6025751|P2|Joined Arm 4 for Surgery Then Returned|Overall Study||0
2457360|NCT01027364|6025752|P1|Joined Arm 4 for Surgery Then Returned|Overall Study||5
2457361|NCT01027364|6025749|P4|Enrolled in Sequential PK Subgroup|Overall Study||0
2457362|NCT01027364|6025750|P3|Enrolled in Sequential PK Subgroup|Overall Study||0
2457363|NCT01027364|6025751|P2|Enrolled in Sequential PK Subgroup|Overall Study||0
2457364|NCT01027364|6025752|P1|Enrolled in Sequential PK Subgroup|Overall Study||22
2457365|NCT01027364|6025749|P4|STARTED|Overall Study|12 total participants in Arm 4 (6 started in Arm 4; 5 joined from Arm 1; 1 joined from Arm 3)|4
2457366|NCT01027364|6025750|P3|STARTED|Overall Study||27
2457367|NCT01027364|6025751|P2|STARTED|Overall Study||29
2457368|NCT01027364|6025752|P1|STARTED|Overall Study||63
2457369|NCT01027351|6025847|P6|NOT COMPLETED|Overall Study||5
2457370|NCT01027351|6025848|P5|NOT COMPLETED|Overall Study||11
2457371|NCT01027351|6025849|P4|NOT COMPLETED|Overall Study||2
2457372|NCT01027351|6025850|P3|NOT COMPLETED|Overall Study||1
2457373|NCT01027351|6025851|P2|NOT COMPLETED|Overall Study||1
2457374|NCT01027351|6025852|P1|NOT COMPLETED|Overall Study||3
2457375|NCT01027351|6025847|P6|COMPLETED|Overall Study||45
2457376|NCT01027351|6025848|P5|COMPLETED|Overall Study||32
2457377|NCT01027351|6025849|P4|COMPLETED|Overall Study||6
2457378|NCT01027351|6025850|P3|COMPLETED|Overall Study||13
2457379|NCT01027351|6025851|P2|COMPLETED|Overall Study||18
2457380|NCT01027351|6025852|P1|COMPLETED|Overall Study||26
2457381|NCT01027351|6025847|P6|STARTED|Overall Study||50
2457382|NCT01027351|6025848|P5|STARTED|Overall Study||43
2457383|NCT01027351|6025849|P4|STARTED|Overall Study||8
2457384|NCT01027351|6025850|P3|STARTED|Overall Study||14
2457385|NCT01027351|6025851|P2|STARTED|Overall Study||19
2457386|NCT01027351|6025852|P1|STARTED|Overall Study||29
2457387|NCT01027286|6025936|P2|NOT COMPLETED|Overall Study||1
2457388|NCT01027286|6025937|P1|NOT COMPLETED|Overall Study||1
2457389|NCT01027286|6025936|P2|COMPLETED|Overall Study||49
2457390|NCT01027286|6025937|P1|COMPLETED|Overall Study||49
2457391|NCT01027286|6025936|P2|12 Week Postoperative|Overall Study||49
2457392|NCT01027286|6025937|P1|12 Week Postoperative|Overall Study||49
2457393|NCT01027286|6025936|P2|4 Week Postoperative|Overall Study||50
2457394|NCT01027286|6025937|P1|4 Week Postoperative|Overall Study||49
2457395|NCT01027286|6025936|P2|Day of Surgery|Overall Study||50
2457396|NCT01027286|6025937|P1|Day of Surgery|Overall Study||50
2457397|NCT01027286|6025936|P2|Preoperative|Overall Study||50
2457398|NCT01027286|6025937|P1|Preoperative|Overall Study||50
2457399|NCT01027286|6025936|P2|STARTED|Overall Study||50
2457400|NCT01027286|6025937|P1|STARTED|Overall Study||50
2457401|NCT01027273|6025957|P2|NOT COMPLETED|Overall Study||33
2457402|NCT01027273|6025958|P1|NOT COMPLETED|Overall Study||59
2457403|NCT01027273|6025957|P2|COMPLETED|Overall Study||266
2457404|NCT01027273|6025958|P1|COMPLETED|Overall Study||242
2457405|NCT01027273|6025957|P2|STARTED|Overall Study||299
2457406|NCT01027273|6025958|P1|STARTED|Overall Study||301
2457407|NCT01027195|6025976|P2|NOT COMPLETED|Overall Study||0
2457408|NCT01027195|6025977|P1|NOT COMPLETED|Overall Study||0
2457409|NCT01027195|6025976|P2|COMPLETED|Overall Study||69
2457410|NCT01027195|6025977|P1|COMPLETED|Overall Study||71
2457411|NCT01027195|6025976|P2|STARTED|Overall Study||69
2457412|NCT01027195|6025977|P1|STARTED|Overall Study||71
2457413|NCT01027000|6025997|P1|NOT COMPLETED|Overall Study||0
2457414|NCT01027000|6025997|P1|COMPLETED|Overall Study||68
2457415|NCT01027000|6025997|P1|STARTED|Overall Study||68
2457416|NCT01026974|6026005|P4|NOT COMPLETED|Overall Study||3
2457417|NCT01026974|6026006|P3|NOT COMPLETED|Overall Study||12
2457418|NCT01026974|6026007|P2|NOT COMPLETED|Overall Study||2
2457419|NCT01026974|6026008|P1|NOT COMPLETED|Overall Study||1
2457420|NCT01026974|6026005|P4|COMPLETED|Overall Study||46
2457421|NCT01026974|6026006|P3|COMPLETED|Overall Study||29
2457422|NCT01026974|6026007|P2|COMPLETED|Overall Study||12
2457423|NCT01026974|6026008|P1|COMPLETED|Overall Study||15
2457424|NCT01026974|6026005|P4|STARTED|Overall Study||49
2457425|NCT01026974|6026006|P3|STARTED|Overall Study||41
2457426|NCT01026974|6026007|P2|STARTED|Overall Study||14
2457427|NCT01026974|6026008|P1|STARTED|Overall Study||16
2457428|NCT01026948|6026065|P1|NOT COMPLETED|Overall Study||8
2457429|NCT01026948|6026065|P1|COMPLETED|Overall Study|8 Women were recalled because of signal loss|62
2457430|NCT01026948|6026065|P1|STARTED|Overall Study||70
2457431|NCT01026909|6026072|P2|NOT COMPLETED|Overall Study||0
2457432|NCT01026909|6026073|P1|NOT COMPLETED|Overall Study||0
2457433|NCT01026909|6026072|P2|COMPLETED|Overall Study||2
2457434|NCT01026909|6026073|P1|COMPLETED|Overall Study||1
2457435|NCT01026909|6026072|P2|STARTED|Overall Study||2
2457436|NCT01026909|6026073|P1|STARTED|Overall Study||1
2457437|NCT01026844|6026083|P2|NOT COMPLETED|Overall Study||0
2457438|NCT01026844|6026084|P1|NOT COMPLETED|Overall Study||0
2457439|NCT01026844|6026083|P2|COMPLETED|Overall Study||8
2457440|NCT01026844|6026084|P1|COMPLETED|Overall Study||19
2457441|NCT01026844|6026083|P2|STARTED|Overall Study||8
2457442|NCT01026844|6026084|P1|STARTED|Overall Study||19
2457443|NCT01026831|6026098|P2|NOT COMPLETED|Overall Study||11
2457444|NCT01026831|6026099|P1|NOT COMPLETED|Overall Study||14
2457445|NCT01026831|6026098|P2|COMPLETED|Overall Study||312
2457446|NCT01026831|6026099|P1|COMPLETED|Overall Study||306
2457447|NCT01026831|6026098|P2|STARTED|Overall Study|randomized|323
2457448|NCT01026831|6026099|P1|STARTED|Overall Study|randomized|320
2457449|NCT01026818|6026110|P4|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||3
2457450|NCT01026818|6026111|P3|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||5
2457451|NCT01026818|6026112|P2|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||7
2457452|NCT01026818|6026113|P1|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||0
2457453|NCT01026818|6026110|P4|COMPLETED|OL Period (Month 10.5 - 13.5)||105
2457454|NCT01026818|6026111|P3|COMPLETED|OL Period (Month 10.5 - 13.5)||112
2457455|NCT01026818|6026112|P2|COMPLETED|OL Period (Month 10.5 - 13.5)||98
2457456|NCT01026818|6026113|P1|COMPLETED|OL Period (Month 10.5 - 13.5)||0
2457457|NCT01026818|6026110|P4|STARTED|OL Period (Month 10.5 - 13.5)||108
2457458|NCT01026818|6026111|P3|STARTED|OL Period (Month 10.5 - 13.5)||117
2457459|NCT01026818|6026112|P2|STARTED|OL Period (Month 10.5 - 13.5)||105
2457460|NCT01026818|6026113|P1|STARTED|OL Period (Month 10.5 - 13.5)||0
2457461|NCT01026818|6026110|P4|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||7
2457462|NCT01026818|6026111|P3|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||5
2457463|NCT01026818|6026112|P2|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||9
2457464|NCT01026818|6026113|P1|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
2457465|NCT01026818|6026110|P4|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||108
2457466|NCT01026818|6026111|P3|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||117
2457467|NCT01026818|6026112|P2|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||105
2457468|NCT01026818|6026113|P1|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
2457469|NCT01026818|6026110|P4|STARTED|Drug-Free Washout Period (Month 9-10.5)||115
2457470|NCT01026818|6026111|P3|STARTED|Drug-Free Washout Period (Month 9-10.5)||122
2457471|NCT01026818|6026112|P2|STARTED|Drug-Free Washout Period (Month 9-10.5)||114
2457472|NCT01026818|6026113|P1|STARTED|Drug-Free Washout Period (Month 9-10.5)||0
2457473|NCT01026818|6026110|P4|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||26
2457474|NCT01026818|6026111|P3|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||21
2457475|NCT01026818|6026112|P2|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||25
2457476|NCT01026818|6026113|P1|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||0
2457477|NCT01026818|6026110|P4|COMPLETED|DB Treatment Period (Month 0 - 9)||115
2457478|NCT01026818|6026111|P3|COMPLETED|DB Treatment Period (Month 0 - 9)||122
2457479|NCT01026818|6026112|P2|COMPLETED|DB Treatment Period (Month 0 - 9)||114
2457480|NCT01026818|6026113|P1|COMPLETED|DB Treatment Period (Month 0 - 9)||0
2457481|NCT01026818|6026110|P4|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||141
2457482|NCT01026818|6026111|P3|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||143
2457483|NCT01026818|6026112|P2|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||139
2457484|NCT01026818|6026113|P1|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||0
2457485|NCT01026818|6026110|P4|STARTED|DB Treatment Period (Month 0 - 9)||141
2457486|NCT01026818|6026111|P3|STARTED|DB Treatment Period (Month 0 - 9)||143
2457487|NCT01026818|6026112|P2|STARTED|DB Treatment Period (Month 0 - 9)||139
2457488|NCT01026818|6026113|P1|STARTED|DB Treatment Period (Month 0 - 9)||0
2457489|NCT01026818|6026110|P4|NOT COMPLETED|Screening Period||0
2457490|NCT01026818|6026111|P3|NOT COMPLETED|Screening Period||0
2457491|NCT01026818|6026112|P2|NOT COMPLETED|Screening Period||0
2457492|NCT01026818|6026113|P1|NOT COMPLETED|Screening Period||160
2457493|NCT01026818|6026110|P4|COMPLETED|Screening Period||0
2457494|NCT01026818|6026111|P3|COMPLETED|Screening Period||0
2457495|NCT01026818|6026112|P2|COMPLETED|Screening Period||0
2457496|NCT01026818|6026113|P1|COMPLETED|Screening Period||423
2457497|NCT01026818|6026110|P4|STARTED|Screening Period||0
2457498|NCT01026818|6026111|P3|STARTED|Screening Period||0
2457499|NCT01026818|6026112|P2|STARTED|Screening Period||0
2457500|NCT01026818|6026113|P1|STARTED|Screening Period||583
2457501|NCT01026805|6026191|P1|NOT COMPLETED|Overall Study||0
2457502|NCT01026805|6026191|P1|COMPLETED|Overall Study||11
2457503|NCT01026805|6026191|P1|STARTED|Overall Study||11
2457504|NCT01026792|6026201|P1|NOT COMPLETED|Overall Study||1
2457505|NCT01026792|6026201|P1|COMPLETED|Overall Study||37
2457506|NCT01026792|6026201|P1|STARTED|Overall Study||38
2457507|NCT01026623|6026208|P3|NOT COMPLETED|Overall Study||0
2457508|NCT01026623|6026209|P2|NOT COMPLETED|Overall Study||0
2457509|NCT01026623|6026210|P1|NOT COMPLETED|Overall Study||0
2457510|NCT01026623|6026208|P3|COMPLETED|Overall Study||5
2457511|NCT01026623|6026209|P2|COMPLETED|Overall Study||5
2457512|NCT01026623|6026210|P1|COMPLETED|Overall Study||6
2457513|NCT01026623|6026208|P3|STARTED|Overall Study||5
2457514|NCT01026623|6026209|P2|STARTED|Overall Study||5
2457515|NCT01026623|6026210|P1|STARTED|Overall Study||6
2457516|NCT01026493|6026244|P8|NOT COMPLETED|Overall Study||1
2457517|NCT01026493|6026245|P7|NOT COMPLETED|Overall Study||4
2457518|NCT01026493|6026246|P6|NOT COMPLETED|Overall Study||3
2457519|NCT01026493|6026247|P5|NOT COMPLETED|Overall Study||2
2457520|NCT01026493|6026248|P4|NOT COMPLETED|Overall Study||0
2457521|NCT01026493|6026249|P3|NOT COMPLETED|Overall Study||0
2457522|NCT01026493|6026250|P2|NOT COMPLETED|Overall Study||1
2457523|NCT01026493|6026251|P1|NOT COMPLETED|Overall Study||0
2457524|NCT01026493|6026244|P8|COMPLETED|Overall Study||37
2457525|NCT01026493|6026245|P7|COMPLETED|Overall Study||32
2457526|NCT01026493|6026246|P6|COMPLETED|Overall Study||73
2457527|NCT01026493|6026247|P5|COMPLETED|Overall Study||73
2457528|NCT01026493|6026248|P4|COMPLETED|Overall Study||8
2457529|NCT01026493|6026249|P3|COMPLETED|Overall Study||9
2457530|NCT01026493|6026250|P2|COMPLETED|Overall Study||6
2457531|NCT01026493|6026251|P1|COMPLETED|Overall Study||8
2457532|NCT01026493|6026244|P8|STARTED|Overall Study||38
2457533|NCT01026493|6026245|P7|STARTED|Overall Study||36
2457534|NCT01026493|6026246|P6|STARTED|Overall Study||76
2457535|NCT01026493|6026247|P5|STARTED|Overall Study||75
2457536|NCT01026493|6026248|P4|STARTED|Overall Study||8
2457537|NCT01026493|6026249|P3|STARTED|Overall Study||9
2457538|NCT01026493|6026250|P2|STARTED|Overall Study||7
2457539|NCT01026493|6026251|P1|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|8
2457540|NCT01026454|6026279|P2|NOT COMPLETED|Second Intervention||1
2457541|NCT01026454|6026280|P1|NOT COMPLETED|Second Intervention||1
2457542|NCT01026454|6026279|P2|COMPLETED|Second Intervention||13
2457543|NCT01026454|6026280|P1|COMPLETED|Second Intervention||16
2457544|NCT01026454|6026279|P2|STARTED|Second Intervention||14
2457545|NCT01026454|6026280|P1|STARTED|Second Intervention||17
2457546|NCT01026454|6026279|P2|NOT COMPLETED|Washout||0
2457547|NCT01026454|6026280|P1|NOT COMPLETED|Washout||0
2457548|NCT01026454|6026279|P2|COMPLETED|Washout||14
2457549|NCT01026454|6026280|P1|COMPLETED|Washout||18
2457550|NCT01026454|6026279|P2|STARTED|Washout||14
2457551|NCT01026454|6026280|P1|STARTED|Washout||18
2457552|NCT01026454|6026279|P2|NOT COMPLETED|First Intervention||0
2457553|NCT01026454|6026280|P1|NOT COMPLETED|First Intervention||0
2457554|NCT01026454|6026279|P2|COMPLETED|First Intervention||14
2457555|NCT01026454|6026280|P1|COMPLETED|First Intervention||18
2457556|NCT01026454|6026279|P2|STARTED|First Intervention||14
2457557|NCT01026454|6026280|P1|STARTED|First Intervention||18
2457558|NCT01026402|6026303|P17|NOT COMPLETED|Overall Study||0
2457559|NCT01026402|6026304|P16|NOT COMPLETED|Overall Study||0
2457560|NCT01026402|6026305|P15|NOT COMPLETED|Overall Study||0
2457561|NCT01026402|6026306|P14|NOT COMPLETED|Overall Study||0
2457562|NCT01026402|6026307|P13|NOT COMPLETED|Overall Study||0
2457563|NCT01026402|6026308|P12|NOT COMPLETED|Overall Study||0
2457564|NCT01026402|6026309|P11|NOT COMPLETED|Overall Study||0
2457565|NCT01026402|6026310|P10|NOT COMPLETED|Overall Study||0
2457566|NCT01026402|6026311|P9|NOT COMPLETED|Overall Study||0
2457567|NCT01026402|6026312|P8|NOT COMPLETED|Overall Study||0
2457568|NCT01026402|6026313|P7|NOT COMPLETED|Overall Study||0
2457569|NCT01026402|6026314|P6|NOT COMPLETED|Overall Study||0
2457570|NCT01026402|6026315|P5|NOT COMPLETED|Overall Study||0
2457571|NCT01026402|6026316|P4|NOT COMPLETED|Overall Study||0
2457572|NCT01026402|6026317|P3|NOT COMPLETED|Overall Study||0
2457573|NCT01026402|6026318|P2|NOT COMPLETED|Overall Study||0
2457574|NCT01026402|6026319|P1|NOT COMPLETED|Overall Study||0
2457575|NCT01026402|6026303|P17|COMPLETED|Overall Study||4
2457576|NCT01026402|6026304|P16|COMPLETED|Overall Study||5
2457577|NCT01026402|6026305|P15|COMPLETED|Overall Study||3
2457578|NCT01026402|6026306|P14|COMPLETED|Overall Study||6
2457579|NCT01026402|6026307|P13|COMPLETED|Overall Study||8
2457580|NCT01026402|6026308|P12|COMPLETED|Overall Study||8
2457581|NCT01026402|6026309|P11|COMPLETED|Overall Study||7
2457582|NCT01026402|6026310|P10|COMPLETED|Overall Study||3
2457583|NCT01026402|6026311|P9|COMPLETED|Overall Study||7
2457584|NCT01026402|6026312|P8|COMPLETED|Overall Study||3
2457585|NCT01026402|6026313|P7|COMPLETED|Overall Study||8
2457586|NCT01026402|6026314|P6|COMPLETED|Overall Study||5
2457587|NCT01026402|6026315|P5|COMPLETED|Overall Study||3
2457588|NCT01026402|6026316|P4|COMPLETED|Overall Study||18
2457589|NCT01026402|6026317|P3|COMPLETED|Overall Study||33
2457590|NCT01026402|6026318|P2|COMPLETED|Overall Study||8
2457591|NCT01026402|6026319|P1|COMPLETED|Overall Study||6
2457592|NCT01026402|6026303|P17|STARTED|Overall Study||4
2457593|NCT01026402|6026304|P16|STARTED|Overall Study||5
2457594|NCT01026402|6026305|P15|STARTED|Overall Study||3
2457595|NCT01026402|6026306|P14|STARTED|Overall Study||6
2457596|NCT01026402|6026307|P13|STARTED|Overall Study||8
2457597|NCT01026402|6026308|P12|STARTED|Overall Study||8
2457598|NCT01026402|6026309|P11|STARTED|Overall Study||7
2457599|NCT01026402|6026310|P10|STARTED|Overall Study||3
2457600|NCT01026402|6026311|P9|STARTED|Overall Study||7
2457601|NCT01026402|6026312|P8|STARTED|Overall Study||3
2457602|NCT01026402|6026313|P7|STARTED|Overall Study||8
2457603|NCT01026402|6026314|P6|STARTED|Overall Study||5
2457604|NCT01026402|6026315|P5|STARTED|Overall Study||3
2457605|NCT01026402|6026316|P4|STARTED|Overall Study||18
2457606|NCT01026402|6026317|P3|STARTED|Overall Study||33
2457607|NCT01026402|6026318|P2|STARTED|Overall Study||8
2457608|NCT01026402|6026319|P1|STARTED|Overall Study||6
2457609|NCT01026389|6026629|P2|NOT COMPLETED|Overall Study||5
2457610|NCT01026389|6026630|P1|NOT COMPLETED|Overall Study||5
2457611|NCT01026389|6026629|P2|COMPLETED|Overall Study||88
2457612|NCT01026389|6026630|P1|COMPLETED|Overall Study||88
2457613|NCT01026389|6026629|P2|STARTED|Overall Study||93
2457614|NCT01026389|6026630|P1|STARTED|Overall Study||93
2457615|NCT01026324|6026645|P3|NOT COMPLETED|Follow up/Survival||0
2457616|NCT01026324|6026646|P2|NOT COMPLETED|Follow up/Survival||0
2457617|NCT01026324|6026647|P1|NOT COMPLETED|Follow up/Survival||1
2457618|NCT01026324|6026645|P3|COMPLETED|Follow up/Survival||4
2457619|NCT01026324|6026646|P2|COMPLETED|Follow up/Survival||3
2457620|NCT01026324|6026647|P1|COMPLETED|Follow up/Survival||4
2457621|NCT01026324|6026645|P3|Follow up Discontinuation (Death)|Follow up/Survival||4
2457622|NCT01026324|6026646|P2|Follow up Discontinuation (Death)|Follow up/Survival||3
2457623|NCT01026324|6026647|P1|Follow up Discontinuation (Death)|Follow up/Survival||4
2457624|NCT01026324|6026645|P3|STARTED|Follow up/Survival||4
2457625|NCT01026324|6026646|P2|STARTED|Follow up/Survival||3
2457626|NCT01026324|6026647|P1|STARTED|Follow up/Survival||5
2457627|NCT01026324|6026645|P3|NOT COMPLETED|Treatment Allocation||0
2457628|NCT01026324|6026646|P2|NOT COMPLETED|Treatment Allocation||0
2457629|NCT01026324|6026647|P1|NOT COMPLETED|Treatment Allocation||0
2457630|NCT01026324|6026645|P3|COMPLETED|Treatment Allocation||4
2457631|NCT01026324|6026646|P2|COMPLETED|Treatment Allocation||3
2457632|NCT01026324|6026647|P1|COMPLETED|Treatment Allocation||5
2457633|NCT01026324|6026645|P3|Discontinued Intervention (Withdrew)|Treatment Allocation||0
2457634|NCT01026324|6026646|P2|Discontinued Intervention (Withdrew)|Treatment Allocation||0
2457635|NCT01026324|6026647|P1|Discontinued Intervention (Withdrew)|Treatment Allocation||1
2457636|NCT01026324|6026645|P3|Discontinuted Intervention (Progression)|Treatment Allocation||4
2457637|NCT01026324|6026646|P2|Discontinuted Intervention (Progression)|Treatment Allocation||3
2457638|NCT01026324|6026647|P1|Discontinuted Intervention (Progression)|Treatment Allocation||3
2457639|NCT01026324|6026645|P3|Discontinued Intervention (Toxicity)|Treatment Allocation||0
2457640|NCT01026324|6026646|P2|Discontinued Intervention (Toxicity)|Treatment Allocation||0
2457641|NCT01026324|6026647|P1|Discontinued Intervention (Toxicity)|Treatment Allocation||1
2457642|NCT01026324|6026645|P3|STARTED|Treatment Allocation||4
2457643|NCT01026324|6026646|P2|STARTED|Treatment Allocation||3
2457644|NCT01026324|6026647|P1|STARTED|Treatment Allocation||5
2457645|NCT01026220|6026657|P3|NOT COMPLETED|Consolidation Maintenance||14
2457646|NCT01026220|6026658|P2|NOT COMPLETED|Consolidation Maintenance||6
2457647|NCT01026220|6026659|P1|NOT COMPLETED|Consolidation Maintenance||0
2457648|NCT01026220|6026657|P3|COMPLETED|Consolidation Maintenance||66
2457649|NCT01026220|6026658|P2|COMPLETED|Consolidation Maintenance||75
2457650|NCT01026220|6026659|P1|COMPLETED|Consolidation Maintenance||0
2457651|NCT01026220|6026657|P3|STARTED|Consolidation Maintenance||80
2457652|NCT01026220|6026658|P2|STARTED|Consolidation Maintenance||81
2457653|NCT01026220|6026659|P1|STARTED|Consolidation Maintenance||0
2457654|NCT01026220|6026657|P3|NOT COMPLETED|Induction||0
2457655|NCT01026220|6026658|P2|NOT COMPLETED|Induction||0
2457656|NCT01026220|6026659|P1|NOT COMPLETED|Induction||25
2457657|NCT01026220|6026657|P3|COMPLETED|Induction||0
2457658|NCT01026220|6026658|P2|COMPLETED|Induction||0
2457659|NCT01026220|6026659|P1|COMPLETED|Induction||141
2457660|NCT01026220|6026657|P3|STARTED|Induction||0
2457661|NCT01026220|6026658|P2|STARTED|Induction||0
2457662|NCT01026220|6026659|P1|STARTED|Induction||166
2457663|NCT01026194|6026683|P2|NOT COMPLETED|Period 2：Open-label Period||10
2457664|NCT01026194|6026684|P1|NOT COMPLETED|Period 2：Open-label Period||7
2457665|NCT01026194|6026683|P2|COMPLETED|Period 2：Open-label Period||88
2457666|NCT01026194|6026684|P1|COMPLETED|Period 2：Open-label Period||91
2457667|NCT01026194|6026683|P2|STARTED|Period 2：Open-label Period||98
2457668|NCT01026194|6026684|P1|STARTED|Period 2：Open-label Period||98
2457669|NCT01026194|6026683|P2|NOT COMPLETED|Period 1：Double Blind Period||5
2457670|NCT01026194|6026684|P1|NOT COMPLETED|Period 1：Double Blind Period||3
2457671|NCT01026194|6026683|P2|COMPLETED|Period 1：Double Blind Period||98
2457672|NCT01026194|6026684|P1|COMPLETED|Period 1：Double Blind Period||98
2457673|NCT01026194|6026683|P2|STARTED|Period 1：Double Blind Period||103
2457674|NCT01026194|6026684|P1|STARTED|Period 1：Double Blind Period||101
2457675|NCT01026181|6026701|P3|NOT COMPLETED|Overall Study||0
2457676|NCT01026181|6026702|P2|NOT COMPLETED|Overall Study||0
2457677|NCT01026181|6026703|P1|NOT COMPLETED|Overall Study||0
2457678|NCT01026181|6026701|P3|COMPLETED|Overall Study||48
2457679|NCT01026181|6026702|P2|COMPLETED|Overall Study||51
2457680|NCT01026181|6026703|P1|COMPLETED|Overall Study||51
2457681|NCT01026181|6026701|P3|STARTED|Overall Study||48
2457682|NCT01026181|6026702|P2|STARTED|Overall Study||51
2457683|NCT01026181|6026703|P1|STARTED|Overall Study||51
2457684|NCT01026142|6026716|P2|NOT COMPLETED|Overall Study||163
2457685|NCT01026142|6026717|P1|NOT COMPLETED|Overall Study||172
2457686|NCT01026142|6026716|P2|COMPLETED|Overall Study||65
2457687|NCT01026142|6026717|P1|COMPLETED|Overall Study||52
2457688|NCT01026142|6026716|P2|STARTED|Overall Study||228
2457689|NCT01026142|6026717|P1|STARTED|Overall Study||224
2457690|NCT01026103|6026739|P1|NOT COMPLETED|Overall Study||2
2457691|NCT01026103|6026739|P1|COMPLETED|Overall Study||28
2457692|NCT01026103|6026739|P1|Consented|Overall Study||30
2457693|NCT01026103|6026739|P1|STARTED|Overall Study||30
2457694|NCT01026038|6026749|P3|NOT COMPLETED|Overall Study||0
2457695|NCT01026038|6026750|P2|NOT COMPLETED|Overall Study||1
2457696|NCT01026038|6026751|P1|NOT COMPLETED|Overall Study||1
2457697|NCT01026038|6026749|P3|COMPLETED|Overall Study||67
2457698|NCT01026038|6026750|P2|COMPLETED|Overall Study||64
2457699|NCT01026038|6026751|P1|COMPLETED|Overall Study||129
2457700|NCT01026038|6026749|P3|STARTED|Overall Study||67
2457701|NCT01026038|6026750|P2|STARTED|Overall Study||65
2457702|NCT01026038|6026751|P1|STARTED|Overall Study||130
2457703|NCT01026012|6026786|P1|NOT COMPLETED|Overall Study||0
2457704|NCT01026012|6026786|P1|COMPLETED|Overall Study||40
2457705|NCT01026012|6026786|P1|STARTED|Overall Study||40
2457706|NCT01025843|6026800|P10|NOT COMPLETED|Period 5||0
2457707|NCT01025843|6026801|P9|NOT COMPLETED|Period 5||0
2457708|NCT01025843|6026802|P8|NOT COMPLETED|Period 5||0
2457709|NCT01025843|6026803|P7|NOT COMPLETED|Period 5||0
2457710|NCT01025843|6026804|P6|NOT COMPLETED|Period 5||0
2457711|NCT01025843|6026805|P5|NOT COMPLETED|Period 5||0
2457712|NCT01025843|6026806|P4|NOT COMPLETED|Period 5||0
2457713|NCT01025843|6026807|P3|NOT COMPLETED|Period 5||0
2457714|NCT01025843|6026808|P2|NOT COMPLETED|Period 5||0
2457715|NCT01025843|6026809|P1|NOT COMPLETED|Period 5||0
2457716|NCT01025843|6026800|P10|COMPLETED|Period 5||2
2457717|NCT01025843|6026801|P9|COMPLETED|Period 5||2
2457718|NCT01025843|6026802|P8|COMPLETED|Period 5||2
2457719|NCT01025843|6026803|P7|COMPLETED|Period 5||2
2457720|NCT01025843|6026804|P6|COMPLETED|Period 5||2
2457721|NCT01025843|6026805|P5|COMPLETED|Period 5||2
2457722|NCT01025843|6026806|P4|COMPLETED|Period 5||1
2457723|NCT01025843|6026807|P3|COMPLETED|Period 5||1
2457724|NCT01025843|6026808|P2|COMPLETED|Period 5||2
2457725|NCT01025843|6026809|P1|COMPLETED|Period 5||2
2457726|NCT01025843|6026800|P10|STARTED|Period 5||2
2457727|NCT01025843|6026801|P9|STARTED|Period 5||2
2457728|NCT01025843|6026802|P8|STARTED|Period 5||2
2457729|NCT01025843|6026803|P7|STARTED|Period 5||2
2457730|NCT01025843|6026804|P6|STARTED|Period 5||2
2457731|NCT01025843|6026805|P5|STARTED|Period 5||2
2457732|NCT01025843|6026806|P4|STARTED|Period 5||1
2457733|NCT01025843|6026807|P3|STARTED|Period 5||1
2457734|NCT01025843|6026808|P2|STARTED|Period 5||2
2457735|NCT01025843|6026809|P1|STARTED|Period 5||2
2457736|NCT01025843|6026800|P10|NOT COMPLETED|Washout 4||0
2457737|NCT01025843|6026801|P9|NOT COMPLETED|Washout 4||0
2457738|NCT01025843|6026802|P8|NOT COMPLETED|Washout 4||0
2457739|NCT01025843|6026803|P7|NOT COMPLETED|Washout 4||0
2457740|NCT01025843|6026804|P6|NOT COMPLETED|Washout 4||0
2457741|NCT01025843|6026805|P5|NOT COMPLETED|Washout 4||0
2457742|NCT01025843|6026806|P4|NOT COMPLETED|Washout 4||1
2457743|NCT01025843|6026807|P3|NOT COMPLETED|Washout 4||1
2457744|NCT01025843|6026808|P2|NOT COMPLETED|Washout 4||0
2457745|NCT01025843|6026809|P1|NOT COMPLETED|Washout 4||0
2457746|NCT01025843|6026800|P10|COMPLETED|Washout 4||2
2457747|NCT01025843|6026801|P9|COMPLETED|Washout 4||2
2457748|NCT01025843|6026802|P8|COMPLETED|Washout 4||2
2457749|NCT01025843|6026803|P7|COMPLETED|Washout 4||2
2457750|NCT01025843|6026804|P6|COMPLETED|Washout 4||2
2457751|NCT01025843|6026805|P5|COMPLETED|Washout 4||2
2457752|NCT01025843|6026806|P4|COMPLETED|Washout 4||1
2457753|NCT01025843|6026807|P3|COMPLETED|Washout 4||1
2457754|NCT01025843|6026808|P2|COMPLETED|Washout 4||2
2457755|NCT01025843|6026809|P1|COMPLETED|Washout 4||2
2457756|NCT01025843|6026800|P10|STARTED|Washout 4||2
2457757|NCT01025843|6026801|P9|STARTED|Washout 4||2
2457758|NCT01025843|6026802|P8|STARTED|Washout 4||2
2457759|NCT01025843|6026803|P7|STARTED|Washout 4||2
2457760|NCT01025843|6026804|P6|STARTED|Washout 4||2
2457761|NCT01025843|6026805|P5|STARTED|Washout 4||2
2457762|NCT01025843|6026806|P4|STARTED|Washout 4||2
2457763|NCT01025843|6026807|P3|STARTED|Washout 4||2
2457764|NCT01025843|6026808|P2|STARTED|Washout 4||2
2457765|NCT01025843|6026809|P1|STARTED|Washout 4||2
2457766|NCT01025843|6026800|P10|NOT COMPLETED|Period 4||0
2457767|NCT01025843|6026801|P9|NOT COMPLETED|Period 4||0
2457768|NCT01025843|6026802|P8|NOT COMPLETED|Period 4||0
2457769|NCT01025843|6026803|P7|NOT COMPLETED|Period 4||0
2457770|NCT01025843|6026804|P6|NOT COMPLETED|Period 4||0
2457771|NCT01025843|6026805|P5|NOT COMPLETED|Period 4||0
2457772|NCT01025843|6026806|P4|NOT COMPLETED|Period 4||0
2457773|NCT01025843|6026807|P3|NOT COMPLETED|Period 4||0
2457774|NCT01025843|6026808|P2|NOT COMPLETED|Period 4||0
2457775|NCT01025843|6026809|P1|NOT COMPLETED|Period 4||0
2457776|NCT01025843|6026800|P10|COMPLETED|Period 4||2
2457777|NCT01025843|6026801|P9|COMPLETED|Period 4||2
2457778|NCT01025843|6026802|P8|COMPLETED|Period 4||2
2457779|NCT01025843|6026803|P7|COMPLETED|Period 4||2
2457780|NCT01025843|6026804|P6|COMPLETED|Period 4||2
2457781|NCT01025843|6026805|P5|COMPLETED|Period 4||2
2457782|NCT01025843|6026806|P4|COMPLETED|Period 4||2
2457783|NCT01025843|6026807|P3|COMPLETED|Period 4||2
2457784|NCT01025843|6026808|P2|COMPLETED|Period 4||2
2457785|NCT01025843|6026809|P1|COMPLETED|Period 4||2
2457786|NCT01025843|6026800|P10|STARTED|Period 4||2
2457787|NCT01025843|6026801|P9|STARTED|Period 4||2
2457788|NCT01025843|6026802|P8|STARTED|Period 4||2
2457789|NCT01025843|6026803|P7|STARTED|Period 4||2
2457790|NCT01025843|6026804|P6|STARTED|Period 4||2
2457791|NCT01025843|6026805|P5|STARTED|Period 4||2
2457792|NCT01025843|6026806|P4|STARTED|Period 4||2
2457793|NCT01025843|6026807|P3|STARTED|Period 4||2
2457794|NCT01025843|6026808|P2|STARTED|Period 4||2
2457795|NCT01025843|6026809|P1|STARTED|Period 4||2
2457796|NCT01025843|6026800|P10|NOT COMPLETED|Washout 3||0
2457797|NCT01025843|6026801|P9|NOT COMPLETED|Washout 3||0
2457798|NCT01025843|6026802|P8|NOT COMPLETED|Washout 3||0
2457799|NCT01025843|6026803|P7|NOT COMPLETED|Washout 3||0
2457800|NCT01025843|6026804|P6|NOT COMPLETED|Washout 3||0
2457801|NCT01025843|6026805|P5|NOT COMPLETED|Washout 3||0
2457802|NCT01025843|6026806|P4|NOT COMPLETED|Washout 3||0
2457803|NCT01025843|6026807|P3|NOT COMPLETED|Washout 3||0
2457804|NCT01025843|6026808|P2|NOT COMPLETED|Washout 3||0
2457805|NCT01025843|6026809|P1|NOT COMPLETED|Washout 3||0
2457806|NCT01025843|6026800|P10|COMPLETED|Washout 3||2
2457807|NCT01025843|6026801|P9|COMPLETED|Washout 3||2
2457808|NCT01025843|6026802|P8|COMPLETED|Washout 3||2
2457809|NCT01025843|6026803|P7|COMPLETED|Washout 3||2
2457810|NCT01025843|6026804|P6|COMPLETED|Washout 3||2
2457811|NCT01025843|6026805|P5|COMPLETED|Washout 3||2
2457812|NCT01025843|6026806|P4|COMPLETED|Washout 3||2
2457813|NCT01025843|6026807|P3|COMPLETED|Washout 3||2
2457814|NCT01025843|6026808|P2|COMPLETED|Washout 3||2
2457815|NCT01025843|6026809|P1|COMPLETED|Washout 3||2
2457816|NCT01025843|6026800|P10|STARTED|Washout 3||2
2457817|NCT01025843|6026801|P9|STARTED|Washout 3||2
2457818|NCT01025843|6026802|P8|STARTED|Washout 3||2
2457819|NCT01025843|6026803|P7|STARTED|Washout 3||2
2457820|NCT01025843|6026804|P6|STARTED|Washout 3||2
2457821|NCT01025843|6026805|P5|STARTED|Washout 3||2
2457822|NCT01025843|6026806|P4|STARTED|Washout 3||2
2457823|NCT01025843|6026807|P3|STARTED|Washout 3||2
2457824|NCT01025843|6026808|P2|STARTED|Washout 3||2
2457825|NCT01025843|6026809|P1|STARTED|Washout 3||2
2457826|NCT01025843|6026800|P10|NOT COMPLETED|Period 3||0
2457827|NCT01025843|6026801|P9|NOT COMPLETED|Period 3||0
2457828|NCT01025843|6026802|P8|NOT COMPLETED|Period 3||0
2457829|NCT01025843|6026803|P7|NOT COMPLETED|Period 3||0
2457830|NCT01025843|6026804|P6|NOT COMPLETED|Period 3||0
2457831|NCT01025843|6026805|P5|NOT COMPLETED|Period 3||0
2457832|NCT01025843|6026806|P4|NOT COMPLETED|Period 3||0
2457833|NCT01025843|6026807|P3|NOT COMPLETED|Period 3||0
2457834|NCT01025843|6026808|P2|NOT COMPLETED|Period 3||0
2457835|NCT01025843|6026809|P1|NOT COMPLETED|Period 3||0
2457836|NCT01025843|6026800|P10|COMPLETED|Period 3||2
2457837|NCT01025843|6026801|P9|COMPLETED|Period 3||2
2457838|NCT01025843|6026802|P8|COMPLETED|Period 3||2
2457839|NCT01025843|6026803|P7|COMPLETED|Period 3||2
2457840|NCT01025843|6026804|P6|COMPLETED|Period 3||2
2457841|NCT01025843|6026805|P5|COMPLETED|Period 3||2
2457842|NCT01025843|6026806|P4|COMPLETED|Period 3||2
2457843|NCT01025843|6026807|P3|COMPLETED|Period 3||2
2457844|NCT01025843|6026808|P2|COMPLETED|Period 3||2
2457845|NCT01025843|6026809|P1|COMPLETED|Period 3||2
2457846|NCT01025843|6026800|P10|STARTED|Period 3||2
2457847|NCT01025843|6026801|P9|STARTED|Period 3||2
2457848|NCT01025843|6026802|P8|STARTED|Period 3||2
2457849|NCT01025843|6026803|P7|STARTED|Period 3||2
2457850|NCT01025843|6026804|P6|STARTED|Period 3||2
2457851|NCT01025843|6026805|P5|STARTED|Period 3||2
2457852|NCT01025843|6026806|P4|STARTED|Period 3||2
2457853|NCT01025843|6026807|P3|STARTED|Period 3||2
2457854|NCT01025843|6026808|P2|STARTED|Period 3||2
2457855|NCT01025843|6026809|P1|STARTED|Period 3||2
2457856|NCT01025843|6026800|P10|NOT COMPLETED|Washout 2||0
2457857|NCT01025843|6026801|P9|NOT COMPLETED|Washout 2||0
2457858|NCT01025843|6026802|P8|NOT COMPLETED|Washout 2||0
2457859|NCT01025843|6026803|P7|NOT COMPLETED|Washout 2||0
2457860|NCT01025843|6026804|P6|NOT COMPLETED|Washout 2||0
2457861|NCT01025843|6026805|P5|NOT COMPLETED|Washout 2||0
2457862|NCT01025843|6026806|P4|NOT COMPLETED|Washout 2||0
2457863|NCT01025843|6026807|P3|NOT COMPLETED|Washout 2||0
2457864|NCT01025843|6026808|P2|NOT COMPLETED|Washout 2||0
2457865|NCT01025843|6026809|P1|NOT COMPLETED|Washout 2||0
2457866|NCT01025843|6026800|P10|COMPLETED|Washout 2||2
2457867|NCT01025843|6026801|P9|COMPLETED|Washout 2||2
2457868|NCT01025843|6026802|P8|COMPLETED|Washout 2||2
2457869|NCT01025843|6026803|P7|COMPLETED|Washout 2||2
2457870|NCT01025843|6026804|P6|COMPLETED|Washout 2||2
2457871|NCT01025843|6026805|P5|COMPLETED|Washout 2||2
2457872|NCT01025843|6026806|P4|COMPLETED|Washout 2||2
2457873|NCT01025843|6026807|P3|COMPLETED|Washout 2||2
2457874|NCT01025843|6026808|P2|COMPLETED|Washout 2||2
2457875|NCT01025843|6026809|P1|COMPLETED|Washout 2||2
2457876|NCT01025843|6026800|P10|STARTED|Washout 2||2
2457877|NCT01025843|6026801|P9|STARTED|Washout 2||2
2457878|NCT01025843|6026802|P8|STARTED|Washout 2||2
2457879|NCT01025843|6026803|P7|STARTED|Washout 2||2
2457880|NCT01025843|6026804|P6|STARTED|Washout 2||2
2457881|NCT01025843|6026805|P5|STARTED|Washout 2||2
2457882|NCT01025843|6026806|P4|STARTED|Washout 2||2
2457883|NCT01025843|6026807|P3|STARTED|Washout 2||2
2457884|NCT01025843|6026808|P2|STARTED|Washout 2||2
2457885|NCT01025843|6026809|P1|STARTED|Washout 2||2
2457886|NCT01025843|6026800|P10|NOT COMPLETED|Period 2||0
2457887|NCT01025843|6026801|P9|NOT COMPLETED|Period 2||0
2457888|NCT01025843|6026802|P8|NOT COMPLETED|Period 2||0
2457889|NCT01025843|6026803|P7|NOT COMPLETED|Period 2||0
2457890|NCT01025843|6026804|P6|NOT COMPLETED|Period 2||0
2457891|NCT01025843|6026805|P5|NOT COMPLETED|Period 2||0
2457892|NCT01025843|6026806|P4|NOT COMPLETED|Period 2||0
2457893|NCT01025843|6026807|P3|NOT COMPLETED|Period 2||0
2457894|NCT01025843|6026808|P2|NOT COMPLETED|Period 2||0
2457895|NCT01025843|6026809|P1|NOT COMPLETED|Period 2||0
2457896|NCT01025843|6026800|P10|COMPLETED|Period 2||2
2457897|NCT01025843|6026801|P9|COMPLETED|Period 2||2
2457898|NCT01025843|6026802|P8|COMPLETED|Period 2||2
2457899|NCT01025843|6026803|P7|COMPLETED|Period 2||2
2457900|NCT01025843|6026804|P6|COMPLETED|Period 2||2
2457901|NCT01025843|6026805|P5|COMPLETED|Period 2||2
2457902|NCT01025843|6026806|P4|COMPLETED|Period 2||2
2457903|NCT01025843|6026807|P3|COMPLETED|Period 2||2
2457904|NCT01025843|6026808|P2|COMPLETED|Period 2||2
2457905|NCT01025843|6026809|P1|COMPLETED|Period 2||2
2457906|NCT01025843|6026800|P10|STARTED|Period 2||2
2457907|NCT01025843|6026801|P9|STARTED|Period 2||2
2457908|NCT01025843|6026802|P8|STARTED|Period 2||2
2457909|NCT01025843|6026803|P7|STARTED|Period 2||2
2457910|NCT01025843|6026804|P6|STARTED|Period 2||2
2457911|NCT01025843|6026805|P5|STARTED|Period 2||2
2457912|NCT01025843|6026806|P4|STARTED|Period 2||2
2457913|NCT01025843|6026807|P3|STARTED|Period 2||2
2457914|NCT01025843|6026808|P2|STARTED|Period 2||2
2457915|NCT01025843|6026809|P1|STARTED|Period 2||2
2457916|NCT01025843|6026800|P10|NOT COMPLETED|Washout 1||0
2457917|NCT01025843|6026801|P9|NOT COMPLETED|Washout 1||0
2457918|NCT01025843|6026802|P8|NOT COMPLETED|Washout 1||0
2457919|NCT01025843|6026803|P7|NOT COMPLETED|Washout 1||0
2457920|NCT01025843|6026804|P6|NOT COMPLETED|Washout 1||0
2457921|NCT01025843|6026805|P5|NOT COMPLETED|Washout 1||0
2457922|NCT01025843|6026806|P4|NOT COMPLETED|Washout 1||0
2457923|NCT01025843|6026807|P3|NOT COMPLETED|Washout 1||0
2457924|NCT01025843|6026808|P2|NOT COMPLETED|Washout 1||0
2457925|NCT01025843|6026809|P1|NOT COMPLETED|Washout 1||0
2457926|NCT01025843|6026800|P10|COMPLETED|Washout 1||2
2457927|NCT01025843|6026801|P9|COMPLETED|Washout 1||2
2457928|NCT01025843|6026802|P8|COMPLETED|Washout 1||2
2457929|NCT01025843|6026803|P7|COMPLETED|Washout 1||2
2457930|NCT01025843|6026804|P6|COMPLETED|Washout 1||2
2457931|NCT01025843|6026805|P5|COMPLETED|Washout 1||2
2457932|NCT01025843|6026806|P4|COMPLETED|Washout 1||2
2457933|NCT01025843|6026807|P3|COMPLETED|Washout 1||2
2457934|NCT01025843|6026808|P2|COMPLETED|Washout 1||2
2457935|NCT01025843|6026809|P1|COMPLETED|Washout 1||2
2457936|NCT01025843|6026800|P10|STARTED|Washout 1||2
2457937|NCT01025843|6026801|P9|STARTED|Washout 1||2
2457938|NCT01025843|6026802|P8|STARTED|Washout 1||2
2457939|NCT01025843|6026803|P7|STARTED|Washout 1||2
2457940|NCT01025843|6026804|P6|STARTED|Washout 1||2
2457941|NCT01025843|6026805|P5|STARTED|Washout 1||2
2457942|NCT01025843|6026806|P4|STARTED|Washout 1||2
2457943|NCT01025843|6026807|P3|STARTED|Washout 1||2
2457944|NCT01025843|6026808|P2|STARTED|Washout 1||2
2457945|NCT01025843|6026809|P1|STARTED|Washout 1||2
2457946|NCT01025843|6026800|P10|NOT COMPLETED|Period 1||0
2457947|NCT01025843|6026801|P9|NOT COMPLETED|Period 1||0
2457948|NCT01025843|6026802|P8|NOT COMPLETED|Period 1||0
2457949|NCT01025843|6026803|P7|NOT COMPLETED|Period 1||0
2457950|NCT01025843|6026804|P6|NOT COMPLETED|Period 1||0
2457951|NCT01025843|6026805|P5|NOT COMPLETED|Period 1||0
2457952|NCT01025843|6026806|P4|NOT COMPLETED|Period 1||0
2457953|NCT01025843|6026807|P3|NOT COMPLETED|Period 1||0
2457954|NCT01025843|6026808|P2|NOT COMPLETED|Period 1||0
2457955|NCT01025843|6026809|P1|NOT COMPLETED|Period 1||0
2457956|NCT01025843|6026800|P10|COMPLETED|Period 1||2
2457957|NCT01025843|6026801|P9|COMPLETED|Period 1||2
2457958|NCT01025843|6026802|P8|COMPLETED|Period 1||2
2457959|NCT01025843|6026803|P7|COMPLETED|Period 1||2
2457960|NCT01025843|6026804|P6|COMPLETED|Period 1||2
2457961|NCT01025843|6026805|P5|COMPLETED|Period 1||2
2457962|NCT01025843|6026806|P4|COMPLETED|Period 1||2
2457963|NCT01025843|6026807|P3|COMPLETED|Period 1||2
2457964|NCT01025843|6026808|P2|COMPLETED|Period 1||2
2457965|NCT01025843|6026809|P1|COMPLETED|Period 1||2
2457966|NCT01025843|6026800|P10|STARTED|Period 1||2
2457967|NCT01025843|6026801|P9|STARTED|Period 1||2
2457968|NCT01025843|6026802|P8|STARTED|Period 1||2
2457969|NCT01025843|6026803|P7|STARTED|Period 1||2
2457970|NCT01025843|6026804|P6|STARTED|Period 1||2
2457971|NCT01025843|6026805|P5|STARTED|Period 1||2
2457972|NCT01025843|6026806|P4|STARTED|Period 1||2
2457973|NCT01025843|6026807|P3|STARTED|Period 1||2
2457974|NCT01025843|6026808|P2|STARTED|Period 1||2
2457975|NCT01025843|6026809|P1|STARTED|Period 1||2
2457976|NCT01025830|6026883|P2|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
2457977|NCT01025830|6026884|P1|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
2457978|NCT01025830|6026883|P2|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
2457979|NCT01025830|6026884|P1|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
2457980|NCT01025830|6026883|P2|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
2457981|NCT01025830|6026884|P1|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
2457982|NCT01025830|6026883|P2|NOT COMPLETED|Washout Period of 30 Days||0
2457983|NCT01025830|6026884|P1|NOT COMPLETED|Washout Period of 30 Days||0
2457984|NCT01025830|6026883|P2|COMPLETED|Washout Period of 30 Days||12
2457985|NCT01025830|6026884|P1|COMPLETED|Washout Period of 30 Days||8
2457986|NCT01025830|6026883|P2|STARTED|Washout Period of 30 Days||12
2457987|NCT01025830|6026884|P1|STARTED|Washout Period of 30 Days||8
2457988|NCT01025830|6026883|P2|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
2457989|NCT01025830|6026884|P1|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
2457990|NCT01025830|6026883|P2|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
2457991|NCT01025830|6026884|P1|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
2457992|NCT01025830|6026883|P2|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
2457993|NCT01025830|6026884|P1|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
2457994|NCT01025817|6026903|P2|NOT COMPLETED|Completed Study||22
2457995|NCT01025817|6026904|P1|NOT COMPLETED|Completed Study||16
2457996|NCT01025817|6026903|P2|COMPLETED|Completed Study|Completed study phase|282
2457997|NCT01025817|6026904|P1|COMPLETED|Completed Study|Completed study phase|293
2457998|NCT01025817|6026903|P2|STARTED|Completed Study||304
2457999|NCT01025817|6026904|P1|STARTED|Completed Study||309
2458000|NCT01025817|6026903|P2|NOT COMPLETED|Completed Study Medication||72
2458001|NCT01025817|6026904|P1|NOT COMPLETED|Completed Study Medication||105
2458002|NCT01025817|6026903|P2|COMPLETED|Completed Study Medication||232
2458003|NCT01025817|6026904|P1|COMPLETED|Completed Study Medication||204
2458004|NCT01025817|6026903|P2|STARTED|Completed Study Medication||304
2458005|NCT01025817|6026904|P1|STARTED|Completed Study Medication||309
2458006|NCT01025791|6026925|P14|NOT COMPLETED|Period 5||0
2458007|NCT01025791|6026926|P13|NOT COMPLETED|Period 5||0
2458008|NCT01025791|6026927|P12|NOT COMPLETED|Period 5||0
2458009|NCT01025791|6026928|P11|NOT COMPLETED|Period 5||0
2458010|NCT01025791|6026929|P10|NOT COMPLETED|Period 5||0
2458011|NCT01025791|6026930|P9|NOT COMPLETED|Period 5||0
2458012|NCT01025791|6026931|P8|NOT COMPLETED|Period 5||0
2458013|NCT01025791|6026932|P7|NOT COMPLETED|Period 5||0
2458014|NCT01025791|6026933|P6|NOT COMPLETED|Period 5||0
2458015|NCT01025791|6026934|P5|NOT COMPLETED|Period 5||0
2458016|NCT01025791|6026935|P4|NOT COMPLETED|Period 5||0
2458017|NCT01025791|6026936|P3|NOT COMPLETED|Period 5||0
2458018|NCT01025791|6026937|P2|NOT COMPLETED|Period 5||0
2458019|NCT01025791|6026938|P1|NOT COMPLETED|Period 5||0
2458020|NCT01025791|6026925|P14|COMPLETED|Period 5||0
2458021|NCT01025791|6026926|P13|COMPLETED|Period 5||0
2458022|NCT01025791|6026927|P12|COMPLETED|Period 5||0
2458023|NCT01025791|6026928|P11|COMPLETED|Period 5||0
2458024|NCT01025791|6026929|P10|COMPLETED|Period 5||0
2458025|NCT01025791|6026930|P9|COMPLETED|Period 5||0
2458026|NCT01025791|6026931|P8|COMPLETED|Period 5||0
2458027|NCT01025791|6026932|P7|COMPLETED|Period 5||0
2458028|NCT01025791|6026933|P6|COMPLETED|Period 5||0
2458029|NCT01025791|6026934|P5|COMPLETED|Period 5||0
2458030|NCT01025791|6026935|P4|COMPLETED|Period 5||2
2458031|NCT01025791|6026936|P3|COMPLETED|Period 5||2
2458032|NCT01025791|6026937|P2|COMPLETED|Period 5||2
2458033|NCT01025791|6026938|P1|COMPLETED|Period 5||2
2458034|NCT01025791|6026925|P14|STARTED|Period 5||0
2458035|NCT01025791|6026926|P13|STARTED|Period 5||0
2458036|NCT01025791|6026927|P12|STARTED|Period 5||0
2458037|NCT01025791|6026928|P11|STARTED|Period 5||0
2458038|NCT01025791|6026929|P10|STARTED|Period 5||0
2458039|NCT01025791|6026930|P9|STARTED|Period 5||0
2458040|NCT01025791|6026931|P8|STARTED|Period 5||0
2458041|NCT01025791|6026932|P7|STARTED|Period 5||0
2458042|NCT01025791|6026933|P6|STARTED|Period 5||0
2458043|NCT01025791|6026934|P5|STARTED|Period 5||0
2458044|NCT01025791|6026935|P4|STARTED|Period 5||2
2458045|NCT01025791|6026936|P3|STARTED|Period 5||2
2458046|NCT01025791|6026937|P2|STARTED|Period 5||2
2458047|NCT01025791|6026938|P1|STARTED|Period 5||2
2458048|NCT01025791|6026925|P14|NOT COMPLETED|Period 4||0
2458049|NCT01025791|6026926|P13|NOT COMPLETED|Period 4||0
2458050|NCT01025791|6026927|P12|NOT COMPLETED|Period 4||0
2458051|NCT01025791|6026928|P11|NOT COMPLETED|Period 4||0
2458052|NCT01025791|6026929|P10|NOT COMPLETED|Period 4||0
2458053|NCT01025791|6026930|P9|NOT COMPLETED|Period 4||0
2458054|NCT01025791|6026931|P8|NOT COMPLETED|Period 4||0
2458055|NCT01025791|6026932|P7|NOT COMPLETED|Period 4||0
2458056|NCT01025791|6026933|P6|NOT COMPLETED|Period 4||0
2458057|NCT01025791|6026934|P5|NOT COMPLETED|Period 4||0
2458058|NCT01025791|6026935|P4|NOT COMPLETED|Period 4||0
2458059|NCT01025791|6026936|P3|NOT COMPLETED|Period 4||0
2458060|NCT01025791|6026937|P2|NOT COMPLETED|Period 4||0
2458061|NCT01025791|6026938|P1|NOT COMPLETED|Period 4||0
2458062|NCT01025791|6026925|P14|COMPLETED|Period 4||1
2458063|NCT01025791|6026926|P13|COMPLETED|Period 4||2
2458064|NCT01025791|6026927|P12|COMPLETED|Period 4||1
2458065|NCT01025791|6026928|P11|COMPLETED|Period 4||2
2458066|NCT01025791|6026929|P10|COMPLETED|Period 4||1
2458067|NCT01025791|6026930|P9|COMPLETED|Period 4||2
2458068|NCT01025791|6026931|P8|COMPLETED|Period 4||2
2458069|NCT01025791|6026932|P7|COMPLETED|Period 4||2
2458070|NCT01025791|6026933|P6|COMPLETED|Period 4||2
2458071|NCT01025791|6026934|P5|COMPLETED|Period 4||2
2458072|NCT01025791|6026935|P4|COMPLETED|Period 4||2
2458073|NCT01025791|6026936|P3|COMPLETED|Period 4||2
2458074|NCT01025791|6026937|P2|COMPLETED|Period 4||2
2458075|NCT01025791|6026938|P1|COMPLETED|Period 4||2
2458076|NCT01025791|6026925|P14|STARTED|Period 4||1
2458077|NCT01025791|6026926|P13|STARTED|Period 4||2
2458078|NCT01025791|6026927|P12|STARTED|Period 4||1
2458079|NCT01025791|6026928|P11|STARTED|Period 4||2
2458080|NCT01025791|6026929|P10|STARTED|Period 4||1
2458081|NCT01025791|6026930|P9|STARTED|Period 4||2
2458082|NCT01025791|6026931|P8|STARTED|Period 4||2
2458083|NCT01025791|6026932|P7|STARTED|Period 4||2
2458084|NCT01025791|6026933|P6|STARTED|Period 4||2
2458085|NCT01025791|6026934|P5|STARTED|Period 4||2
2458086|NCT01025791|6026935|P4|STARTED|Period 4||2
2458087|NCT01025791|6026936|P3|STARTED|Period 4||2
2458088|NCT01025791|6026937|P2|STARTED|Period 4||2
2458089|NCT01025791|6026938|P1|STARTED|Period 4||2
2458090|NCT01025791|6026925|P14|NOT COMPLETED|Period 3||0
2458091|NCT01025791|6026926|P13|NOT COMPLETED|Period 3||0
2458092|NCT01025791|6026927|P12|NOT COMPLETED|Period 3||0
2458093|NCT01025791|6026928|P11|NOT COMPLETED|Period 3||0
2458094|NCT01025791|6026929|P10|NOT COMPLETED|Period 3||0
2458095|NCT01025791|6026930|P9|NOT COMPLETED|Period 3||0
2458096|NCT01025791|6026931|P8|NOT COMPLETED|Period 3||0
2458097|NCT01025791|6026932|P7|NOT COMPLETED|Period 3||0
2458098|NCT01025791|6026933|P6|NOT COMPLETED|Period 3||0
2458099|NCT01025791|6026934|P5|NOT COMPLETED|Period 3||0
2458100|NCT01025791|6026935|P4|NOT COMPLETED|Period 3||0
2458101|NCT01025791|6026936|P3|NOT COMPLETED|Period 3||0
2458102|NCT01025791|6026937|P2|NOT COMPLETED|Period 3||0
2458103|NCT01025791|6026938|P1|NOT COMPLETED|Period 3||0
2458104|NCT01025791|6026925|P14|COMPLETED|Period 3||1
2458105|NCT01025791|6026926|P13|COMPLETED|Period 3||2
2458106|NCT01025791|6026927|P12|COMPLETED|Period 3||1
2458107|NCT01025791|6026928|P11|COMPLETED|Period 3||2
2458108|NCT01025791|6026929|P10|COMPLETED|Period 3||1
2458109|NCT01025791|6026930|P9|COMPLETED|Period 3||2
2458110|NCT01025791|6026931|P8|COMPLETED|Period 3||2
2458111|NCT01025791|6026932|P7|COMPLETED|Period 3||2
2458112|NCT01025791|6026933|P6|COMPLETED|Period 3||2
2458113|NCT01025791|6026934|P5|COMPLETED|Period 3||2
2458114|NCT01025791|6026935|P4|COMPLETED|Period 3||2
2458115|NCT01025791|6026936|P3|COMPLETED|Period 3||2
2458116|NCT01025791|6026937|P2|COMPLETED|Period 3||2
2458117|NCT01025791|6026938|P1|COMPLETED|Period 3||2
2458118|NCT01025791|6026925|P14|STARTED|Period 3||1
2458119|NCT01025791|6026926|P13|STARTED|Period 3||2
2458120|NCT01025791|6026927|P12|STARTED|Period 3||1
2458121|NCT01025791|6026928|P11|STARTED|Period 3||2
2458122|NCT01025791|6026929|P10|STARTED|Period 3||1
2458123|NCT01025791|6026930|P9|STARTED|Period 3||2
2458124|NCT01025791|6026931|P8|STARTED|Period 3||2
2458125|NCT01025791|6026932|P7|STARTED|Period 3||2
2458126|NCT01025791|6026933|P6|STARTED|Period 3||2
2458127|NCT01025791|6026934|P5|STARTED|Period 3||2
2458128|NCT01025791|6026935|P4|STARTED|Period 3||2
2458129|NCT01025791|6026936|P3|STARTED|Period 3||2
2458130|NCT01025791|6026937|P2|STARTED|Period 3||2
2458131|NCT01025791|6026938|P1|STARTED|Period 3||2
2458132|NCT01025791|6026925|P14|NOT COMPLETED|Period 2||0
2458133|NCT01025791|6026926|P13|NOT COMPLETED|Period 2||0
2458134|NCT01025791|6026927|P12|NOT COMPLETED|Period 2||0
2458135|NCT01025791|6026928|P11|NOT COMPLETED|Period 2||0
2458136|NCT01025791|6026929|P10|NOT COMPLETED|Period 2||0
2458137|NCT01025791|6026930|P9|NOT COMPLETED|Period 2||0
2458138|NCT01025791|6026931|P8|NOT COMPLETED|Period 2||0
2458139|NCT01025791|6026932|P7|NOT COMPLETED|Period 2||0
2458140|NCT01025791|6026933|P6|NOT COMPLETED|Period 2||0
2458141|NCT01025791|6026934|P5|NOT COMPLETED|Period 2||0
2458142|NCT01025791|6026935|P4|NOT COMPLETED|Period 2||0
2458143|NCT01025791|6026936|P3|NOT COMPLETED|Period 2||0
2458144|NCT01025791|6026937|P2|NOT COMPLETED|Period 2||0
2458145|NCT01025791|6026938|P1|NOT COMPLETED|Period 2||0
2458146|NCT01025791|6026925|P14|COMPLETED|Period 2||1
2458147|NCT01025791|6026926|P13|COMPLETED|Period 2||2
2458148|NCT01025791|6026927|P12|COMPLETED|Period 2||1
2458149|NCT01025791|6026928|P11|COMPLETED|Period 2||2
2458150|NCT01025791|6026929|P10|COMPLETED|Period 2||1
2458151|NCT01025791|6026930|P9|COMPLETED|Period 2||2
2458152|NCT01025791|6026931|P8|COMPLETED|Period 2||2
2458153|NCT01025791|6026932|P7|COMPLETED|Period 2||2
2458154|NCT01025791|6026933|P6|COMPLETED|Period 2||2
2458155|NCT01025791|6026934|P5|COMPLETED|Period 2||2
2458156|NCT01025791|6026935|P4|COMPLETED|Period 2||2
2458157|NCT01025791|6026936|P3|COMPLETED|Period 2||2
2458158|NCT01025791|6026937|P2|COMPLETED|Period 2||2
2458159|NCT01025791|6026938|P1|COMPLETED|Period 2||2
2458160|NCT01025791|6026925|P14|STARTED|Period 2||1
2458161|NCT01025791|6026926|P13|STARTED|Period 2||2
2458162|NCT01025791|6026927|P12|STARTED|Period 2||1
2458163|NCT01025791|6026928|P11|STARTED|Period 2||2
2458164|NCT01025791|6026929|P10|STARTED|Period 2||1
2458165|NCT01025791|6026930|P9|STARTED|Period 2||2
2458166|NCT01025791|6026931|P8|STARTED|Period 2||2
2458167|NCT01025791|6026932|P7|STARTED|Period 2||2
2458168|NCT01025791|6026933|P6|STARTED|Period 2||2
2458169|NCT01025791|6026934|P5|STARTED|Period 2||2
2458170|NCT01025791|6026935|P4|STARTED|Period 2||2
2458171|NCT01025791|6026936|P3|STARTED|Period 2||2
2458172|NCT01025791|6026937|P2|STARTED|Period 2||2
2458173|NCT01025791|6026938|P1|STARTED|Period 2||2
2458174|NCT01025791|6026925|P14|NOT COMPLETED|Period 1||0
2458175|NCT01025791|6026926|P13|NOT COMPLETED|Period 1||0
2458176|NCT01025791|6026927|P12|NOT COMPLETED|Period 1||0
2458177|NCT01025791|6026928|P11|NOT COMPLETED|Period 1||0
2458178|NCT01025791|6026929|P10|NOT COMPLETED|Period 1||0
2458179|NCT01025791|6026930|P9|NOT COMPLETED|Period 1||0
2458180|NCT01025791|6026931|P8|NOT COMPLETED|Period 1||0
2458181|NCT01025791|6026932|P7|NOT COMPLETED|Period 1||0
2458182|NCT01025791|6026933|P6|NOT COMPLETED|Period 1||0
2458183|NCT01025791|6026934|P5|NOT COMPLETED|Period 1||0
2458184|NCT01025791|6026935|P4|NOT COMPLETED|Period 1||0
2458185|NCT01025791|6026936|P3|NOT COMPLETED|Period 1||0
2458186|NCT01025791|6026937|P2|NOT COMPLETED|Period 1||0
2458187|NCT01025791|6026938|P1|NOT COMPLETED|Period 1||0
2458188|NCT01025791|6026925|P14|COMPLETED|Period 1||1
2458189|NCT01025791|6026926|P13|COMPLETED|Period 1||2
2458190|NCT01025791|6026927|P12|COMPLETED|Period 1||1
2458191|NCT01025791|6026928|P11|COMPLETED|Period 1||2
2458192|NCT01025791|6026929|P10|COMPLETED|Period 1||1
2458193|NCT01025791|6026930|P9|COMPLETED|Period 1||2
2458194|NCT01025791|6026931|P8|COMPLETED|Period 1||2
2458195|NCT01025791|6026932|P7|COMPLETED|Period 1||2
2458196|NCT01025791|6026933|P6|COMPLETED|Period 1||2
2458197|NCT01025791|6026934|P5|COMPLETED|Period 1||2
2458198|NCT01025791|6026935|P4|COMPLETED|Period 1||2
2458199|NCT01025791|6026936|P3|COMPLETED|Period 1||2
2458200|NCT01025791|6026937|P2|COMPLETED|Period 1||2
2458201|NCT01025791|6026938|P1|COMPLETED|Period 1||2
2458202|NCT01025791|6026925|P14|STARTED|Period 1||1
2458203|NCT01025791|6026926|P13|STARTED|Period 1||2
2458204|NCT01025791|6026927|P12|STARTED|Period 1||1
2458205|NCT01025791|6026928|P11|STARTED|Period 1||2
2458206|NCT01025791|6026929|P10|STARTED|Period 1||1
2458207|NCT01025791|6026930|P9|STARTED|Period 1||2
2458208|NCT01025791|6026931|P8|STARTED|Period 1||2
2458209|NCT01025791|6026932|P7|STARTED|Period 1||2
2458210|NCT01025791|6026933|P6|STARTED|Period 1||2
2458211|NCT01025791|6026934|P5|STARTED|Period 1||2
2458212|NCT01025791|6026935|P4|STARTED|Period 1||2
2458213|NCT01025791|6026936|P3|STARTED|Period 1||2
2458214|NCT01025791|6026937|P2|STARTED|Period 1||2
2458215|NCT01025791|6026938|P1|STARTED|Period 1||2
2458216|NCT01025752|6027070|P2|NOT COMPLETED|Overall Study||13
2458217|NCT01025752|6027071|P1|NOT COMPLETED|Overall Study||8
2458218|NCT01025752|6027070|P2|COMPLETED|Overall Study||50
2458219|NCT01025752|6027071|P1|COMPLETED|Overall Study||54
2458220|NCT01025752|6027070|P2|STARTED|Overall Study||63
2458221|NCT01025752|6027071|P1|STARTED|Overall Study||62
2458222|NCT01025635|6027091|P2|NOT COMPLETED|Overall Study||25
2458223|NCT01025635|6027092|P1|NOT COMPLETED|Overall Study||23
2458224|NCT01025635|6027091|P2|COMPLETED|Overall Study||178
2458225|NCT01025635|6027092|P1|COMPLETED|Overall Study||175
2458226|NCT01025635|6027091|P2|STARTED|Overall Study||203
2458227|NCT01025635|6027092|P1|STARTED|Overall Study||198
2458228|NCT01025492|6027104|P1|NOT COMPLETED|Overall Study||0
2458229|NCT01025492|6027104|P1|COMPLETED|Overall Study||24
2458230|NCT01025492|6027104|P1|STARTED|Overall Study||24
2458231|NCT01025453|6027108|P1|NOT COMPLETED|Overall Study||0
2458232|NCT01025453|6027108|P1|COMPLETED|Overall Study||37
2458233|NCT01025453|6027108|P1|STARTED|Overall Study||37
2458234|NCT01025336|6027120|P5|NOT COMPLETED|Overall Study||0
2458235|NCT01025336|6027121|P4|NOT COMPLETED|Overall Study||2
2458236|NCT01025336|6027122|P3|NOT COMPLETED|Overall Study||0
2458237|NCT01025336|6027123|P2|NOT COMPLETED|Overall Study||0
2458238|NCT01025336|6027124|P1|NOT COMPLETED|Overall Study||0
2458239|NCT01025336|6027120|P5|COMPLETED|Overall Study||222
2458240|NCT01025336|6027121|P4|COMPLETED|Overall Study||219
2458241|NCT01025336|6027122|P3|COMPLETED|Overall Study||179
2458242|NCT01025336|6027123|P2|COMPLETED|Overall Study||210
2458243|NCT01025336|6027124|P1|COMPLETED|Overall Study||130
2458244|NCT01025336|6027120|P5|STARTED|Overall Study||222
2458245|NCT01025336|6027121|P4|STARTED|Overall Study||221
2458246|NCT01025336|6027122|P3|STARTED|Overall Study||179
2458247|NCT01025336|6027123|P2|STARTED|Overall Study||210
2458248|NCT01025336|6027124|P1|STARTED|Overall Study||130
2458249|NCT01025284|6027179|P3|NOT COMPLETED|Overall Study||0
2458250|NCT01025284|6027180|P2|NOT COMPLETED|Overall Study||2
2458251|NCT01025284|6027181|P1|NOT COMPLETED|Overall Study||0
2458252|NCT01025284|6027179|P3|COMPLETED|Overall Study||8
2458253|NCT01025284|6027180|P2|COMPLETED|Overall Study||16
2458254|NCT01025284|6027181|P1|COMPLETED|Overall Study||38
2458255|NCT01025284|6027179|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
2458256|NCT01025284|6027180|P2|Received at Least 1 Dose of Study Drug|Overall Study||18
2458257|NCT01025284|6027181|P1|Received at Least 1 Dose of Study Drug|Overall Study||38
2458258|NCT01025284|6027179|P3|STARTED|Overall Study||8
2458259|NCT01025284|6027180|P2|STARTED|Overall Study||18
2458260|NCT01025284|6027181|P1|STARTED|Overall Study||38
2458261|NCT01025271|6027199|P1|NOT COMPLETED|Overall Study||0
2458262|NCT01025271|6027199|P1|COMPLETED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
2458263|NCT01025271|6027199|P1|STARTED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
2458264|NCT01025232|6027206|P2|NOT COMPLETED|Overall Study||6
2458265|NCT01025232|6027207|P1|NOT COMPLETED|Overall Study||3
2458266|NCT01025232|6027206|P2|COMPLETED|Overall Study||36
2458267|NCT01025232|6027207|P1|COMPLETED|Overall Study||43
2458268|NCT01025232|6027206|P2|STARTED|Overall Study||42
2458269|NCT01025232|6027207|P1|STARTED|Overall Study||46
2458270|NCT01025193|6027225|P1|NOT COMPLETED|Overall Study||4
2458271|NCT01025193|6027225|P1|COMPLETED|Overall Study|one patient was transplanted 2 weeks after 8 month belimumab dose and did not receive further doses.|4
2458272|NCT01025193|6027225|P1|STARTED|Overall Study||8
2458273|NCT01025154|6027235|P1|NOT COMPLETED|Overall Study||2
2458274|NCT01025154|6027235|P1|COMPLETED|Overall Study||57
2458275|NCT01025154|6027235|P1|STARTED|Overall Study||59
2458276|NCT01025076|6027240|P1|NOT COMPLETED|Overall Study||0
2458277|NCT01025076|6027240|P1|COMPLETED|Overall Study||14
2458278|NCT01025076|6027240|P1|STARTED|Overall Study||14
2458279|NCT01025037|6027244|P1|NOT COMPLETED|Overall Study||11
2458280|NCT01025037|6027244|P1|COMPLETED|Overall Study||50
2458281|NCT01025037|6027244|P1|STARTED|Overall Study||61
2458282|NCT01024972|6027255|P2|NOT COMPLETED|Overall Study||0
2458283|NCT01024972|6027256|P1|NOT COMPLETED|Overall Study||0
2458284|NCT01024972|6027255|P2|COMPLETED|Overall Study||15
2458285|NCT01024972|6027256|P1|COMPLETED|Overall Study||16
2458286|NCT01024972|6027255|P2|STARTED|Overall Study||15
2458287|NCT01024972|6027256|P1|STARTED|Overall Study||16
2458288|NCT01024959|6027266|P1|NOT COMPLETED|Overall Study||41
2458289|NCT01024959|6027266|P1|COMPLETED|Overall Study||466
2458290|NCT01024959|6027266|P1|STARTED|Overall Study||507
2458291|NCT01024946|6027275|P1|NOT COMPLETED|Overall Study||5
2458292|NCT01024946|6027275|P1|COMPLETED|Overall Study||6
2458293|NCT01024946|6027275|P1|STARTED|Overall Study||11
2458294|NCT01024855|6027279|P1|NOT COMPLETED|Overall Study||1
2458295|NCT01024855|6027279|P1|COMPLETED|Overall Study|One subject of the 30 seen for baseline did not meet the inclusion/exclusion criteria|29
2458296|NCT01024855|6027279|P1|STARTED|Overall Study|30 subjects enrolled in a paired/split-eye evaluation; each subject used both study treatments|30
2458297|NCT01024751|6027286|P2|NOT COMPLETED|Eligible Participants||3
2458298|NCT01024751|6027287|P1|NOT COMPLETED|Eligible Participants||0
2458299|NCT01024751|6027286|P2|COMPLETED|Eligible Participants||149
2458300|NCT01024751|6027287|P1|COMPLETED|Eligible Participants||153
2458301|NCT01024751|6027286|P2|STARTED|Eligible Participants||152
2458302|NCT01024751|6027287|P1|STARTED|Eligible Participants||153
2458303|NCT01024751|6027286|P2|NOT COMPLETED|Enrolled Participants||4
2458304|NCT01024751|6027287|P1|NOT COMPLETED|Enrolled Participants||3
2458305|NCT01024751|6027286|P2|COMPLETED|Enrolled Participants||152
2458306|NCT01024751|6027287|P1|COMPLETED|Enrolled Participants||153
2458307|NCT01024751|6027286|P2|STARTED|Enrolled Participants||156
2458308|NCT01024751|6027287|P1|STARTED|Enrolled Participants||156
2458309|NCT01024738|6027298|P3|NOT COMPLETED|Third Intervention:||0
2458310|NCT01024738|6027299|P2|NOT COMPLETED|Third Intervention:||0
2458311|NCT01024738|6027300|P1|NOT COMPLETED|Third Intervention:||0
2458312|NCT01024738|6027298|P3|COMPLETED|Third Intervention:||8
2458313|NCT01024738|6027299|P2|COMPLETED|Third Intervention:||7
2458314|NCT01024738|6027300|P1|COMPLETED|Third Intervention:||7
2458315|NCT01024738|6027298|P3|STARTED|Third Intervention:||8
2458316|NCT01024738|6027299|P2|STARTED|Third Intervention:||7
2458317|NCT01024738|6027300|P1|STARTED|Third Intervention:||7
2458318|NCT01024738|6027298|P3|NOT COMPLETED|Washout After 2nd Intervention||0
2458319|NCT01024738|6027299|P2|NOT COMPLETED|Washout After 2nd Intervention||0
2458320|NCT01024738|6027300|P1|NOT COMPLETED|Washout After 2nd Intervention||0
2458321|NCT01024738|6027298|P3|COMPLETED|Washout After 2nd Intervention||8
2458322|NCT01024738|6027299|P2|COMPLETED|Washout After 2nd Intervention||7
2458323|NCT01024738|6027300|P1|COMPLETED|Washout After 2nd Intervention||7
2458324|NCT01024738|6027298|P3|STARTED|Washout After 2nd Intervention||8
2458325|NCT01024738|6027299|P2|STARTED|Washout After 2nd Intervention||7
2458326|NCT01024738|6027300|P1|STARTED|Washout After 2nd Intervention||7
2458327|NCT01024738|6027298|P3|NOT COMPLETED|Second Intervention:||0
2458328|NCT01024738|6027299|P2|NOT COMPLETED|Second Intervention:||0
2458329|NCT01024738|6027300|P1|NOT COMPLETED|Second Intervention:||0
2458330|NCT01024738|6027298|P3|COMPLETED|Second Intervention:||8
2458331|NCT01024738|6027299|P2|COMPLETED|Second Intervention:||7
2458332|NCT01024738|6027300|P1|COMPLETED|Second Intervention:||7
2458333|NCT01024738|6027298|P3|STARTED|Second Intervention:||8
2458334|NCT01024738|6027299|P2|STARTED|Second Intervention:||7
2458335|NCT01024738|6027300|P1|STARTED|Second Intervention:||7
2458336|NCT01024738|6027298|P3|NOT COMPLETED|Washout After 1st Intervention||0
2458337|NCT01024738|6027299|P2|NOT COMPLETED|Washout After 1st Intervention||0
2458338|NCT01024738|6027300|P1|NOT COMPLETED|Washout After 1st Intervention||0
2458339|NCT01024738|6027298|P3|COMPLETED|Washout After 1st Intervention||8
2458340|NCT01024738|6027299|P2|COMPLETED|Washout After 1st Intervention||7
2458341|NCT01024738|6027300|P1|COMPLETED|Washout After 1st Intervention||7
2458342|NCT01024738|6027298|P3|STARTED|Washout After 1st Intervention||8
2458343|NCT01024738|6027299|P2|STARTED|Washout After 1st Intervention||7
2458344|NCT01024738|6027300|P1|STARTED|Washout After 1st Intervention||7
2458345|NCT01024738|6027298|P3|NOT COMPLETED|First Intervention:||0
2458346|NCT01024738|6027299|P2|NOT COMPLETED|First Intervention:||0
2458347|NCT01024738|6027300|P1|NOT COMPLETED|First Intervention:||0
2458348|NCT01024738|6027298|P3|COMPLETED|First Intervention:||8
2458349|NCT01024738|6027299|P2|COMPLETED|First Intervention:||7
2458350|NCT01024738|6027300|P1|COMPLETED|First Intervention:||7
2458351|NCT01024738|6027298|P3|STARTED|First Intervention:||8
2458352|NCT01024738|6027299|P2|STARTED|First Intervention:||7
2458353|NCT01024738|6027300|P1|STARTED|First Intervention:||7
2458354|NCT01024686|6027311|P3|NOT COMPLETED|Overall Study||0
2458355|NCT01024686|6027312|P2|NOT COMPLETED|Overall Study||0
2458356|NCT01024686|6027313|P1|NOT COMPLETED|Overall Study||0
2458357|NCT01024686|6027311|P3|COMPLETED|Overall Study|(0) participants because the clinical trial was terminated prior to enrollment.|0
2458358|NCT01024686|6027312|P2|COMPLETED|Overall Study|(0) participants because the clinical trial was terminated prior to enrollment.|0
2458359|NCT01024686|6027313|P1|COMPLETED|Overall Study||6
2458360|NCT01024686|6027311|P3|STARTED|Overall Study||0
2458361|NCT01024686|6027312|P2|STARTED|Overall Study||0
2458362|NCT01024686|6027313|P1|STARTED|Overall Study|July 11, 2010: unexpected adverse event, (1) participant|6
2458363|NCT01024608|6027344|P2|NOT COMPLETED|Overall Study||4
2458364|NCT01024608|6027345|P1|NOT COMPLETED|Overall Study||4
2458365|NCT01024608|6027344|P2|COMPLETED|Overall Study||167
2458366|NCT01024608|6027345|P1|COMPLETED|Overall Study||165
2458367|NCT01024608|6027344|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|171
2458368|NCT01024608|6027345|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|167
2458369|NCT01024608|6027344|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|171
2458370|NCT01024608|6027345|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|167
2458371|NCT01024608|6027344|P2|STARTED|Overall Study||171
2458372|NCT01024608|6027345|P1|STARTED|Overall Study||169
2458373|NCT01024569|6027359|P2|NOT COMPLETED|Overall Study||11
2458374|NCT01024569|6027360|P1|NOT COMPLETED|Overall Study||25
2458375|NCT01024569|6027359|P2|COMPLETED|Overall Study||268
2458376|NCT01024569|6027360|P1|COMPLETED|Overall Study||251
2458377|NCT01024569|6027359|P2|STARTED|Overall Study||279
2458378|NCT01024569|6027360|P1|STARTED|Overall Study||276
2458379|NCT01024465|6027374|P1|NOT COMPLETED|Overall Study||3
2458380|NCT01024465|6027374|P1|COMPLETED|Overall Study||23
2458381|NCT01024465|6027374|P1|STARTED|Overall Study||26
2458382|NCT01024387|6027378|P1|NOT COMPLETED|Overall Study||60
2458383|NCT01024387|6027378|P1|COMPLETED|Overall Study||0
2458384|NCT01024387|6027378|P1|Evaluable for Response|Overall Study||53
2458385|NCT01024387|6027378|P1|Evaluable for PFS|Overall Study||54
2458386|NCT01024387|6027378|P1|STARTED|Overall Study||60
2458387|NCT01024335|6027388|P2|NOT COMPLETED|Overall Study||26
2458388|NCT01024335|6027389|P1|NOT COMPLETED|Overall Study||13
2458389|NCT01024335|6027388|P2|COMPLETED|Overall Study||14
2458390|NCT01024335|6027389|P1|COMPLETED|Overall Study||7
2458391|NCT01024335|6027388|P2|STARTED|Overall Study||40
2458392|NCT01024335|6027389|P1|STARTED|Overall Study||20
2458393|NCT01024309|6027399|P2|NOT COMPLETED|Overall Study||4
2458394|NCT01024309|6027400|P1|NOT COMPLETED|Overall Study||8
2458395|NCT01024309|6027399|P2|COMPLETED|Overall Study||27
2458396|NCT01024309|6027400|P1|COMPLETED|Overall Study||27
2458397|NCT01024309|6027399|P2|STARTED|Overall Study||31
2458398|NCT01024309|6027400|P1|STARTED|Overall Study||35
2458399|NCT01024296|6027422|P1|NOT COMPLETED|Overall Study||0
2458400|NCT01024296|6027422|P1|COMPLETED|Overall Study||4
2458401|NCT01024296|6027422|P1|STARTED|Overall Study||4
2458402|NCT01024244|6027432|P5|NOT COMPLETED|Overall Study||14
2458403|NCT01024244|6027433|P4|NOT COMPLETED|Overall Study||13
2458404|NCT01024244|6027434|P3|NOT COMPLETED|Overall Study||14
2458405|NCT01024244|6027435|P2|NOT COMPLETED|Overall Study||11
2458406|NCT01024244|6027436|P1|NOT COMPLETED|Overall Study||17
2458407|NCT01024244|6027432|P5|COMPLETED|Overall Study||1
2458408|NCT01024244|6027433|P4|COMPLETED|Overall Study||1
2458409|NCT01024244|6027434|P3|COMPLETED|Overall Study||1
2458410|NCT01024244|6027435|P2|COMPLETED|Overall Study||1
2458411|NCT01024244|6027436|P1|COMPLETED|Overall Study||5
2458412|NCT01024244|6027432|P5|STARTED|Overall Study||15
2458413|NCT01024244|6027433|P4|STARTED|Overall Study||14
2458414|NCT01024244|6027434|P3|STARTED|Overall Study||15
2458415|NCT01024244|6027435|P2|STARTED|Overall Study||12
2458416|NCT01024244|6027436|P1|STARTED|Overall Study||22
2458417|NCT01024036|6027550|P2|NOT COMPLETED|Follow-Up Period||3
2458418|NCT01024036|6027551|P1|NOT COMPLETED|Follow-Up Period||5
2458419|NCT01024036|6027550|P2|COMPLETED|Follow-Up Period||3
2458420|NCT01024036|6027551|P1|COMPLETED|Follow-Up Period||9
2458421|NCT01024036|6027550|P2|STARTED|Follow-Up Period||6
2458422|NCT01024036|6027551|P1|STARTED|Follow-Up Period||14
2458423|NCT01024036|6027550|P2|NOT COMPLETED|Unblinded Treatment||3
2458424|NCT01024036|6027551|P1|NOT COMPLETED|Unblinded Treatment||0
2458425|NCT01024036|6027550|P2|COMPLETED|Unblinded Treatment||10
2458426|NCT01024036|6027551|P1|COMPLETED|Unblinded Treatment||0
2458427|NCT01024036|6027550|P2|STARTED|Unblinded Treatment|Placebo participants had an option to receive siltuximab in unblinded treatment period|13
2458428|NCT01024036|6027551|P1|STARTED|Unblinded Treatment|No participants in this group received treatment during unblinded treatment period|0
2458429|NCT01024036|6027550|P2|NOT COMPLETED|Blinded Treatment||20
2458430|NCT01024036|6027551|P1|NOT COMPLETED|Blinded Treatment||22
2458431|NCT01024036|6027550|P2|COMPLETED|Blinded Treatment||6
2458432|NCT01024036|6027551|P1|COMPLETED|Blinded Treatment||31
2458433|NCT01024036|6027550|P2|STARTED|Blinded Treatment||26
2458434|NCT01024036|6027551|P1|STARTED|Blinded Treatment||53
2458435|NCT01024010|6027584|P2|NOT COMPLETED|Overall Study||0
2458436|NCT01024010|6027585|P1|NOT COMPLETED|Overall Study||0
2458437|NCT01024010|6027584|P2|COMPLETED|Overall Study||34
2458438|NCT01024010|6027585|P1|COMPLETED|Overall Study||48
2458439|NCT01024010|6027584|P2|STARTED|Overall Study||34
2458440|NCT01024010|6027585|P1|STARTED|Overall Study||48
2458441|NCT01023958|6027598|P1|NOT COMPLETED|Overall Study||50
2458442|NCT01023958|6027598|P1|COMPLETED|Overall Study||0
2458443|NCT01023958|6027598|P1|STARTED|Overall Study||50
2458444|NCT01023841|6027627|P2|NOT COMPLETED|Overall Study||0
2458445|NCT01023841|6027628|P1|NOT COMPLETED|Overall Study||1
2458446|NCT01023841|6027627|P2|COMPLETED|Overall Study||23
2458447|NCT01023841|6027628|P1|COMPLETED|Overall Study||47
2458448|NCT01023841|6027627|P2|STARTED|Overall Study||23
2458449|NCT01023841|6027628|P1|STARTED|Overall Study||48
2458450|NCT01023815|6027646|P4|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
2458451|NCT01023815|6027647|P3|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||8
2458452|NCT01023815|6027648|P2|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
2458453|NCT01023815|6027649|P1|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||0
2458454|NCT01023815|6027646|P4|COMPLETED|Randomized Period (Day 90 to Month 12)||68
2458455|NCT01023815|6027647|P3|COMPLETED|Randomized Period (Day 90 to Month 12)||60
2458456|NCT01023815|6027648|P2|COMPLETED|Randomized Period (Day 90 to Month 12)||42
2458457|NCT01023815|6027649|P1|COMPLETED|Randomized Period (Day 90 to Month 12)||0
2458458|NCT01023815|6027646|P4|STARTED|Randomized Period (Day 90 to Month 12)||71
2458459|NCT01023815|6027647|P3|STARTED|Randomized Period (Day 90 to Month 12)||68
2458460|NCT01023815|6027648|P2|STARTED|Randomized Period (Day 90 to Month 12)|Randomized patients to Group A, B and C are also intent to treat population.|45
2458461|NCT01023815|6027649|P1|STARTED|Randomized Period (Day 90 to Month 12)||0
2458462|NCT01023815|6027646|P4|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
2458463|NCT01023815|6027647|P3|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
2458464|NCT01023815|6027648|P2|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
2458465|NCT01023815|6027649|P1|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||144
2458466|NCT01023815|6027646|P4|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
2458467|NCT01023815|6027647|P3|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
2458468|NCT01023815|6027648|P2|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
2458469|NCT01023815|6027649|P1|COMPLETED|Pre-randomization Period (Day 1 to 90)||184
2458470|NCT01023815|6027646|P4|STARTED|Pre-randomization Period (Day 1 to 90)||0
2458471|NCT01023815|6027647|P3|STARTED|Pre-randomization Period (Day 1 to 90)||0
2458472|NCT01023815|6027648|P2|STARTED|Pre-randomization Period (Day 1 to 90)||0
2458473|NCT01023815|6027649|P1|STARTED|Pre-randomization Period (Day 1 to 90)|Out of 330 enrolled, 2 patients never received everolimus.|328
2458474|NCT01023789|6027668|P1|NOT COMPLETED|3 - Year Visit||43
2458475|NCT01023789|6027668|P1|COMPLETED|3 - Year Visit||769
2458476|NCT01023789|6027668|P1|STARTED|3 - Year Visit||812
2458477|NCT01023789|6027668|P1|NOT COMPLETED|2 - Year Visit||0
2458478|NCT01023789|6027668|P1|COMPLETED|2 - Year Visit||812
2458479|NCT01023789|6027668|P1|STARTED|2 - Year Visit||812
2458480|NCT01023789|6027668|P1|NOT COMPLETED|1 - Year Visit||0
2458481|NCT01023789|6027668|P1|COMPLETED|1 - Year Visit||812
2458482|NCT01023789|6027668|P1|STARTED|1 - Year Visit||812
2458483|NCT01023789|6027668|P1|NOT COMPLETED|180-day Clinical Follow-up||0
2458484|NCT01023789|6027668|P1|COMPLETED|180-day Clinical Follow-up||812
2458485|NCT01023789|6027668|P1|STARTED|180-day Clinical Follow-up||812
2458486|NCT01023789|6027668|P1|NOT COMPLETED|30-day Follow-up Visit||0
2458487|NCT01023789|6027668|P1|COMPLETED|30-day Follow-up Visit||812
2458488|NCT01023789|6027668|P1|STARTED|30-day Follow-up Visit|Intent-to-treat population (ITT).|812
2458489|NCT01023776|6027735|P1|NOT COMPLETED|Overall Study||0
2458490|NCT01023776|6027735|P1|COMPLETED|Overall Study||20
2458491|NCT01023776|6027735|P1|STARTED|Overall Study|Subjects received 2 dose of vaccine 0.1 ml in each nostril intra nasally 28 days apart|20
2458492|NCT01023724|6027742|P2|NOT COMPLETED|Overall Study||3
2458493|NCT01023724|6027743|P1|NOT COMPLETED|Overall Study||4
2458494|NCT01023724|6027742|P2|COMPLETED|Overall Study||22
2458495|NCT01023724|6027743|P1|COMPLETED|Overall Study||21
2458496|NCT01023724|6027742|P2|STARTED|Overall Study||25
2458497|NCT01023724|6027743|P1|STARTED|Overall Study||25
2458498|NCT01023711|6027749|P1|NOT COMPLETED|Overall Study||0
2458499|NCT01023711|6027749|P1|COMPLETED|Overall Study||107
2458500|NCT01023711|6027749|P1|STARTED|Overall Study||107
2458501|NCT01023672|6027754|P1|NOT COMPLETED|Overall Study||3
2458502|NCT01023672|6027754|P1|COMPLETED|Overall Study||17
2458503|NCT01023672|6027754|P1|STARTED|Overall Study||20
2458504|NCT01023659|6027761|P3|NOT COMPLETED|Overall Study||99
2458505|NCT01023659|6027762|P2|NOT COMPLETED|Overall Study||228
2458506|NCT01023659|6027763|P1|NOT COMPLETED|Overall Study||73
2458507|NCT01023659|6027761|P3|COMPLETED|Overall Study||165
2458508|NCT01023659|6027762|P2|COMPLETED|Overall Study||137
2458509|NCT01023659|6027763|P1|COMPLETED|Overall Study||185
2458510|NCT01023659|6027761|P3|STARTED|Overall Study||264
2458511|NCT01023659|6027762|P2|STARTED|Overall Study||365
2458512|NCT01023659|6027763|P1|STARTED|Overall Study||258
2458513|NCT01023620|6027774|P2|NOT COMPLETED|Overall Study||0
2458514|NCT01023620|6027775|P1|NOT COMPLETED|Overall Study||0
2458515|NCT01023620|6027774|P2|COMPLETED|Overall Study||0
2458516|NCT01023620|6027775|P1|COMPLETED|Overall Study||0
2458517|NCT01023620|6027774|P2|STARTED|Overall Study||0
2458518|NCT01023620|6027775|P1|STARTED|Overall Study||0
2458519|NCT01023581|6027790|P7|NOT COMPLETED|Overall Study||20
2458520|NCT01023581|6027791|P6|NOT COMPLETED|Overall Study||19
2458521|NCT01023581|6027792|P5|NOT COMPLETED|Overall Study||16
2458522|NCT01023581|6027793|P4|NOT COMPLETED|Overall Study||20
2458523|NCT01023581|6027794|P3|NOT COMPLETED|Overall Study||42
2458524|NCT01023581|6027795|P2|NOT COMPLETED|Overall Study||23
2458525|NCT01023581|6027796|P1|NOT COMPLETED|Overall Study||35
2458526|NCT01023581|6027790|P7|COMPLETED|Overall Study||94
2458527|NCT01023581|6027791|P6|COMPLETED|Overall Study||92
2458528|NCT01023581|6027792|P5|COMPLETED|Overall Study||95
2458529|NCT01023581|6027793|P4|COMPLETED|Overall Study||94
2458530|NCT01023581|6027794|P3|COMPLETED|Overall Study||71
2458531|NCT01023581|6027795|P2|COMPLETED|Overall Study||89
2458532|NCT01023581|6027796|P1|COMPLETED|Overall Study|The number of completed patients represents those who completed study drug.|74
2458533|NCT01023581|6027790|P7|Received Study Treatment|Overall Study||114
2458534|NCT01023581|6027791|P6|Received Study Treatment|Overall Study||106
2458535|NCT01023581|6027792|P5|Received Study Treatment|Overall Study||111
2458536|NCT01023581|6027793|P4|Received Study Treatment|Overall Study||109
2458537|NCT01023581|6027794|P3|Received Study Treatment|Overall Study||110
2458538|NCT01023581|6027795|P2|Received Study Treatment|Overall Study||112
2458539|NCT01023581|6027796|P1|Received Study Treatment|Overall Study||106
2458540|NCT01023581|6027790|P7|STARTED|Overall Study||114
2458541|NCT01023581|6027791|P6|STARTED|Overall Study||111
2458542|NCT01023581|6027792|P5|STARTED|Overall Study||111
2458543|NCT01023581|6027793|P4|STARTED|Overall Study||114
2458544|NCT01023581|6027794|P3|STARTED|Overall Study||113
2458545|NCT01023581|6027795|P2|STARTED|Overall Study||112
2458546|NCT01023581|6027796|P1|STARTED|Overall Study||109
2458547|NCT01023568|6027829|P3|NOT COMPLETED|Overall Study||0
2458548|NCT01023568|6027830|P2|NOT COMPLETED|Overall Study||0
2458549|NCT01023568|6027831|P1|NOT COMPLETED|Overall Study||0
2458550|NCT01023568|6027829|P3|COMPLETED|Overall Study||45
2458551|NCT01023568|6027830|P2|COMPLETED|Overall Study||44
2458552|NCT01023568|6027831|P1|COMPLETED|Overall Study||45
2458553|NCT01023568|6027829|P3|STARTED|Overall Study||45
2458554|NCT01023568|6027830|P2|STARTED|Overall Study||44
2458555|NCT01023568|6027831|P1|STARTED|Overall Study||45
2458556|NCT01023516|6027853|P2|NOT COMPLETED|Overall Study||18
2458557|NCT01023516|6027854|P1|NOT COMPLETED|Overall Study||24
2458558|NCT01023516|6027853|P2|COMPLETED|Overall Study||284
2458559|NCT01023516|6027854|P1|COMPLETED|Overall Study||289
2458560|NCT01023516|6027853|P2|STARTED|Overall Study||302
2458561|NCT01023516|6027854|P1|STARTED|Overall Study||313
2458562|NCT01023308|6027936|P2|NOT COMPLETED|Overall Study||279
2458563|NCT01023308|6027937|P1|NOT COMPLETED|Overall Study||285
2458564|NCT01023308|6027936|P2|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
2458565|NCT01023308|6027937|P1|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
2458566|NCT01023308|6027936|P2|STARTED|Overall Study||381
2458567|NCT01023308|6027937|P1|STARTED|Overall Study||387
2458568|NCT01023269|6027963|P2|NOT COMPLETED|Overall Study||0
2458569|NCT01023269|6027964|P1|NOT COMPLETED|Overall Study||2
2458570|NCT01023269|6027963|P2|COMPLETED|Overall Study||2
2458571|NCT01023269|6027964|P1|COMPLETED|Overall Study||1
2458572|NCT01023269|6027963|P2|STARTED|Overall Study||2
2458573|NCT01023269|6027964|P1|STARTED|Overall Study||3
2458574|NCT01023256|6027972|P4|NOT COMPLETED|Overall Study||5
2458575|NCT01023256|6027973|P3|NOT COMPLETED|Overall Study||1
2458576|NCT01023256|6027974|P2|NOT COMPLETED|Overall Study||3
2458577|NCT01023256|6027975|P1|NOT COMPLETED|Overall Study||4
2458578|NCT01023256|6027972|P4|COMPLETED|Overall Study||22
2458579|NCT01023256|6027973|P3|COMPLETED|Overall Study||23
2458580|NCT01023256|6027974|P2|COMPLETED|Overall Study||19
2458581|NCT01023256|6027975|P1|COMPLETED|Overall Study||21
2458582|NCT01023256|6027972|P4|STARTED|Overall Study||27
2458583|NCT01023256|6027973|P3|STARTED|Overall Study||24
2458584|NCT01023256|6027974|P2|STARTED|Overall Study||22
2458585|NCT01023256|6027975|P1|STARTED|Overall Study||25
2458586|NCT01023217|6028017|P2|NOT COMPLETED|Overall Study||0
2458587|NCT01023217|6028018|P1|NOT COMPLETED|Overall Study||1
2458588|NCT01023217|6028017|P2|COMPLETED|Overall Study||45
2458589|NCT01023217|6028018|P1|COMPLETED|Overall Study||44
2458590|NCT01023217|6028017|P2|STARTED|Overall Study||45
2458591|NCT01023217|6028018|P1|STARTED|Overall Study||45
2458592|NCT01023178|6028027|P3|NOT COMPLETED|Overall Study||3
2458593|NCT01023178|6028028|P2|NOT COMPLETED|Overall Study||2
2458594|NCT01023178|6028029|P1|NOT COMPLETED|Overall Study||2
2458595|NCT01023178|6028027|P3|COMPLETED|Overall Study||4
2458596|NCT01023178|6028028|P2|COMPLETED|Overall Study||6
2458597|NCT01023178|6028029|P1|COMPLETED|Overall Study||3
2458598|NCT01023178|6028027|P3|STARTED|Overall Study||7
2458599|NCT01023178|6028028|P2|STARTED|Overall Study||8
2458600|NCT01023178|6028029|P1|STARTED|Overall Study||5
2458601|NCT01023074|6028040|P3|NOT COMPLETED|Overall Study||0
2458602|NCT01023074|6028041|P2|NOT COMPLETED|Overall Study||0
2458603|NCT01023074|6028042|P1|NOT COMPLETED|Overall Study||0
2458604|NCT01023074|6028040|P3|COMPLETED|Overall Study||13
2458605|NCT01023074|6028041|P2|COMPLETED|Overall Study||13
2458606|NCT01023074|6028042|P1|COMPLETED|Overall Study||26
2458607|NCT01023074|6028040|P3|STARTED|Overall Study||13
2458608|NCT01023074|6028041|P2|STARTED|Overall Study||13
2458609|NCT01023074|6028042|P1|STARTED|Overall Study||26
2458610|NCT01023061|6028056|P1|NOT COMPLETED|Overall Study||2
2458611|NCT01023061|6028056|P1|COMPLETED|Overall Study||22
2458612|NCT01023061|6028056|P1|STARTED|Overall Study||24
2458613|NCT01023035|6028065|P3|NOT COMPLETED|Follow-up Period (up to Week 72)||39
2458698|NCT01022203|6028271|P2|COMPLETED|Post Treatment Assessment||42
2458614|NCT01023035|6028066|P2|NOT COMPLETED|Follow-up Period (up to Week 72)||28
2458615|NCT01023035|6028067|P1|NOT COMPLETED|Follow-up Period (up to Week 72)||28
2458616|NCT01023035|6028065|P3|COMPLETED|Follow-up Period (up to Week 72)||108
2458617|NCT01023035|6028066|P2|COMPLETED|Follow-up Period (up to Week 72)||207
2458618|NCT01023035|6028067|P1|COMPLETED|Follow-up Period (up to Week 72)||210
2458619|NCT01023035|6028065|P3|STARTED|Follow-up Period (up to Week 72)||147
2458620|NCT01023035|6028066|P2|STARTED|Follow-up Period (up to Week 72)||235
2458621|NCT01023035|6028067|P1|STARTED|Follow-up Period (up to Week 72)||238
2458622|NCT01023035|6028065|P3|NOT COMPLETED|Treatment Period||118
2458623|NCT01023035|6028066|P2|NOT COMPLETED|Treatment Period||85
2458624|NCT01023035|6028067|P1|NOT COMPLETED|Treatment Period||72
2458625|NCT01023035|6028065|P3|COMPLETED|Treatment Period||69
2458626|NCT01023035|6028066|P2|COMPLETED|Treatment Period||166
2458627|NCT01023035|6028067|P1|COMPLETED|Treatment Period||177
2458628|NCT01023035|6028065|P3|STARTED|Treatment Period||187
2458629|NCT01023035|6028066|P2|STARTED|Treatment Period||251
2458630|NCT01023035|6028067|P1|STARTED|Treatment Period||249
2458631|NCT01023022|6028077|P1|NOT COMPLETED|Overall Study||14
2458632|NCT01023022|6028077|P1|COMPLETED|Overall Study||162
2458633|NCT01023022|6028077|P1|STARTED|Overall Study|Previous No.: 178 subjects incl. 2 pts who withdraw their approval for processing personal data|176
2458634|NCT01022996|6028083|P1|NOT COMPLETED|Overall Study||57
2458635|NCT01022996|6028083|P1|COMPLETED|Overall Study||0
2458636|NCT01022996|6028083|P1|STARTED|Overall Study||57
2458637|NCT01022853|6028097|P5|NOT COMPLETED|Overall Study||2
2458638|NCT01022853|6028098|P4|NOT COMPLETED|Overall Study||8
2458639|NCT01022853|6028099|P3|NOT COMPLETED|Overall Study||13
2458640|NCT01022853|6028100|P2|NOT COMPLETED|Overall Study||4
2458641|NCT01022853|6028101|P1|NOT COMPLETED|Overall Study||3
2458642|NCT01022853|6028097|P5|COMPLETED|Overall Study||0
2458643|NCT01022853|6028098|P4|COMPLETED|Overall Study||0
2458644|NCT01022853|6028099|P3|COMPLETED|Overall Study||0
2458645|NCT01022853|6028100|P2|COMPLETED|Overall Study||0
2458646|NCT01022853|6028101|P1|COMPLETED|Overall Study||0
2458647|NCT01022853|6028097|P5|STARTED|Overall Study|entered and treated|2
2458648|NCT01022853|6028098|P4|STARTED|Overall Study|entered and treated|8
2458649|NCT01022853|6028099|P3|STARTED|Overall Study|entered and treated|13
2458650|NCT01022853|6028100|P2|STARTED|Overall Study|entered and treated|4
2458651|NCT01022853|6028101|P1|STARTED|Overall Study|entered and treated|3
2458652|NCT01022762|6028180|P2|NOT COMPLETED|Overall Study||28
2458653|NCT01022762|6028181|P1|NOT COMPLETED|Overall Study||22
2458654|NCT01022762|6028180|P2|COMPLETED|Overall Study||194
2458655|NCT01022762|6028181|P1|COMPLETED|Overall Study||196
2458656|NCT01022762|6028180|P2|Exposed to Trial Drug|Overall Study|Four participants were not exposed to the treatment due to non-compliance or lost to follow-up|218
2458657|NCT01022762|6028181|P1|Exposed to Trial Drug|Overall Study|One participant was not exposed to the treatment due to fulfillment of exclusion criteria|217
2458658|NCT01022762|6028180|P2|STARTED|Overall Study||222
2458659|NCT01022762|6028181|P1|STARTED|Overall Study||218
2458660|NCT01022567|6028209|P2|NOT COMPLETED|Overall Study||15
2458661|NCT01022567|6028210|P1|NOT COMPLETED|Overall Study||1
2458662|NCT01022567|6028209|P2|COMPLETED|Overall Study||242
2458663|NCT01022567|6028210|P1|COMPLETED|Overall Study||272
2458664|NCT01022567|6028209|P2|STARTED|Overall Study||257
2458665|NCT01022567|6028210|P1|STARTED|Overall Study||273
2458666|NCT01022502|6028216|P1|NOT COMPLETED|Overall Study||3
2458667|NCT01022502|6028216|P1|COMPLETED|Overall Study|3 participants withdrew at week 4,5,6,respectively.|35
2458668|NCT01022502|6028216|P1|STARTED|Overall Study|19 used the refined ointment on the right site, 19 used the crude ointment on the left site.|38
2458669|NCT01022424|6028230|P1|NOT COMPLETED|Overall Study||4
2458670|NCT01022424|6028230|P1|COMPLETED|Overall Study||9
2458671|NCT01022424|6028230|P1|STARTED|Overall Study||13
2458672|NCT01022398|6028245|P2|NOT COMPLETED|Overall Study||2
2458673|NCT01022398|6028246|P1|NOT COMPLETED|Overall Study||2
2458674|NCT01022398|6028245|P2|COMPLETED|Overall Study||0
2458675|NCT01022398|6028246|P1|COMPLETED|Overall Study||0
2458676|NCT01022398|6028245|P2|STARTED|Overall Study||2
2458677|NCT01022398|6028246|P1|STARTED|Overall Study||2
2458678|NCT01022307|6028253|P2|NOT COMPLETED|Overall Study||4
2458679|NCT01022307|6028254|P1|NOT COMPLETED|Overall Study||0
2458680|NCT01022307|6028253|P2|COMPLETED|Overall Study|Some TBI patients could not undergo MR scanning due to contraindications.|24
2458681|NCT01022307|6028254|P1|COMPLETED|Overall Study||184
2458682|NCT01022307|6028253|P2|STARTED|Overall Study||28
2458683|NCT01022307|6028254|P1|STARTED|Overall Study||184
2458684|NCT01022242|6028262|P2|NOT COMPLETED|Overall Study||19
2458685|NCT01022242|6028263|P1|NOT COMPLETED|Overall Study||21
2458686|NCT01022242|6028262|P2|COMPLETED|Overall Study||46
2458687|NCT01022242|6028263|P1|COMPLETED|Overall Study||49
2458688|NCT01022242|6028262|P2|STARTED|Overall Study|67 pat rand to PXL01. 2 got incorrect mix of PXL01. 65 patients treated with the correct PXL01 mix.|65
2458689|NCT01022242|6028263|P1|STARTED|Overall Study|71 pat rand to placebo. 1 got incorrect mix of placebo. 70 patients treated with the correct mix.|70
2458690|NCT01022203|6028271|P2|NOT COMPLETED|Follow-Up Assessment||2
2458691|NCT01022203|6028272|P1|NOT COMPLETED|Follow-Up Assessment||2
2458692|NCT01022203|6028271|P2|COMPLETED|Follow-Up Assessment||40
2458693|NCT01022203|6028272|P1|COMPLETED|Follow-Up Assessment||42
2458694|NCT01022203|6028271|P2|STARTED|Follow-Up Assessment||42
2458695|NCT01022203|6028272|P1|STARTED|Follow-Up Assessment||44
2458696|NCT01022203|6028271|P2|NOT COMPLETED|Post Treatment Assessment||14
2458697|NCT01022203|6028272|P1|NOT COMPLETED|Post Treatment Assessment||14
2458699|NCT01022203|6028272|P1|COMPLETED|Post Treatment Assessment||44
2458700|NCT01022203|6028271|P2|STARTED|Post Treatment Assessment||56
2458701|NCT01022203|6028272|P1|STARTED|Post Treatment Assessment||58
2458702|NCT01022203|6028271|P2|NOT COMPLETED|PreTreatment Assessment||0
2458703|NCT01022203|6028272|P1|NOT COMPLETED|PreTreatment Assessment||0
2458704|NCT01022203|6028271|P2|COMPLETED|PreTreatment Assessment||56
2458705|NCT01022203|6028272|P1|COMPLETED|PreTreatment Assessment||58
2458706|NCT01022203|6028271|P2|STARTED|PreTreatment Assessment||56
2458707|NCT01022203|6028272|P1|STARTED|PreTreatment Assessment||58
2458708|NCT01022190|6028282|P1|NOT COMPLETED|Overall Study||0
2458709|NCT01022190|6028282|P1|COMPLETED|Overall Study||42
2458710|NCT01022190|6028282|P1|STARTED|Overall Study||42
2458711|NCT01022112|6028291|P5|NOT COMPLETED|Overall Study||10
2458712|NCT01022112|6028292|P4|NOT COMPLETED|Overall Study||3
2458713|NCT01022112|6028293|P3|NOT COMPLETED|Overall Study||3
2458714|NCT01022112|6028294|P2|NOT COMPLETED|Overall Study||3
2458715|NCT01022112|6028295|P1|NOT COMPLETED|Overall Study||3
2458716|NCT01022112|6028291|P5|COMPLETED|Overall Study||65
2458717|NCT01022112|6028292|P4|COMPLETED|Overall Study||72
2458718|NCT01022112|6028293|P3|COMPLETED|Overall Study||74
2458719|NCT01022112|6028294|P2|COMPLETED|Overall Study||71
2458720|NCT01022112|6028295|P1|COMPLETED|Overall Study||79
2458721|NCT01022112|6028291|P5|STARTED|Overall Study||75
2458722|NCT01022112|6028292|P4|STARTED|Overall Study||75
2458723|NCT01022112|6028293|P3|STARTED|Overall Study||77
2458724|NCT01022112|6028294|P2|STARTED|Overall Study||74
2458725|NCT01022112|6028295|P1|STARTED|Overall Study||82
2458726|NCT01022073|6028309|P2|NOT COMPLETED|Overall Study||18
2458727|NCT01022073|6028310|P1|NOT COMPLETED|Overall Study||19
2458728|NCT01022073|6028309|P2|COMPLETED|Overall Study||52
2458729|NCT01022073|6028310|P1|COMPLETED|Overall Study||67
2458730|NCT01022073|6028309|P2|STARTED|Overall Study||70
2458731|NCT01022073|6028310|P1|STARTED|Overall Study||86
2458732|NCT01021956|6028320|P4|NOT COMPLETED|Overall Study||0
2458733|NCT01021956|6028321|P3|NOT COMPLETED|Overall Study||0
2458734|NCT01021956|6028322|P2|NOT COMPLETED|Overall Study||0
2458735|NCT01021956|6028323|P1|NOT COMPLETED|Overall Study||0
2458736|NCT01021956|6028320|P4|COMPLETED|Overall Study||1
2458737|NCT01021956|6028321|P3|COMPLETED|Overall Study||3
2458738|NCT01021956|6028322|P2|COMPLETED|Overall Study||3
2458739|NCT01021956|6028323|P1|COMPLETED|Overall Study||3
2458740|NCT01021956|6028320|P4|STARTED|Overall Study||1
2458741|NCT01021956|6028321|P3|STARTED|Overall Study||3
2458742|NCT01021956|6028322|P2|STARTED|Overall Study||3
2458743|NCT01021956|6028323|P1|STARTED|Overall Study||3
2458744|NCT01021878|6028344|P2|NOT COMPLETED|Overall Study||10
2458745|NCT01021878|6028345|P1|NOT COMPLETED|Overall Study||16
2458746|NCT01021878|6028344|P2|COMPLETED|Overall Study||17
2458747|NCT01021878|6028345|P1|COMPLETED|Overall Study||17
2458748|NCT01021878|6028344|P2|Completed Follow-up|Overall Study||17
2458749|NCT01021878|6028345|P1|Completed Follow-up|Overall Study||17
2458750|NCT01021878|6028344|P2|STARTED|Overall Study||27
2458751|NCT01021878|6028345|P1|STARTED|Overall Study||33
2458752|NCT01021852|6028367|P8|NOT COMPLETED|Treatment Period 2||2
2458753|NCT01021852|6028368|P7|NOT COMPLETED|Treatment Period 2||3
2458754|NCT01021852|6028369|P6|NOT COMPLETED|Treatment Period 2||1
2458755|NCT01021852|6028370|P5|NOT COMPLETED|Treatment Period 2||2
2458756|NCT01021852|6028371|P4|NOT COMPLETED|Treatment Period 2||0
2458757|NCT01021852|6028372|P3|NOT COMPLETED|Treatment Period 2||1
2458758|NCT01021852|6028373|P2|NOT COMPLETED|Treatment Period 2||1
2458759|NCT01021852|6028374|P1|NOT COMPLETED|Treatment Period 2||0
2458760|NCT01021852|6028367|P8|COMPLETED|Treatment Period 2||38
2458761|NCT01021852|6028368|P7|COMPLETED|Treatment Period 2||37
2458762|NCT01021852|6028369|P6|COMPLETED|Treatment Period 2||37
2458763|NCT01021852|6028370|P5|COMPLETED|Treatment Period 2||37
2458764|NCT01021852|6028371|P4|COMPLETED|Treatment Period 2||37
2458765|NCT01021852|6028372|P3|COMPLETED|Treatment Period 2||38
2458766|NCT01021852|6028373|P2|COMPLETED|Treatment Period 2||38
2458767|NCT01021852|6028374|P1|COMPLETED|Treatment Period 2||37
2458768|NCT01021852|6028367|P8|STARTED|Treatment Period 2||40
2458769|NCT01021852|6028368|P7|STARTED|Treatment Period 2||40
2458770|NCT01021852|6028369|P6|STARTED|Treatment Period 2||38
2458771|NCT01021852|6028370|P5|STARTED|Treatment Period 2||39
2458772|NCT01021852|6028371|P4|STARTED|Treatment Period 2||37
2458773|NCT01021852|6028372|P3|STARTED|Treatment Period 2||39
2458774|NCT01021852|6028373|P2|STARTED|Treatment Period 2||39
2458775|NCT01021852|6028374|P1|STARTED|Treatment Period 2||37
2458776|NCT01021852|6028367|P8|NOT COMPLETED|Washout Period-No Drug||0
2458777|NCT01021852|6028368|P7|NOT COMPLETED|Washout Period-No Drug||0
2458778|NCT01021852|6028369|P6|NOT COMPLETED|Washout Period-No Drug||1
2458779|NCT01021852|6028370|P5|NOT COMPLETED|Washout Period-No Drug||0
2458780|NCT01021852|6028371|P4|NOT COMPLETED|Washout Period-No Drug||0
2458781|NCT01021852|6028372|P3|NOT COMPLETED|Washout Period-No Drug||0
2458782|NCT01021852|6028373|P2|NOT COMPLETED|Washout Period-No Drug||0
2458783|NCT01021852|6028374|P1|NOT COMPLETED|Washout Period-No Drug||1
2458784|NCT01021852|6028367|P8|COMPLETED|Washout Period-No Drug||40
2458785|NCT01021852|6028368|P7|COMPLETED|Washout Period-No Drug||40
2458786|NCT01021852|6028369|P6|COMPLETED|Washout Period-No Drug||38
2458787|NCT01021852|6028370|P5|COMPLETED|Washout Period-No Drug||39
2458788|NCT01021852|6028371|P4|COMPLETED|Washout Period-No Drug||37
2458789|NCT01021852|6028372|P3|COMPLETED|Washout Period-No Drug||39
2458790|NCT01021852|6028373|P2|COMPLETED|Washout Period-No Drug||39
2458791|NCT01021852|6028374|P1|COMPLETED|Washout Period-No Drug||37
2458792|NCT01021852|6028367|P8|STARTED|Washout Period-No Drug||40
2458793|NCT01021852|6028368|P7|STARTED|Washout Period-No Drug||40
2458794|NCT01021852|6028369|P6|STARTED|Washout Period-No Drug|Includes 1 participant who completed Treatment Period 1 but missed Placebo Washout.|39
2458795|NCT01021852|6028370|P5|STARTED|Washout Period-No Drug||39
2458796|NCT01021852|6028371|P4|STARTED|Washout Period-No Drug||37
2458797|NCT01021852|6028372|P3|STARTED|Washout Period-No Drug||39
2458798|NCT01021852|6028373|P2|STARTED|Washout Period-No Drug||39
2458799|NCT01021852|6028374|P1|STARTED|Washout Period-No Drug|Includes 1 participant who discontinued Treatment Period 1 (AE) and missed Placebo Washout.|38
2458800|NCT01021852|6028367|P8|NOT COMPLETED|Washout Period-Placebo||0
2458801|NCT01021852|6028368|P7|NOT COMPLETED|Washout Period-Placebo||1
2458802|NCT01021852|6028369|P6|NOT COMPLETED|Washout Period-Placebo||1
2458803|NCT01021852|6028370|P5|NOT COMPLETED|Washout Period-Placebo||1
2458804|NCT01021852|6028371|P4|NOT COMPLETED|Washout Period-Placebo||1
2458805|NCT01021852|6028372|P3|NOT COMPLETED|Washout Period-Placebo||0
2458806|NCT01021852|6028373|P2|NOT COMPLETED|Washout Period-Placebo||0
2458807|NCT01021852|6028374|P1|NOT COMPLETED|Washout Period-Placebo||0
2458808|NCT01021852|6028367|P8|COMPLETED|Washout Period-Placebo||40
2458809|NCT01021852|6028368|P7|COMPLETED|Washout Period-Placebo||40
2458810|NCT01021852|6028369|P6|COMPLETED|Washout Period-Placebo||38
2458811|NCT01021852|6028370|P5|COMPLETED|Washout Period-Placebo||39
2458812|NCT01021852|6028371|P4|COMPLETED|Washout Period-Placebo||37
2458813|NCT01021852|6028372|P3|COMPLETED|Washout Period-Placebo||39
2458814|NCT01021852|6028373|P2|COMPLETED|Washout Period-Placebo||39
2458815|NCT01021852|6028374|P1|COMPLETED|Washout Period-Placebo||37
2458816|NCT01021852|6028367|P8|STARTED|Washout Period-Placebo||40
2458817|NCT01021852|6028368|P7|STARTED|Washout Period-Placebo||41
2458818|NCT01021852|6028369|P6|STARTED|Washout Period-Placebo|Excludes 1 participant who completed Treatment Period 1 but missed Placebo Washout|39
2458819|NCT01021852|6028370|P5|STARTED|Washout Period-Placebo|Includes 1 participant that discontinued Treatment Period 1 (AE).|40
2458820|NCT01021852|6028371|P4|STARTED|Washout Period-Placebo||38
2458821|NCT01021852|6028372|P3|STARTED|Washout Period-Placebo||39
2458822|NCT01021852|6028373|P2|STARTED|Washout Period-Placebo||39
2458823|NCT01021852|6028374|P1|STARTED|Washout Period-Placebo||37
2458824|NCT01021852|6028367|P8|NOT COMPLETED|Treatment Period 1||1
2458825|NCT01021852|6028368|P7|NOT COMPLETED|Treatment Period 1||0
2458826|NCT01021852|6028369|P6|NOT COMPLETED|Treatment Period 1||2
2458827|NCT01021852|6028370|P5|NOT COMPLETED|Treatment Period 1||3
2458828|NCT01021852|6028371|P4|NOT COMPLETED|Treatment Period 1||2
2458829|NCT01021852|6028372|P3|NOT COMPLETED|Treatment Period 1||2
2458830|NCT01021852|6028373|P2|NOT COMPLETED|Treatment Period 1||1
2458831|NCT01021852|6028374|P1|NOT COMPLETED|Treatment Period 1||3
2458832|NCT01021852|6028367|P8|COMPLETED|Treatment Period 1||40
2458833|NCT01021852|6028368|P7|COMPLETED|Treatment Period 1||41
2458834|NCT01021852|6028369|P6|COMPLETED|Treatment Period 1||39
2458835|NCT01021852|6028370|P5|COMPLETED|Treatment Period 1||39
2458836|NCT01021852|6028371|P4|COMPLETED|Treatment Period 1||38
2458837|NCT01021852|6028372|P3|COMPLETED|Treatment Period 1||39
2458838|NCT01021852|6028373|P2|COMPLETED|Treatment Period 1||39
2458839|NCT01021852|6028374|P1|COMPLETED|Treatment Period 1||37
2458840|NCT01021852|6028367|P8|Treated|Treatment Period 1||41
2458841|NCT01021852|6028368|P7|Treated|Treatment Period 1||41
2458842|NCT01021852|6028369|P6|Treated|Treatment Period 1|1 participant discontinued Treatment Period 1 (AE) but continued in Placebo Washout|41
2458843|NCT01021852|6028370|P5|Treated|Treatment Period 1||42
2458844|NCT01021852|6028371|P4|Treated|Treatment Period 1||38
2458845|NCT01021852|6028372|P3|Treated|Treatment Period 1||41
2458846|NCT01021852|6028373|P2|Treated|Treatment Period 1||40
2458847|NCT01021852|6028374|P1|Treated|Treatment Period 1||40
2458848|NCT01021852|6028367|P8|STARTED|Treatment Period 1||41
2458849|NCT01021852|6028368|P7|STARTED|Treatment Period 1||41
2458850|NCT01021852|6028369|P6|STARTED|Treatment Period 1||41
2458851|NCT01021852|6028370|P5|STARTED|Treatment Period 1||42
2458852|NCT01021852|6028371|P4|STARTED|Treatment Period 1||40
2458853|NCT01021852|6028372|P3|STARTED|Treatment Period 1||41
2458854|NCT01021852|6028373|P2|STARTED|Treatment Period 1||40
2458855|NCT01021852|6028374|P1|STARTED|Treatment Period 1||40
2458856|NCT01021813|6028410|P5|NOT COMPLETED|DB Randomized Discontinuation Phase||5
2458857|NCT01021813|6028411|P4|NOT COMPLETED|DB Randomized Discontinuation Phase||5
2458858|NCT01021813|6028412|P3|NOT COMPLETED|DB Randomized Discontinuation Phase||4
2458859|NCT01021813|6028413|P2|NOT COMPLETED|DB Randomized Discontinuation Phase||0
2458860|NCT01021813|6028414|P1|NOT COMPLETED|DB Randomized Discontinuation Phase||0
2458861|NCT01021813|6028410|P5|COMPLETED|DB Randomized Discontinuation Phase||157
2458862|NCT01021813|6028411|P4|COMPLETED|DB Randomized Discontinuation Phase||161
2458863|NCT01021813|6028412|P3|COMPLETED|DB Randomized Discontinuation Phase||152
2458864|NCT01021813|6028413|P2|COMPLETED|DB Randomized Discontinuation Phase||0
2458865|NCT01021813|6028414|P1|COMPLETED|DB Randomized Discontinuation Phase||0
2458866|NCT01021813|6028410|P5|STARTED|DB Randomized Discontinuation Phase||162
2458867|NCT01021813|6028411|P4|STARTED|DB Randomized Discontinuation Phase||166
2458868|NCT01021813|6028412|P3|STARTED|DB Randomized Discontinuation Phase||156
2458869|NCT01021813|6028413|P2|STARTED|DB Randomized Discontinuation Phase||0
2458870|NCT01021813|6028414|P1|STARTED|DB Randomized Discontinuation Phase||0
2458871|NCT01021813|6028410|P5|NOT COMPLETED|DB Treatment Phase||0
2458872|NCT01021813|6028411|P4|NOT COMPLETED|DB Treatment Phase||0
2458873|NCT01021813|6028412|P3|NOT COMPLETED|DB Treatment Phase||0
2458874|NCT01021813|6028413|P2|NOT COMPLETED|DB Treatment Phase||97
2458875|NCT01021813|6028414|P1|NOT COMPLETED|DB Treatment Phase||200
2458876|NCT01021813|6028410|P5|COMPLETED|DB Treatment Phase||0
2458877|NCT01021813|6028411|P4|COMPLETED|DB Treatment Phase||0
2458878|NCT01021813|6028412|P3|COMPLETED|DB Treatment Phase||0
2458879|NCT01021813|6028413|P2|COMPLETED|DB Treatment Phase||162
2458880|NCT01021813|6028414|P1|COMPLETED|DB Treatment Phase||322
2458881|NCT01021813|6028410|P5|Treated|DB Treatment Phase||0
2458882|NCT01021813|6028411|P4|Treated|DB Treatment Phase||0
2458883|NCT01021813|6028412|P3|Treated|DB Treatment Phase||0
2458884|NCT01021813|6028413|P2|Treated|DB Treatment Phase||258
2458885|NCT01021813|6028414|P1|Treated|DB Treatment Phase||521
2458886|NCT01021813|6028410|P5|STARTED|DB Treatment Phase||0
2458887|NCT01021813|6028411|P4|STARTED|DB Treatment Phase||0
2458888|NCT01021813|6028412|P3|STARTED|DB Treatment Phase||0
2458889|NCT01021813|6028413|P2|STARTED|DB Treatment Phase||259
2458890|NCT01021813|6028414|P1|STARTED|DB Treatment Phase||522
2458891|NCT01021761|6028456|P3|NOT COMPLETED|Overall Study||0
2458892|NCT01021761|6028457|P2|NOT COMPLETED|Overall Study||4
2458893|NCT01021761|6028458|P1|NOT COMPLETED|Overall Study||1
2458894|NCT01021761|6028456|P3|COMPLETED|Overall Study||42
2458895|NCT01021761|6028457|P2|COMPLETED|Overall Study||38
2458896|NCT01021761|6028458|P1|COMPLETED|Overall Study||41
2458897|NCT01021761|6028456|P3|STARTED|Overall Study||42
2458898|NCT01021761|6028457|P2|STARTED|Overall Study||42
2458899|NCT01021761|6028458|P1|STARTED|Overall Study||42
2458900|NCT01021748|6028475|P9|NOT COMPLETED|Overall Study||16
2458901|NCT01021748|6028476|P8|NOT COMPLETED|Overall Study||6
2458902|NCT01021748|6028477|P7|NOT COMPLETED|Overall Study||3
2458903|NCT01021748|6028478|P6|NOT COMPLETED|Overall Study||3
2458904|NCT01021748|6028479|P5|NOT COMPLETED|Overall Study||9
2458905|NCT01021748|6028480|P4|NOT COMPLETED|Overall Study||7
2458906|NCT01021748|6028481|P3|NOT COMPLETED|Overall Study||7
2458907|NCT01021748|6028482|P2|NOT COMPLETED|Overall Study||5
2458908|NCT01021748|6028483|P1|NOT COMPLETED|Overall Study||6
2458909|NCT01021748|6028475|P9|COMPLETED|Overall Study||1
2458910|NCT01021748|6028476|P8|COMPLETED|Overall Study||0
2458911|NCT01021748|6028477|P7|COMPLETED|Overall Study||0
2458912|NCT01021748|6028478|P6|COMPLETED|Overall Study||0
2458913|NCT01021748|6028479|P5|COMPLETED|Overall Study||0
2458914|NCT01021748|6028480|P4|COMPLETED|Overall Study||0
2458915|NCT01021748|6028481|P3|COMPLETED|Overall Study||0
2458916|NCT01021748|6028482|P2|COMPLETED|Overall Study||0
2458917|NCT01021748|6028483|P1|COMPLETED|Overall Study||0
2458918|NCT01021748|6028475|P9|Treated|Overall Study||17
2458919|NCT01021748|6028476|P8|Treated|Overall Study||6
2458920|NCT01021748|6028477|P7|Treated|Overall Study||3
2458921|NCT01021748|6028478|P6|Treated|Overall Study||3
2458922|NCT01021748|6028479|P5|Treated|Overall Study||9
2458923|NCT01021748|6028480|P4|Treated|Overall Study||7
2458924|NCT01021748|6028481|P3|Treated|Overall Study||7
2458925|NCT01021748|6028482|P2|Treated|Overall Study|One participant was allocated, but not treated.|4
2458926|NCT01021748|6028483|P1|Treated|Overall Study||6
2458927|NCT01021748|6028475|P9|STARTED|Overall Study||17
2458928|NCT01021748|6028476|P8|STARTED|Overall Study||6
2458929|NCT01021748|6028477|P7|STARTED|Overall Study||3
2458930|NCT01021748|6028478|P6|STARTED|Overall Study||3
2458931|NCT01021748|6028479|P5|STARTED|Overall Study||9
2458932|NCT01021748|6028480|P4|STARTED|Overall Study||7
2458933|NCT01021748|6028481|P3|STARTED|Overall Study||7
2458934|NCT01021748|6028482|P2|STARTED|Overall Study||5
2458935|NCT01021748|6028483|P1|STARTED|Overall Study||6
2458936|NCT01021683|6028530|P1|NOT COMPLETED|Overall Study||71
2458937|NCT01021683|6028530|P1|COMPLETED|Overall Study||132
2458938|NCT01021683|6028530|P1|STARTED|Overall Study||203
2458939|NCT01021618|6028544|P2|NOT COMPLETED|Overall Study||0
2458940|NCT01021618|6028545|P1|NOT COMPLETED|Overall Study||0
2458941|NCT01021618|6028544|P2|COMPLETED|Overall Study||96
2458942|NCT01021618|6028545|P1|COMPLETED|Overall Study||44
2458943|NCT01021618|6028544|P2|STARTED|Overall Study||96
2458944|NCT01021618|6028545|P1|STARTED|Overall Study||44
2458945|NCT01021553|6028556|P3|NOT COMPLETED|Overall Study||3
2458946|NCT01021553|6028557|P2|NOT COMPLETED|Overall Study||5
2458947|NCT01021553|6028558|P1|NOT COMPLETED|Overall Study||4
2458948|NCT01021553|6028556|P3|COMPLETED|Overall Study||25
2458949|NCT01021553|6028557|P2|COMPLETED|Overall Study||17
2458950|NCT01021553|6028558|P1|COMPLETED|Overall Study||23
2458951|NCT01021553|6028556|P3|STARTED|Overall Study||28
2458952|NCT01021553|6028557|P2|STARTED|Overall Study||22
2458953|NCT01021553|6028558|P1|STARTED|Overall Study||27
2458954|NCT01021423|6028612|P2|NOT COMPLETED|Overall Study||5
2458955|NCT01021423|6028613|P1|NOT COMPLETED|Overall Study||4
2458956|NCT01021423|6028612|P2|COMPLETED|Overall Study||0
2458957|NCT01021423|6028613|P1|COMPLETED|Overall Study||0
2458958|NCT01021423|6028612|P2|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to disease progression|5
2458959|NCT01021423|6028613|P1|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to an AE|4
2458960|NCT01021332|6028629|P1|NOT COMPLETED|Overall Study||106
2458961|NCT01021332|6028629|P1|COMPLETED|Overall Study||960
2458962|NCT01021332|6028629|P1|Full Analysis Set (FAS)|Overall Study||1009
2458963|NCT01021332|6028629|P1|Safety Analysis Set (SAF)|Overall Study||1066
2458964|NCT01021332|6028629|P1|STARTED|Overall Study|Took ≥ 1 dose of FDC open-label study drug|1066
2458965|NCT01021306|6028667|P4|NOT COMPLETED|6 Month (Follow-up)||3
2458966|NCT01021306|6028668|P3|NOT COMPLETED|6 Month (Follow-up)||0
2458967|NCT01021306|6028669|P2|NOT COMPLETED|6 Month (Follow-up)||1
2458968|NCT01021306|6028670|P1|NOT COMPLETED|6 Month (Follow-up)||3
2458969|NCT01021306|6028667|P4|COMPLETED|6 Month (Follow-up)||14
2458970|NCT01021306|6028668|P3|COMPLETED|6 Month (Follow-up)||14
2458971|NCT01021306|6028669|P2|COMPLETED|6 Month (Follow-up)||13
2458972|NCT01021306|6028670|P1|COMPLETED|6 Month (Follow-up)||11
2458973|NCT01021306|6028667|P4|STARTED|6 Month (Follow-up)||17
2458974|NCT01021306|6028668|P3|STARTED|6 Month (Follow-up)||14
2458975|NCT01021306|6028669|P2|STARTED|6 Month (Follow-up)||14
2458976|NCT01021306|6028670|P1|STARTED|6 Month (Follow-up)||14
2458977|NCT01021306|6028667|P4|NOT COMPLETED|2 Month (Primary Outcome)||4
2458978|NCT01021306|6028668|P3|NOT COMPLETED|2 Month (Primary Outcome)||5
2458979|NCT01021306|6028669|P2|NOT COMPLETED|2 Month (Primary Outcome)||6
2458980|NCT01021306|6028670|P1|NOT COMPLETED|2 Month (Primary Outcome)||6
2458981|NCT01021306|6028667|P4|COMPLETED|2 Month (Primary Outcome)||17
2458982|NCT01021306|6028668|P3|COMPLETED|2 Month (Primary Outcome)||14
2458983|NCT01021306|6028669|P2|COMPLETED|2 Month (Primary Outcome)||14
2458984|NCT01021306|6028670|P1|COMPLETED|2 Month (Primary Outcome)||14
2458985|NCT01021306|6028667|P4|STARTED|2 Month (Primary Outcome)||21
2458986|NCT01021306|6028668|P3|STARTED|2 Month (Primary Outcome)||19
2458987|NCT01021306|6028669|P2|STARTED|2 Month (Primary Outcome)||20
2458988|NCT01021306|6028670|P1|STARTED|2 Month (Primary Outcome)||20
2458989|NCT01021293|6028690|P2|NOT COMPLETED|Overall Study||24
2458990|NCT01021293|6028691|P1|NOT COMPLETED|Overall Study||12
2458991|NCT01021293|6028690|P2|COMPLETED|Overall Study||526
2458992|NCT01021293|6028691|P1|COMPLETED|Overall Study||538
2458993|NCT01021293|6028690|P2|STARTED|Overall Study||550
2458994|NCT01021293|6028691|P1|STARTED|Overall Study||550
2458995|NCT01021215|6028710|P2|NOT COMPLETED|Overall Study||0
2458996|NCT01021215|6028711|P1|NOT COMPLETED|Overall Study||3
2458997|NCT01021215|6028710|P2|COMPLETED|Overall Study||20
2458998|NCT01021215|6028711|P1|COMPLETED|Overall Study||57
2458999|NCT01021215|6028710|P2|Received Allocated Intervention|Overall Study||20
2459000|NCT01021215|6028711|P1|Received Allocated Intervention|Overall Study||60
2459001|NCT01021215|6028710|P2|STARTED|Overall Study||20
2459002|NCT01021215|6028711|P1|STARTED|Overall Study||60
2459003|NCT01021137|6028725|P4|NOT COMPLETED|Overall Study||9
2459004|NCT01021137|6028726|P3|NOT COMPLETED|Overall Study||2
2459005|NCT01021137|6028727|P2|NOT COMPLETED|Overall Study||4
2459006|NCT01021137|6028728|P1|NOT COMPLETED|Overall Study||10
2459007|NCT01021137|6028725|P4|COMPLETED|Overall Study||32
2459008|NCT01021137|6028726|P3|COMPLETED|Overall Study||9
2459009|NCT01021137|6028727|P2|COMPLETED|Overall Study||16
2459010|NCT01021137|6028728|P1|COMPLETED|Overall Study||52
2459011|NCT01021137|6028725|P4|STARTED|Overall Study||41
2459012|NCT01021137|6028726|P3|STARTED|Overall Study||11
2459013|NCT01021137|6028727|P2|STARTED|Overall Study||20
2459014|NCT01021137|6028728|P1|STARTED|Overall Study||62
2459015|NCT01021111|6028766|P1|NOT COMPLETED|Overall Study||0
2459016|NCT01021111|6028766|P1|COMPLETED|Overall Study||17
2459017|NCT01021111|6028766|P1|STARTED|Overall Study||17
2459018|NCT01021020|6028771|P1|NOT COMPLETED|Period III||0
2459019|NCT01021020|6028771|P1|COMPLETED|Period III||25
2459020|NCT01021020|6028771|P1|STARTED|Period III||25
2459021|NCT01021020|6028771|P1|NOT COMPLETED|14 Day Washout Period B||0
2459022|NCT01021020|6028771|P1|COMPLETED|14 Day Washout Period B||25
2459023|NCT01021020|6028771|P1|STARTED|14 Day Washout Period B||25
2459024|NCT01021020|6028771|P1|NOT COMPLETED|Period II||0
2459025|NCT01021020|6028771|P1|COMPLETED|Period II||25
2459026|NCT01021020|6028771|P1|STARTED|Period II||25
2459027|NCT01021020|6028771|P1|NOT COMPLETED|14 Day Washout Period A||1
2459028|NCT01021020|6028771|P1|COMPLETED|14 Day Washout Period A|Colchicine/Probenecid-medical investigator dropped due to abnormal check-in lab results.|25
2459029|NCT01021020|6028771|P1|STARTED|14 Day Washout Period A||26
2459030|NCT01021020|6028771|P1|NOT COMPLETED|Period I||2
2459031|NCT01021020|6028771|P1|COMPLETED|Period I|Colchicine(fasted)-subject took Claritin-D 12hour.Colchicine(fed)arm-subject had schedule conflict.|26
2459032|NCT01021020|6028771|P1|STARTED|Period I||28
2459033|NCT01021007|6028787|P2|NOT COMPLETED|Overall Study||4
2459034|NCT01021007|6028788|P1|NOT COMPLETED|Overall Study||2
2459035|NCT01021007|6028787|P2|COMPLETED|Overall Study||33
2459036|NCT01021007|6028788|P1|COMPLETED|Overall Study||34
2459037|NCT01021007|6028787|P2|STARTED|Overall Study||37
2459038|NCT01021007|6028788|P1|STARTED|Overall Study||36
2459039|NCT01020981|6028800|P2|NOT COMPLETED|Overall Study||90
2459040|NCT01020981|6028801|P1|NOT COMPLETED|Overall Study||84
2459041|NCT01020981|6028800|P2|COMPLETED|Overall Study||60
2459042|NCT01020981|6028801|P1|COMPLETED|Overall Study||66
2459043|NCT01020981|6028800|P2|STARTED|Overall Study||150
2459044|NCT01020981|6028801|P1|STARTED|Overall Study||150
2459045|NCT01020903|6028813|P2|NOT COMPLETED|Overall Study||0
2459046|NCT01020903|6028814|P1|NOT COMPLETED|Overall Study||0
2459047|NCT01020903|6028813|P2|COMPLETED|Overall Study|Please be advised that the investigator of the study entitled left the institution in 2011.|100
2459048|NCT01020903|6028814|P1|COMPLETED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
2459049|NCT01020903|6028813|P2|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
2459050|NCT01020903|6028814|P1|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
2459051|NCT01020877|6028822|P2|NOT COMPLETED|Second Intervention||0
2459052|NCT01020877|6028823|P1|NOT COMPLETED|Second Intervention||1
2459053|NCT01020877|6028822|P2|COMPLETED|Second Intervention||19
2459054|NCT01020877|6028823|P1|COMPLETED|Second Intervention||18
2459055|NCT01020877|6028822|P2|STARTED|Second Intervention||19
2459056|NCT01020877|6028823|P1|STARTED|Second Intervention||19
2459057|NCT01020877|6028822|P2|NOT COMPLETED|Washout of 7 Days||0
2459058|NCT01020877|6028823|P1|NOT COMPLETED|Washout of 7 Days||0
2459059|NCT01020877|6028822|P2|COMPLETED|Washout of 7 Days||19
2459060|NCT01020877|6028823|P1|COMPLETED|Washout of 7 Days||19
2459061|NCT01020877|6028822|P2|STARTED|Washout of 7 Days||19
2459062|NCT01020877|6028823|P1|STARTED|Washout of 7 Days||19
2459063|NCT01020877|6028822|P2|NOT COMPLETED|First Intervention||0
2459064|NCT01020877|6028823|P1|NOT COMPLETED|First Intervention||0
2459065|NCT01020877|6028822|P2|COMPLETED|First Intervention||19
2459066|NCT01020877|6028823|P1|COMPLETED|First Intervention||19
2459067|NCT01020877|6028822|P2|STARTED|First Intervention||19
2459068|NCT01020877|6028823|P1|STARTED|First Intervention||19
2459069|NCT01020838|6028833|P1|NOT COMPLETED|Overall Study||183
2459070|NCT01020838|6028833|P1|COMPLETED|Overall Study||35
2459071|NCT01020838|6028833|P1|Second Annual Repeat Injection|Overall Study|Patients returning for second follow-up administration and PET-scan.|34
2459072|NCT01020838|6028833|P1|First Annual Repeat Injection|Overall Study|Patients returning for first follow-up administration and PET-scan.|91
2459073|NCT01020838|6028833|P1|Final Analysis Set (Whole Brain)|Overall Study|Final analysis set comparing PET scans with different histopathological evaluations.|97
2459074|NCT01020838|6028833|P1|Interim Analysis Set (Primary Efficacy)|Overall Study|Primary efficacy analysis of initial study period (tissue-scan matched regional analysis)|41
2459075|NCT01020838|6028833|P1|Safety Analysis Set|Overall Study|Two patients were excluded from this population because injection of florbetaben was not done.|216
2459076|NCT01020838|6028833|P1|STARTED|Overall Study||218
2459077|NCT01020812|6028848|P1|NOT COMPLETED|Overall Study||3
2459078|NCT01020812|6028848|P1|COMPLETED|Overall Study||8
2459079|NCT01020812|6028848|P1|STARTED|Overall Study||11
2459080|NCT01020799|6028858|P3|NOT COMPLETED|Overall Study||7
2459081|NCT01020799|6028859|P2|NOT COMPLETED|Overall Study||14
2459082|NCT01020799|6028860|P1|NOT COMPLETED|Overall Study||19
2459083|NCT01020799|6028858|P3|COMPLETED|Overall Study||43
2459084|NCT01020799|6028859|P2|COMPLETED|Overall Study||85
2459085|NCT01020799|6028860|P1|COMPLETED|Overall Study||79
2459086|NCT01020799|6028858|P3|Full Analysis Set|Overall Study||49
2459087|NCT01020799|6028859|P2|Full Analysis Set|Overall Study||94
2459088|NCT01020799|6028860|P1|Full Analysis Set|Overall Study||91
2459089|NCT01020799|6028858|P3|Patients Received Treatment|Overall Study||50
2459090|NCT01020799|6028859|P2|Patients Received Treatment|Overall Study||99
2459091|NCT01020799|6028860|P1|Patients Received Treatment|Overall Study||96
2459092|NCT01020799|6028858|P3|STARTED|Overall Study||50
2459093|NCT01020799|6028859|P2|STARTED|Overall Study||99
2459094|NCT01020799|6028860|P1|STARTED|Overall Study||98
2459095|NCT01020786|6028883|P1|NOT COMPLETED|Maintenance Period||60
2459096|NCT01020786|6028883|P1|COMPLETED|Maintenance Period||0
2459097|NCT01020786|6028883|P1|STARTED|Maintenance Period||60
2459098|NCT01020786|6028883|P1|NOT COMPLETED|Induction Period||49
2459099|NCT01020786|6028883|P1|COMPLETED|Induction Period|Completed induction therapy. Completed=starting the maintenance therapy.|60
2459100|NCT01020786|6028883|P1|STARTED|Induction Period||109
2459101|NCT01020773|6028897|P2|NOT COMPLETED|Overall Study||3
2459102|NCT01020773|6028898|P1|NOT COMPLETED|Overall Study||4
2459103|NCT01020773|6028897|P2|COMPLETED|Overall Study||29
2459104|NCT01020773|6028898|P1|COMPLETED|Overall Study||31
2459105|NCT01020773|6028897|P2|STARTED|Overall Study||32
2459106|NCT01020773|6028898|P1|STARTED|Overall Study||35
2459107|NCT01020747|6028904|P1|NOT COMPLETED|Overall Study||1
2459108|NCT01020747|6028904|P1|COMPLETED|Overall Study||19
2459109|NCT01020747|6028904|P1|STARTED|Overall Study||20
2459110|NCT01020591|6028911|P2|NOT COMPLETED|Overall Study||0
2459111|NCT01020591|6028912|P1|NOT COMPLETED|Overall Study||0
2459112|NCT01020591|6028911|P2|COMPLETED|Overall Study||15
2459113|NCT01020591|6028912|P1|COMPLETED|Overall Study||15
2459114|NCT01020591|6028911|P2|STARTED|Overall Study||15
2459115|NCT01020591|6028912|P1|STARTED|Overall Study||15
2459116|NCT01020526|6028920|P1|NOT COMPLETED|Overall Study||14
2459117|NCT01020526|6028920|P1|COMPLETED|Overall Study||49
2459118|NCT01020526|6028920|P1|STARTED|Overall Study||63
2459119|NCT01020474|6028926|P2|NOT COMPLETED|Overall Study||17
2459120|NCT01020474|6028927|P1|NOT COMPLETED|Overall Study||10
2459121|NCT01020474|6028926|P2|COMPLETED|Overall Study||36
2459122|NCT01020474|6028927|P1|COMPLETED|Overall Study||44
2459123|NCT01020474|6028926|P2|STARTED|Overall Study||53
2459124|NCT01020474|6028927|P1|STARTED|Overall Study||54
2459125|NCT01020448|6028947|P1|NOT COMPLETED|Treatment||26
2459126|NCT01020448|6028947|P1|COMPLETED|Treatment||299
2459127|NCT01020448|6028947|P1|STARTED|Treatment|One patient was excluded from the safety population as no post-baseline assessment was available|325
2459128|NCT01020448|6028947|P1|NOT COMPLETED|Pre-assignment||13
2459129|NCT01020448|6028947|P1|COMPLETED|Pre-assignment||326
2459130|NCT01020448|6028947|P1|STARTED|Pre-assignment||339
2459131|NCT01020435|6028958|P2|NOT COMPLETED|Overall Study||1
2459132|NCT01020435|6028959|P1|NOT COMPLETED|Overall Study||0
2459133|NCT01020435|6028958|P2|COMPLETED|Overall Study||26
2459134|NCT01020435|6028959|P1|COMPLETED|Overall Study||24
2459135|NCT01020435|6028958|P2|STARTED|Overall Study||27
2459136|NCT01020435|6028959|P1|STARTED|Overall Study||24
2459137|NCT01020305|6028967|P1|NOT COMPLETED|Overall Study||2
2459138|NCT01020305|6028967|P1|COMPLETED|Overall Study||3
2459139|NCT01020305|6028967|P1|STARTED|Overall Study||5
2459140|NCT01020123|6028978|P7|NOT COMPLETED|Extention Period||1
2459141|NCT01020123|6028979|P6|NOT COMPLETED|Extention Period||2
2459142|NCT01020123|6028980|P5|NOT COMPLETED|Extention Period||0
2459143|NCT01020123|6028981|P4|NOT COMPLETED|Extention Period||1
2459144|NCT01020123|6028982|P3|NOT COMPLETED|Extention Period||2
2459145|NCT01020123|6028983|P2|NOT COMPLETED|Extention Period||2
2459146|NCT01020123|6028984|P1|NOT COMPLETED|Extention Period||3
2459147|NCT01020123|6028978|P7|COMPLETED|Extention Period||18
2459148|NCT01020123|6028979|P6|COMPLETED|Extention Period||36
2459149|NCT01020123|6028980|P5|COMPLETED|Extention Period||31
2459150|NCT01020123|6028981|P4|COMPLETED|Extention Period||12
2459151|NCT01020123|6028982|P3|COMPLETED|Extention Period||17
2459152|NCT01020123|6028983|P2|COMPLETED|Extention Period||33
2459153|NCT01020123|6028984|P1|COMPLETED|Extention Period||37
2459154|NCT01020123|6028978|P7|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
2459155|NCT01020123|6028979|P6|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|38
2459156|NCT01020123|6028980|P5|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|31
2459157|NCT01020123|6028981|P4|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|13
2459158|NCT01020123|6028982|P3|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
2459159|NCT01020123|6028983|P2|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|35
2459160|NCT01020123|6028984|P1|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|40
2459161|NCT01020123|6028978|P7|NOT COMPLETED|Main Period||11
2459162|NCT01020123|6028979|P6|NOT COMPLETED|Main Period||11
2459163|NCT01020123|6028980|P5|NOT COMPLETED|Main Period||11
2459164|NCT01020123|6028981|P4|NOT COMPLETED|Main Period||7
2459165|NCT01020123|6028982|P3|NOT COMPLETED|Main Period||8
2459166|NCT01020123|6028983|P2|NOT COMPLETED|Main Period||14
2459167|NCT01020123|6028984|P1|NOT COMPLETED|Main Period||17
2459168|NCT01020123|6028978|P7|COMPLETED|Main Period||61
2459169|NCT01020123|6028979|P6|COMPLETED|Main Period||83
2459170|NCT01020123|6028980|P5|COMPLETED|Main Period||77
2459171|NCT01020123|6028981|P4|COMPLETED|Main Period||33
2459172|NCT01020123|6028982|P3|COMPLETED|Main Period||44
2459173|NCT01020123|6028983|P2|COMPLETED|Main Period||77
2459174|NCT01020123|6028984|P1|COMPLETED|Main Period||76
2459175|NCT01020123|6028978|P7|STARTED|Main Period||72
2459176|NCT01020123|6028979|P6|STARTED|Main Period||94
2459177|NCT01020123|6028980|P5|STARTED|Main Period||88
2459178|NCT01020123|6028981|P4|STARTED|Main Period||40
2459179|NCT01020123|6028982|P3|STARTED|Main Period||52
2459180|NCT01020123|6028983|P2|STARTED|Main Period||91
2459181|NCT01020123|6028984|P1|STARTED|Main Period||93
2459182|NCT01020019|6029179|P2|NOT COMPLETED|Overall Study||29
2459183|NCT01020019|6029180|P1|NOT COMPLETED|Overall Study||26
2459184|NCT01020019|6029179|P2|COMPLETED|Overall Study||32
2459185|NCT01020019|6029180|P1|COMPLETED|Overall Study||35
2459186|NCT01020019|6029179|P2|STARTED|Overall Study||61
2459187|NCT01020019|6029180|P1|STARTED|Overall Study||61
2459188|NCT01020006|6029189|P3|NOT COMPLETED|Overall Study||16
2459189|NCT01020006|6029190|P2|NOT COMPLETED|Overall Study||18
2459190|NCT01020006|6029191|P1|NOT COMPLETED|Overall Study||8
2459191|NCT01020006|6029189|P3|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
2459192|NCT01020006|6029190|P2|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
2459193|NCT01020006|6029191|P1|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
2459194|NCT01020006|6029189|P3|STARTED|Overall Study||16
2459195|NCT01020006|6029190|P2|STARTED|Overall Study||18
2459196|NCT01020006|6029191|P1|STARTED|Overall Study||8
2459197|NCT01019980|6029201|P2|NOT COMPLETED|Overall Study||0
2459198|NCT01019980|6029202|P1|NOT COMPLETED|Overall Study||2
2459199|NCT01019980|6029201|P2|COMPLETED|Overall Study||0
2459200|NCT01019980|6029202|P1|COMPLETED|Overall Study||0
2459201|NCT01019980|6029201|P2|Discontinued|Overall Study||0
2459202|NCT01019980|6029202|P1|Discontinued|Overall Study||2
2459203|NCT01019980|6029201|P2|STARTED|Overall Study||0
2459204|NCT01019980|6029202|P1|STARTED|Overall Study|2 patients entered study but did not receive any drug since it was not available in the region.|2
2459205|NCT01019928|6029210|P2|NOT COMPLETED|Period 3||0
2459206|NCT01019928|6029211|P1|NOT COMPLETED|Period 3||0
2459207|NCT01019928|6029210|P2|COMPLETED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
2459208|NCT01019928|6029211|P1|COMPLETED|Period 3||7
2459209|NCT01019928|6029210|P2|STARTED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
2459210|NCT01019928|6029211|P1|STARTED|Period 3||7
2459211|NCT01019928|6029210|P2|NOT COMPLETED|Period 2||1
2459212|NCT01019928|6029211|P1|NOT COMPLETED|Period 2||0
2459213|NCT01019928|6029210|P2|COMPLETED|Period 2|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
2459214|NCT01019928|6029211|P1|COMPLETED|Period 2||7
2459215|NCT01019928|6029210|P2|STARTED|Period 2||7
2459216|NCT01019928|6029211|P1|STARTED|Period 2||7
2459217|NCT01019928|6029210|P2|NOT COMPLETED|Period 1||0
2459218|NCT01019928|6029211|P1|NOT COMPLETED|Period 1||0
2459219|NCT01019928|6029210|P2|COMPLETED|Period 1||7
2459220|NCT01019928|6029211|P1|COMPLETED|Period 1||7
2459221|NCT01019928|6029210|P2|STARTED|Period 1||7
2459222|NCT01019928|6029211|P1|STARTED|Period 1||7
2459223|NCT01019707|6029251|P2|NOT COMPLETED|Second Phase||0
2459224|NCT01019707|6029252|P1|NOT COMPLETED|Second Phase||0
2459225|NCT01019707|6029251|P2|COMPLETED|Second Phase||1
2459226|NCT01019707|6029252|P1|COMPLETED|Second Phase||3
2459227|NCT01019707|6029251|P2|STARTED|Second Phase||1
2459228|NCT01019707|6029252|P1|STARTED|Second Phase||3
2459229|NCT01019707|6029251|P2|NOT COMPLETED|Washout||2
2459230|NCT01019707|6029252|P1|NOT COMPLETED|Washout||0
2459231|NCT01019707|6029251|P2|COMPLETED|Washout||1
2459232|NCT01019707|6029252|P1|COMPLETED|Washout||3
2459233|NCT01019707|6029251|P2|STARTED|Washout||3
2459234|NCT01019707|6029252|P1|STARTED|Washout||3
2459235|NCT01019707|6029251|P2|NOT COMPLETED|First Phase||0
2459236|NCT01019707|6029252|P1|NOT COMPLETED|First Phase||0
2459237|NCT01019707|6029251|P2|COMPLETED|First Phase||3
2459238|NCT01019707|6029252|P1|COMPLETED|First Phase||3
2459239|NCT01019707|6029251|P2|STARTED|First Phase||3
2459240|NCT01019707|6029252|P1|STARTED|First Phase||3
2459241|NCT01019694|6029265|P3|NOT COMPLETED|Overall Study||47
2459242|NCT01019694|6029266|P2|NOT COMPLETED|Overall Study||38
2459243|NCT01019694|6029267|P1|NOT COMPLETED|Overall Study||24
2459244|NCT01019694|6029265|P3|COMPLETED|Overall Study||110
2459245|NCT01019694|6029266|P2|COMPLETED|Overall Study||118
2459246|NCT01019694|6029267|P1|COMPLETED|Overall Study||133
2459247|NCT01019694|6029265|P3|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
2459248|NCT01019694|6029266|P2|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|156
2459249|NCT01019694|6029267|P1|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
2459250|NCT01019486|6029392|P3|NOT COMPLETED|Overall Study||1
2459251|NCT01019486|6029393|P2|NOT COMPLETED|Overall Study||1
2459252|NCT01019486|6029394|P1|NOT COMPLETED|Overall Study||1
2459253|NCT01019486|6029392|P3|COMPLETED|Overall Study||15
2459254|NCT01019486|6029393|P2|COMPLETED|Overall Study||4
2459255|NCT01019486|6029394|P1|COMPLETED|Overall Study||4
2459256|NCT01019486|6029392|P3|STARTED|Overall Study||16
2459257|NCT01019486|6029393|P2|STARTED|Overall Study||5
2459258|NCT01019486|6029394|P1|STARTED|Overall Study||5
2459259|NCT01019369|6029408|P2|NOT COMPLETED|Overall Study||7
2459260|NCT01019369|6029409|P1|NOT COMPLETED|Overall Study||10
2459261|NCT01019369|6029408|P2|COMPLETED|Overall Study||39
2459262|NCT01019369|6029409|P1|COMPLETED|Overall Study||76
2459263|NCT01019369|6029408|P2|STARTED|Overall Study||46
2459264|NCT01019369|6029409|P1|STARTED|Overall Study||86
2459265|NCT01019317|6029425|P1|NOT COMPLETED|Overall Study||4
2459266|NCT01019317|6029425|P1|COMPLETED|Overall Study||147
2459267|NCT01019317|6029425|P1|STARTED|Overall Study||151
2459268|NCT01019252|6029431|P2|NOT COMPLETED|Wait List Cross-over to CBT for ADHD||7
2459269|NCT01019252|6029432|P1|NOT COMPLETED|Wait List Cross-over to CBT for ADHD||0
2459270|NCT01019252|6029431|P2|COMPLETED|Wait List Cross-over to CBT for ADHD||15
2459271|NCT01019252|6029432|P1|COMPLETED|Wait List Cross-over to CBT for ADHD||21
2459272|NCT01019252|6029431|P2|STARTED|Wait List Cross-over to CBT for ADHD||22
2459273|NCT01019252|6029432|P1|STARTED|Wait List Cross-over to CBT for ADHD|Lost to follow up, did not start treatment following wait list completion (n=3)|21
2459274|NCT01019252|6029431|P2|NOT COMPLETED|Initial CBT for ADHD vs. Wait List||0
2459275|NCT01019252|6029432|P1|NOT COMPLETED|Initial CBT for ADHD vs. Wait List||3
2459276|NCT01019252|6029431|P2|COMPLETED|Initial CBT for ADHD vs. Wait List||22
2459277|NCT01019252|6029432|P1|COMPLETED|Initial CBT for ADHD vs. Wait List||21
2459278|NCT01019252|6029431|P2|STARTED|Initial CBT for ADHD vs. Wait List|Stratified based on biological sex and clinician-rated severity (CGI score)|22
2459279|NCT01019252|6029432|P1|STARTED|Initial CBT for ADHD vs. Wait List|Stratified based on biological sex and clinician-rated severity (CGI score)|24
2459280|NCT01019135|6029445|P3|NOT COMPLETED|Overall Study||31
2459281|NCT01019135|6029446|P2|NOT COMPLETED|Overall Study||19
2459282|NCT01019135|6029447|P1|NOT COMPLETED|Overall Study||20
2459283|NCT01019135|6029445|P3|COMPLETED|Overall Study||24
2459284|NCT01019135|6029446|P2|COMPLETED|Overall Study||40
2459285|NCT01019135|6029447|P1|COMPLETED|Overall Study||35
2459286|NCT01019135|6029445|P3|STARTED|Overall Study||55
2459287|NCT01019135|6029446|P2|STARTED|Overall Study||59
2459288|NCT01019135|6029447|P1|STARTED|Overall Study||55
2459289|NCT01018992|6029475|P2|NOT COMPLETED|Overall Study||16
2459290|NCT01018992|6029476|P1|NOT COMPLETED|Overall Study||16
2459291|NCT01018992|6029475|P2|COMPLETED|Overall Study||49
2459292|NCT01018992|6029476|P1|COMPLETED|Overall Study||47
2459293|NCT01018992|6029475|P2|STARTED|Overall Study||65
2459294|NCT01018992|6029476|P1|STARTED|Overall Study||63
2459295|NCT01018979|6029490|P2|NOT COMPLETED|Overall Study||10
2459296|NCT01018979|6029491|P1|NOT COMPLETED|Overall Study||3
2459297|NCT01018979|6029490|P2|COMPLETED|Overall Study||3
2459298|NCT01018979|6029491|P1|COMPLETED|Overall Study||4
2459299|NCT01018979|6029490|P2|Received at Least One Dose|Overall Study||12
2459300|NCT01018979|6029491|P1|Received at Least One Dose|Overall Study||7
2459301|NCT01018979|6029490|P2|STARTED|Overall Study|A total of 20 subjects were randomized.|13
2459302|NCT01018979|6029491|P1|STARTED|Overall Study||7
2459303|NCT01018953|6029521|P1|NOT COMPLETED|Overall Study||8
2459304|NCT01018953|6029521|P1|COMPLETED|Overall Study||0
2459305|NCT01018953|6029521|P1|BIM 23A760 4 mg|Overall Study||3
2459306|NCT01018953|6029521|P1|BIM 23A760 2 mg|Overall Study||2
2459307|NCT01018953|6029521|P1|BIM 23A760 1 mg|Overall Study||3
2459308|NCT01018953|6029521|P1|STARTED|Overall Study||8
2459309|NCT01018862|6029534|P3|NOT COMPLETED|Overall Study||16
2459310|NCT01018862|6029535|P2|NOT COMPLETED|Overall Study||10
2459311|NCT01018862|6029536|P1|NOT COMPLETED|Overall Study||13
2459312|NCT01018862|6029534|P3|COMPLETED|Overall Study||146
2459313|NCT01018862|6029535|P2|COMPLETED|Overall Study||156
2459314|NCT01018862|6029536|P1|COMPLETED|Overall Study||148
2459315|NCT01018862|6029534|P3|STARTED|Overall Study||162
2459316|NCT01018862|6029535|P2|STARTED|Overall Study||166
2459317|NCT01018862|6029536|P1|STARTED|Overall Study||161
2459318|NCT01018810|6029558|P5|NOT COMPLETED|Overall Study||1
2459319|NCT01018810|6029559|P4|NOT COMPLETED|Overall Study||1
2459320|NCT01018810|6029560|P3|NOT COMPLETED|Overall Study||1
2459321|NCT01018810|6029561|P2|NOT COMPLETED|Overall Study||1
2459322|NCT01018810|6029562|P1|NOT COMPLETED|Overall Study||2
2459323|NCT01018810|6029558|P5|COMPLETED|Overall Study||0
2459324|NCT01018810|6029559|P4|COMPLETED|Overall Study||0
2459325|NCT01018810|6029560|P3|COMPLETED|Overall Study||0
2459326|NCT01018810|6029561|P2|COMPLETED|Overall Study||0
2459327|NCT01018810|6029562|P1|COMPLETED|Overall Study||2
2459328|NCT01018810|6029558|P5|STARTED|Overall Study||1
2459329|NCT01018810|6029559|P4|STARTED|Overall Study||1
2459330|NCT01018810|6029560|P3|STARTED|Overall Study||1
2459331|NCT01018810|6029561|P2|STARTED|Overall Study||1
2459332|NCT01018810|6029562|P1|STARTED|Overall Study||4
2459333|NCT01018732|6029622|P3|NOT COMPLETED|Overall Study||4
2459334|NCT01018732|6029623|P2|NOT COMPLETED|Overall Study||2
2459335|NCT01018732|6029624|P1|NOT COMPLETED|Overall Study||1
2459336|NCT01018732|6029622|P3|COMPLETED|Overall Study||50
2459337|NCT01018732|6029623|P2|COMPLETED|Overall Study||49
2459338|NCT01018732|6029624|P1|COMPLETED|Overall Study||49
2459339|NCT01018732|6029622|P3|STARTED|Overall Study||54
2459340|NCT01018732|6029623|P2|STARTED|Overall Study||51
2459341|NCT01018732|6029624|P1|STARTED|Overall Study||50
2459342|NCT01018680|6029658|P2|NOT COMPLETED|Overall Study||75
2459343|NCT01018680|6029659|P1|NOT COMPLETED|Overall Study||61
2459344|NCT01018680|6029658|P2|COMPLETED|Overall Study||189
2459345|NCT01018680|6029659|P1|COMPLETED|Overall Study||199
2459346|NCT01018680|6029658|P2|STARTED|Overall Study||264
2459347|NCT01018680|6029659|P1|STARTED|Overall Study||260
2459348|NCT01020487|6029702|P3|NOT COMPLETED|Part 2 Open-label Period||1
2459349|NCT01020487|6029703|P2|NOT COMPLETED|Part 2 Open-label Period||4
2459350|NCT01020487|6029704|P1|NOT COMPLETED|Part 2 Open-label Period||0
2459351|NCT01020487|6029702|P3|COMPLETED|Part 2 Open-label Period||12
2459352|NCT01020487|6029703|P2|COMPLETED|Part 2 Open-label Period||12
2459353|NCT01020487|6029704|P1|COMPLETED|Part 2 Open-label Period||0
2459354|NCT01020487|6029702|P3|STARTED|Part 2 Open-label Period||13
2459355|NCT01020487|6029703|P2|STARTED|Part 2 Open-label Period||16
2459356|NCT01020487|6029704|P1|STARTED|Part 2 Open-label Period||0
2459357|NCT01020487|6029702|P3|NOT COMPLETED|Part 2 Double-blind Treatment Period||6
2459358|NCT01020487|6029703|P2|NOT COMPLETED|Part 2 Double-blind Treatment Period||2
2459359|NCT01020487|6029704|P1|NOT COMPLETED|Part 2 Double-blind Treatment Period||0
2459360|NCT01020487|6029702|P3|COMPLETED|Part 2 Double-blind Treatment Period||13
2459361|NCT01020487|6029703|P2|COMPLETED|Part 2 Double-blind Treatment Period||16
2459362|NCT01020487|6029704|P1|COMPLETED|Part 2 Double-blind Treatment Period||0
2459363|NCT01020487|6029702|P3|Received Treatment|Part 2 Double-blind Treatment Period||18
2459364|NCT01020487|6029703|P2|Received Treatment|Part 2 Double-blind Treatment Period||18
2459365|NCT01020487|6029704|P1|Received Treatment|Part 2 Double-blind Treatment Period||0
2459366|NCT01020487|6029702|P3|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|19
2459367|NCT01020487|6029703|P2|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|18
2459368|NCT01020487|6029704|P1|STARTED|Part 2 Double-blind Treatment Period||0
2459369|NCT01020487|6029702|P3|NOT COMPLETED|Part 1||0
2459370|NCT01020487|6029703|P2|NOT COMPLETED|Part 1||0
2459371|NCT01020487|6029704|P1|NOT COMPLETED|Part 1||0
2459372|NCT01020487|6029702|P3|COMPLETED|Part 1||0
2459373|NCT01020487|6029703|P2|COMPLETED|Part 1||0
2459374|NCT01020487|6029704|P1|COMPLETED|Part 1||12
2459375|NCT01020487|6029702|P3|STARTED|Part 1||0
2459376|NCT01020487|6029703|P2|STARTED|Part 1||0
2459377|NCT01020487|6029704|P1|STARTED|Part 1||12
2459378|NCT01018511|6029729|P4|NOT COMPLETED|Overall Study||33
2459379|NCT01018511|6029730|P3|NOT COMPLETED|Overall Study||40
2459380|NCT01018511|6029731|P2|NOT COMPLETED|Overall Study||32
2459381|NCT01018511|6029732|P1|NOT COMPLETED|Overall Study||26
2459382|NCT01018511|6029729|P4|COMPLETED|Overall Study||294
2459383|NCT01018511|6029730|P3|COMPLETED|Overall Study||299
2459384|NCT01018511|6029731|P2|COMPLETED|Overall Study||295
2459385|NCT01018511|6029732|P1|COMPLETED|Overall Study||315
2459386|NCT01018511|6029729|P4|Randomized and Treated|Overall Study||324
2459387|NCT01018511|6029730|P3|Randomized and Treated|Overall Study||338
2459388|NCT01018511|6029731|P2|Randomized and Treated|Overall Study||326
2459389|NCT01018511|6029732|P1|Randomized and Treated|Overall Study||341
2459390|NCT01018511|6029729|P4|STARTED|Overall Study||327
2459391|NCT01018511|6029730|P3|STARTED|Overall Study||339
2459392|NCT01018511|6029731|P2|STARTED|Overall Study||327
2459393|NCT01018511|6029732|P1|STARTED|Overall Study||341
2459394|NCT01018420|6029901|P2|NOT COMPLETED|Overall Study||0
2459395|NCT01018420|6029902|P1|NOT COMPLETED|Overall Study||0
2459396|NCT01018420|6029901|P2|COMPLETED|Overall Study||3
2459397|NCT01018420|6029902|P1|COMPLETED|Overall Study||15
2459398|NCT01018420|6029901|P2|STARTED|Overall Study||3
2459399|NCT01018420|6029902|P1|STARTED|Overall Study||15
2459400|NCT01018394|6029929|P2|NOT COMPLETED|Overall Study||8
2459401|NCT01018394|6029930|P1|NOT COMPLETED|Overall Study||9
2459402|NCT01018394|6029929|P2|COMPLETED|Overall Study||33
2459403|NCT01018394|6029930|P1|COMPLETED|Overall Study||31
2459404|NCT01018394|6029929|P2|STARTED|Overall Study||41
2459405|NCT01018394|6029930|P1|STARTED|Overall Study||40
2459406|NCT01018264|6029940|P2|NOT COMPLETED|Overall Study||1
2459407|NCT01018264|6029941|P1|NOT COMPLETED|Overall Study||1
2459408|NCT01018264|6029940|P2|COMPLETED|Overall Study||12
2459409|NCT01018264|6029941|P1|COMPLETED|Overall Study||9
2459410|NCT01018264|6029940|P2|STARTED|Overall Study||13
2459411|NCT01018264|6029941|P1|STARTED|Overall Study||10
2459412|NCT01018186|6029958|P4|NOT COMPLETED|52-week Double-blind Treatment Period||29
2459413|NCT01018186|6029959|P3|NOT COMPLETED|52-week Double-blind Treatment Period||41
2459414|NCT01018186|6029960|P2|NOT COMPLETED|52-week Double-blind Treatment Period||40
2459415|NCT01018186|6029961|P1|NOT COMPLETED|52-week Double-blind Treatment Period||0
2459416|NCT01018186|6029958|P4|COMPLETED|52-week Double-blind Treatment Period||71
2459417|NCT01018186|6029959|P3|COMPLETED|52-week Double-blind Treatment Period||161
2459418|NCT01018186|6029960|P2|COMPLETED|52-week Double-blind Treatment Period||161
2459419|NCT01018186|6029961|P1|COMPLETED|52-week Double-blind Treatment Period||0
2459420|NCT01018186|6029958|P4|STARTED|52-week Double-blind Treatment Period||100
2459421|NCT01018186|6029959|P3|STARTED|52-week Double-blind Treatment Period||202
2459422|NCT01018186|6029960|P2|STARTED|52-week Double-blind Treatment Period||201
2459423|NCT01018186|6029961|P1|STARTED|52-week Double-blind Treatment Period||0
2459424|NCT01018186|6029958|P4|NOT COMPLETED|2-week Run-in Period||0
2459425|NCT01018186|6029959|P3|NOT COMPLETED|2-week Run-in Period||0
2459426|NCT01018186|6029960|P2|NOT COMPLETED|2-week Run-in Period||0
2459427|NCT01018186|6029961|P1|NOT COMPLETED|2-week Run-in Period||114
2459428|NCT01018186|6029958|P4|COMPLETED|2-week Run-in Period||0
2459429|NCT01018186|6029959|P3|COMPLETED|2-week Run-in Period||0
2459430|NCT01018186|6029960|P2|COMPLETED|2-week Run-in Period||0
2459431|NCT01018186|6029961|P1|COMPLETED|2-week Run-in Period||503
2459432|NCT01018186|6029958|P4|STARTED|2-week Run-in Period||0
2459433|NCT01018186|6029959|P3|STARTED|2-week Run-in Period||0
2459434|NCT01018186|6029960|P2|STARTED|2-week Run-in Period||0
2459435|NCT01018186|6029961|P1|STARTED|2-week Run-in Period||617
2459436|NCT01018134|6030053|P6|NOT COMPLETED|Overall Study||0
2459437|NCT01018134|6030054|P5|NOT COMPLETED|Overall Study||0
2459438|NCT01018134|6030055|P4|NOT COMPLETED|Overall Study||0
2459439|NCT01018134|6030056|P3|NOT COMPLETED|Overall Study||1
2459440|NCT01018134|6030057|P2|NOT COMPLETED|Overall Study||1
2459441|NCT01018134|6030058|P1|NOT COMPLETED|Overall Study||0
2459442|NCT01018134|6030053|P6|COMPLETED|Overall Study||15
2459443|NCT01018134|6030054|P5|COMPLETED|Overall Study||15
2459444|NCT01018134|6030055|P4|COMPLETED|Overall Study||29
2459445|NCT01018134|6030056|P3|COMPLETED|Overall Study||29
2459446|NCT01018134|6030057|P2|COMPLETED|Overall Study||30
2459447|NCT01018134|6030058|P1|COMPLETED|Overall Study||30
2459448|NCT01018134|6030053|P6|STARTED|Overall Study||15
2459449|NCT01018134|6030054|P5|STARTED|Overall Study||15
2459450|NCT01018134|6030055|P4|STARTED|Overall Study|30 enrolled patients, one who did not use the study medication was excluded from all analyses|29
2459451|NCT01018134|6030056|P3|STARTED|Overall Study||30
2459452|NCT01018134|6030057|P2|STARTED|Overall Study||31
2459453|NCT01018134|6030058|P1|STARTED|Overall Study||30
2459454|NCT01018095|6030098|P2|NOT COMPLETED|Overall Study||62
2459455|NCT01018095|6030099|P1|NOT COMPLETED|Overall Study||56
2459456|NCT01018095|6030098|P2|COMPLETED|Overall Study||73
2459457|NCT01018095|6030099|P1|COMPLETED|Overall Study||79
2459458|NCT01018095|6030098|P2|STARTED|Overall Study||135
2459459|NCT01018095|6030099|P1|STARTED|Overall Study||135
2459460|NCT01018056|6030110|P3|NOT COMPLETED|Overall Study||1
2459461|NCT01018056|6030111|P2|NOT COMPLETED|Overall Study||2
2459462|NCT01018056|6030112|P1|NOT COMPLETED|Overall Study||3
2459463|NCT01018056|6030110|P3|COMPLETED|Overall Study||5
2459464|NCT01018056|6030111|P2|COMPLETED|Overall Study||10
2459465|NCT01018056|6030112|P1|COMPLETED|Overall Study||9
2459466|NCT01018056|6030110|P3|STARTED|Overall Study||6
2459467|NCT01018056|6030111|P2|STARTED|Overall Study||12
2459468|NCT01018056|6030112|P1|STARTED|Overall Study||12
2459469|NCT01018030|6030162|P3|NOT COMPLETED|Overall Study||13
2459470|NCT01018030|6030163|P2|NOT COMPLETED|Overall Study||11
2459471|NCT01018030|6030164|P1|NOT COMPLETED|Overall Study||19
2459472|NCT01018030|6030162|P3|COMPLETED|Overall Study||239
2459473|NCT01018030|6030163|P2|COMPLETED|Overall Study||232
2459474|NCT01018030|6030164|P1|COMPLETED|Overall Study||227
2459475|NCT01018030|6030162|P3|STARTED|Overall Study||252
2459476|NCT01018030|6030163|P2|STARTED|Overall Study||243
2459477|NCT01018030|6030164|P1|STARTED|Overall Study||246
2459478|NCT01017952|6030215|P5|NOT COMPLETED|52-week, Double-blind Treatment Period||103
2459479|NCT01017952|6030216|P4|NOT COMPLETED|52-week, Double-blind Treatment Period||112
2459480|NCT01017952|6030217|P3|NOT COMPLETED|52-week, Double-blind Treatment Period||109
2459481|NCT01017952|6030218|P2|NOT COMPLETED|52-week, Double-blind Treatment Period||125
2459482|NCT01017952|6030219|P1|NOT COMPLETED|52-week, Double-blind Treatment Period||0
2459483|NCT01017952|6030215|P5|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|306
2459484|NCT01017952|6030216|P4|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|291
2459485|NCT01017952|6030217|P3|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|303
2459486|NCT01017952|6030218|P2|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|284
2459487|NCT01017952|6030219|P1|COMPLETED|52-week, Double-blind Treatment Period||0
2459488|NCT01017952|6030215|P5|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|307
2459489|NCT01017952|6030216|P4|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|293
2459490|NCT01017952|6030217|P3|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|305
2459491|NCT01017952|6030218|P2|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|285
2459492|NCT01017952|6030219|P1|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
2459493|NCT01017952|6030215|P5|STARTED|52-week, Double-blind Treatment Period||409
2459494|NCT01017952|6030216|P4|STARTED|52-week, Double-blind Treatment Period||403
2459495|NCT01017952|6030217|P3|STARTED|52-week, Double-blind Treatment Period||412
2459496|NCT01017952|6030218|P2|STARTED|52-week, Double-blind Treatment Period||409
2459497|NCT01017952|6030219|P1|STARTED|52-week, Double-blind Treatment Period||0
2459498|NCT01017952|6030215|P5|NOT COMPLETED|4-week, Open-label Run-In Period||0
2459499|NCT01017952|6030216|P4|NOT COMPLETED|4-week, Open-label Run-In Period||0
2459500|NCT01017952|6030217|P3|NOT COMPLETED|4-week, Open-label Run-In Period||0
2459501|NCT01017952|6030218|P2|NOT COMPLETED|4-week, Open-label Run-In Period||0
2459502|NCT01017952|6030219|P1|NOT COMPLETED|4-week, Open-label Run-In Period||459
2459503|NCT01017952|6030215|P5|COMPLETED|4-week, Open-label Run-In Period||0
2459504|NCT01017952|6030216|P4|COMPLETED|4-week, Open-label Run-In Period||0
2459505|NCT01017952|6030217|P3|COMPLETED|4-week, Open-label Run-In Period||0
2459506|NCT01017952|6030218|P2|COMPLETED|4-week, Open-label Run-In Period||0
2459507|NCT01017952|6030219|P1|COMPLETED|4-week, Open-label Run-In Period||1633
2459508|NCT01017952|6030215|P5|STARTED|4-week, Open-label Run-In Period||0
2459509|NCT01017952|6030216|P4|STARTED|4-week, Open-label Run-In Period||0
2459510|NCT01017952|6030217|P3|STARTED|4-week, Open-label Run-In Period||0
2459511|NCT01017952|6030218|P2|STARTED|4-week, Open-label Run-In Period||0
2459512|NCT01017952|6030219|P1|STARTED|4-week, Open-label Run-In Period||2092
2459513|NCT01017874|6030243|P2|NOT COMPLETED|Overall Study||26
2459514|NCT01017874|6030244|P1|NOT COMPLETED|Overall Study||30
2459515|NCT01017874|6030243|P2|COMPLETED|Overall Study||92
2459516|NCT01017874|6030244|P1|COMPLETED|Overall Study||88
2459517|NCT01017874|6030243|P2|Received at Least 1 Dose of Study Drug|Overall Study||118
2459518|NCT01017874|6030244|P1|Received at Least 1 Dose of Study Drug|Overall Study||114
2459519|NCT01017874|6030243|P2|STARTED|Overall Study||118
2459520|NCT01017874|6030244|P1|STARTED|Overall Study||118
2459521|NCT01017731|6030262|P1|NOT COMPLETED|Overall Study||8
2459522|NCT01017731|6030262|P1|COMPLETED|Overall Study||60
2459523|NCT01017731|6030262|P1|Received at Least 1 Dose of Study Drug|Overall Study||66
2459524|NCT01017731|6030262|P1|STARTED|Overall Study||68
2459525|NCT01017653|6030279|P1|NOT COMPLETED|Overall Study||0
2459526|NCT01017653|6030279|P1|COMPLETED|Overall Study||16
2459527|NCT01017653|6030279|P1|STARTED|Overall Study||16
2459528|NCT01017601|6030291|P2|NOT COMPLETED|Overall Study||13
2459529|NCT01017601|6030292|P1|NOT COMPLETED|Overall Study||12
2459530|NCT01017601|6030291|P2|COMPLETED|Overall Study||11
2459531|NCT01017601|6030292|P1|COMPLETED|Overall Study||14
2459532|NCT01017601|6030291|P2|STARTED|Overall Study||24
2459533|NCT01017601|6030292|P1|STARTED|Overall Study||26
2459534|NCT01017575|6030319|P5|NOT COMPLETED|Overall Study||3
2459535|NCT01017575|6030320|P4|NOT COMPLETED|Overall Study||1
2459536|NCT01017575|6030321|P3|NOT COMPLETED|Overall Study||0
2459537|NCT01017575|6030322|P2|NOT COMPLETED|Overall Study||2
2459538|NCT01017575|6030323|P1|NOT COMPLETED|Overall Study||1
2459539|NCT01017575|6030319|P5|COMPLETED|Overall Study||6
2459540|NCT01017575|6030320|P4|COMPLETED|Overall Study||7
2459541|NCT01017575|6030321|P3|COMPLETED|Overall Study||8
2459542|NCT01017575|6030322|P2|COMPLETED|Overall Study||7
2459543|NCT01017575|6030323|P1|COMPLETED|Overall Study||7
2459544|NCT01017575|6030319|P5|STARTED|Overall Study||9
2459545|NCT01017575|6030320|P4|STARTED|Overall Study||8
2459546|NCT01017575|6030321|P3|STARTED|Overall Study||8
2459547|NCT01017575|6030322|P2|STARTED|Overall Study||9
2459548|NCT01017575|6030323|P1|STARTED|Overall Study||8
2459549|NCT01017549|6030360|P1|NOT COMPLETED|One-year Follow-up||7
2459550|NCT01017549|6030360|P1|COMPLETED|One-year Follow-up||36
2459551|NCT01017549|6030360|P1|STARTED|One-year Follow-up||43
2459552|NCT01017549|6030360|P1|NOT COMPLETED|Eligibility Through 6 Month Follow-up||1
2459553|NCT01017549|6030360|P1|COMPLETED|Eligibility Through 6 Month Follow-up|6 month follow-up complete Oct 2008; data through 6 months and 1 year are published.|43
2459554|NCT01017549|6030360|P1|STARTED|Eligibility Through 6 Month Follow-up||44
2459555|NCT01017536|6030367|P2|NOT COMPLETED|Overall Study||0
2459556|NCT01017536|6030368|P1|NOT COMPLETED|Overall Study||0
2459557|NCT01017536|6030367|P2|COMPLETED|Overall Study||13
2459558|NCT01017536|6030368|P1|COMPLETED|Overall Study||13
2459559|NCT01017536|6030367|P2|STARTED|Overall Study||13
2459560|NCT01017536|6030368|P1|STARTED|Overall Study||13
2459561|NCT01017497|6030378|P1|NOT COMPLETED|Overall Study||0
2459562|NCT01017497|6030378|P1|COMPLETED|Overall Study||49
2459563|NCT01017497|6030378|P1|STARTED|Overall Study||49
2459564|NCT01017263|6030391|P1|NOT COMPLETED|Overall Study||12
2459650|NCT01016912|6030656|P5|Received Treatment|End of Treatment Period||9
2459565|NCT01017263|6030391|P1|COMPLETED|Overall Study|A total of 14 participants screened: 2 qualified and received drug the remaining 12 failed screen|2
2459566|NCT01017263|6030391|P1|STARTED|Overall Study||14
2459567|NCT01017250|6030395|P1|NOT COMPLETED|Overall Study||0
2459568|NCT01017250|6030395|P1|COMPLETED|Overall Study||15
2459569|NCT01017250|6030395|P1|2-month MRI|Overall Study|1 participant did not return for the 2 month MRI at treating facility. Resides out of state.|14
2459570|NCT01017250|6030395|P1|STARTED|Overall Study||15
2459571|NCT01017237|6030417|P2|NOT COMPLETED|Overall Study||2
2459572|NCT01017237|6030418|P1|NOT COMPLETED|Overall Study||5
2459573|NCT01017237|6030417|P2|COMPLETED|Overall Study||6
2459574|NCT01017237|6030418|P1|COMPLETED|Overall Study||5
2459575|NCT01017237|6030417|P2|STARTED|Overall Study||8
2459576|NCT01017237|6030418|P1|STARTED|Overall Study||10
2459577|NCT01017146|6030472|P2|NOT COMPLETED|Overall Study||39
2459578|NCT01017146|6030473|P1|NOT COMPLETED|Overall Study||66
2459579|NCT01017146|6030472|P2|COMPLETED|Overall Study||333
2459580|NCT01017146|6030473|P1|COMPLETED|Overall Study||306
2459581|NCT01017146|6030472|P2|STARTED|Overall Study||372
2459582|NCT01017146|6030473|P1|STARTED|Overall Study||372
2459583|NCT01017120|6030511|P2|NOT COMPLETED|Overall Study||35
2459584|NCT01017120|6030512|P1|NOT COMPLETED|Overall Study||66
2459585|NCT01017120|6030511|P2|COMPLETED|Overall Study||334
2459586|NCT01017120|6030512|P1|COMPLETED|Overall Study||307
2459587|NCT01017120|6030511|P2|STARTED|Overall Study||369
2459588|NCT01017120|6030512|P1|STARTED|Overall Study||373
2459589|NCT01017042|6030560|P1|NOT COMPLETED|Overall Study||0
2459590|NCT01017042|6030560|P1|COMPLETED|Overall Study||13
2459591|NCT01017042|6030560|P1|STARTED|Overall Study||13
2459592|NCT01017029|6030573|P2|NOT COMPLETED|Overall Study||2
2459593|NCT01017029|6030574|P1|NOT COMPLETED|Overall Study||4
2459594|NCT01017029|6030573|P2|COMPLETED|Overall Study||90
2459595|NCT01017029|6030574|P1|COMPLETED|Overall Study||85
2459596|NCT01017029|6030573|P2|STARTED|Overall Study||92
2459597|NCT01017029|6030574|P1|STARTED|Overall Study||89
2459598|NCT01017003|6030590|P1|NOT COMPLETED|Colchicine 0.6 mg Final Dose||0
2459599|NCT01017003|6030590|P1|COMPLETED|Colchicine 0.6 mg Final Dose||13
2459600|NCT01017003|6030590|P1|STARTED|Colchicine 0.6 mg Final Dose||13
2459601|NCT01017003|6030590|P1|NOT COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||0
2459602|NCT01017003|6030590|P1|COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||13
2459603|NCT01017003|6030590|P1|STARTED|Colchicine 0.6 mg Twice Daily x 10 Days||13
2459604|NCT01017003|6030590|P1|NOT COMPLETED|14 Day Washout Period||0
2459605|NCT01017003|6030590|P1|COMPLETED|14 Day Washout Period||13
2459606|NCT01017003|6030590|P1|STARTED|14 Day Washout Period||13
2459607|NCT01017003|6030590|P1|NOT COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||0
2459608|NCT01017003|6030590|P1|COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||13
2459609|NCT01017003|6030590|P1|STARTED|Single Dose Colchicine 0.6 mg, Day 1||13
2459610|NCT01016977|6030602|P2|NOT COMPLETED|Overall Study||2
2459611|NCT01016977|6030603|P1|NOT COMPLETED|Overall Study||3
2459612|NCT01016977|6030602|P2|COMPLETED|Overall Study||18
2459613|NCT01016977|6030603|P1|COMPLETED|Overall Study||17
2459614|NCT01016977|6030602|P2|STARTED|Overall Study||20
2459615|NCT01016977|6030603|P1|STARTED|Overall Study||20
2459616|NCT01016964|6030639|P2|NOT COMPLETED|Overall Study||3
2459617|NCT01016964|6030640|P1|NOT COMPLETED|Overall Study||3
2459618|NCT01016964|6030639|P2|COMPLETED|Overall Study||39
2459619|NCT01016964|6030640|P1|COMPLETED|Overall Study||18
2459620|NCT01016964|6030639|P2|STARTED|Overall Study||42
2459621|NCT01016964|6030640|P1|STARTED|Overall Study||21
2459622|NCT01016938|6030646|P1|NOT COMPLETED|Overall Study||9
2459623|NCT01016938|6030646|P1|COMPLETED|Overall Study||7
2459624|NCT01016938|6030646|P1|STARTED|Overall Study||16
2459625|NCT01016912|6030656|P5|NOT COMPLETED|Follow-up Period||0
2459626|NCT01016912|6030657|P4|NOT COMPLETED|Follow-up Period||1
2459627|NCT01016912|6030658|P3|NOT COMPLETED|Follow-up Period||1
2459628|NCT01016912|6030659|P2|NOT COMPLETED|Follow-up Period||0
2459629|NCT01016912|6030660|P1|NOT COMPLETED|Follow-up Period||0
2459630|NCT01016912|6030656|P5|COMPLETED|Follow-up Period||9
2459631|NCT01016912|6030657|P4|COMPLETED|Follow-up Period||8
2459632|NCT01016912|6030658|P3|COMPLETED|Follow-up Period||9
2459633|NCT01016912|6030659|P2|COMPLETED|Follow-up Period||9
2459634|NCT01016912|6030660|P1|COMPLETED|Follow-up Period||8
2459635|NCT01016912|6030656|P5|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
2459636|NCT01016912|6030657|P4|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
2459637|NCT01016912|6030658|P3|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|10
2459638|NCT01016912|6030659|P2|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
2459639|NCT01016912|6030660|P1|STARTED|Follow-up Period||8
2459640|NCT01016912|6030656|P5|NOT COMPLETED|End of Treatment Period||4
2459641|NCT01016912|6030657|P4|NOT COMPLETED|End of Treatment Period||4
2459642|NCT01016912|6030658|P3|NOT COMPLETED|End of Treatment Period||1
2459643|NCT01016912|6030659|P2|NOT COMPLETED|End of Treatment Period||3
2459644|NCT01016912|6030660|P1|NOT COMPLETED|End of Treatment Period||0
2459645|NCT01016912|6030656|P5|COMPLETED|End of Treatment Period||5
2459646|NCT01016912|6030657|P4|COMPLETED|End of Treatment Period||5
2459647|NCT01016912|6030658|P3|COMPLETED|End of Treatment Period||9
2459648|NCT01016912|6030659|P2|COMPLETED|End of Treatment Period||6
2459649|NCT01016912|6030660|P1|COMPLETED|End of Treatment Period||8
2459651|NCT01016912|6030657|P4|Received Treatment|End of Treatment Period||9
2459652|NCT01016912|6030658|P3|Received Treatment|End of Treatment Period||10
2459653|NCT01016912|6030659|P2|Received Treatment|End of Treatment Period||9
2459654|NCT01016912|6030660|P1|Received Treatment|End of Treatment Period||8
2459655|NCT01016912|6030656|P5|STARTED|End of Treatment Period||9
2459656|NCT01016912|6030657|P4|STARTED|End of Treatment Period||9
2459657|NCT01016912|6030658|P3|STARTED|End of Treatment Period||10
2459658|NCT01016912|6030659|P2|STARTED|End of Treatment Period||9
2459659|NCT01016912|6030660|P1|STARTED|End of Treatment Period||8
2459660|NCT01016873|6030705|P3|NOT COMPLETED|36 Months||6
2459661|NCT01016873|6030706|P2|NOT COMPLETED|36 Months||4
2459662|NCT01016873|6030707|P1|NOT COMPLETED|36 Months||11
2459663|NCT01016873|6030705|P3|COMPLETED|36 Months||67
2459664|NCT01016873|6030706|P2|COMPLETED|36 Months||64
2459665|NCT01016873|6030707|P1|COMPLETED|36 Months||58
2459666|NCT01016873|6030705|P3|STARTED|36 Months||73
2459667|NCT01016873|6030706|P2|STARTED|36 Months||68
2459668|NCT01016873|6030707|P1|STARTED|36 Months||69
2459669|NCT01016873|6030705|P3|NOT COMPLETED|24 Months||6
2459670|NCT01016873|6030706|P2|NOT COMPLETED|24 Months||4
2459671|NCT01016873|6030707|P1|NOT COMPLETED|24 Months||5
2459672|NCT01016873|6030705|P3|COMPLETED|24 Months||73
2459673|NCT01016873|6030706|P2|COMPLETED|24 Months||68
2459674|NCT01016873|6030707|P1|COMPLETED|24 Months||69
2459675|NCT01016873|6030705|P3|STARTED|24 Months||79
2459676|NCT01016873|6030706|P2|STARTED|24 Months||72
2459677|NCT01016873|6030707|P1|STARTED|24 Months||74
2459678|NCT01016873|6030705|P3|NOT COMPLETED|12 Months||1
2459679|NCT01016873|6030706|P2|NOT COMPLETED|12 Months||3
2459680|NCT01016873|6030707|P1|NOT COMPLETED|12 Months||1
2459681|NCT01016873|6030705|P3|COMPLETED|12 Months||79
2459682|NCT01016873|6030706|P2|COMPLETED|12 Months||72
2459683|NCT01016873|6030707|P1|COMPLETED|12 Months||74
2459684|NCT01016873|6030705|P3|STARTED|12 Months||80
2459685|NCT01016873|6030706|P2|STARTED|12 Months||75
2459686|NCT01016873|6030707|P1|STARTED|12 Months||75
2459687|NCT01016847|6030738|P2|NOT COMPLETED|Overall Study||0
2459688|NCT01016847|6030739|P1|NOT COMPLETED|Overall Study||0
2459689|NCT01016847|6030738|P2|COMPLETED|Overall Study||2
2459690|NCT01016847|6030739|P1|COMPLETED|Overall Study||1
2459691|NCT01016847|6030738|P2|STARTED|Overall Study||2
2459692|NCT01016847|6030739|P1|STARTED|Overall Study||1
2459693|NCT01016834|6030755|P1|NOT COMPLETED|Overall Study||22
2459694|NCT01016834|6030755|P1|COMPLETED|Overall Study||220
2459695|NCT01016834|6030755|P1|STARTED|Overall Study||242
2459696|NCT01016769|6030765|P4|NOT COMPLETED|Overall Study||0
2459697|NCT01016769|6030766|P3|NOT COMPLETED|Overall Study||1
2459698|NCT01016769|6030767|P2|NOT COMPLETED|Overall Study||1
2459699|NCT01016769|6030768|P1|NOT COMPLETED|Overall Study||1
2459700|NCT01016769|6030765|P4|COMPLETED|Overall Study||30
2459701|NCT01016769|6030766|P3|COMPLETED|Overall Study||6
2459702|NCT01016769|6030767|P2|COMPLETED|Overall Study||6
2459703|NCT01016769|6030768|P1|COMPLETED|Overall Study||3
2459704|NCT01016769|6030765|P4|STARTED|Overall Study||30
2459705|NCT01016769|6030766|P3|STARTED|Overall Study||7
2459706|NCT01016769|6030767|P2|STARTED|Overall Study||7
2459707|NCT01016769|6030768|P1|STARTED|Overall Study||4
2459708|NCT01016691|6030782|P3|NOT COMPLETED|Overall Study||0
2459709|NCT01016691|6030783|P2|NOT COMPLETED|Overall Study||0
2459710|NCT01016691|6030784|P1|NOT COMPLETED|Overall Study||0
2459711|NCT01016691|6030782|P3|COMPLETED|Overall Study||18
2459712|NCT01016691|6030783|P2|COMPLETED|Overall Study||12
2459713|NCT01016691|6030784|P1|COMPLETED|Overall Study||17
2459714|NCT01016691|6030782|P3|STARTED|Overall Study||18
2459715|NCT01016691|6030783|P2|STARTED|Overall Study||12
2459716|NCT01016691|6030784|P1|STARTED|Overall Study||17
2459717|NCT01016678|6030792|P5|NOT COMPLETED|Overall Study||6
2459718|NCT01016678|6030793|P4|NOT COMPLETED|Overall Study||0
2459719|NCT01016678|6030794|P3|NOT COMPLETED|Overall Study||4
2459720|NCT01016678|6030795|P2|NOT COMPLETED|Overall Study||3
2459721|NCT01016678|6030796|P1|NOT COMPLETED|Overall Study||2
2459722|NCT01016678|6030792|P5|COMPLETED|Overall Study||13
2459723|NCT01016678|6030793|P4|COMPLETED|Overall Study||19
2459724|NCT01016678|6030794|P3|COMPLETED|Overall Study||15
2459725|NCT01016678|6030795|P2|COMPLETED|Overall Study||14
2459726|NCT01016678|6030796|P1|COMPLETED|Overall Study||18
2459727|NCT01016678|6030792|P5|STARTED|Overall Study||19
2459728|NCT01016678|6030793|P4|STARTED|Overall Study||19
2459729|NCT01016678|6030794|P3|STARTED|Overall Study||19
2459730|NCT01016678|6030795|P2|STARTED|Overall Study||17
2459731|NCT01016678|6030796|P1|STARTED|Overall Study||20
2459732|NCT01016652|6030818|P2|NOT COMPLETED|Period 2||0
2459733|NCT01016652|6030819|P1|NOT COMPLETED|Period 2||0
2459734|NCT01016652|6030818|P2|COMPLETED|Period 2||24
2459735|NCT01016652|6030819|P1|COMPLETED|Period 2||25
2459736|NCT01016652|6030818|P2|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|24
2459737|NCT01016652|6030819|P1|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|25
2459738|NCT01016652|6030818|P2|NOT COMPLETED|Period 1||0
2459739|NCT01016652|6030819|P1|NOT COMPLETED|Period 1||0
2459740|NCT01016652|6030818|P2|COMPLETED|Period 1||24
2459741|NCT01016652|6030819|P1|COMPLETED|Period 1||25
2459742|NCT01016652|6030818|P2|STARTED|Period 1||24
2459743|NCT01016652|6030819|P1|STARTED|Period 1||25
2459744|NCT01016600|6030839|P4|NOT COMPLETED|Overall Study||0
2459745|NCT01016600|6030840|P3|NOT COMPLETED|Overall Study||0
2459746|NCT01016600|6030841|P2|NOT COMPLETED|Overall Study||0
2459747|NCT01016600|6030842|P1|NOT COMPLETED|Overall Study||1
2459748|NCT01016600|6030839|P4|COMPLETED|Overall Study||12
2459749|NCT01016600|6030840|P3|COMPLETED|Overall Study||6
2459750|NCT01016600|6030841|P2|COMPLETED|Overall Study||4
2459751|NCT01016600|6030842|P1|COMPLETED|Overall Study||8
2459752|NCT01016600|6030839|P4|STARTED|Overall Study||12
2459753|NCT01016600|6030840|P3|STARTED|Overall Study||6
2459754|NCT01016600|6030841|P2|STARTED|Overall Study||4
2459755|NCT01016600|6030842|P1|STARTED|Overall Study||9
2459756|NCT01016483|6030909|P4|NOT COMPLETED|Phase II||0
2459757|NCT01016483|6030910|P3|NOT COMPLETED|Phase II||0
2459758|NCT01016483|6030911|P2|NOT COMPLETED|Phase II||0
2459759|NCT01016483|6030912|P1|NOT COMPLETED|Phase II||0
2459760|NCT01016483|6030909|P4|COMPLETED|Phase II||44
2459761|NCT01016483|6030910|P3|COMPLETED|Phase II||44
2459762|NCT01016483|6030911|P2|COMPLETED|Phase II||0
2459763|NCT01016483|6030912|P1|COMPLETED|Phase II||0
2459764|NCT01016483|6030909|P4|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|45
2459765|NCT01016483|6030910|P3|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|42
2459766|NCT01016483|6030911|P2|Treated (Safety Analysis Set [SAF])|Phase II||0
2459767|NCT01016483|6030912|P1|Treated (Safety Analysis Set [SAF])|Phase II||0
2459768|NCT01016483|6030909|P4|STARTED|Phase II|Subjects presented as randomized (ITT Analysis Set).|44
2459769|NCT01016483|6030910|P3|STARTED|Phase II|Subjects presented as randomized (Intention-to-Treat [ITT] Analysis Set).|44
2459770|NCT01016483|6030911|P2|STARTED|Phase II||0
2459771|NCT01016483|6030912|P1|STARTED|Phase II||0
2459772|NCT01016483|6030909|P4|NOT COMPLETED|Safety Run-in Part||0
2459773|NCT01016483|6030910|P3|NOT COMPLETED|Safety Run-in Part||0
2459774|NCT01016483|6030911|P2|NOT COMPLETED|Safety Run-in Part||0
2459775|NCT01016483|6030912|P1|NOT COMPLETED|Safety Run-in Part||0
2459776|NCT01016483|6030909|P4|COMPLETED|Safety Run-in Part||0
2459777|NCT01016483|6030910|P3|COMPLETED|Safety Run-in Part||0
2459778|NCT01016483|6030911|P2|COMPLETED|Safety Run-in Part||26
2459779|NCT01016483|6030912|P1|COMPLETED|Safety Run-in Part||27
2459780|NCT01016483|6030909|P4|STARTED|Safety Run-in Part||0
2459781|NCT01016483|6030910|P3|STARTED|Safety Run-in Part||0
2459782|NCT01016483|6030911|P2|STARTED|Safety Run-in Part||26
2459783|NCT01016483|6030912|P1|STARTED|Safety Run-in Part||27
2459784|NCT01016353|6031020|P2|NOT COMPLETED|Overall Study||1
2459785|NCT01016353|6031021|P1|NOT COMPLETED|Overall Study||2
2459786|NCT01016353|6031020|P2|COMPLETED|Overall Study||102
2459787|NCT01016353|6031021|P1|COMPLETED|Overall Study||178
2459788|NCT01016353|6031020|P2|STARTED|Overall Study||103
2459789|NCT01016353|6031021|P1|STARTED|Overall Study||180
2459790|NCT01016262|6031030|P6|NOT COMPLETED|Open-Label Phase||0
2459791|NCT01016262|6031031|P5|NOT COMPLETED|Open-Label Phase||2
2459792|NCT01016262|6031032|P4|NOT COMPLETED|Open-Label Phase||2
2459793|NCT01016262|6031033|P3|NOT COMPLETED|Open-Label Phase||0
2459794|NCT01016262|6031034|P2|NOT COMPLETED|Open-Label Phase||0
2459795|NCT01016262|6031035|P1|NOT COMPLETED|Open-Label Phase||0
2459796|NCT01016262|6031030|P6|COMPLETED|Open-Label Phase||20
2459797|NCT01016262|6031031|P5|COMPLETED|Open-Label Phase||50
2459798|NCT01016262|6031032|P4|COMPLETED|Open-Label Phase||42
2459799|NCT01016262|6031033|P3|COMPLETED|Open-Label Phase||0
2459800|NCT01016262|6031034|P2|COMPLETED|Open-Label Phase||0
2459801|NCT01016262|6031035|P1|COMPLETED|Open-Label Phase||0
2459802|NCT01016262|6031030|P6|STARTED|Open-Label Phase||20
2459803|NCT01016262|6031031|P5|STARTED|Open-Label Phase||52
2459804|NCT01016262|6031032|P4|STARTED|Open-Label Phase||44
2459805|NCT01016262|6031033|P3|STARTED|Open-Label Phase||0
2459806|NCT01016262|6031034|P2|STARTED|Open-Label Phase||0
2459807|NCT01016262|6031035|P1|STARTED|Open-Label Phase||0
2459808|NCT01016262|6031030|P6|NOT COMPLETED|Double-blind Phase||0
2459809|NCT01016262|6031031|P5|NOT COMPLETED|Double-blind Phase||0
2459810|NCT01016262|6031032|P4|NOT COMPLETED|Double-blind Phase||0
2459811|NCT01016262|6031033|P3|NOT COMPLETED|Double-blind Phase||9
2459812|NCT01016262|6031034|P2|NOT COMPLETED|Double-blind Phase||1
2459813|NCT01016262|6031035|P1|NOT COMPLETED|Double-blind Phase||1
2459814|NCT01016262|6031030|P6|COMPLETED|Double-blind Phase||0
2459815|NCT01016262|6031031|P5|COMPLETED|Double-blind Phase||0
2459816|NCT01016262|6031032|P4|COMPLETED|Double-blind Phase||0
2459817|NCT01016262|6031033|P3|COMPLETED|Double-blind Phase||30
2459818|NCT01016262|6031034|P2|COMPLETED|Double-blind Phase||38
2459819|NCT01016262|6031035|P1|COMPLETED|Double-blind Phase||40
2459820|NCT01016262|6031030|P6|STARTED|Double-blind Phase||0
2459821|NCT01016262|6031031|P5|STARTED|Double-blind Phase||0
2459822|NCT01016262|6031032|P4|STARTED|Double-blind Phase||0
2459823|NCT01016262|6031033|P3|STARTED|Double-blind Phase||39
2459824|NCT01016262|6031034|P2|STARTED|Double-blind Phase||39
2459825|NCT01016262|6031035|P1|STARTED|Double-blind Phase||41
2459826|NCT01016132|6031058|P1|NOT COMPLETED|Overall Study||1
2459827|NCT01016132|6031058|P1|COMPLETED|Overall Study||151
2459828|NCT01016132|6031058|P1|STARTED|Overall Study||152
2459829|NCT01016106|6031064|P2|NOT COMPLETED|Overall Study||0
2459830|NCT01016106|6031065|P1|NOT COMPLETED|Overall Study||0
2459831|NCT01016106|6031064|P2|COMPLETED|Overall Study||18
2459832|NCT01016106|6031065|P1|COMPLETED|Overall Study||17
2459833|NCT01016106|6031064|P2|STARTED|Overall Study||18
2459834|NCT01016106|6031065|P1|STARTED|Overall Study||17
2459835|NCT01016067|6031073|P2|NOT COMPLETED|Overall Study||4
2459836|NCT01016067|6031074|P1|NOT COMPLETED|Overall Study||2
2459837|NCT01016067|6031073|P2|COMPLETED|Overall Study||8
2459838|NCT01016067|6031074|P1|COMPLETED|Overall Study||9
2459839|NCT01016067|6031073|P2|STARTED|Overall Study||12
2459840|NCT01016067|6031074|P1|STARTED|Overall Study||11
2459841|NCT01016015|6031092|P1|NOT COMPLETED|Overall Study||19
2459842|NCT01016015|6031092|P1|COMPLETED|Overall Study||159
2459843|NCT01016015|6031092|P1|STARTED|Overall Study||178
2459844|NCT01015976|6031096|P2|NOT COMPLETED|Overall Study||0
2459845|NCT01015976|6031097|P1|NOT COMPLETED|Overall Study||0
2459846|NCT01015976|6031096|P2|COMPLETED|Overall Study||5
2459847|NCT01015976|6031097|P1|COMPLETED|Overall Study||5
2459848|NCT01015976|6031096|P2|STARTED|Overall Study||5
2459849|NCT01015976|6031097|P1|STARTED|Overall Study||5
2459856|NCT01015820|6031120|P2|NOT COMPLETED|Overall Study||0
2459857|NCT01015820|6031121|P1|NOT COMPLETED|Overall Study||1
2459858|NCT01015820|6031120|P2|COMPLETED|Overall Study||15
2459859|NCT01015820|6031121|P1|COMPLETED|Overall Study||14
2459860|NCT01015820|6031120|P2|STARTED|Overall Study||15
2459861|NCT01015820|6031121|P1|STARTED|Overall Study||15
2459862|NCT01015807|6031132|P3|NOT COMPLETED|Overall Study||0
2459863|NCT01015807|6031133|P2|NOT COMPLETED|Overall Study||0
2459864|NCT01015807|6031134|P1|NOT COMPLETED|Overall Study||0
2459865|NCT01015807|6031132|P3|COMPLETED|Overall Study||30
2459866|NCT01015807|6031133|P2|COMPLETED|Overall Study||30
2459867|NCT01015807|6031134|P1|COMPLETED|Overall Study||30
2459868|NCT01015807|6031132|P3|STARTED|Overall Study||30
2459869|NCT01015807|6031133|P2|STARTED|Overall Study||30
2459870|NCT01015807|6031134|P1|STARTED|Overall Study||30
2459871|NCT01015781|6031144|P2|NOT COMPLETED|Overall Study||29
2459872|NCT01015781|6031145|P1|NOT COMPLETED|Overall Study||37
2459873|NCT01015781|6031144|P2|COMPLETED|Overall Study||121
2459874|NCT01015781|6031145|P1|COMPLETED|Overall Study||113
2459875|NCT01015781|6031144|P2|STARTED|Overall Study||150
2459876|NCT01015781|6031145|P1|STARTED|Overall Study||150
2459877|NCT01015703|6031156|P5|NOT COMPLETED|Overall Study||0
2459878|NCT01015703|6031157|P4|NOT COMPLETED|Overall Study||0
2459879|NCT01015703|6031158|P3|NOT COMPLETED|Overall Study||0
2459880|NCT01015703|6031159|P2|NOT COMPLETED|Overall Study||1
2459881|NCT01015703|6031160|P1|NOT COMPLETED|Overall Study||2
2459882|NCT01015703|6031156|P5|COMPLETED|Overall Study||10
2459883|NCT01015703|6031157|P4|COMPLETED|Overall Study||10
2459884|NCT01015703|6031158|P3|COMPLETED|Overall Study||10
2459885|NCT01015703|6031159|P2|COMPLETED|Overall Study||9
2459886|NCT01015703|6031160|P1|COMPLETED|Overall Study||8
2459887|NCT01015703|6031156|P5|STARTED|Overall Study||10
2459888|NCT01015703|6031157|P4|STARTED|Overall Study||10
2459889|NCT01015703|6031158|P3|STARTED|Overall Study||10
2459890|NCT01015703|6031159|P2|STARTED|Overall Study||10
2459891|NCT01015703|6031160|P1|STARTED|Overall Study||10
2459892|NCT01015677|6031175|P3|NOT COMPLETED|Overall Study||0
2459893|NCT01015677|6031176|P2|NOT COMPLETED|Overall Study||4
2459894|NCT01015677|6031177|P1|NOT COMPLETED|Overall Study||1
2459895|NCT01015677|6031175|P3|COMPLETED|Overall Study||33
2459896|NCT01015677|6031176|P2|COMPLETED|Overall Study||28
2459897|NCT01015677|6031177|P1|COMPLETED|Overall Study||33
2459898|NCT01015677|6031175|P3|STARTED|Overall Study||33
2459899|NCT01015677|6031176|P2|STARTED|Overall Study||32
2459900|NCT01015677|6031177|P1|STARTED|Overall Study||34
2459901|NCT01015638|6031199|P2|NOT COMPLETED|Overall Study||0
2459902|NCT01015638|6031200|P1|NOT COMPLETED|Overall Study||1
2459903|NCT01015638|6031199|P2|COMPLETED|Overall Study||19
2459904|NCT01015638|6031200|P1|COMPLETED|Overall Study||16
2459905|NCT01015638|6031199|P2|STARTED|Overall Study||19
2459906|NCT01015638|6031200|P1|STARTED|Overall Study||17
2459907|NCT01015612|6031228|P1|NOT COMPLETED|Overall Study||153
2459908|NCT01015612|6031228|P1|COMPLETED|Overall Study||481
2459909|NCT01015612|6031228|P1|STARTED|Overall Study||634
2459910|NCT01015586|6031240|P2|NOT COMPLETED|Overall Study||11
2459911|NCT01015586|6031241|P1|NOT COMPLETED|Overall Study||7
2459912|NCT01015586|6031240|P2|COMPLETED|Overall Study||11
2459913|NCT01015586|6031241|P1|COMPLETED|Overall Study||14
2459914|NCT01015586|6031240|P2|STARTED|Overall Study||22
2459915|NCT01015586|6031241|P1|STARTED|Overall Study||21
2459916|NCT01015560|6031259|P1|NOT COMPLETED|Overall Study||3
2459917|NCT01015560|6031259|P1|COMPLETED|Overall Study||41
2459918|NCT01015560|6031259|P1|Eligible and Analyzable|Overall Study||43
2459919|NCT01015560|6031259|P1|STARTED|Overall Study||44
2459920|NCT01015534|6031265|P2|NOT COMPLETED|Overall Study||0
2459921|NCT01015534|6031266|P1|NOT COMPLETED|Overall Study||1
2459922|NCT01015534|6031265|P2|COMPLETED|Overall Study||27
2459923|NCT01015534|6031266|P1|COMPLETED|Overall Study||27
2459924|NCT01015534|6031265|P2|STARTED|Overall Study||27
2459925|NCT01015534|6031266|P1|STARTED|Overall Study||28
2459926|NCT01015443|6031280|P2|NOT COMPLETED|Overall Study||0
2459927|NCT01015443|6031281|P1|NOT COMPLETED|Overall Study||0
2459928|NCT01015443|6031280|P2|COMPLETED|Overall Study||94
2459929|NCT01015443|6031281|P1|COMPLETED|Overall Study||191
2459930|NCT01015443|6031280|P2|Treated|Overall Study||93
2459931|NCT01015443|6031281|P1|Treated|Overall Study||191
2459932|NCT01015443|6031280|P2|STARTED|Overall Study||94
2459933|NCT01015443|6031281|P1|STARTED|Overall Study||191
2459934|NCT01015326|6031299|P2|NOT COMPLETED|Overall Study||2
2459935|NCT01015326|6031300|P1|NOT COMPLETED|Overall Study||1
2459936|NCT01015326|6031299|P2|COMPLETED|Overall Study||18
2459937|NCT01015326|6031300|P1|COMPLETED|Overall Study||11
2459938|NCT01015326|6031299|P2|STARTED|Overall Study||20
2459939|NCT01015326|6031300|P1|STARTED|Overall Study||12
2459940|NCT01015287|6031308|P2|NOT COMPLETED|Overall Study||79
2459941|NCT01015287|6031309|P1|NOT COMPLETED|Overall Study||72
2459942|NCT01015287|6031308|P2|COMPLETED|Overall Study||1958
2459943|NCT01015287|6031309|P1|COMPLETED|Overall Study||1924
2459944|NCT01015287|6031308|P2|Received at Least 1 Dose of Study Drug|Overall Study||2037
2459945|NCT01015287|6031309|P1|Received at Least 1 Dose of Study Drug|Overall Study||1996
2459946|NCT01015287|6031308|P2|STARTED|Overall Study||2037
2459947|NCT01015287|6031309|P1|STARTED|Overall Study||1996
2459948|NCT01015170|6031335|P1|NOT COMPLETED|Overall Study||239
2459949|NCT01015170|6031335|P1|COMPLETED|Overall Study||215
2459950|NCT01015170|6031335|P1|STARTED|Overall Study||454
2459951|NCT01015131|6031341|P1|NOT COMPLETED|Overall Study||8
2459952|NCT01015131|6031341|P1|COMPLETED|Overall Study||36
2459953|NCT01015131|6031341|P1|STARTED|Overall Study||44
2459954|NCT01015118|6031357|P2|NOT COMPLETED|Overall Study||327
2459955|NCT01015118|6031358|P1|NOT COMPLETED|Overall Study||669
2459956|NCT01015118|6031357|P2|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|128
2459957|NCT01015118|6031358|P1|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|242
2459958|NCT01015118|6031357|P2|STARTED|Overall Study||455
2459959|NCT01015118|6031358|P1|STARTED|Overall Study||911
2459960|NCT01014988|6031386|P6|NOT COMPLETED|Overall Study||3
2459961|NCT01014988|6031387|P5|NOT COMPLETED|Overall Study||1
2459962|NCT01014988|6031388|P4|NOT COMPLETED|Overall Study||0
2459963|NCT01014988|6031389|P3|NOT COMPLETED|Overall Study||2
2459964|NCT01014988|6031390|P2|NOT COMPLETED|Overall Study||0
2459965|NCT01014988|6031391|P1|NOT COMPLETED|Overall Study||23
2459966|NCT01014988|6031386|P6|COMPLETED|Overall Study||11
2459967|NCT01014988|6031387|P5|COMPLETED|Overall Study||26
2459968|NCT01014988|6031388|P4|COMPLETED|Overall Study||12
2459969|NCT01014988|6031389|P3|COMPLETED|Overall Study||9
2459970|NCT01014988|6031390|P2|COMPLETED|Overall Study||7
2459971|NCT01014988|6031391|P1|COMPLETED|Overall Study||107
2459972|NCT01014988|6031386|P6|STARTED|Overall Study||14
2459973|NCT01014988|6031387|P5|STARTED|Overall Study||27
2459974|NCT01014988|6031388|P4|STARTED|Overall Study||12
2459975|NCT01014988|6031389|P3|STARTED|Overall Study||11
2459976|NCT01014988|6031390|P2|STARTED|Overall Study||7
2459977|NCT01014988|6031391|P1|STARTED|Overall Study||130
2459978|NCT01014975|6031563|P3|NOT COMPLETED|Overall Study||6
2459979|NCT01014975|6031564|P2|NOT COMPLETED|Overall Study||3
2459980|NCT01014975|6031565|P1|NOT COMPLETED|Overall Study||4
2459981|NCT01014975|6031563|P3|COMPLETED|Overall Study||10
2459982|NCT01014975|6031564|P2|COMPLETED|Overall Study||13
2459983|NCT01014975|6031565|P1|COMPLETED|Overall Study||4
2459984|NCT01014975|6031563|P3|STARTED|Overall Study||16
2459985|NCT01014975|6031564|P2|STARTED|Overall Study||16
2459986|NCT01014975|6031565|P1|STARTED|Overall Study||8
2459987|NCT01014936|6031576|P3|NOT COMPLETED|Overall Study||0
2459988|NCT01014936|6031577|P2|NOT COMPLETED|Overall Study||0
2459989|NCT01014936|6031578|P1|NOT COMPLETED|Overall Study||0
2459990|NCT01014936|6031576|P3|COMPLETED|Overall Study||62
2459991|NCT01014936|6031577|P2|COMPLETED|Overall Study||45
2459992|NCT01014936|6031578|P1|COMPLETED|Overall Study||42
2459993|NCT01014936|6031576|P3|STARTED|Overall Study||62
2459994|NCT01014936|6031577|P2|STARTED|Overall Study||45
2459995|NCT01014936|6031578|P1|STARTED|Overall Study||42
2459996|NCT01014910|6032070|P2|NOT COMPLETED|Overall Study||2
2459997|NCT01014910|6032071|P1|NOT COMPLETED|Overall Study||0
2459998|NCT01014910|6032070|P2|COMPLETED|Overall Study||79
2459999|NCT01014910|6032071|P1|COMPLETED|Overall Study||80
2460000|NCT01014910|6032070|P2|STARTED|Overall Study||81
2460001|NCT01014910|6032071|P1|STARTED|Overall Study||80
2460002|NCT01014871|6032079|P1|NOT COMPLETED|Overall Study||0
2460003|NCT01014871|6032079|P1|COMPLETED|Overall Study||30
2460004|NCT01014871|6032079|P1|STARTED|Overall Study||30
2460005|NCT01014767|6032089|P4|NOT COMPLETED|Overall Study||1
2460006|NCT01014767|6032090|P3|NOT COMPLETED|Overall Study||4
2460007|NCT01014767|6032091|P2|NOT COMPLETED|Overall Study||1
2460008|NCT01014767|6032092|P1|NOT COMPLETED|Overall Study||12
2460009|NCT01014767|6032089|P4|COMPLETED|Overall Study||0
2460010|NCT01014767|6032090|P3|COMPLETED|Overall Study||0
2460011|NCT01014767|6032091|P2|COMPLETED|Overall Study||0
2460012|NCT01014767|6032092|P1|COMPLETED|Overall Study||0
2460013|NCT01014767|6032089|P4|STARTED|Overall Study||1
2460014|NCT01014767|6032090|P3|STARTED|Overall Study||4
2460015|NCT01014767|6032091|P2|STARTED|Overall Study||1
2460016|NCT01014767|6032092|P1|STARTED|Overall Study||12
2460017|NCT01014741|6032108|P2|NOT COMPLETED|Overall Study||5
2460018|NCT01014741|6032109|P1|NOT COMPLETED|Overall Study||11
2460019|NCT01014741|6032108|P2|COMPLETED|Overall Study||90
2460020|NCT01014741|6032109|P1|COMPLETED|Overall Study||94
2460021|NCT01014741|6032108|P2|STARTED|Overall Study||95
2460022|NCT01014741|6032109|P1|STARTED|Overall Study||105
2460023|NCT01014728|6032123|P2|NOT COMPLETED|Overall Study||0
2460024|NCT01014728|6032124|P1|NOT COMPLETED|Overall Study||0
2460025|NCT01014728|6032123|P2|COMPLETED|Overall Study||15
2460026|NCT01014728|6032124|P1|COMPLETED|Overall Study||18
2460027|NCT01014728|6032123|P2|STARTED|Overall Study||15
2460028|NCT01014728|6032124|P1|STARTED|Overall Study||18
2460029|NCT01014689|6032136|P2|NOT COMPLETED|Overall Study||13
2460030|NCT01014689|6032137|P1|NOT COMPLETED|Overall Study||13
2460031|NCT01014689|6032136|P2|COMPLETED|Overall Study||174
2460032|NCT01014689|6032137|P1|COMPLETED|Overall Study||178
2460033|NCT01014689|6032136|P2|STARTED|Overall Study||187
2460034|NCT01014689|6032137|P1|STARTED|Overall Study||191
2460035|NCT01014624|6032147|P2|NOT COMPLETED|Overall Study||1
2460036|NCT01014624|6032148|P1|NOT COMPLETED|Overall Study||2
2460037|NCT01014624|6032147|P2|COMPLETED|Overall Study||26
2460038|NCT01014624|6032148|P1|COMPLETED|Overall Study||27
2460039|NCT01014624|6032147|P2|STARTED|Overall Study||27
2460040|NCT01014624|6032148|P1|STARTED|Overall Study||29
2460041|NCT01014585|6032172|P4|NOT COMPLETED|Overall Study||30
2460042|NCT01014585|6032173|P3|NOT COMPLETED|Overall Study||23
2460043|NCT01014585|6032174|P2|NOT COMPLETED|Overall Study||25
2460044|NCT01014585|6032175|P1|NOT COMPLETED|Overall Study||20
2460045|NCT01014585|6032172|P4|COMPLETED|Overall Study||99
2460046|NCT01014585|6032173|P3|COMPLETED|Overall Study||37
2460047|NCT01014585|6032174|P2|COMPLETED|Overall Study||75
2460048|NCT01014585|6032175|P1|COMPLETED|Overall Study||31
2460049|NCT01014585|6032172|P4|STARTED|Overall Study||129
2460050|NCT01014585|6032173|P3|STARTED|Overall Study||60
2460051|NCT01014585|6032174|P2|STARTED|Overall Study||100
2460052|NCT01014585|6032175|P1|STARTED|Overall Study||51
2460053|NCT01014533|6032195|P2|NOT COMPLETED|Overall Study||5
2460054|NCT01014533|6032196|P1|NOT COMPLETED|Overall Study||5
2460055|NCT01014533|6032195|P2|COMPLETED|Overall Study||25
2460056|NCT01014533|6032196|P1|COMPLETED|Overall Study||24
2460057|NCT01014533|6032195|P2|STARTED|Overall Study||30
2460058|NCT01014533|6032196|P1|STARTED|Overall Study||29
2460059|NCT01014455|6032208|P2|NOT COMPLETED|Overall Study||0
2460060|NCT01014455|6032209|P1|NOT COMPLETED|Overall Study||0
2460061|NCT01014455|6032208|P2|COMPLETED|Overall Study||87
2460062|NCT01014455|6032209|P1|COMPLETED|Overall Study||82
2460063|NCT01014455|6032208|P2|STARTED|Overall Study||87
2460064|NCT01014455|6032209|P1|STARTED|Overall Study||82
2460065|NCT01014442|6032217|P2|NOT COMPLETED|Overall Study||19
2460066|NCT01014442|6032218|P1|NOT COMPLETED|Overall Study||7
2460067|NCT01014442|6032217|P2|COMPLETED|Overall Study||16
2460068|NCT01014442|6032218|P1|COMPLETED|Overall Study||26
2460069|NCT01014442|6032217|P2|STARTED|Overall Study||35
2460070|NCT01014442|6032218|P1|STARTED|Overall Study||33
2460074|NCT01014351|6032334|P1|NOT COMPLETED|Overall Study||37
2460075|NCT01014351|6032334|P1|COMPLETED|Overall Study||33
2460076|NCT01014351|6032334|P1|STARTED|Overall Study||70
2460077|NCT01014208|6032342|P2|NOT COMPLETED|Overall Study||100
2460078|NCT01014208|6032343|P1|NOT COMPLETED|Overall Study||94
2460079|NCT01014208|6032342|P2|COMPLETED|Overall Study||122
2460080|NCT01014208|6032343|P1|COMPLETED|Overall Study||131
2460081|NCT01014208|6032342|P2|Intent-to-Treat Population|Overall Study||222
2460082|NCT01014208|6032343|P1|Intent-to-Treat Population|Overall Study||223
2460083|NCT01014208|6032342|P2|STARTED|Overall Study||222
2460084|NCT01014208|6032343|P1|STARTED|Overall Study||225
2460085|NCT01014169|6032371|P2|NOT COMPLETED|Overall Study||13
2460086|NCT01014169|6032372|P1|NOT COMPLETED|Overall Study||7
2460087|NCT01014169|6032371|P2|COMPLETED|Overall Study||48
2460088|NCT01014169|6032372|P1|COMPLETED|Overall Study||58
2460089|NCT01014169|6032371|P2|STARTED|Overall Study||61
2460090|NCT01014169|6032372|P1|STARTED|Overall Study||65
2460091|NCT01014143|6032385|P3|NOT COMPLETED|Third Intervention||0
2460092|NCT01014143|6032386|P2|NOT COMPLETED|Third Intervention||0
2460093|NCT01014143|6032387|P1|NOT COMPLETED|Third Intervention||0
2460094|NCT01014143|6032385|P3|COMPLETED|Third Intervention||9
2460095|NCT01014143|6032386|P2|COMPLETED|Third Intervention||9
2460096|NCT01014143|6032387|P1|COMPLETED|Third Intervention||8
2460097|NCT01014143|6032385|P3|STARTED|Third Intervention||9
2460098|NCT01014143|6032386|P2|STARTED|Third Intervention||9
2460099|NCT01014143|6032387|P1|STARTED|Third Intervention||8
2460100|NCT01014143|6032385|P3|NOT COMPLETED|Washout After 2nd Intervention||0
2460101|NCT01014143|6032386|P2|NOT COMPLETED|Washout After 2nd Intervention||0
2460102|NCT01014143|6032387|P1|NOT COMPLETED|Washout After 2nd Intervention||0
2460103|NCT01014143|6032385|P3|COMPLETED|Washout After 2nd Intervention||9
2460104|NCT01014143|6032386|P2|COMPLETED|Washout After 2nd Intervention||9
2460105|NCT01014143|6032387|P1|COMPLETED|Washout After 2nd Intervention||8
2460106|NCT01014143|6032385|P3|STARTED|Washout After 2nd Intervention||9
2460107|NCT01014143|6032386|P2|STARTED|Washout After 2nd Intervention||9
2460108|NCT01014143|6032387|P1|STARTED|Washout After 2nd Intervention||8
2460109|NCT01014143|6032385|P3|NOT COMPLETED|Second Intervention||0
2460110|NCT01014143|6032386|P2|NOT COMPLETED|Second Intervention||0
2460111|NCT01014143|6032387|P1|NOT COMPLETED|Second Intervention||2
2460112|NCT01014143|6032385|P3|COMPLETED|Second Intervention||9
2460113|NCT01014143|6032386|P2|COMPLETED|Second Intervention||9
2460114|NCT01014143|6032387|P1|COMPLETED|Second Intervention||8
2460115|NCT01014143|6032385|P3|STARTED|Second Intervention||9
2460116|NCT01014143|6032386|P2|STARTED|Second Intervention||9
2460117|NCT01014143|6032387|P1|STARTED|Second Intervention||10
2460118|NCT01014143|6032385|P3|NOT COMPLETED|Washout Period After 1st Intervention||0
2460119|NCT01014143|6032386|P2|NOT COMPLETED|Washout Period After 1st Intervention||0
2460120|NCT01014143|6032387|P1|NOT COMPLETED|Washout Period After 1st Intervention||0
2460121|NCT01014143|6032385|P3|COMPLETED|Washout Period After 1st Intervention||9
2460122|NCT01014143|6032386|P2|COMPLETED|Washout Period After 1st Intervention||9
2460123|NCT01014143|6032387|P1|COMPLETED|Washout Period After 1st Intervention||10
2460124|NCT01014143|6032385|P3|STARTED|Washout Period After 1st Intervention||9
2460125|NCT01014143|6032386|P2|STARTED|Washout Period After 1st Intervention||9
2460126|NCT01014143|6032387|P1|STARTED|Washout Period After 1st Intervention||10
2460127|NCT01014143|6032385|P3|NOT COMPLETED|First Intervention||0
2460128|NCT01014143|6032386|P2|NOT COMPLETED|First Intervention||0
2460129|NCT01014143|6032387|P1|NOT COMPLETED|First Intervention||0
2460130|NCT01014143|6032385|P3|COMPLETED|First Intervention||9
2460131|NCT01014143|6032386|P2|COMPLETED|First Intervention||9
2460132|NCT01014143|6032387|P1|COMPLETED|First Intervention||10
2460133|NCT01014143|6032385|P3|STARTED|First Intervention||9
2460134|NCT01014143|6032386|P2|STARTED|First Intervention||9
2460135|NCT01014143|6032387|P1|STARTED|First Intervention||10
2460136|NCT01014091|6032401|P6|NOT COMPLETED|Overall Study||0
2460137|NCT01014091|6032402|P5|NOT COMPLETED|Overall Study||0
2460138|NCT01014091|6032403|P4|NOT COMPLETED|Overall Study||0
2460139|NCT01014091|6032404|P3|NOT COMPLETED|Overall Study||0
2460140|NCT01014091|6032405|P2|NOT COMPLETED|Overall Study||0
2460141|NCT01014091|6032406|P1|NOT COMPLETED|Overall Study||0
2460142|NCT01014091|6032401|P6|COMPLETED|Overall Study||12
2460143|NCT01014091|6032402|P5|COMPLETED|Overall Study||6
2460144|NCT01014091|6032403|P4|COMPLETED|Overall Study||15
2460145|NCT01014091|6032404|P3|COMPLETED|Overall Study||5
2460146|NCT01014091|6032405|P2|COMPLETED|Overall Study||13
2460147|NCT01014091|6032406|P1|COMPLETED|Overall Study||7
2460148|NCT01014091|6032401|P6|STARTED|Overall Study||12
2460149|NCT01014091|6032402|P5|STARTED|Overall Study||6
2460150|NCT01014091|6032403|P4|STARTED|Overall Study||15
2460151|NCT01014091|6032404|P3|STARTED|Overall Study||5
2460152|NCT01014091|6032405|P2|STARTED|Overall Study||13
2460153|NCT01014091|6032406|P1|STARTED|Overall Study||7
2460154|NCT01014013|6032482|P2|NOT COMPLETED|Overall Study||56
2460155|NCT01014013|6032483|P1|NOT COMPLETED|Overall Study||51
2460156|NCT01014013|6032482|P2|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of Ceftriaxone parentheral therapy|80
2460157|NCT01014013|6032483|P1|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of MK0826 parentheral therapy|84
2460158|NCT01014013|6032482|P2|Completed Parenteral Therapy|Overall Study|Patients completing Ceftriaxone as a single daily dose of 2.0g intravenous infusion at least 3 days|88
2460159|NCT01014013|6032483|P1|Completed Parenteral Therapy|Overall Study|"Patients completing MK0826 as a single daily dose of 1.0g intravenous~infusion at least 3 days"|87
2460160|NCT01014013|6032482|P2|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of Ceftriaxone parenteral therapy|135
2460161|NCT01014013|6032483|P1|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of MK0826 parenteral therapy|132
2460162|NCT01014013|6032482|P2|STARTED|Overall Study||136
2460163|NCT01014013|6032483|P1|STARTED|Overall Study||135
2460164|NCT01013961|6032495|P2|NOT COMPLETED|Overall Study||3
2460165|NCT01013961|6032496|P1|NOT COMPLETED|Overall Study||3
2460166|NCT01013961|6032495|P2|COMPLETED|Overall Study||12
2460167|NCT01013961|6032496|P1|COMPLETED|Overall Study||13
2460168|NCT01013961|6032495|P2|STARTED|Overall Study||15
2460169|NCT01013961|6032496|P1|STARTED|Overall Study||16
2460170|NCT01013883|6032514|P2|NOT COMPLETED|Overall Study||2
2460171|NCT01013883|6032515|P1|NOT COMPLETED|Overall Study||2
2460172|NCT01013883|6032514|P2|COMPLETED|Overall Study||241
2460173|NCT01013883|6032515|P1|COMPLETED|Overall Study||268
2460174|NCT01013883|6032514|P2|STARTED|Overall Study||243
2460175|NCT01013883|6032515|P1|STARTED|Overall Study||270
2460176|NCT01013870|6032527|P2|NOT COMPLETED|Overall Study||3
2460177|NCT01013870|6032528|P1|NOT COMPLETED|Overall Study||1
2460178|NCT01013870|6032527|P2|COMPLETED|Overall Study||21
2460179|NCT01013870|6032528|P1|COMPLETED|Overall Study||27
2460180|NCT01013870|6032527|P2|STARTED|Overall Study||24
2460181|NCT01013870|6032528|P1|STARTED|Overall Study||28
2460182|NCT01013844|6032552|P2|NOT COMPLETED|Overall Study||0
2460183|NCT01013844|6032553|P1|NOT COMPLETED|Overall Study||0
2460184|NCT01013844|6032552|P2|COMPLETED|Overall Study||65
2460185|NCT01013844|6032553|P1|COMPLETED|Overall Study||65
2460186|NCT01013844|6032552|P2|STARTED|Overall Study||65
2460187|NCT01013844|6032553|P1|STARTED|Overall Study||65
2460188|NCT01013792|6032577|P2|NOT COMPLETED|Overall Study||5
2460189|NCT01013792|6032578|P1|NOT COMPLETED|Overall Study||2
2460190|NCT01013792|6032577|P2|COMPLETED|Overall Study||11
2460191|NCT01013792|6032578|P1|COMPLETED|Overall Study||12
2460192|NCT01013792|6032577|P2|STARTED|Overall Study||16
2460193|NCT01013792|6032578|P1|STARTED|Overall Study||14
2460194|NCT01013753|6032584|P1|NOT COMPLETED|Overall Study||16
2460195|NCT01013753|6032584|P1|COMPLETED|Overall Study||182
2460196|NCT01013753|6032584|P1|Received Form 12 mcg Bid|Overall Study||125
2460197|NCT01013753|6032584|P1|Received Olo 20 mcg qd|Overall Study||124
2460198|NCT01013753|6032584|P1|Received Olo 10 mcg qd|Overall Study||127
2460199|NCT01013753|6032584|P1|Received Olo 5 mcg qd|Overall Study||130
2460200|NCT01013753|6032584|P1|Received Olo 2 mcg qd|Overall Study||121
2460201|NCT01013753|6032584|P1|Received Placebo|Overall Study||125
2460202|NCT01013753|6032584|P1|STARTED|Overall Study|Entered and treated|198
2460203|NCT01013740|6032780|P2|NOT COMPLETED|Overall Study||19
2460204|NCT01013740|6032781|P1|NOT COMPLETED|Overall Study||11
2460205|NCT01013740|6032780|P2|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|56
2460206|NCT01013740|6032781|P1|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|26
2460207|NCT01013740|6032780|P2|Ongoing|Overall Study||0
2460208|NCT01013740|6032781|P1|Ongoing|Overall Study||0
2460209|NCT01013740|6032780|P2|STARTED|Overall Study|29 participants experiencing PD in the RP elected to enroll in the optional CP.|75
2460210|NCT01013740|6032781|P1|STARTED|Overall Study|13 participants (par.) experiencing PD in the RP elected to enroll in the optional CP.|37
2460211|NCT01013701|6032805|P1|NOT COMPLETED|Overall Study||7
2460212|NCT01013701|6032805|P1|COMPLETED|Overall Study||0
2460213|NCT01013701|6032805|P1|STARTED|Overall Study||7
2460214|NCT01013597|6032812|P1|NOT COMPLETED|Overall Study||1
2460215|NCT01013597|6032812|P1|COMPLETED|Overall Study||12
2460216|NCT01013597|6032812|P1|STARTED|Overall Study||13
2460217|NCT01013350|6032824|P2|NOT COMPLETED|Overall Study||192
2460218|NCT01013350|6032825|P1|NOT COMPLETED|Overall Study||38
2460219|NCT01013350|6032824|P2|COMPLETED|Overall Study||771
2460220|NCT01013350|6032825|P1|COMPLETED|Overall Study||160
2460221|NCT01013350|6032824|P2|Safety Analysis Set|Overall Study||950
2460222|NCT01013350|6032825|P1|Safety Analysis Set|Overall Study||198
2460223|NCT01013350|6032824|P2|STARTED|Overall Study||963
2460224|NCT01013350|6032825|P1|STARTED|Overall Study||198
2460225|NCT01013207|6032836|P1|NOT COMPLETED|CPAP Post Nexus (S9)||6
2460226|NCT01013207|6032836|P1|COMPLETED|CPAP Post Nexus (S9)||44
2460227|NCT01013207|6032836|P1|STARTED|CPAP Post Nexus (S9)||50
2460228|NCT01013207|6032836|P1|NOT COMPLETED|Nexus (S9)||0
2460229|NCT01013207|6032836|P1|COMPLETED|Nexus (S9)||50
2460230|NCT01013207|6032836|P1|STARTED|Nexus (S9)||50
2460231|NCT01013207|6032836|P1|NOT COMPLETED|CPAP Pre Nexus (S9)||0
2460232|NCT01013207|6032836|P1|COMPLETED|CPAP Pre Nexus (S9)||50
2460233|NCT01013207|6032836|P1|STARTED|CPAP Pre Nexus (S9)||50
2460234|NCT01013194|6032843|P2|NOT COMPLETED|Overall Study||0
2460235|NCT01013194|6032844|P1|NOT COMPLETED|Overall Study||0
2460236|NCT01013194|6032843|P2|COMPLETED|Overall Study|Retrospectively contemporary matched-pair group|16
2460237|NCT01013194|6032844|P1|COMPLETED|Overall Study|Consecutive patients|9
2460238|NCT01013194|6032843|P2|STARTED|Overall Study||16
2460239|NCT01013194|6032844|P1|STARTED|Overall Study||9
2460240|NCT01012999|6032854|P1|NOT COMPLETED|Overall Study||1
2460241|NCT01012999|6032854|P1|COMPLETED|Overall Study||15
2460242|NCT01012999|6032854|P1|STARTED|Overall Study||16
2460243|NCT01012973|6032860|P2|NOT COMPLETED|Overall Study||19
2460244|NCT01012973|6032861|P1|NOT COMPLETED|Overall Study||16
2460245|NCT01012973|6032860|P2|COMPLETED|Overall Study||52
2460246|NCT01012973|6032861|P1|COMPLETED|Overall Study||90
2460247|NCT01012973|6032860|P2|Completed Week 52, From FAS|Overall Study||52
2460248|NCT01012973|6032861|P1|Completed Week 52, From FAS|Overall Study||91
2460249|NCT01012973|6032860|P2|Completed Week 24, From FAS|Overall Study||57
2460250|NCT01012973|6032861|P1|Completed Week 24, From FAS|Overall Study||97
2460251|NCT01012973|6032860|P2|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|68
2460252|NCT01012973|6032861|P1|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|103
2460253|NCT01012973|6032860|P2|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|68
2460254|NCT01012973|6032861|P1|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|104
2460255|NCT01012973|6032860|P2|STARTED|Overall Study||71
2460256|NCT01012973|6032861|P1|STARTED|Overall Study||106
2460257|NCT01012947|6032886|P5|NOT COMPLETED|Overall Study||142
2460258|NCT01012947|6032887|P4|NOT COMPLETED|Overall Study||118
2460259|NCT01012947|6032888|P3|NOT COMPLETED|Overall Study||130
2460260|NCT01012947|6032889|P2|NOT COMPLETED|Overall Study||135
2460261|NCT01012947|6032890|P1|NOT COMPLETED|Overall Study||131
2460262|NCT01012947|6032886|P5|COMPLETED|Overall Study||94
2460263|NCT01012947|6032887|P4|COMPLETED|Overall Study||93
2460264|NCT01012947|6032888|P3|COMPLETED|Overall Study||111
2460265|NCT01012947|6032889|P2|COMPLETED|Overall Study||80
2460266|NCT01012947|6032890|P1|COMPLETED|Overall Study||81
2460267|NCT01012947|6032886|P5|STARTED|Overall Study||236
2460268|NCT01012947|6032887|P4|STARTED|Overall Study||211
2460269|NCT01012947|6032888|P3|STARTED|Overall Study||241
2460270|NCT01012947|6032889|P2|STARTED|Overall Study||215
2460271|NCT01012947|6032890|P1|STARTED|Overall Study||212
2460272|NCT01012921|6032904|P2|NOT COMPLETED|Overall Study||13
2460273|NCT01012921|6032905|P1|NOT COMPLETED|Overall Study||10
2460274|NCT01012921|6032904|P2|COMPLETED|Overall Study||47
2460275|NCT01012921|6032905|P1|COMPLETED|Overall Study||47
2460276|NCT01012921|6032904|P2|STARTED|Overall Study||60
2460277|NCT01012921|6032905|P1|STARTED|Overall Study||57
2460278|NCT01012765|6032911|P6|NOT COMPLETED|Treatment Period 3||0
2460279|NCT01012765|6032912|P5|NOT COMPLETED|Treatment Period 3||0
2460280|NCT01012765|6032913|P4|NOT COMPLETED|Treatment Period 3||0
2460281|NCT01012765|6032914|P3|NOT COMPLETED|Treatment Period 3||0
2460282|NCT01012765|6032915|P2|NOT COMPLETED|Treatment Period 3||0
2460283|NCT01012765|6032916|P1|NOT COMPLETED|Treatment Period 3||0
2460284|NCT01012765|6032911|P6|COMPLETED|Treatment Period 3||24
2460285|NCT01012765|6032912|P5|COMPLETED|Treatment Period 3||18
2460286|NCT01012765|6032913|P4|COMPLETED|Treatment Period 3||15
2460287|NCT01012765|6032914|P3|COMPLETED|Treatment Period 3||18
2460288|NCT01012765|6032915|P2|COMPLETED|Treatment Period 3||19
2460289|NCT01012765|6032916|P1|COMPLETED|Treatment Period 3||16
2460290|NCT01012765|6032911|P6|STARTED|Treatment Period 3||24
2460291|NCT01012765|6032912|P5|STARTED|Treatment Period 3||18
2460292|NCT01012765|6032913|P4|STARTED|Treatment Period 3||15
2460293|NCT01012765|6032914|P3|STARTED|Treatment Period 3||18
2460294|NCT01012765|6032915|P2|STARTED|Treatment Period 3||19
2460295|NCT01012765|6032916|P1|STARTED|Treatment Period 3||16
2460296|NCT01012765|6032911|P6|NOT COMPLETED|Treatment Period 2||1
2460297|NCT01012765|6032912|P5|NOT COMPLETED|Treatment Period 2||1
2460298|NCT01012765|6032913|P4|NOT COMPLETED|Treatment Period 2||0
2460299|NCT01012765|6032914|P3|NOT COMPLETED|Treatment Period 2||3
2460300|NCT01012765|6032915|P2|NOT COMPLETED|Treatment Period 2||2
2460301|NCT01012765|6032916|P1|NOT COMPLETED|Treatment Period 2||1
2460302|NCT01012765|6032911|P6|COMPLETED|Treatment Period 2||24
2460303|NCT01012765|6032912|P5|COMPLETED|Treatment Period 2||18
2460304|NCT01012765|6032913|P4|COMPLETED|Treatment Period 2||15
2460305|NCT01012765|6032914|P3|COMPLETED|Treatment Period 2||18
2460306|NCT01012765|6032915|P2|COMPLETED|Treatment Period 2||19
2460307|NCT01012765|6032916|P1|COMPLETED|Treatment Period 2||16
2460308|NCT01012765|6032911|P6|STARTED|Treatment Period 2||25
2460309|NCT01012765|6032912|P5|STARTED|Treatment Period 2||19
2460310|NCT01012765|6032913|P4|STARTED|Treatment Period 2||15
2460311|NCT01012765|6032914|P3|STARTED|Treatment Period 2||21
2460312|NCT01012765|6032915|P2|STARTED|Treatment Period 2||21
2460313|NCT01012765|6032916|P1|STARTED|Treatment Period 2||17
2460314|NCT01012765|6032911|P6|NOT COMPLETED|Treatment Period 1||0
2460315|NCT01012765|6032912|P5|NOT COMPLETED|Treatment Period 1||3
2460316|NCT01012765|6032913|P4|NOT COMPLETED|Treatment Period 1||3
2460317|NCT01012765|6032914|P3|NOT COMPLETED|Treatment Period 1||2
2460318|NCT01012765|6032915|P2|NOT COMPLETED|Treatment Period 1||0
2460319|NCT01012765|6032916|P1|NOT COMPLETED|Treatment Period 1||3
2460320|NCT01012765|6032911|P6|COMPLETED|Treatment Period 1||25
2460321|NCT01012765|6032912|P5|COMPLETED|Treatment Period 1||19
2460322|NCT01012765|6032913|P4|COMPLETED|Treatment Period 1||15
2460323|NCT01012765|6032914|P3|COMPLETED|Treatment Period 1||21
2460324|NCT01012765|6032915|P2|COMPLETED|Treatment Period 1||21
2460325|NCT01012765|6032916|P1|COMPLETED|Treatment Period 1||17
2460326|NCT01012765|6032911|P6|STARTED|Treatment Period 1||25
2460327|NCT01012765|6032912|P5|STARTED|Treatment Period 1||22
2460328|NCT01012765|6032913|P4|STARTED|Treatment Period 1||18
2460329|NCT01012765|6032914|P3|STARTED|Treatment Period 1||23
2460330|NCT01012765|6032915|P2|STARTED|Treatment Period 1||21
2460331|NCT01012765|6032916|P1|STARTED|Treatment Period 1||20
2460332|NCT01012739|6032945|P4|NOT COMPLETED|Treatment Period 4||0
2460333|NCT01012739|6032946|P3|NOT COMPLETED|Treatment Period 4||0
2460334|NCT01012739|6032947|P2|NOT COMPLETED|Treatment Period 4||0
2460335|NCT01012739|6032948|P1|NOT COMPLETED|Treatment Period 4||0
2460336|NCT01012739|6032945|P4|COMPLETED|Treatment Period 4||7
2460337|NCT01012739|6032946|P3|COMPLETED|Treatment Period 4||9
2460338|NCT01012739|6032947|P2|COMPLETED|Treatment Period 4||8
2460339|NCT01012739|6032948|P1|COMPLETED|Treatment Period 4||9
2460340|NCT01012739|6032945|P4|STARTED|Treatment Period 4||7
2460341|NCT01012739|6032946|P3|STARTED|Treatment Period 4||9
2460342|NCT01012739|6032947|P2|STARTED|Treatment Period 4||8
2460343|NCT01012739|6032948|P1|STARTED|Treatment Period 4||9
2460344|NCT01012739|6032945|P4|NOT COMPLETED|Treatment Period 3||0
2460345|NCT01012739|6032946|P3|NOT COMPLETED|Treatment Period 3||0
2460346|NCT01012739|6032947|P2|NOT COMPLETED|Treatment Period 3||0
2460347|NCT01012739|6032948|P1|NOT COMPLETED|Treatment Period 3||0
2460348|NCT01012739|6032945|P4|COMPLETED|Treatment Period 3||7
2460349|NCT01012739|6032946|P3|COMPLETED|Treatment Period 3||9
2460350|NCT01012739|6032947|P2|COMPLETED|Treatment Period 3||8
2460351|NCT01012739|6032948|P1|COMPLETED|Treatment Period 3||9
2460352|NCT01012739|6032945|P4|STARTED|Treatment Period 3||7
2460353|NCT01012739|6032946|P3|STARTED|Treatment Period 3||9
2460354|NCT01012739|6032947|P2|STARTED|Treatment Period 3||8
2460355|NCT01012739|6032948|P1|STARTED|Treatment Period 3||9
2460356|NCT01012739|6032945|P4|NOT COMPLETED|Treatment Period 2||1
2460357|NCT01012739|6032946|P3|NOT COMPLETED|Treatment Period 2||0
2460358|NCT01012739|6032947|P2|NOT COMPLETED|Treatment Period 2||0
2460359|NCT01012739|6032948|P1|NOT COMPLETED|Treatment Period 2||0
2460360|NCT01012739|6032945|P4|COMPLETED|Treatment Period 2||7
2460361|NCT01012739|6032946|P3|COMPLETED|Treatment Period 2||9
2460362|NCT01012739|6032947|P2|COMPLETED|Treatment Period 2||8
2460363|NCT01012739|6032948|P1|COMPLETED|Treatment Period 2||9
2460364|NCT01012739|6032945|P4|STARTED|Treatment Period 2||8
2460365|NCT01012739|6032946|P3|STARTED|Treatment Period 2||9
2460366|NCT01012739|6032947|P2|STARTED|Treatment Period 2||8
2460367|NCT01012739|6032948|P1|STARTED|Treatment Period 2||9
2460368|NCT01012739|6032945|P4|NOT COMPLETED|Treatment Period 1||1
2460369|NCT01012739|6032946|P3|NOT COMPLETED|Treatment Period 1||0
2460370|NCT01012739|6032947|P2|NOT COMPLETED|Treatment Period 1||0
2460371|NCT01012739|6032948|P1|NOT COMPLETED|Treatment Period 1||0
2460372|NCT01012739|6032945|P4|COMPLETED|Treatment Period 1||8
2460373|NCT01012739|6032946|P3|COMPLETED|Treatment Period 1||9
2460374|NCT01012739|6032947|P2|COMPLETED|Treatment Period 1||8
2460375|NCT01012739|6032948|P1|COMPLETED|Treatment Period 1||9
2460376|NCT01012739|6032945|P4|STARTED|Treatment Period 1||9
2460377|NCT01012739|6032946|P3|STARTED|Treatment Period 1||9
2460378|NCT01012739|6032947|P2|STARTED|Treatment Period 1||8
2460379|NCT01012739|6032948|P1|STARTED|Treatment Period 1||9
2460380|NCT01012713|6032976|P1|NOT COMPLETED|Overall Study||3
2460381|NCT01012713|6032976|P1|COMPLETED|Overall Study||27
2460382|NCT01012713|6032976|P1|STARTED|Overall Study||30
2460383|NCT01012674|6032982|P1|NOT COMPLETED|Overall Study||24
2460384|NCT01012674|6032982|P1|COMPLETED|Overall Study||187
2460385|NCT01012674|6032982|P1|STARTED|Overall Study||211
2460386|NCT01012661|6032994|P1|NOT COMPLETED|Overall Study||0
2460387|NCT01012661|6032994|P1|COMPLETED|Overall Study||50
2460388|NCT01012661|6032994|P1|STARTED|Overall Study||50
2460389|NCT01012622|6033002|P1|NOT COMPLETED|Overall Study||31
2460390|NCT01012622|6033002|P1|COMPLETED|Overall Study||111
2460391|NCT01012622|6033002|P1|STARTED|Overall Study||142
2460392|NCT01012492|6033021|P1|NOT COMPLETED|Overall Study||0
2460393|NCT01012492|6033021|P1|COMPLETED|Overall Study||10
2460394|NCT01012492|6033021|P1|STARTED|Overall Study||10
2460395|NCT01012440|6033028|P1|NOT COMPLETED|Overall Study||2
2460396|NCT01012440|6033028|P1|COMPLETED|Overall Study||3
2460397|NCT01012440|6033028|P1|STARTED|Overall Study||5
2460398|NCT01012414|6033032|P1|NOT COMPLETED|Overall Study||10
2460399|NCT01012414|6033032|P1|COMPLETED|Overall Study|No subjects completed the study.|0
2460400|NCT01012414|6033032|P1|STARTED|Overall Study||10
2460401|NCT01012388|6033039|P1|NOT COMPLETED|Overall Study||0
2460402|NCT01012388|6033039|P1|COMPLETED|Overall Study||100
2460403|NCT01012388|6033039|P1|STARTED|Overall Study||100
2460404|NCT01012362|6033049|P5|NOT COMPLETED|Overall Study||0
2460405|NCT01012362|6033050|P4|NOT COMPLETED|Overall Study||0
2460406|NCT01012362|6033051|P3|NOT COMPLETED|Overall Study||0
2460407|NCT01012362|6033052|P2|NOT COMPLETED|Overall Study||0
2460408|NCT01012362|6033053|P1|NOT COMPLETED|Overall Study||0
2460409|NCT01012362|6033049|P5|COMPLETED|Overall Study||9
2460410|NCT01012362|6033050|P4|COMPLETED|Overall Study||4
2460411|NCT01012362|6033051|P3|COMPLETED|Overall Study||3
2460412|NCT01012362|6033052|P2|COMPLETED|Overall Study||6
2460413|NCT01012362|6033053|P1|COMPLETED|Overall Study||9
2460414|NCT01012362|6033049|P5|STARTED|Overall Study||9
2460415|NCT01012362|6033050|P4|STARTED|Overall Study||4
2460416|NCT01012362|6033051|P3|STARTED|Overall Study||3
2460417|NCT01012362|6033052|P2|STARTED|Overall Study||6
2460418|NCT01012362|6033053|P1|STARTED|Overall Study||9
2460419|NCT01012336|6033069|P1|NOT COMPLETED|Overall Study||0
2460420|NCT01012336|6033069|P1|COMPLETED|Overall Study||85
2460421|NCT01012336|6033069|P1|STARTED|Overall Study||85
2460422|NCT01012323|6033073|P1|NOT COMPLETED|Overall Study||1
2460423|NCT01012323|6033073|P1|COMPLETED|Overall Study||50
2460424|NCT01012323|6033073|P1|STARTED|Overall Study||51
2460425|NCT01012297|6033097|P2|NOT COMPLETED|Overall Study||0
2460426|NCT01012297|6033098|P1|NOT COMPLETED|Overall Study||0
2460427|NCT01012297|6033097|P2|COMPLETED|Overall Study||53
2460428|NCT01012297|6033098|P1|COMPLETED|Overall Study||54
2460429|NCT01012297|6033097|P2|STARTED|Overall Study||53
2460430|NCT01012297|6033098|P1|STARTED|Overall Study||54
2460431|NCT01012258|6033110|P1|NOT COMPLETED|Overall Study||66
2460432|NCT01012258|6033110|P1|COMPLETED|Overall Study||0
2460433|NCT01012258|6033110|P1|STARTED|Overall Study||66
2460434|NCT01012245|6033120|P1|NOT COMPLETED|Overall Study||2427
2460435|NCT01012245|6033120|P1|COMPLETED|Overall Study|More than 1 discontinuation (DC) reason possible per subject. See outcome measure Reasons for DC.|26385
2460436|NCT01012245|6033120|P1|STARTED|Overall Study||28812
2460437|NCT01012219|6033157|P1|NOT COMPLETED|Period 3||0
2460438|NCT01012219|6033157|P1|COMPLETED|Period 3||20
2460439|NCT01012219|6033157|P1|STARTED|Period 3|of the 36 who started Period 1|20
2460440|NCT01012219|6033157|P1|NOT COMPLETED|Period 2||1
2460441|NCT01012219|6033157|P1|COMPLETED|Period 2||34
2460442|NCT01012219|6033157|P1|STARTED|Period 2|Number who completed Period 1|35
2460443|NCT01012219|6033157|P1|NOT COMPLETED|Period 1||1
2460444|NCT01012219|6033157|P1|COMPLETED|Period 1||35
2460445|NCT01012219|6033157|P1|STARTED|Period 1|Number randomized|36
2460446|NCT01012167|6033167|P3|NOT COMPLETED|Overall Study||4
2460447|NCT01012167|6033168|P2|NOT COMPLETED|Overall Study||2
2460448|NCT01012167|6033169|P1|NOT COMPLETED|Overall Study||2
2460449|NCT01012167|6033167|P3|COMPLETED|Overall Study||17
2460450|NCT01012167|6033168|P2|COMPLETED|Overall Study||18
2460451|NCT01012167|6033169|P1|COMPLETED|Overall Study||15
2460452|NCT01012167|6033167|P3|Exposed to Study Drug|Overall Study||20
2460453|NCT01012167|6033168|P2|Exposed to Study Drug|Overall Study||20
2460454|NCT01012167|6033169|P1|Exposed to Study Drug|Overall Study||16
2460455|NCT01012167|6033167|P3|Withdrawn Prior to Study Drug Exposure|Overall Study||1
2460456|NCT01012167|6033168|P2|Withdrawn Prior to Study Drug Exposure|Overall Study||0
2460457|NCT01012167|6033169|P1|Withdrawn Prior to Study Drug Exposure|Overall Study||1
2460458|NCT01012167|6033167|P3|STARTED|Overall Study||21
2460459|NCT01012167|6033168|P2|STARTED|Overall Study||20
2460460|NCT01012167|6033169|P1|STARTED|Overall Study||17
2460461|NCT01012089|6033425|P1|NOT COMPLETED|Overall Study||0
2460462|NCT01012089|6033425|P1|COMPLETED|Overall Study||6
2460463|NCT01012089|6033425|P1|STARTED|Overall Study||6
2460464|NCT01012037|6033448|P3|NOT COMPLETED|Overall Study||10
2460465|NCT01012037|6033449|P2|NOT COMPLETED|Overall Study||16
2460466|NCT01012037|6033450|P1|NOT COMPLETED|Overall Study||1
2460467|NCT01012037|6033448|P3|COMPLETED|Overall Study||214
2460468|NCT01012037|6033449|P2|COMPLETED|Overall Study||207
2460469|NCT01012037|6033450|P1|COMPLETED|Overall Study||43
2460470|NCT01012037|6033448|P3|STARTED|Overall Study||224
2460471|NCT01012037|6033449|P2|STARTED|Overall Study||223
2460472|NCT01012037|6033450|P1|STARTED|Overall Study||44
2460473|NCT01011946|6033485|P1|NOT COMPLETED|Overall Study||3
2460474|NCT01011946|6033485|P1|COMPLETED|Overall Study||33
2460475|NCT01011946|6033485|P1|STARTED|Overall Study||36
2460476|NCT01011933|6033489|P1|NOT COMPLETED|Overall Study||4
2460477|NCT01011933|6033489|P1|COMPLETED|Overall Study|total eligible and evaluable|50
2460478|NCT01011933|6033489|P1|STARTED|Overall Study|total enrolled|54
2460479|NCT01011907|6033506|P2|NOT COMPLETED|Overall Study||15
2460480|NCT01011907|6033507|P1|NOT COMPLETED|Overall Study||14
2460481|NCT01011907|6033506|P2|COMPLETED|Overall Study||18
2460482|NCT01011907|6033507|P1|COMPLETED|Overall Study||17
2460483|NCT01011907|6033506|P2|STARTED|Overall Study||33
2460484|NCT01011907|6033507|P1|STARTED|Overall Study||31
2460485|NCT01011894|6033517|P1|NOT COMPLETED|Overall Study||0
2460486|NCT01011894|6033517|P1|COMPLETED|Overall Study||26
2460487|NCT01011894|6033517|P1|STARTED|Overall Study||26
2460488|NCT01011868|6033524|P3|NOT COMPLETED|After Week 78 Follow-up||44
2460489|NCT01011868|6033525|P2|NOT COMPLETED|After Week 78 Follow-up||38
2460490|NCT01011868|6033526|P1|NOT COMPLETED|After Week 78 Follow-up||52
2460491|NCT01011868|6033524|P3|COMPLETED|After Week 78 Follow-up||111
2460492|NCT01011868|6033525|P2|COMPLETED|After Week 78 Follow-up||131
2460493|NCT01011868|6033526|P1|COMPLETED|After Week 78 Follow-up||118
2460494|NCT01011868|6033524|P3|STARTED|After Week 78 Follow-up||155
2460495|NCT01011868|6033525|P2|STARTED|After Week 78 Follow-up||169
2460496|NCT01011868|6033526|P1|STARTED|After Week 78 Follow-up||170
2460497|NCT01011868|6033524|P3|NOT COMPLETED|After Week 18 Follow-up||26
2460498|NCT01011868|6033525|P2|NOT COMPLETED|After Week 18 Follow-up||16
2460499|NCT01011868|6033526|P1|NOT COMPLETED|After Week 18 Follow-up||23
2460500|NCT01011868|6033524|P3|COMPLETED|After Week 18 Follow-up||129
2460501|NCT01011868|6033525|P2|COMPLETED|After Week 18 Follow-up||153
2460502|NCT01011868|6033526|P1|COMPLETED|After Week 18 Follow-up||147
2460503|NCT01011868|6033524|P3|STARTED|After Week 18 Follow-up||155
2460504|NCT01011868|6033525|P2|STARTED|After Week 18 Follow-up||169
2460505|NCT01011868|6033526|P1|STARTED|After Week 18 Follow-up||170
2460506|NCT01011829|6033563|P2|NOT COMPLETED|Overall Study||9
2460507|NCT01011829|6033564|P1|NOT COMPLETED|Overall Study||4
2460508|NCT01011829|6033563|P2|COMPLETED|Overall Study||1
2460509|NCT01011829|6033564|P1|COMPLETED|Overall Study||6
2460510|NCT01011829|6033563|P2|STARTED|Overall Study||10
2460511|NCT01011829|6033564|P1|STARTED|Overall Study||10
2460512|NCT01011816|6033574|P2|NOT COMPLETED|78-Week Extended Follow-up||28
2460513|NCT01011816|6033575|P1|NOT COMPLETED|78-Week Extended Follow-up||72
2460514|NCT01011816|6033574|P2|COMPLETED|78-Week Extended Follow-up||26
2460515|NCT01011816|6033575|P1|COMPLETED|78-Week Extended Follow-up||85
2460516|NCT01011816|6033574|P2|STARTED|78-Week Extended Follow-up||54
2460517|NCT01011816|6033575|P1|STARTED|78-Week Extended Follow-up||157
2460518|NCT01011816|6033574|P2|NOT COMPLETED|26-Week Primary Endpoint||2
2460519|NCT01011816|6033575|P1|NOT COMPLETED|26-Week Primary Endpoint||7
2460520|NCT01011816|6033574|P2|COMPLETED|26-Week Primary Endpoint||54
2460521|NCT01011816|6033575|P1|COMPLETED|26-Week Primary Endpoint||157
2460522|NCT01011816|6033574|P2|STARTED|26-Week Primary Endpoint||56
2460523|NCT01011816|6033575|P1|STARTED|26-Week Primary Endpoint||164
2460524|NCT01011738|6033588|P3|NOT COMPLETED|Overall Study||17
2460525|NCT01011738|6033589|P2|NOT COMPLETED|Overall Study||294
2460526|NCT01011738|6033590|P1|NOT COMPLETED|Overall Study||324
2460527|NCT01011738|6033588|P3|COMPLETED|Overall Study||36
2460528|NCT01011738|6033589|P2|COMPLETED|Overall Study||618
2460529|NCT01011738|6033590|P1|COMPLETED|Overall Study||553
2460530|NCT01011738|6033588|P3|STARTED|Overall Study||53
2460531|NCT01011738|6033589|P2|STARTED|Overall Study||912
2460532|NCT01011738|6033590|P1|STARTED|Overall Study||877
2460533|NCT01011673|6033630|P2|NOT COMPLETED|24 Hour Follow-up||3
2460534|NCT01011673|6033631|P1|NOT COMPLETED|24 Hour Follow-up||3
2460535|NCT01011673|6033630|P2|COMPLETED|24 Hour Follow-up||57
2460536|NCT01011673|6033631|P1|COMPLETED|24 Hour Follow-up||57
2460537|NCT01011673|6033630|P2|STARTED|24 Hour Follow-up||60
2460538|NCT01011673|6033631|P1|STARTED|24 Hour Follow-up||60
2460539|NCT01011673|6033630|P2|NOT COMPLETED|Emergency Department Portion||0
2460540|NCT01011673|6033631|P1|NOT COMPLETED|Emergency Department Portion||0
2460541|NCT01011673|6033630|P2|COMPLETED|Emergency Department Portion||60
2460542|NCT01011673|6033631|P1|COMPLETED|Emergency Department Portion||60
2460543|NCT01011673|6033630|P2|STARTED|Emergency Department Portion||60
2460544|NCT01011673|6033631|P1|STARTED|Emergency Department Portion||60
2460545|NCT01011673|6033630|P2|NOT COMPLETED|Randomized||1
2460546|NCT01011673|6033631|P1|NOT COMPLETED|Randomized||2
2460547|NCT01011673|6033630|P2|COMPLETED|Randomized|1 patient was randomized but not included in analyses bc they did not truly meet study criteria.|60
2460548|NCT01011673|6033631|P1|COMPLETED|Randomized|2 patients were randomized but not included in analyses bc they did not truly meet study criteria.|60
2460549|NCT01011673|6033630|P2|STARTED|Randomized||61
2460550|NCT01011673|6033631|P1|STARTED|Randomized||62
2460551|NCT01011634|6033641|P2|NOT COMPLETED|Overall Study||1
2460552|NCT01011634|6033642|P1|NOT COMPLETED|Overall Study||0
2460553|NCT01011634|6033641|P2|COMPLETED|Overall Study||8
2460554|NCT01011634|6033642|P1|COMPLETED|Overall Study||9
2460555|NCT01011634|6033641|P2|STARTED|Overall Study||9
2460556|NCT01011634|6033642|P1|STARTED|Overall Study||9
2460557|NCT01011556|6033654|P4|NOT COMPLETED|Overall Study||13
2460558|NCT01011556|6033655|P3|NOT COMPLETED|Overall Study||10
2460559|NCT01011556|6033656|P2|NOT COMPLETED|Overall Study||8
2460560|NCT01011556|6033657|P1|NOT COMPLETED|Overall Study||6
2460561|NCT01011556|6033654|P4|COMPLETED|Overall Study||51
2460562|NCT01011556|6033655|P3|COMPLETED|Overall Study||45
2460563|NCT01011556|6033656|P2|COMPLETED|Overall Study||48
2460564|NCT01011556|6033657|P1|COMPLETED|Overall Study||52
2460565|NCT01011556|6033654|P4|Received at Least 1 Dose of Study Drug|Overall Study||64
2460566|NCT01011556|6033655|P3|Received at Least 1 Dose of Study Drug|Overall Study||54
2460567|NCT01011556|6033656|P2|Received at Least 1 Dose of Study Drug|Overall Study||56
2460568|NCT01011556|6033657|P1|Received at Least 1 Dose of Study Drug|Overall Study||57
2460569|NCT01011556|6033654|P4|STARTED|Overall Study||64
2460570|NCT01011556|6033655|P3|STARTED|Overall Study||55
2460571|NCT01011556|6033656|P2|STARTED|Overall Study||56
2460572|NCT01011556|6033657|P1|STARTED|Overall Study||58
2460573|NCT01011465|6033735|P8|NOT COMPLETED|Overall Study||0
2460574|NCT01011465|6033736|P7|NOT COMPLETED|Overall Study||1
2460575|NCT01011465|6033737|P6|NOT COMPLETED|Overall Study||0
2460576|NCT01011465|6033738|P5|NOT COMPLETED|Overall Study||1
2460577|NCT01011465|6033739|P4|NOT COMPLETED|Overall Study||0
2460578|NCT01011465|6033740|P3|NOT COMPLETED|Overall Study||0
2460579|NCT01011465|6033741|P2|NOT COMPLETED|Overall Study||1
2460580|NCT01011465|6033742|P1|NOT COMPLETED|Overall Study||2
2460581|NCT01011465|6033735|P8|COMPLETED|Overall Study||32
2460582|NCT01011465|6033736|P7|COMPLETED|Overall Study||51
2460583|NCT01011465|6033737|P6|COMPLETED|Overall Study||29
2460584|NCT01011465|6033738|P5|COMPLETED|Overall Study||46
2460585|NCT01011465|6033739|P4|COMPLETED|Overall Study||18
2460586|NCT01011465|6033740|P3|COMPLETED|Overall Study||36
2460587|NCT01011465|6033741|P2|COMPLETED|Overall Study||19
2460588|NCT01011465|6033742|P1|COMPLETED|Overall Study||34
2460589|NCT01011465|6033735|P8|STARTED|Overall Study||32
2460590|NCT01011465|6033736|P7|STARTED|Overall Study||52
2460591|NCT01011465|6033737|P6|STARTED|Overall Study||29
2460592|NCT01011465|6033738|P5|STARTED|Overall Study||47
2460593|NCT01011465|6033739|P4|STARTED|Overall Study||18
2460594|NCT01011465|6033740|P3|STARTED|Overall Study||36
2460595|NCT01011465|6033741|P2|STARTED|Overall Study||20
2460596|NCT01011465|6033742|P1|STARTED|Overall Study||36
2460597|NCT01011439|6033770|P1|NOT COMPLETED|Overall Study||57
2460598|NCT01011439|6033770|P1|COMPLETED|Overall Study||15
2460599|NCT01011439|6033770|P1|STARTED|Overall Study||72
2460624|NCT01011387|6033807|P1|NOT COMPLETED|Overall Study||6
2460625|NCT01011387|6033807|P1|COMPLETED|Overall Study||10
2460626|NCT01011387|6033807|P1|STARTED|Overall Study||16
2460627|NCT01011335|6033815|P13|NOT COMPLETED|Overall Study||3
2460628|NCT01011335|6033816|P12|NOT COMPLETED|Overall Study||1
2460629|NCT01011335|6033817|P11|NOT COMPLETED|Overall Study||6
2460630|NCT01011335|6033818|P10|NOT COMPLETED|Overall Study||0
2460631|NCT01011335|6033819|P9|NOT COMPLETED|Overall Study||2
2460632|NCT01011335|6033820|P8|NOT COMPLETED|Overall Study||2
2460633|NCT01011335|6033821|P7|NOT COMPLETED|Overall Study||3
2460634|NCT01011335|6033822|P6|NOT COMPLETED|Overall Study||1
2460635|NCT01011335|6033823|P5|NOT COMPLETED|Overall Study||1
2460636|NCT01011335|6033824|P4|NOT COMPLETED|Overall Study||2
2460637|NCT01011335|6033825|P3|NOT COMPLETED|Overall Study||1
2460638|NCT01011335|6033826|P2|NOT COMPLETED|Overall Study||1
2460639|NCT01011335|6033827|P1|NOT COMPLETED|Overall Study||1
2460640|NCT01011335|6033815|P13|COMPLETED|Overall Study||19
2460641|NCT01011335|6033816|P12|COMPLETED|Overall Study||21
2460642|NCT01011335|6033817|P11|COMPLETED|Overall Study||6
2460643|NCT01011335|6033818|P10|COMPLETED|Overall Study||12
2460644|NCT01011335|6033819|P9|COMPLETED|Overall Study||10
2460645|NCT01011335|6033820|P8|COMPLETED|Overall Study||10
2460646|NCT01011335|6033821|P7|COMPLETED|Overall Study||9
2460647|NCT01011335|6033822|P6|COMPLETED|Overall Study||11
2460648|NCT01011335|6033823|P5|COMPLETED|Overall Study||12
2460649|NCT01011335|6033824|P4|COMPLETED|Overall Study||10
2460650|NCT01011335|6033825|P3|COMPLETED|Overall Study||11
2460651|NCT01011335|6033826|P2|COMPLETED|Overall Study||11
2460652|NCT01011335|6033827|P1|COMPLETED|Overall Study||10
2460653|NCT01011335|6033815|P13|STARTED|Overall Study||22
2460654|NCT01011335|6033816|P12|STARTED|Overall Study||22
2460655|NCT01011335|6033817|P11|STARTED|Overall Study||12
2460656|NCT01011335|6033818|P10|STARTED|Overall Study||12
2460657|NCT01011335|6033819|P9|STARTED|Overall Study||12
2460658|NCT01011335|6033820|P8|STARTED|Overall Study||12
2460659|NCT01011335|6033821|P7|STARTED|Overall Study||12
2460660|NCT01011335|6033822|P6|STARTED|Overall Study||12
2460661|NCT01011335|6033823|P5|STARTED|Overall Study||13
2460662|NCT01011335|6033824|P4|STARTED|Overall Study||12
2460663|NCT01011335|6033825|P3|STARTED|Overall Study||12
2460664|NCT01011335|6033826|P2|STARTED|Overall Study||12
2460665|NCT01011335|6033827|P1|STARTED|Overall Study||11
2460666|NCT01011309|6033867|P3|NOT COMPLETED|Overall Study||5
2460667|NCT01011309|6033868|P2|NOT COMPLETED|Overall Study||3
2460668|NCT01011309|6033869|P1|NOT COMPLETED|Overall Study||2
2460669|NCT01011309|6033867|P3|COMPLETED|Overall Study||16
2460670|NCT01011309|6033868|P2|COMPLETED|Overall Study||7
2460671|NCT01011309|6033869|P1|COMPLETED|Overall Study||12
2460672|NCT01011309|6033867|P3|STARTED|Overall Study||21
2460673|NCT01011309|6033868|P2|STARTED|Overall Study||10
2460674|NCT01011309|6033869|P1|STARTED|Overall Study||14
2460675|NCT01011283|6033885|P2|NOT COMPLETED|Overall Study||11
2460676|NCT01011283|6033886|P1|NOT COMPLETED|Overall Study||11
2460677|NCT01011283|6033885|P2|COMPLETED|Overall Study||2
2460678|NCT01011283|6033886|P1|COMPLETED|Overall Study||2
2460679|NCT01011283|6033885|P2|STARTED|Overall Study||13
2460680|NCT01011283|6033886|P1|STARTED|Overall Study||13
2460681|NCT01011218|6033898|P4|NOT COMPLETED|Overall Study||0
2460682|NCT01011218|6033899|P3|NOT COMPLETED|Overall Study||0
2460683|NCT01011218|6033900|P2|NOT COMPLETED|Overall Study||0
2460684|NCT01011218|6033901|P1|NOT COMPLETED|Overall Study||0
2460685|NCT01011218|6033898|P4|COMPLETED|Overall Study||26
2460686|NCT01011218|6033899|P3|COMPLETED|Overall Study||26
2460687|NCT01011218|6033900|P2|COMPLETED|Overall Study||9
2460688|NCT01011218|6033901|P1|COMPLETED|Overall Study||9
2460689|NCT01011218|6033898|P4|STARTED|Overall Study||26
2460690|NCT01011218|6033899|P3|STARTED|Overall Study||26
2460691|NCT01011218|6033900|P2|STARTED|Overall Study||9
2460692|NCT01011218|6033901|P1|STARTED|Overall Study||9
2460693|NCT01011179|6033925|P2|NOT COMPLETED|Overall Study||2
2460694|NCT01011179|6033926|P1|NOT COMPLETED|Overall Study||4
2460695|NCT01011179|6033925|P2|COMPLETED|Overall Study||20
2460696|NCT01011179|6033926|P1|COMPLETED|Overall Study||20
2460697|NCT01011179|6033925|P2|STARTED|Overall Study||22
2460698|NCT01011179|6033926|P1|STARTED|Overall Study||24
2460699|NCT01011153|6033935|P3|NOT COMPLETED|Overall Study||9
2460700|NCT01011153|6033936|P2|NOT COMPLETED|Overall Study||11
2460701|NCT01011153|6033937|P1|NOT COMPLETED|Overall Study||8
2460702|NCT01011153|6033935|P3|COMPLETED|Overall Study||45
2460703|NCT01011153|6033936|P2|COMPLETED|Overall Study||64
2460704|NCT01011153|6033937|P1|COMPLETED|Overall Study||46
2460705|NCT01011153|6033935|P3|STARTED|Overall Study||54
2460706|NCT01011153|6033936|P2|STARTED|Overall Study||75
2460707|NCT01011153|6033937|P1|STARTED|Overall Study||54
2460708|NCT01011075|6033955|P1|NOT COMPLETED|Overall Study||0
2460709|NCT01011075|6033955|P1|COMPLETED|Overall Study||34
2460710|NCT01011075|6033955|P1|STARTED|Overall Study||34
2460711|NCT01011049|6033966|P4|NOT COMPLETED|Overall Study||0
2460712|NCT01011049|6033967|P3|NOT COMPLETED|Overall Study||4
2460713|NCT01011049|6033968|P2|NOT COMPLETED|Overall Study||2
2460714|NCT01011049|6033969|P1|NOT COMPLETED|Overall Study||1
2460715|NCT01011049|6033966|P4|COMPLETED|Overall Study||246
2460716|NCT01011049|6033967|P3|COMPLETED|Overall Study||239
2460717|NCT01011049|6033968|P2|COMPLETED|Overall Study||250
2460718|NCT01011049|6033969|P1|COMPLETED|Overall Study||506
2460719|NCT01011049|6033966|P4|STARTED|Overall Study||246
2460720|NCT01011049|6033967|P3|STARTED|Overall Study||243
2460721|NCT01011049|6033968|P2|STARTED|Overall Study||252
2460722|NCT01011049|6033969|P1|STARTED|Overall Study||507
2460723|NCT01010984|6033991|P1|NOT COMPLETED|Overall Study||0
2460724|NCT01010984|6033991|P1|COMPLETED|Overall Study||20
2460725|NCT01010984|6033991|P1|STARTED|Overall Study||20
2460726|NCT01010971|6033999|P3|NOT COMPLETED|Overall Study||13
2460727|NCT01010971|6034000|P2|NOT COMPLETED|Overall Study||8
2460728|NCT01010971|6034001|P1|NOT COMPLETED|Overall Study||3
2460729|NCT01010971|6033999|P3|COMPLETED|Overall Study||207
2460730|NCT01010971|6034000|P2|COMPLETED|Overall Study||218
2460731|NCT01010971|6034001|P1|COMPLETED|Overall Study||222
2460732|NCT01010971|6033999|P3|STARTED|Overall Study||220
2460733|NCT01010971|6034000|P2|STARTED|Overall Study||226
2460734|NCT01010971|6034001|P1|STARTED|Overall Study||225
2460735|NCT01010932|6034086|P1|NOT COMPLETED|Overall Study||22
2460736|NCT01010932|6034086|P1|COMPLETED|Overall Study||200
2460737|NCT01010932|6034086|P1|STARTED|Overall Study||222
2460738|NCT01010906|6034104|P6|NOT COMPLETED|Overall Study||0
2460739|NCT01010906|6034105|P5|NOT COMPLETED|Overall Study||0
2460740|NCT01010906|6034106|P4|NOT COMPLETED|Overall Study||0
2460741|NCT01010906|6034107|P3|NOT COMPLETED|Overall Study||0
2460742|NCT01010906|6034108|P2|NOT COMPLETED|Overall Study||0
2460743|NCT01010906|6034109|P1|NOT COMPLETED|Overall Study||0
2460744|NCT01010906|6034104|P6|COMPLETED|Overall Study||10
2460745|NCT01010906|6034105|P5|COMPLETED|Overall Study||10
2460746|NCT01010906|6034106|P4|COMPLETED|Overall Study||10
2460747|NCT01010906|6034107|P3|COMPLETED|Overall Study||10
2460748|NCT01010906|6034108|P2|COMPLETED|Overall Study||10
2460749|NCT01010906|6034109|P1|COMPLETED|Overall Study||10
2460750|NCT01010906|6034104|P6|STARTED|Overall Study||10
2460751|NCT01010906|6034105|P5|STARTED|Overall Study||10
2460752|NCT01010906|6034106|P4|STARTED|Overall Study||10
2460753|NCT01010906|6034107|P3|STARTED|Overall Study||10
2460754|NCT01010906|6034108|P2|STARTED|Overall Study||10
2460755|NCT01010906|6034109|P1|STARTED|Overall Study||10
2460756|NCT01010867|6034129|P1|NOT COMPLETED|Overall Study||1
2460757|NCT01010867|6034129|P1|COMPLETED|Overall Study||30
2460758|NCT01010867|6034129|P1|STARTED|Overall Study||31
2460759|NCT01010854|6034136|P1|NOT COMPLETED|Overall Study||0
2460760|NCT01010854|6034136|P1|COMPLETED|Overall Study||6
2460761|NCT01010854|6034136|P1|STARTED|Overall Study||6
2460762|NCT01010776|6034141|P1|NOT COMPLETED|Extension Phase||3
2460763|NCT01010776|6034141|P1|COMPLETED|Extension Phase||156
2460764|NCT01010776|6034141|P1|STARTED|Extension Phase||159
2460765|NCT01010776|6034141|P1|NOT COMPLETED|In-Between Main Phase & Extension Phase||15
2460766|NCT01010776|6034141|P1|COMPLETED|In-Between Main Phase & Extension Phase||159
2460767|NCT01010776|6034141|P1|STARTED|In-Between Main Phase & Extension Phase||174
2460768|NCT01010776|6034141|P1|NOT COMPLETED|Main Phase||49
2460769|NCT01010776|6034141|P1|COMPLETED|Main Phase||174
2460770|NCT01010776|6034141|P1|Treated|Main Phase||218
2460771|NCT01010776|6034141|P1|STARTED|Main Phase||223
2460772|NCT01010763|6034165|P2|NOT COMPLETED|Overall Study||30
2460773|NCT01010763|6034166|P1|NOT COMPLETED|Overall Study||35
2460774|NCT01010763|6034165|P2|COMPLETED|Overall Study||54
2460775|NCT01010763|6034166|P1|COMPLETED|Overall Study||61
2460776|NCT01010763|6034165|P2|STARTED|Overall Study||84
2460777|NCT01010763|6034166|P1|STARTED|Overall Study||96
2460778|NCT01010750|6034198|P6|NOT COMPLETED|Third Intervention||0
2460779|NCT01010750|6034199|P5|NOT COMPLETED|Third Intervention||0
2460780|NCT01010750|6034200|P4|NOT COMPLETED|Third Intervention||0
2460781|NCT01010750|6034201|P3|NOT COMPLETED|Third Intervention||0
2460782|NCT01010750|6034202|P2|NOT COMPLETED|Third Intervention||0
2460783|NCT01010750|6034203|P1|NOT COMPLETED|Third Intervention||0
2460784|NCT01010750|6034198|P6|COMPLETED|Third Intervention||3
2460785|NCT01010750|6034199|P5|COMPLETED|Third Intervention||2
2460786|NCT01010750|6034200|P4|COMPLETED|Third Intervention||3
2460787|NCT01010750|6034201|P3|COMPLETED|Third Intervention||3
2460788|NCT01010750|6034202|P2|COMPLETED|Third Intervention||3
2460789|NCT01010750|6034203|P1|COMPLETED|Third Intervention||3
2460790|NCT01010750|6034198|P6|STARTED|Third Intervention||3
2460791|NCT01010750|6034199|P5|STARTED|Third Intervention||2
2460792|NCT01010750|6034200|P4|STARTED|Third Intervention||3
2460793|NCT01010750|6034201|P3|STARTED|Third Intervention||3
2460794|NCT01010750|6034202|P2|STARTED|Third Intervention||3
2460795|NCT01010750|6034203|P1|STARTED|Third Intervention||3
2460796|NCT01010750|6034198|P6|NOT COMPLETED|Second Intervention||0
2460797|NCT01010750|6034199|P5|NOT COMPLETED|Second Intervention||0
2460798|NCT01010750|6034200|P4|NOT COMPLETED|Second Intervention||0
2460799|NCT01010750|6034201|P3|NOT COMPLETED|Second Intervention||0
2460800|NCT01010750|6034202|P2|NOT COMPLETED|Second Intervention||1
2460801|NCT01010750|6034203|P1|NOT COMPLETED|Second Intervention||0
2460802|NCT01010750|6034198|P6|COMPLETED|Second Intervention||3
2460803|NCT01010750|6034199|P5|COMPLETED|Second Intervention||2
2460804|NCT01010750|6034200|P4|COMPLETED|Second Intervention||3
2460805|NCT01010750|6034201|P3|COMPLETED|Second Intervention||3
2460806|NCT01010750|6034202|P2|COMPLETED|Second Intervention||3
2460807|NCT01010750|6034203|P1|COMPLETED|Second Intervention||3
2460808|NCT01010750|6034198|P6|STARTED|Second Intervention||3
2460809|NCT01010750|6034199|P5|STARTED|Second Intervention||2
2460810|NCT01010750|6034200|P4|STARTED|Second Intervention||3
2460811|NCT01010750|6034201|P3|STARTED|Second Intervention||3
2460812|NCT01010750|6034202|P2|STARTED|Second Intervention||4
2460813|NCT01010750|6034203|P1|STARTED|Second Intervention||3
2460814|NCT01010750|6034198|P6|NOT COMPLETED|First Intervention||0
2460815|NCT01010750|6034199|P5|NOT COMPLETED|First Intervention||0
2460816|NCT01010750|6034200|P4|NOT COMPLETED|First Intervention||0
2460817|NCT01010750|6034201|P3|NOT COMPLETED|First Intervention||0
2460818|NCT01010750|6034202|P2|NOT COMPLETED|First Intervention||0
2460819|NCT01010750|6034203|P1|NOT COMPLETED|First Intervention||0
2460820|NCT01010750|6034198|P6|COMPLETED|First Intervention||3
2460821|NCT01010750|6034199|P5|COMPLETED|First Intervention||2
2460822|NCT01010750|6034200|P4|COMPLETED|First Intervention||3
2460823|NCT01010750|6034201|P3|COMPLETED|First Intervention||3
2460824|NCT01010750|6034202|P2|COMPLETED|First Intervention||4
2460825|NCT01010750|6034203|P1|COMPLETED|First Intervention||3
2460826|NCT01010750|6034198|P6|STARTED|First Intervention||3
2460827|NCT01010750|6034199|P5|STARTED|First Intervention||2
2460828|NCT01010750|6034200|P4|STARTED|First Intervention||3
2460829|NCT01010750|6034201|P3|STARTED|First Intervention||3
2460830|NCT01010750|6034202|P2|STARTED|First Intervention||4
2460831|NCT01010750|6034203|P1|STARTED|First Intervention||3
2460832|NCT01010633|6034228|P2|NOT COMPLETED|Overall Study||5
2460833|NCT01010633|6034229|P1|NOT COMPLETED|Overall Study||4
2460834|NCT01010633|6034228|P2|COMPLETED|Overall Study||198
2460835|NCT01010633|6034229|P1|COMPLETED|Overall Study||199
2460836|NCT01010633|6034228|P2|STARTED|Overall Study||203
2460837|NCT01010633|6034229|P1|STARTED|Overall Study||203
2460838|NCT01010568|6034239|P1|NOT COMPLETED|Overall Study||5
2460839|NCT01010568|6034239|P1|COMPLETED|Overall Study||5
2460840|NCT01010568|6034239|P1|STARTED|Overall Study||10
2460841|NCT01010555|6034245|P2|NOT COMPLETED|Second Four Weeks of Wear||0
2460842|NCT01010555|6034246|P1|NOT COMPLETED|Second Four Weeks of Wear||0
2460843|NCT01010555|6034245|P2|COMPLETED|Second Four Weeks of Wear||9
2460844|NCT01010555|6034246|P1|COMPLETED|Second Four Weeks of Wear||10
2460845|NCT01010555|6034245|P2|STARTED|Second Four Weeks of Wear||9
2460846|NCT01010555|6034246|P1|STARTED|Second Four Weeks of Wear||10
2460847|NCT01010555|6034245|P2|NOT COMPLETED|First Four Weeks of Wear||0
2460848|NCT01010555|6034246|P1|NOT COMPLETED|First Four Weeks of Wear||0
2460849|NCT01010555|6034245|P2|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Non-compliance with visit schedule.|10
2460850|NCT01010555|6034246|P1|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Relocation.|11
2460851|NCT01010555|6034245|P2|STARTED|First Four Weeks of Wear||10
2460852|NCT01010555|6034246|P1|STARTED|First Four Weeks of Wear||11
2460853|NCT01010503|6034256|P1|NOT COMPLETED|Overall Study||2
2460854|NCT01010503|6034256|P1|COMPLETED|Overall Study||30
2460855|NCT01010503|6034256|P1|STARTED|Overall Study||32
2460856|NCT01010477|6034276|P2|NOT COMPLETED|Overall Study||3
2460857|NCT01010477|6034277|P1|NOT COMPLETED|Overall Study||6
2460858|NCT01010477|6034276|P2|COMPLETED|Overall Study||22
2460859|NCT01010477|6034277|P1|COMPLETED|Overall Study||21
2460860|NCT01010477|6034276|P2|STARTED|Overall Study||25
2460861|NCT01010477|6034277|P1|STARTED|Overall Study||27
2460862|NCT01010399|6034283|P1|NOT COMPLETED|Overall Study||5
2460863|NCT01010399|6034283|P1|COMPLETED|Overall Study||31
2460864|NCT01010399|6034283|P1|STARTED|Overall Study||36
2460865|NCT01010282|6034291|P3|NOT COMPLETED|Overall Study||19
2460866|NCT01010282|6034292|P2|NOT COMPLETED|Overall Study||7
2460867|NCT01010282|6034293|P1|NOT COMPLETED|Overall Study||6
2460868|NCT01010282|6034291|P3|COMPLETED|Overall Study||77
2460869|NCT01010282|6034292|P2|COMPLETED|Overall Study||88
2460870|NCT01010282|6034293|P1|COMPLETED|Overall Study||91
2460871|NCT01010282|6034291|P3|STARTED|Overall Study||96
2460872|NCT01010282|6034292|P2|STARTED|Overall Study||95
2460873|NCT01010282|6034293|P1|STARTED|Overall Study||97
2460874|NCT01010230|6034315|P2|NOT COMPLETED|Overall Study||7
2460875|NCT01010230|6034316|P1|NOT COMPLETED|Overall Study||10
2460876|NCT01010230|6034315|P2|COMPLETED|Overall Study||26
2460877|NCT01010230|6034316|P1|COMPLETED|Overall Study||22
2460878|NCT01010230|6034315|P2|STARTED|Overall Study||33
2460879|NCT01010230|6034316|P1|STARTED|Overall Study||32
2460880|NCT01010217|6034351|P5|NOT COMPLETED|Overall Study||3
2460881|NCT01010217|6034352|P4|NOT COMPLETED|Overall Study||6
2460882|NCT01010217|6034353|P3|NOT COMPLETED|Overall Study||1
2460883|NCT01010217|6034354|P2|NOT COMPLETED|Overall Study||5
2460884|NCT01010217|6034355|P1|NOT COMPLETED|Overall Study||5
2460885|NCT01010217|6034351|P5|COMPLETED|Overall Study||0
2460886|NCT01010217|6034352|P4|COMPLETED|Overall Study||0
2460887|NCT01010217|6034353|P3|COMPLETED|Overall Study||21
2460888|NCT01010217|6034354|P2|COMPLETED|Overall Study||51
2460889|NCT01010217|6034355|P1|COMPLETED|Overall Study||84
2460890|NCT01010217|6034351|P5|STARTED|Overall Study||3
2460891|NCT01010217|6034352|P4|STARTED|Overall Study||6
2460892|NCT01010217|6034353|P3|STARTED|Overall Study||22
2460893|NCT01010217|6034354|P2|STARTED|Overall Study||56
2460894|NCT01010217|6034355|P1|STARTED|Overall Study||89
2460895|NCT01010204|6034394|P2|NOT COMPLETED|Overall Study||9
2460896|NCT01010204|6034395|P1|NOT COMPLETED|Overall Study||7
2460897|NCT01010204|6034394|P2|COMPLETED|Overall Study||20
2460898|NCT01010204|6034395|P1|COMPLETED|Overall Study||24
2460899|NCT01010204|6034394|P2|STARTED|Overall Study||29
2460900|NCT01010204|6034395|P1|STARTED|Overall Study||31
2460901|NCT01010126|6034411|P6|NOT COMPLETED|Overall Study||0
2460902|NCT01010126|6034412|P5|NOT COMPLETED|Overall Study||3
2460903|NCT01010126|6034413|P4|NOT COMPLETED|Overall Study||0
2460904|NCT01010126|6034414|P3|NOT COMPLETED|Overall Study||1
2460905|NCT01010126|6034415|P2|NOT COMPLETED|Overall Study||0
2460906|NCT01010126|6034416|P1|NOT COMPLETED|Overall Study||1
2460907|NCT01010126|6034411|P6|COMPLETED|Overall Study||24
2460908|NCT01010126|6034412|P5|COMPLETED|Overall Study||55
2460909|NCT01010126|6034413|P4|COMPLETED|Overall Study||57
2460910|NCT01010126|6034414|P3|COMPLETED|Overall Study||27
2460911|NCT01010126|6034415|P2|COMPLETED|Overall Study||58
2460912|NCT01010126|6034416|P1|COMPLETED|Overall Study||26
2460913|NCT01010126|6034411|P6|STARTED|Overall Study||24
2460914|NCT01010126|6034412|P5|STARTED|Overall Study||58
2460915|NCT01010126|6034413|P4|STARTED|Overall Study||57
2460916|NCT01010126|6034414|P3|STARTED|Overall Study||28
2460917|NCT01010126|6034415|P2|STARTED|Overall Study||58
2460918|NCT01010126|6034416|P1|STARTED|Overall Study||27
2460919|NCT01010061|6034468|P2|NOT COMPLETED|Overall Study||40
2460920|NCT01010061|6034469|P1|NOT COMPLETED|Overall Study||48
2460921|NCT01010061|6034468|P2|COMPLETED|Overall Study||78
2460922|NCT01010061|6034469|P1|COMPLETED|Overall Study|Completed=Completed treatment.|190
2460923|NCT01010061|6034468|P2|Received Study Drug|Overall Study||116
2460924|NCT01010061|6034469|P1|Received Study Drug|Overall Study||236
2460925|NCT01010061|6034468|P2|STARTED|Overall Study||118
2460926|NCT01010061|6034469|P1|STARTED|Overall Study||238
2460927|NCT01010009|6034504|P3|NOT COMPLETED|Overall Study||0
2460928|NCT01010009|6034505|P2|NOT COMPLETED|Overall Study||0
2460929|NCT01010009|6034506|P1|NOT COMPLETED|Overall Study||0
2460930|NCT01010009|6034504|P3|COMPLETED|Overall Study||8
2460931|NCT01010009|6034505|P2|COMPLETED|Overall Study||8
2460932|NCT01010009|6034506|P1|COMPLETED|Overall Study||8
2460933|NCT01010009|6034504|P3|STARTED|Overall Study||8
2460934|NCT01010009|6034505|P2|STARTED|Overall Study||8
2460935|NCT01010009|6034506|P1|STARTED|Overall Study||8
2460936|NCT01009983|6034520|P1|NOT COMPLETED|Overall Study||1
2460937|NCT01009983|6034520|P1|COMPLETED|Overall Study||13
2460938|NCT01009983|6034520|P1|STARTED|Overall Study||14
2460939|NCT01009931|6034527|P1|NOT COMPLETED|Overall Study||1
2460940|NCT01009931|6034527|P1|COMPLETED|Overall Study||0
2460941|NCT01009931|6034527|P1|STARTED|Overall Study||1
2460942|NCT01009840|6034533|P1|NOT COMPLETED|Overall Study||14
2460943|NCT01009840|6034533|P1|COMPLETED|Overall Study||16
2460944|NCT01009840|6034533|P1|STARTED|Overall Study||30
2460945|NCT01009814|6034551|P5|NOT COMPLETED|Overall Study||0
2460946|NCT01009814|6034552|P4|NOT COMPLETED|Overall Study||0
2460947|NCT01009814|6034553|P3|NOT COMPLETED|Overall Study||0
2460948|NCT01009814|6034554|P2|NOT COMPLETED|Overall Study||1
2460949|NCT01009814|6034555|P1|NOT COMPLETED|Overall Study||1
2460950|NCT01009814|6034551|P5|COMPLETED|Overall Study||10
2460951|NCT01009814|6034552|P4|COMPLETED|Overall Study||10
2460952|NCT01009814|6034553|P3|COMPLETED|Overall Study||10
2460953|NCT01009814|6034554|P2|COMPLETED|Overall Study||9
2460954|NCT01009814|6034555|P1|COMPLETED|Overall Study||9
2460955|NCT01009814|6034551|P5|STARTED|Overall Study||10
2460956|NCT01009814|6034552|P4|STARTED|Overall Study||10
2460957|NCT01009814|6034553|P3|STARTED|Overall Study||10
2460958|NCT01009814|6034554|P2|STARTED|Overall Study||10
2460959|NCT01009814|6034555|P1|STARTED|Overall Study||10
2460960|NCT01009762|6034664|P2|NOT COMPLETED|Overall Study||0
2460961|NCT01009762|6034665|P1|NOT COMPLETED|Overall Study||0
2460962|NCT01009762|6034664|P2|COMPLETED|Overall Study|10 participants received vaccine|10
2460963|NCT01009762|6034665|P1|COMPLETED|Overall Study|according to randomization this one participant received placebo|1
2460964|NCT01009762|6034664|P2|Primary Outcome|Overall Study|no SAE, no treatment related side effects DLT grade 3 or more|0
2460965|NCT01009762|6034665|P1|Primary Outcome|Overall Study|no Serious Adverse Events (SAE), no treatment related side effects DLT grade 3 or more|0
2460966|NCT01009762|6034664|P2|STARTED|Overall Study||10
2460967|NCT01009762|6034665|P1|STARTED|Overall Study||1
2460968|NCT01009645|6034679|P4|NOT COMPLETED|Overall Study||5
2460969|NCT01009645|6034680|P3|NOT COMPLETED|Overall Study||4
2460970|NCT01009645|6034681|P2|NOT COMPLETED|Overall Study||8
2460971|NCT01009645|6034682|P1|NOT COMPLETED|Overall Study||2
2460972|NCT01009645|6034679|P4|COMPLETED|Overall Study||26
2460973|NCT01009645|6034680|P3|COMPLETED|Overall Study||28
2460974|NCT01009645|6034681|P2|COMPLETED|Overall Study||23
2460975|NCT01009645|6034682|P1|COMPLETED|Overall Study||29
2460976|NCT01009645|6034679|P4|STARTED|Overall Study||31
2460977|NCT01009645|6034680|P3|STARTED|Overall Study||32
2460978|NCT01009645|6034681|P2|STARTED|Overall Study||31
2460979|NCT01009645|6034682|P1|STARTED|Overall Study||31
2460980|NCT01009619|6034698|P2|NOT COMPLETED|Overall Study||0
2460981|NCT01009619|6034699|P1|NOT COMPLETED|Overall Study||0
2460982|NCT01009619|6034698|P2|COMPLETED|Overall Study||43
2460983|NCT01009619|6034699|P1|COMPLETED|Overall Study||40
2460984|NCT01009619|6034698|P2|STARTED|Overall Study||43
2460985|NCT01009619|6034699|P1|STARTED|Overall Study||40
2460986|NCT01009580|6034719|P2|NOT COMPLETED|Overall Study||35
2460987|NCT01009580|6034720|P1|NOT COMPLETED|Overall Study||27
2460988|NCT01009580|6034719|P2|COMPLETED|Overall Study||188
2460989|NCT01009580|6034720|P1|COMPLETED|Overall Study||197
2460990|NCT01009580|6034719|P2|Exposed|Overall Study|One subject was randomised in error and withdrew prior to exposure to drug|222
2460991|NCT01009580|6034720|P1|Exposed|Overall Study||224
2460992|NCT01009580|6034719|P2|STARTED|Overall Study||223
2460993|NCT01009580|6034720|P1|STARTED|Overall Study||224
2460994|NCT01009554|6034734|P2|NOT COMPLETED|Overall Study||7
2460995|NCT01009554|6034735|P1|NOT COMPLETED|Overall Study||2
2460996|NCT01009554|6034734|P2|COMPLETED|Overall Study||41
2460997|NCT01009554|6034735|P1|COMPLETED|Overall Study||46
2460998|NCT01009554|6034734|P2|STARTED|Overall Study||48
2460999|NCT01009554|6034735|P1|STARTED|Overall Study||48
2461000|NCT01009515|6034867|P1|NOT COMPLETED|Overall Study||3
2461001|NCT01009515|6034867|P1|COMPLETED|Overall Study||16
2461002|NCT01009515|6034867|P1|STARTED|Overall Study||19
2461003|NCT01009463|6034878|P5|NOT COMPLETED|52-week, Double-blind Treatment Period||101
2461004|NCT01009463|6034879|P4|NOT COMPLETED|52-week, Double-blind Treatment Period||91
2461005|NCT01009463|6034880|P3|NOT COMPLETED|52-week, Double-blind Treatment Period||93
2461006|NCT01009463|6034881|P2|NOT COMPLETED|52-week, Double-blind Treatment Period||115
2461007|NCT01009463|6034882|P1|NOT COMPLETED|52-week, Double-blind Treatment Period||0
2461008|NCT01009463|6034878|P5|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|301
2461009|NCT01009463|6034879|P4|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|312
2461010|NCT01009463|6034880|P3|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|315
2461011|NCT01009463|6034881|P2|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|294
2461012|NCT01009463|6034882|P1|COMPLETED|52-week, Double-blind Treatment Period||0
2461013|NCT01009463|6034878|P5|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|303
2461014|NCT01009463|6034879|P4|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|314
2461015|NCT01009463|6034880|P3|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|318
2461016|NCT01009463|6034881|P2|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|295
2461017|NCT01009463|6034882|P1|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
2461018|NCT01009463|6034878|P5|STARTED|52-week, Double-blind Treatment Period||402
2461019|NCT01009463|6034879|P4|STARTED|52-week, Double-blind Treatment Period||403
2461020|NCT01009463|6034880|P3|STARTED|52-week, Double-blind Treatment Period||408
2461021|NCT01009463|6034881|P2|STARTED|52-week, Double-blind Treatment Period||409
2461022|NCT01009463|6034882|P1|STARTED|52-week, Double-blind Treatment Period||0
2461023|NCT01009463|6034878|P5|NOT COMPLETED|4-week, Open-label Run-In Period||0
2461024|NCT01009463|6034879|P4|NOT COMPLETED|4-week, Open-label Run-In Period||0
2461025|NCT01009463|6034880|P3|NOT COMPLETED|4-week, Open-label Run-In Period||0
2461026|NCT01009463|6034881|P2|NOT COMPLETED|4-week, Open-label Run-In Period||0
2461027|NCT01009463|6034882|P1|NOT COMPLETED|4-week, Open-label Run-In Period||449
2461028|NCT01009463|6034878|P5|COMPLETED|4-week, Open-label Run-In Period||0
2461029|NCT01009463|6034879|P4|COMPLETED|4-week, Open-label Run-In Period||0
2461030|NCT01009463|6034880|P3|COMPLETED|4-week, Open-label Run-In Period||0
2461031|NCT01009463|6034881|P2|COMPLETED|4-week, Open-label Run-In Period||0
2461032|NCT01009463|6034882|P1|COMPLETED|4-week, Open-label Run-In Period||1622
2461033|NCT01009463|6034878|P5|STARTED|4-week, Open-label Run-In Period||0
2461034|NCT01009463|6034879|P4|STARTED|4-week, Open-label Run-In Period||0
2461035|NCT01009463|6034880|P3|STARTED|4-week, Open-label Run-In Period||0
2461036|NCT01009463|6034881|P2|STARTED|4-week, Open-label Run-In Period||0
2461037|NCT01009463|6034882|P1|STARTED|4-week, Open-label Run-In Period||2071
2461038|NCT01009346|6034904|P1|NOT COMPLETED|Overall Study||4
2461039|NCT01009346|6034904|P1|COMPLETED|Overall Study||5
2461040|NCT01009346|6034904|P1|STARTED|Overall Study||9
2461041|NCT01009333|6034909|P6|NOT COMPLETED|Week 3||0
2461042|NCT01009333|6034910|P5|NOT COMPLETED|Week 3||0
2461043|NCT01009333|6034911|P4|NOT COMPLETED|Week 3||0
2461044|NCT01009333|6034912|P3|NOT COMPLETED|Week 3||0
2461045|NCT01009333|6034913|P2|NOT COMPLETED|Week 3||0
2461046|NCT01009333|6034914|P1|NOT COMPLETED|Week 3||0
2461047|NCT01009333|6034909|P6|COMPLETED|Week 3||2
2461048|NCT01009333|6034910|P5|COMPLETED|Week 3||2
2461049|NCT01009333|6034911|P4|COMPLETED|Week 3||2
2461050|NCT01009333|6034912|P3|COMPLETED|Week 3||2
2461051|NCT01009333|6034913|P2|COMPLETED|Week 3||2
2461052|NCT01009333|6034914|P1|COMPLETED|Week 3||2
2461053|NCT01009333|6034909|P6|STARTED|Week 3||2
2461054|NCT01009333|6034910|P5|STARTED|Week 3||2
2461055|NCT01009333|6034911|P4|STARTED|Week 3||2
2461056|NCT01009333|6034912|P3|STARTED|Week 3||2
2461057|NCT01009333|6034913|P2|STARTED|Week 3||2
2461058|NCT01009333|6034914|P1|STARTED|Week 3||2
2461059|NCT01009333|6034909|P6|NOT COMPLETED|Week 2||0
2461060|NCT01009333|6034910|P5|NOT COMPLETED|Week 2||0
2461061|NCT01009333|6034911|P4|NOT COMPLETED|Week 2||0
2461062|NCT01009333|6034912|P3|NOT COMPLETED|Week 2||0
2461063|NCT01009333|6034913|P2|NOT COMPLETED|Week 2||0
2461064|NCT01009333|6034914|P1|NOT COMPLETED|Week 2||0
2461065|NCT01009333|6034909|P6|COMPLETED|Week 2||2
2461066|NCT01009333|6034910|P5|COMPLETED|Week 2||2
2461067|NCT01009333|6034911|P4|COMPLETED|Week 2||2
2461068|NCT01009333|6034912|P3|COMPLETED|Week 2||2
2461069|NCT01009333|6034913|P2|COMPLETED|Week 2||2
2461070|NCT01009333|6034914|P1|COMPLETED|Week 2||2
2461071|NCT01009333|6034909|P6|STARTED|Week 2||2
2461072|NCT01009333|6034910|P5|STARTED|Week 2||2
2461073|NCT01009333|6034911|P4|STARTED|Week 2||2
2461074|NCT01009333|6034912|P3|STARTED|Week 2||2
2461075|NCT01009333|6034913|P2|STARTED|Week 2||2
2461076|NCT01009333|6034914|P1|STARTED|Week 2||2
2461077|NCT01009333|6034909|P6|NOT COMPLETED|Week 1||0
2461078|NCT01009333|6034910|P5|NOT COMPLETED|Week 1||0
2461079|NCT01009333|6034911|P4|NOT COMPLETED|Week 1||0
2461080|NCT01009333|6034912|P3|NOT COMPLETED|Week 1||0
2461081|NCT01009333|6034913|P2|NOT COMPLETED|Week 1||0
2461082|NCT01009333|6034914|P1|NOT COMPLETED|Week 1||0
2461083|NCT01009333|6034909|P6|COMPLETED|Week 1||2
2461084|NCT01009333|6034910|P5|COMPLETED|Week 1||2
2461085|NCT01009333|6034911|P4|COMPLETED|Week 1||2
2461086|NCT01009333|6034912|P3|COMPLETED|Week 1||2
2461087|NCT01009333|6034913|P2|COMPLETED|Week 1|1 participant did not progress to the second period due to a protocol violation.|3
2461088|NCT01009333|6034914|P1|COMPLETED|Week 1||2
2461089|NCT01009333|6034909|P6|STARTED|Week 1||2
2461090|NCT01009333|6034910|P5|STARTED|Week 1||2
2461091|NCT01009333|6034911|P4|STARTED|Week 1||2
2461092|NCT01009333|6034912|P3|STARTED|Week 1||2
2461093|NCT01009333|6034913|P2|STARTED|Week 1||3
2461094|NCT01009333|6034914|P1|STARTED|Week 1||2
2461095|NCT01009203|6034928|P1|NOT COMPLETED|Overall Study||7
2461096|NCT01009203|6034928|P1|COMPLETED|Overall Study||6
2461097|NCT01009203|6034928|P1|Received Treatment|Overall Study|One patient withdrew consent before treatment started.|12
2461098|NCT01009203|6034928|P1|STARTED|Overall Study||13
2461099|NCT01009138|6034937|P2|NOT COMPLETED|Overall Study||20
2461100|NCT01009138|6034938|P1|NOT COMPLETED|Overall Study||13
2461101|NCT01009138|6034937|P2|COMPLETED|Overall Study||88
2461102|NCT01009138|6034938|P1|COMPLETED|Overall Study||93
2461103|NCT01009138|6034937|P2|STARTED|Overall Study||108
2461104|NCT01009138|6034938|P1|STARTED|Overall Study||106
2461105|NCT01009099|6034968|P2|NOT COMPLETED|Overall Study||4
2461106|NCT01009099|6034969|P1|NOT COMPLETED|Overall Study||5
2461107|NCT01009099|6034968|P2|COMPLETED|Overall Study||57
2461108|NCT01009099|6034969|P1|COMPLETED|Overall Study||53
2461109|NCT01009099|6034968|P2|STARTED|Overall Study||61
2461110|NCT01009099|6034969|P1|STARTED|Overall Study||58
2461111|NCT01009086|6034978|P3|NOT COMPLETED|Overall Study||34
2461112|NCT01009086|6034979|P2|NOT COMPLETED|Overall Study||47
2461113|NCT01009086|6034980|P1|NOT COMPLETED|Overall Study||44
2461114|NCT01009086|6034978|P3|COMPLETED|Overall Study||170
2461115|NCT01009086|6034979|P2|COMPLETED|Overall Study||158
2461116|NCT01009086|6034980|P1|COMPLETED|Overall Study||162
2461117|NCT01009086|6034978|P3|STARTED|Overall Study||204
2461118|NCT01009086|6034979|P2|STARTED|Overall Study||205
2461119|NCT01009086|6034980|P1|STARTED|Overall Study||206
2461120|NCT01009060|6035015|P2|NOT COMPLETED|Overall Study||5
2461121|NCT01009060|6035016|P1|NOT COMPLETED|Overall Study||4
2461122|NCT01009060|6035015|P2|COMPLETED|Overall Study||20
2461123|NCT01009060|6035016|P1|COMPLETED|Overall Study||21
2461124|NCT01009060|6035015|P2|STARTED|Overall Study||25
2461125|NCT01009060|6035016|P1|STARTED|Overall Study||25
2461126|NCT01009047|6035054|P2|NOT COMPLETED|Overall Study||26
2461127|NCT01009047|6035055|P1|NOT COMPLETED|Overall Study||28
2461128|NCT01009047|6035054|P2|COMPLETED|Overall Study||89
2461129|NCT01009047|6035055|P1|COMPLETED|Overall Study||85
2461130|NCT01009047|6035054|P2|STARTED|Overall Study||115
2461131|NCT01009047|6035055|P1|STARTED|Overall Study||113
2461132|NCT01009034|6035077|P1|NOT COMPLETED|Overall Study||4
2461133|NCT01009034|6035077|P1|COMPLETED|Overall Study||10
2461134|NCT01009034|6035077|P1|STARTED|Overall Study||14
2461135|NCT01008995|6035085|P4|NOT COMPLETED|After Controlled Period||1
2461136|NCT01008995|6035086|P3|NOT COMPLETED|After Controlled Period||2
2461137|NCT01008995|6035087|P2|NOT COMPLETED|After Controlled Period||0
2461138|NCT01008995|6035088|P1|NOT COMPLETED|After Controlled Period||0
2461139|NCT01008995|6035085|P4|COMPLETED|After Controlled Period||156
2461140|NCT01008995|6035086|P3|COMPLETED|After Controlled Period||156
2461141|NCT01008995|6035087|P2|COMPLETED|After Controlled Period||0
2461142|NCT01008995|6035088|P1|COMPLETED|After Controlled Period||0
2461143|NCT01008995|6035085|P4|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|157
2461144|NCT01008995|6035086|P3|STARTED|After Controlled Period|1 placebo participant discontinued after completing the CP and did not receive ustekinumab 45 mg.|158
2461145|NCT01008995|6035087|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
2461146|NCT01008995|6035088|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
2461147|NCT01008995|6035085|P4|NOT COMPLETED|Controlled Period||0
2461148|NCT01008995|6035086|P3|NOT COMPLETED|Controlled Period||0
2461149|NCT01008995|6035087|P2|NOT COMPLETED|Controlled Period||3
2461150|NCT01008995|6035088|P1|NOT COMPLETED|Controlled Period||3
2461151|NCT01008995|6035085|P4|COMPLETED|Controlled Period||0
2461152|NCT01008995|6035086|P3|COMPLETED|Controlled Period||0
2461153|NCT01008995|6035087|P2|COMPLETED|Controlled Period||157
2461154|NCT01008995|6035088|P1|COMPLETED|Controlled Period||159
2461155|NCT01008995|6035085|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
2461156|NCT01008995|6035086|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
2461157|NCT01008995|6035087|P2|STARTED|Controlled Period||160
2461158|NCT01008995|6035088|P1|STARTED|Controlled Period||162
2461159|NCT01008969|6035100|P1|NOT COMPLETED|Overall Study||0
2461160|NCT01008969|6035100|P1|COMPLETED|Overall Study||10
2461161|NCT01008969|6035100|P1|STARTED|Overall Study||10
2461162|NCT01008943|6035105|P1|NOT COMPLETED|Overall Study||1
2461163|NCT01008943|6035105|P1|COMPLETED|Overall Study||15
2461164|NCT01008943|6035105|P1|STARTED|Overall Study||16
2461165|NCT01008904|6035112|P1|NOT COMPLETED|Overall Study||4
2461166|NCT01008904|6035112|P1|COMPLETED|Overall Study||25
2461167|NCT01008904|6035112|P1|STARTED|Overall Study||29
2461168|NCT01008722|6035119|P2|NOT COMPLETED|Overall Study||0
2461169|NCT01008722|6035120|P1|NOT COMPLETED|Overall Study||0
2461170|NCT01008722|6035119|P2|COMPLETED|Overall Study||71
2461171|NCT01008722|6035120|P1|COMPLETED|Overall Study||36
2461172|NCT01008722|6035119|P2|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|71
2461173|NCT01008722|6035120|P1|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|36
2461174|NCT01008696|6035130|P2|NOT COMPLETED|Overall Study||17
2461175|NCT01008696|6035131|P1|NOT COMPLETED|Overall Study||17
2461176|NCT01008696|6035130|P2|COMPLETED|Overall Study||92
2461177|NCT01008696|6035131|P1|COMPLETED|Overall Study||91
2461178|NCT01008696|6035130|P2|STARTED|Overall Study||109
2461179|NCT01008696|6035131|P1|STARTED|Overall Study||108
2461180|NCT01008618|6035141|P3|NOT COMPLETED|Period 2 (Double-Blind Period)||38
2461181|NCT01008618|6035142|P2|NOT COMPLETED|Period 2 (Double-Blind Period)||36
2461182|NCT01008618|6035143|P1|NOT COMPLETED|Period 2 (Double-Blind Period)||0
2461183|NCT01008618|6035141|P3|COMPLETED|Period 2 (Double-Blind Period)||39
2461184|NCT01008618|6035142|P2|COMPLETED|Period 2 (Double-Blind Period)||37
2461185|NCT01008618|6035143|P1|COMPLETED|Period 2 (Double-Blind Period)||0
2461186|NCT01008618|6035141|P3|STARTED|Period 2 (Double-Blind Period)||77
2461187|NCT01008618|6035142|P2|STARTED|Period 2 (Double-Blind Period)||73
2461188|NCT01008618|6035143|P1|STARTED|Period 2 (Double-Blind Period)||0
2461189|NCT01008618|6035141|P3|NOT COMPLETED|Period 1 (Titration Period)||0
2461190|NCT01008618|6035142|P2|NOT COMPLETED|Period 1 (Titration Period)||0
2461191|NCT01008618|6035143|P1|NOT COMPLETED|Period 1 (Titration Period)||68
2461192|NCT01008618|6035141|P3|COMPLETED|Period 1 (Titration Period)||0
2461193|NCT01008618|6035142|P2|COMPLETED|Period 1 (Titration Period)||0
2461194|NCT01008618|6035143|P1|COMPLETED|Period 1 (Titration Period)||150
2461195|NCT01008618|6035141|P3|STARTED|Period 1 (Titration Period)||0
2461196|NCT01008618|6035142|P2|STARTED|Period 1 (Titration Period)||0
2461197|NCT01008618|6035143|P1|STARTED|Period 1 (Titration Period)||218
2461198|NCT01008605|6035168|P1|NOT COMPLETED|Overall Study||0
2461199|NCT01008605|6035168|P1|COMPLETED|Overall Study||48
2461200|NCT01008605|6035168|P1|STARTED|Overall Study||48
2461201|NCT01008553|6035192|P3|NOT COMPLETED|Period 2 (Double-Blind Period)||51
2461202|NCT01008553|6035193|P2|NOT COMPLETED|Period 2 (Double-Blind Period)||37
2461203|NCT01008553|6035194|P1|NOT COMPLETED|Period 2 (Double-Blind Period)||0
2461204|NCT01008553|6035192|P3|COMPLETED|Period 2 (Double-Blind Period)||28
2461205|NCT01008553|6035193|P2|COMPLETED|Period 2 (Double-Blind Period)||47
2461206|NCT01008553|6035194|P1|COMPLETED|Period 2 (Double-Blind Period)||0
2461207|NCT01008553|6035192|P3|STARTED|Period 2 (Double-Blind Period)||79
2461208|NCT01008553|6035193|P2|STARTED|Period 2 (Double-Blind Period)||84
2461209|NCT01008553|6035194|P1|STARTED|Period 2 (Double-Blind Period)||0
2461210|NCT01008553|6035192|P3|NOT COMPLETED|Period 1 (Titration Period)||0
2461211|NCT01008553|6035193|P2|NOT COMPLETED|Period 1 (Titration Period)||0
2461212|NCT01008553|6035194|P1|NOT COMPLETED|Period 1 (Titration Period)||95
2461213|NCT01008553|6035192|P3|COMPLETED|Period 1 (Titration Period)||0
2461214|NCT01008553|6035193|P2|COMPLETED|Period 1 (Titration Period)||0
2461215|NCT01008553|6035194|P1|COMPLETED|Period 1 (Titration Period)||163
2461216|NCT01008553|6035192|P3|STARTED|Period 1 (Titration Period)||0
2461217|NCT01008553|6035193|P2|STARTED|Period 1 (Titration Period)||0
2461218|NCT01008553|6035194|P1|STARTED|Period 1 (Titration Period)||258
2461219|NCT01008475|6035226|P7|NOT COMPLETED|Overall Study||4
2461220|NCT01008475|6035227|P6|NOT COMPLETED|Overall Study||6
2461221|NCT01008475|6035228|P5|NOT COMPLETED|Overall Study||5
2461222|NCT01008475|6035229|P4|NOT COMPLETED|Overall Study||0
2461223|NCT01008475|6035230|P3|NOT COMPLETED|Overall Study||0
2461224|NCT01008475|6035231|P2|NOT COMPLETED|Overall Study||0
2461225|NCT01008475|6035232|P1|NOT COMPLETED|Overall Study||0
2461226|NCT01008475|6035226|P7|COMPLETED|Overall Study||67
2461227|NCT01008475|6035227|P6|COMPLETED|Overall Study||67
2461228|NCT01008475|6035228|P5|COMPLETED|Overall Study||67
2461229|NCT01008475|6035229|P4|COMPLETED|Overall Study||3
2461230|NCT01008475|6035230|P3|COMPLETED|Overall Study||7
2461231|NCT01008475|6035231|P2|COMPLETED|Overall Study||3
2461232|NCT01008475|6035232|P1|COMPLETED|Overall Study||3
2461233|NCT01008475|6035226|P7|Safety Analysis Set|Overall Study||69
2461234|NCT01008475|6035227|P6|Safety Analysis Set|Overall Study||72
2461235|NCT01008475|6035228|P5|Safety Analysis Set|Overall Study|1 subject randomized to EMD525797 1000 mg group received only SoC. Hence, reported under SOC group.|73
2461236|NCT01008475|6035229|P4|Safety Analysis Set|Overall Study||3
2461237|NCT01008475|6035230|P3|Safety Analysis Set|Overall Study||7
2461238|NCT01008475|6035231|P2|Safety Analysis Set|Overall Study||3
2461239|NCT01008475|6035232|P1|Safety Analysis Set|Overall Study||3
2461240|NCT01008475|6035226|P7|STARTED|Overall Study||71
2461241|NCT01008475|6035227|P6|STARTED|Overall Study||73
2461242|NCT01008475|6035228|P5|STARTED|Overall Study||72
2461243|NCT01008475|6035229|P4|STARTED|Overall Study||3
2461244|NCT01008475|6035230|P3|STARTED|Overall Study||7
2461245|NCT01008475|6035231|P2|STARTED|Overall Study||3
2461246|NCT01008475|6035232|P1|STARTED|Overall Study||3
2461247|NCT01008462|6035260|P1|NOT COMPLETED|Overall Study||0
2461248|NCT01008462|6035260|P1|COMPLETED|Overall Study||16
2461249|NCT01008462|6035260|P1|STARTED|Overall Study||16
2461250|NCT01008449|6035272|P2|NOT COMPLETED|Overall Study||19
2461251|NCT01008449|6035273|P1|NOT COMPLETED|Overall Study||29
2461252|NCT01008449|6035272|P2|COMPLETED|Overall Study||179
2461253|NCT01008449|6035273|P1|COMPLETED|Overall Study||171
2461254|NCT01008449|6035272|P2|STARTED|Overall Study||198
2461255|NCT01008449|6035273|P1|STARTED|Overall Study||200
2461256|NCT01008423|6035295|P2|NOT COMPLETED|Overall Study||22
2461257|NCT01008423|6035296|P1|NOT COMPLETED|Overall Study||19
2461258|NCT01008423|6035295|P2|COMPLETED|Overall Study||125
2461259|NCT01008423|6035296|P1|COMPLETED|Overall Study||115
2461260|NCT01008423|6035295|P2|Received at Least 1 Dose of Study Drug|Overall Study||147
2461261|NCT01008423|6035296|P1|Received at Least 1 Dose of Study Drug|Overall Study||134
2461262|NCT01008423|6035295|P2|STARTED|Overall Study||147
2461263|NCT01008423|6035296|P1|STARTED|Overall Study||134
2461264|NCT01008410|6035322|P2|NOT COMPLETED|Overall Study||16
2461265|NCT01008410|6035323|P1|NOT COMPLETED|Overall Study||25
2461266|NCT01008410|6035322|P2|COMPLETED|Overall Study||116
2461267|NCT01008410|6035323|P1|COMPLETED|Overall Study||108
2461268|NCT01008410|6035322|P2|Received at Least 1 Dose of Study Drug|Overall Study||132
2461269|NCT01008410|6035323|P1|Received at Least 1 Dose of Study Drug|Overall Study||133
2461270|NCT01008410|6035322|P2|STARTED|Overall Study||132
2461271|NCT01008410|6035323|P1|STARTED|Overall Study||133
2461272|NCT01008319|6035349|P2|NOT COMPLETED|Overall Study||0
2461273|NCT01008319|6035350|P1|NOT COMPLETED|Overall Study||0
2461274|NCT01008319|6035349|P2|COMPLETED|Overall Study||60
2461275|NCT01008319|6035350|P1|COMPLETED|Overall Study||60
2461276|NCT01008319|6035349|P2|STARTED|Overall Study||60
2461277|NCT01008319|6035350|P1|STARTED|Overall Study||60
2461278|NCT01008280|6035362|P2|NOT COMPLETED|Overall Study||19
2461279|NCT01008280|6035363|P1|NOT COMPLETED|Overall Study||21
2461280|NCT01008280|6035362|P2|COMPLETED|Overall Study||73
2461281|NCT01008280|6035363|P1|COMPLETED|Overall Study||67
2461282|NCT01008280|6035362|P2|STARTED|Overall Study||92
2461283|NCT01008280|6035363|P1|STARTED|Overall Study||88
2461284|NCT01008150|6035377|P4|NOT COMPLETED|Overall Study||0
2461285|NCT01008150|6035378|P3|NOT COMPLETED|Overall Study||1
2461286|NCT01008150|6035379|P2|NOT COMPLETED|Overall Study||1
2461287|NCT01008150|6035380|P1|NOT COMPLETED|Overall Study||1
2461288|NCT01008150|6035377|P4|COMPLETED|Overall Study||12
2461289|NCT01008150|6035378|P3|COMPLETED|Overall Study||42
2461290|NCT01008150|6035379|P2|COMPLETED|Overall Study||42
2461291|NCT01008150|6035380|P1|COMPLETED|Overall Study||42
2461292|NCT01008150|6035377|P4|STARTED|Overall Study||12
2461293|NCT01008150|6035378|P3|STARTED|Overall Study||43
2461294|NCT01008150|6035379|P2|STARTED|Overall Study||43
2461295|NCT01008150|6035380|P1|STARTED|Overall Study||43
2461296|NCT01008059|6035410|P8|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
2461297|NCT01008059|6035411|P7|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
2461298|NCT01008059|6035412|P6|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
2461299|NCT01008059|6035413|P5|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
2461300|NCT01008059|6035414|P4|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
2461301|NCT01008059|6035415|P3|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
2461302|NCT01008059|6035416|P2|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
2461303|NCT01008059|6035417|P1|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
2461304|NCT01008059|6035410|P8|COMPLETED|Ketoconazole Simultaneous Alfentanil||6
2461305|NCT01008059|6035411|P7|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
2461306|NCT01008059|6035412|P6|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
2461307|NCT01008059|6035413|P5|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
2461308|NCT01008059|6035414|P4|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
2461309|NCT01008059|6035415|P3|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
2461310|NCT01008059|6035416|P2|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
2461311|NCT01008059|6035417|P1|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
2461312|NCT01008059|6035410|P8|STARTED|Ketoconazole Simultaneous Alfentanil||6
2461313|NCT01008059|6035411|P7|STARTED|Ketoconazole Simultaneous Alfentanil||0
2461314|NCT01008059|6035412|P6|STARTED|Ketoconazole Simultaneous Alfentanil||0
2461315|NCT01008059|6035413|P5|STARTED|Ketoconazole Simultaneous Alfentanil||0
2461316|NCT01008059|6035414|P4|STARTED|Ketoconazole Simultaneous Alfentanil||0
2461317|NCT01008059|6035415|P3|STARTED|Ketoconazole Simultaneous Alfentanil||0
2461318|NCT01008059|6035416|P2|STARTED|Ketoconazole Simultaneous Alfentanil||0
2461319|NCT01008059|6035417|P1|STARTED|Ketoconazole Simultaneous Alfentanil||0
2461320|NCT01008059|6035410|P8|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
2461321|NCT01008059|6035411|P7|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
2461322|NCT01008059|6035412|P6|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
2461323|NCT01008059|6035413|P5|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
2461324|NCT01008059|6035414|P4|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
2461325|NCT01008059|6035415|P3|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
2461326|NCT01008059|6035416|P2|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
2461327|NCT01008059|6035417|P1|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
2461328|NCT01008059|6035410|P8|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
2461329|NCT01008059|6035411|P7|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||6
2461330|NCT01008059|6035412|P6|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
2461331|NCT01008059|6035413|P5|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
2461332|NCT01008059|6035414|P4|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
2461333|NCT01008059|6035415|P3|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
2461334|NCT01008059|6035416|P2|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
2461335|NCT01008059|6035417|P1|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
2461336|NCT01008059|6035410|P8|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
2461337|NCT01008059|6035411|P7|STARTED|Grapefruit Juice Simultaneous Alfentanil||6
2461338|NCT01008059|6035412|P6|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
2461339|NCT01008059|6035413|P5|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
2461340|NCT01008059|6035414|P4|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
2461341|NCT01008059|6035415|P3|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
2461342|NCT01008059|6035416|P2|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
2461343|NCT01008059|6035417|P1|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
2461344|NCT01008059|6035410|P8|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
2461345|NCT01008059|6035411|P7|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
2461346|NCT01008059|6035412|P6|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
2461347|NCT01008059|6035413|P5|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
2461348|NCT01008059|6035414|P4|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
2461349|NCT01008059|6035415|P3|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
2461350|NCT01008059|6035416|P2|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
2461351|NCT01008059|6035417|P1|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
2461352|NCT01008059|6035410|P8|COMPLETED|Rifampin Simultaneous Alfentanil||0
2461353|NCT01008059|6035411|P7|COMPLETED|Rifampin Simultaneous Alfentanil||0
2461354|NCT01008059|6035412|P6|COMPLETED|Rifampin Simultaneous Alfentanil||6
2461355|NCT01008059|6035413|P5|COMPLETED|Rifampin Simultaneous Alfentanil||0
2461356|NCT01008059|6035414|P4|COMPLETED|Rifampin Simultaneous Alfentanil||0
2461357|NCT01008059|6035415|P3|COMPLETED|Rifampin Simultaneous Alfentanil||0
2461358|NCT01008059|6035416|P2|COMPLETED|Rifampin Simultaneous Alfentanil||0
2461359|NCT01008059|6035417|P1|COMPLETED|Rifampin Simultaneous Alfentanil||0
2461360|NCT01008059|6035410|P8|STARTED|Rifampin Simultaneous Alfentanil||0
2461361|NCT01008059|6035411|P7|STARTED|Rifampin Simultaneous Alfentanil||0
2461362|NCT01008059|6035412|P6|STARTED|Rifampin Simultaneous Alfentanil||6
2461363|NCT01008059|6035413|P5|STARTED|Rifampin Simultaneous Alfentanil||0
2461364|NCT01008059|6035414|P4|STARTED|Rifampin Simultaneous Alfentanil||0
2461365|NCT01008059|6035415|P3|STARTED|Rifampin Simultaneous Alfentanil||0
2461366|NCT01008059|6035416|P2|STARTED|Rifampin Simultaneous Alfentanil||0
2461367|NCT01008059|6035417|P1|STARTED|Rifampin Simultaneous Alfentanil||0
2461368|NCT01008059|6035410|P8|NOT COMPLETED|Control Simultaneous Alfentanil||0
2461369|NCT01008059|6035411|P7|NOT COMPLETED|Control Simultaneous Alfentanil||0
2461370|NCT01008059|6035412|P6|NOT COMPLETED|Control Simultaneous Alfentanil||0
2461371|NCT01008059|6035413|P5|NOT COMPLETED|Control Simultaneous Alfentanil||0
2461372|NCT01008059|6035414|P4|NOT COMPLETED|Control Simultaneous Alfentanil||0
2461373|NCT01008059|6035415|P3|NOT COMPLETED|Control Simultaneous Alfentanil||0
2461374|NCT01008059|6035416|P2|NOT COMPLETED|Control Simultaneous Alfentanil||0
2461375|NCT01008059|6035417|P1|NOT COMPLETED|Control Simultaneous Alfentanil||0
2461376|NCT01008059|6035410|P8|COMPLETED|Control Simultaneous Alfentanil||0
2461377|NCT01008059|6035411|P7|COMPLETED|Control Simultaneous Alfentanil||0
2461378|NCT01008059|6035412|P6|COMPLETED|Control Simultaneous Alfentanil||0
2461379|NCT01008059|6035413|P5|COMPLETED|Control Simultaneous Alfentanil||6
2461380|NCT01008059|6035414|P4|COMPLETED|Control Simultaneous Alfentanil||0
2461381|NCT01008059|6035415|P3|COMPLETED|Control Simultaneous Alfentanil||0
2461382|NCT01008059|6035416|P2|COMPLETED|Control Simultaneous Alfentanil||0
2461383|NCT01008059|6035417|P1|COMPLETED|Control Simultaneous Alfentanil||0
2461384|NCT01008059|6035410|P8|STARTED|Control Simultaneous Alfentanil||0
2461385|NCT01008059|6035411|P7|STARTED|Control Simultaneous Alfentanil||0
2461386|NCT01008059|6035412|P6|STARTED|Control Simultaneous Alfentanil||0
2461387|NCT01008059|6035413|P5|STARTED|Control Simultaneous Alfentanil||6
2461388|NCT01008059|6035414|P4|STARTED|Control Simultaneous Alfentanil||0
2461389|NCT01008059|6035415|P3|STARTED|Control Simultaneous Alfentanil||0
2461390|NCT01008059|6035416|P2|STARTED|Control Simultaneous Alfentanil||0
2461391|NCT01008059|6035417|P1|STARTED|Control Simultaneous Alfentanil||0
2461392|NCT01008059|6035410|P8|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
2461393|NCT01008059|6035411|P7|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
2461394|NCT01008059|6035412|P6|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
2461395|NCT01008059|6035413|P5|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
2461396|NCT01008059|6035414|P4|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
2461397|NCT01008059|6035415|P3|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
2461398|NCT01008059|6035416|P2|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
2461399|NCT01008059|6035417|P1|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
2461400|NCT01008059|6035410|P8|COMPLETED|Ketoconazole Sequential Alfentanil||0
2461401|NCT01008059|6035411|P7|COMPLETED|Ketoconazole Sequential Alfentanil||0
2461402|NCT01008059|6035412|P6|COMPLETED|Ketoconazole Sequential Alfentanil||0
2461403|NCT01008059|6035413|P5|COMPLETED|Ketoconazole Sequential Alfentanil||0
2461404|NCT01008059|6035414|P4|COMPLETED|Ketoconazole Sequential Alfentanil||6
2461405|NCT01008059|6035415|P3|COMPLETED|Ketoconazole Sequential Alfentanil||0
2461406|NCT01008059|6035416|P2|COMPLETED|Ketoconazole Sequential Alfentanil||0
2461407|NCT01008059|6035417|P1|COMPLETED|Ketoconazole Sequential Alfentanil||0
2461408|NCT01008059|6035410|P8|STARTED|Ketoconazole Sequential Alfentanil||0
2461409|NCT01008059|6035411|P7|STARTED|Ketoconazole Sequential Alfentanil||0
2461410|NCT01008059|6035412|P6|STARTED|Ketoconazole Sequential Alfentanil||0
2461411|NCT01008059|6035413|P5|STARTED|Ketoconazole Sequential Alfentanil||0
2461412|NCT01008059|6035414|P4|STARTED|Ketoconazole Sequential Alfentanil||6
2461413|NCT01008059|6035415|P3|STARTED|Ketoconazole Sequential Alfentanil||0
2461414|NCT01008059|6035416|P2|STARTED|Ketoconazole Sequential Alfentanil||0
2461415|NCT01008059|6035417|P1|STARTED|Ketoconazole Sequential Alfentanil||0
2461416|NCT01008059|6035410|P8|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
2461417|NCT01008059|6035411|P7|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
2461418|NCT01008059|6035412|P6|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
2461419|NCT01008059|6035413|P5|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
2461420|NCT01008059|6035414|P4|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
2461421|NCT01008059|6035415|P3|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
2461422|NCT01008059|6035416|P2|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
2461423|NCT01008059|6035417|P1|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
2461424|NCT01008059|6035410|P8|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
2461425|NCT01008059|6035411|P7|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
2461426|NCT01008059|6035412|P6|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
2461427|NCT01008059|6035413|P5|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
2461428|NCT01008059|6035414|P4|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
2461429|NCT01008059|6035415|P3|COMPLETED|Grapefruit Juice Sequential Alfentanil||6
2461430|NCT01008059|6035416|P2|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
2461431|NCT01008059|6035417|P1|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
2461432|NCT01008059|6035410|P8|STARTED|Grapefruit Juice Sequential Alfentanil||0
2461433|NCT01008059|6035411|P7|STARTED|Grapefruit Juice Sequential Alfentanil||0
2461434|NCT01008059|6035412|P6|STARTED|Grapefruit Juice Sequential Alfentanil||0
2461435|NCT01008059|6035413|P5|STARTED|Grapefruit Juice Sequential Alfentanil||0
2461436|NCT01008059|6035414|P4|STARTED|Grapefruit Juice Sequential Alfentanil||0
2461437|NCT01008059|6035415|P3|STARTED|Grapefruit Juice Sequential Alfentanil||6
2461438|NCT01008059|6035416|P2|STARTED|Grapefruit Juice Sequential Alfentanil||0
2461439|NCT01008059|6035417|P1|STARTED|Grapefruit Juice Sequential Alfentanil||0
2461440|NCT01008059|6035410|P8|NOT COMPLETED|Rifampin Sequential Alfentanil||0
2461441|NCT01008059|6035411|P7|NOT COMPLETED|Rifampin Sequential Alfentanil||0
2461442|NCT01008059|6035412|P6|NOT COMPLETED|Rifampin Sequential Alfentanil||0
2461443|NCT01008059|6035413|P5|NOT COMPLETED|Rifampin Sequential Alfentanil||0
2461444|NCT01008059|6035414|P4|NOT COMPLETED|Rifampin Sequential Alfentanil||0
2461445|NCT01008059|6035415|P3|NOT COMPLETED|Rifampin Sequential Alfentanil||0
2461446|NCT01008059|6035416|P2|NOT COMPLETED|Rifampin Sequential Alfentanil||0
2461447|NCT01008059|6035417|P1|NOT COMPLETED|Rifampin Sequential Alfentanil||0
2461448|NCT01008059|6035410|P8|COMPLETED|Rifampin Sequential Alfentanil||0
2461449|NCT01008059|6035411|P7|COMPLETED|Rifampin Sequential Alfentanil||0
2461450|NCT01008059|6035412|P6|COMPLETED|Rifampin Sequential Alfentanil||0
2461451|NCT01008059|6035413|P5|COMPLETED|Rifampin Sequential Alfentanil||0
2461452|NCT01008059|6035414|P4|COMPLETED|Rifampin Sequential Alfentanil||0
2461453|NCT01008059|6035415|P3|COMPLETED|Rifampin Sequential Alfentanil||0
2461454|NCT01008059|6035416|P2|COMPLETED|Rifampin Sequential Alfentanil||6
2461455|NCT01008059|6035417|P1|COMPLETED|Rifampin Sequential Alfentanil||0
2461456|NCT01008059|6035410|P8|STARTED|Rifampin Sequential Alfentanil||0
2461457|NCT01008059|6035411|P7|STARTED|Rifampin Sequential Alfentanil||0
2461458|NCT01008059|6035412|P6|STARTED|Rifampin Sequential Alfentanil||0
2461459|NCT01008059|6035413|P5|STARTED|Rifampin Sequential Alfentanil||0
2461460|NCT01008059|6035414|P4|STARTED|Rifampin Sequential Alfentanil||0
2461461|NCT01008059|6035415|P3|STARTED|Rifampin Sequential Alfentanil||0
2461462|NCT01008059|6035416|P2|STARTED|Rifampin Sequential Alfentanil||6
2461463|NCT01008059|6035417|P1|STARTED|Rifampin Sequential Alfentanil||0
2461464|NCT01008059|6035410|P8|NOT COMPLETED|Control Sequential Alfentanil||0
2461465|NCT01008059|6035411|P7|NOT COMPLETED|Control Sequential Alfentanil||0
2461466|NCT01008059|6035412|P6|NOT COMPLETED|Control Sequential Alfentanil||0
2461467|NCT01008059|6035413|P5|NOT COMPLETED|Control Sequential Alfentanil||0
2461468|NCT01008059|6035414|P4|NOT COMPLETED|Control Sequential Alfentanil||0
2461469|NCT01008059|6035415|P3|NOT COMPLETED|Control Sequential Alfentanil||0
2461470|NCT01008059|6035416|P2|NOT COMPLETED|Control Sequential Alfentanil||0
2461471|NCT01008059|6035417|P1|NOT COMPLETED|Control Sequential Alfentanil||0
2461472|NCT01008059|6035410|P8|COMPLETED|Control Sequential Alfentanil||0
2461473|NCT01008059|6035411|P7|COMPLETED|Control Sequential Alfentanil||0
2461474|NCT01008059|6035412|P6|COMPLETED|Control Sequential Alfentanil||0
2461475|NCT01008059|6035413|P5|COMPLETED|Control Sequential Alfentanil||0
2461476|NCT01008059|6035414|P4|COMPLETED|Control Sequential Alfentanil||0
2461477|NCT01008059|6035415|P3|COMPLETED|Control Sequential Alfentanil||0
2461478|NCT01008059|6035416|P2|COMPLETED|Control Sequential Alfentanil||0
2461479|NCT01008059|6035417|P1|COMPLETED|Control Sequential Alfentanil||6
2461480|NCT01008059|6035410|P8|STARTED|Control Sequential Alfentanil||0
2461481|NCT01008059|6035411|P7|STARTED|Control Sequential Alfentanil||0
2461482|NCT01008059|6035412|P6|STARTED|Control Sequential Alfentanil||0
2461483|NCT01008059|6035413|P5|STARTED|Control Sequential Alfentanil||0
2461484|NCT01008059|6035414|P4|STARTED|Control Sequential Alfentanil||0
2461485|NCT01008059|6035415|P3|STARTED|Control Sequential Alfentanil||0
2461486|NCT01008059|6035416|P2|STARTED|Control Sequential Alfentanil||0
2461487|NCT01008059|6035417|P1|STARTED|Control Sequential Alfentanil||6
2461488|NCT01007916|6035428|P2|NOT COMPLETED|Period 2, 4 Weeks of Wear||0
2461489|NCT01007916|6035429|P1|NOT COMPLETED|Period 2, 4 Weeks of Wear||1
2461490|NCT01007916|6035428|P2|COMPLETED|Period 2, 4 Weeks of Wear||25
2461491|NCT01007916|6035429|P1|COMPLETED|Period 2, 4 Weeks of Wear||21
2461492|NCT01007916|6035428|P2|STARTED|Period 2, 4 Weeks of Wear|One participant completed Period 1 but did not start Period 2 due to failing inclusion criteria.|25
2461493|NCT01007916|6035429|P1|STARTED|Period 2, 4 Weeks of Wear||22
2461494|NCT01007916|6035428|P2|NOT COMPLETED|Period 1, 4 Weeks of Wear||0
2461495|NCT01007916|6035429|P1|NOT COMPLETED|Period 1, 4 Weeks of Wear||1
2461496|NCT01007916|6035428|P2|COMPLETED|Period 1, 4 Weeks of Wear||26
2461497|NCT01007916|6035429|P1|COMPLETED|Period 1, 4 Weeks of Wear||22
2461498|NCT01007916|6035428|P2|STARTED|Period 1, 4 Weeks of Wear||26
2461499|NCT01007916|6035429|P1|STARTED|Period 1, 4 Weeks of Wear||23
2461500|NCT01007942|6035437|P2|NOT COMPLETED|Overall Study||278
2461501|NCT01007942|6035438|P1|NOT COMPLETED|Overall Study||281
2461502|NCT01007942|6035437|P2|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|7
2461503|NCT01007942|6035438|P1|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|3
2461504|NCT01007942|6035437|P2|STARTED|Overall Study||285
2461505|NCT01007942|6035438|P1|STARTED|Overall Study||284
2461506|NCT01007838|6035464|P4|NOT COMPLETED|Overall Study||0
2461507|NCT01007838|6035465|P3|NOT COMPLETED|Overall Study||0
2461508|NCT01007838|6035466|P2|NOT COMPLETED|Overall Study||0
2461509|NCT01007838|6035467|P1|NOT COMPLETED|Overall Study||3
2461510|NCT01007838|6035464|P4|COMPLETED|Overall Study||4
2461511|NCT01007838|6035465|P3|COMPLETED|Overall Study||5
2461512|NCT01007838|6035466|P2|COMPLETED|Overall Study||11
2461513|NCT01007838|6035467|P1|COMPLETED|Overall Study||9
2461514|NCT01007838|6035464|P4|STARTED|Overall Study||4
2461515|NCT01007838|6035465|P3|STARTED|Overall Study||5
2461516|NCT01007838|6035466|P2|STARTED|Overall Study||11
2461517|NCT01007838|6035467|P1|STARTED|Overall Study||12
2461518|NCT01007812|6035477|P2|NOT COMPLETED|Period 2, One Week||0
2461519|NCT01007812|6035478|P1|NOT COMPLETED|Period 2, One Week||0
2461520|NCT01007812|6035477|P2|COMPLETED|Period 2, One Week||24
2461521|NCT01007812|6035478|P1|COMPLETED|Period 2, One Week||24
2461522|NCT01007812|6035477|P2|STARTED|Period 2, One Week||24
2461523|NCT01007812|6035478|P1|STARTED|Period 2, One Week||24
2461524|NCT01007812|6035477|P2|NOT COMPLETED|Period 1, One Week||1
2461525|NCT01007812|6035478|P1|NOT COMPLETED|Period 1, One Week||1
2461526|NCT01007812|6035477|P2|COMPLETED|Period 1, One Week||24
2461527|NCT01007812|6035478|P1|COMPLETED|Period 1, One Week||24
2461528|NCT01007812|6035477|P2|STARTED|Period 1, One Week||25
2461529|NCT01007812|6035478|P1|STARTED|Period 1, One Week||25
2461530|NCT01007656|6035484|P1|NOT COMPLETED|Overall Study||0
2461531|NCT01007656|6035484|P1|COMPLETED|Overall Study||31
2461532|NCT01007656|6035484|P1|STARTED|Overall Study||31
2461533|NCT01007643|6035504|P2|NOT COMPLETED|Overall Study||0
2461534|NCT01007643|6035505|P1|NOT COMPLETED|Overall Study||0
2461535|NCT01007643|6035504|P2|COMPLETED|Overall Study||14
2461536|NCT01007643|6035505|P1|COMPLETED|Overall Study||8
2461537|NCT01007643|6035504|P2|STARTED|Overall Study||14
2461538|NCT01007643|6035505|P1|STARTED|Overall Study||8
2461539|NCT01007591|6035513|P2|NOT COMPLETED|Overall Study||1
2461540|NCT01007591|6035514|P1|NOT COMPLETED|Overall Study||1
2461541|NCT01007591|6035513|P2|COMPLETED|Overall Study||12
2461542|NCT01007591|6035514|P1|COMPLETED|Overall Study||26
2461543|NCT01007591|6035513|P2|STARTED|Overall Study||13
2461544|NCT01007591|6035514|P1|STARTED|Overall Study||27
2461545|NCT01007552|6035528|P1|NOT COMPLETED|Overall Study||1
2461546|NCT01007552|6035528|P1|COMPLETED|Overall Study||49
2461547|NCT01007552|6035528|P1|STARTED|Overall Study||50
2461548|NCT01007526|6035538|P1|NOT COMPLETED|Overall Study||0
2461549|NCT01007526|6035538|P1|COMPLETED|Overall Study||31
2461550|NCT01007526|6035538|P1|STARTED|Overall Study||31
2461551|NCT01007448|6035544|P2|NOT COMPLETED|Overall Study||9
2461552|NCT01007448|6035545|P1|NOT COMPLETED|Overall Study||10
2461553|NCT01007448|6035544|P2|COMPLETED|Overall Study||20
2461554|NCT01007448|6035545|P1|COMPLETED|Overall Study||20
2461555|NCT01007448|6035544|P2|Safety Population|Overall Study||29
2461556|NCT01007448|6035545|P1|Safety Population|Overall Study||30
2461557|NCT01007448|6035544|P2|Full Analysis Population|Overall Study||29
2461558|NCT01007448|6035545|P1|Full Analysis Population|Overall Study||30
2461559|NCT01007448|6035544|P2|STARTED|Overall Study||29
2461560|NCT01007448|6035545|P1|STARTED|Overall Study||30
2461561|NCT01007435|6035577|P4|NOT COMPLETED|Overall Study||56
2461562|NCT01007435|6035578|P3|NOT COMPLETED|Overall Study||64
2461563|NCT01007435|6035579|P2|NOT COMPLETED|Overall Study||59
2461564|NCT01007435|6035580|P1|NOT COMPLETED|Overall Study||63
2461565|NCT01007435|6035577|P4|COMPLETED|Overall Study||236
2461566|NCT01007435|6035578|P3|COMPLETED|Overall Study||227
2461567|NCT01007435|6035579|P2|COMPLETED|Overall Study||231
2461568|NCT01007435|6035580|P1|COMPLETED|Overall Study||226
2461569|NCT01007435|6035577|P4|STARTED|Overall Study||292
2461570|NCT01007435|6035578|P3|STARTED|Overall Study||291
2461571|NCT01007435|6035579|P2|STARTED|Overall Study||290
2461572|NCT01007435|6035580|P1|STARTED|Overall Study||289
2461573|NCT01007396|6035622|P1|NOT COMPLETED|Overall Study||47
2461574|NCT01007396|6035622|P1|COMPLETED|Overall Study||275
2461575|NCT01007396|6035622|P1|STARTED|Overall Study||322
2461576|NCT01007253|6035627|P4|NOT COMPLETED|Fourth Intervention||0
2461577|NCT01007253|6035628|P3|NOT COMPLETED|Fourth Intervention||0
2461578|NCT01007253|6035629|P2|NOT COMPLETED|Fourth Intervention||0
2461579|NCT01007253|6035630|P1|NOT COMPLETED|Fourth Intervention||0
2461580|NCT01007253|6035627|P4|COMPLETED|Fourth Intervention||5
2461581|NCT01007253|6035628|P3|COMPLETED|Fourth Intervention||5
2461582|NCT01007253|6035629|P2|COMPLETED|Fourth Intervention||5
2461583|NCT01007253|6035630|P1|COMPLETED|Fourth Intervention||5
2461584|NCT01007253|6035627|P4|STARTED|Fourth Intervention||5
2461585|NCT01007253|6035628|P3|STARTED|Fourth Intervention||5
2461586|NCT01007253|6035629|P2|STARTED|Fourth Intervention||5
2461587|NCT01007253|6035630|P1|STARTED|Fourth Intervention||5
2461588|NCT01007253|6035627|P4|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
2461589|NCT01007253|6035628|P3|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
2461590|NCT01007253|6035629|P2|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
2461591|NCT01007253|6035630|P1|NOT COMPLETED|Washout Period (2 Weeks) # 3||1
2461592|NCT01007253|6035627|P4|COMPLETED|Washout Period (2 Weeks) # 3||5
2461593|NCT01007253|6035628|P3|COMPLETED|Washout Period (2 Weeks) # 3||5
2461594|NCT01007253|6035629|P2|COMPLETED|Washout Period (2 Weeks) # 3||5
2461595|NCT01007253|6035630|P1|COMPLETED|Washout Period (2 Weeks) # 3||5
2461596|NCT01007253|6035627|P4|STARTED|Washout Period (2 Weeks) # 3||5
2461597|NCT01007253|6035628|P3|STARTED|Washout Period (2 Weeks) # 3||5
2461598|NCT01007253|6035629|P2|STARTED|Washout Period (2 Weeks) # 3||5
2461599|NCT01007253|6035630|P1|STARTED|Washout Period (2 Weeks) # 3||6
2461600|NCT01007253|6035627|P4|NOT COMPLETED|Third Intervention||0
2461601|NCT01007253|6035628|P3|NOT COMPLETED|Third Intervention||0
2461602|NCT01007253|6035629|P2|NOT COMPLETED|Third Intervention||0
2461603|NCT01007253|6035630|P1|NOT COMPLETED|Third Intervention||0
2461604|NCT01007253|6035627|P4|COMPLETED|Third Intervention||5
2461605|NCT01007253|6035628|P3|COMPLETED|Third Intervention||5
2461606|NCT01007253|6035629|P2|COMPLETED|Third Intervention||5
2461607|NCT01007253|6035630|P1|COMPLETED|Third Intervention||6
2461608|NCT01007253|6035627|P4|STARTED|Third Intervention||5
2461609|NCT01007253|6035628|P3|STARTED|Third Intervention||5
2461610|NCT01007253|6035629|P2|STARTED|Third Intervention||5
2461611|NCT01007253|6035630|P1|STARTED|Third Intervention||6
2461612|NCT01007253|6035627|P4|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
2461613|NCT01007253|6035628|P3|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
2461614|NCT01007253|6035629|P2|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
2461615|NCT01007253|6035630|P1|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
2461616|NCT01007253|6035627|P4|COMPLETED|Washout Period (2 Weeks) # 2||5
2461617|NCT01007253|6035628|P3|COMPLETED|Washout Period (2 Weeks) # 2||5
2461618|NCT01007253|6035629|P2|COMPLETED|Washout Period (2 Weeks) # 2||5
2461619|NCT01007253|6035630|P1|COMPLETED|Washout Period (2 Weeks) # 2||6
2461620|NCT01007253|6035627|P4|STARTED|Washout Period (2 Weeks) # 2||5
2461621|NCT01007253|6035628|P3|STARTED|Washout Period (2 Weeks) # 2||5
2461622|NCT01007253|6035629|P2|STARTED|Washout Period (2 Weeks) # 2||5
2461623|NCT01007253|6035630|P1|STARTED|Washout Period (2 Weeks) # 2||6
2461624|NCT01007253|6035627|P4|NOT COMPLETED|Second Intervention||0
2461625|NCT01007253|6035628|P3|NOT COMPLETED|Second Intervention||0
2461626|NCT01007253|6035629|P2|NOT COMPLETED|Second Intervention||0
2461627|NCT01007253|6035630|P1|NOT COMPLETED|Second Intervention||0
2461628|NCT01007253|6035627|P4|COMPLETED|Second Intervention||5
2461629|NCT01007253|6035628|P3|COMPLETED|Second Intervention||5
2461630|NCT01007253|6035629|P2|COMPLETED|Second Intervention||5
2461631|NCT01007253|6035630|P1|COMPLETED|Second Intervention||6
2461632|NCT01007253|6035627|P4|STARTED|Second Intervention||5
2461633|NCT01007253|6035628|P3|STARTED|Second Intervention||5
2461634|NCT01007253|6035629|P2|STARTED|Second Intervention||5
2461635|NCT01007253|6035630|P1|STARTED|Second Intervention||6
2461636|NCT01007253|6035627|P4|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
2461637|NCT01007253|6035628|P3|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
2461638|NCT01007253|6035629|P2|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
2461639|NCT01007253|6035630|P1|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
2461640|NCT01007253|6035627|P4|COMPLETED|Washout Period (2 Weeks) # 1||5
2461641|NCT01007253|6035628|P3|COMPLETED|Washout Period (2 Weeks) # 1||5
2461642|NCT01007253|6035629|P2|COMPLETED|Washout Period (2 Weeks) # 1||5
2461643|NCT01007253|6035630|P1|COMPLETED|Washout Period (2 Weeks) # 1||6
2461644|NCT01007253|6035627|P4|STARTED|Washout Period (2 Weeks) # 1||5
2461645|NCT01007253|6035628|P3|STARTED|Washout Period (2 Weeks) # 1||5
2461646|NCT01007253|6035629|P2|STARTED|Washout Period (2 Weeks) # 1||5
2461647|NCT01007253|6035630|P1|STARTED|Washout Period (2 Weeks) # 1||6
2461648|NCT01007253|6035627|P4|NOT COMPLETED|First Intervention||0
2461649|NCT01007253|6035628|P3|NOT COMPLETED|First Intervention||0
2461650|NCT01007253|6035629|P2|NOT COMPLETED|First Intervention||0
2461651|NCT01007253|6035630|P1|NOT COMPLETED|First Intervention||0
2461652|NCT01007253|6035627|P4|COMPLETED|First Intervention||5
2461653|NCT01007253|6035628|P3|COMPLETED|First Intervention||5
2461654|NCT01007253|6035629|P2|COMPLETED|First Intervention||5
2461655|NCT01007253|6035630|P1|COMPLETED|First Intervention||6
2461656|NCT01007253|6035627|P4|STARTED|First Intervention||5
2461657|NCT01007253|6035628|P3|STARTED|First Intervention||5
2461658|NCT01007253|6035629|P2|STARTED|First Intervention||5
2461659|NCT01007253|6035630|P1|STARTED|First Intervention||6
2461660|NCT01007149|6035662|P2|NOT COMPLETED|Overall Study||1
2461661|NCT01007149|6035663|P1|NOT COMPLETED|Overall Study||0
2461662|NCT01007149|6035662|P2|COMPLETED|Overall Study||20
2461663|NCT01007149|6035663|P1|COMPLETED|Overall Study||20
2461664|NCT01007149|6035662|P2|STARTED|Overall Study||21
2461665|NCT01007149|6035663|P1|STARTED|Overall Study||20
2461666|NCT01007123|6035689|P4|NOT COMPLETED|Overall Study||6
2461667|NCT01007123|6035690|P3|NOT COMPLETED|Overall Study||11
2461668|NCT01007123|6035691|P2|NOT COMPLETED|Overall Study||6
2461669|NCT01007123|6035692|P1|NOT COMPLETED|Overall Study||6
2461670|NCT01007123|6035689|P4|COMPLETED|Overall Study||41
2461671|NCT01007123|6035690|P3|COMPLETED|Overall Study||37
2461672|NCT01007123|6035691|P2|COMPLETED|Overall Study||41
2461673|NCT01007123|6035692|P1|COMPLETED|Overall Study||42
2461674|NCT01007123|6035689|P4|STARTED|Overall Study||47
2461675|NCT01007123|6035690|P3|STARTED|Overall Study||48
2461676|NCT01007123|6035691|P2|STARTED|Overall Study||47
2461677|NCT01007123|6035692|P1|STARTED|Overall Study||48
2461678|NCT01007110|6035723|P2|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||5
2461679|NCT01007110|6035724|P1|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
2461680|NCT01007110|6035723|P2|COMPLETED|Neonatal Behavioral Assessment Scale (NB||15
2461681|NCT01007110|6035724|P1|COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
2461682|NCT01007110|6035723|P2|STARTED|Neonatal Behavioral Assessment Scale (NB||20
2461683|NCT01007110|6035724|P1|STARTED|Neonatal Behavioral Assessment Scale (NB||24
2461684|NCT01007110|6035723|P2|NOT COMPLETED|Follow-Up at 36 Weeks||2
2461685|NCT01007110|6035724|P1|NOT COMPLETED|Follow-Up at 36 Weeks||0
2461686|NCT01007110|6035723|P2|COMPLETED|Follow-Up at 36 Weeks||20
2461687|NCT01007110|6035724|P1|COMPLETED|Follow-Up at 36 Weeks||24
2461688|NCT01007110|6035723|P2|STARTED|Follow-Up at 36 Weeks||22
2461689|NCT01007110|6035724|P1|STARTED|Follow-Up at 36 Weeks||24
2461690|NCT01007110|6035723|P2|NOT COMPLETED|Follow-Up at 32 Weeks||1
2461691|NCT01007110|6035724|P1|NOT COMPLETED|Follow-Up at 32 Weeks||1
2461692|NCT01007110|6035723|P2|COMPLETED|Follow-Up at 32 Weeks||22
2461693|NCT01007110|6035724|P1|COMPLETED|Follow-Up at 32 Weeks||24
2461694|NCT01007110|6035723|P2|STARTED|Follow-Up at 32 Weeks||23
2461695|NCT01007110|6035724|P1|STARTED|Follow-Up at 32 Weeks||25
2461696|NCT01007110|6035723|P2|NOT COMPLETED|Follow-Up at 24 Weeks||4
2461697|NCT01007110|6035724|P1|NOT COMPLETED|Follow-Up at 24 Weeks||0
2461698|NCT01007110|6035723|P2|COMPLETED|Follow-Up at 24 Weeks||23
2461699|NCT01007110|6035724|P1|COMPLETED|Follow-Up at 24 Weeks||25
2461700|NCT01007110|6035723|P2|STARTED|Follow-Up at 24 Weeks||27
2461701|NCT01007110|6035724|P1|STARTED|Follow-Up at 24 Weeks||25
2461702|NCT01007110|6035723|P2|NOT COMPLETED|Allocation||8
2461703|NCT01007110|6035724|P1|NOT COMPLETED|Allocation||7
2461704|NCT01007110|6035723|P2|COMPLETED|Allocation||27
2461705|NCT01007110|6035724|P1|COMPLETED|Allocation||25
2461706|NCT01007110|6035723|P2|STARTED|Allocation||35
2461707|NCT01007110|6035724|P1|STARTED|Allocation||32
2461708|NCT01007071|6035740|P2|NOT COMPLETED|Overall Study||0
2461709|NCT01007071|6035741|P1|NOT COMPLETED|Overall Study||0
2461710|NCT01007071|6035740|P2|COMPLETED|Overall Study||5
2461711|NCT01007071|6035741|P1|COMPLETED|Overall Study||6
2461712|NCT01007071|6035740|P2|STARTED|Overall Study||5
2461713|NCT01007071|6035741|P1|STARTED|Overall Study||6
2461714|NCT01007032|6035753|P4|NOT COMPLETED|Overall Study||1
2461715|NCT01007032|6035754|P3|NOT COMPLETED|Overall Study||1
2461716|NCT01007032|6035755|P2|NOT COMPLETED|Overall Study||1
2461717|NCT01007032|6035756|P1|NOT COMPLETED|Overall Study||0
2461718|NCT01007032|6035753|P4|COMPLETED|Overall Study||6
2461719|NCT01007032|6035754|P3|COMPLETED|Overall Study||2
2461720|NCT01007032|6035755|P2|COMPLETED|Overall Study||6
2461721|NCT01007032|6035756|P1|COMPLETED|Overall Study||4
2461722|NCT01007032|6035753|P4|Received at Least 1 Dose of Study Drug|Overall Study||7
2461723|NCT01007032|6035754|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
2461724|NCT01007032|6035755|P2|Received at Least 1 Dose of Study Drug|Overall Study||7
2461725|NCT01007032|6035756|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
2461726|NCT01007032|6035753|P4|STARTED|Overall Study||7
2461727|NCT01007032|6035754|P3|STARTED|Overall Study||3
2461728|NCT01007032|6035755|P2|STARTED|Overall Study||7
2461729|NCT01007032|6035756|P1|STARTED|Overall Study||4
2461730|NCT01006980|6035800|P2|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||84
2461731|NCT01006980|6035801|P1|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
2461732|NCT01006980|6035800|P2|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
2461733|NCT01006980|6035801|P1|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
2461734|NCT01006980|6035800|P2|STARTED|Crossover: Dacarbazine to Vemurafenib|Participants who crossed over from dacarbazine to vemurafenib treatment.|84
2461735|NCT01006980|6035801|P1|STARTED|Crossover: Dacarbazine to Vemurafenib||0
2461736|NCT01006980|6035800|P2|NOT COMPLETED|Vemurafenib and Dacarbazine||338
2461737|NCT01006980|6035801|P1|NOT COMPLETED|Vemurafenib and Dacarbazine||337
2461738|NCT01006980|6035800|P2|COMPLETED|Vemurafenib and Dacarbazine||0
2461739|NCT01006980|6035801|P1|COMPLETED|Vemurafenib and Dacarbazine||0
2461740|NCT01006980|6035800|P2|Treated|Vemurafenib and Dacarbazine||293
2461741|NCT01006980|6035801|P1|Treated|Vemurafenib and Dacarbazine||336
2461742|NCT01006980|6035800|P2|STARTED|Vemurafenib and Dacarbazine||338
2461743|NCT01006980|6035801|P1|STARTED|Vemurafenib and Dacarbazine||337
2461744|NCT01006967|6035823|P2|NOT COMPLETED|Overall Study||63
2461745|NCT01006967|6035824|P1|NOT COMPLETED|Overall Study||66
2461746|NCT01006967|6035823|P2|COMPLETED|Overall Study||190
2461747|NCT01006967|6035824|P1|COMPLETED|Overall Study||187
2461748|NCT01006967|6035823|P2|3 Month Follow-up|Overall Study||210
2461749|NCT01006967|6035824|P1|3 Month Follow-up|Overall Study||212
2461750|NCT01006967|6035823|P2|Received Treatment|Overall Study||245
2461751|NCT01006967|6035824|P1|Received Treatment|Overall Study||245
2461752|NCT01006967|6035823|P2|STARTED|Overall Study||253
2461753|NCT01006967|6035824|P1|STARTED|Overall Study||253
2461754|NCT01006889|6035840|P1|NOT COMPLETED|Overall Study||3
2461755|NCT01006889|6035840|P1|COMPLETED|Overall Study||17
2461756|NCT01006889|6035840|P1|STARTED|Overall Study||20
2461757|NCT01006707|6035851|P3|NOT COMPLETED|Study Session 3||0
2461758|NCT01006707|6035852|P2|NOT COMPLETED|Study Session 3||0
2461759|NCT01006707|6035853|P1|NOT COMPLETED|Study Session 3||0
2461760|NCT01006707|6035851|P3|COMPLETED|Study Session 3||6
2461761|NCT01006707|6035852|P2|COMPLETED|Study Session 3||4
2461762|NCT01006707|6035853|P1|COMPLETED|Study Session 3||0
2461763|NCT01006707|6035851|P3|STARTED|Study Session 3||6
2461764|NCT01006707|6035852|P2|STARTED|Study Session 3||4
2461765|NCT01006707|6035853|P1|STARTED|Study Session 3||0
2461766|NCT01006707|6035851|P3|NOT COMPLETED|Study Session 2||0
2461767|NCT01006707|6035852|P2|NOT COMPLETED|Study Session 2||0
2461768|NCT01006707|6035853|P1|NOT COMPLETED|Study Session 2||0
2461769|NCT01006707|6035851|P3|COMPLETED|Study Session 2||6
2461770|NCT01006707|6035852|P2|COMPLETED|Study Session 2||4
2461771|NCT01006707|6035853|P1|COMPLETED|Study Session 2||0
2461772|NCT01006707|6035851|P3|STARTED|Study Session 2||6
2461773|NCT01006707|6035852|P2|STARTED|Study Session 2||4
2461774|NCT01006707|6035853|P1|STARTED|Study Session 2||0
2461775|NCT01006707|6035851|P3|NOT COMPLETED|Study Session 1||0
2461776|NCT01006707|6035852|P2|NOT COMPLETED|Study Session 1||0
2461777|NCT01006707|6035853|P1|NOT COMPLETED|Study Session 1||5
2461778|NCT01006707|6035851|P3|COMPLETED|Study Session 1||0
2461779|NCT01006707|6035852|P2|COMPLETED|Study Session 1||0
2461780|NCT01006707|6035853|P1|COMPLETED|Study Session 1||10
2461781|NCT01006707|6035851|P3|STARTED|Study Session 1||0
2461782|NCT01006707|6035852|P2|STARTED|Study Session 1||0
2461783|NCT01006707|6035853|P1|STARTED|Study Session 1||15
2461784|NCT01006655|6035866|P2|NOT COMPLETED|Second Intervention||0
2461785|NCT01006655|6035867|P1|NOT COMPLETED|Second Intervention||0
2461786|NCT01006655|6035866|P2|COMPLETED|Second Intervention||10
2461787|NCT01006655|6035867|P1|COMPLETED|Second Intervention||11
2461788|NCT01006655|6035866|P2|STARTED|Second Intervention||10
2461789|NCT01006655|6035867|P1|STARTED|Second Intervention||11
2461790|NCT01006655|6035866|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
2461791|NCT01006655|6035867|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
2461792|NCT01006655|6035866|P2|COMPLETED|Washout Period of 2 Weeks||10
2461793|NCT01006655|6035867|P1|COMPLETED|Washout Period of 2 Weeks||11
2461794|NCT01006655|6035866|P2|STARTED|Washout Period of 2 Weeks||10
2461795|NCT01006655|6035867|P1|STARTED|Washout Period of 2 Weeks||11
2461796|NCT01006655|6035866|P2|NOT COMPLETED|First Intervention||0
2461797|NCT01006655|6035867|P1|NOT COMPLETED|First Intervention||0
2461798|NCT01006655|6035866|P2|COMPLETED|First Intervention||10
2461799|NCT01006655|6035867|P1|COMPLETED|First Intervention||11
2461800|NCT01006655|6035866|P2|STARTED|First Intervention||10
2461801|NCT01006655|6035867|P1|STARTED|First Intervention||11
2461802|NCT01006629|6035873|P1|NOT COMPLETED|Overall Study||6
2461803|NCT01006629|6035873|P1|COMPLETED|Overall Study||94
2461804|NCT01006629|6035873|P1|STARTED|Overall Study||100
2461805|NCT01006616|6035888|P4|NOT COMPLETED|Period 2 (18 Months)||82
2461806|NCT01006616|6035889|P3|NOT COMPLETED|Period 2 (18 Months)||55
2461807|NCT01006616|6035890|P2|NOT COMPLETED|Period 2 (18 Months)||63
2461808|NCT01006616|6035891|P1|NOT COMPLETED|Period 2 (18 Months)||75
2461809|NCT01006616|6035888|P4|COMPLETED|Period 2 (18 Months)||0
2461810|NCT01006616|6035889|P3|COMPLETED|Period 2 (18 Months)||0
2461811|NCT01006616|6035890|P2|COMPLETED|Period 2 (18 Months)||0
2461812|NCT01006616|6035891|P1|COMPLETED|Period 2 (18 Months)||0
2461813|NCT01006616|6035888|P4|Treated|Period 2 (18 Months)||82
2461814|NCT01006616|6035889|P3|Treated|Period 2 (18 Months)||55
2461815|NCT01006616|6035890|P2|Treated|Period 2 (18 Months)||63
2461816|NCT01006616|6035891|P1|Treated|Period 2 (18 Months)||75
2461817|NCT01006616|6035888|P4|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|82
2461818|NCT01006616|6035889|P3|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|55
2461819|NCT01006616|6035890|P2|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|63
2461820|NCT01006616|6035891|P1|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|75
2461821|NCT01006616|6035888|P4|NOT COMPLETED|Period 1 (6 Months)||27
2461822|NCT01006616|6035889|P3|NOT COMPLETED|Period 1 (6 Months)||51
2461823|NCT01006616|6035890|P2|NOT COMPLETED|Period 1 (6 Months)||54
2461824|NCT01006616|6035891|P1|NOT COMPLETED|Period 1 (6 Months)||26
2461825|NCT01006616|6035888|P4|COMPLETED|Period 1 (6 Months)||128
2461826|NCT01006616|6035889|P3|COMPLETED|Period 1 (6 Months)||102
2461827|NCT01006616|6035890|P2|COMPLETED|Period 1 (6 Months)||102
2461828|NCT01006616|6035891|P1|COMPLETED|Period 1 (6 Months)||126
2461829|NCT01006616|6035888|P4|Treated|Period 1 (6 Months)||154
2461830|NCT01006616|6035889|P3|Treated|Period 1 (6 Months)||152
2461831|NCT01006616|6035890|P2|Treated|Period 1 (6 Months)||156
2461832|NCT01006616|6035891|P1|Treated|Period 1 (6 Months)||152
2461833|NCT01006616|6035888|P4|STARTED|Period 1 (6 Months)||155
2461834|NCT01006616|6035889|P3|STARTED|Period 1 (6 Months)||153
2461835|NCT01006616|6035890|P2|STARTED|Period 1 (6 Months)||156
2461836|NCT01006616|6035891|P1|STARTED|Period 1 (6 Months)||152
2461837|NCT01006603|6036027|P2|NOT COMPLETED|Overall Study||75
2461838|NCT01006603|6036028|P1|NOT COMPLETED|Overall Study||71
2461839|NCT01006603|6036027|P2|COMPLETED|Overall Study||285
2461840|NCT01006603|6036028|P1|COMPLETED|Overall Study||289
2461841|NCT01006603|6036027|P2|STARTED|Overall Study|Completed lead-in period and were randomised|360
2461842|NCT01006603|6036028|P1|STARTED|Overall Study|Completed lead-in period and were randomised|360
2461843|NCT01006590|6036048|P2|NOT COMPLETED|Overall Study||32
2461844|NCT01006590|6036049|P1|NOT COMPLETED|Overall Study||28
2461845|NCT01006590|6036048|P2|COMPLETED|Overall Study|Completed 24 weeks of treatment|107
2461846|NCT01006590|6036049|P1|COMPLETED|Overall Study|Completed 24 weeks of treatment|119
2461847|NCT01006590|6036048|P2|STARTED|Overall Study|Randomised and treated|139
2461848|NCT01006590|6036049|P1|STARTED|Overall Study|Randomised and treated|147
2461849|NCT01006538|6036067|P2|NOT COMPLETED|Overall Study||4
2461850|NCT01006538|6036068|P1|NOT COMPLETED|Overall Study||11
2461851|NCT01006538|6036067|P2|COMPLETED|Overall Study||115
2461852|NCT01006538|6036068|P1|COMPLETED|Overall Study||233
2461853|NCT01006538|6036067|P2|STARTED|Overall Study||119
2461854|NCT01006538|6036068|P1|STARTED|Overall Study||244
2461855|NCT01006356|6036088|P1|NOT COMPLETED|Overall Study||42
2461856|NCT01006356|6036088|P1|COMPLETED|Overall Study||99
2461857|NCT01006356|6036088|P1|STARTED|Overall Study||141
2461858|NCT01006291|6036103|P3|NOT COMPLETED|Overall Study||27
2461859|NCT01006291|6036104|P2|NOT COMPLETED|Overall Study||24
2461860|NCT01006291|6036105|P1|NOT COMPLETED|Overall Study||26
2461861|NCT01006291|6036103|P3|COMPLETED|Overall Study||203
2461862|NCT01006291|6036104|P2|COMPLETED|Overall Study||204
2461863|NCT01006291|6036105|P1|COMPLETED|Overall Study||203
2461864|NCT01006291|6036103|P3|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|229
2461865|NCT01006291|6036104|P2|Exposed|Overall Study|2 subjects received IDeg OD FF|226
2461866|NCT01006291|6036105|P1|Exposed|Overall Study|1 subject withdrew before exposure to drug. 2 subjects randomised to IDeg OD received IDeg OD FF|230
2461867|NCT01006291|6036103|P3|STARTED|Overall Study||230
2461868|NCT01006291|6036104|P2|STARTED|Overall Study||228
2461869|NCT01006291|6036105|P1|STARTED|Overall Study||229
2461870|NCT01006252|6036124|P2|NOT COMPLETED|Overall Study||0
2461871|NCT01006252|6036125|P1|NOT COMPLETED|Overall Study||0
2461872|NCT01006252|6036124|P2|COMPLETED|Overall Study||168
2461873|NCT01006252|6036125|P1|COMPLETED|Overall Study||168
2461874|NCT01006252|6036124|P2|Received Treatment|Overall Study||161
2461875|NCT01006252|6036125|P1|Received Treatment|Overall Study||164
2461876|NCT01006252|6036124|P2|STARTED|Overall Study||168
2461877|NCT01006252|6036125|P1|STARTED|Overall Study||168
2461878|NCT01006135|6036155|P1|NOT COMPLETED|Overall Study||140
2461879|NCT01006135|6036155|P1|COMPLETED|Overall Study||4712
2461880|NCT01006135|6036155|P1|STARTED|Overall Study||4852
2461881|NCT01006122|6036162|P2|NOT COMPLETED|Second Double-blind Intervention Period||7
2461882|NCT01006122|6036163|P1|NOT COMPLETED|Second Double-blind Intervention Period||2
2461883|NCT01006122|6036162|P2|COMPLETED|Second Double-blind Intervention Period||24
2461884|NCT01006122|6036163|P1|COMPLETED|Second Double-blind Intervention Period||29
2461885|NCT01006122|6036162|P2|STARTED|Second Double-blind Intervention Period||31
2461886|NCT01006122|6036163|P1|STARTED|Second Double-blind Intervention Period||31
2461887|NCT01006122|6036162|P2|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
2461888|NCT01006122|6036163|P1|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
2461889|NCT01006122|6036162|P2|COMPLETED|Wash-out Period (at Least 7 Days)||31
2461890|NCT01006122|6036163|P1|COMPLETED|Wash-out Period (at Least 7 Days)||31
2461891|NCT01006122|6036162|P2|STARTED|Wash-out Period (at Least 7 Days)||31
2461892|NCT01006122|6036163|P1|STARTED|Wash-out Period (at Least 7 Days)||31
2461893|NCT01006122|6036162|P2|NOT COMPLETED|First Double-blind Intervention Period||17
2461894|NCT01006122|6036163|P1|NOT COMPLETED|First Double-blind Intervention Period||16
2461895|NCT01006122|6036162|P2|COMPLETED|First Double-blind Intervention Period||31
2461896|NCT01006122|6036163|P1|COMPLETED|First Double-blind Intervention Period||31
2461897|NCT01006122|6036162|P2|STARTED|First Double-blind Intervention Period||48
2461898|NCT01006122|6036163|P1|STARTED|First Double-blind Intervention Period||47
2461899|NCT01006018|6036204|P3|NOT COMPLETED|Overall Study||0
2461900|NCT01006018|6036205|P2|NOT COMPLETED|Overall Study||0
2461901|NCT01006018|6036206|P1|NOT COMPLETED|Overall Study||0
2461902|NCT01006018|6036204|P3|COMPLETED|Overall Study||0
2461903|NCT01006018|6036205|P2|COMPLETED|Overall Study||0
2461904|NCT01006018|6036206|P1|COMPLETED|Overall Study||0
2461905|NCT01006018|6036204|P3|STARTED|Overall Study||0
2461906|NCT01006018|6036205|P2|STARTED|Overall Study||0
2461907|NCT01006018|6036206|P1|STARTED|Overall Study||0
2461908|NCT01005966|6036214|P5|NOT COMPLETED|Treatment Period 5 (14 Days)||0
2461909|NCT01005966|6036215|P4|NOT COMPLETED|Treatment Period 5 (14 Days)||0
2461910|NCT01005966|6036216|P3|NOT COMPLETED|Treatment Period 5 (14 Days)||0
2461911|NCT01005966|6036217|P2|NOT COMPLETED|Treatment Period 5 (14 Days)||0
2461912|NCT01005966|6036218|P1|NOT COMPLETED|Treatment Period 5 (14 Days)||0
2461913|NCT01005966|6036214|P5|COMPLETED|Treatment Period 5 (14 Days)||10
2461914|NCT01005966|6036215|P4|COMPLETED|Treatment Period 5 (14 Days)||11
2461915|NCT01005966|6036216|P3|COMPLETED|Treatment Period 5 (14 Days)||11
2461916|NCT01005966|6036217|P2|COMPLETED|Treatment Period 5 (14 Days)||12
2461917|NCT01005966|6036218|P1|COMPLETED|Treatment Period 5 (14 Days)||9
2461918|NCT01005966|6036214|P5|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|10
2461919|NCT01005966|6036215|P4|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
2461920|NCT01005966|6036216|P3|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
2461921|NCT01005966|6036217|P2|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|12
2461922|NCT01005966|6036218|P1|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|9
2461923|NCT01005966|6036214|P5|NOT COMPLETED|Washout Period 4 (4 Days)||0
2461924|NCT01005966|6036215|P4|NOT COMPLETED|Washout Period 4 (4 Days)||0
2461925|NCT01005966|6036216|P3|NOT COMPLETED|Washout Period 4 (4 Days)||0
2461926|NCT01005966|6036217|P2|NOT COMPLETED|Washout Period 4 (4 Days)||0
2461927|NCT01005966|6036218|P1|NOT COMPLETED|Washout Period 4 (4 Days)||0
2461928|NCT01005966|6036214|P5|COMPLETED|Washout Period 4 (4 Days)||12
2461929|NCT01005966|6036215|P4|COMPLETED|Washout Period 4 (4 Days)||10
2461930|NCT01005966|6036216|P3|COMPLETED|Washout Period 4 (4 Days)||11
2461931|NCT01005966|6036217|P2|COMPLETED|Washout Period 4 (4 Days)||10
2461932|NCT01005966|6036218|P1|COMPLETED|Washout Period 4 (4 Days)||10
2461933|NCT01005966|6036214|P5|STARTED|Washout Period 4 (4 Days)||12
2461934|NCT01005966|6036215|P4|STARTED|Washout Period 4 (4 Days)||10
2461935|NCT01005966|6036216|P3|STARTED|Washout Period 4 (4 Days)||11
2461936|NCT01005966|6036217|P2|STARTED|Washout Period 4 (4 Days)||10
2461937|NCT01005966|6036218|P1|STARTED|Washout Period 4 (4 Days)||10
2461938|NCT01005966|6036214|P5|NOT COMPLETED|Treatment Period 4 (14 Days)||1
2461939|NCT01005966|6036215|P4|NOT COMPLETED|Treatment Period 4 (14 Days)||0
2461940|NCT01005966|6036216|P3|NOT COMPLETED|Treatment Period 4 (14 Days)||0
2461941|NCT01005966|6036217|P2|NOT COMPLETED|Treatment Period 4 (14 Days)||1
2461942|NCT01005966|6036218|P1|NOT COMPLETED|Treatment Period 4 (14 Days)||0
2461943|NCT01005966|6036214|P5|COMPLETED|Treatment Period 4 (14 Days)||12
2461944|NCT01005966|6036215|P4|COMPLETED|Treatment Period 4 (14 Days)||10
2461945|NCT01005966|6036216|P3|COMPLETED|Treatment Period 4 (14 Days)||11
2461946|NCT01005966|6036217|P2|COMPLETED|Treatment Period 4 (14 Days)||10
2461947|NCT01005966|6036218|P1|COMPLETED|Treatment Period 4 (14 Days)||10
2461948|NCT01005966|6036214|P5|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|13
2461949|NCT01005966|6036215|P4|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
2461950|NCT01005966|6036216|P3|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
2461951|NCT01005966|6036217|P2|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
2461952|NCT01005966|6036218|P1|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
2461953|NCT01005966|6036214|P5|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
2461954|NCT01005966|6036215|P4|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
2461955|NCT01005966|6036216|P3|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
2461956|NCT01005966|6036217|P2|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
2461957|NCT01005966|6036218|P1|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
2461958|NCT01005966|6036214|P5|COMPLETED|Washout Period 3 ( 4 Days)||11
2461959|NCT01005966|6036215|P4|COMPLETED|Washout Period 3 ( 4 Days)||13
2461960|NCT01005966|6036216|P3|COMPLETED|Washout Period 3 ( 4 Days)||12
2461961|NCT01005966|6036217|P2|COMPLETED|Washout Period 3 ( 4 Days)||7
2461962|NCT01005966|6036218|P1|COMPLETED|Washout Period 3 ( 4 Days)||12
2461963|NCT01005966|6036214|P5|STARTED|Washout Period 3 ( 4 Days)||11
2461964|NCT01005966|6036215|P4|STARTED|Washout Period 3 ( 4 Days)||13
2461965|NCT01005966|6036216|P3|STARTED|Washout Period 3 ( 4 Days)||12
2461966|NCT01005966|6036217|P2|STARTED|Washout Period 3 ( 4 Days)||7
2461967|NCT01005966|6036218|P1|STARTED|Washout Period 3 ( 4 Days)||12
2461968|NCT01005966|6036214|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||1
2461969|NCT01005966|6036215|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
2461970|NCT01005966|6036216|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||0
2461971|NCT01005966|6036217|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||1
2461972|NCT01005966|6036218|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
2461973|NCT01005966|6036214|P5|COMPLETED|Treatment Period 3 (14 Days)||11
2461974|NCT01005966|6036215|P4|COMPLETED|Treatment Period 3 (14 Days)||13
2461975|NCT01005966|6036216|P3|COMPLETED|Treatment Period 3 (14 Days)||12
2461976|NCT01005966|6036217|P2|COMPLETED|Treatment Period 3 (14 Days)||7
2461977|NCT01005966|6036218|P1|COMPLETED|Treatment Period 3 (14 Days)||12
2461978|NCT01005966|6036214|P5|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
2461979|NCT01005966|6036215|P4|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|13
2461980|NCT01005966|6036216|P3|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
2461981|NCT01005966|6036217|P2|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|8
2461982|NCT01005966|6036218|P1|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
2461983|NCT01005966|6036214|P5|NOT COMPLETED|Washout Period 2 (4 Days)||0
2461984|NCT01005966|6036215|P4|NOT COMPLETED|Washout Period 2 (4 Days)||0
2461985|NCT01005966|6036216|P3|NOT COMPLETED|Washout Period 2 (4 Days)||0
2461986|NCT01005966|6036217|P2|NOT COMPLETED|Washout Period 2 (4 Days)||0
2461987|NCT01005966|6036218|P1|NOT COMPLETED|Washout Period 2 (4 Days)||0
2461988|NCT01005966|6036214|P5|COMPLETED|Washout Period 2 (4 Days)||11
2461989|NCT01005966|6036215|P4|COMPLETED|Washout Period 2 (4 Days)||11
2461990|NCT01005966|6036216|P3|COMPLETED|Washout Period 2 (4 Days)||10
2461991|NCT01005966|6036217|P2|COMPLETED|Washout Period 2 (4 Days)||12
2461992|NCT01005966|6036218|P1|COMPLETED|Washout Period 2 (4 Days)||13
2461993|NCT01005966|6036214|P5|STARTED|Washout Period 2 (4 Days)||11
2461994|NCT01005966|6036215|P4|STARTED|Washout Period 2 (4 Days)||11
2461995|NCT01005966|6036216|P3|STARTED|Washout Period 2 (4 Days)||10
2461996|NCT01005966|6036217|P2|STARTED|Washout Period 2 (4 Days)||12
2461997|NCT01005966|6036218|P1|STARTED|Washout Period 2 (4 Days)||13
2461998|NCT01005966|6036214|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
2461999|NCT01005966|6036215|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
2462000|NCT01005966|6036216|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||2
2462001|NCT01005966|6036217|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
2462002|NCT01005966|6036218|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
2462003|NCT01005966|6036214|P5|COMPLETED|Treatment Period 2 (14 Days)||11
2462004|NCT01005966|6036215|P4|COMPLETED|Treatment Period 2 (14 Days)||11
2462005|NCT01005966|6036216|P3|COMPLETED|Treatment Period 2 (14 Days)||10
2462006|NCT01005966|6036217|P2|COMPLETED|Treatment Period 2 (14 Days)||12
2462007|NCT01005966|6036218|P1|COMPLETED|Treatment Period 2 (14 Days)||13
2462008|NCT01005966|6036214|P5|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
2462009|NCT01005966|6036215|P4|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
2462010|NCT01005966|6036216|P3|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
2462011|NCT01005966|6036217|P2|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
2462012|NCT01005966|6036218|P1|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
2462013|NCT01005966|6036214|P5|NOT COMPLETED|Washout Period 1 (4 Days)||0
2462014|NCT01005966|6036215|P4|NOT COMPLETED|Washout Period 1 (4 Days)||1
2462015|NCT01005966|6036216|P3|NOT COMPLETED|Washout Period 1 (4 Days)||0
2462016|NCT01005966|6036217|P2|NOT COMPLETED|Washout Period 1 (4 Days)||0
2462017|NCT01005966|6036218|P1|NOT COMPLETED|Washout Period 1 (4 Days)||0
2462018|NCT01005966|6036214|P5|COMPLETED|Washout Period 1 (4 Days)||13
2462019|NCT01005966|6036215|P4|COMPLETED|Washout Period 1 (4 Days)||12
2462020|NCT01005966|6036216|P3|COMPLETED|Washout Period 1 (4 Days)||12
2462021|NCT01005966|6036217|P2|COMPLETED|Washout Period 1 (4 Days)||13
2462022|NCT01005966|6036218|P1|COMPLETED|Washout Period 1 (4 Days)||11
2462023|NCT01005966|6036214|P5|STARTED|Washout Period 1 (4 Days)||13
2462024|NCT01005966|6036215|P4|STARTED|Washout Period 1 (4 Days)||13
2462025|NCT01005966|6036216|P3|STARTED|Washout Period 1 (4 Days)||12
2462026|NCT01005966|6036217|P2|STARTED|Washout Period 1 (4 Days)||13
2462027|NCT01005966|6036218|P1|STARTED|Washout Period 1 (4 Days)||11
2462028|NCT01005966|6036214|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||0
2462029|NCT01005966|6036215|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||0
2462030|NCT01005966|6036216|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||1
2462031|NCT01005966|6036217|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||0
2462032|NCT01005966|6036218|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
2462033|NCT01005966|6036214|P5|COMPLETED|Treatment Period 1 (14 Days)||13
2462034|NCT01005966|6036215|P4|COMPLETED|Treatment Period 1 (14 Days)||13
2462035|NCT01005966|6036216|P3|COMPLETED|Treatment Period 1 (14 Days)||12
2462036|NCT01005966|6036217|P2|COMPLETED|Treatment Period 1 (14 Days)||13
2462037|NCT01005966|6036218|P1|COMPLETED|Treatment Period 1 (14 Days)||11
2462038|NCT01005966|6036214|P5|STARTED|Treatment Period 1 (14 Days)||13
2462039|NCT01005966|6036215|P4|STARTED|Treatment Period 1 (14 Days)||13
2462040|NCT01005966|6036216|P3|STARTED|Treatment Period 1 (14 Days)||13
2462041|NCT01005966|6036217|P2|STARTED|Treatment Period 1 (14 Days)||13
2462042|NCT01005966|6036218|P1|STARTED|Treatment Period 1 (14 Days)||13
2462043|NCT01005914|6036238|P1|NOT COMPLETED|Overall Study||10
2462044|NCT01005914|6036238|P1|COMPLETED|Overall Study||1
2462045|NCT01005914|6036238|P1|STARTED|Overall Study||11
2462046|NCT01005901|6036244|P2|NOT COMPLETED|Overall Study||58
2462047|NCT01005901|6036245|P1|NOT COMPLETED|Overall Study||102
2462048|NCT01005901|6036244|P2|COMPLETED|Overall Study||212
2462049|NCT01005901|6036245|P1|COMPLETED|Overall Study||450
2462050|NCT01005901|6036244|P2|Full Analysis Set|Overall Study||260
2462051|NCT01005901|6036245|P1|Full Analysis Set|Overall Study||534
2462052|NCT01005901|6036244|P2|Safety Population|Overall Study||267
2462053|NCT01005901|6036245|P1|Safety Population|Overall Study||550
2462054|NCT01005901|6036244|P2|STARTED|Overall Study||270
2462055|NCT01005901|6036245|P1|STARTED|Overall Study||552
2462056|NCT01005888|6036287|P2|NOT COMPLETED|Second Intervention||1
2462057|NCT01005888|6036288|P1|NOT COMPLETED|Second Intervention||1
2462058|NCT01005888|6036287|P2|COMPLETED|Second Intervention||10
2462059|NCT01005888|6036288|P1|COMPLETED|Second Intervention||10
2462060|NCT01005888|6036287|P2|STARTED|Second Intervention||11
2462061|NCT01005888|6036288|P1|STARTED|Second Intervention||11
2462062|NCT01005888|6036287|P2|NOT COMPLETED|First Intervention||1
2462063|NCT01005888|6036288|P1|NOT COMPLETED|First Intervention||1
2462064|NCT01005888|6036287|P2|COMPLETED|First Intervention||11
2462065|NCT01005888|6036288|P1|COMPLETED|First Intervention||11
2462066|NCT01005888|6036287|P2|STARTED|First Intervention||12
2462067|NCT01005888|6036288|P1|STARTED|First Intervention||12
2462068|NCT01005875|6036308|P1|NOT COMPLETED|Overall Study||3
2462069|NCT01005875|6036308|P1|COMPLETED|Overall Study||2
2462070|NCT01005875|6036308|P1|STARTED|Overall Study||5
2462071|NCT01005810|6036318|P2|NOT COMPLETED|Overall Study||25
2462072|NCT01005810|6036319|P1|NOT COMPLETED|Overall Study||21
2462073|NCT01005810|6036318|P2|COMPLETED|Overall Study||33
2462074|NCT01005810|6036319|P1|COMPLETED|Overall Study||37
2462075|NCT01005810|6036318|P2|STARTED|Overall Study||58
2462076|NCT01005810|6036319|P1|STARTED|Overall Study||58
2462080|NCT01005732|6036330|P1|NOT COMPLETED|Overall Study||11
2462081|NCT01005732|6036330|P1|COMPLETED|Overall Study||43
2462082|NCT01005732|6036330|P1|STARTED|Overall Study||54
2462083|NCT01005719|6036346|P6|NOT COMPLETED|Period 3||0
2462084|NCT01005719|6036347|P5|NOT COMPLETED|Period 3||0
2462085|NCT01005719|6036348|P4|NOT COMPLETED|Period 3||0
2462086|NCT01005719|6036349|P3|NOT COMPLETED|Period 3||0
2462087|NCT01005719|6036350|P2|NOT COMPLETED|Period 3||0
2462088|NCT01005719|6036351|P1|NOT COMPLETED|Period 3||0
2462089|NCT01005719|6036346|P6|COMPLETED|Period 3||9
2462090|NCT01005719|6036347|P5|COMPLETED|Period 3||10
2462091|NCT01005719|6036348|P4|COMPLETED|Period 3||10
2462092|NCT01005719|6036349|P3|COMPLETED|Period 3||10
2462093|NCT01005719|6036350|P2|COMPLETED|Period 3||10
2462094|NCT01005719|6036351|P1|COMPLETED|Period 3||10
2462095|NCT01005719|6036346|P6|STARTED|Period 3||9
2462096|NCT01005719|6036347|P5|STARTED|Period 3||10
2462097|NCT01005719|6036348|P4|STARTED|Period 3||10
2462098|NCT01005719|6036349|P3|STARTED|Period 3||10
2462099|NCT01005719|6036350|P2|STARTED|Period 3||10
2462100|NCT01005719|6036351|P1|STARTED|Period 3||10
2462101|NCT01005719|6036346|P6|NOT COMPLETED|Period 2||1
2462102|NCT01005719|6036347|P5|NOT COMPLETED|Period 2||1
2462103|NCT01005719|6036348|P4|NOT COMPLETED|Period 2||0
2462104|NCT01005719|6036349|P3|NOT COMPLETED|Period 2||0
2462105|NCT01005719|6036350|P2|NOT COMPLETED|Period 2||0
2462106|NCT01005719|6036351|P1|NOT COMPLETED|Period 2||0
2462107|NCT01005719|6036346|P6|COMPLETED|Period 2||9
2462108|NCT01005719|6036347|P5|COMPLETED|Period 2||10
2462109|NCT01005719|6036348|P4|COMPLETED|Period 2||10
2462110|NCT01005719|6036349|P3|COMPLETED|Period 2||10
2462111|NCT01005719|6036350|P2|COMPLETED|Period 2||10
2462112|NCT01005719|6036351|P1|COMPLETED|Period 2||10
2462113|NCT01005719|6036346|P6|STARTED|Period 2||10
2462114|NCT01005719|6036347|P5|STARTED|Period 2||11
2462115|NCT01005719|6036348|P4|STARTED|Period 2||10
2462116|NCT01005719|6036349|P3|STARTED|Period 2||10
2462117|NCT01005719|6036350|P2|STARTED|Period 2||10
2462118|NCT01005719|6036351|P1|STARTED|Period 2||10
2462119|NCT01005719|6036346|P6|NOT COMPLETED|Period 1||1
2462120|NCT01005719|6036347|P5|NOT COMPLETED|Period 1||0
2462121|NCT01005719|6036348|P4|NOT COMPLETED|Period 1||1
2462122|NCT01005719|6036349|P3|NOT COMPLETED|Period 1||0
2462123|NCT01005719|6036350|P2|NOT COMPLETED|Period 1||0
2462124|NCT01005719|6036351|P1|NOT COMPLETED|Period 1||0
2462125|NCT01005719|6036346|P6|COMPLETED|Period 1||10
2462126|NCT01005719|6036347|P5|COMPLETED|Period 1||11
2462127|NCT01005719|6036348|P4|COMPLETED|Period 1||10
2462128|NCT01005719|6036349|P3|COMPLETED|Period 1||10
2462129|NCT01005719|6036350|P2|COMPLETED|Period 1||10
2462130|NCT01005719|6036351|P1|COMPLETED|Period 1||10
2462131|NCT01005719|6036346|P6|STARTED|Period 1||11
2462132|NCT01005719|6036347|P5|STARTED|Period 1||11
2462133|NCT01005719|6036348|P4|STARTED|Period 1||11
2462134|NCT01005719|6036349|P3|STARTED|Period 1||10
2462135|NCT01005719|6036350|P2|STARTED|Period 1||10
2462136|NCT01005719|6036351|P1|STARTED|Period 1||10
2462137|NCT01005706|6036409|P2|NOT COMPLETED|Overall Study||0
2462138|NCT01005706|6036410|P1|NOT COMPLETED|Overall Study||0
2462139|NCT01005706|6036409|P2|COMPLETED|Overall Study||17
2462140|NCT01005706|6036410|P1|COMPLETED|Overall Study||23
2462141|NCT01005706|6036409|P2|STARTED|Overall Study||17
2462142|NCT01005706|6036410|P1|STARTED|Overall Study||23
2462143|NCT01005680|6036418|P2|NOT COMPLETED|Overall Study||11
2462144|NCT01005680|6036419|P1|NOT COMPLETED|Overall Study||6
2462145|NCT01005680|6036418|P2|COMPLETED|Overall Study||119
2462146|NCT01005680|6036419|P1|COMPLETED|Overall Study||120
2462147|NCT01005680|6036418|P2|Received at Least 1 Dose of Study Drug|Overall Study||127
2462148|NCT01005680|6036419|P1|Received at Least 1 Dose of Study Drug|Overall Study||125
2462149|NCT01005680|6036418|P2|STARTED|Overall Study||130
2462150|NCT01005680|6036419|P1|STARTED|Overall Study||126
2462151|NCT01005602|6036443|P2|NOT COMPLETED|Overall Study||0
2462152|NCT01005602|6036444|P1|NOT COMPLETED|Overall Study||1
2462153|NCT01005602|6036443|P2|COMPLETED|Overall Study||66
2462154|NCT01005602|6036444|P1|COMPLETED|Overall Study|One patient completed the trial but was excluded from data analyses due to unreliable clinical data.|65
2462155|NCT01005602|6036443|P2|STARTED|Overall Study||66
2462156|NCT01005602|6036444|P1|STARTED|Overall Study||66
2462157|NCT01005576|6036464|P1|NOT COMPLETED|Overall Study||0
2462158|NCT01005576|6036464|P1|COMPLETED|Overall Study|All participants completed the conditioning regimen and received their stem cell transplant|21
2462159|NCT01005576|6036464|P1|STARTED|Overall Study||21
2462160|NCT01005459|6036474|P2|NOT COMPLETED|Overall Study||0
2462161|NCT01005459|6036475|P1|NOT COMPLETED|Overall Study||0
2462162|NCT01005459|6036474|P2|COMPLETED|Overall Study||23
2462163|NCT01005459|6036475|P1|COMPLETED|Overall Study||23
2462164|NCT01005459|6036474|P2|STARTED|Overall Study||23
2462165|NCT01005459|6036475|P1|STARTED|Overall Study||23
2462166|NCT01005407|6036483|P2|NOT COMPLETED|Overall Study||32
2462167|NCT01005407|6036484|P1|NOT COMPLETED|Overall Study||151
2462168|NCT01005407|6036483|P2|COMPLETED|Overall Study||451
2462169|NCT01005407|6036484|P1|COMPLETED|Overall Study||1818
2462170|NCT01005407|6036483|P2|STARTED|Overall Study||483
2462171|NCT01005407|6036484|P1|STARTED|Overall Study||1969
2462172|NCT01005355|6036495|P3|NOT COMPLETED|Overall Study||0
2462173|NCT01005355|6036496|P2|NOT COMPLETED|Overall Study||0
2462174|NCT01005355|6036497|P1|NOT COMPLETED|Overall Study||0
2462175|NCT01005355|6036495|P3|COMPLETED|Overall Study||6
2462176|NCT01005355|6036496|P2|COMPLETED|Overall Study||6
2462177|NCT01005355|6036497|P1|COMPLETED|Overall Study||3
2462178|NCT01005355|6036495|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
2462179|NCT01005355|6036496|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
2462180|NCT01005355|6036497|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
2462181|NCT01005355|6036495|P3|STARTED|Overall Study||6
2462182|NCT01005355|6036496|P2|STARTED|Overall Study||6
2462183|NCT01005355|6036497|P1|STARTED|Overall Study||3
2462184|NCT01005329|6036532|P1|NOT COMPLETED|Overall Study||4
2462185|NCT01005329|6036532|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|30
2462186|NCT01005329|6036532|P1|STARTED|Overall Study||34
2462187|NCT01005316|6036545|P4|NOT COMPLETED|Overall Study||108
2462188|NCT01005316|6036546|P3|NOT COMPLETED|Overall Study||11
2462189|NCT01005316|6036547|P2|NOT COMPLETED|Overall Study||76
2462190|NCT01005316|6036548|P1|NOT COMPLETED|Overall Study||50
2462191|NCT01005316|6036545|P4|COMPLETED|Overall Study||19
2462192|NCT01005316|6036546|P3|COMPLETED|Overall Study||5
2462193|NCT01005316|6036547|P2|COMPLETED|Overall Study||21
2462194|NCT01005316|6036548|P1|COMPLETED|Overall Study||0
2462195|NCT01005316|6036545|P4|STARTED|Overall Study||127
2462196|NCT01005316|6036546|P3|STARTED|Overall Study||16
2462197|NCT01005316|6036547|P2|STARTED|Overall Study||97
2462198|NCT01005316|6036548|P1|STARTED|Overall Study||50
2462199|NCT01005290|6036600|P3|NOT COMPLETED|Period 2 (5 Weeks)||2
2462200|NCT01005290|6036601|P2|NOT COMPLETED|Period 2 (5 Weeks)||0
2462201|NCT01005290|6036602|P1|NOT COMPLETED|Period 2 (5 Weeks)||0
2462202|NCT01005290|6036600|P3|COMPLETED|Period 2 (5 Weeks)||7
2462203|NCT01005290|6036601|P2|COMPLETED|Period 2 (5 Weeks)||13
2462204|NCT01005290|6036602|P1|COMPLETED|Period 2 (5 Weeks)||0
2462205|NCT01005290|6036600|P3|STARTED|Period 2 (5 Weeks)||9
2462206|NCT01005290|6036601|P2|STARTED|Period 2 (5 Weeks)||13
2462207|NCT01005290|6036602|P1|STARTED|Period 2 (5 Weeks)||0
2462208|NCT01005290|6036600|P3|NOT COMPLETED|Washout Period (2 Weeks)||0
2462209|NCT01005290|6036601|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
2462210|NCT01005290|6036602|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
2462211|NCT01005290|6036600|P3|COMPLETED|Washout Period (2 Weeks)||9
2462212|NCT01005290|6036601|P2|COMPLETED|Washout Period (2 Weeks)||13
2462213|NCT01005290|6036602|P1|COMPLETED|Washout Period (2 Weeks)||0
2462214|NCT01005290|6036600|P3|STARTED|Washout Period (2 Weeks)||9
2462215|NCT01005290|6036601|P2|STARTED|Washout Period (2 Weeks)||13
2462216|NCT01005290|6036602|P1|STARTED|Washout Period (2 Weeks)||0
2462217|NCT01005290|6036600|P3|NOT COMPLETED|Period 1 (5 Weeks)||9
2462218|NCT01005290|6036601|P2|NOT COMPLETED|Period 1 (5 Weeks)||7
2462219|NCT01005290|6036602|P1|NOT COMPLETED|Period 1 (5 Weeks)||0
2462220|NCT01005290|6036600|P3|COMPLETED|Period 1 (5 Weeks)||9
2462221|NCT01005290|6036601|P2|COMPLETED|Period 1 (5 Weeks)||13
2462222|NCT01005290|6036602|P1|COMPLETED|Period 1 (5 Weeks)||0
2462223|NCT01005290|6036600|P3|STARTED|Period 1 (5 Weeks)||18
2462224|NCT01005290|6036601|P2|STARTED|Period 1 (5 Weeks)||20
2462225|NCT01005290|6036602|P1|STARTED|Period 1 (5 Weeks)||0
2462226|NCT01005290|6036600|P3|NOT COMPLETED|Run-In||0
2462227|NCT01005290|6036601|P2|NOT COMPLETED|Run-In||0
2462228|NCT01005290|6036602|P1|NOT COMPLETED|Run-In||14
2462229|NCT01005290|6036600|P3|COMPLETED|Run-In||0
2462230|NCT01005290|6036601|P2|COMPLETED|Run-In||0
2462231|NCT01005290|6036602|P1|COMPLETED|Run-In||38
2462232|NCT01005290|6036600|P3|STARTED|Run-In||0
2462233|NCT01005290|6036601|P2|STARTED|Run-In||0
2462234|NCT01005290|6036602|P1|STARTED|Run-In||52
2462235|NCT01005251|6036615|P5|NOT COMPLETED|Overall Study||18
2462236|NCT01005251|6036616|P4|NOT COMPLETED|Overall Study||12
2462237|NCT01005251|6036617|P3|NOT COMPLETED|Overall Study||22
2462238|NCT01005251|6036618|P2|NOT COMPLETED|Overall Study||16
2462239|NCT01005251|6036619|P1|NOT COMPLETED|Overall Study||13
2462240|NCT01005251|6036615|P5|COMPLETED|Overall Study||122
2462241|NCT01005251|6036616|P4|COMPLETED|Overall Study||114
2462242|NCT01005251|6036617|P3|COMPLETED|Overall Study||114
2462243|NCT01005251|6036618|P2|COMPLETED|Overall Study||109
2462244|NCT01005251|6036619|P1|COMPLETED|Overall Study||121
2462245|NCT01005251|6036615|P5|STARTED|Overall Study||140
2462246|NCT01005251|6036616|P4|STARTED|Overall Study||126
2462247|NCT01005251|6036617|P3|STARTED|Overall Study||136
2462248|NCT01005251|6036618|P2|STARTED|Overall Study||125
2462249|NCT01005251|6036619|P1|STARTED|Overall Study||134
2462250|NCT01004991|6036636|P1|NOT COMPLETED|Overall Study||0
2462251|NCT01004991|6036636|P1|COMPLETED|Overall Study||12
2462252|NCT01004991|6036636|P1|STARTED|Overall Study||12
2462253|NCT01004939|6036640|P1|NOT COMPLETED|Overall Study||0
2462254|NCT01004939|6036640|P1|COMPLETED|Overall Study||120
2462255|NCT01004939|6036640|P1|STARTED|Overall Study||120
2462256|NCT01004874|6036681|P1|NOT COMPLETED|Overall Study||0
2462257|NCT01004874|6036681|P1|COMPLETED|Overall Study||80
2462258|NCT01004874|6036681|P1|STARTED|Overall Study||80
2462259|NCT01004848|6036692|P2|NOT COMPLETED|Overall Study||45
2462260|NCT01004848|6036693|P1|NOT COMPLETED|Overall Study||55
2462261|NCT01004848|6036692|P2|COMPLETED|Overall Study||147
2462262|NCT01004848|6036693|P1|COMPLETED|Overall Study||155
2462263|NCT01004848|6036692|P2|STARTED|Overall Study||192
2462264|NCT01004848|6036693|P1|STARTED|Overall Study||210
2462265|NCT01004822|6036731|P8|NOT COMPLETED|Overall Study||5
2462266|NCT01004822|6036732|P7|NOT COMPLETED|Overall Study||4
2462267|NCT01004822|6036733|P6|NOT COMPLETED|Overall Study||4
2462268|NCT01004822|6036734|P5|NOT COMPLETED|Overall Study||4
2462269|NCT01004822|6036735|P4|NOT COMPLETED|Overall Study||4
2462270|NCT01004822|6036736|P3|NOT COMPLETED|Overall Study||4
2462271|NCT01004822|6036737|P2|NOT COMPLETED|Overall Study||3
2462272|NCT01004822|6036738|P1|NOT COMPLETED|Overall Study||3
2462273|NCT01004822|6036731|P8|COMPLETED|Overall Study||0
2462274|NCT01004822|6036732|P7|COMPLETED|Overall Study||0
2462275|NCT01004822|6036733|P6|COMPLETED|Overall Study||0
2462276|NCT01004822|6036734|P5|COMPLETED|Overall Study||0
2462277|NCT01004822|6036735|P4|COMPLETED|Overall Study||0
2462278|NCT01004822|6036736|P3|COMPLETED|Overall Study||0
2462279|NCT01004822|6036737|P2|COMPLETED|Overall Study||0
2462280|NCT01004822|6036738|P1|COMPLETED|Overall Study||0
2462281|NCT01004822|6036731|P8|Treated|Overall Study||5
2462282|NCT01004822|6036732|P7|Treated|Overall Study||4
2462283|NCT01004822|6036733|P6|Treated|Overall Study||4
2462284|NCT01004822|6036734|P5|Treated|Overall Study||4
2462285|NCT01004822|6036735|P4|Treated|Overall Study||4
2462286|NCT01004822|6036736|P3|Treated|Overall Study||3
2462287|NCT01004822|6036737|P2|Treated|Overall Study||3
2462288|NCT01004822|6036738|P1|Treated|Overall Study||3
2462289|NCT01004822|6036731|P8|STARTED|Overall Study||5
2462290|NCT01004822|6036732|P7|STARTED|Overall Study||4
2462291|NCT01004822|6036733|P6|STARTED|Overall Study||4
2462292|NCT01004822|6036734|P5|STARTED|Overall Study||4
2462293|NCT01004822|6036735|P4|STARTED|Overall Study||4
2462294|NCT01004822|6036736|P3|STARTED|Overall Study||4
2462295|NCT01004822|6036737|P2|STARTED|Overall Study||3
2462296|NCT01004822|6036738|P1|STARTED|Overall Study||3
2462297|NCT01004770|6036852|P5|NOT COMPLETED|Overall Study||0
2462298|NCT01004770|6036853|P4|NOT COMPLETED|Overall Study||0
2462299|NCT01004770|6036854|P3|NOT COMPLETED|Overall Study||0
2462300|NCT01004770|6036855|P2|NOT COMPLETED|Overall Study||0
2462301|NCT01004770|6036856|P1|NOT COMPLETED|Overall Study||0
2462302|NCT01004770|6036852|P5|COMPLETED|Overall Study||10
2462303|NCT01004770|6036853|P4|COMPLETED|Overall Study||10
2462304|NCT01004770|6036854|P3|COMPLETED|Overall Study||10
2462305|NCT01004770|6036855|P2|COMPLETED|Overall Study||10
2462306|NCT01004770|6036856|P1|COMPLETED|Overall Study||10
2462307|NCT01004770|6036852|P5|STARTED|Overall Study||10
2462308|NCT01004770|6036853|P4|STARTED|Overall Study||10
2462309|NCT01004770|6036854|P3|STARTED|Overall Study||10
2462310|NCT01004770|6036855|P2|STARTED|Overall Study||10
2462311|NCT01004770|6036856|P1|STARTED|Overall Study||10
2462312|NCT01004705|6036888|P3|NOT COMPLETED|Period 2 (12 Weeks)||4
2462313|NCT01004705|6036889|P2|NOT COMPLETED|Period 2 (12 Weeks)||0
2462314|NCT01004705|6036890|P1|NOT COMPLETED|Period 2 (12 Weeks)||0
2462315|NCT01004705|6036888|P3|COMPLETED|Period 2 (12 Weeks)||9
2462316|NCT01004705|6036889|P2|COMPLETED|Period 2 (12 Weeks)||13
2462317|NCT01004705|6036890|P1|COMPLETED|Period 2 (12 Weeks)||0
2462318|NCT01004705|6036888|P3|STARTED|Period 2 (12 Weeks)||13
2462319|NCT01004705|6036889|P2|STARTED|Period 2 (12 Weeks)||13
2462320|NCT01004705|6036890|P1|STARTED|Period 2 (12 Weeks)||0
2462321|NCT01004705|6036888|P3|NOT COMPLETED|Washout Period (6 Weeks)||0
2462322|NCT01004705|6036889|P2|NOT COMPLETED|Washout Period (6 Weeks)||0
2462323|NCT01004705|6036890|P1|NOT COMPLETED|Washout Period (6 Weeks)||0
2462324|NCT01004705|6036888|P3|COMPLETED|Washout Period (6 Weeks)||13
2462325|NCT01004705|6036889|P2|COMPLETED|Washout Period (6 Weeks)||13
2462326|NCT01004705|6036890|P1|COMPLETED|Washout Period (6 Weeks)||0
2462327|NCT01004705|6036888|P3|STARTED|Washout Period (6 Weeks)||13
2462328|NCT01004705|6036889|P2|STARTED|Washout Period (6 Weeks)||13
2462329|NCT01004705|6036890|P1|STARTED|Washout Period (6 Weeks)||0
2462330|NCT01004705|6036888|P3|NOT COMPLETED|Period 1 (12 Weeks)||5
2462331|NCT01004705|6036889|P2|NOT COMPLETED|Period 1 (12 Weeks)||5
2462332|NCT01004705|6036890|P1|NOT COMPLETED|Period 1 (12 Weeks)||0
2462333|NCT01004705|6036888|P3|COMPLETED|Period 1 (12 Weeks)||13
2462334|NCT01004705|6036889|P2|COMPLETED|Period 1 (12 Weeks)||13
2462335|NCT01004705|6036890|P1|COMPLETED|Period 1 (12 Weeks)||0
2462336|NCT01004705|6036888|P3|STARTED|Period 1 (12 Weeks)||18
2462337|NCT01004705|6036889|P2|STARTED|Period 1 (12 Weeks)||18
2462338|NCT01004705|6036890|P1|STARTED|Period 1 (12 Weeks)||0
2462339|NCT01004705|6036888|P3|NOT COMPLETED|Run-In||0
2462340|NCT01004705|6036889|P2|NOT COMPLETED|Run-In||0
2462341|NCT01004705|6036890|P1|NOT COMPLETED|Run-In||8
2462342|NCT01004705|6036888|P3|COMPLETED|Run-In||0
2462343|NCT01004705|6036889|P2|COMPLETED|Run-In||0
2462344|NCT01004705|6036890|P1|COMPLETED|Run-In||36
2462345|NCT01004705|6036888|P3|STARTED|Run-In||0
2462346|NCT01004705|6036889|P2|STARTED|Run-In||0
2462347|NCT01004705|6036890|P1|STARTED|Run-In||44
2462348|NCT01004614|6036903|P4|NOT COMPLETED|Second Intervention||0
2462349|NCT01004614|6036904|P3|NOT COMPLETED|Second Intervention||0
2462350|NCT01004614|6036905|P2|NOT COMPLETED|Second Intervention||0
2462351|NCT01004614|6036906|P1|NOT COMPLETED|Second Intervention||0
2462352|NCT01004614|6036903|P4|COMPLETED|Second Intervention||12
2462353|NCT01004614|6036904|P3|COMPLETED|Second Intervention||12
2462354|NCT01004614|6036905|P2|COMPLETED|Second Intervention||11
2462355|NCT01004614|6036906|P1|COMPLETED|Second Intervention||12
2462356|NCT01004614|6036903|P4|STARTED|Second Intervention||12
2462357|NCT01004614|6036904|P3|STARTED|Second Intervention||12
2462358|NCT01004614|6036905|P2|STARTED|Second Intervention||11
2462359|NCT01004614|6036906|P1|STARTED|Second Intervention||12
2462360|NCT01004614|6036903|P4|NOT COMPLETED|Washout||0
2462361|NCT01004614|6036904|P3|NOT COMPLETED|Washout||0
2462362|NCT01004614|6036905|P2|NOT COMPLETED|Washout||1
2462363|NCT01004614|6036906|P1|NOT COMPLETED|Washout||0
2462364|NCT01004614|6036903|P4|COMPLETED|Washout||12
2462365|NCT01004614|6036904|P3|COMPLETED|Washout||12
2462366|NCT01004614|6036905|P2|COMPLETED|Washout||11
2462367|NCT01004614|6036906|P1|COMPLETED|Washout||12
2462368|NCT01004614|6036903|P4|STARTED|Washout||12
2462369|NCT01004614|6036904|P3|STARTED|Washout||12
2462370|NCT01004614|6036905|P2|STARTED|Washout||12
2462371|NCT01004614|6036906|P1|STARTED|Washout||12
2462372|NCT01004614|6036903|P4|NOT COMPLETED|First Intervention||0
2462373|NCT01004614|6036904|P3|NOT COMPLETED|First Intervention||0
2462374|NCT01004614|6036905|P2|NOT COMPLETED|First Intervention||0
2462375|NCT01004614|6036906|P1|NOT COMPLETED|First Intervention||0
2462376|NCT01004614|6036903|P4|COMPLETED|First Intervention||12
2462377|NCT01004614|6036904|P3|COMPLETED|First Intervention||12
2462378|NCT01004614|6036905|P2|COMPLETED|First Intervention||12
2462379|NCT01004614|6036906|P1|COMPLETED|First Intervention||12
2462380|NCT01004614|6036903|P4|STARTED|First Intervention||12
2462381|NCT01004614|6036904|P3|STARTED|First Intervention||12
2462382|NCT01004614|6036905|P2|STARTED|First Intervention||12
2462383|NCT01004614|6036906|P1|STARTED|First Intervention||12
2462384|NCT01004510|6036940|P1|NOT COMPLETED|Overall Study||1
2462385|NCT01004510|6036940|P1|COMPLETED|Overall Study||2
2462386|NCT01004510|6036940|P1|STARTED|Overall Study||3
2462387|NCT01004432|6036944|P5|NOT COMPLETED|OL Study Extension (Week 52 - 76)||18
2462388|NCT01004432|6036945|P4|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
2462389|NCT01004432|6036946|P3|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
2462390|NCT01004432|6036947|P2|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
2462391|NCT01004432|6036948|P1|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
2462392|NCT01004432|6036944|P5|COMPLETED|OL Study Extension (Week 52 - 76)||194
2462393|NCT01004432|6036945|P4|COMPLETED|OL Study Extension (Week 52 - 76)||0
2462394|NCT01004432|6036946|P3|COMPLETED|OL Study Extension (Week 52 - 76)||0
2462395|NCT01004432|6036947|P2|COMPLETED|OL Study Extension (Week 52 - 76)||0
2462396|NCT01004432|6036948|P1|COMPLETED|OL Study Extension (Week 52 - 76)||0
2462397|NCT01004432|6036944|P5|STARTED|OL Study Extension (Week 52 - 76)||212
2462398|NCT01004432|6036945|P4|STARTED|OL Study Extension (Week 52 - 76)||0
2462399|NCT01004432|6036946|P3|STARTED|OL Study Extension (Week 52 - 76)||0
2462400|NCT01004432|6036947|P2|STARTED|OL Study Extension (Week 52 - 76)||0
2462401|NCT01004432|6036948|P1|STARTED|OL Study Extension (Week 52 - 76)||0
2462402|NCT01004432|6036944|P5|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
2462403|NCT01004432|6036945|P4|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||58
2462404|NCT01004432|6036946|P3|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||37
2462405|NCT01004432|6036947|P2|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||10
2462406|NCT01004432|6036948|P1|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
2462407|NCT01004432|6036944|P5|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
2462408|NCT01004432|6036945|P4|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||126
2462409|NCT01004432|6036946|P3|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||54
2462410|NCT01004432|6036947|P2|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||65
2462411|NCT01004432|6036948|P1|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
2462412|NCT01004432|6036944|P5|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
2462413|NCT01004432|6036945|P4|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||184
2462414|NCT01004432|6036946|P3|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||91
2462415|NCT01004432|6036947|P2|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||75
2462416|NCT01004432|6036948|P1|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
2462417|NCT01004432|6036944|P5|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
2462418|NCT01004432|6036945|P4|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
2462419|NCT01004432|6036946|P3|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
2462420|NCT01004432|6036947|P2|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
2462421|NCT01004432|6036948|P1|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||83
2462422|NCT01004432|6036944|P5|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
2462423|NCT01004432|6036945|P4|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
2462424|NCT01004432|6036946|P3|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
2462425|NCT01004432|6036947|P2|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
2462426|NCT01004432|6036948|P1|COMPLETED|Open-label (OL) Period (Week 0 – 16)|1 Participant died after completing open-label period. Discontinuation was noted as adverse event.|350
2462427|NCT01004432|6036944|P5|STARTED|Open-label (OL) Period (Week 0 – 16)||0
2462428|NCT01004432|6036945|P4|STARTED|Open-label (OL) Period (Week 0 – 16)||0
2462429|NCT01004432|6036946|P3|STARTED|Open-label (OL) Period (Week 0 – 16)||0
2462430|NCT01004432|6036947|P2|STARTED|Open-label (OL) Period (Week 0 – 16)||0
2462431|NCT01004432|6036948|P1|STARTED|Open-label (OL) Period (Week 0 – 16)||433
2462432|NCT01004406|6036970|P2|NOT COMPLETED|Overall Study||0
2462433|NCT01004406|6036971|P1|NOT COMPLETED|Overall Study||3
2462434|NCT01004406|6036970|P2|COMPLETED|Overall Study||10
2462435|NCT01004406|6036971|P1|COMPLETED|Overall Study||18
2462436|NCT01004406|6036970|P2|STARTED|Overall Study||10
2462437|NCT01004406|6036971|P1|STARTED|Overall Study||21
2462438|NCT01004393|6036983|P1|NOT COMPLETED|Overall Study||0
2462439|NCT01004393|6036983|P1|COMPLETED|Overall Study||12
2462440|NCT01004393|6036983|P1|STARTED|Overall Study||12
2462441|NCT01004354|6036994|P1|NOT COMPLETED|Overall Study||0
2462442|NCT01004354|6036994|P1|COMPLETED|Overall Study||12
2462443|NCT01004354|6036994|P1|STARTED|Overall Study||12
2462444|NCT01004263|6037006|P1|NOT COMPLETED|Overall Study||179
2462445|NCT01004263|6037006|P1|COMPLETED|Overall Study||427
2462446|NCT01004263|6037006|P1|STARTED|Overall Study|Participants who took study drug|606
2462447|NCT01004250|6037014|P1|NOT COMPLETED|Follow-Up (FU) Period||1
2462448|NCT01004250|6037014|P1|COMPLETED|Follow-Up (FU) Period||100
2462449|NCT01004250|6037014|P1|STARTED|Follow-Up (FU) Period|Did not enter FU:Death-4pts Ind,1pts Maint; Pt Withdrew-1 pts Ind,1pts Maint; Lost to FU-1 pts Maint|101
2462450|NCT01004250|6037014|P1|NOT COMPLETED|Maintenance Therapy Period||26
2462451|NCT01004250|6037014|P1|COMPLETED|Maintenance Therapy Period||46
2462452|NCT01004250|6037014|P1|Death (Any Cause) or Disease Progression|Maintenance Therapy Period|Pts with death or disease progression considered to have completed phase.|46
2462453|NCT01004250|6037014|P1|STARTED|Maintenance Therapy Period|Did not enter Maint: 21 pts due to death or disease progression; 1 pts had performance status 2.|72
2462454|NCT01004250|6037014|P1|NOT COMPLETED|Induction Therapy Period||15
2462455|NCT01004250|6037014|P1|COMPLETED|Induction Therapy Period||94
2462456|NCT01004250|6037014|P1|Death (Any Cause) or Disease Progression|Induction Therapy Period|Participants (pts) with death or disease progression considered to have completed phase.|21
2462457|NCT01004250|6037014|P1|Received at Least One Dose of Study Drug|Induction Therapy Period||109
2462458|NCT01004250|6037014|P1|STARTED|Induction Therapy Period||109
2462459|NCT01004185|6037026|P2|NOT COMPLETED|Overall Study||9
2462460|NCT01004185|6037027|P1|NOT COMPLETED|Overall Study||9
2462461|NCT01004185|6037026|P2|COMPLETED|Overall Study||11
2462462|NCT01004185|6037027|P1|COMPLETED|Overall Study||10
2462463|NCT01004185|6037026|P2|STARTED|Overall Study||20
2462464|NCT01004185|6037027|P1|STARTED|Overall Study||19
2462465|NCT01004172|6037035|P1|NOT COMPLETED|Overall Study||38
2462466|NCT01004172|6037035|P1|COMPLETED|Overall Study||0
2462467|NCT01004172|6037035|P1|STARTED|Overall Study||38
2462468|NCT01004159|6037043|P1|NOT COMPLETED|Overall Study||20
2462469|NCT01004159|6037043|P1|COMPLETED|Overall Study||0
2462470|NCT01004159|6037043|P1|STARTED|Overall Study||20
2462471|NCT01004146|6037050|P2|NOT COMPLETED|Overall Study||5
2462472|NCT01004146|6037051|P1|NOT COMPLETED|Overall Study||4
2462473|NCT01004146|6037050|P2|COMPLETED|Overall Study||20
2462474|NCT01004146|6037051|P1|COMPLETED|Overall Study||21
2462475|NCT01004146|6037050|P2|Have Incentive Spirometry Data|Overall Study||20
2462476|NCT01004146|6037051|P1|Have Incentive Spirometry Data|Overall Study||21
2462477|NCT01004146|6037050|P2|STARTED|Overall Study||25
2462478|NCT01004146|6037051|P1|STARTED|Overall Study||25
2462479|NCT01004107|6037059|P2|NOT COMPLETED|Overall Study||2
2462480|NCT01004107|6037060|P1|NOT COMPLETED|Overall Study||1
2462481|NCT01004107|6037059|P2|COMPLETED|Overall Study||23
2462482|NCT01004107|6037060|P1|COMPLETED|Overall Study||75
2462483|NCT01004107|6037059|P2|STARTED|Overall Study||25
2462484|NCT01004107|6037060|P1|STARTED|Overall Study||76
2462485|NCT01004003|6037145|P9|NOT COMPLETED|Overall Study||30
2462486|NCT01004003|6037146|P8|NOT COMPLETED|Overall Study||60
2462487|NCT01004003|6037147|P7|NOT COMPLETED|Overall Study||8
2462488|NCT01004003|6037148|P6|NOT COMPLETED|Overall Study||4
2462489|NCT01004003|6037149|P5|NOT COMPLETED|Overall Study||4
2462490|NCT01004003|6037150|P4|NOT COMPLETED|Overall Study||3
2462491|NCT01004003|6037151|P3|NOT COMPLETED|Overall Study||4
2462492|NCT01004003|6037152|P2|NOT COMPLETED|Overall Study||3
2462493|NCT01004003|6037153|P1|NOT COMPLETED|Overall Study||6
2462494|NCT01004003|6037145|P9|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|1
2462495|NCT01004003|6037146|P8|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|2
2462496|NCT01004003|6037147|P7|COMPLETED|Overall Study||0
2462497|NCT01004003|6037148|P6|COMPLETED|Overall Study||0
2462498|NCT01004003|6037149|P5|COMPLETED|Overall Study||0
2462499|NCT01004003|6037150|P4|COMPLETED|Overall Study||0
2462500|NCT01004003|6037151|P3|COMPLETED|Overall Study||0
2462501|NCT01004003|6037152|P2|COMPLETED|Overall Study||0
2462502|NCT01004003|6037153|P1|COMPLETED|Overall Study||0
2462503|NCT01004003|6037145|P9|STARTED|Overall Study||31
2462504|NCT01004003|6037146|P8|STARTED|Overall Study||62
2462505|NCT01004003|6037147|P7|STARTED|Overall Study||8
2462506|NCT01004003|6037148|P6|STARTED|Overall Study||4
2462507|NCT01004003|6037149|P5|STARTED|Overall Study||4
2462508|NCT01004003|6037150|P4|STARTED|Overall Study||3
2462509|NCT01004003|6037151|P3|STARTED|Overall Study||4
2462510|NCT01004003|6037152|P2|STARTED|Overall Study||3
2462511|NCT01004003|6037153|P1|STARTED|Overall Study||6
2462512|NCT01003990|6037184|P3|NOT COMPLETED|Overall Study||43
2462513|NCT01003990|6037185|P2|NOT COMPLETED|Overall Study||51
2462514|NCT01003990|6037186|P1|NOT COMPLETED|Overall Study||92
2462515|NCT01003990|6037184|P3|COMPLETED|Overall Study||53
2462516|NCT01003990|6037185|P2|COMPLETED|Overall Study||103
2462517|NCT01003990|6037186|P1|COMPLETED|Overall Study||367
2462518|NCT01003990|6037184|P3|STARTED|Overall Study||96
2462519|NCT01003990|6037185|P2|STARTED|Overall Study||154
2462520|NCT01003990|6037186|P1|STARTED|Overall Study||459
2462521|NCT01003938|6037194|P1|NOT COMPLETED|Overall Study||0
2462522|NCT01003938|6037194|P1|COMPLETED|Overall Study||6
2462523|NCT01003938|6037194|P1|STARTED|Overall Study||6
2462524|NCT01003899|6037203|P1|NOT COMPLETED|Overall Study||47
2462525|NCT01003899|6037203|P1|COMPLETED|Overall Study||0
2462526|NCT01003899|6037203|P1|STARTED|Overall Study|enrolled|47
2462527|NCT01003886|6037212|P1|NOT COMPLETED|Overall Study||230
2462528|NCT01003886|6037212|P1|COMPLETED|Overall Study||759
2462529|NCT01003886|6037212|P1|STARTED|Overall Study||989
2462530|NCT01003639|6037223|P2|NOT COMPLETED|Overall Study||22
2462531|NCT01003639|6037224|P1|NOT COMPLETED|Overall Study||17
2462532|NCT01003639|6037223|P2|COMPLETED|Overall Study||57
2462533|NCT01003639|6037224|P1|COMPLETED|Overall Study||69
2462534|NCT01003639|6037223|P2|STARTED|Overall Study||79
2462535|NCT01003639|6037224|P1|STARTED|Overall Study||86
2462536|NCT01003418|6037238|P2|NOT COMPLETED|Overall Study||0
2462537|NCT01003418|6037239|P1|NOT COMPLETED|Overall Study||0
2462538|NCT01003418|6037238|P2|COMPLETED|Overall Study||3
2462539|NCT01003418|6037239|P1|COMPLETED|Overall Study||5
2462540|NCT01003418|6037238|P2|STARTED|Overall Study||3
2462541|NCT01003418|6037239|P1|STARTED|Overall Study||5
2462542|NCT01003301|6037257|P2|NOT COMPLETED|Overall Study||0
2462543|NCT01003301|6037258|P1|NOT COMPLETED|Overall Study||0
2462544|NCT01003301|6037257|P2|COMPLETED|Overall Study||9
2462545|NCT01003301|6037258|P1|COMPLETED|Overall Study||10
2462546|NCT01003301|6037257|P2|STARTED|Overall Study||9
2462547|NCT01003301|6037258|P1|STARTED|Overall Study||10
2462548|NCT01003288|6037266|P1|NOT COMPLETED|Overall Study||0
2462549|NCT01003288|6037266|P1|COMPLETED|Overall Study||255
2462550|NCT01003288|6037266|P1|STARTED|Overall Study||255
2462551|NCT01003275|6037273|P2|NOT COMPLETED|Overall Study||0
2462552|NCT01003275|6037274|P1|NOT COMPLETED|Overall Study||1
2462553|NCT01003275|6037273|P2|COMPLETED|Overall Study||11
2462554|NCT01003275|6037274|P1|COMPLETED|Overall Study||10
2462555|NCT01003275|6037273|P2|STARTED|Overall Study||11
2462556|NCT01003275|6037274|P1|STARTED|Overall Study||11
2462557|NCT01003249|6037280|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
2462558|NCT01003249|6037281|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
2462559|NCT01003249|6037280|P2|COMPLETED|Second Intervention (4 Weeks)||2
2462560|NCT01003249|6037281|P1|COMPLETED|Second Intervention (4 Weeks)||3
2462561|NCT01003249|6037280|P2|STARTED|Second Intervention (4 Weeks)||3
2462562|NCT01003249|6037281|P1|STARTED|Second Intervention (4 Weeks)||4
2462563|NCT01003249|6037280|P2|NOT COMPLETED|Washout (3 Weeks)||0
2462564|NCT01003249|6037281|P1|NOT COMPLETED|Washout (3 Weeks)||0
2462565|NCT01003249|6037280|P2|COMPLETED|Washout (3 Weeks)||3
2462566|NCT01003249|6037281|P1|COMPLETED|Washout (3 Weeks)||4
2462567|NCT01003249|6037280|P2|STARTED|Washout (3 Weeks)||3
2462568|NCT01003249|6037281|P1|STARTED|Washout (3 Weeks)||4
2462569|NCT01003249|6037280|P2|NOT COMPLETED|First Intervention (4 Weeks)||2
2462570|NCT01003249|6037281|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
2462571|NCT01003249|6037280|P2|COMPLETED|First Intervention (4 Weeks)||3
2462572|NCT01003249|6037281|P1|COMPLETED|First Intervention (4 Weeks)||5
2462573|NCT01003249|6037280|P2|Received Intervention|First Intervention (4 Weeks)||5
2462574|NCT01003249|6037281|P1|Received Intervention|First Intervention (4 Weeks)||7
2462575|NCT01003249|6037280|P2|STARTED|First Intervention (4 Weeks)||5
2462576|NCT01003249|6037281|P1|STARTED|First Intervention (4 Weeks)||7
2462577|NCT01003210|6037299|P2|NOT COMPLETED|Overall Study||3
2462578|NCT01003210|6037300|P1|NOT COMPLETED|Overall Study||1
2462579|NCT01003210|6037299|P2|COMPLETED|Overall Study||102
2462580|NCT01003210|6037300|P1|COMPLETED|Overall Study||104
2462581|NCT01003210|6037299|P2|STARTED|Overall Study||105
2462582|NCT01003210|6037300|P1|STARTED|Overall Study||105
2462583|NCT01003184|6037312|P2|NOT COMPLETED|Overall Study||12
2462584|NCT01003184|6037313|P1|NOT COMPLETED|Overall Study||19
2462585|NCT01003184|6037312|P2|COMPLETED|Overall Study||99
2462586|NCT01003184|6037313|P1|COMPLETED|Overall Study||92
2462587|NCT01003184|6037312|P2|Full Analysis Set (FAS)|Overall Study||105
2462588|NCT01003184|6037313|P1|Full Analysis Set (FAS)|Overall Study||111
2462589|NCT01003184|6037312|P2|STARTED|Overall Study||111
2462590|NCT01003184|6037313|P1|STARTED|Overall Study||111
2462591|NCT01003106|6037349|P8|NOT COMPLETED|Month 6-Month 36||0
2462592|NCT01003106|6037350|P7|NOT COMPLETED|Month 6-Month 36||1
2462593|NCT01003106|6037351|P6|NOT COMPLETED|Month 6-Month 36||0
2462594|NCT01003106|6037352|P5|NOT COMPLETED|Month 6-Month 36||0
2462595|NCT01003106|6037353|P4|NOT COMPLETED|Month 6-Month 36||0
2462596|NCT01003106|6037354|P3|NOT COMPLETED|Month 6-Month 36||1
2462597|NCT01003106|6037355|P2|NOT COMPLETED|Month 6-Month 36||0
2462598|NCT01003106|6037356|P1|NOT COMPLETED|Month 6-Month 36||0
2462599|NCT01003106|6037349|P8|COMPLETED|Month 6-Month 36||18
2462600|NCT01003106|6037350|P7|COMPLETED|Month 6-Month 36||19
2462601|NCT01003106|6037351|P6|COMPLETED|Month 6-Month 36||0
2462602|NCT01003106|6037352|P5|COMPLETED|Month 6-Month 36||0
2462603|NCT01003106|6037353|P4|COMPLETED|Month 6-Month 36||20
2462604|NCT01003106|6037354|P3|COMPLETED|Month 6-Month 36||18
2462605|NCT01003106|6037355|P2|COMPLETED|Month 6-Month 36||0
2462606|NCT01003106|6037356|P1|COMPLETED|Month 6-Month 36||0
2462607|NCT01003106|6037349|P8|STARTED|Month 6-Month 36||18
2462608|NCT01003106|6037350|P7|STARTED|Month 6-Month 36||20
2462609|NCT01003106|6037351|P6|STARTED|Month 6-Month 36||0
2462610|NCT01003106|6037352|P5|STARTED|Month 6-Month 36||0
2462611|NCT01003106|6037353|P4|STARTED|Month 6-Month 36||20
2462612|NCT01003106|6037354|P3|STARTED|Month 6-Month 36||19
2462613|NCT01003106|6037355|P2|STARTED|Month 6-Month 36||0
2462614|NCT01003106|6037356|P1|STARTED|Month 6-Month 36||0
2462615|NCT01003106|6037349|P8|NOT COMPLETED|Baseline to Month 6||0
2462616|NCT01003106|6037350|P7|NOT COMPLETED|Baseline to Month 6||0
2462617|NCT01003106|6037351|P6|NOT COMPLETED|Baseline to Month 6||0
2462618|NCT01003106|6037352|P5|NOT COMPLETED|Baseline to Month 6||0
2462619|NCT01003106|6037353|P4|NOT COMPLETED|Baseline to Month 6||0
2462620|NCT01003106|6037354|P3|NOT COMPLETED|Baseline to Month 6||0
2462621|NCT01003106|6037355|P2|NOT COMPLETED|Baseline to Month 6||0
2462622|NCT01003106|6037356|P1|NOT COMPLETED|Baseline to Month 6||0
2462623|NCT01003106|6037349|P8|COMPLETED|Baseline to Month 6||0
2462624|NCT01003106|6037350|P7|COMPLETED|Baseline to Month 6||0
2462625|NCT01003106|6037351|P6|COMPLETED|Baseline to Month 6||20
2462626|NCT01003106|6037352|P5|COMPLETED|Baseline to Month 6||19
2462627|NCT01003106|6037353|P4|COMPLETED|Baseline to Month 6||0
2462628|NCT01003106|6037354|P3|COMPLETED|Baseline to Month 6||0
2462629|NCT01003106|6037355|P2|COMPLETED|Baseline to Month 6||20
2462630|NCT01003106|6037356|P1|COMPLETED|Baseline to Month 6||22
2462631|NCT01003106|6037349|P8|STARTED|Baseline to Month 6||0
2462632|NCT01003106|6037350|P7|STARTED|Baseline to Month 6||0
2462633|NCT01003106|6037351|P6|STARTED|Baseline to Month 6||20
2462634|NCT01003106|6037352|P5|STARTED|Baseline to Month 6||19
2462635|NCT01003106|6037353|P4|STARTED|Baseline to Month 6||0
2462636|NCT01003106|6037354|P3|STARTED|Baseline to Month 6||0
2462637|NCT01003106|6037355|P2|STARTED|Baseline to Month 6||20
2462638|NCT01003106|6037356|P1|STARTED|Baseline to Month 6||22
2462639|NCT01003080|6037380|P2|NOT COMPLETED|Overall Study||0
2462640|NCT01003080|6037381|P1|NOT COMPLETED|Overall Study||0
2462641|NCT01003080|6037380|P2|COMPLETED|Overall Study||61
2462642|NCT01003080|6037381|P1|COMPLETED|Overall Study||50
2462643|NCT01003080|6037380|P2|STARTED|Overall Study||61
2462644|NCT01003080|6037381|P1|STARTED|Overall Study||50
2462645|NCT01003067|6037389|P2|NOT COMPLETED|Overall Study||24
2462646|NCT01003067|6037390|P1|NOT COMPLETED|Overall Study||33
2462647|NCT01003067|6037389|P2|COMPLETED|Overall Study||107
2462648|NCT01003067|6037390|P1|COMPLETED|Overall Study||103
2462649|NCT01003067|6037389|P2|STARTED|Overall Study||131
2462650|NCT01003067|6037390|P1|STARTED|Overall Study||136
2462651|NCT01002989|6037396|P1|NOT COMPLETED|Overall Study||5
2462652|NCT01002989|6037396|P1|COMPLETED|Overall Study||93
2462653|NCT01002989|6037396|P1|STARTED|Overall Study||98
2462654|NCT01002755|6037403|P1|NOT COMPLETED|Overall Study||0
2462655|NCT01002755|6037403|P1|COMPLETED|Overall Study||36
2462656|NCT01002755|6037403|P1|STARTED|Overall Study||36
2462657|NCT01002742|6037411|P2|NOT COMPLETED|Overall Study||1
2462658|NCT01002742|6037412|P1|NOT COMPLETED|Overall Study||0
2462659|NCT01002742|6037411|P2|COMPLETED|Overall Study||116
2462660|NCT01002742|6037412|P1|COMPLETED|Overall Study||119
2462661|NCT01002742|6037411|P2|STARTED|Overall Study||117
2462662|NCT01002742|6037412|P1|STARTED|Overall Study||119
2462663|NCT01002573|6037448|P2|NOT COMPLETED|Overall Study||7
2462664|NCT01002573|6037449|P1|NOT COMPLETED|Overall Study||11
2462665|NCT01002573|6037448|P2|COMPLETED|Overall Study||53
2462666|NCT01002573|6037449|P1|COMPLETED|Overall Study||47
2462667|NCT01002573|6037448|P2|STARTED|Overall Study||60
2462668|NCT01002573|6037449|P1|STARTED|Overall Study||58
2462669|NCT01002547|6037470|P3|NOT COMPLETED|Overall Study||8
2462670|NCT01002547|6037471|P2|NOT COMPLETED|Overall Study||3
2462671|NCT01002547|6037472|P1|NOT COMPLETED|Overall Study||8
2462672|NCT01002547|6037470|P3|COMPLETED|Overall Study||29
2462673|NCT01002547|6037471|P2|COMPLETED|Overall Study||33
2462674|NCT01002547|6037472|P1|COMPLETED|Overall Study||24
2462675|NCT01002547|6037470|P3|STARTED|Overall Study||37
2462676|NCT01002547|6037471|P2|STARTED|Overall Study||36
2462677|NCT01002547|6037472|P1|STARTED|Overall Study||32
2462678|NCT01002482|6037530|P2|NOT COMPLETED|Overall Study||21
2462679|NCT01002482|6037531|P1|NOT COMPLETED|Overall Study||15
2462680|NCT01002482|6037530|P2|COMPLETED|Overall Study||1312
2462681|NCT01002482|6037531|P1|COMPLETED|Overall Study||1336
2462682|NCT01002482|6037530|P2|STARTED|Overall Study||1333
2462683|NCT01002482|6037531|P1|STARTED|Overall Study||1351
2462684|NCT01002456|6037553|P2|NOT COMPLETED|Overall Study||0
2462685|NCT01002456|6037554|P1|NOT COMPLETED|Overall Study||0
2462686|NCT01002456|6037553|P2|COMPLETED|Overall Study||122
2462687|NCT01002456|6037554|P1|COMPLETED|Overall Study||98
2462688|NCT01002456|6037553|P2|STARTED|Overall Study||122
2462689|NCT01002456|6037554|P1|STARTED|Overall Study||98
2462690|NCT01002339|6037565|P3|NOT COMPLETED|Overall Study||5
2462691|NCT01002339|6037566|P2|NOT COMPLETED|Overall Study||1
2462692|NCT01002339|6037567|P1|NOT COMPLETED|Overall Study||0
2462693|NCT01002339|6037565|P3|COMPLETED|Overall Study||42
2462694|NCT01002339|6037566|P2|COMPLETED|Overall Study||42
2462695|NCT01002339|6037567|P1|COMPLETED|Overall Study||44
2462696|NCT01002339|6037565|P3|STARTED|Overall Study||47
2462697|NCT01002339|6037566|P2|STARTED|Overall Study||43
2462698|NCT01002339|6037567|P1|STARTED|Overall Study||44
2462699|NCT01002287|6037622|P2|NOT COMPLETED|Overall Study||0
2462700|NCT01002287|6037623|P1|NOT COMPLETED|Overall Study||0
2462701|NCT01002287|6037622|P2|COMPLETED|Overall Study||3
2462702|NCT01002287|6037623|P1|COMPLETED|Overall Study||8
2462703|NCT01002287|6037622|P2|STARTED|Overall Study||3
2462704|NCT01002287|6037623|P1|STARTED|Overall Study||8
2462705|NCT01002118|6037635|P1|NOT COMPLETED|Overall Study||0
2462706|NCT01002118|6037635|P1|COMPLETED|Overall Study||1
2462707|NCT01002118|6037635|P1|Randomized Only Patient|Overall Study||1
2462708|NCT01002118|6037635|P1|STARTED|Overall Study||1
2462709|NCT01002105|6037643|P2|NOT COMPLETED|Overall Study||21
2462710|NCT01002105|6037644|P1|NOT COMPLETED|Overall Study||19
2462711|NCT01002105|6037643|P2|COMPLETED|Overall Study||11
2462712|NCT01002105|6037644|P1|COMPLETED|Overall Study||13
2462713|NCT01002105|6037643|P2|STARTED|Overall Study||32
2462714|NCT01002105|6037644|P1|STARTED|Overall Study||32
2462715|NCT01001988|6037660|P1|NOT COMPLETED|Overall Study||117
2462716|NCT01001988|6037660|P1|COMPLETED|Overall Study||479
2462717|NCT01001988|6037660|P1|STARTED|Overall Study||596
2462718|NCT01001975|6037667|P2|NOT COMPLETED|Overall Study||0
2462719|NCT01001975|6037668|P1|NOT COMPLETED|Overall Study||0
2462720|NCT01001975|6037667|P2|COMPLETED|Overall Study||5
2462721|NCT01001975|6037668|P1|COMPLETED|Overall Study||5
2462722|NCT01001975|6037667|P2|STARTED|Overall Study||5
2462723|NCT01001975|6037668|P1|STARTED|Overall Study||5
2462724|NCT01001832|6037678|P2|NOT COMPLETED|Follow-up Period||21
2462725|NCT01001832|6037679|P1|NOT COMPLETED|Follow-up Period||18
2462726|NCT01001832|6037678|P2|COMPLETED|Follow-up Period||30
2462727|NCT01001832|6037679|P1|COMPLETED|Follow-up Period||34
2462728|NCT01001832|6037678|P2|STARTED|Follow-up Period||51
2462729|NCT01001832|6037679|P1|STARTED|Follow-up Period||52
2462730|NCT01001832|6037678|P2|NOT COMPLETED|Long-term Period||5
2462731|NCT01001832|6037679|P1|NOT COMPLETED|Long-term Period||4
2462732|NCT01001832|6037678|P2|COMPLETED|Long-term Period||51
2462733|NCT01001832|6037679|P1|COMPLETED|Long-term Period||52
2462734|NCT01001832|6037678|P2|STARTED|Long-term Period||56
2462735|NCT01001832|6037679|P1|STARTED|Long-term Period|1 participant completed the short term period but discontinued before start of the Long-term Period.|56
2462736|NCT01001832|6037678|P2|NOT COMPLETED|Short-term Period||3
2462737|NCT01001832|6037679|P1|NOT COMPLETED|Short-term Period||2
2462738|NCT01001832|6037678|P2|COMPLETED|Short-term Period||56
2462739|NCT01001832|6037679|P1|COMPLETED|Short-term Period||57
2462740|NCT01001832|6037678|P2|STARTED|Short-term Period||59
2462741|NCT01001832|6037679|P1|STARTED|Short-term Period||59
2462742|NCT01001806|6037725|P3|NOT COMPLETED|Overall Study||4
2462743|NCT01001806|6037726|P2|NOT COMPLETED|Overall Study||1
2462744|NCT01001806|6037727|P1|NOT COMPLETED|Overall Study||0
2462745|NCT01001806|6037725|P3|COMPLETED|Overall Study||38
2462746|NCT01001806|6037726|P2|COMPLETED|Overall Study||41
2462747|NCT01001806|6037727|P1|COMPLETED|Overall Study||42
2462748|NCT01001806|6037725|P3|STARTED|Overall Study||42
2462749|NCT01001806|6037726|P2|STARTED|Overall Study||42
2462750|NCT01001806|6037727|P1|STARTED|Overall Study||42
2462751|NCT01001767|6037737|P2|NOT COMPLETED|Overall Study||0
2462752|NCT01001767|6037738|P1|NOT COMPLETED|Overall Study||4
2462753|NCT01001767|6037737|P2|COMPLETED|Overall Study||17
2462754|NCT01001767|6037738|P1|COMPLETED|Overall Study||14
2462755|NCT01001767|6037737|P2|STARTED|Overall Study||17
2462756|NCT01001767|6037738|P1|STARTED|Overall Study||18
2462757|NCT01001702|6037744|P1|NOT COMPLETED|Overall Study||72
2462758|NCT01001702|6037744|P1|COMPLETED|Overall Study||13
2462759|NCT01001702|6037744|P1|STARTED|Overall Study||85
2462760|NCT01001598|6037755|P1|NOT COMPLETED|Overall Study||2
2462761|NCT01001598|6037755|P1|COMPLETED|Overall Study|3 completed study (2 FA and 1 DC) in 2011|3
2462762|NCT01001598|6037755|P1|STARTED|Overall Study||5
2462763|NCT01001572|6037763|P3|NOT COMPLETED|Double-Blind Treatment Phase||19
2462764|NCT01001572|6037764|P2|NOT COMPLETED|Double-Blind Treatment Phase||10
2462765|NCT01001572|6037765|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
2462766|NCT01001572|6037763|P3|COMPLETED|Double-Blind Treatment Phase||306
2462767|NCT01001572|6037764|P2|COMPLETED|Double-Blind Treatment Phase||319
2462768|NCT01001572|6037765|P1|COMPLETED|Double-Blind Treatment Phase||0
2462769|NCT01001572|6037763|P3|Full Analysis Set (FAS)|Double-Blind Treatment Phase|Two patients were excluded from full analysis set for having no post-baseline efficacy assessment.|323
2462770|NCT01001572|6037764|P2|Full Analysis Set (FAS)|Double-Blind Treatment Phase|One patient was excluded from full analysis set for having no post-baseline efficacy assessment.|328
2462771|NCT01001572|6037765|P1|Full Analysis Set (FAS)|Double-Blind Treatment Phase||0
2462772|NCT01001572|6037763|P3|STARTED|Double-Blind Treatment Phase||325
2462773|NCT01001572|6037764|P2|STARTED|Double-Blind Treatment Phase||329
2462774|NCT01001572|6037765|P1|STARTED|Double-Blind Treatment Phase|This arm is only used for single blind period. So, no enrollment during double blind period.|0
2462775|NCT01001572|6037763|P3|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
2462776|NCT01001572|6037764|P2|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
2462777|NCT01001572|6037765|P1|NOT COMPLETED|Single-Blind Valsartan 160 mg||278
2462778|NCT01001572|6037763|P3|COMPLETED|Single-Blind Valsartan 160 mg||0
2462779|NCT01001572|6037764|P2|COMPLETED|Single-Blind Valsartan 160 mg||0
2462780|NCT01001572|6037765|P1|COMPLETED|Single-Blind Valsartan 160 mg||654
2462781|NCT01001572|6037763|P3|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
2462782|NCT01001572|6037764|P2|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
2462783|NCT01001572|6037765|P1|STARTED|Single-Blind Valsartan 160 mg||932
2462784|NCT01001559|6037781|P2|NOT COMPLETED|Overall Study||0
2462785|NCT01001559|6037782|P1|NOT COMPLETED|Overall Study||0
2462786|NCT01001559|6037781|P2|COMPLETED|Overall Study||147
2462787|NCT01001559|6037782|P1|COMPLETED|Overall Study||95
2462788|NCT01001559|6037781|P2|STARTED|Overall Study||147
2462789|NCT01001559|6037782|P1|STARTED|Overall Study||95
2462790|NCT01001546|6037796|P2|NOT COMPLETED|Overall Study||0
2462791|NCT01001546|6037797|P1|NOT COMPLETED|Overall Study||0
2462792|NCT01001546|6037796|P2|COMPLETED|Overall Study||207
2462793|NCT01001546|6037797|P1|COMPLETED|Overall Study||206
2462794|NCT01001546|6037796|P2|STARTED|Overall Study||207
2462795|NCT01001546|6037797|P1|STARTED|Overall Study||206
2462796|NCT01001520|6037803|P2|NOT COMPLETED|Medication Period 2||3
2462797|NCT01001520|6037804|P1|NOT COMPLETED|Medication Period 2||0
2462798|NCT01001520|6037803|P2|COMPLETED|Medication Period 2||13
2462799|NCT01001520|6037804|P1|COMPLETED|Medication Period 2||16
2462800|NCT01001520|6037803|P2|STARTED|Medication Period 2||16
2462801|NCT01001520|6037804|P1|STARTED|Medication Period 2||16
2462802|NCT01001520|6037803|P2|NOT COMPLETED|Washout Period||1
2462803|NCT01001520|6037804|P1|NOT COMPLETED|Washout Period||2
2462804|NCT01001520|6037803|P2|COMPLETED|Washout Period||16
2462805|NCT01001520|6037804|P1|COMPLETED|Washout Period||16
2462806|NCT01001520|6037803|P2|STARTED|Washout Period||17
2462807|NCT01001520|6037804|P1|STARTED|Washout Period||18
2462808|NCT01001520|6037803|P2|NOT COMPLETED|Medication Period 1||7
2462809|NCT01001520|6037804|P1|NOT COMPLETED|Medication Period 1||4
2462810|NCT01001520|6037803|P2|COMPLETED|Medication Period 1||17
2462811|NCT01001520|6037804|P1|COMPLETED|Medication Period 1||18
2462812|NCT01001520|6037803|P2|STARTED|Medication Period 1||24
2462813|NCT01001520|6037804|P1|STARTED|Medication Period 1||22
2462814|NCT01001494|6037831|P3|NOT COMPLETED|Overall Study||41
2462815|NCT01001494|6037832|P2|NOT COMPLETED|Overall Study||17
2462816|NCT01001494|6037833|P1|NOT COMPLETED|Overall Study||24
2462817|NCT01001494|6037831|P3|COMPLETED|Overall Study||232
2462818|NCT01001494|6037832|P2|COMPLETED|Overall Study||252
2462819|NCT01001494|6037833|P1|COMPLETED|Overall Study||253
2462820|NCT01001494|6037831|P3|STARTED|Overall Study|276 patients were randomized, but baseline data was missing from 3 patients in one center|273
2462821|NCT01001494|6037832|P2|STARTED|Overall Study|272 patients were randomized, but baseline data was missing from 3 patients in one center|269
2462822|NCT01001494|6037833|P1|STARTED|Overall Study|280 patients were randomized, but baseline data was missing from 3 patients in one center|277
2462823|NCT01001442|6037861|P8|NOT COMPLETED|Overall Study||2
2462824|NCT01001442|6037862|P7|NOT COMPLETED|Overall Study||4
2462825|NCT01001442|6037863|P6|NOT COMPLETED|Overall Study||0
2462826|NCT01001442|6037864|P5|NOT COMPLETED|Overall Study||2
2462827|NCT01001442|6037865|P4|NOT COMPLETED|Overall Study||0
2462828|NCT01001442|6037866|P3|NOT COMPLETED|Overall Study||0
2462829|NCT01001442|6037867|P2|NOT COMPLETED|Overall Study||0
2462830|NCT01001442|6037868|P1|NOT COMPLETED|Overall Study||0
2462831|NCT01001442|6037861|P8|COMPLETED|Overall Study||2
2462832|NCT01001442|6037862|P7|COMPLETED|Overall Study||6
2462833|NCT01001442|6037863|P6|COMPLETED|Overall Study||3
2462834|NCT01001442|6037864|P5|COMPLETED|Overall Study||2
2462835|NCT01001442|6037865|P4|COMPLETED|Overall Study||3
2462836|NCT01001442|6037866|P3|COMPLETED|Overall Study||4
2462837|NCT01001442|6037867|P2|COMPLETED|Overall Study||3
2462838|NCT01001442|6037868|P1|COMPLETED|Overall Study||4
2462839|NCT01001442|6037861|P8|STARTED|Overall Study||4
2462840|NCT01001442|6037862|P7|STARTED|Overall Study||10
2462841|NCT01001442|6037863|P6|STARTED|Overall Study||3
2462842|NCT01001442|6037864|P5|STARTED|Overall Study||4
2462843|NCT01001442|6037865|P4|STARTED|Overall Study||3
2462844|NCT01001442|6037866|P3|STARTED|Overall Study||4
2462845|NCT01001442|6037867|P2|STARTED|Overall Study||3
2462846|NCT01001442|6037868|P1|STARTED|Overall Study||4
2462847|NCT01001429|6037918|P2|NOT COMPLETED|Overall Study||1
2462848|NCT01001429|6037919|P1|NOT COMPLETED|Overall Study||0
2462849|NCT01001429|6037918|P2|COMPLETED|Overall Study||37
2462850|NCT01001429|6037919|P1|COMPLETED|Overall Study||39
2462851|NCT01001429|6037918|P2|STARTED|Overall Study||38
2462852|NCT01001429|6037919|P1|STARTED|Overall Study||39
2462853|NCT01001403|6037951|P2|NOT COMPLETED|Overall Study||0
2462854|NCT01001403|6037952|P1|NOT COMPLETED|Overall Study||0
2462855|NCT01001403|6037951|P2|COMPLETED|Overall Study||31
2462856|NCT01001403|6037952|P1|COMPLETED|Overall Study||31
2462857|NCT01001403|6037951|P2|STARTED|Overall Study||31
2462858|NCT01001403|6037952|P1|STARTED|Overall Study||31
2462859|NCT01001390|6037958|P2|NOT COMPLETED|Overall Study||0
2462860|NCT01001390|6037959|P1|NOT COMPLETED|Overall Study||2
2462861|NCT01001390|6037958|P2|COMPLETED|Overall Study||0
2462862|NCT01001390|6037959|P1|COMPLETED|Overall Study||0
2462863|NCT01001390|6037958|P2|STARTED|Overall Study||0
2462864|NCT01001390|6037959|P1|STARTED|Overall Study||2
2462865|NCT01001377|6037967|P2|NOT COMPLETED|Overall Study||421
2462866|NCT01001377|6037968|P1|NOT COMPLETED|Overall Study||426
2462867|NCT01001377|6037967|P2|COMPLETED|Overall Study|Indicates participants continuing in study|85
2462868|NCT01001377|6037968|P1|COMPLETED|Overall Study|Indicates participants continuing in study|78
2462869|NCT01001377|6037967|P2|Received Treatment|Overall Study||499
2462870|NCT01001377|6037968|P1|Received Treatment|Overall Study||500
2462871|NCT01001377|6037967|P2|STARTED|Overall Study||506
2462872|NCT01001377|6037968|P1|STARTED|Overall Study||504
2462873|NCT01001325|6037998|P2|NOT COMPLETED|Overall Study||10
2462874|NCT01001325|6037999|P1|NOT COMPLETED|Overall Study||18
2462875|NCT01001325|6037998|P2|COMPLETED|Overall Study||224
2462876|NCT01001325|6037999|P1|COMPLETED|Overall Study||216
2462877|NCT01001325|6037998|P2|STARTED|Overall Study||234
2462878|NCT01001325|6037999|P1|STARTED|Overall Study||234
2462879|NCT01001299|6038005|P1|NOT COMPLETED|Overall Study||25
2462880|NCT01001299|6038005|P1|COMPLETED|Overall Study||0
2462881|NCT01001299|6038005|P1|STARTED|Overall Study||25
2462882|NCT01001234|6038034|P5|NOT COMPLETED|Overall Study||0
2462883|NCT01001234|6038035|P4|NOT COMPLETED|Overall Study||25
2462884|NCT01001234|6038036|P3|NOT COMPLETED|Overall Study||32
2462885|NCT01001234|6038037|P2|NOT COMPLETED|Overall Study||26
2462886|NCT01001234|6038038|P1|NOT COMPLETED|Overall Study||405
2462887|NCT01001234|6038034|P5|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|40
2462888|NCT01001234|6038035|P4|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|385
2462889|NCT01001234|6038036|P3|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|377
2462890|NCT01001234|6038037|P2|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|5
2462891|NCT01001234|6038038|P1|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|87
2462892|NCT01001234|6038034|P5|Participants Not Treated|Overall Study|Participants who did not take study drug|0
2462893|NCT01001234|6038035|P4|Participants Not Treated|Overall Study|Participants who did not take study drug|5
2462894|NCT01001234|6038036|P3|Participants Not Treated|Overall Study|Participants who did not take study drug|9
2462895|NCT01001234|6038037|P2|Participants Not Treated|Overall Study|Participants who did not take study drug|23
2462896|NCT01001234|6038038|P1|Participants Not Treated|Overall Study|Participants who did not take study drug|368
2462897|NCT01001234|6038034|P5|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|40
2462898|NCT01001234|6038035|P4|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|405
2462899|NCT01001234|6038036|P3|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|400
2462900|NCT01001234|6038037|P2|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|8
2462901|NCT01001234|6038038|P1|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|124
2462902|NCT01001234|6038034|P5|STARTED|Overall Study|Participants who were randomized to study drug|40
2462903|NCT01001234|6038035|P4|STARTED|Overall Study|Participants who were randomized to study drug|410
2462904|NCT01001234|6038036|P3|STARTED|Overall Study|Participants who were randomized to study drug|409
2462905|NCT01001234|6038037|P2|STARTED|Overall Study|Participants who were randomized to study drug|31
2462906|NCT01001234|6038038|P1|STARTED|Overall Study|Participants who were randomized to study drug|492
2462907|NCT01001221|6038054|P5|NOT COMPLETED|Overall Study||0
2462908|NCT01001221|6038055|P4|NOT COMPLETED|Overall Study||6
2462909|NCT01001221|6038056|P3|NOT COMPLETED|Overall Study||3
2462910|NCT01001221|6038057|P2|NOT COMPLETED|Overall Study||5
2462911|NCT01001221|6038058|P1|NOT COMPLETED|Overall Study||5
2462912|NCT01001221|6038054|P5|COMPLETED|Overall Study||0
2462913|NCT01001221|6038055|P4|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
2462914|NCT01001221|6038056|P3|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
2462915|NCT01001221|6038057|P2|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
2462916|NCT01001221|6038058|P1|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
2462917|NCT01001221|6038054|P5|Completed 1st Treatment Cycle|Overall Study||0
2462918|NCT01001221|6038055|P4|Completed 1st Treatment Cycle|Overall Study||6
2462919|NCT01001221|6038056|P3|Completed 1st Treatment Cycle|Overall Study||2
2462920|NCT01001221|6038057|P2|Completed 1st Treatment Cycle|Overall Study||5
2462921|NCT01001221|6038058|P1|Completed 1st Treatment Cycle|Overall Study||5
2462922|NCT01001221|6038054|P5|Treated|Overall Study||0
2462923|NCT01001221|6038055|P4|Treated|Overall Study||6
2462924|NCT01001221|6038056|P3|Treated|Overall Study||2
2462925|NCT01001221|6038057|P2|Treated|Overall Study||5
2462926|NCT01001221|6038058|P1|Treated|Overall Study||5
2462927|NCT01001221|6038054|P5|STARTED|Overall Study|Inability to determine the MTD during study part 1|0
2462928|NCT01001221|6038055|P4|STARTED|Overall Study||6
2462929|NCT01001221|6038056|P3|STARTED|Overall Study||3
2462930|NCT01001221|6038057|P2|STARTED|Overall Study||5
2462931|NCT01001221|6038058|P1|STARTED|Overall Study||5
2462932|NCT01001208|6038233|P2|NOT COMPLETED|Overall Study||33
2462933|NCT01001208|6038234|P1|NOT COMPLETED|Overall Study||28
2462934|NCT01001208|6038233|P2|COMPLETED|Overall Study||206
2462935|NCT01001208|6038234|P1|COMPLETED|Overall Study||211
2462936|NCT01001208|6038233|P2|STARTED|Overall Study||239
2462937|NCT01001208|6038234|P1|STARTED|Overall Study||239
2462938|NCT01001195|6038262|P4|NOT COMPLETED|Overall Study||0
2462939|NCT01001195|6038263|P3|NOT COMPLETED|Overall Study||0
2462940|NCT01001195|6038264|P2|NOT COMPLETED|Overall Study||2
2462941|NCT01001195|6038265|P1|NOT COMPLETED|Overall Study||2
2462942|NCT01001195|6038262|P4|COMPLETED|Overall Study||41
2462943|NCT01001195|6038263|P3|COMPLETED|Overall Study||44
2462944|NCT01001195|6038264|P2|COMPLETED|Overall Study||39
2462945|NCT01001195|6038265|P1|COMPLETED|Overall Study||37
2462946|NCT01001195|6038262|P4|STARTED|Overall Study||41
2462947|NCT01001195|6038263|P3|STARTED|Overall Study||44
2462948|NCT01001195|6038264|P2|STARTED|Overall Study||41
2462949|NCT01001195|6038265|P1|STARTED|Overall Study||39
2462950|NCT01001169|6038277|P2|NOT COMPLETED|Overall Study||1
2462951|NCT01001169|6038278|P1|NOT COMPLETED|Overall Study||2
2462952|NCT01001169|6038277|P2|COMPLETED|Overall Study||29
2462953|NCT01001169|6038278|P1|COMPLETED|Overall Study||28
2462954|NCT01001169|6038277|P2|STARTED|Overall Study||30
2462955|NCT01001169|6038278|P1|STARTED|Overall Study||30
2462956|NCT01001104|6038386|P4|NOT COMPLETED|Overall Study||3
2462957|NCT01001104|6038387|P3|NOT COMPLETED|Overall Study||1
2462958|NCT01001104|6038388|P2|NOT COMPLETED|Overall Study||1
2462959|NCT01001104|6038389|P1|NOT COMPLETED|Overall Study||2
2462960|NCT01001104|6038386|P4|COMPLETED|Overall Study||34
2462961|NCT01001104|6038387|P3|COMPLETED|Overall Study||35
2462962|NCT01001104|6038388|P2|COMPLETED|Overall Study||36
2462963|NCT01001104|6038389|P1|COMPLETED|Overall Study||33
2462964|NCT01001104|6038386|P4|STARTED|Overall Study||37
2462965|NCT01001104|6038387|P3|STARTED|Overall Study||36
2462966|NCT01001104|6038388|P2|STARTED|Overall Study||37
2462967|NCT01001104|6038389|P1|STARTED|Overall Study||35
2462968|NCT01001078|6038436|P2|NOT COMPLETED|Overall Study||0
2462969|NCT01001078|6038437|P1|NOT COMPLETED|Overall Study||0
2462970|NCT01001078|6038436|P2|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 2|50
2462971|NCT01001078|6038437|P1|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 5|50
2462972|NCT01001078|6038436|P2|Lost to Followup Interview|Overall Study|Could not be interviewed.|2
2462973|NCT01001078|6038437|P1|Lost to Followup Interview|Overall Study|Could not be interviewed.|5
2462974|NCT01001078|6038436|P2|Intubated|Overall Study||1
2462975|NCT01001078|6038437|P1|Intubated|Overall Study||2
2462976|NCT01001078|6038436|P2|Received Crossover|Overall Study||3
2462977|NCT01001078|6038437|P1|Received Crossover|Overall Study||2
2462978|NCT01001078|6038436|P2|Received Allocated Intervention|Overall Study||46
2462979|NCT01001078|6038437|P1|Received Allocated Intervention|Overall Study||46
2462980|NCT01001078|6038436|P2|STARTED|Overall Study||50
2462981|NCT01001078|6038437|P1|STARTED|Overall Study||50
2462982|NCT01001052|6038453|P2|NOT COMPLETED|Overall Study||0
2462983|NCT01001052|6038454|P1|NOT COMPLETED|Overall Study||0
2462984|NCT01001052|6038453|P2|COMPLETED|Overall Study||18
2462985|NCT01001052|6038454|P1|COMPLETED|Overall Study||20
2462986|NCT01001052|6038453|P2|STARTED|Overall Study||18
2462987|NCT01001052|6038454|P1|STARTED|Overall Study||20
2462988|NCT01000987|6038467|P3|NOT COMPLETED|Overall Study||0
2462989|NCT01000987|6038468|P2|NOT COMPLETED|Overall Study||0
2462990|NCT01000987|6038469|P1|NOT COMPLETED|Overall Study||0
2462991|NCT01000987|6038467|P3|COMPLETED|Overall Study||17
2462992|NCT01000987|6038468|P2|COMPLETED|Overall Study||15
2462993|NCT01000987|6038469|P1|COMPLETED|Overall Study||12
2462994|NCT01000987|6038467|P3|STARTED|Overall Study||17
2462995|NCT01000987|6038468|P2|STARTED|Overall Study||15
2462996|NCT01000987|6038469|P1|STARTED|Overall Study||12
2462997|NCT01000974|6038480|P3|NOT COMPLETED|Booster Vaccination Phase||14
2462998|NCT01000974|6038481|P2|NOT COMPLETED|Booster Vaccination Phase||12
2462999|NCT01000974|6038482|P1|NOT COMPLETED|Booster Vaccination Phase||67
2463000|NCT01000974|6038480|P3|COMPLETED|Booster Vaccination Phase||386
2463001|NCT01000974|6038481|P2|COMPLETED|Booster Vaccination Phase||423
2463002|NCT01000974|6038482|P1|COMPLETED|Booster Vaccination Phase||2270
2463003|NCT01000974|6038480|P3|STARTED|Booster Vaccination Phase||400
2463004|NCT01000974|6038481|P2|STARTED|Booster Vaccination Phase||435
2463005|NCT01000974|6038482|P1|STARTED|Booster Vaccination Phase||2337
2463006|NCT01000974|6038480|P3|NOT COMPLETED|Primary Vaccination Phase||63
2463007|NCT01000974|6038481|P2|NOT COMPLETED|Primary Vaccination Phase||50
2463008|NCT01000974|6038482|P1|NOT COMPLETED|Primary Vaccination Phase||338
2463009|NCT01000974|6038480|P3|COMPLETED|Primary Vaccination Phase||457
2463010|NCT01000974|6038481|P2|COMPLETED|Primary Vaccination Phase||470
2463011|NCT01000974|6038482|P1|COMPLETED|Primary Vaccination Phase||2625
2463012|NCT01000974|6038480|P3|STARTED|Primary Vaccination Phase||520
2463013|NCT01000974|6038481|P2|STARTED|Primary Vaccination Phase||520
2463014|NCT01000974|6038482|P1|STARTED|Primary Vaccination Phase||2963
2463015|NCT01000961|6038589|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
2463016|NCT01000961|6038590|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
2463017|NCT01000961|6038589|P2|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|20
2463018|NCT01000961|6038590|P1|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|21
2463019|NCT01000961|6038589|P2|STARTED|Second Intervention (3 Weeks)||20
2463020|NCT01000961|6038590|P1|STARTED|Second Intervention (3 Weeks)||21
2463021|NCT01000961|6038589|P2|NOT COMPLETED|First Intervention (3 Weeks)||2
2463022|NCT01000961|6038590|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
2463023|NCT01000961|6038589|P2|COMPLETED|First Intervention (3 Weeks)||20
2463024|NCT01000961|6038590|P1|COMPLETED|First Intervention (3 Weeks)||21
2463025|NCT01000961|6038589|P2|STARTED|First Intervention (3 Weeks)||22
2463026|NCT01000961|6038590|P1|STARTED|First Intervention (3 Weeks)||21
2463027|NCT01000961|6038589|P2|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
2463028|NCT01000961|6038590|P1|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
2463029|NCT01000961|6038589|P2|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||22
2463030|NCT01000961|6038590|P1|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||21
2463031|NCT01000961|6038589|P2|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|22
2463032|NCT01000961|6038590|P1|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|21
2463033|NCT01000818|6038602|P1|NOT COMPLETED|Omeprazole + Raltegravir||0
2463034|NCT01000818|6038602|P1|COMPLETED|Omeprazole + Raltegravir||18
2463035|NCT01000818|6038602|P1|STARTED|Omeprazole + Raltegravir||18
2463036|NCT01000818|6038602|P1|NOT COMPLETED|Famotidine + Raltegravir||0
2463037|NCT01000818|6038602|P1|COMPLETED|Famotidine + Raltegravir||18
2463038|NCT01000818|6038602|P1|STARTED|Famotidine + Raltegravir||18
2463039|NCT01000818|6038602|P1|NOT COMPLETED|Raltegravir||0
2463040|NCT01000818|6038602|P1|COMPLETED|Raltegravir||18
2463041|NCT01000818|6038602|P1|STARTED|Raltegravir||18
2463042|NCT01000805|6038613|P2|NOT COMPLETED|Overall Study||62
2463043|NCT01000805|6038614|P1|NOT COMPLETED|Overall Study||70
2463044|NCT01000805|6038613|P2|COMPLETED|Overall Study||204
2463045|NCT01000805|6038614|P1|COMPLETED|Overall Study||192
2463046|NCT01000805|6038613|P2|STARTED|Overall Study||266
2463047|NCT01000805|6038614|P1|STARTED|Overall Study||262
2463048|NCT01000727|6038648|P2|NOT COMPLETED|Overall Study||176
2463049|NCT01000727|6038649|P1|NOT COMPLETED|Overall Study||175
2463050|NCT01000727|6038648|P2|COMPLETED|Overall Study||6328
2463051|NCT01000727|6038649|P1|COMPLETED|Overall Study||6347
2463052|NCT01000727|6038648|P2|STARTED|Overall Study||6504
2463053|NCT01000727|6038649|P1|STARTED|Overall Study||6522
2463054|NCT01000662|6038679|P2|NOT COMPLETED|Overall Study||8
2463055|NCT01000662|6038680|P1|NOT COMPLETED|Overall Study||4
2463056|NCT01000662|6038679|P2|COMPLETED|Overall Study||198
2463057|NCT01000662|6038680|P1|COMPLETED|Overall Study||202
2463058|NCT01000662|6038679|P2|STARTED|Overall Study||206
2463059|NCT01000662|6038680|P1|STARTED|Overall Study||206
2463060|NCT01000649|6038690|P4|NOT COMPLETED|Overall Study||6
2463061|NCT01000649|6038691|P3|NOT COMPLETED|Overall Study||2
2463062|NCT01000649|6038692|P2|NOT COMPLETED|Overall Study||3
2463063|NCT01000649|6038693|P1|NOT COMPLETED|Overall Study||5
2463064|NCT01000649|6038690|P4|COMPLETED|Overall Study||15
2463065|NCT01000649|6038691|P3|COMPLETED|Overall Study||0
2463066|NCT01000649|6038692|P2|COMPLETED|Overall Study||16
2463067|NCT01000649|6038693|P1|COMPLETED|Overall Study||5
2463068|NCT01000649|6038690|P4|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|21
2463069|NCT01000649|6038691|P3|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|2
2463070|NCT01000649|6038692|P2|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|20
2463071|NCT01000649|6038693|P1|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|10
2463072|NCT01000649|6038690|P4|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|21
2463073|NCT01000649|6038691|P3|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|2
2463074|NCT01000649|6038692|P2|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|19
2463075|NCT01000649|6038693|P1|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|10
2463076|NCT01000610|6038774|P1|NOT COMPLETED|Overall Study||6
2463077|NCT01000610|6038774|P1|COMPLETED|Overall Study||12
2463078|NCT01000610|6038774|P1|STARTED|Overall Study||18
2463079|NCT01000506|6038785|P4|NOT COMPLETED|Overall Study||23
2463080|NCT01000506|6038786|P3|NOT COMPLETED|Overall Study||21
2463081|NCT01000506|6038787|P2|NOT COMPLETED|Overall Study||24
2463082|NCT01000506|6038788|P1|NOT COMPLETED|Overall Study||28
2463083|NCT01000506|6038785|P4|COMPLETED|Overall Study||133
2463084|NCT01000506|6038786|P3|COMPLETED|Overall Study||131
2463085|NCT01000506|6038787|P2|COMPLETED|Overall Study||129
2463086|NCT01000506|6038788|P1|COMPLETED|Overall Study||127
2463087|NCT01000506|6038785|P4|STARTED|Overall Study||156
2463088|NCT01000506|6038786|P3|STARTED|Overall Study||152
2463089|NCT01000506|6038787|P2|STARTED|Overall Study||153
2463090|NCT01000506|6038788|P1|STARTED|Overall Study||155
2463091|NCT01000493|6038832|P2|NOT COMPLETED|Overall Study||55
2463092|NCT01000493|6038833|P1|NOT COMPLETED|Overall Study||39
2463093|NCT01000493|6038832|P2|COMPLETED|Overall Study||14
2463094|NCT01000493|6038833|P1|COMPLETED|Overall Study||21
2463095|NCT01000493|6038832|P2|STARTED|Overall Study||69
2463096|NCT01000493|6038833|P1|STARTED|Overall Study||60
2463097|NCT01000480|6038883|P1|NOT COMPLETED|Follow-Up Period||0
2463098|NCT01000480|6038883|P1|COMPLETED|Follow-Up Period||88
2463099|NCT01000480|6038883|P1|STARTED|Follow-Up Period|One pt lost to follow-up during induction, 1 pt died in concurrent therapy, both not enter follow-up|88
2463100|NCT01000480|6038883|P1|NOT COMPLETED|Concurrent Therapy Phase||10
2463101|NCT01000480|6038883|P1|COMPLETED|Concurrent Therapy Phase||65
2463102|NCT01000480|6038883|P1|Death (Any Cause) or Disease Progression|Concurrent Therapy Phase|Pts who died (any cause) or had disease progression considered to have completed the phase.|1
2463103|NCT01000480|6038883|P1|STARTED|Concurrent Therapy Phase|Eight participants (pts) who completed Induction Phase, not eligible for Concurrent Therapy Phase.|75
2463104|NCT01000480|6038883|P1|NOT COMPLETED|Induction Phase||7
2463105|NCT01000480|6038883|P1|COMPLETED|Induction Phase||83
2463106|NCT01000480|6038883|P1|Death (Any Cause) or Disease Progression|Induction Phase|Participants who died (any cause) or had disease progression considered to have completed phase.|8
2463107|NCT01000480|6038883|P1|Received at Least 1 Dose of Either Drug|Induction Phase||90
2463108|NCT01000480|6038883|P1|STARTED|Induction Phase||90
2463109|NCT01000376|6038891|P2|NOT COMPLETED|Cycle 1 Day 15||0
2463110|NCT01000376|6038892|P1|NOT COMPLETED|Cycle 1 Day 15||0
2463111|NCT01000376|6038891|P2|COMPLETED|Cycle 1 Day 15||6
2463112|NCT01000376|6038892|P1|COMPLETED|Cycle 1 Day 15||4
2463113|NCT01000376|6038891|P2|STARTED|Cycle 1 Day 15||6
2463114|NCT01000376|6038892|P1|STARTED|Cycle 1 Day 15||4
2463115|NCT01000376|6038891|P2|NOT COMPLETED|Cycle 1 Day 1||0
2463116|NCT01000376|6038892|P1|NOT COMPLETED|Cycle 1 Day 1||2
2463117|NCT01000376|6038891|P2|COMPLETED|Cycle 1 Day 1||6
2463118|NCT01000376|6038892|P1|COMPLETED|Cycle 1 Day 1||4
2463119|NCT01000376|6038891|P2|STARTED|Cycle 1 Day 1||6
2463120|NCT01000376|6038892|P1|STARTED|Cycle 1 Day 1||6
2463121|NCT01000337|6038902|P2|NOT COMPLETED|Overall Study||3
2463122|NCT01000337|6038903|P1|NOT COMPLETED|Overall Study||4
2463123|NCT01000337|6038902|P2|COMPLETED|Overall Study||30
2463124|NCT01000337|6038903|P1|COMPLETED|Overall Study||30
2463125|NCT01000337|6038902|P2|STARTED|Overall Study||33
2463126|NCT01000337|6038903|P1|STARTED|Overall Study||34
2463127|NCT01000324|6038909|P1|NOT COMPLETED|Year 20||0
2463128|NCT01000324|6038909|P1|COMPLETED|Year 20||28
2463129|NCT01000324|6038909|P1|STARTED|Year 20||28
2463130|NCT01000324|6038909|P1|NOT COMPLETED|Year 19||0
2463131|NCT01000324|6038909|P1|COMPLETED|Year 19||28
2463132|NCT01000324|6038909|P1|STARTED|Year 19||28
2463133|NCT01000324|6038909|P1|NOT COMPLETED|Year 18||0
2463134|NCT01000324|6038909|P1|COMPLETED|Year 18||29
2463135|NCT01000324|6038909|P1|STARTED|Year 18||29
2463136|NCT01000324|6038909|P1|NOT COMPLETED|Year 17||0
2463137|NCT01000324|6038909|P1|COMPLETED|Year 17||32
2463138|NCT01000324|6038909|P1|STARTED|Year 17||32
2463139|NCT01000324|6038909|P1|NOT COMPLETED|Year 16||0
2463140|NCT01000324|6038909|P1|COMPLETED|Year 16||40
2463141|NCT01000324|6038909|P1|STARTED|Year 16||40
2463142|NCT01000311|6038921|P2|NOT COMPLETED|Overall Study||70
2463143|NCT01000311|6038922|P1|NOT COMPLETED|Overall Study||45
2463144|NCT01000311|6038921|P2|COMPLETED|Overall Study||201
2463145|NCT01000311|6038922|P1|COMPLETED|Overall Study||213
2463146|NCT01000311|6038921|P2|STARTED|Overall Study||271
2463147|NCT01000311|6038922|P1|STARTED|Overall Study||258
2463148|NCT01000285|6038952|P1|NOT COMPLETED|Overall Study||0
2463149|NCT01000285|6038952|P1|COMPLETED|Overall Study||18
2463150|NCT01000285|6038952|P1|STARTED|Overall Study||18
2463151|NCT01000155|6038972|P1|NOT COMPLETED|Overall Study||2
2463152|NCT01000155|6038972|P1|COMPLETED|Overall Study||3
2463153|NCT01000155|6038972|P1|STARTED|Overall Study||5
2463154|NCT01000064|6038978|P2|NOT COMPLETED|Overall Study||1
2463155|NCT01000064|6038979|P1|NOT COMPLETED|Overall Study||1
2463156|NCT01000064|6038978|P2|COMPLETED|Overall Study||5
2463157|NCT01000064|6038979|P1|COMPLETED|Overall Study||6
2463158|NCT01000064|6038978|P2|STARTED|Overall Study||6
2463159|NCT01000064|6038979|P1|STARTED|Overall Study||7
2463160|NCT01000051|6039002|P2|NOT COMPLETED|Overall Study||1
2463161|NCT01000051|6039003|P1|NOT COMPLETED|Overall Study||3
2463162|NCT01000051|6039002|P2|COMPLETED|Overall Study||17
2463163|NCT01000051|6039003|P1|COMPLETED|Overall Study||39
2463164|NCT01000051|6039002|P2|STARTED|Overall Study||18
2463165|NCT01000051|6039003|P1|STARTED|Overall Study||42
2463166|NCT01000025|6039011|P2|NOT COMPLETED|Overall Study||238
2463167|NCT01000025|6039012|P1|NOT COMPLETED|Overall Study||468
2463168|NCT01000025|6039011|P2|COMPLETED|Overall Study||2
2463169|NCT01000025|6039012|P1|COMPLETED|Overall Study||12
2463170|NCT01000025|6039011|P2|STARTED|Overall Study||240
2463171|NCT01000025|6039012|P1|STARTED|Overall Study||480
2463172|NCT00999921|6039030|P2|NOT COMPLETED|Overall Study||19
2463173|NCT00999921|6039031|P1|NOT COMPLETED|Overall Study||10
2463174|NCT00999921|6039030|P2|COMPLETED|Overall Study||110
2463175|NCT00999921|6039031|P1|COMPLETED|Overall Study||117
2463176|NCT00999921|6039030|P2|STARTED|Overall Study||129
2463177|NCT00999921|6039031|P1|STARTED|Overall Study||127
2463178|NCT00999908|6039041|P3|NOT COMPLETED|Treatment Period 3||0
2463179|NCT00999908|6039042|P2|NOT COMPLETED|Treatment Period 3||0
2463180|NCT00999908|6039043|P1|NOT COMPLETED|Treatment Period 3||0
2463181|NCT00999908|6039041|P3|COMPLETED|Treatment Period 3||19
2463182|NCT00999908|6039042|P2|COMPLETED|Treatment Period 3||16
2463183|NCT00999908|6039043|P1|COMPLETED|Treatment Period 3||16
2463184|NCT00999908|6039041|P3|STARTED|Treatment Period 3||19
2463185|NCT00999908|6039042|P2|STARTED|Treatment Period 3||16
2463186|NCT00999908|6039043|P1|STARTED|Treatment Period 3||16
2463187|NCT00999908|6039041|P3|NOT COMPLETED|Treatment Period 2||0
2463188|NCT00999908|6039042|P2|NOT COMPLETED|Treatment Period 2||0
2463189|NCT00999908|6039043|P1|NOT COMPLETED|Treatment Period 2||1
2463190|NCT00999908|6039041|P3|COMPLETED|Treatment Period 2||19
2463191|NCT00999908|6039042|P2|COMPLETED|Treatment Period 2||16
2463192|NCT00999908|6039043|P1|COMPLETED|Treatment Period 2||16
2463193|NCT00999908|6039041|P3|STARTED|Treatment Period 2||19
2463194|NCT00999908|6039042|P2|STARTED|Treatment Period 2||16
2463195|NCT00999908|6039043|P1|STARTED|Treatment Period 2||17
2463196|NCT00999908|6039041|P3|NOT COMPLETED|Treatment Period 1||0
2463197|NCT00999908|6039042|P2|NOT COMPLETED|Treatment Period 1||0
2463198|NCT00999908|6039043|P1|NOT COMPLETED|Treatment Period 1||2
2463199|NCT00999908|6039041|P3|COMPLETED|Treatment Period 1||19
2463200|NCT00999908|6039042|P2|COMPLETED|Treatment Period 1||16
2463201|NCT00999908|6039043|P1|COMPLETED|Treatment Period 1||17
2463202|NCT00999908|6039041|P3|STARTED|Treatment Period 1||19
2463203|NCT00999908|6039042|P2|STARTED|Treatment Period 1||16
2463204|NCT00999908|6039043|P1|STARTED|Treatment Period 1||19
2463205|NCT00999830|6039059|P2|NOT COMPLETED|Overall Study||0
2463206|NCT00999830|6039060|P1|NOT COMPLETED|Overall Study||0
2463207|NCT00999830|6039059|P2|COMPLETED|Overall Study||13
2463208|NCT00999830|6039060|P1|COMPLETED|Overall Study||14
2463209|NCT00999830|6039059|P2|STARTED|Overall Study||13
2463210|NCT00999830|6039060|P1|STARTED|Overall Study||14
2463211|NCT00999804|6039072|P2|NOT COMPLETED|Overall Study||5
2463212|NCT00999804|6039073|P1|NOT COMPLETED|Overall Study||21
2463213|NCT00999804|6039072|P2|COMPLETED|Overall Study||38
2463214|NCT00999804|6039073|P1|COMPLETED|Overall Study||64
2463215|NCT00999804|6039072|P2|STARTED|Overall Study||43
2463216|NCT00999804|6039073|P1|STARTED|Overall Study||85
2463217|NCT00999713|6039087|P2|NOT COMPLETED|Overall Study||0
2463218|NCT00999713|6039088|P1|NOT COMPLETED|Overall Study||2
2463219|NCT00999713|6039087|P2|COMPLETED|Overall Study||17
2463220|NCT00999713|6039088|P1|COMPLETED|Overall Study||24
2463221|NCT00999713|6039087|P2|STARTED|Overall Study||17
2463222|NCT00999713|6039088|P1|STARTED|Overall Study||26
2463223|NCT00999687|6039102|P1|NOT COMPLETED|Second Intervention||3
2463224|NCT00999687|6039102|P1|COMPLETED|Second Intervention||27
2463225|NCT00999687|6039102|P1|STARTED|Second Intervention|From week 13 to 24, all participants applied INOE to both hands twice daily.|30
2463226|NCT00999687|6039102|P1|NOT COMPLETED|First Intervention||1
2463227|NCT00999687|6039102|P1|COMPLETED|First Intervention||30
2463228|NCT00999687|6039102|P1|STARTED|First Intervention|16 used the INOE on the right hand,15 used the INOE on the left hand.|31
2463229|NCT00999661|6039109|P1|NOT COMPLETED|Overall Study||70
2463230|NCT00999661|6039109|P1|COMPLETED|Overall Study||161
2463231|NCT00999661|6039109|P1|STARTED|Overall Study||231
2463232|NCT00999609|6039117|P2|NOT COMPLETED|Overall Study||1
2463233|NCT00999609|6039118|P1|NOT COMPLETED|Overall Study||1
2463234|NCT00999609|6039117|P2|COMPLETED|Overall Study|1 year post intervention|9
2463235|NCT00999609|6039118|P1|COMPLETED|Overall Study|1 year post intervention|20
2463236|NCT00999609|6039117|P2|STARTED|Overall Study||10
2463237|NCT00999609|6039118|P1|STARTED|Overall Study|Before intervention|21
2463238|NCT00999596|6039130|P1|NOT COMPLETED|Overall Study||101
2463239|NCT00999596|6039130|P1|COMPLETED|Overall Study|Not all patient images were used for the reader evaluation based on new FDA Guidelines|6
2463240|NCT00999596|6039130|P1|New FDA Guideline Released|Overall Study|FDA Guidance: Class II Special Controls Guidance Document: Full-Field Digital Mammography System|6
2463241|NCT00999596|6039130|P1|STARTED|Overall Study||107
2463242|NCT00999544|6039135|P1|NOT COMPLETED|Overall Study||1
2463243|NCT00999544|6039135|P1|COMPLETED|Overall Study||8
2463244|NCT00999544|6039135|P1|STARTED|Overall Study||9
2463245|NCT00999466|6039171|P3|NOT COMPLETED|Main Part||4
2463246|NCT00999466|6039172|P2|NOT COMPLETED|Main Part||4
2463247|NCT00999466|6039173|P1|NOT COMPLETED|Main Part||0
2463248|NCT00999466|6039171|P3|COMPLETED|Main Part||21
2463249|NCT00999466|6039172|P2|COMPLETED|Main Part||22
2463250|NCT00999466|6039173|P1|COMPLETED|Main Part||0
2463251|NCT00999466|6039171|P3|STARTED|Main Part||25
2463252|NCT00999466|6039172|P2|STARTED|Main Part||26
2463253|NCT00999466|6039173|P1|STARTED|Main Part|AZD8848 nasal spray 30 μg group was not participated in the Main part|0
2463254|NCT00999466|6039171|P3|NOT COMPLETED|Pilot Part||0
2463255|NCT00999466|6039172|P2|NOT COMPLETED|Pilot Part||0
2463256|NCT00999466|6039173|P1|NOT COMPLETED|Pilot Part||0
2463257|NCT00999466|6039171|P3|COMPLETED|Pilot Part||3
2463258|NCT00999466|6039172|P2|COMPLETED|Pilot Part||0
2463259|NCT00999466|6039173|P1|COMPLETED|Pilot Part||6
2463260|NCT00999466|6039171|P3|STARTED|Pilot Part||3
2463261|NCT00999466|6039172|P2|STARTED|Pilot Part|AZD8848 nasal spray 60 μg group was not participated in the Pilot part|0
2463262|NCT00999466|6039173|P1|STARTED|Pilot Part||6
2463263|NCT00999167|6039450|P3|NOT COMPLETED|Part B: Randomized, Placebo Controlled||21
2463264|NCT00999167|6039451|P2|NOT COMPLETED|Part B: Randomized, Placebo Controlled||35
2463265|NCT00999167|6039452|P1|NOT COMPLETED|Part B: Randomized, Placebo Controlled||0
2463266|NCT00999167|6039450|P3|COMPLETED|Part B: Randomized, Placebo Controlled||67
2463267|NCT00999167|6039451|P2|COMPLETED|Part B: Randomized, Placebo Controlled||55
2463268|NCT00999167|6039452|P1|COMPLETED|Part B: Randomized, Placebo Controlled||0
2463269|NCT00999167|6039450|P3|STARTED|Part B: Randomized, Placebo Controlled||88
2463270|NCT00999167|6039451|P2|STARTED|Part B: Randomized, Placebo Controlled|4 subjects who participated in Part A enrolled in Part B and remainder were newly enrolled|90
2463271|NCT00999167|6039452|P1|STARTED|Part B: Randomized, Placebo Controlled||0
2463272|NCT00999167|6039450|P3|NOT COMPLETED|Part A: Open Label Safety run-in||0
2463273|NCT00999167|6039451|P2|NOT COMPLETED|Part A: Open Label Safety run-in||0
2463274|NCT00999167|6039452|P1|NOT COMPLETED|Part A: Open Label Safety run-in||7
2463275|NCT00999167|6039450|P3|COMPLETED|Part A: Open Label Safety run-in||0
2463276|NCT00999167|6039451|P2|COMPLETED|Part A: Open Label Safety run-in||0
2463277|NCT00999167|6039452|P1|COMPLETED|Part A: Open Label Safety run-in||8
2463278|NCT00999167|6039450|P3|Received 9 mL BID|Part A: Open Label Safety run-in||0
2463279|NCT00999167|6039451|P2|Received 9 mL BID|Part A: Open Label Safety run-in||0
2463280|NCT00999167|6039452|P1|Received 9 mL BID|Part A: Open Label Safety run-in||15
2463281|NCT00999167|6039450|P3|STARTED|Part A: Open Label Safety run-in||0
2463282|NCT00999167|6039451|P2|STARTED|Part A: Open Label Safety run-in||0
2463283|NCT00999167|6039452|P1|STARTED|Part A: Open Label Safety run-in||15
2463284|NCT00999141|6039466|P1|NOT COMPLETED|Overall Study||0
2463285|NCT00999141|6039466|P1|COMPLETED|Overall Study||75
2463286|NCT00999141|6039466|P1|STARTED|Overall Study|Randomized and treated|75
2463287|NCT00999102|6039548|P2|NOT COMPLETED|4 Weeks at Higher Dose of Second Drug||0
2463288|NCT00999102|6039549|P1|NOT COMPLETED|4 Weeks at Higher Dose of Second Drug||0
2463289|NCT00999102|6039548|P2|COMPLETED|4 Weeks at Higher Dose of Second Drug||16
2463290|NCT00999102|6039549|P1|COMPLETED|4 Weeks at Higher Dose of Second Drug||15
2463291|NCT00999102|6039548|P2|STARTED|4 Weeks at Higher Dose of Second Drug||16
2463292|NCT00999102|6039549|P1|STARTED|4 Weeks at Higher Dose of Second Drug||15
2463293|NCT00999102|6039548|P2|NOT COMPLETED|4 Weeks at Lower Dose of Second Drug||0
2463294|NCT00999102|6039549|P1|NOT COMPLETED|4 Weeks at Lower Dose of Second Drug||0
2463295|NCT00999102|6039548|P2|COMPLETED|4 Weeks at Lower Dose of Second Drug||16
2463296|NCT00999102|6039549|P1|COMPLETED|4 Weeks at Lower Dose of Second Drug||15
2463297|NCT00999102|6039548|P2|STARTED|4 Weeks at Lower Dose of Second Drug||16
2463298|NCT00999102|6039549|P1|STARTED|4 Weeks at Lower Dose of Second Drug||15
2463299|NCT00999102|6039548|P2|NOT COMPLETED|4 Weeks at Higher Dose of First Drug||0
2463300|NCT00999102|6039549|P1|NOT COMPLETED|4 Weeks at Higher Dose of First Drug||0
2463301|NCT00999102|6039548|P2|COMPLETED|4 Weeks at Higher Dose of First Drug||16
2463302|NCT00999102|6039549|P1|COMPLETED|4 Weeks at Higher Dose of First Drug||15
2463303|NCT00999102|6039548|P2|STARTED|4 Weeks at Higher Dose of First Drug||16
2463304|NCT00999102|6039549|P1|STARTED|4 Weeks at Higher Dose of First Drug||15
2463305|NCT00999102|6039548|P2|NOT COMPLETED|4 Weeks at Lower Dose of First Drug||1
2463306|NCT00999102|6039549|P1|NOT COMPLETED|4 Weeks at Lower Dose of First Drug||1
2463307|NCT00999102|6039548|P2|COMPLETED|4 Weeks at Lower Dose of First Drug||16
2463308|NCT00999102|6039549|P1|COMPLETED|4 Weeks at Lower Dose of First Drug||15
2463309|NCT00999102|6039548|P2|STARTED|4 Weeks at Lower Dose of First Drug||17
2463310|NCT00999102|6039549|P1|STARTED|4 Weeks at Lower Dose of First Drug||16
2463311|NCT00999037|6039565|P2|NOT COMPLETED|Overall Study||0
2463312|NCT00999037|6039566|P1|NOT COMPLETED|Overall Study||0
2463313|NCT00999037|6039565|P2|COMPLETED|Overall Study||9
2463314|NCT00999037|6039566|P1|COMPLETED|Overall Study||9
2463315|NCT00999037|6039565|P2|STARTED|Overall Study|20|9
2463316|NCT00999037|6039566|P1|STARTED|Overall Study||9
2463317|NCT00998985|6039590|P14|NOT COMPLETED|Overall Study||0
2463318|NCT00998985|6039591|P13|NOT COMPLETED|Overall Study||0
2463319|NCT00998985|6039592|P12|NOT COMPLETED|Overall Study||0
2463320|NCT00998985|6039593|P11|NOT COMPLETED|Overall Study||0
2463321|NCT00998985|6039594|P10|NOT COMPLETED|Overall Study||0
2463322|NCT00998985|6039595|P9|NOT COMPLETED|Overall Study||1
2463323|NCT00998985|6039596|P8|NOT COMPLETED|Overall Study||0
2463324|NCT00998985|6039597|P7|NOT COMPLETED|Overall Study||0
2463325|NCT00998985|6039598|P6|NOT COMPLETED|Overall Study||1
2463326|NCT00998985|6039599|P5|NOT COMPLETED|Overall Study||0
2463327|NCT00998985|6039600|P4|NOT COMPLETED|Overall Study||0
2463328|NCT00998985|6039601|P3|NOT COMPLETED|Overall Study||0
2463329|NCT00998985|6039602|P2|NOT COMPLETED|Overall Study||0
2463330|NCT00998985|6039603|P1|NOT COMPLETED|Overall Study||0
2463331|NCT00998985|6039590|P14|COMPLETED|Overall Study||15
2463332|NCT00998985|6039591|P13|COMPLETED|Overall Study||5
2463333|NCT00998985|6039592|P12|COMPLETED|Overall Study||5
2463334|NCT00998985|6039593|P11|COMPLETED|Overall Study||5
2463335|NCT00998985|6039594|P10|COMPLETED|Overall Study||5
2463336|NCT00998985|6039595|P9|COMPLETED|Overall Study||5
2463337|NCT00998985|6039596|P8|COMPLETED|Overall Study||5
2463338|NCT00998985|6039597|P7|COMPLETED|Overall Study||5
2463339|NCT00998985|6039598|P6|COMPLETED|Overall Study||4
2463340|NCT00998985|6039599|P5|COMPLETED|Overall Study||5
2463341|NCT00998985|6039600|P4|COMPLETED|Overall Study||5
2463342|NCT00998985|6039601|P3|COMPLETED|Overall Study||15
2463343|NCT00998985|6039602|P2|COMPLETED|Overall Study||5
2463344|NCT00998985|6039603|P1|COMPLETED|Overall Study||5
2463345|NCT00998985|6039590|P14|STARTED|Overall Study||15
2463346|NCT00998985|6039591|P13|STARTED|Overall Study||5
2463347|NCT00998985|6039592|P12|STARTED|Overall Study||5
2463348|NCT00998985|6039593|P11|STARTED|Overall Study||5
2463349|NCT00998985|6039594|P10|STARTED|Overall Study||5
2463350|NCT00998985|6039595|P9|STARTED|Overall Study||6
2463351|NCT00998985|6039596|P8|STARTED|Overall Study||5
2463352|NCT00998985|6039597|P7|STARTED|Overall Study||5
2463353|NCT00998985|6039598|P6|STARTED|Overall Study||5
2463354|NCT00998985|6039599|P5|STARTED|Overall Study||5
2463355|NCT00998985|6039600|P4|STARTED|Overall Study||5
2463356|NCT00998985|6039601|P3|STARTED|Overall Study||15
2463357|NCT00998985|6039602|P2|STARTED|Overall Study||5
2463358|NCT00998985|6039603|P1|STARTED|Overall Study||5
2463359|NCT00998881|6039671|P2|NOT COMPLETED|Overall Study||2
2463360|NCT00998881|6039672|P1|NOT COMPLETED|Overall Study||8
2463361|NCT00998881|6039671|P2|COMPLETED|Overall Study||97
2463362|NCT00998881|6039672|P1|COMPLETED|Overall Study||96
2463363|NCT00998881|6039671|P2|STARTED|Overall Study||99
2463364|NCT00998881|6039672|P1|STARTED|Overall Study||104
2463365|NCT00998868|6039684|P1|NOT COMPLETED|Overall Study||0
2463366|NCT00998868|6039684|P1|COMPLETED|Overall Study||51
2463367|NCT00998868|6039684|P1|STARTED|Overall Study|>=10 for each muscle strength per MRC scale, after excluding the cases following exclusion criteria|51
2463368|NCT00998790|6039691|P1|NOT COMPLETED|Overall Study||21
2463369|NCT00998790|6039691|P1|COMPLETED|Overall Study||93
2463370|NCT00998790|6039691|P1|Participants Who Were Treated|Overall Study||113
2463371|NCT00998790|6039691|P1|STARTED|Overall Study||114
2463372|NCT00998764|6039701|P2|NOT COMPLETED|Overall Study||274
2463373|NCT00998764|6039702|P1|NOT COMPLETED|Overall Study||216
2463374|NCT00998764|6039701|P2|COMPLETED|Overall Study||2
2463375|NCT00998764|6039702|P1|COMPLETED|Overall Study||0
2463376|NCT00998764|6039701|P2|Treated|Overall Study||275
2463377|NCT00998764|6039702|P1|Treated|Overall Study||215
2463378|NCT00998764|6039701|P2|STARTED|Overall Study||276
2463379|NCT00998764|6039702|P1|STARTED|Overall Study||216
2463380|NCT00998738|6039724|P1|NOT COMPLETED|Overall Study||1
2463381|NCT00998738|6039724|P1|COMPLETED|Overall Study||0
2463382|NCT00998738|6039724|P1|STARTED|Overall Study||1
2463383|NCT00998660|6039739|P1|NOT COMPLETED|Overall Study||13
2463384|NCT00998660|6039739|P1|COMPLETED|Overall Study|87 subjects reached the final study visit at Month 6.|87
2463385|NCT00998660|6039739|P1|Month 3 Visit|Overall Study||87
2463386|NCT00998660|6039739|P1|Implanted|Overall Study||93
2463387|NCT00998660|6039739|P1|STARTED|Overall Study||100
2463388|NCT00998582|6039745|P2|NOT COMPLETED|Overall Study||0
2463389|NCT00998582|6039746|P1|NOT COMPLETED|Overall Study||0
2463390|NCT00998582|6039745|P2|COMPLETED|Overall Study||14
2463391|NCT00998582|6039746|P1|COMPLETED|Overall Study||13
2463392|NCT00998582|6039745|P2|STARTED|Overall Study||14
2463393|NCT00998582|6039746|P1|STARTED|Overall Study||13
2463394|NCT00998517|6039757|P3|NOT COMPLETED|Overall Study||0
2463395|NCT00998517|6039758|P2|NOT COMPLETED|Overall Study||0
2463396|NCT00998517|6039759|P1|NOT COMPLETED|Overall Study||0
2463397|NCT00998517|6039757|P3|COMPLETED|Overall Study||918
2463398|NCT00998517|6039758|P2|COMPLETED|Overall Study||906
2463399|NCT00998517|6039759|P1|COMPLETED|Overall Study||888
2463400|NCT00998517|6039757|P3|STARTED|Overall Study||918
2463401|NCT00998517|6039758|P2|STARTED|Overall Study||906
2463402|NCT00998517|6039759|P1|STARTED|Overall Study||888
2463403|NCT00998426|6039785|P1|NOT COMPLETED|Overall Study||0
2463404|NCT00998426|6039785|P1|COMPLETED|Overall Study||5
2463405|NCT00998426|6039785|P1|Blood Glucose Monitoring|Overall Study||5
2463406|NCT00998426|6039785|P1|STARTED|Overall Study||5
2463407|NCT00998400|6039792|P2|NOT COMPLETED|Overall Study||2
2463408|NCT00998400|6039793|P1|NOT COMPLETED|Overall Study||2
2463409|NCT00998400|6039792|P2|COMPLETED|Overall Study||48
2463410|NCT00998400|6039793|P1|COMPLETED|Overall Study||48
2463411|NCT00998400|6039792|P2|STARTED|Overall Study||50
2463412|NCT00998400|6039793|P1|STARTED|Overall Study||50
2463413|NCT00998374|6039823|P2|NOT COMPLETED|Overall Study||11
2463414|NCT00998374|6039824|P1|NOT COMPLETED|Overall Study||12
2463415|NCT00998374|6039823|P2|COMPLETED|Overall Study||12
2463416|NCT00998374|6039824|P1|COMPLETED|Overall Study||27
2463417|NCT00998374|6039823|P2|STARTED|Overall Study||23
2463418|NCT00998374|6039824|P1|STARTED|Overall Study||39
2463419|NCT00998335|6039838|P2|NOT COMPLETED|Randomized Period (Months 3 to 6)||2
2463420|NCT00998335|6039839|P1|NOT COMPLETED|Randomized Period (Months 3 to 6)||0
2463421|NCT00998335|6039838|P2|COMPLETED|Randomized Period (Months 3 to 6)||20
2463422|NCT00998335|6039839|P1|COMPLETED|Randomized Period (Months 3 to 6)||8
2463423|NCT00998335|6039838|P2|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|22
2463424|NCT00998335|6039839|P1|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|8
2463425|NCT00998335|6039838|P2|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
2463426|NCT00998335|6039839|P1|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
2463427|NCT00998335|6039838|P2|COMPLETED|Initial Treatment (Months 0 - 3)||0
2463428|NCT00998335|6039839|P1|COMPLETED|Initial Treatment (Months 0 - 3)||30
2463429|NCT00998335|6039838|P2|STARTED|Initial Treatment (Months 0 - 3)||0
2463430|NCT00998335|6039839|P1|STARTED|Initial Treatment (Months 0 - 3)||30
2463431|NCT00998309|6039867|P1|NOT COMPLETED|Overall Study||4
2463432|NCT00998309|6039867|P1|COMPLETED|Overall Study||498
2463433|NCT00998309|6039867|P1|STARTED|Overall Study||502
2463434|NCT00998296|6039934|P11|NOT COMPLETED|Overall Study||7
2463435|NCT00998296|6039935|P10|NOT COMPLETED|Overall Study||18
2463436|NCT00998296|6039936|P9|NOT COMPLETED|Overall Study||2
2463437|NCT00998296|6039937|P8|NOT COMPLETED|Overall Study||2
2463438|NCT00998296|6039938|P7|NOT COMPLETED|Overall Study||1
2463439|NCT00998296|6039939|P6|NOT COMPLETED|Overall Study||0
2463440|NCT00998296|6039940|P5|NOT COMPLETED|Overall Study||2
2463441|NCT00998296|6039941|P4|NOT COMPLETED|Overall Study||0
2463442|NCT00998296|6039942|P3|NOT COMPLETED|Overall Study||0
2463443|NCT00998296|6039943|P2|NOT COMPLETED|Overall Study||1
2463444|NCT00998296|6039944|P1|NOT COMPLETED|Overall Study||0
2463445|NCT00998296|6039934|P11|COMPLETED|Overall Study||0
2463446|NCT00998296|6039935|P10|COMPLETED|Overall Study||0
2463447|NCT00998296|6039936|P9|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
2463448|NCT00998296|6039937|P8|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
2463449|NCT00998296|6039938|P7|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
2463450|NCT00998296|6039939|P6|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
2463451|NCT00998296|6039940|P5|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
2463452|NCT00998296|6039941|P4|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
2463453|NCT00998296|6039942|P3|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
2463454|NCT00998296|6039943|P2|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|2
2463455|NCT00998296|6039944|P1|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
2463456|NCT00998296|6039934|P11|STARTED|Overall Study||7
2463457|NCT00998296|6039935|P10|STARTED|Overall Study||18
2463458|NCT00998296|6039936|P9|STARTED|Overall Study||6
2463459|NCT00998296|6039937|P8|STARTED|Overall Study||6
2463460|NCT00998296|6039938|P7|STARTED|Overall Study||7
2463461|NCT00998296|6039939|P6|STARTED|Overall Study||3
2463462|NCT00998296|6039940|P5|STARTED|Overall Study||8
2463463|NCT00998296|6039941|P4|STARTED|Overall Study||3
2463464|NCT00998296|6039942|P3|STARTED|Overall Study||3
2463465|NCT00998296|6039943|P2|STARTED|Overall Study||3
2463466|NCT00998296|6039944|P1|STARTED|Overall Study||6
2463467|NCT00998205|6040011|P1|NOT COMPLETED|Overall Study||0
2463468|NCT00998205|6040011|P1|COMPLETED|Overall Study||16
2463469|NCT00998205|6040011|P1|STARTED|Overall Study||16
2463470|NCT00998049|6040016|P1|NOT COMPLETED|Overall Study||0
2463471|NCT00998049|6040016|P1|COMPLETED|Overall Study||39
2463472|NCT00998049|6040016|P1|STARTED|Overall Study||39
2463473|NCT00998023|6040027|P2|NOT COMPLETED|Overall Study||0
2463474|NCT00998023|6040028|P1|NOT COMPLETED|Overall Study||0
2463475|NCT00998023|6040027|P2|COMPLETED|Overall Study||32
2463476|NCT00998023|6040028|P1|COMPLETED|Overall Study||32
2463477|NCT00998023|6040027|P2|STARTED|Overall Study||32
2463478|NCT00998023|6040028|P1|STARTED|Overall Study||32
2463479|NCT00997984|6040039|P3|NOT COMPLETED|Overall Study||26
2463480|NCT00997984|6040040|P2|NOT COMPLETED|Overall Study||34
2463481|NCT00997984|6040041|P1|NOT COMPLETED|Overall Study||37
2463482|NCT00997984|6040039|P3|COMPLETED|Overall Study||88
2463483|NCT00997984|6040040|P2|COMPLETED|Overall Study||79
2463484|NCT00997984|6040041|P1|COMPLETED|Overall Study||76
2463485|NCT00997984|6040039|P3|STARTED|Overall Study||114
2463486|NCT00997984|6040040|P2|STARTED|Overall Study||113
2463487|NCT00997984|6040041|P1|STARTED|Overall Study||113
2463488|NCT00997932|6040107|P1|NOT COMPLETED|Overall Study||2
2463489|NCT00997932|6040107|P1|COMPLETED|Overall Study||27
2463490|NCT00997932|6040107|P1|STARTED|Overall Study||29
2463491|NCT00997672|6040114|P2|NOT COMPLETED|Overall Study||4
2463492|NCT00997672|6040115|P1|NOT COMPLETED|Overall Study||4
2463493|NCT00997672|6040114|P2|COMPLETED|Overall Study||1
2463494|NCT00997672|6040115|P1|COMPLETED|Overall Study||0
2463495|NCT00997672|6040114|P2|STARTED|Overall Study||5
2463496|NCT00997672|6040115|P1|STARTED|Overall Study||4
2463497|NCT00997620|6040123|P2|NOT COMPLETED|Overall Study||0
2463498|NCT00997620|6040124|P1|NOT COMPLETED|Overall Study||0
2463499|NCT00997620|6040123|P2|COMPLETED|Overall Study||21
2463500|NCT00997620|6040124|P1|COMPLETED|Overall Study||19
2463501|NCT00997620|6040123|P2|STARTED|Overall Study||21
2463502|NCT00997620|6040124|P1|STARTED|Overall Study||19
2463503|NCT00997594|6040142|P2|NOT COMPLETED|Overall Study||0
2463504|NCT00997594|6040143|P1|NOT COMPLETED|Overall Study||0
2463505|NCT00997594|6040142|P2|COMPLETED|Overall Study||9
2463506|NCT00997594|6040143|P1|COMPLETED|Overall Study||9
2463507|NCT00997594|6040142|P2|Completion of Ablation Procedure|Overall Study||9
2463508|NCT00997594|6040143|P1|Completion of Ablation Procedure|Overall Study||9
2463509|NCT00997594|6040142|P2|STARTED|Overall Study||9
2463510|NCT00997594|6040143|P1|STARTED|Overall Study||9
2463511|NCT00997555|6040151|P2|NOT COMPLETED|Overall Study||0
2463512|NCT00997555|6040152|P1|NOT COMPLETED|Overall Study||0
2463513|NCT00997555|6040151|P2|COMPLETED|Overall Study||15
2463514|NCT00997555|6040152|P1|COMPLETED|Overall Study||13
2463515|NCT00997555|6040151|P2|STARTED|Overall Study||15
2463516|NCT00997555|6040152|P1|STARTED|Overall Study||13
2463517|NCT00997516|6040170|P2|NOT COMPLETED|Long-term Follow-up (After 6 Months)||2
2463518|NCT00997516|6040171|P1|NOT COMPLETED|Long-term Follow-up (After 6 Months)||6
2463519|NCT00997516|6040170|P2|COMPLETED|Long-term Follow-up (After 6 Months)||36
2463520|NCT00997516|6040171|P1|COMPLETED|Long-term Follow-up (After 6 Months)||31
2463521|NCT00997516|6040170|P2|STARTED|Long-term Follow-up (After 6 Months)||38
2463522|NCT00997516|6040171|P1|STARTED|Long-term Follow-up (After 6 Months)||37
2463523|NCT00997516|6040170|P2|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
2463524|NCT00997516|6040171|P1|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
2463525|NCT00997516|6040170|P2|COMPLETED|Short-term Follow-up (Post Operative)||38
2463526|NCT00997516|6040171|P1|COMPLETED|Short-term Follow-up (Post Operative)||37
2463527|NCT00997516|6040170|P2|STARTED|Short-term Follow-up (Post Operative)||38
2463528|NCT00997516|6040171|P1|STARTED|Short-term Follow-up (Post Operative)||37
2463529|NCT00997503|6040199|P1|NOT COMPLETED|Overall Study||273
2463530|NCT00997503|6040199|P1|COMPLETED|Overall Study||3926
2463531|NCT00997503|6040199|P1|12 Months|Overall Study|4059 subjects evaluable at 12-months (cardiac death/MI within 365 days or completed follow-up)|4059
2463532|NCT00997503|6040199|P1|STARTED|Overall Study||4199
2463533|NCT00997438|6040242|P3|NOT COMPLETED|Overall Study||4
2463534|NCT00997438|6040243|P2|NOT COMPLETED|Overall Study||3
2463535|NCT00997438|6040244|P1|NOT COMPLETED|Overall Study||5
2463536|NCT00997438|6040242|P3|COMPLETED|Overall Study||20
2463537|NCT00997438|6040243|P2|COMPLETED|Overall Study||21
2463538|NCT00997438|6040244|P1|COMPLETED|Overall Study||16
2463539|NCT00997438|6040242|P3|STARTED|Overall Study||24
2463540|NCT00997438|6040243|P2|STARTED|Overall Study||24
2463541|NCT00997438|6040244|P1|STARTED|Overall Study||21
2463542|NCT00997425|6040279|P1|NOT COMPLETED|Overall Study||0
2463543|NCT00997425|6040279|P1|COMPLETED|Overall Study||19
2463544|NCT00997425|6040279|P1|STARTED|Overall Study||19
2463545|NCT00997386|6040284|P1|NOT COMPLETED|Overall Study||7
2463546|NCT00997386|6040284|P1|COMPLETED|Overall Study||9
2463547|NCT00997386|6040284|P1|STARTED|Overall Study||16
2463548|NCT00997373|6040293|P2|NOT COMPLETED|Overall Study||0
2463549|NCT00997373|6040294|P1|NOT COMPLETED|Overall Study||15
2463550|NCT00997373|6040293|P2|COMPLETED|Overall Study||15
2463551|NCT00997373|6040294|P1|COMPLETED|Overall Study||13
2463552|NCT00997373|6040293|P2|Completed Hysterectomy|Overall Study||15
2463553|NCT00997373|6040294|P1|Completed Hysterectomy|Overall Study||17
2463554|NCT00997373|6040293|P2|Received Letrozole|Overall Study||0
2463555|NCT00997373|6040294|P1|Received Letrozole|Overall Study||23
2463556|NCT00997373|6040293|P2|STARTED|Overall Study||15
2463557|NCT00997373|6040294|P1|STARTED|Overall Study||28
2463558|NCT00997334|6040300|P1|NOT COMPLETED|Overall Study||25
2463559|NCT00997334|6040300|P1|COMPLETED|Overall Study||35
2463560|NCT00997334|6040300|P1|Evaluable|Overall Study|Patients with tissue available for re-biopsy at time of progression|35
2463561|NCT00997334|6040300|P1|Eligible for Repeat Biopsy|Overall Study|Patients who experience disease progression on treatment were eligible for repeat biopsy|44
2463562|NCT00997334|6040300|P1|STARTED|Overall Study||60
2463563|NCT00997321|6040309|P2|NOT COMPLETED|Overall Study||3
2463564|NCT00997321|6040310|P1|NOT COMPLETED|Overall Study||0
2463565|NCT00997321|6040309|P2|COMPLETED|Overall Study||47
2463566|NCT00997321|6040310|P1|COMPLETED|Overall Study||50
2463567|NCT00997321|6040309|P2|STARTED|Overall Study||50
2463568|NCT00997321|6040310|P1|STARTED|Overall Study||50
2463569|NCT00997243|6040322|P1|NOT COMPLETED|Overall Study||7
2463570|NCT00997243|6040322|P1|COMPLETED|Overall Study||0
2463571|NCT00997243|6040322|P1|STARTED|Overall Study||7
2463572|NCT00997204|6040334|P2|NOT COMPLETED|Self-administration Phase||1
2463573|NCT00997204|6040335|P1|NOT COMPLETED|Self-administration Phase||0
2463574|NCT00997204|6040334|P2|COMPLETED|Self-administration Phase||77
2463575|NCT00997204|6040335|P1|COMPLETED|Self-administration Phase||19
2463576|NCT00997204|6040334|P2|STARTED|Self-administration Phase|1 subject did not self-administered icatibant but had a HCP to perform. the data were not included.|78
2463577|NCT00997204|6040335|P1|STARTED|Self-administration Phase||19
2463578|NCT00997204|6040334|P2|NOT COMPLETED|Naive Treatment Phase||79
2463579|NCT00997204|6040335|P1|NOT COMPLETED|Naive Treatment Phase||6
2463580|NCT00997204|6040334|P2|COMPLETED|Naive Treatment Phase||0
2463581|NCT00997204|6040335|P1|COMPLETED|Naive Treatment Phase||19
2463582|NCT00997204|6040334|P2|STARTED|Naive Treatment Phase|Non-naive patients participated in the study but they were not treated in the naive treatment phase|79
2463583|NCT00997204|6040335|P1|STARTED|Naive Treatment Phase||25
2463584|NCT00997139|6040346|P1|NOT COMPLETED|Overall Study||186
2463585|NCT00997139|6040346|P1|COMPLETED|Overall Study||30
2463586|NCT00997139|6040346|P1|Treated for Positive Baseline Culture|Overall Study||30
2463587|NCT00997139|6040346|P1|STARTED|Overall Study||216
2463588|NCT00997126|6040354|P2|NOT COMPLETED|Overall Study||11
2463589|NCT00997126|6040355|P1|NOT COMPLETED|Overall Study||7
2463590|NCT00997126|6040354|P2|COMPLETED|Overall Study||52
2463591|NCT00997126|6040355|P1|COMPLETED|Overall Study||56
2463592|NCT00997126|6040354|P2|STARTED|Overall Study||63
2463593|NCT00997126|6040355|P1|STARTED|Overall Study||63
2463594|NCT00997113|6040371|P2|NOT COMPLETED|Overall Study||0
2463595|NCT00997113|6040372|P1|NOT COMPLETED|Overall Study||0
2463596|NCT00997113|6040371|P2|COMPLETED|Overall Study||10
2463597|NCT00997113|6040372|P1|COMPLETED|Overall Study||10
2463598|NCT00997113|6040371|P2|STARTED|Overall Study||10
2463599|NCT00997113|6040372|P1|STARTED|Overall Study||10
2463600|NCT00997035|6040384|P2|NOT COMPLETED|3-month Follow-up Visit||6
2463601|NCT00997035|6040385|P1|NOT COMPLETED|3-month Follow-up Visit||12
2463602|NCT00997035|6040384|P2|COMPLETED|3-month Follow-up Visit||107
2463603|NCT00997035|6040385|P1|COMPLETED|3-month Follow-up Visit||100
2463604|NCT00997035|6040384|P2|STARTED|3-month Follow-up Visit||113
2463605|NCT00997035|6040385|P1|STARTED|3-month Follow-up Visit||112
2463606|NCT00997035|6040384|P2|NOT COMPLETED|3-week Followup Visit||6
2463607|NCT00997035|6040385|P1|NOT COMPLETED|3-week Followup Visit||9
2463608|NCT00997035|6040384|P2|COMPLETED|3-week Followup Visit||113
2463609|NCT00997035|6040385|P1|COMPLETED|3-week Followup Visit||112
2463610|NCT00997035|6040384|P2|STARTED|3-week Followup Visit||119
2463611|NCT00997035|6040385|P1|STARTED|3-week Followup Visit||121
2463612|NCT00996996|6040409|P1|NOT COMPLETED|Overall Study||33
2463613|NCT00996996|6040409|P1|COMPLETED|Overall Study|These participants completed 12 years of follow-up.|44
2463614|NCT00996996|6040409|P1|STARTED|Overall Study||77
2463615|NCT00996944|6040443|P2|NOT COMPLETED|Long-term Treatment Period||5
2463616|NCT00996944|6040444|P1|NOT COMPLETED|Long-term Treatment Period||12
2463617|NCT00996944|6040443|P2|COMPLETED|Long-term Treatment Period||0
2463618|NCT00996944|6040444|P1|COMPLETED|Long-term Treatment Period||0
2463619|NCT00996944|6040443|P2|STARTED|Long-term Treatment Period||5
2463620|NCT00996944|6040444|P1|STARTED|Long-term Treatment Period||12
2463621|NCT00996944|6040443|P2|NOT COMPLETED|Double-blind Treatment Period||7
2463622|NCT00996944|6040444|P1|NOT COMPLETED|Double-blind Treatment Period||10
2463623|NCT00996944|6040443|P2|COMPLETED|Double-blind Treatment Period||5
2463624|NCT00996944|6040444|P1|COMPLETED|Double-blind Treatment Period||12
2463625|NCT00996944|6040443|P2|STARTED|Double-blind Treatment Period||12
2463626|NCT00996944|6040444|P1|STARTED|Double-blind Treatment Period||22
2463627|NCT00996931|6040486|P1|NOT COMPLETED|Overall Study||0
2463628|NCT00996931|6040486|P1|COMPLETED|Overall Study||6
2463629|NCT00996931|6040486|P1|STARTED|Overall Study||6
2463630|NCT00996918|6040496|P5|NOT COMPLETED|Overall Study||4
2463631|NCT00996918|6040497|P4|NOT COMPLETED|Overall Study||56
2463632|NCT00996918|6040498|P3|NOT COMPLETED|Overall Study||37
2463633|NCT00996918|6040499|P2|NOT COMPLETED|Overall Study||66
2463634|NCT00996918|6040500|P1|NOT COMPLETED|Overall Study||39
2463635|NCT00996918|6040496|P5|COMPLETED|Overall Study||0
2463636|NCT00996918|6040497|P4|COMPLETED|Overall Study||0
2463637|NCT00996918|6040498|P3|COMPLETED|Overall Study||0
2463638|NCT00996918|6040499|P2|COMPLETED|Overall Study||0
2463639|NCT00996918|6040500|P1|COMPLETED|Overall Study||0
2463640|NCT00996918|6040496|P5|Treated|Overall Study||4
2463641|NCT00996918|6040497|P4|Treated|Overall Study||56
2463642|NCT00996918|6040498|P3|Treated|Overall Study||37
2463643|NCT00996918|6040499|P2|Treated|Overall Study||66
2463644|NCT00996918|6040500|P1|Treated|Overall Study||39
2463645|NCT00996918|6040496|P5|STARTED|Overall Study||4
2463646|NCT00996918|6040497|P4|STARTED|Overall Study||56
2463647|NCT00996918|6040498|P3|STARTED|Overall Study||37
2463648|NCT00996918|6040499|P2|STARTED|Overall Study||66
2463649|NCT00996918|6040500|P1|STARTED|Overall Study||39
2463650|NCT00996892|6040544|P20|NOT COMPLETED|Expansion Stage 2A||45
2463651|NCT00996892|6040545|P19|NOT COMPLETED|Expansion Stage 2A||0
2463652|NCT00996892|6040546|P18|NOT COMPLETED|Expansion Stage 2A||0
2463653|NCT00996892|6040547|P17|NOT COMPLETED|Expansion Stage 2A||0
2463654|NCT00996892|6040548|P16|NOT COMPLETED|Expansion Stage 2A||0
2463655|NCT00996892|6040549|P15|NOT COMPLETED|Expansion Stage 2A||0
2463656|NCT00996892|6040550|P14|NOT COMPLETED|Expansion Stage 2A||0
2463657|NCT00996892|6040551|P13|NOT COMPLETED|Expansion Stage 2A||0
2463658|NCT00996892|6040552|P12|NOT COMPLETED|Expansion Stage 2A||0
2463659|NCT00996892|6040553|P11|NOT COMPLETED|Expansion Stage 2A||0
2463660|NCT00996892|6040554|P10|NOT COMPLETED|Expansion Stage 2A||0
2463661|NCT00996892|6040555|P9|NOT COMPLETED|Expansion Stage 2A||0
2463662|NCT00996892|6040556|P8|NOT COMPLETED|Expansion Stage 2A||0
2463663|NCT00996892|6040557|P7|NOT COMPLETED|Expansion Stage 2A||0
2463664|NCT00996892|6040558|P6|NOT COMPLETED|Expansion Stage 2A||0
2463665|NCT00996892|6040559|P5|NOT COMPLETED|Expansion Stage 2A||0
2463666|NCT00996892|6040560|P4|NOT COMPLETED|Expansion Stage 2A||0
2463667|NCT00996892|6040561|P3|NOT COMPLETED|Expansion Stage 2A||0
2463668|NCT00996892|6040562|P2|NOT COMPLETED|Expansion Stage 2A||0
2463669|NCT00996892|6040563|P1|NOT COMPLETED|Expansion Stage 2A||0
2463670|NCT00996892|6040544|P20|COMPLETED|Expansion Stage 2A||0
2463671|NCT00996892|6040545|P19|COMPLETED|Expansion Stage 2A||0
2463672|NCT00996892|6040546|P18|COMPLETED|Expansion Stage 2A||0
2463673|NCT00996892|6040547|P17|COMPLETED|Expansion Stage 2A||0
2463674|NCT00996892|6040548|P16|COMPLETED|Expansion Stage 2A||0
2463675|NCT00996892|6040549|P15|COMPLETED|Expansion Stage 2A||0
2463676|NCT00996892|6040550|P14|COMPLETED|Expansion Stage 2A||0
2463677|NCT00996892|6040551|P13|COMPLETED|Expansion Stage 2A||0
2463678|NCT00996892|6040552|P12|COMPLETED|Expansion Stage 2A||0
2463679|NCT00996892|6040553|P11|COMPLETED|Expansion Stage 2A||0
2463680|NCT00996892|6040554|P10|COMPLETED|Expansion Stage 2A||0
2463681|NCT00996892|6040555|P9|COMPLETED|Expansion Stage 2A||0
2463682|NCT00996892|6040556|P8|COMPLETED|Expansion Stage 2A||0
2463683|NCT00996892|6040557|P7|COMPLETED|Expansion Stage 2A||0
2463684|NCT00996892|6040558|P6|COMPLETED|Expansion Stage 2A||0
2463685|NCT00996892|6040559|P5|COMPLETED|Expansion Stage 2A||0
2463686|NCT00996892|6040560|P4|COMPLETED|Expansion Stage 2A||0
2463687|NCT00996892|6040561|P3|COMPLETED|Expansion Stage 2A||0
2463688|NCT00996892|6040562|P2|COMPLETED|Expansion Stage 2A||0
2463689|NCT00996892|6040563|P1|COMPLETED|Expansion Stage 2A||0
2463690|NCT00996892|6040544|P20|STARTED|Expansion Stage 2A||45
2463691|NCT00996892|6040545|P19|STARTED|Expansion Stage 2A||0
2463692|NCT00996892|6040546|P18|STARTED|Expansion Stage 2A||0
2463693|NCT00996892|6040547|P17|STARTED|Expansion Stage 2A||0
2463694|NCT00996892|6040548|P16|STARTED|Expansion Stage 2A||0
2463695|NCT00996892|6040549|P15|STARTED|Expansion Stage 2A||0
2463696|NCT00996892|6040550|P14|STARTED|Expansion Stage 2A||0
2463697|NCT00996892|6040551|P13|STARTED|Expansion Stage 2A||0
2463698|NCT00996892|6040552|P12|STARTED|Expansion Stage 2A||0
2463699|NCT00996892|6040553|P11|STARTED|Expansion Stage 2A||0
2463700|NCT00996892|6040554|P10|STARTED|Expansion Stage 2A||0
2463701|NCT00996892|6040555|P9|STARTED|Expansion Stage 2A||0
2463702|NCT00996892|6040556|P8|STARTED|Expansion Stage 2A||0
2463703|NCT00996892|6040557|P7|STARTED|Expansion Stage 2A||0
2463704|NCT00996892|6040558|P6|STARTED|Expansion Stage 2A||0
2463705|NCT00996892|6040559|P5|STARTED|Expansion Stage 2A||0
2463706|NCT00996892|6040560|P4|STARTED|Expansion Stage 2A||0
2463707|NCT00996892|6040561|P3|STARTED|Expansion Stage 2A||0
2463708|NCT00996892|6040562|P2|STARTED|Expansion Stage 2A||0
2463709|NCT00996892|6040563|P1|STARTED|Expansion Stage 2A||0
2463710|NCT00996892|6040544|P20|NOT COMPLETED|Expansion Stage 2||0
2463711|NCT00996892|6040545|P19|NOT COMPLETED|Expansion Stage 2||35
2463712|NCT00996892|6040546|P18|NOT COMPLETED|Expansion Stage 2||0
2463713|NCT00996892|6040547|P17|NOT COMPLETED|Expansion Stage 2||0
2463714|NCT00996892|6040548|P16|NOT COMPLETED|Expansion Stage 2||0
2463715|NCT00996892|6040549|P15|NOT COMPLETED|Expansion Stage 2||0
2463716|NCT00996892|6040550|P14|NOT COMPLETED|Expansion Stage 2||0
2463717|NCT00996892|6040551|P13|NOT COMPLETED|Expansion Stage 2||0
2463718|NCT00996892|6040552|P12|NOT COMPLETED|Expansion Stage 2||0
2463719|NCT00996892|6040553|P11|NOT COMPLETED|Expansion Stage 2||0
2463720|NCT00996892|6040554|P10|NOT COMPLETED|Expansion Stage 2||0
2463721|NCT00996892|6040555|P9|NOT COMPLETED|Expansion Stage 2||0
2463722|NCT00996892|6040556|P8|NOT COMPLETED|Expansion Stage 2||0
2463723|NCT00996892|6040557|P7|NOT COMPLETED|Expansion Stage 2||0
2463724|NCT00996892|6040558|P6|NOT COMPLETED|Expansion Stage 2||0
2463725|NCT00996892|6040559|P5|NOT COMPLETED|Expansion Stage 2||0
2463726|NCT00996892|6040560|P4|NOT COMPLETED|Expansion Stage 2||0
2463727|NCT00996892|6040561|P3|NOT COMPLETED|Expansion Stage 2||0
2463728|NCT00996892|6040562|P2|NOT COMPLETED|Expansion Stage 2||0
2463729|NCT00996892|6040563|P1|NOT COMPLETED|Expansion Stage 2||0
2463730|NCT00996892|6040544|P20|COMPLETED|Expansion Stage 2||0
2463731|NCT00996892|6040545|P19|COMPLETED|Expansion Stage 2||0
2463732|NCT00996892|6040546|P18|COMPLETED|Expansion Stage 2||0
2463733|NCT00996892|6040547|P17|COMPLETED|Expansion Stage 2||0
2463734|NCT00996892|6040548|P16|COMPLETED|Expansion Stage 2||0
2463735|NCT00996892|6040549|P15|COMPLETED|Expansion Stage 2||0
2463736|NCT00996892|6040550|P14|COMPLETED|Expansion Stage 2||0
2463737|NCT00996892|6040551|P13|COMPLETED|Expansion Stage 2||0
2463738|NCT00996892|6040552|P12|COMPLETED|Expansion Stage 2||0
2463739|NCT00996892|6040553|P11|COMPLETED|Expansion Stage 2||0
2463740|NCT00996892|6040554|P10|COMPLETED|Expansion Stage 2||0
2463741|NCT00996892|6040555|P9|COMPLETED|Expansion Stage 2||0
2463742|NCT00996892|6040556|P8|COMPLETED|Expansion Stage 2||0
2463743|NCT00996892|6040557|P7|COMPLETED|Expansion Stage 2||0
2463744|NCT00996892|6040558|P6|COMPLETED|Expansion Stage 2||0
2463745|NCT00996892|6040559|P5|COMPLETED|Expansion Stage 2||0
2463746|NCT00996892|6040560|P4|COMPLETED|Expansion Stage 2||0
2463747|NCT00996892|6040561|P3|COMPLETED|Expansion Stage 2||0
2463748|NCT00996892|6040562|P2|COMPLETED|Expansion Stage 2||0
2463749|NCT00996892|6040563|P1|COMPLETED|Expansion Stage 2||0
2463750|NCT00996892|6040544|P20|STARTED|Expansion Stage 2||0
2463751|NCT00996892|6040545|P19|STARTED|Expansion Stage 2||35
2463752|NCT00996892|6040546|P18|STARTED|Expansion Stage 2||0
2463753|NCT00996892|6040547|P17|STARTED|Expansion Stage 2||0
2463754|NCT00996892|6040548|P16|STARTED|Expansion Stage 2||0
2463755|NCT00996892|6040549|P15|STARTED|Expansion Stage 2||0
2463756|NCT00996892|6040550|P14|STARTED|Expansion Stage 2||0
2463757|NCT00996892|6040551|P13|STARTED|Expansion Stage 2||0
2463758|NCT00996892|6040552|P12|STARTED|Expansion Stage 2||0
2463759|NCT00996892|6040553|P11|STARTED|Expansion Stage 2||0
2463760|NCT00996892|6040554|P10|STARTED|Expansion Stage 2||0
2463761|NCT00996892|6040555|P9|STARTED|Expansion Stage 2||0
2463762|NCT00996892|6040556|P8|STARTED|Expansion Stage 2||0
2463763|NCT00996892|6040557|P7|STARTED|Expansion Stage 2||0
2463764|NCT00996892|6040558|P6|STARTED|Expansion Stage 2||0
2463765|NCT00996892|6040559|P5|STARTED|Expansion Stage 2||0
2463766|NCT00996892|6040560|P4|STARTED|Expansion Stage 2||0
2463767|NCT00996892|6040561|P3|STARTED|Expansion Stage 2||0
2463768|NCT00996892|6040562|P2|STARTED|Expansion Stage 2||0
2463769|NCT00996892|6040563|P1|STARTED|Expansion Stage 2||0
2463770|NCT00996892|6040544|P20|NOT COMPLETED|Dose-Escalation Stage 1B||0
2463771|NCT00996892|6040545|P19|NOT COMPLETED|Dose-Escalation Stage 1B||0
2463772|NCT00996892|6040546|P18|NOT COMPLETED|Dose-Escalation Stage 1B||5
2463773|NCT00996892|6040547|P17|NOT COMPLETED|Dose-Escalation Stage 1B||3
2463774|NCT00996892|6040548|P16|NOT COMPLETED|Dose-Escalation Stage 1B||3
2463775|NCT00996892|6040549|P15|NOT COMPLETED|Dose-Escalation Stage 1B||4
2463776|NCT00996892|6040550|P14|NOT COMPLETED|Dose-Escalation Stage 1B||0
2463777|NCT00996892|6040551|P13|NOT COMPLETED|Dose-Escalation Stage 1B||0
2463778|NCT00996892|6040552|P12|NOT COMPLETED|Dose-Escalation Stage 1B||0
2463779|NCT00996892|6040553|P11|NOT COMPLETED|Dose-Escalation Stage 1B||0
2463780|NCT00996892|6040554|P10|NOT COMPLETED|Dose-Escalation Stage 1B||0
2463781|NCT00996892|6040555|P9|NOT COMPLETED|Dose-Escalation Stage 1B||0
2463782|NCT00996892|6040556|P8|NOT COMPLETED|Dose-Escalation Stage 1B||0
2463783|NCT00996892|6040557|P7|NOT COMPLETED|Dose-Escalation Stage 1B||0
2463784|NCT00996892|6040558|P6|NOT COMPLETED|Dose-Escalation Stage 1B||0
2463785|NCT00996892|6040559|P5|NOT COMPLETED|Dose-Escalation Stage 1B||0
2463786|NCT00996892|6040560|P4|NOT COMPLETED|Dose-Escalation Stage 1B||0
2463787|NCT00996892|6040561|P3|NOT COMPLETED|Dose-Escalation Stage 1B||0
2463788|NCT00996892|6040562|P2|NOT COMPLETED|Dose-Escalation Stage 1B||0
2463789|NCT00996892|6040563|P1|NOT COMPLETED|Dose-Escalation Stage 1B||0
2463790|NCT00996892|6040544|P20|COMPLETED|Dose-Escalation Stage 1B||0
2463791|NCT00996892|6040545|P19|COMPLETED|Dose-Escalation Stage 1B||0
2463792|NCT00996892|6040546|P18|COMPLETED|Dose-Escalation Stage 1B||0
2463793|NCT00996892|6040547|P17|COMPLETED|Dose-Escalation Stage 1B||0
2463794|NCT00996892|6040548|P16|COMPLETED|Dose-Escalation Stage 1B||0
2463795|NCT00996892|6040549|P15|COMPLETED|Dose-Escalation Stage 1B||0
2463796|NCT00996892|6040550|P14|COMPLETED|Dose-Escalation Stage 1B||0
2463797|NCT00996892|6040551|P13|COMPLETED|Dose-Escalation Stage 1B||0
2463798|NCT00996892|6040552|P12|COMPLETED|Dose-Escalation Stage 1B||0
2463799|NCT00996892|6040553|P11|COMPLETED|Dose-Escalation Stage 1B||0
2463800|NCT00996892|6040554|P10|COMPLETED|Dose-Escalation Stage 1B||0
2463801|NCT00996892|6040555|P9|COMPLETED|Dose-Escalation Stage 1B||0
2463802|NCT00996892|6040556|P8|COMPLETED|Dose-Escalation Stage 1B||0
2463803|NCT00996892|6040557|P7|COMPLETED|Dose-Escalation Stage 1B||0
2463804|NCT00996892|6040558|P6|COMPLETED|Dose-Escalation Stage 1B||0
2463805|NCT00996892|6040559|P5|COMPLETED|Dose-Escalation Stage 1B||0
2463806|NCT00996892|6040560|P4|COMPLETED|Dose-Escalation Stage 1B||0
2463807|NCT00996892|6040561|P3|COMPLETED|Dose-Escalation Stage 1B||0
2463808|NCT00996892|6040562|P2|COMPLETED|Dose-Escalation Stage 1B||0
2463809|NCT00996892|6040563|P1|COMPLETED|Dose-Escalation Stage 1B||0
2463810|NCT00996892|6040544|P20|STARTED|Dose-Escalation Stage 1B||0
2463811|NCT00996892|6040545|P19|STARTED|Dose-Escalation Stage 1B||0
2463812|NCT00996892|6040546|P18|STARTED|Dose-Escalation Stage 1B||5
2463813|NCT00996892|6040547|P17|STARTED|Dose-Escalation Stage 1B||3
2463814|NCT00996892|6040548|P16|STARTED|Dose-Escalation Stage 1B||3
2463815|NCT00996892|6040549|P15|STARTED|Dose-Escalation Stage 1B||4
2463816|NCT00996892|6040550|P14|STARTED|Dose-Escalation Stage 1B||0
2463817|NCT00996892|6040551|P13|STARTED|Dose-Escalation Stage 1B||0
2463818|NCT00996892|6040552|P12|STARTED|Dose-Escalation Stage 1B||0
2463819|NCT00996892|6040553|P11|STARTED|Dose-Escalation Stage 1B||0
2463820|NCT00996892|6040554|P10|STARTED|Dose-Escalation Stage 1B||0
2463821|NCT00996892|6040555|P9|STARTED|Dose-Escalation Stage 1B||0
2463822|NCT00996892|6040556|P8|STARTED|Dose-Escalation Stage 1B||0
2463823|NCT00996892|6040557|P7|STARTED|Dose-Escalation Stage 1B||0
2463824|NCT00996892|6040558|P6|STARTED|Dose-Escalation Stage 1B||0
2463825|NCT00996892|6040559|P5|STARTED|Dose-Escalation Stage 1B||0
2463826|NCT00996892|6040560|P4|STARTED|Dose-Escalation Stage 1B||0
2463827|NCT00996892|6040561|P3|STARTED|Dose-Escalation Stage 1B||0
2463828|NCT00996892|6040562|P2|STARTED|Dose-Escalation Stage 1B||0
2463829|NCT00996892|6040563|P1|STARTED|Dose-Escalation Stage 1B||0
2463830|NCT00996892|6040544|P20|NOT COMPLETED|Dose-Escalation Stage 1A||0
2463831|NCT00996892|6040545|P19|NOT COMPLETED|Dose-Escalation Stage 1A||0
2463832|NCT00996892|6040546|P18|NOT COMPLETED|Dose-Escalation Stage 1A||0
2463833|NCT00996892|6040547|P17|NOT COMPLETED|Dose-Escalation Stage 1A||0
2463834|NCT00996892|6040548|P16|NOT COMPLETED|Dose-Escalation Stage 1A||0
2463835|NCT00996892|6040549|P15|NOT COMPLETED|Dose-Escalation Stage 1A||0
2463836|NCT00996892|6040550|P14|NOT COMPLETED|Dose-Escalation Stage 1A||5
2463837|NCT00996892|6040551|P13|NOT COMPLETED|Dose-Escalation Stage 1A||8
2463838|NCT00996892|6040552|P12|NOT COMPLETED|Dose-Escalation Stage 1A||9
2463839|NCT00996892|6040553|P11|NOT COMPLETED|Dose-Escalation Stage 1A||7
2463840|NCT00996892|6040554|P10|NOT COMPLETED|Dose-Escalation Stage 1A||4
2463841|NCT00996892|6040555|P9|NOT COMPLETED|Dose-Escalation Stage 1A||3
2463842|NCT00996892|6040556|P8|NOT COMPLETED|Dose-Escalation Stage 1A||3
2463843|NCT00996892|6040557|P7|NOT COMPLETED|Dose-Escalation Stage 1A||0
2463844|NCT00996892|6040558|P6|NOT COMPLETED|Dose-Escalation Stage 1A||0
2463845|NCT00996892|6040559|P5|NOT COMPLETED|Dose-Escalation Stage 1A||0
2463846|NCT00996892|6040560|P4|NOT COMPLETED|Dose-Escalation Stage 1A||0
2463847|NCT00996892|6040561|P3|NOT COMPLETED|Dose-Escalation Stage 1A||0
2463848|NCT00996892|6040562|P2|NOT COMPLETED|Dose-Escalation Stage 1A||0
2463849|NCT00996892|6040563|P1|NOT COMPLETED|Dose-Escalation Stage 1A||0
2463850|NCT00996892|6040544|P20|COMPLETED|Dose-Escalation Stage 1A||0
2463851|NCT00996892|6040545|P19|COMPLETED|Dose-Escalation Stage 1A||0
2463852|NCT00996892|6040546|P18|COMPLETED|Dose-Escalation Stage 1A||0
2463853|NCT00996892|6040547|P17|COMPLETED|Dose-Escalation Stage 1A||0
2463854|NCT00996892|6040548|P16|COMPLETED|Dose-Escalation Stage 1A||0
2463855|NCT00996892|6040549|P15|COMPLETED|Dose-Escalation Stage 1A||0
2463856|NCT00996892|6040550|P14|COMPLETED|Dose-Escalation Stage 1A||0
2463857|NCT00996892|6040551|P13|COMPLETED|Dose-Escalation Stage 1A||0
2463858|NCT00996892|6040552|P12|COMPLETED|Dose-Escalation Stage 1A||0
2463859|NCT00996892|6040553|P11|COMPLETED|Dose-Escalation Stage 1A||0
2463860|NCT00996892|6040554|P10|COMPLETED|Dose-Escalation Stage 1A||0
2463861|NCT00996892|6040555|P9|COMPLETED|Dose-Escalation Stage 1A||0
2463862|NCT00996892|6040556|P8|COMPLETED|Dose-Escalation Stage 1A||0
2463863|NCT00996892|6040557|P7|COMPLETED|Dose-Escalation Stage 1A||0
2463864|NCT00996892|6040558|P6|COMPLETED|Dose-Escalation Stage 1A||0
2463865|NCT00996892|6040559|P5|COMPLETED|Dose-Escalation Stage 1A||0
2463866|NCT00996892|6040560|P4|COMPLETED|Dose-Escalation Stage 1A||0
2463867|NCT00996892|6040561|P3|COMPLETED|Dose-Escalation Stage 1A||0
2463868|NCT00996892|6040562|P2|COMPLETED|Dose-Escalation Stage 1A||0
2463869|NCT00996892|6040563|P1|COMPLETED|Dose-Escalation Stage 1A||0
2463870|NCT00996892|6040544|P20|STARTED|Dose-Escalation Stage 1A||0
2463871|NCT00996892|6040545|P19|STARTED|Dose-Escalation Stage 1A||0
2463872|NCT00996892|6040546|P18|STARTED|Dose-Escalation Stage 1A||0
2463873|NCT00996892|6040547|P17|STARTED|Dose-Escalation Stage 1A||0
2463874|NCT00996892|6040548|P16|STARTED|Dose-Escalation Stage 1A||0
2463875|NCT00996892|6040549|P15|STARTED|Dose-Escalation Stage 1A||0
2463876|NCT00996892|6040550|P14|STARTED|Dose-Escalation Stage 1A||5
2463877|NCT00996892|6040551|P13|STARTED|Dose-Escalation Stage 1A||8
2463878|NCT00996892|6040552|P12|STARTED|Dose-Escalation Stage 1A||9
2463879|NCT00996892|6040553|P11|STARTED|Dose-Escalation Stage 1A||7
2463880|NCT00996892|6040554|P10|STARTED|Dose-Escalation Stage 1A||4
2463881|NCT00996892|6040555|P9|STARTED|Dose-Escalation Stage 1A||3
2463882|NCT00996892|6040556|P8|STARTED|Dose-Escalation Stage 1A||3
2463883|NCT00996892|6040557|P7|STARTED|Dose-Escalation Stage 1A||0
2463884|NCT00996892|6040558|P6|STARTED|Dose-Escalation Stage 1A||0
2463885|NCT00996892|6040559|P5|STARTED|Dose-Escalation Stage 1A||0
2463886|NCT00996892|6040560|P4|STARTED|Dose-Escalation Stage 1A||0
2463887|NCT00996892|6040561|P3|STARTED|Dose-Escalation Stage 1A||0
2463888|NCT00996892|6040562|P2|STARTED|Dose-Escalation Stage 1A||0
2463889|NCT00996892|6040563|P1|STARTED|Dose-Escalation Stage 1A||0
2463890|NCT00996892|6040544|P20|NOT COMPLETED|Dose-Escalation Stage 1||0
2463891|NCT00996892|6040545|P19|NOT COMPLETED|Dose-Escalation Stage 1||0
2463892|NCT00996892|6040546|P18|NOT COMPLETED|Dose-Escalation Stage 1||0
2463893|NCT00996892|6040547|P17|NOT COMPLETED|Dose-Escalation Stage 1||0
2463894|NCT00996892|6040548|P16|NOT COMPLETED|Dose-Escalation Stage 1||0
2463895|NCT00996892|6040549|P15|NOT COMPLETED|Dose-Escalation Stage 1||0
2463896|NCT00996892|6040550|P14|NOT COMPLETED|Dose-Escalation Stage 1||0
2463897|NCT00996892|6040551|P13|NOT COMPLETED|Dose-Escalation Stage 1||0
2463898|NCT00996892|6040552|P12|NOT COMPLETED|Dose-Escalation Stage 1||0
2463899|NCT00996892|6040553|P11|NOT COMPLETED|Dose-Escalation Stage 1||0
2463900|NCT00996892|6040554|P10|NOT COMPLETED|Dose-Escalation Stage 1||0
2463901|NCT00996892|6040555|P9|NOT COMPLETED|Dose-Escalation Stage 1||0
2463902|NCT00996892|6040556|P8|NOT COMPLETED|Dose-Escalation Stage 1||0
2463903|NCT00996892|6040557|P7|NOT COMPLETED|Dose-Escalation Stage 1||4
2463904|NCT00996892|6040558|P6|NOT COMPLETED|Dose-Escalation Stage 1||10
2463905|NCT00996892|6040559|P5|NOT COMPLETED|Dose-Escalation Stage 1||11
2463906|NCT00996892|6040560|P4|NOT COMPLETED|Dose-Escalation Stage 1||9
2463907|NCT00996892|6040561|P3|NOT COMPLETED|Dose-Escalation Stage 1||3
2463908|NCT00996892|6040562|P2|NOT COMPLETED|Dose-Escalation Stage 1||3
2463909|NCT00996892|6040563|P1|NOT COMPLETED|Dose-Escalation Stage 1||4
2463910|NCT00996892|6040544|P20|COMPLETED|Dose-Escalation Stage 1||0
2463911|NCT00996892|6040545|P19|COMPLETED|Dose-Escalation Stage 1||0
2463912|NCT00996892|6040546|P18|COMPLETED|Dose-Escalation Stage 1||0
2463913|NCT00996892|6040547|P17|COMPLETED|Dose-Escalation Stage 1||0
2463914|NCT00996892|6040548|P16|COMPLETED|Dose-Escalation Stage 1||0
2463915|NCT00996892|6040549|P15|COMPLETED|Dose-Escalation Stage 1||0
2463916|NCT00996892|6040550|P14|COMPLETED|Dose-Escalation Stage 1||0
2463917|NCT00996892|6040551|P13|COMPLETED|Dose-Escalation Stage 1||0
2463918|NCT00996892|6040552|P12|COMPLETED|Dose-Escalation Stage 1||0
2463919|NCT00996892|6040553|P11|COMPLETED|Dose-Escalation Stage 1||0
2463920|NCT00996892|6040554|P10|COMPLETED|Dose-Escalation Stage 1||0
2463921|NCT00996892|6040555|P9|COMPLETED|Dose-Escalation Stage 1||0
2463922|NCT00996892|6040556|P8|COMPLETED|Dose-Escalation Stage 1||0
2463923|NCT00996892|6040557|P7|COMPLETED|Dose-Escalation Stage 1||0
2463924|NCT00996892|6040558|P6|COMPLETED|Dose-Escalation Stage 1||0
2463925|NCT00996892|6040559|P5|COMPLETED|Dose-Escalation Stage 1||0
2463926|NCT00996892|6040560|P4|COMPLETED|Dose-Escalation Stage 1||0
2463927|NCT00996892|6040561|P3|COMPLETED|Dose-Escalation Stage 1||0
2463928|NCT00996892|6040562|P2|COMPLETED|Dose-Escalation Stage 1||0
2463929|NCT00996892|6040563|P1|COMPLETED|Dose-Escalation Stage 1||0
2463930|NCT00996892|6040544|P20|STARTED|Dose-Escalation Stage 1||0
2463931|NCT00996892|6040545|P19|STARTED|Dose-Escalation Stage 1||0
2463932|NCT00996892|6040546|P18|STARTED|Dose-Escalation Stage 1||0
2463933|NCT00996892|6040547|P17|STARTED|Dose-Escalation Stage 1||0
2463934|NCT00996892|6040548|P16|STARTED|Dose-Escalation Stage 1||0
2463935|NCT00996892|6040549|P15|STARTED|Dose-Escalation Stage 1||0
2463936|NCT00996892|6040550|P14|STARTED|Dose-Escalation Stage 1||0
2463937|NCT00996892|6040551|P13|STARTED|Dose-Escalation Stage 1||0
2463938|NCT00996892|6040552|P12|STARTED|Dose-Escalation Stage 1||0
2463939|NCT00996892|6040553|P11|STARTED|Dose-Escalation Stage 1||0
2463940|NCT00996892|6040554|P10|STARTED|Dose-Escalation Stage 1||0
2463941|NCT00996892|6040555|P9|STARTED|Dose-Escalation Stage 1||0
2463942|NCT00996892|6040556|P8|STARTED|Dose-Escalation Stage 1||0
2463943|NCT00996892|6040557|P7|STARTED|Dose-Escalation Stage 1||4
2463944|NCT00996892|6040558|P6|STARTED|Dose-Escalation Stage 1||10
2463945|NCT00996892|6040559|P5|STARTED|Dose-Escalation Stage 1||11
2463946|NCT00996892|6040560|P4|STARTED|Dose-Escalation Stage 1||9
2463947|NCT00996892|6040561|P3|STARTED|Dose-Escalation Stage 1||3
2463948|NCT00996892|6040562|P2|STARTED|Dose-Escalation Stage 1||3
2463949|NCT00996892|6040563|P1|STARTED|Dose-Escalation Stage 1||4
2463950|NCT00996840|6041157|P5|NOT COMPLETED|Overall Study||2
2463951|NCT00996840|6041158|P4|NOT COMPLETED|Overall Study||1
2463952|NCT00996840|6041159|P3|NOT COMPLETED|Overall Study||1
2463953|NCT00996840|6041160|P2|NOT COMPLETED|Overall Study||2
2463954|NCT00996840|6041161|P1|NOT COMPLETED|Overall Study||1
2463955|NCT00996840|6041157|P5|COMPLETED|Overall Study||16
2463956|NCT00996840|6041158|P4|COMPLETED|Overall Study||17
2463957|NCT00996840|6041159|P3|COMPLETED|Overall Study||11
2463958|NCT00996840|6041160|P2|COMPLETED|Overall Study||7
2463959|NCT00996840|6041161|P1|COMPLETED|Overall Study||19
2463960|NCT00996840|6041157|P5|STARTED|Overall Study||18
2463961|NCT00996840|6041158|P4|STARTED|Overall Study||18
2463962|NCT00996840|6041159|P3|STARTED|Overall Study||12
2463963|NCT00996840|6041160|P2|STARTED|Overall Study||9
2463964|NCT00996840|6041161|P1|STARTED|Overall Study||20
2463965|NCT00996801|6041311|P6|NOT COMPLETED|Overall Study||19
2463966|NCT00996801|6041312|P5|NOT COMPLETED|Overall Study||88
2463967|NCT00996801|6041313|P4|NOT COMPLETED|Overall Study||31
2463968|NCT00996801|6041314|P3|NOT COMPLETED|Overall Study||23
2463969|NCT00996801|6041315|P2|NOT COMPLETED|Overall Study||16
2463970|NCT00996801|6041316|P1|NOT COMPLETED|Overall Study||20
2463971|NCT00996801|6041311|P6|COMPLETED|Overall Study||68
2463972|NCT00996801|6041312|P5|COMPLETED|Overall Study||0
2463973|NCT00996801|6041313|P4|COMPLETED|Overall Study||56
2463974|NCT00996801|6041314|P3|COMPLETED|Overall Study||65
2463975|NCT00996801|6041315|P2|COMPLETED|Overall Study||72
2463976|NCT00996801|6041316|P1|COMPLETED|Overall Study||68
2463977|NCT00996801|6041311|P6|STARTED|Overall Study||87
2463978|NCT00996801|6041312|P5|STARTED|Overall Study|15-mg arm was discontinued as a result of Protocol Amendment 1.|88
2463979|NCT00996801|6041313|P4|STARTED|Overall Study||87
2463980|NCT00996801|6041314|P3|STARTED|Overall Study||88
2463981|NCT00996801|6041315|P2|STARTED|Overall Study||88
2463982|NCT00996801|6041316|P1|STARTED|Overall Study||88
2463983|NCT00996775|6041419|P2|NOT COMPLETED|Overall Study||14
2463984|NCT00996775|6041420|P1|NOT COMPLETED|Overall Study||11
2463985|NCT00996775|6041419|P2|COMPLETED|Overall Study||75
2463986|NCT00996775|6041420|P1|COMPLETED|Overall Study||67
2463987|NCT00996775|6041419|P2|STARTED|Overall Study||89
2463988|NCT00996775|6041420|P1|STARTED|Overall Study||78
2463989|NCT00996736|6041428|P2|NOT COMPLETED|Overall Study||18
2463990|NCT00996736|6041429|P1|NOT COMPLETED|Overall Study||21
2463991|NCT00996736|6041428|P2|COMPLETED|Overall Study||143
2463992|NCT00996736|6041429|P1|COMPLETED|Overall Study||141
2463993|NCT00996736|6041428|P2|3-month Visit|Overall Study||146
2463994|NCT00996736|6041429|P1|3-month Visit|Overall Study||146
2463995|NCT00996736|6041428|P2|3-week Visit|Overall Study|144 visited within pre-specified 3-week window (2.5-5 weeks); 7 had a second visit not within window|151
2463996|NCT00996736|6041429|P1|3-week Visit|Overall Study|149 visited within pre-specified 3-week window (2.5-5 weeks); 6 had a second visit not within window|155
2463997|NCT00996736|6041428|P2|STARTED|Overall Study||161
2463998|NCT00996736|6041429|P1|STARTED|Overall Study||162
2463999|NCT00996658|6041449|P2|NOT COMPLETED|Overall Study||21
2464000|NCT00996658|6041450|P1|NOT COMPLETED|Overall Study||16
2464001|NCT00996658|6041449|P2|COMPLETED|Overall Study||165
2464002|NCT00996658|6041450|P1|COMPLETED|Overall Study||76
2464003|NCT00996658|6041449|P2|STARTED|Overall Study||186
2464004|NCT00996658|6041450|P1|STARTED|Overall Study||92
2464005|NCT00996632|6041478|P2|NOT COMPLETED|Overall Study||0
2464006|NCT00996632|6041479|P1|NOT COMPLETED|Overall Study||0
2464007|NCT00996632|6041478|P2|COMPLETED|Overall Study||56
2464008|NCT00996632|6041479|P1|COMPLETED|Overall Study||38
2464009|NCT00996632|6041478|P2|STARTED|Overall Study||56
2464010|NCT00996632|6041479|P1|STARTED|Overall Study||38
2464011|NCT00996606|6041487|P1|NOT COMPLETED|Overall Study||8
2464012|NCT00996606|6041487|P1|COMPLETED|Overall Study||50
2464013|NCT00996606|6041487|P1|STARTED|Overall Study||58
2464014|NCT00996593|6041581|P1|NOT COMPLETED|Long-Term Follow-Up||3
2464015|NCT00996593|6041581|P1|COMPLETED|Long-Term Follow-Up||6
2464016|NCT00996593|6041581|P1|STARTED|Long-Term Follow-Up|9 of the 40 participants withdrawing from Study BEX104507 enrolled in long-term follow-up study.|9
2464017|NCT00996593|6041581|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||43
2464018|NCT00996593|6041581|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
2464019|NCT00996593|6041581|P1|STARTED|Dosimetric and Therapeutic Treatment||43
2464020|NCT00996580|6041609|P1|NOT COMPLETED|Overall Study||1453
2464021|NCT00996580|6041609|P1|COMPLETED|Overall Study||2144
2464022|NCT00996580|6041609|P1|Pregnancy Intent-to-Treat Population|Overall Study||3019
2464023|NCT00996580|6041609|P1|STARTED|Overall Study||3597
2464024|NCT00996502|6041637|P1|NOT COMPLETED|Overall Study||0
2464025|NCT00996502|6041637|P1|COMPLETED|Overall Study||4
2464026|NCT00996502|6041637|P1|STARTED|Overall Study||4
2464027|NCT00996489|6041644|P1|NOT COMPLETED|Overall Study||161
2464028|NCT00996489|6041644|P1|COMPLETED|Overall Study||298
2464029|NCT00996489|6041644|P1|STARTED|Overall Study||459
2464030|NCT00996476|6041664|P5|NOT COMPLETED|Overall Study||2
2464031|NCT00996476|6041665|P4|NOT COMPLETED|Overall Study||0
2464032|NCT00996476|6041666|P3|NOT COMPLETED|Overall Study||1
2464033|NCT00996476|6041667|P2|NOT COMPLETED|Overall Study||3
2464034|NCT00996476|6041668|P1|NOT COMPLETED|Overall Study||1
2464035|NCT00996476|6041664|P5|COMPLETED|Overall Study||11
2464036|NCT00996476|6041665|P4|COMPLETED|Overall Study||13
2464037|NCT00996476|6041666|P3|COMPLETED|Overall Study||12
2464038|NCT00996476|6041667|P2|COMPLETED|Overall Study||23
2464039|NCT00996476|6041668|P1|COMPLETED|Overall Study||26
2464040|NCT00996476|6041664|P5|STARTED|Overall Study||13
2464041|NCT00996476|6041665|P4|STARTED|Overall Study||13
2464042|NCT00996476|6041666|P3|STARTED|Overall Study||13
2464043|NCT00996476|6041667|P2|STARTED|Overall Study||26
2464044|NCT00996476|6041668|P1|STARTED|Overall Study||27
2464045|NCT00996437|6041736|P2|NOT COMPLETED|Overall Study||7
2464046|NCT00996437|6041737|P1|NOT COMPLETED|Overall Study||5
2464047|NCT00996437|6041736|P2|COMPLETED|Overall Study||129
2464048|NCT00996437|6041737|P1|COMPLETED|Overall Study||120
2464049|NCT00996437|6041736|P2|STARTED|Overall Study||136
2464050|NCT00996437|6041737|P1|STARTED|Overall Study||125
2464051|NCT00996372|6041759|P2|NOT COMPLETED|Overall Study||84
2464052|NCT00996372|6041760|P1|NOT COMPLETED|Overall Study||103
2464053|NCT00996372|6041759|P2|COMPLETED|Overall Study||397
2464054|NCT00996372|6041760|P1|COMPLETED|Overall Study||365
2464055|NCT00996372|6041759|P2|STARTED|Overall Study||481
2464056|NCT00996372|6041760|P1|STARTED|Overall Study||468
2464057|NCT00996346|6041773|P3|NOT COMPLETED|Overall Study||0
2464058|NCT00996346|6041774|P2|NOT COMPLETED|Overall Study||0
2464059|NCT00996346|6041775|P1|NOT COMPLETED|Overall Study||0
2464060|NCT00996346|6041773|P3|COMPLETED|Overall Study||3
2464061|NCT00996346|6041774|P2|COMPLETED|Overall Study||8
2464062|NCT00996346|6041775|P1|COMPLETED|Overall Study||6
2464063|NCT00996346|6041773|P3|STARTED|Overall Study||3
2464064|NCT00996346|6041774|P2|STARTED|Overall Study||8
2464065|NCT00996346|6041775|P1|STARTED|Overall Study||6
2464066|NCT00996333|6041782|P1|NOT COMPLETED|Overall Study||13
2464067|NCT00996333|6041782|P1|COMPLETED|Overall Study||33
2464068|NCT00996333|6041782|P1|STARTED|Overall Study||46
2464069|NCT00996307|6041792|P4|NOT COMPLETED|Overall Study||21
2464070|NCT00996307|6041793|P3|NOT COMPLETED|Overall Study||14
2464071|NCT00996307|6041794|P2|NOT COMPLETED|Overall Study||17
2464072|NCT00996307|6041795|P1|NOT COMPLETED|Overall Study||20
2464073|NCT00996307|6041792|P4|COMPLETED|Overall Study||144
2464074|NCT00996307|6041793|P3|COMPLETED|Overall Study||146
2464075|NCT00996307|6041794|P2|COMPLETED|Overall Study||148
2464076|NCT00996307|6041795|P1|COMPLETED|Overall Study||144
2464077|NCT00996307|6041792|P4|STARTED|Overall Study||165
2464078|NCT00996307|6041793|P3|STARTED|Overall Study||160
2464079|NCT00996307|6041794|P2|STARTED|Overall Study||165
2464080|NCT00996307|6041795|P1|STARTED|Overall Study||164
2464081|NCT00996281|6041855|P2|NOT COMPLETED|Overall Study||89
2464082|NCT00996281|6041856|P1|NOT COMPLETED|Overall Study||131
2464083|NCT00996281|6041855|P2|COMPLETED|Overall Study||330
2464084|NCT00996281|6041856|P1|COMPLETED|Overall Study||287
2464085|NCT00996281|6041855|P2|STARTED|Overall Study||419
2464086|NCT00996281|6041856|P1|STARTED|Overall Study||418
2464087|NCT00996216|6041864|P1|NOT COMPLETED|Part 2 (Antiviral Treatment Phase)||4
2464088|NCT00996216|6041864|P1|COMPLETED|Part 2 (Antiviral Treatment Phase)||21
2464089|NCT00996216|6041864|P1|STARTED|Part 2 (Antiviral Treatment Phase)|One participant who completed Part 1 didn’t qualify to begin antiviral treatment in Part 2.|25
2464090|NCT00996216|6041864|P1|NOT COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||1
2464091|NCT00996216|6041864|P1|COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||26
2464092|NCT00996216|6041864|P1|STARTED|Part 1 (Pre-Antiviral Treatment Phase)||27
2464093|NCT00996203|6041880|P1|NOT COMPLETED|Overall Study||7
2464094|NCT00996203|6041880|P1|COMPLETED|Overall Study||194
2464095|NCT00996203|6041880|P1|STARTED|Overall Study||201
2464096|NCT00996164|6041901|P2|NOT COMPLETED|Overall Study||101
2464097|NCT00996164|6041902|P1|NOT COMPLETED|Overall Study||135
2464098|NCT00996164|6041901|P2|COMPLETED|Overall Study||446
2464099|NCT00996164|6041902|P1|COMPLETED|Overall Study||408
2464100|NCT00996164|6041901|P2|STARTED|Overall Study||547
2464101|NCT00996164|6041902|P1|STARTED|Overall Study||543
2464102|NCT00996125|6041912|P2|NOT COMPLETED|Overall Study||11
2464103|NCT00996125|6041913|P1|NOT COMPLETED|Overall Study||5
2464104|NCT00996125|6041912|P2|COMPLETED|Overall Study||365
2464105|NCT00996125|6041913|P1|COMPLETED|Overall Study||369
2464106|NCT00996125|6041912|P2|STARTED|Overall Study||376
2464107|NCT00996125|6041913|P1|STARTED|Overall Study||374
2464108|NCT00996034|6041933|P1|NOT COMPLETED|Overall Study||3
2464109|NCT00996034|6041933|P1|COMPLETED|Overall Study||11
2464110|NCT00996034|6041933|P1|STARTED|Overall Study||14
2464111|NCT00995930|6041939|P2|NOT COMPLETED|Overall Study||28
2464112|NCT00995930|6041940|P1|NOT COMPLETED|Overall Study||21
2464113|NCT00995930|6041939|P2|COMPLETED|Overall Study||67
2464114|NCT00995930|6041940|P1|COMPLETED|Overall Study||73
2464115|NCT00995930|6041939|P2|Imaging Analysis Set|Overall Study||92
2464116|NCT00995930|6041940|P1|Imaging Analysis Set|Overall Study||92
2464117|NCT00995930|6041939|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||92
2464118|NCT00995930|6041940|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||92
2464119|NCT00995930|6041939|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||95
2464120|NCT00995930|6041940|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||0
2464121|NCT00995930|6041939|P2|Safety Analysis Set|Overall Study||95
2464122|NCT00995930|6041940|P1|Safety Analysis Set|Overall Study||94
2464123|NCT00995930|6041939|P2|STARTED|Overall Study||95
2464124|NCT00995930|6041940|P1|STARTED|Overall Study||94
2464125|NCT00995904|6041969|P6|NOT COMPLETED|Follow-up Visit (Final Visit)||0
2464126|NCT00995904|6041970|P5|NOT COMPLETED|Follow-up Visit (Final Visit)||0
2464127|NCT00995904|6041971|P4|NOT COMPLETED|Follow-up Visit (Final Visit)||0
2464128|NCT00995904|6041972|P3|NOT COMPLETED|Follow-up Visit (Final Visit)||0
2464129|NCT00995904|6041973|P2|NOT COMPLETED|Follow-up Visit (Final Visit)||0
2464130|NCT00995904|6041974|P1|NOT COMPLETED|Follow-up Visit (Final Visit)||0
2464131|NCT00995904|6041969|P6|COMPLETED|Follow-up Visit (Final Visit)||3
2464132|NCT00995904|6041970|P5|COMPLETED|Follow-up Visit (Final Visit)||5
2464133|NCT00995904|6041971|P4|COMPLETED|Follow-up Visit (Final Visit)||5
2464134|NCT00995904|6041972|P3|COMPLETED|Follow-up Visit (Final Visit)||4
2464135|NCT00995904|6041973|P2|COMPLETED|Follow-up Visit (Final Visit)||3
2464136|NCT00995904|6041974|P1|COMPLETED|Follow-up Visit (Final Visit)||4
2464137|NCT00995904|6041969|P6|STARTED|Follow-up Visit (Final Visit)||3
2464138|NCT00995904|6041970|P5|STARTED|Follow-up Visit (Final Visit)||5
2464139|NCT00995904|6041971|P4|STARTED|Follow-up Visit (Final Visit)||5
2464140|NCT00995904|6041972|P3|STARTED|Follow-up Visit (Final Visit)||4
2464141|NCT00995904|6041973|P2|STARTED|Follow-up Visit (Final Visit)||3
2464142|NCT00995904|6041974|P1|STARTED|Follow-up Visit (Final Visit)||4
2464143|NCT00995904|6041969|P6|NOT COMPLETED|Visit 4||0
2464144|NCT00995904|6041970|P5|NOT COMPLETED|Visit 4||0
2464145|NCT00995904|6041971|P4|NOT COMPLETED|Visit 4||0
2464146|NCT00995904|6041972|P3|NOT COMPLETED|Visit 4||0
2464147|NCT00995904|6041973|P2|NOT COMPLETED|Visit 4||0
2464148|NCT00995904|6041974|P1|NOT COMPLETED|Visit 4||0
2464149|NCT00995904|6041969|P6|COMPLETED|Visit 4||3
2464150|NCT00995904|6041970|P5|COMPLETED|Visit 4||5
2464151|NCT00995904|6041971|P4|COMPLETED|Visit 4||5
2464152|NCT00995904|6041972|P3|COMPLETED|Visit 4||4
2464153|NCT00995904|6041973|P2|COMPLETED|Visit 4||3
2464154|NCT00995904|6041974|P1|COMPLETED|Visit 4||4
2464155|NCT00995904|6041969|P6|STARTED|Visit 4||3
2464156|NCT00995904|6041970|P5|STARTED|Visit 4||5
2464157|NCT00995904|6041971|P4|STARTED|Visit 4||5
2464158|NCT00995904|6041972|P3|STARTED|Visit 4||4
2464159|NCT00995904|6041973|P2|STARTED|Visit 4||3
2464160|NCT00995904|6041974|P1|STARTED|Visit 4||4
2464161|NCT00995904|6041969|P6|NOT COMPLETED|Visit 3||0
2464162|NCT00995904|6041970|P5|NOT COMPLETED|Visit 3||0
2464163|NCT00995904|6041971|P4|NOT COMPLETED|Visit 3||0
2464164|NCT00995904|6041972|P3|NOT COMPLETED|Visit 3||0
2464165|NCT00995904|6041973|P2|NOT COMPLETED|Visit 3||0
2464166|NCT00995904|6041974|P1|NOT COMPLETED|Visit 3||0
2464167|NCT00995904|6041969|P6|COMPLETED|Visit 3||3
2464168|NCT00995904|6041970|P5|COMPLETED|Visit 3||5
2464169|NCT00995904|6041971|P4|COMPLETED|Visit 3||5
2464170|NCT00995904|6041972|P3|COMPLETED|Visit 3||4
2464171|NCT00995904|6041973|P2|COMPLETED|Visit 3||3
2464172|NCT00995904|6041974|P1|COMPLETED|Visit 3||4
2464173|NCT00995904|6041969|P6|STARTED|Visit 3|One subject was withdrawn from the study after completion of Visit 2 but prior to Visit 3.|3
2464174|NCT00995904|6041970|P5|STARTED|Visit 3||5
2464175|NCT00995904|6041971|P4|STARTED|Visit 3||5
2464176|NCT00995904|6041972|P3|STARTED|Visit 3||4
2464177|NCT00995904|6041973|P2|STARTED|Visit 3||3
2464178|NCT00995904|6041974|P1|STARTED|Visit 3||4
2464179|NCT00995904|6041969|P6|NOT COMPLETED|Visit 2 (Randomization)||0
2464180|NCT00995904|6041970|P5|NOT COMPLETED|Visit 2 (Randomization)||0
2464181|NCT00995904|6041971|P4|NOT COMPLETED|Visit 2 (Randomization)||0
2464182|NCT00995904|6041972|P3|NOT COMPLETED|Visit 2 (Randomization)||0
2464183|NCT00995904|6041973|P2|NOT COMPLETED|Visit 2 (Randomization)||0
2464184|NCT00995904|6041974|P1|NOT COMPLETED|Visit 2 (Randomization)||0
2464185|NCT00995904|6041969|P6|COMPLETED|Visit 2 (Randomization)||4
2464186|NCT00995904|6041970|P5|COMPLETED|Visit 2 (Randomization)||5
2464187|NCT00995904|6041971|P4|COMPLETED|Visit 2 (Randomization)||5
2464188|NCT00995904|6041972|P3|COMPLETED|Visit 2 (Randomization)||4
2464189|NCT00995904|6041973|P2|COMPLETED|Visit 2 (Randomization)||3
2464190|NCT00995904|6041974|P1|COMPLETED|Visit 2 (Randomization)||4
2464191|NCT00995904|6041969|P6|STARTED|Visit 2 (Randomization)||4
2464192|NCT00995904|6041970|P5|STARTED|Visit 2 (Randomization)||5
2464193|NCT00995904|6041971|P4|STARTED|Visit 2 (Randomization)||5
2464194|NCT00995904|6041972|P3|STARTED|Visit 2 (Randomization)||4
2464195|NCT00995904|6041973|P2|STARTED|Visit 2 (Randomization)||3
2464196|NCT00995904|6041974|P1|STARTED|Visit 2 (Randomization)||4
2464197|NCT00995865|6041991|P3|NOT COMPLETED|Overall Study||1
2464198|NCT00995865|6041992|P2|NOT COMPLETED|Overall Study||0
2464199|NCT00995865|6041993|P1|NOT COMPLETED|Overall Study||2
2464200|NCT00995865|6041991|P3|COMPLETED|Overall Study||11
2464201|NCT00995865|6041992|P2|COMPLETED|Overall Study||24
2464202|NCT00995865|6041993|P1|COMPLETED|Overall Study||22
2464203|NCT00995865|6041991|P3|STARTED|Overall Study||12
2464204|NCT00995865|6041992|P2|STARTED|Overall Study||24
2464205|NCT00995865|6041993|P1|STARTED|Overall Study||24
2464206|NCT00995774|6042015|P2|NOT COMPLETED|Training Period 2||0
2464207|NCT00995774|6042016|P1|NOT COMPLETED|Training Period 2||2
2464208|NCT00995774|6042015|P2|COMPLETED|Training Period 2||5
2464209|NCT00995774|6042016|P1|COMPLETED|Training Period 2||5
2464210|NCT00995774|6042015|P2|STARTED|Training Period 2||5
2464211|NCT00995774|6042016|P1|STARTED|Training Period 2||7
2464212|NCT00995774|6042015|P2|NOT COMPLETED|Washout Period||0
2464213|NCT00995774|6042016|P1|NOT COMPLETED|Washout Period||0
2464214|NCT00995774|6042015|P2|COMPLETED|Washout Period||5
2464215|NCT00995774|6042016|P1|COMPLETED|Washout Period||7
2464216|NCT00995774|6042015|P2|STARTED|Washout Period||5
2464217|NCT00995774|6042016|P1|STARTED|Washout Period||7
2464218|NCT00995774|6042015|P2|NOT COMPLETED|Training Period 1||0
2464219|NCT00995774|6042016|P1|NOT COMPLETED|Training Period 1||0
2464220|NCT00995774|6042015|P2|COMPLETED|Training Period 1||5
2464221|NCT00995774|6042016|P1|COMPLETED|Training Period 1||7
2464222|NCT00995774|6042015|P2|STARTED|Training Period 1||5
2464223|NCT00995774|6042016|P1|STARTED|Training Period 1||7
2464224|NCT00995761|6042026|P1|NOT COMPLETED|Overall Study||0
2464225|NCT00995761|6042026|P1|COMPLETED|Overall Study||48
2464226|NCT00995761|6042026|P1|STARTED|Overall Study||48
2464227|NCT00995722|6042032|P2|NOT COMPLETED|Overall Study: 36 Weeks||2
2464228|NCT00995722|6042033|P1|NOT COMPLETED|Overall Study: 36 Weeks||2
2464229|NCT00995722|6042032|P2|COMPLETED|Overall Study: 36 Weeks||2
2464230|NCT00995722|6042033|P1|COMPLETED|Overall Study: 36 Weeks||3
2464231|NCT00995722|6042032|P2|STARTED|Overall Study: 36 Weeks||4
2464232|NCT00995722|6042033|P1|STARTED|Overall Study: 36 Weeks||5
2464233|NCT00995722|6042032|P2|NOT COMPLETED|Double Blinded: 16 Weeks||1
2464234|NCT00995722|6042033|P1|NOT COMPLETED|Double Blinded: 16 Weeks||1
2464235|NCT00995722|6042032|P2|COMPLETED|Double Blinded: 16 Weeks||4
2464236|NCT00995722|6042033|P1|COMPLETED|Double Blinded: 16 Weeks||5
2464237|NCT00995722|6042032|P2|STARTED|Double Blinded: 16 Weeks||5
2464238|NCT00995722|6042033|P1|STARTED|Double Blinded: 16 Weeks||6
2464239|NCT00995709|6042050|P3|NOT COMPLETED|Overall Study||5
2464240|NCT00995709|6042051|P2|NOT COMPLETED|Overall Study||9
2464241|NCT00995709|6042052|P1|NOT COMPLETED|Overall Study||7
2464242|NCT00995709|6042050|P3|COMPLETED|Overall Study||34
2464243|NCT00995709|6042051|P2|COMPLETED|Overall Study|patient in the 300 mg monthly group was randomized,was not eligible,never received study medication|31
2464244|NCT00995709|6042052|P1|COMPLETED|Overall Study||32
2464245|NCT00995709|6042050|P3|STARTED|Overall Study||39
2464246|NCT00995709|6042051|P2|STARTED|Overall Study||40
2464247|NCT00995709|6042052|P1|STARTED|Overall Study||39
2464248|NCT00995670|6042078|P3|NOT COMPLETED|Overall Study||3
2464249|NCT00995670|6042079|P2|NOT COMPLETED|Overall Study||0
2464250|NCT00995670|6042080|P1|NOT COMPLETED|Overall Study||1
2464251|NCT00995670|6042078|P3|COMPLETED|Overall Study|These 17 volunteers underwent 33 studies on the effect of statins, glucose, and glucose & statins.|14
2464252|NCT00995670|6042079|P2|COMPLETED|Overall Study|These 16 subjects underwent a total of 25 studies on the effect of Vitamin C.|16
2464253|NCT00995670|6042080|P1|COMPLETED|Overall Study|These 26 subjects underwent a total of 58 studies to determine the effect of dose of glucose on I/R.|25
2464254|NCT00995670|6042078|P3|STARTED|Overall Study||17
2464255|NCT00995670|6042079|P2|STARTED|Overall Study||16
2464256|NCT00995670|6042080|P1|STARTED|Overall Study||26
2464257|NCT00995566|6042088|P1|NOT COMPLETED|Overall Study||54
2464258|NCT00995566|6042088|P1|COMPLETED|Overall Study||0
2464259|NCT00995566|6042088|P1|STARTED|Overall Study||54
2464260|NCT00995553|6042102|P2|NOT COMPLETED|Overall Study||6
2464261|NCT00995553|6042103|P1|NOT COMPLETED|Overall Study||2
2464262|NCT00995553|6042102|P2|COMPLETED|Overall Study||35
2464263|NCT00995553|6042103|P1|COMPLETED|Overall Study||38
2464264|NCT00995553|6042102|P2|STARTED|Overall Study||41
2464265|NCT00995553|6042103|P1|STARTED|Overall Study||40
2464266|NCT00995501|6042119|P8|NOT COMPLETED|Overall Study||0
2464267|NCT00995501|6042120|P7|NOT COMPLETED|Overall Study||0
2464268|NCT00995501|6042121|P6|NOT COMPLETED|Overall Study||0
2464269|NCT00995501|6042122|P5|NOT COMPLETED|Overall Study||0
2464270|NCT00995501|6042123|P4|NOT COMPLETED|Overall Study||0
2464271|NCT00995501|6042124|P3|NOT COMPLETED|Overall Study||0
2464272|NCT00995501|6042125|P2|NOT COMPLETED|Overall Study||0
2464273|NCT00995501|6042126|P1|NOT COMPLETED|Overall Study||0
2464274|NCT00995501|6042119|P8|COMPLETED|Overall Study||46
2464275|NCT00995501|6042120|P7|COMPLETED|Overall Study||49
2464276|NCT00995501|6042121|P6|COMPLETED|Overall Study||44
2464277|NCT00995501|6042122|P5|COMPLETED|Overall Study||46
2464278|NCT00995501|6042123|P4|COMPLETED|Overall Study||46
2464279|NCT00995501|6042124|P3|COMPLETED|Overall Study||47
2464280|NCT00995501|6042125|P2|COMPLETED|Overall Study||51
2464281|NCT00995501|6042126|P1|COMPLETED|Overall Study||52
2464282|NCT00995501|6042119|P8|STARTED|Overall Study||46
2464283|NCT00995501|6042120|P7|STARTED|Overall Study||49
2464284|NCT00995501|6042121|P6|STARTED|Overall Study||44
2464285|NCT00995501|6042122|P5|STARTED|Overall Study||46
2464286|NCT00995501|6042123|P4|STARTED|Overall Study||46
2464287|NCT00995501|6042124|P3|STARTED|Overall Study||47
2464288|NCT00995501|6042125|P2|STARTED|Overall Study||51
2464289|NCT00995501|6042126|P1|STARTED|Overall Study||52
2464290|NCT00995488|6042152|P1|NOT COMPLETED|Overall Study||1
2464291|NCT00995488|6042152|P1|COMPLETED|Overall Study||15
2464292|NCT00995488|6042152|P1|STARTED|Overall Study||16
2464293|NCT00995475|6042157|P2|NOT COMPLETED|Second Intervention||0
2464294|NCT00995475|6042158|P1|NOT COMPLETED|Second Intervention||0
2464295|NCT00995475|6042157|P2|COMPLETED|Second Intervention||9
2464296|NCT00995475|6042158|P1|COMPLETED|Second Intervention||9
2464297|NCT00995475|6042157|P2|STARTED|Second Intervention||9
2464298|NCT00995475|6042158|P1|STARTED|Second Intervention||9
2464299|NCT00995475|6042157|P2|NOT COMPLETED|Wash-out Two Week||0
2464300|NCT00995475|6042158|P1|NOT COMPLETED|Wash-out Two Week||0
2464301|NCT00995475|6042157|P2|COMPLETED|Wash-out Two Week||9
2464302|NCT00995475|6042158|P1|COMPLETED|Wash-out Two Week||9
2464303|NCT00995475|6042157|P2|STARTED|Wash-out Two Week||9
2464304|NCT00995475|6042158|P1|STARTED|Wash-out Two Week||9
2464305|NCT00995475|6042157|P2|NOT COMPLETED|First Intervention||0
2464306|NCT00995475|6042158|P1|NOT COMPLETED|First Intervention||0
2464307|NCT00995475|6042157|P2|COMPLETED|First Intervention||9
2464308|NCT00995475|6042158|P1|COMPLETED|First Intervention||9
2464309|NCT00995475|6042157|P2|STARTED|First Intervention||9
2464310|NCT00995475|6042158|P1|STARTED|First Intervention||9
2464311|NCT00995449|6042172|P4|NOT COMPLETED|Overall Study||0
2464312|NCT00995449|6042173|P3|NOT COMPLETED|Overall Study||2
2464313|NCT00995449|6042174|P2|NOT COMPLETED|Overall Study||0
2464314|NCT00995449|6042175|P1|NOT COMPLETED|Overall Study||0
2464315|NCT00995449|6042172|P4|COMPLETED|Overall Study||2
2464316|NCT00995449|6042173|P3|COMPLETED|Overall Study||5
2464317|NCT00995449|6042174|P2|COMPLETED|Overall Study||0
2464318|NCT00995449|6042175|P1|COMPLETED|Overall Study||0
2464319|NCT00995449|6042172|P4|STARTED|Overall Study||2
2464320|NCT00995449|6042173|P3|STARTED|Overall Study||7
2464321|NCT00995449|6042174|P2|STARTED|Overall Study||0
2464322|NCT00995449|6042175|P1|STARTED|Overall Study||0
2464323|NCT00995436|6042186|P3|NOT COMPLETED|Overall Study||0
2464324|NCT00995436|6042187|P2|NOT COMPLETED|Overall Study||5
2464325|NCT00995436|6042188|P1|NOT COMPLETED|Overall Study||2
2464326|NCT00995436|6042186|P3|COMPLETED|Overall Study||26
2464327|NCT00995436|6042187|P2|COMPLETED|Overall Study||22
2464328|NCT00995436|6042188|P1|COMPLETED|Overall Study||23
2464329|NCT00995436|6042186|P3|STARTED|Overall Study||26
2464330|NCT00995436|6042187|P2|STARTED|Overall Study||27
2464331|NCT00995436|6042188|P1|STARTED|Overall Study|25|25
2464332|NCT00995410|6042196|P1|NOT COMPLETED|Overall Study||88
2464333|NCT00995410|6042196|P1|COMPLETED|Overall Study||292
2464334|NCT00995410|6042196|P1|Treated|Overall Study||379
2464335|NCT00995410|6042196|P1|STARTED|Overall Study||380
2464336|NCT00995371|6042203|P2|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
2464337|NCT00995371|6042204|P1|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
2464338|NCT00995371|6042203|P2|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 17 completed Wk 6 Intent to Treat analysis prior to x-over. After x-over 12 reported Wk 26|12
2464339|NCT00995371|6042204|P1|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 21 completed Wk 6 Intent to Treat analysis. Sixteen reported Week 26 outcomes.|16
2464340|NCT00995371|6042203|P2|STARTED|After ESI Cross-over to Mild, 26 Weeks||17
2464341|NCT00995371|6042204|P1|STARTED|After ESI Cross-over to Mild, 26 Weeks||21
2464342|NCT00995371|6042203|P2|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
2464343|NCT00995371|6042204|P1|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
2464344|NCT00995371|6042203|P2|COMPLETED|Prior to ESI Cross-over, 6 Weeks||17
2464345|NCT00995371|6042204|P1|COMPLETED|Prior to ESI Cross-over, 6 Weeks||21
2464346|NCT00995371|6042203|P2|STARTED|Prior to ESI Cross-over, 6 Weeks||17
2464347|NCT00995371|6042204|P1|STARTED|Prior to ESI Cross-over, 6 Weeks||21
2464348|NCT00995345|6042222|P5|NOT COMPLETED|Overall Study||5
2464349|NCT00995345|6042223|P4|NOT COMPLETED|Overall Study||5
2464350|NCT00995345|6042224|P3|NOT COMPLETED|Overall Study||7
2464351|NCT00995345|6042225|P2|NOT COMPLETED|Overall Study||7
2464352|NCT00995345|6042226|P1|NOT COMPLETED|Overall Study||11
2464353|NCT00995345|6042222|P5|COMPLETED|Overall Study||75
2464354|NCT00995345|6042223|P4|COMPLETED|Overall Study||76
2464355|NCT00995345|6042224|P3|COMPLETED|Overall Study||73
2464356|NCT00995345|6042225|P2|COMPLETED|Overall Study||74
2464357|NCT00995345|6042226|P1|COMPLETED|Overall Study||70
2464358|NCT00995345|6042222|P5|STARTED|Overall Study||80
2464359|NCT00995345|6042223|P4|STARTED|Overall Study||81
2464360|NCT00995345|6042224|P3|STARTED|Overall Study||80
2464361|NCT00995345|6042225|P2|STARTED|Overall Study||81
2464362|NCT00995345|6042226|P1|STARTED|Overall Study||81
2464363|NCT00995085|6042253|P1|NOT COMPLETED|Overall Study||5
2464364|NCT00995085|6042253|P1|COMPLETED|Overall Study||38
2464365|NCT00995085|6042253|P1|STARTED|Overall Study||43
2464366|NCT00995072|6042259|P2|NOT COMPLETED|Overall Study||3
2464367|NCT00995072|6042260|P1|NOT COMPLETED|Overall Study||1
2464368|NCT00995072|6042259|P2|COMPLETED|Overall Study||12
2464369|NCT00995072|6042260|P1|COMPLETED|Overall Study||9
2464370|NCT00995072|6042259|P2|STARTED|Overall Study||15
2464371|NCT00995072|6042260|P1|STARTED|Overall Study||10
2464372|NCT00995020|6042270|P2|NOT COMPLETED|Overall Study||7
2464373|NCT00995020|6042271|P1|NOT COMPLETED|Overall Study||3
2464374|NCT00995020|6042270|P2|COMPLETED|Overall Study|"Reasons for not completed:~margin analysis not performed specimen fragmentation thermal damage"|45
2464375|NCT00995020|6042271|P1|COMPLETED|Overall Study|"Reasons for not completed:~margin analysis not performed specimen fragmentation thermal damage"|48
2464376|NCT00995020|6042270|P2|STARTED|Overall Study||52
2464377|NCT00995020|6042271|P1|STARTED|Overall Study||51
2464378|NCT00995007|6042281|P2|NOT COMPLETED|Overall Study||2
2464379|NCT00995007|6042282|P1|NOT COMPLETED|Overall Study||17
2464380|NCT00995007|6042281|P2|COMPLETED|Overall Study||54
2464381|NCT00995007|6042282|P1|COMPLETED|Overall Study||39
2464382|NCT00995007|6042281|P2|Crossover to Vandetanib|Overall Study||0
2464383|NCT00995007|6042282|P1|Crossover to Vandetanib|Overall Study||42
2464384|NCT00995007|6042281|P2|STARTED|Overall Study||56
2464385|NCT00995007|6042282|P1|STARTED|Overall Study||56
2464386|NCT00994929|6042298|P1|NOT COMPLETED|Overall Study||0
2464387|NCT00994929|6042298|P1|COMPLETED|Overall Study||9
2464388|NCT00994929|6042298|P1|STARTED|Overall Study||9
2464389|NCT00994760|6042304|P1|NOT COMPLETED|Overall Study||24
2464390|NCT00994760|6042304|P1|COMPLETED|Overall Study||107
2464391|NCT00994760|6042304|P1|STARTED|Overall Study||131
2464392|NCT00994682|6042345|P2|NOT COMPLETED|Pioglitazone Open Label||7
2464393|NCT00994682|6042346|P1|NOT COMPLETED|Pioglitazone Open Label||13
2464394|NCT00994682|6042345|P2|COMPLETED|Pioglitazone Open Label||34
2464395|NCT00994682|6042346|P1|COMPLETED|Pioglitazone Open Label||29
2464396|NCT00994682|6042345|P2|STARTED|Pioglitazone Open Label||41
2464397|NCT00994682|6042346|P1|STARTED|Pioglitazone Open Label||42
2464398|NCT00994682|6042345|P2|NOT COMPLETED|Double Bilnd||9
2464399|NCT00994682|6042346|P1|NOT COMPLETED|Double Bilnd||9
2464400|NCT00994682|6042345|P2|COMPLETED|Double Bilnd||41
2464401|NCT00994682|6042346|P1|COMPLETED|Double Bilnd||42
2464402|NCT00994682|6042345|P2|STARTED|Double Bilnd||50
2464403|NCT00994682|6042346|P1|STARTED|Double Bilnd||51
2464404|NCT00994643|6042390|P1|NOT COMPLETED|Overall Study||1
2464405|NCT00994643|6042390|P1|COMPLETED|Overall Study||10
2464406|NCT00994643|6042390|P1|STARTED|Overall Study||11
2464407|NCT00994604|6042394|P1|NOT COMPLETED|Overall Study||6
2464408|NCT00994604|6042394|P1|COMPLETED|Overall Study||45
2464409|NCT00994604|6042394|P1|STARTED|Overall Study||51
2464410|NCT00994461|6042404|P3|NOT COMPLETED|Overall Study||0
2464411|NCT00994461|6042405|P2|NOT COMPLETED|Overall Study||1
2464412|NCT00994461|6042406|P1|NOT COMPLETED|Overall Study||2
2464413|NCT00994461|6042404|P3|COMPLETED|Overall Study||37
2464414|NCT00994461|6042405|P2|COMPLETED|Overall Study||75
2464415|NCT00994461|6042406|P1|COMPLETED|Overall Study||74
2464416|NCT00994461|6042404|P3|STARTED|Overall Study|One subject was randomized but did not receive study drug.|37
2464417|NCT00994461|6042405|P2|STARTED|Overall Study||76
2464418|NCT00994461|6042406|P1|STARTED|Overall Study||76
2464419|NCT00994448|6042434|P2|NOT COMPLETED|Overall Study||2
2464420|NCT00994448|6042435|P1|NOT COMPLETED|Overall Study||8
2464421|NCT00994448|6042434|P2|COMPLETED|Overall Study||5
2464422|NCT00994448|6042435|P1|COMPLETED|Overall Study||4
2464423|NCT00994448|6042434|P2|STARTED|Overall Study||7
2464424|NCT00994448|6042435|P1|STARTED|Overall Study||12
2464425|NCT00994422|6042443|P2|NOT COMPLETED|Overall Study||1
2464426|NCT00994422|6042444|P1|NOT COMPLETED|Overall Study||7
2464427|NCT00994422|6042443|P2|COMPLETED|Overall Study||54
2464428|NCT00994422|6042444|P1|COMPLETED|Overall Study||185
2464429|NCT00994422|6042443|P2|STARTED|Overall Study||55
2464430|NCT00994422|6042444|P1|STARTED|Overall Study||192
2464431|NCT00994318|6042457|P3|NOT COMPLETED|Overall Study||67
2464432|NCT00994318|6042458|P2|NOT COMPLETED|Overall Study||18
2464433|NCT00994318|6042459|P1|NOT COMPLETED|Overall Study||22
2464434|NCT00994318|6042457|P3|COMPLETED|Overall Study||250
2464435|NCT00994318|6042458|P2|COMPLETED|Overall Study||136
2464436|NCT00994318|6042459|P1|COMPLETED|Overall Study||133
2464437|NCT00994318|6042457|P3|STARTED|Overall Study||317
2464438|NCT00994318|6042458|P2|STARTED|Overall Study||154
2464439|NCT00994318|6042459|P1|STARTED|Overall Study||155
2464440|NCT00994279|6042469|P2|NOT COMPLETED|Overall Study||5
2464441|NCT00994279|6042470|P1|NOT COMPLETED|Overall Study||4
2464442|NCT00994279|6042469|P2|COMPLETED|Overall Study||13
2464443|NCT00994279|6042470|P1|COMPLETED|Overall Study||18
2464444|NCT00994279|6042469|P2|STARTED|Overall Study||18
2464445|NCT00994279|6042470|P1|STARTED|Overall Study||22
2464446|NCT00994240|6042480|P2|NOT COMPLETED|Overall Study||5
2464447|NCT00994240|6042481|P1|NOT COMPLETED|Overall Study||6
2464448|NCT00994240|6042480|P2|COMPLETED|Overall Study||39
2464449|NCT00994240|6042481|P1|COMPLETED|Overall Study||35
2464450|NCT00994240|6042480|P2|STARTED|Overall Study||44
2464451|NCT00994240|6042481|P1|STARTED|Overall Study||41
2464452|NCT00994214|6042491|P4|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
2464453|NCT00994214|6042492|P3|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||2
2464454|NCT00994214|6042493|P2|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
2464455|NCT00994214|6042494|P1|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||4
2464456|NCT00994214|6042491|P4|COMPLETED|ITT (Intention-to-Treat) - Part B||0
2464457|NCT00994214|6042492|P3|COMPLETED|ITT (Intention-to-Treat) - Part B||0
2464458|NCT00994214|6042493|P2|COMPLETED|ITT (Intention-to-Treat) - Part B||0
2464459|NCT00994214|6042494|P1|COMPLETED|ITT (Intention-to-Treat) - Part B||0
2464460|NCT00994214|6042491|P4|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||3
2464461|NCT00994214|6042492|P3|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||2
2464462|NCT00994214|6042493|P2|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
2464463|NCT00994214|6042494|P1|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
2464464|NCT00994214|6042491|P4|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
2464465|NCT00994214|6042492|P3|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
2464466|NCT00994214|6042493|P2|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||3
2464467|NCT00994214|6042494|P1|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||1
2464468|NCT00994214|6042491|P4|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
2464469|NCT00994214|6042492|P3|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
2464470|NCT00994214|6042493|P2|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
2464471|NCT00994214|6042494|P1|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||3
2464472|NCT00994214|6042491|P4|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
2464473|NCT00994214|6042492|P3|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
2464474|NCT00994214|6042493|P2|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
2464475|NCT00994214|6042494|P1|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
2464476|NCT00994214|6042491|P4|STARTED|ITT (Intention-to-Treat) - Part B|2 subjects did not enter Part B Arm D|3
2464477|NCT00994214|6042492|P3|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm C|2
2464478|NCT00994214|6042493|P2|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm B|3
2464479|NCT00994214|6042494|P1|STARTED|ITT (Intention-to-Treat) - Part B|1 subject did not enter Part B Arm A|4
2464480|NCT00994214|6042491|P4|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||15
2464481|NCT00994214|6042492|P3|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
2464482|NCT00994214|6042493|P2|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
2464483|NCT00994214|6042494|P1|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||14
2464484|NCT00994214|6042491|P4|COMPLETED|ITT (Intention-to-Treat) - Part A||5
2464485|NCT00994214|6042492|P3|COMPLETED|ITT (Intention-to-Treat) - Part A||5
2464486|NCT00994214|6042493|P2|COMPLETED|ITT (Intention-to-Treat) - Part A||6
2464487|NCT00994214|6042494|P1|COMPLETED|ITT (Intention-to-Treat) - Part A||5
2464488|NCT00994214|6042491|P4|STARTED|ITT (Intention-to-Treat) - Part A||20
2464489|NCT00994214|6042492|P3|STARTED|ITT (Intention-to-Treat) - Part A||18
2464490|NCT00994214|6042493|P2|STARTED|ITT (Intention-to-Treat) - Part A||19
2464491|NCT00994214|6042494|P1|STARTED|ITT (Intention-to-Treat) - Part A||19
2464492|NCT00994175|6042538|P2|NOT COMPLETED|Second Intervention||0
2464493|NCT00994175|6042539|P1|NOT COMPLETED|Second Intervention||0
2464494|NCT00994175|6042538|P2|COMPLETED|Second Intervention||8
2464495|NCT00994175|6042539|P1|COMPLETED|Second Intervention||4
2464496|NCT00994175|6042538|P2|STARTED|Second Intervention||8
2464497|NCT00994175|6042539|P1|STARTED|Second Intervention||4
2464498|NCT00994175|6042538|P2|NOT COMPLETED|First Intervention||1
2464499|NCT00994175|6042539|P1|NOT COMPLETED|First Intervention||2
2464500|NCT00994175|6042538|P2|COMPLETED|First Intervention||8
2464501|NCT00994175|6042539|P1|COMPLETED|First Intervention||4
2464502|NCT00994175|6042538|P2|STARTED|First Intervention||9
2464503|NCT00994175|6042539|P1|STARTED|First Intervention||6
2464504|NCT00994123|6042550|P3|NOT COMPLETED|Overall Study||0
2464505|NCT00994123|6042551|P2|NOT COMPLETED|Overall Study||0
2464506|NCT00994123|6042552|P1|NOT COMPLETED|Overall Study||0
2464507|NCT00994123|6042550|P3|COMPLETED|Overall Study||44
2464508|NCT00994123|6042551|P2|COMPLETED|Overall Study||85
2464509|NCT00994123|6042552|P1|COMPLETED|Overall Study||33
2464510|NCT00994123|6042550|P3|STARTED|Overall Study||44
2464511|NCT00994123|6042551|P2|STARTED|Overall Study||85
2464512|NCT00994123|6042552|P1|STARTED|Overall Study||33
2464513|NCT00994110|6042573|P2|NOT COMPLETED|Overall Study||74
2464514|NCT00994110|6042574|P1|NOT COMPLETED|Overall Study||65
2464515|NCT00994110|6042573|P2|COMPLETED|Overall Study||148
2464516|NCT00994110|6042574|P1|COMPLETED|Overall Study||152
2464517|NCT00994110|6042573|P2|STARTED|Overall Study||222
2464518|NCT00994110|6042574|P1|STARTED|Overall Study||217
2464519|NCT00993967|6042580|P1|NOT COMPLETED|Overall Study||61
2464520|NCT00993967|6042580|P1|COMPLETED|Overall Study||139
2464521|NCT00993967|6042580|P1|STARTED|Overall Study||200
2464522|NCT00993954|6042587|P2|NOT COMPLETED|Overall Study||2
2464523|NCT00993954|6042588|P1|NOT COMPLETED|Overall Study||21
2464524|NCT00993954|6042587|P2|COMPLETED|Overall Study||121
2464525|NCT00993954|6042588|P1|COMPLETED|Overall Study||124
2464526|NCT00993954|6042587|P2|STARTED|Overall Study||123
2464527|NCT00993954|6042588|P1|STARTED|Overall Study||145
2464528|NCT00993928|6042601|P2|NOT COMPLETED|Overall Study||7
2464529|NCT00993928|6042602|P1|NOT COMPLETED|Overall Study||5
2464530|NCT00993928|6042601|P2|COMPLETED|Overall Study||38
2464531|NCT00993928|6042602|P1|COMPLETED|Overall Study||43
2464532|NCT00993928|6042601|P2|STARTED|Overall Study||45
2464533|NCT00993928|6042602|P1|STARTED|Overall Study||48
2464534|NCT00993915|6042616|P1|NOT COMPLETED|Overall Study||9
2464535|NCT00993915|6042616|P1|COMPLETED|Overall Study||678
2464536|NCT00993915|6042616|P1|STARTED|Overall Study||687
2464537|NCT00993824|6042627|P2|NOT COMPLETED|Overall Study||0
2464538|NCT00993824|6042628|P1|NOT COMPLETED|Overall Study||0
2464539|NCT00993824|6042627|P2|COMPLETED|Overall Study||10
2464540|NCT00993824|6042628|P1|COMPLETED|Overall Study||11
2464541|NCT00993824|6042627|P2|STARTED|Overall Study||10
2464542|NCT00993824|6042628|P1|STARTED|Overall Study||11
2464543|NCT00993668|6042642|P2|NOT COMPLETED|Open-Label Period||15
2464544|NCT00993668|6042643|P1|NOT COMPLETED|Open-Label Period||23
2464545|NCT00993668|6042642|P2|COMPLETED|Open-Label Period||91
2464546|NCT00993668|6042643|P1|COMPLETED|Open-Label Period||86
2464547|NCT00993668|6042642|P2|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|106
2464548|NCT00993668|6042643|P1|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|109
2464549|NCT00993668|6042642|P2|NOT COMPLETED|Single-Blind Period||3
2464550|NCT00993668|6042643|P1|NOT COMPLETED|Single-Blind Period||4
2464551|NCT00993668|6042642|P2|COMPLETED|Single-Blind Period||107
2464552|NCT00993668|6042643|P1|COMPLETED|Single-Blind Period||110
2464553|NCT00993668|6042642|P2|STARTED|Single-Blind Period||110
2464554|NCT00993668|6042643|P1|STARTED|Single-Blind Period||114
2464555|NCT00993655|6042671|P3|NOT COMPLETED|Overall Study||0
2464556|NCT00993655|6042672|P2|NOT COMPLETED|Overall Study||0
2464557|NCT00993655|6042673|P1|NOT COMPLETED|Overall Study||0
2464558|NCT00993655|6042671|P3|COMPLETED|Overall Study||102
2464559|NCT00993655|6042672|P2|COMPLETED|Overall Study||72
2464560|NCT00993655|6042673|P1|COMPLETED|Overall Study||101
2464561|NCT00993655|6042671|P3|STARTED|Overall Study||102
2464562|NCT00993655|6042672|P2|STARTED|Overall Study||72
2464563|NCT00993655|6042673|P1|STARTED|Overall Study||101
2464564|NCT00993616|6042687|P1|NOT COMPLETED|Overall Study||2
2464565|NCT00993616|6042687|P1|COMPLETED|Overall Study|Number of eligible and evaluable participants|27
2464566|NCT00993616|6042687|P1|STARTED|Overall Study||29
2464567|NCT00993499|6042705|P6|NOT COMPLETED|Discontinued After Starting Course 3||3
2464568|NCT00993499|6042706|P5|NOT COMPLETED|Discontinued After Starting Course 3||3
2464569|NCT00993499|6042707|P4|NOT COMPLETED|Discontinued After Starting Course 3||2
2464570|NCT00993499|6042708|P3|NOT COMPLETED|Discontinued After Starting Course 3||6
2464571|NCT00993499|6042709|P2|NOT COMPLETED|Discontinued After Starting Course 3||5
2464572|NCT00993499|6042710|P1|NOT COMPLETED|Discontinued After Starting Course 3||8
2464573|NCT00993499|6042705|P6|COMPLETED|Discontinued After Starting Course 3||0
2464574|NCT00993499|6042706|P5|COMPLETED|Discontinued After Starting Course 3||0
2464575|NCT00993499|6042707|P4|COMPLETED|Discontinued After Starting Course 3||1
2464576|NCT00993499|6042708|P3|COMPLETED|Discontinued After Starting Course 3||3
2464577|NCT00993499|6042709|P2|COMPLETED|Discontinued After Starting Course 3||4
2464578|NCT00993499|6042710|P1|COMPLETED|Discontinued After Starting Course 3||4
2464579|NCT00993499|6042705|P6|STARTED|Discontinued After Starting Course 3||3
2464580|NCT00993499|6042706|P5|STARTED|Discontinued After Starting Course 3||3
2464581|NCT00993499|6042707|P4|STARTED|Discontinued After Starting Course 3||3
2464582|NCT00993499|6042708|P3|STARTED|Discontinued After Starting Course 3||9
2464583|NCT00993499|6042709|P2|STARTED|Discontinued After Starting Course 3||9
2464584|NCT00993499|6042710|P1|STARTED|Discontinued After Starting Course 3||12
2464585|NCT00993499|6042705|P6|NOT COMPLETED|Discontinued Before Starting Course 3||0
2464586|NCT00993499|6042706|P5|NOT COMPLETED|Discontinued Before Starting Course 3||0
2464587|NCT00993499|6042707|P4|NOT COMPLETED|Discontinued Before Starting Course 3||1
2464588|NCT00993499|6042708|P3|NOT COMPLETED|Discontinued Before Starting Course 3||3
2464589|NCT00993499|6042709|P2|NOT COMPLETED|Discontinued Before Starting Course 3||4
2464590|NCT00993499|6042710|P1|NOT COMPLETED|Discontinued Before Starting Course 3||4
2464591|NCT00993499|6042705|P6|COMPLETED|Discontinued Before Starting Course 3||3
2464592|NCT00993499|6042706|P5|COMPLETED|Discontinued Before Starting Course 3||3
2464593|NCT00993499|6042707|P4|COMPLETED|Discontinued Before Starting Course 3||2
2464594|NCT00993499|6042708|P3|COMPLETED|Discontinued Before Starting Course 3||6
2464595|NCT00993499|6042709|P2|COMPLETED|Discontinued Before Starting Course 3||5
2464596|NCT00993499|6042710|P1|COMPLETED|Discontinued Before Starting Course 3||8
2464597|NCT00993499|6042705|P6|STARTED|Discontinued Before Starting Course 3||3
2464598|NCT00993499|6042706|P5|STARTED|Discontinued Before Starting Course 3||3
2464599|NCT00993499|6042707|P4|STARTED|Discontinued Before Starting Course 3||3
2464600|NCT00993499|6042708|P3|STARTED|Discontinued Before Starting Course 3||9
2464601|NCT00993499|6042709|P2|STARTED|Discontinued Before Starting Course 3||9
2464602|NCT00993499|6042710|P1|STARTED|Discontinued Before Starting Course 3||12
2464603|NCT00993499|6042705|P6|NOT COMPLETED|Run-in Period (8 Days)||0
2464604|NCT00993499|6042706|P5|NOT COMPLETED|Run-in Period (8 Days)||0
2464605|NCT00993499|6042707|P4|NOT COMPLETED|Run-in Period (8 Days)||0
2464606|NCT00993499|6042708|P3|NOT COMPLETED|Run-in Period (8 Days)||1
2464607|NCT00993499|6042709|P2|NOT COMPLETED|Run-in Period (8 Days)||3
2464608|NCT00993499|6042710|P1|NOT COMPLETED|Run-in Period (8 Days)||1
2464609|NCT00993499|6042705|P6|COMPLETED|Run-in Period (8 Days)||3
2464610|NCT00993499|6042706|P5|COMPLETED|Run-in Period (8 Days)||3
2464611|NCT00993499|6042707|P4|COMPLETED|Run-in Period (8 Days)||3
2464612|NCT00993499|6042708|P3|COMPLETED|Run-in Period (8 Days)||9
2464613|NCT00993499|6042709|P2|COMPLETED|Run-in Period (8 Days)||9
2464614|NCT00993499|6042710|P1|COMPLETED|Run-in Period (8 Days)||12
2464615|NCT00993499|6042705|P6|STARTED|Run-in Period (8 Days)||3
2464616|NCT00993499|6042706|P5|STARTED|Run-in Period (8 Days)||3
2464617|NCT00993499|6042707|P4|STARTED|Run-in Period (8 Days)||3
2464618|NCT00993499|6042708|P3|STARTED|Run-in Period (8 Days)||10
2464619|NCT00993499|6042709|P2|STARTED|Run-in Period (8 Days)||12
2464620|NCT00993499|6042710|P1|STARTED|Run-in Period (8 Days)||13
2464621|NCT00993473|6042792|P2|NOT COMPLETED|Overall Study||10
2464622|NCT00993473|6042793|P1|NOT COMPLETED|Overall Study||4
2464623|NCT00993473|6042792|P2|COMPLETED|Overall Study||54
2464624|NCT00993473|6042793|P1|COMPLETED|Overall Study||57
2464625|NCT00993473|6042792|P2|STARTED|Overall Study|64 patients randomized to NPH but only 63 patients treated with NPH due to a dispensation's error|64
2464626|NCT00993473|6042793|P1|STARTED|Overall Study|61 patients randomized to Lantus but 62 patients treated with Lantus due to a dispensation's error|61
2464627|NCT00993447|6042831|P2|NOT COMPLETED|Overall Study||19
2464628|NCT00993447|6042832|P1|NOT COMPLETED|Overall Study||37
2464629|NCT00993447|6042831|P2|COMPLETED|Overall Study||180
2464630|NCT00993447|6042832|P1|COMPLETED|Overall Study||364
2464631|NCT00993447|6042831|P2|STARTED|Overall Study||199
2464632|NCT00993447|6042832|P1|STARTED|Overall Study||401
2464633|NCT00993421|6042869|P7|NOT COMPLETED|Overall Study||42
2464634|NCT00993421|6042870|P6|NOT COMPLETED|Overall Study||46
2464635|NCT00993421|6042871|P5|NOT COMPLETED|Overall Study||46
2464636|NCT00993421|6042872|P4|NOT COMPLETED|Overall Study||45
2464637|NCT00993421|6042873|P3|NOT COMPLETED|Overall Study||43
2464638|NCT00993421|6042874|P2|NOT COMPLETED|Overall Study||45
2464639|NCT00993421|6042875|P1|NOT COMPLETED|Overall Study||44
2464640|NCT00993421|6042869|P7|COMPLETED|Overall Study||4
2464641|NCT00993421|6042870|P6|COMPLETED|Overall Study||4
2464642|NCT00993421|6042871|P5|COMPLETED|Overall Study||6
2464643|NCT00993421|6042872|P4|COMPLETED|Overall Study||4
2464644|NCT00993421|6042873|P3|COMPLETED|Overall Study||5
2464645|NCT00993421|6042874|P2|COMPLETED|Overall Study||4
2464646|NCT00993421|6042875|P1|COMPLETED|Overall Study||5
2464647|NCT00993421|6042869|P7|STARTED|Overall Study||46
2464648|NCT00993421|6042870|P6|STARTED|Overall Study||50
2464649|NCT00993421|6042871|P5|STARTED|Overall Study||52
2464650|NCT00993421|6042872|P4|STARTED|Overall Study||49
2464651|NCT00993421|6042873|P3|STARTED|Overall Study||48
2464652|NCT00993421|6042874|P2|STARTED|Overall Study||49
2464653|NCT00993421|6042875|P1|STARTED|Overall Study||49
2464654|NCT00993317|6043026|P2|NOT COMPLETED|Overall Study||25
2464655|NCT00993317|6043027|P1|NOT COMPLETED|Overall Study||21
2464656|NCT00993317|6043026|P2|COMPLETED|Overall Study||60
2464657|NCT00993317|6043027|P1|COMPLETED|Overall Study||21
2464658|NCT00993317|6043026|P2|STARTED|Overall Study||85
2464659|NCT00993317|6043027|P1|STARTED|Overall Study||42
2464660|NCT00993291|6043045|P1|NOT COMPLETED|Overall Study||1
2464661|NCT00993291|6043045|P1|COMPLETED|Overall Study||19
2464662|NCT00993291|6043045|P1|STARTED|Overall Study||20
2464663|NCT00993265|6043051|P2|NOT COMPLETED|Overall Study||0
2464664|NCT00993265|6043052|P1|NOT COMPLETED|Overall Study||4
2464665|NCT00993265|6043051|P2|COMPLETED|Overall Study||19
2464666|NCT00993265|6043052|P1|COMPLETED|Overall Study||16
2464667|NCT00993265|6043051|P2|STARTED|Overall Study||19
2464668|NCT00993265|6043052|P1|STARTED|Overall Study||20
2464669|NCT00993200|6043072|P2|NOT COMPLETED|Overall Study||0
2464670|NCT00993200|6043073|P1|NOT COMPLETED|Overall Study||0
2464671|NCT00993200|6043072|P2|COMPLETED|Overall Study||13
2464672|NCT00993200|6043073|P1|COMPLETED|Overall Study||13
2464673|NCT00993200|6043072|P2|STARTED|Overall Study||13
2464674|NCT00993200|6043073|P1|STARTED|Overall Study||13
2464675|NCT00993187|6043085|P2|NOT COMPLETED|Overall Study||37
2464676|NCT00993187|6043086|P1|NOT COMPLETED|Overall Study||26
2464677|NCT00993187|6043085|P2|COMPLETED|Overall Study||108
2464678|NCT00993187|6043086|P1|COMPLETED|Overall Study||121
2464679|NCT00993187|6043085|P2|Received at Least 1 Dose of Study Drug|Overall Study||144
2464680|NCT00993187|6043086|P1|Received at Least 1 Dose of Study Drug|Overall Study||146
2464681|NCT00993187|6043085|P2|STARTED|Overall Study||145
2464682|NCT00993187|6043086|P1|STARTED|Overall Study||147
2464683|NCT00993148|6043104|P1|NOT COMPLETED|Overall Study||3
2464684|NCT00993148|6043104|P1|COMPLETED|Overall Study||22
2464685|NCT00993148|6043104|P1|STARTED|Overall Study||25
2464686|NCT00993044|6043116|P1|NOT COMPLETED|Irinotecan 50 mg||1
2464687|NCT00993044|6043116|P1|COMPLETED|Irinotecan 50 mg||6
2464688|NCT00993044|6043116|P1|STARTED|Irinotecan 50 mg||7
2464689|NCT00993044|6043116|P1|NOT COMPLETED|Irinotecan 30 mg||0
2464690|NCT00993044|6043116|P1|COMPLETED|Irinotecan 30 mg||6
2464691|NCT00993044|6043116|P1|STARTED|Irinotecan 30 mg||6
2464692|NCT00993031|6043123|P2|NOT COMPLETED|Overall Study||19
2464693|NCT00993031|6043124|P1|NOT COMPLETED|Overall Study||22
2464694|NCT00993031|6043123|P2|COMPLETED|Overall Study||175
2464695|NCT00993031|6043124|P1|COMPLETED|Overall Study||173
2464696|NCT00993031|6043123|P2|Delivered|Overall Study||190
2464697|NCT00993031|6043124|P1|Delivered|Overall Study||187
2464698|NCT00993031|6043123|P2|STARTED|Overall Study||194
2464699|NCT00993031|6043124|P1|STARTED|Overall Study||195
2464700|NCT00992992|6043156|P1|NOT COMPLETED|Overall Study||25
2464701|NCT00992992|6043156|P1|COMPLETED|Overall Study||0
2464702|NCT00992992|6043156|P1|STARTED|Overall Study||25
2464703|NCT00992927|6043178|P2|NOT COMPLETED|Overall Study||0
2464704|NCT00992927|6043179|P1|NOT COMPLETED|Overall Study||0
2464705|NCT00992927|6043178|P2|COMPLETED|Overall Study||22
2464706|NCT00992927|6043179|P1|COMPLETED|Overall Study||32
2464707|NCT00992927|6043178|P2|STARTED|Overall Study||22
2464708|NCT00992927|6043179|P1|STARTED|Overall Study||32
2464709|NCT00992836|6043187|P1|NOT COMPLETED|Overall Study||5
2464710|NCT00992836|6043187|P1|COMPLETED|Overall Study||150
2464711|NCT00992836|6043187|P1|Received Both Study Vaccinations|Overall Study||150
2464712|NCT00992836|6043187|P1|STARTED|Overall Study||155
2464713|NCT00992784|6043202|P3|NOT COMPLETED|Overall Study||1
2464714|NCT00992784|6043203|P2|NOT COMPLETED|Overall Study||2
2464715|NCT00992784|6043204|P1|NOT COMPLETED|Overall Study||3
2464716|NCT00992784|6043202|P3|COMPLETED|Overall Study||85
2464717|NCT00992784|6043203|P2|COMPLETED|Overall Study||102
2464718|NCT00992784|6043204|P1|COMPLETED|Overall Study||177
2464719|NCT00992784|6043202|P3|STARTED|Overall Study||86
2464720|NCT00992784|6043203|P2|STARTED|Overall Study||104
2464721|NCT00992784|6043204|P1|STARTED|Overall Study||180
2464722|NCT00992719|6043275|P3|NOT COMPLETED|Overall Study||0
2464723|NCT00992719|6043276|P2|NOT COMPLETED|Overall Study||1
2464724|NCT00992719|6043277|P1|NOT COMPLETED|Overall Study||1
2464725|NCT00992719|6043275|P3|COMPLETED|Overall Study||28
2464726|NCT00992719|6043276|P2|COMPLETED|Overall Study||27
2464727|NCT00992719|6043277|P1|COMPLETED|Overall Study||27
2464728|NCT00992719|6043275|P3|STARTED|Overall Study||28
2464729|NCT00992719|6043276|P2|STARTED|Overall Study||28
2464730|NCT00992719|6043277|P1|STARTED|Overall Study||28
2464731|NCT00992602|6043311|P1|NOT COMPLETED|Overall Study||3
2464732|NCT00992602|6043311|P1|COMPLETED|Overall Study||0
2464733|NCT00992602|6043311|P1|STARTED|Overall Study||3
2464734|NCT00992589|6043316|P4|NOT COMPLETED|Double-Blind Phase||10
2464735|NCT00992589|6043317|P3|NOT COMPLETED|Double-Blind Phase||13
2464736|NCT00992589|6043318|P2|NOT COMPLETED|Double-Blind Phase||13
2464737|NCT00992589|6043319|P1|NOT COMPLETED|Double-Blind Phase||0
2464738|NCT00992589|6043316|P4|COMPLETED|Double-Blind Phase||78
2464739|NCT00992589|6043317|P3|COMPLETED|Double-Blind Phase||77
2464740|NCT00992589|6043318|P2|COMPLETED|Double-Blind Phase||76
2464741|NCT00992589|6043319|P1|COMPLETED|Double-Blind Phase||0
2464742|NCT00992589|6043316|P4|STARTED|Double-Blind Phase||88
2464743|NCT00992589|6043317|P3|STARTED|Double-Blind Phase||90
2464744|NCT00992589|6043318|P2|STARTED|Double-Blind Phase||89
2464745|NCT00992589|6043319|P1|STARTED|Double-Blind Phase||0
2464746|NCT00992589|6043316|P4|NOT COMPLETED|Open-Label Phase||0
2464747|NCT00992589|6043317|P3|NOT COMPLETED|Open-Label Phase||0
2464748|NCT00992589|6043318|P2|NOT COMPLETED|Open-Label Phase||0
2464749|NCT00992589|6043319|P1|NOT COMPLETED|Open-Label Phase||77
2464750|NCT00992589|6043316|P4|COMPLETED|Open-Label Phase||0
2464751|NCT00992589|6043317|P3|COMPLETED|Open-Label Phase||0
2464752|NCT00992589|6043318|P2|COMPLETED|Open-Label Phase||0
2464753|NCT00992589|6043319|P1|COMPLETED|Open-Label Phase||267
2464754|NCT00992589|6043316|P4|STARTED|Open-Label Phase||0
2464755|NCT00992589|6043317|P3|STARTED|Open-Label Phase||0
2464756|NCT00992589|6043318|P2|STARTED|Open-Label Phase||0
2464757|NCT00992589|6043319|P1|STARTED|Open-Label Phase||344
2464758|NCT00992511|6043365|P4|NOT COMPLETED|Overall Study||5
2464759|NCT00992511|6043366|P3|NOT COMPLETED|Overall Study||2
2464760|NCT00992511|6043367|P2|NOT COMPLETED|Overall Study||0
2464761|NCT00992511|6043368|P1|NOT COMPLETED|Overall Study||2
2464762|NCT00992511|6043365|P4|COMPLETED|Overall Study||70
2464763|NCT00992511|6043366|P3|COMPLETED|Overall Study||74
2464764|NCT00992511|6043367|P2|COMPLETED|Overall Study||73
2464765|NCT00992511|6043368|P1|COMPLETED|Overall Study||74
2464766|NCT00992511|6043365|P4|STARTED|Overall Study||75
2464767|NCT00992511|6043366|P3|STARTED|Overall Study||76
2464768|NCT00992511|6043367|P2|STARTED|Overall Study||73
2464769|NCT00992511|6043368|P1|STARTED|Overall Study||76
2464770|NCT00992459|6043452|P2|NOT COMPLETED|Overall Study||1
2464771|NCT00992459|6043453|P1|NOT COMPLETED|Overall Study||1
2464772|NCT00992459|6043452|P2|COMPLETED|Overall Study|Totals enrolled and completed in Arm B HPN 100 treatment + NaPBA Placebo are not mutually exclusive.|23
2464773|NCT00992459|6043453|P1|COMPLETED|Overall Study|Totals enrolled and completed in Arm A NaPBA treatment + HPN 100 Placebo are not mutually exclusive.|21
2464774|NCT00992459|6043452|P2|STARTED|Overall Study|All patients received NaPBA placebo in Arm B (+ concomitant active HPN 100)|24
2464775|NCT00992459|6043453|P1|STARTED|Overall Study|All patients received HPN 100 placebo in Arm A (+ concomitant active NaPBA)|22
2464776|NCT00992446|6043477|P1|NOT COMPLETED|Overall Study||8
2464777|NCT00992446|6043477|P1|COMPLETED|Overall Study||19
2464778|NCT00992446|6043477|P1|STARTED|Overall Study||27
2464779|NCT00992433|6043484|P2|NOT COMPLETED|Overall Study||7
2464780|NCT00992433|6043485|P1|NOT COMPLETED|Overall Study||4
2464781|NCT00992433|6043484|P2|COMPLETED|Overall Study||90
2464782|NCT00992433|6043485|P1|COMPLETED|Overall Study||91
2464783|NCT00992433|6043484|P2|STARTED|Overall Study||97
2464784|NCT00992433|6043485|P1|STARTED|Overall Study||95
2464785|NCT00992407|6043549|P2|NOT COMPLETED|Overall Study||24
2464786|NCT00992407|6043550|P1|NOT COMPLETED|Overall Study||31
2464787|NCT00992407|6043549|P2|COMPLETED|Overall Study||14
2464788|NCT00992407|6043550|P1|COMPLETED|Overall Study||6
2464789|NCT00992407|6043549|P2|Treated|Overall Study||25
2464790|NCT00992407|6043550|P1|Treated|Overall Study||20
2464791|NCT00992407|6043549|P2|STARTED|Overall Study||38
2464792|NCT00992407|6043550|P1|STARTED|Overall Study||37
2464793|NCT00992394|6043600|P2|NOT COMPLETED|Overall Study||14
2464794|NCT00992394|6043601|P1|NOT COMPLETED|Overall Study||24
2464795|NCT00992394|6043600|P2|COMPLETED|Overall Study||72
2464796|NCT00992394|6043601|P1|COMPLETED|Overall Study||64
2464797|NCT00992394|6043600|P2|mITT Population|Overall Study||84
2464798|NCT00992394|6043601|P1|mITT Population|Overall Study||86
2464799|NCT00992394|6043600|P2|Safety Population|Overall Study||84
2464800|NCT00992394|6043601|P1|Safety Population|Overall Study||87
2464801|NCT00992394|6043600|P2|STARTED|Overall Study||86
2464802|NCT00992394|6043601|P1|STARTED|Overall Study||88
2464803|NCT00992264|6043659|P16|NOT COMPLETED|Overall Study||0
2464804|NCT00992264|6043660|P15|NOT COMPLETED|Overall Study||0
2464805|NCT00992264|6043661|P14|NOT COMPLETED|Overall Study||0
2464806|NCT00992264|6043662|P13|NOT COMPLETED|Overall Study||0
2464807|NCT00992264|6043663|P12|NOT COMPLETED|Overall Study||0
2464808|NCT00992264|6043664|P11|NOT COMPLETED|Overall Study||0
2464809|NCT00992264|6043665|P10|NOT COMPLETED|Overall Study||0
2464810|NCT00992264|6043666|P9|NOT COMPLETED|Overall Study||0
2464811|NCT00992264|6043667|P8|NOT COMPLETED|Overall Study||0
2464812|NCT00992264|6043668|P7|NOT COMPLETED|Overall Study||0
2464813|NCT00992264|6043669|P6|NOT COMPLETED|Overall Study||0
2464814|NCT00992264|6043670|P5|NOT COMPLETED|Overall Study||0
2464815|NCT00992264|6043671|P4|NOT COMPLETED|Overall Study||0
2464816|NCT00992264|6043672|P3|NOT COMPLETED|Overall Study||0
2464817|NCT00992264|6043673|P2|NOT COMPLETED|Overall Study||0
2464818|NCT00992264|6043674|P1|NOT COMPLETED|Overall Study||0
2464819|NCT00992264|6043659|P16|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
2464820|NCT00992264|6043660|P15|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
2464821|NCT00992264|6043661|P14|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
2464822|NCT00992264|6043662|P13|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
2464823|NCT00992264|6043663|P12|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
2464824|NCT00992264|6043664|P11|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
2464825|NCT00992264|6043665|P10|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
2464826|NCT00992264|6043666|P9|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
2464827|NCT00992264|6043667|P8|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
2464828|NCT00992264|6043668|P7|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
2464829|NCT00992264|6043669|P6|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
2464830|NCT00992264|6043670|P5|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
2464831|NCT00992264|6043671|P4|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
2464832|NCT00992264|6043672|P3|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
2464833|NCT00992264|6043673|P2|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
2464834|NCT00992264|6043674|P1|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
2464835|NCT00992264|6043659|P16|STARTED|Overall Study||116
2464836|NCT00992264|6043660|P15|STARTED|Overall Study||117
2464837|NCT00992264|6043661|P14|STARTED|Overall Study||117
2464838|NCT00992264|6043662|P13|STARTED|Overall Study||116
2464839|NCT00992264|6043663|P12|STARTED|Overall Study||117
2464840|NCT00992264|6043664|P11|STARTED|Overall Study||117
2464841|NCT00992264|6043665|P10|STARTED|Overall Study||116
2464842|NCT00992264|6043666|P9|STARTED|Overall Study||116
2464843|NCT00992264|6043667|P8|STARTED|Overall Study||117
2464844|NCT00992264|6043668|P7|STARTED|Overall Study||116
2464845|NCT00992264|6043669|P6|STARTED|Overall Study||117
2464846|NCT00992264|6043670|P5|STARTED|Overall Study||117
2464847|NCT00992264|6043671|P4|STARTED|Overall Study||117
2464848|NCT00992264|6043672|P3|STARTED|Overall Study||117
2464849|NCT00992264|6043673|P2|STARTED|Overall Study||116
2464850|NCT00992264|6043674|P1|STARTED|Overall Study||116
2464851|NCT00992225|6043688|P1|NOT COMPLETED|Overall Study||10
2464852|NCT00992225|6043688|P1|COMPLETED|Overall Study||33
2464853|NCT00992225|6043688|P1|Received at Least One Dose of Study Drug|Overall Study||33
2464854|NCT00992225|6043688|P1|STARTED|Overall Study||43
2464855|NCT00992186|6043698|P1|NOT COMPLETED|Overall Study||46
2464856|NCT00992186|6043698|P1|COMPLETED|Overall Study||0
2464857|NCT00992186|6043698|P1|STARTED|Overall Study||46
2464858|NCT00992108|6043717|P2|NOT COMPLETED|Overall Study||1
2464859|NCT00992108|6043718|P1|NOT COMPLETED|Overall Study||0
2464860|NCT00992108|6043717|P2|COMPLETED|Overall Study||9
2464861|NCT00992108|6043718|P1|COMPLETED|Overall Study||7
2464862|NCT00992108|6043717|P2|STARTED|Overall Study||10
2464863|NCT00992108|6043718|P1|STARTED|Overall Study||7
2464864|NCT00992056|6043732|P2|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
2464865|NCT00992056|6043733|P1|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
2464866|NCT00992056|6043732|P2|COMPLETED|Treatment Period 2 (6 Weeks)||10
2464867|NCT00992056|6043733|P1|COMPLETED|Treatment Period 2 (6 Weeks)||10
2464868|NCT00992056|6043732|P2|STARTED|Treatment Period 2 (6 Weeks)||10
2464869|NCT00992056|6043733|P1|STARTED|Treatment Period 2 (6 Weeks)||10
2464870|NCT00992056|6043732|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
2464871|NCT00992056|6043733|P1|NOT COMPLETED|Washout Period (2 Weeks)||1
2464872|NCT00992056|6043732|P2|COMPLETED|Washout Period (2 Weeks)||10
2464873|NCT00992056|6043733|P1|COMPLETED|Washout Period (2 Weeks)||10
2464874|NCT00992056|6043732|P2|STARTED|Washout Period (2 Weeks)||10
2464875|NCT00992056|6043733|P1|STARTED|Washout Period (2 Weeks)||11
2464876|NCT00992056|6043732|P2|NOT COMPLETED|Treatment Period 1 (6 Weeks)||2
2464877|NCT00992056|6043733|P1|NOT COMPLETED|Treatment Period 1 (6 Weeks)||1
2464878|NCT00992056|6043732|P2|COMPLETED|Treatment Period 1 (6 Weeks)||10
2464879|NCT00992056|6043733|P1|COMPLETED|Treatment Period 1 (6 Weeks)|February 2012|11
2464880|NCT00992056|6043732|P2|STARTED|Treatment Period 1 (6 Weeks)||12
2464881|NCT00992056|6043733|P1|STARTED|Treatment Period 1 (6 Weeks)||12
2464882|NCT00992017|6043739|P1|NOT COMPLETED|Overall Study||10
2464883|NCT00992017|6043739|P1|COMPLETED|Overall Study||118
2464884|NCT00992017|6043739|P1|Received Only One Study Vaccination|Overall Study|Reasons: delivered and LFU; moved; no transportation; ineligible - blood transfusion at delivery|4
2464885|NCT00992017|6043739|P1|Received Both Study Vaccinations|Overall Study||124
2464886|NCT00992017|6043739|P1|STARTED|Overall Study|Two additional women were enrolled but left the clinic before vaccine was administered.|128
2464887|NCT00991952|6043754|P2|NOT COMPLETED|Overall Study||1
2464888|NCT00991952|6043755|P1|NOT COMPLETED|Overall Study||0
2464889|NCT00991952|6043754|P2|COMPLETED|Overall Study||5
2464890|NCT00991952|6043755|P1|COMPLETED|Overall Study||13
2464891|NCT00991952|6043754|P2|STARTED|Overall Study||6
2464892|NCT00991952|6043755|P1|STARTED|Overall Study||13
2464893|NCT00991939|6043763|P2|NOT COMPLETED|Overall Study||2
2464894|NCT00991939|6043764|P1|NOT COMPLETED|Overall Study||5
2464895|NCT00991939|6043763|P2|COMPLETED|Overall Study||1
2464896|NCT00991939|6043764|P1|COMPLETED|Overall Study||0
2464897|NCT00991939|6043763|P2|STARTED|Overall Study||3
2464898|NCT00991939|6043764|P1|STARTED|Overall Study||5
2464899|NCT00991887|6043798|P2|NOT COMPLETED|Overall Study||1
2464900|NCT00991887|6043799|P1|NOT COMPLETED|Overall Study||2
2464901|NCT00991887|6043798|P2|COMPLETED|Overall Study||21
2464902|NCT00991887|6043799|P1|COMPLETED|Overall Study||24
2464903|NCT00991887|6043798|P2|STARTED|Overall Study||22
2464904|NCT00991887|6043799|P1|STARTED|Overall Study||26
2464905|NCT00991809|6043807|P2|NOT COMPLETED|Overall Study||6
2464906|NCT00991809|6043808|P1|NOT COMPLETED|Overall Study||4
2464907|NCT00991809|6043807|P2|COMPLETED|Overall Study||4
2464908|NCT00991809|6043808|P1|COMPLETED|Overall Study||8
2464909|NCT00991809|6043807|P2|STARTED|Overall Study||10
2464910|NCT00991809|6043808|P1|STARTED|Overall Study||12
2464911|NCT00991510|6043818|P2|NOT COMPLETED|Period III (Days 29-112)||1
2464912|NCT00991510|6043819|P1|NOT COMPLETED|Period III (Days 29-112)||1
2464913|NCT00991510|6043818|P2|COMPLETED|Period III (Days 29-112)||20
2464914|NCT00991510|6043819|P1|COMPLETED|Period III (Days 29-112)||20
2464915|NCT00991510|6043818|P2|STARTED|Period III (Days 29-112)||21
2464916|NCT00991510|6043819|P1|STARTED|Period III (Days 29-112)||21
2464917|NCT00991510|6043818|P2|NOT COMPLETED|Period II (Days 15-28)||0
2464918|NCT00991510|6043819|P1|NOT COMPLETED|Period II (Days 15-28)||0
2464919|NCT00991510|6043818|P2|COMPLETED|Period II (Days 15-28)||21
2464920|NCT00991510|6043819|P1|COMPLETED|Period II (Days 15-28)||21
2464921|NCT00991510|6043818|P2|STARTED|Period II (Days 15-28)||21
2464922|NCT00991510|6043819|P1|STARTED|Period II (Days 15-28)||21
2464923|NCT00991510|6043818|P2|NOT COMPLETED|Period I (Days 1-14)||0
2464924|NCT00991510|6043819|P1|NOT COMPLETED|Period I (Days 1-14)||1
2464925|NCT00991510|6043818|P2|COMPLETED|Period I (Days 1-14)||21
2464926|NCT00991510|6043819|P1|COMPLETED|Period I (Days 1-14)||21
2464927|NCT00991510|6043818|P2|STARTED|Period I (Days 1-14)||21
2464928|NCT00991510|6043819|P1|STARTED|Period I (Days 1-14)||22
2464929|NCT00991458|6043844|P3|NOT COMPLETED|Overall Study||25
2464930|NCT00991458|6043845|P2|NOT COMPLETED|Overall Study||28
2464931|NCT00991458|6043846|P1|NOT COMPLETED|Overall Study||20
2464932|NCT00991458|6043844|P3|COMPLETED|Overall Study||180
2464933|NCT00991458|6043845|P2|COMPLETED|Overall Study||181
2464934|NCT00991458|6043846|P1|COMPLETED|Overall Study||187
2464935|NCT00991458|6043844|P3|STARTED|Overall Study||205
2464936|NCT00991458|6043845|P2|STARTED|Overall Study||209
2464937|NCT00991458|6043846|P1|STARTED|Overall Study||207
2464938|NCT00991406|6043863|P1|NOT COMPLETED|Overall Study||1
2464939|NCT00991406|6043863|P1|COMPLETED|Overall Study|One participant did not respond to FES due to tone.|8
2464940|NCT00991406|6043863|P1|STARTED|Overall Study||9
2464941|NCT00991341|6043872|P2|NOT COMPLETED|Overall Study||179
2464942|NCT00991341|6043873|P1|NOT COMPLETED|Overall Study||204
2464943|NCT00991341|6043872|P2|COMPLETED|Overall Study||560
2464944|NCT00991341|6043873|P1|COMPLETED|Overall Study||538
2464945|NCT00991341|6043872|P2|STARTED|Overall Study||739
2464946|NCT00991341|6043873|P1|STARTED|Overall Study||742
2464947|NCT00991302|6043911|P2|NOT COMPLETED|Overall Study||13
2464948|NCT00991302|6043912|P1|NOT COMPLETED|Overall Study||14
2464949|NCT00991302|6043911|P2|COMPLETED|Overall Study||73
2464950|NCT00991302|6043912|P1|COMPLETED|Overall Study||72
2464951|NCT00991302|6043911|P2|STARTED|Overall Study||86
2464952|NCT00991302|6043912|P1|STARTED|Overall Study||86
2464953|NCT00991289|6043928|P1|NOT COMPLETED|Overall Study||12
2464954|NCT00991289|6043928|P1|COMPLETED|Overall Study|Completed study.|55
2464955|NCT00991289|6043928|P1|COMPLETED Week 16|Overall Study|Completed 16 weeks of the study (the primary endpoint time point). The study continued to Week 76.|61
2464956|NCT00991289|6043928|P1|STARTED|Overall Study|68 participants enrolled, one was found to have been ineligible and was excluded.|67
2464957|NCT00991276|6043948|P6|NOT COMPLETED|Third Intervention Period||1
2464958|NCT00991276|6043949|P5|NOT COMPLETED|Third Intervention Period||0
2464959|NCT00991276|6043950|P4|NOT COMPLETED|Third Intervention Period||1
2464960|NCT00991276|6043951|P3|NOT COMPLETED|Third Intervention Period||1
2464961|NCT00991276|6043952|P2|NOT COMPLETED|Third Intervention Period||0
2464962|NCT00991276|6043953|P1|NOT COMPLETED|Third Intervention Period||1
2464963|NCT00991276|6043948|P6|COMPLETED|Third Intervention Period||10
2464964|NCT00991276|6043949|P5|COMPLETED|Third Intervention Period||10
2464965|NCT00991276|6043950|P4|COMPLETED|Third Intervention Period||8
2464966|NCT00991276|6043951|P3|COMPLETED|Third Intervention Period||13
2464967|NCT00991276|6043952|P2|COMPLETED|Third Intervention Period||8
2464968|NCT00991276|6043953|P1|COMPLETED|Third Intervention Period||13
2464969|NCT00991276|6043948|P6|STARTED|Third Intervention Period||11
2464970|NCT00991276|6043949|P5|STARTED|Third Intervention Period||10
2464971|NCT00991276|6043950|P4|STARTED|Third Intervention Period||9
2464972|NCT00991276|6043951|P3|STARTED|Third Intervention Period||14
2464973|NCT00991276|6043952|P2|STARTED|Third Intervention Period||8
2464974|NCT00991276|6043953|P1|STARTED|Third Intervention Period||14
2464975|NCT00991276|6043948|P6|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
2464976|NCT00991276|6043949|P5|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
2464977|NCT00991276|6043950|P4|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
2464978|NCT00991276|6043951|P3|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
2464979|NCT00991276|6043952|P2|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
2464980|NCT00991276|6043953|P1|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
2464981|NCT00991276|6043948|P6|COMPLETED|Placebo Wash-out Period (7 Days)||11
2464982|NCT00991276|6043949|P5|COMPLETED|Placebo Wash-out Period (7 Days)||10
2464983|NCT00991276|6043950|P4|COMPLETED|Placebo Wash-out Period (7 Days)||9
2464984|NCT00991276|6043951|P3|COMPLETED|Placebo Wash-out Period (7 Days)||14
2464985|NCT00991276|6043952|P2|COMPLETED|Placebo Wash-out Period (7 Days)||8
2464986|NCT00991276|6043953|P1|COMPLETED|Placebo Wash-out Period (7 Days)||14
2464987|NCT00991276|6043948|P6|STARTED|Placebo Wash-out Period (7 Days)||11
2464988|NCT00991276|6043949|P5|STARTED|Placebo Wash-out Period (7 Days)||10
2464989|NCT00991276|6043950|P4|STARTED|Placebo Wash-out Period (7 Days)||9
2464990|NCT00991276|6043951|P3|STARTED|Placebo Wash-out Period (7 Days)||14
2464991|NCT00991276|6043952|P2|STARTED|Placebo Wash-out Period (7 Days)||8
2464992|NCT00991276|6043953|P1|STARTED|Placebo Wash-out Period (7 Days)||14
2464993|NCT00991276|6043948|P6|NOT COMPLETED|Second Intervention Period||1
2464994|NCT00991276|6043949|P5|NOT COMPLETED|Second Intervention Period||1
2464995|NCT00991276|6043950|P4|NOT COMPLETED|Second Intervention Period||2
2464996|NCT00991276|6043951|P3|NOT COMPLETED|Second Intervention Period||0
2464997|NCT00991276|6043952|P2|NOT COMPLETED|Second Intervention Period||2
2464998|NCT00991276|6043953|P1|NOT COMPLETED|Second Intervention Period||1
2464999|NCT00991276|6043948|P6|COMPLETED|Second Intervention Period||11
2465000|NCT00991276|6043949|P5|COMPLETED|Second Intervention Period||10
2465001|NCT00991276|6043950|P4|COMPLETED|Second Intervention Period||9
2465002|NCT00991276|6043951|P3|COMPLETED|Second Intervention Period||14
2465003|NCT00991276|6043952|P2|COMPLETED|Second Intervention Period||8
2465004|NCT00991276|6043953|P1|COMPLETED|Second Intervention Period||14
2465005|NCT00991276|6043948|P6|STARTED|Second Intervention Period||12
2465006|NCT00991276|6043949|P5|STARTED|Second Intervention Period||11
2465007|NCT00991276|6043950|P4|STARTED|Second Intervention Period||11
2465008|NCT00991276|6043951|P3|STARTED|Second Intervention Period||14
2465009|NCT00991276|6043952|P2|STARTED|Second Intervention Period||10
2465010|NCT00991276|6043953|P1|STARTED|Second Intervention Period||15
2465011|NCT00991276|6043948|P6|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
2465012|NCT00991276|6043949|P5|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
2465013|NCT00991276|6043950|P4|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
2465014|NCT00991276|6043951|P3|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
2465015|NCT00991276|6043952|P2|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
2465016|NCT00991276|6043953|P1|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
2465017|NCT00991276|6043948|P6|COMPLETED|Placebo Wash-out Period (7 Days)||12
2465018|NCT00991276|6043949|P5|COMPLETED|Placebo Wash-out Period (7 Days)||11
2465019|NCT00991276|6043950|P4|COMPLETED|Placebo Wash-out Period (7 Days)||11
2465020|NCT00991276|6043951|P3|COMPLETED|Placebo Wash-out Period (7 Days)||14
2465021|NCT00991276|6043952|P2|COMPLETED|Placebo Wash-out Period (7 Days)||10
2465022|NCT00991276|6043953|P1|COMPLETED|Placebo Wash-out Period (7 Days)||15
2465023|NCT00991276|6043948|P6|STARTED|Placebo Wash-out Period (7 Days)||12
2465024|NCT00991276|6043949|P5|STARTED|Placebo Wash-out Period (7 Days)||11
2465025|NCT00991276|6043950|P4|STARTED|Placebo Wash-out Period (7 Days)||11
2465026|NCT00991276|6043951|P3|STARTED|Placebo Wash-out Period (7 Days)||14
2465027|NCT00991276|6043952|P2|STARTED|Placebo Wash-out Period (7 Days)||10
2465028|NCT00991276|6043953|P1|STARTED|Placebo Wash-out Period (7 Days)||15
2465029|NCT00991276|6043948|P6|NOT COMPLETED|First Intervention Period||1
2465030|NCT00991276|6043949|P5|NOT COMPLETED|First Intervention Period||4
2465031|NCT00991276|6043950|P4|NOT COMPLETED|First Intervention Period||4
2465032|NCT00991276|6043951|P3|NOT COMPLETED|First Intervention Period||0
2465033|NCT00991276|6043952|P2|NOT COMPLETED|First Intervention Period||3
2465034|NCT00991276|6043953|P1|NOT COMPLETED|First Intervention Period||0
2465035|NCT00991276|6043948|P6|COMPLETED|First Intervention Period||12
2465036|NCT00991276|6043949|P5|COMPLETED|First Intervention Period||11
2465037|NCT00991276|6043950|P4|COMPLETED|First Intervention Period||11
2465038|NCT00991276|6043951|P3|COMPLETED|First Intervention Period||14
2465039|NCT00991276|6043952|P2|COMPLETED|First Intervention Period||10
2465040|NCT00991276|6043953|P1|COMPLETED|First Intervention Period||15
2465041|NCT00991276|6043948|P6|STARTED|First Intervention Period||13
2465042|NCT00991276|6043949|P5|STARTED|First Intervention Period||15
2465043|NCT00991276|6043950|P4|STARTED|First Intervention Period||15
2465044|NCT00991276|6043951|P3|STARTED|First Intervention Period||14
2465045|NCT00991276|6043952|P2|STARTED|First Intervention Period||13
2465046|NCT00991276|6043953|P1|STARTED|First Intervention Period||15
2465047|NCT00991185|6044051|P1|NOT COMPLETED|Overall Study||0
2465048|NCT00991185|6044051|P1|COMPLETED|Overall Study||8
2465049|NCT00991185|6044051|P1|STARTED|Overall Study||8
2465050|NCT00991081|6044057|P3|NOT COMPLETED|Phase II, Randomized Control Trial||4
2465051|NCT00991081|6044058|P2|NOT COMPLETED|Phase II, Randomized Control Trial||2
2465052|NCT00991081|6044059|P1|NOT COMPLETED|Phase II, Randomized Control Trial||0
2465053|NCT00991081|6044057|P3|COMPLETED|Phase II, Randomized Control Trial||15
2465054|NCT00991081|6044058|P2|COMPLETED|Phase II, Randomized Control Trial||15
2465055|NCT00991081|6044059|P1|COMPLETED|Phase II, Randomized Control Trial||0
2465056|NCT00991081|6044057|P3|Received First Clinical Call|Phase II, Randomized Control Trial||17
2465057|NCT00991081|6044058|P2|Received First Clinical Call|Phase II, Randomized Control Trial||16
2465058|NCT00991081|6044059|P1|Received First Clinical Call|Phase II, Randomized Control Trial||0
2465059|NCT00991081|6044057|P3|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|19
2465060|NCT00991081|6044058|P2|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|17
2465061|NCT00991081|6044059|P1|STARTED|Phase II, Randomized Control Trial||0
2465062|NCT00991081|6044057|P3|NOT COMPLETED|Phase I, Formative Research||0
2465063|NCT00991081|6044058|P2|NOT COMPLETED|Phase I, Formative Research||0
2465064|NCT00991081|6044059|P1|NOT COMPLETED|Phase I, Formative Research||0
2465065|NCT00991081|6044057|P3|COMPLETED|Phase I, Formative Research||0
2465066|NCT00991081|6044058|P2|COMPLETED|Phase I, Formative Research||0
2465067|NCT00991081|6044059|P1|COMPLETED|Phase I, Formative Research|The 10 smokers interviewed were not enrolled in the Phase II RCT.|20
2465068|NCT00991081|6044057|P3|STARTED|Phase I, Formative Research||0
2465069|NCT00991081|6044058|P2|STARTED|Phase I, Formative Research||0
2465070|NCT00991081|6044059|P1|STARTED|Phase I, Formative Research||20
2465071|NCT00991029|6044093|P2|NOT COMPLETED|Overall Study||168
2465072|NCT00991029|6044094|P1|NOT COMPLETED|Overall Study||156
2465073|NCT00991029|6044093|P2|COMPLETED|Overall Study||2281
2465074|NCT00991029|6044094|P1|COMPLETED|Overall Study||2276
2465075|NCT00991029|6044093|P2|STARTED|Overall Study||2449
2465076|NCT00991029|6044094|P1|STARTED|Overall Study||2432
2465077|NCT00990964|6044124|P1|NOT COMPLETED|Overall Study||212
2465078|NCT00990964|6044124|P1|COMPLETED|Overall Study|Total number of subjects with successful Attain Family lead using Attain Family catheter|1802
2465079|NCT00990964|6044124|P1|Attain Family Study System Attempt|Overall Study|Total number of subjects with an Attain Family lead attempt after an Attain Family catheter attempt|1917
2465080|NCT00990964|6044124|P1|STARTED|Overall Study|Total number of subjects enrolled|2014
2465081|NCT00990938|6044135|P6|NOT COMPLETED|Overall Study||0
2465082|NCT00990938|6044136|P5|NOT COMPLETED|Overall Study||0
2465083|NCT00990938|6044137|P4|NOT COMPLETED|Overall Study||0
2465084|NCT00990938|6044138|P3|NOT COMPLETED|Overall Study||0
2465085|NCT00990938|6044139|P2|NOT COMPLETED|Overall Study||0
2465086|NCT00990938|6044140|P1|NOT COMPLETED|Overall Study||0
2465087|NCT00990938|6044135|P6|COMPLETED|Overall Study||12
2465088|NCT00990938|6044136|P5|COMPLETED|Overall Study||12
2465089|NCT00990938|6044137|P4|COMPLETED|Overall Study||12
2465090|NCT00990938|6044138|P3|COMPLETED|Overall Study||12
2465091|NCT00990938|6044139|P2|COMPLETED|Overall Study||12
2465092|NCT00990938|6044140|P1|COMPLETED|Overall Study||3
2465093|NCT00990938|6044135|P6|STARTED|Overall Study||12
2465094|NCT00990938|6044136|P5|STARTED|Overall Study||12
2465095|NCT00990938|6044137|P4|STARTED|Overall Study||12
2465096|NCT00990938|6044138|P3|STARTED|Overall Study||12
2465097|NCT00990938|6044139|P2|STARTED|Overall Study||12
2465098|NCT00990938|6044140|P1|STARTED|Overall Study||3
2465099|NCT00990821|6044168|P14|NOT COMPLETED|Overall Study||1
2465100|NCT00990821|6044169|P13|NOT COMPLETED|Overall Study||2
2465101|NCT00990821|6044170|P12|NOT COMPLETED|Overall Study||5
2465102|NCT00990821|6044171|P11|NOT COMPLETED|Overall Study||3
2465103|NCT00990821|6044172|P10|NOT COMPLETED|Overall Study||1
2465104|NCT00990821|6044173|P9|NOT COMPLETED|Overall Study||0
2465105|NCT00990821|6044174|P8|NOT COMPLETED|Overall Study||0
2465106|NCT00990821|6044175|P7|NOT COMPLETED|Overall Study||1
2465107|NCT00990821|6044176|P6|NOT COMPLETED|Overall Study||3
2465108|NCT00990821|6044177|P5|NOT COMPLETED|Overall Study||3
2465109|NCT00990821|6044178|P4|NOT COMPLETED|Overall Study||0
2465110|NCT00990821|6044179|P3|NOT COMPLETED|Overall Study||0
2465111|NCT00990821|6044180|P2|NOT COMPLETED|Overall Study||2
2465112|NCT00990821|6044181|P1|NOT COMPLETED|Overall Study||0
2465113|NCT00990821|6044168|P14|COMPLETED|Overall Study||11
2465114|NCT00990821|6044169|P13|COMPLETED|Overall Study||10
2465115|NCT00990821|6044170|P12|COMPLETED|Overall Study||9
2465116|NCT00990821|6044171|P11|COMPLETED|Overall Study||9
2465117|NCT00990821|6044172|P10|COMPLETED|Overall Study||13
2465118|NCT00990821|6044173|P9|COMPLETED|Overall Study||12
2465119|NCT00990821|6044174|P8|COMPLETED|Overall Study||14
2465120|NCT00990821|6044175|P7|COMPLETED|Overall Study||11
2465121|NCT00990821|6044176|P6|COMPLETED|Overall Study||14
2465122|NCT00990821|6044177|P5|COMPLETED|Overall Study||14
2465123|NCT00990821|6044178|P4|COMPLETED|Overall Study||8
2465124|NCT00990821|6044179|P3|COMPLETED|Overall Study||14
2465125|NCT00990821|6044180|P2|COMPLETED|Overall Study||14
2465126|NCT00990821|6044181|P1|COMPLETED|Overall Study||14
2465127|NCT00990821|6044168|P14|STARTED|Overall Study||12
2465128|NCT00990821|6044169|P13|STARTED|Overall Study||12
2465129|NCT00990821|6044170|P12|STARTED|Overall Study||14
2465130|NCT00990821|6044171|P11|STARTED|Overall Study||12
2465131|NCT00990821|6044172|P10|STARTED|Overall Study||14
2465132|NCT00990821|6044173|P9|STARTED|Overall Study||12
2465133|NCT00990821|6044174|P8|STARTED|Overall Study||14
2465134|NCT00990821|6044175|P7|STARTED|Overall Study||12
2465135|NCT00990821|6044176|P6|STARTED|Overall Study||17
2465136|NCT00990821|6044177|P5|STARTED|Overall Study||17
2465137|NCT00990821|6044178|P4|STARTED|Overall Study||8
2465138|NCT00990821|6044179|P3|STARTED|Overall Study||14
2465139|NCT00990821|6044180|P2|STARTED|Overall Study||16
2465140|NCT00990821|6044181|P1|STARTED|Overall Study||14
2465141|NCT00990782|6044198|P1|NOT COMPLETED|Overall Study||5
2465142|NCT00990782|6044198|P1|COMPLETED|Overall Study||88
2465143|NCT00990782|6044198|P1|STARTED|Overall Study||93
2465144|NCT00990769|6044205|P2|NOT COMPLETED|Overall Study||0
2465145|NCT00990769|6044206|P1|NOT COMPLETED|Overall Study||0
2465146|NCT00990769|6044205|P2|COMPLETED|Overall Study||18
2465147|NCT00990769|6044206|P1|COMPLETED|Overall Study||22
2465148|NCT00990769|6044205|P2|STARTED|Overall Study|Signed consent and assigned to Low-normal BIS|18
2465149|NCT00990769|6044206|P1|STARTED|Overall Study|Signed consent and assigned to High-normal BIS|22
2465150|NCT00990704|6044218|P2|NOT COMPLETED|Overall Study||2
2465151|NCT00990704|6044219|P1|NOT COMPLETED|Overall Study||1
2465152|NCT00990704|6044218|P2|COMPLETED|Overall Study||31
2465153|NCT00990704|6044219|P1|COMPLETED|Overall Study||13
2465154|NCT00990704|6044218|P2|STARTED|Overall Study||33
2465155|NCT00990704|6044219|P1|STARTED|Overall Study||14
2465156|NCT00990665|6044239|P1|NOT COMPLETED|Overall Study||48
2465157|NCT00990665|6044239|P1|COMPLETED|Overall Study||130
2465158|NCT00990665|6044239|P1|STARTED|Overall Study||178
2465159|NCT00990652|6044246|P1|NOT COMPLETED|Post-sugery Bortezomib + Temozolomide||1
2465160|NCT00990652|6044246|P1|COMPLETED|Post-sugery Bortezomib + Temozolomide||8
2465161|NCT00990652|6044246|P1|STARTED|Post-sugery Bortezomib + Temozolomide||9
2465162|NCT00990652|6044246|P1|NOT COMPLETED|Surgical Resection||0
2465163|NCT00990652|6044246|P1|COMPLETED|Surgical Resection||9
2465164|NCT00990652|6044246|P1|STARTED|Surgical Resection||9
2465165|NCT00990652|6044246|P1|NOT COMPLETED|Pre-surgical Bortezomib||1
2465166|NCT00990652|6044246|P1|COMPLETED|Pre-surgical Bortezomib||9
2465167|NCT00990652|6044246|P1|STARTED|Pre-surgical Bortezomib||10
2465168|NCT00990561|6044256|P4|NOT COMPLETED|Period 2||2
2465169|NCT00990561|6044257|P3|NOT COMPLETED|Period 2||0
2465170|NCT00990561|6044258|P2|NOT COMPLETED|Period 2||0
2465171|NCT00990561|6044259|P1|NOT COMPLETED|Period 2||0
2465172|NCT00990561|6044256|P4|COMPLETED|Period 2||17
2465173|NCT00990561|6044257|P3|COMPLETED|Period 2||20
2465174|NCT00990561|6044258|P2|COMPLETED|Period 2||0
2465175|NCT00990561|6044259|P1|COMPLETED|Period 2||0
2465176|NCT00990561|6044256|P4|STARTED|Period 2||19
2465177|NCT00990561|6044257|P3|STARTED|Period 2||20
2465178|NCT00990561|6044258|P2|STARTED|Period 2||0
2465179|NCT00990561|6044259|P1|STARTED|Period 2||0
2465180|NCT00990561|6044256|P4|NOT COMPLETED|Period 1||0
2465181|NCT00990561|6044257|P3|NOT COMPLETED|Period 1||0
2465182|NCT00990561|6044258|P2|NOT COMPLETED|Period 1||1
2465183|NCT00990561|6044259|P1|NOT COMPLETED|Period 1||0
2465184|NCT00990561|6044256|P4|COMPLETED|Period 1||0
2465185|NCT00990561|6044257|P3|COMPLETED|Period 1||0
2465186|NCT00990561|6044258|P2|COMPLETED|Period 1||19
2465187|NCT00990561|6044259|P1|COMPLETED|Period 1||20
2465188|NCT00990561|6044256|P4|STARTED|Period 1||0
2465189|NCT00990561|6044257|P3|STARTED|Period 1||0
2465190|NCT00990561|6044258|P2|STARTED|Period 1||20
2465191|NCT00990561|6044259|P1|STARTED|Period 1||20
2465192|NCT00990509|6044267|P2|NOT COMPLETED|Overall Study||1
2465193|NCT00990509|6044268|P1|NOT COMPLETED|Overall Study||0
2465194|NCT00990509|6044267|P2|COMPLETED|Overall Study||8
2465195|NCT00990509|6044268|P1|COMPLETED|Overall Study||5
2465196|NCT00990509|6044267|P2|STARTED|Overall Study||9
2465197|NCT00990509|6044268|P1|STARTED|Overall Study||5
2465198|NCT00990340|6044280|P2|NOT COMPLETED|Second 14-day Treatment||0
2465199|NCT00990340|6044281|P1|NOT COMPLETED|Second 14-day Treatment||0
2465200|NCT00990340|6044280|P2|COMPLETED|Second 14-day Treatment||21
2465201|NCT00990340|6044281|P1|COMPLETED|Second 14-day Treatment||21
2465202|NCT00990340|6044280|P2|STARTED|Second 14-day Treatment||21
2465203|NCT00990340|6044281|P1|STARTED|Second 14-day Treatment||21
2465204|NCT00990340|6044280|P2|NOT COMPLETED|First 14-day Treatment||4
2465205|NCT00990340|6044281|P1|NOT COMPLETED|First 14-day Treatment||6
2465206|NCT00990340|6044280|P2|COMPLETED|First 14-day Treatment||21
2465207|NCT00990340|6044281|P1|COMPLETED|First 14-day Treatment||21
2465208|NCT00990340|6044280|P2|STARTED|First 14-day Treatment||25
2465209|NCT00990340|6044281|P1|STARTED|First 14-day Treatment||27
2465210|NCT00990314|6044295|P1|NOT COMPLETED|Overall Study||12
2465211|NCT00990314|6044295|P1|COMPLETED|Overall Study||19
2465212|NCT00990314|6044295|P1|STARTED|Overall Study||31
2465213|NCT00990288|6044306|P2|NOT COMPLETED|Overall Study||0
2465214|NCT00990288|6044307|P1|NOT COMPLETED|Overall Study||0
2465215|NCT00990288|6044306|P2|COMPLETED|Overall Study||99
2465216|NCT00990288|6044307|P1|COMPLETED|Overall Study||97
2465217|NCT00990288|6044306|P2|STARTED|Overall Study||99
2465218|NCT00990288|6044307|P1|STARTED|Overall Study||97
2465219|NCT00990249|6044337|P1|NOT COMPLETED|Overall Study||13
2465220|NCT00990249|6044337|P1|COMPLETED|Overall Study||107
2465221|NCT00990249|6044337|P1|STARTED|Overall Study||120
2465222|NCT00990184|6044341|P1|NOT COMPLETED|Overall Study||1
2465223|NCT00990184|6044341|P1|COMPLETED|Overall Study||20
2465224|NCT00990184|6044341|P1|STARTED|Overall Study||21
2465225|NCT00990106|6044349|P2|NOT COMPLETED|Overall Study||12
2465226|NCT00990106|6044350|P1|NOT COMPLETED|Overall Study||9
2465227|NCT00990106|6044349|P2|COMPLETED|Overall Study||23
2465228|NCT00990106|6044350|P1|COMPLETED|Overall Study||23
2465229|NCT00990106|6044349|P2|STARTED|Overall Study||35
2465230|NCT00990106|6044350|P1|STARTED|Overall Study||32
2465231|NCT00990093|6044360|P2|NOT COMPLETED|Test Period 2 (15-28 Days)||1
2465232|NCT00990093|6044361|P1|NOT COMPLETED|Test Period 2 (15-28 Days)||2
2465233|NCT00990093|6044360|P2|COMPLETED|Test Period 2 (15-28 Days)||14
2465234|NCT00990093|6044361|P1|COMPLETED|Test Period 2 (15-28 Days)||13
2465235|NCT00990093|6044360|P2|STARTED|Test Period 2 (15-28 Days)||15
2465236|NCT00990093|6044361|P1|STARTED|Test Period 2 (15-28 Days)||15
2465237|NCT00990093|6044360|P2|NOT COMPLETED|Test Period 1 (1-14 Days)||2
2465238|NCT00990093|6044361|P1|NOT COMPLETED|Test Period 1 (1-14 Days)||4
2465239|NCT00990093|6044360|P2|COMPLETED|Test Period 1 (1-14 Days)||15
2465240|NCT00990093|6044361|P1|COMPLETED|Test Period 1 (1-14 Days)||15
2465241|NCT00990093|6044360|P2|STARTED|Test Period 1 (1-14 Days)||17
2465242|NCT00990093|6044361|P1|STARTED|Test Period 1 (1-14 Days)||19
2465243|NCT00989989|6044370|P3|NOT COMPLETED|Overall Study||23
2465244|NCT00989989|6044371|P2|NOT COMPLETED|Overall Study||10
2465245|NCT00989989|6044372|P1|NOT COMPLETED|Overall Study||18
2465246|NCT00989989|6044370|P3|COMPLETED|Overall Study||108
2465247|NCT00989989|6044371|P2|COMPLETED|Overall Study||123
2465248|NCT00989989|6044372|P1|COMPLETED|Overall Study||114
2465249|NCT00989989|6044370|P3|STARTED|Overall Study||131
2465250|NCT00989989|6044371|P2|STARTED|Overall Study||133
2465251|NCT00989989|6044372|P1|STARTED|Overall Study||132
2465252|NCT00989950|6044414|P4|NOT COMPLETED|Randomized Phase||0
2465253|NCT00989950|6044415|P3|NOT COMPLETED|Randomized Phase||0
2465254|NCT00989950|6044416|P2|NOT COMPLETED|Randomized Phase||1
2465255|NCT00989950|6044417|P1|NOT COMPLETED|Randomized Phase||1
2465256|NCT00989950|6044414|P4|COMPLETED|Randomized Phase||7
2465257|NCT00989950|6044415|P3|COMPLETED|Randomized Phase||4
2465258|NCT00989950|6044416|P2|COMPLETED|Randomized Phase||8
2465259|NCT00989950|6044417|P1|COMPLETED|Randomized Phase||5
2465260|NCT00989950|6044414|P4|STARTED|Randomized Phase||7
2465261|NCT00989950|6044415|P3|STARTED|Randomized Phase||4
2465262|NCT00989950|6044416|P2|STARTED|Randomized Phase||9
2465263|NCT00989950|6044417|P1|STARTED|Randomized Phase||6
2465264|NCT00989950|6044414|P4|NOT COMPLETED|Open Label Dose Optimization||0
2465265|NCT00989950|6044415|P3|NOT COMPLETED|Open Label Dose Optimization||0
2465266|NCT00989950|6044416|P2|NOT COMPLETED|Open Label Dose Optimization||0
2465267|NCT00989950|6044417|P1|NOT COMPLETED|Open Label Dose Optimization||0
2465268|NCT00989950|6044414|P4|COMPLETED|Open Label Dose Optimization||7
2465269|NCT00989950|6044415|P3|COMPLETED|Open Label Dose Optimization||4
2465270|NCT00989950|6044416|P2|COMPLETED|Open Label Dose Optimization||9
2465271|NCT00989950|6044417|P1|COMPLETED|Open Label Dose Optimization||6
2465272|NCT00989950|6044414|P4|STARTED|Open Label Dose Optimization||7
2465273|NCT00989950|6044415|P3|STARTED|Open Label Dose Optimization||4
2465274|NCT00989950|6044416|P2|STARTED|Open Label Dose Optimization||9
2465275|NCT00989950|6044417|P1|STARTED|Open Label Dose Optimization||6
2465276|NCT00989937|6044427|P1|NOT COMPLETED|Overall Study||0
2465277|NCT00989937|6044427|P1|COMPLETED|Overall Study||0
2465278|NCT00989937|6044427|P1|STARTED|Overall Study||0
2465279|NCT00989911|6044442|P1|NOT COMPLETED|Overall Study||3
2465280|NCT00989911|6044442|P1|COMPLETED|Overall Study||7
2465281|NCT00989911|6044442|P1|STARTED|Overall Study||10
2465282|NCT00989833|6044449|P3|NOT COMPLETED|Overall Study||2
2465283|NCT00989833|6044450|P2|NOT COMPLETED|Overall Study||3
2465284|NCT00989833|6044451|P1|NOT COMPLETED|Overall Study||2
2465285|NCT00989833|6044449|P3|COMPLETED|Overall Study||21
2465286|NCT00989833|6044450|P2|COMPLETED|Overall Study||19
2465287|NCT00989833|6044451|P1|COMPLETED|Overall Study||19
2465288|NCT00989833|6044449|P3|STARTED|Overall Study||23
2465289|NCT00989833|6044450|P2|STARTED|Overall Study||22
2465290|NCT00989833|6044451|P1|STARTED|Overall Study||21
2465291|NCT00989781|6044482|P2|NOT COMPLETED|Adrenal Response ot ACTH||3
2465292|NCT00989781|6044483|P1|NOT COMPLETED|Adrenal Response ot ACTH||5
2465293|NCT00989781|6044482|P2|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented and completed study|15
2465294|NCT00989781|6044483|P1|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented. 2 dropped out and 13 completed study|13
2465295|NCT00989781|6044482|P2|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
2465296|NCT00989781|6044483|P1|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
2465297|NCT00989781|6044482|P2|NOT COMPLETED|Ovarian Response to hCG||2
2465298|NCT00989781|6044483|P1|NOT COMPLETED|Ovarian Response to hCG||3
2465299|NCT00989781|6044482|P2|COMPLETED|Ovarian Response to hCG||18
2465300|NCT00989781|6044483|P1|COMPLETED|Ovarian Response to hCG||18
2465301|NCT00989781|6044482|P2|STARTED|Ovarian Response to hCG||20
2465302|NCT00989781|6044483|P1|STARTED|Ovarian Response to hCG||21
2465303|NCT00989768|6044502|P1|NOT COMPLETED|Overall Study||1
2465304|NCT00989768|6044502|P1|COMPLETED|Overall Study||28
2465305|NCT00989768|6044502|P1|STARTED|Overall Study|All patients received both treatments. They are their own controls|29
2465306|NCT00989664|6044513|P1|NOT COMPLETED|Long-Term Follow-Up||3
2465307|NCT00989664|6044513|P1|COMPLETED|Long-Term Follow-Up||11
2465308|NCT00989664|6044513|P1|STARTED|Long-Term Follow-Up|14 of the 61 participants withdrawing from Study BEX104504 enrolled in the LTFU study.|14
2465309|NCT00989664|6044513|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||61
2465310|NCT00989664|6044513|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
2465311|NCT00989664|6044513|P1|STARTED|Dosimetric and Therapeutic Treatment||61
2465312|NCT00989612|6044541|P1|NOT COMPLETED|Overall Study||0
2465313|NCT00989612|6044541|P1|COMPLETED|Overall Study||100
2465314|NCT00989612|6044541|P1|STARTED|Overall Study||100
2465315|NCT00989586|6044582|P2|NOT COMPLETED|Overall Study||0
2465316|NCT00989586|6044583|P1|NOT COMPLETED|Overall Study||0
2465317|NCT00989586|6044582|P2|COMPLETED|Overall Study||17
2465318|NCT00989586|6044583|P1|COMPLETED|Overall Study||18
2465319|NCT00989586|6044582|P2|STARTED|Overall Study||17
2465320|NCT00989586|6044583|P1|STARTED|Overall Study||18
2465321|NCT00989287|6044598|P2|NOT COMPLETED|Overall Study||1
2465322|NCT00989287|6044599|P1|NOT COMPLETED|Overall Study||1
2465323|NCT00989287|6044598|P2|COMPLETED|Overall Study||65
2465324|NCT00989287|6044599|P1|COMPLETED|Overall Study||64
2465325|NCT00989287|6044598|P2|STARTED|Overall Study||66
2465326|NCT00989287|6044599|P1|STARTED|Overall Study||65
2465327|NCT00989261|6044701|P2|NOT COMPLETED|Overall Study||22
2465328|NCT00989261|6044702|P1|NOT COMPLETED|Overall Study||15
2465329|NCT00989261|6044701|P2|COMPLETED|Overall Study||154
2465330|NCT00989261|6044702|P1|COMPLETED|Overall Study||142
2465331|NCT00989261|6044701|P2|STARTED|Overall Study||176
2465332|NCT00989261|6044702|P1|STARTED|Overall Study||157
2465333|NCT00989235|6044732|P2|NOT COMPLETED|Overall Study||6
2465334|NCT00989235|6044733|P1|NOT COMPLETED|Overall Study||3
2465335|NCT00989235|6044732|P2|COMPLETED|Overall Study||44
2465336|NCT00989235|6044733|P1|COMPLETED|Overall Study||55
2465337|NCT00989235|6044732|P2|Number Completing Double-Blind Treatment|Overall Study||41
2465338|NCT00989235|6044733|P1|Number Completing Double-Blind Treatment|Overall Study||51
2465339|NCT00989235|6044732|P2|Number Rescued to Open-Label Treatment|Overall Study|Of these, 1 was discontinued from open-label treatment (lost to follow-up).|4
2465340|NCT00989235|6044733|P1|Number Rescued to Open-Label Treatment|Overall Study||4
2465341|NCT00989235|6044732|P2|STARTED|Overall Study||50
2465342|NCT00989235|6044733|P1|STARTED|Overall Study||58
2465343|NCT00989196|6044778|P2|NOT COMPLETED|Treatment Period||0
2465344|NCT00989196|6044779|P1|NOT COMPLETED|Treatment Period||1
2465345|NCT00989196|6044778|P2|COMPLETED|Treatment Period||12
2465346|NCT00989196|6044779|P1|COMPLETED|Treatment Period||9
2465347|NCT00989196|6044778|P2|STARTED|Treatment Period||12
2465348|NCT00989196|6044779|P1|STARTED|Treatment Period||10
2465349|NCT00989196|6044778|P2|NOT COMPLETED|PK Crossover Period||0
2465350|NCT00989196|6044779|P1|NOT COMPLETED|PK Crossover Period||0
2465351|NCT00989196|6044778|P2|COMPLETED|PK Crossover Period||12
2465352|NCT00989196|6044779|P1|COMPLETED|PK Crossover Period||10
2465353|NCT00989196|6044778|P2|STARTED|PK Crossover Period||12
2465354|NCT00989196|6044779|P1|STARTED|PK Crossover Period||10
2465355|NCT00989157|6044800|P2|NOT COMPLETED|Overall Study||0
2465356|NCT00989157|6044801|P1|NOT COMPLETED|Overall Study||0
2465357|NCT00989157|6044800|P2|COMPLETED|Overall Study||10
2465358|NCT00989157|6044801|P1|COMPLETED|Overall Study||10
2465359|NCT00989157|6044800|P2|STARTED|Overall Study||10
2465360|NCT00989157|6044801|P1|STARTED|Overall Study||10
2465361|NCT00989092|6044817|P2|NOT COMPLETED|Overall Study||28
2465362|NCT00989092|6044818|P1|NOT COMPLETED|Overall Study||90
2465363|NCT00989092|6044817|P2|COMPLETED|Overall Study||31
2465364|NCT00989092|6044818|P1|COMPLETED|Overall Study||138
2465365|NCT00989092|6044817|P2|Treated With Darbepoetin Alfa|Overall Study||33
2465366|NCT00989092|6044818|P1|Treated With Darbepoetin Alfa|Overall Study||226
2465367|NCT00989092|6044817|P2|STARTED|Overall Study||59
2465368|NCT00989092|6044818|P1|STARTED|Overall Study||228
2465369|NCT00989014|6044855|P4|NOT COMPLETED|Overall Study||0
2465370|NCT00989014|6044856|P3|NOT COMPLETED|Overall Study||0
2465371|NCT00989014|6044857|P2|NOT COMPLETED|Overall Study||0
2465372|NCT00989014|6044858|P1|NOT COMPLETED|Overall Study||0
2465373|NCT00989014|6044855|P4|COMPLETED|Overall Study||32
2465374|NCT00989014|6044856|P3|COMPLETED|Overall Study||28
2465375|NCT00989014|6044857|P2|COMPLETED|Overall Study||31
2465376|NCT00989014|6044858|P1|COMPLETED|Overall Study||31
2465377|NCT00989014|6044855|P4|STARTED|Overall Study||32
2465378|NCT00989014|6044856|P3|STARTED|Overall Study||28
2465379|NCT00989014|6044857|P2|STARTED|Overall Study||31
2465380|NCT00989014|6044858|P1|STARTED|Overall Study||31
2465381|NCT00988884|6044870|P2|NOT COMPLETED|Overall Study||36
2465382|NCT00988884|6044871|P1|NOT COMPLETED|Overall Study||35
2465383|NCT00988884|6044870|P2|COMPLETED|Overall Study||584
2465384|NCT00988884|6044871|P1|COMPLETED|Overall Study||586
2465385|NCT00988884|6044870|P2|STARTED|Overall Study||620
2465386|NCT00988884|6044871|P1|STARTED|Overall Study||621
2465387|NCT00988858|6044893|P1|NOT COMPLETED|Overall Study||10
2465388|NCT00988858|6044893|P1|COMPLETED|Overall Study||45
2465389|NCT00988858|6044893|P1|STARTED|Overall Study||55
2465390|NCT00988832|6044905|P1|NOT COMPLETED|Overall Study||0
2465391|NCT00988832|6044905|P1|COMPLETED|Overall Study||380
2465392|NCT00988832|6044905|P1|STARTED|Overall Study||380
2465393|NCT00988637|6044942|P2|NOT COMPLETED|Overall Study||3
2465394|NCT00988637|6044943|P1|NOT COMPLETED|Overall Study||3
2465395|NCT00988637|6044942|P2|COMPLETED|Overall Study||65
2465396|NCT00988637|6044943|P1|COMPLETED|Overall Study||67
2465397|NCT00988637|6044942|P2|STARTED|Overall Study||68
2465398|NCT00988637|6044943|P1|STARTED|Overall Study||70
2465399|NCT00988559|6044977|P4|NOT COMPLETED|Overall Study||1
2465400|NCT00988559|6044978|P3|NOT COMPLETED|Overall Study||2
2465401|NCT00988559|6044979|P2|NOT COMPLETED|Overall Study||2
2465402|NCT00988559|6044980|P1|NOT COMPLETED|Overall Study||1
2465403|NCT00988559|6044977|P4|COMPLETED|Overall Study||6
2465404|NCT00988559|6044978|P3|COMPLETED|Overall Study||9
2465405|NCT00988559|6044979|P2|COMPLETED|Overall Study||9
2465406|NCT00988559|6044980|P1|COMPLETED|Overall Study||9
2465407|NCT00988559|6044977|P4|STARTED|Overall Study||7
2465408|NCT00988559|6044978|P3|STARTED|Overall Study||11
2465409|NCT00988559|6044979|P2|STARTED|Overall Study||11
2465410|NCT00988559|6044980|P1|STARTED|Overall Study||10
2465411|NCT00988533|6044994|P1|NOT COMPLETED|Overall Study||3
2465412|NCT00988533|6044994|P1|COMPLETED|Overall Study||27
2465413|NCT00988533|6044994|P1|STARTED|Overall Study||30
2465414|NCT00988442|6045008|P2|NOT COMPLETED|Overall Study||28
2465415|NCT00988442|6045009|P1|NOT COMPLETED|Overall Study||30
2465416|NCT00988442|6045008|P2|COMPLETED|Overall Study||1
2465417|NCT00988442|6045009|P1|COMPLETED|Overall Study||0
2465418|NCT00988442|6045008|P2|STARTED|Overall Study||29
2465419|NCT00988442|6045009|P1|STARTED|Overall Study||30
2465420|NCT00988429|6045072|P3|NOT COMPLETED|Overall Study||69
2465421|NCT00988429|6045073|P2|NOT COMPLETED|Overall Study||43
2465422|NCT00988429|6045074|P1|NOT COMPLETED|Overall Study||37
2465423|NCT00988429|6045072|P3|COMPLETED|Overall Study||142
2465424|NCT00988429|6045073|P2|COMPLETED|Overall Study||173
2465425|NCT00988429|6045074|P1|COMPLETED|Overall Study||189
2465426|NCT00988429|6045072|P3|Intention-to-treat (ITT) Population|Overall Study||205
2465427|NCT00988429|6045073|P2|Intention-to-treat (ITT) Population|Overall Study||215
2465428|NCT00988429|6045074|P1|Intention-to-treat (ITT) Population|Overall Study||220
2465429|NCT00988429|6045072|P3|Safety Population|Overall Study||210
2465430|NCT00988429|6045073|P2|Safety Population|Overall Study||216
2465431|NCT00988429|6045074|P1|Safety Population|Overall Study||224
2465432|NCT00988429|6045072|P3|STARTED|Overall Study||211
2465433|NCT00988429|6045073|P2|STARTED|Overall Study||216
2465434|NCT00988429|6045074|P1|STARTED|Overall Study||226
2465435|NCT00988351|6045087|P2|NOT COMPLETED|Overall Study||12
2465436|NCT00988351|6045088|P1|NOT COMPLETED|Overall Study||19
2465437|NCT00988351|6045087|P2|COMPLETED|Overall Study||66
2465438|NCT00988351|6045088|P1|COMPLETED|Overall Study||59
2465439|NCT00988351|6045087|P2|Using CPAP or APAP|Overall Study|3 not using APAP (less than 1/2 hour per night)|66
2465440|NCT00988351|6045088|P1|Using CPAP or APAP|Overall Study|5 not using CPAP (use < 1/2 hour per night)|59
2465441|NCT00988351|6045087|P2|Clinic Visit|Overall Study|9 lost to follow-up or no show for clinic|69
2465442|NCT00988351|6045088|P1|Clinic Visit|Overall Study|6 lost to follow-up or no show for clinic|64
2465443|NCT00988351|6045087|P2|PAP Setup|Overall Study|APAP treatment started|78
2465444|NCT00988351|6045088|P1|PAP Setup|Overall Study|CPAP treatment started|70
2465445|NCT00988351|6045087|P2|CPAP Titration|Overall Study|no titration needed|78
2465446|NCT00988351|6045088|P1|CPAP Titration|Overall Study|8 declined CPAP treatment|78
2465447|NCT00988351|6045087|P2|STARTED|Overall Study||78
2465448|NCT00988351|6045088|P1|STARTED|Overall Study||78
2465449|NCT00988325|6045105|P3|NOT COMPLETED|Overall Study||0
2465450|NCT00988325|6045106|P2|NOT COMPLETED|Overall Study||0
2465451|NCT00988325|6045107|P1|NOT COMPLETED|Overall Study||0
2465452|NCT00988325|6045105|P3|COMPLETED|Overall Study||5
2465453|NCT00988325|6045106|P2|COMPLETED|Overall Study||20
2465454|NCT00988325|6045107|P1|COMPLETED|Overall Study||40
2465455|NCT00988325|6045105|P3|STARTED|Overall Study||5
2465456|NCT00988325|6045106|P2|STARTED|Overall Study||20
2465457|NCT00988325|6045107|P1|STARTED|Overall Study||40
2465458|NCT00988247|6045165|P2|NOT COMPLETED|Overall Study||26
2465459|NCT00988247|6045166|P1|NOT COMPLETED|Overall Study||83
2465460|NCT00988247|6045165|P2|COMPLETED|Overall Study||85
2465461|NCT00988247|6045166|P1|COMPLETED|Overall Study||335
2465462|NCT00988247|6045165|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|110
2465548|NCT00988091|6045441|P2|NOT COMPLETED|Double-blind Period||47
2465463|NCT00988247|6045166|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|414
2465464|NCT00988247|6045165|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|111
2465465|NCT00988247|6045166|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|415
2465466|NCT00988247|6045165|P2|STARTED|Overall Study||111
2465467|NCT00988247|6045166|P1|STARTED|Overall Study||418
2465468|NCT00988221|6045185|P4|NOT COMPLETED|Part III||0
2465469|NCT00988221|6045186|P3|NOT COMPLETED|Part III||3
2465470|NCT00988221|6045187|P2|NOT COMPLETED|Part III||1
2465471|NCT00988221|6045188|P1|NOT COMPLETED|Part III||1
2465472|NCT00988221|6045185|P4|COMPLETED|Part III||0
2465473|NCT00988221|6045186|P3|COMPLETED|Part III||103
2465474|NCT00988221|6045187|P2|COMPLETED|Part III||23
2465475|NCT00988221|6045188|P1|COMPLETED|Part III||29
2465476|NCT00988221|6045185|P4|STARTED|Part III|No patients received placebo in Part III of this study.|0
2465477|NCT00988221|6045186|P3|STARTED|Part III||106
2465478|NCT00988221|6045187|P2|STARTED|Part III||24
2465479|NCT00988221|6045188|P1|STARTED|Part III||30
2465480|NCT00988221|6045185|P4|NOT COMPLETED|Part II||3
2465481|NCT00988221|6045186|P3|NOT COMPLETED|Part II||3
2465482|NCT00988221|6045187|P2|NOT COMPLETED|Part II||0
2465483|NCT00988221|6045188|P1|NOT COMPLETED|Part II||1
2465484|NCT00988221|6045185|P4|COMPLETED|Part II||81
2465485|NCT00988221|6045186|P3|COMPLETED|Part II|One participant who did not complete Part II was available to continue in the study and did.|52
2465486|NCT00988221|6045187|P2|COMPLETED|Part II||11
2465487|NCT00988221|6045188|P1|COMPLETED|Part II||15
2465488|NCT00988221|6045185|P4|STARTED|Part II||84
2465489|NCT00988221|6045186|P3|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|55
2465490|NCT00988221|6045187|P2|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|11
2465491|NCT00988221|6045188|P1|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|16
2465492|NCT00988221|6045185|P4|NOT COMPLETED|Part I||0
2465493|NCT00988221|6045186|P3|NOT COMPLETED|Part I||8
2465494|NCT00988221|6045187|P2|NOT COMPLETED|Part I||10
2465495|NCT00988221|6045188|P1|NOT COMPLETED|Part I||4
2465496|NCT00988221|6045185|P4|COMPLETED|Part I||0
2465497|NCT00988221|6045186|P3|COMPLETED|Part I||111
2465498|NCT00988221|6045187|P2|COMPLETED|Part I||24
2465499|NCT00988221|6045188|P1|COMPLETED|Part I||31
2465500|NCT00988221|6045185|P4|STARTED|Part I|No patients received placebo in Part I of this study.|0
2465501|NCT00988221|6045186|P3|STARTED|Part I||119
2465502|NCT00988221|6045187|P2|STARTED|Part I||34
2465503|NCT00988221|6045188|P1|STARTED|Part I||35
2465504|NCT00988208|6045361|P2|NOT COMPLETED|Overall Study||438
2465505|NCT00988208|6045362|P1|NOT COMPLETED|Overall Study||431
2465506|NCT00988208|6045361|P2|COMPLETED|Overall Study|DPL Completed = kept on treatment with docetaxel/prednisone; Lenalidomide discontinued in DPL arm|95
2465507|NCT00988208|6045362|P1|COMPLETED|Overall Study|DP Completed = kept on treatment with docetaxel/prednisone; Placebo was discontinued in DP arm|95
2465508|NCT00988208|6045361|P2|Treated|Overall Study||525
2465509|NCT00988208|6045362|P1|Treated|Overall Study||521
2465510|NCT00988208|6045361|P2|STARTED|Overall Study||533
2465511|NCT00988208|6045362|P1|STARTED|Overall Study||526
2465512|NCT00988169|6045380|P1|NOT COMPLETED|Overall Study||1
2465513|NCT00988169|6045380|P1|COMPLETED|Overall Study||5
2465514|NCT00988169|6045380|P1|STARTED|Overall Study||6
2465515|NCT00988156|6045386|P2|NOT COMPLETED|Overall Study||20
2465516|NCT00988156|6045387|P1|NOT COMPLETED|Overall Study||17
2465517|NCT00988156|6045386|P2|COMPLETED|Overall Study||135
2465518|NCT00988156|6045387|P1|COMPLETED|Overall Study||132
2465519|NCT00988156|6045386|P2|Safety Set|Overall Study||134
2465520|NCT00988156|6045387|P1|Safety Set|Overall Study||129
2465521|NCT00988156|6045386|P2|Per Protocol Set (PP)|Overall Study||97
2465522|NCT00988156|6045387|P1|Per Protocol Set (PP)|Overall Study||101
2465523|NCT00988156|6045386|P2|Intention-to-Treat Set (ITT)|Overall Study||134
2465524|NCT00988156|6045387|P1|Intention-to-Treat Set (ITT)|Overall Study||129
2465525|NCT00988156|6045386|P2|STARTED|Overall Study||155
2465526|NCT00988156|6045387|P1|STARTED|Overall Study||149
2465527|NCT00988143|6045398|P3|NOT COMPLETED|Overall Study||0
2465528|NCT00988143|6045399|P2|NOT COMPLETED|Overall Study||0
2465529|NCT00988143|6045400|P1|NOT COMPLETED|Overall Study||0
2465530|NCT00988143|6045398|P3|COMPLETED|Overall Study||190
2465531|NCT00988143|6045399|P2|COMPLETED|Overall Study||190
2465532|NCT00988143|6045400|P1|COMPLETED|Overall Study||220
2465533|NCT00988143|6045398|P3|STARTED|Overall Study||190
2465534|NCT00988143|6045399|P2|STARTED|Overall Study||190
2465535|NCT00988143|6045400|P1|STARTED|Overall Study||220
2465536|NCT00988117|6045432|P1|NOT COMPLETED|9.5 mg/24 Hours From Week 4 to 12||2
2465537|NCT00988117|6045432|P1|COMPLETED|9.5 mg/24 Hours From Week 4 to 12||12
2465538|NCT00988117|6045432|P1|STARTED|9.5 mg/24 Hours From Week 4 to 12||14
2465539|NCT00988117|6045432|P1|NOT COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||1
2465540|NCT00988117|6045432|P1|COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||14
2465541|NCT00988117|6045432|P1|STARTED|4.6 mg/24 Hours From Baseline to Week 4||15
2465542|NCT00988091|6045441|P2|NOT COMPLETED|Open-label Period||33
2465543|NCT00988091|6045442|P1|NOT COMPLETED|Open-label Period||21
2465544|NCT00988091|6045441|P2|COMPLETED|Open-label Period||192
2465545|NCT00988091|6045442|P1|COMPLETED|Open-label Period||208
2465546|NCT00988091|6045441|P2|STARTED|Open-label Period|Participation in the Open-label period was optional.|225
2465547|NCT00988091|6045442|P1|STARTED|Open-label Period|Participation in the Open-label period was optional.|229
2465549|NCT00988091|6045442|P1|NOT COMPLETED|Double-blind Period||43
2465550|NCT00988091|6045441|P2|COMPLETED|Double-blind Period||251
2465551|NCT00988091|6045442|P1|COMPLETED|Double-blind Period||255
2465552|NCT00988091|6045441|P2|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|295
2465553|NCT00988091|6045442|P1|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|294
2465554|NCT00988091|6045441|P2|STARTED|Double-blind Period||298
2465555|NCT00988091|6045442|P1|STARTED|Double-blind Period||298
2465556|NCT00988065|6045464|P3|NOT COMPLETED|Overall Study||15
2465557|NCT00988065|6045465|P2|NOT COMPLETED|Overall Study||23
2465558|NCT00988065|6045466|P1|NOT COMPLETED|Overall Study||13
2465559|NCT00988065|6045464|P3|COMPLETED|Overall Study||135
2465560|NCT00988065|6045465|P2|COMPLETED|Overall Study||127
2465561|NCT00988065|6045466|P1|COMPLETED|Overall Study||135
2465562|NCT00988065|6045464|P3|Received Third Randomized Dose|Overall Study||135
2465563|NCT00988065|6045465|P2|Received Third Randomized Dose|Overall Study||127
2465564|NCT00988065|6045466|P1|Received Third Randomized Dose|Overall Study||135
2465565|NCT00988065|6045464|P3|Received Second Randomized Dose|Overall Study||145
2465566|NCT00988065|6045465|P2|Received Second Randomized Dose|Overall Study||135
2465567|NCT00988065|6045466|P1|Received Second Randomized Dose|Overall Study||139
2465568|NCT00988065|6045464|P3|Received First Randomized Dose|Overall Study||150
2465569|NCT00988065|6045465|P2|Received First Randomized Dose|Overall Study||150
2465570|NCT00988065|6045466|P1|Received First Randomized Dose|Overall Study||148
2465571|NCT00988065|6045464|P3|STARTED|Overall Study|Randomized to double-blind treatment|150
2465572|NCT00988065|6045465|P2|STARTED|Overall Study|Randomized to double-blind treatment|150
2465573|NCT00988065|6045466|P1|STARTED|Overall Study|Randomized to double-blind treatment|148
2465574|NCT00988052|6045488|P2|NOT COMPLETED|Overall Study||416
2465575|NCT00988052|6045489|P1|NOT COMPLETED|Overall Study||423
2465576|NCT00988052|6045488|P2|COMPLETED|Overall Study||0
2465577|NCT00988052|6045489|P1|COMPLETED|Overall Study||0
2465578|NCT00988052|6045488|P2|STARTED|Overall Study||416
2465579|NCT00988052|6045489|P1|STARTED|Overall Study||423
2465580|NCT00988000|6045506|P3|NOT COMPLETED|Overall Study||0
2465581|NCT00988000|6045507|P2|NOT COMPLETED|Overall Study||0
2465582|NCT00988000|6045508|P1|NOT COMPLETED|Overall Study||0
2465583|NCT00988000|6045506|P3|COMPLETED|Overall Study||57
2465584|NCT00988000|6045507|P2|COMPLETED|Overall Study||51
2465585|NCT00988000|6045508|P1|COMPLETED|Overall Study||49
2465586|NCT00988000|6045506|P3|STARTED|Overall Study||57
2465587|NCT00988000|6045507|P2|STARTED|Overall Study||51
2465588|NCT00988000|6045508|P1|STARTED|Overall Study||49
2465589|NCT00987948|6045519|P1|NOT COMPLETED|Overall Study||3
2465590|NCT00987948|6045519|P1|COMPLETED|Overall Study||12
2465591|NCT00987948|6045519|P1|STARTED|Overall Study||15
2465592|NCT00987935|6045533|P9|NOT COMPLETED|Overall Study||32
2465593|NCT00987935|6045534|P8|NOT COMPLETED|Overall Study||62
2465594|NCT00987935|6045535|P7|NOT COMPLETED|Overall Study||15
2465595|NCT00987935|6045536|P6|NOT COMPLETED|Overall Study||3
2465596|NCT00987935|6045537|P5|NOT COMPLETED|Overall Study||7
2465597|NCT00987935|6045538|P4|NOT COMPLETED|Overall Study||3
2465598|NCT00987935|6045539|P3|NOT COMPLETED|Overall Study||3
2465599|NCT00987935|6045540|P2|NOT COMPLETED|Overall Study||3
2465600|NCT00987935|6045541|P1|NOT COMPLETED|Overall Study||4
2465601|NCT00987935|6045533|P9|COMPLETED|Overall Study||0
2465602|NCT00987935|6045534|P8|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
2465603|NCT00987935|6045535|P7|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
2465604|NCT00987935|6045536|P6|COMPLETED|Overall Study||0
2465605|NCT00987935|6045537|P5|COMPLETED|Overall Study||0
2465606|NCT00987935|6045538|P4|COMPLETED|Overall Study||0
2465607|NCT00987935|6045539|P3|COMPLETED|Overall Study||0
2465608|NCT00987935|6045540|P2|COMPLETED|Overall Study||0
2465609|NCT00987935|6045541|P1|COMPLETED|Overall Study||0
2465610|NCT00987935|6045533|P9|STARTED|Overall Study||32
2465611|NCT00987935|6045534|P8|STARTED|Overall Study||63
2465612|NCT00987935|6045535|P7|STARTED|Overall Study||16
2465613|NCT00987935|6045536|P6|STARTED|Overall Study||3
2465614|NCT00987935|6045537|P5|STARTED|Overall Study||7
2465615|NCT00987935|6045538|P4|STARTED|Overall Study||3
2465616|NCT00987935|6045539|P3|STARTED|Overall Study||3
2465617|NCT00987935|6045540|P2|STARTED|Overall Study||3
2465618|NCT00987935|6045541|P1|STARTED|Overall Study||4
2465619|NCT00987831|6045597|P3|NOT COMPLETED|Overall Study||0
2465620|NCT00987831|6045598|P2|NOT COMPLETED|Overall Study||3
2465621|NCT00987831|6045599|P1|NOT COMPLETED|Overall Study||1
2465622|NCT00987831|6045597|P3|COMPLETED|Overall Study|Anyone who entered this arm completed it the same day|62
2465623|NCT00987831|6045598|P2|COMPLETED|Overall Study|all controls returned for two visits|52
2465624|NCT00987831|6045599|P1|COMPLETED|Overall Study|40 patients completed in 6 months. 1 patient did not meet completion definition in 12 months.|40
2465625|NCT00987831|6045597|P3|STARTED|Overall Study|Anyone who entered this arm completed it the same day|62
2465626|NCT00987831|6045598|P2|STARTED|Overall Study|52 healthy controls donated biomarkers on two occasions in order to verify biomarkers ranges|55
2465627|NCT00987831|6045599|P1|STARTED|Overall Study|41 patients improved after depomedrol, if not improved, treated and moved to Group B|41
2465628|NCT00987727|6045610|P2|NOT COMPLETED|Overall Study||7
2465629|NCT00987727|6045611|P1|NOT COMPLETED|Overall Study||5
2465630|NCT00987727|6045610|P2|COMPLETED|Overall Study||34
2465631|NCT00987727|6045611|P1|COMPLETED|Overall Study||36
2465632|NCT00987727|6045610|P2|STARTED|Overall Study||41
2465633|NCT00987727|6045611|P1|STARTED|Overall Study||41
2465634|NCT00987623|6045621|P2|NOT COMPLETED|Overall Study||3
2465635|NCT00987623|6045622|P1|NOT COMPLETED|Overall Study||5
2465636|NCT00987623|6045621|P2|COMPLETED|Overall Study||151
2465637|NCT00987623|6045622|P1|COMPLETED|Overall Study||140
2465638|NCT00987623|6045621|P2|STARTED|Overall Study||154
2465639|NCT00987623|6045622|P1|STARTED|Overall Study||145
2465640|NCT00987558|6045628|P2|NOT COMPLETED|Overall Study||5
2465641|NCT00987558|6045629|P1|NOT COMPLETED|Overall Study||1
2465642|NCT00987558|6045628|P2|COMPLETED|Overall Study||12
2465643|NCT00987558|6045629|P1|COMPLETED|Overall Study||12
2465644|NCT00987558|6045628|P2|Eslicarbazepine Acetate + Simvastatin|Overall Study||17
2465645|NCT00987558|6045629|P1|Eslicarbazepine Acetate + Simvastatin|Overall Study||13
2465646|NCT00987558|6045628|P2|Washout|Overall Study||12
2465647|NCT00987558|6045629|P1|Washout|Overall Study||13
2465648|NCT00987558|6045628|P2|Simvastatin|Overall Study||12
2465649|NCT00987558|6045629|P1|Simvastatin|Overall Study||13
2465650|NCT00987558|6045628|P2|STARTED|Overall Study||17
2465651|NCT00987558|6045629|P1|STARTED|Overall Study||13
2465652|NCT00987480|6045642|P1|NOT COMPLETED|Overall Study||0
2465653|NCT00987480|6045642|P1|COMPLETED|Overall Study||45
2465654|NCT00987480|6045642|P1|STARTED|Overall Study||45
2465655|NCT00987467|6045651|P1|NOT COMPLETED|Overall Study||2
2465656|NCT00987467|6045651|P1|COMPLETED|Overall Study||10
2465657|NCT00987467|6045651|P1|STARTED|Overall Study||12
2465658|NCT00987415|6045658|P2|NOT COMPLETED|Overall Study||9
2465659|NCT00987415|6045659|P1|NOT COMPLETED|Overall Study||9
2465660|NCT00987415|6045658|P2|COMPLETED|Overall Study||116
2465661|NCT00987415|6045659|P1|COMPLETED|Overall Study||119
2465662|NCT00987415|6045658|P2|STARTED|Overall Study||125
2465663|NCT00987415|6045659|P1|STARTED|Overall Study||128
2465664|NCT00987402|6045675|P2|NOT COMPLETED|Overall Study||98
2465665|NCT00987402|6045676|P1|NOT COMPLETED|Overall Study||86
2465666|NCT00987402|6045675|P2|COMPLETED|Overall Study|98 patients did not have sufficient data|1537
2465667|NCT00987402|6045676|P1|COMPLETED|Overall Study|86 patients did not have some data, and could not be evaluated|1596
2465668|NCT00987402|6045675|P2|STARTED|Overall Study|January 2007 with crossover every 2 months|1635
2465669|NCT00987402|6045676|P1|STARTED|Overall Study|January 2007, with crossover every 2 months|1682
2465670|NCT00987337|6045685|P3|NOT COMPLETED|Overall Study||51
2465671|NCT00987337|6045686|P2|NOT COMPLETED|Overall Study||55
2465672|NCT00987337|6045687|P1|NOT COMPLETED|Overall Study||57
2465673|NCT00987337|6045685|P3|COMPLETED|Overall Study||45
2465674|NCT00987337|6045686|P2|COMPLETED|Overall Study||41
2465675|NCT00987337|6045687|P1|COMPLETED|Overall Study||39
2465676|NCT00987337|6045685|P3|STARTED|Overall Study||96
2465677|NCT00987337|6045686|P2|STARTED|Overall Study||96
2465678|NCT00987337|6045687|P1|STARTED|Overall Study||96
2465679|NCT00986999|6045731|P1|NOT COMPLETED|Overall Study||1
2465680|NCT00986999|6045731|P1|COMPLETED|Overall Study||6
2465681|NCT00986999|6045731|P1|STARTED|Overall Study||7
2465682|NCT00986986|6045742|P2|NOT COMPLETED|Overall Study||1
2465683|NCT00986986|6045743|P1|NOT COMPLETED|Overall Study||0
2465684|NCT00986986|6045742|P2|COMPLETED|Overall Study||9
2465685|NCT00986986|6045743|P1|COMPLETED|Overall Study||10
2465686|NCT00986986|6045742|P2|STARTED|Overall Study||10
2465687|NCT00986986|6045743|P1|STARTED|Overall Study||10
2465688|NCT00986973|6045753|P1|NOT COMPLETED|Overall Study||1
2465689|NCT00986973|6045753|P1|COMPLETED|Overall Study|One subject was withdrawn from the study due to poor compliance with KUVAN therapy.|5
2465690|NCT00986973|6045753|P1|STARTED|Overall Study||6
2465691|NCT00986960|6045765|P2|NOT COMPLETED|Overall Study||0
2465692|NCT00986960|6045766|P1|NOT COMPLETED|Overall Study||0
2465693|NCT00986960|6045765|P2|COMPLETED|Overall Study||0
2465694|NCT00986960|6045766|P1|COMPLETED|Overall Study||0
2465695|NCT00986960|6045765|P2|STARTED|Overall Study||0
2465696|NCT00986960|6045766|P1|STARTED|Overall Study||0
2465697|NCT00986947|6045772|P1|NOT COMPLETED|Overall Study||20
2465698|NCT00986947|6045772|P1|COMPLETED|Overall Study||0
2465699|NCT00986947|6045772|P1|STARTED|Overall Study||20
2465700|NCT00986921|6045779|P2|NOT COMPLETED|Overall Study||0
2465701|NCT00986921|6045780|P1|NOT COMPLETED|Overall Study||1
2465702|NCT00986921|6045779|P2|COMPLETED|Overall Study||25
2465703|NCT00986921|6045780|P1|COMPLETED|Overall Study||24
2465704|NCT00986921|6045779|P2|STARTED|Overall Study||25
2465705|NCT00986921|6045780|P1|STARTED|Overall Study||25
2465706|NCT00986856|6045792|P2|NOT COMPLETED|Overall Study||0
2465707|NCT00986856|6045793|P1|NOT COMPLETED|Overall Study||0
2465708|NCT00986856|6045792|P2|COMPLETED|Overall Study||16
2465709|NCT00986856|6045793|P1|COMPLETED|Overall Study||42
2465710|NCT00986856|6045792|P2|STARTED|Overall Study||16
2465711|NCT00986856|6045793|P1|STARTED|Overall Study||42
2465712|NCT00986674|6045816|P3|NOT COMPLETED|Overall Study||48
2465713|NCT00986674|6045817|P2|NOT COMPLETED|Overall Study||45
2465714|NCT00986674|6045818|P1|NOT COMPLETED|Overall Study||47
2465715|NCT00986674|6045816|P3|COMPLETED|Overall Study||0
2465716|NCT00986674|6045817|P2|COMPLETED|Overall Study||0
2465717|NCT00986674|6045818|P1|COMPLETED|Overall Study||0
2465718|NCT00986674|6045816|P3|Eligible and Treated|Overall Study||47
2465719|NCT00986674|6045817|P2|Eligible and Treated|Overall Study||41
2465720|NCT00986674|6045818|P1|Eligible and Treated|Overall Study||39
2465721|NCT00986674|6045816|P3|Treated|Overall Study||47
2465722|NCT00986674|6045817|P2|Treated|Overall Study||42
2465723|NCT00986674|6045818|P1|Treated|Overall Study||43
2465724|NCT00986674|6045816|P3|STARTED|Overall Study||48
2465725|NCT00986674|6045817|P2|STARTED|Overall Study||45
2465726|NCT00986674|6045818|P1|STARTED|Overall Study||47
2465727|NCT00986583|6045834|P2|NOT COMPLETED|Overall Study||0
2465728|NCT00986583|6045835|P1|NOT COMPLETED|Overall Study||0
2465729|NCT00986583|6045834|P2|COMPLETED|Overall Study||32
2465730|NCT00986583|6045835|P1|COMPLETED|Overall Study||38
2465731|NCT00986583|6045834|P2|STARTED|Overall Study||32
2465732|NCT00986583|6045835|P1|STARTED|Overall Study||38
2465733|NCT00986570|6045851|P1|NOT COMPLETED|Overall Study||7
2465734|NCT00986570|6045851|P1|COMPLETED|Overall Study||114
2465735|NCT00986570|6045851|P1|STARTED|Overall Study||121
2465736|NCT00986544|6045857|P2|NOT COMPLETED|Overall Study||0
2465737|NCT00986544|6045858|P1|NOT COMPLETED|Overall Study||0
2465738|NCT00986544|6045857|P2|COMPLETED|Overall Study||53
2465739|NCT00986544|6045858|P1|COMPLETED|Overall Study||53
2465740|NCT00986544|6045857|P2|STARTED|Overall Study||53
2465741|NCT00986544|6045858|P1|STARTED|Overall Study||53
2465742|NCT00986479|6045868|P2|NOT COMPLETED|Period 2||0
2465743|NCT00986479|6045869|P1|NOT COMPLETED|Period 2||0
2465744|NCT00986479|6045868|P2|COMPLETED|Period 2||10
2465745|NCT00986479|6045869|P1|COMPLETED|Period 2||10
2465746|NCT00986479|6045868|P2|STARTED|Period 2||10
2465747|NCT00986479|6045869|P1|STARTED|Period 2||10
2465748|NCT00986479|6045868|P2|NOT COMPLETED|Period 1||0
2465749|NCT00986479|6045869|P1|NOT COMPLETED|Period 1||2
2465750|NCT00986479|6045868|P2|COMPLETED|Period 1||10
2465751|NCT00986479|6045869|P1|COMPLETED|Period 1||10
2465752|NCT00986479|6045868|P2|STARTED|Period 1||10
2465753|NCT00986479|6045869|P1|STARTED|Period 1||12
2465754|NCT00986453|6045899|P1|NOT COMPLETED|Overall Study||2
2465755|NCT00986453|6045899|P1|COMPLETED|Overall Study||43
2465756|NCT00986453|6045899|P1|STARTED|Overall Study||45
2465757|NCT00986427|6045915|P2|NOT COMPLETED|Overall Study||0
2465758|NCT00986427|6045916|P1|NOT COMPLETED|Overall Study||4
2465759|NCT00986427|6045915|P2|COMPLETED|Overall Study||12
2465760|NCT00986427|6045916|P1|COMPLETED|Overall Study||8
2465761|NCT00986427|6045915|P2|STARTED|Overall Study||12
2465762|NCT00986427|6045916|P1|STARTED|Overall Study||12
2465763|NCT00986401|6045932|P2|NOT COMPLETED|Period 2||0
2465764|NCT00986401|6045933|P1|NOT COMPLETED|Period 2||0
2465765|NCT00986401|6045932|P2|COMPLETED|Period 2||21
2465766|NCT00986401|6045933|P1|COMPLETED|Period 2||22
2465767|NCT00986401|6045932|P2|STARTED|Period 2||21
2465768|NCT00986401|6045933|P1|STARTED|Period 2||22
2465769|NCT00986401|6045932|P2|NOT COMPLETED|Period 1||1
2465770|NCT00986401|6045933|P1|NOT COMPLETED|Period 1||0
2465771|NCT00986401|6045932|P2|COMPLETED|Period 1||21
2465772|NCT00986401|6045933|P1|COMPLETED|Period 1||22
2465773|NCT00986401|6045932|P2|STARTED|Period 1||22
2465774|NCT00986401|6045933|P1|STARTED|Period 1||22
2465775|NCT00986362|6045944|P2|NOT COMPLETED|Overall Study||1
2465776|NCT00986362|6045945|P1|NOT COMPLETED|Overall Study||2
2465777|NCT00986362|6045944|P2|COMPLETED|Overall Study|7 eyes completed the study (in 7 subjects).|7
2465778|NCT00986362|6045945|P1|COMPLETED|Overall Study|14 eyes completed the study (in 14 subjects).|14
2465779|NCT00986362|6045944|P2|STARTED|Overall Study|8 eyes randomized and treated (in 8 subjects).|8
2465780|NCT00986362|6045945|P1|STARTED|Overall Study|16 eyes randomized and treated (in 15 subjects).|16
2465781|NCT00986349|6045951|P1|NOT COMPLETED|Overall Study||7
2465782|NCT00986349|6045951|P1|COMPLETED|Overall Study||16
2465783|NCT00986349|6045951|P1|Early Explant|Overall Study||4
2465784|NCT00986349|6045951|P1|Successful Implant Procedure|Overall Study|successful device implant procedure|20
2465785|NCT00986349|6045951|P1|STARTED|Overall Study|attempted implant procedures|23
2465786|NCT00986310|6045966|P2|NOT COMPLETED|Overall Study||0
2465787|NCT00986310|6045967|P1|NOT COMPLETED|Overall Study||0
2465788|NCT00986310|6045966|P2|COMPLETED|Overall Study||0
2465789|NCT00986310|6045967|P1|COMPLETED|Overall Study||0
2465790|NCT00986310|6045966|P2|STARTED|Overall Study||0
2465791|NCT00986310|6045967|P1|STARTED|Overall Study||0
2465792|NCT00986258|6045975|P1|NOT COMPLETED|Maintenance Period||9
2465793|NCT00986258|6045975|P1|COMPLETED|Maintenance Period||93
2465794|NCT00986258|6045975|P1|STARTED|Maintenance Period||102
2465795|NCT00986258|6045975|P1|NOT COMPLETED|Titration and Optimal Dose Period||23
2465796|NCT00986258|6045975|P1|COMPLETED|Titration and Optimal Dose Period||102
2465797|NCT00986258|6045975|P1|STARTED|Titration and Optimal Dose Period||125
2465798|NCT00986258|6045975|P1|NOT COMPLETED|Observation Period||11
2465799|NCT00986258|6045975|P1|COMPLETED|Observation Period||125
2465800|NCT00986258|6045975|P1|STARTED|Observation Period||136
2465801|NCT00986245|6046003|P2|NOT COMPLETED|Second Intervention||1
2465802|NCT00986245|6046004|P1|NOT COMPLETED|Second Intervention||2
2465803|NCT00986245|6046003|P2|COMPLETED|Second Intervention||32
2465804|NCT00986245|6046004|P1|COMPLETED|Second Intervention||29
2465805|NCT00986245|6046003|P2|STARTED|Second Intervention||33
2465806|NCT00986245|6046004|P1|STARTED|Second Intervention||31
2465807|NCT00986245|6046003|P2|NOT COMPLETED|First Intervention||8
2465808|NCT00986245|6046004|P1|NOT COMPLETED|First Intervention||10
2465809|NCT00986245|6046003|P2|COMPLETED|First Intervention||33
2465810|NCT00986245|6046004|P1|COMPLETED|First Intervention||31
2465811|NCT00986245|6046003|P2|STARTED|First Intervention||41
2465812|NCT00986245|6046004|P1|STARTED|First Intervention||41
2465813|NCT00986232|6046041|P4|NOT COMPLETED|Overall Study||20
2465814|NCT00986232|6046042|P3|NOT COMPLETED|Overall Study||35
2465815|NCT00986232|6046043|P2|NOT COMPLETED|Overall Study||50
2465816|NCT00986232|6046044|P1|NOT COMPLETED|Overall Study||51
2465817|NCT00986232|6046041|P4|COMPLETED|Overall Study||370
2465818|NCT00986232|6046042|P3|COMPLETED|Overall Study||346
2465819|NCT00986232|6046043|P2|COMPLETED|Overall Study||343
2465820|NCT00986232|6046044|P1|COMPLETED|Overall Study||336
2465821|NCT00986232|6046041|P4|Vaccination Visit 2|Overall Study||0
2465822|NCT00986232|6046042|P3|Vaccination Visit 2|Overall Study||360
2465823|NCT00986232|6046043|P2|Vaccination Visit 2|Overall Study||365
2465824|NCT00986232|6046044|P1|Vaccination Visit 2|Overall Study||360
2465825|NCT00986232|6046041|P4|Vaccination Visit 1|Overall Study||390
2465826|NCT00986232|6046042|P3|Vaccination Visit 1|Overall Study||381
2465827|NCT00986232|6046043|P2|Vaccination Visit 1|Overall Study||393
2465828|NCT00986232|6046044|P1|Vaccination Visit 1|Overall Study||387
2465829|NCT00986232|6046041|P4|STARTED|Overall Study|Excludes 1 patient who was randomized to receive M-M-R™ II + PUVV, but was not vaccinated.|390
2465830|NCT00986232|6046042|P3|STARTED|Overall Study||381
2465831|NCT00986232|6046043|P2|STARTED|Overall Study|Excludes 1 patient who was randomized to receive ProQuad (Middle Dose), but was not vaccinated.|393
2465832|NCT00986232|6046044|P1|STARTED|Overall Study||387
2465833|NCT00986180|6046118|P2|NOT COMPLETED|Overall Study||56
2465834|NCT00986180|6046119|P1|NOT COMPLETED|Overall Study||44
2465835|NCT00986180|6046118|P2|COMPLETED|Overall Study||268
2465836|NCT00986180|6046119|P1|COMPLETED|Overall Study||277
2465837|NCT00986180|6046118|P2|STARTED|Overall Study||324
2465838|NCT00986180|6046119|P1|STARTED|Overall Study||321
2465839|NCT00986154|6046197|P2|NOT COMPLETED|Overall Study||194
2465840|NCT00986154|6046198|P1|NOT COMPLETED|Overall Study||206
2465841|NCT00986154|6046197|P2|COMPLETED|Overall Study||3955
2465842|NCT00986154|6046198|P1|COMPLETED|Overall Study||3937
2465843|NCT00986154|6046197|P2|Safety Analysis Set (Received Drug)|Overall Study||4122
2465844|NCT00986154|6046198|P1|Safety Analysis Set (Received Drug)|Overall Study||4118
2465845|NCT00986154|6046197|P2|STARTED|Overall Study||4149
2465846|NCT00986154|6046198|P1|STARTED|Overall Study||4143
2465847|NCT00986102|6046212|P4|NOT COMPLETED|Overall Study||1
2465848|NCT00986102|6046213|P3|NOT COMPLETED|Overall Study||0
2465849|NCT00986102|6046214|P2|NOT COMPLETED|Overall Study||2
2465850|NCT00986102|6046215|P1|NOT COMPLETED|Overall Study||1
2465851|NCT00986102|6046212|P4|COMPLETED|Overall Study||66
2465852|NCT00986102|6046213|P3|COMPLETED|Overall Study||19
2465853|NCT00986102|6046214|P2|COMPLETED|Overall Study||75
2465854|NCT00986102|6046215|P1|COMPLETED|Overall Study||52
2465855|NCT00986102|6046212|P4|STARTED|Overall Study|Number of participants who received study medication|67
2465856|NCT00986102|6046213|P3|STARTED|Overall Study|Number of participants who received study medication|19
2465857|NCT00986102|6046214|P2|STARTED|Overall Study|Number of participants who received study medication|77
2465858|NCT00986102|6046215|P1|STARTED|Overall Study|Number of participants who received study medication|53
2465859|NCT00985985|6046265|P4|NOT COMPLETED|Overall Study||13
2465860|NCT00985985|6046266|P3|NOT COMPLETED|Overall Study||11
2465861|NCT00985985|6046267|P2|NOT COMPLETED|Overall Study||24
2465862|NCT00985985|6046268|P1|NOT COMPLETED|Overall Study||24
2465863|NCT00985985|6046265|P4|COMPLETED|Overall Study||107
2465864|NCT00985985|6046266|P3|COMPLETED|Overall Study||109
2465865|NCT00985985|6046267|P2|COMPLETED|Overall Study||218
2465866|NCT00985985|6046268|P1|COMPLETED|Overall Study||217
2465867|NCT00985985|6046265|P4|Full Analysis Set (FAS) Population|Overall Study|One participant withdrew consent and was not included as the FAS population.|119
2465868|NCT00985985|6046266|P3|Full Analysis Set (FAS) Population|Overall Study||120
2465869|NCT00985985|6046267|P2|Full Analysis Set (FAS) Population|Overall Study||242
2465870|NCT00985985|6046268|P1|Full Analysis Set (FAS) Population|Overall Study||241
2465871|NCT00985985|6046265|P4|Safety Population|Overall Study||118
2465872|NCT00985985|6046266|P3|Safety Population|Overall Study||119
2465873|NCT00985985|6046267|P2|Safety Population|Overall Study||242
2465874|NCT00985985|6046268|P1|Safety Population|Overall Study||241
2465875|NCT00985985|6046265|P4|STARTED|Overall Study||120
2465876|NCT00985985|6046266|P3|STARTED|Overall Study||120
2465877|NCT00985985|6046267|P2|STARTED|Overall Study||242
2465878|NCT00985985|6046268|P1|STARTED|Overall Study||241
2465879|NCT00985959|6046309|P3|NOT COMPLETED|Overall Study||59
2465880|NCT00985959|6046310|P2|NOT COMPLETED|Overall Study||3
2465881|NCT00985959|6046311|P1|NOT COMPLETED|Overall Study||3
2465882|NCT00985959|6046309|P3|COMPLETED|Overall Study||28
2465883|NCT00985959|6046310|P2|COMPLETED|Overall Study|Completed all 9 cycles|3
2465884|NCT00985959|6046311|P1|COMPLETED|Overall Study|Completed all 9 cycles|3
2465885|NCT00985959|6046309|P3|STARTED|Overall Study|Number of participants treated|87
2465886|NCT00985959|6046310|P2|STARTED|Overall Study|Number of participants treated|6
2465887|NCT00985959|6046311|P1|STARTED|Overall Study|Number of participants treated|6
2465888|NCT00985946|6046334|P1|NOT COMPLETED|Overall Study||7
2465889|NCT00985946|6046334|P1|COMPLETED|Overall Study||8
2465890|NCT00985946|6046334|P1|STARTED|Overall Study|Eighty-seven percent (n=13) were evaluable for response.|15
2465891|NCT00985829|6046342|P1|NOT COMPLETED|Overall Study||0
2465892|NCT00985829|6046342|P1|COMPLETED|Overall Study||28
2465893|NCT00985829|6046342|P1|STARTED|Overall Study||28
2465894|NCT00985790|6046353|P2|NOT COMPLETED|Overall Study||8
2465895|NCT00985790|6046354|P1|NOT COMPLETED|Overall Study||7
2465896|NCT00985790|6046353|P2|COMPLETED|Overall Study||293
2465897|NCT00985790|6046354|P1|COMPLETED|Overall Study||291
2465898|NCT00985790|6046353|P2|STARTED|Overall Study|97 were primed and 204 were unprimed subjects.|301
2465899|NCT00985790|6046354|P1|STARTED|Overall Study|95 were primed and 203 were unprimed subjects.|298
2465900|NCT00985751|6046395|P5|NOT COMPLETED|Overall Study||1
2465901|NCT00985751|6046396|P4|NOT COMPLETED|Overall Study||0
2465902|NCT00985751|6046397|P3|NOT COMPLETED|Overall Study||0
2465903|NCT00985751|6046398|P2|NOT COMPLETED|Overall Study||0
2465904|NCT00985751|6046399|P1|NOT COMPLETED|Overall Study||0
2465905|NCT00985751|6046395|P5|COMPLETED|Overall Study||50
2465906|NCT00985751|6046396|P4|COMPLETED|Overall Study||51
2465907|NCT00985751|6046397|P3|COMPLETED|Overall Study||52
2465908|NCT00985751|6046398|P2|COMPLETED|Overall Study||52
2465909|NCT00985751|6046399|P1|COMPLETED|Overall Study||51
2465910|NCT00985751|6046395|P5|STARTED|Overall Study||51
2465911|NCT00985751|6046396|P4|STARTED|Overall Study||51
2465912|NCT00985751|6046397|P3|STARTED|Overall Study||52
2465913|NCT00985751|6046398|P2|STARTED|Overall Study||52
2465914|NCT00985751|6046399|P1|STARTED|Overall Study||51
2465915|NCT00985738|6046462|P2|NOT COMPLETED|Overall Study||8
2465916|NCT00985738|6046463|P1|NOT COMPLETED|Overall Study||8
2465917|NCT00985738|6046462|P2|COMPLETED|Overall Study||0
2465918|NCT00985738|6046463|P1|COMPLETED|Overall Study||0
2465919|NCT00985738|6046462|P2|STARTED|Overall Study||8
2465920|NCT00985738|6046463|P1|STARTED|Overall Study||8
2465921|NCT00985725|6046471|P2|NOT COMPLETED|Overall Study||13
2465922|NCT00985725|6046472|P1|NOT COMPLETED|Overall Study||11
2465923|NCT00985725|6046471|P2|COMPLETED|Overall Study||59
2465924|NCT00985725|6046472|P1|COMPLETED|Overall Study||60
2465925|NCT00985725|6046471|P2|STARTED|Overall Study||72
2465926|NCT00985725|6046472|P1|STARTED|Overall Study||71
2465927|NCT00985712|6046508|P2|NOT COMPLETED|Overall Study||7
2465928|NCT00985712|6046509|P1|NOT COMPLETED|Overall Study||6
2465929|NCT00985712|6046508|P2|COMPLETED|Overall Study||123
2465930|NCT00985712|6046509|P1|COMPLETED|Overall Study||127
2465931|NCT00985712|6046508|P2|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|129
2465932|NCT00985712|6046509|P1|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|128
2465933|NCT00985712|6046508|P2|Received at Least One Dose of Study Drug|Overall Study||130
2465934|NCT00985712|6046509|P1|Received at Least One Dose of Study Drug|Overall Study||131
2465935|NCT00985712|6046508|P2|STARTED|Overall Study||130
2465936|NCT00985712|6046509|P1|STARTED|Overall Study||133
2465937|NCT00985686|6046527|P4|NOT COMPLETED|Overall Study||2
2465938|NCT00985686|6046528|P3|NOT COMPLETED|Overall Study||0
2465939|NCT00985686|6046529|P2|NOT COMPLETED|Overall Study||1
2465940|NCT00985686|6046530|P1|NOT COMPLETED|Overall Study||1
2465941|NCT00985686|6046527|P4|COMPLETED|Overall Study||14
2465942|NCT00985686|6046528|P3|COMPLETED|Overall Study||13
2465943|NCT00985686|6046529|P2|COMPLETED|Overall Study||15
2465944|NCT00985686|6046530|P1|COMPLETED|Overall Study||17
2465945|NCT00985686|6046527|P4|Visit 4: Data Collection at 24 Weeks|Overall Study||14
2465946|NCT00985686|6046528|P3|Visit 4: Data Collection at 24 Weeks|Overall Study||13
2465947|NCT00985686|6046529|P2|Visit 4: Data Collection at 24 Weeks|Overall Study||15
2465948|NCT00985686|6046530|P1|Visit 4: Data Collection at 24 Weeks|Overall Study||17
2465949|NCT00985686|6046527|P4|Visit 3: Data Collection at 16 Weeks|Overall Study||16
2465950|NCT00985686|6046528|P3|Visit 3: Data Collection at 16 Weeks|Overall Study||13
2465951|NCT00985686|6046529|P2|Visit 3: Data Collection at 16 Weeks|Overall Study||15
2465952|NCT00985686|6046530|P1|Visit 3: Data Collection at 16 Weeks|Overall Study||17
2465953|NCT00985686|6046527|P4|Visit 2: Data Collection at 8 Weeks|Overall Study||16
2465954|NCT00985686|6046528|P3|Visit 2: Data Collection at 8 Weeks|Overall Study||13
2465955|NCT00985686|6046529|P2|Visit 2: Data Collection at 8 Weeks|Overall Study||15
2465956|NCT00985686|6046530|P1|Visit 2: Data Collection at 8 Weeks|Overall Study||18
2465957|NCT00985686|6046527|P4|Visit 1: Baseline Data Collection|Overall Study||16
2465958|NCT00985686|6046528|P3|Visit 1: Baseline Data Collection|Overall Study||13
2465959|NCT00985686|6046529|P2|Visit 1: Baseline Data Collection|Overall Study||15
2465960|NCT00985686|6046530|P1|Visit 1: Baseline Data Collection|Overall Study||18
2465961|NCT00985686|6046527|P4|STARTED|Overall Study||16
2465962|NCT00985686|6046528|P3|STARTED|Overall Study||13
2465963|NCT00985686|6046529|P2|STARTED|Overall Study||16
2465964|NCT00985686|6046530|P1|STARTED|Overall Study||18
2465965|NCT00985673|6046544|P6|NOT COMPLETED|Overall Study||6
2465966|NCT00985673|6046545|P5|NOT COMPLETED|Overall Study||8
2465967|NCT00985673|6046546|P4|NOT COMPLETED|Overall Study||12
2465968|NCT00985673|6046547|P3|NOT COMPLETED|Overall Study||12
2465969|NCT00985673|6046548|P2|NOT COMPLETED|Overall Study||11
2465970|NCT00985673|6046549|P1|NOT COMPLETED|Overall Study||7
2465971|NCT00985673|6046544|P6|COMPLETED|Overall Study||96
2465972|NCT00985673|6046545|P5|COMPLETED|Overall Study||93
2465973|NCT00985673|6046546|P4|COMPLETED|Overall Study||88
2465974|NCT00985673|6046547|P3|COMPLETED|Overall Study||90
2465975|NCT00985673|6046548|P2|COMPLETED|Overall Study||93
2465976|NCT00985673|6046549|P1|COMPLETED|Overall Study||95
2465977|NCT00985673|6046544|P6|STARTED|Overall Study||102
2465978|NCT00985673|6046545|P5|STARTED|Overall Study||101
2465979|NCT00985673|6046546|P4|STARTED|Overall Study||100
2465980|NCT00985673|6046547|P3|STARTED|Overall Study||102
2465981|NCT00985673|6046548|P2|STARTED|Overall Study||104
2465982|NCT00985673|6046549|P1|STARTED|Overall Study||102
2465983|NCT00985543|6046800|P1|NOT COMPLETED|Overall Study||0
2465984|NCT00985543|6046800|P1|COMPLETED|Overall Study||22
2465985|NCT00985543|6046800|P1|STARTED|Overall Study||22
2465986|NCT00985504|6046811|P2|NOT COMPLETED|Optimization Period||23
2465987|NCT00985504|6046812|P1|NOT COMPLETED|Optimization Period||26
2465988|NCT00985504|6046811|P2|COMPLETED|Optimization Period||204
2465989|NCT00985504|6046812|P1|COMPLETED|Optimization Period||203
2465990|NCT00985504|6046811|P2|STARTED|Optimization Period||227
2465991|NCT00985504|6046812|P1|STARTED|Optimization Period||229
2465992|NCT00985504|6046811|P2|NOT COMPLETED|Acute Treatment Period||12
2465993|NCT00985504|6046812|P1|NOT COMPLETED|Acute Treatment Period||15
2465994|NCT00985504|6046811|P2|COMPLETED|Acute Treatment Period||227
2465995|NCT00985504|6046812|P1|COMPLETED|Acute Treatment Period||229
2465996|NCT00985504|6046811|P2|STARTED|Acute Treatment Period||239
2465997|NCT00985504|6046812|P1|STARTED|Acute Treatment Period||244
2465998|NCT00985491|6046838|P1|NOT COMPLETED|Overall Study||19
2465999|NCT00985491|6046838|P1|COMPLETED|Overall Study|43 subjects received a device, 27 subjects completed 12 month implant period|27
2466000|NCT00985491|6046838|P1|Received Device|Overall Study||43
2466001|NCT00985491|6046838|P1|STARTED|Overall Study|46 subjects underwent an attempted implantation procedure|46
2466002|NCT00985465|6046845|P2|NOT COMPLETED|Overall Study||3
2466003|NCT00985465|6046846|P1|NOT COMPLETED|Overall Study||1
2466004|NCT00985465|6046845|P2|COMPLETED|Overall Study||66
2466005|NCT00985465|6046846|P1|COMPLETED|Overall Study||140
2466006|NCT00985465|6046845|P2|STARTED|Overall Study||69
2466007|NCT00985465|6046846|P1|STARTED|Overall Study||141
2466008|NCT00985439|6046873|P4|NOT COMPLETED|Overall Study||0
2466009|NCT00985439|6046874|P3|NOT COMPLETED|Overall Study||1
2466010|NCT00985439|6046875|P2|NOT COMPLETED|Overall Study||0
2466011|NCT00985439|6046876|P1|NOT COMPLETED|Overall Study||0
2466012|NCT00985439|6046873|P4|COMPLETED|Overall Study||51
2466013|NCT00985439|6046874|P3|COMPLETED|Overall Study||50
2466014|NCT00985439|6046875|P2|COMPLETED|Overall Study||51
2466015|NCT00985439|6046876|P1|COMPLETED|Overall Study||49
2466016|NCT00985439|6046873|P4|STARTED|Overall Study||51
2466017|NCT00985439|6046874|P3|STARTED|Overall Study||51
2466018|NCT00985439|6046875|P2|STARTED|Overall Study||51
2466019|NCT00985439|6046876|P1|STARTED|Overall Study||49
2466020|NCT00985257|6046886|P1|NOT COMPLETED|Overall Study||0
2466021|NCT00985257|6046886|P1|COMPLETED|Overall Study||123
2466022|NCT00985257|6046886|P1|STARTED|Overall Study||123
2466023|NCT00985231|6046892|P2|NOT COMPLETED|Overall Study||3
2466024|NCT00985231|6046893|P1|NOT COMPLETED|Overall Study||3
2466025|NCT00985231|6046892|P2|COMPLETED|Overall Study||129
2466026|NCT00985231|6046893|P1|COMPLETED|Overall Study||130
2466027|NCT00985231|6046892|P2|STARTED|Overall Study||132
2466028|NCT00985231|6046893|P1|STARTED|Overall Study||133
2466029|NCT00985192|6046901|P1|NOT COMPLETED|Overall Study||4
2466030|NCT00985192|6046901|P1|COMPLETED|Overall Study||45
2466031|NCT00985192|6046901|P1|STARTED|Overall Study||49
2466032|NCT00985166|6046913|P3|NOT COMPLETED|Overall Study||7
2466033|NCT00985166|6046914|P2|NOT COMPLETED|Overall Study||4
2466034|NCT00985166|6046915|P1|NOT COMPLETED|Overall Study||9
2466035|NCT00985166|6046913|P3|COMPLETED|Overall Study||188
2466036|NCT00985166|6046914|P2|COMPLETED|Overall Study||201
2466037|NCT00985166|6046915|P1|COMPLETED|Overall Study||392
2466038|NCT00985166|6046913|P3|Vaccinated at Visit 1|Overall Study||195
2466039|NCT00985166|6046914|P2|Vaccinated at Visit 1|Overall Study||205
2466040|NCT00985166|6046915|P1|Vaccinated at Visit 1|Overall Study||399
2466041|NCT00985166|6046913|P3|STARTED|Overall Study||195
2466042|NCT00985166|6046914|P2|STARTED|Overall Study||205
2466043|NCT00985166|6046915|P1|STARTED|Overall Study|Two randomized subjects withdrew consent before vaccination: no demographic information available.|401
2466044|NCT00985153|6046935|P4|NOT COMPLETED|Overall Study||47
2466045|NCT00985153|6046936|P3|NOT COMPLETED|Overall Study||44
2466046|NCT00985153|6046937|P2|NOT COMPLETED|Overall Study||44
2466047|NCT00985153|6046938|P1|NOT COMPLETED|Overall Study||35
2466048|NCT00985153|6046935|P4|COMPLETED|Overall Study||965
2466049|NCT00985153|6046936|P3|COMPLETED|Overall Study||918
2466050|NCT00985153|6046937|P2|COMPLETED|Overall Study||924
2466051|NCT00985153|6046938|P1|COMPLETED|Overall Study||950
2466052|NCT00985153|6046935|P4|Vaccinated at Visit 1|Overall Study||1012
2466053|NCT00985153|6046936|P3|Vaccinated at Visit 1|Overall Study||962
2466054|NCT00985153|6046937|P2|Vaccinated at Visit 1|Overall Study||968
2466055|NCT00985153|6046938|P1|Vaccinated at Visit 1|Overall Study||985
2466056|NCT00985153|6046935|P4|STARTED|Overall Study||1012
2466057|NCT00985153|6046936|P3|STARTED|Overall Study||962
2466058|NCT00985153|6046937|P2|STARTED|Overall Study||968
2466059|NCT00985153|6046938|P1|STARTED|Overall Study||985
2466060|NCT00985140|6046980|P1|NOT COMPLETED|Overall Study||0
2466061|NCT00985140|6046980|P1|COMPLETED|Overall Study||15
2466062|NCT00985140|6046980|P1|STARTED|Overall Study||15
2466063|NCT00985114|6046986|P2|NOT COMPLETED|Overall Study||2
2466064|NCT00985114|6046987|P1|NOT COMPLETED|Overall Study||1
2466065|NCT00985114|6046986|P2|COMPLETED|Overall Study||37
2466066|NCT00985114|6046987|P1|COMPLETED|Overall Study||33
2466067|NCT00985114|6046986|P2|Diet + Lifestyle Counseling Cross-over|Overall Study|Received device for intended period of 12 months with 6 months follow up|28
2466068|NCT00985114|6046987|P1|Diet + Lifestyle Counseling Cross-over|Overall Study||0
2466069|NCT00985114|6046986|P2|STARTED|Overall Study||39
2466070|NCT00985114|6046987|P1|STARTED|Overall Study|38 randomized, 34 received the device|34
2466071|NCT00985088|6047001|P8|NOT COMPLETED|Overall Study||6
2466072|NCT00985088|6047002|P7|NOT COMPLETED|Overall Study||4
2466073|NCT00985088|6047003|P6|NOT COMPLETED|Overall Study||7
2466074|NCT00985088|6047004|P5|NOT COMPLETED|Overall Study||9
2466075|NCT00985088|6047005|P4|NOT COMPLETED|Overall Study||7
2466076|NCT00985088|6047006|P3|NOT COMPLETED|Overall Study||4
2466077|NCT00985088|6047007|P2|NOT COMPLETED|Overall Study||2
2466078|NCT00985088|6047008|P1|NOT COMPLETED|Overall Study||11
2466079|NCT00985088|6047001|P8|COMPLETED|Overall Study||216
2466080|NCT00985088|6047002|P7|COMPLETED|Overall Study||107
2466081|NCT00985088|6047003|P6|COMPLETED|Overall Study||108
2466082|NCT00985088|6047004|P5|COMPLETED|Overall Study||214
2466083|NCT00985088|6047005|P4|COMPLETED|Overall Study||214
2466084|NCT00985088|6047006|P3|COMPLETED|Overall Study||108
2466085|NCT00985088|6047007|P2|COMPLETED|Overall Study||112
2466086|NCT00985088|6047008|P1|COMPLETED|Overall Study||211
2466087|NCT00985088|6047001|P8|STARTED|Overall Study||222
2466088|NCT00985088|6047002|P7|STARTED|Overall Study||111
2466089|NCT00985088|6047003|P6|STARTED|Overall Study||115
2466090|NCT00985088|6047004|P5|STARTED|Overall Study||223
2466091|NCT00985088|6047005|P4|STARTED|Overall Study||221
2466092|NCT00985088|6047006|P3|STARTED|Overall Study||112
2466093|NCT00985088|6047007|P2|STARTED|Overall Study||114
2466094|NCT00985088|6047008|P1|STARTED|Overall Study||222
2466095|NCT00985010|6047266|P2|NOT COMPLETED|Overall Study||0
2466096|NCT00985010|6047267|P1|NOT COMPLETED|Overall Study||0
2466097|NCT00985010|6047266|P2|COMPLETED|Overall Study||5
2466098|NCT00985010|6047267|P1|COMPLETED|Overall Study||4
2466099|NCT00985010|6047266|P2|STARTED|Overall Study||5
2466100|NCT00985010|6047267|P1|STARTED|Overall Study||4
2466101|NCT00984867|6047277|P2|NOT COMPLETED|Overall Study||17
2466102|NCT00984867|6047278|P1|NOT COMPLETED|Overall Study||23
2466103|NCT00984867|6047277|P2|COMPLETED|Overall Study||208
2466104|NCT00984867|6047278|P1|COMPLETED|Overall Study||203
2466105|NCT00984867|6047277|P2|STARTED|Overall Study|Of the 225 randomized and treated participants only 223 were included in the full analysis set.|225
2466106|NCT00984867|6047278|P1|STARTED|Overall Study|Of the 226 randomized and treated participants only 224 were included in the full analysis set.|226
2466107|NCT00984815|6047296|P1|NOT COMPLETED|Overall Study||30
2466108|NCT00984815|6047296|P1|COMPLETED|Overall Study||56
2466109|NCT00984815|6047296|P1|STARTED|Overall Study||86
2466110|NCT00984698|6047305|P2|NOT COMPLETED|Overall Study||8
2466111|NCT00984698|6047306|P1|NOT COMPLETED|Overall Study||3
2466112|NCT00984698|6047305|P2|COMPLETED|Overall Study||14
2466113|NCT00984698|6047306|P1|COMPLETED|Overall Study||18
2466114|NCT00984698|6047305|P2|STARTED|Overall Study||22
2466115|NCT00984698|6047306|P1|STARTED|Overall Study||21
2466116|NCT00984659|6047318|P4|NOT COMPLETED|6-week Double-blind Treatment Period||13
2466117|NCT00984659|6047319|P3|NOT COMPLETED|6-week Double-blind Treatment Period||11
2466118|NCT00984659|6047320|P2|NOT COMPLETED|6-week Double-blind Treatment Period||6
2466119|NCT00984659|6047321|P1|NOT COMPLETED|6-week Double-blind Treatment Period||0
2466120|NCT00984659|6047318|P4|COMPLETED|6-week Double-blind Treatment Period||126
2466121|NCT00984659|6047319|P3|COMPLETED|6-week Double-blind Treatment Period||141
2466122|NCT00984659|6047320|P2|COMPLETED|6-week Double-blind Treatment Period||69
2466123|NCT00984659|6047321|P1|COMPLETED|6-week Double-blind Treatment Period||0
2466124|NCT00984659|6047318|P4|STARTED|6-week Double-blind Treatment Period||139
2466125|NCT00984659|6047319|P3|STARTED|6-week Double-blind Treatment Period||152
2466126|NCT00984659|6047320|P2|STARTED|6-week Double-blind Treatment Period||75
2466127|NCT00984659|6047321|P1|STARTED|6-week Double-blind Treatment Period||0
2466128|NCT00984659|6047318|P4|NOT COMPLETED|2-week Run-in Period||0
2466129|NCT00984659|6047319|P3|NOT COMPLETED|2-week Run-in Period||0
2466130|NCT00984659|6047320|P2|NOT COMPLETED|2-week Run-in Period||0
2466131|NCT00984659|6047321|P1|NOT COMPLETED|2-week Run-in Period||52
2466132|NCT00984659|6047318|P4|COMPLETED|2-week Run-in Period||0
2466133|NCT00984659|6047319|P3|COMPLETED|2-week Run-in Period||0
2466134|NCT00984659|6047320|P2|COMPLETED|2-week Run-in Period||0
2466135|NCT00984659|6047321|P1|COMPLETED|2-week Run-in Period||366
2466136|NCT00984659|6047318|P4|STARTED|2-week Run-in Period||0
2466137|NCT00984659|6047319|P3|STARTED|2-week Run-in Period||0
2466138|NCT00984659|6047320|P2|STARTED|2-week Run-in Period||0
2466139|NCT00984659|6047321|P1|STARTED|2-week Run-in Period||418
2466140|NCT00984620|6047348|P2|NOT COMPLETED|Overall Study||12
2466141|NCT00984620|6047349|P1|NOT COMPLETED|Overall Study||6
2466142|NCT00984620|6047348|P2|COMPLETED|Overall Study||67
2466143|NCT00984620|6047349|P1|COMPLETED|Overall Study||75
2466144|NCT00984620|6047348|P2|STARTED|Overall Study||79
2466145|NCT00984620|6047349|P1|STARTED|Overall Study||81
2466146|NCT00984594|6047387|P2|NOT COMPLETED|Overall Study||1
2466147|NCT00984594|6047388|P1|NOT COMPLETED|Overall Study||1
2466148|NCT00984594|6047387|P2|COMPLETED|Overall Study||1
2466149|NCT00984594|6047388|P1|COMPLETED|Overall Study||1
2466150|NCT00984594|6047387|P2|STARTED|Overall Study|One patient withdrew consent and left the study before treatment.|2
2466151|NCT00984594|6047388|P1|STARTED|Overall Study||2
2466152|NCT00984568|6047404|P2|NOT COMPLETED|Overall Study||6
2466153|NCT00984568|6047405|P1|NOT COMPLETED|Overall Study||8
2466154|NCT00984568|6047404|P2|COMPLETED|Overall Study||7
2466155|NCT00984568|6047405|P1|COMPLETED|Overall Study||7
2466156|NCT00984568|6047404|P2|STARTED|Overall Study||13
2466157|NCT00984568|6047405|P1|STARTED|Overall Study||15
2466158|NCT00984542|6047413|P1|NOT COMPLETED|Overall Study||41
2466159|NCT00984542|6047413|P1|COMPLETED|Overall Study||9
2466160|NCT00984542|6047413|P1|STARTED|Overall Study||50
2466161|NCT00984490|6047421|P1|NOT COMPLETED|Overall Study||0
2466162|NCT00984490|6047421|P1|COMPLETED|Overall Study||5
2466163|NCT00984490|6047421|P1|STARTED|Overall Study||5
2466164|NCT00984334|6047431|P5|NOT COMPLETED|Overall Study||1
2466165|NCT00984334|6047432|P4|NOT COMPLETED|Overall Study||1
2466166|NCT00984334|6047433|P3|NOT COMPLETED|Overall Study||0
2466167|NCT00984334|6047434|P2|NOT COMPLETED|Overall Study||1
2466168|NCT00984334|6047435|P1|NOT COMPLETED|Overall Study||1
2466169|NCT00984334|6047431|P5|COMPLETED|Overall Study||7
2466170|NCT00984334|6047432|P4|COMPLETED|Overall Study||7
2466171|NCT00984334|6047433|P3|COMPLETED|Overall Study||8
2466172|NCT00984334|6047434|P2|COMPLETED|Overall Study||7
2466173|NCT00984334|6047435|P1|COMPLETED|Overall Study||7
2466174|NCT00984334|6047431|P5|STARTED|Overall Study||8
2466175|NCT00984334|6047432|P4|STARTED|Overall Study||8
2466176|NCT00984334|6047433|P3|STARTED|Overall Study||8
2466177|NCT00984334|6047434|P2|STARTED|Overall Study||8
2466178|NCT00984334|6047435|P1|STARTED|Overall Study||8
2466179|NCT00984308|6047449|P2|NOT COMPLETED|Overall Study||6
2466180|NCT00984308|6047450|P1|NOT COMPLETED|Overall Study||18
2466181|NCT00984308|6047449|P2|COMPLETED|Overall Study||109
2466182|NCT00984308|6047450|P1|COMPLETED|Overall Study||92
2466183|NCT00984308|6047449|P2|STARTED|Overall Study||115
2466184|NCT00984308|6047450|P1|STARTED|Overall Study||110
2466185|NCT00984295|6047463|P3|NOT COMPLETED|Overall Study||37
2466186|NCT00984295|6047464|P2|NOT COMPLETED|Overall Study||32
2466187|NCT00984295|6047465|P1|NOT COMPLETED|Overall Study||65
2466188|NCT00984295|6047463|P3|COMPLETED|Overall Study||442
2466189|NCT00984295|6047464|P2|COMPLETED|Overall Study||453
2466190|NCT00984295|6047465|P1|COMPLETED|Overall Study||884
2466191|NCT00984295|6047463|P3|Visit 2|Overall Study||453
2466192|NCT00984295|6047464|P2|Visit 2|Overall Study||468
2466193|NCT00984295|6047465|P1|Visit 2|Overall Study||909
2466194|NCT00984295|6047463|P3|Visit 1|Overall Study||479
2466195|NCT00984295|6047464|P2|Visit 1|Overall Study||485
2466196|NCT00984295|6047465|P1|Visit 1|Overall Study||949
2466197|NCT00984295|6047463|P3|STARTED|Overall Study||479
2466198|NCT00984295|6047464|P2|STARTED|Overall Study||485
2466199|NCT00984295|6047465|P1|STARTED|Overall Study|2 patients were incorrectly vaccinated and are excluded from this table.|949
2466200|NCT00984282|6047532|P2|NOT COMPLETED|Long Term Follow-up||120
2466201|NCT00984282|6047533|P1|NOT COMPLETED|Long Term Follow-up||69
2466202|NCT00984282|6047532|P2|COMPLETED|Long Term Follow-up||4
2466203|NCT00984282|6047533|P1|COMPLETED|Long Term Follow-up||3
2466204|NCT00984282|6047532|P2|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|124
2466205|NCT00984282|6047533|P1|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|72
2466206|NCT00984282|6047532|P2|NOT COMPLETED|Open-label Treatment||161
2466207|NCT00984282|6047533|P1|NOT COMPLETED|Open-label Treatment||86
2466208|NCT00984282|6047532|P2|COMPLETED|Open-label Treatment||0
2466209|NCT00984282|6047533|P1|COMPLETED|Open-label Treatment||0
2466210|NCT00984282|6047532|P2|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG4 (RG= Reporting Group for Safety Data)|161
2466211|NCT00984282|6047533|P1|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG3 (RG= Reporting Group for Safety Data)|86
2466212|NCT00984282|6047532|P2|STARTED|Open-label Treatment||161
2466213|NCT00984282|6047533|P1|STARTED|Open-label Treatment||86
2466214|NCT00984282|6047532|P2|NOT COMPLETED|Double Blind Treatment||38
2466215|NCT00984282|6047533|P1|NOT COMPLETED|Double Blind Treatment||104
2466216|NCT00984282|6047532|P2|COMPLETED|Double Blind Treatment||172
2466217|NCT00984282|6047533|P1|COMPLETED|Double Blind Treatment||103
2466218|NCT00984282|6047532|P2|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG2 (RG= Reporting Group for Safety Data)|209
2466219|NCT00984282|6047533|P1|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG1 (RG= Reporting Group for Safety Data)|207
2466220|NCT00984282|6047532|P2|STARTED|Double Blind Treatment||210
2466221|NCT00984282|6047533|P1|STARTED|Double Blind Treatment||207
2466222|NCT00984256|6047556|P2|NOT COMPLETED|Overall Study||1
2466223|NCT00984256|6047557|P1|NOT COMPLETED|Overall Study||0
2466224|NCT00984256|6047556|P2|COMPLETED|Overall Study||29
2466225|NCT00984256|6047557|P1|COMPLETED|Overall Study||6
2466226|NCT00984256|6047556|P2|STARTED|Overall Study||30
2466227|NCT00984256|6047557|P1|STARTED|Overall Study||6
2466228|NCT00984204|6047577|P1|NOT COMPLETED|Overall Study||15
2466229|NCT00984204|6047577|P1|COMPLETED|Overall Study|"Seven subjects of the ten Lack of efficacy were acute failures that had no block after 30 min"|173
2466230|NCT00984204|6047577|P1|STARTED|Overall Study||188
2466231|NCT00984165|6047587|P4|NOT COMPLETED|Overall Study||4
2466232|NCT00984165|6047588|P3|NOT COMPLETED|Overall Study||0
2466233|NCT00984165|6047589|P2|NOT COMPLETED|Overall Study||1
2466234|NCT00984165|6047590|P1|NOT COMPLETED|Overall Study||7
2466235|NCT00984165|6047587|P4|COMPLETED|Overall Study||0
2466236|NCT00984165|6047588|P3|COMPLETED|Overall Study||4
2466237|NCT00984165|6047589|P2|COMPLETED|Overall Study||0
2466238|NCT00984165|6047590|P1|COMPLETED|Overall Study||2
2466239|NCT00984165|6047587|P4|STARTED|Overall Study||4
2466240|NCT00984165|6047588|P3|STARTED|Overall Study||4
2466241|NCT00984165|6047589|P2|STARTED|Overall Study||1
2466242|NCT00984165|6047590|P1|STARTED|Overall Study||9
2466243|NCT00984139|6047603|P1|NOT COMPLETED|Overall Study||0
2466244|NCT00984139|6047603|P1|COMPLETED|Overall Study||306
2466245|NCT00984139|6047603|P1|STARTED|Overall Study||306
2466246|NCT00984126|6047619|P4|NOT COMPLETED|Overall Study||59
2466247|NCT00984126|6047620|P3|NOT COMPLETED|Overall Study||7
2466248|NCT00984126|6047621|P2|NOT COMPLETED|Overall Study||8
2466249|NCT00984126|6047622|P1|NOT COMPLETED|Overall Study||7
2466250|NCT00984126|6047619|P4|COMPLETED|Overall Study||76
2466251|NCT00984126|6047620|P3|COMPLETED|Overall Study||16
2466252|NCT00984126|6047621|P2|COMPLETED|Overall Study||20
2466253|NCT00984126|6047622|P1|COMPLETED|Overall Study||20
2466254|NCT00984126|6047619|P4|STARTED|Overall Study||135
2466255|NCT00984126|6047620|P3|STARTED|Overall Study||23
2466256|NCT00984126|6047621|P2|STARTED|Overall Study||28
2466257|NCT00984126|6047622|P1|STARTED|Overall Study||27
2466258|NCT00984061|6047647|P1|NOT COMPLETED|Colchicine With Clarithromycin||0
2466259|NCT00984061|6047647|P1|COMPLETED|Colchicine With Clarithromycin||23
2466260|NCT00984061|6047647|P1|STARTED|Colchicine With Clarithromycin||23
2466261|NCT00984061|6047647|P1|NOT COMPLETED|Clarithromycin Alone||1
2466262|NCT00984061|6047647|P1|COMPLETED|Clarithromycin Alone|One subject was dropped due to noncompliance with outpatient clarithromycin regimen.|23
2466263|NCT00984061|6047647|P1|STARTED|Clarithromycin Alone||24
2466264|NCT00984061|6047647|P1|NOT COMPLETED|21 Day Washout Period||0
2466265|NCT00984061|6047647|P1|COMPLETED|21 Day Washout Period||24
2466266|NCT00984061|6047647|P1|STARTED|21 Day Washout Period||24
2466267|NCT00984061|6047647|P1|NOT COMPLETED|Colchicine Alone||0
2466268|NCT00984061|6047647|P1|COMPLETED|Colchicine Alone||24
2466269|NCT00984061|6047647|P1|STARTED|Colchicine Alone||24
2466270|NCT00984022|6047660|P2|NOT COMPLETED|Overall Study||14
2466271|NCT00984022|6047661|P1|NOT COMPLETED|Overall Study||10
2466272|NCT00984022|6047660|P2|COMPLETED|Overall Study||35
2466273|NCT00984022|6047661|P1|COMPLETED|Overall Study||33
2466274|NCT00984022|6047660|P2|STARTED|Overall Study||49
2466275|NCT00984022|6047661|P1|STARTED|Overall Study||43
2466276|NCT00984009|6047671|P1|NOT COMPLETED|Colchicine With Grapefruit Juice||0
2466277|NCT00984009|6047671|P1|COMPLETED|Colchicine With Grapefruit Juice||21
2466278|NCT00984009|6047671|P1|STARTED|Colchicine With Grapefruit Juice||21
2466279|NCT00984009|6047671|P1|NOT COMPLETED|Grapefruit Juice Alone||1
2466280|NCT00984009|6047671|P1|COMPLETED|Grapefruit Juice Alone|one subject dropped due to missed a.m. serving of grapefruit juice on Day 16|21
2466281|NCT00984009|6047671|P1|STARTED|Grapefruit Juice Alone||22
2466282|NCT00984009|6047671|P1|NOT COMPLETED|14 Day Washout Period||0
2466283|NCT00984009|6047671|P1|COMPLETED|14 Day Washout Period||22
2466284|NCT00984009|6047671|P1|STARTED|14 Day Washout Period||22
2466285|NCT00984009|6047671|P1|NOT COMPLETED|Colchicine Alone||0
2466286|NCT00984009|6047671|P1|COMPLETED|Colchicine Alone||22
2466287|NCT00984009|6047671|P1|STARTED|Colchicine Alone||22
2466288|NCT00983983|6047685|P3|NOT COMPLETED|Overall Study||1
2466289|NCT00983983|6047686|P2|NOT COMPLETED|Overall Study||1
2466290|NCT00983983|6047687|P1|NOT COMPLETED|Overall Study||2
2466291|NCT00983983|6047685|P3|COMPLETED|Overall Study||6
2466292|NCT00983983|6047686|P2|COMPLETED|Overall Study||8
2466293|NCT00983983|6047687|P1|COMPLETED|Overall Study||6
2466294|NCT00983983|6047685|P3|STARTED|Overall Study||7
2466295|NCT00983983|6047686|P2|STARTED|Overall Study||9
2466296|NCT00983983|6047687|P1|STARTED|Overall Study||8
2466297|NCT00983957|6047704|P1|NOT COMPLETED|Overall Study||2
2466298|NCT00983957|6047704|P1|COMPLETED|Overall Study||18
2466299|NCT00983957|6047704|P1|Treatment C|Overall Study||18
2466300|NCT00983957|6047704|P1|Treatment B|Overall Study||20
2466301|NCT00983957|6047704|P1|Treatment A|Overall Study||20
2466302|NCT00983957|6047704|P1|STARTED|Overall Study||20
2466303|NCT00983931|6047738|P1|NOT COMPLETED|Colchicine With Cyclosporine||0
2466304|NCT00983931|6047738|P1|COMPLETED|Colchicine With Cyclosporine||23
2466305|NCT00983931|6047738|P1|STARTED|Colchicine With Cyclosporine||23
2466306|NCT00983931|6047738|P1|NOT COMPLETED|14 Day Washout Period||1
2466307|NCT00983931|6047738|P1|COMPLETED|14 Day Washout Period|one subject withdrawn due to creatine kinase out of range|23
2466308|NCT00983931|6047738|P1|STARTED|14 Day Washout Period||24
2466309|NCT00983931|6047738|P1|NOT COMPLETED|Colchicine Alone||0
2466310|NCT00983931|6047738|P1|COMPLETED|Colchicine Alone||24
2466311|NCT00983931|6047738|P1|STARTED|Colchicine Alone||24
2466312|NCT00983918|6047752|P4|NOT COMPLETED|Overall Study||2
2466313|NCT00983918|6047753|P3|NOT COMPLETED|Overall Study||2
2466314|NCT00983918|6047754|P2|NOT COMPLETED|Overall Study||2
2466315|NCT00983918|6047755|P1|NOT COMPLETED|Overall Study||0
2466316|NCT00983918|6047752|P4|COMPLETED|Overall Study||18
2466317|NCT00983918|6047753|P3|COMPLETED|Overall Study||18
2466318|NCT00983918|6047754|P2|COMPLETED|Overall Study||18
2466319|NCT00983918|6047755|P1|COMPLETED|Overall Study||20
2466320|NCT00983918|6047752|P4|STARTED|Overall Study||20
2466321|NCT00983918|6047753|P3|STARTED|Overall Study||20
2466322|NCT00983918|6047754|P2|STARTED|Overall Study||20
2466323|NCT00983918|6047755|P1|STARTED|Overall Study||20
2466324|NCT00983905|6047765|P1|NOT COMPLETED|Theophylline With Colchicine||0
2466325|NCT00983905|6047765|P1|COMPLETED|Theophylline With Colchicine||27
2466326|NCT00983905|6047765|P1|STARTED|Theophylline With Colchicine||27
2466327|NCT00983905|6047765|P1|NOT COMPLETED|Colchicine Alone||2
2466328|NCT00983905|6047765|P1|COMPLETED|Colchicine Alone|withdrawn by sponsor due to: diarrhea(1); vomiting and diarrhea(1)|27
2466329|NCT00983905|6047765|P1|STARTED|Colchicine Alone||29
2466330|NCT00983905|6047765|P1|NOT COMPLETED|4 Day Washout Period||0
2466331|NCT00983905|6047765|P1|COMPLETED|4 Day Washout Period||29
2466332|NCT00983905|6047765|P1|STARTED|4 Day Washout Period||29
2466333|NCT00983905|6047765|P1|NOT COMPLETED|Theophylline Alone||1
2466334|NCT00983905|6047765|P1|COMPLETED|Theophylline Alone|withdrawn by sponsor due to vomiting(1)|29
2466335|NCT00983905|6047765|P1|STARTED|Theophylline Alone||30
2466336|NCT00983892|6047778|P2|NOT COMPLETED|Overall Study||12
2466337|NCT00983892|6047779|P1|NOT COMPLETED|Overall Study||10
2466338|NCT00983892|6047778|P2|COMPLETED|Overall Study||56
2466339|NCT00983892|6047779|P1|COMPLETED|Overall Study||56
2466340|NCT00983892|6047778|P2|STARTED|Overall Study||68
2466341|NCT00983892|6047779|P1|STARTED|Overall Study||66
2466342|NCT00983853|6047791|P6|NOT COMPLETED|Overall Study||1
2466343|NCT00983853|6047792|P5|NOT COMPLETED|Overall Study||3
2466344|NCT00983853|6047793|P4|NOT COMPLETED|Overall Study||2
2466345|NCT00983853|6047794|P3|NOT COMPLETED|Overall Study||3
2466346|NCT00983853|6047795|P2|NOT COMPLETED|Overall Study||2
2466347|NCT00983853|6047796|P1|NOT COMPLETED|Overall Study||1
2466348|NCT00983853|6047791|P6|COMPLETED|Overall Study||7
2466349|NCT00983853|6047792|P5|COMPLETED|Overall Study||12
2466350|NCT00983853|6047793|P4|COMPLETED|Overall Study||6
2466351|NCT00983853|6047794|P3|COMPLETED|Overall Study||14
2466352|NCT00983853|6047795|P2|COMPLETED|Overall Study||5
2466353|NCT00983853|6047796|P1|COMPLETED|Overall Study||6
2466354|NCT00983853|6047791|P6|STARTED|Overall Study||8
2466355|NCT00983853|6047792|P5|STARTED|Overall Study||15
2466356|NCT00983853|6047793|P4|STARTED|Overall Study||8
2466357|NCT00983853|6047794|P3|STARTED|Overall Study|1 subject was randomized but not dosed|17
2466358|NCT00983853|6047795|P2|STARTED|Overall Study|1 subject was randomized but not dosed|7
2466359|NCT00983853|6047796|P1|STARTED|Overall Study||7
2466360|NCT00983827|6047824|P1|NOT COMPLETED|Overall Study||1
2466361|NCT00983827|6047824|P1|COMPLETED|Overall Study||7
2466362|NCT00983827|6047824|P1|STARTED|Overall Study||8
2466363|NCT00983801|6047828|P1|NOT COMPLETED|Overall Study||0
2466364|NCT00983801|6047828|P1|COMPLETED|Overall Study|Participants who were taken off treatment.|52
2466365|NCT00983801|6047828|P1|STARTED|Overall Study|Participants who received treatment.|52
2466366|NCT00983749|6047842|P2|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||3
2466367|NCT00983749|6047843|P1|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||1
2466368|NCT00983749|6047842|P2|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||7
2466369|NCT00983749|6047843|P1|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||12
2466370|NCT00983749|6047842|P2|STARTED|Follow-up Phase (Hospital DC to 30 Days)||10
2466371|NCT00983749|6047843|P1|STARTED|Follow-up Phase (Hospital DC to 30 Days)||13
2466372|NCT00983749|6047842|P2|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
2466373|NCT00983749|6047843|P1|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
2466374|NCT00983749|6047842|P2|COMPLETED|Acute Phase (Enrollment to Hospital DC)||10
2466375|NCT00983749|6047843|P1|COMPLETED|Acute Phase (Enrollment to Hospital DC)||13
2466376|NCT00983749|6047842|P2|STARTED|Acute Phase (Enrollment to Hospital DC)||10
2466377|NCT00983749|6047843|P1|STARTED|Acute Phase (Enrollment to Hospital DC)||13
2466378|NCT00983645|6047853|P2|NOT COMPLETED|Overall Study||0
2466379|NCT00983645|6047854|P1|NOT COMPLETED|Overall Study||0
2466380|NCT00983645|6047853|P2|COMPLETED|Overall Study||7
2466381|NCT00983645|6047854|P1|COMPLETED|Overall Study||8
2466382|NCT00983645|6047853|P2|STARTED|Overall Study||7
2466383|NCT00983645|6047854|P1|STARTED|Overall Study||8
2466384|NCT00983580|6047868|P2|NOT COMPLETED|Overall Study||4
2466385|NCT00983580|6047869|P1|NOT COMPLETED|Overall Study||5
2466386|NCT00983580|6047868|P2|COMPLETED|Overall Study||49
2466387|NCT00983580|6047869|P1|COMPLETED|Overall Study||49
2466388|NCT00983580|6047868|P2|STARTED|Overall Study||53
2466389|NCT00983580|6047869|P1|STARTED|Overall Study||54
2466390|NCT00983541|6047885|P1|NOT COMPLETED|Overall Study||0
2466391|NCT00983541|6047885|P1|COMPLETED|Overall Study||1
2466392|NCT00983541|6047885|P1|STARTED|Overall Study||1
2466393|NCT00983515|6047895|P1|NOT COMPLETED|Colchicine With Ritonavir||1
2466394|NCT00983515|6047895|P1|COMPLETED|Colchicine With Ritonavir|pharmacokinetic data included since parameters could be estimated for both dosing conditions|17
2466395|NCT00983515|6047895|P1|STARTED|Colchicine With Ritonavir||18
2466396|NCT00983515|6047895|P1|NOT COMPLETED|Ritonavir Alone||6
2466397|NCT00983515|6047895|P1|COMPLETED|Ritonavir Alone||18
2466398|NCT00983515|6047895|P1|STARTED|Ritonavir Alone||24
2466399|NCT00983515|6047895|P1|NOT COMPLETED|14 Day Washout Period||0
2466400|NCT00983515|6047895|P1|COMPLETED|14 Day Washout Period||24
2466401|NCT00983515|6047895|P1|STARTED|14 Day Washout Period||24
2466402|NCT00983515|6047895|P1|NOT COMPLETED|Colchicine Alone||0
2466403|NCT00983515|6047895|P1|COMPLETED|Colchicine Alone||24
2466404|NCT00983515|6047895|P1|STARTED|Colchicine Alone||24
2466405|NCT00983489|6047909|P3|NOT COMPLETED|Overall Study||312
2466406|NCT00983489|6047910|P2|NOT COMPLETED|Overall Study||285
2466407|NCT00983489|6047911|P1|NOT COMPLETED|Overall Study||185
2466408|NCT00983489|6047909|P3|COMPLETED|Overall Study||135
2466409|NCT00983489|6047910|P2|COMPLETED|Overall Study||168
2466410|NCT00983489|6047911|P1|COMPLETED|Overall Study||326
2466411|NCT00983489|6047909|P3|STARTED|Overall Study||447
2466412|NCT00983489|6047910|P2|STARTED|Overall Study||453
2466413|NCT00983489|6047911|P1|STARTED|Overall Study||511
2466414|NCT00983476|6047922|P3|NOT COMPLETED|Overall Study||0
2466415|NCT00983476|6047923|P2|NOT COMPLETED|Overall Study||22
2466416|NCT00983476|6047924|P1|NOT COMPLETED|Overall Study||17
2466417|NCT00983476|6047922|P3|COMPLETED|Overall Study||88
2466418|NCT00983476|6047923|P2|COMPLETED|Overall Study||71
2466419|NCT00983476|6047924|P1|COMPLETED|Overall Study||78
2466420|NCT00983476|6047922|P3|6 Month Follow up Assessment|Overall Study||74
2466421|NCT00983476|6047923|P2|6 Month Follow up Assessment|Overall Study||62
2466422|NCT00983476|6047924|P1|6 Month Follow up Assessment|Overall Study||71
2466423|NCT00983476|6047922|P3|STARTED|Overall Study||88
2466424|NCT00983476|6047923|P2|STARTED|Overall Study||93
2466425|NCT00983476|6047924|P1|STARTED|Overall Study||95
2466426|NCT00983437|6047956|P1|NOT COMPLETED|Overall Study||47
2466427|NCT00983437|6047956|P1|COMPLETED|Overall Study|Completed 12 months of treatment with armodafinil.|0
2466428|NCT00983437|6047956|P1|Full Analysis Set (FAS)|Overall Study|Participants had to have at least 1 postbaseline efficacy assessment to be evaluable for efficacy.|45
2466429|NCT00983437|6047956|P1|Safety Analysis Set (SAS)|Overall Study|Participants who received at least 1 dose of study drug were evaluable for safety.|47
2466430|NCT00983437|6047956|P1|STARTED|Overall Study||47
2466431|NCT00983385|6047975|P1|NOT COMPLETED|Maintenance Period||23
2466432|NCT00983385|6047975|P1|COMPLETED|Maintenance Period||117
2466433|NCT00983385|6047975|P1|STARTED|Maintenance Period||140
2466434|NCT00983385|6047975|P1|NOT COMPLETED|Titration and Optimal Dose Period||36
2466435|NCT00983385|6047975|P1|COMPLETED|Titration and Optimal Dose Period||140
2466436|NCT00983385|6047975|P1|STARTED|Titration and Optimal Dose Period||176
2466437|NCT00983385|6047975|P1|NOT COMPLETED|Observation Period||32
2466438|NCT00983385|6047975|P1|COMPLETED|Observation Period||176
2466439|NCT00983385|6047975|P1|STARTED|Observation Period||208
2466440|NCT00983372|6048020|P1|NOT COMPLETED|Colchicine With Diltiazem ER||0
2466441|NCT00983372|6048020|P1|COMPLETED|Colchicine With Diltiazem ER||20
2466442|NCT00983372|6048020|P1|STARTED|Colchicine With Diltiazem ER||20
2466443|NCT00983372|6048020|P1|NOT COMPLETED|Diltiazem ER Alone||3
2466444|NCT00983372|6048020|P1|COMPLETED|Diltiazem ER Alone|two subjects dropped due to missed diltiazem ER dose; one subject dropped due to vomitting|20
2466445|NCT00983372|6048020|P1|STARTED|Diltiazem ER Alone||23
2466446|NCT00983372|6048020|P1|NOT COMPLETED|14 Day Washout Period||1
2466447|NCT00983372|6048020|P1|COMPLETED|14 Day Washout Period|subject withdrew consent due to schedule conflict - during washout period or diltiazem alone|23
2466448|NCT00983372|6048020|P1|STARTED|14 Day Washout Period||24
2466449|NCT00983372|6048020|P1|NOT COMPLETED|Colchicine Alone||0
2466450|NCT00983372|6048020|P1|COMPLETED|Colchicine Alone||24
2466451|NCT00983372|6048020|P1|STARTED|Colchicine Alone||24
2466452|NCT00983359|6048031|P1|NOT COMPLETED|Overall Study||1
2466453|NCT00983359|6048031|P1|COMPLETED|Overall Study||39
2466454|NCT00983359|6048031|P1|Not Eligible for Analysis|Overall Study||1
2466455|NCT00983359|6048031|P1|STARTED|Overall Study||40
2466456|NCT00983346|6048039|P1|NOT COMPLETED|Overall Study||0
2466457|NCT00983346|6048039|P1|COMPLETED|Overall Study||17
2466458|NCT00983346|6048039|P1|STARTED|Overall Study||17
2466459|NCT00983307|6048043|P1|NOT COMPLETED|Overall Study||0
2466460|NCT00983307|6048043|P1|COMPLETED|Overall Study||17
2466461|NCT00983307|6048043|P1|STARTED|Overall Study||17
2466462|NCT00983294|6048047|P1|NOT COMPLETED|Colchicine With Azithromycin||1
2466463|NCT00983294|6048047|P1|COMPLETED|Colchicine With Azithromycin|withdrawn by sponsor on Day 21 due to vomiting on Day 15, prior to azithromycin dosing(1)|21
2466464|NCT00983294|6048047|P1|STARTED|Colchicine With Azithromycin||22
2466465|NCT00983294|6048047|P1|NOT COMPLETED|Azithromycin Alone||0
2466466|NCT00983294|6048047|P1|COMPLETED|Azithromycin Alone||22
2466467|NCT00983294|6048047|P1|STARTED|Azithromycin Alone||22
2466468|NCT00983294|6048047|P1|NOT COMPLETED|14 Day Washout Period||2
2466469|NCT00983294|6048047|P1|COMPLETED|14 Day Washout Period|two subjects withdrew consent due to personal reasons|22
2466470|NCT00983294|6048047|P1|STARTED|14 Day Washout Period||24
2466471|NCT00983294|6048047|P1|NOT COMPLETED|Colchicine Alone||0
2466472|NCT00983294|6048047|P1|COMPLETED|Colchicine Alone||24
2466473|NCT00983294|6048047|P1|STARTED|Colchicine Alone||24
2466474|NCT00983281|6048060|P2|NOT COMPLETED|Overall Study||0
2466475|NCT00983281|6048061|P1|NOT COMPLETED|Overall Study||0
2466476|NCT00983281|6048060|P2|COMPLETED|Overall Study||909
2466477|NCT00983281|6048061|P1|COMPLETED|Overall Study||805
2466478|NCT00983281|6048060|P2|STARTED|Overall Study||909
2466479|NCT00983281|6048061|P1|STARTED|Overall Study||805
2466480|NCT00983242|6048067|P1|NOT COMPLETED|Colchicine With Verapamil HCl ER||0
2466481|NCT00983242|6048067|P1|COMPLETED|Colchicine With Verapamil HCl ER||24
2466482|NCT00983242|6048067|P1|STARTED|Colchicine With Verapamil HCl ER||24
2466483|NCT00983242|6048067|P1|NOT COMPLETED|Verapamil HCl ER Alone||0
2466484|NCT00983242|6048067|P1|COMPLETED|Verapamil HCl ER Alone||24
2466485|NCT00983242|6048067|P1|STARTED|Verapamil HCl ER Alone||24
2466486|NCT00983242|6048067|P1|NOT COMPLETED|14 Day Washout Period||0
2466487|NCT00983242|6048067|P1|COMPLETED|14 Day Washout Period||24
2466488|NCT00983242|6048067|P1|STARTED|14 Day Washout Period||24
2466489|NCT00983242|6048067|P1|NOT COMPLETED|Colchicine Alone||0
2466490|NCT00983242|6048067|P1|COMPLETED|Colchicine Alone||24
2466491|NCT00983242|6048067|P1|STARTED|Colchicine Alone||24
2466492|NCT00983216|6048078|P1|NOT COMPLETED|Colchicine With Ketoconazole||0
2466493|NCT00983216|6048078|P1|COMPLETED|Colchicine With Ketoconazole||24
2466494|NCT00983216|6048078|P1|STARTED|Colchicine With Ketoconazole||24
2466495|NCT00983216|6048078|P1|NOT COMPLETED|Ketoconazole Alone||0
2466496|NCT00983216|6048078|P1|COMPLETED|Ketoconazole Alone||24
2466497|NCT00983216|6048078|P1|STARTED|Ketoconazole Alone||24
2466498|NCT00983216|6048078|P1|NOT COMPLETED|14 Day Washout Period||0
2466499|NCT00983216|6048078|P1|COMPLETED|14 Day Washout Period||24
2466500|NCT00983216|6048078|P1|STARTED|14 Day Washout Period||24
2466501|NCT00983216|6048078|P1|NOT COMPLETED|Colchicine Alone||0
2466502|NCT00983216|6048078|P1|COMPLETED|Colchicine Alone||24
2466503|NCT00983216|6048078|P1|STARTED|Colchicine Alone||24
2466504|NCT00983073|6048089|P1|NOT COMPLETED|Maintenance Period||16
2466505|NCT00983073|6048089|P1|COMPLETED|Maintenance Period||144
2466506|NCT00983073|6048089|P1|STARTED|Maintenance Period||160
2466507|NCT00983073|6048089|P1|NOT COMPLETED|Titration and Optimal Dose Period||40
2466508|NCT00983073|6048089|P1|COMPLETED|Titration and Optimal Dose Period||160
2466509|NCT00983073|6048089|P1|STARTED|Titration and Optimal Dose Period||200
2466510|NCT00983073|6048089|P1|NOT COMPLETED|Observation Period||24
2466511|NCT00983073|6048089|P1|COMPLETED|Observation Period|24 participants not eligible to be dosed.|200
2466512|NCT00983073|6048089|P1|STARTED|Observation Period||224
2466513|NCT00982995|6048110|P1|NOT COMPLETED|Overall Study||0
2466514|NCT00982995|6048110|P1|COMPLETED|Overall Study||3
2466515|NCT00982995|6048110|P1|STARTED|Overall Study||3
2466516|NCT00982878|6048115|P1|NOT COMPLETED|Overall Study||1
2466517|NCT00982878|6048115|P1|COMPLETED|Overall Study||12
2466518|NCT00982878|6048115|P1|STARTED|Overall Study||13
2466519|NCT00982865|6048124|P4|NOT COMPLETED|Overall Study||0
2466520|NCT00982865|6048125|P3|NOT COMPLETED|Overall Study||0
2466521|NCT00982865|6048126|P2|NOT COMPLETED|Overall Study||0
2466522|NCT00982865|6048127|P1|NOT COMPLETED|Overall Study||0
2466523|NCT00982865|6048124|P4|COMPLETED|Overall Study||34
2466524|NCT00982865|6048125|P3|COMPLETED|Overall Study||15
2466525|NCT00982865|6048126|P2|COMPLETED|Overall Study||82
2466526|NCT00982865|6048127|P1|COMPLETED|Overall Study||49
2466527|NCT00982865|6048124|P4|STARTED|Overall Study||34
2466528|NCT00982865|6048125|P3|STARTED|Overall Study||15
2466529|NCT00982865|6048126|P2|STARTED|Overall Study||82
2466530|NCT00982865|6048127|P1|STARTED|Overall Study||49
2466531|NCT00982735|6048413|P1|NOT COMPLETED|Overall Study||230
2466532|NCT00982735|6048413|P1|COMPLETED|Overall Study||757
2466533|NCT00982735|6048413|P1|STARTED|Overall Study||987
2466534|NCT00982657|6048423|P4|NOT COMPLETED|Overall Study||9
2466535|NCT00982657|6048424|P3|NOT COMPLETED|Overall Study||2
2466536|NCT00982657|6048425|P2|NOT COMPLETED|Overall Study||0
2466537|NCT00982657|6048426|P1|NOT COMPLETED|Overall Study||1
2466538|NCT00982657|6048423|P4|COMPLETED|Overall Study||7
2466539|NCT00982657|6048424|P3|COMPLETED|Overall Study||1
2466540|NCT00982657|6048425|P2|COMPLETED|Overall Study||3
2466541|NCT00982657|6048426|P1|COMPLETED|Overall Study||11
2466542|NCT00982657|6048423|P4|STARTED|Overall Study||16
2466543|NCT00982657|6048424|P3|STARTED|Overall Study||3
2466544|NCT00982657|6048425|P2|STARTED|Overall Study||3
2466545|NCT00982657|6048426|P1|STARTED|Overall Study||12
2466546|NCT00982644|6048467|P2|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||20
2466547|NCT00982644|6048468|P1|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||46
2466548|NCT00982644|6048467|P2|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||154
2466549|NCT00982644|6048468|P1|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||505
2466550|NCT00982644|6048467|P2|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Twenty-three subjects did not continue into extension trial|174
2466551|NCT00982644|6048468|P1|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Fifty-six subjects did not continue into extension trial|551
2466552|NCT00982644|6048467|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||60
2466553|NCT00982644|6048468|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||166
2466554|NCT00982644|6048467|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||197
2466555|NCT00982644|6048468|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||607
2466556|NCT00982644|6048467|P2|Exposed|Main: Week 0 to 52 (NN1250-3579)||257
2466557|NCT00982644|6048468|P1|Exposed|Main: Week 0 to 52 (NN1250-3579)|7 subjects were withdrawn prior to exposure to trial products|766
2466558|NCT00982644|6048467|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||257
2466559|NCT00982644|6048468|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||773
2466560|NCT00982644|6048467|P2|STARTED|Main: Week 0 to 52 (NN1250-3579)||257
2466561|NCT00982644|6048468|P1|STARTED|Main: Week 0 to 52 (NN1250-3579)||773
2466562|NCT00982592|6048492|P2|NOT COMPLETED|Overall Study||33
2466563|NCT00982592|6048493|P1|NOT COMPLETED|Overall Study||31
2466564|NCT00982592|6048492|P2|COMPLETED|Overall Study|patients who were off treatment due to disease progression|27
2466565|NCT00982592|6048493|P1|COMPLETED|Overall Study|patients who were off treatment due to disease progression|33
2466566|NCT00982592|6048492|P2|Treatment Received|Overall Study||52
2466567|NCT00982592|6048493|P1|Treatment Received|Overall Study||63
2466568|NCT00982592|6048492|P2|STARTED|Overall Study||60
2466569|NCT00982592|6048493|P1|STARTED|Overall Study||64
2466570|NCT00982553|6048507|P1|NOT COMPLETED|Phase3||0
2466571|NCT00982553|6048507|P1|COMPLETED|Phase3||14
2466572|NCT00982553|6048507|P1|STARTED|Phase3||14
2466573|NCT00982553|6048507|P1|NOT COMPLETED|Phase2||0
2466574|NCT00982553|6048507|P1|COMPLETED|Phase2||14
2466575|NCT00982553|6048507|P1|STARTED|Phase2||14
2466576|NCT00982553|6048507|P1|NOT COMPLETED|Phase1||0
2466577|NCT00982553|6048507|P1|COMPLETED|Phase1||14
2466578|NCT00982553|6048507|P1|STARTED|Phase1||14
2466579|NCT00982488|6048523|P5|NOT COMPLETED|Overall Study||1
2466580|NCT00982488|6048524|P4|NOT COMPLETED|Overall Study||3
2466581|NCT00982488|6048525|P3|NOT COMPLETED|Overall Study||34
2466582|NCT00982488|6048526|P2|NOT COMPLETED|Overall Study||14
2466583|NCT00982488|6048527|P1|NOT COMPLETED|Overall Study||185
2466584|NCT00982488|6048523|P5|COMPLETED|Overall Study|Still receiving treatment|0
2466585|NCT00982488|6048524|P4|COMPLETED|Overall Study|Still receiving treatment|0
2466586|NCT00982488|6048525|P3|COMPLETED|Overall Study|Still receiving treatment|0
2466587|NCT00982488|6048526|P2|COMPLETED|Overall Study|Still receiving treatment|0
2466588|NCT00982488|6048527|P1|COMPLETED|Overall Study|Still receiving treatment|0
2466589|NCT00982488|6048523|P5|STARTED|Overall Study|Received treatment|1
2466590|NCT00982488|6048524|P4|STARTED|Overall Study|Received treatment|3
2466591|NCT00982488|6048525|P3|STARTED|Overall Study|Received treatment|34
2466592|NCT00982488|6048526|P2|STARTED|Overall Study|Received treatment|14
2466593|NCT00982488|6048527|P1|STARTED|Overall Study|Received treatment|185
2466594|NCT00982423|6048541|P2|NOT COMPLETED|Overall Study||0
2466595|NCT00982423|6048542|P1|NOT COMPLETED|Overall Study||0
2466596|NCT00982423|6048541|P2|COMPLETED|Overall Study||19
2466597|NCT00982423|6048542|P1|COMPLETED|Overall Study||13
2466598|NCT00982423|6048541|P2|STARTED|Overall Study||19
2466599|NCT00982423|6048542|P1|STARTED|Overall Study||13
2466600|NCT00982410|6048560|P2|NOT COMPLETED|12-month Follow-up Assessment||9
2466601|NCT00982410|6048561|P1|NOT COMPLETED|12-month Follow-up Assessment||9
2466602|NCT00982410|6048560|P2|COMPLETED|12-month Follow-up Assessment||55
2466603|NCT00982410|6048561|P1|COMPLETED|12-month Follow-up Assessment||56
2466604|NCT00982410|6048560|P2|STARTED|12-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
2466605|NCT00982410|6048561|P1|STARTED|12-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
2466606|NCT00982410|6048560|P2|NOT COMPLETED|6-month Follow-up Assessment||11
2466607|NCT00982410|6048561|P1|NOT COMPLETED|6-month Follow-up Assessment||6
2466608|NCT00982410|6048560|P2|COMPLETED|6-month Follow-up Assessment||53
2466609|NCT00982410|6048561|P1|COMPLETED|6-month Follow-up Assessment||59
2466610|NCT00982410|6048560|P2|STARTED|6-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
2466611|NCT00982410|6048561|P1|STARTED|6-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
2466612|NCT00982410|6048560|P2|NOT COMPLETED|3-month Follow-up Assessment||13
2466613|NCT00982410|6048561|P1|NOT COMPLETED|3-month Follow-up Assessment||9
2466614|NCT00982410|6048560|P2|COMPLETED|3-month Follow-up Assessment||53
2466615|NCT00982410|6048561|P1|COMPLETED|3-month Follow-up Assessment||56
2466616|NCT00982410|6048560|P2|STARTED|3-month Follow-up Assessment||66
2466617|NCT00982410|6048561|P1|STARTED|3-month Follow-up Assessment||65
2466618|NCT00982397|6048585|P2|NOT COMPLETED|Phase II/Overall Study||0
2466619|NCT00982397|6048586|P1|NOT COMPLETED|Phase II/Overall Study||0
2466620|NCT00982397|6048585|P2|COMPLETED|Phase II/Overall Study||751
2466621|NCT00982397|6048586|P1|COMPLETED|Phase II/Overall Study||2019
2466622|NCT00982397|6048585|P2|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||131
2466623|NCT00982397|6048586|P1|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||221
2466624|NCT00982397|6048585|P2|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||122
2466625|NCT00982397|6048586|P1|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||231
2466626|NCT00982397|6048585|P2|STARTED|Phase II/Overall Study||751
2466627|NCT00982397|6048586|P1|STARTED|Phase II/Overall Study||2019
2466628|NCT00982397|6048585|P2|NOT COMPLETED|Phase I||0
2466629|NCT00982397|6048586|P1|NOT COMPLETED|Phase I||0
2466630|NCT00982397|6048585|P2|COMPLETED|Phase I||0
2466631|NCT00982397|6048586|P1|COMPLETED|Phase I||236
2466632|NCT00982397|6048585|P2|STARTED|Phase I||0
2466633|NCT00982397|6048586|P1|STARTED|Phase I||236
2466634|NCT00982345|6048596|P1|NOT COMPLETED|Overall Study||2
2466635|NCT00982345|6048596|P1|COMPLETED|Overall Study||18
2466636|NCT00982345|6048596|P1|STARTED|Overall Study||20
2466637|NCT00982319|6048602|P2|NOT COMPLETED|Overall Study||2
2466638|NCT00982319|6048603|P1|NOT COMPLETED|Overall Study||2
2466639|NCT00982319|6048602|P2|COMPLETED|Overall Study||15
2466640|NCT00982319|6048603|P1|COMPLETED|Overall Study||15
2466641|NCT00982319|6048602|P2|STARTED|Overall Study||17
2466642|NCT00982319|6048603|P1|STARTED|Overall Study||17
2466643|NCT00982280|6048611|P1|NOT COMPLETED|Maintenance Period||1
2466644|NCT00982280|6048611|P1|COMPLETED|Maintenance Period||54
2466645|NCT00982280|6048611|P1|STARTED|Maintenance Period||55
2466646|NCT00982280|6048611|P1|NOT COMPLETED|Titration and Optimal Dose Period||8
2466647|NCT00982280|6048611|P1|COMPLETED|Titration and Optimal Dose Period||55
2466648|NCT00982280|6048611|P1|STARTED|Titration and Optimal Dose Period||63
2466649|NCT00982280|6048611|P1|NOT COMPLETED|Observation Period||19
2466650|NCT00982280|6048611|P1|COMPLETED|Observation Period||63
2466651|NCT00982280|6048611|P1|STARTED|Observation Period||82
2466652|NCT00982228|6048636|P2|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||5
2466653|NCT00982228|6048637|P1|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||21
2466654|NCT00982228|6048636|P2|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||113
2466655|NCT00982228|6048637|P1|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||330
2466656|NCT00982228|6048636|P2|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Nineteen subjects from the main trial did not continue into the extension|118
2466657|NCT00982228|6048637|P1|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Fifty-three subjects from the main trial did not continue into the extension|351
2466658|NCT00982228|6048636|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||20
2466659|NCT00982228|6048637|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||68
2466660|NCT00982228|6048636|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||137
2466661|NCT00982228|6048637|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||404
2466662|NCT00982228|6048636|P2|Exposed|Main: Week 0 to 52 (NN1250-3583)|Three subjects withdrew prior to exposure to trial drug|154
2466663|NCT00982228|6048637|P1|Exposed|Main: Week 0 to 52 (NN1250-3583)||472
2466664|NCT00982228|6048636|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||157
2466665|NCT00982228|6048637|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||472
2466666|NCT00982228|6048636|P2|STARTED|Main: Week 0 to 52 (NN1250-3583)||157
2466667|NCT00982228|6048637|P1|STARTED|Main: Week 0 to 52 (NN1250-3583)||472
2466668|NCT00982189|6048665|P4|NOT COMPLETED|Overall Study||0
2466669|NCT00982189|6048666|P3|NOT COMPLETED|Overall Study||0
2466670|NCT00982189|6048667|P2|NOT COMPLETED|Overall Study||0
2466671|NCT00982189|6048668|P1|NOT COMPLETED|Overall Study||0
2466672|NCT00982189|6048665|P4|COMPLETED|Overall Study||9
2466673|NCT00982189|6048666|P3|COMPLETED|Overall Study||9
2466674|NCT00982189|6048667|P2|COMPLETED|Overall Study||9
2466675|NCT00982189|6048668|P1|COMPLETED|Overall Study||10
2466676|NCT00982189|6048665|P4|STARTED|Overall Study||9
2466677|NCT00982189|6048666|P3|STARTED|Overall Study||9
2466678|NCT00982189|6048667|P2|STARTED|Overall Study||9
2466679|NCT00982189|6048668|P1|STARTED|Overall Study||10
2466680|NCT00982137|6048696|P4|NOT COMPLETED|Overall Study||1
2466681|NCT00982137|6048697|P3|NOT COMPLETED|Overall Study||0
2466682|NCT00982137|6048698|P2|NOT COMPLETED|Overall Study||1
2466683|NCT00982137|6048699|P1|NOT COMPLETED|Overall Study||0
2466684|NCT00982137|6048696|P4|COMPLETED|Overall Study||17
2466685|NCT00982137|6048697|P3|COMPLETED|Overall Study||18
2466686|NCT00982137|6048698|P2|COMPLETED|Overall Study||35
2466687|NCT00982137|6048699|P1|COMPLETED|Overall Study||36
2466688|NCT00982137|6048696|P4|STARTED|Overall Study||18
2466689|NCT00982137|6048697|P3|STARTED|Overall Study||18
2466690|NCT00982137|6048698|P2|STARTED|Overall Study||36
2466691|NCT00982137|6048699|P1|STARTED|Overall Study||36
2466692|NCT00982111|6048731|P2|NOT COMPLETED|Overall Study||66
2466693|NCT00982111|6048732|P1|NOT COMPLETED|Overall Study||75
2466694|NCT00982111|6048731|P2|COMPLETED|Overall Study||252
2466695|NCT00982111|6048732|P1|COMPLETED|Overall Study||240
2466696|NCT00982111|6048731|P2|On Study at Conclusion, Off Treatment|Overall Study||6
2466697|NCT00982111|6048732|P1|On Study at Conclusion, Off Treatment|Overall Study||4
2466698|NCT00982111|6048731|P2|Death Due to Any Cause|Overall Study||246
2466699|NCT00982111|6048732|P1|Death Due to Any Cause|Overall Study||236
2466700|NCT00982111|6048731|P2|Received at Least 1 Dose of Study Drug|Overall Study||312
2466701|NCT00982111|6048732|P1|Received at Least 1 Dose of Study Drug|Overall Study||304
2466702|NCT00982111|6048731|P2|STARTED|Overall Study||318
2466703|NCT00982111|6048732|P1|STARTED|Overall Study||315
2466704|NCT00982033|6048756|P2|NOT COMPLETED|Overall Study||0
2466705|NCT00982033|6048757|P1|NOT COMPLETED|Overall Study||0
2466706|NCT00982033|6048756|P2|COMPLETED|Overall Study||27
2466707|NCT00982033|6048757|P1|COMPLETED|Overall Study||25
2466708|NCT00982033|6048756|P2|STARTED|Overall Study||27
2466709|NCT00982033|6048757|P1|STARTED|Overall Study||25
2466710|NCT00982020|6048765|P2|NOT COMPLETED|Overall Study||64
2466711|NCT00982020|6048766|P1|NOT COMPLETED|Overall Study||57
2466712|NCT00982020|6048765|P2|COMPLETED|Overall Study||37
2466713|NCT00982020|6048766|P1|COMPLETED|Overall Study||45
2466714|NCT00982020|6048765|P2|Received at Least 1 Dose of Study Drug|Overall Study||101
2466715|NCT00982020|6048766|P1|Received at Least 1 Dose of Study Drug|Overall Study||102
2466716|NCT00982020|6048765|P2|STARTED|Overall Study||101
2466717|NCT00982020|6048766|P1|STARTED|Overall Study||102
2466718|NCT00982007|6048790|P4|NOT COMPLETED|Overall Study||6
2466719|NCT00982007|6048791|P3|NOT COMPLETED|Overall Study||0
2466720|NCT00982007|6048792|P2|NOT COMPLETED|Overall Study||4
2466721|NCT00982007|6048793|P1|NOT COMPLETED|Overall Study||4
2466722|NCT00982007|6048790|P4|COMPLETED|Overall Study||245
2466723|NCT00982007|6048791|P3|COMPLETED|Overall Study||253
2466724|NCT00982007|6048792|P2|COMPLETED|Overall Study||253
2466725|NCT00982007|6048793|P1|COMPLETED|Overall Study||246
2466726|NCT00982007|6048790|P4|STARTED|Overall Study||251
2466727|NCT00982007|6048791|P3|STARTED|Overall Study||253
2466728|NCT00982007|6048792|P2|STARTED|Overall Study||257
2466729|NCT00982007|6048793|P1|STARTED|Overall Study||250
2466730|NCT00981825|6048805|P2|NOT COMPLETED|Second Intervention||0
2466731|NCT00981825|6048806|P1|NOT COMPLETED|Second Intervention||0
2466732|NCT00981825|6048805|P2|COMPLETED|Second Intervention||11
2466733|NCT00981825|6048806|P1|COMPLETED|Second Intervention||11
2466734|NCT00981825|6048805|P2|STARTED|Second Intervention||11
2466735|NCT00981825|6048806|P1|STARTED|Second Intervention||11
2466736|NCT00981825|6048805|P2|NOT COMPLETED|Washout After 1st Intervention||0
2466737|NCT00981825|6048806|P1|NOT COMPLETED|Washout After 1st Intervention||0
2466738|NCT00981825|6048805|P2|COMPLETED|Washout After 1st Intervention||11
2466739|NCT00981825|6048806|P1|COMPLETED|Washout After 1st Intervention||11
2466740|NCT00981825|6048805|P2|STARTED|Washout After 1st Intervention||11
2466741|NCT00981825|6048806|P1|STARTED|Washout After 1st Intervention||11
2466742|NCT00981825|6048805|P2|NOT COMPLETED|First Intervention||0
2466743|NCT00981825|6048806|P1|NOT COMPLETED|First Intervention||0
2466744|NCT00981825|6048805|P2|COMPLETED|First Intervention||11
2466745|NCT00981825|6048806|P1|COMPLETED|First Intervention||11
2466746|NCT00981825|6048805|P2|STARTED|First Intervention||11
2466747|NCT00981825|6048806|P1|STARTED|First Intervention||11
2466748|NCT00981812|6048812|P1|NOT COMPLETED|Overall Study||0
2466749|NCT00981812|6048812|P1|COMPLETED|Overall Study||20
2466750|NCT00981812|6048812|P1|STARTED|Overall Study||20
2466751|NCT00981747|6048816|P1|NOT COMPLETED|Sildenafil and Losartan||0
2466752|NCT00981747|6048816|P1|COMPLETED|Sildenafil and Losartan||9
2466753|NCT00981747|6048816|P1|Completed Sildenafil and Losartan|Sildenafil and Losartan||9
2466754|NCT00981747|6048816|P1|Started Sildenafil and Losartan|Sildenafil and Losartan||9
2466755|NCT00981747|6048816|P1|STARTED|Sildenafil and Losartan||9
2466756|NCT00981747|6048816|P1|NOT COMPLETED|Sildenafil||0
2466757|NCT00981747|6048816|P1|COMPLETED|Sildenafil||9
2466758|NCT00981747|6048816|P1|Completed Sildenafil|Sildenafil||9
2466759|NCT00981747|6048816|P1|Started Sildenafil|Sildenafil||9
2466760|NCT00981747|6048816|P1|STARTED|Sildenafil||9
2466761|NCT00981747|6048816|P1|NOT COMPLETED|Placebo Oral Tablet||1
2466762|NCT00981747|6048816|P1|COMPLETED|Placebo Oral Tablet||9
2466763|NCT00981747|6048816|P1|Completed Placebo Oral Tablet|Placebo Oral Tablet||9
2466764|NCT00981747|6048816|P1|Started Placebo Oral Tablet|Placebo Oral Tablet||10
2466765|NCT00981747|6048816|P1|STARTED|Placebo Oral Tablet||10
2466766|NCT00981747|6048816|P1|NOT COMPLETED|Losartan||2
2466767|NCT00981747|6048816|P1|COMPLETED|Losartan|Only 9 were analyzed because only 9 completed all four interventions.|10
2466768|NCT00981747|6048816|P1|Completed Losartan|Losartan|Only 9 were analyzed because only 9 completed all four interventions.|10
2466769|NCT00981747|6048816|P1|Started Losartan|Losartan||12
2466770|NCT00981747|6048816|P1|STARTED|Losartan||12
2466771|NCT00981669|6048836|P2|NOT COMPLETED|Overall Study||0
2466772|NCT00981669|6048837|P1|NOT COMPLETED|Overall Study||1
2466773|NCT00981669|6048836|P2|COMPLETED|Overall Study||40
2466774|NCT00981669|6048837|P1|COMPLETED|Overall Study||39
2466775|NCT00981669|6048836|P2|STARTED|Overall Study||40
2466776|NCT00981669|6048837|P1|STARTED|Overall Study||40
2466777|NCT00981630|6048849|P4|NOT COMPLETED|Overall Study||0
2466778|NCT00981630|6048850|P3|NOT COMPLETED|Overall Study||0
2466779|NCT00981630|6048851|P2|NOT COMPLETED|Overall Study||0
2466780|NCT00981630|6048852|P1|NOT COMPLETED|Overall Study||0
2466781|NCT00981630|6048849|P4|COMPLETED|Overall Study||32
2466782|NCT00981630|6048850|P3|COMPLETED|Overall Study||32
2466783|NCT00981630|6048851|P2|COMPLETED|Overall Study||32
2466784|NCT00981630|6048852|P1|COMPLETED|Overall Study||32
2466785|NCT00981630|6048849|P4|STARTED|Overall Study||32
2466786|NCT00981630|6048850|P3|STARTED|Overall Study||32
2466787|NCT00981630|6048851|P2|STARTED|Overall Study||32
2466788|NCT00981630|6048852|P1|STARTED|Overall Study||32
2466789|NCT00981526|6048884|P2|NOT COMPLETED|Overall Study||6
2466790|NCT00981526|6048885|P1|NOT COMPLETED|Overall Study||4
2466791|NCT00981526|6048884|P2|COMPLETED|Overall Study||22
2466792|NCT00981526|6048885|P1|COMPLETED|Overall Study||22
2466793|NCT00981526|6048884|P2|STARTED|Overall Study||28
2466794|NCT00981526|6048885|P1|STARTED|Overall Study||26
2466795|NCT00981461|6048903|P2|NOT COMPLETED|Overall Study||2
2466796|NCT00981461|6048904|P1|NOT COMPLETED|Overall Study||5
2466797|NCT00981461|6048903|P2|COMPLETED|Overall Study||22
2466798|NCT00981461|6048904|P1|COMPLETED|Overall Study||43
2466799|NCT00981461|6048903|P2|STARTED|Overall Study||24
2466800|NCT00981461|6048904|P1|STARTED|Overall Study||48
2466801|NCT00981435|6048913|P3|NOT COMPLETED|Overall Study||0
2466802|NCT00981435|6048914|P2|NOT COMPLETED|Overall Study||0
2466803|NCT00981435|6048915|P1|NOT COMPLETED|Overall Study||0
2466804|NCT00981435|6048913|P3|COMPLETED|Overall Study||37
2466805|NCT00981435|6048914|P2|COMPLETED|Overall Study||29
2466806|NCT00981435|6048915|P1|COMPLETED|Overall Study||31
2466807|NCT00981435|6048913|P3|STARTED|Overall Study||37
2466808|NCT00981435|6048914|P2|STARTED|Overall Study||29
2466809|NCT00981435|6048915|P1|STARTED|Overall Study||31
2466810|NCT00981409|6048928|P2|NOT COMPLETED|Overall Study||1
2466811|NCT00981409|6048929|P1|NOT COMPLETED|Overall Study||6
2466812|NCT00981409|6048928|P2|COMPLETED|Overall Study||10
2466813|NCT00981409|6048929|P1|COMPLETED|Overall Study||24
2466814|NCT00981409|6048928|P2|STARTED|Overall Study||11
2466815|NCT00981409|6048929|P1|STARTED|Overall Study||30
2466816|NCT00981370|6048943|P1|NOT COMPLETED|Overall Study||0
2466817|NCT00981370|6048943|P1|COMPLETED|Overall Study||0
2466818|NCT00981370|6048943|P1|STARTED|Overall Study||0
2466819|NCT00981305|6048949|P2|NOT COMPLETED|Overall Study||10
2466820|NCT00981305|6048950|P1|NOT COMPLETED|Overall Study||19
2466821|NCT00981305|6048949|P2|COMPLETED|Overall Study||57
2466822|NCT00981305|6048950|P1|COMPLETED|Overall Study||50
2466823|NCT00981305|6048949|P2|STARTED|Overall Study||67
2466824|NCT00981305|6048950|P1|STARTED|Overall Study||69
2466825|NCT00981292|6048968|P6|NOT COMPLETED|Day 3||1
2466826|NCT00981292|6048969|P5|NOT COMPLETED|Day 3||0
2466827|NCT00981292|6048970|P4|NOT COMPLETED|Day 3||0
2466828|NCT00981292|6048971|P3|NOT COMPLETED|Day 3||0
2466829|NCT00981292|6048972|P2|NOT COMPLETED|Day 3||0
2466830|NCT00981292|6048973|P1|NOT COMPLETED|Day 3||0
2466831|NCT00981292|6048968|P6|COMPLETED|Day 3||4
2466832|NCT00981292|6048969|P5|COMPLETED|Day 3||4
2466833|NCT00981292|6048970|P4|COMPLETED|Day 3||4
2466834|NCT00981292|6048971|P3|COMPLETED|Day 3||6
2466835|NCT00981292|6048972|P2|COMPLETED|Day 3||4
2466836|NCT00981292|6048973|P1|COMPLETED|Day 3||4
2466837|NCT00981292|6048968|P6|STARTED|Day 3||5
2466838|NCT00981292|6048969|P5|STARTED|Day 3||4
2466839|NCT00981292|6048970|P4|STARTED|Day 3||4
2466840|NCT00981292|6048971|P3|STARTED|Day 3||6
2466841|NCT00981292|6048972|P2|STARTED|Day 3||4
2466842|NCT00981292|6048973|P1|STARTED|Day 3||4
2466843|NCT00981292|6048968|P6|NOT COMPLETED|Day 2||0
2466844|NCT00981292|6048969|P5|NOT COMPLETED|Day 2||0
2466845|NCT00981292|6048970|P4|NOT COMPLETED|Day 2||0
2466846|NCT00981292|6048971|P3|NOT COMPLETED|Day 2||0
2466847|NCT00981292|6048972|P2|NOT COMPLETED|Day 2||0
2466848|NCT00981292|6048973|P1|NOT COMPLETED|Day 2||2
2466849|NCT00981292|6048968|P6|COMPLETED|Day 2||5
2466850|NCT00981292|6048969|P5|COMPLETED|Day 2||4
2466851|NCT00981292|6048970|P4|COMPLETED|Day 2||4
2466852|NCT00981292|6048971|P3|COMPLETED|Day 2||6
2466853|NCT00981292|6048972|P2|COMPLETED|Day 2||4
2466854|NCT00981292|6048973|P1|COMPLETED|Day 2||4
2466855|NCT00981292|6048968|P6|STARTED|Day 2||5
2466856|NCT00981292|6048969|P5|STARTED|Day 2||4
2466857|NCT00981292|6048970|P4|STARTED|Day 2||4
2466858|NCT00981292|6048971|P3|STARTED|Day 2||6
2466859|NCT00981292|6048972|P2|STARTED|Day 2||4
2466860|NCT00981292|6048973|P1|STARTED|Day 2||6
2466861|NCT00981292|6048968|P6|NOT COMPLETED|Day 1||2
2466862|NCT00981292|6048969|P5|NOT COMPLETED|Day 1||0
2466863|NCT00981292|6048970|P4|NOT COMPLETED|Day 1||0
2466864|NCT00981292|6048971|P3|NOT COMPLETED|Day 1||0
2466865|NCT00981292|6048972|P2|NOT COMPLETED|Day 1||0
2466866|NCT00981292|6048973|P1|NOT COMPLETED|Day 1||1
2466867|NCT00981292|6048968|P6|COMPLETED|Day 1||5
2466868|NCT00981292|6048969|P5|COMPLETED|Day 1||4
2466869|NCT00981292|6048970|P4|COMPLETED|Day 1||4
2466870|NCT00981292|6048971|P3|COMPLETED|Day 1||6
2466871|NCT00981292|6048972|P2|COMPLETED|Day 1||4
2466872|NCT00981292|6048973|P1|COMPLETED|Day 1||6
2466873|NCT00981292|6048968|P6|STARTED|Day 1||7
2466874|NCT00981292|6048969|P5|STARTED|Day 1||4
2466875|NCT00981292|6048970|P4|STARTED|Day 1||4
2466876|NCT00981292|6048971|P3|STARTED|Day 1||6
2466877|NCT00981292|6048972|P2|STARTED|Day 1||4
2466878|NCT00981292|6048973|P1|STARTED|Day 1||7
2466879|NCT00981253|6048992|P2|NOT COMPLETED|Overall Study||3
2466880|NCT00981253|6048993|P1|NOT COMPLETED|Overall Study||3
2466881|NCT00981253|6048992|P2|COMPLETED|Overall Study||72
2466882|NCT00981253|6048993|P1|COMPLETED|Overall Study||73
2466883|NCT00981253|6048992|P2|STARTED|Overall Study||75
2466884|NCT00981253|6048993|P1|STARTED|Overall Study||76
2466885|NCT00981227|6049017|P6|NOT COMPLETED|Overall Study||18
2466886|NCT00981227|6049018|P5|NOT COMPLETED|Overall Study||30
2466887|NCT00981227|6049019|P4|NOT COMPLETED|Overall Study||21
2466888|NCT00981227|6049020|P3|NOT COMPLETED|Overall Study||21
2466889|NCT00981227|6049021|P2|NOT COMPLETED|Overall Study||19
2466890|NCT00981227|6049022|P1|NOT COMPLETED|Overall Study||22
2466891|NCT00981227|6049017|P6|COMPLETED|Overall Study||75
2466892|NCT00981227|6049018|P5|COMPLETED|Overall Study||60
2466893|NCT00981227|6049019|P4|COMPLETED|Overall Study||73
2466894|NCT00981227|6049020|P3|COMPLETED|Overall Study||73
2466895|NCT00981227|6049021|P2|COMPLETED|Overall Study||75
2466896|NCT00981227|6049022|P1|COMPLETED|Overall Study||80
2466897|NCT00981227|6049017|P6|Per–Protocol|Overall Study||70
2466898|NCT00981227|6049018|P5|Per–Protocol|Overall Study||50
2466899|NCT00981227|6049019|P4|Per–Protocol|Overall Study||68
2466900|NCT00981227|6049020|P3|Per–Protocol|Overall Study||67
2466901|NCT00981227|6049021|P2|Per–Protocol|Overall Study||72
2466902|NCT00981227|6049022|P1|Per–Protocol|Overall Study||69
2466903|NCT00981227|6049017|P6|Safety Population|Overall Study||93
2466904|NCT00981227|6049018|P5|Safety Population|Overall Study||90
2466905|NCT00981227|6049019|P4|Safety Population|Overall Study||94
2466906|NCT00981227|6049020|P3|Safety Population|Overall Study||94
2466907|NCT00981227|6049021|P2|Safety Population|Overall Study||94
2466908|NCT00981227|6049022|P1|Safety Population|Overall Study||102
2466909|NCT00981227|6049017|P6|Randomized|Overall Study||93
2466910|NCT00981227|6049018|P5|Randomized|Overall Study||90
2466911|NCT00981227|6049019|P4|Randomized|Overall Study||94
2466912|NCT00981227|6049020|P3|Randomized|Overall Study||94
2466913|NCT00981227|6049021|P2|Randomized|Overall Study||94
2466914|NCT00981227|6049022|P1|Randomized|Overall Study||102
2466915|NCT00981227|6049017|P6|STARTED|Overall Study||93
2466916|NCT00981227|6049018|P5|STARTED|Overall Study||90
2466917|NCT00981227|6049019|P4|STARTED|Overall Study||94
2466918|NCT00981227|6049020|P3|STARTED|Overall Study||94
2466919|NCT00981227|6049021|P2|STARTED|Overall Study||94
2466920|NCT00981227|6049022|P1|STARTED|Overall Study||102
2466921|NCT00981214|6049040|P1|NOT COMPLETED|Overall Study||0
2466922|NCT00981214|6049040|P1|COMPLETED|Overall Study||19
2466923|NCT00981214|6049040|P1|STARTED|Overall Study||19
2466924|NCT00981175|6049057|P2|NOT COMPLETED|Booster Dose Vaccination||3
2466925|NCT00981175|6049058|P1|NOT COMPLETED|Booster Dose Vaccination||2
2466926|NCT00981175|6049057|P2|COMPLETED|Booster Dose Vaccination||40
2466927|NCT00981175|6049058|P1|COMPLETED|Booster Dose Vaccination||53
2466928|NCT00981175|6049057|P2|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|43
2466929|NCT00981175|6049058|P1|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|55
2466930|NCT00981175|6049057|P2|NOT COMPLETED|Primary Dose Vaccination||2
2466931|NCT00981175|6049058|P1|NOT COMPLETED|Primary Dose Vaccination||3
2466932|NCT00981175|6049057|P2|COMPLETED|Primary Dose Vaccination||99
2466933|NCT00981175|6049058|P1|COMPLETED|Primary Dose Vaccination||98
2466934|NCT00981175|6049057|P2|STARTED|Primary Dose Vaccination||101
2466935|NCT00981175|6049058|P1|STARTED|Primary Dose Vaccination||101
2466936|NCT00981149|6049083|P2|NOT COMPLETED|Overall Study||3
2466937|NCT00981149|6049084|P1|NOT COMPLETED|Overall Study||2
2466938|NCT00981149|6049083|P2|COMPLETED|Overall Study||9
2466939|NCT00981149|6049084|P1|COMPLETED|Overall Study||10
2466940|NCT00981149|6049083|P2|STARTED|Overall Study||12
2466941|NCT00981149|6049084|P1|STARTED|Overall Study||12
2466942|NCT00981084|6049094|P2|NOT COMPLETED|Post Intervention (Data Analysis)||1
2466943|NCT00981084|6049095|P1|NOT COMPLETED|Post Intervention (Data Analysis)||2
2466944|NCT00981084|6049094|P2|COMPLETED|Post Intervention (Data Analysis)||16
2466945|NCT00981084|6049095|P1|COMPLETED|Post Intervention (Data Analysis)||14
2466946|NCT00981084|6049094|P2|STARTED|Post Intervention (Data Analysis)||17
2466947|NCT00981084|6049095|P1|STARTED|Post Intervention (Data Analysis)||16
2466948|NCT00981084|6049094|P2|NOT COMPLETED|Second Intervention (One Day)||0
2466949|NCT00981084|6049095|P1|NOT COMPLETED|Second Intervention (One Day)||0
2466950|NCT00981084|6049094|P2|COMPLETED|Second Intervention (One Day)||17
2466951|NCT00981084|6049095|P1|COMPLETED|Second Intervention (One Day)||16
2466952|NCT00981084|6049094|P2|STARTED|Second Intervention (One Day)||17
2466953|NCT00981084|6049095|P1|STARTED|Second Intervention (One Day)||16
2466954|NCT00981084|6049094|P2|NOT COMPLETED|Washout Period (7 Days)||0
2466955|NCT00981084|6049095|P1|NOT COMPLETED|Washout Period (7 Days)||0
2466956|NCT00981084|6049094|P2|COMPLETED|Washout Period (7 Days)||17
2466957|NCT00981084|6049095|P1|COMPLETED|Washout Period (7 Days)||16
2466958|NCT00981084|6049094|P2|STARTED|Washout Period (7 Days)||17
2466959|NCT00981084|6049095|P1|STARTED|Washout Period (7 Days)||16
2466960|NCT00981084|6049094|P2|NOT COMPLETED|First Intervention (One Day)||0
2466961|NCT00981084|6049095|P1|NOT COMPLETED|First Intervention (One Day)||0
2466962|NCT00981084|6049094|P2|COMPLETED|First Intervention (One Day)||17
2466963|NCT00981084|6049095|P1|COMPLETED|First Intervention (One Day)||16
2466964|NCT00981084|6049094|P2|STARTED|First Intervention (One Day)||17
2466965|NCT00981084|6049095|P1|STARTED|First Intervention (One Day)||16
2466966|NCT00981058|6049111|P2|NOT COMPLETED|Overall Study||97
2466967|NCT00981058|6049112|P1|NOT COMPLETED|Overall Study||120
2466968|NCT00981058|6049111|P2|COMPLETED|Overall Study||451
2466969|NCT00981058|6049112|P1|COMPLETED|Overall Study||425
2466970|NCT00981058|6049111|P2|Death Due to Any Cause|Overall Study||442
2466971|NCT00981058|6049112|P1|Death Due to Any Cause|Overall Study||418
2466972|NCT00981058|6049111|P2|Received at Least 1 Dose of Study Drug|Overall Study||541
2466973|NCT00981058|6049112|P1|Received at Least 1 Dose of Study Drug|Overall Study||538
2466974|NCT00981058|6049111|P2|STARTED|Overall Study||548
2466975|NCT00981058|6049112|P1|STARTED|Overall Study||545
2466976|NCT00981045|6049134|P2|NOT COMPLETED|Overall Study||9
2466977|NCT00981045|6049135|P1|NOT COMPLETED|Overall Study||14
2466978|NCT00981045|6049134|P2|COMPLETED|Overall Study||1285
2466979|NCT00981045|6049135|P1|COMPLETED|Overall Study||1276
2466980|NCT00981045|6049134|P2|STARTED|Overall Study||1294
2466981|NCT00981045|6049135|P1|STARTED|Overall Study||1290
2466982|NCT00981019|6049143|P1|NOT COMPLETED|Overall Study||477
2466983|NCT00981019|6049143|P1|COMPLETED|Overall Study||301
2466984|NCT00981019|6049143|P1|STARTED|Overall Study||778
2466985|NCT00980980|6049150|P3|NOT COMPLETED|Overall Study||0
2466986|NCT00980980|6049151|P2|NOT COMPLETED|Overall Study||1
2466987|NCT00980980|6049152|P1|NOT COMPLETED|Overall Study||0
2466988|NCT00980980|6049150|P3|COMPLETED|Overall Study||13
2466989|NCT00980980|6049151|P2|COMPLETED|Overall Study||13
2466990|NCT00980980|6049152|P1|COMPLETED|Overall Study||16
2466991|NCT00980980|6049150|P3|STARTED|Overall Study||13
2466992|NCT00980980|6049151|P2|STARTED|Overall Study||14
2466993|NCT00980980|6049152|P1|STARTED|Overall Study||16
2466994|NCT00980798|6049183|P2|NOT COMPLETED|Overall Study||55
2466995|NCT00980798|6049184|P1|NOT COMPLETED|Overall Study||33
2466996|NCT00980798|6049183|P2|COMPLETED|Overall Study||84
2466997|NCT00980798|6049184|P1|COMPLETED|Overall Study||116
2466998|NCT00980798|6049183|P2|STARTED|Overall Study||139
2466999|NCT00980798|6049184|P1|STARTED|Overall Study||149
2467000|NCT00980746|6049198|P6|NOT COMPLETED|Overall Study||18
2467001|NCT00980746|6049199|P5|NOT COMPLETED|Overall Study||17
2467002|NCT00980746|6049200|P4|NOT COMPLETED|Overall Study||36
2467003|NCT00980746|6049201|P3|NOT COMPLETED|Overall Study||20
2467004|NCT00980746|6049202|P2|NOT COMPLETED|Overall Study||22
2467005|NCT00980746|6049203|P1|NOT COMPLETED|Overall Study||27
2467006|NCT00980746|6049198|P6|COMPLETED|Overall Study||78
2467007|NCT00980746|6049199|P5|COMPLETED|Overall Study||75
2467008|NCT00980746|6049200|P4|COMPLETED|Overall Study||64
2467009|NCT00980746|6049201|P3|COMPLETED|Overall Study||75
2467010|NCT00980746|6049202|P2|COMPLETED|Overall Study||67
2467011|NCT00980746|6049203|P1|COMPLETED|Overall Study||58
2467012|NCT00980746|6049198|P6|Per-protocol|Overall Study||74
2467013|NCT00980746|6049199|P5|Per-protocol|Overall Study||73
2467014|NCT00980746|6049200|P4|Per-protocol|Overall Study||62
2467015|NCT00980746|6049201|P3|Per-protocol|Overall Study||73
2467016|NCT00980746|6049202|P2|Per-protocol|Overall Study||66
2467017|NCT00980746|6049203|P1|Per-protocol|Overall Study||55
2467018|NCT00980746|6049198|P6|Safety Population|Overall Study||96
2467019|NCT00980746|6049199|P5|Safety Population|Overall Study||92
2467020|NCT00980746|6049200|P4|Safety Population|Overall Study||100
2467021|NCT00980746|6049201|P3|Safety Population|Overall Study||95
2467022|NCT00980746|6049202|P2|Safety Population|Overall Study||89
2467023|NCT00980746|6049203|P1|Safety Population|Overall Study||85
2467024|NCT00980746|6049198|P6|Randomized|Overall Study||96
2467025|NCT00980746|6049199|P5|Randomized|Overall Study||92
2467026|NCT00980746|6049200|P4|Randomized|Overall Study||100
2467027|NCT00980746|6049201|P3|Randomized|Overall Study||95
2467028|NCT00980746|6049202|P2|Randomized|Overall Study||89
2467029|NCT00980746|6049203|P1|Randomized|Overall Study||85
2467030|NCT00980746|6049198|P6|STARTED|Overall Study||96
2467031|NCT00980746|6049199|P5|STARTED|Overall Study||92
2467032|NCT00980746|6049200|P4|STARTED|Overall Study||100
2467033|NCT00980746|6049201|P3|STARTED|Overall Study||95
2467034|NCT00980746|6049202|P2|STARTED|Overall Study||89
2467035|NCT00980746|6049203|P1|STARTED|Overall Study||85
2467036|NCT00980681|6049217|P1|NOT COMPLETED|Dotarem MRA||0
2467037|NCT00980681|6049217|P1|COMPLETED|Dotarem MRA||10
2467038|NCT00980681|6049217|P1|STARTED|Dotarem MRA|Out of the 13 enrolled patients, three did not receive treatment|10
2467039|NCT00980681|6049217|P1|NOT COMPLETED|TOF MRA||0
2467040|NCT00980681|6049217|P1|COMPLETED|TOF MRA||10
2467041|NCT00980681|6049217|P1|STARTED|TOF MRA|Out of the 13 enrolled patients, three did not receive treatment|10
2467042|NCT00980655|6049225|P2|NOT COMPLETED|Overall Study||51
2467043|NCT00980655|6049226|P1|NOT COMPLETED|Overall Study||16
2467044|NCT00980655|6049225|P2|COMPLETED|Overall Study||139
2467045|NCT00980655|6049226|P1|COMPLETED|Overall Study||45
2467046|NCT00980655|6049225|P2|Vaccinated 23vPS Dose|Overall Study||140
2467047|NCT00980655|6049226|P1|Vaccinated 23vPS Dose|Overall Study||45
2467048|NCT00980655|6049225|P2|Vaccinated 13vPnC Dose 4|Overall Study||146
2467049|NCT00980655|6049226|P1|Vaccinated 13vPnC Dose 4|Overall Study||46
2467050|NCT00980655|6049225|P2|Vaccinated 13vPnC Dose 3|Overall Study||167
2467051|NCT00980655|6049226|P1|Vaccinated 13vPnC Dose 3|Overall Study||54
2467052|NCT00980655|6049225|P2|Vaccinated 13vPnC Dose 2|Overall Study||176
2467053|NCT00980655|6049226|P1|Vaccinated 13vPnC Dose 2|Overall Study||55
2467054|NCT00980655|6049225|P2|Vaccinated 13vPnC Dose 1|Overall Study||188
2467055|NCT00980655|6049226|P1|Vaccinated 13vPnC Dose 1|Overall Study||59
2467056|NCT00980655|6049225|P2|STARTED|Overall Study||190
2467057|NCT00980655|6049226|P1|STARTED|Overall Study||61
2467058|NCT00980642|6049274|P2|NOT COMPLETED|Overall Study||0
2467059|NCT00980642|6049275|P1|NOT COMPLETED|Overall Study||0
2467060|NCT00980642|6049274|P2|COMPLETED|Overall Study||20
2467061|NCT00980642|6049275|P1|COMPLETED|Overall Study||36
2467062|NCT00980642|6049274|P2|STARTED|Overall Study||20
2467063|NCT00980642|6049275|P1|STARTED|Overall Study||36
2467064|NCT00980590|6049287|P2|NOT COMPLETED|Overall Study||0
2467065|NCT00980590|6049288|P1|NOT COMPLETED|Overall Study||0
2467066|NCT00980590|6049287|P2|COMPLETED|Overall Study||50
2467067|NCT00980590|6049288|P1|COMPLETED|Overall Study||50
2467068|NCT00980590|6049287|P2|STARTED|Overall Study||50
2467069|NCT00980590|6049288|P1|STARTED|Overall Study||50
2467070|NCT00980395|6049300|P1|NOT COMPLETED|Overall Study||0
2467071|NCT00980395|6049300|P1|COMPLETED|Overall Study||24
2467072|NCT00980395|6049300|P1|STARTED|Overall Study||24
2467073|NCT00980343|6049309|P2|NOT COMPLETED|Overall Study||3
2467074|NCT00980343|6049310|P1|NOT COMPLETED|Overall Study||1
2467075|NCT00980343|6049309|P2|COMPLETED|Overall Study||20
2467076|NCT00980343|6049310|P1|COMPLETED|Overall Study||20
2467077|NCT00980343|6049309|P2|STARTED|Overall Study||23
2467078|NCT00980343|6049310|P1|STARTED|Overall Study||21
2467079|NCT00980330|6049334|P7|NOT COMPLETED|Overall Study||7
2467080|NCT00980330|6049335|P6|NOT COMPLETED|Overall Study||4
2467081|NCT00980330|6049336|P5|NOT COMPLETED|Overall Study||5
2467082|NCT00980330|6049337|P4|NOT COMPLETED|Overall Study||5
2467083|NCT00980330|6049338|P3|NOT COMPLETED|Overall Study||8
2467084|NCT00980330|6049339|P2|NOT COMPLETED|Overall Study||5
2467085|NCT00980330|6049340|P1|NOT COMPLETED|Overall Study||5
2467086|NCT00980330|6049334|P7|COMPLETED|Overall Study||59
2467087|NCT00980330|6049335|P6|COMPLETED|Overall Study||61
2467088|NCT00980330|6049336|P5|COMPLETED|Overall Study||63
2467089|NCT00980330|6049337|P4|COMPLETED|Overall Study||61
2467090|NCT00980330|6049338|P3|COMPLETED|Overall Study||58
2467091|NCT00980330|6049339|P2|COMPLETED|Overall Study||60
2467092|NCT00980330|6049340|P1|COMPLETED|Overall Study||61
2467093|NCT00980330|6049334|P7|STARTED|Overall Study||66
2467094|NCT00980330|6049335|P6|STARTED|Overall Study||65
2467095|NCT00980330|6049336|P5|STARTED|Overall Study||68
2467096|NCT00980330|6049337|P4|STARTED|Overall Study||66
2467097|NCT00980330|6049338|P3|STARTED|Overall Study||66
2467098|NCT00980330|6049339|P2|STARTED|Overall Study||65
2467099|NCT00980330|6049340|P1|STARTED|Overall Study||66
2467100|NCT00980278|6049440|P2|NOT COMPLETED|Overall Study||0
2467101|NCT00980278|6049441|P1|NOT COMPLETED|Overall Study||2
2467102|NCT00980278|6049440|P2|COMPLETED|Overall Study||13
2467103|NCT00980278|6049441|P1|COMPLETED|Overall Study||11
2467104|NCT00980278|6049440|P2|STARTED|Overall Study||13
2467105|NCT00980278|6049441|P1|STARTED|Overall Study||13
2467106|NCT00980200|6049455|P5|NOT COMPLETED|7-day Treatment Period 5||0
2467107|NCT00980200|6049456|P4|NOT COMPLETED|7-day Treatment Period 5||0
2467108|NCT00980200|6049457|P3|NOT COMPLETED|7-day Treatment Period 5||0
2467109|NCT00980200|6049458|P2|NOT COMPLETED|7-day Treatment Period 5||0
2467110|NCT00980200|6049459|P1|NOT COMPLETED|7-day Treatment Period 5||0
2467111|NCT00980200|6049455|P5|COMPLETED|7-day Treatment Period 5||14
2467112|NCT00980200|6049456|P4|COMPLETED|7-day Treatment Period 5||16
2467113|NCT00980200|6049457|P3|COMPLETED|7-day Treatment Period 5||15
2467114|NCT00980200|6049458|P2|COMPLETED|7-day Treatment Period 5||12
2467115|NCT00980200|6049459|P1|COMPLETED|7-day Treatment Period 5||15
2467116|NCT00980200|6049455|P5|STARTED|7-day Treatment Period 5||14
2467117|NCT00980200|6049456|P4|STARTED|7-day Treatment Period 5||16
2467118|NCT00980200|6049457|P3|STARTED|7-day Treatment Period 5||15
2467119|NCT00980200|6049458|P2|STARTED|7-day Treatment Period 5||12
2467120|NCT00980200|6049459|P1|STARTED|7-day Treatment Period 5||15
2467121|NCT00980200|6049455|P5|NOT COMPLETED|7-day Washout Period 4||0
2467122|NCT00980200|6049456|P4|NOT COMPLETED|7-day Washout Period 4||0
2467123|NCT00980200|6049457|P3|NOT COMPLETED|7-day Washout Period 4||0
2467124|NCT00980200|6049458|P2|NOT COMPLETED|7-day Washout Period 4||0
2467125|NCT00980200|6049459|P1|NOT COMPLETED|7-day Washout Period 4||0
2467126|NCT00980200|6049455|P5|COMPLETED|7-day Washout Period 4||14
2467127|NCT00980200|6049456|P4|COMPLETED|7-day Washout Period 4||16
2467128|NCT00980200|6049457|P3|COMPLETED|7-day Washout Period 4||15
2467129|NCT00980200|6049458|P2|COMPLETED|7-day Washout Period 4||12
2467130|NCT00980200|6049459|P1|COMPLETED|7-day Washout Period 4||15
2467131|NCT00980200|6049455|P5|STARTED|7-day Washout Period 4||14
2467132|NCT00980200|6049456|P4|STARTED|7-day Washout Period 4||16
2467133|NCT00980200|6049457|P3|STARTED|7-day Washout Period 4||15
2467134|NCT00980200|6049458|P2|STARTED|7-day Washout Period 4||12
2467135|NCT00980200|6049459|P1|STARTED|7-day Washout Period 4||15
2467136|NCT00980200|6049455|P5|NOT COMPLETED|7-day Treatment Period 4||0
2467137|NCT00980200|6049456|P4|NOT COMPLETED|7-day Treatment Period 4||0
2467138|NCT00980200|6049457|P3|NOT COMPLETED|7-day Treatment Period 4||0
2467139|NCT00980200|6049458|P2|NOT COMPLETED|7-day Treatment Period 4||0
2467140|NCT00980200|6049459|P1|NOT COMPLETED|7-day Treatment Period 4||0
2467141|NCT00980200|6049455|P5|COMPLETED|7-day Treatment Period 4||14
2467142|NCT00980200|6049456|P4|COMPLETED|7-day Treatment Period 4||16
2467143|NCT00980200|6049457|P3|COMPLETED|7-day Treatment Period 4||15
2467144|NCT00980200|6049458|P2|COMPLETED|7-day Treatment Period 4||12
2467145|NCT00980200|6049459|P1|COMPLETED|7-day Treatment Period 4||15
2467146|NCT00980200|6049455|P5|STARTED|7-day Treatment Period 4||14
2467147|NCT00980200|6049456|P4|STARTED|7-day Treatment Period 4||16
2467148|NCT00980200|6049457|P3|STARTED|7-day Treatment Period 4||15
2467149|NCT00980200|6049458|P2|STARTED|7-day Treatment Period 4||12
2467150|NCT00980200|6049459|P1|STARTED|7-day Treatment Period 4||15
2467151|NCT00980200|6049455|P5|NOT COMPLETED|7-day Washout Period 3||0
2467152|NCT00980200|6049456|P4|NOT COMPLETED|7-day Washout Period 3||0
2467153|NCT00980200|6049457|P3|NOT COMPLETED|7-day Washout Period 3||0
2467154|NCT00980200|6049458|P2|NOT COMPLETED|7-day Washout Period 3||0
2467155|NCT00980200|6049459|P1|NOT COMPLETED|7-day Washout Period 3||0
2467156|NCT00980200|6049455|P5|COMPLETED|7-day Washout Period 3||14
2467157|NCT00980200|6049456|P4|COMPLETED|7-day Washout Period 3||16
2467158|NCT00980200|6049457|P3|COMPLETED|7-day Washout Period 3||15
2467159|NCT00980200|6049458|P2|COMPLETED|7-day Washout Period 3||12
2467160|NCT00980200|6049459|P1|COMPLETED|7-day Washout Period 3||15
2467161|NCT00980200|6049455|P5|STARTED|7-day Washout Period 3||14
2467162|NCT00980200|6049456|P4|STARTED|7-day Washout Period 3||16
2467163|NCT00980200|6049457|P3|STARTED|7-day Washout Period 3||15
2467164|NCT00980200|6049458|P2|STARTED|7-day Washout Period 3||12
2467165|NCT00980200|6049459|P1|STARTED|7-day Washout Period 3||15
2467166|NCT00980200|6049455|P5|NOT COMPLETED|7-day Treatment Period 3||1
2467167|NCT00980200|6049456|P4|NOT COMPLETED|7-day Treatment Period 3||0
2467168|NCT00980200|6049457|P3|NOT COMPLETED|7-day Treatment Period 3||0
2467169|NCT00980200|6049458|P2|NOT COMPLETED|7-day Treatment Period 3||1
2467170|NCT00980200|6049459|P1|NOT COMPLETED|7-day Treatment Period 3||0
2467171|NCT00980200|6049455|P5|COMPLETED|7-day Treatment Period 3||14
2467172|NCT00980200|6049456|P4|COMPLETED|7-day Treatment Period 3||16
2467173|NCT00980200|6049457|P3|COMPLETED|7-day Treatment Period 3||15
2467174|NCT00980200|6049458|P2|COMPLETED|7-day Treatment Period 3||12
2467175|NCT00980200|6049459|P1|COMPLETED|7-day Treatment Period 3||15
2467176|NCT00980200|6049455|P5|STARTED|7-day Treatment Period 3||15
2467177|NCT00980200|6049456|P4|STARTED|7-day Treatment Period 3||16
2467178|NCT00980200|6049457|P3|STARTED|7-day Treatment Period 3||15
2467179|NCT00980200|6049458|P2|STARTED|7-day Treatment Period 3||13
2467180|NCT00980200|6049459|P1|STARTED|7-day Treatment Period 3||15
2467181|NCT00980200|6049455|P5|NOT COMPLETED|7-day Washout Period 2||0
2467182|NCT00980200|6049456|P4|NOT COMPLETED|7-day Washout Period 2||0
2467183|NCT00980200|6049457|P3|NOT COMPLETED|7-day Washout Period 2||0
2467184|NCT00980200|6049458|P2|NOT COMPLETED|7-day Washout Period 2||0
2467185|NCT00980200|6049459|P1|NOT COMPLETED|7-day Washout Period 2||0
2467186|NCT00980200|6049455|P5|COMPLETED|7-day Washout Period 2||15
2467187|NCT00980200|6049456|P4|COMPLETED|7-day Washout Period 2||16
2467188|NCT00980200|6049457|P3|COMPLETED|7-day Washout Period 2||15
2467189|NCT00980200|6049458|P2|COMPLETED|7-day Washout Period 2||13
2467190|NCT00980200|6049459|P1|COMPLETED|7-day Washout Period 2||15
2467191|NCT00980200|6049455|P5|STARTED|7-day Washout Period 2||15
2467192|NCT00980200|6049456|P4|STARTED|7-day Washout Period 2||16
2467193|NCT00980200|6049457|P3|STARTED|7-day Washout Period 2||15
2467194|NCT00980200|6049458|P2|STARTED|7-day Washout Period 2||13
2467195|NCT00980200|6049459|P1|STARTED|7-day Washout Period 2||15
2467196|NCT00980200|6049455|P5|NOT COMPLETED|7-day Treatment Period 2||0
2467197|NCT00980200|6049456|P4|NOT COMPLETED|7-day Treatment Period 2||0
2467198|NCT00980200|6049457|P3|NOT COMPLETED|7-day Treatment Period 2||0
2467199|NCT00980200|6049458|P2|NOT COMPLETED|7-day Treatment Period 2||0
2467200|NCT00980200|6049459|P1|NOT COMPLETED|7-day Treatment Period 2||0
2467201|NCT00980200|6049455|P5|COMPLETED|7-day Treatment Period 2||15
2467202|NCT00980200|6049456|P4|COMPLETED|7-day Treatment Period 2||16
2467203|NCT00980200|6049457|P3|COMPLETED|7-day Treatment Period 2||15
2467204|NCT00980200|6049458|P2|COMPLETED|7-day Treatment Period 2||13
2467205|NCT00980200|6049459|P1|COMPLETED|7-day Treatment Period 2||15
2467206|NCT00980200|6049455|P5|STARTED|7-day Treatment Period 2||15
2467207|NCT00980200|6049456|P4|STARTED|7-day Treatment Period 2||16
2467208|NCT00980200|6049457|P3|STARTED|7-day Treatment Period 2||15
2467209|NCT00980200|6049458|P2|STARTED|7-day Treatment Period 2||13
2467210|NCT00980200|6049459|P1|STARTED|7-day Treatment Period 2||15
2467211|NCT00980200|6049455|P5|NOT COMPLETED|7-day Washout Period 1||0
2467212|NCT00980200|6049456|P4|NOT COMPLETED|7-day Washout Period 1||0
2467213|NCT00980200|6049457|P3|NOT COMPLETED|7-day Washout Period 1||0
2467214|NCT00980200|6049458|P2|NOT COMPLETED|7-day Washout Period 1||0
2467215|NCT00980200|6049459|P1|NOT COMPLETED|7-day Washout Period 1||0
2467216|NCT00980200|6049455|P5|COMPLETED|7-day Washout Period 1||15
2467217|NCT00980200|6049456|P4|COMPLETED|7-day Washout Period 1||16
2467218|NCT00980200|6049457|P3|COMPLETED|7-day Washout Period 1||15
2467219|NCT00980200|6049458|P2|COMPLETED|7-day Washout Period 1||13
2467220|NCT00980200|6049459|P1|COMPLETED|7-day Washout Period 1||15
2467221|NCT00980200|6049455|P5|STARTED|7-day Washout Period 1||15
2467222|NCT00980200|6049456|P4|STARTED|7-day Washout Period 1||16
2467223|NCT00980200|6049457|P3|STARTED|7-day Washout Period 1||15
2467224|NCT00980200|6049458|P2|STARTED|7-day Washout Period 1||13
2467225|NCT00980200|6049459|P1|STARTED|7-day Washout Period 1||15
2467226|NCT00980200|6049455|P5|NOT COMPLETED|7-day Treatment Period 1||0
2467227|NCT00980200|6049456|P4|NOT COMPLETED|7-day Treatment Period 1||0
2467228|NCT00980200|6049457|P3|NOT COMPLETED|7-day Treatment Period 1||0
2467229|NCT00980200|6049458|P2|NOT COMPLETED|7-day Treatment Period 1||1
2467230|NCT00980200|6049459|P1|NOT COMPLETED|7-day Treatment Period 1||0
2467231|NCT00980200|6049455|P5|COMPLETED|7-day Treatment Period 1||15
2467232|NCT00980200|6049456|P4|COMPLETED|7-day Treatment Period 1||16
2467233|NCT00980200|6049457|P3|COMPLETED|7-day Treatment Period 1||15
2467234|NCT00980200|6049458|P2|COMPLETED|7-day Treatment Period 1||13
2467235|NCT00980200|6049459|P1|COMPLETED|7-day Treatment Period 1||15
2467236|NCT00980200|6049455|P5|STARTED|7-day Treatment Period 1||15
2467237|NCT00980200|6049456|P4|STARTED|7-day Treatment Period 1||16
2467238|NCT00980200|6049457|P3|STARTED|7-day Treatment Period 1||15
2467239|NCT00980200|6049458|P2|STARTED|7-day Treatment Period 1||14
2467240|NCT00980200|6049459|P1|STARTED|7-day Treatment Period 1||15
2467241|NCT00980174|6049478|P2|NOT COMPLETED|Overall Study||10
2467242|NCT00980174|6049479|P1|NOT COMPLETED|Overall Study||4
2467243|NCT00980174|6049478|P2|COMPLETED|Overall Study||111
2467244|NCT00980174|6049479|P1|COMPLETED|Overall Study||117
2467245|NCT00980174|6049478|P2|STARTED|Overall Study||121
2467246|NCT00980174|6049479|P1|STARTED|Overall Study||121
2467247|NCT00980148|6049497|P2|NOT COMPLETED|Overall Study||128
2467248|NCT00980148|6049498|P1|NOT COMPLETED|Overall Study||129
2467249|NCT00980148|6049497|P2|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
2467250|NCT00980148|6049498|P1|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
2467251|NCT00980148|6049497|P2|STARTED|Overall Study||283
2467252|NCT00980148|6049498|P1|STARTED|Overall Study||284
2467253|NCT00980057|6049506|P2|NOT COMPLETED|Overall Study||5
2467254|NCT00980057|6049507|P1|NOT COMPLETED|Overall Study||19
2467255|NCT00980057|6049506|P2|COMPLETED|Overall Study||155
2467256|NCT00980057|6049507|P1|COMPLETED|Overall Study||299
2467257|NCT00980057|6049506|P2|STARTED|Overall Study||160
2467258|NCT00980057|6049507|P1|STARTED|Overall Study||318
2467259|NCT00980044|6049530|P3|NOT COMPLETED|Overall Study||5
2467260|NCT00980044|6049531|P2|NOT COMPLETED|Overall Study||7
2467261|NCT00980044|6049532|P1|NOT COMPLETED|Overall Study||5
2467262|NCT00980044|6049530|P3|COMPLETED|Overall Study||12
2467263|NCT00980044|6049531|P2|COMPLETED|Overall Study||12
2467264|NCT00980044|6049532|P1|COMPLETED|Overall Study||12
2467265|NCT00980044|6049530|P3|STARTED|Overall Study||17
2467266|NCT00980044|6049531|P2|STARTED|Overall Study||19
2467267|NCT00980044|6049532|P1|STARTED|Overall Study||17
2467268|NCT00980005|6049551|P2|NOT COMPLETED|Overall Study||63
2467269|NCT00980005|6049552|P1|NOT COMPLETED|Overall Study||47
2467270|NCT00980005|6049551|P2|COMPLETED|Overall Study||998
2467271|NCT00980005|6049552|P1|COMPLETED|Overall Study||1008
2467272|NCT00980005|6049551|P2|STARTED|Overall Study||1061
2467273|NCT00980005|6049552|P1|STARTED|Overall Study||1055
2467277|NCT00979953|6049604|P4|NOT COMPLETED|Overall Study||7
2467278|NCT00979953|6049605|P3|NOT COMPLETED|Overall Study||22
2467279|NCT00979953|6049606|P2|NOT COMPLETED|Overall Study||5
2467280|NCT00979953|6049607|P1|NOT COMPLETED|Overall Study||8
2467281|NCT00979953|6049604|P4|COMPLETED|Overall Study||97
2467282|NCT00979953|6049605|P3|COMPLETED|Overall Study||82
2467283|NCT00979953|6049606|P2|COMPLETED|Overall Study||94
2467284|NCT00979953|6049607|P1|COMPLETED|Overall Study||93
2467285|NCT00979953|6049604|P4|Received at Least 1 Dose of Study Drug|Overall Study||104
2467286|NCT00979953|6049605|P3|Received at Least 1 Dose of Study Drug|Overall Study||104
2467287|NCT00979953|6049606|P2|Received at Least 1 Dose of Study Drug|Overall Study||99
2467288|NCT00979953|6049607|P1|Received at Least 1 Dose of Study Drug|Overall Study||101
2467289|NCT00979953|6049604|P4|STARTED|Overall Study||104
2467290|NCT00979953|6049605|P3|STARTED|Overall Study||104
2467291|NCT00979953|6049606|P2|STARTED|Overall Study||99
2467292|NCT00979953|6049607|P1|STARTED|Overall Study||101
2467293|NCT00979940|6049619|P2|NOT COMPLETED|Overall Study||0
2467294|NCT00979940|6049620|P1|NOT COMPLETED|Overall Study||0
2467295|NCT00979940|6049619|P2|COMPLETED|Overall Study||28
2467296|NCT00979940|6049620|P1|COMPLETED|Overall Study||32
2467297|NCT00979940|6049619|P2|STARTED|Overall Study||28
2467298|NCT00979940|6049620|P1|STARTED|Overall Study||32
2467299|NCT00979901|6049630|P4|NOT COMPLETED|Overall Study||116
2467300|NCT00979901|6049631|P3|NOT COMPLETED|Overall Study||29
2467301|NCT00979901|6049632|P2|NOT COMPLETED|Overall Study||12
2467302|NCT00979901|6049633|P1|NOT COMPLETED|Overall Study||18
2467303|NCT00979901|6049630|P4|COMPLETED|Overall Study||159
2467304|NCT00979901|6049631|P3|COMPLETED|Overall Study||573
2467305|NCT00979901|6049632|P2|COMPLETED|Overall Study||336
2467306|NCT00979901|6049633|P1|COMPLETED|Overall Study||334
2467307|NCT00979901|6049630|P4|STARTED|Overall Study||275
2467308|NCT00979901|6049631|P3|STARTED|Overall Study||602
2467309|NCT00979901|6049632|P2|STARTED|Overall Study||348
2467310|NCT00979901|6049633|P1|STARTED|Overall Study||352
2467311|NCT00979875|6049657|P6|NOT COMPLETED|Intervention 3||0
2467312|NCT00979875|6049658|P5|NOT COMPLETED|Intervention 3||0
2467313|NCT00979875|6049659|P4|NOT COMPLETED|Intervention 3||0
2467314|NCT00979875|6049660|P3|NOT COMPLETED|Intervention 3||0
2467315|NCT00979875|6049661|P2|NOT COMPLETED|Intervention 3||0
2467316|NCT00979875|6049662|P1|NOT COMPLETED|Intervention 3||0
2467317|NCT00979875|6049657|P6|COMPLETED|Intervention 3||2
2467318|NCT00979875|6049658|P5|COMPLETED|Intervention 3||3
2467319|NCT00979875|6049659|P4|COMPLETED|Intervention 3||2
2467320|NCT00979875|6049660|P3|COMPLETED|Intervention 3||3
2467321|NCT00979875|6049661|P2|COMPLETED|Intervention 3||2
2467322|NCT00979875|6049662|P1|COMPLETED|Intervention 3||2
2467323|NCT00979875|6049657|P6|STARTED|Intervention 3||2
2467324|NCT00979875|6049658|P5|STARTED|Intervention 3||3
2467325|NCT00979875|6049659|P4|STARTED|Intervention 3||2
2467326|NCT00979875|6049660|P3|STARTED|Intervention 3||3
2467327|NCT00979875|6049661|P2|STARTED|Intervention 3||2
2467328|NCT00979875|6049662|P1|STARTED|Intervention 3||2
2467329|NCT00979875|6049657|P6|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
2467330|NCT00979875|6049658|P5|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
2467331|NCT00979875|6049659|P4|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
2467332|NCT00979875|6049660|P3|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
2467333|NCT00979875|6049661|P2|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
2467334|NCT00979875|6049662|P1|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
2467335|NCT00979875|6049657|P6|COMPLETED|Washout 2 (3 to 14 Days)||2
2467336|NCT00979875|6049658|P5|COMPLETED|Washout 2 (3 to 14 Days)||3
2467337|NCT00979875|6049659|P4|COMPLETED|Washout 2 (3 to 14 Days)||2
2467338|NCT00979875|6049660|P3|COMPLETED|Washout 2 (3 to 14 Days)||3
2467339|NCT00979875|6049661|P2|COMPLETED|Washout 2 (3 to 14 Days)||2
2467340|NCT00979875|6049662|P1|COMPLETED|Washout 2 (3 to 14 Days)||2
2467341|NCT00979875|6049657|P6|STARTED|Washout 2 (3 to 14 Days)||2
2467342|NCT00979875|6049658|P5|STARTED|Washout 2 (3 to 14 Days)||3
2467343|NCT00979875|6049659|P4|STARTED|Washout 2 (3 to 14 Days)||2
2467344|NCT00979875|6049660|P3|STARTED|Washout 2 (3 to 14 Days)||3
2467345|NCT00979875|6049661|P2|STARTED|Washout 2 (3 to 14 Days)||2
2467346|NCT00979875|6049662|P1|STARTED|Washout 2 (3 to 14 Days)||2
2467347|NCT00979875|6049657|P6|NOT COMPLETED|Intervention 2||0
2467348|NCT00979875|6049658|P5|NOT COMPLETED|Intervention 2||0
2467349|NCT00979875|6049659|P4|NOT COMPLETED|Intervention 2||0
2467350|NCT00979875|6049660|P3|NOT COMPLETED|Intervention 2||0
2467351|NCT00979875|6049661|P2|NOT COMPLETED|Intervention 2||0
2467352|NCT00979875|6049662|P1|NOT COMPLETED|Intervention 2||0
2467353|NCT00979875|6049657|P6|COMPLETED|Intervention 2||2
2467354|NCT00979875|6049658|P5|COMPLETED|Intervention 2||3
2467355|NCT00979875|6049659|P4|COMPLETED|Intervention 2||2
2467356|NCT00979875|6049660|P3|COMPLETED|Intervention 2||3
2467357|NCT00979875|6049661|P2|COMPLETED|Intervention 2||2
2467358|NCT00979875|6049662|P1|COMPLETED|Intervention 2||2
2467359|NCT00979875|6049657|P6|STARTED|Intervention 2||2
2467360|NCT00979875|6049658|P5|STARTED|Intervention 2||3
2467361|NCT00979875|6049659|P4|STARTED|Intervention 2||2
2467362|NCT00979875|6049660|P3|STARTED|Intervention 2||3
2467363|NCT00979875|6049661|P2|STARTED|Intervention 2||2
2467364|NCT00979875|6049662|P1|STARTED|Intervention 2||2
2467365|NCT00979875|6049657|P6|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
2467366|NCT00979875|6049658|P5|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
2467367|NCT00979875|6049659|P4|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
2467368|NCT00979875|6049660|P3|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
2467369|NCT00979875|6049661|P2|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
2467370|NCT00979875|6049662|P1|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
2467371|NCT00979875|6049657|P6|COMPLETED|Washout 1 (3 to 14 Days)||2
2467372|NCT00979875|6049658|P5|COMPLETED|Washout 1 (3 to 14 Days)||3
2467373|NCT00979875|6049659|P4|COMPLETED|Washout 1 (3 to 14 Days)||2
2467374|NCT00979875|6049660|P3|COMPLETED|Washout 1 (3 to 14 Days)||3
2467375|NCT00979875|6049661|P2|COMPLETED|Washout 1 (3 to 14 Days)||2
2467376|NCT00979875|6049662|P1|COMPLETED|Washout 1 (3 to 14 Days)||2
2467377|NCT00979875|6049657|P6|STARTED|Washout 1 (3 to 14 Days)||2
2467378|NCT00979875|6049658|P5|STARTED|Washout 1 (3 to 14 Days)||3
2467379|NCT00979875|6049659|P4|STARTED|Washout 1 (3 to 14 Days)||2
2467380|NCT00979875|6049660|P3|STARTED|Washout 1 (3 to 14 Days)||3
2467381|NCT00979875|6049661|P2|STARTED|Washout 1 (3 to 14 Days)||2
2467382|NCT00979875|6049662|P1|STARTED|Washout 1 (3 to 14 Days)||2
2467383|NCT00979875|6049657|P6|NOT COMPLETED|Intervention 1||0
2467384|NCT00979875|6049658|P5|NOT COMPLETED|Intervention 1||0
2467385|NCT00979875|6049659|P4|NOT COMPLETED|Intervention 1||0
2467386|NCT00979875|6049660|P3|NOT COMPLETED|Intervention 1||0
2467387|NCT00979875|6049661|P2|NOT COMPLETED|Intervention 1||0
2467388|NCT00979875|6049662|P1|NOT COMPLETED|Intervention 1||0
2467389|NCT00979875|6049657|P6|COMPLETED|Intervention 1||2
2467390|NCT00979875|6049658|P5|COMPLETED|Intervention 1||3
2467391|NCT00979875|6049659|P4|COMPLETED|Intervention 1||2
2467392|NCT00979875|6049660|P3|COMPLETED|Intervention 1||3
2467393|NCT00979875|6049661|P2|COMPLETED|Intervention 1||2
2467394|NCT00979875|6049662|P1|COMPLETED|Intervention 1||2
2467395|NCT00979875|6049657|P6|Received at Least 1 Dose of Study Drug|Intervention 1||2
2467396|NCT00979875|6049658|P5|Received at Least 1 Dose of Study Drug|Intervention 1||3
2467397|NCT00979875|6049659|P4|Received at Least 1 Dose of Study Drug|Intervention 1||2
2467398|NCT00979875|6049660|P3|Received at Least 1 Dose of Study Drug|Intervention 1||3
2467399|NCT00979875|6049661|P2|Received at Least 1 Dose of Study Drug|Intervention 1||2
2467400|NCT00979875|6049662|P1|Received at Least 1 Dose of Study Drug|Intervention 1||2
2467401|NCT00979875|6049657|P6|STARTED|Intervention 1||2
2467402|NCT00979875|6049658|P5|STARTED|Intervention 1||3
2467403|NCT00979875|6049659|P4|STARTED|Intervention 1||2
2467404|NCT00979875|6049660|P3|STARTED|Intervention 1||3
2467405|NCT00979875|6049661|P2|STARTED|Intervention 1||2
2467406|NCT00979875|6049662|P1|STARTED|Intervention 1||2
2467407|NCT00979654|6049706|P1|NOT COMPLETED|Overall Study||36
2467408|NCT00979654|6049706|P1|COMPLETED|Overall Study||67
2467409|NCT00979654|6049706|P1|STARTED|Overall Study||103
2467410|NCT00979628|6049721|P3|NOT COMPLETED|Overall Study||6
2467411|NCT00979628|6049722|P2|NOT COMPLETED|Overall Study||9
2467412|NCT00979628|6049723|P1|NOT COMPLETED|Overall Study||9
2467413|NCT00979628|6049721|P3|COMPLETED|Overall Study||74
2467414|NCT00979628|6049722|P2|COMPLETED|Overall Study||133
2467415|NCT00979628|6049723|P1|COMPLETED|Overall Study||144
2467416|NCT00979628|6049721|P3|STARTED|Overall Study||80
2467417|NCT00979628|6049722|P2|STARTED|Overall Study||142
2467418|NCT00979628|6049723|P1|STARTED|Overall Study||153
2467419|NCT00979615|6049736|P2|NOT COMPLETED|Overall Study||8
2467420|NCT00979615|6049737|P1|NOT COMPLETED|Overall Study||6
2467421|NCT00979615|6049736|P2|COMPLETED|Overall Study||58
2467422|NCT00979615|6049737|P1|COMPLETED|Overall Study||57
2467423|NCT00979615|6049736|P2|STARTED|Overall Study||66
2467424|NCT00979615|6049737|P1|STARTED|Overall Study||63
2467425|NCT00979602|6049753|P2|NOT COMPLETED|Overall Study||133
2467426|NCT00979602|6049754|P1|NOT COMPLETED|Overall Study||145
2467427|NCT00979602|6049753|P2|COMPLETED|Overall Study||1890
2467428|NCT00979602|6049754|P1|COMPLETED|Overall Study||1880
2467429|NCT00979602|6049753|P2|STARTED|Overall Study||2023
2467430|NCT00979602|6049754|P1|STARTED|Overall Study||2025
2467431|NCT00979576|6049925|P3|NOT COMPLETED|Combination Followed by Monotherapy||1
2467432|NCT00979576|6049926|P2|NOT COMPLETED|Combination Followed by Monotherapy||2
2467433|NCT00979576|6049927|P1|NOT COMPLETED|Combination Followed by Monotherapy||0
2467434|NCT00979576|6049925|P3|COMPLETED|Combination Followed by Monotherapy||0
2467435|NCT00979576|6049926|P2|COMPLETED|Combination Followed by Monotherapy||0
2467436|NCT00979576|6049927|P1|COMPLETED|Combination Followed by Monotherapy||0
2467437|NCT00979576|6049925|P3|STARTED|Combination Followed by Monotherapy||1
2467438|NCT00979576|6049926|P2|STARTED|Combination Followed by Monotherapy||2
2467439|NCT00979576|6049927|P1|STARTED|Combination Followed by Monotherapy||0
2467440|NCT00979576|6049925|P3|NOT COMPLETED|Combination Treatment Phase||9
2467441|NCT00979576|6049926|P2|NOT COMPLETED|Combination Treatment Phase||6
2467442|NCT00979576|6049927|P1|NOT COMPLETED|Combination Treatment Phase||3
2467443|NCT00979576|6049925|P3|COMPLETED|Combination Treatment Phase||0
2467444|NCT00979576|6049926|P2|COMPLETED|Combination Treatment Phase||0
2467445|NCT00979576|6049927|P1|COMPLETED|Combination Treatment Phase||0
2467446|NCT00979576|6049925|P3|STARTED|Combination Treatment Phase||9
2467447|NCT00979576|6049926|P2|STARTED|Combination Treatment Phase||6
2467448|NCT00979576|6049927|P1|STARTED|Combination Treatment Phase||3
2467449|NCT00979550|6049960|P2|NOT COMPLETED|Overall Study||0
2467450|NCT00979550|6049961|P1|NOT COMPLETED|Overall Study||0
2467451|NCT00979550|6049960|P2|COMPLETED|Overall Study||3
2467452|NCT00979550|6049961|P1|COMPLETED|Overall Study||4
2467453|NCT00979550|6049960|P2|STARTED|Overall Study||3
2467454|NCT00979550|6049961|P1|STARTED|Overall Study||4
2467455|NCT00979459|6049967|P2|NOT COMPLETED|Second Intervention||0
2467456|NCT00979459|6049968|P1|NOT COMPLETED|Second Intervention||0
2467457|NCT00979459|6049967|P2|COMPLETED|Second Intervention||6
2467458|NCT00979459|6049968|P1|COMPLETED|Second Intervention||6
2467459|NCT00979459|6049967|P2|STARTED|Second Intervention||6
2467460|NCT00979459|6049968|P1|STARTED|Second Intervention||6
2467461|NCT00979459|6049967|P2|NOT COMPLETED|7-day Washout Period||0
2467462|NCT00979459|6049968|P1|NOT COMPLETED|7-day Washout Period||0
2467463|NCT00979459|6049967|P2|COMPLETED|7-day Washout Period||6
2467464|NCT00979459|6049968|P1|COMPLETED|7-day Washout Period||6
2467465|NCT00979459|6049967|P2|STARTED|7-day Washout Period||6
2467466|NCT00979459|6049968|P1|STARTED|7-day Washout Period||6
2467467|NCT00979459|6049967|P2|NOT COMPLETED|First Intervention||0
2467468|NCT00979459|6049968|P1|NOT COMPLETED|First Intervention||0
2467469|NCT00979459|6049967|P2|COMPLETED|First Intervention||6
2467470|NCT00979459|6049968|P1|COMPLETED|First Intervention||6
2467471|NCT00979459|6049967|P2|STARTED|First Intervention||6
2467472|NCT00979459|6049968|P1|STARTED|First Intervention||6
2467473|NCT00979420|6049984|P4|NOT COMPLETED|Overall Study||2
2467474|NCT00979420|6049985|P3|NOT COMPLETED|Overall Study||1
2467475|NCT00979420|6049986|P2|NOT COMPLETED|Overall Study||0
2467476|NCT00979420|6049987|P1|NOT COMPLETED|Overall Study||7
2467477|NCT00979420|6049984|P4|COMPLETED|Overall Study||59
2467478|NCT00979420|6049985|P3|COMPLETED|Overall Study||59
2467479|NCT00979420|6049986|P2|COMPLETED|Overall Study||57
2467480|NCT00979420|6049987|P1|COMPLETED|Overall Study||171
2467481|NCT00979420|6049984|P4|STARTED|Overall Study||61
2467482|NCT00979420|6049985|P3|STARTED|Overall Study||60
2467483|NCT00979420|6049986|P2|STARTED|Overall Study||57
2467484|NCT00979420|6049987|P1|STARTED|Overall Study||178
2467485|NCT00979407|6050057|P2|NOT COMPLETED|Overall Study||7
2467486|NCT00979407|6050058|P1|NOT COMPLETED|Overall Study||6
2467487|NCT00979407|6050057|P2|COMPLETED|Overall Study||160
2467488|NCT00979407|6050058|P1|COMPLETED|Overall Study||161
2467489|NCT00979407|6050057|P2|STARTED|Overall Study||167
2467490|NCT00979407|6050058|P1|STARTED|Overall Study||167
2467491|NCT00979303|6050100|P2|NOT COMPLETED|Overall Study||0
2467492|NCT00979303|6050101|P1|NOT COMPLETED|Overall Study||0
2467493|NCT00979303|6050100|P2|COMPLETED|Overall Study||37
2467494|NCT00979303|6050101|P1|COMPLETED|Overall Study||37
2467495|NCT00979303|6050100|P2|STARTED|Overall Study||37
2467496|NCT00979303|6050101|P1|STARTED|Overall Study||37
2467497|NCT00979212|6050111|P2|NOT COMPLETED|Overall Study||8
2467498|NCT00979212|6050112|P1|NOT COMPLETED|Overall Study||2
2467499|NCT00979212|6050111|P2|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|39
2467588|NCT00978380|6050374|P1|STARTED|Overall Study||63
2467500|NCT00979212|6050112|P1|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|22
2467501|NCT00979212|6050111|P2|STARTED|Overall Study||47
2467502|NCT00979212|6050112|P1|STARTED|Overall Study||24
2467503|NCT00979199|6050130|P1|NOT COMPLETED|Overall Study||222
2467504|NCT00979199|6050130|P1|COMPLETED|Overall Study||475
2467505|NCT00979199|6050130|P1|STARTED|Overall Study||697
2467506|NCT00979134|6050138|P3|NOT COMPLETED|Overall Study||40
2467507|NCT00979134|6050139|P2|NOT COMPLETED|Overall Study||6
2467508|NCT00979134|6050140|P1|NOT COMPLETED|Overall Study||33
2467509|NCT00979134|6050138|P3|COMPLETED|Overall Study|At DCO|5
2467510|NCT00979134|6050139|P2|COMPLETED|Overall Study|At DCO|0
2467511|NCT00979134|6050140|P1|COMPLETED|Overall Study|At DCO|10
2467512|NCT00979134|6050138|P3|STARTED|Overall Study||45
2467513|NCT00979134|6050139|P2|STARTED|Overall Study||6
2467514|NCT00979134|6050140|P1|STARTED|Overall Study||43
2467515|NCT00979121|6050192|P2|NOT COMPLETED|Overall Study||0
2467516|NCT00979121|6050193|P1|NOT COMPLETED|Overall Study||0
2467517|NCT00979121|6050192|P2|COMPLETED|Overall Study||366
2467518|NCT00979121|6050193|P1|COMPLETED|Overall Study||379
2467519|NCT00979121|6050192|P2|STARTED|Overall Study||366
2467520|NCT00979121|6050193|P1|STARTED|Overall Study||379
2467521|NCT00979069|6050211|P2|NOT COMPLETED|Overall Study||2
2467522|NCT00979069|6050212|P1|NOT COMPLETED|Overall Study||0
2467523|NCT00979069|6050211|P2|COMPLETED|Overall Study||8
2467524|NCT00979069|6050212|P1|COMPLETED|Overall Study||10
2467525|NCT00979069|6050211|P2|STARTED|Overall Study||10
2467526|NCT00979069|6050212|P1|STARTED|Overall Study||10
2467527|NCT00979017|6050218|P1|NOT COMPLETED|Overall Study||0
2467528|NCT00979017|6050218|P1|COMPLETED|Overall Study||41
2467529|NCT00979017|6050218|P1|STARTED|Overall Study||41
2467530|NCT00978757|6050228|P2|NOT COMPLETED|Overall Study||3
2467531|NCT00978757|6050229|P1|NOT COMPLETED|Overall Study||1
2467532|NCT00978757|6050228|P2|COMPLETED|Overall Study|June 2008|17
2467533|NCT00978757|6050229|P1|COMPLETED|Overall Study|June 2008|21
2467534|NCT00978757|6050228|P2|STARTED|Overall Study|June 2001|20
2467535|NCT00978757|6050229|P1|STARTED|Overall Study|June 2001|22
2467536|NCT00978731|6050239|P4|NOT COMPLETED|Overall Study||4
2467537|NCT00978731|6050240|P3|NOT COMPLETED|Overall Study||5
2467538|NCT00978731|6050241|P2|NOT COMPLETED|Overall Study||15
2467539|NCT00978731|6050242|P1|NOT COMPLETED|Overall Study||22
2467540|NCT00978731|6050239|P4|COMPLETED|Overall Study||0
2467541|NCT00978731|6050240|P3|COMPLETED|Overall Study||0
2467542|NCT00978731|6050241|P2|COMPLETED|Overall Study||0
2467543|NCT00978731|6050242|P1|COMPLETED|Overall Study||0
2467544|NCT00978731|6050239|P4|STARTED|Overall Study||4
2467545|NCT00978731|6050240|P3|STARTED|Overall Study||5
2467546|NCT00978731|6050241|P2|STARTED|Overall Study||15
2467547|NCT00978731|6050242|P1|STARTED|Overall Study||22
2467548|NCT00978627|6050282|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||9
2467549|NCT00978627|6050283|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||21
2467550|NCT00978627|6050282|P2|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||113
2467551|NCT00978627|6050283|P1|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||233
2467552|NCT00978627|6050282|P2|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Thirty four subjects from main trial did not continue into extension trial|122
2467553|NCT00978627|6050283|P1|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Sixty six subjects from main trial did not continue into extension trial|254
2467554|NCT00978627|6050282|P2|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||26
2467555|NCT00978627|6050283|P1|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||46
2467556|NCT00978627|6050282|P2|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||156
2467557|NCT00978627|6050283|P1|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||320
2467558|NCT00978627|6050282|P2|Exposed|Main: Week 0 to 26 (NN5401-3594)|Two subjects withdrew prior to exposure to trial products|180
2467559|NCT00978627|6050283|P1|Exposed|Main: Week 0 to 26 (NN5401-3594)|Four subjects withdrew prior to exposure to trial products|362
2467560|NCT00978627|6050282|P2|STARTED|Main: Week 0 to 26 (NN5401-3594)||182
2467561|NCT00978627|6050283|P1|STARTED|Main: Week 0 to 26 (NN5401-3594)||366
2467562|NCT00978562|6050305|P1|NOT COMPLETED|Overall Study||0
2467563|NCT00978562|6050305|P1|COMPLETED|Overall Study||7
2467564|NCT00978562|6050305|P1|STARTED|Overall Study||7
2467565|NCT00978445|6050310|P2|NOT COMPLETED|Overall Study||1
2467566|NCT00978445|6050311|P1|NOT COMPLETED|Overall Study||2
2467567|NCT00978445|6050310|P2|COMPLETED|Overall Study||12
2467568|NCT00978445|6050311|P1|COMPLETED|Overall Study||10
2467569|NCT00978445|6050310|P2|STARTED|Overall Study||13
2467570|NCT00978445|6050311|P1|STARTED|Overall Study||12
2467571|NCT00978432|6050321|P3|NOT COMPLETED|Overall Study||5
2467572|NCT00978432|6050322|P2|NOT COMPLETED|Overall Study||1
2467573|NCT00978432|6050323|P1|NOT COMPLETED|Overall Study||3
2467574|NCT00978432|6050321|P3|COMPLETED|Overall Study||13
2467575|NCT00978432|6050322|P2|COMPLETED|Overall Study||4
2467576|NCT00978432|6050323|P1|COMPLETED|Overall Study||7
2467577|NCT00978432|6050321|P3|STARTED|Overall Study||18
2467578|NCT00978432|6050322|P2|STARTED|Overall Study||5
2467579|NCT00978432|6050323|P1|STARTED|Overall Study||10
2467580|NCT00978419|6050345|P2|NOT COMPLETED|Overall Study||0
2467581|NCT00978419|6050346|P1|NOT COMPLETED|Overall Study||0
2467582|NCT00978419|6050345|P2|COMPLETED|Overall Study||0
2467583|NCT00978419|6050346|P1|COMPLETED|Overall Study||0
2467584|NCT00978419|6050345|P2|STARTED|Overall Study||0
2467585|NCT00978419|6050346|P1|STARTED|Overall Study||0
2467586|NCT00978380|6050374|P1|NOT COMPLETED|Overall Study||19
2467587|NCT00978380|6050374|P1|COMPLETED|Overall Study||44
2467589|NCT00978341|6050380|P2|NOT COMPLETED|Second Intervention||0
2467590|NCT00978341|6050381|P1|NOT COMPLETED|Second Intervention||0
2467591|NCT00978341|6050380|P2|COMPLETED|Second Intervention||7
2467592|NCT00978341|6050381|P1|COMPLETED|Second Intervention||7
2467593|NCT00978341|6050380|P2|STARTED|Second Intervention||7
2467594|NCT00978341|6050381|P1|STARTED|Second Intervention||7
2467595|NCT00978341|6050380|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
2467596|NCT00978341|6050381|P1|NOT COMPLETED|Washout Period of 2 Weeks||1
2467597|NCT00978341|6050380|P2|COMPLETED|Washout Period of 2 Weeks||7
2467598|NCT00978341|6050381|P1|COMPLETED|Washout Period of 2 Weeks||7
2467599|NCT00978341|6050380|P2|STARTED|Washout Period of 2 Weeks||7
2467600|NCT00978341|6050381|P1|STARTED|Washout Period of 2 Weeks||8
2467601|NCT00978341|6050380|P2|NOT COMPLETED|First Intervention||0
2467602|NCT00978341|6050381|P1|NOT COMPLETED|First Intervention||0
2467603|NCT00978341|6050380|P2|COMPLETED|First Intervention||7
2467604|NCT00978341|6050381|P1|COMPLETED|First Intervention||8
2467605|NCT00978341|6050380|P2|STARTED|First Intervention||7
2467606|NCT00978341|6050381|P1|STARTED|First Intervention||8
2467607|NCT00978250|6050403|P4|NOT COMPLETED|Overall Study||1
2467608|NCT00978250|6050404|P3|NOT COMPLETED|Overall Study||0
2467609|NCT00978250|6050405|P2|NOT COMPLETED|Overall Study||1
2467610|NCT00978250|6050406|P1|NOT COMPLETED|Overall Study||0
2467611|NCT00978250|6050403|P4|COMPLETED|Overall Study||21
2467612|NCT00978250|6050404|P3|COMPLETED|Overall Study||18
2467613|NCT00978250|6050405|P2|COMPLETED|Overall Study||29
2467614|NCT00978250|6050406|P1|COMPLETED|Overall Study||25
2467615|NCT00978250|6050403|P4|STARTED|Overall Study||22
2467616|NCT00978250|6050404|P3|STARTED|Overall Study||18
2467617|NCT00978250|6050405|P2|STARTED|Overall Study||30
2467618|NCT00978250|6050406|P1|STARTED|Overall Study||25
2467619|NCT00978120|6050422|P4|NOT COMPLETED|Overall Study||2
2467620|NCT00978120|6050423|P3|NOT COMPLETED|Overall Study||3
2467621|NCT00978120|6050424|P2|NOT COMPLETED|Overall Study||0
2467622|NCT00978120|6050425|P1|NOT COMPLETED|Overall Study||2
2467623|NCT00978120|6050422|P4|COMPLETED|Overall Study||84
2467624|NCT00978120|6050423|P3|COMPLETED|Overall Study||84
2467625|NCT00978120|6050424|P2|COMPLETED|Overall Study||107
2467626|NCT00978120|6050425|P1|COMPLETED|Overall Study||108
2467627|NCT00978120|6050422|P4|STARTED|Overall Study||86
2467628|NCT00978120|6050423|P3|STARTED|Overall Study||87
2467629|NCT00978120|6050424|P2|STARTED|Overall Study||107
2467630|NCT00978120|6050425|P1|STARTED|Overall Study||110
2467631|NCT00978068|6050477|P2|NOT COMPLETED|Overall Study||9
2467632|NCT00978068|6050478|P1|NOT COMPLETED|Overall Study||4
2467633|NCT00978068|6050477|P2|COMPLETED|Overall Study||80
2467634|NCT00978068|6050478|P1|COMPLETED|Overall Study||83
2467635|NCT00978068|6050477|P2|Initiated Study Drugs|Overall Study||86
2467636|NCT00978068|6050478|P1|Initiated Study Drugs|Overall Study||84
2467637|NCT00978068|6050477|P2|STARTED|Overall Study||89
2467638|NCT00978068|6050478|P1|STARTED|Overall Study||87
2467639|NCT00978042|6050496|P2|NOT COMPLETED|Received Repeat Treatment||3
2467640|NCT00978042|6050497|P1|NOT COMPLETED|Received Repeat Treatment||43
2467641|NCT00978042|6050496|P2|COMPLETED|Received Repeat Treatment||23
2467642|NCT00978042|6050497|P1|COMPLETED|Received Repeat Treatment|Completed=Completed Repeat Treatment Follow-up|98
2467643|NCT00978042|6050496|P2|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|26
2467644|NCT00978042|6050497|P1|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|141
2467645|NCT00978042|6050496|P2|NOT COMPLETED|Initial Treatment Period||15
2467646|NCT00978042|6050497|P1|NOT COMPLETED|Initial Treatment Period||61
2467647|NCT00978042|6050496|P2|COMPLETED|Initial Treatment Period||32
2467648|NCT00978042|6050497|P1|COMPLETED|Initial Treatment Period|Completed 24-month Follow-Up|174
2467649|NCT00978042|6050496|P2|MITT_treated With VOLUMA XC|Initial Treatment Period||35
2467650|NCT00978042|6050497|P1|MITT_treated With VOLUMA XC|Initial Treatment Period||235
2467651|NCT00978042|6050496|P2|STARTED|Initial Treatment Period||47
2467652|NCT00978042|6050497|P1|STARTED|Initial Treatment Period||235
2467653|NCT00978029|6050510|P3|NOT COMPLETED|Overall Study||6
2467654|NCT00978029|6050511|P2|NOT COMPLETED|Overall Study||3
2467655|NCT00978029|6050512|P1|NOT COMPLETED|Overall Study||1
2467656|NCT00978029|6050510|P3|COMPLETED|Overall Study||59
2467657|NCT00978029|6050511|P2|COMPLETED|Overall Study||63
2467658|NCT00978029|6050512|P1|COMPLETED|Overall Study||64
2467659|NCT00978029|6050510|P3|STARTED|Overall Study||65
2467660|NCT00978029|6050511|P2|STARTED|Overall Study||66
2467661|NCT00978029|6050512|P1|STARTED|Overall Study||65
2467662|NCT00977938|6050539|P4|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||3
2467663|NCT00977938|6050540|P3|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||12
2467664|NCT00977938|6050541|P2|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||58
2467665|NCT00977938|6050542|P1|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||51
2467666|NCT00977938|6050539|P4|COMPLETED|Observation (30-33 mo. Post Procedure)||781
2467667|NCT00977938|6050540|P3|COMPLETED|Observation (30-33 mo. Post Procedure)||784
2467668|NCT00977938|6050541|P2|COMPLETED|Observation (30-33 mo. Post Procedure)||4658
2467669|NCT00977938|6050542|P1|COMPLETED|Observation (30-33 mo. Post Procedure)||4732
2467670|NCT00977938|6050539|P4|STARTED|Observation (30-33 mo. Post Procedure)||784
2467671|NCT00977938|6050540|P3|STARTED|Observation (30-33 mo. Post Procedure)||796
2467672|NCT00977938|6050541|P2|STARTED|Observation (30-33 mo. Post Procedure)||4716
2467673|NCT00977938|6050542|P1|STARTED|Observation (30-33 mo. Post Procedure)||4783
2467674|NCT00977938|6050539|P4|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||61
2467675|NCT00977938|6050540|P3|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||46
2467676|NCT00977938|6050541|P2|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||225
2467677|NCT00977938|6050542|P1|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||237
2467678|NCT00977938|6050539|P4|COMPLETED|Treatment (12-30 mo. Post Procedure)||784
2467679|NCT00977938|6050540|P3|COMPLETED|Treatment (12-30 mo. Post Procedure)||796
2467680|NCT00977938|6050541|P2|COMPLETED|Treatment (12-30 mo. Post Procedure)||4716
2467681|NCT00977938|6050542|P1|COMPLETED|Treatment (12-30 mo. Post Procedure)||4783
2467682|NCT00977938|6050539|P4|STARTED|Treatment (12-30 mo. Post Procedure)||845
2467683|NCT00977938|6050540|P3|STARTED|Treatment (12-30 mo. Post Procedure)||842
2467684|NCT00977938|6050541|P2|STARTED|Treatment (12-30 mo. Post Procedure)||4941
2467685|NCT00977938|6050542|P1|STARTED|Treatment (12-30 mo. Post Procedure)||5020
2467686|NCT00977808|6050576|P1|NOT COMPLETED|Overall Study||1
2467687|NCT00977808|6050576|P1|COMPLETED|Overall Study||11
2467688|NCT00977808|6050576|P1|Completion of Closed-Loop Admission|Overall Study||11
2467689|NCT00977808|6050576|P1|Completion of Open-Loop Admission|Overall Study||12
2467690|NCT00977808|6050576|P1|STARTED|Overall Study||12
2467691|NCT00977769|6050584|P3|NOT COMPLETED|Overall Study||0
2467692|NCT00977769|6050585|P2|NOT COMPLETED|Overall Study||0
2467693|NCT00977769|6050586|P1|NOT COMPLETED|Overall Study||0
2467694|NCT00977769|6050584|P3|COMPLETED|Overall Study||25
2467695|NCT00977769|6050585|P2|COMPLETED|Overall Study||26
2467696|NCT00977769|6050586|P1|COMPLETED|Overall Study||25
2467697|NCT00977769|6050584|P3|STARTED|Overall Study||25
2467698|NCT00977769|6050585|P2|STARTED|Overall Study||26
2467699|NCT00977769|6050586|P1|STARTED|Overall Study||25
2467700|NCT00977704|6050600|P1|NOT COMPLETED|Overall Study||0
2467701|NCT00977704|6050600|P1|COMPLETED|Overall Study||20
2467702|NCT00977704|6050600|P1|STARTED|Overall Study||20
2467703|NCT00977691|6050607|P3|NOT COMPLETED|Overall Study||0
2467704|NCT00977691|6050608|P2|NOT COMPLETED|Overall Study||1
2467705|NCT00977691|6050609|P1|NOT COMPLETED|Overall Study||0
2467706|NCT00977691|6050607|P3|COMPLETED|Overall Study||12
2467707|NCT00977691|6050608|P2|COMPLETED|Overall Study||7
2467708|NCT00977691|6050609|P1|COMPLETED|Overall Study||3
2467709|NCT00977691|6050607|P3|STARTED|Overall Study||12
2467710|NCT00977691|6050608|P2|STARTED|Overall Study||8
2467711|NCT00977691|6050609|P1|STARTED|Overall Study||3
2467712|NCT00977665|6050619|P2|NOT COMPLETED|Overall Study||15
2467713|NCT00977665|6050620|P1|NOT COMPLETED|Overall Study||21
2467714|NCT00977665|6050619|P2|COMPLETED|Overall Study||75
2467715|NCT00977665|6050620|P1|COMPLETED|Overall Study||63
2467716|NCT00977665|6050619|P2|STARTED|Overall Study||90
2467717|NCT00977665|6050620|P1|STARTED|Overall Study||84
2467718|NCT00977613|6050652|P1|NOT COMPLETED|Overall Study||16
2467719|NCT00977613|6050652|P1|COMPLETED|Overall Study||34
2467720|NCT00977613|6050652|P1|STARTED|Overall Study||50
2467721|NCT00977574|6050659|P3|NOT COMPLETED|Overall Study||4
2467722|NCT00977574|6050660|P2|NOT COMPLETED|Overall Study||2
2467723|NCT00977574|6050661|P1|NOT COMPLETED|Overall Study||4
2467724|NCT00977574|6050659|P3|COMPLETED|Overall Study||114
2467725|NCT00977574|6050660|P2|COMPLETED|Overall Study||113
2467726|NCT00977574|6050661|P1|COMPLETED|Overall Study||112
2467727|NCT00977574|6050659|P3|STARTED|Overall Study||118
2467728|NCT00977574|6050660|P2|STARTED|Overall Study||115
2467729|NCT00977574|6050661|P1|STARTED|Overall Study||116
2467730|NCT00977561|6050680|P2|NOT COMPLETED|Overall Study||4
2467731|NCT00977561|6050681|P1|NOT COMPLETED|Overall Study||5
2467732|NCT00977561|6050680|P2|COMPLETED|Overall Study||0
2467733|NCT00977561|6050681|P1|COMPLETED|Overall Study||0
2467734|NCT00977561|6050680|P2|STARTED|Overall Study||4
2467735|NCT00977561|6050681|P1|STARTED|Overall Study||5
2467736|NCT00977548|6050708|P1|NOT COMPLETED|Overall Study||13
2467737|NCT00977548|6050708|P1|COMPLETED|Overall Study||26
2467738|NCT00977548|6050708|P1|STARTED|Overall Study||39
2467739|NCT00977470|6050717|P2|NOT COMPLETED|Overall Study||38
2467740|NCT00977470|6050718|P1|NOT COMPLETED|Overall Study||38
2467741|NCT00977470|6050717|P2|COMPLETED|Overall Study||0
2467742|NCT00977470|6050718|P1|COMPLETED|Overall Study||0
2467743|NCT00977470|6050717|P2|STARTED|Overall Study||38
2467744|NCT00977470|6050718|P1|STARTED|Overall Study||38
2467745|NCT00977431|6050741|P5|NOT COMPLETED|Overall Study||13
2467746|NCT00977431|6050742|P4|NOT COMPLETED|Overall Study||3
2467747|NCT00977431|6050743|P3|NOT COMPLETED|Overall Study||7
2467748|NCT00977431|6050744|P2|NOT COMPLETED|Overall Study||6
2467749|NCT00977431|6050745|P1|NOT COMPLETED|Overall Study||7
2467750|NCT00977431|6050741|P5|COMPLETED|Overall Study||0
2467751|NCT00977431|6050742|P4|COMPLETED|Overall Study||0
2467752|NCT00977431|6050743|P3|COMPLETED|Overall Study||0
2467753|NCT00977431|6050744|P2|COMPLETED|Overall Study||0
2467754|NCT00977431|6050745|P1|COMPLETED|Overall Study||0
2467755|NCT00977431|6050741|P5|Discontinued Afatinib Before/on Day 42|Overall Study||3
2467756|NCT00977431|6050742|P4|Discontinued Afatinib Before/on Day 42|Overall Study||0
2467757|NCT00977431|6050743|P3|Discontinued Afatinib Before/on Day 42|Overall Study||4
2467758|NCT00977431|6050744|P2|Discontinued Afatinib Before/on Day 42|Overall Study||0
2467759|NCT00977431|6050745|P1|Discontinued Afatinib Before/on Day 42|Overall Study||1
2467760|NCT00977431|6050741|P5|STARTED|Overall Study||13
2467761|NCT00977431|6050742|P4|STARTED|Overall Study||3
2467762|NCT00977431|6050743|P3|STARTED|Overall Study||7
2467763|NCT00977431|6050744|P2|STARTED|Overall Study||6
2467764|NCT00977431|6050745|P1|STARTED|Overall Study||7
2467765|NCT00977379|6050778|P2|NOT COMPLETED|Overall Study||12
2467766|NCT00977379|6050779|P1|NOT COMPLETED|Overall Study||12
2467767|NCT00977379|6050778|P2|COMPLETED|Overall Study||0
2467768|NCT00977379|6050779|P1|COMPLETED|Overall Study||0
2467769|NCT00977379|6050778|P2|Treated|Overall Study||11
2467770|NCT00977379|6050779|P1|Treated|Overall Study||12
2467771|NCT00977379|6050778|P2|STARTED|Overall Study|Randomized|12
2467772|NCT00977379|6050779|P1|STARTED|Overall Study|Randomized|12
2467773|NCT00977314|6050815|P2|NOT COMPLETED|Overall Study||0
2467774|NCT00977314|6050816|P1|NOT COMPLETED|Overall Study||2
2467775|NCT00977314|6050815|P2|COMPLETED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
2467776|NCT00977314|6050816|P1|COMPLETED|Overall Study||28
2467777|NCT00977314|6050815|P2|STARTED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
2467778|NCT00977314|6050816|P1|STARTED|Overall Study||30
2467779|NCT00977197|6050824|P2|NOT COMPLETED|Overall Study||9
2467780|NCT00977197|6050825|P1|NOT COMPLETED|Overall Study||9
2467781|NCT00977197|6050824|P2|COMPLETED|Overall Study||35
2467782|NCT00977197|6050825|P1|COMPLETED|Overall Study||32
2467783|NCT00977197|6050824|P2|STARTED|Overall Study||44
2467784|NCT00977197|6050825|P1|STARTED|Overall Study||41
2467785|NCT00977184|6050855|P2|NOT COMPLETED|Overall Study||0
2467786|NCT00977184|6050856|P1|NOT COMPLETED|Overall Study||0
2467787|NCT00977184|6050855|P2|COMPLETED|Overall Study||13
2467788|NCT00977184|6050856|P1|COMPLETED|Overall Study||13
2467789|NCT00977184|6050855|P2|STARTED|Overall Study||13
2467790|NCT00977184|6050856|P1|STARTED|Overall Study||13
2467791|NCT00977171|6050882|P1|NOT COMPLETED|Overall Study||0
2467792|NCT00977171|6050882|P1|COMPLETED|Overall Study||3
2467793|NCT00977171|6050882|P1|STARTED|Overall Study||3
2467794|NCT00977106|6050888|P2|NOT COMPLETED|Overall Study||11
2467795|NCT00977106|6050889|P1|NOT COMPLETED|Overall Study||10
2467796|NCT00977106|6050888|P2|COMPLETED|Overall Study||45
2467797|NCT00977106|6050889|P1|COMPLETED|Overall Study||37
2467798|NCT00977106|6050888|P2|STARTED|Overall Study|Includes 3 participants who were randomized to placebo, but received tocilizumab.|56
2467799|NCT00977106|6050889|P1|STARTED|Overall Study||47
2467800|NCT00977080|6050981|P4|NOT COMPLETED|Overall Study||17
2467801|NCT00977080|6050982|P3|NOT COMPLETED|Overall Study||16
2467802|NCT00977080|6050983|P2|NOT COMPLETED|Overall Study||20
2467803|NCT00977080|6050984|P1|NOT COMPLETED|Overall Study||12
2467804|NCT00977080|6050981|P4|COMPLETED|Overall Study||53
2467805|NCT00977080|6050982|P3|COMPLETED|Overall Study||56
2467806|NCT00977080|6050983|P2|COMPLETED|Overall Study||44
2467807|NCT00977080|6050984|P1|COMPLETED|Overall Study||50
2467808|NCT00977080|6050981|P4|STARTED|Overall Study||70
2467809|NCT00977080|6050982|P3|STARTED|Overall Study||72
2467810|NCT00977080|6050983|P2|STARTED|Overall Study||64
2467811|NCT00977080|6050984|P1|STARTED|Overall Study||62
2467812|NCT00976989|6051017|P3|NOT COMPLETED|Overall Study||17
2467813|NCT00976989|6051018|P2|NOT COMPLETED|Overall Study||12
2467814|NCT00976989|6051019|P1|NOT COMPLETED|Overall Study||13
2467815|NCT00976989|6051017|P3|COMPLETED|Overall Study||60
2467816|NCT00976989|6051018|P2|COMPLETED|Overall Study||63
2467817|NCT00976989|6051019|P1|COMPLETED|Overall Study||60
2467818|NCT00976989|6051017|P3|STARTED|Overall Study||77
2467819|NCT00976989|6051018|P2|STARTED|Overall Study||75
2467820|NCT00976989|6051019|P1|STARTED|Overall Study||73
2467821|NCT00976950|6051060|P1|NOT COMPLETED|Overall Study||6
2467822|NCT00976950|6051060|P1|COMPLETED|Overall Study||36
2467823|NCT00976950|6051060|P1|STARTED|Overall Study||42
2467824|NCT00976937|6051068|P2|NOT COMPLETED|Overall Study||11
2467825|NCT00976937|6051069|P1|NOT COMPLETED|Overall Study||16
2467826|NCT00976937|6051068|P2|COMPLETED|Overall Study||150
2467827|NCT00976937|6051069|P1|COMPLETED|Overall Study||142
2467828|NCT00976937|6051068|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||161
2467829|NCT00976937|6051069|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All randomized patients who received at least 1 dose of study drug.|158
2467830|NCT00976937|6051068|P2|Treated/Safety Population|Overall Study||161
2467831|NCT00976937|6051069|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|158
2467832|NCT00976937|6051068|P2|STARTED|Overall Study||161
2467833|NCT00976937|6051069|P1|STARTED|Overall Study|Randomized|158
2467834|NCT00976911|6051111|P2|NOT COMPLETED|Overall Study||179
2467835|NCT00976911|6051112|P1|NOT COMPLETED|Overall Study||182
2467836|NCT00976911|6051111|P2|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
2467837|NCT00976911|6051112|P1|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
2467838|NCT00976911|6051111|P2|STARTED|Overall Study||179
2467839|NCT00976911|6051112|P1|STARTED|Overall Study||182
2467840|NCT00976898|6051130|P1|NOT COMPLETED|Overall Study||5
2467841|NCT00976898|6051130|P1|COMPLETED|Overall Study||78
2467842|NCT00976898|6051130|P1|STARTED|Overall Study||83
2467843|NCT00976820|6051141|P4|NOT COMPLETED|Overall Study||7
2467844|NCT00976820|6051142|P3|NOT COMPLETED|Overall Study||4
2467845|NCT00976820|6051143|P2|NOT COMPLETED|Overall Study||20
2467846|NCT00976820|6051144|P1|NOT COMPLETED|Overall Study||8
2467847|NCT00976820|6051141|P4|COMPLETED|Overall Study||56
2467848|NCT00976820|6051142|P3|COMPLETED|Overall Study||60
2467849|NCT00976820|6051143|P2|COMPLETED|Overall Study||108
2467850|NCT00976820|6051144|P1|COMPLETED|Overall Study||59
2467851|NCT00976820|6051141|P4|STARTED|Overall Study||63
2467852|NCT00976820|6051142|P3|STARTED|Overall Study||64
2467853|NCT00976820|6051143|P2|STARTED|Overall Study||128
2467854|NCT00976820|6051144|P1|STARTED|Overall Study||67
2467855|NCT00976716|6051480|P1|NOT COMPLETED|Overall Study||1
2467856|NCT00976716|6051480|P1|COMPLETED|Overall Study||79
2467857|NCT00976716|6051480|P1|STARTED|Overall Study||80
2467858|NCT00976703|6051498|P2|NOT COMPLETED|Overall Study||3
2467859|NCT00976703|6051499|P1|NOT COMPLETED|Overall Study||3
2467860|NCT00976703|6051498|P2|COMPLETED|Overall Study||95
2467861|NCT00976703|6051499|P1|COMPLETED|Overall Study||96
2467862|NCT00976703|6051498|P2|STARTED|Overall Study||98
2467863|NCT00976703|6051499|P1|STARTED|Overall Study||99
2467864|NCT00976677|6051513|P2|NOT COMPLETED|Overall Study||5
2467865|NCT00976677|6051514|P1|NOT COMPLETED|Overall Study||5
2467866|NCT00976677|6051513|P2|COMPLETED|Overall Study||0
2467867|NCT00976677|6051514|P1|COMPLETED|Overall Study||0
2467868|NCT00976677|6051513|P2|STARTED|Overall Study||5
2467869|NCT00976677|6051514|P1|STARTED|Overall Study||5
2467870|NCT00976664|6051522|P2|NOT COMPLETED|Overall Study||1
2467871|NCT00976664|6051523|P1|NOT COMPLETED|Overall Study||3
2467872|NCT00976664|6051522|P2|COMPLETED|Overall Study||24
2467873|NCT00976664|6051523|P1|COMPLETED|Overall Study||22
2467874|NCT00976664|6051522|P2|STARTED|Overall Study||25
2467875|NCT00976664|6051523|P1|STARTED|Overall Study||25
2467876|NCT00976599|6051533|P2|NOT COMPLETED|Overall Study||0
2467877|NCT00976599|6051534|P1|NOT COMPLETED|Overall Study||0
2467878|NCT00976599|6051533|P2|COMPLETED|Overall Study||14
2467879|NCT00976599|6051534|P1|COMPLETED|Overall Study||15
2467880|NCT00976599|6051533|P2|STARTED|Overall Study||14
2467881|NCT00976599|6051534|P1|STARTED|Overall Study||15
2467882|NCT00976573|6051722|P2|NOT COMPLETED|Overall Study||3
2467883|NCT00976573|6051723|P1|NOT COMPLETED|Overall Study||4
2467884|NCT00976573|6051722|P2|COMPLETED|Overall Study||71
2467885|NCT00976573|6051723|P1|COMPLETED|Overall Study||71
2467886|NCT00976573|6051722|P2|STARTED|Overall Study||74
2467887|NCT00976573|6051723|P1|STARTED|Overall Study||75
2467888|NCT00976560|6051737|P2|NOT COMPLETED|Overall Study||13
2467889|NCT00976560|6051738|P1|NOT COMPLETED|Overall Study||14
2467890|NCT00976560|6051737|P2|COMPLETED|Overall Study||51
2467891|NCT00976560|6051738|P1|COMPLETED|Overall Study||50
2467892|NCT00976560|6051737|P2|STARTED|Overall Study||64
2467893|NCT00976560|6051738|P1|STARTED|Overall Study||64
2467894|NCT00976521|6051790|P4|NOT COMPLETED|Overall Study||19
2467895|NCT00976521|6051791|P3|NOT COMPLETED|Overall Study||9
2467896|NCT00976521|6051792|P2|NOT COMPLETED|Overall Study||12
2467897|NCT00976521|6051793|P1|NOT COMPLETED|Overall Study||9
2467898|NCT00976521|6051790|P4|COMPLETED|Overall Study||93
2467899|NCT00976521|6051791|P3|COMPLETED|Overall Study||102
2467900|NCT00976521|6051792|P2|COMPLETED|Overall Study||99
2467901|NCT00976521|6051793|P1|COMPLETED|Overall Study||109
2467902|NCT00976521|6051790|P4|STARTED|Overall Study||112
2467903|NCT00976521|6051791|P3|STARTED|Overall Study||111
2467904|NCT00976521|6051792|P2|STARTED|Overall Study||111
2467905|NCT00976521|6051793|P1|STARTED|Overall Study||118
2467906|NCT00976508|6051807|P2|NOT COMPLETED|Overall Study||6
2467907|NCT00976508|6051808|P1|NOT COMPLETED|Overall Study||14
2467908|NCT00976508|6051807|P2|COMPLETED|Overall Study||0
2467909|NCT00976508|6051808|P1|COMPLETED|Overall Study|These subjects withdrew from last study treatment due to progressive disease.|3
2467910|NCT00976508|6051807|P2|STARTED|Overall Study||6
2467911|NCT00976508|6051808|P1|STARTED|Overall Study|18 subjects were enrolled; 17 subjects were treated; 1 subject was not eligible.|17
2467912|NCT00976495|6051841|P3|NOT COMPLETED|Overall Study||0
2467913|NCT00976495|6051842|P2|NOT COMPLETED|Overall Study||1
2467914|NCT00976495|6051843|P1|NOT COMPLETED|Overall Study||0
2467915|NCT00976495|6051841|P3|COMPLETED|Overall Study||26
2467916|NCT00976495|6051842|P2|COMPLETED|Overall Study||23
2467917|NCT00976495|6051843|P1|COMPLETED|Overall Study||25
2467918|NCT00976495|6051841|P3|STARTED|Overall Study||26
2467919|NCT00976495|6051842|P2|STARTED|Overall Study||24
2467920|NCT00976495|6051843|P1|STARTED|Overall Study||25
2467921|NCT00976482|6051860|P1|NOT COMPLETED|Overall Study||259
2467922|NCT00976482|6051860|P1|COMPLETED|Overall Study||1486
2467923|NCT00976482|6051860|P1|Eligible for Last Follow up|Overall Study||1487
2467924|NCT00976482|6051860|P1|STARTED|Overall Study||1745
2467925|NCT00976456|6051866|P2|NOT COMPLETED|Overall Study||38
2467926|NCT00976456|6051867|P1|NOT COMPLETED|Overall Study||43
2467927|NCT00976456|6051866|P2|COMPLETED|Overall Study||98
2467928|NCT00976456|6051867|P1|COMPLETED|Overall Study||92
2467929|NCT00976456|6051866|P2|STARTED|Overall Study||136
2467930|NCT00976456|6051867|P1|STARTED|Overall Study||135
2467931|NCT00976404|6051877|P2|NOT COMPLETED|Overall Study||0
2467932|NCT00976404|6051878|P1|NOT COMPLETED|Overall Study||0
2467933|NCT00976404|6051877|P2|COMPLETED|Overall Study||14
2467934|NCT00976404|6051878|P1|COMPLETED|Overall Study||14
2467935|NCT00976404|6051877|P2|STARTED|Overall Study||14
2467936|NCT00976404|6051878|P1|STARTED|Overall Study||14
2467937|NCT00976391|6051894|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||34
2467938|NCT00976391|6051895|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||29
2467939|NCT00976391|6051894|P2|COMPLETED|Follow-up Period (8 Weeks)||247
2467940|NCT00976391|6051895|P1|COMPLETED|Follow-up Period (8 Weeks)||256
2467941|NCT00976391|6051894|P2|STARTED|Follow-up Period (8 Weeks)||281
2467942|NCT00976391|6051895|P1|STARTED|Follow-up Period (8 Weeks)||285
2467943|NCT00976391|6051894|P2|NOT COMPLETED|Treatment Period (52 Weeks)||39
2467944|NCT00976391|6051895|P1|NOT COMPLETED|Treatment Period (52 Weeks)||42
2467945|NCT00976391|6051894|P2|COMPLETED|Treatment Period (52 Weeks)||242
2467946|NCT00976391|6051895|P1|COMPLETED|Treatment Period (52 Weeks)||243
2467947|NCT00976391|6051894|P2|STARTED|Treatment Period (52 Weeks)||281
2467948|NCT00976391|6051895|P1|STARTED|Treatment Period (52 Weeks)||285
2467949|NCT00976352|6051917|P2|NOT COMPLETED|Overall Study||4
2467950|NCT00976352|6051918|P1|NOT COMPLETED|Overall Study||0
2467951|NCT00976352|6051917|P2|COMPLETED|Overall Study|Last evaluation of last subject in cohort.|6
2467952|NCT00976352|6051918|P1|COMPLETED|Overall Study||3
2467953|NCT00976352|6051917|P2|STARTED|Overall Study||10
2467954|NCT00976352|6051918|P1|STARTED|Overall Study||3
2467955|NCT00976339|6051932|P2|NOT COMPLETED|Overall Study||0
2467956|NCT00976339|6051933|P1|NOT COMPLETED|Overall Study||0
2467957|NCT00976339|6051932|P2|COMPLETED|Overall Study||10
2467958|NCT00976339|6051933|P1|COMPLETED|Overall Study||10
2467959|NCT00976339|6051932|P2|STARTED|Overall Study||10
2467960|NCT00976339|6051933|P1|STARTED|Overall Study||10
2467961|NCT00976274|6051943|P2|NOT COMPLETED|Overall Study||8
2467962|NCT00976274|6051944|P1|NOT COMPLETED|Overall Study||7
2467963|NCT00976274|6051943|P2|COMPLETED|Overall Study||21
2467964|NCT00976274|6051944|P1|COMPLETED|Overall Study||24
2467965|NCT00976274|6051943|P2|STARTED|Overall Study||29
2467966|NCT00976274|6051944|P1|STARTED|Overall Study||31
2467967|NCT00976248|6051952|P1|NOT COMPLETED|Overall Study||0
2467968|NCT00976248|6051952|P1|COMPLETED|Overall Study||33
2467969|NCT00976248|6051952|P1|STARTED|Overall Study||33
2467970|NCT00976209|6051960|P2|NOT COMPLETED|Treatment Period 2||2
2467971|NCT00976209|6051961|P1|NOT COMPLETED|Treatment Period 2||0
2467972|NCT00976209|6051960|P2|COMPLETED|Treatment Period 2||161
2467973|NCT00976209|6051961|P1|COMPLETED|Treatment Period 2||158
2467974|NCT00976209|6051960|P2|STARTED|Treatment Period 2||163
2467975|NCT00976209|6051961|P1|STARTED|Treatment Period 2||158
2467976|NCT00976209|6051960|P2|NOT COMPLETED|Wash-out Period||2
2467977|NCT00976209|6051961|P1|NOT COMPLETED|Wash-out Period||4
2467978|NCT00976209|6051960|P2|COMPLETED|Wash-out Period||163
2467979|NCT00976209|6051961|P1|COMPLETED|Wash-out Period||158
2467980|NCT00976209|6051960|P2|STARTED|Wash-out Period||165
2467981|NCT00976209|6051961|P1|STARTED|Wash-out Period||162
2467982|NCT00976209|6051960|P2|NOT COMPLETED|Treatment Period 1||1
2467983|NCT00976209|6051961|P1|NOT COMPLETED|Treatment Period 1||3
2467984|NCT00976209|6051960|P2|COMPLETED|Treatment Period 1||165
2467985|NCT00976209|6051961|P1|COMPLETED|Treatment Period 1||162
2467986|NCT00976209|6051960|P2|STARTED|Treatment Period 1||166
2467987|NCT00976209|6051961|P1|STARTED|Treatment Period 1||165
2467988|NCT00976183|6051967|P1|NOT COMPLETED|Overall Study||0
2467989|NCT00976183|6051967|P1|COMPLETED|Overall Study|The study was closed on 05/30/12 due to adverse events. We did not complete enrollment|18
2467990|NCT00976183|6051967|P1|STARTED|Overall Study||18
2467991|NCT00976027|6051974|P2|NOT COMPLETED|Overall Study||215
2467992|NCT00976027|6051975|P1|NOT COMPLETED|Overall Study||411
2467993|NCT00976027|6051974|P2|COMPLETED|Overall Study||2835
2467994|NCT00976027|6051975|P1|COMPLETED|Overall Study||5697
2467995|NCT00976027|6051974|P2|STARTED|Overall Study||3050
2467996|NCT00976027|6051975|P1|STARTED|Overall Study||6108
2467997|NCT00975975|6051987|P1|NOT COMPLETED|Overall Study||6
2467998|NCT00975975|6051987|P1|COMPLETED|Overall Study||11
2467999|NCT00975975|6051987|P1|STARTED|Overall Study||17
2468000|NCT00975923|6051995|P2|NOT COMPLETED|Overall Study||1
2468001|NCT00975923|6051996|P1|NOT COMPLETED|Overall Study||0
2468002|NCT00975923|6051995|P2|COMPLETED|Overall Study|1 hospital was sold, yielding 29 hospitals in the Tool Kit Group|29
2468003|NCT00975923|6051996|P1|COMPLETED|Overall Study||30
2468004|NCT00975923|6051995|P2|STARTED|Overall Study||30
2468005|NCT00975923|6051996|P1|STARTED|Overall Study||30
2468006|NCT00975884|6052006|P2|NOT COMPLETED|Overall Study||15
2468007|NCT00975884|6052007|P1|NOT COMPLETED|Overall Study||16
2468008|NCT00975884|6052006|P2|COMPLETED|Overall Study||107
2468009|NCT00975884|6052007|P1|COMPLETED|Overall Study||168
2468010|NCT00975884|6052006|P2|STARTED|Overall Study||122
2468011|NCT00975884|6052007|P1|STARTED|Overall Study||184
2468012|NCT00975806|6052164|P3|NOT COMPLETED|Overall Study||4
2468013|NCT00975806|6052165|P2|NOT COMPLETED|Overall Study||7
2468014|NCT00975806|6052166|P1|NOT COMPLETED|Overall Study||5
2468015|NCT00975806|6052164|P3|COMPLETED|Overall Study|Participants were prematurely discontinued|0
2468016|NCT00975806|6052165|P2|COMPLETED|Overall Study|Participants were prematurely discontinued|0
2468017|NCT00975806|6052166|P1|COMPLETED|Overall Study|Participants were prematurely discontinued|0
2468018|NCT00975806|6052164|P3|STARTED|Overall Study||4
2468019|NCT00975806|6052165|P2|STARTED|Overall Study||7
2468020|NCT00975806|6052166|P1|STARTED|Overall Study||5
2468021|NCT00975780|6052190|P2|NOT COMPLETED|Follow Up||157
2468022|NCT00975780|6052191|P1|NOT COMPLETED|Follow Up||102
2468023|NCT00975780|6052190|P2|COMPLETED|Follow Up||277
2468024|NCT00975780|6052191|P1|COMPLETED|Follow Up||298
2468025|NCT00975780|6052190|P2|STARTED|Follow Up||434
2468026|NCT00975780|6052191|P1|STARTED|Follow Up||400
2468027|NCT00975780|6052190|P2|NOT COMPLETED|Allocation||0
2468028|NCT00975780|6052191|P1|NOT COMPLETED|Allocation||0
2468029|NCT00975780|6052190|P2|COMPLETED|Allocation||434
2468030|NCT00975780|6052191|P1|COMPLETED|Allocation||400
2468031|NCT00975780|6052190|P2|STARTED|Allocation||434
2468032|NCT00975780|6052191|P1|STARTED|Allocation||400
2468033|NCT00975715|6052201|P2|NOT COMPLETED|Maintenance Period||1
2468034|NCT00975715|6052202|P1|NOT COMPLETED|Maintenance Period||2
2468035|NCT00975715|6052201|P2|COMPLETED|Maintenance Period||50
2468036|NCT00975715|6052202|P1|COMPLETED|Maintenance Period||39
2468037|NCT00975715|6052201|P2|STARTED|Maintenance Period||51
2468038|NCT00975715|6052202|P1|STARTED|Maintenance Period||41
2468039|NCT00975715|6052201|P2|NOT COMPLETED|Titration Period||0
2468040|NCT00975715|6052202|P1|NOT COMPLETED|Titration Period||7
2468041|NCT00975715|6052201|P2|COMPLETED|Titration Period||51
2468042|NCT00975715|6052202|P1|COMPLETED|Titration Period||41
2468043|NCT00975715|6052201|P2|STARTED|Titration Period||51
2468044|NCT00975715|6052202|P1|STARTED|Titration Period||48
2468045|NCT00975689|6052218|P2|NOT COMPLETED|Overall Study||3
2468046|NCT00975689|6052219|P1|NOT COMPLETED|Overall Study||2
2468047|NCT00975689|6052218|P2|COMPLETED|Overall Study||15
2468048|NCT00975689|6052219|P1|COMPLETED|Overall Study||15
2468049|NCT00975689|6052218|P2|STARTED|Overall Study||18
2468050|NCT00975689|6052219|P1|STARTED|Overall Study||17
2468051|NCT00975650|6052225|P4|NOT COMPLETED|Period 4||0
2468052|NCT00975650|6052226|P3|NOT COMPLETED|Period 4||0
2468053|NCT00975650|6052227|P2|NOT COMPLETED|Period 4||0
2468054|NCT00975650|6052228|P1|NOT COMPLETED|Period 4||0
2468055|NCT00975650|6052225|P4|COMPLETED|Period 4||14
2468056|NCT00975650|6052226|P3|COMPLETED|Period 4||14
2468057|NCT00975650|6052227|P2|COMPLETED|Period 4||14
2468058|NCT00975650|6052228|P1|COMPLETED|Period 4||12
2468059|NCT00975650|6052225|P4|STARTED|Period 4||14
2468060|NCT00975650|6052226|P3|STARTED|Period 4||14
2468061|NCT00975650|6052227|P2|STARTED|Period 4||14
2468062|NCT00975650|6052228|P1|STARTED|Period 4||12
2468063|NCT00975650|6052225|P4|NOT COMPLETED|Period 3||0
2468064|NCT00975650|6052226|P3|NOT COMPLETED|Period 3||0
2468065|NCT00975650|6052227|P2|NOT COMPLETED|Period 3||0
2468066|NCT00975650|6052228|P1|NOT COMPLETED|Period 3||0
2468067|NCT00975650|6052225|P4|COMPLETED|Period 3||14
2468068|NCT00975650|6052226|P3|COMPLETED|Period 3||14
2468069|NCT00975650|6052227|P2|COMPLETED|Period 3||14
2468070|NCT00975650|6052228|P1|COMPLETED|Period 3||12
2468071|NCT00975650|6052225|P4|STARTED|Period 3||14
2468072|NCT00975650|6052226|P3|STARTED|Period 3||14
2468073|NCT00975650|6052227|P2|STARTED|Period 3||14
2468074|NCT00975650|6052228|P1|STARTED|Period 3||12
2468075|NCT00975650|6052225|P4|NOT COMPLETED|Period 2||0
2468076|NCT00975650|6052226|P3|NOT COMPLETED|Period 2||0
2468077|NCT00975650|6052227|P2|NOT COMPLETED|Period 2||2
2468078|NCT00975650|6052228|P1|NOT COMPLETED|Period 2||1
2468079|NCT00975650|6052225|P4|COMPLETED|Period 2||14
2468080|NCT00975650|6052226|P3|COMPLETED|Period 2||14
2468081|NCT00975650|6052227|P2|COMPLETED|Period 2||14
2468082|NCT00975650|6052228|P1|COMPLETED|Period 2||12
2468083|NCT00975650|6052225|P4|STARTED|Period 2||14
2468084|NCT00975650|6052226|P3|STARTED|Period 2||14
2468085|NCT00975650|6052227|P2|STARTED|Period 2||16
2468086|NCT00975650|6052228|P1|STARTED|Period 2||13
2468087|NCT00975650|6052225|P4|NOT COMPLETED|Period 1||0
2468088|NCT00975650|6052226|P3|NOT COMPLETED|Period 1||0
2468089|NCT00975650|6052227|P2|NOT COMPLETED|Period 1||0
2468090|NCT00975650|6052228|P1|NOT COMPLETED|Period 1||0
2468091|NCT00975650|6052225|P4|COMPLETED|Period 1||14
2468092|NCT00975650|6052226|P3|COMPLETED|Period 1||14
2468093|NCT00975650|6052227|P2|COMPLETED|Period 1||16
2468094|NCT00975650|6052228|P1|COMPLETED|Period 1||13
2468095|NCT00975650|6052225|P4|STARTED|Period 1||14
2468096|NCT00975650|6052226|P3|STARTED|Period 1||14
2468097|NCT00975650|6052227|P2|STARTED|Period 1||16
2468098|NCT00975650|6052228|P1|STARTED|Period 1||13
2468099|NCT00975637|6052267|P5|NOT COMPLETED|Overall Study||2
2468100|NCT00975637|6052268|P4|NOT COMPLETED|Overall Study||6
2468101|NCT00975637|6052269|P3|NOT COMPLETED|Overall Study||2
2468102|NCT00975637|6052270|P2|NOT COMPLETED|Overall Study||1
2468103|NCT00975637|6052271|P1|NOT COMPLETED|Overall Study||3
2468104|NCT00975637|6052267|P5|COMPLETED|Overall Study||37
2468105|NCT00975637|6052268|P4|COMPLETED|Overall Study||32
2468106|NCT00975637|6052269|P3|COMPLETED|Overall Study||40
2468107|NCT00975637|6052270|P2|COMPLETED|Overall Study||38
2468108|NCT00975637|6052271|P1|COMPLETED|Overall Study||37
2468109|NCT00975637|6052267|P5|STARTED|Overall Study||39
2468110|NCT00975637|6052268|P4|STARTED|Overall Study||38
2468111|NCT00975637|6052269|P3|STARTED|Overall Study||42
2468112|NCT00975637|6052270|P2|STARTED|Overall Study||39
2468113|NCT00975637|6052271|P1|STARTED|Overall Study||40
2468114|NCT00975611|6052288|P1|NOT COMPLETED|Overall Study||17
2468115|NCT00975611|6052288|P1|COMPLETED|Overall Study||5
2468116|NCT00975611|6052288|P1|STARTED|Overall Study||22
2468117|NCT00975585|6052294|P2|NOT COMPLETED|Overall Study||12
2468118|NCT00975585|6052295|P1|NOT COMPLETED|Overall Study||7
2468119|NCT00975585|6052294|P2|COMPLETED|Overall Study||183
2468120|NCT00975585|6052295|P1|COMPLETED|Overall Study||177
2468121|NCT00975585|6052294|P2|STARTED|Overall Study||195
2468122|NCT00975585|6052295|P1|STARTED|Overall Study||184
2468123|NCT00975507|6052315|P2|NOT COMPLETED|Overall Study||4
2468124|NCT00975507|6052316|P1|NOT COMPLETED|Overall Study||20
2468125|NCT00975507|6052315|P2|COMPLETED|Overall Study||153
2468126|NCT00975507|6052316|P1|COMPLETED|Overall Study||303
2468127|NCT00975507|6052315|P2|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects receiving M-M-R™ II + VARIVAX™ at Visit 1 were not vaccinated at Visit 2|0
2468128|NCT00975507|6052316|P1|Vaccinated at Visit 2|Overall Study||310
2468129|NCT00975507|6052315|P2|Vaccinated at Visit 1|Overall Study||157
2468130|NCT00975507|6052316|P1|Vaccinated at Visit 1|Overall Study||323
2468131|NCT00975507|6052315|P2|STARTED|Overall Study||157
2468132|NCT00975507|6052316|P1|STARTED|Overall Study||323
2468133|NCT00975481|6052336|P6|NOT COMPLETED|Sixth Intervention Period||0
2468134|NCT00975481|6052337|P5|NOT COMPLETED|Sixth Intervention Period||0
2468135|NCT00975481|6052338|P4|NOT COMPLETED|Sixth Intervention Period||0
2468136|NCT00975481|6052339|P3|NOT COMPLETED|Sixth Intervention Period||0
2468137|NCT00975481|6052340|P2|NOT COMPLETED|Sixth Intervention Period||0
2468138|NCT00975481|6052341|P1|NOT COMPLETED|Sixth Intervention Period||0
2468139|NCT00975481|6052336|P6|COMPLETED|Sixth Intervention Period||6
2468140|NCT00975481|6052337|P5|COMPLETED|Sixth Intervention Period||5
2468141|NCT00975481|6052338|P4|COMPLETED|Sixth Intervention Period||5
2468142|NCT00975481|6052339|P3|COMPLETED|Sixth Intervention Period||4
2468143|NCT00975481|6052340|P2|COMPLETED|Sixth Intervention Period||5
2468144|NCT00975481|6052341|P1|COMPLETED|Sixth Intervention Period||4
2468145|NCT00975481|6052336|P6|STARTED|Sixth Intervention Period||6
2468146|NCT00975481|6052337|P5|STARTED|Sixth Intervention Period||5
2468147|NCT00975481|6052338|P4|STARTED|Sixth Intervention Period||5
2468148|NCT00975481|6052339|P3|STARTED|Sixth Intervention Period||4
2468149|NCT00975481|6052340|P2|STARTED|Sixth Intervention Period||5
2468150|NCT00975481|6052341|P1|STARTED|Sixth Intervention Period||4
2468151|NCT00975481|6052336|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2468152|NCT00975481|6052337|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2468153|NCT00975481|6052338|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2468154|NCT00975481|6052339|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2468155|NCT00975481|6052340|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2468156|NCT00975481|6052341|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2468157|NCT00975481|6052336|P6|COMPLETED|Washout Period (at Least 7 Days)||6
2468158|NCT00975481|6052337|P5|COMPLETED|Washout Period (at Least 7 Days)||5
2468159|NCT00975481|6052338|P4|COMPLETED|Washout Period (at Least 7 Days)||5
2468160|NCT00975481|6052339|P3|COMPLETED|Washout Period (at Least 7 Days)||4
2468161|NCT00975481|6052340|P2|COMPLETED|Washout Period (at Least 7 Days)||5
2468162|NCT00975481|6052341|P1|COMPLETED|Washout Period (at Least 7 Days)||4
2468163|NCT00975481|6052336|P6|STARTED|Washout Period (at Least 7 Days)||6
2468164|NCT00975481|6052337|P5|STARTED|Washout Period (at Least 7 Days)||5
2468165|NCT00975481|6052338|P4|STARTED|Washout Period (at Least 7 Days)||5
2468166|NCT00975481|6052339|P3|STARTED|Washout Period (at Least 7 Days)||4
2468167|NCT00975481|6052340|P2|STARTED|Washout Period (at Least 7 Days)||5
2468168|NCT00975481|6052341|P1|STARTED|Washout Period (at Least 7 Days)||4
2468169|NCT00975481|6052336|P6|NOT COMPLETED|Fifth Intervention Period||0
2468170|NCT00975481|6052337|P5|NOT COMPLETED|Fifth Intervention Period||1
2468171|NCT00975481|6052338|P4|NOT COMPLETED|Fifth Intervention Period||0
2468172|NCT00975481|6052339|P3|NOT COMPLETED|Fifth Intervention Period||0
2468173|NCT00975481|6052340|P2|NOT COMPLETED|Fifth Intervention Period||0
2468174|NCT00975481|6052341|P1|NOT COMPLETED|Fifth Intervention Period||0
2468175|NCT00975481|6052336|P6|COMPLETED|Fifth Intervention Period||6
2468176|NCT00975481|6052337|P5|COMPLETED|Fifth Intervention Period||5
2468177|NCT00975481|6052338|P4|COMPLETED|Fifth Intervention Period||5
2468178|NCT00975481|6052339|P3|COMPLETED|Fifth Intervention Period||4
2468179|NCT00975481|6052340|P2|COMPLETED|Fifth Intervention Period||5
2468180|NCT00975481|6052341|P1|COMPLETED|Fifth Intervention Period||4
2468181|NCT00975481|6052336|P6|STARTED|Fifth Intervention Period||6
2468182|NCT00975481|6052337|P5|STARTED|Fifth Intervention Period||6
2468183|NCT00975481|6052338|P4|STARTED|Fifth Intervention Period||5
2468184|NCT00975481|6052339|P3|STARTED|Fifth Intervention Period||4
2468185|NCT00975481|6052340|P2|STARTED|Fifth Intervention Period||5
2468186|NCT00975481|6052341|P1|STARTED|Fifth Intervention Period||4
2468187|NCT00975481|6052336|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2468188|NCT00975481|6052337|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2468189|NCT00975481|6052338|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2468190|NCT00975481|6052339|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2468191|NCT00975481|6052340|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2468192|NCT00975481|6052341|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2468193|NCT00975481|6052336|P6|COMPLETED|Washout Period (at Least 7 Days)||6
2468194|NCT00975481|6052337|P5|COMPLETED|Washout Period (at Least 7 Days)||6
2468195|NCT00975481|6052338|P4|COMPLETED|Washout Period (at Least 7 Days)||5
2468196|NCT00975481|6052339|P3|COMPLETED|Washout Period (at Least 7 Days)||4
2468197|NCT00975481|6052340|P2|COMPLETED|Washout Period (at Least 7 Days)||5
2468198|NCT00975481|6052341|P1|COMPLETED|Washout Period (at Least 7 Days)||4
2468199|NCT00975481|6052336|P6|STARTED|Washout Period (at Least 7 Days)||6
2468200|NCT00975481|6052337|P5|STARTED|Washout Period (at Least 7 Days)||6
2468201|NCT00975481|6052338|P4|STARTED|Washout Period (at Least 7 Days)||5
2468202|NCT00975481|6052339|P3|STARTED|Washout Period (at Least 7 Days)||4
2468203|NCT00975481|6052340|P2|STARTED|Washout Period (at Least 7 Days)||5
2468204|NCT00975481|6052341|P1|STARTED|Washout Period (at Least 7 Days)||4
2468205|NCT00975481|6052336|P6|NOT COMPLETED|Fourth Intervention Period||0
2468206|NCT00975481|6052337|P5|NOT COMPLETED|Fourth Intervention Period||0
2468207|NCT00975481|6052338|P4|NOT COMPLETED|Fourth Intervention Period||1
2468208|NCT00975481|6052339|P3|NOT COMPLETED|Fourth Intervention Period||1
2468209|NCT00975481|6052340|P2|NOT COMPLETED|Fourth Intervention Period||0
2468210|NCT00975481|6052341|P1|NOT COMPLETED|Fourth Intervention Period||0
2468211|NCT00975481|6052336|P6|COMPLETED|Fourth Intervention Period||6
2468212|NCT00975481|6052337|P5|COMPLETED|Fourth Intervention Period||6
2468213|NCT00975481|6052338|P4|COMPLETED|Fourth Intervention Period||5
2468214|NCT00975481|6052339|P3|COMPLETED|Fourth Intervention Period||4
2468215|NCT00975481|6052340|P2|COMPLETED|Fourth Intervention Period||5
2468216|NCT00975481|6052341|P1|COMPLETED|Fourth Intervention Period||4
2468217|NCT00975481|6052336|P6|STARTED|Fourth Intervention Period||6
2468218|NCT00975481|6052337|P5|STARTED|Fourth Intervention Period||6
2468219|NCT00975481|6052338|P4|STARTED|Fourth Intervention Period||6
2468220|NCT00975481|6052339|P3|STARTED|Fourth Intervention Period||5
2468221|NCT00975481|6052340|P2|STARTED|Fourth Intervention Period||5
2468222|NCT00975481|6052341|P1|STARTED|Fourth Intervention Period||4
2468223|NCT00975481|6052336|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2468224|NCT00975481|6052337|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2468225|NCT00975481|6052338|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2468226|NCT00975481|6052339|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2468227|NCT00975481|6052340|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2468228|NCT00975481|6052341|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2468229|NCT00975481|6052336|P6|COMPLETED|Washout Period (at Least 7 Days)||6
2468230|NCT00975481|6052337|P5|COMPLETED|Washout Period (at Least 7 Days)||6
2468231|NCT00975481|6052338|P4|COMPLETED|Washout Period (at Least 7 Days)||6
2468232|NCT00975481|6052339|P3|COMPLETED|Washout Period (at Least 7 Days)||5
2468233|NCT00975481|6052340|P2|COMPLETED|Washout Period (at Least 7 Days)||5
2468234|NCT00975481|6052341|P1|COMPLETED|Washout Period (at Least 7 Days)||4
2468235|NCT00975481|6052336|P6|STARTED|Washout Period (at Least 7 Days)||6
2468236|NCT00975481|6052337|P5|STARTED|Washout Period (at Least 7 Days)||6
2468237|NCT00975481|6052338|P4|STARTED|Washout Period (at Least 7 Days)||6
2468238|NCT00975481|6052339|P3|STARTED|Washout Period (at Least 7 Days)||5
2468239|NCT00975481|6052340|P2|STARTED|Washout Period (at Least 7 Days)||5
2468240|NCT00975481|6052341|P1|STARTED|Washout Period (at Least 7 Days)||4
2468241|NCT00975481|6052336|P6|NOT COMPLETED|Third Intervention Period||0
2468242|NCT00975481|6052337|P5|NOT COMPLETED|Third Intervention Period||0
2468243|NCT00975481|6052338|P4|NOT COMPLETED|Third Intervention Period||0
2468244|NCT00975481|6052339|P3|NOT COMPLETED|Third Intervention Period||0
2468245|NCT00975481|6052340|P2|NOT COMPLETED|Third Intervention Period||0
2468246|NCT00975481|6052341|P1|NOT COMPLETED|Third Intervention Period||0
2468247|NCT00975481|6052336|P6|COMPLETED|Third Intervention Period||6
2468248|NCT00975481|6052337|P5|COMPLETED|Third Intervention Period||6
2468249|NCT00975481|6052338|P4|COMPLETED|Third Intervention Period||6
2468250|NCT00975481|6052339|P3|COMPLETED|Third Intervention Period||5
2468251|NCT00975481|6052340|P2|COMPLETED|Third Intervention Period||5
2468252|NCT00975481|6052341|P1|COMPLETED|Third Intervention Period||4
2468253|NCT00975481|6052336|P6|STARTED|Third Intervention Period||6
2468254|NCT00975481|6052337|P5|STARTED|Third Intervention Period||6
2468255|NCT00975481|6052338|P4|STARTED|Third Intervention Period||6
2468256|NCT00975481|6052339|P3|STARTED|Third Intervention Period||5
2468257|NCT00975481|6052340|P2|STARTED|Third Intervention Period||5
2468258|NCT00975481|6052341|P1|STARTED|Third Intervention Period||4
2468259|NCT00975481|6052336|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2468260|NCT00975481|6052337|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2468261|NCT00975481|6052338|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2468262|NCT00975481|6052339|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2468263|NCT00975481|6052340|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2468264|NCT00975481|6052341|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2468265|NCT00975481|6052336|P6|COMPLETED|Washout Period (at Least 7 Days)||6
2468266|NCT00975481|6052337|P5|COMPLETED|Washout Period (at Least 7 Days)||6
2468267|NCT00975481|6052338|P4|COMPLETED|Washout Period (at Least 7 Days)||6
2468268|NCT00975481|6052339|P3|COMPLETED|Washout Period (at Least 7 Days)||5
2468269|NCT00975481|6052340|P2|COMPLETED|Washout Period (at Least 7 Days)||5
2468270|NCT00975481|6052341|P1|COMPLETED|Washout Period (at Least 7 Days)||4
2468271|NCT00975481|6052336|P6|STARTED|Washout Period (at Least 7 Days)||6
2468272|NCT00975481|6052337|P5|STARTED|Washout Period (at Least 7 Days)||6
2468273|NCT00975481|6052338|P4|STARTED|Washout Period (at Least 7 Days)||6
2468274|NCT00975481|6052339|P3|STARTED|Washout Period (at Least 7 Days)||5
2468275|NCT00975481|6052340|P2|STARTED|Washout Period (at Least 7 Days)||5
2468276|NCT00975481|6052341|P1|STARTED|Washout Period (at Least 7 Days)||4
2468277|NCT00975481|6052336|P6|NOT COMPLETED|Second Intervention Period||0
2468278|NCT00975481|6052337|P5|NOT COMPLETED|Second Intervention Period||0
2468279|NCT00975481|6052338|P4|NOT COMPLETED|Second Intervention Period||0
2468280|NCT00975481|6052339|P3|NOT COMPLETED|Second Intervention Period||1
2468281|NCT00975481|6052340|P2|NOT COMPLETED|Second Intervention Period||1
2468282|NCT00975481|6052341|P1|NOT COMPLETED|Second Intervention Period||2
2468283|NCT00975481|6052336|P6|COMPLETED|Second Intervention Period||6
2468284|NCT00975481|6052337|P5|COMPLETED|Second Intervention Period||6
2468285|NCT00975481|6052338|P4|COMPLETED|Second Intervention Period||6
2468286|NCT00975481|6052339|P3|COMPLETED|Second Intervention Period||5
2468287|NCT00975481|6052340|P2|COMPLETED|Second Intervention Period||5
2468288|NCT00975481|6052341|P1|COMPLETED|Second Intervention Period||4
2468289|NCT00975481|6052336|P6|STARTED|Second Intervention Period||6
2468290|NCT00975481|6052337|P5|STARTED|Second Intervention Period||6
2468291|NCT00975481|6052338|P4|STARTED|Second Intervention Period||6
2468292|NCT00975481|6052339|P3|STARTED|Second Intervention Period||6
2468293|NCT00975481|6052340|P2|STARTED|Second Intervention Period||6
2468294|NCT00975481|6052341|P1|STARTED|Second Intervention Period||6
2468295|NCT00975481|6052336|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2468296|NCT00975481|6052337|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2468297|NCT00975481|6052338|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2468298|NCT00975481|6052339|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2468299|NCT00975481|6052340|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2468300|NCT00975481|6052341|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
2468301|NCT00975481|6052336|P6|COMPLETED|Washout Period (at Least 7 Days)||6
2468302|NCT00975481|6052337|P5|COMPLETED|Washout Period (at Least 7 Days)||6
2468303|NCT00975481|6052338|P4|COMPLETED|Washout Period (at Least 7 Days)||6
2468304|NCT00975481|6052339|P3|COMPLETED|Washout Period (at Least 7 Days)||6
2468305|NCT00975481|6052340|P2|COMPLETED|Washout Period (at Least 7 Days)||6
2468306|NCT00975481|6052341|P1|COMPLETED|Washout Period (at Least 7 Days)||6
2468307|NCT00975481|6052336|P6|STARTED|Washout Period (at Least 7 Days)||6
2468308|NCT00975481|6052337|P5|STARTED|Washout Period (at Least 7 Days)||6
2468309|NCT00975481|6052338|P4|STARTED|Washout Period (at Least 7 Days)||6
2468310|NCT00975481|6052339|P3|STARTED|Washout Period (at Least 7 Days)||6
2468311|NCT00975481|6052340|P2|STARTED|Washout Period (at Least 7 Days)||6
2468312|NCT00975481|6052341|P1|STARTED|Washout Period (at Least 7 Days)||6
2468313|NCT00975481|6052336|P6|NOT COMPLETED|First Intervention Period||0
2468314|NCT00975481|6052337|P5|NOT COMPLETED|First Intervention Period||0
2468315|NCT00975481|6052338|P4|NOT COMPLETED|First Intervention Period||0
2468316|NCT00975481|6052339|P3|NOT COMPLETED|First Intervention Period||0
2468317|NCT00975481|6052340|P2|NOT COMPLETED|First Intervention Period||0
2468318|NCT00975481|6052341|P1|NOT COMPLETED|First Intervention Period||0
2468319|NCT00975481|6052336|P6|COMPLETED|First Intervention Period||6
2468320|NCT00975481|6052337|P5|COMPLETED|First Intervention Period||6
2468321|NCT00975481|6052338|P4|COMPLETED|First Intervention Period||6
2468322|NCT00975481|6052339|P3|COMPLETED|First Intervention Period||6
2468323|NCT00975481|6052340|P2|COMPLETED|First Intervention Period||6
2468324|NCT00975481|6052341|P1|COMPLETED|First Intervention Period||6
2468325|NCT00975481|6052336|P6|STARTED|First Intervention Period||6
2468326|NCT00975481|6052337|P5|STARTED|First Intervention Period||6
2468327|NCT00975481|6052338|P4|STARTED|First Intervention Period||6
2468328|NCT00975481|6052339|P3|STARTED|First Intervention Period||6
2468329|NCT00975481|6052340|P2|STARTED|First Intervention Period||6
2468330|NCT00975481|6052341|P1|STARTED|First Intervention Period||6
2468331|NCT00975416|6052441|P2|NOT COMPLETED|Overall Study||5
2468332|NCT00975416|6052442|P1|NOT COMPLETED|Overall Study||3
2468333|NCT00975416|6052441|P2|COMPLETED|Overall Study||11
2468334|NCT00975416|6052442|P1|COMPLETED|Overall Study||11
2468335|NCT00975416|6052441|P2|STARTED|Overall Study||16
2468336|NCT00975416|6052442|P1|STARTED|Overall Study||14
2468337|NCT00975286|6052451|P2|NOT COMPLETED|Overall Study||29
2468338|NCT00975286|6052452|P1|NOT COMPLETED|Overall Study||12
2468339|NCT00975286|6052451|P2|COMPLETED|Overall Study||194
2468340|NCT00975286|6052452|P1|COMPLETED|Overall Study||211
2468341|NCT00975286|6052451|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||223
2468342|NCT00975286|6052452|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|223
2468343|NCT00975286|6052451|P2|Safety Population|Overall Study||223
2468344|NCT00975286|6052452|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|223
2468345|NCT00975286|6052451|P2|STARTED|Overall Study||223
2468346|NCT00975286|6052452|P1|STARTED|Overall Study|Randomized.|223
2468347|NCT00975221|6052484|P2|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||1
2468348|NCT00975221|6052485|P1|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||2
2468349|NCT00975221|6052484|P2|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
2468350|NCT00975221|6052485|P1|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
2468351|NCT00975221|6052484|P2|STARTED|Open-label Extension Phase (Weeks 29-52)||28
2468352|NCT00975221|6052485|P1|STARTED|Open-label Extension Phase (Weeks 29-52)|1 participant who completed the EAP did not enter the open-label phase|29
2468353|NCT00975221|6052484|P2|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||1
2468354|NCT00975221|6052485|P1|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||0
2468355|NCT00975221|6052484|P2|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||28
2468356|NCT00975221|6052485|P1|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||30
2468357|NCT00975221|6052484|P2|STARTED|Efficacy Assessment Phase (Weeks 13-28)||29
2468358|NCT00975221|6052485|P1|STARTED|Efficacy Assessment Phase (Weeks 13-28)|1 participant who completed the Titration Phase did not enter the EAP|30
2468359|NCT00975221|6052484|P2|NOT COMPLETED|Titration Phase (Weeks 1-12)||4
2468360|NCT00975221|6052485|P1|NOT COMPLETED|Titration Phase (Weeks 1-12)||3
2468361|NCT00975221|6052484|P2|COMPLETED|Titration Phase (Weeks 1-12)||29
2468362|NCT00975221|6052485|P1|COMPLETED|Titration Phase (Weeks 1-12)||31
2468363|NCT00975221|6052484|P2|Received Study Drug|Titration Phase (Weeks 1-12)||33
2468364|NCT00975221|6052485|P1|Received Study Drug|Titration Phase (Weeks 1-12)||34
2468365|NCT00975221|6052484|P2|STARTED|Titration Phase (Weeks 1-12)||33
2468366|NCT00975221|6052485|P1|STARTED|Titration Phase (Weeks 1-12)||34
2468367|NCT00975195|6052501|P2|NOT COMPLETED|Overall Study||233
2468368|NCT00975195|6052502|P1|NOT COMPLETED|Overall Study||228
2468369|NCT00975195|6052501|P2|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1011
2468370|NCT00975195|6052502|P1|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1016
2468371|NCT00975195|6052501|P2|STARTED|Overall Study||1244
2468372|NCT00975195|6052502|P1|STARTED|Overall Study||1244
2468373|NCT00975156|6052562|P2|NOT COMPLETED|Overall Study||1
2468374|NCT00975156|6052563|P1|NOT COMPLETED|Overall Study||0
2468375|NCT00975156|6052562|P2|COMPLETED|Overall Study||9
2468376|NCT00975156|6052563|P1|COMPLETED|Overall Study||11
2468377|NCT00975156|6052562|P2|STARTED|Overall Study||10
2468378|NCT00975156|6052563|P1|STARTED|Overall Study||11
2468379|NCT00975143|6052575|P2|NOT COMPLETED|Overall Study||60
2468380|NCT00975143|6052576|P1|NOT COMPLETED|Overall Study||70
2468381|NCT00975143|6052575|P2|COMPLETED|Overall Study||401
2468382|NCT00975143|6052576|P1|COMPLETED|Overall Study||394
2468383|NCT00975143|6052575|P2|Completed Treatment (Week 20)|Overall Study||410
2468384|NCT00975143|6052576|P1|Completed Treatment (Week 20)|Overall Study||403
2468385|NCT00975143|6052575|P2|STARTED|Overall Study||461
2468386|NCT00975143|6052576|P1|STARTED|Overall Study||464
2468387|NCT00975130|6052586|P3|NOT COMPLETED|Study Part 2||17
2468388|NCT00975130|6052587|P2|NOT COMPLETED|Study Part 2||38
2468389|NCT00975130|6052588|P1|NOT COMPLETED|Study Part 2||0
2468390|NCT00975130|6052586|P3|COMPLETED|Study Part 2||238
2468391|NCT00975130|6052587|P2|COMPLETED|Study Part 2||212
2468392|NCT00975130|6052588|P1|COMPLETED|Study Part 2||0
2468393|NCT00975130|6052586|P3|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|255
2468394|NCT00975130|6052587|P2|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|250
2468395|NCT00975130|6052588|P1|STARTED|Study Part 2||0
2468396|NCT00975130|6052586|P3|NOT COMPLETED|Study Part 1||0
2468397|NCT00975130|6052587|P2|NOT COMPLETED|Study Part 1||0
2468398|NCT00975130|6052588|P1|NOT COMPLETED|Study Part 1||280
2468399|NCT00975130|6052586|P3|COMPLETED|Study Part 1||0
2468400|NCT00975130|6052587|P2|COMPLETED|Study Part 1||0
2468401|NCT00975130|6052588|P1|COMPLETED|Study Part 1||3086
2468402|NCT00975130|6052586|P3|STARTED|Study Part 1||0
2468403|NCT00975130|6052587|P2|STARTED|Study Part 1||0
2468404|NCT00975130|6052588|P1|STARTED|Study Part 1||3366
2468405|NCT00975000|6052772|P2|NOT COMPLETED|Overall Study||5
2468406|NCT00975000|6052773|P1|NOT COMPLETED|Overall Study||5
2468407|NCT00975000|6052772|P2|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
2468408|NCT00975000|6052773|P1|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
2468409|NCT00975000|6052772|P2|Completed Maintenance Phase|Overall Study||52
2468410|NCT00975000|6052773|P1|Completed Maintenance Phase|Overall Study||52
2468411|NCT00975000|6052772|P2|Completed Efficacy Assessment Phase|Overall Study||54
2468412|NCT00975000|6052773|P1|Completed Efficacy Assessment Phase|Overall Study||54
2468413|NCT00975000|6052772|P2|Completed Titration Phase|Overall Study||55
2468414|NCT00975000|6052773|P1|Completed Titration Phase|Overall Study||54
2468415|NCT00975000|6052772|P2|STARTED|Overall Study||57
2468416|NCT00975000|6052773|P1|STARTED|Overall Study||57
2468417|NCT00974974|6052797|P2|NOT COMPLETED|Maintenance - Double Blind Treatment||10
2468418|NCT00974974|6052798|P1|NOT COMPLETED|Maintenance - Double Blind Treatment||15
2468419|NCT00974974|6052797|P2|COMPLETED|Maintenance - Double Blind Treatment||182
2468420|NCT00974974|6052798|P1|COMPLETED|Maintenance - Double Blind Treatment||186
2468421|NCT00974974|6052797|P2|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|192
2468422|NCT00974974|6052798|P1|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|201
2468423|NCT00974974|6052797|P2|NOT COMPLETED|IPX066 Dose Conversion||0
2468424|NCT00974974|6052798|P1|NOT COMPLETED|IPX066 Dose Conversion||57
2468425|NCT00974974|6052797|P2|COMPLETED|IPX066 Dose Conversion||0
2468426|NCT00974974|6052798|P1|COMPLETED|IPX066 Dose Conversion||393
2468427|NCT00974974|6052797|P2|STARTED|IPX066 Dose Conversion|IR is not applicable in IPX066 dose conversion.|0
2468428|NCT00974974|6052798|P1|STARTED|IPX066 Dose Conversion|All subjects who completed IR Dose adjustment entered into IPX066 dose conversion.|450
2468429|NCT00974974|6052797|P2|NOT COMPLETED|IR CD-LD Dose Adjustment||21
2468430|NCT00974974|6052798|P1|NOT COMPLETED|IR CD-LD Dose Adjustment||0
2468431|NCT00974974|6052797|P2|COMPLETED|IR CD-LD Dose Adjustment||450
2468432|NCT00974974|6052798|P1|COMPLETED|IR CD-LD Dose Adjustment||0
2468433|NCT00974974|6052797|P2|STARTED|IR CD-LD Dose Adjustment||471
2468434|NCT00974974|6052798|P1|STARTED|IR CD-LD Dose Adjustment||0
2468435|NCT00974922|6052808|P1|NOT COMPLETED|Overall Study||24
2468436|NCT00974922|6052808|P1|COMPLETED|Overall Study||16
2468437|NCT00974922|6052808|P1|STARTED|Overall Study||40
2468438|NCT00974818|6052815|P2|NOT COMPLETED|Overall Study||0
2468439|NCT00974818|6052816|P1|NOT COMPLETED|Overall Study||0
2468440|NCT00974818|6052815|P2|COMPLETED|Overall Study||25
2468441|NCT00974818|6052816|P1|COMPLETED|Overall Study||25
2468442|NCT00974818|6052815|P2|STARTED|Overall Study||25
2468443|NCT00974818|6052816|P1|STARTED|Overall Study||25
2468444|NCT00974675|6052826|P4|NOT COMPLETED|Overall Study||2
2468445|NCT00974675|6052827|P3|NOT COMPLETED|Overall Study||2
2468446|NCT00974675|6052828|P2|NOT COMPLETED|Overall Study||1
2468447|NCT00974675|6052829|P1|NOT COMPLETED|Overall Study||2
2468448|NCT00974675|6052826|P4|COMPLETED|Overall Study||2
2468449|NCT00974675|6052827|P3|COMPLETED|Overall Study||1
2468450|NCT00974675|6052828|P2|COMPLETED|Overall Study||7
2468451|NCT00974675|6052829|P1|COMPLETED|Overall Study||6
2468452|NCT00974675|6052826|P4|STARTED|Overall Study||4
2468453|NCT00974675|6052827|P3|STARTED|Overall Study||3
2468454|NCT00974675|6052828|P2|STARTED|Overall Study||8
2468455|NCT00974675|6052829|P1|STARTED|Overall Study||8
2468456|NCT00974571|6052878|P3|NOT COMPLETED|Overall Study||83
2468457|NCT00974571|6052879|P2|NOT COMPLETED|Overall Study||16
2468458|NCT00974571|6052880|P1|NOT COMPLETED|Overall Study||68
2468459|NCT00974571|6052878|P3|COMPLETED|Overall Study||530
2468460|NCT00974571|6052879|P2|COMPLETED|Overall Study||106
2468461|NCT00974571|6052880|P1|COMPLETED|Overall Study||562
2468462|NCT00974571|6052878|P3|STARTED|Overall Study||613
2468463|NCT00974571|6052879|P2|STARTED|Overall Study||122
2468464|NCT00974571|6052880|P1|STARTED|Overall Study||630
2468465|NCT00974480|6052903|P3|NOT COMPLETED|Overall Study||10
2468466|NCT00974480|6052904|P2|NOT COMPLETED|Overall Study||7
2468467|NCT00974480|6052905|P1|NOT COMPLETED|Overall Study||11
2468468|NCT00974480|6052903|P3|COMPLETED|Overall Study||30
2468469|NCT00974480|6052904|P2|COMPLETED|Overall Study||33
2468470|NCT00974480|6052905|P1|COMPLETED|Overall Study||29
2468471|NCT00974480|6052903|P3|STARTED|Overall Study||40
2468472|NCT00974480|6052904|P2|STARTED|Overall Study||40
2468473|NCT00974480|6052905|P1|STARTED|Overall Study||40
2468474|NCT00974376|6052945|P2|NOT COMPLETED|Overall Study||33
2468475|NCT00974376|6052946|P1|NOT COMPLETED|Overall Study||34
2468476|NCT00974376|6052945|P2|COMPLETED|Overall Study||42
2468477|NCT00974376|6052946|P1|COMPLETED|Overall Study||41
2468478|NCT00974376|6052945|P2|STARTED|Overall Study||75
2468479|NCT00974376|6052946|P1|STARTED|Overall Study||75
2468480|NCT00974363|6052954|P2|NOT COMPLETED|Overall Study||0
2468481|NCT00974363|6052955|P1|NOT COMPLETED|Overall Study||0
2468482|NCT00974363|6052954|P2|COMPLETED|Overall Study||168
2468483|NCT00974363|6052955|P1|COMPLETED|Overall Study||521
2468484|NCT00974363|6052954|P2|STARTED|Overall Study||168
2468485|NCT00974363|6052955|P1|STARTED|Overall Study||521
2468486|NCT00974311|6052977|P2|NOT COMPLETED|OLE Phase (up to 77 Months)||50
2468487|NCT00974311|6052978|P1|NOT COMPLETED|OLE Phase (up to 77 Months)||109
2468488|NCT00974311|6052977|P2|COMPLETED|OLE Phase (up to 77 Months)||0
2468489|NCT00974311|6052978|P1|COMPLETED|OLE Phase (up to 77 Months)||0
2468490|NCT00974311|6052977|P2|STARTED|OLE Phase (up to 77 Months)||50
2468491|NCT00974311|6052978|P1|STARTED|OLE Phase (up to 77 Months)||109
2468492|NCT00974311|6052977|P2|NOT COMPLETED|DB Phase (up to 24 Months)||349
2468493|NCT00974311|6052978|P1|NOT COMPLETED|DB Phase (up to 24 Months)||691
2468494|NCT00974311|6052977|P2|COMPLETED|DB Phase (up to 24 Months)||50
2468495|NCT00974311|6052978|P1|COMPLETED|DB Phase (up to 24 Months)||109
2468496|NCT00974311|6052977|P2|STARTED|DB Phase (up to 24 Months)||399
2468497|NCT00974311|6052978|P1|STARTED|DB Phase (up to 24 Months)||800
2468498|NCT00974259|6053016|P2|NOT COMPLETED|Overall Study||1
2468499|NCT00974259|6053017|P1|NOT COMPLETED|Overall Study||2
2468500|NCT00974259|6053016|P2|COMPLETED|Overall Study||62
2468501|NCT00974259|6053017|P1|COMPLETED|Overall Study||57
2468502|NCT00974259|6053016|P2|STARTED|Overall Study||63
2468503|NCT00974259|6053017|P1|STARTED|Overall Study||59
2468504|NCT00974246|6053029|P1|NOT COMPLETED|Overall Study||0
2468505|NCT00974246|6053029|P1|COMPLETED|Overall Study||27
2468506|NCT00974246|6053029|P1|STARTED|Overall Study||27
2468507|NCT00974233|6053035|P1|NOT COMPLETED|Maintenance Lenalidomide||13
2468508|NCT00974233|6053035|P1|COMPLETED|Maintenance Lenalidomide||6
2468509|NCT00974233|6053035|P1|STARTED|Maintenance Lenalidomide||19
2468510|NCT00974233|6053035|P1|NOT COMPLETED|Induction Chemoimmunotherapy||15
2468511|NCT00974233|6053035|P1|COMPLETED|Induction Chemoimmunotherapy||19
2468512|NCT00974233|6053035|P1|STARTED|Induction Chemoimmunotherapy||34
2468513|NCT00974220|6053050|P2|NOT COMPLETED|Treatment Period 2||0
2468514|NCT00974220|6053051|P1|NOT COMPLETED|Treatment Period 2||0
2468515|NCT00974220|6053050|P2|COMPLETED|Treatment Period 2||5
2468516|NCT00974220|6053051|P1|COMPLETED|Treatment Period 2||7
2468517|NCT00974220|6053050|P2|STARTED|Treatment Period 2||5
2468518|NCT00974220|6053051|P1|STARTED|Treatment Period 2||7
2468519|NCT00974220|6053050|P2|NOT COMPLETED|Treatment Period 1||2
2468520|NCT00974220|6053051|P1|NOT COMPLETED|Treatment Period 1||2
2468521|NCT00974220|6053050|P2|COMPLETED|Treatment Period 1||5
2468522|NCT00974220|6053051|P1|COMPLETED|Treatment Period 1||7
2468523|NCT00974220|6053050|P2|STARTED|Treatment Period 1||7
2468524|NCT00974220|6053051|P1|STARTED|Treatment Period 1||9
2468525|NCT00974142|6053061|P2|NOT COMPLETED|Overall Study||0
2468526|NCT00974142|6053062|P1|NOT COMPLETED|Overall Study||0
2468527|NCT00974142|6053061|P2|COMPLETED|Overall Study||9
2468528|NCT00974142|6053062|P1|COMPLETED|Overall Study||8
2468529|NCT00974142|6053061|P2|STARTED|Overall Study||9
2468530|NCT00974142|6053062|P1|STARTED|Overall Study||8
2468531|NCT00974090|6053096|P2|NOT COMPLETED|Period 2: Open-label Period||10
2468532|NCT00974090|6053097|P1|NOT COMPLETED|Period 2: Open-label Period||8
2468533|NCT00974090|6053096|P2|COMPLETED|Period 2: Open-label Period||85
2468534|NCT00974090|6053097|P1|COMPLETED|Period 2: Open-label Period||87
2468535|NCT00974090|6053096|P2|STARTED|Period 2: Open-label Period||95
2468536|NCT00974090|6053097|P1|STARTED|Period 2: Open-label Period||95
2468537|NCT00974090|6053096|P2|NOT COMPLETED|Period 1: Double Blind Period||1
2468538|NCT00974090|6053097|P1|NOT COMPLETED|Period 1: Double Blind Period||3
2468539|NCT00974090|6053096|P2|COMPLETED|Period 1: Double Blind Period||95
2468540|NCT00974090|6053097|P1|COMPLETED|Period 1: Double Blind Period||95
2468541|NCT00974090|6053096|P2|STARTED|Period 1: Double Blind Period||96
2468542|NCT00974090|6053097|P1|STARTED|Period 1: Double Blind Period||98
2468543|NCT00974051|6053111|P3|NOT COMPLETED|Overall Study||0
2468544|NCT00974051|6053112|P2|NOT COMPLETED|Overall Study||0
2468545|NCT00974051|6053113|P1|NOT COMPLETED|Overall Study||0
2468546|NCT00974051|6053111|P3|COMPLETED|Overall Study||6
2468547|NCT00974051|6053112|P2|COMPLETED|Overall Study||4
2468548|NCT00974051|6053113|P1|COMPLETED|Overall Study||6
2468549|NCT00974051|6053111|P3|STARTED|Overall Study||6
2468550|NCT00974051|6053112|P2|STARTED|Overall Study||4
2468551|NCT00974051|6053113|P1|STARTED|Overall Study||6
2468552|NCT00973973|6053133|P2|NOT COMPLETED|Open-label Treatment Phase (Weeks 8-24)||5
2468553|NCT00973973|6053134|P1|NOT COMPLETED|Open-label Treatment Phase (Weeks 8-24)||6
2468554|NCT00973973|6053133|P2|COMPLETED|Open-label Treatment Phase (Weeks 8-24)||55
2468555|NCT00973973|6053134|P1|COMPLETED|Open-label Treatment Phase (Weeks 8-24)||57
2468644|NCT00973349|6053364|P8|NOT COMPLETED|Overall Study||3
2468556|NCT00973973|6053133|P2|STARTED|Open-label Treatment Phase (Weeks 8-24)||60
2468557|NCT00973973|6053134|P1|STARTED|Open-label Treatment Phase (Weeks 8-24)||63
2468558|NCT00973973|6053133|P2|NOT COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||8
2468559|NCT00973973|6053134|P1|NOT COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||6
2468560|NCT00973973|6053133|P2|COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||60
2468561|NCT00973973|6053134|P1|COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||63
2468562|NCT00973973|6053133|P2|Received Study Drug|Double-blind Treatment Phase (Weeks 1-8)||68
2468563|NCT00973973|6053134|P1|Received Study Drug|Double-blind Treatment Phase (Weeks 1-8)||69
2468564|NCT00973973|6053133|P2|STARTED|Double-blind Treatment Phase (Weeks 1-8)||68
2468565|NCT00973973|6053134|P1|STARTED|Double-blind Treatment Phase (Weeks 1-8)||69
2468566|NCT00973921|6053194|P1|NOT COMPLETED|Overall Study||9
2468567|NCT00973921|6053194|P1|COMPLETED|Overall Study||31
2468568|NCT00973921|6053194|P1|STARTED|Overall Study||40
2468569|NCT00973856|6053203|P2|NOT COMPLETED|Overall Study||0
2468570|NCT00973856|6053204|P1|NOT COMPLETED|Overall Study||0
2468571|NCT00973856|6053203|P2|COMPLETED|Overall Study||2
2468572|NCT00973856|6053204|P1|COMPLETED|Overall Study||3
2468573|NCT00973856|6053203|P2|STARTED|Overall Study||2
2468574|NCT00973856|6053204|P1|STARTED|Overall Study||3
2468575|NCT00973765|6053211|P2|NOT COMPLETED|Overall Study||14
2468576|NCT00973765|6053212|P1|NOT COMPLETED|Overall Study||8
2468577|NCT00973765|6053211|P2|COMPLETED|Overall Study|102|102
2468578|NCT00973765|6053212|P1|COMPLETED|Overall Study|88|88
2468579|NCT00973765|6053211|P2|STARTED|Overall Study|116|116
2468580|NCT00973765|6053212|P1|STARTED|Overall Study|96|96
2468581|NCT00973752|6053218|P1|NOT COMPLETED|Overall Study||0
2468582|NCT00973752|6053218|P1|COMPLETED|Overall Study||30
2468583|NCT00973752|6053218|P1|STARTED|Overall Study||30
2468584|NCT00973739|6053222|P1|NOT COMPLETED|Overall Study||4
2468585|NCT00973739|6053222|P1|COMPLETED|Overall Study||17
2468586|NCT00973739|6053222|P1|STARTED|Overall Study||21
2468587|NCT00973700|6053234|P5|NOT COMPLETED|Overall Study||10
2468588|NCT00973700|6053235|P4|NOT COMPLETED|Overall Study||18
2468589|NCT00973700|6053236|P3|NOT COMPLETED|Overall Study||10
2468590|NCT00973700|6053237|P2|NOT COMPLETED|Overall Study||2
2468591|NCT00973700|6053238|P1|NOT COMPLETED|Overall Study||7
2468592|NCT00973700|6053234|P5|COMPLETED|Overall Study||158
2468593|NCT00973700|6053235|P4|COMPLETED|Overall Study||318
2468594|NCT00973700|6053236|P3|COMPLETED|Overall Study||158
2468595|NCT00973700|6053237|P2|COMPLETED|Overall Study||54
2468596|NCT00973700|6053238|P1|COMPLETED|Overall Study||49
2468597|NCT00973700|6053234|P5|STARTED|Overall Study||168
2468598|NCT00973700|6053235|P4|STARTED|Overall Study||336
2468599|NCT00973700|6053236|P3|STARTED|Overall Study||168
2468600|NCT00973700|6053237|P2|STARTED|Overall Study||56
2468601|NCT00973700|6053238|P1|STARTED|Overall Study||56
2468602|NCT00973674|6053287|P2|NOT COMPLETED|Overall Study||0
2468603|NCT00973674|6053288|P1|NOT COMPLETED|Overall Study||2
2468604|NCT00973674|6053287|P2|COMPLETED|Overall Study||26
2468605|NCT00973674|6053288|P1|COMPLETED|Overall Study||22
2468606|NCT00973674|6053287|P2|STARTED|Overall Study||26
2468607|NCT00973674|6053288|P1|STARTED|Overall Study||24
2468608|NCT00973622|6053302|P2|NOT COMPLETED|Overall Study||5
2468609|NCT00973622|6053303|P1|NOT COMPLETED|Overall Study||31
2468610|NCT00973622|6053302|P2|COMPLETED|Overall Study|Completed three sessions of rTMS|14
2468611|NCT00973622|6053303|P1|COMPLETED|Overall Study|Completed three sessions of rTMS|16
2468612|NCT00973622|6053302|P2|STARTED|Overall Study|21 passed telephone interview; 19 passed the in-person interview, were enrolled, and sent for MRI.|19
2468613|NCT00973622|6053303|P1|STARTED|Overall Study|75 passed telephone interview; 28 passed in-person interview, were enrolled, and sent for MRI.|47
2468614|NCT00973479|6053311|P2|NOT COMPLETED|Overall Study||69
2468615|NCT00973479|6053312|P1|NOT COMPLETED|Overall Study||37
2468616|NCT00973479|6053311|P2|COMPLETED|Overall Study||326
2468617|NCT00973479|6053312|P1|COMPLETED|Overall Study||160
2468618|NCT00973479|6053311|P2|STARTED|Overall Study||395
2468619|NCT00973479|6053312|P1|STARTED|Overall Study||197
2468620|NCT00973362|6053330|P2|NOT COMPLETED|3-Year Follow-up||0
2468621|NCT00973362|6053331|P1|NOT COMPLETED|3-Year Follow-up||17
2468622|NCT00973362|6053330|P2|COMPLETED|3-Year Follow-up||0
2468623|NCT00973362|6053331|P1|COMPLETED|3-Year Follow-up||10854
2468624|NCT00973362|6053330|P2|STARTED|3-Year Follow-up|ASC-US study arm did not have a follow-up period|0
2468625|NCT00973362|6053331|P1|STARTED|3-Year Follow-up||10871
2468626|NCT00973362|6053330|P2|NOT COMPLETED|Baseline Evaluation||223
2468627|NCT00973362|6053331|P1|NOT COMPLETED|Baseline Evaluation||773
2468628|NCT00973362|6053330|P2|COMPLETED|Baseline Evaluation||1029
2468629|NCT00973362|6053331|P1|COMPLETED|Baseline Evaluation||10871
2468630|NCT00973362|6053330|P2|Conclusive Disease Status|Baseline Evaluation||939
2468631|NCT00973362|6053331|P1|Conclusive Disease Status|Baseline Evaluation||819
2468632|NCT00973362|6053330|P2|Evaluable for Analysis|Baseline Evaluation||958
2468633|NCT00973362|6053331|P1|Evaluable for Analysis|Baseline Evaluation||10871
2468634|NCT00973362|6053330|P2|STARTED|Baseline Evaluation||1252
2468635|NCT00973362|6053331|P1|STARTED|Baseline Evaluation||11644
2468636|NCT00973349|6053356|P16|NOT COMPLETED|Overall Study||2
2468637|NCT00973349|6053357|P15|NOT COMPLETED|Overall Study||2
2468638|NCT00973349|6053358|P14|NOT COMPLETED|Overall Study||0
2468639|NCT00973349|6053359|P13|NOT COMPLETED|Overall Study||1
2468640|NCT00973349|6053360|P12|NOT COMPLETED|Overall Study||2
2468641|NCT00973349|6053361|P11|NOT COMPLETED|Overall Study||0
2468642|NCT00973349|6053362|P10|NOT COMPLETED|Overall Study||6
2468643|NCT00973349|6053363|P9|NOT COMPLETED|Overall Study||4
2468645|NCT00973349|6053365|P7|NOT COMPLETED|Overall Study||2
2468646|NCT00973349|6053366|P6|NOT COMPLETED|Overall Study||4
2468647|NCT00973349|6053367|P5|NOT COMPLETED|Overall Study||5
2468648|NCT00973349|6053368|P4|NOT COMPLETED|Overall Study||5
2468649|NCT00973349|6053369|P3|NOT COMPLETED|Overall Study||5
2468650|NCT00973349|6053370|P2|NOT COMPLETED|Overall Study||3
2468651|NCT00973349|6053371|P1|NOT COMPLETED|Overall Study||4
2468652|NCT00973349|6053356|P16|COMPLETED|Overall Study||165
2468653|NCT00973349|6053357|P15|COMPLETED|Overall Study||168
2468654|NCT00973349|6053358|P14|COMPLETED|Overall Study||171
2468655|NCT00973349|6053359|P13|COMPLETED|Overall Study||168
2468656|NCT00973349|6053360|P12|COMPLETED|Overall Study||167
2468657|NCT00973349|6053361|P11|COMPLETED|Overall Study||174
2468658|NCT00973349|6053362|P10|COMPLETED|Overall Study||163
2468659|NCT00973349|6053363|P9|COMPLETED|Overall Study||167
2468660|NCT00973349|6053364|P8|COMPLETED|Overall Study||166
2468661|NCT00973349|6053365|P7|COMPLETED|Overall Study||172
2468662|NCT00973349|6053366|P6|COMPLETED|Overall Study||165
2468663|NCT00973349|6053367|P5|COMPLETED|Overall Study||165
2468664|NCT00973349|6053368|P4|COMPLETED|Overall Study||163
2468665|NCT00973349|6053369|P3|COMPLETED|Overall Study||166
2468666|NCT00973349|6053370|P2|COMPLETED|Overall Study||165
2468667|NCT00973349|6053371|P1|COMPLETED|Overall Study||166
2468668|NCT00973349|6053356|P16|STARTED|Overall Study||167
2468669|NCT00973349|6053357|P15|STARTED|Overall Study||170
2468670|NCT00973349|6053358|P14|STARTED|Overall Study||171
2468671|NCT00973349|6053359|P13|STARTED|Overall Study||169
2468672|NCT00973349|6053360|P12|STARTED|Overall Study||169
2468673|NCT00973349|6053361|P11|STARTED|Overall Study||174
2468674|NCT00973349|6053362|P10|STARTED|Overall Study||169
2468675|NCT00973349|6053363|P9|STARTED|Overall Study||171
2468676|NCT00973349|6053364|P8|STARTED|Overall Study||169
2468677|NCT00973349|6053365|P7|STARTED|Overall Study||174
2468678|NCT00973349|6053366|P6|STARTED|Overall Study||169
2468679|NCT00973349|6053367|P5|STARTED|Overall Study||170
2468680|NCT00973349|6053368|P4|STARTED|Overall Study||168
2468681|NCT00973349|6053369|P3|STARTED|Overall Study||171
2468682|NCT00973349|6053370|P2|STARTED|Overall Study||168
2468683|NCT00973349|6053371|P1|STARTED|Overall Study||170
2468684|NCT00972959|6053469|P1|NOT COMPLETED|Overall Study||0
2468685|NCT00972959|6053469|P1|COMPLETED|Overall Study||17
2468686|NCT00972959|6053469|P1|STARTED|Overall Study||17
2468687|NCT00972816|6053492|P8|NOT COMPLETED|Overall Study||9
2468688|NCT00972816|6053493|P7|NOT COMPLETED|Overall Study||10
2468689|NCT00972816|6053494|P6|NOT COMPLETED|Overall Study||11
2468690|NCT00972816|6053495|P5|NOT COMPLETED|Overall Study||12
2468691|NCT00972816|6053496|P4|NOT COMPLETED|Overall Study||8
2468692|NCT00972816|6053497|P3|NOT COMPLETED|Overall Study||9
2468693|NCT00972816|6053498|P2|NOT COMPLETED|Overall Study||11
2468694|NCT00972816|6053499|P1|NOT COMPLETED|Overall Study||17
2468695|NCT00972816|6053492|P8|COMPLETED|Overall Study||161
2468696|NCT00972816|6053493|P7|COMPLETED|Overall Study||159
2468697|NCT00972816|6053494|P6|COMPLETED|Overall Study||158
2468698|NCT00972816|6053495|P5|COMPLETED|Overall Study||157
2468699|NCT00972816|6053496|P4|COMPLETED|Overall Study||161
2468700|NCT00972816|6053497|P3|COMPLETED|Overall Study||160
2468701|NCT00972816|6053498|P2|COMPLETED|Overall Study||158
2468702|NCT00972816|6053499|P1|COMPLETED|Overall Study||156
2468703|NCT00972816|6053492|P8|STARTED|Overall Study||170
2468704|NCT00972816|6053493|P7|STARTED|Overall Study||169
2468705|NCT00972816|6053494|P6|STARTED|Overall Study||169
2468706|NCT00972816|6053495|P5|STARTED|Overall Study||169
2468707|NCT00972816|6053496|P4|STARTED|Overall Study||169
2468708|NCT00972816|6053497|P3|STARTED|Overall Study||169
2468709|NCT00972816|6053498|P2|STARTED|Overall Study||169
2468710|NCT00972816|6053499|P1|STARTED|Overall Study||173
2468711|NCT00972777|6053583|P2|NOT COMPLETED|Overall Study||14
2468712|NCT00972777|6053584|P1|NOT COMPLETED|Overall Study||14
2468713|NCT00972777|6053583|P2|COMPLETED|Overall Study||229
2468714|NCT00972777|6053584|P1|COMPLETED|Overall Study||217
2468715|NCT00972777|6053583|P2|STARTED|Overall Study||243
2468716|NCT00972777|6053584|P1|STARTED|Overall Study||231
2468717|NCT00972738|6053599|P3|NOT COMPLETED|Overall Study||29
2468718|NCT00972738|6053600|P2|NOT COMPLETED|Overall Study||6
2468719|NCT00972738|6053601|P1|NOT COMPLETED|Overall Study||21
2468720|NCT00972738|6053599|P3|COMPLETED|Overall Study||492
2468721|NCT00972738|6053600|P2|COMPLETED|Overall Study||165
2468722|NCT00972738|6053601|P1|COMPLETED|Overall Study||501
2468723|NCT00972738|6053599|P3|STARTED|Overall Study||521
2468724|NCT00972738|6053600|P2|STARTED|Overall Study||171
2468725|NCT00972738|6053601|P1|STARTED|Overall Study||522
2468726|NCT00972725|6053626|P2|NOT COMPLETED|Overall Study||0
2468727|NCT00972725|6053627|P1|NOT COMPLETED|Overall Study||0
2468728|NCT00972725|6053626|P2|COMPLETED|Overall Study||15
2468729|NCT00972725|6053627|P1|COMPLETED|Overall Study||13
2468730|NCT00972725|6053626|P2|STARTED|Overall Study||15
2468731|NCT00972725|6053627|P1|STARTED|Overall Study||13
2468732|NCT00972621|6053709|P2|NOT COMPLETED|Overall Study||1
2468733|NCT00972621|6053710|P1|NOT COMPLETED|Overall Study||0
2468734|NCT00972621|6053709|P2|COMPLETED|Overall Study|One subject discontinued due to lens exchange.|199
2468735|NCT00972621|6053710|P1|COMPLETED|Overall Study||200
2468736|NCT00972621|6053709|P2|STARTED|Overall Study||200
2468737|NCT00972621|6053710|P1|STARTED|Overall Study||200
2468738|NCT00972595|6053718|P2|NOT COMPLETED|Period 2||0
2468739|NCT00972595|6053719|P1|NOT COMPLETED|Period 2||0
2468740|NCT00972595|6053718|P2|COMPLETED|Period 2||22
2468741|NCT00972595|6053719|P1|COMPLETED|Period 2||22
2468742|NCT00972595|6053718|P2|STARTED|Period 2||22
2468743|NCT00972595|6053719|P1|STARTED|Period 2||22
2468744|NCT00972595|6053718|P2|NOT COMPLETED|Period 1||0
2468745|NCT00972595|6053719|P1|NOT COMPLETED|Period 1||1
2468746|NCT00972595|6053718|P2|COMPLETED|Period 1||22
2468747|NCT00972595|6053719|P1|COMPLETED|Period 1||22
2468748|NCT00972595|6053718|P2|STARTED|Period 1||22
2468749|NCT00972595|6053719|P1|STARTED|Period 1||23
2468750|NCT00972543|6053729|P2|NOT COMPLETED|Overall Study||1
2468751|NCT00972543|6053730|P1|NOT COMPLETED|Overall Study||5
2468752|NCT00972543|6053729|P2|COMPLETED|Overall Study||0
2468753|NCT00972543|6053730|P1|COMPLETED|Overall Study||0
2468754|NCT00972543|6053729|P2|STARTED|Overall Study||1
2468755|NCT00972543|6053730|P1|STARTED|Overall Study||5
2468756|NCT00972530|6053806|P2|NOT COMPLETED|Overall Study||0
2468757|NCT00972530|6053807|P1|NOT COMPLETED|Overall Study||0
2468758|NCT00972530|6053806|P2|COMPLETED|Overall Study||46
2468759|NCT00972530|6053807|P1|COMPLETED|Overall Study||44
2468760|NCT00972530|6053806|P2|STARTED|Overall Study||46
2468761|NCT00972530|6053807|P1|STARTED|Overall Study||44
2468762|NCT00972517|6053813|P6|NOT COMPLETED|Overall Study||0
2468763|NCT00972517|6053814|P5|NOT COMPLETED|Overall Study||1
2468764|NCT00972517|6053815|P4|NOT COMPLETED|Overall Study||3
2468765|NCT00972517|6053816|P3|NOT COMPLETED|Overall Study||0
2468766|NCT00972517|6053817|P2|NOT COMPLETED|Overall Study||1
2468767|NCT00972517|6053818|P1|NOT COMPLETED|Overall Study||0
2468768|NCT00972517|6053813|P6|COMPLETED|Overall Study||58
2468769|NCT00972517|6053814|P5|COMPLETED|Overall Study||33
2468770|NCT00972517|6053815|P4|COMPLETED|Overall Study||27
2468771|NCT00972517|6053816|P3|COMPLETED|Overall Study||60
2468772|NCT00972517|6053817|P2|COMPLETED|Overall Study||30
2468773|NCT00972517|6053818|P1|COMPLETED|Overall Study||31
2468774|NCT00972517|6053813|P6|STARTED|Overall Study||58
2468775|NCT00972517|6053814|P5|STARTED|Overall Study||34
2468776|NCT00972517|6053815|P4|STARTED|Overall Study||30
2468777|NCT00972517|6053816|P3|STARTED|Overall Study||60
2468778|NCT00972517|6053817|P2|STARTED|Overall Study||31
2468779|NCT00972517|6053818|P1|STARTED|Overall Study||31
2468780|NCT00972504|6053913|P1|NOT COMPLETED|Overall Study||3
2468781|NCT00972504|6053913|P1|COMPLETED|Overall Study||51
2468782|NCT00972504|6053913|P1|STARTED|Overall Study||54
2468791|NCT00972439|6053958|P2|NOT COMPLETED|Overall Study||0
2468792|NCT00972439|6053959|P1|NOT COMPLETED|Overall Study||0
2468793|NCT00972439|6053958|P2|COMPLETED|Overall Study||16
2468794|NCT00972439|6053959|P1|COMPLETED|Overall Study||17
2468795|NCT00972439|6053958|P2|STARTED|Overall Study||16
2468796|NCT00972439|6053959|P1|STARTED|Overall Study||17
2468797|NCT00972374|6053968|P3|NOT COMPLETED|Overall Study||1
2468798|NCT00972374|6053969|P2|NOT COMPLETED|Overall Study||0
2468799|NCT00972374|6053970|P1|NOT COMPLETED|Overall Study||2
2468800|NCT00972374|6053968|P3|COMPLETED|Overall Study||13
2468801|NCT00972374|6053969|P2|COMPLETED|Overall Study||15
2468802|NCT00972374|6053970|P1|COMPLETED|Overall Study||13
2468803|NCT00972374|6053968|P3|STARTED|Overall Study||14
2468804|NCT00972374|6053969|P2|STARTED|Overall Study||15
2468805|NCT00972374|6053970|P1|STARTED|Overall Study||15
2468806|NCT00972335|6053984|P1|NOT COMPLETED|Overall Study||17
2468807|NCT00972335|6053984|P1|COMPLETED|Overall Study|Patients were on study until an event or condition occured which required them to come off study|0
2468808|NCT00972335|6053984|P1|STARTED|Overall Study|One patient was enrolled but showed no evidence of disease at study entry and was not treated|17
2468809|NCT00972322|6053991|P2|NOT COMPLETED|Overall Study||3
2468810|NCT00972322|6053992|P1|NOT COMPLETED|Overall Study||3
2468811|NCT00972322|6053991|P2|COMPLETED|Overall Study||25
2468812|NCT00972322|6053992|P1|COMPLETED|Overall Study||25
2468813|NCT00972322|6053991|P2|STARTED|Overall Study||28
2468814|NCT00972322|6053992|P1|STARTED|Overall Study||28
2468815|NCT00972283|6054004|P2|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||8
2468816|NCT00972283|6054005|P1|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||27
2468817|NCT00972283|6054004|P2|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||183
2468818|NCT00972283|6054005|P1|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||539
2468819|NCT00972283|6054004|P2|STARTED|Extension: Week 53 to 78 (NN1250-3667)|20 subjects did not continue into the extension from main trial|191
2468820|NCT00972283|6054005|P1|STARTED|Extension: Week 53 to 78 (NN1250-3667)|52 subjects did not continue into the extension from main trial|566
2468821|NCT00972283|6054004|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||40
2468822|NCT00972283|6054005|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||137
2468823|NCT00972283|6054004|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||211
2468824|NCT00972283|6054005|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||618
2468825|NCT00972283|6054004|P2|Exposed|Main: Week 0 to 52 (NN1250-3582)||251
2468826|NCT00972283|6054005|P1|Exposed|Main: Week 0 to 52 (NN1250-3582)|2 subjects were withdrawn prior to exposure to trial products|753
2468827|NCT00972283|6054004|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|3 subjects were excluded due to closure of a site|248
2468925|NCT00971633|6054164|P2|NOT COMPLETED|Period 1||0
2468828|NCT00972283|6054005|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|11 subjects were excluded due to closure of a site|744
2468829|NCT00972283|6054004|P2|STARTED|Main: Week 0 to 52 (NN1250-3582)||251
2468830|NCT00972283|6054005|P1|STARTED|Main: Week 0 to 52 (NN1250-3582)||755
2468831|NCT00972244|6054032|P5|NOT COMPLETED|Overall Study||9
2468832|NCT00972244|6054033|P4|NOT COMPLETED|Overall Study||0
2468833|NCT00972244|6054034|P3|NOT COMPLETED|Overall Study||2
2468834|NCT00972244|6054035|P2|NOT COMPLETED|Overall Study||5
2468835|NCT00972244|6054036|P1|NOT COMPLETED|Overall Study||5
2468836|NCT00972244|6054032|P5|COMPLETED|Overall Study||45
2468837|NCT00972244|6054033|P4|COMPLETED|Overall Study||52
2468838|NCT00972244|6054034|P3|COMPLETED|Overall Study||56
2468839|NCT00972244|6054035|P2|COMPLETED|Overall Study||51
2468840|NCT00972244|6054036|P1|COMPLETED|Overall Study||54
2468841|NCT00972244|6054032|P5|STARTED|Overall Study||54
2468842|NCT00972244|6054033|P4|STARTED|Overall Study||52
2468843|NCT00972244|6054034|P3|STARTED|Overall Study||58
2468844|NCT00972244|6054035|P2|STARTED|Overall Study||56
2468845|NCT00972244|6054036|P1|STARTED|Overall Study||59
2468846|NCT00972205|6054058|P1|NOT COMPLETED|Overall Study||0
2468847|NCT00972205|6054058|P1|COMPLETED|Overall Study||12
2468848|NCT00972205|6054058|P1|STARTED|Overall Study||12
2468849|NCT00972153|6054068|P3|NOT COMPLETED|Overall Study||0
2468850|NCT00972153|6054069|P2|NOT COMPLETED|Overall Study||1
2468851|NCT00972153|6054070|P1|NOT COMPLETED|Overall Study||0
2468852|NCT00972153|6054068|P3|COMPLETED|Overall Study||12
2468853|NCT00972153|6054069|P2|COMPLETED|Overall Study|One case excluded due to technical problem with measuring equipment.|11
2468854|NCT00972153|6054070|P1|COMPLETED|Overall Study||12
2468855|NCT00972153|6054068|P3|STARTED|Overall Study||12
2468856|NCT00972153|6054069|P2|STARTED|Overall Study||12
2468857|NCT00972153|6054070|P1|STARTED|Overall Study||12
2468858|NCT00972088|6054081|P1|NOT COMPLETED|Overall Study||0
2468859|NCT00972088|6054081|P1|COMPLETED|Overall Study||26
2468860|NCT00972088|6054081|P1|STARTED|Overall Study||26
2468861|NCT00972023|6054085|P1|NOT COMPLETED|Overall Study||1
2468862|NCT00972023|6054085|P1|COMPLETED|Overall Study||0
2468863|NCT00972023|6054085|P1|STARTED|Overall Study||1
2468864|NCT00971997|6054092|P1|NOT COMPLETED|Overall Study||19
2468865|NCT00971997|6054092|P1|COMPLETED|Overall Study||116
2468866|NCT00971997|6054092|P1|STARTED|Overall Study||135
2468867|NCT00971932|6054110|P1|NOT COMPLETED|Overall Study||7
2468868|NCT00971932|6054110|P1|COMPLETED|Overall Study||26
2468869|NCT00971932|6054110|P1|STARTED|Overall Study|Number of participants treated.|33
2468870|NCT00971841|6054120|P1|NOT COMPLETED|Overall Study||0
2468871|NCT00971841|6054120|P1|COMPLETED|Overall Study||1
2468872|NCT00971841|6054120|P1|STARTED|Overall Study||1
2468873|NCT00971789|6054125|P1|NOT COMPLETED|Overall Study||0
2468874|NCT00971789|6054125|P1|COMPLETED|Overall Study||18
2468875|NCT00971789|6054125|P1|STARTED|Overall Study||18
2468876|NCT00971750|6054130|P1|NOT COMPLETED|Overall Study||0
2468877|NCT00971750|6054130|P1|COMPLETED|Overall Study||253
2468878|NCT00971750|6054130|P1|STARTED|Overall Study||253
2468879|NCT00971737|6054141|P2|NOT COMPLETED|Overall Study||0
2468880|NCT00971737|6054142|P1|NOT COMPLETED|Overall Study||0
2468881|NCT00971737|6054141|P2|COMPLETED|Overall Study||30
2468882|NCT00971737|6054142|P1|COMPLETED|Overall Study||30
2468883|NCT00971737|6054141|P2|STARTED|Overall Study||30
2468884|NCT00971737|6054142|P1|STARTED|Overall Study||30
2468885|NCT00971633|6054160|P6|NOT COMPLETED|Period 3||0
2468886|NCT00971633|6054161|P5|NOT COMPLETED|Period 3||0
2468887|NCT00971633|6054162|P4|NOT COMPLETED|Period 3||0
2468888|NCT00971633|6054163|P3|NOT COMPLETED|Period 3||0
2468889|NCT00971633|6054164|P2|NOT COMPLETED|Period 3||0
2468890|NCT00971633|6054165|P1|NOT COMPLETED|Period 3||0
2468891|NCT00971633|6054160|P6|COMPLETED|Period 3||2
2468892|NCT00971633|6054161|P5|COMPLETED|Period 3||2
2468893|NCT00971633|6054162|P4|COMPLETED|Period 3||2
2468894|NCT00971633|6054163|P3|COMPLETED|Period 3||2
2468895|NCT00971633|6054164|P2|COMPLETED|Period 3||2
2468896|NCT00971633|6054165|P1|COMPLETED|Period 3||2
2468897|NCT00971633|6054160|P6|STARTED|Period 3||2
2468898|NCT00971633|6054161|P5|STARTED|Period 3||2
2468899|NCT00971633|6054162|P4|STARTED|Period 3||2
2468900|NCT00971633|6054163|P3|STARTED|Period 3||2
2468901|NCT00971633|6054164|P2|STARTED|Period 3||2
2468902|NCT00971633|6054165|P1|STARTED|Period 3||2
2468903|NCT00971633|6054160|P6|NOT COMPLETED|Period 2||0
2468904|NCT00971633|6054161|P5|NOT COMPLETED|Period 2||0
2468905|NCT00971633|6054162|P4|NOT COMPLETED|Period 2||0
2468906|NCT00971633|6054163|P3|NOT COMPLETED|Period 2||0
2468907|NCT00971633|6054164|P2|NOT COMPLETED|Period 2||0
2468908|NCT00971633|6054165|P1|NOT COMPLETED|Period 2||0
2468909|NCT00971633|6054160|P6|COMPLETED|Period 2||2
2468910|NCT00971633|6054161|P5|COMPLETED|Period 2||2
2468911|NCT00971633|6054162|P4|COMPLETED|Period 2||2
2468912|NCT00971633|6054163|P3|COMPLETED|Period 2||2
2468913|NCT00971633|6054164|P2|COMPLETED|Period 2||2
2468914|NCT00971633|6054165|P1|COMPLETED|Period 2||2
2468915|NCT00971633|6054160|P6|STARTED|Period 2||2
2468916|NCT00971633|6054161|P5|STARTED|Period 2||2
2468917|NCT00971633|6054162|P4|STARTED|Period 2||2
2468918|NCT00971633|6054163|P3|STARTED|Period 2||2
2468919|NCT00971633|6054164|P2|STARTED|Period 2||2
2468920|NCT00971633|6054165|P1|STARTED|Period 2||2
2468921|NCT00971633|6054160|P6|NOT COMPLETED|Period 1||0
2468922|NCT00971633|6054161|P5|NOT COMPLETED|Period 1||0
2468923|NCT00971633|6054162|P4|NOT COMPLETED|Period 1||0
2468924|NCT00971633|6054163|P3|NOT COMPLETED|Period 1||0
2468926|NCT00971633|6054165|P1|NOT COMPLETED|Period 1||0
2468927|NCT00971633|6054160|P6|COMPLETED|Period 1||2
2468928|NCT00971633|6054161|P5|COMPLETED|Period 1||2
2468929|NCT00971633|6054162|P4|COMPLETED|Period 1||2
2468930|NCT00971633|6054163|P3|COMPLETED|Period 1||2
2468931|NCT00971633|6054164|P2|COMPLETED|Period 1||2
2468932|NCT00971633|6054165|P1|COMPLETED|Period 1||2
2468933|NCT00971633|6054160|P6|STARTED|Period 1||2
2468934|NCT00971633|6054161|P5|STARTED|Period 1||2
2468935|NCT00971633|6054162|P4|STARTED|Period 1||2
2468936|NCT00971633|6054163|P3|STARTED|Period 1||2
2468937|NCT00971633|6054164|P2|STARTED|Period 1||2
2468938|NCT00971633|6054165|P1|STARTED|Period 1||2
2468939|NCT00971620|6054178|P2|NOT COMPLETED|Overall Study||0
2468940|NCT00971620|6054179|P1|NOT COMPLETED|Overall Study||0
2468941|NCT00971620|6054178|P2|COMPLETED|Overall Study||9
2468942|NCT00971620|6054179|P1|COMPLETED|Overall Study||9
2468943|NCT00971620|6054178|P2|STARTED|Overall Study||9
2468944|NCT00971620|6054179|P1|STARTED|Overall Study||9
2468945|NCT00971425|6054211|P2|NOT COMPLETED|Overall Study||2
2468946|NCT00971425|6054212|P1|NOT COMPLETED|Overall Study||1
2468947|NCT00971425|6054211|P2|COMPLETED|Overall Study||71
2468948|NCT00971425|6054212|P1|COMPLETED|Overall Study||71
2468949|NCT00971425|6054211|P2|STARTED|Overall Study||73
2468950|NCT00971425|6054212|P1|STARTED|Overall Study||72
2468951|NCT00971321|6054248|P2|NOT COMPLETED|Up to Month 11-12||3
2468952|NCT00971321|6054249|P1|NOT COMPLETED|Up to Month 11-12||5
2468953|NCT00971321|6054248|P2|COMPLETED|Up to Month 11-12||50
2468954|NCT00971321|6054249|P1|COMPLETED|Up to Month 11-12||99
2468955|NCT00971321|6054248|P2|STARTED|Up to Month 11-12||53
2468956|NCT00971321|6054249|P1|STARTED|Up to Month 11-12||104
2468957|NCT00971321|6054248|P2|NOT COMPLETED|Up to Month 7||2
2468958|NCT00971321|6054249|P1|NOT COMPLETED|Up to Month 7||4
2468959|NCT00971321|6054248|P2|COMPLETED|Up to Month 7||51
2468960|NCT00971321|6054249|P1|COMPLETED|Up to Month 7||100
2468961|NCT00971321|6054248|P2|STARTED|Up to Month 7||53
2468962|NCT00971321|6054249|P1|STARTED|Up to Month 7||104
2468963|NCT00971321|6054248|P2|NOT COMPLETED|Up to Day 42||0
2468964|NCT00971321|6054249|P1|NOT COMPLETED|Up to Day 42||0
2468965|NCT00971321|6054248|P2|COMPLETED|Up to Day 42||53
2468966|NCT00971321|6054249|P1|COMPLETED|Up to Day 42||104
2468967|NCT00971321|6054248|P2|STARTED|Up to Day 42||53
2468968|NCT00971321|6054249|P1|STARTED|Up to Day 42||104
2468969|NCT00971295|6054299|P2|NOT COMPLETED|Overall Study||1
2468970|NCT00971295|6054300|P1|NOT COMPLETED|Overall Study||0
2468971|NCT00971295|6054299|P2|COMPLETED|Overall Study||9
2468972|NCT00971295|6054300|P1|COMPLETED|Overall Study||10
2468973|NCT00971295|6054299|P2|STARTED|Overall Study||10
2468974|NCT00971295|6054300|P1|STARTED|Overall Study||10
2468975|NCT00971282|6054310|P1|NOT COMPLETED|Overall Study||0
2468976|NCT00971282|6054310|P1|COMPLETED|Overall Study||30
2468977|NCT00971282|6054310|P1|STARTED|Overall Study||30
2468978|NCT00971243|6054329|P5|NOT COMPLETED|Open-label Period||6
2468979|NCT00971243|6054330|P4|NOT COMPLETED|Open-label Period||10
2468980|NCT00971243|6054331|P3|NOT COMPLETED|Open-label Period||5
2468981|NCT00971243|6054332|P2|NOT COMPLETED|Open-label Period||10
2468982|NCT00971243|6054333|P1|NOT COMPLETED|Open-label Period||8
2468983|NCT00971243|6054329|P5|COMPLETED|Open-label Period||64
2468984|NCT00971243|6054330|P4|COMPLETED|Open-label Period||64
2468985|NCT00971243|6054331|P3|COMPLETED|Open-label Period||66
2468986|NCT00971243|6054332|P2|COMPLETED|Open-label Period||71
2468987|NCT00971243|6054333|P1|COMPLETED|Open-label Period||60
2468988|NCT00971243|6054329|P5|STARTED|Open-label Period||70
2468989|NCT00971243|6054330|P4|STARTED|Open-label Period||74
2468990|NCT00971243|6054331|P3|STARTED|Open-label Period|One Subject did not entered the Open-label Period because of the withdrawal of consent.|71
2468991|NCT00971243|6054332|P2|STARTED|Open-label Period|One Subject did not entered because of the failure of inclusion/exclusion criteria.|81
2468992|NCT00971243|6054333|P1|STARTED|Open-label Period||68
2468993|NCT00971243|6054329|P5|NOT COMPLETED|Double Blind Period||18
2468994|NCT00971243|6054330|P4|NOT COMPLETED|Double Blind Period||14
2468995|NCT00971243|6054331|P3|NOT COMPLETED|Double Blind Period||19
2468996|NCT00971243|6054332|P2|NOT COMPLETED|Double Blind Period||11
2468997|NCT00971243|6054333|P1|NOT COMPLETED|Double Blind Period||19
2468998|NCT00971243|6054329|P5|COMPLETED|Double Blind Period||70
2468999|NCT00971243|6054330|P4|COMPLETED|Double Blind Period||74
2469000|NCT00971243|6054331|P3|COMPLETED|Double Blind Period||72
2469001|NCT00971243|6054332|P2|COMPLETED|Double Blind Period||82
2469002|NCT00971243|6054333|P1|COMPLETED|Double Blind Period||68
2469003|NCT00971243|6054329|P5|STARTED|Double Blind Period||88
2469004|NCT00971243|6054330|P4|STARTED|Double Blind Period|One subject who did not receive any study drug was excluded from the ITT|88
2469005|NCT00971243|6054331|P3|STARTED|Double Blind Period||91
2469006|NCT00971243|6054332|P2|STARTED|Double Blind Period||93
2469007|NCT00971243|6054333|P1|STARTED|Double Blind Period||87
2469008|NCT00971204|6054350|P1|NOT COMPLETED|Overall Study||24
2469009|NCT00971204|6054350|P1|COMPLETED|Overall Study|86 participants were treated and of these 86, 76 completed the study.|76
2469010|NCT00971204|6054350|P1|Treated|Overall Study||86
2469011|NCT00971204|6054350|P1|STARTED|Overall Study|100 enrolled participants|100
2469012|NCT00971048|6054358|P4|NOT COMPLETED|Overall Study||2
2469013|NCT00971048|6054359|P3|NOT COMPLETED|Overall Study||1
2469014|NCT00971048|6054360|P2|NOT COMPLETED|Overall Study||2
2469015|NCT00971048|6054361|P1|NOT COMPLETED|Overall Study||1
2469016|NCT00971048|6054358|P4|COMPLETED|Overall Study||11
2469017|NCT00971048|6054359|P3|COMPLETED|Overall Study||11
2469018|NCT00971048|6054360|P2|COMPLETED|Overall Study||31
2469019|NCT00971048|6054361|P1|COMPLETED|Overall Study||29
2469020|NCT00971048|6054358|P4|STARTED|Overall Study||13
2469021|NCT00971048|6054359|P3|STARTED|Overall Study||12
2469022|NCT00971048|6054360|P2|STARTED|Overall Study||33
2469023|NCT00971048|6054361|P1|STARTED|Overall Study||30
2469024|NCT00970944|6054385|P2|NOT COMPLETED|Overall Study||2
2469025|NCT00970944|6054386|P1|NOT COMPLETED|Overall Study||1
2469026|NCT00970944|6054385|P2|COMPLETED|Overall Study||95
2469027|NCT00970944|6054386|P1|COMPLETED|Overall Study||86
2469028|NCT00970944|6054385|P2|STARTED|Overall Study||97
2469029|NCT00970944|6054386|P1|STARTED|Overall Study||87
2469030|NCT00970853|6054396|P2|NOT COMPLETED|Overall Study||0
2469031|NCT00970853|6054397|P1|NOT COMPLETED|Overall Study||0
2469032|NCT00970853|6054396|P2|COMPLETED|Overall Study||98
2469033|NCT00970853|6054397|P1|COMPLETED|Overall Study||89
2469034|NCT00970853|6054396|P2|STARTED|Overall Study||98
2469035|NCT00970853|6054397|P1|STARTED|Overall Study||89
2469036|NCT00970814|6054421|P2|NOT COMPLETED|Overall Study||14
2469037|NCT00970814|6054422|P1|NOT COMPLETED|Overall Study||8
2469038|NCT00970814|6054421|P2|COMPLETED|Overall Study||50
2469039|NCT00970814|6054422|P1|COMPLETED|Overall Study||58
2469040|NCT00970814|6054421|P2|STARTED|Overall Study||64
2469041|NCT00970814|6054422|P1|STARTED|Overall Study||66
2469042|NCT00970736|6054432|P1|NOT COMPLETED|Overall Study||2
2469043|NCT00970736|6054432|P1|COMPLETED|Overall Study||18
2469044|NCT00970736|6054432|P1|STARTED|Overall Study||20
2469045|NCT00970684|6054438|P1|NOT COMPLETED|Overall Study||10
2469046|NCT00970684|6054438|P1|COMPLETED|Overall Study||3
2469047|NCT00970684|6054438|P1|STARTED|Overall Study||13
2469048|NCT00970632|6054447|P3|NOT COMPLETED|Overall Study||18
2469049|NCT00970632|6054448|P2|NOT COMPLETED|Overall Study||15
2469050|NCT00970632|6054449|P1|NOT COMPLETED|Overall Study||24
2469051|NCT00970632|6054447|P3|COMPLETED|Overall Study||150
2469052|NCT00970632|6054448|P2|COMPLETED|Overall Study||156
2469053|NCT00970632|6054449|P1|COMPLETED|Overall Study||148
2469054|NCT00970632|6054447|P3|STARTED|Overall Study||168
2469055|NCT00970632|6054448|P2|STARTED|Overall Study||171
2469056|NCT00970632|6054449|P1|STARTED|Overall Study||172
2469057|NCT00970606|6054507|P2|NOT COMPLETED|Overall Study||0
2469058|NCT00970606|6054508|P1|NOT COMPLETED|Overall Study||0
2469059|NCT00970606|6054507|P2|COMPLETED|Overall Study||3
2469060|NCT00970606|6054508|P1|COMPLETED|Overall Study||4
2469061|NCT00970606|6054507|P2|STARTED|Overall Study||3
2469062|NCT00970606|6054508|P1|STARTED|Overall Study||4
2469063|NCT00970502|6054514|P1|NOT COMPLETED|Overall Study||1
2469064|NCT00970502|6054514|P1|COMPLETED|Overall Study||14
2469065|NCT00970502|6054514|P1|STARTED|Overall Study||15
2469066|NCT00970489|6054525|P2|NOT COMPLETED|Overall Study||41
2469067|NCT00970489|6054526|P1|NOT COMPLETED|Overall Study||54
2469068|NCT00970489|6054525|P2|COMPLETED|Overall Study||717
2469069|NCT00970489|6054526|P1|COMPLETED|Overall Study||704
2469070|NCT00970489|6054525|P2|STARTED|Overall Study||758
2469071|NCT00970489|6054526|P1|STARTED|Overall Study||758
2469072|NCT00970359|6054538|P1|NOT COMPLETED|Overall Study||4
2469073|NCT00970359|6054538|P1|COMPLETED|Overall Study||20
2469074|NCT00970359|6054538|P1|STARTED|Overall Study||24
2469075|NCT00970320|6054549|P5|NOT COMPLETED|Overall Study||540
2469076|NCT00970320|6054550|P4|NOT COMPLETED|Overall Study||14
2469077|NCT00970320|6054551|P3|NOT COMPLETED|Overall Study||13
2469078|NCT00970320|6054552|P2|NOT COMPLETED|Overall Study||11
2469079|NCT00970320|6054553|P1|NOT COMPLETED|Overall Study||0
2469080|NCT00970320|6054549|P5|COMPLETED|Overall Study||1031
2469081|NCT00970320|6054550|P4|COMPLETED|Overall Study||36
2469082|NCT00970320|6054551|P3|COMPLETED|Overall Study||35
2469083|NCT00970320|6054552|P2|COMPLETED|Overall Study||13
2469084|NCT00970320|6054553|P1|COMPLETED|Overall Study||25
2469085|NCT00970320|6054549|P5|STARTED|Overall Study||1571
2469086|NCT00970320|6054550|P4|STARTED|Overall Study||50
2469087|NCT00970320|6054551|P3|STARTED|Overall Study||48
2469088|NCT00970320|6054552|P2|STARTED|Overall Study||24
2469089|NCT00970320|6054553|P1|STARTED|Overall Study||25
2469090|NCT00970307|6054568|P3|NOT COMPLETED|Overall Study||2
2469091|NCT00970307|6054569|P2|NOT COMPLETED|Overall Study||3
2469092|NCT00970307|6054570|P1|NOT COMPLETED|Overall Study||3
2469093|NCT00970307|6054568|P3|COMPLETED|Overall Study||139
2469094|NCT00970307|6054569|P2|COMPLETED|Overall Study||136
2469095|NCT00970307|6054570|P1|COMPLETED|Overall Study||138
2469096|NCT00970307|6054568|P3|STARTED|Overall Study||141
2469097|NCT00970307|6054569|P2|STARTED|Overall Study||139
2469098|NCT00970307|6054570|P1|STARTED|Overall Study||141
2469099|NCT00970294|6054644|P1|NOT COMPLETED|Overall Study||5
2469100|NCT00970294|6054644|P1|COMPLETED|Overall Study||6
2469101|NCT00970294|6054644|P1|STARTED|Overall Study||11
2469102|NCT00970281|6054652|P2|NOT COMPLETED|Overall Study||16
2469103|NCT00970281|6054653|P1|NOT COMPLETED|Overall Study||2
2469104|NCT00970281|6054652|P2|COMPLETED|Overall Study||29
2469105|NCT00970281|6054653|P1|COMPLETED|Overall Study||44
2469106|NCT00970281|6054652|P2|Full Analysis Set|Overall Study||45
2469107|NCT00970281|6054653|P1|Full Analysis Set|Overall Study|1 participant in the olanzapine arm discontinued before the first intramuscular (IM) injection.|45
2469108|NCT00970281|6054652|P2|STARTED|Overall Study||45
2469109|NCT00970281|6054653|P1|STARTED|Overall Study||46
2469110|NCT00970268|6054671|P2|NOT COMPLETED|Overall Study||49
2469111|NCT00970268|6054672|P1|NOT COMPLETED|Overall Study||43
2469112|NCT00970268|6054671|P2|COMPLETED|Overall Study||103
2469113|NCT00970268|6054672|P1|COMPLETED|Overall Study||96
2469114|NCT00970268|6054671|P2|STARTED|Overall Study||152
2469115|NCT00970268|6054672|P1|STARTED|Overall Study||139
2469116|NCT00970216|6054686|P1|NOT COMPLETED|Overall Study||80
2469117|NCT00970216|6054686|P1|COMPLETED|Overall Study||80
2469118|NCT00970216|6054686|P1|STARTED|Overall Study||160
2469119|NCT00970073|6054693|P3|NOT COMPLETED|Overall Study||0
2469120|NCT00970073|6054694|P2|NOT COMPLETED|Overall Study||0
2469121|NCT00970073|6054695|P1|NOT COMPLETED|Overall Study||0
2469122|NCT00970073|6054693|P3|COMPLETED|Overall Study||10
2469123|NCT00970073|6054694|P2|COMPLETED|Overall Study||10
2469124|NCT00970073|6054695|P1|COMPLETED|Overall Study||10
2469125|NCT00970073|6054693|P3|STARTED|Overall Study||10
2469126|NCT00970073|6054694|P2|STARTED|Overall Study||10
2469127|NCT00970073|6054695|P1|STARTED|Overall Study||10
2469128|NCT00969878|6054714|P2|NOT COMPLETED|Overall Study||26
2469129|NCT00969878|6054715|P1|NOT COMPLETED|Overall Study||30
2469130|NCT00969878|6054714|P2|COMPLETED|Overall Study||126
2469131|NCT00969878|6054715|P1|COMPLETED|Overall Study||118
2469132|NCT00969878|6054714|P2|STARTED|Overall Study||152
2469133|NCT00969878|6054715|P1|STARTED|Overall Study||148
2469134|NCT00969761|6054735|P12|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
2469135|NCT00969761|6054736|P11|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
2469136|NCT00969761|6054737|P10|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||2
2469137|NCT00969761|6054738|P9|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||11
2469138|NCT00969761|6054739|P8|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||6
2469139|NCT00969761|6054740|P7|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
2469140|NCT00969761|6054741|P6|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
2469141|NCT00969761|6054742|P5|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
2469142|NCT00969761|6054743|P4|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||5
2469143|NCT00969761|6054744|P3|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||10
2469144|NCT00969761|6054745|P2|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
2469145|NCT00969761|6054746|P1|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||2
2469146|NCT00969761|6054735|P12|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
2469147|NCT00969761|6054736|P11|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
2469148|NCT00969761|6054737|P10|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
2469149|NCT00969761|6054738|P9|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
2469150|NCT00969761|6054739|P8|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
2469151|NCT00969761|6054740|P7|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
2469152|NCT00969761|6054741|P6|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
2469153|NCT00969761|6054742|P5|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
2469154|NCT00969761|6054743|P4|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
2469155|NCT00969761|6054744|P3|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
2469156|NCT00969761|6054745|P2|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
2469157|NCT00969761|6054746|P1|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
2469158|NCT00969761|6054735|P12|STARTED|Treated in and Beyond Treat. Cycle 2||3
2469159|NCT00969761|6054736|P11|STARTED|Treated in and Beyond Treat. Cycle 2||3
2469160|NCT00969761|6054737|P10|STARTED|Treated in and Beyond Treat. Cycle 2||2
2469161|NCT00969761|6054738|P9|STARTED|Treated in and Beyond Treat. Cycle 2||11
2469162|NCT00969761|6054739|P8|STARTED|Treated in and Beyond Treat. Cycle 2||6
2469163|NCT00969761|6054740|P7|STARTED|Treated in and Beyond Treat. Cycle 2||3
2469164|NCT00969761|6054741|P6|STARTED|Treated in and Beyond Treat. Cycle 2||3
2469165|NCT00969761|6054742|P5|STARTED|Treated in and Beyond Treat. Cycle 2||3
2469166|NCT00969761|6054743|P4|STARTED|Treated in and Beyond Treat. Cycle 2||5
2469167|NCT00969761|6054744|P3|STARTED|Treated in and Beyond Treat. Cycle 2||10
2469168|NCT00969761|6054745|P2|STARTED|Treated in and Beyond Treat. Cycle 2||3
2469169|NCT00969761|6054746|P1|STARTED|Treated in and Beyond Treat. Cycle 2||2
2469170|NCT00969761|6054735|P12|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
2469171|NCT00969761|6054736|P11|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
2469172|NCT00969761|6054737|P10|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
2469173|NCT00969761|6054738|P9|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||2
2469174|NCT00969761|6054739|P8|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
2469175|NCT00969761|6054740|P7|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
2469176|NCT00969761|6054741|P6|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
2469177|NCT00969761|6054742|P5|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
2469178|NCT00969761|6054743|P4|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
2469179|NCT00969761|6054744|P3|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||2
2469180|NCT00969761|6054745|P2|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
2469181|NCT00969761|6054746|P1|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
2469182|NCT00969761|6054735|P12|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
2469183|NCT00969761|6054736|P11|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
2469184|NCT00969761|6054737|P10|COMPLETED|Discont. Before Start of Treat. Cycle 2||2
2469185|NCT00969761|6054738|P9|COMPLETED|Discont. Before Start of Treat. Cycle 2||11
2469186|NCT00969761|6054739|P8|COMPLETED|Discont. Before Start of Treat. Cycle 2||6
2469187|NCT00969761|6054740|P7|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
2469188|NCT00969761|6054741|P6|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
2469189|NCT00969761|6054742|P5|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
2469190|NCT00969761|6054743|P4|COMPLETED|Discont. Before Start of Treat. Cycle 2||5
2469191|NCT00969761|6054744|P3|COMPLETED|Discont. Before Start of Treat. Cycle 2||10
2469192|NCT00969761|6054745|P2|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
2469193|NCT00969761|6054746|P1|COMPLETED|Discont. Before Start of Treat. Cycle 2||2
2469194|NCT00969761|6054735|P12|STARTED|Discont. Before Start of Treat. Cycle 2||3
2469195|NCT00969761|6054736|P11|STARTED|Discont. Before Start of Treat. Cycle 2||3
2469196|NCT00969761|6054737|P10|STARTED|Discont. Before Start of Treat. Cycle 2||3
2469197|NCT00969761|6054738|P9|STARTED|Discont. Before Start of Treat. Cycle 2||13
2469198|NCT00969761|6054739|P8|STARTED|Discont. Before Start of Treat. Cycle 2||6
2469199|NCT00969761|6054740|P7|STARTED|Discont. Before Start of Treat. Cycle 2||3
2469200|NCT00969761|6054741|P6|STARTED|Discont. Before Start of Treat. Cycle 2||3
2469201|NCT00969761|6054742|P5|STARTED|Discont. Before Start of Treat. Cycle 2||3
2469202|NCT00969761|6054743|P4|STARTED|Discont. Before Start of Treat. Cycle 2||6
2469203|NCT00969761|6054744|P3|STARTED|Discont. Before Start of Treat. Cycle 2||12
2469204|NCT00969761|6054745|P2|STARTED|Discont. Before Start of Treat. Cycle 2||3
2469205|NCT00969761|6054746|P1|STARTED|Discont. Before Start of Treat. Cycle 2||3
2469206|NCT00969709|6055052|P4|NOT COMPLETED|Overall Study||63
2469207|NCT00969709|6055053|P3|NOT COMPLETED|Overall Study||58
2469208|NCT00969709|6055054|P2|NOT COMPLETED|Overall Study||48
2469209|NCT00969709|6055055|P1|NOT COMPLETED|Overall Study||38
2469210|NCT00969709|6055052|P4|COMPLETED|Overall Study||117
2469211|NCT00969709|6055053|P3|COMPLETED|Overall Study||121
2469212|NCT00969709|6055054|P2|COMPLETED|Overall Study||130
2469213|NCT00969709|6055055|P1|COMPLETED|Overall Study||138
2469214|NCT00969709|6055052|P4|STARTED|Overall Study||180
2469215|NCT00969709|6055053|P3|STARTED|Overall Study||179
2469216|NCT00969709|6055054|P2|STARTED|Overall Study||178
2469217|NCT00969709|6055055|P1|STARTED|Overall Study||176
2469218|NCT00969618|6055069|P1|NOT COMPLETED|Overall Study||78
2469219|NCT00969618|6055069|P1|COMPLETED|Overall Study||133
2469220|NCT00969618|6055069|P1|STARTED|Overall Study||211
2469221|NCT00969553|6055089|P9|NOT COMPLETED|Overall Study||3
2469222|NCT00969553|6055090|P8|NOT COMPLETED|Overall Study||14
2469223|NCT00969553|6055091|P7|NOT COMPLETED|Overall Study||4
2469224|NCT00969553|6055092|P6|NOT COMPLETED|Overall Study||4
2469225|NCT00969553|6055093|P5|NOT COMPLETED|Overall Study||3
2469226|NCT00969553|6055094|P4|NOT COMPLETED|Overall Study||16
2469227|NCT00969553|6055095|P3|NOT COMPLETED|Overall Study||6
2469228|NCT00969553|6055096|P2|NOT COMPLETED|Overall Study||3
2469229|NCT00969553|6055097|P1|NOT COMPLETED|Overall Study||3
2469230|NCT00969553|6055089|P9|COMPLETED|Overall Study||0
2469231|NCT00969553|6055090|P8|COMPLETED|Overall Study|on-treatment at analysis data base lock date (27-Oct-2011)|2
2469232|NCT00969553|6055091|P7|COMPLETED|Overall Study||0
2469233|NCT00969553|6055092|P6|COMPLETED|Overall Study||0
2469234|NCT00969553|6055093|P5|COMPLETED|Overall Study||0
2469235|NCT00969553|6055094|P4|COMPLETED|Overall Study|on-treatment at analysis data base lock date (27-Oct-2011)|1
2469236|NCT00969553|6055095|P3|COMPLETED|Overall Study||0
2469237|NCT00969553|6055096|P2|COMPLETED|Overall Study||0
2469238|NCT00969553|6055097|P1|COMPLETED|Overall Study||0
2469239|NCT00969553|6055089|P9|STARTED|Overall Study||3
2469240|NCT00969553|6055090|P8|STARTED|Overall Study||16
2469241|NCT00969553|6055091|P7|STARTED|Overall Study||4
2469242|NCT00969553|6055092|P6|STARTED|Overall Study||4
2469243|NCT00969553|6055093|P5|STARTED|Overall Study||3
2469244|NCT00969553|6055094|P4|STARTED|Overall Study||17
2469245|NCT00969553|6055095|P3|STARTED|Overall Study||6
2469246|NCT00969553|6055096|P2|STARTED|Overall Study||3
2469247|NCT00969553|6055097|P1|STARTED|Overall Study||3
2469248|NCT00969540|6055240|P2|NOT COMPLETED|Overall Study||1
2469249|NCT00969540|6055241|P1|NOT COMPLETED|Overall Study||1
2469250|NCT00969540|6055240|P2|COMPLETED|Overall Study||3
2469251|NCT00969540|6055241|P1|COMPLETED|Overall Study||3
2469252|NCT00969540|6055240|P2|STARTED|Overall Study||4
2469253|NCT00969540|6055241|P1|STARTED|Overall Study||4
2469254|NCT00969501|6055259|P1|NOT COMPLETED|Overall Study||5
2469255|NCT00969501|6055259|P1|COMPLETED|Overall Study||27
2469256|NCT00969501|6055259|P1|STARTED|Overall Study||32
2469257|NCT00969436|6055266|P3|NOT COMPLETED|Overall Study||11
2469258|NCT00969436|6055267|P2|NOT COMPLETED|Overall Study||21
2469259|NCT00969436|6055268|P1|NOT COMPLETED|Overall Study||25
2469260|NCT00969436|6055266|P3|COMPLETED|Overall Study||79
2469261|NCT00969436|6055267|P2|COMPLETED|Overall Study||159
2469262|NCT00969436|6055268|P1|COMPLETED|Overall Study||155
2469263|NCT00969436|6055266|P3|STARTED|Overall Study||90
2469264|NCT00969436|6055267|P2|STARTED|Overall Study||180
2469265|NCT00969436|6055268|P1|STARTED|Overall Study||180
2469269|NCT00969280|6055316|P2|NOT COMPLETED|Overall Study||3
2469270|NCT00969280|6055317|P1|NOT COMPLETED|Overall Study||2
2469271|NCT00969280|6055316|P2|COMPLETED|Overall Study||18
2469272|NCT00969280|6055317|P1|COMPLETED|Overall Study||19
2469273|NCT00969280|6055316|P2|STARTED|Overall Study||21
2469274|NCT00969280|6055317|P1|STARTED|Overall Study||21
2469275|NCT00969228|6055325|P2|NOT COMPLETED|Overall Study||14
2469276|NCT00969228|6055326|P1|NOT COMPLETED|Overall Study||43
2469277|NCT00969228|6055325|P2|COMPLETED|Overall Study||162
2469278|NCT00969228|6055326|P1|COMPLETED|Overall Study||465
2469279|NCT00969228|6055325|P2|STARTED|Overall Study||176
2469280|NCT00969228|6055326|P1|STARTED|Overall Study||508
2469281|NCT00969150|6055344|P2|NOT COMPLETED|Overall Study||40
2469282|NCT00969150|6055345|P1|NOT COMPLETED|Overall Study||33
2469283|NCT00969150|6055344|P2|COMPLETED|Overall Study||135
2469284|NCT00969150|6055345|P1|COMPLETED|Overall Study||149
2469285|NCT00969150|6055344|P2|STARTED|Overall Study||175
2469286|NCT00969150|6055345|P1|STARTED|Overall Study||182
2469287|NCT00969124|6055353|P1|NOT COMPLETED|Overall Study||30
2469288|NCT00969124|6055353|P1|COMPLETED|Overall Study||298
2469289|NCT00969124|6055353|P1|STARTED|Overall Study||328
2469290|NCT00968981|6055362|P3|NOT COMPLETED|Overall Study||22
2469291|NCT00968981|6055363|P2|NOT COMPLETED|Overall Study||22
2469292|NCT00968981|6055364|P1|NOT COMPLETED|Overall Study||22
2469293|NCT00968981|6055362|P3|COMPLETED|Overall Study||0
2469294|NCT00968981|6055363|P2|COMPLETED|Overall Study||0
2469295|NCT00968981|6055364|P1|COMPLETED|Overall Study||1
2469296|NCT00968981|6055362|P3|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|22
2469297|NCT00968981|6055363|P2|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|21
2469298|NCT00968981|6055364|P1|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|20
2469299|NCT00968981|6055362|P3|STARTED|Overall Study||22
2469300|NCT00968981|6055363|P2|STARTED|Overall Study||22
2469301|NCT00968981|6055364|P1|STARTED|Overall Study||23
2469302|NCT00968968|6055402|P2|NOT COMPLETED|Overall Study||14
2469303|NCT00968968|6055403|P1|NOT COMPLETED|Overall Study||16
2469304|NCT00968968|6055402|P2|COMPLETED|Overall Study||3
2469305|NCT00968968|6055403|P1|COMPLETED|Overall Study||4
2469306|NCT00968968|6055402|P2|STARTED|Overall Study||17
2469307|NCT00968968|6055403|P1|STARTED|Overall Study||20
2469308|NCT00968890|6055420|P2|NOT COMPLETED|Overall Study||0
2469309|NCT00968890|6055421|P1|NOT COMPLETED|Overall Study||0
2469310|NCT00968890|6055420|P2|COMPLETED|Overall Study||84
2469311|NCT00968890|6055421|P1|COMPLETED|Overall Study||84
2469312|NCT00968890|6055420|P2|STARTED|Overall Study||84
2469313|NCT00968890|6055421|P1|STARTED|Overall Study||84
2469314|NCT00968864|6055449|P1|NOT COMPLETED|Overall Study||1
2469315|NCT00968864|6055449|P1|COMPLETED|Overall Study||52
2469316|NCT00968864|6055449|P1|STARTED|Overall Study|One patient, FDA and IRB approved to enroll as an exception, was not evaluable for study endpoints.|53
2469317|NCT00968838|6055467|P2|NOT COMPLETED|Overall Study||0
2469318|NCT00968838|6055468|P1|NOT COMPLETED|Overall Study||0
2469319|NCT00968838|6055467|P2|COMPLETED|Overall Study||58
2469320|NCT00968838|6055468|P1|COMPLETED|Overall Study||50
2469321|NCT00968838|6055467|P2|STARTED|Overall Study||58
2469322|NCT00968838|6055468|P1|STARTED|Overall Study||50
2469323|NCT00968812|6055477|P3|NOT COMPLETED|Overall Study||168
2469324|NCT00968812|6055478|P2|NOT COMPLETED|Overall Study||162
2469325|NCT00968812|6055479|P1|NOT COMPLETED|Overall Study||140
2469326|NCT00968812|6055477|P3|COMPLETED|Overall Study||314
2469327|NCT00968812|6055478|P2|COMPLETED|Overall Study||323
2469328|NCT00968812|6055479|P1|COMPLETED|Overall Study||343
2469329|NCT00968812|6055477|P3|STARTED|Overall Study||482
2469330|NCT00968812|6055478|P2|STARTED|Overall Study||485
2469331|NCT00968812|6055479|P1|STARTED|Overall Study||483
2469332|NCT00968799|6055499|P1|NOT COMPLETED|Overall Study||2
2469333|NCT00968799|6055499|P1|COMPLETED|Overall Study||4
2469334|NCT00968799|6055499|P1|STARTED|Overall Study||6
2469335|NCT00968708|6055509|P2|NOT COMPLETED|Overall Study||298
2469336|NCT00968708|6055510|P1|NOT COMPLETED|Overall Study||318
2469337|NCT00968708|6055509|P2|COMPLETED|Overall Study||2403
2469338|NCT00968708|6055510|P1|COMPLETED|Overall Study||2361
2469339|NCT00968708|6055509|P2|Treated|Overall Study||2698
2469340|NCT00968708|6055510|P1|Treated|Overall Study||2676
2469341|NCT00968708|6055509|P2|STARTED|Overall Study||2701
2469342|NCT00968708|6055510|P1|STARTED|Overall Study||2679
2469343|NCT00968669|6055522|P4|NOT COMPLETED|Overall Study||9
2469344|NCT00968669|6055523|P3|NOT COMPLETED|Overall Study||11
2469345|NCT00968669|6055524|P2|NOT COMPLETED|Overall Study||18
2469346|NCT00968669|6055525|P1|NOT COMPLETED|Overall Study||18
2469347|NCT00968669|6055522|P4|COMPLETED|Overall Study||72
2469348|NCT00968669|6055523|P3|COMPLETED|Overall Study||72
2469349|NCT00968669|6055524|P2|COMPLETED|Overall Study||63
2469350|NCT00968669|6055525|P1|COMPLETED|Overall Study||64
2469351|NCT00968669|6055522|P4|STARTED|Overall Study||81
2469352|NCT00968669|6055523|P3|STARTED|Overall Study||83
2469353|NCT00968669|6055524|P2|STARTED|Overall Study||81
2469354|NCT00968669|6055525|P1|STARTED|Overall Study||82
2469355|NCT00968617|6055615|P1|NOT COMPLETED|Overall Study||6
2469356|NCT00968617|6055615|P1|COMPLETED|Overall Study||1
2469357|NCT00968617|6055615|P1|STARTED|Overall Study||7
2469358|NCT00968539|6055629|P2|NOT COMPLETED|Overall Study||0
2469359|NCT00968539|6055630|P1|NOT COMPLETED|Overall Study||1
2469360|NCT00968539|6055629|P2|COMPLETED|Overall Study||66
2469361|NCT00968539|6055630|P1|COMPLETED|Overall Study||63
2469362|NCT00968539|6055629|P2|STARTED|Overall Study||66
2469363|NCT00968539|6055630|P1|STARTED|Overall Study||64
2469364|NCT00968526|6055690|P2|NOT COMPLETED|Overall Study||0
2469365|NCT00968526|6055691|P1|NOT COMPLETED|Overall Study||3
2469366|NCT00968526|6055690|P2|COMPLETED|Overall Study||102
2469367|NCT00968526|6055691|P1|COMPLETED|Overall Study||135
2469368|NCT00968526|6055690|P2|STARTED|Overall Study||102
2469369|NCT00968526|6055691|P1|STARTED|Overall Study||138
2469370|NCT00968344|6055783|P2|NOT COMPLETED|Overall Study||11
2469371|NCT00968344|6055784|P1|NOT COMPLETED|Overall Study||10
2469372|NCT00968344|6055783|P2|COMPLETED|Overall Study||9
2469373|NCT00968344|6055784|P1|COMPLETED|Overall Study||10
2469374|NCT00968344|6055783|P2|STARTED|Overall Study|Includes screen fails|20
2469375|NCT00968344|6055784|P1|STARTED|Overall Study|Includes screen fails|20
2469376|NCT00968253|6055793|P3|NOT COMPLETED|Overall Study||7
2469377|NCT00968253|6055794|P2|NOT COMPLETED|Overall Study||3
2469378|NCT00968253|6055795|P1|NOT COMPLETED|Overall Study||0
2469379|NCT00968253|6055793|P3|COMPLETED|Overall Study||5
2469380|NCT00968253|6055794|P2|COMPLETED|Overall Study||6
2469381|NCT00968253|6055795|P1|COMPLETED|Overall Study||3
2469382|NCT00968253|6055793|P3|STARTED|Overall Study||12
2469383|NCT00968253|6055794|P2|STARTED|Overall Study||9
2469384|NCT00968253|6055795|P1|STARTED|Overall Study||3
2469385|NCT00968227|6055809|P1|NOT COMPLETED|Overall Study||0
2469386|NCT00968227|6055809|P1|COMPLETED|Overall Study||56
2469387|NCT00968227|6055809|P1|STARTED|Overall Study||56
2469388|NCT00968201|6055816|P3|NOT COMPLETED|Extension Study - (Period III)||280
2469389|NCT00968201|6055817|P2|NOT COMPLETED|Extension Study - (Period III)||124
2469390|NCT00968201|6055818|P1|NOT COMPLETED|Extension Study - (Period III)||0
2469391|NCT00968201|6055816|P3|COMPLETED|Extension Study - (Period III)||84
2469392|NCT00968201|6055817|P2|COMPLETED|Extension Study - (Period III)||33
2469393|NCT00968201|6055818|P1|COMPLETED|Extension Study - (Period III)||0
2469394|NCT00968201|6055816|P3|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|364
2469395|NCT00968201|6055817|P2|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|157
2469396|NCT00968201|6055818|P1|STARTED|Extension Study - (Period III)||0
2469397|NCT00968201|6055816|P3|NOT COMPLETED|Base Study - (Period II)||45
2469398|NCT00968201|6055817|P2|NOT COMPLETED|Base Study - (Period II)||0
2469399|NCT00968201|6055818|P1|NOT COMPLETED|Base Study - (Period II)||26
2469400|NCT00968201|6055816|P3|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|416
2469401|NCT00968201|6055817|P2|COMPLETED|Base Study - (Period II)||0
2469402|NCT00968201|6055818|P1|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|202
2469403|NCT00968201|6055816|P3|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to montelukast.|461
2469404|NCT00968201|6055817|P2|STARTED|Base Study - (Period II)||0
2469405|NCT00968201|6055818|P1|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to placebo.|228
2469406|NCT00968149|6055879|P2|NOT COMPLETED|Overall Study||6
2469407|NCT00968149|6055880|P1|NOT COMPLETED|Overall Study||11
2469408|NCT00968149|6055879|P2|COMPLETED|Overall Study||127
2469409|NCT00968149|6055880|P1|COMPLETED|Overall Study||269
2469410|NCT00968149|6055879|P2|STARTED|Overall Study||133
2469411|NCT00968149|6055880|P1|STARTED|Overall Study||280
2469412|NCT00968071|6055900|P1|NOT COMPLETED|Overall Study||0
2469413|NCT00968071|6055900|P1|COMPLETED|Overall Study||71
2469414|NCT00968071|6055900|P1|STARTED|Overall Study||71
2469415|NCT00968032|6055904|P1|NOT COMPLETED|Overall Study||2
2469416|NCT00968032|6055904|P1|COMPLETED|Overall Study|"1 patient not receiving investigational device due to failure in usage~1 patient denied latest FU"|61
2469417|NCT00968032|6055904|P1|STARTED|Overall Study||63
2469418|NCT00968019|6055908|P1|NOT COMPLETED|Overall Study||15
2469419|NCT00968019|6055908|P1|COMPLETED|Overall Study||303
2469420|NCT00968019|6055908|P1|STARTED|Overall Study||318
2469421|NCT00967993|6055929|P1|NOT COMPLETED|Overall Study||4
2469422|NCT00967993|6055929|P1|COMPLETED|Overall Study||18
2469423|NCT00967993|6055929|P1|STARTED|Overall Study||22
2469424|NCT00967798|6055935|P2|NOT COMPLETED|Overall Study||3
2469425|NCT00967798|6055936|P1|NOT COMPLETED|Overall Study||9
2469426|NCT00967798|6055935|P2|COMPLETED|Overall Study||13
2469427|NCT00967798|6055936|P1|COMPLETED|Overall Study||8
2469428|NCT00967798|6055935|P2|STARTED|Overall Study||16
2469429|NCT00967798|6055936|P1|STARTED|Overall Study||17
2469430|NCT00967694|6055950|P1|NOT COMPLETED|Overall Study||6
2469431|NCT00967694|6055950|P1|COMPLETED|Overall Study|5 discontinued during N2O administration due to agitation ⁄ dysphoria, one due to nausea⁄vomiting.|20
2469432|NCT00967694|6055950|P1|STARTED|Overall Study||26
2469433|NCT00967668|6055957|P3|NOT COMPLETED|Overall Study||69
2469434|NCT00967668|6055958|P2|NOT COMPLETED|Overall Study||56
2469435|NCT00967668|6055959|P1|NOT COMPLETED|Overall Study||71
2469436|NCT00967668|6055957|P3|COMPLETED|Overall Study||90
2469437|NCT00967668|6055958|P2|COMPLETED|Overall Study||104
2469438|NCT00967668|6055959|P1|COMPLETED|Overall Study||91
2469439|NCT00967668|6055957|P3|18-mo Assessment|Overall Study||92
2469440|NCT00967668|6055958|P2|18-mo Assessment|Overall Study||102
2469441|NCT00967668|6055959|P1|18-mo Assessment|Overall Study||95
2469442|NCT00967668|6055957|P3|Completed Year 1 - 12-mo Assessment|Overall Study||119
2469443|NCT00967668|6055958|P2|Completed Year 1 - 12-mo Assessment|Overall Study||122
2469444|NCT00967668|6055959|P1|Completed Year 1 - 12-mo Assessment|Overall Study||120
2469445|NCT00967668|6055957|P3|3-mo Assessment|Overall Study||115
2469446|NCT00967668|6055958|P2|3-mo Assessment|Overall Study||127
2469447|NCT00967668|6055959|P1|3-mo Assessment|Overall Study||131
2469448|NCT00967668|6055957|P3|STARTED|Overall Study||159
2469449|NCT00967668|6055958|P2|STARTED|Overall Study||160
2469450|NCT00967668|6055959|P1|STARTED|Overall Study||162
2469451|NCT00967551|6055972|P2|NOT COMPLETED|Overall Study||0
2469452|NCT00967551|6055973|P1|NOT COMPLETED|Overall Study||0
2469453|NCT00967551|6055972|P2|COMPLETED|Overall Study||75
2469454|NCT00967551|6055973|P1|COMPLETED|Overall Study||68
2469455|NCT00967551|6055972|P2|STARTED|Overall Study||75
2469456|NCT00967551|6055973|P1|STARTED|Overall Study||68
2469457|NCT00967486|6055983|P2|NOT COMPLETED|Overall Study||0
2469458|NCT00967486|6055984|P1|NOT COMPLETED|Overall Study||0
2469459|NCT00967486|6055983|P2|COMPLETED|Overall Study||102
2469460|NCT00967486|6055984|P1|COMPLETED|Overall Study||98
2469461|NCT00967486|6055983|P2|STARTED|Overall Study||102
2469462|NCT00967486|6055984|P1|STARTED|Overall Study||98
2469463|NCT00967473|6055990|P1|NOT COMPLETED|Overall Study||0
2469464|NCT00967473|6055990|P1|COMPLETED|Overall Study||15
2469465|NCT00967473|6055990|P1|STARTED|Overall Study||15
2469466|NCT00967447|6055996|P1|NOT COMPLETED|Overall Study||0
2469467|NCT00967447|6055996|P1|COMPLETED|Overall Study|there are no collected data in CRF|2
2469468|NCT00967447|6055996|P1|STARTED|Overall Study|there are no collected data in CRF|2
2469469|NCT00967330|6056005|P2|NOT COMPLETED|Overall Study||60
2469470|NCT00967330|6056006|P1|NOT COMPLETED|Overall Study||122
2469471|NCT00967330|6056005|P2|COMPLETED|Overall Study||0
2469472|NCT00967330|6056006|P1|COMPLETED|Overall Study||0
2469473|NCT00967330|6056005|P2|STARTED|Overall Study||60
2469474|NCT00967330|6056006|P1|STARTED|Overall Study||122
2469475|NCT00967226|6056036|P2|NOT COMPLETED|Overall Study||6
2469476|NCT00967226|6056037|P1|NOT COMPLETED|Overall Study||2
2469477|NCT00967226|6056036|P2|COMPLETED|Overall Study||2
2469478|NCT00967226|6056037|P1|COMPLETED|Overall Study||9
2469479|NCT00967226|6056036|P2|STARTED|Overall Study||8
2469480|NCT00967226|6056037|P1|STARTED|Overall Study||11
2469481|NCT00967044|6056067|P1|NOT COMPLETED|Overall Study||0
2469482|NCT00967044|6056067|P1|COMPLETED|Overall Study||30
2469483|NCT00967044|6056067|P1|STARTED|Overall Study||30
2469484|NCT00967018|6056071|P1|NOT COMPLETED|Overall Study||21
2469485|NCT00967018|6056071|P1|COMPLETED|Overall Study||56
2469486|NCT00967018|6056071|P1|STARTED|Overall Study||77
2469487|NCT00967005|6056080|P2|NOT COMPLETED|Overall Study||10
2469488|NCT00967005|6056081|P1|NOT COMPLETED|Overall Study||7
2469489|NCT00967005|6056080|P2|COMPLETED|Overall Study||5
2469490|NCT00967005|6056081|P1|COMPLETED|Overall Study||6
2469491|NCT00967005|6056080|P2|Treatment Completion|Overall Study||10
2469492|NCT00967005|6056081|P1|Treatment Completion|Overall Study||10
2469493|NCT00967005|6056080|P2|STARTED|Overall Study||15
2469494|NCT00967005|6056081|P1|STARTED|Overall Study||13
2469495|NCT00966992|6056135|P2|NOT COMPLETED|Overall Study||0
2469496|NCT00966992|6056136|P1|NOT COMPLETED|Overall Study||0
2469497|NCT00966992|6056135|P2|COMPLETED|Overall Study||0
2469498|NCT00966992|6056136|P1|COMPLETED|Overall Study||3
2469499|NCT00966992|6056135|P2|STARTED|Overall Study||0
2469500|NCT00966992|6056136|P1|STARTED|Overall Study||3
2469501|NCT00966953|6056156|P4|NOT COMPLETED|4th Intervention Order||0
2469502|NCT00966953|6056157|P3|NOT COMPLETED|4th Intervention Order||0
2469503|NCT00966953|6056158|P2|NOT COMPLETED|4th Intervention Order||0
2469504|NCT00966953|6056159|P1|NOT COMPLETED|4th Intervention Order||0
2469505|NCT00966953|6056156|P4|COMPLETED|4th Intervention Order||7
2469506|NCT00966953|6056157|P3|COMPLETED|4th Intervention Order||6
2469507|NCT00966953|6056158|P2|COMPLETED|4th Intervention Order||6
2469508|NCT00966953|6056159|P1|COMPLETED|4th Intervention Order||6
2469509|NCT00966953|6056156|P4|STARTED|4th Intervention Order||7
2469510|NCT00966953|6056157|P3|STARTED|4th Intervention Order||6
2469511|NCT00966953|6056158|P2|STARTED|4th Intervention Order||6
2469512|NCT00966953|6056159|P1|STARTED|4th Intervention Order||6
2469513|NCT00966953|6056156|P4|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
2469514|NCT00966953|6056157|P3|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
2469515|NCT00966953|6056158|P2|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
2469516|NCT00966953|6056159|P1|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
2469517|NCT00966953|6056156|P4|COMPLETED|1 Week Washout After 3rd Intervention||7
2469518|NCT00966953|6056157|P3|COMPLETED|1 Week Washout After 3rd Intervention||6
2469519|NCT00966953|6056158|P2|COMPLETED|1 Week Washout After 3rd Intervention||6
2469520|NCT00966953|6056159|P1|COMPLETED|1 Week Washout After 3rd Intervention||6
2469521|NCT00966953|6056156|P4|STARTED|1 Week Washout After 3rd Intervention||7
2469522|NCT00966953|6056157|P3|STARTED|1 Week Washout After 3rd Intervention||6
2469523|NCT00966953|6056158|P2|STARTED|1 Week Washout After 3rd Intervention||6
2469524|NCT00966953|6056159|P1|STARTED|1 Week Washout After 3rd Intervention||6
2469525|NCT00966953|6056156|P4|NOT COMPLETED|3rd Intervention Order||0
2469526|NCT00966953|6056157|P3|NOT COMPLETED|3rd Intervention Order||0
2469527|NCT00966953|6056158|P2|NOT COMPLETED|3rd Intervention Order||0
2469528|NCT00966953|6056159|P1|NOT COMPLETED|3rd Intervention Order||0
2469529|NCT00966953|6056156|P4|COMPLETED|3rd Intervention Order||7
2469530|NCT00966953|6056157|P3|COMPLETED|3rd Intervention Order||6
2469531|NCT00966953|6056158|P2|COMPLETED|3rd Intervention Order||6
2469532|NCT00966953|6056159|P1|COMPLETED|3rd Intervention Order||6
2469533|NCT00966953|6056156|P4|STARTED|3rd Intervention Order||7
2469534|NCT00966953|6056157|P3|STARTED|3rd Intervention Order||6
2469535|NCT00966953|6056158|P2|STARTED|3rd Intervention Order||6
2469536|NCT00966953|6056159|P1|STARTED|3rd Intervention Order||6
2469537|NCT00966953|6056156|P4|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
2469538|NCT00966953|6056157|P3|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
2469539|NCT00966953|6056158|P2|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
2469540|NCT00966953|6056159|P1|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
2469541|NCT00966953|6056156|P4|COMPLETED|1 Week Washout After 2nd Intervention||7
2469542|NCT00966953|6056157|P3|COMPLETED|1 Week Washout After 2nd Intervention||6
2469543|NCT00966953|6056158|P2|COMPLETED|1 Week Washout After 2nd Intervention||6
2469544|NCT00966953|6056159|P1|COMPLETED|1 Week Washout After 2nd Intervention||6
2469545|NCT00966953|6056156|P4|STARTED|1 Week Washout After 2nd Intervention||7
2469546|NCT00966953|6056157|P3|STARTED|1 Week Washout After 2nd Intervention||6
2469547|NCT00966953|6056158|P2|STARTED|1 Week Washout After 2nd Intervention||6
2469548|NCT00966953|6056159|P1|STARTED|1 Week Washout After 2nd Intervention||6
2469549|NCT00966953|6056156|P4|NOT COMPLETED|2nd Intervention||0
2469550|NCT00966953|6056157|P3|NOT COMPLETED|2nd Intervention||0
2469551|NCT00966953|6056158|P2|NOT COMPLETED|2nd Intervention||0
2469552|NCT00966953|6056159|P1|NOT COMPLETED|2nd Intervention||0
2469553|NCT00966953|6056156|P4|COMPLETED|2nd Intervention||7
2469554|NCT00966953|6056157|P3|COMPLETED|2nd Intervention||6
2469555|NCT00966953|6056158|P2|COMPLETED|2nd Intervention||6
2469556|NCT00966953|6056159|P1|COMPLETED|2nd Intervention||6
2469557|NCT00966953|6056156|P4|STARTED|2nd Intervention||7
2469558|NCT00966953|6056157|P3|STARTED|2nd Intervention||6
2469559|NCT00966953|6056158|P2|STARTED|2nd Intervention||6
2469560|NCT00966953|6056159|P1|STARTED|2nd Intervention||6
2469561|NCT00966953|6056156|P4|NOT COMPLETED|1 Week Washout After 1st Intervention||0
2469562|NCT00966953|6056157|P3|NOT COMPLETED|1 Week Washout After 1st Intervention||0
2469563|NCT00966953|6056158|P2|NOT COMPLETED|1 Week Washout After 1st Intervention||0
2469564|NCT00966953|6056159|P1|NOT COMPLETED|1 Week Washout After 1st Intervention||0
2469565|NCT00966953|6056156|P4|COMPLETED|1 Week Washout After 1st Intervention||7
2469566|NCT00966953|6056157|P3|COMPLETED|1 Week Washout After 1st Intervention||6
2469567|NCT00966953|6056158|P2|COMPLETED|1 Week Washout After 1st Intervention||6
2469568|NCT00966953|6056159|P1|COMPLETED|1 Week Washout After 1st Intervention||6
2469569|NCT00966953|6056156|P4|STARTED|1 Week Washout After 1st Intervention||7
2469570|NCT00966953|6056157|P3|STARTED|1 Week Washout After 1st Intervention||6
2469571|NCT00966953|6056158|P2|STARTED|1 Week Washout After 1st Intervention||6
2469572|NCT00966953|6056159|P1|STARTED|1 Week Washout After 1st Intervention||6
2469573|NCT00966953|6056156|P4|NOT COMPLETED|1st Intervention||0
2469574|NCT00966953|6056157|P3|NOT COMPLETED|1st Intervention||0
2469575|NCT00966953|6056158|P2|NOT COMPLETED|1st Intervention||0
2469576|NCT00966953|6056159|P1|NOT COMPLETED|1st Intervention||0
2469577|NCT00966953|6056156|P4|COMPLETED|1st Intervention||7
2469578|NCT00966953|6056157|P3|COMPLETED|1st Intervention||6
2469579|NCT00966953|6056158|P2|COMPLETED|1st Intervention||6
2469580|NCT00966953|6056159|P1|COMPLETED|1st Intervention||6
2469581|NCT00966953|6056156|P4|STARTED|1st Intervention||7
2469582|NCT00966953|6056157|P3|STARTED|1st Intervention||6
2469583|NCT00966953|6056158|P2|STARTED|1st Intervention||6
2469584|NCT00966953|6056159|P1|STARTED|1st Intervention||6
2469585|NCT00966940|6056167|P2|NOT COMPLETED|Period 2, Second 6 Weeks||0
2469586|NCT00966940|6056168|P1|NOT COMPLETED|Period 2, Second 6 Weeks||0
2469587|NCT00966940|6056167|P2|COMPLETED|Period 2, Second 6 Weeks||23
2469588|NCT00966940|6056168|P1|COMPLETED|Period 2, Second 6 Weeks||25
2469589|NCT00966940|6056167|P2|STARTED|Period 2, Second 6 Weeks||23
2469590|NCT00966940|6056168|P1|STARTED|Period 2, Second 6 Weeks||25
2469591|NCT00966940|6056167|P2|NOT COMPLETED|Period 1, First 6 Weeks||0
2469592|NCT00966940|6056168|P1|NOT COMPLETED|Period 1, First 6 Weeks||3
2469593|NCT00966940|6056167|P2|COMPLETED|Period 1, First 6 Weeks||23
2469594|NCT00966940|6056168|P1|COMPLETED|Period 1, First 6 Weeks||25
2469595|NCT00966940|6056167|P2|STARTED|Period 1, First 6 Weeks||23
2469596|NCT00966940|6056168|P1|STARTED|Period 1, First 6 Weeks||28
2469597|NCT00966875|6056195|P9|NOT COMPLETED|Part B||18
2469598|NCT00966875|6056196|P8|NOT COMPLETED|Part B||19
2469599|NCT00966875|6056197|P7|NOT COMPLETED|Part B||22
2469600|NCT00966875|6056198|P6|NOT COMPLETED|Part B||6
2469601|NCT00966875|6056199|P5|NOT COMPLETED|Part B||7
2469602|NCT00966875|6056200|P4|NOT COMPLETED|Part B||3
2469603|NCT00966875|6056201|P3|NOT COMPLETED|Part B||6
2469604|NCT00966875|6056202|P2|NOT COMPLETED|Part B||3
2469605|NCT00966875|6056203|P1|NOT COMPLETED|Part B||5
2469606|NCT00966875|6056195|P9|COMPLETED|Part B||32
2469607|NCT00966875|6056196|P8|COMPLETED|Part B||38
2469608|NCT00966875|6056197|P7|COMPLETED|Part B||29
2469609|NCT00966875|6056198|P6|COMPLETED|Part B||26
2469610|NCT00966875|6056199|P5|COMPLETED|Part B||44
2469611|NCT00966875|6056200|P4|COMPLETED|Part B||31
2469612|NCT00966875|6056201|P3|COMPLETED|Part B||27
2469613|NCT00966875|6056202|P2|COMPLETED|Part B||33
2469614|NCT00966875|6056203|P1|COMPLETED|Part B||41
2469615|NCT00966875|6056195|P9|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|50
2469616|NCT00966875|6056196|P8|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|57
2469617|NCT00966875|6056197|P7|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
2469618|NCT00966875|6056198|P6|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|32
2469619|NCT00966875|6056199|P5|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
2469620|NCT00966875|6056200|P4|STARTED|Part B||34
2469621|NCT00966875|6056201|P3|STARTED|Part B||33
2469622|NCT00966875|6056202|P2|STARTED|Part B||36
2469623|NCT00966875|6056203|P1|STARTED|Part B|Two (2) participants who completed Part A did not enter Part B.|46
2469624|NCT00966875|6056195|P9|NOT COMPLETED|Part A||8
2469625|NCT00966875|6056196|P8|NOT COMPLETED|Part A||7
2469626|NCT00966875|6056197|P7|NOT COMPLETED|Part A||12
2469627|NCT00966875|6056198|P6|NOT COMPLETED|Part A||4
2469628|NCT00966875|6056199|P5|NOT COMPLETED|Part A||5
2469629|NCT00966875|6056200|P4|NOT COMPLETED|Part A||3
2469630|NCT00966875|6056201|P3|NOT COMPLETED|Part A||2
2469631|NCT00966875|6056202|P2|NOT COMPLETED|Part A||4
2469632|NCT00966875|6056203|P1|NOT COMPLETED|Part A||6
2469633|NCT00966875|6056195|P9|COMPLETED|Part A||51
2469634|NCT00966875|6056196|P8|COMPLETED|Part A||58
2469635|NCT00966875|6056197|P7|COMPLETED|Part A||52
2469636|NCT00966875|6056198|P6|COMPLETED|Part A||33
2469637|NCT00966875|6056199|P5|COMPLETED|Part A||52
2469638|NCT00966875|6056200|P4|COMPLETED|Part A||34
2469639|NCT00966875|6056201|P3|COMPLETED|Part A||33
2469640|NCT00966875|6056202|P2|COMPLETED|Part A||36
2469641|NCT00966875|6056203|P1|COMPLETED|Part A||48
2469642|NCT00966875|6056195|P9|Received ≥1 Doses of Study Drug|Part A||59
2469643|NCT00966875|6056196|P8|Received ≥1 Doses of Study Drug|Part A||65
2469644|NCT00966875|6056197|P7|Received ≥1 Doses of Study Drug|Part A||64
2469645|NCT00966875|6056198|P6|Received ≥1 Doses of Study Drug|Part A||37
2469646|NCT00966875|6056199|P5|Received ≥1 Doses of Study Drug|Part A||57
2469647|NCT00966875|6056200|P4|Received ≥1 Doses of Study Drug|Part A||37
2469648|NCT00966875|6056201|P3|Received ≥1 Doses of Study Drug|Part A||35
2469649|NCT00966875|6056202|P2|Received ≥1 Doses of Study Drug|Part A||40
2469650|NCT00966875|6056203|P1|Received ≥1 Doses of Study Drug|Part A||54
2469651|NCT00966875|6056195|P9|STARTED|Part A||59
2469652|NCT00966875|6056196|P8|STARTED|Part A||65
2469653|NCT00966875|6056197|P7|STARTED|Part A||64
2469654|NCT00966875|6056198|P6|STARTED|Part A||37
2469655|NCT00966875|6056199|P5|STARTED|Part A||57
2469656|NCT00966875|6056200|P4|STARTED|Part A||37
2469657|NCT00966875|6056201|P3|STARTED|Part A||35
2469658|NCT00966875|6056202|P2|STARTED|Part A||40
2469659|NCT00966875|6056203|P1|STARTED|Part A||54
2469660|NCT00966849|6056525|P3|NOT COMPLETED|Overall Study||1293
2469661|NCT00966849|6056526|P2|NOT COMPLETED|Overall Study||1478
2469662|NCT00966849|6056527|P1|NOT COMPLETED|Overall Study||1541
2469663|NCT00966849|6056525|P3|COMPLETED|Overall Study||1876
2469664|NCT00966849|6056526|P2|COMPLETED|Overall Study||2498
2469665|NCT00966849|6056527|P1|COMPLETED|Overall Study||2119
2469666|NCT00966849|6056525|P3|STARTED|Overall Study||3169
2469667|NCT00966849|6056526|P2|STARTED|Overall Study||3976
2469668|NCT00966849|6056527|P1|STARTED|Overall Study||3660
2469669|NCT00966823|6056544|P1|NOT COMPLETED|Overall Study||1
2469670|NCT00966823|6056544|P1|COMPLETED|Overall Study||2
2469671|NCT00966823|6056544|P1|STARTED|Overall Study||3
2469672|NCT00966719|6056554|P2|NOT COMPLETED|Overall Study||11
2469673|NCT00966719|6056555|P1|NOT COMPLETED|Overall Study||6
2469674|NCT00966719|6056554|P2|COMPLETED|Overall Study||38
2469675|NCT00966719|6056555|P1|COMPLETED|Overall Study||44
2469676|NCT00966719|6056554|P2|STARTED|Overall Study||49
2469677|NCT00966719|6056555|P1|STARTED|Overall Study||50
2469678|NCT00966654|6056575|P1|NOT COMPLETED|Overall Study||12
2469679|NCT00966654|6056575|P1|COMPLETED|Overall Study||0
2469680|NCT00966654|6056575|P1|STARTED|Overall Study||12
2469681|NCT00966641|6056583|P2|NOT COMPLETED|Second Intervention||0
2469682|NCT00966641|6056584|P1|NOT COMPLETED|Second Intervention||0
2469683|NCT00966641|6056583|P2|COMPLETED|Second Intervention||17
2469684|NCT00966641|6056584|P1|COMPLETED|Second Intervention||17
2469685|NCT00966641|6056583|P2|STARTED|Second Intervention||17
2469686|NCT00966641|6056584|P1|STARTED|Second Intervention||17
2469687|NCT00966641|6056583|P2|NOT COMPLETED|First Intervention||0
2469688|NCT00966641|6056584|P1|NOT COMPLETED|First Intervention||0
2469689|NCT00966641|6056583|P2|COMPLETED|First Intervention||17
2469690|NCT00966641|6056584|P1|COMPLETED|First Intervention||17
2469691|NCT00966641|6056583|P2|STARTED|First Intervention||17
2469692|NCT00966641|6056584|P1|STARTED|First Intervention||17
2469693|NCT00966550|6056592|P2|NOT COMPLETED|Overall Study||0
2469694|NCT00966550|6056593|P1|NOT COMPLETED|Overall Study||0
2469695|NCT00966550|6056592|P2|COMPLETED|Overall Study||12
2469696|NCT00966550|6056593|P1|COMPLETED|Overall Study||13
2469697|NCT00966550|6056592|P2|STARTED|Overall Study||12
2469698|NCT00966550|6056593|P1|STARTED|Overall Study||13
2469699|NCT00966446|6056602|P3|NOT COMPLETED|Overall Study||21
2469700|NCT00966446|6056603|P2|NOT COMPLETED|Overall Study||25
2469701|NCT00966446|6056604|P1|NOT COMPLETED|Overall Study||28
2469702|NCT00966446|6056602|P3|COMPLETED|Overall Study||52
2469703|NCT00966446|6056603|P2|COMPLETED|Overall Study||49
2469704|NCT00966446|6056604|P1|COMPLETED|Overall Study||48
2469705|NCT00966446|6056602|P3|STARTED|Overall Study||73
2469706|NCT00966446|6056603|P2|STARTED|Overall Study||74
2469707|NCT00966446|6056604|P1|STARTED|Overall Study||76
2469708|NCT00966433|6056621|P3|NOT COMPLETED|Overall Study||0
2469709|NCT00966433|6056622|P2|NOT COMPLETED|Overall Study||1
2469710|NCT00966433|6056623|P1|NOT COMPLETED|Overall Study||1
2469711|NCT00966433|6056621|P3|COMPLETED|Overall Study||11
2469712|NCT00966433|6056622|P2|COMPLETED|Overall Study||10
2469713|NCT00966433|6056623|P1|COMPLETED|Overall Study||10
2469714|NCT00966433|6056621|P3|STARTED|Overall Study||11
2469715|NCT00966433|6056622|P2|STARTED|Overall Study||11
2469716|NCT00966433|6056623|P1|STARTED|Overall Study||11
2469717|NCT00966355|6056649|P3|NOT COMPLETED|Overall Study||84
2469718|NCT00966355|6056650|P2|NOT COMPLETED|Overall Study||86
2469719|NCT00966355|6056651|P1|NOT COMPLETED|Overall Study||84
2469720|NCT00966355|6056649|P3|COMPLETED|Overall Study||261
2469721|NCT00966355|6056650|P2|COMPLETED|Overall Study||259
2469722|NCT00966355|6056651|P1|COMPLETED|Overall Study||260
2469723|NCT00966355|6056649|P3|STARTED|Overall Study||345
2469724|NCT00966355|6056650|P2|STARTED|Overall Study||345
2469725|NCT00966355|6056651|P1|STARTED|Overall Study||344
2469726|NCT00966277|6056664|P2|NOT COMPLETED|Overall Study||4
2469727|NCT00966277|6056665|P1|NOT COMPLETED|Overall Study||4
2469728|NCT00966277|6056664|P2|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|33
2469729|NCT00966277|6056665|P1|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|34
2469730|NCT00966277|6056664|P2|STARTED|Overall Study||37
2469731|NCT00966277|6056665|P1|STARTED|Overall Study||38
2469732|NCT00966264|6056673|P2|NOT COMPLETED|Overall Study||3
2469733|NCT00966264|6056674|P1|NOT COMPLETED|Overall Study||4
2469734|NCT00966264|6056673|P2|COMPLETED|Overall Study|5 years results|114
2469735|NCT00966264|6056674|P1|COMPLETED|Overall Study|5 years results|115
2469736|NCT00966264|6056673|P2|STARTED|Overall Study||117
2469737|NCT00966264|6056674|P1|STARTED|Overall Study||119
2469738|NCT00966238|6056686|P6|NOT COMPLETED|Overall Study||0
2469739|NCT00966238|6056687|P5|NOT COMPLETED|Overall Study||0
2469740|NCT00966238|6056688|P4|NOT COMPLETED|Overall Study||0
2469741|NCT00966238|6056689|P3|NOT COMPLETED|Overall Study||0
2469742|NCT00966238|6056690|P2|NOT COMPLETED|Overall Study||0
2469743|NCT00966238|6056691|P1|NOT COMPLETED|Overall Study||0
2469744|NCT00966238|6056686|P6|COMPLETED|Overall Study||20
2469745|NCT00966238|6056687|P5|COMPLETED|Overall Study||20
2469746|NCT00966238|6056688|P4|COMPLETED|Overall Study||20
2469747|NCT00966238|6056689|P3|COMPLETED|Overall Study||20
2469748|NCT00966238|6056690|P2|COMPLETED|Overall Study||20
2469749|NCT00966238|6056691|P1|COMPLETED|Overall Study||20
2469750|NCT00966238|6056686|P6|STARTED|Overall Study||20
2469751|NCT00966238|6056687|P5|STARTED|Overall Study||20
2469752|NCT00966238|6056688|P4|STARTED|Overall Study||20
2469753|NCT00966238|6056689|P3|STARTED|Overall Study||20
2469754|NCT00966238|6056690|P2|STARTED|Overall Study||20
2469755|NCT00966238|6056691|P1|STARTED|Overall Study||20
2469756|NCT00966186|6056713|P2|NOT COMPLETED|Overall Study||0
2469757|NCT00966186|6056714|P1|NOT COMPLETED|Overall Study||0
2469758|NCT00966186|6056713|P2|COMPLETED|Overall Study||60
2469759|NCT00966186|6056714|P1|COMPLETED|Overall Study||60
2469760|NCT00966186|6056713|P2|STARTED|Overall Study||60
2469761|NCT00966186|6056714|P1|STARTED|Overall Study||60
2469762|NCT00965848|6056720|P3|NOT COMPLETED|Overall Study||10
2469763|NCT00965848|6056721|P2|NOT COMPLETED|Overall Study||2
2469764|NCT00965848|6056722|P1|NOT COMPLETED|Overall Study||29
2469765|NCT00965848|6056720|P3|COMPLETED|Overall Study||117
2469766|NCT00965848|6056721|P2|COMPLETED|Overall Study||32
2469767|NCT00965848|6056722|P1|COMPLETED|Overall Study||78
2469768|NCT00965848|6056720|P3|STARTED|Overall Study||127
2469769|NCT00965848|6056721|P2|STARTED|Overall Study||34
2469770|NCT00965848|6056722|P1|STARTED|Overall Study||107
2469771|NCT00965757|6056741|P4|NOT COMPLETED|Extension Phase||24
2469772|NCT00965757|6056742|P3|NOT COMPLETED|Extension Phase||33
2469773|NCT00965757|6056743|P2|NOT COMPLETED|Extension Phase||0
2469774|NCT00965757|6056744|P1|NOT COMPLETED|Extension Phase||0
2469775|NCT00965757|6056741|P4|COMPLETED|Extension Phase||64
2469776|NCT00965757|6056742|P3|COMPLETED|Extension Phase||132
2469777|NCT00965757|6056743|P2|COMPLETED|Extension Phase||0
2469778|NCT00965757|6056744|P1|COMPLETED|Extension Phase||0
2469779|NCT00965757|6056741|P4|STARTED|Extension Phase||88
2469780|NCT00965757|6056742|P3|STARTED|Extension Phase||165
2469781|NCT00965757|6056743|P2|STARTED|Extension Phase||0
2469782|NCT00965757|6056744|P1|STARTED|Extension Phase||0
2469783|NCT00965757|6056741|P4|NOT COMPLETED|Double-blind Phase||0
2469784|NCT00965757|6056742|P3|NOT COMPLETED|Double-blind Phase||0
2469785|NCT00965757|6056743|P2|NOT COMPLETED|Double-blind Phase||18
2469786|NCT00965757|6056744|P1|NOT COMPLETED|Double-blind Phase||17
2469787|NCT00965757|6056741|P4|COMPLETED|Double-blind Phase||0
2469788|NCT00965757|6056742|P3|COMPLETED|Double-blind Phase||0
2469789|NCT00965757|6056743|P2|COMPLETED|Double-blind Phase||70
2469790|NCT00965757|6056744|P1|COMPLETED|Double-blind Phase||148
2469791|NCT00965757|6056741|P4|STARTED|Double-blind Phase||0
2469792|NCT00965757|6056742|P3|STARTED|Double-blind Phase||0
2469793|NCT00965757|6056743|P2|STARTED|Double-blind Phase||88
2469794|NCT00965757|6056744|P1|STARTED|Double-blind Phase||165
2469795|NCT00965731|6056778|P2|NOT COMPLETED|Overall Study||20
2469796|NCT00965731|6056779|P1|NOT COMPLETED|Overall Study||7
2469797|NCT00965731|6056778|P2|COMPLETED|Overall Study||0
2469798|NCT00965731|6056779|P1|COMPLETED|Overall Study||0
2469799|NCT00965731|6056778|P2|STARTED|Overall Study|Dose level given only after lower dose was successfully administered|20
2469800|NCT00965731|6056779|P1|STARTED|Overall Study||7
2469801|NCT00965718|6056843|P1|NOT COMPLETED|Overall Study||4
2469802|NCT00965718|6056843|P1|COMPLETED|Overall Study||16
2469803|NCT00965718|6056843|P1|STARTED|Overall Study||20
2469804|NCT00965562|6056856|P3|NOT COMPLETED|Overall Study||3
2469805|NCT00965562|6056857|P2|NOT COMPLETED|Overall Study||4
2469806|NCT00965562|6056858|P1|NOT COMPLETED|Overall Study||3
2469807|NCT00965562|6056856|P3|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
2469808|NCT00965562|6056857|P2|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
2469809|NCT00965562|6056858|P1|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
2469810|NCT00965562|6056856|P3|Women Who Participated Full Follow up|Overall Study|2 patients discontinued intervention: 2 patient requests|11
2469811|NCT00965562|6056857|P2|Women Who Participated Full Follow up|Overall Study|3 patients discontinued intervention: 1 out of contact, 2 patient requests|10
2469812|NCT00965562|6056858|P1|Women Who Participated Full Follow up|Overall Study|7 patients discontinued intervention: 2 out of contact, 4 patient requests, 1 suspended by IRB|6
2469901|NCT00965081|6057095|P2|STARTED|Overall Study||153
2469813|NCT00965562|6056856|P3|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 3 out of contact|13
2469814|NCT00965562|6056857|P2|Women With at Least 2 Follow up Visits|Overall Study|4 patients with no follow up visits: 2 out of contact, 2 patient requests|13
2469815|NCT00965562|6056858|P1|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 1 out of contact, 2 patient requests|13
2469816|NCT00965562|6056856|P3|STARTED|Overall Study||16
2469817|NCT00965562|6056857|P2|STARTED|Overall Study||17
2469818|NCT00965562|6056858|P1|STARTED|Overall Study||16
2469819|NCT00965523|6056896|P1|NOT COMPLETED|Study 224||6
2469820|NCT00965523|6056896|P1|COMPLETED|Study 224||0
2469821|NCT00965523|6056896|P1|STARTED|Study 224|Six subjects continued into Study 224 from Study 221.|6
2469822|NCT00965523|6056896|P1|NOT COMPLETED|Study 221||7
2469823|NCT00965523|6056896|P1|COMPLETED|Study 221||74
2469824|NCT00965523|6056896|P1|STARTED|Study 221|Study 221 (Safety Analysis Set).|81
2469825|NCT00965497|6056901|P1|NOT COMPLETED|Overall Study||1
2469826|NCT00965497|6056901|P1|COMPLETED|Overall Study||13
2469827|NCT00965497|6056901|P1|STARTED|Overall Study||14
2469828|NCT00965484|6056906|P1|NOT COMPLETED|Overall Study||2
2469829|NCT00965484|6056906|P1|COMPLETED|Overall Study||134
2469830|NCT00965484|6056906|P1|STARTED|Overall Study||136
2469831|NCT00965458|6056915|P2|NOT COMPLETED|Overall Study||4
2469832|NCT00965458|6056916|P1|NOT COMPLETED|Overall Study||2
2469833|NCT00965458|6056915|P2|COMPLETED|Overall Study||12
2469834|NCT00965458|6056916|P1|COMPLETED|Overall Study||31
2469835|NCT00965458|6056915|P2|STARTED|Overall Study||16
2469836|NCT00965458|6056916|P1|STARTED|Overall Study||33
2469837|NCT00965419|6056932|P1|NOT COMPLETED|Follow-up Phase||62
2469838|NCT00965419|6056932|P1|COMPLETED|Follow-up Phase||18
2469839|NCT00965419|6056932|P1|STARTED|Follow-up Phase||80
2469840|NCT00965419|6056932|P1|NOT COMPLETED|Open Label Treatment for Responders||247
2469841|NCT00965419|6056932|P1|COMPLETED|Open Label Treatment for Responders||20
2469842|NCT00965419|6056932|P1|Not Lost to f/u at First Post-baseline|Open Label Treatment for Responders||264
2469843|NCT00965419|6056932|P1|STARTED|Open Label Treatment for Responders||267
2469844|NCT00965341|6056978|P2|NOT COMPLETED|Overall Study||8
2469845|NCT00965341|6056979|P1|NOT COMPLETED|Overall Study||6
2469846|NCT00965341|6056978|P2|COMPLETED|Overall Study||16
2469847|NCT00965341|6056979|P1|COMPLETED|Overall Study||13
2469848|NCT00965341|6056978|P2|STARTED|Overall Study||24
2469849|NCT00965341|6056979|P1|STARTED|Overall Study||19
2469850|NCT00965263|6056989|P2|NOT COMPLETED|Overall Study||3
2469851|NCT00965263|6056990|P1|NOT COMPLETED|Overall Study||2
2469852|NCT00965263|6056989|P2|COMPLETED|Overall Study||6
2469853|NCT00965263|6056990|P1|COMPLETED|Overall Study||4
2469854|NCT00965263|6056989|P2|STARTED|Overall Study||9
2469855|NCT00965263|6056990|P1|STARTED|Overall Study||6
2469856|NCT00965250|6057022|P2|NOT COMPLETED|Overall Study||0
2469857|NCT00965250|6057023|P1|NOT COMPLETED|Overall Study||0
2469858|NCT00965250|6057022|P2|COMPLETED|Overall Study||12
2469859|NCT00965250|6057023|P1|COMPLETED|Overall Study||37
2469860|NCT00965250|6057022|P2|STARTED|Overall Study||12
2469861|NCT00965250|6057023|P1|STARTED|Overall Study||37
2469862|NCT00965237|6057041|P2|NOT COMPLETED|Period 2, One Week of Wear||0
2469863|NCT00965237|6057042|P1|NOT COMPLETED|Period 2, One Week of Wear||0
2469864|NCT00965237|6057041|P2|COMPLETED|Period 2, One Week of Wear||8
2469865|NCT00965237|6057042|P1|COMPLETED|Period 2, One Week of Wear||8
2469866|NCT00965237|6057041|P2|STARTED|Period 2, One Week of Wear||8
2469867|NCT00965237|6057042|P1|STARTED|Period 2, One Week of Wear||8
2469868|NCT00965237|6057041|P2|NOT COMPLETED|Period 1, One Week of Wear||0
2469869|NCT00965237|6057042|P1|NOT COMPLETED|Period 1, One Week of Wear||0
2469870|NCT00965237|6057041|P2|COMPLETED|Period 1, One Week of Wear||8
2469871|NCT00965237|6057042|P1|COMPLETED|Period 1, One Week of Wear||8
2469872|NCT00965237|6057041|P2|STARTED|Period 1, One Week of Wear||8
2469873|NCT00965237|6057042|P1|STARTED|Period 1, One Week of Wear||8
2469874|NCT00965185|6057050|P2|NOT COMPLETED|Overall Study||1
2469875|NCT00965185|6057051|P1|NOT COMPLETED|Overall Study||2
2469876|NCT00965185|6057050|P2|COMPLETED|Overall Study||20
2469877|NCT00965185|6057051|P1|COMPLETED|Overall Study||17
2469878|NCT00965185|6057050|P2|9 Month Visit|Overall Study||21
2469879|NCT00965185|6057051|P1|9 Month Visit|Overall Study||18
2469880|NCT00965185|6057050|P2|6 Month Visit|Overall Study||21
2469881|NCT00965185|6057051|P1|6 Month Visit|Overall Study||18
2469882|NCT00965185|6057050|P2|3 Month Visit|Overall Study||21
2469883|NCT00965185|6057051|P1|3 Month Visit|Overall Study||18
2469884|NCT00965185|6057050|P2|1 Month Visit|Overall Study||21
2469885|NCT00965185|6057051|P1|1 Month Visit|Overall Study||18
2469886|NCT00965185|6057050|P2|STARTED|Overall Study||21
2469887|NCT00965185|6057051|P1|STARTED|Overall Study||19
2469888|NCT00965146|6057071|P1|NOT COMPLETED|Overall Study||210
2469889|NCT00965146|6057071|P1|COMPLETED|Overall Study|Study was terminated prior to reaching 15 year endpoint.|0
2469890|NCT00965146|6057071|P1|STARTED|Overall Study||210
2469891|NCT00965094|6057078|P2|NOT COMPLETED|Overall Study||1
2469892|NCT00965094|6057079|P1|NOT COMPLETED|Overall Study||5
2469893|NCT00965094|6057078|P2|COMPLETED|Overall Study||16
2469894|NCT00965094|6057079|P1|COMPLETED|Overall Study||14
2469895|NCT00965094|6057078|P2|STARTED|Overall Study||17
2469896|NCT00965094|6057079|P1|STARTED|Overall Study||19
2469897|NCT00965081|6057095|P2|NOT COMPLETED|Overall Study||43
2469898|NCT00965081|6057096|P1|NOT COMPLETED|Overall Study||34
2469899|NCT00965081|6057095|P2|COMPLETED|Overall Study||110
2469900|NCT00965081|6057096|P1|COMPLETED|Overall Study|In addition, 16/17 rescue participants completed study on protocol-specified study medication.|121
2469902|NCT00965081|6057096|P1|STARTED|Overall Study|2 randomized participants had no post-baseline measures and are not included in outcome measures.|155
2469903|NCT00965055|6057119|P1|NOT COMPLETED|Overall Study||0
2469904|NCT00965055|6057119|P1|COMPLETED|Overall Study||2
2469905|NCT00965055|6057119|P1|STARTED|Overall Study||2
2469906|NCT00964886|6057128|P4|NOT COMPLETED|Overall Study||9
2469907|NCT00964886|6057129|P3|NOT COMPLETED|Overall Study||16
2469908|NCT00964886|6057130|P2|NOT COMPLETED|Overall Study||7
2469909|NCT00964886|6057131|P1|NOT COMPLETED|Overall Study||11
2469910|NCT00964886|6057128|P4|COMPLETED|Overall Study||24
2469911|NCT00964886|6057129|P3|COMPLETED|Overall Study||21
2469912|NCT00964886|6057130|P2|COMPLETED|Overall Study||27
2469913|NCT00964886|6057131|P1|COMPLETED|Overall Study||27
2469914|NCT00964886|6057128|P4|STARTED|Overall Study||33
2469915|NCT00964886|6057129|P3|STARTED|Overall Study||37
2469916|NCT00964886|6057130|P2|STARTED|Overall Study||34
2469917|NCT00964886|6057131|P1|STARTED|Overall Study||38
2469918|NCT00964860|6057147|P2|NOT COMPLETED|Overall Study||1
2469919|NCT00964860|6057148|P1|NOT COMPLETED|Overall Study||0
2469920|NCT00964860|6057147|P2|COMPLETED|Overall Study||29
2469921|NCT00964860|6057148|P1|COMPLETED|Overall Study||30
2469922|NCT00964860|6057147|P2|STARTED|Overall Study||30
2469923|NCT00964860|6057148|P1|STARTED|Overall Study||30
2469924|NCT00964795|6057156|P1|NOT COMPLETED|Overall Study||307
2469925|NCT00964795|6057156|P1|COMPLETED|Overall Study|Prior to amendment 4, 16 participants completed up to Week 120. No participants completed Week 180.|16
2469926|NCT00964795|6057156|P1|Number of Participants Treated|Overall Study||320
2469927|NCT00964795|6057156|P1|STARTED|Overall Study|randomized|323
2469928|NCT00964782|6057165|P2|NOT COMPLETED|Overall Study||0
2469929|NCT00964782|6057166|P1|NOT COMPLETED|Overall Study||1
2469930|NCT00964782|6057165|P2|COMPLETED|Overall Study||8
2469931|NCT00964782|6057166|P1|COMPLETED|Overall Study||7
2469932|NCT00964782|6057165|P2|STARTED|Overall Study||8
2469933|NCT00964782|6057166|P1|STARTED|Overall Study||8
2469934|NCT00964743|6057180|P1|NOT COMPLETED|Overall Study||2
2469935|NCT00964743|6057180|P1|COMPLETED|Overall Study||0
2469936|NCT00964743|6057180|P1|STARTED|Overall Study||2
2469937|NCT00964678|6057188|P1|NOT COMPLETED|Overall Study||4
2469938|NCT00964678|6057188|P1|COMPLETED|Overall Study||6
2469939|NCT00964678|6057188|P1|STARTED|Overall Study||10
2469940|NCT00964548|6057197|P2|NOT COMPLETED|Overall Study||0
2469941|NCT00964548|6057198|P1|NOT COMPLETED|Overall Study||0
2469942|NCT00964548|6057197|P2|COMPLETED|Overall Study||5
2469943|NCT00964548|6057198|P1|COMPLETED|Overall Study||5
2469944|NCT00964548|6057197|P2|STARTED|Overall Study||5
2469945|NCT00964548|6057198|P1|STARTED|Overall Study||5
2469946|NCT00964496|6057210|P2|NOT COMPLETED|Overall Study||1
2469947|NCT00964496|6057211|P1|NOT COMPLETED|Overall Study||2
2469948|NCT00964496|6057210|P2|COMPLETED|Overall Study||26
2469949|NCT00964496|6057211|P1|COMPLETED|Overall Study||26
2469950|NCT00964496|6057210|P2|STARTED|Overall Study||27
2469951|NCT00964496|6057211|P1|STARTED|Overall Study||28
2469952|NCT00964444|6057229|P1|NOT COMPLETED|Overall Study||0
2469953|NCT00964444|6057229|P1|COMPLETED|Overall Study||10
2469954|NCT00964444|6057229|P1|STARTED|Overall Study||10
2469955|NCT00964431|6057237|P4|NOT COMPLETED|Overall Study||0
2469956|NCT00964431|6057238|P3|NOT COMPLETED|Overall Study||0
2469957|NCT00964431|6057239|P2|NOT COMPLETED|Overall Study||0
2469958|NCT00964431|6057240|P1|NOT COMPLETED|Overall Study||0
2469959|NCT00964431|6057237|P4|COMPLETED|Overall Study||51
2469960|NCT00964431|6057238|P3|COMPLETED|Overall Study||51
2469961|NCT00964431|6057239|P2|COMPLETED|Overall Study||51
2469962|NCT00964431|6057240|P1|COMPLETED|Overall Study||50
2469963|NCT00964431|6057237|P4|STARTED|Overall Study||51
2469964|NCT00964431|6057238|P3|STARTED|Overall Study||51
2469965|NCT00964431|6057239|P2|STARTED|Overall Study||51
2469966|NCT00964431|6057240|P1|STARTED|Overall Study||50
2469967|NCT00964392|6057252|P2|NOT COMPLETED|Overall Study||190
2469968|NCT00964392|6057253|P1|NOT COMPLETED|Overall Study||53
2469969|NCT00964392|6057252|P2|COMPLETED|Overall Study||92
2469970|NCT00964392|6057253|P1|COMPLETED|Overall Study||72
2469971|NCT00964392|6057252|P2|STARTED|Overall Study|Both safety and efficacy cohort: Total 292 (10 LEP Excluded)|282
2469972|NCT00964392|6057253|P1|STARTED|Overall Study|Both safety and efficacy cohort: Total 128 (3 MEP Excluded)|125
2469973|NCT00964366|6057263|P2|NOT COMPLETED|Overall Study||1
2469974|NCT00964366|6057264|P1|NOT COMPLETED|Overall Study||1
2469975|NCT00964366|6057263|P2|COMPLETED|Overall Study||24
2469976|NCT00964366|6057264|P1|COMPLETED|Overall Study||27
2469977|NCT00964366|6057263|P2|STARTED|Overall Study||25
2469978|NCT00964366|6057264|P1|STARTED|Overall Study|27 of the 28 enrolled were eligible after screening.|28
2469979|NCT00964353|6057280|P2|NOT COMPLETED|Overall Study||0
2469980|NCT00964353|6057281|P1|NOT COMPLETED|Overall Study||0
2469981|NCT00964353|6057280|P2|COMPLETED|Overall Study||178
2469982|NCT00964353|6057281|P1|COMPLETED|Overall Study||181
2469983|NCT00964353|6057280|P2|STARTED|Overall Study||178
2469984|NCT00964353|6057281|P1|STARTED|Overall Study||181
2469985|NCT00964223|6057289|P1|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||1
2469986|NCT00964223|6057289|P1|COMPLETED|Full Face Treatment (Weeks 5 and 8)||27
2469987|NCT00964223|6057289|P1|STARTED|Full Face Treatment (Weeks 5 and 8)||28
2469988|NCT00964223|6057289|P1|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
2469989|NCT00964223|6057289|P1|COMPLETED|Split Face Treatment (Weeks 1 and 2)||28
2469990|NCT00964223|6057289|P1|STARTED|Split Face Treatment (Weeks 1 and 2)||28
2469991|NCT00964158|6057357|P3|NOT COMPLETED|Overall Study||8
2469992|NCT00964158|6057358|P2|NOT COMPLETED|Overall Study||1
2469993|NCT00964158|6057359|P1|NOT COMPLETED|Overall Study||0
2469994|NCT00964158|6057357|P3|COMPLETED|Overall Study||92
2469995|NCT00964158|6057358|P2|COMPLETED|Overall Study||56
2469996|NCT00964158|6057359|P1|COMPLETED|Overall Study||53
2469997|NCT00964158|6057357|P3|STARTED|Overall Study||100
2469998|NCT00964158|6057358|P2|STARTED|Overall Study||57
2469999|NCT00964158|6057359|P1|STARTED|Overall Study||53
2470000|NCT00964119|6057428|P1|NOT COMPLETED|Overall Study||0
2470001|NCT00964119|6057428|P1|COMPLETED|Overall Study||15
2470002|NCT00964119|6057428|P1|STARTED|Overall Study||15
2470003|NCT00964028|6057434|P2|NOT COMPLETED|Overall Study||1
2470004|NCT00964028|6057435|P1|NOT COMPLETED|Overall Study||0
2470005|NCT00964028|6057434|P2|COMPLETED|Overall Study||24
2470006|NCT00964028|6057435|P1|COMPLETED|Overall Study||25
2470007|NCT00964028|6057434|P2|STARTED|Overall Study||25
2470008|NCT00964028|6057435|P1|STARTED|Overall Study||25
2470009|NCT00963937|6057450|P3|NOT COMPLETED|Overall Study||4
2470010|NCT00963937|6057451|P2|NOT COMPLETED|Overall Study||11
2470011|NCT00963937|6057452|P1|NOT COMPLETED|Overall Study||19
2470012|NCT00963937|6057450|P3|COMPLETED|Overall Study||41
2470013|NCT00963937|6057451|P2|COMPLETED|Overall Study||33
2470014|NCT00963937|6057452|P1|COMPLETED|Overall Study||70
2470015|NCT00963937|6057450|P3|STARTED|Overall Study||45
2470016|NCT00963937|6057451|P2|STARTED|Overall Study||44
2470017|NCT00963937|6057452|P1|STARTED|Overall Study||89
2470018|NCT00963924|6057490|P2|NOT COMPLETED|Overall Study||3
2470019|NCT00963924|6057491|P1|NOT COMPLETED|Overall Study||1
2470020|NCT00963924|6057490|P2|COMPLETED|Overall Study||15
2470021|NCT00963924|6057491|P1|COMPLETED|Overall Study||17
2470022|NCT00963924|6057490|P2|STARTED|Overall Study||18
2470023|NCT00963924|6057491|P1|STARTED|Overall Study||18
2470024|NCT00963872|6057515|P2|NOT COMPLETED|Overall Study||1
2470025|NCT00963872|6057516|P1|NOT COMPLETED|Overall Study||1
2470026|NCT00963872|6057515|P2|COMPLETED|Overall Study||5
2470027|NCT00963872|6057516|P1|COMPLETED|Overall Study||24
2470028|NCT00963872|6057515|P2|STARTED|Overall Study||6
2470029|NCT00963872|6057516|P1|STARTED|Overall Study||25
2470030|NCT00963859|6057560|P1|NOT COMPLETED|Overall Study||0
2470031|NCT00963859|6057560|P1|COMPLETED|Overall Study||11
2470032|NCT00963859|6057560|P1|STARTED|Overall Study||11
2470033|NCT00963820|6057565|P12|NOT COMPLETED|Expansion Phase||4
2470034|NCT00963820|6057566|P11|NOT COMPLETED|Expansion Phase||5
2470035|NCT00963820|6057567|P10|NOT COMPLETED|Expansion Phase||9
2470036|NCT00963820|6057568|P9|NOT COMPLETED|Expansion Phase||10
2470037|NCT00963820|6057569|P8|NOT COMPLETED|Expansion Phase||0
2470038|NCT00963820|6057570|P7|NOT COMPLETED|Expansion Phase||0
2470039|NCT00963820|6057571|P6|NOT COMPLETED|Expansion Phase||0
2470040|NCT00963820|6057572|P5|NOT COMPLETED|Expansion Phase||0
2470041|NCT00963820|6057573|P4|NOT COMPLETED|Expansion Phase||0
2470042|NCT00963820|6057574|P3|NOT COMPLETED|Expansion Phase||0
2470043|NCT00963820|6057575|P2|NOT COMPLETED|Expansion Phase||0
2470044|NCT00963820|6057576|P1|NOT COMPLETED|Expansion Phase||0
2470045|NCT00963820|6057565|P12|COMPLETED|Expansion Phase||0
2470046|NCT00963820|6057566|P11|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
2470047|NCT00963820|6057567|P10|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
2470048|NCT00963820|6057568|P9|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
2470049|NCT00963820|6057569|P8|COMPLETED|Expansion Phase||0
2470050|NCT00963820|6057570|P7|COMPLETED|Expansion Phase||0
2470051|NCT00963820|6057571|P6|COMPLETED|Expansion Phase||0
2470052|NCT00963820|6057572|P5|COMPLETED|Expansion Phase||0
2470053|NCT00963820|6057573|P4|COMPLETED|Expansion Phase||0
2470054|NCT00963820|6057574|P3|COMPLETED|Expansion Phase||0
2470055|NCT00963820|6057575|P2|COMPLETED|Expansion Phase||0
2470056|NCT00963820|6057576|P1|COMPLETED|Expansion Phase||0
2470057|NCT00963820|6057565|P12|STARTED|Expansion Phase|Includes participants with last dose of carfilzomib 21 to 60 days before 1st ixazomib citrate dose.|4
2470058|NCT00963820|6057566|P11|STARTED|Expansion Phase|Includes only participants who are proteasome inhibitor (PI)-naïve.|6
2470059|NCT00963820|6057567|P10|STARTED|Expansion Phase|Includes 1 participant from the dose escalation cohort 2.97 mg/m^2.|10
2470060|NCT00963820|6057568|P9|STARTED|Expansion Phase|Includes 2 participants from the dose escalation cohort 2.97 mg/m^2.|11
2470061|NCT00963820|6057569|P8|STARTED|Expansion Phase||0
2470062|NCT00963820|6057570|P7|STARTED|Expansion Phase||0
2470063|NCT00963820|6057571|P6|STARTED|Expansion Phase||0
2470064|NCT00963820|6057572|P5|STARTED|Expansion Phase||0
2470065|NCT00963820|6057573|P4|STARTED|Expansion Phase||0
2470066|NCT00963820|6057574|P3|STARTED|Expansion Phase||0
2470067|NCT00963820|6057575|P2|STARTED|Expansion Phase||0
2470068|NCT00963820|6057576|P1|STARTED|Expansion Phase|Dose escalation cohorts were not part of the Expansion Phase except as noted in comments.|0
2470069|NCT00963820|6057565|P12|NOT COMPLETED|Dose Escalation Phase||0
2470070|NCT00963820|6057566|P11|NOT COMPLETED|Dose Escalation Phase||0
2470071|NCT00963820|6057567|P10|NOT COMPLETED|Dose Escalation Phase||0
2470072|NCT00963820|6057568|P9|NOT COMPLETED|Dose Escalation Phase||0
2470073|NCT00963820|6057569|P8|NOT COMPLETED|Dose Escalation Phase||5
2470074|NCT00963820|6057570|P7|NOT COMPLETED|Dose Escalation Phase||8
2470075|NCT00963820|6057571|P6|NOT COMPLETED|Dose Escalation Phase||3
2470076|NCT00963820|6057572|P5|NOT COMPLETED|Dose Escalation Phase||4
2470077|NCT00963820|6057573|P4|NOT COMPLETED|Dose Escalation Phase||3
2470078|NCT00963820|6057574|P3|NOT COMPLETED|Dose Escalation Phase||3
2470079|NCT00963820|6057575|P2|NOT COMPLETED|Dose Escalation Phase||3
2470080|NCT00963820|6057576|P1|NOT COMPLETED|Dose Escalation Phase||3
2470081|NCT00963820|6057565|P12|COMPLETED|Dose Escalation Phase||0
2470082|NCT00963820|6057566|P11|COMPLETED|Dose Escalation Phase||0
2470083|NCT00963820|6057567|P10|COMPLETED|Dose Escalation Phase||0
2470084|NCT00963820|6057568|P9|COMPLETED|Dose Escalation Phase||0
2470085|NCT00963820|6057569|P8|COMPLETED|Dose Escalation Phase||0
2470086|NCT00963820|6057570|P7|COMPLETED|Dose Escalation Phase||0
2470087|NCT00963820|6057571|P6|COMPLETED|Dose Escalation Phase||0
2470088|NCT00963820|6057572|P5|COMPLETED|Dose Escalation Phase||0
2470089|NCT00963820|6057573|P4|COMPLETED|Dose Escalation Phase||0
2470090|NCT00963820|6057574|P3|COMPLETED|Dose Escalation Phase||0
2470091|NCT00963820|6057575|P2|COMPLETED|Dose Escalation Phase||0
2470092|NCT00963820|6057576|P1|COMPLETED|Dose Escalation Phase||0
2470093|NCT00963820|6057565|P12|STARTED|Dose Escalation Phase||0
2470094|NCT00963820|6057566|P11|STARTED|Dose Escalation Phase||0
2470095|NCT00963820|6057567|P10|STARTED|Dose Escalation Phase||0
2470096|NCT00963820|6057568|P9|STARTED|Dose Escalation Phase|Expansion cohorts were not part of Dose Escalation except as noted in comments.|0
2470097|NCT00963820|6057569|P8|STARTED|Dose Escalation Phase||5
2470098|NCT00963820|6057570|P7|STARTED|Dose Escalation Phase||8
2470099|NCT00963820|6057571|P6|STARTED|Dose Escalation Phase||3
2470100|NCT00963820|6057572|P5|STARTED|Dose Escalation Phase||4
2470101|NCT00963820|6057573|P4|STARTED|Dose Escalation Phase||3
2470102|NCT00963820|6057574|P3|STARTED|Dose Escalation Phase||3
2470103|NCT00963820|6057575|P2|STARTED|Dose Escalation Phase||3
2470104|NCT00963820|6057576|P1|STARTED|Dose Escalation Phase||3
2470105|NCT00963807|6057712|P1|NOT COMPLETED|Overall Study||18
2470106|NCT00963807|6057712|P1|COMPLETED|Overall Study||8
2470107|NCT00963807|6057712|P1|Completed Post-Cycle 2 FDG Imaging|Overall Study||8
2470108|NCT00963807|6057712|P1|Completed Post-Cycle 2 FLT Imaging|Overall Study||9
2470109|NCT00963807|6057712|P1|Completed Post-Cycle 1 Imaging|Overall Study||9
2470110|NCT00963807|6057712|P1|Completed Baseline Imaging|Overall Study||11
2470111|NCT00963807|6057712|P1|STARTED|Overall Study||26
2470112|NCT00963677|6057723|P2|NOT COMPLETED|Overall Study||2
2470113|NCT00963677|6057724|P1|NOT COMPLETED|Overall Study||0
2470114|NCT00963677|6057723|P2|COMPLETED|Overall Study|Two patients were excluded from the study due to the difficult ventilation with facemask ventilation|18
2470115|NCT00963677|6057724|P1|COMPLETED|Overall Study||35
2470116|NCT00963677|6057723|P2|STARTED|Overall Study|Patients with predicted difficult intubation but not ventilation|20
2470117|NCT00963677|6057724|P1|STARTED|Overall Study|Patients without predicted difficult intubation|35
2470118|NCT00963638|6057734|P2|NOT COMPLETED|Overall Study||0
2470119|NCT00963638|6057735|P1|NOT COMPLETED|Overall Study||0
2470120|NCT00963638|6057734|P2|COMPLETED|Overall Study||20
2470121|NCT00963638|6057735|P1|COMPLETED|Overall Study||20
2470122|NCT00963638|6057734|P2|STARTED|Overall Study||20
2470123|NCT00963638|6057735|P1|STARTED|Overall Study||20
2470124|NCT00963599|6057745|P4|NOT COMPLETED|Overall Study||14
2470125|NCT00963599|6057746|P3|NOT COMPLETED|Overall Study||9
2470126|NCT00963599|6057747|P2|NOT COMPLETED|Overall Study||6
2470127|NCT00963599|6057748|P1|NOT COMPLETED|Overall Study||6
2470128|NCT00963599|6057745|P4|COMPLETED|Overall Study||288
2470129|NCT00963599|6057746|P3|COMPLETED|Overall Study||292
2470130|NCT00963599|6057747|P2|COMPLETED|Overall Study||149
2470131|NCT00963599|6057748|P1|COMPLETED|Overall Study||143
2470132|NCT00963599|6057745|P4|STARTED|Overall Study||302
2470133|NCT00963599|6057746|P3|STARTED|Overall Study||301
2470134|NCT00963599|6057747|P2|STARTED|Overall Study||155
2470135|NCT00963599|6057748|P1|STARTED|Overall Study||149
2470136|NCT00963560|6057805|P3|NOT COMPLETED|Overall Study||0
2470137|NCT00963560|6057806|P2|NOT COMPLETED|Overall Study||3
2470138|NCT00963560|6057807|P1|NOT COMPLETED|Overall Study||3
2470139|NCT00963560|6057805|P3|COMPLETED|Overall Study||41
2470140|NCT00963560|6057806|P2|COMPLETED|Overall Study||41
2470141|NCT00963560|6057807|P1|COMPLETED|Overall Study||44
2470142|NCT00963560|6057805|P3|STARTED|Overall Study||41
2470143|NCT00963560|6057806|P2|STARTED|Overall Study||44
2470144|NCT00963560|6057807|P1|STARTED|Overall Study||47
2470145|NCT00963547|6057819|P7|NOT COMPLETED|Overall Study||0
2470146|NCT00963547|6057820|P6|NOT COMPLETED|Overall Study||0
2470147|NCT00963547|6057821|P5|NOT COMPLETED|Overall Study||0
2470148|NCT00963547|6057822|P4|NOT COMPLETED|Overall Study||6
2470149|NCT00963547|6057823|P3|NOT COMPLETED|Overall Study||12
2470150|NCT00963547|6057824|P2|NOT COMPLETED|Overall Study||11
2470151|NCT00963547|6057825|P1|NOT COMPLETED|Overall Study||4
2470152|NCT00963547|6057819|P7|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
2470153|NCT00963547|6057820|P6|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
2470154|NCT00963547|6057821|P5|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
2470155|NCT00963547|6057822|P4|COMPLETED|Overall Study||0
2470156|NCT00963547|6057823|P3|COMPLETED|Overall Study||0
2470157|NCT00963547|6057824|P2|COMPLETED|Overall Study||0
2470158|NCT00963547|6057825|P1|COMPLETED|Overall Study||0
2470159|NCT00963547|6057819|P7|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
2470160|NCT00963547|6057820|P6|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
2470161|NCT00963547|6057821|P5|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
2470162|NCT00963547|6057822|P4|Treated|Overall Study||6
2470163|NCT00963547|6057823|P3|Treated|Overall Study||11
2470164|NCT00963547|6057824|P2|Treated|Overall Study||11
2470165|NCT00963547|6057825|P1|Treated|Overall Study||3
2470166|NCT00963547|6057819|P7|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
2470167|NCT00963547|6057820|P6|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
2470168|NCT00963547|6057821|P5|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
2470169|NCT00963547|6057822|P4|STARTED|Overall Study||6
2470170|NCT00963547|6057823|P3|STARTED|Overall Study||12
2470171|NCT00963547|6057824|P2|STARTED|Overall Study||11
2470172|NCT00963547|6057825|P1|STARTED|Overall Study||4
2470173|NCT00963508|6057851|P2|NOT COMPLETED|Overall Study||28
2470174|NCT00963508|6057852|P1|NOT COMPLETED|Overall Study||10
2470175|NCT00963508|6057851|P2|COMPLETED|Overall Study||169
2470176|NCT00963508|6057852|P1|COMPLETED|Overall Study||196
2470177|NCT00963508|6057851|P2|STARTED|Overall Study||197
2470178|NCT00963508|6057852|P1|STARTED|Overall Study||206
2470179|NCT00963482|6057862|P2|NOT COMPLETED|Overall Study||17
2470180|NCT00963482|6057863|P1|NOT COMPLETED|Overall Study||28
2470181|NCT00963482|6057862|P2|COMPLETED|Overall Study||33
2470182|NCT00963482|6057863|P1|COMPLETED|Overall Study||25
2470183|NCT00963482|6057862|P2|STARTED|Overall Study||50
2470184|NCT00963482|6057863|P1|STARTED|Overall Study||53
2470185|NCT00963469|6057872|P3|NOT COMPLETED|Overall Study||10
2470186|NCT00963469|6057873|P2|NOT COMPLETED|Overall Study||28
2470187|NCT00963469|6057874|P1|NOT COMPLETED|Overall Study||41
2470188|NCT00963469|6057872|P3|COMPLETED|Overall Study||170
2470189|NCT00963469|6057873|P2|COMPLETED|Overall Study||420
2470190|NCT00963469|6057874|P1|COMPLETED|Overall Study||410
2470191|NCT00963469|6057872|P3|STARTED|Overall Study||180
2470192|NCT00963469|6057873|P2|STARTED|Overall Study||448
2470193|NCT00963469|6057874|P1|STARTED|Overall Study||451
2470194|NCT00963430|6057902|P2|NOT COMPLETED|Overall Study||3
2470195|NCT00963430|6057903|P1|NOT COMPLETED|Overall Study||1
2470196|NCT00963430|6057902|P2|COMPLETED|Overall Study||57
2470197|NCT00963430|6057903|P1|COMPLETED|Overall Study||59
2470198|NCT00963430|6057902|P2|STARTED|Overall Study||60
2470199|NCT00963430|6057903|P1|STARTED|Overall Study||60
2470200|NCT00963235|6057941|P1|NOT COMPLETED|Overall Study||60
2470201|NCT00963235|6057941|P1|COMPLETED|Overall Study||271
2470202|NCT00963235|6057941|P1|Completed Dose 3 1-month Blood Draw|Overall Study||277
2470203|NCT00963235|6057941|P1|Vaccinated Dose 3|Overall Study||279
2470204|NCT00963235|6057941|P1|Vaccinated Dose 2|Overall Study||300
2470205|NCT00963235|6057941|P1|Vaccinated Dose 1|Overall Study||329
2470206|NCT00963235|6057941|P1|STARTED|Overall Study||331
2470207|NCT00963157|6057965|P5|NOT COMPLETED|Overall Study||2
2470208|NCT00963157|6057966|P4|NOT COMPLETED|Overall Study||7
2470209|NCT00963157|6057967|P3|NOT COMPLETED|Overall Study||5
2470210|NCT00963157|6057968|P2|NOT COMPLETED|Overall Study||4
2470211|NCT00963157|6057969|P1|NOT COMPLETED|Overall Study||5
2470212|NCT00963157|6057965|P5|COMPLETED|Overall Study||151
2470213|NCT00963157|6057966|P4|COMPLETED|Overall Study||150
2470214|NCT00963157|6057967|P3|COMPLETED|Overall Study||155
2470215|NCT00963157|6057968|P2|COMPLETED|Overall Study||159
2470216|NCT00963157|6057969|P1|COMPLETED|Overall Study||151
2470217|NCT00963157|6057965|P5|STARTED|Overall Study||153
2470218|NCT00963157|6057966|P4|STARTED|Overall Study||157
2470219|NCT00963157|6057967|P3|STARTED|Overall Study||160
2470220|NCT00963157|6057968|P2|STARTED|Overall Study||163
2470221|NCT00963157|6057969|P1|STARTED|Overall Study||156
2470222|NCT00963105|6058164|P3|NOT COMPLETED|Overall Study||0
2470223|NCT00963105|6058165|P2|NOT COMPLETED|Overall Study||0
2470224|NCT00963105|6058166|P1|NOT COMPLETED|Overall Study||0
2470225|NCT00963105|6058164|P3|COMPLETED|Overall Study||35
2470226|NCT00963105|6058165|P2|COMPLETED|Overall Study||35
2470227|NCT00963105|6058166|P1|COMPLETED|Overall Study||34
2470228|NCT00963105|6058164|P3|Received Treatment|Overall Study||35
2470229|NCT00963105|6058165|P2|Received Treatment|Overall Study||34
2470230|NCT00963105|6058166|P1|Received Treatment|Overall Study||34
2470231|NCT00963105|6058164|P3|STARTED|Overall Study||35
2470232|NCT00963105|6058165|P2|STARTED|Overall Study||35
2470233|NCT00963105|6058166|P1|STARTED|Overall Study||34
2470234|NCT00962949|6058197|P2|NOT COMPLETED|Overall Study||0
2470235|NCT00962949|6058198|P1|NOT COMPLETED|Overall Study||0
2470236|NCT00962949|6058197|P2|COMPLETED|Overall Study||15
2470237|NCT00962949|6058198|P1|COMPLETED|Overall Study||13
2470238|NCT00962949|6058197|P2|STARTED|Overall Study||15
2470239|NCT00962949|6058198|P1|STARTED|Overall Study||13
2470240|NCT00962871|6058214|P4|NOT COMPLETED|Overall Study||0
2470241|NCT00962871|6058215|P3|NOT COMPLETED|Overall Study||0
2470242|NCT00962871|6058216|P2|NOT COMPLETED|Overall Study||0
2470243|NCT00962871|6058217|P1|NOT COMPLETED|Overall Study||0
2470244|NCT00962871|6058214|P4|COMPLETED|Overall Study||6
2470245|NCT00962871|6058215|P3|COMPLETED|Overall Study||12
2470246|NCT00962871|6058216|P2|COMPLETED|Overall Study||6
2470247|NCT00962871|6058217|P1|COMPLETED|Overall Study||6
2470248|NCT00962871|6058214|P4|STARTED|Overall Study||6
2470249|NCT00962871|6058215|P3|STARTED|Overall Study||12
2470250|NCT00962871|6058216|P2|STARTED|Overall Study||6
2470251|NCT00962871|6058217|P1|STARTED|Overall Study||6
2470252|NCT00962780|6058233|P2|NOT COMPLETED|Overall Study||14
2470253|NCT00962780|6058234|P1|NOT COMPLETED|Overall Study||10
2470254|NCT00962780|6058233|P2|COMPLETED|Overall Study||138
2470255|NCT00962780|6058234|P1|COMPLETED|Overall Study||141
2470256|NCT00962780|6058233|P2|Vaccinated 23vPS Dose|Overall Study||139
2470257|NCT00962780|6058234|P1|Vaccinated 23vPS Dose|Overall Study||143
2470258|NCT00962780|6058233|P2|Vaccinated 13vPnC Dose 3|Overall Study||142
2470259|NCT00962780|6058234|P1|Vaccinated 13vPnC Dose 3|Overall Study||144
2470260|NCT00962780|6058233|P2|Vaccinated 13vPnC Dose 2|Overall Study||145
2470261|NCT00962780|6058234|P1|Vaccinated 13vPnC Dose 2|Overall Study||145
2470262|NCT00962780|6058233|P2|Vaccinated 13vPnC Dose 1|Overall Study||151
2470263|NCT00962780|6058234|P1|Vaccinated 13vPnC Dose 1|Overall Study||150
2470264|NCT00962780|6058233|P2|STARTED|Overall Study||152
2470265|NCT00962780|6058234|P1|STARTED|Overall Study||151
2470266|NCT00962754|6058298|P2|NOT COMPLETED|Overall Study||0
2470267|NCT00962754|6058299|P1|NOT COMPLETED|Overall Study||0
2470268|NCT00962754|6058298|P2|COMPLETED|Overall Study||84
2470269|NCT00962754|6058299|P1|COMPLETED|Overall Study||86
2470270|NCT00962754|6058298|P2|STARTED|Overall Study||84
2470271|NCT00962754|6058299|P1|STARTED|Overall Study||86
2470272|NCT00962741|6058309|P1|NOT COMPLETED|Overall Study||8
2470273|NCT00962741|6058309|P1|COMPLETED|Overall Study||119
2470274|NCT00962741|6058309|P1|STARTED|Overall Study||127
2470275|NCT00962650|6058400|P1|NOT COMPLETED|Overall Study||2
2470276|NCT00962650|6058400|P1|COMPLETED|Overall Study||8
2470277|NCT00962650|6058400|P1|STARTED|Overall Study||10
2470278|NCT00962598|6058406|P2|NOT COMPLETED|Overall Study||0
2470279|NCT00962598|6058407|P1|NOT COMPLETED|Overall Study||0
2470280|NCT00962598|6058406|P2|COMPLETED|Overall Study||9
2470281|NCT00962598|6058407|P1|COMPLETED|Overall Study||7
2470282|NCT00962598|6058406|P2|STARTED|Overall Study||9
2470283|NCT00962598|6058407|P1|STARTED|Overall Study||7
2470284|NCT00962585|6058419|P4|NOT COMPLETED|Overall Study||0
2470285|NCT00962585|6058420|P3|NOT COMPLETED|Overall Study||3
2470286|NCT00962585|6058421|P2|NOT COMPLETED|Overall Study||2
2470287|NCT00962585|6058422|P1|NOT COMPLETED|Overall Study||6
2470288|NCT00962585|6058419|P4|COMPLETED|Overall Study||42
2470289|NCT00962585|6058420|P3|COMPLETED|Overall Study||39
2470290|NCT00962585|6058421|P2|COMPLETED|Overall Study||40
2470291|NCT00962585|6058422|P1|COMPLETED|Overall Study||37
2470292|NCT00962585|6058419|P4|STARTED|Overall Study||42
2470293|NCT00962585|6058420|P3|STARTED|Overall Study||42
2470294|NCT00962585|6058421|P2|STARTED|Overall Study||42
2470295|NCT00962585|6058422|P1|STARTED|Overall Study||43
2470296|NCT00962390|6058484|P4|NOT COMPLETED|Overall Study||1
2470297|NCT00962390|6058485|P3|NOT COMPLETED|Overall Study||4
2470298|NCT00962390|6058486|P2|NOT COMPLETED|Overall Study||3
2470299|NCT00962390|6058487|P1|NOT COMPLETED|Overall Study||4
2470300|NCT00962390|6058484|P4|COMPLETED|Overall Study||28
2470301|NCT00962390|6058485|P3|COMPLETED|Overall Study||25
2470302|NCT00962390|6058486|P2|COMPLETED|Overall Study||26
2470303|NCT00962390|6058487|P1|COMPLETED|Overall Study||25
2470304|NCT00962390|6058484|P4|STARTED|Overall Study||29
2470305|NCT00962390|6058485|P3|STARTED|Overall Study||29
2470306|NCT00962390|6058486|P2|STARTED|Overall Study||29
2470307|NCT00962390|6058487|P1|STARTED|Overall Study||29
2470308|NCT00962247|6058549|P1|NOT COMPLETED|50% Reduction of Sedentary Activity||0
2470309|NCT00962247|6058549|P1|COMPLETED|50% Reduction of Sedentary Activity||56
2470310|NCT00962247|6058549|P1|STARTED|50% Reduction of Sedentary Activity||56
2470311|NCT00962247|6058549|P1|NOT COMPLETED|25% Reduction of Sedentary Activity||5
2470312|NCT00962247|6058549|P1|COMPLETED|25% Reduction of Sedentary Activity||56
2470313|NCT00962247|6058549|P1|STARTED|25% Reduction of Sedentary Activity||61
2470314|NCT00962247|6058549|P1|NOT COMPLETED|Usual Sedentary||0
2470315|NCT00962247|6058549|P1|COMPLETED|Usual Sedentary||61
2470316|NCT00962247|6058549|P1|STARTED|Usual Sedentary||61
2470317|NCT00962208|6058560|P2|NOT COMPLETED|Overall Study||10
2470318|NCT00962208|6058561|P1|NOT COMPLETED|Overall Study||14
2470319|NCT00962208|6058560|P2|COMPLETED|Overall Study||41
2470320|NCT00962208|6058561|P1|COMPLETED|Overall Study||37
2470321|NCT00962208|6058560|P2|STARTED|Overall Study||51
2470322|NCT00962208|6058561|P1|STARTED|Overall Study||51
2470323|NCT00962104|6058569|P2|NOT COMPLETED|Overall Study||25
2470324|NCT00962104|6058570|P1|NOT COMPLETED|Overall Study||40
2470325|NCT00962104|6058569|P2|COMPLETED|Overall Study||171
2470326|NCT00962104|6058570|P1|COMPLETED|Overall Study||155
2470327|NCT00962104|6058569|P2|Full Analysis Set|Overall Study|1 participant was excluded because that participant failed to take the assigned study medication.|195
2470328|NCT00962104|6058570|P1|Full Analysis Set|Overall Study|2 participants were excluded because they failed to take the assigned study medication.|193
2470329|NCT00962104|6058569|P2|STARTED|Overall Study||196
2470330|NCT00962104|6058570|P1|STARTED|Overall Study||195
2470331|NCT00962091|6058603|P7|NOT COMPLETED|Overall Study||1
2470332|NCT00962091|6058604|P6|NOT COMPLETED|Overall Study||1
2470333|NCT00962091|6058605|P5|NOT COMPLETED|Overall Study||0
2470334|NCT00962091|6058606|P4|NOT COMPLETED|Overall Study||1
2470335|NCT00962091|6058607|P3|NOT COMPLETED|Overall Study||1
2470336|NCT00962091|6058608|P2|NOT COMPLETED|Overall Study||2
2470337|NCT00962091|6058609|P1|NOT COMPLETED|Overall Study||1
2470338|NCT00962091|6058603|P7|COMPLETED|Overall Study||11
2470339|NCT00962091|6058604|P6|COMPLETED|Overall Study||11
2470340|NCT00962091|6058605|P5|COMPLETED|Overall Study||3
2470341|NCT00962091|6058606|P4|COMPLETED|Overall Study||2
2470342|NCT00962091|6058607|P3|COMPLETED|Overall Study||9
2470343|NCT00962091|6058608|P2|COMPLETED|Overall Study||7
2470344|NCT00962091|6058609|P1|COMPLETED|Overall Study||3
2470345|NCT00962091|6058603|P7|STARTED|Overall Study||12
2470346|NCT00962091|6058604|P6|STARTED|Overall Study||12
2470347|NCT00962091|6058605|P5|STARTED|Overall Study||3
2470348|NCT00962091|6058606|P4|STARTED|Overall Study||3
2470349|NCT00962091|6058607|P3|STARTED|Overall Study||10
2470350|NCT00962091|6058608|P2|STARTED|Overall Study||9
2470351|NCT00962091|6058609|P1|STARTED|Overall Study||4
2470352|NCT00962078|6058656|P2|NOT COMPLETED|Overall Study||6
2470353|NCT00962078|6058657|P1|NOT COMPLETED|Overall Study||5
2470354|NCT00962078|6058656|P2|COMPLETED|Overall Study||30
2470355|NCT00962078|6058657|P1|COMPLETED|Overall Study||30
2470356|NCT00962078|6058656|P2|STARTED|Overall Study||36
2470357|NCT00962078|6058657|P1|STARTED|Overall Study||35
2470358|NCT00962065|6058668|P3|NOT COMPLETED|Overall Study||0
2470359|NCT00962065|6058669|P2|NOT COMPLETED|Overall Study||0
2470360|NCT00962065|6058670|P1|NOT COMPLETED|Overall Study||0
2470361|NCT00962065|6058668|P3|COMPLETED|Overall Study||12
2470362|NCT00962065|6058669|P2|COMPLETED|Overall Study||12
2470363|NCT00962065|6058670|P1|COMPLETED|Overall Study||12
2470364|NCT00962065|6058668|P3|STARTED|Overall Study||12
2470365|NCT00962065|6058669|P2|STARTED|Overall Study||12
2470366|NCT00962065|6058670|P1|STARTED|Overall Study||12
2470367|NCT00962013|6058693|P1|NOT COMPLETED|Overall Study||68
2470368|NCT00962013|6058693|P1|COMPLETED|Overall Study|Number of participants with 5 year primary endpoint data|52
2470369|NCT00962013|6058693|P1|STARTED|Overall Study||120
2470370|NCT00962000|6058702|P2|NOT COMPLETED|Period 4 - 1 Week||0
2470371|NCT00962000|6058703|P1|NOT COMPLETED|Period 4 - 1 Week||0
2470372|NCT00962000|6058702|P2|COMPLETED|Period 4 - 1 Week||21
2470373|NCT00962000|6058703|P1|COMPLETED|Period 4 - 1 Week||21
2470374|NCT00962000|6058702|P2|STARTED|Period 4 - 1 Week||21
2470375|NCT00962000|6058703|P1|STARTED|Period 4 - 1 Week||21
2470376|NCT00962000|6058702|P2|NOT COMPLETED|Period 3 - 1 Week||0
2470377|NCT00962000|6058703|P1|NOT COMPLETED|Period 3 - 1 Week||0
2470378|NCT00962000|6058702|P2|COMPLETED|Period 3 - 1 Week||21
2470379|NCT00962000|6058703|P1|COMPLETED|Period 3 - 1 Week||21
2470380|NCT00962000|6058702|P2|STARTED|Period 3 - 1 Week||21
2470381|NCT00962000|6058703|P1|STARTED|Period 3 - 1 Week||21
2470382|NCT00962000|6058702|P2|NOT COMPLETED|Period 2 - 1 Week||0
2470383|NCT00962000|6058703|P1|NOT COMPLETED|Period 2 - 1 Week||0
2470384|NCT00962000|6058702|P2|COMPLETED|Period 2 - 1 Week||21
2470385|NCT00962000|6058703|P1|COMPLETED|Period 2 - 1 Week||21
2470386|NCT00962000|6058702|P2|STARTED|Period 2 - 1 Week||21
2470387|NCT00962000|6058703|P1|STARTED|Period 2 - 1 Week||21
2470388|NCT00962000|6058702|P2|NOT COMPLETED|Period 1 - 1 Week||0
2470389|NCT00962000|6058703|P1|NOT COMPLETED|Period 1 - 1 Week||0
2470390|NCT00962000|6058702|P2|COMPLETED|Period 1 - 1 Week||21
2470391|NCT00962000|6058703|P1|COMPLETED|Period 1 - 1 Week||21
2470392|NCT00962000|6058702|P2|STARTED|Period 1 - 1 Week||21
2470393|NCT00962000|6058703|P1|STARTED|Period 1 - 1 Week||21
2470394|NCT00961896|6058716|P3|NOT COMPLETED|Overall Study||1
2470395|NCT00961896|6058717|P2|NOT COMPLETED|Overall Study||0
2470396|NCT00961896|6058718|P1|NOT COMPLETED|Overall Study||0
2470397|NCT00961896|6058716|P3|COMPLETED|Overall Study||6
2470398|NCT00961896|6058717|P2|COMPLETED|Overall Study||3
2470399|NCT00961896|6058718|P1|COMPLETED|Overall Study||8
2470400|NCT00961896|6058716|P3|STARTED|Overall Study||7
2470401|NCT00961896|6058717|P2|STARTED|Overall Study||3
2470402|NCT00961896|6058718|P1|STARTED|Overall Study||8
2470403|NCT00961805|6058739|P2|NOT COMPLETED|Overall Study||0
2470404|NCT00961805|6058740|P1|NOT COMPLETED|Overall Study||0
2470405|NCT00961805|6058739|P2|COMPLETED|Overall Study||40
2470406|NCT00961805|6058740|P1|COMPLETED|Overall Study||40
2470407|NCT00961805|6058739|P2|STARTED|Overall Study||40
2470408|NCT00961805|6058740|P1|STARTED|Overall Study||40
2470409|NCT00961662|6058771|P3|NOT COMPLETED|Overall Study||19
2470410|NCT00961662|6058772|P2|NOT COMPLETED|Overall Study||19
2470411|NCT00961662|6058773|P1|NOT COMPLETED|Overall Study||22
2470412|NCT00961662|6058771|P3|COMPLETED|Overall Study||34
2470413|NCT00961662|6058772|P2|COMPLETED|Overall Study||32
2470414|NCT00961662|6058773|P1|COMPLETED|Overall Study||35
2470415|NCT00961662|6058771|P3|STARTED|Overall Study||53
2470416|NCT00961662|6058772|P2|STARTED|Overall Study||51
2470417|NCT00961662|6058773|P1|STARTED|Overall Study||57
2470418|NCT00961649|6058785|P4|NOT COMPLETED|Overall Study||4
2470419|NCT00961649|6058786|P3|NOT COMPLETED|Overall Study||5
2470420|NCT00961649|6058787|P2|NOT COMPLETED|Overall Study||4
2470421|NCT00961649|6058788|P1|NOT COMPLETED|Overall Study||9
2470422|NCT00961649|6058785|P4|COMPLETED|Overall Study||37
2470423|NCT00961649|6058786|P3|COMPLETED|Overall Study||39
2470424|NCT00961649|6058787|P2|COMPLETED|Overall Study||40
2470425|NCT00961649|6058788|P1|COMPLETED|Overall Study||32
2470426|NCT00961649|6058785|P4|STARTED|Overall Study||41
2470427|NCT00961649|6058786|P3|STARTED|Overall Study||44
2470428|NCT00961649|6058787|P2|STARTED|Overall Study||44
2470429|NCT00961649|6058788|P1|STARTED|Overall Study||41
2470430|NCT00961636|6058802|P3|NOT COMPLETED|Overall Study||32
2470431|NCT00961636|6058803|P2|NOT COMPLETED|Overall Study||131
2470432|NCT00961636|6058804|P1|NOT COMPLETED|Overall Study||107
2470433|NCT00961636|6058802|P3|COMPLETED|Overall Study||201
2470434|NCT00961636|6058803|P2|COMPLETED|Overall Study||325
2470435|NCT00961636|6058804|P1|COMPLETED|Overall Study||356
2470436|NCT00961636|6058802|P3|STARTED|Overall Study||233
2470437|NCT00961636|6058803|P2|STARTED|Overall Study||456
2470438|NCT00961636|6058804|P1|STARTED|Overall Study||463
2470439|NCT00961571|6058815|P1|NOT COMPLETED|Overall Study||39
2470440|NCT00961571|6058815|P1|COMPLETED|Overall Study|high percentage of patient drop-off study prior cancer progression|11
2470441|NCT00961571|6058815|P1|STARTED|Overall Study||50
2470442|NCT00961532|6058819|P1|NOT COMPLETED|Overall Study||0
2470443|NCT00961532|6058819|P1|COMPLETED|Overall Study||14
2470444|NCT00961532|6058819|P1|STARTED|Overall Study||14
2470445|NCT00961441|6058826|P2|NOT COMPLETED|Overall Study||0
2470446|NCT00961441|6058827|P1|NOT COMPLETED|Overall Study||0
2470447|NCT00961441|6058826|P2|COMPLETED|Overall Study||13
2470448|NCT00961441|6058827|P1|COMPLETED|Overall Study||12
2470449|NCT00961441|6058826|P2|Pharmacokinetic (PK-PP) Population|Overall Study|Two subjects were excluded due to study medication noncompliance, one due to wrong dosing regimen.|10
2470450|NCT00961441|6058827|P1|Pharmacokinetic (PK-PP) Population|Overall Study||12
2470451|NCT00961441|6058826|P2|STARTED|Overall Study||13
2470452|NCT00961441|6058827|P1|STARTED|Overall Study||12
2470453|NCT00961415|6058843|P3|NOT COMPLETED|Maintenance Treatment Phase||45
2470454|NCT00961415|6058844|P2|NOT COMPLETED|Maintenance Treatment Phase||48
2470455|NCT00961415|6058845|P1|NOT COMPLETED|Maintenance Treatment Phase||0
2470456|NCT00961415|6058843|P3|COMPLETED|Maintenance Treatment Phase||83
2470457|NCT00961415|6058844|P2|COMPLETED|Maintenance Treatment Phase||77
2470458|NCT00961415|6058845|P1|COMPLETED|Maintenance Treatment Phase||0
2470459|NCT00961415|6058843|P3|STARTED|Maintenance Treatment Phase||128
2470460|NCT00961415|6058844|P2|STARTED|Maintenance Treatment Phase||125
2470461|NCT00961415|6058845|P1|STARTED|Maintenance Treatment Phase||0
2470462|NCT00961415|6058843|P3|NOT COMPLETED|Induction Treatment Phase||0
2470463|NCT00961415|6058844|P2|NOT COMPLETED|Induction Treatment Phase||0
2470464|NCT00961415|6058845|P1|NOT COMPLETED|Induction Treatment Phase||123
2470465|NCT00961415|6058843|P3|COMPLETED|Induction Treatment Phase||0
2470466|NCT00961415|6058844|P2|COMPLETED|Induction Treatment Phase||0
2470467|NCT00961415|6058845|P1|COMPLETED|Induction Treatment Phase||253
2470468|NCT00961415|6058843|P3|STARTED|Induction Treatment Phase||0
2470469|NCT00961415|6058844|P2|STARTED|Induction Treatment Phase||0
2470470|NCT00961415|6058845|P1|STARTED|Induction Treatment Phase||376
2470471|NCT00961402|6058870|P2|NOT COMPLETED|Overall Study||5
2470472|NCT00961402|6058871|P1|NOT COMPLETED|Overall Study||1
2470473|NCT00961402|6058870|P2|COMPLETED|Overall Study||61
2470474|NCT00961402|6058871|P1|COMPLETED|Overall Study||63
2470475|NCT00961402|6058870|P2|Randomized|Overall Study||66
2470476|NCT00961402|6058871|P1|Randomized|Overall Study||64
2470477|NCT00961402|6058870|P2|STARTED|Overall Study||66
2470478|NCT00961402|6058871|P1|STARTED|Overall Study||64
2470479|NCT00961350|6058885|P2|NOT COMPLETED|Overall Study||67
2470480|NCT00961350|6058886|P1|NOT COMPLETED|Overall Study||47
2470481|NCT00961350|6058885|P2|COMPLETED|Overall Study||198
2470482|NCT00961350|6058886|P1|COMPLETED|Overall Study||218
2470483|NCT00961350|6058885|P2|Safety Population|Overall Study||265
2470484|NCT00961350|6058886|P1|Safety Population|Overall Study|1. One sub rand to PA32540 took EC-Aspirin|264
2470485|NCT00961350|6058885|P2|Intent-to-Treat Population (ITT)|Overall Study||265
2470486|NCT00961350|6058886|P1|Intent-to-Treat Population (ITT)|Overall Study||265
2470487|NCT00961350|6058885|P2|STARTED|Overall Study||265
2470488|NCT00961350|6058886|P1|STARTED|Overall Study||265
2470489|NCT00961311|6058900|P1|NOT COMPLETED|Overall Study||0
2470490|NCT00961311|6058900|P1|COMPLETED|Overall Study||51
2470491|NCT00961311|6058900|P1|STARTED|Overall Study||51
2470492|NCT00961298|6058907|P1|NOT COMPLETED|12 Weeks Duloxetine Treatment Phase||3
2470493|NCT00961298|6058907|P1|COMPLETED|12 Weeks Duloxetine Treatment Phase||11
2470494|NCT00961298|6058907|P1|STARTED|12 Weeks Duloxetine Treatment Phase||14
2470495|NCT00961298|6058907|P1|NOT COMPLETED|Two Week Placebo Run in||1
2470496|NCT00961298|6058907|P1|COMPLETED|Two Week Placebo Run in||14
2470497|NCT00961298|6058907|P1|STARTED|Two Week Placebo Run in||15
2470498|NCT00961259|6058914|P3|NOT COMPLETED|Third Intervention||0
2470499|NCT00961259|6058915|P2|NOT COMPLETED|Third Intervention||0
2470500|NCT00961259|6058916|P1|NOT COMPLETED|Third Intervention||0
2470501|NCT00961259|6058914|P3|COMPLETED|Third Intervention||18
2470502|NCT00961259|6058915|P2|COMPLETED|Third Intervention||17
2470503|NCT00961259|6058916|P1|COMPLETED|Third Intervention||18
2470504|NCT00961259|6058914|P3|STARTED|Third Intervention||18
2470505|NCT00961259|6058915|P2|STARTED|Third Intervention||17
2470506|NCT00961259|6058916|P1|STARTED|Third Intervention||18
2470507|NCT00961259|6058914|P3|NOT COMPLETED|Washout Period of 7 Days||0
2470508|NCT00961259|6058915|P2|NOT COMPLETED|Washout Period of 7 Days||0
2470509|NCT00961259|6058916|P1|NOT COMPLETED|Washout Period of 7 Days||0
2470510|NCT00961259|6058914|P3|COMPLETED|Washout Period of 7 Days||18
2470511|NCT00961259|6058915|P2|COMPLETED|Washout Period of 7 Days||17
2470512|NCT00961259|6058916|P1|COMPLETED|Washout Period of 7 Days||18
2470513|NCT00961259|6058914|P3|STARTED|Washout Period of 7 Days||18
2470514|NCT00961259|6058915|P2|STARTED|Washout Period of 7 Days||17
2470515|NCT00961259|6058916|P1|STARTED|Washout Period of 7 Days||18
2470516|NCT00961259|6058914|P3|NOT COMPLETED|Second Intervention||0
2470517|NCT00961259|6058915|P2|NOT COMPLETED|Second Intervention||0
2470518|NCT00961259|6058916|P1|NOT COMPLETED|Second Intervention||0
2470519|NCT00961259|6058914|P3|COMPLETED|Second Intervention||18
2470520|NCT00961259|6058915|P2|COMPLETED|Second Intervention||17
2470521|NCT00961259|6058916|P1|COMPLETED|Second Intervention||18
2470522|NCT00961259|6058914|P3|STARTED|Second Intervention||18
2470523|NCT00961259|6058915|P2|STARTED|Second Intervention||17
2470524|NCT00961259|6058916|P1|STARTED|Second Intervention||18
2470525|NCT00961259|6058914|P3|NOT COMPLETED|Washout Period of 7 Days||0
2470526|NCT00961259|6058915|P2|NOT COMPLETED|Washout Period of 7 Days||1
2470527|NCT00961259|6058916|P1|NOT COMPLETED|Washout Period of 7 Days||0
2470528|NCT00961259|6058914|P3|COMPLETED|Washout Period of 7 Days||18
2470529|NCT00961259|6058915|P2|COMPLETED|Washout Period of 7 Days|dropped due to concomitant medication used prior to admission.|17
2470530|NCT00961259|6058916|P1|COMPLETED|Washout Period of 7 Days||18
2470531|NCT00961259|6058914|P3|STARTED|Washout Period of 7 Days||18
2470532|NCT00961259|6058915|P2|STARTED|Washout Period of 7 Days||18
2470533|NCT00961259|6058916|P1|STARTED|Washout Period of 7 Days||18
2470534|NCT00961259|6058914|P3|NOT COMPLETED|First Intervention||0
2470535|NCT00961259|6058915|P2|NOT COMPLETED|First Intervention||0
2470536|NCT00961259|6058916|P1|NOT COMPLETED|First Intervention||0
2470537|NCT00961259|6058914|P3|COMPLETED|First Intervention||18
2470538|NCT00961259|6058915|P2|COMPLETED|First Intervention||18
2470539|NCT00961259|6058916|P1|COMPLETED|First Intervention||18
2470540|NCT00961259|6058914|P3|STARTED|First Intervention||18
2470541|NCT00961259|6058915|P2|STARTED|First Intervention||18
2470542|NCT00961259|6058916|P1|STARTED|First Intervention||18
2470543|NCT00961233|6058935|P2|NOT COMPLETED|Overall Study||1
2470544|NCT00961233|6058936|P1|NOT COMPLETED|Overall Study||2
2470545|NCT00961233|6058935|P2|COMPLETED|Overall Study||11
2470546|NCT00961233|6058936|P1|COMPLETED|Overall Study||11
2470547|NCT00961233|6058935|P2|STARTED|Overall Study||12
2470548|NCT00961233|6058936|P1|STARTED|Overall Study||13
2470549|NCT00961220|6058944|P1|NOT COMPLETED|Overall Study||7
2470550|NCT00961220|6058944|P1|COMPLETED|Overall Study||10
2470551|NCT00961220|6058944|P1|STARTED|Overall Study||17
2470552|NCT00961181|6058960|P1|NOT COMPLETED|Overall Study||5
2470553|NCT00961181|6058960|P1|COMPLETED|Overall Study||76
2470554|NCT00961181|6058960|P1|STARTED|Overall Study||81
2470555|NCT00961116|6058973|P2|NOT COMPLETED|Second Intervention||0
2470556|NCT00961116|6058974|P1|NOT COMPLETED|Second Intervention||0
2470557|NCT00961116|6058973|P2|COMPLETED|Second Intervention||24
2470558|NCT00961116|6058974|P1|COMPLETED|Second Intervention||25
2470559|NCT00961116|6058973|P2|STARTED|Second Intervention||24
2470560|NCT00961116|6058974|P1|STARTED|Second Intervention||25
2470561|NCT00961116|6058973|P2|NOT COMPLETED|Washout Period of 7 Days||3
2470562|NCT00961116|6058974|P1|NOT COMPLETED|Washout Period of 7 Days||2
2470563|NCT00961116|6058973|P2|COMPLETED|Washout Period of 7 Days||24
2470564|NCT00961116|6058974|P1|COMPLETED|Washout Period of 7 Days||25
2470565|NCT00961116|6058973|P2|STARTED|Washout Period of 7 Days||27
2470566|NCT00961116|6058974|P1|STARTED|Washout Period of 7 Days||27
2470567|NCT00961116|6058973|P2|NOT COMPLETED|First Intervention||0
2470568|NCT00961116|6058974|P1|NOT COMPLETED|First Intervention||0
2470569|NCT00961116|6058973|P2|COMPLETED|First Intervention||27
2470570|NCT00961116|6058974|P1|COMPLETED|First Intervention||27
2470571|NCT00961116|6058973|P2|STARTED|First Intervention||27
2470572|NCT00961116|6058974|P1|STARTED|First Intervention||27
2470573|NCT00961064|6058984|P1|NOT COMPLETED|Overall Study||0
2470574|NCT00961064|6058984|P1|COMPLETED|Overall Study||30
2470575|NCT00961064|6058984|P1|STARTED|Overall Study||30
2470576|NCT00961051|6058990|P2|NOT COMPLETED|Overall Study||14
2470577|NCT00961051|6058991|P1|NOT COMPLETED|Overall Study||12
2470578|NCT00961051|6058990|P2|COMPLETED|Overall Study||79
2470579|NCT00961051|6058991|P1|COMPLETED|Overall Study||165
2470580|NCT00961051|6058990|P2|STARTED|Overall Study||93
2470581|NCT00961051|6058991|P1|STARTED|Overall Study||177
2470582|NCT00960999|6059001|P2|NOT COMPLETED|Overall Study||2
2470583|NCT00960999|6059002|P1|NOT COMPLETED|Overall Study||8
2470584|NCT00960999|6059001|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|45
2470585|NCT00960999|6059002|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|39
2470586|NCT00960999|6059001|P2|STARTED|Overall Study||47
2470587|NCT00960999|6059002|P1|STARTED|Overall Study||47
2470588|NCT00960986|6059012|P4|NOT COMPLETED|Period 3 (7-week Therapy Period)||25
2470589|NCT00960986|6059013|P3|NOT COMPLETED|Period 3 (7-week Therapy Period)||20
2470590|NCT00960986|6059014|P2|NOT COMPLETED|Period 3 (7-week Therapy Period)||23
2470591|NCT00960986|6059015|P1|NOT COMPLETED|Period 3 (7-week Therapy Period)||30
2470592|NCT00960986|6059012|P4|COMPLETED|Period 3 (7-week Therapy Period)||36
2470593|NCT00960986|6059013|P3|COMPLETED|Period 3 (7-week Therapy Period)||39
2470594|NCT00960986|6059014|P2|COMPLETED|Period 3 (7-week Therapy Period)||36
2470595|NCT00960986|6059015|P1|COMPLETED|Period 3 (7-week Therapy Period)||26
2470596|NCT00960986|6059012|P4|STARTED|Period 3 (7-week Therapy Period)||61
2470597|NCT00960986|6059013|P3|STARTED|Period 3 (7-week Therapy Period)||59
2470598|NCT00960986|6059014|P2|STARTED|Period 3 (7-week Therapy Period)||59
2470599|NCT00960986|6059015|P1|STARTED|Period 3 (7-week Therapy Period)||56
2470600|NCT00960986|6059012|P4|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
2470601|NCT00960986|6059013|P3|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
2470602|NCT00960986|6059014|P2|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
2470603|NCT00960986|6059015|P1|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
2470604|NCT00960986|6059012|P4|COMPLETED|Period 2 (1-week Initial Dosing Period)||61
2470605|NCT00960986|6059013|P3|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
2470606|NCT00960986|6059014|P2|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
2470607|NCT00960986|6059015|P1|COMPLETED|Period 2 (1-week Initial Dosing Period)||56
2470608|NCT00960986|6059012|P4|STARTED|Period 2 (1-week Initial Dosing Period)||61
2470609|NCT00960986|6059013|P3|STARTED|Period 2 (1-week Initial Dosing Period)||59
2470610|NCT00960986|6059014|P2|STARTED|Period 2 (1-week Initial Dosing Period)||59
2470611|NCT00960986|6059015|P1|STARTED|Period 2 (1-week Initial Dosing Period)||56
2470612|NCT00960986|6059012|P4|NOT COMPLETED|Period 1 (Screening and Washout)||3
2470613|NCT00960986|6059013|P3|NOT COMPLETED|Period 1 (Screening and Washout)||4
2470614|NCT00960986|6059014|P2|NOT COMPLETED|Period 1 (Screening and Washout)||4
2470615|NCT00960986|6059015|P1|NOT COMPLETED|Period 1 (Screening and Washout)||3
2470616|NCT00960986|6059012|P4|COMPLETED|Period 1 (Screening and Washout)||61
2470617|NCT00960986|6059013|P3|COMPLETED|Period 1 (Screening and Washout)||59
2470618|NCT00960986|6059014|P2|COMPLETED|Period 1 (Screening and Washout)||59
2470619|NCT00960986|6059015|P1|COMPLETED|Period 1 (Screening and Washout)||56
2470620|NCT00960986|6059012|P4|STARTED|Period 1 (Screening and Washout)||64
2470621|NCT00960986|6059013|P3|STARTED|Period 1 (Screening and Washout)||63
2470622|NCT00960986|6059014|P2|STARTED|Period 1 (Screening and Washout)||63
2470623|NCT00960986|6059015|P1|STARTED|Period 1 (Screening and Washout)||59
2470624|NCT00960934|6059091|P6|NOT COMPLETED|Overall Study||64
2470625|NCT00960934|6059092|P5|NOT COMPLETED|Overall Study||64
2470626|NCT00960934|6059093|P4|NOT COMPLETED|Overall Study||64
2470627|NCT00960934|6059094|P3|NOT COMPLETED|Overall Study||64
2470628|NCT00960934|6059095|P2|NOT COMPLETED|Overall Study||63
2470629|NCT00960934|6059096|P1|NOT COMPLETED|Overall Study||64
2470630|NCT00960934|6059091|P6|COMPLETED|Overall Study||0
2470631|NCT00960934|6059092|P5|COMPLETED|Overall Study||0
2470632|NCT00960934|6059093|P4|COMPLETED|Overall Study||0
2470633|NCT00960934|6059094|P3|COMPLETED|Overall Study||0
2470634|NCT00960934|6059095|P2|COMPLETED|Overall Study||0
2470635|NCT00960934|6059096|P1|COMPLETED|Overall Study||0
2470636|NCT00960934|6059091|P6|Number Treated|Overall Study|1 participant was randomized but not treated|63
2470637|NCT00960934|6059092|P5|Number Treated|Overall Study|1 participant was randomized but not treated|63
2470638|NCT00960934|6059093|P4|Number Treated|Overall Study||64
2470639|NCT00960934|6059094|P3|Number Treated|Overall Study||64
2470640|NCT00960934|6059095|P2|Number Treated|Overall Study|1 participant was randomized but not treated|62
2470641|NCT00960934|6059096|P1|Number Treated|Overall Study||64
2470642|NCT00960934|6059091|P6|STARTED|Overall Study||64
2470643|NCT00960934|6059092|P5|STARTED|Overall Study||64
2470644|NCT00960934|6059093|P4|STARTED|Overall Study||64
2470645|NCT00960934|6059094|P3|STARTED|Overall Study||64
2470646|NCT00960934|6059095|P2|STARTED|Overall Study||63
2470647|NCT00960934|6059096|P1|STARTED|Overall Study||64
2470648|NCT00960869|6059208|P2|NOT COMPLETED|Overall Study||62
2470649|NCT00960869|6059209|P1|NOT COMPLETED|Overall Study||53
2470650|NCT00960869|6059208|P2|COMPLETED|Overall Study||198
2470651|NCT00960869|6059209|P1|COMPLETED|Overall Study||206
2470652|NCT00960869|6059208|P2|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|259
2470653|NCT00960869|6059209|P1|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|257
2470654|NCT00960869|6059208|P2|Intent-to-Treat Population (ITT)|Overall Study||260
2470655|NCT00960869|6059209|P1|Intent-to-Treat Population (ITT)|Overall Study||259
2470656|NCT00960869|6059208|P2|STARTED|Overall Study||260
2470657|NCT00960869|6059209|P1|STARTED|Overall Study||259
2470658|NCT00960856|6059223|P4|NOT COMPLETED|Period IV||0
2470659|NCT00960856|6059224|P3|NOT COMPLETED|Period IV||0
2470660|NCT00960856|6059225|P2|NOT COMPLETED|Period IV||0
2470661|NCT00960856|6059226|P1|NOT COMPLETED|Period IV||0
2470662|NCT00960856|6059223|P4|COMPLETED|Period IV||9
2470663|NCT00960856|6059224|P3|COMPLETED|Period IV||8
2470664|NCT00960856|6059225|P2|COMPLETED|Period IV||7
2470665|NCT00960856|6059226|P1|COMPLETED|Period IV||10
2470666|NCT00960856|6059223|P4|STARTED|Period IV||9
2470667|NCT00960856|6059224|P3|STARTED|Period IV||8
2470668|NCT00960856|6059225|P2|STARTED|Period IV||7
2470669|NCT00960856|6059226|P1|STARTED|Period IV||10
2470670|NCT00960856|6059223|P4|NOT COMPLETED|Washout Period of 7 Days||0
2470671|NCT00960856|6059224|P3|NOT COMPLETED|Washout Period of 7 Days||1
2470672|NCT00960856|6059225|P2|NOT COMPLETED|Washout Period of 7 Days||0
2470673|NCT00960856|6059226|P1|NOT COMPLETED|Washout Period of 7 Days||0
2470674|NCT00960856|6059223|P4|COMPLETED|Washout Period of 7 Days||9
2470675|NCT00960856|6059224|P3|COMPLETED|Washout Period of 7 Days||8
2470676|NCT00960856|6059225|P2|COMPLETED|Washout Period of 7 Days||7
2470677|NCT00960856|6059226|P1|COMPLETED|Washout Period of 7 Days||10
2470678|NCT00960856|6059223|P4|STARTED|Washout Period of 7 Days||9
2470679|NCT00960856|6059224|P3|STARTED|Washout Period of 7 Days||9
2470680|NCT00960856|6059225|P2|STARTED|Washout Period of 7 Days||7
2470681|NCT00960856|6059226|P1|STARTED|Washout Period of 7 Days||10
2470682|NCT00960856|6059223|P4|NOT COMPLETED|Period III||0
2470683|NCT00960856|6059224|P3|NOT COMPLETED|Period III||0
2470684|NCT00960856|6059225|P2|NOT COMPLETED|Period III||0
2470685|NCT00960856|6059226|P1|NOT COMPLETED|Period III||0
2470686|NCT00960856|6059223|P4|COMPLETED|Period III||9
2470687|NCT00960856|6059224|P3|COMPLETED|Period III||9
2470688|NCT00960856|6059225|P2|COMPLETED|Period III||7
2470689|NCT00960856|6059226|P1|COMPLETED|Period III||10
2470690|NCT00960856|6059223|P4|STARTED|Period III||9
2470691|NCT00960856|6059224|P3|STARTED|Period III||9
2470692|NCT00960856|6059225|P2|STARTED|Period III||7
2470693|NCT00960856|6059226|P1|STARTED|Period III||10
2470694|NCT00960856|6059223|P4|NOT COMPLETED|Washout Period of 7 Days||0
2470695|NCT00960856|6059224|P3|NOT COMPLETED|Washout Period of 7 Days||0
2470696|NCT00960856|6059225|P2|NOT COMPLETED|Washout Period of 7 Days||0
2470697|NCT00960856|6059226|P1|NOT COMPLETED|Washout Period of 7 Days||0
2470698|NCT00960856|6059223|P4|COMPLETED|Washout Period of 7 Days||9
2470699|NCT00960856|6059224|P3|COMPLETED|Washout Period of 7 Days||9
2470700|NCT00960856|6059225|P2|COMPLETED|Washout Period of 7 Days||7
2470701|NCT00960856|6059226|P1|COMPLETED|Washout Period of 7 Days||10
2470702|NCT00960856|6059223|P4|STARTED|Washout Period of 7 Days||9
2470703|NCT00960856|6059224|P3|STARTED|Washout Period of 7 Days||9
2470704|NCT00960856|6059225|P2|STARTED|Washout Period of 7 Days||7
2470705|NCT00960856|6059226|P1|STARTED|Washout Period of 7 Days||10
2470706|NCT00960856|6059223|P4|NOT COMPLETED|Period II||0
2470707|NCT00960856|6059224|P3|NOT COMPLETED|Period II||0
2470708|NCT00960856|6059225|P2|NOT COMPLETED|Period II||0
2470709|NCT00960856|6059226|P1|NOT COMPLETED|Period II||0
2470710|NCT00960856|6059223|P4|COMPLETED|Period II||9
2470711|NCT00960856|6059224|P3|COMPLETED|Period II||9
2470712|NCT00960856|6059225|P2|COMPLETED|Period II||7
2470713|NCT00960856|6059226|P1|COMPLETED|Period II||10
2470714|NCT00960856|6059223|P4|STARTED|Period II||9
2470715|NCT00960856|6059224|P3|STARTED|Period II||9
2470716|NCT00960856|6059225|P2|STARTED|Period II||7
2470717|NCT00960856|6059226|P1|STARTED|Period II||10
2470718|NCT00960856|6059223|P4|NOT COMPLETED|Washout Period of 7 Days||0
2470719|NCT00960856|6059224|P3|NOT COMPLETED|Washout Period of 7 Days||0
2470720|NCT00960856|6059225|P2|NOT COMPLETED|Washout Period of 7 Days||2
2470721|NCT00960856|6059226|P1|NOT COMPLETED|Washout Period of 7 Days||0
2470722|NCT00960856|6059223|P4|COMPLETED|Washout Period of 7 Days||9
2470723|NCT00960856|6059224|P3|COMPLETED|Washout Period of 7 Days||9
2470724|NCT00960856|6059225|P2|COMPLETED|Washout Period of 7 Days|personal reasons|7
2470725|NCT00960856|6059226|P1|COMPLETED|Washout Period of 7 Days||10
2470726|NCT00960856|6059223|P4|STARTED|Washout Period of 7 Days||9
2470727|NCT00960856|6059224|P3|STARTED|Washout Period of 7 Days||9
2470728|NCT00960856|6059225|P2|STARTED|Washout Period of 7 Days||9
2470729|NCT00960856|6059226|P1|STARTED|Washout Period of 7 Days||10
2470730|NCT00960856|6059223|P4|NOT COMPLETED|Period I||0
2470731|NCT00960856|6059224|P3|NOT COMPLETED|Period I||0
2470732|NCT00960856|6059225|P2|NOT COMPLETED|Period I||0
2470733|NCT00960856|6059226|P1|NOT COMPLETED|Period I||0
2470734|NCT00960856|6059223|P4|COMPLETED|Period I||9
2470735|NCT00960856|6059224|P3|COMPLETED|Period I||9
2470736|NCT00960856|6059225|P2|COMPLETED|Period I||9
2470737|NCT00960856|6059226|P1|COMPLETED|Period I||10
2470738|NCT00960856|6059223|P4|STARTED|Period I||9
2470739|NCT00960856|6059224|P3|STARTED|Period I||9
2470740|NCT00960856|6059225|P2|STARTED|Period I||9
2470741|NCT00960856|6059226|P1|STARTED|Period I||10
2470742|NCT00960843|6059246|P2|NOT COMPLETED|Overall Study||5
2470743|NCT00960843|6059247|P1|NOT COMPLETED|Overall Study||2
2470744|NCT00960843|6059246|P2|COMPLETED|Overall Study||21
2470745|NCT00960843|6059247|P1|COMPLETED|Overall Study||23
2470746|NCT00960843|6059246|P2|STARTED|Overall Study||26
2470747|NCT00960843|6059247|P1|STARTED|Overall Study||25
2470748|NCT00960778|6059259|P2|NOT COMPLETED|Overall Study||3
2470749|NCT00960778|6059260|P1|NOT COMPLETED|Overall Study||9
2470750|NCT00960778|6059259|P2|COMPLETED|Overall Study||13
2470751|NCT00960778|6059260|P1|COMPLETED|Overall Study||8
2470752|NCT00960778|6059259|P2|STARTED|Overall Study||16
2470753|NCT00960778|6059260|P1|STARTED|Overall Study||17
2470754|NCT00960687|6059268|P2|NOT COMPLETED|Second Intervention||0
2470755|NCT00960687|6059269|P1|NOT COMPLETED|Second Intervention||0
2470756|NCT00960687|6059268|P2|COMPLETED|Second Intervention||24
2470757|NCT00960687|6059269|P1|COMPLETED|Second Intervention||23
2470758|NCT00960687|6059268|P2|STARTED|Second Intervention||24
2470759|NCT00960687|6059269|P1|STARTED|Second Intervention||23
2470760|NCT00960687|6059268|P2|NOT COMPLETED|Washout Period of 7 Days||3
2470761|NCT00960687|6059269|P1|NOT COMPLETED|Washout Period of 7 Days||4
2470762|NCT00960687|6059268|P2|COMPLETED|Washout Period of 7 Days|two subjects withdrew due to adverse events and one subject withdrew for personal reasons.|24
2470763|NCT00960687|6059269|P1|COMPLETED|Washout Period of 7 Days|three subjects withdrew due to adverse events and one subject withdrew for personal reasons.|23
2470764|NCT00960687|6059268|P2|STARTED|Washout Period of 7 Days||27
2470765|NCT00960687|6059269|P1|STARTED|Washout Period of 7 Days||27
2470766|NCT00960687|6059268|P2|NOT COMPLETED|First Intervention||0
2470767|NCT00960687|6059269|P1|NOT COMPLETED|First Intervention||0
2470768|NCT00960687|6059268|P2|COMPLETED|First Intervention||27
2470769|NCT00960687|6059269|P1|COMPLETED|First Intervention||27
2470770|NCT00960687|6059268|P2|STARTED|First Intervention||27
2470771|NCT00960687|6059269|P1|STARTED|First Intervention||27
2470772|NCT00960661|6059281|P3|NOT COMPLETED|Interventional Phase||46
2470773|NCT00960661|6059282|P2|NOT COMPLETED|Interventional Phase||52
2470774|NCT00960661|6059283|P1|NOT COMPLETED|Interventional Phase||0
2470775|NCT00960661|6059281|P3|COMPLETED|Interventional Phase||275
2470776|NCT00960661|6059282|P2|COMPLETED|Interventional Phase||264
2470777|NCT00960661|6059283|P1|COMPLETED|Interventional Phase||0
2470778|NCT00960661|6059281|P3|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|263
2470779|NCT00960661|6059282|P2|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|247
2470780|NCT00960661|6059283|P1|Per Protocol Population|Interventional Phase||0
2470781|NCT00960661|6059281|P3|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|312
2470782|NCT00960661|6059282|P2|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|315
2470783|NCT00960661|6059283|P1|Intent to Treat Population|Interventional Phase||0
2470784|NCT00960661|6059281|P3|STARTED|Interventional Phase||321
2470785|NCT00960661|6059282|P2|STARTED|Interventional Phase||316
2470786|NCT00960661|6059283|P1|STARTED|Interventional Phase||0
2470787|NCT00960661|6059281|P3|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
2470788|NCT00960661|6059282|P2|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
2470789|NCT00960661|6059283|P1|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||399
2470790|NCT00960661|6059281|P3|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
2470791|NCT00960661|6059282|P2|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
2470792|NCT00960661|6059283|P1|COMPLETED|Basal Insulin Optimization Phase (BIO)||637
2470793|NCT00960661|6059281|P3|STARTED|Basal Insulin Optimization Phase (BIO)||0
2470794|NCT00960661|6059282|P2|STARTED|Basal Insulin Optimization Phase (BIO)||0
2470795|NCT00960661|6059283|P1|STARTED|Basal Insulin Optimization Phase (BIO)||1036
2470796|NCT00960622|6059315|P2|NOT COMPLETED|Overall Study||3
2470797|NCT00960622|6059316|P1|NOT COMPLETED|Overall Study||0
2470798|NCT00960622|6059315|P2|COMPLETED|Overall Study||7
2470799|NCT00960622|6059316|P1|COMPLETED|Overall Study||10
2470800|NCT00960622|6059315|P2|STARTED|Overall Study||10
2470801|NCT00960622|6059316|P1|STARTED|Overall Study||10
2470802|NCT00960570|6059322|P1|NOT COMPLETED|Efavirenz and Fenofibric Acid||0
2470803|NCT00960570|6059322|P1|COMPLETED|Efavirenz and Fenofibric Acid||25
2470804|NCT00960570|6059322|P1|STARTED|Efavirenz and Fenofibric Acid||25
2470805|NCT00960570|6059322|P1|NOT COMPLETED|1 Day Period Between Dosing||3
2470806|NCT00960570|6059322|P1|COMPLETED|1 Day Period Between Dosing||25
2470807|NCT00960570|6059322|P1|STARTED|1 Day Period Between Dosing||28
2470808|NCT00960570|6059322|P1|NOT COMPLETED|Fenofibric Acid Alone||0
2470809|NCT00960570|6059322|P1|COMPLETED|Fenofibric Acid Alone||28
2470810|NCT00960570|6059322|P1|STARTED|Fenofibric Acid Alone||28
2470811|NCT00960570|6059322|P1|NOT COMPLETED|21 Day Washout Period||2
2470812|NCT00960570|6059322|P1|COMPLETED|21 Day Washout Period||28
2470813|NCT00960570|6059322|P1|STARTED|21 Day Washout Period||30
2470814|NCT00960570|6059322|P1|NOT COMPLETED|Efavirenz Alone||0
2470815|NCT00960570|6059322|P1|COMPLETED|Efavirenz Alone||30
2470816|NCT00960570|6059322|P1|STARTED|Efavirenz Alone||30
2470817|NCT00960531|6059343|P10|NOT COMPLETED|Overall Study||1
2470818|NCT00960531|6059344|P9|NOT COMPLETED|Overall Study||14
2470819|NCT00960531|6059345|P8|NOT COMPLETED|Overall Study||4
2470820|NCT00960531|6059346|P7|NOT COMPLETED|Overall Study||24
2470821|NCT00960531|6059347|P6|NOT COMPLETED|Overall Study||3
2470822|NCT00960531|6059348|P5|NOT COMPLETED|Overall Study||2
2470823|NCT00960531|6059349|P4|NOT COMPLETED|Overall Study||8
2470824|NCT00960531|6059350|P3|NOT COMPLETED|Overall Study||26
2470825|NCT00960531|6059351|P2|NOT COMPLETED|Overall Study||1
2470826|NCT00960531|6059352|P1|NOT COMPLETED|Overall Study||10
2470827|NCT00960531|6059343|P10|COMPLETED|Overall Study|Completed study|3
2470828|NCT00960531|6059344|P9|COMPLETED|Overall Study|Completed study|2
2470829|NCT00960531|6059345|P8|COMPLETED|Overall Study|Completed study|2
2470830|NCT00960531|6059346|P7|COMPLETED|Overall Study|Completed study|3
2470831|NCT00960531|6059347|P6|COMPLETED|Overall Study|Completed study|6
2470832|NCT00960531|6059348|P5|COMPLETED|Overall Study|Completed study|3
2470833|NCT00960531|6059349|P4|COMPLETED|Overall Study|Completed study|17
2470834|NCT00960531|6059350|P3|COMPLETED|Overall Study|Completed study|15
2470835|NCT00960531|6059351|P2|COMPLETED|Overall Study|Completed study|5
2470836|NCT00960531|6059352|P1|COMPLETED|Overall Study|Completed study|11
2470837|NCT00960531|6059343|P10|Completed Treatment|Overall Study||4
2470838|NCT00960531|6059344|P9|Completed Treatment|Overall Study||2
2470839|NCT00960531|6059345|P8|Completed Treatment|Overall Study||3
2470840|NCT00960531|6059346|P7|Completed Treatment|Overall Study||4
2470841|NCT00960531|6059347|P6|Completed Treatment|Overall Study||7
2470842|NCT00960531|6059348|P5|Completed Treatment|Overall Study||3
2470843|NCT00960531|6059349|P4|Completed Treatment|Overall Study||17
2470844|NCT00960531|6059350|P3|Completed Treatment|Overall Study||15
2470845|NCT00960531|6059351|P2|Completed Treatment|Overall Study||5
2470846|NCT00960531|6059352|P1|Completed Treatment|Overall Study||12
2470847|NCT00960531|6059343|P10|Treated|Overall Study||4
2470848|NCT00960531|6059344|P9|Treated|Overall Study||16
2470849|NCT00960531|6059345|P8|Treated|Overall Study||6
2470850|NCT00960531|6059346|P7|Treated|Overall Study||27
2470851|NCT00960531|6059347|P6|Treated|Overall Study||9
2470852|NCT00960531|6059348|P5|Treated|Overall Study||5
2470853|NCT00960531|6059349|P4|Treated|Overall Study||24
2470854|NCT00960531|6059350|P3|Treated|Overall Study||41
2470855|NCT00960531|6059351|P2|Treated|Overall Study||6
2470856|NCT00960531|6059352|P1|Treated|Overall Study||21
2470857|NCT00960531|6059343|P10|STARTED|Overall Study|Started=Randomized|4
2470858|NCT00960531|6059344|P9|STARTED|Overall Study|Started=Randomized|16
2470859|NCT00960531|6059345|P8|STARTED|Overall Study|Started=Randomized|6
2470860|NCT00960531|6059346|P7|STARTED|Overall Study|Started=Randomized|27
2470861|NCT00960531|6059347|P6|STARTED|Overall Study|Started=Randomized|9
2470862|NCT00960531|6059348|P5|STARTED|Overall Study|Started=Randomized|5
2470863|NCT00960531|6059349|P4|STARTED|Overall Study|Started=Randomized.|25
2470864|NCT00960531|6059350|P3|STARTED|Overall Study|Started=Randomized|41
2470865|NCT00960531|6059351|P2|STARTED|Overall Study|Started=Randomized|6
2470866|NCT00960531|6059352|P1|STARTED|Overall Study|Started=Randomized|21
2470867|NCT00960440|6059400|P4|NOT COMPLETED|Overall Study||18
2470868|NCT00960440|6059401|P3|NOT COMPLETED|Overall Study||13
2470869|NCT00960440|6059402|P2|NOT COMPLETED|Overall Study||31
2470870|NCT00960440|6059403|P1|NOT COMPLETED|Overall Study||26
2470871|NCT00960440|6059400|P4|COMPLETED|Overall Study||48
2470872|NCT00960440|6059401|P3|COMPLETED|Overall Study||53
2470873|NCT00960440|6059402|P2|COMPLETED|Overall Study||103
2470874|NCT00960440|6059403|P1|COMPLETED|Overall Study||107
2470875|NCT00960440|6059400|P4|STARTED|Overall Study||66
2470876|NCT00960440|6059401|P3|STARTED|Overall Study||66
2470877|NCT00960440|6059402|P2|STARTED|Overall Study||134
2470878|NCT00960440|6059403|P1|STARTED|Overall Study||133
2470879|NCT00960375|6059575|P2|NOT COMPLETED|Overall Study||22
2470880|NCT00960375|6059576|P1|NOT COMPLETED|Overall Study||20
2470881|NCT00960375|6059575|P2|COMPLETED|Overall Study||65
2470882|NCT00960375|6059576|P1|COMPLETED|Overall Study||72
2470883|NCT00960375|6059575|P2|STARTED|Overall Study||87
2470884|NCT00960375|6059576|P1|STARTED|Overall Study||92
2470885|NCT00960323|6059584|P1|NOT COMPLETED|Colchicine and Atorvastatin||0
2470886|NCT00960323|6059584|P1|COMPLETED|Colchicine and Atorvastatin||23
2470887|NCT00960323|6059584|P1|STARTED|Colchicine and Atorvastatin||23
2470888|NCT00960323|6059584|P1|NOT COMPLETED|Atorvastatin Alone||1
2470889|NCT00960323|6059584|P1|COMPLETED|Atorvastatin Alone||23
2470890|NCT00960323|6059584|P1|STARTED|Atorvastatin Alone||24
2470891|NCT00960323|6059584|P1|NOT COMPLETED|14 Day Washout Period||0
2470892|NCT00960323|6059584|P1|COMPLETED|14 Day Washout Period||24
2470893|NCT00960323|6059584|P1|STARTED|14 Day Washout Period||24
2470894|NCT00960323|6059584|P1|NOT COMPLETED|Colchicine Alone||0
2470895|NCT00960323|6059584|P1|COMPLETED|Colchicine Alone||24
2470896|NCT00960323|6059584|P1|STARTED|Colchicine Alone||24
2470897|NCT00960297|6059595|P1|NOT COMPLETED|Overall Study||3
2470898|NCT00960297|6059595|P1|COMPLETED|Overall Study||1
2470899|NCT00960297|6059595|P1|STARTED|Overall Study||4
2470900|NCT00960206|6059602|P3|NOT COMPLETED|Overall Study||12
2470901|NCT00960206|6059603|P2|NOT COMPLETED|Overall Study||27
2470902|NCT00960206|6059604|P1|NOT COMPLETED|Overall Study||40
2470903|NCT00960206|6059602|P3|COMPLETED|Overall Study||77
2470904|NCT00960206|6059603|P2|COMPLETED|Overall Study||158
2470905|NCT00960206|6059604|P1|COMPLETED|Overall Study||150
2470906|NCT00960206|6059602|P3|STARTED|Overall Study||89
2470907|NCT00960206|6059603|P2|STARTED|Overall Study||185
2470908|NCT00960206|6059604|P1|STARTED|Overall Study||190
2470909|NCT00960193|6059622|P1|NOT COMPLETED|Colchicine With Seville Orange Juice||0
2470910|NCT00960193|6059622|P1|COMPLETED|Colchicine With Seville Orange Juice||23
2470911|NCT00960193|6059622|P1|STARTED|Colchicine With Seville Orange Juice||23
2470912|NCT00960193|6059622|P1|NOT COMPLETED|Seville Orange Juice Alone||0
2470913|NCT00960193|6059622|P1|COMPLETED|Seville Orange Juice Alone||23
2470914|NCT00960193|6059622|P1|STARTED|Seville Orange Juice Alone||23
2470915|NCT00960193|6059622|P1|NOT COMPLETED|14 Day Washout Period||1
2470916|NCT00960193|6059622|P1|COMPLETED|14 Day Washout Period||23
2470917|NCT00960193|6059622|P1|STARTED|14 Day Washout Period||24
2470918|NCT00960193|6059622|P1|NOT COMPLETED|Colchicine Alone||0
2470919|NCT00960193|6059622|P1|COMPLETED|Colchicine Alone||24
2470920|NCT00960193|6059622|P1|STARTED|Colchicine Alone||24
2470921|NCT00960154|6059635|P2|NOT COMPLETED|Overall Study||25
2470922|NCT00960154|6059636|P1|NOT COMPLETED|Overall Study||25
2470923|NCT00960154|6059635|P2|COMPLETED|Overall Study||0
2470924|NCT00960154|6059636|P1|COMPLETED|Overall Study||0
2470925|NCT00960154|6059635|P2|STARTED|Overall Study||25
2470926|NCT00960154|6059636|P1|STARTED|Overall Study||25
2470927|NCT00960141|6059647|P3|NOT COMPLETED|Overall Study||7
2470928|NCT00960141|6059648|P2|NOT COMPLETED|Overall Study||17
2470929|NCT00960141|6059649|P1|NOT COMPLETED|Overall Study||10
2470930|NCT00960141|6059647|P3|COMPLETED|Overall Study||163
2470931|NCT00960141|6059648|P2|COMPLETED|Overall Study||309
2470932|NCT00960141|6059649|P1|COMPLETED|Overall Study||323
2470933|NCT00960141|6059647|P3|STARTED|Overall Study||170
2470934|NCT00960141|6059648|P2|STARTED|Overall Study||326
2470935|NCT00960141|6059649|P1|STARTED|Overall Study||333
2470936|NCT00960115|6059674|P2|NOT COMPLETED|Overall Study||15
2470937|NCT00960115|6059675|P1|NOT COMPLETED|Overall Study||19
2470938|NCT00960115|6059674|P2|COMPLETED|Overall Study||43
2470939|NCT00960115|6059675|P1|COMPLETED|Overall Study||95
2470940|NCT00960115|6059674|P2|STARTED|Overall Study||58
2470941|NCT00960115|6059675|P1|STARTED|Overall Study||114
2470942|NCT00960076|6059689|P2|NOT COMPLETED|Overall Study||25
2470943|NCT00960076|6059690|P1|NOT COMPLETED|Overall Study||8
2470944|NCT00960076|6059689|P2|COMPLETED|Overall Study|Completing 18 weeks of treatment|119
2470945|NCT00960076|6059690|P1|COMPLETED|Overall Study|Completing 18 weeks of treatment|130
2470946|NCT00960076|6059689|P2|STARTED|Overall Study|Randomized and treated|144
2470947|NCT00960076|6059690|P1|STARTED|Overall Study|Randomized and treated|138
2470948|NCT00960063|6059705|P3|NOT COMPLETED|Overall Study||3
2470949|NCT00960063|6059706|P2|NOT COMPLETED|Overall Study||0
2470950|NCT00960063|6059707|P1|NOT COMPLETED|Overall Study||1
2470951|NCT00960063|6059705|P3|COMPLETED|Overall Study||0
2470952|NCT00960063|6059706|P2|COMPLETED|Overall Study||0
2470953|NCT00960063|6059707|P1|COMPLETED|Overall Study||0
2470954|NCT00960063|6059705|P3|STARTED|Overall Study||3
2470955|NCT00960063|6059706|P2|STARTED|Overall Study||0
2470956|NCT00960063|6059707|P1|STARTED|Overall Study||1
2470957|NCT00959985|6059749|P4|NOT COMPLETED|Overall Study||0
2470958|NCT00959985|6059750|P3|NOT COMPLETED|Overall Study||0
2470959|NCT00959985|6059751|P2|NOT COMPLETED|Overall Study||0
2470960|NCT00959985|6059752|P1|NOT COMPLETED|Overall Study||0
2470961|NCT00959985|6059749|P4|COMPLETED|Overall Study||4
2470962|NCT00959985|6059750|P3|COMPLETED|Overall Study||4
2470963|NCT00959985|6059751|P2|COMPLETED|Overall Study||7
2470964|NCT00959985|6059752|P1|COMPLETED|Overall Study||8
2470965|NCT00959985|6059749|P4|STARTED|Overall Study||4
2470966|NCT00959985|6059750|P3|STARTED|Overall Study||4
2470967|NCT00959985|6059751|P2|STARTED|Overall Study||7
2470968|NCT00959985|6059752|P1|STARTED|Overall Study||8
2470969|NCT00959946|6059798|P8|NOT COMPLETED|Overall Study||2
2470970|NCT00959946|6059799|P7|NOT COMPLETED|Overall Study||2
2470971|NCT00959946|6059800|P6|NOT COMPLETED|Overall Study||9
2470972|NCT00959946|6059801|P5|NOT COMPLETED|Overall Study||4
2470973|NCT00959946|6059802|P4|NOT COMPLETED|Overall Study||5
2470974|NCT00959946|6059803|P3|NOT COMPLETED|Overall Study||4
2470975|NCT00959946|6059804|P2|NOT COMPLETED|Overall Study||4
2470976|NCT00959946|6059805|P1|NOT COMPLETED|Overall Study||2
2470977|NCT00959946|6059798|P8|COMPLETED|Overall Study||0
2470978|NCT00959946|6059799|P7|COMPLETED|Overall Study||0
2470979|NCT00959946|6059800|P6|COMPLETED|Overall Study||0
2470980|NCT00959946|6059801|P5|COMPLETED|Overall Study||0
2470981|NCT00959946|6059802|P4|COMPLETED|Overall Study||0
2470982|NCT00959946|6059803|P3|COMPLETED|Overall Study||0
2470983|NCT00959946|6059804|P2|COMPLETED|Overall Study||0
2470984|NCT00959946|6059805|P1|COMPLETED|Overall Study||0
2470985|NCT00959946|6059798|P8|STARTED|Overall Study||2
2470986|NCT00959946|6059799|P7|STARTED|Overall Study||2
2470987|NCT00959946|6059800|P6|STARTED|Overall Study||9
2470988|NCT00959946|6059801|P5|STARTED|Overall Study||4
2470989|NCT00959946|6059802|P4|STARTED|Overall Study||5
2470990|NCT00959946|6059803|P3|STARTED|Overall Study||4
2470991|NCT00959946|6059804|P2|STARTED|Overall Study||4
2470992|NCT00959946|6059805|P1|STARTED|Overall Study||2
2470993|NCT00959920|6059858|P2|NOT COMPLETED|Overall Study||1
2470994|NCT00959920|6059859|P1|NOT COMPLETED|Overall Study||0
2470995|NCT00959920|6059858|P2|COMPLETED|Overall Study||66
2470996|NCT00959920|6059859|P1|COMPLETED|Overall Study||72
2470997|NCT00959920|6059858|P2|STARTED|Overall Study||67
2470998|NCT00959920|6059859|P1|STARTED|Overall Study||72
2470999|NCT00959907|6059869|P2|NOT COMPLETED|Overall Study||1
2471000|NCT00959907|6059870|P1|NOT COMPLETED|Overall Study||3
2471001|NCT00959907|6059869|P2|COMPLETED|Overall Study||28
2471002|NCT00959907|6059870|P1|COMPLETED|Overall Study||27
2471003|NCT00959907|6059869|P2|STARTED|Overall Study||29
2471004|NCT00959907|6059870|P1|STARTED|Overall Study||30
2471005|NCT00959894|6059880|P1|NOT COMPLETED|Overall Study||16
2471006|NCT00959894|6059880|P1|COMPLETED|Overall Study||63
2471007|NCT00959894|6059880|P1|STARTED|Overall Study|One (1) additional subject became ineligible on the day of entry and never started study medication.|79
2471008|NCT00959764|6059911|P3|NOT COMPLETED|Overall Study||36
2471009|NCT00959764|6059912|P2|NOT COMPLETED|Overall Study||57
2471010|NCT00959764|6059913|P1|NOT COMPLETED|Overall Study||95
2471011|NCT00959764|6059911|P3|COMPLETED|Overall Study||73
2471012|NCT00959764|6059912|P2|COMPLETED|Overall Study||128
2471013|NCT00959764|6059913|P1|COMPLETED|Overall Study||176
2471014|NCT00959764|6059911|P3|STARTED|Overall Study||109
2471015|NCT00959764|6059912|P2|STARTED|Overall Study||185
2471016|NCT00959764|6059913|P1|STARTED|Overall Study||271
2471017|NCT00959751|6059929|P2|NOT COMPLETED|Overall Study||12
2471018|NCT00959751|6059930|P1|NOT COMPLETED|Overall Study||9
2471019|NCT00959751|6059929|P2|COMPLETED|Overall Study||86
2471020|NCT00959751|6059930|P1|COMPLETED|Overall Study||88
2471021|NCT00959751|6059929|P2|STARTED|Overall Study||98
2471022|NCT00959751|6059930|P1|STARTED|Overall Study||97
2471023|NCT00959699|6059952|P2|NOT COMPLETED|Follow-up Period||6
2471024|NCT00959699|6059953|P1|NOT COMPLETED|Follow-up Period||6
2471025|NCT00959699|6059952|P2|COMPLETED|Follow-up Period||56
2471026|NCT00959699|6059953|P1|COMPLETED|Follow-up Period||27
2471027|NCT00959699|6059952|P2|STARTED|Follow-up Period|2 participants didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|62
2471028|NCT00959699|6059953|P1|STARTED|Follow-up Period|1 participant didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|33
2471029|NCT00959699|6059952|P2|NOT COMPLETED|Treatment Period||25
2471030|NCT00959699|6059953|P1|NOT COMPLETED|Treatment Period||23
2471031|NCT00959699|6059952|P2|COMPLETED|Treatment Period||40
2471032|NCT00959699|6059953|P1|COMPLETED|Treatment Period|At TW24, 4 participants not achieving undetectable HCV-RNA crossed-over and received boceprevir.|11
2471033|NCT00959699|6059952|P2|Treated|Treatment Period||64
2471034|NCT00959699|6059953|P1|Treated|Treatment Period||34
2471035|NCT00959699|6059952|P2|STARTED|Treatment Period||65
2471036|NCT00959699|6059953|P1|STARTED|Treatment Period||34
2471037|NCT00959660|6059974|P4|NOT COMPLETED|Overall Study||3
2471038|NCT00959660|6059975|P3|NOT COMPLETED|Overall Study||3
2471039|NCT00959660|6059976|P2|NOT COMPLETED|Overall Study||0
2471040|NCT00959660|6059977|P1|NOT COMPLETED|Overall Study||2
2471041|NCT00959660|6059974|P4|COMPLETED|Overall Study||22
2471042|NCT00959660|6059975|P3|COMPLETED|Overall Study||22
2471043|NCT00959660|6059976|P2|COMPLETED|Overall Study||24
2471044|NCT00959660|6059977|P1|COMPLETED|Overall Study||24
2471045|NCT00959660|6059974|P4|STARTED|Overall Study||25
2471046|NCT00959660|6059975|P3|STARTED|Overall Study||25
2471047|NCT00959660|6059976|P2|STARTED|Overall Study||24
2471048|NCT00959660|6059977|P1|STARTED|Overall Study||26
2471049|NCT00959647|6059999|P1|NOT COMPLETED|Overall Study||19
2471050|NCT00959647|6059999|P1|COMPLETED|Overall Study||0
2471051|NCT00959647|6059999|P1|STARTED|Overall Study||19
2471052|NCT00959374|6060004|P1|NOT COMPLETED|Overall Study||23
2471053|NCT00959374|6060004|P1|COMPLETED|Overall Study||218
2471054|NCT00959374|6060004|P1|STARTED|Overall Study|Of the 241 enrolled subjects, 229 were randomized and treated|241
2471055|NCT00959192|6060018|P4|NOT COMPLETED|Overall Study||1
2471056|NCT00959192|6060019|P3|NOT COMPLETED|Overall Study||3
2471057|NCT00959192|6060020|P2|NOT COMPLETED|Overall Study||1
2471058|NCT00959192|6060021|P1|NOT COMPLETED|Overall Study||2
2471059|NCT00959192|6060018|P4|COMPLETED|Overall Study||7
2471060|NCT00959192|6060019|P3|COMPLETED|Overall Study||6
2471061|NCT00959192|6060020|P2|COMPLETED|Overall Study||8
2471062|NCT00959192|6060021|P1|COMPLETED|Overall Study||4
2471063|NCT00959192|6060018|P4|STARTED|Overall Study||8
2471064|NCT00959192|6060019|P3|STARTED|Overall Study||9
2471065|NCT00959192|6060020|P2|STARTED|Overall Study||9
2471066|NCT00959192|6060021|P1|STARTED|Overall Study||6
2471067|NCT00959166|6060065|P2|NOT COMPLETED|Overall Study||0
2471068|NCT00959166|6060066|P1|NOT COMPLETED|Overall Study||0
2471069|NCT00959166|6060065|P2|COMPLETED|Overall Study||57
2471070|NCT00959166|6060066|P1|COMPLETED|Overall Study||24
2471071|NCT00959166|6060065|P2|STARTED|Overall Study||57
2471072|NCT00959166|6060066|P1|STARTED|Overall Study||24
2471073|NCT00959049|6060080|P6|NOT COMPLETED|Overall Study||1
2471074|NCT00959049|6060081|P5|NOT COMPLETED|Overall Study||9
2471075|NCT00959049|6060082|P4|NOT COMPLETED|Overall Study||11
2471076|NCT00959049|6060083|P3|NOT COMPLETED|Overall Study||1
2471077|NCT00959049|6060084|P2|NOT COMPLETED|Overall Study||7
2471078|NCT00959049|6060085|P1|NOT COMPLETED|Overall Study||18
2471079|NCT00959049|6060080|P6|COMPLETED|Overall Study||249
2471080|NCT00959049|6060081|P5|COMPLETED|Overall Study||248
2471081|NCT00959049|6060082|P4|COMPLETED|Overall Study||217
2471082|NCT00959049|6060083|P3|COMPLETED|Overall Study||253
2471083|NCT00959049|6060084|P2|COMPLETED|Overall Study||247
2471084|NCT00959049|6060085|P1|COMPLETED|Overall Study||213
2471085|NCT00959049|6060080|P6|STARTED|Overall Study||250
2471086|NCT00959049|6060081|P5|STARTED|Overall Study||257
2471087|NCT00959049|6060082|P4|STARTED|Overall Study||228
2471088|NCT00959049|6060083|P3|STARTED|Overall Study||254
2471089|NCT00959049|6060084|P2|STARTED|Overall Study||254
2471090|NCT00959049|6060085|P1|STARTED|Overall Study||231
2471091|NCT00958919|6060135|P2|NOT COMPLETED|Second Intervention||0
2471092|NCT00958919|6060136|P1|NOT COMPLETED|Second Intervention||0
2471093|NCT00958919|6060135|P2|COMPLETED|Second Intervention||7
2471094|NCT00958919|6060136|P1|COMPLETED|Second Intervention||7
2471095|NCT00958919|6060135|P2|STARTED|Second Intervention||7
2471096|NCT00958919|6060136|P1|STARTED|Second Intervention||7
2471097|NCT00958919|6060135|P2|NOT COMPLETED|First Intervention||0
2471098|NCT00958919|6060136|P1|NOT COMPLETED|First Intervention||0
2471099|NCT00958919|6060135|P2|COMPLETED|First Intervention||7
2471100|NCT00958919|6060136|P1|COMPLETED|First Intervention||7
2471101|NCT00958919|6060135|P2|STARTED|First Intervention||7
2471102|NCT00958919|6060136|P1|STARTED|First Intervention||7
2471103|NCT00958893|6060150|P1|NOT COMPLETED|Overall Study||4
2471104|NCT00958893|6060150|P1|COMPLETED|Overall Study||0
2471105|NCT00958893|6060150|P1|STARTED|Overall Study||4
2471106|NCT00958880|6060156|P2|NOT COMPLETED|Overall Study||2
2471107|NCT00958880|6060157|P1|NOT COMPLETED|Overall Study||2
2471108|NCT00958880|6060156|P2|COMPLETED|Overall Study||18
2471109|NCT00958880|6060157|P1|COMPLETED|Overall Study||18
2471110|NCT00958880|6060156|P2|STARTED|Overall Study||20
2471111|NCT00958880|6060157|P1|STARTED|Overall Study||20
2471112|NCT00958841|6060165|P1|NOT COMPLETED|Overall Study||96
2471113|NCT00958841|6060165|P1|COMPLETED|Overall Study|Completed = Completed extension|22
2471114|NCT00958841|6060165|P1|Entered in Extension|Overall Study||63
2471115|NCT00958841|6060165|P1|Completed Month 6 (M6)|Overall Study||90
2471116|NCT00958841|6060165|P1|STARTED|Overall Study||118
2471117|NCT00958828|6060183|P2|NOT COMPLETED|Period 2, 1 Week of Wear||1
2471118|NCT00958828|6060184|P1|NOT COMPLETED|Period 2, 1 Week of Wear||0
2471119|NCT00958828|6060183|P2|COMPLETED|Period 2, 1 Week of Wear||87
2471120|NCT00958828|6060184|P1|COMPLETED|Period 2, 1 Week of Wear||89
2471121|NCT00958828|6060183|P2|STARTED|Period 2, 1 Week of Wear||88
2471122|NCT00958828|6060184|P1|STARTED|Period 2, 1 Week of Wear||89
2471123|NCT00958828|6060183|P2|NOT COMPLETED|Period 1, 1 Week of Wear||1
2471124|NCT00958828|6060184|P1|NOT COMPLETED|Period 1, 1 Week of Wear||0
2471125|NCT00958828|6060183|P2|COMPLETED|Period 1, 1 Week of Wear||88
2471126|NCT00958828|6060184|P1|COMPLETED|Period 1, 1 Week of Wear||89
2471127|NCT00958828|6060183|P2|STARTED|Period 1, 1 Week of Wear||89
2471128|NCT00958828|6060184|P1|STARTED|Period 1, 1 Week of Wear||89
2471129|NCT00958789|6060190|P1|NOT COMPLETED|Overall Study||50
2471130|NCT00958789|6060190|P1|COMPLETED|Overall Study|Participant status at the 2 year primary outcome interval determined Completed/Not Completed counts.|130
2471131|NCT00958789|6060190|P1|STARTED|Overall Study||180
2471132|NCT00958776|6060197|P2|NOT COMPLETED|Overall Study||29
2471133|NCT00958776|6060198|P1|NOT COMPLETED|Overall Study||16
2471134|NCT00958776|6060197|P2|COMPLETED|Overall Study||239
2471135|NCT00958776|6060198|P1|COMPLETED|Overall Study||121
2471136|NCT00958776|6060197|P2|STARTED|Overall Study||268
2471137|NCT00958776|6060198|P1|STARTED|Overall Study||137
2471138|NCT00958724|6060228|P1|NOT COMPLETED|Overall Study||6
2471139|NCT00958724|6060228|P1|COMPLETED|Overall Study||0
2471140|NCT00958724|6060228|P1|STARTED|Overall Study||6
2471141|NCT00958711|6060240|P2|NOT COMPLETED|Overall Study||21
2471142|NCT00958711|6060241|P1|NOT COMPLETED|Overall Study||13
2471143|NCT00958711|6060240|P2|COMPLETED|Overall Study||27
2471144|NCT00958711|6060241|P1|COMPLETED|Overall Study||29
2471145|NCT00958711|6060240|P2|STARTED|Overall Study||48
2471146|NCT00958711|6060241|P1|STARTED|Overall Study||42
2471147|NCT00958581|6060270|P3|NOT COMPLETED|Overall Study||0
2471148|NCT00958581|6060271|P2|NOT COMPLETED|Overall Study||0
2471149|NCT00958581|6060272|P1|NOT COMPLETED|Overall Study||0
2471150|NCT00958581|6060270|P3|COMPLETED|Overall Study||55
2471151|NCT00958581|6060271|P2|COMPLETED|Overall Study||61
2471152|NCT00958581|6060272|P1|COMPLETED|Overall Study||61
2471153|NCT00958581|6060270|P3|STARTED|Overall Study||55
2471154|NCT00958581|6060271|P2|STARTED|Overall Study||61
2471155|NCT00958581|6060272|P1|STARTED|Overall Study||61
2471156|NCT00958568|6060286|P4|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||106
2471157|NCT00958568|6060287|P3|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||82
2471158|NCT00958568|6060288|P2|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
2471159|NCT00958568|6060289|P1|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
2471160|NCT00958568|6060286|P4|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||117
2471161|NCT00958568|6060287|P3|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||139
2471162|NCT00958568|6060288|P2|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
2471163|NCT00958568|6060289|P1|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
2471164|NCT00958568|6060286|P4|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||223
2471165|NCT00958568|6060287|P3|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||221
2471166|NCT00958568|6060288|P2|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
2471167|NCT00958568|6060289|P1|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
2471168|NCT00958568|6060286|P4|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
2471169|NCT00958568|6060287|P3|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
2471170|NCT00958568|6060288|P2|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||211
2471171|NCT00958568|6060289|P1|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
2471172|NCT00958568|6060286|P4|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
2471173|NCT00958568|6060287|P3|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
2471174|NCT00958568|6060288|P2|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||444
2471175|NCT00958568|6060289|P1|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
2471176|NCT00958568|6060286|P4|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
2471177|NCT00958568|6060287|P3|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
2471178|NCT00958568|6060288|P2|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||655
2471179|NCT00958568|6060289|P1|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
2471180|NCT00958568|6060286|P4|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
2471181|NCT00958568|6060287|P3|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
2471182|NCT00958568|6060288|P2|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
2471183|NCT00958568|6060289|P1|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||237
2471184|NCT00958568|6060286|P4|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
2471185|NCT00958568|6060287|P3|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
2471186|NCT00958568|6060288|P2|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
2471187|NCT00958568|6060289|P1|COMPLETED|SPII (Wk 0-8, Acute Open-label)||655
2471188|NCT00958568|6060286|P4|STARTED|SPII (Wk 0-8, Acute Open-label)||0
2471189|NCT00958568|6060287|P3|STARTED|SPII (Wk 0-8, Acute Open-label)||0
2471190|NCT00958568|6060288|P2|STARTED|SPII (Wk 0-8, Acute Open-label)||0
2471191|NCT00958568|6060289|P1|STARTED|SPII (Wk 0-8, Acute Open-label)||892
2471192|NCT00958477|6060374|P4|NOT COMPLETED|Overall Study||0
2471193|NCT00958477|6060375|P3|NOT COMPLETED|Overall Study||0
2471194|NCT00958477|6060376|P2|NOT COMPLETED|Overall Study||0
2471195|NCT00958477|6060377|P1|NOT COMPLETED|Overall Study||0
2471196|NCT00958477|6060374|P4|COMPLETED|Overall Study||6
2471197|NCT00958477|6060375|P3|COMPLETED|Overall Study||6
2471198|NCT00958477|6060376|P2|COMPLETED|Overall Study||6
2471199|NCT00958477|6060377|P1|COMPLETED|Overall Study||8
2471200|NCT00958477|6060374|P4|STARTED|Overall Study||6
2471201|NCT00958477|6060375|P3|STARTED|Overall Study||6
2471202|NCT00958477|6060376|P2|STARTED|Overall Study||6
2471203|NCT00958477|6060377|P1|STARTED|Overall Study||8
2471204|NCT00958438|6060526|P3|NOT COMPLETED|Overall Study||6
2471205|NCT00958438|6060527|P2|NOT COMPLETED|Overall Study||10
2471206|NCT00958438|6060528|P1|NOT COMPLETED|Overall Study||10
2471207|NCT00958438|6060526|P3|COMPLETED|Overall Study||78
2471208|NCT00958438|6060527|P2|COMPLETED|Overall Study||72
2471209|NCT00958438|6060528|P1|COMPLETED|Overall Study||72
2471210|NCT00958438|6060526|P3|STARTED|Overall Study||84
2471211|NCT00958438|6060527|P2|STARTED|Overall Study||82
2471212|NCT00958438|6060528|P1|STARTED|Overall Study||82
2471213|NCT00958412|6060551|P1|NOT COMPLETED|Overall Study||18
2471214|NCT00958412|6060551|P1|COMPLETED|Overall Study||0
2471215|NCT00958412|6060551|P1|STARTED|Overall Study||18
2471216|NCT00958360|6060557|P2|NOT COMPLETED|Overall Study||10
2471217|NCT00958360|6060558|P1|NOT COMPLETED|Overall Study||11
2471218|NCT00958360|6060557|P2|COMPLETED|Overall Study||150
2471219|NCT00958360|6060558|P1|COMPLETED|Overall Study||152
2471220|NCT00958360|6060557|P2|STARTED|Overall Study||160
2471221|NCT00958360|6060558|P1|STARTED|Overall Study||163
2471222|NCT00958347|6060572|P1|NOT COMPLETED|Overall Study||226
2471223|NCT00958347|6060572|P1|COMPLETED|Overall Study|11 revisions total, one was a bilateral participant with the other hip counted as not completed.|0
2471224|NCT00958347|6060572|P1|STARTED|Overall Study||226
2471225|NCT00958334|6060579|P3|NOT COMPLETED|Overall Study||13
2471226|NCT00958334|6060580|P2|NOT COMPLETED|Overall Study||17
2471227|NCT00958334|6060581|P1|NOT COMPLETED|Overall Study||14
2471228|NCT00958334|6060579|P3|COMPLETED|Overall Study||8
2471229|NCT00958334|6060580|P2|COMPLETED|Overall Study||5
2471230|NCT00958334|6060581|P1|COMPLETED|Overall Study||8
2471231|NCT00958334|6060579|P3|STARTED|Overall Study||21
2471232|NCT00958334|6060580|P2|STARTED|Overall Study||22
2471233|NCT00958334|6060581|P1|STARTED|Overall Study||22
2471234|NCT00958308|6060595|P3|NOT COMPLETED|Overall Study||0
2471235|NCT00958308|6060596|P2|NOT COMPLETED|Overall Study||0
2471236|NCT00958308|6060597|P1|NOT COMPLETED|Overall Study||0
2471237|NCT00958308|6060595|P3|COMPLETED|Overall Study||86
2471238|NCT00958308|6060596|P2|COMPLETED|Overall Study||85
2471239|NCT00958308|6060597|P1|COMPLETED|Overall Study||84
2471240|NCT00958308|6060595|P3|STARTED|Overall Study||86
2471241|NCT00958308|6060596|P2|STARTED|Overall Study||85
2471242|NCT00958308|6060597|P1|STARTED|Overall Study||84
2471243|NCT00958282|6060607|P2|NOT COMPLETED|Overall Study||6
2471244|NCT00958282|6060608|P1|NOT COMPLETED|Overall Study||10
2471245|NCT00958282|6060607|P2|COMPLETED|Overall Study||15
2471246|NCT00958282|6060608|P1|COMPLETED|Overall Study||12
2471247|NCT00958282|6060607|P2|STARTED|Overall Study||21
2471248|NCT00958282|6060608|P1|STARTED|Overall Study||22
2471249|NCT00958256|6060616|P1|NOT COMPLETED|Overall Study||3
2471250|NCT00958256|6060616|P1|COMPLETED|Overall Study||18
2471251|NCT00958256|6060616|P1|STARTED|Overall Study||21
2471252|NCT00958243|6060626|P6|NOT COMPLETED|Overall Study||10
2471253|NCT00958243|6060627|P5|NOT COMPLETED|Overall Study||9
2471254|NCT00958243|6060628|P4|NOT COMPLETED|Overall Study||3
2471255|NCT00958243|6060629|P3|NOT COMPLETED|Overall Study||14
2471256|NCT00958243|6060630|P2|NOT COMPLETED|Overall Study||6
2471257|NCT00958243|6060631|P1|NOT COMPLETED|Overall Study||2
2471258|NCT00958243|6060626|P6|COMPLETED|Overall Study||99
2471259|NCT00958243|6060627|P5|COMPLETED|Overall Study||100
2471260|NCT00958243|6060628|P4|COMPLETED|Overall Study||25
2471261|NCT00958243|6060629|P3|COMPLETED|Overall Study||82
2471262|NCT00958243|6060630|P2|COMPLETED|Overall Study||99
2471263|NCT00958243|6060631|P1|COMPLETED|Overall Study||24
2471264|NCT00958243|6060626|P6|STARTED|Overall Study||109
2471265|NCT00958243|6060627|P5|STARTED|Overall Study||109
2471266|NCT00958243|6060628|P4|STARTED|Overall Study||28
2471267|NCT00958243|6060629|P3|STARTED|Overall Study||96
2471268|NCT00958243|6060630|P2|STARTED|Overall Study||105
2471269|NCT00958243|6060631|P1|STARTED|Overall Study||26
2471270|NCT00958217|6060689|P2|NOT COMPLETED|Overall Study||25
2471271|NCT00958217|6060690|P1|NOT COMPLETED|Overall Study||24
2471272|NCT00958217|6060689|P2|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
2471273|NCT00958217|6060690|P1|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
2471274|NCT00958217|6060689|P2|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|57
2471275|NCT00958217|6060690|P1|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|56
2471276|NCT00958217|6060689|P2|STARTED|Overall Study||62
2471277|NCT00958217|6060690|P1|STARTED|Overall Study||61
2471278|NCT00958191|6060701|P1|NOT COMPLETED|Overall Study||111
2471279|NCT00958191|6060701|P1|COMPLETED|Overall Study||110
2471280|NCT00958191|6060701|P1|STARTED|Overall Study||221
2471281|NCT00958165|6060716|P1|NOT COMPLETED|Overall Study||14
2471282|NCT00958165|6060716|P1|COMPLETED|Overall Study|Of the 72 treated participants, 67 completed follow-up and were evaluable for effectiveness.|67
2471283|NCT00958165|6060716|P1|Treated|Overall Study||72
2471284|NCT00958165|6060716|P1|STARTED|Overall Study|81 enrolled participants resulted in 72 eligible participants that were treated.|81
2471285|NCT00958126|6060728|P8|NOT COMPLETED|Overall Study||0
2471286|NCT00958126|6060729|P7|NOT COMPLETED|Overall Study||1
2471287|NCT00958126|6060730|P6|NOT COMPLETED|Overall Study||1
2471288|NCT00958126|6060731|P5|NOT COMPLETED|Overall Study||0
2471289|NCT00958126|6060732|P4|NOT COMPLETED|Overall Study||11
2471290|NCT00958126|6060733|P3|NOT COMPLETED|Overall Study||10
2471291|NCT00958126|6060734|P2|NOT COMPLETED|Overall Study||9
2471292|NCT00958126|6060735|P1|NOT COMPLETED|Overall Study||1
2471293|NCT00958126|6060728|P8|COMPLETED|Overall Study||202
2471294|NCT00958126|6060729|P7|COMPLETED|Overall Study||199
2471295|NCT00958126|6060730|P6|COMPLETED|Overall Study||202
2471296|NCT00958126|6060731|P5|COMPLETED|Overall Study||50
2471297|NCT00958126|6060732|P4|COMPLETED|Overall Study||192
2471298|NCT00958126|6060733|P3|COMPLETED|Overall Study||191
2471299|NCT00958126|6060734|P2|COMPLETED|Overall Study||196
2471300|NCT00958126|6060735|P1|COMPLETED|Overall Study||48
2471301|NCT00958126|6060728|P8|STARTED|Overall Study||202
2471302|NCT00958126|6060729|P7|STARTED|Overall Study||200
2471303|NCT00958126|6060730|P6|STARTED|Overall Study||203
2471304|NCT00958126|6060731|P5|STARTED|Overall Study||50
2471305|NCT00958126|6060732|P4|STARTED|Overall Study||203
2471306|NCT00958126|6060733|P3|STARTED|Overall Study||201
2471307|NCT00958126|6060734|P2|STARTED|Overall Study||205
2471308|NCT00958126|6060735|P1|STARTED|Overall Study||49
2471309|NCT00958074|6060807|P2|NOT COMPLETED|Overall Study||1
2471310|NCT00958074|6060808|P1|NOT COMPLETED|Overall Study||0
2471311|NCT00958074|6060807|P2|COMPLETED|Overall Study||6
2471312|NCT00958074|6060808|P1|COMPLETED|Overall Study||4
2471313|NCT00958074|6060807|P2|STARTED|Overall Study||7
2471314|NCT00958074|6060808|P1|STARTED|Overall Study||4
2471315|NCT00958035|6060824|P2|NOT COMPLETED|Overall Study||4
2471316|NCT00958035|6060825|P1|NOT COMPLETED|Overall Study||3
2471317|NCT00958035|6060824|P2|COMPLETED|Overall Study||39
2471318|NCT00958035|6060825|P1|COMPLETED|Overall Study||43
2471319|NCT00958035|6060824|P2|STARTED|Overall Study||43
2471320|NCT00958035|6060825|P1|STARTED|Overall Study||46
2471321|NCT00958009|6060831|P1|NOT COMPLETED|Overall Study||2
2471322|NCT00958009|6060831|P1|COMPLETED|Overall Study||107
2471323|NCT00958009|6060831|P1|STARTED|Overall Study||109
2471324|NCT00957996|6060838|P2|NOT COMPLETED|Overall Study||28
2471325|NCT00957996|6060839|P1|NOT COMPLETED|Overall Study||26
2471326|NCT00957996|6060838|P2|COMPLETED|Overall Study||89
2471327|NCT00957996|6060839|P1|COMPLETED|Overall Study||91
2471328|NCT00957996|6060838|P2|STARTED|Overall Study||117
2471329|NCT00957996|6060839|P1|STARTED|Overall Study||117
2471330|NCT00957944|6060871|P2|NOT COMPLETED|Second Intervention- 24 Hours||0
2471331|NCT00957944|6060872|P1|NOT COMPLETED|Second Intervention- 24 Hours||0
2471332|NCT00957944|6060871|P2|COMPLETED|Second Intervention- 24 Hours||19
2471333|NCT00957944|6060872|P1|COMPLETED|Second Intervention- 24 Hours||20
2471334|NCT00957944|6060871|P2|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours|One subject that fullfilled predefined criteria for patch adhesiveness was excluded from the PKS|18
2471335|NCT00957944|6060872|P1|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours||20
2471336|NCT00957944|6060871|P2|STARTED|Second Intervention- 24 Hours||19
2471337|NCT00957944|6060872|P1|STARTED|Second Intervention- 24 Hours||20
2471338|NCT00957944|6060871|P2|NOT COMPLETED|Washout Period of at Least 5 Days||0
2471339|NCT00957944|6060872|P1|NOT COMPLETED|Washout Period of at Least 5 Days||0
2471340|NCT00957944|6060871|P2|COMPLETED|Washout Period of at Least 5 Days||19
2471341|NCT00957944|6060872|P1|COMPLETED|Washout Period of at Least 5 Days||20
2471342|NCT00957944|6060871|P2|STARTED|Washout Period of at Least 5 Days||19
2471343|NCT00957944|6060872|P1|STARTED|Washout Period of at Least 5 Days||20
2471344|NCT00957944|6060871|P2|NOT COMPLETED|First Intervention- 24 Hours||1
2471345|NCT00957944|6060872|P1|NOT COMPLETED|First Intervention- 24 Hours||0
2471346|NCT00957944|6060871|P2|COMPLETED|First Intervention- 24 Hours||19
2471347|NCT00957944|6060872|P1|COMPLETED|First Intervention- 24 Hours||20
2471348|NCT00957944|6060871|P2|STARTED|First Intervention- 24 Hours||20
2471349|NCT00957944|6060872|P1|STARTED|First Intervention- 24 Hours||20
2471350|NCT00957931|6060906|P1|NOT COMPLETED|Overall Study||4
2471351|NCT00957931|6060906|P1|COMPLETED|Overall Study||2
2471352|NCT00957931|6060906|P1|STARTED|Overall Study||6
2471353|NCT00957905|6060916|P2|NOT COMPLETED|Part B||4
2471354|NCT00957905|6060917|P1|NOT COMPLETED|Part B||0
2471355|NCT00957905|6060916|P2|COMPLETED|Part B||25
2471356|NCT00957905|6060917|P1|COMPLETED|Part B||0
2471357|NCT00957905|6060916|P2|STARTED|Part B||29
2471358|NCT00957905|6060917|P1|STARTED|Part B||0
2471359|NCT00957905|6060916|P2|NOT COMPLETED|Part A||0
2471360|NCT00957905|6060917|P1|NOT COMPLETED|Part A||0
2471361|NCT00957905|6060916|P2|COMPLETED|Part A||0
2471362|NCT00957905|6060917|P1|COMPLETED|Part A||7
2471363|NCT00957905|6060916|P2|STARTED|Part A||0
2471364|NCT00957905|6060917|P1|STARTED|Part A||7
2471365|NCT00957827|6060925|P2|NOT COMPLETED|Overall Study||0
2471366|NCT00957827|6060926|P1|NOT COMPLETED|Overall Study||0
2471367|NCT00957827|6060925|P2|COMPLETED|Overall Study||2
2471368|NCT00957827|6060926|P1|COMPLETED|Overall Study||2
2471369|NCT00957827|6060925|P2|STARTED|Overall Study||2
2471370|NCT00957827|6060926|P1|STARTED|Overall Study||2
2471371|NCT00957801|6060936|P4|NOT COMPLETED|Overall Study||1
2471372|NCT00957801|6060937|P3|NOT COMPLETED|Overall Study||0
2471373|NCT00957801|6060938|P2|NOT COMPLETED|Overall Study||0
2471374|NCT00957801|6060939|P1|NOT COMPLETED|Overall Study||0
2471375|NCT00957801|6060936|P4|COMPLETED|Overall Study||7
2471376|NCT00957801|6060937|P3|COMPLETED|Overall Study||7
2471377|NCT00957801|6060938|P2|COMPLETED|Overall Study||7
2471378|NCT00957801|6060939|P1|COMPLETED|Overall Study||7
2471379|NCT00957801|6060936|P4|STARTED|Overall Study||8
2471380|NCT00957801|6060937|P3|STARTED|Overall Study||7
2471381|NCT00957801|6060938|P2|STARTED|Overall Study||7
2471382|NCT00957801|6060939|P1|STARTED|Overall Study||7
2471383|NCT00957723|6061105|P1|NOT COMPLETED|Overall Study||113
2471384|NCT00957723|6061105|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|298
2471385|NCT00957723|6061105|P1|STARTED|Overall Study||411
2471386|NCT00957684|6061123|P5|NOT COMPLETED|PART II||75
2471387|NCT00957684|6061124|P4|NOT COMPLETED|PART II||0
2471388|NCT00957684|6061125|P3|NOT COMPLETED|PART II||0
2471389|NCT00957684|6061126|P2|NOT COMPLETED|PART II||0
2471390|NCT00957684|6061127|P1|NOT COMPLETED|PART II||0
2471391|NCT00957684|6061123|P5|COMPLETED|PART II||239
2471392|NCT00957684|6061124|P4|COMPLETED|PART II||0
2471393|NCT00957684|6061125|P3|COMPLETED|PART II||0
2471394|NCT00957684|6061126|P2|COMPLETED|PART II||0
2471395|NCT00957684|6061127|P1|COMPLETED|PART II||0
2471396|NCT00957684|6061123|P5|Patients Entered Part II|PART II||314
2471397|NCT00957684|6061124|P4|Patients Entered Part II|PART II||0
2471398|NCT00957684|6061125|P3|Patients Entered Part II|PART II||0
2471399|NCT00957684|6061126|P2|Patients Entered Part II|PART II||0
2471400|NCT00957684|6061127|P1|Patients Entered Part II|PART II||0
2471401|NCT00957684|6061123|P5|STARTED|PART II||314
2471402|NCT00957684|6061124|P4|STARTED|PART II||0
2471403|NCT00957684|6061125|P3|STARTED|PART II||0
2471404|NCT00957684|6061126|P2|STARTED|PART II||0
2471405|NCT00957684|6061127|P1|STARTED|PART II||0
2471406|NCT00957684|6061123|P5|NOT COMPLETED|PART I||0
2471407|NCT00957684|6061124|P4|NOT COMPLETED|PART I||18
2471408|NCT00957684|6061125|P3|NOT COMPLETED|PART I||10
2471409|NCT00957684|6061126|P2|NOT COMPLETED|PART I||13
2471410|NCT00957684|6061127|P1|NOT COMPLETED|PART I||31
2471411|NCT00957684|6061123|P5|COMPLETED|PART I||0
2471412|NCT00957684|6061124|P4|COMPLETED|PART I||84
2471413|NCT00957684|6061125|P3|COMPLETED|PART I||90
2471414|NCT00957684|6061126|P2|COMPLETED|PART I||85
2471415|NCT00957684|6061127|P1|COMPLETED|PART I||71
2471416|NCT00957684|6061123|P5|Per-protocol (PP)Population|PART I||0
2471417|NCT00957684|6061124|P4|Per-protocol (PP)Population|PART I||91
2471418|NCT00957684|6061125|P3|Per-protocol (PP)Population|PART I||94
2471419|NCT00957684|6061126|P2|Per-protocol (PP)Population|PART I||86
2471420|NCT00957684|6061127|P1|Per-protocol (PP)Population|PART I||72
2471421|NCT00957684|6061123|P5|Intention-to-treat (ITT) Population|PART I||0
2471422|NCT00957684|6061124|P4|Intention-to-treat (ITT) Population|PART I||102
2471423|NCT00957684|6061125|P3|Intention-to-treat (ITT) Population|PART I||99
2471424|NCT00957684|6061126|P2|Intention-to-treat (ITT) Population|PART I||98
2471425|NCT00957684|6061127|P1|Intention-to-treat (ITT) Population|PART I||98
2471426|NCT00957684|6061123|P5|Randomised (Safety Population)|PART I||0
2471427|NCT00957684|6061124|P4|Randomised (Safety Population)|PART I||102
2471428|NCT00957684|6061125|P3|Randomised (Safety Population)|PART I||100
2471429|NCT00957684|6061126|P2|Randomised (Safety Population)|PART I||98
2471430|NCT00957684|6061127|P1|Randomised (Safety Population)|PART I||102
2471431|NCT00957684|6061123|P5|STARTED|PART I||0
2471432|NCT00957684|6061124|P4|STARTED|PART I||102
2471433|NCT00957684|6061125|P3|STARTED|PART I||100
2471434|NCT00957684|6061126|P2|STARTED|PART I||98
2471435|NCT00957684|6061127|P1|STARTED|PART I||102
2471436|NCT00957671|6061137|P1|NOT COMPLETED|Overall Study||0
2471437|NCT00957671|6061137|P1|COMPLETED|Overall Study|15 subjects completed the treatment phase of the study.|15
2471438|NCT00957671|6061137|P1|STARTED|Overall Study|15 subjects began the treatment phase.|15
2471439|NCT00957658|6061194|P1|NOT COMPLETED|Overall Study||65
2471440|NCT00957658|6061194|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|169
2471441|NCT00957658|6061194|P1|STARTED|Overall Study||234
2471442|NCT00957593|6061209|P2|NOT COMPLETED|Overall Study||0
2471443|NCT00957593|6061210|P1|NOT COMPLETED|Overall Study||0
2471444|NCT00957593|6061209|P2|COMPLETED|Overall Study||125
2471445|NCT00957593|6061210|P1|COMPLETED|Overall Study||127
2471446|NCT00957593|6061209|P2|STARTED|Overall Study||125
2471447|NCT00957593|6061210|P1|STARTED|Overall Study||127
2471448|NCT00957580|6061221|P3|NOT COMPLETED|Overall Study||0
2471449|NCT00957580|6061222|P2|NOT COMPLETED|Overall Study||2
2471450|NCT00957580|6061223|P1|NOT COMPLETED|Overall Study||0
2471451|NCT00957580|6061221|P3|COMPLETED|Overall Study||15
2471452|NCT00957580|6061222|P2|COMPLETED|Overall Study||31
2471453|NCT00957580|6061223|P1|COMPLETED|Overall Study||33
2471454|NCT00957580|6061221|P3|Treated|Overall Study||15
2471455|NCT00957580|6061222|P2|Treated|Overall Study||32
2471456|NCT00957580|6061223|P1|Treated|Overall Study||33
2471457|NCT00957580|6061221|P3|STARTED|Overall Study||15
2471458|NCT00957580|6061222|P2|STARTED|Overall Study||33
2471459|NCT00957580|6061223|P1|STARTED|Overall Study||33
2471460|NCT00957528|6061370|P3|NOT COMPLETED|Overall Study||1
2471461|NCT00957528|6061371|P2|NOT COMPLETED|Overall Study||1
2471462|NCT00957528|6061372|P1|NOT COMPLETED|Overall Study||0
2471463|NCT00957528|6061370|P3|COMPLETED|Overall Study||8
2471464|NCT00957528|6061371|P2|COMPLETED|Overall Study||8
2471465|NCT00957528|6061372|P1|COMPLETED|Overall Study||8
2471466|NCT00957528|6061370|P3|STARTED|Overall Study||9
2471467|NCT00957528|6061371|P2|STARTED|Overall Study||9
2471468|NCT00957528|6061372|P1|STARTED|Overall Study||8
2471469|NCT00957424|6061395|P1|NOT COMPLETED|Overall Study||23
2471470|NCT00957424|6061395|P1|COMPLETED|Overall Study||44
2471471|NCT00957424|6061395|P1|Follow-up #2|Overall Study||50
2471472|NCT00957424|6061395|P1|Follow-up #1|Overall Study||59
2471473|NCT00957424|6061395|P1|STARTED|Overall Study||67
2471474|NCT00957372|6061405|P4|NOT COMPLETED|PART II||44
2471475|NCT00957372|6061406|P3|NOT COMPLETED|PART II||0
2471476|NCT00957372|6061407|P2|NOT COMPLETED|PART II||0
2471477|NCT00957372|6061408|P1|NOT COMPLETED|PART II||0
2471478|NCT00957372|6061405|P4|COMPLETED|PART II||150
2471479|NCT00957372|6061406|P3|COMPLETED|PART II||0
2471480|NCT00957372|6061407|P2|COMPLETED|PART II||0
2471481|NCT00957372|6061408|P1|COMPLETED|PART II||0
2471482|NCT00957372|6061405|P4|Per-Protocol Population|PART II||108
2471483|NCT00957372|6061406|P3|Per-Protocol Population|PART II||0
2471484|NCT00957372|6061407|P2|Per-Protocol Population|PART II||0
2471485|NCT00957372|6061408|P1|Per-Protocol Population|PART II||0
2471486|NCT00957372|6061405|P4|Intention-to-treat (ITT) Population|PART II||191
2471487|NCT00957372|6061406|P3|Intention-to-treat (ITT) Population|PART II||0
2471488|NCT00957372|6061407|P2|Intention-to-treat (ITT) Population|PART II||0
2471489|NCT00957372|6061408|P1|Intention-to-treat (ITT) Population|PART II||0
2471490|NCT00957372|6061405|P4|Safety Population|PART II||194
2471491|NCT00957372|6061406|P3|Safety Population|PART II||0
2471492|NCT00957372|6061407|P2|Safety Population|PART II||0
2471493|NCT00957372|6061408|P1|Safety Population|PART II||0
2471494|NCT00957372|6061405|P4|STARTED|PART II||194
2471495|NCT00957372|6061406|P3|STARTED|PART II||0
2471496|NCT00957372|6061407|P2|STARTED|PART II||0
2471497|NCT00957372|6061408|P1|STARTED|PART II||0
2471498|NCT00957372|6061405|P4|NOT COMPLETED|PART I||0
2471499|NCT00957372|6061406|P3|NOT COMPLETED|PART I||1
2471500|NCT00957372|6061407|P2|NOT COMPLETED|PART I||0
2471501|NCT00957372|6061408|P1|NOT COMPLETED|PART I||0
2471502|NCT00957372|6061405|P4|COMPLETED|PART I||0
2471503|NCT00957372|6061406|P3|COMPLETED|PART I||87
2471504|NCT00957372|6061407|P2|COMPLETED|PART I||85
2471505|NCT00957372|6061408|P1|COMPLETED|PART I||80
2471506|NCT00957372|6061405|P4|Randomized But Not Treated|PART I||0
2471507|NCT00957372|6061406|P3|Randomized But Not Treated|PART I||1
2471508|NCT00957372|6061407|P2|Randomized But Not Treated|PART I||0
2471509|NCT00957372|6061408|P1|Randomized But Not Treated|PART I||0
2471510|NCT00957372|6061405|P4|Per-Protocol Population|PART I||0
2471511|NCT00957372|6061406|P3|Per-Protocol Population|PART I||51
2471512|NCT00957372|6061407|P2|Per-Protocol Population|PART I||47
2471513|NCT00957372|6061408|P1|Per-Protocol Population|PART I||35
2471514|NCT00957372|6061405|P4|Intention-to-Treat Population|PART I||0
2471515|NCT00957372|6061406|P3|Intention-to-Treat Population|PART I||84
2471516|NCT00957372|6061407|P2|Intention-to-Treat Population|PART I||84
2471517|NCT00957372|6061408|P1|Intention-to-Treat Population|PART I||77
2471518|NCT00957372|6061405|P4|Safety Population|PART I||0
2471519|NCT00957372|6061406|P3|Safety Population|PART I||87
2471520|NCT00957372|6061407|P2|Safety Population|PART I||85
2471521|NCT00957372|6061408|P1|Safety Population|PART I||80
2471522|NCT00957372|6061405|P4|STARTED|PART I||0
2471523|NCT00957372|6061406|P3|STARTED|PART I||88
2471524|NCT00957372|6061407|P2|STARTED|PART I||85
2471525|NCT00957372|6061408|P1|STARTED|PART I||80
2471526|NCT00957359|6061426|P2|NOT COMPLETED|Overall Study||0
2471527|NCT00957359|6061427|P1|NOT COMPLETED|Overall Study||0
2471528|NCT00957359|6061426|P2|COMPLETED|Overall Study||15
2471529|NCT00957359|6061427|P1|COMPLETED|Overall Study||14
2471530|NCT00957359|6061426|P2|STARTED|Overall Study||15
2471531|NCT00957359|6061427|P1|STARTED|Overall Study||14
2471532|NCT00957333|6061539|P1|NOT COMPLETED|Overall Study||0
2471533|NCT00957333|6061539|P1|COMPLETED|Overall Study||44
2471534|NCT00957333|6061539|P1|STARTED|Overall Study||44
2471535|NCT00957268|6061548|P5|NOT COMPLETED|Overall Study||0
2471536|NCT00957268|6061549|P4|NOT COMPLETED|Overall Study||0
2471537|NCT00957268|6061550|P3|NOT COMPLETED|Overall Study||1
2471538|NCT00957268|6061551|P2|NOT COMPLETED|Overall Study||0
2471539|NCT00957268|6061552|P1|NOT COMPLETED|Overall Study||0
2471540|NCT00957268|6061548|P5|COMPLETED|Overall Study||22
2471541|NCT00957268|6061549|P4|COMPLETED|Overall Study||7
2471542|NCT00957268|6061550|P3|COMPLETED|Overall Study||7
2471543|NCT00957268|6061551|P2|COMPLETED|Overall Study||4
2471544|NCT00957268|6061552|P1|COMPLETED|Overall Study||5
2471545|NCT00957268|6061548|P5|STARTED|Overall Study||22
2471546|NCT00957268|6061549|P4|STARTED|Overall Study||7
2471547|NCT00957268|6061550|P3|STARTED|Overall Study||8
2471548|NCT00957268|6061551|P2|STARTED|Overall Study||4
2471549|NCT00957268|6061552|P1|STARTED|Overall Study||5
2471550|NCT00957242|6061616|P2|NOT COMPLETED|Overall Study||0
2471551|NCT00957242|6061617|P1|NOT COMPLETED|Overall Study||0
2471552|NCT00957242|6061616|P2|COMPLETED|Overall Study||72
2471553|NCT00957242|6061617|P1|COMPLETED|Overall Study||73
2471554|NCT00957242|6061616|P2|STARTED|Overall Study||72
2471555|NCT00957242|6061617|P1|STARTED|Overall Study||73
2471556|NCT00957047|6061649|P5|NOT COMPLETED|PART II||102
2471557|NCT00957047|6061650|P4|NOT COMPLETED|PART II||0
2471558|NCT00957047|6061651|P3|NOT COMPLETED|PART II||0
2471559|NCT00957047|6061652|P2|NOT COMPLETED|PART II||0
2471560|NCT00957047|6061653|P1|NOT COMPLETED|PART II||0
2471561|NCT00957047|6061649|P5|COMPLETED|PART II||223
2471562|NCT00957047|6061650|P4|COMPLETED|PART II||0
2471563|NCT00957047|6061651|P3|COMPLETED|PART II||0
2471564|NCT00957047|6061652|P2|COMPLETED|PART II||0
2471565|NCT00957047|6061653|P1|COMPLETED|PART II||0
2471566|NCT00957047|6061649|P5|Terminated Prematurely|PART II|Terminated Prematurely during 1-year Open-Label Period|102
2471567|NCT00957047|6061650|P4|Terminated Prematurely|PART II||0
2471568|NCT00957047|6061651|P3|Terminated Prematurely|PART II||0
2471569|NCT00957047|6061652|P2|Terminated Prematurely|PART II||0
2471570|NCT00957047|6061653|P1|Terminated Prematurely|PART II||0
2471571|NCT00957047|6061649|P5|STARTED|PART II|325 patients who completed Part I were enrolled in Part II.|325
2471572|NCT00957047|6061650|P4|STARTED|PART II||0
2471573|NCT00957047|6061651|P3|STARTED|PART II||0
2471574|NCT00957047|6061652|P2|STARTED|PART II||0
2471575|NCT00957047|6061653|P1|STARTED|PART II||0
2471576|NCT00957047|6061649|P5|NOT COMPLETED|PART I||0
2471577|NCT00957047|6061650|P4|NOT COMPLETED|PART I||30
2471578|NCT00957047|6061651|P3|NOT COMPLETED|PART I||21
2471579|NCT00957047|6061652|P2|NOT COMPLETED|PART I||13
2471580|NCT00957047|6061653|P1|NOT COMPLETED|PART I||6
2471581|NCT00957047|6061649|P5|COMPLETED|PART I||0
2471582|NCT00957047|6061650|P4|COMPLETED|PART I||68
2471583|NCT00957047|6061651|P3|COMPLETED|PART I||80
2471584|NCT00957047|6061652|P2|COMPLETED|PART I||83
2471585|NCT00957047|6061653|P1|COMPLETED|PART I||94
2471586|NCT00957047|6061649|P5|Per-Protocol Population|PART I||0
2471587|NCT00957047|6061650|P4|Per-Protocol Population|PART I||54
2471588|NCT00957047|6061651|P3|Per-Protocol Population|PART I||75
2471589|NCT00957047|6061652|P2|Per-Protocol Population|PART I||70
2471590|NCT00957047|6061653|P1|Per-Protocol Population|PART I||81
2471591|NCT00957047|6061649|P5|Intention-to-treat (ITT) Population|PART I||0
2471592|NCT00957047|6061650|P4|Intention-to-treat (ITT) Population|PART I||97
2471593|NCT00957047|6061651|P3|Intention-to-treat (ITT) Population|PART I||100
2471594|NCT00957047|6061652|P2|Intention-to-treat (ITT) Population|PART I||96
2471595|NCT00957047|6061653|P1|Intention-to-treat (ITT) Population|PART I||100
2471596|NCT00957047|6061649|P5|Randomized/Safety Population|PART I||0
2471597|NCT00957047|6061650|P4|Randomized/Safety Population|PART I||98
2471598|NCT00957047|6061651|P3|Randomized/Safety Population|PART I||101
2471599|NCT00957047|6061652|P2|Randomized/Safety Population|PART I||96
2471600|NCT00957047|6061653|P1|Randomized/Safety Population|PART I||100
2471601|NCT00957047|6061649|P5|STARTED|PART I||0
2471602|NCT00957047|6061650|P4|STARTED|PART I||98
2471603|NCT00957047|6061651|P3|STARTED|PART I||101
2471604|NCT00957047|6061652|P2|STARTED|PART I||96
2471605|NCT00957047|6061653|P1|STARTED|PART I||100
2471606|NCT00957034|6061674|P3|NOT COMPLETED|Overall Study||6
2471607|NCT00957034|6061675|P2|NOT COMPLETED|Overall Study||4
2471608|NCT00957034|6061676|P1|NOT COMPLETED|Overall Study||6
2471609|NCT00957034|6061674|P3|COMPLETED|Overall Study||1
2471610|NCT00957034|6061675|P2|COMPLETED|Overall Study||0
2471611|NCT00957034|6061676|P1|COMPLETED|Overall Study||0
2471612|NCT00957034|6061674|P3|STARTED|Overall Study||7
2471613|NCT00957034|6061675|P2|STARTED|Overall Study||4
2471614|NCT00957034|6061676|P1|STARTED|Overall Study||6
2471615|NCT00957021|6061699|P1|NOT COMPLETED|Overall Study||117
2471616|NCT00957021|6061699|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2 yr primary outcome interval.|237
2471617|NCT00957021|6061699|P1|STARTED|Overall Study||354
2471618|NCT00957008|6061712|P4|NOT COMPLETED|Overall Study||24
2471619|NCT00957008|6061713|P3|NOT COMPLETED|Overall Study||17
2471620|NCT00957008|6061714|P2|NOT COMPLETED|Overall Study||12
2471621|NCT00957008|6061715|P1|NOT COMPLETED|Overall Study||21
2471622|NCT00957008|6061712|P4|COMPLETED|Overall Study||26
2471623|NCT00957008|6061713|P3|COMPLETED|Overall Study||32
2471624|NCT00957008|6061714|P2|COMPLETED|Overall Study||37
2471625|NCT00957008|6061715|P1|COMPLETED|Overall Study||28
2471626|NCT00957008|6061712|P4|STARTED|Overall Study||50
2471627|NCT00957008|6061713|P3|STARTED|Overall Study||49
2471628|NCT00957008|6061714|P2|STARTED|Overall Study||49
2471629|NCT00957008|6061715|P1|STARTED|Overall Study||49
2471630|NCT00956943|6061743|P2|NOT COMPLETED|Overall Study||10
2471631|NCT00956943|6061744|P1|NOT COMPLETED|Overall Study||9
2471632|NCT00956943|6061743|P2|COMPLETED|Overall Study||34
2471633|NCT00956943|6061744|P1|COMPLETED|Overall Study||34
2471634|NCT00956943|6061743|P2|Baseline|Overall Study||44
2471635|NCT00956943|6061744|P1|Baseline|Overall Study||43
2471636|NCT00956943|6061743|P2|STARTED|Overall Study||44
2471637|NCT00956943|6061744|P1|STARTED|Overall Study||43
2471638|NCT00956930|6061754|P2|NOT COMPLETED|Overall Study||0
2471639|NCT00956930|6061755|P1|NOT COMPLETED|Overall Study||0
2471640|NCT00956930|6061754|P2|COMPLETED|Overall Study||21
2471641|NCT00956930|6061755|P1|COMPLETED|Overall Study||24
2471642|NCT00956930|6061754|P2|STARTED|Overall Study||21
2471643|NCT00956930|6061755|P1|STARTED|Overall Study||24
2471644|NCT00956839|6061768|P3|NOT COMPLETED|Overall Study||3
2471645|NCT00956839|6061769|P2|NOT COMPLETED|Overall Study||0
2471646|NCT00956839|6061770|P1|NOT COMPLETED|Overall Study||3
2471647|NCT00956839|6061768|P3|COMPLETED|Overall Study||10
2471648|NCT00956839|6061769|P2|COMPLETED|Overall Study||13
2471649|NCT00956839|6061770|P1|COMPLETED|Overall Study||11
2471650|NCT00956839|6061768|P3|STARTED|Overall Study||13
2471651|NCT00956839|6061769|P2|STARTED|Overall Study||13
2471652|NCT00956839|6061770|P1|STARTED|Overall Study||14
2471653|NCT00956813|6061783|P2|NOT COMPLETED|Continuation Phase||0
2471654|NCT00956813|6061784|P1|NOT COMPLETED|Continuation Phase||0
2471655|NCT00956813|6061783|P2|COMPLETED|Continuation Phase||0
2471656|NCT00956813|6061784|P1|COMPLETED|Continuation Phase||80
2471657|NCT00956813|6061783|P2|STARTED|Continuation Phase||0
2471658|NCT00956813|6061784|P1|STARTED|Continuation Phase||80
2471659|NCT00956813|6061783|P2|NOT COMPLETED|Flaxseed and Placebo||5
2471660|NCT00956813|6061784|P1|NOT COMPLETED|Flaxseed and Placebo||8
2471661|NCT00956813|6061783|P2|COMPLETED|Flaxseed and Placebo||100
2471662|NCT00956813|6061784|P1|COMPLETED|Flaxseed and Placebo||97
2471663|NCT00956813|6061783|P2|STARTED|Flaxseed and Placebo||105
2471664|NCT00956813|6061784|P1|STARTED|Flaxseed and Placebo||105
2471665|NCT00956761|6061799|P1|NOT COMPLETED|Overall Study||0
2471666|NCT00956761|6061799|P1|COMPLETED|Overall Study||63
2471667|NCT00956761|6061799|P1|STARTED|Overall Study||63
2471668|NCT00956709|6061808|P2|NOT COMPLETED|Overall Study||0
2471669|NCT00956709|6061809|P1|NOT COMPLETED|Overall Study||0
2471670|NCT00956709|6061808|P2|COMPLETED|Overall Study||19
2471671|NCT00956709|6061809|P1|COMPLETED|Overall Study||16
2471672|NCT00956709|6061808|P2|STARTED|Overall Study||19
2471673|NCT00956709|6061809|P1|STARTED|Overall Study||16
2471674|NCT00956657|6061821|P2|NOT COMPLETED|Overall Study||0
2471675|NCT00956657|6061822|P1|NOT COMPLETED|Overall Study||0
2471676|NCT00956657|6061821|P2|COMPLETED|Overall Study||13
2471677|NCT00956657|6061822|P1|COMPLETED|Overall Study||18
2471678|NCT00956657|6061821|P2|STARTED|Overall Study||13
2471679|NCT00956657|6061822|P1|STARTED|Overall Study||18
2471680|NCT00956631|6061828|P1|NOT COMPLETED|Overall Study||16
2471681|NCT00956631|6061828|P1|COMPLETED|Overall Study||62
2471682|NCT00956631|6061828|P1|STARTED|Overall Study||78
2471683|NCT00956592|6061836|P2|NOT COMPLETED|Overall Study||3
2471684|NCT00956592|6061837|P1|NOT COMPLETED|Overall Study||1
2471685|NCT00956592|6061836|P2|COMPLETED|Overall Study||147
2471686|NCT00956592|6061837|P1|COMPLETED|Overall Study||149
2471687|NCT00956592|6061836|P2|STARTED|Overall Study||150
2471688|NCT00956592|6061837|P1|STARTED|Overall Study||150
2471689|NCT00956540|6061857|P4|NOT COMPLETED|Overall Study||4
2471690|NCT00956540|6061858|P3|NOT COMPLETED|Overall Study||3
2471691|NCT00956540|6061859|P2|NOT COMPLETED|Overall Study||4
2471692|NCT00956540|6061860|P1|NOT COMPLETED|Overall Study||3
2471693|NCT00956540|6061857|P4|COMPLETED|Overall Study||41
2471694|NCT00956540|6061858|P3|COMPLETED|Overall Study||43
2471695|NCT00956540|6061859|P2|COMPLETED|Overall Study||46
2471696|NCT00956540|6061860|P1|COMPLETED|Overall Study||51
2471697|NCT00956540|6061857|P4|STARTED|Overall Study||45
2471698|NCT00956540|6061858|P3|STARTED|Overall Study||46
2471699|NCT00956540|6061859|P2|STARTED|Overall Study||50
2471700|NCT00956540|6061860|P1|STARTED|Overall Study||54
2471701|NCT00956293|6061872|P3|NOT COMPLETED|Follow-up Period||0
2471702|NCT00956293|6061873|P2|NOT COMPLETED|Follow-up Period||32
2471703|NCT00956293|6061874|P1|NOT COMPLETED|Follow-up Period||20
2471704|NCT00956293|6061872|P3|COMPLETED|Follow-up Period||0
2471705|NCT00956293|6061873|P2|COMPLETED|Follow-up Period||0
2471706|NCT00956293|6061874|P1|COMPLETED|Follow-up Period||0
2471707|NCT00956293|6061872|P3|STARTED|Follow-up Period||0
2471708|NCT00956293|6061873|P2|STARTED|Follow-up Period||32
2471709|NCT00956293|6061874|P1|STARTED|Follow-up Period||20
2471710|NCT00956293|6061872|P3|NOT COMPLETED|Main Period (Randomization)||0
2471711|NCT00956293|6061873|P2|NOT COMPLETED|Main Period (Randomization)||27
2471712|NCT00956293|6061874|P1|NOT COMPLETED|Main Period (Randomization)||1
2471713|NCT00956293|6061872|P3|COMPLETED|Main Period (Randomization)||0
2471714|NCT00956293|6061873|P2|COMPLETED|Main Period (Randomization)||26
2471715|NCT00956293|6061874|P1|COMPLETED|Main Period (Randomization)||23
2471716|NCT00956293|6061872|P3|Randomized Safety Set|Main Period (Randomization)||0
2471717|NCT00956293|6061873|P2|Randomized Safety Set|Main Period (Randomization)||51
2471718|NCT00956293|6061874|P1|Randomized Safety Set|Main Period (Randomization)||24
2471719|NCT00956293|6061872|P3|Full Analysis Set|Main Period (Randomization)||0
2471720|NCT00956293|6061873|P2|Full Analysis Set|Main Period (Randomization)|Two participants, randomized to this arm, did not receive everolimus.|51
2471721|NCT00956293|6061874|P1|Full Analysis Set|Main Period (Randomization)||24
2471722|NCT00956293|6061872|P3|STARTED|Main Period (Randomization)||0
2471723|NCT00956293|6061873|P2|STARTED|Main Period (Randomization)||53
2471724|NCT00956293|6061874|P1|STARTED|Main Period (Randomization)||24
2471725|NCT00956293|6061872|P3|NOT COMPLETED|Main Period (Pre-randomization)||130
2471726|NCT00956293|6061873|P2|NOT COMPLETED|Main Period (Pre-randomization)||0
2471727|NCT00956293|6061874|P1|NOT COMPLETED|Main Period (Pre-randomization)||0
2471728|NCT00956293|6061872|P3|COMPLETED|Main Period (Pre-randomization)||77
2471729|NCT00956293|6061873|P2|COMPLETED|Main Period (Pre-randomization)||0
2471730|NCT00956293|6061874|P1|COMPLETED|Main Period (Pre-randomization)||0
2471731|NCT00956293|6061872|P3|Enrolled Safety Set|Main Period (Pre-randomization)||203
2471732|NCT00956293|6061873|P2|Enrolled Safety Set|Main Period (Pre-randomization)||0
2471733|NCT00956293|6061874|P1|Enrolled Safety Set|Main Period (Pre-randomization)||0
2471734|NCT00956293|6061872|P3|STARTED|Main Period (Pre-randomization)||207
2471735|NCT00956293|6061873|P2|STARTED|Main Period (Pre-randomization)||0
2471736|NCT00956293|6061874|P1|STARTED|Main Period (Pre-randomization)||0
2471737|NCT00956254|6061898|P1|NOT COMPLETED|Overall Study||0
2471738|NCT00956254|6061898|P1|COMPLETED|Overall Study||18
2471739|NCT00956254|6061898|P1|STARTED|Overall Study||18
2471740|NCT00956085|6061908|P1|NOT COMPLETED|Overall Study||0
2471741|NCT00956085|6061908|P1|COMPLETED|Overall Study||12
2471742|NCT00956085|6061908|P1|STARTED|Overall Study||12
2471743|NCT00956020|6061912|P1|NOT COMPLETED|Overall Study||0
2471744|NCT00956020|6061912|P1|COMPLETED|Overall Study||4
2471745|NCT00956020|6061912|P1|STARTED|Overall Study||4
2471746|NCT00955968|6061929|P2|NOT COMPLETED|Overall Study||126
2471747|NCT00955968|6061930|P1|NOT COMPLETED|Overall Study||137
2471748|NCT00955968|6061929|P2|COMPLETED|Overall Study||699
2471749|NCT00955968|6061930|P1|COMPLETED|Overall Study||691
2471750|NCT00955968|6061929|P2|STARTED|Overall Study||825
2471751|NCT00955968|6061930|P1|STARTED|Overall Study||828
2471752|NCT00955955|6061968|P3|NOT COMPLETED|Overall Study||0
2471753|NCT00955955|6061969|P2|NOT COMPLETED|Overall Study||0
2471754|NCT00955955|6061970|P1|NOT COMPLETED|Overall Study||2
2471755|NCT00955955|6061968|P3|COMPLETED|Overall Study||28
2471756|NCT00955955|6061969|P2|COMPLETED|Overall Study||28
2471757|NCT00955955|6061970|P1|COMPLETED|Overall Study||17
2471758|NCT00955955|6061968|P3|STARTED|Overall Study||28
2471759|NCT00955955|6061969|P2|STARTED|Overall Study||28
2471760|NCT00955955|6061970|P1|STARTED|Overall Study||19
2471761|NCT00955916|6061984|P1|NOT COMPLETED|Overall Study||0
2471762|NCT00955916|6061984|P1|COMPLETED|Overall Study||38
2471763|NCT00955916|6061984|P1|STARTED|Overall Study||38
2471764|NCT00955903|6061993|P3|NOT COMPLETED|Overall Study||7
2471765|NCT00955903|6061994|P2|NOT COMPLETED|Overall Study||3
2471766|NCT00955903|6061995|P1|NOT COMPLETED|Overall Study||6
2471767|NCT00955903|6061993|P3|COMPLETED|Overall Study||48
2471768|NCT00955903|6061994|P2|COMPLETED|Overall Study||51
2471769|NCT00955903|6061995|P1|COMPLETED|Overall Study||49
2471770|NCT00955903|6061993|P3|STARTED|Overall Study||55
2471771|NCT00955903|6061994|P2|STARTED|Overall Study||54
2471772|NCT00955903|6061995|P1|STARTED|Overall Study||55
2471773|NCT00955877|6062012|P3|NOT COMPLETED|Overall Study||0
2471774|NCT00955877|6062013|P2|NOT COMPLETED|Overall Study||0
2471775|NCT00955877|6062014|P1|NOT COMPLETED|Overall Study||0
2471776|NCT00955877|6062012|P3|COMPLETED|Overall Study||7
2471777|NCT00955877|6062013|P2|COMPLETED|Overall Study||0
2471778|NCT00955877|6062014|P1|COMPLETED|Overall Study||6
2471779|NCT00955877|6062012|P3|STARTED|Overall Study||7
2471780|NCT00955877|6062013|P2|STARTED|Overall Study|No patients were enrolled because analysis of previous arm wasn't completed.|0
2471781|NCT00955877|6062014|P1|STARTED|Overall Study|Drug manufacturer ceased producing the drug prior to completion of 10 enrolled in this arm.|6
2471782|NCT00955825|6062054|P2|NOT COMPLETED|Overall Study||17
2471783|NCT00955825|6062055|P1|NOT COMPLETED|Overall Study||26
2471784|NCT00955825|6062054|P2|COMPLETED|Overall Study||223
2471785|NCT00955825|6062055|P1|COMPLETED|Overall Study||207
2471786|NCT00955825|6062054|P2|STARTED|Overall Study||240
2471787|NCT00955825|6062055|P1|STARTED|Overall Study||233
2471788|NCT00955747|6062063|P2|NOT COMPLETED|Overall Study||69
2471789|NCT00955747|6062064|P1|NOT COMPLETED|Overall Study||69
2471790|NCT00955747|6062063|P2|COMPLETED|Overall Study||172
2471791|NCT00955747|6062064|P1|COMPLETED|Overall Study||184
2471792|NCT00955747|6062063|P2|STARTED|Overall Study||241
2471793|NCT00955747|6062064|P1|STARTED|Overall Study||253
2471794|NCT00955721|6062072|P2|NOT COMPLETED|Overall Study||0
2471795|NCT00955721|6062073|P1|NOT COMPLETED|Overall Study||3
2471796|NCT00955721|6062072|P2|COMPLETED|Overall Study||0
2471797|NCT00955721|6062073|P1|COMPLETED|Overall Study||6
2471798|NCT00955721|6062072|P2|STARTED|Overall Study||0
2471799|NCT00955721|6062073|P1|STARTED|Overall Study||9
2471800|NCT00955708|6062083|P1|NOT COMPLETED|Overall Study||1058
2471801|NCT00955708|6062083|P1|COMPLETED|Overall Study||250
2471802|NCT00955708|6062083|P1|STARTED|Overall Study||1308
2471803|NCT00955682|6062089|P2|NOT COMPLETED|Year 5 Period||0
2471804|NCT00955682|6062090|P1|NOT COMPLETED|Year 5 Period||0
2471805|NCT00955682|6062089|P2|COMPLETED|Year 5 Period||47
2471806|NCT00955682|6062090|P1|COMPLETED|Year 5 Period||239
2471807|NCT00955682|6062089|P2|STARTED|Year 5 Period||47
2471808|NCT00955682|6062090|P1|STARTED|Year 5 Period||239
2471809|NCT00955682|6062089|P2|NOT COMPLETED|Booster Period (Month 49)||1
2471810|NCT00955682|6062090|P1|NOT COMPLETED|Booster Period (Month 49)||1
2471811|NCT00955682|6062089|P2|COMPLETED|Booster Period (Month 49)||47
2471812|NCT00955682|6062090|P1|COMPLETED|Booster Period (Month 49)||244
2471813|NCT00955682|6062089|P2|STARTED|Booster Period (Month 49)||48
2471814|NCT00955682|6062090|P1|STARTED|Booster Period (Month 49)||245
2471815|NCT00955682|6062089|P2|NOT COMPLETED|Year 4 Period||0
2471816|NCT00955682|6062090|P1|NOT COMPLETED|Year 4 Period||0
2471817|NCT00955682|6062089|P2|COMPLETED|Year 4 Period||48
2471818|NCT00955682|6062090|P1|COMPLETED|Year 4 Period||246
2471819|NCT00955682|6062089|P2|STARTED|Year 4 Period||48
2471820|NCT00955682|6062090|P1|STARTED|Year 4 Period||246
2471821|NCT00955682|6062089|P2|NOT COMPLETED|Year 3 Period||0
2471822|NCT00955682|6062090|P1|NOT COMPLETED|Year 3 Period||0
2471823|NCT00955682|6062089|P2|COMPLETED|Year 3 Period||47
2471824|NCT00955682|6062090|P1|COMPLETED|Year 3 Period||273
2471825|NCT00955682|6062089|P2|STARTED|Year 3 Period||47
2471826|NCT00955682|6062090|P1|STARTED|Year 3 Period||273
2471827|NCT00955682|6062089|P2|NOT COMPLETED|Year 2 Period||0
2471828|NCT00955682|6062090|P1|NOT COMPLETED|Year 2 Period||0
2471829|NCT00955682|6062089|P2|COMPLETED|Year 2 Period||42
2471830|NCT00955682|6062090|P1|COMPLETED|Year 2 Period||253
2471831|NCT00955682|6062089|P2|STARTED|Year 2 Period||42
2471832|NCT00955682|6062090|P1|STARTED|Year 2 Period||253
2471833|NCT00955617|6062200|P2|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
2471834|NCT00955617|6062201|P1|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
2471835|NCT00955617|6062200|P2|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
2471836|NCT00955617|6062201|P1|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
2471837|NCT00955617|6062200|P2|STARTED|Second MRA (Between Day 1 and Day 51)||10
2471838|NCT00955617|6062201|P1|STARTED|Second MRA (Between Day 1 and Day 51)||10
2471839|NCT00955617|6062200|P2|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
2471840|NCT00955617|6062201|P1|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
2471841|NCT00955617|6062200|P2|COMPLETED|First MRA (Between Day0 and Day21)||10
2471842|NCT00955617|6062201|P1|COMPLETED|First MRA (Between Day0 and Day21)||10
2471843|NCT00955617|6062200|P2|STARTED|First MRA (Between Day0 and Day21)||10
2471844|NCT00955617|6062201|P1|STARTED|First MRA (Between Day0 and Day21)||10
2471845|NCT00955513|6062214|P3|NOT COMPLETED|Overall Study||3
2471846|NCT00955513|6062215|P2|NOT COMPLETED|Overall Study||2
2471847|NCT00955513|6062216|P1|NOT COMPLETED|Overall Study||1
2471848|NCT00955513|6062214|P3|COMPLETED|Overall Study||79
2471849|NCT00955513|6062215|P2|COMPLETED|Overall Study||78
2471850|NCT00955513|6062216|P1|COMPLETED|Overall Study||79
2471851|NCT00955513|6062214|P3|STARTED|Overall Study||82
2471852|NCT00955513|6062215|P2|STARTED|Overall Study||80
2471853|NCT00955513|6062216|P1|STARTED|Overall Study||80
2471854|NCT00955487|6062226|P6|NOT COMPLETED|Overall Study||0
2471855|NCT00955487|6062227|P5|NOT COMPLETED|Overall Study||0
2471856|NCT00955487|6062228|P4|NOT COMPLETED|Overall Study||0
2471857|NCT00955487|6062229|P3|NOT COMPLETED|Overall Study||0
2471858|NCT00955487|6062230|P2|NOT COMPLETED|Overall Study||0
2471859|NCT00955487|6062231|P1|NOT COMPLETED|Overall Study||0
2471860|NCT00955487|6062226|P6|COMPLETED|Overall Study||35
2471861|NCT00955487|6062227|P5|COMPLETED|Overall Study||32
2471862|NCT00955487|6062228|P4|COMPLETED|Overall Study||21
2471863|NCT00955487|6062229|P3|COMPLETED|Overall Study||17
2471864|NCT00955487|6062230|P2|COMPLETED|Overall Study||9
2471865|NCT00955487|6062231|P1|COMPLETED|Overall Study||10
2471866|NCT00955487|6062226|P6|STARTED|Overall Study||35
2471867|NCT00955487|6062227|P5|STARTED|Overall Study||32
2471868|NCT00955487|6062228|P4|STARTED|Overall Study||21
2471869|NCT00955487|6062229|P3|STARTED|Overall Study||17
2471870|NCT00955487|6062230|P2|STARTED|Overall Study||9
2471871|NCT00955487|6062231|P1|STARTED|Overall Study||10
2471872|NCT00955474|6062265|P2|NOT COMPLETED|Overall Study||5
2471873|NCT00955474|6062266|P1|NOT COMPLETED|Overall Study||7
2471874|NCT00955474|6062265|P2|COMPLETED|Overall Study||8
2471875|NCT00955474|6062266|P1|COMPLETED|Overall Study||5
2471876|NCT00955474|6062265|P2|STARTED|Overall Study||13
2471877|NCT00955474|6062266|P1|STARTED|Overall Study||12
2471878|NCT00955357|6062302|P2|NOT COMPLETED|Maintenance Phase||45
2471879|NCT00955357|6062303|P1|NOT COMPLETED|Maintenance Phase||12
2471880|NCT00955357|6062302|P2|COMPLETED|Maintenance Phase||249
2471881|NCT00955357|6062303|P1|COMPLETED|Maintenance Phase||68
2471882|NCT00955357|6062302|P2|STARTED|Maintenance Phase||294
2471883|NCT00955357|6062303|P1|STARTED|Maintenance Phase||80
2471884|NCT00955357|6062302|P2|NOT COMPLETED|Titration Phase||66
2471885|NCT00955357|6062303|P1|NOT COMPLETED|Titration Phase||16
2471886|NCT00955357|6062302|P2|COMPLETED|Titration Phase||294
2471887|NCT00955357|6062303|P1|COMPLETED|Titration Phase||80
2471888|NCT00955357|6062302|P2|STARTED|Titration Phase||360
2471889|NCT00955357|6062303|P1|STARTED|Titration Phase||96
2471890|NCT00955305|6062311|P2|NOT COMPLETED|Overall Study||87
2471891|NCT00955305|6062312|P1|NOT COMPLETED|Overall Study||88
2471892|NCT00955305|6062311|P2|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
2471893|NCT00955305|6062312|P1|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
2471894|NCT00955305|6062311|P2|Eligible and Treated|Overall Study||75
2471895|NCT00955305|6062312|P1|Eligible and Treated|Overall Study||78
2471896|NCT00955305|6062311|P2|Treated|Overall Study||82
2471897|NCT00955305|6062312|P1|Treated|Overall Study||83
2471898|NCT00955305|6062311|P2|STARTED|Overall Study||87
2471899|NCT00955305|6062312|P1|STARTED|Overall Study||88
2471900|NCT00955279|6062325|P3|NOT COMPLETED|Overall Study||8
2471901|NCT00955279|6062326|P2|NOT COMPLETED|Overall Study||4
2471902|NCT00955279|6062327|P1|NOT COMPLETED|Overall Study||3
2471903|NCT00955279|6062325|P3|COMPLETED|Overall Study||52
2471904|NCT00955279|6062326|P2|COMPLETED|Overall Study||51
2471905|NCT00955279|6062327|P1|COMPLETED|Overall Study||55
2471906|NCT00955279|6062325|P3|STARTED|Overall Study||60
2471907|NCT00955279|6062326|P2|STARTED|Overall Study||55
2471908|NCT00955279|6062327|P1|STARTED|Overall Study||58
2471909|NCT00955266|6062349|P2|NOT COMPLETED|Overall Study||0
2471910|NCT00955266|6062350|P1|NOT COMPLETED|Overall Study||0
2471911|NCT00955266|6062349|P2|COMPLETED|Overall Study||4
2471912|NCT00955266|6062350|P1|COMPLETED|Overall Study||4
2471913|NCT00955266|6062349|P2|STARTED|Overall Study||4
2471914|NCT00955266|6062350|P1|STARTED|Overall Study||4
2471915|NCT00955253|6062364|P2|NOT COMPLETED|Second Intervention (Day 4)||0
2471916|NCT00955253|6062365|P1|NOT COMPLETED|Second Intervention (Day 4)||0
2471917|NCT00955253|6062364|P2|COMPLETED|Second Intervention (Day 4)||6
2471918|NCT00955253|6062365|P1|COMPLETED|Second Intervention (Day 4)||7
2471919|NCT00955253|6062364|P2|STARTED|Second Intervention (Day 4)||6
2471920|NCT00955253|6062365|P1|STARTED|Second Intervention (Day 4)||7
2471921|NCT00955253|6062364|P2|NOT COMPLETED|First Intervention (Day 2)||0
2471922|NCT00955253|6062365|P1|NOT COMPLETED|First Intervention (Day 2)||0
2471923|NCT00955253|6062364|P2|COMPLETED|First Intervention (Day 2)||6
2471924|NCT00955253|6062365|P1|COMPLETED|First Intervention (Day 2)||7
2471925|NCT00955253|6062364|P2|STARTED|First Intervention (Day 2)||6
2471926|NCT00955253|6062365|P1|STARTED|First Intervention (Day 2)||7
2471927|NCT00955201|6062374|P4|NOT COMPLETED|Overall Study||4
2471928|NCT00955201|6062375|P3|NOT COMPLETED|Overall Study||1
2471929|NCT00955201|6062376|P2|NOT COMPLETED|Overall Study||0
2471930|NCT00955201|6062377|P1|NOT COMPLETED|Overall Study||4
2471931|NCT00955201|6062374|P4|COMPLETED|Overall Study||7
2471932|NCT00955201|6062375|P3|COMPLETED|Overall Study||10
2471933|NCT00955201|6062376|P2|COMPLETED|Overall Study||11
2471934|NCT00955201|6062377|P1|COMPLETED|Overall Study||8
2471935|NCT00955201|6062374|P4|STARTED|Overall Study||11
2471936|NCT00955201|6062375|P3|STARTED|Overall Study||11
2471937|NCT00955201|6062376|P2|STARTED|Overall Study||11
2471938|NCT00955201|6062377|P1|STARTED|Overall Study||12
2471939|NCT00955110|6062535|P1|NOT COMPLETED|Treatment Phase||6
2471940|NCT00955110|6062535|P1|COMPLETED|Treatment Phase||35
2471941|NCT00955110|6062535|P1|Oxycodone CR 60 mg|Treatment Phase||40
2471942|NCT00955110|6062535|P1|Oxycodone CR 30 mg|Treatment Phase||40
2471943|NCT00955110|6062535|P1|Oxymorphone ER 30 mg|Treatment Phase||38
2471944|NCT00955110|6062535|P1|Oxymorphone ER 15 mg|Treatment Phase||37
2471945|NCT00955110|6062535|P1|Placebo|Treatment Phase||38
2471946|NCT00955110|6062535|P1|STARTED|Treatment Phase||41
2471947|NCT00955110|6062535|P1|NOT COMPLETED|Qualification Phase||24
2471948|NCT00955110|6062535|P1|COMPLETED|Qualification Phase||54
2471949|NCT00955110|6062535|P1|STARTED|Qualification Phase||78
2471950|NCT00955032|6062549|P2|NOT COMPLETED|Overall Study||0
2471951|NCT00955032|6062550|P1|NOT COMPLETED|Overall Study||0
2471952|NCT00955032|6062549|P2|COMPLETED|Overall Study||8
2471953|NCT00955032|6062550|P1|COMPLETED|Overall Study||16
2471954|NCT00955032|6062549|P2|STARTED|Overall Study||8
2471955|NCT00955032|6062550|P1|STARTED|Overall Study||16
2471956|NCT00954993|6062570|P1|NOT COMPLETED|Period 2||0
2471957|NCT00954993|6062570|P1|COMPLETED|Period 2||3
2471958|NCT00954993|6062570|P1|STARTED|Period 2||3
2471959|NCT00954993|6062570|P1|NOT COMPLETED|Washout||0
2471960|NCT00954993|6062570|P1|COMPLETED|Washout||3
2471961|NCT00954993|6062570|P1|STARTED|Washout||3
2471962|NCT00954993|6062570|P1|NOT COMPLETED|Period 1||0
2471963|NCT00954993|6062570|P1|COMPLETED|Period 1||3
2471964|NCT00954993|6062570|P1|STARTED|Period 1||3
2471965|NCT00954941|6062582|P2|NOT COMPLETED|Overall Study||7
2471966|NCT00954941|6062583|P1|NOT COMPLETED|Overall Study||8
2471967|NCT00954941|6062582|P2|COMPLETED|Overall Study||41
2471968|NCT00954941|6062583|P1|COMPLETED|Overall Study||42
2471969|NCT00954941|6062582|P2|STARTED|Overall Study||48
2471970|NCT00954941|6062583|P1|STARTED|Overall Study||50
2471971|NCT00954915|6062591|P1|NOT COMPLETED|Overall Study||0
2471972|NCT00954915|6062591|P1|COMPLETED|Overall Study||1
2471973|NCT00954915|6062591|P1|STARTED|Overall Study||1
2471974|NCT00954824|6062595|P1|NOT COMPLETED|Overall Study||50
2471975|NCT00954824|6062595|P1|COMPLETED|Overall Study||50
2471976|NCT00954824|6062595|P1|STARTED|Overall Study||100
2471977|NCT00954733|6062599|P1|NOT COMPLETED|Overall Study||1
2471978|NCT00954733|6062599|P1|COMPLETED|Overall Study||39
2471979|NCT00954733|6062599|P1|STARTED|Overall Study||40
2471980|NCT00954707|6062603|P1|NOT COMPLETED|Overall Study||167
2471981|NCT00954707|6062603|P1|COMPLETED|Overall Study|2342 Subjects completed 12-month Phase 1 follow-up; 167 subjects didn't complete the Phase 1.|2342
2471982|NCT00954707|6062603|P1|STARTED|Overall Study||2509
2471983|NCT00954681|6062619|P1|NOT COMPLETED|Overall Study||5
2471984|NCT00954681|6062619|P1|COMPLETED|Overall Study||10
2471985|NCT00954681|6062619|P1|STARTED|Overall Study||15
2471986|NCT00954538|6062625|P6|NOT COMPLETED|Part III||0
2471987|NCT00954538|6062626|P5|NOT COMPLETED|Part III||1
2471988|NCT00954538|6062627|P4|NOT COMPLETED|Part III||0
2471989|NCT00954538|6062628|P3|NOT COMPLETED|Part III||0
2471990|NCT00954538|6062629|P2|NOT COMPLETED|Part III||0
2471991|NCT00954538|6062630|P1|NOT COMPLETED|Part III||0
2471992|NCT00954538|6062625|P6|COMPLETED|Part III||2
2471993|NCT00954538|6062626|P5|COMPLETED|Part III|The subject who did not complete received 1 dose of study drug|5
2471994|NCT00954538|6062627|P4|COMPLETED|Part III||4
2471995|NCT00954538|6062628|P3|COMPLETED|Part III||0
2471996|NCT00954538|6062629|P2|COMPLETED|Part III||0
2471997|NCT00954538|6062630|P1|COMPLETED|Part III||0
2471998|NCT00954538|6062625|P6|STARTED|Part III|These subjects did not participate in Part I and did participate in Part II and III|2
2471999|NCT00954538|6062626|P5|STARTED|Part III|These subjects did not participate in Part I or II|6
2472000|NCT00954538|6062627|P4|STARTED|Part III|These subjects did not participate in Part I or II|4
2472001|NCT00954538|6062628|P3|STARTED|Part III||0
2472002|NCT00954538|6062629|P2|STARTED|Part III||0
2472003|NCT00954538|6062630|P1|STARTED|Part III||0
2472004|NCT00954538|6062625|P6|NOT COMPLETED|Part II||0
2472005|NCT00954538|6062626|P5|NOT COMPLETED|Part II||0
2472006|NCT00954538|6062627|P4|NOT COMPLETED|Part II||0
2472007|NCT00954538|6062628|P3|NOT COMPLETED|Part II||0
2472008|NCT00954538|6062629|P2|NOT COMPLETED|Part II||0
2472009|NCT00954538|6062630|P1|NOT COMPLETED|Part II||0
2472010|NCT00954538|6062625|P6|COMPLETED|Part II||2
2472011|NCT00954538|6062626|P5|COMPLETED|Part II||0
2472012|NCT00954538|6062627|P4|COMPLETED|Part II||0
2472013|NCT00954538|6062628|P3|COMPLETED|Part II||3
2472014|NCT00954538|6062629|P2|COMPLETED|Part II||1
2472015|NCT00954538|6062630|P1|COMPLETED|Part II||0
2472016|NCT00954538|6062625|P6|STARTED|Part II|These subjects did not participate in Part I and did participate in Part II and III|2
2472017|NCT00954538|6062626|P5|STARTED|Part II||0
2472018|NCT00954538|6062627|P4|STARTED|Part II||0
2472019|NCT00954538|6062628|P3|STARTED|Part II|These subjects did not participate in Part I or III|3
2472020|NCT00954538|6062629|P2|STARTED|Part II|This subject did not participate in Part I or III|1
2472021|NCT00954538|6062630|P1|STARTED|Part II||0
2472022|NCT00954538|6062625|P6|NOT COMPLETED|Part I||0
2472023|NCT00954538|6062626|P5|NOT COMPLETED|Part I||0
2472024|NCT00954538|6062627|P4|NOT COMPLETED|Part I||0
2472025|NCT00954538|6062628|P3|NOT COMPLETED|Part I||0
2472026|NCT00954538|6062629|P2|NOT COMPLETED|Part I||0
2472027|NCT00954538|6062630|P1|NOT COMPLETED|Part I||0
2472028|NCT00954538|6062625|P6|COMPLETED|Part I||0
2472029|NCT00954538|6062626|P5|COMPLETED|Part I||0
2472030|NCT00954538|6062627|P4|COMPLETED|Part I||0
2472031|NCT00954538|6062628|P3|COMPLETED|Part I||0
2472032|NCT00954538|6062629|P2|COMPLETED|Part I||0
2472033|NCT00954538|6062630|P1|COMPLETED|Part I||3
2472034|NCT00954538|6062625|P6|STARTED|Part I||0
2472035|NCT00954538|6062626|P5|STARTED|Part I||0
2472036|NCT00954538|6062627|P4|STARTED|Part I||0
2472037|NCT00954538|6062628|P3|STARTED|Part I||0
2472038|NCT00954538|6062629|P2|STARTED|Part I||0
2472039|NCT00954538|6062630|P1|STARTED|Part I|These subjects did not participate in Part II or III|3
2472040|NCT00954512|6062647|P6|NOT COMPLETED|Overall Study||4
2472041|NCT00954512|6062648|P5|NOT COMPLETED|Overall Study||4
2472042|NCT00954512|6062649|P4|NOT COMPLETED|Overall Study||2
2472043|NCT00954512|6062650|P3|NOT COMPLETED|Overall Study||0
2472044|NCT00954512|6062651|P2|NOT COMPLETED|Overall Study||3
2472045|NCT00954512|6062652|P1|NOT COMPLETED|Overall Study||2
2472046|NCT00954512|6062647|P6|COMPLETED|Overall Study||0
2472047|NCT00954512|6062648|P5|COMPLETED|Overall Study||0
2472048|NCT00954512|6062649|P4|COMPLETED|Overall Study||0
2472049|NCT00954512|6062650|P3|COMPLETED|Overall Study||0
2472050|NCT00954512|6062651|P2|COMPLETED|Overall Study||0
2472051|NCT00954512|6062652|P1|COMPLETED|Overall Study||0
2472052|NCT00954512|6062647|P6|STARTED|Overall Study||4
2472053|NCT00954512|6062648|P5|STARTED|Overall Study||4
2472054|NCT00954512|6062649|P4|STARTED|Overall Study||2
2472055|NCT00954512|6062650|P3|STARTED|Overall Study||0
2472056|NCT00954512|6062651|P2|STARTED|Overall Study||3
2472057|NCT00954512|6062652|P1|STARTED|Overall Study||2
2472058|NCT00954447|6062673|P2|NOT COMPLETED|Overall Study||88
2472059|NCT00954447|6062674|P1|NOT COMPLETED|Overall Study||110
2472060|NCT00954447|6062673|P2|COMPLETED|Overall Study||543
2472061|NCT00954447|6062674|P1|COMPLETED|Overall Study||520
2472062|NCT00954447|6062673|P2|STARTED|Overall Study||631
2472063|NCT00954447|6062674|P1|STARTED|Overall Study||630
2472064|NCT00954421|6062710|P1|NOT COMPLETED|VIM=ON VO=OFF at 6 Months||1
2472065|NCT00954421|6062710|P1|COMPLETED|VIM=ON VO=OFF at 6 Months||11
2472066|NCT00954421|6062710|P1|STARTED|VIM=ON VO=OFF at 6 Months||12
2472067|NCT00954421|6062710|P1|NOT COMPLETED|VIM=OFF VO=ON at 6 Months||0
2472068|NCT00954421|6062710|P1|COMPLETED|VIM=OFF VO=ON at 6 Months||12
2472069|NCT00954421|6062710|P1|STARTED|VIM=OFF VO=ON at 6 Months||12
2472070|NCT00954421|6062710|P1|NOT COMPLETED|VIM=OFF VO=OFF at 6 Months||0
2472071|NCT00954421|6062710|P1|COMPLETED|VIM=OFF VO=OFF at 6 Months||12
2472072|NCT00954421|6062710|P1|STARTED|VIM=OFF VO=OFF at 6 Months||12
2472073|NCT00954421|6062710|P1|NOT COMPLETED|VIM=ON VO=ON at 6 Months||0
2472074|NCT00954421|6062710|P1|COMPLETED|VIM=ON VO=ON at 6 Months||12
2472075|NCT00954421|6062710|P1|STARTED|VIM=ON VO=ON at 6 Months|This is the point of evaluation: Order of assessment was random for periods 4-7|12
2472076|NCT00954421|6062710|P1|NOT COMPLETED|6 Months of DBS||1
2472077|NCT00954421|6062710|P1|COMPLETED|6 Months of DBS||12
2472078|NCT00954421|6062710|P1|STARTED|6 Months of DBS||13
2472079|NCT00954421|6062710|P1|NOT COMPLETED|Baseline||0
2472080|NCT00954421|6062710|P1|COMPLETED|Baseline||13
2472081|NCT00954421|6062710|P1|STARTED|Baseline||13
2472082|NCT00954421|6062710|P1|NOT COMPLETED|Screening||3
2472083|NCT00954421|6062710|P1|COMPLETED|Screening||13
2472084|NCT00954421|6062710|P1|STARTED|Screening||16
2472085|NCT00954356|6062718|P2|NOT COMPLETED|Overall Study||0
2472086|NCT00954356|6062719|P1|NOT COMPLETED|Overall Study||0
2472087|NCT00954356|6062718|P2|COMPLETED|Overall Study||20
2472088|NCT00954356|6062719|P1|COMPLETED|Overall Study||41
2472089|NCT00954356|6062718|P2|STARTED|Overall Study||20
2472090|NCT00954356|6062719|P1|STARTED|Overall Study||41
2472091|NCT00954187|6062749|P2|NOT COMPLETED|Overall Study||0
2472092|NCT00954187|6062750|P1|NOT COMPLETED|Overall Study||0
2472093|NCT00954187|6062749|P2|COMPLETED|Overall Study||0
2472094|NCT00954187|6062750|P1|COMPLETED|Overall Study||0
2472095|NCT00954187|6062749|P2|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
2472096|NCT00954187|6062750|P1|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
2472097|NCT00954122|6062756|P1|NOT COMPLETED|Overall Study||7
2472098|NCT00954122|6062756|P1|COMPLETED|Overall Study||28
2472099|NCT00954122|6062756|P1|STARTED|Overall Study||35
2472100|NCT00954109|6062766|P1|NOT COMPLETED|Overall Study||0
2472101|NCT00954109|6062766|P1|COMPLETED|Overall Study||11
2472102|NCT00954109|6062766|P1|STARTED|Overall Study||11
2472103|NCT00953927|6062773|P2|NOT COMPLETED|Overall Study||95
2472104|NCT00953927|6062774|P1|NOT COMPLETED|Overall Study||105
2472105|NCT00953927|6062773|P2|COMPLETED|Overall Study||1303
2472106|NCT00953927|6062774|P1|COMPLETED|Overall Study||1294
2472107|NCT00953927|6062773|P2|STARTED|Overall Study||1398
2472108|NCT00953927|6062774|P1|STARTED|Overall Study||1399
2472109|NCT00953862|6062792|P1|NOT COMPLETED|Overall Study||6
2472110|NCT00953862|6062792|P1|COMPLETED|Overall Study||12
2472111|NCT00953862|6062792|P1|STARTED|Overall Study||18
2472112|NCT00953849|6062802|P4|NOT COMPLETED|Overall Study||0
2472113|NCT00953849|6062803|P3|NOT COMPLETED|Overall Study||0
2472114|NCT00953849|6062804|P2|NOT COMPLETED|Overall Study||0
2472115|NCT00953849|6062805|P1|NOT COMPLETED|Overall Study||0
2472116|NCT00953849|6062802|P4|COMPLETED|Overall Study||5
2472117|NCT00953849|6062803|P3|COMPLETED|Overall Study||4
2472118|NCT00953849|6062804|P2|COMPLETED|Overall Study||6
2472119|NCT00953849|6062805|P1|COMPLETED|Overall Study||6
2472120|NCT00953849|6062802|P4|STARTED|Overall Study||5
2472121|NCT00953849|6062803|P3|STARTED|Overall Study||4
2472122|NCT00953849|6062804|P2|STARTED|Overall Study||6
2472123|NCT00953849|6062805|P1|STARTED|Overall Study||6
2472124|NCT00953745|6062829|P2|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
2472125|NCT00953745|6062830|P1|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
2472126|NCT00953745|6062829|P2|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
2472127|NCT00953745|6062830|P1|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||17
2472128|NCT00953745|6062829|P2|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||0
2472129|NCT00953745|6062830|P1|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||17
2472130|NCT00953745|6062829|P2|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0
2472131|NCT00953745|6062830|P1|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||1
2472132|NCT00953745|6062829|P2|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0
2472133|NCT00953745|6062830|P1|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||17
2472134|NCT00953745|6062829|P2|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||0
2472135|NCT00953745|6062830|P1|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||18
2472136|NCT00953745|6062829|P2|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||0
2472137|NCT00953745|6062830|P1|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||13
2472138|NCT00953745|6062829|P2|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||6
2472139|NCT00953745|6062830|P1|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||24
2472140|NCT00953745|6062829|P2|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||6
2472141|NCT00953745|6062830|P1|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||37
2472142|NCT00953719|6062840|P2|NOT COMPLETED|Overall Study||5
2472143|NCT00953719|6062841|P1|NOT COMPLETED|Overall Study||19
2472144|NCT00953719|6062840|P2|COMPLETED|Overall Study||69
2472145|NCT00953719|6062841|P1|COMPLETED|Overall Study||150
2472146|NCT00953719|6062840|P2|STARTED|Overall Study||74
2472147|NCT00953719|6062841|P1|STARTED|Overall Study||169
2472148|NCT00953706|6062863|P4|NOT COMPLETED|Part B (96-Week Open-Label Extension)||33
2472149|NCT00953706|6062864|P3|NOT COMPLETED|Part B (96-Week Open-Label Extension)||5
2472150|NCT00953706|6062865|P2|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
2472151|NCT00953706|6062866|P1|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
2472152|NCT00953706|6062863|P4|COMPLETED|Part B (96-Week Open-Label Extension)||0
2472153|NCT00953706|6062864|P3|COMPLETED|Part B (96-Week Open-Label Extension)||0
2472154|NCT00953706|6062865|P2|COMPLETED|Part B (96-Week Open-Label Extension)||0
2472155|NCT00953706|6062866|P1|COMPLETED|Part B (96-Week Open-Label Extension)||0
2472156|NCT00953706|6062863|P4|STARTED|Part B (96-Week Open-Label Extension)||33
2472157|NCT00953706|6062864|P3|STARTED|Part B (96-Week Open-Label Extension)||5
2472158|NCT00953706|6062865|P2|STARTED|Part B (96-Week Open-Label Extension)||0
2472159|NCT00953706|6062866|P1|STARTED|Part B (96-Week Open-Label Extension)||0
2472160|NCT00953706|6062863|P4|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
2472161|NCT00953706|6062864|P3|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
2472162|NCT00953706|6062865|P2|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||8
2472163|NCT00953706|6062866|P1|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||2
2472164|NCT00953706|6062863|P4|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
2472165|NCT00953706|6062864|P3|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
2472166|NCT00953706|6062865|P2|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 33 participants continued in Part B.|104
2472167|NCT00953706|6062866|P1|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 5 participants continued in Part B.|26
2472168|NCT00953706|6062863|P4|STARTED|Part A (16-Week Double-Blind Treatment)||0
2472169|NCT00953706|6062864|P3|STARTED|Part A (16-Week Double-Blind Treatment)||0
2472170|NCT00953706|6062865|P2|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (ivacaftor)|112
2472171|NCT00953706|6062866|P1|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (placebo)|28
2472172|NCT00953680|6062898|P2|NOT COMPLETED|Period 2||0
2472173|NCT00953680|6062899|P1|NOT COMPLETED|Period 2||0
2472174|NCT00953680|6062898|P2|COMPLETED|Period 2||38
2472175|NCT00953680|6062899|P1|COMPLETED|Period 2||38
2472176|NCT00953680|6062898|P2|STARTED|Period 2||38
2472177|NCT00953680|6062899|P1|STARTED|Period 2||38
2472178|NCT00953680|6062898|P2|NOT COMPLETED|Period 1||1
2472179|NCT00953680|6062899|P1|NOT COMPLETED|Period 1||0
2472180|NCT00953680|6062898|P2|COMPLETED|Period 1||38
2472181|NCT00953680|6062899|P1|COMPLETED|Period 1||38
2472182|NCT00953680|6062898|P2|STARTED|Period 1||39
2472183|NCT00953680|6062899|P1|STARTED|Period 1||38
2472184|NCT00953667|6062911|P1|NOT COMPLETED|Overall Study||123
2472185|NCT00953667|6062911|P1|COMPLETED|Overall Study||277
2472186|NCT00953667|6062911|P1|STARTED|Overall Study||400
2472187|NCT00953654|6062919|P3|NOT COMPLETED|Overall Study||0
2472188|NCT00953654|6062920|P2|NOT COMPLETED|Overall Study||0
2472189|NCT00953654|6062921|P1|NOT COMPLETED|Overall Study||0
2472190|NCT00953654|6062919|P3|COMPLETED|Overall Study||10
2472191|NCT00953654|6062920|P2|COMPLETED|Overall Study||10
2472192|NCT00953654|6062921|P1|COMPLETED|Overall Study||10
2472193|NCT00953654|6062919|P3|STARTED|Overall Study||10
2472194|NCT00953654|6062920|P2|STARTED|Overall Study||10
2472195|NCT00953654|6062921|P1|STARTED|Overall Study||10
2472196|NCT00953615|6062932|P1|NOT COMPLETED|Overall Study||1
2472197|NCT00953615|6062932|P1|COMPLETED|Overall Study||0
2472198|NCT00953615|6062932|P1|STARTED|Overall Study||1
2472199|NCT00953576|6062941|P2|NOT COMPLETED|Overall Study||1
2472200|NCT00953576|6062942|P1|NOT COMPLETED|Overall Study||2
2472201|NCT00953576|6062941|P2|COMPLETED|Overall Study||4
2472202|NCT00953576|6062942|P1|COMPLETED|Overall Study|One participant enrolled on dose level 1 did not receive full dose ketoconazole and was replaced.|4
2472203|NCT00953576|6062941|P2|Pharmacokinetic (PK) Evaluable|Overall Study||3
2472204|NCT00953576|6062942|P1|Pharmacokinetic (PK) Evaluable|Overall Study||4
2472205|NCT00953576|6062941|P2|Treated|Overall Study||5
2472206|NCT00953576|6062942|P1|Treated|Overall Study||4
2472207|NCT00953576|6062941|P2|DLT Evaluable|Overall Study||5
2472208|NCT00953576|6062942|P1|DLT Evaluable|Overall Study||3
2472209|NCT00953576|6062941|P2|STARTED|Overall Study||5
2472210|NCT00953576|6062942|P1|STARTED|Overall Study||6
2472211|NCT00953524|6062957|P4|NOT COMPLETED|Overall Study||8
2472212|NCT00953524|6062958|P3|NOT COMPLETED|Overall Study||14
2472213|NCT00953524|6062959|P2|NOT COMPLETED|Overall Study||15
2472214|NCT00953524|6062960|P1|NOT COMPLETED|Overall Study||22
2472215|NCT00953524|6062957|P4|COMPLETED|Overall Study||91
2472216|NCT00953524|6062958|P3|COMPLETED|Overall Study||233
2472217|NCT00953524|6062959|P2|COMPLETED|Overall Study||239
2472218|NCT00953524|6062960|P1|COMPLETED|Overall Study||227
2472219|NCT00953524|6062957|P4|STARTED|Overall Study||99
2472220|NCT00953524|6062958|P3|STARTED|Overall Study||247
2472221|NCT00953524|6062959|P2|STARTED|Overall Study||254
2472222|NCT00953524|6062960|P1|STARTED|Overall Study||249
2472223|NCT00953407|6063003|P5|NOT COMPLETED|Overall Study||1
2472224|NCT00953407|6063004|P4|NOT COMPLETED|Overall Study||2
2472225|NCT00953407|6063005|P3|NOT COMPLETED|Overall Study||1
2472226|NCT00953407|6063006|P2|NOT COMPLETED|Overall Study||1
2472227|NCT00953407|6063007|P1|NOT COMPLETED|Overall Study||1
2472228|NCT00953407|6063003|P5|COMPLETED|Overall Study||23
2472229|NCT00953407|6063004|P4|COMPLETED|Overall Study||23
2472230|NCT00953407|6063005|P3|COMPLETED|Overall Study||25
2472231|NCT00953407|6063006|P2|COMPLETED|Overall Study||24
2472232|NCT00953407|6063007|P1|COMPLETED|Overall Study||25
2472233|NCT00953407|6063003|P5|STARTED|Overall Study||24
2472234|NCT00953407|6063004|P4|STARTED|Overall Study||25
2472235|NCT00953407|6063005|P3|STARTED|Overall Study||26
2472236|NCT00953407|6063006|P2|STARTED|Overall Study||25
2472237|NCT00953407|6063007|P1|STARTED|Overall Study||26
2472238|NCT00953329|6063019|P1|NOT COMPLETED|Overall Study||1
2472239|NCT00953329|6063019|P1|COMPLETED|Overall Study||0
2472240|NCT00953329|6063019|P1|STARTED|Overall Study||1
2472241|NCT00953290|6063023|P1|NOT COMPLETED|Overall Study||0
2472242|NCT00953290|6063023|P1|COMPLETED|Overall Study||4
2472243|NCT00953290|6063023|P1|STARTED|Overall Study||4
2472244|NCT00953225|6063032|P2|NOT COMPLETED|Overall Study||0
2472245|NCT00953225|6063033|P1|NOT COMPLETED|Overall Study||2
2472246|NCT00953225|6063032|P2|COMPLETED|Overall Study||37
2472247|NCT00953225|6063033|P1|COMPLETED|Overall Study||44
2472248|NCT00953225|6063032|P2|STARTED|Overall Study||37
2472249|NCT00953225|6063033|P1|STARTED|Overall Study||46
2472250|NCT00953212|6063045|P4|NOT COMPLETED|Overall Study||0
2472251|NCT00953212|6063046|P3|NOT COMPLETED|Overall Study||0
2472252|NCT00953212|6063047|P2|NOT COMPLETED|Overall Study||0
2472253|NCT00953212|6063048|P1|NOT COMPLETED|Overall Study||0
2472254|NCT00953212|6063045|P4|COMPLETED|Overall Study||76
2472255|NCT00953212|6063046|P3|COMPLETED|Overall Study||78
2472256|NCT00953212|6063047|P2|COMPLETED|Overall Study||74
2472257|NCT00953212|6063048|P1|COMPLETED|Overall Study||76
2472258|NCT00953212|6063045|P4|STARTED|Overall Study||76
2472259|NCT00953212|6063046|P3|STARTED|Overall Study||78
2472260|NCT00953212|6063047|P2|STARTED|Overall Study||74
2472261|NCT00953212|6063048|P1|STARTED|Overall Study||76
2472262|NCT00953199|6063104|P2|NOT COMPLETED|Overall Study||0
2472263|NCT00953199|6063105|P1|NOT COMPLETED|Overall Study||0
2472264|NCT00953199|6063104|P2|COMPLETED|Overall Study||252
2472265|NCT00953199|6063105|P1|COMPLETED|Overall Study||254
2472266|NCT00953199|6063104|P2|STARTED|Overall Study||252
2472267|NCT00953199|6063105|P1|STARTED|Overall Study||254
2472268|NCT00953173|6063113|P1|NOT COMPLETED|Overall Study||282
2472269|NCT00953173|6063113|P1|COMPLETED|Overall Study||389
2472270|NCT00953173|6063113|P1|STARTED|Overall Study||671
2472271|NCT00953160|6063117|P1|NOT COMPLETED|Overall Study||27
2472272|NCT00953160|6063117|P1|COMPLETED|Overall Study||49
2472273|NCT00953160|6063117|P1|STARTED|Overall Study||76
2472274|NCT00953147|6063126|P3|NOT COMPLETED|Overall Study||42
2472275|NCT00953147|6063127|P2|NOT COMPLETED|Overall Study||66
2472276|NCT00953147|6063128|P1|NOT COMPLETED|Overall Study||37
2472277|NCT00953147|6063126|P3|COMPLETED|Overall Study||265
2472278|NCT00953147|6063127|P2|COMPLETED|Overall Study||439
2472279|NCT00953147|6063128|P1|COMPLETED|Overall Study||261
2472280|NCT00953147|6063126|P3|STARTED|Overall Study||307
2472281|NCT00953147|6063127|P2|STARTED|Overall Study||505
2472282|NCT00953147|6063128|P1|STARTED|Overall Study||298
2472283|NCT00953121|6063178|P3|NOT COMPLETED|Overall Study||0
2472284|NCT00953121|6063179|P2|NOT COMPLETED|Overall Study||0
2472285|NCT00953121|6063180|P1|NOT COMPLETED|Overall Study||0
2472286|NCT00953121|6063178|P3|COMPLETED|Overall Study||25
2472287|NCT00953121|6063179|P2|COMPLETED|Overall Study||39
2472288|NCT00953121|6063180|P1|COMPLETED|Overall Study||40
2472289|NCT00953121|6063178|P3|STARTED|Overall Study||25
2472290|NCT00953121|6063179|P2|STARTED|Overall Study||39
2472291|NCT00953121|6063180|P1|STARTED|Overall Study||40
2472292|NCT00953056|6063206|P6|NOT COMPLETED|Overall Study||4
2472293|NCT00953056|6063207|P5|NOT COMPLETED|Overall Study||2
2472294|NCT00953056|6063208|P4|NOT COMPLETED|Overall Study||0
2472295|NCT00953056|6063209|P3|NOT COMPLETED|Overall Study||0
2472296|NCT00953056|6063210|P2|NOT COMPLETED|Overall Study||0
2472297|NCT00953056|6063211|P1|NOT COMPLETED|Overall Study||0
2472298|NCT00953056|6063206|P6|COMPLETED|Overall Study||20
2472299|NCT00953056|6063207|P5|COMPLETED|Overall Study|One participant received placebo at the second dose in error, but completed the study.|22
2472300|NCT00953056|6063208|P4|COMPLETED|Overall Study||24
2472301|NCT00953056|6063209|P3|COMPLETED|Overall Study||24
2472302|NCT00953056|6063210|P2|COMPLETED|Overall Study||24
2472303|NCT00953056|6063211|P1|COMPLETED|Overall Study||24
2472304|NCT00953056|6063206|P6|STARTED|Overall Study||24
2472305|NCT00953056|6063207|P5|STARTED|Overall Study||24
2472306|NCT00953056|6063208|P4|STARTED|Overall Study||24
2472307|NCT00953056|6063209|P3|STARTED|Overall Study||24
2472308|NCT00953056|6063210|P2|STARTED|Overall Study||24
2472309|NCT00953056|6063211|P1|STARTED|Overall Study||24
2472310|NCT00953043|6063235|P2|NOT COMPLETED|Overall Study||2
2472311|NCT00953043|6063236|P1|NOT COMPLETED|Overall Study||4
2472312|NCT00953043|6063235|P2|COMPLETED|Overall Study||28
2472313|NCT00953043|6063236|P1|COMPLETED|Overall Study||26
2472314|NCT00953043|6063235|P2|STARTED|Overall Study||30
2472315|NCT00953043|6063236|P1|STARTED|Overall Study||30
2472316|NCT00953017|6063260|P4|NOT COMPLETED|Overall Study||5
2472317|NCT00953017|6063261|P3|NOT COMPLETED|Overall Study||6
2472318|NCT00953017|6063262|P2|NOT COMPLETED|Overall Study||6
2472319|NCT00953017|6063263|P1|NOT COMPLETED|Overall Study||5
2472320|NCT00953017|6063260|P4|COMPLETED|Overall Study||101
2472321|NCT00953017|6063261|P3|COMPLETED|Overall Study||100
2472322|NCT00953017|6063262|P2|COMPLETED|Overall Study||101
2472323|NCT00953017|6063263|P1|COMPLETED|Overall Study||101
2472324|NCT00953017|6063260|P4|STARTED|Overall Study||106
2472325|NCT00953017|6063261|P3|STARTED|Overall Study||106
2472326|NCT00953017|6063262|P2|STARTED|Overall Study||107
2472327|NCT00953017|6063263|P1|STARTED|Overall Study||106
2472328|NCT00952848|6063285|P1|NOT COMPLETED|Overall Study||4
2472329|NCT00952848|6063285|P1|COMPLETED|Overall Study||14
2472330|NCT00952848|6063285|P1|STARTED|Overall Study||18
2472331|NCT00952822|6063292|P4|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
2472332|NCT00952822|6063293|P3|NOT COMPLETED|2nd Pharmacokinetic Evaluation||1
2472333|NCT00952822|6063294|P2|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
2472334|NCT00952822|6063295|P1|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
2472335|NCT00952822|6063292|P4|COMPLETED|2nd Pharmacokinetic Evaluation||4
2472336|NCT00952822|6063293|P3|COMPLETED|2nd Pharmacokinetic Evaluation||10
2472337|NCT00952822|6063294|P2|COMPLETED|2nd Pharmacokinetic Evaluation||17
2472338|NCT00952822|6063295|P1|COMPLETED|2nd Pharmacokinetic Evaluation||9
2472339|NCT00952822|6063292|P4|STARTED|2nd Pharmacokinetic Evaluation||4
2472340|NCT00952822|6063293|P3|STARTED|2nd Pharmacokinetic Evaluation||11
2472341|NCT00952822|6063294|P2|STARTED|2nd Pharmacokinetic Evaluation||17
2472342|NCT00952822|6063295|P1|STARTED|2nd Pharmacokinetic Evaluation||9
2472343|NCT00952822|6063292|P4|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
2472344|NCT00952822|6063293|P3|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
2472345|NCT00952822|6063294|P2|NOT COMPLETED|1st Pharmacokinetic Evaluation||1
2472346|NCT00952822|6063295|P1|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
2472347|NCT00952822|6063292|P4|COMPLETED|1st Pharmacokinetic Evaluation||4
2472348|NCT00952822|6063293|P3|COMPLETED|1st Pharmacokinetic Evaluation||11
2472349|NCT00952822|6063294|P2|COMPLETED|1st Pharmacokinetic Evaluation||17
2472350|NCT00952822|6063295|P1|COMPLETED|1st Pharmacokinetic Evaluation||9
2472351|NCT00952822|6063292|P4|STARTED|1st Pharmacokinetic Evaluation||4
2472352|NCT00952822|6063293|P3|STARTED|1st Pharmacokinetic Evaluation||11
2472353|NCT00952822|6063294|P2|STARTED|1st Pharmacokinetic Evaluation||18
2472354|NCT00952822|6063295|P1|STARTED|1st Pharmacokinetic Evaluation||9
2472355|NCT00952731|6063327|P2|NOT COMPLETED|Overall Study||0
2472356|NCT00952731|6063328|P1|NOT COMPLETED|Overall Study||1
2472357|NCT00952731|6063327|P2|COMPLETED|Overall Study||14
2472358|NCT00952731|6063328|P1|COMPLETED|Overall Study||12
2472359|NCT00952731|6063327|P2|Follow-up|Overall Study||14
2472360|NCT00952731|6063328|P1|Follow-up|Overall Study||12
2472361|NCT00952731|6063327|P2|Surgery|Overall Study||14
2472362|NCT00952731|6063328|P1|Surgery|Overall Study||12
2472363|NCT00952731|6063327|P2|Treatment & Pre-Surgery|Overall Study||14
2472364|NCT00952731|6063328|P1|Treatment & Pre-Surgery|Overall Study||12
2472365|NCT00952731|6063327|P2|Randomization|Overall Study||14
2472366|NCT00952731|6063328|P1|Randomization|Overall Study||13
2472367|NCT00952731|6063327|P2|STARTED|Overall Study||14
2472368|NCT00952731|6063328|P1|STARTED|Overall Study||13
2472369|NCT00952718|6063346|P2|NOT COMPLETED|Overall Study||6
2472370|NCT00952718|6063347|P1|NOT COMPLETED|Overall Study||6
2472371|NCT00952718|6063346|P2|COMPLETED|Overall Study||13
2472372|NCT00952718|6063347|P1|COMPLETED|Overall Study||13
2472373|NCT00952718|6063346|P2|STARTED|Overall Study||19
2472374|NCT00952718|6063347|P1|STARTED|Overall Study||19
2472375|NCT00952705|6063360|P3|NOT COMPLETED|Overall Study||10
2472376|NCT00952705|6063361|P2|NOT COMPLETED|Overall Study||10
2472377|NCT00952705|6063362|P1|NOT COMPLETED|Overall Study||33
2472378|NCT00952705|6063360|P3|COMPLETED|Overall Study||288
2472379|NCT00952705|6063361|P2|COMPLETED|Overall Study||290
2472380|NCT00952705|6063362|P1|COMPLETED|Overall Study||1169
2472381|NCT00952705|6063360|P3|STARTED|Overall Study||298
2472382|NCT00952705|6063361|P2|STARTED|Overall Study||300
2472383|NCT00952705|6063362|P1|STARTED|Overall Study|Three not treated with Q/LAIV-BFS (1 treated with FluMist/B/Yamagata; 2 withdrew prior to dosing).|1202
2472384|NCT00952653|6063424|P1|NOT COMPLETED|Period 2: Coadministration DVS SR, MDZ||0
2472385|NCT00952653|6063424|P1|COMPLETED|Period 2: Coadministration DVS SR, MDZ||28
2472386|NCT00952653|6063424|P1|STARTED|Period 2: Coadministration DVS SR, MDZ||28
2472387|NCT00952653|6063424|P1|NOT COMPLETED|Period 1: MDZ Alone||0
2472388|NCT00952653|6063424|P1|COMPLETED|Period 1: MDZ Alone||28
2472389|NCT00952653|6063424|P1|STARTED|Period 1: MDZ Alone||28
2472390|NCT00952614|6063449|P1|NOT COMPLETED|Overall Study||7
2472391|NCT00952614|6063449|P1|COMPLETED|Overall Study|3 subjects died from unrelated causes, 3 were lost to follow-up & 1 had both eyes included in study.|23
2472392|NCT00952614|6063449|P1|Participants Started Treatment|Overall Study|29 subjects signed consent; 1 agreed for both eyes to enroll. 30 eyes rec'd drug delivery implant|30
2472393|NCT00952614|6063449|P1|STARTED|Overall Study||30
2472400|NCT00952523|6063475|P1|NOT COMPLETED|Overall Study||7
2472401|NCT00952523|6063475|P1|COMPLETED|Overall Study||155
2472402|NCT00952523|6063475|P1|STARTED|Overall Study||162
2472403|NCT00952484|6063484|P3|NOT COMPLETED|Overall Study||0
2472404|NCT00952484|6063485|P2|NOT COMPLETED|Overall Study||1
2472405|NCT00952484|6063486|P1|NOT COMPLETED|Overall Study||0
2472406|NCT00952484|6063484|P3|COMPLETED|Overall Study||16
2472407|NCT00952484|6063485|P2|COMPLETED|Overall Study||6
2472408|NCT00952484|6063486|P1|COMPLETED|Overall Study||6
2472409|NCT00952484|6063484|P3|STARTED|Overall Study||16
2472410|NCT00952484|6063485|P2|STARTED|Overall Study||7
2472411|NCT00952484|6063486|P1|STARTED|Overall Study||6
2472412|NCT00952419|6063513|P3|NOT COMPLETED|Overall Study||0
2472413|NCT00952419|6063514|P2|NOT COMPLETED|Overall Study||10
2472414|NCT00952419|6063515|P1|NOT COMPLETED|Overall Study||6
2472415|NCT00952419|6063513|P3|COMPLETED|Overall Study||51
2472416|NCT00952419|6063514|P2|COMPLETED|Overall Study||198
2472417|NCT00952419|6063515|P1|COMPLETED|Overall Study||209
2472418|NCT00952419|6063513|P3|STARTED|Overall Study||51
2472419|NCT00952419|6063514|P2|STARTED|Overall Study||208
2472420|NCT00952419|6063515|P1|STARTED|Overall Study||215
2472421|NCT00952393|6063547|P1|NOT COMPLETED|Overall Study||0
2472422|NCT00952393|6063547|P1|COMPLETED|Overall Study||10
2472423|NCT00952393|6063547|P1|STARTED|Overall Study|10|10
2472424|NCT00952380|6063556|P5|NOT COMPLETED|Overall Study||6
2472425|NCT00952380|6063557|P4|NOT COMPLETED|Overall Study||3
2472426|NCT00952380|6063558|P3|NOT COMPLETED|Overall Study||2
2472427|NCT00952380|6063559|P2|NOT COMPLETED|Overall Study||1
2472428|NCT00952380|6063560|P1|NOT COMPLETED|Overall Study||0
2472429|NCT00952380|6063556|P5|COMPLETED|Overall Study||14
2472430|NCT00952380|6063557|P4|COMPLETED|Overall Study||4
2472431|NCT00952380|6063558|P3|COMPLETED|Overall Study||6
2472432|NCT00952380|6063559|P2|COMPLETED|Overall Study||1
2472433|NCT00952380|6063560|P1|COMPLETED|Overall Study||1
2472434|NCT00952380|6063556|P5|STARTED|Overall Study||20
2472435|NCT00952380|6063557|P4|STARTED|Overall Study||7
2472436|NCT00952380|6063558|P3|STARTED|Overall Study||8
2472437|NCT00952380|6063559|P2|STARTED|Overall Study||2
2472438|NCT00952380|6063560|P1|STARTED|Overall Study||1
2472439|NCT00952367|6063661|P1|NOT COMPLETED|Overall Study||6
2472440|NCT00952367|6063661|P1|COMPLETED|Overall Study||3635
2472441|NCT00952367|6063661|P1|STARTED|Overall Study||3641
2472442|NCT00952341|6063676|P2|NOT COMPLETED|Cycle 2||12
2472443|NCT00952341|6063677|P1|NOT COMPLETED|Cycle 2||9
2472444|NCT00952341|6063676|P2|COMPLETED|Cycle 2||118
2472445|NCT00952341|6063677|P1|COMPLETED|Cycle 2||101
2472446|NCT00952341|6063676|P2|STARTED|Cycle 2||130
2472447|NCT00952341|6063677|P1|STARTED|Cycle 2||110
2472448|NCT00952341|6063676|P2|NOT COMPLETED|Cycle 1||13
2472449|NCT00952341|6063677|P1|NOT COMPLETED|Cycle 1||20
2472450|NCT00952341|6063676|P2|COMPLETED|Cycle 1||199
2472451|NCT00952341|6063677|P1|COMPLETED|Cycle 1||189
2472452|NCT00952341|6063676|P2|STARTED|Cycle 1||212
2472453|NCT00952341|6063677|P1|STARTED|Cycle 1||209
2472454|NCT00952315|6063700|P3|NOT COMPLETED|Overall Study||19
2472455|NCT00952315|6063701|P2|NOT COMPLETED|Overall Study||24
2472456|NCT00952315|6063702|P1|NOT COMPLETED|Overall Study||26
2472457|NCT00952315|6063700|P3|COMPLETED|Overall Study||71
2472458|NCT00952315|6063701|P2|COMPLETED|Overall Study||66
2472459|NCT00952315|6063702|P1|COMPLETED|Overall Study||64
2472460|NCT00952315|6063700|P3|STARTED|Overall Study||90
2472461|NCT00952315|6063701|P2|STARTED|Overall Study||90
2472462|NCT00952315|6063702|P1|STARTED|Overall Study||90
2472463|NCT00952289|6063739|P2|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||54
2472464|NCT00952289|6063740|P1|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
2472465|NCT00952289|6063739|P2|COMPLETED|Patients Who Crossed Over to Ruxolitinib|Number of cross over subjects who were still in the study as of 25 JAN 2013|57
2472466|NCT00952289|6063740|P1|COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
2472467|NCT00952289|6063739|P2|STARTED|Patients Who Crossed Over to Ruxolitinib||111
2472468|NCT00952289|6063740|P1|STARTED|Patients Who Crossed Over to Ruxolitinib||0
2472469|NCT00952289|6063739|P2|NOT COMPLETED|All Participants||40
2472470|NCT00952289|6063740|P1|NOT COMPLETED|All Participants||21
2472471|NCT00952289|6063739|P2|COMPLETED|All Participants|Includes patients in the study as of 2 November 2010 (78) + those who crossed over to Ruxolitinib.|114
2472472|NCT00952289|6063740|P1|COMPLETED|All Participants|Represents the number of patients who were still in the study as of 02 November 2010|134
2472473|NCT00952289|6063739|P2|Safety Population|All Participants|Randomized patients who are documented to have received at least 1 dose of study medication.|151
2472474|NCT00952289|6063740|P1|Safety Population|All Participants||155
2472475|NCT00952289|6063739|P2|STARTED|All Participants||154
2472476|NCT00952289|6063740|P1|STARTED|All Participants||155
2472477|NCT00952276|6063769|P5|NOT COMPLETED|Overall Study||0
2472478|NCT00952276|6063770|P4|NOT COMPLETED|Overall Study||1
2472479|NCT00952276|6063771|P3|NOT COMPLETED|Overall Study||0
2472480|NCT00952276|6063772|P2|NOT COMPLETED|Overall Study||0
2472481|NCT00952276|6063773|P1|NOT COMPLETED|Overall Study||1
2472482|NCT00952276|6063769|P5|COMPLETED|Overall Study||63
2472483|NCT00952276|6063770|P4|COMPLETED|Overall Study||120
2472484|NCT00952276|6063771|P3|COMPLETED|Overall Study||122
2472485|NCT00952276|6063772|P2|COMPLETED|Overall Study||115
2472486|NCT00952276|6063773|P1|COMPLETED|Overall Study||126
2472487|NCT00952276|6063769|P5|STARTED|Overall Study||63
2472488|NCT00952276|6063770|P4|STARTED|Overall Study||121
2472489|NCT00952276|6063771|P3|STARTED|Overall Study||122
2472490|NCT00952276|6063772|P2|STARTED|Overall Study||115
2472491|NCT00952276|6063773|P1|STARTED|Overall Study||127
2472492|NCT00952211|6063822|P2|NOT COMPLETED|Overall Study||0
2472493|NCT00952211|6063823|P1|NOT COMPLETED|Overall Study||0
2472494|NCT00952211|6063822|P2|COMPLETED|Overall Study||0
2472495|NCT00952211|6063823|P1|COMPLETED|Overall Study||3
2472496|NCT00952211|6063822|P2|STARTED|Overall Study||0
2472497|NCT00952211|6063823|P1|STARTED|Overall Study||3
2472498|NCT00952133|6063833|P2|NOT COMPLETED|Overall Study||0
2472499|NCT00952133|6063834|P1|NOT COMPLETED|Overall Study||0
2472500|NCT00952133|6063833|P2|COMPLETED|Overall Study||59
2472501|NCT00952133|6063834|P1|COMPLETED|Overall Study||59
2472502|NCT00952133|6063833|P2|STARTED|Overall Study||59
2472503|NCT00952133|6063834|P1|STARTED|Overall Study||59
2472504|NCT00952120|6063845|P3|NOT COMPLETED|Overall Study||0
2472505|NCT00952120|6063846|P2|NOT COMPLETED|Overall Study||0
2472506|NCT00952120|6063847|P1|NOT COMPLETED|Overall Study||0
2472507|NCT00952120|6063845|P3|COMPLETED|Overall Study||5
2472508|NCT00952120|6063846|P2|COMPLETED|Overall Study||47
2472509|NCT00952120|6063847|P1|COMPLETED|Overall Study||52
2472510|NCT00952120|6063845|P3|STARTED|Overall Study||5
2472511|NCT00952120|6063846|P2|STARTED|Overall Study||47
2472512|NCT00952120|6063847|P1|STARTED|Overall Study||52
2472513|NCT00952081|6063855|P1|NOT COMPLETED|Overall Study||0
2472514|NCT00952081|6063855|P1|COMPLETED|Overall Study||22
2472515|NCT00952081|6063855|P1|STARTED|Overall Study||22
2472516|NCT00952068|6063859|P1|NOT COMPLETED|Overall Study||7
2472517|NCT00952068|6063859|P1|COMPLETED|Overall Study||40
2472518|NCT00952068|6063859|P1|STARTED|Overall Study||47
2472519|NCT00951912|6063870|P3|NOT COMPLETED|Overall Study||2
2472520|NCT00951912|6063871|P2|NOT COMPLETED|Overall Study||5
2472521|NCT00951912|6063872|P1|NOT COMPLETED|Overall Study||7
2472522|NCT00951912|6063870|P3|COMPLETED|Overall Study||54
2472523|NCT00951912|6063871|P2|COMPLETED|Overall Study||50
2472524|NCT00951912|6063872|P1|COMPLETED|Overall Study||47
2472525|NCT00951912|6063870|P3|STARTED|Overall Study||56
2472526|NCT00951912|6063871|P2|STARTED|Overall Study||55
2472527|NCT00951912|6063872|P1|STARTED|Overall Study||54
2472528|NCT00951899|6063924|P2|NOT COMPLETED|Overall Study||0
2472529|NCT00951899|6063925|P1|NOT COMPLETED|Overall Study||0
2472530|NCT00951899|6063924|P2|COMPLETED|Overall Study||19
2472531|NCT00951899|6063925|P1|COMPLETED|Overall Study||19
2472532|NCT00951899|6063924|P2|STARTED|Overall Study||19
2472533|NCT00951899|6063925|P1|STARTED|Overall Study||19
2472534|NCT00951821|6063949|P2|NOT COMPLETED|Overall Study||0
2472535|NCT00951821|6063950|P1|NOT COMPLETED|Overall Study||0
2472536|NCT00951821|6063949|P2|COMPLETED|Overall Study||8
2472537|NCT00951821|6063950|P1|COMPLETED|Overall Study||16
2472538|NCT00951821|6063949|P2|STARTED|Overall Study||8
2472539|NCT00951821|6063950|P1|STARTED|Overall Study||16
2472540|NCT00951808|6063958|P3|NOT COMPLETED|Overall Study||4
2472541|NCT00951808|6063959|P2|NOT COMPLETED|Overall Study||0
2472542|NCT00951808|6063960|P1|NOT COMPLETED|Overall Study||0
2472543|NCT00951808|6063958|P3|COMPLETED|Overall Study|Four subjects withdrew from the study.|223
2472544|NCT00951808|6063959|P2|COMPLETED|Overall Study||6
2472545|NCT00951808|6063960|P1|COMPLETED|Overall Study||4
2472546|NCT00951808|6063958|P3|STARTED|Overall Study||227
2472547|NCT00951808|6063959|P2|STARTED|Overall Study||6
2472548|NCT00951808|6063960|P1|STARTED|Overall Study||4
2472549|NCT00951665|6063972|P6|NOT COMPLETED|Phase 2a||7
2472550|NCT00951665|6063973|P5|NOT COMPLETED|Phase 2a||12
2472551|NCT00951665|6063974|P4|NOT COMPLETED|Phase 2a||0
2472552|NCT00951665|6063975|P3|NOT COMPLETED|Phase 2a||0
2472553|NCT00951665|6063976|P2|NOT COMPLETED|Phase 2a||0
2472554|NCT00951665|6063977|P1|NOT COMPLETED|Phase 2a||0
2472555|NCT00951665|6063972|P6|COMPLETED|Phase 2a||15
2472556|NCT00951665|6063973|P5|COMPLETED|Phase 2a||10
2472557|NCT00951665|6063974|P4|COMPLETED|Phase 2a||0
2472558|NCT00951665|6063975|P3|COMPLETED|Phase 2a||0
2472559|NCT00951665|6063976|P2|COMPLETED|Phase 2a||0
2472560|NCT00951665|6063977|P1|COMPLETED|Phase 2a||0
2472561|NCT00951665|6063972|P6|STARTED|Phase 2a||22
2472562|NCT00951665|6063973|P5|STARTED|Phase 2a||22
2472563|NCT00951665|6063974|P4|STARTED|Phase 2a||0
2472564|NCT00951665|6063975|P3|STARTED|Phase 2a||0
2472565|NCT00951665|6063976|P2|STARTED|Phase 2a||0
2472566|NCT00951665|6063977|P1|STARTED|Phase 2a||0
2472567|NCT00951665|6063972|P6|NOT COMPLETED|Phase 1b||0
2472568|NCT00951665|6063973|P5|NOT COMPLETED|Phase 1b||0
2472569|NCT00951665|6063974|P4|NOT COMPLETED|Phase 1b||1
2472570|NCT00951665|6063975|P3|NOT COMPLETED|Phase 1b||17
2472571|NCT00951665|6063976|P2|NOT COMPLETED|Phase 1b||4
2472572|NCT00951665|6063977|P1|NOT COMPLETED|Phase 1b||22
2472573|NCT00951665|6063972|P6|COMPLETED|Phase 1b||0
2472574|NCT00951665|6063973|P5|COMPLETED|Phase 1b||0
2472575|NCT00951665|6063974|P4|COMPLETED|Phase 1b||2
2472576|NCT00951665|6063975|P3|COMPLETED|Phase 1b||4
2472577|NCT00951665|6063976|P2|COMPLETED|Phase 1b||6
2472578|NCT00951665|6063977|P1|COMPLETED|Phase 1b||7
2472579|NCT00951665|6063972|P6|Started Treatment|Phase 1b||0
2472580|NCT00951665|6063973|P5|Started Treatment|Phase 1b||0
2472581|NCT00951665|6063974|P4|Started Treatment|Phase 1b||3
2472582|NCT00951665|6063975|P3|Started Treatment|Phase 1b||21
2472583|NCT00951665|6063976|P2|Started Treatment|Phase 1b||10
2472584|NCT00951665|6063977|P1|Started Treatment|Phase 1b||26
2472585|NCT00951665|6063972|P6|STARTED|Phase 1b||0
2472586|NCT00951665|6063973|P5|STARTED|Phase 1b||0
2472587|NCT00951665|6063974|P4|STARTED|Phase 1b||3
2472588|NCT00951665|6063975|P3|STARTED|Phase 1b||21
2472589|NCT00951665|6063976|P2|STARTED|Phase 1b||10
2472590|NCT00951665|6063977|P1|STARTED|Phase 1b||29
2472591|NCT00951561|6064078|P4|NOT COMPLETED|Overall Study||1
2472592|NCT00951561|6064079|P3|NOT COMPLETED|Overall Study||3
2472593|NCT00951561|6064080|P2|NOT COMPLETED|Overall Study||0
2472594|NCT00951561|6064081|P1|NOT COMPLETED|Overall Study||0
2472595|NCT00951561|6064078|P4|COMPLETED|Overall Study|1 subject dropped after period 2|26
2472596|NCT00951561|6064079|P3|COMPLETED|Overall Study|3 subjects dropped after period 2|18
2472597|NCT00951561|6064080|P2|COMPLETED|Overall Study||29
2472598|NCT00951561|6064081|P1|COMPLETED|Overall Study||25
2472599|NCT00951561|6064078|P4|STARTED|Overall Study||27
2472600|NCT00951561|6064079|P3|STARTED|Overall Study|1 subject used Vipon periods 1 & 2 instead of Ibuprofen period 2.|21
2472601|NCT00951561|6064080|P2|STARTED|Overall Study||29
2472602|NCT00951561|6064081|P1|STARTED|Overall Study|Randomized Vipon or Ibuprofen period 1, crossover period 2, randomized period 3, crossover period 4|25
2472603|NCT00951509|6064086|P1|NOT COMPLETED|Overall Study||2
2472604|NCT00951509|6064086|P1|COMPLETED|Overall Study||29
2472605|NCT00951509|6064086|P1|Driving Condition 5|Overall Study||30
2472606|NCT00951509|6064086|P1|Driving Condition 4|Overall Study||28
2472607|NCT00951509|6064086|P1|Driving Condition 3|Overall Study||25
2472608|NCT00951509|6064086|P1|Driving Condition 2|Overall Study||29
2472609|NCT00951509|6064086|P1|Driving Condition 1|Overall Study||29
2472610|NCT00951509|6064086|P1|STARTED|Overall Study||31
2472620|NCT00951483|6064127|P2|NOT COMPLETED|Overall Study||0
2472621|NCT00951483|6064128|P1|NOT COMPLETED|Overall Study||19
2472622|NCT00951483|6064127|P2|COMPLETED|Overall Study||44
2472623|NCT00951483|6064128|P1|COMPLETED|Overall Study||28
2472624|NCT00951483|6064127|P2|STARTED|Overall Study||44
2472625|NCT00951483|6064128|P1|STARTED|Overall Study||47
2472626|NCT00951379|6064148|P2|NOT COMPLETED|Overall Study||2
2472627|NCT00951379|6064149|P1|NOT COMPLETED|Overall Study||6
2472628|NCT00951379|6064148|P2|COMPLETED|Overall Study||23
2472629|NCT00951379|6064149|P1|COMPLETED|Overall Study||21
2472630|NCT00951379|6064148|P2|STARTED|Overall Study||25
2472631|NCT00951379|6064149|P1|STARTED|Overall Study||27
2472632|NCT00951275|6064191|P1|NOT COMPLETED|Overall Study||13
2472633|NCT00951275|6064191|P1|COMPLETED|Overall Study||92
2472634|NCT00951275|6064191|P1|STARTED|Overall Study||105
2472635|NCT00951171|6064223|P2|NOT COMPLETED|Overall Study||0
2472636|NCT00951171|6064224|P1|NOT COMPLETED|Overall Study||2
2472637|NCT00951171|6064223|P2|COMPLETED|Overall Study|2 of the cervical occlusion group transferred to standard group because of pain during attempted IUI|55
2472638|NCT00951171|6064224|P1|COMPLETED|Overall Study||38
2472639|NCT00951171|6064223|P2|Pregnancy|Overall Study||7
2472640|NCT00951171|6064224|P1|Pregnancy|Overall Study||1
2472641|NCT00951171|6064223|P2|STARTED|Overall Study||55
2472642|NCT00951171|6064224|P1|STARTED|Overall Study||40
2472643|NCT00951093|6064230|P1|NOT COMPLETED|6 Months After GBP||0
2472644|NCT00951093|6064230|P1|COMPLETED|6 Months After GBP||53
2472645|NCT00951093|6064230|P1|STARTED|6 Months After GBP||53
2472646|NCT00951093|6064230|P1|NOT COMPLETED|Before GBP||0
2472647|NCT00951093|6064230|P1|COMPLETED|Before GBP||53
2472648|NCT00951093|6064230|P1|STARTED|Before GBP||53
2472649|NCT00951041|6064256|P2|NOT COMPLETED|Overall Study||1
2472650|NCT00951041|6064257|P1|NOT COMPLETED|Overall Study||5
2472651|NCT00951041|6064256|P2|COMPLETED|Overall Study||65
2472652|NCT00951041|6064257|P1|COMPLETED|Overall Study||59
2472653|NCT00951041|6064256|P2|STARTED|Overall Study||66
2472654|NCT00951041|6064257|P1|STARTED|Overall Study||64
2472655|NCT00951015|6064312|P5|NOT COMPLETED|Open-label Phase||50
2472656|NCT00951015|6064313|P4|NOT COMPLETED|Open-label Phase||0
2472657|NCT00951015|6064314|P3|NOT COMPLETED|Open-label Phase||0
2472658|NCT00951015|6064315|P2|NOT COMPLETED|Open-label Phase||0
2472659|NCT00951015|6064316|P1|NOT COMPLETED|Open-label Phase||0
2472660|NCT00951015|6064312|P5|COMPLETED|Open-label Phase||88
2472661|NCT00951015|6064313|P4|COMPLETED|Open-label Phase||0
2472662|NCT00951015|6064314|P3|COMPLETED|Open-label Phase||0
2472663|NCT00951015|6064315|P2|COMPLETED|Open-label Phase||0
2472664|NCT00951015|6064316|P1|COMPLETED|Open-label Phase||0
2472665|NCT00951015|6064312|P5|STARTED|Open-label Phase||138
2472666|NCT00951015|6064313|P4|STARTED|Open-label Phase||0
2472667|NCT00951015|6064314|P3|STARTED|Open-label Phase||0
2472668|NCT00951015|6064315|P2|STARTED|Open-label Phase||0
2472669|NCT00951015|6064316|P1|STARTED|Open-label Phase||0
2472670|NCT00951015|6064312|P5|NOT COMPLETED|Randomization Phase 96 Week||0
2472671|NCT00951015|6064313|P4|NOT COMPLETED|Randomization Phase 96 Week||10
2472672|NCT00951015|6064314|P3|NOT COMPLETED|Randomization Phase 96 Week||5
2472673|NCT00951015|6064315|P2|NOT COMPLETED|Randomization Phase 96 Week||7
2472674|NCT00951015|6064316|P1|NOT COMPLETED|Randomization Phase 96 Week||5
2472675|NCT00951015|6064312|P5|COMPLETED|Randomization Phase 96 Week||0
2472676|NCT00951015|6064313|P4|COMPLETED|Randomization Phase 96 Week||40
2472677|NCT00951015|6064314|P3|COMPLETED|Randomization Phase 96 Week||46
2472678|NCT00951015|6064315|P2|COMPLETED|Randomization Phase 96 Week||44
2472679|NCT00951015|6064316|P1|COMPLETED|Randomization Phase 96 Week||48
2472680|NCT00951015|6064312|P5|STARTED|Randomization Phase 96 Week||0
2472681|NCT00951015|6064313|P4|STARTED|Randomization Phase 96 Week||50
2472682|NCT00951015|6064314|P3|STARTED|Randomization Phase 96 Week||51
2472683|NCT00951015|6064315|P2|STARTED|Randomization Phase 96 Week||51
2472684|NCT00951015|6064316|P1|STARTED|Randomization Phase 96 Week||53
2472685|NCT00950963|6064413|P2|NOT COMPLETED|Overall Study||24
2472686|NCT00950963|6064414|P1|NOT COMPLETED|Overall Study||29
2472687|NCT00950963|6064413|P2|COMPLETED|Overall Study||357
2472688|NCT00950963|6064414|P1|COMPLETED|Overall Study||352
2472689|NCT00950963|6064413|P2|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
2472690|NCT00950963|6064414|P1|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
2472691|NCT00950950|6064430|P2|NOT COMPLETED|Overall Study||1
2472692|NCT00950950|6064431|P1|NOT COMPLETED|Overall Study||1
2472693|NCT00950950|6064430|P2|COMPLETED|Overall Study||11
2472694|NCT00950950|6064431|P1|COMPLETED|Overall Study||11
2472695|NCT00950950|6064430|P2|STARTED|Overall Study||12
2472696|NCT00950950|6064431|P1|STARTED|Overall Study||12
2472697|NCT00950937|6064494|P2|NOT COMPLETED|Overall Study||0
2472698|NCT00950937|6064495|P1|NOT COMPLETED|Overall Study||0
2472699|NCT00950937|6064494|P2|COMPLETED|Overall Study||14
2472700|NCT00950937|6064495|P1|COMPLETED|Overall Study||14
2472701|NCT00950937|6064494|P2|STARTED|Overall Study||14
2472702|NCT00950937|6064495|P1|STARTED|Overall Study||14
2472703|NCT00950911|6064513|P2|NOT COMPLETED|Overall Study||15
2472704|NCT00950911|6064514|P1|NOT COMPLETED|Overall Study||12
2472705|NCT00950911|6064513|P2|COMPLETED|Overall Study||3
2472706|NCT00950911|6064514|P1|COMPLETED|Overall Study||5
2472707|NCT00950911|6064513|P2|STARTED|Overall Study||18
2472708|NCT00950911|6064514|P1|STARTED|Overall Study||17
2472709|NCT00950872|6064520|P1|NOT COMPLETED|Overall Study||3
2472710|NCT00950872|6064520|P1|COMPLETED|Overall Study||26
2472711|NCT00950872|6064520|P1|STARTED|Overall Study||29
2472712|NCT00950859|6064529|P2|NOT COMPLETED|Overall Study||10
2472713|NCT00950859|6064530|P1|NOT COMPLETED|Overall Study||16
2472714|NCT00950859|6064529|P2|COMPLETED|Overall Study||14
2472715|NCT00950859|6064530|P1|COMPLETED|Overall Study||11
2472716|NCT00950859|6064529|P2|STARTED|Overall Study||24
2472717|NCT00950859|6064530|P1|STARTED|Overall Study||27
2472718|NCT00950833|6064573|P3|NOT COMPLETED|Overall Study||0
2472719|NCT00950833|6064574|P2|NOT COMPLETED|Overall Study||0
2472720|NCT00950833|6064575|P1|NOT COMPLETED|Overall Study||0
2472721|NCT00950833|6064573|P3|COMPLETED|Overall Study||223
2472722|NCT00950833|6064574|P2|COMPLETED|Overall Study||108
2472723|NCT00950833|6064575|P1|COMPLETED|Overall Study||112
2472724|NCT00950833|6064573|P3|STARTED|Overall Study||223
2472725|NCT00950833|6064574|P2|STARTED|Overall Study||108
2472726|NCT00950833|6064575|P1|STARTED|Overall Study||112
2472727|NCT00950807|6064629|P10|NOT COMPLETED|Treatment Period 3||1
2472728|NCT00950807|6064630|P9|NOT COMPLETED|Treatment Period 3||0
2472729|NCT00950807|6064631|P8|NOT COMPLETED|Treatment Period 3||1
2472730|NCT00950807|6064632|P7|NOT COMPLETED|Treatment Period 3||1
2472731|NCT00950807|6064633|P6|NOT COMPLETED|Treatment Period 3||0
2472732|NCT00950807|6064634|P5|NOT COMPLETED|Treatment Period 3||0
2472733|NCT00950807|6064635|P4|NOT COMPLETED|Treatment Period 3||0
2472734|NCT00950807|6064636|P3|NOT COMPLETED|Treatment Period 3||0
2472735|NCT00950807|6064637|P2|NOT COMPLETED|Treatment Period 3||0
2472736|NCT00950807|6064638|P1|NOT COMPLETED|Treatment Period 3||1
2472737|NCT00950807|6064629|P10|COMPLETED|Treatment Period 3||10
2472738|NCT00950807|6064630|P9|COMPLETED|Treatment Period 3||9
2472739|NCT00950807|6064631|P8|COMPLETED|Treatment Period 3||9
2472740|NCT00950807|6064632|P7|COMPLETED|Treatment Period 3||11
2472741|NCT00950807|6064633|P6|COMPLETED|Treatment Period 3||9
2472742|NCT00950807|6064634|P5|COMPLETED|Treatment Period 3||12
2472743|NCT00950807|6064635|P4|COMPLETED|Treatment Period 3||11
2472744|NCT00950807|6064636|P3|COMPLETED|Treatment Period 3||10
2472745|NCT00950807|6064637|P2|COMPLETED|Treatment Period 3||9
2472746|NCT00950807|6064638|P1|COMPLETED|Treatment Period 3||45
2472747|NCT00950807|6064629|P10|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
2472748|NCT00950807|6064630|P9|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
2472749|NCT00950807|6064631|P8|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
2472750|NCT00950807|6064632|P7|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
2472751|NCT00950807|6064633|P6|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
2472752|NCT00950807|6064634|P5|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
2472753|NCT00950807|6064635|P4|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
2472754|NCT00950807|6064636|P3|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
2472755|NCT00950807|6064637|P2|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
2472756|NCT00950807|6064638|P1|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|46
2472757|NCT00950807|6064629|P10|NOT COMPLETED|Washout Period 2||0
2472758|NCT00950807|6064630|P9|NOT COMPLETED|Washout Period 2||0
2472759|NCT00950807|6064631|P8|NOT COMPLETED|Washout Period 2||1
2472760|NCT00950807|6064632|P7|NOT COMPLETED|Washout Period 2||1
2472761|NCT00950807|6064633|P6|NOT COMPLETED|Washout Period 2||0
2472762|NCT00950807|6064634|P5|NOT COMPLETED|Washout Period 2||1
2472763|NCT00950807|6064635|P4|NOT COMPLETED|Washout Period 2||1
2472764|NCT00950807|6064636|P3|NOT COMPLETED|Washout Period 2||0
2472765|NCT00950807|6064637|P2|NOT COMPLETED|Washout Period 2||1
2472766|NCT00950807|6064638|P1|NOT COMPLETED|Washout Period 2||4
2472767|NCT00950807|6064629|P10|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
2472768|NCT00950807|6064630|P9|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
2472769|NCT00950807|6064631|P8|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
2472770|NCT00950807|6064632|P7|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|8
2472771|NCT00950807|6064633|P6|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
2472772|NCT00950807|6064634|P5|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|12
2472773|NCT00950807|6064635|P4|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
2472774|NCT00950807|6064636|P3|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|10
2472775|NCT00950807|6064637|P2|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
2472776|NCT00950807|6064638|P1|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|47
2472777|NCT00950807|6064629|P10|STARTED|Washout Period 2||11
2472778|NCT00950807|6064630|P9|STARTED|Washout Period 2||11
2472779|NCT00950807|6064631|P8|STARTED|Washout Period 2||10
2472780|NCT00950807|6064632|P7|STARTED|Washout Period 2||9
2472781|NCT00950807|6064633|P6|STARTED|Washout Period 2||9
2472782|NCT00950807|6064634|P5|STARTED|Washout Period 2||13
2472783|NCT00950807|6064635|P4|STARTED|Washout Period 2||12
2472784|NCT00950807|6064636|P3|STARTED|Washout Period 2||10
2472785|NCT00950807|6064637|P2|STARTED|Washout Period 2||12
2472786|NCT00950807|6064638|P1|STARTED|Washout Period 2||51
2472787|NCT00950807|6064629|P10|NOT COMPLETED|Treatment Period 2||0
2472788|NCT00950807|6064630|P9|NOT COMPLETED|Treatment Period 2||0
2472789|NCT00950807|6064631|P8|NOT COMPLETED|Treatment Period 2||3
2472790|NCT00950807|6064632|P7|NOT COMPLETED|Treatment Period 2||1
2472791|NCT00950807|6064633|P6|NOT COMPLETED|Treatment Period 2||1
2472792|NCT00950807|6064634|P5|NOT COMPLETED|Treatment Period 2||0
2472793|NCT00950807|6064635|P4|NOT COMPLETED|Treatment Period 2||1
2472794|NCT00950807|6064636|P3|NOT COMPLETED|Treatment Period 2||0
2472795|NCT00950807|6064637|P2|NOT COMPLETED|Treatment Period 2||1
2472796|NCT00950807|6064638|P1|NOT COMPLETED|Treatment Period 2||2
2472797|NCT00950807|6064629|P10|COMPLETED|Treatment Period 2||11
2472798|NCT00950807|6064630|P9|COMPLETED|Treatment Period 2||11
2472799|NCT00950807|6064631|P8|COMPLETED|Treatment Period 2||10
2472800|NCT00950807|6064632|P7|COMPLETED|Treatment Period 2||9
2472801|NCT00950807|6064633|P6|COMPLETED|Treatment Period 2||9
2472802|NCT00950807|6064634|P5|COMPLETED|Treatment Period 2||13
2472803|NCT00950807|6064635|P4|COMPLETED|Treatment Period 2||12
2472804|NCT00950807|6064636|P3|COMPLETED|Treatment Period 2||10
2472805|NCT00950807|6064637|P2|COMPLETED|Treatment Period 2||12
2472806|NCT00950807|6064638|P1|COMPLETED|Treatment Period 2||51
2472807|NCT00950807|6064629|P10|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
2472808|NCT00950807|6064630|P9|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
2472809|NCT00950807|6064631|P8|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
2472810|NCT00950807|6064632|P7|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
2472811|NCT00950807|6064633|P6|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
2472812|NCT00950807|6064634|P5|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
2472813|NCT00950807|6064635|P4|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
2472814|NCT00950807|6064636|P3|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
2472815|NCT00950807|6064637|P2|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
2472816|NCT00950807|6064638|P1|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|53
2472817|NCT00950807|6064629|P10|NOT COMPLETED|Washout Period 1||0
2472818|NCT00950807|6064630|P9|NOT COMPLETED|Washout Period 1||1
2472819|NCT00950807|6064631|P8|NOT COMPLETED|Washout Period 1||1
2472820|NCT00950807|6064632|P7|NOT COMPLETED|Washout Period 1||2
2472821|NCT00950807|6064633|P6|NOT COMPLETED|Washout Period 1||0
2472822|NCT00950807|6064634|P5|NOT COMPLETED|Washout Period 1||1
2472823|NCT00950807|6064635|P4|NOT COMPLETED|Washout Period 1||1
2472824|NCT00950807|6064636|P3|NOT COMPLETED|Washout Period 1||0
2472825|NCT00950807|6064637|P2|NOT COMPLETED|Washout Period 1||0
2472826|NCT00950807|6064638|P1|NOT COMPLETED|Washout Period 1||5
2472827|NCT00950807|6064629|P10|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
2472828|NCT00950807|6064630|P9|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
2472829|NCT00950807|6064631|P8|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
2472830|NCT00950807|6064632|P7|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|10
2472831|NCT00950807|6064633|P6|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
2472832|NCT00950807|6064634|P5|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
2472833|NCT00950807|6064635|P4|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
2472834|NCT00950807|6064636|P3|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
2472835|NCT00950807|6064637|P2|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
2472836|NCT00950807|6064638|P1|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|51
2472837|NCT00950807|6064629|P10|STARTED|Washout Period 1||13
2472838|NCT00950807|6064630|P9|STARTED|Washout Period 1||12
2472839|NCT00950807|6064631|P8|STARTED|Washout Period 1||14
2472840|NCT00950807|6064632|P7|STARTED|Washout Period 1||12
2472841|NCT00950807|6064633|P6|STARTED|Washout Period 1||11
2472842|NCT00950807|6064634|P5|STARTED|Washout Period 1||12
2472843|NCT00950807|6064635|P4|STARTED|Washout Period 1||12
2472844|NCT00950807|6064636|P3|STARTED|Washout Period 1||13
2472845|NCT00950807|6064637|P2|STARTED|Washout Period 1||13
2472846|NCT00950807|6064638|P1|STARTED|Washout Period 1||56
2472847|NCT00950807|6064629|P10|NOT COMPLETED|Treatment Period 1||0
2472848|NCT00950807|6064630|P9|NOT COMPLETED|Treatment Period 1||1
2472849|NCT00950807|6064631|P8|NOT COMPLETED|Treatment Period 1||0
2472850|NCT00950807|6064632|P7|NOT COMPLETED|Treatment Period 1||0
2472851|NCT00950807|6064633|P6|NOT COMPLETED|Treatment Period 1||2
2472852|NCT00950807|6064634|P5|NOT COMPLETED|Treatment Period 1||1
2472853|NCT00950807|6064635|P4|NOT COMPLETED|Treatment Period 1||0
2472854|NCT00950807|6064636|P3|NOT COMPLETED|Treatment Period 1||1
2472855|NCT00950807|6064637|P2|NOT COMPLETED|Treatment Period 1||0
2472856|NCT00950807|6064638|P1|NOT COMPLETED|Treatment Period 1||3
2472857|NCT00950807|6064629|P10|COMPLETED|Treatment Period 1||13
2472858|NCT00950807|6064630|P9|COMPLETED|Treatment Period 1||12
2472859|NCT00950807|6064631|P8|COMPLETED|Treatment Period 1||14
2472860|NCT00950807|6064632|P7|COMPLETED|Treatment Period 1||12
2472861|NCT00950807|6064633|P6|COMPLETED|Treatment Period 1||11
2472862|NCT00950807|6064634|P5|COMPLETED|Treatment Period 1||12
2472863|NCT00950807|6064635|P4|COMPLETED|Treatment Period 1||12
2472864|NCT00950807|6064636|P3|COMPLETED|Treatment Period 1||13
2472865|NCT00950807|6064637|P2|COMPLETED|Treatment Period 1||13
2472866|NCT00950807|6064638|P1|COMPLETED|Treatment Period 1||56
2472867|NCT00950807|6064629|P10|STARTED|Treatment Period 1||13
2472868|NCT00950807|6064630|P9|STARTED|Treatment Period 1||13
2472869|NCT00950807|6064631|P8|STARTED|Treatment Period 1||14
2472870|NCT00950807|6064632|P7|STARTED|Treatment Period 1||12
2472871|NCT00950807|6064633|P6|STARTED|Treatment Period 1||13
2472872|NCT00950807|6064634|P5|STARTED|Treatment Period 1||13
2472873|NCT00950807|6064635|P4|STARTED|Treatment Period 1||12
2472874|NCT00950807|6064636|P3|STARTED|Treatment Period 1||14
2472875|NCT00950807|6064637|P2|STARTED|Treatment Period 1||13
2472876|NCT00950807|6064638|P1|STARTED|Treatment Period 1||59
2472877|NCT00950755|6064680|P1|NOT COMPLETED|Long-Term Follow-Up||9
2472878|NCT00950755|6064680|P1|COMPLETED|Long-Term Follow-Up||9
2472879|NCT00950755|6064680|P1|STARTED|Long-Term Follow-Up|18 of the 41 participants withdrawing from Study BEX104505 enrolled in the LTFU study.|18
2472880|NCT00950755|6064680|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||41
2472881|NCT00950755|6064680|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
2472882|NCT00950755|6064680|P1|STARTED|Dosimetric and Therapeutic Treatment||41
2472883|NCT00950742|6064706|P2|NOT COMPLETED|Overall Study||2
2472884|NCT00950742|6064707|P1|NOT COMPLETED|Overall Study||16
2472885|NCT00950742|6064706|P2|COMPLETED|Overall Study||0
2472886|NCT00950742|6064707|P1|COMPLETED|Overall Study||0
2472887|NCT00950742|6064706|P2|STARTED|Overall Study|entered and treated|2
2472888|NCT00950742|6064707|P1|STARTED|Overall Study|entered and treated|16
2472889|NCT00950729|6064723|P1|NOT COMPLETED|Driving With Aircast||0
2472890|NCT00950729|6064723|P1|COMPLETED|Driving With Aircast||48
2472891|NCT00950729|6064723|P1|STARTED|Driving With Aircast||48
2472892|NCT00950729|6064723|P1|NOT COMPLETED|Driving With Plaster Cast||0
2472893|NCT00950729|6064723|P1|COMPLETED|Driving With Plaster Cast||48
2472894|NCT00950729|6064723|P1|STARTED|Driving With Plaster Cast||48
2472895|NCT00950729|6064723|P1|NOT COMPLETED|Driving With Running Shoes||0
2472896|NCT00950729|6064723|P1|COMPLETED|Driving With Running Shoes|June 2007|48
2472897|NCT00950729|6064723|P1|STARTED|Driving With Running Shoes|March 2007|48
2472898|NCT00950690|6064728|P1|NOT COMPLETED|Overall Study||244
2472899|NCT00950690|6064728|P1|COMPLETED|Overall Study||1105
2472900|NCT00950690|6064728|P1|STARTED|Overall Study||1349
2472901|NCT00950664|6064735|P2|NOT COMPLETED|Second Intervention||48
2472902|NCT00950664|6064736|P1|NOT COMPLETED|Second Intervention||46
2472903|NCT00950664|6064735|P2|COMPLETED|Second Intervention||0
2472904|NCT00950664|6064736|P1|COMPLETED|Second Intervention||0
2472905|NCT00950664|6064735|P2|STARTED|Second Intervention||48
2472906|NCT00950664|6064736|P1|STARTED|Second Intervention||46
2472907|NCT00950664|6064735|P2|NOT COMPLETED|Washout Period of 4 Weeks||0
2472908|NCT00950664|6064736|P1|NOT COMPLETED|Washout Period of 4 Weeks||0
2472909|NCT00950664|6064735|P2|COMPLETED|Washout Period of 4 Weeks||48
2472910|NCT00950664|6064736|P1|COMPLETED|Washout Period of 4 Weeks||46
2472911|NCT00950664|6064735|P2|STARTED|Washout Period of 4 Weeks||48
2472912|NCT00950664|6064736|P1|STARTED|Washout Period of 4 Weeks||46
2472913|NCT00950664|6064735|P2|NOT COMPLETED|First Intervention||5
2472914|NCT00950664|6064736|P1|NOT COMPLETED|First Intervention||3
2472915|NCT00950664|6064735|P2|COMPLETED|First Intervention||48
2472916|NCT00950664|6064736|P1|COMPLETED|First Intervention||46
2472917|NCT00950664|6064735|P2|STARTED|First Intervention||53
2472918|NCT00950664|6064736|P1|STARTED|First Intervention||49
2472919|NCT00950651|6064756|P2|NOT COMPLETED|Overall Study||35
2472920|NCT00950651|6064757|P1|NOT COMPLETED|Overall Study||31
2472921|NCT00950651|6064756|P2|COMPLETED|Overall Study||181
2472922|NCT00950651|6064757|P1|COMPLETED|Overall Study||184
2472923|NCT00950651|6064756|P2|STARTED|Overall Study|216 patients randomized but one never took study medication|216
2472924|NCT00950651|6064757|P1|STARTED|Overall Study||215
2472925|NCT00950612|6064805|P2|NOT COMPLETED|Overall Study||0
2472926|NCT00950612|6064806|P1|NOT COMPLETED|Overall Study||0
2472927|NCT00950612|6064805|P2|COMPLETED|Overall Study||20
2472928|NCT00950612|6064806|P1|COMPLETED|Overall Study||40
2472929|NCT00950612|6064805|P2|STARTED|Overall Study||20
2472930|NCT00950612|6064806|P1|STARTED|Overall Study||40
2472931|NCT00950599|6064850|P10|NOT COMPLETED|Follow-Up Period||2
2472932|NCT00950599|6064851|P9|NOT COMPLETED|Follow-Up Period||13
2472933|NCT00950599|6064852|P8|NOT COMPLETED|Follow-Up Period||0
2472934|NCT00950599|6064853|P7|NOT COMPLETED|Follow-Up Period||0
2472935|NCT00950599|6064854|P6|NOT COMPLETED|Follow-Up Period||0
2472936|NCT00950599|6064855|P5|NOT COMPLETED|Follow-Up Period||0
2472937|NCT00950599|6064856|P4|NOT COMPLETED|Follow-Up Period||0
2472938|NCT00950599|6064857|P3|NOT COMPLETED|Follow-Up Period||0
2472939|NCT00950599|6064858|P2|NOT COMPLETED|Follow-Up Period||0
2472940|NCT00950599|6064859|P1|NOT COMPLETED|Follow-Up Period||0
2472941|NCT00950599|6064850|P10|COMPLETED|Follow-Up Period||78
2472942|NCT00950599|6064851|P9|COMPLETED|Follow-Up Period||296
2472943|NCT00950599|6064852|P8|COMPLETED|Follow-Up Period||0
2472944|NCT00950599|6064853|P7|COMPLETED|Follow-Up Period||0
2472945|NCT00950599|6064854|P6|COMPLETED|Follow-Up Period||0
2472946|NCT00950599|6064855|P5|COMPLETED|Follow-Up Period||0
2472947|NCT00950599|6064856|P4|COMPLETED|Follow-Up Period||0
2472948|NCT00950599|6064857|P3|COMPLETED|Follow-Up Period||0
2472949|NCT00950599|6064858|P2|COMPLETED|Follow-Up Period||0
2472950|NCT00950599|6064859|P1|COMPLETED|Follow-Up Period||0
2472951|NCT00950599|6064850|P10|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|80
2472952|NCT00950599|6064851|P9|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|309
2472953|NCT00950599|6064852|P8|STARTED|Follow-Up Period||0
2472954|NCT00950599|6064853|P7|STARTED|Follow-Up Period||0
2472955|NCT00950599|6064854|P6|STARTED|Follow-Up Period||0
2472956|NCT00950599|6064855|P5|STARTED|Follow-Up Period||0
2472957|NCT00950599|6064856|P4|STARTED|Follow-Up Period||0
2472958|NCT00950599|6064857|P3|STARTED|Follow-Up Period||0
2472959|NCT00950599|6064858|P2|STARTED|Follow-Up Period||0
2472960|NCT00950599|6064859|P1|STARTED|Follow-Up Period||0
2472961|NCT00950599|6064850|P10|NOT COMPLETED|Double-Blind Treatment Period||0
2472962|NCT00950599|6064851|P9|NOT COMPLETED|Double-Blind Treatment Period||0
2472963|NCT00950599|6064852|P8|NOT COMPLETED|Double-Blind Treatment Period||6
2472964|NCT00950599|6064853|P7|NOT COMPLETED|Double-Blind Treatment Period||0
2472965|NCT00950599|6064854|P6|NOT COMPLETED|Double-Blind Treatment Period||12
2472966|NCT00950599|6064855|P5|NOT COMPLETED|Double-Blind Treatment Period||7
2472967|NCT00950599|6064856|P4|NOT COMPLETED|Double-Blind Treatment Period||11
2472968|NCT00950599|6064857|P3|NOT COMPLETED|Double-Blind Treatment Period||9
2472969|NCT00950599|6064858|P2|NOT COMPLETED|Double-Blind Treatment Period||10
2472970|NCT00950599|6064859|P1|NOT COMPLETED|Double-Blind Treatment Period||7
2472971|NCT00950599|6064850|P10|COMPLETED|Double-Blind Treatment Period||0
2472972|NCT00950599|6064851|P9|COMPLETED|Double-Blind Treatment Period||0
2472973|NCT00950599|6064852|P8|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|35
2472974|NCT00950599|6064853|P7|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|44
2472975|NCT00950599|6064854|P6|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|55
2472976|NCT00950599|6064855|P5|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|45
2472977|NCT00950599|6064856|P4|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|43
2472978|NCT00950599|6064857|P3|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|54
2472979|NCT00950599|6064858|P2|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|37
2472980|NCT00950599|6064859|P1|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|48
2472981|NCT00950599|6064850|P10|STARTED|Double-Blind Treatment Period||0
2472982|NCT00950599|6064851|P9|STARTED|Double-Blind Treatment Period||0
2472983|NCT00950599|6064852|P8|STARTED|Double-Blind Treatment Period||41
2472984|NCT00950599|6064853|P7|STARTED|Double-Blind Treatment Period||44
2472985|NCT00950599|6064854|P6|STARTED|Double-Blind Treatment Period||67
2472986|NCT00950599|6064855|P5|STARTED|Double-Blind Treatment Period||52
2472987|NCT00950599|6064856|P4|STARTED|Double-Blind Treatment Period||54
2472988|NCT00950599|6064857|P3|STARTED|Double-Blind Treatment Period||63
2472989|NCT00950599|6064858|P2|STARTED|Double-Blind Treatment Period||47
2472990|NCT00950599|6064859|P1|STARTED|Double-Blind Treatment Period||55
2472991|NCT00950352|6065423|P2|NOT COMPLETED|Overall Study||11
2472992|NCT00950352|6065424|P1|NOT COMPLETED|Overall Study||42
2472993|NCT00950352|6065423|P2|COMPLETED|Overall Study||21
2472994|NCT00950352|6065424|P1|COMPLETED|Overall Study||30
2472995|NCT00950352|6065423|P2|STARTED|Overall Study||32
2472996|NCT00950352|6065424|P1|STARTED|Overall Study||72
2472997|NCT00950300|6065432|P2|NOT COMPLETED|SFU Period||78
2472998|NCT00950300|6065433|P1|NOT COMPLETED|SFU Period||78
2472999|NCT00950300|6065432|P2|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|45
2473000|NCT00950300|6065433|P1|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|40
2473001|NCT00950300|6065432|P2|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|123
2473002|NCT00950300|6065433|P1|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|118
2473003|NCT00950300|6065432|P2|NOT COMPLETED|TFFU Period||107
2473004|NCT00950300|6065433|P1|NOT COMPLETED|TFFU Period||100
2473005|NCT00950300|6065432|P2|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|161
2473006|NCT00950300|6065433|P1|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|165
2473007|NCT00950300|6065432|P2|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|268
2473008|NCT00950300|6065433|P1|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|265
2473009|NCT00950300|6065432|P2|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
2473010|NCT00950300|6065433|P1|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
2473011|NCT00950300|6065432|P2|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||255
2473012|NCT00950300|6065433|P1|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||257
2473013|NCT00950300|6065432|P2|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||274
2473014|NCT00950300|6065433|P1|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||277
2473015|NCT00950300|6065432|P2|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||273
2473016|NCT00950300|6065433|P1|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||277
2473017|NCT00950300|6065432|P2|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||297
2473018|NCT00950300|6065433|P1|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||298
2473019|NCT00950300|6065432|P2|STARTED|Neoadjuvant/Adjuvant Treatment Periods||297
2473020|NCT00950300|6065433|P1|STARTED|Neoadjuvant/Adjuvant Treatment Periods||299
2473021|NCT00950248|6065482|P3|NOT COMPLETED|Year 2&3 Treatment Randomization||5
2473022|NCT00950248|6065483|P2|NOT COMPLETED|Year 2&3 Treatment Randomization||6
2473023|NCT00950248|6065484|P1|NOT COMPLETED|Year 2&3 Treatment Randomization||0
2473024|NCT00950248|6065482|P3|COMPLETED|Year 2&3 Treatment Randomization||33
2473025|NCT00950248|6065483|P2|COMPLETED|Year 2&3 Treatment Randomization||33
2473026|NCT00950248|6065484|P1|COMPLETED|Year 2&3 Treatment Randomization||0
2473027|NCT00950248|6065482|P3|STARTED|Year 2&3 Treatment Randomization||38
2473028|NCT00950248|6065483|P2|STARTED|Year 2&3 Treatment Randomization||39
2473029|NCT00950248|6065484|P1|STARTED|Year 2&3 Treatment Randomization||0
2473030|NCT00950248|6065482|P3|NOT COMPLETED|Year 1: Baseline||0
2473031|NCT00950248|6065483|P2|NOT COMPLETED|Year 1: Baseline||0
2473032|NCT00950248|6065484|P1|NOT COMPLETED|Year 1: Baseline||8
2473033|NCT00950248|6065482|P3|COMPLETED|Year 1: Baseline||0
2473034|NCT00950248|6065483|P2|COMPLETED|Year 1: Baseline||0
2473035|NCT00950248|6065484|P1|COMPLETED|Year 1: Baseline||77
2473036|NCT00950248|6065482|P3|STARTED|Year 1: Baseline||0
2473037|NCT00950248|6065483|P2|STARTED|Year 1: Baseline||0
2473038|NCT00950248|6065484|P1|STARTED|Year 1: Baseline||85
2473039|NCT00950235|6065505|P2|NOT COMPLETED|Overall Study||4
2473040|NCT00950235|6065506|P1|NOT COMPLETED|Overall Study||2
2473041|NCT00950235|6065505|P2|COMPLETED|Overall Study||54
2473042|NCT00950235|6065506|P1|COMPLETED|Overall Study||58
2473043|NCT00950235|6065505|P2|STARTED|Overall Study||58
2473044|NCT00950235|6065506|P1|STARTED|Overall Study||60
2473045|NCT00950183|6065516|P1|NOT COMPLETED|Overall Study||36
2473046|NCT00950183|6065516|P1|COMPLETED|Overall Study||0
2473047|NCT00950183|6065516|P1|STARTED|Overall Study||36
2473048|NCT00950170|6065524|P1|NOT COMPLETED|Overall Study||4
2473049|NCT00950170|6065524|P1|COMPLETED|Overall Study||19
2473050|NCT00950170|6065524|P1|STARTED|Overall Study||23
2473051|NCT00949988|6065575|P1|NOT COMPLETED|Overall Study||3
2473052|NCT00949988|6065575|P1|COMPLETED|Overall Study||0
2473053|NCT00949988|6065575|P1|STARTED|Overall Study||3
2473054|NCT00949975|6065590|P4|NOT COMPLETED|Overall Study||28
2473055|NCT00949975|6065591|P3|NOT COMPLETED|Overall Study||19
2473056|NCT00949975|6065592|P2|NOT COMPLETED|Overall Study||29
2473057|NCT00949975|6065593|P1|NOT COMPLETED|Overall Study||27
2473058|NCT00949975|6065590|P4|COMPLETED|Overall Study||190
2473059|NCT00949975|6065591|P3|COMPLETED|Overall Study||183
2473060|NCT00949975|6065592|P2|COMPLETED|Overall Study||177
2473061|NCT00949975|6065593|P1|COMPLETED|Overall Study||185
2473062|NCT00949975|6065590|P4|STARTED|Overall Study||218
2473063|NCT00949975|6065591|P3|STARTED|Overall Study||202
2473064|NCT00949975|6065592|P2|STARTED|Overall Study||206
2473065|NCT00949975|6065593|P1|STARTED|Overall Study||212
2473066|NCT00949910|6065711|P1|NOT COMPLETED|Overall Study||6576
2473067|NCT00949910|6065711|P1|COMPLETED|Overall Study||10
2473068|NCT00949910|6065711|P1|STARTED|Overall Study||6586
2473069|NCT00949884|6065724|P3|NOT COMPLETED|Overall Study||58
2473070|NCT00949884|6065725|P2|NOT COMPLETED|Overall Study||15
2473071|NCT00949884|6065726|P1|NOT COMPLETED|Overall Study||50
2473072|NCT00949884|6065724|P3|COMPLETED|Overall Study||411
2473073|NCT00949884|6065725|P2|COMPLETED|Overall Study||37
2473074|NCT00949884|6065726|P1|COMPLETED|Overall Study||370
2473075|NCT00949884|6065724|P3|STARTED|Overall Study||469
2473076|NCT00949884|6065725|P2|STARTED|Overall Study||52
2473077|NCT00949884|6065726|P1|STARTED|Overall Study||420
2473078|NCT00949715|6065781|P2|NOT COMPLETED|Overall Study||0
2473079|NCT00949715|6065782|P1|NOT COMPLETED|Overall Study||4
2473080|NCT00949715|6065781|P2|COMPLETED|Overall Study||33
2473081|NCT00949715|6065782|P1|COMPLETED|Overall Study||28
2473082|NCT00949715|6065781|P2|STARTED|Overall Study||33
2473083|NCT00949715|6065782|P1|STARTED|Overall Study||32
2473084|NCT00949702|6065793|P1|NOT COMPLETED|Overall Study||48
2473085|NCT00949702|6065793|P1|COMPLETED|Overall Study||84
2473086|NCT00949702|6065793|P1|STARTED|Overall Study||132
2473087|NCT00949650|6065810|P2|NOT COMPLETED|Overall Study||115
2473088|NCT00949650|6065811|P1|NOT COMPLETED|Overall Study||230
2473089|NCT00949650|6065810|P2|COMPLETED|Overall Study||0
2473090|NCT00949650|6065811|P1|COMPLETED|Overall Study|On treatment at the cut-off date 17MAR2017.|0
2473091|NCT00949650|6065810|P2|STARTED|Overall Study|Treated patients.|115
2473092|NCT00949650|6065811|P1|STARTED|Overall Study|Treated patients.|230
2473093|NCT00949533|6065849|P2|NOT COMPLETED|Overall Study||1
2473094|NCT00949533|6065850|P1|NOT COMPLETED|Overall Study||0
2473095|NCT00949533|6065849|P2|COMPLETED|Overall Study||17
2473096|NCT00949533|6065850|P1|COMPLETED|Overall Study||19
2473097|NCT00949533|6065849|P2|STARTED|Overall Study||18
2473098|NCT00949533|6065850|P1|STARTED|Overall Study||19
2473099|NCT00949325|6065862|P3|NOT COMPLETED|Overall Study||0
2473100|NCT00949325|6065863|P2|NOT COMPLETED|Overall Study||2
2473101|NCT00949325|6065864|P1|NOT COMPLETED|Overall Study||0
2473102|NCT00949325|6065862|P3|COMPLETED|Overall Study||3
2473103|NCT00949325|6065863|P2|COMPLETED|Overall Study||16
2473104|NCT00949325|6065864|P1|COMPLETED|Overall Study||3
2473105|NCT00949325|6065862|P3|STARTED|Overall Study||3
2473106|NCT00949325|6065863|P2|STARTED|Overall Study||18
2473107|NCT00949325|6065864|P1|STARTED|Overall Study||3
2473108|NCT00949234|6065882|P1|NOT COMPLETED|Overall Study||42
2473109|NCT00949234|6065882|P1|COMPLETED|Overall Study||225
2473110|NCT00949234|6065882|P1|STARTED|Overall Study||267
2473111|NCT00949117|6065888|P2|NOT COMPLETED|Overall Study||5
2473112|NCT00949117|6065889|P1|NOT COMPLETED|Overall Study||3
2473113|NCT00949117|6065888|P2|COMPLETED|Overall Study||0
2473114|NCT00949117|6065889|P1|COMPLETED|Overall Study||1
2473115|NCT00949117|6065888|P2|STARTED|Overall Study||5
2473116|NCT00949117|6065889|P1|STARTED|Overall Study||4
2473117|NCT00949078|6065905|P2|NOT COMPLETED|Overall Study||0
2473118|NCT00949078|6065906|P1|NOT COMPLETED|Overall Study||0
2473119|NCT00949078|6065905|P2|COMPLETED|Overall Study||9
2473120|NCT00949078|6065906|P1|COMPLETED|Overall Study||5
2473121|NCT00949078|6065905|P2|STARTED|Overall Study||9
2473122|NCT00949078|6065906|P1|STARTED|Overall Study||5
2473123|NCT00948974|6065930|P2|NOT COMPLETED|Overall Study||20
2473124|NCT00948974|6065931|P1|NOT COMPLETED|Overall Study||23
2473125|NCT00948974|6065930|P2|COMPLETED|Overall Study||28
2473126|NCT00948974|6065931|P1|COMPLETED|Overall Study||17
2473127|NCT00948974|6065930|P2|STARTED|Overall Study||48
2473128|NCT00948974|6065931|P1|STARTED|Overall Study||40
2473129|NCT00948935|6065941|P1|NOT COMPLETED|Overall Study||0
2473130|NCT00948935|6065941|P1|COMPLETED|Overall Study||35
2473131|NCT00948935|6065941|P1|STARTED|Overall Study||35
2473132|NCT00948922|6065949|P3|NOT COMPLETED|Overall Study||1
2473133|NCT00948922|6065950|P2|NOT COMPLETED|Overall Study||14
2473134|NCT00948922|6065951|P1|NOT COMPLETED|Overall Study||8
2473135|NCT00948922|6065949|P3|COMPLETED|Overall Study||38
2473136|NCT00948922|6065950|P2|COMPLETED|Overall Study||37
2473137|NCT00948922|6065951|P1|COMPLETED|Overall Study||26
2473138|NCT00948922|6065949|P3|STARTED|Overall Study||39
2473139|NCT00948922|6065950|P2|STARTED|Overall Study||51
2473140|NCT00948922|6065951|P1|STARTED|Overall Study||34
2473141|NCT00948896|6065974|P8|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
2473142|NCT00948896|6065975|P7|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
2473143|NCT00948896|6065976|P6|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
2473144|NCT00948896|6065977|P5|NOT COMPLETED|24 Months of Age to 36 Months of Age||1
2473145|NCT00948896|6065978|P4|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
2473146|NCT00948896|6065979|P3|NOT COMPLETED|24 Months of Age to 36 Months of Age||5
2473147|NCT00948896|6065980|P2|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
2473148|NCT00948896|6065981|P1|NOT COMPLETED|24 Months of Age to 36 Months of Age||3
2473149|NCT00948896|6065974|P8|COMPLETED|24 Months of Age to 36 Months of Age||45
2473150|NCT00948896|6065975|P7|COMPLETED|24 Months of Age to 36 Months of Age||43
2473151|NCT00948896|6065976|P6|COMPLETED|24 Months of Age to 36 Months of Age||40
2473152|NCT00948896|6065977|P5|COMPLETED|24 Months of Age to 36 Months of Age||43
2473153|NCT00948896|6065978|P4|COMPLETED|24 Months of Age to 36 Months of Age||85
2473154|NCT00948896|6065979|P3|COMPLETED|24 Months of Age to 36 Months of Age||85
2473155|NCT00948896|6065980|P2|COMPLETED|24 Months of Age to 36 Months of Age||83
2473156|NCT00948896|6065981|P1|COMPLETED|24 Months of Age to 36 Months of Age||87
2473157|NCT00948896|6065974|P8|STARTED|24 Months of Age to 36 Months of Age||45
2473158|NCT00948896|6065975|P7|STARTED|24 Months of Age to 36 Months of Age||43
2473159|NCT00948896|6065976|P6|STARTED|24 Months of Age to 36 Months of Age||42
2473160|NCT00948896|6065977|P5|STARTED|24 Months of Age to 36 Months of Age||44
2473161|NCT00948896|6065978|P4|STARTED|24 Months of Age to 36 Months of Age||87
2473162|NCT00948896|6065979|P3|STARTED|24 Months of Age to 36 Months of Age||90
2473163|NCT00948896|6065980|P2|STARTED|24 Months of Age to 36 Months of Age||85
2473164|NCT00948896|6065981|P1|STARTED|24 Months of Age to 36 Months of Age||90
2473165|NCT00948896|6065974|P8|NOT COMPLETED|Randomization to 24 Months of Age||2
2473166|NCT00948896|6065975|P7|NOT COMPLETED|Randomization to 24 Months of Age||4
2473167|NCT00948896|6065976|P6|NOT COMPLETED|Randomization to 24 Months of Age||4
2473168|NCT00948896|6065977|P5|NOT COMPLETED|Randomization to 24 Months of Age||2
2473169|NCT00948896|6065978|P4|NOT COMPLETED|Randomization to 24 Months of Age||11
2473170|NCT00948896|6065979|P3|NOT COMPLETED|Randomization to 24 Months of Age||9
2473171|NCT00948896|6065980|P2|NOT COMPLETED|Randomization to 24 Months of Age||13
2473172|NCT00948896|6065981|P1|NOT COMPLETED|Randomization to 24 Months of Age||8
2473173|NCT00948896|6065974|P8|COMPLETED|Randomization to 24 Months of Age||45
2473174|NCT00948896|6065975|P7|COMPLETED|Randomization to 24 Months of Age||43
2473175|NCT00948896|6065976|P6|COMPLETED|Randomization to 24 Months of Age||42
2473176|NCT00948896|6065977|P5|COMPLETED|Randomization to 24 Months of Age||44
2473177|NCT00948896|6065978|P4|COMPLETED|Randomization to 24 Months of Age||87
2473178|NCT00948896|6065979|P3|COMPLETED|Randomization to 24 Months of Age||90
2473179|NCT00948896|6065980|P2|COMPLETED|Randomization to 24 Months of Age||85
2473180|NCT00948896|6065981|P1|COMPLETED|Randomization to 24 Months of Age||90
2473181|NCT00948896|6065974|P8|STARTED|Randomization to 24 Months of Age||47
2473182|NCT00948896|6065975|P7|STARTED|Randomization to 24 Months of Age||47
2473183|NCT00948896|6065976|P6|STARTED|Randomization to 24 Months of Age||46
2473184|NCT00948896|6065977|P5|STARTED|Randomization to 24 Months of Age||46
2473185|NCT00948896|6065978|P4|STARTED|Randomization to 24 Months of Age||98
2473186|NCT00948896|6065979|P3|STARTED|Randomization to 24 Months of Age||99
2473187|NCT00948896|6065980|P2|STARTED|Randomization to 24 Months of Age||98
2473188|NCT00948896|6065981|P1|STARTED|Randomization to 24 Months of Age||98
2473189|NCT00948857|6066017|P2|NOT COMPLETED|Overall Study||0
2473190|NCT00948857|6066018|P1|NOT COMPLETED|Overall Study||1
2473191|NCT00948857|6066017|P2|COMPLETED|Overall Study||2
2473192|NCT00948857|6066018|P1|COMPLETED|Overall Study|3 completed and 1 dropped out.|2
2473193|NCT00948857|6066017|P2|STARTED|Overall Study||2
2473194|NCT00948857|6066018|P1|STARTED|Overall Study||3
2473195|NCT00948818|6066026|P2|NOT COMPLETED|Overall Study||94
2473196|NCT00948818|6066027|P1|NOT COMPLETED|Overall Study||62
2473197|NCT00948818|6066026|P2|COMPLETED|Overall Study||312
2473198|NCT00948818|6066027|P1|COMPLETED|Overall Study||335
2473199|NCT00948818|6066026|P2|STARTED|Overall Study||406
2473200|NCT00948818|6066027|P1|STARTED|Overall Study||397
2473201|NCT00948792|6066062|P1|NOT COMPLETED|Overall Study||0
2473202|NCT00948792|6066062|P1|COMPLETED|Overall Study||21
2473203|NCT00948792|6066062|P1|STARTED|Overall Study||21
2473204|NCT00948766|6066074|P2|NOT COMPLETED|Extension Study||0
2473205|NCT00948766|6066075|P1|NOT COMPLETED|Extension Study||91
2473206|NCT00948766|6066074|P2|COMPLETED|Extension Study||0
2473207|NCT00948766|6066075|P1|COMPLETED|Extension Study||306
2473208|NCT00948766|6066074|P2|Exposed to Study Medication|Extension Study||0
2473209|NCT00948766|6066075|P1|Exposed to Study Medication|Extension Study||396
2473210|NCT00948766|6066074|P2|STARTED|Extension Study|No patients received this treatment in the extension study.|0
2473211|NCT00948766|6066075|P1|STARTED|Extension Study|397 of the 463 patients who completed the core study entered the extension study.|397
2473212|NCT00948766|6066074|P2|NOT COMPLETED|Core Study||126
2473213|NCT00948766|6066075|P1|NOT COMPLETED|Core Study||127
2473214|NCT00948766|6066074|P2|COMPLETED|Core Study||234
2473215|NCT00948766|6066075|P1|COMPLETED|Core Study||229
2473216|NCT00948766|6066074|P2|Exposed to Study Medication|Core Study||359
2473217|NCT00948766|6066075|P1|Exposed to Study Medication|Core Study||355
2473218|NCT00948766|6066074|P2|STARTED|Core Study||360
2473219|NCT00948766|6066075|P1|STARTED|Core Study||356
2473220|NCT00948688|6066091|P2|NOT COMPLETED|Period 2: 100 mg Vorinostat||1
2473221|NCT00948688|6066092|P1|NOT COMPLETED|Period 2: 100 mg Vorinostat||0
2473222|NCT00948688|6066091|P2|COMPLETED|Period 2: 100 mg Vorinostat||5
2473223|NCT00948688|6066092|P1|COMPLETED|Period 2: 100 mg Vorinostat||0
2473224|NCT00948688|6066091|P2|STARTED|Period 2: 100 mg Vorinostat||6
2473225|NCT00948688|6066092|P1|STARTED|Period 2: 100 mg Vorinostat||0
2473226|NCT00948688|6066091|P2|NOT COMPLETED|Period 1: 200 mg Vorinostat||0
2473227|NCT00948688|6066092|P1|NOT COMPLETED|Period 1: 200 mg Vorinostat||2
2473228|NCT00948688|6066091|P2|COMPLETED|Period 1: 200 mg Vorinostat||0
2473229|NCT00948688|6066092|P1|COMPLETED|Period 1: 200 mg Vorinostat||2
2473230|NCT00948688|6066091|P2|STARTED|Period 1: 200 mg Vorinostat||0
2473231|NCT00948688|6066092|P1|STARTED|Period 1: 200 mg Vorinostat||4
2473232|NCT00948675|6066106|P2|NOT COMPLETED|Overall Study||4
2473233|NCT00948675|6066107|P1|NOT COMPLETED|Overall Study||7
2473234|NCT00948675|6066106|P2|COMPLETED|Overall Study||175
2473235|NCT00948675|6066107|P1|COMPLETED|Overall Study||175
2473236|NCT00948675|6066106|P2|STARTED|Overall Study||179
2473237|NCT00948675|6066107|P1|STARTED|Overall Study||182
2473238|NCT00948610|6066123|P2|NOT COMPLETED|Overall Study||1
2473239|NCT00948610|6066124|P1|NOT COMPLETED|Overall Study||1
2473240|NCT00948610|6066123|P2|COMPLETED|Overall Study||9
2473241|NCT00948610|6066124|P1|COMPLETED|Overall Study||9
2473242|NCT00948610|6066123|P2|STARTED|Overall Study||10
2473243|NCT00948610|6066124|P1|STARTED|Overall Study||10
2473244|NCT00948506|6066134|P2|NOT COMPLETED|Overall Study||1
2473245|NCT00948506|6066135|P1|NOT COMPLETED|Overall Study||3
2473246|NCT00948506|6066134|P2|COMPLETED|Overall Study||8
2473247|NCT00948506|6066135|P1|COMPLETED|Overall Study||8
2473248|NCT00948506|6066134|P2|STARTED|Overall Study||9
2473249|NCT00948506|6066135|P1|STARTED|Overall Study||11
2473250|NCT00948441|6066146|P2|NOT COMPLETED|Overall Study||4
2473251|NCT00948441|6066147|P1|NOT COMPLETED|Overall Study||1
2473252|NCT00948441|6066146|P2|COMPLETED|Overall Study||4
2473253|NCT00948441|6066147|P1|COMPLETED|Overall Study||7
2473254|NCT00948441|6066146|P2|STARTED|Overall Study||8
2473255|NCT00948441|6066147|P1|STARTED|Overall Study||8
2473256|NCT00948389|6066160|P5|NOT COMPLETED|Overall Study||1
2473257|NCT00948389|6066161|P4|NOT COMPLETED|Overall Study||9
2473258|NCT00948389|6066162|P3|NOT COMPLETED|Overall Study||7
2473259|NCT00948389|6066163|P2|NOT COMPLETED|Overall Study||3
2473260|NCT00948389|6066164|P1|NOT COMPLETED|Overall Study||6
2473261|NCT00948389|6066160|P5|COMPLETED|Overall Study||0
2473262|NCT00948389|6066161|P4|COMPLETED|Overall Study||0
2473263|NCT00948389|6066162|P3|COMPLETED|Overall Study||0
2473264|NCT00948389|6066163|P2|COMPLETED|Overall Study||0
2473265|NCT00948389|6066164|P1|COMPLETED|Overall Study||0
2473266|NCT00948389|6066160|P5|STARTED|Overall Study||1
2473267|NCT00948389|6066161|P4|STARTED|Overall Study||9
2473268|NCT00948389|6066162|P3|STARTED|Overall Study||7
2473269|NCT00948389|6066163|P2|STARTED|Overall Study||3
2473270|NCT00948389|6066164|P1|STARTED|Overall Study||6
2473271|NCT00948298|6066203|P2|NOT COMPLETED|Overall Study||5
2473272|NCT00948298|6066204|P1|NOT COMPLETED|Overall Study||10
2473273|NCT00948298|6066203|P2|COMPLETED|Overall Study||60
2473274|NCT00948298|6066204|P1|COMPLETED|Overall Study||55
2473275|NCT00948298|6066203|P2|STARTED|Overall Study||65
2473276|NCT00948298|6066204|P1|STARTED|Overall Study||65
2473277|NCT00948246|6066212|P1|NOT COMPLETED|Overall Study||24
2473278|NCT00948246|6066212|P1|COMPLETED|Overall Study||86
2473279|NCT00948246|6066212|P1|STARTED|Overall Study||110
2473280|NCT00948155|6066221|P2|NOT COMPLETED|Second Intervention 21 Days||3
2473281|NCT00948155|6066222|P1|NOT COMPLETED|Second Intervention 21 Days||2
2473282|NCT00948155|6066221|P2|COMPLETED|Second Intervention 21 Days||8
2473283|NCT00948155|6066222|P1|COMPLETED|Second Intervention 21 Days||9
2473284|NCT00948155|6066221|P2|STARTED|Second Intervention 21 Days||11
2473285|NCT00948155|6066222|P1|STARTED|Second Intervention 21 Days||11
2473286|NCT00948155|6066221|P2|NOT COMPLETED|Washout 14 Days||2
2473287|NCT00948155|6066222|P1|NOT COMPLETED|Washout 14 Days||1
2473288|NCT00948155|6066221|P2|COMPLETED|Washout 14 Days||11
2473289|NCT00948155|6066222|P1|COMPLETED|Washout 14 Days||11
2473290|NCT00948155|6066221|P2|STARTED|Washout 14 Days||13
2473291|NCT00948155|6066222|P1|STARTED|Washout 14 Days||12
2473292|NCT00948155|6066221|P2|NOT COMPLETED|First Intervention 21 Days||2
2473293|NCT00948155|6066222|P1|NOT COMPLETED|First Intervention 21 Days||2
2473294|NCT00948155|6066221|P2|COMPLETED|First Intervention 21 Days||13
2473295|NCT00948155|6066222|P1|COMPLETED|First Intervention 21 Days||12
2473296|NCT00948155|6066221|P2|STARTED|First Intervention 21 Days||15
2473297|NCT00948155|6066222|P1|STARTED|First Intervention 21 Days||14
2473298|NCT00948090|6066244|P4|NOT COMPLETED|Overall Study||11
2473299|NCT00948090|6066245|P3|NOT COMPLETED|Overall Study||56
2473300|NCT00948090|6066246|P2|NOT COMPLETED|Overall Study||1
2473301|NCT00948090|6066247|P1|NOT COMPLETED|Overall Study||43
2473302|NCT00948090|6066244|P4|COMPLETED|Overall Study||7
2473303|NCT00948090|6066245|P3|COMPLETED|Overall Study||67
2473304|NCT00948090|6066246|P2|COMPLETED|Overall Study||0
2473305|NCT00948090|6066247|P1|COMPLETED|Overall Study||22
2473306|NCT00948090|6066244|P4|STARTED|Overall Study||18
2473307|NCT00948090|6066245|P3|STARTED|Overall Study||123
2473308|NCT00948090|6066246|P2|STARTED|Overall Study||1
2473309|NCT00948090|6066247|P1|STARTED|Overall Study||65
2473328|NCT00947882|6066286|P4|NOT COMPLETED|Overall Study||82
2473329|NCT00947882|6066287|P3|NOT COMPLETED|Overall Study||79
2473330|NCT00947882|6066288|P2|NOT COMPLETED|Overall Study||77
2473331|NCT00947882|6066289|P1|NOT COMPLETED|Overall Study||74
2473332|NCT00947882|6066286|P4|COMPLETED|Overall Study||20
2473333|NCT00947882|6066287|P3|COMPLETED|Overall Study||22
2473334|NCT00947882|6066288|P2|COMPLETED|Overall Study||24
2473335|NCT00947882|6066289|P1|COMPLETED|Overall Study|End of Trial, Month 12: Patients who had completed the 12-month period when the trial was stopped.|26
2473336|NCT00947882|6066286|P4|Visit 12, Month 6|Overall Study||95
2473337|NCT00947882|6066287|P3|Visit 12, Month 6|Overall Study||90
2473338|NCT00947882|6066288|P2|Visit 12, Month 6|Overall Study||91
2473339|NCT00947882|6066289|P1|Visit 12, Month 6|Overall Study|The trial was stopped when all patients had completed Visit 12, scheduled 6 months after the dosing.|93
2473340|NCT00947882|6066286|P4|Safety Analysis Set|Overall Study||105
2473341|NCT00947882|6066287|P3|Safety Analysis Set|Overall Study||100
2473342|NCT00947882|6066288|P2|Safety Analysis Set|Overall Study||101
2473343|NCT00947882|6066289|P1|Safety Analysis Set|Overall Study|Safety Analysis Set: Received a dose of Investigational Medicinal Product (IMP).|98
2473344|NCT00947882|6066286|P4|Actual Treatment|Overall Study||105
2473345|NCT00947882|6066287|P3|Actual Treatment|Overall Study|1 patient randomised to 20 mg degarelix received 30 mg degarelix|100
2473346|NCT00947882|6066288|P2|Actual Treatment|Overall Study||101
2473347|NCT00947882|6066289|P1|Actual Treatment|Overall Study|2 placebo patients received 30 mg degarelix|98
2473348|NCT00947882|6066286|P4|Full Analysis Set (FAS)|Overall Study||102
2473349|NCT00947882|6066287|P3|Full Analysis Set (FAS)|Overall Study|1 patient received 20 mg degarelix but had no post-baseline IPSS value and was excluded from the FAS|100
2473350|NCT00947882|6066288|P2|Full Analysis Set (FAS)|Overall Study||101
2473351|NCT00947882|6066289|P1|Full Analysis Set (FAS)|Overall Study|FAS: Received a dose of IMP and completed at least one post-baseline IPSS questionnaire.|100
2473352|NCT00947882|6066286|P4|STARTED|Overall Study||102
2473353|NCT00947882|6066287|P3|STARTED|Overall Study||101
2473354|NCT00947882|6066288|P2|STARTED|Overall Study||101
2473355|NCT00947882|6066289|P1|STARTED|Overall Study|Started: Randomised.|100
2473356|NCT00947856|6066317|P2|NOT COMPLETED|Follow-up Period||23
2473357|NCT00947856|6066318|P1|NOT COMPLETED|Follow-up Period||51
2473358|NCT00947856|6066317|P2|COMPLETED|Follow-up Period|Completed survival follow-up due to death|9
2473359|NCT00947856|6066318|P1|COMPLETED|Follow-up Period||27
2473360|NCT00947856|6066317|P2|STARTED|Follow-up Period|All participants were followed after treatment; thus, number started will not match number completed|32
2473361|NCT00947856|6066318|P1|STARTED|Follow-up Period||78
2473362|NCT00947856|6066317|P2|NOT COMPLETED|Treatment Period||32
2473363|NCT00947856|6066318|P1|NOT COMPLETED|Treatment Period||78
2473364|NCT00947856|6066317|P2|COMPLETED|Treatment Period|Patients treated until disease progression, unacceptable toxicity or study closure|0
2473365|NCT00947856|6066318|P1|COMPLETED|Treatment Period||0
2473366|NCT00947856|6066317|P2|STARTED|Treatment Period|Two patients in extension arm re-enrolled in retreatment arm and are represented in both arms|32
2473367|NCT00947856|6066318|P1|STARTED|Treatment Period||78
2473368|NCT00947791|6066347|P2|NOT COMPLETED|Overall Study||0
2473369|NCT00947791|6066348|P1|NOT COMPLETED|Overall Study||0
2473370|NCT00947791|6066347|P2|COMPLETED|Overall Study||1
2473371|NCT00947791|6066348|P1|COMPLETED|Overall Study||0
2473372|NCT00947791|6066347|P2|STARTED|Overall Study||1
2473373|NCT00947791|6066348|P1|STARTED|Overall Study||0
2473374|NCT00947765|6066366|P2|NOT COMPLETED|Overall Study||0
2473375|NCT00947765|6066367|P1|NOT COMPLETED|Overall Study||0
2473376|NCT00947765|6066366|P2|COMPLETED|Overall Study||30
2473377|NCT00947765|6066367|P1|COMPLETED|Overall Study||30
2473378|NCT00947765|6066366|P2|STARTED|Overall Study||30
2473379|NCT00947765|6066367|P1|STARTED|Overall Study||30
2473380|NCT00947752|6066389|P2|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
2473381|NCT00947752|6066390|P1|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
2473382|NCT00947752|6066389|P2|COMPLETED|Crossover to 2nd 14-day Treatment Period||76
2473383|NCT00947752|6066390|P1|COMPLETED|Crossover to 2nd 14-day Treatment Period||71
2473384|NCT00947752|6066389|P2|STARTED|Crossover to 2nd 14-day Treatment Period||76
2473385|NCT00947752|6066390|P1|STARTED|Crossover to 2nd 14-day Treatment Period||71
2473386|NCT00947752|6066389|P2|NOT COMPLETED|1st 14-day Treatment Period||0
2473387|NCT00947752|6066390|P1|NOT COMPLETED|1st 14-day Treatment Period||0
2473388|NCT00947752|6066389|P2|COMPLETED|1st 14-day Treatment Period||71
2473389|NCT00947752|6066390|P1|COMPLETED|1st 14-day Treatment Period||76
2473390|NCT00947752|6066389|P2|STARTED|1st 14-day Treatment Period||71
2473391|NCT00947752|6066390|P1|STARTED|1st 14-day Treatment Period||76
2473392|NCT00947752|6066389|P2|NOT COMPLETED|7-Day Run-in Treatment Period||0
2473393|NCT00947752|6066390|P1|NOT COMPLETED|7-Day Run-in Treatment Period||0
2473394|NCT00947752|6066389|P2|COMPLETED|7-Day Run-in Treatment Period||0
2473395|NCT00947752|6066390|P1|COMPLETED|7-Day Run-in Treatment Period||147
2473396|NCT00947752|6066389|P2|STARTED|7-Day Run-in Treatment Period||0
2473397|NCT00947752|6066390|P1|STARTED|7-Day Run-in Treatment Period|All subjects started with a daily does of F1 for 7 days|147
2473398|NCT00947661|6066400|P2|NOT COMPLETED|Overall Study||15
2473399|NCT00947661|6066401|P1|NOT COMPLETED|Overall Study||13
2473400|NCT00947661|6066400|P2|COMPLETED|Overall Study||274
2473401|NCT00947661|6066401|P1|COMPLETED|Overall Study||276
2473402|NCT00947661|6066400|P2|STARTED|Overall Study||289
2473403|NCT00947661|6066401|P1|STARTED|Overall Study||289
2473404|NCT00947544|6066407|P2|NOT COMPLETED|Safety-Extension Period (12 Months)||0
2473405|NCT00947544|6066408|P1|NOT COMPLETED|Safety-Extension Period (12 Months)||1
2473406|NCT00947544|6066407|P2|COMPLETED|Safety-Extension Period (12 Months)||6
2473407|NCT00947544|6066408|P1|COMPLETED|Safety-Extension Period (12 Months)||10
2473408|NCT00947544|6066407|P2|STARTED|Safety-Extension Period (12 Months)|New participants were enrolled due to DSMB approval.|6
2473409|NCT00947544|6066408|P1|STARTED|Safety-Extension Period (12 Months)||11
2473410|NCT00947544|6066407|P2|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
2473411|NCT00947544|6066408|P1|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
2473412|NCT00947544|6066407|P2|COMPLETED|Switch-Over Period (2 Weeks)||0
2473413|NCT00947544|6066408|P1|COMPLETED|Switch-Over Period (2 Weeks)||11
2473414|NCT00947544|6066407|P2|STARTED|Switch-Over Period (2 Weeks)||0
2473415|NCT00947544|6066408|P1|STARTED|Switch-Over Period (2 Weeks)||11
2473416|NCT00947531|6066434|P2|NOT COMPLETED|Overall Study||11
2473417|NCT00947531|6066435|P1|NOT COMPLETED|Overall Study||14
2473418|NCT00947531|6066434|P2|COMPLETED|Overall Study||110
2473419|NCT00947531|6066435|P1|COMPLETED|Overall Study||107
2473420|NCT00947531|6066434|P2|STARTED|Overall Study||121
2473421|NCT00947531|6066435|P1|STARTED|Overall Study||121
2473422|NCT00947518|6066444|P3|NOT COMPLETED|Overall Study||0
2473423|NCT00947518|6066445|P2|NOT COMPLETED|Overall Study||0
2473424|NCT00947518|6066446|P1|NOT COMPLETED|Overall Study||0
2473425|NCT00947518|6066444|P3|COMPLETED|Overall Study||20
2473426|NCT00947518|6066445|P2|COMPLETED|Overall Study||20
2473427|NCT00947518|6066446|P1|COMPLETED|Overall Study||20
2473428|NCT00947518|6066444|P3|STARTED|Overall Study||20
2473429|NCT00947518|6066445|P2|STARTED|Overall Study||20
2473430|NCT00947518|6066446|P1|STARTED|Overall Study||20
2473431|NCT00947505|6066462|P2|NOT COMPLETED|Overall Study||2
2473432|NCT00947505|6066463|P1|NOT COMPLETED|Overall Study||9
2473433|NCT00947505|6066462|P2|COMPLETED|Overall Study||14
2473434|NCT00947505|6066463|P1|COMPLETED|Overall Study||24
2473435|NCT00947505|6066462|P2|STARTED|Overall Study||16
2473436|NCT00947505|6066463|P1|STARTED|Overall Study||33
2473437|NCT00947427|6066471|P2|NOT COMPLETED|Overall Study||4
2473438|NCT00947427|6066472|P1|NOT COMPLETED|Overall Study||1
2473439|NCT00947427|6066471|P2|COMPLETED|Overall Study||45
2473440|NCT00947427|6066472|P1|COMPLETED|Overall Study||21
2473441|NCT00947427|6066471|P2|STARTED|Overall Study|2 participants discontinued prior to any study drug administration|49
2473442|NCT00947427|6066472|P1|STARTED|Overall Study||22
2473443|NCT00947349|6066482|P4|NOT COMPLETED|Overall Study Standard of Care||2
2473444|NCT00947349|6066483|P3|NOT COMPLETED|Overall Study Standard of Care||2
2473445|NCT00947349|6066484|P2|NOT COMPLETED|Overall Study Standard of Care||0
2473446|NCT00947349|6066485|P1|NOT COMPLETED|Overall Study Standard of Care||0
2473447|NCT00947349|6066482|P4|COMPLETED|Overall Study Standard of Care||4
2473448|NCT00947349|6066483|P3|COMPLETED|Overall Study Standard of Care||4
2473449|NCT00947349|6066484|P2|COMPLETED|Overall Study Standard of Care||5
2473450|NCT00947349|6066485|P1|COMPLETED|Overall Study Standard of Care||4
2473451|NCT00947349|6066482|P4|STARTED|Overall Study Standard of Care||6
2473452|NCT00947349|6066483|P3|STARTED|Overall Study Standard of Care||6
2473453|NCT00947349|6066484|P2|STARTED|Overall Study Standard of Care||5
2473454|NCT00947349|6066485|P1|STARTED|Overall Study Standard of Care||4
2473455|NCT00947349|6066482|P4|NOT COMPLETED|Triple Treatment Combination Period||0
2473456|NCT00947349|6066483|P3|NOT COMPLETED|Triple Treatment Combination Period||0
2473457|NCT00947349|6066484|P2|NOT COMPLETED|Triple Treatment Combination Period||1
2473458|NCT00947349|6066485|P1|NOT COMPLETED|Triple Treatment Combination Period||0
2473459|NCT00947349|6066482|P4|COMPLETED|Triple Treatment Combination Period||6
2473460|NCT00947349|6066483|P3|COMPLETED|Triple Treatment Combination Period||6
2473461|NCT00947349|6066484|P2|COMPLETED|Triple Treatment Combination Period||5
2473462|NCT00947349|6066485|P1|COMPLETED|Triple Treatment Combination Period||4
2473463|NCT00947349|6066482|P4|STARTED|Triple Treatment Combination Period||6
2473464|NCT00947349|6066483|P3|STARTED|Triple Treatment Combination Period||6
2473465|NCT00947349|6066484|P2|STARTED|Triple Treatment Combination Period||6
2473466|NCT00947349|6066485|P1|STARTED|Triple Treatment Combination Period||4
2473467|NCT00947310|6066620|P3|NOT COMPLETED|Overall Study||0
2473468|NCT00947310|6066621|P2|NOT COMPLETED|Overall Study||0
2473469|NCT00947310|6066622|P1|NOT COMPLETED|Overall Study||0
2473470|NCT00947310|6066620|P3|COMPLETED|Overall Study||486
2473471|NCT00947310|6066621|P2|COMPLETED|Overall Study||500
2473472|NCT00947310|6066622|P1|COMPLETED|Overall Study||514
2473473|NCT00947310|6066620|P3|STARTED|Overall Study||486
2473474|NCT00947310|6066621|P2|STARTED|Overall Study||500
2473475|NCT00947310|6066622|P1|STARTED|Overall Study||514
2473476|NCT00947297|6066636|P1|NOT COMPLETED|Overall Study||7
2473477|NCT00947297|6066636|P1|COMPLETED|Overall Study||53
2473478|NCT00947297|6066636|P1|STARTED|Overall Study||60
2473479|NCT00947284|6066643|P2|NOT COMPLETED|Overall Study||3
2473480|NCT00947284|6066644|P1|NOT COMPLETED|Overall Study||0
2473481|NCT00947284|6066643|P2|COMPLETED|Overall Study||0
2473482|NCT00947284|6066644|P1|COMPLETED|Overall Study||0
2473483|NCT00947284|6066643|P2|STARTED|Overall Study||3
2473484|NCT00947284|6066644|P1|STARTED|Overall Study||0
2473485|NCT00947271|6066652|P4|NOT COMPLETED|12 Months Post Intervention||62
2473486|NCT00947271|6066653|P3|NOT COMPLETED|12 Months Post Intervention||59
2473487|NCT00947271|6066654|P2|NOT COMPLETED|12 Months Post Intervention||60
2473488|NCT00947271|6066655|P1|NOT COMPLETED|12 Months Post Intervention||71
2473489|NCT00947271|6066652|P4|COMPLETED|12 Months Post Intervention||188
2473490|NCT00947271|6066653|P3|COMPLETED|12 Months Post Intervention||195
2473491|NCT00947271|6066654|P2|COMPLETED|12 Months Post Intervention||192
2473492|NCT00947271|6066655|P1|COMPLETED|12 Months Post Intervention||183
2473493|NCT00947271|6066652|P4|STARTED|12 Months Post Intervention||250
2473494|NCT00947271|6066653|P3|STARTED|12 Months Post Intervention||254
2473495|NCT00947271|6066654|P2|STARTED|12 Months Post Intervention||252
2473496|NCT00947271|6066655|P1|STARTED|12 Months Post Intervention||254
2473497|NCT00947271|6066652|P4|NOT COMPLETED|9 Months Post Intervention||59
2473498|NCT00947271|6066653|P3|NOT COMPLETED|9 Months Post Intervention||61
2473499|NCT00947271|6066654|P2|NOT COMPLETED|9 Months Post Intervention||60
2473500|NCT00947271|6066655|P1|NOT COMPLETED|9 Months Post Intervention||70
2473501|NCT00947271|6066652|P4|COMPLETED|9 Months Post Intervention||191
2473502|NCT00947271|6066653|P3|COMPLETED|9 Months Post Intervention||193
2473503|NCT00947271|6066654|P2|COMPLETED|9 Months Post Intervention||192
2473504|NCT00947271|6066655|P1|COMPLETED|9 Months Post Intervention||184
2473505|NCT00947271|6066652|P4|STARTED|9 Months Post Intervention||250
2473506|NCT00947271|6066653|P3|STARTED|9 Months Post Intervention||254
2473507|NCT00947271|6066654|P2|STARTED|9 Months Post Intervention||252
2473508|NCT00947271|6066655|P1|STARTED|9 Months Post Intervention||254
2473509|NCT00947271|6066652|P4|NOT COMPLETED|6 Months Post Intervention||54
2473510|NCT00947271|6066653|P3|NOT COMPLETED|6 Months Post Intervention||58
2473511|NCT00947271|6066654|P2|NOT COMPLETED|6 Months Post Intervention||53
2473512|NCT00947271|6066655|P1|NOT COMPLETED|6 Months Post Intervention||55
2473513|NCT00947271|6066652|P4|COMPLETED|6 Months Post Intervention||196
2473514|NCT00947271|6066653|P3|COMPLETED|6 Months Post Intervention||196
2473515|NCT00947271|6066654|P2|COMPLETED|6 Months Post Intervention||199
2473516|NCT00947271|6066655|P1|COMPLETED|6 Months Post Intervention||199
2473517|NCT00947271|6066652|P4|STARTED|6 Months Post Intervention||250
2473518|NCT00947271|6066653|P3|STARTED|6 Months Post Intervention||254
2473519|NCT00947271|6066654|P2|STARTED|6 Months Post Intervention||252
2473520|NCT00947271|6066655|P1|STARTED|6 Months Post Intervention||254
2473521|NCT00947271|6066652|P4|NOT COMPLETED|3 Months Post Intervention||44
2473522|NCT00947271|6066653|P3|NOT COMPLETED|3 Months Post Intervention||36
2473523|NCT00947271|6066654|P2|NOT COMPLETED|3 Months Post Intervention||48
2473524|NCT00947271|6066655|P1|NOT COMPLETED|3 Months Post Intervention||52
2473525|NCT00947271|6066652|P4|COMPLETED|3 Months Post Intervention||206
2473526|NCT00947271|6066653|P3|COMPLETED|3 Months Post Intervention||218
2473527|NCT00947271|6066654|P2|COMPLETED|3 Months Post Intervention||204
2473528|NCT00947271|6066655|P1|COMPLETED|3 Months Post Intervention||202
2473529|NCT00947271|6066652|P4|STARTED|3 Months Post Intervention||250
2473530|NCT00947271|6066653|P3|STARTED|3 Months Post Intervention||254
2473531|NCT00947271|6066654|P2|STARTED|3 Months Post Intervention||252
2473532|NCT00947271|6066655|P1|STARTED|3 Months Post Intervention||254
2473533|NCT00947219|6066684|P3|NOT COMPLETED|Overall Study||4
2473534|NCT00947219|6066685|P2|NOT COMPLETED|Overall Study||4
2473535|NCT00947219|6066686|P1|NOT COMPLETED|Overall Study||6
2473536|NCT00947219|6066684|P3|COMPLETED|Overall Study||22
2473537|NCT00947219|6066685|P2|COMPLETED|Overall Study||21
2473538|NCT00947219|6066686|P1|COMPLETED|Overall Study||22
2473539|NCT00947219|6066684|P3|STARTED|Overall Study||26
2473540|NCT00947219|6066685|P2|STARTED|Overall Study||25
2473541|NCT00947219|6066686|P1|STARTED|Overall Study||28
2473542|NCT00947167|6066694|P1|NOT COMPLETED|Erlotinib Added to Pertuzumab||0
2473543|NCT00947167|6066694|P1|COMPLETED|Erlotinib Added to Pertuzumab||3
2473544|NCT00947167|6066694|P1|STARTED|Erlotinib Added to Pertuzumab||3
2473545|NCT00947167|6066694|P1|NOT COMPLETED|Pertuzumab Alone||0
2473546|NCT00947167|6066694|P1|COMPLETED|Pertuzumab Alone||4
2473547|NCT00947167|6066694|P1|STARTED|Pertuzumab Alone||4
2473548|NCT00947154|6066699|P1|NOT COMPLETED|Overall Study||1
2473549|NCT00947154|6066699|P1|COMPLETED|Overall Study||11
2473550|NCT00947154|6066699|P1|STARTED|Overall Study||12
2473551|NCT00947115|6066709|P3|NOT COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||15
2473552|NCT00947115|6066710|P2|NOT COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||22
2473553|NCT00947115|6066711|P1|NOT COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||17
2473554|NCT00947115|6066709|P3|COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||156
2473555|NCT00947115|6066710|P2|COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||172
2473556|NCT00947115|6066711|P1|COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||142
2473557|NCT00947115|6066709|P3|STARTED|Year 0 (Month 0) - Year 10 (Month 120)||171
2473558|NCT00947115|6066710|P2|STARTED|Year 0 (Month 0) - Year 10 (Month 120)||194
2473559|NCT00947115|6066711|P1|STARTED|Year 0 (Month 0) - Year 10 (Month 120)||159
2473560|NCT00947115|6066709|P3|NOT COMPLETED|Year 10 (Month 120)||0
2473561|NCT00947115|6066710|P2|NOT COMPLETED|Year 10 (Month 120)||0
2473562|NCT00947115|6066711|P1|NOT COMPLETED|Year 10 (Month 120)||0
2473563|NCT00947115|6066709|P3|COMPLETED|Year 10 (Month 120)||156
2473564|NCT00947115|6066710|P2|COMPLETED|Year 10 (Month 120)||172
2473565|NCT00947115|6066711|P1|COMPLETED|Year 10 (Month 120)||142
2473566|NCT00947115|6066709|P3|STARTED|Year 10 (Month 120)||156
2473567|NCT00947115|6066710|P2|STARTED|Year 10 (Month 120)||172
2473568|NCT00947115|6066711|P1|STARTED|Year 10 (Month 120)||142
2473569|NCT00947115|6066709|P3|NOT COMPLETED|Year 9 (Month 108)||0
2473570|NCT00947115|6066710|P2|NOT COMPLETED|Year 9 (Month 108)||0
2473571|NCT00947115|6066711|P1|NOT COMPLETED|Year 9 (Month 108)||0
2473572|NCT00947115|6066709|P3|COMPLETED|Year 9 (Month 108)||157
2473573|NCT00947115|6066710|P2|COMPLETED|Year 9 (Month 108)||180
2473574|NCT00947115|6066711|P1|COMPLETED|Year 9 (Month 108)||146
2473575|NCT00947115|6066709|P3|STARTED|Year 9 (Month 108)||157
2473576|NCT00947115|6066710|P2|STARTED|Year 9 (Month 108)||180
2473577|NCT00947115|6066711|P1|STARTED|Year 9 (Month 108)||146
2473578|NCT00947115|6066709|P3|NOT COMPLETED|Year 8 (Month 96)||0
2473579|NCT00947115|6066710|P2|NOT COMPLETED|Year 8 (Month 96)||0
2473580|NCT00947115|6066711|P1|NOT COMPLETED|Year 8 (Month 96)||0
2473581|NCT00947115|6066709|P3|COMPLETED|Year 8 (Month 96)||141
2473582|NCT00947115|6066710|P2|COMPLETED|Year 8 (Month 96)||152
2473583|NCT00947115|6066711|P1|COMPLETED|Year 8 (Month 96)||137
2473584|NCT00947115|6066709|P3|STARTED|Year 8 (Month 96)||141
2473585|NCT00947115|6066710|P2|STARTED|Year 8 (Month 96)||152
2473586|NCT00947115|6066711|P1|STARTED|Year 8 (Month 96)||137
2473587|NCT00947115|6066709|P3|NOT COMPLETED|Year 7 (Month 84)||0
2473588|NCT00947115|6066710|P2|NOT COMPLETED|Year 7 (Month 84)||0
2473589|NCT00947115|6066711|P1|NOT COMPLETED|Year 7 (Month 84)||0
2473590|NCT00947115|6066709|P3|COMPLETED|Year 7 (Month 84)||160
2473591|NCT00947115|6066710|P2|COMPLETED|Year 7 (Month 84)||165
2473592|NCT00947115|6066711|P1|COMPLETED|Year 7 (Month 84)||149
2473593|NCT00947115|6066709|P3|STARTED|Year 7 (Month 84)||160
2473594|NCT00947115|6066710|P2|STARTED|Year 7 (Month 84)||165
2473595|NCT00947115|6066711|P1|STARTED|Year 7 (Month 84)||149
2473596|NCT00947115|6066709|P3|NOT COMPLETED|Year 6 (Month 72)||0
2473597|NCT00947115|6066710|P2|NOT COMPLETED|Year 6 (Month 72)||0
2473598|NCT00947115|6066711|P1|NOT COMPLETED|Year 6 (Month 72)||0
2473599|NCT00947115|6066709|P3|COMPLETED|Year 6 (Month 72)||164
2473600|NCT00947115|6066710|P2|COMPLETED|Year 6 (Month 72)||177
2473601|NCT00947115|6066711|P1|COMPLETED|Year 6 (Month 72)||147
2473602|NCT00947115|6066709|P3|STARTED|Year 6 (Month 72)||164
2473603|NCT00947115|6066710|P2|STARTED|Year 6 (Month 72)||177
2473604|NCT00947115|6066711|P1|STARTED|Year 6 (Month 72)||147
2473605|NCT00947115|6066709|P3|NOT COMPLETED|Year 5 (Month 60)||0
2473606|NCT00947115|6066710|P2|NOT COMPLETED|Year 5 (Month 60)||0
2473607|NCT00947115|6066711|P1|NOT COMPLETED|Year 5 (Month 60)||0
2473608|NCT00947115|6066709|P3|COMPLETED|Year 5 (Month 60)||170
2473609|NCT00947115|6066710|P2|COMPLETED|Year 5 (Month 60)||184
2473610|NCT00947115|6066711|P1|COMPLETED|Year 5 (Month 60)||153
2473611|NCT00947115|6066709|P3|STARTED|Year 5 (Month 60)||170
2473612|NCT00947115|6066710|P2|STARTED|Year 5 (Month 60)||184
2473613|NCT00947115|6066711|P1|STARTED|Year 5 (Month 60)||153
2473614|NCT00947011|6066773|P1|NOT COMPLETED|Overall Study||12
2473615|NCT00947011|6066773|P1|COMPLETED|Overall Study||0
2473616|NCT00947011|6066773|P1|STARTED|Overall Study||12
2473617|NCT00946998|6066783|P2|NOT COMPLETED|Overall Study||3
2473618|NCT00946998|6066784|P1|NOT COMPLETED|Overall Study||5
2473619|NCT00946998|6066783|P2|COMPLETED|Overall Study||96
2473620|NCT00946998|6066784|P1|COMPLETED|Overall Study||97
2473621|NCT00946998|6066783|P2|Received Treatment as Randomized|Overall Study||99
2473622|NCT00946998|6066784|P1|Received Treatment as Randomized|Overall Study||102
2473623|NCT00946998|6066783|P2|STARTED|Overall Study||99
2473624|NCT00946998|6066784|P1|STARTED|Overall Study||102
2473625|NCT00946985|6066798|P1|NOT COMPLETED|Relapse Prevention Phase (24 Months)||2
2473626|NCT00946985|6066798|P1|COMPLETED|Relapse Prevention Phase (24 Months)||0
2473627|NCT00946985|6066798|P1|STARTED|Relapse Prevention Phase (24 Months)|Both randomized patients were discontinued when the sponsor terminated the trial early.|2
2473628|NCT00946985|6066798|P1|NOT COMPLETED|Stabilization Phase (25 Weeks)||160
2473629|NCT00946985|6066798|P1|COMPLETED|Stabilization Phase (25 Weeks)||2
2473630|NCT00946985|6066798|P1|STARTED|Stabilization Phase (25 Weeks)||162
2473631|NCT00946920|6066804|P2|NOT COMPLETED|Overall Study||44
2473632|NCT00946920|6066805|P1|NOT COMPLETED|Overall Study||110
2473633|NCT00946920|6066804|P2|COMPLETED|Overall Study||239
2473634|NCT00946920|6066805|P1|COMPLETED|Overall Study||455
2473635|NCT00946920|6066804|P2|Full Analysis Set (FAS)|Overall Study|Received at least one dose of goserelin and had at least one post-dosing efficacy assessment.|282
2473636|NCT00946920|6066805|P1|Full Analysis Set (FAS)|Overall Study|Received at least one dose of degarelix and had at least one post-dosing efficacy assessment.|565
2473637|NCT00946920|6066804|P2|STARTED|Overall Study|Received at least one dose of goserelin acetate.|283
2473638|NCT00946920|6066805|P1|STARTED|Overall Study|Received at least one dose of degarelix.|565
2473639|NCT00946881|6066820|P1|NOT COMPLETED|Retreatment||1
2473640|NCT00946881|6066820|P1|COMPLETED|Retreatment||7
2473641|NCT00946881|6066820|P1|STARTED|Retreatment||8
2473642|NCT00946881|6066820|P1|NOT COMPLETED|First Treatment||2
2473643|NCT00946881|6066820|P1|COMPLETED|First Treatment||28
2473644|NCT00946881|6066820|P1|STARTED|First Treatment||30
2473645|NCT00946712|6066851|P2|NOT COMPLETED|Overall Study||662
2473646|NCT00946712|6066852|P1|NOT COMPLETED|Overall Study||547
2473647|NCT00946712|6066851|P2|COMPLETED|Overall Study||0
2473648|NCT00946712|6066852|P1|COMPLETED|Overall Study||124
2473649|NCT00946712|6066851|P2|STARTED|Overall Study||662
2473650|NCT00946712|6066852|P1|STARTED|Overall Study||671
2473651|NCT00946530|6066876|P4|NOT COMPLETED|Overall Study||4
2473652|NCT00946530|6066877|P3|NOT COMPLETED|Overall Study||1
2473653|NCT00946530|6066878|P2|NOT COMPLETED|Overall Study||4
2473654|NCT00946530|6066879|P1|NOT COMPLETED|Overall Study||1
2473655|NCT00946530|6066876|P4|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|23
2473656|NCT00946530|6066877|P3|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
2473657|NCT00946530|6066878|P2|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver completed to the Dim Light (Control) arm|23
2473658|NCT00946530|6066879|P1|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
2473659|NCT00946530|6066876|P4|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
2473660|NCT00946530|6066877|P3|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
2473661|NCT00946530|6066878|P2|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
2473662|NCT00946530|6066879|P1|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
2473663|NCT00946478|6066895|P2|NOT COMPLETED|Overall Study||0
2473664|NCT00946478|6066896|P1|NOT COMPLETED|Overall Study||0
2473665|NCT00946478|6066895|P2|COMPLETED|Overall Study||20
2473666|NCT00946478|6066896|P1|COMPLETED|Overall Study||20
2473667|NCT00946478|6066895|P2|STARTED|Overall Study||20
2473668|NCT00946478|6066896|P1|STARTED|Overall Study||20
2473669|NCT00946348|6066904|P2|NOT COMPLETED|Overall Study||0
2473670|NCT00946348|6066905|P1|NOT COMPLETED|Overall Study||0
2473671|NCT00946348|6066904|P2|COMPLETED|Overall Study||6
2473672|NCT00946348|6066905|P1|COMPLETED|Overall Study||6
2473673|NCT00946348|6066904|P2|STARTED|Overall Study||6
2473674|NCT00946348|6066905|P1|STARTED|Overall Study||6
2473675|NCT00946322|6066911|P1|NOT COMPLETED|Post-treatment||2
2473676|NCT00946322|6066911|P1|COMPLETED|Post-treatment||9
2473677|NCT00946322|6066911|P1|STARTED|Post-treatment||11
2473678|NCT00946322|6066911|P1|NOT COMPLETED|Pre-treatment||1
2473679|NCT00946322|6066911|P1|COMPLETED|Pre-treatment||11
2473680|NCT00946322|6066911|P1|STARTED|Pre-treatment||12
2473681|NCT00946309|6066924|P2|NOT COMPLETED|Overall Study||4
2473682|NCT00946309|6066925|P1|NOT COMPLETED|Overall Study||1
2473683|NCT00946309|6066924|P2|COMPLETED|Overall Study||19
2473684|NCT00946309|6066925|P1|COMPLETED|Overall Study||21
2473685|NCT00946309|6066924|P2|STARTED|Overall Study||23
2473686|NCT00946309|6066925|P1|STARTED|Overall Study||22
2473687|NCT00946296|6066943|P2|NOT COMPLETED|Overall Study||0
2473688|NCT00946296|6066944|P1|NOT COMPLETED|Overall Study||3
2473689|NCT00946296|6066943|P2|COMPLETED|Overall Study||15
2473690|NCT00946296|6066944|P1|COMPLETED|Overall Study||18
2473691|NCT00946296|6066943|P2|STARTED|Overall Study||15
2473692|NCT00946296|6066944|P1|STARTED|Overall Study||21
2473693|NCT00946270|6066953|P3|NOT COMPLETED|Overall Study||0
2473694|NCT00946270|6066954|P2|NOT COMPLETED|Overall Study||0
2473695|NCT00946270|6066955|P1|NOT COMPLETED|Overall Study||0
2473696|NCT00946270|6066953|P3|COMPLETED|Overall Study||29
2473697|NCT00946270|6066954|P2|COMPLETED|Overall Study||20
2473698|NCT00946270|6066955|P1|COMPLETED|Overall Study||21
2473699|NCT00946270|6066953|P3|STARTED|Overall Study||29
2473700|NCT00946270|6066954|P2|STARTED|Overall Study||20
2473701|NCT00946270|6066955|P1|STARTED|Overall Study||21
2473702|NCT00946153|6066968|P5|NOT COMPLETED|Phase 2||13
2473703|NCT00946153|6066969|P4|NOT COMPLETED|Phase 2||0
2473704|NCT00946153|6066970|P3|NOT COMPLETED|Phase 2||0
2473705|NCT00946153|6066971|P2|NOT COMPLETED|Phase 2||0
2473706|NCT00946153|6066972|P1|NOT COMPLETED|Phase 2||0
2473707|NCT00946153|6066968|P5|COMPLETED|Phase 2||33
2473708|NCT00946153|6066969|P4|COMPLETED|Phase 2||0
2473709|NCT00946153|6066970|P3|COMPLETED|Phase 2||0
2473710|NCT00946153|6066971|P2|COMPLETED|Phase 2||0
2473711|NCT00946153|6066972|P1|COMPLETED|Phase 2||0
2473712|NCT00946153|6066968|P5|STARTED|Phase 2||46
2473713|NCT00946153|6066969|P4|STARTED|Phase 2||0
2473714|NCT00946153|6066970|P3|STARTED|Phase 2||0
2473715|NCT00946153|6066971|P2|STARTED|Phase 2||0
2473716|NCT00946153|6066972|P1|STARTED|Phase 2||0
2473717|NCT00946153|6066968|P5|NOT COMPLETED|Phase 1||0
2473718|NCT00946153|6066969|P4|NOT COMPLETED|Phase 1||0
2473719|NCT00946153|6066970|P3|NOT COMPLETED|Phase 1||0
2473720|NCT00946153|6066971|P2|NOT COMPLETED|Phase 1||0
2473721|NCT00946153|6066972|P1|NOT COMPLETED|Phase 1||0
2473722|NCT00946153|6066968|P5|COMPLETED|Phase 1||0
2473723|NCT00946153|6066969|P4|COMPLETED|Phase 1||5
2473724|NCT00946153|6066970|P3|COMPLETED|Phase 1||6
2473725|NCT00946153|6066971|P2|COMPLETED|Phase 1||3
2473726|NCT00946153|6066972|P1|COMPLETED|Phase 1||6
2473727|NCT00946153|6066968|P5|STARTED|Phase 1||0
2473728|NCT00946153|6066969|P4|STARTED|Phase 1||5
2473729|NCT00946153|6066970|P3|STARTED|Phase 1||6
2473730|NCT00946153|6066971|P2|STARTED|Phase 1||3
2473731|NCT00946153|6066972|P1|STARTED|Phase 1||6
2473732|NCT00946114|6067000|P2|NOT COMPLETED|Overall Study||2
2473733|NCT00946114|6067001|P1|NOT COMPLETED|Overall Study||8
2473734|NCT00946114|6067000|P2|COMPLETED|Overall Study||10
2473735|NCT00946114|6067001|P1|COMPLETED|Overall Study||12
2473736|NCT00946114|6067000|P2|STARTED|Overall Study||12
2473737|NCT00946114|6067001|P1|STARTED|Overall Study||20
2473738|NCT00946101|6067009|P2|NOT COMPLETED|Overall Study||2
2473739|NCT00946101|6067010|P1|NOT COMPLETED|Overall Study||4
2473740|NCT00946101|6067009|P2|COMPLETED|Overall Study||63
2473741|NCT00946101|6067010|P1|COMPLETED|Overall Study||257
2473742|NCT00946101|6067009|P2|Day 15 Post Dose 2|Overall Study||63
2473743|NCT00946101|6067010|P1|Day 15 Post Dose 2|Overall Study||254
2473744|NCT00946101|6067009|P2|Day 15 Post Dose 1|Overall Study||64
2473745|NCT00946101|6067010|P1|Day 15 Post Dose 1|Overall Study||260
2473746|NCT00946101|6067009|P2|STARTED|Overall Study||65
2473747|NCT00946101|6067010|P1|STARTED|Overall Study|Intent to Treat population, enrolled and randomized|261
2473748|NCT00946088|6067076|P2|NOT COMPLETED|Overall Study||1
2473749|NCT00946088|6067077|P1|NOT COMPLETED|Overall Study||0
2473750|NCT00946088|6067076|P2|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|2
2473751|NCT00946088|6067077|P1|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|4
2473752|NCT00946088|6067076|P2|STARTED|Overall Study||3
2473753|NCT00946088|6067077|P1|STARTED|Overall Study||4
2473754|NCT00946023|6067099|P1|NOT COMPLETED|Overall Study||0
2473755|NCT00946023|6067099|P1|COMPLETED|Overall Study||83
2473756|NCT00946023|6067099|P1|STARTED|Overall Study||83
2473757|NCT00945958|6067114|P1|NOT COMPLETED|Overall Study||12
2473758|NCT00945958|6067114|P1|COMPLETED|Overall Study||149
2473759|NCT00945958|6067114|P1|STARTED|Overall Study||161
2473760|NCT00945945|6067121|P2|NOT COMPLETED|Overall Study||55
2473761|NCT00945945|6067122|P1|NOT COMPLETED|Overall Study||36
2473762|NCT00945945|6067121|P2|COMPLETED|Overall Study||162
2473763|NCT00945945|6067122|P1|COMPLETED|Overall Study||171
2473764|NCT00945945|6067121|P2|STARTED|Overall Study||217
2473765|NCT00945945|6067122|P1|STARTED|Overall Study||207
2473766|NCT00945906|6067148|P1|NOT COMPLETED|Overall Study||7
2473767|NCT00945906|6067148|P1|COMPLETED|Overall Study||54
2473768|NCT00945906|6067148|P1|STARTED|Overall Study||61
2473769|NCT00945893|6067159|P2|NOT COMPLETED|Overall Study||10
2473770|NCT00945893|6067160|P1|NOT COMPLETED|Overall Study||3
2473771|NCT00945893|6067159|P2|COMPLETED|Overall Study||230
2473772|NCT00945893|6067160|P1|COMPLETED|Overall Study||57
2473773|NCT00945893|6067159|P2|Day 15 Post Dose 2|Overall Study||226
2473774|NCT00945893|6067160|P1|Day 15 Post Dose 2|Overall Study||54
2473775|NCT00945893|6067159|P2|Day 15 Post Dose 1|Overall Study||238
2473776|NCT00945893|6067160|P1|Day 15 Post Dose 1|Overall Study||60
2473777|NCT00945893|6067159|P2|STARTED|Overall Study||240
2473778|NCT00945893|6067160|P1|STARTED|Overall Study||60
2473779|NCT00945854|6067226|P2|NOT COMPLETED|Overall Study||4
2473780|NCT00945854|6067227|P1|NOT COMPLETED|Overall Study||2
2473781|NCT00945854|6067226|P2|COMPLETED|Overall Study||26
2473782|NCT00945854|6067227|P1|COMPLETED|Overall Study||28
2473783|NCT00945854|6067226|P2|STARTED|Overall Study||30
2473784|NCT00945854|6067227|P1|STARTED|Overall Study||30
2473785|NCT00945815|6067237|P1|NOT COMPLETED|Overall Study||8
2473786|NCT00945815|6067237|P1|COMPLETED|Overall Study||27
2473787|NCT00945815|6067237|P1|Eligible and Began Protocol Therapy|Overall Study||31
2473788|NCT00945815|6067237|P1|Eligible|Overall Study||32
2473789|NCT00945815|6067237|P1|STARTED|Overall Study||35
2473790|NCT00945750|6067248|P6|NOT COMPLETED|Period III||0
2473791|NCT00945750|6067249|P5|NOT COMPLETED|Period III||0
2473792|NCT00945750|6067250|P4|NOT COMPLETED|Period III||0
2473793|NCT00945750|6067251|P3|NOT COMPLETED|Period III||0
2473794|NCT00945750|6067252|P2|NOT COMPLETED|Period III||0
2473795|NCT00945750|6067253|P1|NOT COMPLETED|Period III||0
2473796|NCT00945750|6067248|P6|COMPLETED|Period III||5
2473797|NCT00945750|6067249|P5|COMPLETED|Period III||5
2473798|NCT00945750|6067250|P4|COMPLETED|Period III||5
2473799|NCT00945750|6067251|P3|COMPLETED|Period III||5
2473800|NCT00945750|6067252|P2|COMPLETED|Period III||5
2473801|NCT00945750|6067253|P1|COMPLETED|Period III||5
2473802|NCT00945750|6067248|P6|STARTED|Period III||5
2473803|NCT00945750|6067249|P5|STARTED|Period III||5
2473804|NCT00945750|6067250|P4|STARTED|Period III||5
2473805|NCT00945750|6067251|P3|STARTED|Period III||5
2473806|NCT00945750|6067252|P2|STARTED|Period III||5
2473807|NCT00945750|6067253|P1|STARTED|Period III||5
2473808|NCT00945750|6067248|P6|NOT COMPLETED|Period II||0
2473809|NCT00945750|6067249|P5|NOT COMPLETED|Period II||0
2473810|NCT00945750|6067250|P4|NOT COMPLETED|Period II||0
2473811|NCT00945750|6067251|P3|NOT COMPLETED|Period II||0
2473812|NCT00945750|6067252|P2|NOT COMPLETED|Period II||0
2473813|NCT00945750|6067253|P1|NOT COMPLETED|Period II||0
2473814|NCT00945750|6067248|P6|COMPLETED|Period II||5
2473815|NCT00945750|6067249|P5|COMPLETED|Period II||5
2473816|NCT00945750|6067250|P4|COMPLETED|Period II||5
2473817|NCT00945750|6067251|P3|COMPLETED|Period II||5
2473818|NCT00945750|6067252|P2|COMPLETED|Period II||5
2473819|NCT00945750|6067253|P1|COMPLETED|Period II||5
2473820|NCT00945750|6067248|P6|STARTED|Period II||5
2473821|NCT00945750|6067249|P5|STARTED|Period II||5
2473822|NCT00945750|6067250|P4|STARTED|Period II||5
2473823|NCT00945750|6067251|P3|STARTED|Period II||5
2473824|NCT00945750|6067252|P2|STARTED|Period II||5
2473825|NCT00945750|6067253|P1|STARTED|Period II||5
2473826|NCT00945750|6067248|P6|NOT COMPLETED|Period I||0
2473827|NCT00945750|6067249|P5|NOT COMPLETED|Period I||0
2473828|NCT00945750|6067250|P4|NOT COMPLETED|Period I||0
2473829|NCT00945750|6067251|P3|NOT COMPLETED|Period I||0
2473830|NCT00945750|6067252|P2|NOT COMPLETED|Period I||0
2473831|NCT00945750|6067253|P1|NOT COMPLETED|Period I||0
2473832|NCT00945750|6067248|P6|COMPLETED|Period I||5
2473833|NCT00945750|6067249|P5|COMPLETED|Period I||5
2473834|NCT00945750|6067250|P4|COMPLETED|Period I||5
2473835|NCT00945750|6067251|P3|COMPLETED|Period I||5
2473836|NCT00945750|6067252|P2|COMPLETED|Period I||5
2473837|NCT00945750|6067253|P1|COMPLETED|Period I||5
2473838|NCT00945750|6067248|P6|STARTED|Period I||5
2473839|NCT00945750|6067249|P5|STARTED|Period I||5
2473840|NCT00945750|6067250|P4|STARTED|Period I||5
2473841|NCT00945750|6067251|P3|STARTED|Period I||5
2473842|NCT00945750|6067252|P2|STARTED|Period I||5
2473843|NCT00945750|6067253|P1|STARTED|Period I||5
2473844|NCT00945659|6067269|P3|NOT COMPLETED|Overall Study||17
2473845|NCT00945659|6067270|P2|NOT COMPLETED|Overall Study||20
2473846|NCT00945659|6067271|P1|NOT COMPLETED|Overall Study||7
2473847|NCT00945659|6067269|P3|COMPLETED|Overall Study||20
2473848|NCT00945659|6067270|P2|COMPLETED|Overall Study||20
2473849|NCT00945659|6067271|P1|COMPLETED|Overall Study||32
2473850|NCT00945659|6067269|P3|12-Months|Overall Study||20
2473851|NCT00945659|6067270|P2|12-Months|Overall Study||20
2473852|NCT00945659|6067271|P1|12-Months|Overall Study||32
2473853|NCT00945659|6067269|P3|9-Months|Overall Study||20
2473854|NCT00945659|6067270|P2|9-Months|Overall Study||20
2473855|NCT00945659|6067271|P1|9-Months|Overall Study||32
2473856|NCT00945659|6067269|P3|6-Months|Overall Study||25
2473857|NCT00945659|6067270|P2|6-Months|Overall Study||29
2473858|NCT00945659|6067271|P1|6-Months|Overall Study||31
2473859|NCT00945659|6067269|P3|3-Months|Overall Study||35
2473860|NCT00945659|6067270|P2|3-Months|Overall Study||39
2473861|NCT00945659|6067271|P1|3-Months|Overall Study||38
2473862|NCT00945659|6067269|P3|Baseline|Overall Study||37
2473863|NCT00945659|6067270|P2|Baseline|Overall Study||40
2473864|NCT00945659|6067271|P1|Baseline|Overall Study||39
2473865|NCT00945659|6067269|P3|STARTED|Overall Study||37
2473866|NCT00945659|6067270|P2|STARTED|Overall Study||40
2473867|NCT00945659|6067271|P1|STARTED|Overall Study||39
2473868|NCT00945594|6067317|P2|NOT COMPLETED|Overall Study||0
2473869|NCT00945594|6067318|P1|NOT COMPLETED|Overall Study||0
2473870|NCT00945594|6067317|P2|COMPLETED|Overall Study||50
2473871|NCT00945594|6067318|P1|COMPLETED|Overall Study||50
2473872|NCT00945594|6067317|P2|STARTED|Overall Study||50
2473873|NCT00945594|6067318|P1|STARTED|Overall Study||50
2473874|NCT00945555|6067328|P1|NOT COMPLETED|Overall Study||28
2473875|NCT00945555|6067328|P1|COMPLETED|Overall Study||236
2473876|NCT00945555|6067328|P1|STARTED|Overall Study||264
2473877|NCT00945477|6067339|P1|NOT COMPLETED|Overall Study||6
2473878|NCT00945477|6067339|P1|COMPLETED|Overall Study||5
2473879|NCT00945477|6067339|P1|STARTED|Overall Study||11
2473880|NCT00945334|6067346|P2|NOT COMPLETED|Overall Study||3
2473881|NCT00945334|6067347|P1|NOT COMPLETED|Overall Study||3
2473882|NCT00945334|6067346|P2|COMPLETED|Overall Study||15
2473883|NCT00945334|6067347|P1|COMPLETED|Overall Study||16
2473884|NCT00945334|6067346|P2|STARTED|Overall Study||18
2473885|NCT00945334|6067347|P1|STARTED|Overall Study||19
2473886|NCT00945321|6067355|P6|NOT COMPLETED|Period 4||1
2473887|NCT00945321|6067356|P5|NOT COMPLETED|Period 4||0
2473888|NCT00945321|6067357|P4|NOT COMPLETED|Period 4||0
2473889|NCT00945321|6067358|P3|NOT COMPLETED|Period 4||0
2473890|NCT00945321|6067359|P2|NOT COMPLETED|Period 4||0
2473891|NCT00945321|6067360|P1|NOT COMPLETED|Period 4||0
2473892|NCT00945321|6067355|P6|COMPLETED|Period 4||6
2473893|NCT00945321|6067356|P5|COMPLETED|Period 4||6
2473894|NCT00945321|6067357|P4|COMPLETED|Period 4||7
2473895|NCT00945321|6067358|P3|COMPLETED|Period 4||7
2473896|NCT00945321|6067359|P2|COMPLETED|Period 4||7
2473897|NCT00945321|6067360|P1|COMPLETED|Period 4||7
2473898|NCT00945321|6067355|P6|STARTED|Period 4||7
2473899|NCT00945321|6067356|P5|STARTED|Period 4||6
2473900|NCT00945321|6067357|P4|STARTED|Period 4||7
2473901|NCT00945321|6067358|P3|STARTED|Period 4||7
2473902|NCT00945321|6067359|P2|STARTED|Period 4||7
2473903|NCT00945321|6067360|P1|STARTED|Period 4||7
2473904|NCT00945321|6067355|P6|NOT COMPLETED|Period 3||0
2473905|NCT00945321|6067356|P5|NOT COMPLETED|Period 3||0
2473906|NCT00945321|6067357|P4|NOT COMPLETED|Period 3||0
2473907|NCT00945321|6067358|P3|NOT COMPLETED|Period 3||0
2473908|NCT00945321|6067359|P2|NOT COMPLETED|Period 3||0
2473909|NCT00945321|6067360|P1|NOT COMPLETED|Period 3||0
2473910|NCT00945321|6067355|P6|COMPLETED|Period 3||7
2473911|NCT00945321|6067356|P5|COMPLETED|Period 3||6
2473912|NCT00945321|6067357|P4|COMPLETED|Period 3||7
2473913|NCT00945321|6067358|P3|COMPLETED|Period 3||7
2473914|NCT00945321|6067359|P2|COMPLETED|Period 3||7
2473915|NCT00945321|6067360|P1|COMPLETED|Period 3||7
2473916|NCT00945321|6067355|P6|STARTED|Period 3||7
2473917|NCT00945321|6067356|P5|STARTED|Period 3||6
2473918|NCT00945321|6067357|P4|STARTED|Period 3||7
2473919|NCT00945321|6067358|P3|STARTED|Period 3||7
2473920|NCT00945321|6067359|P2|STARTED|Period 3||7
2473921|NCT00945321|6067360|P1|STARTED|Period 3||7
2473922|NCT00945321|6067355|P6|NOT COMPLETED|Period 2||0
2473923|NCT00945321|6067356|P5|NOT COMPLETED|Period 2||0
2473924|NCT00945321|6067357|P4|NOT COMPLETED|Period 2||0
2473925|NCT00945321|6067358|P3|NOT COMPLETED|Period 2||0
2473926|NCT00945321|6067359|P2|NOT COMPLETED|Period 2||0
2473927|NCT00945321|6067360|P1|NOT COMPLETED|Period 2||0
2473928|NCT00945321|6067355|P6|COMPLETED|Period 2||7
2473929|NCT00945321|6067356|P5|COMPLETED|Period 2||6
2473930|NCT00945321|6067357|P4|COMPLETED|Period 2||7
2473931|NCT00945321|6067358|P3|COMPLETED|Period 2||7
2473932|NCT00945321|6067359|P2|COMPLETED|Period 2||7
2473933|NCT00945321|6067360|P1|COMPLETED|Period 2||7
2473934|NCT00945321|6067355|P6|STARTED|Period 2||7
2473935|NCT00945321|6067356|P5|STARTED|Period 2||6
2473936|NCT00945321|6067357|P4|STARTED|Period 2||7
2473937|NCT00945321|6067358|P3|STARTED|Period 2||7
2473938|NCT00945321|6067359|P2|STARTED|Period 2||7
2473939|NCT00945321|6067360|P1|STARTED|Period 2||7
2473940|NCT00945321|6067355|P6|NOT COMPLETED|Period 1||0
2473941|NCT00945321|6067356|P5|NOT COMPLETED|Period 1||1
2473942|NCT00945321|6067357|P4|NOT COMPLETED|Period 1||0
2473943|NCT00945321|6067358|P3|NOT COMPLETED|Period 1||0
2473944|NCT00945321|6067359|P2|NOT COMPLETED|Period 1||0
2473945|NCT00945321|6067360|P1|NOT COMPLETED|Period 1||0
2473946|NCT00945321|6067355|P6|COMPLETED|Period 1||7
2473947|NCT00945321|6067356|P5|COMPLETED|Period 1||6
2473948|NCT00945321|6067357|P4|COMPLETED|Period 1||7
2473949|NCT00945321|6067358|P3|COMPLETED|Period 1||7
2473950|NCT00945321|6067359|P2|COMPLETED|Period 1||7
2473951|NCT00945321|6067360|P1|COMPLETED|Period 1||7
2473952|NCT00945321|6067355|P6|STARTED|Period 1||7
2473953|NCT00945321|6067356|P5|STARTED|Period 1||7
2473954|NCT00945321|6067357|P4|STARTED|Period 1||7
2473955|NCT00945321|6067358|P3|STARTED|Period 1||7
2473956|NCT00945321|6067359|P2|STARTED|Period 1||7
2473957|NCT00945321|6067360|P1|STARTED|Period 1||7
2473958|NCT00945295|6067382|P2|NOT COMPLETED|Overall Study||2
2473959|NCT00945295|6067383|P1|NOT COMPLETED|Overall Study||0
2473960|NCT00945295|6067382|P2|COMPLETED|Overall Study||14
2473961|NCT00945295|6067383|P1|COMPLETED|Overall Study||15
2473962|NCT00945295|6067382|P2|STARTED|Overall Study||16
2473963|NCT00945295|6067383|P1|STARTED|Overall Study||15
2473964|NCT00945282|6067393|P2|NOT COMPLETED|Overall Study||0
2473965|NCT00945282|6067394|P1|NOT COMPLETED|Overall Study||0
2473966|NCT00945282|6067393|P2|COMPLETED|Overall Study||2
2473967|NCT00945282|6067394|P1|COMPLETED|Overall Study||6
2473968|NCT00945282|6067393|P2|STARTED|Overall Study||2
2473969|NCT00945282|6067394|P1|STARTED|Overall Study||6
2473970|NCT00945256|6067477|P5|NOT COMPLETED|Overall Study||1
2473971|NCT00945256|6067478|P4|NOT COMPLETED|Overall Study||9
2473972|NCT00945256|6067479|P3|NOT COMPLETED|Overall Study||8
2473973|NCT00945256|6067480|P2|NOT COMPLETED|Overall Study||2
2473974|NCT00945256|6067481|P1|NOT COMPLETED|Overall Study||4
2473975|NCT00945256|6067477|P5|COMPLETED|Overall Study||7
2473976|NCT00945256|6067478|P4|COMPLETED|Overall Study||7
2473977|NCT00945256|6067479|P3|COMPLETED|Overall Study||7
2473978|NCT00945256|6067480|P2|COMPLETED|Overall Study||8
2473979|NCT00945256|6067481|P1|COMPLETED|Overall Study||9
2473980|NCT00945256|6067477|P5|STARTED|Overall Study||8
2473981|NCT00945256|6067478|P4|STARTED|Overall Study||16
2473982|NCT00945256|6067479|P3|STARTED|Overall Study||15
2473983|NCT00945256|6067480|P2|STARTED|Overall Study||10
2473984|NCT00945256|6067481|P1|STARTED|Overall Study||13
2473985|NCT00945243|6067493|P1|NOT COMPLETED|Overall Study||3
2473986|NCT00945243|6067493|P1|COMPLETED|Overall Study||8
2473987|NCT00945243|6067493|P1|STARTED|Overall Study|Enrolled and Treated Per Protocol|11
2473988|NCT00945139|6067499|P1|NOT COMPLETED|Overall Study||0
2473989|NCT00945139|6067499|P1|COMPLETED|Overall Study||46
2473990|NCT00945139|6067499|P1|STARTED|Overall Study||46
2473991|NCT00945100|6067510|P2|NOT COMPLETED|Post-10 Week Primary Outcome||7
2473992|NCT00945100|6067511|P1|NOT COMPLETED|Post-10 Week Primary Outcome||4
2473993|NCT00945100|6067510|P2|COMPLETED|Post-10 Week Primary Outcome||56
2473994|NCT00945100|6067511|P1|COMPLETED|Post-10 Week Primary Outcome||51
2473995|NCT00945100|6067510|P2|STARTED|Post-10 Week Primary Outcome|20 participants were not eligible for Post 10 week Primary Outcome phase|63
2473996|NCT00945100|6067511|P1|STARTED|Post-10 Week Primary Outcome|27 participants were not eligible for Post 10 week Primary Outcome phase|55
2473997|NCT00945100|6067510|P2|NOT COMPLETED|10-week Primary Outcome||3
2473998|NCT00945100|6067511|P1|NOT COMPLETED|10-week Primary Outcome||1
2473999|NCT00945100|6067510|P2|COMPLETED|10-week Primary Outcome||83
2474000|NCT00945100|6067511|P1|COMPLETED|10-week Primary Outcome||82
2474001|NCT00945100|6067510|P2|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|20
2474002|NCT00945100|6067511|P1|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|27
2474003|NCT00945100|6067510|P2|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|63
2474004|NCT00945100|6067511|P1|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|55
2474005|NCT00945100|6067510|P2|STARTED|10-week Primary Outcome||86
2474006|NCT00945100|6067511|P1|STARTED|10-week Primary Outcome||83
2474007|NCT00945035|6067575|P2|NOT COMPLETED|Period 2||0
2474008|NCT00945035|6067576|P1|NOT COMPLETED|Period 2||0
2474009|NCT00945035|6067575|P2|COMPLETED|Period 2||18
2474010|NCT00945035|6067576|P1|COMPLETED|Period 2||18
2474011|NCT00945035|6067575|P2|STARTED|Period 2||18
2474012|NCT00945035|6067576|P1|STARTED|Period 2||18
2474013|NCT00945035|6067575|P2|NOT COMPLETED|Period 1||0
2474014|NCT00945035|6067576|P1|NOT COMPLETED|Period 1||0
2474015|NCT00945035|6067575|P2|COMPLETED|Period 1||18
2474016|NCT00945035|6067576|P1|COMPLETED|Period 1||18
2474017|NCT00945035|6067575|P2|STARTED|Period 1||18
2474018|NCT00945035|6067576|P1|STARTED|Period 1||18
2474019|NCT00945009|6067587|P3|NOT COMPLETED|Overall Study||3
2474020|NCT00945009|6067588|P2|NOT COMPLETED|Overall Study||7
2474021|NCT00945009|6067589|P1|NOT COMPLETED|Overall Study||45
2474022|NCT00945009|6067587|P3|COMPLETED|Overall Study||6
2474023|NCT00945009|6067588|P2|COMPLETED|Overall Study||32
2474024|NCT00945009|6067589|P1|COMPLETED|Overall Study||156
2474025|NCT00945009|6067587|P3|STARTED|Overall Study||9
2474026|NCT00945009|6067588|P2|STARTED|Overall Study||39
2474027|NCT00945009|6067589|P1|STARTED|Overall Study||201
2474028|NCT00944749|6067599|P1|NOT COMPLETED|Overall Study||1
2474029|NCT00944749|6067599|P1|COMPLETED|Overall Study||22
2474030|NCT00944749|6067599|P1|STARTED|Overall Study||23
2474031|NCT00944710|6067606|P2|NOT COMPLETED|Additional Post 10-week Primary Outcome||11
2474032|NCT00944710|6067607|P1|NOT COMPLETED|Additional Post 10-week Primary Outcome||17
2474033|NCT00944710|6067606|P2|COMPLETED|Additional Post 10-week Primary Outcome||22
2474034|NCT00944710|6067607|P1|COMPLETED|Additional Post 10-week Primary Outcome||23
2474035|NCT00944710|6067606|P2|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||26
2474036|NCT00944710|6067607|P1|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||24
2474037|NCT00944710|6067606|P2|STARTED|Additional Post 10-week Primary Outcome||33
2474038|NCT00944710|6067607|P1|STARTED|Additional Post 10-week Primary Outcome||40
2474039|NCT00944710|6067606|P2|NOT COMPLETED|12-week Visit (Off-treatment)||0
2474040|NCT00944710|6067607|P1|NOT COMPLETED|12-week Visit (Off-treatment)||0
2474041|NCT00944710|6067606|P2|COMPLETED|12-week Visit (Off-treatment)||33
2474042|NCT00944710|6067607|P1|COMPLETED|12-week Visit (Off-treatment)||40
2474043|NCT00944710|6067606|P2|STARTED|12-week Visit (Off-treatment)||33
2474044|NCT00944710|6067607|P1|STARTED|12-week Visit (Off-treatment)||40
2474045|NCT00944710|6067606|P2|NOT COMPLETED|10-week Primary Outcome||0
2474046|NCT00944710|6067607|P1|NOT COMPLETED|10-week Primary Outcome||0
2474047|NCT00944710|6067606|P2|COMPLETED|10-week Primary Outcome||33
2474048|NCT00944710|6067607|P1|COMPLETED|10-week Primary Outcome||40
2474049|NCT00944710|6067606|P2|STARTED|10-week Primary Outcome||33
2474050|NCT00944710|6067607|P1|STARTED|10-week Primary Outcome||40
2474051|NCT00944697|6067665|P2|NOT COMPLETED|Overall Study||5
2474052|NCT00944697|6067666|P1|NOT COMPLETED|Overall Study||2
2474053|NCT00944697|6067665|P2|COMPLETED|Overall Study||43
2474054|NCT00944697|6067666|P1|COMPLETED|Overall Study||48
2474055|NCT00944697|6067665|P2|STARTED|Overall Study||48
2474056|NCT00944697|6067666|P1|STARTED|Overall Study||50
2474057|NCT00944671|6067678|P6|NOT COMPLETED|Period III||0
2474058|NCT00944671|6067679|P5|NOT COMPLETED|Period III||0
2474059|NCT00944671|6067680|P4|NOT COMPLETED|Period III||0
2474060|NCT00944671|6067681|P3|NOT COMPLETED|Period III||0
2474061|NCT00944671|6067682|P2|NOT COMPLETED|Period III||0
2474062|NCT00944671|6067683|P1|NOT COMPLETED|Period III||0
2474063|NCT00944671|6067678|P6|COMPLETED|Period III||4
2474064|NCT00944671|6067679|P5|COMPLETED|Period III||4
2474065|NCT00944671|6067680|P4|COMPLETED|Period III||4
2474066|NCT00944671|6067681|P3|COMPLETED|Period III||4
2474067|NCT00944671|6067682|P2|COMPLETED|Period III||4
2474068|NCT00944671|6067683|P1|COMPLETED|Period III||4
2474069|NCT00944671|6067678|P6|STARTED|Period III||4
2474070|NCT00944671|6067679|P5|STARTED|Period III||4
2474071|NCT00944671|6067680|P4|STARTED|Period III||4
2474072|NCT00944671|6067681|P3|STARTED|Period III||4
2474073|NCT00944671|6067682|P2|STARTED|Period III||4
2474074|NCT00944671|6067683|P1|STARTED|Period III||4
2474075|NCT00944671|6067678|P6|NOT COMPLETED|Period II||0
2474076|NCT00944671|6067679|P5|NOT COMPLETED|Period II||0
2474077|NCT00944671|6067680|P4|NOT COMPLETED|Period II||0
2474078|NCT00944671|6067681|P3|NOT COMPLETED|Period II||0
2474079|NCT00944671|6067682|P2|NOT COMPLETED|Period II||0
2474080|NCT00944671|6067683|P1|NOT COMPLETED|Period II||0
2474081|NCT00944671|6067678|P6|COMPLETED|Period II||4
2474082|NCT00944671|6067679|P5|COMPLETED|Period II||4
2474083|NCT00944671|6067680|P4|COMPLETED|Period II||4
2474084|NCT00944671|6067681|P3|COMPLETED|Period II||4
2474085|NCT00944671|6067682|P2|COMPLETED|Period II||4
2474086|NCT00944671|6067683|P1|COMPLETED|Period II||4
2474087|NCT00944671|6067678|P6|STARTED|Period II||4
2474088|NCT00944671|6067679|P5|STARTED|Period II||4
2474089|NCT00944671|6067680|P4|STARTED|Period II||4
2474090|NCT00944671|6067681|P3|STARTED|Period II||4
2474091|NCT00944671|6067682|P2|STARTED|Period II||4
2474092|NCT00944671|6067683|P1|STARTED|Period II||4
2474093|NCT00944671|6067678|P6|NOT COMPLETED|Period I||0
2474094|NCT00944671|6067679|P5|NOT COMPLETED|Period I||0
2474095|NCT00944671|6067680|P4|NOT COMPLETED|Period I||0
2474096|NCT00944671|6067681|P3|NOT COMPLETED|Period I||0
2474097|NCT00944671|6067682|P2|NOT COMPLETED|Period I||0
2474098|NCT00944671|6067683|P1|NOT COMPLETED|Period I||0
2474099|NCT00944671|6067678|P6|COMPLETED|Period I||4
2474100|NCT00944671|6067679|P5|COMPLETED|Period I||4
2474101|NCT00944671|6067680|P4|COMPLETED|Period I||4
2474102|NCT00944671|6067681|P3|COMPLETED|Period I||4
2474103|NCT00944671|6067682|P2|COMPLETED|Period I||4
2474104|NCT00944671|6067683|P1|COMPLETED|Period I||4
2474105|NCT00944671|6067678|P6|STARTED|Period I||4
2474106|NCT00944671|6067679|P5|STARTED|Period I||4
2474107|NCT00944671|6067680|P4|STARTED|Period I||4
2474108|NCT00944671|6067681|P3|STARTED|Period I||4
2474109|NCT00944671|6067682|P2|STARTED|Period I||4
2474110|NCT00944671|6067683|P1|STARTED|Period I||4
2474111|NCT00944658|6067698|P2|NOT COMPLETED|Follow up 4 Weeks||0
2474112|NCT00944658|6067699|P1|NOT COMPLETED|Follow up 4 Weeks||0
2474113|NCT00944658|6067698|P2|COMPLETED|Follow up 4 Weeks||17
2474114|NCT00944658|6067699|P1|COMPLETED|Follow up 4 Weeks||19
2474115|NCT00944658|6067698|P2|STARTED|Follow up 4 Weeks||17
2474116|NCT00944658|6067699|P1|STARTED|Follow up 4 Weeks||19
2474117|NCT00944658|6067698|P2|NOT COMPLETED|Treatment 12 Weeks||2
2474118|NCT00944658|6067699|P1|NOT COMPLETED|Treatment 12 Weeks||0
2474119|NCT00944658|6067698|P2|COMPLETED|Treatment 12 Weeks||17
2474120|NCT00944658|6067699|P1|COMPLETED|Treatment 12 Weeks||19
2474121|NCT00944658|6067698|P2|STARTED|Treatment 12 Weeks||19
2474122|NCT00944658|6067699|P1|STARTED|Treatment 12 Weeks||19
2474123|NCT00944645|6067711|P2|NOT COMPLETED|Period 2||9
2474124|NCT00944645|6067712|P1|NOT COMPLETED|Period 2||8
2474125|NCT00944645|6067711|P2|COMPLETED|Period 2||85
2474126|NCT00944645|6067712|P1|COMPLETED|Period 2||86
2474127|NCT00944645|6067711|P2|STARTED|Period 2||94
2474128|NCT00944645|6067712|P1|STARTED|Period 2||94
2474129|NCT00944645|6067711|P2|NOT COMPLETED|Period 1||0
2474130|NCT00944645|6067712|P1|NOT COMPLETED|Period 1||0
2474131|NCT00944645|6067711|P2|COMPLETED|Period 1||94
2474132|NCT00944645|6067712|P1|COMPLETED|Period 1||94
2474133|NCT00944645|6067711|P2|STARTED|Period 1||94
2474134|NCT00944645|6067712|P1|STARTED|Period 1||94
2474135|NCT00944554|6067726|P2|NOT COMPLETED|Overall Study||29
2474136|NCT00944554|6067727|P1|NOT COMPLETED|Overall Study||28
2474137|NCT00944554|6067726|P2|COMPLETED|Overall Study||25
2474138|NCT00944554|6067727|P1|COMPLETED|Overall Study||22
2474139|NCT00944554|6067726|P2|STARTED|Overall Study||54
2474140|NCT00944554|6067727|P1|STARTED|Overall Study||50
2474141|NCT00944528|6067736|P3|NOT COMPLETED|Overall Study||0
2474142|NCT00944528|6067737|P2|NOT COMPLETED|Overall Study||2
2474143|NCT00944528|6067738|P1|NOT COMPLETED|Overall Study||1
2474144|NCT00944528|6067736|P3|COMPLETED|Overall Study||16
2474145|NCT00944528|6067737|P2|COMPLETED|Overall Study||8
2474146|NCT00944528|6067738|P1|COMPLETED|Overall Study||8
2474147|NCT00944528|6067736|P3|STARTED|Overall Study||16
2474148|NCT00944528|6067737|P2|STARTED|Overall Study||10
2474149|NCT00944528|6067738|P1|STARTED|Overall Study||9
2474150|NCT00944450|6067750|P2|NOT COMPLETED|Period 2||0
2474151|NCT00944450|6067751|P1|NOT COMPLETED|Period 2||0
2474152|NCT00944450|6067750|P2|COMPLETED|Period 2||6
2474153|NCT00944450|6067751|P1|COMPLETED|Period 2||6
2474154|NCT00944450|6067750|P2|STARTED|Period 2||6
2474155|NCT00944450|6067751|P1|STARTED|Period 2||6
2474156|NCT00944450|6067750|P2|NOT COMPLETED|Period 1||0
2474157|NCT00944450|6067751|P1|NOT COMPLETED|Period 1||0
2474158|NCT00944450|6067750|P2|COMPLETED|Period 1||6
2474159|NCT00944450|6067751|P1|COMPLETED|Period 1||6
2474160|NCT00944450|6067750|P2|STARTED|Period 1||6
2474161|NCT00944450|6067751|P1|STARTED|Period 1||6
2474162|NCT00944229|6067759|P1|NOT COMPLETED|Overall Study||25
2474163|NCT00944229|6067759|P1|COMPLETED|Overall Study||33
2474164|NCT00944229|6067759|P1|STARTED|Overall Study||58
2474165|NCT00944125|6067765|P2|NOT COMPLETED|6 Months to Study Completion||2
2474166|NCT00944125|6067766|P1|NOT COMPLETED|6 Months to Study Completion||0
2474167|NCT00944125|6067765|P2|COMPLETED|6 Months to Study Completion||18
2474168|NCT00944125|6067766|P1|COMPLETED|6 Months to Study Completion||19
2474169|NCT00944125|6067765|P2|STARTED|6 Months to Study Completion||20
2474170|NCT00944125|6067766|P1|STARTED|6 Months to Study Completion||19
2474171|NCT00944125|6067765|P2|NOT COMPLETED|3 to 6 Months||2
2474172|NCT00944125|6067766|P1|NOT COMPLETED|3 to 6 Months||0
2474173|NCT00944125|6067765|P2|COMPLETED|3 to 6 Months||20
2474174|NCT00944125|6067766|P1|COMPLETED|3 to 6 Months||19
2474175|NCT00944125|6067765|P2|STARTED|3 to 6 Months||22
2474176|NCT00944125|6067766|P1|STARTED|3 to 6 Months||19
2474177|NCT00944125|6067765|P2|NOT COMPLETED|Baseline to 3 Months||0
2474178|NCT00944125|6067766|P1|NOT COMPLETED|Baseline to 3 Months||0
2474179|NCT00944125|6067765|P2|COMPLETED|Baseline to 3 Months||22
2474180|NCT00944125|6067766|P1|COMPLETED|Baseline to 3 Months||19
2474181|NCT00944125|6067765|P2|STARTED|Baseline to 3 Months||22
2474182|NCT00944125|6067766|P1|STARTED|Baseline to 3 Months||19
2474183|NCT00944073|6067774|P2|NOT COMPLETED|Overall Study||4
2474184|NCT00944073|6067775|P1|NOT COMPLETED|Overall Study||5
2474185|NCT00944073|6067774|P2|COMPLETED|Overall Study||287
2474186|NCT00944073|6067775|P1|COMPLETED|Overall Study||287
2474187|NCT00944073|6067774|P2|STARTED|Overall Study||291
2474188|NCT00944073|6067775|P1|STARTED|Overall Study||292
2474189|NCT00944047|6067853|P1|NOT COMPLETED|Overall Study||5
2474190|NCT00944047|6067853|P1|COMPLETED|Overall Study||27
2474191|NCT00944047|6067853|P1|STARTED|Overall Study||32
2474192|NCT00944034|6067869|P12|NOT COMPLETED|Overall Study||4
2474193|NCT00944034|6067870|P11|NOT COMPLETED|Overall Study||1
2474194|NCT00944034|6067871|P10|NOT COMPLETED|Overall Study||10
2474195|NCT00944034|6067872|P9|NOT COMPLETED|Overall Study||10
2474196|NCT00944034|6067873|P8|NOT COMPLETED|Overall Study||5
2474197|NCT00944034|6067874|P7|NOT COMPLETED|Overall Study||4
2474198|NCT00944034|6067875|P6|NOT COMPLETED|Overall Study||20
2474199|NCT00944034|6067876|P5|NOT COMPLETED|Overall Study||14
2474200|NCT00944034|6067877|P4|NOT COMPLETED|Overall Study||4
2474201|NCT00944034|6067878|P3|NOT COMPLETED|Overall Study||9
2474202|NCT00944034|6067879|P2|NOT COMPLETED|Overall Study||7
2474203|NCT00944034|6067880|P1|NOT COMPLETED|Overall Study||5
2474204|NCT00944034|6067869|P12|COMPLETED|Overall Study||52
2474205|NCT00944034|6067870|P11|COMPLETED|Overall Study||50
2474206|NCT00944034|6067871|P10|COMPLETED|Overall Study||236
2474207|NCT00944034|6067872|P9|COMPLETED|Overall Study||63
2474208|NCT00944034|6067873|P8|COMPLETED|Overall Study||73
2474209|NCT00944034|6067874|P7|COMPLETED|Overall Study||102
2474210|NCT00944034|6067875|P6|COMPLETED|Overall Study||123
2474211|NCT00944034|6067876|P5|COMPLETED|Overall Study||150
2474212|NCT00944034|6067877|P4|COMPLETED|Overall Study||170
2474213|NCT00944034|6067878|P3|COMPLETED|Overall Study||143
2474214|NCT00944034|6067879|P2|COMPLETED|Overall Study||150
2474215|NCT00944034|6067880|P1|COMPLETED|Overall Study||183
2474216|NCT00944034|6067869|P12|STARTED|Overall Study||56
2474217|NCT00944034|6067870|P11|STARTED|Overall Study||51
2474218|NCT00944034|6067871|P10|STARTED|Overall Study||246
2474219|NCT00944034|6067872|P9|STARTED|Overall Study||73
2474220|NCT00944034|6067873|P8|STARTED|Overall Study||78
2474221|NCT00944034|6067874|P7|STARTED|Overall Study||106
2474222|NCT00944034|6067875|P6|STARTED|Overall Study||143
2474223|NCT00944034|6067876|P5|STARTED|Overall Study||164
2474224|NCT00944034|6067877|P4|STARTED|Overall Study||174
2474225|NCT00944034|6067878|P3|STARTED|Overall Study||152
2474226|NCT00944034|6067879|P2|STARTED|Overall Study||157
2474227|NCT00944034|6067880|P1|STARTED|Overall Study||188
2474228|NCT00944021|6067950|P5|NOT COMPLETED|Overall Study||0
2474229|NCT00944021|6067951|P4|NOT COMPLETED|Overall Study||0
2474230|NCT00944021|6067952|P3|NOT COMPLETED|Overall Study||0
2474231|NCT00944021|6067953|P2|NOT COMPLETED|Overall Study||0
2474232|NCT00944021|6067954|P1|NOT COMPLETED|Overall Study||1
2474233|NCT00944021|6067950|P5|COMPLETED|Overall Study||8
2474234|NCT00944021|6067951|P4|COMPLETED|Overall Study||16
2474235|NCT00944021|6067952|P3|COMPLETED|Overall Study||15
2474236|NCT00944021|6067953|P2|COMPLETED|Overall Study||15
2474237|NCT00944021|6067954|P1|COMPLETED|Overall Study||14
2474238|NCT00944021|6067950|P5|STARTED|Overall Study||8
2474239|NCT00944021|6067951|P4|STARTED|Overall Study||16
2474240|NCT00944021|6067952|P3|STARTED|Overall Study||15
2474241|NCT00944021|6067953|P2|STARTED|Overall Study||15
2474242|NCT00944021|6067954|P1|STARTED|Overall Study||15
2474243|NCT00943917|6068026|P15|NOT COMPLETED|Stage II Continuation||4
2474244|NCT00943917|6068027|P14|NOT COMPLETED|Stage II Continuation||3
2474245|NCT00943917|6068028|P13|NOT COMPLETED|Stage II Continuation||3
2474246|NCT00943917|6068029|P12|NOT COMPLETED|Stage II Continuation||2
2474247|NCT00943917|6068030|P11|NOT COMPLETED|Stage II Continuation||0
2474248|NCT00943917|6068031|P10|NOT COMPLETED|Stage II Continuation||1
2474249|NCT00943917|6068032|P9|NOT COMPLETED|Stage II Continuation||0
2474250|NCT00943917|6068033|P8|NOT COMPLETED|Stage II Continuation||0
2474251|NCT00943917|6068034|P7|NOT COMPLETED|Stage II Continuation||0
2474252|NCT00943917|6068035|P6|NOT COMPLETED|Stage II Continuation||0
2474253|NCT00943917|6068036|P5|NOT COMPLETED|Stage II Continuation||0
2474254|NCT00943917|6068037|P4|NOT COMPLETED|Stage II Continuation||0
2474255|NCT00943917|6068038|P3|NOT COMPLETED|Stage II Continuation||0
2474256|NCT00943917|6068039|P2|NOT COMPLETED|Stage II Continuation||0
2474257|NCT00943917|6068040|P1|NOT COMPLETED|Stage II Continuation||0
2474258|NCT00943917|6068026|P15|COMPLETED|Stage II Continuation||8
2474259|NCT00943917|6068027|P14|COMPLETED|Stage II Continuation||12
2474260|NCT00943917|6068028|P13|COMPLETED|Stage II Continuation||13
2474261|NCT00943917|6068029|P12|COMPLETED|Stage II Continuation||11
2474262|NCT00943917|6068030|P11|COMPLETED|Stage II Continuation||15
2474263|NCT00943917|6068031|P10|COMPLETED|Stage II Continuation||14
2474264|NCT00943917|6068032|P9|COMPLETED|Stage II Continuation||0
2474265|NCT00943917|6068033|P8|COMPLETED|Stage II Continuation||0
2474266|NCT00943917|6068034|P7|COMPLETED|Stage II Continuation||0
2474267|NCT00943917|6068035|P6|COMPLETED|Stage II Continuation||0
2474268|NCT00943917|6068036|P5|COMPLETED|Stage II Continuation||0
2474269|NCT00943917|6068037|P4|COMPLETED|Stage II Continuation||0
2474270|NCT00943917|6068038|P3|COMPLETED|Stage II Continuation||0
2474271|NCT00943917|6068039|P2|COMPLETED|Stage II Continuation||0
2474272|NCT00943917|6068040|P1|COMPLETED|Stage II Continuation||0
2474273|NCT00943917|6068026|P15|STARTED|Stage II Continuation||12
2474274|NCT00943917|6068027|P14|STARTED|Stage II Continuation||15
2474275|NCT00943917|6068028|P13|STARTED|Stage II Continuation||16
2474276|NCT00943917|6068029|P12|STARTED|Stage II Continuation||13
2474277|NCT00943917|6068030|P11|STARTED|Stage II Continuation||15
2474278|NCT00943917|6068031|P10|STARTED|Stage II Continuation||15
2474279|NCT00943917|6068032|P9|STARTED|Stage II Continuation||0
2474280|NCT00943917|6068033|P8|STARTED|Stage II Continuation||0
2474281|NCT00943917|6068034|P7|STARTED|Stage II Continuation||0
2474282|NCT00943917|6068035|P6|STARTED|Stage II Continuation||0
2474283|NCT00943917|6068036|P5|STARTED|Stage II Continuation||0
2474284|NCT00943917|6068037|P4|STARTED|Stage II Continuation||0
2474285|NCT00943917|6068038|P3|STARTED|Stage II Continuation||0
2474286|NCT00943917|6068039|P2|STARTED|Stage II Continuation||0
2474287|NCT00943917|6068040|P1|STARTED|Stage II Continuation||0
2474288|NCT00943917|6068026|P15|NOT COMPLETED|Stage II||0
2474289|NCT00943917|6068027|P14|NOT COMPLETED|Stage II||0
2474290|NCT00943917|6068028|P13|NOT COMPLETED|Stage II||0
2474291|NCT00943917|6068029|P12|NOT COMPLETED|Stage II||0
2474292|NCT00943917|6068030|P11|NOT COMPLETED|Stage II||0
2474293|NCT00943917|6068031|P10|NOT COMPLETED|Stage II||0
2474294|NCT00943917|6068032|P9|NOT COMPLETED|Stage II||1
2474295|NCT00943917|6068033|P8|NOT COMPLETED|Stage II||0
2474296|NCT00943917|6068034|P7|NOT COMPLETED|Stage II||3
2474297|NCT00943917|6068035|P6|NOT COMPLETED|Stage II||3
2474298|NCT00943917|6068036|P5|NOT COMPLETED|Stage II||0
2474299|NCT00943917|6068037|P4|NOT COMPLETED|Stage II||0
2474300|NCT00943917|6068038|P3|NOT COMPLETED|Stage II||0
2474301|NCT00943917|6068039|P2|NOT COMPLETED|Stage II||0
2474302|NCT00943917|6068040|P1|NOT COMPLETED|Stage II||0
2474303|NCT00943917|6068026|P15|COMPLETED|Stage II||0
2474304|NCT00943917|6068027|P14|COMPLETED|Stage II||0
2474305|NCT00943917|6068028|P13|COMPLETED|Stage II||0
2474306|NCT00943917|6068029|P12|COMPLETED|Stage II||0
2474307|NCT00943917|6068030|P11|COMPLETED|Stage II||0
2474308|NCT00943917|6068031|P10|COMPLETED|Stage II||0
2474309|NCT00943917|6068032|P9|COMPLETED|Stage II||20
2474310|NCT00943917|6068033|P8|COMPLETED|Stage II||23
2474311|NCT00943917|6068034|P7|COMPLETED|Stage II||20
2474312|NCT00943917|6068035|P6|COMPLETED|Stage II||20
2474313|NCT00943917|6068036|P5|COMPLETED|Stage II||21
2474314|NCT00943917|6068037|P4|COMPLETED|Stage II||20
2474315|NCT00943917|6068038|P3|COMPLETED|Stage II||0
2474316|NCT00943917|6068039|P2|COMPLETED|Stage II||0
2474317|NCT00943917|6068040|P1|COMPLETED|Stage II||0
2474318|NCT00943917|6068026|P15|STARTED|Stage II||0
2474319|NCT00943917|6068027|P14|STARTED|Stage II||0
2474320|NCT00943917|6068028|P13|STARTED|Stage II||0
2474321|NCT00943917|6068029|P12|STARTED|Stage II||0
2474322|NCT00943917|6068030|P11|STARTED|Stage II||0
2474323|NCT00943917|6068031|P10|STARTED|Stage II||0
2474324|NCT00943917|6068032|P9|STARTED|Stage II||21
2474325|NCT00943917|6068033|P8|STARTED|Stage II||23
2474326|NCT00943917|6068034|P7|STARTED|Stage II||23
2474327|NCT00943917|6068035|P6|STARTED|Stage II||23
2474328|NCT00943917|6068036|P5|STARTED|Stage II||21
2474329|NCT00943917|6068037|P4|STARTED|Stage II||20
2474330|NCT00943917|6068038|P3|STARTED|Stage II||0
2474331|NCT00943917|6068039|P2|STARTED|Stage II||0
2474332|NCT00943917|6068040|P1|STARTED|Stage II||0
2474333|NCT00943917|6068026|P15|NOT COMPLETED|Stage I||0
2474334|NCT00943917|6068027|P14|NOT COMPLETED|Stage I||0
2474335|NCT00943917|6068028|P13|NOT COMPLETED|Stage I||0
2474336|NCT00943917|6068029|P12|NOT COMPLETED|Stage I||0
2474337|NCT00943917|6068030|P11|NOT COMPLETED|Stage I||0
2474338|NCT00943917|6068031|P10|NOT COMPLETED|Stage I||0
2474339|NCT00943917|6068032|P9|NOT COMPLETED|Stage I||0
2474340|NCT00943917|6068033|P8|NOT COMPLETED|Stage I||0
2474341|NCT00943917|6068034|P7|NOT COMPLETED|Stage I||0
2474342|NCT00943917|6068035|P6|NOT COMPLETED|Stage I||0
2474343|NCT00943917|6068036|P5|NOT COMPLETED|Stage I||0
2474344|NCT00943917|6068037|P4|NOT COMPLETED|Stage I||0
2474345|NCT00943917|6068038|P3|NOT COMPLETED|Stage I||6
2474346|NCT00943917|6068039|P2|NOT COMPLETED|Stage I||3
2474347|NCT00943917|6068040|P1|NOT COMPLETED|Stage I||4
2474348|NCT00943917|6068026|P15|COMPLETED|Stage I||0
2474349|NCT00943917|6068027|P14|COMPLETED|Stage I||0
2474350|NCT00943917|6068028|P13|COMPLETED|Stage I||0
2474351|NCT00943917|6068029|P12|COMPLETED|Stage I||0
2474352|NCT00943917|6068030|P11|COMPLETED|Stage I||0
2474353|NCT00943917|6068031|P10|COMPLETED|Stage I||0
2474354|NCT00943917|6068032|P9|COMPLETED|Stage I||0
2474355|NCT00943917|6068033|P8|COMPLETED|Stage I||0
2474356|NCT00943917|6068034|P7|COMPLETED|Stage I||0
2474357|NCT00943917|6068035|P6|COMPLETED|Stage I||0
2474358|NCT00943917|6068036|P5|COMPLETED|Stage I||0
2474359|NCT00943917|6068037|P4|COMPLETED|Stage I||0
2474360|NCT00943917|6068038|P3|COMPLETED|Stage I||47
2474361|NCT00943917|6068039|P2|COMPLETED|Stage I||48
2474362|NCT00943917|6068040|P1|COMPLETED|Stage I||47
2474363|NCT00943917|6068026|P15|STARTED|Stage I||0
2474364|NCT00943917|6068027|P14|STARTED|Stage I||0
2474365|NCT00943917|6068028|P13|STARTED|Stage I||0
2474366|NCT00943917|6068029|P12|STARTED|Stage I||0
2474367|NCT00943917|6068030|P11|STARTED|Stage I||0
2474368|NCT00943917|6068031|P10|STARTED|Stage I||0
2474369|NCT00943917|6068032|P9|STARTED|Stage I||0
2474370|NCT00943917|6068033|P8|STARTED|Stage I||0
2474371|NCT00943917|6068034|P7|STARTED|Stage I||0
2474372|NCT00943917|6068035|P6|STARTED|Stage I||0
2474373|NCT00943917|6068036|P5|STARTED|Stage I||0
2474374|NCT00943917|6068037|P4|STARTED|Stage I||0
2474375|NCT00943917|6068038|P3|STARTED|Stage I||53
2474376|NCT00943917|6068039|P2|STARTED|Stage I||51
2474377|NCT00943917|6068040|P1|STARTED|Stage I||51
2474378|NCT00943878|6068091|P4|NOT COMPLETED|Overall Study||2
2474379|NCT00943878|6068092|P3|NOT COMPLETED|Overall Study||6
2474380|NCT00943878|6068093|P2|NOT COMPLETED|Overall Study||2
2474381|NCT00943878|6068094|P1|NOT COMPLETED|Overall Study||2
2474382|NCT00943878|6068091|P4|COMPLETED|Overall Study||198
2474383|NCT00943878|6068092|P3|COMPLETED|Overall Study||197
2474384|NCT00943878|6068093|P2|COMPLETED|Overall Study||198
2474385|NCT00943878|6068094|P1|COMPLETED|Overall Study||200
2474386|NCT00943878|6068091|P4|STARTED|Overall Study||200
2474387|NCT00943878|6068092|P3|STARTED|Overall Study||203
2474388|NCT00943878|6068093|P2|STARTED|Overall Study||200
2474389|NCT00943878|6068094|P1|STARTED|Overall Study||202
2474390|NCT00943852|6068216|P10|NOT COMPLETED|Fifth Period of Treatment Intervention||0
2474391|NCT00943852|6068217|P9|NOT COMPLETED|Fifth Period of Treatment Intervention||0
2474392|NCT00943852|6068218|P8|NOT COMPLETED|Fifth Period of Treatment Intervention||0
2474393|NCT00943852|6068219|P7|NOT COMPLETED|Fifth Period of Treatment Intervention||0
2474394|NCT00943852|6068220|P6|NOT COMPLETED|Fifth Period of Treatment Intervention||0
2474395|NCT00943852|6068221|P5|NOT COMPLETED|Fifth Period of Treatment Intervention||0
2474396|NCT00943852|6068222|P4|NOT COMPLETED|Fifth Period of Treatment Intervention||0
2474397|NCT00943852|6068223|P3|NOT COMPLETED|Fifth Period of Treatment Intervention||0
2474398|NCT00943852|6068224|P2|NOT COMPLETED|Fifth Period of Treatment Intervention||0
2474399|NCT00943852|6068225|P1|NOT COMPLETED|Fifth Period of Treatment Intervention||0
2474400|NCT00943852|6068216|P10|COMPLETED|Fifth Period of Treatment Intervention||1
2474401|NCT00943852|6068217|P9|COMPLETED|Fifth Period of Treatment Intervention||1
2474402|NCT00943852|6068218|P8|COMPLETED|Fifth Period of Treatment Intervention||0
2474403|NCT00943852|6068219|P7|COMPLETED|Fifth Period of Treatment Intervention||0
2474404|NCT00943852|6068220|P6|COMPLETED|Fifth Period of Treatment Intervention||0
2474405|NCT00943852|6068221|P5|COMPLETED|Fifth Period of Treatment Intervention||1
2474406|NCT00943852|6068222|P4|COMPLETED|Fifth Period of Treatment Intervention||0
2474407|NCT00943852|6068223|P3|COMPLETED|Fifth Period of Treatment Intervention||0
2474408|NCT00943852|6068224|P2|COMPLETED|Fifth Period of Treatment Intervention||1
2474409|NCT00943852|6068225|P1|COMPLETED|Fifth Period of Treatment Intervention||1
2474410|NCT00943852|6068216|P10|STARTED|Fifth Period of Treatment Intervention||1
2474411|NCT00943852|6068217|P9|STARTED|Fifth Period of Treatment Intervention||1
2474412|NCT00943852|6068218|P8|STARTED|Fifth Period of Treatment Intervention||0
2474413|NCT00943852|6068219|P7|STARTED|Fifth Period of Treatment Intervention||0
2474414|NCT00943852|6068220|P6|STARTED|Fifth Period of Treatment Intervention||0
2474415|NCT00943852|6068221|P5|STARTED|Fifth Period of Treatment Intervention||1
2474416|NCT00943852|6068222|P4|STARTED|Fifth Period of Treatment Intervention||0
2474417|NCT00943852|6068223|P3|STARTED|Fifth Period of Treatment Intervention||0
2474418|NCT00943852|6068224|P2|STARTED|Fifth Period of Treatment Intervention||1
2474419|NCT00943852|6068225|P1|STARTED|Fifth Period of Treatment Intervention||1
2474420|NCT00943852|6068216|P10|NOT COMPLETED|Washout Period After Period 4 Treatment||0
2474421|NCT00943852|6068217|P9|NOT COMPLETED|Washout Period After Period 4 Treatment||0
2474422|NCT00943852|6068218|P8|NOT COMPLETED|Washout Period After Period 4 Treatment||1
2474423|NCT00943852|6068219|P7|NOT COMPLETED|Washout Period After Period 4 Treatment||1
2474424|NCT00943852|6068220|P6|NOT COMPLETED|Washout Period After Period 4 Treatment||0
2474425|NCT00943852|6068221|P5|NOT COMPLETED|Washout Period After Period 4 Treatment||0
2474426|NCT00943852|6068222|P4|NOT COMPLETED|Washout Period After Period 4 Treatment||1
2474427|NCT00943852|6068223|P3|NOT COMPLETED|Washout Period After Period 4 Treatment||1
2474428|NCT00943852|6068224|P2|NOT COMPLETED|Washout Period After Period 4 Treatment||0
2474429|NCT00943852|6068225|P1|NOT COMPLETED|Washout Period After Period 4 Treatment||1
2474430|NCT00943852|6068216|P10|COMPLETED|Washout Period After Period 4 Treatment||1
2474431|NCT00943852|6068217|P9|COMPLETED|Washout Period After Period 4 Treatment||1
2474432|NCT00943852|6068218|P8|COMPLETED|Washout Period After Period 4 Treatment||0
2474433|NCT00943852|6068219|P7|COMPLETED|Washout Period After Period 4 Treatment||0
2474434|NCT00943852|6068220|P6|COMPLETED|Washout Period After Period 4 Treatment||0
2474435|NCT00943852|6068221|P5|COMPLETED|Washout Period After Period 4 Treatment||1
2474436|NCT00943852|6068222|P4|COMPLETED|Washout Period After Period 4 Treatment||0
2474437|NCT00943852|6068223|P3|COMPLETED|Washout Period After Period 4 Treatment||0
2474438|NCT00943852|6068224|P2|COMPLETED|Washout Period After Period 4 Treatment||1
2474439|NCT00943852|6068225|P1|COMPLETED|Washout Period After Period 4 Treatment||1
2474440|NCT00943852|6068216|P10|STARTED|Washout Period After Period 4 Treatment||1
2474441|NCT00943852|6068217|P9|STARTED|Washout Period After Period 4 Treatment||1
2474442|NCT00943852|6068218|P8|STARTED|Washout Period After Period 4 Treatment||1
2474443|NCT00943852|6068219|P7|STARTED|Washout Period After Period 4 Treatment||1
2474444|NCT00943852|6068220|P6|STARTED|Washout Period After Period 4 Treatment||0
2474445|NCT00943852|6068221|P5|STARTED|Washout Period After Period 4 Treatment||1
2474446|NCT00943852|6068222|P4|STARTED|Washout Period After Period 4 Treatment||1
2474447|NCT00943852|6068223|P3|STARTED|Washout Period After Period 4 Treatment||1
2474448|NCT00943852|6068224|P2|STARTED|Washout Period After Period 4 Treatment||1
2474449|NCT00943852|6068225|P1|STARTED|Washout Period After Period 4 Treatment||2
2474450|NCT00943852|6068216|P10|NOT COMPLETED|Fourth Period of Treatment Intervention||0
2474451|NCT00943852|6068217|P9|NOT COMPLETED|Fourth Period of Treatment Intervention||0
2474452|NCT00943852|6068218|P8|NOT COMPLETED|Fourth Period of Treatment Intervention||0
2474453|NCT00943852|6068219|P7|NOT COMPLETED|Fourth Period of Treatment Intervention||0
2474454|NCT00943852|6068220|P6|NOT COMPLETED|Fourth Period of Treatment Intervention||0
2474455|NCT00943852|6068221|P5|NOT COMPLETED|Fourth Period of Treatment Intervention||0
2474456|NCT00943852|6068222|P4|NOT COMPLETED|Fourth Period of Treatment Intervention||0
2474457|NCT00943852|6068223|P3|NOT COMPLETED|Fourth Period of Treatment Intervention||0
2474458|NCT00943852|6068224|P2|NOT COMPLETED|Fourth Period of Treatment Intervention||0
2474459|NCT00943852|6068225|P1|NOT COMPLETED|Fourth Period of Treatment Intervention||0
2474460|NCT00943852|6068216|P10|COMPLETED|Fourth Period of Treatment Intervention||1
2474461|NCT00943852|6068217|P9|COMPLETED|Fourth Period of Treatment Intervention||1
2474462|NCT00943852|6068218|P8|COMPLETED|Fourth Period of Treatment Intervention||1
2474463|NCT00943852|6068219|P7|COMPLETED|Fourth Period of Treatment Intervention||1
2474464|NCT00943852|6068220|P6|COMPLETED|Fourth Period of Treatment Intervention||0
2474465|NCT00943852|6068221|P5|COMPLETED|Fourth Period of Treatment Intervention||1
2474466|NCT00943852|6068222|P4|COMPLETED|Fourth Period of Treatment Intervention||1
2474467|NCT00943852|6068223|P3|COMPLETED|Fourth Period of Treatment Intervention||1
2474468|NCT00943852|6068224|P2|COMPLETED|Fourth Period of Treatment Intervention||1
2474469|NCT00943852|6068225|P1|COMPLETED|Fourth Period of Treatment Intervention||2
2474470|NCT00943852|6068216|P10|STARTED|Fourth Period of Treatment Intervention||1
2474471|NCT00943852|6068217|P9|STARTED|Fourth Period of Treatment Intervention||1
2474472|NCT00943852|6068218|P8|STARTED|Fourth Period of Treatment Intervention||1
2474473|NCT00943852|6068219|P7|STARTED|Fourth Period of Treatment Intervention||1
2474474|NCT00943852|6068220|P6|STARTED|Fourth Period of Treatment Intervention||0
2474475|NCT00943852|6068221|P5|STARTED|Fourth Period of Treatment Intervention||1
2474476|NCT00943852|6068222|P4|STARTED|Fourth Period of Treatment Intervention||1
2474477|NCT00943852|6068223|P3|STARTED|Fourth Period of Treatment Intervention||1
2474478|NCT00943852|6068224|P2|STARTED|Fourth Period of Treatment Intervention||1
2474479|NCT00943852|6068225|P1|STARTED|Fourth Period of Treatment Intervention||2
2474480|NCT00943852|6068216|P10|NOT COMPLETED|Washout Period After Period 3 Treatment||0
2474481|NCT00943852|6068217|P9|NOT COMPLETED|Washout Period After Period 3 Treatment||0
2474482|NCT00943852|6068218|P8|NOT COMPLETED|Washout Period After Period 3 Treatment||0
2474483|NCT00943852|6068219|P7|NOT COMPLETED|Washout Period After Period 3 Treatment||1
2474484|NCT00943852|6068220|P6|NOT COMPLETED|Washout Period After Period 3 Treatment||0
2474485|NCT00943852|6068221|P5|NOT COMPLETED|Washout Period After Period 3 Treatment||0
2474486|NCT00943852|6068222|P4|NOT COMPLETED|Washout Period After Period 3 Treatment||0
2474487|NCT00943852|6068223|P3|NOT COMPLETED|Washout Period After Period 3 Treatment||0
2474488|NCT00943852|6068224|P2|NOT COMPLETED|Washout Period After Period 3 Treatment||0
2474489|NCT00943852|6068225|P1|NOT COMPLETED|Washout Period After Period 3 Treatment||0
2474490|NCT00943852|6068216|P10|COMPLETED|Washout Period After Period 3 Treatment||1
2474491|NCT00943852|6068217|P9|COMPLETED|Washout Period After Period 3 Treatment||1
2474492|NCT00943852|6068218|P8|COMPLETED|Washout Period After Period 3 Treatment||1
2474493|NCT00943852|6068219|P7|COMPLETED|Washout Period After Period 3 Treatment||1
2474494|NCT00943852|6068220|P6|COMPLETED|Washout Period After Period 3 Treatment||0
2474495|NCT00943852|6068221|P5|COMPLETED|Washout Period After Period 3 Treatment||1
2474496|NCT00943852|6068222|P4|COMPLETED|Washout Period After Period 3 Treatment||1
2474497|NCT00943852|6068223|P3|COMPLETED|Washout Period After Period 3 Treatment||1
2474498|NCT00943852|6068224|P2|COMPLETED|Washout Period After Period 3 Treatment||1
2474499|NCT00943852|6068225|P1|COMPLETED|Washout Period After Period 3 Treatment||2
2474500|NCT00943852|6068216|P10|STARTED|Washout Period After Period 3 Treatment||1
2474501|NCT00943852|6068217|P9|STARTED|Washout Period After Period 3 Treatment||1
2474502|NCT00943852|6068218|P8|STARTED|Washout Period After Period 3 Treatment||1
2474503|NCT00943852|6068219|P7|STARTED|Washout Period After Period 3 Treatment||2
2474504|NCT00943852|6068220|P6|STARTED|Washout Period After Period 3 Treatment||0
2474505|NCT00943852|6068221|P5|STARTED|Washout Period After Period 3 Treatment||1
2474506|NCT00943852|6068222|P4|STARTED|Washout Period After Period 3 Treatment||1
2474507|NCT00943852|6068223|P3|STARTED|Washout Period After Period 3 Treatment||1
2474508|NCT00943852|6068224|P2|STARTED|Washout Period After Period 3 Treatment||1
2474509|NCT00943852|6068225|P1|STARTED|Washout Period After Period 3 Treatment||2
2474510|NCT00943852|6068216|P10|NOT COMPLETED|Third Period of Treatment Intervention||0
2474511|NCT00943852|6068217|P9|NOT COMPLETED|Third Period of Treatment Intervention||0
2474512|NCT00943852|6068218|P8|NOT COMPLETED|Third Period of Treatment Intervention||0
2474513|NCT00943852|6068219|P7|NOT COMPLETED|Third Period of Treatment Intervention||0
2474514|NCT00943852|6068220|P6|NOT COMPLETED|Third Period of Treatment Intervention||0
2474515|NCT00943852|6068221|P5|NOT COMPLETED|Third Period of Treatment Intervention||0
2474516|NCT00943852|6068222|P4|NOT COMPLETED|Third Period of Treatment Intervention||0
2474517|NCT00943852|6068223|P3|NOT COMPLETED|Third Period of Treatment Intervention||0
2474518|NCT00943852|6068224|P2|NOT COMPLETED|Third Period of Treatment Intervention||0
2474519|NCT00943852|6068225|P1|NOT COMPLETED|Third Period of Treatment Intervention||0
2474520|NCT00943852|6068216|P10|COMPLETED|Third Period of Treatment Intervention||1
2474521|NCT00943852|6068217|P9|COMPLETED|Third Period of Treatment Intervention||1
2474522|NCT00943852|6068218|P8|COMPLETED|Third Period of Treatment Intervention||1
2474523|NCT00943852|6068219|P7|COMPLETED|Third Period of Treatment Intervention||2
2474524|NCT00943852|6068220|P6|COMPLETED|Third Period of Treatment Intervention||0
2474525|NCT00943852|6068221|P5|COMPLETED|Third Period of Treatment Intervention||1
2474526|NCT00943852|6068222|P4|COMPLETED|Third Period of Treatment Intervention||1
2474527|NCT00943852|6068223|P3|COMPLETED|Third Period of Treatment Intervention||1
2474528|NCT00943852|6068224|P2|COMPLETED|Third Period of Treatment Intervention||1
2474529|NCT00943852|6068225|P1|COMPLETED|Third Period of Treatment Intervention||2
2474530|NCT00943852|6068216|P10|STARTED|Third Period of Treatment Intervention||1
2474531|NCT00943852|6068217|P9|STARTED|Third Period of Treatment Intervention||1
2474532|NCT00943852|6068218|P8|STARTED|Third Period of Treatment Intervention||1
2474533|NCT00943852|6068219|P7|STARTED|Third Period of Treatment Intervention||2
2474534|NCT00943852|6068220|P6|STARTED|Third Period of Treatment Intervention||0
2474535|NCT00943852|6068221|P5|STARTED|Third Period of Treatment Intervention||1
2474536|NCT00943852|6068222|P4|STARTED|Third Period of Treatment Intervention||1
2474537|NCT00943852|6068223|P3|STARTED|Third Period of Treatment Intervention||1
2474538|NCT00943852|6068224|P2|STARTED|Third Period of Treatment Intervention||1
2474539|NCT00943852|6068225|P1|STARTED|Third Period of Treatment Intervention||2
2474540|NCT00943852|6068216|P10|NOT COMPLETED|Washout Period After Period 2 Treatment||0
2474541|NCT00943852|6068217|P9|NOT COMPLETED|Washout Period After Period 2 Treatment||0
2474542|NCT00943852|6068218|P8|NOT COMPLETED|Washout Period After Period 2 Treatment||0
2474543|NCT00943852|6068219|P7|NOT COMPLETED|Washout Period After Period 2 Treatment||0
2474544|NCT00943852|6068220|P6|NOT COMPLETED|Washout Period After Period 2 Treatment||1
2474545|NCT00943852|6068221|P5|NOT COMPLETED|Washout Period After Period 2 Treatment||0
2474546|NCT00943852|6068222|P4|NOT COMPLETED|Washout Period After Period 2 Treatment||0
2474547|NCT00943852|6068223|P3|NOT COMPLETED|Washout Period After Period 2 Treatment||0
2474548|NCT00943852|6068224|P2|NOT COMPLETED|Washout Period After Period 2 Treatment||0
2474549|NCT00943852|6068225|P1|NOT COMPLETED|Washout Period After Period 2 Treatment||0
2474550|NCT00943852|6068216|P10|COMPLETED|Washout Period After Period 2 Treatment||1
2474551|NCT00943852|6068217|P9|COMPLETED|Washout Period After Period 2 Treatment||1
2474552|NCT00943852|6068218|P8|COMPLETED|Washout Period After Period 2 Treatment||1
2474553|NCT00943852|6068219|P7|COMPLETED|Washout Period After Period 2 Treatment||2
2474554|NCT00943852|6068220|P6|COMPLETED|Washout Period After Period 2 Treatment||0
2474555|NCT00943852|6068221|P5|COMPLETED|Washout Period After Period 2 Treatment||1
2474556|NCT00943852|6068222|P4|COMPLETED|Washout Period After Period 2 Treatment||1
2474557|NCT00943852|6068223|P3|COMPLETED|Washout Period After Period 2 Treatment||1
2474558|NCT00943852|6068224|P2|COMPLETED|Washout Period After Period 2 Treatment||1
2474559|NCT00943852|6068225|P1|COMPLETED|Washout Period After Period 2 Treatment||2
2474560|NCT00943852|6068216|P10|STARTED|Washout Period After Period 2 Treatment||1
2474561|NCT00943852|6068217|P9|STARTED|Washout Period After Period 2 Treatment||1
2474562|NCT00943852|6068218|P8|STARTED|Washout Period After Period 2 Treatment||1
2474563|NCT00943852|6068219|P7|STARTED|Washout Period After Period 2 Treatment||2
2474564|NCT00943852|6068220|P6|STARTED|Washout Period After Period 2 Treatment||1
2474565|NCT00943852|6068221|P5|STARTED|Washout Period After Period 2 Treatment||1
2474566|NCT00943852|6068222|P4|STARTED|Washout Period After Period 2 Treatment||1
2474567|NCT00943852|6068223|P3|STARTED|Washout Period After Period 2 Treatment||1
2474568|NCT00943852|6068224|P2|STARTED|Washout Period After Period 2 Treatment||1
2474569|NCT00943852|6068225|P1|STARTED|Washout Period After Period 2 Treatment||2
2474570|NCT00943852|6068216|P10|NOT COMPLETED|Second Period of Treatment Intervention||0
2474571|NCT00943852|6068217|P9|NOT COMPLETED|Second Period of Treatment Intervention||0
2474572|NCT00943852|6068218|P8|NOT COMPLETED|Second Period of Treatment Intervention||0
2474573|NCT00943852|6068219|P7|NOT COMPLETED|Second Period of Treatment Intervention||0
2474574|NCT00943852|6068220|P6|NOT COMPLETED|Second Period of Treatment Intervention||0
2474575|NCT00943852|6068221|P5|NOT COMPLETED|Second Period of Treatment Intervention||0
2474576|NCT00943852|6068222|P4|NOT COMPLETED|Second Period of Treatment Intervention||0
2474577|NCT00943852|6068223|P3|NOT COMPLETED|Second Period of Treatment Intervention||0
2474578|NCT00943852|6068224|P2|NOT COMPLETED|Second Period of Treatment Intervention||0
2474579|NCT00943852|6068225|P1|NOT COMPLETED|Second Period of Treatment Intervention||0
2474580|NCT00943852|6068216|P10|COMPLETED|Second Period of Treatment Intervention||1
2474581|NCT00943852|6068217|P9|COMPLETED|Second Period of Treatment Intervention||1
2474582|NCT00943852|6068218|P8|COMPLETED|Second Period of Treatment Intervention||1
2474583|NCT00943852|6068219|P7|COMPLETED|Second Period of Treatment Intervention||2
2474584|NCT00943852|6068220|P6|COMPLETED|Second Period of Treatment Intervention||1
2474585|NCT00943852|6068221|P5|COMPLETED|Second Period of Treatment Intervention||1
2474586|NCT00943852|6068222|P4|COMPLETED|Second Period of Treatment Intervention||1
2474587|NCT00943852|6068223|P3|COMPLETED|Second Period of Treatment Intervention||1
2474588|NCT00943852|6068224|P2|COMPLETED|Second Period of Treatment Intervention||1
2474589|NCT00943852|6068225|P1|COMPLETED|Second Period of Treatment Intervention||2
2474590|NCT00943852|6068216|P10|STARTED|Second Period of Treatment Intervention||1
2474591|NCT00943852|6068217|P9|STARTED|Second Period of Treatment Intervention||1
2474592|NCT00943852|6068218|P8|STARTED|Second Period of Treatment Intervention||1
2474593|NCT00943852|6068219|P7|STARTED|Second Period of Treatment Intervention||2
2474594|NCT00943852|6068220|P6|STARTED|Second Period of Treatment Intervention||1
2474595|NCT00943852|6068221|P5|STARTED|Second Period of Treatment Intervention||1
2474596|NCT00943852|6068222|P4|STARTED|Second Period of Treatment Intervention||1
2474597|NCT00943852|6068223|P3|STARTED|Second Period of Treatment Intervention||1
2474598|NCT00943852|6068224|P2|STARTED|Second Period of Treatment Intervention||1
2474599|NCT00943852|6068225|P1|STARTED|Second Period of Treatment Intervention||2
2474600|NCT00943852|6068216|P10|NOT COMPLETED|Washout Period After Period 1 Treatment||0
2474601|NCT00943852|6068217|P9|NOT COMPLETED|Washout Period After Period 1 Treatment||0
2474674|NCT00943826|6068238|P2|COMPLETED|Maintenance Phase||331
2474602|NCT00943852|6068218|P8|NOT COMPLETED|Washout Period After Period 1 Treatment||0
2474603|NCT00943852|6068219|P7|NOT COMPLETED|Washout Period After Period 1 Treatment||0
2474604|NCT00943852|6068220|P6|NOT COMPLETED|Washout Period After Period 1 Treatment||0
2474605|NCT00943852|6068221|P5|NOT COMPLETED|Washout Period After Period 1 Treatment||0
2474606|NCT00943852|6068222|P4|NOT COMPLETED|Washout Period After Period 1 Treatment||1
2474607|NCT00943852|6068223|P3|NOT COMPLETED|Washout Period After Period 1 Treatment||0
2474608|NCT00943852|6068224|P2|NOT COMPLETED|Washout Period After Period 1 Treatment||0
2474609|NCT00943852|6068225|P1|NOT COMPLETED|Washout Period After Period 1 Treatment||0
2474610|NCT00943852|6068216|P10|COMPLETED|Washout Period After Period 1 Treatment||1
2474611|NCT00943852|6068217|P9|COMPLETED|Washout Period After Period 1 Treatment||1
2474612|NCT00943852|6068218|P8|COMPLETED|Washout Period After Period 1 Treatment||1
2474613|NCT00943852|6068219|P7|COMPLETED|Washout Period After Period 1 Treatment||2
2474614|NCT00943852|6068220|P6|COMPLETED|Washout Period After Period 1 Treatment||1
2474615|NCT00943852|6068221|P5|COMPLETED|Washout Period After Period 1 Treatment||1
2474616|NCT00943852|6068222|P4|COMPLETED|Washout Period After Period 1 Treatment||1
2474617|NCT00943852|6068223|P3|COMPLETED|Washout Period After Period 1 Treatment||1
2474618|NCT00943852|6068224|P2|COMPLETED|Washout Period After Period 1 Treatment||1
2474619|NCT00943852|6068225|P1|COMPLETED|Washout Period After Period 1 Treatment||2
2474620|NCT00943852|6068216|P10|STARTED|Washout Period After Period 1 Treatment||1
2474621|NCT00943852|6068217|P9|STARTED|Washout Period After Period 1 Treatment||1
2474622|NCT00943852|6068218|P8|STARTED|Washout Period After Period 1 Treatment||1
2474623|NCT00943852|6068219|P7|STARTED|Washout Period After Period 1 Treatment||2
2474624|NCT00943852|6068220|P6|STARTED|Washout Period After Period 1 Treatment||1
2474625|NCT00943852|6068221|P5|STARTED|Washout Period After Period 1 Treatment||1
2474626|NCT00943852|6068222|P4|STARTED|Washout Period After Period 1 Treatment||2
2474627|NCT00943852|6068223|P3|STARTED|Washout Period After Period 1 Treatment||1
2474628|NCT00943852|6068224|P2|STARTED|Washout Period After Period 1 Treatment||1
2474629|NCT00943852|6068225|P1|STARTED|Washout Period After Period 1 Treatment||2
2474630|NCT00943852|6068216|P10|NOT COMPLETED|First Period of Treatment Intervention||0
2474631|NCT00943852|6068217|P9|NOT COMPLETED|First Period of Treatment Intervention||0
2474632|NCT00943852|6068218|P8|NOT COMPLETED|First Period of Treatment Intervention||0
2474633|NCT00943852|6068219|P7|NOT COMPLETED|First Period of Treatment Intervention||0
2474634|NCT00943852|6068220|P6|NOT COMPLETED|First Period of Treatment Intervention||0
2474635|NCT00943852|6068221|P5|NOT COMPLETED|First Period of Treatment Intervention||0
2474636|NCT00943852|6068222|P4|NOT COMPLETED|First Period of Treatment Intervention||0
2474637|NCT00943852|6068223|P3|NOT COMPLETED|First Period of Treatment Intervention||0
2474638|NCT00943852|6068224|P2|NOT COMPLETED|First Period of Treatment Intervention||0
2474639|NCT00943852|6068225|P1|NOT COMPLETED|First Period of Treatment Intervention||0
2474640|NCT00943852|6068216|P10|COMPLETED|First Period of Treatment Intervention||1
2474641|NCT00943852|6068217|P9|COMPLETED|First Period of Treatment Intervention||1
2474642|NCT00943852|6068218|P8|COMPLETED|First Period of Treatment Intervention||1
2474643|NCT00943852|6068219|P7|COMPLETED|First Period of Treatment Intervention||2
2474644|NCT00943852|6068220|P6|COMPLETED|First Period of Treatment Intervention||1
2474645|NCT00943852|6068221|P5|COMPLETED|First Period of Treatment Intervention||1
2474646|NCT00943852|6068222|P4|COMPLETED|First Period of Treatment Intervention||2
2474647|NCT00943852|6068223|P3|COMPLETED|First Period of Treatment Intervention||1
2474648|NCT00943852|6068224|P2|COMPLETED|First Period of Treatment Intervention||1
2474649|NCT00943852|6068225|P1|COMPLETED|First Period of Treatment Intervention||2
2474650|NCT00943852|6068216|P10|STARTED|First Period of Treatment Intervention||1
2474651|NCT00943852|6068217|P9|STARTED|First Period of Treatment Intervention||1
2474652|NCT00943852|6068218|P8|STARTED|First Period of Treatment Intervention||1
2474653|NCT00943852|6068219|P7|STARTED|First Period of Treatment Intervention||2
2474654|NCT00943852|6068220|P6|STARTED|First Period of Treatment Intervention||1
2474655|NCT00943852|6068221|P5|STARTED|First Period of Treatment Intervention||1
2474656|NCT00943852|6068222|P4|STARTED|First Period of Treatment Intervention||2
2474657|NCT00943852|6068223|P3|STARTED|First Period of Treatment Intervention||1
2474658|NCT00943852|6068224|P2|STARTED|First Period of Treatment Intervention||1
2474659|NCT00943852|6068225|P1|STARTED|First Period of Treatment Intervention||2
2474660|NCT00943826|6068238|P2|NOT COMPLETED|After Primary Overall Survival Analysis||20
2474661|NCT00943826|6068239|P1|NOT COMPLETED|After Primary Overall Survival Analysis||27
2474662|NCT00943826|6068238|P2|COMPLETED|After Primary Overall Survival Analysis||0
2474663|NCT00943826|6068239|P1|COMPLETED|After Primary Overall Survival Analysis||0
2474664|NCT00943826|6068238|P2|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|20
2474665|NCT00943826|6068239|P1|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|27
2474666|NCT00943826|6068238|P2|NOT COMPLETED|Monotherapy Phase||16
2474667|NCT00943826|6068239|P1|NOT COMPLETED|Monotherapy Phase||65
2474668|NCT00943826|6068238|P2|COMPLETED|Monotherapy Phase||143
2474669|NCT00943826|6068239|P1|COMPLETED|Monotherapy Phase||204
2474670|NCT00943826|6068238|P2|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|159
2474671|NCT00943826|6068239|P1|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|269
2474672|NCT00943826|6068238|P2|NOT COMPLETED|Maintenance Phase||39
2474673|NCT00943826|6068239|P1|NOT COMPLETED|Maintenance Phase||43
2474675|NCT00943826|6068239|P1|COMPLETED|Maintenance Phase||353
2474676|NCT00943826|6068238|P2|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|370
2474677|NCT00943826|6068239|P1|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|396
2474678|NCT00943826|6068238|P2|NOT COMPLETED|Concurrent Phase||42
2474679|NCT00943826|6068239|P1|NOT COMPLETED|Concurrent Phase||61
2474680|NCT00943826|6068238|P2|COMPLETED|Concurrent Phase||421
2474681|NCT00943826|6068239|P1|COMPLETED|Concurrent Phase||397
2474682|NCT00943826|6068238|P2|Treated|Concurrent Phase||459
2474683|NCT00943826|6068239|P1|Treated|Concurrent Phase||452
2474684|NCT00943826|6068238|P2|STARTED|Concurrent Phase||463
2474685|NCT00943826|6068239|P1|STARTED|Concurrent Phase||458
2474686|NCT00943787|6068257|P1|NOT COMPLETED|Overall Study||7
2474687|NCT00943787|6068257|P1|COMPLETED|Overall Study||34
2474688|NCT00943787|6068257|P1|STARTED|Overall Study||41
2474689|NCT00943761|6068264|P2|NOT COMPLETED|Overall Study||1
2474690|NCT00943761|6068265|P1|NOT COMPLETED|Overall Study||4
2474691|NCT00943761|6068264|P2|COMPLETED|Overall Study||23
2474692|NCT00943761|6068265|P1|COMPLETED|Overall Study||17
2474693|NCT00943761|6068264|P2|STARTED|Overall Study||24
2474694|NCT00943761|6068265|P1|STARTED|Overall Study||21
2474695|NCT00943735|6068277|P1|NOT COMPLETED|Overall Study||32
2474696|NCT00943735|6068277|P1|COMPLETED|Overall Study||742
2474697|NCT00943735|6068277|P1|Per Protocol Population|Overall Study||500
2474698|NCT00943735|6068277|P1|STARTED|Overall Study||774
2474699|NCT00943722|6068315|P5|NOT COMPLETED|Overall Study||22
2474700|NCT00943722|6068316|P4|NOT COMPLETED|Overall Study||22
2474701|NCT00943722|6068317|P3|NOT COMPLETED|Overall Study||13
2474702|NCT00943722|6068318|P2|NOT COMPLETED|Overall Study||22
2474703|NCT00943722|6068319|P1|NOT COMPLETED|Overall Study||25
2474704|NCT00943722|6068315|P5|COMPLETED|Overall Study|Includes 4 participants for whom completion status is unknown|448
2474705|NCT00943722|6068316|P4|COMPLETED|Overall Study||647
2474706|NCT00943722|6068317|P3|COMPLETED|Overall Study||631
2474707|NCT00943722|6068318|P2|COMPLETED|Overall Study||621
2474708|NCT00943722|6068319|P1|COMPLETED|Overall Study||623
2474709|NCT00943722|6068315|P5|Vaccination 3|Overall Study||455
2474710|NCT00943722|6068316|P4|Vaccination 3|Overall Study||653
2474711|NCT00943722|6068317|P3|Vaccination 3|Overall Study||637
2474712|NCT00943722|6068318|P2|Vaccination 3|Overall Study||627
2474713|NCT00943722|6068319|P1|Vaccination 3|Overall Study||635
2474714|NCT00943722|6068315|P5|Vaccination 2|Overall Study||462
2474715|NCT00943722|6068316|P4|Vaccination 2|Overall Study||658
2474716|NCT00943722|6068317|P3|Vaccination 2|Overall Study||638
2474717|NCT00943722|6068318|P2|Vaccination 2|Overall Study||633
2474718|NCT00943722|6068319|P1|Vaccination 2|Overall Study||637
2474719|NCT00943722|6068315|P5|Vaccination 1|Overall Study||468
2474720|NCT00943722|6068316|P4|Vaccination 1|Overall Study||666
2474721|NCT00943722|6068317|P3|Vaccination 1|Overall Study||644
2474722|NCT00943722|6068318|P2|Vaccination 1|Overall Study||642
2474723|NCT00943722|6068319|P1|Vaccination 1|Overall Study||646
2474724|NCT00943722|6068315|P5|STARTED|Overall Study||470
2474725|NCT00943722|6068316|P4|STARTED|Overall Study||669
2474726|NCT00943722|6068317|P3|STARTED|Overall Study||644
2474727|NCT00943722|6068318|P2|STARTED|Overall Study||643
2474728|NCT00943722|6068319|P1|STARTED|Overall Study||648
2474729|NCT00943683|6068349|P2|NOT COMPLETED|Overall Study||6
2474730|NCT00943683|6068350|P1|NOT COMPLETED|Overall Study||7
2474731|NCT00943683|6068349|P2|COMPLETED|Overall Study||169
2474732|NCT00943683|6068350|P1|COMPLETED|Overall Study||74
2474733|NCT00943683|6068349|P2|STARTED|Overall Study||175
2474734|NCT00943683|6068350|P1|STARTED|Overall Study||81
2474735|NCT00943670|6068356|P1|NOT COMPLETED|Trastuzumab Emtansine + Pertuzumab||18
2474736|NCT00943670|6068356|P1|COMPLETED|Trastuzumab Emtansine + Pertuzumab|Completed treatment defined as receiving a total of 17 cycles of therapy in both treatment periods.|2
2474737|NCT00943670|6068356|P1|STARTED|Trastuzumab Emtansine + Pertuzumab|Patients with early progressive disease who elected to receive T-DM1 and pertuzumab.|20
2474738|NCT00943670|6068356|P1|NOT COMPLETED|Single-agent Trastuzumab Emtansine||42
2474739|NCT00943670|6068356|P1|COMPLETED|Single-agent Trastuzumab Emtansine|Completed single-agent treatment defined as receiving 17 cycles of trastuzumab emtansine therapy.|9
2474740|NCT00943670|6068356|P1|Treated|Single-agent Trastuzumab Emtansine||51
2474741|NCT00943670|6068356|P1|STARTED|Single-agent Trastuzumab Emtansine||51
2474742|NCT00943631|6068392|P2|NOT COMPLETED|Overall Study||2
2474743|NCT00943631|6068393|P1|NOT COMPLETED|Overall Study||4
2474744|NCT00943631|6068392|P2|COMPLETED|Overall Study||202
2474745|NCT00943631|6068393|P1|COMPLETED|Overall Study||198
2474746|NCT00943631|6068392|P2|STARTED|Overall Study||204
2474747|NCT00943631|6068393|P1|STARTED|Overall Study||202
2474748|NCT00943605|6068445|P2|NOT COMPLETED|Overall Study||30
2474749|NCT00943605|6068446|P1|NOT COMPLETED|Overall Study||30
2474750|NCT00943605|6068445|P2|COMPLETED|Overall Study||0
2474751|NCT00943605|6068446|P1|COMPLETED|Overall Study||0
2474752|NCT00943605|6068445|P2|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
2474753|NCT00943605|6068446|P1|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
2474754|NCT00943592|6068456|P1|NOT COMPLETED|Overall Study||3
2474755|NCT00943592|6068456|P1|COMPLETED|Overall Study|None of the three deaths were attributed to the conditioning regimen|79
2474756|NCT00943592|6068456|P1|Maximum Tolerated Dose|Overall Study|74 patients received the Maximum Tolerated Dose|74
2474757|NCT00943592|6068456|P1|STARTED|Overall Study||82
2474758|NCT00943579|6068469|P2|NOT COMPLETED|Overall Study||5
2474759|NCT00943579|6068470|P1|NOT COMPLETED|Overall Study||6
2474760|NCT00943579|6068469|P2|COMPLETED|Overall Study||15
2474761|NCT00943579|6068470|P1|COMPLETED|Overall Study||15
2474762|NCT00943579|6068469|P2|STARTED|Overall Study||20
2474763|NCT00943579|6068470|P1|STARTED|Overall Study||21
2474764|NCT00943488|6068491|P2|NOT COMPLETED|Overall Study||2
2474765|NCT00943488|6068492|P1|NOT COMPLETED|Overall Study||1
2474766|NCT00943488|6068491|P2|COMPLETED|Overall Study||202
2474767|NCT00943488|6068492|P1|COMPLETED|Overall Study||203
2474768|NCT00943488|6068491|P2|STARTED|Overall Study||204
2474769|NCT00943488|6068492|P1|STARTED|Overall Study||204
2474770|NCT00943436|6068548|P2|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
2474771|NCT00943436|6068549|P1|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
2474772|NCT00943436|6068548|P2|COMPLETED|Rest Session: 45 Minutes of Reading||10
2474773|NCT00943436|6068549|P1|COMPLETED|Rest Session: 45 Minutes of Reading||10
2474774|NCT00943436|6068548|P2|STARTED|Rest Session: 45 Minutes of Reading||10
2474775|NCT00943436|6068549|P1|STARTED|Rest Session: 45 Minutes of Reading||10
2474776|NCT00943436|6068548|P2|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
2474777|NCT00943436|6068549|P1|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
2474778|NCT00943436|6068548|P2|COMPLETED|Exercise Session: 45 Minutes of Activity||10
2474779|NCT00943436|6068549|P1|COMPLETED|Exercise Session: 45 Minutes of Activity||10
2474780|NCT00943436|6068548|P2|STARTED|Exercise Session: 45 Minutes of Activity||10
2474781|NCT00943436|6068549|P1|STARTED|Exercise Session: 45 Minutes of Activity||10
2474782|NCT00943397|6068571|P2|NOT COMPLETED|Overall Study||72
2474783|NCT00943397|6068572|P1|NOT COMPLETED|Overall Study||15
2474784|NCT00943397|6068571|P2|COMPLETED|Overall Study|Site terminated - Merck administrative decision (52); Patient moved (1); Discontinued for other (3)|86
2474785|NCT00943397|6068572|P1|COMPLETED|Overall Study|Site terminated - Merck administrative decision (11); Discontinued for other (1)|17
2474786|NCT00943397|6068571|P2|STARTED|Overall Study||158
2474787|NCT00943397|6068572|P1|STARTED|Overall Study||32
2474788|NCT00943384|6068578|P1|NOT COMPLETED|Overall Study||49
2474789|NCT00943384|6068578|P1|COMPLETED|Overall Study|evaluated at the Month 24 visit with complete or partial data|55
2474790|NCT00943384|6068578|P1|Treated on Protocol|Overall Study|5 subjects were treated off protocol due to intraoperative decisions made by the surgeon|76
2474791|NCT00943384|6068578|P1|Treated|Overall Study|81 subjects were eligible and willing to participate in the study and were treated|81
2474792|NCT00943384|6068578|P1|STARTED|Overall Study|104 subjects consented and underwent additional screening to determine eligibility to participate|104
2474793|NCT00943319|6068592|P1|NOT COMPLETED|Overall Study||1
2474794|NCT00943319|6068592|P1|COMPLETED|Overall Study||49
2474795|NCT00943319|6068592|P1|STARTED|Overall Study||50
2474796|NCT00943306|6068598|P1|NOT COMPLETED|Overall Study||3
2474797|NCT00943306|6068598|P1|COMPLETED|Overall Study||16
2474798|NCT00943306|6068598|P1|STARTED|Overall Study||19
2474799|NCT00943202|6068659|P4|NOT COMPLETED|Overall Study||1
2474800|NCT00943202|6068660|P3|NOT COMPLETED|Overall Study||0
2474801|NCT00943202|6068661|P2|NOT COMPLETED|Overall Study||2
2474802|NCT00943202|6068662|P1|NOT COMPLETED|Overall Study||1
2474803|NCT00943202|6068659|P4|COMPLETED|Overall Study||131
2474804|NCT00943202|6068660|P3|COMPLETED|Overall Study||133
2474805|NCT00943202|6068661|P2|COMPLETED|Overall Study||131
2474806|NCT00943202|6068662|P1|COMPLETED|Overall Study||132
2474807|NCT00943202|6068659|P4|STARTED|Overall Study||132
2474808|NCT00943202|6068660|P3|STARTED|Overall Study||133
2474809|NCT00943202|6068661|P2|STARTED|Overall Study||133
2474810|NCT00943202|6068662|P1|STARTED|Overall Study||133
2474811|NCT00943150|6068878|P2|NOT COMPLETED|Overall Study||0
2474812|NCT00943150|6068879|P1|NOT COMPLETED|Overall Study||0
2474813|NCT00943150|6068878|P2|COMPLETED|Overall Study||10
2474814|NCT00943150|6068879|P1|COMPLETED|Overall Study||10
2474815|NCT00943150|6068878|P2|STARTED|Overall Study||10
2474816|NCT00943150|6068879|P1|STARTED|Overall Study||10
2474817|NCT00943124|6068900|P2|NOT COMPLETED|Period 2||0
2474818|NCT00943124|6068901|P1|NOT COMPLETED|Period 2||0
2474819|NCT00943124|6068900|P2|COMPLETED|Period 2||108
2474820|NCT00943124|6068901|P1|COMPLETED|Period 2||108
2474821|NCT00943124|6068900|P2|STARTED|Period 2||108
2474822|NCT00943124|6068901|P1|STARTED|Period 2||108
2474823|NCT00943124|6068900|P2|NOT COMPLETED|Period 1||2
2474824|NCT00943124|6068901|P1|NOT COMPLETED|Period 1||2
2474825|NCT00943124|6068900|P2|COMPLETED|Period 1||108
2474826|NCT00943124|6068901|P1|COMPLETED|Period 1||108
2474827|NCT00943124|6068900|P2|STARTED|Period 1||110
2474828|NCT00943124|6068901|P1|STARTED|Period 1||110
2474829|NCT00943111|6068923|P3|NOT COMPLETED|5 Years Long-term Treatment Period||75
2474830|NCT00943111|6068924|P2|NOT COMPLETED|5 Years Long-term Treatment Period||0
2474831|NCT00943111|6068925|P1|NOT COMPLETED|5 Years Long-term Treatment Period||0
2474832|NCT00943111|6068923|P3|COMPLETED|5 Years Long-term Treatment Period||77
2474833|NCT00943111|6068924|P2|COMPLETED|5 Years Long-term Treatment Period||0
2474834|NCT00943111|6068925|P1|COMPLETED|5 Years Long-term Treatment Period||0
2474835|NCT00943111|6068923|P3|STARTED|5 Years Long-term Treatment Period|Participants from both the arms of PAP who completed PAP and remained on-study|152
2474836|NCT00943111|6068924|P2|STARTED|5 Years Long-term Treatment Period||0
2474837|NCT00943111|6068925|P1|STARTED|5 Years Long-term Treatment Period||0
2474838|NCT00943111|6068923|P3|NOT COMPLETED|52-Weeks Primary Analysis Period||0
2474839|NCT00943111|6068924|P2|NOT COMPLETED|52-Weeks Primary Analysis Period||2
2474840|NCT00943111|6068925|P1|NOT COMPLETED|52-Weeks Primary Analysis Period||2
2474841|NCT00943111|6068923|P3|COMPLETED|52-Weeks Primary Analysis Period||0
2474842|NCT00943111|6068924|P2|COMPLETED|52-Weeks Primary Analysis Period||52
2474843|NCT00943111|6068925|P1|COMPLETED|52-Weeks Primary Analysis Period||104
2474844|NCT00943111|6068923|P3|Treated|52-Weeks Primary Analysis Period||0
2474845|NCT00943111|6068924|P2|Treated|52-Weeks Primary Analysis Period||53
2474846|NCT00943111|6068925|P1|Treated|52-Weeks Primary Analysis Period||106
2474847|NCT00943111|6068923|P3|STARTED|52-Weeks Primary Analysis Period||0
2474848|NCT00943111|6068924|P2|STARTED|52-Weeks Primary Analysis Period||54
2474849|NCT00943111|6068925|P1|STARTED|52-Weeks Primary Analysis Period||106
2474850|NCT00943098|6068958|P2|NOT COMPLETED|Overall Study||0
2474851|NCT00943098|6068959|P1|NOT COMPLETED|Overall Study||0
2474852|NCT00943098|6068958|P2|COMPLETED|Overall Study||72
2474853|NCT00943098|6068959|P1|COMPLETED|Overall Study||70
2474854|NCT00943098|6068958|P2|STARTED|Overall Study|1 patient was excluded from the ITT and therefore the baseline population is 71|72
2474855|NCT00943098|6068959|P1|STARTED|Overall Study||70
2474856|NCT00943072|6068993|P2|NOT COMPLETED|Overall Study||14
2474857|NCT00943072|6068994|P1|NOT COMPLETED|Overall Study||5
2474858|NCT00943072|6068993|P2|COMPLETED|Overall Study|60 Participants completed Week 24, From FAS; 50 Participants completed up to Week 100, From SAF|60
2474859|NCT00943072|6068994|P1|COMPLETED|Overall Study|110 Participants completed Week 24, From FAS; 102 Participants completed up to Week 100, From SAF|110
2474860|NCT00943072|6068993|P2|Full Analysis Set (FAS) Population|Overall Study||73
2474861|NCT00943072|6068994|P1|Full Analysis Set (FAS) Population|Overall Study|FAS population used for analysis of Primary and Secondary Outcome Measures|114
2474862|NCT00943072|6068993|P2|Participants Received Treatment|Overall Study||74
2474863|NCT00943072|6068994|P1|Participants Received Treatment|Overall Study|Safety population (SAF)|114
2474864|NCT00943072|6068993|P2|STARTED|Overall Study||74
2474865|NCT00943072|6068994|P1|STARTED|Overall Study||115
2474866|NCT00942994|6069012|P2|NOT COMPLETED|Overall Study||19
2474867|NCT00942994|6069013|P1|NOT COMPLETED|Overall Study||16
2474868|NCT00942994|6069012|P2|COMPLETED|Overall Study||190
2474869|NCT00942994|6069013|P1|COMPLETED|Overall Study||187
2474870|NCT00942994|6069012|P2|STARTED|Overall Study||209
2474871|NCT00942994|6069013|P1|STARTED|Overall Study||203
2474872|NCT00942968|6069029|P1|NOT COMPLETED|Overall Study||229
2474873|NCT00942968|6069029|P1|COMPLETED|Overall Study||109
2474874|NCT00942968|6069029|P1|Treated|Overall Study||334
2474875|NCT00942968|6069029|P1|STARTED|Overall Study||338
2474876|NCT00942903|6069050|P1|NOT COMPLETED|Overall Study||0
2474877|NCT00942903|6069050|P1|COMPLETED|Overall Study||20
2474878|NCT00942903|6069050|P1|STARTED|Overall Study||20
2474879|NCT00942890|6069057|P2|NOT COMPLETED|Overall Study||0
2474880|NCT00942890|6069058|P1|NOT COMPLETED|Overall Study||0
2474881|NCT00942890|6069057|P2|COMPLETED|Overall Study||23
2474882|NCT00942890|6069058|P1|COMPLETED|Overall Study||21
2474883|NCT00942890|6069057|P2|STARTED|Overall Study||23
2474884|NCT00942890|6069058|P1|STARTED|Overall Study||21
2474885|NCT00942851|6069080|P2|NOT COMPLETED|Overall Study||1
2474886|NCT00942851|6069081|P1|NOT COMPLETED|Overall Study||0
2474887|NCT00942851|6069080|P2|COMPLETED|Overall Study||11
2474888|NCT00942851|6069081|P1|COMPLETED|Overall Study||12
2474889|NCT00942851|6069080|P2|STARTED|Overall Study||12
2474890|NCT00942851|6069081|P1|STARTED|Overall Study||12
2474891|NCT00942825|6069093|P2|NOT COMPLETED|Overall Study||0
2474892|NCT00942825|6069094|P1|NOT COMPLETED|Overall Study||0
2474893|NCT00942825|6069093|P2|COMPLETED|Overall Study||98
2474894|NCT00942825|6069094|P1|COMPLETED|Overall Study||97
2474895|NCT00942825|6069093|P2|STARTED|Overall Study||98
2474896|NCT00942825|6069094|P1|STARTED|Overall Study||97
2474897|NCT00942786|6069100|P1|NOT COMPLETED|Overall Study||0
2474898|NCT00942786|6069100|P1|COMPLETED|Overall Study|date of last follow-up|297
2474899|NCT00942786|6069100|P1|STARTED|Overall Study||297
2474900|NCT00942734|6069107|P1|NOT COMPLETED|Overall Study||8
2474901|NCT00942734|6069107|P1|COMPLETED|Overall Study||35
2474902|NCT00942734|6069107|P1|STARTED|Overall Study||43
2474903|NCT00942708|6069111|P1|NOT COMPLETED|Overall Study||1
2474904|NCT00942708|6069111|P1|COMPLETED|Overall Study||5
2474905|NCT00942708|6069111|P1|STARTED|Overall Study||6
2474906|NCT00942604|6069119|P2|NOT COMPLETED|Overall Study||4
2474907|NCT00942604|6069120|P1|NOT COMPLETED|Overall Study||2
2474908|NCT00942604|6069119|P2|COMPLETED|Overall Study||99
2474909|NCT00942604|6069120|P1|COMPLETED|Overall Study||98
2474910|NCT00942604|6069119|P2|STARTED|Overall Study||103
2474911|NCT00942604|6069120|P1|STARTED|Overall Study||100
2474912|NCT00942578|6069131|P3|NOT COMPLETED|Expansion Phase||0
2474913|NCT00942578|6069132|P2|NOT COMPLETED|Expansion Phase||0
2474914|NCT00942578|6069133|P1|NOT COMPLETED|Expansion Phase||0
2474915|NCT00942578|6069131|P3|COMPLETED|Expansion Phase||43
2474916|NCT00942578|6069132|P2|COMPLETED|Expansion Phase||0
2474917|NCT00942578|6069133|P1|COMPLETED|Expansion Phase||11
2474918|NCT00942578|6069131|P3|STARTED|Expansion Phase||43
2474919|NCT00942578|6069132|P2|STARTED|Expansion Phase||0
2474920|NCT00942578|6069133|P1|STARTED|Expansion Phase||11
2474921|NCT00942578|6069131|P3|NOT COMPLETED|Dose Escalation Phase||0
2474922|NCT00942578|6069132|P2|NOT COMPLETED|Dose Escalation Phase||0
2474923|NCT00942578|6069133|P1|NOT COMPLETED|Dose Escalation Phase||0
2474924|NCT00942578|6069131|P3|COMPLETED|Dose Escalation Phase||3
2474925|NCT00942578|6069132|P2|COMPLETED|Dose Escalation Phase||3
2474926|NCT00942578|6069133|P1|COMPLETED|Dose Escalation Phase||3
2474927|NCT00942578|6069131|P3|STARTED|Dose Escalation Phase||3
2474928|NCT00942578|6069132|P2|STARTED|Dose Escalation Phase||3
2474929|NCT00942578|6069133|P1|STARTED|Dose Escalation Phase||3
2474930|NCT00942448|6069163|P4|NOT COMPLETED|Overall Study||0
2474931|NCT00942448|6069164|P3|NOT COMPLETED|Overall Study||0
2474932|NCT00942448|6069165|P2|NOT COMPLETED|Overall Study||0
2474933|NCT00942448|6069166|P1|NOT COMPLETED|Overall Study||0
2474934|NCT00942448|6069163|P4|COMPLETED|Overall Study||75
2474935|NCT00942448|6069164|P3|COMPLETED|Overall Study||78
2474936|NCT00942448|6069165|P2|COMPLETED|Overall Study||76
2474937|NCT00942448|6069166|P1|COMPLETED|Overall Study||77
2474938|NCT00942448|6069163|P4|STARTED|Overall Study||75
2474939|NCT00942448|6069164|P3|STARTED|Overall Study||78
2474940|NCT00942448|6069165|P2|STARTED|Overall Study||76
2474941|NCT00942448|6069166|P1|STARTED|Overall Study||77
2474942|NCT00942422|6069228|P1|NOT COMPLETED|Overall Study||3
2474943|NCT00942422|6069228|P1|COMPLETED|Overall Study||5
2474944|NCT00942422|6069228|P1|STARTED|Overall Study||8
2474945|NCT00942409|6069232|P1|NOT COMPLETED|Overall Study||3
2474946|NCT00942409|6069232|P1|COMPLETED|Overall Study||2
2474947|NCT00942409|6069232|P1|STARTED|Overall Study||5
2474948|NCT00942357|6069238|P2|NOT COMPLETED|Overall Study||40
2474949|NCT00942357|6069239|P1|NOT COMPLETED|Overall Study||37
2474950|NCT00942357|6069238|P2|COMPLETED|Overall Study||366
2474951|NCT00942357|6069239|P1|COMPLETED|Overall Study||370
2474952|NCT00942357|6069238|P2|STARTED|Overall Study||406
2474953|NCT00942357|6069239|P1|STARTED|Overall Study||407
2474962|NCT00942266|6069266|P2|NOT COMPLETED|Overall Study||15
2474963|NCT00942266|6069267|P1|NOT COMPLETED|Overall Study||43
2474964|NCT00942266|6069266|P2|COMPLETED|Overall Study||0
2474965|NCT00942266|6069267|P1|COMPLETED|Overall Study||0
2474966|NCT00942266|6069266|P2|STARTED|Overall Study||15
2474967|NCT00942266|6069267|P1|STARTED|Overall Study||43
2474968|NCT00942188|6069289|P4|NOT COMPLETED|Overall Study||4
2474969|NCT00942188|6069290|P3|NOT COMPLETED|Overall Study||9
2474970|NCT00942188|6069291|P2|NOT COMPLETED|Overall Study||10
2474971|NCT00942188|6069292|P1|NOT COMPLETED|Overall Study||4
2474972|NCT00942188|6069289|P4|COMPLETED|Overall Study||23
2474973|NCT00942188|6069290|P3|COMPLETED|Overall Study||18
2474974|NCT00942188|6069291|P2|COMPLETED|Overall Study||16
2474975|NCT00942188|6069292|P1|COMPLETED|Overall Study||22
2474976|NCT00942188|6069289|P4|STARTED|Overall Study||27
2474977|NCT00942188|6069290|P3|STARTED|Overall Study||27
2474978|NCT00942188|6069291|P2|STARTED|Overall Study||26
2474979|NCT00942188|6069292|P1|STARTED|Overall Study||26
2474980|NCT00942175|6069331|P4|NOT COMPLETED|Overall Study||2
2474981|NCT00942175|6069332|P3|NOT COMPLETED|Overall Study||2
2474982|NCT00942175|6069333|P2|NOT COMPLETED|Overall Study||4
2474983|NCT00942175|6069334|P1|NOT COMPLETED|Overall Study||2
2474984|NCT00942175|6069331|P4|COMPLETED|Overall Study||38
2474985|NCT00942175|6069332|P3|COMPLETED|Overall Study||38
2474986|NCT00942175|6069333|P2|COMPLETED|Overall Study||36
2474987|NCT00942175|6069334|P1|COMPLETED|Overall Study||38
2474988|NCT00942175|6069331|P4|STARTED|Overall Study||40
2474989|NCT00942175|6069332|P3|STARTED|Overall Study||40
2474990|NCT00942175|6069333|P2|STARTED|Overall Study||40
2474991|NCT00942175|6069334|P1|STARTED|Overall Study||40
2474992|NCT00942162|6069387|P3|NOT COMPLETED|Overall Study||1
2474993|NCT00942162|6069388|P2|NOT COMPLETED|Overall Study||47
2474994|NCT00942162|6069389|P1|NOT COMPLETED|Overall Study||68
2474995|NCT00942162|6069387|P3|COMPLETED|Overall Study||1
2474996|NCT00942162|6069388|P2|COMPLETED|Overall Study||3
2474997|NCT00942162|6069389|P1|COMPLETED|Overall Study||3
2474998|NCT00942162|6069387|P3|STARTED|Overall Study||2
2474999|NCT00942162|6069388|P2|STARTED|Overall Study||50
2475000|NCT00942162|6069389|P1|STARTED|Overall Study||71
2475001|NCT00942149|6069454|P1|NOT COMPLETED|Overall Study||0
2475002|NCT00942149|6069454|P1|COMPLETED|Overall Study||20
2475003|NCT00942149|6069454|P1|STARTED|Overall Study||20
2475004|NCT00942084|6069458|P1|NOT COMPLETED|Overall Study||2
2475005|NCT00942084|6069458|P1|COMPLETED|Overall Study|There were 2 infant deaths. None determined to be related to study drug.|30
2475006|NCT00942084|6069458|P1|STARTED|Overall Study||32
2475007|NCT00941993|6069467|P1|NOT COMPLETED|Overall Study||0
2475008|NCT00941993|6069467|P1|COMPLETED|Overall Study||109
2475009|NCT00941993|6069467|P1|STARTED|Overall Study||109
2475010|NCT00941928|6069475|P1|NOT COMPLETED|Overall Study||2
2475011|NCT00941928|6069475|P1|COMPLETED|Overall Study||0
2475012|NCT00941928|6069475|P1|STARTED|Overall Study||2
2475013|NCT00941889|6069481|P2|NOT COMPLETED|Overall Study||12
2475014|NCT00941889|6069482|P1|NOT COMPLETED|Overall Study||12
2475015|NCT00941889|6069481|P2|COMPLETED|Overall Study||3
2475016|NCT00941889|6069482|P1|COMPLETED|Overall Study||5
2475017|NCT00941889|6069481|P2|STARTED|Overall Study||15
2475018|NCT00941889|6069482|P1|STARTED|Overall Study||17
2475019|NCT00941863|6069493|P5|NOT COMPLETED|Continued After PCD||19
2475020|NCT00941863|6069494|P4|NOT COMPLETED|Continued After PCD||0
2475021|NCT00941863|6069495|P3|NOT COMPLETED|Continued After PCD||0
2475022|NCT00941863|6069496|P2|NOT COMPLETED|Continued After PCD||0
2475023|NCT00941863|6069497|P1|NOT COMPLETED|Continued After PCD||0
2475024|NCT00941863|6069493|P5|COMPLETED|Continued After PCD||6
2475025|NCT00941863|6069494|P4|COMPLETED|Continued After PCD||0
2475026|NCT00941863|6069495|P3|COMPLETED|Continued After PCD||0
2475027|NCT00941863|6069496|P2|COMPLETED|Continued After PCD||0
2475028|NCT00941863|6069497|P1|COMPLETED|Continued After PCD||0
2475029|NCT00941863|6069493|P5|STARTED|Continued After PCD|25 of 119 participants from the Expansion Phase, were still on the treatment as of 31 May 2005.|25
2475030|NCT00941863|6069494|P4|STARTED|Continued After PCD||0
2475031|NCT00941863|6069495|P3|STARTED|Continued After PCD||0
2475032|NCT00941863|6069496|P2|STARTED|Continued After PCD||0
2475033|NCT00941863|6069497|P1|STARTED|Continued After PCD||0
2475034|NCT00941863|6069493|P5|NOT COMPLETED|Until Primary Completion Date (PCD)||94
2475035|NCT00941863|6069494|P4|NOT COMPLETED|Until Primary Completion Date (PCD)||17
2475036|NCT00941863|6069495|P3|NOT COMPLETED|Until Primary Completion Date (PCD)||12
2475037|NCT00941863|6069496|P2|NOT COMPLETED|Until Primary Completion Date (PCD)||3
2475038|NCT00941863|6069497|P1|NOT COMPLETED|Until Primary Completion Date (PCD)||7
2475039|NCT00941863|6069493|P5|COMPLETED|Until Primary Completion Date (PCD)||25
2475040|NCT00941863|6069494|P4|COMPLETED|Until Primary Completion Date (PCD)||0
2475041|NCT00941863|6069495|P3|COMPLETED|Until Primary Completion Date (PCD)||0
2475042|NCT00941863|6069496|P2|COMPLETED|Until Primary Completion Date (PCD)||0
2475043|NCT00941863|6069497|P1|COMPLETED|Until Primary Completion Date (PCD)||0
2475044|NCT00941863|6069493|P5|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||94
2475045|NCT00941863|6069494|P4|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||17
2475046|NCT00941863|6069495|P3|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||12
2475047|NCT00941863|6069496|P2|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||3
2475048|NCT00941863|6069497|P1|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||7
2475049|NCT00941863|6069493|P5|STARTED|Until Primary Completion Date (PCD)||119
2475050|NCT00941863|6069494|P4|STARTED|Until Primary Completion Date (PCD)||17
2475051|NCT00941863|6069495|P3|STARTED|Until Primary Completion Date (PCD)||12
2475052|NCT00941863|6069496|P2|STARTED|Until Primary Completion Date (PCD)||3
2475053|NCT00941863|6069497|P1|STARTED|Until Primary Completion Date (PCD)||7
2475054|NCT00941798|6069524|P2|NOT COMPLETED|Overall Study||185
2475055|NCT00941798|6069525|P1|NOT COMPLETED|Overall Study||194
2475056|NCT00941798|6069524|P2|COMPLETED|Overall Study||578
2475057|NCT00941798|6069525|P1|COMPLETED|Overall Study||561
2475058|NCT00941798|6069524|P2|Full Analysis Set|Overall Study||759
2475059|NCT00941798|6069525|P1|Full Analysis Set|Overall Study||749
2475060|NCT00941798|6069524|P2|STARTED|Overall Study||763
2475061|NCT00941798|6069525|P1|STARTED|Overall Study||755
2475062|NCT00941733|6069555|P2|NOT COMPLETED|Overall Study||28
2475063|NCT00941733|6069556|P1|NOT COMPLETED|Overall Study||74
2475064|NCT00941733|6069555|P2|COMPLETED|Overall Study|1 year follow-up|91
2475065|NCT00941733|6069556|P1|COMPLETED|Overall Study|1 year follow-up|165
2475066|NCT00941733|6069555|P2|STARTED|Overall Study||119
2475067|NCT00941733|6069556|P1|STARTED|Overall Study||239
2475068|NCT00941720|6069596|P1|NOT COMPLETED|Overall Study||14
2475069|NCT00941720|6069596|P1|COMPLETED|Overall Study||57
2475070|NCT00941720|6069596|P1|STARTED|Overall Study||71
2475071|NCT00941681|6069605|P3|NOT COMPLETED|Overall Study||0
2475072|NCT00941681|6069606|P2|NOT COMPLETED|Overall Study||1
2475073|NCT00941681|6069607|P1|NOT COMPLETED|Overall Study||0
2475074|NCT00941681|6069605|P3|COMPLETED|Overall Study||12
2475075|NCT00941681|6069606|P2|COMPLETED|Overall Study||10
2475076|NCT00941681|6069607|P1|COMPLETED|Overall Study||12
2475077|NCT00941681|6069605|P3|STARTED|Overall Study||12
2475078|NCT00941681|6069606|P2|STARTED|Overall Study||11
2475079|NCT00941681|6069607|P1|STARTED|Overall Study||12
2475080|NCT00941668|6069632|P2|NOT COMPLETED|Overall Study||25
2475081|NCT00941668|6069633|P1|NOT COMPLETED|Overall Study||24
2475082|NCT00941668|6069632|P2|COMPLETED|Overall Study||0
2475083|NCT00941668|6069633|P1|COMPLETED|Overall Study||0
2475084|NCT00941668|6069632|P2|STARTED|Overall Study||25
2475085|NCT00941668|6069633|P1|STARTED|Overall Study||24
2475086|NCT00941655|6069643|P2|NOT COMPLETED|Overall Study||5
2475087|NCT00941655|6069644|P1|NOT COMPLETED|Overall Study||5
2475088|NCT00941655|6069643|P2|COMPLETED|Overall Study||2
2475089|NCT00941655|6069644|P1|COMPLETED|Overall Study||3
2475090|NCT00941655|6069643|P2|STARTED|Overall Study||7
2475091|NCT00941655|6069644|P1|STARTED|Overall Study||8
2475092|NCT00941603|6069669|P6|NOT COMPLETED|Overall Study||3
2475093|NCT00941603|6069670|P5|NOT COMPLETED|Overall Study||4
2475094|NCT00941603|6069671|P4|NOT COMPLETED|Overall Study||4
2475095|NCT00941603|6069672|P3|NOT COMPLETED|Overall Study||5
2475096|NCT00941603|6069673|P2|NOT COMPLETED|Overall Study||16
2475097|NCT00941603|6069674|P1|NOT COMPLETED|Overall Study||11
2475098|NCT00941603|6069669|P6|COMPLETED|Overall Study||94
2475099|NCT00941603|6069670|P5|COMPLETED|Overall Study||101
2475100|NCT00941603|6069671|P4|COMPLETED|Overall Study||100
2475101|NCT00941603|6069672|P3|COMPLETED|Overall Study||99
2475102|NCT00941603|6069673|P2|COMPLETED|Overall Study||89
2475103|NCT00941603|6069674|P1|COMPLETED|Overall Study||93
2475104|NCT00941603|6069669|P6|STARTED|Overall Study||97
2475105|NCT00941603|6069670|P5|STARTED|Overall Study||105
2475106|NCT00941603|6069671|P4|STARTED|Overall Study||104
2475107|NCT00941603|6069672|P3|STARTED|Overall Study||104
2475108|NCT00941603|6069673|P2|STARTED|Overall Study||105
2475109|NCT00941603|6069674|P1|STARTED|Overall Study||104
2475110|NCT00941330|6069696|P2|NOT COMPLETED|Overall Study||2
2475111|NCT00941330|6069697|P1|NOT COMPLETED|Overall Study||1
2475112|NCT00941330|6069696|P2|COMPLETED|Overall Study||9
2475113|NCT00941330|6069697|P1|COMPLETED|Overall Study||14
2475114|NCT00941330|6069696|P2|STARTED|Overall Study||11
2475115|NCT00941330|6069697|P1|STARTED|Overall Study||15
2475116|NCT00941304|6069710|P5|NOT COMPLETED|Overall Study||0
2475117|NCT00941304|6069711|P4|NOT COMPLETED|Overall Study||0
2475118|NCT00941304|6069712|P3|NOT COMPLETED|Overall Study||0
2475119|NCT00941304|6069713|P2|NOT COMPLETED|Overall Study||0
2475120|NCT00941304|6069714|P1|NOT COMPLETED|Overall Study||1
2475121|NCT00941304|6069710|P5|COMPLETED|Overall Study||31
2475122|NCT00941304|6069711|P4|COMPLETED|Overall Study||30
2475123|NCT00941304|6069712|P3|COMPLETED|Overall Study||31
2475124|NCT00941304|6069713|P2|COMPLETED|Overall Study||30
2475125|NCT00941304|6069714|P1|COMPLETED|Overall Study||30
2475126|NCT00941304|6069710|P5|STARTED|Overall Study||31
2475127|NCT00941304|6069711|P4|STARTED|Overall Study||30
2475128|NCT00941304|6069712|P3|STARTED|Overall Study||31
2475129|NCT00941304|6069713|P2|STARTED|Overall Study||30
2475130|NCT00941304|6069714|P1|STARTED|Overall Study||31
2475131|NCT00941070|6069776|P1|NOT COMPLETED|Overall Study||1
2475132|NCT00941070|6069776|P1|COMPLETED|Overall Study||25
2475133|NCT00941070|6069776|P1|STARTED|Overall Study||26
2475134|NCT00941031|6069796|P7|NOT COMPLETED|Maintenance Period||43
2475135|NCT00941031|6069797|P6|NOT COMPLETED|Maintenance Period||6
2475136|NCT00941031|6069798|P5|NOT COMPLETED|Maintenance Period||9
2475137|NCT00941031|6069799|P4|NOT COMPLETED|Maintenance Period||0
2475138|NCT00941031|6069800|P3|NOT COMPLETED|Maintenance Period||0
2475139|NCT00941031|6069801|P2|NOT COMPLETED|Maintenance Period||0
2475140|NCT00941031|6069802|P1|NOT COMPLETED|Maintenance Period||0
2475141|NCT00941031|6069796|P7|COMPLETED|Maintenance Period||204
2475142|NCT00941031|6069797|P6|COMPLETED|Maintenance Period||61
2475143|NCT00941031|6069798|P5|COMPLETED|Maintenance Period||56
2475144|NCT00941031|6069799|P4|COMPLETED|Maintenance Period|Non Responders treated with an open label regimen.|0
2475145|NCT00941031|6069800|P3|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
2475146|NCT00941031|6069801|P2|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
2475147|NCT00941031|6069802|P1|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
2475148|NCT00941031|6069796|P7|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|247
2475149|NCT00941031|6069797|P6|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|67
2475150|NCT00941031|6069798|P5|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|65
2475151|NCT00941031|6069799|P4|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|0
2475152|NCT00941031|6069800|P3|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
2475153|NCT00941031|6069801|P2|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
2475154|NCT00941031|6069802|P1|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
2475155|NCT00941031|6069796|P7|NOT COMPLETED|Induction Period||0
2475156|NCT00941031|6069797|P6|NOT COMPLETED|Induction Period||0
2475157|NCT00941031|6069798|P5|NOT COMPLETED|Induction Period||0
2475158|NCT00941031|6069799|P4|NOT COMPLETED|Induction Period||9
2475159|NCT00941031|6069800|P3|NOT COMPLETED|Induction Period||6
2475160|NCT00941031|6069801|P2|NOT COMPLETED|Induction Period||4
2475161|NCT00941031|6069802|P1|NOT COMPLETED|Induction Period||5
2475162|NCT00941031|6069796|P7|COMPLETED|Induction Period||0
2475163|NCT00941031|6069797|P6|COMPLETED|Induction Period||0
2475164|NCT00941031|6069798|P5|COMPLETED|Induction Period||0
2475165|NCT00941031|6069799|P4|COMPLETED|Induction Period||58
2475166|NCT00941031|6069800|P3|COMPLETED|Induction Period||127
2475167|NCT00941031|6069801|P2|COMPLETED|Induction Period||134
2475168|NCT00941031|6069802|P1|COMPLETED|Induction Period||61
2475169|NCT00941031|6069796|P7|STARTED|Induction Period||0
2475170|NCT00941031|6069797|P6|STARTED|Induction Period||0
2475171|NCT00941031|6069798|P5|STARTED|Induction Period||0
2475172|NCT00941031|6069799|P4|STARTED|Induction Period||67
2475173|NCT00941031|6069800|P3|STARTED|Induction Period||133
2475174|NCT00941031|6069801|P2|STARTED|Induction Period||138
2475175|NCT00941031|6069802|P1|STARTED|Induction Period||66
2475176|NCT00940992|6069828|P3|NOT COMPLETED|Overall Study||2
2475177|NCT00940992|6069829|P2|NOT COMPLETED|Overall Study||2
2475178|NCT00940992|6069830|P1|NOT COMPLETED|Overall Study||4
2475179|NCT00940992|6069828|P3|COMPLETED|Overall Study||28
2475180|NCT00940992|6069829|P2|COMPLETED|Overall Study||28
2475181|NCT00940992|6069830|P1|COMPLETED|Overall Study||28
2475182|NCT00940992|6069828|P3|STARTED|Overall Study||30
2475183|NCT00940992|6069829|P2|STARTED|Overall Study||30
2475184|NCT00940992|6069830|P1|STARTED|Overall Study||32
2475185|NCT00940927|6069841|P1|NOT COMPLETED|Overall Study||0
2475186|NCT00940927|6069841|P1|COMPLETED|Overall Study||81
2475187|NCT00940927|6069841|P1|STARTED|Overall Study||81
2475188|NCT00940901|6069848|P2|NOT COMPLETED|Week 9-16 (Phase 2)||3
2475189|NCT00940901|6069849|P1|NOT COMPLETED|Week 9-16 (Phase 2)||2
2475190|NCT00940901|6069848|P2|COMPLETED|Week 9-16 (Phase 2)||4
2475191|NCT00940901|6069849|P1|COMPLETED|Week 9-16 (Phase 2)||4
2475192|NCT00940901|6069848|P2|STARTED|Week 9-16 (Phase 2)||7
2475193|NCT00940901|6069849|P1|STARTED|Week 9-16 (Phase 2)||6
2475194|NCT00940901|6069848|P2|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
2475195|NCT00940901|6069849|P1|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
2475196|NCT00940901|6069848|P2|COMPLETED|Weeks 1-8 (Phase 1)||7
2475197|NCT00940901|6069849|P1|COMPLETED|Weeks 1-8 (Phase 1)||6
2475198|NCT00940901|6069848|P2|STARTED|Weeks 1-8 (Phase 1)||7
2475199|NCT00940901|6069849|P1|STARTED|Weeks 1-8 (Phase 1)||6
2475200|NCT00940888|6069859|P1|NOT COMPLETED|Overall Study||835
2475201|NCT00940888|6069859|P1|COMPLETED|Overall Study|Subjects that completed the 60 month follow up visit|866
2475202|NCT00940888|6069859|P1|STARTED|Overall Study|Total number of subjects consented|1701
2475203|NCT00940875|6069866|P2|NOT COMPLETED|Post-Study Treatment||3
2475204|NCT00940875|6069867|P1|NOT COMPLETED|Post-Study Treatment||0
2475205|NCT00940875|6069866|P2|COMPLETED|Post-Study Treatment||1
2475206|NCT00940875|6069867|P1|COMPLETED|Post-Study Treatment||0
2475207|NCT00940875|6069866|P2|STARTED|Post-Study Treatment||4
2475208|NCT00940875|6069867|P1|STARTED|Post-Study Treatment||0
2475209|NCT00940875|6069866|P2|NOT COMPLETED|Treatment Phase||19
2475210|NCT00940875|6069867|P1|NOT COMPLETED|Treatment Phase||26
2475211|NCT00940875|6069866|P2|COMPLETED|Treatment Phase||4
2475212|NCT00940875|6069867|P1|COMPLETED|Treatment Phase||5
2475213|NCT00940875|6069866|P2|STARTED|Treatment Phase|3 participants randomized to G+E arm received only gemcitabine and were analyzed in Gemcitabine arm|23
2475214|NCT00940875|6069867|P1|STARTED|Treatment Phase|Disposition analysis includes 3 participants randomized to G+E but received only gemcitabine|31
2475215|NCT00940823|6069887|P2|NOT COMPLETED|Overall Study||32
2475216|NCT00940823|6069888|P1|NOT COMPLETED|Overall Study||35
2475217|NCT00940823|6069887|P2|COMPLETED|Overall Study||82
2475218|NCT00940823|6069888|P1|COMPLETED|Overall Study||89
2475219|NCT00940823|6069887|P2|STARTED|Overall Study||114
2475220|NCT00940823|6069888|P1|STARTED|Overall Study||124
2475221|NCT00940589|6069906|P2|NOT COMPLETED|Overall Study||5
2475222|NCT00940589|6069907|P1|NOT COMPLETED|Overall Study||8
2475223|NCT00940589|6069906|P2|COMPLETED|Overall Study||29
2475224|NCT00940589|6069907|P1|COMPLETED|Overall Study||31
2475225|NCT00940589|6069906|P2|STARTED|Overall Study||34
2475226|NCT00940589|6069907|P1|STARTED|Overall Study||39
2475227|NCT00940576|6069917|P2|NOT COMPLETED|Overall Study||0
2475228|NCT00940576|6069918|P1|NOT COMPLETED|Overall Study||0
2475229|NCT00940576|6069917|P2|COMPLETED|Overall Study||9
2475230|NCT00940576|6069918|P1|COMPLETED|Overall Study||8
2475231|NCT00940576|6069917|P2|STARTED|Overall Study||9
2475232|NCT00940576|6069918|P1|STARTED|Overall Study||8
2475233|NCT00940537|6069927|P2|NOT COMPLETED|Overall Study||0
2475234|NCT00940537|6069928|P1|NOT COMPLETED|Overall Study||0
2475235|NCT00940537|6069927|P2|COMPLETED|Overall Study||9
2475236|NCT00940537|6069928|P1|COMPLETED|Overall Study||5
2475237|NCT00940537|6069927|P2|STARTED|Overall Study||9
2475238|NCT00940537|6069928|P1|STARTED|Overall Study||5
2475239|NCT00940498|6069945|P8|NOT COMPLETED|Overall Study||1
2475240|NCT00940498|6069946|P7|NOT COMPLETED|Overall Study||1
2475241|NCT00940498|6069947|P6|NOT COMPLETED|Overall Study||1
2475242|NCT00940498|6069948|P5|NOT COMPLETED|Overall Study||9
2475243|NCT00940498|6069949|P4|NOT COMPLETED|Overall Study||2
2475244|NCT00940498|6069950|P3|NOT COMPLETED|Overall Study||3
2475245|NCT00940498|6069951|P2|NOT COMPLETED|Overall Study||1
2475246|NCT00940498|6069952|P1|NOT COMPLETED|Overall Study||3
2475247|NCT00940498|6069945|P8|COMPLETED|Overall Study||3
2475248|NCT00940498|6069946|P7|COMPLETED|Overall Study||7
2475249|NCT00940498|6069947|P6|COMPLETED|Overall Study||6
2475250|NCT00940498|6069948|P5|COMPLETED|Overall Study||34
2475251|NCT00940498|6069949|P4|COMPLETED|Overall Study||2
2475252|NCT00940498|6069950|P3|COMPLETED|Overall Study||1
2475253|NCT00940498|6069951|P2|COMPLETED|Overall Study||3
2475254|NCT00940498|6069952|P1|COMPLETED|Overall Study||1
2475255|NCT00940498|6069945|P8|STARTED|Overall Study||4
2475256|NCT00940498|6069946|P7|STARTED|Overall Study||8
2475257|NCT00940498|6069947|P6|STARTED|Overall Study||7
2475258|NCT00940498|6069948|P5|STARTED|Overall Study||43
2475259|NCT00940498|6069949|P4|STARTED|Overall Study||4
2475260|NCT00940498|6069950|P3|STARTED|Overall Study||4
2475261|NCT00940498|6069951|P2|STARTED|Overall Study||4
2475262|NCT00940498|6069952|P1|STARTED|Overall Study||4
2475263|NCT00940485|6070070|P2|NOT COMPLETED|Overall Study||7
2475264|NCT00940485|6070071|P1|NOT COMPLETED|Overall Study||15
2475265|NCT00940485|6070070|P2|COMPLETED|Overall Study||93
2475266|NCT00940485|6070071|P1|COMPLETED|Overall Study||82
2475267|NCT00940485|6070070|P2|STARTED|Overall Study||100
2475268|NCT00940485|6070071|P1|STARTED|Overall Study||97
2475269|NCT00940446|6070097|P2|NOT COMPLETED|Overall Study||0
2475270|NCT00940446|6070098|P1|NOT COMPLETED|Overall Study||0
2475271|NCT00940446|6070097|P2|COMPLETED|Overall Study||30
2475272|NCT00940446|6070098|P1|COMPLETED|Overall Study||30
2475273|NCT00940446|6070097|P2|STARTED|Overall Study||30
2475274|NCT00940446|6070098|P1|STARTED|Overall Study||30
2475275|NCT00940342|6070109|P3|NOT COMPLETED|Overall Study||1
2475276|NCT00940342|6070110|P2|NOT COMPLETED|Overall Study||2
2475277|NCT00940342|6070111|P1|NOT COMPLETED|Overall Study||0
2475278|NCT00940342|6070109|P3|COMPLETED|Overall Study||39
2475279|NCT00940342|6070110|P2|COMPLETED|Overall Study||38
2475280|NCT00940342|6070111|P1|COMPLETED|Overall Study||50
2475281|NCT00940342|6070109|P3|STARTED|Overall Study||40
2475282|NCT00940342|6070110|P2|STARTED|Overall Study||40
2475283|NCT00940342|6070111|P1|STARTED|Overall Study||50
2475284|NCT00940316|6070122|P3|NOT COMPLETED|Follow up Every 3 Months||0
2475285|NCT00940316|6070123|P2|NOT COMPLETED|Follow up Every 3 Months||0
2475286|NCT00940316|6070124|P1|NOT COMPLETED|Follow up Every 3 Months||0
2475287|NCT00940316|6070122|P3|COMPLETED|Follow up Every 3 Months||2
2475288|NCT00940316|6070123|P2|COMPLETED|Follow up Every 3 Months||13
2475289|NCT00940316|6070124|P1|COMPLETED|Follow up Every 3 Months||13
2475290|NCT00940316|6070122|P3|STARTED|Follow up Every 3 Months||2
2475291|NCT00940316|6070123|P2|STARTED|Follow up Every 3 Months||13
2475292|NCT00940316|6070124|P1|STARTED|Follow up Every 3 Months||13
2475293|NCT00940316|6070122|P3|NOT COMPLETED|Crossed Over to Arm A After Progression||0
2475294|NCT00940316|6070123|P2|NOT COMPLETED|Crossed Over to Arm A After Progression||0
2475295|NCT00940316|6070124|P1|NOT COMPLETED|Crossed Over to Arm A After Progression||0
2475296|NCT00940316|6070122|P3|COMPLETED|Crossed Over to Arm A After Progression||0
2475297|NCT00940316|6070123|P2|COMPLETED|Crossed Over to Arm A After Progression||3
2475298|NCT00940316|6070124|P1|COMPLETED|Crossed Over to Arm A After Progression||0
2475299|NCT00940316|6070122|P3|Treated for Cycle One|Crossed Over to Arm A After Progression||0
2475300|NCT00940316|6070123|P2|Treated for Cycle One|Crossed Over to Arm A After Progression||3
2475301|NCT00940316|6070124|P1|Treated for Cycle One|Crossed Over to Arm A After Progression||0
2475302|NCT00940316|6070122|P3|STARTED|Crossed Over to Arm A After Progression||0
2475303|NCT00940316|6070123|P2|STARTED|Crossed Over to Arm A After Progression||3
2475304|NCT00940316|6070124|P1|STARTED|Crossed Over to Arm A After Progression||0
2475305|NCT00940316|6070122|P3|NOT COMPLETED|Treated After Cycle 5||1
2475306|NCT00940316|6070123|P2|NOT COMPLETED|Treated After Cycle 5||1
2475307|NCT00940316|6070124|P1|NOT COMPLETED|Treated After Cycle 5||0
2475308|NCT00940316|6070122|P3|COMPLETED|Treated After Cycle 5||1
2475309|NCT00940316|6070123|P2|COMPLETED|Treated After Cycle 5||8
2475310|NCT00940316|6070124|P1|COMPLETED|Treated After Cycle 5||8
2475311|NCT00940316|6070122|P3|STARTED|Treated After Cycle 5||2
2475312|NCT00940316|6070123|P2|STARTED|Treated After Cycle 5||9
2475313|NCT00940316|6070124|P1|STARTED|Treated After Cycle 5||8
2475314|NCT00940316|6070122|P3|NOT COMPLETED|Moved on to be Treated Cycle 5||0
2475315|NCT00940316|6070123|P2|NOT COMPLETED|Moved on to be Treated Cycle 5||0
2475316|NCT00940316|6070124|P1|NOT COMPLETED|Moved on to be Treated Cycle 5||2
2475317|NCT00940316|6070122|P3|COMPLETED|Moved on to be Treated Cycle 5||2
2475318|NCT00940316|6070123|P2|COMPLETED|Moved on to be Treated Cycle 5||9
2475319|NCT00940316|6070124|P1|COMPLETED|Moved on to be Treated Cycle 5||8
2475320|NCT00940316|6070122|P3|STARTED|Moved on to be Treated Cycle 5||2
2475321|NCT00940316|6070123|P2|STARTED|Moved on to be Treated Cycle 5||9
2475322|NCT00940316|6070124|P1|STARTED|Moved on to be Treated Cycle 5||10
2475323|NCT00940316|6070122|P3|NOT COMPLETED|Reached First Response at 8 Weeks||0
2475324|NCT00940316|6070123|P2|NOT COMPLETED|Reached First Response at 8 Weeks||4
2475325|NCT00940316|6070124|P1|NOT COMPLETED|Reached First Response at 8 Weeks||3
2475326|NCT00940316|6070122|P3|COMPLETED|Reached First Response at 8 Weeks||2
2475327|NCT00940316|6070123|P2|COMPLETED|Reached First Response at 8 Weeks||9
2475328|NCT00940316|6070124|P1|COMPLETED|Reached First Response at 8 Weeks||10
2475329|NCT00940316|6070122|P3|STARTED|Reached First Response at 8 Weeks||2
2475330|NCT00940316|6070123|P2|STARTED|Reached First Response at 8 Weeks||13
2475331|NCT00940316|6070124|P1|STARTED|Reached First Response at 8 Weeks||13
2475332|NCT00940290|6070150|P4|NOT COMPLETED|Overall Study||0
2475333|NCT00940290|6070151|P3|NOT COMPLETED|Overall Study||0
2475334|NCT00940290|6070152|P2|NOT COMPLETED|Overall Study||0
2475335|NCT00940290|6070153|P1|NOT COMPLETED|Overall Study||0
2475336|NCT00940290|6070150|P4|COMPLETED|Overall Study||54
2475337|NCT00940290|6070151|P3|COMPLETED|Overall Study||55
2475338|NCT00940290|6070152|P2|COMPLETED|Overall Study||53
2475339|NCT00940290|6070153|P1|COMPLETED|Overall Study||54
2475340|NCT00940290|6070150|P4|STARTED|Overall Study||54
2475341|NCT00940290|6070151|P3|STARTED|Overall Study||55
2475342|NCT00940290|6070152|P2|STARTED|Overall Study||53
2475343|NCT00940290|6070153|P1|STARTED|Overall Study||54
2475344|NCT00940108|6070167|P4|NOT COMPLETED|Overall Study||5
2475345|NCT00940108|6070168|P3|NOT COMPLETED|Overall Study||3
2475346|NCT00940108|6070169|P2|NOT COMPLETED|Overall Study||9
2475347|NCT00940108|6070170|P1|NOT COMPLETED|Overall Study||5
2475348|NCT00940108|6070167|P4|COMPLETED|Overall Study||99
2475349|NCT00940108|6070168|P3|COMPLETED|Overall Study||100
2475350|NCT00940108|6070169|P2|COMPLETED|Overall Study||71
2475351|NCT00940108|6070170|P1|COMPLETED|Overall Study||77
2475352|NCT00940108|6070167|P4|STARTED|Overall Study||104
2475353|NCT00940108|6070168|P3|STARTED|Overall Study||103
2475354|NCT00940108|6070169|P2|STARTED|Overall Study||80
2475355|NCT00940108|6070170|P1|STARTED|Overall Study||82
2475356|NCT00940017|6070220|P1|NOT COMPLETED|Overall Study||4
2475357|NCT00940017|6070220|P1|COMPLETED|Overall Study||20
2475358|NCT00940017|6070220|P1|Subjects Treated|Overall Study||21
2475359|NCT00940017|6070220|P1|STARTED|Overall Study||24
2475360|NCT00939991|6070241|P2|NOT COMPLETED|Overall Study||0
2475361|NCT00939991|6070242|P1|NOT COMPLETED|Overall Study||0
2475362|NCT00939991|6070241|P2|COMPLETED|Overall Study||39
2475363|NCT00939991|6070242|P1|COMPLETED|Overall Study||9
2475364|NCT00939991|6070241|P2|STARTED|Overall Study||39
2475365|NCT00939991|6070242|P1|STARTED|Overall Study||9
2475366|NCT00939952|6070252|P1|NOT COMPLETED|Overall Study||0
2475367|NCT00939952|6070252|P1|COMPLETED|Overall Study||7
2475368|NCT00939952|6070252|P1|STARTED|Overall Study||7
2475369|NCT00939900|6070264|P2|NOT COMPLETED|Overall Study||7
2475370|NCT00939900|6070265|P1|NOT COMPLETED|Overall Study||2
2475371|NCT00939900|6070264|P2|COMPLETED|Overall Study||48
2475372|NCT00939900|6070265|P1|COMPLETED|Overall Study||53
2475373|NCT00939900|6070264|P2|STARTED|Overall Study||55
2475374|NCT00939900|6070265|P1|STARTED|Overall Study||55
2475375|NCT00939874|6070271|P1|NOT COMPLETED|Overall Study||20
2475376|NCT00939874|6070271|P1|COMPLETED|Overall Study||32
2475377|NCT00939874|6070271|P1|Completed Week 48|Overall Study||37
2475378|NCT00939874|6070271|P1|STARTED|Overall Study||52
2475379|NCT00939822|6070278|P2|NOT COMPLETED|Overall Study||3
2475380|NCT00939822|6070279|P1|NOT COMPLETED|Overall Study||2
2475381|NCT00939822|6070278|P2|COMPLETED|Overall Study||41
2475382|NCT00939822|6070279|P1|COMPLETED|Overall Study||42
2475383|NCT00939822|6070278|P2|STARTED|Overall Study||44
2475384|NCT00939822|6070279|P1|STARTED|Overall Study||44
2475385|NCT00939809|6070291|P1|NOT COMPLETED|Overall Study||3
2475386|NCT00939809|6070291|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|28
2475387|NCT00939809|6070291|P1|STARTED|Overall Study||31
2475388|NCT00939796|6070300|P1|NOT COMPLETED|Overall Study||0
2475389|NCT00939796|6070300|P1|COMPLETED|Overall Study||16
2475390|NCT00939796|6070300|P1|STARTED|Overall Study||16
2475391|NCT00939783|6070306|P1|NOT COMPLETED|Overall Study||649
2475392|NCT00939783|6070306|P1|COMPLETED|Overall Study||0
2475393|NCT00939783|6070306|P1|Treated|Overall Study||648
2475394|NCT00939783|6070306|P1|STARTED|Overall Study||649
2475395|NCT00939731|6070313|P2|NOT COMPLETED|Second Intervention Period||0
2475396|NCT00939731|6070314|P1|NOT COMPLETED|Second Intervention Period||0
2475397|NCT00939731|6070313|P2|COMPLETED|Second Intervention Period||12
2475398|NCT00939731|6070314|P1|COMPLETED|Second Intervention Period||12
2475399|NCT00939731|6070313|P2|STARTED|Second Intervention Period||12
2475400|NCT00939731|6070314|P1|STARTED|Second Intervention Period||12
2475401|NCT00939731|6070313|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2475402|NCT00939731|6070314|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2475403|NCT00939731|6070313|P2|COMPLETED|Washout Period (at Least 14 Days)||12
2475404|NCT00939731|6070314|P1|COMPLETED|Washout Period (at Least 14 Days)||12
2475405|NCT00939731|6070313|P2|STARTED|Washout Period (at Least 14 Days)||12
2475406|NCT00939731|6070314|P1|STARTED|Washout Period (at Least 14 Days)||12
2475407|NCT00939731|6070313|P2|NOT COMPLETED|First Intervention Period||0
2475408|NCT00939731|6070314|P1|NOT COMPLETED|First Intervention Period||0
2475409|NCT00939731|6070313|P2|COMPLETED|First Intervention Period||12
2475410|NCT00939731|6070314|P1|COMPLETED|First Intervention Period||12
2475411|NCT00939731|6070313|P2|STARTED|First Intervention Period||12
2475412|NCT00939731|6070314|P1|STARTED|First Intervention Period||12
2475413|NCT00939705|6070334|P2|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
2475414|NCT00939705|6070335|P1|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
2475415|NCT00939705|6070334|P2|COMPLETED|Period 3 - Second Intervent - 5 Days||9
2475416|NCT00939705|6070335|P1|COMPLETED|Period 3 - Second Intervent - 5 Days||9
2475417|NCT00939705|6070334|P2|STARTED|Period 3 - Second Intervent - 5 Days||9
2475418|NCT00939705|6070335|P1|STARTED|Period 3 - Second Intervent - 5 Days||9
2475419|NCT00939705|6070334|P2|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
2475420|NCT00939705|6070335|P1|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
2475421|NCT00939705|6070334|P2|COMPLETED|Period 2 - Washout Period - 21 Days||9
2475422|NCT00939705|6070335|P1|COMPLETED|Period 2 - Washout Period - 21 Days||9
2475423|NCT00939705|6070334|P2|STARTED|Period 2 - Washout Period - 21 Days||9
2475424|NCT00939705|6070335|P1|STARTED|Period 2 - Washout Period - 21 Days||9
2475425|NCT00939705|6070334|P2|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
2475426|NCT00939705|6070335|P1|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
2475427|NCT00939705|6070334|P2|COMPLETED|Period 1 - First Intervention - 5 Days||9
2475428|NCT00939705|6070335|P1|COMPLETED|Period 1 - First Intervention - 5 Days||9
2475429|NCT00939705|6070334|P2|STARTED|Period 1 - First Intervention - 5 Days||9
2475430|NCT00939705|6070335|P1|STARTED|Period 1 - First Intervention - 5 Days||9
2475431|NCT00939692|6070347|P2|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||1
2475432|NCT00939692|6070348|P1|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||0
2475433|NCT00939692|6070347|P2|COMPLETED|Period 2 - Second Intervent - 5 Days||12
2475434|NCT00939692|6070348|P1|COMPLETED|Period 2 - Second Intervent - 5 Days||12
2475435|NCT00939692|6070347|P2|STARTED|Period 2 - Second Intervent - 5 Days||13
2475436|NCT00939692|6070348|P1|STARTED|Period 2 - Second Intervent - 5 Days||12
2475437|NCT00939692|6070347|P2|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
2475438|NCT00939692|6070348|P1|NOT COMPLETED|Period 1 - First Intervention - 5 Days||1
2475439|NCT00939692|6070347|P2|COMPLETED|Period 1 - First Intervention - 5 Days||13
2475440|NCT00939692|6070348|P1|COMPLETED|Period 1 - First Intervention - 5 Days||12
2475441|NCT00939692|6070347|P2|STARTED|Period 1 - First Intervention - 5 Days||13
2475442|NCT00939692|6070348|P1|STARTED|Period 1 - First Intervention - 5 Days||13
2475455|NCT00939640|6070363|P1|NOT COMPLETED|Overall Study||1
2475456|NCT00939640|6070363|P1|COMPLETED|Overall Study||13
2475457|NCT00939640|6070363|P1|STARTED|Overall Study||14
2475458|NCT00939627|6070384|P3|NOT COMPLETED|Overall Study||0
2475459|NCT00939627|6070385|P2|NOT COMPLETED|Overall Study||28
2475460|NCT00939627|6070386|P1|NOT COMPLETED|Overall Study||27
2475461|NCT00939627|6070384|P3|COMPLETED|Overall Study||0
2475462|NCT00939627|6070385|P2|COMPLETED|Overall Study||0
2475463|NCT00939627|6070386|P1|COMPLETED|Overall Study||0
2475464|NCT00939627|6070384|P3|STARTED|Overall Study||0
2475465|NCT00939627|6070385|P2|STARTED|Overall Study||28
2475466|NCT00939627|6070386|P1|STARTED|Overall Study||27
2475467|NCT00939562|6070404|P2|NOT COMPLETED|Period 2||0
2475468|NCT00939562|6070405|P1|NOT COMPLETED|Period 2||0
2475469|NCT00939562|6070404|P2|COMPLETED|Period 2||12
2475470|NCT00939562|6070405|P1|COMPLETED|Period 2||12
2475471|NCT00939562|6070404|P2|STARTED|Period 2||12
2475472|NCT00939562|6070405|P1|STARTED|Period 2||12
2475473|NCT00939562|6070404|P2|NOT COMPLETED|Period 1||0
2475474|NCT00939562|6070405|P1|NOT COMPLETED|Period 1||0
2475475|NCT00939562|6070404|P2|COMPLETED|Period 1||12
2475476|NCT00939562|6070405|P1|COMPLETED|Period 1||12
2475477|NCT00939562|6070404|P2|STARTED|Period 1||12
2475478|NCT00939562|6070405|P1|STARTED|Period 1||12
2475479|NCT00939536|6070415|P2|NOT COMPLETED|Second Intervention||0
2475480|NCT00939536|6070416|P1|NOT COMPLETED|Second Intervention||0
2475481|NCT00939536|6070415|P2|COMPLETED|Second Intervention||12
2475482|NCT00939536|6070416|P1|COMPLETED|Second Intervention||12
2475483|NCT00939536|6070415|P2|STARTED|Second Intervention||12
2475484|NCT00939536|6070416|P1|STARTED|Second Intervention||12
2475485|NCT00939536|6070415|P2|NOT COMPLETED|First Intervention||0
2475486|NCT00939536|6070416|P1|NOT COMPLETED|First Intervention||0
2475487|NCT00939536|6070415|P2|COMPLETED|First Intervention||12
2475488|NCT00939536|6070416|P1|COMPLETED|First Intervention||12
2475489|NCT00939536|6070415|P2|STARTED|First Intervention||12
2475490|NCT00939536|6070416|P1|STARTED|First Intervention||12
2475491|NCT00939523|6070426|P1|NOT COMPLETED|Overall Study||3
2475492|NCT00939523|6070426|P1|COMPLETED|Overall Study||6
2475493|NCT00939523|6070426|P1|STARTED|Overall Study||9
2475494|NCT00939510|6070433|P1|NOT COMPLETED|Overall Study||1
2475495|NCT00939510|6070433|P1|COMPLETED|Overall Study||31
2475496|NCT00939510|6070433|P1|STARTED|Overall Study||32
2475497|NCT00939484|6070442|P3|NOT COMPLETED|Overall Study||3
2475498|NCT00939484|6070443|P2|NOT COMPLETED|Overall Study||20
2475499|NCT00939484|6070444|P1|NOT COMPLETED|Overall Study||8
2475500|NCT00939484|6070442|P3|COMPLETED|Overall Study||0
2475501|NCT00939484|6070443|P2|COMPLETED|Overall Study||0
2475502|NCT00939484|6070444|P1|COMPLETED|Overall Study||0
2475503|NCT00939484|6070442|P3|STARTED|Overall Study||3
2475504|NCT00939484|6070443|P2|STARTED|Overall Study||20
2475505|NCT00939484|6070444|P1|STARTED|Overall Study||8
2475506|NCT00939471|6070457|P1|NOT COMPLETED|Overall Study||11
2475507|NCT00939471|6070457|P1|COMPLETED|Overall Study||33
2475508|NCT00939471|6070457|P1|STARTED|Overall Study||44
2475509|NCT00939393|6070470|P2|NOT COMPLETED|Overall Study||0
2475510|NCT00939393|6070471|P1|NOT COMPLETED|Overall Study||4
2475511|NCT00939393|6070470|P2|COMPLETED|Overall Study||35
2475512|NCT00939393|6070471|P1|COMPLETED|Overall Study||33
2475513|NCT00939393|6070470|P2|STARTED|Overall Study||35
2475514|NCT00939393|6070471|P1|STARTED|Overall Study||37
2475515|NCT00939367|6070491|P2|NOT COMPLETED|Second Intervention||0
2475516|NCT00939367|6070492|P1|NOT COMPLETED|Second Intervention||0
2475517|NCT00939367|6070491|P2|COMPLETED|Second Intervention||15
2475518|NCT00939367|6070492|P1|COMPLETED|Second Intervention||15
2475519|NCT00939367|6070491|P2|STARTED|Second Intervention||15
2475520|NCT00939367|6070492|P1|STARTED|Second Intervention||15
2475521|NCT00939367|6070491|P2|NOT COMPLETED|First Intervention||0
2475522|NCT00939367|6070492|P1|NOT COMPLETED|First Intervention||0
2475523|NCT00939367|6070491|P2|COMPLETED|First Intervention||15
2475524|NCT00939367|6070492|P1|COMPLETED|First Intervention||15
2475525|NCT00939367|6070491|P2|STARTED|First Intervention||15
2475526|NCT00939367|6070492|P1|STARTED|First Intervention||15
2475527|NCT00939341|6070502|P1|NOT COMPLETED|Overall Study||66
2475528|NCT00939341|6070502|P1|COMPLETED|Overall Study|862 participants entered into the 12-week treatment,66 discontinued, 796 completed the treatment.|796
2475529|NCT00939341|6070502|P1|STARTED|Overall Study|1022 participants were enrolled. There were 160 screen failures, 862 proceeded to treatment period.|862
2475530|NCT00939211|6070522|P1|NOT COMPLETED|Placebo||0
2475531|NCT00939211|6070522|P1|COMPLETED|Placebo||28
2475532|NCT00939211|6070522|P1|STARTED|Placebo||28
2475533|NCT00939211|6070522|P1|NOT COMPLETED|Spiriva 18 Mcg First, Then Placebo||0
2475534|NCT00939211|6070522|P1|COMPLETED|Spiriva 18 Mcg First, Then Placebo||28
2475535|NCT00939211|6070522|P1|STARTED|Spiriva 18 Mcg First, Then Placebo||28
2475536|NCT00939211|6070522|P1|NOT COMPLETED|AZD9164 1200 Mcg First, Then Placebo||0
2475537|NCT00939211|6070522|P1|COMPLETED|AZD9164 1200 Mcg First, Then Placebo||28
2475538|NCT00939211|6070522|P1|STARTED|AZD9164 1200 Mcg First, Then Placebo||28
2475539|NCT00939211|6070522|P1|NOT COMPLETED|AZD9164 400 Mcg First, Then Placebo||0
2475540|NCT00939211|6070522|P1|COMPLETED|AZD9164 400 Mcg First, Then Placebo||28
2475541|NCT00939211|6070522|P1|STARTED|AZD9164 400 Mcg First, Then Placebo||28
2475542|NCT00939211|6070522|P1|NOT COMPLETED|AZD9164 100 Mcg First, Then Placebo||0
2475543|NCT00939211|6070522|P1|COMPLETED|AZD9164 100 Mcg First, Then Placebo||28
2475544|NCT00939211|6070522|P1|STARTED|AZD9164 100 Mcg First, Then Placebo|Cross-over study|28
2475545|NCT00939198|6070584|P1|NOT COMPLETED|Overall Study||0
2475546|NCT00939198|6070584|P1|COMPLETED|Overall Study||87
2475547|NCT00939198|6070584|P1|STARTED|Overall Study||87
2475548|NCT00939185|6070589|P1|NOT COMPLETED|Overall Study||25
2475549|NCT00939185|6070589|P1|COMPLETED|Overall Study||375
2475550|NCT00939185|6070589|P1|Received Treatment|Overall Study||390
2475551|NCT00939185|6070589|P1|STARTED|Overall Study||400
2475552|NCT00939159|6070596|P1|NOT COMPLETED|Overall Study||0
2475553|NCT00939159|6070596|P1|COMPLETED|Overall Study||13
2475554|NCT00939159|6070596|P1|STARTED|Overall Study||13
2475555|NCT00939120|6070602|P2|NOT COMPLETED|Overall Study||5
2475556|NCT00939120|6070603|P1|NOT COMPLETED|Overall Study||8
2475557|NCT00939120|6070602|P2|COMPLETED|Overall Study||18
2475558|NCT00939120|6070603|P1|COMPLETED|Overall Study||15
2475559|NCT00939120|6070602|P2|STARTED|Overall Study||23
2475560|NCT00939120|6070603|P1|STARTED|Overall Study||23
2475561|NCT00939107|6070627|P2|NOT COMPLETED|Overall Study||12
2475562|NCT00939107|6070628|P1|NOT COMPLETED|Overall Study||14
2475563|NCT00939107|6070627|P2|COMPLETED|Overall Study||163
2475564|NCT00939107|6070628|P1|COMPLETED|Overall Study||161
2475565|NCT00939107|6070627|P2|12 Months Follow-up|Overall Study||163
2475566|NCT00939107|6070628|P1|12 Months Follow-up|Overall Study||161
2475567|NCT00939107|6070627|P2|STARTED|Overall Study||175
2475568|NCT00939107|6070628|P1|STARTED|Overall Study||175
2475569|NCT00939094|6070642|P2|NOT COMPLETED|Overall Study||10
2475570|NCT00939094|6070643|P1|NOT COMPLETED|Overall Study||14
2475571|NCT00939094|6070642|P2|COMPLETED|Overall Study||35
2475572|NCT00939094|6070643|P1|COMPLETED|Overall Study||28
2475573|NCT00939094|6070642|P2|STARTED|Overall Study||45
2475574|NCT00939094|6070643|P1|STARTED|Overall Study||42
2475575|NCT00939055|6070665|P2|NOT COMPLETED|Overall Study||0
2475576|NCT00939055|6070666|P1|NOT COMPLETED|Overall Study||4
2475577|NCT00939055|6070665|P2|COMPLETED|Overall Study||39
2475578|NCT00939055|6070666|P1|COMPLETED|Overall Study||69
2475579|NCT00939055|6070665|P2|STARTED|Overall Study||39
2475580|NCT00939055|6070666|P1|STARTED|Overall Study||73
2475581|NCT00939029|6070676|P2|NOT COMPLETED|Overall Study||12
2475582|NCT00939029|6070677|P1|NOT COMPLETED|Overall Study||6
2475583|NCT00939029|6070676|P2|COMPLETED|Overall Study||15
2475584|NCT00939029|6070677|P1|COMPLETED|Overall Study||19
2475585|NCT00939029|6070676|P2|STARTED|Overall Study||27
2475586|NCT00939029|6070677|P1|STARTED|Overall Study||25
2475587|NCT00939003|6070689|P2|NOT COMPLETED|Open-label Treatment Period||29
2475588|NCT00939003|6070690|P1|NOT COMPLETED|Open-label Treatment Period||29
2475589|NCT00939003|6070689|P2|COMPLETED|Open-label Treatment Period||62
2475590|NCT00939003|6070690|P1|COMPLETED|Open-label Treatment Period||66
2475591|NCT00939003|6070689|P2|STARTED|Open-label Treatment Period||91
2475592|NCT00939003|6070690|P1|STARTED|Open-label Treatment Period||95
2475593|NCT00939003|6070689|P2|NOT COMPLETED|Double-blind Treatment Period||4
2475594|NCT00939003|6070690|P1|NOT COMPLETED|Double-blind Treatment Period||2
2475595|NCT00939003|6070689|P2|COMPLETED|Double-blind Treatment Period||91
2475596|NCT00939003|6070690|P1|COMPLETED|Double-blind Treatment Period||95
2475597|NCT00939003|6070689|P2|STARTED|Double-blind Treatment Period||95
2475598|NCT00939003|6070690|P1|STARTED|Double-blind Treatment Period||97
2475599|NCT00938964|6070727|P2|NOT COMPLETED|Overall Study||28
2475600|NCT00938964|6070728|P1|NOT COMPLETED|Overall Study||30
2475601|NCT00938964|6070727|P2|COMPLETED|Overall Study||209
2475602|NCT00938964|6070728|P1|COMPLETED|Overall Study||211
2475603|NCT00938964|6070727|P2|STARTED|Overall Study||237
2475604|NCT00938964|6070728|P1|STARTED|Overall Study||241
2475605|NCT00938886|6070792|P2|NOT COMPLETED|Overall Study||10
2475606|NCT00938886|6070793|P1|NOT COMPLETED|Overall Study||7
2475607|NCT00938886|6070792|P2|COMPLETED|Overall Study||65
2475608|NCT00938886|6070793|P1|COMPLETED|Overall Study||68
2475609|NCT00938886|6070792|P2|Attended 1 Counseling Session|Overall Study||70
2475610|NCT00938886|6070793|P1|Attended 1 Counseling Session|Overall Study||70
2475611|NCT00938886|6070792|P2|STARTED|Overall Study||75
2475612|NCT00938886|6070793|P1|STARTED|Overall Study||75
2475613|NCT00938860|6070803|P2|NOT COMPLETED|Overall Study||17
2475614|NCT00938860|6070804|P1|NOT COMPLETED|Overall Study||25
2475615|NCT00938860|6070803|P2|COMPLETED|Overall Study||25
2475616|NCT00938860|6070804|P1|COMPLETED|Overall Study||25
2475617|NCT00938860|6070803|P2|Efficacy Population|Overall Study||41
2475618|NCT00938860|6070804|P1|Efficacy Population|Overall Study||40
2475619|NCT00938860|6070803|P2|STARTED|Overall Study||42
2475620|NCT00938860|6070804|P1|STARTED|Overall Study|Intent-to-Treat (ITT) population. ITT population consisted of all randomized patients|50
2475621|NCT00938782|6070828|P2|NOT COMPLETED|Overall Study||0
2475622|NCT00938782|6070829|P1|NOT COMPLETED|Overall Study||0
2475623|NCT00938782|6070828|P2|COMPLETED|Overall Study|Upon discharge from PACU|35
2475624|NCT00938782|6070829|P1|COMPLETED|Overall Study|Upon discharge from PACU|32
2475625|NCT00938782|6070828|P2|STARTED|Overall Study|Monitoring started pre-induction of anesthesia|35
2475626|NCT00938782|6070829|P1|STARTED|Overall Study|Pre-induction of anesthesia|32
2475627|NCT00938717|6070837|P2|NOT COMPLETED|Overall Study||108
2475628|NCT00938717|6070838|P1|NOT COMPLETED|Overall Study||98
2475629|NCT00938717|6070837|P2|COMPLETED|Overall Study||294
2475630|NCT00938717|6070838|P1|COMPLETED|Overall Study||305
2475631|NCT00938717|6070837|P2|STARTED|Overall Study||402
2475632|NCT00938717|6070838|P1|STARTED|Overall Study||403
2475633|NCT00938704|6070872|P2|NOT COMPLETED|Overall Study||0
2475634|NCT00938704|6070873|P1|NOT COMPLETED|Overall Study||0
2475635|NCT00938704|6070872|P2|COMPLETED|Overall Study||37
2475636|NCT00938704|6070873|P1|COMPLETED|Overall Study||33
2475637|NCT00938704|6070872|P2|STARTED|Overall Study||37
2475638|NCT00938704|6070873|P1|STARTED|Overall Study||33
2475639|NCT00938639|6070889|P2|NOT COMPLETED|Overall Study||4
2475640|NCT00938639|6070890|P1|NOT COMPLETED|Overall Study||3
2475641|NCT00938639|6070889|P2|COMPLETED|Overall Study||116
2475642|NCT00938639|6070890|P1|COMPLETED|Overall Study||117
2475643|NCT00938639|6070889|P2|STARTED|Overall Study||120
2475644|NCT00938639|6070890|P1|STARTED|Overall Study||120
2475645|NCT00938548|6070960|P2|NOT COMPLETED|Overall Study||0
2475646|NCT00938548|6070961|P1|NOT COMPLETED|Overall Study||0
2475647|NCT00938548|6070960|P2|COMPLETED|Overall Study||35
2475648|NCT00938548|6070961|P1|COMPLETED|Overall Study||35
2475649|NCT00938548|6070960|P2|STARTED|Overall Study||35
2475650|NCT00938548|6070961|P1|STARTED|Overall Study||35
2475651|NCT00938470|6070973|P2|NOT COMPLETED|Overall Study||3
2475652|NCT00938470|6070974|P1|NOT COMPLETED|Overall Study||7
2475653|NCT00938470|6070973|P2|COMPLETED|Overall Study||25
2475654|NCT00938470|6070974|P1|COMPLETED|Overall Study||27
2475655|NCT00938470|6070973|P2|STARTED|Overall Study||28
2475656|NCT00938470|6070974|P1|STARTED|Overall Study||34
2475657|NCT00938457|6070988|P1|NOT COMPLETED|Overall Study||0
2475658|NCT00938457|6070988|P1|COMPLETED|Overall Study||3
2475659|NCT00938457|6070988|P1|STARTED|Overall Study||3
2475660|NCT00938431|6071004|P3|NOT COMPLETED|Overall Study||8
2475661|NCT00938431|6071005|P2|NOT COMPLETED|Overall Study||9
2475662|NCT00938431|6071006|P1|NOT COMPLETED|Overall Study||6
2475663|NCT00938431|6071004|P3|COMPLETED|Overall Study||1
2475664|NCT00938431|6071005|P2|COMPLETED|Overall Study||14
2475665|NCT00938431|6071006|P1|COMPLETED|Overall Study||9
2475666|NCT00938431|6071004|P3|STARTED|Overall Study||9
2475667|NCT00938431|6071005|P2|STARTED|Overall Study||23
2475668|NCT00938431|6071006|P1|STARTED|Overall Study||15
2475669|NCT00938392|6071033|P2|NOT COMPLETED|Overall Study||4
2475670|NCT00938392|6071034|P1|NOT COMPLETED|Overall Study||2
2475671|NCT00938392|6071033|P2|COMPLETED|Overall Study||358
2475672|NCT00938392|6071034|P1|COMPLETED|Overall Study||360
2475673|NCT00938392|6071033|P2|STARTED|Overall Study||362
2475674|NCT00938392|6071034|P1|STARTED|Overall Study||362
2475675|NCT00938366|6071060|P2|NOT COMPLETED|Overall Study||0
2475676|NCT00938366|6071061|P1|NOT COMPLETED|Overall Study||1
2475677|NCT00938366|6071060|P2|COMPLETED|Overall Study||9
2475678|NCT00938366|6071061|P1|COMPLETED|Overall Study||8
2475679|NCT00938366|6071060|P2|STARTED|Overall Study||9
2475680|NCT00938366|6071061|P1|STARTED|Overall Study||9
2475681|NCT00938340|6071081|P1|NOT COMPLETED|Overall Study||5
2475682|NCT00938340|6071081|P1|COMPLETED|Overall Study||15
2475683|NCT00938340|6071081|P1|Received Walnut Oil Intervention|Overall Study||15
2475684|NCT00938340|6071081|P1|Received Walnut Skins Intervention|Overall Study||15
2475685|NCT00938340|6071081|P1|Received Walnut Nutmeat Intervention|Overall Study||19
2475686|NCT00938340|6071081|P1|Received Whole Walnut Intervention|Overall Study||16
2475687|NCT00938340|6071081|P1|STARTED|Overall Study||20
2475688|NCT00938327|6071211|P1|NOT COMPLETED|Overall Study||60
2475689|NCT00938327|6071211|P1|COMPLETED|Overall Study||272
2475690|NCT00938327|6071211|P1|STARTED|Overall Study||332
2475691|NCT00938314|6071222|P4|NOT COMPLETED|Cohort 3||1
2475692|NCT00938314|6071223|P3|NOT COMPLETED|Cohort 3||4
2475693|NCT00938314|6071224|P2|NOT COMPLETED|Cohort 3||0
2475694|NCT00938314|6071225|P1|NOT COMPLETED|Cohort 3||0
2475695|NCT00938314|6071222|P4|COMPLETED|Cohort 3||7
2475696|NCT00938314|6071223|P3|COMPLETED|Cohort 3||20
2475697|NCT00938314|6071224|P2|COMPLETED|Cohort 3||0
2475698|NCT00938314|6071225|P1|COMPLETED|Cohort 3||0
2475699|NCT00938314|6071222|P4|STARTED|Cohort 3||8
2475700|NCT00938314|6071223|P3|STARTED|Cohort 3||24
2475701|NCT00938314|6071224|P2|STARTED|Cohort 3||0
2475702|NCT00938314|6071225|P1|STARTED|Cohort 3||0
2475703|NCT00938314|6071222|P4|NOT COMPLETED|Cohort 2||2
2475704|NCT00938314|6071223|P3|NOT COMPLETED|Cohort 2||0
2475705|NCT00938314|6071224|P2|NOT COMPLETED|Cohort 2||6
2475706|NCT00938314|6071225|P1|NOT COMPLETED|Cohort 2||0
2475707|NCT00938314|6071222|P4|COMPLETED|Cohort 2||6
2475708|NCT00938314|6071223|P3|COMPLETED|Cohort 2||0
2475709|NCT00938314|6071224|P2|COMPLETED|Cohort 2||18
2475710|NCT00938314|6071225|P1|COMPLETED|Cohort 2||0
2475711|NCT00938314|6071222|P4|STARTED|Cohort 2||8
2475712|NCT00938314|6071223|P3|STARTED|Cohort 2||0
2475713|NCT00938314|6071224|P2|STARTED|Cohort 2||24
2475714|NCT00938314|6071225|P1|STARTED|Cohort 2||0
2475715|NCT00938314|6071222|P4|NOT COMPLETED|Cohort 1||2
2475716|NCT00938314|6071223|P3|NOT COMPLETED|Cohort 1||0
2475717|NCT00938314|6071224|P2|NOT COMPLETED|Cohort 1||0
2475718|NCT00938314|6071225|P1|NOT COMPLETED|Cohort 1||2
2475719|NCT00938314|6071222|P4|COMPLETED|Cohort 1||6
2475720|NCT00938314|6071223|P3|COMPLETED|Cohort 1||0
2475721|NCT00938314|6071224|P2|COMPLETED|Cohort 1||0
2475722|NCT00938314|6071225|P1|COMPLETED|Cohort 1||22
2475723|NCT00938314|6071222|P4|STARTED|Cohort 1||8
2475724|NCT00938314|6071223|P3|STARTED|Cohort 1||0
2475725|NCT00938314|6071224|P2|STARTED|Cohort 1||0
2475726|NCT00938314|6071225|P1|STARTED|Cohort 1||24
2475727|NCT00938041|6071279|P1|NOT COMPLETED|Overall Study||27
2475728|NCT00938041|6071279|P1|COMPLETED|Overall Study||5
2475729|NCT00938041|6071279|P1|STARTED|Overall Study||32
2475730|NCT00938015|6071288|P1|NOT COMPLETED|Overall Study||147
2475731|NCT00938015|6071288|P1|COMPLETED|Overall Study||156
2475732|NCT00938015|6071288|P1|STARTED|Overall Study||303
2475733|NCT00937950|6071304|P1|NOT COMPLETED|Overall Study||216
2475734|NCT00937950|6071304|P1|COMPLETED|Overall Study||1787
2475735|NCT00937950|6071304|P1|STARTED|Overall Study||2003
2475736|NCT00937937|6071320|P1|NOT COMPLETED|Overall Study||72
2475737|NCT00937937|6071320|P1|COMPLETED|Overall Study||0
2475738|NCT00937937|6071320|P1|STARTED|Overall Study||72
2475739|NCT00937833|6071329|P2|NOT COMPLETED|Overall Study||17
2475740|NCT00937833|6071330|P1|NOT COMPLETED|Overall Study||15
2475741|NCT00937833|6071329|P2|COMPLETED|Overall Study||60
2475742|NCT00937833|6071330|P1|COMPLETED|Overall Study||58
2475743|NCT00937833|6071329|P2|STARTED|Overall Study||77
2475744|NCT00937833|6071330|P1|STARTED|Overall Study||73
2475745|NCT00937794|6071336|P1|NOT COMPLETED|Overall Study||0
2475746|NCT00937794|6071336|P1|COMPLETED|Overall Study||33
2475747|NCT00937794|6071336|P1|STARTED|Overall Study||33
2475748|NCT00937768|6071343|P2|NOT COMPLETED|Overall Study||8
2475749|NCT00937768|6071344|P1|NOT COMPLETED|Overall Study||8
2475750|NCT00937768|6071343|P2|COMPLETED|Overall Study||0
2475751|NCT00937768|6071344|P1|COMPLETED|Overall Study||0
2475752|NCT00937768|6071343|P2|STARTED|Overall Study||8
2475753|NCT00937768|6071344|P1|STARTED|Overall Study||8
2475754|NCT00937560|6071364|P1|NOT COMPLETED|Maintenance Treatment||18
2475755|NCT00937560|6071364|P1|COMPLETED|Maintenance Treatment||150
2475756|NCT00937560|6071364|P1|STARTED|Maintenance Treatment||168
2475757|NCT00937560|6071364|P1|NOT COMPLETED|Initial Treatment||21
2475758|NCT00937560|6071364|P1|COMPLETED|Initial Treatment||168
2475759|NCT00937560|6071364|P1|Received Treatment|Initial Treatment||189
2475760|NCT00937560|6071364|P1|STARTED|Initial Treatment||189
2475761|NCT00937547|6071375|P3|NOT COMPLETED|Overall Study||7
2475762|NCT00937547|6071376|P2|NOT COMPLETED|Overall Study||6
2475763|NCT00937547|6071377|P1|NOT COMPLETED|Overall Study||1
2475764|NCT00937547|6071375|P3|COMPLETED|Overall Study||142
2475765|NCT00937547|6071376|P2|COMPLETED|Overall Study||78
2475766|NCT00937547|6071377|P1|COMPLETED|Overall Study||95
2475767|NCT00937547|6071375|P3|Histological Samples|Overall Study||142
2475768|NCT00937547|6071376|P2|Histological Samples|Overall Study||78
2475769|NCT00937547|6071377|P1|Histological Samples|Overall Study||95
2475770|NCT00937547|6071375|P3|STARTED|Overall Study||149
2475771|NCT00937547|6071376|P2|STARTED|Overall Study||84
2475772|NCT00937547|6071377|P1|STARTED|Overall Study||96
2475773|NCT00937521|6071414|P8|NOT COMPLETED|Booster Phase||2
2475774|NCT00937521|6071415|P7|NOT COMPLETED|Booster Phase||5
2475775|NCT00937521|6071416|P6|NOT COMPLETED|Booster Phase||5
2475776|NCT00937521|6071417|P5|NOT COMPLETED|Booster Phase||5
2475777|NCT00937521|6071418|P4|NOT COMPLETED|Booster Phase||3
2475778|NCT00937521|6071419|P3|NOT COMPLETED|Booster Phase||5
2475779|NCT00937521|6071420|P2|NOT COMPLETED|Booster Phase||2
2475780|NCT00937521|6071421|P1|NOT COMPLETED|Booster Phase||3
2475781|NCT00937521|6071414|P8|COMPLETED|Booster Phase||159
2475782|NCT00937521|6071415|P7|COMPLETED|Booster Phase||160
2475783|NCT00937521|6071416|P6|COMPLETED|Booster Phase||160
2475784|NCT00937521|6071417|P5|COMPLETED|Booster Phase||163
2475785|NCT00937521|6071418|P4|COMPLETED|Booster Phase||167
2475786|NCT00937521|6071419|P3|COMPLETED|Booster Phase||164
2475787|NCT00937521|6071420|P2|COMPLETED|Booster Phase||161
2475788|NCT00937521|6071421|P1|COMPLETED|Booster Phase||152
2475789|NCT00937521|6071414|P8|Premature Withdrawal|Booster Phase||2
2475790|NCT00937521|6071415|P7|Premature Withdrawal|Booster Phase||5
2475791|NCT00937521|6071416|P6|Premature Withdrawal|Booster Phase||5
2475792|NCT00937521|6071417|P5|Premature Withdrawal|Booster Phase||5
2475793|NCT00937521|6071418|P4|Premature Withdrawal|Booster Phase||3
2475794|NCT00937521|6071419|P3|Premature Withdrawal|Booster Phase||5
2475795|NCT00937521|6071420|P2|Premature Withdrawal|Booster Phase||2
2475796|NCT00937521|6071421|P1|Premature Withdrawal|Booster Phase||3
2475797|NCT00937521|6071414|P8|STARTED|Booster Phase||161
2475798|NCT00937521|6071415|P7|STARTED|Booster Phase||165
2475799|NCT00937521|6071416|P6|STARTED|Booster Phase||165
2475800|NCT00937521|6071417|P5|STARTED|Booster Phase||168
2475801|NCT00937521|6071418|P4|STARTED|Booster Phase||170
2475802|NCT00937521|6071419|P3|STARTED|Booster Phase||169
2475803|NCT00937521|6071420|P2|STARTED|Booster Phase||163
2475804|NCT00937521|6071421|P1|STARTED|Booster Phase||155
2475805|NCT00937521|6071414|P8|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
2475806|NCT00937521|6071415|P7|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
2475807|NCT00937521|6071416|P6|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
2475808|NCT00937521|6071417|P5|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
2475809|NCT00937521|6071418|P4|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
2475810|NCT00937521|6071419|P3|NOT COMPLETED|Overall Study - Prior to Booster Dose||6
2475811|NCT00937521|6071420|P2|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
2475812|NCT00937521|6071421|P1|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
2475813|NCT00937521|6071414|P8|COMPLETED|Overall Study - Prior to Booster Dose||183
2475814|NCT00937521|6071415|P7|COMPLETED|Overall Study - Prior to Booster Dose||181
2475815|NCT00937521|6071416|P6|COMPLETED|Overall Study - Prior to Booster Dose||187
2475816|NCT00937521|6071417|P5|COMPLETED|Overall Study - Prior to Booster Dose||188
2475817|NCT00937521|6071418|P4|COMPLETED|Overall Study - Prior to Booster Dose||187
2475818|NCT00937521|6071419|P3|COMPLETED|Overall Study - Prior to Booster Dose||186
2475819|NCT00937521|6071420|P2|COMPLETED|Overall Study - Prior to Booster Dose||185
2475820|NCT00937521|6071421|P1|COMPLETED|Overall Study - Prior to Booster Dose||185
2475821|NCT00937521|6071414|P8|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
2475822|NCT00937521|6071415|P7|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
2475823|NCT00937521|6071416|P6|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
2475824|NCT00937521|6071417|P5|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
2475825|NCT00937521|6071418|P4|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
2475826|NCT00937521|6071419|P3|Premature Withdrawal|Overall Study - Prior to Booster Dose||6
2475827|NCT00937521|6071420|P2|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
2475828|NCT00937521|6071421|P1|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
2475829|NCT00937521|6071414|P8|STARTED|Overall Study - Prior to Booster Dose||184
2475830|NCT00937521|6071415|P7|STARTED|Overall Study - Prior to Booster Dose||186
2475831|NCT00937521|6071416|P6|STARTED|Overall Study - Prior to Booster Dose||188
2475832|NCT00937521|6071417|P5|STARTED|Overall Study - Prior to Booster Dose||191
2475833|NCT00937521|6071418|P4|STARTED|Overall Study - Prior to Booster Dose||188
2475834|NCT00937521|6071419|P3|STARTED|Overall Study - Prior to Booster Dose||192
2475835|NCT00937521|6071420|P2|STARTED|Overall Study - Prior to Booster Dose||190
2475836|NCT00937521|6071421|P1|STARTED|Overall Study - Prior to Booster Dose||188
2475837|NCT00937495|6071527|P1|NOT COMPLETED|Overall Study||2
2475838|NCT00937495|6071527|P1|COMPLETED|Overall Study||14
2475839|NCT00937495|6071527|P1|STARTED|Overall Study||16
2475840|NCT00937404|6071533|P1|NOT COMPLETED|Overall Study||2
2475841|NCT00937404|6071533|P1|COMPLETED|Overall Study||23
2475842|NCT00937404|6071533|P1|STARTED|Overall Study||25
2475843|NCT00937391|6071542|P1|NOT COMPLETED|Stage 2||1
2475844|NCT00937391|6071542|P1|COMPLETED|Stage 2|The number completed includes participants within the FAS and Per Protocol Set (PPS)|33
2475845|NCT00937391|6071542|P1|Treated|Stage 2|Valid for Full Analysis Set; participants administered correct Magnevist dose based on body weight|34
2475846|NCT00937391|6071542|P1|STARTED|Stage 2|Stage 1 and Stage 2 are independent each enrolling a different set of participants|34
2475847|NCT00937391|6071542|P1|NOT COMPLETED|Stage 1||0
2475848|NCT00937391|6071542|P1|COMPLETED|Stage 1||20
2475849|NCT00937391|6071542|P1|Treated|Stage 1|Valid for Full Analysis Set (FAS); includes all participants administered Magnevist Injection|20
2475850|NCT00937391|6071542|P1|STARTED|Stage 1||20
2475851|NCT00937326|6071598|P5|NOT COMPLETED|Overall Study||5
2475852|NCT00937326|6071599|P4|NOT COMPLETED|Overall Study||5
2475853|NCT00937326|6071600|P3|NOT COMPLETED|Overall Study||4
2475854|NCT00937326|6071601|P2|NOT COMPLETED|Overall Study||7
2475855|NCT00937326|6071602|P1|NOT COMPLETED|Overall Study||3
2475856|NCT00937326|6071598|P5|COMPLETED|Overall Study||40
2475857|NCT00937326|6071599|P4|COMPLETED|Overall Study||40
2475858|NCT00937326|6071600|P3|COMPLETED|Overall Study||42
2475859|NCT00937326|6071601|P2|COMPLETED|Overall Study||38
2475860|NCT00937326|6071602|P1|COMPLETED|Overall Study||43
2475861|NCT00937326|6071598|P5|STARTED|Overall Study||45
2475862|NCT00937326|6071599|P4|STARTED|Overall Study||45
2475863|NCT00937326|6071600|P3|STARTED|Overall Study||46
2475864|NCT00937326|6071601|P2|STARTED|Overall Study||45
2475865|NCT00937326|6071602|P1|STARTED|Overall Study||46
2475866|NCT00937235|6071830|P2|NOT COMPLETED|Overall Study||0
2475867|NCT00937235|6071831|P1|NOT COMPLETED|Overall Study||0
2475868|NCT00937235|6071830|P2|COMPLETED|Overall Study||70
2475869|NCT00937235|6071831|P1|COMPLETED|Overall Study||72
2475870|NCT00937235|6071830|P2|STARTED|Overall Study||70
2475871|NCT00937235|6071831|P1|STARTED|Overall Study||72
2475872|NCT00937157|6071851|P1|NOT COMPLETED|Overall Study||4
2475873|NCT00937157|6071851|P1|COMPLETED|Overall Study||8
2475874|NCT00937157|6071851|P1|STARTED|Overall Study||12
2475875|NCT00937118|6071855|P1|NOT COMPLETED|Overall Study||0
2475876|NCT00937118|6071855|P1|COMPLETED|Overall Study||41
2475877|NCT00937118|6071855|P1|STARTED|Overall Study||41
2475878|NCT00937105|6071864|P2|NOT COMPLETED|Overall Study||39
2475879|NCT00937105|6071865|P1|NOT COMPLETED|Overall Study||40
2475880|NCT00937105|6071864|P2|COMPLETED|Overall Study||70
2475881|NCT00937105|6071865|P1|COMPLETED|Overall Study||69
2475882|NCT00937105|6071864|P2|STARTED|Overall Study||109
2475883|NCT00937105|6071865|P1|STARTED|Overall Study||109
2475884|NCT00937040|6071882|P2|NOT COMPLETED|Overall Study||37
2475885|NCT00937040|6071883|P1|NOT COMPLETED|Overall Study||41
2475886|NCT00937040|6071882|P2|COMPLETED|Overall Study||141
2475887|NCT00937040|6071883|P1|COMPLETED|Overall Study||138
2475888|NCT00937040|6071882|P2|STARTED|Overall Study||178
2475889|NCT00937040|6071883|P1|STARTED|Overall Study||179
2475890|NCT00936975|6071925|P1|NOT COMPLETED|Overall Study||6
2475891|NCT00936975|6071925|P1|COMPLETED|Overall Study||12
2475892|NCT00936975|6071925|P1|STARTED|Overall Study||18
2475893|NCT00936910|6071934|P1|NOT COMPLETED|Overall Study||3
2475894|NCT00936910|6071934|P1|COMPLETED|Overall Study|The primary endpt. of 2 (-) cultures within 5 d of lock therapy was met for 10 patients|10
2475895|NCT00936910|6071934|P1|STARTED|Overall Study||13
2475896|NCT00936897|6071943|P2|NOT COMPLETED|Overall Study||60
2475897|NCT00936897|6071944|P1|NOT COMPLETED|Overall Study||19
2475898|NCT00936897|6071943|P2|COMPLETED|Overall Study||356
2475899|NCT00936897|6071944|P1|COMPLETED|Overall Study||398
2475900|NCT00936897|6071943|P2|STARTED|Overall Study|Randomized|416
2475901|NCT00936897|6071944|P1|STARTED|Overall Study|Randomized|417
2475902|NCT00936884|6071958|P3|NOT COMPLETED|Open-label||19
2475903|NCT00936884|6071959|P2|NOT COMPLETED|Open-label||0
2475904|NCT00936884|6071960|P1|NOT COMPLETED|Open-label||0
2475905|NCT00936884|6071958|P3|COMPLETED|Open-label||12
2475906|NCT00936884|6071959|P2|COMPLETED|Open-label||0
2475907|NCT00936884|6071960|P1|COMPLETED|Open-label||0
2475908|NCT00936884|6071958|P3|STARTED|Open-label||31
2475909|NCT00936884|6071959|P2|STARTED|Open-label||0
2475910|NCT00936884|6071960|P1|STARTED|Open-label||0
2475911|NCT00936884|6071958|P3|NOT COMPLETED|Double-blind||0
2475912|NCT00936884|6071959|P2|NOT COMPLETED|Double-blind||7
2475913|NCT00936884|6071960|P1|NOT COMPLETED|Double-blind||12
2475914|NCT00936884|6071958|P3|COMPLETED|Double-blind||0
2475915|NCT00936884|6071959|P2|COMPLETED|Double-blind||18
2475916|NCT00936884|6071960|P1|COMPLETED|Double-blind||13
2475917|NCT00936884|6071958|P3|STARTED|Double-blind|Thirteen subjects from the MNTX group and 18 from the placebo group entered the 12-week extension.|0
2475918|NCT00936884|6071959|P2|STARTED|Double-blind|Twenty-four subjects received placebo, and 23 had ≥ 1 post baseline diary assessment.|25
2475919|NCT00936884|6071960|P1|STARTED|Double-blind|Twenty-five subjects received MNTX, and 24 had ≥ 1 post baseline diary assessment.|25
2475920|NCT00936741|6071971|P1|NOT COMPLETED|Overall Study||9
2475921|NCT00936741|6071971|P1|COMPLETED|Overall Study||21
2475922|NCT00936741|6071971|P1|STARTED|Overall Study||30
2475923|NCT00936715|6071976|P1|NOT COMPLETED|Overall Study||6
2475924|NCT00936715|6071976|P1|COMPLETED|Overall Study||18
2475925|NCT00936715|6071976|P1|STARTED|Overall Study||24
2475926|NCT00936702|6071980|P1|NOT COMPLETED|Overall Study||46
2475927|NCT00936702|6071980|P1|COMPLETED|Overall Study||0
2475928|NCT00936702|6071980|P1|STARTED|Overall Study||46
2475929|NCT00936663|6071990|P2|NOT COMPLETED|Overall Study||0
2475930|NCT00936663|6071991|P1|NOT COMPLETED|Overall Study||0
2475931|NCT00936663|6071990|P2|COMPLETED|Overall Study||2
2475932|NCT00936663|6071991|P1|COMPLETED|Overall Study||1
2475933|NCT00936663|6071990|P2|STARTED|Overall Study||2
2475934|NCT00936663|6071991|P1|STARTED|Overall Study||1
2475935|NCT00936598|6072013|P2|NOT COMPLETED|Overall Study||0
2475936|NCT00936598|6072014|P1|NOT COMPLETED|Overall Study||2
2475937|NCT00936598|6072013|P2|COMPLETED|Overall Study||1
2475938|NCT00936598|6072014|P1|COMPLETED|Overall Study||2
2475939|NCT00936598|6072013|P2|STARTED|Overall Study||1
2475940|NCT00936598|6072014|P1|STARTED|Overall Study||4
2475941|NCT00936585|6072024|P1|NOT COMPLETED|Overall Study||0
2475942|NCT00936585|6072024|P1|COMPLETED|Overall Study||2
2475943|NCT00936585|6072024|P1|STARTED|Overall Study||2
2475944|NCT00936481|6072030|P2|NOT COMPLETED|Overall Study||0
2475945|NCT00936481|6072031|P1|NOT COMPLETED|Overall Study||0
2475946|NCT00936481|6072030|P2|COMPLETED|Overall Study||17
2475947|NCT00936481|6072031|P1|COMPLETED|Overall Study||17
2475948|NCT00936481|6072030|P2|STARTED|Overall Study||17
2475949|NCT00936481|6072031|P1|STARTED|Overall Study||17
2475950|NCT00936455|6072041|P2|NOT COMPLETED|Overall Study||0
2475951|NCT00936455|6072042|P1|NOT COMPLETED|Overall Study||0
2475952|NCT00936455|6072041|P2|COMPLETED|Overall Study||38
2475953|NCT00936455|6072042|P1|COMPLETED|Overall Study||37
2475954|NCT00936455|6072041|P2|STARTED|Overall Study||38
2475955|NCT00936455|6072042|P1|STARTED|Overall Study||37
2475956|NCT00936377|6072057|P3|NOT COMPLETED|Overall Study||0
2475957|NCT00936377|6072058|P2|NOT COMPLETED|Overall Study||0
2475958|NCT00936377|6072059|P1|NOT COMPLETED|Overall Study||0
2475959|NCT00936377|6072057|P3|COMPLETED|Overall Study||8
2475960|NCT00936377|6072058|P2|COMPLETED|Overall Study||8
2475961|NCT00936377|6072059|P1|COMPLETED|Overall Study||8
2475962|NCT00936377|6072057|P3|STARTED|Overall Study||8
2475963|NCT00936377|6072058|P2|STARTED|Overall Study||8
2475964|NCT00936377|6072059|P1|STARTED|Overall Study||8
2475965|NCT00936351|6072090|P2|NOT COMPLETED|Overall Study||2
2475966|NCT00936351|6072091|P1|NOT COMPLETED|Overall Study||3
2475967|NCT00936351|6072090|P2|COMPLETED|Overall Study||14
2475968|NCT00936351|6072091|P1|COMPLETED|Overall Study||15
2475969|NCT00936351|6072090|P2|STARTED|Overall Study||16
2475970|NCT00936351|6072091|P1|STARTED|Overall Study||18
2475971|NCT00936299|6072103|P2|NOT COMPLETED|Overall Study||12
2475972|NCT00936299|6072104|P1|NOT COMPLETED|Overall Study||13
2475973|NCT00936299|6072103|P2|COMPLETED|Overall Study||40
2475974|NCT00936299|6072104|P1|COMPLETED|Overall Study||40
2475975|NCT00936299|6072103|P2|STARTED|Overall Study||52
2475976|NCT00936299|6072104|P1|STARTED|Overall Study||53
2475977|NCT00936221|6072116|P2|NOT COMPLETED|Overall Study||1
2475978|NCT00936221|6072117|P1|NOT COMPLETED|Overall Study||1
2475979|NCT00936221|6072116|P2|COMPLETED|Overall Study|10 patients ongoing at data cutoff + 35 patients who had died.|45
2475980|NCT00936221|6072117|P1|COMPLETED|Overall Study|13 patients ongoing cutoff + 31 patients who had died.|44
2475981|NCT00936221|6072116|P2|Received Treatment|Overall Study||45
2475982|NCT00936221|6072117|P1|Received Treatment|Overall Study||44
2475983|NCT00936221|6072116|P2|STARTED|Overall Study||46
2475984|NCT00936221|6072117|P1|STARTED|Overall Study||45
2475985|NCT00936208|6072131|P2|NOT COMPLETED|Overall Study||22
2475986|NCT00936208|6072132|P1|NOT COMPLETED|Overall Study||37
2475987|NCT00936208|6072131|P2|COMPLETED|Overall Study||1574
2475988|NCT00936208|6072132|P1|COMPLETED|Overall Study||1462
2475989|NCT00936208|6072131|P2|STARTED|Overall Study||1596
2475990|NCT00936208|6072132|P1|STARTED|Overall Study||1499
2475991|NCT00936117|6072150|P1|NOT COMPLETED|Overall Study||10
2475992|NCT00936117|6072150|P1|COMPLETED|Overall Study|Completed 42 days on study drug|10
2475993|NCT00936117|6072150|P1|STARTED|Overall Study||20
2475994|NCT00936065|6072158|P3|NOT COMPLETED|Overall Study||7
2475995|NCT00936065|6072159|P2|NOT COMPLETED|Overall Study||4
2475996|NCT00936065|6072160|P1|NOT COMPLETED|Overall Study||4
2475997|NCT00936065|6072158|P3|COMPLETED|Overall Study||12
2475998|NCT00936065|6072159|P2|COMPLETED|Overall Study||16
2475999|NCT00936065|6072160|P1|COMPLETED|Overall Study||17
2476000|NCT00936065|6072158|P3|Study Assessments Performed|Overall Study||18
2476001|NCT00936065|6072159|P2|Study Assessments Performed|Overall Study||19
2476002|NCT00936065|6072160|P1|Study Assessments Performed|Overall Study||21
2476003|NCT00936065|6072158|P3|Received Treatment|Overall Study||18
2476004|NCT00936065|6072159|P2|Received Treatment|Overall Study||20
2476005|NCT00936065|6072160|P1|Received Treatment|Overall Study||21
2476006|NCT00936065|6072158|P3|STARTED|Overall Study||19
2476007|NCT00936065|6072159|P2|STARTED|Overall Study||20
2476008|NCT00936065|6072160|P1|STARTED|Overall Study||21
2476009|NCT00935883|6072266|P2|NOT COMPLETED|Follow-Up Period||0
2476010|NCT00935883|6072267|P1|NOT COMPLETED|Follow-Up Period||0
2476011|NCT00935883|6072266|P2|COMPLETED|Follow-Up Period||38
2476012|NCT00935883|6072267|P1|COMPLETED|Follow-Up Period||19
2476013|NCT00935883|6072266|P2|STARTED|Follow-Up Period||38
2476014|NCT00935883|6072267|P1|STARTED|Follow-Up Period||19
2476015|NCT00935883|6072266|P2|NOT COMPLETED|Treatment Period||2
2476016|NCT00935883|6072267|P1|NOT COMPLETED|Treatment Period||1
2476017|NCT00935883|6072266|P2|COMPLETED|Treatment Period||38
2476018|NCT00935883|6072267|P1|COMPLETED|Treatment Period||19
2476019|NCT00935883|6072266|P2|STARTED|Treatment Period||40
2476020|NCT00935883|6072267|P1|STARTED|Treatment Period||20
2476021|NCT00935857|6072281|P2|NOT COMPLETED|Overall Study||0
2476022|NCT00935857|6072282|P1|NOT COMPLETED|Overall Study||0
2476023|NCT00935857|6072281|P2|COMPLETED|Overall Study||16
2476024|NCT00935857|6072282|P1|COMPLETED|Overall Study||14
2476025|NCT00935857|6072281|P2|STARTED|Overall Study||16
2476026|NCT00935857|6072282|P1|STARTED|Overall Study||14
2476027|NCT00935818|6072294|P2|NOT COMPLETED|Overall Study||100
2476028|NCT00935818|6072295|P1|NOT COMPLETED|Overall Study||91
2476029|NCT00935818|6072294|P2|COMPLETED|Overall Study||157
2476030|NCT00935818|6072295|P1|COMPLETED|Overall Study||158
2476031|NCT00935818|6072294|P2|End of Medication Phase|Overall Study||184
2476032|NCT00935818|6072295|P1|End of Medication Phase|Overall Study||182
2476033|NCT00935818|6072294|P2|STARTED|Overall Study||257
2476034|NCT00935818|6072295|P1|STARTED|Overall Study||249
2476035|NCT00935792|6072316|P3|NOT COMPLETED|Overall Study||0
2476036|NCT00935792|6072317|P2|NOT COMPLETED|Overall Study||3
2476037|NCT00935792|6072318|P1|NOT COMPLETED|Overall Study||1
2476038|NCT00935792|6072316|P3|COMPLETED|Overall Study||12
2476039|NCT00935792|6072317|P2|COMPLETED|Overall Study||6
2476040|NCT00935792|6072318|P1|COMPLETED|Overall Study||6
2476041|NCT00935792|6072316|P3|STARTED|Overall Study||12
2476042|NCT00935792|6072317|P2|STARTED|Overall Study||9
2476043|NCT00935792|6072318|P1|STARTED|Overall Study||7
2476044|NCT00935766|6072335|P2|NOT COMPLETED|Overall Study||7
2476045|NCT00935766|6072336|P1|NOT COMPLETED|Overall Study||7
2476046|NCT00935766|6072335|P2|COMPLETED|Overall Study||27
2476047|NCT00935766|6072336|P1|COMPLETED|Overall Study||35
2476048|NCT00935766|6072335|P2|STARTED|Overall Study||34
2476049|NCT00935766|6072336|P1|STARTED|Overall Study||42
2476050|NCT00935701|6072346|P1|NOT COMPLETED|Overall Study||1
2476051|NCT00935701|6072346|P1|COMPLETED|Overall Study||9
2476052|NCT00935701|6072346|P1|Transition Acupressure to Acupuncture|Overall Study||9
2476053|NCT00935701|6072346|P1|STARTED|Overall Study||10
2476054|NCT00935649|6072353|P1|NOT COMPLETED|Overall Study||5
2476055|NCT00935649|6072353|P1|COMPLETED|Overall Study||134
2476056|NCT00935649|6072353|P1|STARTED|Overall Study||139
2476057|NCT00935584|6072363|P2|NOT COMPLETED|Overall Study||4
2476058|NCT00935584|6072364|P1|NOT COMPLETED|Overall Study||49
2476059|NCT00935584|6072363|P2|COMPLETED|Overall Study||19
2476060|NCT00935584|6072364|P1|COMPLETED|Overall Study||77
2476061|NCT00935584|6072363|P2|STARTED|Overall Study||23
2476062|NCT00935584|6072364|P1|STARTED|Overall Study|Out of 128 participants consented, 2 patients had no data collected, as the clinic was cancelled.|126
2476063|NCT00935532|6072376|P2|NOT COMPLETED|Overall Study||11
2476064|NCT00935532|6072377|P1|NOT COMPLETED|Overall Study||22
2476065|NCT00935532|6072376|P2|COMPLETED|Overall Study||201
2476066|NCT00935532|6072377|P1|COMPLETED|Overall Study||193
2476067|NCT00935532|6072376|P2|STARTED|Overall Study||212
2476068|NCT00935532|6072377|P1|STARTED|Overall Study||215
2476069|NCT00935493|6072406|P3|NOT COMPLETED|Overall Study||1
2476070|NCT00935493|6072407|P2|NOT COMPLETED|Overall Study||2
2476071|NCT00935493|6072408|P1|NOT COMPLETED|Overall Study||1
2476072|NCT00935493|6072406|P3|COMPLETED|Overall Study||40
2476073|NCT00935493|6072407|P2|COMPLETED|Overall Study||39
2476074|NCT00935493|6072408|P1|COMPLETED|Overall Study||40
2476075|NCT00935493|6072406|P3|STARTED|Overall Study||41
2476076|NCT00935493|6072407|P2|STARTED|Overall Study||41
2476077|NCT00935493|6072408|P1|STARTED|Overall Study||41
2476078|NCT00935428|6072422|P1|NOT COMPLETED|Overall Study||0
2476079|NCT00935428|6072422|P1|COMPLETED|Overall Study||231
2476080|NCT00935428|6072422|P1|STARTED|Overall Study||231
2476081|NCT00935311|6072436|P3|NOT COMPLETED|Overall Study||0
2476082|NCT00935311|6072437|P2|NOT COMPLETED|Overall Study||0
2476083|NCT00935311|6072438|P1|NOT COMPLETED|Overall Study||0
2476084|NCT00935311|6072436|P3|COMPLETED|Overall Study||40
2476085|NCT00935311|6072437|P2|COMPLETED|Overall Study||39
2476086|NCT00935311|6072438|P1|COMPLETED|Overall Study||43
2476087|NCT00935311|6072436|P3|STARTED|Overall Study||40
2476088|NCT00935311|6072437|P2|STARTED|Overall Study||39
2476089|NCT00935311|6072438|P1|STARTED|Overall Study||43
2476090|NCT00935272|6072457|P2|NOT COMPLETED|Overall Study||6
2476091|NCT00935272|6072458|P1|NOT COMPLETED|Overall Study||19
2476092|NCT00935272|6072457|P2|COMPLETED|Overall Study||39
2476093|NCT00935272|6072458|P1|COMPLETED|Overall Study||116
2476094|NCT00935272|6072457|P2|STARTED|Overall Study||45
2476095|NCT00935272|6072458|P1|STARTED|Overall Study||135
2476096|NCT00935259|6072467|P2|NOT COMPLETED|Period 2||0
2476097|NCT00935259|6072468|P1|NOT COMPLETED|Period 2||0
2476098|NCT00935259|6072467|P2|COMPLETED|Period 2||14
2476099|NCT00935259|6072468|P1|COMPLETED|Period 2||15
2476100|NCT00935259|6072467|P2|STARTED|Period 2||14
2476101|NCT00935259|6072468|P1|STARTED|Period 2||15
2476102|NCT00935259|6072467|P2|NOT COMPLETED|Period 1||1
2476103|NCT00935259|6072468|P1|NOT COMPLETED|Period 1||1
2476104|NCT00935259|6072467|P2|COMPLETED|Period 1||14
2476105|NCT00935259|6072468|P1|COMPLETED|Period 1||15
2476106|NCT00935259|6072467|P2|STARTED|Period 1||15
2476107|NCT00935259|6072468|P1|STARTED|Period 1||16
2476108|NCT00935220|6072482|P1|NOT COMPLETED|Overall Study||2
2476109|NCT00935220|6072482|P1|COMPLETED|Overall Study||39
2476110|NCT00935220|6072482|P1|STARTED|Overall Study||41
2476111|NCT00935064|6072496|P2|NOT COMPLETED|Overall Study||0
2476112|NCT00935064|6072497|P1|NOT COMPLETED|Overall Study||0
2476113|NCT00935064|6072496|P2|COMPLETED|Overall Study||30
2476114|NCT00935064|6072497|P1|COMPLETED|Overall Study||30
2476115|NCT00935064|6072496|P2|STARTED|Overall Study||30
2476116|NCT00935064|6072497|P1|STARTED|Overall Study||30
2476117|NCT00934947|6072513|P2|NOT COMPLETED|Overall Study||2
2476118|NCT00934947|6072514|P1|NOT COMPLETED|Overall Study||0
2476119|NCT00934947|6072513|P2|COMPLETED|Overall Study||20
2476120|NCT00934947|6072514|P1|COMPLETED|Overall Study||23
2476121|NCT00934947|6072513|P2|STARTED|Overall Study||22
2476122|NCT00934947|6072514|P1|STARTED|Overall Study||23
2476123|NCT00934921|6072528|P2|NOT COMPLETED|Second Intervention||0
2476124|NCT00934921|6072529|P1|NOT COMPLETED|Second Intervention||0
2476125|NCT00934921|6072528|P2|COMPLETED|Second Intervention||12
2476126|NCT00934921|6072529|P1|COMPLETED|Second Intervention||12
2476127|NCT00934921|6072528|P2|STARTED|Second Intervention||12
2476128|NCT00934921|6072529|P1|STARTED|Second Intervention||12
2476129|NCT00934921|6072528|P2|NOT COMPLETED|First Intervention||0
2476130|NCT00934921|6072529|P1|NOT COMPLETED|First Intervention||0
2476131|NCT00934921|6072528|P2|COMPLETED|First Intervention||12
2476132|NCT00934921|6072529|P1|COMPLETED|First Intervention||12
2476133|NCT00934921|6072528|P2|STARTED|First Intervention||12
2476134|NCT00934921|6072529|P1|STARTED|First Intervention||12
2476135|NCT00934856|6072543|P6|NOT COMPLETED|Extension Part||5
2476136|NCT00934856|6072544|P5|NOT COMPLETED|Extension Part||4
2476137|NCT00934856|6072545|P4|NOT COMPLETED|Extension Part||2
2476138|NCT00934856|6072546|P3|NOT COMPLETED|Extension Part||0
2476139|NCT00934856|6072547|P2|NOT COMPLETED|Extension Part||0
2476140|NCT00934856|6072548|P1|NOT COMPLETED|Extension Part||0
2476141|NCT00934856|6072543|P6|COMPLETED|Extension Part||19
2476142|NCT00934856|6072544|P5|COMPLETED|Extension Part||24
2476143|NCT00934856|6072545|P4|COMPLETED|Extension Part||2
2476144|NCT00934856|6072546|P3|COMPLETED|Extension Part||0
2476145|NCT00934856|6072547|P2|COMPLETED|Extension Part||0
2476146|NCT00934856|6072548|P1|COMPLETED|Extension Part||0
2476147|NCT00934856|6072543|P6|STARTED|Extension Part|New participants were enrolled in the extension part.|24
2476148|NCT00934856|6072544|P5|STARTED|Extension Part|New participants were enrolled in the extension part.|28
2476149|NCT00934856|6072545|P4|STARTED|Extension Part|New participants were enrolled in the extension part.|4
2476150|NCT00934856|6072546|P3|STARTED|Extension Part||0
2476151|NCT00934856|6072547|P2|STARTED|Extension Part||0
2476152|NCT00934856|6072548|P1|STARTED|Extension Part||0
2476153|NCT00934856|6072543|P6|NOT COMPLETED|Feasibility Part||3
2476154|NCT00934856|6072544|P5|NOT COMPLETED|Feasibility Part||0
2476155|NCT00934856|6072545|P4|NOT COMPLETED|Feasibility Part||5
2476156|NCT00934856|6072546|P3|NOT COMPLETED|Feasibility Part||3
2476157|NCT00934856|6072547|P2|NOT COMPLETED|Feasibility Part||5
2476158|NCT00934856|6072548|P1|NOT COMPLETED|Feasibility Part||5
2476159|NCT00934856|6072543|P6|COMPLETED|Feasibility Part||6
2476160|NCT00934856|6072544|P5|COMPLETED|Feasibility Part||12
2476161|NCT00934856|6072545|P4|COMPLETED|Feasibility Part||1
2476162|NCT00934856|6072546|P3|COMPLETED|Feasibility Part||0
2476163|NCT00934856|6072547|P2|COMPLETED|Feasibility Part||1
2476164|NCT00934856|6072548|P1|COMPLETED|Feasibility Part||1
2476165|NCT00934856|6072543|P6|STARTED|Feasibility Part||9
2476166|NCT00934856|6072544|P5|STARTED|Feasibility Part||12
2476167|NCT00934856|6072545|P4|STARTED|Feasibility Part||6
2476168|NCT00934856|6072546|P3|STARTED|Feasibility Part||3
2476169|NCT00934856|6072547|P2|STARTED|Feasibility Part||6
2476170|NCT00934856|6072548|P1|STARTED|Feasibility Part||6
2476171|NCT00934843|6072646|P2|NOT COMPLETED|Overall Study||1
2476172|NCT00934843|6072647|P1|NOT COMPLETED|Overall Study||0
2476173|NCT00934843|6072646|P2|COMPLETED|Overall Study|1 subject discontinued intervention, surgery plan changed and did not require CPB|39
2476174|NCT00934843|6072647|P1|COMPLETED|Overall Study||37
2476175|NCT00934843|6072646|P2|STARTED|Overall Study||40
2476176|NCT00934843|6072647|P1|STARTED|Overall Study||37
2476177|NCT00934791|6072663|P2|NOT COMPLETED|Overall Study||0
2476178|NCT00934791|6072664|P1|NOT COMPLETED|Overall Study||1
2476179|NCT00934791|6072663|P2|COMPLETED|Overall Study||0
2476180|NCT00934791|6072664|P1|COMPLETED|Overall Study||0
2476181|NCT00934791|6072663|P2|STARTED|Overall Study||0
2476182|NCT00934791|6072664|P1|STARTED|Overall Study||1
2476183|NCT00934661|6072672|P2|NOT COMPLETED|Overall Study||0
2476184|NCT00934661|6072673|P1|NOT COMPLETED|Overall Study||1
2476185|NCT00934661|6072672|P2|COMPLETED|Overall Study||20
2476186|NCT00934661|6072673|P1|COMPLETED|Overall Study||19
2476187|NCT00934661|6072672|P2|STARTED|Overall Study||20
2476188|NCT00934661|6072673|P1|STARTED|Overall Study||20
2476189|NCT00934648|6072693|P1|NOT COMPLETED|Overall Study||9
2476190|NCT00934648|6072693|P1|COMPLETED|Overall Study||6
2476191|NCT00934648|6072693|P1|STARTED|Overall Study||15
2476192|NCT00934635|6072709|P9|NOT COMPLETED|Overall Study||0
2476193|NCT00934635|6072710|P8|NOT COMPLETED|Overall Study||0
2476194|NCT00934635|6072711|P7|NOT COMPLETED|Overall Study||0
2476195|NCT00934635|6072712|P6|NOT COMPLETED|Overall Study||0
2476196|NCT00934635|6072713|P5|NOT COMPLETED|Overall Study||0
2476197|NCT00934635|6072714|P4|NOT COMPLETED|Overall Study||0
2476198|NCT00934635|6072715|P3|NOT COMPLETED|Overall Study||0
2476199|NCT00934635|6072716|P2|NOT COMPLETED|Overall Study||0
2476200|NCT00934635|6072717|P1|NOT COMPLETED|Overall Study||0
2476201|NCT00934635|6072709|P9|COMPLETED|Overall Study||1
2476202|NCT00934635|6072710|P8|COMPLETED|Overall Study||0
2476203|NCT00934635|6072711|P7|COMPLETED|Overall Study||0
2476204|NCT00934635|6072712|P6|COMPLETED|Overall Study||0
2476205|NCT00934635|6072713|P5|COMPLETED|Overall Study||0
2476206|NCT00934635|6072714|P4|COMPLETED|Overall Study||0
2476207|NCT00934635|6072715|P3|COMPLETED|Overall Study||0
2476208|NCT00934635|6072716|P2|COMPLETED|Overall Study||1
2476209|NCT00934635|6072717|P1|COMPLETED|Overall Study||0
2476210|NCT00934635|6072709|P9|STARTED|Overall Study||1
2476211|NCT00934635|6072710|P8|STARTED|Overall Study||0
2476212|NCT00934635|6072711|P7|STARTED|Overall Study||0
2476213|NCT00934635|6072712|P6|STARTED|Overall Study||0
2476214|NCT00934635|6072713|P5|STARTED|Overall Study||0
2476215|NCT00934635|6072714|P4|STARTED|Overall Study||0
2476216|NCT00934635|6072715|P3|STARTED|Overall Study||0
2476217|NCT00934635|6072716|P2|STARTED|Overall Study||1
2476218|NCT00934635|6072717|P1|STARTED|Overall Study||0
2476219|NCT00934622|6072737|P1|NOT COMPLETED|Overall Study||8
2476220|NCT00934622|6072737|P1|COMPLETED|Overall Study||68
2476221|NCT00934622|6072737|P1|STARTED|Overall Study||76
2476222|NCT00934596|6072744|P2|NOT COMPLETED|Overall Study||0
2476223|NCT00934596|6072745|P1|NOT COMPLETED|Overall Study||0
2476224|NCT00934596|6072744|P2|COMPLETED|Overall Study||10
2476225|NCT00934596|6072745|P1|COMPLETED|Overall Study||10
2476226|NCT00934596|6072744|P2|STARTED|Overall Study||10
2476227|NCT00934596|6072745|P1|STARTED|Overall Study|Twenty patients were prospectively randomly assigned to the two arms|10
2476228|NCT00934544|6072775|P3|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||34
2476229|NCT00934544|6072776|P2|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||28
2476230|NCT00934544|6072777|P1|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||107
2476231|NCT00934544|6072775|P3|COMPLETED|Overall Disposition at 5 Year Follow-up||11
2476232|NCT00934544|6072776|P2|COMPLETED|Overall Disposition at 5 Year Follow-up||0
2476233|NCT00934544|6072777|P1|COMPLETED|Overall Disposition at 5 Year Follow-up||39
2476234|NCT00934544|6072775|P3|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||6
2476235|NCT00934544|6072776|P2|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||0
2476236|NCT00934544|6072777|P1|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||0
2476237|NCT00934544|6072775|P3|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||12
2476238|NCT00934544|6072776|P2|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||0
2476239|NCT00934544|6072777|P1|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||0
2476240|NCT00934544|6072775|P3|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||27
2476241|NCT00934544|6072776|P2|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||0
2476242|NCT00934544|6072777|P1|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||0
2476243|NCT00934544|6072775|P3|STARTED|Overall Disposition at 5 Year Follow-up||45
2476244|NCT00934544|6072776|P2|STARTED|Overall Disposition at 5 Year Follow-up||28
2476245|NCT00934544|6072777|P1|STARTED|Overall Disposition at 5 Year Follow-up||146
2476246|NCT00934544|6072775|P3|NOT COMPLETED|Primary Endpoint Analysis (Interim)||0
2476247|NCT00934544|6072776|P2|NOT COMPLETED|Primary Endpoint Analysis (Interim)||42
2476248|NCT00934544|6072777|P1|NOT COMPLETED|Primary Endpoint Analysis (Interim)||55
2476249|NCT00934544|6072775|P3|COMPLETED|Primary Endpoint Analysis (Interim)||0
2476250|NCT00934544|6072776|P2|COMPLETED|Primary Endpoint Analysis (Interim)||31
2476251|NCT00934544|6072777|P1|COMPLETED|Primary Endpoint Analysis (Interim)||91
2476252|NCT00934544|6072775|P3|STARTED|Primary Endpoint Analysis (Interim)||0
2476253|NCT00934544|6072776|P2|STARTED|Primary Endpoint Analysis (Interim)||73
2476254|NCT00934544|6072777|P1|STARTED|Primary Endpoint Analysis (Interim)||146
2476255|NCT00934440|6072813|P1|NOT COMPLETED|Overall Study||1
2476256|NCT00934440|6072813|P1|COMPLETED|Overall Study||10
2476257|NCT00934440|6072813|P1|STARTED|Overall Study||11
2476258|NCT00934375|6072820|P2|NOT COMPLETED|Overall Study||22
2476259|NCT00934375|6072821|P1|NOT COMPLETED|Overall Study||13
2476260|NCT00934375|6072820|P2|COMPLETED|Overall Study||55
2476261|NCT00934375|6072821|P1|COMPLETED|Overall Study||55
2476262|NCT00934375|6072820|P2|STARTED|Overall Study||77
2476263|NCT00934375|6072821|P1|STARTED|Overall Study||68
2476264|NCT00934362|6072829|P2|NOT COMPLETED|Overall Study||0
2476265|NCT00934362|6072830|P1|NOT COMPLETED|Overall Study||1
2476266|NCT00934362|6072829|P2|COMPLETED|Overall Study||8
2476267|NCT00934362|6072830|P1|COMPLETED|Overall Study||7
2476268|NCT00934362|6072829|P2|STARTED|Overall Study||8
2476269|NCT00934362|6072830|P1|STARTED|Overall Study||8
2476270|NCT00934180|6072840|P2|NOT COMPLETED|Second Intervention||0
2476271|NCT00934180|6072841|P1|NOT COMPLETED|Second Intervention||0
2476272|NCT00934180|6072840|P2|COMPLETED|Second Intervention||12
2476273|NCT00934180|6072841|P1|COMPLETED|Second Intervention||12
2476274|NCT00934180|6072840|P2|STARTED|Second Intervention||12
2476275|NCT00934180|6072841|P1|STARTED|Second Intervention||12
2476276|NCT00934180|6072840|P2|NOT COMPLETED|First Intervention||0
2476277|NCT00934180|6072841|P1|NOT COMPLETED|First Intervention||0
2476278|NCT00934180|6072840|P2|COMPLETED|First Intervention||12
2476279|NCT00934180|6072841|P1|COMPLETED|First Intervention||12
2476280|NCT00934180|6072840|P2|STARTED|First Intervention||12
2476281|NCT00934180|6072841|P1|STARTED|First Intervention||12
2476282|NCT00934141|6072853|P4|NOT COMPLETED|Overall Study||3
2476283|NCT00934141|6072854|P3|NOT COMPLETED|Overall Study||0
2476284|NCT00934141|6072855|P2|NOT COMPLETED|Overall Study||3
2476285|NCT00934141|6072856|P1|NOT COMPLETED|Overall Study||4
2476286|NCT00934141|6072853|P4|COMPLETED|Overall Study||51
2476287|NCT00934141|6072854|P3|COMPLETED|Overall Study||48
2476288|NCT00934141|6072855|P2|COMPLETED|Overall Study||47
2476289|NCT00934141|6072856|P1|COMPLETED|Overall Study||45
2476290|NCT00934141|6072853|P4|STARTED|Overall Study||54
2476291|NCT00934141|6072854|P3|STARTED|Overall Study||48
2476292|NCT00934141|6072855|P2|STARTED|Overall Study||50
2476293|NCT00934141|6072856|P1|STARTED|Overall Study||49
2476294|NCT00934128|6072880|P2|NOT COMPLETED|Second Intervention (2 Hours)||3
2476295|NCT00934128|6072881|P1|NOT COMPLETED|Second Intervention (2 Hours)||0
2476296|NCT00934128|6072880|P2|COMPLETED|Second Intervention (2 Hours)||5
2476297|NCT00934128|6072881|P1|COMPLETED|Second Intervention (2 Hours)||3
2476298|NCT00934128|6072880|P2|STARTED|Second Intervention (2 Hours)||8
2476299|NCT00934128|6072881|P1|STARTED|Second Intervention (2 Hours)||3
2476300|NCT00934128|6072880|P2|NOT COMPLETED|Washout Period (1 Hour)||5
2476301|NCT00934128|6072881|P1|NOT COMPLETED|Washout Period (1 Hour)||7
2476302|NCT00934128|6072880|P2|COMPLETED|Washout Period (1 Hour)||8
2476303|NCT00934128|6072881|P1|COMPLETED|Washout Period (1 Hour)||3
2476304|NCT00934128|6072880|P2|STARTED|Washout Period (1 Hour)||13
2476305|NCT00934128|6072881|P1|STARTED|Washout Period (1 Hour)||10
2476306|NCT00934128|6072880|P2|NOT COMPLETED|First Intervention (2 Hours)||2
2476307|NCT00934128|6072881|P1|NOT COMPLETED|First Intervention (2 Hours)||5
2476308|NCT00934128|6072880|P2|COMPLETED|First Intervention (2 Hours)||13
2476309|NCT00934128|6072881|P1|COMPLETED|First Intervention (2 Hours)||10
2476310|NCT00934128|6072880|P2|STARTED|First Intervention (2 Hours)||15
2476311|NCT00934128|6072881|P1|STARTED|First Intervention (2 Hours)||15
2476312|NCT00934102|6072889|P3|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
2476313|NCT00934102|6072890|P2|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
2476314|NCT00934102|6072891|P1|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
2476315|NCT00934102|6072889|P3|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
2476316|NCT00934102|6072890|P2|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
2476317|NCT00934102|6072891|P1|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
2476318|NCT00934102|6072889|P3|STARTED|Period 2, 7 Days/6 Nights of Wear||15
2476319|NCT00934102|6072890|P2|STARTED|Period 2, 7 Days/6 Nights of Wear||15
2476320|NCT00934102|6072891|P1|STARTED|Period 2, 7 Days/6 Nights of Wear||15
2476321|NCT00934102|6072889|P3|NOT COMPLETED|Period 1, One Night of Wear||0
2476322|NCT00934102|6072890|P2|NOT COMPLETED|Period 1, One Night of Wear||0
2476323|NCT00934102|6072891|P1|NOT COMPLETED|Period 1, One Night of Wear||1
2476324|NCT00934102|6072889|P3|COMPLETED|Period 1, One Night of Wear||15
2476325|NCT00934102|6072890|P2|COMPLETED|Period 1, One Night of Wear||15
2476326|NCT00934102|6072891|P1|COMPLETED|Period 1, One Night of Wear||15
2476327|NCT00934102|6072889|P3|STARTED|Period 1, One Night of Wear||15
2476328|NCT00934102|6072890|P2|STARTED|Period 1, One Night of Wear||15
2476329|NCT00934102|6072891|P1|STARTED|Period 1, One Night of Wear||16
2476330|NCT00934050|6072905|P6|NOT COMPLETED|Enrolled After 15 Dec 2009||4
2476331|NCT00934050|6072906|P5|NOT COMPLETED|Enrolled After 15 Dec 2009||7
2476332|NCT00934050|6072907|P4|NOT COMPLETED|Enrolled After 15 Dec 2009||0
2476333|NCT00934050|6072908|P3|NOT COMPLETED|Enrolled After 15 Dec 2009||0
2476334|NCT00934050|6072909|P2|NOT COMPLETED|Enrolled After 15 Dec 2009||0
2476335|NCT00934050|6072910|P1|NOT COMPLETED|Enrolled After 15 Dec 2009||0
2476336|NCT00934050|6072905|P6|COMPLETED|Enrolled After 15 Dec 2009||23
2476337|NCT00934050|6072906|P5|COMPLETED|Enrolled After 15 Dec 2009||19
2476338|NCT00934050|6072907|P4|COMPLETED|Enrolled After 15 Dec 2009||0
2476339|NCT00934050|6072908|P3|COMPLETED|Enrolled After 15 Dec 2009||0
2476340|NCT00934050|6072909|P2|COMPLETED|Enrolled After 15 Dec 2009||0
2476341|NCT00934050|6072910|P1|COMPLETED|Enrolled After 15 Dec 2009||0
2476342|NCT00934050|6072905|P6|STARTED|Enrolled After 15 Dec 2009||27
2476343|NCT00934050|6072906|P5|STARTED|Enrolled After 15 Dec 2009||26
2476344|NCT00934050|6072907|P4|STARTED|Enrolled After 15 Dec 2009||0
2476345|NCT00934050|6072908|P3|STARTED|Enrolled After 15 Dec 2009||0
2476346|NCT00934050|6072909|P2|STARTED|Enrolled After 15 Dec 2009||0
2476347|NCT00934050|6072910|P1|STARTED|Enrolled After 15 Dec 2009||0
2476348|NCT00934050|6072905|P6|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
2476349|NCT00934050|6072906|P5|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
2476350|NCT00934050|6072907|P4|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||14
2476351|NCT00934050|6072908|P3|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
2476352|NCT00934050|6072909|P2|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
2476353|NCT00934050|6072910|P1|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
2476354|NCT00934050|6072905|P6|COMPLETED|Enrolled Prior to 15 Dec 2009||0
2476355|NCT00934050|6072906|P5|COMPLETED|Enrolled Prior to 15 Dec 2009||0
2476356|NCT00934050|6072907|P4|COMPLETED|Enrolled Prior to 15 Dec 2009||0
2476357|NCT00934050|6072908|P3|COMPLETED|Enrolled Prior to 15 Dec 2009||0
2476358|NCT00934050|6072909|P2|COMPLETED|Enrolled Prior to 15 Dec 2009||0
2476359|NCT00934050|6072910|P1|COMPLETED|Enrolled Prior to 15 Dec 2009||0
2476360|NCT00934050|6072905|P6|STARTED|Enrolled Prior to 15 Dec 2009||0
2476361|NCT00934050|6072906|P5|STARTED|Enrolled Prior to 15 Dec 2009||0
2476362|NCT00934050|6072907|P4|STARTED|Enrolled Prior to 15 Dec 2009||14
2476363|NCT00934050|6072908|P3|STARTED|Enrolled Prior to 15 Dec 2009||12
2476364|NCT00934050|6072909|P2|STARTED|Enrolled Prior to 15 Dec 2009||12
2476365|NCT00934050|6072910|P1|STARTED|Enrolled Prior to 15 Dec 2009||12
2476366|NCT00934024|6072922|P2|NOT COMPLETED|Overall Study||5
2476367|NCT00934024|6072923|P1|NOT COMPLETED|Overall Study||0
2476368|NCT00934024|6072922|P2|COMPLETED|Overall Study||6
2476369|NCT00934024|6072923|P1|COMPLETED|Overall Study||10
2476370|NCT00934024|6072922|P2|STARTED|Overall Study||11
2476371|NCT00934024|6072923|P1|STARTED|Overall Study||10
2476372|NCT00933933|6072933|P3|NOT COMPLETED|Pediatric From 2 to 21 Years||0
2476373|NCT00933933|6072934|P2|NOT COMPLETED|Pediatric From 2 to 21 Years||0
2476374|NCT00933933|6072935|P1|NOT COMPLETED|Pediatric From 2 to 21 Years||0
2476375|NCT00933933|6072933|P3|COMPLETED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women|0
2476376|NCT00933933|6072934|P2|COMPLETED|Pediatric From 2 to 21 Years||64
2476377|NCT00933933|6072935|P1|COMPLETED|Pediatric From 2 to 21 Years||588
2476378|NCT00933933|6072933|P3|STARTED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women.|0
2476379|NCT00933933|6072934|P2|STARTED|Pediatric From 2 to 21 Years||64
2476380|NCT00933933|6072935|P1|STARTED|Pediatric From 2 to 21 Years||588
2476381|NCT00933933|6072933|P3|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
2476382|NCT00933933|6072934|P2|NOT COMPLETED|Pregnant Females Between 16-44 Years||2
2476383|NCT00933933|6072935|P1|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
2476384|NCT00933933|6072933|P3|COMPLETED|Pregnant Females Between 16-44 Years||203
2476385|NCT00933933|6072934|P2|COMPLETED|Pregnant Females Between 16-44 Years||65
2476386|NCT00933933|6072935|P1|COMPLETED|Pregnant Females Between 16-44 Years||448
2476387|NCT00933933|6072933|P3|STARTED|Pregnant Females Between 16-44 Years||203
2476388|NCT00933933|6072934|P2|STARTED|Pregnant Females Between 16-44 Years||67
2476389|NCT00933933|6072935|P1|STARTED|Pregnant Females Between 16-44 Years||448
2476390|NCT00933933|6072933|P3|NOT COMPLETED|General Population From 16 to 89 Years||0
2476391|NCT00933933|6072934|P2|NOT COMPLETED|General Population From 16 to 89 Years||20
2476392|NCT00933933|6072935|P1|NOT COMPLETED|General Population From 16 to 89 Years||0
2476393|NCT00933933|6072933|P3|COMPLETED|General Population From 16 to 89 Years||1206
2476394|NCT00933933|6072934|P2|COMPLETED|General Population From 16 to 89 Years||1267
2476395|NCT00933933|6072935|P1|COMPLETED|General Population From 16 to 89 Years||6164
2476396|NCT00933933|6072933|P3|STARTED|General Population From 16 to 89 Years||1206
2476397|NCT00933933|6072934|P2|STARTED|General Population From 16 to 89 Years||1287
2476398|NCT00933933|6072935|P1|STARTED|General Population From 16 to 89 Years||6164
2476399|NCT00933686|6072953|P2|NOT COMPLETED|Overall Study||11
2476400|NCT00933686|6072954|P1|NOT COMPLETED|Overall Study||10
2476401|NCT00933686|6072953|P2|COMPLETED|Overall Study||47
2476402|NCT00933686|6072954|P1|COMPLETED|Overall Study||45
2476403|NCT00933686|6072953|P2|STARTED|Overall Study||58
2476404|NCT00933686|6072954|P1|STARTED|Overall Study||55
2476405|NCT00933608|6072974|P2|NOT COMPLETED|Overall Study||2
2476406|NCT00933608|6072975|P1|NOT COMPLETED|Overall Study||5
2476407|NCT00933608|6072974|P2|COMPLETED|Overall Study||8
2476408|NCT00933608|6072975|P1|COMPLETED|Overall Study||2
2476409|NCT00933608|6072974|P2|STARTED|Overall Study||10
2476410|NCT00933608|6072975|P1|STARTED|Overall Study||7
2476411|NCT00933543|6072983|P2|NOT COMPLETED|Overall Study||7
2476412|NCT00933543|6072984|P1|NOT COMPLETED|Overall Study||3
2476413|NCT00933543|6072983|P2|COMPLETED|Overall Study||46
2476414|NCT00933543|6072984|P1|COMPLETED|Overall Study||51
2476415|NCT00933543|6072983|P2|STARTED|Overall Study||53
2476416|NCT00933543|6072984|P1|STARTED|Overall Study||54
2476417|NCT00933491|6073042|P2|NOT COMPLETED|Overall Study||0
2476418|NCT00933491|6073043|P1|NOT COMPLETED|Overall Study||0
2476419|NCT00933491|6073042|P2|COMPLETED|Overall Study||18
2476420|NCT00933491|6073043|P1|COMPLETED|Overall Study||14
2476421|NCT00933491|6073042|P2|STARTED|Overall Study||18
2476422|NCT00933491|6073043|P1|STARTED|Overall Study||14
2476423|NCT00933335|6073053|P2|NOT COMPLETED|Overall Study||16
2476424|NCT00933335|6073054|P1|NOT COMPLETED|Overall Study||2
2476425|NCT00933335|6073053|P2|COMPLETED|Overall Study||20
2476426|NCT00933335|6073054|P1|COMPLETED|Overall Study||0
2476427|NCT00933335|6073053|P2|STARTED|Overall Study|35/36 participants who received 3 cycles of fludarabine later received a DD and TD of TST/I 131 TST.|36
2476428|NCT00933335|6073054|P1|STARTED|Overall Study||2
2476429|NCT00933270|6073124|P1|NOT COMPLETED|Overall Study||87
2476430|NCT00933270|6073124|P1|COMPLETED|Overall Study||177
2476431|NCT00933270|6073124|P1|STARTED|Overall Study|ITT population|264
2476432|NCT00933244|6073218|P3|NOT COMPLETED|Overall Study||3
2476433|NCT00933244|6073219|P2|NOT COMPLETED|Overall Study||1
2476434|NCT00933244|6073220|P1|NOT COMPLETED|Overall Study||5
2476435|NCT00933244|6073218|P3|COMPLETED|Overall Study||73
2476436|NCT00933244|6073219|P2|COMPLETED|Overall Study||74
2476437|NCT00933244|6073220|P1|COMPLETED|Overall Study||74
2476438|NCT00933244|6073218|P3|STARTED|Overall Study||76
2476439|NCT00933244|6073219|P2|STARTED|Overall Study||75
2476440|NCT00933244|6073220|P1|STARTED|Overall Study||79
2476441|NCT00933166|6073237|P1|NOT COMPLETED|Overall Study||18
2476442|NCT00933166|6073237|P1|COMPLETED|Overall Study||151
2476443|NCT00933166|6073237|P1|STARTED|Overall Study||169
2476444|NCT00932893|6073243|P2|NOT COMPLETED|Overall Study||170
2476445|NCT00932893|6073244|P1|NOT COMPLETED|Overall Study||133
2476446|NCT00932893|6073243|P2|COMPLETED|Overall Study||4
2476447|NCT00932893|6073244|P1|COMPLETED|Overall Study||40
2476448|NCT00932893|6073243|P2|Treated|Overall Study||171
2476449|NCT00932893|6073244|P1|Treated|Overall Study||172
2476450|NCT00932893|6073243|P2|STARTED|Overall Study||174
2476451|NCT00932893|6073244|P1|STARTED|Overall Study||173
2476452|NCT00932828|6073275|P1|NOT COMPLETED|Overall Study||5
2476453|NCT00932828|6073275|P1|COMPLETED|Overall Study|5 subjects who did not complete the protocol were considered in an ITT analysis.|32
2476454|NCT00932828|6073275|P1|STARTED|Overall Study||37
2476455|NCT00932698|6073292|P11|NOT COMPLETED|Part 2 (Dose Expansion)||2
2476456|NCT00932698|6073293|P10|NOT COMPLETED|Part 2 (Dose Expansion)||6
2476457|NCT00932698|6073294|P9|NOT COMPLETED|Part 2 (Dose Expansion)||12
2476458|NCT00932698|6073295|P8|NOT COMPLETED|Part 2 (Dose Expansion)||20
2476459|NCT00932698|6073296|P7|NOT COMPLETED|Part 2 (Dose Expansion)||0
2476460|NCT00932698|6073297|P6|NOT COMPLETED|Part 2 (Dose Expansion)||0
2476461|NCT00932698|6073298|P5|NOT COMPLETED|Part 2 (Dose Expansion)||0
2476462|NCT00932698|6073299|P4|NOT COMPLETED|Part 2 (Dose Expansion)||0
2476463|NCT00932698|6073300|P3|NOT COMPLETED|Part 2 (Dose Expansion)||0
2476464|NCT00932698|6073301|P2|NOT COMPLETED|Part 2 (Dose Expansion)||0
2476465|NCT00932698|6073302|P1|NOT COMPLETED|Part 2 (Dose Expansion)||0
2476466|NCT00932698|6073292|P11|COMPLETED|Part 2 (Dose Expansion)||0
2476467|NCT00932698|6073293|P10|COMPLETED|Part 2 (Dose Expansion)||0
2476468|NCT00932698|6073294|P9|COMPLETED|Part 2 (Dose Expansion)||0
2476469|NCT00932698|6073295|P8|COMPLETED|Part 2 (Dose Expansion)||0
2476470|NCT00932698|6073296|P7|COMPLETED|Part 2 (Dose Expansion)||0
2476471|NCT00932698|6073297|P6|COMPLETED|Part 2 (Dose Expansion)||0
2476472|NCT00932698|6073298|P5|COMPLETED|Part 2 (Dose Expansion)||0
2476473|NCT00932698|6073299|P4|COMPLETED|Part 2 (Dose Expansion)||0
2476474|NCT00932698|6073300|P3|COMPLETED|Part 2 (Dose Expansion)||0
2476475|NCT00932698|6073301|P2|COMPLETED|Part 2 (Dose Expansion)||0
2476476|NCT00932698|6073302|P1|COMPLETED|Part 2 (Dose Expansion)||0
2476477|NCT00932698|6073292|P11|STARTED|Part 2 (Dose Expansion)||2
2476478|NCT00932698|6073293|P10|STARTED|Part 2 (Dose Expansion)||6
2476479|NCT00932698|6073294|P9|STARTED|Part 2 (Dose Expansion)||12
2476480|NCT00932698|6073295|P8|STARTED|Part 2 (Dose Expansion)||20
2476481|NCT00932698|6073296|P7|STARTED|Part 2 (Dose Expansion)||0
2476482|NCT00932698|6073297|P6|STARTED|Part 2 (Dose Expansion)||0
2476483|NCT00932698|6073298|P5|STARTED|Part 2 (Dose Expansion)||0
2476484|NCT00932698|6073299|P4|STARTED|Part 2 (Dose Expansion)||0
2476485|NCT00932698|6073300|P3|STARTED|Part 2 (Dose Expansion)||0
2476486|NCT00932698|6073301|P2|STARTED|Part 2 (Dose Expansion)||0
2476487|NCT00932698|6073302|P1|STARTED|Part 2 (Dose Expansion)||0
2476488|NCT00932698|6073292|P11|NOT COMPLETED|Part 1 (Dose Escalation)||0
2476489|NCT00932698|6073293|P10|NOT COMPLETED|Part 1 (Dose Escalation)||0
2476490|NCT00932698|6073294|P9|NOT COMPLETED|Part 1 (Dose Escalation)||0
2476491|NCT00932698|6073295|P8|NOT COMPLETED|Part 1 (Dose Escalation)||0
2476492|NCT00932698|6073296|P7|NOT COMPLETED|Part 1 (Dose Escalation)||4
2476493|NCT00932698|6073297|P6|NOT COMPLETED|Part 1 (Dose Escalation)||7
2476494|NCT00932698|6073298|P5|NOT COMPLETED|Part 1 (Dose Escalation)||3
2476495|NCT00932698|6073299|P4|NOT COMPLETED|Part 1 (Dose Escalation)||3
2476496|NCT00932698|6073300|P3|NOT COMPLETED|Part 1 (Dose Escalation)||3
2476497|NCT00932698|6073301|P2|NOT COMPLETED|Part 1 (Dose Escalation)||3
2476498|NCT00932698|6073302|P1|NOT COMPLETED|Part 1 (Dose Escalation)||3
2476499|NCT00932698|6073292|P11|COMPLETED|Part 1 (Dose Escalation)||0
2476500|NCT00932698|6073293|P10|COMPLETED|Part 1 (Dose Escalation)||0
2476501|NCT00932698|6073294|P9|COMPLETED|Part 1 (Dose Escalation)||0
2476502|NCT00932698|6073295|P8|COMPLETED|Part 1 (Dose Escalation)||0
2476503|NCT00932698|6073296|P7|COMPLETED|Part 1 (Dose Escalation)||0
2476504|NCT00932698|6073297|P6|COMPLETED|Part 1 (Dose Escalation)|6 participants from 2.0 mg/m^2 dose cohort transitioned to dose expansion cohort: 5 in RR, 1 in VR.|0
2476505|NCT00932698|6073298|P5|COMPLETED|Part 1 (Dose Escalation)||0
2476506|NCT00932698|6073299|P4|COMPLETED|Part 1 (Dose Escalation)||0
2476507|NCT00932698|6073300|P3|COMPLETED|Part 1 (Dose Escalation)||0
2476508|NCT00932698|6073301|P2|COMPLETED|Part 1 (Dose Escalation)||0
2476509|NCT00932698|6073302|P1|COMPLETED|Part 1 (Dose Escalation)||0
2476510|NCT00932698|6073292|P11|STARTED|Part 1 (Dose Escalation)||0
2476511|NCT00932698|6073293|P10|STARTED|Part 1 (Dose Escalation)||0
2476512|NCT00932698|6073294|P9|STARTED|Part 1 (Dose Escalation)||0
2476513|NCT00932698|6073295|P8|STARTED|Part 1 (Dose Escalation)||0
2476514|NCT00932698|6073296|P7|STARTED|Part 1 (Dose Escalation)||4
2476515|NCT00932698|6073297|P6|STARTED|Part 1 (Dose Escalation)||7
2476516|NCT00932698|6073298|P5|STARTED|Part 1 (Dose Escalation)||3
2476517|NCT00932698|6073299|P4|STARTED|Part 1 (Dose Escalation)||3
2476518|NCT00932698|6073300|P3|STARTED|Part 1 (Dose Escalation)||3
2476519|NCT00932698|6073301|P2|STARTED|Part 1 (Dose Escalation)||3
2476520|NCT00932698|6073302|P1|STARTED|Part 1 (Dose Escalation)||3
2476521|NCT00932659|6073471|P1|NOT COMPLETED|Overall Study||0
2476522|NCT00932659|6073471|P1|COMPLETED|Overall Study||8
2476523|NCT00932659|6073471|P1|STARTED|Overall Study||8
2476524|NCT00932646|6073476|P4|NOT COMPLETED|Overall Study||1
2476525|NCT00932646|6073477|P3|NOT COMPLETED|Overall Study||4
2476526|NCT00932646|6073478|P2|NOT COMPLETED|Overall Study||3
2476527|NCT00932646|6073479|P1|NOT COMPLETED|Overall Study||5
2476528|NCT00932646|6073476|P4|COMPLETED|Overall Study||24
2476529|NCT00932646|6073477|P3|COMPLETED|Overall Study||21
2476530|NCT00932646|6073478|P2|COMPLETED|Overall Study||22
2476531|NCT00932646|6073479|P1|COMPLETED|Overall Study||20
2476532|NCT00932646|6073476|P4|STARTED|Overall Study||25
2476533|NCT00932646|6073477|P3|STARTED|Overall Study||25
2476534|NCT00932646|6073478|P2|STARTED|Overall Study||25
2476535|NCT00932646|6073479|P1|STARTED|Overall Study||25
2476536|NCT00932620|6073535|P2|NOT COMPLETED|Overall Study||0
2476537|NCT00932620|6073536|P1|NOT COMPLETED|Overall Study||0
2476538|NCT00932620|6073535|P2|COMPLETED|Overall Study||50
2476539|NCT00932620|6073536|P1|COMPLETED|Overall Study||50
2476540|NCT00932620|6073535|P2|STARTED|Overall Study||50
2476541|NCT00932620|6073536|P1|STARTED|Overall Study||50
2476542|NCT00932477|6073544|P6|NOT COMPLETED|Treatment 3||0
2476543|NCT00932477|6073545|P5|NOT COMPLETED|Treatment 3||0
2476544|NCT00932477|6073546|P4|NOT COMPLETED|Treatment 3||0
2476545|NCT00932477|6073547|P3|NOT COMPLETED|Treatment 3||0
2476546|NCT00932477|6073548|P2|NOT COMPLETED|Treatment 3||0
2476547|NCT00932477|6073549|P1|NOT COMPLETED|Treatment 3||0
2476548|NCT00932477|6073544|P6|COMPLETED|Treatment 3||8
2476549|NCT00932477|6073545|P5|COMPLETED|Treatment 3||8
2476550|NCT00932477|6073546|P4|COMPLETED|Treatment 3||7
2476551|NCT00932477|6073547|P3|COMPLETED|Treatment 3||9
2476552|NCT00932477|6073548|P2|COMPLETED|Treatment 3||8
2476553|NCT00932477|6073549|P1|COMPLETED|Treatment 3||7
2476554|NCT00932477|6073544|P6|STARTED|Treatment 3||8
2476555|NCT00932477|6073545|P5|STARTED|Treatment 3||8
2476556|NCT00932477|6073546|P4|STARTED|Treatment 3||7
2476557|NCT00932477|6073547|P3|STARTED|Treatment 3||9
2476558|NCT00932477|6073548|P2|STARTED|Treatment 3||8
2476559|NCT00932477|6073549|P1|STARTED|Treatment 3||7
2476560|NCT00932477|6073544|P6|NOT COMPLETED|Treatment 2||0
2476561|NCT00932477|6073545|P5|NOT COMPLETED|Treatment 2||0
2476562|NCT00932477|6073546|P4|NOT COMPLETED|Treatment 2||0
2476563|NCT00932477|6073547|P3|NOT COMPLETED|Treatment 2||0
2476564|NCT00932477|6073548|P2|NOT COMPLETED|Treatment 2||0
2476565|NCT00932477|6073549|P1|NOT COMPLETED|Treatment 2||0
2476566|NCT00932477|6073544|P6|COMPLETED|Treatment 2||8
2476567|NCT00932477|6073545|P5|COMPLETED|Treatment 2||8
2476568|NCT00932477|6073546|P4|COMPLETED|Treatment 2||7
2476569|NCT00932477|6073547|P3|COMPLETED|Treatment 2||9
2476570|NCT00932477|6073548|P2|COMPLETED|Treatment 2||8
2476571|NCT00932477|6073549|P1|COMPLETED|Treatment 2||7
2476572|NCT00932477|6073544|P6|STARTED|Treatment 2||8
2476573|NCT00932477|6073545|P5|STARTED|Treatment 2||8
2476574|NCT00932477|6073546|P4|STARTED|Treatment 2||7
2476575|NCT00932477|6073547|P3|STARTED|Treatment 2||9
2476576|NCT00932477|6073548|P2|STARTED|Treatment 2||8
2476577|NCT00932477|6073549|P1|STARTED|Treatment 2||7
2476578|NCT00932477|6073544|P6|NOT COMPLETED|Treatment 1||0
2476579|NCT00932477|6073545|P5|NOT COMPLETED|Treatment 1||0
2476580|NCT00932477|6073546|P4|NOT COMPLETED|Treatment 1||0
2476581|NCT00932477|6073547|P3|NOT COMPLETED|Treatment 1||0
2476582|NCT00932477|6073548|P2|NOT COMPLETED|Treatment 1||0
2476583|NCT00932477|6073549|P1|NOT COMPLETED|Treatment 1||0
2476584|NCT00932477|6073544|P6|COMPLETED|Treatment 1||8
2476585|NCT00932477|6073545|P5|COMPLETED|Treatment 1||8
2476586|NCT00932477|6073546|P4|COMPLETED|Treatment 1||7
2476587|NCT00932477|6073547|P3|COMPLETED|Treatment 1||9
2476588|NCT00932477|6073548|P2|COMPLETED|Treatment 1||8
2476589|NCT00932477|6073549|P1|COMPLETED|Treatment 1||7
2476590|NCT00932477|6073544|P6|STARTED|Treatment 1||8
2476591|NCT00932477|6073545|P5|STARTED|Treatment 1||8
2476592|NCT00932477|6073546|P4|STARTED|Treatment 1||7
2476593|NCT00932477|6073547|P3|STARTED|Treatment 1||9
2476594|NCT00932477|6073548|P2|STARTED|Treatment 1||8
2476595|NCT00932477|6073549|P1|STARTED|Treatment 1||7
2476596|NCT00932451|6073566|P1|NOT COMPLETED|Overall Study||822
2476597|NCT00932451|6073566|P1|COMPLETED|Overall Study||244
2476598|NCT00932451|6073566|P1|STARTED|Overall Study||1066
2476599|NCT00932425|6073590|P2|NOT COMPLETED|Overall Study||2
2476600|NCT00932425|6073591|P1|NOT COMPLETED|Overall Study||0
2476601|NCT00932425|6073590|P2|COMPLETED|Overall Study||18
2476602|NCT00932425|6073591|P1|COMPLETED|Overall Study||20
2476603|NCT00932425|6073590|P2|STARTED|Overall Study||20
2476604|NCT00932425|6073591|P1|STARTED|Overall Study||20
2476605|NCT00932399|6073606|P2|NOT COMPLETED|Overall Study||0
2476606|NCT00932399|6073607|P1|NOT COMPLETED|Overall Study||0
2476607|NCT00932399|6073606|P2|COMPLETED|Overall Study||3790
2476608|NCT00932399|6073607|P1|COMPLETED|Overall Study||759
2476609|NCT00932399|6073606|P2|STARTED|Overall Study||3790
2476610|NCT00932399|6073607|P1|STARTED|Overall Study||759
2476611|NCT00932373|6073624|P11|NOT COMPLETED|Overall Study||3
2476612|NCT00932373|6073625|P10|NOT COMPLETED|Overall Study||13
2476613|NCT00932373|6073626|P9|NOT COMPLETED|Overall Study||2
2476614|NCT00932373|6073627|P8|NOT COMPLETED|Overall Study||3
2476615|NCT00932373|6073628|P7|NOT COMPLETED|Overall Study||1
2476616|NCT00932373|6073629|P6|NOT COMPLETED|Overall Study||3
2476617|NCT00932373|6073630|P5|NOT COMPLETED|Overall Study||14
2476618|NCT00932373|6073631|P4|NOT COMPLETED|Overall Study||0
2476619|NCT00932373|6073632|P3|NOT COMPLETED|Overall Study||1
2476620|NCT00932373|6073633|P2|NOT COMPLETED|Overall Study||1
2476621|NCT00932373|6073634|P1|NOT COMPLETED|Overall Study||3
2476622|NCT00932373|6073624|P11|COMPLETED|Overall Study||0
2476623|NCT00932373|6073625|P10|COMPLETED|Overall Study||3
2476624|NCT00932373|6073626|P9|COMPLETED|Overall Study||1
2476625|NCT00932373|6073627|P8|COMPLETED|Overall Study||0
2476626|NCT00932373|6073628|P7|COMPLETED|Overall Study||2
2476627|NCT00932373|6073629|P6|COMPLETED|Overall Study||0
2476628|NCT00932373|6073630|P5|COMPLETED|Overall Study||1
2476629|NCT00932373|6073631|P4|COMPLETED|Overall Study||1
2476630|NCT00932373|6073632|P3|COMPLETED|Overall Study||0
2476631|NCT00932373|6073633|P2|COMPLETED|Overall Study||0
2476632|NCT00932373|6073634|P1|COMPLETED|Overall Study||0
2476633|NCT00932373|6073624|P11|STARTED|Overall Study||3
2476634|NCT00932373|6073625|P10|STARTED|Overall Study||16
2476635|NCT00932373|6073626|P9|STARTED|Overall Study||3
2476636|NCT00932373|6073627|P8|STARTED|Overall Study||3
2476637|NCT00932373|6073628|P7|STARTED|Overall Study||3
2476638|NCT00932373|6073629|P6|STARTED|Overall Study||3
2476639|NCT00932373|6073630|P5|STARTED|Overall Study||15
2476640|NCT00932373|6073631|P4|STARTED|Overall Study||1
2476641|NCT00932373|6073632|P3|STARTED|Overall Study||1
2476642|NCT00932373|6073633|P2|STARTED|Overall Study||1
2476643|NCT00932373|6073634|P1|STARTED|Overall Study||3
2476644|NCT00932360|6073734|P6|NOT COMPLETED|Visit 3/Week 3||0
2476645|NCT00932360|6073735|P5|NOT COMPLETED|Visit 3/Week 3||0
2476646|NCT00932360|6073736|P4|NOT COMPLETED|Visit 3/Week 3||0
2476647|NCT00932360|6073737|P3|NOT COMPLETED|Visit 3/Week 3||0
2476648|NCT00932360|6073738|P2|NOT COMPLETED|Visit 3/Week 3||0
2476649|NCT00932360|6073739|P1|NOT COMPLETED|Visit 3/Week 3||0
2476650|NCT00932360|6073734|P6|COMPLETED|Visit 3/Week 3||7
2476651|NCT00932360|6073735|P5|COMPLETED|Visit 3/Week 3||2
2476652|NCT00932360|6073736|P4|COMPLETED|Visit 3/Week 3||13
2476653|NCT00932360|6073737|P3|COMPLETED|Visit 3/Week 3||3
2476654|NCT00932360|6073738|P2|COMPLETED|Visit 3/Week 3||6
2476655|NCT00932360|6073739|P1|COMPLETED|Visit 3/Week 3||10
2476656|NCT00932360|6073734|P6|STARTED|Visit 3/Week 3||7
2476657|NCT00932360|6073735|P5|STARTED|Visit 3/Week 3||2
2476658|NCT00932360|6073736|P4|STARTED|Visit 3/Week 3||13
2476659|NCT00932360|6073737|P3|STARTED|Visit 3/Week 3||3
2476660|NCT00932360|6073738|P2|STARTED|Visit 3/Week 3||6
2476661|NCT00932360|6073739|P1|STARTED|Visit 3/Week 3||10
2476662|NCT00932360|6073734|P6|NOT COMPLETED|Washout (One Week)||0
2476663|NCT00932360|6073735|P5|NOT COMPLETED|Washout (One Week)||0
2476664|NCT00932360|6073736|P4|NOT COMPLETED|Washout (One Week)||0
2476665|NCT00932360|6073737|P3|NOT COMPLETED|Washout (One Week)||0
2476666|NCT00932360|6073738|P2|NOT COMPLETED|Washout (One Week)||0
2476667|NCT00932360|6073739|P1|NOT COMPLETED|Washout (One Week)||0
2476668|NCT00932360|6073734|P6|COMPLETED|Washout (One Week)||7
2476669|NCT00932360|6073735|P5|COMPLETED|Washout (One Week)||2
2476670|NCT00932360|6073736|P4|COMPLETED|Washout (One Week)||13
2476671|NCT00932360|6073737|P3|COMPLETED|Washout (One Week)||3
2476672|NCT00932360|6073738|P2|COMPLETED|Washout (One Week)||6
2476673|NCT00932360|6073739|P1|COMPLETED|Washout (One Week)||10
2476674|NCT00932360|6073734|P6|STARTED|Washout (One Week)||7
2476675|NCT00932360|6073735|P5|STARTED|Washout (One Week)||2
2476676|NCT00932360|6073736|P4|STARTED|Washout (One Week)||13
2476677|NCT00932360|6073737|P3|STARTED|Washout (One Week)||3
2476678|NCT00932360|6073738|P2|STARTED|Washout (One Week)||6
2476679|NCT00932360|6073739|P1|STARTED|Washout (One Week)||10
2476680|NCT00932360|6073734|P6|NOT COMPLETED|Visit 2/Week 2||0
2476681|NCT00932360|6073735|P5|NOT COMPLETED|Visit 2/Week 2||0
2476682|NCT00932360|6073736|P4|NOT COMPLETED|Visit 2/Week 2||0
2476683|NCT00932360|6073737|P3|NOT COMPLETED|Visit 2/Week 2||0
2476684|NCT00932360|6073738|P2|NOT COMPLETED|Visit 2/Week 2||0
2476685|NCT00932360|6073739|P1|NOT COMPLETED|Visit 2/Week 2||0
2476686|NCT00932360|6073734|P6|COMPLETED|Visit 2/Week 2||7
2476687|NCT00932360|6073735|P5|COMPLETED|Visit 2/Week 2||2
2476688|NCT00932360|6073736|P4|COMPLETED|Visit 2/Week 2||13
2476689|NCT00932360|6073737|P3|COMPLETED|Visit 2/Week 2||3
2476690|NCT00932360|6073738|P2|COMPLETED|Visit 2/Week 2||6
2476691|NCT00932360|6073739|P1|COMPLETED|Visit 2/Week 2||10
2476692|NCT00932360|6073734|P6|STARTED|Visit 2/Week 2||7
2476693|NCT00932360|6073735|P5|STARTED|Visit 2/Week 2||2
2476694|NCT00932360|6073736|P4|STARTED|Visit 2/Week 2||13
2476695|NCT00932360|6073737|P3|STARTED|Visit 2/Week 2||3
2476696|NCT00932360|6073738|P2|STARTED|Visit 2/Week 2||6
2476697|NCT00932360|6073739|P1|STARTED|Visit 2/Week 2||10
2476698|NCT00932360|6073734|P6|NOT COMPLETED|Washout (One Week)||0
2476699|NCT00932360|6073735|P5|NOT COMPLETED|Washout (One Week)||2
2476700|NCT00932360|6073736|P4|NOT COMPLETED|Washout (One Week)||0
2476701|NCT00932360|6073737|P3|NOT COMPLETED|Washout (One Week)||0
2476702|NCT00932360|6073738|P2|NOT COMPLETED|Washout (One Week)||0
2476703|NCT00932360|6073739|P1|NOT COMPLETED|Washout (One Week)||0
2476704|NCT00932360|6073734|P6|COMPLETED|Washout (One Week)||7
2476705|NCT00932360|6073735|P5|COMPLETED|Washout (One Week)||2
2476706|NCT00932360|6073736|P4|COMPLETED|Washout (One Week)||13
2476707|NCT00932360|6073737|P3|COMPLETED|Washout (One Week)||3
2476708|NCT00932360|6073738|P2|COMPLETED|Washout (One Week)||6
2476709|NCT00932360|6073739|P1|COMPLETED|Washout (One Week)||10
2476710|NCT00932360|6073734|P6|STARTED|Washout (One Week)||7
2476711|NCT00932360|6073735|P5|STARTED|Washout (One Week)||4
2476712|NCT00932360|6073736|P4|STARTED|Washout (One Week)||13
2476713|NCT00932360|6073737|P3|STARTED|Washout (One Week)||3
2476714|NCT00932360|6073738|P2|STARTED|Washout (One Week)||6
2476715|NCT00932360|6073739|P1|STARTED|Washout (One Week)||10
2476716|NCT00932360|6073734|P6|NOT COMPLETED|1: Visit 1/Week1||0
2476717|NCT00932360|6073735|P5|NOT COMPLETED|1: Visit 1/Week1||0
2476718|NCT00932360|6073736|P4|NOT COMPLETED|1: Visit 1/Week1||0
2476719|NCT00932360|6073737|P3|NOT COMPLETED|1: Visit 1/Week1||0
2476720|NCT00932360|6073738|P2|NOT COMPLETED|1: Visit 1/Week1||0
2476721|NCT00932360|6073739|P1|NOT COMPLETED|1: Visit 1/Week1||0
2476722|NCT00932360|6073734|P6|COMPLETED|1: Visit 1/Week1||7
2476723|NCT00932360|6073735|P5|COMPLETED|1: Visit 1/Week1||4
2476724|NCT00932360|6073736|P4|COMPLETED|1: Visit 1/Week1||13
2476725|NCT00932360|6073737|P3|COMPLETED|1: Visit 1/Week1||3
2476726|NCT00932360|6073738|P2|COMPLETED|1: Visit 1/Week1||6
2476727|NCT00932360|6073739|P1|COMPLETED|1: Visit 1/Week1||10
2476728|NCT00932360|6073734|P6|STARTED|1: Visit 1/Week1||7
2476729|NCT00932360|6073735|P5|STARTED|1: Visit 1/Week1||4
2476730|NCT00932360|6073736|P4|STARTED|1: Visit 1/Week1||13
2476731|NCT00932360|6073737|P3|STARTED|1: Visit 1/Week1||3
2476732|NCT00932360|6073738|P2|STARTED|1: Visit 1/Week1||6
2476733|NCT00932360|6073739|P1|STARTED|1: Visit 1/Week1||10
2476734|NCT00932321|6073770|P2|NOT COMPLETED|Overall Study||46
2476735|NCT00932321|6073771|P1|NOT COMPLETED|Overall Study||171
2476736|NCT00932321|6073770|P2|COMPLETED|Overall Study||141
2476737|NCT00932321|6073771|P1|COMPLETED|Overall Study||580
2476738|NCT00932321|6073770|P2|MITT Population|Overall Study||181
2476739|NCT00932321|6073771|P1|MITT Population|Overall Study||705
2476740|NCT00932321|6073770|P2|STARTED|Overall Study||187
2476741|NCT00932321|6073771|P1|STARTED|Overall Study||751
2476742|NCT00932282|6073781|P2|NOT COMPLETED|OIT Maintenance Phase||2
2476743|NCT00932282|6073782|P1|NOT COMPLETED|OIT Maintenance Phase||1
2476744|NCT00932282|6073781|P2|COMPLETED|OIT Maintenance Phase||2
2476745|NCT00932282|6073782|P1|COMPLETED|OIT Maintenance Phase||4
2476746|NCT00932282|6073781|P2|STARTED|OIT Maintenance Phase||4
2476747|NCT00932282|6073782|P1|STARTED|OIT Maintenance Phase||5
2476748|NCT00932282|6073781|P2|NOT COMPLETED|Biweekly OIT Buildup Phase||1
2476749|NCT00932282|6073782|P1|NOT COMPLETED|Biweekly OIT Buildup Phase||1
2476750|NCT00932282|6073781|P2|COMPLETED|Biweekly OIT Buildup Phase||4
2476751|NCT00932282|6073782|P1|COMPLETED|Biweekly OIT Buildup Phase||5
2476752|NCT00932282|6073781|P2|STARTED|Biweekly OIT Buildup Phase||5
2476753|NCT00932282|6073782|P1|STARTED|Biweekly OIT Buildup Phase||6
2476754|NCT00932282|6073781|P2|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
2476755|NCT00932282|6073782|P1|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
2476756|NCT00932282|6073781|P2|COMPLETED|Modified OIT Rush Desensitization Phase||5
2476757|NCT00932282|6073782|P1|COMPLETED|Modified OIT Rush Desensitization Phase||6
2476758|NCT00932282|6073781|P2|STARTED|Modified OIT Rush Desensitization Phase||5
2476759|NCT00932282|6073782|P1|STARTED|Modified OIT Rush Desensitization Phase||6
2476760|NCT00932282|6073781|P2|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
2476761|NCT00932282|6073782|P1|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
2476762|NCT00932282|6073781|P2|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||5
2476763|NCT00932282|6073782|P1|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||6
2476764|NCT00932282|6073781|P2|STARTED|Pre-OIT Anti-IgE Therapy Phase||6
2476765|NCT00932282|6073782|P1|STARTED|Pre-OIT Anti-IgE Therapy Phase||7
2476766|NCT00932165|6073796|P1|NOT COMPLETED|Overall Study||1
2476767|NCT00932165|6073796|P1|COMPLETED|Overall Study||450
2476768|NCT00932165|6073796|P1|STARTED|Overall Study||451
2476769|NCT00932152|6073809|P2|NOT COMPLETED|Overall Study||2
2476770|NCT00932152|6073810|P1|NOT COMPLETED|Overall Study||1
2476771|NCT00932152|6073809|P2|COMPLETED|Overall Study||0
2476772|NCT00932152|6073810|P1|COMPLETED|Overall Study||0
2476773|NCT00932152|6073809|P2|STARTED|Overall Study||2
2476774|NCT00932152|6073810|P1|STARTED|Overall Study||1
2476775|NCT00932126|6073820|P8|NOT COMPLETED|Overall Study||10
2476776|NCT00932126|6073821|P7|NOT COMPLETED|Overall Study||5
2476777|NCT00932126|6073822|P6|NOT COMPLETED|Overall Study||3
2476778|NCT00932126|6073823|P5|NOT COMPLETED|Overall Study||5
2476779|NCT00932126|6073824|P4|NOT COMPLETED|Overall Study||3
2476780|NCT00932126|6073825|P3|NOT COMPLETED|Overall Study||3
2476781|NCT00932126|6073826|P2|NOT COMPLETED|Overall Study||3
2476782|NCT00932126|6073827|P1|NOT COMPLETED|Overall Study||3
2476783|NCT00932126|6073820|P8|COMPLETED|Overall Study||0
2476784|NCT00932126|6073821|P7|COMPLETED|Overall Study||0
2476785|NCT00932126|6073822|P6|COMPLETED|Overall Study||0
2476786|NCT00932126|6073823|P5|COMPLETED|Overall Study||0
2476787|NCT00932126|6073824|P4|COMPLETED|Overall Study||0
2476788|NCT00932126|6073825|P3|COMPLETED|Overall Study||0
2476789|NCT00932126|6073826|P2|COMPLETED|Overall Study||0
2476790|NCT00932126|6073827|P1|COMPLETED|Overall Study||0
2476791|NCT00932126|6073820|P8|STARTED|Overall Study||10
2476792|NCT00932126|6073821|P7|STARTED|Overall Study||5
2476793|NCT00932126|6073822|P6|STARTED|Overall Study||3
2476794|NCT00932126|6073823|P5|STARTED|Overall Study||5
2476795|NCT00932126|6073824|P4|STARTED|Overall Study||3
2476796|NCT00932126|6073825|P3|STARTED|Overall Study||3
2476797|NCT00932126|6073826|P2|STARTED|Overall Study||3
2476798|NCT00932126|6073827|P1|STARTED|Overall Study||3
2476799|NCT00932113|6073865|P2|NOT COMPLETED|Overall Study||0
2476800|NCT00932113|6073866|P1|NOT COMPLETED|Overall Study||1
2476801|NCT00932113|6073865|P2|COMPLETED|Overall Study||15
2476802|NCT00932113|6073866|P1|COMPLETED|Overall Study||14
2476803|NCT00932113|6073865|P2|STARTED|Overall Study||15
2476804|NCT00932113|6073866|P1|STARTED|Overall Study||15
2476805|NCT00932035|6073884|P2|NOT COMPLETED|Overall Study||0
2476806|NCT00932035|6073885|P1|NOT COMPLETED|Overall Study||0
2476807|NCT00932035|6073884|P2|COMPLETED|Overall Study||21
2476808|NCT00932035|6073885|P1|COMPLETED|Overall Study||18
2476809|NCT00932035|6073884|P2|STARTED|Overall Study||21
2476810|NCT00932035|6073885|P1|STARTED|Overall Study||18
2476811|NCT00932022|6073897|P2|NOT COMPLETED|Overall Study||4
2476812|NCT00932022|6073898|P1|NOT COMPLETED|Overall Study||5
2476813|NCT00932022|6073897|P2|COMPLETED|Overall Study||59
2476814|NCT00932022|6073898|P1|COMPLETED|Overall Study||59
2476815|NCT00932022|6073897|P2|STARTED|Overall Study||63
2476816|NCT00932022|6073898|P1|STARTED|Overall Study||64
2476817|NCT00931996|6073912|P1|NOT COMPLETED|Overall Study||7
2476818|NCT00931996|6073912|P1|COMPLETED|Overall Study||5
2476819|NCT00931996|6073912|P1|STARTED|Overall Study||12
2476820|NCT00931918|6073918|P2|NOT COMPLETED|Overall Study||17
2476821|NCT00931918|6073919|P1|NOT COMPLETED|Overall Study||17
2476822|NCT00931918|6073918|P2|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
2476823|NCT00931918|6073919|P1|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
2476824|NCT00931918|6073918|P2|Safety Population: Received Study Drug|Overall Study||101
2476825|NCT00931918|6073919|P1|Safety Population: Received Study Drug|Overall Study||100
2476826|NCT00931918|6073918|P2|STARTED|Overall Study||103
2476827|NCT00931918|6073919|P1|STARTED|Overall Study||103
2476828|NCT00931879|6073945|P2|NOT COMPLETED|Overall Study||3
2476829|NCT00931879|6073946|P1|NOT COMPLETED|Overall Study||3
2476830|NCT00931879|6073945|P2|COMPLETED|Overall Study||19
2476831|NCT00931879|6073946|P1|COMPLETED|Overall Study||19
2476832|NCT00931879|6073945|P2|STARTED|Overall Study||22
2476833|NCT00931879|6073946|P1|STARTED|Overall Study||22
2476834|NCT00931801|6073971|P3|NOT COMPLETED|Overall Study||4
2476835|NCT00931801|6073972|P2|NOT COMPLETED|Overall Study||1
2476836|NCT00931801|6073973|P1|NOT COMPLETED|Overall Study||1
2476837|NCT00931801|6073971|P3|COMPLETED|Overall Study||10
2476838|NCT00931801|6073972|P2|COMPLETED|Overall Study||14
2476839|NCT00931801|6073973|P1|COMPLETED|Overall Study||13
2476840|NCT00931801|6073971|P3|STARTED|Overall Study||14
2476841|NCT00931801|6073972|P2|STARTED|Overall Study||15
2476842|NCT00931801|6073973|P1|STARTED|Overall Study||14
2476843|NCT00931723|6073996|P2|NOT COMPLETED|Overall Study||39
2476844|NCT00931723|6073997|P1|NOT COMPLETED|Overall Study||26
2476845|NCT00931723|6073996|P2|COMPLETED|Overall Study||144
2476846|NCT00931723|6073997|P1|COMPLETED|Overall Study||147
2476847|NCT00931723|6073996|P2|STARTED|Overall Study||183
2476848|NCT00931723|6073997|P1|STARTED|Overall Study||173
2476849|NCT00931710|6074045|P2|NOT COMPLETED|Overall Study||38
2476850|NCT00931710|6074046|P1|NOT COMPLETED|Overall Study||34
2476851|NCT00931710|6074045|P2|COMPLETED|Overall Study||209
2476852|NCT00931710|6074046|P1|COMPLETED|Overall Study||207
2476853|NCT00931710|6074045|P2|STARTED|Overall Study||247
2476854|NCT00931710|6074046|P1|STARTED|Overall Study||241
2476855|NCT00931632|6074064|P2|NOT COMPLETED|Overall Study||18
2476856|NCT00931632|6074065|P1|NOT COMPLETED|Overall Study||21
2476857|NCT00931632|6074064|P2|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|204
2476858|NCT00931632|6074065|P1|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|208
2476859|NCT00931632|6074064|P2|STARTED|Overall Study|Randomized|222
2476860|NCT00931632|6074065|P1|STARTED|Overall Study|Randomized|229
2476861|NCT00931528|6074087|P2|NOT COMPLETED|Overall Study||60
2476862|NCT00931528|6074088|P1|NOT COMPLETED|Overall Study||41
2476863|NCT00931528|6074087|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|61
2476864|NCT00931528|6074088|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|80
2476865|NCT00931528|6074087|P2|STARTED|Overall Study||121
2476866|NCT00931528|6074088|P1|STARTED|Overall Study||121
2476867|NCT00931515|6074108|P2|NOT COMPLETED|Overall Study||5
2476868|NCT00931515|6074109|P1|NOT COMPLETED|Overall Study||2
2476869|NCT00931515|6074108|P2|COMPLETED|Overall Study||10
2476870|NCT00931515|6074109|P1|COMPLETED|Overall Study||13
2476871|NCT00931515|6074108|P2|STARTED|Overall Study||15
2476872|NCT00931515|6074109|P1|STARTED|Overall Study||15
2476873|NCT00931489|6074120|P5|NOT COMPLETED|Overall Study||0
2476874|NCT00931489|6074121|P4|NOT COMPLETED|Overall Study||0
2476875|NCT00931489|6074122|P3|NOT COMPLETED|Overall Study||0
2476876|NCT00931489|6074123|P2|NOT COMPLETED|Overall Study||0
2476877|NCT00931489|6074124|P1|NOT COMPLETED|Overall Study||0
2476878|NCT00931489|6074120|P5|COMPLETED|Overall Study||7
2476879|NCT00931489|6074121|P4|COMPLETED|Overall Study||39
2476880|NCT00931489|6074122|P3|COMPLETED|Overall Study|3 subjects enrolled in Group 1 (responders) were moved to Group 3 (non-responders)|5
2476881|NCT00931489|6074123|P2|COMPLETED|Overall Study||40
2476882|NCT00931489|6074124|P1|COMPLETED|Overall Study||40
2476883|NCT00931489|6074120|P5|STARTED|Overall Study||7
2476884|NCT00931489|6074121|P4|STARTED|Overall Study||39
2476885|NCT00931489|6074122|P3|STARTED|Overall Study||5
2476886|NCT00931489|6074123|P2|STARTED|Overall Study||40
2476887|NCT00931489|6074124|P1|STARTED|Overall Study||40
2476888|NCT00931463|6074139|P2|NOT COMPLETED|Overall Study||5
2476889|NCT00931463|6074140|P1|NOT COMPLETED|Overall Study||17
2476890|NCT00931463|6074139|P2|COMPLETED|Overall Study||265
2476891|NCT00931463|6074140|P1|COMPLETED|Overall Study||254
2476892|NCT00931463|6074139|P2|STARTED|Overall Study||270
2476893|NCT00931463|6074140|P1|STARTED|Overall Study||271
2476894|NCT00931411|6074156|P2|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||1
2476895|NCT00931411|6074157|P1|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||0
2476896|NCT00931411|6074156|P2|COMPLETED|After Crossover - 14 Days (up to Day 56)||34
2476897|NCT00931411|6074157|P1|COMPLETED|After Crossover - 14 Days (up to Day 56)||31
2476898|NCT00931411|6074156|P2|STARTED|After Crossover - 14 Days (up to Day 56)||35
2476899|NCT00931411|6074157|P1|STARTED|After Crossover - 14 Days (up to Day 56)||31
2476900|NCT00931411|6074156|P2|NOT COMPLETED|First Intervention - 42 Days||3
2476901|NCT00931411|6074157|P1|NOT COMPLETED|First Intervention - 42 Days||4
2476902|NCT00931411|6074156|P2|COMPLETED|First Intervention - 42 Days||35
2476903|NCT00931411|6074157|P1|COMPLETED|First Intervention - 42 Days||31
2476904|NCT00931411|6074156|P2|STARTED|First Intervention - 42 Days||38
2476905|NCT00931411|6074157|P1|STARTED|First Intervention - 42 Days||35
2476906|NCT00931385|6074178|P4|NOT COMPLETED|Overall Study||5
2476907|NCT00931385|6074179|P3|NOT COMPLETED|Overall Study||1
2476908|NCT00931385|6074180|P2|NOT COMPLETED|Overall Study||2
2476909|NCT00931385|6074181|P1|NOT COMPLETED|Overall Study||2
2476910|NCT00931385|6074178|P4|COMPLETED|Overall Study||21
2476911|NCT00931385|6074179|P3|COMPLETED|Overall Study||24
2476912|NCT00931385|6074180|P2|COMPLETED|Overall Study||21
2476913|NCT00931385|6074181|P1|COMPLETED|Overall Study||23
2476914|NCT00931385|6074178|P4|STARTED|Overall Study||26
2476915|NCT00931385|6074179|P3|STARTED|Overall Study||25
2476916|NCT00931385|6074180|P2|STARTED|Overall Study||23
2476917|NCT00931385|6074181|P1|STARTED|Overall Study||25
2476918|NCT00931359|6074237|P2|NOT COMPLETED|Overall Study||13
2476919|NCT00931359|6074238|P1|NOT COMPLETED|Overall Study||6
2476920|NCT00931359|6074237|P2|COMPLETED|Overall Study||68
2476921|NCT00931359|6074238|P1|COMPLETED|Overall Study||33
2476922|NCT00931359|6074237|P2|STARTED|Overall Study||81
2476923|NCT00931359|6074238|P1|STARTED|Overall Study||39
2476924|NCT00931307|6074250|P1|NOT COMPLETED|Overall Study||13
2476925|NCT00931307|6074250|P1|COMPLETED|Overall Study||9
2476926|NCT00931307|6074250|P1|STARTED|Overall Study||22
2476927|NCT00931268|6074254|P1|NOT COMPLETED|Overall Study||6
2476928|NCT00931268|6074254|P1|COMPLETED|Overall Study||4
2476929|NCT00931268|6074254|P1|STARTED|Overall Study||10
2476930|NCT00931255|6074266|P2|NOT COMPLETED|Overall Study||3
2476931|NCT00931255|6074267|P1|NOT COMPLETED|Overall Study||2
2476932|NCT00931255|6074266|P2|COMPLETED|Overall Study||12
2476933|NCT00931255|6074267|P1|COMPLETED|Overall Study||15
2476934|NCT00931255|6074266|P2|STARTED|Overall Study||15
2476935|NCT00931255|6074267|P1|STARTED|Overall Study||17
2476936|NCT00931242|6074291|P2|NOT COMPLETED|Overall Study||2
2476937|NCT00931242|6074292|P1|NOT COMPLETED|Overall Study||5
2476938|NCT00931242|6074291|P2|COMPLETED|Overall Study||0
2476939|NCT00931242|6074292|P1|COMPLETED|Overall Study||5
2476940|NCT00931242|6074291|P2|STARTED|Overall Study||2
2476941|NCT00931242|6074292|P1|STARTED|Overall Study||10
2476942|NCT00931164|6074298|P1|NOT COMPLETED|Overall Study||0
2476943|NCT00931164|6074298|P1|COMPLETED|Overall Study||6
2476944|NCT00931164|6074298|P1|STARTED|Overall Study||6
2476945|NCT00930982|6074304|P2|NOT COMPLETED|Overall Study||29
2476946|NCT00930982|6074305|P1|NOT COMPLETED|Overall Study||21
2476947|NCT00930982|6074304|P2|COMPLETED|Overall Study||35
2476948|NCT00930982|6074305|P1|COMPLETED|Overall Study||39
2476949|NCT00930982|6074304|P2|STARTED|Overall Study||64
2476950|NCT00930982|6074305|P1|STARTED|Overall Study||60
2476951|NCT00930969|6074339|P1|NOT COMPLETED|Overall Study||38
2476952|NCT00930969|6074339|P1|COMPLETED|Overall Study||137
2476953|NCT00930969|6074339|P1|STARTED|Overall Study||175
2476954|NCT00930930|6074349|P2|NOT COMPLETED|Overall Study||9
2476955|NCT00930930|6074350|P1|NOT COMPLETED|Overall Study||21
2476956|NCT00930930|6074349|P2|COMPLETED|Overall Study||40
2476957|NCT00930930|6074350|P1|COMPLETED|Overall Study||75
2476958|NCT00930930|6074349|P2|STARTED|Overall Study||49
2476959|NCT00930930|6074350|P1|STARTED|Overall Study||96
2476960|NCT00930813|6074364|P2|NOT COMPLETED|Overall Study||14
2476961|NCT00930813|6074365|P1|NOT COMPLETED|Overall Study||8
2476962|NCT00930813|6074364|P2|COMPLETED|Overall Study||38
2476963|NCT00930813|6074365|P1|COMPLETED|Overall Study||41
2476964|NCT00930813|6074364|P2|STARTED|Overall Study||52
2476965|NCT00930813|6074365|P1|STARTED|Overall Study||49
2476966|NCT00930787|6074375|P2|NOT COMPLETED|Overall Study||0
2476967|NCT00930787|6074376|P1|NOT COMPLETED|Overall Study||0
2476968|NCT00930787|6074375|P2|COMPLETED|Overall Study||9
2476969|NCT00930787|6074376|P1|COMPLETED|Overall Study||14
2476970|NCT00930787|6074375|P2|STARTED|Overall Study||9
2476971|NCT00930787|6074376|P1|STARTED|Overall Study||14
2476972|NCT00930774|6074386|P4|NOT COMPLETED|Overall Study||0
2476973|NCT00930774|6074387|P3|NOT COMPLETED|Overall Study||2
2476974|NCT00930774|6074388|P2|NOT COMPLETED|Overall Study||9
2476975|NCT00930774|6074389|P1|NOT COMPLETED|Overall Study||1
2476976|NCT00930774|6074386|P4|COMPLETED|Overall Study||25
2476977|NCT00930774|6074387|P3|COMPLETED|Overall Study||22
2476978|NCT00930774|6074388|P2|COMPLETED|Overall Study||16
2476979|NCT00930774|6074389|P1|COMPLETED|Overall Study||24
2476980|NCT00930774|6074386|P4|STARTED|Overall Study||25
2476981|NCT00930774|6074387|P3|STARTED|Overall Study||24
2476982|NCT00930774|6074388|P2|STARTED|Overall Study||25
2476983|NCT00930774|6074389|P1|STARTED|Overall Study||25
2476984|NCT00930761|6074429|P2|NOT COMPLETED|Overall Study||3
2476985|NCT00930761|6074430|P1|NOT COMPLETED|Overall Study||4
2476986|NCT00930761|6074429|P2|COMPLETED|Overall Study||48
2476987|NCT00930761|6074430|P1|COMPLETED|Overall Study||46
2476988|NCT00930761|6074429|P2|STARTED|Overall Study||51
2476989|NCT00930761|6074430|P1|STARTED|Overall Study||50
2476990|NCT00930722|6074442|P1|NOT COMPLETED|Overall Study||27
2476991|NCT00930722|6074442|P1|COMPLETED|Overall Study||302
2476992|NCT00930722|6074442|P1|STARTED|Overall Study||329
2476993|NCT00930644|6074457|P1|NOT COMPLETED|Overall Study||23
2476994|NCT00930644|6074457|P1|COMPLETED|Overall Study||65
2476995|NCT00930644|6074457|P1|STARTED|Overall Study||88
2476996|NCT00930553|6074470|P1|NOT COMPLETED|Overall Study||223
2476997|NCT00930553|6074470|P1|COMPLETED|Overall Study||1091
2476998|NCT00930553|6074470|P1|Participants Entered From CAMMS324|Overall Study||685
2476999|NCT00930553|6074470|P1|Participants Entered From CAMMS323|Overall Study||488
2477000|NCT00930553|6074470|P1|Participants Entered From CAMMS223|Overall Study||141
2477001|NCT00930553|6074470|P1|STARTED|Overall Study||1314
2477002|NCT00930293|6074538|P2|NOT COMPLETED|Overall Study||7
2477003|NCT00930293|6074539|P1|NOT COMPLETED|Overall Study||7
2477004|NCT00930293|6074538|P2|COMPLETED|Overall Study||19
2477005|NCT00930293|6074539|P1|COMPLETED|Overall Study||17
2477006|NCT00930293|6074538|P2|STARTED|Overall Study||26
2477007|NCT00930293|6074539|P1|STARTED|Overall Study||24
2477008|NCT00930176|6074547|P1|NOT COMPLETED|Overall Study||1
2477009|NCT00930176|6074547|P1|COMPLETED|Overall Study||15
2477010|NCT00930176|6074547|P1|STARTED|Overall Study||16
2477011|NCT00929994|6074552|P1|NOT COMPLETED|Overall Study||6
2477012|NCT00929994|6074552|P1|COMPLETED|Overall Study||14
2477013|NCT00929994|6074552|P1|STARTED|Overall Study||20
2477014|NCT00929981|6074559|P1|NOT COMPLETED|Overall Study||0
2477015|NCT00929981|6074559|P1|COMPLETED|Overall Study||80
2477016|NCT00929981|6074559|P1|STARTED|Overall Study||80
2477017|NCT00929864|6074571|P2|NOT COMPLETED|Overall Study||83
2477018|NCT00929864|6074572|P1|NOT COMPLETED|Overall Study||66
2477019|NCT00929864|6074571|P2|COMPLETED|Overall Study||245
2477020|NCT00929864|6074572|P1|COMPLETED|Overall Study||252
2477021|NCT00929864|6074571|P2|STARTED|Overall Study||328
2477022|NCT00929864|6074572|P1|STARTED|Overall Study||318
2477023|NCT00929838|6074594|P4|NOT COMPLETED|Overall Study||9
2477024|NCT00929838|6074595|P3|NOT COMPLETED|Overall Study||10
2477025|NCT00929838|6074596|P2|NOT COMPLETED|Overall Study||9
2477026|NCT00929838|6074597|P1|NOT COMPLETED|Overall Study||10
2477027|NCT00929838|6074594|P4|COMPLETED|Overall Study||55
2477028|NCT00929838|6074595|P3|COMPLETED|Overall Study||53
2477029|NCT00929838|6074596|P2|COMPLETED|Overall Study||56
2477030|NCT00929838|6074597|P1|COMPLETED|Overall Study||53
2477031|NCT00929838|6074594|P4|STARTED|Overall Study||64
2477032|NCT00929838|6074595|P3|STARTED|Overall Study||63
2477033|NCT00929838|6074596|P2|STARTED|Overall Study||65
2477034|NCT00929838|6074597|P1|STARTED|Overall Study||63
2477035|NCT00929773|6074609|P2|NOT COMPLETED|Overall Study||0
2477036|NCT00929773|6074610|P1|NOT COMPLETED|Overall Study||0
2477037|NCT00929773|6074609|P2|COMPLETED|Overall Study||50
2477038|NCT00929773|6074610|P1|COMPLETED|Overall Study||50
2477039|NCT00929773|6074609|P2|STARTED|Overall Study||50
2477040|NCT00929773|6074610|P1|STARTED|Overall Study||50
2477041|NCT00929734|6074628|P2|NOT COMPLETED|Overall Study||3
2477042|NCT00929734|6074629|P1|NOT COMPLETED|Overall Study||2
2477043|NCT00929734|6074628|P2|COMPLETED|Overall Study||47
2477044|NCT00929734|6074629|P1|COMPLETED|Overall Study||47
2477045|NCT00929734|6074628|P2|STARTED|Overall Study||50
2477046|NCT00929734|6074629|P1|STARTED|Overall Study||49
2477047|NCT00929708|6074646|P5|NOT COMPLETED|Overall Study||6
2477048|NCT00929708|6074647|P4|NOT COMPLETED|Overall Study||6
2477049|NCT00929708|6074648|P3|NOT COMPLETED|Overall Study||3
2477050|NCT00929708|6074649|P2|NOT COMPLETED|Overall Study||3
2477051|NCT00929708|6074650|P1|NOT COMPLETED|Overall Study||4
2477052|NCT00929708|6074646|P5|COMPLETED|Overall Study||57
2477053|NCT00929708|6074647|P4|COMPLETED|Overall Study||61
2477054|NCT00929708|6074648|P3|COMPLETED|Overall Study||62
2477055|NCT00929708|6074649|P2|COMPLETED|Overall Study||66
2477056|NCT00929708|6074650|P1|COMPLETED|Overall Study||61
2477057|NCT00929708|6074646|P5|STARTED|Overall Study||63
2477058|NCT00929708|6074647|P4|STARTED|Overall Study||67
2477059|NCT00929708|6074648|P3|STARTED|Overall Study||65
2477060|NCT00929708|6074649|P2|STARTED|Overall Study||69
2477061|NCT00929708|6074650|P1|STARTED|Overall Study||65
2477062|NCT00929695|6074704|P2|NOT COMPLETED|Overall Study||6
2477063|NCT00929695|6074705|P1|NOT COMPLETED|Overall Study||8
2477064|NCT00929695|6074704|P2|COMPLETED|Overall Study||77
2477065|NCT00929695|6074705|P1|COMPLETED|Overall Study||73
2477066|NCT00929695|6074704|P2|STARTED|Overall Study||83
2477067|NCT00929695|6074705|P1|STARTED|Overall Study||81
2477068|NCT00929669|6074735|P1|NOT COMPLETED|Overall Study||1
2477069|NCT00929669|6074735|P1|COMPLETED|Overall Study||1
2477070|NCT00929669|6074735|P1|STARTED|Overall Study||2
2477071|NCT00929656|6074742|P2|NOT COMPLETED|Overall Study||1
2477072|NCT00929656|6074743|P1|NOT COMPLETED|Overall Study||0
2477073|NCT00929656|6074742|P2|COMPLETED|Overall Study||8
2477074|NCT00929656|6074743|P1|COMPLETED|Overall Study||13
2477075|NCT00929656|6074742|P2|STARTED|Overall Study||9
2477076|NCT00929656|6074743|P1|STARTED|Overall Study||13
2477077|NCT00929643|6074757|P1|NOT COMPLETED|Overall Study||2
2477078|NCT00929643|6074757|P1|COMPLETED|Overall Study||201
2477079|NCT00929643|6074757|P1|STARTED|Overall Study||203
2477080|NCT00929578|6074766|P1|NOT COMPLETED|Overall Study||0
2477081|NCT00929578|6074766|P1|COMPLETED|Overall Study||15
2477082|NCT00929578|6074766|P1|STARTED|Overall Study||15
2477083|NCT00929526|6074779|P2|NOT COMPLETED|Overall Study||29
2477084|NCT00929526|6074780|P1|NOT COMPLETED|Overall Study||17
2477085|NCT00929526|6074779|P2|COMPLETED|Overall Study||348
2477086|NCT00929526|6074780|P1|COMPLETED|Overall Study||358
2477087|NCT00929526|6074779|P2|STARTED|Overall Study||377
2477088|NCT00929526|6074780|P1|STARTED|Overall Study||375
2477089|NCT00929500|6074816|P2|NOT COMPLETED|Overall Study||0
2477090|NCT00929500|6074817|P1|NOT COMPLETED|Overall Study||4
2477091|NCT00929500|6074816|P2|COMPLETED|Overall Study||4
2477092|NCT00929500|6074817|P1|COMPLETED|Overall Study||4
2477093|NCT00929500|6074816|P2|STARTED|Overall Study||4
2477094|NCT00929500|6074817|P1|STARTED|Overall Study||8
2477095|NCT00929474|6074831|P2|NOT COMPLETED|Overall Study||9
2477096|NCT00929474|6074832|P1|NOT COMPLETED|Overall Study||8
2477097|NCT00929474|6074831|P2|COMPLETED|Overall Study||0
2477098|NCT00929474|6074832|P1|COMPLETED|Overall Study||0
2477099|NCT00929474|6074831|P2|STARTED|Overall Study||9
2477100|NCT00929474|6074832|P1|STARTED|Overall Study||8
2477101|NCT00929383|6074838|P1|NOT COMPLETED|Overall Study||15
2477102|NCT00929383|6074838|P1|COMPLETED|Overall Study||67
2477103|NCT00929383|6074838|P1|STARTED|Overall Study||82
2477104|NCT00929357|6074848|P2|NOT COMPLETED|Overall Study||0
2477105|NCT00929357|6074849|P1|NOT COMPLETED|Overall Study||0
2477106|NCT00929357|6074848|P2|COMPLETED|Overall Study||64
2477107|NCT00929357|6074849|P1|COMPLETED|Overall Study||92
2477108|NCT00929357|6074848|P2|STARTED|Overall Study||64
2477109|NCT00929357|6074849|P1|STARTED|Overall Study||92
2477110|NCT00929344|6074872|P3|NOT COMPLETED|Overall Study||21
2477111|NCT00929344|6074873|P2|NOT COMPLETED|Overall Study||13
2477112|NCT00929344|6074874|P1|NOT COMPLETED|Overall Study||22
2477113|NCT00929344|6074872|P3|COMPLETED|Overall Study||29
2477114|NCT00929344|6074873|P2|COMPLETED|Overall Study||37
2477115|NCT00929344|6074874|P1|COMPLETED|Overall Study||28
2477116|NCT00929344|6074872|P3|STARTED|Overall Study||50
2477117|NCT00929344|6074873|P2|STARTED|Overall Study||50
2477118|NCT00929344|6074874|P1|STARTED|Overall Study||50
2477119|NCT00929331|6074890|P2|NOT COMPLETED|Overall Study||0
2477120|NCT00929331|6074891|P1|NOT COMPLETED|Overall Study||0
2477121|NCT00929331|6074890|P2|COMPLETED|Overall Study||55
2477122|NCT00929331|6074891|P1|COMPLETED|Overall Study||55
2477123|NCT00929331|6074890|P2|STARTED|Overall Study||55
2477124|NCT00929331|6074891|P1|STARTED|Overall Study||55
2477125|NCT00929305|6074925|P2|NOT COMPLETED|Overall Study||0
2477126|NCT00929305|6074926|P1|NOT COMPLETED|Overall Study||0
2477127|NCT00929305|6074925|P2|COMPLETED|Overall Study||43
2477128|NCT00929305|6074926|P1|COMPLETED|Overall Study||43
2477129|NCT00929305|6074925|P2|STARTED|Overall Study||43
2477130|NCT00929305|6074926|P1|STARTED|Overall Study||43
2477131|NCT00929240|6074934|P3|NOT COMPLETED|Maintenance Phase||91
2477132|NCT00929240|6074935|P2|NOT COMPLETED|Maintenance Phase||94
2477133|NCT00929240|6074936|P1|NOT COMPLETED|Maintenance Phase||0
2477134|NCT00929240|6074934|P3|COMPLETED|Maintenance Phase||0
2477135|NCT00929240|6074935|P2|COMPLETED|Maintenance Phase||0
2477136|NCT00929240|6074936|P1|COMPLETED|Maintenance Phase||0
2477137|NCT00929240|6074934|P3|STARTED|Maintenance Phase||91
2477138|NCT00929240|6074935|P2|STARTED|Maintenance Phase||94
2477139|NCT00929240|6074936|P1|STARTED|Maintenance Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
2477140|NCT00929240|6074934|P3|NOT COMPLETED|Initial Treatment Phase||0
2477141|NCT00929240|6074935|P2|NOT COMPLETED|Initial Treatment Phase||0
2477142|NCT00929240|6074936|P1|NOT COMPLETED|Initial Treatment Phase||99
2477143|NCT00929240|6074934|P3|COMPLETED|Initial Treatment Phase||0
2477144|NCT00929240|6074935|P2|COMPLETED|Initial Treatment Phase||0
2477145|NCT00929240|6074936|P1|COMPLETED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|185
2477146|NCT00929240|6074934|P3|STARTED|Initial Treatment Phase||0
2477147|NCT00929240|6074935|P2|STARTED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
2477148|NCT00929240|6074936|P1|STARTED|Initial Treatment Phase|Includes only the participants that received Initial Phase Treatment.|284
2477149|NCT00929201|6074963|P2|NOT COMPLETED|Period 2||0
2477150|NCT00929201|6074964|P1|NOT COMPLETED|Period 2||0
2477151|NCT00929201|6074963|P2|COMPLETED|Period 2||30
2477152|NCT00929201|6074964|P1|COMPLETED|Period 2||30
2477153|NCT00929201|6074963|P2|STARTED|Period 2||30
2477154|NCT00929201|6074964|P1|STARTED|Period 2||30
2477155|NCT00929201|6074963|P2|NOT COMPLETED|7-day Washout||0
2477156|NCT00929201|6074964|P1|NOT COMPLETED|7-day Washout||0
2477157|NCT00929201|6074963|P2|COMPLETED|7-day Washout||30
2477158|NCT00929201|6074964|P1|COMPLETED|7-day Washout||30
2477159|NCT00929201|6074963|P2|STARTED|7-day Washout||30
2477160|NCT00929201|6074964|P1|STARTED|7-day Washout||30
2477161|NCT00929201|6074963|P2|NOT COMPLETED|Period 1||1
2477162|NCT00929201|6074964|P1|NOT COMPLETED|Period 1||0
2477163|NCT00929201|6074963|P2|COMPLETED|Period 1||30
2477164|NCT00929201|6074964|P1|COMPLETED|Period 1||30
2477165|NCT00929201|6074963|P2|STARTED|Period 1||31
2477166|NCT00929201|6074964|P1|STARTED|Period 1||30
2477167|NCT00929162|6074974|P2|NOT COMPLETED|Overall Study||42
2477168|NCT00929162|6074975|P1|NOT COMPLETED|Overall Study||48
2477169|NCT00929162|6074974|P2|COMPLETED|Overall Study||19
2477170|NCT00929162|6074975|P1|COMPLETED|Overall Study||11
2477171|NCT00929162|6074974|P2|Patients Who Received Treatment|Overall Study||58
2477172|NCT00929162|6074975|P1|Patients Who Received Treatment|Overall Study||58
2477173|NCT00929162|6074974|P2|STARTED|Overall Study||61
2477174|NCT00929162|6074975|P1|STARTED|Overall Study||59
2477175|NCT00929110|6074988|P3|NOT COMPLETED|Overall Study||62
2477176|NCT00929110|6074989|P2|NOT COMPLETED|Overall Study||76
2477177|NCT00929110|6074990|P1|NOT COMPLETED|Overall Study||118
2477178|NCT00929110|6074988|P3|COMPLETED|Overall Study||206
2477179|NCT00929110|6074989|P2|COMPLETED|Overall Study||193
2477180|NCT00929110|6074990|P1|COMPLETED|Overall Study||411
2477181|NCT00929110|6074988|P3|STARTED|Overall Study||268
2477182|NCT00929110|6074989|P2|STARTED|Overall Study||269
2477183|NCT00929110|6074990|P1|STARTED|Overall Study||529
2477184|NCT00929071|6075055|P1|NOT COMPLETED|Overall Study||0
2477185|NCT00929071|6075055|P1|COMPLETED|Overall Study||10
2477186|NCT00929071|6075055|P1|STARTED|Overall Study||10
2477187|NCT00928954|6075062|P2|NOT COMPLETED|Overall Study||0
2477188|NCT00928954|6075063|P1|NOT COMPLETED|Overall Study||0
2477189|NCT00928954|6075062|P2|COMPLETED|Overall Study||6
2477190|NCT00928954|6075063|P1|COMPLETED|Overall Study||4
2477191|NCT00928954|6075062|P2|STARTED|Overall Study||6
2477192|NCT00928954|6075063|P1|STARTED|Overall Study||4
2477193|NCT00928889|6075073|P2|NOT COMPLETED|Overall Study||2
2477194|NCT00928889|6075074|P1|NOT COMPLETED|Overall Study||5
2477195|NCT00928889|6075073|P2|COMPLETED|Overall Study||78
2477196|NCT00928889|6075074|P1|COMPLETED|Overall Study||75
2477197|NCT00928889|6075073|P2|STARTED|Overall Study||80
2477198|NCT00928889|6075074|P1|STARTED|Overall Study||80
2477199|NCT00928772|6075101|P3|NOT COMPLETED|Overall Study||0
2477200|NCT00928772|6075102|P2|NOT COMPLETED|Overall Study||0
2477201|NCT00928772|6075103|P1|NOT COMPLETED|Overall Study||0
2477202|NCT00928772|6075101|P3|COMPLETED|Overall Study||38
2477203|NCT00928772|6075102|P2|COMPLETED|Overall Study||38
2477204|NCT00928772|6075103|P1|COMPLETED|Overall Study||39
2477205|NCT00928772|6075101|P3|STARTED|Overall Study||38
2477206|NCT00928772|6075102|P2|STARTED|Overall Study||38
2477207|NCT00928772|6075103|P1|STARTED|Overall Study||39
2477208|NCT00928746|6075120|P1|NOT COMPLETED|Overall Study||6
2477209|NCT00928746|6075120|P1|COMPLETED|Overall Study||136
2477210|NCT00928746|6075120|P1|STARTED|Overall Study||142
2477211|NCT00928720|6075143|P3|NOT COMPLETED|Overall Study||3
2477212|NCT00928720|6075144|P2|NOT COMPLETED|Overall Study||6
2477213|NCT00928720|6075145|P1|NOT COMPLETED|Overall Study||2
2477214|NCT00928720|6075143|P3|COMPLETED|Overall Study||15
2477215|NCT00928720|6075144|P2|COMPLETED|Overall Study||14
2477216|NCT00928720|6075145|P1|COMPLETED|Overall Study||17
2477217|NCT00928720|6075143|P3|STARTED|Overall Study||18
2477218|NCT00928720|6075144|P2|STARTED|Overall Study||20
2477219|NCT00928720|6075145|P1|STARTED|Overall Study||19
2477220|NCT00928707|6075170|P2|NOT COMPLETED|Overall Study||0
2477221|NCT00928707|6075171|P1|NOT COMPLETED|Overall Study||1
2477222|NCT00928707|6075170|P2|COMPLETED|Overall Study||22
2477223|NCT00928707|6075171|P1|COMPLETED|Overall Study||22
2477224|NCT00928707|6075170|P2|STARTED|Overall Study||22
2477225|NCT00928707|6075171|P1|STARTED|Overall Study||23
2477226|NCT00928694|6075183|P2|NOT COMPLETED|Second Intervention||0
2477227|NCT00928694|6075184|P1|NOT COMPLETED|Second Intervention||0
2477228|NCT00928694|6075183|P2|COMPLETED|Second Intervention||7
2477229|NCT00928694|6075184|P1|COMPLETED|Second Intervention||7
2477230|NCT00928694|6075183|P2|STARTED|Second Intervention||7
2477231|NCT00928694|6075184|P1|STARTED|Second Intervention||7
2477232|NCT00928694|6075183|P2|NOT COMPLETED|First Intervention||0
2477233|NCT00928694|6075184|P1|NOT COMPLETED|First Intervention||0
2477234|NCT00928694|6075183|P2|COMPLETED|First Intervention||7
2477235|NCT00928694|6075184|P1|COMPLETED|First Intervention||7
2477236|NCT00928694|6075183|P2|STARTED|First Intervention||7
2477237|NCT00928694|6075184|P1|STARTED|First Intervention||7
2477238|NCT00928668|6075192|P5|NOT COMPLETED|Overall Study||1
2477239|NCT00928668|6075193|P4|NOT COMPLETED|Overall Study||1
2477240|NCT00928668|6075194|P3|NOT COMPLETED|Overall Study||1
2477241|NCT00928668|6075195|P2|NOT COMPLETED|Overall Study||1
2477242|NCT00928668|6075196|P1|NOT COMPLETED|Overall Study||1
2477243|NCT00928668|6075192|P5|COMPLETED|Overall Study||5
2477244|NCT00928668|6075193|P4|COMPLETED|Overall Study||3
2477245|NCT00928668|6075194|P3|COMPLETED|Overall Study||6
2477246|NCT00928668|6075195|P2|COMPLETED|Overall Study||6
2477247|NCT00928668|6075196|P1|COMPLETED|Overall Study||6
2477248|NCT00928668|6075192|P5|STARTED|Overall Study||6
2477249|NCT00928668|6075193|P4|STARTED|Overall Study||4
2477250|NCT00928668|6075194|P3|STARTED|Overall Study||7
2477251|NCT00928668|6075195|P2|STARTED|Overall Study||7
2477252|NCT00928668|6075196|P1|STARTED|Overall Study||7
2477253|NCT00928642|6075238|P1|NOT COMPLETED|Overall Study||0
2477254|NCT00928642|6075238|P1|COMPLETED|Overall Study|1 subject withdrew after 1st cycle but before disease assessment. 7 of 8 are evaluable for response|8
2477255|NCT00928642|6075238|P1|STARTED|Overall Study||8
2477256|NCT00928512|6075252|P5|NOT COMPLETED|Overall Study||15
2477257|NCT00928512|6075253|P4|NOT COMPLETED|Overall Study||21
2477258|NCT00928512|6075254|P3|NOT COMPLETED|Overall Study||11
2477259|NCT00928512|6075255|P2|NOT COMPLETED|Overall Study||6
2477260|NCT00928512|6075256|P1|NOT COMPLETED|Overall Study||10
2477261|NCT00928512|6075252|P5|COMPLETED|Overall Study||35
2477262|NCT00928512|6075253|P4|COMPLETED|Overall Study||33
2477263|NCT00928512|6075254|P3|COMPLETED|Overall Study||38
2477264|NCT00928512|6075255|P2|COMPLETED|Overall Study||37
2477265|NCT00928512|6075256|P1|COMPLETED|Overall Study||31
2477266|NCT00928512|6075252|P5|Entered/Continued to Week 20 (All)|Overall Study||45
2477267|NCT00928512|6075253|P4|Entered/Continued to Week 20 (All)|Overall Study||45
2477268|NCT00928512|6075254|P3|Entered/Continued to Week 20 (All)|Overall Study||46
2477269|NCT00928512|6075255|P2|Entered/Continued to Week 20 (All)|Overall Study||43
2477270|NCT00928512|6075256|P1|Entered/Continued to Week 20 (All)|Overall Study||37
2477271|NCT00928512|6075252|P5|Completed Week 16|Overall Study||45
2477272|NCT00928512|6075253|P4|Completed Week 16|Overall Study||48
2477273|NCT00928512|6075254|P3|Completed Week 16|Overall Study||47
2477274|NCT00928512|6075255|P2|Completed Week 16|Overall Study||43
2477275|NCT00928512|6075256|P1|Completed Week 16|Overall Study||38
2477276|NCT00928512|6075252|P5|New Groups After Reassignment|Overall Study||0
2477277|NCT00928512|6075253|P4|New Groups After Reassignment|Overall Study|2 patients in this group continued at Week 16 but did not receive any study drug at Week 20|18
2477278|NCT00928512|6075254|P3|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|23
2477279|NCT00928512|6075255|P2|New Groups After Reassignment|Overall Study||115
2477280|NCT00928512|6075256|P1|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|60
2477281|NCT00928512|6075252|P5|Not Reassigned at Week 20 (Responders)|Overall Study||0
2477282|NCT00928512|6075253|P4|Not Reassigned at Week 20 (Responders)|Overall Study||18
2477283|NCT00928512|6075254|P3|Not Reassigned at Week 20 (Responders)|Overall Study||23
2477284|NCT00928512|6075255|P2|Not Reassigned at Week 20 (Responders)|Overall Study||20
2477285|NCT00928512|6075256|P1|Not Reassigned at Week 20 (Responders)|Overall Study||37
2477286|NCT00928512|6075252|P5|Reassigned at Week 20 (Non-responders)|Overall Study|All placebo patients (responders & non-responders) were reassigned treatment to the 150 mg group.|45
2477287|NCT00928512|6075253|P4|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 25 mg group were reassigned treatment to the 150 mg group.|27
2477288|NCT00928512|6075254|P3|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 75 mg group were reassigned treatment to the 150 mg group.|23
2477289|NCT00928512|6075255|P2|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 150 mg group were reassigned treatment to the 300 mg group.|23
2477290|NCT00928512|6075256|P1|Reassigned at Week 20 (Non-responders)|Overall Study|All patients in the 300 mg group at Week 20 remained at this dose in this group.|0
2477291|NCT00928512|6075252|P5|Discontinued Prior to Week 16|Overall Study||5
2477292|NCT00928512|6075253|P4|Discontinued Prior to Week 16|Overall Study||6
2477293|NCT00928512|6075254|P3|Discontinued Prior to Week 16|Overall Study||2
2477294|NCT00928512|6075255|P2|Discontinued Prior to Week 16|Overall Study||0
2477295|NCT00928512|6075256|P1|Discontinued Prior to Week 16|Overall Study||3
2477296|NCT00928512|6075252|P5|STARTED|Overall Study||50
2477297|NCT00928512|6075253|P4|STARTED|Overall Study||54
2477298|NCT00928512|6075254|P3|STARTED|Overall Study||49
2477299|NCT00928512|6075255|P2|STARTED|Overall Study||43
2477300|NCT00928512|6075256|P1|STARTED|Overall Study||41
2477301|NCT00928486|6075357|P1|NOT COMPLETED|Overall Study||10
2477302|NCT00928486|6075357|P1|COMPLETED|Overall Study|Completed = those who continued responding to treatment; upon marketing approval, given lenalidomide|15
2477303|NCT00928486|6075357|P1|Efficacy Evaluable (EE)|Overall Study|EE population = given at least 1 dose of study drug, evaluated for efficacy and met eligibility|24
2477304|NCT00928486|6075357|P1|STARTED|Overall Study||25
2477305|NCT00928434|6075366|P3|NOT COMPLETED|Overall Study||44
2477306|NCT00928434|6075367|P2|NOT COMPLETED|Overall Study||14
2477307|NCT00928434|6075368|P1|NOT COMPLETED|Overall Study||44
2477308|NCT00928434|6075366|P3|COMPLETED|Overall Study||134
2477309|NCT00928434|6075367|P2|COMPLETED|Overall Study||36
2477310|NCT00928434|6075368|P1|COMPLETED|Overall Study||131
2477311|NCT00928434|6075366|P3|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|150
2477312|NCT00928434|6075367|P2|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|41
2477313|NCT00928434|6075368|P1|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|137
2477314|NCT00928434|6075366|P3|STARTED|Overall Study|Full Analysis Set Patients|178
2477315|NCT00928434|6075367|P2|STARTED|Overall Study|Full Analysis Set Patients|50
2477316|NCT00928434|6075368|P1|STARTED|Overall Study|Full Analysis Set Patients|175
2477317|NCT00928421|6075440|P1|NOT COMPLETED|Overall Study||0
2477318|NCT00928421|6075440|P1|COMPLETED|Overall Study||16
2477319|NCT00928421|6075440|P1|Treated With Study Drug|Overall Study||16
2477320|NCT00928421|6075440|P1|STARTED|Overall Study||16
2477321|NCT00928408|6075444|P1|NOT COMPLETED|Overall Study||23
2477322|NCT00928408|6075444|P1|COMPLETED|Overall Study||282
2477323|NCT00928408|6075444|P1|Full Analysis Set|Overall Study|All enrolled participants who fulfilled the study inclusion/exclusion criteria|303
2477324|NCT00928408|6075444|P1|STARTED|Overall Study|Number Enrolled|305
2477325|NCT00928395|6075473|P1|NOT COMPLETED|Overall Study||21
2477326|NCT00928395|6075473|P1|COMPLETED|Overall Study||29
2477327|NCT00928395|6075473|P1|STARTED|Overall Study||50
2477328|NCT00928304|6075477|P2|NOT COMPLETED|Overall Study||0
2477329|NCT00928304|6075478|P1|NOT COMPLETED|Overall Study||0
2477330|NCT00928304|6075477|P2|COMPLETED|Overall Study||70
2477331|NCT00928304|6075478|P1|COMPLETED|Overall Study||39
2477332|NCT00928304|6075477|P2|STARTED|Overall Study||70
2477333|NCT00928304|6075478|P1|STARTED|Overall Study||39
2477334|NCT00928252|6075490|P1|NOT COMPLETED|Overall Study||3
2477335|NCT00928252|6075490|P1|COMPLETED|Overall Study||42
2477336|NCT00928252|6075490|P1|STARTED|Overall Study||45
2477337|NCT00928226|6075500|P4|NOT COMPLETED|Overall Study||0
2477338|NCT00928226|6075501|P3|NOT COMPLETED|Overall Study||0
2477339|NCT00928226|6075502|P2|NOT COMPLETED|Overall Study||0
2477340|NCT00928226|6075503|P1|NOT COMPLETED|Overall Study||0
2477341|NCT00928226|6075500|P4|COMPLETED|Overall Study||12
2477342|NCT00928226|6075501|P3|COMPLETED|Overall Study||12
2477343|NCT00928226|6075502|P2|COMPLETED|Overall Study||12
2477344|NCT00928226|6075503|P1|COMPLETED|Overall Study||20
2477345|NCT00928226|6075500|P4|Strata D: Large Tumor, Not Resected|Overall Study||0
2477346|NCT00928226|6075501|P3|Strata D: Large Tumor, Not Resected|Overall Study||0
2477347|NCT00928226|6075502|P2|Strata D: Large Tumor, Not Resected|Overall Study||0
2477348|NCT00928226|6075503|P1|Strata D: Large Tumor, Not Resected|Overall Study||1
2477349|NCT00928226|6075500|P4|Strata C: Large Tumor, Resected|Overall Study||6
2477350|NCT00928226|6075501|P3|Strata C: Large Tumor, Resected|Overall Study||6
2477351|NCT00928226|6075502|P2|Strata C: Large Tumor, Resected|Overall Study||6
2477352|NCT00928226|6075503|P1|Strata C: Large Tumor, Resected|Overall Study||8
2477353|NCT00928226|6075500|P4|Strata B: Small Tumor, Not Resected|Overall Study||0
2477354|NCT00928226|6075501|P3|Strata B: Small Tumor, Not Resected|Overall Study||0
2477355|NCT00928226|6075502|P2|Strata B: Small Tumor, Not Resected|Overall Study||0
2477356|NCT00928226|6075503|P1|Strata B: Small Tumor, Not Resected|Overall Study||5
2477357|NCT00928226|6075500|P4|Strata A: Small Tumor, Resected|Overall Study||6
2477358|NCT00928226|6075501|P3|Strata A: Small Tumor, Resected|Overall Study||6
2477359|NCT00928226|6075502|P2|Strata A: Small Tumor, Resected|Overall Study||6
2477360|NCT00928226|6075503|P1|Strata A: Small Tumor, Resected|Overall Study||6
2477361|NCT00928226|6075500|P4|STARTED|Overall Study||12
2477362|NCT00928226|6075501|P3|STARTED|Overall Study||12
2477363|NCT00928226|6075502|P2|STARTED|Overall Study||12
2477364|NCT00928226|6075503|P1|STARTED|Overall Study||20
2477365|NCT00928200|6075541|P1|NOT COMPLETED|Overall Study||0
2477366|NCT00928200|6075541|P1|COMPLETED|Overall Study||1
2477367|NCT00928200|6075541|P1|STARTED|Overall Study||1
2477368|NCT00928187|6075550|P3|NOT COMPLETED|Overall Study||5
2477369|NCT00928187|6075551|P2|NOT COMPLETED|Overall Study||6
2477370|NCT00928187|6075552|P1|NOT COMPLETED|Overall Study||2
2477371|NCT00928187|6075550|P3|COMPLETED|Overall Study||150
2477372|NCT00928187|6075551|P2|COMPLETED|Overall Study||141
2477373|NCT00928187|6075552|P1|COMPLETED|Overall Study||150
2477374|NCT00928187|6075550|P3|Analysed|Overall Study||154
2477375|NCT00928187|6075551|P2|Analysed|Overall Study||145
2477376|NCT00928187|6075552|P1|Analysed|Overall Study||152
2477377|NCT00928187|6075550|P3|STARTED|Overall Study||155
2477378|NCT00928187|6075551|P2|STARTED|Overall Study||147
2477379|NCT00928187|6075552|P1|STARTED|Overall Study||152
2477380|NCT00928174|6075596|P1|NOT COMPLETED|Overall Study||5
2477381|NCT00928174|6075596|P1|COMPLETED|Overall Study|3 withdrawn before start of participation|22
2477382|NCT00928174|6075596|P1|STARTED|Overall Study||27
2477383|NCT00928083|6075603|P9|NOT COMPLETED|Overall Study||0
2477384|NCT00928083|6075604|P8|NOT COMPLETED|Overall Study||0
2477385|NCT00928083|6075605|P7|NOT COMPLETED|Overall Study||0
2477386|NCT00928083|6075606|P6|NOT COMPLETED|Overall Study||0
2477387|NCT00928083|6075607|P5|NOT COMPLETED|Overall Study||1
2477388|NCT00928083|6075608|P4|NOT COMPLETED|Overall Study||1
2477389|NCT00928083|6075609|P3|NOT COMPLETED|Overall Study||0
2477390|NCT00928083|6075610|P2|NOT COMPLETED|Overall Study||0
2477391|NCT00928083|6075611|P1|NOT COMPLETED|Overall Study||4
2477392|NCT00928083|6075603|P9|COMPLETED|Overall Study||6
2477393|NCT00928083|6075604|P8|COMPLETED|Overall Study||6
2477394|NCT00928083|6075605|P7|COMPLETED|Overall Study||6
2477395|NCT00928083|6075606|P6|COMPLETED|Overall Study||6
2477396|NCT00928083|6075607|P5|COMPLETED|Overall Study||6
2477397|NCT00928083|6075608|P4|COMPLETED|Overall Study||5
2477398|NCT00928083|6075609|P3|COMPLETED|Overall Study||8
2477399|NCT00928083|6075610|P2|COMPLETED|Overall Study||8
2477400|NCT00928083|6075611|P1|COMPLETED|Overall Study||6
2477401|NCT00928083|6075603|P9|STARTED|Overall Study||6
2477402|NCT00928083|6075604|P8|STARTED|Overall Study||6
2477403|NCT00928083|6075605|P7|STARTED|Overall Study||6
2477404|NCT00928083|6075606|P6|STARTED|Overall Study||6
2477405|NCT00928083|6075607|P5|STARTED|Overall Study||7
2477406|NCT00928083|6075608|P4|STARTED|Overall Study||6
2477407|NCT00928083|6075609|P3|STARTED|Overall Study||8
2477408|NCT00928083|6075610|P2|STARTED|Overall Study||8
2477409|NCT00928083|6075611|P1|STARTED|Overall Study||10
2477410|NCT00928070|6075722|P2|NOT COMPLETED|Overall Study||57
2477411|NCT00928070|6075723|P1|NOT COMPLETED|Overall Study||63
2477412|NCT00928070|6075722|P2|COMPLETED|Overall Study||226
2477413|NCT00928070|6075723|P1|COMPLETED|Overall Study||220
2477414|NCT00928070|6075722|P2|Treated|Overall Study||281
2477415|NCT00928070|6075723|P1|Treated|Overall Study||281
2477416|NCT00928070|6075722|P2|STARTED|Overall Study||283
2477417|NCT00928070|6075723|P1|STARTED|Overall Study||283
2477418|NCT00928057|6075781|P2|NOT COMPLETED|Overall Study||4
2477419|NCT00928057|6075782|P1|NOT COMPLETED|Overall Study||2
2477420|NCT00928057|6075781|P2|COMPLETED|Overall Study||85
2477421|NCT00928057|6075782|P1|COMPLETED|Overall Study||82
2477422|NCT00928057|6075781|P2|STARTED|Overall Study||89
2477423|NCT00928057|6075782|P1|STARTED|Overall Study||84
2477424|NCT00928018|6075807|P2|NOT COMPLETED|Overall Study||0
2477425|NCT00928018|6075808|P1|NOT COMPLETED|Overall Study||1
2477426|NCT00928018|6075807|P2|COMPLETED|Overall Study||73
2477427|NCT00928018|6075808|P1|COMPLETED|Overall Study||65
2477428|NCT00928018|6075807|P2|STARTED|Overall Study||73
2477429|NCT00928018|6075808|P1|STARTED|Overall Study|One Arm A patient withdrew consent, treated as Arm B, but analyzed on Arm A based on intent-to-treat|66
2477430|NCT00927992|6075826|P1|NOT COMPLETED|Overall Study||0
2477431|NCT00927992|6075826|P1|COMPLETED|Overall Study||11
2477432|NCT00927992|6075826|P1|STARTED|Overall Study||11
2477433|NCT00927953|6075838|P2|NOT COMPLETED|Overall Study||1
2477434|NCT00927953|6075839|P1|NOT COMPLETED|Overall Study||2
2477435|NCT00927953|6075838|P2|COMPLETED|Overall Study||6
2477436|NCT00927953|6075839|P1|COMPLETED|Overall Study||4
2477437|NCT00927953|6075838|P2|STARTED|Overall Study||7
2477438|NCT00927953|6075839|P1|STARTED|Overall Study||6
2477439|NCT00927940|6075853|P1|NOT COMPLETED|Overall Study||1
2477440|NCT00927940|6075853|P1|COMPLETED|Overall Study|A patient died before 30 days follow up. This pasitent is excluded from primary analysis.|99
2477441|NCT00927940|6075853|P1|STARTED|Overall Study||100
2477442|NCT00927927|6075873|P15|NOT COMPLETED|Overall Study||0
2477443|NCT00927927|6075874|P14|NOT COMPLETED|Overall Study||0
2477444|NCT00927927|6075875|P13|NOT COMPLETED|Overall Study||0
2477445|NCT00927927|6075876|P12|NOT COMPLETED|Overall Study||2
2477446|NCT00927927|6075877|P11|NOT COMPLETED|Overall Study||0
2477447|NCT00927927|6075878|P10|NOT COMPLETED|Overall Study||0
2477448|NCT00927927|6075879|P9|NOT COMPLETED|Overall Study||0
2477449|NCT00927927|6075880|P8|NOT COMPLETED|Overall Study||2
2477450|NCT00927927|6075881|P7|NOT COMPLETED|Overall Study||0
2477451|NCT00927927|6075882|P6|NOT COMPLETED|Overall Study||0
2477452|NCT00927927|6075883|P5|NOT COMPLETED|Overall Study||0
2477453|NCT00927927|6075884|P4|NOT COMPLETED|Overall Study||0
2477454|NCT00927927|6075885|P3|NOT COMPLETED|Overall Study||0
2477455|NCT00927927|6075886|P2|NOT COMPLETED|Overall Study||0
2477456|NCT00927927|6075887|P1|NOT COMPLETED|Overall Study||0
2477457|NCT00927927|6075873|P15|COMPLETED|Overall Study||9
2477458|NCT00927927|6075874|P14|COMPLETED|Overall Study||5
2477459|NCT00927927|6075875|P13|COMPLETED|Overall Study||5
2477460|NCT00927927|6075876|P12|COMPLETED|Overall Study|One subject withdrew consent after being randomised but before receiving any trial product.|4
2477461|NCT00927927|6075877|P11|COMPLETED|Overall Study||5
2477462|NCT00927927|6075878|P10|COMPLETED|Overall Study||3
2477463|NCT00927927|6075879|P9|COMPLETED|Overall Study||8
2477464|NCT00927927|6075880|P8|COMPLETED|Overall Study||1
2477465|NCT00927927|6075881|P7|COMPLETED|Overall Study||3
2477466|NCT00927927|6075882|P6|COMPLETED|Overall Study||3
2477467|NCT00927927|6075883|P5|COMPLETED|Overall Study||3
2477468|NCT00927927|6075884|P4|COMPLETED|Overall Study||3
2477469|NCT00927927|6075885|P3|COMPLETED|Overall Study||3
2477470|NCT00927927|6075886|P2|COMPLETED|Overall Study||3
2477471|NCT00927927|6075887|P1|COMPLETED|Overall Study||3
2477472|NCT00927927|6075873|P15|Exposed|Overall Study||9
2477473|NCT00927927|6075874|P14|Exposed|Overall Study||5
2477474|NCT00927927|6075875|P13|Exposed|Overall Study||5
2477475|NCT00927927|6075876|P12|Exposed|Overall Study||5
2477476|NCT00927927|6075877|P11|Exposed|Overall Study||5
2477477|NCT00927927|6075878|P10|Exposed|Overall Study||3
2477478|NCT00927927|6075879|P9|Exposed|Overall Study||8
2477479|NCT00927927|6075880|P8|Exposed|Overall Study||3
2477480|NCT00927927|6075881|P7|Exposed|Overall Study||3
2477481|NCT00927927|6075882|P6|Exposed|Overall Study||3
2477482|NCT00927927|6075883|P5|Exposed|Overall Study||3
2477483|NCT00927927|6075884|P4|Exposed|Overall Study||3
2477484|NCT00927927|6075885|P3|Exposed|Overall Study||3
2477485|NCT00927927|6075886|P2|Exposed|Overall Study||3
2477486|NCT00927927|6075887|P1|Exposed|Overall Study||3
2477487|NCT00927927|6075873|P15|STARTED|Overall Study||9
2477488|NCT00927927|6075874|P14|STARTED|Overall Study||5
2477489|NCT00927927|6075875|P13|STARTED|Overall Study||5
2477490|NCT00927927|6075876|P12|STARTED|Overall Study||6
2477491|NCT00927927|6075877|P11|STARTED|Overall Study||5
2477492|NCT00927927|6075878|P10|STARTED|Overall Study||3
2477493|NCT00927927|6075879|P9|STARTED|Overall Study||8
2477494|NCT00927927|6075880|P8|STARTED|Overall Study||3
2477495|NCT00927927|6075881|P7|STARTED|Overall Study||3
2477496|NCT00927927|6075882|P6|STARTED|Overall Study||3
2477497|NCT00927927|6075883|P5|STARTED|Overall Study||3
2477498|NCT00927927|6075884|P4|STARTED|Overall Study||3
2477499|NCT00927927|6075885|P3|STARTED|Overall Study||3
2477500|NCT00927927|6075886|P2|STARTED|Overall Study||3
2477501|NCT00927927|6075887|P1|STARTED|Overall Study||3
2477502|NCT00927901|6075934|P4|NOT COMPLETED|Treatment Period 4||1
2477503|NCT00927901|6075935|P3|NOT COMPLETED|Treatment Period 4||1
2477504|NCT00927901|6075936|P2|NOT COMPLETED|Treatment Period 4||0
2477505|NCT00927901|6075937|P1|NOT COMPLETED|Treatment Period 4||0
2477506|NCT00927901|6075934|P4|COMPLETED|Treatment Period 4||8
2477507|NCT00927901|6075935|P3|COMPLETED|Treatment Period 4||5
2477508|NCT00927901|6075936|P2|COMPLETED|Treatment Period 4||7
2477509|NCT00927901|6075937|P1|COMPLETED|Treatment Period 4||7
2477510|NCT00927901|6075934|P4|STARTED|Treatment Period 4||9
2477511|NCT00927901|6075935|P3|STARTED|Treatment Period 4||6
2477512|NCT00927901|6075936|P2|STARTED|Treatment Period 4||7
2477513|NCT00927901|6075937|P1|STARTED|Treatment Period 4||7
2477514|NCT00927901|6075934|P4|NOT COMPLETED|Treatment Period 3||0
2477515|NCT00927901|6075935|P3|NOT COMPLETED|Treatment Period 3||0
2477516|NCT00927901|6075936|P2|NOT COMPLETED|Treatment Period 3||0
2477517|NCT00927901|6075937|P1|NOT COMPLETED|Treatment Period 3||0
2477518|NCT00927901|6075934|P4|COMPLETED|Treatment Period 3||9
2477519|NCT00927901|6075935|P3|COMPLETED|Treatment Period 3||6
2477520|NCT00927901|6075936|P2|COMPLETED|Treatment Period 3||7
2477521|NCT00927901|6075937|P1|COMPLETED|Treatment Period 3||7
2477522|NCT00927901|6075934|P4|STARTED|Treatment Period 3||9
2477523|NCT00927901|6075935|P3|STARTED|Treatment Period 3||6
2477524|NCT00927901|6075936|P2|STARTED|Treatment Period 3||7
2477525|NCT00927901|6075937|P1|STARTED|Treatment Period 3||7
2477526|NCT00927901|6075934|P4|NOT COMPLETED|Treatment Period 2||0
2477527|NCT00927901|6075935|P3|NOT COMPLETED|Treatment Period 2||0
2477528|NCT00927901|6075936|P2|NOT COMPLETED|Treatment Period 2||0
2477529|NCT00927901|6075937|P1|NOT COMPLETED|Treatment Period 2||0
2477530|NCT00927901|6075934|P4|COMPLETED|Treatment Period 2||9
2477531|NCT00927901|6075935|P3|COMPLETED|Treatment Period 2||6
2477532|NCT00927901|6075936|P2|COMPLETED|Treatment Period 2||7
2477533|NCT00927901|6075937|P1|COMPLETED|Treatment Period 2||7
2477534|NCT00927901|6075934|P4|STARTED|Treatment Period 2||9
2477535|NCT00927901|6075935|P3|STARTED|Treatment Period 2||6
2477536|NCT00927901|6075936|P2|STARTED|Treatment Period 2||7
2477537|NCT00927901|6075937|P1|STARTED|Treatment Period 2||7
2477538|NCT00927901|6075934|P4|NOT COMPLETED|Treatment Period 1||0
2477539|NCT00927901|6075935|P3|NOT COMPLETED|Treatment Period 1||1
2477540|NCT00927901|6075936|P2|NOT COMPLETED|Treatment Period 1||0
2477541|NCT00927901|6075937|P1|NOT COMPLETED|Treatment Period 1||0
2477542|NCT00927901|6075934|P4|COMPLETED|Treatment Period 1||9
2477543|NCT00927901|6075935|P3|COMPLETED|Treatment Period 1||6
2477544|NCT00927901|6075936|P2|COMPLETED|Treatment Period 1||7
2477545|NCT00927901|6075937|P1|COMPLETED|Treatment Period 1||7
2477546|NCT00927901|6075934|P4|STARTED|Treatment Period 1||9
2477547|NCT00927901|6075935|P3|STARTED|Treatment Period 1||7
2477548|NCT00927901|6075936|P2|STARTED|Treatment Period 1||7
2477549|NCT00927901|6075937|P1|STARTED|Treatment Period 1||7
2477550|NCT00927888|6075967|P2|NOT COMPLETED|Overall Study||0
2477551|NCT00927888|6075968|P1|NOT COMPLETED|Overall Study||0
2477552|NCT00927888|6075967|P2|COMPLETED|Overall Study||27
2477553|NCT00927888|6075968|P1|COMPLETED|Overall Study||29
2477554|NCT00927888|6075967|P2|STARTED|Overall Study||27
2477555|NCT00927888|6075968|P1|STARTED|Overall Study||29
2477556|NCT00927862|6075978|P2|NOT COMPLETED|Overall Study||45
2477557|NCT00927862|6075979|P1|NOT COMPLETED|Overall Study||27
2477558|NCT00927862|6075978|P2|COMPLETED|Overall Study||1866
2477559|NCT00927862|6075979|P1|COMPLETED|Overall Study|477 patients evaluated in primary analyses and 488 evaluated in secondary analyses.|477
2477560|NCT00927862|6075978|P2|STARTED|Overall Study||1911
2477561|NCT00927862|6075979|P1|STARTED|Overall Study||504
2477562|NCT00927849|6076004|P3|NOT COMPLETED|Overall Study||0
2477563|NCT00927849|6076005|P2|NOT COMPLETED|Overall Study||0
2477564|NCT00927849|6076006|P1|NOT COMPLETED|Overall Study||0
2477565|NCT00927849|6076004|P3|COMPLETED|Overall Study||21
2477566|NCT00927849|6076005|P2|COMPLETED|Overall Study||21
2477567|NCT00927849|6076006|P1|COMPLETED|Overall Study||21
2477568|NCT00927849|6076004|P3|STARTED|Overall Study||21
2477569|NCT00927849|6076005|P2|STARTED|Overall Study||21
2477570|NCT00927849|6076006|P1|STARTED|Overall Study||21
2477571|NCT00927823|6076014|P4|NOT COMPLETED|Continuous Dosing Period||5
2477572|NCT00927823|6076015|P3|NOT COMPLETED|Continuous Dosing Period||26
2477573|NCT00927823|6076016|P2|NOT COMPLETED|Continuous Dosing Period||3
2477574|NCT00927823|6076017|P1|NOT COMPLETED|Continuous Dosing Period||3
2477575|NCT00927823|6076014|P4|COMPLETED|Continuous Dosing Period||0
2477576|NCT00927823|6076015|P3|COMPLETED|Continuous Dosing Period||0
2477577|NCT00927823|6076016|P2|COMPLETED|Continuous Dosing Period||0
2477578|NCT00927823|6076017|P1|COMPLETED|Continuous Dosing Period||0
2477579|NCT00927823|6076014|P4|Treated|Continuous Dosing Period||5
2477580|NCT00927823|6076015|P3|Treated|Continuous Dosing Period||23
2477581|NCT00927823|6076016|P2|Treated|Continuous Dosing Period||3
2477582|NCT00927823|6076017|P1|Treated|Continuous Dosing Period||3
2477583|NCT00927823|6076014|P4|STARTED|Continuous Dosing Period||5
2477584|NCT00927823|6076015|P3|STARTED|Continuous Dosing Period||26
2477585|NCT00927823|6076016|P2|STARTED|Continuous Dosing Period||3
2477586|NCT00927823|6076017|P1|STARTED|Continuous Dosing Period||3
2477587|NCT00927823|6076014|P4|NOT COMPLETED|Lead-In Period||0
2477588|NCT00927823|6076015|P3|NOT COMPLETED|Lead-In Period||0
2477589|NCT00927823|6076016|P2|NOT COMPLETED|Lead-In Period||0
2477590|NCT00927823|6076017|P1|NOT COMPLETED|Lead-In Period||0
2477591|NCT00927823|6076014|P4|COMPLETED|Lead-In Period||5
2477592|NCT00927823|6076015|P3|COMPLETED|Lead-In Period||26
2477593|NCT00927823|6076016|P2|COMPLETED|Lead-In Period||3
2477594|NCT00927823|6076017|P1|COMPLETED|Lead-In Period||3
2477595|NCT00927823|6076014|P4|STARTED|Lead-In Period||5
2477596|NCT00927823|6076015|P3|STARTED|Lead-In Period||26
2477597|NCT00927823|6076016|P2|STARTED|Lead-In Period||3
2477598|NCT00927823|6076017|P1|STARTED|Lead-In Period||3
2477599|NCT00927784|6076083|P2|NOT COMPLETED|Overall Study||0
2477600|NCT00927784|6076084|P1|NOT COMPLETED|Overall Study||2
2477601|NCT00927784|6076083|P2|COMPLETED|Overall Study||2
2477602|NCT00927784|6076084|P1|COMPLETED|Overall Study||6
2477603|NCT00927784|6076083|P2|STARTED|Overall Study||2
2477604|NCT00927784|6076084|P1|STARTED|Overall Study||8
2477605|NCT00927758|6076114|P6|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
2477606|NCT00927758|6076115|P5|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
2477607|NCT00927758|6076116|P4|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
2477608|NCT00927758|6076117|P3|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
2477609|NCT00927758|6076118|P2|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
2477610|NCT00927758|6076119|P1|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
2477611|NCT00927758|6076114|P6|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||2
2477612|NCT00927758|6076115|P5|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
2477613|NCT00927758|6076116|P4|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||1
2477614|NCT00927758|6076117|P3|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
2477615|NCT00927758|6076118|P2|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
2477616|NCT00927758|6076119|P1|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
2477617|NCT00927758|6076114|P6|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||2
2477618|NCT00927758|6076115|P5|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
2477619|NCT00927758|6076116|P4|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||1
2477620|NCT00927758|6076117|P3|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
2477621|NCT00927758|6076118|P2|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
2477622|NCT00927758|6076119|P1|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
2477623|NCT00927758|6076114|P6|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
2477624|NCT00927758|6076115|P5|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
2477625|NCT00927758|6076116|P4|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
2477626|NCT00927758|6076117|P3|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
2477627|NCT00927758|6076118|P2|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
2477628|NCT00927758|6076119|P1|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
2477629|NCT00927758|6076114|P6|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||2
2477630|NCT00927758|6076115|P5|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
2477631|NCT00927758|6076116|P4|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
2477632|NCT00927758|6076117|P3|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
2477633|NCT00927758|6076118|P2|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
2477634|NCT00927758|6076119|P1|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
2477635|NCT00927758|6076114|P6|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||2
2477636|NCT00927758|6076115|P5|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
2477637|NCT00927758|6076116|P4|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||1
2477638|NCT00927758|6076117|P3|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
2477639|NCT00927758|6076118|P2|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
2477640|NCT00927758|6076119|P1|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
2477641|NCT00927758|6076114|P6|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
2477642|NCT00927758|6076115|P5|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
2477643|NCT00927758|6076116|P4|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||2
2477644|NCT00927758|6076117|P3|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
2477645|NCT00927758|6076118|P2|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
2477646|NCT00927758|6076119|P1|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
2477647|NCT00927758|6076114|P6|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
2477648|NCT00927758|6076115|P5|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
2477649|NCT00927758|6076116|P4|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
2477650|NCT00927758|6076117|P3|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
2477651|NCT00927758|6076118|P2|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
2477652|NCT00927758|6076119|P1|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
2477653|NCT00927758|6076114|P6|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
2477654|NCT00927758|6076115|P5|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
2477655|NCT00927758|6076116|P4|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||2
2477656|NCT00927758|6076117|P3|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
2477657|NCT00927758|6076118|P2|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
2477658|NCT00927758|6076119|P1|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
2477659|NCT00927758|6076114|P6|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
2477660|NCT00927758|6076115|P5|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
2477661|NCT00927758|6076116|P4|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||2
2477662|NCT00927758|6076117|P3|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
2477663|NCT00927758|6076118|P2|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
2477664|NCT00927758|6076119|P1|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
2477665|NCT00927758|6076114|P6|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
2477666|NCT00927758|6076115|P5|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
2477667|NCT00927758|6076116|P4|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
2477668|NCT00927758|6076117|P3|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
2477669|NCT00927758|6076118|P2|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
2477670|NCT00927758|6076119|P1|STARTED|Treatment Cycle 1 (Day 1 - Day 7)|"Started  indicates randomized as well as safety set."|4
2477671|NCT00927589|6076127|P1|NOT COMPLETED|Overall Study||16
2477672|NCT00927589|6076127|P1|COMPLETED|Overall Study|Participants were considered to have completed the study after receiving 3 cycles of treatment.|43
2477673|NCT00927589|6076127|P1|STARTED|Overall Study||59
2477674|NCT00927576|6076151|P2|NOT COMPLETED|Overall Study||0
2477675|NCT00927576|6076152|P1|NOT COMPLETED|Overall Study||0
2477676|NCT00927576|6076151|P2|COMPLETED|Overall Study||28
2477677|NCT00927576|6076152|P1|COMPLETED|Overall Study||237
2477678|NCT00927576|6076151|P2|Cognitive Testing|Overall Study||28
2477679|NCT00927576|6076152|P1|Cognitive Testing|Overall Study||237
2477680|NCT00927576|6076151|P2|STARTED|Overall Study||28
2477681|NCT00927576|6076152|P1|STARTED|Overall Study||237
2477682|NCT00927563|6076157|P1|NOT COMPLETED|Overall Study||2
2477683|NCT00927563|6076157|P1|COMPLETED|Overall Study||22
2477684|NCT00927563|6076157|P1|STARTED|Overall Study||24
2477685|NCT00927472|6076165|P2|NOT COMPLETED|Overall Study||22
2477686|NCT00927472|6076166|P1|NOT COMPLETED|Overall Study||11
2477687|NCT00927472|6076165|P2|COMPLETED|Overall Study||106
2477688|NCT00927472|6076166|P1|COMPLETED|Overall Study||115
2477689|NCT00927472|6076165|P2|STARTED|Overall Study||128
2477690|NCT00927472|6076166|P1|STARTED|Overall Study||126
2477691|NCT00927394|6076192|P2|NOT COMPLETED|Overall Study||85
2477692|NCT00927394|6076193|P1|NOT COMPLETED|Overall Study||77
2477693|NCT00927394|6076192|P2|COMPLETED|Overall Study||483
2477694|NCT00927394|6076193|P1|COMPLETED|Overall Study||498
2477695|NCT00927394|6076192|P2|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||562
2477696|NCT00927394|6076193|P1|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||574
2477697|NCT00927394|6076192|P2|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study||323
2477698|NCT00927394|6076193|P1|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study|consists of all patients in FAS 2 who had both valid baseline and post-baseline ABPM assessments.|342
2477699|NCT00927394|6076192|P2|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study||398
2477700|NCT00927394|6076193|P1|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study|FAS 2= all patients randomized to Cohort 2 and who had a valid baseline assessment of 24 hours ABPM.|417
2477701|NCT00927394|6076192|P2|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study||164
2477702|NCT00927394|6076193|P1|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study|FAS 1 includes all patients in Cohort 1 to whom study treatments were given through randomization.|157
2477703|NCT00927394|6076192|P2|Combined Safety Set (Cohort 1 and 2)|Overall Study||565
2477704|NCT00927394|6076193|P1|Combined Safety Set (Cohort 1 and 2)|Overall Study||574
2477705|NCT00927394|6076192|P2|Cohort 2 (Randomized)|Overall Study||403
2477706|NCT00927394|6076193|P1|Cohort 2 (Randomized)|Overall Study|Cohort 2 includes patients with specific eligibility criteria mentioned in protocol section|418
2477707|NCT00927394|6076192|P2|Cohort 1 (Randomized)|Overall Study||165
2477708|NCT00927394|6076193|P1|Cohort 1 (Randomized)|Overall Study|Cohort 1 includes patients with specific eligibility criteria mentioned in protocol section|157
2477709|NCT00927394|6076192|P2|STARTED|Overall Study|One patient was randomized in error and was discontinued by site.|568
2477710|NCT00927394|6076193|P1|STARTED|Overall Study||575
2477711|NCT00927368|6076224|P3|NOT COMPLETED|Overall Study||5
2477712|NCT00927368|6076225|P2|NOT COMPLETED|Overall Study||5
2477713|NCT00927368|6076226|P1|NOT COMPLETED|Overall Study||6
2477714|NCT00927368|6076224|P3|COMPLETED|Overall Study||138
2477715|NCT00927368|6076225|P2|COMPLETED|Overall Study||152
2477716|NCT00927368|6076226|P1|COMPLETED|Overall Study||147
2477717|NCT00927368|6076224|P3|STARTED|Overall Study||143
2477718|NCT00927368|6076225|P2|STARTED|Overall Study||157
2477719|NCT00927368|6076226|P1|STARTED|Overall Study||153
2477720|NCT00927355|6076245|P2|NOT COMPLETED|Overall Study||1
2477721|NCT00927355|6076246|P1|NOT COMPLETED|Overall Study||1
2477722|NCT00927355|6076245|P2|COMPLETED|Overall Study||4
2477723|NCT00927355|6076246|P1|COMPLETED|Overall Study||4
2477724|NCT00927355|6076245|P2|STARTED|Overall Study||5
2477725|NCT00927355|6076246|P1|STARTED|Overall Study||5
2477726|NCT00927264|6076266|P2|NOT COMPLETED|Overall Study||25
2477727|NCT00927264|6076267|P1|NOT COMPLETED|Overall Study||56
2477728|NCT00927264|6076266|P2|COMPLETED|Overall Study||140
2477729|NCT00927264|6076267|P1|COMPLETED|Overall Study||109
2477730|NCT00927264|6076266|P2|STARTED|Overall Study||165
2477731|NCT00927264|6076267|P1|STARTED|Overall Study||165
2477732|NCT00927251|6076281|P1|NOT COMPLETED|Overall Study||8
2477733|NCT00927251|6076281|P1|COMPLETED|Overall Study||82
2477734|NCT00927251|6076281|P1|STARTED|Overall Study||90
2477735|NCT00927186|6076287|P2|NOT COMPLETED|12 - 24 Months Extension Treatment||0
2477736|NCT00927186|6076288|P1|NOT COMPLETED|12 - 24 Months Extension Treatment||0
2477737|NCT00927186|6076287|P2|COMPLETED|12 - 24 Months Extension Treatment||11
2477738|NCT00927186|6076288|P1|COMPLETED|12 - 24 Months Extension Treatment||10
2477739|NCT00927186|6076287|P2|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|11
2477740|NCT00927186|6076288|P1|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|10
2477741|NCT00927186|6076287|P2|NOT COMPLETED|12 Months Primary Study||4
2477742|NCT00927186|6076288|P1|NOT COMPLETED|12 Months Primary Study||7
2477743|NCT00927186|6076287|P2|COMPLETED|12 Months Primary Study||31
2477744|NCT00927186|6076288|P1|COMPLETED|12 Months Primary Study||27
2477745|NCT00927186|6076287|P2|Completed 6 Months Double Blind Phase|12 Months Primary Study||31
2477746|NCT00927186|6076288|P1|Completed 6 Months Double Blind Phase|12 Months Primary Study||28
2477747|NCT00927186|6076287|P2|STARTED|12 Months Primary Study||35
2477748|NCT00927186|6076288|P1|STARTED|12 Months Primary Study||34
2477749|NCT00927160|6076406|P2|NOT COMPLETED|Overall Study||0
2477750|NCT00927160|6076407|P1|NOT COMPLETED|Overall Study||0
2477751|NCT00927160|6076406|P2|COMPLETED|Overall Study||173
2477752|NCT00927160|6076407|P1|COMPLETED|Overall Study||173
2477753|NCT00927160|6076406|P2|STARTED|Overall Study||173
2477754|NCT00927160|6076407|P1|STARTED|Overall Study||173
2477755|NCT00927095|6076418|P3|NOT COMPLETED|Overall Study||2
2477756|NCT00927095|6076419|P2|NOT COMPLETED|Overall Study||4
2477757|NCT00927095|6076420|P1|NOT COMPLETED|Overall Study||6
2477758|NCT00927095|6076418|P3|COMPLETED|Overall Study||22
2477759|NCT00927095|6076419|P2|COMPLETED|Overall Study||17
2477760|NCT00927095|6076420|P1|COMPLETED|Overall Study||16
2477761|NCT00927095|6076418|P3|STARTED|Overall Study||24
2477762|NCT00927095|6076419|P2|STARTED|Overall Study||21
2477763|NCT00927095|6076420|P1|STARTED|Overall Study||22
2477764|NCT00927082|6076432|P4|NOT COMPLETED|Overall Study||19
2477765|NCT00927082|6076433|P3|NOT COMPLETED|Overall Study||22
2477766|NCT00927082|6076434|P2|NOT COMPLETED|Overall Study||10
2477767|NCT00927082|6076435|P1|NOT COMPLETED|Overall Study||12
2477768|NCT00927082|6076432|P4|COMPLETED|Overall Study||78
2477769|NCT00927082|6076433|P3|COMPLETED|Overall Study||86
2477770|NCT00927082|6076434|P2|COMPLETED|Overall Study||77
2477771|NCT00927082|6076435|P1|COMPLETED|Overall Study||79
2477772|NCT00927082|6076432|P4|STARTED|Overall Study||97
2477773|NCT00927082|6076433|P3|STARTED|Overall Study||108
2477774|NCT00927082|6076434|P2|STARTED|Overall Study||87
2477775|NCT00927082|6076435|P1|STARTED|Overall Study||91
2477776|NCT00927069|6076499|P4|NOT COMPLETED|Week 12 to Week 24||3
2477777|NCT00927069|6076500|P3|NOT COMPLETED|Week 12 to Week 24||3
2477778|NCT00927069|6076501|P2|NOT COMPLETED|Week 12 to Week 24||0
2477779|NCT00927069|6076502|P1|NOT COMPLETED|Week 12 to Week 24||2
2477780|NCT00927069|6076499|P4|COMPLETED|Week 12 to Week 24||20
2477781|NCT00927069|6076500|P3|COMPLETED|Week 12 to Week 24||28
2477782|NCT00927069|6076501|P2|COMPLETED|Week 12 to Week 24||11
2477783|NCT00927069|6076502|P1|COMPLETED|Week 12 to Week 24||16
2477784|NCT00927069|6076499|P4|STARTED|Week 12 to Week 24|23 Pts. from Group B had a dose incr. since they did not respond to 40mg adalimumab every other week|23
2477785|NCT00927069|6076500|P3|STARTED|Week 12 to Week 24|31 Pts. from Group A had a dose incr. since they did not respond to 40mg adalimumab every other week|31
2477786|NCT00927069|6076501|P2|STARTED|Week 12 to Week 24|11 patients stayed at the same dose of 40 mg Adalimumab every other week|11
2477787|NCT00927069|6076502|P1|STARTED|Week 12 to Week 24|17 patients stayed at the same dose. One patient withdrew at Week 12 and also had no dose increase|18
2477788|NCT00927069|6076499|P4|NOT COMPLETED|Week 0 to Week 12||0
2477789|NCT00927069|6076500|P3|NOT COMPLETED|Week 0 to Week 12||0
2477790|NCT00927069|6076501|P2|NOT COMPLETED|Week 0 to Week 12||1
2477791|NCT00927069|6076502|P1|NOT COMPLETED|Week 0 to Week 12||1
2477792|NCT00927069|6076499|P4|COMPLETED|Week 0 to Week 12||0
2477793|NCT00927069|6076500|P3|COMPLETED|Week 0 to Week 12||0
2477794|NCT00927069|6076501|P2|COMPLETED|Week 0 to Week 12||34
2477795|NCT00927069|6076502|P1|COMPLETED|Week 0 to Week 12||49
2477796|NCT00927069|6076499|P4|STARTED|Week 0 to Week 12||0
2477797|NCT00927069|6076500|P3|STARTED|Week 0 to Week 12||0
2477798|NCT00927069|6076501|P2|STARTED|Week 0 to Week 12||35
2477799|NCT00927069|6076502|P1|STARTED|Week 0 to Week 12||50
2477800|NCT00926952|6076512|P1|NOT COMPLETED|Overall Study||0
2477801|NCT00926952|6076512|P1|COMPLETED|Overall Study||20
2477802|NCT00926952|6076512|P1|STARTED|Overall Study||20
2477803|NCT00926887|6076526|P2|NOT COMPLETED|Overall Study||0
2477804|NCT00926887|6076527|P1|NOT COMPLETED|Overall Study||0
2477805|NCT00926887|6076526|P2|COMPLETED|Overall Study||50
2477806|NCT00926887|6076527|P1|COMPLETED|Overall Study||54
2477807|NCT00926887|6076526|P2|STARTED|Overall Study||50
2477808|NCT00926887|6076527|P1|STARTED|Overall Study||54
2477809|NCT00926848|6076539|P2|NOT COMPLETED|Overall Study||0
2477810|NCT00926848|6076540|P1|NOT COMPLETED|Overall Study||0
2477811|NCT00926848|6076539|P2|COMPLETED|Overall Study||34
2477812|NCT00926848|6076540|P1|COMPLETED|Overall Study||34
2477813|NCT00926848|6076539|P2|STARTED|Overall Study||34
2477814|NCT00926848|6076540|P1|STARTED|Overall Study||34
2477815|NCT00926796|6076558|P2|NOT COMPLETED|Overall Study||106
2477816|NCT00926796|6076559|P1|NOT COMPLETED|Overall Study||107
2477817|NCT00926796|6076558|P2|COMPLETED|Overall Study|Number eligible and in the full analysis set|199
2477818|NCT00926796|6076559|P1|COMPLETED|Overall Study|Number eligible and in the full analysis set|202
2477819|NCT00926796|6076558|P2|STARTED|Overall Study|Number randomized|305
2477820|NCT00926796|6076559|P1|STARTED|Overall Study|Number randomized|309
2477821|NCT00926783|6076580|P2|NOT COMPLETED|Overall Study||3
2477822|NCT00926783|6076581|P1|NOT COMPLETED|Overall Study||3
2477823|NCT00926783|6076580|P2|COMPLETED|Overall Study||38
2477824|NCT00926783|6076581|P1|COMPLETED|Overall Study||39
2477825|NCT00926783|6076580|P2|STARTED|Overall Study||41
2477826|NCT00926783|6076581|P1|STARTED|Overall Study||42
2477827|NCT00926588|6076599|P2|NOT COMPLETED|Overall Study||4
2477828|NCT00926588|6076600|P1|NOT COMPLETED|Overall Study||8
2477829|NCT00926588|6076599|P2|COMPLETED|Overall Study||122
2477830|NCT00926588|6076600|P1|COMPLETED|Overall Study||116
2477831|NCT00926588|6076599|P2|STARTED|Overall Study||126
2477832|NCT00926588|6076600|P1|STARTED|Overall Study||124
2477833|NCT00926575|6076608|P2|NOT COMPLETED|Overall Study||17
2477834|NCT00926575|6076609|P1|NOT COMPLETED|Overall Study||16
2477835|NCT00926575|6076608|P2|COMPLETED|Overall Study||53
2477836|NCT00926575|6076609|P1|COMPLETED|Overall Study||54
2477837|NCT00926575|6076608|P2|STARTED|Overall Study||70
2477838|NCT00926575|6076609|P1|STARTED|Overall Study||70
2477839|NCT00926536|6076621|P2|NOT COMPLETED|Overall Study||2
2477840|NCT00926536|6076622|P1|NOT COMPLETED|Overall Study||1
2477841|NCT00926536|6076621|P2|COMPLETED|Overall Study||41
2477842|NCT00926536|6076622|P1|COMPLETED|Overall Study||43
2477843|NCT00926536|6076621|P2|STARTED|Overall Study||43
2477844|NCT00926536|6076622|P1|STARTED|Overall Study||44
2477845|NCT00926497|6076632|P2|NOT COMPLETED|Overall Study||0
2477846|NCT00926497|6076633|P1|NOT COMPLETED|Overall Study||0
2477847|NCT00926497|6076632|P2|COMPLETED|Overall Study||61
2477848|NCT00926497|6076633|P1|COMPLETED|Overall Study||60
2477849|NCT00926497|6076632|P2|STARTED|Overall Study||61
2477850|NCT00926497|6076633|P1|STARTED|Overall Study||60
2477851|NCT00926393|6076643|P2|NOT COMPLETED|Overall Study||3
2477852|NCT00926393|6076644|P1|NOT COMPLETED|Overall Study||2
2477853|NCT00926393|6076643|P2|COMPLETED|Overall Study||67
2477854|NCT00926393|6076644|P1|COMPLETED|Overall Study||67
2477855|NCT00926393|6076643|P2|STARTED|Overall Study||70
2477856|NCT00926393|6076644|P1|STARTED|Overall Study||69
2477857|NCT00926380|6076677|P3|NOT COMPLETED|Year 2||5
2477858|NCT00926380|6076678|P2|NOT COMPLETED|Year 2||2
2477859|NCT00926380|6076679|P1|NOT COMPLETED|Year 2||2
2477860|NCT00926380|6076677|P3|COMPLETED|Year 2||24
2477861|NCT00926380|6076678|P2|COMPLETED|Year 2||28
2477862|NCT00926380|6076679|P1|COMPLETED|Year 2||31
2477863|NCT00926380|6076677|P3|STARTED|Year 2||29
2477864|NCT00926380|6076678|P2|STARTED|Year 2||30
2477865|NCT00926380|6076679|P1|STARTED|Year 2||33
2477866|NCT00926380|6076677|P3|NOT COMPLETED|Year 1||1
2477867|NCT00926380|6076678|P2|NOT COMPLETED|Year 1||1
2477868|NCT00926380|6076679|P1|NOT COMPLETED|Year 1||0
2477869|NCT00926380|6076677|P3|COMPLETED|Year 1||29
2477870|NCT00926380|6076678|P2|COMPLETED|Year 1||30
2477871|NCT00926380|6076679|P1|COMPLETED|Year 1||33
2477872|NCT00926380|6076677|P3|STARTED|Year 1||30
2477873|NCT00926380|6076678|P2|STARTED|Year 1||31
2477874|NCT00926380|6076679|P1|STARTED|Year 1||33
2477875|NCT00926367|6076689|P2|NOT COMPLETED|Overall Study||3
2477876|NCT00926367|6076690|P1|NOT COMPLETED|Overall Study||2
2477877|NCT00926367|6076689|P2|COMPLETED|Overall Study||24
2477878|NCT00926367|6076690|P1|COMPLETED|Overall Study||23
2477879|NCT00926367|6076689|P2|STARTED|Overall Study||27
2477880|NCT00926367|6076690|P1|STARTED|Overall Study||25
2477881|NCT00926328|6076732|P2|NOT COMPLETED|Overall Study||14
2477882|NCT00926328|6076733|P1|NOT COMPLETED|Overall Study||12
2477883|NCT00926328|6076732|P2|COMPLETED|Overall Study||46
2477884|NCT00926328|6076733|P1|COMPLETED|Overall Study||48
2477885|NCT00926328|6076732|P2|STARTED|Overall Study||60
2477886|NCT00926328|6076733|P1|STARTED|Overall Study||60
2477887|NCT00926289|6076743|P2|NOT COMPLETED|Overall Study||36
2477888|NCT00926289|6076744|P1|NOT COMPLETED|Overall Study||25
2477889|NCT00926289|6076743|P2|COMPLETED|Overall Study||558
2477890|NCT00926289|6076744|P1|COMPLETED|Overall Study||269
2477891|NCT00926289|6076743|P2|STARTED|Overall Study|Number of treated patients|594
2477892|NCT00926289|6076744|P1|STARTED|Overall Study|Number of treated patients|294
2477893|NCT00926263|6076780|P2|NOT COMPLETED|Overall Study||0
2477894|NCT00926263|6076781|P1|NOT COMPLETED|Overall Study||0
2477895|NCT00926263|6076780|P2|COMPLETED|Overall Study||12
2477896|NCT00926263|6076781|P1|COMPLETED|Overall Study||16
2477897|NCT00926263|6076780|P2|STARTED|Overall Study||12
2477898|NCT00926263|6076781|P1|STARTED|Overall Study||16
2477899|NCT00926211|6076812|P1|NOT COMPLETED|Overall Study||1
2477900|NCT00926211|6076812|P1|COMPLETED|Overall Study||35
2477901|NCT00926211|6076812|P1|STARTED|Overall Study|One additional subject was not randomized and did not receive the treatment procedure.|36
2477902|NCT00926185|6076823|P4|NOT COMPLETED|Overall Study||10
2477903|NCT00926185|6076824|P3|NOT COMPLETED|Overall Study||10
2477904|NCT00926185|6076825|P2|NOT COMPLETED|Overall Study||6
2477905|NCT00926185|6076826|P1|NOT COMPLETED|Overall Study||3
2477906|NCT00926185|6076823|P4|COMPLETED|Overall Study||48
2477907|NCT00926185|6076824|P3|COMPLETED|Overall Study||48
2477908|NCT00926185|6076825|P2|COMPLETED|Overall Study||51
2477909|NCT00926185|6076826|P1|COMPLETED|Overall Study||54
2477910|NCT00926185|6076823|P4|STARTED|Overall Study||58
2477911|NCT00926185|6076824|P3|STARTED|Overall Study||58
2477912|NCT00926185|6076825|P2|STARTED|Overall Study||57
2477913|NCT00926185|6076826|P1|STARTED|Overall Study||57
2477914|NCT00926029|6076843|P3|NOT COMPLETED|Overall Study||1
2477915|NCT00926029|6076844|P2|NOT COMPLETED|Overall Study||1
2477916|NCT00926029|6076845|P1|NOT COMPLETED|Overall Study||2
2477917|NCT00926029|6076843|P3|COMPLETED|Overall Study||33
2477918|NCT00926029|6076844|P2|COMPLETED|Overall Study||33
2477919|NCT00926029|6076845|P1|COMPLETED|Overall Study||32
2477920|NCT00926029|6076843|P3|STARTED|Overall Study||34
2477921|NCT00926029|6076844|P2|STARTED|Overall Study||34
2477922|NCT00926029|6076845|P1|STARTED|Overall Study||34
2477923|NCT00926003|6076859|P3|NOT COMPLETED|Post-Training 3-month Follow-up||0
2477924|NCT00926003|6076860|P2|NOT COMPLETED|Post-Training 3-month Follow-up||0
2477925|NCT00926003|6076861|P1|NOT COMPLETED|Post-Training 3-month Follow-up||1
2477926|NCT00926003|6076859|P3|COMPLETED|Post-Training 3-month Follow-up||52
2477927|NCT00926003|6076860|P2|COMPLETED|Post-Training 3-month Follow-up||54
2477928|NCT00926003|6076861|P1|COMPLETED|Post-Training 3-month Follow-up||51
2477929|NCT00926003|6076859|P3|STARTED|Post-Training 3-month Follow-up||52
2477930|NCT00926003|6076860|P2|STARTED|Post-Training 3-month Follow-up||54
2477931|NCT00926003|6076861|P1|STARTED|Post-Training 3-month Follow-up||52
2477932|NCT00926003|6076859|P3|NOT COMPLETED|Post-Training Evaluation||0
2477933|NCT00926003|6076860|P2|NOT COMPLETED|Post-Training Evaluation||0
2477934|NCT00926003|6076861|P1|NOT COMPLETED|Post-Training Evaluation||1
2477935|NCT00926003|6076859|P3|COMPLETED|Post-Training Evaluation||52
2477936|NCT00926003|6076860|P2|COMPLETED|Post-Training Evaluation||54
2477937|NCT00926003|6076861|P1|COMPLETED|Post-Training Evaluation||52
2477938|NCT00926003|6076859|P3|STARTED|Post-Training Evaluation||52
2477939|NCT00926003|6076860|P2|STARTED|Post-Training Evaluation||54
2477940|NCT00926003|6076861|P1|STARTED|Post-Training Evaluation||53
2477941|NCT00926003|6076859|P3|NOT COMPLETED|Baseline||0
2477942|NCT00926003|6076860|P2|NOT COMPLETED|Baseline||0
2477943|NCT00926003|6076861|P1|NOT COMPLETED|Baseline||0
2477944|NCT00926003|6076859|P3|COMPLETED|Baseline||52
2477945|NCT00926003|6076860|P2|COMPLETED|Baseline||54
2477946|NCT00926003|6076861|P1|COMPLETED|Baseline||53
2477947|NCT00926003|6076859|P3|STARTED|Baseline||52
2477948|NCT00926003|6076860|P2|STARTED|Baseline||54
2477949|NCT00926003|6076861|P1|STARTED|Baseline||53
2477950|NCT00925990|6076874|P2|NOT COMPLETED|Overall Study||11
2477951|NCT00925990|6076875|P1|NOT COMPLETED|Overall Study||5
2477952|NCT00925990|6076874|P2|COMPLETED|Overall Study||24
2477953|NCT00925990|6076875|P1|COMPLETED|Overall Study||30
2477954|NCT00925990|6076874|P2|STARTED|Overall Study||35
2477955|NCT00925990|6076875|P1|STARTED|Overall Study||35
2477956|NCT00925938|6076886|P3|NOT COMPLETED|Overall Study||0
2477957|NCT00925938|6076887|P2|NOT COMPLETED|Overall Study||0
2477958|NCT00925938|6076888|P1|NOT COMPLETED|Overall Study||0
2477959|NCT00925938|6076886|P3|COMPLETED|Overall Study||17
2477960|NCT00925938|6076887|P2|COMPLETED|Overall Study||25
2477961|NCT00925938|6076888|P1|COMPLETED|Overall Study||9
2477962|NCT00925938|6076886|P3|STARTED|Overall Study||17
2477963|NCT00925938|6076887|P2|STARTED|Overall Study||25
2477964|NCT00925938|6076888|P1|STARTED|Overall Study||9
2477965|NCT00925899|6076910|P2|NOT COMPLETED|Part 2||12
2477966|NCT00925899|6076911|P1|NOT COMPLETED|Part 2||6
2477967|NCT00925899|6076910|P2|COMPLETED|Part 2||9
2477968|NCT00925899|6076911|P1|COMPLETED|Part 2||9
2477969|NCT00925899|6076910|P2|STARTED|Part 2|Nine patients withdrew because they did not wish to continue in the study|21
2477970|NCT00925899|6076911|P1|STARTED|Part 2|All patients received the same intervention in the second part of the study (20 mg melatonin)|15
2477971|NCT00925899|6076910|P2|NOT COMPLETED|Part 1||11
2477972|NCT00925899|6076911|P1|NOT COMPLETED|Part 1||11
2477973|NCT00925899|6076910|P2|COMPLETED|Part 1||27
2477974|NCT00925899|6076911|P1|COMPLETED|Part 1||23
2477975|NCT00925899|6076910|P2|STARTED|Part 1||38
2477976|NCT00925899|6076911|P1|STARTED|Part 1||34
2477977|NCT00925782|6076929|P2|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
2477978|NCT00925782|6076930|P1|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
2477979|NCT00925782|6076929|P2|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
2477980|NCT00925782|6076930|P1|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
2477981|NCT00925782|6076929|P2|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
2477982|NCT00925782|6076930|P1|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
2477983|NCT00925782|6076929|P2|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
2477984|NCT00925782|6076930|P1|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
2477985|NCT00925782|6076929|P2|COMPLETED|Study Period (Day -3 to Day 0)||12
2477986|NCT00925782|6076930|P1|COMPLETED|Study Period (Day -3 to Day 0)||12
2477987|NCT00925782|6076929|P2|STARTED|Study Period (Day -3 to Day 0)||12
2477988|NCT00925782|6076930|P1|STARTED|Study Period (Day -3 to Day 0)||12
2477989|NCT00925782|6076929|P2|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
2477990|NCT00925782|6076930|P1|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
2477991|NCT00925782|6076929|P2|COMPLETED|Pretreatment (Day -30 to Day -3)||12
2477992|NCT00925782|6076930|P1|COMPLETED|Pretreatment (Day -30 to Day -3)||12
2477993|NCT00925782|6076929|P2|STARTED|Pretreatment (Day -30 to Day -3)||12
2477994|NCT00925782|6076930|P1|STARTED|Pretreatment (Day -30 to Day -3)||12
2477995|NCT00925769|6076939|P6|NOT COMPLETED|Overall Study||3
2477996|NCT00925769|6076940|P5|NOT COMPLETED|Overall Study||3
2477997|NCT00925769|6076941|P4|NOT COMPLETED|Overall Study||6
2477998|NCT00925769|6076942|P3|NOT COMPLETED|Overall Study||6
2477999|NCT00925769|6076943|P2|NOT COMPLETED|Overall Study||6
2478000|NCT00925769|6076944|P1|NOT COMPLETED|Overall Study||6
2478001|NCT00925769|6076939|P6|COMPLETED|Overall Study||0
2478002|NCT00925769|6076940|P5|COMPLETED|Overall Study||0
2478003|NCT00925769|6076941|P4|COMPLETED|Overall Study||0
2478004|NCT00925769|6076942|P3|COMPLETED|Overall Study||0
2478005|NCT00925769|6076943|P2|COMPLETED|Overall Study||0
2478006|NCT00925769|6076944|P1|COMPLETED|Overall Study||0
2478007|NCT00925769|6076939|P6|STARTED|Overall Study||3
2478008|NCT00925769|6076940|P5|STARTED|Overall Study||3
2478009|NCT00925769|6076941|P4|STARTED|Overall Study||6
2478010|NCT00925769|6076942|P3|STARTED|Overall Study||6
2478011|NCT00925769|6076943|P2|STARTED|Overall Study||6
2478012|NCT00925769|6076944|P1|STARTED|Overall Study||6
2478013|NCT00925704|6077012|P6|NOT COMPLETED|Third Intervention||1
2478014|NCT00925704|6077013|P5|NOT COMPLETED|Third Intervention||0
2478015|NCT00925704|6077014|P4|NOT COMPLETED|Third Intervention||0
2478016|NCT00925704|6077015|P3|NOT COMPLETED|Third Intervention||0
2478017|NCT00925704|6077016|P2|NOT COMPLETED|Third Intervention||0
2478018|NCT00925704|6077017|P1|NOT COMPLETED|Third Intervention||0
2478019|NCT00925704|6077012|P6|COMPLETED|Third Intervention||6
2478020|NCT00925704|6077013|P5|COMPLETED|Third Intervention||5
2478021|NCT00925704|6077014|P4|COMPLETED|Third Intervention||6
2478022|NCT00925704|6077015|P3|COMPLETED|Third Intervention||7
2478023|NCT00925704|6077016|P2|COMPLETED|Third Intervention||7
2478024|NCT00925704|6077017|P1|COMPLETED|Third Intervention||5
2478025|NCT00925704|6077012|P6|STARTED|Third Intervention||7
2478026|NCT00925704|6077013|P5|STARTED|Third Intervention||5
2478027|NCT00925704|6077014|P4|STARTED|Third Intervention||6
2478028|NCT00925704|6077015|P3|STARTED|Third Intervention||7
2478029|NCT00925704|6077016|P2|STARTED|Third Intervention||7
2478030|NCT00925704|6077017|P1|STARTED|Third Intervention||5
2478031|NCT00925704|6077012|P6|NOT COMPLETED|Washout||0
2478032|NCT00925704|6077013|P5|NOT COMPLETED|Washout||0
2478033|NCT00925704|6077014|P4|NOT COMPLETED|Washout||0
2478034|NCT00925704|6077015|P3|NOT COMPLETED|Washout||0
2478035|NCT00925704|6077016|P2|NOT COMPLETED|Washout||0
2478036|NCT00925704|6077017|P1|NOT COMPLETED|Washout||0
2478037|NCT00925704|6077012|P6|COMPLETED|Washout||7
2478038|NCT00925704|6077013|P5|COMPLETED|Washout||5
2478039|NCT00925704|6077014|P4|COMPLETED|Washout||6
2478040|NCT00925704|6077015|P3|COMPLETED|Washout||7
2478041|NCT00925704|6077016|P2|COMPLETED|Washout||7
2478042|NCT00925704|6077017|P1|COMPLETED|Washout||5
2478043|NCT00925704|6077012|P6|STARTED|Washout||7
2478044|NCT00925704|6077013|P5|STARTED|Washout||5
2478045|NCT00925704|6077014|P4|STARTED|Washout||6
2478046|NCT00925704|6077015|P3|STARTED|Washout||7
2478047|NCT00925704|6077016|P2|STARTED|Washout||7
2478048|NCT00925704|6077017|P1|STARTED|Washout||5
2478049|NCT00925704|6077012|P6|NOT COMPLETED|Second Intervention||0
2478050|NCT00925704|6077013|P5|NOT COMPLETED|Second Intervention||1
2478051|NCT00925704|6077014|P4|NOT COMPLETED|Second Intervention||0
2478052|NCT00925704|6077015|P3|NOT COMPLETED|Second Intervention||0
2478053|NCT00925704|6077016|P2|NOT COMPLETED|Second Intervention||0
2478054|NCT00925704|6077017|P1|NOT COMPLETED|Second Intervention||1
2478055|NCT00925704|6077012|P6|COMPLETED|Second Intervention||7
2478056|NCT00925704|6077013|P5|COMPLETED|Second Intervention||5
2478057|NCT00925704|6077014|P4|COMPLETED|Second Intervention||6
2478058|NCT00925704|6077015|P3|COMPLETED|Second Intervention||7
2478059|NCT00925704|6077016|P2|COMPLETED|Second Intervention||7
2478060|NCT00925704|6077017|P1|COMPLETED|Second Intervention||5
2478061|NCT00925704|6077012|P6|STARTED|Second Intervention||7
2478062|NCT00925704|6077013|P5|STARTED|Second Intervention||6
2478063|NCT00925704|6077014|P4|STARTED|Second Intervention||6
2478064|NCT00925704|6077015|P3|STARTED|Second Intervention||7
2478065|NCT00925704|6077016|P2|STARTED|Second Intervention||7
2478066|NCT00925704|6077017|P1|STARTED|Second Intervention||6
2478067|NCT00925704|6077012|P6|NOT COMPLETED|Washout||0
2478068|NCT00925704|6077013|P5|NOT COMPLETED|Washout||0
2478069|NCT00925704|6077014|P4|NOT COMPLETED|Washout||0
2478070|NCT00925704|6077015|P3|NOT COMPLETED|Washout||0
2478071|NCT00925704|6077016|P2|NOT COMPLETED|Washout||0
2478072|NCT00925704|6077017|P1|NOT COMPLETED|Washout||0
2478073|NCT00925704|6077012|P6|COMPLETED|Washout||7
2478074|NCT00925704|6077013|P5|COMPLETED|Washout||6
2478075|NCT00925704|6077014|P4|COMPLETED|Washout||6
2478076|NCT00925704|6077015|P3|COMPLETED|Washout||7
2478077|NCT00925704|6077016|P2|COMPLETED|Washout||7
2478078|NCT00925704|6077017|P1|COMPLETED|Washout||6
2478079|NCT00925704|6077012|P6|STARTED|Washout||7
2478080|NCT00925704|6077013|P5|STARTED|Washout||6
2478081|NCT00925704|6077014|P4|STARTED|Washout||6
2478082|NCT00925704|6077015|P3|STARTED|Washout||7
2478083|NCT00925704|6077016|P2|STARTED|Washout||7
2478084|NCT00925704|6077017|P1|STARTED|Washout||6
2478085|NCT00925704|6077012|P6|NOT COMPLETED|First Intervention||0
2478086|NCT00925704|6077013|P5|NOT COMPLETED|First Intervention||1
2478087|NCT00925704|6077014|P4|NOT COMPLETED|First Intervention||1
2478088|NCT00925704|6077015|P3|NOT COMPLETED|First Intervention||0
2478089|NCT00925704|6077016|P2|NOT COMPLETED|First Intervention||0
2478090|NCT00925704|6077017|P1|NOT COMPLETED|First Intervention||0
2478091|NCT00925704|6077012|P6|COMPLETED|First Intervention||7
2478092|NCT00925704|6077013|P5|COMPLETED|First Intervention||6
2478093|NCT00925704|6077014|P4|COMPLETED|First Intervention||6
2478094|NCT00925704|6077015|P3|COMPLETED|First Intervention||7
2478095|NCT00925704|6077016|P2|COMPLETED|First Intervention||7
2478096|NCT00925704|6077017|P1|COMPLETED|First Intervention||6
2478097|NCT00925704|6077012|P6|STARTED|First Intervention||7
2478098|NCT00925704|6077013|P5|STARTED|First Intervention||7
2478099|NCT00925704|6077014|P4|STARTED|First Intervention||7
2478100|NCT00925704|6077015|P3|STARTED|First Intervention||7
2478101|NCT00925704|6077016|P2|STARTED|First Intervention||7
2478102|NCT00925704|6077017|P1|STARTED|First Intervention||6
2478103|NCT00925600|6077030|P2|NOT COMPLETED|Overall Study||28
2478104|NCT00925600|6077031|P1|NOT COMPLETED|Overall Study||32
2478105|NCT00925600|6077030|P2|COMPLETED|Overall Study||355
2478106|NCT00925600|6077031|P1|COMPLETED|Overall Study||354
2478107|NCT00925600|6077030|P2|Received Treatment|Overall Study||382
2478108|NCT00925600|6077031|P1|Received Treatment|Overall Study|Three participants received at least 1 dose of denosumab in error|383
2478109|NCT00925600|6077030|P2|STARTED|Overall Study||383
2478110|NCT00925600|6077031|P1|STARTED|Overall Study||386
2478111|NCT00925587|6077053|P2|NOT COMPLETED|Overall Study||25
2478112|NCT00925587|6077054|P1|NOT COMPLETED|Overall Study||36
2478113|NCT00925587|6077053|P2|COMPLETED|Overall Study||155
2478114|NCT00925587|6077054|P1|COMPLETED|Overall Study||142
2478115|NCT00925587|6077053|P2|STARTED|Overall Study||180
2478116|NCT00925587|6077054|P1|STARTED|Overall Study||178
2478117|NCT00925548|6077168|P2|NOT COMPLETED|Overall Study||5
2478118|NCT00925548|6077169|P1|NOT COMPLETED|Overall Study||10
2478119|NCT00925548|6077168|P2|COMPLETED|Overall Study||0
2478120|NCT00925548|6077169|P1|COMPLETED|Overall Study||1
2478121|NCT00925548|6077168|P2|STARTED|Overall Study||5
2478122|NCT00925548|6077169|P1|STARTED|Overall Study||11
2478123|NCT00925522|6077195|P1|NOT COMPLETED|Overall Study||20
2478124|NCT00925522|6077195|P1|COMPLETED|Overall Study||0
2478125|NCT00925522|6077195|P1|STARTED|Overall Study||20
2478126|NCT00925353|6077199|P1|NOT COMPLETED|Overall Study||3
2478127|NCT00925353|6077199|P1|COMPLETED|Overall Study||10
2478128|NCT00925353|6077199|P1|STARTED|Overall Study||13
2478129|NCT00925301|6077205|P4|NOT COMPLETED|12-Month Open-label Extension (Optional)||3
2478130|NCT00925301|6077206|P3|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
2478131|NCT00925301|6077207|P2|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
2478132|NCT00925301|6077208|P1|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
2478133|NCT00925301|6077205|P4|COMPLETED|12-Month Open-label Extension (Optional)||54
2478134|NCT00925301|6077206|P3|COMPLETED|12-Month Open-label Extension (Optional)||0
2478135|NCT00925301|6077207|P2|COMPLETED|12-Month Open-label Extension (Optional)||0
2478136|NCT00925301|6077208|P1|COMPLETED|12-Month Open-label Extension (Optional)||0
2478137|NCT00925301|6077205|P4|ITT-amenable|12-Month Open-label Extension (Optional)||42
2478138|NCT00925301|6077206|P3|ITT-amenable|12-Month Open-label Extension (Optional)||0
2478139|NCT00925301|6077207|P2|ITT-amenable|12-Month Open-label Extension (Optional)||0
2478140|NCT00925301|6077208|P1|ITT-amenable|12-Month Open-label Extension (Optional)||0
2478141|NCT00925301|6077205|P4|STARTED|12-Month Open-label Extension (Optional)|The OLE was optional for those who completed Stage 2. Reasons for not entering were not recorded.|57
2478142|NCT00925301|6077206|P3|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 2.|0
2478143|NCT00925301|6077207|P2|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 1.|0
2478144|NCT00925301|6077208|P1|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 1.|0
2478145|NCT00925301|6077205|P4|NOT COMPLETED|6-Month Open-label (Stage 2)||0
2478146|NCT00925301|6077206|P3|NOT COMPLETED|6-Month Open-label (Stage 2)||3
2478147|NCT00925301|6077207|P2|NOT COMPLETED|6-Month Open-label (Stage 2)||0
2478148|NCT00925301|6077208|P1|NOT COMPLETED|6-Month Open-label (Stage 2)||0
2478149|NCT00925301|6077205|P4|COMPLETED|6-Month Open-label (Stage 2)||0
2478150|NCT00925301|6077206|P3|COMPLETED|6-Month Open-label (Stage 2)||60
2478151|NCT00925301|6077207|P2|COMPLETED|6-Month Open-label (Stage 2)||0
2478152|NCT00925301|6077208|P1|COMPLETED|6-Month Open-label (Stage 2)||0
2478153|NCT00925301|6077205|P4|ITT-amenable|6-Month Open-label (Stage 2)||0
2478154|NCT00925301|6077206|P3|ITT-amenable|6-Month Open-label (Stage 2)||47
2478155|NCT00925301|6077207|P2|ITT-amenable|6-Month Open-label (Stage 2)||0
2478156|NCT00925301|6077208|P1|ITT-amenable|6-Month Open-label (Stage 2)||0
2478157|NCT00925301|6077205|P4|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants did not start the OLE yet.|0
2478158|NCT00925301|6077206|P3|STARTED|6-Month Open-label (Stage 2)|One participant (Migalastat [0-6 Months]) withdrew consent after completing Month 6.|63
2478159|NCT00925301|6077207|P2|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants had completed Stage 1.|0
2478160|NCT00925301|6077208|P1|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants had completed Stage 1.|0
2478161|NCT00925301|6077205|P4|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
2478162|NCT00925301|6077206|P3|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
2478163|NCT00925301|6077207|P2|NOT COMPLETED|6-Month Double-blind (Stage 1)||3
2478164|NCT00925301|6077208|P1|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
2478165|NCT00925301|6077205|P4|COMPLETED|6-Month Double-blind (Stage 1)||0
2478166|NCT00925301|6077206|P3|COMPLETED|6-Month Double-blind (Stage 1)||0
2478167|NCT00925301|6077207|P2|COMPLETED|6-Month Double-blind (Stage 1)||30
2478168|NCT00925301|6077208|P1|COMPLETED|6-Month Double-blind (Stage 1)||34
2478169|NCT00925301|6077205|P4|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||0
2478170|NCT00925301|6077206|P3|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||0
2478171|NCT00925301|6077207|P2|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||30
2478172|NCT00925301|6077208|P1|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||30
2478173|NCT00925301|6077205|P4|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||0
2478174|NCT00925301|6077206|P3|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||0
2478175|NCT00925301|6077207|P2|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||33
2478176|NCT00925301|6077208|P1|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||34
2478177|NCT00925301|6077205|P4|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||0
2478178|NCT00925301|6077206|P3|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||0
2478179|NCT00925301|6077207|P2|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||33
2478180|NCT00925301|6077208|P1|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||34
2478181|NCT00925301|6077205|P4|STARTED|6-Month Double-blind (Stage 1)|Zero participants noted because participants did not start the OLE yet.|0
2478182|NCT00925301|6077206|P3|STARTED|6-Month Double-blind (Stage 1)|Zero participants noted because participants did not start Stage 2 yet.|0
2478183|NCT00925301|6077207|P2|STARTED|6-Month Double-blind (Stage 1)||33
2478184|NCT00925301|6077208|P1|STARTED|6-Month Double-blind (Stage 1)||34
2478185|NCT00925288|6077224|P2|NOT COMPLETED|Overall Study||7
2478186|NCT00925288|6077225|P1|NOT COMPLETED|Overall Study||9
2478187|NCT00925288|6077224|P2|COMPLETED|Overall Study||93
2478188|NCT00925288|6077225|P1|COMPLETED|Overall Study||91
2478189|NCT00925288|6077224|P2|STARTED|Overall Study||100
2478190|NCT00925288|6077225|P1|STARTED|Overall Study||100
2478191|NCT00925132|6077237|P5|NOT COMPLETED|Overall Study||5
2478192|NCT00925132|6077238|P4|NOT COMPLETED|Overall Study||0
2478193|NCT00925132|6077239|P3|NOT COMPLETED|Overall Study||0
2478194|NCT00925132|6077240|P2|NOT COMPLETED|Overall Study||0
2478195|NCT00925132|6077241|P1|NOT COMPLETED|Overall Study||2
2478196|NCT00925132|6077237|P5|COMPLETED|Overall Study||17
2478197|NCT00925132|6077238|P4|COMPLETED|Overall Study||4
2478198|NCT00925132|6077239|P3|COMPLETED|Overall Study||4
2478199|NCT00925132|6077240|P2|COMPLETED|Overall Study||4
2478200|NCT00925132|6077241|P1|COMPLETED|Overall Study||3
2478201|NCT00925132|6077237|P5|STARTED|Overall Study||22
2478202|NCT00925132|6077238|P4|STARTED|Overall Study||4
2478203|NCT00925132|6077239|P3|STARTED|Overall Study||4
2478204|NCT00925132|6077240|P2|STARTED|Overall Study||4
2478205|NCT00925132|6077241|P1|STARTED|Overall Study||5
2478206|NCT00925119|6077247|P1|NOT COMPLETED|Overall Study||12
2478207|NCT00925119|6077247|P1|COMPLETED|Overall Study||19
2478208|NCT00925119|6077247|P1|STARTED|Overall Study||31
2478209|NCT00925054|6077262|P5|NOT COMPLETED|Overall Study||0
2478210|NCT00925054|6077263|P4|NOT COMPLETED|Overall Study||1
2478211|NCT00925054|6077264|P3|NOT COMPLETED|Overall Study||1
2478212|NCT00925054|6077265|P2|NOT COMPLETED|Overall Study||1
2478213|NCT00925054|6077266|P1|NOT COMPLETED|Overall Study||0
2478214|NCT00925054|6077262|P5|COMPLETED|Overall Study||10
2478215|NCT00925054|6077263|P4|COMPLETED|Overall Study||0
2478216|NCT00925054|6077264|P3|COMPLETED|Overall Study||12
2478217|NCT00925054|6077265|P2|COMPLETED|Overall Study||8
2478218|NCT00925054|6077266|P1|COMPLETED|Overall Study||7
2478219|NCT00925054|6077262|P5|STARTED|Overall Study||10
2478220|NCT00925054|6077263|P4|STARTED|Overall Study||1
2478221|NCT00925054|6077264|P3|STARTED|Overall Study||13
2478222|NCT00925054|6077265|P2|STARTED|Overall Study||9
2478223|NCT00925054|6077266|P1|STARTED|Overall Study||7
2478224|NCT00925015|6077336|P3|NOT COMPLETED|Overall Study||6
2478225|NCT00925015|6077337|P2|NOT COMPLETED|Overall Study||6
2478226|NCT00925015|6077338|P1|NOT COMPLETED|Overall Study||8
2478227|NCT00925015|6077336|P3|COMPLETED|Overall Study||0
2478228|NCT00925015|6077337|P2|COMPLETED|Overall Study||0
2478229|NCT00925015|6077338|P1|COMPLETED|Overall Study||0
2478230|NCT00925015|6077336|P3|STARTED|Overall Study||6
2478231|NCT00925015|6077337|P2|STARTED|Overall Study||6
2478232|NCT00925015|6077338|P1|STARTED|Overall Study||8
2478233|NCT00924950|6077394|P1|NOT COMPLETED|Overall Study||2
2478234|NCT00924950|6077394|P1|COMPLETED|Overall Study||28
2478235|NCT00924950|6077394|P1|STARTED|Overall Study||30
2478236|NCT00924898|6077401|P1|NOT COMPLETED|Overall Study||2
2478237|NCT00924898|6077401|P1|COMPLETED|Overall Study||90
2478238|NCT00924898|6077401|P1|STARTED|Overall Study||92
2478239|NCT00924833|6077413|P3|NOT COMPLETED|Overall Study||0
2478240|NCT00924833|6077414|P2|NOT COMPLETED|Overall Study||0
2478241|NCT00924833|6077415|P1|NOT COMPLETED|Overall Study||0
2478242|NCT00924833|6077413|P3|COMPLETED|Overall Study|1 subject was excluded from the analysis for medical problems unrelated to the study.|9
2478243|NCT00924833|6077414|P2|COMPLETED|Overall Study|1 subject was excluded from the analysis for incomplete data.|9
2478244|NCT00924833|6077415|P1|COMPLETED|Overall Study|7 subjects analyzed (2 were excluded for poor cardiopulmonary exercise stress test quality).|9
2478245|NCT00924833|6077413|P3|STARTED|Overall Study||9
2478246|NCT00924833|6077414|P2|STARTED|Overall Study||9
2478247|NCT00924833|6077415|P1|STARTED|Overall Study||9
2478248|NCT00924807|6077429|P1|NOT COMPLETED|Overall Study||0
2478249|NCT00924807|6077429|P1|COMPLETED|Overall Study||4
2478250|NCT00924807|6077429|P1|STARTED|Overall Study||4
2478251|NCT00924781|6077438|P2|NOT COMPLETED|Overall Study||10
2478252|NCT00924781|6077439|P1|NOT COMPLETED|Overall Study||12
2478253|NCT00924781|6077438|P2|COMPLETED|Overall Study||9
2478254|NCT00924781|6077439|P1|COMPLETED|Overall Study||8
2478255|NCT00924781|6077438|P2|STARTED|Overall Study||19
2478256|NCT00924781|6077439|P1|STARTED|Overall Study||20
2478257|NCT00924729|6077473|P2|NOT COMPLETED|Overall Study||0
2478258|NCT00924729|6077474|P1|NOT COMPLETED|Overall Study||2
2478259|NCT00924729|6077473|P2|COMPLETED|Overall Study||25
2478260|NCT00924729|6077474|P1|COMPLETED|Overall Study||23
2478261|NCT00924729|6077473|P2|STARTED|Overall Study||25
2478262|NCT00924729|6077474|P1|STARTED|Overall Study||25
2478263|NCT00924651|6077484|P2|NOT COMPLETED|Overall Study||25
2478264|NCT00924651|6077485|P1|NOT COMPLETED|Overall Study||25
2478265|NCT00924651|6077484|P2|COMPLETED|Overall Study||312
2478266|NCT00924651|6077485|P1|COMPLETED|Overall Study||331
2478267|NCT00924651|6077484|P2|STARTED|Overall Study||337
2478268|NCT00924651|6077485|P1|STARTED|Overall Study||356
2478269|NCT00924638|6077493|P2|NOT COMPLETED|Overall Study||13
2478270|NCT00924638|6077494|P1|NOT COMPLETED|Overall Study||12
2478271|NCT00924638|6077493|P2|COMPLETED|Overall Study|Completed 6 months of follow-up|207
2478272|NCT00924638|6077494|P1|COMPLETED|Overall Study|Completed 6 months of follow-up|209
2478273|NCT00924638|6077493|P2|STARTED|Overall Study|Randomized to Control Arm|220
2478274|NCT00924638|6077494|P1|STARTED|Overall Study|Randomized to Continuous Monitoring Arm|221
2478275|NCT00924560|6077516|P3|NOT COMPLETED|Overall Study||83
2478276|NCT00924560|6077517|P2|NOT COMPLETED|Overall Study||208
2478277|NCT00924560|6077518|P1|NOT COMPLETED|Overall Study||211
2478278|NCT00924560|6077516|P3|COMPLETED|Overall Study||372
2478279|NCT00924560|6077517|P2|COMPLETED|Overall Study||240
2478280|NCT00924560|6077518|P1|COMPLETED|Overall Study||247
2478281|NCT00924560|6077516|P3|Received Treatment|Overall Study||0
2478282|NCT00924560|6077517|P2|Received Treatment|Overall Study|Excludes 9 participants from one site that was closed due to audit findings.|411
2478283|NCT00924560|6077518|P1|Received Treatment|Overall Study|Excludes 7 participants at 1 site that was closed. One participant received 28-day OC in error.|422
2478284|NCT00924560|6077516|P3|STARTED|Overall Study||455
2478285|NCT00924560|6077517|P2|STARTED|Overall Study||448
2478286|NCT00924560|6077518|P1|STARTED|Overall Study||458
2478287|NCT00924508|6077562|P1|NOT COMPLETED|Overall Study||3
2478288|NCT00924508|6077562|P1|COMPLETED|Overall Study||20
2478289|NCT00924508|6077562|P1|STARTED|Overall Study||23
2478290|NCT00924482|6077569|P1|NOT COMPLETED|Overall Study||0
2478291|NCT00924482|6077569|P1|COMPLETED|Overall Study||261
2478292|NCT00924482|6077569|P1|STARTED|Overall Study||261
2478293|NCT00924469|6077576|P2|NOT COMPLETED|Overall Study||2
2478294|NCT00924469|6077577|P1|NOT COMPLETED|Overall Study||2
2478295|NCT00924469|6077576|P2|COMPLETED|Overall Study||26
2478296|NCT00924469|6077577|P1|COMPLETED|Overall Study||28
2478297|NCT00924469|6077576|P2|STARTED|Overall Study||28
2478298|NCT00924469|6077577|P1|STARTED|Overall Study||30
2478299|NCT00924443|6077599|P1|NOT COMPLETED|Overall Study||3
2478300|NCT00924443|6077599|P1|COMPLETED|Overall Study||66
2478301|NCT00924443|6077599|P1|Full Analysis Set (Received Study Drug)|Overall Study||66
2478302|NCT00924443|6077599|P1|STARTED|Overall Study||69
2478303|NCT00924404|6077609|P2|NOT COMPLETED|Overall Study||4
2478304|NCT00924404|6077610|P1|NOT COMPLETED|Overall Study||6
2478305|NCT00924404|6077609|P2|COMPLETED|Overall Study||22
2478306|NCT00924404|6077610|P1|COMPLETED|Overall Study||21
2478307|NCT00924404|6077609|P2|STARTED|Overall Study||26
2478308|NCT00924404|6077610|P1|STARTED|Overall Study||27
2478309|NCT00924352|6077618|P2|NOT COMPLETED|Overall Study||0
2478310|NCT00924352|6077619|P1|NOT COMPLETED|Overall Study||0
2478311|NCT00924352|6077618|P2|COMPLETED|Overall Study||44
2478312|NCT00924352|6077619|P1|COMPLETED|Overall Study||12
2478313|NCT00924352|6077618|P2|STARTED|Overall Study||44
2478314|NCT00924352|6077619|P1|STARTED|Overall Study||12
2478315|NCT00924326|6077641|P9|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
2478316|NCT00924326|6077642|P8|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
2478317|NCT00924326|6077643|P7|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
2478318|NCT00924326|6077644|P6|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
2478319|NCT00924326|6077645|P5|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
2478320|NCT00924326|6077646|P4|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
2478321|NCT00924326|6077647|P3|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
2478322|NCT00924326|6077648|P2|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
2478323|NCT00924326|6077649|P1|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
2478324|NCT00924326|6077641|P9|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
2478325|NCT00924326|6077642|P8|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
2478326|NCT00924326|6077643|P7|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
2478327|NCT00924326|6077644|P6|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
2478328|NCT00924326|6077645|P5|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
2478329|NCT00924326|6077646|P4|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
2478330|NCT00924326|6077647|P3|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
2478331|NCT00924326|6077648|P2|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
2478332|NCT00924326|6077649|P1|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||3
2478333|NCT00924326|6077641|P9|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
2478334|NCT00924326|6077642|P8|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
2478335|NCT00924326|6077643|P7|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
2478336|NCT00924326|6077644|P6|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
2478337|NCT00924326|6077645|P5|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
2478338|NCT00924326|6077646|P4|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
2478339|NCT00924326|6077647|P3|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
2478340|NCT00924326|6077648|P2|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
2478341|NCT00924326|6077649|P1|STARTED|1x10^9-1x10^10 + High Dose Retreat||3
2478342|NCT00924326|6077641|P9|NOT COMPLETED|Dose Administration||0
2478343|NCT00924326|6077642|P8|NOT COMPLETED|Dose Administration||0
2478344|NCT00924326|6077643|P7|NOT COMPLETED|Dose Administration||0
2478345|NCT00924326|6077644|P6|NOT COMPLETED|Dose Administration||0
2478346|NCT00924326|6077645|P5|NOT COMPLETED|Dose Administration||0
2478347|NCT00924326|6077646|P4|NOT COMPLETED|Dose Administration||0
2478348|NCT00924326|6077647|P3|NOT COMPLETED|Dose Administration||0
2478349|NCT00924326|6077648|P2|NOT COMPLETED|Dose Administration||0
2478350|NCT00924326|6077649|P1|NOT COMPLETED|Dose Administration||0
2478351|NCT00924326|6077641|P9|COMPLETED|Dose Administration||2
2478352|NCT00924326|6077642|P8|COMPLETED|Dose Administration||2
2478353|NCT00924326|6077643|P7|COMPLETED|Dose Administration||1
2478354|NCT00924326|6077644|P6|COMPLETED|Dose Administration||10
2478355|NCT00924326|6077645|P5|COMPLETED|Dose Administration||7
2478356|NCT00924326|6077646|P4|COMPLETED|Dose Administration||6
2478357|NCT00924326|6077647|P3|COMPLETED|Dose Administration||5
2478358|NCT00924326|6077648|P2|COMPLETED|Dose Administration||2
2478359|NCT00924326|6077649|P1|COMPLETED|Dose Administration||8
2478360|NCT00924326|6077641|P9|STARTED|Dose Administration||2
2478361|NCT00924326|6077642|P8|STARTED|Dose Administration||2
2478362|NCT00924326|6077643|P7|STARTED|Dose Administration||1
2478363|NCT00924326|6077644|P6|STARTED|Dose Administration||10
2478364|NCT00924326|6077645|P5|STARTED|Dose Administration||7
2478365|NCT00924326|6077646|P4|STARTED|Dose Administration||6
2478366|NCT00924326|6077647|P3|STARTED|Dose Administration||5
2478367|NCT00924326|6077648|P2|STARTED|Dose Administration||2
2478368|NCT00924326|6077649|P1|STARTED|Dose Administration||8
2478369|NCT00924313|6077681|P1|NOT COMPLETED|Overall Study||1
2478370|NCT00924313|6077681|P1|COMPLETED|Overall Study||39
2478371|NCT00924313|6077681|P1|STARTED|Overall Study||40
2478372|NCT00924287|6077693|P1|NOT COMPLETED|Overall Study||1
2478373|NCT00924287|6077693|P1|COMPLETED|Overall Study||0
2478374|NCT00924287|6077693|P1|STARTED|Overall Study||1
2478375|NCT00924209|6077699|P1|NOT COMPLETED|Overall Study||0
2478376|NCT00924209|6077699|P1|COMPLETED|Overall Study||7
2478377|NCT00924209|6077699|P1|STARTED|Overall Study||7
2478378|NCT00924170|6077709|P2|NOT COMPLETED|Overall Study||8
2478379|NCT00924170|6077710|P1|NOT COMPLETED|Overall Study||7
2478380|NCT00924170|6077709|P2|COMPLETED|Overall Study||0
2478381|NCT00924170|6077710|P1|COMPLETED|Overall Study||3
2478382|NCT00924170|6077709|P2|STARTED|Overall Study||8
2478383|NCT00924170|6077710|P1|STARTED|Overall Study||10
2478384|NCT00924118|6077750|P2|NOT COMPLETED|Overall Study||0
2478385|NCT00924118|6077751|P1|NOT COMPLETED|Overall Study||0
2478386|NCT00924118|6077750|P2|COMPLETED|Overall Study||15
2478387|NCT00924118|6077751|P1|COMPLETED|Overall Study||15
2478388|NCT00924118|6077750|P2|STARTED|Overall Study||15
2478389|NCT00924118|6077751|P1|STARTED|Overall Study||15
2478390|NCT00924066|6077759|P1|NOT COMPLETED|Overall Study||0
2478391|NCT00924066|6077759|P1|COMPLETED|Overall Study||41
2478392|NCT00924066|6077759|P1|STARTED|Overall Study||41
2478393|NCT00924053|6077768|P4|NOT COMPLETED|Overall Study||0
2478394|NCT00924053|6077769|P3|NOT COMPLETED|Overall Study||0
2478395|NCT00924053|6077770|P2|NOT COMPLETED|Overall Study||0
2478396|NCT00924053|6077771|P1|NOT COMPLETED|Overall Study||0
2478397|NCT00924053|6077768|P4|COMPLETED|Overall Study||6
2478398|NCT00924053|6077769|P3|COMPLETED|Overall Study||6
2478399|NCT00924053|6077770|P2|COMPLETED|Overall Study||6
2478400|NCT00924053|6077771|P1|COMPLETED|Overall Study||6
2478401|NCT00924053|6077768|P4|STARTED|Overall Study||6
2478402|NCT00924053|6077769|P3|STARTED|Overall Study||6
2478403|NCT00924053|6077770|P2|STARTED|Overall Study||6
2478404|NCT00924053|6077771|P1|STARTED|Overall Study||6
2478405|NCT00924040|6077817|P1|NOT COMPLETED|Overall Study||0
2478406|NCT00924040|6077817|P1|COMPLETED|Overall Study||1
2478407|NCT00924040|6077817|P1|STARTED|Overall Study||1
2478408|NCT00924001|6077829|P1|NOT COMPLETED|Overall Study||0
2478409|NCT00924001|6077829|P1|COMPLETED|Overall Study||1
2478410|NCT00924001|6077829|P1|STARTED|Overall Study||1
2478411|NCT00923975|6077835|P1|NOT COMPLETED|Overall Study||1
2478412|NCT00923975|6077835|P1|COMPLETED|Overall Study|One subject did not meet inclusion criteria; the data was not used in analysis.|50
2478413|NCT00923975|6077835|P1|STARTED|Overall Study||51
2478414|NCT00923949|6077842|P1|NOT COMPLETED|Overall Study||0
2478415|NCT00923949|6077842|P1|COMPLETED|Overall Study||1
2478416|NCT00923949|6077842|P1|STARTED|Overall Study||1
2478417|NCT00923936|6077854|P2|NOT COMPLETED|Overall Study||3
2478418|NCT00923936|6077855|P1|NOT COMPLETED|Overall Study||8
2478419|NCT00923936|6077854|P2|COMPLETED|Overall Study||3
2478420|NCT00923936|6077855|P1|COMPLETED|Overall Study||2
2478421|NCT00923936|6077854|P2|STARTED|Overall Study||6
2478422|NCT00923936|6077855|P1|STARTED|Overall Study||10
2478423|NCT00923910|6077871|P2|NOT COMPLETED|Period 2||0
2478424|NCT00923910|6077872|P1|NOT COMPLETED|Period 2||0
2478425|NCT00923910|6077871|P2|COMPLETED|Period 2||5
2478426|NCT00923910|6077872|P1|COMPLETED|Period 2||5
2478427|NCT00923910|6077871|P2|STARTED|Period 2||5
2478428|NCT00923910|6077872|P1|STARTED|Period 2||5
2478429|NCT00923910|6077871|P2|NOT COMPLETED|Period 1||0
2478430|NCT00923910|6077872|P1|NOT COMPLETED|Period 1||0
2478431|NCT00923910|6077871|P2|COMPLETED|Period 1||5
2478432|NCT00923910|6077872|P1|COMPLETED|Period 1||5
2478433|NCT00923910|6077871|P2|STARTED|Period 1||5
2478434|NCT00923910|6077872|P1|STARTED|Period 1||5
2478435|NCT00923845|6077884|P2|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
2478436|NCT00923845|6077885|P1|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
2478437|NCT00923845|6077884|P2|COMPLETED|Allogeneic Stem Cell Therapy||10
2478438|NCT00923845|6077885|P1|COMPLETED|Allogeneic Stem Cell Therapy||0
2478439|NCT00923845|6077884|P2|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||6
2478440|NCT00923845|6077885|P1|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||0
2478441|NCT00923845|6077884|P2|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||8
2478442|NCT00923845|6077885|P1|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||0
2478443|NCT00923845|6077884|P2|STARTED|Allogeneic Stem Cell Therapy||10
2478444|NCT00923845|6077885|P1|STARTED|Allogeneic Stem Cell Therapy||0
2478445|NCT00923845|6077884|P2|NOT COMPLETED|Induction Therapy||2
2478446|NCT00923845|6077885|P1|NOT COMPLETED|Induction Therapy||0
2478447|NCT00923845|6077884|P2|COMPLETED|Induction Therapy||10
2478448|NCT00923845|6077885|P1|COMPLETED|Induction Therapy||0
2478449|NCT00923845|6077884|P2|STARTED|Induction Therapy||12
2478450|NCT00923845|6077885|P1|STARTED|Induction Therapy||0
2478451|NCT00923845|6077884|P2|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
2478452|NCT00923845|6077885|P1|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
2478453|NCT00923845|6077884|P2|COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
2478454|NCT00923845|6077885|P1|COMPLETED|Donor Hematopoietic Stem Cell Harvest||13
2478455|NCT00923845|6077884|P2|STARTED|Donor Hematopoietic Stem Cell Harvest||0
2478456|NCT00923845|6077885|P1|STARTED|Donor Hematopoietic Stem Cell Harvest||13
2478457|NCT00923845|6077884|P2|NOT COMPLETED|Donor Lymphocyte Harvest||0
2478458|NCT00923845|6077885|P1|NOT COMPLETED|Donor Lymphocyte Harvest||0
2478459|NCT00923845|6077884|P2|COMPLETED|Donor Lymphocyte Harvest||0
2478460|NCT00923845|6077885|P1|COMPLETED|Donor Lymphocyte Harvest||13
2478461|NCT00923845|6077884|P2|STARTED|Donor Lymphocyte Harvest||0
2478462|NCT00923845|6077885|P1|STARTED|Donor Lymphocyte Harvest||13
2478463|NCT00923598|6077908|P2|NOT COMPLETED|Overall Study||5
2478464|NCT00923598|6077909|P1|NOT COMPLETED|Overall Study||4
2478465|NCT00923598|6077908|P2|COMPLETED|Overall Study||17
2478466|NCT00923598|6077909|P1|COMPLETED|Overall Study||19
2478467|NCT00923598|6077908|P2|STARTED|Overall Study||22
2478468|NCT00923598|6077909|P1|STARTED|Overall Study||23
2478469|NCT00923481|6077915|P1|NOT COMPLETED|Overall Study||0
2478470|NCT00923481|6077915|P1|COMPLETED|Overall Study||37
2478471|NCT00923481|6077915|P1|STARTED|Overall Study||37
2478472|NCT00923364|6077920|P2|NOT COMPLETED|Overall Study||0
2478473|NCT00923364|6077921|P1|NOT COMPLETED|Overall Study||4
2478474|NCT00923364|6077920|P2|COMPLETED|Overall Study||5
2478475|NCT00923364|6077921|P1|COMPLETED|Overall Study||10
2478476|NCT00923364|6077920|P2|STARTED|Overall Study||5
2478477|NCT00923364|6077921|P1|STARTED|Overall Study||14
2478478|NCT00923351|6077933|P3|NOT COMPLETED|Overall Study||12
2478479|NCT00923351|6077934|P2|NOT COMPLETED|Overall Study||0
2478480|NCT00923351|6077935|P1|NOT COMPLETED|Overall Study||0
2478481|NCT00923351|6077933|P3|COMPLETED|Overall Study||0
2478482|NCT00923351|6077934|P2|COMPLETED|Overall Study||26
2478483|NCT00923351|6077935|P1|COMPLETED|Overall Study||6
2478484|NCT00923351|6077933|P3|STARTED|Overall Study||12
2478485|NCT00923351|6077934|P2|STARTED|Overall Study||26
2478486|NCT00923351|6077935|P1|STARTED|Overall Study||6
2478487|NCT00923273|6077950|P5|NOT COMPLETED|Phase II Treatment Period||0
2478488|NCT00923273|6077951|P4|NOT COMPLETED|Phase II Treatment Period||7
2478489|NCT00923273|6077952|P3|NOT COMPLETED|Phase II Treatment Period||0
2478490|NCT00923273|6077953|P2|NOT COMPLETED|Phase II Treatment Period||0
2478491|NCT00923273|6077954|P1|NOT COMPLETED|Phase II Treatment Period||0
2478492|NCT00923273|6077950|P5|COMPLETED|Phase II Treatment Period||0
2478493|NCT00923273|6077951|P4|COMPLETED|Phase II Treatment Period||20
2478494|NCT00923273|6077952|P3|COMPLETED|Phase II Treatment Period||0
2478495|NCT00923273|6077953|P2|COMPLETED|Phase II Treatment Period||0
2478496|NCT00923273|6077954|P1|COMPLETED|Phase II Treatment Period||0
2478497|NCT00923273|6077950|P5|STARTED|Phase II Treatment Period||0
2478498|NCT00923273|6077951|P4|STARTED|Phase II Treatment Period|Includes 8 subjects with prior peme;12 subjects who were peme naive; 7 subjects rolled over from phI|27
2478499|NCT00923273|6077952|P3|STARTED|Phase II Treatment Period||0
2478500|NCT00923273|6077953|P2|STARTED|Phase II Treatment Period||0
2478501|NCT00923273|6077954|P1|STARTED|Phase II Treatment Period|The phase II portion will utilize the MTD from the phase I portion.|0
2478502|NCT00923273|6077950|P5|NOT COMPLETED|Phase I Treatment Period||0
2478503|NCT00923273|6077951|P4|NOT COMPLETED|Phase I Treatment Period||0
2478504|NCT00923273|6077952|P3|NOT COMPLETED|Phase I Treatment Period||0
2478505|NCT00923273|6077953|P2|NOT COMPLETED|Phase I Treatment Period||0
2478506|NCT00923273|6077954|P1|NOT COMPLETED|Phase I Treatment Period||0
2478507|NCT00923273|6077950|P5|COMPLETED|Phase I Treatment Period||5
2478508|NCT00923273|6077951|P4|COMPLETED|Phase I Treatment Period||7
2478509|NCT00923273|6077952|P3|COMPLETED|Phase I Treatment Period||3
2478510|NCT00923273|6077953|P2|COMPLETED|Phase I Treatment Period||3
2478511|NCT00923273|6077954|P1|COMPLETED|Phase I Treatment Period||4
2478512|NCT00923273|6077950|P5|STARTED|Phase I Treatment Period|5 subjects peme naive.|5
2478513|NCT00923273|6077951|P4|STARTED|Phase I Treatment Period|3 subjects initially enrolled and 4 subjects added after dose level 5; peme naive.|7
2478514|NCT00923273|6077952|P3|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
2478515|NCT00923273|6077953|P2|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
2478516|NCT00923273|6077954|P1|STARTED|Phase I Treatment Period|The phase I portion will establish the maximum tolerated dose. 4 subjects peme naive.|4
2478517|NCT00923260|6077979|P2|NOT COMPLETED|Overall Study||1
2478518|NCT00923260|6077980|P1|NOT COMPLETED|Overall Study||1
2478519|NCT00923260|6077979|P2|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
2478520|NCT00923260|6077980|P1|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
2478521|NCT00923260|6077979|P2|STARTED|Overall Study||12
2478522|NCT00923260|6077980|P1|STARTED|Overall Study||12
2478523|NCT00923247|6078114|P2|NOT COMPLETED|Overall Study||0
2478524|NCT00923247|6078115|P1|NOT COMPLETED|Overall Study||0
2478525|NCT00923247|6078114|P2|COMPLETED|Overall Study||1
2478526|NCT00923247|6078115|P1|COMPLETED|Overall Study||21
2478527|NCT00923247|6078114|P2|STARTED|Overall Study||1
2478528|NCT00923247|6078115|P1|STARTED|Overall Study||21
2478529|NCT00923195|6078143|P2|NOT COMPLETED|Overall Study||1
2478530|NCT00923195|6078144|P1|NOT COMPLETED|Overall Study||0
2478531|NCT00923195|6078143|P2|COMPLETED|Overall Study||1
2478532|NCT00923195|6078144|P1|COMPLETED|Overall Study||2
2478533|NCT00923195|6078143|P2|STARTED|Overall Study||2
2478534|NCT00923195|6078144|P1|STARTED|Overall Study||2
2478535|NCT00923156|6078155|P3|NOT COMPLETED|Overall Study||3
2478536|NCT00923156|6078156|P2|NOT COMPLETED|Overall Study||4
2478537|NCT00923156|6078157|P1|NOT COMPLETED|Overall Study||0
2478538|NCT00923156|6078155|P3|COMPLETED|Overall Study||38
2478539|NCT00923156|6078156|P2|COMPLETED|Overall Study||38
2478540|NCT00923156|6078157|P1|COMPLETED|Overall Study||40
2478541|NCT00923156|6078155|P3|STARTED|Overall Study||41
2478542|NCT00923156|6078156|P2|STARTED|Overall Study||42
2478543|NCT00923156|6078157|P1|STARTED|Overall Study|"Started indicates randomized, safety and pharmacodynamic population"|40
2478544|NCT00923130|6078183|P1|NOT COMPLETED|Overall Study||25
2478545|NCT00923130|6078183|P1|COMPLETED|Overall Study||5
2478546|NCT00923130|6078183|P1|STARTED|Overall Study||30
2478547|NCT00923117|6078201|P2|NOT COMPLETED|Overall Study||0
2478548|NCT00923117|6078202|P1|NOT COMPLETED|Overall Study||0
2478549|NCT00923117|6078201|P2|COMPLETED|Overall Study||43
2478550|NCT00923117|6078202|P1|COMPLETED|Overall Study||44
2478551|NCT00923117|6078201|P2|STARTED|Overall Study||43
2478552|NCT00923117|6078202|P1|STARTED|Overall Study||44
2478553|NCT00923091|6078218|P13|NOT COMPLETED|Period VI (Open-Label)||0
2478554|NCT00923091|6078219|P12|NOT COMPLETED|Period VI (Open-Label)||0
2478555|NCT00923091|6078220|P11|NOT COMPLETED|Period VI (Open-Label)||0
2478556|NCT00923091|6078221|P10|NOT COMPLETED|Period VI (Open-Label)||0
2478557|NCT00923091|6078222|P9|NOT COMPLETED|Period VI (Open-Label)||0
2478558|NCT00923091|6078223|P8|NOT COMPLETED|Period VI (Open-Label)||0
2478559|NCT00923091|6078224|P7|NOT COMPLETED|Period VI (Open-Label)||0
2478560|NCT00923091|6078225|P6|NOT COMPLETED|Period VI (Open-Label)||0
2478561|NCT00923091|6078226|P5|NOT COMPLETED|Period VI (Open-Label)||7
2478562|NCT00923091|6078227|P4|NOT COMPLETED|Period VI (Open-Label)||3
2478563|NCT00923091|6078228|P3|NOT COMPLETED|Period VI (Open-Label)||13
2478564|NCT00923091|6078229|P2|NOT COMPLETED|Period VI (Open-Label)||8
2478565|NCT00923091|6078230|P1|NOT COMPLETED|Period VI (Open-Label)||39
2478566|NCT00923091|6078218|P13|COMPLETED|Period VI (Open-Label)||0
2478567|NCT00923091|6078219|P12|COMPLETED|Period VI (Open-Label)||0
2478568|NCT00923091|6078220|P11|COMPLETED|Period VI (Open-Label)||0
2478569|NCT00923091|6078221|P10|COMPLETED|Period VI (Open-Label)||0
2478570|NCT00923091|6078222|P9|COMPLETED|Period VI (Open-Label)||0
2478571|NCT00923091|6078223|P8|COMPLETED|Period VI (Open-Label)||0
2478572|NCT00923091|6078224|P7|COMPLETED|Period VI (Open-Label)||0
2478573|NCT00923091|6078225|P6|COMPLETED|Period VI (Open-Label)||0
2478574|NCT00923091|6078226|P5|COMPLETED|Period VI (Open-Label)||157
2478575|NCT00923091|6078227|P4|COMPLETED|Period VI (Open-Label)||143
2478576|NCT00923091|6078228|P3|COMPLETED|Period VI (Open-Label)||467
2478577|NCT00923091|6078229|P2|COMPLETED|Period VI (Open-Label)||264
2478578|NCT00923091|6078230|P1|COMPLETED|Period VI (Open-Label)||1408
2478579|NCT00923091|6078218|P13|STARTED|Period VI (Open-Label)||0
2478580|NCT00923091|6078219|P12|STARTED|Period VI (Open-Label)||0
2478581|NCT00923091|6078220|P11|STARTED|Period VI (Open-Label)||0
2478582|NCT00923091|6078221|P10|STARTED|Period VI (Open-Label)||0
2478583|NCT00923091|6078222|P9|STARTED|Period VI (Open-Label)||0
2478584|NCT00923091|6078223|P8|STARTED|Period VI (Open-Label)||0
2478585|NCT00923091|6078224|P7|STARTED|Period VI (Open-Label)||0
2478586|NCT00923091|6078225|P6|STARTED|Period VI (Open-Label)||0
2478587|NCT00923091|6078226|P5|STARTED|Period VI (Open-Label)||164
2478588|NCT00923091|6078227|P4|STARTED|Period VI (Open-Label)||146
2478589|NCT00923091|6078228|P3|STARTED|Period VI (Open-Label)||480
2478590|NCT00923091|6078229|P2|STARTED|Period VI (Open-Label)||272
2478591|NCT00923091|6078230|P1|STARTED|Period VI (Open-Label)|1837 from Period III+2 from Period IV + 670 from Period 5 = 2509|1447
2478592|NCT00923091|6078218|P13|NOT COMPLETED|Period V (Double -Blind)||2
2478593|NCT00923091|6078219|P12|NOT COMPLETED|Period V (Double -Blind)||0
2478594|NCT00923091|6078220|P11|NOT COMPLETED|Period V (Double -Blind)||1
2478595|NCT00923091|6078221|P10|NOT COMPLETED|Period V (Double -Blind)||0
2478596|NCT00923091|6078222|P9|NOT COMPLETED|Period V (Double -Blind)||1
2478597|NCT00923091|6078223|P8|NOT COMPLETED|Period V (Double -Blind)||0
2478598|NCT00923091|6078224|P7|NOT COMPLETED|Period V (Double -Blind)||0
2478599|NCT00923091|6078225|P6|NOT COMPLETED|Period V (Double -Blind)||0
2478600|NCT00923091|6078226|P5|NOT COMPLETED|Period V (Double -Blind)||0
2478601|NCT00923091|6078227|P4|NOT COMPLETED|Period V (Double -Blind)||0
2478602|NCT00923091|6078228|P3|NOT COMPLETED|Period V (Double -Blind)||0
2478603|NCT00923091|6078229|P2|NOT COMPLETED|Period V (Double -Blind)||0
2478604|NCT00923091|6078230|P1|NOT COMPLETED|Period V (Double -Blind)||0
2478605|NCT00923091|6078218|P13|COMPLETED|Period V (Double -Blind)||73
2478606|NCT00923091|6078219|P12|COMPLETED|Period V (Double -Blind)||151
2478607|NCT00923091|6078220|P11|COMPLETED|Period V (Double -Blind)||193
2478608|NCT00923091|6078221|P10|COMPLETED|Period V (Double -Blind)||119
2478609|NCT00923091|6078222|P9|COMPLETED|Period V (Double -Blind)||134
2478610|NCT00923091|6078223|P8|COMPLETED|Period V (Double -Blind)||0
2478611|NCT00923091|6078224|P7|COMPLETED|Period V (Double -Blind)||0
2478612|NCT00923091|6078225|P6|COMPLETED|Period V (Double -Blind)||0
2478613|NCT00923091|6078226|P5|COMPLETED|Period V (Double -Blind)||0
2478614|NCT00923091|6078227|P4|COMPLETED|Period V (Double -Blind)||0
2478615|NCT00923091|6078228|P3|COMPLETED|Period V (Double -Blind)||0
2478616|NCT00923091|6078229|P2|COMPLETED|Period V (Double -Blind)||0
2478617|NCT00923091|6078230|P1|COMPLETED|Period V (Double -Blind)||0
2478618|NCT00923091|6078218|P13|STARTED|Period V (Double -Blind)||75
2478619|NCT00923091|6078219|P12|STARTED|Period V (Double -Blind)||151
2478620|NCT00923091|6078220|P11|STARTED|Period V (Double -Blind)||194
2478621|NCT00923091|6078221|P10|STARTED|Period V (Double -Blind)||119
2478622|NCT00923091|6078222|P9|STARTED|Period V (Double -Blind)||135
2478623|NCT00923091|6078223|P8|STARTED|Period V (Double -Blind)||0
2478624|NCT00923091|6078224|P7|STARTED|Period V (Double -Blind)||0
2478625|NCT00923091|6078225|P6|STARTED|Period V (Double -Blind)||0
2478626|NCT00923091|6078226|P5|STARTED|Period V (Double -Blind)||0
2478627|NCT00923091|6078227|P4|STARTED|Period V (Double -Blind)||0
2478628|NCT00923091|6078228|P3|STARTED|Period V (Double -Blind)||0
2478629|NCT00923091|6078229|P2|STARTED|Period V (Double -Blind)||0
2478630|NCT00923091|6078230|P1|STARTED|Period V (Double -Blind)|677 completed Period 4. 1 did not continue and 2 erroneously responders were not counted = 674|0
2478631|NCT00923091|6078218|P13|NOT COMPLETED|Period IV (Double-Blind)||0
2478632|NCT00923091|6078219|P12|NOT COMPLETED|Period IV (Double-Blind)||0
2478633|NCT00923091|6078220|P11|NOT COMPLETED|Period IV (Double-Blind)||0
2478634|NCT00923091|6078221|P10|NOT COMPLETED|Period IV (Double-Blind)||0
2478635|NCT00923091|6078222|P9|NOT COMPLETED|Period IV (Double-Blind)||0
2478636|NCT00923091|6078223|P8|NOT COMPLETED|Period IV (Double-Blind)||0
2478637|NCT00923091|6078224|P7|NOT COMPLETED|Period IV (Double-Blind)||0
2478638|NCT00923091|6078225|P6|NOT COMPLETED|Period IV (Double-Blind)||0
2478639|NCT00923091|6078226|P5|NOT COMPLETED|Period IV (Double-Blind)||0
2478640|NCT00923091|6078227|P4|NOT COMPLETED|Period IV (Double-Blind)||0
2478641|NCT00923091|6078228|P3|NOT COMPLETED|Period IV (Double-Blind)||0
2478642|NCT00923091|6078229|P2|NOT COMPLETED|Period IV (Double-Blind)||2
2478643|NCT00923091|6078230|P1|NOT COMPLETED|Period IV (Double-Blind)||2
2478644|NCT00923091|6078218|P13|COMPLETED|Period IV (Double-Blind)||0
2478645|NCT00923091|6078219|P12|COMPLETED|Period IV (Double-Blind)||0
2478646|NCT00923091|6078220|P11|COMPLETED|Period IV (Double-Blind)||0
2478647|NCT00923091|6078221|P10|COMPLETED|Period IV (Double-Blind)||0
2478648|NCT00923091|6078222|P9|COMPLETED|Period IV (Double-Blind)||0
2478649|NCT00923091|6078223|P8|COMPLETED|Period IV (Double-Blind)||0
2478650|NCT00923091|6078224|P7|COMPLETED|Period IV (Double-Blind)||0
2478651|NCT00923091|6078225|P6|COMPLETED|Period IV (Double-Blind)||0
2478652|NCT00923091|6078226|P5|COMPLETED|Period IV (Double-Blind)||0
2478653|NCT00923091|6078227|P4|COMPLETED|Period IV (Double-Blind)||0
2478654|NCT00923091|6078228|P3|COMPLETED|Period IV (Double-Blind)||0
2478655|NCT00923091|6078229|P2|COMPLETED|Period IV (Double-Blind)||451
2478656|NCT00923091|6078230|P1|COMPLETED|Period IV (Double-Blind)||226
2478657|NCT00923091|6078218|P13|STARTED|Period IV (Double-Blind)||0
2478658|NCT00923091|6078219|P12|STARTED|Period IV (Double-Blind)||0
2478659|NCT00923091|6078220|P11|STARTED|Period IV (Double-Blind)||0
2478660|NCT00923091|6078221|P10|STARTED|Period IV (Double-Blind)||0
2478661|NCT00923091|6078222|P9|STARTED|Period IV (Double-Blind)||0
2478662|NCT00923091|6078223|P8|STARTED|Period IV (Double-Blind)||0
2478663|NCT00923091|6078224|P7|STARTED|Period IV (Double-Blind)||0
2478664|NCT00923091|6078225|P6|STARTED|Period IV (Double-Blind)||0
2478665|NCT00923091|6078226|P5|STARTED|Period IV (Double-Blind)||0
2478666|NCT00923091|6078227|P4|STARTED|Period IV (Double-Blind)||0
2478667|NCT00923091|6078228|P3|STARTED|Period IV (Double-Blind)||0
2478668|NCT00923091|6078229|P2|STARTED|Period IV (Double-Blind)||453
2478669|NCT00923091|6078230|P1|STARTED|Period IV (Double-Blind)|2 did not continue in the study and 1837 responders went directly to Period VI. 228+453+2+1837=2520|228
2478670|NCT00923091|6078218|P13|NOT COMPLETED|Period III (Single-Blind)||0
2478671|NCT00923091|6078219|P12|NOT COMPLETED|Period III (Single-Blind)||0
2478672|NCT00923091|6078220|P11|NOT COMPLETED|Period III (Single-Blind)||0
2478673|NCT00923091|6078221|P10|NOT COMPLETED|Period III (Single-Blind)||0
2478674|NCT00923091|6078222|P9|NOT COMPLETED|Period III (Single-Blind)||0
2478675|NCT00923091|6078223|P8|NOT COMPLETED|Period III (Single-Blind)||0
2478676|NCT00923091|6078224|P7|NOT COMPLETED|Period III (Single-Blind)||0
2478677|NCT00923091|6078225|P6|NOT COMPLETED|Period III (Single-Blind)||0
2478678|NCT00923091|6078226|P5|NOT COMPLETED|Period III (Single-Blind)||0
2478679|NCT00923091|6078227|P4|NOT COMPLETED|Period III (Single-Blind)||0
2478680|NCT00923091|6078228|P3|NOT COMPLETED|Period III (Single-Blind)||0
2478681|NCT00923091|6078229|P2|NOT COMPLETED|Period III (Single-Blind)||0
2478682|NCT00923091|6078230|P1|NOT COMPLETED|Period III (Single-Blind)||20
2478683|NCT00923091|6078218|P13|COMPLETED|Period III (Single-Blind)||0
2478684|NCT00923091|6078219|P12|COMPLETED|Period III (Single-Blind)||0
2478685|NCT00923091|6078220|P11|COMPLETED|Period III (Single-Blind)||0
2478686|NCT00923091|6078221|P10|COMPLETED|Period III (Single-Blind)||0
2478687|NCT00923091|6078222|P9|COMPLETED|Period III (Single-Blind)||0
2478688|NCT00923091|6078223|P8|COMPLETED|Period III (Single-Blind)||0
2478689|NCT00923091|6078224|P7|COMPLETED|Period III (Single-Blind)||0
2478690|NCT00923091|6078225|P6|COMPLETED|Period III (Single-Blind)||0
2478691|NCT00923091|6078226|P5|COMPLETED|Period III (Single-Blind)||0
2478692|NCT00923091|6078227|P4|COMPLETED|Period III (Single-Blind)||0
2478693|NCT00923091|6078228|P3|COMPLETED|Period III (Single-Blind)||0
2478694|NCT00923091|6078229|P2|COMPLETED|Period III (Single-Blind)||0
2478695|NCT00923091|6078230|P1|COMPLETED|Period III (Single-Blind)||2520
2478696|NCT00923091|6078218|P13|STARTED|Period III (Single-Blind)||0
2478697|NCT00923091|6078219|P12|STARTED|Period III (Single-Blind)||0
2478698|NCT00923091|6078220|P11|STARTED|Period III (Single-Blind)||0
2478699|NCT00923091|6078221|P10|STARTED|Period III (Single-Blind)||0
2478700|NCT00923091|6078222|P9|STARTED|Period III (Single-Blind)||0
2478701|NCT00923091|6078223|P8|STARTED|Period III (Single-Blind)||0
2478702|NCT00923091|6078224|P7|STARTED|Period III (Single-Blind)||0
2478703|NCT00923091|6078225|P6|STARTED|Period III (Single-Blind)||0
2478704|NCT00923091|6078226|P5|STARTED|Period III (Single-Blind)||0
2478705|NCT00923091|6078227|P4|STARTED|Period III (Single-Blind)||0
2478706|NCT00923091|6078228|P3|STARTED|Period III (Single-Blind)||0
2478707|NCT00923091|6078229|P2|STARTED|Period III (Single-Blind)||0
2478708|NCT00923091|6078230|P1|STARTED|Period III (Single-Blind)|2543 completed Period 2. Three decided not to continue in the study=2540.|2540
2478709|NCT00923091|6078218|P13|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
2478710|NCT00923091|6078219|P12|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
2478711|NCT00923091|6078220|P11|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
2478712|NCT00923091|6078221|P10|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
2478713|NCT00923091|6078222|P9|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
2478714|NCT00923091|6078223|P8|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||25
2478715|NCT00923091|6078224|P7|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||18
2478716|NCT00923091|6078225|P6|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||15
2478717|NCT00923091|6078226|P5|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||21
2478718|NCT00923091|6078227|P4|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||27
2478719|NCT00923091|6078228|P3|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||13
2478720|NCT00923091|6078229|P2|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||11
2478721|NCT00923091|6078230|P1|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||16
2478722|NCT00923091|6078218|P13|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
2478723|NCT00923091|6078219|P12|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
2478724|NCT00923091|6078220|P11|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
2478725|NCT00923091|6078221|P10|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
2478726|NCT00923091|6078222|P9|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
2478727|NCT00923091|6078223|P8|COMPLETED|PeriodI-II (Randomized, Double-Blind)||311
2478728|NCT00923091|6078224|P7|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
2478729|NCT00923091|6078225|P6|COMPLETED|PeriodI-II (Randomized, Double-Blind)||322
2478730|NCT00923091|6078226|P5|COMPLETED|PeriodI-II (Randomized, Double-Blind)||315
2478731|NCT00923091|6078227|P4|COMPLETED|PeriodI-II (Randomized, Double-Blind)||309
2478732|NCT00923091|6078228|P3|COMPLETED|PeriodI-II (Randomized, Double-Blind)||323
2478733|NCT00923091|6078229|P2|COMPLETED|PeriodI-II (Randomized, Double-Blind)||325
2478734|NCT00923091|6078230|P1|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
2478735|NCT00923091|6078218|P13|STARTED|PeriodI-II (Randomized, Double-Blind)||0
2478736|NCT00923091|6078219|P12|STARTED|PeriodI-II (Randomized, Double-Blind)||0
2478737|NCT00923091|6078220|P11|STARTED|PeriodI-II (Randomized, Double-Blind)||0
2478738|NCT00923091|6078221|P10|STARTED|PeriodI-II (Randomized, Double-Blind)||0
2478739|NCT00923091|6078222|P9|STARTED|PeriodI-II (Randomized, Double-Blind)||0
2478740|NCT00923091|6078223|P8|STARTED|PeriodI-II (Randomized, Double-Blind)||336
2478741|NCT00923091|6078224|P7|STARTED|PeriodI-II (Randomized, Double-Blind)||337
2478742|NCT00923091|6078225|P6|STARTED|PeriodI-II (Randomized, Double-Blind)||337
2478743|NCT00923091|6078226|P5|STARTED|PeriodI-II (Randomized, Double-Blind)||336
2478744|NCT00923091|6078227|P4|STARTED|PeriodI-II (Randomized, Double-Blind)||336
2478745|NCT00923091|6078228|P3|STARTED|PeriodI-II (Randomized, Double-Blind)||336
2478746|NCT00923091|6078229|P2|STARTED|PeriodI-II (Randomized, Double-Blind)||336
2478747|NCT00923091|6078230|P1|STARTED|PeriodI-II (Randomized, Double-Blind)||335
2478748|NCT00923078|6078280|P3|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
2478749|NCT00923078|6078281|P2|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
2478750|NCT00923078|6078282|P1|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
2478751|NCT00923078|6078280|P3|COMPLETED|Second Intervention (Weeks 5-8)||0
2478752|NCT00923078|6078281|P2|COMPLETED|Second Intervention (Weeks 5-8)||19
2478753|NCT00923078|6078282|P1|COMPLETED|Second Intervention (Weeks 5-8)||19
2478754|NCT00923078|6078280|P3|STARTED|Second Intervention (Weeks 5-8)|Healthy Comparison sample subjects completed only a single test session (baseline)|0
2478755|NCT00923078|6078281|P2|STARTED|Second Intervention (Weeks 5-8)||19
2478756|NCT00923078|6078282|P1|STARTED|Second Intervention (Weeks 5-8)||19
2478757|NCT00923078|6078280|P3|NOT COMPLETED|First Intervention (Weeks 1-4)||20
2478758|NCT00923078|6078281|P2|NOT COMPLETED|First Intervention (Weeks 1-4)||1
2478759|NCT00923078|6078282|P1|NOT COMPLETED|First Intervention (Weeks 1-4)||1
2478760|NCT00923078|6078280|P3|COMPLETED|First Intervention (Weeks 1-4)||0
2478761|NCT00923078|6078281|P2|COMPLETED|First Intervention (Weeks 1-4)||19
2478762|NCT00923078|6078282|P1|COMPLETED|First Intervention (Weeks 1-4)||19
2478763|NCT00923078|6078280|P3|STARTED|First Intervention (Weeks 1-4)||20
2478764|NCT00923078|6078281|P2|STARTED|First Intervention (Weeks 1-4)||20
2478765|NCT00923078|6078282|P1|STARTED|First Intervention (Weeks 1-4)||20
2478766|NCT00922987|6078301|P1|NOT COMPLETED|Overall Study||4
2478767|NCT00922987|6078301|P1|COMPLETED|Overall Study||277
2478768|NCT00922987|6078301|P1|STARTED|Overall Study||281
2478769|NCT00922974|6078316|P2|NOT COMPLETED|Phase III Component||6
2478770|NCT00922974|6078317|P1|NOT COMPLETED|Phase III Component||8
2478771|NCT00922974|6078316|P2|COMPLETED|Phase III Component||130
2478772|NCT00922974|6078317|P1|COMPLETED|Phase III Component||209
2478773|NCT00922974|6078316|P2|Eligible, Treated, Adverse Event Data|Phase III Component||83
2478774|NCT00922974|6078317|P1|Eligible, Treated, Adverse Event Data|Phase III Component||148
2478775|NCT00922974|6078316|P2|Eligible With Adverse Event Data|Phase III Component||117
2478776|NCT00922974|6078317|P1|Eligible With Adverse Event Data|Phase III Component||202
2478777|NCT00922974|6078316|P2|Eligible With 3 mo. FACT-G Data|Phase III Component||58
2478778|NCT00922974|6078317|P1|Eligible With 3 mo. FACT-G Data|Phase III Component||87
2478779|NCT00922974|6078316|P2|Eligible With 3 mo. NRPS Data|Phase III Component||76
2478780|NCT00922974|6078317|P1|Eligible With 3 mo. NRPS Data|Phase III Component||139
2478781|NCT00922974|6078316|P2|Eligible|Phase III Component||130
2478782|NCT00922974|6078317|P1|Eligible|Phase III Component||209
2478783|NCT00922974|6078316|P2|STARTED|Phase III Component||136
2478784|NCT00922974|6078317|P1|STARTED|Phase III Component|The phase III component accrues new subjects; these are not continuing phase II subjects.|217
2478785|NCT00922974|6078316|P2|NOT COMPLETED|Phase II Component||0
2478786|NCT00922974|6078317|P1|NOT COMPLETED|Phase II Component||7
2478787|NCT00922974|6078316|P2|COMPLETED|Phase II Component||0
2478788|NCT00922974|6078317|P1|COMPLETED|Phase II Component|These subjects do not participate in the phase III component.|39
2478789|NCT00922974|6078316|P2|Eligible, Treated, Adverse Event Data|Phase II Component||0
2478790|NCT00922974|6078317|P1|Eligible, Treated, Adverse Event Data|Phase II Component||34
2478791|NCT00922974|6078316|P2|Eligible and Started Treatment|Phase II Component||0
2478792|NCT00922974|6078317|P1|Eligible and Started Treatment|Phase II Component||39
2478793|NCT00922974|6078316|P2|Eligible|Phase II Component||0
2478794|NCT00922974|6078317|P1|Eligible|Phase II Component||44
2478795|NCT00922974|6078316|P2|STARTED|Phase II Component||0
2478796|NCT00922974|6078317|P1|STARTED|Phase II Component||46
2478797|NCT00922935|6078332|P3|NOT COMPLETED|Overall Study||0
2478798|NCT00922935|6078333|P2|NOT COMPLETED|Overall Study||5
2478799|NCT00922935|6078334|P1|NOT COMPLETED|Overall Study||1
2478800|NCT00922935|6078332|P3|COMPLETED|Overall Study||10
2478801|NCT00922935|6078333|P2|COMPLETED|Overall Study||11
2478802|NCT00922935|6078334|P1|COMPLETED|Overall Study||9
2478803|NCT00922935|6078332|P3|STARTED|Overall Study||10
2478804|NCT00922935|6078333|P2|STARTED|Overall Study||16
2478805|NCT00922935|6078334|P1|STARTED|Overall Study||10
2478806|NCT00922883|6078342|P1|NOT COMPLETED|Overall Study||0
2478807|NCT00922883|6078342|P1|COMPLETED|Overall Study||43
2478808|NCT00922883|6078342|P1|STARTED|Overall Study||43
2478809|NCT00922779|6078346|P1|NOT COMPLETED|Overall Study||2327
2478810|NCT00922779|6078346|P1|COMPLETED|Overall Study||4334
2478811|NCT00922779|6078346|P1|STARTED|Overall Study||6661
2478812|NCT00922766|6078353|P1|NOT COMPLETED|Overall Study||7
2478813|NCT00922766|6078353|P1|COMPLETED|Overall Study||610
2478814|NCT00922766|6078353|P1|STARTED|Overall Study||617
2478815|NCT00922701|6078362|P1|NOT COMPLETED|Overall Study||0
2478816|NCT00922701|6078362|P1|COMPLETED|Overall Study||4
2478817|NCT00922701|6078362|P1|STARTED|Overall Study||4
2478818|NCT00922636|6078371|P5|NOT COMPLETED|Overall Study||16
2478819|NCT00922636|6078372|P4|NOT COMPLETED|Overall Study||17
2478820|NCT00922636|6078373|P3|NOT COMPLETED|Overall Study||20
2478821|NCT00922636|6078374|P2|NOT COMPLETED|Overall Study||16
2478822|NCT00922636|6078375|P1|NOT COMPLETED|Overall Study||7
2478823|NCT00922636|6078371|P5|COMPLETED|Overall Study||59
2478824|NCT00922636|6078372|P4|COMPLETED|Overall Study||58
2478825|NCT00922636|6078373|P3|COMPLETED|Overall Study||56
2478826|NCT00922636|6078374|P2|COMPLETED|Overall Study||62
2478827|NCT00922636|6078375|P1|COMPLETED|Overall Study||29
2478828|NCT00922636|6078371|P5|Entered Optional Taper Phase|Overall Study||12
2478829|NCT00922636|6078372|P4|Entered Optional Taper Phase|Overall Study||7
2478830|NCT00922636|6078373|P3|Entered Optional Taper Phase|Overall Study||15
2478831|NCT00922636|6078374|P2|Entered Optional Taper Phase|Overall Study||10
2478832|NCT00922636|6078375|P1|Entered Optional Taper Phase|Overall Study||4
2478833|NCT00922636|6078371|P5|STARTED|Overall Study||75
2478834|NCT00922636|6078372|P4|STARTED|Overall Study||75
2478835|NCT00922636|6078373|P3|STARTED|Overall Study||76
2478836|NCT00922636|6078374|P2|STARTED|Overall Study||78
2478837|NCT00922636|6078375|P1|STARTED|Overall Study||36
2478838|NCT00922623|6078522|P1|NOT COMPLETED|Overall Study||5
2478839|NCT00922623|6078522|P1|COMPLETED|Overall Study||88
2478840|NCT00922623|6078522|P1|STARTED|Overall Study||93
2478841|NCT00922480|6078530|P2|NOT COMPLETED|Extension Study||3
2478842|NCT00922480|6078531|P1|NOT COMPLETED|Extension Study||5
2478843|NCT00922480|6078530|P2|COMPLETED|Extension Study||82
2478844|NCT00922480|6078531|P1|COMPLETED|Extension Study||68
2478845|NCT00922480|6078530|P2|STARTED|Extension Study||85
2478846|NCT00922480|6078531|P1|STARTED|Extension Study||73
2478847|NCT00922480|6078530|P2|NOT COMPLETED|Main Study||29
2478848|NCT00922480|6078531|P1|NOT COMPLETED|Main Study||37
2478849|NCT00922480|6078530|P2|COMPLETED|Main Study||226
2478850|NCT00922480|6078531|P1|COMPLETED|Main Study||213
2478851|NCT00922480|6078530|P2|STARTED|Main Study||255
2478852|NCT00922480|6078531|P1|STARTED|Main Study||250
2478853|NCT00922441|6078542|P3|NOT COMPLETED|Overall Study||3
2478854|NCT00922441|6078543|P2|NOT COMPLETED|Overall Study||0
2478855|NCT00922441|6078544|P1|NOT COMPLETED|Overall Study||0
2478856|NCT00922441|6078542|P3|COMPLETED|Overall Study||29
2478857|NCT00922441|6078543|P2|COMPLETED|Overall Study||30
2478858|NCT00922441|6078544|P1|COMPLETED|Overall Study||30
2478859|NCT00922441|6078542|P3|STARTED|Overall Study||32
2478860|NCT00922441|6078543|P2|STARTED|Overall Study||30
2478861|NCT00922441|6078544|P1|STARTED|Overall Study||30
2478862|NCT00922428|6078552|P1|NOT COMPLETED|Overall Study||15
2478863|NCT00922428|6078552|P1|COMPLETED|Overall Study|for 11 participants no gender was given|1374
2478864|NCT00922428|6078552|P1|STARTED|Overall Study|13 patients were completely not analysed, 2 not for demographic or efficacy but for safety|1389
2478865|NCT00922272|6078581|P2|NOT COMPLETED|Double-blind Phase||6
2478866|NCT00922272|6078582|P1|NOT COMPLETED|Double-blind Phase||7
2478867|NCT00922272|6078581|P2|COMPLETED|Double-blind Phase||29
2478868|NCT00922272|6078582|P1|COMPLETED|Double-blind Phase||27
2478869|NCT00922272|6078581|P2|STARTED|Double-blind Phase||35
2478870|NCT00922272|6078582|P1|STARTED|Double-blind Phase||34
2478871|NCT00922272|6078581|P2|NOT COMPLETED|Open-label Phase||0
2478872|NCT00922272|6078582|P1|NOT COMPLETED|Open-label Phase||23
2478873|NCT00922272|6078581|P2|COMPLETED|Open-label Phase||0
2478874|NCT00922272|6078582|P1|COMPLETED|Open-label Phase||69
2478875|NCT00922272|6078581|P2|STARTED|Open-label Phase||0
2478876|NCT00922272|6078582|P1|STARTED|Open-label Phase||92
2478877|NCT00922233|6078638|P1|NOT COMPLETED|Overall Study||4
2478878|NCT00922233|6078638|P1|COMPLETED|Overall Study||68
2478879|NCT00922233|6078638|P1|STARTED|Overall Study||72
2478880|NCT00922207|6078647|P3|NOT COMPLETED|Overall Study||4
2478881|NCT00922207|6078648|P2|NOT COMPLETED|Overall Study||7
2478882|NCT00922207|6078649|P1|NOT COMPLETED|Overall Study||6
2478883|NCT00922207|6078647|P3|COMPLETED|Overall Study||90
2478884|NCT00922207|6078648|P2|COMPLETED|Overall Study||88
2478885|NCT00922207|6078649|P1|COMPLETED|Overall Study||85
2478886|NCT00922207|6078647|P3|STARTED|Overall Study||94
2478887|NCT00922207|6078648|P2|STARTED|Overall Study||95
2478888|NCT00922207|6078649|P1|STARTED|Overall Study||91
2478889|NCT00922194|6078675|P1|NOT COMPLETED|Metformin for 12 Months or More||0
2478890|NCT00922194|6078675|P1|COMPLETED|Metformin for 12 Months or More||102
2478891|NCT00922194|6078675|P1|STARTED|Metformin for 12 Months or More|Gradually increasing dose of Extended Release Metformin|102
2478892|NCT00922194|6078675|P1|NOT COMPLETED|Metformin in Maximum Tolerated Dose||0
2478893|NCT00922194|6078675|P1|COMPLETED|Metformin in Maximum Tolerated Dose|June 2009|102
2478894|NCT00922194|6078675|P1|STARTED|Metformin in Maximum Tolerated Dose|February 2006|102
2478895|NCT00922116|6078685|P1|NOT COMPLETED|Overall Study||15
2478896|NCT00922116|6078685|P1|COMPLETED|Overall Study||176
2478897|NCT00922116|6078685|P1|STARTED|Overall Study||191
2478898|NCT00921947|6078696|P2|NOT COMPLETED|Day 28||0
2478899|NCT00921947|6078697|P1|NOT COMPLETED|Day 28||0
2478900|NCT00921947|6078696|P2|COMPLETED|Day 28||30
2478901|NCT00921947|6078697|P1|COMPLETED|Day 28||28
2478902|NCT00921947|6078696|P2|STARTED|Day 28||30
2478903|NCT00921947|6078697|P1|STARTED|Day 28|2 subjects were lost to follow-up and did not receive the 2nd vaccination of 1.0 ug i.m.|28
2478904|NCT00921947|6078696|P2|NOT COMPLETED|Day 0||0
2478905|NCT00921947|6078697|P1|NOT COMPLETED|Day 0||0
2478906|NCT00921947|6078696|P2|COMPLETED|Day 0||30
2478907|NCT00921947|6078697|P1|COMPLETED|Day 0||30
2478908|NCT00921947|6078696|P2|STARTED|Day 0||30
2478909|NCT00921947|6078697|P1|STARTED|Day 0||30
2478910|NCT00921934|6078707|P1|NOT COMPLETED|Overall Study||0
2478911|NCT00921934|6078707|P1|COMPLETED|Overall Study||68
2478912|NCT00921934|6078707|P1|STARTED|Overall Study||68
2478913|NCT00921895|6078711|P1|NOT COMPLETED|Overall Study||0
2478914|NCT00921895|6078711|P1|COMPLETED|Overall Study||128
2478915|NCT00921895|6078711|P1|STARTED|Overall Study||128
2478916|NCT00921843|6078720|P4|NOT COMPLETED|Overall Study||0
2478917|NCT00921843|6078721|P3|NOT COMPLETED|Overall Study||0
2478918|NCT00921843|6078722|P2|NOT COMPLETED|Overall Study||0
2478919|NCT00921843|6078723|P1|NOT COMPLETED|Overall Study||0
2478920|NCT00921843|6078720|P4|COMPLETED|Overall Study||30
2478921|NCT00921843|6078721|P3|COMPLETED|Overall Study||11
2478922|NCT00921843|6078722|P2|COMPLETED|Overall Study||10
2478923|NCT00921843|6078723|P1|COMPLETED|Overall Study||10
2478924|NCT00921843|6078720|P4|STARTED|Overall Study||30
2478925|NCT00921843|6078721|P3|STARTED|Overall Study||11
2478926|NCT00921843|6078722|P2|STARTED|Overall Study||10
2478927|NCT00921843|6078723|P1|STARTED|Overall Study||10
2478928|NCT00921687|6078735|P2|NOT COMPLETED|Overall Study||0
2478929|NCT00921687|6078736|P1|NOT COMPLETED|Overall Study||0
2478930|NCT00921687|6078735|P2|COMPLETED|Overall Study||363
2478931|NCT00921687|6078736|P1|COMPLETED|Overall Study||418
2478932|NCT00921687|6078735|P2|STARTED|Overall Study||363
2478933|NCT00921687|6078736|P1|STARTED|Overall Study|eligible patients seen in clinic between 1/1/09 and 1/1/10|418
2478934|NCT00921557|6078747|P3|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
2478935|NCT00921557|6078748|P2|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
2478936|NCT00921557|6078749|P1|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||3
2478937|NCT00921557|6078747|P3|COMPLETED|Weeks 96-144 (Off Study Treatment)||16
2478938|NCT00921557|6078748|P2|COMPLETED|Weeks 96-144 (Off Study Treatment)||15
2478939|NCT00921557|6078749|P1|COMPLETED|Weeks 96-144 (Off Study Treatment)||12
2478940|NCT00921557|6078747|P3|STARTED|Weeks 96-144 (Off Study Treatment)||17
2478941|NCT00921557|6078748|P2|STARTED|Weeks 96-144 (Off Study Treatment)||16
2478942|NCT00921557|6078749|P1|STARTED|Weeks 96-144 (Off Study Treatment)||15
2478943|NCT00921557|6078747|P3|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
2478944|NCT00921557|6078748|P2|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
2478945|NCT00921557|6078749|P1|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||0
2478946|NCT00921557|6078747|P3|COMPLETED|Weeks 48-96 (on Study Treatment)||17
2478947|NCT00921557|6078748|P2|COMPLETED|Weeks 48-96 (on Study Treatment)||16
2478948|NCT00921557|6078749|P1|COMPLETED|Weeks 48-96 (on Study Treatment)||15
2478949|NCT00921557|6078747|P3|STARTED|Weeks 48-96 (on Study Treatment)||18
2478950|NCT00921557|6078748|P2|STARTED|Weeks 48-96 (on Study Treatment)||17
2478951|NCT00921557|6078749|P1|STARTED|Weeks 48-96 (on Study Treatment)||15
2478952|NCT00921557|6078747|P3|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
2478953|NCT00921557|6078748|P2|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
2478954|NCT00921557|6078749|P1|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||2
2478955|NCT00921557|6078747|P3|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|18
2478956|NCT00921557|6078748|P2|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|17
2478957|NCT00921557|6078749|P1|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|15
2478958|NCT00921557|6078747|P3|STARTED|Weeks 0-48 (on Study Treatment)||18
2478959|NCT00921557|6078748|P2|STARTED|Weeks 0-48 (on Study Treatment)||17
2478960|NCT00921557|6078749|P1|STARTED|Weeks 0-48 (on Study Treatment)||17
2478961|NCT00921518|6078809|P2|NOT COMPLETED|Overall Study||0
2478962|NCT00921518|6078810|P1|NOT COMPLETED|Overall Study||0
2478963|NCT00921518|6078809|P2|COMPLETED|Overall Study||44
2478964|NCT00921518|6078810|P1|COMPLETED|Overall Study||48
2478965|NCT00921518|6078809|P2|STARTED|Overall Study||44
2478966|NCT00921518|6078810|P1|STARTED|Overall Study||48
2478967|NCT00921310|6078818|P3|NOT COMPLETED|Overall Study||0
2478968|NCT00921310|6078819|P2|NOT COMPLETED|Overall Study||0
2478969|NCT00921310|6078820|P1|NOT COMPLETED|Overall Study||0
2478970|NCT00921310|6078818|P3|COMPLETED|Overall Study||4
2478971|NCT00921310|6078819|P2|COMPLETED|Overall Study||6
2478972|NCT00921310|6078820|P1|COMPLETED|Overall Study||2
2478973|NCT00921310|6078818|P3|STARTED|Overall Study||4
2478974|NCT00921310|6078819|P2|STARTED|Overall Study||6
2478975|NCT00921310|6078820|P1|STARTED|Overall Study||2
2478976|NCT00921115|6078845|P1|NOT COMPLETED|Overall Study||0
2478977|NCT00921115|6078845|P1|COMPLETED|Overall Study||42
2478978|NCT00921115|6078845|P1|STARTED|Overall Study||42
2478979|NCT00921024|6078851|P2|NOT COMPLETED|Overall Study||3
2478980|NCT00921024|6078852|P1|NOT COMPLETED|Overall Study||4
2478981|NCT00921024|6078851|P2|COMPLETED|Overall Study||39
2478982|NCT00921024|6078852|P1|COMPLETED|Overall Study||81
2478983|NCT00921024|6078851|P2|STARTED|Overall Study||42
2478984|NCT00921024|6078852|P1|STARTED|Overall Study||85
2478985|NCT00920907|6078862|P2|NOT COMPLETED|Maintenance Period||13
2478986|NCT00920907|6078863|P1|NOT COMPLETED|Maintenance Period||12
2478987|NCT00920907|6078862|P2|COMPLETED|Maintenance Period|2 participants who entered Maintenance Period did not receive study drug during the period.|2
2478988|NCT00920907|6078863|P1|COMPLETED|Maintenance Period|All participants who entered Maintenance were treated with study drug.|3
2478989|NCT00920907|6078862|P2|STARTED|Maintenance Period|1 patient completed Induction phase but discontinued the study prior to start of maintenance phase.|15
2478990|NCT00920907|6078863|P1|STARTED|Maintenance Period||15
2478991|NCT00920907|6078862|P2|NOT COMPLETED|Induction Period||22
2478992|NCT00920907|6078863|P1|NOT COMPLETED|Induction Period||22
2478993|NCT00920907|6078862|P2|COMPLETED|Induction Period||16
2478994|NCT00920907|6078863|P1|COMPLETED|Induction Period||15
2478995|NCT00920907|6078862|P2|STARTED|Induction Period||38
2478996|NCT00920907|6078863|P1|STARTED|Induction Period||37
2478997|NCT00920855|6078904|P3|NOT COMPLETED|Overall Study||22
2478998|NCT00920855|6078905|P2|NOT COMPLETED|Overall Study||3
2478999|NCT00920855|6078906|P1|NOT COMPLETED|Overall Study||5
2479000|NCT00920855|6078904|P3|COMPLETED|Overall Study|completed eight cycles of treatment|9
2479001|NCT00920855|6078905|P2|COMPLETED|Overall Study|completed eight cycles of treatment|1
2479096|NCT00920556|6079135|P1|STARTED|Overall Study||24
2479002|NCT00920855|6078906|P1|COMPLETED|Overall Study|completed eight cycles of treatment|0
2479003|NCT00920855|6078904|P3|Safety and Efficacy Populations|Overall Study||31
2479004|NCT00920855|6078905|P2|Safety and Efficacy Populations|Overall Study||4
2479005|NCT00920855|6078906|P1|Safety and Efficacy Populations|Overall Study||5
2479006|NCT00920855|6078904|P3|STARTED|Overall Study||31
2479007|NCT00920855|6078905|P2|STARTED|Overall Study||4
2479008|NCT00920855|6078906|P1|STARTED|Overall Study||5
2479009|NCT00920829|6078932|P4|NOT COMPLETED|Available for Analysis||11
2479010|NCT00920829|6078933|P3|NOT COMPLETED|Available for Analysis||10
2479011|NCT00920829|6078934|P2|NOT COMPLETED|Available for Analysis||11
2479012|NCT00920829|6078935|P1|NOT COMPLETED|Available for Analysis||8
2479013|NCT00920829|6078932|P4|COMPLETED|Available for Analysis||24
2479014|NCT00920829|6078933|P3|COMPLETED|Available for Analysis||28
2479015|NCT00920829|6078934|P2|COMPLETED|Available for Analysis||27
2479016|NCT00920829|6078935|P1|COMPLETED|Available for Analysis||27
2479017|NCT00920829|6078932|P4|STARTED|Available for Analysis||35
2479018|NCT00920829|6078933|P3|STARTED|Available for Analysis||38
2479019|NCT00920829|6078934|P2|STARTED|Available for Analysis||38
2479020|NCT00920829|6078935|P1|STARTED|Available for Analysis||35
2479021|NCT00920829|6078932|P4|NOT COMPLETED|Allocation||2
2479022|NCT00920829|6078933|P3|NOT COMPLETED|Allocation||0
2479023|NCT00920829|6078934|P2|NOT COMPLETED|Allocation||1
2479024|NCT00920829|6078935|P1|NOT COMPLETED|Allocation||3
2479025|NCT00920829|6078932|P4|COMPLETED|Allocation||35
2479026|NCT00920829|6078933|P3|COMPLETED|Allocation||38
2479027|NCT00920829|6078934|P2|COMPLETED|Allocation||38
2479028|NCT00920829|6078935|P1|COMPLETED|Allocation||35
2479029|NCT00920829|6078932|P4|STARTED|Allocation||37
2479030|NCT00920829|6078933|P3|STARTED|Allocation||38
2479031|NCT00920829|6078934|P2|STARTED|Allocation||39
2479032|NCT00920829|6078935|P1|STARTED|Allocation||38
2479033|NCT00920816|6078949|P4|NOT COMPLETED|Overall Study||69
2479034|NCT00920816|6078950|P3|NOT COMPLETED|Overall Study||135
2479035|NCT00920816|6078951|P2|NOT COMPLETED|Overall Study||96
2479036|NCT00920816|6078952|P1|NOT COMPLETED|Overall Study||192
2479037|NCT00920816|6078949|P4|COMPLETED|Overall Study||0
2479038|NCT00920816|6078950|P3|COMPLETED|Overall Study||0
2479039|NCT00920816|6078951|P2|COMPLETED|Overall Study||0
2479040|NCT00920816|6078952|P1|COMPLETED|Overall Study||0
2479041|NCT00920816|6078949|P4|Treated|Overall Study||69
2479042|NCT00920816|6078950|P3|Treated|Overall Study||135
2479043|NCT00920816|6078951|P2|Treated|Overall Study||96
2479044|NCT00920816|6078952|P1|Treated|Overall Study||189
2479045|NCT00920816|6078949|P4|STARTED|Overall Study||69
2479046|NCT00920816|6078950|P3|STARTED|Overall Study||135
2479047|NCT00920816|6078951|P2|STARTED|Overall Study||96
2479048|NCT00920816|6078952|P1|STARTED|Overall Study||192
2479049|NCT00920790|6078990|P1|NOT COMPLETED|Overall Study||14
2479050|NCT00920790|6078990|P1|COMPLETED|Overall Study||13
2479051|NCT00920790|6078990|P1|STARTED|Overall Study||27
2479052|NCT00920699|6079002|P3|NOT COMPLETED|Overall Study||4
2479053|NCT00920699|6079003|P2|NOT COMPLETED|Overall Study||1
2479054|NCT00920699|6079004|P1|NOT COMPLETED|Overall Study||2
2479055|NCT00920699|6079002|P3|COMPLETED|Overall Study||28
2479056|NCT00920699|6079003|P2|COMPLETED|Overall Study||29
2479057|NCT00920699|6079004|P1|COMPLETED|Overall Study||27
2479058|NCT00920699|6079002|P3|STARTED|Overall Study||32
2479059|NCT00920699|6079003|P2|STARTED|Overall Study||30
2479060|NCT00920699|6079004|P1|STARTED|Overall Study||29
2479061|NCT00920686|6079021|P3|NOT COMPLETED|Overall Study||13
2479062|NCT00920686|6079022|P2|NOT COMPLETED|Overall Study||22
2479063|NCT00920686|6079023|P1|NOT COMPLETED|Overall Study||19
2479064|NCT00920686|6079021|P3|COMPLETED|Overall Study||62
2479065|NCT00920686|6079022|P2|COMPLETED|Overall Study||60
2479066|NCT00920686|6079023|P1|COMPLETED|Overall Study||63
2479067|NCT00920686|6079021|P3|STARTED|Overall Study||75
2479068|NCT00920686|6079022|P2|STARTED|Overall Study||82
2479069|NCT00920686|6079023|P1|STARTED|Overall Study||82
2479070|NCT00920647|6079047|P4|NOT COMPLETED|Overall Study||0
2479071|NCT00920647|6079048|P3|NOT COMPLETED|Overall Study||0
2479072|NCT00920647|6079049|P2|NOT COMPLETED|Overall Study||0
2479073|NCT00920647|6079050|P1|NOT COMPLETED|Overall Study||0
2479074|NCT00920647|6079047|P4|COMPLETED|Overall Study||4
2479075|NCT00920647|6079048|P3|COMPLETED|Overall Study||4
2479076|NCT00920647|6079049|P2|COMPLETED|Overall Study||4
2479077|NCT00920647|6079050|P1|COMPLETED|Overall Study||4
2479078|NCT00920647|6079047|P4|STARTED|Overall Study||4
2479079|NCT00920647|6079048|P3|STARTED|Overall Study||4
2479080|NCT00920647|6079049|P2|STARTED|Overall Study||4
2479081|NCT00920647|6079050|P1|STARTED|Overall Study||4
2479082|NCT00920621|6079102|P4|NOT COMPLETED|Overall Study||35
2479083|NCT00920621|6079103|P3|NOT COMPLETED|Overall Study||35
2479084|NCT00920621|6079104|P2|NOT COMPLETED|Overall Study||45
2479085|NCT00920621|6079105|P1|NOT COMPLETED|Overall Study||54
2479086|NCT00920621|6079102|P4|COMPLETED|Overall Study||401
2479087|NCT00920621|6079103|P3|COMPLETED|Overall Study||405
2479088|NCT00920621|6079104|P2|COMPLETED|Overall Study||391
2479089|NCT00920621|6079105|P1|COMPLETED|Overall Study||386
2479090|NCT00920621|6079102|P4|STARTED|Overall Study||436
2479091|NCT00920621|6079103|P3|STARTED|Overall Study||440
2479092|NCT00920621|6079104|P2|STARTED|Overall Study||436
2479093|NCT00920621|6079105|P1|STARTED|Overall Study||440
2479094|NCT00920556|6079135|P1|NOT COMPLETED|Overall Study||24
2479095|NCT00920556|6079135|P1|COMPLETED|Overall Study||0
2479097|NCT00920439|6079174|P1|NOT COMPLETED|Overall Study||0
2479098|NCT00920439|6079174|P1|COMPLETED|Overall Study||25
2479099|NCT00920439|6079174|P1|STARTED|Overall Study||25
2479100|NCT00920426|6079184|P4|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
2479101|NCT00920426|6079185|P3|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
2479102|NCT00920426|6079186|P2|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
2479103|NCT00920426|6079187|P1|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
2479104|NCT00920426|6079184|P4|COMPLETED|ITZ112929: Optimized Therapy (OT)||8
2479105|NCT00920426|6079185|P3|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
2479106|NCT00920426|6079186|P2|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
2479107|NCT00920426|6079187|P1|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
2479108|NCT00920426|6079184|P4|STARTED|ITZ112929: Optimized Therapy (OT)|Out of 9 participants receiving randomized regimen, 8 participants continued to receive OT.|8
2479109|NCT00920426|6079185|P3|STARTED|ITZ112929: Optimized Therapy (OT)||0
2479110|NCT00920426|6079186|P2|STARTED|ITZ112929: Optimized Therapy (OT)||0
2479111|NCT00920426|6079187|P1|STARTED|ITZ112929: Optimized Therapy (OT)||0
2479112|NCT00920426|6079184|P4|NOT COMPLETED|ITZ112929: Randomized Regimen||0
2479113|NCT00920426|6079185|P3|NOT COMPLETED|ITZ112929: Randomized Regimen||0
2479114|NCT00920426|6079186|P2|NOT COMPLETED|ITZ112929: Randomized Regimen||0
2479115|NCT00920426|6079187|P1|NOT COMPLETED|ITZ112929: Randomized Regimen||0
2479116|NCT00920426|6079184|P4|COMPLETED|ITZ112929: Randomized Regimen||0
2479117|NCT00920426|6079185|P3|COMPLETED|ITZ112929: Randomized Regimen||2
2479118|NCT00920426|6079186|P2|COMPLETED|ITZ112929: Randomized Regimen||7
2479119|NCT00920426|6079187|P1|COMPLETED|ITZ112929: Randomized Regimen||0
2479120|NCT00920426|6079184|P4|STARTED|ITZ112929: Randomized Regimen||0
2479121|NCT00920426|6079185|P3|STARTED|ITZ112929: Randomized Regimen||2
2479122|NCT00920426|6079186|P2|STARTED|ITZ112929: Randomized Regimen||7
2479123|NCT00920426|6079187|P1|STARTED|ITZ112929: Randomized Regimen||0
2479124|NCT00920426|6079184|P4|NOT COMPLETED|ITZ111451||0
2479125|NCT00920426|6079185|P3|NOT COMPLETED|ITZ111451||0
2479126|NCT00920426|6079186|P2|NOT COMPLETED|ITZ111451||0
2479127|NCT00920426|6079187|P1|NOT COMPLETED|ITZ111451||1
2479128|NCT00920426|6079184|P4|COMPLETED|ITZ111451||0
2479129|NCT00920426|6079185|P3|COMPLETED|ITZ111451||0
2479130|NCT00920426|6079186|P2|COMPLETED|ITZ111451||0
2479131|NCT00920426|6079187|P1|COMPLETED|ITZ111451||7
2479132|NCT00920426|6079184|P4|STARTED|ITZ111451||0
2479133|NCT00920426|6079185|P3|STARTED|ITZ111451||0
2479134|NCT00920426|6079186|P2|STARTED|ITZ111451||0
2479135|NCT00920426|6079187|P1|STARTED|ITZ111451||8
2479136|NCT00920374|6079256|P2|NOT COMPLETED|Overall Study||0
2479137|NCT00920374|6079257|P1|NOT COMPLETED|Overall Study||0
2479138|NCT00920374|6079256|P2|COMPLETED|Overall Study||57
2479139|NCT00920374|6079257|P1|COMPLETED|Overall Study||61
2479140|NCT00920374|6079256|P2|STARTED|Overall Study||57
2479141|NCT00920374|6079257|P1|STARTED|Overall Study||61
2479142|NCT00920309|6079283|P2|NOT COMPLETED|Overall Study||0
2479143|NCT00920309|6079284|P1|NOT COMPLETED|Overall Study||0
2479144|NCT00920309|6079283|P2|COMPLETED|Overall Study||7
2479145|NCT00920309|6079284|P1|COMPLETED|Overall Study||14
2479146|NCT00920309|6079283|P2|STARTED|Overall Study||7
2479147|NCT00920309|6079284|P1|STARTED|Overall Study||14
2479148|NCT00920231|6079294|P2|NOT COMPLETED|Overall Study||0
2479149|NCT00920231|6079295|P1|NOT COMPLETED|Overall Study||0
2479150|NCT00920231|6079294|P2|COMPLETED|Overall Study||8
2479151|NCT00920231|6079295|P1|COMPLETED|Overall Study||8
2479152|NCT00920231|6079294|P2|STARTED|Overall Study||8
2479153|NCT00920231|6079295|P1|STARTED|Overall Study||8
2479154|NCT00920218|6079307|P4|NOT COMPLETED|Overall Study||7
2479155|NCT00920218|6079308|P3|NOT COMPLETED|Overall Study||8
2479156|NCT00920218|6079309|P2|NOT COMPLETED|Overall Study||5
2479157|NCT00920218|6079310|P1|NOT COMPLETED|Overall Study||2
2479158|NCT00920218|6079307|P4|COMPLETED|Overall Study||23
2479159|NCT00920218|6079308|P3|COMPLETED|Overall Study||23
2479160|NCT00920218|6079309|P2|COMPLETED|Overall Study||24
2479161|NCT00920218|6079310|P1|COMPLETED|Overall Study||28
2479162|NCT00920218|6079307|P4|STARTED|Overall Study||30
2479163|NCT00920218|6079308|P3|STARTED|Overall Study||31
2479164|NCT00920218|6079309|P2|STARTED|Overall Study||29
2479165|NCT00920218|6079310|P1|STARTED|Overall Study||30
2479166|NCT00920140|6079413|P5|NOT COMPLETED|Phase 2||11
2479167|NCT00920140|6079414|P4|NOT COMPLETED|Phase 2||22
2479168|NCT00920140|6079415|P3|NOT COMPLETED|Phase 2||50
2479169|NCT00920140|6079416|P2|NOT COMPLETED|Phase 2||0
2479170|NCT00920140|6079417|P1|NOT COMPLETED|Phase 2||0
2479171|NCT00920140|6079413|P5|COMPLETED|Phase 2||0
2479172|NCT00920140|6079414|P4|COMPLETED|Phase 2||0
2479173|NCT00920140|6079415|P3|COMPLETED|Phase 2||0
2479174|NCT00920140|6079416|P2|COMPLETED|Phase 2||0
2479175|NCT00920140|6079417|P1|COMPLETED|Phase 2||0
2479176|NCT00920140|6079413|P5|STARTED|Phase 2||11
2479177|NCT00920140|6079414|P4|STARTED|Phase 2||22
2479178|NCT00920140|6079415|P3|STARTED|Phase 2||50
2479179|NCT00920140|6079416|P2|STARTED|Phase 2||0
2479180|NCT00920140|6079417|P1|STARTED|Phase 2||0
2479181|NCT00920140|6079413|P5|NOT COMPLETED|Phase 1 (Dose Escalation)||0
2479182|NCT00920140|6079414|P4|NOT COMPLETED|Phase 1 (Dose Escalation)||0
2479183|NCT00920140|6079415|P3|NOT COMPLETED|Phase 1 (Dose Escalation)||0
2479184|NCT00920140|6079416|P2|NOT COMPLETED|Phase 1 (Dose Escalation)||9
2479185|NCT00920140|6079417|P1|NOT COMPLETED|Phase 1 (Dose Escalation)||5
2479186|NCT00920140|6079413|P5|COMPLETED|Phase 1 (Dose Escalation)||0
2479187|NCT00920140|6079414|P4|COMPLETED|Phase 1 (Dose Escalation)||0
2479188|NCT00920140|6079415|P3|COMPLETED|Phase 1 (Dose Escalation)||0
2479189|NCT00920140|6079416|P2|COMPLETED|Phase 1 (Dose Escalation)||0
2479190|NCT00920140|6079417|P1|COMPLETED|Phase 1 (Dose Escalation)||0
2479191|NCT00920140|6079413|P5|STARTED|Phase 1 (Dose Escalation)||0
2479192|NCT00920140|6079414|P4|STARTED|Phase 1 (Dose Escalation)||0
2479193|NCT00920140|6079415|P3|STARTED|Phase 1 (Dose Escalation)||0
2479194|NCT00920140|6079416|P2|STARTED|Phase 1 (Dose Escalation)||9
2479195|NCT00920140|6079417|P1|STARTED|Phase 1 (Dose Escalation)||5
2479196|NCT00920075|6079455|P1|NOT COMPLETED|Post Study, 11 Pts Responded||0
2479197|NCT00920075|6079455|P1|COMPLETED|Post Study, 11 Pts Responded||11
2479198|NCT00920075|6079455|P1|STARTED|Post Study, 11 Pts Responded||11
2479199|NCT00920075|6079455|P1|NOT COMPLETED|Last Study, 25 Pts Invited,11 Responded||0
2479200|NCT00920075|6079455|P1|COMPLETED|Last Study, 25 Pts Invited,11 Responded||11
2479201|NCT00920075|6079455|P1|STARTED|Last Study, 25 Pts Invited,11 Responded||11
2479202|NCT00920023|6079461|P1|NOT COMPLETED|Overall Study||0
2479203|NCT00920023|6079461|P1|COMPLETED|Overall Study||15
2479204|NCT00920023|6079461|P1|STARTED|Overall Study||15
2479205|NCT00919932|6079468|P2|NOT COMPLETED|Overall Study||0
2479206|NCT00919932|6079469|P1|NOT COMPLETED|Overall Study||0
2479207|NCT00919932|6079468|P2|COMPLETED|Overall Study||5
2479208|NCT00919932|6079469|P1|COMPLETED|Overall Study||4
2479209|NCT00919932|6079468|P2|STARTED|Overall Study||5
2479210|NCT00919932|6079469|P1|STARTED|Overall Study||4
2479211|NCT00919893|6079479|P2|NOT COMPLETED|Overall Study||9
2479212|NCT00919893|6079480|P1|NOT COMPLETED|Overall Study||19
2479213|NCT00919893|6079479|P2|COMPLETED|Overall Study||60
2479214|NCT00919893|6079480|P1|COMPLETED|Overall Study||51
2479215|NCT00919893|6079479|P2|STARTED|Overall Study||69
2479216|NCT00919893|6079480|P1|STARTED|Overall Study||70
2479217|NCT00919867|6079492|P6|NOT COMPLETED|Third Intervention||0
2479218|NCT00919867|6079493|P5|NOT COMPLETED|Third Intervention||0
2479219|NCT00919867|6079494|P4|NOT COMPLETED|Third Intervention||0
2479220|NCT00919867|6079495|P3|NOT COMPLETED|Third Intervention||0
2479221|NCT00919867|6079496|P2|NOT COMPLETED|Third Intervention||0
2479222|NCT00919867|6079497|P1|NOT COMPLETED|Third Intervention||0
2479223|NCT00919867|6079492|P6|COMPLETED|Third Intervention||6
2479224|NCT00919867|6079493|P5|COMPLETED|Third Intervention||7
2479225|NCT00919867|6079494|P4|COMPLETED|Third Intervention||7
2479226|NCT00919867|6079495|P3|COMPLETED|Third Intervention||6
2479227|NCT00919867|6079496|P2|COMPLETED|Third Intervention||7
2479228|NCT00919867|6079497|P1|COMPLETED|Third Intervention||7
2479229|NCT00919867|6079492|P6|STARTED|Third Intervention||6
2479230|NCT00919867|6079493|P5|STARTED|Third Intervention||7
2479231|NCT00919867|6079494|P4|STARTED|Third Intervention||7
2479232|NCT00919867|6079495|P3|STARTED|Third Intervention||6
2479233|NCT00919867|6079496|P2|STARTED|Third Intervention||7
2479234|NCT00919867|6079497|P1|STARTED|Third Intervention||7
2479235|NCT00919867|6079492|P6|NOT COMPLETED|Washout||0
2479236|NCT00919867|6079493|P5|NOT COMPLETED|Washout||0
2479237|NCT00919867|6079494|P4|NOT COMPLETED|Washout||0
2479238|NCT00919867|6079495|P3|NOT COMPLETED|Washout||0
2479239|NCT00919867|6079496|P2|NOT COMPLETED|Washout||0
2479240|NCT00919867|6079497|P1|NOT COMPLETED|Washout||0
2479241|NCT00919867|6079492|P6|COMPLETED|Washout||6
2479242|NCT00919867|6079493|P5|COMPLETED|Washout||7
2479243|NCT00919867|6079494|P4|COMPLETED|Washout||7
2479244|NCT00919867|6079495|P3|COMPLETED|Washout||6
2479245|NCT00919867|6079496|P2|COMPLETED|Washout||7
2479246|NCT00919867|6079497|P1|COMPLETED|Washout||7
2479247|NCT00919867|6079492|P6|STARTED|Washout||6
2479248|NCT00919867|6079493|P5|STARTED|Washout||7
2479249|NCT00919867|6079494|P4|STARTED|Washout||7
2479250|NCT00919867|6079495|P3|STARTED|Washout||6
2479251|NCT00919867|6079496|P2|STARTED|Washout||7
2479252|NCT00919867|6079497|P1|STARTED|Washout||7
2479253|NCT00919867|6079492|P6|NOT COMPLETED|Second Intervention||0
2479254|NCT00919867|6079493|P5|NOT COMPLETED|Second Intervention||0
2479255|NCT00919867|6079494|P4|NOT COMPLETED|Second Intervention||0
2479256|NCT00919867|6079495|P3|NOT COMPLETED|Second Intervention||0
2479257|NCT00919867|6079496|P2|NOT COMPLETED|Second Intervention||0
2479258|NCT00919867|6079497|P1|NOT COMPLETED|Second Intervention||0
2479259|NCT00919867|6079492|P6|COMPLETED|Second Intervention||6
2479260|NCT00919867|6079493|P5|COMPLETED|Second Intervention||7
2479261|NCT00919867|6079494|P4|COMPLETED|Second Intervention||7
2479262|NCT00919867|6079495|P3|COMPLETED|Second Intervention||6
2479263|NCT00919867|6079496|P2|COMPLETED|Second Intervention||7
2479264|NCT00919867|6079497|P1|COMPLETED|Second Intervention||7
2479265|NCT00919867|6079492|P6|STARTED|Second Intervention||6
2479266|NCT00919867|6079493|P5|STARTED|Second Intervention||7
2479267|NCT00919867|6079494|P4|STARTED|Second Intervention||7
2479268|NCT00919867|6079495|P3|STARTED|Second Intervention||6
2479269|NCT00919867|6079496|P2|STARTED|Second Intervention||7
2479270|NCT00919867|6079497|P1|STARTED|Second Intervention||7
2479271|NCT00919867|6079492|P6|NOT COMPLETED|Washout||0
2479272|NCT00919867|6079493|P5|NOT COMPLETED|Washout||0
2479273|NCT00919867|6079494|P4|NOT COMPLETED|Washout||0
2479274|NCT00919867|6079495|P3|NOT COMPLETED|Washout||0
2479275|NCT00919867|6079496|P2|NOT COMPLETED|Washout||0
2479276|NCT00919867|6079497|P1|NOT COMPLETED|Washout||0
2479277|NCT00919867|6079492|P6|COMPLETED|Washout||6
2479278|NCT00919867|6079493|P5|COMPLETED|Washout||7
2479279|NCT00919867|6079494|P4|COMPLETED|Washout||7
2479280|NCT00919867|6079495|P3|COMPLETED|Washout||6
2479281|NCT00919867|6079496|P2|COMPLETED|Washout||7
2479282|NCT00919867|6079497|P1|COMPLETED|Washout||7
2479283|NCT00919867|6079492|P6|STARTED|Washout||6
2479284|NCT00919867|6079493|P5|STARTED|Washout||7
2479285|NCT00919867|6079494|P4|STARTED|Washout||7
2479286|NCT00919867|6079495|P3|STARTED|Washout||6
2479287|NCT00919867|6079496|P2|STARTED|Washout||7
2479288|NCT00919867|6079497|P1|STARTED|Washout||7
2479289|NCT00919867|6079492|P6|NOT COMPLETED|First Intervention||1
2479290|NCT00919867|6079493|P5|NOT COMPLETED|First Intervention||0
2479291|NCT00919867|6079494|P4|NOT COMPLETED|First Intervention||0
2479292|NCT00919867|6079495|P3|NOT COMPLETED|First Intervention||1
2479293|NCT00919867|6079496|P2|NOT COMPLETED|First Intervention||0
2479294|NCT00919867|6079497|P1|NOT COMPLETED|First Intervention||0
2479295|NCT00919867|6079492|P6|COMPLETED|First Intervention||6
2479296|NCT00919867|6079493|P5|COMPLETED|First Intervention||7
2479297|NCT00919867|6079494|P4|COMPLETED|First Intervention||7
2479298|NCT00919867|6079495|P3|COMPLETED|First Intervention||6
2479299|NCT00919867|6079496|P2|COMPLETED|First Intervention||7
2479300|NCT00919867|6079497|P1|COMPLETED|First Intervention||7
2479301|NCT00919867|6079492|P6|STARTED|First Intervention||7
2479302|NCT00919867|6079493|P5|STARTED|First Intervention||7
2479303|NCT00919867|6079494|P4|STARTED|First Intervention||7
2479304|NCT00919867|6079495|P3|STARTED|First Intervention||7
2479305|NCT00919867|6079496|P2|STARTED|First Intervention||7
2479306|NCT00919867|6079497|P1|STARTED|First Intervention||7
2479307|NCT00919854|6079518|P1|NOT COMPLETED|Overall Study||1
2479308|NCT00919854|6079518|P1|COMPLETED|Overall Study|'Completed' represents the patients that are ongoing at the time of cut-off for the Week 24 analysis|20
2479309|NCT00919854|6079518|P1|STARTED|Overall Study||21
2479310|NCT00919802|6079527|P2|NOT COMPLETED|Second Intervention - (24 Hours)||0
2479311|NCT00919802|6079528|P1|NOT COMPLETED|Second Intervention - (24 Hours)||0
2479312|NCT00919802|6079527|P2|COMPLETED|Second Intervention - (24 Hours)||13
2479313|NCT00919802|6079528|P1|COMPLETED|Second Intervention - (24 Hours)||12
2479314|NCT00919802|6079527|P2|STARTED|Second Intervention - (24 Hours)||13
2479315|NCT00919802|6079528|P1|STARTED|Second Intervention - (24 Hours)||12
2479316|NCT00919802|6079527|P2|NOT COMPLETED|First Intervention - (24 Hours)||0
2479317|NCT00919802|6079528|P1|NOT COMPLETED|First Intervention - (24 Hours)||0
2479318|NCT00919802|6079527|P2|COMPLETED|First Intervention - (24 Hours)||13
2479319|NCT00919802|6079528|P1|COMPLETED|First Intervention - (24 Hours)||12
2479320|NCT00919802|6079527|P2|STARTED|First Intervention - (24 Hours)||13
2479321|NCT00919802|6079528|P1|STARTED|First Intervention - (24 Hours)||12
2479322|NCT00919763|6079538|P2|NOT COMPLETED|Overall Study||4
2479323|NCT00919763|6079539|P1|NOT COMPLETED|Overall Study||12
2479324|NCT00919763|6079538|P2|COMPLETED|Overall Study||45
2479325|NCT00919763|6079539|P1|COMPLETED|Overall Study||41
2479326|NCT00919763|6079538|P2|STARTED|Overall Study||49
2479327|NCT00919763|6079539|P1|STARTED|Overall Study||53
2479328|NCT00919724|6079547|P2|NOT COMPLETED|Overall Study||0
2479329|NCT00919724|6079548|P1|NOT COMPLETED|Overall Study||0
2479330|NCT00919724|6079547|P2|COMPLETED|Overall Study||44
2479331|NCT00919724|6079548|P1|COMPLETED|Overall Study||45
2479332|NCT00919724|6079547|P2|STARTED|Overall Study||44
2479333|NCT00919724|6079548|P1|STARTED|Overall Study||45
2479334|NCT00919711|6079556|P2|NOT COMPLETED|Overall Study||13
2479335|NCT00919711|6079557|P1|NOT COMPLETED|Overall Study||33
2479336|NCT00919711|6079556|P2|COMPLETED|Overall Study||422
2479337|NCT00919711|6079557|P1|COMPLETED|Overall Study||402
2479338|NCT00919711|6079556|P2|STARTED|Overall Study||435
2479339|NCT00919711|6079557|P1|STARTED|Overall Study||435
2479340|NCT00919633|6079573|P4|NOT COMPLETED|Overall Study||21
2479341|NCT00919633|6079574|P3|NOT COMPLETED|Overall Study||23
2479342|NCT00919633|6079575|P2|NOT COMPLETED|Overall Study||15
2479343|NCT00919633|6079576|P1|NOT COMPLETED|Overall Study||22
2479344|NCT00919633|6079573|P4|COMPLETED|Overall Study||5
2479345|NCT00919633|6079574|P3|COMPLETED|Overall Study||4
2479346|NCT00919633|6079575|P2|COMPLETED|Overall Study||10
2479347|NCT00919633|6079576|P1|COMPLETED|Overall Study||6
2479348|NCT00919633|6079573|P4|STARTED|Overall Study||26
2479349|NCT00919633|6079574|P3|STARTED|Overall Study||27
2479350|NCT00919633|6079575|P2|STARTED|Overall Study||25
2479351|NCT00919633|6079576|P1|STARTED|Overall Study||28
2479352|NCT00919191|6079594|P1|NOT COMPLETED|Overall Study||0
2479353|NCT00919191|6079594|P1|COMPLETED|Overall Study||26
2479354|NCT00919191|6079594|P1|STARTED|Overall Study||26
2479355|NCT00919126|6079604|P3|NOT COMPLETED|Overall Study||1
2479356|NCT00919126|6079605|P2|NOT COMPLETED|Overall Study||5
2479357|NCT00919126|6079606|P1|NOT COMPLETED|Overall Study||1
2479358|NCT00919126|6079604|P3|COMPLETED|Overall Study||32
2479359|NCT00919126|6079605|P2|COMPLETED|Overall Study||32
2479360|NCT00919126|6079606|P1|COMPLETED|Overall Study||31
2479361|NCT00919126|6079604|P3|STARTED|Overall Study||33
2479362|NCT00919126|6079605|P2|STARTED|Overall Study||37
2479363|NCT00919126|6079606|P1|STARTED|Overall Study||32
2479364|NCT00919113|6079652|P2|NOT COMPLETED|Overall Study||8
2479365|NCT00919113|6079653|P1|NOT COMPLETED|Overall Study||9
2479366|NCT00919113|6079652|P2|COMPLETED|Overall Study||40
2479367|NCT00919113|6079653|P1|COMPLETED|Overall Study||41
2479368|NCT00919113|6079652|P2|Received Placebo|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
2479369|NCT00919113|6079653|P1|Received Placebo|Overall Study||0
2479370|NCT00919113|6079652|P2|Received Uracyst|Overall Study||0
2479371|NCT00919113|6079653|P1|Received Uracyst|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
2479372|NCT00919113|6079652|P2|STARTED|Overall Study||48
2479373|NCT00919113|6079653|P1|STARTED|Overall Study||50
2479374|NCT00919100|6079663|P2|NOT COMPLETED|Overall Study||0
2479375|NCT00919100|6079664|P1|NOT COMPLETED|Overall Study||0
2479376|NCT00919100|6079663|P2|COMPLETED|Overall Study||41
2479377|NCT00919100|6079664|P1|COMPLETED|Overall Study||40
2479378|NCT00919100|6079663|P2|STARTED|Overall Study||41
2479379|NCT00919100|6079664|P1|STARTED|Overall Study||40
2479380|NCT00919061|6079674|P1|NOT COMPLETED|Overall Study||2
2479381|NCT00919061|6079674|P1|COMPLETED|Overall Study||37
2479382|NCT00919061|6079674|P1|STARTED|Overall Study||39
2479383|NCT00919035|6079679|P1|NOT COMPLETED|Overall Study||0
2479384|NCT00919035|6079679|P1|COMPLETED|Overall Study||21
2479385|NCT00919035|6079679|P1|STARTED|Overall Study||21
2479386|NCT00918957|6079687|P2|NOT COMPLETED|Overall Study||0
2479387|NCT00918957|6079688|P1|NOT COMPLETED|Overall Study||3
2479388|NCT00918957|6079687|P2|COMPLETED|Overall Study||30
2479389|NCT00918957|6079688|P1|COMPLETED|Overall Study||29
2479390|NCT00918957|6079687|P2|STARTED|Overall Study||30
2479391|NCT00918957|6079688|P1|STARTED|Overall Study||32
2479392|NCT00918931|6079715|P1|NOT COMPLETED|Overall Study||0
2479393|NCT00918931|6079715|P1|COMPLETED|Overall Study||3
2479394|NCT00918931|6079715|P1|STARTED|Overall Study||3
2479395|NCT00918879|6079721|P2|NOT COMPLETED|Overall Study||6
2479396|NCT00918879|6079722|P1|NOT COMPLETED|Overall Study||6
2479397|NCT00918879|6079721|P2|COMPLETED|Overall Study|Completed 24 weeks of treatment|100
2479398|NCT00918879|6079722|P1|COMPLETED|Overall Study|Completed 24 weeks of treatment|101
2479399|NCT00918879|6079721|P2|STARTED|Overall Study|Randomized and treated|106
2479400|NCT00918879|6079722|P1|STARTED|Overall Study|Randomized and treated|107
2479401|NCT00918866|6079736|P2|NOT COMPLETED|Overall Study||0
2479402|NCT00918866|6079737|P1|NOT COMPLETED|Overall Study||0
2479403|NCT00918866|6079736|P2|COMPLETED|Overall Study||16
2479404|NCT00918866|6079737|P1|COMPLETED|Overall Study||16
2479405|NCT00918866|6079736|P2|STARTED|Overall Study||16
2479406|NCT00918866|6079737|P1|STARTED|Overall Study||16
2479407|NCT00918749|6079754|P3|NOT COMPLETED|Overall Study||7
2479408|NCT00918749|6079755|P2|NOT COMPLETED|Overall Study||3
2479409|NCT00918749|6079756|P1|NOT COMPLETED|Overall Study||7
2479410|NCT00918749|6079754|P3|COMPLETED|Overall Study||62
2479411|NCT00918749|6079755|P2|COMPLETED|Overall Study||63
2479412|NCT00918749|6079756|P1|COMPLETED|Overall Study||63
2479413|NCT00918749|6079754|P3|ITT (Intent to Treat) Population|Overall Study||69
2479414|NCT00918749|6079755|P2|ITT (Intent to Treat) Population|Overall Study||66
2479415|NCT00918749|6079756|P1|ITT (Intent to Treat) Population|Overall Study|One subject took no study drug and was not included in ITT Population|69
2479416|NCT00918749|6079754|P3|STARTED|Overall Study||69
2479417|NCT00918749|6079755|P2|STARTED|Overall Study||66
2479418|NCT00918749|6079756|P1|STARTED|Overall Study||70
2479419|NCT00918736|6079788|P1|NOT COMPLETED|Overall Study||4
2479420|NCT00918736|6079788|P1|COMPLETED|Overall Study|October, 2008|46
2479421|NCT00918736|6079788|P1|STARTED|Overall Study|October, 2007|50
2479425|NCT00918684|6079801|P1|NOT COMPLETED|Treatment Phase||25
2479426|NCT00918684|6079801|P1|COMPLETED|Treatment Phase||65
2479427|NCT00918684|6079801|P1|STARTED|Treatment Phase||90
2479428|NCT00918684|6079801|P1|NOT COMPLETED|Two Week Drug Washout and Placebo Phase||16
2479429|NCT00918684|6079801|P1|COMPLETED|Two Week Drug Washout and Placebo Phase||90
2479430|NCT00918684|6079801|P1|STARTED|Two Week Drug Washout and Placebo Phase||106
2479431|NCT00918671|6079807|P1|NOT COMPLETED|Overall Study||0
2479432|NCT00918671|6079807|P1|COMPLETED|Overall Study||60
2479433|NCT00918671|6079807|P1|STARTED|Overall Study||60
2479434|NCT00918645|6079812|P1|NOT COMPLETED|Overall Study||1
2479435|NCT00918645|6079812|P1|COMPLETED|Overall Study||12
2479436|NCT00918645|6079812|P1|STARTED|Overall Study||13
2479437|NCT00918580|6079818|P1|NOT COMPLETED|After 6-month FU to 1-year FU||60
2479438|NCT00918580|6079818|P1|COMPLETED|After 6-month FU to 1-year FU||87
2479439|NCT00918580|6079818|P1|Continued After 6-Month FU|After 6-month FU to 1-year FU||89
2479440|NCT00918580|6079818|P1|STARTED|After 6-month FU to 1-year FU||147
2479441|NCT00918580|6079818|P1|NOT COMPLETED|Up to 6-month Follow-up(FU)||11
2479442|NCT00918580|6079818|P1|COMPLETED|Up to 6-month Follow-up(FU)|Completed include 1 participant:withdrew before Dose 2 (protocol violation) but completed 6-month FU|147
2479443|NCT00918580|6079818|P1|Vaccinated Dose 2|Up to 6-month Follow-up(FU)||146
2479444|NCT00918580|6079818|P1|Vaccinated Dose 1|Up to 6-month Follow-up(FU)||158
2479445|NCT00918580|6079818|P1|STARTED|Up to 6-month Follow-up(FU)||158
2479446|NCT00918463|6079836|P1|NOT COMPLETED|Overall Study||2
2479447|NCT00918463|6079836|P1|COMPLETED|Overall Study||0
2479448|NCT00918463|6079836|P1|STARTED|Overall Study||2
2479449|NCT00918385|6079844|P2|NOT COMPLETED|Combination Nilutamide and Dasatinib||8
2479450|NCT00918385|6079845|P1|NOT COMPLETED|Combination Nilutamide and Dasatinib||6
2479451|NCT00918385|6079844|P2|COMPLETED|Combination Nilutamide and Dasatinib||3
2479452|NCT00918385|6079845|P1|COMPLETED|Combination Nilutamide and Dasatinib||6
2479453|NCT00918385|6079844|P2|STARTED|Combination Nilutamide and Dasatinib||11
2479454|NCT00918385|6079845|P1|STARTED|Combination Nilutamide and Dasatinib||12
2479455|NCT00918385|6079844|P2|NOT COMPLETED|Monotherapy||6
2479456|NCT00918385|6079845|P1|NOT COMPLETED|Monotherapy||2
2479457|NCT00918385|6079844|P2|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|11
2479539|NCT00918125|6079987|P2|NOT COMPLETED|Overall Study||0
2479458|NCT00918385|6079845|P1|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|12
2479459|NCT00918385|6079844|P2|STARTED|Monotherapy||17
2479460|NCT00918385|6079845|P1|STARTED|Monotherapy||14
2479461|NCT00918346|6079854|P2|NOT COMPLETED|Post Study Period||0
2479462|NCT00918346|6079855|P1|NOT COMPLETED|Post Study Period||0
2479463|NCT00918346|6079854|P2|COMPLETED|Post Study Period||21
2479464|NCT00918346|6079855|P1|COMPLETED|Post Study Period||21
2479465|NCT00918346|6079854|P2|STARTED|Post Study Period||21
2479466|NCT00918346|6079855|P1|STARTED|Post Study Period||21
2479467|NCT00918346|6079854|P2|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
2479468|NCT00918346|6079855|P1|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
2479469|NCT00918346|6079854|P2|COMPLETED|Second Treatment Period (4 Weeks)||21
2479470|NCT00918346|6079855|P1|COMPLETED|Second Treatment Period (4 Weeks)||21
2479471|NCT00918346|6079854|P2|STARTED|Second Treatment Period (4 Weeks)||21
2479472|NCT00918346|6079855|P1|STARTED|Second Treatment Period (4 Weeks)||21
2479473|NCT00918346|6079854|P2|NOT COMPLETED|Washout (at Least 4 Weeks)||0
2479474|NCT00918346|6079855|P1|NOT COMPLETED|Washout (at Least 4 Weeks)||0
2479475|NCT00918346|6079854|P2|COMPLETED|Washout (at Least 4 Weeks)||21
2479476|NCT00918346|6079855|P1|COMPLETED|Washout (at Least 4 Weeks)||21
2479477|NCT00918346|6079854|P2|STARTED|Washout (at Least 4 Weeks)||21
2479478|NCT00918346|6079855|P1|STARTED|Washout (at Least 4 Weeks)||21
2479479|NCT00918346|6079854|P2|NOT COMPLETED|First Treatment Period (4 Weeks)||1
2479480|NCT00918346|6079855|P1|NOT COMPLETED|First Treatment Period (4 Weeks)||0
2479481|NCT00918346|6079854|P2|COMPLETED|First Treatment Period (4 Weeks)|A patient completed the first treatment period but discontinued thereafter (did not start washout).|21
2479482|NCT00918346|6079855|P1|COMPLETED|First Treatment Period (4 Weeks)||21
2479483|NCT00918346|6079854|P2|STARTED|First Treatment Period (4 Weeks)||22
2479484|NCT00918346|6079855|P1|STARTED|First Treatment Period (4 Weeks)||21
2479491|NCT00918281|6079892|P1|NOT COMPLETED|Overall Study||29
2479492|NCT00918281|6079892|P1|COMPLETED|Overall Study||41
2479493|NCT00918281|6079892|P1|STARTED|Overall Study||70
2479494|NCT00918255|6079902|P3|NOT COMPLETED|Overall Study||5
2479495|NCT00918255|6079903|P2|NOT COMPLETED|Overall Study||0
2479496|NCT00918255|6079904|P1|NOT COMPLETED|Overall Study||6
2479497|NCT00918255|6079902|P3|COMPLETED|Overall Study||46
2479498|NCT00918255|6079903|P2|COMPLETED|Overall Study||52
2479499|NCT00918255|6079904|P1|COMPLETED|Overall Study||45
2479500|NCT00918255|6079902|P3|STARTED|Overall Study||51
2479501|NCT00918255|6079903|P2|STARTED|Overall Study||52
2479502|NCT00918255|6079904|P1|STARTED|Overall Study||51
2479503|NCT00918229|6079930|P1|NOT COMPLETED|Overall Study||0
2479504|NCT00918229|6079930|P1|COMPLETED|Overall Study||24
2479505|NCT00918229|6079930|P1|STARTED|Overall Study||24
2479506|NCT00918203|6079937|P3|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
2479507|NCT00918203|6079938|P2|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
2479508|NCT00918203|6079939|P1|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
2479509|NCT00918203|6079937|P3|COMPLETED|Crossover to Olaratumab Monotherapy||18
2479510|NCT00918203|6079938|P2|COMPLETED|Crossover to Olaratumab Monotherapy||0
2479511|NCT00918203|6079939|P1|COMPLETED|Crossover to Olaratumab Monotherapy||0
2479512|NCT00918203|6079937|P3|STARTED|Crossover to Olaratumab Monotherapy|18 participants who had progressive disease crossed over to monotherapy.|18
2479513|NCT00918203|6079938|P2|STARTED|Crossover to Olaratumab Monotherapy||0
2479514|NCT00918203|6079939|P1|STARTED|Crossover to Olaratumab Monotherapy||0
2479515|NCT00918203|6079937|P3|NOT COMPLETED|Treatment With or Without Olaratumab||0
2479516|NCT00918203|6079938|P2|NOT COMPLETED|Treatment With or Without Olaratumab||10
2479517|NCT00918203|6079939|P1|NOT COMPLETED|Treatment With or Without Olaratumab||6
2479518|NCT00918203|6079937|P3|COMPLETED|Treatment With or Without Olaratumab||0
2479519|NCT00918203|6079938|P2|COMPLETED|Treatment With or Without Olaratumab||57
2479520|NCT00918203|6079939|P1|COMPLETED|Treatment With or Without Olaratumab||64
2479521|NCT00918203|6079937|P3|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||0
2479522|NCT00918203|6079938|P2|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||10
2479523|NCT00918203|6079939|P1|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||11
2479524|NCT00918203|6079937|P3|Death Due to Any Cause|Treatment With or Without Olaratumab||0
2479525|NCT00918203|6079938|P2|Death Due to Any Cause|Treatment With or Without Olaratumab||47
2479526|NCT00918203|6079939|P1|Death Due to Any Cause|Treatment With or Without Olaratumab||53
2479527|NCT00918203|6079937|P3|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||0
2479528|NCT00918203|6079938|P2|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||64
2479529|NCT00918203|6079939|P1|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||67
2479530|NCT00918203|6079937|P3|STARTED|Treatment With or Without Olaratumab||0
2479531|NCT00918203|6079938|P2|STARTED|Treatment With or Without Olaratumab||67
2479532|NCT00918203|6079939|P1|STARTED|Treatment With or Without Olaratumab||70
2479533|NCT00918138|6079970|P2|NOT COMPLETED|Overall Study||1
2479534|NCT00918138|6079971|P1|NOT COMPLETED|Overall Study||2
2479535|NCT00918138|6079970|P2|COMPLETED|Overall Study||46
2479536|NCT00918138|6079971|P1|COMPLETED|Overall Study||44
2479537|NCT00918138|6079970|P2|STARTED|Overall Study||47
2479538|NCT00918138|6079971|P1|STARTED|Overall Study||46
2479540|NCT00918125|6079988|P1|NOT COMPLETED|Overall Study||0
2479541|NCT00918125|6079987|P2|COMPLETED|Overall Study||39
2479542|NCT00918125|6079988|P1|COMPLETED|Overall Study||20
2479543|NCT00918125|6079987|P2|STARTED|Overall Study||39
2479544|NCT00918125|6079988|P1|STARTED|Overall Study||20
2479545|NCT00917865|6079999|P1|NOT COMPLETED|Overall Study||0
2479546|NCT00917865|6079999|P1|COMPLETED|Overall Study||11
2479547|NCT00917865|6079999|P1|STARTED|Overall Study||11
2479548|NCT00917852|6080010|P1|NOT COMPLETED|Overall Study||6
2479549|NCT00917852|6080010|P1|COMPLETED|Overall Study||45
2479550|NCT00917852|6080010|P1|STARTED|Overall Study||51
2479551|NCT00917735|6080017|P2|NOT COMPLETED|Overall Study||63
2479552|NCT00917735|6080018|P1|NOT COMPLETED|Overall Study||75
2479553|NCT00917735|6080017|P2|COMPLETED|Overall Study||474
2479554|NCT00917735|6080018|P1|COMPLETED|Overall Study||463
2479555|NCT00917735|6080017|P2|STARTED|Overall Study||537
2479556|NCT00917735|6080018|P1|STARTED|Overall Study||538
2479557|NCT00917644|6080028|P2|NOT COMPLETED|Period 2: Second Intervention||0
2479558|NCT00917644|6080029|P1|NOT COMPLETED|Period 2: Second Intervention||1
2479559|NCT00917644|6080028|P2|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Ref drug = 73.|37
2479560|NCT00917644|6080029|P1|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Test drug = 74.|36
2479561|NCT00917644|6080028|P2|STARTED|Period 2: Second Intervention|Washout: Reference drug (Ref) 1st, completed = 37; 2nd period: Ref drug 2nd, completed = 36.|37
2479562|NCT00917644|6080029|P1|STARTED|Period 2: Second Intervention|Washout: Test drug 1st, completed = 37; 2nd period: Test drug 2nd, completed = 37.|37
2479563|NCT00917644|6080028|P2|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||0
2479564|NCT00917644|6080029|P1|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||2
2479565|NCT00917644|6080028|P2|COMPLETED|Period: Washout Period of > = 2 Weeks||37
2479566|NCT00917644|6080029|P1|COMPLETED|Period: Washout Period of > = 2 Weeks||37
2479567|NCT00917644|6080028|P2|STARTED|Period: Washout Period of > = 2 Weeks||37
2479568|NCT00917644|6080029|P1|STARTED|Period: Washout Period of > = 2 Weeks||39
2479569|NCT00917644|6080028|P2|NOT COMPLETED|Period 1: First Intervention||0
2479570|NCT00917644|6080029|P1|NOT COMPLETED|Period 1: First Intervention||0
2479571|NCT00917644|6080028|P2|COMPLETED|Period 1: First Intervention||37
2479572|NCT00917644|6080029|P1|COMPLETED|Period 1: First Intervention||39
2479573|NCT00917644|6080028|P2|STARTED|Period 1: First Intervention||37
2479574|NCT00917644|6080029|P1|STARTED|Period 1: First Intervention||39
2479575|NCT00917579|6080043|P2|NOT COMPLETED|Period 2: 2nd Intervention||0
2479576|NCT00917579|6080044|P1|NOT COMPLETED|Period 2: 2nd Intervention||0
2479577|NCT00917579|6080043|P2|COMPLETED|Period 2: 2nd Intervention||37
2479578|NCT00917579|6080044|P1|COMPLETED|Period 2: 2nd Intervention||37
2479579|NCT00917579|6080043|P2|STARTED|Period 2: 2nd Intervention||37
2479580|NCT00917579|6080044|P1|STARTED|Period 2: 2nd Intervention||37
2479581|NCT00917579|6080043|P2|NOT COMPLETED|Washout >= 2 Weeks||0
2479582|NCT00917579|6080044|P1|NOT COMPLETED|Washout >= 2 Weeks||2
2479583|NCT00917579|6080043|P2|COMPLETED|Washout >= 2 Weeks||37
2479584|NCT00917579|6080044|P1|COMPLETED|Washout >= 2 Weeks||37
2479585|NCT00917579|6080043|P2|STARTED|Washout >= 2 Weeks||37
2479586|NCT00917579|6080044|P1|STARTED|Washout >= 2 Weeks||39
2479587|NCT00917579|6080043|P2|NOT COMPLETED|Period 1: 1st Intervention||0
2479588|NCT00917579|6080044|P1|NOT COMPLETED|Period 1: 1st Intervention||0
2479589|NCT00917579|6080043|P2|COMPLETED|Period 1: 1st Intervention||37
2479590|NCT00917579|6080044|P1|COMPLETED|Period 1: 1st Intervention||39
2479591|NCT00917579|6080043|P2|STARTED|Period 1: 1st Intervention||37
2479592|NCT00917579|6080044|P1|STARTED|Period 1: 1st Intervention||39
2479593|NCT00917553|6080060|P2|NOT COMPLETED|Overall Study||1
2479594|NCT00917553|6080061|P1|NOT COMPLETED|Overall Study||2
2479595|NCT00917553|6080060|P2|COMPLETED|Overall Study||15
2479596|NCT00917553|6080061|P1|COMPLETED|Overall Study||15
2479597|NCT00917553|6080060|P2|STARTED|Overall Study||16
2479598|NCT00917553|6080061|P1|STARTED|Overall Study||17
2479599|NCT00917501|6080077|P2|NOT COMPLETED|Overall Study||5
2479600|NCT00917501|6080078|P1|NOT COMPLETED|Overall Study||8
2479601|NCT00917501|6080077|P2|COMPLETED|Overall Study||21
2479602|NCT00917501|6080078|P1|COMPLETED|Overall Study||21
2479603|NCT00917501|6080077|P2|STARTED|Overall Study||26
2479604|NCT00917501|6080078|P1|STARTED|Overall Study||29
2479605|NCT00917462|6080084|P1|NOT COMPLETED|Overall Study||1
2479606|NCT00917462|6080084|P1|COMPLETED|Overall Study||34
2479607|NCT00917462|6080084|P1|STARTED|Overall Study||35
2479608|NCT00917384|6080094|P2|NOT COMPLETED|Overall Study||4
2479609|NCT00917384|6080095|P1|NOT COMPLETED|Overall Study||14
2479610|NCT00917384|6080094|P2|COMPLETED|Overall Study||113
2479611|NCT00917384|6080095|P1|COMPLETED|Overall Study||224
2479612|NCT00917384|6080094|P2|Received at Least 1 Dose of Study Drug|Overall Study||115
2479613|NCT00917384|6080095|P1|Received at Least 1 Dose of Study Drug|Overall Study||236
2479614|NCT00917384|6080094|P2|STARTED|Overall Study||117
2479615|NCT00917384|6080095|P1|STARTED|Overall Study||238
2479616|NCT00917267|6080119|P2|NOT COMPLETED|Overall Study||79
2479617|NCT00917267|6080120|P1|NOT COMPLETED|Overall Study||39
2479618|NCT00917267|6080119|P2|COMPLETED|Overall Study||266
2479619|NCT00917267|6080120|P1|COMPLETED|Overall Study||307
2479620|NCT00917267|6080119|P2|Intent to Treat (ITT)|Overall Study||338
2479621|NCT00917267|6080120|P1|Intent to Treat (ITT)|Overall Study||340
2479622|NCT00917267|6080119|P2|STARTED|Overall Study||345
2479623|NCT00917267|6080120|P1|STARTED|Overall Study||346
2479624|NCT00917124|6080148|P2|NOT COMPLETED|Overall Study||6
2479625|NCT00917124|6080149|P1|NOT COMPLETED|Overall Study||4
2479626|NCT00917124|6080148|P2|COMPLETED|Overall Study||94
2479627|NCT00917124|6080149|P1|COMPLETED|Overall Study||96
2479628|NCT00917124|6080148|P2|STARTED|Overall Study||100
2479629|NCT00917124|6080149|P1|STARTED|Overall Study||100
2479630|NCT00916929|6080159|P2|NOT COMPLETED|Overall Study||29
2479631|NCT00916929|6080160|P1|NOT COMPLETED|Overall Study||10
2479632|NCT00916929|6080159|P2|COMPLETED|Overall Study||53
2479633|NCT00916929|6080160|P1|COMPLETED|Overall Study||70
2479634|NCT00916929|6080159|P2|STARTED|Overall Study||82
2479635|NCT00916929|6080160|P1|STARTED|Overall Study||80
2479636|NCT00916721|6080170|P2|NOT COMPLETED|Overall Study||10
2479637|NCT00916721|6080171|P1|NOT COMPLETED|Overall Study||10
2479638|NCT00916721|6080170|P2|COMPLETED|Overall Study||29
2479639|NCT00916721|6080171|P1|COMPLETED|Overall Study||25
2479640|NCT00916721|6080170|P2|STARTED|Overall Study||39
2479641|NCT00916721|6080171|P1|STARTED|Overall Study||35
2479642|NCT00916643|6080183|P1|NOT COMPLETED|Overall Study||0
2479643|NCT00916643|6080183|P1|COMPLETED|Overall Study||113
2479644|NCT00916643|6080183|P1|STARTED|Overall Study||113
2479645|NCT00916617|6080194|P4|NOT COMPLETED|Overall Study||7
2479646|NCT00916617|6080195|P3|NOT COMPLETED|Overall Study||10
2479647|NCT00916617|6080196|P2|NOT COMPLETED|Overall Study||21
2479648|NCT00916617|6080197|P1|NOT COMPLETED|Overall Study||23
2479649|NCT00916617|6080194|P4|COMPLETED|Overall Study||0
2479650|NCT00916617|6080195|P3|COMPLETED|Overall Study||0
2479651|NCT00916617|6080196|P2|COMPLETED|Overall Study||0
2479652|NCT00916617|6080197|P1|COMPLETED|Overall Study||1
2479653|NCT00916617|6080194|P4|STARTED|Overall Study||7
2479654|NCT00916617|6080195|P3|STARTED|Overall Study||10
2479655|NCT00916617|6080196|P2|STARTED|Overall Study||21
2479656|NCT00916617|6080197|P1|STARTED|Overall Study||24
2479657|NCT00916578|6080211|P1|NOT COMPLETED|Overall Study||7
2479658|NCT00916578|6080211|P1|COMPLETED|Overall Study||26
2479659|NCT00916578|6080211|P1|STARTED|Overall Study||33
2479660|NCT00916539|6080217|P2|NOT COMPLETED|Overall Study||0
2479661|NCT00916539|6080218|P1|NOT COMPLETED|Overall Study||0
2479662|NCT00916539|6080217|P2|COMPLETED|Overall Study||31
2479663|NCT00916539|6080218|P1|COMPLETED|Overall Study||31
2479664|NCT00916539|6080217|P2|STARTED|Overall Study||31
2479665|NCT00916539|6080218|P1|STARTED|Overall Study||31
2479666|NCT00916383|6080240|P1|NOT COMPLETED|Overall Study||3
2479667|NCT00916383|6080240|P1|COMPLETED|Overall Study||46
2479668|NCT00916383|6080240|P1|STARTED|Overall Study||49
2479669|NCT00916370|6080268|P2|NOT COMPLETED|Overall Study||2
2479670|NCT00916370|6080269|P1|NOT COMPLETED|Overall Study||5
2479671|NCT00916370|6080268|P2|COMPLETED|Overall Study||102
2479672|NCT00916370|6080269|P1|COMPLETED|Overall Study||396
2479673|NCT00916370|6080268|P2|STARTED|Overall Study||104
2479674|NCT00916370|6080269|P1|STARTED|Overall Study||401
2479675|NCT00916357|6080443|P6|NOT COMPLETED|Period 3||0
2479676|NCT00916357|6080444|P5|NOT COMPLETED|Period 3||0
2479677|NCT00916357|6080445|P4|NOT COMPLETED|Period 3||0
2479678|NCT00916357|6080446|P3|NOT COMPLETED|Period 3||0
2479679|NCT00916357|6080447|P2|NOT COMPLETED|Period 3||0
2479680|NCT00916357|6080448|P1|NOT COMPLETED|Period 3||0
2479681|NCT00916357|6080443|P6|COMPLETED|Period 3||4
2479682|NCT00916357|6080444|P5|COMPLETED|Period 3||3
2479683|NCT00916357|6080445|P4|COMPLETED|Period 3||3
2479684|NCT00916357|6080446|P3|COMPLETED|Period 3||4
2479685|NCT00916357|6080447|P2|COMPLETED|Period 3||4
2479686|NCT00916357|6080448|P1|COMPLETED|Period 3||3
2479687|NCT00916357|6080443|P6|STARTED|Period 3||4
2479688|NCT00916357|6080444|P5|STARTED|Period 3||3
2479689|NCT00916357|6080445|P4|STARTED|Period 3||3
2479690|NCT00916357|6080446|P3|STARTED|Period 3||4
2479691|NCT00916357|6080447|P2|STARTED|Period 3||4
2479692|NCT00916357|6080448|P1|STARTED|Period 3||3
2479693|NCT00916357|6080443|P6|NOT COMPLETED|Washout (3 to 14 Days)||0
2479694|NCT00916357|6080444|P5|NOT COMPLETED|Washout (3 to 14 Days)||0
2479695|NCT00916357|6080445|P4|NOT COMPLETED|Washout (3 to 14 Days)||0
2479696|NCT00916357|6080446|P3|NOT COMPLETED|Washout (3 to 14 Days)||0
2479697|NCT00916357|6080447|P2|NOT COMPLETED|Washout (3 to 14 Days)||0
2479698|NCT00916357|6080448|P1|NOT COMPLETED|Washout (3 to 14 Days)||0
2479699|NCT00916357|6080443|P6|COMPLETED|Washout (3 to 14 Days)||4
2479700|NCT00916357|6080444|P5|COMPLETED|Washout (3 to 14 Days)||3
2479701|NCT00916357|6080445|P4|COMPLETED|Washout (3 to 14 Days)||3
2479702|NCT00916357|6080446|P3|COMPLETED|Washout (3 to 14 Days)||4
2479703|NCT00916357|6080447|P2|COMPLETED|Washout (3 to 14 Days)||4
2479704|NCT00916357|6080448|P1|COMPLETED|Washout (3 to 14 Days)||3
2479705|NCT00916357|6080443|P6|STARTED|Washout (3 to 14 Days)||4
2479706|NCT00916357|6080444|P5|STARTED|Washout (3 to 14 Days)||3
2479707|NCT00916357|6080445|P4|STARTED|Washout (3 to 14 Days)||3
2479708|NCT00916357|6080446|P3|STARTED|Washout (3 to 14 Days)||4
2479709|NCT00916357|6080447|P2|STARTED|Washout (3 to 14 Days)||4
2479710|NCT00916357|6080448|P1|STARTED|Washout (3 to 14 Days)||3
2479711|NCT00916357|6080443|P6|NOT COMPLETED|Period 2||0
2479712|NCT00916357|6080444|P5|NOT COMPLETED|Period 2||0
2479713|NCT00916357|6080445|P4|NOT COMPLETED|Period 2||1
2479714|NCT00916357|6080446|P3|NOT COMPLETED|Period 2||0
2479715|NCT00916357|6080447|P2|NOT COMPLETED|Period 2||0
2479716|NCT00916357|6080448|P1|NOT COMPLETED|Period 2||0
2479717|NCT00916357|6080443|P6|COMPLETED|Period 2||4
2479718|NCT00916357|6080444|P5|COMPLETED|Period 2||3
2479719|NCT00916357|6080445|P4|COMPLETED|Period 2||3
2479720|NCT00916357|6080446|P3|COMPLETED|Period 2||4
2479721|NCT00916357|6080447|P2|COMPLETED|Period 2||4
2479722|NCT00916357|6080448|P1|COMPLETED|Period 2||3
2479723|NCT00916357|6080443|P6|STARTED|Period 2||4
2479724|NCT00916357|6080444|P5|STARTED|Period 2||3
2479725|NCT00916357|6080445|P4|STARTED|Period 2||4
2479726|NCT00916357|6080446|P3|STARTED|Period 2||4
2479727|NCT00916357|6080447|P2|STARTED|Period 2||4
2479728|NCT00916357|6080448|P1|STARTED|Period 2||3
2479729|NCT00916357|6080443|P6|NOT COMPLETED|Washout (3 to 14 Days)||0
2479730|NCT00916357|6080444|P5|NOT COMPLETED|Washout (3 to 14 Days)||0
2479731|NCT00916357|6080445|P4|NOT COMPLETED|Washout (3 to 14 Days)||0
2479732|NCT00916357|6080446|P3|NOT COMPLETED|Washout (3 to 14 Days)||0
2479733|NCT00916357|6080447|P2|NOT COMPLETED|Washout (3 to 14 Days)||0
2479734|NCT00916357|6080448|P1|NOT COMPLETED|Washout (3 to 14 Days)||0
2479735|NCT00916357|6080443|P6|COMPLETED|Washout (3 to 14 Days)||4
2479736|NCT00916357|6080444|P5|COMPLETED|Washout (3 to 14 Days)||3
2479737|NCT00916357|6080445|P4|COMPLETED|Washout (3 to 14 Days)||4
2479738|NCT00916357|6080446|P3|COMPLETED|Washout (3 to 14 Days)||4
2479739|NCT00916357|6080447|P2|COMPLETED|Washout (3 to 14 Days)||4
2479740|NCT00916357|6080448|P1|COMPLETED|Washout (3 to 14 Days)||3
2479741|NCT00916357|6080443|P6|STARTED|Washout (3 to 14 Days)||4
2479742|NCT00916357|6080444|P5|STARTED|Washout (3 to 14 Days)||3
2479743|NCT00916357|6080445|P4|STARTED|Washout (3 to 14 Days)||4
2479744|NCT00916357|6080446|P3|STARTED|Washout (3 to 14 Days)||4
2479745|NCT00916357|6080447|P2|STARTED|Washout (3 to 14 Days)||4
2479746|NCT00916357|6080448|P1|STARTED|Washout (3 to 14 Days)||3
2479747|NCT00916357|6080443|P6|NOT COMPLETED|Period 1||0
2479748|NCT00916357|6080444|P5|NOT COMPLETED|Period 1||0
2479749|NCT00916357|6080445|P4|NOT COMPLETED|Period 1||0
2479750|NCT00916357|6080446|P3|NOT COMPLETED|Period 1||0
2479751|NCT00916357|6080447|P2|NOT COMPLETED|Period 1||0
2479752|NCT00916357|6080448|P1|NOT COMPLETED|Period 1||1
2479753|NCT00916357|6080443|P6|COMPLETED|Period 1||4
2479754|NCT00916357|6080444|P5|COMPLETED|Period 1||3
2479755|NCT00916357|6080445|P4|COMPLETED|Period 1||4
2479756|NCT00916357|6080446|P3|COMPLETED|Period 1||4
2479757|NCT00916357|6080447|P2|COMPLETED|Period 1||4
2479758|NCT00916357|6080448|P1|COMPLETED|Period 1||3
2479759|NCT00916357|6080443|P6|Received at Least 1 Dose of Study Drug|Period 1||4
2479760|NCT00916357|6080444|P5|Received at Least 1 Dose of Study Drug|Period 1||3
2479761|NCT00916357|6080445|P4|Received at Least 1 Dose of Study Drug|Period 1||4
2479762|NCT00916357|6080446|P3|Received at Least 1 Dose of Study Drug|Period 1||4
2479763|NCT00916357|6080447|P2|Received at Least 1 Dose of Study Drug|Period 1||4
2479764|NCT00916357|6080448|P1|Received at Least 1 Dose of Study Drug|Period 1||4
2479765|NCT00916357|6080443|P6|STARTED|Period 1||4
2479766|NCT00916357|6080444|P5|STARTED|Period 1||3
2479767|NCT00916357|6080445|P4|STARTED|Period 1||4
2479768|NCT00916357|6080446|P3|STARTED|Period 1||4
2479769|NCT00916357|6080447|P2|STARTED|Period 1||4
2479770|NCT00916357|6080448|P1|STARTED|Period 1||4
2479771|NCT00916344|6080486|P1|NOT COMPLETED|Overall Study||8
2479772|NCT00916344|6080486|P1|COMPLETED|Overall Study||167
2479773|NCT00916344|6080486|P1|STARTED|Overall Study||175
2479774|NCT00916305|6080493|P2|NOT COMPLETED|Overall Study||28
2479775|NCT00916305|6080494|P1|NOT COMPLETED|Overall Study||21
2479776|NCT00916305|6080493|P2|COMPLETED|Overall Study||9
2479777|NCT00916305|6080494|P1|COMPLETED|Overall Study||7
2479778|NCT00916305|6080493|P2|STARTED|Overall Study||37
2479779|NCT00916305|6080494|P1|STARTED|Overall Study||28
2479780|NCT00916279|6080502|P1|NOT COMPLETED|Overall Study||4
2479781|NCT00916279|6080502|P1|COMPLETED|Overall Study||37
2479782|NCT00916279|6080502|P1|24 Months|Overall Study||37
2479783|NCT00916279|6080502|P1|6 Months|Overall Study||41
2479784|NCT00916279|6080502|P1|30 Days|Overall Study||41
2479785|NCT00916279|6080502|P1|STARTED|Overall Study||41
2479786|NCT00916149|6080513|P3|NOT COMPLETED|Overall Study||0
2479787|NCT00916149|6080514|P2|NOT COMPLETED|Overall Study||2
2479788|NCT00916149|6080515|P1|NOT COMPLETED|Overall Study||4
2479789|NCT00916149|6080513|P3|COMPLETED|Overall Study||5
2479790|NCT00916149|6080514|P2|COMPLETED|Overall Study||8
2479791|NCT00916149|6080515|P1|COMPLETED|Overall Study||12
2479792|NCT00916149|6080513|P3|STARTED|Overall Study||5
2479793|NCT00916149|6080514|P2|STARTED|Overall Study||10
2479794|NCT00916149|6080515|P1|STARTED|Overall Study||16
2479795|NCT00916136|6080586|P2|NOT COMPLETED|Overall Study||0
2479796|NCT00916136|6080587|P1|NOT COMPLETED|Overall Study||0
2479797|NCT00916136|6080586|P2|COMPLETED|Overall Study||29
2479798|NCT00916136|6080587|P1|COMPLETED|Overall Study||37
2479799|NCT00916136|6080586|P2|STARTED|Overall Study||29
2479800|NCT00916136|6080587|P1|STARTED|Overall Study||37
2479801|NCT00916058|6080602|P7|NOT COMPLETED|Phase 2||3
2479802|NCT00916058|6080603|P6|NOT COMPLETED|Phase 2||0
2479803|NCT00916058|6080604|P5|NOT COMPLETED|Phase 2||0
2479804|NCT00916058|6080605|P4|NOT COMPLETED|Phase 2||0
2479805|NCT00916058|6080606|P3|NOT COMPLETED|Phase 2||0
2479806|NCT00916058|6080607|P2|NOT COMPLETED|Phase 2||0
2479807|NCT00916058|6080608|P1|NOT COMPLETED|Phase 2||0
2479808|NCT00916058|6080602|P7|COMPLETED|Phase 2||28
2479809|NCT00916058|6080603|P6|COMPLETED|Phase 2||0
2479810|NCT00916058|6080604|P5|COMPLETED|Phase 2||0
2479811|NCT00916058|6080605|P4|COMPLETED|Phase 2||0
2479812|NCT00916058|6080606|P3|COMPLETED|Phase 2||0
2479813|NCT00916058|6080607|P2|COMPLETED|Phase 2||0
2479814|NCT00916058|6080608|P1|COMPLETED|Phase 2||0
2479815|NCT00916058|6080602|P7|STARTED|Phase 2||31
2479816|NCT00916058|6080603|P6|STARTED|Phase 2||0
2479817|NCT00916058|6080604|P5|STARTED|Phase 2||0
2479818|NCT00916058|6080605|P4|STARTED|Phase 2||0
2479819|NCT00916058|6080606|P3|STARTED|Phase 2||0
2479820|NCT00916058|6080607|P2|STARTED|Phase 2||0
2479821|NCT00916058|6080608|P1|STARTED|Phase 2||0
2479822|NCT00916058|6080602|P7|NOT COMPLETED|Phase 1||0
2479823|NCT00916058|6080603|P6|NOT COMPLETED|Phase 1||1
2479824|NCT00916058|6080604|P5|NOT COMPLETED|Phase 1||0
2479825|NCT00916058|6080605|P4|NOT COMPLETED|Phase 1||0
2479826|NCT00916058|6080606|P3|NOT COMPLETED|Phase 1||0
2479827|NCT00916058|6080607|P2|NOT COMPLETED|Phase 1||0
2479828|NCT00916058|6080608|P1|NOT COMPLETED|Phase 1||0
2479829|NCT00916058|6080602|P7|COMPLETED|Phase 1||0
2479830|NCT00916058|6080603|P6|COMPLETED|Phase 1||7
2479831|NCT00916058|6080604|P5|COMPLETED|Phase 1||3
2479832|NCT00916058|6080605|P4|COMPLETED|Phase 1||3
2479833|NCT00916058|6080606|P3|COMPLETED|Phase 1||3
2479834|NCT00916058|6080607|P2|COMPLETED|Phase 1||6
2479835|NCT00916058|6080608|P1|COMPLETED|Phase 1||3
2479836|NCT00916058|6080602|P7|STARTED|Phase 1||0
2479837|NCT00916058|6080603|P6|STARTED|Phase 1||8
2479838|NCT00916058|6080604|P5|STARTED|Phase 1||3
2479839|NCT00916058|6080605|P4|STARTED|Phase 1||3
2479840|NCT00916058|6080606|P3|STARTED|Phase 1||3
2479841|NCT00916058|6080607|P2|STARTED|Phase 1||6
2479842|NCT00916058|6080608|P1|STARTED|Phase 1||3
2479843|NCT00916032|6080628|P2|NOT COMPLETED|Overall Study||0
2479844|NCT00916032|6080629|P1|NOT COMPLETED|Overall Study||0
2479845|NCT00916032|6080628|P2|COMPLETED|Overall Study||11
2479846|NCT00916032|6080629|P1|COMPLETED|Overall Study||12
2479847|NCT00916032|6080628|P2|STARTED|Overall Study||11
2479848|NCT00916032|6080629|P1|STARTED|Overall Study||12
2479849|NCT00916006|6080671|P2|NOT COMPLETED|Overall Study||7
2479850|NCT00916006|6080672|P1|NOT COMPLETED|Overall Study||3
2479851|NCT00916006|6080671|P2|COMPLETED|Overall Study||127
2479852|NCT00916006|6080672|P1|COMPLETED|Overall Study||132
2479853|NCT00916006|6080671|P2|STARTED|Overall Study||134
2479854|NCT00916006|6080672|P1|STARTED|Overall Study||135
2479855|NCT00915967|6080682|P2|NOT COMPLETED|Overall Study||2
2479856|NCT00915967|6080683|P1|NOT COMPLETED|Overall Study||1
2479857|NCT00915967|6080682|P2|COMPLETED|Overall Study||98
2479858|NCT00915967|6080683|P1|COMPLETED|Overall Study||97
2479859|NCT00915967|6080682|P2|STARTED|Overall Study||100
2479860|NCT00915967|6080683|P1|STARTED|Overall Study||98
2479861|NCT00915954|6080692|P3|NOT COMPLETED|Overall Study||0
2479862|NCT00915954|6080693|P2|NOT COMPLETED|Overall Study||0
2479863|NCT00915954|6080694|P1|NOT COMPLETED|Overall Study||0
2479864|NCT00915954|6080692|P3|COMPLETED|Overall Study||10
2479865|NCT00915954|6080693|P2|COMPLETED|Overall Study||8
2479866|NCT00915954|6080694|P1|COMPLETED|Overall Study||10
2479867|NCT00915954|6080692|P3|STARTED|Overall Study||10
2479868|NCT00915954|6080693|P2|STARTED|Overall Study||8
2479869|NCT00915954|6080694|P1|STARTED|Overall Study||10
2479870|NCT00915902|6080713|P2|NOT COMPLETED|2nd Treatment Period||1
2479871|NCT00915902|6080714|P1|NOT COMPLETED|2nd Treatment Period||0
2479872|NCT00915902|6080713|P2|COMPLETED|2nd Treatment Period||20
2479873|NCT00915902|6080714|P1|COMPLETED|2nd Treatment Period||19
2479874|NCT00915902|6080713|P2|STARTED|2nd Treatment Period||21
2479875|NCT00915902|6080714|P1|STARTED|2nd Treatment Period||19
2479876|NCT00915902|6080713|P2|NOT COMPLETED|Washout (4 Weeks)||1
2479877|NCT00915902|6080714|P1|NOT COMPLETED|Washout (4 Weeks)||0
2479878|NCT00915902|6080713|P2|COMPLETED|Washout (4 Weeks)||21
2479879|NCT00915902|6080714|P1|COMPLETED|Washout (4 Weeks)||19
2479880|NCT00915902|6080713|P2|STARTED|Washout (4 Weeks)||22
2479881|NCT00915902|6080714|P1|STARTED|Washout (4 Weeks)||19
2479882|NCT00915902|6080713|P2|NOT COMPLETED|1st Treatment Period||0
2479883|NCT00915902|6080714|P1|NOT COMPLETED|1st Treatment Period||1
2479884|NCT00915902|6080713|P2|COMPLETED|1st Treatment Period||22
2479885|NCT00915902|6080714|P1|COMPLETED|1st Treatment Period||19
2479886|NCT00915902|6080713|P2|STARTED|1st Treatment Period||22
2479887|NCT00915902|6080714|P1|STARTED|1st Treatment Period||20
2479888|NCT00915876|6080724|P2|NOT COMPLETED|Overall Study||1
2479889|NCT00915876|6080725|P1|NOT COMPLETED|Overall Study||0
2479890|NCT00915876|6080724|P2|COMPLETED|Overall Study||20
2479891|NCT00915876|6080725|P1|COMPLETED|Overall Study||20
2479892|NCT00915876|6080724|P2|Moving Beyond First Dose|Overall Study||20
2479893|NCT00915876|6080725|P1|Moving Beyond First Dose|Overall Study||20
2479894|NCT00915876|6080724|P2|STARTED|Overall Study||21
2479895|NCT00915876|6080725|P1|STARTED|Overall Study||20
2479896|NCT00915798|6080735|P4|NOT COMPLETED|Overall Study||0
2479897|NCT00915798|6080736|P3|NOT COMPLETED|Overall Study||0
2479898|NCT00915798|6080737|P2|NOT COMPLETED|Overall Study||0
2479899|NCT00915798|6080738|P1|NOT COMPLETED|Overall Study||0
2479900|NCT00915798|6080735|P4|COMPLETED|Overall Study||26
2479901|NCT00915798|6080736|P3|COMPLETED|Overall Study||23
2479902|NCT00915798|6080737|P2|COMPLETED|Overall Study||21
2479903|NCT00915798|6080738|P1|COMPLETED|Overall Study||19
2479904|NCT00915798|6080735|P4|STARTED|Overall Study||26
2479905|NCT00915798|6080736|P3|STARTED|Overall Study||23
2479906|NCT00915798|6080737|P2|STARTED|Overall Study||21
2479907|NCT00915798|6080738|P1|STARTED|Overall Study||19
2479908|NCT00915772|6080761|P3|NOT COMPLETED|Overall Study||29
2479909|NCT00915772|6080762|P2|NOT COMPLETED|Overall Study||46
2479910|NCT00915772|6080763|P1|NOT COMPLETED|Overall Study||36
2479911|NCT00915772|6080761|P3|COMPLETED|Overall Study||142
2479912|NCT00915772|6080762|P2|COMPLETED|Overall Study||179
2479913|NCT00915772|6080763|P1|COMPLETED|Overall Study||134
2479914|NCT00915772|6080761|P3|STARTED|Overall Study||171
2479915|NCT00915772|6080762|P2|STARTED|Overall Study||225
2479916|NCT00915772|6080763|P1|STARTED|Overall Study||170
2479917|NCT00915759|6080808|P1|NOT COMPLETED|Overall Study||0
2479918|NCT00915759|6080808|P1|COMPLETED|Overall Study|number of participants|40
2479919|NCT00915759|6080808|P1|STARTED|Overall Study|number of participants|40
2479920|NCT00915655|6080818|P1|NOT COMPLETED|Overall Study||0
2479921|NCT00915655|6080818|P1|COMPLETED|Overall Study|'Completed' represents patients who have not discontinued at time of cut-off for Week 24 analysis|12
2479922|NCT00915655|6080818|P1|STARTED|Overall Study||12
2479923|NCT00915603|6080825|P2|NOT COMPLETED|Overall Study||55
2479924|NCT00915603|6080826|P1|NOT COMPLETED|Overall Study||56
2479925|NCT00915603|6080825|P2|COMPLETED|Overall Study||0
2479926|NCT00915603|6080826|P1|COMPLETED|Overall Study||0
2479927|NCT00915603|6080825|P2|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|55
2479928|NCT00915603|6080826|P1|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|56
2479929|NCT00915590|6080842|P2|NOT COMPLETED|Overall Study||1
2479930|NCT00915590|6080843|P1|NOT COMPLETED|Overall Study||2
2479931|NCT00915590|6080842|P2|COMPLETED|Overall Study||4
2479932|NCT00915590|6080843|P1|COMPLETED|Overall Study||3
2479933|NCT00915590|6080842|P2|STARTED|Overall Study||5
2479934|NCT00915590|6080843|P1|STARTED|Overall Study||5
2479935|NCT00915551|6080862|P2|NOT COMPLETED|Overall Study||1
2479936|NCT00915551|6080863|P1|NOT COMPLETED|Overall Study||0
2479937|NCT00915551|6080862|P2|COMPLETED|Overall Study||135
2479938|NCT00915551|6080863|P1|COMPLETED|Overall Study||142
2479939|NCT00915551|6080862|P2|STARTED|Overall Study||136
2479940|NCT00915551|6080863|P1|STARTED|Overall Study||142
2479941|NCT00915525|6080873|P2|NOT COMPLETED|Overall Study||135
2479942|NCT00915525|6080874|P1|NOT COMPLETED|Overall Study||265
2479943|NCT00915525|6080873|P2|COMPLETED|Overall Study||151
2479944|NCT00915525|6080874|P1|COMPLETED|Overall Study||278
2479945|NCT00915525|6080873|P2|STARTED|Overall Study||286
2479946|NCT00915525|6080874|P1|STARTED|Overall Study||543
2479947|NCT00915499|6080977|P2|NOT COMPLETED|Overall Study||2
2479948|NCT00915499|6080978|P1|NOT COMPLETED|Overall Study||4
2479949|NCT00915499|6080977|P2|COMPLETED|Overall Study||31
2479950|NCT00915499|6080978|P1|COMPLETED|Overall Study||29
2479951|NCT00915499|6080977|P2|STARTED|Overall Study||33
2479952|NCT00915499|6080978|P1|STARTED|Overall Study||33
2479953|NCT00915473|6080988|P2|NOT COMPLETED|4-week Follow Up||5
2479954|NCT00915473|6080989|P1|NOT COMPLETED|4-week Follow Up||1
2479955|NCT00915473|6080988|P2|COMPLETED|4-week Follow Up||30
2479956|NCT00915473|6080989|P1|COMPLETED|4-week Follow Up||33
2479957|NCT00915473|6080988|P2|STARTED|4-week Follow Up||35
2479958|NCT00915473|6080989|P1|STARTED|4-week Follow Up||34
2479959|NCT00915473|6080988|P2|NOT COMPLETED|Injection||0
2479960|NCT00915473|6080989|P1|NOT COMPLETED|Injection||0
2479961|NCT00915473|6080988|P2|COMPLETED|Injection||35
2479962|NCT00915473|6080989|P1|COMPLETED|Injection||34
2479963|NCT00915473|6080988|P2|STARTED|Injection||35
2479964|NCT00915473|6080989|P1|STARTED|Injection||34
2479965|NCT00915473|6080988|P2|NOT COMPLETED|Screening||0
2479966|NCT00915473|6080989|P1|NOT COMPLETED|Screening||1
2479967|NCT00915473|6080988|P2|COMPLETED|Screening||35
2479968|NCT00915473|6080989|P1|COMPLETED|Screening||34
2479969|NCT00915473|6080988|P2|STARTED|Screening||35
2479970|NCT00915473|6080989|P1|STARTED|Screening||35
2479971|NCT00915356|6081006|P5|NOT COMPLETED|Overall Study||0
2479972|NCT00915356|6081007|P4|NOT COMPLETED|Overall Study||0
2479973|NCT00915356|6081008|P3|NOT COMPLETED|Overall Study||0
2479974|NCT00915356|6081009|P2|NOT COMPLETED|Overall Study||0
2479975|NCT00915356|6081010|P1|NOT COMPLETED|Overall Study||1
2479976|NCT00915356|6081006|P5|COMPLETED|Overall Study||43
2479977|NCT00915356|6081007|P4|COMPLETED|Overall Study||12
2479978|NCT00915356|6081008|P3|COMPLETED|Overall Study||45
2479979|NCT00915356|6081009|P2|COMPLETED|Overall Study||45
2479980|NCT00915356|6081010|P1|COMPLETED|Overall Study||25
2479981|NCT00915356|6081006|P5|STARTED|Overall Study||43
2479982|NCT00915356|6081007|P4|STARTED|Overall Study||12
2479983|NCT00915356|6081008|P3|STARTED|Overall Study||45
2479984|NCT00915356|6081009|P2|STARTED|Overall Study||45
2479985|NCT00915356|6081010|P1|STARTED|Overall Study||26
2479986|NCT00915343|6081072|P3|NOT COMPLETED|Part B - Open Label Period||2
2479987|NCT00915343|6081073|P2|NOT COMPLETED|Part B - Open Label Period||0
2479988|NCT00915343|6081074|P1|NOT COMPLETED|Part B - Open Label Period||0
2479989|NCT00915343|6081072|P3|COMPLETED|Part B - Open Label Period||57
2479990|NCT00915343|6081073|P2|COMPLETED|Part B - Open Label Period||0
2479991|NCT00915343|6081074|P1|COMPLETED|Part B - Open Label Period||0
2479992|NCT00915343|6081072|P3|STARTED|Part B - Open Label Period||59
2479993|NCT00915343|6081073|P2|STARTED|Part B - Open Label Period||0
2479994|NCT00915343|6081074|P1|STARTED|Part B - Open Label Period||0
2479995|NCT00915343|6081072|P3|NOT COMPLETED|Part A - Second Intervention Period||0
2479996|NCT00915343|6081073|P2|NOT COMPLETED|Part A - Second Intervention Period||0
2479997|NCT00915343|6081074|P1|NOT COMPLETED|Part A - Second Intervention Period||0
2479998|NCT00915343|6081072|P3|COMPLETED|Part A - Second Intervention Period||0
2479999|NCT00915343|6081073|P2|COMPLETED|Part A - Second Intervention Period||32
2480000|NCT00915343|6081074|P1|COMPLETED|Part A - Second Intervention Period||32
2480001|NCT00915343|6081072|P3|STARTED|Part A - Second Intervention Period||0
2480002|NCT00915343|6081073|P2|STARTED|Part A - Second Intervention Period||32
2480003|NCT00915343|6081074|P1|STARTED|Part A - Second Intervention Period||32
2480004|NCT00915343|6081072|P3|NOT COMPLETED|Part A - First Intervention Period||0
2480005|NCT00915343|6081073|P2|NOT COMPLETED|Part A - First Intervention Period||0
2480006|NCT00915343|6081074|P1|NOT COMPLETED|Part A - First Intervention Period||0
2480007|NCT00915343|6081072|P3|COMPLETED|Part A - First Intervention Period||0
2480008|NCT00915343|6081073|P2|COMPLETED|Part A - First Intervention Period||32
2480009|NCT00915343|6081074|P1|COMPLETED|Part A - First Intervention Period||32
2480010|NCT00915343|6081072|P3|STARTED|Part A - First Intervention Period||0
2480011|NCT00915343|6081073|P2|STARTED|Part A - First Intervention Period||32
2480012|NCT00915343|6081074|P1|STARTED|Part A - First Intervention Period||32
2480013|NCT00915278|6081159|P6|NOT COMPLETED|Overall Study||8
2480014|NCT00915278|6081160|P5|NOT COMPLETED|Overall Study||2
2480015|NCT00915278|6081161|P4|NOT COMPLETED|Overall Study||3
2480016|NCT00915278|6081162|P3|NOT COMPLETED|Overall Study||1
2480017|NCT00915278|6081163|P2|NOT COMPLETED|Overall Study||3
2480018|NCT00915278|6081164|P1|NOT COMPLETED|Overall Study||5
2480019|NCT00915278|6081159|P6|COMPLETED|Overall Study||1
2480020|NCT00915278|6081160|P5|COMPLETED|Overall Study||1
2480021|NCT00915278|6081161|P4|COMPLETED|Overall Study||2
2480022|NCT00915278|6081162|P3|COMPLETED|Overall Study||2
2480023|NCT00915278|6081163|P2|COMPLETED|Overall Study||2
2480024|NCT00915278|6081164|P1|COMPLETED|Overall Study||3
2480025|NCT00915278|6081159|P6|STARTED|Overall Study||9
2480026|NCT00915278|6081160|P5|STARTED|Overall Study||3
2480027|NCT00915278|6081161|P4|STARTED|Overall Study||5
2480028|NCT00915278|6081162|P3|STARTED|Overall Study||3
2480029|NCT00915278|6081163|P2|STARTED|Overall Study||5
2480030|NCT00915278|6081164|P1|STARTED|Overall Study||8
2480031|NCT00915148|6081310|P1|NOT COMPLETED|Overall Study||0
2480032|NCT00915148|6081310|P1|COMPLETED|Overall Study|August 2010|110
2480033|NCT00915148|6081310|P1|STARTED|Overall Study|October 2009|110
2480034|NCT00915031|6081317|P2|NOT COMPLETED|Overall Study||0
2480035|NCT00915031|6081318|P1|NOT COMPLETED|Overall Study||0
2480036|NCT00915031|6081317|P2|COMPLETED|Overall Study||24
2480037|NCT00915031|6081318|P1|COMPLETED|Overall Study||714
2480038|NCT00915031|6081317|P2|STARTED|Overall Study||24
2480039|NCT00915031|6081318|P1|STARTED|Overall Study||714
2480040|NCT00915018|6081325|P2|NOT COMPLETED|Overall Study||207
2480041|NCT00915018|6081326|P1|NOT COMPLETED|Overall Study||215
2480042|NCT00915018|6081325|P2|COMPLETED|Overall Study||30
2480043|NCT00915018|6081326|P1|COMPLETED|Overall Study||27
2480044|NCT00915018|6081325|P2|Received Treatment|Overall Study||234
2480045|NCT00915018|6081326|P1|Received Treatment|Overall Study||240
2480046|NCT00915018|6081325|P2|STARTED|Overall Study||237
2480047|NCT00915018|6081326|P1|STARTED|Overall Study||242
2480048|NCT00914966|6081340|P1|NOT COMPLETED|Step 3: 2500 Units||0
2480049|NCT00914966|6081340|P1|COMPLETED|Step 3: 2500 Units||12
2480050|NCT00914966|6081340|P1|STARTED|Step 3: 2500 Units||12
2480051|NCT00914966|6081340|P1|NOT COMPLETED|Step 2: 2000 Units||1
2480052|NCT00914966|6081340|P1|COMPLETED|Step 2: 2000 Units||12
2480053|NCT00914966|6081340|P1|STARTED|Step 2: 2000 Units||13
2480054|NCT00914966|6081340|P1|NOT COMPLETED|Step 1: 1500 Units||2
2480055|NCT00914966|6081340|P1|COMPLETED|Step 1: 1500 Units|5/18 subjects completing Step 1 (1500 Units) entered the 3 month follow-up and did not dose escalate|18
2480056|NCT00914966|6081340|P1|STARTED|Step 1: 1500 Units||20
2480057|NCT00914927|6081359|P7|NOT COMPLETED|Overall Study||0
2480058|NCT00914927|6081360|P6|NOT COMPLETED|Overall Study||0
2480059|NCT00914927|6081361|P5|NOT COMPLETED|Overall Study||2
2480060|NCT00914927|6081362|P4|NOT COMPLETED|Overall Study||2
2480061|NCT00914927|6081363|P3|NOT COMPLETED|Overall Study||0
2480062|NCT00914927|6081364|P2|NOT COMPLETED|Overall Study||2
2480063|NCT00914927|6081365|P1|NOT COMPLETED|Overall Study||2
2480064|NCT00914927|6081359|P7|COMPLETED|Overall Study||21
2480065|NCT00914927|6081360|P6|COMPLETED|Overall Study||21
2480066|NCT00914927|6081361|P5|COMPLETED|Overall Study||19
2480067|NCT00914927|6081362|P4|COMPLETED|Overall Study||14
2480068|NCT00914927|6081363|P3|COMPLETED|Overall Study||17
2480069|NCT00914927|6081364|P2|COMPLETED|Overall Study||14
2480070|NCT00914927|6081365|P1|COMPLETED|Overall Study||16
2480071|NCT00914927|6081359|P7|STARTED|Overall Study||21
2480072|NCT00914927|6081360|P6|STARTED|Overall Study||21
2480073|NCT00914927|6081361|P5|STARTED|Overall Study||21
2480074|NCT00914927|6081362|P4|STARTED|Overall Study||16
2480075|NCT00914927|6081363|P3|STARTED|Overall Study||17
2480076|NCT00914927|6081364|P2|STARTED|Overall Study||16
2480077|NCT00914927|6081365|P1|STARTED|Overall Study||18
2480078|NCT00914862|6081414|P5|NOT COMPLETED|Overall Study||0
2480079|NCT00914862|6081415|P4|NOT COMPLETED|Overall Study||0
2480080|NCT00914862|6081416|P3|NOT COMPLETED|Overall Study||0
2480081|NCT00914862|6081417|P2|NOT COMPLETED|Overall Study||0
2480082|NCT00914862|6081418|P1|NOT COMPLETED|Overall Study||0
2480083|NCT00914862|6081414|P5|COMPLETED|Overall Study||28
2480084|NCT00914862|6081415|P4|COMPLETED|Overall Study||8
2480085|NCT00914862|6081416|P3|COMPLETED|Overall Study||8
2480086|NCT00914862|6081417|P2|COMPLETED|Overall Study||6
2480087|NCT00914862|6081418|P1|COMPLETED|Overall Study||6
2480088|NCT00914862|6081414|P5|STARTED|Overall Study||28
2480089|NCT00914862|6081415|P4|STARTED|Overall Study||8
2480090|NCT00914862|6081416|P3|STARTED|Overall Study||8
2480091|NCT00914862|6081417|P2|STARTED|Overall Study||6
2480092|NCT00914862|6081418|P1|STARTED|Overall Study||6
2480093|NCT00914849|6081492|P2|NOT COMPLETED|Overall Study||1
2480094|NCT00914849|6081493|P1|NOT COMPLETED|Overall Study||1
2480095|NCT00914849|6081492|P2|COMPLETED|Overall Study||33
2480096|NCT00914849|6081493|P1|COMPLETED|Overall Study||33
2480097|NCT00914849|6081492|P2|STARTED|Overall Study||34
2480098|NCT00914849|6081493|P1|STARTED|Overall Study||34
2480099|NCT00914810|6081527|P2|NOT COMPLETED|Overall Study||1
2480100|NCT00914810|6081528|P1|NOT COMPLETED|Overall Study||2
2480101|NCT00914810|6081527|P2|COMPLETED|Overall Study||18
2480102|NCT00914810|6081528|P1|COMPLETED|Overall Study||18
2480103|NCT00914810|6081527|P2|STARTED|Overall Study||19
2480104|NCT00914810|6081528|P1|STARTED|Overall Study||20
2480105|NCT00914589|6081539|P3|NOT COMPLETED|Overall Study||12
2480106|NCT00914589|6081540|P2|NOT COMPLETED|Overall Study||16
2480107|NCT00914589|6081541|P1|NOT COMPLETED|Overall Study||25
2480108|NCT00914589|6081539|P3|COMPLETED|Overall Study||126
2480109|NCT00914589|6081540|P2|COMPLETED|Overall Study||127
2480110|NCT00914589|6081541|P1|COMPLETED|Overall Study||103
2480111|NCT00914589|6081539|P3|STARTED|Overall Study||138
2480112|NCT00914589|6081540|P2|STARTED|Overall Study||143
2480113|NCT00914589|6081541|P1|STARTED|Overall Study||128
2480114|NCT00914485|6081561|P1|NOT COMPLETED|Overall Study||0
2480115|NCT00914485|6081561|P1|COMPLETED|Overall Study||369
2480116|NCT00914485|6081561|P1|STARTED|Overall Study||369
2480117|NCT00914459|6081567|P2|NOT COMPLETED|Overall Study||1
2480118|NCT00914459|6081568|P1|NOT COMPLETED|Overall Study||1
2480119|NCT00914459|6081567|P2|COMPLETED|Overall Study||18
2480120|NCT00914459|6081568|P1|COMPLETED|Overall Study||17
2480121|NCT00914459|6081567|P2|STARTED|Overall Study||19
2480122|NCT00914459|6081568|P1|STARTED|Overall Study||18
2480123|NCT00914316|6081598|P4|NOT COMPLETED|Phase 2||0
2480124|NCT00914316|6081599|P3|NOT COMPLETED|Phase 2||1
2480125|NCT00914316|6081600|P2|NOT COMPLETED|Phase 2||0
2480126|NCT00914316|6081601|P1|NOT COMPLETED|Phase 2||1
2480127|NCT00914316|6081598|P4|COMPLETED|Phase 2||6
2480128|NCT00914316|6081599|P3|COMPLETED|Phase 2||2
2480129|NCT00914316|6081600|P2|COMPLETED|Phase 2||4
2480130|NCT00914316|6081601|P1|COMPLETED|Phase 2||1
2480131|NCT00914316|6081598|P4|STARTED|Phase 2||6
2480132|NCT00914316|6081599|P3|STARTED|Phase 2||3
2480133|NCT00914316|6081600|P2|STARTED|Phase 2||4
2480134|NCT00914316|6081601|P1|STARTED|Phase 2||2
2480135|NCT00914316|6081598|P4|NOT COMPLETED|Phase 1||2
2480136|NCT00914316|6081599|P3|NOT COMPLETED|Phase 1||5
2480137|NCT00914316|6081600|P2|NOT COMPLETED|Phase 1||2
2480138|NCT00914316|6081601|P1|NOT COMPLETED|Phase 1||5
2480139|NCT00914316|6081598|P4|COMPLETED|Phase 1||6
2480140|NCT00914316|6081599|P3|COMPLETED|Phase 1||3
2480141|NCT00914316|6081600|P2|COMPLETED|Phase 1||4
2480142|NCT00914316|6081601|P1|COMPLETED|Phase 1||2
2480143|NCT00914316|6081598|P4|STARTED|Phase 1||8
2480144|NCT00914316|6081599|P3|STARTED|Phase 1||8
2480145|NCT00914316|6081600|P2|STARTED|Phase 1||6
2480146|NCT00914316|6081601|P1|STARTED|Phase 1||7
2480147|NCT00914186|6081619|P4|NOT COMPLETED|Overall Study||10
2480148|NCT00914186|6081620|P3|NOT COMPLETED|Overall Study||2
2480149|NCT00914186|6081621|P2|NOT COMPLETED|Overall Study||2
2480150|NCT00914186|6081622|P1|NOT COMPLETED|Overall Study||3
2480151|NCT00914186|6081619|P4|COMPLETED|Overall Study||20
2480152|NCT00914186|6081620|P3|COMPLETED|Overall Study||29
2480153|NCT00914186|6081621|P2|COMPLETED|Overall Study||28
2480154|NCT00914186|6081622|P1|COMPLETED|Overall Study||28
2480155|NCT00914186|6081619|P4|STARTED|Overall Study||30
2480156|NCT00914186|6081620|P3|STARTED|Overall Study||31
2480157|NCT00914186|6081621|P2|STARTED|Overall Study||30
2480158|NCT00914186|6081622|P1|STARTED|Overall Study||31
2480159|NCT00914069|6081656|P2|NOT COMPLETED|Overall Study||0
2480160|NCT00914069|6081657|P1|NOT COMPLETED|Overall Study||0
2480161|NCT00914069|6081656|P2|COMPLETED|Overall Study||88
2480162|NCT00914069|6081657|P1|COMPLETED|Overall Study||84
2480163|NCT00914069|6081656|P2|STARTED|Overall Study||88
2480164|NCT00914069|6081657|P1|STARTED|Overall Study||84
2480165|NCT00913978|6081673|P2|NOT COMPLETED|Overall Study||3
2480166|NCT00913978|6081674|P1|NOT COMPLETED|Overall Study||1
2480167|NCT00913978|6081673|P2|COMPLETED|Overall Study||21
2480168|NCT00913978|6081674|P1|COMPLETED|Overall Study||25
2480169|NCT00913978|6081673|P2|STARTED|Overall Study||24
2480170|NCT00913978|6081674|P1|STARTED|Overall Study||26
2480171|NCT00913913|6081682|P1|NOT COMPLETED|Overall Study||8
2480172|NCT00913913|6081682|P1|COMPLETED|Overall Study||0
2480173|NCT00913913|6081682|P1|STARTED|Overall Study||8
2480174|NCT00913835|6081691|P2|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||3
2480175|NCT00913835|6081692|P1|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||0
2480176|NCT00913835|6081691|P2|COMPLETED|Lip Dox: Olaratumab Monotherapy||25
2480177|NCT00913835|6081692|P1|COMPLETED|Lip Dox: Olaratumab Monotherapy||0
2480178|NCT00913835|6081691|P2|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||28
2480179|NCT00913835|6081692|P1|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||0
2480180|NCT00913835|6081691|P2|STARTED|Lip Dox: Olaratumab Monotherapy||28
2480181|NCT00913835|6081692|P1|STARTED|Lip Dox: Olaratumab Monotherapy||0
2480182|NCT00913835|6081691|P2|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||7
2480183|NCT00913835|6081692|P1|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||8
2480184|NCT00913835|6081691|P2|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
2480185|NCT00913835|6081692|P1|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
2480186|NCT00913835|6081691|P2|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||61
2480187|NCT00913835|6081692|P1|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||62
2480188|NCT00913835|6081691|P2|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||62
2480189|NCT00913835|6081692|P1|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||63
2480190|NCT00913770|6081731|P3|NOT COMPLETED|Overall Study||21
2480191|NCT00913770|6081732|P2|NOT COMPLETED|Overall Study||29
2480192|NCT00913770|6081733|P1|NOT COMPLETED|Overall Study||35
2480193|NCT00913770|6081731|P3|COMPLETED|Overall Study||93
2480194|NCT00913770|6081732|P2|COMPLETED|Overall Study||82
2480195|NCT00913770|6081733|P1|COMPLETED|Overall Study||69
2480196|NCT00913770|6081731|P3|STARTED|Overall Study||114
2480197|NCT00913770|6081732|P2|STARTED|Overall Study||111
2480198|NCT00913770|6081733|P1|STARTED|Overall Study||104
2480199|NCT00913744|6081746|P2|NOT COMPLETED|Overall Study||1
2480200|NCT00913744|6081747|P1|NOT COMPLETED|Overall Study||5
2480201|NCT00913744|6081746|P2|COMPLETED|Overall Study||24
2480202|NCT00913744|6081747|P1|COMPLETED|Overall Study||70
2480203|NCT00913744|6081746|P2|STARTED|Overall Study||25
2480204|NCT00913744|6081747|P1|STARTED|Overall Study||75
2480205|NCT00913692|6081753|P1|NOT COMPLETED|Treatment Phase 2 (5 Months)||0
2480206|NCT00913692|6081753|P1|COMPLETED|Treatment Phase 2 (5 Months)||1
2480207|NCT00913692|6081753|P1|STARTED|Treatment Phase 2 (5 Months)||1
2480208|NCT00913692|6081753|P1|NOT COMPLETED|Washout (2 Weeks)||0
2480209|NCT00913692|6081753|P1|COMPLETED|Washout (2 Weeks)||1
2480210|NCT00913692|6081753|P1|STARTED|Washout (2 Weeks)||1
2480211|NCT00913692|6081753|P1|NOT COMPLETED|Treatment Phase 1 (5 Months)||1
2480212|NCT00913692|6081753|P1|COMPLETED|Treatment Phase 1 (5 Months)||1
2480213|NCT00913692|6081753|P1|STARTED|Treatment Phase 1 (5 Months)||2
2480214|NCT00913692|6081753|P1|NOT COMPLETED|Screening (4 Months)||9
2480215|NCT00913692|6081753|P1|COMPLETED|Screening (4 Months)||2
2480216|NCT00913692|6081753|P1|STARTED|Screening (4 Months)||11
2480217|NCT00913627|6081767|P4|NOT COMPLETED|Overall Study||0
2480218|NCT00913627|6081768|P3|NOT COMPLETED|Overall Study||0
2480219|NCT00913627|6081769|P2|NOT COMPLETED|Overall Study||0
2480220|NCT00913627|6081770|P1|NOT COMPLETED|Overall Study||0
2480221|NCT00913627|6081767|P4|COMPLETED|Overall Study||58
2480222|NCT00913627|6081768|P3|COMPLETED|Overall Study||56
2480223|NCT00913627|6081769|P2|COMPLETED|Overall Study||53
2480224|NCT00913627|6081770|P1|COMPLETED|Overall Study||29
2480225|NCT00913627|6081767|P4|STARTED|Overall Study||58
2480226|NCT00913627|6081768|P3|STARTED|Overall Study||56
2480227|NCT00913627|6081769|P2|STARTED|Overall Study||53
2480228|NCT00913627|6081770|P1|STARTED|Overall Study||29
2480229|NCT00913523|6081847|P3|NOT COMPLETED|Overall Study||14
2480230|NCT00913523|6081848|P2|NOT COMPLETED|Overall Study||16
2480231|NCT00913523|6081849|P1|NOT COMPLETED|Overall Study||18
2480232|NCT00913523|6081847|P3|COMPLETED|Overall Study||147
2480233|NCT00913523|6081848|P2|COMPLETED|Overall Study||143
2480234|NCT00913523|6081849|P1|COMPLETED|Overall Study||144
2480235|NCT00913523|6081847|P3|STARTED|Overall Study||161
2480236|NCT00913523|6081848|P2|STARTED|Overall Study||159
2480237|NCT00913523|6081849|P1|STARTED|Overall Study||162
2480238|NCT00913510|6081874|P2|NOT COMPLETED|Overall Study||4
2480239|NCT00913510|6081875|P1|NOT COMPLETED|Overall Study||8
2480240|NCT00913510|6081874|P2|COMPLETED|Overall Study||3
2480241|NCT00913510|6081875|P1|COMPLETED|Overall Study||5
2480242|NCT00913510|6081874|P2|STARTED|Overall Study||7
2480243|NCT00913510|6081875|P1|STARTED|Overall Study||13
2480244|NCT00913458|6081881|P7|NOT COMPLETED|Phase 3||8
2480245|NCT00913458|6081882|P6|NOT COMPLETED|Phase 3||18
2480246|NCT00913458|6081883|P5|NOT COMPLETED|Phase 3||22
2480247|NCT00913458|6081884|P4|NOT COMPLETED|Phase 3||0
2480248|NCT00913458|6081885|P3|NOT COMPLETED|Phase 3||0
2480249|NCT00913458|6081886|P2|NOT COMPLETED|Phase 3||0
2480250|NCT00913458|6081887|P1|NOT COMPLETED|Phase 3||0
2480251|NCT00913458|6081881|P7|COMPLETED|Phase 3||24
2480252|NCT00913458|6081882|P6|COMPLETED|Phase 3||28
2480253|NCT00913458|6081883|P5|COMPLETED|Phase 3||31
2480254|NCT00913458|6081884|P4|COMPLETED|Phase 3||0
2480255|NCT00913458|6081885|P3|COMPLETED|Phase 3||0
2480256|NCT00913458|6081886|P2|COMPLETED|Phase 3||0
2480257|NCT00913458|6081887|P1|COMPLETED|Phase 3|This arm is part of Phase 1 of the study.|0
2480258|NCT00913458|6081881|P7|STARTED|Phase 3|Participants who completed Phase 2 study|32
2480259|NCT00913458|6081882|P6|STARTED|Phase 3|Participants who completed Phase 2 study|46
2480260|NCT00913458|6081883|P5|STARTED|Phase 3|Participants who completed Phase 2 study|53
2480261|NCT00913458|6081884|P4|STARTED|Phase 3||0
2480262|NCT00913458|6081885|P3|STARTED|Phase 3||0
2480263|NCT00913458|6081886|P2|STARTED|Phase 3||0
2480264|NCT00913458|6081887|P1|STARTED|Phase 3|This arm is part of Phase 1 of the study.|0
2480265|NCT00913458|6081881|P7|NOT COMPLETED|Phase 2||0
2480266|NCT00913458|6081882|P6|NOT COMPLETED|Phase 2||0
2480267|NCT00913458|6081883|P5|NOT COMPLETED|Phase 2||0
2480268|NCT00913458|6081884|P4|NOT COMPLETED|Phase 2||33
2480269|NCT00913458|6081885|P3|NOT COMPLETED|Phase 2||19
2480270|NCT00913458|6081886|P2|NOT COMPLETED|Phase 2||10
2480271|NCT00913458|6081887|P1|NOT COMPLETED|Phase 2||0
2480272|NCT00913458|6081881|P7|COMPLETED|Phase 2||0
2480273|NCT00913458|6081882|P6|COMPLETED|Phase 2||0
2480274|NCT00913458|6081883|P5|COMPLETED|Phase 2||0
2480275|NCT00913458|6081884|P4|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|32
2480276|NCT00913458|6081885|P3|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|46
2480277|NCT00913458|6081886|P2|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|53
2480278|NCT00913458|6081887|P1|COMPLETED|Phase 2|This arm is part of Phase 1 of the study.|0
2480279|NCT00913458|6081881|P7|STARTED|Phase 2||0
2480280|NCT00913458|6081882|P6|STARTED|Phase 2||0
2480281|NCT00913458|6081883|P5|STARTED|Phase 2||0
2480282|NCT00913458|6081884|P4|STARTED|Phase 2||65
2480283|NCT00913458|6081885|P3|STARTED|Phase 2||65
2480284|NCT00913458|6081886|P2|STARTED|Phase 2||63
2480285|NCT00913458|6081887|P1|STARTED|Phase 2|This arm is part of Phase 1 of the study.|0
2480286|NCT00913458|6081881|P7|NOT COMPLETED|Phase 1||0
2480287|NCT00913458|6081882|P6|NOT COMPLETED|Phase 1||0
2480288|NCT00913458|6081883|P5|NOT COMPLETED|Phase 1||0
2480289|NCT00913458|6081884|P4|NOT COMPLETED|Phase 1||0
2480290|NCT00913458|6081885|P3|NOT COMPLETED|Phase 1||0
2480291|NCT00913458|6081886|P2|NOT COMPLETED|Phase 1||0
2480292|NCT00913458|6081887|P1|NOT COMPLETED|Phase 1||112
2480293|NCT00913458|6081881|P7|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
2480294|NCT00913458|6081882|P6|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
2480295|NCT00913458|6081883|P5|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
2480296|NCT00913458|6081884|P4|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
2480297|NCT00913458|6081885|P3|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
2480298|NCT00913458|6081886|P2|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
2480299|NCT00913458|6081887|P1|COMPLETED|Phase 1|194 continued to Phase 2 but 1 was randomized in error leaving 193 in the phase 2 analysis.|194
2480300|NCT00913458|6081881|P7|STARTED|Phase 1|This arm is part of Phase 3 study|0
2480301|NCT00913458|6081882|P6|STARTED|Phase 1|This arm is part of Phase 3 study|0
2480302|NCT00913458|6081883|P5|STARTED|Phase 1|This arm is part of Phase 3 study|0
2480303|NCT00913458|6081884|P4|STARTED|Phase 1|This arm is part of Phase 2 study|0
2480304|NCT00913458|6081885|P3|STARTED|Phase 1|This arm is part of Phase 2 study|0
2480305|NCT00913458|6081886|P2|STARTED|Phase 1|This arm is part of Phase 2 study|0
2480306|NCT00913458|6081887|P1|STARTED|Phase 1||306
2480307|NCT00913380|6081980|P2|NOT COMPLETED|Clinical Outcomes||6
2480308|NCT00913380|6081981|P1|NOT COMPLETED|Clinical Outcomes||6
2480309|NCT00913380|6081980|P2|COMPLETED|Clinical Outcomes||441
2480310|NCT00913380|6081981|P1|COMPLETED|Clinical Outcomes||438
2480311|NCT00913380|6081980|P2|STARTED|Clinical Outcomes||447
2480312|NCT00913380|6081981|P1|STARTED|Clinical Outcomes||444
2480313|NCT00913380|6081980|P2|NOT COMPLETED|CT Examination||0
2480314|NCT00913380|6081981|P1|NOT COMPLETED|CT Examination||0
2480315|NCT00913380|6081980|P2|COMPLETED|CT Examination||447
2480316|NCT00913380|6081981|P1|COMPLETED|CT Examination||444
2480317|NCT00913380|6081980|P2|STARTED|CT Examination||447
2480318|NCT00913380|6081981|P1|STARTED|CT Examination||444
2480319|NCT00913263|6082007|P1|NOT COMPLETED|Overall Study||0
2480320|NCT00913263|6082007|P1|COMPLETED|Overall Study||24
2480321|NCT00913263|6082007|P1|STARTED|Overall Study||24
2480322|NCT00913133|6082016|P1|NOT COMPLETED|Overall Study||0
2480323|NCT00913133|6082016|P1|COMPLETED|Overall Study||516
2480324|NCT00913133|6082016|P1|STARTED|Overall Study||516
2480325|NCT00913081|6082021|P1|NOT COMPLETED|Placebo + Niacin 500 mg (1day)||0
2480326|NCT00913081|6082021|P1|COMPLETED|Placebo + Niacin 500 mg (1day)||17
2480327|NCT00913081|6082021|P1|STARTED|Placebo + Niacin 500 mg (1day)||17
2480328|NCT00913081|6082021|P1|NOT COMPLETED|Washout #3 (7days)||0
2480329|NCT00913081|6082021|P1|COMPLETED|Washout #3 (7days)||17
2480330|NCT00913081|6082021|P1|STARTED|Washout #3 (7days)||17
2480331|NCT00913081|6082021|P1|NOT COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||0
2480332|NCT00913081|6082021|P1|COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
2480333|NCT00913081|6082021|P1|STARTED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
2480334|NCT00913081|6082021|P1|NOT COMPLETED|Washout #2 (7 Days)||0
2480335|NCT00913081|6082021|P1|COMPLETED|Washout #2 (7 Days)||17
2480336|NCT00913081|6082021|P1|STARTED|Washout #2 (7 Days)||17
2480337|NCT00913081|6082021|P1|NOT COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||0
2480338|NCT00913081|6082021|P1|COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
2480339|NCT00913081|6082021|P1|STARTED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
2480340|NCT00913081|6082021|P1|NOT COMPLETED|Washout #1 (7 Days)||0
2480341|NCT00913081|6082021|P1|COMPLETED|Washout #1 (7 Days)||17
2480342|NCT00913081|6082021|P1|STARTED|Washout #1 (7 Days)||17
2480343|NCT00913081|6082021|P1|NOT COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||0
2480344|NCT00913081|6082021|P1|COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||17
2480345|NCT00913081|6082021|P1|STARTED|Quercetin 500 mg + Niacin 500 mg (1day)||17
2480346|NCT00913003|6082033|P2|NOT COMPLETED|Overall Study||0
2480347|NCT00913003|6082034|P1|NOT COMPLETED|Overall Study||0
2480348|NCT00913003|6082033|P2|COMPLETED|Overall Study||11
2480349|NCT00913003|6082034|P1|COMPLETED|Overall Study||11
2480350|NCT00913003|6082033|P2|STARTED|Overall Study||11
2480351|NCT00913003|6082034|P1|STARTED|Overall Study||11
2480352|NCT00912964|6082047|P3|NOT COMPLETED|Overall Study||54
2480353|NCT00912964|6082048|P2|NOT COMPLETED|Overall Study||46
2480354|NCT00912964|6082049|P1|NOT COMPLETED|Overall Study||66
2480355|NCT00912964|6082047|P3|COMPLETED|Overall Study||386
2480356|NCT00912964|6082048|P2|COMPLETED|Overall Study||387
2480357|NCT00912964|6082049|P1|COMPLETED|Overall Study||367
2480358|NCT00912964|6082047|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|257
2480359|NCT00912964|6082048|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|254
2480360|NCT00912964|6082049|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|262
2480361|NCT00912964|6082047|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|426
2480362|NCT00912964|6082048|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|410
2480363|NCT00912964|6082049|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|415
2480364|NCT00912964|6082047|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|440
2480365|NCT00912964|6082048|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|432
2480366|NCT00912964|6082049|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
2480367|NCT00912964|6082047|P3|STARTED|Overall Study||440
2480368|NCT00912964|6082048|P2|STARTED|Overall Study||433
2480369|NCT00912964|6082049|P1|STARTED|Overall Study||433
2480370|NCT00912925|6082173|P2|NOT COMPLETED|Overall Study||0
2480371|NCT00912925|6082174|P1|NOT COMPLETED|Overall Study||0
2480372|NCT00912925|6082173|P2|COMPLETED|Overall Study||22
2480373|NCT00912925|6082174|P1|COMPLETED|Overall Study||23
2480374|NCT00912925|6082173|P2|STARTED|Overall Study||22
2480375|NCT00912925|6082174|P1|STARTED|Overall Study||23
2480376|NCT00912912|6082192|P1|NOT COMPLETED|Overall Study||4
2480377|NCT00912912|6082192|P1|COMPLETED|Overall Study||1
2480378|NCT00912912|6082192|P1|STARTED|Overall Study||5
2480379|NCT00912808|6082198|P2|NOT COMPLETED|Second Intervention (6 Weeks)||1
2480380|NCT00912808|6082199|P1|NOT COMPLETED|Second Intervention (6 Weeks)||1
2480381|NCT00912808|6082198|P2|COMPLETED|Second Intervention (6 Weeks)||9
2480382|NCT00912808|6082199|P1|COMPLETED|Second Intervention (6 Weeks)||8
2480383|NCT00912808|6082198|P2|Received Intervention|Second Intervention (6 Weeks)||10
2480384|NCT00912808|6082199|P1|Received Intervention|Second Intervention (6 Weeks)||9
2480385|NCT00912808|6082198|P2|STARTED|Second Intervention (6 Weeks)||10
2480386|NCT00912808|6082199|P1|STARTED|Second Intervention (6 Weeks)||9
2480387|NCT00912808|6082198|P2|NOT COMPLETED|Washout||1
2480388|NCT00912808|6082199|P1|NOT COMPLETED|Washout||0
2480389|NCT00912808|6082198|P2|COMPLETED|Washout||10
2480390|NCT00912808|6082199|P1|COMPLETED|Washout||9
2480391|NCT00912808|6082198|P2|STARTED|Washout||11
2480392|NCT00912808|6082199|P1|STARTED|Washout||9
2480393|NCT00912808|6082198|P2|NOT COMPLETED|First Intervention (6 Weeks)||1
2480394|NCT00912808|6082199|P1|NOT COMPLETED|First Intervention (6 Weeks)||2
2480395|NCT00912808|6082198|P2|COMPLETED|First Intervention (6 Weeks)||11
2480396|NCT00912808|6082199|P1|COMPLETED|First Intervention (6 Weeks)||9
2480397|NCT00912808|6082198|P2|Received Intervention|First Intervention (6 Weeks)||12
2480398|NCT00912808|6082199|P1|Received Intervention|First Intervention (6 Weeks)||11
2480399|NCT00912808|6082198|P2|STARTED|First Intervention (6 Weeks)||12
2480400|NCT00912808|6082199|P1|STARTED|First Intervention (6 Weeks)||11
2480401|NCT00912795|6082209|P2|NOT COMPLETED|Overall Study||58
2480402|NCT00912795|6082210|P1|NOT COMPLETED|Overall Study||47
2480403|NCT00912795|6082209|P2|COMPLETED|Overall Study||17
2480404|NCT00912795|6082210|P1|COMPLETED|Overall Study||29
2480405|NCT00912795|6082209|P2|STARTED|Overall Study||75
2480406|NCT00912795|6082210|P1|STARTED|Overall Study||76
2480407|NCT00912782|6082224|P2|NOT COMPLETED|Overall Study||5
2480408|NCT00912782|6082225|P1|NOT COMPLETED|Overall Study||3
2480409|NCT00912782|6082224|P2|COMPLETED|Overall Study||20
2480410|NCT00912782|6082225|P1|COMPLETED|Overall Study||24
2480411|NCT00912782|6082224|P2|STARTED|Overall Study||25
2480412|NCT00912782|6082225|P1|STARTED|Overall Study||27
2480413|NCT00912743|6082235|P2|NOT COMPLETED|Overall Study||20
2480414|NCT00912743|6082236|P1|NOT COMPLETED|Overall Study||13
2480415|NCT00912743|6082235|P2|COMPLETED|Overall Study||0
2480416|NCT00912743|6082236|P1|COMPLETED|Overall Study||0
2480417|NCT00912743|6082235|P2|STARTED|Overall Study||20
2480418|NCT00912743|6082236|P1|STARTED|Overall Study||13
2480419|NCT00912509|6082248|P2|NOT COMPLETED|Overall Study||3
2480420|NCT00912509|6082249|P1|NOT COMPLETED|Overall Study||5
2480421|NCT00912509|6082248|P2|COMPLETED|Overall Study||7
2480422|NCT00912509|6082249|P1|COMPLETED|Overall Study||15
2480423|NCT00912509|6082248|P2|STARTED|Overall Study||10
2480424|NCT00912509|6082249|P1|STARTED|Overall Study||20
2480425|NCT00912405|6082257|P1|NOT COMPLETED|Overall Study||5
2480426|NCT00912405|6082257|P1|COMPLETED|Overall Study||45
2480427|NCT00912405|6082257|P1|STARTED|Overall Study||50
2480428|NCT00912340|6082267|P3|NOT COMPLETED|Overall Study||4
2480429|NCT00912340|6082268|P2|NOT COMPLETED|Overall Study||4
2480430|NCT00912340|6082269|P1|NOT COMPLETED|Overall Study||2
2480431|NCT00912340|6082267|P3|COMPLETED|Overall Study||0
2480432|NCT00912340|6082268|P2|COMPLETED|Overall Study||26
2480433|NCT00912340|6082269|P1|COMPLETED|Overall Study||22
2480434|NCT00912340|6082267|P3|STARTED|Overall Study||4
2480435|NCT00912340|6082268|P2|STARTED|Overall Study||30
2480436|NCT00912340|6082269|P1|STARTED|Overall Study||24
2480437|NCT00912301|6082283|P3|NOT COMPLETED|Overall Study||0
2480438|NCT00912301|6082284|P2|NOT COMPLETED|Overall Study||0
2480439|NCT00912301|6082285|P1|NOT COMPLETED|Overall Study||0
2480440|NCT00912301|6082283|P3|COMPLETED|Overall Study||13
2480441|NCT00912301|6082284|P2|COMPLETED|Overall Study||12
2480442|NCT00912301|6082285|P1|COMPLETED|Overall Study||11
2480443|NCT00912301|6082283|P3|STARTED|Overall Study||13
2480444|NCT00912301|6082284|P2|STARTED|Overall Study||12
2480445|NCT00912301|6082285|P1|STARTED|Overall Study||11
2480446|NCT00912288|6082307|P2|NOT COMPLETED|Overall Study||40
2480447|NCT00912288|6082308|P1|NOT COMPLETED|Overall Study||41
2480448|NCT00912288|6082307|P2|COMPLETED|Overall Study||2
2480449|NCT00912288|6082308|P1|COMPLETED|Overall Study||3
2480450|NCT00912288|6082307|P2|STARTED|Overall Study||42
2480451|NCT00912288|6082308|P1|STARTED|Overall Study||44
2480452|NCT00912223|6082330|P1|NOT COMPLETED|Overall Study||3
2480453|NCT00912223|6082330|P1|COMPLETED|Overall Study||62
2480454|NCT00912223|6082330|P1|STARTED|Overall Study||65
2480455|NCT00912158|6082349|P3|NOT COMPLETED|Overall Study||0
2480456|NCT00912158|6082350|P2|NOT COMPLETED|Overall Study||0
2480457|NCT00912158|6082351|P1|NOT COMPLETED|Overall Study||0
2480458|NCT00912158|6082349|P3|COMPLETED|Overall Study||41
2480459|NCT00912158|6082350|P2|COMPLETED|Overall Study||44
2480460|NCT00912158|6082351|P1|COMPLETED|Overall Study||44
2480461|NCT00912158|6082349|P3|STARTED|Overall Study||41
2480462|NCT00912158|6082350|P2|STARTED|Overall Study||44
2480463|NCT00912158|6082351|P1|STARTED|Overall Study||44
2480464|NCT00912093|6082361|P5|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
2480465|NCT00912093|6082362|P4|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
2480466|NCT00912093|6082363|P3|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
2480467|NCT00912093|6082364|P2|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
2480468|NCT00912093|6082365|P1|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
2480469|NCT00912093|6082361|P5|COMPLETED|The Open Label Extension (OLE) Phase||4
2480470|NCT00912093|6082362|P4|COMPLETED|The Open Label Extension (OLE) Phase||2
2480471|NCT00912093|6082363|P3|COMPLETED|The Open Label Extension (OLE) Phase||3
2480472|NCT00912093|6082364|P2|COMPLETED|The Open Label Extension (OLE) Phase||35
2480473|NCT00912093|6082365|P1|COMPLETED|The Open Label Extension (OLE) Phase||38
2480474|NCT00912093|6082361|P5|STARTED|The Open Label Extension (OLE) Phase||4
2480475|NCT00912093|6082362|P4|STARTED|The Open Label Extension (OLE) Phase||2
2480476|NCT00912093|6082363|P3|STARTED|The Open Label Extension (OLE) Phase||3
2480477|NCT00912093|6082364|P2|STARTED|The Open Label Extension (OLE) Phase||35
2480478|NCT00912093|6082365|P1|STARTED|The Open Label Extension (OLE) Phase||38
2480479|NCT00912093|6082361|P5|NOT COMPLETED|The Controlled Phase||1
2480480|NCT00912093|6082362|P4|NOT COMPLETED|The Controlled Phase||0
2480481|NCT00912093|6082363|P3|NOT COMPLETED|The Controlled Phase||0
2480482|NCT00912093|6082364|P2|NOT COMPLETED|The Controlled Phase||2
2480483|NCT00912093|6082365|P1|NOT COMPLETED|The Controlled Phase||0
2480484|NCT00912093|6082361|P5|COMPLETED|The Controlled Phase||4
2480485|NCT00912093|6082362|P4|COMPLETED|The Controlled Phase||2
2480486|NCT00912093|6082363|P3|COMPLETED|The Controlled Phase||3
2480487|NCT00912093|6082364|P2|COMPLETED|The Controlled Phase||43
2480488|NCT00912093|6082365|P1|COMPLETED|The Controlled Phase||43
2480489|NCT00912093|6082361|P5|STARTED|The Controlled Phase||5
2480490|NCT00912093|6082362|P4|STARTED|The Controlled Phase||2
2480491|NCT00912093|6082363|P3|STARTED|The Controlled Phase||3
2480492|NCT00912093|6082364|P2|STARTED|The Controlled Phase||45
2480493|NCT00912093|6082365|P1|STARTED|The Controlled Phase||43
2480494|NCT00912028|6082384|P5|NOT COMPLETED|Overall Study||3
2480495|NCT00912028|6082385|P4|NOT COMPLETED|Overall Study||1
2480496|NCT00912028|6082386|P3|NOT COMPLETED|Overall Study||0
2480497|NCT00912028|6082387|P2|NOT COMPLETED|Overall Study||3
2480498|NCT00912028|6082388|P1|NOT COMPLETED|Overall Study||5
2480499|NCT00912028|6082384|P5|COMPLETED|Overall Study||0
2480500|NCT00912028|6082385|P4|COMPLETED|Overall Study||16
2480501|NCT00912028|6082386|P3|COMPLETED|Overall Study||13
2480502|NCT00912028|6082387|P2|COMPLETED|Overall Study||0
2480503|NCT00912028|6082388|P1|COMPLETED|Overall Study||30
2480504|NCT00912028|6082384|P5|STARTED|Overall Study||3
2480505|NCT00912028|6082385|P4|STARTED|Overall Study||17
2480506|NCT00912028|6082386|P3|STARTED|Overall Study||13
2480507|NCT00912028|6082387|P2|STARTED|Overall Study||3
2480508|NCT00912028|6082388|P1|STARTED|Overall Study||35
2480509|NCT00912015|6082417|P4|NOT COMPLETED|Overall Study||2
2480510|NCT00912015|6082418|P3|NOT COMPLETED|Overall Study||3
2480511|NCT00912015|6082419|P2|NOT COMPLETED|Overall Study||8
2480512|NCT00912015|6082420|P1|NOT COMPLETED|Overall Study||16
2480513|NCT00912015|6082417|P4|COMPLETED|Overall Study||0
2480514|NCT00912015|6082418|P3|COMPLETED|Overall Study||22
2480515|NCT00912015|6082419|P2|COMPLETED|Overall Study||62
2480516|NCT00912015|6082420|P1|COMPLETED|Overall Study||125
2480517|NCT00912015|6082417|P4|STARTED|Overall Study|Two patients took 100 mg against instructions in protocol that the minimum daily dose was 200 mg.|2
2480518|NCT00912015|6082418|P3|STARTED|Overall Study|Dose at which a patient spent the longest time.|25
2480519|NCT00912015|6082419|P2|STARTED|Overall Study|Dose at which a patient spent the longest time.|70
2480520|NCT00912015|6082420|P1|STARTED|Overall Study|Dose at which a patient spent the longest time.|141
2480521|NCT00912002|6082430|P1|NOT COMPLETED|Overall Study||0
2480522|NCT00912002|6082430|P1|COMPLETED|Overall Study||6
2480523|NCT00912002|6082430|P1|STARTED|Overall Study||6
2480524|NCT00911989|6082436|P1|NOT COMPLETED|Overall Study||1
2480525|NCT00911989|6082436|P1|COMPLETED|Overall Study||3
2480526|NCT00911989|6082436|P1|STARTED|Overall Study||4
2480527|NCT00911937|6082442|P2|NOT COMPLETED|Overall Study||95
2480528|NCT00911937|6082443|P1|NOT COMPLETED|Overall Study||87
2480529|NCT00911937|6082442|P2|COMPLETED|Overall Study||381
2480530|NCT00911937|6082443|P1|COMPLETED|Overall Study||400
2480531|NCT00911937|6082442|P2|Treated|Overall Study||463
2480532|NCT00911937|6082443|P1|Treated|Overall Study||474
2480533|NCT00911937|6082442|P2|STARTED|Overall Study||476
2480534|NCT00911937|6082443|P1|STARTED|Overall Study||487
2480535|NCT00911898|6082503|P1|NOT COMPLETED|Overall Study||0
2480536|NCT00911898|6082503|P1|COMPLETED|Overall Study||20
2480537|NCT00911898|6082503|P1|STARTED|Overall Study||20
2480538|NCT00911859|6082510|P3|NOT COMPLETED|Follow-up Period||41
2480539|NCT00911859|6082511|P2|NOT COMPLETED|Follow-up Period||46
2480540|NCT00911859|6082512|P1|NOT COMPLETED|Follow-up Period||11
2480541|NCT00911859|6082510|P3|COMPLETED|Follow-up Period||11
2480542|NCT00911859|6082511|P2|COMPLETED|Follow-up Period||7
2480543|NCT00911859|6082512|P1|COMPLETED|Follow-up Period||1
2480544|NCT00911859|6082510|P3|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|52
2480545|NCT00911859|6082511|P2|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|53
2480546|NCT00911859|6082512|P1|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|12
2480547|NCT00911859|6082510|P3|NOT COMPLETED|Maintainance Period||21
2480548|NCT00911859|6082511|P2|NOT COMPLETED|Maintainance Period||0
2480549|NCT00911859|6082512|P1|NOT COMPLETED|Maintainance Period||0
2480550|NCT00911859|6082510|P3|COMPLETED|Maintainance Period||0
2480551|NCT00911859|6082511|P2|COMPLETED|Maintainance Period||0
2480552|NCT00911859|6082512|P1|COMPLETED|Maintainance Period||0
2480553|NCT00911859|6082510|P3|STARTED|Maintainance Period|Participants who received siltuximab only during the 18-month maintenance period|21
2480554|NCT00911859|6082511|P2|STARTED|Maintainance Period||0
2480555|NCT00911859|6082512|P1|STARTED|Maintainance Period||0
2480556|NCT00911859|6082510|P3|NOT COMPLETED|Treatment Period||25
2480557|NCT00911859|6082511|P2|NOT COMPLETED|Treatment Period||21
2480558|NCT00911859|6082512|P1|NOT COMPLETED|Treatment Period||8
2480559|NCT00911859|6082510|P3|COMPLETED|Treatment Period||27
2480560|NCT00911859|6082511|P2|COMPLETED|Treatment Period||33
2480561|NCT00911859|6082512|P1|COMPLETED|Treatment Period||4
2480562|NCT00911859|6082510|P3|Received Treatment|Treatment Period||52
2480563|NCT00911859|6082511|P2|Received Treatment|Treatment Period||53
2480564|NCT00911859|6082512|P1|Received Treatment|Treatment Period||12
2480565|NCT00911859|6082510|P3|STARTED|Treatment Period||52
2480566|NCT00911859|6082511|P2|STARTED|Treatment Period||54
2480567|NCT00911859|6082512|P1|STARTED|Treatment Period||12
2480568|NCT00911820|6082538|P2|NOT COMPLETED|Overall Study||43
2480569|NCT00911820|6082539|P1|NOT COMPLETED|Overall Study||45
2480570|NCT00911820|6082538|P2|COMPLETED|Overall Study||0
2480571|NCT00911820|6082539|P1|COMPLETED|Overall Study||0
2480572|NCT00911820|6082538|P2|Treated|Overall Study|Randomized patients not treated: withdrew consent (n=2)|41
2480573|NCT00911820|6082539|P1|Treated|Overall Study|Randomized patients not treated: unable to confirm pathology (n=1)|44
2480574|NCT00911820|6082538|P2|STARTED|Overall Study||43
2480575|NCT00911820|6082539|P1|STARTED|Overall Study||45
2480576|NCT00911807|6082556|P3|NOT COMPLETED|Overall Study||23
2480577|NCT00911807|6082557|P2|NOT COMPLETED|Overall Study||18
2480578|NCT00911807|6082558|P1|NOT COMPLETED|Overall Study||17
2480579|NCT00911807|6082556|P3|COMPLETED|Overall Study||52
2480580|NCT00911807|6082557|P2|COMPLETED|Overall Study||52
2480581|NCT00911807|6082558|P1|COMPLETED|Overall Study||55
2480582|NCT00911807|6082556|P3|STARTED|Overall Study||75
2480583|NCT00911807|6082557|P2|STARTED|Overall Study||70
2480584|NCT00911807|6082558|P1|STARTED|Overall Study||72
2480585|NCT00911768|6082568|P2|NOT COMPLETED|Overall Study||4
2480586|NCT00911768|6082569|P1|NOT COMPLETED|Overall Study||6
2480587|NCT00911768|6082568|P2|COMPLETED|Overall Study||46
2480588|NCT00911768|6082569|P1|COMPLETED|Overall Study||44
2480589|NCT00911768|6082568|P2|STARTED|Overall Study||50
2480590|NCT00911768|6082569|P1|STARTED|Overall Study||50
2480591|NCT00911742|6082581|P2|NOT COMPLETED|Treatment Phase II||0
2480592|NCT00911742|6082582|P1|NOT COMPLETED|Treatment Phase II||0
2480593|NCT00911742|6082581|P2|COMPLETED|Treatment Phase II||13
2480594|NCT00911742|6082582|P1|COMPLETED|Treatment Phase II||13
2480595|NCT00911742|6082581|P2|STARTED|Treatment Phase II||13
2480596|NCT00911742|6082582|P1|STARTED|Treatment Phase II||13
2480597|NCT00911742|6082581|P2|NOT COMPLETED|Treatment Phase I||0
2480598|NCT00911742|6082582|P1|NOT COMPLETED|Treatment Phase I||0
2480599|NCT00911742|6082581|P2|COMPLETED|Treatment Phase I||13
2480600|NCT00911742|6082582|P1|COMPLETED|Treatment Phase I||13
2480601|NCT00911742|6082581|P2|STARTED|Treatment Phase I||13
2480602|NCT00911742|6082582|P1|STARTED|Treatment Phase I||13
2480603|NCT00911625|6082598|P2|NOT COMPLETED|Overall Study||0
2480604|NCT00911625|6082599|P1|NOT COMPLETED|Overall Study||7
2480605|NCT00911625|6082598|P2|COMPLETED|Overall Study||57
2480606|NCT00911625|6082599|P1|COMPLETED|Overall Study||50
2480607|NCT00911625|6082598|P2|STARTED|Overall Study||57
2480608|NCT00911625|6082599|P1|STARTED|Overall Study||57
2480609|NCT00911612|6082609|P2|NOT COMPLETED|Overall Study||0
2480610|NCT00911612|6082610|P1|NOT COMPLETED|Overall Study||0
2480611|NCT00911612|6082609|P2|COMPLETED|Overall Study||12
2480612|NCT00911612|6082610|P1|COMPLETED|Overall Study||12
2480613|NCT00911612|6082609|P2|STARTED|Overall Study||12
2480614|NCT00911612|6082610|P1|STARTED|Overall Study||12
2480615|NCT00911547|6082628|P4|NOT COMPLETED|Overall Study||16
2480616|NCT00911547|6082629|P3|NOT COMPLETED|Overall Study||22
2480617|NCT00911547|6082630|P2|NOT COMPLETED|Overall Study||42
2480618|NCT00911547|6082631|P1|NOT COMPLETED|Overall Study||11
2480619|NCT00911547|6082628|P4|COMPLETED|Overall Study||177
2480620|NCT00911547|6082629|P3|COMPLETED|Overall Study||178
2480621|NCT00911547|6082630|P2|COMPLETED|Overall Study||159
2480622|NCT00911547|6082631|P1|COMPLETED|Overall Study||37
2480623|NCT00911547|6082628|P4|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|193
2480624|NCT00911547|6082629|P3|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|200
2480625|NCT00911547|6082630|P2|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|201
2480626|NCT00911547|6082631|P1|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|48
2480627|NCT00911534|6082659|P2|NOT COMPLETED|Overall Study||16
2480628|NCT00911534|6082660|P1|NOT COMPLETED|Overall Study||15
2480629|NCT00911534|6082659|P2|COMPLETED|Overall Study||137
2480630|NCT00911534|6082660|P1|COMPLETED|Overall Study||132
2480631|NCT00911534|6082659|P2|STARTED|Overall Study|Randomized (treated)|153
2480632|NCT00911534|6082660|P1|STARTED|Overall Study|Randomized (treated)|147
2480633|NCT00911508|6082674|P2|NOT COMPLETED|Overall Study||130
2480634|NCT00911508|6082675|P1|NOT COMPLETED|Overall Study||106
2480635|NCT00911508|6082674|P2|COMPLETED|Overall Study||966
2480636|NCT00911508|6082675|P1|COMPLETED|Overall Study||1002
2480637|NCT00911508|6082674|P2|STARTED|Overall Study||1096
2480638|NCT00911508|6082675|P1|STARTED|Overall Study||1108
2480639|NCT00911495|6082707|P1|NOT COMPLETED|Overall Study||1
2480640|NCT00911495|6082707|P1|COMPLETED|Overall Study||14
2480641|NCT00911495|6082707|P1|STARTED|Overall Study||15
2480642|NCT00911443|6082720|P5|NOT COMPLETED|Overall Study||0
2480643|NCT00911443|6082721|P4|NOT COMPLETED|Overall Study||0
2480644|NCT00911443|6082722|P3|NOT COMPLETED|Overall Study||0
2480645|NCT00911443|6082723|P2|NOT COMPLETED|Overall Study||0
2480646|NCT00911443|6082724|P1|NOT COMPLETED|Overall Study||0
2480647|NCT00911443|6082720|P5|COMPLETED|Overall Study||97
2480648|NCT00911443|6082721|P4|COMPLETED|Overall Study||99
2480649|NCT00911443|6082722|P3|COMPLETED|Overall Study||98
2480650|NCT00911443|6082723|P2|COMPLETED|Overall Study||97
2480651|NCT00911443|6082724|P1|COMPLETED|Overall Study||97
2480652|NCT00911443|6082720|P5|STARTED|Overall Study||97
2480653|NCT00911443|6082721|P4|STARTED|Overall Study||99
2480654|NCT00911443|6082722|P3|STARTED|Overall Study||98
2480655|NCT00911443|6082723|P2|STARTED|Overall Study||97
2480656|NCT00911443|6082724|P1|STARTED|Overall Study||97
2480657|NCT00911326|6082741|P1|NOT COMPLETED|Overall Study||16
2480658|NCT00911326|6082741|P1|COMPLETED|Overall Study||85
2480659|NCT00911326|6082741|P1|STARTED|Overall Study||101
2480660|NCT00911300|6082750|P2|NOT COMPLETED|Overall Study||43
2480661|NCT00911300|6082751|P1|NOT COMPLETED|Overall Study||35
2480662|NCT00911300|6082750|P2|COMPLETED|Overall Study||131
2480663|NCT00911300|6082751|P1|COMPLETED|Overall Study||140
2480664|NCT00911300|6082750|P2|STARTED|Overall Study||174
2480665|NCT00911300|6082751|P1|STARTED|Overall Study||175
2480666|NCT00911274|6082777|P2|NOT COMPLETED|Period 2||0
2480667|NCT00911274|6082778|P1|NOT COMPLETED|Period 2||0
2480668|NCT00911274|6082777|P2|COMPLETED|Period 2||26
2480669|NCT00911274|6082778|P1|COMPLETED|Period 2||27
2480670|NCT00911274|6082777|P2|STARTED|Period 2||26
2480671|NCT00911274|6082778|P1|STARTED|Period 2||27
2480672|NCT00911274|6082777|P2|NOT COMPLETED|Period 1||0
2480673|NCT00911274|6082778|P1|NOT COMPLETED|Period 1||0
2480674|NCT00911274|6082777|P2|COMPLETED|Period 1||26
2480675|NCT00911274|6082778|P1|COMPLETED|Period 1||27
2480676|NCT00911274|6082777|P2|STARTED|Period 1||26
2480677|NCT00911274|6082778|P1|STARTED|Period 1||27
2480678|NCT00911170|6082788|P2|NOT COMPLETED|Long Term Follow-Up||422
2480679|NCT00911170|6082789|P1|NOT COMPLETED|Long Term Follow-Up||423
2480680|NCT00911170|6082788|P2|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
2480681|NCT00911170|6082789|P1|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
2480682|NCT00911170|6082788|P2|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|422
2480683|NCT00911170|6082789|P1|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|423
2480684|NCT00911170|6082788|P2|NOT COMPLETED|Treatment Period||37
2480685|NCT00911170|6082789|P1|NOT COMPLETED|Treatment Period||27
2480686|NCT00911170|6082788|P2|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|386
2480687|NCT00911170|6082789|P1|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|397
2480688|NCT00911170|6082788|P2|Received Investigational Product|Treatment Period||419
2480689|NCT00911170|6082789|P1|Received Investigational Product|Treatment Period|Includes one participant who received pegfilgrastim in error.|422
2480690|NCT00911170|6082788|P2|Received Bevacizumab|Treatment Period||420
2480691|NCT00911170|6082789|P1|Received Bevacizumab|Treatment Period||423
2480692|NCT00911170|6082788|P2|Received Chemotherapy|Treatment Period|Primary Analysis Set|422
2480693|NCT00911170|6082789|P1|Received Chemotherapy|Treatment Period|Primary Analysis Set|423
2480694|NCT00911170|6082788|P2|STARTED|Treatment Period||423
2480695|NCT00911170|6082789|P1|STARTED|Treatment Period||424
2480696|NCT00911157|6082813|P2|NOT COMPLETED|Overall Study||2
2480697|NCT00911157|6082814|P1|NOT COMPLETED|Overall Study||7
2480698|NCT00911157|6082813|P2|COMPLETED|Overall Study||8
2480699|NCT00911157|6082814|P1|COMPLETED|Overall Study||22
2480700|NCT00911157|6082813|P2|STARTED|Overall Study||10
2480701|NCT00911157|6082814|P1|STARTED|Overall Study||29
2480702|NCT00911144|6082830|P2|NOT COMPLETED|Overall Study||5
2480703|NCT00911144|6082831|P1|NOT COMPLETED|Overall Study||16
2480704|NCT00911144|6082830|P2|COMPLETED|Overall Study||108
2480705|NCT00911144|6082831|P1|COMPLETED|Overall Study||319
2480706|NCT00911144|6082830|P2|STARTED|Overall Study||113
2480707|NCT00911144|6082831|P1|STARTED|Overall Study||335
2480708|NCT00911053|6082860|P5|NOT COMPLETED|Overall Study||0
2480709|NCT00911053|6082861|P4|NOT COMPLETED|Overall Study||0
2480710|NCT00911053|6082862|P3|NOT COMPLETED|Overall Study||0
2480711|NCT00911053|6082863|P2|NOT COMPLETED|Overall Study||0
2480712|NCT00911053|6082864|P1|NOT COMPLETED|Overall Study||0
2480713|NCT00911053|6082860|P5|COMPLETED|Overall Study||0
2480714|NCT00911053|6082861|P4|COMPLETED|Overall Study||0
2480715|NCT00911053|6082862|P3|COMPLETED|Overall Study||0
2480716|NCT00911053|6082863|P2|COMPLETED|Overall Study||0
2480717|NCT00911053|6082864|P1|COMPLETED|Overall Study||0
2480718|NCT00911053|6082860|P5|STARTED|Overall Study||0
2480719|NCT00911053|6082861|P4|STARTED|Overall Study||0
2480720|NCT00911053|6082862|P3|STARTED|Overall Study||0
2480721|NCT00911053|6082863|P2|STARTED|Overall Study||0
2480722|NCT00911053|6082864|P1|STARTED|Overall Study||0
2480723|NCT00910988|6082885|P4|NOT COMPLETED|Overall Study||0
2480724|NCT00910988|6082886|P3|NOT COMPLETED|Overall Study||3
2480725|NCT00910988|6082887|P2|NOT COMPLETED|Overall Study||4
2480726|NCT00910988|6082888|P1|NOT COMPLETED|Overall Study||2
2480727|NCT00910988|6082885|P4|COMPLETED|Overall Study||6
2480728|NCT00910988|6082886|P3|COMPLETED|Overall Study||5
2480729|NCT00910988|6082887|P2|COMPLETED|Overall Study||12
2480730|NCT00910988|6082888|P1|COMPLETED|Overall Study||14
2480731|NCT00910988|6082885|P4|STARTED|Overall Study||6
2480732|NCT00910988|6082886|P3|STARTED|Overall Study||8
2480733|NCT00910988|6082887|P2|STARTED|Overall Study||16
2480734|NCT00910988|6082888|P1|STARTED|Overall Study||16
2480735|NCT00910962|6082933|P3|NOT COMPLETED|Overall Study||76
2480736|NCT00910962|6082934|P2|NOT COMPLETED|Overall Study||78
2480737|NCT00910962|6082935|P1|NOT COMPLETED|Overall Study||43
2480738|NCT00910962|6082933|P3|COMPLETED|Overall Study||116
2480739|NCT00910962|6082934|P2|COMPLETED|Overall Study||121
2480740|NCT00910962|6082935|P1|COMPLETED|Overall Study||92
2480741|NCT00910962|6082933|P3|STARTED|Overall Study||192
2480742|NCT00910962|6082934|P2|STARTED|Overall Study||199
2480743|NCT00910962|6082935|P1|STARTED|Overall Study||135
2480744|NCT00910910|6083027|P2|NOT COMPLETED|Overall Study||224
2480745|NCT00910910|6083028|P1|NOT COMPLETED|Overall Study||225
2480746|NCT00910910|6083027|P2|COMPLETED|Overall Study|Completed includes participants who continued with ongoing treatment|1
2480747|NCT00910910|6083028|P1|COMPLETED|Overall Study|Completed includes participants who continued with ongoing treatment|0
2480748|NCT00910910|6083027|P2|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|223
2480749|NCT00910910|6083028|P1|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|224
2480750|NCT00910910|6083027|P2|STARTED|Overall Study||225
2480751|NCT00910910|6083028|P1|STARTED|Overall Study||225
2480752|NCT00910871|6083064|P1|NOT COMPLETED|Overall Study||54
2480753|NCT00910871|6083064|P1|COMPLETED|Overall Study||179
2480754|NCT00910871|6083064|P1|STARTED|Overall Study||233
2480755|NCT00910858|6083072|P3|NOT COMPLETED|Combined Treatment Phase||4
2480756|NCT00910858|6083073|P2|NOT COMPLETED|Combined Treatment Phase||10
2480757|NCT00910858|6083074|P1|NOT COMPLETED|Combined Treatment Phase||9
2480758|NCT00910858|6083072|P3|COMPLETED|Combined Treatment Phase||0
2480759|NCT00910858|6083073|P2|COMPLETED|Combined Treatment Phase||0
2480760|NCT00910858|6083074|P1|COMPLETED|Combined Treatment Phase||0
2480761|NCT00910858|6083072|P3|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|4
2480762|NCT00910858|6083073|P2|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|10
2480763|NCT00910858|6083074|P1|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|9
2480764|NCT00910858|6083072|P3|NOT COMPLETED|Monotherapy Phase||7
2480765|NCT00910858|6083073|P2|NOT COMPLETED|Monotherapy Phase||15
2480766|NCT00910858|6083074|P1|NOT COMPLETED|Monotherapy Phase||17
2480767|NCT00910858|6083072|P3|COMPLETED|Monotherapy Phase||0
2480768|NCT00910858|6083073|P2|COMPLETED|Monotherapy Phase||0
2480769|NCT00910858|6083074|P1|COMPLETED|Monotherapy Phase||0
2480770|NCT00910858|6083072|P3|Pharmacokinetic Population|Monotherapy Phase||7
2480771|NCT00910858|6083073|P2|Pharmacokinetic Population|Monotherapy Phase|Patients in the 15 mg Non-del 5q group were not included in the pharmacokinetic assessment.|0
2480772|NCT00910858|6083074|P1|Pharmacokinetic Population|Monotherapy Phase||17
2480773|NCT00910858|6083072|P3|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|7
2480774|NCT00910858|6083073|P2|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|15
2480775|NCT00910858|6083074|P1|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|17
2480776|NCT00910858|6083072|P3|STARTED|Monotherapy Phase|Includes 3 participants from the PK Phase and 4 newly enrolled participants.|7
2480777|NCT00910858|6083073|P2|STARTED|Monotherapy Phase|All 15 participants were newly enrolled into the Monotherapy Phase.|15
2480778|NCT00910858|6083074|P1|STARTED|Monotherapy Phase|Includes 8 participants from the PK Phase and 9 newly enrolled participants.|17
2480779|NCT00910858|6083072|P3|NOT COMPLETED|Pharmacokinetic Phase||0
2480780|NCT00910858|6083073|P2|NOT COMPLETED|Pharmacokinetic Phase||0
2480781|NCT00910858|6083074|P1|NOT COMPLETED|Pharmacokinetic Phase||1
2480782|NCT00910858|6083072|P3|COMPLETED|Pharmacokinetic Phase||3
2480783|NCT00910858|6083073|P2|COMPLETED|Pharmacokinetic Phase||0
2480784|NCT00910858|6083074|P1|COMPLETED|Pharmacokinetic Phase||8
2480785|NCT00910858|6083072|P3|STARTED|Pharmacokinetic Phase||3
2480786|NCT00910858|6083073|P2|STARTED|Pharmacokinetic Phase||0
2480787|NCT00910858|6083074|P1|STARTED|Pharmacokinetic Phase||9
2480788|NCT00910845|6083099|P2|NOT COMPLETED|Treatment Cycle 2||9
2480789|NCT00910845|6083100|P1|NOT COMPLETED|Treatment Cycle 2||5
2480790|NCT00910845|6083099|P2|COMPLETED|Treatment Cycle 2||203
2480791|NCT00910845|6083100|P1|COMPLETED|Treatment Cycle 2||136
2480792|NCT00910845|6083099|P2|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|212
2480793|NCT00910845|6083100|P1|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|141
2480794|NCT00910845|6083099|P2|NOT COMPLETED|Treatment Cycle 1||34
2480795|NCT00910845|6083100|P1|NOT COMPLETED|Treatment Cycle 1||31
2480796|NCT00910845|6083099|P2|COMPLETED|Treatment Cycle 1||243
2480797|NCT00910845|6083100|P1|COMPLETED|Treatment Cycle 1||249
2480798|NCT00910845|6083099|P2|STARTED|Treatment Cycle 1||277
2480799|NCT00910845|6083100|P1|STARTED|Treatment Cycle 1||280
2480800|NCT00910728|6083119|P9|NOT COMPLETED|Overall Study||3
2480801|NCT00910728|6083120|P8|NOT COMPLETED|Overall Study||3
2480802|NCT00910728|6083121|P7|NOT COMPLETED|Overall Study||6
2480803|NCT00910728|6083122|P6|NOT COMPLETED|Overall Study||1
2480804|NCT00910728|6083123|P5|NOT COMPLETED|Overall Study||5
2480805|NCT00910728|6083124|P4|NOT COMPLETED|Overall Study||3
2480806|NCT00910728|6083125|P3|NOT COMPLETED|Overall Study||3
2480807|NCT00910728|6083126|P2|NOT COMPLETED|Overall Study||3
2480808|NCT00910728|6083127|P1|NOT COMPLETED|Overall Study||6
2480809|NCT00910728|6083119|P9|COMPLETED|Overall Study||0
2480810|NCT00910728|6083120|P8|COMPLETED|Overall Study||1
2480811|NCT00910728|6083121|P7|COMPLETED|Overall Study||0
2480812|NCT00910728|6083122|P6|COMPLETED|Overall Study||0
2480813|NCT00910728|6083123|P5|COMPLETED|Overall Study||1
2480814|NCT00910728|6083124|P4|COMPLETED|Overall Study||0
2480815|NCT00910728|6083125|P3|COMPLETED|Overall Study||0
2480816|NCT00910728|6083126|P2|COMPLETED|Overall Study||0
2480817|NCT00910728|6083127|P1|COMPLETED|Overall Study||0
2480818|NCT00910728|6083119|P9|STARTED|Overall Study||3
2480819|NCT00910728|6083120|P8|STARTED|Overall Study||4
2480820|NCT00910728|6083121|P7|STARTED|Overall Study||6
2480821|NCT00910728|6083122|P6|STARTED|Overall Study||1
2480822|NCT00910728|6083123|P5|STARTED|Overall Study||6
2480823|NCT00910728|6083124|P4|STARTED|Overall Study||3
2480824|NCT00910728|6083125|P3|STARTED|Overall Study||3
2480825|NCT00910728|6083126|P2|STARTED|Overall Study||3
2480826|NCT00910728|6083127|P1|STARTED|Overall Study||6
2480827|NCT00910715|6083249|P3|NOT COMPLETED|Overall Study||0
2480828|NCT00910715|6083250|P2|NOT COMPLETED|Overall Study||26
2480829|NCT00910715|6083251|P1|NOT COMPLETED|Overall Study||22
2480830|NCT00910715|6083249|P3|COMPLETED|Overall Study||81
2480831|NCT00910715|6083250|P2|COMPLETED|Overall Study||91
2480832|NCT00910715|6083251|P1|COMPLETED|Overall Study||86
2480833|NCT00910715|6083249|P3|STARTED|Overall Study||81
2480834|NCT00910715|6083250|P2|STARTED|Overall Study||117
2480835|NCT00910715|6083251|P1|STARTED|Overall Study||108
2480836|NCT00910689|6083265|P4|NOT COMPLETED|Months 11- 16: Evaluation Period II||6
2480837|NCT00910689|6083266|P3|NOT COMPLETED|Months 11- 16: Evaluation Period II||7
2480838|NCT00910689|6083267|P2|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
2480839|NCT00910689|6083268|P1|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
2480840|NCT00910689|6083265|P4|COMPLETED|Months 11- 16: Evaluation Period II||35
2480841|NCT00910689|6083266|P3|COMPLETED|Months 11- 16: Evaluation Period II||28
2480842|NCT00910689|6083267|P2|COMPLETED|Months 11- 16: Evaluation Period II||25
2480843|NCT00910689|6083268|P1|COMPLETED|Months 11- 16: Evaluation Period II||30
2480844|NCT00910689|6083265|P4|STARTED|Months 11- 16: Evaluation Period II||41
2480845|NCT00910689|6083266|P3|STARTED|Months 11- 16: Evaluation Period II||35
2480846|NCT00910689|6083267|P2|STARTED|Months 11- 16: Evaluation Period II||35
2480847|NCT00910689|6083268|P1|STARTED|Months 11- 16: Evaluation Period II||40
2480848|NCT00910689|6083265|P4|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
2480849|NCT00910689|6083266|P3|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
2480850|NCT00910689|6083267|P2|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
2480851|NCT00910689|6083268|P1|NOT COMPLETED|Months 5 - 10: Evaluation Period I||4
2480852|NCT00910689|6083265|P4|COMPLETED|Months 5 - 10: Evaluation Period I||41
2480853|NCT00910689|6083266|P3|COMPLETED|Months 5 - 10: Evaluation Period I||35
2480854|NCT00910689|6083267|P2|COMPLETED|Months 5 - 10: Evaluation Period I||35
2480855|NCT00910689|6083268|P1|COMPLETED|Months 5 - 10: Evaluation Period I||40
2480856|NCT00910689|6083265|P4|STARTED|Months 5 - 10: Evaluation Period I||48
2480857|NCT00910689|6083266|P3|STARTED|Months 5 - 10: Evaluation Period I||42
2480858|NCT00910689|6083267|P2|STARTED|Months 5 - 10: Evaluation Period I||42
2480859|NCT00910689|6083268|P1|STARTED|Months 5 - 10: Evaluation Period I||44
2480860|NCT00910689|6083265|P4|NOT COMPLETED|Month 2- 4: Treatment Period||11
2480861|NCT00910689|6083266|P3|NOT COMPLETED|Month 2- 4: Treatment Period||8
2480862|NCT00910689|6083267|P2|NOT COMPLETED|Month 2- 4: Treatment Period||10
2480863|NCT00910689|6083268|P1|NOT COMPLETED|Month 2- 4: Treatment Period||9
2480864|NCT00910689|6083265|P4|COMPLETED|Month 2- 4: Treatment Period||48
2480865|NCT00910689|6083266|P3|COMPLETED|Month 2- 4: Treatment Period||42
2480866|NCT00910689|6083267|P2|COMPLETED|Month 2- 4: Treatment Period||42
2480867|NCT00910689|6083268|P1|COMPLETED|Month 2- 4: Treatment Period||44
2480868|NCT00910689|6083265|P4|STARTED|Month 2- 4: Treatment Period||59
2480869|NCT00910689|6083266|P3|STARTED|Month 2- 4: Treatment Period||50
2480870|NCT00910689|6083267|P2|STARTED|Month 2- 4: Treatment Period||52
2480871|NCT00910689|6083268|P1|STARTED|Month 2- 4: Treatment Period||53
2480872|NCT00910689|6083265|P4|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||10
2480873|NCT00910689|6083266|P3|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||5
2480874|NCT00910689|6083267|P2|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||1
2480875|NCT00910689|6083268|P1|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||2
2480876|NCT00910689|6083265|P4|COMPLETED|Month 1: Optimal Acute Therapy Run in||59
2480877|NCT00910689|6083266|P3|COMPLETED|Month 1: Optimal Acute Therapy Run in||50
2480878|NCT00910689|6083267|P2|COMPLETED|Month 1: Optimal Acute Therapy Run in||52
2480879|NCT00910689|6083268|P1|COMPLETED|Month 1: Optimal Acute Therapy Run in||53
2480880|NCT00910689|6083265|P4|STARTED|Month 1: Optimal Acute Therapy Run in||69
2480881|NCT00910689|6083266|P3|STARTED|Month 1: Optimal Acute Therapy Run in||55
2480882|NCT00910689|6083267|P2|STARTED|Month 1: Optimal Acute Therapy Run in||53
2480883|NCT00910689|6083268|P1|STARTED|Month 1: Optimal Acute Therapy Run in||55
2480884|NCT00910663|6083300|P2|NOT COMPLETED|Period 2||0
2480885|NCT00910663|6083301|P1|NOT COMPLETED|Period 2||0
2480886|NCT00910663|6083300|P2|COMPLETED|Period 2||29
2480887|NCT00910663|6083301|P1|COMPLETED|Period 2||30
2480888|NCT00910663|6083300|P2|STARTED|Period 2||29
2480889|NCT00910663|6083301|P1|STARTED|Period 2||30
2480890|NCT00910663|6083300|P2|NOT COMPLETED|Period 1||1
2480891|NCT00910663|6083301|P1|NOT COMPLETED|Period 1||0
2480892|NCT00910663|6083300|P2|COMPLETED|Period 1||29
2480893|NCT00910663|6083301|P1|COMPLETED|Period 1||30
2480894|NCT00910663|6083300|P2|STARTED|Period 1||30
2480895|NCT00910663|6083301|P1|STARTED|Period 1||30
2480896|NCT00910624|6083315|P4|NOT COMPLETED|Follow-Up Phase||0
2480897|NCT00910624|6083316|P3|NOT COMPLETED|Follow-Up Phase||4
2480898|NCT00910624|6083317|P2|NOT COMPLETED|Follow-Up Phase||4
2480899|NCT00910624|6083318|P1|NOT COMPLETED|Follow-Up Phase||6
2480900|NCT00910624|6083315|P4|COMPLETED|Follow-Up Phase||2
2480901|NCT00910624|6083316|P3|COMPLETED|Follow-Up Phase||25
2480902|NCT00910624|6083317|P2|COMPLETED|Follow-Up Phase||76
2480903|NCT00910624|6083318|P1|COMPLETED|Follow-Up Phase||42
2480904|NCT00910624|6083315|P4|STARTED|Follow-Up Phase||2
2480905|NCT00910624|6083316|P3|STARTED|Follow-Up Phase||29
2480906|NCT00910624|6083317|P2|STARTED|Follow-Up Phase||80
2480907|NCT00910624|6083318|P1|STARTED|Follow-Up Phase||48
2480908|NCT00910624|6083315|P4|NOT COMPLETED|Treatment Phase||0
2480909|NCT00910624|6083316|P3|NOT COMPLETED|Treatment Phase||9
2480910|NCT00910624|6083317|P2|NOT COMPLETED|Treatment Phase||21
2480911|NCT00910624|6083318|P1|NOT COMPLETED|Treatment Phase||30
2480912|NCT00910624|6083315|P4|COMPLETED|Treatment Phase||2
2480913|NCT00910624|6083316|P3|COMPLETED|Treatment Phase||20
2480914|NCT00910624|6083317|P2|COMPLETED|Treatment Phase||64
2480915|NCT00910624|6083318|P1|COMPLETED|Treatment Phase||22
2480916|NCT00910624|6083315|P4|STARTED|Treatment Phase||2
2480917|NCT00910624|6083316|P3|STARTED|Treatment Phase||29
2480918|NCT00910624|6083317|P2|STARTED|Treatment Phase||85
2480919|NCT00910624|6083318|P1|STARTED|Treatment Phase||52
2480920|NCT00910520|6083332|P2|NOT COMPLETED|Treatment Cycle 2||8
2480921|NCT00910520|6083333|P1|NOT COMPLETED|Treatment Cycle 2||7
2480922|NCT00910520|6083332|P2|COMPLETED|Treatment Cycle 2||215
2480923|NCT00910520|6083333|P1|COMPLETED|Treatment Cycle 2||156
2480924|NCT00910520|6083332|P2|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|223
2480925|NCT00910520|6083333|P1|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|163
2480926|NCT00910520|6083332|P2|NOT COMPLETED|Treatment Cycle 1||24
2480927|NCT00910520|6083333|P1|NOT COMPLETED|Treatment Cycle 1||20
2480928|NCT00910520|6083332|P2|COMPLETED|Treatment Cycle 1||247
2480929|NCT00910520|6083333|P1|COMPLETED|Treatment Cycle 1||257
2480930|NCT00910520|6083332|P2|STARTED|Treatment Cycle 1||271
2480931|NCT00910520|6083333|P1|STARTED|Treatment Cycle 1||277
2480932|NCT00910299|6083345|P2|NOT COMPLETED|Overall Study||74
2480933|NCT00910299|6083346|P1|NOT COMPLETED|Overall Study||76
2480934|NCT00910299|6083345|P2|COMPLETED|Overall Study|1 participant died of sepsis while on study drug and was considered a “protocol completer.”|137
2480935|NCT00910299|6083346|P1|COMPLETED|Overall Study||136
2480936|NCT00910299|6083345|P2|Received at Least 1 Dose of Study Drug|Overall Study||210
2480937|NCT00910299|6083346|P1|Received at Least 1 Dose of Study Drug|Overall Study||210
2480938|NCT00910299|6083345|P2|STARTED|Overall Study||211
2480939|NCT00910299|6083346|P1|STARTED|Overall Study||212
2480940|NCT00910273|6083358|P2|NOT COMPLETED|Overall Study||13
2480941|NCT00910273|6083359|P1|NOT COMPLETED|Overall Study||18
2480942|NCT00910273|6083358|P2|COMPLETED|Overall Study||3
2480943|NCT00910273|6083359|P1|COMPLETED|Overall Study||0
2480944|NCT00910273|6083358|P2|STARTED|Overall Study||16
2480945|NCT00910273|6083359|P1|STARTED|Overall Study||18
2480946|NCT00910247|6083409|P1|NOT COMPLETED|Overall Study||69
2480947|NCT00910247|6083409|P1|COMPLETED|Overall Study||205
2480948|NCT00910247|6083409|P1|STARTED|Overall Study||274
2480949|NCT00910208|6083432|P3|NOT COMPLETED|Overall Study||1
2480950|NCT00910208|6083433|P2|NOT COMPLETED|Overall Study||2
2480951|NCT00910208|6083434|P1|NOT COMPLETED|Overall Study||2
2480952|NCT00910208|6083432|P3|COMPLETED|Overall Study||69
2480953|NCT00910208|6083433|P2|COMPLETED|Overall Study||70
2480954|NCT00910208|6083434|P1|COMPLETED|Overall Study||67
2480955|NCT00910208|6083432|P3|STARTED|Overall Study||70
2480956|NCT00910208|6083433|P2|STARTED|Overall Study||72
2480957|NCT00910208|6083434|P1|STARTED|Overall Study||69
2480958|NCT00910091|6083459|P2|NOT COMPLETED|Treatment and Survival||4
2480959|NCT00910091|6083460|P1|NOT COMPLETED|Treatment and Survival||4
2480960|NCT00910091|6083459|P2|COMPLETED|Treatment and Survival||31
2480961|NCT00910091|6083460|P1|COMPLETED|Treatment and Survival||32
2480962|NCT00910091|6083459|P2|STARTED|Treatment and Survival||35
2480963|NCT00910091|6083460|P1|STARTED|Treatment and Survival||36
2480964|NCT00910091|6083459|P2|NOT COMPLETED|Pre-assignment||2
2480965|NCT00910091|6083460|P1|NOT COMPLETED|Pre-assignment||0
2480966|NCT00910091|6083459|P2|COMPLETED|Pre-assignment||35
2480967|NCT00910091|6083460|P1|COMPLETED|Pre-assignment||36
2480968|NCT00910091|6083459|P2|STARTED|Pre-assignment||37
2480969|NCT00910091|6083460|P1|STARTED|Pre-assignment||36
2480970|NCT00910039|6083488|P1|NOT COMPLETED|Overall Study||1
2480971|NCT00910039|6083488|P1|COMPLETED|Overall Study||13
2480972|NCT00910039|6083488|P1|STARTED|Overall Study||14
2480973|NCT00910000|6083505|P6|NOT COMPLETED|Overall Study||1
2480974|NCT00910000|6083506|P5|NOT COMPLETED|Overall Study||1
2480975|NCT00910000|6083507|P4|NOT COMPLETED|Overall Study||2
2480976|NCT00910000|6083508|P3|NOT COMPLETED|Overall Study||3
2480977|NCT00910000|6083509|P2|NOT COMPLETED|Overall Study||3
2480978|NCT00910000|6083510|P1|NOT COMPLETED|Overall Study||0
2480979|NCT00910000|6083505|P6|COMPLETED|Overall Study||0
2480980|NCT00910000|6083506|P5|COMPLETED|Overall Study||2
2480981|NCT00910000|6083507|P4|COMPLETED|Overall Study||0
2480982|NCT00910000|6083508|P3|COMPLETED|Overall Study||0
2480983|NCT00910000|6083509|P2|COMPLETED|Overall Study||0
2480984|NCT00910000|6083510|P1|COMPLETED|Overall Study||3
2480985|NCT00910000|6083505|P6|STARTED|Overall Study||1
2480986|NCT00910000|6083506|P5|STARTED|Overall Study||3
2480987|NCT00910000|6083507|P4|STARTED|Overall Study||2
2480988|NCT00910000|6083508|P3|STARTED|Overall Study||3
2480989|NCT00910000|6083509|P2|STARTED|Overall Study||3
2480990|NCT00910000|6083510|P1|STARTED|Overall Study||3
2480991|NCT00909870|6083528|P2|NOT COMPLETED|Overall Study||27
2480992|NCT00909870|6083529|P1|NOT COMPLETED|Overall Study||23
2480993|NCT00909870|6083528|P2|COMPLETED|Overall Study||236
2480994|NCT00909870|6083529|P1|COMPLETED|Overall Study||251
2480995|NCT00909870|6083528|P2|STARTED|Overall Study||263
2480996|NCT00909870|6083529|P1|STARTED|Overall Study||274
2480997|NCT00909857|6083541|P2|NOT COMPLETED|Overall Study||45
2480998|NCT00909857|6083542|P1|NOT COMPLETED|Overall Study||36
2480999|NCT00909857|6083541|P2|COMPLETED|Overall Study||209
2481000|NCT00909857|6083542|P1|COMPLETED|Overall Study||217
2481001|NCT00909857|6083541|P2|Treated|Overall Study||230
2481002|NCT00909857|6083542|P1|Treated|Overall Study||234
2481003|NCT00909857|6083541|P2|STARTED|Overall Study||254
2481004|NCT00909857|6083542|P1|STARTED|Overall Study||253
2481005|NCT00909844|6083682|P1|NOT COMPLETED|Overall Study||4
2481006|NCT00909844|6083682|P1|COMPLETED|Overall Study||31
2481007|NCT00909844|6083682|P1|STARTED|Overall Study||35
2481008|NCT00909792|6083700|P2|NOT COMPLETED|Period 2||1
2481009|NCT00909792|6083701|P1|NOT COMPLETED|Period 2||1
2481010|NCT00909792|6083700|P2|COMPLETED|Period 2||124
2481011|NCT00909792|6083701|P1|COMPLETED|Period 2||128
2481012|NCT00909792|6083700|P2|STARTED|Period 2|Two discontinuations between P1 & P2: 1 for fail inc/exc criteria; 1 for lack of efficacy.|125
2481013|NCT00909792|6083701|P1|STARTED|Period 2|One participant discontinued between Period 1 and Period 2 due to lack of efficacy.|129
2481014|NCT00909792|6083700|P2|NOT COMPLETED|Period 1||1
2481015|NCT00909792|6083701|P1|NOT COMPLETED|Period 1||0
2481016|NCT00909792|6083700|P2|COMPLETED|Period 1||127
2481017|NCT00909792|6083701|P1|COMPLETED|Period 1||130
2481018|NCT00909792|6083700|P2|STARTED|Period 1||128
2481019|NCT00909792|6083701|P1|STARTED|Period 1||130
2481020|NCT00909779|6083709|P2|NOT COMPLETED|Overall Study||165
2481021|NCT00909779|6083710|P1|NOT COMPLETED|Overall Study||210
2481022|NCT00909779|6083709|P2|COMPLETED|Overall Study|All subjects but 42 were followed for 12 months/until death (whichever was earlier).|255
2481023|NCT00909779|6083710|P1|COMPLETED|Overall Study|All subjects but 47 were followed for 12 months/until death (whichever was earlier).|211
2481024|NCT00909779|6083709|P2|STARTED|Overall Study||420
2481025|NCT00909779|6083710|P1|STARTED|Overall Study||421
2481026|NCT00909753|6083734|P2|NOT COMPLETED|Period: Second Intervention||0
2481027|NCT00909753|6083735|P1|NOT COMPLETED|Period: Second Intervention||1
2481028|NCT00909753|6083734|P2|COMPLETED|Period: Second Intervention||43
2481029|NCT00909753|6083735|P1|COMPLETED|Period: Second Intervention||43
2481030|NCT00909753|6083734|P2|STARTED|Period: Second Intervention||43
2481031|NCT00909753|6083735|P1|STARTED|Period: Second Intervention||44
2481032|NCT00909753|6083734|P2|NOT COMPLETED|Period: Washout of 28 Days||3
2481033|NCT00909753|6083735|P1|NOT COMPLETED|Period: Washout of 28 Days||2
2481034|NCT00909753|6083734|P2|COMPLETED|Period: Washout of 28 Days||43
2481035|NCT00909753|6083735|P1|COMPLETED|Period: Washout of 28 Days||44
2481036|NCT00909753|6083734|P2|STARTED|Period: Washout of 28 Days||46
2481037|NCT00909753|6083735|P1|STARTED|Period: Washout of 28 Days||46
2481038|NCT00909753|6083734|P2|NOT COMPLETED|Period: First Intervention||0
2481039|NCT00909753|6083735|P1|NOT COMPLETED|Period: First Intervention||0
2481040|NCT00909753|6083734|P2|COMPLETED|Period: First Intervention||46
2481041|NCT00909753|6083735|P1|COMPLETED|Period: First Intervention||46
2481042|NCT00909753|6083734|P2|STARTED|Period: First Intervention||46
2481043|NCT00909753|6083735|P1|STARTED|Period: First Intervention||46
2481044|NCT00909727|6083755|P2|NOT COMPLETED|Overall Study||0
2481045|NCT00909727|6083756|P1|NOT COMPLETED|Overall Study||4
2481046|NCT00909727|6083755|P2|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|26
2481047|NCT00909727|6083756|P1|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|22
2481048|NCT00909727|6083755|P2|Completed Treatment Period, Week 24|Overall Study||26
2481049|NCT00909727|6083756|P1|Completed Treatment Period, Week 24|Overall Study||23
2481050|NCT00909727|6083755|P2|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor)|26
2481051|NCT00909727|6083756|P1|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo)|26
2481052|NCT00909649|6083772|P2|NOT COMPLETED|Overall Study||0
2481053|NCT00909649|6083773|P1|NOT COMPLETED|Overall Study||0
2481054|NCT00909649|6083772|P2|COMPLETED|Overall Study||25
2481055|NCT00909649|6083773|P1|COMPLETED|Overall Study||25
2481056|NCT00909649|6083772|P2|STARTED|Overall Study||25
2481057|NCT00909649|6083773|P1|STARTED|Overall Study||25
2481058|NCT00909610|6083779|P2|NOT COMPLETED|Period: Second Intervention||0
2481059|NCT00909610|6083780|P1|NOT COMPLETED|Period: Second Intervention||1
2481060|NCT00909610|6083779|P2|COMPLETED|Period: Second Intervention||33
2481061|NCT00909610|6083780|P1|COMPLETED|Period: Second Intervention||36
2481062|NCT00909610|6083779|P2|STARTED|Period: Second Intervention||33
2481063|NCT00909610|6083780|P1|STARTED|Period: Second Intervention||37
2481064|NCT00909610|6083779|P2|NOT COMPLETED|Period: Washout of 28 Days||6
2481065|NCT00909610|6083780|P1|NOT COMPLETED|Period: Washout of 28 Days||3
2481066|NCT00909610|6083779|P2|COMPLETED|Period: Washout of 28 Days||33
2481067|NCT00909610|6083780|P1|COMPLETED|Period: Washout of 28 Days||37
2481068|NCT00909610|6083779|P2|STARTED|Period: Washout of 28 Days||39
2481069|NCT00909610|6083780|P1|STARTED|Period: Washout of 28 Days||40
2481070|NCT00909610|6083779|P2|NOT COMPLETED|Period: First Intervention||1
2481071|NCT00909610|6083780|P1|NOT COMPLETED|Period: First Intervention||0
2481072|NCT00909610|6083779|P2|COMPLETED|Period: First Intervention||39
2481073|NCT00909610|6083780|P1|COMPLETED|Period: First Intervention||40
2481074|NCT00909610|6083779|P2|STARTED|Period: First Intervention||40
2481075|NCT00909610|6083780|P1|STARTED|Period: First Intervention||40
2481076|NCT00909545|6083802|P4|NOT COMPLETED|Overall Study||5
2481077|NCT00909545|6083803|P3|NOT COMPLETED|Overall Study||1
2481078|NCT00909545|6083804|P2|NOT COMPLETED|Overall Study||1
2481079|NCT00909545|6083805|P1|NOT COMPLETED|Overall Study||1
2481080|NCT00909545|6083802|P4|COMPLETED|Overall Study||19
2481081|NCT00909545|6083803|P3|COMPLETED|Overall Study||25
2481082|NCT00909545|6083804|P2|COMPLETED|Overall Study||22
2481083|NCT00909545|6083805|P1|COMPLETED|Overall Study||25
2481084|NCT00909545|6083802|P4|STARTED|Overall Study||24
2481085|NCT00909545|6083803|P3|STARTED|Overall Study||26
2481086|NCT00909545|6083804|P2|STARTED|Overall Study||23
2481087|NCT00909545|6083805|P1|STARTED|Overall Study||26
2481088|NCT00909532|6083941|P2|NOT COMPLETED|Overall Study||6
2481089|NCT00909532|6083942|P1|NOT COMPLETED|Overall Study||10
2481090|NCT00909532|6083941|P2|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|77
2481091|NCT00909532|6083942|P1|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|68
2481092|NCT00909532|6083941|P2|Completed Treatment Period, Week 24|Overall Study||80
2481093|NCT00909532|6083942|P1|Completed Treatment Period, Week 24|Overall Study||71
2481094|NCT00909532|6083941|P2|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor).|83
2481095|NCT00909532|6083942|P1|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo).|78
2481096|NCT00909480|6083960|P2|NOT COMPLETED|Overall Study||41
2481097|NCT00909480|6083961|P1|NOT COMPLETED|Overall Study||38
2481098|NCT00909480|6083960|P2|COMPLETED|Overall Study||188
2481099|NCT00909480|6083961|P1|COMPLETED|Overall Study||190
2481100|NCT00909480|6083960|P2|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|227
2481101|NCT00909480|6083961|P1|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|226
2481102|NCT00909480|6083960|P2|STARTED|Overall Study||229
2481103|NCT00909480|6083961|P1|STARTED|Overall Study||228
2481104|NCT00909428|6083996|P3|NOT COMPLETED|Overall Study||9
2481105|NCT00909428|6083997|P2|NOT COMPLETED|Overall Study||10
2481106|NCT00909428|6083998|P1|NOT COMPLETED|Overall Study||13
2481107|NCT00909428|6083996|P3|COMPLETED|Overall Study||0
2481108|NCT00909428|6083997|P2|COMPLETED|Overall Study||5
2481109|NCT00909428|6083998|P1|COMPLETED|Overall Study||5
2481110|NCT00909428|6083996|P3|STARTED|Overall Study||9
2481111|NCT00909428|6083997|P2|STARTED|Overall Study||15
2481112|NCT00909428|6083998|P1|STARTED|Overall Study||18
2481113|NCT00909389|6084005|P1|NOT COMPLETED|Overall Study||133
2481114|NCT00909389|6084005|P1|COMPLETED|Overall Study||4615
2481115|NCT00909389|6084005|P1|STARTED|Overall Study||4748
2481116|NCT00909363|6084012|P3|NOT COMPLETED|Overall Study||0
2481117|NCT00909363|6084013|P2|NOT COMPLETED|Overall Study||0
2481118|NCT00909363|6084014|P1|NOT COMPLETED|Overall Study||2
2481119|NCT00909363|6084012|P3|COMPLETED|Overall Study||5
2481120|NCT00909363|6084013|P2|COMPLETED|Overall Study||8
2481121|NCT00909363|6084014|P1|COMPLETED|Overall Study|1 patient started bleeding 3 days after starting eltrombopag; he underwent bone marrow transplant|9
2481122|NCT00909363|6084012|P3|STARTED|Overall Study||5
2481123|NCT00909363|6084013|P2|STARTED|Overall Study||8
2481124|NCT00909363|6084014|P1|STARTED|Overall Study||11
2481125|NCT00909324|6084033|P2|NOT COMPLETED|Overall Study||0
2481126|NCT00909324|6084034|P1|NOT COMPLETED|Overall Study||0
2481127|NCT00909324|6084033|P2|COMPLETED|Overall Study||90
2481128|NCT00909324|6084034|P1|COMPLETED|Overall Study||72
2481129|NCT00909324|6084033|P2|STARTED|Overall Study||90
2481130|NCT00909324|6084034|P1|STARTED|Overall Study||72
2481131|NCT00909220|6084046|P2|NOT COMPLETED|Overall Study||0
2481132|NCT00909220|6084047|P1|NOT COMPLETED|Overall Study||0
2481133|NCT00909220|6084046|P2|COMPLETED|Overall Study||36
2481134|NCT00909220|6084047|P1|COMPLETED|Overall Study||41
2481135|NCT00909220|6084046|P2|Submission for Publication|Overall Study||36
2481136|NCT00909220|6084047|P1|Submission for Publication|Overall Study||41
2481137|NCT00909220|6084046|P2|Data Analyses|Overall Study||36
2481138|NCT00909220|6084047|P1|Data Analyses|Overall Study||41
2481139|NCT00909220|6084046|P2|Data Entry|Overall Study||36
2481140|NCT00909220|6084047|P1|Data Entry|Overall Study||41
2481141|NCT00909220|6084046|P2|STARTED|Overall Study|Started enrolling participants May 2009|36
2481142|NCT00909220|6084047|P1|STARTED|Overall Study|Started enrolling participants May 2009|41
2481143|NCT00909181|6084061|P3|NOT COMPLETED|Overall Study||33
2481144|NCT00909181|6084062|P2|NOT COMPLETED|Overall Study||18
2481145|NCT00909181|6084063|P1|NOT COMPLETED|Overall Study||39
2481146|NCT00909181|6084061|P3|COMPLETED|Overall Study||169
2481147|NCT00909181|6084062|P2|COMPLETED|Overall Study||196
2481148|NCT00909181|6084063|P1|COMPLETED|Overall Study||171
2481149|NCT00909181|6084061|P3|STARTED|Overall Study||202
2481150|NCT00909181|6084062|P2|STARTED|Overall Study||214
2481151|NCT00909181|6084063|P1|STARTED|Overall Study||210
2481152|NCT00909155|6084074|P3|NOT COMPLETED|Overall Study||7
2481153|NCT00909155|6084075|P2|NOT COMPLETED|Overall Study||5
2481154|NCT00909155|6084076|P1|NOT COMPLETED|Overall Study||3
2481155|NCT00909155|6084074|P3|COMPLETED|Overall Study||14
2481156|NCT00909155|6084075|P2|COMPLETED|Overall Study||9
2481157|NCT00909155|6084076|P1|COMPLETED|Overall Study||12
2481158|NCT00909155|6084074|P3|STARTED|Overall Study||21
2481159|NCT00909155|6084075|P2|STARTED|Overall Study||14
2481160|NCT00909155|6084076|P1|STARTED|Overall Study||15
2481161|NCT00909064|6084087|P1|NOT COMPLETED|Overall Study||0
2481162|NCT00909064|6084087|P1|COMPLETED|Overall Study||114
2481163|NCT00909064|6084087|P1|STARTED|Overall Study||114
2481164|NCT00909038|6084093|P1|NOT COMPLETED|Overall Study||417
2481165|NCT00909038|6084093|P1|COMPLETED|Overall Study||1994
2481166|NCT00909038|6084093|P1|STARTED|Overall Study||2411
2481167|NCT00908960|6084105|P3|NOT COMPLETED|Overall Study||2
2481168|NCT00908960|6084106|P2|NOT COMPLETED|Overall Study||1
2481169|NCT00908960|6084107|P1|NOT COMPLETED|Overall Study||1
2481170|NCT00908960|6084105|P3|COMPLETED|Overall Study||32
2481171|NCT00908960|6084106|P2|COMPLETED|Overall Study||11
2481172|NCT00908960|6084107|P1|COMPLETED|Overall Study||23
2481173|NCT00908960|6084105|P3|Evaluable|Overall Study||32
2481174|NCT00908960|6084106|P2|Evaluable|Overall Study||11
2481175|NCT00908960|6084107|P1|Evaluable|Overall Study||23
2481176|NCT00908960|6084105|P3|STARTED|Overall Study||34
2481177|NCT00908960|6084106|P2|STARTED|Overall Study||12
2481178|NCT00908960|6084107|P1|STARTED|Overall Study||24
2481179|NCT00908947|6084121|P1|NOT COMPLETED|Overall Study||90
2481180|NCT00908947|6084121|P1|COMPLETED|Overall Study||83
2481181|NCT00908947|6084121|P1|STARTED|Overall Study||173
2481182|NCT00908908|6084143|P1|NOT COMPLETED|Overall Study||0
2481183|NCT00908908|6084143|P1|COMPLETED|Overall Study||6
2481184|NCT00908908|6084143|P1|Physician Decision|Overall Study||0
2481185|NCT00908908|6084143|P1|Administrative/Other|Overall Study||0
2481186|NCT00908908|6084143|P1|Withdrawl by Subject|Overall Study||0
2481187|NCT00908908|6084143|P1|Adverse Event|Overall Study||0
2481188|NCT00908908|6084143|P1|STARTED|Overall Study||6
2481189|NCT00908895|6084151|P2|NOT COMPLETED|Overall Study||6
2481190|NCT00908895|6084152|P1|NOT COMPLETED|Overall Study||4
2481191|NCT00908895|6084151|P2|COMPLETED|Overall Study||57
2481192|NCT00908895|6084152|P1|COMPLETED|Overall Study||53
2481193|NCT00908895|6084151|P2|STARTED|Overall Study||63
2481194|NCT00908895|6084152|P1|STARTED|Overall Study||57
2481195|NCT00908882|6084162|P2|NOT COMPLETED|Overall Study||30
2481196|NCT00908882|6084163|P1|NOT COMPLETED|Overall Study||28
2481197|NCT00908882|6084162|P2|COMPLETED|Overall Study||59
2481198|NCT00908882|6084163|P1|COMPLETED|Overall Study||61
2481199|NCT00908882|6084162|P2|STARTED|Overall Study||89
2481200|NCT00908882|6084163|P1|STARTED|Overall Study||89
2481201|NCT00908830|6084189|P2|NOT COMPLETED|Overall Study||0
2481202|NCT00908830|6084190|P1|NOT COMPLETED|Overall Study||0
2481203|NCT00908830|6084189|P2|COMPLETED|Overall Study||5
2481204|NCT00908830|6084190|P1|COMPLETED|Overall Study||5
2481205|NCT00908830|6084189|P2|STARTED|Overall Study||5
2481206|NCT00908830|6084190|P1|STARTED|Overall Study||5
2481207|NCT00908791|6084198|P1|NOT COMPLETED|Overall Study||0
2481208|NCT00908791|6084198|P1|COMPLETED|Overall Study||24
2481209|NCT00908791|6084198|P1|STARTED|Overall Study||24
2481210|NCT00908687|6084221|P6|NOT COMPLETED|Overall Study||6
2481211|NCT00908687|6084222|P5|NOT COMPLETED|Overall Study||4
2481212|NCT00908687|6084223|P4|NOT COMPLETED|Overall Study||3
2481213|NCT00908687|6084224|P3|NOT COMPLETED|Overall Study||3
2481214|NCT00908687|6084225|P2|NOT COMPLETED|Overall Study||1
2481215|NCT00908687|6084226|P1|NOT COMPLETED|Overall Study||1
2481216|NCT00908687|6084221|P6|COMPLETED|Overall Study||94
2481217|NCT00908687|6084222|P5|COMPLETED|Overall Study||94
2481218|NCT00908687|6084223|P4|COMPLETED|Overall Study||47
2481219|NCT00908687|6084224|P3|COMPLETED|Overall Study||99
2481220|NCT00908687|6084225|P2|COMPLETED|Overall Study||99
2481221|NCT00908687|6084226|P1|COMPLETED|Overall Study||49
2481222|NCT00908687|6084221|P6|STARTED|Overall Study||100
2481223|NCT00908687|6084222|P5|STARTED|Overall Study||98
2481224|NCT00908687|6084223|P4|STARTED|Overall Study||50
2481225|NCT00908687|6084224|P3|STARTED|Overall Study||102
2481226|NCT00908687|6084225|P2|STARTED|Overall Study||100
2481227|NCT00908687|6084226|P1|STARTED|Overall Study||50
2481228|NCT00908648|6084242|P2|NOT COMPLETED|Overall Study||0
2481229|NCT00908648|6084243|P1|NOT COMPLETED|Overall Study||0
2481230|NCT00908648|6084242|P2|COMPLETED|Overall Study||103
2481231|NCT00908648|6084243|P1|COMPLETED|Overall Study||108
2481232|NCT00908648|6084242|P2|STARTED|Overall Study||103
2481233|NCT00908648|6084243|P1|STARTED|Overall Study||108
2481234|NCT00908596|6084253|P4|NOT COMPLETED|Overall Study||37
2481235|NCT00908596|6084254|P3|NOT COMPLETED|Overall Study||74
2481236|NCT00908596|6084255|P2|NOT COMPLETED|Overall Study||13
2481237|NCT00908596|6084256|P1|NOT COMPLETED|Overall Study||47
2481238|NCT00908596|6084253|P4|COMPLETED|Overall Study||48
2481239|NCT00908596|6084254|P3|COMPLETED|Overall Study||119
2481240|NCT00908596|6084255|P2|COMPLETED|Overall Study||19
2481241|NCT00908596|6084256|P1|COMPLETED|Overall Study||0
2481242|NCT00908596|6084253|P4|STARTED|Overall Study||85
2481243|NCT00908596|6084254|P3|STARTED|Overall Study||193
2481244|NCT00908596|6084255|P2|STARTED|Overall Study||32
2481245|NCT00908596|6084256|P1|STARTED|Overall Study||47
2481246|NCT00908583|6084286|P1|NOT COMPLETED|Phase 5||3
2481247|NCT00908583|6084286|P1|COMPLETED|Phase 5||2
2481248|NCT00908583|6084286|P1|STARTED|Phase 5||5
2481249|NCT00908583|6084286|P1|NOT COMPLETED|Phase 4||2
2481250|NCT00908583|6084286|P1|COMPLETED|Phase 4||3
2481251|NCT00908583|6084286|P1|STARTED|Phase 4||5
2481252|NCT00908583|6084286|P1|NOT COMPLETED|Phase 3||2
2481253|NCT00908583|6084286|P1|COMPLETED|Phase 3||8
2481254|NCT00908583|6084286|P1|STARTED|Phase 3||10
2481255|NCT00908583|6084286|P1|NOT COMPLETED|Phase 2||2
2481256|NCT00908583|6084286|P1|COMPLETED|Phase 2||10
2481257|NCT00908583|6084286|P1|STARTED|Phase 2||12
2481258|NCT00908583|6084286|P1|NOT COMPLETED|Phase 1||5
2481259|NCT00908583|6084286|P1|COMPLETED|Phase 1||15
2481260|NCT00908583|6084286|P1|STARTED|Phase 1||20
2481261|NCT00908544|6084306|P2|NOT COMPLETED|Overall Study||6
2481262|NCT00908544|6084307|P1|NOT COMPLETED|Overall Study||5
2481263|NCT00908544|6084306|P2|COMPLETED|Overall Study||16
2481264|NCT00908544|6084307|P1|COMPLETED|Overall Study||15
2481265|NCT00908544|6084306|P2|STARTED|Overall Study||22
2481266|NCT00908544|6084307|P1|STARTED|Overall Study||20
2481267|NCT00908466|6084349|P2|NOT COMPLETED|Overall Study||1
2481268|NCT00908466|6084350|P1|NOT COMPLETED|Overall Study||1
2481269|NCT00908466|6084349|P2|COMPLETED|Overall Study||14
2481270|NCT00908466|6084350|P1|COMPLETED|Overall Study||14
2481271|NCT00908466|6084349|P2|STARTED|Overall Study||15
2481272|NCT00908466|6084350|P1|STARTED|Overall Study||15
2481273|NCT00908388|6084356|P1|NOT COMPLETED|Overall Study||10
2481274|NCT00908388|6084356|P1|COMPLETED|Overall Study||40
2481275|NCT00908388|6084356|P1|STARTED|Overall Study||50
2481276|NCT00908375|6084366|P2|NOT COMPLETED|Overall Study||10
2481277|NCT00908375|6084367|P1|NOT COMPLETED|Overall Study||10
2481278|NCT00908375|6084366|P2|COMPLETED|Overall Study||9
2481279|NCT00908375|6084367|P1|COMPLETED|Overall Study||10
2481280|NCT00908375|6084366|P2|STARTED|Overall Study||19
2481281|NCT00908375|6084367|P1|STARTED|Overall Study||20
2481282|NCT00908349|6084377|P1|NOT COMPLETED|Overall Study||35
2481283|NCT00908349|6084377|P1|COMPLETED|Overall Study||179
2481284|NCT00908349|6084377|P1|STARTED|Overall Study||214
2481285|NCT00908310|6084381|P1|NOT COMPLETED|Overall Study||60
2481286|NCT00908310|6084381|P1|COMPLETED|Overall Study||153
2481287|NCT00908310|6084381|P1|STARTED|Overall Study||213
2481288|NCT00908232|6084385|P4|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||0
2481289|NCT00908232|6084386|P3|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||1
2481290|NCT00908232|6084387|P2|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||3
2481291|NCT00908232|6084388|P1|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||35
2481292|NCT00908232|6084385|P4|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
2481293|NCT00908232|6084386|P3|COMPLETED|Randomization (Cycle 5) to Cycle 8||7
2481294|NCT00908232|6084387|P2|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
2481295|NCT00908232|6084388|P1|COMPLETED|Randomization (Cycle 5) to Cycle 8||63
2481296|NCT00908232|6084385|P4|STARTED|Randomization (Cycle 5) to Cycle 8||4
2481297|NCT00908232|6084386|P3|STARTED|Randomization (Cycle 5) to Cycle 8||8
2481298|NCT00908232|6084387|P2|STARTED|Randomization (Cycle 5) to Cycle 8||7
2481299|NCT00908232|6084388|P1|STARTED|Randomization (Cycle 5) to Cycle 8|Responding patients (not randomized) who received 4 more cycles of VD|98
2481300|NCT00908232|6084385|P4|NOT COMPLETED|Cycle 1 to 4||0
2481301|NCT00908232|6084386|P3|NOT COMPLETED|Cycle 1 to 4||0
2481302|NCT00908232|6084387|P2|NOT COMPLETED|Cycle 1 to 4||0
2481303|NCT00908232|6084388|P1|NOT COMPLETED|Cycle 1 to 4||28
2481304|NCT00908232|6084385|P4|COMPLETED|Cycle 1 to 4||0
2481305|NCT00908232|6084386|P3|COMPLETED|Cycle 1 to 4||0
2481306|NCT00908232|6084387|P2|COMPLETED|Cycle 1 to 4||0
2481307|NCT00908232|6084388|P1|COMPLETED|Cycle 1 to 4|Of those completed, 120 subjects were assessed for response, 117 w/ Response or SD continued.|135
2481308|NCT00908232|6084385|P4|STARTED|Cycle 1 to 4||0
2481309|NCT00908232|6084386|P3|STARTED|Cycle 1 to 4||0
2481310|NCT00908232|6084387|P2|STARTED|Cycle 1 to 4||0
2481311|NCT00908232|6084388|P1|STARTED|Cycle 1 to 4|All participants started VD treatment for 4 cycles prior to local site response assessments|163
2481312|NCT00908141|6084406|P2|NOT COMPLETED|Overall Study||1
2481313|NCT00908141|6084407|P1|NOT COMPLETED|Overall Study||0
2481314|NCT00908141|6084406|P2|COMPLETED|Overall Study||8
2481315|NCT00908141|6084407|P1|COMPLETED|Overall Study||8
2481316|NCT00908141|6084406|P2|STARTED|Overall Study||9
2481317|NCT00908141|6084407|P1|STARTED|Overall Study||8
2481318|NCT00908128|6084415|P2|NOT COMPLETED|Period 4||0
2481319|NCT00908128|6084416|P1|NOT COMPLETED|Period 4||0
2481320|NCT00908128|6084415|P2|COMPLETED|Period 4||19
2481321|NCT00908128|6084416|P1|COMPLETED|Period 4||20
2481322|NCT00908128|6084415|P2|STARTED|Period 4|One subject withdrew prior to Period 4 dosing due to adverse events|19
2481323|NCT00908128|6084416|P1|STARTED|Period 4||20
2481324|NCT00908128|6084415|P2|NOT COMPLETED|Period 3||0
2481325|NCT00908128|6084416|P1|NOT COMPLETED|Period 3||0
2481326|NCT00908128|6084415|P2|COMPLETED|Period 3||20
2481327|NCT00908128|6084416|P1|COMPLETED|Period 3||20
2481328|NCT00908128|6084415|P2|STARTED|Period 3||20
2481329|NCT00908128|6084416|P1|STARTED|Period 3||20
2481330|NCT00908128|6084415|P2|NOT COMPLETED|Period 2||0
2481331|NCT00908128|6084416|P1|NOT COMPLETED|Period 2||0
2481332|NCT00908128|6084415|P2|COMPLETED|Period 2||20
2481333|NCT00908128|6084416|P1|COMPLETED|Period 2||20
2481334|NCT00908128|6084415|P2|STARTED|Period 2||20
2481335|NCT00908128|6084416|P1|STARTED|Period 2||20
2481336|NCT00908128|6084415|P2|NOT COMPLETED|Period 1||0
2481337|NCT00908128|6084416|P1|NOT COMPLETED|Period 1||0
2481338|NCT00908128|6084415|P2|COMPLETED|Period 1||20
2481339|NCT00908128|6084416|P1|COMPLETED|Period 1||20
2481340|NCT00908128|6084415|P2|STARTED|Period 1||20
2481341|NCT00908128|6084416|P1|STARTED|Period 1||20
2481342|NCT00908115|6084424|P1|NOT COMPLETED|Overall Study||14
2481343|NCT00908115|6084424|P1|COMPLETED|Overall Study||1244
2481344|NCT00908115|6084424|P1|STARTED|Overall Study||1258
2481345|NCT00908076|6084432|P2|NOT COMPLETED|Overall Study||1
2481346|NCT00908076|6084433|P1|NOT COMPLETED|Overall Study||1
2481347|NCT00908076|6084432|P2|COMPLETED|Overall Study||26
2481348|NCT00908076|6084433|P1|COMPLETED|Overall Study||26
2481349|NCT00908076|6084432|P2|STARTED|Overall Study||27
2481350|NCT00908076|6084433|P1|STARTED|Overall Study||27
2481351|NCT00908037|6084446|P12|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
2481352|NCT00908037|6084447|P11|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||4
2481353|NCT00908037|6084448|P10|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
2481354|NCT00908037|6084449|P9|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
2481355|NCT00908037|6084450|P8|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
2481356|NCT00908037|6084451|P7|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
2481357|NCT00908037|6084452|P6|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
2481358|NCT00908037|6084453|P5|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
2481359|NCT00908037|6084454|P4|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
2481360|NCT00908037|6084455|P3|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
2481361|NCT00908037|6084456|P2|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
2481362|NCT00908037|6084457|P1|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
2481363|NCT00908037|6084446|P12|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||12
2481364|NCT00908037|6084447|P11|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|24
2481365|NCT00908037|6084448|P10|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||21
2481366|NCT00908037|6084449|P9|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
2481367|NCT00908037|6084450|P8|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
2481368|NCT00908037|6084451|P7|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
2481369|NCT00908037|6084452|P6|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
2481370|NCT00908037|6084453|P5|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
2481371|NCT00908037|6084454|P4|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
2481372|NCT00908037|6084455|P3|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
2481373|NCT00908037|6084456|P2|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
2481374|NCT00908037|6084457|P1|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
2481375|NCT00908037|6084446|P12|STARTED|Part 2/3(Eltrombopag Open-Label Period)||15
2481376|NCT00908037|6084447|P11|STARTED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|28
2481377|NCT00908037|6084448|P10|STARTED|Part 2/3(Eltrombopag Open-Label Period)||24
2481378|NCT00908037|6084449|P9|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
2481379|NCT00908037|6084450|P8|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
2481380|NCT00908037|6084451|P7|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
2481381|NCT00908037|6084452|P6|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
2481382|NCT00908037|6084453|P5|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
2481383|NCT00908037|6084454|P4|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
2481384|NCT00908037|6084455|P3|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
2481385|NCT00908037|6084456|P2|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
2481386|NCT00908037|6084457|P1|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
2481387|NCT00908037|6084446|P12|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
2481388|NCT00908037|6084447|P11|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
2481389|NCT00908037|6084448|P10|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
2481390|NCT00908037|6084449|P9|NOT COMPLETED|Part 2 (7 Week Randomized Period)||5
2481391|NCT00908037|6084450|P8|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
2481392|NCT00908037|6084451|P7|NOT COMPLETED|Part 2 (7 Week Randomized Period)||4
2481393|NCT00908037|6084452|P6|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
2481394|NCT00908037|6084453|P5|NOT COMPLETED|Part 2 (7 Week Randomized Period)||3
2481395|NCT00908037|6084454|P4|NOT COMPLETED|Part 2 (7 Week Randomized Period)||1
2481396|NCT00908037|6084455|P3|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
2481397|NCT00908037|6084456|P2|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
2481398|NCT00908037|6084457|P1|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
2481399|NCT00908037|6084446|P12|COMPLETED|Part 2 (7 Week Randomized Period)||0
2481400|NCT00908037|6084447|P11|COMPLETED|Part 2 (7 Week Randomized Period)||0
2481401|NCT00908037|6084448|P10|COMPLETED|Part 2 (7 Week Randomized Period)||0
2481402|NCT00908037|6084449|P9|COMPLETED|Part 2 (7 Week Randomized Period)||5
2481403|NCT00908037|6084450|P8|COMPLETED|Part 2 (7 Week Randomized Period)||5
2481404|NCT00908037|6084451|P7|COMPLETED|Part 2 (7 Week Randomized Period)||15
2481405|NCT00908037|6084452|P6|COMPLETED|Part 2 (7 Week Randomized Period)||9
2481406|NCT00908037|6084453|P5|COMPLETED|Part 2 (7 Week Randomized Period)||13
2481407|NCT00908037|6084454|P4|COMPLETED|Part 2 (7 Week Randomized Period)||7
2481408|NCT00908037|6084455|P3|COMPLETED|Part 2 (7 Week Randomized Period)||0
2481409|NCT00908037|6084456|P2|COMPLETED|Part 2 (7 Week Randomized Period)||0
2481410|NCT00908037|6084457|P1|COMPLETED|Part 2 (7 Week Randomized Period)||0
2481411|NCT00908037|6084446|P12|STARTED|Part 2 (7 Week Randomized Period)||0
2481412|NCT00908037|6084447|P11|STARTED|Part 2 (7 Week Randomized Period)||0
2481413|NCT00908037|6084448|P10|STARTED|Part 2 (7 Week Randomized Period)||0
2481414|NCT00908037|6084449|P9|STARTED|Part 2 (7 Week Randomized Period)||10
2481415|NCT00908037|6084450|P8|STARTED|Part 2 (7 Week Randomized Period)||5
2481416|NCT00908037|6084451|P7|STARTED|Part 2 (7 Week Randomized Period)||19
2481417|NCT00908037|6084452|P6|STARTED|Part 2 (7 Week Randomized Period)||9
2481418|NCT00908037|6084453|P5|STARTED|Part 2 (7 Week Randomized Period)||16
2481419|NCT00908037|6084454|P4|STARTED|Part 2 (7 Week Randomized Period)||8
2481420|NCT00908037|6084455|P3|STARTED|Part 2 (7 Week Randomized Period)||0
2481421|NCT00908037|6084456|P2|STARTED|Part 2 (7 Week Randomized Period)||0
2481422|NCT00908037|6084457|P1|STARTED|Part 2 (7 Week Randomized Period)||0
2481423|NCT00908037|6084446|P12|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2481424|NCT00908037|6084447|P11|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2481425|NCT00908037|6084448|P10|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2481426|NCT00908037|6084449|P9|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2481427|NCT00908037|6084450|P8|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2481428|NCT00908037|6084451|P7|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2481429|NCT00908037|6084452|P6|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2481430|NCT00908037|6084453|P5|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2481431|NCT00908037|6084454|P4|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2481432|NCT00908037|6084455|P3|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2481433|NCT00908037|6084456|P2|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2481434|NCT00908037|6084457|P1|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2481435|NCT00908037|6084446|P12|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2481436|NCT00908037|6084447|P11|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2481437|NCT00908037|6084448|P10|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2481438|NCT00908037|6084449|P9|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2481439|NCT00908037|6084450|P8|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2481440|NCT00908037|6084451|P7|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2481441|NCT00908037|6084452|P6|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2481442|NCT00908037|6084453|P5|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2481443|NCT00908037|6084454|P4|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
2481444|NCT00908037|6084455|P3|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
2481445|NCT00908037|6084456|P2|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
2481446|NCT00908037|6084457|P1|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
2481447|NCT00908037|6084446|P12|STARTED|Part1 (24 Week Dose-Finding Period)||0
2481448|NCT00908037|6084447|P11|STARTED|Part1 (24 Week Dose-Finding Period)||0
2481449|NCT00908037|6084448|P10|STARTED|Part1 (24 Week Dose-Finding Period)||0
2481450|NCT00908037|6084449|P9|STARTED|Part1 (24 Week Dose-Finding Period)||0
2481451|NCT00908037|6084450|P8|STARTED|Part1 (24 Week Dose-Finding Period)||0
2481452|NCT00908037|6084451|P7|STARTED|Part1 (24 Week Dose-Finding Period)||0
2481453|NCT00908037|6084452|P6|STARTED|Part1 (24 Week Dose-Finding Period)||0
2481454|NCT00908037|6084453|P5|STARTED|Part1 (24 Week Dose-Finding Period)||0
2481455|NCT00908037|6084454|P4|STARTED|Part1 (24 Week Dose-Finding Period)||0
2481456|NCT00908037|6084455|P3|STARTED|Part1 (24 Week Dose-Finding Period)||5
2481457|NCT00908037|6084456|P2|STARTED|Part1 (24 Week Dose-Finding Period)||5
2481458|NCT00908037|6084457|P1|STARTED|Part1 (24 Week Dose-Finding Period)||5
2481459|NCT00908011|6084606|P2|NOT COMPLETED|Overall Study||2
2481460|NCT00908011|6084607|P1|NOT COMPLETED|Overall Study||2
2481461|NCT00908011|6084606|P2|COMPLETED|Overall Study||18
2481462|NCT00908011|6084607|P1|COMPLETED|Overall Study||21
2481463|NCT00908011|6084606|P2|STARTED|Overall Study||20
2481464|NCT00908011|6084607|P1|STARTED|Overall Study||23
2481465|NCT00907907|6084615|P2|NOT COMPLETED|Period 4||0
2481466|NCT00907907|6084616|P1|NOT COMPLETED|Period 4||0
2481467|NCT00907907|6084615|P2|COMPLETED|Period 4||18
2481468|NCT00907907|6084616|P1|COMPLETED|Period 4||19
2481469|NCT00907907|6084615|P2|STARTED|Period 4|two subjects were withdrawn prior to Period 4 dosing|18
2481470|NCT00907907|6084616|P1|STARTED|Period 4|one subject withdrew prior to Period 4 dosing|19
2481471|NCT00907907|6084615|P2|NOT COMPLETED|Period 3||0
2481472|NCT00907907|6084616|P1|NOT COMPLETED|Period 3||0
2481473|NCT00907907|6084615|P2|COMPLETED|Period 3||20
2481474|NCT00907907|6084616|P1|COMPLETED|Period 3||20
2481475|NCT00907907|6084615|P2|STARTED|Period 3||20
2481476|NCT00907907|6084616|P1|STARTED|Period 3||20
2481477|NCT00907907|6084615|P2|NOT COMPLETED|Period 2||0
2481478|NCT00907907|6084616|P1|NOT COMPLETED|Period 2||0
2481479|NCT00907907|6084615|P2|COMPLETED|Period 2||20
2481480|NCT00907907|6084616|P1|COMPLETED|Period 2||20
2481481|NCT00907907|6084615|P2|STARTED|Period 2||20
2481482|NCT00907907|6084616|P1|STARTED|Period 2||20
2481483|NCT00907907|6084615|P2|NOT COMPLETED|Period 1||0
2481484|NCT00907907|6084616|P1|NOT COMPLETED|Period 1||0
2481485|NCT00907907|6084615|P2|COMPLETED|Period 1||20
2481486|NCT00907907|6084616|P1|COMPLETED|Period 1||20
2481487|NCT00907907|6084615|P2|STARTED|Period 1||20
2481488|NCT00907907|6084616|P1|STARTED|Period 1||20
2481489|NCT00907881|6084624|P1|NOT COMPLETED|Overall Study||85
2481490|NCT00907881|6084624|P1|COMPLETED|Overall Study||984
2481491|NCT00907881|6084624|P1|STARTED|Overall Study||1069
2481492|NCT00907803|6084634|P3|NOT COMPLETED|Overall Study||0
2481493|NCT00907803|6084635|P2|NOT COMPLETED|Overall Study||3
2481494|NCT00907803|6084636|P1|NOT COMPLETED|Overall Study||3
2481495|NCT00907803|6084634|P3|COMPLETED|Overall Study||16
2481496|NCT00907803|6084635|P2|COMPLETED|Overall Study||43
2481497|NCT00907803|6084636|P1|COMPLETED|Overall Study||42
2481498|NCT00907803|6084634|P3|STARTED|Overall Study||16
2481499|NCT00907803|6084635|P2|STARTED|Overall Study||46
2481500|NCT00907803|6084636|P1|STARTED|Overall Study||45
2481501|NCT00907777|6084667|P2|NOT COMPLETED|Overall Study||1
2481502|NCT00907777|6084668|P1|NOT COMPLETED|Overall Study||0
2481503|NCT00907777|6084667|P2|COMPLETED|Overall Study||26
2481504|NCT00907777|6084668|P1|COMPLETED|Overall Study||25
2481505|NCT00907777|6084667|P2|STARTED|Overall Study||27
2481506|NCT00907777|6084668|P1|STARTED|Overall Study||25
2481507|NCT00907738|6084695|P5|NOT COMPLETED|Overall Study||2
2481508|NCT00907738|6084696|P4|NOT COMPLETED|Overall Study||4
2481509|NCT00907738|6084697|P3|NOT COMPLETED|Overall Study||7
2481510|NCT00907738|6084698|P2|NOT COMPLETED|Overall Study||1
2481511|NCT00907738|6084699|P1|NOT COMPLETED|Overall Study||13
2481512|NCT00907738|6084695|P5|COMPLETED|Overall Study||0
2481513|NCT00907738|6084696|P4|COMPLETED|Overall Study||0
2481514|NCT00907738|6084697|P3|COMPLETED|Overall Study||0
2481515|NCT00907738|6084698|P2|COMPLETED|Overall Study||0
2481516|NCT00907738|6084699|P1|COMPLETED|Overall Study||0
2481517|NCT00907738|6084695|P5|STARTED|Overall Study||2
2481518|NCT00907738|6084696|P4|STARTED|Overall Study||4
2481519|NCT00907738|6084697|P3|STARTED|Overall Study||7
2481520|NCT00907738|6084698|P2|STARTED|Overall Study||1
2481521|NCT00907738|6084699|P1|STARTED|Overall Study||13
2481522|NCT00907621|6084717|P2|NOT COMPLETED|Overall Study||4
2481523|NCT00907621|6084718|P1|NOT COMPLETED|Overall Study||7
2481524|NCT00907621|6084717|P2|COMPLETED|Overall Study||41
2481525|NCT00907621|6084718|P1|COMPLETED|Overall Study||38
2481526|NCT00907621|6084717|P2|STARTED|Overall Study||45
2481527|NCT00907621|6084718|P1|STARTED|Overall Study||45
2481528|NCT00907517|6084731|P5|NOT COMPLETED|Overall Study||5
2481529|NCT00907517|6084732|P4|NOT COMPLETED|Overall Study||4
2481530|NCT00907517|6084733|P3|NOT COMPLETED|Overall Study||4
2481531|NCT00907517|6084734|P2|NOT COMPLETED|Overall Study||3
2481532|NCT00907517|6084735|P1|NOT COMPLETED|Overall Study||3
2481533|NCT00907517|6084731|P5|COMPLETED|Overall Study||1
2481534|NCT00907517|6084732|P4|COMPLETED|Overall Study||2
2481535|NCT00907517|6084733|P3|COMPLETED|Overall Study||2
2481536|NCT00907517|6084734|P2|COMPLETED|Overall Study||0
2481537|NCT00907517|6084735|P1|COMPLETED|Overall Study||0
2481538|NCT00907517|6084731|P5|STARTED|Overall Study||6
2481539|NCT00907517|6084732|P4|STARTED|Overall Study||6
2481540|NCT00907517|6084733|P3|STARTED|Overall Study||6
2481541|NCT00907517|6084734|P2|STARTED|Overall Study||3
2481542|NCT00907517|6084735|P1|STARTED|Overall Study||3
2481543|NCT00907478|6084760|P3|NOT COMPLETED|Overall Study||22
2481544|NCT00907478|6084761|P2|NOT COMPLETED|Overall Study||17
2481545|NCT00907478|6084762|P1|NOT COMPLETED|Overall Study||27
2481546|NCT00907478|6084760|P3|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|47
2481547|NCT00907478|6084761|P2|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|33
2481548|NCT00907478|6084762|P1|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|23
2481549|NCT00907478|6084760|P3|STARTED|Overall Study||69
2481550|NCT00907478|6084761|P2|STARTED|Overall Study||50
2481551|NCT00907478|6084762|P1|STARTED|Overall Study||50
2481552|NCT00907426|6084793|P3|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||7
2481553|NCT00907426|6084794|P2|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||3
2481554|NCT00907426|6084795|P1|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||11
2481555|NCT00907426|6084793|P3|COMPLETED|Treatment Period 2 (6 to 12 Months)||77
2481556|NCT00907426|6084794|P2|COMPLETED|Treatment Period 2 (6 to 12 Months)||52
2481557|NCT00907426|6084795|P1|COMPLETED|Treatment Period 2 (6 to 12 Months)||184
2481558|NCT00907426|6084793|P3|STARTED|Treatment Period 2 (6 to 12 Months)||84
2481559|NCT00907426|6084794|P2|STARTED|Treatment Period 2 (6 to 12 Months)||55
2481560|NCT00907426|6084795|P1|STARTED|Treatment Period 2 (6 to 12 Months)||195
2481561|NCT00907426|6084793|P3|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||9
2481562|NCT00907426|6084794|P2|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||5
2481563|NCT00907426|6084795|P1|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||20
2481564|NCT00907426|6084793|P3|COMPLETED|Treatment Period 1 (0 to 6 Months)||84
2481565|NCT00907426|6084794|P2|COMPLETED|Treatment Period 1 (0 to 6 Months)||55
2481566|NCT00907426|6084795|P1|COMPLETED|Treatment Period 1 (0 to 6 Months)||195
2481567|NCT00907426|6084793|P3|STARTED|Treatment Period 1 (0 to 6 Months)||93
2481568|NCT00907426|6084794|P2|STARTED|Treatment Period 1 (0 to 6 Months)||60
2481569|NCT00907426|6084795|P1|STARTED|Treatment Period 1 (0 to 6 Months)||215
2481570|NCT00907374|6084812|P2|NOT COMPLETED|Overall Study||2
2481571|NCT00907374|6084813|P1|NOT COMPLETED|Overall Study||2
2481572|NCT00907374|6084812|P2|COMPLETED|Overall Study||11
2481573|NCT00907374|6084813|P1|COMPLETED|Overall Study||12
2481574|NCT00907374|6084812|P2|STARTED|Overall Study||13
2481575|NCT00907374|6084813|P1|STARTED|Overall Study||14
2481576|NCT00907335|6084827|P2|NOT COMPLETED|Overall Study||1
2481577|NCT00907335|6084828|P1|NOT COMPLETED|Overall Study||8
2481578|NCT00907335|6084827|P2|COMPLETED|Overall Study||54
2481579|NCT00907335|6084828|P1|COMPLETED|Overall Study||47
2481580|NCT00907335|6084827|P2|STARTED|Overall Study||55
2481581|NCT00907335|6084828|P1|STARTED|Overall Study||55
2481582|NCT00907296|6084854|P10|NOT COMPLETED|Overall Study||7
2481583|NCT00907296|6084855|P9|NOT COMPLETED|Overall Study||4
2481584|NCT00907296|6084856|P8|NOT COMPLETED|Overall Study||7
2481585|NCT00907296|6084857|P7|NOT COMPLETED|Overall Study||6
2481586|NCT00907296|6084858|P6|NOT COMPLETED|Overall Study||9
2481587|NCT00907296|6084859|P5|NOT COMPLETED|Overall Study||1
2481588|NCT00907296|6084860|P4|NOT COMPLETED|Overall Study||4
2481589|NCT00907296|6084861|P3|NOT COMPLETED|Overall Study||2
2481590|NCT00907296|6084862|P2|NOT COMPLETED|Overall Study||5
2481591|NCT00907296|6084863|P1|NOT COMPLETED|Overall Study||20
2481592|NCT00907296|6084854|P10|COMPLETED|Overall Study||28
2481593|NCT00907296|6084855|P9|COMPLETED|Overall Study||27
2481594|NCT00907296|6084856|P8|COMPLETED|Overall Study||26
2481595|NCT00907296|6084857|P7|COMPLETED|Overall Study||27
2481596|NCT00907296|6084858|P6|COMPLETED|Overall Study||24
2481597|NCT00907296|6084859|P5|COMPLETED|Overall Study||32
2481598|NCT00907296|6084860|P4|COMPLETED|Overall Study||29
2481599|NCT00907296|6084861|P3|COMPLETED|Overall Study||32
2481600|NCT00907296|6084862|P2|COMPLETED|Overall Study||29
2481601|NCT00907296|6084863|P1|COMPLETED|Overall Study||83
2481602|NCT00907296|6084854|P10|Received Treatment|Overall Study||35
2481603|NCT00907296|6084855|P9|Received Treatment|Overall Study||30
2481604|NCT00907296|6084856|P8|Received Treatment|Overall Study||32
2481605|NCT00907296|6084857|P7|Received Treatment|Overall Study||31
2481606|NCT00907296|6084858|P6|Received Treatment|Overall Study||32
2481607|NCT00907296|6084859|P5|Received Treatment|Overall Study||33
2481608|NCT00907296|6084860|P4|Received Treatment|Overall Study||32
2481609|NCT00907296|6084861|P3|Received Treatment|Overall Study||34
2481610|NCT00907296|6084862|P2|Received Treatment|Overall Study||34
2481611|NCT00907296|6084863|P1|Received Treatment|Overall Study||100
2481612|NCT00907296|6084854|P10|STARTED|Overall Study||35
2481613|NCT00907296|6084855|P9|STARTED|Overall Study||31
2481614|NCT00907296|6084856|P8|STARTED|Overall Study||33
2481615|NCT00907296|6084857|P7|STARTED|Overall Study||33
2481616|NCT00907296|6084858|P6|STARTED|Overall Study||33
2481617|NCT00907296|6084859|P5|STARTED|Overall Study||33
2481618|NCT00907296|6084860|P4|STARTED|Overall Study||33
2481619|NCT00907296|6084861|P3|STARTED|Overall Study||34
2481620|NCT00907296|6084862|P2|STARTED|Overall Study||34
2481621|NCT00907296|6084863|P1|STARTED|Overall Study||103
2481622|NCT00907257|6084917|P2|NOT COMPLETED|Overall Study||12
2481623|NCT00907257|6084918|P1|NOT COMPLETED|Overall Study||13
2481624|NCT00907257|6084917|P2|COMPLETED|Overall Study||112
2481625|NCT00907257|6084918|P1|COMPLETED|Overall Study||110
2481626|NCT00907257|6084917|P2|STARTED|Overall Study||124
2481627|NCT00907257|6084918|P1|STARTED|Overall Study||123
2481628|NCT00907218|6084928|P1|NOT COMPLETED|Overall Study||0
2481629|NCT00907218|6084928|P1|COMPLETED|Overall Study||2
2481630|NCT00907218|6084928|P1|STARTED|Overall Study||2
2481631|NCT00907153|6084940|P2|NOT COMPLETED|Overall Study||4
2481632|NCT00907153|6084941|P1|NOT COMPLETED|Overall Study||2
2481633|NCT00907153|6084940|P2|COMPLETED|Overall Study||11
2481634|NCT00907153|6084941|P1|COMPLETED|Overall Study||11
2481635|NCT00907153|6084940|P2|STARTED|Overall Study||15
2481636|NCT00907153|6084941|P1|STARTED|Overall Study||13
2481637|NCT00907101|6084983|P1|NOT COMPLETED|Overall Study||0
2481638|NCT00907101|6084983|P1|COMPLETED|Overall Study||30
2481639|NCT00907101|6084983|P1|STARTED|Overall Study||30
2481640|NCT00907088|6084993|P2|NOT COMPLETED|Overall Study||30
2481641|NCT00907088|6084994|P1|NOT COMPLETED|Overall Study||20
2481642|NCT00907088|6084993|P2|COMPLETED|Overall Study||99
2481643|NCT00907088|6084994|P1|COMPLETED|Overall Study||102
2481644|NCT00907088|6084993|P2|STARTED|Overall Study||129
2481645|NCT00907088|6084994|P1|STARTED|Overall Study||122
2481646|NCT00906971|6085002|P2|NOT COMPLETED|Overall Study||3
2481647|NCT00906971|6085003|P1|NOT COMPLETED|Overall Study||8
2481648|NCT00906971|6085002|P2|COMPLETED|Overall Study||33
2481649|NCT00906971|6085003|P1|COMPLETED|Overall Study||28
2481650|NCT00906971|6085002|P2|STARTED|Overall Study||36
2481651|NCT00906971|6085003|P1|STARTED|Overall Study||36
2481652|NCT00906945|6085016|P6|NOT COMPLETED|Overall Study||2
2481653|NCT00906945|6085017|P5|NOT COMPLETED|Overall Study||1
2481654|NCT00906945|6085018|P4|NOT COMPLETED|Overall Study||1
2481655|NCT00906945|6085019|P3|NOT COMPLETED|Overall Study||0
2481656|NCT00906945|6085020|P2|NOT COMPLETED|Overall Study||0
2481657|NCT00906945|6085021|P1|NOT COMPLETED|Overall Study||0
2481658|NCT00906945|6085016|P6|COMPLETED|Overall Study||14
2481659|NCT00906945|6085017|P5|COMPLETED|Overall Study||6
2481660|NCT00906945|6085018|P4|COMPLETED|Overall Study||6
2481661|NCT00906945|6085019|P3|COMPLETED|Overall Study||3
2481662|NCT00906945|6085020|P2|COMPLETED|Overall Study||3
2481663|NCT00906945|6085021|P1|COMPLETED|Overall Study||3
2481664|NCT00906945|6085016|P6|STARTED|Overall Study||16
2481665|NCT00906945|6085017|P5|STARTED|Overall Study||7
2481666|NCT00906945|6085018|P4|STARTED|Overall Study||7
2481667|NCT00906945|6085019|P3|STARTED|Overall Study||3
2481668|NCT00906945|6085020|P2|STARTED|Overall Study||3
2481669|NCT00906945|6085021|P1|STARTED|Overall Study||3
2481670|NCT00906789|6085048|P1|NOT COMPLETED|Overall Study||0
2481671|NCT00906789|6085048|P1|COMPLETED|Overall Study||15
2481672|NCT00906789|6085048|P1|STARTED|Overall Study|Radiologists served as own control. Total enrollment is 15 radiologists.|15
2481673|NCT00906776|6085058|P2|NOT COMPLETED|Overall Study||0
2481674|NCT00906776|6085059|P1|NOT COMPLETED|Overall Study||0
2481675|NCT00906776|6085058|P2|COMPLETED|Overall Study||8
2481676|NCT00906776|6085059|P1|COMPLETED|Overall Study||11
2481677|NCT00906776|6085058|P2|STARTED|Overall Study||8
2481678|NCT00906776|6085059|P1|STARTED|Overall Study||11
2481679|NCT00906698|6085081|P6|NOT COMPLETED|Overall Study||5
2481680|NCT00906698|6085082|P5|NOT COMPLETED|Overall Study||18
2481681|NCT00906698|6085083|P4|NOT COMPLETED|Overall Study||4
2481682|NCT00906698|6085084|P3|NOT COMPLETED|Overall Study||6
2481683|NCT00906698|6085085|P2|NOT COMPLETED|Overall Study||19
2481684|NCT00906698|6085086|P1|NOT COMPLETED|Overall Study||3
2481685|NCT00906698|6085081|P6|COMPLETED|Overall Study||0
2481686|NCT00906698|6085082|P5|COMPLETED|Overall Study||0
2481687|NCT00906698|6085083|P4|COMPLETED|Overall Study||0
2481688|NCT00906698|6085084|P3|COMPLETED|Overall Study||0
2481689|NCT00906698|6085085|P2|COMPLETED|Overall Study||0
2481690|NCT00906698|6085086|P1|COMPLETED|Overall Study||0
2481691|NCT00906698|6085081|P6|STARTED|Overall Study||5
2481692|NCT00906698|6085082|P5|STARTED|Overall Study||18
2481693|NCT00906698|6085083|P4|STARTED|Overall Study||4
2481694|NCT00906698|6085084|P3|STARTED|Overall Study||6
2481695|NCT00906698|6085085|P2|STARTED|Overall Study||19
2481696|NCT00906698|6085086|P1|STARTED|Overall Study||3
2481697|NCT00906503|6085168|P1|NOT COMPLETED|Overall Study||0
2481698|NCT00906503|6085168|P1|COMPLETED|Overall Study||9
2481699|NCT00906503|6085168|P1|STARTED|Overall Study||9
2481700|NCT00906425|6085174|P2|NOT COMPLETED|Overall Study||72
2481701|NCT00906425|6085175|P1|NOT COMPLETED|Overall Study||73
2481702|NCT00906425|6085174|P2|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
2481703|NCT00906425|6085175|P1|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
2481704|NCT00906425|6085174|P2|2 Year|Overall Study|ITT population|58
2481705|NCT00906425|6085175|P1|2 Year|Overall Study|ITT population|62
2481706|NCT00906425|6085174|P2|1 Year|Overall Study|ITT population|60
2481707|NCT00906425|6085175|P1|1 Year|Overall Study|ITT population|67
2481708|NCT00906425|6085174|P2|6 Months|Overall Study|ITT population|64
2481709|NCT00906425|6085175|P1|6 Months|Overall Study|ITT population|69
2481710|NCT00906425|6085174|P2|STARTED|Overall Study||72
2481711|NCT00906425|6085175|P1|STARTED|Overall Study||73
2481712|NCT00906399|6085188|P7|NOT COMPLETED|Year 2||29
2481713|NCT00906399|6085189|P6|NOT COMPLETED|Year 2||47
2481714|NCT00906399|6085190|P5|NOT COMPLETED|Year 2||35
2481715|NCT00906399|6085191|P4|NOT COMPLETED|Year 2||30
2481716|NCT00906399|6085192|P3|NOT COMPLETED|Year 2||0
2481717|NCT00906399|6085193|P2|NOT COMPLETED|Year 2||0
2481718|NCT00906399|6085194|P1|NOT COMPLETED|Year 2||0
2481719|NCT00906399|6085188|P7|COMPLETED|Year 2||409
2481720|NCT00906399|6085189|P6|COMPLETED|Year 2||391
2481721|NCT00906399|6085190|P5|COMPLETED|Year 2||193
2481722|NCT00906399|6085191|P4|COMPLETED|Year 2||198
2481723|NCT00906399|6085192|P3|COMPLETED|Year 2||0
2481724|NCT00906399|6085193|P2|COMPLETED|Year 2||0
2481725|NCT00906399|6085194|P1|COMPLETED|Year 2||0
2481726|NCT00906399|6085188|P7|Completed Year 2 Study Treatment|Year 2||411
2481727|NCT00906399|6085189|P6|Completed Year 2 Study Treatment|Year 2||391
2481728|NCT00906399|6085190|P5|Completed Year 2 Study Treatment|Year 2||196
2481729|NCT00906399|6085191|P4|Completed Year 2 Study Treatment|Year 2||200
2481730|NCT00906399|6085192|P3|Completed Year 2 Study Treatment|Year 2||0
2481731|NCT00906399|6085193|P2|Completed Year 2 Study Treatment|Year 2||0
2481732|NCT00906399|6085194|P1|Completed Year 2 Study Treatment|Year 2||0
2481733|NCT00906399|6085188|P7|STARTED|Year 2||438
2481734|NCT00906399|6085189|P6|STARTED|Year 2||438
2481735|NCT00906399|6085190|P5|STARTED|Year 2||228
2481736|NCT00906399|6085191|P4|STARTED|Year 2||228
2481737|NCT00906399|6085192|P3|STARTED|Year 2||0
2481738|NCT00906399|6085193|P2|STARTED|Year 2||0
2481739|NCT00906399|6085194|P1|STARTED|Year 2||0
2481740|NCT00906399|6085188|P7|NOT COMPLETED|Year 1||0
2481741|NCT00906399|6085189|P6|NOT COMPLETED|Year 1||0
2481742|NCT00906399|6085190|P5|NOT COMPLETED|Year 1||0
2481743|NCT00906399|6085191|P4|NOT COMPLETED|Year 1||0
2481744|NCT00906399|6085192|P3|NOT COMPLETED|Year 1||76
2481745|NCT00906399|6085193|P2|NOT COMPLETED|Year 1||63
2481746|NCT00906399|6085194|P1|NOT COMPLETED|Year 1||44
2481747|NCT00906399|6085188|P7|COMPLETED|Year 1||0
2481748|NCT00906399|6085189|P6|COMPLETED|Year 1||0
2481749|NCT00906399|6085190|P5|COMPLETED|Year 1||0
2481750|NCT00906399|6085191|P4|COMPLETED|Year 1||0
2481751|NCT00906399|6085192|P3|COMPLETED|Year 1|1 participant discontinued treatment before end of study period but remained to complete follow-up.|439
2481752|NCT00906399|6085193|P2|COMPLETED|Year 1||438
2481753|NCT00906399|6085194|P1|COMPLETED|Year 1||456
2481754|NCT00906399|6085188|P7|Completed Year 1 Study Treatment|Year 1||0
2481755|NCT00906399|6085189|P6|Completed Year 1 Study Treatment|Year 1||0
2481756|NCT00906399|6085190|P5|Completed Year 1 Study Treatment|Year 1||0
2481757|NCT00906399|6085191|P4|Completed Year 1 Study Treatment|Year 1||0
2481758|NCT00906399|6085192|P3|Completed Year 1 Study Treatment|Year 1||438
2481759|NCT00906399|6085193|P2|Completed Year 1 Study Treatment|Year 1||438
2481760|NCT00906399|6085194|P1|Completed Year 1 Study Treatment|Year 1||456
2481761|NCT00906399|6085188|P7|STARTED|Year 1||0
2481762|NCT00906399|6085189|P6|STARTED|Year 1||0
2481763|NCT00906399|6085190|P5|STARTED|Year 1||0
2481764|NCT00906399|6085191|P4|STARTED|Year 1||0
2481765|NCT00906399|6085192|P3|STARTED|Year 1||515
2481766|NCT00906399|6085193|P2|STARTED|Year 1||501
2481767|NCT00906399|6085194|P1|STARTED|Year 1||500
2481768|NCT00906373|6085217|P2|NOT COMPLETED|Overall Study||8
2481769|NCT00906373|6085218|P1|NOT COMPLETED|Overall Study||0
2481770|NCT00906373|6085217|P2|COMPLETED|Overall Study||33
2481771|NCT00906373|6085218|P1|COMPLETED|Overall Study||6
2481772|NCT00906373|6085217|P2|Received Any Amount of Study Drug|Overall Study||41
2481773|NCT00906373|6085218|P1|Received Any Amount of Study Drug|Overall Study||6
2481774|NCT00906373|6085217|P2|STARTED|Overall Study||41
2481775|NCT00906373|6085218|P1|STARTED|Overall Study||6
2481776|NCT00906347|6085257|P2|NOT COMPLETED|Received Study Drug||31
2481777|NCT00906347|6085258|P1|NOT COMPLETED|Received Study Drug||40
2481778|NCT00906347|6085257|P2|COMPLETED|Received Study Drug||143
2481779|NCT00906347|6085258|P1|COMPLETED|Received Study Drug||136
2481780|NCT00906347|6085257|P2|STARTED|Received Study Drug||174
2481781|NCT00906347|6085258|P1|STARTED|Received Study Drug||176
2481782|NCT00906347|6085257|P2|NOT COMPLETED|Randomized||0
2481783|NCT00906347|6085258|P1|NOT COMPLETED|Randomized||0
2481784|NCT00906347|6085257|P2|COMPLETED|Randomized||174
2481785|NCT00906347|6085258|P1|COMPLETED|Randomized||176
2481786|NCT00906347|6085257|P2|STARTED|Randomized||174
2481787|NCT00906347|6085258|P1|STARTED|Randomized||176
2481788|NCT00906282|6085278|P1|NOT COMPLETED|Surgical Resection||0
2481789|NCT00906282|6085278|P1|COMPLETED|Surgical Resection||27
2481790|NCT00906282|6085278|P1|STARTED|Surgical Resection||27
2481791|NCT00906282|6085278|P1|NOT COMPLETED|Preoperative Chemotherapy||19
2481792|NCT00906282|6085278|P1|COMPLETED|Preoperative Chemotherapy|2 of 27 patients completed less than 4 cycles and were deemed surgical candidates.|27
2481793|NCT00906282|6085278|P1|STARTED|Preoperative Chemotherapy||46
2481794|NCT00906243|6085286|P1|NOT COMPLETED|Overall Study||0
2481795|NCT00906243|6085286|P1|COMPLETED|Overall Study||6
2481796|NCT00906243|6085286|P1|STARTED|Overall Study||6
2481797|NCT00906204|6085292|P2|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||3
2481798|NCT00906204|6085293|P1|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||2
2481799|NCT00906204|6085292|P2|COMPLETED|Secondary Endpoints (Long-term Safety)||48
2481800|NCT00906204|6085293|P1|COMPLETED|Secondary Endpoints (Long-term Safety)||41
2481801|NCT00906204|6085292|P2|STARTED|Secondary Endpoints (Long-term Safety)||51
2481802|NCT00906204|6085293|P1|STARTED|Secondary Endpoints (Long-term Safety)||43
2481803|NCT00906204|6085292|P2|NOT COMPLETED|Primary Endpoint (Early Safety)||1
2481804|NCT00906204|6085293|P1|NOT COMPLETED|Primary Endpoint (Early Safety)||2
2481805|NCT00906204|6085292|P2|COMPLETED|Primary Endpoint (Early Safety)||51
2481806|NCT00906204|6085293|P1|COMPLETED|Primary Endpoint (Early Safety)||43
2481807|NCT00906204|6085292|P2|STARTED|Primary Endpoint (Early Safety)||52
2481808|NCT00906204|6085293|P1|STARTED|Primary Endpoint (Early Safety)||45
2481809|NCT00906178|6085311|P2|NOT COMPLETED|Overall Study||16
2481810|NCT00906178|6085312|P1|NOT COMPLETED|Overall Study||15
2481811|NCT00906178|6085311|P2|COMPLETED|Overall Study||167
2481812|NCT00906178|6085312|P1|COMPLETED|Overall Study||168
2481813|NCT00906178|6085311|P2|STARTED|Overall Study||183
2481814|NCT00906178|6085312|P1|STARTED|Overall Study||183
2481815|NCT00906165|6085326|P2|NOT COMPLETED|Overall Study||0
2481816|NCT00906165|6085327|P1|NOT COMPLETED|Overall Study||4
2481817|NCT00906165|6085326|P2|COMPLETED|Overall Study||14
2481818|NCT00906165|6085327|P1|COMPLETED|Overall Study||10
2481819|NCT00906165|6085326|P2|STARTED|Overall Study||14
2481820|NCT00906165|6085327|P1|STARTED|Overall Study||14
2481821|NCT00906087|6085347|P1|NOT COMPLETED|Final Washout Period 4 Weeks||0
2481822|NCT00906087|6085347|P1|COMPLETED|Final Washout Period 4 Weeks||12
2481823|NCT00906087|6085347|P1|STARTED|Final Washout Period 4 Weeks||12
2481824|NCT00906087|6085347|P1|NOT COMPLETED|Cosopt Treatment 6 Weeks||0
2481825|NCT00906087|6085347|P1|COMPLETED|Cosopt Treatment 6 Weeks||12
2481826|NCT00906087|6085347|P1|STARTED|Cosopt Treatment 6 Weeks||12
2481827|NCT00906087|6085347|P1|NOT COMPLETED|Initial Washout||2
2481828|NCT00906087|6085347|P1|COMPLETED|Initial Washout||12
2481829|NCT00906087|6085347|P1|Completed Washout and Continue Protocol|Initial Washout||12
2481830|NCT00906087|6085347|P1|Begin Washout|Initial Washout||13
2481831|NCT00906087|6085347|P1|Completed Screening|Initial Washout||14
2481832|NCT00906087|6085347|P1|STARTED|Initial Washout||14
2481833|NCT00906074|6085356|P2|NOT COMPLETED|Overall Study||0
2481834|NCT00906074|6085357|P1|NOT COMPLETED|Overall Study||0
2481835|NCT00906074|6085356|P2|COMPLETED|Overall Study||90
2481836|NCT00906074|6085357|P1|COMPLETED|Overall Study||90
2481837|NCT00906074|6085356|P2|STARTED|Overall Study||90
2481838|NCT00906074|6085357|P1|STARTED|Overall Study||90
2481839|NCT00906035|6085384|P3|NOT COMPLETED|Overall Study||0
2481840|NCT00906035|6085385|P2|NOT COMPLETED|Overall Study||3
2481841|NCT00906035|6085386|P1|NOT COMPLETED|Overall Study||2
2481842|NCT00906035|6085384|P3|COMPLETED|Overall Study||8
2481843|NCT00906035|6085385|P2|COMPLETED|Overall Study|2 subjects Withdrew after Visit 1 and 1 subject Withdrew shortly after Visit 1due to an AE|6
2481844|NCT00906035|6085386|P1|COMPLETED|Overall Study|One Drop-Out; SAE day before Visit 1 and One subject Withrew prior to visit 1|6
2481845|NCT00906035|6085384|P3|STARTED|Overall Study||8
2481846|NCT00906035|6085385|P2|STARTED|Overall Study||9
2481847|NCT00906035|6085386|P1|STARTED|Overall Study||8
2481848|NCT00905840|6085400|P1|NOT COMPLETED|Overall Study||16
2481849|NCT00905840|6085400|P1|COMPLETED|Overall Study||75
2481850|NCT00905840|6085400|P1|STARTED|Overall Study||91
2481851|NCT00905827|6085412|P3|NOT COMPLETED|Overall Study||0
2481852|NCT00905827|6085413|P2|NOT COMPLETED|Overall Study||0
2481853|NCT00905827|6085414|P1|NOT COMPLETED|Overall Study||0
2481854|NCT00905827|6085412|P3|COMPLETED|Overall Study||73
2481855|NCT00905827|6085413|P2|COMPLETED|Overall Study||69
2481856|NCT00905827|6085414|P1|COMPLETED|Overall Study||70
2481857|NCT00905827|6085412|P3|STARTED|Overall Study||73
2481858|NCT00905827|6085413|P2|STARTED|Overall Study||69
2481859|NCT00905827|6085414|P1|STARTED|Overall Study||70
2481860|NCT00905632|6085431|P7|NOT COMPLETED|Overall Study||4
2481861|NCT00905632|6085432|P6|NOT COMPLETED|Overall Study||1
2481862|NCT00905632|6085433|P5|NOT COMPLETED|Overall Study||0
2481863|NCT00905632|6085434|P4|NOT COMPLETED|Overall Study||0
2481864|NCT00905632|6085435|P3|NOT COMPLETED|Overall Study||0
2481865|NCT00905632|6085436|P2|NOT COMPLETED|Overall Study||0
2481866|NCT00905632|6085437|P1|NOT COMPLETED|Overall Study||0
2481867|NCT00905632|6085431|P7|COMPLETED|Overall Study||7
2481868|NCT00905632|6085432|P6|COMPLETED|Overall Study||8
2481869|NCT00905632|6085433|P5|COMPLETED|Overall Study||10
2481870|NCT00905632|6085434|P4|COMPLETED|Overall Study||6
2481871|NCT00905632|6085435|P3|COMPLETED|Overall Study||7
2481872|NCT00905632|6085436|P2|COMPLETED|Overall Study||6
2481873|NCT00905632|6085437|P1|COMPLETED|Overall Study||8
2481874|NCT00905632|6085431|P7|STARTED|Overall Study||11
2481875|NCT00905632|6085432|P6|STARTED|Overall Study||9
2481876|NCT00905632|6085433|P5|STARTED|Overall Study||10
2481877|NCT00905632|6085434|P4|STARTED|Overall Study||6
2481878|NCT00905632|6085435|P3|STARTED|Overall Study||7
2481879|NCT00905632|6085436|P2|STARTED|Overall Study||6
2481880|NCT00905632|6085437|P1|STARTED|Overall Study||8
2481881|NCT00905606|6085575|P2|NOT COMPLETED|Period 2||0
2481882|NCT00905606|6085576|P1|NOT COMPLETED|Period 2||0
2481883|NCT00905606|6085575|P2|COMPLETED|Period 2||14
2481884|NCT00905606|6085576|P1|COMPLETED|Period 2||14
2481885|NCT00905606|6085575|P2|STARTED|Period 2||14
2481886|NCT00905606|6085576|P1|STARTED|Period 2||14
2481887|NCT00905606|6085575|P2|NOT COMPLETED|Washout||0
2481888|NCT00905606|6085576|P1|NOT COMPLETED|Washout||1
2481889|NCT00905606|6085575|P2|COMPLETED|Washout||14
2481890|NCT00905606|6085576|P1|COMPLETED|Washout||14
2481891|NCT00905606|6085575|P2|STARTED|Washout||14
2481892|NCT00905606|6085576|P1|STARTED|Washout||15
2481893|NCT00905606|6085575|P2|NOT COMPLETED|Period 1||1
2481894|NCT00905606|6085576|P1|NOT COMPLETED|Period 1||0
2481895|NCT00905606|6085575|P2|COMPLETED|Period 1||14
2481896|NCT00905606|6085576|P1|COMPLETED|Period 1||15
2481897|NCT00905606|6085575|P2|STARTED|Period 1||15
2481898|NCT00905606|6085576|P1|STARTED|Period 1||15
2481899|NCT00905580|6085586|P2|NOT COMPLETED|Overall Study||3
2481900|NCT00905580|6085587|P1|NOT COMPLETED|Overall Study||2
2481901|NCT00905580|6085586|P2|COMPLETED|Overall Study||47
2481902|NCT00905580|6085587|P1|COMPLETED|Overall Study||47
2481903|NCT00905580|6085586|P2|STARTED|Overall Study||50
2481904|NCT00905580|6085587|P1|STARTED|Overall Study||49
2481905|NCT00905567|6085601|P2|NOT COMPLETED|Period 2||0
2481906|NCT00905567|6085602|P1|NOT COMPLETED|Period 2||0
2481907|NCT00905567|6085601|P2|COMPLETED|Period 2||11
2481908|NCT00905567|6085602|P1|COMPLETED|Period 2||12
2481909|NCT00905567|6085601|P2|STARTED|Period 2||11
2481910|NCT00905567|6085602|P1|STARTED|Period 2||12
2481911|NCT00905567|6085601|P2|NOT COMPLETED|Washout||1
2481912|NCT00905567|6085602|P1|NOT COMPLETED|Washout||0
2481913|NCT00905567|6085601|P2|COMPLETED|Washout||11
2481914|NCT00905567|6085602|P1|COMPLETED|Washout||12
2481915|NCT00905567|6085601|P2|STARTED|Washout||12
2481916|NCT00905567|6085602|P1|STARTED|Washout||12
2481917|NCT00905567|6085601|P2|NOT COMPLETED|Period 1||0
2481918|NCT00905567|6085602|P1|NOT COMPLETED|Period 1||0
2481919|NCT00905567|6085601|P2|COMPLETED|Period 1||12
2481920|NCT00905567|6085602|P1|COMPLETED|Period 1||12
2481921|NCT00905567|6085601|P2|STARTED|Period 1||12
2481922|NCT00905567|6085602|P1|STARTED|Period 1||12
2481923|NCT00905554|6085612|P2|NOT COMPLETED|Overall Study||0
2481924|NCT00905554|6085613|P1|NOT COMPLETED|Overall Study||0
2481925|NCT00905554|6085612|P2|COMPLETED|Overall Study||114
2481926|NCT00905554|6085613|P1|COMPLETED|Overall Study||116
2481927|NCT00905554|6085612|P2|STARTED|Overall Study||114
2481928|NCT00905554|6085613|P1|STARTED|Overall Study||116
2481929|NCT00905515|6085624|P3|NOT COMPLETED|Overall Study||2
2481930|NCT00905515|6085625|P2|NOT COMPLETED|Overall Study||0
2481931|NCT00905515|6085626|P1|NOT COMPLETED|Overall Study||2
2481932|NCT00905515|6085624|P3|COMPLETED|Overall Study||20
2481933|NCT00905515|6085625|P2|COMPLETED|Overall Study||20
2481934|NCT00905515|6085626|P1|COMPLETED|Overall Study||19
2481935|NCT00905515|6085624|P3|STARTED|Overall Study||22
2481936|NCT00905515|6085625|P2|STARTED|Overall Study||20
2481937|NCT00905515|6085626|P1|STARTED|Overall Study||21
2481938|NCT00905489|6085634|P1|NOT COMPLETED|Optional Extension Phase (OEP)||1
2481939|NCT00905489|6085634|P1|COMPLETED|Optional Extension Phase (OEP)||39
2481940|NCT00905489|6085634|P1|STARTED|Optional Extension Phase (OEP)|Includes only subjects who chose to continue trt with nevirapine XR after completing the PK phase.|40
2481941|NCT00905489|6085634|P1|NOT COMPLETED|Pharmaco-kinetic (PK) Phase||5
2481942|NCT00905489|6085634|P1|COMPLETED|Pharmaco-kinetic (PK) Phase||80
2481943|NCT00905489|6085634|P1|STARTED|Pharmaco-kinetic (PK) Phase||85
2481944|NCT00905437|6085683|P2|NOT COMPLETED|Overall Study||10
2481945|NCT00905437|6085684|P1|NOT COMPLETED|Overall Study||8
2481946|NCT00905437|6085683|P2|COMPLETED|Overall Study||27
2481947|NCT00905437|6085684|P1|COMPLETED|Overall Study||27
2481948|NCT00905437|6085683|P2|STARTED|Overall Study||37
2481949|NCT00905437|6085684|P1|STARTED|Overall Study||35
2481950|NCT00905424|6085704|P2|NOT COMPLETED|Overall Study||9
2481951|NCT00905424|6085705|P1|NOT COMPLETED|Overall Study||11
2481952|NCT00905424|6085704|P2|COMPLETED|Overall Study||79
2481953|NCT00905424|6085705|P1|COMPLETED|Overall Study||78
2481954|NCT00905424|6085704|P2|STARTED|Overall Study||88
2481955|NCT00905424|6085705|P1|STARTED|Overall Study||89
2481956|NCT00905359|6085747|P2|NOT COMPLETED|Overall Study||16
2481957|NCT00905359|6085748|P1|NOT COMPLETED|Overall Study||24
2481958|NCT00905359|6085747|P2|COMPLETED|Overall Study||65
2481959|NCT00905359|6085748|P1|COMPLETED|Overall Study||58
2481960|NCT00905359|6085747|P2|24 Months Follow up|Overall Study||65
2481961|NCT00905359|6085748|P1|24 Months Follow up|Overall Study||58
2481962|NCT00905359|6085747|P2|12 Months Follow up|Overall Study||72
2481963|NCT00905359|6085748|P1|12 Months Follow up|Overall Study||68
2481964|NCT00905359|6085747|P2|STARTED|Overall Study||81
2481965|NCT00905359|6085748|P1|STARTED|Overall Study||82
2481966|NCT00905346|6085784|P2|NOT COMPLETED|Period 2||0
2481967|NCT00905346|6085785|P1|NOT COMPLETED|Period 2||0
2481968|NCT00905346|6085784|P2|COMPLETED|Period 2||11
2481969|NCT00905346|6085785|P1|COMPLETED|Period 2||10
2481970|NCT00905346|6085784|P2|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|11
2481971|NCT00905346|6085785|P1|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|10
2481972|NCT00905346|6085784|P2|NOT COMPLETED|Period 1||0
2481973|NCT00905346|6085785|P1|NOT COMPLETED|Period 1||1
2481974|NCT00905346|6085784|P2|COMPLETED|Period 1||12
2481975|NCT00905346|6085785|P1|COMPLETED|Period 1||11
2481976|NCT00905346|6085784|P2|STARTED|Period 1||12
2481977|NCT00905346|6085785|P1|STARTED|Period 1||12
2481978|NCT00905307|6085799|P6|NOT COMPLETED|Overall Study||42
2481979|NCT00905307|6085800|P5|NOT COMPLETED|Overall Study||16
2481980|NCT00905307|6085801|P4|NOT COMPLETED|Overall Study||37
2481981|NCT00905307|6085802|P3|NOT COMPLETED|Overall Study||37
2481982|NCT00905307|6085803|P2|NOT COMPLETED|Overall Study||37
2481983|NCT00905307|6085804|P1|NOT COMPLETED|Overall Study||22
2481984|NCT00905307|6085799|P6|COMPLETED|Overall Study||53
2481985|NCT00905307|6085800|P5|COMPLETED|Overall Study||34
2481986|NCT00905307|6085801|P4|COMPLETED|Overall Study||56
2481987|NCT00905307|6085802|P3|COMPLETED|Overall Study||53
2481988|NCT00905307|6085803|P2|COMPLETED|Overall Study||52
2481989|NCT00905307|6085804|P1|COMPLETED|Overall Study||20
2481990|NCT00905307|6085799|P6|STARTED|Overall Study||95
2481991|NCT00905307|6085800|P5|STARTED|Overall Study||50
2481992|NCT00905307|6085801|P4|STARTED|Overall Study||93
2481993|NCT00905307|6085802|P3|STARTED|Overall Study||90
2481994|NCT00905307|6085803|P2|STARTED|Overall Study||89
2481995|NCT00905307|6085804|P1|STARTED|Overall Study||42
2481996|NCT00905268|6085864|P4|NOT COMPLETED|Overall Study||2
2481997|NCT00905268|6085865|P3|NOT COMPLETED|Overall Study||0
2481998|NCT00905268|6085866|P2|NOT COMPLETED|Overall Study||1
2481999|NCT00905268|6085867|P1|NOT COMPLETED|Overall Study||4
2482000|NCT00905268|6085864|P4|COMPLETED|Overall Study||57
2482001|NCT00905268|6085865|P3|COMPLETED|Overall Study||59
2482002|NCT00905268|6085866|P2|COMPLETED|Overall Study||56
2482003|NCT00905268|6085867|P1|COMPLETED|Overall Study||53
2482004|NCT00905268|6085864|P4|STARTED|Overall Study||59
2482005|NCT00905268|6085865|P3|STARTED|Overall Study||59
2482006|NCT00905268|6085866|P2|STARTED|Overall Study||57
2482007|NCT00905268|6085867|P1|STARTED|Overall Study||57
2482008|NCT00905255|6085899|P2|NOT COMPLETED|Overall Study||9
2482009|NCT00905255|6085900|P1|NOT COMPLETED|Overall Study||13
2482010|NCT00905255|6085899|P2|COMPLETED|Overall Study||27
2482011|NCT00905255|6085900|P1|COMPLETED|Overall Study||20
2482012|NCT00905255|6085899|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||36
2482013|NCT00905255|6085900|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|33
2482014|NCT00905255|6085899|P2|Safety Population|Overall Study||36
2482015|NCT00905255|6085900|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|33
2482016|NCT00905255|6085899|P2|STARTED|Overall Study||36
2482017|NCT00905255|6085900|P1|STARTED|Overall Study|Randomized.|33
2482018|NCT00905164|6085918|P2|NOT COMPLETED|Period 2||0
2482019|NCT00905164|6085919|P1|NOT COMPLETED|Period 2||0
2482020|NCT00905164|6085918|P2|COMPLETED|Period 2||11
2482021|NCT00905164|6085919|P1|COMPLETED|Period 2||12
2482022|NCT00905164|6085918|P2|STARTED|Period 2||11
2482023|NCT00905164|6085919|P1|STARTED|Period 2||12
2482024|NCT00905164|6085918|P2|NOT COMPLETED|Period 1||1
2482025|NCT00905164|6085919|P1|NOT COMPLETED|Period 1||0
2482026|NCT00905164|6085918|P2|COMPLETED|Period 1||11
2482027|NCT00905164|6085919|P1|COMPLETED|Period 1||12
2482028|NCT00905164|6085918|P2|STARTED|Period 1||12
2482029|NCT00905164|6085919|P1|STARTED|Period 1||12
2482030|NCT00905151|6085927|P1|NOT COMPLETED|Overall Study||6
2482031|NCT00905151|6085927|P1|COMPLETED|Overall Study||200
2482032|NCT00905151|6085927|P1|STARTED|Overall Study||206
2482033|NCT00905125|6085933|P2|NOT COMPLETED|Overall Study||3
2482034|NCT00905125|6085934|P1|NOT COMPLETED|Overall Study||4
2482035|NCT00905125|6085933|P2|COMPLETED|Overall Study||53
2482036|NCT00905125|6085934|P1|COMPLETED|Overall Study||42
2482037|NCT00905125|6085933|P2|STARTED|Overall Study||56
2482038|NCT00905125|6085934|P1|STARTED|Overall Study||46
2482039|NCT00905034|6085966|P1|NOT COMPLETED|Overall Study||1
2482040|NCT00905034|6085966|P1|COMPLETED|Overall Study||36
2482041|NCT00905034|6085966|P1|STARTED|Overall Study||37
2482042|NCT00905021|6085970|P1|NOT COMPLETED|Overall Study||2
2482043|NCT00905021|6085970|P1|COMPLETED|Overall Study|2 patients were off study due to AE.|2
2482044|NCT00905021|6085970|P1|STARTED|Overall Study||4
2482045|NCT00904995|6085977|P2|NOT COMPLETED|Overall Study||0
2482046|NCT00904995|6085978|P1|NOT COMPLETED|Overall Study||0
2482047|NCT00904995|6085977|P2|COMPLETED|Overall Study||11
2482048|NCT00904995|6085978|P1|COMPLETED|Overall Study||10
2482049|NCT00904995|6085977|P2|STARTED|Overall Study||11
2482050|NCT00904995|6085978|P1|STARTED|Overall Study||10
2482051|NCT00904982|6085988|P4|NOT COMPLETED|Overall Study||0
2482052|NCT00904982|6085989|P3|NOT COMPLETED|Overall Study||0
2482053|NCT00904982|6085990|P2|NOT COMPLETED|Overall Study||0
2482054|NCT00904982|6085991|P1|NOT COMPLETED|Overall Study||2
2482055|NCT00904982|6085988|P4|COMPLETED|Overall Study||68
2482056|NCT00904982|6085989|P3|COMPLETED|Overall Study||67
2482057|NCT00904982|6085990|P2|COMPLETED|Overall Study||67
2482058|NCT00904982|6085991|P1|COMPLETED|Overall Study||66
2482059|NCT00904982|6085988|P4|STARTED|Overall Study||68
2482060|NCT00904982|6085989|P3|STARTED|Overall Study||67
2482061|NCT00904982|6085990|P2|STARTED|Overall Study||67
2482062|NCT00904982|6085991|P1|STARTED|Overall Study||68
2482063|NCT00904969|6086001|P1|NOT COMPLETED|Overall Study||19
2482064|NCT00904969|6086001|P1|COMPLETED|Overall Study|# of Implanted Subjects Who Completed the Study|31
2482065|NCT00904969|6086001|P1|STARTED|Overall Study|Number of patients with an attempted implant; 1 subject with procedure aborted|50
2482066|NCT00904943|6086053|P2|NOT COMPLETED|Period 2||0
2482067|NCT00904943|6086054|P1|NOT COMPLETED|Period 2||0
2482068|NCT00904943|6086053|P2|COMPLETED|Period 2||8
2482069|NCT00904943|6086054|P1|COMPLETED|Period 2||9
2482070|NCT00904943|6086053|P2|STARTED|Period 2|one subject was withdrawn prior to Pd. 2 dosing|8
2482071|NCT00904943|6086054|P1|STARTED|Period 2||9
2482072|NCT00904943|6086053|P2|NOT COMPLETED|Period 1||0
2482073|NCT00904943|6086054|P1|NOT COMPLETED|Period 1||0
2482074|NCT00904943|6086053|P2|COMPLETED|Period 1||9
2482075|NCT00904943|6086054|P1|COMPLETED|Period 1||9
2482076|NCT00904943|6086053|P2|STARTED|Period 1||9
2482077|NCT00904943|6086054|P1|STARTED|Period 1||9
2482078|NCT00904917|6086066|P4|NOT COMPLETED|Overall Study||2
2482079|NCT00904917|6086067|P3|NOT COMPLETED|Overall Study||2
2482080|NCT00904917|6086068|P2|NOT COMPLETED|Overall Study||2
2482081|NCT00904917|6086069|P1|NOT COMPLETED|Overall Study||2
2482082|NCT00904917|6086066|P4|COMPLETED|Overall Study||6
2482083|NCT00904917|6086067|P3|COMPLETED|Overall Study||6
2482084|NCT00904917|6086068|P2|COMPLETED|Overall Study||9
2482085|NCT00904917|6086069|P1|COMPLETED|Overall Study||5
2482086|NCT00904917|6086066|P4|STARTED|Overall Study||8
2482087|NCT00904917|6086067|P3|STARTED|Overall Study||8
2482088|NCT00904917|6086068|P2|STARTED|Overall Study||11
2482089|NCT00904917|6086069|P1|STARTED|Overall Study||7
2482090|NCT00904839|6086087|P3|NOT COMPLETED|Overall Study||15
2482091|NCT00904839|6086088|P2|NOT COMPLETED|Overall Study||18
2482092|NCT00904839|6086089|P1|NOT COMPLETED|Overall Study||1
2482093|NCT00904839|6086087|P3|COMPLETED|Overall Study||27
2482094|NCT00904839|6086088|P2|COMPLETED|Overall Study||64
2482095|NCT00904839|6086089|P1|COMPLETED|Overall Study||3
2482096|NCT00904839|6086087|P3|STARTED|Overall Study|Randomised|42
2482097|NCT00904839|6086088|P2|STARTED|Overall Study|11 patients were randomised to Maximum Tolerable Dose analysis set.|82
2482098|NCT00904839|6086089|P1|STARTED|Overall Study|All 4 patients were randomised to Maximum Tolerable Dose analysis set.|4
2482099|NCT00904826|6086123|P1|NOT COMPLETED|Overall Study||0
2482100|NCT00904826|6086123|P1|COMPLETED|Overall Study||14
2482101|NCT00904826|6086123|P1|STARTED|Overall Study||14
2482102|NCT00904748|6086135|P6|NOT COMPLETED|Overall Study||0
2482103|NCT00904748|6086136|P5|NOT COMPLETED|Overall Study||1
2482104|NCT00904748|6086137|P4|NOT COMPLETED|Overall Study||2
2482105|NCT00904748|6086138|P3|NOT COMPLETED|Overall Study||1
2482106|NCT00904748|6086139|P2|NOT COMPLETED|Overall Study||1
2482107|NCT00904748|6086140|P1|NOT COMPLETED|Overall Study||1
2482108|NCT00904748|6086135|P6|COMPLETED|Overall Study||8
2482109|NCT00904748|6086136|P5|COMPLETED|Overall Study||7
2482110|NCT00904748|6086137|P4|COMPLETED|Overall Study||6
2482111|NCT00904748|6086138|P3|COMPLETED|Overall Study||7
2482112|NCT00904748|6086139|P2|COMPLETED|Overall Study||7
2482113|NCT00904748|6086140|P1|COMPLETED|Overall Study||7
2482114|NCT00904748|6086135|P6|Received Treatment|Overall Study||8
2482115|NCT00904748|6086136|P5|Received Treatment|Overall Study||7
2482116|NCT00904748|6086137|P4|Received Treatment|Overall Study||8
2482117|NCT00904748|6086138|P3|Received Treatment|Overall Study||8
2482118|NCT00904748|6086139|P2|Received Treatment|Overall Study||8
2482119|NCT00904748|6086140|P1|Received Treatment|Overall Study||8
2482120|NCT00904748|6086135|P6|STARTED|Overall Study||8
2482121|NCT00904748|6086136|P5|STARTED|Overall Study|1 participant randomized to this sequence discontinued prior to receipt of study medication.|8
2482122|NCT00904748|6086137|P4|STARTED|Overall Study||8
2482123|NCT00904748|6086138|P3|STARTED|Overall Study||8
2482124|NCT00904748|6086139|P2|STARTED|Overall Study||8
2482125|NCT00904748|6086140|P1|STARTED|Overall Study||8
2482126|NCT00904722|6086164|P1|NOT COMPLETED|Overall Study||1
2482127|NCT00904722|6086164|P1|COMPLETED|Overall Study||29
2482128|NCT00904722|6086164|P1|STARTED|Overall Study||30
2482129|NCT00904670|6086169|P2|NOT COMPLETED|Second Intervention Period||0
2482130|NCT00904670|6086170|P1|NOT COMPLETED|Second Intervention Period||0
2482131|NCT00904670|6086169|P2|COMPLETED|Second Intervention Period||22
2482132|NCT00904670|6086170|P1|COMPLETED|Second Intervention Period||17
2482133|NCT00904670|6086169|P2|STARTED|Second Intervention Period||22
2482134|NCT00904670|6086170|P1|STARTED|Second Intervention Period||17
2482135|NCT00904670|6086169|P2|NOT COMPLETED|First Intervention Period||0
2482136|NCT00904670|6086170|P1|NOT COMPLETED|First Intervention Period||0
2482137|NCT00904670|6086169|P2|COMPLETED|First Intervention Period||22
2482138|NCT00904670|6086170|P1|COMPLETED|First Intervention Period||17
2482139|NCT00904670|6086169|P2|STARTED|First Intervention Period||22
2482140|NCT00904670|6086170|P1|STARTED|First Intervention Period||17
2482141|NCT00904670|6086169|P2|NOT COMPLETED|Open Label Phase||0
2482142|NCT00904670|6086170|P1|NOT COMPLETED|Open Label Phase||6
2482143|NCT00904670|6086169|P2|COMPLETED|Open Label Phase||22
2482144|NCT00904670|6086170|P1|COMPLETED|Open Label Phase||17
2482145|NCT00904670|6086169|P2|STARTED|Open Label Phase||22
2482146|NCT00904670|6086170|P1|STARTED|Open Label Phase||23
2482147|NCT00904618|6086191|P1|NOT COMPLETED|Overall Study||0
2482148|NCT00904618|6086191|P1|COMPLETED|Overall Study||48
2482149|NCT00904618|6086191|P1|STARTED|Overall Study||48
2482150|NCT00904488|6086201|P2|NOT COMPLETED|Overall Study||0
2482151|NCT00904488|6086202|P1|NOT COMPLETED|Overall Study||0
2482152|NCT00904488|6086201|P2|COMPLETED|Overall Study||6
2482153|NCT00904488|6086202|P1|COMPLETED|Overall Study||5
2482154|NCT00904488|6086201|P2|STARTED|Overall Study||6
2482155|NCT00904488|6086202|P1|STARTED|Overall Study||5
2482156|NCT00904423|6086232|P1|NOT COMPLETED|Overall Study||0
2482157|NCT00904423|6086232|P1|COMPLETED|Overall Study||8
2482158|NCT00904423|6086232|P1|STARTED|Overall Study||8
2482159|NCT00904371|6086240|P1|NOT COMPLETED|Overall Study||9
2482160|NCT00904371|6086240|P1|COMPLETED|Overall Study||202
2482161|NCT00904371|6086240|P1|STARTED|Overall Study||211
2482162|NCT00904215|6086254|P1|NOT COMPLETED|Overall Study||135
2482163|NCT00904215|6086254|P1|COMPLETED|Overall Study||960
2482164|NCT00904215|6086254|P1|STARTED|Overall Study||1095
2482165|NCT00904189|6086261|P1|NOT COMPLETED|Overall Study||0
2482166|NCT00904189|6086261|P1|COMPLETED|Overall Study||2
2482167|NCT00904189|6086261|P1|STARTED|Overall Study||2
2482168|NCT00904150|6086268|P2|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
2482169|NCT00904150|6086269|P1|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
2482170|NCT00904150|6086268|P2|COMPLETED|Blood Samples (RNA): Luteal Phase||30
2482171|NCT00904150|6086269|P1|COMPLETED|Blood Samples (RNA): Luteal Phase||34
2482172|NCT00904150|6086268|P2|STARTED|Blood Samples (RNA): Luteal Phase||30
2482173|NCT00904150|6086269|P1|STARTED|Blood Samples (RNA): Luteal Phase||34
2482174|NCT00904150|6086268|P2|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
2482175|NCT00904150|6086269|P1|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
2482176|NCT00904150|6086268|P2|COMPLETED|Blood Samples (RNA): Follicular Phase||32
2482177|NCT00904150|6086269|P1|COMPLETED|Blood Samples (RNA): Follicular Phase||37
2482178|NCT00904150|6086268|P2|STARTED|Blood Samples (RNA): Follicular Phase||32
2482179|NCT00904150|6086269|P1|STARTED|Blood Samples (RNA): Follicular Phase||37
2482180|NCT00904150|6086268|P2|NOT COMPLETED|Saliva Samples (DNA)||145
2482181|NCT00904150|6086269|P1|NOT COMPLETED|Saliva Samples (DNA)||3
2482182|NCT00904150|6086268|P2|COMPLETED|Saliva Samples (DNA)||155
2482183|NCT00904150|6086269|P1|COMPLETED|Saliva Samples (DNA)||282
2482184|NCT00904150|6086268|P2|STARTED|Saliva Samples (DNA)||300
2482185|NCT00904150|6086269|P1|STARTED|Saliva Samples (DNA)||285
2482186|NCT00904033|6086291|P4|NOT COMPLETED|Overall Study||2
2482187|NCT00904033|6086292|P3|NOT COMPLETED|Overall Study||1
2482188|NCT00904033|6086293|P2|NOT COMPLETED|Overall Study||1
2482189|NCT00904033|6086294|P1|NOT COMPLETED|Overall Study||1
2482190|NCT00904033|6086291|P4|COMPLETED|Overall Study||9
2482191|NCT00904033|6086292|P3|COMPLETED|Overall Study||9
2482192|NCT00904033|6086293|P2|COMPLETED|Overall Study||9
2482193|NCT00904033|6086294|P1|COMPLETED|Overall Study||9
2482194|NCT00904033|6086291|P4|STARTED|Overall Study||11
2482195|NCT00904033|6086292|P3|STARTED|Overall Study||10
2482196|NCT00904033|6086293|P2|STARTED|Overall Study||10
2482197|NCT00904033|6086294|P1|STARTED|Overall Study||10
2482198|NCT00904007|6086318|P2|NOT COMPLETED|Overall Study||0
2482199|NCT00904007|6086319|P1|NOT COMPLETED|Overall Study||0
2482200|NCT00904007|6086318|P2|COMPLETED|Overall Study||56
2482201|NCT00904007|6086319|P1|COMPLETED|Overall Study||55
2482202|NCT00904007|6086318|P2|STARTED|Overall Study||56
2482203|NCT00904007|6086319|P1|STARTED|Overall Study||55
2482204|NCT00903968|6086359|P8|NOT COMPLETED|Overall Study||33
2482205|NCT00903968|6086360|P7|NOT COMPLETED|Overall Study||3
2482206|NCT00903968|6086361|P6|NOT COMPLETED|Overall Study||6
2482207|NCT00903968|6086362|P5|NOT COMPLETED|Overall Study||4
2482208|NCT00903968|6086363|P4|NOT COMPLETED|Overall Study||3
2482209|NCT00903968|6086364|P3|NOT COMPLETED|Overall Study||3
2482210|NCT00903968|6086365|P2|NOT COMPLETED|Overall Study||3
2482211|NCT00903968|6086366|P1|NOT COMPLETED|Overall Study||3
2482212|NCT00903968|6086359|P8|COMPLETED|Overall Study||0
2482213|NCT00903968|6086360|P7|COMPLETED|Overall Study||0
2482214|NCT00903968|6086361|P6|COMPLETED|Overall Study||0
2482215|NCT00903968|6086362|P5|COMPLETED|Overall Study||0
2482216|NCT00903968|6086363|P4|COMPLETED|Overall Study||0
2482217|NCT00903968|6086364|P3|COMPLETED|Overall Study||0
2482218|NCT00903968|6086365|P2|COMPLETED|Overall Study||0
2482219|NCT00903968|6086366|P1|COMPLETED|Overall Study||0
2482220|NCT00903968|6086359|P8|STARTED|Overall Study||33
2482221|NCT00903968|6086360|P7|STARTED|Overall Study||3
2482222|NCT00903968|6086361|P6|STARTED|Overall Study||6
2482223|NCT00903968|6086362|P5|STARTED|Overall Study||4
2482224|NCT00903968|6086363|P4|STARTED|Overall Study||3
2482225|NCT00903968|6086364|P3|STARTED|Overall Study||3
2482226|NCT00903968|6086365|P2|STARTED|Overall Study||3
2482227|NCT00903968|6086366|P1|STARTED|Overall Study||3
2482228|NCT00903929|6086396|P4|NOT COMPLETED|Overall Study||3
2482229|NCT00903929|6086397|P3|NOT COMPLETED|Overall Study||1
2482230|NCT00903929|6086398|P2|NOT COMPLETED|Overall Study||0
2482231|NCT00903929|6086399|P1|NOT COMPLETED|Overall Study||0
2482232|NCT00903929|6086396|P4|COMPLETED|Overall Study||6
2482233|NCT00903929|6086397|P3|COMPLETED|Overall Study||3
2482234|NCT00903929|6086398|P2|COMPLETED|Overall Study||3
2482235|NCT00903929|6086399|P1|COMPLETED|Overall Study||3
2482236|NCT00903929|6086396|P4|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|9
2482237|NCT00903929|6086397|P3|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|4
2482238|NCT00903929|6086398|P2|STARTED|Overall Study||3
2482239|NCT00903929|6086399|P1|STARTED|Overall Study||3
2482240|NCT00903877|6086405|P1|NOT COMPLETED|Overall Study||43
2482241|NCT00903877|6086405|P1|COMPLETED|Overall Study||8
2482242|NCT00903877|6086405|P1|STARTED|Overall Study||51
2482243|NCT00903786|6086409|P1|NOT COMPLETED|Overall Study||15
2482244|NCT00903786|6086409|P1|COMPLETED|Overall Study||6
2482245|NCT00903786|6086409|P1|STARTED|Overall Study||21
2482246|NCT00903760|6086419|P2|NOT COMPLETED|Overall Study||16
2482247|NCT00903760|6086420|P1|NOT COMPLETED|Overall Study||19
2482248|NCT00903760|6086419|P2|COMPLETED|Overall Study|Completed all 24 courses|2
2482249|NCT00903760|6086420|P1|COMPLETED|Overall Study|Completed all 24 courses|0
2482250|NCT00903760|6086419|P2|STARTED|Overall Study||18
2482251|NCT00903760|6086420|P1|STARTED|Overall Study||19
2482252|NCT00903695|6086430|P2|NOT COMPLETED|Overall Study||0
2482253|NCT00903695|6086431|P1|NOT COMPLETED|Overall Study||2
2482254|NCT00903695|6086430|P2|COMPLETED|Overall Study||2
2482255|NCT00903695|6086431|P1|COMPLETED|Overall Study||6
2482256|NCT00903695|6086430|P2|STARTED|Overall Study||2
2482257|NCT00903695|6086431|P1|STARTED|Overall Study||8
2482258|NCT00903682|6086453|P2|NOT COMPLETED|Overall Study||15
2482259|NCT00903682|6086454|P1|NOT COMPLETED|Overall Study||16
2482260|NCT00903682|6086453|P2|COMPLETED|Overall Study||63
2482261|NCT00903682|6086454|P1|COMPLETED|Overall Study||63
2482262|NCT00903682|6086453|P2|STARTED|Overall Study||78
2482263|NCT00903682|6086454|P1|STARTED|Overall Study||79
2482264|NCT00903630|6086475|P3|NOT COMPLETED|Phase 2||1
2482265|NCT00903630|6086476|P2|NOT COMPLETED|Phase 2||0
2482266|NCT00903630|6086477|P1|NOT COMPLETED|Phase 2||0
2482267|NCT00903630|6086475|P3|COMPLETED|Phase 2|One participant was removed from the study after 2 weeks of treatment due to skin toxicity.|3
2482268|NCT00903630|6086476|P2|COMPLETED|Phase 2||0
2482269|NCT00903630|6086477|P1|COMPLETED|Phase 2||6
2482270|NCT00903630|6086475|P3|STARTED|Phase 2||4
2482271|NCT00903630|6086476|P2|STARTED|Phase 2||0
2482272|NCT00903630|6086477|P1|STARTED|Phase 2||6
2482273|NCT00903630|6086475|P3|NOT COMPLETED|Phase l||0
2482274|NCT00903630|6086476|P2|NOT COMPLETED|Phase l||0
2482275|NCT00903630|6086477|P1|NOT COMPLETED|Phase l||0
2482276|NCT00903630|6086475|P3|COMPLETED|Phase l||0
2482277|NCT00903630|6086476|P2|COMPLETED|Phase l||5
2482278|NCT00903630|6086477|P1|COMPLETED|Phase l||6
2482279|NCT00903630|6086475|P3|STARTED|Phase l||0
2482280|NCT00903630|6086476|P2|STARTED|Phase l||5
2482281|NCT00903630|6086477|P1|STARTED|Phase l||6
2482282|NCT00903617|6086495|P4|NOT COMPLETED|Overall Study||1
2482283|NCT00903617|6086496|P3|NOT COMPLETED|Overall Study||5
2482284|NCT00903617|6086497|P2|NOT COMPLETED|Overall Study||5
2482285|NCT00903617|6086498|P1|NOT COMPLETED|Overall Study||3
2482286|NCT00903617|6086495|P4|COMPLETED|Overall Study||20
2482287|NCT00903617|6086496|P3|COMPLETED|Overall Study||15
2482288|NCT00903617|6086497|P2|COMPLETED|Overall Study||15
2482289|NCT00903617|6086498|P1|COMPLETED|Overall Study||16
2482290|NCT00903617|6086495|P4|STARTED|Overall Study||21
2482291|NCT00903617|6086496|P3|STARTED|Overall Study||20
2482292|NCT00903617|6086497|P2|STARTED|Overall Study||20
2482293|NCT00903617|6086498|P1|STARTED|Overall Study||19
2482294|NCT00903448|6086592|P2|NOT COMPLETED|Period 3: 5 Days||0
2482295|NCT00903448|6086593|P1|NOT COMPLETED|Period 3: 5 Days||0
2482296|NCT00903448|6086592|P2|COMPLETED|Period 3: 5 Days||20
2482297|NCT00903448|6086593|P1|COMPLETED|Period 3: 5 Days||20
2482298|NCT00903448|6086592|P2|STARTED|Period 3: 5 Days||20
2482299|NCT00903448|6086593|P1|STARTED|Period 3: 5 Days||20
2482300|NCT00903448|6086592|P2|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
2482301|NCT00903448|6086593|P1|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
2482302|NCT00903448|6086592|P2|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
2482303|NCT00903448|6086593|P1|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
2482304|NCT00903448|6086592|P2|STARTED|Period 2: 5 Days Then 10 Day Washout||20
2482305|NCT00903448|6086593|P1|STARTED|Period 2: 5 Days Then 10 Day Washout||20
2482306|NCT00903448|6086592|P2|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
2482307|NCT00903448|6086593|P1|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
2482308|NCT00903448|6086592|P2|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
2482309|NCT00903448|6086593|P1|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
2482310|NCT00903448|6086592|P2|STARTED|Period 1: 5 Days Then 10 Day Washout||20
2482311|NCT00903448|6086593|P1|STARTED|Period 1: 5 Days Then 10 Day Washout||20
2482312|NCT00903409|6086601|P2|NOT COMPLETED|Overall Study||27
2482313|NCT00903409|6086602|P1|NOT COMPLETED|Overall Study||26
2482314|NCT00903409|6086601|P2|COMPLETED|Overall Study||73
2482315|NCT00903409|6086602|P1|COMPLETED|Overall Study||62
2482316|NCT00903409|6086601|P2|STARTED|Overall Study||100
2482317|NCT00903409|6086602|P1|STARTED|Overall Study||88
2482318|NCT00903396|6086620|P4|NOT COMPLETED|Overall Study||0
2482319|NCT00903396|6086621|P3|NOT COMPLETED|Overall Study||0
2482320|NCT00903396|6086622|P2|NOT COMPLETED|Overall Study||0
2482321|NCT00903396|6086623|P1|NOT COMPLETED|Overall Study||0
2482322|NCT00903396|6086620|P4|COMPLETED|Overall Study||1
2482323|NCT00903396|6086621|P3|COMPLETED|Overall Study||3
2482324|NCT00903396|6086622|P2|COMPLETED|Overall Study||1
2482325|NCT00903396|6086623|P1|COMPLETED|Overall Study||2
2482326|NCT00903396|6086620|P4|STARTED|Overall Study||1
2482327|NCT00903396|6086621|P3|STARTED|Overall Study||3
2482328|NCT00903396|6086622|P2|STARTED|Overall Study||1
2482329|NCT00903396|6086623|P1|STARTED|Overall Study||2
2482330|NCT00903383|6086653|P4|NOT COMPLETED|Overall Study||5
2482331|NCT00903383|6086654|P3|NOT COMPLETED|Overall Study||3
2482332|NCT00903383|6086655|P2|NOT COMPLETED|Overall Study||6
2482333|NCT00903383|6086656|P1|NOT COMPLETED|Overall Study||7
2482334|NCT00903383|6086653|P4|COMPLETED|Overall Study||44
2482335|NCT00903383|6086654|P3|COMPLETED|Overall Study||47
2482336|NCT00903383|6086655|P2|COMPLETED|Overall Study||48
2482337|NCT00903383|6086656|P1|COMPLETED|Overall Study||48
2482338|NCT00903383|6086653|P4|STARTED|Overall Study||49
2482339|NCT00903383|6086654|P3|STARTED|Overall Study||50
2482340|NCT00903383|6086655|P2|STARTED|Overall Study||54
2482341|NCT00903383|6086656|P1|STARTED|Overall Study||55
2482342|NCT00903370|6086688|P2|NOT COMPLETED|Overall Study||24
2482343|NCT00903370|6086689|P1|NOT COMPLETED|Overall Study||28
2482344|NCT00903370|6086688|P2|COMPLETED|Overall Study||109
2482345|NCT00903370|6086689|P1|COMPLETED|Overall Study||99
2482346|NCT00903370|6086688|P2|STARTED|Overall Study||133
2482347|NCT00903370|6086689|P1|STARTED|Overall Study||127
2482348|NCT00903357|6086697|P2|NOT COMPLETED|Second Intervention||0
2482349|NCT00903357|6086698|P1|NOT COMPLETED|Second Intervention||1
2482350|NCT00903357|6086697|P2|COMPLETED|Second Intervention||22
2482351|NCT00903357|6086698|P1|COMPLETED|Second Intervention||21
2482352|NCT00903357|6086697|P2|STARTED|Second Intervention||22
2482353|NCT00903357|6086698|P1|STARTED|Second Intervention||22
2482354|NCT00903357|6086697|P2|NOT COMPLETED|Wash Out Period of 2 Weeks||1
2482355|NCT00903357|6086698|P1|NOT COMPLETED|Wash Out Period of 2 Weeks||0
2482356|NCT00903357|6086697|P2|COMPLETED|Wash Out Period of 2 Weeks||22
2482357|NCT00903357|6086698|P1|COMPLETED|Wash Out Period of 2 Weeks||22
2482358|NCT00903357|6086697|P2|STARTED|Wash Out Period of 2 Weeks||23
2482359|NCT00903357|6086698|P1|STARTED|Wash Out Period of 2 Weeks||22
2482360|NCT00903357|6086697|P2|NOT COMPLETED|First Intervention||4
2482361|NCT00903357|6086698|P1|NOT COMPLETED|First Intervention||5
2482362|NCT00903357|6086697|P2|COMPLETED|First Intervention||23
2482363|NCT00903357|6086698|P1|COMPLETED|First Intervention||22
2482364|NCT00903357|6086697|P2|STARTED|First Intervention||27
2482365|NCT00903357|6086698|P1|STARTED|First Intervention||27
2482366|NCT00903344|6086710|P2|NOT COMPLETED|Overall Study||3
2482367|NCT00903344|6086711|P1|NOT COMPLETED|Overall Study||5
2482368|NCT00903344|6086710|P2|COMPLETED|Overall Study||7
2482369|NCT00903344|6086711|P1|COMPLETED|Overall Study||7
2482370|NCT00903344|6086710|P2|6 Month Visit|Overall Study||10
2482371|NCT00903344|6086711|P1|6 Month Visit|Overall Study||9
2482372|NCT00903344|6086710|P2|3 Month Visit|Overall Study||10
2482373|NCT00903344|6086711|P1|3 Month Visit|Overall Study||10
2482374|NCT00903344|6086710|P2|STARTED|Overall Study||10
2482375|NCT00903344|6086711|P1|STARTED|Overall Study||12
2482376|NCT00903331|6086729|P2|NOT COMPLETED|Overall Study||18
2482377|NCT00903331|6086730|P1|NOT COMPLETED|Overall Study||5
2482378|NCT00903331|6086729|P2|COMPLETED|Overall Study||101
2482379|NCT00903331|6086730|P1|COMPLETED|Overall Study||54
2482380|NCT00903331|6086729|P2|STARTED|Overall Study||119
2482381|NCT00903331|6086730|P1|STARTED|Overall Study||59
2482382|NCT00903201|6086741|P3|NOT COMPLETED|Overall Study||2
2482383|NCT00903201|6086742|P2|NOT COMPLETED|Overall Study||6
2482384|NCT00903201|6086743|P1|NOT COMPLETED|Overall Study||5
2482385|NCT00903201|6086741|P3|COMPLETED|Overall Study||39
2482386|NCT00903201|6086742|P2|COMPLETED|Overall Study||38
2482387|NCT00903201|6086743|P1|COMPLETED|Overall Study||56
2482388|NCT00903201|6086741|P3|STARTED|Overall Study||41
2482389|NCT00903201|6086742|P2|STARTED|Overall Study||44
2482390|NCT00903201|6086743|P1|STARTED|Overall Study||61
2482391|NCT00903175|6086801|P2|NOT COMPLETED|Period 2 - Second Line||36
2482392|NCT00903175|6086802|P1|NOT COMPLETED|Period 2 - Second Line||49
2482393|NCT00903175|6086801|P2|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|80
2482394|NCT00903175|6086802|P1|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|79
2482395|NCT00903175|6086801|P2|STARTED|Period 2 - Second Line|130 from Sunitinib 1L planned to enter 2L period and cross over to everolimus but only 116 did.|116
2482396|NCT00903175|6086802|P1|STARTED|Period 2 - Second Line|139 from everolimus 1L planned to enter 2L period and cross over to sunitinib but only 128 did.|128
2482397|NCT00903175|6086801|P2|NOT COMPLETED|Period 1 - First Line||89
2482398|NCT00903175|6086802|P1|NOT COMPLETED|Period 1 - First Line||77
2482399|NCT00903175|6086801|P2|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|142
2482400|NCT00903175|6086802|P1|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|161
2482401|NCT00903175|6086801|P2|STARTED|Period 1 - First Line||231
2482402|NCT00903175|6086802|P1|STARTED|Period 1 - First Line||238
2482403|NCT00903162|6086832|P1|NOT COMPLETED|Overall Study||4
2482404|NCT00903162|6086832|P1|COMPLETED|Overall Study||12
2482405|NCT00903162|6086832|P1|STARTED|Overall Study||16
2482406|NCT00903032|6086840|P2|NOT COMPLETED|Overall Study||5
2482407|NCT00903032|6086841|P1|NOT COMPLETED|Overall Study||7
2482408|NCT00903032|6086840|P2|COMPLETED|Overall Study||119
2482409|NCT00903032|6086841|P1|COMPLETED|Overall Study||122
2482410|NCT00903032|6086840|P2|STARTED|Overall Study||124
2482411|NCT00903032|6086841|P1|STARTED|Overall Study||129
2482412|NCT00903006|6086851|P4|NOT COMPLETED|Overall Study||0
2482413|NCT00903006|6086852|P3|NOT COMPLETED|Overall Study||1
2482414|NCT00903006|6086853|P2|NOT COMPLETED|Overall Study||3
2482415|NCT00903006|6086854|P1|NOT COMPLETED|Overall Study||2
2482416|NCT00903006|6086851|P4|COMPLETED|Overall Study||0
2482417|NCT00903006|6086852|P3|COMPLETED|Overall Study||0
2482418|NCT00903006|6086853|P2|COMPLETED|Overall Study||0
2482419|NCT00903006|6086854|P1|COMPLETED|Overall Study||0
2482420|NCT00903006|6086851|P4|STARTED|Overall Study|Zero participants started due to smaller sample size.|0
2482421|NCT00903006|6086852|P3|STARTED|Overall Study||1
2482422|NCT00903006|6086853|P2|STARTED|Overall Study||3
2482423|NCT00903006|6086854|P1|STARTED|Overall Study||2
2482424|NCT00902850|6086866|P2|NOT COMPLETED|Overall Study||2
2482425|NCT00902850|6086867|P1|NOT COMPLETED|Overall Study||2
2482426|NCT00902850|6086866|P2|COMPLETED|Overall Study||12
2482427|NCT00902850|6086867|P1|COMPLETED|Overall Study||12
2482428|NCT00902850|6086866|P2|STARTED|Overall Study||14
2482429|NCT00902850|6086867|P1|STARTED|Overall Study||14
2482430|NCT00902746|6086873|P1|NOT COMPLETED|Overall Study||36
2482431|NCT00902746|6086873|P1|COMPLETED|Overall Study||113
2482432|NCT00902746|6086873|P1|Transfer to Step 2|Overall Study||133
2482433|NCT00902746|6086873|P1|Initiation of Study Drug Administration|Overall Study||148
2482434|NCT00902746|6086873|P1|STARTED|Overall Study||149
2482435|NCT00902668|6086878|P1|NOT COMPLETED|Overall Study||3
2482436|NCT00902668|6086878|P1|COMPLETED|Overall Study||0
2482437|NCT00902668|6086878|P1|STARTED|Overall Study||3
2482438|NCT00902577|6086882|P1|NOT COMPLETED|Overall Study||8
2482439|NCT00902577|6086882|P1|COMPLETED|Overall Study||42
2482440|NCT00902577|6086882|P1|DWI MRI|Overall Study||39
2482441|NCT00902577|6086882|P1|DSE MRI|Overall Study||37
2482442|NCT00902577|6086882|P1|DCE MRI|Overall Study||31
2482443|NCT00902577|6086882|P1|FMISO/PET|Overall Study||38
2482444|NCT00902577|6086882|P1|STARTED|Overall Study||50
2482445|NCT00902564|6086911|P1|NOT COMPLETED|Overall Study||2
2482446|NCT00902564|6086911|P1|COMPLETED|Overall Study||28
2482447|NCT00902564|6086911|P1|STARTED|Overall Study||30
2482448|NCT00902538|6086926|P6|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||1
2482449|NCT00902538|6086927|P5|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||2
2482450|NCT00902538|6086928|P4|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||9
2482451|NCT00902538|6086929|P3|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
2482452|NCT00902538|6086930|P2|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
2482453|NCT00902538|6086931|P1|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
2482454|NCT00902538|6086926|P6|COMPLETED|4-Randomized Double-blind 2 Treatments||196
2482455|NCT00902538|6086927|P5|COMPLETED|4-Randomized Double-blind 2 Treatments||95
2482456|NCT00902538|6086928|P4|COMPLETED|4-Randomized Double-blind 2 Treatments||458
2482457|NCT00902538|6086929|P3|COMPLETED|4-Randomized Double-blind 2 Treatments||0
2482458|NCT00902538|6086930|P2|COMPLETED|4-Randomized Double-blind 2 Treatments||0
2482459|NCT00902538|6086931|P1|COMPLETED|4-Randomized Double-blind 2 Treatments||0
2482460|NCT00902538|6086926|P6|STARTED|4-Randomized Double-blind 2 Treatments||197
2482461|NCT00902538|6086927|P5|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 non-responders were randomized to OLM 40-AML 10-HCTZ 12.5 or 25 in a 2:1 ratio|97
2482462|NCT00902538|6086928|P4|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 responders were continued on OLM 40-AML 10-HCTZ 12.5|467
2482463|NCT00902538|6086929|P3|STARTED|4-Randomized Double-blind 2 Treatments||0
2482464|NCT00902538|6086930|P2|STARTED|4-Randomized Double-blind 2 Treatments||0
2482465|NCT00902538|6086931|P1|STARTED|4-Randomized Double-blind 2 Treatments||0
2482466|NCT00902538|6086926|P6|NOT COMPLETED|3-Single-blind, Single Treatment||0
2482467|NCT00902538|6086927|P5|NOT COMPLETED|3-Single-blind, Single Treatment||0
2482468|NCT00902538|6086928|P4|NOT COMPLETED|3-Single-blind, Single Treatment||0
2482469|NCT00902538|6086929|P3|NOT COMPLETED|3-Single-blind, Single Treatment||0
2482470|NCT00902538|6086930|P2|NOT COMPLETED|3-Single-blind, Single Treatment||15
2482471|NCT00902538|6086931|P1|NOT COMPLETED|3-Single-blind, Single Treatment||0
2482472|NCT00902538|6086926|P6|COMPLETED|3-Single-blind, Single Treatment||0
2482473|NCT00902538|6086927|P5|COMPLETED|3-Single-blind, Single Treatment||0
2482474|NCT00902538|6086928|P4|COMPLETED|3-Single-blind, Single Treatment||0
2482475|NCT00902538|6086929|P3|COMPLETED|3-Single-blind, Single Treatment||0
2482476|NCT00902538|6086930|P2|COMPLETED|3-Single-blind, Single Treatment||767
2482477|NCT00902538|6086931|P1|COMPLETED|3-Single-blind, Single Treatment||0
2482478|NCT00902538|6086926|P6|STARTED|3-Single-blind, Single Treatment||0
2482479|NCT00902538|6086927|P5|STARTED|3-Single-blind, Single Treatment||0
2482480|NCT00902538|6086928|P4|STARTED|3-Single-blind, Single Treatment||0
2482481|NCT00902538|6086929|P3|STARTED|3-Single-blind, Single Treatment||0
2482482|NCT00902538|6086930|P2|STARTED|3-Single-blind, Single Treatment|Number starting is < total completing previous arm since 3 subjects did not receive at least 1 dose.|782
2482483|NCT00902538|6086931|P1|STARTED|3-Single-blind, Single Treatment||0
2482484|NCT00902538|6086926|P6|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
2482485|NCT00902538|6086927|P5|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
2482486|NCT00902538|6086928|P4|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
2482487|NCT00902538|6086929|P3|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||8
2482488|NCT00902538|6086930|P2|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||6
2482489|NCT00902538|6086931|P1|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||9
2482490|NCT00902538|6086926|P6|COMPLETED|2-Randomized Double-blind 3 Treatments||0
2482491|NCT00902538|6086927|P5|COMPLETED|2-Randomized Double-blind 3 Treatments||0
2482492|NCT00902538|6086928|P4|COMPLETED|2-Randomized Double-blind 3 Treatments||0
2482493|NCT00902538|6086929|P3|COMPLETED|2-Randomized Double-blind 3 Treatments||262
2482494|NCT00902538|6086930|P2|COMPLETED|2-Randomized Double-blind 3 Treatments||263
2482495|NCT00902538|6086931|P1|COMPLETED|2-Randomized Double-blind 3 Treatments||260
2482496|NCT00902538|6086926|P6|STARTED|2-Randomized Double-blind 3 Treatments||0
2482497|NCT00902538|6086927|P5|STARTED|2-Randomized Double-blind 3 Treatments||0
2482498|NCT00902538|6086928|P4|STARTED|2-Randomized Double-blind 3 Treatments||0
2482499|NCT00902538|6086929|P3|STARTED|2-Randomized Double-blind 3 Treatments||270
2482500|NCT00902538|6086930|P2|STARTED|2-Randomized Double-blind 3 Treatments||269
2482501|NCT00902538|6086931|P1|STARTED|2-Randomized Double-blind 3 Treatments|Only 808 began Period 2 because the others finishing Period 1 did not meet the entry criteria.|269
2482502|NCT00902538|6086926|P6|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
2482503|NCT00902538|6086927|P5|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
2482504|NCT00902538|6086928|P4|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
2482505|NCT00902538|6086929|P3|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
2482506|NCT00902538|6086930|P2|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
2482507|NCT00902538|6086931|P1|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||118
2482508|NCT00902538|6086926|P6|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
2482509|NCT00902538|6086927|P5|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
2482510|NCT00902538|6086928|P4|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
2482511|NCT00902538|6086929|P3|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
2482512|NCT00902538|6086930|P2|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
2482513|NCT00902538|6086931|P1|COMPLETED|1-Single-blind, Run-in, Single-Treatment||2086
2482514|NCT00902538|6086926|P6|STARTED|1-Single-blind, Run-in, Single-Treatment||0
2482515|NCT00902538|6086927|P5|STARTED|1-Single-blind, Run-in, Single-Treatment||0
2482516|NCT00902538|6086928|P4|STARTED|1-Single-blind, Run-in, Single-Treatment||0
2482517|NCT00902538|6086929|P3|STARTED|1-Single-blind, Run-in, Single-Treatment||0
2482518|NCT00902538|6086930|P2|STARTED|1-Single-blind, Run-in, Single-Treatment||0
2482519|NCT00902538|6086931|P1|STARTED|1-Single-blind, Run-in, Single-Treatment||2204
2482520|NCT00902486|6086965|P6|NOT COMPLETED|Follow-up (After Week 24)||0
2482521|NCT00902486|6086966|P5|NOT COMPLETED|Follow-up (After Week 24)||0
2482522|NCT00902486|6086967|P4|NOT COMPLETED|Follow-up (After Week 24)||1
2482523|NCT00902486|6086968|P3|NOT COMPLETED|Follow-up (After Week 24)||0
2482524|NCT00902486|6086969|P2|NOT COMPLETED|Follow-up (After Week 24)||0
2482525|NCT00902486|6086970|P1|NOT COMPLETED|Follow-up (After Week 24)||0
2482526|NCT00902486|6086965|P6|COMPLETED|Follow-up (After Week 24)||24
2482527|NCT00902486|6086966|P5|COMPLETED|Follow-up (After Week 24)||29
2482528|NCT00902486|6086967|P4|COMPLETED|Follow-up (After Week 24)||26
2482529|NCT00902486|6086968|P3|COMPLETED|Follow-up (After Week 24)||13
2482530|NCT00902486|6086969|P2|COMPLETED|Follow-up (After Week 24)||14
2482531|NCT00902486|6086970|P1|COMPLETED|Follow-up (After Week 24)||0
2482532|NCT00902486|6086965|P6|Safety Evaluable Participants|Follow-up (After Week 24)||27
2482533|NCT00902486|6086966|P5|Safety Evaluable Participants|Follow-up (After Week 24)||30
2482534|NCT00902486|6086967|P4|Safety Evaluable Participants|Follow-up (After Week 24)||29
2482535|NCT00902486|6086968|P3|Safety Evaluable Participants|Follow-up (After Week 24)||15
2482536|NCT00902486|6086969|P2|Safety Evaluable Participants|Follow-up (After Week 24)||14
2482537|NCT00902486|6086970|P1|Safety Evaluable Participants|Follow-up (After Week 24)||0
2482538|NCT00902486|6086965|P6|STARTED|Follow-up (After Week 24)||24
2482539|NCT00902486|6086966|P5|STARTED|Follow-up (After Week 24)||29
2482540|NCT00902486|6086967|P4|STARTED|Follow-up (After Week 24)||27
2482541|NCT00902486|6086968|P3|STARTED|Follow-up (After Week 24)||13
2482542|NCT00902486|6086969|P2|STARTED|Follow-up (After Week 24)||14
2482543|NCT00902486|6086970|P1|STARTED|Follow-up (After Week 24)||0
2482544|NCT00902486|6086965|P6|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||3
2482545|NCT00902486|6086966|P5|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||1
2482546|NCT00902486|6086967|P4|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||2
2482547|NCT00902486|6086968|P3|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||2
2482548|NCT00902486|6086969|P2|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||0
2482549|NCT00902486|6086970|P1|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||0
2482550|NCT00902486|6086965|P6|COMPLETED|Extension Period (Weeks 12 Through 24)||24
2482551|NCT00902486|6086966|P5|COMPLETED|Extension Period (Weeks 12 Through 24)||29
2482552|NCT00902486|6086967|P4|COMPLETED|Extension Period (Weeks 12 Through 24)||27
2482553|NCT00902486|6086968|P3|COMPLETED|Extension Period (Weeks 12 Through 24)||13
2482554|NCT00902486|6086969|P2|COMPLETED|Extension Period (Weeks 12 Through 24)||14
2482555|NCT00902486|6086970|P1|COMPLETED|Extension Period (Weeks 12 Through 24)||0
2482556|NCT00902486|6086965|P6|STARTED|Extension Period (Weeks 12 Through 24)||27
2482557|NCT00902486|6086966|P5|STARTED|Extension Period (Weeks 12 Through 24)||30
2482558|NCT00902486|6086967|P4|STARTED|Extension Period (Weeks 12 Through 24)||29
2482559|NCT00902486|6086968|P3|STARTED|Extension Period (Weeks 12 Through 24)||15
2482560|NCT00902486|6086969|P2|STARTED|Extension Period (Weeks 12 Through 24)||14
2482561|NCT00902486|6086970|P1|STARTED|Extension Period (Weeks 12 Through 24)||0
2482562|NCT00902486|6086965|P6|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||5
2482563|NCT00902486|6086966|P5|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||2
2482564|NCT00902486|6086967|P4|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||3
2482565|NCT00902486|6086968|P3|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||0
2482566|NCT00902486|6086969|P2|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||0
2482567|NCT00902486|6086970|P1|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||2
2482568|NCT00902486|6086965|P6|COMPLETED|Treatment Period (Weeks 0 Through 12)||27
2482569|NCT00902486|6086966|P5|COMPLETED|Treatment Period (Weeks 0 Through 12)||30
2482570|NCT00902486|6086967|P4|COMPLETED|Treatment Period (Weeks 0 Through 12)||29
2482571|NCT00902486|6086968|P3|COMPLETED|Treatment Period (Weeks 0 Through 12)||0
2482572|NCT00902486|6086969|P2|COMPLETED|Treatment Period (Weeks 0 Through 12)||0
2482573|NCT00902486|6086970|P1|COMPLETED|Treatment Period (Weeks 0 Through 12)||29
2482574|NCT00902486|6086965|P6|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||30
2482575|NCT00902486|6086966|P5|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||32
2482576|NCT00902486|6086967|P4|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||31
2482577|NCT00902486|6086968|P3|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||0
2482578|NCT00902486|6086969|P2|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||0
2482579|NCT00902486|6086970|P1|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||31
2482580|NCT00902486|6086965|P6|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
2482581|NCT00902486|6086966|P5|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||32
2482582|NCT00902486|6086967|P4|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
2482583|NCT00902486|6086968|P3|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||0
2482584|NCT00902486|6086969|P2|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||0
2482585|NCT00902486|6086970|P1|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
2482586|NCT00902486|6086965|P6|STARTED|Treatment Period (Weeks 0 Through 12)||32
2482587|NCT00902486|6086966|P5|STARTED|Treatment Period (Weeks 0 Through 12)||32
2482588|NCT00902486|6086967|P4|STARTED|Treatment Period (Weeks 0 Through 12)||32
2482589|NCT00902486|6086968|P3|STARTED|Treatment Period (Weeks 0 Through 12)||0
2482590|NCT00902486|6086969|P2|STARTED|Treatment Period (Weeks 0 Through 12)||0
2482591|NCT00902486|6086970|P1|STARTED|Treatment Period (Weeks 0 Through 12)||31
2482592|NCT00902330|6087108|P2|NOT COMPLETED|Overall Study||5
2482593|NCT00902330|6087109|P1|NOT COMPLETED|Overall Study||4
2482594|NCT00902330|6087108|P2|COMPLETED|Overall Study||75
2482595|NCT00902330|6087109|P1|COMPLETED|Overall Study||77
2482596|NCT00902330|6087108|P2|STARTED|Overall Study||80
2482597|NCT00902330|6087109|P1|STARTED|Overall Study||81
2482598|NCT00902304|6087146|P3|NOT COMPLETED|Overall Study||110
2482599|NCT00902304|6087147|P2|NOT COMPLETED|Overall Study||71
2482600|NCT00902304|6087148|P1|NOT COMPLETED|Overall Study||58
2482601|NCT00902304|6087146|P3|COMPLETED|Overall Study||568
2482602|NCT00902304|6087147|P2|COMPLETED|Overall Study||289
2482603|NCT00902304|6087148|P1|COMPLETED|Overall Study||466
2482604|NCT00902304|6087146|P3|STARTED|Overall Study||678
2482605|NCT00902304|6087147|P2|STARTED|Overall Study||360
2482606|NCT00902304|6087148|P1|STARTED|Overall Study||524
2482607|NCT00902278|6087198|P5|NOT COMPLETED|Overall Study||2
2482608|NCT00902278|6087199|P4|NOT COMPLETED|Overall Study||0
2482609|NCT00902278|6087200|P3|NOT COMPLETED|Overall Study||5
2482610|NCT00902278|6087201|P2|NOT COMPLETED|Overall Study||2
2482611|NCT00902278|6087202|P1|NOT COMPLETED|Overall Study||4
2482612|NCT00902278|6087198|P5|COMPLETED|Overall Study||35
2482613|NCT00902278|6087199|P4|COMPLETED|Overall Study||12
2482614|NCT00902278|6087200|P3|COMPLETED|Overall Study||49
2482615|NCT00902278|6087201|P2|COMPLETED|Overall Study||34
2482616|NCT00902278|6087202|P1|COMPLETED|Overall Study||50
2482617|NCT00902278|6087198|P5|STARTED|Overall Study||37
2482618|NCT00902278|6087199|P4|STARTED|Overall Study||12
2482619|NCT00902278|6087200|P3|STARTED|Overall Study||54
2482620|NCT00902278|6087201|P2|STARTED|Overall Study||36
2482621|NCT00902278|6087202|P1|STARTED|Overall Study||54
2482622|NCT00902265|6087219|P1|NOT COMPLETED|Overall Study||6
2482623|NCT00902265|6087219|P1|COMPLETED|Overall Study||132
2482624|NCT00902265|6087219|P1|Participants Who Received Treatment|Overall Study||137
2482625|NCT00902265|6087219|P1|STARTED|Overall Study||138
2482626|NCT00902226|6087231|P1|NOT COMPLETED|Overall Study||0
2482627|NCT00902226|6087231|P1|COMPLETED|Overall Study||30
2482628|NCT00902226|6087231|P1|STARTED|Overall Study||30
2482629|NCT00902174|6087243|P2|NOT COMPLETED|Overall Study||18
2482630|NCT00902174|6087244|P1|NOT COMPLETED|Overall Study||34
2482631|NCT00902174|6087243|P2|COMPLETED|Overall Study||81
2482632|NCT00902174|6087244|P1|COMPLETED|Overall Study||69
2482633|NCT00902174|6087243|P2|STARTED|Overall Study||99
2482634|NCT00902174|6087244|P1|STARTED|Overall Study||103
2482635|NCT00902161|6087282|P3|NOT COMPLETED|Period 2||0
2482636|NCT00902161|6087283|P2|NOT COMPLETED|Period 2||0
2482637|NCT00902161|6087284|P1|NOT COMPLETED|Period 2||0
2482638|NCT00902161|6087282|P3|COMPLETED|Period 2||0
2482639|NCT00902161|6087283|P2|COMPLETED|Period 2||9
2482640|NCT00902161|6087284|P1|COMPLETED|Period 2|2 participants discontinued and were replaced; 1 due to protocol deviation and 1 withdrew consent|8
2482641|NCT00902161|6087282|P3|STARTED|Period 2||0
2482642|NCT00902161|6087283|P2|STARTED|Period 2||9
2482643|NCT00902161|6087284|P1|STARTED|Period 2||8
2482644|NCT00902161|6087282|P3|NOT COMPLETED|Post-clamp Washout||0
2482645|NCT00902161|6087283|P2|NOT COMPLETED|Post-clamp Washout||0
2482646|NCT00902161|6087284|P1|NOT COMPLETED|Post-clamp Washout||0
2482647|NCT00902161|6087282|P3|COMPLETED|Post-clamp Washout|2 participants discontinued washout and were replaced; 1 due to an AE and 1 due to lack of efficacy|22
2482648|NCT00902161|6087283|P2|COMPLETED|Post-clamp Washout||0
2482649|NCT00902161|6087284|P1|COMPLETED|Post-clamp Washout||0
2482650|NCT00902161|6087282|P3|STARTED|Post-clamp Washout||22
2482651|NCT00902161|6087283|P2|STARTED|Post-clamp Washout||0
2482652|NCT00902161|6087284|P1|STARTED|Post-clamp Washout||0
2482653|NCT00902161|6087282|P3|NOT COMPLETED|Period 1||0
2482654|NCT00902161|6087283|P2|NOT COMPLETED|Period 1||0
2482655|NCT00902161|6087284|P1|NOT COMPLETED|Period 1||0
2482656|NCT00902161|6087282|P3|COMPLETED|Period 1||0
2482657|NCT00902161|6087283|P2|COMPLETED|Period 1||10
2482658|NCT00902161|6087284|P1|COMPLETED|Period 1||12
2482659|NCT00902161|6087282|P3|STARTED|Period 1||0
2482660|NCT00902161|6087283|P2|STARTED|Period 1||10
2482661|NCT00902161|6087284|P1|STARTED|Period 1||12
2482662|NCT00902161|6087282|P3|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
2482663|NCT00902161|6087283|P2|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
2482664|NCT00902161|6087284|P1|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
2482665|NCT00902161|6087282|P3|COMPLETED|Pre-study Washout/Propanolol Run-in||22
2482666|NCT00902161|6087283|P2|COMPLETED|Pre-study Washout/Propanolol Run-in||0
2482667|NCT00902161|6087284|P1|COMPLETED|Pre-study Washout/Propanolol Run-in||0
2482668|NCT00902161|6087282|P3|STARTED|Pre-study Washout/Propanolol Run-in||22
2482669|NCT00902161|6087283|P2|STARTED|Pre-study Washout/Propanolol Run-in||0
2482670|NCT00902161|6087284|P1|STARTED|Pre-study Washout/Propanolol Run-in||0
2482671|NCT00902018|6087302|P3|NOT COMPLETED|Overall Study||0
2482672|NCT00902018|6087303|P2|NOT COMPLETED|Overall Study||0
2482673|NCT00902018|6087304|P1|NOT COMPLETED|Overall Study||0
2482674|NCT00902018|6087302|P3|COMPLETED|Overall Study||10
2482675|NCT00902018|6087303|P2|COMPLETED|Overall Study||3
2482676|NCT00902018|6087304|P1|COMPLETED|Overall Study||7
2482677|NCT00902018|6087302|P3|STARTED|Overall Study||10
2482678|NCT00902018|6087303|P2|STARTED|Overall Study||3
2482679|NCT00902018|6087304|P1|STARTED|Overall Study||7
2482680|NCT00901901|6087321|P2|NOT COMPLETED|Follow-up Period||341
2482681|NCT00901901|6087322|P1|NOT COMPLETED|Follow-up Period||340
2482682|NCT00901901|6087321|P2|COMPLETED|Follow-up Period||0
2482683|NCT00901901|6087322|P1|COMPLETED|Follow-up Period||0
2482684|NCT00901901|6087321|P2|STARTED|Follow-up Period||341
2482685|NCT00901901|6087322|P1|STARTED|Follow-up Period||340
2482686|NCT00901901|6087321|P2|NOT COMPLETED|Treatment Period||177
2482687|NCT00901901|6087322|P1|NOT COMPLETED|Treatment Period||169
2482688|NCT00901901|6087321|P2|COMPLETED|Treatment Period||181
2482689|NCT00901901|6087322|P1|COMPLETED|Treatment Period||193
2482690|NCT00901901|6087321|P2|Participants Received Treatment|Treatment Period||355
2482691|NCT00901901|6087322|P1|Participants Received Treatment|Treatment Period||362
2482692|NCT00901901|6087321|P2|STARTED|Treatment Period||358
2482693|NCT00901901|6087322|P1|STARTED|Treatment Period||362
2482694|NCT00901628|6087344|P2|NOT COMPLETED|Overall Study||10
2482695|NCT00901628|6087345|P1|NOT COMPLETED|Overall Study||4
2482696|NCT00901628|6087344|P2|COMPLETED|Overall Study||42
2482697|NCT00901628|6087345|P1|COMPLETED|Overall Study||45
2482698|NCT00901628|6087344|P2|STARTED|Overall Study||52
2482699|NCT00901628|6087345|P1|STARTED|Overall Study||49
2482700|NCT00901576|6087367|P6|NOT COMPLETED|Third Intervention||0
2482701|NCT00901576|6087368|P5|NOT COMPLETED|Third Intervention||0
2482702|NCT00901576|6087369|P4|NOT COMPLETED|Third Intervention||0
2482703|NCT00901576|6087370|P3|NOT COMPLETED|Third Intervention||0
2482704|NCT00901576|6087371|P2|NOT COMPLETED|Third Intervention||0
2482705|NCT00901576|6087372|P1|NOT COMPLETED|Third Intervention||0
2482706|NCT00901576|6087367|P6|COMPLETED|Third Intervention||5
2482707|NCT00901576|6087368|P5|COMPLETED|Third Intervention||6
2482708|NCT00901576|6087369|P4|COMPLETED|Third Intervention||5
2482709|NCT00901576|6087370|P3|COMPLETED|Third Intervention||7
2482710|NCT00901576|6087371|P2|COMPLETED|Third Intervention||7
2482711|NCT00901576|6087372|P1|COMPLETED|Third Intervention||5
2482712|NCT00901576|6087367|P6|STARTED|Third Intervention||5
2482713|NCT00901576|6087368|P5|STARTED|Third Intervention||6
2482714|NCT00901576|6087369|P4|STARTED|Third Intervention||5
2482715|NCT00901576|6087370|P3|STARTED|Third Intervention||7
2482716|NCT00901576|6087371|P2|STARTED|Third Intervention||7
2482717|NCT00901576|6087372|P1|STARTED|Third Intervention||5
2482718|NCT00901576|6087367|P6|NOT COMPLETED|Washout||0
2482719|NCT00901576|6087368|P5|NOT COMPLETED|Washout||0
2482720|NCT00901576|6087369|P4|NOT COMPLETED|Washout||0
2482721|NCT00901576|6087370|P3|NOT COMPLETED|Washout||0
2482722|NCT00901576|6087371|P2|NOT COMPLETED|Washout||0
2482723|NCT00901576|6087372|P1|NOT COMPLETED|Washout||0
2482724|NCT00901576|6087367|P6|COMPLETED|Washout||5
2482725|NCT00901576|6087368|P5|COMPLETED|Washout||6
2482726|NCT00901576|6087369|P4|COMPLETED|Washout||5
2482727|NCT00901576|6087370|P3|COMPLETED|Washout||7
2482728|NCT00901576|6087371|P2|COMPLETED|Washout||7
2482729|NCT00901576|6087372|P1|COMPLETED|Washout||5
2482730|NCT00901576|6087367|P6|STARTED|Washout||5
2482731|NCT00901576|6087368|P5|STARTED|Washout||6
2482732|NCT00901576|6087369|P4|STARTED|Washout||5
2482733|NCT00901576|6087370|P3|STARTED|Washout||7
2482734|NCT00901576|6087371|P2|STARTED|Washout||7
2482735|NCT00901576|6087372|P1|STARTED|Washout||5
2482736|NCT00901576|6087367|P6|NOT COMPLETED|Second Intervention||1
2482737|NCT00901576|6087368|P5|NOT COMPLETED|Second Intervention||0
2482738|NCT00901576|6087369|P4|NOT COMPLETED|Second Intervention||1
2482739|NCT00901576|6087370|P3|NOT COMPLETED|Second Intervention||0
2482740|NCT00901576|6087371|P2|NOT COMPLETED|Second Intervention||0
2482741|NCT00901576|6087372|P1|NOT COMPLETED|Second Intervention||1
2482742|NCT00901576|6087367|P6|COMPLETED|Second Intervention||5
2482743|NCT00901576|6087368|P5|COMPLETED|Second Intervention||6
2482744|NCT00901576|6087369|P4|COMPLETED|Second Intervention||5
2482745|NCT00901576|6087370|P3|COMPLETED|Second Intervention||7
2482746|NCT00901576|6087371|P2|COMPLETED|Second Intervention||7
2482747|NCT00901576|6087372|P1|COMPLETED|Second Intervention||5
2482748|NCT00901576|6087367|P6|STARTED|Second Intervention||6
2482749|NCT00901576|6087368|P5|STARTED|Second Intervention||6
2482750|NCT00901576|6087369|P4|STARTED|Second Intervention||6
2482751|NCT00901576|6087370|P3|STARTED|Second Intervention||7
2482752|NCT00901576|6087371|P2|STARTED|Second Intervention||7
2482753|NCT00901576|6087372|P1|STARTED|Second Intervention||6
2482754|NCT00901576|6087367|P6|NOT COMPLETED|Washout||0
2482755|NCT00901576|6087368|P5|NOT COMPLETED|Washout||0
2482756|NCT00901576|6087369|P4|NOT COMPLETED|Washout||0
2482757|NCT00901576|6087370|P3|NOT COMPLETED|Washout||0
2482758|NCT00901576|6087371|P2|NOT COMPLETED|Washout||0
2482759|NCT00901576|6087372|P1|NOT COMPLETED|Washout||0
2482760|NCT00901576|6087367|P6|COMPLETED|Washout||6
2482761|NCT00901576|6087368|P5|COMPLETED|Washout||6
2482762|NCT00901576|6087369|P4|COMPLETED|Washout||6
2482763|NCT00901576|6087370|P3|COMPLETED|Washout||7
2482764|NCT00901576|6087371|P2|COMPLETED|Washout||7
2482765|NCT00901576|6087372|P1|COMPLETED|Washout||6
2482766|NCT00901576|6087367|P6|STARTED|Washout||6
2482767|NCT00901576|6087368|P5|STARTED|Washout||6
2482768|NCT00901576|6087369|P4|STARTED|Washout||6
2482769|NCT00901576|6087370|P3|STARTED|Washout||7
2482770|NCT00901576|6087371|P2|STARTED|Washout||7
2482771|NCT00901576|6087372|P1|STARTED|Washout||6
2482772|NCT00901576|6087367|P6|NOT COMPLETED|First Intervention||0
2482773|NCT00901576|6087368|P5|NOT COMPLETED|First Intervention||0
2482774|NCT00901576|6087369|P4|NOT COMPLETED|First Intervention||0
2482775|NCT00901576|6087370|P3|NOT COMPLETED|First Intervention||0
2482776|NCT00901576|6087371|P2|NOT COMPLETED|First Intervention||0
2482777|NCT00901576|6087372|P1|NOT COMPLETED|First Intervention||0
2482778|NCT00901576|6087367|P6|COMPLETED|First Intervention||6
2482779|NCT00901576|6087368|P5|COMPLETED|First Intervention||6
2482780|NCT00901576|6087369|P4|COMPLETED|First Intervention||6
2482781|NCT00901576|6087370|P3|COMPLETED|First Intervention||7
2482782|NCT00901576|6087371|P2|COMPLETED|First Intervention||7
2482783|NCT00901576|6087372|P1|COMPLETED|First Intervention||6
2482784|NCT00901576|6087367|P6|STARTED|First Intervention||6
2482785|NCT00901576|6087368|P5|STARTED|First Intervention||6
2482786|NCT00901576|6087369|P4|STARTED|First Intervention||6
2482787|NCT00901576|6087370|P3|STARTED|First Intervention||7
2482788|NCT00901576|6087371|P2|STARTED|First Intervention||7
2482789|NCT00901576|6087372|P1|STARTED|First Intervention||6
2482790|NCT00901459|6087393|P1|NOT COMPLETED|Overall Study||6
2482791|NCT00901459|6087393|P1|COMPLETED|Overall Study||15
2482792|NCT00901459|6087393|P1|STARTED|Overall Study||21
2482793|NCT00901342|6087404|P1|NOT COMPLETED|Overall Study||15
2482794|NCT00901342|6087404|P1|COMPLETED|Overall Study|89 subjects completed the study completion visit|89
2482795|NCT00901342|6087404|P1|Received at Least 1 Infusion|Overall Study||98
2482796|NCT00901342|6087404|P1|STARTED|Overall Study||104
2482797|NCT00901316|6087410|P2|NOT COMPLETED|Overall Study||0
2482798|NCT00901316|6087411|P1|NOT COMPLETED|Overall Study||0
2482799|NCT00901316|6087410|P2|COMPLETED|Overall Study||495
2482800|NCT00901316|6087411|P1|COMPLETED|Overall Study||492
2482801|NCT00901316|6087410|P2|STARTED|Overall Study||495
2482802|NCT00901316|6087411|P1|STARTED|Overall Study||492
2482803|NCT00901303|6087419|P2|NOT COMPLETED|Overall Study||0
2482804|NCT00901303|6087420|P1|NOT COMPLETED|Overall Study||0
2482805|NCT00901303|6087419|P2|COMPLETED|Overall Study||1
2482806|NCT00901303|6087420|P1|COMPLETED|Overall Study||5
2482807|NCT00901303|6087419|P2|STARTED|Overall Study||1
2482808|NCT00901303|6087420|P1|STARTED|Overall Study||5
2482809|NCT00901225|6087426|P1|NOT COMPLETED|Overall Study||1
2482810|NCT00901225|6087426|P1|COMPLETED|Overall Study||20
2482811|NCT00901225|6087426|P1|STARTED|Overall Study||21
2482812|NCT00901186|6087437|P2|NOT COMPLETED|Overall Study||11
2482813|NCT00901186|6087438|P1|NOT COMPLETED|Overall Study||9
2482814|NCT00901186|6087437|P2|COMPLETED|Overall Study||32
2482815|NCT00901186|6087438|P1|COMPLETED|Overall Study||31
2482816|NCT00901186|6087437|P2|Intent to Treat|Overall Study|Five treated participants did not have at least a baseline and one post-treatment BCVA.|38
2482817|NCT00901186|6087438|P1|Intent to Treat|Overall Study|Four treated participants did not have at least a baseline and one post-treatment BCVA.|35
2482818|NCT00901186|6087437|P2|Safety Set|Overall Study||43
2482819|NCT00901186|6087438|P1|Safety Set|Overall Study|One participant did not receive one intravitreal RFB002 injection.|39
2482820|NCT00901186|6087437|P2|STARTED|Overall Study||43
2482821|NCT00901186|6087438|P1|STARTED|Overall Study||40
2482822|NCT00901017|6087454|P1|NOT COMPLETED|Overall Study||0
2482823|NCT00901017|6087454|P1|COMPLETED|Overall Study||14
2482824|NCT00901017|6087454|P1|STARTED|Overall Study||14
2482825|NCT00900822|6087468|P1|NOT COMPLETED|12 Months Clinical Evaluation||0
2482826|NCT00900822|6087468|P1|COMPLETED|12 Months Clinical Evaluation||11
2482827|NCT00900822|6087468|P1|STARTED|12 Months Clinical Evaluation||11
2482828|NCT00900822|6087468|P1|NOT COMPLETED|9 Months Histological Evaluation||0
2482829|NCT00900822|6087468|P1|COMPLETED|9 Months Histological Evaluation||11
2482830|NCT00900822|6087468|P1|STARTED|9 Months Histological Evaluation||11
2482831|NCT00900796|6087478|P1|NOT COMPLETED|Phase 2||5
2482832|NCT00900796|6087478|P1|COMPLETED|Phase 2||6
2482833|NCT00900796|6087478|P1|STARTED|Phase 2||11
2482834|NCT00900796|6087478|P1|NOT COMPLETED|Between Phase 1 and Phase 2||110
2482835|NCT00900796|6087478|P1|COMPLETED|Between Phase 1 and Phase 2||11
2482836|NCT00900796|6087478|P1|STARTED|Between Phase 1 and Phase 2||121
2482837|NCT00900796|6087478|P1|NOT COMPLETED|Phase 1||11
2482838|NCT00900796|6087478|P1|COMPLETED|Phase 1||121
2482839|NCT00900796|6087478|P1|STARTED|Phase 1||132
2482840|NCT00900757|6087488|P1|NOT COMPLETED|Overall Study||19
2482841|NCT00900757|6087488|P1|COMPLETED|Overall Study||38
2482842|NCT00900757|6087488|P1|STARTED|Overall Study||57
2482843|NCT00900731|6087498|P2|NOT COMPLETED|Overall Study||61
2482844|NCT00900731|6087499|P1|NOT COMPLETED|Overall Study||60
2482845|NCT00900731|6087498|P2|COMPLETED|Overall Study||740
2482846|NCT00900731|6087499|P1|COMPLETED|Overall Study||737
2482847|NCT00900731|6087498|P2|Safety Set: Received Study Drug|Overall Study||799
2482848|NCT00900731|6087499|P1|Safety Set: Received Study Drug|Overall Study||794
2482849|NCT00900731|6087498|P2|STARTED|Overall Study||801
2482850|NCT00900731|6087499|P1|STARTED|Overall Study|Randomized participants|797
2482851|NCT00900666|6087521|P2|NOT COMPLETED|Overall Study||0
2482852|NCT00900666|6087522|P1|NOT COMPLETED|Overall Study||0
2482853|NCT00900666|6087521|P2|COMPLETED|Overall Study||9
2482854|NCT00900666|6087522|P1|COMPLETED|Overall Study||10
2482855|NCT00900666|6087521|P2|STARTED|Overall Study||9
2482856|NCT00900666|6087522|P1|STARTED|Overall Study||10
2482857|NCT00900627|6087536|P6|NOT COMPLETED|Overall Study||26
2482858|NCT00900627|6087537|P5|NOT COMPLETED|Overall Study||29
2482859|NCT00900627|6087538|P4|NOT COMPLETED|Overall Study||6
2482860|NCT00900627|6087539|P3|NOT COMPLETED|Overall Study||6
2482861|NCT00900627|6087540|P2|NOT COMPLETED|Overall Study||2
2482862|NCT00900627|6087541|P1|NOT COMPLETED|Overall Study||6
2482863|NCT00900627|6087536|P6|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|70
2482864|NCT00900627|6087537|P5|COMPLETED|Overall Study|No set completion, pts were to remain in study until withdrawn|65
2482865|NCT00900627|6087538|P4|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
2482866|NCT00900627|6087539|P3|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
2482867|NCT00900627|6087540|P2|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
2482868|NCT00900627|6087541|P1|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
2482869|NCT00900627|6087536|P6|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|96
2482870|NCT00900627|6087537|P5|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|94
2482871|NCT00900627|6087538|P4|STARTED|Overall Study||6
2482872|NCT00900627|6087539|P3|STARTED|Overall Study||6
2482873|NCT00900627|6087540|P2|STARTED|Overall Study||2
2482874|NCT00900627|6087541|P1|STARTED|Overall Study||6
2482875|NCT00900601|6087559|P1|NOT COMPLETED|Overall Study||1
2482876|NCT00900601|6087559|P1|COMPLETED|Overall Study||8
2482877|NCT00900601|6087559|P1|STARTED|Overall Study||9
2482878|NCT00900237|6087567|P2|NOT COMPLETED|Overall Study||0
2482879|NCT00900237|6087568|P1|NOT COMPLETED|Overall Study||0
2482880|NCT00900237|6087567|P2|COMPLETED|Overall Study||7
2482881|NCT00900237|6087568|P1|COMPLETED|Overall Study||7
2482882|NCT00900237|6087567|P2|STARTED|Overall Study||7
2482883|NCT00900237|6087568|P1|STARTED|Overall Study||7
2482884|NCT00900159|6087578|P2|NOT COMPLETED|Second Intervention||0
2482885|NCT00900159|6087579|P1|NOT COMPLETED|Second Intervention||1
2482886|NCT00900159|6087578|P2|COMPLETED|Second Intervention||13
2482887|NCT00900159|6087579|P1|COMPLETED|Second Intervention||10
2482888|NCT00900159|6087578|P2|STARTED|Second Intervention||13
2482889|NCT00900159|6087579|P1|STARTED|Second Intervention||11
2482890|NCT00900159|6087578|P2|NOT COMPLETED|Washout||0
2482891|NCT00900159|6087579|P1|NOT COMPLETED|Washout||0
2482892|NCT00900159|6087578|P2|COMPLETED|Washout||13
2482893|NCT00900159|6087579|P1|COMPLETED|Washout||11
2482894|NCT00900159|6087578|P2|STARTED|Washout||13
2482895|NCT00900159|6087579|P1|STARTED|Washout||11
2482896|NCT00900159|6087578|P2|NOT COMPLETED|First Intervention||0
2482897|NCT00900159|6087579|P1|NOT COMPLETED|First Intervention||0
2482898|NCT00900159|6087578|P2|COMPLETED|First Intervention||13
2482899|NCT00900159|6087579|P1|COMPLETED|First Intervention||11
2482900|NCT00900159|6087578|P2|STARTED|First Intervention||13
2482901|NCT00900159|6087579|P1|STARTED|First Intervention||11
2482902|NCT00900146|6087598|P5|NOT COMPLETED|Intermediate: Period III||167
2482903|NCT00900146|6087599|P4|NOT COMPLETED|Intermediate: Period III||90
2482904|NCT00900146|6087600|P3|NOT COMPLETED|Intermediate: Period III||84
2482905|NCT00900146|6087601|P2|NOT COMPLETED|Intermediate: Period III||93
2482906|NCT00900146|6087602|P1|NOT COMPLETED|Intermediate: Period III||87
2482907|NCT00900146|6087598|P5|COMPLETED|Intermediate: Period III||0
2482908|NCT00900146|6087599|P4|COMPLETED|Intermediate: Period III||0
2482909|NCT00900146|6087600|P3|COMPLETED|Intermediate: Period III||0
2482910|NCT00900146|6087601|P2|COMPLETED|Intermediate: Period III||0
2482911|NCT00900146|6087602|P1|COMPLETED|Intermediate: Period III||0
2482912|NCT00900146|6087598|P5|Safety Set|Intermediate: Period III||166
2482913|NCT00900146|6087599|P4|Safety Set|Intermediate: Period III||90
2482914|NCT00900146|6087600|P3|Safety Set|Intermediate: Period III||84
2482915|NCT00900146|6087601|P2|Safety Set|Intermediate: Period III||92
2482916|NCT00900146|6087602|P1|Safety Set|Intermediate: Period III||86
2482917|NCT00900146|6087598|P5|STARTED|Intermediate: Period III||167
2482918|NCT00900146|6087599|P4|STARTED|Intermediate: Period III||90
2482919|NCT00900146|6087600|P3|STARTED|Intermediate: Period III||84
2482920|NCT00900146|6087601|P2|STARTED|Intermediate: Period III||93
2482921|NCT00900146|6087602|P1|STARTED|Intermediate: Period III||87
2482922|NCT00900146|6087598|P5|NOT COMPLETED|Dose Finding: Period II (4 Months)||12
2482923|NCT00900146|6087599|P4|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
2482924|NCT00900146|6087600|P3|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
2482925|NCT00900146|6087601|P2|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
2482926|NCT00900146|6087602|P1|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
2482927|NCT00900146|6087598|P5|COMPLETED|Dose Finding: Period II (4 Months)|Placebo also included 1 patient with no study completion page.|167
2482928|NCT00900146|6087599|P4|COMPLETED|Dose Finding: Period II (4 Months)||90
2482929|NCT00900146|6087600|P3|COMPLETED|Dose Finding: Period II (4 Months)||87
2482930|NCT00900146|6087601|P2|COMPLETED|Dose Finding: Period II (4 Months)||93
2482931|NCT00900146|6087602|P1|COMPLETED|Dose Finding: Period II (4 Months)||88
2482932|NCT00900146|6087598|P5|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||179
2482933|NCT00900146|6087599|P4|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
2482934|NCT00900146|6087600|P3|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
2482935|NCT00900146|6087601|P2|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||95
2482936|NCT00900146|6087602|P1|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||93
2482937|NCT00900146|6087598|P5|STARTED|Dose Finding: Period II (4 Months)||179
2482938|NCT00900146|6087599|P4|STARTED|Dose Finding: Period II (4 Months)||92
2482939|NCT00900146|6087600|P3|STARTED|Dose Finding: Period II (4 Months)||92
2482940|NCT00900146|6087601|P2|STARTED|Dose Finding: Period II (4 Months)||95
2482941|NCT00900146|6087602|P1|STARTED|Dose Finding: Period II (4 Months)||93
2482942|NCT00900029|6087719|P5|NOT COMPLETED|Overall Study||6
2482943|NCT00900029|6087720|P4|NOT COMPLETED|Overall Study||7
2482944|NCT00900029|6087721|P3|NOT COMPLETED|Overall Study||3
2482945|NCT00900029|6087722|P2|NOT COMPLETED|Overall Study||4
2482946|NCT00900029|6087723|P1|NOT COMPLETED|Overall Study||3
2482947|NCT00900029|6087719|P5|COMPLETED|Overall Study||38
2482948|NCT00900029|6087720|P4|COMPLETED|Overall Study||35
2482949|NCT00900029|6087721|P3|COMPLETED|Overall Study||38
2482950|NCT00900029|6087722|P2|COMPLETED|Overall Study||37
2482951|NCT00900029|6087723|P1|COMPLETED|Overall Study||35
2482952|NCT00900029|6087719|P5|STARTED|Overall Study||44
2482953|NCT00900029|6087720|P4|STARTED|Overall Study||42
2482954|NCT00900029|6087721|P3|STARTED|Overall Study||41
2482955|NCT00900029|6087722|P2|STARTED|Overall Study||41
2482956|NCT00900029|6087723|P1|STARTED|Overall Study||38
2482957|NCT00899847|6087740|P1|NOT COMPLETED|Overall Study||2
2482958|NCT00899847|6087740|P1|COMPLETED|Overall Study||7
2482959|NCT00899847|6087740|P1|STARTED|Overall Study||9
2482960|NCT00899717|6087753|P2|NOT COMPLETED|Overall Study||0
2482961|NCT00899717|6087754|P1|NOT COMPLETED|Overall Study||0
2482962|NCT00899717|6087753|P2|COMPLETED|Overall Study||11
2482963|NCT00899717|6087754|P1|COMPLETED|Overall Study||10
2482964|NCT00899717|6087753|P2|STARTED|Overall Study||11
2482965|NCT00899717|6087754|P1|STARTED|Overall Study||10
2482966|NCT00899678|6087771|P3|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||28
2482967|NCT00899678|6087772|P2|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||25
2482968|NCT00899678|6087773|P1|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||0
2482969|NCT00899678|6087771|P3|COMPLETED|Maintenance Period (Weeks 8 to 62)||7
2482970|NCT00899678|6087772|P2|COMPLETED|Maintenance Period (Weeks 8 to 62)||12
2482971|NCT00899678|6087773|P1|COMPLETED|Maintenance Period (Weeks 8 to 62)||0
2482972|NCT00899678|6087771|P3|STARTED|Maintenance Period (Weeks 8 to 62)||35
2482973|NCT00899678|6087772|P2|STARTED|Maintenance Period (Weeks 8 to 62)||37
2482974|NCT00899678|6087773|P1|STARTED|Maintenance Period (Weeks 8 to 62)|Induction only includes subjects that discontinued before Maintenance Period.|0
2482975|NCT00899678|6087771|P3|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
2482976|NCT00899678|6087772|P2|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
2482977|NCT00899678|6087773|P1|NOT COMPLETED|Induction Period (Weeks 0 to 6)||25
2482978|NCT00899678|6087771|P3|COMPLETED|Induction Period (Weeks 0 to 6)||35
2482979|NCT00899678|6087772|P2|COMPLETED|Induction Period (Weeks 0 to 6)||37
2482980|NCT00899678|6087773|P1|COMPLETED|Induction Period (Weeks 0 to 6)|2 subjects completed the Induction Phase, but discontinued prior to receiving any Maintenance doses.|2
2482981|NCT00899678|6087771|P3|STARTED|Induction Period (Weeks 0 to 6)||35
2482982|NCT00899678|6087772|P2|STARTED|Induction Period (Weeks 0 to 6)||37
2482983|NCT00899678|6087773|P1|STARTED|Induction Period (Weeks 0 to 6)|Induction only includes subjects that discontinued before Maintenance Period.|27
2482984|NCT00899600|6087803|P2|NOT COMPLETED|Overall Study||0
2482985|NCT00899600|6087804|P1|NOT COMPLETED|Overall Study||0
2482986|NCT00899600|6087803|P2|COMPLETED|Overall Study||52
2482987|NCT00899600|6087804|P1|COMPLETED|Overall Study||50
2482988|NCT00899600|6087803|P2|STARTED|Overall Study||52
2482989|NCT00899600|6087804|P1|STARTED|Overall Study||50
2482990|NCT00899574|6087818|P1|NOT COMPLETED|Overall Study||0
2482991|NCT00899574|6087818|P1|COMPLETED|Overall Study||10
2482992|NCT00899574|6087818|P1|STARTED|Overall Study||10
2482993|NCT00899548|6087823|P1|NOT COMPLETED|Overall Study||3
2482994|NCT00899548|6087823|P1|COMPLETED|Overall Study||179
2482995|NCT00899548|6087823|P1|STARTED|Overall Study||182
2482996|NCT00899470|6087835|P4|NOT COMPLETED|Fourth Therapy||0
2482997|NCT00899470|6087836|P3|NOT COMPLETED|Fourth Therapy||0
2482998|NCT00899470|6087837|P2|NOT COMPLETED|Fourth Therapy||0
2482999|NCT00899470|6087838|P1|NOT COMPLETED|Fourth Therapy||0
2483000|NCT00899470|6087835|P4|COMPLETED|Fourth Therapy||6
2483001|NCT00899470|6087836|P3|COMPLETED|Fourth Therapy||6
2483002|NCT00899470|6087837|P2|COMPLETED|Fourth Therapy||6
2483003|NCT00899470|6087838|P1|COMPLETED|Fourth Therapy||6
2483004|NCT00899470|6087835|P4|STARTED|Fourth Therapy||6
2483005|NCT00899470|6087836|P3|STARTED|Fourth Therapy||6
2483006|NCT00899470|6087837|P2|STARTED|Fourth Therapy||6
2483007|NCT00899470|6087838|P1|STARTED|Fourth Therapy||6
2483008|NCT00899470|6087835|P4|NOT COMPLETED|Third Washout||0
2483009|NCT00899470|6087836|P3|NOT COMPLETED|Third Washout||0
2483010|NCT00899470|6087837|P2|NOT COMPLETED|Third Washout||0
2483011|NCT00899470|6087838|P1|NOT COMPLETED|Third Washout||0
2483012|NCT00899470|6087835|P4|COMPLETED|Third Washout||6
2483013|NCT00899470|6087836|P3|COMPLETED|Third Washout||6
2483014|NCT00899470|6087837|P2|COMPLETED|Third Washout||6
2483015|NCT00899470|6087838|P1|COMPLETED|Third Washout||6
2483016|NCT00899470|6087835|P4|STARTED|Third Washout||6
2483017|NCT00899470|6087836|P3|STARTED|Third Washout||6
2483018|NCT00899470|6087837|P2|STARTED|Third Washout||6
2483019|NCT00899470|6087838|P1|STARTED|Third Washout||6
2483020|NCT00899470|6087835|P4|NOT COMPLETED|Third Therapy||0
2483021|NCT00899470|6087836|P3|NOT COMPLETED|Third Therapy||0
2483022|NCT00899470|6087837|P2|NOT COMPLETED|Third Therapy||0
2483023|NCT00899470|6087838|P1|NOT COMPLETED|Third Therapy||0
2483024|NCT00899470|6087835|P4|COMPLETED|Third Therapy||6
2483025|NCT00899470|6087836|P3|COMPLETED|Third Therapy||6
2483026|NCT00899470|6087837|P2|COMPLETED|Third Therapy||6
2483027|NCT00899470|6087838|P1|COMPLETED|Third Therapy||6
2483028|NCT00899470|6087835|P4|STARTED|Third Therapy||6
2483029|NCT00899470|6087836|P3|STARTED|Third Therapy||6
2483030|NCT00899470|6087837|P2|STARTED|Third Therapy||6
2483031|NCT00899470|6087838|P1|STARTED|Third Therapy||6
2483032|NCT00899470|6087835|P4|NOT COMPLETED|Second Washout||0
2483033|NCT00899470|6087836|P3|NOT COMPLETED|Second Washout||0
2483034|NCT00899470|6087837|P2|NOT COMPLETED|Second Washout||0
2483035|NCT00899470|6087838|P1|NOT COMPLETED|Second Washout||0
2483036|NCT00899470|6087835|P4|COMPLETED|Second Washout||6
2483037|NCT00899470|6087836|P3|COMPLETED|Second Washout||6
2483038|NCT00899470|6087837|P2|COMPLETED|Second Washout||6
2483039|NCT00899470|6087838|P1|COMPLETED|Second Washout||6
2483040|NCT00899470|6087835|P4|STARTED|Second Washout||6
2483041|NCT00899470|6087836|P3|STARTED|Second Washout||6
2483042|NCT00899470|6087837|P2|STARTED|Second Washout||6
2483043|NCT00899470|6087838|P1|STARTED|Second Washout||6
2483044|NCT00899470|6087835|P4|NOT COMPLETED|Second Therapy||0
2483045|NCT00899470|6087836|P3|NOT COMPLETED|Second Therapy||0
2483046|NCT00899470|6087837|P2|NOT COMPLETED|Second Therapy||0
2483047|NCT00899470|6087838|P1|NOT COMPLETED|Second Therapy||0
2483048|NCT00899470|6087835|P4|COMPLETED|Second Therapy||6
2483049|NCT00899470|6087836|P3|COMPLETED|Second Therapy||6
2483050|NCT00899470|6087837|P2|COMPLETED|Second Therapy||6
2483051|NCT00899470|6087838|P1|COMPLETED|Second Therapy||6
2483052|NCT00899470|6087835|P4|STARTED|Second Therapy||6
2483053|NCT00899470|6087836|P3|STARTED|Second Therapy||6
2483054|NCT00899470|6087837|P2|STARTED|Second Therapy||6
2483055|NCT00899470|6087838|P1|STARTED|Second Therapy||6
2483056|NCT00899470|6087835|P4|NOT COMPLETED|First Washout Period||0
2483057|NCT00899470|6087836|P3|NOT COMPLETED|First Washout Period||0
2483058|NCT00899470|6087837|P2|NOT COMPLETED|First Washout Period||0
2483059|NCT00899470|6087838|P1|NOT COMPLETED|First Washout Period||0
2483060|NCT00899470|6087835|P4|COMPLETED|First Washout Period||6
2483061|NCT00899470|6087836|P3|COMPLETED|First Washout Period||6
2483062|NCT00899470|6087837|P2|COMPLETED|First Washout Period||6
2483063|NCT00899470|6087838|P1|COMPLETED|First Washout Period||6
2483064|NCT00899470|6087835|P4|STARTED|First Washout Period||6
2483065|NCT00899470|6087836|P3|STARTED|First Washout Period||6
2483066|NCT00899470|6087837|P2|STARTED|First Washout Period||6
2483067|NCT00899470|6087838|P1|STARTED|First Washout Period||6
2483068|NCT00899470|6087835|P4|NOT COMPLETED|First Therapy||0
2483069|NCT00899470|6087836|P3|NOT COMPLETED|First Therapy||0
2483070|NCT00899470|6087837|P2|NOT COMPLETED|First Therapy||0
2483071|NCT00899470|6087838|P1|NOT COMPLETED|First Therapy||0
2483072|NCT00899470|6087835|P4|COMPLETED|First Therapy||6
2483073|NCT00899470|6087836|P3|COMPLETED|First Therapy||6
2483074|NCT00899470|6087837|P2|COMPLETED|First Therapy||6
2483075|NCT00899470|6087838|P1|COMPLETED|First Therapy||6
2483076|NCT00899470|6087835|P4|STARTED|First Therapy||6
2483077|NCT00899470|6087836|P3|STARTED|First Therapy||6
2483078|NCT00899470|6087837|P2|STARTED|First Therapy||6
2483079|NCT00899470|6087838|P1|STARTED|First Therapy||6
2483080|NCT00899431|6087917|P3|NOT COMPLETED|Overall Study||0
2483081|NCT00899431|6087918|P2|NOT COMPLETED|Overall Study||0
2483082|NCT00899431|6087919|P1|NOT COMPLETED|Overall Study||1
2483083|NCT00899431|6087917|P3|COMPLETED|Overall Study||9
2483084|NCT00899431|6087918|P2|COMPLETED|Overall Study||8
2483085|NCT00899431|6087919|P1|COMPLETED|Overall Study||21
2483086|NCT00899431|6087917|P3|STARTED|Overall Study||9
2483087|NCT00899431|6087918|P2|STARTED|Overall Study||8
2483088|NCT00899431|6087919|P1|STARTED|Overall Study||22
2483089|NCT00899392|6087932|P2|NOT COMPLETED|Overall Study||24
2483090|NCT00899392|6087933|P1|NOT COMPLETED|Overall Study||21
2483091|NCT00899392|6087932|P2|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|50
2483092|NCT00899392|6087933|P1|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|47
2483093|NCT00899392|6087932|P2|STARTED|Overall Study||74
2483094|NCT00899392|6087933|P1|STARTED|Overall Study||68
2483095|NCT00899379|6087950|P5|NOT COMPLETED|Overall Study||31
2483096|NCT00899379|6087951|P4|NOT COMPLETED|Overall Study||37
2483097|NCT00899379|6087952|P3|NOT COMPLETED|Overall Study||29
2483098|NCT00899379|6087953|P2|NOT COMPLETED|Overall Study||29
2483099|NCT00899379|6087954|P1|NOT COMPLETED|Overall Study||34
2483100|NCT00899379|6087950|P5|COMPLETED|Overall Study|Patients who took study drug and completed the study|63
2483101|NCT00899379|6087951|P4|COMPLETED|Overall Study|Patients who took study drug and completed the study|57
2483102|NCT00899379|6087952|P3|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
2483103|NCT00899379|6087953|P2|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
2483104|NCT00899379|6087954|P1|COMPLETED|Overall Study|Patients who took study drug and completed the study|61
2483105|NCT00899379|6087950|P5|Patients Not Treated|Overall Study|Patients who did not take study drug|13
2483106|NCT00899379|6087951|P4|Patients Not Treated|Overall Study|Patients who did not take study drug|17
2483107|NCT00899379|6087952|P3|Patients Not Treated|Overall Study|Patients who did not take study drug|11
2483108|NCT00899379|6087953|P2|Patients Not Treated|Overall Study|Patients who did not take study drug|13
2483109|NCT00899379|6087954|P1|Patients Not Treated|Overall Study|Patients who did not take study drug|12
2483110|NCT00899379|6087950|P5|Patients Treated|Overall Study|Patients who took study drug|81
2483111|NCT00899379|6087951|P4|Patients Treated|Overall Study|Patients who took study drug|77
2483112|NCT00899379|6087952|P3|Patients Treated|Overall Study|Patients who took study drug|84
2483113|NCT00899379|6087953|P2|Patients Treated|Overall Study|Patients who took study drug|82
2483114|NCT00899379|6087954|P1|Patients Treated|Overall Study|Patients who took study drug|83
2483115|NCT00899379|6087950|P5|STARTED|Overall Study|Patients who were allocated study drug|94
2483116|NCT00899379|6087951|P4|STARTED|Overall Study|Patients who were allocated study drug|94
2483117|NCT00899379|6087952|P3|STARTED|Overall Study|Patients who were allocated study drug|95
2483118|NCT00899379|6087953|P2|STARTED|Overall Study|Patients who were allocated study drug|95
2483119|NCT00899379|6087954|P1|STARTED|Overall Study|Patients who were allocated study drug|95
2483120|NCT00899353|6087966|P1|NOT COMPLETED|Overall Study||5
2483121|NCT00899353|6087966|P1|COMPLETED|Overall Study||11
2483122|NCT00899353|6087966|P1|STARTED|Overall Study||16
2483123|NCT00898937|6087990|P3|NOT COMPLETED|Overall Study||0
2483124|NCT00898937|6087991|P2|NOT COMPLETED|Overall Study||0
2483125|NCT00898937|6087992|P1|NOT COMPLETED|Overall Study||0
2483126|NCT00898937|6087990|P3|COMPLETED|Overall Study||9
2483127|NCT00898937|6087991|P2|COMPLETED|Overall Study||21
2483128|NCT00898937|6087992|P1|COMPLETED|Overall Study||25
2483129|NCT00898937|6087990|P3|STARTED|Overall Study||9
2483130|NCT00898937|6087991|P2|STARTED|Overall Study||21
2483131|NCT00898937|6087992|P1|STARTED|Overall Study||25
2483132|NCT00898807|6088002|P2|NOT COMPLETED|Overall Study||9
2483133|NCT00898807|6088003|P1|NOT COMPLETED|Overall Study||8
2483134|NCT00898807|6088002|P2|COMPLETED|Overall Study||83
2483135|NCT00898807|6088003|P1|COMPLETED|Overall Study||86
2483136|NCT00898807|6088002|P2|STARTED|Overall Study||92
2483137|NCT00898807|6088003|P1|STARTED|Overall Study||94
2483138|NCT00898677|6088019|P4|NOT COMPLETED|Overall Study||19
2483139|NCT00898677|6088020|P3|NOT COMPLETED|Overall Study||72
2483140|NCT00898677|6088021|P2|NOT COMPLETED|Overall Study||69
2483141|NCT00898677|6088022|P1|NOT COMPLETED|Overall Study||17
2483142|NCT00898677|6088019|P4|COMPLETED|Overall Study||159
2483143|NCT00898677|6088020|P3|COMPLETED|Overall Study||383
2483144|NCT00898677|6088021|P2|COMPLETED|Overall Study||386
2483145|NCT00898677|6088022|P1|COMPLETED|Overall Study||163
2483146|NCT00898677|6088019|P4|Patients Treated|Overall Study|Patients Not Treated: 18|160
2483147|NCT00898677|6088020|P3|Patients Treated|Overall Study|Patients Not Treated: 67|388
2483148|NCT00898677|6088021|P2|Patients Treated|Overall Study|Patients Not Treated: 68|387
2483149|NCT00898677|6088022|P1|Patients Treated|Overall Study|Patients Not Treated: 16|164
2483150|NCT00898677|6088019|P4|STARTED|Overall Study||178
2483151|NCT00898677|6088020|P3|STARTED|Overall Study||455
2483152|NCT00898677|6088021|P2|STARTED|Overall Study||455
2483153|NCT00898677|6088022|P1|STARTED|Overall Study||180
2483154|NCT00898560|6088048|P1|NOT COMPLETED|Overall Study||1
2483155|NCT00898560|6088048|P1|COMPLETED|Overall Study||19
2483156|NCT00898560|6088048|P1|STARTED|Overall Study||20
2483157|NCT00898443|6088060|P2|NOT COMPLETED|Overall Study||0
2483158|NCT00898443|6088061|P1|NOT COMPLETED|Overall Study||1
2483159|NCT00898443|6088060|P2|COMPLETED|Overall Study||8
2483160|NCT00898443|6088061|P1|COMPLETED|Overall Study||9
2483161|NCT00898443|6088060|P2|STARTED|Overall Study||8
2483162|NCT00898443|6088061|P1|STARTED|Overall Study||10
2483163|NCT00898222|6088069|P1|NOT COMPLETED|Overall Study||0
2483164|NCT00898222|6088069|P1|COMPLETED|Overall Study||4
2483165|NCT00898222|6088069|P1|STARTED|Overall Study||4
2483166|NCT00897949|6088076|P3|NOT COMPLETED|Overall Study||69
2483167|NCT00897949|6088077|P2|NOT COMPLETED|Overall Study||103
2483168|NCT00897949|6088078|P1|NOT COMPLETED|Overall Study||104
2483169|NCT00897949|6088076|P3|COMPLETED|Overall Study|Patients who took study drug and completed the study|301
2483170|NCT00897949|6088077|P2|COMPLETED|Overall Study|Patients who took study drug and completed the study|446
2483171|NCT00897949|6088078|P1|COMPLETED|Overall Study|Patients who took study drug and completed the study|450
2483172|NCT00897949|6088076|P3|Patients Treated|Overall Study|Patients who took study drug|304
2483173|NCT00897949|6088077|P2|Patients Treated|Overall Study|Patients who took study drug|456
2483174|NCT00897949|6088078|P1|Patients Treated|Overall Study|Patients who took study drug|458
2483175|NCT00897949|6088076|P3|STARTED|Overall Study|Patients who were allocated study drug|370
2483176|NCT00897949|6088077|P2|STARTED|Overall Study|Patients who were allocated study drug|549
2483177|NCT00897949|6088078|P1|STARTED|Overall Study|Patients who were allocated study drug|554
2483178|NCT00897910|6088101|P1|NOT COMPLETED|Overall Study||0
2483258|NCT00896532|6088284|P17|COMPLETED|Months 48-72: Follow-on Phase||0
2483179|NCT00897910|6088101|P1|COMPLETED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected|6
2483180|NCT00897910|6088101|P1|STARTED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected.|6
2483181|NCT00897897|6088105|P1|NOT COMPLETED|Overall Study||0
2483182|NCT00897897|6088105|P1|COMPLETED|Overall Study||33
2483183|NCT00897897|6088105|P1|STARTED|Overall Study||33
2483184|NCT00897715|6088112|P2|NOT COMPLETED|Overall Study||1
2483185|NCT00897715|6088113|P1|NOT COMPLETED|Overall Study||2
2483186|NCT00897715|6088112|P2|COMPLETED|Overall Study||6
2483187|NCT00897715|6088113|P1|COMPLETED|Overall Study||6
2483188|NCT00897715|6088112|P2|STARTED|Overall Study||7
2483189|NCT00897715|6088113|P1|STARTED|Overall Study||8
2483190|NCT00897676|6088121|P2|NOT COMPLETED|Intervention 2(6 Hours)||0
2483191|NCT00897676|6088122|P1|NOT COMPLETED|Intervention 2(6 Hours)||0
2483192|NCT00897676|6088121|P2|COMPLETED|Intervention 2(6 Hours)||7
2483193|NCT00897676|6088122|P1|COMPLETED|Intervention 2(6 Hours)||9
2483194|NCT00897676|6088121|P2|STARTED|Intervention 2(6 Hours)||7
2483195|NCT00897676|6088122|P1|STARTED|Intervention 2(6 Hours)||9
2483196|NCT00897676|6088121|P2|NOT COMPLETED|Intervention 1(6 Hours)||0
2483197|NCT00897676|6088122|P1|NOT COMPLETED|Intervention 1(6 Hours)||0
2483198|NCT00897676|6088121|P2|COMPLETED|Intervention 1(6 Hours)||7
2483199|NCT00897676|6088122|P1|COMPLETED|Intervention 1(6 Hours)||9
2483200|NCT00897676|6088121|P2|STARTED|Intervention 1(6 Hours)||7
2483201|NCT00897676|6088122|P1|STARTED|Intervention 1(6 Hours)||9
2483202|NCT00897390|6088138|P1|NOT COMPLETED|Overall Study||6
2483203|NCT00897390|6088138|P1|COMPLETED|Overall Study||18
2483204|NCT00897390|6088138|P1|STARTED|Overall Study||24
2483205|NCT00897104|6088228|P3|NOT COMPLETED|Overall Study||8
2483206|NCT00897104|6088229|P2|NOT COMPLETED|Overall Study||71
2483207|NCT00897104|6088230|P1|NOT COMPLETED|Overall Study||64
2483208|NCT00897104|6088228|P3|COMPLETED|Overall Study|Participants who took study drug and completed the study|79
2483209|NCT00897104|6088229|P2|COMPLETED|Overall Study|Participants who took study drug and completed the study|357
2483210|NCT00897104|6088230|P1|COMPLETED|Overall Study|Participants who took study drug and completed the study|354
2483211|NCT00897104|6088228|P3|Participants Not Treated|Overall Study|Participants who did not take study drug|7
2483212|NCT00897104|6088229|P2|Participants Not Treated|Overall Study|Participants who did not take study drug|71
2483213|NCT00897104|6088230|P1|Participants Not Treated|Overall Study|Participants who did not take study drug|63
2483214|NCT00897104|6088228|P3|Participants Treated|Overall Study|Participants who took study drug|80
2483215|NCT00897104|6088229|P2|Participants Treated|Overall Study|Participants who took study drug|357
2483216|NCT00897104|6088230|P1|Participants Treated|Overall Study|Participants who took study drug|355
2483217|NCT00897104|6088228|P3|STARTED|Overall Study|Participants who were allocated study drug|87
2483218|NCT00897104|6088229|P2|STARTED|Overall Study|Participants who were allocated study drug|428
2483219|NCT00897104|6088230|P1|STARTED|Overall Study|Participants who were allocated study drug|418
2483220|NCT00896779|6088258|P2|NOT COMPLETED|Overall Study||1
2483221|NCT00896779|6088259|P1|NOT COMPLETED|Overall Study||0
2483222|NCT00896779|6088258|P2|COMPLETED|Overall Study||11
2483223|NCT00896779|6088259|P1|COMPLETED|Overall Study||8
2483224|NCT00896779|6088258|P2|STARTED|Overall Study||12
2483225|NCT00896779|6088259|P1|STARTED|Overall Study||8
2483226|NCT00896649|6088265|P1|NOT COMPLETED|Overall Study||5
2483227|NCT00896649|6088265|P1|COMPLETED|Overall Study||188
2483228|NCT00896649|6088265|P1|STARTED|Overall Study||193
2483229|NCT00896532|6088278|P23|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2483230|NCT00896532|6088279|P22|NOT COMPLETED|Months 48-72: Follow-on Phase||2
2483231|NCT00896532|6088280|P21|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2483232|NCT00896532|6088281|P20|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2483233|NCT00896532|6088282|P19|NOT COMPLETED|Months 48-72: Follow-on Phase||1
2483234|NCT00896532|6088283|P18|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2483235|NCT00896532|6088284|P17|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2483236|NCT00896532|6088285|P16|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2483237|NCT00896532|6088286|P15|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2483238|NCT00896532|6088287|P14|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2483239|NCT00896532|6088288|P13|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2483240|NCT00896532|6088289|P12|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2483241|NCT00896532|6088290|P11|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2483242|NCT00896532|6088291|P10|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2483243|NCT00896532|6088292|P9|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2483244|NCT00896532|6088293|P8|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2483245|NCT00896532|6088294|P7|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2483246|NCT00896532|6088295|P6|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2483247|NCT00896532|6088296|P5|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2483248|NCT00896532|6088297|P4|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2483249|NCT00896532|6088298|P3|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2483250|NCT00896532|6088299|P2|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2483251|NCT00896532|6088300|P1|NOT COMPLETED|Months 48-72: Follow-on Phase||0
2483252|NCT00896532|6088278|P23|COMPLETED|Months 48-72: Follow-on Phase||8
2483253|NCT00896532|6088279|P22|COMPLETED|Months 48-72: Follow-on Phase||57
2483254|NCT00896532|6088280|P21|COMPLETED|Months 48-72: Follow-on Phase||12
2483255|NCT00896532|6088281|P20|COMPLETED|Months 48-72: Follow-on Phase||11
2483256|NCT00896532|6088282|P19|COMPLETED|Months 48-72: Follow-on Phase||50
2483257|NCT00896532|6088283|P18|COMPLETED|Months 48-72: Follow-on Phase||0
2483259|NCT00896532|6088285|P16|COMPLETED|Months 48-72: Follow-on Phase||0
2483260|NCT00896532|6088286|P15|COMPLETED|Months 48-72: Follow-on Phase||0
2483261|NCT00896532|6088287|P14|COMPLETED|Months 48-72: Follow-on Phase||0
2483262|NCT00896532|6088288|P13|COMPLETED|Months 48-72: Follow-on Phase||0
2483263|NCT00896532|6088289|P12|COMPLETED|Months 48-72: Follow-on Phase||0
2483264|NCT00896532|6088290|P11|COMPLETED|Months 48-72: Follow-on Phase||0
2483265|NCT00896532|6088291|P10|COMPLETED|Months 48-72: Follow-on Phase||0
2483266|NCT00896532|6088292|P9|COMPLETED|Months 48-72: Follow-on Phase||0
2483267|NCT00896532|6088293|P8|COMPLETED|Months 48-72: Follow-on Phase||0
2483268|NCT00896532|6088294|P7|COMPLETED|Months 48-72: Follow-on Phase||0
2483269|NCT00896532|6088295|P6|COMPLETED|Months 48-72: Follow-on Phase||0
2483270|NCT00896532|6088296|P5|COMPLETED|Months 48-72: Follow-on Phase||0
2483271|NCT00896532|6088297|P4|COMPLETED|Months 48-72: Follow-on Phase||0
2483272|NCT00896532|6088298|P3|COMPLETED|Months 48-72: Follow-on Phase||0
2483273|NCT00896532|6088299|P2|COMPLETED|Months 48-72: Follow-on Phase||0
2483274|NCT00896532|6088300|P1|COMPLETED|Months 48-72: Follow-on Phase||0
2483275|NCT00896532|6088278|P23|Received Zoledronic Acid|Months 48-72: Follow-on Phase||8
2483276|NCT00896532|6088279|P22|Received Zoledronic Acid|Months 48-72: Follow-on Phase||56
2483277|NCT00896532|6088280|P21|Received Zoledronic Acid|Months 48-72: Follow-on Phase||12
2483278|NCT00896532|6088281|P20|Received Zoledronic Acid|Months 48-72: Follow-on Phase||11
2483279|NCT00896532|6088282|P19|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2483280|NCT00896532|6088283|P18|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2483281|NCT00896532|6088284|P17|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2483282|NCT00896532|6088285|P16|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2483283|NCT00896532|6088286|P15|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2483284|NCT00896532|6088287|P14|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2483285|NCT00896532|6088288|P13|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2483286|NCT00896532|6088289|P12|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2483287|NCT00896532|6088290|P11|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2483288|NCT00896532|6088291|P10|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2483289|NCT00896532|6088292|P9|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2483290|NCT00896532|6088293|P8|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2483291|NCT00896532|6088294|P7|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2483292|NCT00896532|6088295|P6|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2483293|NCT00896532|6088296|P5|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2483294|NCT00896532|6088297|P4|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2483295|NCT00896532|6088298|P3|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2483296|NCT00896532|6088299|P2|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2483297|NCT00896532|6088300|P1|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
2483298|NCT00896532|6088278|P23|STARTED|Months 48-72: Follow-on Phase||8
2483299|NCT00896532|6088279|P22|STARTED|Months 48-72: Follow-on Phase||59
2483300|NCT00896532|6088280|P21|STARTED|Months 48-72: Follow-on Phase||12
2483301|NCT00896532|6088281|P20|STARTED|Months 48-72: Follow-on Phase||11
2483302|NCT00896532|6088282|P19|STARTED|Months 48-72: Follow-on Phase||51
2483303|NCT00896532|6088283|P18|STARTED|Months 48-72: Follow-on Phase||0
2483304|NCT00896532|6088284|P17|STARTED|Months 48-72: Follow-on Phase||0
2483305|NCT00896532|6088285|P16|STARTED|Months 48-72: Follow-on Phase||0
2483306|NCT00896532|6088286|P15|STARTED|Months 48-72: Follow-on Phase||0
2483307|NCT00896532|6088287|P14|STARTED|Months 48-72: Follow-on Phase||0
2483308|NCT00896532|6088288|P13|STARTED|Months 48-72: Follow-on Phase||0
2483309|NCT00896532|6088289|P12|STARTED|Months 48-72: Follow-on Phase||0
2483310|NCT00896532|6088290|P11|STARTED|Months 48-72: Follow-on Phase||0
2483311|NCT00896532|6088291|P10|STARTED|Months 48-72: Follow-on Phase||0
2483312|NCT00896532|6088292|P9|STARTED|Months 48-72: Follow-on Phase||0
2483313|NCT00896532|6088293|P8|STARTED|Months 48-72: Follow-on Phase||0
2483314|NCT00896532|6088294|P7|STARTED|Months 48-72: Follow-on Phase||0
2483315|NCT00896532|6088295|P6|STARTED|Months 48-72: Follow-on Phase||0
2483316|NCT00896532|6088296|P5|STARTED|Months 48-72: Follow-on Phase||0
2483317|NCT00896532|6088297|P4|STARTED|Months 48-72: Follow-on Phase||0
2483318|NCT00896532|6088298|P3|STARTED|Months 48-72: Follow-on Phase||0
2483319|NCT00896532|6088299|P2|STARTED|Months 48-72: Follow-on Phase||0
2483320|NCT00896532|6088300|P1|STARTED|Months 48-72: Follow-on Phase||0
2483321|NCT00896532|6088278|P23|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483322|NCT00896532|6088279|P22|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483323|NCT00896532|6088280|P21|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483324|NCT00896532|6088281|P20|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483325|NCT00896532|6088282|P19|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483326|NCT00896532|6088283|P18|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||3
2483327|NCT00896532|6088284|P17|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||7
2483328|NCT00896532|6088285|P16|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||2
2483329|NCT00896532|6088286|P15|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483330|NCT00896532|6088287|P14|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483331|NCT00896532|6088288|P13|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483332|NCT00896532|6088289|P12|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483333|NCT00896532|6088290|P11|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483334|NCT00896532|6088291|P10|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483335|NCT00896532|6088292|P9|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483336|NCT00896532|6088293|P8|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483337|NCT00896532|6088294|P7|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483338|NCT00896532|6088295|P6|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483339|NCT00896532|6088296|P5|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483340|NCT00896532|6088297|P4|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483341|NCT00896532|6088298|P3|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483342|NCT00896532|6088299|P2|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483343|NCT00896532|6088300|P1|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483344|NCT00896532|6088278|P23|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483345|NCT00896532|6088279|P22|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483346|NCT00896532|6088280|P21|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483347|NCT00896532|6088281|P20|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483348|NCT00896532|6088282|P19|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483349|NCT00896532|6088283|P18|COMPLETED|Months 36-48: Romosozumab Retreatment||64
2483350|NCT00896532|6088284|P17|COMPLETED|Months 36-48: Romosozumab Retreatment||65
2483351|NCT00896532|6088285|P16|COMPLETED|Months 36-48: Romosozumab Retreatment||14
2483352|NCT00896532|6088286|P15|COMPLETED|Months 36-48: Romosozumab Retreatment||12
2483353|NCT00896532|6088287|P14|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483354|NCT00896532|6088288|P13|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483355|NCT00896532|6088289|P12|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483356|NCT00896532|6088290|P11|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483357|NCT00896532|6088291|P10|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483358|NCT00896532|6088292|P9|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483359|NCT00896532|6088293|P8|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483360|NCT00896532|6088294|P7|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483361|NCT00896532|6088295|P6|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483362|NCT00896532|6088296|P5|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483363|NCT00896532|6088297|P4|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483364|NCT00896532|6088298|P3|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483365|NCT00896532|6088299|P2|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483366|NCT00896532|6088300|P1|COMPLETED|Months 36-48: Romosozumab Retreatment||0
2483367|NCT00896532|6088278|P23|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2483368|NCT00896532|6088279|P22|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2483369|NCT00896532|6088280|P21|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2483370|NCT00896532|6088281|P20|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2483371|NCT00896532|6088282|P19|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2483372|NCT00896532|6088283|P18|Received Romosozumab|Months 36-48: Romosozumab Retreatment||67
2483373|NCT00896532|6088284|P17|Received Romosozumab|Months 36-48: Romosozumab Retreatment||72
2483374|NCT00896532|6088285|P16|Received Romosozumab|Months 36-48: Romosozumab Retreatment|Includes one participant who received 1 dose of romosozumab 70 mg in error in first 12 months|16
2483375|NCT00896532|6088286|P15|Received Romosozumab|Months 36-48: Romosozumab Retreatment||12
2483376|NCT00896532|6088287|P14|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2483377|NCT00896532|6088288|P13|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2483378|NCT00896532|6088289|P12|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2483379|NCT00896532|6088290|P11|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2483380|NCT00896532|6088291|P10|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2483381|NCT00896532|6088292|P9|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2483382|NCT00896532|6088293|P8|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2483383|NCT00896532|6088294|P7|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2483384|NCT00896532|6088295|P6|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2483385|NCT00896532|6088296|P5|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2483386|NCT00896532|6088297|P4|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2483387|NCT00896532|6088298|P3|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2483388|NCT00896532|6088299|P2|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2483389|NCT00896532|6088300|P1|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
2483390|NCT00896532|6088278|P23|STARTED|Months 36-48: Romosozumab Retreatment||0
2483391|NCT00896532|6088279|P22|STARTED|Months 36-48: Romosozumab Retreatment||0
2483392|NCT00896532|6088280|P21|STARTED|Months 36-48: Romosozumab Retreatment||0
2483393|NCT00896532|6088281|P20|STARTED|Months 36-48: Romosozumab Retreatment||0
2483394|NCT00896532|6088282|P19|STARTED|Months 36-48: Romosozumab Retreatment||0
2483395|NCT00896532|6088283|P18|STARTED|Months 36-48: Romosozumab Retreatment||67
2483396|NCT00896532|6088284|P17|STARTED|Months 36-48: Romosozumab Retreatment||72
2483397|NCT00896532|6088285|P16|STARTED|Months 36-48: Romosozumab Retreatment||16
2483398|NCT00896532|6088286|P15|STARTED|Months 36-48: Romosozumab Retreatment||12
2483399|NCT00896532|6088287|P14|STARTED|Months 36-48: Romosozumab Retreatment||0
2483400|NCT00896532|6088288|P13|STARTED|Months 36-48: Romosozumab Retreatment||0
2483401|NCT00896532|6088289|P12|STARTED|Months 36-48: Romosozumab Retreatment||0
2483402|NCT00896532|6088290|P11|STARTED|Months 36-48: Romosozumab Retreatment||0
2483403|NCT00896532|6088291|P10|STARTED|Months 36-48: Romosozumab Retreatment||0
2483404|NCT00896532|6088292|P9|STARTED|Months 36-48: Romosozumab Retreatment||0
2483405|NCT00896532|6088293|P8|STARTED|Months 36-48: Romosozumab Retreatment||0
2483710|NCT00895934|6088843|P1|NOT COMPLETED|Dose Escalation||0
2483406|NCT00896532|6088294|P7|STARTED|Months 36-48: Romosozumab Retreatment||0
2483407|NCT00896532|6088295|P6|STARTED|Months 36-48: Romosozumab Retreatment||0
2483408|NCT00896532|6088296|P5|STARTED|Months 36-48: Romosozumab Retreatment||0
2483409|NCT00896532|6088297|P4|STARTED|Months 36-48: Romosozumab Retreatment||0
2483410|NCT00896532|6088298|P3|STARTED|Months 36-48: Romosozumab Retreatment||0
2483411|NCT00896532|6088299|P2|STARTED|Months 36-48: Romosozumab Retreatment||0
2483412|NCT00896532|6088300|P1|STARTED|Months 36-48: Romosozumab Retreatment||0
2483413|NCT00896532|6088278|P23|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2483414|NCT00896532|6088279|P22|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2483415|NCT00896532|6088280|P21|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2483416|NCT00896532|6088281|P20|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2483417|NCT00896532|6088282|P19|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2483418|NCT00896532|6088283|P18|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2483419|NCT00896532|6088284|P17|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2483420|NCT00896532|6088285|P16|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2483421|NCT00896532|6088286|P15|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2483422|NCT00896532|6088287|P14|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
2483423|NCT00896532|6088288|P13|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||5
2483424|NCT00896532|6088289|P12|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
2483425|NCT00896532|6088290|P11|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
2483426|NCT00896532|6088291|P10|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2483427|NCT00896532|6088292|P9|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||1
2483428|NCT00896532|6088293|P8|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2483429|NCT00896532|6088294|P7|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2483430|NCT00896532|6088295|P6|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2483431|NCT00896532|6088296|P5|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2483432|NCT00896532|6088297|P4|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2483433|NCT00896532|6088298|P3|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2483434|NCT00896532|6088299|P2|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2483435|NCT00896532|6088300|P1|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
2483436|NCT00896532|6088278|P23|COMPLETED|Months 24-36: Denosumab Extension Phase||0
2483437|NCT00896532|6088279|P22|COMPLETED|Months 24-36: Denosumab Extension Phase||0
2483438|NCT00896532|6088280|P21|COMPLETED|Months 24-36: Denosumab Extension Phase||0
2483439|NCT00896532|6088281|P20|COMPLETED|Months 24-36: Denosumab Extension Phase||0
2483440|NCT00896532|6088282|P19|COMPLETED|Months 24-36: Denosumab Extension Phase||0
2483441|NCT00896532|6088283|P18|COMPLETED|Months 24-36: Denosumab Extension Phase||0
2483442|NCT00896532|6088284|P17|COMPLETED|Months 24-36: Denosumab Extension Phase||0
2483443|NCT00896532|6088285|P16|COMPLETED|Months 24-36: Denosumab Extension Phase||0
2483444|NCT00896532|6088286|P15|COMPLETED|Months 24-36: Denosumab Extension Phase||0
2483445|NCT00896532|6088287|P14|COMPLETED|Months 24-36: Denosumab Extension Phase||88
2483446|NCT00896532|6088288|P13|COMPLETED|Months 24-36: Denosumab Extension Phase||88
2483447|NCT00896532|6088289|P12|COMPLETED|Months 24-36: Denosumab Extension Phase||19
2483448|NCT00896532|6088290|P11|COMPLETED|Months 24-36: Denosumab Extension Phase||18
2483449|NCT00896532|6088291|P10|COMPLETED|Months 24-36: Denosumab Extension Phase||18
2483450|NCT00896532|6088292|P9|COMPLETED|Months 24-36: Denosumab Extension Phase||17
2483451|NCT00896532|6088293|P8|COMPLETED|Months 24-36: Denosumab Extension Phase||0
2483452|NCT00896532|6088294|P7|COMPLETED|Months 24-36: Denosumab Extension Phase||0
2483453|NCT00896532|6088295|P6|COMPLETED|Months 24-36: Denosumab Extension Phase||0
2483454|NCT00896532|6088296|P5|COMPLETED|Months 24-36: Denosumab Extension Phase||0
2483455|NCT00896532|6088297|P4|COMPLETED|Months 24-36: Denosumab Extension Phase||0
2483456|NCT00896532|6088298|P3|COMPLETED|Months 24-36: Denosumab Extension Phase||0
2483457|NCT00896532|6088299|P2|COMPLETED|Months 24-36: Denosumab Extension Phase||0
2483458|NCT00896532|6088300|P1|COMPLETED|Months 24-36: Denosumab Extension Phase||0
2483459|NCT00896532|6088278|P23|Received Treatment|Months 24-36: Denosumab Extension Phase||0
2483460|NCT00896532|6088279|P22|Received Treatment|Months 24-36: Denosumab Extension Phase||0
2483461|NCT00896532|6088280|P21|Received Treatment|Months 24-36: Denosumab Extension Phase||0
2483462|NCT00896532|6088281|P20|Received Treatment|Months 24-36: Denosumab Extension Phase||0
2483463|NCT00896532|6088282|P19|Received Treatment|Months 24-36: Denosumab Extension Phase||0
2483464|NCT00896532|6088283|P18|Received Treatment|Months 24-36: Denosumab Extension Phase||0
2483465|NCT00896532|6088284|P17|Received Treatment|Months 24-36: Denosumab Extension Phase||0
2483466|NCT00896532|6088285|P16|Received Treatment|Months 24-36: Denosumab Extension Phase||0
2483467|NCT00896532|6088286|P15|Received Treatment|Months 24-36: Denosumab Extension Phase||0
2483468|NCT00896532|6088287|P14|Received Treatment|Months 24-36: Denosumab Extension Phase||88
2483469|NCT00896532|6088288|P13|Received Treatment|Months 24-36: Denosumab Extension Phase||90
2483470|NCT00896532|6088289|P12|Received Treatment|Months 24-36: Denosumab Extension Phase||19
2483471|NCT00896532|6088290|P11|Received Treatment|Months 24-36: Denosumab Extension Phase||19
2483472|NCT00896532|6088291|P10|Received Treatment|Months 24-36: Denosumab Extension Phase|Includes one participant who received 1 dose of romosozumab 70 mg in error in first 12 months|18
2483473|NCT00896532|6088292|P9|Received Treatment|Months 24-36: Denosumab Extension Phase||18
2483474|NCT00896532|6088293|P8|Received Treatment|Months 24-36: Denosumab Extension Phase||0
2483475|NCT00896532|6088294|P7|Received Treatment|Months 24-36: Denosumab Extension Phase||0
2483476|NCT00896532|6088295|P6|Received Treatment|Months 24-36: Denosumab Extension Phase||0
2483477|NCT00896532|6088296|P5|Received Treatment|Months 24-36: Denosumab Extension Phase||0
2483478|NCT00896532|6088297|P4|Received Treatment|Months 24-36: Denosumab Extension Phase||0
2483479|NCT00896532|6088298|P3|Received Treatment|Months 24-36: Denosumab Extension Phase||0
2483480|NCT00896532|6088299|P2|Received Treatment|Months 24-36: Denosumab Extension Phase||0
2483481|NCT00896532|6088300|P1|Received Treatment|Months 24-36: Denosumab Extension Phase||0
2483482|NCT00896532|6088278|P23|STARTED|Months 24-36: Denosumab Extension Phase||0
2483483|NCT00896532|6088279|P22|STARTED|Months 24-36: Denosumab Extension Phase||0
2483484|NCT00896532|6088280|P21|STARTED|Months 24-36: Denosumab Extension Phase||0
2483485|NCT00896532|6088281|P20|STARTED|Months 24-36: Denosumab Extension Phase||0
2483486|NCT00896532|6088282|P19|STARTED|Months 24-36: Denosumab Extension Phase||0
2483487|NCT00896532|6088283|P18|STARTED|Months 24-36: Denosumab Extension Phase||0
2483488|NCT00896532|6088284|P17|STARTED|Months 24-36: Denosumab Extension Phase||0
2483489|NCT00896532|6088285|P16|STARTED|Months 24-36: Denosumab Extension Phase||0
2483490|NCT00896532|6088286|P15|STARTED|Months 24-36: Denosumab Extension Phase||0
2483491|NCT00896532|6088287|P14|STARTED|Months 24-36: Denosumab Extension Phase||90
2483492|NCT00896532|6088288|P13|STARTED|Months 24-36: Denosumab Extension Phase||93
2483493|NCT00896532|6088289|P12|STARTED|Months 24-36: Denosumab Extension Phase||21
2483494|NCT00896532|6088290|P11|STARTED|Months 24-36: Denosumab Extension Phase||20
2483495|NCT00896532|6088291|P10|STARTED|Months 24-36: Denosumab Extension Phase||18
2483496|NCT00896532|6088292|P9|STARTED|Months 24-36: Denosumab Extension Phase||18
2483497|NCT00896532|6088293|P8|STARTED|Months 24-36: Denosumab Extension Phase||0
2483498|NCT00896532|6088294|P7|STARTED|Months 24-36: Denosumab Extension Phase||0
2483499|NCT00896532|6088295|P6|STARTED|Months 24-36: Denosumab Extension Phase||0
2483500|NCT00896532|6088296|P5|STARTED|Months 24-36: Denosumab Extension Phase||0
2483501|NCT00896532|6088297|P4|STARTED|Months 24-36: Denosumab Extension Phase||0
2483502|NCT00896532|6088298|P3|STARTED|Months 24-36: Denosumab Extension Phase||0
2483503|NCT00896532|6088299|P2|STARTED|Months 24-36: Denosumab Extension Phase||0
2483504|NCT00896532|6088300|P1|STARTED|Months 24-36: Denosumab Extension Phase||0
2483505|NCT00896532|6088278|P23|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2483506|NCT00896532|6088279|P22|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2483507|NCT00896532|6088280|P21|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2483508|NCT00896532|6088281|P20|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2483509|NCT00896532|6088282|P19|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2483510|NCT00896532|6088283|P18|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2483511|NCT00896532|6088284|P17|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2483512|NCT00896532|6088285|P16|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2483513|NCT00896532|6088286|P15|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2483514|NCT00896532|6088287|P14|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2483515|NCT00896532|6088288|P13|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2483516|NCT00896532|6088289|P12|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2483517|NCT00896532|6088290|P11|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2483518|NCT00896532|6088291|P10|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2483519|NCT00896532|6088292|P9|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2483520|NCT00896532|6088293|P8|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||4
2483521|NCT00896532|6088294|P7|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||5
2483522|NCT00896532|6088295|P6|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||8
2483523|NCT00896532|6088296|P5|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||8
2483524|NCT00896532|6088297|P4|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||12
2483525|NCT00896532|6088298|P3|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||9
2483526|NCT00896532|6088299|P2|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||6
2483527|NCT00896532|6088300|P1|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||6
2483528|NCT00896532|6088278|P23|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2483529|NCT00896532|6088279|P22|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2483530|NCT00896532|6088280|P21|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2483531|NCT00896532|6088281|P20|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2483532|NCT00896532|6088282|P19|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2483533|NCT00896532|6088283|P18|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2483534|NCT00896532|6088284|P17|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2483535|NCT00896532|6088285|P16|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2483536|NCT00896532|6088286|P15|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2483537|NCT00896532|6088287|P14|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2483538|NCT00896532|6088288|P13|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2483539|NCT00896532|6088289|P12|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2483540|NCT00896532|6088290|P11|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2483541|NCT00896532|6088291|P10|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2483542|NCT00896532|6088292|P9|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
2483543|NCT00896532|6088293|P8|COMPLETED|Months 1-24: Romosozumab Treatment Phase||48
2483544|NCT00896532|6088294|P7|COMPLETED|Months 1-24: Romosozumab Treatment Phase||48
2483545|NCT00896532|6088295|P6|COMPLETED|Months 1-24: Romosozumab Treatment Phase||43
2483546|NCT00896532|6088296|P5|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
2483547|NCT00896532|6088297|P4|COMPLETED|Months 1-24: Romosozumab Treatment Phase||39
2483548|NCT00896532|6088298|P3|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
2483549|NCT00896532|6088299|P2|COMPLETED|Months 1-24: Romosozumab Treatment Phase||45
2483550|NCT00896532|6088300|P1|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
2483551|NCT00896532|6088278|P23|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
2483552|NCT00896532|6088279|P22|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
2483553|NCT00896532|6088280|P21|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
2483554|NCT00896532|6088281|P20|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
2483555|NCT00896532|6088282|P19|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
2483556|NCT00896532|6088283|P18|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
2483557|NCT00896532|6088284|P17|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
2483558|NCT00896532|6088285|P16|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
2483559|NCT00896532|6088286|P15|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
2483560|NCT00896532|6088287|P14|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
2483561|NCT00896532|6088288|P13|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
2483562|NCT00896532|6088289|P12|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
2483563|NCT00896532|6088290|P11|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
2483564|NCT00896532|6088291|P10|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
2483565|NCT00896532|6088292|P9|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
2483566|NCT00896532|6088293|P8|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||49
2483567|NCT00896532|6088294|P7|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||51
2483568|NCT00896532|6088295|P6|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||46
2483569|NCT00896532|6088296|P5|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||50
2483570|NCT00896532|6088297|P4|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||45
2483571|NCT00896532|6088298|P3|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||46
2483572|NCT00896532|6088299|P2|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||49
2483573|NCT00896532|6088300|P1|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||47
2483574|NCT00896532|6088278|P23|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
2483575|NCT00896532|6088279|P22|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
2483576|NCT00896532|6088280|P21|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
2483577|NCT00896532|6088281|P20|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
2483578|NCT00896532|6088282|P19|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
2483579|NCT00896532|6088283|P18|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
2483580|NCT00896532|6088284|P17|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
2483581|NCT00896532|6088285|P16|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
2483582|NCT00896532|6088286|P15|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
2483583|NCT00896532|6088287|P14|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
2483584|NCT00896532|6088288|P13|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
2483585|NCT00896532|6088289|P12|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
2483586|NCT00896532|6088290|P11|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
2483587|NCT00896532|6088291|P10|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
2483588|NCT00896532|6088292|P9|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
2483589|NCT00896532|6088293|P8|Received Treatment|Months 1-24: Romosozumab Treatment Phase||51
2483590|NCT00896532|6088294|P7|Received Treatment|Months 1-24: Romosozumab Treatment Phase||53
2483591|NCT00896532|6088295|P6|Received Treatment|Months 1-24: Romosozumab Treatment Phase||48
2483592|NCT00896532|6088296|P5|Received Treatment|Months 1-24: Romosozumab Treatment Phase||53
2483593|NCT00896532|6088297|P4|Received Treatment|Months 1-24: Romosozumab Treatment Phase||49
2483594|NCT00896532|6088298|P3|Received Treatment|Months 1-24: Romosozumab Treatment Phase||54
2483595|NCT00896532|6088299|P2|Received Treatment|Months 1-24: Romosozumab Treatment Phase||51
2483596|NCT00896532|6088300|P1|Received Treatment|Months 1-24: Romosozumab Treatment Phase|One participant received 1 dose of romosozumab 70 mg in error|51
2483597|NCT00896532|6088278|P23|STARTED|Months 1-24: Romosozumab Treatment Phase||0
2483598|NCT00896532|6088279|P22|STARTED|Months 1-24: Romosozumab Treatment Phase||0
2483599|NCT00896532|6088280|P21|STARTED|Months 1-24: Romosozumab Treatment Phase||0
2483600|NCT00896532|6088281|P20|STARTED|Months 1-24: Romosozumab Treatment Phase||0
2483601|NCT00896532|6088282|P19|STARTED|Months 1-24: Romosozumab Treatment Phase||0
2483602|NCT00896532|6088283|P18|STARTED|Months 1-24: Romosozumab Treatment Phase||0
2483603|NCT00896532|6088284|P17|STARTED|Months 1-24: Romosozumab Treatment Phase||0
2483604|NCT00896532|6088285|P16|STARTED|Months 1-24: Romosozumab Treatment Phase||0
2483605|NCT00896532|6088286|P15|STARTED|Months 1-24: Romosozumab Treatment Phase||0
2483606|NCT00896532|6088287|P14|STARTED|Months 1-24: Romosozumab Treatment Phase||0
2483607|NCT00896532|6088288|P13|STARTED|Months 1-24: Romosozumab Treatment Phase||0
2483608|NCT00896532|6088289|P12|STARTED|Months 1-24: Romosozumab Treatment Phase||0
2483609|NCT00896532|6088290|P11|STARTED|Months 1-24: Romosozumab Treatment Phase||0
2483610|NCT00896532|6088291|P10|STARTED|Months 1-24: Romosozumab Treatment Phase||0
2483611|NCT00896532|6088292|P9|STARTED|Months 1-24: Romosozumab Treatment Phase||0
2483612|NCT00896532|6088293|P8|STARTED|Months 1-24: Romosozumab Treatment Phase||52
2483613|NCT00896532|6088294|P7|STARTED|Months 1-24: Romosozumab Treatment Phase||53
2483614|NCT00896532|6088295|P6|STARTED|Months 1-24: Romosozumab Treatment Phase||51
2483615|NCT00896532|6088296|P5|STARTED|Months 1-24: Romosozumab Treatment Phase||54
2483616|NCT00896532|6088297|P4|STARTED|Months 1-24: Romosozumab Treatment Phase||51
2483617|NCT00896532|6088298|P3|STARTED|Months 1-24: Romosozumab Treatment Phase||55
2483618|NCT00896532|6088299|P2|STARTED|Months 1-24: Romosozumab Treatment Phase||51
2483619|NCT00896532|6088300|P1|STARTED|Months 1-24: Romosozumab Treatment Phase||52
2483620|NCT00896480|6088427|P1|NOT COMPLETED|Overall Study||21
2483621|NCT00896480|6088427|P1|COMPLETED|Overall Study||3
2483622|NCT00896480|6088427|P1|STARTED|Overall Study||24
2483623|NCT00896454|6088475|P1|NOT COMPLETED|Overall Study||33
2483624|NCT00896454|6088475|P1|COMPLETED|Overall Study||0
2483625|NCT00896454|6088475|P1|STARTED|Overall Study||33
2483626|NCT00896441|6088489|P2|NOT COMPLETED|Overall Study||0
2483627|NCT00896441|6088490|P1|NOT COMPLETED|Overall Study||2
2483628|NCT00896441|6088489|P2|COMPLETED|Overall Study||9
2483629|NCT00896441|6088490|P1|COMPLETED|Overall Study||15
2483630|NCT00896441|6088489|P2|STARTED|Overall Study||9
2483631|NCT00896441|6088490|P1|STARTED|Overall Study||17
2483632|NCT00896389|6088497|P1|NOT COMPLETED|HCTZ High Dose||0
2483633|NCT00896389|6088497|P1|COMPLETED|HCTZ High Dose||25
2483634|NCT00896389|6088497|P1|STARTED|HCTZ High Dose||25
2483635|NCT00896389|6088497|P1|NOT COMPLETED|HCTZ Low Dose||0
2483636|NCT00896389|6088497|P1|COMPLETED|HCTZ Low Dose||28
2483637|NCT00896389|6088497|P1|STARTED|HCTZ Low Dose|Only subjects with SBP > 120 mmHg and agreeable to the HCTZ protocol continued to the next period.|28
2483638|NCT00896389|6088497|P1|NOT COMPLETED|Salt Loading||0
2483639|NCT00896389|6088497|P1|COMPLETED|Salt Loading||124
2483640|NCT00896389|6088497|P1|STARTED|Salt Loading||124
2483641|NCT00896363|6088514|P3|NOT COMPLETED|Overall Study||8
2483642|NCT00896363|6088515|P2|NOT COMPLETED|Overall Study||11
2483643|NCT00896363|6088516|P1|NOT COMPLETED|Overall Study||6
2483644|NCT00896363|6088514|P3|COMPLETED|Overall Study||24
2483645|NCT00896363|6088515|P2|COMPLETED|Overall Study||25
2483646|NCT00896363|6088516|P1|COMPLETED|Overall Study||25
2483647|NCT00896363|6088514|P3|STARTED|Overall Study||32
2483648|NCT00896363|6088515|P2|STARTED|Overall Study||36
2483649|NCT00896363|6088516|P1|STARTED|Overall Study||31
2483650|NCT00896337|6088568|P1|NOT COMPLETED|Overall Study||25
2483651|NCT00896337|6088568|P1|COMPLETED|Overall Study||100
2483652|NCT00896337|6088568|P1|STARTED|Overall Study||125
2483653|NCT00896298|6088637|P2|NOT COMPLETED|Overall Study||3
2483654|NCT00896298|6088638|P1|NOT COMPLETED|Overall Study||3
2483655|NCT00896298|6088637|P2|COMPLETED|Overall Study||9
2483656|NCT00896298|6088638|P1|COMPLETED|Overall Study||10
2483657|NCT00896298|6088637|P2|STARTED|Overall Study||12
2483658|NCT00896298|6088638|P1|STARTED|Overall Study||13
2483659|NCT00896233|6088650|P1|NOT COMPLETED|Overall Study||1
2483660|NCT00896233|6088650|P1|COMPLETED|Overall Study||9
2483661|NCT00896233|6088650|P1|STARTED|Overall Study||10
2483662|NCT00896168|6088663|P2|NOT COMPLETED|Overall Study||19
2483663|NCT00896168|6088664|P1|NOT COMPLETED|Overall Study||14
2483664|NCT00896168|6088663|P2|COMPLETED|Overall Study||111
2483665|NCT00896168|6088664|P1|COMPLETED|Overall Study||90
2483666|NCT00896168|6088663|P2|STARTED|Overall Study||130
2483667|NCT00896168|6088664|P1|STARTED|Overall Study||104
2483668|NCT00896064|6088694|P2|NOT COMPLETED|Overall Study||0
2483669|NCT00896064|6088695|P1|NOT COMPLETED|Overall Study||0
2483670|NCT00896064|6088694|P2|COMPLETED|Overall Study||21
2483671|NCT00896064|6088695|P1|COMPLETED|Overall Study||22
2483672|NCT00896064|6088694|P2|STARTED|Overall Study||21
2483673|NCT00896064|6088695|P1|STARTED|Overall Study||22
2483674|NCT00896051|6088725|P2|NOT COMPLETED|Overall Study||9
2483675|NCT00896051|6088726|P1|NOT COMPLETED|Overall Study||10
2483676|NCT00896051|6088725|P2|COMPLETED|Overall Study||16
2483677|NCT00896051|6088726|P1|COMPLETED|Overall Study||15
2483678|NCT00896051|6088725|P2|STARTED|Overall Study||25
2483679|NCT00896051|6088726|P1|STARTED|Overall Study||25
2483680|NCT00896038|6088768|P2|NOT COMPLETED|Overall Study||1
2483681|NCT00896038|6088769|P1|NOT COMPLETED|Overall Study||4
2483682|NCT00896038|6088768|P2|COMPLETED|Overall Study||27
2483683|NCT00896038|6088769|P1|COMPLETED|Overall Study||26
2483684|NCT00896038|6088768|P2|STARTED|Overall Study||28
2483685|NCT00896038|6088769|P1|STARTED|Overall Study||30
2483686|NCT00896025|6088807|P1|NOT COMPLETED|Overall Study||0
2483687|NCT00896025|6088807|P1|COMPLETED|Overall Study||8
2483688|NCT00896025|6088807|P1|STARTED|Overall Study||8
2483689|NCT00895947|6088821|P2|NOT COMPLETED|Overall Study||10
2483690|NCT00895947|6088822|P1|NOT COMPLETED|Overall Study||12
2483691|NCT00895947|6088821|P2|COMPLETED|Overall Study||90
2483692|NCT00895947|6088822|P1|COMPLETED|Overall Study||88
2483693|NCT00895947|6088821|P2|STARTED|Overall Study||100
2483694|NCT00895947|6088822|P1|STARTED|Overall Study||100
2483695|NCT00895934|6088840|P4|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
2483696|NCT00895934|6088841|P3|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
2483697|NCT00895934|6088842|P2|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
2483698|NCT00895934|6088843|P1|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
2483699|NCT00895934|6088840|P4|COMPLETED|Efficacy of Most Tolerated Dose||37
2483700|NCT00895934|6088841|P3|COMPLETED|Efficacy of Most Tolerated Dose||0
2483701|NCT00895934|6088842|P2|COMPLETED|Efficacy of Most Tolerated Dose||0
2483702|NCT00895934|6088843|P1|COMPLETED|Efficacy of Most Tolerated Dose||0
2483703|NCT00895934|6088840|P4|STARTED|Efficacy of Most Tolerated Dose||37
2483704|NCT00895934|6088841|P3|STARTED|Efficacy of Most Tolerated Dose||0
2483705|NCT00895934|6088842|P2|STARTED|Efficacy of Most Tolerated Dose||0
2483706|NCT00895934|6088843|P1|STARTED|Efficacy of Most Tolerated Dose||0
2483707|NCT00895934|6088840|P4|NOT COMPLETED|Dose Escalation||0
2483708|NCT00895934|6088841|P3|NOT COMPLETED|Dose Escalation||0
2483709|NCT00895934|6088842|P2|NOT COMPLETED|Dose Escalation||0
2483711|NCT00895934|6088840|P4|COMPLETED|Dose Escalation||6
2483712|NCT00895934|6088841|P3|COMPLETED|Dose Escalation||3
2483713|NCT00895934|6088842|P2|COMPLETED|Dose Escalation||3
2483714|NCT00895934|6088843|P1|COMPLETED|Dose Escalation||3
2483715|NCT00895934|6088840|P4|STARTED|Dose Escalation||6
2483716|NCT00895934|6088841|P3|STARTED|Dose Escalation||3
2483717|NCT00895934|6088842|P2|STARTED|Dose Escalation||3
2483718|NCT00895934|6088843|P1|STARTED|Dose Escalation||3
2483719|NCT00895895|6088860|P5|NOT COMPLETED|Period 2||49
2483720|NCT00895895|6088861|P4|NOT COMPLETED|Period 2||54
2483721|NCT00895895|6088862|P3|NOT COMPLETED|Period 2||49
2483722|NCT00895895|6088863|P2|NOT COMPLETED|Period 2||53
2483723|NCT00895895|6088864|P1|NOT COMPLETED|Period 2||56
2483724|NCT00895895|6088860|P5|COMPLETED|Period 2||35
2483725|NCT00895895|6088861|P4|COMPLETED|Period 2||37
2483726|NCT00895895|6088862|P3|COMPLETED|Period 2||33
2483727|NCT00895895|6088863|P2|COMPLETED|Period 2||31
2483728|NCT00895895|6088864|P1|COMPLETED|Period 2||30
2483729|NCT00895895|6088860|P5|STARTED|Period 2||84
2483730|NCT00895895|6088861|P4|STARTED|Period 2||91
2483731|NCT00895895|6088862|P3|STARTED|Period 2||82
2483732|NCT00895895|6088863|P2|STARTED|Period 2||84
2483733|NCT00895895|6088864|P1|STARTED|Period 2||86
2483734|NCT00895895|6088860|P5|NOT COMPLETED|After Period 1, Prior to Period 2||2
2483735|NCT00895895|6088861|P4|NOT COMPLETED|After Period 1, Prior to Period 2||0
2483736|NCT00895895|6088862|P3|NOT COMPLETED|After Period 1, Prior to Period 2||2
2483737|NCT00895895|6088863|P2|NOT COMPLETED|After Period 1, Prior to Period 2||0
2483738|NCT00895895|6088864|P1|NOT COMPLETED|After Period 1, Prior to Period 2||0
2483739|NCT00895895|6088860|P5|COMPLETED|After Period 1, Prior to Period 2||84
2483740|NCT00895895|6088861|P4|COMPLETED|After Period 1, Prior to Period 2||91
2483741|NCT00895895|6088862|P3|COMPLETED|After Period 1, Prior to Period 2||82
2483742|NCT00895895|6088863|P2|COMPLETED|After Period 1, Prior to Period 2||84
2483743|NCT00895895|6088864|P1|COMPLETED|After Period 1, Prior to Period 2||86
2483744|NCT00895895|6088860|P5|STARTED|After Period 1, Prior to Period 2||86
2483745|NCT00895895|6088861|P4|STARTED|After Period 1, Prior to Period 2||91
2483746|NCT00895895|6088862|P3|STARTED|After Period 1, Prior to Period 2||84
2483747|NCT00895895|6088863|P2|STARTED|After Period 1, Prior to Period 2||84
2483748|NCT00895895|6088864|P1|STARTED|After Period 1, Prior to Period 2||86
2483749|NCT00895895|6088860|P5|NOT COMPLETED|Period 1||20
2483750|NCT00895895|6088861|P4|NOT COMPLETED|Period 1||13
2483751|NCT00895895|6088862|P3|NOT COMPLETED|Period 1||20
2483752|NCT00895895|6088863|P2|NOT COMPLETED|Period 1||21
2483753|NCT00895895|6088864|P1|NOT COMPLETED|Period 1||21
2483754|NCT00895895|6088860|P5|COMPLETED|Period 1||86
2483755|NCT00895895|6088861|P4|COMPLETED|Period 1||91
2483756|NCT00895895|6088862|P3|COMPLETED|Period 1||84
2483757|NCT00895895|6088863|P2|COMPLETED|Period 1||84
2483758|NCT00895895|6088864|P1|COMPLETED|Period 1||86
2483759|NCT00895895|6088860|P5|Randomized But Not Treated|Period 1||2
2483760|NCT00895895|6088861|P4|Randomized But Not Treated|Period 1||1
2483761|NCT00895895|6088862|P3|Randomized But Not Treated|Period 1||1
2483762|NCT00895895|6088863|P2|Randomized But Not Treated|Period 1||3
2483763|NCT00895895|6088864|P1|Randomized But Not Treated|Period 1||1
2483764|NCT00895895|6088860|P5|STARTED|Period 1||106
2483765|NCT00895895|6088861|P4|STARTED|Period 1||104
2483766|NCT00895895|6088862|P3|STARTED|Period 1||104
2483767|NCT00895895|6088863|P2|STARTED|Period 1||105
2483768|NCT00895895|6088864|P1|STARTED|Period 1||107
2483769|NCT00895843|6088978|P2|NOT COMPLETED|Overall Study||12
2483770|NCT00895843|6088979|P1|NOT COMPLETED|Overall Study||12
2483771|NCT00895843|6088978|P2|COMPLETED|Overall Study||50
2483772|NCT00895843|6088979|P1|COMPLETED|Overall Study||48
2483773|NCT00895843|6088978|P2|STARTED|Overall Study||62
2483774|NCT00895843|6088979|P1|STARTED|Overall Study||60
2483775|NCT00895830|6088990|P5|NOT COMPLETED|Overall Study||0
2483776|NCT00895830|6088991|P4|NOT COMPLETED|Overall Study||0
2483777|NCT00895830|6088992|P3|NOT COMPLETED|Overall Study||0
2483778|NCT00895830|6088993|P2|NOT COMPLETED|Overall Study||0
2483779|NCT00895830|6088994|P1|NOT COMPLETED|Overall Study||0
2483780|NCT00895830|6088990|P5|COMPLETED|Overall Study||55
2483781|NCT00895830|6088991|P4|COMPLETED|Overall Study||52
2483782|NCT00895830|6088992|P3|COMPLETED|Overall Study||49
2483783|NCT00895830|6088993|P2|COMPLETED|Overall Study||50
2483784|NCT00895830|6088994|P1|COMPLETED|Overall Study||51
2483785|NCT00895830|6088990|P5|STARTED|Overall Study||55
2483786|NCT00895830|6088991|P4|STARTED|Overall Study||52
2483787|NCT00895830|6088992|P3|STARTED|Overall Study||49
2483788|NCT00895830|6088993|P2|STARTED|Overall Study||50
2483789|NCT00895830|6088994|P1|STARTED|Overall Study||51
2483790|NCT00895817|6089008|P2|NOT COMPLETED|Overall Study||0
2483791|NCT00895817|6089009|P1|NOT COMPLETED|Overall Study||0
2483792|NCT00895817|6089008|P2|COMPLETED|Overall Study||21
2483793|NCT00895817|6089009|P1|COMPLETED|Overall Study||21
2483794|NCT00895817|6089008|P2|STARTED|Overall Study||21
2483795|NCT00895817|6089009|P1|STARTED|Overall Study||21
2483796|NCT00895752|6089015|P1|NOT COMPLETED|Overall Study||0
2483797|NCT00895752|6089015|P1|COMPLETED|Overall Study||6
2483798|NCT00895752|6089015|P1|STARTED|Overall Study||6
2483799|NCT00895661|6089026|P1|NOT COMPLETED|Overall Study||3
2483800|NCT00895661|6089026|P1|COMPLETED|Overall Study||37
2483801|NCT00895661|6089026|P1|STARTED|Overall Study||40
2483802|NCT00895622|6089036|P3|NOT COMPLETED|Overall Study||4
2483803|NCT00895622|6089037|P2|NOT COMPLETED|Overall Study||4
2483804|NCT00895622|6089038|P1|NOT COMPLETED|Overall Study||5
2483805|NCT00895622|6089036|P3|COMPLETED|Overall Study||53
2483806|NCT00895622|6089037|P2|COMPLETED|Overall Study||52
2483807|NCT00895622|6089038|P1|COMPLETED|Overall Study||60
2483808|NCT00895622|6089036|P3|STARTED|Overall Study||57
2483809|NCT00895622|6089037|P2|STARTED|Overall Study||56
2483810|NCT00895622|6089038|P1|STARTED|Overall Study||65
2483811|NCT00895583|6089061|P2|NOT COMPLETED|Overall Study||12
2483812|NCT00895583|6089062|P1|NOT COMPLETED|Overall Study||44
2483813|NCT00895583|6089061|P2|COMPLETED|Overall Study||111
2483814|NCT00895583|6089062|P1|COMPLETED|Overall Study||87
2483815|NCT00895583|6089061|P2|STARTED|Overall Study||123
2483816|NCT00895583|6089062|P1|STARTED|Overall Study||131
2483817|NCT00895531|6089142|P2|NOT COMPLETED|Overall Study||0
2483818|NCT00895531|6089143|P1|NOT COMPLETED|Overall Study||0
2483819|NCT00895531|6089142|P2|COMPLETED|Overall Study||37
2483820|NCT00895531|6089143|P1|COMPLETED|Overall Study||38
2483821|NCT00895531|6089142|P2|STARTED|Overall Study||37
2483822|NCT00895531|6089143|P1|STARTED|Overall Study||38
2483823|NCT00895453|6089152|P3|NOT COMPLETED|Overall Study||23
2483824|NCT00895453|6089153|P2|NOT COMPLETED|Overall Study||25
2483825|NCT00895453|6089154|P1|NOT COMPLETED|Overall Study||25
2483826|NCT00895453|6089152|P3|COMPLETED|Overall Study||23
2483827|NCT00895453|6089153|P2|COMPLETED|Overall Study||25
2483828|NCT00895453|6089154|P1|COMPLETED|Overall Study||23
2483829|NCT00895453|6089152|P3|STARTED|Overall Study||46
2483830|NCT00895453|6089153|P2|STARTED|Overall Study||50
2483831|NCT00895453|6089154|P1|STARTED|Overall Study||48
2483832|NCT00895414|6089162|P2|NOT COMPLETED|Second Intervention (14 Days)||0
2483833|NCT00895414|6089163|P1|NOT COMPLETED|Second Intervention (14 Days)||0
2483834|NCT00895414|6089162|P2|COMPLETED|Second Intervention (14 Days)||9
2483835|NCT00895414|6089163|P1|COMPLETED|Second Intervention (14 Days)||8
2483836|NCT00895414|6089162|P2|STARTED|Second Intervention (14 Days)||9
2483837|NCT00895414|6089163|P1|STARTED|Second Intervention (14 Days)||8
2483838|NCT00895414|6089162|P2|NOT COMPLETED|First Intervention (14 Days)||1
2483839|NCT00895414|6089163|P1|NOT COMPLETED|First Intervention (14 Days)||1
2483840|NCT00895414|6089162|P2|COMPLETED|First Intervention (14 Days)||9
2483841|NCT00895414|6089163|P1|COMPLETED|First Intervention (14 Days)||8
2483842|NCT00895414|6089162|P2|STARTED|First Intervention (14 Days)||10
2483843|NCT00895414|6089163|P1|STARTED|First Intervention (14 Days)||9
2483844|NCT00895310|6089173|P1|NOT COMPLETED|Overall Study||1
2483845|NCT00895310|6089173|P1|COMPLETED|Overall Study||29
2483846|NCT00895310|6089173|P1|STARTED|Overall Study||30
2483847|NCT00895284|6089182|P2|NOT COMPLETED|Overall Study||0
2483848|NCT00895284|6089183|P1|NOT COMPLETED|Overall Study||0
2483849|NCT00895284|6089182|P2|COMPLETED|Overall Study||0
2483850|NCT00895284|6089183|P1|COMPLETED|Overall Study||3
2483851|NCT00895284|6089182|P2|STARTED|Overall Study||0
2483852|NCT00895284|6089183|P1|STARTED|Overall Study||3
2483853|NCT00895245|6089189|P1|NOT COMPLETED|Overall Study||6
2483854|NCT00895245|6089189|P1|COMPLETED|Overall Study||0
2483855|NCT00895245|6089189|P1|STARTED|Overall Study||6
2483856|NCT00895232|6089199|P3|NOT COMPLETED|Overall Study||5
2483857|NCT00895232|6089200|P2|NOT COMPLETED|Overall Study||4
2483858|NCT00895232|6089201|P1|NOT COMPLETED|Overall Study||3
2483859|NCT00895232|6089199|P3|COMPLETED|Overall Study||3
2483860|NCT00895232|6089200|P2|COMPLETED|Overall Study||2
2483861|NCT00895232|6089201|P1|COMPLETED|Overall Study||4
2483862|NCT00895232|6089199|P3|STARTED|Overall Study||8
2483863|NCT00895232|6089200|P2|STARTED|Overall Study||6
2483864|NCT00895232|6089201|P1|STARTED|Overall Study||7
2483865|NCT00895193|6089219|P4|NOT COMPLETED|Overall Study||0
2483866|NCT00895193|6089220|P3|NOT COMPLETED|Overall Study||0
2483867|NCT00895193|6089221|P2|NOT COMPLETED|Overall Study||0
2483868|NCT00895193|6089222|P1|NOT COMPLETED|Overall Study||0
2483869|NCT00895193|6089219|P4|COMPLETED|Overall Study||25
2483870|NCT00895193|6089220|P3|COMPLETED|Overall Study||25
2483871|NCT00895193|6089221|P2|COMPLETED|Overall Study||25
2483872|NCT00895193|6089222|P1|COMPLETED|Overall Study||25
2483873|NCT00895193|6089219|P4|STARTED|Overall Study||25
2483874|NCT00895193|6089220|P3|STARTED|Overall Study||25
2483875|NCT00895193|6089221|P2|STARTED|Overall Study||25
2483876|NCT00895193|6089222|P1|STARTED|Overall Study||25
2483877|NCT00895180|6089246|P2|NOT COMPLETED|Overall Study||0
2483878|NCT00895180|6089247|P1|NOT COMPLETED|Overall Study||0
2483879|NCT00895180|6089246|P2|COMPLETED|Overall Study||40
2483880|NCT00895180|6089247|P1|COMPLETED|Overall Study||40
2483881|NCT00895180|6089246|P2|Received at Least 1 Dose of Study Drug|Overall Study||40
2483882|NCT00895180|6089247|P1|Received at Least 1 Dose of Study Drug|Overall Study||40
2483883|NCT00895180|6089246|P2|STARTED|Overall Study||40
2483884|NCT00895180|6089247|P1|STARTED|Overall Study||40
2483885|NCT00895154|6089267|P2|NOT COMPLETED|Overall Study||2
2483886|NCT00895154|6089268|P1|NOT COMPLETED|Overall Study||1
2483887|NCT00895154|6089267|P2|COMPLETED|Overall Study||8
2483888|NCT00895154|6089268|P1|COMPLETED|Overall Study||7
2483889|NCT00895154|6089267|P2|Follow Up|Overall Study||8
2483890|NCT00895154|6089268|P1|Follow Up|Overall Study||7
2483891|NCT00895154|6089267|P2|STARTED|Overall Study||10
2483892|NCT00895154|6089268|P1|STARTED|Overall Study||8
2483893|NCT00895037|6089303|P3|NOT COMPLETED|Overall Study||1
2483894|NCT00895037|6089304|P2|NOT COMPLETED|Overall Study||2
2483895|NCT00895037|6089305|P1|NOT COMPLETED|Overall Study||0
2483896|NCT00895037|6089303|P3|COMPLETED|Overall Study||1
2483897|NCT00895037|6089304|P2|COMPLETED|Overall Study||75
2483898|NCT00895037|6089305|P1|COMPLETED|Overall Study||22
2483899|NCT00895037|6089303|P3|STARTED|Overall Study||2
2483900|NCT00895037|6089304|P2|STARTED|Overall Study||77
2483901|NCT00895037|6089305|P1|STARTED|Overall Study||22
2483902|NCT00895011|6089336|P3|NOT COMPLETED|Overall Study||8
2483903|NCT00895011|6089337|P2|NOT COMPLETED|Overall Study||14
2483904|NCT00895011|6089338|P1|NOT COMPLETED|Overall Study||24
2483905|NCT00895011|6089336|P3|COMPLETED|Overall Study||91
2483906|NCT00895011|6089337|P2|COMPLETED|Overall Study||85
2483907|NCT00895011|6089338|P1|COMPLETED|Overall Study||76
2483908|NCT00895011|6089336|P3|STARTED|Overall Study||99
2483909|NCT00895011|6089337|P2|STARTED|Overall Study||99
2483910|NCT00895011|6089338|P1|STARTED|Overall Study||100
2483911|NCT00894933|6089352|P1|NOT COMPLETED|Overall Study||4
2483912|NCT00894933|6089352|P1|COMPLETED|Overall Study||29
2483913|NCT00894933|6089352|P1|STARTED|Overall Study||33
2483914|NCT00894803|6089370|P2|NOT COMPLETED|Overall Study||5
2483915|NCT00894803|6089371|P1|NOT COMPLETED|Overall Study||20
2483916|NCT00894803|6089370|P2|COMPLETED|Overall Study||20
2483917|NCT00894803|6089371|P1|COMPLETED|Overall Study||81
2483918|NCT00894803|6089370|P2|STARTED|Overall Study||25
2483919|NCT00894803|6089371|P1|STARTED|Overall Study||101
2483920|NCT00894790|6089407|P2|NOT COMPLETED|Overall Study||2
2483921|NCT00894790|6089408|P1|NOT COMPLETED|Overall Study||1
2483922|NCT00894790|6089407|P2|COMPLETED|Overall Study||2
2483923|NCT00894790|6089408|P1|COMPLETED|Overall Study||3
2483924|NCT00894790|6089407|P2|STARTED|Overall Study||4
2483925|NCT00894790|6089408|P1|STARTED|Overall Study||4
2483926|NCT00894738|6089432|P2|NOT COMPLETED|Overall Study||0
2483927|NCT00894738|6089433|P1|NOT COMPLETED|Overall Study||0
2483928|NCT00894738|6089432|P2|COMPLETED|Overall Study||19
2483929|NCT00894738|6089433|P1|COMPLETED|Overall Study||25
2483930|NCT00894738|6089432|P2|STARTED|Overall Study||19
2483931|NCT00894738|6089433|P1|STARTED|Overall Study||25
2483932|NCT00894699|6089443|P2|NOT COMPLETED|Overall Study||0
2483933|NCT00894699|6089444|P1|NOT COMPLETED|Overall Study||0
2483934|NCT00894699|6089443|P2|COMPLETED|Overall Study||19
2483935|NCT00894699|6089444|P1|COMPLETED|Overall Study||21
2483936|NCT00894699|6089443|P2|STARTED|Overall Study||19
2483937|NCT00894699|6089444|P1|STARTED|Overall Study||21
2483938|NCT00894686|6089450|P1|NOT COMPLETED|Overall Study||56
2483939|NCT00894686|6089450|P1|COMPLETED|Overall Study||123
2483940|NCT00894686|6089450|P1|STARTED|Overall Study||179
2483941|NCT00894647|6089474|P2|NOT COMPLETED|Overall Study||14
2483942|NCT00894647|6089475|P1|NOT COMPLETED|Overall Study||10
2483943|NCT00894647|6089474|P2|COMPLETED|Overall Study||112
2483944|NCT00894647|6089475|P1|COMPLETED|Overall Study||111
2483945|NCT00894647|6089474|P2|STARTED|Overall Study||126
2483946|NCT00894647|6089475|P1|STARTED|Overall Study||121
2483947|NCT00894556|6089488|P4|NOT COMPLETED|Treatment Phase||0
2483948|NCT00894556|6089489|P3|NOT COMPLETED|Treatment Phase||1
2483949|NCT00894556|6089490|P2|NOT COMPLETED|Treatment Phase||4
2483950|NCT00894556|6089491|P1|NOT COMPLETED|Treatment Phase||4
2483951|NCT00894556|6089488|P4|COMPLETED|Treatment Phase||0
2483952|NCT00894556|6089489|P3|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|35
2483953|NCT00894556|6089490|P2|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|32
2483954|NCT00894556|6089491|P1|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|33
2483955|NCT00894556|6089488|P4|STARTED|Treatment Phase||0
2483956|NCT00894556|6089489|P3|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
2483957|NCT00894556|6089490|P2|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
2483958|NCT00894556|6089491|P1|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|37
2483959|NCT00894556|6089488|P4|NOT COMPLETED|Baseline Phase||85
2483960|NCT00894556|6089489|P3|NOT COMPLETED|Baseline Phase||0
2483961|NCT00894556|6089490|P2|NOT COMPLETED|Baseline Phase||0
2483962|NCT00894556|6089491|P1|NOT COMPLETED|Baseline Phase||0
2483963|NCT00894556|6089488|P4|COMPLETED|Baseline Phase||109
2483964|NCT00894556|6089489|P3|COMPLETED|Baseline Phase||0
2483965|NCT00894556|6089490|P2|COMPLETED|Baseline Phase||0
2483966|NCT00894556|6089491|P1|COMPLETED|Baseline Phase||0
2483967|NCT00894556|6089488|P4|STARTED|Baseline Phase||194
2483968|NCT00894556|6089489|P3|STARTED|Baseline Phase||0
2483969|NCT00894556|6089490|P2|STARTED|Baseline Phase||0
2483970|NCT00894556|6089491|P1|STARTED|Baseline Phase||0
2483971|NCT00894543|6089502|P2|NOT COMPLETED|Week 4 to Week 8||2
2483972|NCT00894543|6089503|P1|NOT COMPLETED|Week 4 to Week 8||4
2483973|NCT00894543|6089502|P2|COMPLETED|Week 4 to Week 8||97
2483974|NCT00894543|6089503|P1|COMPLETED|Week 4 to Week 8||97
2483975|NCT00894543|6089502|P2|STARTED|Week 4 to Week 8||99
2483976|NCT00894543|6089503|P1|STARTED|Week 4 to Week 8||101
2483977|NCT00894543|6089502|P2|NOT COMPLETED|Baseline to Week 4||2
2483978|NCT00894543|6089503|P1|NOT COMPLETED|Baseline to Week 4||3
2483979|NCT00894543|6089502|P2|COMPLETED|Baseline to Week 4||99
2483980|NCT00894543|6089503|P1|COMPLETED|Baseline to Week 4||101
2483981|NCT00894543|6089502|P2|STARTED|Baseline to Week 4||101
2483982|NCT00894543|6089503|P1|STARTED|Baseline to Week 4||104
2483983|NCT00894543|6089502|P2|NOT COMPLETED|Baseline||0
2483984|NCT00894543|6089503|P1|NOT COMPLETED|Baseline||0
2483985|NCT00894543|6089502|P2|COMPLETED|Baseline||101
2483986|NCT00894543|6089503|P1|COMPLETED|Baseline||104
2483987|NCT00894543|6089502|P2|STARTED|Baseline||101
2483988|NCT00894543|6089503|P1|STARTED|Baseline||104
2483989|NCT00894517|6089527|P2|NOT COMPLETED|Overall Study||5
2483990|NCT00894517|6089528|P1|NOT COMPLETED|Overall Study||2
2483991|NCT00894517|6089527|P2|COMPLETED|Overall Study||26
2483992|NCT00894517|6089528|P1|COMPLETED|Overall Study||28
2483993|NCT00894517|6089527|P2|STARTED|Overall Study||31
2483994|NCT00894517|6089528|P1|STARTED|Overall Study||30
2483995|NCT00894504|6089542|P1|NOT COMPLETED|Overall Study||71
2483996|NCT00894504|6089542|P1|COMPLETED|Overall Study||0
2483997|NCT00894504|6089542|P1|STARTED|Overall Study||71
2483998|NCT00894465|6089558|P2|NOT COMPLETED|Overall Study||0
2483999|NCT00894465|6089559|P1|NOT COMPLETED|Overall Study||0
2484000|NCT00894465|6089558|P2|COMPLETED|Overall Study||22
2484001|NCT00894465|6089559|P1|COMPLETED|Overall Study||22
2484002|NCT00894465|6089558|P2|STARTED|Overall Study||22
2484003|NCT00894465|6089559|P1|STARTED|Overall Study||22
2484004|NCT00894413|6089569|P2|NOT COMPLETED|Overall Study||8
2484005|NCT00894413|6089570|P1|NOT COMPLETED|Overall Study||0
2484006|NCT00894413|6089569|P2|COMPLETED|Overall Study||17
2484007|NCT00894413|6089570|P1|COMPLETED|Overall Study||15
2484008|NCT00894413|6089569|P2|STARTED|Overall Study||25
2484009|NCT00894413|6089570|P1|STARTED|Overall Study||15
2484010|NCT00894387|6089578|P2|NOT COMPLETED|Overall Study||175
2484011|NCT00894387|6089579|P1|NOT COMPLETED|Overall Study||175
2484012|NCT00894387|6089578|P2|COMPLETED|Overall Study||643
2484013|NCT00894387|6089579|P1|COMPLETED|Overall Study|"Completed indicates patients whose treatment duration completed as per protocol"|646
2484014|NCT00894387|6089578|P2|Completed Secondary Efficacy Phase (12m)|Overall Study||640
2484015|NCT00894387|6089579|P1|Completed Secondary Efficacy Phase (12m)|Overall Study||654
2484016|NCT00894387|6089578|P2|Completed Primary Efficacy Phase (6 m)|Overall Study||707
2484017|NCT00894387|6089579|P1|Completed Primary Efficacy Phase (6 m)|Overall Study||717
2484018|NCT00894387|6089578|P2|Full Analysis Set|Overall Study||807
2484019|NCT00894387|6089579|P1|Full Analysis Set|Overall Study||808
2484020|NCT00894387|6089578|P2|Safety Set|Overall Study||810
2484021|NCT00894387|6089579|P1|Safety Set|Overall Study||808
2484022|NCT00894387|6089578|P2|STARTED|Overall Study||818
2484023|NCT00894387|6089579|P1|STARTED|Overall Study|"Started indicates all randomized patients"|821
2484024|NCT00894361|6089599|P2|NOT COMPLETED|Overall Study||64
2484025|NCT00894361|6089600|P1|NOT COMPLETED|Overall Study||24
2484026|NCT00894361|6089599|P2|COMPLETED|Overall Study||136
2484027|NCT00894361|6089600|P1|COMPLETED|Overall Study||176
2484028|NCT00894361|6089599|P2|STARTED|Overall Study||200
2484029|NCT00894361|6089600|P1|STARTED|Overall Study||200
2484030|NCT00894322|6089609|P3|NOT COMPLETED|Overall Study||0
2484031|NCT00894322|6089610|P2|NOT COMPLETED|Overall Study||0
2484032|NCT00894322|6089611|P1|NOT COMPLETED|Overall Study||1
2484033|NCT00894322|6089609|P3|COMPLETED|Overall Study||12
2484034|NCT00894322|6089610|P2|COMPLETED|Overall Study||23
2484035|NCT00894322|6089611|P1|COMPLETED|Overall Study||29
2484036|NCT00894322|6089609|P3|STARTED|Overall Study||12
2484037|NCT00894322|6089610|P2|STARTED|Overall Study||23
2484038|NCT00894322|6089611|P1|STARTED|Overall Study||30
2484039|NCT00894244|6089650|P1|NOT COMPLETED|Overall Study||1
2484040|NCT00894244|6089650|P1|COMPLETED|Overall Study||24
2484041|NCT00894244|6089650|P1|STARTED|Overall Study||25
2484042|NCT00894166|6089662|P8|NOT COMPLETED|Overall Study||34
2484043|NCT00894166|6089663|P7|NOT COMPLETED|Overall Study||16
2484044|NCT00894166|6089664|P6|NOT COMPLETED|Overall Study||16
2484045|NCT00894166|6089665|P5|NOT COMPLETED|Overall Study||24
2484046|NCT00894166|6089666|P4|NOT COMPLETED|Overall Study||69
2484047|NCT00894166|6089667|P3|NOT COMPLETED|Overall Study||62
2484048|NCT00894166|6089668|P2|NOT COMPLETED|Overall Study||63
2484049|NCT00894166|6089669|P1|NOT COMPLETED|Overall Study||61
2484050|NCT00894166|6089662|P8|COMPLETED|Overall Study||0
2484051|NCT00894166|6089663|P7|COMPLETED|Overall Study||19
2484052|NCT00894166|6089664|P6|COMPLETED|Overall Study||20
2484053|NCT00894166|6089665|P5|COMPLETED|Overall Study||10
2484054|NCT00894166|6089666|P4|COMPLETED|Overall Study||45
2484055|NCT00894166|6089667|P3|COMPLETED|Overall Study||50
2484056|NCT00894166|6089668|P2|COMPLETED|Overall Study||46
2484057|NCT00894166|6089669|P1|COMPLETED|Overall Study||71
2484058|NCT00894166|6089662|P8|STARTED|Overall Study||34
2484059|NCT00894166|6089663|P7|STARTED|Overall Study||35
2484060|NCT00894166|6089664|P6|STARTED|Overall Study||36
2484061|NCT00894166|6089665|P5|STARTED|Overall Study||34
2484062|NCT00894166|6089666|P4|STARTED|Overall Study||114
2484063|NCT00894166|6089667|P3|STARTED|Overall Study||112
2484064|NCT00894166|6089668|P2|STARTED|Overall Study||109
2484065|NCT00894166|6089669|P1|STARTED|Overall Study||132
2484066|NCT00894127|6089699|P1|NOT COMPLETED|Overall Study||0
2484067|NCT00894127|6089699|P1|COMPLETED|Overall Study||128
2484068|NCT00894127|6089699|P1|STARTED|Overall Study||128
2484069|NCT00893997|6089703|P1|NOT COMPLETED|Overall Study||0
2484070|NCT00893997|6089703|P1|COMPLETED|Overall Study||10
2484071|NCT00893997|6089703|P1|STARTED|Overall Study||10
2484072|NCT00893984|6089708|P1|NOT COMPLETED|Overall Study||6
2484073|NCT00893984|6089708|P1|COMPLETED|Overall Study||0
2484074|NCT00893984|6089708|P1|STARTED|Overall Study||6
2484075|NCT00893971|6089715|P1|NOT COMPLETED|Overall Study||3
2484076|NCT00893971|6089715|P1|COMPLETED|Overall Study||13
2484077|NCT00893971|6089715|P1|GP MDI (PT001) + FF MDI (PT005)|Overall Study||16
2484078|NCT00893971|6089715|P1|Placebo + FF MDI (PT005)|Overall Study||13
2484079|NCT00893971|6089715|P1|Placebo + GFF MDI (PT003)|Overall Study||15
2484080|NCT00893971|6089715|P1|Placebo + GP MDI (PT001)|Overall Study||15
2484081|NCT00893971|6089715|P1|STARTED|Overall Study||16
2484082|NCT00893789|6089833|P4|NOT COMPLETED|Overall Study||13
2484083|NCT00893789|6089834|P3|NOT COMPLETED|Overall Study||7
2484084|NCT00893789|6089835|P2|NOT COMPLETED|Overall Study||4
2484085|NCT00893789|6089836|P1|NOT COMPLETED|Overall Study||6
2484086|NCT00893789|6089833|P4|COMPLETED|Overall Study||16
2484087|NCT00893789|6089834|P3|COMPLETED|Overall Study||22
2484088|NCT00893789|6089835|P2|COMPLETED|Overall Study||26
2484089|NCT00893789|6089836|P1|COMPLETED|Overall Study||23
2484090|NCT00893789|6089833|P4|Full Analysis Set (FAS)|Overall Study||27
2484091|NCT00893789|6089834|P3|Full Analysis Set (FAS)|Overall Study||28
2484092|NCT00893789|6089835|P2|Full Analysis Set (FAS)|Overall Study||29
2484093|NCT00893789|6089836|P1|Full Analysis Set (FAS)|Overall Study|FAS = participants in the safety analysis set with ≥1 postbaseline primary efficacy assessment.|29
2484094|NCT00893789|6089833|P4|Safety Analysis Set (SAS)|Overall Study||29
2484095|NCT00893789|6089834|P3|Safety Analysis Set (SAS)|Overall Study||29
2484096|NCT00893789|6089835|P2|Safety Analysis Set (SAS)|Overall Study||30
2484097|NCT00893789|6089836|P1|Safety Analysis Set (SAS)|Overall Study|SAS = all participants who received 1 or more doses of study drug.|29
2484098|NCT00893789|6089833|P4|STARTED|Overall Study||29
2484099|NCT00893789|6089834|P3|STARTED|Overall Study||29
2484100|NCT00893789|6089835|P2|STARTED|Overall Study||30
2484101|NCT00893789|6089836|P1|STARTED|Overall Study||29
2484102|NCT00893763|6089920|P2|NOT COMPLETED|Overall Study||110
2484103|NCT00893763|6089921|P1|NOT COMPLETED|Overall Study||110
2484104|NCT00893763|6089920|P2|COMPLETED|Overall Study||47
2484105|NCT00893763|6089921|P1|COMPLETED|Overall Study||47
2484106|NCT00893763|6089920|P2|STARTED|Overall Study||157
2484107|NCT00893763|6089921|P1|STARTED|Overall Study||157
2484108|NCT00893737|6089929|P1|NOT COMPLETED|Overall Study||12
2484109|NCT00893737|6089929|P1|COMPLETED|Overall Study||135
2484110|NCT00893737|6089929|P1|STARTED|Overall Study||147
2484111|NCT00893464|6089943|P8|NOT COMPLETED|Overall Study||2
2484112|NCT00893464|6089944|P7|NOT COMPLETED|Overall Study||2
2484113|NCT00893464|6089945|P6|NOT COMPLETED|Overall Study||0
2484114|NCT00893464|6089946|P5|NOT COMPLETED|Overall Study||0
2484115|NCT00893464|6089947|P4|NOT COMPLETED|Overall Study||0
2484116|NCT00893464|6089948|P3|NOT COMPLETED|Overall Study||0
2484117|NCT00893464|6089949|P2|NOT COMPLETED|Overall Study||0
2484118|NCT00893464|6089950|P1|NOT COMPLETED|Overall Study||0
2484119|NCT00893464|6089943|P8|COMPLETED|Overall Study||3
2484120|NCT00893464|6089944|P7|COMPLETED|Overall Study||8
2484121|NCT00893464|6089945|P6|COMPLETED|Overall Study||7
2484122|NCT00893464|6089946|P5|COMPLETED|Overall Study||4
2484123|NCT00893464|6089947|P4|COMPLETED|Overall Study||1
2484124|NCT00893464|6089948|P3|COMPLETED|Overall Study||1
2484125|NCT00893464|6089949|P2|COMPLETED|Overall Study||1
2484126|NCT00893464|6089950|P1|COMPLETED|Overall Study||1
2484127|NCT00893464|6089943|P8|STARTED|Overall Study||5
2484128|NCT00893464|6089944|P7|STARTED|Overall Study||10
2484129|NCT00893464|6089945|P6|STARTED|Overall Study||7
2484130|NCT00893464|6089946|P5|STARTED|Overall Study||4
2484131|NCT00893464|6089947|P4|STARTED|Overall Study||1
2484132|NCT00893464|6089948|P3|STARTED|Overall Study||1
2484133|NCT00893464|6089949|P2|STARTED|Overall Study||1
2484134|NCT00893464|6089950|P1|STARTED|Overall Study||1
2484135|NCT00893152|6090068|P2|NOT COMPLETED|Overall Study||0
2484136|NCT00893152|6090069|P1|NOT COMPLETED|Overall Study||0
2484137|NCT00893152|6090068|P2|COMPLETED|Overall Study||36
2484138|NCT00893152|6090069|P1|COMPLETED|Overall Study||47
2484139|NCT00893152|6090068|P2|STARTED|Overall Study||36
2484140|NCT00893152|6090069|P1|STARTED|Overall Study||47
2484141|NCT00893113|6090077|P2|NOT COMPLETED|Overall Study||16
2484142|NCT00893113|6090078|P1|NOT COMPLETED|Overall Study||13
2484143|NCT00893113|6090077|P2|COMPLETED|Overall Study||22
2484144|NCT00893113|6090078|P1|COMPLETED|Overall Study||23
2484145|NCT00893113|6090077|P2|STARTED|Overall Study||38
2484146|NCT00893113|6090078|P1|STARTED|Overall Study||36
2484147|NCT00893074|6090088|P1|NOT COMPLETED|Overall Study||11
2484148|NCT00893074|6090088|P1|COMPLETED|Overall Study||13
2484149|NCT00893074|6090088|P1|STARTED|Overall Study||24
2484150|NCT00892957|6090108|P2|NOT COMPLETED|Postoperative Day 30 Assessment||0
2484151|NCT00892957|6090109|P1|NOT COMPLETED|Postoperative Day 30 Assessment||0
2484152|NCT00892957|6090108|P2|COMPLETED|Postoperative Day 30 Assessment||66
2484153|NCT00892957|6090109|P1|COMPLETED|Postoperative Day 30 Assessment||70
2484154|NCT00892957|6090108|P2|STARTED|Postoperative Day 30 Assessment||66
2484155|NCT00892957|6090109|P1|STARTED|Postoperative Day 30 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|70
2484156|NCT00892957|6090108|P2|NOT COMPLETED|Postoperative Day 14 Assessment||0
2484157|NCT00892957|6090109|P1|NOT COMPLETED|Postoperative Day 14 Assessment||0
2484158|NCT00892957|6090108|P2|COMPLETED|Postoperative Day 14 Assessment||66
2484159|NCT00892957|6090109|P1|COMPLETED|Postoperative Day 14 Assessment||68
2484160|NCT00892957|6090108|P2|STARTED|Postoperative Day 14 Assessment||66
2484161|NCT00892957|6090109|P1|STARTED|Postoperative Day 14 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|68
2484162|NCT00892957|6090108|P2|NOT COMPLETED|Between Postoperative Day 1 and Day 14||4
2484163|NCT00892957|6090109|P1|NOT COMPLETED|Between Postoperative Day 1 and Day 14||0
2484164|NCT00892957|6090108|P2|COMPLETED|Between Postoperative Day 1 and Day 14||66
2484165|NCT00892957|6090109|P1|COMPLETED|Between Postoperative Day 1 and Day 14||70
2484166|NCT00892957|6090108|P2|STARTED|Between Postoperative Day 1 and Day 14||70
2484167|NCT00892957|6090109|P1|STARTED|Between Postoperative Day 1 and Day 14||70
2484168|NCT00892957|6090108|P2|NOT COMPLETED|Postoperative Day 1 Assessment||0
2484169|NCT00892957|6090109|P1|NOT COMPLETED|Postoperative Day 1 Assessment||0
2484170|NCT00892957|6090108|P2|COMPLETED|Postoperative Day 1 Assessment||70
2484171|NCT00892957|6090109|P1|COMPLETED|Postoperative Day 1 Assessment||70
2484172|NCT00892957|6090108|P2|STARTED|Postoperative Day 1 Assessment||70
2484173|NCT00892957|6090109|P1|STARTED|Postoperative Day 1 Assessment||70
2484174|NCT00892957|6090108|P2|NOT COMPLETED|Intraoperative Day 0||0
2484175|NCT00892957|6090109|P1|NOT COMPLETED|Intraoperative Day 0||0
2484176|NCT00892957|6090108|P2|COMPLETED|Intraoperative Day 0||70
2484177|NCT00892957|6090109|P1|COMPLETED|Intraoperative Day 0||70
2484178|NCT00892957|6090108|P2|STARTED|Intraoperative Day 0||70
2484179|NCT00892957|6090109|P1|STARTED|Intraoperative Day 0||70
2484180|NCT00892775|6090197|P2|NOT COMPLETED|Overall Study||1
2484181|NCT00892775|6090198|P1|NOT COMPLETED|Overall Study||5
2484182|NCT00892775|6090197|P2|COMPLETED|Overall Study||165
2484183|NCT00892775|6090198|P1|COMPLETED|Overall Study||327
2484184|NCT00892775|6090197|P2|STARTED|Overall Study||166
2484185|NCT00892775|6090198|P1|STARTED|Overall Study||332
2484186|NCT00892723|6090225|P3|NOT COMPLETED|Overall Study||2
2484187|NCT00892723|6090226|P2|NOT COMPLETED|Overall Study||4
2484188|NCT00892723|6090227|P1|NOT COMPLETED|Overall Study||2
2484189|NCT00892723|6090225|P3|COMPLETED|Overall Study||17
2484190|NCT00892723|6090226|P2|COMPLETED|Overall Study||15
2484191|NCT00892723|6090227|P1|COMPLETED|Overall Study||19
2484192|NCT00892723|6090225|P3|STARTED|Overall Study||19
2484193|NCT00892723|6090226|P2|STARTED|Overall Study||19
2484194|NCT00892723|6090227|P1|STARTED|Overall Study||21
2484195|NCT00892710|6090271|P3|NOT COMPLETED|Overall Study||55
2484196|NCT00892710|6090272|P2|NOT COMPLETED|Overall Study||59
2484197|NCT00892710|6090273|P1|NOT COMPLETED|Overall Study||48
2484198|NCT00892710|6090271|P3|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
2484199|NCT00892710|6090272|P2|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
2484200|NCT00892710|6090273|P1|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
2484201|NCT00892710|6090271|P3|STARTED|Overall Study||55
2484202|NCT00892710|6090272|P2|STARTED|Overall Study||59
2484203|NCT00892710|6090273|P1|STARTED|Overall Study||48
2484204|NCT00892697|6090296|P1|NOT COMPLETED|Overall Study||0
2484205|NCT00892697|6090296|P1|COMPLETED|Overall Study||15
2484206|NCT00892697|6090296|P1|STARTED|Overall Study||15
2484207|NCT00892606|6090303|P2|NOT COMPLETED|Overall Study||4
2484208|NCT00892606|6090304|P1|NOT COMPLETED|Overall Study||5
2484209|NCT00892606|6090303|P2|COMPLETED|Overall Study||33
2484210|NCT00892606|6090304|P1|COMPLETED|Overall Study||33
2484211|NCT00892606|6090303|P2|STARTED|Overall Study||37
2484212|NCT00892606|6090304|P1|STARTED|Overall Study||38
2484213|NCT00892437|6090316|P2|NOT COMPLETED|Open-Label Extension Phase||4
2484214|NCT00892437|6090317|P1|NOT COMPLETED|Open-Label Extension Phase||12
2484215|NCT00892437|6090316|P2|COMPLETED|Open-Label Extension Phase||15
2484216|NCT00892437|6090317|P1|COMPLETED|Open-Label Extension Phase||32
2484217|NCT00892437|6090316|P2|STARTED|Open-Label Extension Phase|5 participants completed the randomized phase but did not enter the open-label extension phase.|19
2484218|NCT00892437|6090317|P1|STARTED|Open-Label Extension Phase|1 participant completed the randomized phase but did not enter the open-label extension phase.|44
2484219|NCT00892437|6090316|P2|NOT COMPLETED|Randomized Phase||5
2484220|NCT00892437|6090317|P1|NOT COMPLETED|Randomized Phase||11
2484221|NCT00892437|6090316|P2|COMPLETED|Randomized Phase||24
2484222|NCT00892437|6090317|P1|COMPLETED|Randomized Phase||45
2484223|NCT00892437|6090316|P2|Randomized and Treated|Randomized Phase||29
2484224|NCT00892437|6090317|P1|Randomized and Treated|Randomized Phase||50
2484225|NCT00892437|6090316|P2|STARTED|Randomized Phase||29
2484226|NCT00892437|6090317|P1|STARTED|Randomized Phase||56
2484227|NCT00892281|6090336|P2|NOT COMPLETED|Overall Study||37
2484228|NCT00892281|6090337|P1|NOT COMPLETED|Overall Study||267
2484229|NCT00892281|6090336|P2|COMPLETED|Overall Study||187
2484230|NCT00892281|6090337|P1|COMPLETED|Overall Study||930
2484231|NCT00892281|6090336|P2|STARTED|Overall Study||224
2484232|NCT00892281|6090337|P1|STARTED|Overall Study||1197
2484233|NCT00892177|6090350|P6|NOT COMPLETED|Phase II||2
2484234|NCT00892177|6090351|P5|NOT COMPLETED|Phase II||5
2484235|NCT00892177|6090352|P4|NOT COMPLETED|Phase II||0
2484236|NCT00892177|6090353|P3|NOT COMPLETED|Phase II||0
2484237|NCT00892177|6090354|P2|NOT COMPLETED|Phase II||0
2484238|NCT00892177|6090355|P1|NOT COMPLETED|Phase II||0
2484239|NCT00892177|6090350|P6|COMPLETED|Phase II||38
2484240|NCT00892177|6090351|P5|COMPLETED|Phase II||83
2484241|NCT00892177|6090352|P4|COMPLETED|Phase II||0
2484242|NCT00892177|6090353|P3|COMPLETED|Phase II||0
2484243|NCT00892177|6090354|P2|COMPLETED|Phase II||0
2484244|NCT00892177|6090355|P1|COMPLETED|Phase II||0
2484245|NCT00892177|6090350|P6|STARTED|Phase II||40
2484246|NCT00892177|6090351|P5|STARTED|Phase II||88
2484247|NCT00892177|6090352|P4|STARTED|Phase II||0
2484248|NCT00892177|6090353|P3|STARTED|Phase II||0
2484249|NCT00892177|6090354|P2|STARTED|Phase II||0
2484250|NCT00892177|6090355|P1|STARTED|Phase II||0
2484251|NCT00892177|6090350|P6|NOT COMPLETED|Phase I: Dose Level 3||0
2484252|NCT00892177|6090351|P5|NOT COMPLETED|Phase I: Dose Level 3||0
2484253|NCT00892177|6090352|P4|NOT COMPLETED|Phase I: Dose Level 3||0
2484254|NCT00892177|6090353|P3|NOT COMPLETED|Phase I: Dose Level 3||0
2484255|NCT00892177|6090354|P2|NOT COMPLETED|Phase I: Dose Level 3||0
2484256|NCT00892177|6090355|P1|NOT COMPLETED|Phase I: Dose Level 3||0
2484257|NCT00892177|6090350|P6|COMPLETED|Phase I: Dose Level 3||0
2484258|NCT00892177|6090351|P5|COMPLETED|Phase I: Dose Level 3||0
2484259|NCT00892177|6090352|P4|COMPLETED|Phase I: Dose Level 3||6
2484260|NCT00892177|6090353|P3|COMPLETED|Phase I: Dose Level 3||0
2484261|NCT00892177|6090354|P2|COMPLETED|Phase I: Dose Level 3||0
2484262|NCT00892177|6090355|P1|COMPLETED|Phase I: Dose Level 3||0
2484263|NCT00892177|6090350|P6|STARTED|Phase I: Dose Level 3||0
2484264|NCT00892177|6090351|P5|STARTED|Phase I: Dose Level 3||0
2484265|NCT00892177|6090352|P4|STARTED|Phase I: Dose Level 3||6
2484266|NCT00892177|6090353|P3|STARTED|Phase I: Dose Level 3||0
2484267|NCT00892177|6090354|P2|STARTED|Phase I: Dose Level 3||0
2484268|NCT00892177|6090355|P1|STARTED|Phase I: Dose Level 3||0
2484269|NCT00892177|6090350|P6|NOT COMPLETED|Phase I: Dose Level 2||0
2484270|NCT00892177|6090351|P5|NOT COMPLETED|Phase I: Dose Level 2||0
2484271|NCT00892177|6090352|P4|NOT COMPLETED|Phase I: Dose Level 2||0
2484272|NCT00892177|6090353|P3|NOT COMPLETED|Phase I: Dose Level 2||0
2484273|NCT00892177|6090354|P2|NOT COMPLETED|Phase I: Dose Level 2||0
2484274|NCT00892177|6090355|P1|NOT COMPLETED|Phase I: Dose Level 2||0
2484275|NCT00892177|6090350|P6|COMPLETED|Phase I: Dose Level 2||0
2484276|NCT00892177|6090351|P5|COMPLETED|Phase I: Dose Level 2||0
2484277|NCT00892177|6090352|P4|COMPLETED|Phase I: Dose Level 2||0
2484278|NCT00892177|6090353|P3|COMPLETED|Phase I: Dose Level 2||3
2484279|NCT00892177|6090354|P2|COMPLETED|Phase I: Dose Level 2||0
2484280|NCT00892177|6090355|P1|COMPLETED|Phase I: Dose Level 2||0
2484281|NCT00892177|6090350|P6|STARTED|Phase I: Dose Level 2||0
2484282|NCT00892177|6090351|P5|STARTED|Phase I: Dose Level 2||0
2484283|NCT00892177|6090352|P4|STARTED|Phase I: Dose Level 2||0
2484284|NCT00892177|6090353|P3|STARTED|Phase I: Dose Level 2||3
2484285|NCT00892177|6090354|P2|STARTED|Phase I: Dose Level 2||0
2484286|NCT00892177|6090355|P1|STARTED|Phase I: Dose Level 2||0
2484287|NCT00892177|6090350|P6|NOT COMPLETED|Phase I: Dose Level 1||0
2484288|NCT00892177|6090351|P5|NOT COMPLETED|Phase I: Dose Level 1||0
2484289|NCT00892177|6090352|P4|NOT COMPLETED|Phase I: Dose Level 1||0
2484290|NCT00892177|6090353|P3|NOT COMPLETED|Phase I: Dose Level 1||0
2484291|NCT00892177|6090354|P2|NOT COMPLETED|Phase I: Dose Level 1||0
2484292|NCT00892177|6090355|P1|NOT COMPLETED|Phase I: Dose Level 1||0
2484293|NCT00892177|6090350|P6|COMPLETED|Phase I: Dose Level 1||0
2484294|NCT00892177|6090351|P5|COMPLETED|Phase I: Dose Level 1||0
2484295|NCT00892177|6090352|P4|COMPLETED|Phase I: Dose Level 1||0
2484296|NCT00892177|6090353|P3|COMPLETED|Phase I: Dose Level 1||0
2484297|NCT00892177|6090354|P2|COMPLETED|Phase I: Dose Level 1||4
2484298|NCT00892177|6090355|P1|COMPLETED|Phase I: Dose Level 1||0
2484299|NCT00892177|6090350|P6|STARTED|Phase I: Dose Level 1||0
2484300|NCT00892177|6090351|P5|STARTED|Phase I: Dose Level 1||0
2484301|NCT00892177|6090352|P4|STARTED|Phase I: Dose Level 1||0
2484302|NCT00892177|6090353|P3|STARTED|Phase I: Dose Level 1||0
2484303|NCT00892177|6090354|P2|STARTED|Phase I: Dose Level 1||4
2484304|NCT00892177|6090355|P1|STARTED|Phase I: Dose Level 1||0
2484305|NCT00892177|6090350|P6|NOT COMPLETED|Phase I: Dose Level 0||0
2484306|NCT00892177|6090351|P5|NOT COMPLETED|Phase I: Dose Level 0||0
2484307|NCT00892177|6090352|P4|NOT COMPLETED|Phase I: Dose Level 0||0
2484308|NCT00892177|6090353|P3|NOT COMPLETED|Phase I: Dose Level 0||0
2484309|NCT00892177|6090354|P2|NOT COMPLETED|Phase I: Dose Level 0||0
2484310|NCT00892177|6090355|P1|NOT COMPLETED|Phase I: Dose Level 0||0
2484311|NCT00892177|6090350|P6|COMPLETED|Phase I: Dose Level 0||0
2484312|NCT00892177|6090351|P5|COMPLETED|Phase I: Dose Level 0||0
2484313|NCT00892177|6090352|P4|COMPLETED|Phase I: Dose Level 0||0
2484314|NCT00892177|6090353|P3|COMPLETED|Phase I: Dose Level 0||0
2484315|NCT00892177|6090354|P2|COMPLETED|Phase I: Dose Level 0||0
2484316|NCT00892177|6090355|P1|COMPLETED|Phase I: Dose Level 0||3
2484317|NCT00892177|6090350|P6|STARTED|Phase I: Dose Level 0||0
2484318|NCT00892177|6090351|P5|STARTED|Phase I: Dose Level 0||0
2484319|NCT00892177|6090352|P4|STARTED|Phase I: Dose Level 0||0
2484320|NCT00892177|6090353|P3|STARTED|Phase I: Dose Level 0||0
2484321|NCT00892177|6090354|P2|STARTED|Phase I: Dose Level 0||0
2484322|NCT00892177|6090355|P1|STARTED|Phase I: Dose Level 0||3
2484323|NCT00892151|6090380|P1|NOT COMPLETED|Overall Study||1
2484324|NCT00892151|6090380|P1|COMPLETED|Overall Study||50
2484325|NCT00892151|6090380|P1|STARTED|Overall Study||51
2484326|NCT00892099|6090389|P3|NOT COMPLETED|Overall Study||7
2484327|NCT00892099|6090390|P2|NOT COMPLETED|Overall Study||1
2484328|NCT00892099|6090391|P1|NOT COMPLETED|Overall Study||5
2484329|NCT00892099|6090389|P3|COMPLETED|Overall Study||29
2484330|NCT00892099|6090390|P2|COMPLETED|Overall Study||32
2484331|NCT00892099|6090391|P1|COMPLETED|Overall Study||31
2484332|NCT00892099|6090389|P3|STARTED|Overall Study||36
2484333|NCT00892099|6090390|P2|STARTED|Overall Study||33
2484334|NCT00892099|6090391|P1|STARTED|Overall Study||36
2484335|NCT00892047|6090416|P2|NOT COMPLETED|Overall Study||7
2484336|NCT00892047|6090417|P1|NOT COMPLETED|Overall Study||4
2484337|NCT00892047|6090416|P2|COMPLETED|Overall Study||83
2484338|NCT00892047|6090417|P1|COMPLETED|Overall Study||87
2484339|NCT00892047|6090416|P2|STARTED|Overall Study||90
2484340|NCT00892047|6090417|P1|STARTED|Overall Study||91
2484341|NCT00892008|6090433|P1|NOT COMPLETED|Overall Study||565
2484342|NCT00892008|6090433|P1|COMPLETED|Overall Study||1713
2484343|NCT00892008|6090433|P1|STARTED|Overall Study||2278
2484344|NCT00891995|6090449|P2|NOT COMPLETED|Overall Study||0
2484345|NCT00891995|6090450|P1|NOT COMPLETED|Overall Study||0
2484346|NCT00891995|6090449|P2|COMPLETED|Overall Study||21
2484347|NCT00891995|6090450|P1|COMPLETED|Overall Study||50
2484348|NCT00891995|6090449|P2|STARTED|Overall Study||21
2484349|NCT00891995|6090450|P1|STARTED|Overall Study||50
2484350|NCT00891982|6090474|P2|NOT COMPLETED|Overall Study||1
2484351|NCT00891982|6090475|P1|NOT COMPLETED|Overall Study||2
2484352|NCT00891982|6090474|P2|COMPLETED|Overall Study||30
2484353|NCT00891982|6090475|P1|COMPLETED|Overall Study||28
2484354|NCT00891982|6090474|P2|STARTED|Overall Study||31
2484355|NCT00891982|6090475|P1|STARTED|Overall Study||30
2484356|NCT00891930|6090519|P1|NOT COMPLETED|Part 2: Panitumumab + Ganitumab||31
2484357|NCT00891930|6090519|P1|COMPLETED|Part 2: Panitumumab + Ganitumab||5
2484358|NCT00891930|6090519|P1|STARTED|Part 2: Panitumumab + Ganitumab||36
2484359|NCT00891930|6090519|P1|NOT COMPLETED|Part 1: Panitumumab +Irinotecan||40
2484360|NCT00891930|6090519|P1|COMPLETED|Part 1: Panitumumab +Irinotecan||36
2484361|NCT00891930|6090519|P1|Received Treatment|Part 1: Panitumumab +Irinotecan||74
2484362|NCT00891930|6090519|P1|STARTED|Part 1: Panitumumab +Irinotecan||76
2484363|NCT00891904|6090540|P1|NOT COMPLETED|Overall Study||2
2484364|NCT00891904|6090540|P1|COMPLETED|Overall Study||0
2484365|NCT00891904|6090540|P1|STARTED|Overall Study||2
2484366|NCT00891878|6090549|P2|NOT COMPLETED|Overall Study||0
2484367|NCT00891878|6090550|P1|NOT COMPLETED|Overall Study||0
2484368|NCT00891878|6090549|P2|COMPLETED|Overall Study||6
2484369|NCT00891878|6090550|P1|COMPLETED|Overall Study||6
2484370|NCT00891878|6090549|P2|STARTED|Overall Study||6
2484371|NCT00891878|6090550|P1|STARTED|Overall Study||6
2484372|NCT00891839|6090566|P1|NOT COMPLETED|Overall Study||7
2484373|NCT00891839|6090566|P1|COMPLETED|Overall Study|completed treatment|38
2484374|NCT00891839|6090566|P1|STARTED|Overall Study||45
2484375|NCT00891813|6090575|P1|NOT COMPLETED|Overall Study||12
2484376|NCT00891813|6090575|P1|COMPLETED|Overall Study||88
2484377|NCT00891813|6090575|P1|STARTED|Overall Study||100
2484378|NCT00891774|6090581|P1|NOT COMPLETED|Overall Study||14
2484379|NCT00891774|6090581|P1|COMPLETED|Overall Study||158
2484380|NCT00891774|6090581|P1|STARTED|Overall Study||172
2484381|NCT00891735|6090592|P4|NOT COMPLETED|Overall Study||15
2484382|NCT00891735|6090593|P3|NOT COMPLETED|Overall Study||12
2484383|NCT00891735|6090594|P2|NOT COMPLETED|Overall Study||16
2484384|NCT00891735|6090595|P1|NOT COMPLETED|Overall Study||17
2484385|NCT00891735|6090592|P4|COMPLETED|Overall Study||258
2484386|NCT00891735|6090593|P3|COMPLETED|Overall Study||263
2484387|NCT00891735|6090594|P2|COMPLETED|Overall Study||258
2484388|NCT00891735|6090595|P1|COMPLETED|Overall Study||258
2484389|NCT00891735|6090592|P4|STARTED|Overall Study||273
2484390|NCT00891735|6090593|P3|STARTED|Overall Study||275
2484391|NCT00891735|6090594|P2|STARTED|Overall Study||274
2484392|NCT00891735|6090595|P1|STARTED|Overall Study||275
2484393|NCT00891657|6090635|P2|NOT COMPLETED|Overall Study||1
2484394|NCT00891657|6090636|P1|NOT COMPLETED|Overall Study||1
2484395|NCT00891657|6090635|P2|COMPLETED|Overall Study||5
2484396|NCT00891657|6090636|P1|COMPLETED|Overall Study||8
2484397|NCT00891657|6090635|P2|STARTED|Overall Study||6
2484398|NCT00891657|6090636|P1|STARTED|Overall Study||9
2484399|NCT00891618|6090648|P1|NOT COMPLETED|Overall Study||1
2484400|NCT00891618|6090648|P1|COMPLETED|Overall Study||20
2484401|NCT00891618|6090648|P1|STARTED|Overall Study||21
2484402|NCT00891527|6090652|P1|NOT COMPLETED|Overall Study||2
2484403|NCT00891527|6090652|P1|COMPLETED|Overall Study||48
2484404|NCT00891527|6090652|P1|STARTED|Overall Study||50
2484405|NCT00891462|6090661|P3|NOT COMPLETED|Overall Study||24
2484406|NCT00891462|6090662|P2|NOT COMPLETED|Overall Study||33
2484407|NCT00891462|6090663|P1|NOT COMPLETED|Overall Study||37
2484408|NCT00891462|6090661|P3|COMPLETED|Overall Study||166
2484409|NCT00891462|6090662|P2|COMPLETED|Overall Study||152
2484410|NCT00891462|6090663|P1|COMPLETED|Overall Study||149
2484411|NCT00891462|6090661|P3|STARTED|Overall Study||190
2484412|NCT00891462|6090662|P2|STARTED|Overall Study||185
2484413|NCT00891462|6090663|P1|STARTED|Overall Study||186
2484414|NCT00891436|6090676|P2|NOT COMPLETED|Overall Study||0
2484415|NCT00891436|6090677|P1|NOT COMPLETED|Overall Study||0
2484416|NCT00891436|6090676|P2|COMPLETED|Overall Study||10
2484417|NCT00891436|6090677|P1|COMPLETED|Overall Study||10
2484418|NCT00891436|6090676|P2|STARTED|Overall Study||10
2484419|NCT00891436|6090677|P1|STARTED|Overall Study||10
2484420|NCT00891371|6090685|P1|NOT COMPLETED|Treatment||9
2484421|NCT00891371|6090685|P1|COMPLETED|Treatment||27
2484422|NCT00891371|6090685|P1|STARTED|Treatment||36
2484423|NCT00891371|6090685|P1|NOT COMPLETED|Pre-assignment||6
2484424|NCT00891371|6090685|P1|COMPLETED|Pre-assignment||36
2484425|NCT00891371|6090685|P1|STARTED|Pre-assignment||42
2484426|NCT00891319|6090696|P2|NOT COMPLETED|Overall Study||0
2484427|NCT00891319|6090697|P1|NOT COMPLETED|Overall Study||8
2484428|NCT00891319|6090696|P2|COMPLETED|Overall Study||40
2484429|NCT00891319|6090697|P1|COMPLETED|Overall Study||32
2484430|NCT00891319|6090696|P2|STARTED|Overall Study||40
2484431|NCT00891319|6090697|P1|STARTED|Overall Study||40
2484432|NCT00891293|6090707|P1|NOT COMPLETED|Overall Study||84
2484433|NCT00891293|6090707|P1|COMPLETED|Overall Study||9
2484434|NCT00891293|6090707|P1|STARTED|Overall Study|93 participants were enrolled; baseline data are provided for 89 participants (Safety Population).|93
2484435|NCT00891228|6090722|P3|NOT COMPLETED|Overall Study||15
2484436|NCT00891228|6090723|P2|NOT COMPLETED|Overall Study||13
2484437|NCT00891228|6090724|P1|NOT COMPLETED|Overall Study||11
2484438|NCT00891228|6090722|P3|COMPLETED|Overall Study||19
2484439|NCT00891228|6090723|P2|COMPLETED|Overall Study||20
2484440|NCT00891228|6090724|P1|COMPLETED|Overall Study||21
2484441|NCT00891228|6090722|P3|STARTED|Overall Study||34
2484442|NCT00891228|6090723|P2|STARTED|Overall Study||33
2484443|NCT00891228|6090724|P1|STARTED|Overall Study||32
2484444|NCT00891202|6090746|P4|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||5
2484445|NCT00891202|6090747|P3|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||7
2484446|NCT00891202|6090748|P2|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
2484447|NCT00891202|6090749|P1|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
2484448|NCT00891202|6090746|P4|COMPLETED|LTTP (Post-Week 39 up to Week 312)||15
2484449|NCT00891202|6090747|P3|COMPLETED|LTTP (Post-Week 39 up to Week 312)||12
2484450|NCT00891202|6090748|P2|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
2484451|NCT00891202|6090749|P1|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
2484452|NCT00891202|6090746|P4|STARTED|LTTP (Post-Week 39 up to Week 312)||20
2484453|NCT00891202|6090747|P3|STARTED|LTTP (Post-Week 39 up to Week 312)||19
2484454|NCT00891202|6090748|P2|STARTED|LTTP (Post-Week 39 up to Week 312)||0
2484455|NCT00891202|6090749|P1|STARTED|LTTP (Post-Week 39 up to Week 312)||0
2484456|NCT00891202|6090746|P4|NOT COMPLETED|PAP (Up To Week 39)||0
2484457|NCT00891202|6090747|P3|NOT COMPLETED|PAP (Up To Week 39)||0
2484458|NCT00891202|6090748|P2|NOT COMPLETED|PAP (Up To Week 39)||0
2484459|NCT00891202|6090749|P1|NOT COMPLETED|PAP (Up To Week 39)||1
2484460|NCT00891202|6090746|P4|COMPLETED|PAP (Up To Week 39)||0
2484461|NCT00891202|6090747|P3|COMPLETED|PAP (Up To Week 39)||0
2484462|NCT00891202|6090748|P2|COMPLETED|PAP (Up To Week 39)||20
2484463|NCT00891202|6090749|P1|COMPLETED|PAP (Up To Week 39)||19
2484464|NCT00891202|6090746|P4|STARTED|PAP (Up To Week 39)||0
2484465|NCT00891202|6090747|P3|STARTED|PAP (Up To Week 39)||0
2484466|NCT00891202|6090748|P2|STARTED|PAP (Up To Week 39)||20
2484467|NCT00891202|6090749|P1|STARTED|PAP (Up To Week 39)||20
2484468|NCT00891176|6090775|P4|NOT COMPLETED|At 6 Years of Age||0
2484469|NCT00891176|6090776|P3|NOT COMPLETED|At 6 Years of Age||0
2484470|NCT00891176|6090777|P2|NOT COMPLETED|At 6 Years of Age||0
2484471|NCT00891176|6090778|P1|NOT COMPLETED|At 6 Years of Age||0
2484472|NCT00891176|6090775|P4|COMPLETED|At 6 Years of Age||135
2484473|NCT00891176|6090776|P3|COMPLETED|At 6 Years of Age||135
2484474|NCT00891176|6090777|P2|COMPLETED|At 6 Years of Age||138
2484475|NCT00891176|6090778|P1|COMPLETED|At 6 Years of Age||131
2484476|NCT00891176|6090775|P4|STARTED|At 6 Years of Age||135
2484477|NCT00891176|6090776|P3|STARTED|At 6 Years of Age||135
2484478|NCT00891176|6090777|P2|STARTED|At 6 Years of Age||138
2484479|NCT00891176|6090778|P1|STARTED|At 6 Years of Age||131
2484480|NCT00891176|6090775|P4|NOT COMPLETED|At 4 Years of Age||0
2484481|NCT00891176|6090776|P3|NOT COMPLETED|At 4 Years of Age||0
2484482|NCT00891176|6090777|P2|NOT COMPLETED|At 4 Years of Age||0
2484483|NCT00891176|6090778|P1|NOT COMPLETED|At 4 Years of Age||0
2484484|NCT00891176|6090775|P4|COMPLETED|At 4 Years of Age||137
2484485|NCT00891176|6090776|P3|COMPLETED|At 4 Years of Age||142
2484486|NCT00891176|6090777|P2|COMPLETED|At 4 Years of Age||142
2484487|NCT00891176|6090778|P1|COMPLETED|At 4 Years of Age||140
2484488|NCT00891176|6090775|P4|STARTED|At 4 Years of Age||137
2484489|NCT00891176|6090776|P3|STARTED|At 4 Years of Age||142
2484490|NCT00891176|6090777|P2|STARTED|At 4 Years of Age||142
2484491|NCT00891176|6090778|P1|STARTED|At 4 Years of Age||140
2484492|NCT00891176|6090775|P4|NOT COMPLETED|At 3 Years of Age||0
2484493|NCT00891176|6090776|P3|NOT COMPLETED|At 3 Years of Age||0
2484494|NCT00891176|6090777|P2|NOT COMPLETED|At 3 Years of Age||0
2484495|NCT00891176|6090778|P1|NOT COMPLETED|At 3 Years of Age||0
2484496|NCT00891176|6090775|P4|COMPLETED|At 3 Years of Age||141
2484497|NCT00891176|6090776|P3|COMPLETED|At 3 Years of Age||149
2484498|NCT00891176|6090777|P2|COMPLETED|At 3 Years of Age||147
2484499|NCT00891176|6090778|P1|COMPLETED|At 3 Years of Age||144
2484500|NCT00891176|6090775|P4|STARTED|At 3 Years of Age||141
2484501|NCT00891176|6090776|P3|STARTED|At 3 Years of Age||149
2484502|NCT00891176|6090777|P2|STARTED|At 3 Years of Age||147
2484503|NCT00891176|6090778|P1|STARTED|At 3 Years of Age||144
2484504|NCT00891046|6090925|P5|NOT COMPLETED|Overall Study||39
2484505|NCT00891046|6090926|P4|NOT COMPLETED|Overall Study||3
2484506|NCT00891046|6090927|P3|NOT COMPLETED|Overall Study||23
2484507|NCT00891046|6090928|P2|NOT COMPLETED|Overall Study||9
2484508|NCT00891046|6090929|P1|NOT COMPLETED|Overall Study||12
2484509|NCT00891046|6090925|P5|COMPLETED|Overall Study||84
2484510|NCT00891046|6090926|P4|COMPLETED|Overall Study||8
2484511|NCT00891046|6090927|P3|COMPLETED|Overall Study||17
2484512|NCT00891046|6090928|P2|COMPLETED|Overall Study||54
2484513|NCT00891046|6090929|P1|COMPLETED|Overall Study||21
2484514|NCT00891046|6090925|P5|STARTED|Overall Study||123
2484515|NCT00891046|6090926|P4|STARTED|Overall Study||11
2484516|NCT00891046|6090927|P3|STARTED|Overall Study||40
2484517|NCT00891046|6090928|P2|STARTED|Overall Study||63
2484518|NCT00891046|6090929|P1|STARTED|Overall Study||33
2484519|NCT00891020|6091005|P3|NOT COMPLETED|Long-term Extension Period||23
2484520|NCT00891020|6091006|P2|NOT COMPLETED|Long-term Extension Period||24
2484521|NCT00891020|6091007|P1|NOT COMPLETED|Long-term Extension Period||6
2484522|NCT00891020|6091005|P3|COMPLETED|Long-term Extension Period||170
2484523|NCT00891020|6091006|P2|COMPLETED|Long-term Extension Period||172
2484524|NCT00891020|6091007|P1|COMPLETED|Long-term Extension Period||49
2484525|NCT00891020|6091005|P3|STARTED|Long-term Extension Period||193
2484526|NCT00891020|6091006|P2|STARTED|Long-term Extension Period||196
2484527|NCT00891020|6091007|P1|STARTED|Long-term Extension Period||55
2484528|NCT00891020|6091005|P3|NOT COMPLETED|24 Week Treatment Period||58
2484529|NCT00891020|6091006|P2|NOT COMPLETED|24 Week Treatment Period||60
2484530|NCT00891020|6091007|P1|NOT COMPLETED|24 Week Treatment Period||37
2484531|NCT00891020|6091005|P3|COMPLETED|24 Week Treatment Period||302
2484532|NCT00891020|6091006|P2|COMPLETED|24 Week Treatment Period||303
2484533|NCT00891020|6091007|P1|COMPLETED|24 Week Treatment Period||126
2484534|NCT00891020|6091005|P3|Safety Set|24 Week Treatment Period|28 patients from Monotherapy arm received DMARD, included in 8 mg/kg +DMARD arm for safety.|381
2484535|NCT00891020|6091006|P2|Safety Set|24 Week Treatment Period|1 patient from Monotherapy arm and 1 from 8 mg/kg +DMARD, included in 4 mg/kg +DMARD arm for safety.|364
2484536|NCT00891020|6091007|P1|Safety Set|24 Week Treatment Period|4 patients from 8 mg/kg +DMARD arm did not receive DMARD, included in Monotherapy arm for safety.|138
2484537|NCT00891020|6091005|P3|Intent-to-Treat (ITT)|24 Week Treatment Period||358
2484538|NCT00891020|6091006|P2|Intent-to-Treat (ITT)|24 Week Treatment Period||362
2484539|NCT00891020|6091007|P1|Intent-to-Treat (ITT)|24 Week Treatment Period||163
2484540|NCT00891020|6091005|P3|STARTED|24 Week Treatment Period||360
2484541|NCT00891020|6091006|P2|STARTED|24 Week Treatment Period||363
2484542|NCT00891020|6091007|P1|STARTED|24 Week Treatment Period||163
2484543|NCT00890981|6091040|P2|NOT COMPLETED|Overall Study||0
2484544|NCT00890981|6091041|P1|NOT COMPLETED|Overall Study||0
2484545|NCT00890981|6091040|P2|COMPLETED|Overall Study||40
2484546|NCT00890981|6091041|P1|COMPLETED|Overall Study||39
2484547|NCT00890981|6091040|P2|STARTED|Overall Study||40
2484548|NCT00890981|6091041|P1|STARTED|Overall Study||39
2484549|NCT00890929|6091071|P1|NOT COMPLETED|Overall Study||6
2484550|NCT00890929|6091071|P1|COMPLETED|Overall Study||39
2484551|NCT00890929|6091071|P1|Initiated Treatment|Overall Study||43
2484552|NCT00890929|6091071|P1|Consented & Enrolled|Overall Study||45
2484553|NCT00890929|6091071|P1|STARTED|Overall Study||45
2484554|NCT00890916|6091083|P1|NOT COMPLETED|"Rehab - NP Off"||0
2484555|NCT00890916|6091083|P1|COMPLETED|"Rehab - NP Off"||10
2484556|NCT00890916|6091083|P1|"Grasp Release Pre-Test OFF"|"Rehab - NP Off"||10
2484557|NCT00890916|6091083|P1|STARTED|"Rehab - NP Off"||10
2484558|NCT00890916|6091083|P1|NOT COMPLETED|"Rehab - Neuroprosthesis (NP) On"||0
2484559|NCT00890916|6091083|P1|COMPLETED|"Rehab - Neuroprosthesis (NP) On"||10
2484560|NCT00890916|6091083|P1|"Grasp Release Pre-Test ON"|"Rehab - Neuroprosthesis (NP) On"||10
2484561|NCT00890916|6091083|P1|STARTED|"Rehab - Neuroprosthesis (NP) On"|First Implanted Stimulator-Telemeter (IST-12) Implant.|10
2484562|NCT00890825|6091089|P2|NOT COMPLETED|Overall Study||14
2484563|NCT00890825|6091090|P1|NOT COMPLETED|Overall Study||14
2484564|NCT00890825|6091089|P2|COMPLETED|Overall Study||29
2484565|NCT00890825|6091090|P1|COMPLETED|Overall Study||30
2484566|NCT00890825|6091089|P2|STARTED|Overall Study|A patient randomized to this arm was excluded from the safety population for not receiving treatment|43
2484567|NCT00890825|6091090|P1|STARTED|Overall Study||44
2484568|NCT00890721|6091110|P2|NOT COMPLETED|Overall Study||1
2484569|NCT00890721|6091111|P1|NOT COMPLETED|Overall Study||1
2484570|NCT00890721|6091110|P2|COMPLETED|Overall Study||93
2484571|NCT00890721|6091111|P1|COMPLETED|Overall Study||94
2484572|NCT00890721|6091110|P2|STARTED|Overall Study||94
2484573|NCT00890721|6091111|P1|STARTED|Overall Study||95
2484574|NCT00890695|6091119|P2|NOT COMPLETED|Overall Study||0
2484575|NCT00890695|6091120|P1|NOT COMPLETED|Overall Study||1
2484576|NCT00890695|6091119|P2|COMPLETED|Overall Study||33
2484577|NCT00890695|6091120|P1|COMPLETED|Overall Study||31
2484578|NCT00890695|6091119|P2|STARTED|Overall Study||33
2484579|NCT00890695|6091120|P1|STARTED|Overall Study||32
2484580|NCT00890682|6091138|P2|NOT COMPLETED|Overall Study||2
2484581|NCT00890682|6091139|P1|NOT COMPLETED|Overall Study||4
2484582|NCT00890682|6091138|P2|COMPLETED|Overall Study||94
2484583|NCT00890682|6091139|P1|COMPLETED|Overall Study||93
2484584|NCT00890682|6091138|P2|STARTED|Overall Study||96
2484585|NCT00890682|6091139|P1|STARTED|Overall Study||97
2484586|NCT00890656|6091145|P1|NOT COMPLETED|Overall Study||0
2484587|NCT00890656|6091145|P1|COMPLETED|Overall Study||90
2484588|NCT00890656|6091145|P1|STARTED|Overall Study||90
2484589|NCT00890591|6091149|P1|NOT COMPLETED|Overall Study||20
2484590|NCT00890591|6091149|P1|COMPLETED|Overall Study||124
2484591|NCT00890591|6091149|P1|STARTED|Overall Study||144
2484592|NCT00890552|6091155|P1|NOT COMPLETED|On-treatment||10
2484593|NCT00890552|6091155|P1|COMPLETED|On-treatment||14
2484594|NCT00890552|6091155|P1|STARTED|On-treatment||24
2484595|NCT00890552|6091155|P1|NOT COMPLETED|Enrollment and Pre-treatment||1
2484596|NCT00890552|6091155|P1|COMPLETED|Enrollment and Pre-treatment||24
2484597|NCT00890552|6091155|P1|STARTED|Enrollment and Pre-treatment||25
2484598|NCT00890409|6091164|P2|NOT COMPLETED|Overall Study||21
2484599|NCT00890409|6091165|P1|NOT COMPLETED|Overall Study||20
2484600|NCT00890409|6091164|P2|COMPLETED|Overall Study||119
2484601|NCT00890409|6091165|P1|COMPLETED|Overall Study||96
2484602|NCT00890409|6091164|P2|STARTED|Overall Study||140
2484603|NCT00890409|6091165|P1|STARTED|Overall Study||116
2484604|NCT00890201|6091175|P2|NOT COMPLETED|Overall Study||56
2484605|NCT00890201|6091176|P1|NOT COMPLETED|Overall Study||5
2484606|NCT00890201|6091175|P2|COMPLETED|Overall Study|103 patients without acute cholecystitis or common bile duct stones|103
2484607|NCT00890201|6091176|P1|COMPLETED|Overall Study|33 patients with gastric cancer and without gallstone disease|33
2484608|NCT00890201|6091175|P2|STARTED|Overall Study|41 patients with acute cholecystitis and 15 patients with common bile duct stones|159
2484609|NCT00890201|6091176|P1|STARTED|Overall Study|5 patients with gastric cancer and gallstone disease|38
2484610|NCT00890162|6091184|P2|NOT COMPLETED|Overall Study||1
2484611|NCT00890162|6091185|P1|NOT COMPLETED|Overall Study||2
2484612|NCT00890162|6091184|P2|COMPLETED|Overall Study||7
2484613|NCT00890162|6091185|P1|COMPLETED|Overall Study||6
2484614|NCT00890162|6091184|P2|STARTED|Overall Study||8
2484615|NCT00890162|6091185|P1|STARTED|Overall Study||8
2484616|NCT00890097|6091194|P3|NOT COMPLETED|Overall Study||77
2484617|NCT00890097|6091195|P2|NOT COMPLETED|Overall Study||86
2484618|NCT00890097|6091196|P1|NOT COMPLETED|Overall Study||68
2484619|NCT00890097|6091194|P3|COMPLETED|Overall Study||184
2484620|NCT00890097|6091195|P2|COMPLETED|Overall Study||173
2484621|NCT00890097|6091196|P1|COMPLETED|Overall Study||184
2484622|NCT00890097|6091194|P3|STARTED|Overall Study||261
2484623|NCT00890097|6091195|P2|STARTED|Overall Study||259
2484624|NCT00890097|6091196|P1|STARTED|Overall Study||252
2484625|NCT00890084|6091204|P1|NOT COMPLETED|Overall Study||142
2484626|NCT00890084|6091204|P1|COMPLETED|Overall Study||2771
2484627|NCT00890084|6091204|P1|STARTED|Overall Study||2913
2484628|NCT00889928|6091215|P1|NOT COMPLETED|Overall Study||0
2484629|NCT00889928|6091215|P1|COMPLETED|Overall Study||7
2484630|NCT00889928|6091215|P1|STARTED|Overall Study||7
2484631|NCT00889915|6091223|P4|NOT COMPLETED|Overall Study||8
2484632|NCT00889915|6091224|P3|NOT COMPLETED|Overall Study||13
2484633|NCT00889915|6091225|P2|NOT COMPLETED|Overall Study||5
2484634|NCT00889915|6091226|P1|NOT COMPLETED|Overall Study||2
2484635|NCT00889915|6091223|P4|COMPLETED|Overall Study||40
2484636|NCT00889915|6091224|P3|COMPLETED|Overall Study||54
2484637|NCT00889915|6091225|P2|COMPLETED|Overall Study||71
2484638|NCT00889915|6091226|P1|COMPLETED|Overall Study||35
2484639|NCT00889915|6091223|P4|STARTED|Overall Study||48
2484640|NCT00889915|6091224|P3|STARTED|Overall Study||67
2484641|NCT00889915|6091225|P2|STARTED|Overall Study||76
2484642|NCT00889915|6091226|P1|STARTED|Overall Study||37
2484643|NCT00889863|6091244|P2|NOT COMPLETED|Part II: Randomized Double Blind||26
2484644|NCT00889863|6091245|P1|NOT COMPLETED|Part II: Randomized Double Blind||11
2484645|NCT00889863|6091244|P2|COMPLETED|Part II: Randomized Double Blind||24
2484646|NCT00889863|6091245|P1|COMPLETED|Part II: Randomized Double Blind||39
2484647|NCT00889863|6091244|P2|STARTED|Part II: Randomized Double Blind||50
2484648|NCT00889863|6091245|P1|STARTED|Part II: Randomized Double Blind||50
2484649|NCT00889863|6091244|P2|NOT COMPLETED|Part I: Open Label||0
2484650|NCT00889863|6091245|P1|NOT COMPLETED|Part I: Open Label||77
2484651|NCT00889863|6091244|P2|COMPLETED|Part I: Open Label||0
2484652|NCT00889863|6091245|P1|COMPLETED|Part I: Open Label||100
2484653|NCT00889863|6091244|P2|Entered Part 1d|Part I: Open Label||0
2484654|NCT00889863|6091245|P1|Entered Part 1d|Part I: Open Label||103
2484655|NCT00889863|6091244|P2|Entered Part Ic|Part I: Open Label||0
2484656|NCT00889863|6091245|P1|Entered Part Ic|Part I: Open Label|Patients steroid free at study entry entered Part Id directly and did not participate in Part Ic.|92
2484657|NCT00889863|6091244|P2|Entered Part Ib|Part I: Open Label||0
2484658|NCT00889863|6091245|P1|Entered Part Ib|Part I: Open Label||142
2484659|NCT00889863|6091244|P2|Entered Part Ia|Part I: Open Label||0
2484660|NCT00889863|6091245|P1|Entered Part Ia|Part I: Open Label||145
2484661|NCT00889863|6091244|P2|STARTED|Part I: Open Label|No participants received placebo in Part I.|0
2484662|NCT00889863|6091245|P1|STARTED|Part I: Open Label||177
2484663|NCT00889824|6091267|P1|NOT COMPLETED|Overall Study||0
2484664|NCT00889824|6091267|P1|COMPLETED|Overall Study||5
2484665|NCT00889824|6091267|P1|STARTED|Overall Study||5
2484666|NCT00889720|6091271|P1|NOT COMPLETED|Overall Study||8
2484667|NCT00889720|6091271|P1|COMPLETED|Overall Study||8
2484668|NCT00889720|6091271|P1|Surgical Population|Overall Study||12
2484669|NCT00889720|6091271|P1|STARTED|Overall Study||16
2484670|NCT00889707|6091298|P2|NOT COMPLETED|Overall Study||10
2484671|NCT00889707|6091299|P1|NOT COMPLETED|Overall Study||7
2484672|NCT00889707|6091298|P2|COMPLETED|Overall Study||21
2484673|NCT00889707|6091299|P1|COMPLETED|Overall Study||54
2484674|NCT00889707|6091298|P2|STARTED|Overall Study||31
2484675|NCT00889707|6091299|P1|STARTED|Overall Study||61
2484676|NCT00889681|6091307|P1|NOT COMPLETED|Overall Study||3
2484677|NCT00889681|6091307|P1|COMPLETED|Overall Study||78
2484678|NCT00889681|6091307|P1|Received Treatment|Overall Study||78
2484679|NCT00889681|6091307|P1|STARTED|Overall Study||81
2484680|NCT00889603|6091314|P1|NOT COMPLETED|Overall Study||37
2484681|NCT00889603|6091314|P1|COMPLETED|Overall Study||333
2484682|NCT00889603|6091314|P1|STARTED|Overall Study||370
2484683|NCT00889512|6091329|P2|NOT COMPLETED|Overall Study||0
2484684|NCT00889512|6091330|P1|NOT COMPLETED|Overall Study||0
2484685|NCT00889512|6091329|P2|COMPLETED|Overall Study||9
2484686|NCT00889512|6091330|P1|COMPLETED|Overall Study||5
2484687|NCT00889512|6091329|P2|STARTED|Overall Study||9
2484688|NCT00889512|6091330|P1|STARTED|Overall Study||5
2484689|NCT00889421|6091336|P1|NOT COMPLETED|Overall Study||3
2484690|NCT00889421|6091336|P1|COMPLETED|Overall Study||0
2484691|NCT00889421|6091336|P1|STARTED|Overall Study||3
2484692|NCT00889330|6091346|P2|NOT COMPLETED|Overall Study||0
2484693|NCT00889330|6091347|P1|NOT COMPLETED|Overall Study||0
2484694|NCT00889330|6091346|P2|COMPLETED|Overall Study||30
2484695|NCT00889330|6091347|P1|COMPLETED|Overall Study||30
2484696|NCT00889330|6091346|P2|STARTED|Overall Study||30
2484697|NCT00889330|6091347|P1|STARTED|Overall Study||30
2484698|NCT00889265|6091377|P1|NOT COMPLETED|Overall Study||7
2484699|NCT00889265|6091377|P1|COMPLETED|Overall Study||44
2484700|NCT00889265|6091377|P1|STARTED|Overall Study|Date Enrollment Started: 07/21/2009 Date Enrollment Completed: 02/15/2011 Total enrolled: 51|51
2484701|NCT00889252|6091384|P2|NOT COMPLETED|Overall Study||4
2484702|NCT00889252|6091385|P1|NOT COMPLETED|Overall Study||7
2484703|NCT00889252|6091384|P2|COMPLETED|Overall Study||78
2484704|NCT00889252|6091385|P1|COMPLETED|Overall Study||161
2484705|NCT00889252|6091384|P2|STARTED|Overall Study||82
2484706|NCT00889252|6091385|P1|STARTED|Overall Study||168
2484707|NCT00889226|6091429|P2|NOT COMPLETED|Overall Study||35
2484708|NCT00889226|6091430|P1|NOT COMPLETED|Overall Study||25
2484709|NCT00889226|6091429|P2|COMPLETED|Overall Study||43
2484710|NCT00889226|6091430|P1|COMPLETED|Overall Study||58
2484711|NCT00889226|6091429|P2|STARTED|Overall Study||78
2484712|NCT00889226|6091430|P1|STARTED|Overall Study||83
2484713|NCT00889200|6091438|P1|NOT COMPLETED|Overall Study||0
2484714|NCT00889200|6091438|P1|COMPLETED|Overall Study||12
2484715|NCT00889200|6091438|P1|STARTED|Overall Study||12
2484716|NCT00889187|6091442|P4|NOT COMPLETED|Overall Study||0
2484717|NCT00889187|6091443|P3|NOT COMPLETED|Overall Study||0
2484718|NCT00889187|6091444|P2|NOT COMPLETED|Overall Study||0
2484719|NCT00889187|6091445|P1|NOT COMPLETED|Overall Study||0
2484720|NCT00889187|6091442|P4|COMPLETED|Overall Study||0
2484721|NCT00889187|6091443|P3|COMPLETED|Overall Study||4
2484722|NCT00889187|6091444|P2|COMPLETED|Overall Study||3
2484723|NCT00889187|6091445|P1|COMPLETED|Overall Study||3
2484724|NCT00889187|6091442|P4|STARTED|Overall Study||0
2484725|NCT00889187|6091443|P3|STARTED|Overall Study||4
2484726|NCT00889187|6091444|P2|STARTED|Overall Study||3
2484727|NCT00889187|6091445|P1|STARTED|Overall Study||3
2484728|NCT00889005|6091462|P2|NOT COMPLETED|Overall Study||2
2484729|NCT00889005|6091463|P1|NOT COMPLETED|Overall Study||8
2484730|NCT00889005|6091462|P2|COMPLETED|Overall Study||72
2484731|NCT00889005|6091463|P1|COMPLETED|Overall Study||57
2484732|NCT00889005|6091462|P2|STARTED|Overall Study||74
2484733|NCT00889005|6091463|P1|STARTED|Overall Study||65
2484734|NCT00888979|6091469|P1|NOT COMPLETED|Overall Study||4
2484735|NCT00888979|6091469|P1|COMPLETED|Overall Study||6
2484736|NCT00888979|6091469|P1|Received the Inhaler/Counseling|Overall Study||8
2484737|NCT00888979|6091469|P1|STARTED|Overall Study||10
2484738|NCT00888940|6091477|P2|NOT COMPLETED|Overall Study||21
2484739|NCT00888940|6091478|P1|NOT COMPLETED|Overall Study||28
2484740|NCT00888940|6091477|P2|COMPLETED|Overall Study||101
2484741|NCT00888940|6091478|P1|COMPLETED|Overall Study||92
2484742|NCT00888940|6091477|P2|Completed Therapy|Overall Study||106
2484743|NCT00888940|6091478|P1|Completed Therapy|Overall Study||107
2484744|NCT00888940|6091477|P2|STARTED|Overall Study||122
2484745|NCT00888940|6091478|P1|STARTED|Overall Study||120
2484746|NCT00888849|6091488|P2|NOT COMPLETED|Overall Study||9
2484747|NCT00888849|6091489|P1|NOT COMPLETED|Overall Study||5
2484748|NCT00888849|6091488|P2|COMPLETED|Overall Study||129
2484749|NCT00888849|6091489|P1|COMPLETED|Overall Study||137
2484750|NCT00888849|6091488|P2|STARTED|Overall Study||138
2484751|NCT00888849|6091489|P1|STARTED|Overall Study||142
2484752|NCT00888654|6091499|P1|NOT COMPLETED|Overall Study||10
2484753|NCT00888654|6091499|P1|COMPLETED|Overall Study||31
2484754|NCT00888654|6091499|P1|STARTED|Overall Study||41
2484755|NCT00888628|6091505|P1|NOT COMPLETED|Overall Study||3
2484756|NCT00888628|6091505|P1|COMPLETED|Overall Study||4
2484757|NCT00888628|6091505|P1|Transplanted|Overall Study||4
2484758|NCT00888628|6091505|P1|Withdrawn|Overall Study||1
2484759|NCT00888628|6091505|P1|Screen Failure|Overall Study||2
2484760|NCT00888628|6091505|P1|Enrolled|Overall Study||7
2484761|NCT00888628|6091505|P1|STARTED|Overall Study||7
2484762|NCT00888615|6091517|P1|NOT COMPLETED|Overall Study||2
2484763|NCT00888615|6091517|P1|COMPLETED|Overall Study||56
2484764|NCT00888615|6091517|P1|STARTED|Overall Study||58
2484765|NCT00888459|6091528|P2|NOT COMPLETED|Overall Study||0
2484766|NCT00888459|6091529|P1|NOT COMPLETED|Overall Study||0
2484767|NCT00888459|6091528|P2|COMPLETED|Overall Study||30
2484768|NCT00888459|6091529|P1|COMPLETED|Overall Study||30
2484769|NCT00888459|6091528|P2|STARTED|Overall Study||30
2484770|NCT00888459|6091529|P1|STARTED|Overall Study||30
2484771|NCT00888433|6091537|P2|NOT COMPLETED|Overall Study||3
2484772|NCT00888433|6091538|P1|NOT COMPLETED|Overall Study||3
2484773|NCT00888433|6091537|P2|COMPLETED|Overall Study||51
2484774|NCT00888433|6091538|P1|COMPLETED|Overall Study||49
2484775|NCT00888433|6091537|P2|STARTED|Overall Study||54
2484776|NCT00888433|6091538|P1|STARTED|Overall Study||52
2484777|NCT00888381|6091546|P2|NOT COMPLETED|Overall Study||1
2484778|NCT00888381|6091547|P1|NOT COMPLETED|Overall Study||0
2484779|NCT00888381|6091546|P2|COMPLETED|Overall Study||59
2484780|NCT00888381|6091547|P1|COMPLETED|Overall Study||60
2484781|NCT00888381|6091546|P2|STARTED|Overall Study||60
2484782|NCT00888381|6091547|P1|STARTED|Overall Study||60
2484783|NCT00888355|6091567|P4|NOT COMPLETED|Overall Study||10
2484784|NCT00888355|6091568|P3|NOT COMPLETED|Overall Study||12
2484785|NCT00888355|6091569|P2|NOT COMPLETED|Overall Study||9
2484786|NCT00888355|6091570|P1|NOT COMPLETED|Overall Study||22
2484787|NCT00888355|6091567|P4|COMPLETED|Overall Study||96
2484788|NCT00888355|6091568|P3|COMPLETED|Overall Study||94
2484789|NCT00888355|6091569|P2|COMPLETED|Overall Study||99
2484790|NCT00888355|6091570|P1|COMPLETED|Overall Study||86
2484791|NCT00888355|6091567|P4|STARTED|Overall Study||106
2484792|NCT00888355|6091568|P3|STARTED|Overall Study||106
2484793|NCT00888355|6091569|P2|STARTED|Overall Study||108
2484794|NCT00888355|6091570|P1|STARTED|Overall Study||108
2484795|NCT00888329|6091626|P2|NOT COMPLETED|Overall Study||9
2484796|NCT00888329|6091627|P1|NOT COMPLETED|Overall Study||6
2484797|NCT00888329|6091626|P2|COMPLETED|Overall Study||122
2484798|NCT00888329|6091627|P1|COMPLETED|Overall Study||119
2484799|NCT00888329|6091626|P2|STARTED|Overall Study||131
2484800|NCT00888329|6091627|P1|STARTED|Overall Study||125
2484801|NCT00888238|6091633|P3|NOT COMPLETED|Third Period of Treatment Intervention||0
2484802|NCT00888238|6091634|P2|NOT COMPLETED|Third Period of Treatment Intervention||0
2484803|NCT00888238|6091635|P1|NOT COMPLETED|Third Period of Treatment Intervention||0
2484804|NCT00888238|6091633|P3|COMPLETED|Third Period of Treatment Intervention||3
2484805|NCT00888238|6091634|P2|COMPLETED|Third Period of Treatment Intervention||4
2484806|NCT00888238|6091635|P1|COMPLETED|Third Period of Treatment Intervention||4
2484807|NCT00888238|6091633|P3|STARTED|Third Period of Treatment Intervention||3
2484808|NCT00888238|6091634|P2|STARTED|Third Period of Treatment Intervention||4
2484809|NCT00888238|6091635|P1|STARTED|Third Period of Treatment Intervention||4
2484810|NCT00888238|6091633|P3|NOT COMPLETED|Washout Period After Period 2||1
2484811|NCT00888238|6091634|P2|NOT COMPLETED|Washout Period After Period 2||0
2484812|NCT00888238|6091635|P1|NOT COMPLETED|Washout Period After Period 2||0
2484813|NCT00888238|6091633|P3|COMPLETED|Washout Period After Period 2||3
2484814|NCT00888238|6091634|P2|COMPLETED|Washout Period After Period 2||4
2484815|NCT00888238|6091635|P1|COMPLETED|Washout Period After Period 2||4
2484816|NCT00888238|6091633|P3|STARTED|Washout Period After Period 2||4
2484817|NCT00888238|6091634|P2|STARTED|Washout Period After Period 2||4
2484818|NCT00888238|6091635|P1|STARTED|Washout Period After Period 2||4
2484819|NCT00888238|6091633|P3|NOT COMPLETED|Second Period of Treatment Intervention||0
2484820|NCT00888238|6091634|P2|NOT COMPLETED|Second Period of Treatment Intervention||0
2484821|NCT00888238|6091635|P1|NOT COMPLETED|Second Period of Treatment Intervention||0
2484822|NCT00888238|6091633|P3|COMPLETED|Second Period of Treatment Intervention||4
2484823|NCT00888238|6091634|P2|COMPLETED|Second Period of Treatment Intervention||4
2484824|NCT00888238|6091635|P1|COMPLETED|Second Period of Treatment Intervention||4
2484825|NCT00888238|6091633|P3|STARTED|Second Period of Treatment Intervention||4
2484826|NCT00888238|6091634|P2|STARTED|Second Period of Treatment Intervention||4
2484827|NCT00888238|6091635|P1|STARTED|Second Period of Treatment Intervention||4
2484828|NCT00888238|6091633|P3|NOT COMPLETED|Washout Period After Period 1||0
2484829|NCT00888238|6091634|P2|NOT COMPLETED|Washout Period After Period 1||0
2484830|NCT00888238|6091635|P1|NOT COMPLETED|Washout Period After Period 1||0
2484831|NCT00888238|6091633|P3|COMPLETED|Washout Period After Period 1||4
2484832|NCT00888238|6091634|P2|COMPLETED|Washout Period After Period 1||4
2484833|NCT00888238|6091635|P1|COMPLETED|Washout Period After Period 1||4
2484834|NCT00888238|6091633|P3|STARTED|Washout Period After Period 1||4
2484835|NCT00888238|6091634|P2|STARTED|Washout Period After Period 1||4
2484836|NCT00888238|6091635|P1|STARTED|Washout Period After Period 1||4
2484837|NCT00888238|6091633|P3|NOT COMPLETED|First Period of Treatment Intervention||0
2484838|NCT00888238|6091634|P2|NOT COMPLETED|First Period of Treatment Intervention||0
2484839|NCT00888238|6091635|P1|NOT COMPLETED|First Period of Treatment Intervention||0
2484840|NCT00888238|6091633|P3|COMPLETED|First Period of Treatment Intervention||4
2484841|NCT00888238|6091634|P2|COMPLETED|First Period of Treatment Intervention||4
2484842|NCT00888238|6091635|P1|COMPLETED|First Period of Treatment Intervention||4
2484843|NCT00888238|6091633|P3|STARTED|First Period of Treatment Intervention||4
2484844|NCT00888238|6091634|P2|STARTED|First Period of Treatment Intervention||4
2484845|NCT00888238|6091635|P1|STARTED|First Period of Treatment Intervention||4
2484846|NCT00888173|6091643|P1|NOT COMPLETED|Overall Study||2
2484847|NCT00888173|6091643|P1|COMPLETED|Overall Study||43
2484848|NCT00888173|6091643|P1|STARTED|Overall Study||45
2484849|NCT00888134|6091651|P1|NOT COMPLETED|Follow-up||1
2484850|NCT00888134|6091651|P1|COMPLETED|Follow-up|23 died; 3 were lost-to-follow-up|26
2484851|NCT00888134|6091651|P1|STARTED|Follow-up||27
2484852|NCT00888134|6091651|P1|NOT COMPLETED|Treatment With Study Drug||1
2484853|NCT00888134|6091651|P1|COMPLETED|Treatment With Study Drug|21 had progressive disease; 5 had unacceptable toxicity; 1 finished treatment|27
2484854|NCT00888134|6091651|P1|STARTED|Treatment With Study Drug||28
2484855|NCT00887978|6091661|P2|NOT COMPLETED|Overall Study||15
2484856|NCT00887978|6091662|P1|NOT COMPLETED|Overall Study||25
2484857|NCT00887978|6091661|P2|COMPLETED|Overall Study||138
2484858|NCT00887978|6091662|P1|COMPLETED|Overall Study||132
2484859|NCT00887978|6091661|P2|STARTED|Overall Study||153
2484860|NCT00887978|6091662|P1|STARTED|Overall Study||157
2484861|NCT00887965|6091698|P1|NOT COMPLETED|Overall Study||0
2484862|NCT00887965|6091698|P1|COMPLETED|Overall Study||15
2484863|NCT00887965|6091698|P1|STARTED|Overall Study||15
2484864|NCT00887926|6091732|P4|NOT COMPLETED|Overall Study||0
2484865|NCT00887926|6091733|P3|NOT COMPLETED|Overall Study||0
2484866|NCT00887926|6091734|P2|NOT COMPLETED|Overall Study||1
2484867|NCT00887926|6091735|P1|NOT COMPLETED|Overall Study||0
2484868|NCT00887926|6091732|P4|COMPLETED|Overall Study||5
2484869|NCT00887926|6091733|P3|COMPLETED|Overall Study||3
2484870|NCT00887926|6091734|P2|COMPLETED|Overall Study||13
2484871|NCT00887926|6091735|P1|COMPLETED|Overall Study||3
2484872|NCT00887926|6091732|P4|Received at Least 1 Dose of Study Drug|Overall Study||5
2484873|NCT00887926|6091733|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
2484874|NCT00887926|6091734|P2|Received at Least 1 Dose of Study Drug|Overall Study||13
2484875|NCT00887926|6091735|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
2484876|NCT00887926|6091732|P4|STARTED|Overall Study||5
2484877|NCT00887926|6091733|P3|STARTED|Overall Study||3
2484878|NCT00887926|6091734|P2|STARTED|Overall Study||14
2484879|NCT00887926|6091735|P1|STARTED|Overall Study||3
2484880|NCT00887913|6091770|P1|NOT COMPLETED|Overall Study||6
2484881|NCT00887913|6091770|P1|COMPLETED|Overall Study||63
2484882|NCT00887913|6091770|P1|STARTED|Overall Study||69
2484883|NCT00887822|6091778|P2|NOT COMPLETED|Overall Study||102
2484884|NCT00887822|6091779|P1|NOT COMPLETED|Overall Study||97
2484885|NCT00887822|6091778|P2|COMPLETED|Overall Study||0
2484886|NCT00887822|6091779|P1|COMPLETED|Overall Study||3
2484887|NCT00887822|6091778|P2|Treated (Safety Population)|Overall Study||101
2484888|NCT00887822|6091779|P1|Treated (Safety Population)|Overall Study||100
2484889|NCT00887822|6091778|P2|STARTED|Overall Study||102
2484890|NCT00887822|6091779|P1|STARTED|Overall Study||100
2484891|NCT00887809|6091811|P2|NOT COMPLETED|Overall Study||0
2484892|NCT00887809|6091812|P1|NOT COMPLETED|Overall Study||4
2484893|NCT00887809|6091811|P2|COMPLETED|Overall Study||10
2484894|NCT00887809|6091812|P1|COMPLETED|Overall Study||33
2484895|NCT00887809|6091811|P2|STARTED|Overall Study||10
2484896|NCT00887809|6091812|P1|STARTED|Overall Study||37
2484897|NCT00887744|6091818|P1|NOT COMPLETED|Overall Study||34
2484898|NCT00887744|6091818|P1|COMPLETED|Overall Study||128
2484899|NCT00887744|6091818|P1|STARTED|Overall Study|162 patients signed an informed consent but only 157 patients were treated with the Aperius.|162
2484900|NCT00887679|6091827|P1|NOT COMPLETED|Overall Study||10
2484901|NCT00887679|6091827|P1|COMPLETED|Overall Study|20 subjects completed the study.|20
2484902|NCT00887679|6091827|P1|STARTED|Overall Study||30
2484903|NCT00887653|6091836|P1|NOT COMPLETED|Overall Study||0
2484904|NCT00887653|6091836|P1|COMPLETED|Overall Study||20
2484905|NCT00887653|6091836|P1|STARTED|Overall Study||20
2484906|NCT00887640|6091842|P1|NOT COMPLETED|Overall Study||0
2484907|NCT00887640|6091842|P1|COMPLETED|Overall Study||11
2484908|NCT00887640|6091842|P1|STARTED|Overall Study||11
2484909|NCT00887588|6091857|P2|NOT COMPLETED|Extension Period||5
2484910|NCT00887588|6091858|P1|NOT COMPLETED|Extension Period||6
2484911|NCT00887588|6091857|P2|COMPLETED|Extension Period||120
2484912|NCT00887588|6091858|P1|COMPLETED|Extension Period||121
2484913|NCT00887588|6091857|P2|Arterial Stiffness Set|Extension Period||94
2484914|NCT00887588|6091858|P1|Arterial Stiffness Set|Extension Period||86
2484915|NCT00887588|6091857|P2|STARTED|Extension Period||125
2484916|NCT00887588|6091858|P1|STARTED|Extension Period||127
2484917|NCT00887588|6091857|P2|NOT COMPLETED|Core Period||21
2484918|NCT00887588|6091858|P1|NOT COMPLETED|Core Period||19
2484919|NCT00887588|6091857|P2|COMPLETED|Core Period||131
2484920|NCT00887588|6091858|P1|COMPLETED|Core Period||130
2484921|NCT00887588|6091857|P2|Arterial Stiffness Set|Core Period||94
2484922|NCT00887588|6091858|P1|Arterial Stiffness Set|Core Period||86
2484923|NCT00887588|6091857|P2|Full Analysis Set|Core Period||146
2484924|NCT00887588|6091858|P1|Full Analysis Set|Core Period||148
2484925|NCT00887588|6091857|P2|Extension Efficacy Set|Core Period||125
2484926|NCT00887588|6091858|P1|Extension Efficacy Set|Core Period||127
2484927|NCT00887588|6091857|P2|STARTED|Core Period||152
2484928|NCT00887588|6091858|P1|STARTED|Core Period||149
2484929|NCT00887575|6091910|P3|NOT COMPLETED|Phase II - Maintenance Therapy||0
2484930|NCT00887575|6091911|P2|NOT COMPLETED|Phase II - Maintenance Therapy||0
2484931|NCT00887575|6091912|P1|NOT COMPLETED|Phase II - Maintenance Therapy||2
2484932|NCT00887575|6091910|P3|COMPLETED|Phase II - Maintenance Therapy||0
2484933|NCT00887575|6091911|P2|COMPLETED|Phase II - Maintenance Therapy||0
2484934|NCT00887575|6091912|P1|COMPLETED|Phase II - Maintenance Therapy||6
2484935|NCT00887575|6091910|P3|STARTED|Phase II - Maintenance Therapy||0
2484936|NCT00887575|6091911|P2|STARTED|Phase II - Maintenance Therapy||0
2484937|NCT00887575|6091912|P1|STARTED|Phase II - Maintenance Therapy|Pts who completed 6 cycles of Neoadjuvant Therapy & underwent surgery were eligible for maintenance|8
2484938|NCT00887575|6091910|P3|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
2484939|NCT00887575|6091911|P2|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
2484940|NCT00887575|6091912|P1|NOT COMPLETED|Phase II - Neoadjuvant Therapy||25
2484941|NCT00887575|6091910|P3|COMPLETED|Phase II - Neoadjuvant Therapy||0
2484942|NCT00887575|6091911|P2|COMPLETED|Phase II - Neoadjuvant Therapy||0
2484943|NCT00887575|6091912|P1|COMPLETED|Phase II - Neoadjuvant Therapy||16
2484944|NCT00887575|6091910|P3|STARTED|Phase II - Neoadjuvant Therapy||0
2484945|NCT00887575|6091911|P2|STARTED|Phase II - Neoadjuvant Therapy||0
2484946|NCT00887575|6091912|P1|STARTED|Phase II - Neoadjuvant Therapy|Includes patients treated at MTD during Phase I, 39 additional patients enrolled, 4 were not treated|41
2484947|NCT00887575|6091910|P3|NOT COMPLETED|Phase I||3
2484948|NCT00887575|6091911|P2|NOT COMPLETED|Phase I||6
2484949|NCT00887575|6091912|P1|NOT COMPLETED|Phase I||0
2484950|NCT00887575|6091910|P3|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
2484951|NCT00887575|6091911|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
2484952|NCT00887575|6091912|P1|COMPLETED|Phase I||6
2484953|NCT00887575|6091910|P3|STARTED|Phase I||3
2484954|NCT00887575|6091911|P2|STARTED|Phase I||6
2484955|NCT00887575|6091912|P1|STARTED|Phase I||6
2484956|NCT00887562|6091923|P3|NOT COMPLETED|Overall Study||1
2484957|NCT00887562|6091924|P2|NOT COMPLETED|Overall Study||2
2484958|NCT00887562|6091925|P1|NOT COMPLETED|Overall Study||3
2484959|NCT00887562|6091923|P3|COMPLETED|Overall Study||7
2484960|NCT00887562|6091924|P2|COMPLETED|Overall Study||7
2484961|NCT00887562|6091925|P1|COMPLETED|Overall Study||7
2484962|NCT00887562|6091923|P3|STARTED|Overall Study||8
2484963|NCT00887562|6091924|P2|STARTED|Overall Study||9
2484964|NCT00887562|6091925|P1|STARTED|Overall Study||10
2484965|NCT00887549|6091939|P1|NOT COMPLETED|Maintenance Therapy||43
2484966|NCT00887549|6091939|P1|COMPLETED|Maintenance Therapy||0
2484967|NCT00887549|6091939|P1|STARTED|Maintenance Therapy||43
2484968|NCT00887549|6091939|P1|NOT COMPLETED|Induction Therapy||27
2484969|NCT00887549|6091939|P1|COMPLETED|Induction Therapy||43
2484970|NCT00887549|6091939|P1|STARTED|Induction Therapy||70
2484971|NCT00887510|6091948|P2|NOT COMPLETED|Overall Study||0
2484972|NCT00887510|6091949|P1|NOT COMPLETED|Overall Study||0
2484973|NCT00887510|6091948|P2|COMPLETED|Overall Study||12
2484974|NCT00887510|6091949|P1|COMPLETED|Overall Study||12
2484975|NCT00887510|6091948|P2|STARTED|Overall Study||12
2484976|NCT00887510|6091949|P1|STARTED|Overall Study||12
2484977|NCT00887484|6091957|P1|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||3
2484978|NCT00887484|6091957|P1|COMPLETED|Full Face Treatment (Weeks 5 and 8)||45
2484979|NCT00887484|6091957|P1|STARTED|Full Face Treatment (Weeks 5 and 8)||48
2484980|NCT00887484|6091957|P1|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
2484981|NCT00887484|6091957|P1|COMPLETED|Split Face Treatment (Weeks 1 and 2)||48
2484982|NCT00887484|6091957|P1|STARTED|Split Face Treatment (Weeks 1 and 2)||48
2484983|NCT00887471|6092023|P2|NOT COMPLETED|Overall Study||0
2484984|NCT00887471|6092024|P1|NOT COMPLETED|Overall Study||0
2484985|NCT00887471|6092023|P2|COMPLETED|Overall Study||15
2484986|NCT00887471|6092024|P1|COMPLETED|Overall Study||15
2484987|NCT00887471|6092023|P2|STARTED|Overall Study||15
2484988|NCT00887471|6092024|P1|STARTED|Overall Study||15
2484989|NCT00887458|6092034|P2|NOT COMPLETED|Overall Study||4
2484990|NCT00887458|6092035|P1|NOT COMPLETED|Overall Study||0
2484991|NCT00887458|6092034|P2|COMPLETED|Overall Study||25
2484992|NCT00887458|6092035|P1|COMPLETED|Overall Study||17
2484993|NCT00887458|6092034|P2|STARTED|Overall Study||29
2484994|NCT00887458|6092035|P1|STARTED|Overall Study||17
2484995|NCT00887354|6092045|P2|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||6
2484996|NCT00887354|6092046|P1|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||3
2484997|NCT00887354|6092045|P2|COMPLETED|Open Label Phase (Week 26 to Week 78)||59
2484998|NCT00887354|6092046|P1|COMPLETED|Open Label Phase (Week 26 to Week 78)||57
2484999|NCT00887354|6092045|P2|STARTED|Open Label Phase (Week 26 to Week 78)||65
2485000|NCT00887354|6092046|P1|STARTED|Open Label Phase (Week 26 to Week 78)||60
2485001|NCT00887354|6092045|P2|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||48
2485002|NCT00887354|6092046|P1|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||51
2485003|NCT00887354|6092045|P2|COMPLETED|Treatment Phase (Week 0 to Week 26)||65
2485004|NCT00887354|6092046|P1|COMPLETED|Treatment Phase (Week 0 to Week 26)||60
2485005|NCT00887354|6092045|P2|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||85
2485006|NCT00887354|6092046|P1|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||86
2485007|NCT00887354|6092045|P2|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||110
2485008|NCT00887354|6092046|P1|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||106
2485009|NCT00887354|6092045|P2|STARTED|Treatment Phase (Week 0 to Week 26)||113
2485010|NCT00887354|6092046|P1|STARTED|Treatment Phase (Week 0 to Week 26)||111
2485011|NCT00887341|6092066|P2|NOT COMPLETED|Overall Study||3
2485012|NCT00887341|6092067|P1|NOT COMPLETED|Overall Study||2
2485013|NCT00887341|6092066|P2|COMPLETED|Overall Study||36
2485014|NCT00887341|6092067|P1|COMPLETED|Overall Study||35
2485015|NCT00887341|6092066|P2|STARTED|Overall Study||39
2485016|NCT00887341|6092067|P1|STARTED|Overall Study||37
2485017|NCT00887315|6092103|P2|NOT COMPLETED|Overall Study||4
2485018|NCT00887315|6092104|P1|NOT COMPLETED|Overall Study||7
2485019|NCT00887315|6092103|P2|COMPLETED|Overall Study||0
2485020|NCT00887315|6092104|P1|COMPLETED|Overall Study||0
2485021|NCT00887315|6092103|P2|STARTED|Overall Study||4
2485022|NCT00887315|6092104|P1|STARTED|Overall Study||7
2485023|NCT00887289|6092112|P1|NOT COMPLETED|Overall Study||95
2485024|NCT00887289|6092112|P1|COMPLETED|Overall Study||1409
2485025|NCT00887289|6092112|P1|STARTED|Overall Study||1504
2485026|NCT00887250|6092124|P3|NOT COMPLETED|Overall Study||13
2485027|NCT00887250|6092125|P2|NOT COMPLETED|Overall Study||12
2485028|NCT00887250|6092126|P1|NOT COMPLETED|Overall Study||18
2485029|NCT00887250|6092124|P3|COMPLETED|Overall Study||110
2485030|NCT00887250|6092125|P2|COMPLETED|Overall Study||115
2485031|NCT00887250|6092126|P1|COMPLETED|Overall Study||98
2485032|NCT00887250|6092124|P3|STARTED|Overall Study||123
2485033|NCT00887250|6092125|P2|STARTED|Overall Study||127
2485034|NCT00887250|6092126|P1|STARTED|Overall Study||116
2485035|NCT00887224|6092149|P3|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||30
2485036|NCT00887224|6092150|P2|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||41
2485037|NCT00887224|6092151|P1|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||0
2485038|NCT00887224|6092149|P3|COMPLETED|DB Taper Phase / Post Study Follow Up||235
2485039|NCT00887224|6092150|P2|COMPLETED|DB Taper Phase / Post Study Follow Up||226
2485040|NCT00887224|6092151|P1|COMPLETED|DB Taper Phase / Post Study Follow Up||0
2485041|NCT00887224|6092149|P3|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||30
2485042|NCT00887224|6092150|P2|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up|DBp could have discontinued at anytime during DB taper period or Follow-up (7 days after last dose).|41
2485043|NCT00887224|6092151|P1|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||0
2485044|NCT00887224|6092149|P3|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||7
2485045|NCT00887224|6092150|P2|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||9
2485046|NCT00887224|6092151|P1|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||0
2485047|NCT00887224|6092149|P3|STARTED|DB Taper Phase / Post Study Follow Up||265
2485048|NCT00887224|6092150|P2|STARTED|DB Taper Phase / Post Study Follow Up|Double-blind participants (DBp) could have entered 7-day taper period at any time during DB phase.|267
2485049|NCT00887224|6092151|P1|STARTED|DB Taper Phase / Post Study Follow Up||0
2485050|NCT00887224|6092149|P3|NOT COMPLETED|Double-blind (DB) Phase||62
2485051|NCT00887224|6092150|P2|NOT COMPLETED|Double-blind (DB) Phase||100
2485052|NCT00887224|6092151|P1|NOT COMPLETED|Double-blind (DB) Phase||0
2485053|NCT00887224|6092149|P3|COMPLETED|Double-blind (DB) Phase||210
2485054|NCT00887224|6092150|P2|COMPLETED|Double-blind (DB) Phase||176
2485055|NCT00887224|6092151|P1|COMPLETED|Double-blind (DB) Phase||0
2485056|NCT00887224|6092149|P3|STARTED|Double-blind (DB) Phase||272
2485057|NCT00887224|6092150|P2|STARTED|Double-blind (DB) Phase|2 participants randomized in error to DB, then entered OL Taper; counted in OL Taper and DB phases.|276
2485058|NCT00887224|6092151|P1|STARTED|Double-blind (DB) Phase||0
2485059|NCT00887224|6092149|P3|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
2485060|NCT00887224|6092150|P2|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
2485061|NCT00887224|6092151|P1|NOT COMPLETED|OL Taper Phase / OL Follow Up||144
2485062|NCT00887224|6092149|P3|COMPLETED|OL Taper Phase / OL Follow Up||0
2485063|NCT00887224|6092150|P2|COMPLETED|OL Taper Phase / OL Follow Up||0
2485064|NCT00887224|6092151|P1|COMPLETED|OL Taper Phase / OL Follow Up||163
2485065|NCT00887224|6092149|P3|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
2485066|NCT00887224|6092150|P2|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
2485067|NCT00887224|6092151|P1|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up|Could have discontinued at any time during OL taper phase or OL Follow-up (7 days after last dose).|144
2485068|NCT00887224|6092149|P3|STARTED|OL Taper Phase / OL Follow Up||0
2485069|NCT00887224|6092150|P2|STARTED|OL Taper Phase / OL Follow Up||0
2485070|NCT00887224|6092151|P1|STARTED|OL Taper Phase / OL Follow Up|Could have entered 7-day taper period at any time during either the OLR phase or OLS phase.|307
2485071|NCT00887224|6092149|P3|NOT COMPLETED|Between OLS and DB Phases||0
2485072|NCT00887224|6092150|P2|NOT COMPLETED|Between OLS and DB Phases||0
2485073|NCT00887224|6092151|P1|NOT COMPLETED|Between OLS and DB Phases||28
2485074|NCT00887224|6092149|P3|COMPLETED|Between OLS and DB Phases||0
2485075|NCT00887224|6092150|P2|COMPLETED|Between OLS and DB Phases||0
2485076|NCT00887224|6092151|P1|COMPLETED|Between OLS and DB Phases||548
2485077|NCT00887224|6092149|P3|STARTED|Between OLS and DB Phases||0
2485078|NCT00887224|6092150|P2|STARTED|Between OLS and DB Phases||0
2485079|NCT00887224|6092151|P1|STARTED|Between OLS and DB Phases||576
2485080|NCT00887224|6092149|P3|NOT COMPLETED|Open-label Stability (OLS) Phase||0
2485081|NCT00887224|6092150|P2|NOT COMPLETED|Open-label Stability (OLS) Phase||0
2485082|NCT00887224|6092151|P1|NOT COMPLETED|Open-label Stability (OLS) Phase||83
2485083|NCT00887224|6092149|P3|COMPLETED|Open-label Stability (OLS) Phase||0
2485084|NCT00887224|6092150|P2|COMPLETED|Open-label Stability (OLS) Phase||0
2485085|NCT00887224|6092151|P1|COMPLETED|Open-label Stability (OLS) Phase||576
2485086|NCT00887224|6092149|P3|STARTED|Open-label Stability (OLS) Phase||0
2485087|NCT00887224|6092150|P2|STARTED|Open-label Stability (OLS) Phase||0
2485088|NCT00887224|6092151|P1|STARTED|Open-label Stability (OLS) Phase||659
2485089|NCT00887224|6092149|P3|NOT COMPLETED|Between OLR and OLS Phases||0
2485090|NCT00887224|6092150|P2|NOT COMPLETED|Between OLR and OLS Phases||0
2485091|NCT00887224|6092151|P1|NOT COMPLETED|Between OLR and OLS Phases||93
2485092|NCT00887224|6092149|P3|COMPLETED|Between OLR and OLS Phases||0
2485093|NCT00887224|6092150|P2|COMPLETED|Between OLR and OLS Phases||0
2485094|NCT00887224|6092151|P1|COMPLETED|Between OLR and OLS Phases||659
2485095|NCT00887224|6092149|P3|STARTED|Between OLR and OLS Phases||0
2485096|NCT00887224|6092150|P2|STARTED|Between OLR and OLS Phases||0
2485097|NCT00887224|6092151|P1|STARTED|Between OLR and OLS Phases||752
2485098|NCT00887224|6092149|P3|NOT COMPLETED|Open-label Response (OLR) Phase||0
2485099|NCT00887224|6092150|P2|NOT COMPLETED|Open-label Response (OLR) Phase||0
2485100|NCT00887224|6092151|P1|NOT COMPLETED|Open-label Response (OLR) Phase||122
2485101|NCT00887224|6092149|P3|COMPLETED|Open-label Response (OLR) Phase||0
2485102|NCT00887224|6092150|P2|COMPLETED|Open-label Response (OLR) Phase||0
2485103|NCT00887224|6092151|P1|COMPLETED|Open-label Response (OLR) Phase||752
2485104|NCT00887224|6092149|P3|STARTED|Open-label Response (OLR) Phase||0
2485105|NCT00887224|6092150|P2|STARTED|Open-label Response (OLR) Phase||0
2485106|NCT00887224|6092151|P1|STARTED|Open-label Response (OLR) Phase||874
2485107|NCT00887198|6092178|P3|NOT COMPLETED|Cross Over (Placebo to AA)||93
2485108|NCT00887198|6092179|P2|NOT COMPLETED|Cross Over (Placebo to AA)||0
2485109|NCT00887198|6092180|P1|NOT COMPLETED|Cross Over (Placebo to AA)||0
2485110|NCT00887198|6092178|P3|COMPLETED|Cross Over (Placebo to AA)||0
2485111|NCT00887198|6092179|P2|COMPLETED|Cross Over (Placebo to AA)||0
2485112|NCT00887198|6092180|P1|COMPLETED|Cross Over (Placebo to AA)||0
2485113|NCT00887198|6092178|P3|STARTED|Cross Over (Placebo to AA)|93= 51 participants(crossed over under amendment 3)+42 participants (crossed over under amendment 4)|93
2485114|NCT00887198|6092179|P2|STARTED|Cross Over (Placebo to AA)||0
2485115|NCT00887198|6092180|P1|STARTED|Cross Over (Placebo to AA)||0
2485116|NCT00887198|6092178|P3|NOT COMPLETED|Randomized Period||0
2485117|NCT00887198|6092179|P2|NOT COMPLETED|Randomized Period||542
2485118|NCT00887198|6092180|P1|NOT COMPLETED|Randomized Period||546
2485119|NCT00887198|6092178|P3|COMPLETED|Randomized Period||0
2485120|NCT00887198|6092179|P2|COMPLETED|Randomized Period||0
2485121|NCT00887198|6092180|P1|COMPLETED|Randomized Period||0
2485122|NCT00887198|6092178|P3|Treated|Randomized Period||0
2485123|NCT00887198|6092179|P2|Treated|Randomized Period||540
2485124|NCT00887198|6092180|P1|Treated|Randomized Period||542
2485125|NCT00887198|6092178|P3|STARTED|Randomized Period||0
2485126|NCT00887198|6092179|P2|STARTED|Randomized Period||542
2485127|NCT00887198|6092180|P1|STARTED|Randomized Period||546
2485128|NCT00887159|6092211|P3|NOT COMPLETED|Overall Study||56
2485129|NCT00887159|6092212|P2|NOT COMPLETED|Overall Study||56
2485130|NCT00887159|6092213|P1|NOT COMPLETED|Overall Study||29
2485131|NCT00887159|6092211|P3|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
2485132|NCT00887159|6092212|P2|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
2485133|NCT00887159|6092213|P1|COMPLETED|Overall Study||27
2485134|NCT00887159|6092211|P3|Eligible/Treated Pts With CTCs Results|Overall Study||38
2485135|NCT00887159|6092212|P2|Eligible/Treated Pts With CTCs Results|Overall Study||42
2485136|NCT00887159|6092213|P1|Eligible/Treated Pts With CTCs Results|Overall Study||40
2485137|NCT00887159|6092211|P3|Eligible and Treated Patients|Overall Study||52
2485138|NCT00887159|6092212|P2|Eligible and Treated Patients|Overall Study||52
2485139|NCT00887159|6092213|P1|Eligible and Treated Patients|Overall Study||48
2485140|NCT00887159|6092211|P3|Patients Who Started Assigned Treatment|Overall Study||52
2485141|NCT00887159|6092212|P2|Patients Who Started Assigned Treatment|Overall Study||53
2485142|NCT00887159|6092213|P1|Patients Who Started Assigned Treatment|Overall Study||53
2485143|NCT00887159|6092211|P3|STARTED|Overall Study||56
2485144|NCT00887159|6092212|P2|STARTED|Overall Study||56
2485145|NCT00887159|6092213|P1|STARTED|Overall Study||56
2485146|NCT00887068|6092231|P2|NOT COMPLETED|Overall Study||0
2485147|NCT00887068|6092232|P1|NOT COMPLETED|Overall Study||6
2485148|NCT00887068|6092231|P2|COMPLETED|Overall Study||94
2485149|NCT00887068|6092232|P1|COMPLETED|Overall Study||87
2485150|NCT00887068|6092231|P2|STARTED|Overall Study||94
2485151|NCT00887068|6092232|P1|STARTED|Overall Study||93
2485152|NCT00886938|6092240|P1|NOT COMPLETED|Overall Study||2
2485153|NCT00886938|6092240|P1|COMPLETED|Overall Study||10
2485154|NCT00886938|6092240|P1|STARTED|Overall Study||12
2485155|NCT00886899|6092244|P1|NOT COMPLETED|Overall Study||0
2485156|NCT00886899|6092244|P1|COMPLETED|Overall Study||147
2485157|NCT00886899|6092244|P1|STARTED|Overall Study||147
2485158|NCT00886834|6092253|P2|NOT COMPLETED|Overall Study||3
2485159|NCT00886834|6092254|P1|NOT COMPLETED|Overall Study||0
2485160|NCT00886834|6092253|P2|COMPLETED|Overall Study||51
2485161|NCT00886834|6092254|P1|COMPLETED|Overall Study||54
2485162|NCT00886834|6092253|P2|STARTED|Overall Study||54
2485163|NCT00886834|6092254|P1|STARTED|Overall Study||54
2485164|NCT00886821|6092276|P14|NOT COMPLETED|Stage 2||1
2485165|NCT00886821|6092277|P13|NOT COMPLETED|Stage 2||5
2485166|NCT00886821|6092278|P12|NOT COMPLETED|Stage 2||1
2485167|NCT00886821|6092279|P11|NOT COMPLETED|Stage 2||0
2485168|NCT00886821|6092280|P10|NOT COMPLETED|Stage 2||0
2485169|NCT00886821|6092281|P9|NOT COMPLETED|Stage 2||0
2485170|NCT00886821|6092282|P8|NOT COMPLETED|Stage 2||0
2485171|NCT00886821|6092283|P7|NOT COMPLETED|Stage 2||0
2485172|NCT00886821|6092284|P6|NOT COMPLETED|Stage 2||0
2485173|NCT00886821|6092285|P5|NOT COMPLETED|Stage 2||0
2485174|NCT00886821|6092286|P4|NOT COMPLETED|Stage 2||0
2485175|NCT00886821|6092287|P3|NOT COMPLETED|Stage 2||0
2485176|NCT00886821|6092288|P2|NOT COMPLETED|Stage 2||0
2485177|NCT00886821|6092289|P1|NOT COMPLETED|Stage 2||0
2485178|NCT00886821|6092276|P14|COMPLETED|Stage 2||8
2485179|NCT00886821|6092277|P13|COMPLETED|Stage 2||8
2485180|NCT00886821|6092278|P12|COMPLETED|Stage 2||8
2485181|NCT00886821|6092279|P11|COMPLETED|Stage 2||9
2485182|NCT00886821|6092280|P10|COMPLETED|Stage 2||0
2485183|NCT00886821|6092281|P9|COMPLETED|Stage 2||0
2485184|NCT00886821|6092282|P8|COMPLETED|Stage 2||0
2485185|NCT00886821|6092283|P7|COMPLETED|Stage 2||0
2485186|NCT00886821|6092284|P6|COMPLETED|Stage 2||0
2485187|NCT00886821|6092285|P5|COMPLETED|Stage 2||0
2485188|NCT00886821|6092286|P4|COMPLETED|Stage 2||0
2485189|NCT00886821|6092287|P3|COMPLETED|Stage 2||0
2485190|NCT00886821|6092288|P2|COMPLETED|Stage 2||0
2485191|NCT00886821|6092289|P1|COMPLETED|Stage 2||0
2485192|NCT00886821|6092276|P14|STARTED|Stage 2||9
2485193|NCT00886821|6092277|P13|STARTED|Stage 2||13
2485194|NCT00886821|6092278|P12|STARTED|Stage 2||9
2485195|NCT00886821|6092279|P11|STARTED|Stage 2||9
2485196|NCT00886821|6092280|P10|STARTED|Stage 2||0
2485197|NCT00886821|6092281|P9|STARTED|Stage 2||0
2485198|NCT00886821|6092282|P8|STARTED|Stage 2||0
2485199|NCT00886821|6092283|P7|STARTED|Stage 2||0
2485200|NCT00886821|6092284|P6|STARTED|Stage 2||0
2485201|NCT00886821|6092285|P5|STARTED|Stage 2||0
2485202|NCT00886821|6092286|P4|STARTED|Stage 2||0
2485203|NCT00886821|6092287|P3|STARTED|Stage 2||0
2485204|NCT00886821|6092288|P2|STARTED|Stage 2||0
2485205|NCT00886821|6092289|P1|STARTED|Stage 2||0
2485206|NCT00886821|6092276|P14|NOT COMPLETED|Stage 1||0
2485207|NCT00886821|6092277|P13|NOT COMPLETED|Stage 1||0
2485208|NCT00886821|6092278|P12|NOT COMPLETED|Stage 1||0
2485209|NCT00886821|6092279|P11|NOT COMPLETED|Stage 1||0
2485210|NCT00886821|6092280|P10|NOT COMPLETED|Stage 1||0
2485211|NCT00886821|6092281|P9|NOT COMPLETED|Stage 1||0
2485212|NCT00886821|6092282|P8|NOT COMPLETED|Stage 1||0
2485213|NCT00886821|6092283|P7|NOT COMPLETED|Stage 1||0
2485214|NCT00886821|6092284|P6|NOT COMPLETED|Stage 1||0
2485215|NCT00886821|6092285|P5|NOT COMPLETED|Stage 1||0
2485216|NCT00886821|6092286|P4|NOT COMPLETED|Stage 1||0
2485217|NCT00886821|6092287|P3|NOT COMPLETED|Stage 1||0
2485218|NCT00886821|6092288|P2|NOT COMPLETED|Stage 1||0
2485219|NCT00886821|6092289|P1|NOT COMPLETED|Stage 1||0
2485220|NCT00886821|6092276|P14|COMPLETED|Stage 1||0
2485221|NCT00886821|6092277|P13|COMPLETED|Stage 1||0
2485222|NCT00886821|6092278|P12|COMPLETED|Stage 1||0
2485223|NCT00886821|6092279|P11|COMPLETED|Stage 1||0
2485224|NCT00886821|6092280|P10|COMPLETED|Stage 1||18
2485225|NCT00886821|6092281|P9|COMPLETED|Stage 1||6
2485226|NCT00886821|6092282|P8|COMPLETED|Stage 1||6
2485227|NCT00886821|6092283|P7|COMPLETED|Stage 1||6
2485228|NCT00886821|6092284|P6|COMPLETED|Stage 1||6
2485229|NCT00886821|6092285|P5|COMPLETED|Stage 1||6
2485230|NCT00886821|6092286|P4|COMPLETED|Stage 1||7
2485231|NCT00886821|6092287|P3|COMPLETED|Stage 1||6
2485232|NCT00886821|6092288|P2|COMPLETED|Stage 1||6
2485233|NCT00886821|6092289|P1|COMPLETED|Stage 1||7
2485234|NCT00886821|6092276|P14|STARTED|Stage 1||0
2485235|NCT00886821|6092277|P13|STARTED|Stage 1||0
2485236|NCT00886821|6092278|P12|STARTED|Stage 1||0
2485237|NCT00886821|6092279|P11|STARTED|Stage 1||0
2485238|NCT00886821|6092280|P10|STARTED|Stage 1||18
2485239|NCT00886821|6092281|P9|STARTED|Stage 1||6
2485240|NCT00886821|6092282|P8|STARTED|Stage 1||6
2485241|NCT00886821|6092283|P7|STARTED|Stage 1||6
2485242|NCT00886821|6092284|P6|STARTED|Stage 1||6
2485243|NCT00886821|6092285|P5|STARTED|Stage 1||6
2485244|NCT00886821|6092286|P4|STARTED|Stage 1||7
2485245|NCT00886821|6092287|P3|STARTED|Stage 1||6
2485246|NCT00886821|6092288|P2|STARTED|Stage 1||6
2485247|NCT00886821|6092289|P1|STARTED|Stage 1||7
2485248|NCT00886795|6092514|P1|NOT COMPLETED|Overall Study||1
2485249|NCT00886795|6092514|P1|COMPLETED|Overall Study||3
2485250|NCT00886795|6092514|P1|STARTED|Overall Study||4
2485251|NCT00886769|6092521|P2|NOT COMPLETED|Overall Study||37
2485252|NCT00886769|6092522|P1|NOT COMPLETED|Overall Study||6
2485253|NCT00886769|6092521|P2|COMPLETED|Overall Study||4
2485254|NCT00886769|6092522|P1|COMPLETED|Overall Study||37
2485255|NCT00886769|6092521|P2|STARTED|Overall Study||41
2485256|NCT00886769|6092522|P1|STARTED|Overall Study||43
2485257|NCT00886743|6092546|P1|NOT COMPLETED|Overall Study||4
2485258|NCT00886743|6092546|P1|COMPLETED|Overall Study||15
2485259|NCT00886743|6092546|P1|STARTED|Overall Study|Received treatment|19
2485260|NCT00886704|6092556|P2|NOT COMPLETED|Overall Study||0
2485261|NCT00886704|6092557|P1|NOT COMPLETED|Overall Study||0
2485262|NCT00886704|6092556|P2|COMPLETED|Overall Study||10
2485263|NCT00886704|6092557|P1|COMPLETED|Overall Study||40
2485264|NCT00886704|6092556|P2|STARTED|Overall Study||10
2485265|NCT00886704|6092557|P1|STARTED|Overall Study||40
2485266|NCT00886691|6092567|P2|NOT COMPLETED|Overall Study||0
2485267|NCT00886691|6092568|P1|NOT COMPLETED|Overall Study||0
2485268|NCT00886691|6092567|P2|COMPLETED|Overall Study||75
2485269|NCT00886691|6092568|P1|COMPLETED|Overall Study||75
2485270|NCT00886691|6092567|P2|STARTED|Overall Study||75
2485271|NCT00886691|6092568|P1|STARTED|Overall Study||75
2485272|NCT00886639|6092584|P1|NOT COMPLETED|Overall Study||16
2485273|NCT00886639|6092584|P1|COMPLETED|Overall Study||111
2485274|NCT00886639|6092584|P1|STARTED|Overall Study||127
2485275|NCT00886626|6092588|P2|NOT COMPLETED|Period 2 (90 Days)||0
2485276|NCT00886626|6092589|P1|NOT COMPLETED|Period 2 (90 Days)||0
2485277|NCT00886626|6092588|P2|COMPLETED|Period 2 (90 Days)||6
2485278|NCT00886626|6092589|P1|COMPLETED|Period 2 (90 Days)||5
2485279|NCT00886626|6092588|P2|STARTED|Period 2 (90 Days)||6
2485280|NCT00886626|6092589|P1|STARTED|Period 2 (90 Days)||5
2485281|NCT00886626|6092588|P2|NOT COMPLETED|Period 1 (90 Days)||0
2485282|NCT00886626|6092589|P1|NOT COMPLETED|Period 1 (90 Days)||1
2485283|NCT00886626|6092588|P2|COMPLETED|Period 1 (90 Days)||6
2485284|NCT00886626|6092589|P1|COMPLETED|Period 1 (90 Days)||5
2485285|NCT00886626|6092588|P2|STARTED|Period 1 (90 Days)||6
2485286|NCT00886626|6092589|P1|STARTED|Period 1 (90 Days)||6
2485287|NCT00886613|6092598|P3|NOT COMPLETED|Overall Study||3
2485288|NCT00886613|6092599|P2|NOT COMPLETED|Overall Study||0
2485289|NCT00886613|6092600|P1|NOT COMPLETED|Overall Study||2
2485290|NCT00886613|6092598|P3|COMPLETED|Overall Study||37
2485291|NCT00886613|6092599|P2|COMPLETED|Overall Study||39
2485292|NCT00886613|6092600|P1|COMPLETED|Overall Study||39
2485293|NCT00886613|6092598|P3|STARTED|Overall Study||40
2485294|NCT00886613|6092599|P2|STARTED|Overall Study||39
2485295|NCT00886613|6092600|P1|STARTED|Overall Study||41
2485296|NCT00886600|6092622|P4|NOT COMPLETED|Combination Therapy Period||0
2485297|NCT00886600|6092623|P3|NOT COMPLETED|Combination Therapy Period||2
2485298|NCT00886600|6092624|P2|NOT COMPLETED|Combination Therapy Period||0
2485299|NCT00886600|6092625|P1|NOT COMPLETED|Combination Therapy Period||0
2485300|NCT00886600|6092622|P4|COMPLETED|Combination Therapy Period||23
2485301|NCT00886600|6092623|P3|COMPLETED|Combination Therapy Period||19
2485302|NCT00886600|6092624|P2|COMPLETED|Combination Therapy Period||21
2485303|NCT00886600|6092625|P1|COMPLETED|Combination Therapy Period||28
2485304|NCT00886600|6092622|P4|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 5-(SiDBP <85); 1-(SiDBP ≥85)|23
2485305|NCT00886600|6092623|P3|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 7-(SiDBP <85); 1-(SiDBP ≥85)|21
2485306|NCT00886600|6092624|P2|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 4-(SiDBP <85); 3-(SiDBP ≥85)|21
2485307|NCT00886600|6092625|P1|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 2-(Sitting Diastolic Blood Pressure (SiDBP) <85)|28
2485308|NCT00886600|6092622|P4|NOT COMPLETED|Double-blind Monotherapy||2
2485309|NCT00886600|6092623|P3|NOT COMPLETED|Double-blind Monotherapy||1
2485310|NCT00886600|6092624|P2|NOT COMPLETED|Double-blind Monotherapy||1
2485311|NCT00886600|6092625|P1|NOT COMPLETED|Double-blind Monotherapy||2
2485312|NCT00886600|6092622|P4|COMPLETED|Double-blind Monotherapy||29
2485313|NCT00886600|6092623|P3|COMPLETED|Double-blind Monotherapy||29
2485314|NCT00886600|6092624|P2|COMPLETED|Double-blind Monotherapy|1 pt discontinued after Wk 4 due to AE starting in placebo baseline and continuing into double-blind|28
2485315|NCT00886600|6092625|P1|COMPLETED|Double-blind Monotherapy||30
2485316|NCT00886600|6092622|P4|STARTED|Double-blind Monotherapy||31
2485317|NCT00886600|6092623|P3|STARTED|Double-blind Monotherapy||30
2485318|NCT00886600|6092624|P2|STARTED|Double-blind Monotherapy||29
2485319|NCT00886600|6092625|P1|STARTED|Double-blind Monotherapy||32
2485320|NCT00886587|6092649|P2|NOT COMPLETED|Overall Study||2
2485321|NCT00886587|6092650|P1|NOT COMPLETED|Overall Study||4
2485322|NCT00886587|6092649|P2|COMPLETED|Overall Study||39
2485323|NCT00886587|6092650|P1|COMPLETED|Overall Study||37
2485324|NCT00886587|6092649|P2|STARTED|Overall Study||41
2485325|NCT00886587|6092650|P1|STARTED|Overall Study||41
2485326|NCT00886483|6092664|P2|NOT COMPLETED|Overall Study||3
2485327|NCT00886483|6092665|P1|NOT COMPLETED|Overall Study||2
2485328|NCT00886483|6092664|P2|COMPLETED|Overall Study||10
2485329|NCT00886483|6092665|P1|COMPLETED|Overall Study||24
2485330|NCT00886483|6092664|P2|Completed 20 Treatments|Overall Study||11
2485331|NCT00886483|6092665|P1|Completed 20 Treatments|Overall Study||25
2485332|NCT00886483|6092664|P2|STARTED|Overall Study||13
2485333|NCT00886483|6092665|P1|STARTED|Overall Study||26
2485334|NCT00886340|6092683|P2|NOT COMPLETED|Overall Study||7
2485335|NCT00886340|6092684|P1|NOT COMPLETED|Overall Study||0
2485336|NCT00886340|6092683|P2|COMPLETED|Overall Study||24
2485337|NCT00886340|6092684|P1|COMPLETED|Overall Study||27
2485338|NCT00886340|6092683|P2|STARTED|Overall Study||31
2485339|NCT00886340|6092684|P1|STARTED|Overall Study||27
2485340|NCT00886288|6092692|P2|NOT COMPLETED|Overall Study||227
2485341|NCT00886288|6092693|P1|NOT COMPLETED|Overall Study||743
2485342|NCT00886288|6092692|P2|COMPLETED|Overall Study||457
2485343|NCT00886288|6092693|P1|COMPLETED|Overall Study||1284
2485344|NCT00886288|6092692|P2|STARTED|Overall Study|Baseline Population|684
2485345|NCT00886288|6092693|P1|STARTED|Overall Study|Baseline Population|2027
2485346|NCT00886262|6092711|P2|NOT COMPLETED|Overall Study||3
2485347|NCT00886262|6092712|P1|NOT COMPLETED|Overall Study||0
2485348|NCT00886262|6092711|P2|COMPLETED|Overall Study||7
2485349|NCT00886262|6092712|P1|COMPLETED|Overall Study||8
2485350|NCT00886262|6092711|P2|STARTED|Overall Study||10
2485351|NCT00886262|6092712|P1|STARTED|Overall Study||8
2485352|NCT00886236|6092727|P3|NOT COMPLETED|Overall Study||4
2485353|NCT00886236|6092728|P2|NOT COMPLETED|Overall Study||4
2485354|NCT00886236|6092729|P1|NOT COMPLETED|Overall Study||2
2485355|NCT00886236|6092727|P3|COMPLETED|Overall Study||17
2485356|NCT00886236|6092728|P2|COMPLETED|Overall Study||17
2485357|NCT00886236|6092729|P1|COMPLETED|Overall Study||18
2485358|NCT00886236|6092727|P3|STARTED|Overall Study||21
2485359|NCT00886236|6092728|P2|STARTED|Overall Study||21
2485360|NCT00886236|6092729|P1|STARTED|Overall Study||20
2485361|NCT00886145|6092743|P1|NOT COMPLETED|Overall Study||0
2485362|NCT00886145|6092743|P1|COMPLETED|Overall Study||1
2485363|NCT00886145|6092743|P1|STARTED|Overall Study||1
2485364|NCT00886119|6092749|P2|NOT COMPLETED|Period 2||0
2485365|NCT00886119|6092750|P1|NOT COMPLETED|Period 2||0
2485366|NCT00886119|6092749|P2|COMPLETED|Period 2||22
2485367|NCT00886119|6092750|P1|COMPLETED|Period 2||23
2485368|NCT00886119|6092749|P2|STARTED|Period 2||22
2485369|NCT00886119|6092750|P1|STARTED|Period 2||23
2485370|NCT00886119|6092749|P2|NOT COMPLETED|Period 1||0
2485371|NCT00886119|6092750|P1|NOT COMPLETED|Period 1||1
2485372|NCT00886119|6092749|P2|COMPLETED|Period 1||22
2485373|NCT00886119|6092750|P1|COMPLETED|Period 1||23
2485374|NCT00886119|6092749|P2|STARTED|Period 1||22
2485375|NCT00886119|6092750|P1|STARTED|Period 1||24
2485376|NCT00886015|6092758|P2|NOT COMPLETED|Overall Study||2
2485377|NCT00886015|6092759|P1|NOT COMPLETED|Overall Study||0
2485378|NCT00886015|6092758|P2|COMPLETED|Overall Study|1669 eyes; 956 participants|1669
2485379|NCT00886015|6092759|P1|COMPLETED|Overall Study|1674 eyes; 960 participants|1674
2485380|NCT00886015|6092758|P2|STARTED|Overall Study|1671 eyes; 957 participants|1671
2485381|NCT00886015|6092759|P1|STARTED|Overall Study|1674 eyes; 960 participants|1674
2485382|NCT00885846|6092778|P3|NOT COMPLETED|Overall Study||2
2485383|NCT00885846|6092779|P2|NOT COMPLETED|Overall Study||5
2485384|NCT00885846|6092780|P1|NOT COMPLETED|Overall Study||2
2485385|NCT00885846|6092778|P3|COMPLETED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|8
2485386|NCT00885846|6092779|P2|COMPLETED|Overall Study|Cohort 1 = 1 Cohort 2 = 5|6
2485387|NCT00885846|6092780|P1|COMPLETED|Overall Study|Cohort 1 = 3 Cohort 2 = 6|9
2485388|NCT00885846|6092778|P3|STARTED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|10
2485389|NCT00885846|6092779|P2|STARTED|Overall Study|Cohort 1 = 6 Cohort 2 = 5|11
2485390|NCT00885846|6092780|P1|STARTED|Overall Study|Cohort 1 = 5 Cohort 2 = 6|11
2485391|NCT00885768|6092788|P1|NOT COMPLETED|Overall Study||0
2485392|NCT00885768|6092788|P1|COMPLETED|Overall Study|all patients with including criteria completed the study|146
2485393|NCT00885768|6092788|P1|STARTED|Overall Study|all patients with coronary artery stenosis on angiography entered the study|146
2485394|NCT00885755|6092795|P3|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
2485395|NCT00885755|6092796|P2|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
2485396|NCT00885755|6092797|P1|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||5
2485397|NCT00885755|6092795|P3|COMPLETED|Part II: Trastuzumab + Capecitabine.||0
2485398|NCT00885755|6092796|P2|COMPLETED|Part II: Trastuzumab + Capecitabine.||1
2485399|NCT00885755|6092797|P1|COMPLETED|Part II: Trastuzumab + Capecitabine.||8
2485400|NCT00885755|6092795|P3|STARTED|Part II: Trastuzumab + Capecitabine.||0
2485401|NCT00885755|6092796|P2|STARTED|Part II: Trastuzumab + Capecitabine.||1
2485402|NCT00885755|6092797|P1|STARTED|Part II: Trastuzumab + Capecitabine.||13
2485403|NCT00885755|6092795|P3|NOT COMPLETED|Part I: Trastuzumab+Taxane||1
2485404|NCT00885755|6092796|P2|NOT COMPLETED|Part I: Trastuzumab+Taxane||0
2485405|NCT00885755|6092797|P1|NOT COMPLETED|Part I: Trastuzumab+Taxane||18
2485406|NCT00885755|6092795|P3|COMPLETED|Part I: Trastuzumab+Taxane||0
2485407|NCT00885755|6092796|P2|COMPLETED|Part I: Trastuzumab+Taxane||1
2485408|NCT00885755|6092797|P1|COMPLETED|Part I: Trastuzumab+Taxane||13
2485409|NCT00885755|6092795|P3|STARTED|Part I: Trastuzumab+Taxane||1
2485410|NCT00885755|6092796|P2|STARTED|Part I: Trastuzumab+Taxane||1
2485411|NCT00885755|6092797|P1|STARTED|Part I: Trastuzumab+Taxane||31
2485412|NCT00885742|6092822|P1|NOT COMPLETED|Overall Study||0
2485413|NCT00885742|6092822|P1|COMPLETED|Overall Study||41
2485414|NCT00885742|6092822|P1|STARTED|Overall Study||41
2485415|NCT00885703|6092840|P7|NOT COMPLETED|Overall Study||6
2485416|NCT00885703|6092841|P6|NOT COMPLETED|Overall Study||13
2485417|NCT00885703|6092842|P5|NOT COMPLETED|Overall Study||12
2485418|NCT00885703|6092843|P4|NOT COMPLETED|Overall Study||9
2485419|NCT00885703|6092844|P3|NOT COMPLETED|Overall Study||11
2485420|NCT00885703|6092845|P2|NOT COMPLETED|Overall Study||10
2485421|NCT00885703|6092846|P1|NOT COMPLETED|Overall Study||10
2485422|NCT00885703|6092840|P7|COMPLETED|Overall Study||18
2485423|NCT00885703|6092841|P6|COMPLETED|Overall Study||11
2485424|NCT00885703|6092842|P5|COMPLETED|Overall Study||12
2485425|NCT00885703|6092843|P4|COMPLETED|Overall Study||15
2485426|NCT00885703|6092844|P3|COMPLETED|Overall Study||13
2485427|NCT00885703|6092845|P2|COMPLETED|Overall Study||16
2485428|NCT00885703|6092846|P1|COMPLETED|Overall Study||12
2485429|NCT00885703|6092840|P7|STARTED|Overall Study||24
2485430|NCT00885703|6092841|P6|STARTED|Overall Study||24
2485431|NCT00885703|6092842|P5|STARTED|Overall Study||24
2485432|NCT00885703|6092843|P4|STARTED|Overall Study||24
2485433|NCT00885703|6092844|P3|STARTED|Overall Study||24
2485434|NCT00885703|6092845|P2|STARTED|Overall Study||26
2485435|NCT00885703|6092846|P1|STARTED|Overall Study||22
2485436|NCT00885677|6092904|P2|NOT COMPLETED|Overall Study||178
2485437|NCT00885677|6092905|P1|NOT COMPLETED|Overall Study||183
2485438|NCT00885677|6092904|P2|COMPLETED|Overall Study||277
2485439|NCT00885677|6092905|P1|COMPLETED|Overall Study||279
2485440|NCT00885677|6092904|P2|Intention To Treat|Overall Study||428
2485441|NCT00885677|6092905|P1|Intention To Treat|Overall Study||437
2485442|NCT00885677|6092904|P2|STARTED|Overall Study||455
2485443|NCT00885677|6092905|P1|STARTED|Overall Study||462
2485444|NCT00885638|6092913|P2|NOT COMPLETED|Overall Study||0
2485445|NCT00885638|6092914|P1|NOT COMPLETED|Overall Study||0
2485446|NCT00885638|6092913|P2|COMPLETED|Overall Study||6
2485447|NCT00885638|6092914|P1|COMPLETED|Overall Study||6
2485448|NCT00885638|6092913|P2|STARTED|Overall Study||6
2485449|NCT00885638|6092914|P1|STARTED|Overall Study||6
2485450|NCT00885534|6092921|P1|NOT COMPLETED|Overall Study||1
2485451|NCT00885534|6092921|P1|COMPLETED|Overall Study||6
2485452|NCT00885534|6092921|P1|STARTED|Overall Study||7
2485453|NCT00885482|6092925|P1|NOT COMPLETED|Overall Study||4
2485454|NCT00885482|6092925|P1|COMPLETED|Overall Study||36
2485455|NCT00885482|6092925|P1|STARTED|Overall Study||40
2485456|NCT00885378|6092931|P2|NOT COMPLETED|Overall Study||8
2485457|NCT00885378|6092932|P1|NOT COMPLETED|Overall Study||8
2485458|NCT00885378|6092931|P2|COMPLETED|Overall Study||78
2485459|NCT00885378|6092932|P1|COMPLETED|Overall Study||66
2485460|NCT00885378|6092931|P2|STARTED|Overall Study|Number randomized.|86
2485461|NCT00885378|6092932|P1|STARTED|Overall Study|Number randomized.|74
2485462|NCT00885365|6092962|P2|NOT COMPLETED|4 Weeks OFF Treatment||0
2485463|NCT00885365|6092963|P1|NOT COMPLETED|4 Weeks OFF Treatment||0
2485464|NCT00885365|6092962|P2|COMPLETED|4 Weeks OFF Treatment||159
2485465|NCT00885365|6092963|P1|COMPLETED|4 Weeks OFF Treatment||155
2485466|NCT00885365|6092962|P2|STARTED|4 Weeks OFF Treatment||159
2485467|NCT00885365|6092963|P1|STARTED|4 Weeks OFF Treatment||155
2485468|NCT00885365|6092962|P2|NOT COMPLETED|4 Weeks ON Treatment||6
2485469|NCT00885365|6092963|P1|NOT COMPLETED|4 Weeks ON Treatment||4
2485470|NCT00885365|6092962|P2|COMPLETED|4 Weeks ON Treatment||159
2485471|NCT00885365|6092963|P1|COMPLETED|4 Weeks ON Treatment||155
2485472|NCT00885365|6092962|P2|Safety Population|4 Weeks ON Treatment|Six participants randomized to TOBI were administered Bramitob|168
2485473|NCT00885365|6092963|P1|Safety Population|4 Weeks ON Treatment|Nine participants randomized to Bramitob were administered TOBI.|156
2485474|NCT00885365|6092962|P2|Intent-to-Treat Population|4 Weeks ON Treatment||163
2485475|NCT00885365|6092963|P1|Intent-to-Treat Population|4 Weeks ON Treatment|Participants who took 1 dose of study medication and had baseline and at least 1 post-treatment FEV1|158
2485476|NCT00885365|6092962|P2|STARTED|4 Weeks ON Treatment||165
2485477|NCT00885365|6092963|P1|STARTED|4 Weeks ON Treatment||159
2485478|NCT00885352|6092999|P2|NOT COMPLETED|Overall Study||20
2485479|NCT00885352|6093000|P1|NOT COMPLETED|Overall Study||8
2485480|NCT00885352|6092999|P2|COMPLETED|Overall Study||136
2485481|NCT00885352|6093000|P1|COMPLETED|Overall Study||149
2485482|NCT00885352|6092999|P2|STARTED|Overall Study||156
2485483|NCT00885352|6093000|P1|STARTED|Overall Study||157
2485484|NCT00885170|6093012|P2|NOT COMPLETED|Overall Study||23
2485485|NCT00885170|6093013|P1|NOT COMPLETED|Overall Study||38
2485486|NCT00885170|6093012|P2|COMPLETED|Overall Study||99
2485487|NCT00885170|6093013|P1|COMPLETED|Overall Study||86
2485488|NCT00885170|6093012|P2|Treated|Overall Study||121
2485489|NCT00885170|6093013|P1|Treated|Overall Study||122
2485490|NCT00885170|6093012|P2|STARTED|Overall Study||122
2485491|NCT00885170|6093013|P1|STARTED|Overall Study||124
2485492|NCT00885118|6093072|P5|NOT COMPLETED|Overall Study||1
2485493|NCT00885118|6093073|P4|NOT COMPLETED|Overall Study||0
2485494|NCT00885118|6093074|P3|NOT COMPLETED|Overall Study||1
2485495|NCT00885118|6093075|P2|NOT COMPLETED|Overall Study||0
2485496|NCT00885118|6093076|P1|NOT COMPLETED|Overall Study||1
2485497|NCT00885118|6093072|P5|COMPLETED|Overall Study||18
2485498|NCT00885118|6093073|P4|COMPLETED|Overall Study||20
2485499|NCT00885118|6093074|P3|COMPLETED|Overall Study||20
2485500|NCT00885118|6093075|P2|COMPLETED|Overall Study||19
2485501|NCT00885118|6093076|P1|COMPLETED|Overall Study||20
2485502|NCT00885118|6093072|P5|STARTED|Overall Study||19
2485503|NCT00885118|6093073|P4|STARTED|Overall Study||20
2485504|NCT00885118|6093074|P3|STARTED|Overall Study||21
2485505|NCT00885118|6093075|P2|STARTED|Overall Study||19
2485506|NCT00885118|6093076|P1|STARTED|Overall Study||21
2485507|NCT00885105|6093215|P2|NOT COMPLETED|Overall Study||10
2485508|NCT00885105|6093216|P1|NOT COMPLETED|Overall Study||1
2485509|NCT00885105|6093215|P2|COMPLETED|Overall Study||120
2485510|NCT00885105|6093216|P1|COMPLETED|Overall Study||111
2485511|NCT00885105|6093215|P2|STARTED|Overall Study||130
2485512|NCT00885105|6093216|P1|STARTED|Overall Study||112
2485513|NCT00885092|6093234|P2|NOT COMPLETED|Period 2, 7 Days||0
2485514|NCT00885092|6093235|P1|NOT COMPLETED|Period 2, 7 Days||0
2485515|NCT00885092|6093234|P2|COMPLETED|Period 2, 7 Days||20
2485516|NCT00885092|6093235|P1|COMPLETED|Period 2, 7 Days||20
2485517|NCT00885092|6093234|P2|STARTED|Period 2, 7 Days||20
2485518|NCT00885092|6093235|P1|STARTED|Period 2, 7 Days||20
2485519|NCT00885092|6093234|P2|NOT COMPLETED|Period 1, 7 Days||0
2485520|NCT00885092|6093235|P1|NOT COMPLETED|Period 1, 7 Days||0
2485521|NCT00885092|6093234|P2|COMPLETED|Period 1, 7 Days||20
2485522|NCT00885092|6093235|P1|COMPLETED|Period 1, 7 Days||20
2485523|NCT00885092|6093234|P2|STARTED|Period 1, 7 Days||20
2485524|NCT00885092|6093235|P1|STARTED|Period 1, 7 Days||20
2485525|NCT00885079|6093247|P2|NOT COMPLETED|Overall Study||4
2485526|NCT00885079|6093248|P1|NOT COMPLETED|Overall Study||2
2485527|NCT00885079|6093247|P2|COMPLETED|Overall Study||91
2485528|NCT00885079|6093248|P1|COMPLETED|Overall Study||91
2485529|NCT00885079|6093247|P2|STARTED|Overall Study||95
2485530|NCT00885079|6093248|P1|STARTED|Overall Study||93
2485531|NCT00884949|6093256|P1|NOT COMPLETED|Continuation Period||0
2485532|NCT00884949|6093256|P1|COMPLETED|Continuation Period||18
2485533|NCT00884949|6093256|P1|STARTED|Continuation Period||18
2485534|NCT00884949|6093256|P1|NOT COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||0
2485535|NCT00884949|6093256|P1|COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||18
2485536|NCT00884949|6093256|P1|STARTED|Weeks 25-36: 2.0 mg/kg/Week||18
2485537|NCT00884949|6093256|P1|NOT COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||0
2485538|NCT00884949|6093256|P1|COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||18
2485539|NCT00884949|6093256|P1|STARTED|Weeks 13-24: 1.0 mg/kg/Week||18
2485540|NCT00884949|6093256|P1|NOT COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||2
2485541|NCT00884949|6093256|P1|COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||18
2485542|NCT00884949|6093256|P1|STARTED|Weeks 1-12: 0.1 mg/kg/Week||20
2485543|NCT00884910|6093273|P1|NOT COMPLETED|Overall Study||1
2485544|NCT00884910|6093273|P1|COMPLETED|Overall Study|patient diagnosed with primary pulmonary tumor during study|32
2485545|NCT00884910|6093273|P1|STARTED|Overall Study||33
2485546|NCT00884897|6093280|P2|NOT COMPLETED|Overall Study||0
2485547|NCT00884897|6093281|P1|NOT COMPLETED|Overall Study||0
2485548|NCT00884897|6093280|P2|COMPLETED|Overall Study||15
2485549|NCT00884897|6093281|P1|COMPLETED|Overall Study||13
2485550|NCT00884897|6093280|P2|STARTED|Overall Study||15
2485551|NCT00884897|6093281|P1|STARTED|Overall Study||13
2485552|NCT00884832|6093291|P2|NOT COMPLETED|Overall Study||1
2485553|NCT00884832|6093292|P1|NOT COMPLETED|Overall Study||0
2485554|NCT00884832|6093291|P2|COMPLETED|Overall Study||21
2485555|NCT00884832|6093292|P1|COMPLETED|Overall Study||22
2485556|NCT00884832|6093291|P2|STARTED|Overall Study||22
2485557|NCT00884832|6093292|P1|STARTED|Overall Study||22
2485558|NCT00884806|6093322|P1|NOT COMPLETED|Overall Study||0
2485559|NCT00884806|6093322|P1|COMPLETED|Overall Study||110
2485560|NCT00884806|6093322|P1|STARTED|Overall Study||110
2485561|NCT00884793|6093327|P1|NOT COMPLETED|Overall Study||1
2485562|NCT00884793|6093327|P1|COMPLETED|Overall Study||7
2485563|NCT00884793|6093327|P1|STARTED|Overall Study||8
2485564|NCT00884754|6093336|P2|NOT COMPLETED|Overall Study||0
2485565|NCT00884754|6093337|P1|NOT COMPLETED|Overall Study||0
2485566|NCT00884754|6093336|P2|COMPLETED|Overall Study||30
2485567|NCT00884754|6093337|P1|COMPLETED|Overall Study||30
2485568|NCT00884754|6093336|P2|STARTED|Overall Study||30
2485569|NCT00884754|6093337|P1|STARTED|Overall Study||30
2485570|NCT00884741|6093346|P4|NOT COMPLETED|Randomization||8
2485571|NCT00884741|6093347|P3|NOT COMPLETED|Randomization||8
2485572|NCT00884741|6093348|P2|NOT COMPLETED|Randomization||0
2485573|NCT00884741|6093349|P1|NOT COMPLETED|Randomization||0
2485574|NCT00884741|6093346|P4|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|312
2485575|NCT00884741|6093347|P3|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|309
2485576|NCT00884741|6093348|P2|COMPLETED|Randomization||0
2485577|NCT00884741|6093349|P1|COMPLETED|Randomization||0
2485578|NCT00884741|6093346|P4|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|320
2485579|NCT00884741|6093347|P3|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|317
2485580|NCT00884741|6093348|P2|STARTED|Randomization|Step 2 Registration Arm goes to a randomized arm.|0
2485581|NCT00884741|6093349|P1|STARTED|Randomization||0
2485582|NCT00884741|6093346|P4|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
2485583|NCT00884741|6093347|P3|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
2485584|NCT00884741|6093348|P2|NOT COMPLETED|Step 2 Registration: Tissue Analysis||29
2485585|NCT00884741|6093349|P1|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
2485586|NCT00884741|6093346|P4|COMPLETED|Step 2 Registration: Tissue Analysis||0
2485587|NCT00884741|6093347|P3|COMPLETED|Step 2 Registration: Tissue Analysis||0
2485588|NCT00884741|6093348|P2|COMPLETED|Step 2 Registration: Tissue Analysis||637
2485589|NCT00884741|6093349|P1|COMPLETED|Step 2 Registration: Tissue Analysis||0
2485590|NCT00884741|6093346|P4|STARTED|Step 2 Registration: Tissue Analysis||0
2485591|NCT00884741|6093347|P3|STARTED|Step 2 Registration: Tissue Analysis||0
2485592|NCT00884741|6093348|P2|STARTED|Step 2 Registration: Tissue Analysis|These patients completed the previous period on the Step 1 Registration arm.|666
2485593|NCT00884741|6093349|P1|STARTED|Step 2 Registration: Tissue Analysis|Step 1 Registration Arm goes to Step 2 Registration Arm|0
2485594|NCT00884741|6093346|P4|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
2485595|NCT00884741|6093347|P3|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
2485596|NCT00884741|6093348|P2|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
2485597|NCT00884741|6093349|P1|NOT COMPLETED|Step 1 Registration: Tissue Screening||312
2485598|NCT00884741|6093346|P4|COMPLETED|Step 1 Registration: Tissue Screening||0
2485599|NCT00884741|6093347|P3|COMPLETED|Step 1 Registration: Tissue Screening||0
2485600|NCT00884741|6093348|P2|COMPLETED|Step 1 Registration: Tissue Screening||0
2485601|NCT00884741|6093349|P1|COMPLETED|Step 1 Registration: Tissue Screening||666
2485602|NCT00884741|6093346|P4|STARTED|Step 1 Registration: Tissue Screening||0
2485603|NCT00884741|6093347|P3|STARTED|Step 1 Registration: Tissue Screening||0
2485604|NCT00884741|6093348|P2|STARTED|Step 1 Registration: Tissue Screening||0
2485605|NCT00884741|6093349|P1|STARTED|Step 1 Registration: Tissue Screening||978
2485606|NCT00884611|6093360|P1|NOT COMPLETED|Overall Study||1
2485607|NCT00884611|6093360|P1|COMPLETED|Overall Study||19
2485608|NCT00884611|6093360|P1|Enrolled, Not Treated|Overall Study||1
2485609|NCT00884611|6093360|P1|STARTED|Overall Study||20
2485610|NCT00884585|6093384|P2|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||0
2485611|NCT00884585|6093385|P1|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||3
2485612|NCT00884585|6093384|P2|COMPLETED|Open-Label Maintenance (Months 9-12)||0
2485613|NCT00884585|6093385|P1|COMPLETED|Open-Label Maintenance (Months 9-12)||144
2485614|NCT00884585|6093384|P2|STARTED|Open-Label Maintenance (Months 9-12)||0
2485615|NCT00884585|6093385|P1|STARTED|Open-Label Maintenance (Months 9-12)||147
2485616|NCT00884585|6093384|P2|NOT COMPLETED|Open-Label Phase (Months 3-9)||0
2485617|NCT00884585|6093385|P1|NOT COMPLETED|Open-Label Phase (Months 3-9)||15
2485618|NCT00884585|6093384|P2|COMPLETED|Open-Label Phase (Months 3-9)||0
2485619|NCT00884585|6093385|P1|COMPLETED|Open-Label Phase (Months 3-9)||147
2485620|NCT00884585|6093384|P2|STARTED|Open-Label Phase (Months 3-9)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|0
2485621|NCT00884585|6093385|P1|STARTED|Open-Label Phase (Months 3-9)|All patients who completed the double-masked phase received COS in the open-label phase.|162
2485622|NCT00884585|6093384|P2|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||4
2485623|NCT00884585|6093385|P1|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||10
2485624|NCT00884585|6093384|P2|COMPLETED|Double-Masked Phase (Day 1-Month 3)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|83
2485625|NCT00884585|6093385|P1|COMPLETED|Double-Masked Phase (Day 1-Month 3)||79
2485626|NCT00884585|6093384|P2|STARTED|Double-Masked Phase (Day 1-Month 3)||87
2485627|NCT00884585|6093385|P1|STARTED|Double-Masked Phase (Day 1-Month 3)||89
2485628|NCT00884390|6093399|P2|NOT COMPLETED|Overall Study||8
2485629|NCT00884390|6093400|P1|NOT COMPLETED|Overall Study||23
2485630|NCT00884390|6093399|P2|COMPLETED|Overall Study||54
2485631|NCT00884390|6093400|P1|COMPLETED|Overall Study||123
2485632|NCT00884390|6093399|P2|STARTED|Overall Study||62
2485633|NCT00884390|6093400|P1|STARTED|Overall Study||146
2485634|NCT00884377|6093418|P2|NOT COMPLETED|Overall Study||1
2485635|NCT00884377|6093419|P1|NOT COMPLETED|Overall Study||2
2485636|NCT00884377|6093418|P2|COMPLETED|Overall Study||27
2485637|NCT00884377|6093419|P1|COMPLETED|Overall Study|1 received full course of therapy,withdrew consent before completion of the 12 month follow up|26
2485638|NCT00884377|6093418|P2|STARTED|Overall Study|1 was not treated due to concerns arising from the location of cutaneous leishmaniasis lesion|28
2485639|NCT00884377|6093419|P1|STARTED|Overall Study|1 not treated because infecting parasite could not be confirmed as L. major on rapid PCR testing,|28
2485640|NCT00884325|6093441|P2|NOT COMPLETED|Overall Study||4
2485641|NCT00884325|6093442|P1|NOT COMPLETED|Overall Study||3
2485642|NCT00884325|6093441|P2|COMPLETED|Overall Study||16
2485643|NCT00884325|6093442|P1|COMPLETED|Overall Study||17
2485644|NCT00884325|6093441|P2|STARTED|Overall Study||20
2485645|NCT00884325|6093442|P1|STARTED|Overall Study||20
2485646|NCT00884312|6093452|P2|NOT COMPLETED|Overall Study||25
2485647|NCT00884312|6093453|P1|NOT COMPLETED|Overall Study||2
2485648|NCT00884312|6093452|P2|COMPLETED|Overall Study||67
2485649|NCT00884312|6093453|P1|COMPLETED|Overall Study||7
2485650|NCT00884312|6093452|P2|Received Treatment|Overall Study||91
2485651|NCT00884312|6093453|P1|Received Treatment|Overall Study||9
2485652|NCT00884312|6093452|P2|STARTED|Overall Study||92
2485653|NCT00884312|6093453|P1|STARTED|Overall Study||9
2485654|NCT00884286|6093469|P2|NOT COMPLETED|Overall Study||33
2485655|NCT00884286|6093470|P1|NOT COMPLETED|Overall Study||32
2485656|NCT00884286|6093469|P2|COMPLETED|Overall Study||0
2485657|NCT00884286|6093470|P1|COMPLETED|Overall Study||2
2485658|NCT00884286|6093469|P2|STARTED|Overall Study||33
2485659|NCT00884286|6093470|P1|STARTED|Overall Study||34
2485660|NCT00884273|6093484|P2|NOT COMPLETED|Overall Study||5
2485661|NCT00884273|6093485|P1|NOT COMPLETED|Overall Study||2
2485662|NCT00884273|6093484|P2|COMPLETED|Overall Study||93
2485663|NCT00884273|6093485|P1|COMPLETED|Overall Study||82
2485664|NCT00884273|6093484|P2|Safety Analysis Set|Overall Study||98
2485665|NCT00884273|6093485|P1|Safety Analysis Set|Overall Study||84
2485666|NCT00884273|6093484|P2|Per Protocol (PP) Analysis Set|Overall Study||92
2485667|NCT00884273|6093485|P1|Per Protocol (PP) Analysis Set|Overall Study||81
2485668|NCT00884273|6093484|P2|Full Analysis Set (FAS)|Overall Study|One participant did not have any post-dose efficacy assessment and was excluded from the FAS.|97
2485669|NCT00884273|6093485|P1|Full Analysis Set (FAS)|Overall Study|Two participants did not have any post-dose efficacy assessment and were excluded from the FAS.|82
2485670|NCT00884273|6093484|P2|STARTED|Overall Study|ITT population.|98
2485671|NCT00884273|6093485|P1|STARTED|Overall Study|Intention-to-treat (ITT) population.|84
2485672|NCT00884221|6093511|P2|NOT COMPLETED|Overall Study||32
2485673|NCT00884221|6093512|P1|NOT COMPLETED|Overall Study||34
2485674|NCT00884221|6093511|P2|COMPLETED|Overall Study||343
2485675|NCT00884221|6093512|P1|COMPLETED|Overall Study||340
2485676|NCT00884221|6093511|P2|STARTED|Overall Study||375
2485677|NCT00884221|6093512|P1|STARTED|Overall Study||374
2485678|NCT00884117|6093548|P1|NOT COMPLETED|Overall Study||249
2485679|NCT00884117|6093548|P1|COMPLETED|Overall Study|Defined as Day 6 visit for those enrolled before Amendment D; thereafter defined as Day 10 visit.|4312
2485680|NCT00884117|6093548|P1|STARTED|Overall Study||4561
2485681|NCT00884065|6093592|P2|NOT COMPLETED|Overall Study||0
2485682|NCT00884065|6093593|P1|NOT COMPLETED|Overall Study||0
2485683|NCT00884065|6093592|P2|COMPLETED|Overall Study||25
2485684|NCT00884065|6093593|P1|COMPLETED|Overall Study||25
2485685|NCT00884065|6093592|P2|STARTED|Overall Study||25
2485686|NCT00884065|6093593|P1|STARTED|Overall Study||25
2485687|NCT00884039|6093611|P2|NOT COMPLETED|Overall Study||1
2485688|NCT00884039|6093612|P1|NOT COMPLETED|Overall Study||2
2485689|NCT00884039|6093611|P2|COMPLETED|Overall Study||1
2485690|NCT00884039|6093612|P1|COMPLETED|Overall Study||3
2485691|NCT00884039|6093611|P2|STARTED|Overall Study||2
2485692|NCT00884039|6093612|P1|STARTED|Overall Study||5
2485693|NCT00883779|6093620|P2|NOT COMPLETED|Off-study Phase||202
2485694|NCT00883779|6093621|P1|NOT COMPLETED|Off-study Phase||209
2485695|NCT00883779|6093620|P2|COMPLETED|Off-study Phase||0
2485696|NCT00883779|6093621|P1|COMPLETED|Off-study Phase||0
2485697|NCT00883779|6093620|P2|STARTED|Off-study Phase||202
2485698|NCT00883779|6093621|P1|STARTED|Off-study Phase||209
2485699|NCT00883779|6093620|P2|NOT COMPLETED|Post-Study Treatment Phase||135
2485700|NCT00883779|6093621|P1|NOT COMPLETED|Post-Study Treatment Phase||112
2485701|NCT00883779|6093620|P2|COMPLETED|Post-Study Treatment Phase||0
2485702|NCT00883779|6093621|P1|COMPLETED|Post-Study Treatment Phase||0
2485703|NCT00883779|6093620|P2|STARTED|Post-Study Treatment Phase||135
2485704|NCT00883779|6093621|P1|STARTED|Post-Study Treatment Phase||112
2485705|NCT00883779|6093620|P2|NOT COMPLETED|Primary Study Treatment Phase||86
2485706|NCT00883779|6093621|P1|NOT COMPLETED|Primary Study Treatment Phase||105
2485707|NCT00883779|6093620|P2|COMPLETED|Primary Study Treatment Phase||140
2485708|NCT00883779|6093621|P1|COMPLETED|Primary Study Treatment Phase||120
2485709|NCT00883779|6093620|P2|STARTED|Primary Study Treatment Phase||226
2485710|NCT00883779|6093621|P1|STARTED|Primary Study Treatment Phase||225
2485711|NCT00883753|6093657|P1|NOT COMPLETED|Overall Study||107
2485712|NCT00883753|6093657|P1|COMPLETED|Overall Study||827
2485713|NCT00883753|6093657|P1|STARTED|Overall Study||934
2485714|NCT00883740|6093697|P2|NOT COMPLETED|Second Intervention||1
2485715|NCT00883740|6093698|P1|NOT COMPLETED|Second Intervention||1
2485716|NCT00883740|6093697|P2|COMPLETED|Second Intervention||50
2485717|NCT00883740|6093698|P1|COMPLETED|Second Intervention||52
2485718|NCT00883740|6093697|P2|STARTED|Second Intervention||51
2485719|NCT00883740|6093698|P1|STARTED|Second Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
2485720|NCT00883740|6093697|P2|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
2485721|NCT00883740|6093698|P1|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
2485722|NCT00883740|6093697|P2|COMPLETED|Taper and Washout Period (2 Weeks)||51
2485723|NCT00883740|6093698|P1|COMPLETED|Taper and Washout Period (2 Weeks)||54
2485724|NCT00883740|6093697|P2|STARTED|Taper and Washout Period (2 Weeks)||51
2485725|NCT00883740|6093698|P1|STARTED|Taper and Washout Period (2 Weeks)|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|54
2485726|NCT00883740|6093697|P2|NOT COMPLETED|First Intervention||8
2485727|NCT00883740|6093698|P1|NOT COMPLETED|First Intervention||7
2485728|NCT00883740|6093697|P2|COMPLETED|First Intervention||51
2485729|NCT00883740|6093698|P1|COMPLETED|First Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
2485730|NCT00883740|6093697|P2|STARTED|First Intervention||59
2485731|NCT00883740|6093698|P1|STARTED|First Intervention||60
2485732|NCT00883675|6093738|P1|NOT COMPLETED|Overall Study||0
2485733|NCT00883675|6093738|P1|COMPLETED|Overall Study||133
2485734|NCT00883675|6093738|P1|STARTED|Overall Study||133
2485735|NCT00883558|6093742|P3|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||1
2485736|NCT00883558|6093743|P2|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
2485737|NCT00883558|6093744|P1|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
2485738|NCT00883558|6093742|P3|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||22
2485739|NCT00883558|6093743|P2|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||19
2485740|NCT00883558|6093744|P1|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
2485741|NCT00883558|6093742|P3|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||23
2485742|NCT00883558|6093743|P2|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||19
2485743|NCT00883558|6093744|P1|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||0
2485744|NCT00883558|6093742|P3|STARTED|Second Treatment Cycle (Weeks 16 to 28)||23
2485745|NCT00883558|6093743|P2|STARTED|Second Treatment Cycle (Weeks 16 to 28)||19
2485746|NCT00883558|6093744|P1|STARTED|Second Treatment Cycle (Weeks 16 to 28)||0
2485747|NCT00883558|6093742|P3|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||1
2485748|NCT00883558|6093743|P2|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||3
2485749|NCT00883558|6093744|P1|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
2485750|NCT00883558|6093742|P3|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||23
2485751|NCT00883558|6093743|P2|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||19
2485752|NCT00883558|6093744|P1|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
2485753|NCT00883558|6093742|P3|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||24
2485754|NCT00883558|6093743|P2|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||22
2485755|NCT00883558|6093744|P1|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||0
2485756|NCT00883558|6093742|P3|STARTED|First Treatment Cycle (Weeks 4 to 16)||24
2485757|NCT00883558|6093743|P2|STARTED|First Treatment Cycle (Weeks 4 to 16)||22
2485758|NCT00883558|6093744|P1|STARTED|First Treatment Cycle (Weeks 4 to 16)||0
2485759|NCT00883558|6093742|P3|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
2485760|NCT00883558|6093743|P2|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
2485761|NCT00883558|6093744|P1|NOT COMPLETED|Titration Period (Weeks 0 to 4)||2
2485762|NCT00883558|6093742|P3|COMPLETED|Titration Period (Weeks 0 to 4)||0
2485763|NCT00883558|6093743|P2|COMPLETED|Titration Period (Weeks 0 to 4)||0
2485764|NCT00883558|6093744|P1|COMPLETED|Titration Period (Weeks 0 to 4)||46
2485765|NCT00883558|6093742|P3|STARTED|Titration Period (Weeks 0 to 4)||0
2485766|NCT00883558|6093743|P2|STARTED|Titration Period (Weeks 0 to 4)||0
2485767|NCT00883558|6093744|P1|STARTED|Titration Period (Weeks 0 to 4)||48
2485768|NCT00883493|6093756|P2|NOT COMPLETED|Overall Study||50
2485769|NCT00883493|6093757|P1|NOT COMPLETED|Overall Study||46
2485770|NCT00883493|6093756|P2|COMPLETED|Overall Study||159
2485771|NCT00883493|6093757|P1|COMPLETED|Overall Study||166
2485772|NCT00883493|6093756|P2|Per Protocol Analysis Population|Overall Study||155
2485773|NCT00883493|6093757|P1|Per Protocol Analysis Population|Overall Study||162
2485774|NCT00883493|6093756|P2|Intention To Treat Analysis Population|Overall Study||195
2485775|NCT00883493|6093757|P1|Intention To Treat Analysis Population|Overall Study||204
2485776|NCT00883493|6093756|P2|STARTED|Overall Study||209
2485777|NCT00883493|6093757|P1|STARTED|Overall Study||212
2485778|NCT00883389|6093781|P1|NOT COMPLETED|Overall Study||0
2485779|NCT00883389|6093781|P1|COMPLETED|Overall Study||26
2485780|NCT00883389|6093781|P1|STARTED|Overall Study||26
2485781|NCT00883337|6093788|P3|NOT COMPLETED|Extension Treatment Period||19
2485782|NCT00883337|6093789|P2|NOT COMPLETED|Extension Treatment Period||23
2485783|NCT00883337|6093790|P1|NOT COMPLETED|Extension Treatment Period||28
2485784|NCT00883337|6093788|P3|COMPLETED|Extension Treatment Period||40
2485785|NCT00883337|6093789|P2|COMPLETED|Extension Treatment Period||66
2485786|NCT00883337|6093790|P1|COMPLETED|Extension Treatment Period||61
2485787|NCT00883337|6093788|P3|STARTED|Extension Treatment Period|12 participants completed the core period but didn't enter the extension period.|59
2485788|NCT00883337|6093789|P2|STARTED|Extension Treatment Period||89
2485789|NCT00883337|6093790|P1|STARTED|Extension Treatment Period||89
2485790|NCT00883337|6093788|P3|NOT COMPLETED|Core Treatment Period||33
2485791|NCT00883337|6093789|P2|NOT COMPLETED|Core Treatment Period||22
2485792|NCT00883337|6093790|P1|NOT COMPLETED|Core Treatment Period||20
2485793|NCT00883337|6093788|P3|COMPLETED|Core Treatment Period||71
2485794|NCT00883337|6093789|P2|COMPLETED|Core Treatment Period||89
2485795|NCT00883337|6093790|P1|COMPLETED|Core Treatment Period||89
2485796|NCT00883337|6093788|P3|Treated|Core Treatment Period|3 participants refused treatment with Rebif®|101
2485797|NCT00883337|6093789|P2|Treated|Core Treatment Period|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|111
2485798|NCT00883337|6093790|P1|Treated|Core Treatment Period||109
2485799|NCT00883337|6093788|P3|STARTED|Core Treatment Period||104
2485800|NCT00883337|6093789|P2|STARTED|Core Treatment Period||111
2485801|NCT00883337|6093790|P1|STARTED|Core Treatment Period||109
2485802|NCT00883246|6093822|P1|NOT COMPLETED|Overall Study||173
2485803|NCT00883246|6093822|P1|COMPLETED|Overall Study||626
2485804|NCT00883246|6093822|P1|STARTED|Overall Study||799
2485805|NCT00883233|6093844|P4|NOT COMPLETED|Overall Study||5
2485806|NCT00883233|6093845|P3|NOT COMPLETED|Overall Study||4
2485807|NCT00883233|6093846|P2|NOT COMPLETED|Overall Study||4
2485808|NCT00883233|6093847|P1|NOT COMPLETED|Overall Study||5
2485809|NCT00883233|6093844|P4|COMPLETED|Overall Study||25
2485810|NCT00883233|6093845|P3|COMPLETED|Overall Study||25
2485811|NCT00883233|6093846|P2|COMPLETED|Overall Study||28
2485812|NCT00883233|6093847|P1|COMPLETED|Overall Study||27
2485813|NCT00883233|6093844|P4|STARTED|Overall Study||30
2485814|NCT00883233|6093845|P3|STARTED|Overall Study||29
2485815|NCT00883233|6093846|P2|STARTED|Overall Study||32
2485816|NCT00883233|6093847|P1|STARTED|Overall Study||32
2485817|NCT00883181|6093857|P1|NOT COMPLETED|Overall Study||278
2485818|NCT00883181|6093857|P1|COMPLETED|Overall Study|Completed planned chemotherapy|1069
2485819|NCT00883181|6093857|P1|STARTED|Overall Study|Full analysis set|1347
2485820|NCT00883168|6094070|P4|NOT COMPLETED|Overall Study||15
2485821|NCT00883168|6094071|P3|NOT COMPLETED|Overall Study||19
2485822|NCT00883168|6094072|P2|NOT COMPLETED|Overall Study||15
2485823|NCT00883168|6094073|P1|NOT COMPLETED|Overall Study||14
2485824|NCT00883168|6094070|P4|COMPLETED|Overall Study||433
2485825|NCT00883168|6094071|P3|COMPLETED|Overall Study||431
2485826|NCT00883168|6094072|P2|COMPLETED|Overall Study||430
2485827|NCT00883168|6094073|P1|COMPLETED|Overall Study||434
2485828|NCT00883168|6094070|P4|STARTED|Overall Study||448
2485829|NCT00883168|6094071|P3|STARTED|Overall Study||450
2485830|NCT00883168|6094072|P2|STARTED|Overall Study||445
2485831|NCT00883168|6094073|P1|STARTED|Overall Study||448
2485832|NCT00883129|6094093|P2|NOT COMPLETED|Overall Study||36
2485833|NCT00883129|6094094|P1|NOT COMPLETED|Overall Study||20
2485834|NCT00883129|6094093|P2|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 16 of whom had prematurely withdrawn from drug treatment.|37
2485835|NCT00883129|6094094|P1|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 4 of whom had prematurely withdrawn from drug treatment.|49
2485836|NCT00883129|6094093|P2|STARTED|Overall Study||73
2485837|NCT00883129|6094094|P1|STARTED|Overall Study||69
2485838|NCT00883116|6094118|P2|NOT COMPLETED|Overall Study||219
2485839|NCT00883116|6094119|P1|NOT COMPLETED|Overall Study||209
2485840|NCT00883116|6094118|P2|COMPLETED|Overall Study||29
2485841|NCT00883116|6094119|P1|COMPLETED|Overall Study||39
2485842|NCT00883116|6094118|P2|Received Treatment|Overall Study||239
2485843|NCT00883116|6094119|P1|Received Treatment|Overall Study||248
2485844|NCT00883116|6094118|P2|STARTED|Overall Study||248
2485845|NCT00883116|6094119|P1|STARTED|Overall Study||248
2485846|NCT00883103|6094134|P2|NOT COMPLETED|Overall Study||0
2485847|NCT00883103|6094135|P1|NOT COMPLETED|Overall Study||0
2485848|NCT00883103|6094134|P2|COMPLETED|Overall Study||68
2485849|NCT00883103|6094135|P1|COMPLETED|Overall Study||69
2485850|NCT00883103|6094134|P2|STARTED|Overall Study||68
2485851|NCT00883103|6094135|P1|STARTED|Overall Study||69
2485852|NCT00883090|6094141|P1|NOT COMPLETED|Overall Study||2
2485853|NCT00883090|6094141|P1|COMPLETED|Overall Study||13
2485854|NCT00883090|6094141|P1|STARTED|Overall Study|Of the 15 participants started, 14 were administered FXIII|15
2485855|NCT00883051|6094161|P5|NOT COMPLETED|Overall Study||18
2485856|NCT00883051|6094162|P4|NOT COMPLETED|Overall Study||29
2485857|NCT00883051|6094163|P3|NOT COMPLETED|Overall Study||29
2485858|NCT00883051|6094164|P2|NOT COMPLETED|Overall Study||22
2485859|NCT00883051|6094165|P1|NOT COMPLETED|Overall Study||24
2485860|NCT00883051|6094161|P5|COMPLETED|Overall Study|One participant was lost to follow up and did not provide adverse event data.|85
2485861|NCT00883051|6094162|P4|COMPLETED|Overall Study||70
2485862|NCT00883051|6094163|P3|COMPLETED|Overall Study||71
2485863|NCT00883051|6094164|P2|COMPLETED|Overall Study||82
2485864|NCT00883051|6094165|P1|COMPLETED|Overall Study||82
2485865|NCT00883051|6094161|P5|Received at Least 1 Dose of Study Drug|Overall Study||86
2485866|NCT00883051|6094162|P4|Received at Least 1 Dose of Study Drug|Overall Study||70
2485867|NCT00883051|6094163|P3|Received at Least 1 Dose of Study Drug|Overall Study||71
2485868|NCT00883051|6094164|P2|Received at Least 1 Dose of Study Drug|Overall Study||82
2485869|NCT00883051|6094165|P1|Received at Least 1 Dose of Study Drug|Overall Study||82
2485870|NCT00883051|6094161|P5|No Study Medication Used|Overall Study||17
2485871|NCT00883051|6094162|P4|No Study Medication Used|Overall Study||29
2485872|NCT00883051|6094163|P3|No Study Medication Used|Overall Study||29
2485873|NCT00883051|6094164|P2|No Study Medication Used|Overall Study||22
2485874|NCT00883051|6094165|P1|No Study Medication Used|Overall Study||24
2485875|NCT00883051|6094161|P5|STARTED|Overall Study||103
2485876|NCT00883051|6094162|P4|STARTED|Overall Study||99
2485877|NCT00883051|6094163|P3|STARTED|Overall Study||100
2485878|NCT00883051|6094164|P2|STARTED|Overall Study||104
2485879|NCT00883051|6094165|P1|STARTED|Overall Study||106
2485880|NCT00882999|6094269|P7|NOT COMPLETED|Overall Study||8
2485881|NCT00882999|6094270|P6|NOT COMPLETED|Overall Study||7
2485882|NCT00882999|6094271|P5|NOT COMPLETED|Overall Study||8
2485883|NCT00882999|6094272|P4|NOT COMPLETED|Overall Study||5
2485884|NCT00882999|6094273|P3|NOT COMPLETED|Overall Study||4
2485885|NCT00882999|6094274|P2|NOT COMPLETED|Overall Study||8
2485886|NCT00882999|6094275|P1|NOT COMPLETED|Overall Study||8
2485887|NCT00882999|6094269|P7|COMPLETED|Overall Study||27
2485888|NCT00882999|6094270|P6|COMPLETED|Overall Study||28
2485889|NCT00882999|6094271|P5|COMPLETED|Overall Study||28
2485890|NCT00882999|6094272|P4|COMPLETED|Overall Study||31
2485891|NCT00882999|6094273|P3|COMPLETED|Overall Study||30
2485892|NCT00882999|6094274|P2|COMPLETED|Overall Study||26
2485893|NCT00882999|6094275|P1|COMPLETED|Overall Study||27
2485894|NCT00882999|6094269|P7|Completed Study Treatment|Overall Study||31
2485895|NCT00882999|6094270|P6|Completed Study Treatment|Overall Study||30
2485896|NCT00882999|6094271|P5|Completed Study Treatment|Overall Study||29
2485897|NCT00882999|6094272|P4|Completed Study Treatment|Overall Study||33
2485898|NCT00882999|6094273|P3|Completed Study Treatment|Overall Study||31
2485899|NCT00882999|6094274|P2|Completed Study Treatment|Overall Study||29
2485900|NCT00882999|6094275|P1|Completed Study Treatment|Overall Study||29
2485901|NCT00882999|6094269|P7|Received Any Amount of Study Drug|Overall Study||35
2485902|NCT00882999|6094270|P6|Received Any Amount of Study Drug|Overall Study||35
2485903|NCT00882999|6094271|P5|Received Any Amount of Study Drug|Overall Study||36
2485904|NCT00882999|6094272|P4|Received Any Amount of Study Drug|Overall Study||36
2485905|NCT00882999|6094273|P3|Received Any Amount of Study Drug|Overall Study||34
2485906|NCT00882999|6094274|P2|Received Any Amount of Study Drug|Overall Study||34
2485907|NCT00882999|6094275|P1|Received Any Amount of Study Drug|Overall Study||35
2485908|NCT00882999|6094269|P7|STARTED|Overall Study||35
2485909|NCT00882999|6094270|P6|STARTED|Overall Study||35
2485910|NCT00882999|6094271|P5|STARTED|Overall Study||36
2485911|NCT00882999|6094272|P4|STARTED|Overall Study||36
2485912|NCT00882999|6094273|P3|STARTED|Overall Study||34
2485913|NCT00882999|6094274|P2|STARTED|Overall Study||34
2485914|NCT00882999|6094275|P1|STARTED|Overall Study||35
2485915|NCT00882921|6094402|P1|NOT COMPLETED|Overall Study||11
2485916|NCT00882921|6094402|P1|COMPLETED|Overall Study||15
2485917|NCT00882921|6094402|P1|STARTED|Overall Study||26
2485918|NCT00882908|6094412|P5|NOT COMPLETED|Overall Study||6
2485919|NCT00882908|6094413|P4|NOT COMPLETED|Overall Study||7
2485920|NCT00882908|6094414|P3|NOT COMPLETED|Overall Study||7
2485921|NCT00882908|6094415|P2|NOT COMPLETED|Overall Study||6
2485922|NCT00882908|6094416|P1|NOT COMPLETED|Overall Study||3
2485923|NCT00882908|6094412|P5|COMPLETED|Overall Study||71
2485924|NCT00882908|6094413|P4|COMPLETED|Overall Study||72
2485925|NCT00882908|6094414|P3|COMPLETED|Overall Study||70
2485926|NCT00882908|6094415|P2|COMPLETED|Overall Study||69
2485927|NCT00882908|6094416|P1|COMPLETED|Overall Study||75
2485928|NCT00882908|6094412|P5|STARTED|Overall Study||77
2485929|NCT00882908|6094413|P4|STARTED|Overall Study||79
2485930|NCT00882908|6094414|P3|STARTED|Overall Study||77
2485931|NCT00882908|6094415|P2|STARTED|Overall Study||75
2485932|NCT00882908|6094416|P1|STARTED|Overall Study||78
2485933|NCT00882778|6094491|P1|NOT COMPLETED|Overall Study||0
2485934|NCT00882778|6094491|P1|COMPLETED|Overall Study||86
2485935|NCT00882778|6094491|P1|STARTED|Overall Study||86
2485936|NCT00882713|6094522|P1|NOT COMPLETED|Overall Study||22
2485937|NCT00882713|6094522|P1|COMPLETED|Overall Study||172
2485938|NCT00882713|6094522|P1|STARTED|Overall Study||194
2485939|NCT00882687|6094548|P4|NOT COMPLETED|Overall Study||2
2485940|NCT00882687|6094549|P3|NOT COMPLETED|Overall Study||3
2485941|NCT00882687|6094550|P2|NOT COMPLETED|Overall Study||2
2485942|NCT00882687|6094551|P1|NOT COMPLETED|Overall Study||2
2485943|NCT00882687|6094548|P4|COMPLETED|Overall Study||13
2485944|NCT00882687|6094549|P3|COMPLETED|Overall Study||12
2485945|NCT00882687|6094550|P2|COMPLETED|Overall Study||13
2485946|NCT00882687|6094551|P1|COMPLETED|Overall Study||13
2485947|NCT00882687|6094548|P4|STARTED|Overall Study||15
2485948|NCT00882687|6094549|P3|STARTED|Overall Study||15
2485949|NCT00882687|6094550|P2|STARTED|Overall Study||15
2485950|NCT00882687|6094551|P1|STARTED|Overall Study||15
2485951|NCT00882661|6094584|P2|NOT COMPLETED|Treatment||26
2485952|NCT00882661|6094585|P1|NOT COMPLETED|Treatment||10
2485953|NCT00882661|6094584|P2|COMPLETED|Treatment||114
2485954|NCT00882661|6094585|P1|COMPLETED|Treatment||141
2485955|NCT00882661|6094584|P2|STARTED|Treatment||140
2485956|NCT00882661|6094585|P1|STARTED|Treatment||151
2485957|NCT00882661|6094584|P2|NOT COMPLETED|Investigational Training||0
2485958|NCT00882661|6094585|P1|NOT COMPLETED|Investigational Training||10
2485959|NCT00882661|6094584|P2|COMPLETED|Investigational Training||0
2485960|NCT00882661|6094585|P1|COMPLETED|Investigational Training||79
2485961|NCT00882661|6094584|P2|STARTED|Investigational Training||0
2485962|NCT00882661|6094585|P1|STARTED|Investigational Training||89
2485963|NCT00882583|6094615|P2|NOT COMPLETED|Overall Study||1
2485964|NCT00882583|6094616|P1|NOT COMPLETED|Overall Study||1
2485965|NCT00882583|6094615|P2|COMPLETED|Overall Study||11
2485966|NCT00882583|6094616|P1|COMPLETED|Overall Study||6
2485967|NCT00882583|6094615|P2|STARTED|Overall Study||12
2485968|NCT00882583|6094616|P1|STARTED|Overall Study||7
2485969|NCT00882557|6094624|P2|NOT COMPLETED|Overall Study||1
2485970|NCT00882557|6094625|P1|NOT COMPLETED|Overall Study||2
2485971|NCT00882557|6094624|P2|COMPLETED|Overall Study||7
2485972|NCT00882557|6094625|P1|COMPLETED|Overall Study||6
2485973|NCT00882557|6094624|P2|Completed Dose 2|Overall Study||7
2485974|NCT00882557|6094625|P1|Completed Dose 2|Overall Study||6
2485975|NCT00882557|6094624|P2|Completed Dose 1|Overall Study||7
2485976|NCT00882557|6094625|P1|Completed Dose 1|Overall Study||8
2485977|NCT00882557|6094624|P2|STARTED|Overall Study||8
2485978|NCT00882557|6094625|P1|STARTED|Overall Study||8
2485979|NCT00882518|6094645|P2|NOT COMPLETED|Overall Study||44
2485980|NCT00882518|6094646|P1|NOT COMPLETED|Overall Study||38
2485981|NCT00882518|6094645|P2|COMPLETED|Overall Study||148
2485982|NCT00882518|6094646|P1|COMPLETED|Overall Study||158
2485983|NCT00882518|6094645|P2|STARTED|Overall Study||192
2485984|NCT00882518|6094646|P1|STARTED|Overall Study||196
2485985|NCT00882440|6094675|P7|NOT COMPLETED|Overall Study||4
2485986|NCT00882440|6094676|P6|NOT COMPLETED|Overall Study||7
2485987|NCT00882440|6094677|P5|NOT COMPLETED|Overall Study||10
2485988|NCT00882440|6094678|P4|NOT COMPLETED|Overall Study||3
2485989|NCT00882440|6094679|P3|NOT COMPLETED|Overall Study||7
2485990|NCT00882440|6094680|P2|NOT COMPLETED|Overall Study||8
2485991|NCT00882440|6094681|P1|NOT COMPLETED|Overall Study||11
2485992|NCT00882440|6094675|P7|COMPLETED|Overall Study||79
2485993|NCT00882440|6094676|P6|COMPLETED|Overall Study||77
2485994|NCT00882440|6094677|P5|COMPLETED|Overall Study||80
2485995|NCT00882440|6094678|P4|COMPLETED|Overall Study||76
2485996|NCT00882440|6094679|P3|COMPLETED|Overall Study||75
2485997|NCT00882440|6094680|P2|COMPLETED|Overall Study||72
2485998|NCT00882440|6094681|P1|COMPLETED|Overall Study||67
2485999|NCT00882440|6094675|P7|STARTED|Overall Study||83
2486000|NCT00882440|6094676|P6|STARTED|Overall Study||84
2486001|NCT00882440|6094677|P5|STARTED|Overall Study||90
2486002|NCT00882440|6094678|P4|STARTED|Overall Study||79
2486003|NCT00882440|6094679|P3|STARTED|Overall Study||82
2486004|NCT00882440|6094680|P2|STARTED|Overall Study||80
2486005|NCT00882440|6094681|P1|STARTED|Overall Study||78
2486006|NCT00882362|6094706|P2|NOT COMPLETED|Overall Study||23
2486007|NCT00882362|6094707|P1|NOT COMPLETED|Overall Study||49
2486008|NCT00882362|6094706|P2|COMPLETED|Overall Study||10
2486009|NCT00882362|6094707|P1|COMPLETED|Overall Study||73
2486010|NCT00882362|6094706|P2|STARTED|Overall Study||33
2486011|NCT00882362|6094707|P1|STARTED|Overall Study||122
2486012|NCT00882310|6094713|P1|NOT COMPLETED|Overall Study||22
2486013|NCT00882310|6094713|P1|COMPLETED|Overall Study||15
2486014|NCT00882310|6094713|P1|STARTED|Overall Study||37
2486015|NCT00882206|6094719|P1|NOT COMPLETED|Overall Study||0
2486016|NCT00882206|6094719|P1|COMPLETED|Overall Study||13
2486017|NCT00882206|6094719|P1|STARTED|Overall Study||13
2486018|NCT00882115|6094726|P1|NOT COMPLETED|Overall Study||9
2486019|NCT00882115|6094726|P1|COMPLETED|Overall Study||29
2486020|NCT00882115|6094726|P1|STARTED|Overall Study||38
2486021|NCT00882102|6094730|P1|NOT COMPLETED|Overall Study||0
2486022|NCT00882102|6094730|P1|COMPLETED|Overall Study||40
2486023|NCT00882102|6094730|P1|STARTED|Overall Study||40
2486024|NCT00881959|6094736|P2|NOT COMPLETED|Overall Study||4
2486025|NCT00881959|6094737|P1|NOT COMPLETED|Overall Study||2
2486026|NCT00881959|6094736|P2|COMPLETED|Overall Study||38
2486027|NCT00881959|6094737|P1|COMPLETED|Overall Study||36
2486028|NCT00881959|6094736|P2|STARTED|Overall Study||42
2486029|NCT00881959|6094737|P1|STARTED|Overall Study||38
2486030|NCT00881894|6094745|P2|NOT COMPLETED|Overall Study||3
2486031|NCT00881894|6094746|P1|NOT COMPLETED|Overall Study||1
2486032|NCT00881894|6094745|P2|COMPLETED|Overall Study||23
2486033|NCT00881894|6094746|P1|COMPLETED|Overall Study||25
2486034|NCT00881894|6094745|P2|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|21
2486035|NCT00881894|6094746|P1|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|23
2486036|NCT00881894|6094745|P2|STARTED|Overall Study||26
2486037|NCT00881894|6094746|P1|STARTED|Overall Study||26
2486038|NCT00881868|6094778|P2|NOT COMPLETED|Overall Study||2
2486039|NCT00881868|6094779|P1|NOT COMPLETED|Overall Study||8
2486040|NCT00881868|6094778|P2|COMPLETED|Overall Study||38
2486041|NCT00881868|6094779|P1|COMPLETED|Overall Study||33
2486042|NCT00881868|6094778|P2|STARTED|Overall Study||40
2486043|NCT00881868|6094779|P1|STARTED|Overall Study||41
2486044|NCT00881751|6094793|P2|NOT COMPLETED|Overall Study||5
2486045|NCT00881751|6094794|P1|NOT COMPLETED|Overall Study||0
2486046|NCT00881751|6094793|P2|COMPLETED|Overall Study||43
2486047|NCT00881751|6094794|P1|COMPLETED|Overall Study||47
2486048|NCT00881751|6094793|P2|STARTED|Overall Study||48
2486049|NCT00881751|6094794|P1|STARTED|Overall Study||47
2486050|NCT00881712|6094809|P3|NOT COMPLETED|Overall Study||0
2486051|NCT00881712|6094810|P2|NOT COMPLETED|Overall Study||0
2486052|NCT00881712|6094811|P1|NOT COMPLETED|Overall Study||2
2486053|NCT00881712|6094809|P3|COMPLETED|Overall Study||0
2486054|NCT00881712|6094810|P2|COMPLETED|Overall Study||0
2486055|NCT00881712|6094811|P1|COMPLETED|Overall Study||13
2486056|NCT00881712|6094809|P3|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
2486057|NCT00881712|6094810|P2|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
2486058|NCT00881712|6094811|P1|STARTED|Overall Study||15
2486059|NCT00881647|6094833|P2|NOT COMPLETED|Overall Study||1
2486060|NCT00881647|6094834|P1|NOT COMPLETED|Overall Study||2
2486061|NCT00881647|6094833|P2|COMPLETED|Overall Study||15
2486062|NCT00881647|6094834|P1|COMPLETED|Overall Study||27
2486063|NCT00881647|6094833|P2|STARTED|Overall Study||16
2486064|NCT00881647|6094834|P1|STARTED|Overall Study||29
2486065|NCT00881621|6094844|P1|NOT COMPLETED|Overall Study||34
2486066|NCT00881621|6094844|P1|COMPLETED|Overall Study||17
2486067|NCT00881621|6094844|P1|STARTED|Overall Study||51
2486068|NCT00881608|6094856|P1|NOT COMPLETED|Overall Study||11
2486069|NCT00881608|6094856|P1|COMPLETED|Overall Study||0
2486070|NCT00881608|6094856|P1|STARTED|Overall Study||11
2486071|NCT00881530|6094879|P6|NOT COMPLETED|Overall Study||5
2486072|NCT00881530|6094880|P5|NOT COMPLETED|Overall Study||14
2486073|NCT00881530|6094881|P4|NOT COMPLETED|Overall Study||9
2486074|NCT00881530|6094882|P3|NOT COMPLETED|Overall Study||5
2486075|NCT00881530|6094883|P2|NOT COMPLETED|Overall Study||5
2486076|NCT00881530|6094884|P1|NOT COMPLETED|Overall Study||14
2486077|NCT00881530|6094879|P6|COMPLETED|Overall Study||51
2486078|NCT00881530|6094880|P5|COMPLETED|Overall Study||152
2486079|NCT00881530|6094881|P4|COMPLETED|Overall Study||157
2486080|NCT00881530|6094882|P3|COMPLETED|Overall Study||51
2486081|NCT00881530|6094883|P2|COMPLETED|Overall Study||104
2486082|NCT00881530|6094884|P1|COMPLETED|Overall Study||92
2486083|NCT00881530|6094879|P6|STARTED|Overall Study||56
2486084|NCT00881530|6094880|P5|STARTED|Overall Study||166
2486085|NCT00881530|6094881|P4|STARTED|Overall Study||166
2486086|NCT00881530|6094882|P3|STARTED|Overall Study||56
2486087|NCT00881530|6094883|P2|STARTED|Overall Study||109
2486088|NCT00881530|6094884|P1|STARTED|Overall Study||106
2486089|NCT00881504|6094940|P1|NOT COMPLETED|Overall Study||1
2486090|NCT00881504|6094940|P1|COMPLETED|Overall Study||8
2486091|NCT00881504|6094940|P1|STARTED|Overall Study||9
2486092|NCT00881465|6094947|P2|NOT COMPLETED|Overall Study||0
2486093|NCT00881465|6094948|P1|NOT COMPLETED|Overall Study||2
2486094|NCT00881465|6094947|P2|COMPLETED|Overall Study||15
2486095|NCT00881465|6094948|P1|COMPLETED|Overall Study||14
2486096|NCT00881465|6094947|P2|STARTED|Overall Study||15
2486097|NCT00881465|6094948|P1|STARTED|Overall Study||16
2486098|NCT00881361|6094960|P3|NOT COMPLETED|Overall Study||2
2486099|NCT00881361|6094961|P2|NOT COMPLETED|Overall Study||9
2486100|NCT00881361|6094962|P1|NOT COMPLETED|Overall Study||44
2486101|NCT00881361|6094960|P3|COMPLETED|Overall Study||0
2486102|NCT00881361|6094961|P2|COMPLETED|Overall Study||38
2486103|NCT00881361|6094962|P1|COMPLETED|Overall Study||663
2486104|NCT00881361|6094960|P3|STARTED|Overall Study||2
2486105|NCT00881361|6094961|P2|STARTED|Overall Study||47
2486106|NCT00881361|6094962|P1|STARTED|Overall Study||707
2486107|NCT00881335|6094977|P2|NOT COMPLETED|Overall Study||2
2486108|NCT00881335|6094978|P1|NOT COMPLETED|Overall Study||3
2486109|NCT00881335|6094977|P2|COMPLETED|Overall Study|2 participants did not complete the period|28
2486110|NCT00881335|6094978|P1|COMPLETED|Overall Study|3 participants did not complete the period|27
2486111|NCT00881335|6094977|P2|STARTED|Overall Study||30
2486112|NCT00881335|6094978|P1|STARTED|Overall Study||30
2486113|NCT00881205|6094998|P2|NOT COMPLETED|Overall Study||7
2486114|NCT00881205|6094999|P1|NOT COMPLETED|Overall Study||11
2486115|NCT00881205|6094998|P2|COMPLETED|Overall Study||34
2486116|NCT00881205|6094999|P1|COMPLETED|Overall Study||34
2486117|NCT00881205|6094998|P2|STARTED|Overall Study||41
2486118|NCT00881205|6094999|P1|STARTED|Overall Study||45
2486119|NCT00880997|6095009|P3|NOT COMPLETED|Overall Study||8
2486120|NCT00880997|6095010|P2|NOT COMPLETED|Overall Study||2
2486121|NCT00880997|6095011|P1|NOT COMPLETED|Overall Study||3
2486122|NCT00880997|6095009|P3|COMPLETED|Overall Study||5
2486123|NCT00880997|6095010|P2|COMPLETED|Overall Study||6
2486124|NCT00880997|6095011|P1|COMPLETED|Overall Study||6
2486125|NCT00880997|6095009|P3|STARTED|Overall Study||13
2486126|NCT00880997|6095010|P2|STARTED|Overall Study||8
2486127|NCT00880997|6095011|P1|STARTED|Overall Study||9
2486128|NCT00880919|6095031|P3|NOT COMPLETED|Overall Study||6
2486129|NCT00880919|6095032|P2|NOT COMPLETED|Overall Study||14
2486130|NCT00880919|6095033|P1|NOT COMPLETED|Overall Study||15
2486131|NCT00880919|6095031|P3|COMPLETED|Overall Study||23
2486132|NCT00880919|6095032|P2|COMPLETED|Overall Study||19
2486133|NCT00880919|6095033|P1|COMPLETED|Overall Study||18
2486134|NCT00880919|6095031|P3|STARTED|Overall Study||29
2486135|NCT00880919|6095032|P2|STARTED|Overall Study||33
2486136|NCT00880919|6095033|P1|STARTED|Overall Study||33
2486137|NCT00880906|6095067|P2|NOT COMPLETED|Overall Study||7
2486138|NCT00880906|6095068|P1|NOT COMPLETED|Overall Study||12
2486139|NCT00880906|6095067|P2|COMPLETED|Overall Study||14
2486140|NCT00880906|6095068|P1|COMPLETED|Overall Study||17
2486141|NCT00880906|6095067|P2|STARTED|Overall Study||21
2486142|NCT00880906|6095068|P1|STARTED|Overall Study||29
2486143|NCT00880893|6095078|P2|NOT COMPLETED|Overall Study||45
2486144|NCT00880893|6095079|P1|NOT COMPLETED|Overall Study||107
2486145|NCT00880893|6095078|P2|COMPLETED|Overall Study||255
2486146|NCT00880893|6095079|P1|COMPLETED|Overall Study||791
2486147|NCT00880893|6095078|P2|STARTED|Overall Study||300
2486148|NCT00880893|6095079|P1|STARTED|Overall Study||898
2486149|NCT00880763|6095131|P4|NOT COMPLETED|Extension Period (Part 2)||3
2486150|NCT00880763|6095132|P3|NOT COMPLETED|Extension Period (Part 2)||3
2486151|NCT00880763|6095133|P2|NOT COMPLETED|Extension Period (Part 2)||3
2486152|NCT00880763|6095134|P1|NOT COMPLETED|Extension Period (Part 2)||0
2486153|NCT00880763|6095131|P4|COMPLETED|Extension Period (Part 2)||19
2486154|NCT00880763|6095132|P3|COMPLETED|Extension Period (Part 2)||20
2486155|NCT00880763|6095133|P2|COMPLETED|Extension Period (Part 2)||19
2486156|NCT00880763|6095134|P1|COMPLETED|Extension Period (Part 2)||23
2486157|NCT00880763|6095131|P4|STARTED|Extension Period (Part 2)||22
2486158|NCT00880763|6095132|P3|STARTED|Extension Period (Part 2)||23
2486159|NCT00880763|6095133|P2|STARTED|Extension Period (Part 2)||22
2486160|NCT00880763|6095134|P1|STARTED|Extension Period (Part 2)||23
2486161|NCT00880763|6095131|P4|NOT COMPLETED|Initial Treatment Period (Part 1)||0
2486162|NCT00880763|6095132|P3|NOT COMPLETED|Initial Treatment Period (Part 1)||0
2486163|NCT00880763|6095133|P2|NOT COMPLETED|Initial Treatment Period (Part 1)||0
2486164|NCT00880763|6095134|P1|NOT COMPLETED|Initial Treatment Period (Part 1)||0
2486165|NCT00880763|6095131|P4|COMPLETED|Initial Treatment Period (Part 1)||22
2486166|NCT00880763|6095132|P3|COMPLETED|Initial Treatment Period (Part 1)||23
2486167|NCT00880763|6095133|P2|COMPLETED|Initial Treatment Period (Part 1)||22
2486168|NCT00880763|6095134|P1|COMPLETED|Initial Treatment Period (Part 1)||23
2486169|NCT00880763|6095131|P4|STARTED|Initial Treatment Period (Part 1)||22
2486170|NCT00880763|6095132|P3|STARTED|Initial Treatment Period (Part 1)||23
2486171|NCT00880763|6095133|P2|STARTED|Initial Treatment Period (Part 1)||22
2486172|NCT00880763|6095134|P1|STARTED|Initial Treatment Period (Part 1)||23
2486173|NCT00880750|6095166|P2|NOT COMPLETED|Second Intervention||2
2486174|NCT00880750|6095167|P1|NOT COMPLETED|Second Intervention||4
2486175|NCT00880750|6095166|P2|COMPLETED|Second Intervention||30
2486176|NCT00880750|6095167|P1|COMPLETED|Second Intervention||26
2486177|NCT00880750|6095166|P2|STARTED|Second Intervention||32
2486178|NCT00880750|6095167|P1|STARTED|Second Intervention||30
2486179|NCT00880750|6095166|P2|NOT COMPLETED|Washout Period||0
2486180|NCT00880750|6095167|P1|NOT COMPLETED|Washout Period||0
2486181|NCT00880750|6095166|P2|COMPLETED|Washout Period||32
2486182|NCT00880750|6095167|P1|COMPLETED|Washout Period||30
2486183|NCT00880750|6095166|P2|STARTED|Washout Period||32
2486184|NCT00880750|6095167|P1|STARTED|Washout Period||30
2486185|NCT00880750|6095166|P2|NOT COMPLETED|First Intervention||1
2486186|NCT00880750|6095167|P1|NOT COMPLETED|First Intervention||9
2486187|NCT00880750|6095166|P2|COMPLETED|First Intervention||32
2486188|NCT00880750|6095167|P1|COMPLETED|First Intervention||30
2486189|NCT00880750|6095166|P2|STARTED|First Intervention||33
2486190|NCT00880750|6095167|P1|STARTED|First Intervention||39
2486191|NCT00880698|6095185|P4|NOT COMPLETED|Overall Study||3
2486192|NCT00880698|6095186|P3|NOT COMPLETED|Overall Study||1
2486193|NCT00880698|6095187|P2|NOT COMPLETED|Overall Study||3
2486194|NCT00880698|6095188|P1|NOT COMPLETED|Overall Study||1
2486195|NCT00880698|6095185|P4|COMPLETED|Overall Study||36
2486196|NCT00880698|6095186|P3|COMPLETED|Overall Study||36
2486197|NCT00880698|6095187|P2|COMPLETED|Overall Study||61
2486198|NCT00880698|6095188|P1|COMPLETED|Overall Study||61
2486199|NCT00880698|6095185|P4|STARTED|Overall Study||39
2486200|NCT00880698|6095186|P3|STARTED|Overall Study||37
2486201|NCT00880698|6095187|P2|STARTED|Overall Study||64
2486202|NCT00880698|6095188|P1|STARTED|Overall Study||62
2486203|NCT00880685|6095214|P1|NOT COMPLETED|Memantine 30mg||0
2486204|NCT00880685|6095214|P1|COMPLETED|Memantine 30mg||9
2486205|NCT00880685|6095214|P1|STARTED|Memantine 30mg||9
2486206|NCT00880685|6095214|P1|NOT COMPLETED|Memantine 20mg||1
2486207|NCT00880685|6095214|P1|COMPLETED|Memantine 20mg||9
2486208|NCT00880685|6095214|P1|STARTED|Memantine 20mg||10
2486209|NCT00880685|6095214|P1|NOT COMPLETED|Memantine 10mg||2
2486210|NCT00880685|6095214|P1|COMPLETED|Memantine 10mg||10
2486211|NCT00880685|6095214|P1|STARTED|Memantine 10mg||12
2486212|NCT00880620|6095226|P4|NOT COMPLETED|Overall Study||24
2486213|NCT00880620|6095227|P3|NOT COMPLETED|Overall Study||21
2486214|NCT00880620|6095228|P2|NOT COMPLETED|Overall Study||15
2486215|NCT00880620|6095229|P1|NOT COMPLETED|Overall Study||21
2486216|NCT00880620|6095226|P4|COMPLETED|Overall Study||74
2486217|NCT00880620|6095227|P3|COMPLETED|Overall Study||83
2486218|NCT00880620|6095228|P2|COMPLETED|Overall Study||72
2486219|NCT00880620|6095229|P1|COMPLETED|Overall Study||71
2486220|NCT00880620|6095226|P4|Week 23|Overall Study||74
2486221|NCT00880620|6095227|P3|Week 23|Overall Study||85
2486222|NCT00880620|6095228|P2|Week 23|Overall Study||72
2486223|NCT00880620|6095229|P1|Week 23|Overall Study||71
2486224|NCT00880620|6095226|P4|Week 16|Overall Study||74
2486225|NCT00880620|6095227|P3|Week 16|Overall Study||87
2486226|NCT00880620|6095228|P2|Week 16|Overall Study||73
2486227|NCT00880620|6095229|P1|Week 16|Overall Study||74
2486228|NCT00880620|6095226|P4|Week 9|Overall Study||78
2486229|NCT00880620|6095227|P3|Week 9|Overall Study||88
2486230|NCT00880620|6095228|P2|Week 9|Overall Study||73
2486231|NCT00880620|6095229|P1|Week 9|Overall Study||80
2486232|NCT00880620|6095226|P4|Week 4|Overall Study||86
2486233|NCT00880620|6095227|P3|Week 4|Overall Study||94
2486234|NCT00880620|6095228|P2|Week 4|Overall Study||79
2486235|NCT00880620|6095229|P1|Week 4|Overall Study||88
2486236|NCT00880620|6095226|P4|STARTED|Overall Study||98
2486237|NCT00880620|6095227|P3|STARTED|Overall Study||104
2486238|NCT00880620|6095228|P2|STARTED|Overall Study||87
2486239|NCT00880620|6095229|P1|STARTED|Overall Study||92
2486240|NCT00880581|6095243|P1|NOT COMPLETED|Cycle 2 Re-treatment||0
2486241|NCT00880581|6095243|P1|COMPLETED|Cycle 2 Re-treatment||24
2486242|NCT00880581|6095243|P1|STARTED|Cycle 2 Re-treatment|6 subjects with progessive disease were not treated and evaluated in Cycle 2|24
2486243|NCT00880581|6095243|P1|NOT COMPLETED|Cycle 1||0
2486244|NCT00880581|6095243|P1|COMPLETED|Cycle 1||30
2486245|NCT00880581|6095243|P1|STARTED|Cycle 1||30
2486246|NCT00880568|6095257|P9|NOT COMPLETED|Overall Study||3
2486247|NCT00880568|6095258|P8|NOT COMPLETED|Overall Study||2
2486248|NCT00880568|6095259|P7|NOT COMPLETED|Overall Study||6
2486249|NCT00880568|6095260|P6|NOT COMPLETED|Overall Study||3
2486250|NCT00880568|6095261|P5|NOT COMPLETED|Overall Study||3
2486251|NCT00880568|6095262|P4|NOT COMPLETED|Overall Study||1
2486252|NCT00880568|6095263|P3|NOT COMPLETED|Overall Study||3
2486253|NCT00880568|6095264|P2|NOT COMPLETED|Overall Study||3
2486254|NCT00880568|6095265|P1|NOT COMPLETED|Overall Study||3
2486255|NCT00880568|6095257|P9|COMPLETED|Overall Study||0
2486256|NCT00880568|6095258|P8|COMPLETED|Overall Study||0
2486257|NCT00880568|6095259|P7|COMPLETED|Overall Study||0
2486258|NCT00880568|6095260|P6|COMPLETED|Overall Study||0
2486259|NCT00880568|6095261|P5|COMPLETED|Overall Study||0
2486260|NCT00880568|6095262|P4|COMPLETED|Overall Study||0
2486261|NCT00880568|6095263|P3|COMPLETED|Overall Study||0
2486262|NCT00880568|6095264|P2|COMPLETED|Overall Study||0
2486263|NCT00880568|6095265|P1|COMPLETED|Overall Study||0
2486264|NCT00880568|6095257|P9|STARTED|Overall Study||3
2486265|NCT00880568|6095258|P8|STARTED|Overall Study||2
2486266|NCT00880568|6095259|P7|STARTED|Overall Study||6
2486267|NCT00880568|6095260|P6|STARTED|Overall Study||3
2486268|NCT00880568|6095261|P5|STARTED|Overall Study||3
2486269|NCT00880568|6095262|P4|STARTED|Overall Study||1
2486270|NCT00880568|6095263|P3|STARTED|Overall Study||3
2486271|NCT00880568|6095264|P2|STARTED|Overall Study||3
2486272|NCT00880568|6095265|P1|STARTED|Overall Study||3
2486273|NCT00880555|6095311|P6|NOT COMPLETED|Overall Study||1
2486274|NCT00880555|6095312|P5|NOT COMPLETED|Overall Study||1
2486275|NCT00880555|6095313|P4|NOT COMPLETED|Overall Study||2
2486276|NCT00880555|6095314|P3|NOT COMPLETED|Overall Study||5
2486277|NCT00880555|6095315|P2|NOT COMPLETED|Overall Study||17
2486278|NCT00880555|6095316|P1|NOT COMPLETED|Overall Study||10
2486279|NCT00880555|6095311|P6|COMPLETED|Overall Study||0
2486280|NCT00880555|6095312|P5|COMPLETED|Overall Study||0
2486281|NCT00880555|6095313|P4|COMPLETED|Overall Study||0
2486282|NCT00880555|6095314|P3|COMPLETED|Overall Study||6
2486283|NCT00880555|6095315|P2|COMPLETED|Overall Study||23
2486284|NCT00880555|6095316|P1|COMPLETED|Overall Study||13
2486285|NCT00880555|6095311|P6|STARTED|Overall Study||1
2486286|NCT00880555|6095312|P5|STARTED|Overall Study||1
2486287|NCT00880555|6095313|P4|STARTED|Overall Study||2
2486288|NCT00880555|6095314|P3|STARTED|Overall Study||11
2486289|NCT00880555|6095315|P2|STARTED|Overall Study||40
2486290|NCT00880555|6095316|P1|STARTED|Overall Study||23
2486291|NCT00880542|6095327|P1|NOT COMPLETED|Follow-up Period||0
2486292|NCT00880542|6095327|P1|COMPLETED|Follow-up Period||7
2486293|NCT00880542|6095327|P1|STARTED|Follow-up Period|All 7 patients who started the treatment period completed the follow-up period.|7
2486294|NCT00880542|6095327|P1|NOT COMPLETED|Continued Treatment Period||0
2486295|NCT00880542|6095327|P1|COMPLETED|Continued Treatment Period||0
2486296|NCT00880542|6095327|P1|STARTED|Continued Treatment Period|None of the 3 subjects from previous period met study criteria for continuation of therapy.|0
2486297|NCT00880542|6095327|P1|NOT COMPLETED|Post Surgical Evaluation||0
2486298|NCT00880542|6095327|P1|COMPLETED|Post Surgical Evaluation|none of the 3 subjects met study criteria for continuation of therapy.|3
2486299|NCT00880542|6095327|P1|STARTED|Post Surgical Evaluation||3
2486300|NCT00880542|6095327|P1|NOT COMPLETED|REP: Surgical Resection||1
2486301|NCT00880542|6095327|P1|COMPLETED|REP: Surgical Resection||3
2486302|NCT00880542|6095327|P1|STARTED|REP: Surgical Resection||4
2486303|NCT00880542|6095327|P1|NOT COMPLETED|Response Evaluation Period(REP): PET/CT||0
2486304|NCT00880542|6095327|P1|COMPLETED|Response Evaluation Period(REP): PET/CT||4
2486305|NCT00880542|6095327|P1|STARTED|Response Evaluation Period(REP): PET/CT||4
2486306|NCT00880542|6095327|P1|NOT COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||3
2486307|NCT00880542|6095327|P1|COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||4
2486308|NCT00880542|6095327|P1|STARTED|Treatment Period (Sorafenib+Ifosfamide)||7
2486309|NCT00880425|6095332|P2|NOT COMPLETED|Overall Study||0
2486310|NCT00880425|6095333|P1|NOT COMPLETED|Overall Study||0
2486311|NCT00880425|6095332|P2|COMPLETED|Overall Study||27
2486312|NCT00880425|6095333|P1|COMPLETED|Overall Study||18
2486313|NCT00880425|6095332|P2|STARTED|Overall Study||27
2486314|NCT00880425|6095333|P1|STARTED|Overall Study||18
2486315|NCT00880399|6095344|P3|NOT COMPLETED|Overall Study||26
2486316|NCT00880399|6095345|P2|NOT COMPLETED|Overall Study||29
2486317|NCT00880399|6095346|P1|NOT COMPLETED|Overall Study||31
2486318|NCT00880399|6095344|P3|COMPLETED|Overall Study||81
2486319|NCT00880399|6095345|P2|COMPLETED|Overall Study||84
2486320|NCT00880399|6095346|P1|COMPLETED|Overall Study||77
2486321|NCT00880399|6095344|P3|STARTED|Overall Study||107
2486322|NCT00880399|6095345|P2|STARTED|Overall Study||113
2486323|NCT00880399|6095346|P1|STARTED|Overall Study||108
2486324|NCT00880360|6095402|P1|NOT COMPLETED|Overall Study||0
2486325|NCT00880360|6095402|P1|COMPLETED|Overall Study||19
2486326|NCT00880360|6095402|P1|STARTED|Overall Study||19
2486327|NCT00880334|6095409|P2|NOT COMPLETED|Crossover Phase||0
2486328|NCT00880334|6095410|P1|NOT COMPLETED|Crossover Phase||0
2486329|NCT00880334|6095409|P2|COMPLETED|Crossover Phase||37
2486330|NCT00880334|6095410|P1|COMPLETED|Crossover Phase||0
2486331|NCT00880334|6095409|P2|STARTED|Crossover Phase|Only participants randomized to placebo and docetaxel potentially received crossover treatment.|37
2486332|NCT00880334|6095410|P1|STARTED|Crossover Phase||0
2486333|NCT00880334|6095409|P2|NOT COMPLETED|Randomized Phase||40
2486334|NCT00880334|6095410|P1|NOT COMPLETED|Randomized Phase||4
2486335|NCT00880334|6095409|P2|COMPLETED|Randomized Phase||35
2486336|NCT00880334|6095410|P1|COMPLETED|Randomized Phase||70
2486337|NCT00880334|6095409|P2|Eligible & Treated|Randomized Phase||72
2486338|NCT00880334|6095410|P1|Eligible & Treated|Randomized Phase||70
2486339|NCT00880334|6095409|P2|STARTED|Randomized Phase||75
2486340|NCT00880334|6095410|P1|STARTED|Randomized Phase||74
2486341|NCT00880269|6095427|P2|NOT COMPLETED|Overall Study||27
2486342|NCT00880269|6095428|P1|NOT COMPLETED|Overall Study||32
2486343|NCT00880269|6095427|P2|COMPLETED|Overall Study||0
2486344|NCT00880269|6095428|P1|COMPLETED|Overall Study||0
2486345|NCT00880269|6095427|P2|Discontinued Treatment|Overall Study||27
2486346|NCT00880269|6095428|P1|Discontinued Treatment|Overall Study||32
2486347|NCT00880269|6095427|P2|STARTED|Overall Study||27
2486348|NCT00880269|6095428|P1|STARTED|Overall Study||32
2486349|NCT00880256|6095444|P1|NOT COMPLETED|Overall Study||28
2486350|NCT00880256|6095444|P1|COMPLETED|Overall Study||65
2486351|NCT00880256|6095444|P1|STARTED|Overall Study||93
2486352|NCT00880230|6095449|P1|NOT COMPLETED|Overall Study||7
2486353|NCT00880230|6095449|P1|COMPLETED|Overall Study||134
2486354|NCT00880230|6095449|P1|STARTED|Overall Study||141
2486355|NCT00880191|6095471|P2|NOT COMPLETED|Overall Study||8
2486356|NCT00880191|6095472|P1|NOT COMPLETED|Overall Study||13
2486357|NCT00880191|6095471|P2|COMPLETED|Overall Study||198
2486358|NCT00880191|6095472|P1|COMPLETED|Overall Study||194
2486359|NCT00880191|6095471|P2|Available for Primary Endpoint Analysis|Overall Study||206
2486360|NCT00880191|6095472|P1|Available for Primary Endpoint Analysis|Overall Study||207
2486361|NCT00880191|6095471|P2|STARTED|Overall Study||206
2486362|NCT00880191|6095472|P1|STARTED|Overall Study||207
2486363|NCT00880165|6095492|P2|NOT COMPLETED|Overall Study||50
2486364|NCT00880165|6095493|P1|NOT COMPLETED|Overall Study||62
2486365|NCT00880165|6095492|P2|COMPLETED|Overall Study||98
2486366|NCT00880165|6095493|P1|COMPLETED|Overall Study||86
2486367|NCT00880165|6095492|P2|STARTED|Overall Study||148
2486368|NCT00880165|6095493|P1|STARTED|Overall Study||148
2486369|NCT00880100|6095503|P1|NOT COMPLETED|Treatment Phase With Ultrase® MT12||3
2486370|NCT00880100|6095503|P1|COMPLETED|Treatment Phase With Ultrase® MT12||45
2486371|NCT00880100|6095503|P1|STARTED|Treatment Phase With Ultrase® MT12||48
2486372|NCT00880100|6095503|P1|NOT COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||1
2486373|NCT00880100|6095503|P1|COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||48
2486374|NCT00880100|6095503|P1|STARTED|Baseline Phase-Usual Pancreatic Enzymes||49
2486375|NCT00880087|6095516|P2|NOT COMPLETED|Overall Study||2
2486376|NCT00880087|6095517|P1|NOT COMPLETED|Overall Study||0
2486377|NCT00880087|6095516|P2|COMPLETED|Overall Study|Of 161 with 1-year vital status, 158 had received Therapeutic Normothermia, 3 received no treatment.|161
2486378|NCT00880087|6095517|P1|COMPLETED|Overall Study|1-year vital status available for all 166 Started patients.|166
2486379|NCT00880087|6095516|P2|STARTED|Overall Study|Among the 163 Started, 160 received Therapeutic Normothermia and 3 received no treatment.|163
2486380|NCT00880087|6095517|P1|STARTED|Overall Study|Among the 166 Started, 161 received Therapeutic Hypothermia and 5 received no treatment.|166
2486381|NCT00880048|6095532|P3|NOT COMPLETED|Overall Study||35
2486382|NCT00880048|6095533|P2|NOT COMPLETED|Overall Study||33
2486383|NCT00880048|6095534|P1|NOT COMPLETED|Overall Study||28
2486384|NCT00880048|6095532|P3|COMPLETED|Overall Study||77
2486385|NCT00880048|6095533|P2|COMPLETED|Overall Study||82
2486386|NCT00880048|6095534|P1|COMPLETED|Overall Study||88
2486387|NCT00880048|6095532|P3|STARTED|Overall Study||112
2486388|NCT00880048|6095533|P2|STARTED|Overall Study||115
2486389|NCT00880048|6095534|P1|STARTED|Overall Study||116
2486390|NCT00880022|6095592|P2|NOT COMPLETED|Overall Study||3
2486391|NCT00880022|6095593|P1|NOT COMPLETED|Overall Study||2
2486392|NCT00880022|6095592|P2|COMPLETED|Overall Study||21
2486393|NCT00880022|6095593|P1|COMPLETED|Overall Study||21
2486394|NCT00880022|6095592|P2|STARTED|Overall Study||24
2486395|NCT00880022|6095593|P1|STARTED|Overall Study||23
2486396|NCT00880009|6095601|P1|NOT COMPLETED|Overall Study||16
2486397|NCT00880009|6095601|P1|COMPLETED|Overall Study||0
2486398|NCT00880009|6095601|P1|STARTED|Overall Study||16
2486399|NCT00879996|6095625|P2|NOT COMPLETED|Overall Study||13
2486400|NCT00879996|6095626|P1|NOT COMPLETED|Overall Study||15
2486401|NCT00879996|6095625|P2|COMPLETED|Overall Study||13
2486402|NCT00879996|6095626|P1|COMPLETED|Overall Study||13
2486403|NCT00879996|6095625|P2|STARTED|Overall Study||26
2486404|NCT00879996|6095626|P1|STARTED|Overall Study||28
2486405|NCT00879970|6095641|P5|NOT COMPLETED|Period 2 Vitamin D Randomization||7
2486406|NCT00879970|6095642|P4|NOT COMPLETED|Period 2 Vitamin D Randomization||4
2486407|NCT00879970|6095643|P3|NOT COMPLETED|Period 2 Vitamin D Randomization||0
2486408|NCT00879970|6095644|P2|NOT COMPLETED|Period 2 Vitamin D Randomization||0
2486409|NCT00879970|6095645|P1|NOT COMPLETED|Period 2 Vitamin D Randomization||0
2486410|NCT00879970|6095641|P5|COMPLETED|Period 2 Vitamin D Randomization||600
2486411|NCT00879970|6095642|P4|COMPLETED|Period 2 Vitamin D Randomization||610
2486412|NCT00879970|6095643|P3|COMPLETED|Period 2 Vitamin D Randomization||0
2486413|NCT00879970|6095644|P2|COMPLETED|Period 2 Vitamin D Randomization||0
2486414|NCT00879970|6095645|P1|COMPLETED|Period 2 Vitamin D Randomization||0
2486415|NCT00879970|6095641|P5|STARTED|Period 2 Vitamin D Randomization||607
2486416|NCT00879970|6095642|P4|STARTED|Period 2 Vitamin D Randomization||614
2486417|NCT00879970|6095643|P3|STARTED|Period 2 Vitamin D Randomization||0
2486418|NCT00879970|6095644|P2|STARTED|Period 2 Vitamin D Randomization||0
2486419|NCT00879970|6095645|P1|STARTED|Period 2 Vitamin D Randomization||0
2486420|NCT00879970|6095641|P5|NOT COMPLETED|Period 1 TZD Randomization||0
2486421|NCT00879970|6095642|P4|NOT COMPLETED|Period 1 TZD Randomization||0
2486422|NCT00879970|6095643|P3|NOT COMPLETED|Period 1 TZD Randomization||6
2486423|NCT00879970|6095644|P2|NOT COMPLETED|Period 1 TZD Randomization||4
2486424|NCT00879970|6095645|P1|NOT COMPLETED|Period 1 TZD Randomization||8
2486425|NCT00879970|6095641|P5|COMPLETED|Period 1 TZD Randomization||0
2486426|NCT00879970|6095642|P4|COMPLETED|Period 1 TZD Randomization||0
2486427|NCT00879970|6095643|P3|COMPLETED|Period 1 TZD Randomization||393
2486428|NCT00879970|6095644|P2|COMPLETED|Period 1 TZD Randomization||388
2486429|NCT00879970|6095645|P1|COMPLETED|Period 1 TZD Randomization||533
2486430|NCT00879970|6095641|P5|STARTED|Period 1 TZD Randomization||0
2486431|NCT00879970|6095642|P4|STARTED|Period 1 TZD Randomization||0
2486432|NCT00879970|6095643|P3|STARTED|Period 1 TZD Randomization||399
2486433|NCT00879970|6095644|P2|STARTED|Period 1 TZD Randomization||392
2486434|NCT00879970|6095645|P1|STARTED|Period 1 TZD Randomization||541
2486435|NCT00879879|6095727|P1|NOT COMPLETED|Overall Study||3
2486436|NCT00879879|6095727|P1|COMPLETED|Overall Study||17
2486437|NCT00879879|6095727|P1|STARTED|Overall Study||20
2486438|NCT00879814|6095735|P4|NOT COMPLETED|Overall Study||5
2486439|NCT00879814|6095736|P3|NOT COMPLETED|Overall Study||3
2486440|NCT00879814|6095737|P2|NOT COMPLETED|Overall Study||2
2486441|NCT00879814|6095738|P1|NOT COMPLETED|Overall Study||4
2486442|NCT00879814|6095735|P4|COMPLETED|Overall Study||7
2486443|NCT00879814|6095736|P3|COMPLETED|Overall Study||9
2486444|NCT00879814|6095737|P2|COMPLETED|Overall Study||10
2486445|NCT00879814|6095738|P1|COMPLETED|Overall Study||8
2486446|NCT00879814|6095735|P4|STARTED|Overall Study||12
2486447|NCT00879814|6095736|P3|STARTED|Overall Study||12
2486448|NCT00879814|6095737|P2|STARTED|Overall Study||12
2486449|NCT00879814|6095738|P1|STARTED|Overall Study||12
2486450|NCT00879775|6095846|P2|NOT COMPLETED|Overall Study||1
2486451|NCT00879775|6095847|P1|NOT COMPLETED|Overall Study||2
2486452|NCT00879775|6095846|P2|COMPLETED|Overall Study||20
2486453|NCT00879775|6095847|P1|COMPLETED|Overall Study||18
2486454|NCT00879775|6095846|P2|STARTED|Overall Study||21
2486455|NCT00879775|6095847|P1|STARTED|Overall Study||20
2486456|NCT00879710|6095863|P4|NOT COMPLETED|Phase 2 6 Weeks||0
2486457|NCT00879710|6095864|P3|NOT COMPLETED|Phase 2 6 Weeks||0
2486458|NCT00879710|6095865|P2|NOT COMPLETED|Phase 2 6 Weeks||0
2486459|NCT00879710|6095866|P1|NOT COMPLETED|Phase 2 6 Weeks||0
2486460|NCT00879710|6095863|P4|COMPLETED|Phase 2 6 Weeks||13
2486461|NCT00879710|6095864|P3|COMPLETED|Phase 2 6 Weeks||10
2486462|NCT00879710|6095865|P2|COMPLETED|Phase 2 6 Weeks||14
2486463|NCT00879710|6095866|P1|COMPLETED|Phase 2 6 Weeks||10
2486464|NCT00879710|6095863|P4|STARTED|Phase 2 6 Weeks||13
2486465|NCT00879710|6095864|P3|STARTED|Phase 2 6 Weeks||10
2486466|NCT00879710|6095865|P2|STARTED|Phase 2 6 Weeks||14
2486467|NCT00879710|6095866|P1|STARTED|Phase 2 6 Weeks||10
2486468|NCT00879710|6095863|P4|NOT COMPLETED|Wash Out Period of 4 Weeks||0
2486469|NCT00879710|6095864|P3|NOT COMPLETED|Wash Out Period of 4 Weeks||0
2486470|NCT00879710|6095865|P2|NOT COMPLETED|Wash Out Period of 4 Weeks||0
2486471|NCT00879710|6095866|P1|NOT COMPLETED|Wash Out Period of 4 Weeks||0
2486472|NCT00879710|6095863|P4|COMPLETED|Wash Out Period of 4 Weeks||13
2486473|NCT00879710|6095864|P3|COMPLETED|Wash Out Period of 4 Weeks||10
2486474|NCT00879710|6095865|P2|COMPLETED|Wash Out Period of 4 Weeks||14
2486475|NCT00879710|6095866|P1|COMPLETED|Wash Out Period of 4 Weeks||10
2486476|NCT00879710|6095863|P4|STARTED|Wash Out Period of 4 Weeks||13
2486477|NCT00879710|6095864|P3|STARTED|Wash Out Period of 4 Weeks|The person who did not complete ezetimibe arm came back to complete simvastatin arm.|10
2486478|NCT00879710|6095865|P2|STARTED|Wash Out Period of 4 Weeks||14
2486479|NCT00879710|6095866|P1|STARTED|Wash Out Period of 4 Weeks||10
2486480|NCT00879710|6095863|P4|NOT COMPLETED|Phase 1 - 6 Weeks||4
2486481|NCT00879710|6095864|P3|NOT COMPLETED|Phase 1 - 6 Weeks||2
2486482|NCT00879710|6095865|P2|NOT COMPLETED|Phase 1 - 6 Weeks||3
2486483|NCT00879710|6095866|P1|NOT COMPLETED|Phase 1 - 6 Weeks||2
2486484|NCT00879710|6095863|P4|COMPLETED|Phase 1 - 6 Weeks||13
2486485|NCT00879710|6095864|P3|COMPLETED|Phase 1 - 6 Weeks||9
2486486|NCT00879710|6095865|P2|COMPLETED|Phase 1 - 6 Weeks||14
2486487|NCT00879710|6095866|P1|COMPLETED|Phase 1 - 6 Weeks||10
2486488|NCT00879710|6095863|P4|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|17
2486489|NCT00879710|6095864|P3|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|11
2486490|NCT00879710|6095865|P2|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|17
2486491|NCT00879710|6095866|P1|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|12
2486492|NCT00879697|6095876|P2|NOT COMPLETED|Overall Study||2
2486493|NCT00879697|6095877|P1|NOT COMPLETED|Overall Study||2
2486494|NCT00879697|6095876|P2|COMPLETED|Overall Study|Two patients did not finish the trial|15
2486495|NCT00879697|6095877|P1|COMPLETED|Overall Study|Two patients did not finish the trial|15
2486496|NCT00879697|6095876|P2|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
2486497|NCT00879697|6095877|P1|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
2486498|NCT00879684|6095883|P7|NOT COMPLETED|Stage 2: Expanded Cohort||13
2486499|NCT00879684|6095884|P6|NOT COMPLETED|Stage 2: Expanded Cohort||0
2486500|NCT00879684|6095885|P5|NOT COMPLETED|Stage 2: Expanded Cohort||0
2486501|NCT00879684|6095886|P4|NOT COMPLETED|Stage 2: Expanded Cohort||0
2486502|NCT00879684|6095887|P3|NOT COMPLETED|Stage 2: Expanded Cohort||0
2486503|NCT00879684|6095888|P2|NOT COMPLETED|Stage 2: Expanded Cohort||0
2486504|NCT00879684|6095889|P1|NOT COMPLETED|Stage 2: Expanded Cohort||0
2486505|NCT00879684|6095883|P7|COMPLETED|Stage 2: Expanded Cohort||0
2486506|NCT00879684|6095884|P6|COMPLETED|Stage 2: Expanded Cohort||0
2486507|NCT00879684|6095885|P5|COMPLETED|Stage 2: Expanded Cohort||0
2486508|NCT00879684|6095886|P4|COMPLETED|Stage 2: Expanded Cohort||0
2486509|NCT00879684|6095887|P3|COMPLETED|Stage 2: Expanded Cohort||0
2486510|NCT00879684|6095888|P2|COMPLETED|Stage 2: Expanded Cohort||0
2486511|NCT00879684|6095889|P1|COMPLETED|Stage 2: Expanded Cohort||0
2486512|NCT00879684|6095883|P7|STARTED|Stage 2: Expanded Cohort||13
2486513|NCT00879684|6095884|P6|STARTED|Stage 2: Expanded Cohort||0
2486514|NCT00879684|6095885|P5|STARTED|Stage 2: Expanded Cohort||0
2486515|NCT00879684|6095886|P4|STARTED|Stage 2: Expanded Cohort||0
2486516|NCT00879684|6095887|P3|STARTED|Stage 2: Expanded Cohort||0
2486517|NCT00879684|6095888|P2|STARTED|Stage 2: Expanded Cohort||0
2486518|NCT00879684|6095889|P1|STARTED|Stage 2: Expanded Cohort||0
2486519|NCT00879684|6095883|P7|NOT COMPLETED|Stage 1: Dose Escalation||0
2486520|NCT00879684|6095884|P6|NOT COMPLETED|Stage 1: Dose Escalation||3
2486521|NCT00879684|6095885|P5|NOT COMPLETED|Stage 1: Dose Escalation||3
2486522|NCT00879684|6095886|P4|NOT COMPLETED|Stage 1: Dose Escalation||6
2486523|NCT00879684|6095887|P3|NOT COMPLETED|Stage 1: Dose Escalation||3
2486524|NCT00879684|6095888|P2|NOT COMPLETED|Stage 1: Dose Escalation||3
2486525|NCT00879684|6095889|P1|NOT COMPLETED|Stage 1: Dose Escalation||3
2486526|NCT00879684|6095883|P7|COMPLETED|Stage 1: Dose Escalation||0
2486527|NCT00879684|6095884|P6|COMPLETED|Stage 1: Dose Escalation||0
2486528|NCT00879684|6095885|P5|COMPLETED|Stage 1: Dose Escalation||0
2486529|NCT00879684|6095886|P4|COMPLETED|Stage 1: Dose Escalation||0
2486530|NCT00879684|6095887|P3|COMPLETED|Stage 1: Dose Escalation||0
2486531|NCT00879684|6095888|P2|COMPLETED|Stage 1: Dose Escalation||0
2486532|NCT00879684|6095889|P1|COMPLETED|Stage 1: Dose Escalation||0
2486533|NCT00879684|6095883|P7|STARTED|Stage 1: Dose Escalation||0
2486534|NCT00879684|6095884|P6|STARTED|Stage 1: Dose Escalation||3
2486535|NCT00879684|6095885|P5|STARTED|Stage 1: Dose Escalation||3
2486536|NCT00879684|6095886|P4|STARTED|Stage 1: Dose Escalation||6
2486537|NCT00879684|6095887|P3|STARTED|Stage 1: Dose Escalation||3
2486538|NCT00879684|6095888|P2|STARTED|Stage 1: Dose Escalation||3
2486539|NCT00879684|6095889|P1|STARTED|Stage 1: Dose Escalation||3
2486540|NCT00879658|6095958|P7|NOT COMPLETED|Overall Study||0
2486541|NCT00879658|6095959|P6|NOT COMPLETED|Overall Study||1
2486542|NCT00879658|6095960|P5|NOT COMPLETED|Overall Study||2
2486543|NCT00879658|6095961|P4|NOT COMPLETED|Overall Study||4
2486544|NCT00879658|6095962|P3|NOT COMPLETED|Overall Study||7
2486545|NCT00879658|6095963|P2|NOT COMPLETED|Overall Study||5
2486546|NCT00879658|6095964|P1|NOT COMPLETED|Overall Study||15
2486547|NCT00879658|6095958|P7|COMPLETED|Overall Study||16
2486548|NCT00879658|6095959|P6|COMPLETED|Overall Study||50
2486549|NCT00879658|6095960|P5|COMPLETED|Overall Study||40
2486550|NCT00879658|6095961|P4|COMPLETED|Overall Study||42
2486551|NCT00879658|6095962|P3|COMPLETED|Overall Study||36
2486552|NCT00879658|6095963|P2|COMPLETED|Overall Study||44
2486553|NCT00879658|6095964|P1|COMPLETED|Overall Study||35
2486554|NCT00879658|6095958|P7|STARTED|Overall Study||16
2486555|NCT00879658|6095959|P6|STARTED|Overall Study||51
2486556|NCT00879658|6095960|P5|STARTED|Overall Study||42
2486557|NCT00879658|6095961|P4|STARTED|Overall Study||46
2486558|NCT00879658|6095962|P3|STARTED|Overall Study||43
2486559|NCT00879658|6095963|P2|STARTED|Overall Study||49
2486560|NCT00879658|6095964|P1|STARTED|Overall Study||50
2486561|NCT00879645|6096050|P4|NOT COMPLETED|Overall Study||0
2486562|NCT00879645|6096051|P3|NOT COMPLETED|Overall Study||0
2486563|NCT00879645|6096052|P2|NOT COMPLETED|Overall Study||0
2486564|NCT00879645|6096053|P1|NOT COMPLETED|Overall Study||1
2486565|NCT00879645|6096050|P4|COMPLETED|Overall Study||7
2486566|NCT00879645|6096051|P3|COMPLETED|Overall Study||6
2486567|NCT00879645|6096052|P2|COMPLETED|Overall Study||6
2486568|NCT00879645|6096053|P1|COMPLETED|Overall Study||8
2486569|NCT00879645|6096050|P4|STARTED|Overall Study||7
2486570|NCT00879645|6096051|P3|STARTED|Overall Study||6
2486571|NCT00879645|6096052|P2|STARTED|Overall Study||6
2486572|NCT00879645|6096053|P1|STARTED|Overall Study||9
2486573|NCT00879619|6096071|P1|NOT COMPLETED|Overall Study||0
2486574|NCT00879619|6096071|P1|COMPLETED|Overall Study||4
2486575|NCT00879619|6096071|P1|STARTED|Overall Study||4
2486576|NCT00879411|6096080|P1|NOT COMPLETED|Overall Study||162
2486577|NCT00879411|6096080|P1|COMPLETED|Overall Study||539
2486578|NCT00879411|6096080|P1|STARTED|Overall Study||701
2486579|NCT00879398|6096086|P1|NOT COMPLETED|Overall Study||675
2486580|NCT00879398|6096086|P1|COMPLETED|Overall Study||2434
2486581|NCT00879398|6096086|P1|STARTED|Overall Study||3109
2486582|NCT00879359|6096096|P1|NOT COMPLETED|Overall Study||0
2486583|NCT00879359|6096096|P1|COMPLETED|Overall Study||15
2486584|NCT00879359|6096096|P1|STARTED|Overall Study||15
2486585|NCT00879333|6096104|P2|NOT COMPLETED|Overall Study||217
2486586|NCT00879333|6096105|P1|NOT COMPLETED|Overall Study||428
2486587|NCT00879333|6096104|P2|COMPLETED|Overall Study||0
2486588|NCT00879333|6096105|P1|COMPLETED|Overall Study|Completed=Patients Still on Treatment; At data cutoff final analysis, 11 patients were on treatment|11
2486589|NCT00879333|6096104|P2|Discontinued Study Treatment|Overall Study||217
2486590|NCT00879333|6096105|P1|Discontinued Study Treatment|Overall Study||428
2486591|NCT00879333|6096104|P2|STARTED|Overall Study||217
2486592|NCT00879333|6096105|P1|STARTED|Overall Study||439
2486593|NCT00879255|6096125|P2|NOT COMPLETED|Overall Study||19
2486594|NCT00879255|6096126|P1|NOT COMPLETED|Overall Study||16
2486595|NCT00879255|6096125|P2|COMPLETED|Overall Study|Completed 6-mo follow-up|45
2486596|NCT00879255|6096126|P1|COMPLETED|Overall Study|Completed 6-mo follow-up|45
2486597|NCT00879255|6096125|P2|Completed 3-mo Follow-up|Overall Study||49
2486598|NCT00879255|6096126|P1|Completed 3-mo Follow-up|Overall Study||48
2486599|NCT00879255|6096125|P2|Completed Posttreatment Follow-up|Overall Study||55
2486600|NCT00879255|6096126|P1|Completed Posttreatment Follow-up|Overall Study||50
2486601|NCT00879255|6096125|P2|Received Allocated Intervention:|Overall Study||56
2486602|NCT00879255|6096126|P1|Received Allocated Intervention:|Overall Study||51
2486603|NCT00879255|6096125|P2|STARTED|Overall Study||64
2486604|NCT00879255|6096126|P1|STARTED|Overall Study||61
2486605|NCT00879229|6096138|P2|NOT COMPLETED|Overall Study||14
2486606|NCT00879229|6096139|P1|NOT COMPLETED|Overall Study||22
2486607|NCT00879229|6096138|P2|COMPLETED|Overall Study||1
2486608|NCT00879229|6096139|P1|COMPLETED|Overall Study||3
2486609|NCT00879229|6096138|P2|STARTED|Overall Study||15
2486610|NCT00879229|6096139|P1|STARTED|Overall Study||25
2486611|NCT00879190|6096165|P2|NOT COMPLETED|Overall Study||0
2486612|NCT00879190|6096166|P1|NOT COMPLETED|Overall Study||0
2486613|NCT00879190|6096165|P2|COMPLETED|Overall Study||49
2486614|NCT00879190|6096166|P1|COMPLETED|Overall Study||43
2486615|NCT00879190|6096165|P2|STARTED|Overall Study||49
2486616|NCT00879190|6096166|P1|STARTED|Overall Study||43
2486617|NCT00879034|6096176|P1|NOT COMPLETED|Overall Study||0
2486618|NCT00879034|6096176|P1|COMPLETED|Overall Study||5
2486619|NCT00879034|6096176|P1|Received Treatment|Overall Study||4
2486620|NCT00879034|6096176|P1|STARTED|Overall Study||5
2486621|NCT00878995|6096187|P2|NOT COMPLETED|Midpoint Study - Post Study||0
2486622|NCT00878995|6096188|P1|NOT COMPLETED|Midpoint Study - Post Study||0
2486623|NCT00878995|6096187|P2|COMPLETED|Midpoint Study - Post Study||10
2486624|NCT00878995|6096188|P1|COMPLETED|Midpoint Study - Post Study||12
2486625|NCT00878995|6096187|P2|STARTED|Midpoint Study - Post Study||10
2486626|NCT00878995|6096188|P1|STARTED|Midpoint Study - Post Study||12
2486627|NCT00878995|6096187|P2|NOT COMPLETED|Baseline Study - Midpoint Study||2
2486628|NCT00878995|6096188|P1|NOT COMPLETED|Baseline Study - Midpoint Study||0
2486629|NCT00878995|6096187|P2|COMPLETED|Baseline Study - Midpoint Study|2 subjects dropped after the baseline study. They decided to seek treatment closer to home.|10
2486630|NCT00878995|6096188|P1|COMPLETED|Baseline Study - Midpoint Study||12
2486631|NCT00878995|6096187|P2|Baseline Study|Baseline Study - Midpoint Study||12
2486726|NCT00878553|6096535|P1|NOT COMPLETED|PK Study||0
2486632|NCT00878995|6096188|P1|Baseline Study|Baseline Study - Midpoint Study||12
2486633|NCT00878995|6096187|P2|STARTED|Baseline Study - Midpoint Study||12
2486634|NCT00878995|6096188|P1|STARTED|Baseline Study - Midpoint Study||12
2486635|NCT00878969|6096289|P3|NOT COMPLETED|Overall Study||11
2486636|NCT00878969|6096290|P2|NOT COMPLETED|Overall Study||15
2486637|NCT00878969|6096291|P1|NOT COMPLETED|Overall Study||15
2486638|NCT00878969|6096289|P3|COMPLETED|Overall Study||15
2486639|NCT00878969|6096290|P2|COMPLETED|Overall Study||12
2486640|NCT00878969|6096291|P1|COMPLETED|Overall Study||10
2486641|NCT00878969|6096289|P3|STARTED|Overall Study||26
2486642|NCT00878969|6096290|P2|STARTED|Overall Study||27
2486643|NCT00878969|6096291|P1|STARTED|Overall Study||25
2486644|NCT00878878|6096301|P2|NOT COMPLETED|Overall Study||0
2486645|NCT00878878|6096302|P1|NOT COMPLETED|Overall Study||0
2486646|NCT00878878|6096301|P2|COMPLETED|Overall Study||15
2486647|NCT00878878|6096302|P1|COMPLETED|Overall Study||15
2486648|NCT00878878|6096301|P2|STARTED|Overall Study||15
2486649|NCT00878878|6096302|P1|STARTED|Overall Study||15
2486650|NCT00878826|6096315|P3|NOT COMPLETED|Overall Study||0
2486651|NCT00878826|6096316|P2|NOT COMPLETED|Overall Study||0
2486652|NCT00878826|6096317|P1|NOT COMPLETED|Overall Study||0
2486653|NCT00878826|6096315|P3|COMPLETED|Overall Study||2
2486654|NCT00878826|6096316|P2|COMPLETED|Overall Study||6
2486655|NCT00878826|6096317|P1|COMPLETED|Overall Study||3
2486656|NCT00878826|6096315|P3|STARTED|Overall Study||2
2486657|NCT00878826|6096316|P2|STARTED|Overall Study||6
2486658|NCT00878826|6096317|P1|STARTED|Overall Study||3
2486659|NCT00878800|6096339|P5|NOT COMPLETED|Overall Study||16
2486660|NCT00878800|6096340|P4|NOT COMPLETED|Overall Study||6
2486661|NCT00878800|6096341|P3|NOT COMPLETED|Overall Study||9
2486662|NCT00878800|6096342|P2|NOT COMPLETED|Overall Study||7
2486663|NCT00878800|6096343|P1|NOT COMPLETED|Overall Study||3
2486664|NCT00878800|6096339|P5|COMPLETED|Overall Study|Mean number of cycles administered: 6.4|0
2486665|NCT00878800|6096340|P4|COMPLETED|Overall Study|Mean number of cycles administered: 5.3|0
2486666|NCT00878800|6096341|P3|COMPLETED|Overall Study|Mean number of cycles administered: 3.0|0
2486667|NCT00878800|6096342|P2|COMPLETED|Overall Study|Mean number of cycles administered: 4.6|0
2486668|NCT00878800|6096343|P1|COMPLETED|Overall Study|Mean number of cycles administered: 4.0|0
2486669|NCT00878800|6096339|P5|STARTED|Overall Study||16
2486670|NCT00878800|6096340|P4|STARTED|Overall Study||6
2486671|NCT00878800|6096341|P3|STARTED|Overall Study||9
2486672|NCT00878800|6096342|P2|STARTED|Overall Study||7
2486673|NCT00878800|6096343|P1|STARTED|Overall Study||3
2486674|NCT00878722|6096378|P8|NOT COMPLETED|Overall Study||7
2486675|NCT00878722|6096379|P7|NOT COMPLETED|Overall Study||6
2486676|NCT00878722|6096380|P6|NOT COMPLETED|Overall Study||2
2486677|NCT00878722|6096381|P5|NOT COMPLETED|Overall Study||7
2486678|NCT00878722|6096382|P4|NOT COMPLETED|Overall Study||9
2486679|NCT00878722|6096383|P3|NOT COMPLETED|Overall Study||3
2486680|NCT00878722|6096384|P2|NOT COMPLETED|Overall Study||3
2486681|NCT00878722|6096385|P1|NOT COMPLETED|Overall Study||3
2486682|NCT00878722|6096378|P8|COMPLETED|Overall Study||0
2486683|NCT00878722|6096379|P7|COMPLETED|Overall Study||0
2486684|NCT00878722|6096380|P6|COMPLETED|Overall Study||1
2486685|NCT00878722|6096381|P5|COMPLETED|Overall Study||0
2486686|NCT00878722|6096382|P4|COMPLETED|Overall Study||0
2486687|NCT00878722|6096383|P3|COMPLETED|Overall Study||0
2486688|NCT00878722|6096384|P2|COMPLETED|Overall Study||0
2486689|NCT00878722|6096385|P1|COMPLETED|Overall Study||0
2486690|NCT00878722|6096378|P8|STARTED|Overall Study||7
2486691|NCT00878722|6096379|P7|STARTED|Overall Study||6
2486692|NCT00878722|6096380|P6|STARTED|Overall Study||3
2486693|NCT00878722|6096381|P5|STARTED|Overall Study||7
2486694|NCT00878722|6096382|P4|STARTED|Overall Study||9
2486695|NCT00878722|6096383|P3|STARTED|Overall Study||3
2486696|NCT00878722|6096384|P2|STARTED|Overall Study||3
2486697|NCT00878722|6096385|P1|STARTED|Overall Study||3
2486698|NCT00878709|6096470|P2|NOT COMPLETED|Overall Study||237
2486699|NCT00878709|6096471|P1|NOT COMPLETED|Overall Study||325
2486700|NCT00878709|6096470|P2|COMPLETED|Overall Study||1183
2486701|NCT00878709|6096471|P1|COMPLETED|Overall Study||1095
2486702|NCT00878709|6096470|P2|STARTED|Overall Study||1420
2486703|NCT00878709|6096471|P1|STARTED|Overall Study||1420
2486704|NCT00878644|6096497|P2|NOT COMPLETED|Overall Study||4
2486705|NCT00878644|6096498|P1|NOT COMPLETED|Overall Study||4
2486706|NCT00878644|6096497|P2|COMPLETED|Overall Study||136
2486707|NCT00878644|6096498|P1|COMPLETED|Overall Study||151
2486708|NCT00878644|6096497|P2|STARTED|Overall Study||140
2486709|NCT00878644|6096498|P1|STARTED|Overall Study||155
2486710|NCT00878605|6096514|P4|NOT COMPLETED|Overall Study||3
2486711|NCT00878605|6096515|P3|NOT COMPLETED|Overall Study||1
2486712|NCT00878605|6096516|P2|NOT COMPLETED|Overall Study||3
2486713|NCT00878605|6096517|P1|NOT COMPLETED|Overall Study||3
2486714|NCT00878605|6096514|P4|COMPLETED|Overall Study||6
2486715|NCT00878605|6096515|P3|COMPLETED|Overall Study||8
2486716|NCT00878605|6096516|P2|COMPLETED|Overall Study||7
2486717|NCT00878605|6096517|P1|COMPLETED|Overall Study||7
2486718|NCT00878605|6096514|P4|STARTED|Overall Study||9
2486719|NCT00878605|6096515|P3|STARTED|Overall Study||9
2486720|NCT00878605|6096516|P2|STARTED|Overall Study||10
2486721|NCT00878605|6096517|P1|STARTED|Overall Study||10
2486722|NCT00878553|6096531|P5|NOT COMPLETED|PK Study||0
2486723|NCT00878553|6096532|P4|NOT COMPLETED|PK Study||1
2486724|NCT00878553|6096533|P3|NOT COMPLETED|PK Study||0
2486725|NCT00878553|6096534|P2|NOT COMPLETED|PK Study||0
2486727|NCT00878553|6096531|P5|COMPLETED|PK Study||15
2486728|NCT00878553|6096532|P4|COMPLETED|PK Study|One patient withdrew consent after completing the Sleep Substudy and prior to starting PK substudy.|13
2486729|NCT00878553|6096533|P3|COMPLETED|PK Study||17
2486730|NCT00878553|6096534|P2|COMPLETED|PK Study||16
2486731|NCT00878553|6096535|P1|COMPLETED|PK Study|A total of 61 randomized patients completed this parallel group, single dose PK substudy.|0
2486732|NCT00878553|6096531|P5|STARTED|PK Study|During the PK period, 15 randomized participants received one bedtime dose of 20mg SKP-1041.|15
2486733|NCT00878553|6096532|P4|STARTED|PK Study|During the PK period, 14 participants were randomized to receive one bedtime dose of 15mg SKP-1041.|14
2486734|NCT00878553|6096533|P3|STARTED|PK Study|During the PK period, 17 randomized participants received one bedtime dose of 10mg SKP-1041.|17
2486735|NCT00878553|6096534|P2|STARTED|PK Study|During the PK period, 16 randomized participants received one bedtime dose of SKP-1041 placebo.|16
2486736|NCT00878553|6096535|P1|STARTED|PK Study|A total of 62 randomized patients started this parallel group, single dose PK substudy.|0
2486737|NCT00878553|6096531|P5|NOT COMPLETED|Sleep Study||0
2486738|NCT00878553|6096532|P4|NOT COMPLETED|Sleep Study||0
2486739|NCT00878553|6096533|P3|NOT COMPLETED|Sleep Study||0
2486740|NCT00878553|6096534|P2|NOT COMPLETED|Sleep Study||0
2486741|NCT00878553|6096535|P1|NOT COMPLETED|Sleep Study||5
2486742|NCT00878553|6096531|P5|COMPLETED|Sleep Study||0
2486743|NCT00878553|6096532|P4|COMPLETED|Sleep Study||0
2486744|NCT00878553|6096533|P3|COMPLETED|Sleep Study||0
2486745|NCT00878553|6096534|P2|COMPLETED|Sleep Study||0
2486746|NCT00878553|6096535|P1|COMPLETED|Sleep Study|5 patient withdraws result in greater than 5 lost patient data across groups due to CROSSOVER design|62
2486747|NCT00878553|6096531|P5|Number of Patients Receiving 20mg|Sleep Study||0
2486748|NCT00878553|6096532|P4|Number of Patients Receiving 20mg|Sleep Study||0
2486749|NCT00878553|6096533|P3|Number of Patients Receiving 20mg|Sleep Study||0
2486750|NCT00878553|6096534|P2|Number of Patients Receiving 20mg|Sleep Study||0
2486751|NCT00878553|6096535|P1|Number of Patients Receiving 20mg|Sleep Study||65
2486752|NCT00878553|6096531|P5|Number of Patients Receiving 15mg|Sleep Study||0
2486753|NCT00878553|6096532|P4|Number of Patients Receiving 15mg|Sleep Study||0
2486754|NCT00878553|6096533|P3|Number of Patients Receiving 15mg|Sleep Study||0
2486755|NCT00878553|6096534|P2|Number of Patients Receiving 15mg|Sleep Study||0
2486756|NCT00878553|6096535|P1|Number of Patients Receiving 15mg|Sleep Study||65
2486757|NCT00878553|6096531|P5|Number of Patients Receiving 10mg|Sleep Study||0
2486758|NCT00878553|6096532|P4|Number of Patients Receiving 10mg|Sleep Study||0
2486759|NCT00878553|6096533|P3|Number of Patients Receiving 10mg|Sleep Study||0
2486760|NCT00878553|6096534|P2|Number of Patients Receiving 10mg|Sleep Study||0
2486761|NCT00878553|6096535|P1|Number of Patients Receiving 10mg|Sleep Study||65
2486762|NCT00878553|6096531|P5|Number of Patients Receiving Placebo|Sleep Study||0
2486763|NCT00878553|6096532|P4|Number of Patients Receiving Placebo|Sleep Study||0
2486764|NCT00878553|6096533|P3|Number of Patients Receiving Placebo|Sleep Study||0
2486765|NCT00878553|6096534|P2|Number of Patients Receiving Placebo|Sleep Study||0
2486766|NCT00878553|6096535|P1|Number of Patients Receiving Placebo|Sleep Study||66
2486767|NCT00878553|6096531|P5|STARTED|Sleep Study||0
2486768|NCT00878553|6096532|P4|STARTED|Sleep Study||0
2486769|NCT00878553|6096533|P3|STARTED|Sleep Study||0
2486770|NCT00878553|6096534|P2|STARTED|Sleep Study||0
2486771|NCT00878553|6096535|P1|STARTED|Sleep Study|This Intention to Treat population includes all randomized patients; one dropped prior to treatment.|67
2486772|NCT00878501|6096594|P3|NOT COMPLETED|Overall Study||8
2486773|NCT00878501|6096595|P2|NOT COMPLETED|Overall Study||7
2486774|NCT00878501|6096596|P1|NOT COMPLETED|Overall Study||17
2486775|NCT00878501|6096594|P3|COMPLETED|Overall Study||85
2486776|NCT00878501|6096595|P2|COMPLETED|Overall Study||37
2486777|NCT00878501|6096596|P1|COMPLETED|Overall Study||87
2486778|NCT00878501|6096594|P3|Interim Analysis|Overall Study||81
2486779|NCT00878501|6096595|P2|Interim Analysis|Overall Study||37
2486780|NCT00878501|6096596|P1|Interim Analysis|Overall Study||83
2486781|NCT00878501|6096594|P3|STARTED|Overall Study||93
2486782|NCT00878501|6096595|P2|STARTED|Overall Study||44
2486783|NCT00878501|6096596|P1|STARTED|Overall Study|One of these patients did not receive study drug since incorrectly enrolled (mis-randomisation)|104
2486784|NCT00878436|6096615|P2|NOT COMPLETED|Overall Study||24
2486785|NCT00878436|6096616|P1|NOT COMPLETED|Overall Study||23
2486786|NCT00878436|6096615|P2|COMPLETED|Overall Study||0
2486787|NCT00878436|6096616|P1|COMPLETED|Overall Study||5
2486788|NCT00878436|6096615|P2|6 Months|Overall Study||0
2486789|NCT00878436|6096616|P1|6 Months|Overall Study||8
2486790|NCT00878436|6096615|P2|Completed 2 Cycles|Overall Study||20
2486791|NCT00878436|6096616|P1|Completed 2 Cycles|Overall Study||21
2486792|NCT00878436|6096615|P2|STARTED|Overall Study||24
2486793|NCT00878436|6096616|P1|STARTED|Overall Study||28
2486794|NCT00878228|6096630|P2|NOT COMPLETED|Overall Study||12
2486795|NCT00878228|6096631|P1|NOT COMPLETED|Overall Study||10
2486796|NCT00878228|6096630|P2|COMPLETED|Overall Study||37
2486797|NCT00878228|6096631|P1|COMPLETED|Overall Study||39
2486798|NCT00878228|6096630|P2|STARTED|Overall Study||49
2486799|NCT00878228|6096631|P1|STARTED|Overall Study||49
2486800|NCT00878215|6096645|P4|NOT COMPLETED|Overall Study||0
2486801|NCT00878215|6096646|P3|NOT COMPLETED|Overall Study||0
2486802|NCT00878215|6096647|P2|NOT COMPLETED|Overall Study||10
2486803|NCT00878215|6096648|P1|NOT COMPLETED|Overall Study||0
2486804|NCT00878215|6096645|P4|COMPLETED|Overall Study||0
2486805|NCT00878215|6096646|P3|COMPLETED|Overall Study||0
2486806|NCT00878215|6096647|P2|COMPLETED|Overall Study||9
2486807|NCT00878215|6096648|P1|COMPLETED|Overall Study||21
2486808|NCT00878215|6096645|P4|STARTED|Overall Study|Phase 4 not performed because the liver imaging system became commercially available|0
2486809|NCT00878215|6096646|P3|STARTED|Overall Study|Phase 3 not performed because the liver imaging system became commercially available|0
2486810|NCT00878215|6096647|P2|STARTED|Overall Study||19
2486811|NCT00878215|6096648|P1|STARTED|Overall Study||21
2486812|NCT00878189|6096660|P9|NOT COMPLETED|Overall Study||8
2486813|NCT00878189|6096661|P8|NOT COMPLETED|Overall Study||3
2486814|NCT00878189|6096662|P7|NOT COMPLETED|Overall Study||16
2486815|NCT00878189|6096663|P6|NOT COMPLETED|Overall Study||23
2486816|NCT00878189|6096664|P5|NOT COMPLETED|Overall Study||4
2486817|NCT00878189|6096665|P4|NOT COMPLETED|Overall Study||8
2486818|NCT00878189|6096666|P3|NOT COMPLETED|Overall Study||4
2486819|NCT00878189|6096667|P2|NOT COMPLETED|Overall Study||3
2486820|NCT00878189|6096668|P1|NOT COMPLETED|Overall Study||3
2486821|NCT00878189|6096660|P9|COMPLETED|Overall Study||0
2486822|NCT00878189|6096661|P8|COMPLETED|Overall Study||0
2486823|NCT00878189|6096662|P7|COMPLETED|Overall Study||0
2486824|NCT00878189|6096663|P6|COMPLETED|Overall Study||0
2486825|NCT00878189|6096664|P5|COMPLETED|Overall Study||0
2486826|NCT00878189|6096665|P4|COMPLETED|Overall Study||0
2486827|NCT00878189|6096666|P3|COMPLETED|Overall Study||0
2486828|NCT00878189|6096667|P2|COMPLETED|Overall Study||0
2486829|NCT00878189|6096668|P1|COMPLETED|Overall Study||0
2486830|NCT00878189|6096660|P9|STARTED|Overall Study||8
2486831|NCT00878189|6096661|P8|STARTED|Overall Study||3
2486832|NCT00878189|6096662|P7|STARTED|Overall Study||16
2486833|NCT00878189|6096663|P6|STARTED|Overall Study||23
2486834|NCT00878189|6096664|P5|STARTED|Overall Study||4
2486835|NCT00878189|6096665|P4|STARTED|Overall Study||8
2486836|NCT00878189|6096666|P3|STARTED|Overall Study||4
2486837|NCT00878189|6096667|P2|STARTED|Overall Study||3
2486838|NCT00878189|6096668|P1|STARTED|Overall Study||3
2486839|NCT00877929|6096936|P2|NOT COMPLETED|Overall Study||35
2486840|NCT00877929|6096937|P1|NOT COMPLETED|Overall Study||20
2486841|NCT00877929|6096936|P2|COMPLETED|Overall Study||319
2486842|NCT00877929|6096937|P1|COMPLETED|Overall Study||332
2486843|NCT00877929|6096936|P2|STARTED|Overall Study||354
2486844|NCT00877929|6096937|P1|STARTED|Overall Study||352
2486845|NCT00877890|6097025|P2|NOT COMPLETED|Overall Study||30
2486846|NCT00877890|6097026|P1|NOT COMPLETED|Overall Study||20
2486847|NCT00877890|6097025|P2|COMPLETED|Overall Study||95
2486848|NCT00877890|6097026|P1|COMPLETED|Overall Study||109
2486849|NCT00877890|6097025|P2|Intent to Treat (ITT)|Overall Study||123
2486850|NCT00877890|6097026|P1|Intent to Treat (ITT)|Overall Study||129
2486851|NCT00877890|6097025|P2|STARTED|Overall Study||125
2486852|NCT00877890|6097026|P1|STARTED|Overall Study||129
2486853|NCT00877877|6097060|P1|NOT COMPLETED|Year 10||0
2486854|NCT00877877|6097060|P1|COMPLETED|Year 10||495
2486855|NCT00877877|6097060|P1|STARTED|Year 10||495
2486856|NCT00877877|6097060|P1|NOT COMPLETED|Year 9||0
2486857|NCT00877877|6097060|P1|COMPLETED|Year 9||507
2486858|NCT00877877|6097060|P1|STARTED|Year 9||507
2486859|NCT00877877|6097060|P1|NOT COMPLETED|Year 8||0
2486860|NCT00877877|6097060|P1|COMPLETED|Year 8||522
2486861|NCT00877877|6097060|P1|STARTED|Year 8||522
2486862|NCT00877877|6097060|P1|NOT COMPLETED|Year 7||0
2486863|NCT00877877|6097060|P1|COMPLETED|Year 7||523
2486864|NCT00877877|6097060|P1|STARTED|Year 7||523
2486865|NCT00877877|6097060|P1|NOT COMPLETED|Year 6||0
2486866|NCT00877877|6097060|P1|COMPLETED|Year 6||529
2486867|NCT00877877|6097060|P1|STARTED|Year 6||529
2486868|NCT00877877|6097060|P1|NOT COMPLETED|Year 5||0
2486869|NCT00877877|6097060|P1|COMPLETED|Year 5||397
2486870|NCT00877877|6097060|P1|STARTED|Year 5||397
2486871|NCT00877799|6097091|P5|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||1
2486872|NCT00877799|6097092|P4|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||2
2486873|NCT00877799|6097093|P3|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
2486874|NCT00877799|6097094|P2|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
2486875|NCT00877799|6097095|P1|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
2486876|NCT00877799|6097091|P5|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||19
2486877|NCT00877799|6097092|P4|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||24
2486878|NCT00877799|6097093|P3|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
2486879|NCT00877799|6097094|P2|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
2486880|NCT00877799|6097095|P1|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
2486881|NCT00877799|6097091|P5|STARTED|Cohort 2: Immediately Post-op (Day 0)||20
2486882|NCT00877799|6097092|P4|STARTED|Cohort 2: Immediately Post-op (Day 0)||26
2486883|NCT00877799|6097093|P3|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
2486884|NCT00877799|6097094|P2|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
2486885|NCT00877799|6097095|P1|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
2486886|NCT00877799|6097091|P5|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
2486887|NCT00877799|6097092|P4|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
2486888|NCT00877799|6097093|P3|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
2486889|NCT00877799|6097094|P2|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||5
2486890|NCT00877799|6097095|P1|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
2486891|NCT00877799|6097091|P5|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
2486892|NCT00877799|6097092|P4|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
2486893|NCT00877799|6097093|P3|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||18
2486894|NCT00877799|6097094|P2|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||17
2486895|NCT00877799|6097095|P1|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||22
2486896|NCT00877799|6097091|P5|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
2486897|NCT00877799|6097092|P4|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
2486898|NCT00877799|6097093|P3|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||21
2486899|NCT00877799|6097094|P2|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||22
2486900|NCT00877799|6097095|P1|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||25
2486901|NCT00877773|6097110|P1|NOT COMPLETED|Overall Study||44
2486902|NCT00877773|6097110|P1|COMPLETED|Overall Study|No participant reached to first restaging.|0
2486903|NCT00877773|6097110|P1|STARTED|Overall Study||44
2486904|NCT00877604|6097116|P2|NOT COMPLETED|Overall Study||3
2486905|NCT00877604|6097117|P1|NOT COMPLETED|Overall Study||2
2486906|NCT00877604|6097116|P2|COMPLETED|Overall Study||14
2486907|NCT00877604|6097117|P1|COMPLETED|Overall Study||15
2486908|NCT00877604|6097116|P2|STARTED|Overall Study||17
2486909|NCT00877604|6097117|P1|STARTED|Overall Study||17
2486910|NCT00877487|6097123|P2|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||47
2486911|NCT00877487|6097124|P1|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||6
2486912|NCT00877487|6097123|P2|COMPLETED|Double-blind Randomized Withdrawal Phase||13
2486913|NCT00877487|6097124|P1|COMPLETED|Double-blind Randomized Withdrawal Phase||50
2486914|NCT00877487|6097123|P2|STARTED|Double-blind Randomized Withdrawal Phase||60
2486915|NCT00877487|6097124|P1|STARTED|Double-blind Randomized Withdrawal Phase||56
2486916|NCT00877487|6097123|P2|NOT COMPLETED|Open-label Treatment Phase||0
2486917|NCT00877487|6097124|P1|NOT COMPLETED|Open-label Treatment Phase||7
2486918|NCT00877487|6097123|P2|COMPLETED|Open-label Treatment Phase||0
2486919|NCT00877487|6097124|P1|COMPLETED|Open-label Treatment Phase||116
2486920|NCT00877487|6097123|P2|STARTED|Open-label Treatment Phase||0
2486921|NCT00877487|6097124|P1|STARTED|Open-label Treatment Phase||123
2486922|NCT00877448|6097141|P7|NOT COMPLETED|Overall Study||0
2486923|NCT00877448|6097142|P6|NOT COMPLETED|Overall Study||1
2486924|NCT00877448|6097143|P5|NOT COMPLETED|Overall Study||0
2486925|NCT00877448|6097144|P4|NOT COMPLETED|Overall Study||1
2486926|NCT00877448|6097145|P3|NOT COMPLETED|Overall Study||0
2486927|NCT00877448|6097146|P2|NOT COMPLETED|Overall Study||1
2486928|NCT00877448|6097147|P1|NOT COMPLETED|Overall Study||0
2486929|NCT00877448|6097141|P7|COMPLETED|Overall Study||3
2486930|NCT00877448|6097142|P6|COMPLETED|Overall Study||9
2486931|NCT00877448|6097143|P5|COMPLETED|Overall Study||10
2486932|NCT00877448|6097144|P4|COMPLETED|Overall Study||9
2486933|NCT00877448|6097145|P3|COMPLETED|Overall Study||10
2486934|NCT00877448|6097146|P2|COMPLETED|Overall Study||9
2486935|NCT00877448|6097147|P1|COMPLETED|Overall Study||10
2486936|NCT00877448|6097141|P7|STARTED|Overall Study||3
2486937|NCT00877448|6097142|P6|STARTED|Overall Study||10
2486938|NCT00877448|6097143|P5|STARTED|Overall Study||10
2486939|NCT00877448|6097144|P4|STARTED|Overall Study||10
2486940|NCT00877448|6097145|P3|STARTED|Overall Study||10
2486941|NCT00877448|6097146|P2|STARTED|Overall Study||10
2486942|NCT00877448|6097147|P1|STARTED|Overall Study||10
2486943|NCT00877383|6097172|P2|NOT COMPLETED|Overall Study||37
2486944|NCT00877383|6097173|P1|NOT COMPLETED|Overall Study||29
2486945|NCT00877383|6097172|P2|COMPLETED|Overall Study||533
2486946|NCT00877383|6097173|P1|COMPLETED|Overall Study||543
2486947|NCT00877383|6097172|P2|STARTED|Overall Study||570
2486948|NCT00877383|6097173|P1|STARTED|Overall Study||572
2486949|NCT00877370|6097189|P1|NOT COMPLETED|Overall Study||0
2486950|NCT00877370|6097189|P1|COMPLETED|Overall Study||8
2486951|NCT00877370|6097189|P1|STARTED|Overall Study||8
2486952|NCT00877071|6097193|P1|NOT COMPLETED|Overall Study||2
2486953|NCT00877071|6097193|P1|COMPLETED|Overall Study||0
2486954|NCT00877071|6097193|P1|STARTED|Overall Study||2
2486955|NCT00877058|6097203|P3|NOT COMPLETED|Overall Study||39
2486956|NCT00877058|6097204|P2|NOT COMPLETED|Overall Study||40
2486957|NCT00877058|6097205|P1|NOT COMPLETED|Overall Study||37
2486958|NCT00877058|6097203|P3|COMPLETED|Overall Study||75
2486959|NCT00877058|6097204|P2|COMPLETED|Overall Study||131
2486960|NCT00877058|6097205|P1|COMPLETED|Overall Study||137
2486961|NCT00877058|6097203|P3|STARTED|Overall Study||114
2486962|NCT00877058|6097204|P2|STARTED|Overall Study||171
2486963|NCT00877058|6097205|P1|STARTED|Overall Study||174
2486964|NCT00877032|6097226|P7|NOT COMPLETED|Overall Study||2
2486965|NCT00877032|6097227|P6|NOT COMPLETED|Overall Study||0
2486966|NCT00877032|6097228|P5|NOT COMPLETED|Overall Study||0
2486967|NCT00877032|6097229|P4|NOT COMPLETED|Overall Study||1
2486968|NCT00877032|6097230|P3|NOT COMPLETED|Overall Study||0
2486969|NCT00877032|6097231|P2|NOT COMPLETED|Overall Study||0
2486970|NCT00877032|6097232|P1|NOT COMPLETED|Overall Study||0
2486971|NCT00877032|6097226|P7|COMPLETED|Overall Study||18
2486972|NCT00877032|6097227|P6|COMPLETED|Overall Study||6
2486973|NCT00877032|6097228|P5|COMPLETED|Overall Study||6
2486974|NCT00877032|6097229|P4|COMPLETED|Overall Study||6
2486975|NCT00877032|6097230|P3|COMPLETED|Overall Study||6
2486976|NCT00877032|6097231|P2|COMPLETED|Overall Study||6
2486977|NCT00877032|6097232|P1|COMPLETED|Overall Study||6
2486978|NCT00877032|6097226|P7|Treated|Overall Study||18
2486979|NCT00877032|6097227|P6|Treated|Overall Study||6
2486980|NCT00877032|6097228|P5|Treated|Overall Study||6
2486981|NCT00877032|6097229|P4|Treated|Overall Study||6
2486982|NCT00877032|6097230|P3|Treated|Overall Study||6
2486983|NCT00877032|6097231|P2|Treated|Overall Study||6
2486984|NCT00877032|6097232|P1|Treated|Overall Study||6
2486985|NCT00877032|6097226|P7|STARTED|Overall Study||20
2486986|NCT00877032|6097227|P6|STARTED|Overall Study||6
2486987|NCT00877032|6097228|P5|STARTED|Overall Study||6
2486988|NCT00877032|6097229|P4|STARTED|Overall Study||7
2486989|NCT00877032|6097230|P3|STARTED|Overall Study||6
2486990|NCT00877032|6097231|P2|STARTED|Overall Study||6
2486991|NCT00877032|6097232|P1|STARTED|Overall Study||6
2486992|NCT00877006|6097333|P2|NOT COMPLETED|Long-Term Follow-up Period||55
2486993|NCT00877006|6097334|P1|NOT COMPLETED|Long-Term Follow-up Period||53
2486994|NCT00877006|6097333|P2|COMPLETED|Long-Term Follow-up Period||154
2486995|NCT00877006|6097334|P1|COMPLETED|Long-Term Follow-up Period||157
2486996|NCT00877006|6097333|P2|STARTED|Long-Term Follow-up Period||209
2486997|NCT00877006|6097334|P1|STARTED|Long-Term Follow-up Period||210
2486998|NCT00877006|6097333|P2|NOT COMPLETED|Treatment Period||27
2486999|NCT00877006|6097334|P1|NOT COMPLETED|Treatment Period||25
2487000|NCT00877006|6097333|P2|COMPLETED|Treatment Period||196
2487001|NCT00877006|6097334|P1|COMPLETED|Treatment Period||199
2487002|NCT00877006|6097333|P2|STARTED|Treatment Period||223
2487003|NCT00877006|6097334|P1|STARTED|Treatment Period||224
2487004|NCT00876993|6097377|P5|NOT COMPLETED|Overall Study||2
2487005|NCT00876993|6097378|P4|NOT COMPLETED|Overall Study||0
2487006|NCT00876993|6097379|P3|NOT COMPLETED|Overall Study||2
2487007|NCT00876993|6097380|P2|NOT COMPLETED|Overall Study||0
2487008|NCT00876993|6097381|P1|NOT COMPLETED|Overall Study||1
2487009|NCT00876993|6097377|P5|COMPLETED|Overall Study||3
2487010|NCT00876993|6097378|P4|COMPLETED|Overall Study||5
2487011|NCT00876993|6097379|P3|COMPLETED|Overall Study||3
2487012|NCT00876993|6097380|P2|COMPLETED|Overall Study||6
2487013|NCT00876993|6097381|P1|COMPLETED|Overall Study||4
2487014|NCT00876993|6097377|P5|STARTED|Overall Study||5
2487015|NCT00876993|6097378|P4|STARTED|Overall Study||5
2487016|NCT00876993|6097379|P3|STARTED|Overall Study||5
2487017|NCT00876993|6097380|P2|STARTED|Overall Study||6
2487018|NCT00876993|6097381|P1|STARTED|Overall Study||5
2487019|NCT00876928|6097410|P2|NOT COMPLETED|Overall Study||5
2487020|NCT00876928|6097411|P1|NOT COMPLETED|Overall Study||3
2487021|NCT00876928|6097410|P2|COMPLETED|Overall Study||56
2487022|NCT00876928|6097411|P1|COMPLETED|Overall Study||53
2487023|NCT00876928|6097410|P2|STARTED|Overall Study||61
2487024|NCT00876928|6097411|P1|STARTED|Overall Study||56
2487025|NCT00876915|6097422|P3|NOT COMPLETED|Overall Study||0
2487026|NCT00876915|6097423|P2|NOT COMPLETED|Overall Study||14
2487027|NCT00876915|6097424|P1|NOT COMPLETED|Overall Study||19
2487028|NCT00876915|6097422|P3|COMPLETED|Overall Study||101
2487029|NCT00876915|6097423|P2|COMPLETED|Overall Study||34
2487030|NCT00876915|6097424|P1|COMPLETED|Overall Study||31
2487031|NCT00876915|6097422|P3|Week 8|Overall Study||0
2487032|NCT00876915|6097423|P2|Week 8|Overall Study||36
2487033|NCT00876915|6097424|P1|Week 8|Overall Study||33
2487034|NCT00876915|6097422|P3|Week 4|Overall Study||0
2487035|NCT00876915|6097423|P2|Week 4|Overall Study||45
2487036|NCT00876915|6097424|P1|Week 4|Overall Study||38
2487037|NCT00876915|6097422|P3|STARTED|Overall Study||101
2487038|NCT00876915|6097423|P2|STARTED|Overall Study||48
2487039|NCT00876915|6097424|P1|STARTED|Overall Study||50
2487040|NCT00876733|6097448|P4|NOT COMPLETED|Overall Study||7
2487041|NCT00876733|6097449|P3|NOT COMPLETED|Overall Study||30
2487042|NCT00876733|6097450|P2|NOT COMPLETED|Overall Study||42
2487043|NCT00876733|6097451|P1|NOT COMPLETED|Overall Study||91
2487044|NCT00876733|6097448|P4|COMPLETED|Overall Study||14
2487045|NCT00876733|6097449|P3|COMPLETED|Overall Study||63
2487046|NCT00876733|6097450|P2|COMPLETED|Overall Study||161
2487047|NCT00876733|6097451|P1|COMPLETED|Overall Study||197
2487048|NCT00876733|6097448|P4|STARTED|Overall Study||21
2487049|NCT00876733|6097449|P3|STARTED|Overall Study||93
2487050|NCT00876733|6097450|P2|STARTED|Overall Study||203
2487051|NCT00876733|6097451|P1|STARTED|Overall Study||288
2487052|NCT00876694|6097559|P2|NOT COMPLETED|Overall Study||12
2487053|NCT00876694|6097560|P1|NOT COMPLETED|Overall Study||21
2487054|NCT00876694|6097559|P2|COMPLETED|Overall Study||49
2487055|NCT00876694|6097560|P1|COMPLETED|Overall Study||104
2487056|NCT00876694|6097559|P2|STARTED|Overall Study||61
2487057|NCT00876694|6097560|P1|STARTED|Overall Study||125
2487058|NCT00876460|6097586|P8|NOT COMPLETED|Mono Therapy Phase||3
2487059|NCT00876460|6097587|P7|NOT COMPLETED|Mono Therapy Phase||1
2487060|NCT00876460|6097588|P6|NOT COMPLETED|Mono Therapy Phase||0
2487061|NCT00876460|6097589|P5|NOT COMPLETED|Mono Therapy Phase||2
2487062|NCT00876460|6097590|P4|NOT COMPLETED|Mono Therapy Phase||1
2487063|NCT00876460|6097591|P3|NOT COMPLETED|Mono Therapy Phase||0
2487064|NCT00876460|6097592|P2|NOT COMPLETED|Mono Therapy Phase||1
2487065|NCT00876460|6097593|P1|NOT COMPLETED|Mono Therapy Phase||0
2487066|NCT00876460|6097586|P8|COMPLETED|Mono Therapy Phase||0
2487067|NCT00876460|6097587|P7|COMPLETED|Mono Therapy Phase||0
2487068|NCT00876460|6097588|P6|COMPLETED|Mono Therapy Phase||0
2487069|NCT00876460|6097589|P5|COMPLETED|Mono Therapy Phase||0
2487070|NCT00876460|6097590|P4|COMPLETED|Mono Therapy Phase||0
2487071|NCT00876460|6097591|P3|COMPLETED|Mono Therapy Phase||0
2487072|NCT00876460|6097592|P2|COMPLETED|Mono Therapy Phase||0
2487073|NCT00876460|6097593|P1|COMPLETED|Mono Therapy Phase||0
2487074|NCT00876460|6097586|P8|STARTED|Mono Therapy Phase|Three patients started mono therapy phase after discontinued from combination therapy phase.|3
2487075|NCT00876460|6097587|P7|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
2487076|NCT00876460|6097588|P6|STARTED|Mono Therapy Phase||0
2487077|NCT00876460|6097589|P5|STARTED|Mono Therapy Phase|Two patients started mono therapy phase after discontinued from combination therapy phase.|2
2487166|NCT00875836|6097873|P1|NOT COMPLETED|Overall Study||43
2487078|NCT00876460|6097590|P4|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
2487079|NCT00876460|6097591|P3|STARTED|Mono Therapy Phase||0
2487080|NCT00876460|6097592|P2|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
2487081|NCT00876460|6097593|P1|STARTED|Mono Therapy Phase||0
2487082|NCT00876460|6097586|P8|NOT COMPLETED|Combination Therapy Phase||6
2487083|NCT00876460|6097587|P7|NOT COMPLETED|Combination Therapy Phase||8
2487084|NCT00876460|6097588|P6|NOT COMPLETED|Combination Therapy Phase||3
2487085|NCT00876460|6097589|P5|NOT COMPLETED|Combination Therapy Phase||7
2487086|NCT00876460|6097590|P4|NOT COMPLETED|Combination Therapy Phase||6
2487087|NCT00876460|6097591|P3|NOT COMPLETED|Combination Therapy Phase||3
2487088|NCT00876460|6097592|P2|NOT COMPLETED|Combination Therapy Phase||7
2487089|NCT00876460|6097593|P1|NOT COMPLETED|Combination Therapy Phase||3
2487090|NCT00876460|6097586|P8|COMPLETED|Combination Therapy Phase||0
2487091|NCT00876460|6097587|P7|COMPLETED|Combination Therapy Phase||0
2487092|NCT00876460|6097588|P6|COMPLETED|Combination Therapy Phase||0
2487093|NCT00876460|6097589|P5|COMPLETED|Combination Therapy Phase||0
2487094|NCT00876460|6097590|P4|COMPLETED|Combination Therapy Phase||0
2487095|NCT00876460|6097591|P3|COMPLETED|Combination Therapy Phase||0
2487096|NCT00876460|6097592|P2|COMPLETED|Combination Therapy Phase||0
2487097|NCT00876460|6097593|P1|COMPLETED|Combination Therapy Phase||0
2487098|NCT00876460|6097586|P8|STARTED|Combination Therapy Phase||6
2487099|NCT00876460|6097587|P7|STARTED|Combination Therapy Phase||8
2487100|NCT00876460|6097588|P6|STARTED|Combination Therapy Phase||3
2487101|NCT00876460|6097589|P5|STARTED|Combination Therapy Phase||7
2487102|NCT00876460|6097590|P4|STARTED|Combination Therapy Phase||6
2487103|NCT00876460|6097591|P3|STARTED|Combination Therapy Phase||3
2487104|NCT00876460|6097592|P2|STARTED|Combination Therapy Phase||7
2487105|NCT00876460|6097593|P1|STARTED|Combination Therapy Phase||3
2487106|NCT00876447|6097665|P2|NOT COMPLETED|Overall Study||81
2487107|NCT00876447|6097666|P1|NOT COMPLETED|Overall Study||80
2487108|NCT00876447|6097665|P2|COMPLETED|Overall Study||122
2487109|NCT00876447|6097666|P1|COMPLETED|Overall Study||105
2487110|NCT00876447|6097665|P2|STARTED|Overall Study||203
2487111|NCT00876447|6097666|P1|STARTED|Overall Study||185
2487112|NCT00876395|6097726|P2|NOT COMPLETED|Overall Study||239
2487113|NCT00876395|6097727|P1|NOT COMPLETED|Overall Study||480
2487114|NCT00876395|6097726|P2|COMPLETED|Overall Study||0
2487115|NCT00876395|6097727|P1|COMPLETED|Overall Study||0
2487116|NCT00876395|6097726|P2|Untreated|Overall Study||1
2487117|NCT00876395|6097727|P1|Untreated|Overall Study||8
2487118|NCT00876395|6097726|P2|STARTED|Overall Study||239
2487119|NCT00876395|6097727|P1|STARTED|Overall Study||480
2487120|NCT00876343|6097768|P3|NOT COMPLETED|Overall Study||12
2487121|NCT00876343|6097769|P2|NOT COMPLETED|Overall Study||17
2487122|NCT00876343|6097770|P1|NOT COMPLETED|Overall Study||17
2487123|NCT00876343|6097768|P3|COMPLETED|Overall Study||183
2487124|NCT00876343|6097769|P2|COMPLETED|Overall Study||180
2487125|NCT00876343|6097770|P1|COMPLETED|Overall Study||177
2487126|NCT00876343|6097768|P3|STARTED|Overall Study||195
2487127|NCT00876343|6097769|P2|STARTED|Overall Study||197
2487128|NCT00876343|6097770|P1|STARTED|Overall Study||194
2487129|NCT00876265|6097784|P1|NOT COMPLETED|Overall Study||12
2487130|NCT00876265|6097784|P1|COMPLETED|Overall Study||106
2487131|NCT00876265|6097784|P1|STARTED|Overall Study||118
2487132|NCT00876200|6097792|P2|NOT COMPLETED|Overall Study||3
2487133|NCT00876200|6097793|P1|NOT COMPLETED|Overall Study||1
2487134|NCT00876200|6097792|P2|COMPLETED|Overall Study||9
2487135|NCT00876200|6097793|P1|COMPLETED|Overall Study||8
2487136|NCT00876200|6097792|P2|STARTED|Overall Study||12
2487137|NCT00876200|6097793|P1|STARTED|Overall Study||9
2487138|NCT00876018|6097802|P3|NOT COMPLETED|Overall Study||3
2487139|NCT00876018|6097803|P2|NOT COMPLETED|Overall Study||5
2487140|NCT00876018|6097804|P1|NOT COMPLETED|Overall Study||5
2487141|NCT00876018|6097802|P3|COMPLETED|Overall Study||97
2487142|NCT00876018|6097803|P2|COMPLETED|Overall Study||95
2487143|NCT00876018|6097804|P1|COMPLETED|Overall Study||95
2487144|NCT00876018|6097802|P3|STARTED|Overall Study||100
2487145|NCT00876018|6097803|P2|STARTED|Overall Study||100
2487146|NCT00876018|6097804|P1|STARTED|Overall Study||100
2487147|NCT00875979|6097859|P2|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||47
2487148|NCT00875979|6097860|P1|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
2487149|NCT00875979|6097859|P2|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||11
2487150|NCT00875979|6097860|P1|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
2487151|NCT00875979|6097859|P2|STARTED|Dose Expansion Phase - 3.6 mg/kg||58
2487152|NCT00875979|6097860|P1|STARTED|Dose Expansion Phase - 3.6 mg/kg||0
2487153|NCT00875979|6097859|P2|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||6
2487154|NCT00875979|6097860|P1|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
2487155|NCT00875979|6097859|P2|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
2487156|NCT00875979|6097860|P1|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
2487157|NCT00875979|6097859|P2|STARTED|Dose Escalation Phase - 3.6 mg/kg||6
2487158|NCT00875979|6097860|P1|STARTED|Dose Escalation Phase - 3.6 mg/kg||0
2487159|NCT00875979|6097859|P2|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
2487160|NCT00875979|6097860|P1|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||3
2487161|NCT00875979|6097859|P2|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
2487162|NCT00875979|6097860|P1|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
2487163|NCT00875979|6097859|P2|STARTED|Dose Escalation Phase - 3.0 mg/kg||0
2487164|NCT00875979|6097860|P1|STARTED|Dose Escalation Phase - 3.0 mg/kg||3
2487165|NCT00875836|6097872|P2|NOT COMPLETED|Overall Study||40
2487167|NCT00875836|6097872|P2|COMPLETED|Overall Study||47
2487168|NCT00875836|6097873|P1|COMPLETED|Overall Study||45
2487169|NCT00875836|6097872|P2|STARTED|Overall Study||87
2487170|NCT00875836|6097873|P1|STARTED|Overall Study||88
2487171|NCT00875810|6097883|P1|NOT COMPLETED|Overall Study||46
2487172|NCT00875810|6097883|P1|COMPLETED|Overall Study||148
2487173|NCT00875810|6097883|P1|24 Months Follow up|Overall Study||148
2487174|NCT00875810|6097883|P1|12 Months Follow up|Overall Study||112
2487175|NCT00875810|6097883|P1|6 Months Follow up|Overall Study||80
2487176|NCT00875810|6097883|P1|3 Months Follow up|Overall Study||175
2487177|NCT00875810|6097883|P1|Discharged|Overall Study||177
2487178|NCT00875810|6097883|P1|Implanted|Overall Study||190
2487179|NCT00875810|6097883|P1|STARTED|Overall Study||194
2487180|NCT00875797|6097892|P2|NOT COMPLETED|Overall Study||3
2487181|NCT00875797|6097893|P1|NOT COMPLETED|Overall Study||6
2487182|NCT00875797|6097892|P2|COMPLETED|Overall Study||42
2487183|NCT00875797|6097893|P1|COMPLETED|Overall Study||39
2487184|NCT00875797|6097892|P2|STARTED|Overall Study||45
2487185|NCT00875797|6097893|P1|STARTED|Overall Study||45
2487186|NCT00875706|6097906|P3|NOT COMPLETED|Overall Study||0
2487187|NCT00875706|6097907|P2|NOT COMPLETED|Overall Study||0
2487188|NCT00875706|6097908|P1|NOT COMPLETED|Overall Study||1
2487189|NCT00875706|6097906|P3|COMPLETED|Overall Study||13
2487190|NCT00875706|6097907|P2|COMPLETED|Overall Study||24
2487191|NCT00875706|6097908|P1|COMPLETED|Overall Study||7
2487192|NCT00875706|6097906|P3|STARTED|Overall Study||13
2487193|NCT00875706|6097907|P2|STARTED|Overall Study||24
2487194|NCT00875706|6097908|P1|STARTED|Overall Study||8
2487195|NCT00875667|6097927|P2|NOT COMPLETED|Overall Study||73
2487196|NCT00875667|6097928|P1|NOT COMPLETED|Overall Study||170
2487197|NCT00875667|6097927|P2|COMPLETED|Overall Study|Participants completed 6 cycles of IC single agent cytarabine, fludarabine, or gemcitabine.|11
2487198|NCT00875667|6097928|P1|COMPLETED|Overall Study||0
2487199|NCT00875667|6097927|P2|Participants Treated|Overall Study||83
2487200|NCT00875667|6097928|P1|Participants Treated|Overall Study||167
2487201|NCT00875667|6097927|P2|Crossover From IC to Lenalidomide|Overall Study|Upon disease progression, participants crossed over to lenalidomide|40
2487202|NCT00875667|6097928|P1|Crossover From IC to Lenalidomide|Overall Study|NA = Participants in the IC arm were able to crossover to lenalidomide|0
2487203|NCT00875667|6097927|P2|STARTED|Overall Study||84
2487204|NCT00875667|6097928|P1|STARTED|Overall Study||170
2487205|NCT00875641|6098029|P3|NOT COMPLETED|Overall Study||0
2487206|NCT00875641|6098030|P2|NOT COMPLETED|Overall Study||0
2487207|NCT00875641|6098031|P1|NOT COMPLETED|Overall Study||0
2487208|NCT00875641|6098029|P3|COMPLETED|Overall Study||159344
2487209|NCT00875641|6098030|P2|COMPLETED|Overall Study||173384
2487210|NCT00875641|6098031|P1|COMPLETED|Overall Study||57931
2487211|NCT00875641|6098029|P3|STARTED|Overall Study||159344
2487212|NCT00875641|6098030|P2|STARTED|Overall Study||173384
2487213|NCT00875641|6098031|P1|STARTED|Overall Study||57931
2487214|NCT00875615|6098063|P1|NOT COMPLETED|Overall Study||1
2487215|NCT00875615|6098063|P1|COMPLETED|Overall Study||10
2487216|NCT00875615|6098063|P1|STARTED|Overall Study||11
2487217|NCT00875589|6098070|P2|NOT COMPLETED|Overall Study||0
2487218|NCT00875589|6098071|P1|NOT COMPLETED|Overall Study||0
2487219|NCT00875589|6098070|P2|COMPLETED|Overall Study||11
2487220|NCT00875589|6098071|P1|COMPLETED|Overall Study||15
2487221|NCT00875589|6098070|P2|STARTED|Overall Study||11
2487222|NCT00875589|6098071|P1|STARTED|Overall Study||15
2487223|NCT00875563|6098077|P1|NOT COMPLETED|Overall Study||24
2487224|NCT00875563|6098077|P1|COMPLETED|Overall Study||18
2487225|NCT00875563|6098077|P1|STARTED|Overall Study||42
2487226|NCT00875550|6098083|P2|NOT COMPLETED|Overall Study||10
2487227|NCT00875550|6098084|P1|NOT COMPLETED|Overall Study||12
2487228|NCT00875550|6098083|P2|COMPLETED|Overall Study||76
2487229|NCT00875550|6098084|P1|COMPLETED|Overall Study||77
2487230|NCT00875550|6098083|P2|STARTED|Overall Study||86
2487231|NCT00875550|6098084|P1|STARTED|Overall Study||89
2487232|NCT00875524|6098102|P2|NOT COMPLETED|Overall Study||6
2487233|NCT00875524|6098103|P1|NOT COMPLETED|Overall Study||8
2487234|NCT00875524|6098102|P2|COMPLETED|Overall Study||54
2487235|NCT00875524|6098103|P1|COMPLETED|Overall Study||112
2487236|NCT00875524|6098102|P2|Received Vaccination 3|Overall Study||58
2487237|NCT00875524|6098103|P1|Received Vaccination 3|Overall Study||114
2487238|NCT00875524|6098102|P2|Received Vaccination 2|Overall Study||58
2487239|NCT00875524|6098103|P1|Received Vaccination 2|Overall Study||116
2487240|NCT00875524|6098102|P2|Received Vaccination 1|Overall Study||60
2487241|NCT00875524|6098103|P1|Received Vaccination 1|Overall Study||120
2487242|NCT00875524|6098102|P2|STARTED|Overall Study||60
2487243|NCT00875524|6098103|P1|STARTED|Overall Study||120
2487244|NCT00875485|6098121|P2|NOT COMPLETED|Challenge Dose Epoch||0
2487245|NCT00875485|6098122|P1|NOT COMPLETED|Challenge Dose Epoch||1
2487246|NCT00875485|6098121|P2|COMPLETED|Challenge Dose Epoch||11
2487247|NCT00875485|6098122|P1|COMPLETED|Challenge Dose Epoch||7
2487248|NCT00875485|6098121|P2|STARTED|Challenge Dose Epoch||11
2487249|NCT00875485|6098122|P1|STARTED|Challenge Dose Epoch||8
2487250|NCT00875485|6098121|P2|NOT COMPLETED|Year 15||0
2487251|NCT00875485|6098122|P1|NOT COMPLETED|Year 15||0
2487252|NCT00875485|6098121|P2|COMPLETED|Year 15||111
2487253|NCT00875485|6098122|P1|COMPLETED|Year 15||98
2487254|NCT00875485|6098121|P2|STARTED|Year 15||111
2487255|NCT00875485|6098122|P1|STARTED|Year 15||98
2487256|NCT00875485|6098121|P2|NOT COMPLETED|Year 14||0
2487257|NCT00875485|6098122|P1|NOT COMPLETED|Year 14||0
2487258|NCT00875485|6098121|P2|COMPLETED|Year 14||113
2487259|NCT00875485|6098122|P1|COMPLETED|Year 14||100
2487260|NCT00875485|6098121|P2|STARTED|Year 14||113
2487261|NCT00875485|6098122|P1|STARTED|Year 14||100
2487262|NCT00875485|6098121|P2|NOT COMPLETED|Year 13||0
2487263|NCT00875485|6098122|P1|NOT COMPLETED|Year 13||0
2487264|NCT00875485|6098121|P2|COMPLETED|Year 13||113
2487265|NCT00875485|6098122|P1|COMPLETED|Year 13||102
2487266|NCT00875485|6098121|P2|STARTED|Year 13||113
2487267|NCT00875485|6098122|P1|STARTED|Year 13||102
2487268|NCT00875485|6098121|P2|NOT COMPLETED|Year 12||0
2487269|NCT00875485|6098122|P1|NOT COMPLETED|Year 12||0
2487270|NCT00875485|6098121|P2|COMPLETED|Year 12||109
2487271|NCT00875485|6098122|P1|COMPLETED|Year 12||101
2487272|NCT00875485|6098121|P2|STARTED|Year 12||109
2487273|NCT00875485|6098122|P1|STARTED|Year 12||101
2487274|NCT00875485|6098121|P2|NOT COMPLETED|Year 11||0
2487275|NCT00875485|6098122|P1|NOT COMPLETED|Year 11||0
2487276|NCT00875485|6098121|P2|COMPLETED|Year 11||111
2487277|NCT00875485|6098122|P1|COMPLETED|Year 11||99
2487278|NCT00875485|6098121|P2|STARTED|Year 11||111
2487279|NCT00875485|6098122|P1|STARTED|Year 11||99
2487280|NCT00875433|6098162|P1|NOT COMPLETED|Overall Study||60
2487281|NCT00875433|6098162|P1|COMPLETED|Overall Study||0
2487282|NCT00875433|6098162|P1|STARTED|Overall Study|Treated|60
2487283|NCT00875420|6098192|P5|NOT COMPLETED|Overall Study||2
2487284|NCT00875420|6098193|P4|NOT COMPLETED|Overall Study||2
2487285|NCT00875420|6098194|P3|NOT COMPLETED|Overall Study||3
2487286|NCT00875420|6098195|P2|NOT COMPLETED|Overall Study||2
2487287|NCT00875420|6098196|P1|NOT COMPLETED|Overall Study||2
2487288|NCT00875420|6098192|P5|COMPLETED|Overall Study||17
2487289|NCT00875420|6098193|P4|COMPLETED|Overall Study||16
2487290|NCT00875420|6098194|P3|COMPLETED|Overall Study||18
2487291|NCT00875420|6098195|P2|COMPLETED|Overall Study||18
2487292|NCT00875420|6098196|P1|COMPLETED|Overall Study||20
2487293|NCT00875420|6098192|P5|STARTED|Overall Study||19
2487294|NCT00875420|6098193|P4|STARTED|Overall Study||18
2487295|NCT00875420|6098194|P3|STARTED|Overall Study||21
2487296|NCT00875420|6098195|P2|STARTED|Overall Study||20
2487297|NCT00875420|6098196|P1|STARTED|Overall Study||22
2487298|NCT00875394|6098226|P3|NOT COMPLETED|Overall Study||0
2487299|NCT00875394|6098227|P2|NOT COMPLETED|Overall Study||0
2487300|NCT00875394|6098228|P1|NOT COMPLETED|Overall Study||0
2487301|NCT00875394|6098226|P3|COMPLETED|Overall Study||9
2487302|NCT00875394|6098227|P2|COMPLETED|Overall Study||23
2487303|NCT00875394|6098228|P1|COMPLETED|Overall Study||36
2487304|NCT00875394|6098226|P3|STARTED|Overall Study||9
2487305|NCT00875394|6098227|P2|STARTED|Overall Study||23
2487306|NCT00875394|6098228|P1|STARTED|Overall Study||36
2487307|NCT00875329|6098236|P1|NOT COMPLETED|Overall Study||0
2487308|NCT00875329|6098236|P1|COMPLETED|Overall Study||97
2487309|NCT00875329|6098236|P1|STARTED|Overall Study||97
2487310|NCT00875277|6098240|P1|NOT COMPLETED|Overall Study||0
2487311|NCT00875277|6098240|P1|COMPLETED|Overall Study||24
2487312|NCT00875277|6098240|P1|STARTED|Overall Study||24
2487313|NCT00875212|6098321|P1|NOT COMPLETED|CaGP and Fluoride Dentifrice||0
2487314|NCT00875212|6098321|P1|COMPLETED|CaGP and Fluoride Dentifrice||12
2487315|NCT00875212|6098321|P1|STARTED|CaGP and Fluoride Dentifrice||12
2487316|NCT00875212|6098321|P1|NOT COMPLETED|Fluoride Only Dentifrice||0
2487317|NCT00875212|6098321|P1|COMPLETED|Fluoride Only Dentifrice||12
2487318|NCT00875212|6098321|P1|STARTED|Fluoride Only Dentifrice||12
2487319|NCT00875212|6098321|P1|NOT COMPLETED|CaGP Only Dentifrice||0
2487320|NCT00875212|6098321|P1|COMPLETED|CaGP Only Dentifrice||12
2487321|NCT00875212|6098321|P1|STARTED|CaGP Only Dentifrice||12
2487322|NCT00875212|6098321|P1|NOT COMPLETED|Placebo Dentifrice||0
2487323|NCT00875212|6098321|P1|COMPLETED|Placebo Dentifrice|all participants completed this group|12
2487324|NCT00875212|6098321|P1|STARTED|Placebo Dentifrice||12
2487325|NCT00875017|6098338|P6|NOT COMPLETED|Fourth Intervention||1
2487326|NCT00875017|6098339|P5|NOT COMPLETED|Fourth Intervention||0
2487327|NCT00875017|6098340|P4|NOT COMPLETED|Fourth Intervention||0
2487328|NCT00875017|6098341|P3|NOT COMPLETED|Fourth Intervention||0
2487329|NCT00875017|6098342|P2|NOT COMPLETED|Fourth Intervention||0
2487330|NCT00875017|6098343|P1|NOT COMPLETED|Fourth Intervention||0
2487331|NCT00875017|6098338|P6|COMPLETED|Fourth Intervention||4
2487332|NCT00875017|6098339|P5|COMPLETED|Fourth Intervention||3
2487333|NCT00875017|6098340|P4|COMPLETED|Fourth Intervention||4
2487334|NCT00875017|6098341|P3|COMPLETED|Fourth Intervention||2
2487335|NCT00875017|6098342|P2|COMPLETED|Fourth Intervention||3
2487336|NCT00875017|6098343|P1|COMPLETED|Fourth Intervention||3
2487337|NCT00875017|6098338|P6|STARTED|Fourth Intervention||5
2487338|NCT00875017|6098339|P5|STARTED|Fourth Intervention||3
2487339|NCT00875017|6098340|P4|STARTED|Fourth Intervention||4
2487340|NCT00875017|6098341|P3|STARTED|Fourth Intervention||2
2487341|NCT00875017|6098342|P2|STARTED|Fourth Intervention||3
2487342|NCT00875017|6098343|P1|STARTED|Fourth Intervention||3
2487343|NCT00875017|6098338|P6|NOT COMPLETED|Washout||0
2487344|NCT00875017|6098339|P5|NOT COMPLETED|Washout||1
2487345|NCT00875017|6098340|P4|NOT COMPLETED|Washout||0
2487346|NCT00875017|6098341|P3|NOT COMPLETED|Washout||0
2487347|NCT00875017|6098342|P2|NOT COMPLETED|Washout||0
2487348|NCT00875017|6098343|P1|NOT COMPLETED|Washout||0
2487349|NCT00875017|6098338|P6|COMPLETED|Washout||5
2487350|NCT00875017|6098339|P5|COMPLETED|Washout||3
2487351|NCT00875017|6098340|P4|COMPLETED|Washout||4
2487352|NCT00875017|6098341|P3|COMPLETED|Washout||2
2487353|NCT00875017|6098342|P2|COMPLETED|Washout||3
2487354|NCT00875017|6098343|P1|COMPLETED|Washout||3
2487355|NCT00875017|6098338|P6|STARTED|Washout||5
2487356|NCT00875017|6098339|P5|STARTED|Washout||4
2487357|NCT00875017|6098340|P4|STARTED|Washout||4
2487358|NCT00875017|6098341|P3|STARTED|Washout||2
2487359|NCT00875017|6098342|P2|STARTED|Washout||3
2487360|NCT00875017|6098343|P1|STARTED|Washout||3
2487361|NCT00875017|6098338|P6|NOT COMPLETED|Third Intervention||0
2487362|NCT00875017|6098339|P5|NOT COMPLETED|Third Intervention||0
2487363|NCT00875017|6098340|P4|NOT COMPLETED|Third Intervention||0
2487364|NCT00875017|6098341|P3|NOT COMPLETED|Third Intervention||1
2487365|NCT00875017|6098342|P2|NOT COMPLETED|Third Intervention||1
2487366|NCT00875017|6098343|P1|NOT COMPLETED|Third Intervention||0
2487367|NCT00875017|6098338|P6|COMPLETED|Third Intervention||5
2487368|NCT00875017|6098339|P5|COMPLETED|Third Intervention||4
2487369|NCT00875017|6098340|P4|COMPLETED|Third Intervention||4
2487370|NCT00875017|6098341|P3|COMPLETED|Third Intervention||2
2487371|NCT00875017|6098342|P2|COMPLETED|Third Intervention||3
2487372|NCT00875017|6098343|P1|COMPLETED|Third Intervention||3
2487373|NCT00875017|6098338|P6|STARTED|Third Intervention||5
2487374|NCT00875017|6098339|P5|STARTED|Third Intervention||4
2487375|NCT00875017|6098340|P4|STARTED|Third Intervention||4
2487376|NCT00875017|6098341|P3|STARTED|Third Intervention||3
2487377|NCT00875017|6098342|P2|STARTED|Third Intervention||4
2487378|NCT00875017|6098343|P1|STARTED|Third Intervention||3
2487379|NCT00875017|6098338|P6|NOT COMPLETED|Washout||0
2487380|NCT00875017|6098339|P5|NOT COMPLETED|Washout||0
2487381|NCT00875017|6098340|P4|NOT COMPLETED|Washout||0
2487382|NCT00875017|6098341|P3|NOT COMPLETED|Washout||0
2487383|NCT00875017|6098342|P2|NOT COMPLETED|Washout||1
2487384|NCT00875017|6098343|P1|NOT COMPLETED|Washout||0
2487385|NCT00875017|6098338|P6|COMPLETED|Washout||5
2487386|NCT00875017|6098339|P5|COMPLETED|Washout||4
2487387|NCT00875017|6098340|P4|COMPLETED|Washout||4
2487388|NCT00875017|6098341|P3|COMPLETED|Washout||3
2487389|NCT00875017|6098342|P2|COMPLETED|Washout||4
2487390|NCT00875017|6098343|P1|COMPLETED|Washout||3
2487391|NCT00875017|6098338|P6|STARTED|Washout||5
2487392|NCT00875017|6098339|P5|STARTED|Washout||4
2487393|NCT00875017|6098340|P4|STARTED|Washout||4
2487394|NCT00875017|6098341|P3|STARTED|Washout||3
2487395|NCT00875017|6098342|P2|STARTED|Washout||5
2487396|NCT00875017|6098343|P1|STARTED|Washout||3
2487397|NCT00875017|6098338|P6|NOT COMPLETED|Second Intervention||0
2487398|NCT00875017|6098339|P5|NOT COMPLETED|Second Intervention||0
2487399|NCT00875017|6098340|P4|NOT COMPLETED|Second Intervention||1
2487400|NCT00875017|6098341|P3|NOT COMPLETED|Second Intervention||0
2487401|NCT00875017|6098342|P2|NOT COMPLETED|Second Intervention||0
2487402|NCT00875017|6098343|P1|NOT COMPLETED|Second Intervention||0
2487403|NCT00875017|6098338|P6|COMPLETED|Second Intervention||5
2487404|NCT00875017|6098339|P5|COMPLETED|Second Intervention||4
2487405|NCT00875017|6098340|P4|COMPLETED|Second Intervention||4
2487406|NCT00875017|6098341|P3|COMPLETED|Second Intervention||3
2487407|NCT00875017|6098342|P2|COMPLETED|Second Intervention||5
2487408|NCT00875017|6098343|P1|COMPLETED|Second Intervention||3
2487409|NCT00875017|6098338|P6|STARTED|Second Intervention||5
2487410|NCT00875017|6098339|P5|STARTED|Second Intervention||4
2487411|NCT00875017|6098340|P4|STARTED|Second Intervention||5
2487412|NCT00875017|6098341|P3|STARTED|Second Intervention||3
2487413|NCT00875017|6098342|P2|STARTED|Second Intervention||5
2487414|NCT00875017|6098343|P1|STARTED|Second Intervention||3
2487415|NCT00875017|6098338|P6|NOT COMPLETED|Washout||0
2487416|NCT00875017|6098339|P5|NOT COMPLETED|Washout||0
2487417|NCT00875017|6098340|P4|NOT COMPLETED|Washout||0
2487418|NCT00875017|6098341|P3|NOT COMPLETED|Washout||1
2487419|NCT00875017|6098342|P2|NOT COMPLETED|Washout||0
2487420|NCT00875017|6098343|P1|NOT COMPLETED|Washout||0
2487421|NCT00875017|6098338|P6|COMPLETED|Washout||5
2487422|NCT00875017|6098339|P5|COMPLETED|Washout||4
2487423|NCT00875017|6098340|P4|COMPLETED|Washout||5
2487424|NCT00875017|6098341|P3|COMPLETED|Washout||3
2487425|NCT00875017|6098342|P2|COMPLETED|Washout||5
2487426|NCT00875017|6098343|P1|COMPLETED|Washout||3
2487427|NCT00875017|6098338|P6|STARTED|Washout||5
2487428|NCT00875017|6098339|P5|STARTED|Washout||4
2487429|NCT00875017|6098340|P4|STARTED|Washout||5
2487430|NCT00875017|6098341|P3|STARTED|Washout||4
2487431|NCT00875017|6098342|P2|STARTED|Washout||5
2487432|NCT00875017|6098343|P1|STARTED|Washout||3
2487433|NCT00875017|6098338|P6|NOT COMPLETED|First Intervention||0
2487434|NCT00875017|6098339|P5|NOT COMPLETED|First Intervention||1
2487435|NCT00875017|6098340|P4|NOT COMPLETED|First Intervention||1
2487436|NCT00875017|6098341|P3|NOT COMPLETED|First Intervention||1
2487437|NCT00875017|6098342|P2|NOT COMPLETED|First Intervention||0
2487438|NCT00875017|6098343|P1|NOT COMPLETED|First Intervention||2
2487439|NCT00875017|6098338|P6|COMPLETED|First Intervention||5
2487440|NCT00875017|6098339|P5|COMPLETED|First Intervention||4
2487441|NCT00875017|6098340|P4|COMPLETED|First Intervention||5
2487442|NCT00875017|6098341|P3|COMPLETED|First Intervention||4
2487443|NCT00875017|6098342|P2|COMPLETED|First Intervention||5
2487444|NCT00875017|6098343|P1|COMPLETED|First Intervention||3
2487445|NCT00875017|6098338|P6|STARTED|First Intervention||5
2487446|NCT00875017|6098339|P5|STARTED|First Intervention||5
2487447|NCT00875017|6098340|P4|STARTED|First Intervention||6
2487448|NCT00875017|6098341|P3|STARTED|First Intervention||5
2487449|NCT00875017|6098342|P2|STARTED|First Intervention||5
2487450|NCT00875017|6098343|P1|STARTED|First Intervention||5
2487451|NCT00874939|6098357|P1|NOT COMPLETED|Overall Study||4
2487452|NCT00874939|6098357|P1|COMPLETED|Overall Study||0
2487453|NCT00874939|6098357|P1|Treated|Overall Study||0
2487454|NCT00874939|6098357|P1|STARTED|Overall Study||4
2487455|NCT00874887|6098373|P2|NOT COMPLETED|Overall Study||0
2487456|NCT00874887|6098374|P1|NOT COMPLETED|Overall Study||0
2487457|NCT00874887|6098373|P2|COMPLETED|Overall Study||34
2487458|NCT00874887|6098374|P1|COMPLETED|Overall Study||32
2487459|NCT00874887|6098373|P2|STARTED|Overall Study||34
2487460|NCT00874887|6098374|P1|STARTED|Overall Study||32
2487461|NCT00874848|6098390|P2|NOT COMPLETED|Overall Study||28
2487462|NCT00874848|6098391|P1|NOT COMPLETED|Overall Study||59
2487463|NCT00874848|6098390|P2|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|1
2487464|NCT00874848|6098391|P1|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|0
2487465|NCT00874848|6098390|P2|Discontinued|Overall Study||28
2487466|NCT00874848|6098391|P1|Discontinued|Overall Study||59
2487467|NCT00874848|6098390|P2|STARTED|Overall Study||29
2487468|NCT00874848|6098391|P1|STARTED|Overall Study||59
2487469|NCT00874822|6098407|P1|NOT COMPLETED|Overall Study||8
2487470|NCT00874822|6098407|P1|COMPLETED|Overall Study||208
2487471|NCT00874822|6098407|P1|STARTED|Overall Study||216
2487472|NCT00874770|6098415|P4|NOT COMPLETED|Overall Study||5
2487473|NCT00874770|6098416|P3|NOT COMPLETED|Overall Study||4
2487474|NCT00874770|6098417|P2|NOT COMPLETED|Overall Study||1
2487475|NCT00874770|6098418|P1|NOT COMPLETED|Overall Study||5
2487476|NCT00874770|6098415|P4|COMPLETED|Overall Study||7
2487477|NCT00874770|6098416|P3|COMPLETED|Overall Study||8
2487478|NCT00874770|6098417|P2|COMPLETED|Overall Study||11
2487479|NCT00874770|6098418|P1|COMPLETED|Overall Study||7
2487480|NCT00874770|6098415|P4|STARTED|Overall Study||12
2487481|NCT00874770|6098416|P3|STARTED|Overall Study||12
2487482|NCT00874770|6098417|P2|STARTED|Overall Study||12
2487483|NCT00874770|6098418|P1|STARTED|Overall Study||12
2487484|NCT00874731|6098452|P3|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||22
2487485|NCT00874731|6098453|P2|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||0
2487486|NCT00874731|6098454|P1|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||0
2487487|NCT00874731|6098452|P3|COMPLETED|Part 2: Ridaforolimus 40 mg||0
2487488|NCT00874731|6098453|P2|COMPLETED|Part 2: Ridaforolimus 40 mg||0
2487489|NCT00874731|6098454|P1|COMPLETED|Part 2: Ridaforolimus 40 mg||0
2487490|NCT00874731|6098452|P3|STARTED|Part 2: Ridaforolimus 40 mg|Participants completing Pt 1 and washout, started this period in “Pt 2. Ridaforolimus 40 mg” arm.|22
2487491|NCT00874731|6098453|P2|STARTED|Part 2: Ridaforolimus 40 mg|Participants completing Pt 1 and washout, enter into the “Pt 2. Ridaforolimus 40 mg” arm.|0
2487492|NCT00874731|6098454|P1|STARTED|Part 2: Ridaforolimus 40 mg||0
2487493|NCT00874731|6098452|P3|NOT COMPLETED|Washout Period||0
2487494|NCT00874731|6098453|P2|NOT COMPLETED|Washout Period||0
2487495|NCT00874731|6098454|P1|NOT COMPLETED|Washout Period||0
2487496|NCT00874731|6098452|P3|COMPLETED|Washout Period||0
2487497|NCT00874731|6098453|P2|COMPLETED|Washout Period||22
2487498|NCT00874731|6098454|P1|COMPLETED|Washout Period||0
2487499|NCT00874731|6098452|P3|STARTED|Washout Period||0
2487500|NCT00874731|6098453|P2|STARTED|Washout Period||22
2487501|NCT00874731|6098454|P1|STARTED|Washout Period||0
2487502|NCT00874731|6098452|P3|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
2487503|NCT00874731|6098453|P2|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
2487504|NCT00874731|6098454|P1|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
2487505|NCT00874731|6098452|P3|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
2487506|NCT00874731|6098453|P2|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||22
2487507|NCT00874731|6098454|P1|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
2487508|NCT00874731|6098452|P3|STARTED|Part 1, Day 2: Ridaforolimus 100 mg||0
2487509|NCT00874731|6098453|P2|STARTED|Part 1, Day 2: Ridaforolimus 100 mg|Participants completing Pt 1, Day 1, started this period in “Pt 1, Day 2. Ridaforolimus 100 mg” arm.|22
2487510|NCT00874731|6098454|P1|STARTED|Part 1, Day 2: Ridaforolimus 100 mg|Participants completing Pt 1, Day 1, enter into the “Pt 1, Day 2. Ridaforolimus 100 mg” arm.|0
2487511|NCT00874731|6098452|P3|NOT COMPLETED|Part 1, Day 1: Placebo||0
2487512|NCT00874731|6098453|P2|NOT COMPLETED|Part 1, Day 1: Placebo||0
2487513|NCT00874731|6098454|P1|NOT COMPLETED|Part 1, Day 1: Placebo||1
2487514|NCT00874731|6098452|P3|COMPLETED|Part 1, Day 1: Placebo||0
2487515|NCT00874731|6098453|P2|COMPLETED|Part 1, Day 1: Placebo||0
2487516|NCT00874731|6098454|P1|COMPLETED|Part 1, Day 1: Placebo||22
2487517|NCT00874731|6098452|P3|STARTED|Part 1, Day 1: Placebo||0
2487518|NCT00874731|6098453|P2|STARTED|Part 1, Day 1: Placebo||0
2487519|NCT00874731|6098454|P1|STARTED|Part 1, Day 1: Placebo||23
2487525|NCT00874549|6098495|P4|NOT COMPLETED|Overall Study||2
2487526|NCT00874549|6098496|P3|NOT COMPLETED|Overall Study||4
2487527|NCT00874549|6098497|P2|NOT COMPLETED|Overall Study||1
2487528|NCT00874549|6098498|P1|NOT COMPLETED|Overall Study||1
2487529|NCT00874549|6098495|P4|COMPLETED|Overall Study||56
2487530|NCT00874549|6098496|P3|COMPLETED|Overall Study||47
2487531|NCT00874549|6098497|P2|COMPLETED|Overall Study||55
2487532|NCT00874549|6098498|P1|COMPLETED|Overall Study||50
2487533|NCT00874549|6098495|P4|STARTED|Overall Study||58
2487534|NCT00874549|6098496|P3|STARTED|Overall Study||51
2487535|NCT00874549|6098497|P2|STARTED|Overall Study||56
2487536|NCT00874549|6098498|P1|STARTED|Overall Study||51
2487537|NCT00874510|6098566|P2|NOT COMPLETED|Year 2||0
2487538|NCT00874510|6098567|P1|NOT COMPLETED|Year 2||0
2487539|NCT00874510|6098566|P2|COMPLETED|Year 2||87
2487540|NCT00874510|6098567|P1|COMPLETED|Year 2||92
2487541|NCT00874510|6098566|P2|STARTED|Year 2||87
2487542|NCT00874510|6098567|P1|STARTED|Year 2||92
2487543|NCT00874510|6098566|P2|NOT COMPLETED|Year 1||0
2487544|NCT00874510|6098567|P1|NOT COMPLETED|Year 1||0
2487545|NCT00874510|6098566|P2|COMPLETED|Year 1||85
2487546|NCT00874510|6098567|P1|COMPLETED|Year 1||88
2487547|NCT00874510|6098566|P2|STARTED|Year 1||85
2487548|NCT00874510|6098567|P1|STARTED|Year 1||88
2487549|NCT00874497|6098575|P2|NOT COMPLETED|Overall Study||18
2487550|NCT00874497|6098576|P1|NOT COMPLETED|Overall Study||28
2487551|NCT00874497|6098575|P2|COMPLETED|Overall Study||15
2487552|NCT00874497|6098576|P1|COMPLETED|Overall Study||23
2487553|NCT00874497|6098575|P2|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|33
2487554|NCT00874497|6098576|P1|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|51
2487555|NCT00874276|6098616|P2|NOT COMPLETED|Overall Study||1
2487556|NCT00874276|6098617|P1|NOT COMPLETED|Overall Study||1
2487557|NCT00874276|6098616|P2|COMPLETED|Overall Study||7
2487558|NCT00874276|6098617|P1|COMPLETED|Overall Study||5
2487559|NCT00874276|6098616|P2|STARTED|Overall Study||8
2487560|NCT00874276|6098617|P1|STARTED|Overall Study||6
2487561|NCT00874250|6098625|P1|NOT COMPLETED|Overall Study||51
2487562|NCT00874250|6098625|P1|COMPLETED|Overall Study||0
2487563|NCT00874250|6098625|P1|STARTED|Overall Study||51
2487564|NCT00874237|6098637|P6|NOT COMPLETED|Overall Study||0
2487565|NCT00874237|6098638|P5|NOT COMPLETED|Overall Study||0
2487566|NCT00874237|6098639|P4|NOT COMPLETED|Overall Study||0
2487567|NCT00874237|6098640|P3|NOT COMPLETED|Overall Study||1
2487568|NCT00874237|6098641|P2|NOT COMPLETED|Overall Study||1
2487569|NCT00874237|6098642|P1|NOT COMPLETED|Overall Study||0
2487570|NCT00874237|6098637|P6|COMPLETED|Overall Study||8
2487571|NCT00874237|6098638|P5|COMPLETED|Overall Study||8
2487572|NCT00874237|6098639|P4|COMPLETED|Overall Study||8
2487573|NCT00874237|6098640|P3|COMPLETED|Overall Study||7
2487574|NCT00874237|6098641|P2|COMPLETED|Overall Study||7
2487575|NCT00874237|6098642|P1|COMPLETED|Overall Study||8
2487576|NCT00874237|6098637|P6|STARTED|Overall Study||8
2487577|NCT00874237|6098638|P5|STARTED|Overall Study||8
2487578|NCT00874237|6098639|P4|STARTED|Overall Study||8
2487579|NCT00874237|6098640|P3|STARTED|Overall Study||8
2487580|NCT00874237|6098641|P2|STARTED|Overall Study||8
2487581|NCT00874237|6098642|P1|STARTED|Overall Study||8
2487582|NCT00874120|6098660|P2|NOT COMPLETED|Second Intervention||0
2487583|NCT00874120|6098661|P1|NOT COMPLETED|Second Intervention||2
2487584|NCT00874120|6098660|P2|COMPLETED|Second Intervention||56
2487585|NCT00874120|6098661|P1|COMPLETED|Second Intervention||50
2487586|NCT00874120|6098660|P2|STARTED|Second Intervention||56
2487587|NCT00874120|6098661|P1|STARTED|Second Intervention||52
2487588|NCT00874120|6098660|P2|NOT COMPLETED|Wash-out Period||0
2487589|NCT00874120|6098661|P1|NOT COMPLETED|Wash-out Period||0
2487590|NCT00874120|6098660|P2|COMPLETED|Wash-out Period||56
2487591|NCT00874120|6098661|P1|COMPLETED|Wash-out Period||52
2487592|NCT00874120|6098660|P2|STARTED|Wash-out Period||56
2487593|NCT00874120|6098661|P1|STARTED|Wash-out Period||52
2487594|NCT00874120|6098660|P2|NOT COMPLETED|First Intervention||2
2487595|NCT00874120|6098661|P1|NOT COMPLETED|First Intervention||6
2487596|NCT00874120|6098660|P2|COMPLETED|First Intervention||56
2487597|NCT00874120|6098661|P1|COMPLETED|First Intervention||52
2487598|NCT00874120|6098660|P2|STARTED|First Intervention||58
2487599|NCT00874120|6098661|P1|STARTED|First Intervention||58
2487600|NCT00874094|6098667|P1|NOT COMPLETED|Overall Study||0
2487601|NCT00874094|6098667|P1|COMPLETED|Overall Study||15
2487602|NCT00874094|6098667|P1|STARTED|Overall Study||15
2487603|NCT00874029|6098674|P1|NOT COMPLETED|Overall Study||21
2487604|NCT00874029|6098674|P1|COMPLETED|Overall Study||116
2487605|NCT00874029|6098674|P1|STARTED|Overall Study||137
2487606|NCT00873912|6098690|P2|NOT COMPLETED|Overall Study||0
2487607|NCT00873912|6098691|P1|NOT COMPLETED|Overall Study||3
2487608|NCT00873912|6098690|P2|COMPLETED|Overall Study||60
2487609|NCT00873912|6098691|P1|COMPLETED|Overall Study||237
2487610|NCT00873912|6098690|P2|STARTED|Overall Study||60
2487611|NCT00873912|6098691|P1|STARTED|Overall Study||240
2487612|NCT00873873|6098709|P4|NOT COMPLETED|Overall Study||0
2487613|NCT00873873|6098710|P3|NOT COMPLETED|Overall Study||0
2487614|NCT00873873|6098711|P2|NOT COMPLETED|Overall Study||0
2487615|NCT00873873|6098712|P1|NOT COMPLETED|Overall Study||0
2487616|NCT00873873|6098709|P4|COMPLETED|Overall Study||18
2487617|NCT00873873|6098710|P3|COMPLETED|Overall Study||9
2487618|NCT00873873|6098711|P2|COMPLETED|Overall Study||8
2487619|NCT00873873|6098712|P1|COMPLETED|Overall Study||20
2487620|NCT00873873|6098709|P4|STARTED|Overall Study||18
2487621|NCT00873873|6098710|P3|STARTED|Overall Study||9
2487622|NCT00873873|6098711|P2|STARTED|Overall Study||8
2487623|NCT00873873|6098712|P1|STARTED|Overall Study||20
2487624|NCT00873860|6098730|P4|NOT COMPLETED|Overall Study||1
2487625|NCT00873860|6098731|P3|NOT COMPLETED|Overall Study||3
2487626|NCT00873860|6098732|P2|NOT COMPLETED|Overall Study||0
2487627|NCT00873860|6098733|P1|NOT COMPLETED|Overall Study||4
2487628|NCT00873860|6098730|P4|COMPLETED|Overall Study||47
2487629|NCT00873860|6098731|P3|COMPLETED|Overall Study||48
2487630|NCT00873860|6098732|P2|COMPLETED|Overall Study||47
2487631|NCT00873860|6098733|P1|COMPLETED|Overall Study||44
2487632|NCT00873860|6098730|P4|Treated|Overall Study||48
2487633|NCT00873860|6098731|P3|Treated|Overall Study||51
2487634|NCT00873860|6098732|P2|Treated|Overall Study||47
2487635|NCT00873860|6098733|P1|Treated|Overall Study||47
2487636|NCT00873860|6098730|P4|STARTED|Overall Study||48
2487637|NCT00873860|6098731|P3|STARTED|Overall Study||51
2487638|NCT00873860|6098732|P2|STARTED|Overall Study||47
2487639|NCT00873860|6098733|P1|STARTED|Overall Study||48
2487640|NCT00873821|6098804|P2|NOT COMPLETED|Overall Study||0
2487641|NCT00873821|6098805|P1|NOT COMPLETED|Overall Study||0
2487642|NCT00873821|6098804|P2|COMPLETED|Overall Study||22
2487643|NCT00873821|6098805|P1|COMPLETED|Overall Study||22
2487644|NCT00873821|6098804|P2|STARTED|Overall Study||22
2487645|NCT00873821|6098805|P1|STARTED|Overall Study||22
2487646|NCT00873782|6098815|P1|NOT COMPLETED|Overall Study||0
2487647|NCT00873782|6098815|P1|COMPLETED|Overall Study||16
2487648|NCT00873782|6098815|P1|STARTED|Overall Study||16
2487649|NCT00873730|6098821|P2|NOT COMPLETED|Overall Study||5
2487650|NCT00873730|6098822|P1|NOT COMPLETED|Overall Study||6
2487651|NCT00873730|6098821|P2|COMPLETED|Overall Study||49
2487652|NCT00873730|6098822|P1|COMPLETED|Overall Study||48
2487653|NCT00873730|6098821|P2|STARTED|Overall Study||54
2487654|NCT00873730|6098822|P1|STARTED|Overall Study||54
2487655|NCT00873457|6098858|P1|NOT COMPLETED|Overall Study||0
2487656|NCT00873457|6098858|P1|COMPLETED|Overall Study||16
2487657|NCT00873457|6098858|P1|STARTED|Overall Study||16
2487658|NCT00873366|6098865|P1|NOT COMPLETED|Overall Study||6
2487659|NCT00873366|6098865|P1|COMPLETED|Overall Study||71
2487660|NCT00873366|6098865|P1|STARTED|Overall Study||77
2487661|NCT00873327|6098884|P1|NOT COMPLETED|Overall Study||0
2487662|NCT00873327|6098884|P1|COMPLETED|Overall Study||32
2487663|NCT00873327|6098884|P1|STARTED|Overall Study||32
2487664|NCT00873119|6098890|P2|NOT COMPLETED|Overall Study||26
2487665|NCT00873119|6098891|P1|NOT COMPLETED|Overall Study||44
2487666|NCT00873119|6098890|P2|COMPLETED|Overall Study||19
2487667|NCT00873119|6098891|P1|COMPLETED|Overall Study|Of 42 patients treated with belinostat, 23 patients received 6 or more treatment cycles.|0
2487668|NCT00873119|6098890|P2|STARTED|Overall Study||45
2487669|NCT00873119|6098891|P1|STARTED|Overall Study||44
2487670|NCT00873093|6098912|P5|NOT COMPLETED|Overall Study||2
2487671|NCT00873093|6098913|P4|NOT COMPLETED|Overall Study||11
2487672|NCT00873093|6098914|P3|NOT COMPLETED|Overall Study||16
2487673|NCT00873093|6098915|P2|NOT COMPLETED|Overall Study||27
2487674|NCT00873093|6098916|P1|NOT COMPLETED|Overall Study||1
2487675|NCT00873093|6098912|P5|COMPLETED|Overall Study||8
2487676|NCT00873093|6098913|P4|COMPLETED|Overall Study||12
2487677|NCT00873093|6098914|P3|COMPLETED|Overall Study||33
2487678|NCT00873093|6098915|P2|COMPLETED|Overall Study||35
2487679|NCT00873093|6098916|P1|COMPLETED|Overall Study||3
2487680|NCT00873093|6098912|P5|STARTED|Overall Study||10
2487681|NCT00873093|6098913|P4|STARTED|Overall Study||23
2487682|NCT00873093|6098914|P3|STARTED|Overall Study||49
2487683|NCT00873093|6098915|P2|STARTED|Overall Study||62
2487684|NCT00873093|6098916|P1|STARTED|Overall Study||4
2487685|NCT00873041|6098973|P3|NOT COMPLETED|Extension Study||2
2487686|NCT00873041|6098974|P2|NOT COMPLETED|Extension Study||0
2487687|NCT00873041|6098975|P1|NOT COMPLETED|Extension Study||1
2487688|NCT00873041|6098973|P3|COMPLETED|Extension Study||46
2487689|NCT00873041|6098974|P2|COMPLETED|Extension Study||44
2487690|NCT00873041|6098975|P1|COMPLETED|Extension Study||40
2487691|NCT00873041|6098973|P3|STARTED|Extension Study||48
2487692|NCT00873041|6098974|P2|STARTED|Extension Study||44
2487693|NCT00873041|6098975|P1|STARTED|Extension Study||41
2487694|NCT00873041|6098973|P3|NOT COMPLETED|Core Study||5
2487695|NCT00873041|6098974|P2|NOT COMPLETED|Core Study||6
2487696|NCT00873041|6098975|P1|NOT COMPLETED|Core Study||7
2487697|NCT00873041|6098973|P3|COMPLETED|Core Study||51
2487698|NCT00873041|6098974|P2|COMPLETED|Core Study||49
2487699|NCT00873041|6098975|P1|COMPLETED|Core Study||48
2487700|NCT00873041|6098973|P3|STARTED|Core Study||56
2487701|NCT00873041|6098974|P2|STARTED|Core Study||55
2487702|NCT00873041|6098975|P1|STARTED|Core Study||55
2487703|NCT00873015|6099033|P4|NOT COMPLETED|Overall Study||0
2487704|NCT00873015|6099034|P3|NOT COMPLETED|Overall Study||0
2487705|NCT00873015|6099035|P2|NOT COMPLETED|Overall Study||1
2487706|NCT00873015|6099036|P1|NOT COMPLETED|Overall Study||0
2487707|NCT00873015|6099033|P4|COMPLETED|Overall Study||3
2487708|NCT00873015|6099034|P3|COMPLETED|Overall Study||3
2487709|NCT00873015|6099035|P2|COMPLETED|Overall Study||3
2487710|NCT00873015|6099036|P1|COMPLETED|Overall Study||9
2487711|NCT00873015|6099033|P4|STARTED|Overall Study||3
2487712|NCT00873015|6099034|P3|STARTED|Overall Study||3
2487713|NCT00873015|6099035|P2|STARTED|Overall Study||4
2487714|NCT00873015|6099036|P1|STARTED|Overall Study||9
2487715|NCT00872989|6099045|P2|NOT COMPLETED|Overall Study||63
2487716|NCT00872989|6099046|P1|NOT COMPLETED|Overall Study||65
2487717|NCT00872989|6099045|P2|COMPLETED|Overall Study||0
2487718|NCT00872989|6099046|P1|COMPLETED|Overall Study||1
2487719|NCT00872989|6099045|P2|STARTED|Overall Study||63
2487720|NCT00872989|6099046|P1|STARTED|Overall Study||66
2487721|NCT00872898|6099065|P2|NOT COMPLETED|Part Two - Double Blind||6
2487722|NCT00872898|6099066|P1|NOT COMPLETED|Part Two - Double Blind||11
2487723|NCT00872898|6099065|P2|COMPLETED|Part Two - Double Blind||54
2487724|NCT00872898|6099066|P1|COMPLETED|Part Two - Double Blind||50
2487725|NCT00872898|6099065|P2|STARTED|Part Two - Double Blind||60
2487726|NCT00872898|6099066|P1|STARTED|Part Two - Double Blind||61
2487727|NCT00872898|6099065|P2|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
2487728|NCT00872898|6099066|P1|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
2487729|NCT00872898|6099065|P2|COMPLETED|Part One - Open Label, Pharmacokinetics||4
2487730|NCT00872898|6099066|P1|COMPLETED|Part One - Open Label, Pharmacokinetics||0
2487731|NCT00872898|6099065|P2|STARTED|Part One - Open Label, Pharmacokinetics||4
2487732|NCT00872898|6099066|P1|STARTED|Part One - Open Label, Pharmacokinetics||0
2487733|NCT00872833|6099100|P2|NOT COMPLETED|Overall Study||0
2487734|NCT00872833|6099101|P1|NOT COMPLETED|Overall Study||0
2487735|NCT00872833|6099100|P2|COMPLETED|Overall Study||17
2487736|NCT00872833|6099101|P1|COMPLETED|Overall Study||15
2487737|NCT00872833|6099100|P2|STARTED|Overall Study||17
2487738|NCT00872833|6099101|P1|STARTED|Overall Study||15
2487739|NCT00872729|6099110|P1|NOT COMPLETED|Overall Study||0
2487740|NCT00872729|6099110|P1|COMPLETED|Overall Study||9
2487741|NCT00872729|6099110|P1|STARTED|Overall Study||9
2487742|NCT00872599|6099140|P2|NOT COMPLETED|Second Drug During High Salt Intake||0
2487743|NCT00872599|6099141|P1|NOT COMPLETED|Second Drug During High Salt Intake||0
2487744|NCT00872599|6099140|P2|COMPLETED|Second Drug During High Salt Intake||16
2487745|NCT00872599|6099141|P1|COMPLETED|Second Drug During High Salt Intake||15
2487746|NCT00872599|6099140|P2|STARTED|Second Drug During High Salt Intake||16
2487747|NCT00872599|6099141|P1|STARTED|Second Drug During High Salt Intake||15
2487748|NCT00872599|6099140|P2|NOT COMPLETED|Second Washout Period||1
2487749|NCT00872599|6099141|P1|NOT COMPLETED|Second Washout Period||1
2487750|NCT00872599|6099140|P2|COMPLETED|Second Washout Period||16
2487751|NCT00872599|6099141|P1|COMPLETED|Second Washout Period||15
2487752|NCT00872599|6099140|P2|STARTED|Second Washout Period||17
2487753|NCT00872599|6099141|P1|STARTED|Second Washout Period||16
2487754|NCT00872599|6099140|P2|NOT COMPLETED|First Drug During High Salt Intake||0
2487755|NCT00872599|6099141|P1|NOT COMPLETED|First Drug During High Salt Intake||0
2487756|NCT00872599|6099140|P2|COMPLETED|First Drug During High Salt Intake||17
2487757|NCT00872599|6099141|P1|COMPLETED|First Drug During High Salt Intake||16
2487758|NCT00872599|6099140|P2|STARTED|First Drug During High Salt Intake||17
2487759|NCT00872599|6099141|P1|STARTED|First Drug During High Salt Intake||16
2487760|NCT00872599|6099140|P2|NOT COMPLETED|First Washout Period After Low Salt||0
2487761|NCT00872599|6099141|P1|NOT COMPLETED|First Washout Period After Low Salt||0
2487762|NCT00872599|6099140|P2|COMPLETED|First Washout Period After Low Salt||17
2487763|NCT00872599|6099141|P1|COMPLETED|First Washout Period After Low Salt||16
2487764|NCT00872599|6099140|P2|STARTED|First Washout Period After Low Salt||17
2487765|NCT00872599|6099141|P1|STARTED|First Washout Period After Low Salt||16
2487766|NCT00872534|6099151|P2|NOT COMPLETED|Overall Study||3
2487767|NCT00872534|6099152|P1|NOT COMPLETED|Overall Study||3
2487768|NCT00872534|6099151|P2|COMPLETED|Overall Study||101
2487769|NCT00872534|6099152|P1|COMPLETED|Overall Study||97
2487770|NCT00872534|6099151|P2|STARTED|Overall Study||104
2487771|NCT00872534|6099152|P1|STARTED|Overall Study||100
2487772|NCT00872521|6099161|P3|NOT COMPLETED|Secondary Endpoint Analysis||1
2487773|NCT00872521|6099162|P2|NOT COMPLETED|Secondary Endpoint Analysis||2
2487774|NCT00872521|6099163|P1|NOT COMPLETED|Secondary Endpoint Analysis||0
2487775|NCT00872521|6099161|P3|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|7
2487776|NCT00872521|6099162|P2|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|58
2487777|NCT00872521|6099163|P1|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|20
2487778|NCT00872521|6099161|P3|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|8
2487779|NCT00872521|6099162|P2|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|60
2487780|NCT00872521|6099163|P1|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|20
2487781|NCT00872521|6099161|P3|NOT COMPLETED|Completed 3-month Follow up||0
2487782|NCT00872521|6099162|P2|NOT COMPLETED|Completed 3-month Follow up||3
2487783|NCT00872521|6099163|P1|NOT COMPLETED|Completed 3-month Follow up||0
2487784|NCT00872521|6099161|P3|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|8
2487785|NCT00872521|6099162|P2|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|60
2487786|NCT00872521|6099163|P1|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|20
2487787|NCT00872521|6099161|P3|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|8
2487788|NCT00872521|6099162|P2|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|63
2487789|NCT00872521|6099163|P1|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|20
2487790|NCT00872521|6099161|P3|NOT COMPLETED|Primary Endpoint Analysis||1
2487791|NCT00872521|6099162|P2|NOT COMPLETED|Primary Endpoint Analysis||5
2487792|NCT00872521|6099163|P1|NOT COMPLETED|Primary Endpoint Analysis||1
2487793|NCT00872521|6099161|P3|COMPLETED|Primary Endpoint Analysis|participants analyzed|8
2487794|NCT00872521|6099162|P2|COMPLETED|Primary Endpoint Analysis|participants analyzed|63
2487795|NCT00872521|6099163|P1|COMPLETED|Primary Endpoint Analysis|participants analyzed|20
2487796|NCT00872521|6099161|P3|STARTED|Primary Endpoint Analysis|Completed PAD induction|9
2487797|NCT00872521|6099162|P2|STARTED|Primary Endpoint Analysis|Completed PAD induction|68
2487798|NCT00872521|6099163|P1|STARTED|Primary Endpoint Analysis|Completed PAD induction|21
2487799|NCT00872521|6099161|P3|NOT COMPLETED|Completed PAD Induction||0
2487800|NCT00872521|6099162|P2|NOT COMPLETED|Completed PAD Induction||4
2487801|NCT00872521|6099163|P1|NOT COMPLETED|Completed PAD Induction||5
2487802|NCT00872521|6099161|P3|COMPLETED|Completed PAD Induction|Completed PAD induction|9
2487803|NCT00872521|6099162|P2|COMPLETED|Completed PAD Induction|Completed PAD induction|68
2487804|NCT00872521|6099163|P1|COMPLETED|Completed PAD Induction|Completed PAD induction|21
2487805|NCT00872521|6099161|P3|STARTED|Completed PAD Induction|Received allocated treatment|9
2487806|NCT00872521|6099162|P2|STARTED|Completed PAD Induction|Received allocated treatment|72
2487807|NCT00872521|6099163|P1|STARTED|Completed PAD Induction|Received allocated treatment|26
2487808|NCT00872430|6099211|P2|NOT COMPLETED|Second Intervention||0
2487809|NCT00872430|6099212|P1|NOT COMPLETED|Second Intervention||0
2487810|NCT00872430|6099211|P2|COMPLETED|Second Intervention||10
2487811|NCT00872430|6099212|P1|COMPLETED|Second Intervention||10
2487812|NCT00872430|6099211|P2|STARTED|Second Intervention||10
2487813|NCT00872430|6099212|P1|STARTED|Second Intervention||10
2487814|NCT00872430|6099211|P2|NOT COMPLETED|Washout Period||0
2487815|NCT00872430|6099212|P1|NOT COMPLETED|Washout Period||0
2487816|NCT00872430|6099211|P2|COMPLETED|Washout Period||10
2487817|NCT00872430|6099212|P1|COMPLETED|Washout Period||10
2487818|NCT00872430|6099211|P2|STARTED|Washout Period||10
2487819|NCT00872430|6099212|P1|STARTED|Washout Period||10
2487820|NCT00872430|6099211|P2|NOT COMPLETED|First Intervention||0
2487821|NCT00872430|6099212|P1|NOT COMPLETED|First Intervention||0
2487822|NCT00872430|6099211|P2|COMPLETED|First Intervention||10
2487823|NCT00872430|6099212|P1|COMPLETED|First Intervention||10
2487824|NCT00872430|6099211|P2|STARTED|First Intervention||10
2487825|NCT00872430|6099212|P1|STARTED|First Intervention||10
2487826|NCT00872339|6099221|P3|NOT COMPLETED|Overall Study||0
2487827|NCT00872339|6099222|P2|NOT COMPLETED|Overall Study||0
2487828|NCT00872339|6099223|P1|NOT COMPLETED|Overall Study||0
2487829|NCT00872339|6099221|P3|COMPLETED|Overall Study||37
2487830|NCT00872339|6099222|P2|COMPLETED|Overall Study||14
2487831|NCT00872339|6099223|P1|COMPLETED|Overall Study||201
2487832|NCT00872339|6099221|P3|STARTED|Overall Study||37
2487833|NCT00872339|6099222|P2|STARTED|Overall Study||14
2487834|NCT00872339|6099223|P1|STARTED|Overall Study||201
2487835|NCT00872170|6099234|P2|NOT COMPLETED|Overall Study||0
2487836|NCT00872170|6099235|P1|NOT COMPLETED|Overall Study||1
2487837|NCT00872170|6099234|P2|COMPLETED|Overall Study||13
2487838|NCT00872170|6099235|P1|COMPLETED|Overall Study|One patient withdrew from study at week 2.|13
2487839|NCT00872170|6099234|P2|STARTED|Overall Study||13
2487840|NCT00872170|6099235|P1|STARTED|Overall Study||14
2487841|NCT00872079|6099250|P1|NOT COMPLETED|Overall Study||0
2487842|NCT00872079|6099250|P1|COMPLETED|Overall Study||175
2487843|NCT00872079|6099250|P1|STARTED|Overall Study||175
2487844|NCT00872027|6099256|P2|NOT COMPLETED|Overall Study||0
2487845|NCT00872027|6099257|P1|NOT COMPLETED|Overall Study||0
2487846|NCT00872027|6099256|P2|COMPLETED|Overall Study||8
2487847|NCT00872027|6099257|P1|COMPLETED|Overall Study||7
2487848|NCT00872027|6099256|P2|STARTED|Overall Study||8
2487849|NCT00872027|6099257|P1|STARTED|Overall Study||7
2487850|NCT00872001|6099265|P2|NOT COMPLETED|Overall Study||131
2487851|NCT00872001|6099266|P1|NOT COMPLETED|Overall Study||136
2487852|NCT00872001|6099265|P2|COMPLETED|Overall Study||1413
2487853|NCT00872001|6099266|P1|COMPLETED|Overall Study||1400
2487854|NCT00872001|6099265|P2|STARTED|Overall Study||1544
2487855|NCT00872001|6099266|P1|STARTED|Overall Study||1536
2487856|NCT00871975|6099274|P1|NOT COMPLETED|Overall Study||22
2487857|NCT00871975|6099274|P1|COMPLETED|Overall Study||133
2487858|NCT00871975|6099274|P1|STARTED|Overall Study||155
2487859|NCT00871871|6099280|P4|NOT COMPLETED|Part II||4
2487860|NCT00871871|6099281|P3|NOT COMPLETED|Part II||4
2487861|NCT00871871|6099282|P2|NOT COMPLETED|Part II||0
2487862|NCT00871871|6099283|P1|NOT COMPLETED|Part II||0
2487863|NCT00871871|6099280|P4|COMPLETED|Part II||11
2487864|NCT00871871|6099281|P3|COMPLETED|Part II||9
2487865|NCT00871871|6099282|P2|COMPLETED|Part II||0
2487866|NCT00871871|6099283|P1|COMPLETED|Part II||0
2487867|NCT00871871|6099280|P4|STARTED|Part II||15
2487868|NCT00871871|6099281|P3|STARTED|Part II||13
2487869|NCT00871871|6099282|P2|STARTED|Part II||0
2487870|NCT00871871|6099283|P1|STARTED|Part II||0
2487871|NCT00871871|6099280|P4|NOT COMPLETED|Part I||0
2487872|NCT00871871|6099281|P3|NOT COMPLETED|Part I||0
2487873|NCT00871871|6099282|P2|NOT COMPLETED|Part I||3
2487874|NCT00871871|6099283|P1|NOT COMPLETED|Part I||3
2487875|NCT00871871|6099280|P4|COMPLETED|Part I||0
2487876|NCT00871871|6099281|P3|COMPLETED|Part I||0
2487877|NCT00871871|6099282|P2|COMPLETED|Part I||15
2487878|NCT00871871|6099283|P1|COMPLETED|Part I||15
2487879|NCT00871871|6099280|P4|STARTED|Part I||0
2487880|NCT00871871|6099281|P3|STARTED|Part I||0
2487881|NCT00871871|6099282|P2|STARTED|Part I||18
2487882|NCT00871871|6099283|P1|STARTED|Part I||18
2487883|NCT00871845|6099305|P2|NOT COMPLETED|Overall Study||0
2487884|NCT00871845|6099306|P1|NOT COMPLETED|Overall Study||0
2487885|NCT00871845|6099305|P2|COMPLETED|Overall Study||25
2487886|NCT00871845|6099306|P1|COMPLETED|Overall Study||11
2487887|NCT00871845|6099305|P2|STARTED|Overall Study||25
2487888|NCT00871845|6099306|P1|STARTED|Overall Study||11
2487889|NCT00871819|6099316|P1|NOT COMPLETED|Overall Study||0
2487890|NCT00871819|6099316|P1|COMPLETED|Overall Study||20
2487891|NCT00871819|6099316|P1|STARTED|Overall Study||20
2487892|NCT00871780|6099320|P1|NOT COMPLETED|Overall Study||27
2487893|NCT00871780|6099320|P1|COMPLETED|Overall Study||197
2487894|NCT00871780|6099320|P1|Efficacy Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab and completed at least 1 on-treatment evaluation|215
2487895|NCT00871780|6099320|P1|Safety Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab during the study|218
2487896|NCT00871780|6099320|P1|STARTED|Overall Study|number enrolled|224
2487897|NCT00871741|6099340|P2|NOT COMPLETED|Overall Study||7
2487898|NCT00871741|6099341|P1|NOT COMPLETED|Overall Study||9
2487899|NCT00871741|6099340|P2|COMPLETED|Overall Study||0
2487900|NCT00871741|6099341|P1|COMPLETED|Overall Study||0
2487901|NCT00871741|6099340|P2|STARTED|Overall Study||7
2487902|NCT00871741|6099341|P1|STARTED|Overall Study||9
2487903|NCT00871728|6099355|P1|NOT COMPLETED|Overall Study||20
2487904|NCT00871728|6099355|P1|COMPLETED|Overall Study||112
2487905|NCT00871728|6099355|P1|Treated|Overall Study||130
2487906|NCT00871728|6099355|P1|STARTED|Overall Study||132
2487907|NCT00871715|6099368|P3|NOT COMPLETED|Overall Study||26
2487908|NCT00871715|6099369|P2|NOT COMPLETED|Overall Study||16
2487909|NCT00871715|6099370|P1|NOT COMPLETED|Overall Study||15
2487910|NCT00871715|6099368|P3|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|96
2487911|NCT00871715|6099369|P2|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
2487912|NCT00871715|6099370|P1|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
2487913|NCT00871715|6099368|P3|6-mo Follow-up|Overall Study||112
2487914|NCT00871715|6099369|P2|6-mo Follow-up|Overall Study||113
2487915|NCT00871715|6099370|P1|6-mo Follow-up|Overall Study||110
2487916|NCT00871715|6099368|P3|Post-Intervention|Overall Study||115
2487917|NCT00871715|6099369|P2|Post-Intervention|Overall Study||115
2487918|NCT00871715|6099370|P1|Post-Intervention|Overall Study||112
2487919|NCT00871715|6099368|P3|STARTED|Overall Study||122
2487920|NCT00871715|6099369|P2|STARTED|Overall Study||120
2487921|NCT00871715|6099370|P1|STARTED|Overall Study||119
2487922|NCT00871689|6099421|P1|NOT COMPLETED|Overall Study||0
2487923|NCT00871689|6099421|P1|COMPLETED|Overall Study||2
2487924|NCT00871689|6099421|P1|STARTED|Overall Study||2
2487925|NCT00871624|6099434|P2|NOT COMPLETED|Overall Study||1
2487926|NCT00871624|6099435|P1|NOT COMPLETED|Overall Study||2
2487927|NCT00871624|6099434|P2|COMPLETED|Overall Study||17
2487928|NCT00871624|6099435|P1|COMPLETED|Overall Study||16
2487929|NCT00871624|6099434|P2|STARTED|Overall Study||18
2487930|NCT00871624|6099435|P1|STARTED|Overall Study||18
2487931|NCT00871572|6099447|P4|NOT COMPLETED|Overall Study||7
2487932|NCT00871572|6099448|P3|NOT COMPLETED|Overall Study||4
2487933|NCT00871572|6099449|P2|NOT COMPLETED|Overall Study||6
2487934|NCT00871572|6099450|P1|NOT COMPLETED|Overall Study||2
2487935|NCT00871572|6099447|P4|COMPLETED|Overall Study||19
2487936|NCT00871572|6099448|P3|COMPLETED|Overall Study||30
2487937|NCT00871572|6099449|P2|COMPLETED|Overall Study||11
2487938|NCT00871572|6099450|P1|COMPLETED|Overall Study||8
2487939|NCT00871572|6099447|P4|Received at Least 1 Dose of Study Drug|Overall Study||25
2487940|NCT00871572|6099448|P3|Received at Least 1 Dose of Study Drug|Overall Study||34
2487941|NCT00871572|6099449|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
2487942|NCT00871572|6099450|P1|Received at Least 1 Dose of Study Drug|Overall Study||9
2487943|NCT00871572|6099447|P4|≥1 Post Baseline Value by Assigned Group|Overall Study||25
2487944|NCT00871572|6099448|P3|≥1 Post Baseline Value by Assigned Group|Overall Study||34
2487945|NCT00871572|6099449|P2|≥1 Post Baseline Value by Assigned Group|Overall Study||17
2487946|NCT00871572|6099450|P1|≥1 Post Baseline Value by Assigned Group|Overall Study||9
2487947|NCT00871572|6099447|P4|STARTED|Overall Study||26
2487948|NCT00871572|6099448|P3|STARTED|Overall Study||34
2487949|NCT00871572|6099449|P2|STARTED|Overall Study||17
2487950|NCT00871572|6099450|P1|STARTED|Overall Study||10
2487951|NCT00871494|6099520|P1|NOT COMPLETED|Overall Study||14
2487952|NCT00871494|6099520|P1|COMPLETED|Overall Study||62
2487953|NCT00871494|6099520|P1|STARTED|Overall Study||76
2487954|NCT00871429|6099527|P1|NOT COMPLETED|Overall Study||24
2487955|NCT00871429|6099527|P1|COMPLETED|Overall Study||75
2487956|NCT00871429|6099527|P1|STARTED|Overall Study||99
2487957|NCT00871403|6099538|P3|NOT COMPLETED|Monotherapy Treatment Phase||1
2487958|NCT00871403|6099539|P2|NOT COMPLETED|Monotherapy Treatment Phase||13
2487959|NCT00871403|6099540|P1|NOT COMPLETED|Monotherapy Treatment Phase||0
2487960|NCT00871403|6099538|P3|COMPLETED|Monotherapy Treatment Phase||0
2487961|NCT00871403|6099539|P2|COMPLETED|Monotherapy Treatment Phase||0
2487962|NCT00871403|6099540|P1|COMPLETED|Monotherapy Treatment Phase||0
2487963|NCT00871403|6099538|P3|STARTED|Monotherapy Treatment Phase||1
2487964|NCT00871403|6099539|P2|STARTED|Monotherapy Treatment Phase||13
2487965|NCT00871403|6099540|P1|STARTED|Monotherapy Treatment Phase||0
2487966|NCT00871403|6099538|P3|NOT COMPLETED|Combination Treatment Phase||12
2487967|NCT00871403|6099539|P2|NOT COMPLETED|Combination Treatment Phase||49
2487968|NCT00871403|6099540|P1|NOT COMPLETED|Combination Treatment Phase||9
2487969|NCT00871403|6099538|P3|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|23
2487970|NCT00871403|6099539|P2|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|13
2487971|NCT00871403|6099540|P1|COMPLETED|Combination Treatment Phase|No particiapants completed Combination Treatement.|0
2487972|NCT00871403|6099538|P3|STARTED|Combination Treatment Phase||35
2487973|NCT00871403|6099539|P2|STARTED|Combination Treatment Phase||62
2487974|NCT00871403|6099540|P1|STARTED|Combination Treatment Phase||9
2487975|NCT00871377|6099553|P6|NOT COMPLETED|Third Intervention (10 Weeks)||0
2487976|NCT00871377|6099554|P5|NOT COMPLETED|Third Intervention (10 Weeks)||0
2487977|NCT00871377|6099555|P4|NOT COMPLETED|Third Intervention (10 Weeks)||1
2487978|NCT00871377|6099556|P3|NOT COMPLETED|Third Intervention (10 Weeks)||0
2487979|NCT00871377|6099557|P2|NOT COMPLETED|Third Intervention (10 Weeks)||0
2487980|NCT00871377|6099558|P1|NOT COMPLETED|Third Intervention (10 Weeks)||0
2487981|NCT00871377|6099553|P6|COMPLETED|Third Intervention (10 Weeks)||3
2487982|NCT00871377|6099554|P5|COMPLETED|Third Intervention (10 Weeks)||4
2487983|NCT00871377|6099555|P4|COMPLETED|Third Intervention (10 Weeks)||3
2487984|NCT00871377|6099556|P3|COMPLETED|Third Intervention (10 Weeks)||3
2487985|NCT00871377|6099557|P2|COMPLETED|Third Intervention (10 Weeks)||4
2487986|NCT00871377|6099558|P1|COMPLETED|Third Intervention (10 Weeks)||2
2487987|NCT00871377|6099553|P6|STARTED|Third Intervention (10 Weeks)||3
2487988|NCT00871377|6099554|P5|STARTED|Third Intervention (10 Weeks)||4
2487989|NCT00871377|6099555|P4|STARTED|Third Intervention (10 Weeks)||4
2487990|NCT00871377|6099556|P3|STARTED|Third Intervention (10 Weeks)||3
2487991|NCT00871377|6099557|P2|STARTED|Third Intervention (10 Weeks)||4
2487992|NCT00871377|6099558|P1|STARTED|Third Intervention (10 Weeks)||2
2487993|NCT00871377|6099553|P6|NOT COMPLETED|Washout (6 Weeks)||1
2487994|NCT00871377|6099554|P5|NOT COMPLETED|Washout (6 Weeks)||0
2487995|NCT00871377|6099555|P4|NOT COMPLETED|Washout (6 Weeks)||0
2487996|NCT00871377|6099556|P3|NOT COMPLETED|Washout (6 Weeks)||0
2487997|NCT00871377|6099557|P2|NOT COMPLETED|Washout (6 Weeks)||0
2487998|NCT00871377|6099558|P1|NOT COMPLETED|Washout (6 Weeks)||0
2487999|NCT00871377|6099553|P6|COMPLETED|Washout (6 Weeks)||3
2488000|NCT00871377|6099554|P5|COMPLETED|Washout (6 Weeks)||4
2488001|NCT00871377|6099555|P4|COMPLETED|Washout (6 Weeks)||4
2488002|NCT00871377|6099556|P3|COMPLETED|Washout (6 Weeks)||3
2488003|NCT00871377|6099557|P2|COMPLETED|Washout (6 Weeks)||4
2488004|NCT00871377|6099558|P1|COMPLETED|Washout (6 Weeks)||2
2488005|NCT00871377|6099553|P6|STARTED|Washout (6 Weeks)||4
2488006|NCT00871377|6099554|P5|STARTED|Washout (6 Weeks)||4
2488007|NCT00871377|6099555|P4|STARTED|Washout (6 Weeks)||4
2488008|NCT00871377|6099556|P3|STARTED|Washout (6 Weeks)||3
2488009|NCT00871377|6099557|P2|STARTED|Washout (6 Weeks)||4
2488010|NCT00871377|6099558|P1|STARTED|Washout (6 Weeks)||2
2488011|NCT00871377|6099553|P6|NOT COMPLETED|Second Intervention (10 Weeks)||0
2488012|NCT00871377|6099554|P5|NOT COMPLETED|Second Intervention (10 Weeks)||0
2488013|NCT00871377|6099555|P4|NOT COMPLETED|Second Intervention (10 Weeks)||0
2488014|NCT00871377|6099556|P3|NOT COMPLETED|Second Intervention (10 Weeks)||0
2488015|NCT00871377|6099557|P2|NOT COMPLETED|Second Intervention (10 Weeks)||0
2488016|NCT00871377|6099558|P1|NOT COMPLETED|Second Intervention (10 Weeks)||0
2488017|NCT00871377|6099553|P6|COMPLETED|Second Intervention (10 Weeks)||4
2488018|NCT00871377|6099554|P5|COMPLETED|Second Intervention (10 Weeks)||4
2488019|NCT00871377|6099555|P4|COMPLETED|Second Intervention (10 Weeks)||4
2488020|NCT00871377|6099556|P3|COMPLETED|Second Intervention (10 Weeks)||3
2488021|NCT00871377|6099557|P2|COMPLETED|Second Intervention (10 Weeks)||4
2488022|NCT00871377|6099558|P1|COMPLETED|Second Intervention (10 Weeks)||2
2488023|NCT00871377|6099553|P6|STARTED|Second Intervention (10 Weeks)||4
2488024|NCT00871377|6099554|P5|STARTED|Second Intervention (10 Weeks)||4
2488025|NCT00871377|6099555|P4|STARTED|Second Intervention (10 Weeks)||4
2488026|NCT00871377|6099556|P3|STARTED|Second Intervention (10 Weeks)||3
2488027|NCT00871377|6099557|P2|STARTED|Second Intervention (10 Weeks)||4
2488028|NCT00871377|6099558|P1|STARTED|Second Intervention (10 Weeks)||2
2488029|NCT00871377|6099553|P6|NOT COMPLETED|Washout (6 Weeks)||0
2488030|NCT00871377|6099554|P5|NOT COMPLETED|Washout (6 Weeks)||0
2488031|NCT00871377|6099555|P4|NOT COMPLETED|Washout (6 Weeks)||0
2488032|NCT00871377|6099556|P3|NOT COMPLETED|Washout (6 Weeks)||0
2488033|NCT00871377|6099557|P2|NOT COMPLETED|Washout (6 Weeks)||0
2488034|NCT00871377|6099558|P1|NOT COMPLETED|Washout (6 Weeks)||1
2488035|NCT00871377|6099553|P6|COMPLETED|Washout (6 Weeks)||4
2488036|NCT00871377|6099554|P5|COMPLETED|Washout (6 Weeks)||4
2488037|NCT00871377|6099555|P4|COMPLETED|Washout (6 Weeks)||4
2488038|NCT00871377|6099556|P3|COMPLETED|Washout (6 Weeks)||3
2488039|NCT00871377|6099557|P2|COMPLETED|Washout (6 Weeks)||4
2488040|NCT00871377|6099558|P1|COMPLETED|Washout (6 Weeks)||2
2488041|NCT00871377|6099553|P6|STARTED|Washout (6 Weeks)||4
2488042|NCT00871377|6099554|P5|STARTED|Washout (6 Weeks)||4
2488043|NCT00871377|6099555|P4|STARTED|Washout (6 Weeks)||4
2488044|NCT00871377|6099556|P3|STARTED|Washout (6 Weeks)||3
2488045|NCT00871377|6099557|P2|STARTED|Washout (6 Weeks)||4
2488046|NCT00871377|6099558|P1|STARTED|Washout (6 Weeks)||3
2488047|NCT00871377|6099553|P6|NOT COMPLETED|First Intervention (10 Weeks)||1
2488048|NCT00871377|6099554|P5|NOT COMPLETED|First Intervention (10 Weeks)||0
2488049|NCT00871377|6099555|P4|NOT COMPLETED|First Intervention (10 Weeks)||0
2488050|NCT00871377|6099556|P3|NOT COMPLETED|First Intervention (10 Weeks)||1
2488051|NCT00871377|6099557|P2|NOT COMPLETED|First Intervention (10 Weeks)||0
2488052|NCT00871377|6099558|P1|NOT COMPLETED|First Intervention (10 Weeks)||0
2488053|NCT00871377|6099553|P6|COMPLETED|First Intervention (10 Weeks)||4
2488054|NCT00871377|6099554|P5|COMPLETED|First Intervention (10 Weeks)||4
2488055|NCT00871377|6099555|P4|COMPLETED|First Intervention (10 Weeks)||4
2488056|NCT00871377|6099556|P3|COMPLETED|First Intervention (10 Weeks)||3
2488057|NCT00871377|6099557|P2|COMPLETED|First Intervention (10 Weeks)||4
2488058|NCT00871377|6099558|P1|COMPLETED|First Intervention (10 Weeks)||3
2488059|NCT00871377|6099553|P6|STARTED|First Intervention (10 Weeks)||5
2488060|NCT00871377|6099554|P5|STARTED|First Intervention (10 Weeks)||4
2488061|NCT00871377|6099555|P4|STARTED|First Intervention (10 Weeks)||4
2488062|NCT00871377|6099556|P3|STARTED|First Intervention (10 Weeks)||4
2488063|NCT00871377|6099557|P2|STARTED|First Intervention (10 Weeks)||4
2488064|NCT00871377|6099558|P1|STARTED|First Intervention (10 Weeks)||3
2488065|NCT00871351|6099569|P3|NOT COMPLETED|Overall Study||0
2488066|NCT00871351|6099570|P2|NOT COMPLETED|Overall Study||1
2488067|NCT00871351|6099571|P1|NOT COMPLETED|Overall Study||4
2488068|NCT00871351|6099569|P3|COMPLETED|Overall Study||32
2488069|NCT00871351|6099570|P2|COMPLETED|Overall Study||45
2488070|NCT00871351|6099571|P1|COMPLETED|Overall Study||43
2488071|NCT00871351|6099569|P3|STARTED|Overall Study||32
2488072|NCT00871351|6099570|P2|STARTED|Overall Study||46
2488073|NCT00871351|6099571|P1|STARTED|Overall Study||47
2488074|NCT00871338|6099593|P2|NOT COMPLETED|After Booster||0
2488075|NCT00871338|6099594|P1|NOT COMPLETED|After Booster||0
2488076|NCT00871338|6099593|P2|COMPLETED|After Booster||135
2488077|NCT00871338|6099594|P1|COMPLETED|After Booster||139
2488078|NCT00871338|6099593|P2|STARTED|After Booster||135
2488079|NCT00871338|6099594|P1|STARTED|After Booster||139
2488080|NCT00871338|6099593|P2|NOT COMPLETED|Prior to Booster||3
2488081|NCT00871338|6099594|P1|NOT COMPLETED|Prior to Booster||2
2488082|NCT00871338|6099593|P2|COMPLETED|Prior to Booster||139
2488083|NCT00871338|6099594|P1|COMPLETED|Prior to Booster||140
2488084|NCT00871338|6099593|P2|STARTED|Prior to Booster||142
2488085|NCT00871338|6099594|P1|STARTED|Prior to Booster||142
2488086|NCT00871286|6099674|P2|NOT COMPLETED|Overall Study||6
2488087|NCT00871286|6099675|P1|NOT COMPLETED|Overall Study||0
2488088|NCT00871286|6099674|P2|COMPLETED|Overall Study||14
2488089|NCT00871286|6099675|P1|COMPLETED|Overall Study||20
2488090|NCT00871286|6099674|P2|STARTED|Overall Study||20
2488091|NCT00871286|6099675|P1|STARTED|Overall Study||20
2488092|NCT00871234|6099683|P1|NOT COMPLETED|Overall Study||5
2488093|NCT00871234|6099683|P1|COMPLETED|Overall Study||23
2488094|NCT00871234|6099683|P1|STARTED|Overall Study||28
2488095|NCT00871169|6099687|P1|NOT COMPLETED|Overall Study||3
2488096|NCT00871169|6099687|P1|COMPLETED|Overall Study||58
2488097|NCT00871169|6099687|P1|STARTED|Overall Study||61
2488098|NCT00871143|6099694|P2|NOT COMPLETED|Overall Study||0
2488099|NCT00871143|6099695|P1|NOT COMPLETED|Overall Study||0
2488100|NCT00871143|6099694|P2|COMPLETED|Overall Study||25
2488101|NCT00871143|6099695|P1|COMPLETED|Overall Study||21
2488102|NCT00871143|6099694|P2|STARTED|Overall Study||25
2488103|NCT00871143|6099695|P1|STARTED|Overall Study||21
2488104|NCT00871117|6099715|P2|NOT COMPLETED|Overall Study||10
2488105|NCT00871117|6099716|P1|NOT COMPLETED|Overall Study||5
2488106|NCT00871117|6099715|P2|COMPLETED|Overall Study||227
2488107|NCT00871117|6099716|P1|COMPLETED|Overall Study||234
2488108|NCT00871117|6099715|P2|STARTED|Overall Study||237
2488109|NCT00871117|6099716|P1|STARTED|Overall Study||239
2488110|NCT00871000|6099750|P2|NOT COMPLETED|Overall Study||0
2488111|NCT00871000|6099751|P1|NOT COMPLETED|Overall Study||1
2488112|NCT00871000|6099750|P2|COMPLETED|Overall Study||152
2488113|NCT00871000|6099751|P1|COMPLETED|Overall Study||150
2488114|NCT00871000|6099750|P2|STARTED|Overall Study||152
2488115|NCT00871000|6099751|P1|STARTED|Overall Study||151
2488116|NCT00870896|6099793|P1|NOT COMPLETED|Overall Study||0
2488117|NCT00870896|6099793|P1|COMPLETED|Overall Study||5
2488118|NCT00870896|6099793|P1|STARTED|Overall Study||5
2488119|NCT00870870|6099803|P4|NOT COMPLETED|Overall Study||5
2488120|NCT00870870|6099804|P3|NOT COMPLETED|Overall Study||3
2488121|NCT00870870|6099805|P2|NOT COMPLETED|Overall Study||1
2488122|NCT00870870|6099806|P1|NOT COMPLETED|Overall Study||0
2488123|NCT00870870|6099803|P4|COMPLETED|Overall Study||20
2488124|NCT00870870|6099804|P3|COMPLETED|Overall Study||26
2488125|NCT00870870|6099805|P2|COMPLETED|Overall Study||5
2488126|NCT00870870|6099806|P1|COMPLETED|Overall Study||4
2488127|NCT00870870|6099803|P4|STARTED|Overall Study||25
2488128|NCT00870870|6099804|P3|STARTED|Overall Study||29
2488129|NCT00870870|6099805|P2|STARTED|Overall Study||6
2488130|NCT00870870|6099806|P1|STARTED|Overall Study||4
2488131|NCT00870740|6099850|P6|NOT COMPLETED|Overall Study||17
2488132|NCT00870740|6099851|P5|NOT COMPLETED|Overall Study||11
2488133|NCT00870740|6099852|P4|NOT COMPLETED|Overall Study||12
2488134|NCT00870740|6099853|P3|NOT COMPLETED|Overall Study||10
2488135|NCT00870740|6099854|P2|NOT COMPLETED|Overall Study||9
2488136|NCT00870740|6099855|P1|NOT COMPLETED|Overall Study||12
2488137|NCT00870740|6099850|P6|COMPLETED|Overall Study||70
2488138|NCT00870740|6099851|P5|COMPLETED|Overall Study||77
2488139|NCT00870740|6099852|P4|COMPLETED|Overall Study||74
2488140|NCT00870740|6099853|P3|COMPLETED|Overall Study||76
2488141|NCT00870740|6099854|P2|COMPLETED|Overall Study||75
2488142|NCT00870740|6099855|P1|COMPLETED|Overall Study||74
2488143|NCT00870740|6099850|P6|STARTED|Overall Study|number randomized and dosed|87
2488144|NCT00870740|6099851|P5|STARTED|Overall Study|number randomized and dosed|88
2488145|NCT00870740|6099852|P4|STARTED|Overall Study|number randomized and dosed|86
2488146|NCT00870740|6099853|P3|STARTED|Overall Study|number randomized and dosed|86
2488147|NCT00870740|6099854|P2|STARTED|Overall Study|number randomized and dosed|84
2488148|NCT00870740|6099855|P1|STARTED|Overall Study|number randomized and dosed|86
2488149|NCT00870727|6099931|P2|NOT COMPLETED|Overall Study||5
2488150|NCT00870727|6099932|P1|NOT COMPLETED|Overall Study||1
2488151|NCT00870727|6099931|P2|COMPLETED|Overall Study||11
2488152|NCT00870727|6099932|P1|COMPLETED|Overall Study||16
2488153|NCT00870727|6099931|P2|STARTED|Overall Study||16
2488154|NCT00870727|6099932|P1|STARTED|Overall Study||17
2488155|NCT00870688|6099948|P1|NOT COMPLETED|Overall Study||4
2488156|NCT00870688|6099948|P1|COMPLETED|Overall Study||78
2488157|NCT00870688|6099948|P1|STARTED|Overall Study||82
2488158|NCT00870584|6099953|P2|NOT COMPLETED|Overall Study||13
2488159|NCT00870584|6099954|P1|NOT COMPLETED|Overall Study||16
2488160|NCT00870584|6099953|P2|COMPLETED|Overall Study||122
2488161|NCT00870584|6099954|P1|COMPLETED|Overall Study||120
2488162|NCT00870584|6099953|P2|STARTED|Overall Study||135
2488163|NCT00870584|6099954|P1|STARTED|Overall Study||136
2488164|NCT00870545|6099962|P1|NOT COMPLETED|Overall Study||17
2488165|NCT00870545|6099962|P1|COMPLETED|Overall Study||69
2488166|NCT00870545|6099962|P1|STARTED|Overall Study||86
2488167|NCT00870467|6099973|P6|NOT COMPLETED|Open-label||3
2488168|NCT00870467|6099974|P5|NOT COMPLETED|Open-label||5
2488169|NCT00870467|6099975|P4|NOT COMPLETED|Open-label||7
2488170|NCT00870467|6099976|P3|NOT COMPLETED|Open-label||13
2488171|NCT00870467|6099977|P2|NOT COMPLETED|Open-label||0
2488172|NCT00870467|6099978|P1|NOT COMPLETED|Open-label||0
2488173|NCT00870467|6099973|P6|COMPLETED|Open-label||21
2488174|NCT00870467|6099974|P5|COMPLETED|Open-label||5
2488175|NCT00870467|6099975|P4|COMPLETED|Open-label||120
2488176|NCT00870467|6099976|P3|COMPLETED|Open-label||132
2488177|NCT00870467|6099977|P2|COMPLETED|Open-label||0
2488178|NCT00870467|6099978|P1|COMPLETED|Open-label||0
2488179|NCT00870467|6099973|P6|STARTED|Open-label||24
2488180|NCT00870467|6099974|P5|STARTED|Open-label||10
2488181|NCT00870467|6099975|P4|STARTED|Open-label||127
2488182|NCT00870467|6099976|P3|STARTED|Open-label||145
2488183|NCT00870467|6099977|P2|STARTED|Open-label||0
2488184|NCT00870467|6099978|P1|STARTED|Open-label||0
2488185|NCT00870467|6099973|P6|NOT COMPLETED|Double-blind||0
2488186|NCT00870467|6099974|P5|NOT COMPLETED|Double-blind||0
2488187|NCT00870467|6099975|P4|NOT COMPLETED|Double-blind||0
2488188|NCT00870467|6099976|P3|NOT COMPLETED|Double-blind||0
2488189|NCT00870467|6099977|P2|NOT COMPLETED|Double-blind||12
2488190|NCT00870467|6099978|P1|NOT COMPLETED|Double-blind||16
2488191|NCT00870467|6099973|P6|COMPLETED|Double-blind||0
2488192|NCT00870467|6099974|P5|COMPLETED|Double-blind||0
2488193|NCT00870467|6099975|P4|COMPLETED|Double-blind||0
2488194|NCT00870467|6099976|P3|COMPLETED|Double-blind||0
2488195|NCT00870467|6099977|P2|COMPLETED|Double-blind|24 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|151
2488196|NCT00870467|6099978|P1|COMPLETED|Double-blind|10 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|155
2488197|NCT00870467|6099973|P6|STARTED|Double-blind||0
2488198|NCT00870467|6099974|P5|STARTED|Double-blind||0
2488199|NCT00870467|6099975|P4|STARTED|Double-blind||0
2488200|NCT00870467|6099976|P3|STARTED|Double-blind||0
2488201|NCT00870467|6099977|P2|STARTED|Double-blind||163
2488202|NCT00870467|6099978|P1|STARTED|Double-blind||171
2488203|NCT00870363|6100026|P4|NOT COMPLETED|Overall Study||0
2488204|NCT00870363|6100027|P3|NOT COMPLETED|Overall Study||3
2488205|NCT00870363|6100028|P2|NOT COMPLETED|Overall Study||3
2488206|NCT00870363|6100029|P1|NOT COMPLETED|Overall Study||0
2488207|NCT00870363|6100026|P4|COMPLETED|Overall Study||12
2488208|NCT00870363|6100027|P3|COMPLETED|Overall Study||8
2488209|NCT00870363|6100028|P2|COMPLETED|Overall Study||8
2488210|NCT00870363|6100029|P1|COMPLETED|Overall Study||10
2488211|NCT00870363|6100026|P4|STARTED|Overall Study||12
2488212|NCT00870363|6100027|P3|STARTED|Overall Study||11
2488213|NCT00870363|6100028|P2|STARTED|Overall Study||11
2488214|NCT00870363|6100029|P1|STARTED|Overall Study||10
2488215|NCT00870233|6100063|P1|NOT COMPLETED|Overall Study||24
2488216|NCT00870233|6100063|P1|COMPLETED|Overall Study||96
2488217|NCT00870233|6100063|P1|STARTED|Overall Study||120
2488218|NCT00870194|6100072|P2|NOT COMPLETED|Overall Study||14
2488219|NCT00870194|6100073|P1|NOT COMPLETED|Overall Study||26
2488220|NCT00870194|6100072|P2|COMPLETED|Overall Study||114
2488221|NCT00870194|6100073|P1|COMPLETED|Overall Study||101
2488222|NCT00870194|6100072|P2|Per Protocol Set|Overall Study||111
2488223|NCT00870194|6100073|P1|Per Protocol Set|Overall Study||97
2488224|NCT00870194|6100072|P2|STARTED|Overall Study||128
2488225|NCT00870194|6100073|P1|STARTED|Overall Study||127
2488226|NCT00870103|6100111|P1|NOT COMPLETED|Overall Study||4
2488227|NCT00870103|6100111|P1|COMPLETED|Overall Study||60
2488228|NCT00870103|6100111|P1|STARTED|Overall Study||64
2488229|NCT00869999|6100116|P1|NOT COMPLETED|Overall Study||2
2488230|NCT00869999|6100116|P1|COMPLETED|Overall Study||24
2488231|NCT00869999|6100116|P1|STARTED|Overall Study||26
2488232|NCT00869960|6100122|P1|NOT COMPLETED|Overall Study||2
2488233|NCT00869960|6100122|P1|COMPLETED|Overall Study||22
2488234|NCT00869960|6100122|P1|STARTED|Overall Study||24
2488235|NCT00869947|6100135|P2|NOT COMPLETED|Overall Study||0
2488236|NCT00869947|6100136|P1|NOT COMPLETED|Overall Study||0
2488237|NCT00869947|6100135|P2|COMPLETED|Overall Study||8
2488238|NCT00869947|6100136|P1|COMPLETED|Overall Study||8
2488239|NCT00869947|6100135|P2|STARTED|Overall Study||8
2488240|NCT00869947|6100136|P1|STARTED|Overall Study||8
2488241|NCT00869791|6100149|P2|NOT COMPLETED|Period 2 Treatment for 7 Days||0
2488242|NCT00869791|6100150|P1|NOT COMPLETED|Period 2 Treatment for 7 Days||0
2488243|NCT00869791|6100149|P2|COMPLETED|Period 2 Treatment for 7 Days||13
2488244|NCT00869791|6100150|P1|COMPLETED|Period 2 Treatment for 7 Days||14
2488245|NCT00869791|6100149|P2|STARTED|Period 2 Treatment for 7 Days||13
2488246|NCT00869791|6100150|P1|STARTED|Period 2 Treatment for 7 Days||14
2488247|NCT00869791|6100149|P2|NOT COMPLETED|Period 1 Treatment for 7 Days||0
2488248|NCT00869791|6100150|P1|NOT COMPLETED|Period 1 Treatment for 7 Days||0
2488249|NCT00869791|6100149|P2|COMPLETED|Period 1 Treatment for 7 Days||13
2488250|NCT00869791|6100150|P1|COMPLETED|Period 1 Treatment for 7 Days||14
2488251|NCT00869791|6100149|P2|STARTED|Period 1 Treatment for 7 Days||13
2488252|NCT00869791|6100150|P1|STARTED|Period 1 Treatment for 7 Days||14
2488253|NCT00869778|6100171|P3|NOT COMPLETED|Overall Study||10
2488254|NCT00869778|6100172|P2|NOT COMPLETED|Overall Study||7
2488255|NCT00869778|6100173|P1|NOT COMPLETED|Overall Study||12
2488256|NCT00869778|6100171|P3|COMPLETED|Overall Study||110
2488257|NCT00869778|6100172|P2|COMPLETED|Overall Study||113
2488258|NCT00869778|6100173|P1|COMPLETED|Overall Study||108
2488259|NCT00869778|6100171|P3|STARTED|Overall Study||120
2488260|NCT00869778|6100172|P2|STARTED|Overall Study||120
2488261|NCT00869778|6100173|P1|STARTED|Overall Study||120
2488262|NCT00869622|6100210|P2|NOT COMPLETED|Overall Study||14
2488263|NCT00869622|6100211|P1|NOT COMPLETED|Overall Study||13
2488264|NCT00869622|6100210|P2|COMPLETED|Overall Study||26
2488265|NCT00869622|6100211|P1|COMPLETED|Overall Study||27
2488266|NCT00869622|6100210|P2|STARTED|Overall Study||40
2488267|NCT00869622|6100211|P1|STARTED|Overall Study||40
2488268|NCT00869609|6100221|P2|NOT COMPLETED|Overall Study||3
2488269|NCT00869609|6100222|P1|NOT COMPLETED|Overall Study||6
2488270|NCT00869609|6100221|P2|COMPLETED|Overall Study||26
2488271|NCT00869609|6100222|P1|COMPLETED|Overall Study||25
2488272|NCT00869609|6100221|P2|STARTED|Overall Study||29
2488273|NCT00869609|6100222|P1|STARTED|Overall Study||31
2488274|NCT00869557|6100248|P2|NOT COMPLETED|Extension Phase||3
2488275|NCT00869557|6100249|P1|NOT COMPLETED|Extension Phase||10
2488276|NCT00869557|6100248|P2|COMPLETED|Extension Phase||11
2488277|NCT00869557|6100249|P1|COMPLETED|Extension Phase||35
2488278|NCT00869557|6100248|P2|STARTED|Extension Phase|Seven participants completing randomized Atripla treatment did not enter open-label extension phase.|14
2488279|NCT00869557|6100249|P1|STARTED|Extension Phase||45
2488280|NCT00869557|6100248|P2|NOT COMPLETED|Randomized Phase||2
2488281|NCT00869557|6100249|P1|NOT COMPLETED|Randomized Phase||3
2488282|NCT00869557|6100248|P2|COMPLETED|Randomized Phase||21
2488283|NCT00869557|6100249|P1|COMPLETED|Randomized Phase||45
2488284|NCT00869557|6100248|P2|STARTED|Randomized Phase||23
2488285|NCT00869557|6100249|P1|STARTED|Randomized Phase||48
2488286|NCT00869518|6100268|P2|NOT COMPLETED|Overall Study||1
2488287|NCT00869518|6100269|P1|NOT COMPLETED|Overall Study||1
2488288|NCT00869518|6100268|P2|COMPLETED|Overall Study||5
2488289|NCT00869518|6100269|P1|COMPLETED|Overall Study||5
2488290|NCT00869518|6100268|P2|STARTED|Overall Study||6
2488291|NCT00869518|6100269|P1|STARTED|Overall Study||6
2488292|NCT00869440|6100285|P4|NOT COMPLETED|Overall Study||0
2488293|NCT00869440|6100286|P3|NOT COMPLETED|Overall Study||0
2488294|NCT00869440|6100287|P2|NOT COMPLETED|Overall Study||1
2488295|NCT00869440|6100288|P1|NOT COMPLETED|Overall Study||2
2488296|NCT00869440|6100285|P4|COMPLETED|Overall Study||25
2488297|NCT00869440|6100286|P3|COMPLETED|Overall Study||25
2488298|NCT00869440|6100287|P2|COMPLETED|Overall Study||24
2488299|NCT00869440|6100288|P1|COMPLETED|Overall Study||23
2488300|NCT00869440|6100285|P4|STARTED|Overall Study||25
2488301|NCT00869440|6100286|P3|STARTED|Overall Study||25
2488302|NCT00869440|6100287|P2|STARTED|Overall Study||25
2488303|NCT00869440|6100288|P1|STARTED|Overall Study||25
2488304|NCT00869414|6100306|P3|NOT COMPLETED|Overall Study||0
2488305|NCT00869414|6100307|P2|NOT COMPLETED|Overall Study||0
2488306|NCT00869414|6100308|P1|NOT COMPLETED|Overall Study||0
2488307|NCT00869414|6100306|P3|COMPLETED|Overall Study||0
2488308|NCT00869414|6100307|P2|COMPLETED|Overall Study||0
2488309|NCT00869414|6100308|P1|COMPLETED|Overall Study||0
2488310|NCT00869414|6100306|P3|STARTED|Overall Study||0
2488311|NCT00869414|6100307|P2|STARTED|Overall Study||0
2488312|NCT00869414|6100308|P1|STARTED|Overall Study||0
2488313|NCT00869401|6100322|P5|NOT COMPLETED|Overall Study||3
2488314|NCT00869401|6100323|P4|NOT COMPLETED|Overall Study||5
2488315|NCT00869401|6100324|P3|NOT COMPLETED|Overall Study||0
2488316|NCT00869401|6100325|P2|NOT COMPLETED|Overall Study||0
2488317|NCT00869401|6100326|P1|NOT COMPLETED|Overall Study||0
2488318|NCT00869401|6100322|P5|COMPLETED|Overall Study||63
2488319|NCT00869401|6100323|P4|COMPLETED|Overall Study||133
2488320|NCT00869401|6100324|P3|COMPLETED|Overall Study||7
2488321|NCT00869401|6100325|P2|COMPLETED|Overall Study||3
2488322|NCT00869401|6100326|P1|COMPLETED|Overall Study||3
2488323|NCT00869401|6100322|P5|STARTED|Overall Study||66
2488324|NCT00869401|6100323|P4|STARTED|Overall Study||138
2488325|NCT00869401|6100324|P3|STARTED|Overall Study||7
2488326|NCT00869401|6100325|P2|STARTED|Overall Study||3
2488327|NCT00869401|6100326|P1|STARTED|Overall Study||3
2488328|NCT00869375|6100344|P2|NOT COMPLETED|Overall Study||0
2488329|NCT00869375|6100345|P1|NOT COMPLETED|Overall Study||0
2488330|NCT00869375|6100344|P2|COMPLETED|Overall Study||3
2488331|NCT00869375|6100345|P1|COMPLETED|Overall Study||3
2488332|NCT00869375|6100344|P2|STARTED|Overall Study||3
2488333|NCT00869375|6100345|P1|STARTED|Overall Study||3
2488334|NCT00869362|6100355|P2|NOT COMPLETED|Overall Study||5
2488335|NCT00869362|6100356|P1|NOT COMPLETED|Overall Study||1
2488336|NCT00869362|6100355|P2|COMPLETED|Overall Study||11
2488337|NCT00869362|6100356|P1|COMPLETED|Overall Study||14
2488338|NCT00869362|6100355|P2|STARTED|Overall Study||16
2488339|NCT00869362|6100356|P1|STARTED|Overall Study||15
2488340|NCT00869349|6100366|P2|NOT COMPLETED|Overall Study||4
2488341|NCT00869349|6100367|P1|NOT COMPLETED|Overall Study||7
2488342|NCT00869349|6100366|P2|COMPLETED|Overall Study||36
2488343|NCT00869349|6100367|P1|COMPLETED|Overall Study||32
2488344|NCT00869349|6100366|P2|STARTED|Overall Study||40
2488345|NCT00869349|6100367|P1|STARTED|Overall Study||39
2488346|NCT00869323|6100377|P1|NOT COMPLETED|Maintenance Therapy||1
2488347|NCT00869323|6100377|P1|COMPLETED|Maintenance Therapy||1
2488348|NCT00869323|6100377|P1|STARTED|Maintenance Therapy|One participant removed from study after completing induction therapy due to progressive disease.|2
2488349|NCT00869323|6100377|P1|NOT COMPLETED|Induction Therapy||0
2488350|NCT00869323|6100377|P1|COMPLETED|Induction Therapy||3
2488351|NCT00869323|6100377|P1|STARTED|Induction Therapy||3
2488352|NCT00869258|6100385|P1|NOT COMPLETED|Overall Study||1
2488353|NCT00869258|6100385|P1|COMPLETED|Overall Study||31
2488354|NCT00869258|6100385|P1|STARTED|Overall Study||32
2488355|NCT00869206|6100391|P2|NOT COMPLETED|Overall Study||27
2488356|NCT00869206|6100392|P1|NOT COMPLETED|Overall Study||29
2488357|NCT00869206|6100391|P2|COMPLETED|Overall Study||884
2488358|NCT00869206|6100392|P1|COMPLETED|Overall Study||882
2488359|NCT00869206|6100391|P2|STARTED|Overall Study||911
2488360|NCT00869206|6100392|P1|STARTED|Overall Study||911
2488361|NCT00869167|6100422|P2|NOT COMPLETED|Overall Study||1
2488362|NCT00869167|6100423|P1|NOT COMPLETED|Overall Study||0
2488363|NCT00869167|6100422|P2|COMPLETED|Overall Study||0
2488364|NCT00869167|6100423|P1|COMPLETED|Overall Study||2
2488365|NCT00869167|6100422|P2|STARTED|Overall Study||1
2488366|NCT00869167|6100423|P1|STARTED|Overall Study||2
2488367|NCT00869141|6100439|P2|NOT COMPLETED|Overall Study||0
2488368|NCT00869141|6100440|P1|NOT COMPLETED|Overall Study||0
2488369|NCT00869141|6100439|P2|COMPLETED|Overall Study||26
2488370|NCT00869141|6100440|P1|COMPLETED|Overall Study||26
2488371|NCT00869141|6100439|P2|STARTED|Overall Study||26
2488372|NCT00869141|6100440|P1|STARTED|Overall Study||26
2488373|NCT00869128|6100450|P2|NOT COMPLETED|Overall Study||6
2488374|NCT00869128|6100451|P1|NOT COMPLETED|Overall Study||6
2488375|NCT00869128|6100450|P2|COMPLETED|Overall Study||12
2488376|NCT00869128|6100451|P1|COMPLETED|Overall Study||12
2488377|NCT00869128|6100450|P2|STARTED|Overall Study||18
2488378|NCT00869128|6100451|P1|STARTED|Overall Study||18
2488379|NCT00869089|6100455|P1|NOT COMPLETED|Overall Study||3
2488380|NCT00869089|6100455|P1|COMPLETED|Overall Study||2
2488381|NCT00869089|6100455|P1|STARTED|Overall Study||5
2488382|NCT00869050|6100459|P1|NOT COMPLETED|Overall Study||3
2488383|NCT00869050|6100459|P1|COMPLETED|Overall Study||38
2488384|NCT00869050|6100459|P1|STARTED|Overall Study||41
2488385|NCT00868998|6100464|P1|NOT COMPLETED|Overall Study||5
2488386|NCT00868998|6100464|P1|COMPLETED|Overall Study||0
2488387|NCT00868998|6100464|P1|STARTED|Overall Study||5
2488388|NCT00868959|6100469|P1|NOT COMPLETED|Overall Study||258
2488389|NCT00868959|6100469|P1|COMPLETED|Overall Study||559
2488390|NCT00868959|6100469|P1|STARTED|Overall Study|817 represents total number of subjects who provided informed consent.|817
2488391|NCT00868790|6100475|P14|NOT COMPLETED|Post-study||0
2488392|NCT00868790|6100476|P13|NOT COMPLETED|Post-study||0
2488393|NCT00868790|6100477|P12|NOT COMPLETED|Post-study||0
2488394|NCT00868790|6100478|P11|NOT COMPLETED|Post-study||0
2488395|NCT00868790|6100479|P10|NOT COMPLETED|Post-study||1
2488396|NCT00868790|6100480|P9|NOT COMPLETED|Post-study||0
2488397|NCT00868790|6100481|P8|NOT COMPLETED|Post-study||2
2488398|NCT00868790|6100482|P7|NOT COMPLETED|Post-study||0
2488399|NCT00868790|6100483|P6|NOT COMPLETED|Post-study||0
2488400|NCT00868790|6100484|P5|NOT COMPLETED|Post-study||1
2488401|NCT00868790|6100485|P4|NOT COMPLETED|Post-study||0
2488402|NCT00868790|6100486|P3|NOT COMPLETED|Post-study||0
2488403|NCT00868790|6100487|P2|NOT COMPLETED|Post-study||0
2488404|NCT00868790|6100488|P1|NOT COMPLETED|Post-study||0
2488405|NCT00868790|6100475|P14|COMPLETED|Post-study||7
2488406|NCT00868790|6100476|P13|COMPLETED|Post-study||6
2488407|NCT00868790|6100477|P12|COMPLETED|Post-study||3
2488408|NCT00868790|6100478|P11|COMPLETED|Post-study||5
2488409|NCT00868790|6100479|P10|COMPLETED|Post-study||1
2488410|NCT00868790|6100480|P9|COMPLETED|Post-study||6
2488411|NCT00868790|6100481|P8|COMPLETED|Post-study||12
2488412|NCT00868790|6100482|P7|COMPLETED|Post-study||4
2488413|NCT00868790|6100483|P6|COMPLETED|Post-study||1
2488414|NCT00868790|6100484|P5|COMPLETED|Post-study||17
2488415|NCT00868790|6100485|P4|COMPLETED|Post-study||3
2488416|NCT00868790|6100486|P3|COMPLETED|Post-study||3
2488417|NCT00868790|6100487|P2|COMPLETED|Post-study||6
2488418|NCT00868790|6100488|P1|COMPLETED|Post-study||7
2488419|NCT00868790|6100475|P14|STARTED|Post-study||7
2488420|NCT00868790|6100476|P13|STARTED|Post-study||6
2488421|NCT00868790|6100477|P12|STARTED|Post-study||3
2488422|NCT00868790|6100478|P11|STARTED|Post-study||5
2488423|NCT00868790|6100479|P10|STARTED|Post-study||2
2488424|NCT00868790|6100480|P9|STARTED|Post-study||6
2488425|NCT00868790|6100481|P8|STARTED|Post-study||14
2488426|NCT00868790|6100482|P7|STARTED|Post-study||4
2488427|NCT00868790|6100483|P6|STARTED|Post-study||1
2488428|NCT00868790|6100484|P5|STARTED|Post-study||18
2488429|NCT00868790|6100485|P4|STARTED|Post-study||3
2488430|NCT00868790|6100486|P3|STARTED|Post-study||3
2488431|NCT00868790|6100487|P2|STARTED|Post-study||6
2488432|NCT00868790|6100488|P1|STARTED|Post-study||7
2488433|NCT00868790|6100475|P14|NOT COMPLETED|Period 4||1
2488434|NCT00868790|6100476|P13|NOT COMPLETED|Period 4||1
2488435|NCT00868790|6100477|P12|NOT COMPLETED|Period 4||1
2488436|NCT00868790|6100478|P11|NOT COMPLETED|Period 4||3
2488437|NCT00868790|6100479|P10|NOT COMPLETED|Period 4||0
2488438|NCT00868790|6100480|P9|NOT COMPLETED|Period 4||2
2488439|NCT00868790|6100481|P8|NOT COMPLETED|Period 4||3
2488440|NCT00868790|6100482|P7|NOT COMPLETED|Period 4||0
2488441|NCT00868790|6100483|P6|NOT COMPLETED|Period 4||0
2488442|NCT00868790|6100484|P5|NOT COMPLETED|Period 4||0
2488443|NCT00868790|6100485|P4|NOT COMPLETED|Period 4||0
2488444|NCT00868790|6100486|P3|NOT COMPLETED|Period 4||1
2488445|NCT00868790|6100487|P2|NOT COMPLETED|Period 4||0
2488446|NCT00868790|6100488|P1|NOT COMPLETED|Period 4||2
2488447|NCT00868790|6100475|P14|COMPLETED|Period 4||7
2488448|NCT00868790|6100476|P13|COMPLETED|Period 4||6
2488449|NCT00868790|6100477|P12|COMPLETED|Period 4||3
2488450|NCT00868790|6100478|P11|COMPLETED|Period 4||5
2488451|NCT00868790|6100479|P10|COMPLETED|Period 4||2
2488452|NCT00868790|6100480|P9|COMPLETED|Period 4||6
2488453|NCT00868790|6100481|P8|COMPLETED|Period 4||14
2488454|NCT00868790|6100482|P7|COMPLETED|Period 4||4
2488455|NCT00868790|6100483|P6|COMPLETED|Period 4||1
2488456|NCT00868790|6100484|P5|COMPLETED|Period 4||18
2488457|NCT00868790|6100485|P4|COMPLETED|Period 4||3
2488458|NCT00868790|6100486|P3|COMPLETED|Period 4|One non-completion due to abnormal alanine aminotransferase/aspartate aminotransferase (ALT/AST)|3
2488459|NCT00868790|6100487|P2|COMPLETED|Period 4||6
2488460|NCT00868790|6100488|P1|COMPLETED|Period 4||7
2488461|NCT00868790|6100475|P14|STARTED|Period 4||8
2488462|NCT00868790|6100476|P13|STARTED|Period 4||7
2488463|NCT00868790|6100477|P12|STARTED|Period 4||4
2488464|NCT00868790|6100478|P11|STARTED|Period 4||8
2488465|NCT00868790|6100479|P10|STARTED|Period 4||2
2488466|NCT00868790|6100480|P9|STARTED|Period 4||8
2488467|NCT00868790|6100481|P8|STARTED|Period 4||17
2488468|NCT00868790|6100482|P7|STARTED|Period 4||4
2488469|NCT00868790|6100483|P6|STARTED|Period 4||1
2488470|NCT00868790|6100484|P5|STARTED|Period 4||18
2488471|NCT00868790|6100485|P4|STARTED|Period 4||3
2488472|NCT00868790|6100486|P3|STARTED|Period 4||4
2488473|NCT00868790|6100487|P2|STARTED|Period 4||6
2488474|NCT00868790|6100488|P1|STARTED|Period 4||9
2488475|NCT00868790|6100475|P14|NOT COMPLETED|Period 3||0
2488476|NCT00868790|6100476|P13|NOT COMPLETED|Period 3||0
2488477|NCT00868790|6100477|P12|NOT COMPLETED|Period 3||0
2488478|NCT00868790|6100478|P11|NOT COMPLETED|Period 3||1
2488479|NCT00868790|6100479|P10|NOT COMPLETED|Period 3||1
2488480|NCT00868790|6100480|P9|NOT COMPLETED|Period 3||0
2488481|NCT00868790|6100481|P8|NOT COMPLETED|Period 3||0
2488482|NCT00868790|6100482|P7|NOT COMPLETED|Period 3||0
2488483|NCT00868790|6100483|P6|NOT COMPLETED|Period 3||0
2488484|NCT00868790|6100484|P5|NOT COMPLETED|Period 3||0
2488485|NCT00868790|6100485|P4|NOT COMPLETED|Period 3||1
2488486|NCT00868790|6100486|P3|NOT COMPLETED|Period 3||0
2488487|NCT00868790|6100487|P2|NOT COMPLETED|Period 3||0
2488488|NCT00868790|6100488|P1|NOT COMPLETED|Period 3||0
2488489|NCT00868790|6100475|P14|COMPLETED|Period 3||8
2488490|NCT00868790|6100476|P13|COMPLETED|Period 3||7
2488491|NCT00868790|6100477|P12|COMPLETED|Period 3||4
2488492|NCT00868790|6100478|P11|COMPLETED|Period 3||8
2488493|NCT00868790|6100479|P10|COMPLETED|Period 3||2
2488494|NCT00868790|6100480|P9|COMPLETED|Period 3||8
2488495|NCT00868790|6100481|P8|COMPLETED|Period 3||17
2488496|NCT00868790|6100482|P7|COMPLETED|Period 3||4
2488497|NCT00868790|6100483|P6|COMPLETED|Period 3||1
2488498|NCT00868790|6100484|P5|COMPLETED|Period 3||18
2488499|NCT00868790|6100485|P4|COMPLETED|Period 3||3
2488500|NCT00868790|6100486|P3|COMPLETED|Period 3||4
2488501|NCT00868790|6100487|P2|COMPLETED|Period 3||6
2488502|NCT00868790|6100488|P1|COMPLETED|Period 3||9
2488503|NCT00868790|6100475|P14|STARTED|Period 3||8
2488504|NCT00868790|6100476|P13|STARTED|Period 3||7
2488505|NCT00868790|6100477|P12|STARTED|Period 3||4
2488506|NCT00868790|6100478|P11|STARTED|Period 3||9
2488507|NCT00868790|6100479|P10|STARTED|Period 3||3
2488508|NCT00868790|6100480|P9|STARTED|Period 3||8
2488509|NCT00868790|6100481|P8|STARTED|Period 3||17
2488510|NCT00868790|6100482|P7|STARTED|Period 3||4
2488511|NCT00868790|6100483|P6|STARTED|Period 3||1
2488512|NCT00868790|6100484|P5|STARTED|Period 3||18
2488513|NCT00868790|6100485|P4|STARTED|Period 3||4
2488514|NCT00868790|6100486|P3|STARTED|Period 3||4
2488515|NCT00868790|6100487|P2|STARTED|Period 3||6
2488516|NCT00868790|6100488|P1|STARTED|Period 3||9
2488517|NCT00868790|6100475|P14|NOT COMPLETED|Period 2||1
2488518|NCT00868790|6100476|P13|NOT COMPLETED|Period 2||0
2488519|NCT00868790|6100477|P12|NOT COMPLETED|Period 2||0
2488520|NCT00868790|6100478|P11|NOT COMPLETED|Period 2||0
2488521|NCT00868790|6100479|P10|NOT COMPLETED|Period 2||0
2488522|NCT00868790|6100480|P9|NOT COMPLETED|Period 2||2
2488523|NCT00868790|6100481|P8|NOT COMPLETED|Period 2||0
2488524|NCT00868790|6100482|P7|NOT COMPLETED|Period 2||0
2488525|NCT00868790|6100483|P6|NOT COMPLETED|Period 2||1
2488526|NCT00868790|6100484|P5|NOT COMPLETED|Period 2||0
2488527|NCT00868790|6100485|P4|NOT COMPLETED|Period 2||0
2488528|NCT00868790|6100486|P3|NOT COMPLETED|Period 2||0
2488529|NCT00868790|6100487|P2|NOT COMPLETED|Period 2||1
2488530|NCT00868790|6100488|P1|NOT COMPLETED|Period 2||0
2488531|NCT00868790|6100475|P14|COMPLETED|Period 2||8
2488532|NCT00868790|6100476|P13|COMPLETED|Period 2||7
2488533|NCT00868790|6100477|P12|COMPLETED|Period 2||4
2488534|NCT00868790|6100478|P11|COMPLETED|Period 2||9
2488535|NCT00868790|6100479|P10|COMPLETED|Period 2||3
2488536|NCT00868790|6100480|P9|COMPLETED|Period 2||8
2488537|NCT00868790|6100481|P8|COMPLETED|Period 2||17
2488538|NCT00868790|6100482|P7|COMPLETED|Period 2||4
2488539|NCT00868790|6100483|P6|COMPLETED|Period 2||1
2488540|NCT00868790|6100484|P5|COMPLETED|Period 2||18
2488541|NCT00868790|6100485|P4|COMPLETED|Period 2||4
2488542|NCT00868790|6100486|P3|COMPLETED|Period 2||4
2488543|NCT00868790|6100487|P2|COMPLETED|Period 2||6
2488544|NCT00868790|6100488|P1|COMPLETED|Period 2||9
2488545|NCT00868790|6100475|P14|STARTED|Period 2||9
2488546|NCT00868790|6100476|P13|STARTED|Period 2||7
2488547|NCT00868790|6100477|P12|STARTED|Period 2||4
2488548|NCT00868790|6100478|P11|STARTED|Period 2||9
2488549|NCT00868790|6100479|P10|STARTED|Period 2||3
2488550|NCT00868790|6100480|P9|STARTED|Period 2||10
2488551|NCT00868790|6100481|P8|STARTED|Period 2||17
2488552|NCT00868790|6100482|P7|STARTED|Period 2||4
2488553|NCT00868790|6100483|P6|STARTED|Period 2||2
2488554|NCT00868790|6100484|P5|STARTED|Period 2||18
2488555|NCT00868790|6100485|P4|STARTED|Period 2||4
2488556|NCT00868790|6100486|P3|STARTED|Period 2||4
2488557|NCT00868790|6100487|P2|STARTED|Period 2||7
2488558|NCT00868790|6100488|P1|STARTED|Period 2||9
2488559|NCT00868790|6100475|P14|NOT COMPLETED|Period 1||2
2488560|NCT00868790|6100476|P13|NOT COMPLETED|Period 1||0
2488561|NCT00868790|6100477|P12|NOT COMPLETED|Period 1||0
2488562|NCT00868790|6100478|P11|NOT COMPLETED|Period 1||0
2488563|NCT00868790|6100479|P10|NOT COMPLETED|Period 1||0
2488564|NCT00868790|6100480|P9|NOT COMPLETED|Period 1||1
2488565|NCT00868790|6100481|P8|NOT COMPLETED|Period 1||3
2488566|NCT00868790|6100482|P7|NOT COMPLETED|Period 1||0
2488567|NCT00868790|6100483|P6|NOT COMPLETED|Period 1||1
2488568|NCT00868790|6100484|P5|NOT COMPLETED|Period 1||1
2488569|NCT00868790|6100485|P4|NOT COMPLETED|Period 1||0
2488570|NCT00868790|6100486|P3|NOT COMPLETED|Period 1||0
2488571|NCT00868790|6100487|P2|NOT COMPLETED|Period 1||1
2488572|NCT00868790|6100488|P1|NOT COMPLETED|Period 1||2
2488573|NCT00868790|6100475|P14|COMPLETED|Period 1||9
2488574|NCT00868790|6100476|P13|COMPLETED|Period 1||7
2488575|NCT00868790|6100477|P12|COMPLETED|Period 1||4
2488576|NCT00868790|6100478|P11|COMPLETED|Period 1||9
2488577|NCT00868790|6100479|P10|COMPLETED|Period 1||3
2488578|NCT00868790|6100480|P9|COMPLETED|Period 1||10
2488579|NCT00868790|6100481|P8|COMPLETED|Period 1||17
2488580|NCT00868790|6100482|P7|COMPLETED|Period 1||4
2488581|NCT00868790|6100483|P6|COMPLETED|Period 1||2
2488582|NCT00868790|6100484|P5|COMPLETED|Period 1||18
2488583|NCT00868790|6100485|P4|COMPLETED|Period 1||4
2488584|NCT00868790|6100486|P3|COMPLETED|Period 1||4
2488585|NCT00868790|6100487|P2|COMPLETED|Period 1||7
2488586|NCT00868790|6100488|P1|COMPLETED|Period 1||9
2488587|NCT00868790|6100475|P14|STARTED|Period 1||11
2488588|NCT00868790|6100476|P13|STARTED|Period 1||7
2488589|NCT00868790|6100477|P12|STARTED|Period 1||4
2488590|NCT00868790|6100478|P11|STARTED|Period 1||9
2488591|NCT00868790|6100479|P10|STARTED|Period 1||3
2488592|NCT00868790|6100480|P9|STARTED|Period 1||11
2488593|NCT00868790|6100481|P8|STARTED|Period 1||20
2488594|NCT00868790|6100482|P7|STARTED|Period 1||4
2488595|NCT00868790|6100483|P6|STARTED|Period 1||3
2488596|NCT00868790|6100484|P5|STARTED|Period 1||19
2488597|NCT00868790|6100485|P4|STARTED|Period 1||4
2488598|NCT00868790|6100486|P3|STARTED|Period 1||4
2488599|NCT00868790|6100487|P2|STARTED|Period 1||8
2488600|NCT00868790|6100488|P1|STARTED|Period 1||11
2488601|NCT00868751|6100525|P1|NOT COMPLETED|Overall Study||1
2488602|NCT00868751|6100525|P1|COMPLETED|Overall Study||0
2488603|NCT00868751|6100525|P1|STARTED|Overall Study||1
2488604|NCT00868712|6100536|P3|NOT COMPLETED|Overall Study||0
2488605|NCT00868712|6100537|P2|NOT COMPLETED|Overall Study||0
2488606|NCT00868712|6100538|P1|NOT COMPLETED|Overall Study||0
2488607|NCT00868712|6100536|P3|COMPLETED|Overall Study||28
2488608|NCT00868712|6100537|P2|COMPLETED|Overall Study||11
2488609|NCT00868712|6100538|P1|COMPLETED|Overall Study||31
2488610|NCT00868712|6100536|P3|STARTED|Overall Study||28
2488611|NCT00868712|6100537|P2|STARTED|Overall Study||11
2488612|NCT00868712|6100538|P1|STARTED|Overall Study||31
2488613|NCT00868699|6100552|P3|NOT COMPLETED|Overall Study||43
2488614|NCT00868699|6100553|P2|NOT COMPLETED|Overall Study||45
2488615|NCT00868699|6100554|P1|NOT COMPLETED|Overall Study||43
2488616|NCT00868699|6100552|P3|COMPLETED|Overall Study||123
2488617|NCT00868699|6100553|P2|COMPLETED|Overall Study||124
2488618|NCT00868699|6100554|P1|COMPLETED|Overall Study||127
2488619|NCT00868699|6100552|P3|Safety Population|Overall Study||164
2488620|NCT00868699|6100553|P2|Safety Population|Overall Study||167
2488621|NCT00868699|6100554|P1|Safety Population|Overall Study||168
2488622|NCT00868699|6100552|P3|Intent-to-Treat Population|Overall Study||161
2488623|NCT00868699|6100553|P2|Intent-to-Treat Population|Overall Study||162
2488624|NCT00868699|6100554|P1|Intent-to-Treat Population|Overall Study||162
2488625|NCT00868699|6100552|P3|STARTED|Overall Study||166
2488626|NCT00868699|6100553|P2|STARTED|Overall Study||169
2488627|NCT00868699|6100554|P1|STARTED|Overall Study||170
2488628|NCT00868608|6100571|P3|NOT COMPLETED|Overall Study||5
2488629|NCT00868608|6100572|P2|NOT COMPLETED|Overall Study||3
2488630|NCT00868608|6100573|P1|NOT COMPLETED|Overall Study||23
2488631|NCT00868608|6100571|P3|COMPLETED|Overall Study||0
2488632|NCT00868608|6100572|P2|COMPLETED|Overall Study||1
2488633|NCT00868608|6100573|P1|COMPLETED|Overall Study||49
2488634|NCT00868608|6100571|P3|STARTED|Overall Study||5
2488635|NCT00868608|6100572|P2|STARTED|Overall Study||4
2488636|NCT00868608|6100573|P1|STARTED|Overall Study||72
2488637|NCT00868530|6100597|P1|NOT COMPLETED|Overall Study||4
2488638|NCT00868530|6100597|P1|COMPLETED|Overall Study||49
2488639|NCT00868530|6100597|P1|STARTED|Overall Study||53
2488640|NCT00868517|6100612|P3|NOT COMPLETED|Overall Study||2
2488641|NCT00868517|6100613|P2|NOT COMPLETED|Overall Study||4
2488642|NCT00868517|6100614|P1|NOT COMPLETED|Overall Study||4
2488643|NCT00868517|6100612|P3|COMPLETED|Overall Study||9
2488644|NCT00868517|6100613|P2|COMPLETED|Overall Study||8
2488645|NCT00868517|6100614|P1|COMPLETED|Overall Study||8
2488646|NCT00868517|6100612|P3|STARTED|Overall Study||11
2488647|NCT00868517|6100613|P2|STARTED|Overall Study||12
2488648|NCT00868517|6100614|P1|STARTED|Overall Study||12
2488649|NCT00868452|6100639|P2|NOT COMPLETED|Overall Study||29
2488650|NCT00868452|6100640|P1|NOT COMPLETED|Overall Study||40
2488651|NCT00868452|6100639|P2|COMPLETED|Overall Study||136
2488652|NCT00868452|6100640|P1|COMPLETED|Overall Study||143
2488653|NCT00868452|6100639|P2|STARTED|Overall Study||165
2488654|NCT00868452|6100640|P1|STARTED|Overall Study||183
2488655|NCT00868439|6100652|P2|NOT COMPLETED|Overall Study||9
2488656|NCT00868439|6100653|P1|NOT COMPLETED|Overall Study||8
2488657|NCT00868439|6100652|P2|COMPLETED|Overall Study||40
2488658|NCT00868439|6100653|P1|COMPLETED|Overall Study||48
2488659|NCT00868439|6100652|P2|STARTED|Overall Study||49
2488660|NCT00868439|6100653|P1|STARTED|Overall Study||56
2488661|NCT00868374|6100671|P2|NOT COMPLETED|Overall Study||7
2488662|NCT00868374|6100672|P1|NOT COMPLETED|Overall Study||7
2488663|NCT00868374|6100671|P2|COMPLETED|Overall Study||4
2488664|NCT00868374|6100672|P1|COMPLETED|Overall Study||5
2488665|NCT00868374|6100671|P2|STARTED|Overall Study||11
2488666|NCT00868374|6100672|P1|STARTED|Overall Study||12
2488667|NCT00868348|6100680|P2|NOT COMPLETED|Overall Study||0
2488668|NCT00868348|6100681|P1|NOT COMPLETED|Overall Study||0
2488669|NCT00868348|6100680|P2|COMPLETED|Overall Study||30
2488670|NCT00868348|6100681|P1|COMPLETED|Overall Study||30
2488671|NCT00868348|6100680|P2|STARTED|Overall Study||30
2488672|NCT00868348|6100681|P1|STARTED|Overall Study||30
2488673|NCT00868309|6100699|P2|NOT COMPLETED|Overall Study||0
2488674|NCT00868309|6100700|P1|NOT COMPLETED|Overall Study||0
2488675|NCT00868309|6100699|P2|COMPLETED|Overall Study||6
2488676|NCT00868309|6100700|P1|COMPLETED|Overall Study||6
2488677|NCT00868309|6100699|P2|STARTED|Overall Study||6
2488678|NCT00868309|6100700|P1|STARTED|Overall Study||6
2488679|NCT00868296|6100710|P2|NOT COMPLETED|Overall Study||3
2488680|NCT00868296|6100711|P1|NOT COMPLETED|Overall Study||0
2488681|NCT00868296|6100710|P2|COMPLETED|Overall Study||43
2488682|NCT00868296|6100711|P1|COMPLETED|Overall Study||12
2488683|NCT00868296|6100710|P2|STARTED|Overall Study||46
2488684|NCT00868296|6100711|P1|STARTED|Overall Study||12
2488685|NCT00868231|6100719|P6|NOT COMPLETED|Treatment Period 3||0
2488686|NCT00868231|6100720|P5|NOT COMPLETED|Treatment Period 3||0
2488687|NCT00868231|6100721|P4|NOT COMPLETED|Treatment Period 3||0
2488688|NCT00868231|6100722|P3|NOT COMPLETED|Treatment Period 3||1
2488689|NCT00868231|6100723|P2|NOT COMPLETED|Treatment Period 3||0
2488690|NCT00868231|6100724|P1|NOT COMPLETED|Treatment Period 3||0
2488691|NCT00868231|6100719|P6|COMPLETED|Treatment Period 3||5
2488692|NCT00868231|6100720|P5|COMPLETED|Treatment Period 3||4
2488693|NCT00868231|6100721|P4|COMPLETED|Treatment Period 3||5
2488694|NCT00868231|6100722|P3|COMPLETED|Treatment Period 3||4
2488695|NCT00868231|6100723|P2|COMPLETED|Treatment Period 3||5
2488696|NCT00868231|6100724|P1|COMPLETED|Treatment Period 3||4
2488697|NCT00868231|6100719|P6|STARTED|Treatment Period 3||5
2488698|NCT00868231|6100720|P5|STARTED|Treatment Period 3||4
2488699|NCT00868231|6100721|P4|STARTED|Treatment Period 3||5
2488700|NCT00868231|6100722|P3|STARTED|Treatment Period 3||5
2488701|NCT00868231|6100723|P2|STARTED|Treatment Period 3||5
2488702|NCT00868231|6100724|P1|STARTED|Treatment Period 3||4
2488703|NCT00868231|6100719|P6|NOT COMPLETED|Treatment Period 2||0
2488704|NCT00868231|6100720|P5|NOT COMPLETED|Treatment Period 2||0
2488705|NCT00868231|6100721|P4|NOT COMPLETED|Treatment Period 2||0
2488706|NCT00868231|6100722|P3|NOT COMPLETED|Treatment Period 2||0
2488707|NCT00868231|6100723|P2|NOT COMPLETED|Treatment Period 2||0
2488708|NCT00868231|6100724|P1|NOT COMPLETED|Treatment Period 2||1
2488709|NCT00868231|6100719|P6|COMPLETED|Treatment Period 2||5
2488710|NCT00868231|6100720|P5|COMPLETED|Treatment Period 2||4
2488711|NCT00868231|6100721|P4|COMPLETED|Treatment Period 2||5
2488712|NCT00868231|6100722|P3|COMPLETED|Treatment Period 2||5
2488713|NCT00868231|6100723|P2|COMPLETED|Treatment Period 2||5
2488714|NCT00868231|6100724|P1|COMPLETED|Treatment Period 2||4
2488715|NCT00868231|6100719|P6|STARTED|Treatment Period 2||5
2488716|NCT00868231|6100720|P5|STARTED|Treatment Period 2||4
2488717|NCT00868231|6100721|P4|STARTED|Treatment Period 2||5
2488718|NCT00868231|6100722|P3|STARTED|Treatment Period 2||5
2488719|NCT00868231|6100723|P2|STARTED|Treatment Period 2||5
2488720|NCT00868231|6100724|P1|STARTED|Treatment Period 2||5
2488721|NCT00868231|6100719|P6|NOT COMPLETED|Treatment Period 1||0
2488722|NCT00868231|6100720|P5|NOT COMPLETED|Treatment Period 1||1
2488723|NCT00868231|6100721|P4|NOT COMPLETED|Treatment Period 1||0
2488724|NCT00868231|6100722|P3|NOT COMPLETED|Treatment Period 1||0
2488725|NCT00868231|6100723|P2|NOT COMPLETED|Treatment Period 1||0
2488726|NCT00868231|6100724|P1|NOT COMPLETED|Treatment Period 1||0
2488727|NCT00868231|6100719|P6|COMPLETED|Treatment Period 1||5
2488728|NCT00868231|6100720|P5|COMPLETED|Treatment Period 1||4
2488729|NCT00868231|6100721|P4|COMPLETED|Treatment Period 1||5
2488730|NCT00868231|6100722|P3|COMPLETED|Treatment Period 1||5
2488731|NCT00868231|6100723|P2|COMPLETED|Treatment Period 1||5
2488732|NCT00868231|6100724|P1|COMPLETED|Treatment Period 1||5
2488733|NCT00868231|6100719|P6|STARTED|Treatment Period 1||5
2488734|NCT00868231|6100720|P5|STARTED|Treatment Period 1||5
2488735|NCT00868231|6100721|P4|STARTED|Treatment Period 1||5
2488736|NCT00868231|6100722|P3|STARTED|Treatment Period 1||5
2488737|NCT00868231|6100723|P2|STARTED|Treatment Period 1||5
2488738|NCT00868231|6100724|P1|STARTED|Treatment Period 1||5
2488739|NCT00868218|6100769|P4|NOT COMPLETED|Overall Study||0
2488740|NCT00868218|6100770|P3|NOT COMPLETED|Overall Study||0
2488741|NCT00868218|6100771|P2|NOT COMPLETED|Overall Study||0
2488742|NCT00868218|6100772|P1|NOT COMPLETED|Overall Study||0
2488743|NCT00868218|6100769|P4|COMPLETED|Overall Study||15
2488744|NCT00868218|6100770|P3|COMPLETED|Overall Study||15
2488745|NCT00868218|6100771|P2|COMPLETED|Overall Study||15
2488746|NCT00868218|6100772|P1|COMPLETED|Overall Study||15
2488747|NCT00868218|6100769|P4|STARTED|Overall Study||15
2488748|NCT00868218|6100770|P3|STARTED|Overall Study||15
2488749|NCT00868218|6100771|P2|STARTED|Overall Study||15
2488750|NCT00868218|6100772|P1|STARTED|Overall Study||15
2488751|NCT00868192|6100790|P1|NOT COMPLETED|Overall Study||4
2488752|NCT00868192|6100790|P1|COMPLETED|Overall Study||34
2488753|NCT00868192|6100790|P1|STARTED|Overall Study||38
2488760|NCT00868140|6100830|P2|NOT COMPLETED|Overall Study||0
2488761|NCT00868140|6100831|P1|NOT COMPLETED|Overall Study||0
2488762|NCT00868140|6100830|P2|COMPLETED|Overall Study||25
2488763|NCT00868140|6100831|P1|COMPLETED|Overall Study||26
2488764|NCT00868140|6100830|P2|STARTED|Overall Study||25
2488765|NCT00868140|6100831|P1|STARTED|Overall Study||26
2488766|NCT00868101|6100849|P2|NOT COMPLETED|Overall Study||0
2488767|NCT00868101|6100850|P1|NOT COMPLETED|Overall Study||0
2488768|NCT00868101|6100849|P2|COMPLETED|Overall Study||10
2488769|NCT00868101|6100850|P1|COMPLETED|Overall Study||12
2488770|NCT00868101|6100849|P2|STARTED|Overall Study||10
2488771|NCT00868101|6100850|P1|STARTED|Overall Study||12
2488772|NCT00867932|6100862|P1|NOT COMPLETED|Overall Study||0
2488773|NCT00867932|6100862|P1|COMPLETED|Overall Study||7
2488774|NCT00867932|6100862|P1|Intent-to-Treat (ITT) Population|Overall Study||7
2488775|NCT00867932|6100862|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
2488776|NCT00867932|6100862|P1|Maintenance Phase|Overall Study||7
2488777|NCT00867932|6100862|P1|Induction Phase|Overall Study||7
2488778|NCT00867932|6100862|P1|STARTED|Overall Study||7
2488779|NCT00867815|6100870|P1|NOT COMPLETED|Overall Study||1
2488780|NCT00867815|6100870|P1|COMPLETED|Overall Study||9
2488781|NCT00867815|6100870|P1|STARTED|Overall Study||10
2488782|NCT00867659|6100876|P1|NOT COMPLETED|Overall Study||0
2488783|NCT00867659|6100876|P1|COMPLETED|Overall Study|January 2010|20
2488784|NCT00867659|6100876|P1|STARTED|Overall Study|October 2009|20
2488785|NCT00867568|6100881|P1|NOT COMPLETED|Overall Study||15
2488786|NCT00867568|6100881|P1|COMPLETED|Overall Study||3
2488787|NCT00867568|6100881|P1|STARTED|Overall Study||18
2488788|NCT00867529|6100890|P1|NOT COMPLETED|Overall Study||0
2488789|NCT00867529|6100890|P1|COMPLETED|Overall Study||63
2488790|NCT00867529|6100890|P1|STARTED|Overall Study||63
2488791|NCT00867503|6100898|P1|NOT COMPLETED|Overall Study||1
2488792|NCT00867503|6100898|P1|COMPLETED|Overall Study||9
2488793|NCT00867503|6100898|P1|STARTED|Overall Study||10
2488794|NCT00867490|6100904|P1|NOT COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||0
2488795|NCT00867490|6100904|P1|COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||61
2488796|NCT00867490|6100904|P1|STARTED|Phase 3 - Aliskiren+HCTZ+Amlodipine|The first 60 patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg entered this phase.|61
2488797|NCT00867490|6100904|P1|NOT COMPLETED|Phase 2 - Aliskiren+HCTZ||3
2488798|NCT00867490|6100904|P1|COMPLETED|Phase 2 - Aliskiren+HCTZ||120
2488799|NCT00867490|6100904|P1|STARTED|Phase 2 - Aliskiren+HCTZ|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|123
2488800|NCT00867490|6100904|P1|NOT COMPLETED|Phase 1 - Candesartan+HCTZ||10
2488801|NCT00867490|6100904|P1|COMPLETED|Phase 1 - Candesartan+HCTZ||176
2488802|NCT00867490|6100904|P1|STARTED|Phase 1 - Candesartan+HCTZ||186
2488803|NCT00867451|6100923|P2|NOT COMPLETED|Overall Study||0
2488804|NCT00867451|6100924|P1|NOT COMPLETED|Overall Study||0
2488805|NCT00867451|6100923|P2|COMPLETED|Overall Study||4
2488806|NCT00867451|6100924|P1|COMPLETED|Overall Study||4
2488807|NCT00867451|6100923|P2|STARTED|Overall Study||4
2488808|NCT00867451|6100924|P1|STARTED|Overall Study||4
2488809|NCT00867360|6100946|P2|NOT COMPLETED|Overall Study||1
2488810|NCT00867360|6100947|P1|NOT COMPLETED|Overall Study||1
2488811|NCT00867360|6100946|P2|COMPLETED|Overall Study||5
2488812|NCT00867360|6100947|P1|COMPLETED|Overall Study||3
2488813|NCT00867360|6100946|P2|STARTED|Overall Study||6
2488814|NCT00867360|6100947|P1|STARTED|Overall Study||4
2488815|NCT00867334|6100959|P2|NOT COMPLETED|Overall Study||1
2488816|NCT00867334|6100960|P1|NOT COMPLETED|Overall Study||2
2488817|NCT00867334|6100959|P2|COMPLETED|Overall Study||0
2488818|NCT00867334|6100960|P1|COMPLETED|Overall Study||4
2488819|NCT00867334|6100959|P2|STARTED|Overall Study||1
2488820|NCT00867334|6100960|P1|STARTED|Overall Study||6
2488821|NCT00867321|6100971|P6|NOT COMPLETED|Overall Study||0
2488822|NCT00867321|6100972|P5|NOT COMPLETED|Overall Study||0
2488823|NCT00867321|6100973|P4|NOT COMPLETED|Overall Study||0
2488824|NCT00867321|6100974|P3|NOT COMPLETED|Overall Study||0
2488825|NCT00867321|6100975|P2|NOT COMPLETED|Overall Study||1
2488826|NCT00867321|6100976|P1|NOT COMPLETED|Overall Study||0
2488827|NCT00867321|6100971|P6|COMPLETED|Overall Study||3
2488828|NCT00867321|6100972|P5|COMPLETED|Overall Study||5
2488829|NCT00867321|6100973|P4|COMPLETED|Overall Study||6
2488830|NCT00867321|6100974|P3|COMPLETED|Overall Study||3
2488831|NCT00867321|6100975|P2|COMPLETED|Overall Study||2
2488832|NCT00867321|6100976|P1|COMPLETED|Overall Study||4
2488833|NCT00867321|6100971|P6|STARTED|Overall Study||3
2488834|NCT00867321|6100972|P5|STARTED|Overall Study||5
2488835|NCT00867321|6100973|P4|STARTED|Overall Study||6
2488836|NCT00867321|6100974|P3|STARTED|Overall Study||3
2488837|NCT00867321|6100975|P2|STARTED|Overall Study||3
2488838|NCT00867321|6100976|P1|STARTED|Overall Study||4
2488839|NCT00867308|6100996|P2|NOT COMPLETED|Overall Study||18
2488840|NCT00867308|6100997|P1|NOT COMPLETED|Overall Study||9
2488841|NCT00867308|6100996|P2|COMPLETED|Overall Study||0
2488842|NCT00867308|6100997|P1|COMPLETED|Overall Study||0
2488843|NCT00867308|6100996|P2|STARTED|Overall Study||18
2488844|NCT00867308|6100997|P1|STARTED|Overall Study||9
2488845|NCT00867217|6101007|P2|NOT COMPLETED|Overall Study||10
2488846|NCT00867217|6101008|P1|NOT COMPLETED|Overall Study||3
2488847|NCT00867217|6101007|P2|COMPLETED|Overall Study||70
2488848|NCT00867217|6101008|P1|COMPLETED|Overall Study||77
2488849|NCT00867217|6101007|P2|STARTED|Overall Study||80
2488850|NCT00867217|6101008|P1|STARTED|Overall Study||80
2488851|NCT00867165|6101016|P2|NOT COMPLETED|Overall Study||0
2488852|NCT00867165|6101017|P1|NOT COMPLETED|Overall Study||4
2488853|NCT00867165|6101016|P2|COMPLETED|Overall Study||45
2488854|NCT00867165|6101017|P1|COMPLETED|Overall Study||89
2488855|NCT00867165|6101016|P2|STARTED|Overall Study||45
2488856|NCT00867165|6101017|P1|STARTED|Overall Study||93
2488857|NCT00867139|6101122|P3|NOT COMPLETED|Overall Study||1
2488858|NCT00867139|6101123|P2|NOT COMPLETED|Overall Study||0
2488859|NCT00867139|6101124|P1|NOT COMPLETED|Overall Study||0
2488860|NCT00867139|6101122|P3|COMPLETED|Overall Study|One open-labeled patient withdrew on day 5.|3
2488861|NCT00867139|6101123|P2|COMPLETED|Overall Study||1
2488862|NCT00867139|6101124|P1|COMPLETED|Overall Study||2
2488863|NCT00867139|6101122|P3|STARTED|Overall Study||4
2488864|NCT00867139|6101123|P2|STARTED|Overall Study||1
2488865|NCT00867139|6101124|P1|STARTED|Overall Study||2
2488866|NCT00867113|6101165|P1|NOT COMPLETED|Post Treatment After Survival Follow-up||11
2488867|NCT00867113|6101165|P1|COMPLETED|Post Treatment After Survival Follow-up||57
2488868|NCT00867113|6101165|P1|STARTED|Post Treatment After Survival Follow-up||68
2488869|NCT00867113|6101165|P1|NOT COMPLETED|Treatment Period||45
2488870|NCT00867113|6101165|P1|COMPLETED|Treatment Period||46
2488871|NCT00867113|6101165|P1|Full Analysis Set (FAS)|Treatment Period||91
2488872|NCT00867113|6101165|P1|Safety Set|Treatment Period||91
2488873|NCT00867113|6101165|P1|STARTED|Treatment Period||91
2488874|NCT00867100|6101185|P13|NOT COMPLETED|Overall Study||0
2488875|NCT00867100|6101186|P12|NOT COMPLETED|Overall Study||0
2488876|NCT00867100|6101187|P11|NOT COMPLETED|Overall Study||1
2488877|NCT00867100|6101188|P10|NOT COMPLETED|Overall Study||0
2488878|NCT00867100|6101189|P9|NOT COMPLETED|Overall Study||0
2488879|NCT00867100|6101190|P8|NOT COMPLETED|Overall Study||0
2488880|NCT00867100|6101191|P7|NOT COMPLETED|Overall Study||1
2488881|NCT00867100|6101192|P6|NOT COMPLETED|Overall Study||0
2488882|NCT00867100|6101193|P5|NOT COMPLETED|Overall Study||0
2488883|NCT00867100|6101194|P4|NOT COMPLETED|Overall Study||0
2488884|NCT00867100|6101195|P3|NOT COMPLETED|Overall Study||0
2488885|NCT00867100|6101196|P2|NOT COMPLETED|Overall Study||1
2488886|NCT00867100|6101197|P1|NOT COMPLETED|Overall Study||0
2488887|NCT00867100|6101185|P13|COMPLETED|Overall Study||6
2488888|NCT00867100|6101186|P12|COMPLETED|Overall Study||6
2488889|NCT00867100|6101187|P11|COMPLETED|Overall Study||3
2488890|NCT00867100|6101188|P10|COMPLETED|Overall Study||6
2488891|NCT00867100|6101189|P9|COMPLETED|Overall Study||6
2488892|NCT00867100|6101190|P8|COMPLETED|Overall Study||3
2488893|NCT00867100|6101191|P7|COMPLETED|Overall Study||6
2488894|NCT00867100|6101192|P6|COMPLETED|Overall Study||6
2488895|NCT00867100|6101193|P5|COMPLETED|Overall Study||14
2488896|NCT00867100|6101194|P4|COMPLETED|Overall Study||8
2488897|NCT00867100|6101195|P3|COMPLETED|Overall Study||8
2488898|NCT00867100|6101196|P2|COMPLETED|Overall Study||4
2488899|NCT00867100|6101197|P1|COMPLETED|Overall Study||5
2488900|NCT00867100|6101185|P13|STARTED|Overall Study||6
2488901|NCT00867100|6101186|P12|STARTED|Overall Study||6
2488902|NCT00867100|6101187|P11|STARTED|Overall Study||4
2488903|NCT00867100|6101188|P10|STARTED|Overall Study||6
2488904|NCT00867100|6101189|P9|STARTED|Overall Study||6
2488905|NCT00867100|6101190|P8|STARTED|Overall Study||3
2488906|NCT00867100|6101191|P7|STARTED|Overall Study||7
2488907|NCT00867100|6101192|P6|STARTED|Overall Study||6
2488908|NCT00867100|6101193|P5|STARTED|Overall Study||14
2488909|NCT00867100|6101194|P4|STARTED|Overall Study||8
2488910|NCT00867100|6101195|P3|STARTED|Overall Study||8
2488911|NCT00867100|6101196|P2|STARTED|Overall Study||5
2488912|NCT00867100|6101197|P1|STARTED|Overall Study||5
2488913|NCT00867087|6101229|P1|NOT COMPLETED|Overall Study||42
2488914|NCT00867087|6101229|P1|COMPLETED|Overall Study||21
2488915|NCT00867087|6101229|P1|STARTED|Overall Study||63
2488916|NCT00867035|6101245|P2|NOT COMPLETED|Baseline to 1 Week||0
2488917|NCT00867035|6101246|P1|NOT COMPLETED|Baseline to 1 Week||1
2488918|NCT00867035|6101245|P2|COMPLETED|Baseline to 1 Week||8
2488919|NCT00867035|6101246|P1|COMPLETED|Baseline to 1 Week||11
2488920|NCT00867035|6101245|P2|STARTED|Baseline to 1 Week||8
2488921|NCT00867035|6101246|P1|STARTED|Baseline to 1 Week||12
2488922|NCT00867035|6101245|P2|NOT COMPLETED|Baseline to 4 Hours||0
2488923|NCT00867035|6101246|P1|NOT COMPLETED|Baseline to 4 Hours||0
2488924|NCT00867035|6101245|P2|COMPLETED|Baseline to 4 Hours||8
2488925|NCT00867035|6101246|P1|COMPLETED|Baseline to 4 Hours||12
2488926|NCT00867035|6101245|P2|STARTED|Baseline to 4 Hours||8
2488927|NCT00867035|6101246|P1|STARTED|Baseline to 4 Hours||12
2488928|NCT00867035|6101245|P2|NOT COMPLETED|Baseline to 2 Hours||0
2488929|NCT00867035|6101246|P1|NOT COMPLETED|Baseline to 2 Hours||0
2488930|NCT00867035|6101245|P2|COMPLETED|Baseline to 2 Hours||8
2488931|NCT00867035|6101246|P1|COMPLETED|Baseline to 2 Hours||12
2488932|NCT00867035|6101245|P2|STARTED|Baseline to 2 Hours||8
2488933|NCT00867035|6101246|P1|STARTED|Baseline to 2 Hours||12
2488934|NCT00867035|6101245|P2|NOT COMPLETED|Baseline to 1 Hour||1
2488935|NCT00867035|6101246|P1|NOT COMPLETED|Baseline to 1 Hour||1
2488936|NCT00867035|6101245|P2|COMPLETED|Baseline to 1 Hour||8
2488937|NCT00867035|6101246|P1|COMPLETED|Baseline to 1 Hour||12
2488938|NCT00867035|6101245|P2|STARTED|Baseline to 1 Hour||9
2488939|NCT00867035|6101246|P1|STARTED|Baseline to 1 Hour||13
2488940|NCT00867009|6101272|P1|NOT COMPLETED|Maintenance Period||4
2488941|NCT00867009|6101272|P1|COMPLETED|Maintenance Period|Participant was considered completed if they had PD, death, or stopped receiving study drug.|47
2488942|NCT00867009|6101272|P1|STARTED|Maintenance Period||51
2488943|NCT00867009|6101272|P1|NOT COMPLETED|Induction Period||62
2488944|NCT00867009|6101272|P1|COMPLETED|Induction Period|Participants continued on the study in the Maintenance Period.|51
2488945|NCT00867009|6101272|P1|Protocol Qualified (PQ) Population|Induction Period|Stage IIIB/IV NS-NSCLC, no concurrent chemotherapy, measurable disease, ≥1 dose study drug.|109
2488946|NCT00867009|6101272|P1|Received at Least 1 Dose of Study Drug|Induction Period||113
2488947|NCT00867009|6101272|P1|STARTED|Induction Period|Participants with Stage IIIB/IV non-squamous (NS) non-small cell lung cancer (NSCLC)|113
2488948|NCT00866918|6101281|P2|NOT COMPLETED|Overall Study||12
2488949|NCT00866918|6101282|P1|NOT COMPLETED|Overall Study||16
2488950|NCT00866918|6101281|P2|COMPLETED|Overall Study||27
2488951|NCT00866918|6101282|P1|COMPLETED|Overall Study||53
2488952|NCT00866918|6101281|P2|STARTED|Overall Study||39
2488953|NCT00866918|6101282|P1|STARTED|Overall Study||69
2488954|NCT00866905|6101294|P1|NOT COMPLETED|Overall Study||33
2488955|NCT00866905|6101294|P1|COMPLETED|Overall Study||135
2488956|NCT00866905|6101294|P1|STARTED|Overall Study||168
2488957|NCT00866879|6101301|P2|NOT COMPLETED|Overall Study||0
2488958|NCT00866879|6101302|P1|NOT COMPLETED|Overall Study||0
2488959|NCT00866879|6101301|P2|COMPLETED|Overall Study||185
2488960|NCT00866879|6101302|P1|COMPLETED|Overall Study||90
2488961|NCT00866879|6101301|P2|STARTED|Overall Study||185
2488962|NCT00866879|6101302|P1|STARTED|Overall Study||90
2488963|NCT00866814|6101316|P1|NOT COMPLETED|Overall Study||20
2488964|NCT00866814|6101316|P1|COMPLETED|Overall Study||99
2488965|NCT00866814|6101316|P1|STARTED|Overall Study||119
2488966|NCT00866788|6101329|P4|NOT COMPLETED|Overall Study||5
2488967|NCT00866788|6101330|P3|NOT COMPLETED|Overall Study||2
2488968|NCT00866788|6101331|P2|NOT COMPLETED|Overall Study||6
2488969|NCT00866788|6101332|P1|NOT COMPLETED|Overall Study||6
2488970|NCT00866788|6101329|P4|COMPLETED|Overall Study||16
2488971|NCT00866788|6101330|P3|COMPLETED|Overall Study||23
2488972|NCT00866788|6101331|P2|COMPLETED|Overall Study||17
2488973|NCT00866788|6101332|P1|COMPLETED|Overall Study||15
2488974|NCT00866788|6101329|P4|STARTED|Overall Study||21
2488975|NCT00866788|6101330|P3|STARTED|Overall Study||25
2488976|NCT00866788|6101331|P2|STARTED|Overall Study||23
2488977|NCT00866788|6101332|P1|STARTED|Overall Study||21
2488978|NCT00866775|6101380|P2|NOT COMPLETED|Overall Study||52
2488979|NCT00866775|6101381|P1|NOT COMPLETED|Overall Study||36
2488980|NCT00866775|6101380|P2|COMPLETED|Overall Study||76
2488981|NCT00866775|6101381|P1|COMPLETED|Overall Study||29
2488982|NCT00866775|6101380|P2|STARTED|Overall Study||128
2488983|NCT00866775|6101381|P1|STARTED|Overall Study||65
2488984|NCT00866749|6101417|P1|NOT COMPLETED|Overall Study||0
2488985|NCT00866749|6101417|P1|COMPLETED|Overall Study||120
2488986|NCT00866749|6101417|P1|STARTED|Overall Study||120
2488987|NCT00866723|6101424|P1|NOT COMPLETED|Overall Study||5
2488988|NCT00866723|6101424|P1|COMPLETED|Overall Study||0
2488989|NCT00866723|6101424|P1|STARTED|Overall Study||5
2488990|NCT00866697|6101431|P2|NOT COMPLETED|Overall Study||228
2488991|NCT00866697|6101432|P1|NOT COMPLETED|Overall Study||214
2488992|NCT00866697|6101431|P2|COMPLETED|Overall Study||244
2488993|NCT00866697|6101432|P1|COMPLETED|Overall Study||254
2488994|NCT00866697|6101431|P2|STARTED|Overall Study||472
2488995|NCT00866697|6101432|P1|STARTED|Overall Study||468
2488996|NCT00866658|6101474|P2|NOT COMPLETED|Overall Study||21
2488997|NCT00866658|6101475|P1|NOT COMPLETED|Overall Study||13
2488998|NCT00866658|6101474|P2|COMPLETED|Overall Study||133
2488999|NCT00866658|6101475|P1|COMPLETED|Overall Study||144
2489000|NCT00866658|6101474|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||154
2489001|NCT00866658|6101475|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|157
2489002|NCT00866658|6101474|P2|Safety Population|Overall Study||154
2489003|NCT00866658|6101475|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|157
2489004|NCT00866658|6101474|P2|STARTED|Overall Study||154
2489005|NCT00866658|6101475|P1|STARTED|Overall Study|Randomized.|157
2489006|NCT00866619|6101507|P4|NOT COMPLETED|Overall Study||630
2489007|NCT00866619|6101508|P3|NOT COMPLETED|Overall Study||889
2489008|NCT00866619|6101509|P2|NOT COMPLETED|Overall Study||1270
2489009|NCT00866619|6101510|P1|NOT COMPLETED|Overall Study||1846
2489010|NCT00866619|6101507|P4|COMPLETED|Overall Study||1549
2489011|NCT00866619|6101508|P3|COMPLETED|Overall Study||2085
2489012|NCT00866619|6101509|P2|COMPLETED|Overall Study||3088
2489013|NCT00866619|6101510|P1|COMPLETED|Overall Study||4102
2489014|NCT00866619|6101507|P4|STARTED|Overall Study||2179
2489015|NCT00866619|6101508|P3|STARTED|Overall Study||2974
2489016|NCT00866619|6101509|P2|STARTED|Overall Study||4358
2489017|NCT00866619|6101510|P1|STARTED|Overall Study||5948
2489018|NCT00866606|6101830|P1|NOT COMPLETED|Overall Study||4
2489019|NCT00866606|6101830|P1|COMPLETED|Overall Study||31
2489020|NCT00866606|6101830|P1|STARTED|Overall Study||35
2489021|NCT00866359|6101844|P4|NOT COMPLETED|Observational Follow-Up Phase||0
2489022|NCT00866359|6101845|P3|NOT COMPLETED|Observational Follow-Up Phase||0
2489023|NCT00866359|6101846|P2|NOT COMPLETED|Observational Follow-Up Phase||0
2489024|NCT00866359|6101847|P1|NOT COMPLETED|Observational Follow-Up Phase||0
2489025|NCT00866359|6101844|P4|COMPLETED|Observational Follow-Up Phase||54
2489026|NCT00866359|6101845|P3|COMPLETED|Observational Follow-Up Phase||54
2489027|NCT00866359|6101846|P2|COMPLETED|Observational Follow-Up Phase||0
2489028|NCT00866359|6101847|P1|COMPLETED|Observational Follow-Up Phase||0
2489029|NCT00866359|6101844|P4|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
2489030|NCT00866359|6101845|P3|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
2489031|NCT00866359|6101846|P2|STARTED|Observational Follow-Up Phase||0
2489032|NCT00866359|6101847|P1|STARTED|Observational Follow-Up Phase||0
2489033|NCT00866359|6101844|P4|NOT COMPLETED|Extension Phase (Day 86 to 169)||3
2489034|NCT00866359|6101845|P3|NOT COMPLETED|Extension Phase (Day 86 to 169)||1
2489035|NCT00866359|6101846|P2|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
2489036|NCT00866359|6101847|P1|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
2489037|NCT00866359|6101844|P4|COMPLETED|Extension Phase (Day 86 to 169)||47
2489038|NCT00866359|6101845|P3|COMPLETED|Extension Phase (Day 86 to 169)||44
2489039|NCT00866359|6101846|P2|COMPLETED|Extension Phase (Day 86 to 169)||0
2489040|NCT00866359|6101847|P1|COMPLETED|Extension Phase (Day 86 to 169)||0
2489041|NCT00866359|6101844|P4|STARTED|Extension Phase (Day 86 to 169)||50
2489042|NCT00866359|6101845|P3|STARTED|Extension Phase (Day 86 to 169)||45
2489043|NCT00866359|6101846|P2|STARTED|Extension Phase (Day 86 to 169)||0
2489044|NCT00866359|6101847|P1|STARTED|Extension Phase (Day 86 to 169)||0
2489045|NCT00866359|6101844|P4|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
2489046|NCT00866359|6101845|P3|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
2489047|NCT00866359|6101846|P2|NOT COMPLETED|Treatment Phase (Days 1 to 85)||5
2489048|NCT00866359|6101847|P1|NOT COMPLETED|Treatment Phase (Days 1 to 85)||11
2489049|NCT00866359|6101844|P4|COMPLETED|Treatment Phase (Days 1 to 85)||0
2489050|NCT00866359|6101845|P3|COMPLETED|Treatment Phase (Days 1 to 85)||0
2489051|NCT00866359|6101846|P2|COMPLETED|Treatment Phase (Days 1 to 85)||50
2489052|NCT00866359|6101847|P1|COMPLETED|Treatment Phase (Days 1 to 85)||45
2489053|NCT00866359|6101844|P4|STARTED|Treatment Phase (Days 1 to 85)||0
2489054|NCT00866359|6101845|P3|STARTED|Treatment Phase (Days 1 to 85)||0
2489055|NCT00866359|6101846|P2|STARTED|Treatment Phase (Days 1 to 85)||55
2489056|NCT00866359|6101847|P1|STARTED|Treatment Phase (Days 1 to 85)||56
2489057|NCT00866333|6101903|P3|NOT COMPLETED|Overall Study||12
2489058|NCT00866333|6101904|P2|NOT COMPLETED|Overall Study||7
2489059|NCT00866333|6101905|P1|NOT COMPLETED|Overall Study||5
2489060|NCT00866333|6101903|P3|COMPLETED|Overall Study||4
2489061|NCT00866333|6101904|P2|COMPLETED|Overall Study||10
2489062|NCT00866333|6101905|P1|COMPLETED|Overall Study||11
2489063|NCT00866333|6101903|P3|STARTED|Overall Study||16
2489064|NCT00866333|6101904|P2|STARTED|Overall Study||17
2489065|NCT00866333|6101905|P1|STARTED|Overall Study||16
2489066|NCT00866320|6101922|P1|NOT COMPLETED|Overall Study||6
2489067|NCT00866320|6101922|P1|COMPLETED|Overall Study|All patients that received treatment were analyzed.|43
2489068|NCT00866320|6101922|P1|STARTED|Overall Study||49
2489069|NCT00866307|6101929|P3|NOT COMPLETED|Consolidation/Maintenance||16
2489070|NCT00866307|6101930|P2|NOT COMPLETED|Consolidation/Maintenance||9
2489071|NCT00866307|6101931|P1|NOT COMPLETED|Consolidation/Maintenance||0
2489072|NCT00866307|6101929|P3|COMPLETED|Consolidation/Maintenance||14
2489073|NCT00866307|6101930|P2|COMPLETED|Consolidation/Maintenance||45
2489074|NCT00866307|6101931|P1|COMPLETED|Consolidation/Maintenance||0
2489075|NCT00866307|6101929|P3|STARTED|Consolidation/Maintenance||30
2489076|NCT00866307|6101930|P2|STARTED|Consolidation/Maintenance||54
2489077|NCT00866307|6101931|P1|STARTED|Consolidation/Maintenance||0
2489078|NCT00866307|6101929|P3|NOT COMPLETED|Induction||0
2489079|NCT00866307|6101930|P2|NOT COMPLETED|Induction||0
2489080|NCT00866307|6101931|P1|NOT COMPLETED|Induction||20
2489081|NCT00866307|6101929|P3|COMPLETED|Induction||0
2489082|NCT00866307|6101930|P2|COMPLETED|Induction||0
2489083|NCT00866307|6101931|P1|COMPLETED|Induction||84
2489084|NCT00866307|6101929|P3|STARTED|Induction||0
2489085|NCT00866307|6101930|P2|STARTED|Induction||0
2489086|NCT00866307|6101931|P1|STARTED|Induction||104
2489087|NCT00866294|6101941|P3|NOT COMPLETED|Overall Study||11
2489088|NCT00866294|6101942|P2|NOT COMPLETED|Overall Study||20
2489089|NCT00866294|6101943|P1|NOT COMPLETED|Overall Study||33
2489090|NCT00866294|6101941|P3|COMPLETED|Overall Study||72
2489091|NCT00866294|6101942|P2|COMPLETED|Overall Study||141
2489092|NCT00866294|6101943|P1|COMPLETED|Overall Study||139
2489093|NCT00866294|6101941|P3|STARTED|Overall Study||83
2489094|NCT00866294|6101942|P2|STARTED|Overall Study||161
2489095|NCT00866294|6101943|P1|STARTED|Overall Study||172
2489096|NCT00866281|6101972|P2|NOT COMPLETED|Overall Study||15
2489097|NCT00866281|6101973|P1|NOT COMPLETED|Overall Study||7
2489098|NCT00866281|6101972|P2|COMPLETED|Overall Study||0
2489099|NCT00866281|6101973|P1|COMPLETED|Overall Study||0
2489100|NCT00866281|6101972|P2|STARTED|Overall Study||15
2489101|NCT00866281|6101973|P1|STARTED|Overall Study||7
2489102|NCT00866177|6101989|P1|NOT COMPLETED|Overall Study||152
2489103|NCT00866177|6101989|P1|COMPLETED|Overall Study||15
2489104|NCT00866177|6101989|P1|STARTED|Overall Study||167
2489105|NCT00866047|6101993|P1|NOT COMPLETED|Follow-up Period||5
2489106|NCT00866047|6101993|P1|COMPLETED|Follow-up Period|Completed survival follow-up due to death [25] or study completion [28]|53
2489107|NCT00866047|6101993|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|58
2489108|NCT00866047|6101993|P1|NOT COMPLETED|Treatment Period||48
2489109|NCT00866047|6101993|P1|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|10
2489110|NCT00866047|6101993|P1|STARTED|Treatment Period||58
2489111|NCT00866034|6102011|P2|NOT COMPLETED|Overall Study||8
2489112|NCT00866034|6102012|P1|NOT COMPLETED|Overall Study||16
2489113|NCT00866034|6102011|P2|COMPLETED|Overall Study||301
2489114|NCT00866034|6102012|P1|COMPLETED|Overall Study||292
2489115|NCT00866034|6102011|P2|STARTED|Overall Study||309
2489116|NCT00866034|6102012|P1|STARTED|Overall Study||308
2489117|NCT00865904|6102025|P5|NOT COMPLETED|Overall Study||1
2489118|NCT00865904|6102026|P4|NOT COMPLETED|Overall Study||1
2489119|NCT00865904|6102027|P3|NOT COMPLETED|Overall Study||0
2489120|NCT00865904|6102028|P2|NOT COMPLETED|Overall Study||0
2489121|NCT00865904|6102029|P1|NOT COMPLETED|Overall Study||2
2489122|NCT00865904|6102025|P5|COMPLETED|Overall Study|Completed 14-day follow-up.|19
2489123|NCT00865904|6102026|P4|COMPLETED|Overall Study|Completed 14-day follow-up.|17
2489124|NCT00865904|6102027|P3|COMPLETED|Overall Study|Completed 14-day follow-up.|18
2489125|NCT00865904|6102028|P2|COMPLETED|Overall Study|Completed 14-day follow-up.|18
2489126|NCT00865904|6102029|P1|COMPLETED|Overall Study|Completed 14-day follow-up.|17
2489127|NCT00865904|6102025|P5|STARTED|Overall Study|Randomized.|20
2489128|NCT00865904|6102026|P4|STARTED|Overall Study|Randomized.|18
2489129|NCT00865904|6102027|P3|STARTED|Overall Study|Randomized.|18
2489130|NCT00865904|6102028|P2|STARTED|Overall Study|Randomized.|18
2489131|NCT00865904|6102029|P1|STARTED|Overall Study|Randomized.|19
2489132|NCT00865709|6102086|P2|NOT COMPLETED|Long Term Follow-up||49
2489133|NCT00865709|6102087|P1|NOT COMPLETED|Long Term Follow-up||46
2489134|NCT00865709|6102086|P2|COMPLETED|Long Term Follow-up||33
2489135|NCT00865709|6102087|P1|COMPLETED|Long Term Follow-up||24
2489136|NCT00865709|6102086|P2|STARTED|Long Term Follow-up||82
2489137|NCT00865709|6102087|P1|STARTED|Long Term Follow-up||70
2489138|NCT00865709|6102086|P2|NOT COMPLETED|Active Follow-up||1
2489139|NCT00865709|6102087|P1|NOT COMPLETED|Active Follow-up||8
2489140|NCT00865709|6102086|P2|COMPLETED|Active Follow-up||15
2489141|NCT00865709|6102087|P1|COMPLETED|Active Follow-up||17
2489142|NCT00865709|6102086|P2|STARTED|Active Follow-up||16
2489143|NCT00865709|6102087|P1|STARTED|Active Follow-up||25
2489144|NCT00865709|6102086|P2|NOT COMPLETED|Treatment||18
2489145|NCT00865709|6102087|P1|NOT COMPLETED|Treatment||30
2489146|NCT00865709|6102086|P2|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|83
2489147|NCT00865709|6102087|P1|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|67
2489148|NCT00865709|6102086|P2|Received Treatment|Treatment|Safety population|101
2489149|NCT00865709|6102087|P1|Received Treatment|Treatment|Safety population|97
2489150|NCT00865709|6102086|P2|STARTED|Treatment||101
2489151|NCT00865709|6102087|P1|STARTED|Treatment||97
2489152|NCT00865566|6102105|P2|NOT COMPLETED|Overall Study||687
2489153|NCT00865566|6102106|P1|NOT COMPLETED|Overall Study||624
2489154|NCT00865566|6102105|P2|COMPLETED|Overall Study||564
2489155|NCT00865566|6102106|P1|COMPLETED|Overall Study||629
2489156|NCT00865566|6102105|P2|Modified Intent-to-Treat Population|Overall Study||1245
2489157|NCT00865566|6102106|P1|Modified Intent-to-Treat Population|Overall Study||1251
2489158|NCT00865566|6102105|P2|STARTED|Overall Study||1251
2489159|NCT00865566|6102106|P1|STARTED|Overall Study||1253
2489160|NCT00865514|6102126|P1|NOT COMPLETED|Overall Study||2
2489161|NCT00865514|6102126|P1|COMPLETED|Overall Study||0
2489162|NCT00865514|6102126|P1|STARTED|Overall Study||2
2489163|NCT00865345|6102131|P1|NOT COMPLETED|Overall Study||2
2489164|NCT00865345|6102131|P1|COMPLETED|Overall Study||61
2489165|NCT00865345|6102131|P1|STARTED|Overall Study||63
2489166|NCT00865306|6102138|P2|NOT COMPLETED|One-Year Follow-Up||0
2489167|NCT00865306|6102139|P1|NOT COMPLETED|One-Year Follow-Up||0
2489168|NCT00865306|6102138|P2|COMPLETED|One-Year Follow-Up||15
2489169|NCT00865306|6102139|P1|COMPLETED|One-Year Follow-Up||29
2489170|NCT00865306|6102138|P2|STARTED|One-Year Follow-Up|Only controls who opted for CBT after the waitlist (n=17) were included. 2 were lost (15 included).|15
2489171|NCT00865306|6102139|P1|STARTED|One-Year Follow-Up||29
2489172|NCT00865306|6102138|P2|NOT COMPLETED|Controlled Trial||2
2489173|NCT00865306|6102139|P1|NOT COMPLETED|Controlled Trial||5
2489174|NCT00865306|6102138|P2|COMPLETED|Controlled Trial||28
2489175|NCT00865306|6102139|P1|COMPLETED|Controlled Trial||29
2489176|NCT00865306|6102138|P2|STARTED|Controlled Trial||30
2489177|NCT00865306|6102139|P1|STARTED|Controlled Trial|35 assigned to CBT. One child in trial had 0 anxiety disorders, so we excluded her from analysis.|34
2489178|NCT00865202|6102151|P2|NOT COMPLETED|Overall Study||0
2489179|NCT00865202|6102152|P1|NOT COMPLETED|Overall Study||0
2489180|NCT00865202|6102151|P2|COMPLETED|Overall Study||149
2489181|NCT00865202|6102152|P1|COMPLETED|Overall Study||152
2489182|NCT00865202|6102151|P2|STARTED|Overall Study||149
2489183|NCT00865202|6102152|P1|STARTED|Overall Study||152
2489184|NCT00865189|6102168|P2|NOT COMPLETED|Overall Study||19
2489185|NCT00865189|6102169|P1|NOT COMPLETED|Overall Study||12
2489186|NCT00865189|6102168|P2|COMPLETED|Overall Study||26
2489187|NCT00865189|6102169|P1|COMPLETED|Overall Study||34
2489188|NCT00865189|6102168|P2|STARTED|Overall Study||45
2489189|NCT00865189|6102169|P1|STARTED|Overall Study||46
2489190|NCT00865124|6102197|P3|NOT COMPLETED|Overall Study||0
2489191|NCT00865124|6102198|P2|NOT COMPLETED|Overall Study||1
2489192|NCT00865124|6102199|P1|NOT COMPLETED|Overall Study||4
2489193|NCT00865124|6102197|P3|COMPLETED|Overall Study||17
2489194|NCT00865124|6102198|P2|COMPLETED|Overall Study||24
2489195|NCT00865124|6102199|P1|COMPLETED|Overall Study||23
2489196|NCT00865124|6102197|P3|STARTED|Overall Study||17
2489197|NCT00865124|6102198|P2|STARTED|Overall Study||25
2489198|NCT00865124|6102199|P1|STARTED|Overall Study||27
2489199|NCT00865098|6102216|P1|NOT COMPLETED|Overall Study||1
2489200|NCT00865098|6102216|P1|COMPLETED|Overall Study|Discontinued from the study due to progressive disease, after completing planned treatment schedule|21
2489201|NCT00865098|6102216|P1|STARTED|Overall Study||22
2489202|NCT00865046|6102228|P3|NOT COMPLETED|Overall Study||1
2489203|NCT00865046|6102229|P2|NOT COMPLETED|Overall Study||5
2489204|NCT00865046|6102230|P1|NOT COMPLETED|Overall Study||6
2489205|NCT00865046|6102228|P3|COMPLETED|Overall Study||62
2489206|NCT00865046|6102229|P2|COMPLETED|Overall Study||59
2489207|NCT00865046|6102230|P1|COMPLETED|Overall Study||57
2489208|NCT00865046|6102228|P3|STARTED|Overall Study||63
2489209|NCT00865046|6102229|P2|STARTED|Overall Study||64
2489210|NCT00865046|6102230|P1|STARTED|Overall Study||63
2489211|NCT00865020|6102240|P2|NOT COMPLETED|Overall Study||51
2489212|NCT00865020|6102241|P1|NOT COMPLETED|Overall Study||49
2489213|NCT00865020|6102240|P2|COMPLETED|Overall Study||357
2489214|NCT00865020|6102241|P1|COMPLETED|Overall Study||365
2489215|NCT00865020|6102240|P2|STARTED|Overall Study||408
2489216|NCT00865020|6102241|P1|STARTED|Overall Study||414
2489217|NCT00864916|6102257|P2|NOT COMPLETED|Overall Study||4
2489218|NCT00864916|6102258|P1|NOT COMPLETED|Overall Study||6
2489219|NCT00864916|6102257|P2|COMPLETED|Overall Study||5
2489220|NCT00864916|6102258|P1|COMPLETED|Overall Study||4
2489221|NCT00864916|6102257|P2|STARTED|Overall Study||9
2489222|NCT00864916|6102258|P1|STARTED|Overall Study||10
2489223|NCT00864851|6102267|P3|NOT COMPLETED|Overall Study||0
2489224|NCT00864851|6102268|P2|NOT COMPLETED|Overall Study||1
2489225|NCT00864851|6102269|P1|NOT COMPLETED|Overall Study||3
2489226|NCT00864851|6102267|P3|COMPLETED|Overall Study||5
2489227|NCT00864851|6102268|P2|COMPLETED|Overall Study||18
2489228|NCT00864851|6102269|P1|COMPLETED|Overall Study||17
2489229|NCT00864851|6102267|P3|STARTED|Overall Study||5
2489230|NCT00864851|6102268|P2|STARTED|Overall Study||19
2489231|NCT00864851|6102269|P1|STARTED|Overall Study||20
2489232|NCT00864721|6102303|P1|NOT COMPLETED|Overall Study||34
2489233|NCT00864721|6102303|P1|COMPLETED|Overall Study||29
2489234|NCT00864721|6102303|P1|STARTED|Overall Study||63
2489235|NCT00864708|6102311|P1|NOT COMPLETED|Overall Study||0
2489236|NCT00864708|6102311|P1|COMPLETED|Overall Study||1
2489237|NCT00864708|6102311|P1|STARTED|Overall Study||1
2489238|NCT00864682|6102323|P3|NOT COMPLETED|Overall Study||2
2489239|NCT00864682|6102324|P2|NOT COMPLETED|Overall Study||1
2489240|NCT00864682|6102325|P1|NOT COMPLETED|Overall Study||2
2489241|NCT00864682|6102323|P3|COMPLETED|Overall Study||51
2489242|NCT00864682|6102324|P2|COMPLETED|Overall Study||50
2489243|NCT00864682|6102325|P1|COMPLETED|Overall Study||50
2489244|NCT00864682|6102323|P3|STARTED|Overall Study||53
2489245|NCT00864682|6102324|P2|STARTED|Overall Study||51
2489246|NCT00864682|6102325|P1|STARTED|Overall Study||52
2489247|NCT00864539|6102345|P6|NOT COMPLETED|Overall Study||14
2489248|NCT00864539|6102346|P5|NOT COMPLETED|Overall Study||22
2489249|NCT00864539|6102347|P4|NOT COMPLETED|Overall Study||7
2489250|NCT00864539|6102348|P3|NOT COMPLETED|Overall Study||10
2489251|NCT00864539|6102349|P2|NOT COMPLETED|Overall Study||23
2489252|NCT00864539|6102350|P1|NOT COMPLETED|Overall Study||9
2489253|NCT00864539|6102345|P6|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|71
2489254|NCT00864539|6102346|P5|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|81
2489255|NCT00864539|6102347|P4|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|89
2489256|NCT00864539|6102348|P3|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|92
2489257|NCT00864539|6102349|P2|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|72
2489258|NCT00864539|6102350|P1|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|95
2489259|NCT00864539|6102345|P6|STARTED|Overall Study||85
2489260|NCT00864539|6102346|P5|STARTED|Overall Study||103
2489261|NCT00864539|6102347|P4|STARTED|Overall Study||96
2489262|NCT00864539|6102348|P3|STARTED|Overall Study||102
2489263|NCT00864539|6102349|P2|STARTED|Overall Study||95
2489264|NCT00864539|6102350|P1|STARTED|Overall Study||104
2489265|NCT00864513|6102364|P1|NOT COMPLETED|Overall Study||3
2489266|NCT00864513|6102364|P1|COMPLETED|Overall Study||12
2489267|NCT00864513|6102364|P1|STARTED|Overall Study||15
2489268|NCT00864474|6102371|P1|NOT COMPLETED|Overall Study||0
2489269|NCT00864474|6102371|P1|COMPLETED|Overall Study||68
2489270|NCT00864474|6102371|P1|STARTED|Overall Study||68
2489271|NCT00864383|6102412|P3|NOT COMPLETED|Modified Intent to Treat||85
2489272|NCT00864383|6102413|P2|NOT COMPLETED|Modified Intent to Treat||87
2489273|NCT00864383|6102414|P1|NOT COMPLETED|Modified Intent to Treat||85
2489274|NCT00864383|6102412|P3|COMPLETED|Modified Intent to Treat||551
2489275|NCT00864383|6102413|P2|COMPLETED|Modified Intent to Treat||568
2489276|NCT00864383|6102414|P1|COMPLETED|Modified Intent to Treat||555
2489277|NCT00864383|6102412|P3|STARTED|Modified Intent to Treat||636
2489278|NCT00864383|6102413|P2|STARTED|Modified Intent to Treat||655
2489279|NCT00864383|6102414|P1|STARTED|Modified Intent to Treat||640
2489280|NCT00864383|6102412|P3|NOT COMPLETED|Per- Protocol||112
2489281|NCT00864383|6102413|P2|NOT COMPLETED|Per- Protocol||141
2489282|NCT00864383|6102414|P1|NOT COMPLETED|Per- Protocol||130
2489283|NCT00864383|6102412|P3|COMPLETED|Per- Protocol||524
2489284|NCT00864383|6102413|P2|COMPLETED|Per- Protocol||514
2489285|NCT00864383|6102414|P1|COMPLETED|Per- Protocol||510
2489286|NCT00864383|6102412|P3|STARTED|Per- Protocol||636
2489287|NCT00864383|6102413|P2|STARTED|Per- Protocol||655
2489288|NCT00864383|6102414|P1|STARTED|Per- Protocol||640
2489289|NCT00864253|6102448|P2|NOT COMPLETED|Overall Study||58
2489290|NCT00864253|6102449|P1|NOT COMPLETED|Overall Study||99
2489291|NCT00864253|6102448|P2|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|207
2489292|NCT00864253|6102449|P1|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|165
2489293|NCT00864253|6102448|P2|Treated|Overall Study||258
2489294|NCT00864253|6102449|P1|Treated|Overall Study||257
2489295|NCT00864253|6102448|P2|STARTED|Overall Study||265
2489296|NCT00864253|6102449|P1|STARTED|Overall Study||264
2489297|NCT00864227|6102479|P1|NOT COMPLETED|Overall Study||4
2489298|NCT00864227|6102479|P1|COMPLETED|Overall Study||50
2489299|NCT00864227|6102479|P1|STARTED|Overall Study||54
2489300|NCT00864123|6102496|P2|NOT COMPLETED|Overall Study||0
2489301|NCT00864123|6102497|P1|NOT COMPLETED|Overall Study||0
2489302|NCT00864123|6102496|P2|COMPLETED|Overall Study||15
2489303|NCT00864123|6102497|P1|COMPLETED|Overall Study||15
2489304|NCT00864123|6102496|P2|STARTED|Overall Study||15
2489305|NCT00864123|6102497|P1|STARTED|Overall Study||15
2489306|NCT00864084|6102507|P1|NOT COMPLETED|Overall Study||3
2489307|NCT00864084|6102507|P1|COMPLETED|Overall Study||11
2489308|NCT00864084|6102507|P1|STARTED|Overall Study||14
2489309|NCT00864032|6102530|P3|NOT COMPLETED|Overall Study||0
2489310|NCT00864032|6102531|P2|NOT COMPLETED|Overall Study||0
2489311|NCT00864032|6102532|P1|NOT COMPLETED|Overall Study||0
2489312|NCT00864032|6102530|P3|COMPLETED|Overall Study||0
2489313|NCT00864032|6102531|P2|COMPLETED|Overall Study||5
2489314|NCT00864032|6102532|P1|COMPLETED|Overall Study||3
2489315|NCT00864032|6102530|P3|STARTED|Overall Study||0
2489316|NCT00864032|6102531|P2|STARTED|Overall Study||5
2489317|NCT00864032|6102532|P1|STARTED|Overall Study||3
2489318|NCT00863928|6102540|P2|NOT COMPLETED|Overall Study||0
2489319|NCT00863928|6102541|P1|NOT COMPLETED|Overall Study||36
2489320|NCT00863928|6102540|P2|COMPLETED|Overall Study||41
2489321|NCT00863928|6102541|P1|COMPLETED|Overall Study||58
2489322|NCT00863928|6102540|P2|STARTED|Overall Study||41
2489323|NCT00863928|6102541|P1|STARTED|Overall Study||94
2489324|NCT00863798|6102550|P3|NOT COMPLETED|Overall Study||25
2489325|NCT00863798|6102551|P2|NOT COMPLETED|Overall Study||30
2489326|NCT00863798|6102552|P1|NOT COMPLETED|Overall Study||32
2489327|NCT00863798|6102550|P3|COMPLETED|Overall Study||202
2489328|NCT00863798|6102551|P2|COMPLETED|Overall Study||198
2489329|NCT00863798|6102552|P1|COMPLETED|Overall Study||195
2489330|NCT00863798|6102550|P3|Treated|Overall Study||224
2489331|NCT00863798|6102551|P2|Treated|Overall Study||226
2489332|NCT00863798|6102552|P1|Treated|Overall Study||223
2489333|NCT00863798|6102550|P3|STARTED|Overall Study||227
2489334|NCT00863798|6102551|P2|STARTED|Overall Study||228
2489335|NCT00863798|6102552|P1|STARTED|Overall Study||227
2489336|NCT00863746|6102604|P2|NOT COMPLETED|Survival Follow up||280
2489337|NCT00863746|6102605|P1|NOT COMPLETED|Survival Follow up||253
2489338|NCT00863746|6102604|P2|COMPLETED|Survival Follow up||51
2489339|NCT00863746|6102605|P1|COMPLETED|Survival Follow up||45
2489340|NCT00863746|6102604|P2|STARTED|Survival Follow up|331 patients of 339 patients (=353 randomized - 14 death) entered the survival follow-up.|331
2489341|NCT00863746|6102605|P1|STARTED|Survival Follow up|298 patients of 317 patients (= 346 randomized - 29 deaths) entered the survival follow-up|298
2489342|NCT00863746|6102604|P2|NOT COMPLETED|Treatment||35
2489343|NCT00863746|6102605|P1|NOT COMPLETED|Treatment||71
2489344|NCT00863746|6102604|P2|COMPLETED|Treatment||318
2489345|NCT00863746|6102605|P1|COMPLETED|Treatment||279
2489346|NCT00863746|6102604|P2|Participants Received Treatment|Treatment|Safety population|351
2489347|NCT00863746|6102605|P1|Participants Received Treatment|Treatment|Safety population|346
2489348|NCT00863746|6102604|P2|STARTED|Treatment||353
2489349|NCT00863746|6102605|P1|STARTED|Treatment||350
2489350|NCT00863707|6102631|P2|NOT COMPLETED|Overall Study||3
2489351|NCT00863707|6102632|P1|NOT COMPLETED|Overall Study||4
2489352|NCT00863707|6102631|P2|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|334
2489353|NCT00863707|6102632|P1|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|170
2489354|NCT00863707|6102631|P2|STARTED|Overall Study||337
2489355|NCT00863707|6102632|P1|STARTED|Overall Study||174
2489356|NCT00863655|6102640|P2|NOT COMPLETED|Overall Study||239
2489357|NCT00863655|6102641|P1|NOT COMPLETED|Overall Study||485
2489358|NCT00863655|6102640|P2|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
2489359|NCT00863655|6102641|P1|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
2489360|NCT00863655|6102640|P2|STARTED|Overall Study||239
2489361|NCT00863655|6102641|P1|STARTED|Overall Study||485
2489362|NCT00863551|6102668|P1|NOT COMPLETED|Overall Study||0
2489363|NCT00863551|6102668|P1|COMPLETED|Overall Study||12
2489364|NCT00863551|6102668|P1|STARTED|Overall Study||12
2489365|NCT00863512|6102678|P2|NOT COMPLETED|Overall Study||0
2489366|NCT00863512|6102679|P1|NOT COMPLETED|Overall Study||14
2489367|NCT00863512|6102678|P2|COMPLETED|Overall Study||17
2489368|NCT00863512|6102679|P1|COMPLETED|Overall Study||3
2489369|NCT00863512|6102678|P2|STARTED|Overall Study||17
2489370|NCT00863512|6102679|P1|STARTED|Overall Study||17
2489371|NCT00863434|6102685|P1|NOT COMPLETED|Overall Study||0
2489372|NCT00863434|6102685|P1|COMPLETED|Overall Study||2
2489373|NCT00863434|6102685|P1|STARTED|Overall Study||2
2489374|NCT00863356|6102691|P1|NOT COMPLETED|Overall Study||0
2489375|NCT00863356|6102691|P1|COMPLETED|Overall Study||20
2489376|NCT00863356|6102691|P1|STARTED|Overall Study||20
2489377|NCT00863343|6102697|P2|NOT COMPLETED|Overall Study||0
2489378|NCT00863343|6102698|P1|NOT COMPLETED|Overall Study||0
2489379|NCT00863343|6102697|P2|COMPLETED|Overall Study||374
2489380|NCT00863343|6102698|P1|COMPLETED|Overall Study||17
2489381|NCT00863343|6102697|P2|STARTED|Overall Study||374
2489382|NCT00863343|6102698|P1|STARTED|Overall Study||17
2489383|NCT00863330|6102710|P1|NOT COMPLETED|Overall Study||6
2489384|NCT00863330|6102710|P1|COMPLETED|Overall Study||0
2489385|NCT00863330|6102710|P1|STARTED|Overall Study||6
2489386|NCT00863317|6102716|P2|NOT COMPLETED|Overall Study||9
2489387|NCT00863317|6102717|P1|NOT COMPLETED|Overall Study||8
2489388|NCT00863317|6102716|P2|COMPLETED|Overall Study||64
2489389|NCT00863317|6102717|P1|COMPLETED|Overall Study||60
2489390|NCT00863317|6102716|P2|STARTED|Overall Study||73
2489391|NCT00863317|6102717|P1|STARTED|Overall Study||68
2489392|NCT00863265|6102723|P6|NOT COMPLETED|Overall Study||0
2489393|NCT00863265|6102724|P5|NOT COMPLETED|Overall Study||1
2489394|NCT00863265|6102725|P4|NOT COMPLETED|Overall Study||0
2489395|NCT00863265|6102726|P3|NOT COMPLETED|Overall Study||0
2489396|NCT00863265|6102727|P2|NOT COMPLETED|Overall Study||0
2489397|NCT00863265|6102728|P1|NOT COMPLETED|Overall Study||0
2489398|NCT00863265|6102723|P6|COMPLETED|Overall Study||3
2489399|NCT00863265|6102724|P5|COMPLETED|Overall Study||3
2489400|NCT00863265|6102725|P4|COMPLETED|Overall Study||4
2489401|NCT00863265|6102726|P3|COMPLETED|Overall Study||4
2489402|NCT00863265|6102727|P2|COMPLETED|Overall Study||3
2489403|NCT00863265|6102728|P1|COMPLETED|Overall Study||4
2489404|NCT00863265|6102723|P6|STARTED|Overall Study||3
2489405|NCT00863265|6102724|P5|STARTED|Overall Study||4
2489406|NCT00863265|6102725|P4|STARTED|Overall Study||4
2489407|NCT00863265|6102726|P3|STARTED|Overall Study||4
2489408|NCT00863265|6102727|P2|STARTED|Overall Study||3
2489409|NCT00863265|6102728|P1|STARTED|Overall Study||4
2489410|NCT00863122|6102744|P2|NOT COMPLETED|Overall Study||0
2489411|NCT00863122|6102745|P1|NOT COMPLETED|Overall Study||0
2489412|NCT00863122|6102744|P2|COMPLETED|Overall Study||7
2489413|NCT00863122|6102745|P1|COMPLETED|Overall Study||19
2489414|NCT00863122|6102744|P2|STARTED|Overall Study||7
2489415|NCT00863122|6102745|P1|STARTED|Overall Study||19
2489416|NCT00863109|6102756|P1|NOT COMPLETED|Follow-up Period||11
2489417|NCT00863109|6102756|P1|COMPLETED|Follow-up Period||48
2489418|NCT00863109|6102756|P1|STARTED|Follow-up Period|Follow-up performed on 53 who completed Treatment Period plus 6 who discontinued treatment|59
2489419|NCT00863109|6102756|P1|NOT COMPLETED|Treatment Period||77
2489420|NCT00863109|6102756|P1|COMPLETED|Treatment Period||53
2489421|NCT00863109|6102756|P1|STARTED|Treatment Period||130
2489422|NCT00863057|6102773|P4|NOT COMPLETED|Period 4 (Weeks 16-20)||0
2489423|NCT00863057|6102774|P3|NOT COMPLETED|Period 4 (Weeks 16-20)||0
2489424|NCT00863057|6102775|P2|NOT COMPLETED|Period 4 (Weeks 16-20)||0
2489425|NCT00863057|6102776|P1|NOT COMPLETED|Period 4 (Weeks 16-20)||0
2489426|NCT00863057|6102773|P4|COMPLETED|Period 4 (Weeks 16-20)||2
2489427|NCT00863057|6102774|P3|COMPLETED|Period 4 (Weeks 16-20)||2
2489428|NCT00863057|6102775|P2|COMPLETED|Period 4 (Weeks 16-20)||1
2489429|NCT00863057|6102776|P1|COMPLETED|Period 4 (Weeks 16-20)||3
2489430|NCT00863057|6102773|P4|STARTED|Period 4 (Weeks 16-20)||2
2489431|NCT00863057|6102774|P3|STARTED|Period 4 (Weeks 16-20)||2
2489432|NCT00863057|6102775|P2|STARTED|Period 4 (Weeks 16-20)||1
2489433|NCT00863057|6102776|P1|STARTED|Period 4 (Weeks 16-20)||3
2489434|NCT00863057|6102773|P4|NOT COMPLETED|Period 3 (Weeks 11-15)||0
2489435|NCT00863057|6102774|P3|NOT COMPLETED|Period 3 (Weeks 11-15)||0
2489436|NCT00863057|6102775|P2|NOT COMPLETED|Period 3 (Weeks 11-15)||0
2489437|NCT00863057|6102776|P1|NOT COMPLETED|Period 3 (Weeks 11-15)||0
2489438|NCT00863057|6102773|P4|COMPLETED|Period 3 (Weeks 11-15)||2
2489439|NCT00863057|6102774|P3|COMPLETED|Period 3 (Weeks 11-15)||2
2489440|NCT00863057|6102775|P2|COMPLETED|Period 3 (Weeks 11-15)||1
2489441|NCT00863057|6102776|P1|COMPLETED|Period 3 (Weeks 11-15)||3
2489442|NCT00863057|6102773|P4|STARTED|Period 3 (Weeks 11-15)||2
2489443|NCT00863057|6102774|P3|STARTED|Period 3 (Weeks 11-15)||2
2489444|NCT00863057|6102775|P2|STARTED|Period 3 (Weeks 11-15)||1
2489445|NCT00863057|6102776|P1|STARTED|Period 3 (Weeks 11-15)||3
2489446|NCT00863057|6102773|P4|NOT COMPLETED|Period 2 (Weeks 6-10)||1
2489447|NCT00863057|6102774|P3|NOT COMPLETED|Period 2 (Weeks 6-10)||1
2489448|NCT00863057|6102775|P2|NOT COMPLETED|Period 2 (Weeks 6-10)||1
2489449|NCT00863057|6102776|P1|NOT COMPLETED|Period 2 (Weeks 6-10)||0
2489450|NCT00863057|6102773|P4|COMPLETED|Period 2 (Weeks 6-10)||2
2489451|NCT00863057|6102774|P3|COMPLETED|Period 2 (Weeks 6-10)||2
2489452|NCT00863057|6102775|P2|COMPLETED|Period 2 (Weeks 6-10)||1
2489453|NCT00863057|6102776|P1|COMPLETED|Period 2 (Weeks 6-10)||3
2489454|NCT00863057|6102773|P4|STARTED|Period 2 (Weeks 6-10)||3
2489455|NCT00863057|6102774|P3|STARTED|Period 2 (Weeks 6-10)||3
2489456|NCT00863057|6102775|P2|STARTED|Period 2 (Weeks 6-10)||2
2489457|NCT00863057|6102776|P1|STARTED|Period 2 (Weeks 6-10)||3
2489458|NCT00863057|6102773|P4|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
2489459|NCT00863057|6102774|P3|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||0
2489460|NCT00863057|6102775|P2|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||2
2489461|NCT00863057|6102776|P1|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
2489462|NCT00863057|6102773|P4|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
2489463|NCT00863057|6102774|P3|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
2489464|NCT00863057|6102775|P2|COMPLETED|Milestones Period 1 (Weeks 0-5)||2
2489465|NCT00863057|6102776|P1|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
2489466|NCT00863057|6102773|P4|STARTED|Milestones Period 1 (Weeks 0-5)||4
2489467|NCT00863057|6102774|P3|STARTED|Milestones Period 1 (Weeks 0-5)||3
2489468|NCT00863057|6102775|P2|STARTED|Milestones Period 1 (Weeks 0-5)||4
2489469|NCT00863057|6102776|P1|STARTED|Milestones Period 1 (Weeks 0-5)||4
2489470|NCT00862979|6102834|P2|NOT COMPLETED|Overall Study||7
2489471|NCT00862979|6102835|P1|NOT COMPLETED|Overall Study||8
2489472|NCT00862979|6102834|P2|COMPLETED|Overall Study||71
2489473|NCT00862979|6102835|P1|COMPLETED|Overall Study||76
2489474|NCT00862979|6102834|P2|Full Analysis Set (FAS)|Overall Study||71
2489475|NCT00862979|6102835|P1|Full Analysis Set (FAS)|Overall Study||74
2489476|NCT00862979|6102834|P2|STARTED|Overall Study||78
2489477|NCT00862979|6102835|P1|STARTED|Overall Study||84
2489478|NCT00862940|6102853|P2|NOT COMPLETED|Overall Study||30
2489479|NCT00862940|6102854|P1|NOT COMPLETED|Overall Study||30
2489480|NCT00862940|6102853|P2|COMPLETED|Overall Study||114
2489481|NCT00862940|6102854|P1|COMPLETED|Overall Study||103
2489482|NCT00862940|6102853|P2|STARTED|Overall Study||144
2489483|NCT00862940|6102854|P1|STARTED|Overall Study||133
2489484|NCT00862849|6102866|P6|NOT COMPLETED|Intervention 6||0
2489485|NCT00862849|6102867|P5|NOT COMPLETED|Intervention 6||0
2489486|NCT00862849|6102868|P4|NOT COMPLETED|Intervention 6||0
2489487|NCT00862849|6102869|P3|NOT COMPLETED|Intervention 6||0
2489488|NCT00862849|6102870|P2|NOT COMPLETED|Intervention 6||0
2489489|NCT00862849|6102871|P1|NOT COMPLETED|Intervention 6||0
2489490|NCT00862849|6102866|P6|COMPLETED|Intervention 6||3
2489491|NCT00862849|6102867|P5|COMPLETED|Intervention 6||4
2489492|NCT00862849|6102868|P4|COMPLETED|Intervention 6||4
2489493|NCT00862849|6102869|P3|COMPLETED|Intervention 6||3
2489494|NCT00862849|6102870|P2|COMPLETED|Intervention 6||3
2489495|NCT00862849|6102871|P1|COMPLETED|Intervention 6||3
2489496|NCT00862849|6102866|P6|STARTED|Intervention 6||3
2489497|NCT00862849|6102867|P5|STARTED|Intervention 6||4
2489498|NCT00862849|6102868|P4|STARTED|Intervention 6||4
2489499|NCT00862849|6102869|P3|STARTED|Intervention 6||3
2489500|NCT00862849|6102870|P2|STARTED|Intervention 6||3
2489501|NCT00862849|6102871|P1|STARTED|Intervention 6||3
2489502|NCT00862849|6102866|P6|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
2489503|NCT00862849|6102867|P5|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
2489504|NCT00862849|6102868|P4|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
2489505|NCT00862849|6102869|P3|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
2489506|NCT00862849|6102870|P2|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
2489507|NCT00862849|6102871|P1|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
2489508|NCT00862849|6102866|P6|COMPLETED|Washout 5 (3 to 14 Days)||3
2489509|NCT00862849|6102867|P5|COMPLETED|Washout 5 (3 to 14 Days)||4
2489510|NCT00862849|6102868|P4|COMPLETED|Washout 5 (3 to 14 Days)||4
2489511|NCT00862849|6102869|P3|COMPLETED|Washout 5 (3 to 14 Days)||3
2489512|NCT00862849|6102870|P2|COMPLETED|Washout 5 (3 to 14 Days)||3
2489513|NCT00862849|6102871|P1|COMPLETED|Washout 5 (3 to 14 Days)||3
2489514|NCT00862849|6102866|P6|STARTED|Washout 5 (3 to 14 Days)||3
2489515|NCT00862849|6102867|P5|STARTED|Washout 5 (3 to 14 Days)||4
2489516|NCT00862849|6102868|P4|STARTED|Washout 5 (3 to 14 Days)||4
2489517|NCT00862849|6102869|P3|STARTED|Washout 5 (3 to 14 Days)||3
2489518|NCT00862849|6102870|P2|STARTED|Washout 5 (3 to 14 Days)||3
2489519|NCT00862849|6102871|P1|STARTED|Washout 5 (3 to 14 Days)||3
2489520|NCT00862849|6102866|P6|NOT COMPLETED|Intervention 5||0
2489521|NCT00862849|6102867|P5|NOT COMPLETED|Intervention 5||0
2489522|NCT00862849|6102868|P4|NOT COMPLETED|Intervention 5||0
2489523|NCT00862849|6102869|P3|NOT COMPLETED|Intervention 5||0
2489524|NCT00862849|6102870|P2|NOT COMPLETED|Intervention 5||0
2489525|NCT00862849|6102871|P1|NOT COMPLETED|Intervention 5||0
2489526|NCT00862849|6102866|P6|COMPLETED|Intervention 5||3
2489527|NCT00862849|6102867|P5|COMPLETED|Intervention 5||4
2489528|NCT00862849|6102868|P4|COMPLETED|Intervention 5||4
2489529|NCT00862849|6102869|P3|COMPLETED|Intervention 5||3
2489530|NCT00862849|6102870|P2|COMPLETED|Intervention 5||3
2489531|NCT00862849|6102871|P1|COMPLETED|Intervention 5||3
2489532|NCT00862849|6102866|P6|STARTED|Intervention 5||3
2489533|NCT00862849|6102867|P5|STARTED|Intervention 5||4
2489534|NCT00862849|6102868|P4|STARTED|Intervention 5||4
2489535|NCT00862849|6102869|P3|STARTED|Intervention 5||3
2489536|NCT00862849|6102870|P2|STARTED|Intervention 5||3
2489537|NCT00862849|6102871|P1|STARTED|Intervention 5||3
2489538|NCT00862849|6102866|P6|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
2489539|NCT00862849|6102867|P5|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
2489540|NCT00862849|6102868|P4|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
2489541|NCT00862849|6102869|P3|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
2489542|NCT00862849|6102870|P2|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
2489543|NCT00862849|6102871|P1|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
2489544|NCT00862849|6102866|P6|COMPLETED|Washout 4 (3 to 14 Days)||3
2489545|NCT00862849|6102867|P5|COMPLETED|Washout 4 (3 to 14 Days)||4
2489546|NCT00862849|6102868|P4|COMPLETED|Washout 4 (3 to 14 Days)||4
2489547|NCT00862849|6102869|P3|COMPLETED|Washout 4 (3 to 14 Days)||3
2489548|NCT00862849|6102870|P2|COMPLETED|Washout 4 (3 to 14 Days)||3
2489549|NCT00862849|6102871|P1|COMPLETED|Washout 4 (3 to 14 Days)||3
2489550|NCT00862849|6102866|P6|STARTED|Washout 4 (3 to 14 Days)||3
2489551|NCT00862849|6102867|P5|STARTED|Washout 4 (3 to 14 Days)||4
2489552|NCT00862849|6102868|P4|STARTED|Washout 4 (3 to 14 Days)||4
2489553|NCT00862849|6102869|P3|STARTED|Washout 4 (3 to 14 Days)||3
2489554|NCT00862849|6102870|P2|STARTED|Washout 4 (3 to 14 Days)||3
2489555|NCT00862849|6102871|P1|STARTED|Washout 4 (3 to 14 Days)||3
2489556|NCT00862849|6102866|P6|NOT COMPLETED|Intervention 4||0
2489557|NCT00862849|6102867|P5|NOT COMPLETED|Intervention 4||0
2489558|NCT00862849|6102868|P4|NOT COMPLETED|Intervention 4||0
2489559|NCT00862849|6102869|P3|NOT COMPLETED|Intervention 4||0
2489560|NCT00862849|6102870|P2|NOT COMPLETED|Intervention 4||0
2489561|NCT00862849|6102871|P1|NOT COMPLETED|Intervention 4||0
2489562|NCT00862849|6102866|P6|COMPLETED|Intervention 4||3
2489563|NCT00862849|6102867|P5|COMPLETED|Intervention 4||4
2489564|NCT00862849|6102868|P4|COMPLETED|Intervention 4||4
2489565|NCT00862849|6102869|P3|COMPLETED|Intervention 4||3
2489566|NCT00862849|6102870|P2|COMPLETED|Intervention 4||3
2489567|NCT00862849|6102871|P1|COMPLETED|Intervention 4||3
2489568|NCT00862849|6102866|P6|STARTED|Intervention 4||3
2489569|NCT00862849|6102867|P5|STARTED|Intervention 4||4
2489570|NCT00862849|6102868|P4|STARTED|Intervention 4||4
2489571|NCT00862849|6102869|P3|STARTED|Intervention 4||3
2489572|NCT00862849|6102870|P2|STARTED|Intervention 4||3
2489573|NCT00862849|6102871|P1|STARTED|Intervention 4||3
2489574|NCT00862849|6102866|P6|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
2489575|NCT00862849|6102867|P5|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
2489576|NCT00862849|6102868|P4|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
2489577|NCT00862849|6102869|P3|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
2489578|NCT00862849|6102870|P2|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
2489579|NCT00862849|6102871|P1|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
2489580|NCT00862849|6102866|P6|COMPLETED|Washout 3 (3 to 14 Days)||3
2489581|NCT00862849|6102867|P5|COMPLETED|Washout 3 (3 to 14 Days)||4
2489582|NCT00862849|6102868|P4|COMPLETED|Washout 3 (3 to 14 Days)||4
2489583|NCT00862849|6102869|P3|COMPLETED|Washout 3 (3 to 14 Days)||3
2489584|NCT00862849|6102870|P2|COMPLETED|Washout 3 (3 to 14 Days)||3
2489585|NCT00862849|6102871|P1|COMPLETED|Washout 3 (3 to 14 Days)||3
2489586|NCT00862849|6102866|P6|STARTED|Washout 3 (3 to 14 Days)||3
2489587|NCT00862849|6102867|P5|STARTED|Washout 3 (3 to 14 Days)||4
2489588|NCT00862849|6102868|P4|STARTED|Washout 3 (3 to 14 Days)||4
2489589|NCT00862849|6102869|P3|STARTED|Washout 3 (3 to 14 Days)||3
2489590|NCT00862849|6102870|P2|STARTED|Washout 3 (3 to 14 Days)||3
2489591|NCT00862849|6102871|P1|STARTED|Washout 3 (3 to 14 Days)||3
2489592|NCT00862849|6102866|P6|NOT COMPLETED|Intervention 3||0
2489593|NCT00862849|6102867|P5|NOT COMPLETED|Intervention 3||0
2489594|NCT00862849|6102868|P4|NOT COMPLETED|Intervention 3||0
2489595|NCT00862849|6102869|P3|NOT COMPLETED|Intervention 3||0
2489596|NCT00862849|6102870|P2|NOT COMPLETED|Intervention 3||0
2489597|NCT00862849|6102871|P1|NOT COMPLETED|Intervention 3||0
2489598|NCT00862849|6102866|P6|COMPLETED|Intervention 3||3
2489599|NCT00862849|6102867|P5|COMPLETED|Intervention 3||4
2489600|NCT00862849|6102868|P4|COMPLETED|Intervention 3||4
2489601|NCT00862849|6102869|P3|COMPLETED|Intervention 3||3
2489602|NCT00862849|6102870|P2|COMPLETED|Intervention 3||3
2489603|NCT00862849|6102871|P1|COMPLETED|Intervention 3||3
2489604|NCT00862849|6102866|P6|STARTED|Intervention 3||3
2489605|NCT00862849|6102867|P5|STARTED|Intervention 3||4
2489606|NCT00862849|6102868|P4|STARTED|Intervention 3||4
2489607|NCT00862849|6102869|P3|STARTED|Intervention 3||3
2489608|NCT00862849|6102870|P2|STARTED|Intervention 3||3
2489609|NCT00862849|6102871|P1|STARTED|Intervention 3||3
2489610|NCT00862849|6102866|P6|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
2489611|NCT00862849|6102867|P5|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
2489612|NCT00862849|6102868|P4|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
2489613|NCT00862849|6102869|P3|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
2489614|NCT00862849|6102870|P2|NOT COMPLETED|Washout 2 (3 to 14 Days)||1
2489615|NCT00862849|6102871|P1|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
2489616|NCT00862849|6102866|P6|COMPLETED|Washout 2 (3 to 14 Days)||3
2489617|NCT00862849|6102867|P5|COMPLETED|Washout 2 (3 to 14 Days)||4
2489618|NCT00862849|6102868|P4|COMPLETED|Washout 2 (3 to 14 Days)||4
2489619|NCT00862849|6102869|P3|COMPLETED|Washout 2 (3 to 14 Days)||3
2489620|NCT00862849|6102870|P2|COMPLETED|Washout 2 (3 to 14 Days)||3
2489621|NCT00862849|6102871|P1|COMPLETED|Washout 2 (3 to 14 Days)||3
2489622|NCT00862849|6102866|P6|STARTED|Washout 2 (3 to 14 Days)||3
2489623|NCT00862849|6102867|P5|STARTED|Washout 2 (3 to 14 Days)||4
2489624|NCT00862849|6102868|P4|STARTED|Washout 2 (3 to 14 Days)||4
2489625|NCT00862849|6102869|P3|STARTED|Washout 2 (3 to 14 Days)||3
2489626|NCT00862849|6102870|P2|STARTED|Washout 2 (3 to 14 Days)||4
2489627|NCT00862849|6102871|P1|STARTED|Washout 2 (3 to 14 Days)||3
2489628|NCT00862849|6102866|P6|NOT COMPLETED|Intervention 2||0
2489629|NCT00862849|6102867|P5|NOT COMPLETED|Intervention 2||0
2489630|NCT00862849|6102868|P4|NOT COMPLETED|Intervention 2||0
2489631|NCT00862849|6102869|P3|NOT COMPLETED|Intervention 2||0
2489632|NCT00862849|6102870|P2|NOT COMPLETED|Intervention 2||0
2489633|NCT00862849|6102871|P1|NOT COMPLETED|Intervention 2||0
2489634|NCT00862849|6102866|P6|COMPLETED|Intervention 2||3
2489635|NCT00862849|6102867|P5|COMPLETED|Intervention 2||4
2489636|NCT00862849|6102868|P4|COMPLETED|Intervention 2||4
2489637|NCT00862849|6102869|P3|COMPLETED|Intervention 2||3
2489638|NCT00862849|6102870|P2|COMPLETED|Intervention 2||4
2489639|NCT00862849|6102871|P1|COMPLETED|Intervention 2||3
2489640|NCT00862849|6102866|P6|STARTED|Intervention 2||3
2489641|NCT00862849|6102867|P5|STARTED|Intervention 2||4
2489642|NCT00862849|6102868|P4|STARTED|Intervention 2||4
2489643|NCT00862849|6102869|P3|STARTED|Intervention 2||3
2489644|NCT00862849|6102870|P2|STARTED|Intervention 2||4
2489645|NCT00862849|6102871|P1|STARTED|Intervention 2||3
2489646|NCT00862849|6102866|P6|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
2489647|NCT00862849|6102867|P5|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
2489648|NCT00862849|6102868|P4|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
2489649|NCT00862849|6102869|P3|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
2489650|NCT00862849|6102870|P2|NOT COMPLETED|Washout 1 (3 to 14 Days)||1
2489651|NCT00862849|6102871|P1|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
2489652|NCT00862849|6102866|P6|COMPLETED|Washout 1 (3 to 14 Days)||3
2489653|NCT00862849|6102867|P5|COMPLETED|Washout 1 (3 to 14 Days)||4
2489654|NCT00862849|6102868|P4|COMPLETED|Washout 1 (3 to 14 Days)||4
2489655|NCT00862849|6102869|P3|COMPLETED|Washout 1 (3 to 14 Days)||3
2489656|NCT00862849|6102870|P2|COMPLETED|Washout 1 (3 to 14 Days)||4
2489657|NCT00862849|6102871|P1|COMPLETED|Washout 1 (3 to 14 Days)||3
2489658|NCT00862849|6102866|P6|STARTED|Washout 1 (3 to 14 Days)||3
2489659|NCT00862849|6102867|P5|STARTED|Washout 1 (3 to 14 Days)||4
2489660|NCT00862849|6102868|P4|STARTED|Washout 1 (3 to 14 Days)||4
2489661|NCT00862849|6102869|P3|STARTED|Washout 1 (3 to 14 Days)||3
2489662|NCT00862849|6102870|P2|STARTED|Washout 1 (3 to 14 Days)||5
2489663|NCT00862849|6102871|P1|STARTED|Washout 1 (3 to 14 Days)||3
2489664|NCT00862849|6102866|P6|NOT COMPLETED|Intervention 1||0
2489665|NCT00862849|6102867|P5|NOT COMPLETED|Intervention 1||0
2489666|NCT00862849|6102868|P4|NOT COMPLETED|Intervention 1||0
2489667|NCT00862849|6102869|P3|NOT COMPLETED|Intervention 1||0
2489668|NCT00862849|6102870|P2|NOT COMPLETED|Intervention 1||0
2489669|NCT00862849|6102871|P1|NOT COMPLETED|Intervention 1||0
2489670|NCT00862849|6102866|P6|COMPLETED|Intervention 1||3
2489671|NCT00862849|6102867|P5|COMPLETED|Intervention 1||4
2489672|NCT00862849|6102868|P4|COMPLETED|Intervention 1||4
2489673|NCT00862849|6102869|P3|COMPLETED|Intervention 1||3
2489674|NCT00862849|6102870|P2|COMPLETED|Intervention 1||5
2489675|NCT00862849|6102871|P1|COMPLETED|Intervention 1||3
2489676|NCT00862849|6102866|P6|Received at Least One Dose of Study Drug|Intervention 1||3
2489677|NCT00862849|6102867|P5|Received at Least One Dose of Study Drug|Intervention 1||4
2489678|NCT00862849|6102868|P4|Received at Least One Dose of Study Drug|Intervention 1||4
2489679|NCT00862849|6102869|P3|Received at Least One Dose of Study Drug|Intervention 1||3
2489680|NCT00862849|6102870|P2|Received at Least One Dose of Study Drug|Intervention 1||5
2489681|NCT00862849|6102871|P1|Received at Least One Dose of Study Drug|Intervention 1||3
2489682|NCT00862849|6102866|P6|STARTED|Intervention 1||3
2489683|NCT00862849|6102867|P5|STARTED|Intervention 1||4
2489684|NCT00862849|6102868|P4|STARTED|Intervention 1||4
2489685|NCT00862849|6102869|P3|STARTED|Intervention 1||3
2489686|NCT00862849|6102870|P2|STARTED|Intervention 1||5
2489687|NCT00862849|6102871|P1|STARTED|Intervention 1||3
2489688|NCT00862836|6102894|P1|NOT COMPLETED|Overall Study||1
2489689|NCT00862836|6102894|P1|COMPLETED|Overall Study||14
2489690|NCT00862836|6102894|P1|Evaluable for Activity (Tumour Response)|Overall Study||10
2489691|NCT00862836|6102894|P1|Evaluable for Safety/Toxicity|Overall Study|1 patient withdrew consent before first cycle|14
2489692|NCT00862836|6102894|P1|STARTED|Overall Study||15
2489693|NCT00862823|6102905|P2|NOT COMPLETED|Second Intervention||0
2489694|NCT00862823|6102906|P1|NOT COMPLETED|Second Intervention||0
2489695|NCT00862823|6102905|P2|COMPLETED|Second Intervention||9
2489696|NCT00862823|6102906|P1|COMPLETED|Second Intervention||5
2489697|NCT00862823|6102905|P2|STARTED|Second Intervention||9
2489698|NCT00862823|6102906|P1|STARTED|Second Intervention||5
2489699|NCT00862823|6102905|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
2489700|NCT00862823|6102906|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
2489701|NCT00862823|6102905|P2|COMPLETED|Washout Period of 2 Weeks||9
2489702|NCT00862823|6102906|P1|COMPLETED|Washout Period of 2 Weeks||5
2489703|NCT00862823|6102905|P2|STARTED|Washout Period of 2 Weeks||9
2489704|NCT00862823|6102906|P1|STARTED|Washout Period of 2 Weeks||5
2489705|NCT00862823|6102905|P2|NOT COMPLETED|First Intervention||1
2489706|NCT00862823|6102906|P1|NOT COMPLETED|First Intervention||1
2489707|NCT00862823|6102905|P2|COMPLETED|First Intervention||9
2489708|NCT00862823|6102906|P1|COMPLETED|First Intervention||5
2489709|NCT00862823|6102905|P2|STARTED|First Intervention||10
2489710|NCT00862823|6102906|P1|STARTED|First Intervention||6
2489711|NCT00862810|6102915|P2|NOT COMPLETED|Overall Study||4
2489712|NCT00862810|6102916|P1|NOT COMPLETED|Overall Study||4
2489713|NCT00862810|6102915|P2|COMPLETED|Overall Study||35
2489714|NCT00862810|6102916|P1|COMPLETED|Overall Study||29
2489715|NCT00862810|6102915|P2|STARTED|Overall Study||39
2489716|NCT00862810|6102916|P1|STARTED|Overall Study||33
2489717|NCT00862784|6102922|P1|NOT COMPLETED|Overall Study||0
2489718|NCT00862784|6102922|P1|COMPLETED|Overall Study||48
2489719|NCT00862784|6102922|P1|Received Any Amount of Study Drug|Overall Study||48
2489720|NCT00862784|6102922|P1|STARTED|Overall Study||48
2489721|NCT00862745|6102944|P2|NOT COMPLETED|Open-label Follow-up||49
2489722|NCT00862745|6102945|P1|NOT COMPLETED|Open-label Follow-up||39
2489723|NCT00862745|6102944|P2|COMPLETED|Open-label Follow-up||225
2489724|NCT00862745|6102945|P1|COMPLETED|Open-label Follow-up||229
2489725|NCT00862745|6102944|P2|STARTED|Open-label Follow-up|10 participants elected not to enter the open-label portion of the study after completing the RCT.|274
2489726|NCT00862745|6102945|P1|STARTED|Open-label Follow-up|19 participants elected not to enter the open-label portion of the study after completing the RCT.|268
2489727|NCT00862745|6102944|P2|NOT COMPLETED|Randomized Control Trial||39
2489728|NCT00862745|6102945|P1|NOT COMPLETED|Randomized Control Trial||38
2489729|NCT00862745|6102944|P2|COMPLETED|Randomized Control Trial||284
2489730|NCT00862745|6102945|P1|COMPLETED|Randomized Control Trial||284
2489731|NCT00862745|6102944|P2|STARTED|Randomized Control Trial||323
2489732|NCT00862745|6102945|P1|STARTED|Randomized Control Trial||322
2489733|NCT00862719|6102955|P4|NOT COMPLETED|Overall Study||1
2489734|NCT00862719|6102956|P3|NOT COMPLETED|Overall Study||4
2489735|NCT00862719|6102957|P2|NOT COMPLETED|Overall Study||6
2489736|NCT00862719|6102958|P1|NOT COMPLETED|Overall Study||10
2489737|NCT00862719|6102955|P4|COMPLETED|Overall Study||0
2489738|NCT00862719|6102956|P3|COMPLETED|Overall Study||0
2489739|NCT00862719|6102957|P2|COMPLETED|Overall Study||1
2489740|NCT00862719|6102958|P1|COMPLETED|Overall Study||7
2489741|NCT00862719|6102955|P4|STARTED|Overall Study||1
2489742|NCT00862719|6102956|P3|STARTED|Overall Study||4
2489743|NCT00862719|6102957|P2|STARTED|Overall Study||7
2489744|NCT00862719|6102958|P1|STARTED|Overall Study||17
2489745|NCT00862654|6102981|P4|NOT COMPLETED|Overall Study||6
2489746|NCT00862654|6102982|P3|NOT COMPLETED|Overall Study||6
2489747|NCT00862654|6102983|P2|NOT COMPLETED|Overall Study||8
2489748|NCT00862654|6102984|P1|NOT COMPLETED|Overall Study||6
2489749|NCT00862654|6102981|P4|COMPLETED|Overall Study||74
2489750|NCT00862654|6102982|P3|COMPLETED|Overall Study||76
2489751|NCT00862654|6102983|P2|COMPLETED|Overall Study||74
2489752|NCT00862654|6102984|P1|COMPLETED|Overall Study||76
2489753|NCT00862654|6102981|P4|STARTED|Overall Study||80
2489754|NCT00862654|6102982|P3|STARTED|Overall Study||82
2489755|NCT00862654|6102983|P2|STARTED|Overall Study||82
2489756|NCT00862654|6102984|P1|STARTED|Overall Study||82
2489757|NCT00862641|6102998|P4|NOT COMPLETED|Overall Study||4
2489758|NCT00862641|6102999|P3|NOT COMPLETED|Overall Study||1
2489759|NCT00862641|6103000|P2|NOT COMPLETED|Overall Study||4
2489760|NCT00862641|6103001|P1|NOT COMPLETED|Overall Study||1
2489761|NCT00862641|6102998|P4|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|316
2489762|NCT00862641|6102999|P3|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|151
2489763|NCT00862641|6103000|P2|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|356
2489764|NCT00862641|6103001|P1|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|176
2489765|NCT00862641|6102998|P4|STARTED|Overall Study||320
2489766|NCT00862641|6102999|P3|STARTED|Overall Study||152
2489767|NCT00862641|6103000|P2|STARTED|Overall Study||360
2489768|NCT00862641|6103001|P1|STARTED|Overall Study||177
2489769|NCT00862563|6103047|P4|NOT COMPLETED|Overall Study||5
2489770|NCT00862563|6103048|P3|NOT COMPLETED|Overall Study||6
2489771|NCT00862563|6103049|P2|NOT COMPLETED|Overall Study||4
2489772|NCT00862563|6103050|P1|NOT COMPLETED|Overall Study||4
2489773|NCT00862563|6103047|P4|COMPLETED|Overall Study||19
2489774|NCT00862563|6103048|P3|COMPLETED|Overall Study||15
2489775|NCT00862563|6103049|P2|COMPLETED|Overall Study||17
2489776|NCT00862563|6103050|P1|COMPLETED|Overall Study||15
2489777|NCT00862563|6103047|P4|STARTED|Overall Study||24
2489778|NCT00862563|6103048|P3|STARTED|Overall Study||21
2489779|NCT00862563|6103049|P2|STARTED|Overall Study||21
2489780|NCT00862563|6103050|P1|STARTED|Overall Study||19
2489781|NCT00862537|6103088|P1|NOT COMPLETED|Overall Study||7
2489782|NCT00862537|6103088|P1|COMPLETED|Overall Study||11
2489783|NCT00862537|6103088|P1|STARTED|Overall Study||18
2489784|NCT00862459|6103095|P3|NOT COMPLETED|Overall Study||6
2489785|NCT00862459|6103096|P2|NOT COMPLETED|Overall Study||8
2489786|NCT00862459|6103097|P1|NOT COMPLETED|Overall Study||6
2489787|NCT00862459|6103095|P3|COMPLETED|Overall Study||66
2489788|NCT00862459|6103096|P2|COMPLETED|Overall Study||85
2489789|NCT00862459|6103097|P1|COMPLETED|Overall Study||66
2489790|NCT00862459|6103095|P3|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 68 received Gadobutrol and 69 received OptiMARK|69
2489791|NCT00862459|6103096|P2|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 90 received Gadobutrol and 88 received OptiMARK|90
2489792|NCT00862459|6103097|P1|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 67 received Gadobutrol and 70 received OptiMARK|70
2489793|NCT00862459|6103095|P3|STARTED|Overall Study||72
2489794|NCT00862459|6103096|P2|STARTED|Overall Study||93
2489795|NCT00862459|6103097|P1|STARTED|Overall Study||72
2489796|NCT00862277|6103244|P3|NOT COMPLETED|Overall Study||5
2489797|NCT00862277|6103245|P2|NOT COMPLETED|Overall Study||2
2489798|NCT00862277|6103246|P1|NOT COMPLETED|Overall Study||1
2489799|NCT00862277|6103244|P3|COMPLETED|Overall Study||100
2489800|NCT00862277|6103245|P2|COMPLETED|Overall Study||94
2489801|NCT00862277|6103246|P1|COMPLETED|Overall Study||560
2489802|NCT00862277|6103244|P3|STARTED|Overall Study||105
2489803|NCT00862277|6103245|P2|STARTED|Overall Study||96
2489804|NCT00862277|6103246|P1|STARTED|Overall Study||561
2489805|NCT00862251|6103260|P3|NOT COMPLETED|Overall Study||9
2489806|NCT00862251|6103261|P2|NOT COMPLETED|Overall Study||5
2489807|NCT00862251|6103262|P1|NOT COMPLETED|Overall Study||19
2489808|NCT00862251|6103260|P3|COMPLETED|Overall Study||315
2489809|NCT00862251|6103261|P2|COMPLETED|Overall Study||157
2489810|NCT00862251|6103262|P1|COMPLETED|Overall Study||303
2489811|NCT00862251|6103260|P3|STARTED|Overall Study||324
2489812|NCT00862251|6103261|P2|STARTED|Overall Study||162
2489813|NCT00862251|6103262|P1|STARTED|Overall Study||322
2489814|NCT00862186|6103315|P1|NOT COMPLETED|Overall Study||0
2489815|NCT00862186|6103315|P1|COMPLETED|Overall Study||15
2489816|NCT00862186|6103315|P1|STARTED|Overall Study||15
2489817|NCT00862134|6103322|P2|NOT COMPLETED|Overall Study||12
2489818|NCT00862134|6103323|P1|NOT COMPLETED|Overall Study||11
2489819|NCT00862134|6103322|P2|COMPLETED|Overall Study||11
2489820|NCT00862134|6103323|P1|COMPLETED|Overall Study||8
2489821|NCT00862134|6103322|P2|STARTED|Overall Study||23
2489822|NCT00862134|6103323|P1|STARTED|Overall Study||19
2489823|NCT00862121|6103335|P2|NOT COMPLETED|Overall Study||8
2489824|NCT00862121|6103336|P1|NOT COMPLETED|Overall Study||1
2489825|NCT00862121|6103335|P2|COMPLETED|Overall Study||4
2489826|NCT00862121|6103336|P1|COMPLETED|Overall Study||7
2489827|NCT00862121|6103335|P2|Safety Analysis Set|Overall Study||11
2489828|NCT00862121|6103336|P1|Safety Analysis Set|Overall Study|The participant with no evaluable post-baseline CDAI score was included in the Safety Analysis Set.|8
2489829|NCT00862121|6103335|P2|Full Analysis Set (FAS)|Overall Study|One participant randomised in error (no IMP taken).|11
2489830|NCT00862121|6103336|P1|Full Analysis Set (FAS)|Overall Study|One participant had no evaluable post-baseline CDAI score.|7
2489831|NCT00862121|6103335|P2|STARTED|Overall Study|Randomised, intent-to-treat (ITT)|12
2489832|NCT00862121|6103336|P1|STARTED|Overall Study||8
2489833|NCT00862082|6103354|P2|NOT COMPLETED|Overall Study||1
2489834|NCT00862082|6103355|P1|NOT COMPLETED|Overall Study||5
2489835|NCT00862082|6103354|P2|COMPLETED|Overall Study||5
2489836|NCT00862082|6103355|P1|COMPLETED|Overall Study||3
2489837|NCT00862082|6103354|P2|STARTED|Overall Study||6
2489838|NCT00862082|6103355|P1|STARTED|Overall Study||8
2489839|NCT00861913|6103398|P1|NOT COMPLETED|Overall Study||0
2489840|NCT00861913|6103398|P1|COMPLETED|Overall Study||13
2489841|NCT00861913|6103398|P1|STARTED|Overall Study||13
2489842|NCT00861757|6103410|P4|NOT COMPLETED|Overall Study||9
2489843|NCT00861757|6103411|P3|NOT COMPLETED|Overall Study||18
2489844|NCT00861757|6103412|P2|NOT COMPLETED|Overall Study||15
2489845|NCT00861757|6103413|P1|NOT COMPLETED|Overall Study||9
2489846|NCT00861757|6103410|P4|COMPLETED|Overall Study||143
2489847|NCT00861757|6103411|P3|COMPLETED|Overall Study||137
2489848|NCT00861757|6103412|P2|COMPLETED|Overall Study||136
2489849|NCT00861757|6103413|P1|COMPLETED|Overall Study||145
2489850|NCT00861757|6103410|P4|STARTED|Overall Study||152
2489851|NCT00861757|6103411|P3|STARTED|Overall Study||155
2489852|NCT00861757|6103412|P2|STARTED|Overall Study||151
2489853|NCT00861757|6103413|P1|STARTED|Overall Study||154
2489854|NCT00861744|6103471|P4|NOT COMPLETED|Overall Study||33
2489855|NCT00861744|6103472|P3|NOT COMPLETED|Overall Study||24
2489856|NCT00861744|6103473|P2|NOT COMPLETED|Overall Study||29
2489857|NCT00861744|6103474|P1|NOT COMPLETED|Overall Study||17
2489858|NCT00861744|6103471|P4|COMPLETED|Overall Study||275
2489859|NCT00861744|6103472|P3|COMPLETED|Overall Study||280
2489860|NCT00861744|6103473|P2|COMPLETED|Overall Study||275
2489861|NCT00861744|6103474|P1|COMPLETED|Overall Study||287
2489862|NCT00861744|6103471|P4|STARTED|Overall Study||308
2489863|NCT00861744|6103472|P3|STARTED|Overall Study||304
2489864|NCT00861744|6103473|P2|STARTED|Overall Study||304
2489865|NCT00861744|6103474|P1|STARTED|Overall Study||304
2489866|NCT00861705|6103656|P4|NOT COMPLETED|Overall Study||1
2489867|NCT00861705|6103657|P3|NOT COMPLETED|Overall Study||0
2489868|NCT00861705|6103658|P2|NOT COMPLETED|Overall Study||3
2489869|NCT00861705|6103659|P1|NOT COMPLETED|Overall Study||7
2489870|NCT00861705|6103656|P4|COMPLETED|Overall Study||112
2489871|NCT00861705|6103657|P3|COMPLETED|Overall Study||113
2489872|NCT00861705|6103658|P2|COMPLETED|Overall Study||110
2489873|NCT00861705|6103659|P1|COMPLETED|Overall Study||108
2489874|NCT00861705|6103656|P4|STARTED|Overall Study||113
2489875|NCT00861705|6103657|P3|STARTED|Overall Study||113
2489876|NCT00861705|6103658|P2|STARTED|Overall Study||113
2489877|NCT00861705|6103659|P1|STARTED|Overall Study||115
2489878|NCT00861692|6103675|P1|NOT COMPLETED|Overall Study||6
2489879|NCT00861692|6103675|P1|COMPLETED|Overall Study||14
2489880|NCT00861692|6103675|P1|STARTED|Overall Study||20
2489881|NCT00861614|6103687|P2|NOT COMPLETED|Overall Study||368
2489882|NCT00861614|6103688|P1|NOT COMPLETED|Overall Study||371
2489883|NCT00861614|6103687|P2|COMPLETED|Overall Study||28
2489884|NCT00861614|6103688|P1|COMPLETED|Overall Study||22
2489885|NCT00861614|6103687|P2|STARTED|Overall Study||396
2489886|NCT00861614|6103688|P1|STARTED|Overall Study||393
2489887|NCT00861601|6103721|P3|NOT COMPLETED|Overall Study||0
2489888|NCT00861601|6103722|P2|NOT COMPLETED|Overall Study||0
2489889|NCT00861601|6103723|P1|NOT COMPLETED|Overall Study||0
2489890|NCT00861601|6103721|P3|COMPLETED|Overall Study||12
2489891|NCT00861601|6103722|P2|COMPLETED|Overall Study||14
2489892|NCT00861601|6103723|P1|COMPLETED|Overall Study||12
2489893|NCT00861601|6103721|P3|STARTED|Overall Study||12
2489894|NCT00861601|6103722|P2|STARTED|Overall Study||14
2489895|NCT00861601|6103723|P1|STARTED|Overall Study||12
2489896|NCT00861471|6103773|P1|NOT COMPLETED|Overall Study||9
2489897|NCT00861471|6103773|P1|COMPLETED|Overall Study||3
2489898|NCT00861471|6103773|P1|STARTED|Overall Study||12
2489899|NCT00861341|6103781|P1|NOT COMPLETED|Overall Study||2
2489900|NCT00861341|6103781|P1|COMPLETED|Overall Study||38
2489901|NCT00861341|6103781|P1|STARTED|Overall Study||40
2489902|NCT00861263|6103786|P1|NOT COMPLETED|Overall Study||0
2489903|NCT00861263|6103786|P1|COMPLETED|Overall Study||193
2489904|NCT00861263|6103786|P1|STARTED|Overall Study||193
2489905|NCT00861198|6103790|P1|NOT COMPLETED|Overall Study||5
2489906|NCT00861198|6103790|P1|COMPLETED|Overall Study||70
2489907|NCT00861198|6103790|P1|STARTED|Overall Study||75
2489908|NCT00861146|6103796|P2|NOT COMPLETED|Overall Study||8
2489909|NCT00861146|6103797|P1|NOT COMPLETED|Overall Study||20
2489910|NCT00861146|6103796|P2|COMPLETED|Overall Study||38
2489911|NCT00861146|6103797|P1|COMPLETED|Overall Study||85
2489912|NCT00861146|6103796|P2|Week 13 Assessment|Overall Study||38
2489913|NCT00861146|6103797|P1|Week 13 Assessment|Overall Study||85
2489914|NCT00861146|6103796|P2|Week 2 Assessment|Overall Study||45
2489915|NCT00861146|6103797|P1|Week 2 Assessment|Overall Study||97
2489916|NCT00861146|6103796|P2|STARTED|Overall Study||46
2489917|NCT00861146|6103797|P1|STARTED|Overall Study||105
2489918|NCT00860951|6103807|P1|NOT COMPLETED|Overall Study||7
2489919|NCT00860951|6103807|P1|COMPLETED|Overall Study||22
2489920|NCT00860951|6103807|P1|STARTED|Overall Study||29
2489921|NCT00860938|6103815|P2|NOT COMPLETED|Overall Study||8
2489922|NCT00860938|6103816|P1|NOT COMPLETED|Overall Study||14
2489923|NCT00860938|6103815|P2|COMPLETED|Overall Study||37
2489924|NCT00860938|6103816|P1|COMPLETED|Overall Study||31
2489925|NCT00860938|6103815|P2|STARTED|Overall Study||45
2489926|NCT00860938|6103816|P1|STARTED|Overall Study||45
2489927|NCT00860847|6103830|P2|NOT COMPLETED|Overall Study||5
2489928|NCT00860847|6103831|P1|NOT COMPLETED|Overall Study||4
2489929|NCT00860847|6103830|P2|COMPLETED|Overall Study||28
2489930|NCT00860847|6103831|P1|COMPLETED|Overall Study||28
2489931|NCT00860847|6103830|P2|STARTED|Overall Study||33
2489932|NCT00860847|6103831|P1|STARTED|Overall Study||32
2489933|NCT00860795|6103839|P2|NOT COMPLETED|Overall Study||0
2489934|NCT00860795|6103840|P1|NOT COMPLETED|Overall Study||0
2489935|NCT00860795|6103839|P2|COMPLETED|Overall Study||10
2489936|NCT00860795|6103840|P1|COMPLETED|Overall Study|One participant discontinued study medication on day 5, but completed safety evaluations|10
2489937|NCT00860795|6103839|P2|Number to Complete Study Medication|Overall Study||10
2489938|NCT00860795|6103840|P1|Number to Complete Study Medication|Overall Study||9
2489939|NCT00860795|6103839|P2|STARTED|Overall Study||10
2489940|NCT00860795|6103840|P1|STARTED|Overall Study||10
2489941|NCT00860743|6103864|P2|NOT COMPLETED|Overall Study||0
2489942|NCT00860743|6103865|P1|NOT COMPLETED|Overall Study||3
2489943|NCT00860743|6103864|P2|COMPLETED|Overall Study||23
2489944|NCT00860743|6103865|P1|COMPLETED|Overall Study||37
2489945|NCT00860743|6103864|P2|STARTED|Overall Study||23
2489946|NCT00860743|6103865|P1|STARTED|Overall Study||40
2489947|NCT00860535|6103871|P1|NOT COMPLETED|Overall Study||1
2489948|NCT00860535|6103871|P1|COMPLETED|Overall Study||8
2489949|NCT00860535|6103871|P1|DISCONTINUED|Overall Study|Participant did not meet inclusion criteria and did not complete the study.|1
2489950|NCT00860535|6103871|P1|STARTED|Overall Study||9
2489951|NCT00860470|6103878|P2|NOT COMPLETED|Overall Study||59
2489952|NCT00860470|6103879|P1|NOT COMPLETED|Overall Study||48
2489953|NCT00860470|6103878|P2|COMPLETED|Overall Study||22346
2489954|NCT00860470|6103879|P1|COMPLETED|Overall Study||22114
2489955|NCT00860470|6103878|P2|STARTED|Overall Study||22405
2489956|NCT00860470|6103879|P1|STARTED|Overall Study||22162
2489957|NCT00860457|6103903|P1|NOT COMPLETED|Overall Study||11
2489958|NCT00860457|6103903|P1|COMPLETED|Overall Study||11
2489959|NCT00860457|6103903|P1|STARTED|Overall Study||22
2489960|NCT00860405|6103909|P2|NOT COMPLETED|Overall Study||4
2489961|NCT00860405|6103910|P1|NOT COMPLETED|Overall Study||5
2489962|NCT00860405|6103909|P2|COMPLETED|Overall Study||26
2489963|NCT00860405|6103910|P1|COMPLETED|Overall Study|completed overall study|26
2489964|NCT00860405|6103909|P2|Day 28 Follow-up Performed|Overall Study||29
2489965|NCT00860405|6103910|P1|Day 28 Follow-up Performed|Overall Study||31
2489966|NCT00860405|6103909|P2|Completed Treatment|Overall Study||29
2489967|NCT00860405|6103910|P1|Completed Treatment|Overall Study||31
2489968|NCT00860405|6103909|P2|STARTED|Overall Study||30
2489969|NCT00860405|6103910|P1|STARTED|Overall Study||31
2489970|NCT00860314|6103934|P2|NOT COMPLETED|Overall Study||0
2489971|NCT00860314|6103935|P1|NOT COMPLETED|Overall Study||0
2489972|NCT00860314|6103934|P2|COMPLETED|Overall Study||48
2489973|NCT00860314|6103935|P1|COMPLETED|Overall Study||48
2489974|NCT00860314|6103934|P2|STARTED|Overall Study||48
2489975|NCT00860314|6103935|P1|STARTED|Overall Study||48
2489976|NCT00860262|6103950|P3|NOT COMPLETED|Overall Study||18
2489977|NCT00860262|6103951|P2|NOT COMPLETED|Overall Study||22
2489978|NCT00860262|6103952|P1|NOT COMPLETED|Overall Study||20
2489979|NCT00860262|6103950|P3|COMPLETED|Overall Study||202
2489980|NCT00860262|6103951|P2|COMPLETED|Overall Study||195
2489981|NCT00860262|6103952|P1|COMPLETED|Overall Study||401
2489982|NCT00860262|6103950|P3|STARTED|Overall Study||220
2489983|NCT00860262|6103951|P2|STARTED|Overall Study||217
2489984|NCT00860262|6103952|P1|STARTED|Overall Study||421
2489985|NCT00860249|6104065|P3|NOT COMPLETED|Overall Study||21
2489986|NCT00860249|6104066|P2|NOT COMPLETED|Overall Study||18
2489987|NCT00860249|6104067|P1|NOT COMPLETED|Overall Study||21
2489988|NCT00860249|6104065|P3|COMPLETED|Overall Study||0
2489989|NCT00860249|6104066|P2|COMPLETED|Overall Study||0
2489990|NCT00860249|6104067|P1|COMPLETED|Overall Study||0
2489991|NCT00860249|6104065|P3|STARTED|Overall Study||21
2489992|NCT00860249|6104066|P2|STARTED|Overall Study||18
2489993|NCT00860249|6104067|P1|STARTED|Overall Study||21
2489994|NCT00860171|6104078|P1|NOT COMPLETED|Overall Study||0
2489995|NCT00860171|6104078|P1|COMPLETED|Overall Study||16
2489996|NCT00860171|6104078|P1|STARTED|Overall Study||16
2489997|NCT00860158|6104087|P1|NOT COMPLETED|Overall Study||1
2489998|NCT00860158|6104087|P1|COMPLETED|Overall Study||0
2489999|NCT00860158|6104087|P1|STARTED|Overall Study||1
2490000|NCT00860067|6104099|P3|NOT COMPLETED|Overall Study||9
2490001|NCT00860067|6104100|P2|NOT COMPLETED|Overall Study||9
2490002|NCT00860067|6104101|P1|NOT COMPLETED|Overall Study||51
2490003|NCT00860067|6104099|P3|COMPLETED|Overall Study||292
2490004|NCT00860067|6104100|P2|COMPLETED|Overall Study||290
2490005|NCT00860067|6104101|P1|COMPLETED|Overall Study||1149
2490006|NCT00860067|6104099|P3|STARTED|Overall Study||301
2490007|NCT00860067|6104100|P2|STARTED|Overall Study||299
2490008|NCT00860067|6104101|P1|STARTED|Overall Study||1200
2490009|NCT00860028|6104161|P2|NOT COMPLETED|Smoking Cessation Phase||2
2490010|NCT00860028|6104162|P1|NOT COMPLETED|Smoking Cessation Phase||0
2490011|NCT00860028|6104161|P2|COMPLETED|Smoking Cessation Phase||12
2490012|NCT00860028|6104162|P1|COMPLETED|Smoking Cessation Phase||13
2490013|NCT00860028|6104161|P2|STARTED|Smoking Cessation Phase||14
2490014|NCT00860028|6104162|P1|STARTED|Smoking Cessation Phase||13
2490015|NCT00860028|6104161|P2|NOT COMPLETED|Placebo Controlled Pretreatment Period||1
2490016|NCT00860028|6104162|P1|NOT COMPLETED|Placebo Controlled Pretreatment Period||2
2490017|NCT00860028|6104161|P2|COMPLETED|Placebo Controlled Pretreatment Period||14
2490018|NCT00860028|6104162|P1|COMPLETED|Placebo Controlled Pretreatment Period||13
2490019|NCT00860028|6104161|P2|STARTED|Placebo Controlled Pretreatment Period||15
2490020|NCT00860028|6104162|P1|STARTED|Placebo Controlled Pretreatment Period||15
2490021|NCT00859976|6104174|P2|NOT COMPLETED|Overall Study||18
2490022|NCT00859976|6104175|P1|NOT COMPLETED|Overall Study||16
2490023|NCT00859976|6104174|P2|COMPLETED|Overall Study||67
2490024|NCT00859976|6104175|P1|COMPLETED|Overall Study||66
2490025|NCT00859976|6104174|P2|STARTED|Overall Study||85
2490026|NCT00859976|6104175|P1|STARTED|Overall Study||82
2490027|NCT00859950|6104191|P2|NOT COMPLETED|Overall Study||0
2490028|NCT00859950|6104192|P1|NOT COMPLETED|Overall Study||0
2490029|NCT00859950|6104191|P2|COMPLETED|Overall Study||21
2490030|NCT00859950|6104192|P1|COMPLETED|Overall Study||49
2490031|NCT00859950|6104191|P2|STARTED|Overall Study||21
2490032|NCT00859950|6104192|P1|STARTED|Overall Study||49
2490033|NCT00859937|6104200|P2|NOT COMPLETED|Overall Study||0
2490034|NCT00859937|6104201|P1|NOT COMPLETED|Overall Study||1
2490035|NCT00859937|6104200|P2|COMPLETED|Overall Study||14
2490036|NCT00859937|6104201|P1|COMPLETED|Overall Study||40
2490037|NCT00859937|6104200|P2|STARTED|Overall Study||14
2490038|NCT00859937|6104201|P1|STARTED|Overall Study||41
2490039|NCT00859898|6104216|P3|NOT COMPLETED|Overall Study||27
2490040|NCT00859898|6104217|P2|NOT COMPLETED|Overall Study||31
2490041|NCT00859898|6104218|P1|NOT COMPLETED|Overall Study||28
2490042|NCT00859898|6104216|P3|COMPLETED|Overall Study||181
2490043|NCT00859898|6104217|P2|COMPLETED|Overall Study||188
2490044|NCT00859898|6104218|P1|COMPLETED|Overall Study||183
2490045|NCT00859898|6104216|P3|STARTED|Overall Study||208
2490046|NCT00859898|6104217|P2|STARTED|Overall Study||219
2490047|NCT00859898|6104218|P1|STARTED|Overall Study||211
2490048|NCT00859833|6104259|P1|NOT COMPLETED|Overall Study||0
2490049|NCT00859833|6104259|P1|COMPLETED|Overall Study||30
2490050|NCT00859833|6104259|P1|STARTED|Overall Study||30
2490051|NCT00859651|6104266|P2|NOT COMPLETED|Overall Study||0
2490052|NCT00859651|6104267|P1|NOT COMPLETED|Overall Study||0
2490053|NCT00859651|6104266|P2|COMPLETED|Overall Study||22
2490054|NCT00859651|6104267|P1|COMPLETED|Overall Study||18
2490055|NCT00859651|6104266|P2|STARTED|Overall Study||22
2490056|NCT00859651|6104267|P1|STARTED|Overall Study||18
2490057|NCT00859638|6104277|P2|NOT COMPLETED|Overall Study||4
2490058|NCT00859638|6104278|P1|NOT COMPLETED|Overall Study||10
2490059|NCT00859638|6104277|P2|COMPLETED|Overall Study||55
2490060|NCT00859638|6104278|P1|COMPLETED|Overall Study||55
2490061|NCT00859638|6104277|P2|STARTED|Overall Study||59
2490062|NCT00859638|6104278|P1|STARTED|Overall Study||65
2490063|NCT00859586|6104284|P1|NOT COMPLETED|Overall Study||4
2490064|NCT00859586|6104284|P1|COMPLETED|Overall Study||4
2490065|NCT00859586|6104284|P1|STARTED|Overall Study||8
2490066|NCT00859573|6104290|P2|NOT COMPLETED|Overall Study||2
2490067|NCT00859573|6104291|P1|NOT COMPLETED|Overall Study||5
2490068|NCT00859573|6104290|P2|COMPLETED|Overall Study||1
2490069|NCT00859573|6104291|P1|COMPLETED|Overall Study||1
2490070|NCT00859573|6104290|P2|STARTED|Overall Study||3
2490071|NCT00859573|6104291|P1|STARTED|Overall Study||6
2490072|NCT00859547|6104297|P1|NOT COMPLETED|Overall Study||2
2490073|NCT00859547|6104297|P1|COMPLETED|Overall Study||28
2490074|NCT00859547|6104297|P1|STARTED|Overall Study||30
2490075|NCT00859521|6104310|P2|NOT COMPLETED|Second Intervention||0
2490076|NCT00859521|6104311|P1|NOT COMPLETED|Second Intervention||0
2490077|NCT00859521|6104310|P2|COMPLETED|Second Intervention||14
2490078|NCT00859521|6104311|P1|COMPLETED|Second Intervention||15
2490079|NCT00859521|6104310|P2|STARTED|Second Intervention||14
2490080|NCT00859521|6104311|P1|STARTED|Second Intervention||15
2490081|NCT00859521|6104310|P2|NOT COMPLETED|Washout||1
2490082|NCT00859521|6104311|P1|NOT COMPLETED|Washout||0
2490083|NCT00859521|6104310|P2|COMPLETED|Washout||14
2490084|NCT00859521|6104311|P1|COMPLETED|Washout||15
2490085|NCT00859521|6104310|P2|STARTED|Washout||15
2490086|NCT00859521|6104311|P1|STARTED|Washout||15
2490087|NCT00859521|6104310|P2|NOT COMPLETED|First Intervention||0
2490088|NCT00859521|6104311|P1|NOT COMPLETED|First Intervention||0
2490089|NCT00859521|6104310|P2|COMPLETED|First Intervention||15
2490090|NCT00859521|6104311|P1|COMPLETED|First Intervention||15
2490091|NCT00859521|6104310|P2|STARTED|First Intervention||15
2490092|NCT00859521|6104311|P1|STARTED|First Intervention||15
2490093|NCT00859508|6104321|P2|NOT COMPLETED|Overall Study||0
2490094|NCT00859508|6104322|P1|NOT COMPLETED|Overall Study||6
2490095|NCT00859508|6104321|P2|COMPLETED|Overall Study||37
2490096|NCT00859508|6104322|P1|COMPLETED|Overall Study||62
2490097|NCT00859508|6104321|P2|STARTED|Overall Study||37
2490098|NCT00859508|6104322|P1|STARTED|Overall Study||68
2490099|NCT00859469|6104328|P1|NOT COMPLETED|Overall Study||28
2490100|NCT00859469|6104328|P1|COMPLETED|Overall Study||1
2490101|NCT00859469|6104328|P1|6 Cycles|Overall Study||16
2490102|NCT00859469|6104328|P1|STARTED|Overall Study||29
2490103|NCT00859456|6104334|P1|NOT COMPLETED|Overall Study||8
2490104|NCT00859456|6104334|P1|COMPLETED|Overall Study||1
2490105|NCT00859456|6104334|P1|STARTED|Overall Study||9
2490106|NCT00859430|6104340|P2|NOT COMPLETED|Second Intervention||0
2490107|NCT00859430|6104341|P1|NOT COMPLETED|Second Intervention||0
2490108|NCT00859430|6104340|P2|COMPLETED|Second Intervention||10
2490109|NCT00859430|6104341|P1|COMPLETED|Second Intervention||11
2490110|NCT00859430|6104340|P2|STARTED|Second Intervention||10
2490111|NCT00859430|6104341|P1|STARTED|Second Intervention||11
2490112|NCT00859430|6104340|P2|NOT COMPLETED|First Intervention||1
2490113|NCT00859430|6104341|P1|NOT COMPLETED|First Intervention||0
2490114|NCT00859430|6104340|P2|COMPLETED|First Intervention||10
2490115|NCT00859430|6104341|P1|COMPLETED|First Intervention||11
2490116|NCT00859430|6104340|P2|STARTED|First Intervention||11
2490117|NCT00859430|6104341|P1|STARTED|First Intervention||11
2490118|NCT00859339|6104349|P1|NOT COMPLETED|Overall Study||0
2490119|NCT00859339|6104349|P1|COMPLETED|Overall Study||9
2490120|NCT00859339|6104349|P1|STARTED|Overall Study||9
2490121|NCT00859313|6104357|P1|NOT COMPLETED|Overall Study||4
2490122|NCT00859313|6104357|P1|COMPLETED|Overall Study||26
2490123|NCT00859313|6104357|P1|STARTED|Overall Study||30
2490124|NCT00859222|6104364|P5|NOT COMPLETED|Overall Study||15
2490125|NCT00859222|6104365|P4|NOT COMPLETED|Overall Study||24
2490126|NCT00859222|6104366|P3|NOT COMPLETED|Overall Study||6
2490127|NCT00859222|6104367|P2|NOT COMPLETED|Overall Study||3
2490128|NCT00859222|6104368|P1|NOT COMPLETED|Overall Study||3
2490129|NCT00859222|6104364|P5|COMPLETED|Overall Study||0
2490130|NCT00859222|6104365|P4|COMPLETED|Overall Study||0
2490131|NCT00859222|6104366|P3|COMPLETED|Overall Study||0
2490132|NCT00859222|6104367|P2|COMPLETED|Overall Study||0
2490133|NCT00859222|6104368|P1|COMPLETED|Overall Study||0
2490134|NCT00859222|6104364|P5|STARTED|Overall Study||15
2490135|NCT00859222|6104365|P4|STARTED|Overall Study||24
2490136|NCT00859222|6104366|P3|STARTED|Overall Study||6
2490137|NCT00859222|6104367|P2|STARTED|Overall Study||3
2490138|NCT00859222|6104368|P1|STARTED|Overall Study||3
2490139|NCT00859131|6104395|P2|NOT COMPLETED|Overall Study||0
2490140|NCT00859131|6104396|P1|NOT COMPLETED|Overall Study||0
2490141|NCT00859131|6104395|P2|COMPLETED|Overall Study||98
2490142|NCT00859131|6104396|P1|COMPLETED|Overall Study||102
2490143|NCT00859131|6104395|P2|STARTED|Overall Study||98
2490144|NCT00859131|6104396|P1|STARTED|Overall Study||102
2490145|NCT00859053|6104418|P4|NOT COMPLETED|Overall Study||0
2490146|NCT00859053|6104419|P3|NOT COMPLETED|Overall Study||0
2490147|NCT00859053|6104420|P2|NOT COMPLETED|Overall Study||0
2490148|NCT00859053|6104421|P1|NOT COMPLETED|Overall Study||0
2490149|NCT00859053|6104418|P4|COMPLETED|Overall Study||12
2490150|NCT00859053|6104419|P3|COMPLETED|Overall Study||6
2490151|NCT00859053|6104420|P2|COMPLETED|Overall Study||6
2490152|NCT00859053|6104421|P1|COMPLETED|Overall Study||6
2490153|NCT00859053|6104418|P4|STARTED|Overall Study||12
2490154|NCT00859053|6104419|P3|STARTED|Overall Study||6
2490155|NCT00859053|6104420|P2|STARTED|Overall Study||6
2490156|NCT00859053|6104421|P1|STARTED|Overall Study||6
2490157|NCT00859040|6104465|P2|NOT COMPLETED|Overall Study||0
2490158|NCT00859040|6104466|P1|NOT COMPLETED|Overall Study||0
2490159|NCT00859040|6104465|P2|COMPLETED|Overall Study||16
2490160|NCT00859040|6104466|P1|COMPLETED|Overall Study||18
2490161|NCT00859040|6104465|P2|STARTED|Overall Study||16
2490162|NCT00859040|6104466|P1|STARTED|Overall Study||18
2490163|NCT00859027|6104481|P2|NOT COMPLETED|Overall Study||5
2490164|NCT00859027|6104482|P1|NOT COMPLETED|Overall Study||5
2490165|NCT00859027|6104481|P2|COMPLETED|Overall Study||20
2490166|NCT00859027|6104482|P1|COMPLETED|Overall Study||20
2490167|NCT00859027|6104481|P2|STARTED|Overall Study||25
2490168|NCT00859027|6104482|P1|STARTED|Overall Study||25
2490169|NCT00859014|6104490|P1|NOT COMPLETED|Overall Study||5
2490170|NCT00859014|6104490|P1|COMPLETED|Overall Study||20
2490171|NCT00859014|6104490|P1|STARTED|Overall Study||25
2490172|NCT00858988|6104497|P2|NOT COMPLETED|Analysis||1
2490173|NCT00858988|6104498|P1|NOT COMPLETED|Analysis||2
2490174|NCT00858988|6104497|P2|COMPLETED|Analysis||72
2490175|NCT00858988|6104498|P1|COMPLETED|Analysis||72
2490176|NCT00858988|6104497|P2|STARTED|Analysis||73
2490177|NCT00858988|6104498|P1|STARTED|Analysis||74
2490178|NCT00858988|6104497|P2|NOT COMPLETED|Randomized and Allocation||0
2490179|NCT00858988|6104498|P1|NOT COMPLETED|Randomized and Allocation||0
2490180|NCT00858988|6104497|P2|COMPLETED|Randomized and Allocation||73
2490181|NCT00858988|6104498|P1|COMPLETED|Randomized and Allocation||74
2490182|NCT00858988|6104497|P2|STARTED|Randomized and Allocation||73
2490183|NCT00858988|6104498|P1|STARTED|Randomized and Allocation||74
2490184|NCT00858962|6104504|P1|NOT COMPLETED|Overall Study||0
2490185|NCT00858962|6104504|P1|COMPLETED|Overall Study||12
2490186|NCT00858962|6104504|P1|STARTED|Overall Study||12
2490187|NCT00858858|6104508|P1|NOT COMPLETED|Overall Study||18
2490188|NCT00858858|6104508|P1|COMPLETED|Overall Study||42
2490189|NCT00858858|6104508|P1|STARTED|Overall Study||60
2490190|NCT00858845|6104514|P2|NOT COMPLETED|Overall Study||1
2490191|NCT00858845|6104515|P1|NOT COMPLETED|Overall Study||0
2490192|NCT00858845|6104514|P2|COMPLETED|Overall Study||5
2490193|NCT00858845|6104515|P1|COMPLETED|Overall Study||5
2490194|NCT00858845|6104514|P2|STARTED|Overall Study||6
2490195|NCT00858845|6104515|P1|STARTED|Overall Study||5
2490196|NCT00858832|6104527|P2|NOT COMPLETED|Overall Study||1
2490197|NCT00858832|6104528|P1|NOT COMPLETED|Overall Study||1
2490198|NCT00858832|6104527|P2|COMPLETED|Overall Study||22
2490199|NCT00858832|6104528|P1|COMPLETED|Overall Study||20
2490200|NCT00858832|6104527|P2|STARTED|Overall Study||23
2490201|NCT00858832|6104528|P1|STARTED|Overall Study|study terminated early due to enrollment deficiencies|21
2490202|NCT00858780|6104534|P5|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||2
2490203|NCT00858780|6104535|P4|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
2490204|NCT00858780|6104536|P3|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
2490205|NCT00858780|6104537|P2|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
2490206|NCT00858780|6104538|P1|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
2490207|NCT00858780|6104534|P5|COMPLETED|OL Re-Treatment (Failure to Week 48)||41
2490208|NCT00858780|6104535|P4|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
2490209|NCT00858780|6104536|P3|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
2490210|NCT00858780|6104537|P2|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
2490211|NCT00858780|6104538|P1|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
2490212|NCT00858780|6104534|P5|STARTED|OL Re-Treatment (Failure to Week 48)|43 participants showed treatment failure in Period 2 and entered in Period 3.|43
2490213|NCT00858780|6104535|P4|STARTED|OL Re-Treatment (Failure to Week 48)||0
2490214|NCT00858780|6104536|P3|STARTED|OL Re-Treatment (Failure to Week 48)||0
2490215|NCT00858780|6104537|P2|STARTED|OL Re-Treatment (Failure to Week 48)||0
2490216|NCT00858780|6104538|P1|STARTED|OL Re-Treatment (Failure to Week 48)||0
2490217|NCT00858780|6104534|P5|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
2490218|NCT00858780|6104535|P4|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||1
2490219|NCT00858780|6104536|P3|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
2490220|NCT00858780|6104537|P2|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
2490221|NCT00858780|6104538|P1|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
2490222|NCT00858780|6104534|P5|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
2490223|NCT00858780|6104535|P4|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||22
2490224|NCT00858780|6104536|P3|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||25
2490225|NCT00858780|6104537|P2|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||21
2490226|NCT00858780|6104538|P1|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
2490227|NCT00858780|6104534|P5|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
2490228|NCT00858780|6104535|P4|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
2490229|NCT00858780|6104536|P3|STARTED|Double-Blind (Week 0 to Failure/Week 48)||27
2490230|NCT00858780|6104537|P2|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
2490231|NCT00858780|6104538|P1|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
2490232|NCT00858780|6104534|P5|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
2490233|NCT00858780|6104535|P4|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
2490234|NCT00858780|6104536|P3|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
2490235|NCT00858780|6104537|P2|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
2490236|NCT00858780|6104538|P1|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||18
2490237|NCT00858780|6104534|P5|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
2490238|NCT00858780|6104535|P4|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
2490239|NCT00858780|6104536|P3|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
2490240|NCT00858780|6104537|P2|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
2490241|NCT00858780|6104538|P1|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||73
2490242|NCT00858780|6104534|P5|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
2490243|NCT00858780|6104535|P4|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
2490244|NCT00858780|6104536|P3|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
2490245|NCT00858780|6104537|P2|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
2490246|NCT00858780|6104538|P1|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||91
2490247|NCT00858702|6104613|P2|NOT COMPLETED|Overall Study||2
2490248|NCT00858702|6104614|P1|NOT COMPLETED|Overall Study||5
2490249|NCT00858702|6104613|P2|COMPLETED|Overall Study||50
2490250|NCT00858702|6104614|P1|COMPLETED|Overall Study||48
2490251|NCT00858702|6104613|P2|STARTED|Overall Study||52
2490252|NCT00858702|6104614|P1|STARTED|Overall Study||53
2490253|NCT00858689|6104622|P1|NOT COMPLETED|Overall Study||1
2490254|NCT00858689|6104622|P1|COMPLETED|Overall Study||19
2490255|NCT00858689|6104622|P1|STARTED|Overall Study||20
2490256|NCT00858637|6104629|P6|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
2490257|NCT00858637|6104630|P5|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
2490258|NCT00858637|6104631|P4|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
2490259|NCT00858637|6104632|P3|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
2490260|NCT00858637|6104633|P2|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
2490261|NCT00858637|6104634|P1|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
2490262|NCT00858637|6104629|P6|COMPLETED|Placebo-controlled Withdrawal Phase||58
2490263|NCT00858637|6104630|P5|COMPLETED|Placebo-controlled Withdrawal Phase||55
2490264|NCT00858637|6104631|P4|COMPLETED|Placebo-controlled Withdrawal Phase||0
2490265|NCT00858637|6104632|P3|COMPLETED|Placebo-controlled Withdrawal Phase||53
2490266|NCT00858637|6104633|P2|COMPLETED|Placebo-controlled Withdrawal Phase||49
2490267|NCT00858637|6104634|P1|COMPLETED|Placebo-controlled Withdrawal Phase||0
2490268|NCT00858637|6104629|P6|STARTED|Placebo-controlled Withdrawal Phase||59
2490269|NCT00858637|6104630|P5|STARTED|Placebo-controlled Withdrawal Phase||56
2490270|NCT00858637|6104631|P4|STARTED|Placebo-controlled Withdrawal Phase||0
2490271|NCT00858637|6104632|P3|STARTED|Placebo-controlled Withdrawal Phase||54
2490272|NCT00858637|6104633|P2|STARTED|Placebo-controlled Withdrawal Phase||49
2490273|NCT00858637|6104634|P1|STARTED|Placebo-controlled Withdrawal Phase||0
2490274|NCT00858637|6104629|P6|NOT COMPLETED|Active Comparison Phase||0
2490275|NCT00858637|6104630|P5|NOT COMPLETED|Active Comparison Phase||0
2490276|NCT00858637|6104631|P4|NOT COMPLETED|Active Comparison Phase||18
2490277|NCT00858637|6104632|P3|NOT COMPLETED|Active Comparison Phase||0
2490278|NCT00858637|6104633|P2|NOT COMPLETED|Active Comparison Phase||0
2490279|NCT00858637|6104634|P1|NOT COMPLETED|Active Comparison Phase||24
2490280|NCT00858637|6104629|P6|COMPLETED|Active Comparison Phase||0
2490281|NCT00858637|6104630|P5|COMPLETED|Active Comparison Phase||0
2490282|NCT00858637|6104631|P4|COMPLETED|Active Comparison Phase||115
2490283|NCT00858637|6104632|P3|COMPLETED|Active Comparison Phase||0
2490284|NCT00858637|6104633|P2|COMPLETED|Active Comparison Phase||0
2490285|NCT00858637|6104634|P1|COMPLETED|Active Comparison Phase||103
2490286|NCT00858637|6104629|P6|STARTED|Active Comparison Phase||0
2490287|NCT00858637|6104630|P5|STARTED|Active Comparison Phase||0
2490288|NCT00858637|6104631|P4|STARTED|Active Comparison Phase||133
2490289|NCT00858637|6104632|P3|STARTED|Active Comparison Phase||0
2490290|NCT00858637|6104633|P2|STARTED|Active Comparison Phase||0
2490291|NCT00858637|6104634|P1|STARTED|Active Comparison Phase||127
2490292|NCT00858507|6104646|P2|NOT COMPLETED|Overall Study||15
2490293|NCT00858507|6104647|P1|NOT COMPLETED|Overall Study||22
2490294|NCT00858507|6104646|P2|COMPLETED|Overall Study||101
2490295|NCT00858507|6104647|P1|COMPLETED|Overall Study||83
2490296|NCT00858507|6104646|P2|STARTED|Overall Study||116
2490297|NCT00858507|6104647|P1|STARTED|Overall Study||105
2490298|NCT00858494|6104653|P1|NOT COMPLETED|Overall Study||4
2490299|NCT00858494|6104653|P1|COMPLETED|Overall Study|2 participants dropped out before giving study medication. Symptoms resolved without a dose in 2.|45
2490300|NCT00858494|6104653|P1|STARTED|Overall Study||49
2490301|NCT00858468|6104660|P2|NOT COMPLETED|Overall Study||0
2490302|NCT00858468|6104661|P1|NOT COMPLETED|Overall Study||0
2490303|NCT00858468|6104660|P2|COMPLETED|Overall Study||192
2490304|NCT00858468|6104661|P1|COMPLETED|Overall Study||201
2490305|NCT00858468|6104660|P2|STARTED|Overall Study||192
2490306|NCT00858468|6104661|P1|STARTED|Overall Study|1 enrolled participant was not vaccinated and removed from analysis|201
2490307|NCT00858442|6104675|P2|NOT COMPLETED|Compression:Start to Finish||3
2490308|NCT00858442|6104676|P1|NOT COMPLETED|Compression:Start to Finish||1
2490309|NCT00858442|6104675|P2|COMPLETED|Compression:Start to Finish||20
2490310|NCT00858442|6104676|P1|COMPLETED|Compression:Start to Finish||20
2490311|NCT00858442|6104675|P2|STARTED|Compression:Start to Finish||23
2490312|NCT00858442|6104676|P1|STARTED|Compression:Start to Finish||21
2490313|NCT00858442|6104675|P2|NOT COMPLETED|From Surgery to Start Compression;||0
2490314|NCT00858442|6104676|P1|NOT COMPLETED|From Surgery to Start Compression;||0
2490315|NCT00858442|6104675|P2|COMPLETED|From Surgery to Start Compression;||23
2490316|NCT00858442|6104676|P1|COMPLETED|From Surgery to Start Compression;||21
2490317|NCT00858442|6104675|P2|STARTED|From Surgery to Start Compression;||23
2490318|NCT00858442|6104676|P1|STARTED|From Surgery to Start Compression;||21
2490319|NCT00858403|6104686|P1|NOT COMPLETED|Overall Study||5
2490320|NCT00858403|6104686|P1|COMPLETED|Overall Study||2
2490321|NCT00858403|6104686|P1|STARTED|Overall Study||7
2490322|NCT00858390|6104698|P2|NOT COMPLETED|Overall Study||0
2490323|NCT00858390|6104699|P1|NOT COMPLETED|Overall Study||0
2490324|NCT00858390|6104698|P2|COMPLETED|Overall Study||18
2490325|NCT00858390|6104699|P1|COMPLETED|Overall Study||18
2490326|NCT00858390|6104698|P2|STARTED|Overall Study||18
2490327|NCT00858390|6104699|P1|STARTED|Overall Study||18
2490328|NCT00858364|6104707|P2|NOT COMPLETED|Overall Study||457
2490329|NCT00858364|6104708|P1|NOT COMPLETED|Overall Study||204
2490330|NCT00858364|6104707|P2|COMPLETED|Overall Study||1246
2490331|NCT00858364|6104708|P1|COMPLETED|Overall Study||642
2490332|NCT00858364|6104707|P2|Received Study Drug|Overall Study||1681
2490333|NCT00858364|6104708|P1|Received Study Drug|Overall Study||837
2490334|NCT00858364|6104707|P2|STARTED|Overall Study||1703
2490335|NCT00858364|6104708|P1|STARTED|Overall Study||846
2490336|NCT00858247|6104730|P2|NOT COMPLETED|Week 12 Follow-up||1
2490337|NCT00858247|6104731|P1|NOT COMPLETED|Week 12 Follow-up||0
2490338|NCT00858247|6104730|P2|COMPLETED|Week 12 Follow-up||23
2490339|NCT00858247|6104731|P1|COMPLETED|Week 12 Follow-up||23
2490340|NCT00858247|6104730|P2|STARTED|Week 12 Follow-up||24
2490341|NCT00858247|6104731|P1|STARTED|Week 12 Follow-up||23
2490342|NCT00858247|6104730|P2|NOT COMPLETED|Baseline Assessment||2
2490343|NCT00858247|6104731|P1|NOT COMPLETED|Baseline Assessment||2
2490344|NCT00858247|6104730|P2|COMPLETED|Baseline Assessment||24
2490345|NCT00858247|6104731|P1|COMPLETED|Baseline Assessment||23
2490346|NCT00858247|6104730|P2|STARTED|Baseline Assessment||26
2490347|NCT00858247|6104731|P1|STARTED|Baseline Assessment||25
2490348|NCT00858208|6104747|P1|NOT COMPLETED|Overall Study||79
2490349|NCT00858208|6104747|P1|COMPLETED|Overall Study||6
2490350|NCT00858208|6104747|P1|STARTED|Overall Study||85
2490351|NCT00858143|6104764|P1|NOT COMPLETED|Overall Study||50
2490352|NCT00858143|6104764|P1|COMPLETED|Overall Study||261
2490353|NCT00858143|6104764|P1|STARTED|Overall Study|Baseline|311
2490354|NCT00858130|6104813|P1|NOT COMPLETED|Overall Study||0
2490355|NCT00858130|6104813|P1|COMPLETED|Overall Study||12
2490356|NCT00858130|6104813|P1|STARTED|Overall Study||12
2490357|NCT00858013|6104823|P2|NOT COMPLETED|Overall Study||19
2490358|NCT00858013|6104824|P1|NOT COMPLETED|Overall Study||22
2490359|NCT00858013|6104823|P2|COMPLETED|Overall Study||23
2490360|NCT00858013|6104824|P1|COMPLETED|Overall Study||24
2490361|NCT00858013|6104823|P2|STARTED|Overall Study||42
2490362|NCT00858013|6104824|P1|STARTED|Overall Study||46
2490363|NCT00857961|6104838|P1|NOT COMPLETED|Overall Study||0
2490364|NCT00857961|6104838|P1|COMPLETED|Overall Study||21
2490365|NCT00857961|6104838|P1|STARTED|Overall Study||21
2490366|NCT00857948|6104876|P4|NOT COMPLETED|Overall Study||0
2490367|NCT00857948|6104877|P3|NOT COMPLETED|Overall Study||1
2490368|NCT00857948|6104878|P2|NOT COMPLETED|Overall Study||0
2490369|NCT00857948|6104879|P1|NOT COMPLETED|Overall Study||3
2490370|NCT00857948|6104876|P4|COMPLETED|Overall Study||23
2490371|NCT00857948|6104877|P3|COMPLETED|Overall Study||18
2490372|NCT00857948|6104878|P2|COMPLETED|Overall Study||18
2490373|NCT00857948|6104879|P1|COMPLETED|Overall Study||15
2490374|NCT00857948|6104876|P4|STARTED|Overall Study||23
2490375|NCT00857948|6104877|P3|STARTED|Overall Study||19
2490376|NCT00857948|6104878|P2|STARTED|Overall Study||18
2490377|NCT00857948|6104879|P1|STARTED|Overall Study||18
2490378|NCT00857896|6104901|P1|NOT COMPLETED|Week 5 to Week 8||0
2490379|NCT00857896|6104901|P1|COMPLETED|Week 5 to Week 8||20
2490380|NCT00857896|6104901|P1|STARTED|Week 5 to Week 8||20
2490381|NCT00857896|6104901|P1|NOT COMPLETED|Baseline to Week 4||1
2490382|NCT00857896|6104901|P1|COMPLETED|Baseline to Week 4||20
2490383|NCT00857896|6104901|P1|STARTED|Baseline to Week 4||21
2490384|NCT00857857|6104913|P1|NOT COMPLETED|Overall Study||0
2490385|NCT00857857|6104913|P1|COMPLETED|Overall Study||24
2490386|NCT00857857|6104913|P1|STARTED|Overall Study||24
2490387|NCT00857818|6105057|P2|NOT COMPLETED|Overall Study||8
2490388|NCT00857818|6105058|P1|NOT COMPLETED|Overall Study||11
2490389|NCT00857818|6105057|P2|COMPLETED|Overall Study||6
2490390|NCT00857818|6105058|P1|COMPLETED|Overall Study||3
2490391|NCT00857818|6105057|P2|Received Treatment|Overall Study||12
2490392|NCT00857818|6105058|P1|Received Treatment|Overall Study||14
2490393|NCT00857818|6105057|P2|STARTED|Overall Study||14
2490394|NCT00857818|6105058|P1|STARTED|Overall Study||14
2490395|NCT00857792|6105086|P1|NOT COMPLETED|Overall Study||12
2490396|NCT00857792|6105086|P1|COMPLETED|Overall Study||108
2490397|NCT00857792|6105086|P1|STARTED|Overall Study||120
2490398|NCT00857766|6105092|P2|NOT COMPLETED|Overall Study||30
2490399|NCT00857766|6105093|P1|NOT COMPLETED|Overall Study||31
2490400|NCT00857766|6105092|P2|COMPLETED|Overall Study||96
2490401|NCT00857766|6105093|P1|COMPLETED|Overall Study||92
2490402|NCT00857766|6105092|P2|STARTED|Overall Study||126
2490403|NCT00857766|6105093|P1|STARTED|Overall Study||123
2490404|NCT00857727|6105105|P2|NOT COMPLETED|Overall Study||0
2490405|NCT00857727|6105106|P1|NOT COMPLETED|Overall Study||0
2490406|NCT00857727|6105105|P2|COMPLETED|Overall Study||14
2490407|NCT00857727|6105106|P1|COMPLETED|Overall Study||14
2490408|NCT00857727|6105105|P2|STARTED|Overall Study||14
2490409|NCT00857727|6105106|P1|STARTED|Overall Study||14
2490410|NCT00857714|6105128|P1|NOT COMPLETED|Overall Study||0
2490411|NCT00857714|6105128|P1|COMPLETED|Overall Study||1
2490412|NCT00857714|6105128|P1|STARTED|Overall Study||1
2490413|NCT00857649|6105135|P2|NOT COMPLETED|Overall Study||32
2490414|NCT00857649|6105136|P1|NOT COMPLETED|Overall Study||31
2490415|NCT00857649|6105135|P2|COMPLETED|Overall Study||155
2490416|NCT00857649|6105136|P1|COMPLETED|Overall Study||151
2490417|NCT00857649|6105135|P2|STARTED|Overall Study||187
2490418|NCT00857649|6105136|P1|STARTED|Overall Study||182
2490419|NCT00857623|6105152|P2|NOT COMPLETED|Overall Study||10
2490420|NCT00857623|6105153|P1|NOT COMPLETED|Overall Study||14
2490421|NCT00857623|6105152|P2|COMPLETED|Overall Study||55
2490422|NCT00857623|6105153|P1|COMPLETED|Overall Study||48
2490423|NCT00857623|6105152|P2|STARTED|Overall Study||65
2490424|NCT00857623|6105153|P1|STARTED|Overall Study||62
2490425|NCT00857584|6105177|P2|NOT COMPLETED|Overall Study||5
2490426|NCT00857584|6105178|P1|NOT COMPLETED|Overall Study||4
2490427|NCT00857584|6105177|P2|COMPLETED|Overall Study||8
2490428|NCT00857584|6105178|P1|COMPLETED|Overall Study||10
2490429|NCT00857584|6105177|P2|Week 8|Overall Study||8
2490430|NCT00857584|6105178|P1|Week 8|Overall Study||10
2490431|NCT00857584|6105177|P2|Week 4|Overall Study||9
2490432|NCT00857584|6105178|P1|Week 4|Overall Study||11
2490433|NCT00857584|6105177|P2|Week 2|Overall Study||11
2490434|NCT00857584|6105178|P1|Week 2|Overall Study||14
2490435|NCT00857584|6105177|P2|Week 1|Overall Study||13
2490436|NCT00857584|6105178|P1|Week 1|Overall Study||14
2490437|NCT00857584|6105177|P2|STARTED|Overall Study||13
2490438|NCT00857584|6105178|P1|STARTED|Overall Study||14
2490439|NCT00857545|6105220|P2|NOT COMPLETED|Overall Study||0
2490440|NCT00857545|6105221|P1|NOT COMPLETED|Overall Study||0
2490441|NCT00857545|6105220|P2|COMPLETED|Overall Study||85
2490442|NCT00857545|6105221|P1|COMPLETED|Overall Study|Enrolled and randomized participants.|86
2490443|NCT00857545|6105220|P2|STARTED|Overall Study||85
2490444|NCT00857545|6105221|P1|STARTED|Overall Study||86
2490445|NCT00857532|6105231|P1|NOT COMPLETED|Overall Study||0
2490446|NCT00857532|6105231|P1|COMPLETED|Overall Study||31
2490447|NCT00857532|6105231|P1|STARTED|Overall Study||31
2490448|NCT00857506|6105242|P3|NOT COMPLETED|Overall Study||18
2490449|NCT00857506|6105243|P2|NOT COMPLETED|Overall Study||15
2490450|NCT00857506|6105244|P1|NOT COMPLETED|Overall Study||15
2490451|NCT00857506|6105242|P3|COMPLETED|Overall Study||51
2490452|NCT00857506|6105243|P2|COMPLETED|Overall Study||37
2490453|NCT00857506|6105244|P1|COMPLETED|Overall Study||16
2490454|NCT00857506|6105242|P3|STARTED|Overall Study||69
2490455|NCT00857506|6105243|P2|STARTED|Overall Study||52
2490456|NCT00857506|6105244|P1|STARTED|Overall Study||31
2490457|NCT00857493|6105272|P2|NOT COMPLETED|Overall Study||0
2490458|NCT00857493|6105273|P1|NOT COMPLETED|Overall Study||3
2490459|NCT00857493|6105272|P2|COMPLETED|Overall Study||58
2490460|NCT00857493|6105273|P1|COMPLETED|Overall Study||59
2490461|NCT00857493|6105272|P2|STARTED|Overall Study||58
2490462|NCT00857493|6105273|P1|STARTED|Overall Study||62
2490463|NCT00857454|6105305|P1|NOT COMPLETED|Overall Study||20
2490464|NCT00857454|6105305|P1|COMPLETED|Overall Study||51
2490465|NCT00857454|6105305|P1|STARTED|Overall Study||71
2490466|NCT00857415|6105318|P2|NOT COMPLETED|Overall Study||0
2490467|NCT00857415|6105319|P1|NOT COMPLETED|Overall Study||117
2490468|NCT00857415|6105318|P2|COMPLETED|Overall Study||74
2490469|NCT00857415|6105319|P1|COMPLETED|Overall Study||35
2490470|NCT00857415|6105318|P2|Deceased Within One Year of AV-45 Scan|Overall Study|Subjects in the specificity cohort were not followed to autopsy|0
2490471|NCT00857415|6105319|P1|Deceased Within One Year of AV-45 Scan|Overall Study||37
2490472|NCT00857415|6105318|P2|STARTED|Overall Study||74
2490473|NCT00857415|6105319|P1|STARTED|Overall Study||152
2490474|NCT00857311|6105330|P4|NOT COMPLETED|Overall Study||0
2490475|NCT00857311|6105331|P3|NOT COMPLETED|Overall Study||0
2490476|NCT00857311|6105332|P2|NOT COMPLETED|Overall Study||0
2490477|NCT00857311|6105333|P1|NOT COMPLETED|Overall Study||1
2490478|NCT00857311|6105330|P4|COMPLETED|Overall Study||0
2490479|NCT00857311|6105331|P3|COMPLETED|Overall Study||8
2490480|NCT00857311|6105332|P2|COMPLETED|Overall Study||0
2490481|NCT00857311|6105333|P1|COMPLETED|Overall Study||8
2490482|NCT00857311|6105330|P4|STARTED|Overall Study||0
2490483|NCT00857311|6105331|P3|STARTED|Overall Study||8
2490484|NCT00857311|6105332|P2|STARTED|Overall Study||0
2490485|NCT00857311|6105333|P1|STARTED|Overall Study||9
2490486|NCT00857285|6105345|P2|NOT COMPLETED|Overall Study||6
2490487|NCT00857285|6105346|P1|NOT COMPLETED|Overall Study||12
2490488|NCT00857285|6105345|P2|COMPLETED|Overall Study||59
2490489|NCT00857285|6105346|P1|COMPLETED|Overall Study||53
2490490|NCT00857285|6105345|P2|STARTED|Overall Study||65
2490491|NCT00857285|6105346|P1|STARTED|Overall Study||65
2490492|NCT00857272|6105352|P2|NOT COMPLETED|Overall Study||9
2490493|NCT00857272|6105353|P1|NOT COMPLETED|Overall Study||9
2490494|NCT00857272|6105352|P2|COMPLETED|Overall Study||145
2490495|NCT00857272|6105353|P1|COMPLETED|Overall Study||145
2490496|NCT00857272|6105352|P2|STARTED|Overall Study|Includes 7 non-ITT patients that withdrew consent|154
2490497|NCT00857272|6105353|P1|STARTED|Overall Study|Includes 6 non-ITT patients that withdrew consent|154
2490498|NCT00857259|6105362|P3|NOT COMPLETED|Overall Study||1
2490499|NCT00857259|6105363|P2|NOT COMPLETED|Overall Study||0
2490500|NCT00857259|6105364|P1|NOT COMPLETED|Overall Study||1
2490501|NCT00857259|6105362|P3|COMPLETED|Overall Study||6
2490502|NCT00857259|6105363|P2|COMPLETED|Overall Study||1
2490503|NCT00857259|6105364|P1|COMPLETED|Overall Study||7
2490504|NCT00857259|6105362|P3|STARTED|Overall Study||7
2490505|NCT00857259|6105363|P2|STARTED|Overall Study||1
2490506|NCT00857259|6105364|P1|STARTED|Overall Study||8
2490507|NCT00857246|6105374|P1|NOT COMPLETED|ChemoRT||3
2490508|NCT00857246|6105374|P1|COMPLETED|ChemoRT||12
2490509|NCT00857246|6105374|P1|STARTED|ChemoRT|6 did not start adjuvant therapy due to disease-related complications or patient withdrawal.|15
2490510|NCT00857246|6105374|P1|NOT COMPLETED|Surgery (Curative)||6
2490511|NCT00857246|6105374|P1|COMPLETED|Surgery (Curative)||21
2490512|NCT00857246|6105374|P1|STARTED|Surgery (Curative)||27
2490513|NCT00857246|6105374|P1|NOT COMPLETED|Induction Regimen||3
2490514|NCT00857246|6105374|P1|COMPLETED|Induction Regimen||27
2490515|NCT00857246|6105374|P1|STARTED|Induction Regimen||30
2490516|NCT00857233|6105384|P1|NOT COMPLETED|Overall Study||55
2490517|NCT00857233|6105384|P1|COMPLETED|Overall Study||242
2490518|NCT00857233|6105384|P1|STARTED|Overall Study||297
2490519|NCT00857220|6105393|P1|NOT COMPLETED|Overall Study||183
2490520|NCT00857220|6105393|P1|COMPLETED|Overall Study||121
2490521|NCT00857220|6105393|P1|STARTED|Overall Study||304
2490522|NCT00856999|6105410|P1|NOT COMPLETED|Overall Study||5
2490523|NCT00856999|6105410|P1|COMPLETED|Overall Study||45
2490524|NCT00856999|6105410|P1|STARTED|Overall Study||50
2490525|NCT00856986|6105420|P5|NOT COMPLETED|Extension Period, Weeks 26-52||0
2490526|NCT00856986|6105421|P4|NOT COMPLETED|Extension Period, Weeks 26-52||0
2490527|NCT00856986|6105422|P3|NOT COMPLETED|Extension Period, Weeks 26-52||38
2490528|NCT00856986|6105423|P2|NOT COMPLETED|Extension Period, Weeks 26-52||14
2490529|NCT00856986|6105424|P1|NOT COMPLETED|Extension Period, Weeks 26-52||19
2490530|NCT00856986|6105420|P5|COMPLETED|Extension Period, Weeks 26-52||0
2490531|NCT00856986|6105421|P4|COMPLETED|Extension Period, Weeks 26-52||0
2490532|NCT00856986|6105422|P3|COMPLETED|Extension Period, Weeks 26-52||432
2490533|NCT00856986|6105423|P2|COMPLETED|Extension Period, Weeks 26-52||130
2490534|NCT00856986|6105424|P1|COMPLETED|Extension Period, Weeks 26-52||108
2490535|NCT00856986|6105420|P5|Enrolled in Extension|Extension Period, Weeks 26-52||0
2490536|NCT00856986|6105421|P4|Enrolled in Extension|Extension Period, Weeks 26-52||0
2490537|NCT00856986|6105422|P3|Enrolled in Extension|Extension Period, Weeks 26-52||461
2490538|NCT00856986|6105423|P2|Enrolled in Extension|Extension Period, Weeks 26-52||140
2490539|NCT00856986|6105424|P1|Enrolled in Extension|Extension Period, Weeks 26-52||122
2490540|NCT00856986|6105420|P5|STARTED|Extension Period, Weeks 26-52||0
2490541|NCT00856986|6105421|P4|STARTED|Extension Period, Weeks 26-52||0
2490542|NCT00856986|6105422|P3|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 7 (Intensified Group)|470
2490543|NCT00856986|6105423|P2|STARTED|Extension Period, Weeks 26-52||144
2490544|NCT00856986|6105424|P1|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 17 (Intensified Group)|127
2490545|NCT00856986|6105420|P5|NOT COMPLETED|Main Period, Weeks 0-26||0
2490546|NCT00856986|6105421|P4|NOT COMPLETED|Main Period, Weeks 0-26||0
2490547|NCT00856986|6105422|P3|NOT COMPLETED|Main Period, Weeks 0-26||28
2490548|NCT00856986|6105423|P2|NOT COMPLETED|Main Period, Weeks 0-26||18
2490549|NCT00856986|6105424|P1|NOT COMPLETED|Main Period, Weeks 0-26||34
2490550|NCT00856986|6105420|P5|COMPLETED|Main Period, Weeks 0-26||0
2490551|NCT00856986|6105421|P4|COMPLETED|Main Period, Weeks 0-26||0
2490552|NCT00856986|6105422|P3|COMPLETED|Main Period, Weeks 0-26||470
2490553|NCT00856986|6105423|P2|COMPLETED|Main Period, Weeks 0-26||144
2490554|NCT00856986|6105424|P1|COMPLETED|Main Period, Weeks 0-26||127
2490555|NCT00856986|6105420|P5|STARTED|Main Period, Weeks 0-26||0
2490556|NCT00856986|6105421|P4|STARTED|Main Period, Weeks 0-26||0
2490557|NCT00856986|6105422|P3|STARTED|Main Period, Weeks 0-26||498
2490558|NCT00856986|6105423|P2|STARTED|Main Period, Weeks 0-26||162
2490559|NCT00856986|6105424|P1|STARTED|Main Period, Weeks 0-26||161
2490560|NCT00856986|6105420|P5|NOT COMPLETED|Run-in Period, Weeks -12-0||0
2490561|NCT00856986|6105421|P4|NOT COMPLETED|Run-in Period, Weeks -12-0||167
2490562|NCT00856986|6105422|P3|NOT COMPLETED|Run-in Period, Weeks -12-0||0
2490563|NCT00856986|6105423|P2|NOT COMPLETED|Run-in Period, Weeks -12-0||0
2490564|NCT00856986|6105424|P1|NOT COMPLETED|Run-in Period, Weeks -12-0||0
2490565|NCT00856986|6105420|P5|COMPLETED|Run-in Period, Weeks -12-0||0
2490566|NCT00856986|6105421|P4|COMPLETED|Run-in Period, Weeks -12-0|Subjects who withdrew during run-in and before randomisation were Early Withdrawals|0
2490567|NCT00856986|6105422|P3|COMPLETED|Run-in Period, Weeks -12-0||498
2490568|NCT00856986|6105423|P2|COMPLETED|Run-in Period, Weeks -12-0||162
2490569|NCT00856986|6105424|P1|COMPLETED|Run-in Period, Weeks -12-0||161
2490570|NCT00856986|6105420|P5|STARTED|Run-in Period, Weeks -12-0||0
2490571|NCT00856986|6105421|P4|STARTED|Run-in Period, Weeks -12-0||167
2490572|NCT00856986|6105422|P3|STARTED|Run-in Period, Weeks -12-0||498
2490573|NCT00856986|6105423|P2|STARTED|Run-in Period, Weeks -12-0||162
2490574|NCT00856986|6105424|P1|STARTED|Run-in Period, Weeks -12-0||161
2490575|NCT00856973|6105594|P3|NOT COMPLETED|Overall Study||38
2490576|NCT00856973|6105595|P2|NOT COMPLETED|Overall Study||41
2490577|NCT00856973|6105596|P1|NOT COMPLETED|Overall Study||36
2490578|NCT00856973|6105594|P3|COMPLETED|Overall Study||123
2490579|NCT00856973|6105595|P2|COMPLETED|Overall Study||122
2490580|NCT00856973|6105596|P1|COMPLETED|Overall Study||126
2490581|NCT00856973|6105594|P3|STARTED|Overall Study||161
2490582|NCT00856973|6105595|P2|STARTED|Overall Study||163
2490583|NCT00856973|6105596|P1|STARTED|Overall Study||162
2490584|NCT00856934|6105664|P3|NOT COMPLETED|Overall Study||0
2490585|NCT00856934|6105665|P2|NOT COMPLETED|Overall Study||0
2490586|NCT00856934|6105666|P1|NOT COMPLETED|Overall Study||0
2490587|NCT00856934|6105664|P3|COMPLETED|Overall Study||15
2490588|NCT00856934|6105665|P2|COMPLETED|Overall Study||15
2490589|NCT00856934|6105666|P1|COMPLETED|Overall Study||15
2490590|NCT00856934|6105664|P3|STARTED|Overall Study||15
2490591|NCT00856934|6105665|P2|STARTED|Overall Study||15
2490592|NCT00856934|6105666|P1|STARTED|Overall Study||15
2490593|NCT00856908|6105676|P2|NOT COMPLETED|Overall Study||0
2490594|NCT00856908|6105677|P1|NOT COMPLETED|Overall Study||1
2490595|NCT00856908|6105676|P2|COMPLETED|Overall Study||5
2490596|NCT00856908|6105677|P1|COMPLETED|Overall Study||14
2490597|NCT00856908|6105676|P2|STARTED|Overall Study||5
2490598|NCT00856908|6105677|P1|STARTED|Overall Study||15
2490599|NCT00856856|6105702|P1|NOT COMPLETED|5-year Clinical Follow-up||0
2490600|NCT00856856|6105702|P1|COMPLETED|5-year Clinical Follow-up|One patient missed the 4-year clinical follow-up but returned at 5 year.|100
2490601|NCT00856856|6105702|P1|STARTED|5-year Clinical Follow-up||100
2490602|NCT00856856|6105702|P1|NOT COMPLETED|4-year Clinical Follow-up||1
2490603|NCT00856856|6105702|P1|COMPLETED|4-year Clinical Follow-up||99
2490604|NCT00856856|6105702|P1|STARTED|4-year Clinical Follow-up||100
2490605|NCT00856856|6105702|P1|NOT COMPLETED|3-year Clinical Follow-up||0
2490606|NCT00856856|6105702|P1|COMPLETED|3-year Clinical Follow-up||100
2490607|NCT00856856|6105702|P1|STARTED|3-year Clinical Follow-up||100
2490608|NCT00856856|6105702|P1|NOT COMPLETED|2-year Clinical Follow-up||1
2490609|NCT00856856|6105702|P1|COMPLETED|2-year Clinical Follow-up||100
2490610|NCT00856856|6105702|P1|STARTED|2-year Clinical Follow-up||101
2490611|NCT00856856|6105702|P1|NOT COMPLETED|1-year Clinical Follow-up||0
2490612|NCT00856856|6105702|P1|COMPLETED|1-year Clinical Follow-up||101
2490613|NCT00856856|6105702|P1|STARTED|1-year Clinical Follow-up||101
2490614|NCT00856856|6105702|P1|NOT COMPLETED|270-day Clinical Follow-up||0
2490615|NCT00856856|6105702|P1|COMPLETED|270-day Clinical Follow-up||101
2490616|NCT00856856|6105702|P1|STARTED|270-day Clinical Follow-up||101
2490617|NCT00856856|6105702|P1|NOT COMPLETED|180-day Clinical Follow-up||0
2490618|NCT00856856|6105702|P1|COMPLETED|180-day Clinical Follow-up||101
2490619|NCT00856856|6105702|P1|STARTED|180-day Clinical Follow-up||101
2490620|NCT00856856|6105702|P1|NOT COMPLETED|30-day Clinical Follow-up||0
2490621|NCT00856856|6105702|P1|COMPLETED|30-day Clinical Follow-up||101
2490622|NCT00856856|6105702|P1|STARTED|30-day Clinical Follow-up||101
2490623|NCT00856856|6105702|P1|NOT COMPLETED|Baseline||0
2490624|NCT00856856|6105702|P1|COMPLETED|Baseline||101
2490625|NCT00856856|6105702|P1|STARTED|Baseline||101
2490626|NCT00856843|6105901|P2|NOT COMPLETED|Overall Study||5
2490627|NCT00856843|6105902|P1|NOT COMPLETED|Overall Study||2
2490628|NCT00856843|6105901|P2|COMPLETED|Overall Study||63
2490629|NCT00856843|6105902|P1|COMPLETED|Overall Study||66
2490630|NCT00856843|6105901|P2|STARTED|Overall Study||68
2490631|NCT00856843|6105902|P1|STARTED|Overall Study||68
2490632|NCT00856830|6105938|P4|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
2490633|NCT00856830|6105939|P3|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
2490634|NCT00856830|6105940|P2|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
2490635|NCT00856830|6105941|P1|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
2490636|NCT00856830|6105938|P4|COMPLETED|Regimen - B (Carboplatin & Etoposide)||12
2490637|NCT00856830|6105939|P3|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
2490638|NCT00856830|6105940|P2|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
2490639|NCT00856830|6105941|P1|COMPLETED|Regimen - B (Carboplatin & Etoposide)||3
2490640|NCT00856830|6105938|P4|STARTED|Regimen - B (Carboplatin & Etoposide)||12
2490641|NCT00856830|6105939|P3|STARTED|Regimen - B (Carboplatin & Etoposide)||6
2490642|NCT00856830|6105940|P2|STARTED|Regimen - B (Carboplatin & Etoposide)||6
2490643|NCT00856830|6105941|P1|STARTED|Regimen - B (Carboplatin & Etoposide)||3
2490644|NCT00856830|6105938|P4|NOT COMPLETED|Irinotecan & Bendamustine||3
2490645|NCT00856830|6105939|P3|NOT COMPLETED|Irinotecan & Bendamustine||0
2490646|NCT00856830|6105940|P2|NOT COMPLETED|Irinotecan & Bendamustine||0
2490647|NCT00856830|6105941|P1|NOT COMPLETED|Irinotecan & Bendamustine||0
2490648|NCT00856830|6105938|P4|COMPLETED|Irinotecan & Bendamustine||12
2490649|NCT00856830|6105939|P3|COMPLETED|Irinotecan & Bendamustine||6
2490650|NCT00856830|6105940|P2|COMPLETED|Irinotecan & Bendamustine||6
2490651|NCT00856830|6105941|P1|COMPLETED|Irinotecan & Bendamustine||3
2490652|NCT00856830|6105938|P4|Maximum Tolerated Dose|Irinotecan & Bendamustine||12
2490653|NCT00856830|6105939|P3|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
2490654|NCT00856830|6105940|P2|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
2490655|NCT00856830|6105941|P1|Maximum Tolerated Dose|Irinotecan & Bendamustine||3
2490656|NCT00856830|6105938|P4|STARTED|Irinotecan & Bendamustine||15
2490657|NCT00856830|6105939|P3|STARTED|Irinotecan & Bendamustine||6
2490658|NCT00856830|6105940|P2|STARTED|Irinotecan & Bendamustine||6
2490659|NCT00856830|6105941|P1|STARTED|Irinotecan & Bendamustine||3
2490660|NCT00856791|6105947|P1|NOT COMPLETED|Overall Study||0
2490661|NCT00856791|6105947|P1|COMPLETED|Overall Study||1
2490662|NCT00856791|6105947|P1|STARTED|Overall Study||1
2490663|NCT00856778|6105952|P1|NOT COMPLETED|Overall Study||24
2490664|NCT00856778|6105952|P1|COMPLETED|Overall Study||74
2490665|NCT00856778|6105952|P1|STARTED|Overall Study||98
2490666|NCT00856739|6105971|P3|NOT COMPLETED|Overall Study||0
2490667|NCT00856739|6105972|P2|NOT COMPLETED|Overall Study||0
2490668|NCT00856739|6105973|P1|NOT COMPLETED|Overall Study||0
2490669|NCT00856739|6105971|P3|COMPLETED|Overall Study||55
2490670|NCT00856739|6105972|P2|COMPLETED|Overall Study||52
2490671|NCT00856739|6105973|P1|COMPLETED|Overall Study||70
2490672|NCT00856739|6105971|P3|STARTED|Overall Study||55
2490673|NCT00856739|6105972|P2|STARTED|Overall Study||52
2490674|NCT00856739|6105973|P1|STARTED|Overall Study||70
2490675|NCT00856726|6105984|P1|NOT COMPLETED|Overall Study||0
2490676|NCT00856726|6105984|P1|COMPLETED|Overall Study||26
2490677|NCT00856726|6105984|P1|STARTED|Overall Study||26
2490678|NCT00856661|6105995|P2|NOT COMPLETED|Overall Study||29
2490679|NCT00856661|6105996|P1|NOT COMPLETED|Overall Study||27
2490680|NCT00856661|6105995|P2|COMPLETED|Overall Study||106
2490681|NCT00856661|6105996|P1|COMPLETED|Overall Study||108
2490682|NCT00856661|6105995|P2|Randomized Not Treated|Overall Study||4
2490683|NCT00856661|6105996|P1|Randomized Not Treated|Overall Study||9
2490684|NCT00856661|6105995|P2|Treated|Overall Study||131
2490685|NCT00856661|6105996|P1|Treated|Overall Study||126
2490686|NCT00856661|6105995|P2|STARTED|Overall Study|Randomised|135
2490687|NCT00856661|6105996|P1|STARTED|Overall Study|Randomised|135
2490688|NCT00856635|6106010|P2|NOT COMPLETED|Overall Study||8
2490689|NCT00856635|6106011|P1|NOT COMPLETED|Overall Study||10
2490690|NCT00856635|6106010|P2|COMPLETED|Overall Study||14
2490691|NCT00856635|6106011|P1|COMPLETED|Overall Study||12
2490692|NCT00856635|6106010|P2|Received Study Drug|Overall Study||20
2490693|NCT00856635|6106011|P1|Received Study Drug|Overall Study||20
2490694|NCT00856635|6106010|P2|STARTED|Overall Study||22
2490695|NCT00856635|6106011|P1|STARTED|Overall Study||22
2490696|NCT00856609|6106021|P2|NOT COMPLETED|Overall Study||0
2490697|NCT00856609|6106022|P1|NOT COMPLETED|Overall Study||1
2490698|NCT00856609|6106021|P2|COMPLETED|Overall Study||39
2490699|NCT00856609|6106022|P1|COMPLETED|Overall Study||40
2490700|NCT00856609|6106021|P2|STARTED|Overall Study||39
2490701|NCT00856609|6106022|P1|STARTED|Overall Study||41
2490702|NCT00856583|6106034|P2|NOT COMPLETED|Overall Study||2597
2490703|NCT00856583|6106035|P1|NOT COMPLETED|Overall Study||3137
2490704|NCT00856583|6106034|P2|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|2307
2490705|NCT00856583|6106035|P1|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|1768
2490706|NCT00856583|6106034|P2|STARTED|Overall Study|Patients treated|4904
2490707|NCT00856583|6106035|P1|STARTED|Overall Study|Patients treated|4905
2490708|NCT00856557|6106065|P2|NOT COMPLETED|Overall Study||16
2490709|NCT00856557|6106066|P1|NOT COMPLETED|Overall Study||12
2490710|NCT00856557|6106065|P2|COMPLETED|Overall Study||60
2490711|NCT00856557|6106066|P1|COMPLETED|Overall Study||50
2490712|NCT00856557|6106065|P2|With Patients With Contextual Flags|Overall Study||60
2490713|NCT00856557|6106066|P1|With Patients With Contextual Flags|Overall Study||50
2490714|NCT00856557|6106065|P2|Tested With Standardized Patients|Overall Study||76
2490715|NCT00856557|6106066|P1|Tested With Standardized Patients|Overall Study||62
2490716|NCT00856557|6106065|P2|Received Intervention/Control|Overall Study||76
2490717|NCT00856557|6106066|P1|Received Intervention/Control|Overall Study||62
2490718|NCT00856557|6106065|P2|STARTED|Overall Study||76
2490719|NCT00856557|6106066|P1|STARTED|Overall Study||62
2490720|NCT00856544|6106080|P4|NOT COMPLETED|Overall Study||13
2490721|NCT00856544|6106081|P3|NOT COMPLETED|Overall Study||8
2490722|NCT00856544|6106082|P2|NOT COMPLETED|Overall Study||66
2490723|NCT00856544|6106083|P1|NOT COMPLETED|Overall Study||57
2490724|NCT00856544|6106080|P4|COMPLETED|Overall Study||67
2490725|NCT00856544|6106081|P3|COMPLETED|Overall Study||71
2490726|NCT00856544|6106082|P2|COMPLETED|Overall Study||252
2490727|NCT00856544|6106083|P1|COMPLETED|Overall Study||261
2490728|NCT00856544|6106080|P4|Treated|Overall Study||80
2490729|NCT00856544|6106081|P3|Treated|Overall Study||79
2490730|NCT00856544|6106082|P2|Treated|Overall Study||318
2490731|NCT00856544|6106083|P1|Treated|Overall Study||315
2490732|NCT00856544|6106080|P4|STARTED|Overall Study||80
2490733|NCT00856544|6106081|P3|STARTED|Overall Study||79
2490734|NCT00856544|6106082|P2|STARTED|Overall Study||318
2490735|NCT00856544|6106083|P1|STARTED|Overall Study||318
2490736|NCT00856518|6106262|P2|NOT COMPLETED|Overall Study||2
2490737|NCT00856518|6106263|P1|NOT COMPLETED|Overall Study||4
2490738|NCT00856518|6106262|P2|COMPLETED|Overall Study||16
2490739|NCT00856518|6106263|P1|COMPLETED|Overall Study||20
2490740|NCT00856518|6106262|P2|STARTED|Overall Study||18
2490741|NCT00856518|6106263|P1|STARTED|Overall Study||24
2490742|NCT00856492|6106276|P3|NOT COMPLETED|Overall Study||2
2490743|NCT00856492|6106277|P2|NOT COMPLETED|Overall Study||1
2490744|NCT00856492|6106278|P1|NOT COMPLETED|Overall Study||1
2490745|NCT00856492|6106276|P3|COMPLETED|Overall Study||51
2490746|NCT00856492|6106277|P2|COMPLETED|Overall Study||62
2490747|NCT00856492|6106278|P1|COMPLETED|Overall Study||98
2490748|NCT00856492|6106276|P3|Toxicity Eval|Overall Study||51
2490749|NCT00856492|6106277|P2|Toxicity Eval|Overall Study||60
2490750|NCT00856492|6106278|P1|Toxicity Eval|Overall Study||96
2490751|NCT00856492|6106276|P3|STARTED|Overall Study||53
2490752|NCT00856492|6106277|P2|STARTED|Overall Study||63
2490753|NCT00856492|6106278|P1|STARTED|Overall Study||99
2490754|NCT00856414|6106292|P1|NOT COMPLETED|Overall Study||0
2490755|NCT00856414|6106292|P1|COMPLETED|Overall Study||45
2490756|NCT00856414|6106292|P1|STARTED|Overall Study||45
2490757|NCT00856388|6106300|P1|NOT COMPLETED|Overall Study||1
2490758|NCT00856388|6106300|P1|COMPLETED|Overall Study||61
2490759|NCT00856388|6106300|P1|STARTED|Overall Study||62
2490760|NCT00856349|6106311|P1|NOT COMPLETED|Overall Study||1021
2490761|NCT00856349|6106311|P1|COMPLETED|Overall Study||3111
2490762|NCT00856349|6106311|P1|24 Month Follow-up|Overall Study||1698
2490763|NCT00856349|6106311|P1|18 Month Follow-up|Overall Study||2467
2490764|NCT00856349|6106311|P1|12 Month Follow-up|Overall Study||3228
2490765|NCT00856349|6106311|P1|STARTED|Overall Study||4132
2490766|NCT00856323|6106320|P1|NOT COMPLETED|Overall Study||2
2490767|NCT00856323|6106320|P1|COMPLETED|Overall Study||51
2490768|NCT00856323|6106320|P1|STARTED|Overall Study||53
2490769|NCT00856297|6106332|P5|NOT COMPLETED|Overall Study||0
2490770|NCT00856297|6106333|P4|NOT COMPLETED|Overall Study||0
2490771|NCT00856297|6106334|P3|NOT COMPLETED|Overall Study||0
2490772|NCT00856297|6106335|P2|NOT COMPLETED|Overall Study||0
2490773|NCT00856297|6106336|P1|NOT COMPLETED|Overall Study||2
2490774|NCT00856297|6106332|P5|COMPLETED|Overall Study||31
2490775|NCT00856297|6106333|P4|COMPLETED|Overall Study||44
2490776|NCT00856297|6106334|P3|COMPLETED|Overall Study||107
2490777|NCT00856297|6106335|P2|COMPLETED|Overall Study||76
2490778|NCT00856297|6106336|P1|COMPLETED|Overall Study||129
2490779|NCT00856297|6106332|P5|STARTED|Overall Study||31
2490780|NCT00856297|6106333|P4|STARTED|Overall Study||44
2490781|NCT00856297|6106334|P3|STARTED|Overall Study||107
2490782|NCT00856297|6106335|P2|STARTED|Overall Study||76
2490783|NCT00856297|6106336|P1|STARTED|Overall Study||131
2490784|NCT00856284|6106369|P3|NOT COMPLETED|Overall Study||447
2490785|NCT00856284|6106370|P2|NOT COMPLETED|Overall Study||392
2490786|NCT00856284|6106371|P1|NOT COMPLETED|Overall Study||408
2490787|NCT00856284|6106369|P3|COMPLETED|Overall Study||427
2490788|NCT00856284|6106370|P2|COMPLETED|Overall Study||493
2490789|NCT00856284|6106371|P1|COMPLETED|Overall Study||472
2490790|NCT00856284|6106369|P3|Received Study Drug|Overall Study||869
2490791|NCT00856284|6106370|P2|Received Study Drug|Overall Study||878
2490792|NCT00856284|6106371|P1|Received Study Drug|Overall Study||873
2490793|NCT00856284|6106369|P3|STARTED|Overall Study||874
2490794|NCT00856284|6106370|P2|STARTED|Overall Study||885
2490795|NCT00856284|6106371|P1|STARTED|Overall Study||880
2490796|NCT00856245|6106397|P1|NOT COMPLETED|Overall Study||5
2490797|NCT00856245|6106397|P1|COMPLETED|Overall Study||14
2490798|NCT00856245|6106397|P1|STARTED|Overall Study||19
2490799|NCT00856232|6106405|P3|NOT COMPLETED|Overall Study||0
2490800|NCT00856232|6106406|P2|NOT COMPLETED|Overall Study||0
2490801|NCT00856232|6106407|P1|NOT COMPLETED|Overall Study||0
2490802|NCT00856232|6106405|P3|COMPLETED|Overall Study||36
2490803|NCT00856232|6106406|P2|COMPLETED|Overall Study||29
2490804|NCT00856232|6106407|P1|COMPLETED|Overall Study||26
2490805|NCT00856232|6106405|P3|STARTED|Overall Study||36
2490806|NCT00856232|6106406|P2|STARTED|Overall Study||29
2490807|NCT00856232|6106407|P1|STARTED|Overall Study||26
2490808|NCT00856206|6106420|P2|NOT COMPLETED|Overall Study||161
2490809|NCT00856206|6106421|P1|NOT COMPLETED|Overall Study||54
2490810|NCT00856206|6106420|P2|COMPLETED|Overall Study||824
2490811|NCT00856206|6106421|P1|COMPLETED|Overall Study||276
2490812|NCT00856206|6106420|P2|STARTED|Overall Study||985
2490813|NCT00856206|6106421|P1|STARTED|Overall Study||330
2490814|NCT00856193|6106435|P2|NOT COMPLETED|Period 2||2
2490815|NCT00856193|6106436|P1|NOT COMPLETED|Period 2||0
2490816|NCT00856193|6106435|P2|COMPLETED|Period 2||15
2490817|NCT00856193|6106436|P1|COMPLETED|Period 2||16
2490818|NCT00856193|6106435|P2|STARTED|Period 2||17
2490819|NCT00856193|6106436|P1|STARTED|Period 2||16
2490820|NCT00856193|6106435|P2|NOT COMPLETED|Period 1||0
2490821|NCT00856193|6106436|P1|NOT COMPLETED|Period 1||0
2490822|NCT00856193|6106435|P2|COMPLETED|Period 1||17
2490823|NCT00856193|6106436|P1|COMPLETED|Period 1||16
2490824|NCT00856193|6106435|P2|STARTED|Period 1||17
2490825|NCT00856193|6106436|P1|STARTED|Period 1||16
2490826|NCT00856180|6106448|P1|NOT COMPLETED|Overall Study||20
2490827|NCT00856180|6106448|P1|COMPLETED|Overall Study||0
2490828|NCT00856180|6106448|P1|STARTED|Overall Study||20
2490829|NCT00856050|6106457|P1|NOT COMPLETED|Overall Study||0
2490830|NCT00856050|6106457|P1|COMPLETED|Overall Study||26
2490831|NCT00856050|6106457|P1|STARTED|Overall Study||26
2490832|NCT00856024|6106461|P1|NOT COMPLETED|Overall Study||0
2490833|NCT00856024|6106461|P1|COMPLETED|Overall Study||902
2490834|NCT00856024|6106461|P1|STARTED|Overall Study||902
2490835|NCT00855959|6106473|P1|NOT COMPLETED|Overall Study||9
2490836|NCT00855959|6106473|P1|COMPLETED|Overall Study||99
2490837|NCT00855959|6106473|P1|Patients Who Received Pulmicort Respules|Overall Study||105
2490838|NCT00855959|6106473|P1|STARTED|Overall Study||108
2490839|NCT00855933|6106490|P2|NOT COMPLETED|Overall Study||1
2490840|NCT00855933|6106491|P1|NOT COMPLETED|Overall Study||0
2490841|NCT00855933|6106490|P2|COMPLETED|Overall Study||29
2490842|NCT00855933|6106491|P1|COMPLETED|Overall Study||30
2490843|NCT00855933|6106490|P2|STARTED|Overall Study||30
2490844|NCT00855933|6106491|P1|STARTED|Overall Study||30
2490845|NCT00855920|6106500|P3|NOT COMPLETED|Overall Study||11
2490846|NCT00855920|6106501|P2|NOT COMPLETED|Overall Study||9
2490847|NCT00855920|6106502|P1|NOT COMPLETED|Overall Study||8
2490848|NCT00855920|6106500|P3|COMPLETED|Overall Study||64
2490849|NCT00855920|6106501|P2|COMPLETED|Overall Study||65
2490850|NCT00855920|6106502|P1|COMPLETED|Overall Study||68
2490851|NCT00855920|6106500|P3|Safety Population|Overall Study||75
2490852|NCT00855920|6106501|P2|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|73
2490853|NCT00855920|6106502|P1|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|77
2490854|NCT00855920|6106500|P3|STARTED|Overall Study||75
2490855|NCT00855920|6106501|P2|STARTED|Overall Study||74
2490856|NCT00855920|6106502|P1|STARTED|Overall Study||76
2490857|NCT00855894|6106519|P1|NOT COMPLETED|Overall Study||33
2490858|NCT00855894|6106519|P1|COMPLETED|Overall Study||8
2490859|NCT00855894|6106519|P1|STARTED|Overall Study||41
2490860|NCT00855868|6106529|P2|NOT COMPLETED|Overall Study||1
2490861|NCT00855868|6106530|P1|NOT COMPLETED|Overall Study||1
2490862|NCT00855868|6106529|P2|COMPLETED|Overall Study||14
2490863|NCT00855868|6106530|P1|COMPLETED|Overall Study||12
2490864|NCT00855868|6106529|P2|STARTED|Overall Study||15
2490865|NCT00855868|6106530|P1|STARTED|Overall Study||13
2490866|NCT00855842|6106536|P1|NOT COMPLETED|Overall Study||0
2490867|NCT00855842|6106536|P1|COMPLETED|Overall Study||4
2490868|NCT00855842|6106536|P1|STARTED|Overall Study||4
2490869|NCT00855816|6106542|P2|NOT COMPLETED|Overall Study||21
2490870|NCT00855816|6106543|P1|NOT COMPLETED|Overall Study||26
2490871|NCT00855816|6106542|P2|COMPLETED|Overall Study||12
2490872|NCT00855816|6106543|P1|COMPLETED|Overall Study||21
2490873|NCT00855816|6106542|P2|STARTED|Overall Study||33
2490874|NCT00855816|6106543|P1|STARTED|Overall Study||47
2490875|NCT00855738|6106549|P1|NOT COMPLETED|Overall Study||5
2490876|NCT00855738|6106549|P1|COMPLETED|Overall Study||106
2490877|NCT00855738|6106549|P1|At Least 1 Dose and 1 Endpoint|Overall Study|Received at least 1 dose of study drug and had data for at least 1 efficacy endpoint.|108
2490878|NCT00855738|6106549|P1|STARTED|Overall Study||111
2490879|NCT00855595|6106577|P2|NOT COMPLETED|Overall Study||7
2490880|NCT00855595|6106578|P1|NOT COMPLETED|Overall Study||6
2490881|NCT00855595|6106577|P2|COMPLETED|Overall Study||94
2490882|NCT00855595|6106578|P1|COMPLETED|Overall Study||100
2490883|NCT00855595|6106577|P2|STARTED|Overall Study||101
2490884|NCT00855595|6106578|P1|STARTED|Overall Study||106
2490885|NCT00855582|6106617|P3|NOT COMPLETED|Overall Study||30
2490886|NCT00855582|6106618|P2|NOT COMPLETED|Overall Study||24
2490887|NCT00855582|6106619|P1|NOT COMPLETED|Overall Study||26
2490888|NCT00855582|6106617|P3|COMPLETED|Overall Study||170
2490889|NCT00855582|6106618|P2|COMPLETED|Overall Study||184
2490890|NCT00855582|6106619|P1|COMPLETED|Overall Study||172
2490891|NCT00855582|6106617|P3|STARTED|Overall Study||200
2490892|NCT00855582|6106618|P2|STARTED|Overall Study||208
2490893|NCT00855582|6106619|P1|STARTED|Overall Study||198
2490894|NCT00855465|6106708|P2|NOT COMPLETED|Follow-up Period (FUP)||2
2490895|NCT00855465|6106709|P1|NOT COMPLETED|Follow-up Period (FUP)||8
2490896|NCT00855465|6106708|P2|COMPLETED|Follow-up Period (FUP)||2
2490897|NCT00855465|6106709|P1|COMPLETED|Follow-up Period (FUP)||9
2490898|NCT00855465|6106708|P2|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|4
2490899|NCT00855465|6106709|P1|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|17
2490900|NCT00855465|6106708|P2|NOT COMPLETED|Treatment Period||5
2490901|NCT00855465|6106709|P1|NOT COMPLETED|Treatment Period||14
2490902|NCT00855465|6106708|P2|COMPLETED|Treatment Period||83
2490903|NCT00855465|6106709|P1|COMPLETED|Treatment Period||160
2490904|NCT00855465|6106708|P2|Participants Received Treatment|Treatment Period||88
2490905|NCT00855465|6106709|P1|Participants Received Treatment|Treatment Period|1 subject randomized but not treated|173
2490906|NCT00855465|6106708|P2|STARTED|Treatment Period||88
2490907|NCT00855465|6106709|P1|STARTED|Treatment Period||174
2490908|NCT00855439|6106799|P2|NOT COMPLETED|Overall Study||0
2490909|NCT00855439|6106800|P1|NOT COMPLETED|Overall Study||3
2490910|NCT00855439|6106799|P2|COMPLETED|Overall Study||24
2490911|NCT00855439|6106800|P1|COMPLETED|Overall Study||19
2490912|NCT00855439|6106799|P2|STARTED|Overall Study||24
2490913|NCT00855439|6106800|P1|STARTED|Overall Study||22
2490914|NCT00855413|6106812|P1|NOT COMPLETED|Overall Study||0
2490915|NCT00855413|6106812|P1|COMPLETED|Overall Study||15
2490916|NCT00855413|6106812|P1|STARTED|Overall Study||15
2490917|NCT00855335|6106858|P5|NOT COMPLETED|Overall Study||1
2490918|NCT00855335|6106859|P4|NOT COMPLETED|Overall Study||7
2490919|NCT00855335|6106860|P3|NOT COMPLETED|Overall Study||5
2490920|NCT00855335|6106861|P2|NOT COMPLETED|Overall Study||2
2490921|NCT00855335|6106862|P1|NOT COMPLETED|Overall Study||5
2490922|NCT00855335|6106858|P5|COMPLETED|Overall Study||6
2490923|NCT00855335|6106859|P4|COMPLETED|Overall Study||12
2490924|NCT00855335|6106860|P3|COMPLETED|Overall Study||10
2490925|NCT00855335|6106861|P2|COMPLETED|Overall Study||16
2490926|NCT00855335|6106862|P1|COMPLETED|Overall Study||13
2490927|NCT00855335|6106858|P5|STARTED|Overall Study||7
2490928|NCT00855335|6106859|P4|STARTED|Overall Study||19
2490929|NCT00855335|6106860|P3|STARTED|Overall Study||15
2490930|NCT00855335|6106861|P2|STARTED|Overall Study||18
2490931|NCT00855335|6106862|P1|STARTED|Overall Study||18
2490932|NCT00855309|6106949|P2|NOT COMPLETED|Overall Study||0
2490933|NCT00855309|6106950|P1|NOT COMPLETED|Overall Study||1
2490934|NCT00855309|6106949|P2|COMPLETED|Overall Study||55
2490935|NCT00855309|6106950|P1|COMPLETED|Overall Study||56
2490936|NCT00855309|6106949|P2|STARTED|Overall Study||55
2490937|NCT00855309|6106950|P1|STARTED|Overall Study||57
2490938|NCT00855218|6106958|P2|NOT COMPLETED|Overall Study||153
2490939|NCT00855218|6106959|P1|NOT COMPLETED|Overall Study||154
2490940|NCT00855218|6106958|P2|COMPLETED|Overall Study||0
2490941|NCT00855218|6106959|P1|COMPLETED|Overall Study||0
2490942|NCT00855218|6106958|P2|Participants Received Treatment|Overall Study||151
2490943|NCT00855218|6106959|P1|Participants Received Treatment|Overall Study||153
2490944|NCT00855218|6106958|P2|STARTED|Overall Study||153
2490945|NCT00855218|6106959|P1|STARTED|Overall Study||154
2490946|NCT00855166|6106977|P2|NOT COMPLETED|Overall Study||8
2490947|NCT00855166|6106978|P1|NOT COMPLETED|Overall Study||5
2490948|NCT00855166|6106977|P2|COMPLETED|Overall Study||83
2490949|NCT00855166|6106978|P1|COMPLETED|Overall Study||86
2490950|NCT00855166|6106977|P2|STARTED|Overall Study|Of the 91 randomized participants only 89 were included in the full analysis set.|91
2490951|NCT00855166|6106978|P1|STARTED|Overall Study||91
2490952|NCT00855062|6106998|P2|NOT COMPLETED|Step2||6
2490953|NCT00855062|6106999|P1|NOT COMPLETED|Step2||6
2490954|NCT00855062|6106998|P2|COMPLETED|Step2||15
2490955|NCT00855062|6106999|P1|COMPLETED|Step2||13
2490956|NCT00855062|6106998|P2|STARTED|Step2|26 participants completed STEP1; however, only 21 out of the 26 decided to enroll in STEP2.|21
2490957|NCT00855062|6106999|P1|STARTED|Step2|26 participants completed STEP1; however, only 19 out of the 26 decided to enroll in STEP2.|19
2490958|NCT00855062|6106998|P2|NOT COMPLETED|Step1||11
2490959|NCT00855062|6106999|P1|NOT COMPLETED|Step1||10
2490960|NCT00855062|6106998|P2|COMPLETED|Step1||26
2490961|NCT00855062|6106999|P1|COMPLETED|Step1||26
2490962|NCT00855062|6106998|P2|STARTED|Step1||37
2490963|NCT00855062|6106999|P1|STARTED|Step1||36
2490964|NCT00855010|6107025|P2|NOT COMPLETED|Overall Study||1
2490965|NCT00855010|6107026|P1|NOT COMPLETED|Overall Study||4
2490966|NCT00855010|6107025|P2|COMPLETED|Overall Study||18
2490967|NCT00855010|6107026|P1|COMPLETED|Overall Study||19
2490968|NCT00855010|6107025|P2|STARTED|Overall Study||19
2490969|NCT00855010|6107026|P1|STARTED|Overall Study||23
2490970|NCT00854906|6107048|P1|NOT COMPLETED|Overall Study||1
2490971|NCT00854906|6107048|P1|COMPLETED|Overall Study|There were 26 participants in this group. One person was excluded be causes of no ocular history.|25
2490972|NCT00854906|6107048|P1|STARTED|Overall Study|There were 26 participants whose eyes were measured in the KTBUT group.|26
2490973|NCT00854724|6107057|P2|NOT COMPLETED|Second Intervention||1
2490974|NCT00854724|6107058|P1|NOT COMPLETED|Second Intervention||1
2490975|NCT00854724|6107057|P2|COMPLETED|Second Intervention||5
2490976|NCT00854724|6107058|P1|COMPLETED|Second Intervention||5
2490977|NCT00854724|6107057|P2|STARTED|Second Intervention||6
2490978|NCT00854724|6107058|P1|STARTED|Second Intervention||6
2490979|NCT00854724|6107057|P2|NOT COMPLETED|Washout||1
2490980|NCT00854724|6107058|P1|NOT COMPLETED|Washout||1
2490981|NCT00854724|6107057|P2|COMPLETED|Washout||6
2490982|NCT00854724|6107058|P1|COMPLETED|Washout||6
2490983|NCT00854724|6107057|P2|STARTED|Washout||7
2490984|NCT00854724|6107058|P1|STARTED|Washout||7
2490985|NCT00854724|6107057|P2|NOT COMPLETED|First Intervention||1
2490986|NCT00854724|6107058|P1|NOT COMPLETED|First Intervention||1
2490987|NCT00854724|6107057|P2|COMPLETED|First Intervention||7
2490988|NCT00854724|6107058|P1|COMPLETED|First Intervention||7
2490989|NCT00854724|6107057|P2|STARTED|First Intervention||8
2490990|NCT00854724|6107058|P1|STARTED|First Intervention||8
2490991|NCT00854620|6107064|P1|NOT COMPLETED|Overall Study||1
2490992|NCT00854620|6107064|P1|COMPLETED|Overall Study||8
2490993|NCT00854620|6107064|P1|STARTED|Overall Study||9
2490994|NCT00854607|6107068|P1|NOT COMPLETED|2 Weeks After Start Anti-fungal Therapy||65
2490995|NCT00854607|6107068|P1|COMPLETED|2 Weeks After Start Anti-fungal Therapy||51
2490996|NCT00854607|6107068|P1|STARTED|2 Weeks After Start Anti-fungal Therapy||116
2490997|NCT00854607|6107068|P1|NOT COMPLETED|Enrollment||0
2490998|NCT00854607|6107068|P1|COMPLETED|Enrollment||116
2490999|NCT00854607|6107068|P1|STARTED|Enrollment||116
2491000|NCT00854594|6107103|P2|NOT COMPLETED|Overall Study||0
2491001|NCT00854594|6107104|P1|NOT COMPLETED|Overall Study||0
2491002|NCT00854594|6107103|P2|COMPLETED|Overall Study||69
2491003|NCT00854594|6107104|P1|COMPLETED|Overall Study||48
2491004|NCT00854594|6107103|P2|STARTED|Overall Study|9 sites randomized to intervention, providers completed surveys before and/or after study period|69
2491005|NCT00854594|6107104|P1|STARTED|Overall Study|9 sites randomized to control arm, providers completed surveys before and/or after study period|48
2491006|NCT00854581|6107116|P1|NOT COMPLETED|Part 2 Maintenance (Up to 12 Months)||3
2491007|NCT00854581|6107116|P1|COMPLETED|Part 2 Maintenance (Up to 12 Months)||2
2491008|NCT00854581|6107116|P1|STARTED|Part 2 Maintenance (Up to 12 Months)||5
2491009|NCT00854581|6107116|P1|NOT COMPLETED|Part 1 Maintenance (Up to Day 60)||2
2491010|NCT00854581|6107116|P1|COMPLETED|Part 1 Maintenance (Up to Day 60)||5
2491011|NCT00854581|6107116|P1|STARTED|Part 1 Maintenance (Up to Day 60)||7
2491012|NCT00854581|6107116|P1|NOT COMPLETED|Induction (Up to Day 21)||6
2491013|NCT00854581|6107116|P1|COMPLETED|Induction (Up to Day 21)||7
2491014|NCT00854581|6107116|P1|STARTED|Induction (Up to Day 21)||13
2491015|NCT00854373|6107131|P2|NOT COMPLETED|Overall Study||4
2491016|NCT00854373|6107132|P1|NOT COMPLETED|Overall Study||2
2491017|NCT00854373|6107131|P2|COMPLETED|Overall Study||89
2491018|NCT00854373|6107132|P1|COMPLETED|Overall Study||93
2491019|NCT00854373|6107131|P2|STARTED|Overall Study||93
2491020|NCT00854373|6107132|P1|STARTED|Overall Study||95
2491021|NCT00854360|6107146|P4|NOT COMPLETED|Overall Study||10
2491022|NCT00854360|6107147|P3|NOT COMPLETED|Overall Study||2
2491023|NCT00854360|6107148|P2|NOT COMPLETED|Overall Study||3
2491024|NCT00854360|6107149|P1|NOT COMPLETED|Overall Study||2
2491025|NCT00854360|6107146|P4|COMPLETED|Overall Study||114
2491026|NCT00854360|6107147|P3|COMPLETED|Overall Study||120
2491027|NCT00854360|6107148|P2|COMPLETED|Overall Study|One patient discontinued due to both an AE and study medication discontinuation.|120
2491028|NCT00854360|6107149|P1|COMPLETED|Overall Study||116
2491029|NCT00854360|6107146|P4|Intent to Treat / Safety Population|Overall Study|One patient did not receive any double-blind study medication.|123
2491030|NCT00854360|6107147|P3|Intent to Treat / Safety Population|Overall Study||122
2491031|NCT00854360|6107148|P2|Intent to Treat / Safety Population|Overall Study||123
2491032|NCT00854360|6107149|P1|Intent to Treat / Safety Population|Overall Study||118
2491033|NCT00854360|6107146|P4|STARTED|Overall Study||124
2491034|NCT00854360|6107147|P3|STARTED|Overall Study||122
2491035|NCT00854360|6107148|P2|STARTED|Overall Study||123
2491036|NCT00854360|6107149|P1|STARTED|Overall Study||118
2491037|NCT00854308|6107181|P2|NOT COMPLETED|Overall Study||67
2491038|NCT00854308|6107182|P1|NOT COMPLETED|Overall Study||62
2491039|NCT00854308|6107181|P2|COMPLETED|Overall Study||1
2491040|NCT00854308|6107182|P1|COMPLETED|Overall Study|Completed participants in both arms were still receiving study drug when analyses were performed.|7
2491041|NCT00854308|6107181|P2|Received Study Drug|Overall Study||67
2491042|NCT00854308|6107182|P1|Received Study Drug|Overall Study||69
2491043|NCT00854308|6107181|P2|STARTED|Overall Study||68
2491044|NCT00854308|6107182|P1|STARTED|Overall Study||69
2491045|NCT00854113|6107207|P11|NOT COMPLETED|Overall Study||0
2491046|NCT00854113|6107208|P10|NOT COMPLETED|Overall Study||0
2491047|NCT00854113|6107209|P9|NOT COMPLETED|Overall Study||1
2491048|NCT00854113|6107210|P8|NOT COMPLETED|Overall Study||3
2491049|NCT00854113|6107211|P7|NOT COMPLETED|Overall Study||0
2491050|NCT00854113|6107212|P6|NOT COMPLETED|Overall Study||0
2491051|NCT00854113|6107213|P5|NOT COMPLETED|Overall Study||0
2491052|NCT00854113|6107214|P4|NOT COMPLETED|Overall Study||0
2491053|NCT00854113|6107215|P3|NOT COMPLETED|Overall Study||0
2491054|NCT00854113|6107216|P2|NOT COMPLETED|Overall Study||0
2491055|NCT00854113|6107217|P1|NOT COMPLETED|Overall Study||0
2491056|NCT00854113|6107207|P11|COMPLETED|Overall Study||6
2491057|NCT00854113|6107208|P10|COMPLETED|Overall Study||8
2491058|NCT00854113|6107209|P9|COMPLETED|Overall Study||7
2491059|NCT00854113|6107210|P8|COMPLETED|Overall Study||5
2491060|NCT00854113|6107211|P7|COMPLETED|Overall Study||12
2491061|NCT00854113|6107212|P6|COMPLETED|Overall Study||6
2491062|NCT00854113|6107213|P5|COMPLETED|Overall Study||6
2491063|NCT00854113|6107214|P4|COMPLETED|Overall Study||6
2491064|NCT00854113|6107215|P3|COMPLETED|Overall Study||6
2491065|NCT00854113|6107216|P2|COMPLETED|Overall Study||6
2491066|NCT00854113|6107217|P1|COMPLETED|Overall Study||6
2491067|NCT00854113|6107207|P11|STARTED|Overall Study||6
2491068|NCT00854113|6107208|P10|STARTED|Overall Study||8
2491069|NCT00854113|6107209|P9|STARTED|Overall Study||8
2491070|NCT00854113|6107210|P8|STARTED|Overall Study||8
2491071|NCT00854113|6107211|P7|STARTED|Overall Study||12
2491072|NCT00854113|6107212|P6|STARTED|Overall Study||6
2491073|NCT00854113|6107213|P5|STARTED|Overall Study||6
2491074|NCT00854113|6107214|P4|STARTED|Overall Study||6
2491075|NCT00854113|6107215|P3|STARTED|Overall Study||6
2491076|NCT00854113|6107216|P2|STARTED|Overall Study||6
2491077|NCT00854113|6107217|P1|STARTED|Overall Study||6
2491078|NCT00854100|6107321|P3|NOT COMPLETED|Overall Study||11
2491079|NCT00854100|6107322|P2|NOT COMPLETED|Overall Study||6
2491080|NCT00854100|6107323|P1|NOT COMPLETED|Overall Study||9
2491081|NCT00854100|6107321|P3|COMPLETED|Overall Study||63
2491082|NCT00854100|6107322|P2|COMPLETED|Overall Study||70
2491083|NCT00854100|6107323|P1|COMPLETED|Overall Study||72
2491084|NCT00854100|6107321|P3|STARTED|Overall Study||74
2491085|NCT00854100|6107322|P2|STARTED|Overall Study||76
2491086|NCT00854100|6107323|P1|STARTED|Overall Study||81
2491087|NCT00854087|6107337|P2|NOT COMPLETED|Overall Study||19
2491088|NCT00854087|6107338|P1|NOT COMPLETED|Overall Study||19
2491089|NCT00854087|6107337|P2|COMPLETED|Overall Study||40
2491090|NCT00854087|6107338|P1|COMPLETED|Overall Study||40
2491091|NCT00854087|6107337|P2|STARTED|Overall Study||59
2491092|NCT00854087|6107338|P1|STARTED|Overall Study||59
2491093|NCT00853996|6107344|P1|NOT COMPLETED|Overall Study||0
2491094|NCT00853996|6107344|P1|COMPLETED|Overall Study||25
2491095|NCT00853996|6107344|P1|STARTED|Overall Study||25
2491096|NCT00853970|6107356|P2|NOT COMPLETED|Overall Study||3
2491097|NCT00853970|6107357|P1|NOT COMPLETED|Overall Study||6
2491098|NCT00853970|6107356|P2|COMPLETED|Overall Study||144
2491099|NCT00853970|6107357|P1|COMPLETED|Overall Study||146
2491100|NCT00853970|6107356|P2|STARTED|Overall Study||147
2491101|NCT00853970|6107357|P1|STARTED|Overall Study||152
2491102|NCT00853957|6107367|P2|NOT COMPLETED|Overall Study||19
2491103|NCT00853957|6107368|P1|NOT COMPLETED|Overall Study||14
2491104|NCT00853957|6107367|P2|COMPLETED|Overall Study||204
2491105|NCT00853957|6107368|P1|COMPLETED|Overall Study||206
2491106|NCT00853957|6107367|P2|STARTED|Overall Study||223
2491107|NCT00853957|6107368|P1|STARTED|Overall Study||220
2491108|NCT00853905|6107386|P2|NOT COMPLETED|Overall Study||4
2491109|NCT00853905|6107387|P1|NOT COMPLETED|Overall Study||2
2491110|NCT00853905|6107386|P2|COMPLETED|Overall Study||36
2491111|NCT00853905|6107387|P1|COMPLETED|Overall Study||35
2491112|NCT00853905|6107386|P2|STARTED|Overall Study||40
2491113|NCT00853905|6107387|P1|STARTED|Overall Study||37
2491114|NCT00853840|6107401|P2|NOT COMPLETED|Period 2||0
2491115|NCT00853840|6107402|P1|NOT COMPLETED|Period 2||0
2491116|NCT00853840|6107401|P2|COMPLETED|Period 2||9
2491117|NCT00853840|6107402|P1|COMPLETED|Period 2||9
2491118|NCT00853840|6107401|P2|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
2491119|NCT00853840|6107402|P1|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
2491120|NCT00853840|6107401|P2|Maraviroc (Days 1 - 3)|Period 2||9
2491121|NCT00853840|6107402|P1|Maraviroc (Days 1 - 3)|Period 2||9
2491122|NCT00853840|6107401|P2|STARTED|Period 2||9
2491123|NCT00853840|6107402|P1|STARTED|Period 2||9
2491124|NCT00853840|6107401|P2|NOT COMPLETED|Period 1||0
2491125|NCT00853840|6107402|P1|NOT COMPLETED|Period 1||0
2491126|NCT00853840|6107401|P2|COMPLETED|Period 1||9
2491127|NCT00853840|6107402|P1|COMPLETED|Period 1||9
2491128|NCT00853840|6107401|P2|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
2491129|NCT00853840|6107402|P1|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
2491130|NCT00853840|6107401|P2|Maraviroc (Days 1 - 4)|Period 1||9
2491131|NCT00853840|6107402|P1|Maraviroc (Days 1 - 4)|Period 1||9
2491132|NCT00853840|6107401|P2|STARTED|Period 1||9
2491133|NCT00853840|6107402|P1|STARTED|Period 1||9
2491134|NCT00853827|6107419|P2|NOT COMPLETED|Double Blind Period (103 Weeks)||109
2491135|NCT00853827|6107420|P1|NOT COMPLETED|Double Blind Period (103 Weeks)||104
2491136|NCT00853827|6107419|P2|COMPLETED|Double Blind Period (103 Weeks)||199
2491137|NCT00853827|6107420|P1|COMPLETED|Double Blind Period (103 Weeks)||201
2491138|NCT00853827|6107419|P2|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||233
2491139|NCT00853827|6107420|P1|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||225
2491140|NCT00853827|6107419|P2|STARTED|Double Blind Period (103 Weeks)||308
2491141|NCT00853827|6107420|P1|STARTED|Double Blind Period (103 Weeks)|"Started indicates number of patients in randomized set, full analysis set (FAS) and safety set."|305
2491142|NCT00853827|6107419|P2|NOT COMPLETED|Single Blind Period (1 Week)||0
2491143|NCT00853827|6107420|P1|NOT COMPLETED|Single Blind Period (1 Week)||39
2491144|NCT00853827|6107419|P2|COMPLETED|Single Blind Period (1 Week)||0
2491145|NCT00853827|6107420|P1|COMPLETED|Single Blind Period (1 Week)|Completed patients in single blind period|613
2491146|NCT00853827|6107419|P2|STARTED|Single Blind Period (1 Week)|This arm was only used in double blind period|0
2491147|NCT00853827|6107420|P1|STARTED|Single Blind Period (1 Week)|Enrolled patients in single blind|652
2491148|NCT00853762|6107436|P4|NOT COMPLETED|Overall Study||22
2491149|NCT00853762|6107437|P3|NOT COMPLETED|Overall Study||17
2491150|NCT00853762|6107438|P2|NOT COMPLETED|Overall Study||19
2491151|NCT00853762|6107439|P1|NOT COMPLETED|Overall Study||16
2491152|NCT00853762|6107436|P4|COMPLETED|Overall Study||0
2491153|NCT00853762|6107437|P3|COMPLETED|Overall Study||0
2491154|NCT00853762|6107438|P2|COMPLETED|Overall Study||0
2491155|NCT00853762|6107439|P1|COMPLETED|Overall Study||0
2491156|NCT00853762|6107436|P4|STARTED|Overall Study||22
2491157|NCT00853762|6107437|P3|STARTED|Overall Study||17
2491158|NCT00853762|6107438|P2|STARTED|Overall Study||19
2491159|NCT00853762|6107439|P1|STARTED|Overall Study||16
2491160|NCT00853749|6107507|P2|NOT COMPLETED|Overall Study||1
2491161|NCT00853749|6107508|P1|NOT COMPLETED|Overall Study||0
2491162|NCT00853749|6107507|P2|COMPLETED|Overall Study||38
2491163|NCT00853749|6107508|P1|COMPLETED|Overall Study||50
2491164|NCT00853749|6107507|P2|Vaccinated|Overall Study||39
2491165|NCT00853749|6107508|P1|Vaccinated|Overall Study||50
2491166|NCT00853749|6107507|P2|STARTED|Overall Study||39
2491167|NCT00853749|6107508|P1|STARTED|Overall Study||50
2491168|NCT00853723|6107529|P3|NOT COMPLETED|Overall Study||2
2491169|NCT00853723|6107530|P2|NOT COMPLETED|Overall Study||7
2491170|NCT00853723|6107531|P1|NOT COMPLETED|Overall Study||6
2491171|NCT00853723|6107529|P3|COMPLETED|Overall Study||33
2491172|NCT00853723|6107530|P2|COMPLETED|Overall Study||28
2491173|NCT00853723|6107531|P1|COMPLETED|Overall Study||29
2491174|NCT00853723|6107529|P3|STARTED|Overall Study||35
2491175|NCT00853723|6107530|P2|STARTED|Overall Study||35
2491176|NCT00853723|6107531|P1|STARTED|Overall Study||35
2491177|NCT00853671|6107575|P1|NOT COMPLETED|Overall Study||0
2491178|NCT00853671|6107575|P1|COMPLETED|Overall Study||50
2491179|NCT00853671|6107575|P1|STARTED|Overall Study||50
2491180|NCT00853658|6107585|P3|NOT COMPLETED|Overall Study||815
2491181|NCT00853658|6107586|P2|NOT COMPLETED|Overall Study||832
2491182|NCT00853658|6107587|P1|NOT COMPLETED|Overall Study||787
2491183|NCT00853658|6107585|P3|COMPLETED|Overall Study||1539
2491184|NCT00853658|6107586|P2|COMPLETED|Overall Study||1524
2491185|NCT00853658|6107587|P1|COMPLETED|Overall Study||1567
2491186|NCT00853658|6107585|P3|Safety Set|Overall Study||2345
2491187|NCT00853658|6107586|P2|Safety Set|Overall Study||2348
2491188|NCT00853658|6107587|P1|Safety Set|Overall Study||2347
2491189|NCT00853658|6107585|P3|Full Analysis Set (FAS)|Overall Study||2336
2491190|NCT00853658|6107586|P2|Full Analysis Set (FAS)|Overall Study||2340
2491191|NCT00853658|6107587|P1|Full Analysis Set (FAS)|Overall Study||2340
2491192|NCT00853658|6107585|P3|STARTED|Overall Study||2354
2491193|NCT00853658|6107586|P2|STARTED|Overall Study||2356
2491194|NCT00853658|6107587|P1|STARTED|Overall Study||2354
2491195|NCT00853606|6107601|P1|NOT COMPLETED|Overall Study||220
2491196|NCT00853606|6107601|P1|COMPLETED|Overall Study||492
2491197|NCT00853606|6107601|P1|STARTED|Overall Study||712
2491198|NCT00853593|6107607|P1|NOT COMPLETED|Overall Study||45
2491199|NCT00853593|6107607|P1|COMPLETED|Overall Study||152
2491200|NCT00853593|6107607|P1|Model 4396 Lead Attempted|Overall Study||164
2491201|NCT00853593|6107607|P1|Implant Attempted|Overall Study||193
2491202|NCT00853593|6107607|P1|STARTED|Overall Study||197
2491203|NCT00853580|6107634|P2|NOT COMPLETED|Overall Study||16
2491204|NCT00853580|6107635|P1|NOT COMPLETED|Overall Study||7
2491205|NCT00853580|6107634|P2|COMPLETED|Overall Study||56
2491206|NCT00853580|6107635|P1|COMPLETED|Overall Study||67
2491207|NCT00853580|6107634|P2|STARTED|Overall Study||72
2491208|NCT00853580|6107635|P1|STARTED|Overall Study||74
2491209|NCT00853567|6107682|P1|NOT COMPLETED|Overall Study||71
2491210|NCT00853567|6107682|P1|COMPLETED|Overall Study||0
2491211|NCT00853567|6107682|P1|STARTED|Overall Study||71
2491212|NCT00853489|6107692|P2|NOT COMPLETED|Overall Study||2
2491213|NCT00853489|6107693|P1|NOT COMPLETED|Overall Study||5
2491214|NCT00853489|6107692|P2|COMPLETED|Overall Study||12
2491215|NCT00853489|6107693|P1|COMPLETED|Overall Study||11
2491216|NCT00853489|6107692|P2|STARTED|Overall Study||14
2491217|NCT00853489|6107693|P1|STARTED|Overall Study||16
2491218|NCT00853385|6107708|P5|NOT COMPLETED|Overall Study||42
2491219|NCT00853385|6107709|P4|NOT COMPLETED|Overall Study||13
2491220|NCT00853385|6107710|P3|NOT COMPLETED|Overall Study||9
2491221|NCT00853385|6107711|P2|NOT COMPLETED|Overall Study||43
2491222|NCT00853385|6107712|P1|NOT COMPLETED|Overall Study||54
2491223|NCT00853385|6107708|P5|COMPLETED|Overall Study||162
2491224|NCT00853385|6107709|P4|COMPLETED|Overall Study||39
2491225|NCT00853385|6107710|P3|COMPLETED|Overall Study||47
2491226|NCT00853385|6107711|P2|COMPLETED|Overall Study||158
2491227|NCT00853385|6107712|P1|COMPLETED|Overall Study||150
2491228|NCT00853385|6107708|P5|STARTED|Overall Study||204
2491229|NCT00853385|6107709|P4|STARTED|Overall Study||52
2491230|NCT00853385|6107710|P3|STARTED|Overall Study||56
2491231|NCT00853385|6107711|P2|STARTED|Overall Study||201
2491232|NCT00853385|6107712|P1|STARTED|Overall Study||204
2491233|NCT00853333|6107928|P3|NOT COMPLETED|Overall Study||0
2491234|NCT00853333|6107929|P2|NOT COMPLETED|Overall Study||0
2491235|NCT00853333|6107930|P1|NOT COMPLETED|Overall Study||0
2491236|NCT00853333|6107928|P3|COMPLETED|Overall Study||31
2491237|NCT00853333|6107929|P2|COMPLETED|Overall Study||27
2491238|NCT00853333|6107930|P1|COMPLETED|Overall Study||28
2491239|NCT00853333|6107928|P3|STARTED|Overall Study||31
2491240|NCT00853333|6107929|P2|STARTED|Overall Study||27
2491241|NCT00853333|6107930|P1|STARTED|Overall Study||28
2491242|NCT00853307|6107940|P2|NOT COMPLETED|Overall Study||5
2491243|NCT00853307|6107941|P1|NOT COMPLETED|Overall Study||2
2491244|NCT00853307|6107940|P2|COMPLETED|Overall Study||20
2491245|NCT00853307|6107941|P1|COMPLETED|Overall Study|Completed = participants who completed the study treatment.|4
2491246|NCT00853307|6107940|P2|STARTED|Overall Study||25
2491247|NCT00853307|6107941|P1|STARTED|Overall Study||6
2491248|NCT00853242|6107968|P7|NOT COMPLETED|Overall Study||5
2491249|NCT00853242|6107969|P6|NOT COMPLETED|Overall Study||2
2491250|NCT00853242|6107970|P5|NOT COMPLETED|Overall Study||4
2491251|NCT00853242|6107971|P4|NOT COMPLETED|Overall Study||4
2491252|NCT00853242|6107972|P3|NOT COMPLETED|Overall Study||3
2491253|NCT00853242|6107973|P2|NOT COMPLETED|Overall Study||3
2491254|NCT00853242|6107974|P1|NOT COMPLETED|Overall Study||3
2491255|NCT00853242|6107968|P7|COMPLETED|Overall Study||44
2491256|NCT00853242|6107969|P6|COMPLETED|Overall Study||49
2491257|NCT00853242|6107970|P5|COMPLETED|Overall Study||46
2491258|NCT00853242|6107971|P4|COMPLETED|Overall Study||46
2491259|NCT00853242|6107972|P3|COMPLETED|Overall Study||46
2491260|NCT00853242|6107973|P2|COMPLETED|Overall Study||47
2491261|NCT00853242|6107974|P1|COMPLETED|Overall Study||47
2491262|NCT00853242|6107968|P7|Treated|Overall Study||48
2491263|NCT00853242|6107969|P6|Treated|Overall Study||51
2491264|NCT00853242|6107970|P5|Treated|Overall Study||50
2491265|NCT00853242|6107971|P4|Treated|Overall Study||50
2491266|NCT00853242|6107972|P3|Treated|Overall Study||48
2491267|NCT00853242|6107973|P2|Treated|Overall Study||49
2491268|NCT00853242|6107974|P1|Treated|Overall Study||50
2491269|NCT00853242|6107968|P7|STARTED|Overall Study||49
2491270|NCT00853242|6107969|P6|STARTED|Overall Study||51
2491271|NCT00853242|6107970|P5|STARTED|Overall Study||50
2491272|NCT00853242|6107971|P4|STARTED|Overall Study||50
2491273|NCT00853242|6107972|P3|STARTED|Overall Study||49
2491274|NCT00853242|6107973|P2|STARTED|Overall Study||50
2491275|NCT00853242|6107974|P1|STARTED|Overall Study||50
2491276|NCT00853229|6108016|P2|NOT COMPLETED|Phase 2: Cross Over||0
2491277|NCT00853229|6108017|P1|NOT COMPLETED|Phase 2: Cross Over||0
2491278|NCT00853229|6108016|P2|COMPLETED|Phase 2: Cross Over||0
2491279|NCT00853229|6108017|P1|COMPLETED|Phase 2: Cross Over||0
2491280|NCT00853229|6108016|P2|STARTED|Phase 2: Cross Over||0
2491281|NCT00853229|6108017|P1|STARTED|Phase 2: Cross Over||0
2491282|NCT00853229|6108016|P2|NOT COMPLETED|Phase 1: Initial Intervention||8
2491283|NCT00853229|6108017|P1|NOT COMPLETED|Phase 1: Initial Intervention||8
2491284|NCT00853229|6108016|P2|COMPLETED|Phase 1: Initial Intervention||0
2491285|NCT00853229|6108017|P1|COMPLETED|Phase 1: Initial Intervention||0
2491286|NCT00853229|6108016|P2|STARTED|Phase 1: Initial Intervention||8
2491287|NCT00853229|6108017|P1|STARTED|Phase 1: Initial Intervention||8
2491288|NCT00853151|6108027|P4|NOT COMPLETED|Overall Study||3
2491289|NCT00853151|6108028|P3|NOT COMPLETED|Overall Study||8
2491290|NCT00853151|6108029|P2|NOT COMPLETED|Overall Study||13
2491291|NCT00853151|6108030|P1|NOT COMPLETED|Overall Study||10
2491292|NCT00853151|6108027|P4|COMPLETED|Overall Study||15
2491293|NCT00853151|6108028|P3|COMPLETED|Overall Study||30
2491294|NCT00853151|6108029|P2|COMPLETED|Overall Study||24
2491295|NCT00853151|6108030|P1|COMPLETED|Overall Study||28
2491296|NCT00853151|6108027|P4|STARTED|Overall Study||18
2491297|NCT00853151|6108028|P3|STARTED|Overall Study||38
2491298|NCT00853151|6108029|P2|STARTED|Overall Study||37
2491299|NCT00853151|6108030|P1|STARTED|Overall Study||38
2491300|NCT00853125|6108172|P1|NOT COMPLETED|Overall Study||1
2491301|NCT00853125|6108172|P1|COMPLETED|Overall Study||9
2491302|NCT00853125|6108172|P1|STARTED|Overall Study||10
2491303|NCT00853112|6108184|P7|NOT COMPLETED|Overall Study||1
2491304|NCT00853112|6108185|P6|NOT COMPLETED|Overall Study||0
2491305|NCT00853112|6108186|P5|NOT COMPLETED|Overall Study||0
2491306|NCT00853112|6108187|P4|NOT COMPLETED|Overall Study||2
2491307|NCT00853112|6108188|P3|NOT COMPLETED|Overall Study||0
2491308|NCT00853112|6108189|P2|NOT COMPLETED|Overall Study||1
2491309|NCT00853112|6108190|P1|NOT COMPLETED|Overall Study||0
2491310|NCT00853112|6108184|P7|COMPLETED|Overall Study||6
2491311|NCT00853112|6108185|P6|COMPLETED|Overall Study||7
2491312|NCT00853112|6108186|P5|COMPLETED|Overall Study||6
2491313|NCT00853112|6108187|P4|COMPLETED|Overall Study||6
2491314|NCT00853112|6108188|P3|COMPLETED|Overall Study||7
2491315|NCT00853112|6108189|P2|COMPLETED|Overall Study||6
2491316|NCT00853112|6108190|P1|COMPLETED|Overall Study||6
2491317|NCT00853112|6108184|P7|Treated|Overall Study||6
2491318|NCT00853112|6108185|P6|Treated|Overall Study||7
2491319|NCT00853112|6108186|P5|Treated|Overall Study||6
2491320|NCT00853112|6108187|P4|Treated|Overall Study||6
2491321|NCT00853112|6108188|P3|Treated|Overall Study||7
2491322|NCT00853112|6108189|P2|Treated|Overall Study||6
2491323|NCT00853112|6108190|P1|Treated|Overall Study||6
2491324|NCT00853112|6108184|P7|STARTED|Overall Study||7
2491325|NCT00853112|6108185|P6|STARTED|Overall Study||7
2491326|NCT00853112|6108186|P5|STARTED|Overall Study||6
2491327|NCT00853112|6108187|P4|STARTED|Overall Study||8
2491328|NCT00853112|6108188|P3|STARTED|Overall Study||7
2491329|NCT00853112|6108189|P2|STARTED|Overall Study||7
2491330|NCT00853112|6108190|P1|STARTED|Overall Study||6
2491331|NCT00853099|6108300|P4|NOT COMPLETED|Double-blind + Open-label Periods||147
2491332|NCT00853099|6108301|P3|NOT COMPLETED|Double-blind + Open-label Periods||0
2491333|NCT00853099|6108302|P2|NOT COMPLETED|Double-blind + Open-label Periods||0
2491334|NCT00853099|6108303|P1|NOT COMPLETED|Double-blind + Open-label Periods||0
2491335|NCT00853099|6108300|P4|COMPLETED|Double-blind + Open-label Periods||119
2491336|NCT00853099|6108301|P3|COMPLETED|Double-blind + Open-label Periods||0
2491337|NCT00853099|6108302|P2|COMPLETED|Double-blind + Open-label Periods||0
2491338|NCT00853099|6108303|P1|COMPLETED|Double-blind + Open-label Periods||0
2491339|NCT00853099|6108300|P4|STARTED|Double-blind + Open-label Periods|7 participants randomized to placebo did not receive any adalimumab; 1 participant was excluded.|266
2491340|NCT00853099|6108301|P3|STARTED|Double-blind + Open-label Periods||0
2491341|NCT00853099|6108302|P2|STARTED|Double-blind + Open-label Periods||0
2491342|NCT00853099|6108303|P1|STARTED|Double-blind + Open-label Periods||0
2491343|NCT00853099|6108300|P4|NOT COMPLETED|Double-blind Period||0
2491344|NCT00853099|6108301|P3|NOT COMPLETED|Double-blind Period||31
2491345|NCT00853099|6108302|P2|NOT COMPLETED|Double-blind Period||29
2491346|NCT00853099|6108303|P1|NOT COMPLETED|Double-blind Period||23
2491347|NCT00853099|6108300|P4|COMPLETED|Double-blind Period||0
2491348|NCT00853099|6108301|P3|COMPLETED|Double-blind Period|Participants who completed Week 52.|60
2491349|NCT00853099|6108302|P2|COMPLETED|Double-blind Period|Participants who completed Week 52.|58
2491350|NCT00853099|6108303|P1|COMPLETED|Double-blind Period|Participants who completed Week 52.|73
2491351|NCT00853099|6108300|P4|Completed Week 8|Double-blind Period||0
2491352|NCT00853099|6108301|P3|Completed Week 8|Double-blind Period||86
2491353|NCT00853099|6108302|P2|Completed Week 8|Double-blind Period||85
2491354|NCT00853099|6108303|P1|Completed Week 8|Double-blind Period||92
2491355|NCT00853099|6108300|P4|Treated|Double-blind Period||0
2491356|NCT00853099|6108301|P3|Treated|Double-blind Period|1 participant, incorrectly treated with open-label (rescue) study drug at Week 0, was excluded.|90
2491357|NCT00853099|6108302|P2|Treated|Double-blind Period||87
2491358|NCT00853099|6108303|P1|Treated|Double-blind Period||96
2491359|NCT00853099|6108300|P4|STARTED|Double-blind Period||0
2491360|NCT00853099|6108301|P3|STARTED|Double-blind Period||91
2491361|NCT00853099|6108302|P2|STARTED|Double-blind Period||87
2491362|NCT00853099|6108303|P1|STARTED|Double-blind Period||96
2491363|NCT00853073|6108345|P2|NOT COMPLETED|Overall Study||2
2491364|NCT00853073|6108346|P1|NOT COMPLETED|Overall Study||3
2491365|NCT00853073|6108345|P2|COMPLETED|Overall Study||29
2491366|NCT00853073|6108346|P1|COMPLETED|Overall Study||29
2491367|NCT00853073|6108345|P2|STARTED|Overall Study||31
2491368|NCT00853073|6108346|P1|STARTED|Overall Study||32
2491369|NCT00853047|6108359|P6|NOT COMPLETED|Open-Label Extension Phase||17
2491370|NCT00853047|6108360|P5|NOT COMPLETED|Open-Label Extension Phase||0
2491371|NCT00853047|6108361|P4|NOT COMPLETED|Open-Label Extension Phase||0
2491372|NCT00853047|6108362|P3|NOT COMPLETED|Open-Label Extension Phase||0
2491373|NCT00853047|6108363|P2|NOT COMPLETED|Open-Label Extension Phase||0
2491374|NCT00853047|6108364|P1|NOT COMPLETED|Open-Label Extension Phase||0
2491375|NCT00853047|6108359|P6|COMPLETED|Open-Label Extension Phase||2
2491376|NCT00853047|6108360|P5|COMPLETED|Open-Label Extension Phase||0
2491377|NCT00853047|6108361|P4|COMPLETED|Open-Label Extension Phase||0
2491378|NCT00853047|6108362|P3|COMPLETED|Open-Label Extension Phase||0
2491379|NCT00853047|6108363|P2|COMPLETED|Open-Label Extension Phase||0
2491380|NCT00853047|6108364|P1|COMPLETED|Open-Label Extension Phase||0
2491381|NCT00853047|6108359|P6|Completed 8-week Extension Period|Open-Label Extension Phase||16
2491382|NCT00853047|6108360|P5|Completed 8-week Extension Period|Open-Label Extension Phase||0
2491383|NCT00853047|6108361|P4|Completed 8-week Extension Period|Open-Label Extension Phase||0
2491384|NCT00853047|6108362|P3|Completed 8-week Extension Period|Open-Label Extension Phase||0
2491385|NCT00853047|6108363|P2|Completed 8-week Extension Period|Open-Label Extension Phase||0
2491386|NCT00853047|6108364|P1|Completed 8-week Extension Period|Open-Label Extension Phase||0
2491387|NCT00853047|6108359|P6|STARTED|Open-Label Extension Phase|19 of the 22 participants who completed the Core Phase entered the optional Open-Label Extension.|19
2491388|NCT00853047|6108360|P5|STARTED|Open-Label Extension Phase||0
2491389|NCT00853047|6108361|P4|STARTED|Open-Label Extension Phase||0
2491390|NCT00853047|6108362|P3|STARTED|Open-Label Extension Phase||0
2491391|NCT00853047|6108363|P2|STARTED|Open-Label Extension Phase||0
2491392|NCT00853047|6108364|P1|STARTED|Open-Label Extension Phase||0
2491393|NCT00853047|6108359|P6|NOT COMPLETED|Core Phase||0
2491394|NCT00853047|6108360|P5|NOT COMPLETED|Core Phase||0
2491395|NCT00853047|6108361|P4|NOT COMPLETED|Core Phase||1
2491396|NCT00853047|6108362|P3|NOT COMPLETED|Core Phase||0
2491397|NCT00853047|6108363|P2|NOT COMPLETED|Core Phase||0
2491398|NCT00853047|6108364|P1|NOT COMPLETED|Core Phase||0
2491399|NCT00853047|6108359|P6|COMPLETED|Core Phase||0
2491400|NCT00853047|6108360|P5|COMPLETED|Core Phase||9
2491401|NCT00853047|6108361|P4|COMPLETED|Core Phase||2
2491402|NCT00853047|6108362|P3|COMPLETED|Core Phase||3
2491403|NCT00853047|6108363|P2|COMPLETED|Core Phase||3
2491404|NCT00853047|6108364|P1|COMPLETED|Core Phase||5
2491405|NCT00853047|6108359|P6|STARTED|Core Phase||0
2491406|NCT00853047|6108360|P5|STARTED|Core Phase||9
2491407|NCT00853047|6108361|P4|STARTED|Core Phase||3
2491408|NCT00853047|6108362|P3|STARTED|Core Phase||3
2491409|NCT00853047|6108363|P2|STARTED|Core Phase||3
2491410|NCT00853047|6108364|P1|STARTED|Core Phase||5
2491411|NCT00853021|6108430|P1|NOT COMPLETED|Overall Study||5
2491412|NCT00853021|6108430|P1|COMPLETED|Overall Study||21
2491413|NCT00853021|6108430|P1|STARTED|Overall Study||26
2491414|NCT00852995|6108442|P5|NOT COMPLETED|Overall Study||4
2491415|NCT00852995|6108443|P4|NOT COMPLETED|Overall Study||5
2491416|NCT00852995|6108444|P3|NOT COMPLETED|Overall Study||5
2491417|NCT00852995|6108445|P2|NOT COMPLETED|Overall Study||1
2491418|NCT00852995|6108446|P1|NOT COMPLETED|Overall Study||8
2491419|NCT00852995|6108442|P5|COMPLETED|Overall Study||46
2491420|NCT00852995|6108443|P4|COMPLETED|Overall Study||40
2491421|NCT00852995|6108444|P3|COMPLETED|Overall Study||39
2491422|NCT00852995|6108445|P2|COMPLETED|Overall Study||42
2491423|NCT00852995|6108446|P1|COMPLETED|Overall Study||38
2491424|NCT00852995|6108442|P5|STARTED|Overall Study||50
2491425|NCT00852995|6108443|P4|STARTED|Overall Study||45
2491426|NCT00852995|6108444|P3|STARTED|Overall Study||44
2491427|NCT00852995|6108445|P2|STARTED|Overall Study||43
2491428|NCT00852995|6108446|P1|STARTED|Overall Study||46
2491429|NCT00852969|6108490|P2|NOT COMPLETED|Overall Study||2
2491430|NCT00852969|6108491|P1|NOT COMPLETED|Overall Study||0
2491431|NCT00852969|6108490|P2|COMPLETED|Overall Study||13
2491432|NCT00852969|6108491|P1|COMPLETED|Overall Study||15
2491433|NCT00852969|6108490|P2|STARTED|Overall Study||15
2491434|NCT00852969|6108491|P1|STARTED|Overall Study||15
2491435|NCT00852930|6108502|P3|NOT COMPLETED|Overall Study||2
2491436|NCT00852930|6108503|P2|NOT COMPLETED|Overall Study||1
2491437|NCT00852930|6108504|P1|NOT COMPLETED|Overall Study||1
2491438|NCT00852930|6108502|P3|COMPLETED|Overall Study||15
2491439|NCT00852930|6108503|P2|COMPLETED|Overall Study||16
2491440|NCT00852930|6108504|P1|COMPLETED|Overall Study||15
2491441|NCT00852930|6108502|P3|STARTED|Overall Study||17
2491442|NCT00852930|6108503|P2|STARTED|Overall Study||17
2491443|NCT00852930|6108504|P1|STARTED|Overall Study||16
2491444|NCT00852917|6108525|P4|NOT COMPLETED|Overall Study||93
2491445|NCT00852917|6108526|P3|NOT COMPLETED|Overall Study||58
2491446|NCT00852917|6108527|P2|NOT COMPLETED|Overall Study||46
2491447|NCT00852917|6108528|P1|NOT COMPLETED|Overall Study||44
2491448|NCT00852917|6108525|P4|COMPLETED|Overall Study||134
2491449|NCT00852917|6108526|P3|COMPLETED|Overall Study||50
2491450|NCT00852917|6108527|P2|COMPLETED|Overall Study||65
2491451|NCT00852917|6108528|P1|COMPLETED|Overall Study||62
2491452|NCT00852917|6108525|P4|STARTED|Overall Study||227
2491453|NCT00852917|6108526|P3|STARTED|Overall Study||108
2491454|NCT00852917|6108527|P2|STARTED|Overall Study||111
2491455|NCT00852917|6108528|P1|STARTED|Overall Study||106
2491456|NCT00852761|6108568|P2|NOT COMPLETED|Overall Study||0
2491457|NCT00852761|6108569|P1|NOT COMPLETED|Overall Study||0
2491458|NCT00852761|6108568|P2|COMPLETED|Overall Study||17
2491459|NCT00852761|6108569|P1|COMPLETED|Overall Study||17
2491460|NCT00852761|6108568|P2|STARTED|Overall Study||17
2491461|NCT00852761|6108569|P1|STARTED|Overall Study||17
2491462|NCT00852644|6108611|P6|NOT COMPLETED|Overall Study||0
2491463|NCT00852644|6108612|P5|NOT COMPLETED|Overall Study||0
2491464|NCT00852644|6108613|P4|NOT COMPLETED|Overall Study||0
2491465|NCT00852644|6108614|P3|NOT COMPLETED|Overall Study||0
2491466|NCT00852644|6108615|P2|NOT COMPLETED|Overall Study||0
2491467|NCT00852644|6108616|P1|NOT COMPLETED|Overall Study||0
2491468|NCT00852644|6108611|P6|COMPLETED|Overall Study||0
2491469|NCT00852644|6108612|P5|COMPLETED|Overall Study||0
2491470|NCT00852644|6108613|P4|COMPLETED|Overall Study||3
2491471|NCT00852644|6108614|P3|COMPLETED|Overall Study||0
2491472|NCT00852644|6108615|P2|COMPLETED|Overall Study||3
2491473|NCT00852644|6108616|P1|COMPLETED|Overall Study||3
2491474|NCT00852644|6108611|P6|STARTED|Overall Study||0
2491475|NCT00852644|6108612|P5|STARTED|Overall Study||0
2491476|NCT00852644|6108613|P4|STARTED|Overall Study||3
2491477|NCT00852644|6108614|P3|STARTED|Overall Study||0
2491478|NCT00852644|6108615|P2|STARTED|Overall Study||3
2491479|NCT00852644|6108616|P1|STARTED|Overall Study||3
2491480|NCT00852631|6108637|P1|NOT COMPLETED|Overall Study||11
2491481|NCT00852631|6108637|P1|COMPLETED|Overall Study||17
2491482|NCT00852631|6108637|P1|STARTED|Overall Study||28
2491483|NCT00852592|6108645|P2|NOT COMPLETED|Overall Study||4
2491484|NCT00852592|6108646|P1|NOT COMPLETED|Overall Study||3
2491485|NCT00852592|6108645|P2|COMPLETED|Overall Study||19
2491486|NCT00852592|6108646|P1|COMPLETED|Overall Study||20
2491487|NCT00852592|6108645|P2|STARTED|Overall Study||23
2491488|NCT00852592|6108646|P1|STARTED|Overall Study||23
2491489|NCT00852540|6108656|P2|NOT COMPLETED|Overall Study||18
2491490|NCT00852540|6108657|P1|NOT COMPLETED|Overall Study||36
2491491|NCT00852540|6108656|P2|COMPLETED|Overall Study||122
2491492|NCT00852540|6108657|P1|COMPLETED|Overall Study||234
2491493|NCT00852540|6108656|P2|STARTED|Overall Study||140
2491494|NCT00852540|6108657|P1|STARTED|Overall Study||270
2491495|NCT00852527|6108683|P2|NOT COMPLETED|Overall Study||0
2491496|NCT00852527|6108684|P1|NOT COMPLETED|Overall Study||0
2491497|NCT00852527|6108683|P2|COMPLETED|Overall Study||242
2491498|NCT00852527|6108684|P1|COMPLETED|Overall Study||196
2491499|NCT00852527|6108683|P2|STARTED|Overall Study||242
2491500|NCT00852527|6108684|P1|STARTED|Overall Study||196
2491501|NCT00852475|6108691|P2|NOT COMPLETED|Overall Study||4
2491502|NCT00852475|6108692|P1|NOT COMPLETED|Overall Study||3
2491503|NCT00852475|6108691|P2|COMPLETED|Overall Study||16
2491504|NCT00852475|6108692|P1|COMPLETED|Overall Study||23
2491505|NCT00852475|6108691|P2|STARTED|Overall Study||20
2491506|NCT00852475|6108692|P1|STARTED|Overall Study||26
2491507|NCT00852397|6108703|P3|NOT COMPLETED|Overall Study||14
2491508|NCT00852397|6108704|P2|NOT COMPLETED|Overall Study||8
2491509|NCT00852397|6108705|P1|NOT COMPLETED|Overall Study||11
2491510|NCT00852397|6108703|P3|COMPLETED|Overall Study||36
2491511|NCT00852397|6108704|P2|COMPLETED|Overall Study||41
2491512|NCT00852397|6108705|P1|COMPLETED|Overall Study||41
2491513|NCT00852397|6108703|P3|Treated Participants|Overall Study||49
2491514|NCT00852397|6108704|P2|Treated Participants|Overall Study||49
2491515|NCT00852397|6108705|P1|Treated Participants|Overall Study||51
2491516|NCT00852397|6108703|P3|STARTED|Overall Study||50
2491517|NCT00852397|6108704|P2|STARTED|Overall Study||49
2491518|NCT00852397|6108705|P1|STARTED|Overall Study||52
2491519|NCT00852241|6108734|P1|NOT COMPLETED|Overall Study||18
2491520|NCT00852241|6108734|P1|COMPLETED|Overall Study||0
2491521|NCT00852241|6108734|P1|STARTED|Overall Study||18
2491522|NCT00852202|6108741|P3|NOT COMPLETED|Overall Study||26
2491523|NCT00852202|6108742|P2|NOT COMPLETED|Overall Study||12
2491524|NCT00852202|6108743|P1|NOT COMPLETED|Overall Study||17
2491525|NCT00852202|6108741|P3|COMPLETED|Overall Study||49
2491526|NCT00852202|6108742|P2|COMPLETED|Overall Study||63
2491527|NCT00852202|6108743|P1|COMPLETED|Overall Study||60
2491528|NCT00852202|6108741|P3|STARTED|Overall Study||75
2491529|NCT00852202|6108742|P2|STARTED|Overall Study||75
2491530|NCT00852202|6108743|P1|STARTED|Overall Study||77
2491531|NCT00852137|6108756|P2|NOT COMPLETED|Overall Study||0
2491532|NCT00852137|6108757|P1|NOT COMPLETED|Overall Study||0
2491533|NCT00852137|6108756|P2|COMPLETED|Overall Study||3
2491534|NCT00852137|6108757|P1|COMPLETED|Overall Study||13
2491535|NCT00852137|6108756|P2|STARTED|Overall Study||3
2491536|NCT00852137|6108757|P1|STARTED|Overall Study||13
2491537|NCT00852124|6108779|P2|NOT COMPLETED|Overall Study||0
2491538|NCT00852124|6108780|P1|NOT COMPLETED|Overall Study||0
2491539|NCT00852124|6108779|P2|COMPLETED|Overall Study||0
2491540|NCT00852124|6108780|P1|COMPLETED|Overall Study||3
2491541|NCT00852124|6108779|P2|STARTED|Overall Study||0
2491542|NCT00852124|6108780|P1|STARTED|Overall Study||3
2491543|NCT00851903|6108785|P1|NOT COMPLETED|Overall Study||2
2491544|NCT00851903|6108785|P1|COMPLETED|Overall Study||110
2491545|NCT00851903|6108785|P1|Modified Intent-To-Treat Population|Overall Study|mITT population: patients treated by combination with at least 1 on-treatment efficacy measure|111
2491546|NCT00851903|6108785|P1|Treated by Combination|Overall Study|patients treated with at least one dose of insulin glargine AND one dose of sitagliptin|111
2491547|NCT00851903|6108785|P1|Safety Population|Overall Study|patients treated with at least one dose of insulin glargine OR one dose of sitagliptin|112
2491548|NCT00851903|6108785|P1|STARTED|Overall Study||112
2491549|NCT00851890|6108799|P4|NOT COMPLETED|Overall Study||1
2491550|NCT00851890|6108800|P3|NOT COMPLETED|Overall Study||0
2491551|NCT00851890|6108801|P2|NOT COMPLETED|Overall Study||1
2491552|NCT00851890|6108802|P1|NOT COMPLETED|Overall Study||0
2491553|NCT00851890|6108799|P4|COMPLETED|Overall Study||5
2491554|NCT00851890|6108800|P3|COMPLETED|Overall Study||8
2491555|NCT00851890|6108801|P2|COMPLETED|Overall Study||7
2491556|NCT00851890|6108802|P1|COMPLETED|Overall Study||8
2491557|NCT00851890|6108799|P4|STARTED|Overall Study||6
2491558|NCT00851890|6108800|P3|STARTED|Overall Study||8
2491559|NCT00851890|6108801|P2|STARTED|Overall Study||8
2491560|NCT00851890|6108802|P1|STARTED|Overall Study||8
2491561|NCT00851877|6108859|P3|NOT COMPLETED|Phase II||3
2491562|NCT00851877|6108860|P2|NOT COMPLETED|Phase II||0
2491563|NCT00851877|6108861|P1|NOT COMPLETED|Phase II||0
2491564|NCT00851877|6108859|P3|COMPLETED|Phase II||22
2491565|NCT00851877|6108860|P2|COMPLETED|Phase II||0
2491566|NCT00851877|6108861|P1|COMPLETED|Phase II||0
2491567|NCT00851877|6108859|P3|STARTED|Phase II||25
2491568|NCT00851877|6108860|P2|STARTED|Phase II||0
2491569|NCT00851877|6108861|P1|STARTED|Phase II||0
2491570|NCT00851877|6108859|P3|NOT COMPLETED|Phase I-2||0
2491571|NCT00851877|6108860|P2|NOT COMPLETED|Phase I-2||0
2491572|NCT00851877|6108861|P1|NOT COMPLETED|Phase I-2||0
2491573|NCT00851877|6108859|P3|COMPLETED|Phase I-2||0
2491574|NCT00851877|6108860|P2|COMPLETED|Phase I-2||5
2491575|NCT00851877|6108861|P1|COMPLETED|Phase I-2||0
2491576|NCT00851877|6108859|P3|STARTED|Phase I-2||0
2491577|NCT00851877|6108860|P2|STARTED|Phase I-2||5
2491578|NCT00851877|6108861|P1|STARTED|Phase I-2||0
2491579|NCT00851877|6108859|P3|NOT COMPLETED|Phase I-1||0
2491580|NCT00851877|6108860|P2|NOT COMPLETED|Phase I-1||0
2491581|NCT00851877|6108861|P1|NOT COMPLETED|Phase I-1||1
2491582|NCT00851877|6108859|P3|COMPLETED|Phase I-1||0
2491583|NCT00851877|6108860|P2|COMPLETED|Phase I-1||0
2491584|NCT00851877|6108861|P1|COMPLETED|Phase I-1||6
2491585|NCT00851877|6108859|P3|STARTED|Phase I-1||0
2491586|NCT00851877|6108860|P2|STARTED|Phase I-1||0
2491587|NCT00851877|6108861|P1|STARTED|Phase I-1||7
2491588|NCT00851799|6108871|P3|NOT COMPLETED|Overall Study||24
2491589|NCT00851799|6108872|P2|NOT COMPLETED|Overall Study||13
2491590|NCT00851799|6108873|P1|NOT COMPLETED|Overall Study||16
2491591|NCT00851799|6108871|P3|COMPLETED|Overall Study||89
2491592|NCT00851799|6108872|P2|COMPLETED|Overall Study||93
2491593|NCT00851799|6108873|P1|COMPLETED|Overall Study||93
2491594|NCT00851799|6108871|P3|STARTED|Overall Study||113
2491595|NCT00851799|6108872|P2|STARTED|Overall Study||106
2491596|NCT00851799|6108873|P1|STARTED|Overall Study||109
2491597|NCT00851786|6108961|P2|NOT COMPLETED|Overall Study||2
2491598|NCT00851786|6108962|P1|NOT COMPLETED|Overall Study||5
2491599|NCT00851786|6108961|P2|COMPLETED|Overall Study||97
2491600|NCT00851786|6108962|P1|COMPLETED|Overall Study||291
2491601|NCT00851786|6108961|P2|STARTED|Overall Study|Two subjects (one found ineligible and one withdrew consent) were off study with no vaccine.|99
2491602|NCT00851786|6108962|P1|STARTED|Overall Study|One subject cannot adhere to protocol requirement and was off study with no vaccine.|296
2491603|NCT00851747|6108975|P3|NOT COMPLETED|Overall Study||6
2491604|NCT00851747|6108976|P2|NOT COMPLETED|Overall Study||6
2491605|NCT00851747|6108977|P1|NOT COMPLETED|Overall Study||6
2491606|NCT00851747|6108975|P3|COMPLETED|Overall Study||0
2491607|NCT00851747|6108976|P2|COMPLETED|Overall Study||0
2491608|NCT00851747|6108977|P1|COMPLETED|Overall Study||0
2491609|NCT00851747|6108975|P3|STARTED|Overall Study||6
2491610|NCT00851747|6108976|P2|STARTED|Overall Study||6
2491611|NCT00851747|6108977|P1|STARTED|Overall Study||6
2491612|NCT00851721|6108986|P2|NOT COMPLETED|Overall Study||1
2491613|NCT00851721|6108987|P1|NOT COMPLETED|Overall Study||2
2491614|NCT00851721|6108986|P2|COMPLETED|Overall Study||16
2491615|NCT00851721|6108987|P1|COMPLETED|Overall Study||17
2491616|NCT00851721|6108986|P2|STARTED|Overall Study||17
2491617|NCT00851721|6108987|P1|STARTED|Overall Study||19
2491618|NCT00851682|6109077|P2|NOT COMPLETED|Overall Study||0
2491619|NCT00851682|6109078|P1|NOT COMPLETED|Overall Study||5
2491620|NCT00851682|6109077|P2|COMPLETED|Overall Study||5
2491621|NCT00851682|6109078|P1|COMPLETED|Overall Study||55
2491622|NCT00851682|6109077|P2|STARTED|Overall Study||5
2491623|NCT00851682|6109078|P1|STARTED|Overall Study||60
2491624|NCT00851643|6109092|P6|NOT COMPLETED|Extension Study (Up to 36 Months)||1
2491625|NCT00851643|6109093|P5|NOT COMPLETED|Extension Study (Up to 36 Months)||2
2491626|NCT00851643|6109094|P4|NOT COMPLETED|Extension Study (Up to 36 Months)||2
2491627|NCT00851643|6109095|P3|NOT COMPLETED|Extension Study (Up to 36 Months)||5
2491628|NCT00851643|6109096|P2|NOT COMPLETED|Extension Study (Up to 36 Months)||4
2491629|NCT00851643|6109097|P1|NOT COMPLETED|Extension Study (Up to 36 Months)||4
2491630|NCT00851643|6109092|P6|COMPLETED|Extension Study (Up to 36 Months)||14
2491631|NCT00851643|6109093|P5|COMPLETED|Extension Study (Up to 36 Months)||19
2491632|NCT00851643|6109094|P4|COMPLETED|Extension Study (Up to 36 Months)||5
2491633|NCT00851643|6109095|P3|COMPLETED|Extension Study (Up to 36 Months)||14
2491634|NCT00851643|6109096|P2|COMPLETED|Extension Study (Up to 36 Months)||15
2491635|NCT00851643|6109097|P1|COMPLETED|Extension Study (Up to 36 Months)||6
2491636|NCT00851643|6109092|P6|STARTED|Extension Study (Up to 36 Months)||15
2491637|NCT00851643|6109093|P5|STARTED|Extension Study (Up to 36 Months)||21
2491638|NCT00851643|6109094|P4|STARTED|Extension Study (Up to 36 Months)||7
2491639|NCT00851643|6109095|P3|STARTED|Extension Study (Up to 36 Months)||19
2491640|NCT00851643|6109096|P2|STARTED|Extension Study (Up to 36 Months)||19
2491641|NCT00851643|6109097|P1|STARTED|Extension Study (Up to 36 Months)||10
2491642|NCT00851643|6109092|P6|NOT COMPLETED|Base Study (Up to 12 Months)||1
2491643|NCT00851643|6109093|P5|NOT COMPLETED|Base Study (Up to 12 Months)||0
2491644|NCT00851643|6109094|P4|NOT COMPLETED|Base Study (Up to 12 Months)||0
2491645|NCT00851643|6109095|P3|NOT COMPLETED|Base Study (Up to 12 Months)||0
2491646|NCT00851643|6109096|P2|NOT COMPLETED|Base Study (Up to 12 Months)||0
2491647|NCT00851643|6109097|P1|NOT COMPLETED|Base Study (Up to 12 Months)||1
2491648|NCT00851643|6109092|P6|COMPLETED|Base Study (Up to 12 Months)||29
2491649|NCT00851643|6109093|P5|COMPLETED|Base Study (Up to 12 Months)||30
2491650|NCT00851643|6109094|P4|COMPLETED|Base Study (Up to 12 Months)||15
2491651|NCT00851643|6109095|P3|COMPLETED|Base Study (Up to 12 Months)||30
2491652|NCT00851643|6109096|P2|COMPLETED|Base Study (Up to 12 Months)||30
2491653|NCT00851643|6109097|P1|COMPLETED|Base Study (Up to 12 Months)||14
2491654|NCT00851643|6109092|P6|STARTED|Base Study (Up to 12 Months)||30
2491655|NCT00851643|6109093|P5|STARTED|Base Study (Up to 12 Months)||30
2491656|NCT00851643|6109094|P4|STARTED|Base Study (Up to 12 Months)||15
2491657|NCT00851643|6109095|P3|STARTED|Base Study (Up to 12 Months)||30
2491658|NCT00851643|6109096|P2|STARTED|Base Study (Up to 12 Months)||30
2491659|NCT00851643|6109097|P1|STARTED|Base Study (Up to 12 Months)||15
2491660|NCT00851630|6109118|P2|NOT COMPLETED|Overall Study||2
2491661|NCT00851630|6109119|P1|NOT COMPLETED|Overall Study||2
2491662|NCT00851630|6109118|P2|COMPLETED|Overall Study||33
2491663|NCT00851630|6109119|P1|COMPLETED|Overall Study||33
2491664|NCT00851630|6109118|P2|STARTED|Overall Study||35
2491665|NCT00851630|6109119|P1|STARTED|Overall Study||35
2491666|NCT00851591|6109133|P2|NOT COMPLETED|Overall Study||0
2491667|NCT00851591|6109134|P1|NOT COMPLETED|Overall Study||2
2491668|NCT00851591|6109133|P2|COMPLETED|Overall Study||1
2491669|NCT00851591|6109134|P1|COMPLETED|Overall Study||0
2491670|NCT00851591|6109133|P2|STARTED|Overall Study|One received treatment.|1
2491671|NCT00851591|6109134|P1|STARTED|Overall Study|These 2 participants did not receive treatment.|2
2491672|NCT00851552|6109140|P1|NOT COMPLETED|Overall Study||7
2491673|NCT00851552|6109140|P1|COMPLETED|Overall Study||2
2491674|NCT00851552|6109140|P1|STARTED|Overall Study||9
2491675|NCT00851409|6109145|P1|NOT COMPLETED|Overall Study||0
2491676|NCT00851409|6109145|P1|COMPLETED|Overall Study||25
2491677|NCT00851409|6109145|P1|STARTED|Overall Study||25
2491678|NCT00851357|6109153|P3|NOT COMPLETED|Overall Study||0
2491679|NCT00851357|6109154|P2|NOT COMPLETED|Overall Study||0
2491680|NCT00851357|6109155|P1|NOT COMPLETED|Overall Study||0
2491681|NCT00851357|6109153|P3|COMPLETED|Overall Study||1799
2491682|NCT00851357|6109154|P2|COMPLETED|Overall Study||1201
2491683|NCT00851357|6109155|P1|COMPLETED|Overall Study||1200
2491684|NCT00851357|6109153|P3|STARTED|Overall Study||1799
2491685|NCT00851357|6109154|P2|STARTED|Overall Study||1201
2491686|NCT00851357|6109155|P1|STARTED|Overall Study||1200
2491687|NCT00851318|6109170|P4|NOT COMPLETED|Overall Study||19
2491688|NCT00851318|6109171|P3|NOT COMPLETED|Overall Study||21
2491689|NCT00851318|6109172|P2|NOT COMPLETED|Overall Study||5
2491690|NCT00851318|6109173|P1|NOT COMPLETED|Overall Study||30
2491691|NCT00851318|6109170|P4|COMPLETED|Overall Study||73
2491692|NCT00851318|6109171|P3|COMPLETED|Overall Study||72
2491693|NCT00851318|6109172|P2|COMPLETED|Overall Study||14
2491694|NCT00851318|6109173|P1|COMPLETED|Overall Study||51
2491695|NCT00851318|6109170|P4|Completed Week 52|Overall Study||85
2491696|NCT00851318|6109171|P3|Completed Week 52|Overall Study||87
2491697|NCT00851318|6109172|P2|Completed Week 52|Overall Study||16
2491698|NCT00851318|6109173|P1|Completed Week 52|Overall Study||64
2491699|NCT00851318|6109170|P4|Completed Week 24|Overall Study||87
2491700|NCT00851318|6109171|P3|Completed Week 24|Overall Study||90
2491701|NCT00851318|6109172|P2|Completed Week 24|Overall Study||17
2491702|NCT00851318|6109173|P1|Completed Week 24|Overall Study||69
2491703|NCT00851318|6109170|P4|STARTED|Overall Study||92
2491704|NCT00851318|6109171|P3|STARTED|Overall Study||93
2491705|NCT00851318|6109172|P2|STARTED|Overall Study||19
2491706|NCT00851318|6109173|P1|STARTED|Overall Study||81
2491707|NCT00851279|6109203|P1|NOT COMPLETED|Overall Study||0
2491708|NCT00851279|6109203|P1|COMPLETED|Overall Study||53
2491709|NCT00851279|6109203|P1|STARTED|Overall Study||53
2491710|NCT00851253|6109209|P2|NOT COMPLETED|Overall Study||0
2491711|NCT00851253|6109210|P1|NOT COMPLETED|Overall Study||1
2491712|NCT00851253|6109209|P2|COMPLETED|Overall Study||10
2491713|NCT00851253|6109210|P1|COMPLETED|Overall Study||1
2491714|NCT00851253|6109209|P2|STARTED|Overall Study||10
2491715|NCT00851253|6109210|P1|STARTED|Overall Study||2
2491716|NCT00851084|6109220|P2|NOT COMPLETED|Overall Study||119
2491717|NCT00851084|6109221|P1|NOT COMPLETED|Overall Study||117
2491718|NCT00851084|6109220|P2|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
2491719|NCT00851084|6109221|P1|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
2491720|NCT00851084|6109220|P2|STARTED|Overall Study||119
2491721|NCT00851084|6109221|P1|STARTED|Overall Study||117
2491722|NCT00851006|6109237|P2|NOT COMPLETED|Overall Study||0
2491723|NCT00851006|6109238|P1|NOT COMPLETED|Overall Study||0
2491724|NCT00851006|6109237|P2|COMPLETED|Overall Study||6
2491725|NCT00851006|6109238|P1|COMPLETED|Overall Study||7
2491726|NCT00851006|6109237|P2|STARTED|Overall Study||6
2491727|NCT00851006|6109238|P1|STARTED|Overall Study||7
2491728|NCT00850993|6109249|P4|NOT COMPLETED|Overall Study||1
2491729|NCT00850993|6109250|P3|NOT COMPLETED|Overall Study||0
2491730|NCT00850993|6109251|P2|NOT COMPLETED|Overall Study||0
2491731|NCT00850993|6109252|P1|NOT COMPLETED|Overall Study||1
2491732|NCT00850993|6109249|P4|COMPLETED|Overall Study||14
2491733|NCT00850993|6109250|P3|COMPLETED|Overall Study||8
2491734|NCT00850993|6109251|P2|COMPLETED|Overall Study||18
2491735|NCT00850993|6109252|P1|COMPLETED|Overall Study||16
2491736|NCT00850993|6109249|P4|Per Protocol|Overall Study||13
2491737|NCT00850993|6109250|P3|Per Protocol|Overall Study||5
2491738|NCT00850993|6109251|P2|Per Protocol|Overall Study||13
2491739|NCT00850993|6109252|P1|Per Protocol|Overall Study||10
2491740|NCT00850993|6109249|P4|Received Phototherapy|Overall Study||8
2491741|NCT00850993|6109250|P3|Received Phototherapy|Overall Study||2
2491742|NCT00850993|6109251|P2|Received Phototherapy|Overall Study||6
2491743|NCT00850993|6109252|P1|Received Phototherapy|Overall Study||3
2491744|NCT00850993|6109249|P4|Intent-to-treat|Overall Study||15
2491745|NCT00850993|6109250|P3|Intent-to-treat|Overall Study||8
2491746|NCT00850993|6109251|P2|Intent-to-treat|Overall Study||18
2491747|NCT00850993|6109252|P1|Intent-to-treat|Overall Study||17
2491748|NCT00850993|6109249|P4|Safety|Overall Study||15
2491749|NCT00850993|6109250|P3|Safety|Overall Study||8
2491750|NCT00850993|6109251|P2|Safety|Overall Study||18
2491751|NCT00850993|6109252|P1|Safety|Overall Study||17
2491752|NCT00850993|6109249|P4|STARTED|Overall Study||15
2491753|NCT00850993|6109250|P3|STARTED|Overall Study||8
2491754|NCT00850993|6109251|P2|STARTED|Overall Study||18
2491755|NCT00850993|6109252|P1|STARTED|Overall Study||17
2491756|NCT00850889|6109266|P1|NOT COMPLETED|Overall Study||0
2491757|NCT00850889|6109266|P1|COMPLETED|Overall Study||32
2491758|NCT00850889|6109266|P1|STARTED|Overall Study||32
2491759|NCT00850759|6109281|P4|NOT COMPLETED|Overall Study||3
2491760|NCT00850759|6109282|P3|NOT COMPLETED|Overall Study||5
2491761|NCT00850759|6109283|P2|NOT COMPLETED|Overall Study||5
2491762|NCT00850759|6109284|P1|NOT COMPLETED|Overall Study||7
2491763|NCT00850759|6109281|P4|COMPLETED|Overall Study||55
2491764|NCT00850759|6109282|P3|COMPLETED|Overall Study||52
2491765|NCT00850759|6109283|P2|COMPLETED|Overall Study||52
2491766|NCT00850759|6109284|P1|COMPLETED|Overall Study||52
2491767|NCT00850759|6109281|P4|STARTED|Overall Study||58
2491768|NCT00850759|6109282|P3|STARTED|Overall Study||57
2491769|NCT00850759|6109283|P2|STARTED|Overall Study||57
2491770|NCT00850759|6109284|P1|STARTED|Overall Study||59
2491771|NCT00850720|6109294|P1|NOT COMPLETED|Overall Study||0
2491772|NCT00850720|6109294|P1|COMPLETED|Overall Study||0
2491773|NCT00850720|6109294|P1|STARTED|Overall Study||0
2491774|NCT00850642|6109300|P2|NOT COMPLETED|Overall Study||0
2491775|NCT00850642|6109301|P1|NOT COMPLETED|Overall Study||0
2491776|NCT00850642|6109300|P2|COMPLETED|Overall Study||4
2491777|NCT00850642|6109301|P1|COMPLETED|Overall Study||3
2491778|NCT00850642|6109300|P2|STARTED|Overall Study||4
2491779|NCT00850642|6109301|P1|STARTED|Overall Study||3
2491780|NCT00850603|6109339|P5|NOT COMPLETED|Overall Study||0
2491781|NCT00850603|6109340|P4|NOT COMPLETED|Overall Study||0
2491782|NCT00850603|6109341|P3|NOT COMPLETED|Overall Study||0
2491783|NCT00850603|6109342|P2|NOT COMPLETED|Overall Study||0
2491784|NCT00850603|6109343|P1|NOT COMPLETED|Overall Study||0
2491785|NCT00850603|6109339|P5|COMPLETED|Overall Study||34
2491786|NCT00850603|6109340|P4|COMPLETED|Overall Study||34
2491787|NCT00850603|6109341|P3|COMPLETED|Overall Study||34
2491788|NCT00850603|6109342|P2|COMPLETED|Overall Study||34
2491789|NCT00850603|6109343|P1|COMPLETED|Overall Study||34
2491790|NCT00850603|6109339|P5|STARTED|Overall Study||34
2491791|NCT00850603|6109340|P4|STARTED|Overall Study||34
2491792|NCT00850603|6109341|P3|STARTED|Overall Study||34
2491793|NCT00850603|6109342|P2|STARTED|Overall Study||34
2491794|NCT00850603|6109343|P1|STARTED|Overall Study||34
2491795|NCT00850564|6109365|P1|NOT COMPLETED|Overall Study||2
2491796|NCT00850564|6109365|P1|COMPLETED|Overall Study||13
2491797|NCT00850564|6109365|P1|STARTED|Overall Study||15
2491798|NCT00850538|6109370|P1|NOT COMPLETED|Overall Study||41
2491799|NCT00850538|6109370|P1|COMPLETED|Overall Study||60
2491800|NCT00850538|6109370|P1|STARTED|Overall Study||101
2491801|NCT00850499|6109376|P2|NOT COMPLETED|Overall Study||2
2491802|NCT00850499|6109377|P1|NOT COMPLETED|Overall Study||3
2491803|NCT00850499|6109376|P2|COMPLETED|Overall Study||6
2491804|NCT00850499|6109377|P1|COMPLETED|Overall Study||1
2491805|NCT00850499|6109376|P2|STARTED|Overall Study||8
2491806|NCT00850499|6109377|P1|STARTED|Overall Study||4
2491807|NCT00850473|6109385|P1|NOT COMPLETED|Overall Study||0
2491808|NCT00850473|6109385|P1|COMPLETED|Overall Study||3
2491809|NCT00850473|6109385|P1|STARTED|Overall Study||3
2491810|NCT00850460|6109391|P2|NOT COMPLETED|Overall Study||4
2491811|NCT00850460|6109392|P1|NOT COMPLETED|Overall Study||4
2491812|NCT00850460|6109391|P2|COMPLETED|Overall Study||3
2491813|NCT00850460|6109392|P1|COMPLETED|Overall Study||3
2491814|NCT00850460|6109391|P2|Completion - Week 8|Overall Study||3
2491815|NCT00850460|6109392|P1|Completion - Week 8|Overall Study||3
2491816|NCT00850460|6109391|P2|Started - Week 0|Overall Study||7
2491817|NCT00850460|6109392|P1|Started - Week 0|Overall Study||7
2491818|NCT00850460|6109391|P2|STARTED|Overall Study||7
2491819|NCT00850460|6109392|P1|STARTED|Overall Study||7
2491820|NCT00850421|6109400|P1|NOT COMPLETED|Overall Study||17
2491821|NCT00850421|6109400|P1|COMPLETED|Overall Study||18
2491822|NCT00850421|6109400|P1|STARTED|Overall Study||35
2491823|NCT00850395|6109406|P1|NOT COMPLETED|Overall Study||10
2491824|NCT00850395|6109406|P1|COMPLETED|Overall Study||69
2491825|NCT00850395|6109406|P1|STARTED|Overall Study||79
2491826|NCT00850343|6109426|P4|NOT COMPLETED|Overall Study||13
2491827|NCT00850343|6109427|P3|NOT COMPLETED|Overall Study||14
2491828|NCT00850343|6109428|P2|NOT COMPLETED|Overall Study||3
2491829|NCT00850343|6109429|P1|NOT COMPLETED|Overall Study||46
2491830|NCT00850343|6109426|P4|COMPLETED|Overall Study||30
2491831|NCT00850343|6109427|P3|COMPLETED|Overall Study||29
2491832|NCT00850343|6109428|P2|COMPLETED|Overall Study||9
2491833|NCT00850343|6109429|P1|COMPLETED|Overall Study||64
2491834|NCT00850343|6109426|P4|Completed Week 52|Overall Study||37
2491835|NCT00850343|6109427|P3|Completed Week 52|Overall Study||37
2491836|NCT00850343|6109428|P2|Completed Week 52|Overall Study||11
2491837|NCT00850343|6109429|P1|Completed Week 52|Overall Study||88
2491838|NCT00850343|6109426|P4|Completed Week 24|Overall Study||39
2491839|NCT00850343|6109427|P3|Completed Week 24|Overall Study||39
2491840|NCT00850343|6109428|P2|Completed Week 24|Overall Study||12
2491841|NCT00850343|6109429|P1|Completed Week 24|Overall Study||94
2491842|NCT00850343|6109426|P4|STARTED|Overall Study||43
2491843|NCT00850343|6109427|P3|STARTED|Overall Study||43
2491844|NCT00850343|6109428|P2|STARTED|Overall Study||12
2491845|NCT00850343|6109429|P1|STARTED|Overall Study||110
2491846|NCT00850200|6109459|P1|NOT COMPLETED|Overall Study||5
2491847|NCT00850200|6109459|P1|COMPLETED|Overall Study||15
2491848|NCT00850200|6109459|P1|STARTED|Overall Study||20
2491849|NCT00850174|6109469|P2|NOT COMPLETED|Second Intervention||0
2491850|NCT00850174|6109470|P1|NOT COMPLETED|Second Intervention||1
2491851|NCT00850174|6109469|P2|COMPLETED|Second Intervention||28
2491852|NCT00850174|6109470|P1|COMPLETED|Second Intervention||29
2491853|NCT00850174|6109469|P2|STARTED|Second Intervention||28
2491854|NCT00850174|6109470|P1|STARTED|Second Intervention||30
2491855|NCT00850174|6109469|P2|NOT COMPLETED|Washout: One Week||2
2491856|NCT00850174|6109470|P1|NOT COMPLETED|Washout: One Week||0
2491857|NCT00850174|6109469|P2|COMPLETED|Washout: One Week||28
2491858|NCT00850174|6109470|P1|COMPLETED|Washout: One Week||30
2491859|NCT00850174|6109469|P2|STARTED|Washout: One Week||30
2491860|NCT00850174|6109470|P1|STARTED|Washout: One Week||30
2491861|NCT00850174|6109469|P2|NOT COMPLETED|First Intervention||0
2491862|NCT00850174|6109470|P1|NOT COMPLETED|First Intervention||0
2491863|NCT00850174|6109469|P2|COMPLETED|First Intervention||30
2491864|NCT00850174|6109470|P1|COMPLETED|First Intervention||30
2491865|NCT00850174|6109469|P2|STARTED|First Intervention||30
2491866|NCT00850174|6109470|P1|STARTED|First Intervention||30
2491867|NCT00850135|6109484|P1|NOT COMPLETED|Overall Study||1
2491868|NCT00850135|6109484|P1|COMPLETED|Overall Study||56
2491869|NCT00850135|6109484|P1|STARTED|Overall Study||57
2491870|NCT00850096|6109492|P2|NOT COMPLETED|Overall Study||2
2491871|NCT00850096|6109493|P1|NOT COMPLETED|Overall Study||3
2491872|NCT00850096|6109492|P2|COMPLETED|Overall Study||45
2491873|NCT00850096|6109493|P1|COMPLETED|Overall Study||44
2491874|NCT00850096|6109492|P2|STARTED|Overall Study||47
2491875|NCT00850096|6109493|P1|STARTED|Overall Study||47
2491876|NCT00850070|6109503|P2|NOT COMPLETED|Overall Study||1
2491877|NCT00850070|6109504|P1|NOT COMPLETED|Overall Study||3
2491878|NCT00850070|6109503|P2|COMPLETED|Overall Study||22
2491879|NCT00850070|6109504|P1|COMPLETED|Overall Study||20
2491880|NCT00850070|6109503|P2|STARTED|Overall Study||23
2491881|NCT00850070|6109504|P1|STARTED|Overall Study||23
2491882|NCT00850031|6109528|P1|NOT COMPLETED|Overall Study||17
2491883|NCT00850031|6109528|P1|COMPLETED|Overall Study||101
2491884|NCT00850031|6109528|P1|STARTED|Overall Study||118
2491885|NCT00849940|6109533|P1|NOT COMPLETED|Overall Study||4
2491886|NCT00849940|6109533|P1|COMPLETED|Overall Study||68
2491887|NCT00849940|6109533|P1|STARTED|Overall Study||72
2491888|NCT00849901|6109544|P3|NOT COMPLETED|Extension Phase||17
2491889|NCT00849901|6109545|P2|NOT COMPLETED|Extension Phase||26
2491890|NCT00849901|6109546|P1|NOT COMPLETED|Extension Phase||27
2491891|NCT00849901|6109544|P3|COMPLETED|Extension Phase||69
2491892|NCT00849901|6109545|P2|COMPLETED|Extension Phase||65
2491893|NCT00849901|6109546|P1|COMPLETED|Extension Phase||56
2491894|NCT00849901|6109544|P3|STARTED|Extension Phase||86
2491895|NCT00849901|6109545|P2|STARTED|Extension Phase||91
2491896|NCT00849901|6109546|P1|STARTED|Extension Phase||83
2491897|NCT00849901|6109544|P3|NOT COMPLETED|Acute Treatment Phase||16
2491898|NCT00849901|6109545|P2|NOT COMPLETED|Acute Treatment Phase||26
2491899|NCT00849901|6109546|P1|NOT COMPLETED|Acute Treatment Phase||30
2491900|NCT00849901|6109544|P3|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase.|87
2491901|NCT00849901|6109545|P2|COMPLETED|Acute Treatment Phase||91
2491902|NCT00849901|6109546|P1|COMPLETED|Acute Treatment Phase|4 didn't enter extension phase.|87
2491903|NCT00849901|6109544|P3|STARTED|Acute Treatment Phase||103
2491904|NCT00849901|6109545|P2|STARTED|Acute Treatment Phase||117
2491905|NCT00849901|6109546|P1|STARTED|Acute Treatment Phase||117
2491906|NCT00849875|6109593|P1|NOT COMPLETED|Overall Study||47
2491907|NCT00849875|6109593|P1|COMPLETED|Overall Study||1
2491908|NCT00849875|6109593|P1|STARTED|Overall Study||48
2491909|NCT00849862|6109675|P2|NOT COMPLETED|Second Intervention||0
2491910|NCT00849862|6109676|P1|NOT COMPLETED|Second Intervention||0
2491911|NCT00849862|6109675|P2|COMPLETED|Second Intervention||11
2491912|NCT00849862|6109676|P1|COMPLETED|Second Intervention||11
2491913|NCT00849862|6109675|P2|STARTED|Second Intervention||11
2491914|NCT00849862|6109676|P1|STARTED|Second Intervention||11
2491915|NCT00849862|6109675|P2|NOT COMPLETED|Washout: 7 Days||0
2491916|NCT00849862|6109676|P1|NOT COMPLETED|Washout: 7 Days||0
2491917|NCT00849862|6109675|P2|COMPLETED|Washout: 7 Days||11
2491918|NCT00849862|6109676|P1|COMPLETED|Washout: 7 Days||11
2491919|NCT00849862|6109675|P2|STARTED|Washout: 7 Days||11
2491920|NCT00849862|6109676|P1|STARTED|Washout: 7 Days||11
2491921|NCT00849862|6109675|P2|NOT COMPLETED|First Intervention||0
2491922|NCT00849862|6109676|P1|NOT COMPLETED|First Intervention||0
2491923|NCT00849862|6109675|P2|COMPLETED|First Intervention||11
2491924|NCT00849862|6109676|P1|COMPLETED|First Intervention||11
2491925|NCT00849862|6109675|P2|STARTED|First Intervention||11
2491926|NCT00849862|6109676|P1|STARTED|First Intervention||11
2491927|NCT00849810|6109684|P1|NOT COMPLETED|Overall Study||0
2491928|NCT00849810|6109684|P1|COMPLETED|Overall Study||1
2491929|NCT00849810|6109684|P1|STARTED|Overall Study||1
2491930|NCT00849797|6109690|P2|NOT COMPLETED|Second Intervention||0
2491931|NCT00849797|6109691|P1|NOT COMPLETED|Second Intervention||0
2491932|NCT00849797|6109690|P2|COMPLETED|Second Intervention||57
2491933|NCT00849797|6109691|P1|COMPLETED|Second Intervention||59
2491934|NCT00849797|6109690|P2|STARTED|Second Intervention||57
2491935|NCT00849797|6109691|P1|STARTED|Second Intervention||59
2491936|NCT00849797|6109690|P2|NOT COMPLETED|Washout: One Week||2
2491937|NCT00849797|6109691|P1|NOT COMPLETED|Washout: One Week||0
2491938|NCT00849797|6109690|P2|COMPLETED|Washout: One Week||57
2491939|NCT00849797|6109691|P1|COMPLETED|Washout: One Week||59
2491940|NCT00849797|6109690|P2|STARTED|Washout: One Week||59
2491941|NCT00849797|6109691|P1|STARTED|Washout: One Week||59
2491942|NCT00849797|6109690|P2|NOT COMPLETED|First Intervention||1
2491943|NCT00849797|6109691|P1|NOT COMPLETED|First Intervention||1
2491944|NCT00849797|6109690|P2|COMPLETED|First Intervention||59
2491945|NCT00849797|6109691|P1|COMPLETED|First Intervention||59
2491946|NCT00849797|6109690|P2|STARTED|First Intervention||60
2491947|NCT00849797|6109691|P1|STARTED|First Intervention||60
2491948|NCT00849693|6109709|P4|NOT COMPLETED|Extension Phase||38
2491949|NCT00849693|6109710|P3|NOT COMPLETED|Extension Phase||35
2491950|NCT00849693|6109711|P2|NOT COMPLETED|Extension Phase||30
2491951|NCT00849693|6109712|P1|NOT COMPLETED|Extension Phase||30
2491952|NCT00849693|6109709|P4|COMPLETED|Extension Phase||44
2491953|NCT00849693|6109710|P3|COMPLETED|Extension Phase||49
2491954|NCT00849693|6109711|P2|COMPLETED|Extension Phase||50
2491955|NCT00849693|6109712|P1|COMPLETED|Extension Phase||43
2491956|NCT00849693|6109709|P4|STARTED|Extension Phase||82
2491957|NCT00849693|6109710|P3|STARTED|Extension Phase||84
2491958|NCT00849693|6109711|P2|STARTED|Extension Phase||80
2491959|NCT00849693|6109712|P1|STARTED|Extension Phase||73
2491960|NCT00849693|6109709|P4|NOT COMPLETED|Acute Treatment Phase||37
2491961|NCT00849693|6109710|P3|NOT COMPLETED|Acute Treatment Phase||33
2491962|NCT00849693|6109711|P2|NOT COMPLETED|Acute Treatment Phase||35
2491963|NCT00849693|6109712|P1|NOT COMPLETED|Acute Treatment Phase||33
2491964|NCT00849693|6109709|P4|COMPLETED|Acute Treatment Phase|3 didn't enter extension phase|85
2491965|NCT00849693|6109710|P3|COMPLETED|Acute Treatment Phase||84
2491966|NCT00849693|6109711|P2|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase|81
2491967|NCT00849693|6109712|P1|COMPLETED|Acute Treatment Phase|2 didn't enter extension phase.|75
2491968|NCT00849693|6109709|P4|STARTED|Acute Treatment Phase||122
2491969|NCT00849693|6109710|P3|STARTED|Acute Treatment Phase||117
2491970|NCT00849693|6109711|P2|STARTED|Acute Treatment Phase||116
2491971|NCT00849693|6109712|P1|STARTED|Acute Treatment Phase||108
2491972|NCT00849680|6109779|P8|NOT COMPLETED|Overall Study||8
2491973|NCT00849680|6109780|P7|NOT COMPLETED|Overall Study||17
2491974|NCT00849680|6109781|P6|NOT COMPLETED|Overall Study||15
2491975|NCT00849680|6109782|P5|NOT COMPLETED|Overall Study||10
2491976|NCT00849680|6109783|P4|NOT COMPLETED|Overall Study||14
2491977|NCT00849680|6109784|P3|NOT COMPLETED|Overall Study||15
2491978|NCT00849680|6109785|P2|NOT COMPLETED|Overall Study||3
2491979|NCT00849680|6109786|P1|NOT COMPLETED|Overall Study||11
2491980|NCT00849680|6109779|P8|COMPLETED|Overall Study||23
2491981|NCT00849680|6109780|P7|COMPLETED|Overall Study||61
2491982|NCT00849680|6109781|P6|COMPLETED|Overall Study||27
2491983|NCT00849680|6109782|P5|COMPLETED|Overall Study||32
2491984|NCT00849680|6109783|P4|COMPLETED|Overall Study||28
2491985|NCT00849680|6109784|P3|COMPLETED|Overall Study||27
2491986|NCT00849680|6109785|P2|COMPLETED|Overall Study||10
2491987|NCT00849680|6109786|P1|COMPLETED|Overall Study||16
2491988|NCT00849680|6109779|P8|STARTED|Overall Study||31
2491989|NCT00849680|6109780|P7|STARTED|Overall Study||78
2491990|NCT00849680|6109781|P6|STARTED|Overall Study||42
2491991|NCT00849680|6109782|P5|STARTED|Overall Study||42
2491992|NCT00849680|6109783|P4|STARTED|Overall Study||42
2491993|NCT00849680|6109784|P3|STARTED|Overall Study||42
2491994|NCT00849680|6109785|P2|STARTED|Overall Study||13
2491995|NCT00849680|6109786|P1|STARTED|Overall Study||27
2491996|NCT00849524|6109828|P1|NOT COMPLETED|Overall Study||3
2491997|NCT00849524|6109828|P1|COMPLETED|Overall Study||3
2491998|NCT00849524|6109828|P1|STARTED|Overall Study||6
2491999|NCT00849485|6109836|P2|NOT COMPLETED|Second Intervention||0
2492000|NCT00849485|6109837|P1|NOT COMPLETED|Second Intervention||0
2492001|NCT00849485|6109836|P2|COMPLETED|Second Intervention||11
2492002|NCT00849485|6109837|P1|COMPLETED|Second Intervention||11
2492003|NCT00849485|6109836|P2|STARTED|Second Intervention||11
2492004|NCT00849485|6109837|P1|STARTED|Second Intervention||11
2492005|NCT00849485|6109836|P2|NOT COMPLETED|Washout: 7 Days||0
2492006|NCT00849485|6109837|P1|NOT COMPLETED|Washout: 7 Days||0
2492007|NCT00849485|6109836|P2|COMPLETED|Washout: 7 Days||11
2492008|NCT00849485|6109837|P1|COMPLETED|Washout: 7 Days||11
2492009|NCT00849485|6109836|P2|STARTED|Washout: 7 Days||11
2492010|NCT00849485|6109837|P1|STARTED|Washout: 7 Days||11
2492011|NCT00849485|6109836|P2|NOT COMPLETED|First Intervention||0
2492012|NCT00849485|6109837|P1|NOT COMPLETED|First Intervention||0
2492013|NCT00849485|6109836|P2|COMPLETED|First Intervention||11
2492014|NCT00849485|6109837|P1|COMPLETED|First Intervention||11
2492015|NCT00849485|6109836|P2|STARTED|First Intervention||11
2492016|NCT00849485|6109837|P1|STARTED|First Intervention||11
2492017|NCT00849472|6109845|P1|NOT COMPLETED|Pazopanib Postsurgery Treatment||26
2492018|NCT00849472|6109845|P1|COMPLETED|Pazopanib Postsurgery Treatment||16
2492019|NCT00849472|6109845|P1|STARTED|Pazopanib Postsurgery Treatment|36 participants completed PPT; 7 participants who discontinued PPT resumed treatment postsurgery.|42
2492020|NCT00849472|6109845|P1|NOT COMPLETED|Pazopanib Presurgery Treatment (PPT)||58
2492021|NCT00849472|6109845|P1|COMPLETED|Pazopanib Presurgery Treatment (PPT)||36
2492022|NCT00849472|6109845|P1|STARTED|Pazopanib Presurgery Treatment (PPT)||94
2492023|NCT00849472|6109845|P1|NOT COMPLETED|Weekly Paclitaxel||16
2492024|NCT00849472|6109845|P1|COMPLETED|Weekly Paclitaxel||78
2492025|NCT00849472|6109845|P1|STARTED|Weekly Paclitaxel|One par. was deemed ineligible after completing AC therapy and did not start paclitaxel+pazopanib.|94
2492026|NCT00849472|6109845|P1|NOT COMPLETED|Doxorubicin and Cyclophosphamide (AC)||6
2492027|NCT00849472|6109845|P1|COMPLETED|Doxorubicin and Cyclophosphamide (AC)||95
2492028|NCT00849472|6109845|P1|STARTED|Doxorubicin and Cyclophosphamide (AC)||101
2492029|NCT00849381|6109859|P1|NOT COMPLETED|Overall Study||145
2492030|NCT00849381|6109859|P1|COMPLETED|Overall Study|Out of the subjects who completed, 167 were enrolled at the center having compliance issues.|1092
2492031|NCT00849381|6109859|P1|STARTED|Overall Study|Out of the subjects who started, 243 were enrolled at the center having compliance issues.|1237
2492032|NCT00849290|6109865|P1|NOT COMPLETED|Overall Study||55
2492033|NCT00849290|6109865|P1|COMPLETED|Overall Study||58
2492034|NCT00849290|6109865|P1|STARTED|Overall Study||113
2492035|NCT00849251|6109869|P2|NOT COMPLETED|Overall Study||1
2492036|NCT00849251|6109870|P1|NOT COMPLETED|Overall Study||1
2492037|NCT00849251|6109869|P2|COMPLETED|Overall Study||24
2492038|NCT00849251|6109870|P1|COMPLETED|Overall Study||5
2492039|NCT00849251|6109869|P2|STARTED|Overall Study||25
2492040|NCT00849251|6109870|P1|STARTED|Overall Study||6
2492041|NCT00849212|6109876|P1|NOT COMPLETED|Overall Study||7
2492042|NCT00849212|6109876|P1|COMPLETED|Overall Study||23
2492043|NCT00849212|6109876|P1|STARTED|Overall Study||30
2492044|NCT00849186|6109881|P1|NOT COMPLETED|Overall Study||10
2492045|NCT00849186|6109881|P1|COMPLETED|Overall Study||16
2492046|NCT00849186|6109881|P1|STARTED|Overall Study||26
2492047|NCT00849147|6109887|P1|NOT COMPLETED|Overall Study||5
2492048|NCT00849147|6109887|P1|COMPLETED|Overall Study||50
2492049|NCT00849147|6109887|P1|STARTED|Overall Study||55
2492050|NCT00849121|6109904|P2|NOT COMPLETED|Overall Study||0
2492051|NCT00849121|6109905|P1|NOT COMPLETED|Overall Study||0
2492052|NCT00849121|6109904|P2|COMPLETED|Overall Study||9
2492053|NCT00849121|6109905|P1|COMPLETED|Overall Study||8
2492054|NCT00849121|6109904|P2|STARTED|Overall Study||9
2492055|NCT00849121|6109905|P1|STARTED|Overall Study||8
2492056|NCT00849108|6109920|P2|NOT COMPLETED|Cohort 2 Efficacy||10
2492057|NCT00849108|6109921|P1|NOT COMPLETED|Cohort 2 Efficacy||0
2492058|NCT00849108|6109920|P2|COMPLETED|Cohort 2 Efficacy||133
2492059|NCT00849108|6109921|P1|COMPLETED|Cohort 2 Efficacy||0
2492060|NCT00849108|6109920|P2|STARTED|Cohort 2 Efficacy||143
2492061|NCT00849108|6109921|P1|STARTED|Cohort 2 Efficacy|Cohort 1 subjects did not participate in period 2: efficacy|0
2492062|NCT00849108|6109920|P2|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
2492063|NCT00849108|6109921|P1|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||1
2492064|NCT00849108|6109920|P2|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
2492065|NCT00849108|6109921|P1|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||32
2492066|NCT00849108|6109920|P2|STARTED|Cohort 1 Dose Ranging and Dose Interval|Cohort 2(Pharm Stress) subjects did not participate in dose range, dose frequency|0
2492067|NCT00849108|6109921|P1|STARTED|Cohort 1 Dose Ranging and Dose Interval||33
2492068|NCT00849056|6109931|P2|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||25
2492069|NCT00849056|6109932|P1|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||27
2492070|NCT00849056|6109931|P2|COMPLETED|Follow-up Period (FUP) (8 Weeks)||124
2492071|NCT00849056|6109932|P1|COMPLETED|Follow-up Period (FUP) (8 Weeks)||122
2492072|NCT00849056|6109931|P2|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|149
2492073|NCT00849056|6109932|P1|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Two par. did not participate in the FUP.|149
2492074|NCT00849056|6109931|P2|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||50
2492075|NCT00849056|6109932|P1|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||63
2492076|NCT00849056|6109931|P2|COMPLETED|Treatment Period (TP) (156 Weeks)||100
2492077|NCT00849056|6109932|P1|COMPLETED|Treatment Period (TP) (156 Weeks)||88
2492078|NCT00849056|6109931|P2|STARTED|Treatment Period (TP) (156 Weeks)||150
2492079|NCT00849056|6109932|P1|STARTED|Treatment Period (TP) (156 Weeks)||151
2492080|NCT00849017|6109957|P3|NOT COMPLETED|Follow-up Period (8 Weeks)||25
2492081|NCT00849017|6109958|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||18
2492082|NCT00849017|6109959|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||25
2492083|NCT00849017|6109957|P3|COMPLETED|Follow-up Period (8 Weeks)||74
2492084|NCT00849017|6109958|P2|COMPLETED|Follow-up Period (8 Weeks)||83
2492085|NCT00849017|6109959|P1|COMPLETED|Follow-up Period (8 Weeks)||76
2492086|NCT00849017|6109957|P3|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|99
2492087|NCT00849017|6109958|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
2492088|NCT00849017|6109959|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
2492089|NCT00849017|6109957|P3|NOT COMPLETED|Treatment Period (156 Weeks)||42
2492090|NCT00849017|6109958|P2|NOT COMPLETED|Treatment Period (156 Weeks)||33
2492091|NCT00849017|6109959|P1|NOT COMPLETED|Treatment Period (156 Weeks)||43
2492092|NCT00849017|6109957|P3|COMPLETED|Treatment Period (156 Weeks)||57
2492093|NCT00849017|6109958|P2|COMPLETED|Treatment Period (156 Weeks)||68
2492094|NCT00849017|6109959|P1|COMPLETED|Treatment Period (156 Weeks)||58
2492095|NCT00849017|6109957|P3|STARTED|Treatment Period (156 Weeks)||99
2492096|NCT00849017|6109958|P2|STARTED|Treatment Period (156 Weeks)||101
2492097|NCT00849017|6109959|P1|STARTED|Treatment Period (156 Weeks)||101
2492098|NCT00848965|6110002|P1|NOT COMPLETED|Overall Study||2
2492099|NCT00848965|6110002|P1|COMPLETED|Overall Study||57
2492100|NCT00848965|6110002|P1|STARTED|Overall Study||59
2492101|NCT00848926|6110044|P1|NOT COMPLETED|Follow-up Period||12
2492102|NCT00848926|6110044|P1|COMPLETED|Follow-up Period|Completed survival follow-up due to death [57] or study termination by sponsor [33]|90
2492103|NCT00848926|6110044|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|102
2492104|NCT00848926|6110044|P1|NOT COMPLETED|Treatment Period||84
2492105|NCT00848926|6110044|P1|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|18
2492106|NCT00848926|6110044|P1|STARTED|Treatment Period||102
2492107|NCT00848783|6110063|P3|NOT COMPLETED|Overall Study||0
2492108|NCT00848783|6110064|P2|NOT COMPLETED|Overall Study||2
2492109|NCT00848783|6110065|P1|NOT COMPLETED|Overall Study||3
2492110|NCT00848783|6110063|P3|COMPLETED|Overall Study||1
2492111|NCT00848783|6110064|P2|COMPLETED|Overall Study||1
2492112|NCT00848783|6110065|P1|COMPLETED|Overall Study||1
2492113|NCT00848783|6110063|P3|STARTED|Overall Study||1
2492114|NCT00848783|6110064|P2|STARTED|Overall Study||3
2492115|NCT00848783|6110065|P1|STARTED|Overall Study||4
2492116|NCT00848744|6110074|P1|NOT COMPLETED|Overall Study||0
2492117|NCT00848744|6110074|P1|COMPLETED|Overall Study||10
2492118|NCT00848744|6110074|P1|STARTED|Overall Study||10
2492119|NCT00848718|6110094|P13|NOT COMPLETED|Overall Study||8
2492120|NCT00848718|6110095|P12|NOT COMPLETED|Overall Study||6
2492121|NCT00848718|6110096|P11|NOT COMPLETED|Overall Study||4
2492122|NCT00848718|6110097|P10|NOT COMPLETED|Overall Study||9
2492123|NCT00848718|6110098|P9|NOT COMPLETED|Overall Study||4
2492124|NCT00848718|6110099|P8|NOT COMPLETED|Overall Study||5
2492125|NCT00848718|6110100|P7|NOT COMPLETED|Overall Study||3
2492126|NCT00848718|6110101|P6|NOT COMPLETED|Overall Study||5
2492127|NCT00848718|6110102|P5|NOT COMPLETED|Overall Study||6
2492128|NCT00848718|6110103|P4|NOT COMPLETED|Overall Study||5
2492129|NCT00848718|6110104|P3|NOT COMPLETED|Overall Study||6
2492130|NCT00848718|6110105|P2|NOT COMPLETED|Overall Study||9
2492131|NCT00848718|6110106|P1|NOT COMPLETED|Overall Study||7
2492132|NCT00848718|6110094|P13|COMPLETED|Overall Study||0
2492133|NCT00848718|6110095|P12|COMPLETED|Overall Study||0
2492134|NCT00848718|6110096|P11|COMPLETED|Overall Study||0
2492135|NCT00848718|6110097|P10|COMPLETED|Overall Study||0
2492136|NCT00848718|6110098|P9|COMPLETED|Overall Study||0
2492137|NCT00848718|6110099|P8|COMPLETED|Overall Study||0
2492138|NCT00848718|6110100|P7|COMPLETED|Overall Study||0
2492139|NCT00848718|6110101|P6|COMPLETED|Overall Study||0
2492140|NCT00848718|6110102|P5|COMPLETED|Overall Study||0
2492141|NCT00848718|6110103|P4|COMPLETED|Overall Study||0
2492142|NCT00848718|6110104|P3|COMPLETED|Overall Study||0
2492143|NCT00848718|6110105|P2|COMPLETED|Overall Study||0
2492144|NCT00848718|6110106|P1|COMPLETED|Overall Study||0
2492145|NCT00848718|6110094|P13|Treated|Overall Study|2 participants were allocated but did not receive treatment due to progression of disease|6
2492146|NCT00848718|6110095|P12|Treated|Overall Study||6
2492147|NCT00848718|6110096|P11|Treated|Overall Study||4
2492148|NCT00848718|6110097|P10|Treated|Overall Study||9
2492149|NCT00848718|6110098|P9|Treated|Overall Study||4
2492150|NCT00848718|6110099|P8|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|4
2492151|NCT00848718|6110100|P7|Treated|Overall Study||3
2492152|NCT00848718|6110101|P6|Treated|Overall Study||5
2492153|NCT00848718|6110102|P5|Treated|Overall Study||6
2492154|NCT00848718|6110103|P4|Treated|Overall Study||5
2492155|NCT00848718|6110104|P3|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|5
2492156|NCT00848718|6110105|P2|Treated|Overall Study||9
2492157|NCT00848718|6110106|P1|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|6
2492158|NCT00848718|6110094|P13|STARTED|Overall Study||8
2492159|NCT00848718|6110095|P12|STARTED|Overall Study||6
2492160|NCT00848718|6110096|P11|STARTED|Overall Study||4
2492161|NCT00848718|6110097|P10|STARTED|Overall Study||9
2492162|NCT00848718|6110098|P9|STARTED|Overall Study||4
2492163|NCT00848718|6110099|P8|STARTED|Overall Study||5
2492164|NCT00848718|6110100|P7|STARTED|Overall Study||3
2492165|NCT00848718|6110101|P6|STARTED|Overall Study||5
2492166|NCT00848718|6110102|P5|STARTED|Overall Study||6
2492167|NCT00848718|6110103|P4|STARTED|Overall Study||5
2492168|NCT00848718|6110104|P3|STARTED|Overall Study||6
2492169|NCT00848718|6110105|P2|STARTED|Overall Study||9
2492170|NCT00848718|6110106|P1|STARTED|Overall Study||7
2492171|NCT00848549|6110207|P2|NOT COMPLETED|E2090-E044-314 (Extension Study)||24
2492172|NCT00848549|6110208|P1|NOT COMPLETED|E2090-E044-314 (Extension Study)||17
2492173|NCT00848549|6110207|P2|COMPLETED|E2090-E044-314 (Extension Study)||134
2492174|NCT00848549|6110208|P1|COMPLETED|E2090-E044-314 (Extension Study)||120
2492175|NCT00848549|6110207|P2|STARTED|E2090-E044-314 (Extension Study)||158
2492176|NCT00848549|6110208|P1|STARTED|E2090-E044-314 (Extension Study)||137
2492177|NCT00848549|6110207|P2|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||34
2492178|NCT00848549|6110208|P1|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||24
2492179|NCT00848549|6110207|P2|COMPLETED|E2090-E044-310 (Base Study) Transition||158
2492180|NCT00848549|6110208|P1|COMPLETED|E2090-E044-310 (Base Study) Transition||137
2492181|NCT00848549|6110207|P2|STARTED|E2090-E044-310 (Base Study) Transition||192
2492182|NCT00848549|6110208|P1|STARTED|E2090-E044-310 (Base Study) Transition||161
2492183|NCT00848549|6110207|P2|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||109
2492184|NCT00848549|6110208|P1|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||121
2492185|NCT00848549|6110207|P2|COMPLETED|E2090-E044-310 (Base Study) Disposition||192
2492186|NCT00848549|6110208|P1|COMPLETED|E2090-E044-310 (Base Study) Disposition||161
2492187|NCT00848549|6110207|P2|STARTED|E2090-E044-310 (Base Study) Disposition||301
2492188|NCT00848549|6110208|P1|STARTED|E2090-E044-310 (Base Study) Disposition||282
2492189|NCT00848536|6110226|P2|NOT COMPLETED|Overall Study||7
2492190|NCT00848536|6110227|P1|NOT COMPLETED|Overall Study||4
2492191|NCT00848536|6110226|P2|COMPLETED|Overall Study||179
2492192|NCT00848536|6110227|P1|COMPLETED|Overall Study||181
2492193|NCT00848536|6110226|P2|STARTED|Overall Study||186
2492194|NCT00848536|6110227|P1|STARTED|Overall Study||185
2492195|NCT00848510|6110241|P4|NOT COMPLETED|Overall Study||0
2492196|NCT00848510|6110242|P3|NOT COMPLETED|Overall Study||0
2492197|NCT00848510|6110243|P2|NOT COMPLETED|Overall Study||0
2492198|NCT00848510|6110244|P1|NOT COMPLETED|Overall Study||0
2492199|NCT00848510|6110241|P4|COMPLETED|Overall Study||10
2492200|NCT00848510|6110242|P3|COMPLETED|Overall Study||8
2492201|NCT00848510|6110243|P2|COMPLETED|Overall Study||13
2492202|NCT00848510|6110244|P1|COMPLETED|Overall Study||10
2492203|NCT00848510|6110241|P4|STARTED|Overall Study||10
2492204|NCT00848510|6110242|P3|STARTED|Overall Study||8
2492205|NCT00848510|6110243|P2|STARTED|Overall Study||13
2492206|NCT00848510|6110244|P1|STARTED|Overall Study||10
2492207|NCT00848497|6110292|P2|NOT COMPLETED|Overall Study||1
2492208|NCT00848497|6110293|P1|NOT COMPLETED|Overall Study||2
2492209|NCT00848497|6110292|P2|COMPLETED|Overall Study||0
2492210|NCT00848497|6110293|P1|COMPLETED|Overall Study||0
2492211|NCT00848497|6110292|P2|STARTED|Overall Study|Completed Visit 4|1
2492212|NCT00848497|6110293|P1|STARTED|Overall Study||2
2492213|NCT00848484|6110307|P2|NOT COMPLETED|Second Intervention (Treatment Period 2)||1
2492214|NCT00848484|6110308|P1|NOT COMPLETED|Second Intervention (Treatment Period 2)||0
2492215|NCT00848484|6110307|P2|COMPLETED|Second Intervention (Treatment Period 2)||20
2492216|NCT00848484|6110308|P1|COMPLETED|Second Intervention (Treatment Period 2)||25
2492217|NCT00848484|6110307|P2|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
2492218|NCT00848484|6110308|P1|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
2492219|NCT00848484|6110307|P2|STARTED|Second Intervention (Treatment Period 2)||21
2492220|NCT00848484|6110308|P1|STARTED|Second Intervention (Treatment Period 2)||25
2492221|NCT00848484|6110307|P2|NOT COMPLETED|Washout Period of Two Weeks||3
2492222|NCT00848484|6110308|P1|NOT COMPLETED|Washout Period of Two Weeks||0
2492223|NCT00848484|6110307|P2|COMPLETED|Washout Period of Two Weeks||21
2492224|NCT00848484|6110308|P1|COMPLETED|Washout Period of Two Weeks||25
2492225|NCT00848484|6110307|P2|STARTED|Washout Period of Two Weeks||24
2492226|NCT00848484|6110308|P1|STARTED|Washout Period of Two Weeks||25
2492227|NCT00848484|6110307|P2|NOT COMPLETED|First Intervention (Treatment Period 1)||3
2492228|NCT00848484|6110308|P1|NOT COMPLETED|First Intervention (Treatment Period 1)||2
2492229|NCT00848484|6110307|P2|COMPLETED|First Intervention (Treatment Period 1)||24
2492230|NCT00848484|6110308|P1|COMPLETED|First Intervention (Treatment Period 1)||25
2492231|NCT00848484|6110307|P2|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||1
2492232|NCT00848484|6110308|P1|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||2
2492233|NCT00848484|6110307|P2|STARTED|First Intervention (Treatment Period 1)||27
2492234|NCT00848484|6110308|P1|STARTED|First Intervention (Treatment Period 1)||27
2492235|NCT00848393|6110327|P3|NOT COMPLETED|Overall Study||3
2492236|NCT00848393|6110328|P2|NOT COMPLETED|Overall Study||0
2492237|NCT00848393|6110329|P1|NOT COMPLETED|Overall Study||0
2492238|NCT00848393|6110327|P3|COMPLETED|Overall Study||15
2492239|NCT00848393|6110328|P2|COMPLETED|Overall Study||16
2492240|NCT00848393|6110329|P1|COMPLETED|Overall Study||17
2492241|NCT00848393|6110327|P3|STARTED|Overall Study||18
2492242|NCT00848393|6110328|P2|STARTED|Overall Study||16
2492243|NCT00848393|6110329|P1|STARTED|Overall Study||17
2492244|NCT00848367|6110357|P2|NOT COMPLETED|Overall Study||9
2492245|NCT00848367|6110358|P1|NOT COMPLETED|Overall Study||9
2492246|NCT00848367|6110357|P2|COMPLETED|Overall Study||41
2492247|NCT00848367|6110358|P1|COMPLETED|Overall Study||43
2492248|NCT00848367|6110357|P2|STARTED|Overall Study||50
2492249|NCT00848367|6110358|P1|STARTED|Overall Study||52
2492250|NCT00848354|6110368|P2|NOT COMPLETED|Phase 2 Year 2||7
2492251|NCT00848354|6110369|P1|NOT COMPLETED|Phase 2 Year 2||23
2492252|NCT00848354|6110368|P2|COMPLETED|Phase 2 Year 2||113
2492253|NCT00848354|6110369|P1|COMPLETED|Phase 2 Year 2||218
2492254|NCT00848354|6110368|P2|STARTED|Phase 2 Year 2|Randomized Phase 1 treatment assignment.|120
2492255|NCT00848354|6110369|P1|STARTED|Phase 2 Year 2|"Randomized Phase 1 treatment assignment.~1 participant discontinued between Year 1 and Year 2."|241
2492256|NCT00848354|6110368|P2|NOT COMPLETED|Phase 2 Year 1||6
2492257|NCT00848354|6110369|P1|NOT COMPLETED|Phase 2 Year 1||18
2492258|NCT00848354|6110368|P2|COMPLETED|Phase 2 Year 1||120
2492259|NCT00848354|6110369|P1|COMPLETED|Phase 2 Year 1||242
2492260|NCT00848354|6110368|P2|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 3 participants discontinued between Phase 1 and Phase 2.|126
2492261|NCT00848354|6110369|P1|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 9 participants discontinued between Phase 1 and Phase 2.|260
2492262|NCT00848354|6110368|P2|NOT COMPLETED|Phase 1||14
2492263|NCT00848354|6110369|P1|NOT COMPLETED|Phase 1||12
2492264|NCT00848354|6110368|P2|COMPLETED|Phase 1||129
2492265|NCT00848354|6110369|P1|COMPLETED|Phase 1||269
2492266|NCT00848354|6110368|P2|STARTED|Phase 1||143
2492267|NCT00848354|6110369|P1|STARTED|Phase 1|One participant was randomized to the Etanercept + Methotrexate group but received SSZ in error.|281
2492268|NCT00848250|6110521|P2|NOT COMPLETED|Overall Study||1
2492269|NCT00848250|6110522|P1|NOT COMPLETED|Overall Study||0
2492270|NCT00848250|6110521|P2|COMPLETED|Overall Study||9
2492271|NCT00848250|6110522|P1|COMPLETED|Overall Study||11
2492272|NCT00848250|6110521|P2|STARTED|Overall Study||10
2492273|NCT00848250|6110522|P1|STARTED|Overall Study||11
2492274|NCT00848237|6110540|P1|NOT COMPLETED|Overall Study||539
2492275|NCT00848237|6110540|P1|COMPLETED|Overall Study||4982
2492276|NCT00848237|6110540|P1|STARTED|Overall Study||5521
2492277|NCT00848211|6110553|P4|NOT COMPLETED|Overall Study||0
2492278|NCT00848211|6110554|P3|NOT COMPLETED|Overall Study||1
2492279|NCT00848211|6110555|P2|NOT COMPLETED|Overall Study||1
2492280|NCT00848211|6110556|P1|NOT COMPLETED|Overall Study||0
2492281|NCT00848211|6110553|P4|COMPLETED|Overall Study||5
2492282|NCT00848211|6110554|P3|COMPLETED|Overall Study||5
2492283|NCT00848211|6110555|P2|COMPLETED|Overall Study||6
2492284|NCT00848211|6110556|P1|COMPLETED|Overall Study||6
2492285|NCT00848211|6110553|P4|STARTED|Overall Study||5
2492286|NCT00848211|6110554|P3|STARTED|Overall Study||6
2492287|NCT00848211|6110555|P2|STARTED|Overall Study||7
2492288|NCT00848211|6110556|P1|STARTED|Overall Study||6
2492289|NCT00848198|6110574|P1|NOT COMPLETED|Overall Study||15
2492290|NCT00848198|6110574|P1|COMPLETED|Overall Study||299
2492291|NCT00848198|6110574|P1|STARTED|Overall Study||314
2492292|NCT00848185|6110615|P3|NOT COMPLETED|Overall Study||0
2492293|NCT00848185|6110616|P2|NOT COMPLETED|Overall Study||0
2492294|NCT00848185|6110617|P1|NOT COMPLETED|Overall Study||0
2492295|NCT00848185|6110615|P3|COMPLETED|Overall Study||32
2492296|NCT00848185|6110616|P2|COMPLETED|Overall Study||32
2492297|NCT00848185|6110617|P1|COMPLETED|Overall Study||32
2492298|NCT00848185|6110615|P3|STARTED|Overall Study||32
2492299|NCT00848185|6110616|P2|STARTED|Overall Study||32
2492300|NCT00848185|6110617|P1|STARTED|Overall Study||32
2492301|NCT00848172|6110627|P2|NOT COMPLETED|Visit 3 - Follow Up||0
2492302|NCT00848172|6110628|P1|NOT COMPLETED|Visit 3 - Follow Up||0
2492303|NCT00848172|6110627|P2|COMPLETED|Visit 3 - Follow Up||8
2492304|NCT00848172|6110628|P1|COMPLETED|Visit 3 - Follow Up||10
2492305|NCT00848172|6110627|P2|STARTED|Visit 3 - Follow Up||8
2492306|NCT00848172|6110628|P1|STARTED|Visit 3 - Follow Up||10
2492307|NCT00848172|6110627|P2|NOT COMPLETED|Visit 2 - Drug Administration||1
2492308|NCT00848172|6110628|P1|NOT COMPLETED|Visit 2 - Drug Administration||0
2492309|NCT00848172|6110627|P2|COMPLETED|Visit 2 - Drug Administration||8
2492310|NCT00848172|6110628|P1|COMPLETED|Visit 2 - Drug Administration||10
2492311|NCT00848172|6110627|P2|STARTED|Visit 2 - Drug Administration||9
2492312|NCT00848172|6110628|P1|STARTED|Visit 2 - Drug Administration||10
2492313|NCT00848120|6110639|P1|NOT COMPLETED|Overall Study||1
2492314|NCT00848120|6110639|P1|COMPLETED|Overall Study||28
2492315|NCT00848120|6110639|P1|STARTED|Overall Study||29
2492316|NCT00848107|6110651|P1|NOT COMPLETED|Overall Study||21
2492317|NCT00848107|6110651|P1|COMPLETED|Overall Study||94
2492318|NCT00848107|6110651|P1|STARTED|Overall Study||115
2492319|NCT00848081|6110661|P2|NOT COMPLETED|Overall Study||18
2492320|NCT00848081|6110662|P1|NOT COMPLETED|Overall Study||20
2492321|NCT00848081|6110661|P2|COMPLETED|Overall Study||140
2492322|NCT00848081|6110662|P1|COMPLETED|Overall Study||140
2492323|NCT00848081|6110661|P2|STARTED|Overall Study||158
2492324|NCT00848081|6110662|P1|STARTED|Overall Study||160
2492325|NCT00848042|6110679|P3|NOT COMPLETED|Overall Study||0
2492326|NCT00848042|6110680|P2|NOT COMPLETED|Overall Study||2
2492327|NCT00848042|6110681|P1|NOT COMPLETED|Overall Study||4
2492328|NCT00848042|6110679|P3|COMPLETED|Overall Study||1
2492329|NCT00848042|6110680|P2|COMPLETED|Overall Study||3
2492330|NCT00848042|6110681|P1|COMPLETED|Overall Study||1
2492331|NCT00848042|6110679|P3|Month 6|Overall Study||1
2492332|NCT00848042|6110680|P2|Month 6|Overall Study||3
2492333|NCT00848042|6110681|P1|Month 6|Overall Study||1
2492334|NCT00848042|6110679|P3|Month 5|Overall Study||1
2492335|NCT00848042|6110680|P2|Month 5|Overall Study||3
2492336|NCT00848042|6110681|P1|Month 5|Overall Study||1
2492337|NCT00848042|6110679|P3|Month 4|Overall Study||1
2492338|NCT00848042|6110680|P2|Month 4|Overall Study||4
2492339|NCT00848042|6110681|P1|Month 4|Overall Study||1
2492340|NCT00848042|6110679|P3|Month 3|Overall Study||1
2492341|NCT00848042|6110680|P2|Month 3|Overall Study||4
2492342|NCT00848042|6110681|P1|Month 3|Overall Study||1
2492343|NCT00848042|6110679|P3|Month 2|Overall Study||1
2492344|NCT00848042|6110680|P2|Month 2|Overall Study||5
2492345|NCT00848042|6110681|P1|Month 2|Overall Study||1
2492346|NCT00848042|6110679|P3|Month 1|Overall Study||1
2492347|NCT00848042|6110680|P2|Month 1|Overall Study||5
2492348|NCT00848042|6110681|P1|Month 1|Overall Study||4
2492349|NCT00848042|6110679|P3|Day 15|Overall Study||1
2492350|NCT00848042|6110680|P2|Day 15|Overall Study||5
2492351|NCT00848042|6110681|P1|Day 15|Overall Study||4
2492352|NCT00848042|6110679|P3|Day 8|Overall Study||1
2492353|NCT00848042|6110680|P2|Day 8|Overall Study||5
2492354|NCT00848042|6110681|P1|Day 8|Overall Study||5
2492355|NCT00848042|6110679|P3|Day 3|Overall Study||1
2492356|NCT00848042|6110680|P2|Day 3|Overall Study||5
2492357|NCT00848042|6110681|P1|Day 3|Overall Study||5
2492358|NCT00848042|6110679|P3|Day 2|Overall Study||1
2492359|NCT00848042|6110680|P2|Day 2|Overall Study||5
2492360|NCT00848042|6110681|P1|Day 2|Overall Study||5
2492361|NCT00848042|6110679|P3|Day 1|Overall Study||1
2492362|NCT00848042|6110680|P2|Day 1|Overall Study||5
2492363|NCT00848042|6110681|P1|Day 1|Overall Study||5
2492364|NCT00848042|6110679|P3|STARTED|Overall Study||1
2492365|NCT00848042|6110680|P2|STARTED|Overall Study||5
2492366|NCT00848042|6110681|P1|STARTED|Overall Study||5
2492367|NCT00848016|6110692|P1|NOT COMPLETED|Overall Study||0
2492368|NCT00848016|6110692|P1|COMPLETED|Overall Study||29
2492369|NCT00848016|6110692|P1|STARTED|Overall Study||29
2492370|NCT00847938|6110702|P4|NOT COMPLETED|Overall Study||0
2492371|NCT00847938|6110703|P3|NOT COMPLETED|Overall Study||1
2492372|NCT00847938|6110704|P2|NOT COMPLETED|Overall Study||1
2492373|NCT00847938|6110705|P1|NOT COMPLETED|Overall Study||0
2492374|NCT00847938|6110702|P4|COMPLETED|Overall Study||15
2492375|NCT00847938|6110703|P3|COMPLETED|Overall Study||15
2492376|NCT00847938|6110704|P2|COMPLETED|Overall Study||14
2492377|NCT00847938|6110705|P1|COMPLETED|Overall Study||16
2492378|NCT00847938|6110702|P4|STARTED|Overall Study||15
2492379|NCT00847938|6110703|P3|STARTED|Overall Study||16
2492380|NCT00847938|6110704|P2|STARTED|Overall Study||15
2492381|NCT00847938|6110705|P1|STARTED|Overall Study||16
2492382|NCT00847912|6110717|P2|NOT COMPLETED|Overall Study||13
2492383|NCT00847912|6110718|P1|NOT COMPLETED|Overall Study||9
2492384|NCT00847912|6110717|P2|COMPLETED|Overall Study||464
2492385|NCT00847912|6110718|P1|COMPLETED|Overall Study||468
2492386|NCT00847912|6110717|P2|STARTED|Overall Study||477
2492387|NCT00847912|6110718|P1|STARTED|Overall Study||477
2492388|NCT00847886|6110728|P2|NOT COMPLETED|Overall Study||1
2492389|NCT00847886|6110729|P1|NOT COMPLETED|Overall Study||0
2492390|NCT00847886|6110728|P2|COMPLETED|Overall Study||3
2492391|NCT00847886|6110729|P1|COMPLETED|Overall Study||12
2492392|NCT00847886|6110728|P2|STARTED|Overall Study||4
2492393|NCT00847886|6110729|P1|STARTED|Overall Study||12
2492394|NCT00847808|6110755|P1|NOT COMPLETED|Overall Study||15
2492395|NCT00847808|6110755|P1|COMPLETED|Overall Study||163
2492396|NCT00847808|6110755|P1|STARTED|Overall Study||178
2492397|NCT00847730|6110772|P1|NOT COMPLETED|Overall Study||8
2492398|NCT00847730|6110772|P1|COMPLETED|Overall Study||25
2492399|NCT00847730|6110772|P1|STARTED|Overall Study||33
2492400|NCT00847704|6110776|P1|NOT COMPLETED|Overall Study||1
2492401|NCT00847704|6110776|P1|COMPLETED|Overall Study||2
2492402|NCT00847704|6110776|P1|STARTED|Overall Study||3
2492403|NCT00847665|6110787|P2|NOT COMPLETED|Overall Study||0
2492404|NCT00847665|6110788|P1|NOT COMPLETED|Overall Study||1
2492405|NCT00847665|6110787|P2|COMPLETED|Overall Study||165
2492406|NCT00847665|6110788|P1|COMPLETED|Overall Study||164
2492407|NCT00847665|6110787|P2|STARTED|Overall Study||165
2492408|NCT00847665|6110788|P1|STARTED|Overall Study||165
2492409|NCT00847626|6110811|P11|NOT COMPLETED|Overall Study||20
2492410|NCT00847626|6110812|P10|NOT COMPLETED|Overall Study||14
2492411|NCT00847626|6110813|P9|NOT COMPLETED|Overall Study||14
2492412|NCT00847626|6110814|P8|NOT COMPLETED|Overall Study||19
2492413|NCT00847626|6110815|P7|NOT COMPLETED|Overall Study||22
2492414|NCT00847626|6110816|P6|NOT COMPLETED|Overall Study||37
2492415|NCT00847626|6110817|P5|NOT COMPLETED|Overall Study||28
2492416|NCT00847626|6110818|P4|NOT COMPLETED|Overall Study||31
2492417|NCT00847626|6110819|P3|NOT COMPLETED|Overall Study||16
2492418|NCT00847626|6110820|P2|NOT COMPLETED|Overall Study||23
2492419|NCT00847626|6110821|P1|NOT COMPLETED|Overall Study||21
2492420|NCT00847626|6110811|P11|COMPLETED|Overall Study||142
2492421|NCT00847626|6110812|P10|COMPLETED|Overall Study||139
2492422|NCT00847626|6110813|P9|COMPLETED|Overall Study||141
2492423|NCT00847626|6110814|P8|COMPLETED|Overall Study||141
2492424|NCT00847626|6110815|P7|COMPLETED|Overall Study||135
2492425|NCT00847626|6110816|P6|COMPLETED|Overall Study||125
2492426|NCT00847626|6110817|P5|COMPLETED|Overall Study||125
2492427|NCT00847626|6110818|P4|COMPLETED|Overall Study||125
2492428|NCT00847626|6110819|P3|COMPLETED|Overall Study||131
2492429|NCT00847626|6110820|P2|COMPLETED|Overall Study||131
2492430|NCT00847626|6110821|P1|COMPLETED|Overall Study||135
2492431|NCT00847626|6110811|P11|STARTED|Overall Study||162
2492432|NCT00847626|6110812|P10|STARTED|Overall Study||153
2492433|NCT00847626|6110813|P9|STARTED|Overall Study||155
2492434|NCT00847626|6110814|P8|STARTED|Overall Study|Includes participant who was treated with double-blind study medication but not randomized.|160
2492435|NCT00847626|6110815|P7|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|157
2492436|NCT00847626|6110816|P6|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|162
2492437|NCT00847626|6110817|P5|STARTED|Overall Study||153
2492438|NCT00847626|6110818|P4|STARTED|Overall Study||156
2492439|NCT00847626|6110819|P3|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|147
2492440|NCT00847626|6110820|P2|STARTED|Overall Study||154
2492441|NCT00847626|6110821|P1|STARTED|Overall Study||156
2492442|NCT00847613|6111020|P4|NOT COMPLETED|Overall Study||79
2492443|NCT00847613|6111021|P3|NOT COMPLETED|Overall Study||81
2492444|NCT00847613|6111022|P2|NOT COMPLETED|Overall Study||319
2492445|NCT00847613|6111023|P1|NOT COMPLETED|Overall Study||321
2492446|NCT00847613|6111020|P4|COMPLETED|Overall Study||0
2492447|NCT00847613|6111021|P3|COMPLETED|Overall Study||0
2492448|NCT00847613|6111022|P2|COMPLETED|Overall Study||0
2492449|NCT00847613|6111023|P1|COMPLETED|Overall Study||0
2492450|NCT00847613|6111020|P4|Treated|Overall Study||79
2492451|NCT00847613|6111021|P3|Treated|Overall Study||81
2492452|NCT00847613|6111022|P2|Treated|Overall Study||316
2492453|NCT00847613|6111023|P1|Treated|Overall Study||321
2492454|NCT00847613|6111020|P4|STARTED|Overall Study||79
2492455|NCT00847613|6111021|P3|STARTED|Overall Study||81
2492456|NCT00847613|6111022|P2|STARTED|Overall Study||319
2492457|NCT00847613|6111023|P1|STARTED|Overall Study||321
2492458|NCT00847587|6111263|P2|NOT COMPLETED|Overall Study||0
2492459|NCT00847587|6111264|P1|NOT COMPLETED|Overall Study||1
2492460|NCT00847587|6111263|P2|COMPLETED|Overall Study||34
2492461|NCT00847587|6111264|P1|COMPLETED|Overall Study|Patient declined study after randomization.|34
2492462|NCT00847587|6111263|P2|STARTED|Overall Study||34
2492463|NCT00847587|6111264|P1|STARTED|Overall Study||35
2492464|NCT00847561|6111274|P2|NOT COMPLETED|Overall Study||4
2492465|NCT00847561|6111275|P1|NOT COMPLETED|Overall Study||13
2492466|NCT00847561|6111274|P2|COMPLETED|Overall Study||62
2492467|NCT00847561|6111275|P1|COMPLETED|Overall Study||57
2492468|NCT00847561|6111274|P2|STARTED|Overall Study||66
2492469|NCT00847561|6111275|P1|STARTED|Overall Study||70
2492470|NCT00847535|6111281|P3|NOT COMPLETED|Overall Study||1
2492471|NCT00847535|6111282|P2|NOT COMPLETED|Overall Study||2
2492472|NCT00847535|6111283|P1|NOT COMPLETED|Overall Study||2
2492473|NCT00847535|6111281|P3|COMPLETED|Overall Study||15
2492474|NCT00847535|6111282|P2|COMPLETED|Overall Study||22
2492475|NCT00847535|6111283|P1|COMPLETED|Overall Study||22
2492476|NCT00847535|6111281|P3|200 Million AMDC|Overall Study||8
2492477|NCT00847535|6111282|P2|200 Million AMDC|Overall Study||0
2492478|NCT00847535|6111283|P1|200 Million AMDC|Overall Study||0
2492479|NCT00847535|6111281|P3|100 Million AMDC|Overall Study||8
2492480|NCT00847535|6111282|P2|100 Million AMDC|Overall Study||8
2492481|NCT00847535|6111283|P1|100 Million AMDC|Overall Study||8
2492482|NCT00847535|6111281|P3|50 Million AMDC|Overall Study||0
2492483|NCT00847535|6111282|P2|50 Million AMDC|Overall Study||8
2492484|NCT00847535|6111283|P1|50 Million AMDC|Overall Study||8
2492485|NCT00847535|6111281|P3|10 Million AMDC|Overall Study||0
2492486|NCT00847535|6111282|P2|10 Million AMDC|Overall Study||8
2492487|NCT00847535|6111283|P1|10 Million AMDC|Overall Study||8
2492488|NCT00847535|6111281|P3|STARTED|Overall Study||16
2492489|NCT00847535|6111282|P2|STARTED|Overall Study||24
2492490|NCT00847535|6111283|P1|STARTED|Overall Study||24
2492491|NCT00847522|6111291|P1|NOT COMPLETED|Overall Study||0
2492492|NCT00847522|6111291|P1|COMPLETED|Overall Study||90
2492493|NCT00847522|6111291|P1|Phase II|Overall Study||80
2492494|NCT00847522|6111291|P1|Phase I|Overall Study||10
2492495|NCT00847522|6111291|P1|STARTED|Overall Study||90
2492496|NCT00847509|6111296|P1|NOT COMPLETED|Overall Study||11
2492497|NCT00847509|6111296|P1|COMPLETED|Overall Study||38
2492498|NCT00847509|6111296|P1|STARTED|Overall Study||49
2492499|NCT00847405|6111302|P2|NOT COMPLETED|Second Intervention||0
2492500|NCT00847405|6111303|P1|NOT COMPLETED|Second Intervention||0
2492501|NCT00847405|6111302|P2|COMPLETED|Second Intervention||13
2492502|NCT00847405|6111303|P1|COMPLETED|Second Intervention||13
2492503|NCT00847405|6111302|P2|STARTED|Second Intervention||13
2492504|NCT00847405|6111303|P1|STARTED|Second Intervention||13
2492505|NCT00847405|6111302|P2|NOT COMPLETED|Washout of 7 Days||0
2492506|NCT00847405|6111303|P1|NOT COMPLETED|Washout of 7 Days||1
2492507|NCT00847405|6111302|P2|COMPLETED|Washout of 7 Days||13
2492508|NCT00847405|6111303|P1|COMPLETED|Washout of 7 Days||13
2492509|NCT00847405|6111302|P2|STARTED|Washout of 7 Days||13
2492510|NCT00847405|6111303|P1|STARTED|Washout of 7 Days||14
2492511|NCT00847405|6111302|P2|NOT COMPLETED|First Intervention||1
2492512|NCT00847405|6111303|P1|NOT COMPLETED|First Intervention||0
2492513|NCT00847405|6111302|P2|COMPLETED|First Intervention||13
2492514|NCT00847405|6111303|P1|COMPLETED|First Intervention||14
2492515|NCT00847405|6111302|P2|STARTED|First Intervention||14
2492516|NCT00847405|6111303|P1|STARTED|First Intervention||14
2492517|NCT00847301|6111311|P1|NOT COMPLETED|Overall Study||54
2492518|NCT00847301|6111311|P1|COMPLETED|Overall Study||374
2492519|NCT00847301|6111311|P1|STARTED|Overall Study||428
2492520|NCT00847288|6111321|P2|NOT COMPLETED|Overall Study||47
2492521|NCT00847288|6111322|P1|NOT COMPLETED|Overall Study||30
2492522|NCT00847288|6111321|P2|COMPLETED|Overall Study||780
2492523|NCT00847288|6111322|P1|COMPLETED|Overall Study||811
2492524|NCT00847288|6111321|P2|STARTED|Overall Study||827
2492525|NCT00847288|6111322|P1|STARTED|Overall Study||841
2492526|NCT00847210|6111336|P2|NOT COMPLETED|Overall Study||0
2492527|NCT00847210|6111337|P1|NOT COMPLETED|Overall Study||0
2492528|NCT00847210|6111336|P2|COMPLETED|Overall Study||18
2492529|NCT00847210|6111337|P1|COMPLETED|Overall Study||18
2492530|NCT00847210|6111336|P2|STARTED|Overall Study||18
2492531|NCT00847210|6111337|P1|STARTED|Overall Study||18
2492532|NCT00847197|6111359|P2|NOT COMPLETED|Overall Study||5
2492533|NCT00847197|6111360|P1|NOT COMPLETED|Overall Study||24
2492534|NCT00847197|6111359|P2|COMPLETED|Overall Study||70
2492535|NCT00847197|6111360|P1|COMPLETED|Overall Study||92
2492536|NCT00847197|6111359|P2|STARTED|Overall Study||75
2492537|NCT00847197|6111360|P1|STARTED|Overall Study||116
2492538|NCT00847171|6111370|P1|NOT COMPLETED|Overall Study||0
2492539|NCT00847171|6111370|P1|COMPLETED|Overall Study||20
2492540|NCT00847171|6111370|P1|STARTED|Overall Study||20
2492541|NCT00847145|6111384|P8|NOT COMPLETED|Overall Study||4
2492542|NCT00847145|6111385|P7|NOT COMPLETED|Overall Study||9
2492543|NCT00847145|6111386|P6|NOT COMPLETED|Overall Study||4
2492544|NCT00847145|6111387|P5|NOT COMPLETED|Overall Study||6
2492545|NCT00847145|6111388|P4|NOT COMPLETED|Overall Study||1
2492546|NCT00847145|6111389|P3|NOT COMPLETED|Overall Study||11
2492547|NCT00847145|6111390|P2|NOT COMPLETED|Overall Study||6
2492548|NCT00847145|6111391|P1|NOT COMPLETED|Overall Study||6
2492549|NCT00847145|6111384|P8|COMPLETED|Overall Study||136
2492550|NCT00847145|6111385|P7|COMPLETED|Overall Study||143
2492551|NCT00847145|6111386|P6|COMPLETED|Overall Study||152
2492552|NCT00847145|6111387|P5|COMPLETED|Overall Study||131
2492553|NCT00847145|6111388|P4|COMPLETED|Overall Study||116
2492554|NCT00847145|6111389|P3|COMPLETED|Overall Study||274
2492555|NCT00847145|6111390|P2|COMPLETED|Overall Study||627
2492556|NCT00847145|6111391|P1|COMPLETED|Overall Study||623
2492557|NCT00847145|6111384|P8|STARTED|Overall Study||140
2492558|NCT00847145|6111385|P7|STARTED|Overall Study||152
2492559|NCT00847145|6111386|P6|STARTED|Overall Study||156
2492560|NCT00847145|6111387|P5|STARTED|Overall Study||137
2492561|NCT00847145|6111388|P4|STARTED|Overall Study||117
2492562|NCT00847145|6111389|P3|STARTED|Overall Study||285
2492563|NCT00847145|6111390|P2|STARTED|Overall Study||633
2492564|NCT00847145|6111391|P1|STARTED|Overall Study||629
2492565|NCT00847132|6111441|P2|NOT COMPLETED|Overall Study||1
2492566|NCT00847132|6111442|P1|NOT COMPLETED|Overall Study||1
2492567|NCT00847132|6111441|P2|COMPLETED|Overall Study||84
2492568|NCT00847132|6111442|P1|COMPLETED|Overall Study||89
2492569|NCT00847132|6111441|P2|STARTED|Overall Study||85
2492570|NCT00847132|6111442|P1|STARTED|Overall Study||90
2492571|NCT00847015|6111450|P1|NOT COMPLETED|Overall Study||3
2492572|NCT00847015|6111450|P1|COMPLETED|Overall Study||15
2492573|NCT00847015|6111450|P1|STARTED|Overall Study||18
2492574|NCT00847002|6111458|P2|NOT COMPLETED|Overall Study||0
2492575|NCT00847002|6111459|P1|NOT COMPLETED|Overall Study||0
2492576|NCT00847002|6111458|P2|COMPLETED|Overall Study||4
2492577|NCT00847002|6111459|P1|COMPLETED|Overall Study||4
2492578|NCT00847002|6111458|P2|STARTED|Overall Study||4
2492579|NCT00847002|6111459|P1|STARTED|Overall Study||4
2492580|NCT00846885|6111469|P2|NOT COMPLETED|Second Intervention||0
2492581|NCT00846885|6111470|P1|NOT COMPLETED|Second Intervention||0
2492582|NCT00846885|6111469|P2|COMPLETED|Second Intervention||14
2492583|NCT00846885|6111470|P1|COMPLETED|Second Intervention||14
2492584|NCT00846885|6111469|P2|STARTED|Second Intervention||14
2492585|NCT00846885|6111470|P1|STARTED|Second Intervention||14
2492586|NCT00846885|6111469|P2|NOT COMPLETED|Washout of 7 Days||0
2492587|NCT00846885|6111470|P1|NOT COMPLETED|Washout of 7 Days||0
2492588|NCT00846885|6111469|P2|COMPLETED|Washout of 7 Days||14
2492589|NCT00846885|6111470|P1|COMPLETED|Washout of 7 Days||14
2492590|NCT00846885|6111469|P2|STARTED|Washout of 7 Days||14
2492591|NCT00846885|6111470|P1|STARTED|Washout of 7 Days||14
2492592|NCT00846885|6111469|P2|NOT COMPLETED|First Intervention||0
2492593|NCT00846885|6111470|P1|NOT COMPLETED|First Intervention||0
2492594|NCT00846885|6111469|P2|COMPLETED|First Intervention||14
2492595|NCT00846885|6111470|P1|COMPLETED|First Intervention||14
2492596|NCT00846885|6111469|P2|STARTED|First Intervention||14
2492597|NCT00846885|6111470|P1|STARTED|First Intervention||14
2492598|NCT00846846|6111478|P1|NOT COMPLETED|Overall Study||75
2492599|NCT00846846|6111478|P1|COMPLETED|Overall Study|Study ongoing but not recruiting participants.|943
2492600|NCT00846846|6111478|P1|STARTED|Overall Study||1018
2492601|NCT00846807|6111483|P1|NOT COMPLETED|Overall Study||632
2492602|NCT00846807|6111483|P1|COMPLETED|Overall Study|Completed treatment.|4660
2492603|NCT00846807|6111483|P1|STARTED|Overall Study|Entered and treated.|5292
2492604|NCT00846768|6111491|P4|NOT COMPLETED|Overall Study||0
2492605|NCT00846768|6111492|P3|NOT COMPLETED|Overall Study||0
2492606|NCT00846768|6111493|P2|NOT COMPLETED|Overall Study||1
2492607|NCT00846768|6111494|P1|NOT COMPLETED|Overall Study||0
2492608|NCT00846768|6111491|P4|COMPLETED|Overall Study||12
2492609|NCT00846768|6111492|P3|COMPLETED|Overall Study||12
2492610|NCT00846768|6111493|P2|COMPLETED|Overall Study||11
2492611|NCT00846768|6111494|P1|COMPLETED|Overall Study||11
2492612|NCT00846768|6111491|P4|STARTED|Overall Study||12
2492613|NCT00846768|6111492|P3|STARTED|Overall Study||12
2492614|NCT00846768|6111493|P2|STARTED|Overall Study||12
2492615|NCT00846768|6111494|P1|STARTED|Overall Study||11
2492621|NCT00846651|6111572|P2|NOT COMPLETED|Overall Study||4
2492622|NCT00846651|6111573|P1|NOT COMPLETED|Overall Study||4
2492623|NCT00846651|6111572|P2|COMPLETED|Overall Study||37
2492624|NCT00846651|6111573|P1|COMPLETED|Overall Study||37
2492625|NCT00846651|6111572|P2|STARTED|Overall Study||41
2492626|NCT00846651|6111573|P1|STARTED|Overall Study||41
2492627|NCT00846586|6111591|P2|NOT COMPLETED|Overall Study||35
2492628|NCT00846586|6111592|P1|NOT COMPLETED|Overall Study||39
2492629|NCT00846586|6111591|P2|COMPLETED|Overall Study||529
2492630|NCT00846586|6111592|P1|COMPLETED|Overall Study||531
2492631|NCT00846586|6111591|P2|Received Study Drug|Overall Study|Three patients were not exposed to study treatment in this group.|561
2492632|NCT00846586|6111592|P1|Received Study Drug|Overall Study||570
2492633|NCT00846586|6111591|P2|STARTED|Overall Study||564
2492634|NCT00846586|6111592|P1|STARTED|Overall Study||570
2492635|NCT00846573|6111611|P4|NOT COMPLETED|Overall Study||0
2492636|NCT00846573|6111612|P3|NOT COMPLETED|Overall Study||0
2492637|NCT00846573|6111613|P2|NOT COMPLETED|Overall Study||0
2492638|NCT00846573|6111614|P1|NOT COMPLETED|Overall Study||0
2492639|NCT00846573|6111611|P4|COMPLETED|Overall Study||0
2492640|NCT00846573|6111612|P3|COMPLETED|Overall Study||7
2492641|NCT00846573|6111613|P2|COMPLETED|Overall Study||2
2492642|NCT00846573|6111614|P1|COMPLETED|Overall Study||5
2492643|NCT00846573|6111611|P4|STARTED|Overall Study||0
2492644|NCT00846573|6111612|P3|STARTED|Overall Study||7
2492645|NCT00846573|6111613|P2|STARTED|Overall Study||2
2492646|NCT00846573|6111614|P1|STARTED|Overall Study||5
2492647|NCT00846547|6111622|P1|NOT COMPLETED|Overall Study||7
2492648|NCT00846547|6111622|P1|COMPLETED|Overall Study||25
2492649|NCT00846547|6111622|P1|STARTED|Overall Study||32
2492650|NCT00846521|6111626|P1|NOT COMPLETED|Overall Study||11
2492651|NCT00846521|6111626|P1|COMPLETED|Overall Study||12
2492652|NCT00846521|6111626|P1|STARTED|Overall Study||23
2492653|NCT00846495|6111633|P2|NOT COMPLETED|Overall Study||3
2492654|NCT00846495|6111634|P1|NOT COMPLETED|Overall Study||8
2492655|NCT00846495|6111633|P2|COMPLETED|Overall Study||24
2492656|NCT00846495|6111634|P1|COMPLETED|Overall Study||20
2492657|NCT00846495|6111633|P2|STARTED|Overall Study||27
2492658|NCT00846495|6111634|P1|STARTED|Overall Study||28
2492659|NCT00846391|6111657|P3|NOT COMPLETED|Overall Study||3
2492660|NCT00846391|6111658|P2|NOT COMPLETED|Overall Study||2
2492661|NCT00846391|6111659|P1|NOT COMPLETED|Overall Study||1
2492662|NCT00846391|6111657|P3|COMPLETED|Overall Study||3
2492663|NCT00846391|6111658|P2|COMPLETED|Overall Study||2
2492664|NCT00846391|6111659|P1|COMPLETED|Overall Study||3
2492665|NCT00846391|6111657|P3|STARTED|Overall Study||6
2492666|NCT00846391|6111658|P2|STARTED|Overall Study||4
2492667|NCT00846391|6111659|P1|STARTED|Overall Study||4
2492668|NCT00846365|6111670|P3|NOT COMPLETED|Overall Study||33
2492669|NCT00846365|6111671|P2|NOT COMPLETED|Overall Study||49
2492670|NCT00846365|6111672|P1|NOT COMPLETED|Overall Study||55
2492671|NCT00846365|6111670|P3|COMPLETED|Overall Study||323
2492672|NCT00846365|6111671|P2|COMPLETED|Overall Study||308
2492673|NCT00846365|6111672|P1|COMPLETED|Overall Study||317
2492674|NCT00846365|6111670|P3|STARTED|Overall Study||356
2492675|NCT00846365|6111671|P2|STARTED|Overall Study||357
2492676|NCT00846365|6111672|P1|STARTED|Overall Study||372
2492677|NCT00846287|6111727|P2|NOT COMPLETED|Overall Study||5
2492678|NCT00846287|6111728|P1|NOT COMPLETED|Overall Study||10
2492679|NCT00846287|6111727|P2|COMPLETED|Overall Study||10
2492680|NCT00846287|6111728|P1|COMPLETED|Overall Study||6
2492681|NCT00846287|6111727|P2|STARTED|Overall Study||15
2492682|NCT00846287|6111728|P1|STARTED|Overall Study||16
2492683|NCT00846066|6111738|P2|NOT COMPLETED|Overall Study||0
2492684|NCT00846066|6111739|P1|NOT COMPLETED|Overall Study||0
2492685|NCT00846066|6111738|P2|COMPLETED|Overall Study||29
2492686|NCT00846066|6111739|P1|COMPLETED|Overall Study||27
2492687|NCT00846066|6111738|P2|STARTED|Overall Study||29
2492688|NCT00846066|6111739|P1|STARTED|Overall Study||27
2492689|NCT00846053|6111753|P2|NOT COMPLETED|Overall Study||0
2492690|NCT00846053|6111754|P1|NOT COMPLETED|Overall Study||3
2492691|NCT00846053|6111753|P2|COMPLETED|Overall Study||8
2492692|NCT00846053|6111754|P1|COMPLETED|Overall Study|No milestones. Enrollment continued until end of study. 21 subjects enrolled.|10
2492693|NCT00846053|6111753|P2|STARTED|Overall Study||8
2492694|NCT00846053|6111754|P1|STARTED|Overall Study|No milestones. Enrollment continued until end of study.|13
2492695|NCT00846027|6111762|P1|NOT COMPLETED|Overall Study||90
2492696|NCT00846027|6111762|P1|COMPLETED|Overall Study||0
2492697|NCT00846027|6111762|P1|Received Treatment|Overall Study||83
2492698|NCT00846027|6111762|P1|STARTED|Overall Study||90
2492699|NCT00845975|6111771|P2|NOT COMPLETED|Overall Study||0
2492700|NCT00845975|6111772|P1|NOT COMPLETED|Overall Study||0
2492701|NCT00845975|6111771|P2|COMPLETED|Overall Study||9
2492702|NCT00845975|6111772|P1|COMPLETED|Overall Study||9
2492703|NCT00845975|6111771|P2|STARTED|Overall Study||9
2492704|NCT00845975|6111772|P1|STARTED|Overall Study||9
2492705|NCT00845897|6111785|P3|NOT COMPLETED|Overall Study||3
2492706|NCT00845897|6111786|P2|NOT COMPLETED|Overall Study||5
2492707|NCT00845897|6111787|P1|NOT COMPLETED|Overall Study||2
2492708|NCT00845897|6111785|P3|COMPLETED|Overall Study||2
2492709|NCT00845897|6111786|P2|COMPLETED|Overall Study||2
2492710|NCT00845897|6111787|P1|COMPLETED|Overall Study||3
2492711|NCT00845897|6111785|P3|STARTED|Overall Study||5
2492712|NCT00845897|6111786|P2|STARTED|Overall Study||7
2492713|NCT00845897|6111787|P1|STARTED|Overall Study||5
2492714|NCT00845858|6111801|P3|NOT COMPLETED|Overall Study||8
2492715|NCT00845858|6111802|P2|NOT COMPLETED|Overall Study||12
2492716|NCT00845858|6111803|P1|NOT COMPLETED|Overall Study||8
2492717|NCT00845858|6111801|P3|COMPLETED|Overall Study||87
2492718|NCT00845858|6111802|P2|COMPLETED|Overall Study||84
2492719|NCT00845858|6111803|P1|COMPLETED|Overall Study||88
2492720|NCT00845858|6111801|P3|STARTED|Overall Study||95
2492721|NCT00845858|6111802|P2|STARTED|Overall Study|"95 subjects received allocated intervention.~1 subject was not eligible and was not dosed."|96
2492722|NCT00845858|6111803|P1|STARTED|Overall Study|"95 subjects received allocated intervention.~1 subject withdrew consent and was not dosed."|96
2492723|NCT00845845|6111816|P2|NOT COMPLETED|Overall Study||4
2492724|NCT00845845|6111817|P1|NOT COMPLETED|Overall Study||0
2492725|NCT00845845|6111816|P2|COMPLETED|Overall Study||2
2492726|NCT00845845|6111817|P1|COMPLETED|Overall Study||3
2492727|NCT00845845|6111816|P2|STARTED|Overall Study||6
2492728|NCT00845845|6111817|P1|STARTED|Overall Study||3
2492729|NCT00845832|6111828|P3|NOT COMPLETED|Extended Safety Follow-Up||7
2492730|NCT00845832|6111829|P2|NOT COMPLETED|Extended Safety Follow-Up||0
2492731|NCT00845832|6111830|P1|NOT COMPLETED|Extended Safety Follow-Up||0
2492732|NCT00845832|6111828|P3|COMPLETED|Extended Safety Follow-Up||0
2492733|NCT00845832|6111829|P2|COMPLETED|Extended Safety Follow-Up||5
2492734|NCT00845832|6111830|P1|COMPLETED|Extended Safety Follow-Up||2
2492735|NCT00845832|6111828|P3|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|7
2492736|NCT00845832|6111829|P2|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|5
2492737|NCT00845832|6111830|P1|STARTED|Extended Safety Follow-Up||2
2492738|NCT00845832|6111828|P3|NOT COMPLETED|Safety Follow-Up||0
2492739|NCT00845832|6111829|P2|NOT COMPLETED|Safety Follow-Up||0
2492740|NCT00845832|6111830|P1|NOT COMPLETED|Safety Follow-Up||1
2492741|NCT00845832|6111828|P3|COMPLETED|Safety Follow-Up||12
2492742|NCT00845832|6111829|P2|COMPLETED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|9
2492743|NCT00845832|6111830|P1|COMPLETED|Safety Follow-Up||2
2492744|NCT00845832|6111828|P3|STARTED|Safety Follow-Up|One participant each from the placebo and TCZ (2 mg/kg) groups were re-assigned to this group.|12
2492745|NCT00845832|6111829|P2|STARTED|Safety Follow-Up|All participants who withdrew from study were asked to return for safety follow-up.|9
2492746|NCT00845832|6111830|P1|STARTED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|3
2492747|NCT00845832|6111828|P3|NOT COMPLETED|Treatment Period||0
2492748|NCT00845832|6111829|P2|NOT COMPLETED|Treatment Period||3
2492749|NCT00845832|6111830|P1|NOT COMPLETED|Treatment Period||1
2492750|NCT00845832|6111828|P3|COMPLETED|Treatment Period||10
2492751|NCT00845832|6111829|P2|COMPLETED|Treatment Period||7
2492752|NCT00845832|6111830|P1|COMPLETED|Treatment Period||3
2492753|NCT00845832|6111828|P3|STARTED|Treatment Period||10
2492754|NCT00845832|6111829|P2|STARTED|Treatment Period||10
2492755|NCT00845832|6111830|P1|STARTED|Treatment Period||4
2492756|NCT00845728|6111876|P2|NOT COMPLETED|Overall Study||342
2492757|NCT00845728|6111877|P1|NOT COMPLETED|Overall Study||386
2492758|NCT00845728|6111876|P2|COMPLETED|Overall Study||1379
2492759|NCT00845728|6111877|P1|COMPLETED|Overall Study||1337
2492760|NCT00845728|6111876|P2|Exposed|Overall Study||1718
2492761|NCT00845728|6111877|P1|Exposed|Overall Study||1721
2492762|NCT00845728|6111876|P2|STARTED|Overall Study||1721
2492763|NCT00845728|6111877|P1|STARTED|Overall Study||1723
2492764|NCT00845702|6111885|P1|NOT COMPLETED|Dotarem MRA||0
2492765|NCT00845702|6111885|P1|COMPLETED|Dotarem MRA||32
2492766|NCT00845702|6111885|P1|STARTED|Dotarem MRA||32
2492767|NCT00845702|6111885|P1|NOT COMPLETED|TOF MRA||1
2492768|NCT00845702|6111885|P1|COMPLETED|TOF MRA|One patient did not perform study MRA procedures.|32
2492769|NCT00845702|6111885|P1|STARTED|TOF MRA||33
2492770|NCT00845676|6111891|P1|NOT COMPLETED|Overall Study||2
2492771|NCT00845676|6111891|P1|COMPLETED|Overall Study||19
2492772|NCT00845676|6111891|P1|STARTED|Overall Study||21
2492773|NCT00845663|6111897|P2|NOT COMPLETED|Overall Study||0
2492774|NCT00845663|6111898|P1|NOT COMPLETED|Overall Study||0
2492775|NCT00845663|6111897|P2|COMPLETED|Overall Study||49
2492776|NCT00845663|6111898|P1|COMPLETED|Overall Study||49
2492777|NCT00845663|6111897|P2|STARTED|Overall Study||49
2492778|NCT00845663|6111898|P1|STARTED|Overall Study||49
2492779|NCT00845650|6111952|P6|NOT COMPLETED|Overall Study||2
2492780|NCT00845650|6111953|P5|NOT COMPLETED|Overall Study||3
2492781|NCT00845650|6111954|P4|NOT COMPLETED|Overall Study||1
2492782|NCT00845650|6111955|P3|NOT COMPLETED|Overall Study||3
2492783|NCT00845650|6111956|P2|NOT COMPLETED|Overall Study||0
2492784|NCT00845650|6111957|P1|NOT COMPLETED|Overall Study||1
2492785|NCT00845650|6111952|P6|COMPLETED|Overall Study||15
2492786|NCT00845650|6111953|P5|COMPLETED|Overall Study||28
2492787|NCT00845650|6111954|P4|COMPLETED|Overall Study||13
2492788|NCT00845650|6111955|P3|COMPLETED|Overall Study||28
2492789|NCT00845650|6111956|P2|COMPLETED|Overall Study||5
2492790|NCT00845650|6111957|P1|COMPLETED|Overall Study||30
2492791|NCT00845650|6111952|P6|STARTED|Overall Study|1 subject not dosed|17
2492792|NCT00845650|6111953|P5|STARTED|Overall Study|2 subjects not dosed|31
2492793|NCT00845650|6111954|P4|STARTED|Overall Study||14
2492794|NCT00845650|6111955|P3|STARTED|Overall Study||31
2492795|NCT00845650|6111956|P2|STARTED|Overall Study||5
2492796|NCT00845650|6111957|P1|STARTED|Overall Study|1 subject not dosed|31
2492797|NCT00845520|6111995|P3|NOT COMPLETED|Overall Study||1
2492798|NCT00845520|6111996|P2|NOT COMPLETED|Overall Study||2
2492799|NCT00845520|6111997|P1|NOT COMPLETED|Overall Study||2
2492800|NCT00845520|6111995|P3|COMPLETED|Overall Study||23
2492801|NCT00845520|6111996|P2|COMPLETED|Overall Study||23
2492802|NCT00845520|6111997|P1|COMPLETED|Overall Study||23
2492803|NCT00845520|6111995|P3|STARTED|Overall Study||24
2492804|NCT00845520|6111996|P2|STARTED|Overall Study||25
2492805|NCT00845520|6111997|P1|STARTED|Overall Study||25
2492806|NCT00845507|6112013|P2|NOT COMPLETED|Overall Study||1
2492807|NCT00845507|6112014|P1|NOT COMPLETED|Overall Study||2
2492808|NCT00845507|6112013|P2|COMPLETED|Overall Study||29
2492809|NCT00845507|6112014|P1|COMPLETED|Overall Study||22
2492810|NCT00845507|6112013|P2|STARTED|Overall Study||30
2492811|NCT00845507|6112014|P1|STARTED|Overall Study||24
2492812|NCT00845481|6112022|P1|NOT COMPLETED|Overall Study||0
2492813|NCT00845481|6112022|P1|COMPLETED|Overall Study||24
2492814|NCT00845481|6112022|P1|STARTED|Overall Study||24
2492815|NCT00845429|6112034|P3|NOT COMPLETED|Overall Study||20
2492816|NCT00845429|6112035|P2|NOT COMPLETED|Overall Study||15
2492817|NCT00845429|6112036|P1|NOT COMPLETED|Overall Study||14
2492818|NCT00845429|6112034|P3|COMPLETED|Overall Study||224
2492819|NCT00845429|6112035|P2|COMPLETED|Overall Study||226
2492820|NCT00845429|6112036|P1|COMPLETED|Overall Study||230
2492821|NCT00845429|6112034|P3|STARTED|Overall Study||244
2492822|NCT00845429|6112035|P2|STARTED|Overall Study||241
2492823|NCT00845429|6112036|P1|STARTED|Overall Study||244
2492824|NCT00845195|6112055|P2|NOT COMPLETED|Overall Study||0
2492825|NCT00845195|6112056|P1|NOT COMPLETED|Overall Study||0
2492826|NCT00845195|6112055|P2|COMPLETED|Overall Study||75
2492827|NCT00845195|6112056|P1|COMPLETED|Overall Study||75
2492828|NCT00845195|6112055|P2|STARTED|Overall Study||75
2492829|NCT00845195|6112056|P1|STARTED|Overall Study||75
2492830|NCT00845182|6112071|P3|NOT COMPLETED|Overall Study||6
2492831|NCT00845182|6112072|P2|NOT COMPLETED|Overall Study||4
2492832|NCT00845182|6112073|P1|NOT COMPLETED|Overall Study||3
2492833|NCT00845182|6112071|P3|COMPLETED|Overall Study||9
2492834|NCT00845182|6112072|P2|COMPLETED|Overall Study||11
2492835|NCT00845182|6112073|P1|COMPLETED|Overall Study||10
2492836|NCT00845182|6112071|P3|STARTED|Overall Study||15
2492837|NCT00845182|6112072|P2|STARTED|Overall Study||15
2492838|NCT00845182|6112073|P1|STARTED|Overall Study||13
2492839|NCT00845130|6112087|P2|NOT COMPLETED|Overall Study||3
2492840|NCT00845130|6112088|P1|NOT COMPLETED|Overall Study||4
2492841|NCT00845130|6112087|P2|COMPLETED|Overall Study||19
2492842|NCT00845130|6112088|P1|COMPLETED|Overall Study||16
2492843|NCT00845130|6112087|P2|STARTED|Overall Study||22
2492844|NCT00845130|6112088|P1|STARTED|Overall Study||20
2492845|NCT00845065|6112098|P2|NOT COMPLETED|Overall Study||55
2492846|NCT00845065|6112099|P1|NOT COMPLETED|Overall Study||47
2492847|NCT00845065|6112098|P2|COMPLETED|Overall Study||79
2492848|NCT00845065|6112099|P1|COMPLETED|Overall Study||20
2492849|NCT00845065|6112098|P2|STARTED|Overall Study||134
2492850|NCT00845065|6112099|P1|STARTED|Overall Study||67
2492851|NCT00845039|6112115|P2|NOT COMPLETED|Overall Study||0
2492852|NCT00845039|6112116|P1|NOT COMPLETED|Overall Study||0
2492853|NCT00845039|6112115|P2|COMPLETED|Overall Study||2
2492854|NCT00845039|6112116|P1|COMPLETED|Overall Study||2
2492855|NCT00845039|6112115|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
2492856|NCT00845039|6112116|P1|Received at Least 1 Dose of Study Drug|Overall Study||2
2492857|NCT00845039|6112115|P2|STARTED|Overall Study||2
2492858|NCT00845039|6112116|P1|STARTED|Overall Study||2
2492859|NCT00845000|6112143|P6|NOT COMPLETED|Period 3||0
2492860|NCT00845000|6112144|P5|NOT COMPLETED|Period 3||0
2492861|NCT00845000|6112145|P4|NOT COMPLETED|Period 3||0
2492862|NCT00845000|6112146|P3|NOT COMPLETED|Period 3||0
2492863|NCT00845000|6112147|P2|NOT COMPLETED|Period 3||0
2492864|NCT00845000|6112148|P1|NOT COMPLETED|Period 3||0
2492865|NCT00845000|6112143|P6|COMPLETED|Period 3||2
2492866|NCT00845000|6112144|P5|COMPLETED|Period 3||2
2492867|NCT00845000|6112145|P4|COMPLETED|Period 3||2
2492868|NCT00845000|6112146|P3|COMPLETED|Period 3||2
2492869|NCT00845000|6112147|P2|COMPLETED|Period 3||2
2492870|NCT00845000|6112148|P1|COMPLETED|Period 3||2
2492871|NCT00845000|6112143|P6|STARTED|Period 3||2
2492872|NCT00845000|6112144|P5|STARTED|Period 3||2
2492873|NCT00845000|6112145|P4|STARTED|Period 3||2
2492874|NCT00845000|6112146|P3|STARTED|Period 3||2
2492875|NCT00845000|6112147|P2|STARTED|Period 3||2
2492876|NCT00845000|6112148|P1|STARTED|Period 3||2
2492877|NCT00845000|6112143|P6|NOT COMPLETED|Period 2||0
2492878|NCT00845000|6112144|P5|NOT COMPLETED|Period 2||0
2492879|NCT00845000|6112145|P4|NOT COMPLETED|Period 2||0
2492880|NCT00845000|6112146|P3|NOT COMPLETED|Period 2||0
2492881|NCT00845000|6112147|P2|NOT COMPLETED|Period 2||0
2492882|NCT00845000|6112148|P1|NOT COMPLETED|Period 2||0
2492883|NCT00845000|6112143|P6|COMPLETED|Period 2||2
2492884|NCT00845000|6112144|P5|COMPLETED|Period 2||2
2492885|NCT00845000|6112145|P4|COMPLETED|Period 2||2
2492886|NCT00845000|6112146|P3|COMPLETED|Period 2||2
2492887|NCT00845000|6112147|P2|COMPLETED|Period 2||2
2492888|NCT00845000|6112148|P1|COMPLETED|Period 2||2
2492889|NCT00845000|6112143|P6|STARTED|Period 2||2
2492890|NCT00845000|6112144|P5|STARTED|Period 2||2
2492891|NCT00845000|6112145|P4|STARTED|Period 2||2
2492892|NCT00845000|6112146|P3|STARTED|Period 2||2
2492893|NCT00845000|6112147|P2|STARTED|Period 2||2
2492894|NCT00845000|6112148|P1|STARTED|Period 2||2
2492895|NCT00845000|6112143|P6|NOT COMPLETED|Period 1||0
2492896|NCT00845000|6112144|P5|NOT COMPLETED|Period 1||0
2492897|NCT00845000|6112145|P4|NOT COMPLETED|Period 1||0
2492898|NCT00845000|6112146|P3|NOT COMPLETED|Period 1||0
2492899|NCT00845000|6112147|P2|NOT COMPLETED|Period 1||0
2492900|NCT00845000|6112148|P1|NOT COMPLETED|Period 1||0
2492901|NCT00845000|6112143|P6|COMPLETED|Period 1||2
2492902|NCT00845000|6112144|P5|COMPLETED|Period 1||2
2492903|NCT00845000|6112145|P4|COMPLETED|Period 1||2
2492904|NCT00845000|6112146|P3|COMPLETED|Period 1||2
2492905|NCT00845000|6112147|P2|COMPLETED|Period 1||2
2492906|NCT00845000|6112148|P1|COMPLETED|Period 1||2
2492907|NCT00845000|6112143|P6|STARTED|Period 1||2
2492908|NCT00845000|6112144|P5|STARTED|Period 1||2
2492909|NCT00845000|6112145|P4|STARTED|Period 1||2
2492910|NCT00845000|6112146|P3|STARTED|Period 1||2
2492911|NCT00845000|6112147|P2|STARTED|Period 1||2
2492912|NCT00845000|6112148|P1|STARTED|Period 1||2
2492913|NCT00844896|6112167|P2|NOT COMPLETED|Overall Study||17
2492914|NCT00844896|6112168|P1|NOT COMPLETED|Overall Study||12
2492915|NCT00844896|6112167|P2|COMPLETED|Overall Study||11
2492916|NCT00844896|6112168|P1|COMPLETED|Overall Study||17
2492917|NCT00844896|6112167|P2|STARTED|Overall Study||28
2492918|NCT00844896|6112168|P1|STARTED|Overall Study||29
2492919|NCT00844883|6112190|P1|NOT COMPLETED|Overall Study||4
2492920|NCT00844883|6112190|P1|COMPLETED|Overall Study||46
2492921|NCT00844883|6112190|P1|Patients Who Received TACE|Overall Study|2 patients withdrawn at Week 1 prior to TACE for intolerance to sorafenib|48
2492922|NCT00844883|6112190|P1|STARTED|Overall Study||50
2492923|NCT00844857|6112202|P2|NOT COMPLETED|Overall Study||37
2492924|NCT00844857|6112203|P1|NOT COMPLETED|Overall Study||78
2492925|NCT00844857|6112202|P2|COMPLETED|Overall Study||60
2492926|NCT00844857|6112203|P1|COMPLETED|Overall Study||116
2492927|NCT00844857|6112202|P2|Population Analyzed|Overall Study|randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|85
2492928|NCT00844857|6112203|P1|Population Analyzed|Overall Study|Randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|170
2492929|NCT00844857|6112202|P2|STARTED|Overall Study||97
2492930|NCT00844857|6112203|P1|STARTED|Overall Study||194
2492931|NCT00844844|6112247|P1|NOT COMPLETED|Post Treatment Period||1
2492932|NCT00844844|6112247|P1|COMPLETED|Post Treatment Period||5
2492933|NCT00844844|6112247|P1|STARTED|Post Treatment Period||6
2492934|NCT00844844|6112247|P1|NOT COMPLETED|Extension Treatment Period||2
2492935|NCT00844844|6112247|P1|COMPLETED|Extension Treatment Period||11
2492936|NCT00844844|6112247|P1|STARTED|Extension Treatment Period||13
2492937|NCT00844844|6112247|P1|NOT COMPLETED|Treatment Period (26 Weeks)||2
2492938|NCT00844844|6112247|P1|COMPLETED|Treatment Period (26 Weeks)||15
2492939|NCT00844844|6112247|P1|STARTED|Treatment Period (26 Weeks)||17
2492940|NCT00844844|6112247|P1|NOT COMPLETED|Screening Period||0
2492941|NCT00844844|6112247|P1|COMPLETED|Screening Period||17
2492942|NCT00844844|6112247|P1|STARTED|Screening Period||17
2492943|NCT00844831|6112261|P1|NOT COMPLETED|Overall Study||6
2492944|NCT00844831|6112261|P1|COMPLETED|Overall Study||19
2492945|NCT00844831|6112261|P1|STARTED|Overall Study||25
2492946|NCT00844805|6112271|P4|NOT COMPLETED|Follow-Up Phase||9
2492947|NCT00844805|6112272|P3|NOT COMPLETED|Follow-Up Phase||9
2492948|NCT00844805|6112273|P2|NOT COMPLETED|Follow-Up Phase||0
2492949|NCT00844805|6112274|P1|NOT COMPLETED|Follow-Up Phase||0
2492950|NCT00844805|6112271|P4|COMPLETED|Follow-Up Phase||32
2492951|NCT00844805|6112272|P3|COMPLETED|Follow-Up Phase||32
2492952|NCT00844805|6112273|P2|COMPLETED|Follow-Up Phase||0
2492953|NCT00844805|6112274|P1|COMPLETED|Follow-Up Phase||0
2492954|NCT00844805|6112271|P4|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
2492955|NCT00844805|6112272|P3|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
2492956|NCT00844805|6112273|P2|STARTED|Follow-Up Phase||0
2492957|NCT00844805|6112274|P1|STARTED|Follow-Up Phase||0
2492958|NCT00844805|6112271|P4|NOT COMPLETED|Treatment Phase||0
2492959|NCT00844805|6112272|P3|NOT COMPLETED|Treatment Phase||0
2492960|NCT00844805|6112273|P2|NOT COMPLETED|Treatment Phase||7
2492961|NCT00844805|6112274|P1|NOT COMPLETED|Treatment Phase||10
2492962|NCT00844805|6112271|P4|COMPLETED|Treatment Phase||0
2492963|NCT00844805|6112272|P3|COMPLETED|Treatment Phase||0
2492964|NCT00844805|6112273|P2|COMPLETED|Treatment Phase||45
2492965|NCT00844805|6112274|P1|COMPLETED|Treatment Phase||96
2492966|NCT00844805|6112271|P4|STARTED|Treatment Phase||0
2492967|NCT00844805|6112272|P3|STARTED|Treatment Phase||0
2492968|NCT00844805|6112273|P2|STARTED|Treatment Phase||52
2492969|NCT00844805|6112274|P1|STARTED|Treatment Phase||106
2492970|NCT00844753|6112318|P4|NOT COMPLETED|Overall Study||11
2492971|NCT00844753|6112319|P3|NOT COMPLETED|Overall Study||7
2492972|NCT00844753|6112320|P2|NOT COMPLETED|Overall Study||3
2492973|NCT00844753|6112321|P1|NOT COMPLETED|Overall Study||8
2492974|NCT00844753|6112318|P4|COMPLETED|Overall Study||21
2492975|NCT00844753|6112319|P3|COMPLETED|Overall Study||25
2492976|NCT00844753|6112320|P2|COMPLETED|Overall Study||29
2492977|NCT00844753|6112321|P1|COMPLETED|Overall Study||24
2492978|NCT00844753|6112318|P4|STARTED|Overall Study||32
2492979|NCT00844753|6112319|P3|STARTED|Overall Study||32
2492980|NCT00844753|6112320|P2|STARTED|Overall Study||32
2492981|NCT00844753|6112321|P1|STARTED|Overall Study||32
2492982|NCT00844714|6112333|P1|NOT COMPLETED|Overall Study||0
2492983|NCT00844714|6112333|P1|COMPLETED|Overall Study||20
2492984|NCT00844714|6112333|P1|STARTED|Overall Study||20
2492985|NCT00844649|6112339|P2|NOT COMPLETED|Overall Study||418
2492986|NCT00844649|6112340|P1|NOT COMPLETED|Overall Study||405
2492987|NCT00844649|6112339|P2|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|12
2492988|NCT00844649|6112340|P1|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|26
2492989|NCT00844649|6112339|P2|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|402
2492990|NCT00844649|6112340|P1|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|421
2492991|NCT00844649|6112339|P2|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|430
2492992|NCT00844649|6112340|P1|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|431
2492993|NCT00844597|6112364|P6|NOT COMPLETED|Overall Study||0
2492994|NCT00844597|6112365|P5|NOT COMPLETED|Overall Study||0
2492995|NCT00844597|6112366|P4|NOT COMPLETED|Overall Study||1
2492996|NCT00844597|6112367|P3|NOT COMPLETED|Overall Study||0
2492997|NCT00844597|6112368|P2|NOT COMPLETED|Overall Study||0
2492998|NCT00844597|6112369|P1|NOT COMPLETED|Overall Study||0
2492999|NCT00844597|6112364|P6|COMPLETED|Overall Study||4
2493000|NCT00844597|6112365|P5|COMPLETED|Overall Study||4
2493001|NCT00844597|6112366|P4|COMPLETED|Overall Study||2
2493002|NCT00844597|6112367|P3|COMPLETED|Overall Study||2
2493003|NCT00844597|6112368|P2|COMPLETED|Overall Study||2
2493004|NCT00844597|6112369|P1|COMPLETED|Overall Study||4
2493005|NCT00844597|6112364|P6|STARTED|Overall Study||4
2493006|NCT00844597|6112365|P5|STARTED|Overall Study||4
2493007|NCT00844597|6112366|P4|STARTED|Overall Study||3
2493008|NCT00844597|6112367|P3|STARTED|Overall Study||2
2493009|NCT00844597|6112368|P2|STARTED|Overall Study||2
2493010|NCT00844597|6112369|P1|STARTED|Overall Study||4
2493011|NCT00844558|6112389|P2|NOT COMPLETED|Overall Study||4
2493012|NCT00844558|6112390|P1|NOT COMPLETED|Overall Study||12
2493013|NCT00844558|6112389|P2|COMPLETED|Overall Study||18
2493014|NCT00844558|6112390|P1|COMPLETED|Overall Study||24
2493015|NCT00844558|6112389|P2|12 Month Visit|Overall Study|-Discontinued intervention (n=0)|18
2493016|NCT00844558|6112390|P1|12 Month Visit|Overall Study|Discontinued intervention (n=4)|24
2493017|NCT00844558|6112389|P2|6 Month Visit|Overall Study|-Discontinued intervention (n=1)|18
2493018|NCT00844558|6112390|P1|6 Month Visit|Overall Study|Discontinued intervention (n=1)|28
2493019|NCT00844558|6112389|P2|3 Month Visit|Overall Study|"Lost to follow-up (n=1)~Discontinued Intervention (n=1)"|19
2493020|NCT00844558|6112390|P1|3 Month Visit|Overall Study|Discontinued intervention (n=4)|29
2493021|NCT00844558|6112389|P2|Received Allocated Intervention|Overall Study||21
2493022|NCT00844558|6112390|P1|Received Allocated Intervention|Overall Study||33
2493023|NCT00844558|6112389|P2|STARTED|Overall Study|"Received allocated intervention (n=21)~Did not receive allocated intervention (n=1)"|22
2493024|NCT00844558|6112390|P1|STARTED|Overall Study|"Received allocated intervention (n=33)~Did not receive allocated intervention (n=3)"|36
2493025|NCT00844545|6112406|P1|NOT COMPLETED|Post Treatment Period||1
2493026|NCT00844545|6112406|P1|COMPLETED|Post Treatment Period||5
2493027|NCT00844545|6112406|P1|STARTED|Post Treatment Period||6
2493028|NCT00844545|6112406|P1|NOT COMPLETED|Extension Treatment Period||2
2493029|NCT00844545|6112406|P1|COMPLETED|Extension Treatment Period||11
2493030|NCT00844545|6112406|P1|STARTED|Extension Treatment Period||13
2493031|NCT00844545|6112406|P1|NOT COMPLETED|Treatment Period (26 Weeks)||2
2493032|NCT00844545|6112406|P1|COMPLETED|Treatment Period (26 Weeks)||15
2493033|NCT00844545|6112406|P1|STARTED|Treatment Period (26 Weeks)||17
2493034|NCT00844545|6112406|P1|NOT COMPLETED|Screening Period||0
2493035|NCT00844545|6112406|P1|COMPLETED|Screening Period||17
2493036|NCT00844545|6112406|P1|STARTED|Screening Period||17
2493037|NCT00844532|6112420|P1|NOT COMPLETED|Overall Study||39
2493038|NCT00844532|6112420|P1|COMPLETED|Overall Study||112
2493039|NCT00844532|6112420|P1|STARTED|Overall Study||151
2493040|NCT00844519|6112506|P2|NOT COMPLETED|Overall Study||1
2493041|NCT00844519|6112507|P1|NOT COMPLETED|Overall Study||2
2493042|NCT00844519|6112506|P2|COMPLETED|Overall Study||25
2493043|NCT00844519|6112507|P1|COMPLETED|Overall Study||24
2493044|NCT00844519|6112506|P2|STARTED|Overall Study||26
2493045|NCT00844519|6112507|P1|STARTED|Overall Study||26
2493046|NCT00844480|6112515|P2|NOT COMPLETED|Overall Study||3
2493047|NCT00844480|6112516|P1|NOT COMPLETED|Overall Study||2
2493048|NCT00844480|6112515|P2|COMPLETED|Overall Study||6
2493049|NCT00844480|6112516|P1|COMPLETED|Overall Study||6
2493050|NCT00844480|6112515|P2|STARTED|Overall Study||9
2493051|NCT00844480|6112516|P1|STARTED|Overall Study||8
2493052|NCT00844428|6112524|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
2493053|NCT00844428|6112524|P1|COMPLETED|Post Treatment Period (Patients Who Disc||4
2493054|NCT00844428|6112524|P1|STARTED|Post Treatment Period (Patients Who Disc||5
2493055|NCT00844428|6112524|P1|NOT COMPLETED|Extension Treatment Period||1
2493056|NCT00844428|6112524|P1|COMPLETED|Extension Treatment Period||18
2493057|NCT00844428|6112524|P1|STARTED|Extension Treatment Period||19
2493058|NCT00844428|6112524|P1|NOT COMPLETED|Treatment Period (26 Weeks)||0
2493059|NCT00844428|6112524|P1|COMPLETED|Treatment Period (26 Weeks)||20
2493060|NCT00844428|6112524|P1|STARTED|Treatment Period (26 Weeks)||20
2493061|NCT00844428|6112524|P1|NOT COMPLETED|Observation Period (8 Weeks)||0
2493062|NCT00844428|6112524|P1|COMPLETED|Observation Period (8 Weeks)||20
2493063|NCT00844428|6112524|P1|STARTED|Observation Period (8 Weeks)||20
2493064|NCT00844428|6112524|P1|NOT COMPLETED|Screening Period||3
2493065|NCT00844428|6112524|P1|COMPLETED|Screening Period||20
2493066|NCT00844428|6112524|P1|STARTED|Screening Period||23
2493067|NCT00844415|6112540|P1|NOT COMPLETED|Overall Study||1
2493068|NCT00844415|6112540|P1|COMPLETED|Overall Study|Completed.|8
2493069|NCT00844415|6112540|P1|Pat. Received Single Dose 75mg|Overall Study||1
2493070|NCT00844415|6112540|P1|Pat. Received 125mg Followed by 150mg|Overall Study||2
2493071|NCT00844415|6112540|P1|Pat. Received 100mg Followed by 125mg|Overall Study||3
2493072|NCT00844415|6112540|P1|Pat. Received 75mg Followed by 100mg|Overall Study||3
2493073|NCT00844415|6112540|P1|STARTED|Overall Study|Entered and treated.|9
2493074|NCT00844376|6112554|P2|NOT COMPLETED|Period 2: Second Intervention||0
2493075|NCT00844376|6112555|P1|NOT COMPLETED|Period 2: Second Intervention||0
2493076|NCT00844376|6112554|P2|COMPLETED|Period 2: Second Intervention||6
2493077|NCT00844376|6112555|P1|COMPLETED|Period 2: Second Intervention|Total subjects administered Test drug = 12; total subjects administered Reference drug = 11.|5
2493078|NCT00844376|6112554|P2|STARTED|Period 2: Second Intervention||6
2493079|NCT00844376|6112555|P1|STARTED|Period 2: Second Intervention||5
2493080|NCT00844376|6112554|P2|NOT COMPLETED|Period 1: First Intervention||0
2493081|NCT00844376|6112555|P1|NOT COMPLETED|Period 1: First Intervention||1
2493082|NCT00844376|6112554|P2|COMPLETED|Period 1: First Intervention||6
2493083|NCT00844376|6112555|P1|COMPLETED|Period 1: First Intervention||5
2493084|NCT00844376|6112554|P2|STARTED|Period 1: First Intervention||6
2493085|NCT00844376|6112555|P1|STARTED|Period 1: First Intervention||6
2493086|NCT00844298|6112573|P1|NOT COMPLETED|Overall Study||0
2493087|NCT00844298|6112573|P1|COMPLETED|Overall Study||91
2493088|NCT00844298|6112573|P1|STARTED|Overall Study||91
2493089|NCT00844194|6112579|P2|NOT COMPLETED|Overall Study||8
2493090|NCT00844194|6112580|P1|NOT COMPLETED|Overall Study||25
2493091|NCT00844194|6112579|P2|COMPLETED|Overall Study||22
2493092|NCT00844194|6112580|P1|COMPLETED|Overall Study||53
2493093|NCT00844194|6112579|P2|STARTED|Overall Study||30
2493094|NCT00844194|6112580|P1|STARTED|Overall Study||78
2493095|NCT00844090|6112786|P2|NOT COMPLETED|Overall Study||8
2493096|NCT00844090|6112787|P1|NOT COMPLETED|Overall Study||6
2493097|NCT00844090|6112786|P2|COMPLETED|Overall Study||46
2493098|NCT00844090|6112787|P1|COMPLETED|Overall Study||46
2493099|NCT00844090|6112786|P2|STARTED|Overall Study||54
2493100|NCT00844090|6112787|P1|STARTED|Overall Study||52
2493101|NCT00844051|6112795|P2|NOT COMPLETED|Overall Study||0
2493102|NCT00844051|6112796|P1|NOT COMPLETED|Overall Study||0
2493103|NCT00844051|6112795|P2|COMPLETED|Overall Study||2368
2493104|NCT00844051|6112796|P1|COMPLETED|Overall Study||2087
2493105|NCT00844051|6112795|P2|STARTED|Overall Study||2368
2493106|NCT00844051|6112796|P1|STARTED|Overall Study||2087
2493107|NCT00843986|6112806|P2|NOT COMPLETED|Overall Study||1
2493108|NCT00843986|6112807|P1|NOT COMPLETED|Overall Study||1
2493109|NCT00843986|6112806|P2|COMPLETED|Overall Study||5
2493110|NCT00843986|6112807|P1|COMPLETED|Overall Study||2
2493111|NCT00843986|6112806|P2|Completed Treatment (Infusion)|Overall Study||6
2493112|NCT00843986|6112807|P1|Completed Treatment (Infusion)|Overall Study||2
2493113|NCT00843986|6112806|P2|STARTED|Overall Study||6
2493114|NCT00843986|6112807|P1|STARTED|Overall Study||3
2493115|NCT00843856|6112835|P2|NOT COMPLETED|Overall Study||2
2493116|NCT00843856|6112836|P1|NOT COMPLETED|Overall Study||1
2493117|NCT00843856|6112835|P2|COMPLETED|Overall Study||18
2493118|NCT00843856|6112836|P1|COMPLETED|Overall Study||19
2493119|NCT00843856|6112835|P2|STARTED|Overall Study||20
2493120|NCT00843856|6112836|P1|STARTED|Overall Study||20
2493121|NCT00843843|6112846|P2|NOT COMPLETED|Overall Study||2
2493122|NCT00843843|6112847|P1|NOT COMPLETED|Overall Study||2
2493123|NCT00843843|6112846|P2|COMPLETED|Overall Study||6
2493124|NCT00843843|6112847|P1|COMPLETED|Overall Study||6
2493125|NCT00843843|6112846|P2|STARTED|Overall Study||8
2493126|NCT00843843|6112847|P1|STARTED|Overall Study||8
2493127|NCT00843830|6112855|P1|NOT COMPLETED|Overall Study||0
2493128|NCT00843830|6112855|P1|COMPLETED|Overall Study||4
2493129|NCT00843830|6112855|P1|STARTED|Overall Study||4
2493130|NCT00843778|6112860|P1|NOT COMPLETED|Overall Study||35
2493131|NCT00843778|6112860|P1|COMPLETED|Overall Study||96
2493132|NCT00843778|6112860|P1|STARTED|Overall Study||131
2493133|NCT00843713|6112895|P2|NOT COMPLETED|Overall Study||0
2493134|NCT00843713|6112896|P1|NOT COMPLETED|Overall Study||0
2493135|NCT00843713|6112895|P2|COMPLETED|Overall Study||26
2493136|NCT00843713|6112896|P1|COMPLETED|Overall Study||30
2493137|NCT00843713|6112895|P2|STARTED|Overall Study||26
2493138|NCT00843713|6112896|P1|STARTED|Overall Study||30
2493139|NCT00843635|6112905|P3|NOT COMPLETED|Overall Study||0
2493140|NCT00843635|6112906|P2|NOT COMPLETED|Overall Study||2
2493141|NCT00843635|6112907|P1|NOT COMPLETED|Overall Study||2
2493142|NCT00843635|6112905|P3|COMPLETED|Overall Study||5
2493143|NCT00843635|6112906|P2|COMPLETED|Overall Study||13
2493144|NCT00843635|6112907|P1|COMPLETED|Overall Study||13
2493145|NCT00843635|6112905|P3|STARTED|Overall Study||5
2493146|NCT00843635|6112906|P2|STARTED|Overall Study||15
2493147|NCT00843635|6112907|P1|STARTED|Overall Study||15
2493148|NCT00843622|6112927|P2|NOT COMPLETED|Overall Study||55
2493149|NCT00843622|6112928|P1|NOT COMPLETED|Overall Study||43
2493150|NCT00843622|6112927|P2|COMPLETED|Overall Study||70
2493151|NCT00843622|6112928|P1|COMPLETED|Overall Study||82
2493152|NCT00843622|6112927|P2|STARTED|Overall Study||125
2493153|NCT00843622|6112928|P1|STARTED|Overall Study||125
2493154|NCT00843518|6112936|P2|NOT COMPLETED|Period 3 (Single-blind Washout)||0
2493155|NCT00843518|6112937|P1|NOT COMPLETED|Period 3 (Single-blind Washout)||0
2493156|NCT00843518|6112936|P2|COMPLETED|Period 3 (Single-blind Washout)||49
2493157|NCT00843518|6112937|P1|COMPLETED|Period 3 (Single-blind Washout)||42
2493158|NCT00843518|6112936|P2|STARTED|Period 3 (Single-blind Washout)||49
2493159|NCT00843518|6112937|P1|STARTED|Period 3 (Single-blind Washout)|1 LY451395 participant completed double-blind treatment, but did not enter washout period.|42
2493160|NCT00843518|6112936|P2|NOT COMPLETED|Period 2 (Double-blind Treatment)||20
2493161|NCT00843518|6112937|P1|NOT COMPLETED|Period 2 (Double-blind Treatment)||20
2493162|NCT00843518|6112936|P2|COMPLETED|Period 2 (Double-blind Treatment)||49
2493163|NCT00843518|6112937|P1|COMPLETED|Period 2 (Double-blind Treatment)||43
2493164|NCT00843518|6112936|P2|STARTED|Period 2 (Double-blind Treatment)||69
2493165|NCT00843518|6112937|P1|STARTED|Period 2 (Double-blind Treatment)||63
2493166|NCT00843492|6112967|P2|NOT COMPLETED|Overall Study||14
2493167|NCT00843492|6112968|P1|NOT COMPLETED|Overall Study||8
2493168|NCT00843492|6112967|P2|COMPLETED|Overall Study||607
2493169|NCT00843492|6112968|P1|COMPLETED|Overall Study||614
2493170|NCT00843492|6112967|P2|STARTED|Overall Study||621
2493171|NCT00843492|6112968|P1|STARTED|Overall Study||622
2493172|NCT00843479|6112988|P2|NOT COMPLETED|Overall Study||0
2493173|NCT00843479|6112989|P1|NOT COMPLETED|Overall Study||0
2493174|NCT00843479|6112988|P2|COMPLETED|Overall Study||12
2493175|NCT00843479|6112989|P1|COMPLETED|Overall Study||12
2493176|NCT00843479|6112988|P2|STARTED|Overall Study||12
2493177|NCT00843479|6112989|P1|STARTED|Overall Study||12
2493178|NCT00843466|6113007|P2|NOT COMPLETED|Overall Study||0
2493179|NCT00843466|6113008|P1|NOT COMPLETED|Overall Study||0
2493180|NCT00843466|6113007|P2|COMPLETED|Overall Study||18
2493181|NCT00843466|6113008|P1|COMPLETED|Overall Study||24
2493182|NCT00843466|6113007|P2|STARTED|Overall Study||18
2493183|NCT00843466|6113008|P1|STARTED|Overall Study||24
2493184|NCT00843349|6113018|P4|NOT COMPLETED|Overall Study||1
2493185|NCT00843349|6113019|P3|NOT COMPLETED|Overall Study||0
2493186|NCT00843349|6113020|P2|NOT COMPLETED|Overall Study||0
2493187|NCT00843349|6113021|P1|NOT COMPLETED|Overall Study||3
2493188|NCT00843349|6113018|P4|COMPLETED|Overall Study||10
2493189|NCT00843349|6113019|P3|COMPLETED|Overall Study||10
2493190|NCT00843349|6113020|P2|COMPLETED|Overall Study||11
2493191|NCT00843349|6113021|P1|COMPLETED|Overall Study||8
2493192|NCT00843349|6113018|P4|STARTED|Overall Study||11
2493193|NCT00843349|6113019|P3|STARTED|Overall Study||10
2493194|NCT00843349|6113020|P2|STARTED|Overall Study||11
2493195|NCT00843349|6113021|P1|STARTED|Overall Study||11
2493196|NCT00843310|6113035|P1|NOT COMPLETED|Overall Study||7
2493197|NCT00843310|6113035|P1|COMPLETED|Overall Study||1
2493198|NCT00843310|6113035|P1|STARTED|Overall Study||8
2493199|NCT00843284|6113039|P1|NOT COMPLETED|Overall Study||72
2493200|NCT00843284|6113039|P1|COMPLETED|Overall Study||619
2493201|NCT00843284|6113039|P1|STARTED|Overall Study||691
2493202|NCT00843193|6113049|P2|NOT COMPLETED|Overall Study||11
2493203|NCT00843193|6113050|P1|NOT COMPLETED|Overall Study||8
2493204|NCT00843193|6113049|P2|COMPLETED|Overall Study||88
2493205|NCT00843193|6113050|P1|COMPLETED|Overall Study||91
2493206|NCT00843193|6113049|P2|STARTED|Overall Study||99
2493207|NCT00843193|6113050|P1|STARTED|Overall Study||99
2493208|NCT00843180|6113086|P2|NOT COMPLETED|Overall Study||0
2493209|NCT00843180|6113087|P1|NOT COMPLETED|Overall Study||0
2493210|NCT00843180|6113086|P2|COMPLETED|Overall Study||7
2493211|NCT00843180|6113087|P1|COMPLETED|Overall Study||16
2493212|NCT00843180|6113086|P2|STARTED|Overall Study||7
2493213|NCT00843180|6113087|P1|STARTED|Overall Study||16
2493214|NCT00843167|6113101|P2|NOT COMPLETED|Follow-up||0
2493215|NCT00843167|6113102|P1|NOT COMPLETED|Follow-up||0
2493216|NCT00843167|6113101|P2|COMPLETED|Follow-up||24
2493217|NCT00843167|6113102|P1|COMPLETED|Follow-up||24
2493218|NCT00843167|6113101|P2|Completed Final Visit|Follow-up||24
2493219|NCT00843167|6113102|P1|Completed Final Visit|Follow-up||24
2493220|NCT00843167|6113101|P2|STARTED|Follow-up||24
2493221|NCT00843167|6113102|P1|STARTED|Follow-up||24
2493222|NCT00843167|6113101|P2|NOT COMPLETED|Treatment Period||8
2493223|NCT00843167|6113102|P1|NOT COMPLETED|Treatment Period||3
2493224|NCT00843167|6113101|P2|COMPLETED|Treatment Period||19
2493225|NCT00843167|6113102|P1|COMPLETED|Treatment Period||24
2493226|NCT00843167|6113101|P2|STARTED|Treatment Period||27
2493227|NCT00843167|6113102|P1|STARTED|Treatment Period||27
2493228|NCT00843115|6113115|P1|NOT COMPLETED|Overall Study||66
2493229|NCT00843115|6113115|P1|COMPLETED|Overall Study||304
2493230|NCT00843115|6113115|P1|STARTED|Overall Study||370
2493231|NCT00843050|6113161|P1|NOT COMPLETED|Overall Study||13
2493232|NCT00843050|6113161|P1|COMPLETED|Overall Study||0
2493233|NCT00843050|6113161|P1|STARTED|Overall Study||13
2493234|NCT00843024|6113171|P6|NOT COMPLETED|Double-blind Treatment Phase||25
2493235|NCT00843024|6113172|P5|NOT COMPLETED|Double-blind Treatment Phase||20
2493236|NCT00843024|6113173|P4|NOT COMPLETED|Double-blind Treatment Phase||23
2493237|NCT00843024|6113174|P3|NOT COMPLETED|Double-blind Treatment Phase||31
2493238|NCT00843024|6113175|P2|NOT COMPLETED|Double-blind Treatment Phase||0
2493239|NCT00843024|6113176|P1|NOT COMPLETED|Double-blind Treatment Phase||0
2493240|NCT00843024|6113171|P6|COMPLETED|Double-blind Treatment Phase||152
2493241|NCT00843024|6113172|P5|COMPLETED|Double-blind Treatment Phase||97
2493242|NCT00843024|6113173|P4|COMPLETED|Double-blind Treatment Phase||96
2493243|NCT00843024|6113174|P3|COMPLETED|Double-blind Treatment Phase||145
2493244|NCT00843024|6113175|P2|COMPLETED|Double-blind Treatment Phase||0
2493245|NCT00843024|6113176|P1|COMPLETED|Double-blind Treatment Phase||0
2493246|NCT00843024|6113171|P6|STARTED|Double-blind Treatment Phase||177
2493247|NCT00843024|6113172|P5|STARTED|Double-blind Treatment Phase||117
2493248|NCT00843024|6113173|P4|STARTED|Double-blind Treatment Phase||119
2493249|NCT00843024|6113174|P3|STARTED|Double-blind Treatment Phase||176
2493250|NCT00843024|6113175|P2|STARTED|Double-blind Treatment Phase||0
2493251|NCT00843024|6113176|P1|STARTED|Double-blind Treatment Phase||0
2493252|NCT00843024|6113171|P6|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
2493253|NCT00843024|6113172|P5|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
2493254|NCT00843024|6113173|P4|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
2493255|NCT00843024|6113174|P3|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
2493256|NCT00843024|6113175|P2|NOT COMPLETED|Single-blind Placebo Run-In Phase||136
2493257|NCT00843024|6113176|P1|NOT COMPLETED|Single-blind Placebo Run-In Phase||140
2493258|NCT00843024|6113171|P6|COMPLETED|Single-blind Placebo Run-In Phase||0
2493259|NCT00843024|6113172|P5|COMPLETED|Single-blind Placebo Run-In Phase||0
2493260|NCT00843024|6113173|P4|COMPLETED|Single-blind Placebo Run-In Phase||0
2493261|NCT00843024|6113174|P3|COMPLETED|Single-blind Placebo Run-In Phase||0
2493262|NCT00843024|6113175|P2|COMPLETED|Single-blind Placebo Run-In Phase||321
2493263|NCT00843024|6113176|P1|COMPLETED|Single-blind Placebo Run-In Phase||268
2493264|NCT00843024|6113171|P6|STARTED|Single-blind Placebo Run-In Phase||0
2493265|NCT00843024|6113172|P5|STARTED|Single-blind Placebo Run-In Phase||0
2493266|NCT00843024|6113173|P4|STARTED|Single-blind Placebo Run-In Phase||0
2493267|NCT00843024|6113174|P3|STARTED|Single-blind Placebo Run-In Phase||0
2493268|NCT00843024|6113175|P2|STARTED|Single-blind Placebo Run-In Phase||457
2493269|NCT00843024|6113176|P1|STARTED|Single-blind Placebo Run-In Phase||408
2493270|NCT00842985|6113241|P1|NOT COMPLETED|Fourth Intervention||0
2493271|NCT00842985|6113241|P1|COMPLETED|Fourth Intervention||15
2493272|NCT00842985|6113241|P1|STARTED|Fourth Intervention||15
2493273|NCT00842985|6113241|P1|NOT COMPLETED|Washout Period of GE 4 Days||0
2493274|NCT00842985|6113241|P1|COMPLETED|Washout Period of GE 4 Days||15
2493275|NCT00842985|6113241|P1|STARTED|Washout Period of GE 4 Days||15
2493276|NCT00842985|6113241|P1|NOT COMPLETED|Third Intervention||0
2493277|NCT00842985|6113241|P1|COMPLETED|Third Intervention||15
2493278|NCT00842985|6113241|P1|STARTED|Third Intervention||15
2493279|NCT00842985|6113241|P1|NOT COMPLETED|Washout Period of GE 4 Days||2
2493280|NCT00842985|6113241|P1|COMPLETED|Washout Period of GE 4 Days||15
2493281|NCT00842985|6113241|P1|STARTED|Washout Period of GE 4 Days||17
2493282|NCT00842985|6113241|P1|NOT COMPLETED|Second Intervention||1
2493283|NCT00842985|6113241|P1|COMPLETED|Second Intervention||17
2493284|NCT00842985|6113241|P1|STARTED|Second Intervention||18
2493285|NCT00842985|6113241|P1|NOT COMPLETED|Washout Period of GE 4 Days||2
2493286|NCT00842985|6113241|P1|COMPLETED|Washout Period of GE 4 Days||18
2493287|NCT00842985|6113241|P1|STARTED|Washout Period of GE 4 Days||20
2493288|NCT00842985|6113241|P1|NOT COMPLETED|First Intervention||6
2493289|NCT00842985|6113241|P1|COMPLETED|First Intervention|Completed 1st Intervention|20
2493290|NCT00842985|6113241|P1|STARTED|First Intervention|Signed Consent|26
2493291|NCT00842985|6113241|P1|NOT COMPLETED|Screening||27
2493292|NCT00842985|6113241|P1|COMPLETED|Screening||26
2493293|NCT00842985|6113241|P1|STARTED|Screening||53
2493294|NCT00842946|6113250|P2|NOT COMPLETED|Overall Study||5
2493295|NCT00842946|6113251|P1|NOT COMPLETED|Overall Study||5
2493296|NCT00842946|6113250|P2|COMPLETED|Overall Study||19
2493297|NCT00842946|6113251|P1|COMPLETED|Overall Study||16
2493298|NCT00842946|6113250|P2|STARTED|Overall Study||24
2493299|NCT00842946|6113251|P1|STARTED|Overall Study||21
2493300|NCT00842829|6113259|P3|NOT COMPLETED|Continuation Period||61
2493301|NCT00842829|6113260|P2|NOT COMPLETED|Continuation Period||0
2493302|NCT00842829|6113261|P1|NOT COMPLETED|Continuation Period||0
2493303|NCT00842829|6113259|P3|COMPLETED|Continuation Period||27
2493304|NCT00842829|6113260|P2|COMPLETED|Continuation Period||0
2493305|NCT00842829|6113261|P1|COMPLETED|Continuation Period||0
2493306|NCT00842829|6113259|P3|Continuation Safety Analysis Set|Continuation Period|Received at least one dose of study drug|87
2493307|NCT00842829|6113260|P2|Continuation Safety Analysis Set|Continuation Period||0
2493308|NCT00842829|6113261|P1|Continuation Safety Analysis Set|Continuation Period||0
2493309|NCT00842829|6113259|P3|STARTED|Continuation Period|Eligible for Continuation Period|88
2493310|NCT00842829|6113260|P2|STARTED|Continuation Period||0
2493311|NCT00842829|6113261|P1|STARTED|Continuation Period||0
2493312|NCT00842829|6113259|P3|NOT COMPLETED|Treatment Period||63
2493313|NCT00842829|6113260|P2|NOT COMPLETED|Treatment Period||0
2493314|NCT00842829|6113261|P1|NOT COMPLETED|Treatment Period||0
2493315|NCT00842829|6113259|P3|COMPLETED|Treatment Period||218
2493316|NCT00842829|6113260|P2|COMPLETED|Treatment Period||0
2493317|NCT00842829|6113261|P1|COMPLETED|Treatment Period||0
2493318|NCT00842829|6113259|P3|Safety Analysis Set|Treatment Period|Received at least one dose of study drug|223
2493319|NCT00842829|6113260|P2|Safety Analysis Set|Treatment Period||0
2493320|NCT00842829|6113261|P1|Safety Analysis Set|Treatment Period||0
2493321|NCT00842829|6113259|P3|STARTED|Treatment Period||281
2493322|NCT00842829|6113260|P2|STARTED|Treatment Period||0
2493323|NCT00842829|6113261|P1|STARTED|Treatment Period||0
2493324|NCT00842829|6113259|P3|NOT COMPLETED|Dose Titration Period||0
2493325|NCT00842829|6113260|P2|NOT COMPLETED|Dose Titration Period||23
2493326|NCT00842829|6113261|P1|NOT COMPLETED|Dose Titration Period||26
2493327|NCT00842829|6113259|P3|COMPLETED|Dose Titration Period||0
2493328|NCT00842829|6113260|P2|COMPLETED|Dose Titration Period||151
2493329|NCT00842829|6113261|P1|COMPLETED|Dose Titration Period||130
2493330|NCT00842829|6113259|P3|Titration Safety Analysis Set|Dose Titration Period||0
2493331|NCT00842829|6113260|P2|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|167
2493332|NCT00842829|6113261|P1|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|145
2493333|NCT00842829|6113259|P3|STARTED|Dose Titration Period||0
2493334|NCT00842829|6113260|P2|STARTED|Dose Titration Period||174
2493335|NCT00842829|6113261|P1|STARTED|Dose Titration Period||156
2493336|NCT00842764|6113295|P1|NOT COMPLETED|Overall Study||2
2493337|NCT00842764|6113295|P1|COMPLETED|Overall Study||5
2493338|NCT00842764|6113295|P1|STARTED|Overall Study||7
2493339|NCT00842751|6113299|P1|NOT COMPLETED|Overall Study||0
2493340|NCT00842751|6113299|P1|COMPLETED|Overall Study||11
2493341|NCT00842751|6113299|P1|STARTED|Overall Study||11
2493342|NCT00842712|6113320|P7|NOT COMPLETED|Randomized Part||6
2493343|NCT00842712|6113321|P6|NOT COMPLETED|Randomized Part||1
2493344|NCT00842712|6113322|P5|NOT COMPLETED|Randomized Part||0
2493345|NCT00842712|6113323|P4|NOT COMPLETED|Randomized Part||0
2493346|NCT00842712|6113324|P3|NOT COMPLETED|Randomized Part||0
2493347|NCT00842712|6113325|P2|NOT COMPLETED|Randomized Part||0
2493348|NCT00842712|6113326|P1|NOT COMPLETED|Randomized Part||0
2493349|NCT00842712|6113320|P7|COMPLETED|Randomized Part||78
2493350|NCT00842712|6113321|P6|COMPLETED|Randomized Part||50
2493351|NCT00842712|6113322|P5|COMPLETED|Randomized Part||85
2493352|NCT00842712|6113323|P4|COMPLETED|Randomized Part||0
2493353|NCT00842712|6113324|P3|COMPLETED|Randomized Part||0
2493354|NCT00842712|6113325|P2|COMPLETED|Randomized Part||0
2493355|NCT00842712|6113326|P1|COMPLETED|Randomized Part||0
2493356|NCT00842712|6113320|P7|Treated|Randomized Part||80
2493357|NCT00842712|6113321|P6|Treated|Randomized Part||50
2493358|NCT00842712|6113322|P5|Treated|Randomized Part||85
2493359|NCT00842712|6113323|P4|Treated|Randomized Part||0
2493360|NCT00842712|6113324|P3|Treated|Randomized Part||0
2493361|NCT00842712|6113325|P2|Treated|Randomized Part||0
2493362|NCT00842712|6113326|P1|Treated|Randomized Part||0
2493363|NCT00842712|6113320|P7|STARTED|Randomized Part||84
2493364|NCT00842712|6113321|P6|STARTED|Randomized Part||51
2493365|NCT00842712|6113322|P5|STARTED|Randomized Part||85
2493366|NCT00842712|6113323|P4|STARTED|Randomized Part||0
2493367|NCT00842712|6113324|P3|STARTED|Randomized Part||0
2493368|NCT00842712|6113325|P2|STARTED|Randomized Part||0
2493369|NCT00842712|6113326|P1|STARTED|Randomized Part||0
2493370|NCT00842712|6113320|P7|NOT COMPLETED|Safety Run-in Part||0
2493371|NCT00842712|6113321|P6|NOT COMPLETED|Safety Run-in Part||0
2493372|NCT00842712|6113322|P5|NOT COMPLETED|Safety Run-in Part||0
2493373|NCT00842712|6113323|P4|NOT COMPLETED|Safety Run-in Part||1
2493374|NCT00842712|6113324|P3|NOT COMPLETED|Safety Run-in Part||0
2493375|NCT00842712|6113325|P2|NOT COMPLETED|Safety Run-in Part||2
2493376|NCT00842712|6113326|P1|NOT COMPLETED|Safety Run-in Part||3
2493377|NCT00842712|6113320|P7|COMPLETED|Safety Run-in Part||0
2493378|NCT00842712|6113321|P6|COMPLETED|Safety Run-in Part||0
2493379|NCT00842712|6113322|P5|COMPLETED|Safety Run-in Part||0
2493380|NCT00842712|6113323|P4|COMPLETED|Safety Run-in Part||2
2493381|NCT00842712|6113324|P3|COMPLETED|Safety Run-in Part||3
2493382|NCT00842712|6113325|P2|COMPLETED|Safety Run-in Part||1
2493383|NCT00842712|6113326|P1|COMPLETED|Safety Run-in Part||0
2493384|NCT00842712|6113320|P7|STARTED|Safety Run-in Part||0
2493385|NCT00842712|6113321|P6|STARTED|Safety Run-in Part||0
2493386|NCT00842712|6113322|P5|STARTED|Safety Run-in Part||0
2493387|NCT00842712|6113323|P4|STARTED|Safety Run-in Part||3
2493388|NCT00842712|6113324|P3|STARTED|Safety Run-in Part||3
2493389|NCT00842712|6113325|P2|STARTED|Safety Run-in Part||3
2493390|NCT00842712|6113326|P1|STARTED|Safety Run-in Part||3
2493391|NCT00842608|6113358|P4|NOT COMPLETED|Overall Study||1
2493392|NCT00842608|6113359|P3|NOT COMPLETED|Overall Study||0
2493393|NCT00842608|6113360|P2|NOT COMPLETED|Overall Study||1
2493394|NCT00842608|6113361|P1|NOT COMPLETED|Overall Study||4
2493395|NCT00842608|6113358|P4|COMPLETED|Overall Study||100
2493396|NCT00842608|6113359|P3|COMPLETED|Overall Study||99
2493397|NCT00842608|6113360|P2|COMPLETED|Overall Study||176
2493398|NCT00842608|6113361|P1|COMPLETED|Overall Study||170
2493399|NCT00842608|6113358|P4|STARTED|Overall Study||101
2493400|NCT00842608|6113359|P3|STARTED|Overall Study||99
2493401|NCT00842608|6113360|P2|STARTED|Overall Study||177
2493402|NCT00842608|6113361|P1|STARTED|Overall Study||174
2493403|NCT00842543|6113383|P4|NOT COMPLETED|Overall Study||4
2493404|NCT00842543|6113384|P3|NOT COMPLETED|Overall Study||3
2493405|NCT00842543|6113385|P2|NOT COMPLETED|Overall Study||0
2493406|NCT00842543|6113386|P1|NOT COMPLETED|Overall Study||2
2493407|NCT00842543|6113383|P4|COMPLETED|Overall Study||4
2493408|NCT00842543|6113384|P3|COMPLETED|Overall Study||10
2493409|NCT00842543|6113385|P2|COMPLETED|Overall Study||5
2493410|NCT00842543|6113386|P1|COMPLETED|Overall Study||11
2493411|NCT00842543|6113383|P4|STARTED|Overall Study||8
2493412|NCT00842543|6113384|P3|STARTED|Overall Study||13
2493413|NCT00842543|6113385|P2|STARTED|Overall Study||5
2493414|NCT00842543|6113386|P1|STARTED|Overall Study||13
2493415|NCT00842530|6113400|P2|NOT COMPLETED|Overall Study||57
2493416|NCT00842530|6113401|P1|NOT COMPLETED|Overall Study||117
2493417|NCT00842530|6113400|P2|COMPLETED|Overall Study||1276
2493418|NCT00842530|6113401|P1|COMPLETED|Overall Study||2552
2493419|NCT00842530|6113400|P2|Received Vaccination 3|Overall Study||1282
2493420|NCT00842530|6113401|P1|Received Vaccination 3|Overall Study||2557
2493421|NCT00842530|6113400|P2|Received Vaccination 2|Overall Study||1300
2493422|NCT00842530|6113401|P1|Received Vaccination 2|Overall Study||2584
2493423|NCT00842530|6113400|P2|Received Vaccination 1|Overall Study||1331
2493424|NCT00842530|6113401|P1|Received Vaccination 1|Overall Study||2666
2493425|NCT00842530|6113400|P2|STARTED|Overall Study||1333
2493426|NCT00842530|6113401|P1|STARTED|Overall Study||2669
2493427|NCT00842361|6113431|P2|NOT COMPLETED|Overall Study||2
2493428|NCT00842361|6113432|P1|NOT COMPLETED|Overall Study||1
2493429|NCT00842361|6113431|P2|COMPLETED|Overall Study||31
2493430|NCT00842361|6113432|P1|COMPLETED|Overall Study||32
2493431|NCT00842361|6113431|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|32
2493432|NCT00842361|6113432|P1|Exposed|Overall Study||33
2493433|NCT00842361|6113431|P2|STARTED|Overall Study||33
2493434|NCT00842361|6113432|P1|STARTED|Overall Study||33
2493435|NCT00842348|6113452|P2|NOT COMPLETED|Study 729||38
2493436|NCT00842348|6113453|P1|NOT COMPLETED|Study 729||26
2493437|NCT00842348|6113452|P2|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|9
2493438|NCT00842348|6113453|P1|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|16
2493439|NCT00842348|6113452|P2|STARTED|Study 729||47
2493440|NCT00842348|6113453|P1|STARTED|Study 729||42
2493441|NCT00842348|6113452|P2|NOT COMPLETED|Patients Randomised in Study 726||56
2493442|NCT00842348|6113453|P1|NOT COMPLETED|Patients Randomised in Study 726||59
2493443|NCT00842348|6113452|P2|COMPLETED|Patients Randomised in Study 726|15 patients had stable disease and 32 patients had progressive disease.|47
2493444|NCT00842348|6113453|P1|COMPLETED|Patients Randomised in Study 726|41 patients had stable disease and 1 patient had progressive disease.|42
2493445|NCT00842348|6113452|P2|STARTED|Patients Randomised in Study 726||103
2493446|NCT00842348|6113453|P1|STARTED|Patients Randomised in Study 726||101
2493447|NCT00842335|6113463|P1|NOT COMPLETED|Overall Study||0
2493448|NCT00842335|6113463|P1|COMPLETED|Overall Study||18
2493449|NCT00842335|6113463|P1|STARTED|Overall Study||18
2493450|NCT00842309|6113472|P2|NOT COMPLETED|Overall Study||1
2493451|NCT00842309|6113473|P1|NOT COMPLETED|Overall Study||3
2493452|NCT00842309|6113472|P2|COMPLETED|Overall Study||13
2493453|NCT00842309|6113473|P1|COMPLETED|Overall Study||11
2493454|NCT00842309|6113472|P2|STARTED|Overall Study||14
2493455|NCT00842309|6113473|P1|STARTED|Overall Study|14 randomized. 2 withdrew prior to initiating DCS-not included in modified intent-to-treat analyses.|14
2493456|NCT00842296|6113481|P1|NOT COMPLETED|Overall Study||0
2493457|NCT00842296|6113481|P1|COMPLETED|Overall Study||326
2493458|NCT00842296|6113481|P1|STARTED|Overall Study||326
2493459|NCT00842257|6113507|P1|NOT COMPLETED|Overall Study||1
2493460|NCT00842257|6113507|P1|COMPLETED|Overall Study||19
2493461|NCT00842257|6113507|P1|STARTED|Overall Study||20
2493462|NCT00842244|6113514|P1|NOT COMPLETED|Overall Study||21
2493463|NCT00842244|6113514|P1|COMPLETED|Overall Study||1
2493464|NCT00842244|6113514|P1|STARTED|Overall Study||22
2493465|NCT00842231|6113533|P1|NOT COMPLETED|Overall Study||0
2493466|NCT00842231|6113533|P1|COMPLETED|Overall Study||40
2493467|NCT00842231|6113533|P1|STARTED|Overall Study||40
2493468|NCT00842153|6113541|P2|NOT COMPLETED|Overall Study||3
2493469|NCT00842153|6113542|P1|NOT COMPLETED|Overall Study||1
2493470|NCT00842153|6113541|P2|COMPLETED|Overall Study||27
2493471|NCT00842153|6113542|P1|COMPLETED|Overall Study||27
2493472|NCT00842153|6113541|P2|STARTED|Overall Study||30
2493473|NCT00842153|6113542|P1|STARTED|Overall Study||28
2493474|NCT00842075|6113582|P2|NOT COMPLETED|Overall Study||0
2493475|NCT00842075|6113583|P1|NOT COMPLETED|Overall Study||0
2493476|NCT00842075|6113582|P2|COMPLETED|Overall Study||5
2493477|NCT00842075|6113583|P1|COMPLETED|Overall Study||5
2493478|NCT00842075|6113582|P2|STARTED|Overall Study||5
2493479|NCT00842075|6113583|P1|STARTED|Overall Study||5
2493480|NCT00842023|6113593|P2|NOT COMPLETED|Overall Study||0
2493481|NCT00842023|6113594|P1|NOT COMPLETED|Overall Study||0
2493482|NCT00842023|6113593|P2|COMPLETED|Overall Study||44
2493483|NCT00842023|6113594|P1|COMPLETED|Overall Study||45
2493484|NCT00842023|6113593|P2|STARTED|Overall Study||44
2493485|NCT00842023|6113594|P1|STARTED|Overall Study||45
2493486|NCT00841971|6113606|P2|NOT COMPLETED|Overall Study||1
2493487|NCT00841971|6113607|P1|NOT COMPLETED|Overall Study||2
2493488|NCT00841971|6113606|P2|COMPLETED|Overall Study||99
2493489|NCT00841971|6113607|P1|COMPLETED|Overall Study||98
2493490|NCT00841971|6113606|P2|STARTED|Overall Study||100
2493491|NCT00841971|6113607|P1|STARTED|Overall Study||100
2493492|NCT00841906|6113617|P2|NOT COMPLETED|Overall Study||0
2493493|NCT00841906|6113618|P1|NOT COMPLETED|Overall Study||2
2493494|NCT00841906|6113617|P2|COMPLETED|Overall Study||14
2493495|NCT00841906|6113618|P1|COMPLETED|Overall Study||16
2493496|NCT00841906|6113617|P2|STARTED|Overall Study||14
2493497|NCT00841906|6113618|P1|STARTED|Overall Study||18
2493498|NCT00841828|6113632|P2|NOT COMPLETED|Overall Study||2
2493499|NCT00841828|6113633|P1|NOT COMPLETED|Overall Study||10
2493500|NCT00841828|6113632|P2|COMPLETED|Overall Study||48
2493501|NCT00841828|6113633|P1|COMPLETED|Overall Study||42
2493502|NCT00841828|6113632|P2|STARTED|Overall Study||50
2493503|NCT00841828|6113633|P1|STARTED|Overall Study||52
2493504|NCT00841815|6113643|P2|NOT COMPLETED|Period 2||0
2493505|NCT00841815|6113644|P1|NOT COMPLETED|Period 2||0
2493506|NCT00841815|6113643|P2|COMPLETED|Period 2||13
2493507|NCT00841815|6113644|P1|COMPLETED|Period 2||14
2493508|NCT00841815|6113643|P2|STARTED|Period 2||13
2493509|NCT00841815|6113644|P1|STARTED|Period 2||14
2493510|NCT00841815|6113643|P2|NOT COMPLETED|Washout||1
2493511|NCT00841815|6113644|P1|NOT COMPLETED|Washout||0
2493512|NCT00841815|6113643|P2|COMPLETED|Washout||13
2493513|NCT00841815|6113644|P1|COMPLETED|Washout||14
2493514|NCT00841815|6113643|P2|STARTED|Washout||14
2493515|NCT00841815|6113644|P1|STARTED|Washout||14
2493516|NCT00841815|6113643|P2|NOT COMPLETED|Period 1||0
2493517|NCT00841815|6113644|P1|NOT COMPLETED|Period 1||0
2493518|NCT00841815|6113643|P2|COMPLETED|Period 1||14
2493519|NCT00841815|6113644|P1|COMPLETED|Period 1||14
2493520|NCT00841815|6113643|P2|STARTED|Period 1||14
2493521|NCT00841815|6113644|P1|STARTED|Period 1||14
2493522|NCT00841776|6113654|P2|NOT COMPLETED|Overall Study||3
2493523|NCT00841776|6113655|P1|NOT COMPLETED|Overall Study||2
2493524|NCT00841776|6113654|P2|COMPLETED|Overall Study||24
2493525|NCT00841776|6113655|P1|COMPLETED|Overall Study||25
2493526|NCT00841776|6113654|P2|STARTED|Overall Study||27
2493527|NCT00841776|6113655|P1|STARTED|Overall Study||27
2493528|NCT00841763|6113673|P4|NOT COMPLETED|Overall Study||3
2493529|NCT00841763|6113674|P3|NOT COMPLETED|Overall Study||8
2493530|NCT00841763|6113675|P2|NOT COMPLETED|Overall Study||57
2493531|NCT00841763|6113676|P1|NOT COMPLETED|Overall Study||162
2493532|NCT00841763|6113673|P4|COMPLETED|Overall Study||53
2493533|NCT00841763|6113674|P3|COMPLETED|Overall Study||211
2493534|NCT00841763|6113675|P2|COMPLETED|Overall Study||624
2493535|NCT00841763|6113676|P1|COMPLETED|Overall Study||2529
2493536|NCT00841763|6113673|P4|STARTED|Overall Study||56
2493537|NCT00841763|6113674|P3|STARTED|Overall Study||219
2493538|NCT00841763|6113675|P2|STARTED|Overall Study||681
2493539|NCT00841763|6113676|P1|STARTED|Overall Study||2691
2493540|NCT00841698|6113738|P2|NOT COMPLETED|Second Intervention||0
2493541|NCT00841698|6113739|P1|NOT COMPLETED|Second Intervention||0
2493542|NCT00841698|6113738|P2|COMPLETED|Second Intervention||25
2493543|NCT00841698|6113739|P1|COMPLETED|Second Intervention||24
2493544|NCT00841698|6113738|P2|STARTED|Second Intervention||25
2493545|NCT00841698|6113739|P1|STARTED|Second Intervention||24
2493546|NCT00841698|6113738|P2|NOT COMPLETED|Washout: 2 Weeks||0
2493547|NCT00841698|6113739|P1|NOT COMPLETED|Washout: 2 Weeks||0
2493548|NCT00841698|6113738|P2|COMPLETED|Washout: 2 Weeks||25
2493549|NCT00841698|6113739|P1|COMPLETED|Washout: 2 Weeks||24
2493550|NCT00841698|6113738|P2|STARTED|Washout: 2 Weeks||25
2493551|NCT00841698|6113739|P1|STARTED|Washout: 2 Weeks||24
2493552|NCT00841698|6113738|P2|NOT COMPLETED|First Intervention||0
2493553|NCT00841698|6113739|P1|NOT COMPLETED|First Intervention||1
2493554|NCT00841698|6113738|P2|COMPLETED|First Intervention||25
2493555|NCT00841698|6113739|P1|COMPLETED|First Intervention||24
2493556|NCT00841698|6113738|P2|STARTED|First Intervention||25
2493557|NCT00841698|6113739|P1|STARTED|First Intervention||25
2493558|NCT00841672|6113749|P2|NOT COMPLETED|Overall Study||32
2493559|NCT00841672|6113750|P1|NOT COMPLETED|Overall Study||20
2493560|NCT00841672|6113749|P2|COMPLETED|Overall Study||209
2493561|NCT00841672|6113750|P1|COMPLETED|Overall Study||224
2493562|NCT00841672|6113749|P2|STARTED|Overall Study||241
2493563|NCT00841672|6113750|P1|STARTED|Overall Study|One patient was mis-randomized and was not treated in the double-blind treatment period.|244
2493564|NCT00841659|6113766|P2|NOT COMPLETED|Second Intervention||0
2493565|NCT00841659|6113767|P1|NOT COMPLETED|Second Intervention||0
2493566|NCT00841659|6113766|P2|COMPLETED|Second Intervention||12
2493567|NCT00841659|6113767|P1|COMPLETED|Second Intervention||11
2493568|NCT00841659|6113766|P2|STARTED|Second Intervention||12
2493569|NCT00841659|6113767|P1|STARTED|Second Intervention||11
2493570|NCT00841659|6113766|P2|NOT COMPLETED|Washout: 2 Weeks||0
2493571|NCT00841659|6113767|P1|NOT COMPLETED|Washout: 2 Weeks||1
2493572|NCT00841659|6113766|P2|COMPLETED|Washout: 2 Weeks||12
2493573|NCT00841659|6113767|P1|COMPLETED|Washout: 2 Weeks||11
2493574|NCT00841659|6113766|P2|STARTED|Washout: 2 Weeks||12
2493575|NCT00841659|6113767|P1|STARTED|Washout: 2 Weeks||12
2493576|NCT00841659|6113766|P2|NOT COMPLETED|First Intervention||0
2493577|NCT00841659|6113767|P1|NOT COMPLETED|First Intervention||0
2493578|NCT00841659|6113766|P2|COMPLETED|First Intervention||12
2493579|NCT00841659|6113767|P1|COMPLETED|First Intervention||12
2493580|NCT00841659|6113766|P2|STARTED|First Intervention||12
2493581|NCT00841659|6113767|P1|STARTED|First Intervention||12
2493582|NCT00841568|6113775|P1|NOT COMPLETED|Overall Study||5
2493583|NCT00841568|6113775|P1|COMPLETED|Overall Study||12
2493584|NCT00841568|6113775|P1|STARTED|Overall Study||17
2493585|NCT00841555|6113791|P3|NOT COMPLETED|Overall Study||0
2493586|NCT00841555|6113792|P2|NOT COMPLETED|Overall Study||0
2493587|NCT00841555|6113793|P1|NOT COMPLETED|Overall Study||0
2493588|NCT00841555|6113791|P3|COMPLETED|Overall Study||3
2493589|NCT00841555|6113792|P2|COMPLETED|Overall Study||3
2493590|NCT00841555|6113793|P1|COMPLETED|Overall Study||3
2493591|NCT00841555|6113791|P3|STARTED|Overall Study||3
2493592|NCT00841555|6113792|P2|STARTED|Overall Study||3
2493593|NCT00841555|6113793|P1|STARTED|Overall Study||3
2493594|NCT00841542|6113803|P2|NOT COMPLETED|Period 2||0
2493595|NCT00841542|6113804|P1|NOT COMPLETED|Period 2||0
2493596|NCT00841542|6113803|P2|COMPLETED|Period 2||14
2493597|NCT00841542|6113804|P1|COMPLETED|Period 2||13
2493598|NCT00841542|6113803|P2|STARTED|Period 2||14
2493599|NCT00841542|6113804|P1|STARTED|Period 2||13
2493600|NCT00841542|6113803|P2|NOT COMPLETED|Period 1||0
2493601|NCT00841542|6113804|P1|NOT COMPLETED|Period 1||1
2493602|NCT00841542|6113803|P2|COMPLETED|Period 1||14
2493603|NCT00841542|6113804|P1|COMPLETED|Period 1||13
2493604|NCT00841542|6113803|P2|STARTED|Period 1||14
2493605|NCT00841542|6113804|P1|STARTED|Period 1||14
2493606|NCT00841412|6113812|P2|NOT COMPLETED|Overall Study||30
2493607|NCT00841412|6113813|P1|NOT COMPLETED|Overall Study||40
2493608|NCT00841412|6113812|P2|COMPLETED|Overall Study||50
2493609|NCT00841412|6113813|P1|COMPLETED|Overall Study|130 residents completed all study phases across both groups, including follow-up.|80
2493610|NCT00841412|6113812|P2|STARTED|Overall Study|80 residents were in the delayed intervention group, but all residents received intervention.|80
2493611|NCT00841412|6113813|P1|STARTED|Overall Study|200 of 222 consented residents completed baseline assessments across both groups.|120
2493612|NCT00841321|6113819|P2|NOT COMPLETED|Overall Study||3
2493613|NCT00841321|6113820|P1|NOT COMPLETED|Overall Study||1
2493614|NCT00841321|6113819|P2|COMPLETED|Overall Study||58
2493615|NCT00841321|6113820|P1|COMPLETED|Overall Study||58
2493616|NCT00841321|6113819|P2|STARTED|Overall Study||61
2493617|NCT00841321|6113820|P1|STARTED|Overall Study||59
2493618|NCT00841269|6113834|P2|NOT COMPLETED|Overall Study||9
2493619|NCT00841269|6113835|P1|NOT COMPLETED|Overall Study||8
2493620|NCT00841269|6113834|P2|COMPLETED|Overall Study||13
2493621|NCT00841269|6113835|P1|COMPLETED|Overall Study||12
2493622|NCT00841269|6113834|P2|STARTED|Overall Study||22
2493623|NCT00841269|6113835|P1|STARTED|Overall Study||20
2493624|NCT00841204|6113846|P2|NOT COMPLETED|Overall Study||0
2493625|NCT00841204|6113847|P1|NOT COMPLETED|Overall Study||0
2493626|NCT00841204|6113846|P2|COMPLETED|Overall Study||25
2493627|NCT00841204|6113847|P1|COMPLETED|Overall Study||25
2493628|NCT00841204|6113846|P2|STARTED|Overall Study||25
2493629|NCT00841204|6113847|P1|STARTED|Overall Study||25
2493630|NCT00841100|6113867|P1|NOT COMPLETED|Phase 3 (28 Days)||0
2493631|NCT00841100|6113867|P1|COMPLETED|Phase 3 (28 Days)||4
2493632|NCT00841100|6113867|P1|STARTED|Phase 3 (28 Days)|Participants who achieved a fasting blood phenylalanine of <600 umol/l can continue to Phase 3.|4
2493633|NCT00841100|6113867|P1|NOT COMPLETED|Phase 2 (2 Weeks)||0
2493634|NCT00841100|6113867|P1|COMPLETED|Phase 2 (2 Weeks)||5
2493635|NCT00841100|6113867|P1|STARTED|Phase 2 (2 Weeks)|Participants who were non-responsive on the Phase 1 component of the study continued on to Phase 2.|5
2493636|NCT00841100|6113867|P1|NOT COMPLETED|Phase 1 (28 Days)||3
2493637|NCT00841100|6113867|P1|COMPLETED|Phase 1 (28 Days)||15
2493638|NCT00841100|6113867|P1|STARTED|Phase 1 (28 Days)|3 participants from the acute phase elected not to continue to the Phase 1 component of the study.|18
2493639|NCT00841100|6113867|P1|NOT COMPLETED|Acute Component (24 Hours)||0
2493640|NCT00841100|6113867|P1|COMPLETED|Acute Component (24 Hours)||21
2493641|NCT00841100|6113867|P1|STARTED|Acute Component (24 Hours)||21
2493642|NCT00841087|6113873|P2|NOT COMPLETED|Overall Study||0
2493643|NCT00841087|6113874|P1|NOT COMPLETED|Overall Study||0
2493644|NCT00841087|6113873|P2|COMPLETED|Overall Study||32
2493645|NCT00841087|6113874|P1|COMPLETED|Overall Study||33
2493646|NCT00841087|6113873|P2|STARTED|Overall Study||32
2493647|NCT00841087|6113874|P1|STARTED|Overall Study||33
2493648|NCT00841035|6113892|P1|NOT COMPLETED|Phase 2 of Overall Study||0
2493649|NCT00841035|6113892|P1|COMPLETED|Phase 2 of Overall Study||6
2493650|NCT00841035|6113892|P1|STARTED|Phase 2 of Overall Study||6
2493651|NCT00841035|6113892|P1|NOT COMPLETED|Phase 1 Overall Study||13
2493652|NCT00841035|6113892|P1|COMPLETED|Phase 1 Overall Study||6
2493653|NCT00841035|6113892|P1|STARTED|Phase 1 Overall Study|2 phase enrollment,1st phase enrolled with cancer by fine needle aspiration in endoscopic ultrasound|19
2493654|NCT00840996|6113899|P2|NOT COMPLETED|Overall Study||0
2493655|NCT00840996|6113900|P1|NOT COMPLETED|Overall Study||1
2493656|NCT00840996|6113899|P2|COMPLETED|Overall Study||58
2493657|NCT00840996|6113900|P1|COMPLETED|Overall Study||57
2493658|NCT00840996|6113899|P2|STARTED|Overall Study||58
2493659|NCT00840996|6113900|P1|STARTED|Overall Study||58
2493660|NCT00840879|6113920|P2|NOT COMPLETED|Second Intervention||0
2493661|NCT00840879|6113921|P1|NOT COMPLETED|Second Intervention||1
2493662|NCT00840879|6113920|P2|COMPLETED|Second Intervention||14
2493663|NCT00840879|6113921|P1|COMPLETED|Second Intervention||13
2493664|NCT00840879|6113920|P2|STARTED|Second Intervention||14
2493665|NCT00840879|6113921|P1|STARTED|Second Intervention||14
2493666|NCT00840879|6113920|P2|NOT COMPLETED|Washout: 14 Days||0
2493667|NCT00840879|6113921|P1|NOT COMPLETED|Washout: 14 Days||0
2493668|NCT00840879|6113920|P2|COMPLETED|Washout: 14 Days||14
2493669|NCT00840879|6113921|P1|COMPLETED|Washout: 14 Days||14
2493670|NCT00840879|6113920|P2|STARTED|Washout: 14 Days||14
2493671|NCT00840879|6113921|P1|STARTED|Washout: 14 Days||14
2493672|NCT00840879|6113920|P2|NOT COMPLETED|First Intervention||0
2493673|NCT00840879|6113921|P1|NOT COMPLETED|First Intervention||0
2493674|NCT00840879|6113920|P2|COMPLETED|First Intervention||14
2493675|NCT00840879|6113921|P1|COMPLETED|First Intervention||14
2493676|NCT00840879|6113920|P2|STARTED|First Intervention||14
2493677|NCT00840879|6113921|P1|STARTED|First Intervention||14
2493678|NCT00840866|6113931|P2|NOT COMPLETED|Second Intervention||0
2493679|NCT00840866|6113932|P1|NOT COMPLETED|Second Intervention||0
2493680|NCT00840866|6113931|P2|COMPLETED|Second Intervention||19
2493681|NCT00840866|6113932|P1|COMPLETED|Second Intervention||20
2493682|NCT00840866|6113931|P2|STARTED|Second Intervention||19
2493683|NCT00840866|6113932|P1|STARTED|Second Intervention||20
2493684|NCT00840866|6113931|P2|NOT COMPLETED|Washout of 7 Days||0
2493685|NCT00840866|6113932|P1|NOT COMPLETED|Washout of 7 Days||0
2493686|NCT00840866|6113931|P2|COMPLETED|Washout of 7 Days||19
2493687|NCT00840866|6113932|P1|COMPLETED|Washout of 7 Days||20
2493688|NCT00840866|6113931|P2|STARTED|Washout of 7 Days||19
2493689|NCT00840866|6113932|P1|STARTED|Washout of 7 Days||20
2493690|NCT00840866|6113931|P2|NOT COMPLETED|First Intervention||0
2493691|NCT00840866|6113932|P1|NOT COMPLETED|First Intervention||0
2493692|NCT00840866|6113931|P2|COMPLETED|First Intervention||19
2493693|NCT00840866|6113932|P1|COMPLETED|First Intervention||20
2493694|NCT00840866|6113931|P2|STARTED|First Intervention||19
2493695|NCT00840866|6113932|P1|STARTED|First Intervention||20
2493696|NCT00840840|6113942|P2|NOT COMPLETED|Period 2||0
2493697|NCT00840840|6113943|P1|NOT COMPLETED|Period 2||0
2493698|NCT00840840|6113942|P2|COMPLETED|Period 2||24
2493699|NCT00840840|6113943|P1|COMPLETED|Period 2||23
2493700|NCT00840840|6113942|P2|STARTED|Period 2||24
2493701|NCT00840840|6113943|P1|STARTED|Period 2|One subject was withdrawn due to AE after Period 1|23
2493702|NCT00840840|6113942|P2|NOT COMPLETED|Period 1||0
2493703|NCT00840840|6113943|P1|NOT COMPLETED|Period 1||0
2493704|NCT00840840|6113942|P2|COMPLETED|Period 1||24
2493705|NCT00840840|6113943|P1|COMPLETED|Period 1||24
2493706|NCT00840840|6113942|P2|STARTED|Period 1||24
2493707|NCT00840840|6113943|P1|STARTED|Period 1||24
2493708|NCT00840827|6113957|P1|NOT COMPLETED|Overall Study||6
2493709|NCT00840827|6113957|P1|COMPLETED|Overall Study||0
2493710|NCT00840827|6113957|P1|STARTED|Overall Study||6
2493711|NCT00840658|6113974|P4|NOT COMPLETED|Overall Study||4
2493712|NCT00840658|6113975|P3|NOT COMPLETED|Overall Study||5
2493713|NCT00840658|6113976|P2|NOT COMPLETED|Overall Study||3
2493714|NCT00840658|6113977|P1|NOT COMPLETED|Overall Study||5
2493715|NCT00840658|6113974|P4|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|142
2493716|NCT00840658|6113975|P3|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
2493717|NCT00840658|6113976|P2|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
2493718|NCT00840658|6113977|P1|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|139
2493719|NCT00840658|6113974|P4|STARTED|Overall Study||146
2493720|NCT00840658|6113975|P3|STARTED|Overall Study||148
2493721|NCT00840658|6113976|P2|STARTED|Overall Study||146
2493722|NCT00840658|6113977|P1|STARTED|Overall Study||144
2493723|NCT00840632|6113989|P2|NOT COMPLETED|Second Intervention||0
2493724|NCT00840632|6113990|P1|NOT COMPLETED|Second Intervention||0
2493725|NCT00840632|6113989|P2|COMPLETED|Second Intervention||18
2493726|NCT00840632|6113990|P1|COMPLETED|Second Intervention||19
2493727|NCT00840632|6113989|P2|STARTED|Second Intervention||18
2493728|NCT00840632|6113990|P1|STARTED|Second Intervention||19
2493729|NCT00840632|6113989|P2|NOT COMPLETED|Washout||1
2493730|NCT00840632|6113990|P1|NOT COMPLETED|Washout||1
2493731|NCT00840632|6113989|P2|COMPLETED|Washout||18
2493732|NCT00840632|6113990|P1|COMPLETED|Washout||19
2493733|NCT00840632|6113989|P2|STARTED|Washout||19
2493734|NCT00840632|6113990|P1|STARTED|Washout||20
2493735|NCT00840632|6113989|P2|NOT COMPLETED|First Intervention||1
2493736|NCT00840632|6113990|P1|NOT COMPLETED|First Intervention||0
2493737|NCT00840632|6113989|P2|COMPLETED|First Intervention||19
2493738|NCT00840632|6113990|P1|COMPLETED|First Intervention||20
2493739|NCT00840632|6113989|P2|STARTED|First Intervention||20
2493740|NCT00840632|6113990|P1|STARTED|First Intervention||20
2493741|NCT00840476|6114006|P2|NOT COMPLETED|Second Intervention||0
2493742|NCT00840476|6114007|P1|NOT COMPLETED|Second Intervention||0
2493743|NCT00840476|6114006|P2|COMPLETED|Second Intervention||14
2493744|NCT00840476|6114007|P1|COMPLETED|Second Intervention||14
2493745|NCT00840476|6114006|P2|STARTED|Second Intervention||14
2493746|NCT00840476|6114007|P1|STARTED|Second Intervention||14
2493747|NCT00840476|6114006|P2|NOT COMPLETED|Washout: 14 Days||0
2493748|NCT00840476|6114007|P1|NOT COMPLETED|Washout: 14 Days||0
2493749|NCT00840476|6114006|P2|COMPLETED|Washout: 14 Days||14
2493750|NCT00840476|6114007|P1|COMPLETED|Washout: 14 Days||14
2493751|NCT00840476|6114006|P2|STARTED|Washout: 14 Days||14
2493752|NCT00840476|6114007|P1|STARTED|Washout: 14 Days||14
2493753|NCT00840476|6114006|P2|NOT COMPLETED|First Intervention||0
2493754|NCT00840476|6114007|P1|NOT COMPLETED|First Intervention||0
2493755|NCT00840476|6114006|P2|COMPLETED|First Intervention||14
2493756|NCT00840476|6114007|P1|COMPLETED|First Intervention||14
2493757|NCT00840476|6114006|P2|STARTED|First Intervention||14
2493758|NCT00840476|6114007|P1|STARTED|First Intervention||14
2493759|NCT00840463|6114017|P2|NOT COMPLETED|Overall Study||0
2493760|NCT00840463|6114018|P1|NOT COMPLETED|Overall Study||1
2493761|NCT00840463|6114017|P2|COMPLETED|Overall Study||1
2493762|NCT00840463|6114018|P1|COMPLETED|Overall Study||2
2493763|NCT00840463|6114017|P2|STARTED|Overall Study||1
2493764|NCT00840463|6114018|P1|STARTED|Overall Study||3
2493765|NCT00840450|6114032|P1|NOT COMPLETED|Overall Study||3
2493766|NCT00840450|6114032|P1|COMPLETED|Overall Study||9
2493767|NCT00840450|6114032|P1|STARTED|Overall Study||12
2493768|NCT00840411|6114040|P2|NOT COMPLETED|Second Intervention||0
2493769|NCT00840411|6114041|P1|NOT COMPLETED|Second Intervention||0
2493770|NCT00840411|6114040|P2|COMPLETED|Second Intervention||33
2493771|NCT00840411|6114041|P1|COMPLETED|Second Intervention||31
2493772|NCT00840411|6114040|P2|STARTED|Second Intervention||33
2493773|NCT00840411|6114041|P1|STARTED|Second Intervention||31
2493774|NCT00840411|6114040|P2|NOT COMPLETED|Washout||0
2493775|NCT00840411|6114041|P1|NOT COMPLETED|Washout||1
2493776|NCT00840411|6114040|P2|COMPLETED|Washout||33
2493777|NCT00840411|6114041|P1|COMPLETED|Washout||31
2493778|NCT00840411|6114040|P2|STARTED|Washout||33
2493779|NCT00840411|6114041|P1|STARTED|Washout||32
2493780|NCT00840411|6114040|P2|NOT COMPLETED|First Intervention||0
2493781|NCT00840411|6114041|P1|NOT COMPLETED|First Intervention||1
2493782|NCT00840411|6114040|P2|COMPLETED|First Intervention||33
2493783|NCT00840411|6114041|P1|COMPLETED|First Intervention||32
2493784|NCT00840411|6114040|P2|STARTED|First Intervention||33
2493785|NCT00840411|6114041|P1|STARTED|First Intervention||33
2493786|NCT00840307|6114049|P1|NOT COMPLETED|Overall Study||4
2493787|NCT00840307|6114049|P1|COMPLETED|Overall Study||16
2493788|NCT00840307|6114049|P1|STARTED|Overall Study||20
2493789|NCT00840294|6114055|P2|NOT COMPLETED|Overall Study||5
2493790|NCT00840294|6114056|P1|NOT COMPLETED|Overall Study||3
2493791|NCT00840294|6114055|P2|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|38
2493792|NCT00840294|6114056|P1|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|39
2493793|NCT00840294|6114055|P2|STARTED|Overall Study||43
2493794|NCT00840294|6114056|P1|STARTED|Overall Study||42
2493795|NCT00840281|6114066|P2|NOT COMPLETED|Second Intervention||0
2493796|NCT00840281|6114067|P1|NOT COMPLETED|Second Intervention||0
2493797|NCT00840281|6114066|P2|COMPLETED|Second Intervention||19
2493798|NCT00840281|6114067|P1|COMPLETED|Second Intervention||19
2493799|NCT00840281|6114066|P2|STARTED|Second Intervention||19
2493800|NCT00840281|6114067|P1|STARTED|Second Intervention||19
2493801|NCT00840281|6114066|P2|NOT COMPLETED|Washout of 7 Days||0
2493802|NCT00840281|6114067|P1|NOT COMPLETED|Washout of 7 Days||0
2493803|NCT00840281|6114066|P2|COMPLETED|Washout of 7 Days||19
2493804|NCT00840281|6114067|P1|COMPLETED|Washout of 7 Days||19
2493805|NCT00840281|6114066|P2|STARTED|Washout of 7 Days||19
2493806|NCT00840281|6114067|P1|STARTED|Washout of 7 Days||19
2493807|NCT00840281|6114066|P2|NOT COMPLETED|First Intervention||0
2493808|NCT00840281|6114067|P1|NOT COMPLETED|First Intervention||0
2493809|NCT00840281|6114066|P2|COMPLETED|First Intervention||19
2493810|NCT00840281|6114067|P1|COMPLETED|First Intervention||19
2493811|NCT00840281|6114066|P2|STARTED|First Intervention||19
2493812|NCT00840281|6114067|P1|STARTED|First Intervention||19
2493813|NCT00840216|6114077|P2|NOT COMPLETED|Second Intervention||0
2493814|NCT00840216|6114078|P1|NOT COMPLETED|Second Intervention||0
2493815|NCT00840216|6114077|P2|COMPLETED|Second Intervention||11
2493816|NCT00840216|6114078|P1|COMPLETED|Second Intervention||10
2493817|NCT00840216|6114077|P2|STARTED|Second Intervention||11
2493818|NCT00840216|6114078|P1|STARTED|Second Intervention||10
2493819|NCT00840216|6114077|P2|NOT COMPLETED|Washout: 7 Days||0
2493820|NCT00840216|6114078|P1|NOT COMPLETED|Washout: 7 Days||1
2493821|NCT00840216|6114077|P2|COMPLETED|Washout: 7 Days||11
2493822|NCT00840216|6114078|P1|COMPLETED|Washout: 7 Days||10
2493823|NCT00840216|6114077|P2|STARTED|Washout: 7 Days||11
2493824|NCT00840216|6114078|P1|STARTED|Washout: 7 Days||11
2493825|NCT00840216|6114077|P2|NOT COMPLETED|First Intervention||0
2493826|NCT00840216|6114078|P1|NOT COMPLETED|First Intervention||0
2493827|NCT00840216|6114077|P2|COMPLETED|First Intervention||11
2493828|NCT00840216|6114078|P1|COMPLETED|First Intervention||11
2493829|NCT00840216|6114077|P2|STARTED|First Intervention||11
2493830|NCT00840216|6114078|P1|STARTED|First Intervention||11
2493831|NCT00840203|6114088|P2|NOT COMPLETED|Second Intervention||0
2493832|NCT00840203|6114089|P1|NOT COMPLETED|Second Intervention||0
2493833|NCT00840203|6114088|P2|COMPLETED|Second Intervention||34
2493834|NCT00840203|6114089|P1|COMPLETED|Second Intervention||35
2493835|NCT00840203|6114088|P2|STARTED|Second Intervention||34
2493836|NCT00840203|6114089|P1|STARTED|Second Intervention||35
2493837|NCT00840203|6114088|P2|NOT COMPLETED|Washout||0
2493838|NCT00840203|6114089|P1|NOT COMPLETED|Washout||1
2493839|NCT00840203|6114088|P2|COMPLETED|Washout||34
2493840|NCT00840203|6114089|P1|COMPLETED|Washout||35
2493841|NCT00840203|6114088|P2|STARTED|Washout||34
2493842|NCT00840203|6114089|P1|STARTED|Washout||36
2493843|NCT00840203|6114088|P2|NOT COMPLETED|First Intervention||1
2493844|NCT00840203|6114089|P1|NOT COMPLETED|First Intervention||1
2493845|NCT00840203|6114088|P2|COMPLETED|First Intervention||34
2493846|NCT00840203|6114089|P1|COMPLETED|First Intervention||36
2493847|NCT00840203|6114088|P2|STARTED|First Intervention||35
2493848|NCT00840203|6114089|P1|STARTED|First Intervention||37
2493849|NCT00840177|6114106|P3|NOT COMPLETED|Overall Study||11
2493850|NCT00840177|6114107|P2|NOT COMPLETED|Overall Study||9
2493851|NCT00840177|6114108|P1|NOT COMPLETED|Overall Study||18
2493852|NCT00840177|6114106|P3|COMPLETED|Overall Study||39
2493853|NCT00840177|6114107|P2|COMPLETED|Overall Study||20
2493854|NCT00840177|6114108|P1|COMPLETED|Overall Study||18
2493855|NCT00840177|6114106|P3|Assessed for AEs|Overall Study||46
2493856|NCT00840177|6114107|P2|Assessed for AEs|Overall Study||29
2493857|NCT00840177|6114108|P1|Assessed for AEs|Overall Study||35
2493858|NCT00840177|6114106|P3|Treated|Overall Study||46
2493859|NCT00840177|6114107|P2|Treated|Overall Study||29
2493860|NCT00840177|6114108|P1|Treated|Overall Study||36
2493861|NCT00840177|6114106|P3|STARTED|Overall Study||50
2493862|NCT00840177|6114107|P2|STARTED|Overall Study||29
2493863|NCT00840177|6114108|P1|STARTED|Overall Study||36
2493864|NCT00840099|6114127|P2|NOT COMPLETED|Period 2||0
2493865|NCT00840099|6114128|P1|NOT COMPLETED|Period 2||0
2493866|NCT00840099|6114127|P2|COMPLETED|Period 2||24
2493867|NCT00840099|6114128|P1|COMPLETED|Period 2||21
2493868|NCT00840099|6114127|P2|STARTED|Period 2||24
2493869|NCT00840099|6114128|P1|STARTED|Period 2|3 subjects were dismissed from study prior to period 2 dosing|21
2493870|NCT00840099|6114127|P2|NOT COMPLETED|Period 1||0
2493871|NCT00840099|6114128|P1|NOT COMPLETED|Period 1||0
2493872|NCT00840099|6114127|P2|COMPLETED|Period 1||24
2493873|NCT00840099|6114128|P1|COMPLETED|Period 1||24
2493874|NCT00840099|6114127|P2|STARTED|Period 1||24
2493875|NCT00840099|6114128|P1|STARTED|Period 1||24
2493876|NCT00840086|6114142|P1|NOT COMPLETED|Overall Study||4
2493877|NCT00840086|6114142|P1|COMPLETED|Overall Study||146
2493878|NCT00840086|6114142|P1|STARTED|Overall Study||150
2493879|NCT00840073|6114151|P2|NOT COMPLETED|Second Intervention||1
2493880|NCT00840073|6114152|P1|NOT COMPLETED|Second Intervention||1
2493881|NCT00840073|6114151|P2|COMPLETED|Second Intervention||24
2493882|NCT00840073|6114152|P1|COMPLETED|Second Intervention||24
2493883|NCT00840073|6114151|P2|STARTED|Second Intervention||25
2493884|NCT00840073|6114152|P1|STARTED|Second Intervention||25
2493885|NCT00840073|6114151|P2|NOT COMPLETED|First Intervention||0
2493886|NCT00840073|6114152|P1|NOT COMPLETED|First Intervention||0
2493887|NCT00840073|6114151|P2|COMPLETED|First Intervention||25
2493888|NCT00840073|6114152|P1|COMPLETED|First Intervention||25
2493889|NCT00840073|6114151|P2|STARTED|First Intervention||25
2493890|NCT00840073|6114152|P1|STARTED|First Intervention||25
2493891|NCT00840060|6114166|P2|NOT COMPLETED|Overall Study||1
2493892|NCT00840060|6114167|P1|NOT COMPLETED|Overall Study||1
2493893|NCT00840060|6114166|P2|COMPLETED|Overall Study||19
2493894|NCT00840060|6114167|P1|COMPLETED|Overall Study||19
2493895|NCT00840060|6114166|P2|STARTED|Overall Study||20
2493896|NCT00840060|6114167|P1|STARTED|Overall Study||20
2493897|NCT00840034|6114177|P2|NOT COMPLETED|Taper Phase||2
2493898|NCT00840034|6114178|P1|NOT COMPLETED|Taper Phase||3
2493899|NCT00840034|6114177|P2|COMPLETED|Taper Phase||80
2493900|NCT00840034|6114178|P1|COMPLETED|Taper Phase||87
2493901|NCT00840034|6114177|P2|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|82
2493902|NCT00840034|6114178|P1|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|90
2493903|NCT00840034|6114177|P2|NOT COMPLETED|Acute Treatment Phase||36
2493904|NCT00840034|6114178|P1|NOT COMPLETED|Acute Treatment Phase||21
2493905|NCT00840034|6114177|P2|COMPLETED|Acute Treatment Phase||80
2493906|NCT00840034|6114178|P1|COMPLETED|Acute Treatment Phase||90
2493907|NCT00840034|6114177|P2|STARTED|Acute Treatment Phase||116
2493908|NCT00840034|6114178|P1|STARTED|Acute Treatment Phase||111
2493909|NCT00839982|6114214|P4|NOT COMPLETED|Overall Study||0
2493910|NCT00839982|6114215|P3|NOT COMPLETED|Overall Study||0
2493911|NCT00839982|6114216|P2|NOT COMPLETED|Overall Study||0
2493912|NCT00839982|6114217|P1|NOT COMPLETED|Overall Study||0
2493913|NCT00839982|6114214|P4|COMPLETED|Overall Study||3
2493914|NCT00839982|6114215|P3|COMPLETED|Overall Study||2
2493915|NCT00839982|6114216|P2|COMPLETED|Overall Study||26
2493916|NCT00839982|6114217|P1|COMPLETED|Overall Study||4
2493917|NCT00839982|6114214|P4|STARTED|Overall Study||3
2493918|NCT00839982|6114215|P3|STARTED|Overall Study||2
2493919|NCT00839982|6114216|P2|STARTED|Overall Study||26
2493920|NCT00839982|6114217|P1|STARTED|Overall Study||4
2493921|NCT00839956|6114231|P1|NOT COMPLETED|Overall Study||12
2493922|NCT00839956|6114231|P1|COMPLETED|Overall Study||19
2493923|NCT00839956|6114231|P1|STARTED|Overall Study||31
2493924|NCT00839930|6114240|P2|NOT COMPLETED|Second Intervention||0
2493925|NCT00839930|6114241|P1|NOT COMPLETED|Second Intervention||0
2493926|NCT00839930|6114240|P2|COMPLETED|Second Intervention||15
2493927|NCT00839930|6114241|P1|COMPLETED|Second Intervention||15
2493928|NCT00839930|6114240|P2|STARTED|Second Intervention||15
2493929|NCT00839930|6114241|P1|STARTED|Second Intervention||15
2493930|NCT00839930|6114240|P2|NOT COMPLETED|Washout: 7 Days||0
2493931|NCT00839930|6114241|P1|NOT COMPLETED|Washout: 7 Days||0
2493932|NCT00839930|6114240|P2|COMPLETED|Washout: 7 Days||15
2493933|NCT00839930|6114241|P1|COMPLETED|Washout: 7 Days||15
2493934|NCT00839930|6114240|P2|STARTED|Washout: 7 Days||15
2493935|NCT00839930|6114241|P1|STARTED|Washout: 7 Days||15
2493936|NCT00839930|6114240|P2|NOT COMPLETED|First Intervention||0
2493937|NCT00839930|6114241|P1|NOT COMPLETED|First Intervention||0
2493938|NCT00839930|6114240|P2|COMPLETED|First Intervention||15
2493939|NCT00839930|6114241|P1|COMPLETED|First Intervention||15
2493940|NCT00839930|6114240|P2|STARTED|First Intervention||15
2493941|NCT00839930|6114241|P1|STARTED|First Intervention||15
2493942|NCT00839917|6114251|P2|NOT COMPLETED|Overall Study||1
2493943|NCT00839917|6114252|P1|NOT COMPLETED|Overall Study||1
2493944|NCT00839917|6114251|P2|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|16
2493945|NCT00839917|6114252|P1|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|12
2493946|NCT00839917|6114251|P2|STARTED|Overall Study||17
2493947|NCT00839917|6114252|P1|STARTED|Overall Study||13
2493948|NCT00839852|6114288|P1|NOT COMPLETED|Overall Study||47
2493949|NCT00839852|6114288|P1|COMPLETED|Overall Study||46
2493950|NCT00839852|6114288|P1|STARTED|Overall Study||93
2493951|NCT00839800|6114295|P2|NOT COMPLETED|Overall Study||110
2493952|NCT00839800|6114296|P1|NOT COMPLETED|Overall Study||93
2493953|NCT00839800|6114295|P2|COMPLETED|Overall Study||932
2493954|NCT00839800|6114296|P1|COMPLETED|Overall Study||956
2493955|NCT00839800|6114295|P2|STARTED|Overall Study||1042
2493956|NCT00839800|6114296|P1|STARTED|Overall Study||1049
2493957|NCT00839540|6114329|P3|NOT COMPLETED|Overall Study||0
2493958|NCT00839540|6114330|P2|NOT COMPLETED|Overall Study||0
2493959|NCT00839540|6114331|P1|NOT COMPLETED|Overall Study||0
2493960|NCT00839540|6114329|P3|COMPLETED|Overall Study||5
2493961|NCT00839540|6114330|P2|COMPLETED|Overall Study||8
2493962|NCT00839540|6114331|P1|COMPLETED|Overall Study||8
2493963|NCT00839540|6114329|P3|STARTED|Overall Study||5
2493964|NCT00839540|6114330|P2|STARTED|Overall Study||8
2493965|NCT00839540|6114331|P1|STARTED|Overall Study||8
2493966|NCT00839527|6114342|P3|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||62
2493967|NCT00839527|6114343|P2|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||56
2493968|NCT00839527|6114344|P1|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||28
2493969|NCT00839527|6114342|P3|COMPLETED|Follow-up Period (FUP) (8 Weeks)||204
2493970|NCT00839527|6114343|P2|COMPLETED|Follow-up Period (FUP) (8 Weeks)||217
2493971|NCT00839527|6114344|P1|COMPLETED|Follow-up Period (FUP) (8 Weeks)||86
2493972|NCT00839527|6114342|P3|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Five par. did not participate in the FUP.|266
2493973|NCT00839527|6114343|P2|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Four par. did not participate in the FUP.|273
2493974|NCT00839527|6114344|P1|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|114
2493975|NCT00839527|6114342|P3|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||119
2493976|NCT00839527|6114343|P2|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||118
2493977|NCT00839527|6114344|P1|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||60
2493978|NCT00839527|6114342|P3|COMPLETED|Treatment Period (TP) (156 Weeks)||152
2493979|NCT00839527|6114343|P2|COMPLETED|Treatment Period (TP) (156 Weeks)||159
2493980|NCT00839527|6114344|P1|COMPLETED|Treatment Period (TP) (156 Weeks)||55
2493981|NCT00839527|6114342|P3|STARTED|Treatment Period (TP) (156 Weeks)||271
2493982|NCT00839527|6114343|P2|STARTED|Treatment Period (TP) (156 Weeks)||277
2493983|NCT00839527|6114344|P1|STARTED|Treatment Period (TP) (156 Weeks)||115
2493984|NCT00839436|6114379|P3|NOT COMPLETED|Overall Study||1
2493985|NCT00839436|6114380|P2|NOT COMPLETED|Overall Study||1
2493986|NCT00839436|6114381|P1|NOT COMPLETED|Overall Study||1
2493987|NCT00839436|6114379|P3|COMPLETED|Overall Study||0
2493988|NCT00839436|6114380|P2|COMPLETED|Overall Study||4
2493989|NCT00839436|6114381|P1|COMPLETED|Overall Study||2
2493990|NCT00839436|6114379|P3|STARTED|Overall Study||1
2493991|NCT00839436|6114380|P2|STARTED|Overall Study||5
2493992|NCT00839436|6114381|P1|STARTED|Overall Study||3
2493993|NCT00839423|6114393|P4|NOT COMPLETED|Overall Study||20
2493994|NCT00839423|6114394|P3|NOT COMPLETED|Overall Study||18
2493995|NCT00839423|6114395|P2|NOT COMPLETED|Overall Study||10
2493996|NCT00839423|6114396|P1|NOT COMPLETED|Overall Study||18
2493997|NCT00839423|6114393|P4|COMPLETED|Overall Study||93
2493998|NCT00839423|6114394|P3|COMPLETED|Overall Study||82
2493999|NCT00839423|6114395|P2|COMPLETED|Overall Study||98
2494000|NCT00839423|6114396|P1|COMPLETED|Overall Study||87
2494001|NCT00839423|6114393|P4|STARTED|Overall Study||113
2494002|NCT00839423|6114394|P3|STARTED|Overall Study||100
2494003|NCT00839423|6114395|P2|STARTED|Overall Study||108
2494004|NCT00839423|6114396|P1|STARTED|Overall Study||105
2494005|NCT00839332|6114437|P3|NOT COMPLETED|Phase 2||39
2494006|NCT00839332|6114438|P2|NOT COMPLETED|Phase 2||68
2494007|NCT00839332|6114439|P1|NOT COMPLETED|Phase 2||0
2494008|NCT00839332|6114437|P3|COMPLETED|Phase 2||0
2494009|NCT00839332|6114438|P2|COMPLETED|Phase 2||0
2494010|NCT00839332|6114439|P1|COMPLETED|Phase 2||0
2494011|NCT00839332|6114437|P3|Received at Least 1 Dose of Study Drug|Phase 2||34
2494012|NCT00839332|6114438|P2|Received at Least 1 Dose of Study Drug|Phase 2||65
2494013|NCT00839332|6114439|P1|Received at Least 1 Dose of Study Drug|Phase 2||0
2494014|NCT00839332|6114437|P3|STARTED|Phase 2||39
2494015|NCT00839332|6114438|P2|STARTED|Phase 2||68
2494016|NCT00839332|6114439|P1|STARTED|Phase 2|Participants in Phase 1 did not participate in Phase 2.|0
2494017|NCT00839332|6114437|P3|NOT COMPLETED|Phase 1||0
2494018|NCT00839332|6114438|P2|NOT COMPLETED|Phase 1||0
2494019|NCT00839332|6114439|P1|NOT COMPLETED|Phase 1||50
2494020|NCT00839332|6114437|P3|COMPLETED|Phase 1||0
2494021|NCT00839332|6114438|P2|COMPLETED|Phase 1||0
2494022|NCT00839332|6114439|P1|COMPLETED|Phase 1||0
2494023|NCT00839332|6114437|P3|Received at Least 1 Dose of Study Drug|Phase 1||0
2494024|NCT00839332|6114438|P2|Received at Least 1 Dose of Study Drug|Phase 1||0
2494025|NCT00839332|6114439|P1|Received at Least 1 Dose of Study Drug|Phase 1||50
2494026|NCT00839332|6114437|P3|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0
2494027|NCT00839332|6114438|P2|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0
2494028|NCT00839332|6114439|P1|STARTED|Phase 1||50
2494029|NCT00839319|6114467|P5|NOT COMPLETED|Overall Study||0
2494030|NCT00839319|6114468|P4|NOT COMPLETED|Overall Study||3
2494031|NCT00839319|6114469|P3|NOT COMPLETED|Overall Study||3
2494032|NCT00839319|6114470|P2|NOT COMPLETED|Overall Study||1
2494033|NCT00839319|6114471|P1|NOT COMPLETED|Overall Study||2
2494034|NCT00839319|6114467|P5|COMPLETED|Overall Study||8
2494035|NCT00839319|6114468|P4|COMPLETED|Overall Study|1 withdrawn by investigator for syncopal reaction , 2 excluded from analysis (low serum LH)|5
2494036|NCT00839319|6114469|P3|COMPLETED|Overall Study|1 dropped out after Day 1 visit, 2 excluded from analysis (low serum LH)|5
2494037|NCT00839319|6114470|P2|COMPLETED|Overall Study|1 excluded from analysis (low serum LH)|7
2494038|NCT00839319|6114471|P1|COMPLETED|Overall Study|1 withdrew consent prior to procedures; 1 excluded from analysis (low serum LH)|6
2494039|NCT00839319|6114467|P5|STARTED|Overall Study||8
2494040|NCT00839319|6114468|P4|STARTED|Overall Study||8
2494041|NCT00839319|6114469|P3|STARTED|Overall Study||8
2494042|NCT00839319|6114470|P2|STARTED|Overall Study||8
2494043|NCT00839319|6114471|P1|STARTED|Overall Study||8
2494044|NCT00839306|6114500|P2|NOT COMPLETED|Overall Study||43
2494045|NCT00839306|6114501|P1|NOT COMPLETED|Overall Study||25
2494046|NCT00839306|6114500|P2|COMPLETED|Overall Study||134
2494047|NCT00839306|6114501|P1|COMPLETED|Overall Study||35
2494048|NCT00839306|6114500|P2|STARTED|Overall Study|Treated|177
2494049|NCT00839306|6114501|P1|STARTED|Overall Study|Treated|60
2494050|NCT00839241|6114511|P2|NOT COMPLETED|Overall Study||17
2494051|NCT00839241|6114512|P1|NOT COMPLETED|Overall Study||5
2494052|NCT00839241|6114511|P2|COMPLETED|Overall Study||8
2494053|NCT00839241|6114512|P1|COMPLETED|Overall Study||15
2494054|NCT00839241|6114511|P2|STARTED|Overall Study||25
2494055|NCT00839241|6114512|P1|STARTED|Overall Study||20
2494056|NCT00839098|6114599|P3|NOT COMPLETED|Overall Study||7
2494057|NCT00839098|6114600|P2|NOT COMPLETED|Overall Study||1
2494058|NCT00839098|6114601|P1|NOT COMPLETED|Overall Study||2
2494059|NCT00839098|6114599|P3|COMPLETED|Overall Study||6
2494060|NCT00839098|6114600|P2|COMPLETED|Overall Study||11
2494061|NCT00839098|6114601|P1|COMPLETED|Overall Study||1
2494062|NCT00839098|6114599|P3|STARTED|Overall Study||13
2494063|NCT00839098|6114600|P2|STARTED|Overall Study||12
2494064|NCT00839098|6114601|P1|STARTED|Overall Study||3
2494065|NCT00839072|6114627|P2|NOT COMPLETED|Second Intervention Period||0
2494066|NCT00839072|6114628|P1|NOT COMPLETED|Second Intervention Period||1
2494067|NCT00839072|6114627|P2|COMPLETED|Second Intervention Period||11
2494068|NCT00839072|6114628|P1|COMPLETED|Second Intervention Period||9
2494069|NCT00839072|6114627|P2|STARTED|Second Intervention Period||11
2494070|NCT00839072|6114628|P1|STARTED|Second Intervention Period||10
2494071|NCT00839072|6114627|P2|NOT COMPLETED|Washout Period of 7 Days||0
2494072|NCT00839072|6114628|P1|NOT COMPLETED|Washout Period of 7 Days||0
2494073|NCT00839072|6114627|P2|COMPLETED|Washout Period of 7 Days||11
2494074|NCT00839072|6114628|P1|COMPLETED|Washout Period of 7 Days||10
2494075|NCT00839072|6114627|P2|STARTED|Washout Period of 7 Days||11
2494076|NCT00839072|6114628|P1|STARTED|Washout Period of 7 Days||10
2494077|NCT00839072|6114627|P2|NOT COMPLETED|First Intervention Period||1
2494078|NCT00839072|6114628|P1|NOT COMPLETED|First Intervention Period||2
2494079|NCT00839072|6114627|P2|COMPLETED|First Intervention Period||11
2494080|NCT00839072|6114628|P1|COMPLETED|First Intervention Period||10
2494081|NCT00839072|6114627|P2|STARTED|First Intervention Period||12
2494082|NCT00839072|6114628|P1|STARTED|First Intervention Period||12
2494083|NCT00838981|6114648|P4|NOT COMPLETED|Day 4 to Week 11||7
2494084|NCT00838981|6114649|P3|NOT COMPLETED|Day 4 to Week 11||11
2494085|NCT00838981|6114650|P2|NOT COMPLETED|Day 4 to Week 11||8
2494086|NCT00838981|6114651|P1|NOT COMPLETED|Day 4 to Week 11||7
2494087|NCT00838981|6114648|P4|COMPLETED|Day 4 to Week 11||12
2494088|NCT00838981|6114649|P3|COMPLETED|Day 4 to Week 11||16
2494089|NCT00838981|6114650|P2|COMPLETED|Day 4 to Week 11||11
2494090|NCT00838981|6114651|P1|COMPLETED|Day 4 to Week 11||19
2494091|NCT00838981|6114648|P4|Completed Main Treatment on 400mg|Day 4 to Week 11||14
2494092|NCT00838981|6114649|P3|Completed Main Treatment on 400mg|Day 4 to Week 11||17
2494093|NCT00838981|6114650|P2|Completed Main Treatment on 400mg|Day 4 to Week 11||13
2494094|NCT00838981|6114651|P1|Completed Main Treatment on 400mg|Day 4 to Week 11||22
2494095|NCT00838981|6114648|P4|STARTED|Day 4 to Week 11||19
2494096|NCT00838981|6114649|P3|STARTED|Day 4 to Week 11||27
2494097|NCT00838981|6114650|P2|STARTED|Day 4 to Week 11||19
2494098|NCT00838981|6114651|P1|STARTED|Day 4 to Week 11||26
2494099|NCT00838981|6114648|P4|NOT COMPLETED|Week 1 Days 1-3||0
2494100|NCT00838981|6114649|P3|NOT COMPLETED|Week 1 Days 1-3||0
2494101|NCT00838981|6114650|P2|NOT COMPLETED|Week 1 Days 1-3||0
2494102|NCT00838981|6114651|P1|NOT COMPLETED|Week 1 Days 1-3||0
2494103|NCT00838981|6114648|P4|COMPLETED|Week 1 Days 1-3||19
2494104|NCT00838981|6114649|P3|COMPLETED|Week 1 Days 1-3||27
2494105|NCT00838981|6114650|P2|COMPLETED|Week 1 Days 1-3||19
2494106|NCT00838981|6114651|P1|COMPLETED|Week 1 Days 1-3||26
2494107|NCT00838981|6114648|P4|STARTED|Week 1 Days 1-3||19
2494108|NCT00838981|6114649|P3|STARTED|Week 1 Days 1-3||27
2494109|NCT00838981|6114650|P2|STARTED|Week 1 Days 1-3||19
2494110|NCT00838981|6114651|P1|STARTED|Week 1 Days 1-3||26
2494111|NCT00838929|6114672|P3|NOT COMPLETED|Overall Study||1
2494112|NCT00838929|6114673|P2|NOT COMPLETED|Overall Study||3
2494113|NCT00838929|6114674|P1|NOT COMPLETED|Overall Study||0
2494114|NCT00838929|6114672|P3|COMPLETED|Overall Study||5
2494115|NCT00838929|6114673|P2|COMPLETED|Overall Study||5
2494116|NCT00838929|6114674|P1|COMPLETED|Overall Study||3
2494117|NCT00838929|6114672|P3|STARTED|Overall Study||6
2494118|NCT00838929|6114673|P2|STARTED|Overall Study||8
2494119|NCT00838929|6114674|P1|STARTED|Overall Study||3
2494120|NCT00838916|6114682|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||51
2494121|NCT00838916|6114683|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||96
2494122|NCT00838916|6114682|P2|COMPLETED|Follow-up Period (8 Weeks)||190
2494123|NCT00838916|6114683|P1|COMPLETED|Follow-up Period (8 Weeks)||408
2494124|NCT00838916|6114682|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|241
2494125|NCT00838916|6114683|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|504
2494126|NCT00838916|6114682|P2|NOT COMPLETED|Treatment Period (156 Weeks)||77
2494127|NCT00838916|6114683|P1|NOT COMPLETED|Treatment Period (156 Weeks)||196
2494128|NCT00838916|6114682|P2|COMPLETED|Treatment Period (156 Weeks)||164
2494129|NCT00838916|6114683|P1|COMPLETED|Treatment Period (156 Weeks)||308
2494130|NCT00838916|6114682|P2|STARTED|Treatment Period (156 Weeks)||241
2494131|NCT00838916|6114683|P1|STARTED|Treatment Period (156 Weeks)||504
2494132|NCT00838903|6114712|P4|NOT COMPLETED|Follow-up Period (8 Weeks)||58
2494133|NCT00838903|6114713|P3|NOT COMPLETED|Follow-up Period (8 Weeks)||64
2494134|NCT00838903|6114714|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||65
2494135|NCT00838903|6114715|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||26
2494136|NCT00838903|6114712|P4|COMPLETED|Follow-up Period (8 Weeks)||244
2494137|NCT00838903|6114713|P3|COMPLETED|Follow-up Period (8 Weeks)||243
2494138|NCT00838903|6114714|P2|COMPLETED|Follow-up Period (8 Weeks)||237
2494139|NCT00838903|6114715|P1|COMPLETED|Follow-up Period (8 Weeks)||75
2494140|NCT00838903|6114712|P4|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
2494141|NCT00838903|6114713|P3|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|307
2494142|NCT00838903|6114714|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
2494143|NCT00838903|6114715|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
2494144|NCT00838903|6114712|P4|NOT COMPLETED|Treatment Period (156 Weeks)||110
2494145|NCT00838903|6114713|P3|NOT COMPLETED|Treatment Period (156 Weeks)||116
2494146|NCT00838903|6114714|P2|NOT COMPLETED|Treatment Period (156 Weeks)||112
2494147|NCT00838903|6114715|P1|NOT COMPLETED|Treatment Period (156 Weeks)||46
2494148|NCT00838903|6114712|P4|COMPLETED|Treatment Period (156 Weeks)||192
2494149|NCT00838903|6114713|P3|COMPLETED|Treatment Period (156 Weeks)||191
2494150|NCT00838903|6114714|P2|COMPLETED|Treatment Period (156 Weeks)||190
2494151|NCT00838903|6114715|P1|COMPLETED|Treatment Period (156 Weeks)||55
2494152|NCT00838903|6114712|P4|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
2494153|NCT00838903|6114713|P3|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
2494154|NCT00838903|6114714|P2|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
2494155|NCT00838903|6114715|P1|Missing Active Treatment Status|Treatment Period (156 Weeks)||1
2494156|NCT00838903|6114712|P4|STARTED|Treatment Period (156 Weeks)||302
2494157|NCT00838903|6114713|P3|STARTED|Treatment Period (156 Weeks)||307
2494158|NCT00838903|6114714|P2|STARTED|Treatment Period (156 Weeks)||302
2494159|NCT00838903|6114715|P1|STARTED|Treatment Period (156 Weeks)||101
2494160|NCT00838695|6114759|P2|NOT COMPLETED|Overall Study||0
2494161|NCT00838695|6114760|P1|NOT COMPLETED|Overall Study||0
2494162|NCT00838695|6114759|P2|COMPLETED|Overall Study||64
2494163|NCT00838695|6114760|P1|COMPLETED|Overall Study||42
2494164|NCT00838695|6114759|P2|STARTED|Overall Study||64
2494165|NCT00838695|6114760|P1|STARTED|Overall Study||42
2494166|NCT00838682|6114770|P2|NOT COMPLETED|Overall Study||19
2494167|NCT00838682|6114771|P1|NOT COMPLETED|Overall Study||25
2494168|NCT00838682|6114770|P2|COMPLETED|Overall Study||33
2494169|NCT00838682|6114771|P1|COMPLETED|Overall Study||29
2494170|NCT00838682|6114770|P2|STARTED|Overall Study||52
2494171|NCT00838682|6114771|P1|STARTED|Overall Study||54
2494172|NCT00838630|6114789|P2|NOT COMPLETED|Second Intervention||0
2494173|NCT00838630|6114790|P1|NOT COMPLETED|Second Intervention||0
2494174|NCT00838630|6114789|P2|COMPLETED|Second Intervention||18
2494175|NCT00838630|6114790|P1|COMPLETED|Second Intervention||16
2494176|NCT00838630|6114789|P2|STARTED|Second Intervention||18
2494177|NCT00838630|6114790|P1|STARTED|Second Intervention||16
2494178|NCT00838630|6114789|P2|NOT COMPLETED|Washout: 7 Days||0
2494179|NCT00838630|6114790|P1|NOT COMPLETED|Washout: 7 Days||1
2494180|NCT00838630|6114789|P2|COMPLETED|Washout: 7 Days||18
2494181|NCT00838630|6114790|P1|COMPLETED|Washout: 7 Days||16
2494182|NCT00838630|6114789|P2|STARTED|Washout: 7 Days||18
2494183|NCT00838630|6114790|P1|STARTED|Washout: 7 Days||17
2494184|NCT00838630|6114789|P2|NOT COMPLETED|First Intervention||0
2494185|NCT00838630|6114790|P1|NOT COMPLETED|First Intervention||1
2494186|NCT00838630|6114789|P2|COMPLETED|First Intervention||18
2494187|NCT00838630|6114790|P1|COMPLETED|First Intervention||17
2494188|NCT00838630|6114789|P2|STARTED|First Intervention||18
2494189|NCT00838630|6114790|P1|STARTED|First Intervention||18
2494190|NCT00838578|6114798|P1|NOT COMPLETED|Overall Study||2
2494191|NCT00838578|6114798|P1|COMPLETED|Overall Study||63
2494192|NCT00838578|6114798|P1|STARTED|Overall Study|In this Ph 1/2 study, 65 subjects were enrolled; 2 were protocol violators, so only 63 treated.|65
2494193|NCT00838565|6114812|P6|NOT COMPLETED|Overall Study||2
2494194|NCT00838565|6114813|P5|NOT COMPLETED|Overall Study||0
2494195|NCT00838565|6114814|P4|NOT COMPLETED|Overall Study||0
2494196|NCT00838565|6114815|P3|NOT COMPLETED|Overall Study||1
2494197|NCT00838565|6114816|P2|NOT COMPLETED|Overall Study||3
2494198|NCT00838565|6114817|P1|NOT COMPLETED|Overall Study||0
2494199|NCT00838565|6114812|P6|COMPLETED|Overall Study||5
2494200|NCT00838565|6114813|P5|COMPLETED|Overall Study||6
2494201|NCT00838565|6114814|P4|COMPLETED|Overall Study||6
2494202|NCT00838565|6114815|P3|COMPLETED|Overall Study||5
2494203|NCT00838565|6114816|P2|COMPLETED|Overall Study||4
2494204|NCT00838565|6114817|P1|COMPLETED|Overall Study||9
2494205|NCT00838565|6114812|P6|Treated|Overall Study||7
2494206|NCT00838565|6114813|P5|Treated|Overall Study||6
2494207|NCT00838565|6114814|P4|Treated|Overall Study||6
2494208|NCT00838565|6114815|P3|Treated|Overall Study||6
2494209|NCT00838565|6114816|P2|Treated|Overall Study||6
2494210|NCT00838565|6114817|P1|Treated|Overall Study||9
2494211|NCT00838565|6114812|P6|STARTED|Overall Study||7
2494212|NCT00838565|6114813|P5|STARTED|Overall Study||6
2494213|NCT00838565|6114814|P4|STARTED|Overall Study||6
2494214|NCT00838565|6114815|P3|STARTED|Overall Study||6
2494215|NCT00838565|6114816|P2|STARTED|Overall Study||7
2494216|NCT00838565|6114817|P1|STARTED|Overall Study||9
2494217|NCT00838539|6114922|P12|NOT COMPLETED|Overall Study||4
2494218|NCT00838539|6114923|P11|NOT COMPLETED|Overall Study||5
2494219|NCT00838539|6114924|P10|NOT COMPLETED|Overall Study||8
2494220|NCT00838539|6114925|P9|NOT COMPLETED|Overall Study||5
2494221|NCT00838539|6114926|P8|NOT COMPLETED|Overall Study||6
2494222|NCT00838539|6114927|P7|NOT COMPLETED|Overall Study||5
2494223|NCT00838539|6114928|P6|NOT COMPLETED|Overall Study||4
2494224|NCT00838539|6114929|P5|NOT COMPLETED|Overall Study||6
2494225|NCT00838539|6114930|P4|NOT COMPLETED|Overall Study||4
2494226|NCT00838539|6114931|P3|NOT COMPLETED|Overall Study||5
2494227|NCT00838539|6114932|P2|NOT COMPLETED|Overall Study||6
2494228|NCT00838539|6114933|P1|NOT COMPLETED|Overall Study||3
2494229|NCT00838539|6114922|P12|COMPLETED|Overall Study||0
2494230|NCT00838539|6114923|P11|COMPLETED|Overall Study||0
2494231|NCT00838539|6114924|P10|COMPLETED|Overall Study||0
2494232|NCT00838539|6114925|P9|COMPLETED|Overall Study||0
2494233|NCT00838539|6114926|P8|COMPLETED|Overall Study||0
2494234|NCT00838539|6114927|P7|COMPLETED|Overall Study||2
2494235|NCT00838539|6114928|P6|COMPLETED|Overall Study||0
2494236|NCT00838539|6114929|P5|COMPLETED|Overall Study||0
2494237|NCT00838539|6114930|P4|COMPLETED|Overall Study||0
2494238|NCT00838539|6114931|P3|COMPLETED|Overall Study||0
2494239|NCT00838539|6114932|P2|COMPLETED|Overall Study||0
2494240|NCT00838539|6114933|P1|COMPLETED|Overall Study||0
2494241|NCT00838539|6114922|P12|Received Treatment|Overall Study||4
2494242|NCT00838539|6114923|P11|Received Treatment|Overall Study||5
2494243|NCT00838539|6114924|P10|Received Treatment|Overall Study||8
2494244|NCT00838539|6114925|P9|Received Treatment|Overall Study||5
2494245|NCT00838539|6114926|P8|Received Treatment|Overall Study||6
2494246|NCT00838539|6114927|P7|Received Treatment|Overall Study||7
2494247|NCT00838539|6114928|P6|Received Treatment|Overall Study||4
2494248|NCT00838539|6114929|P5|Received Treatment|Overall Study||4
2494249|NCT00838539|6114930|P4|Received Treatment|Overall Study||4
2494250|NCT00838539|6114931|P3|Received Treatment|Overall Study||5
2494251|NCT00838539|6114932|P2|Received Treatment|Overall Study||5
2494252|NCT00838539|6114933|P1|Received Treatment|Overall Study||3
2494253|NCT00838539|6114922|P12|STARTED|Overall Study||4
2494254|NCT00838539|6114923|P11|STARTED|Overall Study||5
2494255|NCT00838539|6114924|P10|STARTED|Overall Study||8
2494256|NCT00838539|6114925|P9|STARTED|Overall Study||5
2494257|NCT00838539|6114926|P8|STARTED|Overall Study||6
2494258|NCT00838539|6114927|P7|STARTED|Overall Study||7
2494259|NCT00838539|6114928|P6|STARTED|Overall Study||4
2494260|NCT00838539|6114929|P5|STARTED|Overall Study||6
2494261|NCT00838539|6114930|P4|STARTED|Overall Study||4
2494262|NCT00838539|6114931|P3|STARTED|Overall Study||5
2494263|NCT00838539|6114932|P2|STARTED|Overall Study||6
2494264|NCT00838539|6114933|P1|STARTED|Overall Study||3
2494265|NCT00838526|6114983|P2|NOT COMPLETED|Overall Study||39
2494266|NCT00838526|6114984|P1|NOT COMPLETED|Overall Study||24
2494267|NCT00838526|6114983|P2|COMPLETED|Overall Study||137
2494268|NCT00838526|6114984|P1|COMPLETED|Overall Study||35
2494269|NCT00838526|6114983|P2|STARTED|Overall Study|Treated|176
2494270|NCT00838526|6114984|P1|STARTED|Overall Study|Treated|59
2494271|NCT00838513|6114992|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
2494272|NCT00838513|6114992|P1|COMPLETED|Post Treatment Period (Patients Who Disc||4
2494273|NCT00838513|6114992|P1|STARTED|Post Treatment Period (Patients Who Disc||5
2494274|NCT00838513|6114992|P1|NOT COMPLETED|Extension Treatment Period||1
2494275|NCT00838513|6114992|P1|COMPLETED|Extension Treatment Period||18
2494276|NCT00838513|6114992|P1|STARTED|Extension Treatment Period||19
2494277|NCT00838513|6114992|P1|NOT COMPLETED|Treatment Period (26 Weeks)||0
2494278|NCT00838513|6114992|P1|COMPLETED|Treatment Period (26 Weeks)||20
2494279|NCT00838513|6114992|P1|STARTED|Treatment Period (26 Weeks)||20
2494280|NCT00838513|6114992|P1|NOT COMPLETED|Observation Period (8 Weeks)||0
2494281|NCT00838513|6114992|P1|COMPLETED|Observation Period (8 Weeks)||20
2494282|NCT00838513|6114992|P1|STARTED|Observation Period (8 Weeks)||20
2494283|NCT00838513|6114992|P1|NOT COMPLETED|Screening Period||3
2494284|NCT00838513|6114992|P1|COMPLETED|Screening Period||20
2494285|NCT00838513|6114992|P1|STARTED|Screening Period||23
2494286|NCT00838331|6115008|P1|NOT COMPLETED|Aged Blood Transfusion||9
2494287|NCT00838331|6115008|P1|COMPLETED|Aged Blood Transfusion||8
2494288|NCT00838331|6115008|P1|STARTED|Aged Blood Transfusion||17
2494289|NCT00838331|6115008|P1|NOT COMPLETED|Fresh Blood Transfusion||0
2494290|NCT00838331|6115008|P1|COMPLETED|Fresh Blood Transfusion||17
2494291|NCT00838331|6115008|P1|STARTED|Fresh Blood Transfusion||17
2494292|NCT00838279|6115014|P2|NOT COMPLETED|Second Intervention||0
2494293|NCT00838279|6115015|P1|NOT COMPLETED|Second Intervention||0
2494294|NCT00838279|6115014|P2|COMPLETED|Second Intervention||15
2494295|NCT00838279|6115015|P1|COMPLETED|Second Intervention||15
2494296|NCT00838279|6115014|P2|STARTED|Second Intervention||15
2494297|NCT00838279|6115015|P1|STARTED|Second Intervention||15
2494298|NCT00838279|6115014|P2|NOT COMPLETED|Washout||1
2494299|NCT00838279|6115015|P1|NOT COMPLETED|Washout||1
2494300|NCT00838279|6115014|P2|COMPLETED|Washout||15
2494301|NCT00838279|6115015|P1|COMPLETED|Washout||15
2494302|NCT00838279|6115014|P2|STARTED|Washout||16
2494303|NCT00838279|6115015|P1|STARTED|Washout||16
2494304|NCT00838279|6115014|P2|NOT COMPLETED|First Intervention||0
2494305|NCT00838279|6115015|P1|NOT COMPLETED|First Intervention||0
2494306|NCT00838279|6115014|P2|COMPLETED|First Intervention||16
2494307|NCT00838279|6115015|P1|COMPLETED|First Intervention||16
2494308|NCT00838279|6115014|P2|STARTED|First Intervention||16
2494309|NCT00838279|6115015|P1|STARTED|First Intervention||16
2494310|NCT00838201|6115025|P2|NOT COMPLETED|Overall Study||53
2494311|NCT00838201|6115026|P1|NOT COMPLETED|Overall Study||42
2494312|NCT00838201|6115025|P2|COMPLETED|Overall Study||145
2494313|NCT00838201|6115026|P1|COMPLETED|Overall Study||144
2494314|NCT00838201|6115025|P2|STARTED|Overall Study||198
2494315|NCT00838201|6115026|P1|STARTED|Overall Study||186
2494316|NCT00838162|6115036|P4|NOT COMPLETED|Overall Study||0
2494317|NCT00838162|6115037|P3|NOT COMPLETED|Overall Study||0
2494318|NCT00838162|6115038|P2|NOT COMPLETED|Overall Study||0
2494319|NCT00838162|6115039|P1|NOT COMPLETED|Overall Study||0
2494320|NCT00838162|6115036|P4|COMPLETED|Overall Study||8
2494321|NCT00838162|6115037|P3|COMPLETED|Overall Study||8
2494322|NCT00838162|6115038|P2|COMPLETED|Overall Study||8
2494323|NCT00838162|6115039|P1|COMPLETED|Overall Study||9
2494324|NCT00838162|6115036|P4|STARTED|Overall Study||8
2494325|NCT00838162|6115037|P3|STARTED|Overall Study||8
2494326|NCT00838162|6115038|P2|STARTED|Overall Study||8
2494327|NCT00838162|6115039|P1|STARTED|Overall Study||9
2494328|NCT00838136|6115083|P2|NOT COMPLETED|Second Intervention||1
2494329|NCT00838136|6115084|P1|NOT COMPLETED|Second Intervention||0
2494330|NCT00838136|6115083|P2|COMPLETED|Second Intervention||15
2494331|NCT00838136|6115084|P1|COMPLETED|Second Intervention||16
2494332|NCT00838136|6115083|P2|STARTED|Second Intervention||16
2494333|NCT00838136|6115084|P1|STARTED|Second Intervention||16
2494334|NCT00838136|6115083|P2|NOT COMPLETED|First Intervention||0
2494335|NCT00838136|6115084|P1|NOT COMPLETED|First Intervention||0
2494336|NCT00838136|6115083|P2|COMPLETED|First Intervention||16
2494337|NCT00838136|6115084|P1|COMPLETED|First Intervention||16
2494338|NCT00838136|6115083|P2|STARTED|First Intervention||16
2494339|NCT00838136|6115084|P1|STARTED|First Intervention||16
2494340|NCT00838110|6115094|P4|NOT COMPLETED|Overall Study||18
2494341|NCT00838110|6115095|P3|NOT COMPLETED|Overall Study||17
2494342|NCT00838110|6115096|P2|NOT COMPLETED|Overall Study||22
2494343|NCT00838110|6115097|P1|NOT COMPLETED|Overall Study||22
2494344|NCT00838110|6115094|P4|COMPLETED|Overall Study||226
2494345|NCT00838110|6115095|P3|COMPLETED|Overall Study||226
2494346|NCT00838110|6115096|P2|COMPLETED|Overall Study||106
2494347|NCT00838110|6115097|P1|COMPLETED|Overall Study||105
2494348|NCT00838110|6115094|P4|Treated|Overall Study||244
2494349|NCT00838110|6115095|P3|Treated|Overall Study||243
2494350|NCT00838110|6115096|P2|Treated|Overall Study||127
2494351|NCT00838110|6115097|P1|Treated|Overall Study||127
2494352|NCT00838110|6115094|P4|STARTED|Overall Study||244
2494353|NCT00838110|6115095|P3|STARTED|Overall Study||243
2494354|NCT00838110|6115096|P2|STARTED|Overall Study||128
2494355|NCT00838110|6115097|P1|STARTED|Overall Study||127
2494356|NCT00838097|6115117|P1|NOT COMPLETED|Overall Study||176
2494357|NCT00838097|6115117|P1|COMPLETED|Overall Study||145
2494358|NCT00838097|6115117|P1|Received Darbepoetin Alfa|Overall Study||319
2494359|NCT00838097|6115117|P1|STARTED|Overall Study||321
2494360|NCT00837967|6115125|P2|NOT COMPLETED|Second Intervention||0
2494361|NCT00837967|6115126|P1|NOT COMPLETED|Second Intervention||0
2494362|NCT00837967|6115125|P2|COMPLETED|Second Intervention||12
2494363|NCT00837967|6115126|P1|COMPLETED|Second Intervention||11
2494364|NCT00837967|6115125|P2|STARTED|Second Intervention||12
2494365|NCT00837967|6115126|P1|STARTED|Second Intervention||11
2494366|NCT00837967|6115125|P2|NOT COMPLETED|Washout Period of 7 - 14 Days||0
2494367|NCT00837967|6115126|P1|NOT COMPLETED|Washout Period of 7 - 14 Days||2
2494368|NCT00837967|6115125|P2|COMPLETED|Washout Period of 7 - 14 Days||12
2494369|NCT00837967|6115126|P1|COMPLETED|Washout Period of 7 - 14 Days||11
2494370|NCT00837967|6115125|P2|STARTED|Washout Period of 7 - 14 Days||12
2494371|NCT00837967|6115126|P1|STARTED|Washout Period of 7 - 14 Days||13
2494372|NCT00837967|6115125|P2|NOT COMPLETED|First Intervention||0
2494373|NCT00837967|6115126|P1|NOT COMPLETED|First Intervention||0
2494374|NCT00837967|6115125|P2|COMPLETED|First Intervention||12
2494375|NCT00837967|6115126|P1|COMPLETED|First Intervention||13
2494376|NCT00837967|6115125|P2|STARTED|First Intervention||12
2494377|NCT00837967|6115126|P1|STARTED|First Intervention||13
2494378|NCT00837902|6115144|P2|NOT COMPLETED|Overall Study||0
2494379|NCT00837902|6115145|P1|NOT COMPLETED|Overall Study||0
2494380|NCT00837902|6115144|P2|COMPLETED|Overall Study||69
2494381|NCT00837902|6115145|P1|COMPLETED|Overall Study||85
2494382|NCT00837902|6115144|P2|STARTED|Overall Study||69
2494383|NCT00837902|6115145|P1|STARTED|Overall Study||85
2494384|NCT00837876|6115152|P1|NOT COMPLETED|Overall Study||37
2494385|NCT00837876|6115152|P1|COMPLETED|Overall Study||0
2494386|NCT00837876|6115152|P1|STARTED|Overall Study||37
2494387|NCT00837824|6115161|P2|NOT COMPLETED|Overall Study||0
2494388|NCT00837824|6115162|P1|NOT COMPLETED|Overall Study||0
2494389|NCT00837824|6115161|P2|COMPLETED|Overall Study||9
2494390|NCT00837824|6115162|P1|COMPLETED|Overall Study||11
2494391|NCT00837824|6115161|P2|STARTED|Overall Study||9
2494392|NCT00837824|6115162|P1|STARTED|Overall Study||11
2494393|NCT00837811|6115174|P3|NOT COMPLETED|Overall Study||1
2494394|NCT00837811|6115175|P2|NOT COMPLETED|Overall Study||34
2494395|NCT00837811|6115176|P1|NOT COMPLETED|Overall Study||7
2494396|NCT00837811|6115174|P3|COMPLETED|Overall Study||0
2494397|NCT00837811|6115175|P2|COMPLETED|Overall Study||87
2494398|NCT00837811|6115176|P1|COMPLETED|Overall Study||53
2494399|NCT00837811|6115174|P3|Included in Efficacy Analyses|Overall Study||1
2494400|NCT00837811|6115175|P2|Included in Efficacy Analyses|Overall Study|Excludes participant from site with Good Clinical Practice (GCP) violations.|120
2494401|NCT00837811|6115176|P1|Included in Efficacy Analyses|Overall Study||59
2494402|NCT00837811|6115174|P3|Had at Least 1 Efficacy Assessment|Overall Study||1
2494403|NCT00837811|6115175|P2|Had at Least 1 Efficacy Assessment|Overall Study||121
2494404|NCT00837811|6115176|P1|Had at Least 1 Efficacy Assessment|Overall Study||59
2494405|NCT00837811|6115174|P3|Received Any Amount of Study Drug|Overall Study||1
2494406|NCT00837811|6115175|P2|Received Any Amount of Study Drug|Overall Study||121
2494407|NCT00837811|6115176|P1|Received Any Amount of Study Drug|Overall Study||60
2494408|NCT00837811|6115174|P3|STARTED|Overall Study||1
2494409|NCT00837811|6115175|P2|STARTED|Overall Study||121
2494410|NCT00837811|6115176|P1|STARTED|Overall Study||60
2494411|NCT00837759|6115261|P1|NOT COMPLETED|Overall Study||4
2494412|NCT00837759|6115261|P1|COMPLETED|Overall Study||3
2494413|NCT00837759|6115261|P1|STARTED|Overall Study||7
2494414|NCT00837694|6115276|P6|NOT COMPLETED|Overall Study||1
2494415|NCT00837694|6115277|P5|NOT COMPLETED|Overall Study||1
2494416|NCT00837694|6115278|P4|NOT COMPLETED|Overall Study||1
2494417|NCT00837694|6115279|P3|NOT COMPLETED|Overall Study||2
2494418|NCT00837694|6115280|P2|NOT COMPLETED|Overall Study||0
2494419|NCT00837694|6115281|P1|NOT COMPLETED|Overall Study||2
2494420|NCT00837694|6115276|P6|COMPLETED|Overall Study||10
2494421|NCT00837694|6115277|P5|COMPLETED|Overall Study||11
2494422|NCT00837694|6115278|P4|COMPLETED|Overall Study||10
2494423|NCT00837694|6115279|P3|COMPLETED|Overall Study||8
2494424|NCT00837694|6115280|P2|COMPLETED|Overall Study||11
2494425|NCT00837694|6115281|P1|COMPLETED|Overall Study||8
2494426|NCT00837694|6115276|P6|STARTED|Overall Study||11
2494427|NCT00837694|6115277|P5|STARTED|Overall Study||12
2494428|NCT00837694|6115278|P4|STARTED|Overall Study||11
2494429|NCT00837694|6115279|P3|STARTED|Overall Study||10
2494430|NCT00837694|6115280|P2|STARTED|Overall Study||11
2494431|NCT00837694|6115281|P1|STARTED|Overall Study||10
2494432|NCT00837616|6115297|P2|NOT COMPLETED|Overall Study||1
2494433|NCT00837616|6115298|P1|NOT COMPLETED|Overall Study||0
2494434|NCT00837616|6115297|P2|COMPLETED|Overall Study||20
2494435|NCT00837616|6115298|P1|COMPLETED|Overall Study||20
2494436|NCT00837616|6115297|P2|STARTED|Overall Study||21
2494437|NCT00837616|6115298|P1|STARTED|Overall Study||20
2494438|NCT00837590|6115325|P3|NOT COMPLETED|Overall Study||1
2494439|NCT00837590|6115326|P2|NOT COMPLETED|Overall Study||1
2494440|NCT00837590|6115327|P1|NOT COMPLETED|Overall Study||0
2494441|NCT00837590|6115325|P3|COMPLETED|Overall Study||4
2494442|NCT00837590|6115326|P2|COMPLETED|Overall Study||4
2494443|NCT00837590|6115327|P1|COMPLETED|Overall Study||6
2494444|NCT00837590|6115325|P3|STARTED|Overall Study||5
2494445|NCT00837590|6115326|P2|STARTED|Overall Study||5
2494446|NCT00837590|6115327|P1|STARTED|Overall Study||6
2494447|NCT00837577|6115337|P2|NOT COMPLETED|Open-label Period||9
2494448|NCT00837577|6115338|P1|NOT COMPLETED|Open-label Period||8
2494449|NCT00837577|6115337|P2|COMPLETED|Open-label Period||54
2494450|NCT00837577|6115338|P1|COMPLETED|Open-label Period||60
2494451|NCT00837577|6115337|P2|STARTED|Open-label Period||63
2494452|NCT00837577|6115338|P1|STARTED|Open-label Period||68
2494453|NCT00837577|6115337|P2|NOT COMPLETED|Double-blind Period||0
2494454|NCT00837577|6115338|P1|NOT COMPLETED|Double-blind Period||2
2494455|NCT00837577|6115337|P2|COMPLETED|Double-blind Period||63
2494456|NCT00837577|6115338|P1|COMPLETED|Double-blind Period||68
2494457|NCT00837577|6115337|P2|STARTED|Double-blind Period||63
2494458|NCT00837577|6115338|P1|STARTED|Double-blind Period||70
2494459|NCT00837512|6115349|P2|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
2494460|NCT00837512|6115350|P1|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
2494461|NCT00837512|6115349|P2|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
2494462|NCT00837512|6115350|P1|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
2494463|NCT00837512|6115349|P2|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
2494464|NCT00837512|6115350|P1|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
2494465|NCT00837512|6115349|P2|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
2494466|NCT00837512|6115350|P1|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
2494467|NCT00837512|6115349|P2|COMPLETED|Both Arms: Washout (7-28 Days)||8
2494468|NCT00837512|6115350|P1|COMPLETED|Both Arms: Washout (7-28 Days)||8
2494469|NCT00837512|6115349|P2|STARTED|Both Arms: Washout (7-28 Days)||8
2494470|NCT00837512|6115350|P1|STARTED|Both Arms: Washout (7-28 Days)||8
2494471|NCT00837512|6115349|P2|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
2494472|NCT00837512|6115350|P1|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
2494473|NCT00837512|6115349|P2|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
2494474|NCT00837512|6115350|P1|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
2494475|NCT00837512|6115349|P2|STARTED|First Intervention (6hrs) - RANDOMIZED||8
2494476|NCT00837512|6115350|P1|STARTED|First Intervention (6hrs) - RANDOMIZED||8
2494477|NCT00837486|6115358|P2|NOT COMPLETED|Long-term Follow-up Phase - Open Label||0
2494478|NCT00837486|6115359|P1|NOT COMPLETED|Long-term Follow-up Phase - Open Label||5
2494479|NCT00837486|6115358|P2|COMPLETED|Long-term Follow-up Phase - Open Label||0
2494480|NCT00837486|6115359|P1|COMPLETED|Long-term Follow-up Phase - Open Label||24
2494481|NCT00837486|6115358|P2|STARTED|Long-term Follow-up Phase - Open Label||0
2494482|NCT00837486|6115359|P1|STARTED|Long-term Follow-up Phase - Open Label|All subjects received open-label stimulation during this phase.|29
2494483|NCT00837486|6115358|P2|NOT COMPLETED|Blinded-treatment Phase||0
2494484|NCT00837486|6115359|P1|NOT COMPLETED|Blinded-treatment Phase||1
2494485|NCT00837486|6115358|P2|COMPLETED|Blinded-treatment Phase||14
2494486|NCT00837486|6115359|P1|COMPLETED|Blinded-treatment Phase|One subject did not receive the allocated intervention.|15
2494487|NCT00837486|6115358|P2|STARTED|Blinded-treatment Phase||14
2494488|NCT00837486|6115359|P1|STARTED|Blinded-treatment Phase||16
2494489|NCT00837473|6115371|P1|NOT COMPLETED|Overall Study||3
2494490|NCT00837473|6115371|P1|COMPLETED|Overall Study||12
2494491|NCT00837473|6115371|P1|STARTED|Overall Study||15
2494492|NCT00837447|6115384|P1|NOT COMPLETED|Overall Study||0
2494493|NCT00837447|6115384|P1|COMPLETED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
2494494|NCT00837447|6115384|P1|STARTED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
2494495|NCT00837434|6115391|P2|NOT COMPLETED|Overall Study||1
2494496|NCT00837434|6115392|P1|NOT COMPLETED|Overall Study||9
2494497|NCT00837434|6115391|P2|COMPLETED|Overall Study||19
2494498|NCT00837434|6115392|P1|COMPLETED|Overall Study||34
2494499|NCT00837434|6115391|P2|STARTED|Overall Study||20
2494500|NCT00837434|6115392|P1|STARTED|Overall Study||43
2494501|NCT00837330|6115412|P2|NOT COMPLETED|Overall Study||3
2494502|NCT00837330|6115413|P1|NOT COMPLETED|Overall Study||1
2494503|NCT00837330|6115412|P2|COMPLETED|Overall Study||7
2494504|NCT00837330|6115413|P1|COMPLETED|Overall Study||9
2494505|NCT00837330|6115412|P2|STARTED|Overall Study||10
2494506|NCT00837330|6115413|P1|STARTED|Overall Study||10
2494507|NCT00837252|6115419|P1|NOT COMPLETED|Overall Study||0
2494508|NCT00837252|6115419|P1|COMPLETED|Overall Study||5
2494509|NCT00837252|6115419|P1|STARTED|Overall Study||5
2494510|NCT00837213|6115436|P2|NOT COMPLETED|Overall Study||5
2494511|NCT00837213|6115437|P1|NOT COMPLETED|Overall Study||6
2494512|NCT00837213|6115436|P2|COMPLETED|Overall Study||12
2494513|NCT00837213|6115437|P1|COMPLETED|Overall Study||10
2494514|NCT00837213|6115436|P2|STARTED|Overall Study||17
2494515|NCT00837213|6115437|P1|STARTED|Overall Study||16
2494516|NCT00837200|6115457|P1|NOT COMPLETED|Overall Study||0
2494517|NCT00837200|6115457|P1|COMPLETED|Overall Study||13
2494518|NCT00837200|6115457|P1|STARTED|Overall Study||13
2494519|NCT00837161|6115463|P1|NOT COMPLETED|Overall Study||2
2494520|NCT00837161|6115463|P1|COMPLETED|Overall Study||9
2494521|NCT00837161|6115463|P1|STARTED|Overall Study||11
2494522|NCT00837148|6115471|P1|NOT COMPLETED|Overall Study||2
2494523|NCT00837148|6115471|P1|COMPLETED|Overall Study||35
2494524|NCT00837148|6115471|P1|STARTED|Overall Study||37
2494525|NCT00837096|6115477|P2|NOT COMPLETED|Overall Study||9
2494526|NCT00837096|6115478|P1|NOT COMPLETED|Overall Study||10
2494527|NCT00837096|6115477|P2|COMPLETED|Overall Study||0
2494528|NCT00837096|6115478|P1|COMPLETED|Overall Study||0
2494529|NCT00837096|6115477|P2|STARTED|Overall Study||9
2494530|NCT00837096|6115478|P1|STARTED|Overall Study||10
2494531|NCT00837031|6115484|P1|NOT COMPLETED|Overall Study||0
2494532|NCT00837031|6115484|P1|COMPLETED|Overall Study||72
2494533|NCT00837031|6115484|P1|STARTED|Overall Study||72
2494534|NCT00836953|6115490|P1|NOT COMPLETED|Overall Study||2
2494535|NCT00836953|6115490|P1|COMPLETED|Overall Study||31
2494536|NCT00836953|6115490|P1|STARTED|Overall Study||33
2494537|NCT00836927|6115501|P5|NOT COMPLETED|Overall Study||1
2494538|NCT00836927|6115502|P4|NOT COMPLETED|Overall Study||1
2494539|NCT00836927|6115503|P3|NOT COMPLETED|Overall Study||0
2494540|NCT00836927|6115504|P2|NOT COMPLETED|Overall Study||0
2494541|NCT00836927|6115505|P1|NOT COMPLETED|Overall Study||3
2494542|NCT00836927|6115501|P5|COMPLETED|Overall Study||0
2494543|NCT00836927|6115502|P4|COMPLETED|Overall Study||0
2494544|NCT00836927|6115503|P3|COMPLETED|Overall Study|Participant completed treatment by 04 Feb 2018|1
2494545|NCT00836927|6115504|P2|COMPLETED|Overall Study|Participant completed treatment by 04 Feb 2018|1
2494546|NCT00836927|6115505|P1|COMPLETED|Overall Study||0
2494547|NCT00836927|6115501|P5|Completed Dosing Through 03 Apr 2017|Overall Study||0
2494548|NCT00836927|6115502|P4|Completed Dosing Through 03 Apr 2017|Overall Study||0
2494549|NCT00836927|6115503|P3|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continued to receive study drug past the data cut-off date of 03 Apr 2017|1
2494550|NCT00836927|6115504|P2|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continued to receive study drug past the data cut-off date of 03 Apr 2017|1
2494551|NCT00836927|6115505|P1|Completed Dosing Through 03 Apr 2017|Overall Study||0
2494552|NCT00836927|6115501|P5|STARTED|Overall Study||1
2494553|NCT00836927|6115502|P4|STARTED|Overall Study||1
2494554|NCT00836927|6115503|P3|STARTED|Overall Study|One participant received ridaforolimus 3 mg IV infusion before being switched to the oral tablet.|1
2494555|NCT00836927|6115504|P2|STARTED|Overall Study||1
2494556|NCT00836927|6115505|P1|STARTED|Overall Study||3
2494557|NCT00836901|6115541|P2|NOT COMPLETED|Second Intervention||0
2494558|NCT00836901|6115542|P1|NOT COMPLETED|Second Intervention||0
2494559|NCT00836901|6115541|P2|COMPLETED|Second Intervention||28
2494560|NCT00836901|6115542|P1|COMPLETED|Second Intervention||23
2494561|NCT00836901|6115541|P2|STARTED|Second Intervention||28
2494562|NCT00836901|6115542|P1|STARTED|Second Intervention||23
2494563|NCT00836901|6115541|P2|NOT COMPLETED|First Intervention||0
2494564|NCT00836901|6115542|P1|NOT COMPLETED|First Intervention||1
2494565|NCT00836901|6115541|P2|COMPLETED|First Intervention||28
2494566|NCT00836901|6115542|P1|COMPLETED|First Intervention||23
2494567|NCT00836901|6115541|P2|STARTED|First Intervention||28
2494568|NCT00836901|6115542|P1|STARTED|First Intervention||24
2494569|NCT00836875|6115558|P2|NOT COMPLETED|Overall Study||3
2494570|NCT00836875|6115559|P1|NOT COMPLETED|Overall Study||3
2494571|NCT00836875|6115558|P2|COMPLETED|Overall Study||17
2494572|NCT00836875|6115559|P1|COMPLETED|Overall Study||8
2494573|NCT00836875|6115558|P2|STARTED|Overall Study||20
2494574|NCT00836875|6115559|P1|STARTED|Overall Study||11
2494575|NCT00836810|6115575|P2|NOT COMPLETED|Overall Study||0
2494576|NCT00836810|6115576|P1|NOT COMPLETED|Overall Study||1
2494577|NCT00836810|6115575|P2|COMPLETED|Overall Study||6
2494578|NCT00836810|6115576|P1|COMPLETED|Overall Study|1 patient was subsequently diagnosed with SLE and, per protocol, was not included.|4
2494579|NCT00836810|6115575|P2|STARTED|Overall Study||6
2494580|NCT00836810|6115576|P1|STARTED|Overall Study||5
2494581|NCT00836758|6115592|P1|NOT COMPLETED|Overall Study||0
2494582|NCT00836758|6115592|P1|COMPLETED|Overall Study||115
2494583|NCT00836758|6115592|P1|STARTED|Overall Study||115
2494584|NCT00836745|6115598|P1|NOT COMPLETED|Overall Study||21
2494585|NCT00836745|6115598|P1|COMPLETED|Overall Study||15
2494586|NCT00836745|6115598|P1|STARTED|Overall Study||36
2494587|NCT00836719|6115605|P1|NOT COMPLETED|Overall Study||0
2494588|NCT00836719|6115605|P1|COMPLETED|Overall Study||10
2494589|NCT00836719|6115605|P1|STARTED|Overall Study||10
2494590|NCT00836706|6115612|P2|NOT COMPLETED|Second Intervention||0
2494591|NCT00836706|6115613|P1|NOT COMPLETED|Second Intervention||0
2494592|NCT00836706|6115612|P2|COMPLETED|Second Intervention||11
2494593|NCT00836706|6115613|P1|COMPLETED|Second Intervention||11
2494594|NCT00836706|6115612|P2|STARTED|Second Intervention||11
2494595|NCT00836706|6115613|P1|STARTED|Second Intervention||11
2494596|NCT00836706|6115612|P2|NOT COMPLETED|Washout: 7 Days||1
2494597|NCT00836706|6115613|P1|NOT COMPLETED|Washout: 7 Days||0
2494598|NCT00836706|6115612|P2|COMPLETED|Washout: 7 Days||11
2494599|NCT00836706|6115613|P1|COMPLETED|Washout: 7 Days||11
2494600|NCT00836706|6115612|P2|STARTED|Washout: 7 Days||12
2494601|NCT00836706|6115613|P1|STARTED|Washout: 7 Days||11
2494602|NCT00836706|6115612|P2|NOT COMPLETED|First Intervention||0
2494603|NCT00836706|6115613|P1|NOT COMPLETED|First Intervention||0
2494604|NCT00836706|6115612|P2|COMPLETED|First Intervention||12
2494605|NCT00836706|6115613|P1|COMPLETED|First Intervention||11
2494606|NCT00836706|6115612|P2|STARTED|First Intervention||12
2494607|NCT00836706|6115613|P1|STARTED|First Intervention||11
2494608|NCT00836693|6115623|P2|NOT COMPLETED|Overall Study||6
2494609|NCT00836693|6115624|P1|NOT COMPLETED|Overall Study||17
2494610|NCT00836693|6115623|P2|COMPLETED|Overall Study||64
2494611|NCT00836693|6115624|P1|COMPLETED|Overall Study||130
2494612|NCT00836693|6115623|P2|STARTED|Overall Study||70
2494613|NCT00836693|6115624|P1|STARTED|Overall Study||147
2494614|NCT00836641|6115666|P2|NOT COMPLETED|Overall Study||0
2494615|NCT00836641|6115667|P1|NOT COMPLETED|Overall Study||0
2494616|NCT00836641|6115666|P2|COMPLETED|Overall Study||34
2494617|NCT00836641|6115667|P1|COMPLETED|Overall Study||36
2494618|NCT00836641|6115666|P2|STARTED|Overall Study||34
2494619|NCT00836641|6115667|P1|STARTED|Overall Study||36
2494620|NCT00836589|6115674|P1|NOT COMPLETED|Overall Study||1266
2494621|NCT00836589|6115674|P1|COMPLETED|Overall Study||731
2494622|NCT00836589|6115674|P1|STARTED|Overall Study||1997
2494623|NCT00836498|6115707|P2|NOT COMPLETED|Overall Study||1
2494624|NCT00836498|6115708|P1|NOT COMPLETED|Overall Study||4
2494625|NCT00836498|6115707|P2|COMPLETED|Overall Study||21
2494626|NCT00836498|6115708|P1|COMPLETED|Overall Study|Participant who discontinued the study vaccination due to AE completed the 180-day safety follow-up.|40
2494627|NCT00836498|6115707|P2|STARTED|Overall Study||22
2494628|NCT00836498|6115708|P1|STARTED|Overall Study||44
2494629|NCT00836472|6115740|P2|NOT COMPLETED|Second Intervention||0
2494630|NCT00836472|6115741|P1|NOT COMPLETED|Second Intervention||0
2494631|NCT00836472|6115740|P2|COMPLETED|Second Intervention||27
2494632|NCT00836472|6115741|P1|COMPLETED|Second Intervention||28
2494633|NCT00836472|6115740|P2|STARTED|Second Intervention||27
2494634|NCT00836472|6115741|P1|STARTED|Second Intervention||28
2494635|NCT00836472|6115740|P2|NOT COMPLETED|Washout||3
2494636|NCT00836472|6115741|P1|NOT COMPLETED|Washout||2
2494637|NCT00836472|6115740|P2|COMPLETED|Washout||27
2494638|NCT00836472|6115741|P1|COMPLETED|Washout||28
2494639|NCT00836472|6115740|P2|STARTED|Washout||30
2494640|NCT00836472|6115741|P1|STARTED|Washout||30
2494641|NCT00836472|6115740|P2|NOT COMPLETED|First Intervention||0
2494642|NCT00836472|6115741|P1|NOT COMPLETED|First Intervention||0
2494643|NCT00836472|6115740|P2|COMPLETED|First Intervention||30
2494644|NCT00836472|6115741|P1|COMPLETED|First Intervention||30
2494645|NCT00836472|6115740|P2|STARTED|First Intervention||30
2494646|NCT00836472|6115741|P1|STARTED|First Intervention||30
2494647|NCT00836433|6115757|P2|NOT COMPLETED|Overall Study||7
2494648|NCT00836433|6115758|P1|NOT COMPLETED|Overall Study||12
2494649|NCT00836433|6115757|P2|COMPLETED|Overall Study||321
2494650|NCT00836433|6115758|P1|COMPLETED|Overall Study||349
2494651|NCT00836433|6115757|P2|STARTED|Overall Study||328
2494652|NCT00836433|6115758|P1|STARTED|Overall Study||361
2494659|NCT00836355|6115781|P4|NOT COMPLETED|Overall Study||0
2494660|NCT00836355|6115782|P3|NOT COMPLETED|Overall Study||0
2494661|NCT00836355|6115783|P2|NOT COMPLETED|Overall Study||0
2494662|NCT00836355|6115784|P1|NOT COMPLETED|Overall Study||0
2494663|NCT00836355|6115781|P4|COMPLETED|Overall Study||2
2494664|NCT00836355|6115782|P3|COMPLETED|Overall Study||0
2494665|NCT00836355|6115783|P2|COMPLETED|Overall Study||4
2494666|NCT00836355|6115784|P1|COMPLETED|Overall Study||0
2494667|NCT00836355|6115781|P4|STARTED|Overall Study||2
2494668|NCT00836355|6115782|P3|STARTED|Overall Study||0
2494669|NCT00836355|6115783|P2|STARTED|Overall Study||4
2494670|NCT00836355|6115784|P1|STARTED|Overall Study||0
2494671|NCT00836342|6115805|P3|NOT COMPLETED|Overall Study||0
2494672|NCT00836342|6115806|P2|NOT COMPLETED|Overall Study||0
2494673|NCT00836342|6115807|P1|NOT COMPLETED|Overall Study||0
2494674|NCT00836342|6115805|P3|COMPLETED|Overall Study||36
2494675|NCT00836342|6115806|P2|COMPLETED|Overall Study||23
2494676|NCT00836342|6115807|P1|COMPLETED|Overall Study||22
2494677|NCT00836342|6115805|P3|STARTED|Overall Study||36
2494678|NCT00836342|6115806|P2|STARTED|Overall Study||23
2494679|NCT00836342|6115807|P1|STARTED|Overall Study||22
2494680|NCT00836277|6115818|P1|NOT COMPLETED|Overall Study||6
2494681|NCT00836277|6115818|P1|COMPLETED|Overall Study||18
2494682|NCT00836277|6115818|P1|STARTED|Overall Study||24
2494683|NCT00836095|6115828|P2|NOT COMPLETED|Overall Study||3
2494684|NCT00836095|6115829|P1|NOT COMPLETED|Overall Study||0
2494685|NCT00836095|6115828|P2|COMPLETED|Overall Study||27
2494686|NCT00836095|6115829|P1|COMPLETED|Overall Study||22
2494687|NCT00836095|6115828|P2|STARTED|Overall Study||30
2494688|NCT00836095|6115829|P1|STARTED|Overall Study||22
2494689|NCT00836056|6115839|P2|NOT COMPLETED|Second Intervention||0
2494690|NCT00836056|6115840|P1|NOT COMPLETED|Second Intervention||0
2494691|NCT00836056|6115839|P2|COMPLETED|Second Intervention||12
2494692|NCT00836056|6115840|P1|COMPLETED|Second Intervention||11
2494693|NCT00836056|6115839|P2|STARTED|Second Intervention||12
2494694|NCT00836056|6115840|P1|STARTED|Second Intervention||11
2494695|NCT00836056|6115839|P2|NOT COMPLETED|Washout: 7 Days||0
2494696|NCT00836056|6115840|P1|NOT COMPLETED|Washout: 7 Days||0
2494697|NCT00836056|6115839|P2|COMPLETED|Washout: 7 Days||12
2494698|NCT00836056|6115840|P1|COMPLETED|Washout: 7 Days||11
2494699|NCT00836056|6115839|P2|STARTED|Washout: 7 Days||12
2494700|NCT00836056|6115840|P1|STARTED|Washout: 7 Days||11
2494701|NCT00836056|6115839|P2|NOT COMPLETED|First Intervention||0
2494702|NCT00836056|6115840|P1|NOT COMPLETED|First Intervention||1
2494703|NCT00836056|6115839|P2|COMPLETED|First Intervention||12
2494704|NCT00836056|6115840|P1|COMPLETED|First Intervention||11
2494705|NCT00836056|6115839|P2|STARTED|First Intervention||12
2494706|NCT00836056|6115840|P1|STARTED|First Intervention||12
2494707|NCT00836017|6115848|P1|NOT COMPLETED|Overall Study||544
2494708|NCT00836017|6115848|P1|COMPLETED|Overall Study||502
2494709|NCT00836017|6115848|P1|STARTED|Overall Study||1046
2494710|NCT00836004|6115858|P2|NOT COMPLETED|Second Intervention||0
2494711|NCT00836004|6115859|P1|NOT COMPLETED|Second Intervention||0
2494712|NCT00836004|6115858|P2|COMPLETED|Second Intervention||12
2494713|NCT00836004|6115859|P1|COMPLETED|Second Intervention||12
2494714|NCT00836004|6115858|P2|STARTED|Second Intervention||12
2494715|NCT00836004|6115859|P1|STARTED|Second Intervention||12
2494716|NCT00836004|6115858|P2|NOT COMPLETED|Washout: 7 Days||0
2494717|NCT00836004|6115859|P1|NOT COMPLETED|Washout: 7 Days||0
2494718|NCT00836004|6115858|P2|COMPLETED|Washout: 7 Days||12
2494719|NCT00836004|6115859|P1|COMPLETED|Washout: 7 Days||12
2494720|NCT00836004|6115858|P2|STARTED|Washout: 7 Days||12
2494721|NCT00836004|6115859|P1|STARTED|Washout: 7 Days||12
2494722|NCT00836004|6115858|P2|NOT COMPLETED|First Intervention||0
2494723|NCT00836004|6115859|P1|NOT COMPLETED|First Intervention||0
2494724|NCT00836004|6115858|P2|COMPLETED|First Intervention||12
2494725|NCT00836004|6115859|P1|COMPLETED|First Intervention||12
2494726|NCT00836004|6115858|P2|STARTED|First Intervention||12
2494727|NCT00836004|6115859|P1|STARTED|First Intervention||12
2494728|NCT00835991|6115869|P2|NOT COMPLETED|Second Intervention||0
2494729|NCT00835991|6115870|P1|NOT COMPLETED|Second Intervention||0
2494730|NCT00835991|6115869|P2|COMPLETED|Second Intervention||26
2494731|NCT00835991|6115870|P1|COMPLETED|Second Intervention||27
2494732|NCT00835991|6115869|P2|STARTED|Second Intervention||26
2494733|NCT00835991|6115870|P1|STARTED|Second Intervention||27
2494734|NCT00835991|6115869|P2|NOT COMPLETED|Washout||3
2494735|NCT00835991|6115870|P1|NOT COMPLETED|Washout||3
2494736|NCT00835991|6115869|P2|COMPLETED|Washout||26
2494737|NCT00835991|6115870|P1|COMPLETED|Washout||27
2494738|NCT00835991|6115869|P2|STARTED|Washout||29
2494739|NCT00835991|6115870|P1|STARTED|Washout||30
2494740|NCT00835991|6115869|P2|NOT COMPLETED|First Intervention||1
2494741|NCT00835991|6115870|P1|NOT COMPLETED|First Intervention||0
2494742|NCT00835991|6115869|P2|COMPLETED|First Intervention||29
2494743|NCT00835991|6115870|P1|COMPLETED|First Intervention||30
2494744|NCT00835991|6115869|P2|STARTED|First Intervention||30
2494745|NCT00835991|6115870|P1|STARTED|First Intervention||30
2494746|NCT00835978|6115888|P4|NOT COMPLETED|Overall Study||10
2494747|NCT00835978|6115889|P3|NOT COMPLETED|Overall Study||91
2494748|NCT00835978|6115890|P2|NOT COMPLETED|Overall Study||56
2494749|NCT00835978|6115891|P1|NOT COMPLETED|Overall Study||56
2494750|NCT00835978|6115888|P4|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
2494751|NCT00835978|6115889|P3|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
2494752|NCT00835978|6115890|P2|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
2494753|NCT00835978|6115891|P1|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
2494754|NCT00835978|6115888|P4|Treated|Overall Study||10
2494755|NCT00835978|6115889|P3|Treated|Overall Study||91
2494756|NCT00835978|6115890|P2|Treated|Overall Study||56
2494757|NCT00835978|6115891|P1|Treated|Overall Study||56
2494758|NCT00835978|6115888|P4|STARTED|Overall Study||10
2494759|NCT00835978|6115889|P3|STARTED|Overall Study||91
2494760|NCT00835978|6115890|P2|STARTED|Overall Study||56
2494761|NCT00835978|6115891|P1|STARTED|Overall Study||56
2494762|NCT00835926|6115951|P2|NOT COMPLETED|Overall Study||0
2494763|NCT00835926|6115952|P1|NOT COMPLETED|Overall Study||0
2494764|NCT00835926|6115951|P2|COMPLETED|Overall Study||60
2494765|NCT00835926|6115952|P1|COMPLETED|Overall Study||61
2494766|NCT00835926|6115951|P2|STARTED|Overall Study||60
2494767|NCT00835926|6115952|P1|STARTED|Overall Study||61
2494768|NCT00835900|6115966|P2|NOT COMPLETED|Overall Study||6
2494769|NCT00835900|6115967|P1|NOT COMPLETED|Overall Study||5
2494770|NCT00835900|6115966|P2|COMPLETED|Overall Study||22
2494771|NCT00835900|6115967|P1|COMPLETED|Overall Study||27
2494772|NCT00835900|6115966|P2|STARTED|Overall Study||28
2494773|NCT00835900|6115967|P1|STARTED|Overall Study||32
2494774|NCT00835861|6115977|P2|NOT COMPLETED|Overall Study||2
2494775|NCT00835861|6115978|P1|NOT COMPLETED|Overall Study||1
2494776|NCT00835861|6115977|P2|COMPLETED|Overall Study||14
2494777|NCT00835861|6115978|P1|COMPLETED|Overall Study||14
2494778|NCT00835861|6115977|P2|STARTED|Overall Study||16
2494779|NCT00835861|6115978|P1|STARTED|Overall Study||15
2494780|NCT00835796|6116002|P2|NOT COMPLETED|Second Intervention||0
2494781|NCT00835796|6116003|P1|NOT COMPLETED|Second Intervention||0
2494782|NCT00835796|6116002|P2|COMPLETED|Second Intervention||9
2494783|NCT00835796|6116003|P1|COMPLETED|Second Intervention||10
2494784|NCT00835796|6116002|P2|STARTED|Second Intervention||9
2494785|NCT00835796|6116003|P1|STARTED|Second Intervention||10
2494786|NCT00835796|6116002|P2|NOT COMPLETED|Washout||0
2494787|NCT00835796|6116003|P1|NOT COMPLETED|Washout||0
2494788|NCT00835796|6116002|P2|COMPLETED|Washout||9
2494789|NCT00835796|6116003|P1|COMPLETED|Washout||10
2494790|NCT00835796|6116002|P2|STARTED|Washout||9
2494791|NCT00835796|6116003|P1|STARTED|Washout||10
2494792|NCT00835796|6116002|P2|NOT COMPLETED|First Intervention||1
2494793|NCT00835796|6116003|P1|NOT COMPLETED|First Intervention||0
2494794|NCT00835796|6116002|P2|COMPLETED|First Intervention||9
2494795|NCT00835796|6116003|P1|COMPLETED|First Intervention||10
2494796|NCT00835796|6116002|P2|STARTED|First Intervention||10
2494797|NCT00835796|6116003|P1|STARTED|First Intervention||10
2494798|NCT00835731|6116013|P2|NOT COMPLETED|Overall Study||1
2494799|NCT00835731|6116014|P1|NOT COMPLETED|Overall Study||2
2494800|NCT00835731|6116013|P2|COMPLETED|Overall Study||60
2494801|NCT00835731|6116014|P1|COMPLETED|Overall Study||62
2494802|NCT00835731|6116013|P2|STARTED|Overall Study||61
2494803|NCT00835731|6116014|P1|STARTED|Overall Study||64
2494804|NCT00835705|6116034|P2|NOT COMPLETED|Second Intervention||0
2494805|NCT00835705|6116035|P1|NOT COMPLETED|Second Intervention||1
2494806|NCT00835705|6116034|P2|COMPLETED|Second Intervention||28
2494807|NCT00835705|6116035|P1|COMPLETED|Second Intervention||22
2494808|NCT00835705|6116034|P2|STARTED|Second Intervention||28
2494809|NCT00835705|6116035|P1|STARTED|Second Intervention||23
2494810|NCT00835705|6116034|P2|NOT COMPLETED|First Intervention||0
2494811|NCT00835705|6116035|P1|NOT COMPLETED|First Intervention||1
2494812|NCT00835705|6116034|P2|COMPLETED|First Intervention||28
2494813|NCT00835705|6116035|P1|COMPLETED|First Intervention||23
2494814|NCT00835705|6116034|P2|STARTED|First Intervention||28
2494815|NCT00835705|6116035|P1|STARTED|First Intervention||24
2494816|NCT00835692|6116051|P2|NOT COMPLETED|Second Intervention||0
2494817|NCT00835692|6116052|P1|NOT COMPLETED|Second Intervention||0
2494818|NCT00835692|6116051|P2|COMPLETED|Second Intervention||28
2494819|NCT00835692|6116052|P1|COMPLETED|Second Intervention||27
2494820|NCT00835692|6116051|P2|STARTED|Second Intervention||28
2494821|NCT00835692|6116052|P1|STARTED|Second Intervention||27
2494822|NCT00835692|6116051|P2|NOT COMPLETED|Washout||0
2494823|NCT00835692|6116052|P1|NOT COMPLETED|Washout||0
2494824|NCT00835692|6116051|P2|COMPLETED|Washout||28
2494825|NCT00835692|6116052|P1|COMPLETED|Washout||27
2494826|NCT00835692|6116051|P2|STARTED|Washout||28
2494827|NCT00835692|6116052|P1|STARTED|Washout||27
2494828|NCT00835692|6116051|P2|NOT COMPLETED|First Intervention||0
2494829|NCT00835692|6116052|P1|NOT COMPLETED|First Intervention||1
2494830|NCT00835692|6116051|P2|COMPLETED|First Intervention||28
2494831|NCT00835692|6116052|P1|COMPLETED|First Intervention||27
2494832|NCT00835692|6116051|P2|STARTED|First Intervention||28
2494833|NCT00835692|6116052|P1|STARTED|First Intervention||28
2494834|NCT00835679|6116064|P4|NOT COMPLETED|Overall Study||0
2494835|NCT00835679|6116065|P3|NOT COMPLETED|Overall Study||0
2494836|NCT00835679|6116066|P2|NOT COMPLETED|Overall Study||0
2494837|NCT00835679|6116067|P1|NOT COMPLETED|Overall Study||1
2494838|NCT00835679|6116064|P4|COMPLETED|Overall Study||0
2494839|NCT00835679|6116065|P3|COMPLETED|Overall Study||0
2494840|NCT00835679|6116066|P2|COMPLETED|Overall Study||0
2494841|NCT00835679|6116067|P1|COMPLETED|Overall Study||8
2494842|NCT00835679|6116064|P4|STARTED|Overall Study||0
2494843|NCT00835679|6116065|P3|STARTED|Overall Study||0
2494844|NCT00835679|6116066|P2|STARTED|Overall Study|This study closed prematurely, thus no patients went on Cohort B, C or D.|0
2494845|NCT00835679|6116067|P1|STARTED|Overall Study||9
2494846|NCT00835666|6116091|P2|NOT COMPLETED|Second Intervention||0
2494847|NCT00835666|6116092|P1|NOT COMPLETED|Second Intervention||0
2494848|NCT00835666|6116091|P2|COMPLETED|Second Intervention||16
2494849|NCT00835666|6116092|P1|COMPLETED|Second Intervention||14
2494850|NCT00835666|6116091|P2|STARTED|Second Intervention||16
2494851|NCT00835666|6116092|P1|STARTED|Second Intervention||14
2494852|NCT00835666|6116091|P2|NOT COMPLETED|Washout||0
2494853|NCT00835666|6116092|P1|NOT COMPLETED|Washout||2
2494854|NCT00835666|6116091|P2|COMPLETED|Washout||16
2494855|NCT00835666|6116092|P1|COMPLETED|Washout||14
2494856|NCT00835666|6116091|P2|STARTED|Washout||16
2494857|NCT00835666|6116092|P1|STARTED|Washout||16
2494858|NCT00835666|6116091|P2|NOT COMPLETED|First Intervention||0
2494859|NCT00835666|6116092|P1|NOT COMPLETED|First Intervention||0
2494860|NCT00835666|6116091|P2|COMPLETED|First Intervention||16
2494861|NCT00835666|6116092|P1|COMPLETED|First Intervention||16
2494862|NCT00835666|6116091|P2|STARTED|First Intervention||16
2494863|NCT00835666|6116092|P1|STARTED|First Intervention||16
2494864|NCT00835640|6116102|P2|NOT COMPLETED|Second Intervention||0
2494865|NCT00835640|6116103|P1|NOT COMPLETED|Second Intervention||1
2494866|NCT00835640|6116102|P2|COMPLETED|Second Intervention||12
2494867|NCT00835640|6116103|P1|COMPLETED|Second Intervention||11
2494868|NCT00835640|6116102|P2|STARTED|Second Intervention||12
2494869|NCT00835640|6116103|P1|STARTED|Second Intervention||12
2494870|NCT00835640|6116102|P2|NOT COMPLETED|Washout of 7 Days||0
2494871|NCT00835640|6116103|P1|NOT COMPLETED|Washout of 7 Days||0
2494872|NCT00835640|6116102|P2|COMPLETED|Washout of 7 Days||12
2494873|NCT00835640|6116103|P1|COMPLETED|Washout of 7 Days||12
2494874|NCT00835640|6116102|P2|STARTED|Washout of 7 Days||12
2494875|NCT00835640|6116103|P1|STARTED|Washout of 7 Days||12
2494876|NCT00835640|6116102|P2|NOT COMPLETED|First Intervention||0
2494877|NCT00835640|6116103|P1|NOT COMPLETED|First Intervention||0
2494878|NCT00835640|6116102|P2|COMPLETED|First Intervention||12
2494879|NCT00835640|6116103|P1|COMPLETED|First Intervention||12
2494880|NCT00835640|6116102|P2|STARTED|First Intervention||12
2494881|NCT00835640|6116103|P1|STARTED|First Intervention||12
2494882|NCT00835614|6116113|P2|NOT COMPLETED|Second Intervention||0
2494883|NCT00835614|6116114|P1|NOT COMPLETED|Second Intervention||0
2494884|NCT00835614|6116113|P2|COMPLETED|Second Intervention||13
2494885|NCT00835614|6116114|P1|COMPLETED|Second Intervention||13
2494886|NCT00835614|6116113|P2|STARTED|Second Intervention||13
2494887|NCT00835614|6116114|P1|STARTED|Second Intervention||13
2494888|NCT00835614|6116113|P2|NOT COMPLETED|Washout of 7 Days||0
2494889|NCT00835614|6116114|P1|NOT COMPLETED|Washout of 7 Days||0
2494890|NCT00835614|6116113|P2|COMPLETED|Washout of 7 Days||13
2494891|NCT00835614|6116114|P1|COMPLETED|Washout of 7 Days||13
2494892|NCT00835614|6116113|P2|STARTED|Washout of 7 Days||13
2494893|NCT00835614|6116114|P1|STARTED|Washout of 7 Days||13
2494894|NCT00835614|6116113|P2|NOT COMPLETED|First Intervention||0
2494895|NCT00835614|6116114|P1|NOT COMPLETED|First Intervention||0
2494896|NCT00835614|6116113|P2|COMPLETED|First Intervention||13
2494897|NCT00835614|6116114|P1|COMPLETED|First Intervention||13
2494898|NCT00835614|6116113|P2|STARTED|First Intervention||13
2494899|NCT00835614|6116114|P1|STARTED|First Intervention||13
2494900|NCT00835588|6116124|P2|NOT COMPLETED|Second Intervention||0
2494901|NCT00835588|6116125|P1|NOT COMPLETED|Second Intervention||0
2494902|NCT00835588|6116124|P2|COMPLETED|Second Intervention||50
2494903|NCT00835588|6116125|P1|COMPLETED|Second Intervention||50
2494904|NCT00835588|6116124|P2|STARTED|Second Intervention||50
2494905|NCT00835588|6116125|P1|STARTED|Second Intervention||50
2494906|NCT00835588|6116124|P2|NOT COMPLETED|Washout: 5 Days||0
2494907|NCT00835588|6116125|P1|NOT COMPLETED|Washout: 5 Days||0
2494908|NCT00835588|6116124|P2|COMPLETED|Washout: 5 Days||50
2494909|NCT00835588|6116125|P1|COMPLETED|Washout: 5 Days||50
2494910|NCT00835588|6116124|P2|STARTED|Washout: 5 Days||50
2494911|NCT00835588|6116125|P1|STARTED|Washout: 5 Days||50
2494912|NCT00835588|6116124|P2|NOT COMPLETED|First Intervention||0
2494913|NCT00835588|6116125|P1|NOT COMPLETED|First Intervention||0
2494914|NCT00835588|6116124|P2|COMPLETED|First Intervention||50
2494915|NCT00835588|6116125|P1|COMPLETED|First Intervention||50
2494916|NCT00835588|6116124|P2|STARTED|First Intervention||50
2494917|NCT00835588|6116125|P1|STARTED|First Intervention||50
2494918|NCT00835575|6116135|P2|NOT COMPLETED|Second Intervention||0
2494919|NCT00835575|6116136|P1|NOT COMPLETED|Second Intervention||0
2494920|NCT00835575|6116135|P2|COMPLETED|Second Intervention||16
2494921|NCT00835575|6116136|P1|COMPLETED|Second Intervention||15
2494922|NCT00835575|6116135|P2|STARTED|Second Intervention||16
2494923|NCT00835575|6116136|P1|STARTED|Second Intervention||15
2494924|NCT00835575|6116135|P2|NOT COMPLETED|Washout of 14 Days||0
2494925|NCT00835575|6116136|P1|NOT COMPLETED|Washout of 14 Days||1
2494926|NCT00835575|6116135|P2|COMPLETED|Washout of 14 Days||16
2494927|NCT00835575|6116136|P1|COMPLETED|Washout of 14 Days||15
2494928|NCT00835575|6116135|P2|STARTED|Washout of 14 Days||16
2494929|NCT00835575|6116136|P1|STARTED|Washout of 14 Days||16
2494930|NCT00835575|6116135|P2|NOT COMPLETED|First Intervention||0
2494931|NCT00835575|6116136|P1|NOT COMPLETED|First Intervention||0
2494932|NCT00835575|6116135|P2|COMPLETED|First Intervention||16
2494933|NCT00835575|6116136|P1|COMPLETED|First Intervention||16
2494934|NCT00835575|6116135|P2|STARTED|First Intervention||16
2494935|NCT00835575|6116136|P1|STARTED|First Intervention||16
2494936|NCT00835549|6116146|P2|NOT COMPLETED|Second Intervention||0
2494937|NCT00835549|6116147|P1|NOT COMPLETED|Second Intervention||0
2494938|NCT00835549|6116146|P2|COMPLETED|Second Intervention||16
2494939|NCT00835549|6116147|P1|COMPLETED|Second Intervention||14
2494940|NCT00835549|6116146|P2|STARTED|Second Intervention||16
2494941|NCT00835549|6116147|P1|STARTED|Second Intervention||14
2494942|NCT00835549|6116146|P2|NOT COMPLETED|Washout of 7 Days||0
2494943|NCT00835549|6116147|P1|NOT COMPLETED|Washout of 7 Days||2
2494944|NCT00835549|6116146|P2|COMPLETED|Washout of 7 Days||16
2494945|NCT00835549|6116147|P1|COMPLETED|Washout of 7 Days||14
2494946|NCT00835549|6116146|P2|STARTED|Washout of 7 Days||16
2494947|NCT00835549|6116147|P1|STARTED|Washout of 7 Days||16
2494948|NCT00835549|6116146|P2|NOT COMPLETED|First Intervention||0
2494949|NCT00835549|6116147|P1|NOT COMPLETED|First Intervention||0
2494950|NCT00835549|6116146|P2|COMPLETED|First Intervention||16
2494951|NCT00835549|6116147|P1|COMPLETED|First Intervention||16
2494952|NCT00835549|6116146|P2|STARTED|First Intervention||16
2494953|NCT00835549|6116147|P1|STARTED|First Intervention||16
2494954|NCT00835536|6116157|P2|NOT COMPLETED|Second Intervention||0
2494955|NCT00835536|6116158|P1|NOT COMPLETED|Second Intervention||0
2494956|NCT00835536|6116157|P2|COMPLETED|Second Intervention||14
2494957|NCT00835536|6116158|P1|COMPLETED|Second Intervention||12
2494958|NCT00835536|6116157|P2|STARTED|Second Intervention||14
2494959|NCT00835536|6116158|P1|STARTED|Second Intervention||12
2494960|NCT00835536|6116157|P2|NOT COMPLETED|Washout of 5 Weeks||0
2494961|NCT00835536|6116158|P1|NOT COMPLETED|Washout of 5 Weeks||1
2494962|NCT00835536|6116157|P2|COMPLETED|Washout of 5 Weeks||14
2494963|NCT00835536|6116158|P1|COMPLETED|Washout of 5 Weeks||12
2494964|NCT00835536|6116157|P2|STARTED|Washout of 5 Weeks||14
2494965|NCT00835536|6116158|P1|STARTED|Washout of 5 Weeks||13
2494966|NCT00835536|6116157|P2|NOT COMPLETED|First Intervention||0
2494967|NCT00835536|6116158|P1|NOT COMPLETED|First Intervention||0
2494968|NCT00835536|6116157|P2|COMPLETED|First Intervention||14
2494969|NCT00835536|6116158|P1|COMPLETED|First Intervention||13
2494970|NCT00835536|6116157|P2|STARTED|First Intervention||14
2494971|NCT00835536|6116158|P1|STARTED|First Intervention||13
2494972|NCT00835510|6116167|P3|NOT COMPLETED|Overall Study||38
2494973|NCT00835510|6116168|P2|NOT COMPLETED|Overall Study||69
2494974|NCT00835510|6116169|P1|NOT COMPLETED|Overall Study||76
2494975|NCT00835510|6116167|P3|COMPLETED|Overall Study||70
2494976|NCT00835510|6116168|P2|COMPLETED|Overall Study||152
2494977|NCT00835510|6116169|P1|COMPLETED|Overall Study||143
2494978|NCT00835510|6116167|P3|Positive Fungal Culture|Overall Study||71
2494979|NCT00835510|6116168|P2|Positive Fungal Culture|Overall Study||155
2494980|NCT00835510|6116169|P1|Positive Fungal Culture|Overall Study||149
2494981|NCT00835510|6116167|P3|STARTED|Overall Study||108
2494982|NCT00835510|6116168|P2|STARTED|Overall Study||221
2494983|NCT00835510|6116169|P1|STARTED|Overall Study||219
2494984|NCT00835497|6116191|P2|NOT COMPLETED|Second Intervention||0
2494985|NCT00835497|6116192|P1|NOT COMPLETED|Second Intervention||0
2494986|NCT00835497|6116191|P2|COMPLETED|Second Intervention||20
2494987|NCT00835497|6116192|P1|COMPLETED|Second Intervention||20
2494988|NCT00835497|6116191|P2|STARTED|Second Intervention||20
2494989|NCT00835497|6116192|P1|STARTED|Second Intervention||20
2494990|NCT00835497|6116191|P2|NOT COMPLETED|Washout: 7 Days||0
2494991|NCT00835497|6116192|P1|NOT COMPLETED|Washout: 7 Days||0
2494992|NCT00835497|6116191|P2|COMPLETED|Washout: 7 Days||20
2494993|NCT00835497|6116192|P1|COMPLETED|Washout: 7 Days||20
2494994|NCT00835497|6116191|P2|STARTED|Washout: 7 Days||20
2494995|NCT00835497|6116192|P1|STARTED|Washout: 7 Days||20
2494996|NCT00835497|6116191|P2|NOT COMPLETED|First Intervention||0
2494997|NCT00835497|6116192|P1|NOT COMPLETED|First Intervention||0
2494998|NCT00835497|6116191|P2|COMPLETED|First Intervention||20
2494999|NCT00835497|6116192|P1|COMPLETED|First Intervention||20
2495000|NCT00835497|6116191|P2|STARTED|First Intervention||20
2495001|NCT00835497|6116192|P1|STARTED|First Intervention||20
2495002|NCT00835484|6116208|P2|NOT COMPLETED|Second Intervention||0
2495003|NCT00835484|6116209|P1|NOT COMPLETED|Second Intervention||0
2495004|NCT00835484|6116208|P2|COMPLETED|Second Intervention||16
2495005|NCT00835484|6116209|P1|COMPLETED|Second Intervention||16
2495006|NCT00835484|6116208|P2|STARTED|Second Intervention||16
2495007|NCT00835484|6116209|P1|STARTED|Second Intervention||16
2495008|NCT00835484|6116208|P2|NOT COMPLETED|Washout of 7 Days||0
2495009|NCT00835484|6116209|P1|NOT COMPLETED|Washout of 7 Days||0
2495010|NCT00835484|6116208|P2|COMPLETED|Washout of 7 Days||16
2495011|NCT00835484|6116209|P1|COMPLETED|Washout of 7 Days||16
2495012|NCT00835484|6116208|P2|STARTED|Washout of 7 Days||16
2495013|NCT00835484|6116209|P1|STARTED|Washout of 7 Days||16
2495014|NCT00835484|6116208|P2|NOT COMPLETED|First Intervention||0
2495015|NCT00835484|6116209|P1|NOT COMPLETED|First Intervention||0
2495016|NCT00835484|6116208|P2|COMPLETED|First Intervention||16
2495017|NCT00835484|6116209|P1|COMPLETED|First Intervention||16
2495018|NCT00835484|6116208|P2|STARTED|First Intervention||16
2495019|NCT00835484|6116209|P1|STARTED|First Intervention||16
2495020|NCT00835406|6116219|P2|NOT COMPLETED|Period: Second Intervention||0
2495021|NCT00835406|6116220|P1|NOT COMPLETED|Period: Second Intervention||0
2495022|NCT00835406|6116219|P2|COMPLETED|Period: Second Intervention||67
2495023|NCT00835406|6116220|P1|COMPLETED|Period: Second Intervention||68
2495024|NCT00835406|6116219|P2|STARTED|Period: Second Intervention||67
2495025|NCT00835406|6116220|P1|STARTED|Period: Second Intervention||68
2495026|NCT00835406|6116219|P2|NOT COMPLETED|Period: Washout of 7 Days||2
2495027|NCT00835406|6116220|P1|NOT COMPLETED|Period: Washout of 7 Days||0
2495028|NCT00835406|6116219|P2|COMPLETED|Period: Washout of 7 Days||67
2495029|NCT00835406|6116220|P1|COMPLETED|Period: Washout of 7 Days||68
2495030|NCT00835406|6116219|P2|STARTED|Period: Washout of 7 Days||69
2495031|NCT00835406|6116220|P1|STARTED|Period: Washout of 7 Days||68
2495032|NCT00835406|6116219|P2|NOT COMPLETED|Period: First Intervention||1
2495033|NCT00835406|6116220|P1|NOT COMPLETED|Period: First Intervention||2
2495034|NCT00835406|6116219|P2|COMPLETED|Period: First Intervention||69
2495035|NCT00835406|6116220|P1|COMPLETED|Period: First Intervention||68
2495036|NCT00835406|6116219|P2|STARTED|Period: First Intervention||70
2495037|NCT00835406|6116220|P1|STARTED|Period: First Intervention||70
2495038|NCT00835380|6116226|P1|NOT COMPLETED|Overall Study||2
2495039|NCT00835380|6116226|P1|COMPLETED|Overall Study||78
2495040|NCT00835380|6116226|P1|STARTED|Overall Study||80
2495041|NCT00835367|6116233|P2|NOT COMPLETED|Second Intervention||1
2495042|NCT00835367|6116234|P1|NOT COMPLETED|Second Intervention||1
2495043|NCT00835367|6116233|P2|COMPLETED|Second Intervention||33
2495044|NCT00835367|6116234|P1|COMPLETED|Second Intervention||30
2495045|NCT00835367|6116233|P2|STARTED|Second Intervention||34
2495046|NCT00835367|6116234|P1|STARTED|Second Intervention||31
2495047|NCT00835367|6116233|P2|NOT COMPLETED|Washout||0
2495048|NCT00835367|6116234|P1|NOT COMPLETED|Washout||3
2495049|NCT00835367|6116233|P2|COMPLETED|Washout||34
2495050|NCT00835367|6116234|P1|COMPLETED|Washout||31
2495051|NCT00835367|6116233|P2|STARTED|Washout||34
2495052|NCT00835367|6116234|P1|STARTED|Washout||34
2495053|NCT00835367|6116233|P2|NOT COMPLETED|First Intervention||0
2495054|NCT00835367|6116234|P1|NOT COMPLETED|First Intervention||0
2495055|NCT00835367|6116233|P2|COMPLETED|First Intervention||34
2495056|NCT00835367|6116234|P1|COMPLETED|First Intervention||34
2495057|NCT00835367|6116233|P2|STARTED|First Intervention||34
2495058|NCT00835367|6116234|P1|STARTED|First Intervention||34
2495059|NCT00835354|6116256|P2|NOT COMPLETED|Second Intervention||0
2495060|NCT00835354|6116257|P1|NOT COMPLETED|Second Intervention||0
2495061|NCT00835354|6116256|P2|COMPLETED|Second Intervention||12
2495062|NCT00835354|6116257|P1|COMPLETED|Second Intervention||13
2495063|NCT00835354|6116256|P2|STARTED|Second Intervention||12
2495064|NCT00835354|6116257|P1|STARTED|Second Intervention||13
2495065|NCT00835354|6116256|P2|NOT COMPLETED|Washout of 7 Days||0
2495066|NCT00835354|6116257|P1|NOT COMPLETED|Washout of 7 Days||0
2495067|NCT00835354|6116256|P2|COMPLETED|Washout of 7 Days||12
2495068|NCT00835354|6116257|P1|COMPLETED|Washout of 7 Days||13
2495069|NCT00835354|6116256|P2|STARTED|Washout of 7 Days||12
2495070|NCT00835354|6116257|P1|STARTED|Washout of 7 Days||13
2495071|NCT00835354|6116256|P2|NOT COMPLETED|First Intervention||1
2495072|NCT00835354|6116257|P1|NOT COMPLETED|First Intervention||0
2495073|NCT00835354|6116256|P2|COMPLETED|First Intervention||12
2495074|NCT00835354|6116257|P1|COMPLETED|First Intervention||13
2495075|NCT00835354|6116256|P2|STARTED|First Intervention||13
2495076|NCT00835354|6116257|P1|STARTED|First Intervention||13
2495077|NCT00835341|6116267|P2|NOT COMPLETED|Overall Study||12
2495078|NCT00835341|6116268|P1|NOT COMPLETED|Overall Study||3
2495079|NCT00835341|6116267|P2|COMPLETED|Overall Study||46
2495080|NCT00835341|6116268|P1|COMPLETED|Overall Study||32
2495081|NCT00835341|6116267|P2|STARTED|Overall Study||58
2495082|NCT00835341|6116268|P1|STARTED|Overall Study||35
2495083|NCT00835276|6116276|P2|NOT COMPLETED|Second Intervention||0
2495084|NCT00835276|6116277|P1|NOT COMPLETED|Second Intervention||0
2495085|NCT00835276|6116276|P2|COMPLETED|Second Intervention||24
2495086|NCT00835276|6116277|P1|COMPLETED|Second Intervention||24
2495087|NCT00835276|6116276|P2|STARTED|Second Intervention||24
2495088|NCT00835276|6116277|P1|STARTED|Second Intervention||24
2495089|NCT00835276|6116276|P2|NOT COMPLETED|Washout of 7 Days||0
2495090|NCT00835276|6116277|P1|NOT COMPLETED|Washout of 7 Days||0
2495091|NCT00835276|6116276|P2|COMPLETED|Washout of 7 Days||24
2495092|NCT00835276|6116277|P1|COMPLETED|Washout of 7 Days||24
2495093|NCT00835276|6116276|P2|STARTED|Washout of 7 Days||24
2495094|NCT00835276|6116277|P1|STARTED|Washout of 7 Days||24
2495095|NCT00835276|6116276|P2|NOT COMPLETED|First Intervention||0
2495096|NCT00835276|6116277|P1|NOT COMPLETED|First Intervention||0
2495097|NCT00835276|6116276|P2|COMPLETED|First Intervention||24
2495098|NCT00835276|6116277|P1|COMPLETED|First Intervention||24
2495099|NCT00835276|6116276|P2|STARTED|First Intervention||24
2495100|NCT00835276|6116277|P1|STARTED|First Intervention||24
2495101|NCT00835263|6116287|P2|NOT COMPLETED|Second Intervention||0
2495102|NCT00835263|6116288|P1|NOT COMPLETED|Second Intervention||1
2495103|NCT00835263|6116287|P2|COMPLETED|Second Intervention||16
2495104|NCT00835263|6116288|P1|COMPLETED|Second Intervention||15
2495105|NCT00835263|6116287|P2|STARTED|Second Intervention||16
2495106|NCT00835263|6116288|P1|STARTED|Second Intervention||16
2495107|NCT00835263|6116287|P2|NOT COMPLETED|First Intervention||0
2495108|NCT00835263|6116288|P1|NOT COMPLETED|First Intervention||0
2495109|NCT00835263|6116287|P2|COMPLETED|First Intervention||16
2495110|NCT00835263|6116288|P1|COMPLETED|First Intervention||16
2495111|NCT00835263|6116287|P2|STARTED|First Intervention||16
2495112|NCT00835263|6116288|P1|STARTED|First Intervention||16
2495113|NCT00835237|6116298|P2|NOT COMPLETED|Overall Study||0
2495114|NCT00835237|6116299|P1|NOT COMPLETED|Overall Study||6
2495115|NCT00835237|6116298|P2|COMPLETED|Overall Study||445
2495116|NCT00835237|6116299|P1|COMPLETED|Overall Study||881
2495117|NCT00835237|6116298|P2|STARTED|Overall Study||445
2495118|NCT00835237|6116299|P1|STARTED|Overall Study||887
2495119|NCT00835224|6116323|P1|NOT COMPLETED|Overall Study||10
2495120|NCT00835224|6116323|P1|COMPLETED|Overall Study||24
2495121|NCT00835224|6116323|P1|STARTED|Overall Study||34
2495122|NCT00835211|6116339|P2|NOT COMPLETED|Second Intervention||0
2495123|NCT00835211|6116340|P1|NOT COMPLETED|Second Intervention||0
2495124|NCT00835211|6116339|P2|COMPLETED|Second Intervention||22
2495125|NCT00835211|6116340|P1|COMPLETED|Second Intervention||21
2495126|NCT00835211|6116339|P2|STARTED|Second Intervention||22
2495127|NCT00835211|6116340|P1|STARTED|Second Intervention||21
2495128|NCT00835211|6116339|P2|NOT COMPLETED|Washout: 7 Days||1
2495129|NCT00835211|6116340|P1|NOT COMPLETED|Washout: 7 Days||3
2495130|NCT00835211|6116339|P2|COMPLETED|Washout: 7 Days||22
2495131|NCT00835211|6116340|P1|COMPLETED|Washout: 7 Days||21
2495132|NCT00835211|6116339|P2|STARTED|Washout: 7 Days||23
2495133|NCT00835211|6116340|P1|STARTED|Washout: 7 Days||24
2495134|NCT00835211|6116339|P2|NOT COMPLETED|First Intervention||1
2495135|NCT00835211|6116340|P1|NOT COMPLETED|First Intervention||0
2495136|NCT00835211|6116339|P2|COMPLETED|First Intervention||23
2495137|NCT00835211|6116340|P1|COMPLETED|First Intervention||24
2495138|NCT00835211|6116339|P2|STARTED|First Intervention||24
2495139|NCT00835211|6116340|P1|STARTED|First Intervention||24
2495140|NCT00835198|6116350|P2|NOT COMPLETED|Overall Study||7
2495141|NCT00835198|6116351|P1|NOT COMPLETED|Overall Study||8
2495142|NCT00835198|6116350|P2|COMPLETED|Overall Study||74
2495143|NCT00835198|6116351|P1|COMPLETED|Overall Study||74
2495144|NCT00835198|6116350|P2|STARTED|Overall Study||81
2495145|NCT00835198|6116351|P1|STARTED|Overall Study||82
2495146|NCT00835185|6116363|P1|NOT COMPLETED|Overall Study||0
2495147|NCT00835185|6116363|P1|COMPLETED|Overall Study||44
2495148|NCT00835185|6116363|P1|Received at Least 1 Dose of Study Drug|Overall Study||44
2495149|NCT00835185|6116363|P1|STARTED|Overall Study||44
2495150|NCT00835172|6116386|P2|NOT COMPLETED|Second Intervention||0
2495151|NCT00835172|6116387|P1|NOT COMPLETED|Second Intervention||0
2495152|NCT00835172|6116386|P2|COMPLETED|Second Intervention||15
2495153|NCT00835172|6116387|P1|COMPLETED|Second Intervention||16
2495154|NCT00835172|6116386|P2|STARTED|Second Intervention||15
2495155|NCT00835172|6116387|P1|STARTED|Second Intervention||16
2495156|NCT00835172|6116386|P2|NOT COMPLETED|Washout||1
2495157|NCT00835172|6116387|P1|NOT COMPLETED|Washout||0
2495158|NCT00835172|6116386|P2|COMPLETED|Washout||15
2495159|NCT00835172|6116387|P1|COMPLETED|Washout||16
2495160|NCT00835172|6116386|P2|STARTED|Washout||16
2495161|NCT00835172|6116387|P1|STARTED|Washout||16
2495162|NCT00835172|6116386|P2|NOT COMPLETED|First Intervention||0
2495163|NCT00835172|6116387|P1|NOT COMPLETED|First Intervention||0
2495164|NCT00835172|6116386|P2|COMPLETED|First Intervention||16
2495165|NCT00835172|6116387|P1|COMPLETED|First Intervention||16
2495166|NCT00835172|6116386|P2|STARTED|First Intervention||16
2495167|NCT00835172|6116387|P1|STARTED|First Intervention||16
2495168|NCT00835159|6116397|P2|NOT COMPLETED|Overall Study||0
2495169|NCT00835159|6116398|P1|NOT COMPLETED|Overall Study||0
2495170|NCT00835159|6116397|P2|COMPLETED|Overall Study||17
2495171|NCT00835159|6116398|P1|COMPLETED|Overall Study||11
2495172|NCT00835159|6116397|P2|STARTED|Overall Study||17
2495173|NCT00835159|6116398|P1|STARTED|Overall Study||11
2495174|NCT00835146|6116406|P2|NOT COMPLETED|Second Intervention||0
2495175|NCT00835146|6116407|P1|NOT COMPLETED|Second Intervention||0
2495176|NCT00835146|6116406|P2|COMPLETED|Second Intervention||14
2495177|NCT00835146|6116407|P1|COMPLETED|Second Intervention||14
2495178|NCT00835146|6116406|P2|STARTED|Second Intervention||14
2495179|NCT00835146|6116407|P1|STARTED|Second Intervention||14
2495180|NCT00835146|6116406|P2|NOT COMPLETED|Washout of 5 Weeks||0
2495181|NCT00835146|6116407|P1|NOT COMPLETED|Washout of 5 Weeks||0
2495182|NCT00835146|6116406|P2|COMPLETED|Washout of 5 Weeks||14
2495183|NCT00835146|6116407|P1|COMPLETED|Washout of 5 Weeks||14
2495184|NCT00835146|6116406|P2|STARTED|Washout of 5 Weeks||14
2495185|NCT00835146|6116407|P1|STARTED|Washout of 5 Weeks||14
2495186|NCT00835146|6116406|P2|NOT COMPLETED|First Intervention||0
2495187|NCT00835146|6116407|P1|NOT COMPLETED|First Intervention||0
2495188|NCT00835146|6116406|P2|COMPLETED|First Intervention||14
2495189|NCT00835146|6116407|P1|COMPLETED|First Intervention||14
2495190|NCT00835146|6116406|P2|STARTED|First Intervention||14
2495191|NCT00835146|6116407|P1|STARTED|First Intervention||14
2495192|NCT00835120|6116413|P1|NOT COMPLETED|Overall Study||8
2495193|NCT00835120|6116413|P1|COMPLETED|Overall Study||26
2495194|NCT00835120|6116413|P1|STARTED|Overall Study||34
2495195|NCT00835081|6116423|P2|NOT COMPLETED|Second Intervention||0
2495196|NCT00835081|6116424|P1|NOT COMPLETED|Second Intervention||0
2495197|NCT00835081|6116423|P2|COMPLETED|Second Intervention||13
2495198|NCT00835081|6116424|P1|COMPLETED|Second Intervention||12
2495199|NCT00835081|6116423|P2|STARTED|Second Intervention||13
2495200|NCT00835081|6116424|P1|STARTED|Second Intervention||12
2495201|NCT00835081|6116423|P2|NOT COMPLETED|Washout of 7 Days||0
2495202|NCT00835081|6116424|P1|NOT COMPLETED|Washout of 7 Days||1
2495203|NCT00835081|6116423|P2|COMPLETED|Washout of 7 Days||13
2495204|NCT00835081|6116424|P1|COMPLETED|Washout of 7 Days||12
2495205|NCT00835081|6116423|P2|STARTED|Washout of 7 Days||13
2495206|NCT00835081|6116424|P1|STARTED|Washout of 7 Days||13
2495207|NCT00835081|6116423|P2|NOT COMPLETED|First Intervention||0
2495208|NCT00835081|6116424|P1|NOT COMPLETED|First Intervention||0
2495209|NCT00835081|6116423|P2|COMPLETED|First Intervention||13
2495210|NCT00835081|6116424|P1|COMPLETED|First Intervention||13
2495211|NCT00835081|6116423|P2|STARTED|First Intervention||13
2495212|NCT00835081|6116424|P1|STARTED|First Intervention||13
2495213|NCT00835068|6116434|P2|NOT COMPLETED|Overall Study||1
2495214|NCT00835068|6116435|P1|NOT COMPLETED|Overall Study||10
2495215|NCT00835068|6116434|P2|COMPLETED|Overall Study||0
2495216|NCT00835068|6116435|P1|COMPLETED|Overall Study||47
2495217|NCT00835068|6116434|P2|STARTED|Overall Study||1
2495218|NCT00835068|6116435|P1|STARTED|Overall Study||57
2495219|NCT00835042|6116455|P2|NOT COMPLETED|Second Intervention||0
2495220|NCT00835042|6116456|P1|NOT COMPLETED|Second Intervention||0
2495221|NCT00835042|6116455|P2|COMPLETED|Second Intervention||24
2495222|NCT00835042|6116456|P1|COMPLETED|Second Intervention||26
2495223|NCT00835042|6116455|P2|STARTED|Second Intervention||24
2495224|NCT00835042|6116456|P1|STARTED|Second Intervention||26
2495225|NCT00835042|6116455|P2|NOT COMPLETED|Washout of 21 Days||2
2495226|NCT00835042|6116456|P1|NOT COMPLETED|Washout of 21 Days||0
2495227|NCT00835042|6116455|P2|COMPLETED|Washout of 21 Days||24
2495228|NCT00835042|6116456|P1|COMPLETED|Washout of 21 Days||26
2495229|NCT00835042|6116455|P2|STARTED|Washout of 21 Days||26
2495230|NCT00835042|6116456|P1|STARTED|Washout of 21 Days||26
2495231|NCT00835042|6116455|P2|NOT COMPLETED|First Intervention||2
2495232|NCT00835042|6116456|P1|NOT COMPLETED|First Intervention||4
2495233|NCT00835042|6116455|P2|COMPLETED|First Intervention||26
2495234|NCT00835042|6116456|P1|COMPLETED|First Intervention||26
2495235|NCT00835042|6116455|P2|STARTED|First Intervention||28
2495236|NCT00835042|6116456|P1|STARTED|First Intervention||30
2495237|NCT00835003|6116478|P2|NOT COMPLETED|Overall Study||0
2495238|NCT00835003|6116479|P1|NOT COMPLETED|Overall Study||0
2495239|NCT00835003|6116478|P2|COMPLETED|Overall Study||638
2495240|NCT00835003|6116479|P1|COMPLETED|Overall Study||636
2495241|NCT00835003|6116478|P2|STARTED|Overall Study||638
2495242|NCT00835003|6116479|P1|STARTED|Overall Study||636
2495243|NCT00834990|6116487|P2|NOT COMPLETED|Second Intervention||0
2495244|NCT00834990|6116488|P1|NOT COMPLETED|Second Intervention||0
2495245|NCT00834990|6116487|P2|COMPLETED|Second Intervention||11
2495246|NCT00834990|6116488|P1|COMPLETED|Second Intervention||12
2495247|NCT00834990|6116487|P2|STARTED|Second Intervention||11
2495248|NCT00834990|6116488|P1|STARTED|Second Intervention||12
2495249|NCT00834990|6116487|P2|NOT COMPLETED|Washout of 7 Days||0
2495250|NCT00834990|6116488|P1|NOT COMPLETED|Washout of 7 Days||0
2495251|NCT00834990|6116487|P2|COMPLETED|Washout of 7 Days||11
2495252|NCT00834990|6116488|P1|COMPLETED|Washout of 7 Days||12
2495253|NCT00834990|6116487|P2|STARTED|Washout of 7 Days||11
2495254|NCT00834990|6116488|P1|STARTED|Washout of 7 Days||12
2495255|NCT00834990|6116487|P2|NOT COMPLETED|First Intervention||0
2495256|NCT00834990|6116488|P1|NOT COMPLETED|First Intervention||0
2495257|NCT00834990|6116487|P2|COMPLETED|First Intervention||11
2495258|NCT00834990|6116488|P1|COMPLETED|First Intervention||12
2495259|NCT00834990|6116487|P2|STARTED|First Intervention||11
2495260|NCT00834990|6116488|P1|STARTED|First Intervention||12
2495261|NCT00834977|6116498|P2|NOT COMPLETED|Second Intervention||0
2495262|NCT00834977|6116499|P1|NOT COMPLETED|Second Intervention||0
2495263|NCT00834977|6116498|P2|COMPLETED|Second Intervention||24
2495264|NCT00834977|6116499|P1|COMPLETED|Second Intervention||24
2495265|NCT00834977|6116498|P2|STARTED|Second Intervention||24
2495266|NCT00834977|6116499|P1|STARTED|Second Intervention||24
2495267|NCT00834977|6116498|P2|NOT COMPLETED|First Intervention||0
2495268|NCT00834977|6116499|P1|NOT COMPLETED|First Intervention||0
2495269|NCT00834977|6116498|P2|COMPLETED|First Intervention||24
2495270|NCT00834977|6116499|P1|COMPLETED|First Intervention||24
2495271|NCT00834977|6116498|P2|STARTED|First Intervention||24
2495272|NCT00834977|6116499|P1|STARTED|First Intervention||24
2495273|NCT00834964|6116521|P2|NOT COMPLETED|Second Intervention||0
2495274|NCT00834964|6116522|P1|NOT COMPLETED|Second Intervention||0
2495275|NCT00834964|6116521|P2|COMPLETED|Second Intervention||15
2495276|NCT00834964|6116522|P1|COMPLETED|Second Intervention||15
2495277|NCT00834964|6116521|P2|STARTED|Second Intervention||15
2495278|NCT00834964|6116522|P1|STARTED|Second Intervention||15
2495279|NCT00834964|6116521|P2|NOT COMPLETED|Washout: 7 Days||0
2495280|NCT00834964|6116522|P1|NOT COMPLETED|Washout: 7 Days||0
2495281|NCT00834964|6116521|P2|COMPLETED|Washout: 7 Days||15
2495282|NCT00834964|6116522|P1|COMPLETED|Washout: 7 Days||15
2495283|NCT00834964|6116521|P2|STARTED|Washout: 7 Days||15
2495284|NCT00834964|6116522|P1|STARTED|Washout: 7 Days||15
2495285|NCT00834964|6116521|P2|NOT COMPLETED|First Intervention||0
2495286|NCT00834964|6116522|P1|NOT COMPLETED|First Intervention||0
2495287|NCT00834964|6116521|P2|COMPLETED|First Intervention||15
2495288|NCT00834964|6116522|P1|COMPLETED|First Intervention||15
2495289|NCT00834964|6116521|P2|STARTED|First Intervention||15
2495290|NCT00834964|6116522|P1|STARTED|First Intervention||15
2495291|NCT00834912|6116542|P6|NOT COMPLETED|Treatment Period 3||0
2495292|NCT00834912|6116543|P5|NOT COMPLETED|Treatment Period 3||0
2495293|NCT00834912|6116544|P4|NOT COMPLETED|Treatment Period 3||0
2495294|NCT00834912|6116545|P3|NOT COMPLETED|Treatment Period 3||0
2495295|NCT00834912|6116546|P2|NOT COMPLETED|Treatment Period 3||0
2495296|NCT00834912|6116547|P1|NOT COMPLETED|Treatment Period 3||0
2495297|NCT00834912|6116542|P6|COMPLETED|Treatment Period 3||6
2495298|NCT00834912|6116543|P5|COMPLETED|Treatment Period 3||5
2495299|NCT00834912|6116544|P4|COMPLETED|Treatment Period 3||5
2495300|NCT00834912|6116545|P3|COMPLETED|Treatment Period 3||5
2495301|NCT00834912|6116546|P2|COMPLETED|Treatment Period 3||5
2495302|NCT00834912|6116547|P1|COMPLETED|Treatment Period 3||6
2495303|NCT00834912|6116542|P6|STARTED|Treatment Period 3||6
2495304|NCT00834912|6116543|P5|STARTED|Treatment Period 3||5
2495305|NCT00834912|6116544|P4|STARTED|Treatment Period 3||5
2495306|NCT00834912|6116545|P3|STARTED|Treatment Period 3||5
2495307|NCT00834912|6116546|P2|STARTED|Treatment Period 3||5
2495308|NCT00834912|6116547|P1|STARTED|Treatment Period 3||6
2495309|NCT00834912|6116542|P6|NOT COMPLETED|Treatment Period 2||0
2495310|NCT00834912|6116543|P5|NOT COMPLETED|Treatment Period 2||1
2495311|NCT00834912|6116544|P4|NOT COMPLETED|Treatment Period 2||0
2495312|NCT00834912|6116545|P3|NOT COMPLETED|Treatment Period 2||1
2495313|NCT00834912|6116546|P2|NOT COMPLETED|Treatment Period 2||0
2495314|NCT00834912|6116547|P1|NOT COMPLETED|Treatment Period 2||0
2495315|NCT00834912|6116542|P6|COMPLETED|Treatment Period 2||6
2495316|NCT00834912|6116543|P5|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
2495317|NCT00834912|6116544|P4|COMPLETED|Treatment Period 2||5
2495318|NCT00834912|6116545|P3|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
2495319|NCT00834912|6116546|P2|COMPLETED|Treatment Period 2||5
2495320|NCT00834912|6116547|P1|COMPLETED|Treatment Period 2||6
2495321|NCT00834912|6116542|P6|STARTED|Treatment Period 2||6
2495322|NCT00834912|6116543|P5|STARTED|Treatment Period 2||6
2495323|NCT00834912|6116544|P4|STARTED|Treatment Period 2||5
2495324|NCT00834912|6116545|P3|STARTED|Treatment Period 2||6
2495325|NCT00834912|6116546|P2|STARTED|Treatment Period 2||5
2495326|NCT00834912|6116547|P1|STARTED|Treatment Period 2||6
2495327|NCT00834912|6116542|P6|NOT COMPLETED|Treatment Period 1||0
2495328|NCT00834912|6116543|P5|NOT COMPLETED|Treatment Period 1||0
2495329|NCT00834912|6116544|P4|NOT COMPLETED|Treatment Period 1||1
2495330|NCT00834912|6116545|P3|NOT COMPLETED|Treatment Period 1||0
2495331|NCT00834912|6116546|P2|NOT COMPLETED|Treatment Period 1||1
2495332|NCT00834912|6116547|P1|NOT COMPLETED|Treatment Period 1||0
2495333|NCT00834912|6116542|P6|COMPLETED|Treatment Period 1||6
2495334|NCT00834912|6116543|P5|COMPLETED|Treatment Period 1||6
2495335|NCT00834912|6116544|P4|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
2495336|NCT00834912|6116545|P3|COMPLETED|Treatment Period 1||6
2495337|NCT00834912|6116546|P2|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
2495338|NCT00834912|6116547|P1|COMPLETED|Treatment Period 1||6
2495339|NCT00834912|6116542|P6|STARTED|Treatment Period 1||6
2495340|NCT00834912|6116543|P5|STARTED|Treatment Period 1||6
2495341|NCT00834912|6116544|P4|STARTED|Treatment Period 1||6
2495342|NCT00834912|6116545|P3|STARTED|Treatment Period 1||6
2495343|NCT00834912|6116546|P2|STARTED|Treatment Period 1||6
2495344|NCT00834912|6116547|P1|STARTED|Treatment Period 1||6
2495345|NCT00834899|6116569|P2|NOT COMPLETED|Overall Study||1
2495346|NCT00834899|6116570|P1|NOT COMPLETED|Overall Study||1
2495347|NCT00834899|6116569|P2|COMPLETED|Overall Study|One patient was withdrawn early because she did not meet eligibility criteria.|3
2495348|NCT00834899|6116570|P1|COMPLETED|Overall Study|One patient withdrew consent following completion of the study drug infusion.|8
2495349|NCT00834899|6116569|P2|STARTED|Overall Study||4
2495350|NCT00834899|6116570|P1|STARTED|Overall Study||9
2495351|NCT00834886|6116586|P4|NOT COMPLETED|Overall Study||0
2495352|NCT00834886|6116587|P3|NOT COMPLETED|Overall Study||1
2495353|NCT00834886|6116588|P2|NOT COMPLETED|Overall Study||1
2495354|NCT00834886|6116589|P1|NOT COMPLETED|Overall Study||0
2495355|NCT00834886|6116586|P4|COMPLETED|Overall Study||10
2495356|NCT00834886|6116587|P3|COMPLETED|Overall Study||9
2495357|NCT00834886|6116588|P2|COMPLETED|Overall Study||9
2495358|NCT00834886|6116589|P1|COMPLETED|Overall Study||10
2495359|NCT00834886|6116586|P4|STARTED|Overall Study||10
2495360|NCT00834886|6116587|P3|STARTED|Overall Study||10
2495361|NCT00834886|6116588|P2|STARTED|Overall Study||10
2495362|NCT00834886|6116589|P1|STARTED|Overall Study||10
2495363|NCT00834873|6116609|P2|NOT COMPLETED|Second Intervention||0
2495364|NCT00834873|6116610|P1|NOT COMPLETED|Second Intervention||0
2495365|NCT00834873|6116609|P2|COMPLETED|Second Intervention||11
2495366|NCT00834873|6116610|P1|COMPLETED|Second Intervention||12
2495367|NCT00834873|6116609|P2|STARTED|Second Intervention||11
2495368|NCT00834873|6116610|P1|STARTED|Second Intervention||12
2495369|NCT00834873|6116609|P2|NOT COMPLETED|Washout: 7 Days||0
2495370|NCT00834873|6116610|P1|NOT COMPLETED|Washout: 7 Days||0
2495371|NCT00834873|6116609|P2|COMPLETED|Washout: 7 Days||11
2495372|NCT00834873|6116610|P1|COMPLETED|Washout: 7 Days||12
2495373|NCT00834873|6116609|P2|STARTED|Washout: 7 Days||11
2495374|NCT00834873|6116610|P1|STARTED|Washout: 7 Days||12
2495375|NCT00834873|6116609|P2|NOT COMPLETED|First Intervention||1
2495376|NCT00834873|6116610|P1|NOT COMPLETED|First Intervention||0
2495377|NCT00834873|6116609|P2|COMPLETED|First Intervention||11
2495378|NCT00834873|6116610|P1|COMPLETED|First Intervention||12
2495379|NCT00834873|6116609|P2|STARTED|First Intervention||12
2495380|NCT00834873|6116610|P1|STARTED|First Intervention||12
2495381|NCT00834834|6116620|P2|NOT COMPLETED|Overall Study||3
2495382|NCT00834834|6116621|P1|NOT COMPLETED|Overall Study||4
2495383|NCT00834834|6116620|P2|COMPLETED|Overall Study||39
2495384|NCT00834834|6116621|P1|COMPLETED|Overall Study||38
2495385|NCT00834834|6116620|P2|STARTED|Overall Study||42
2495386|NCT00834834|6116621|P1|STARTED|Overall Study||42
2495387|NCT00834808|6116632|P3|NOT COMPLETED|Treatment Period 3 (Day 15)||0
2495388|NCT00834808|6116633|P2|NOT COMPLETED|Treatment Period 3 (Day 15)||0
2495389|NCT00834808|6116634|P1|NOT COMPLETED|Treatment Period 3 (Day 15)||0
2495390|NCT00834808|6116632|P3|COMPLETED|Treatment Period 3 (Day 15)||9
2495391|NCT00834808|6116633|P2|COMPLETED|Treatment Period 3 (Day 15)||9
2495392|NCT00834808|6116634|P1|COMPLETED|Treatment Period 3 (Day 15)||9
2495393|NCT00834808|6116632|P3|STARTED|Treatment Period 3 (Day 15)||9
2495394|NCT00834808|6116633|P2|STARTED|Treatment Period 3 (Day 15)||9
2495395|NCT00834808|6116634|P1|STARTED|Treatment Period 3 (Day 15)||9
2495396|NCT00834808|6116632|P3|NOT COMPLETED|Treatment Period 2 (Day 8)||0
2495397|NCT00834808|6116633|P2|NOT COMPLETED|Treatment Period 2 (Day 8)||0
2495398|NCT00834808|6116634|P1|NOT COMPLETED|Treatment Period 2 (Day 8)||0
2495399|NCT00834808|6116632|P3|COMPLETED|Treatment Period 2 (Day 8)||9
2495400|NCT00834808|6116633|P2|COMPLETED|Treatment Period 2 (Day 8)||9
2495401|NCT00834808|6116634|P1|COMPLETED|Treatment Period 2 (Day 8)||9
2495402|NCT00834808|6116632|P3|STARTED|Treatment Period 2 (Day 8)||9
2495403|NCT00834808|6116633|P2|STARTED|Treatment Period 2 (Day 8)||9
2495404|NCT00834808|6116634|P1|STARTED|Treatment Period 2 (Day 8)||9
2495405|NCT00834808|6116632|P3|NOT COMPLETED|Treatment Period 1 (Day 1)||0
2495406|NCT00834808|6116633|P2|NOT COMPLETED|Treatment Period 1 (Day 1)||0
2495407|NCT00834808|6116634|P1|NOT COMPLETED|Treatment Period 1 (Day 1)||0
2495408|NCT00834808|6116632|P3|COMPLETED|Treatment Period 1 (Day 1)||9
2495409|NCT00834808|6116633|P2|COMPLETED|Treatment Period 1 (Day 1)||9
2495410|NCT00834808|6116634|P1|COMPLETED|Treatment Period 1 (Day 1)||9
2495411|NCT00834808|6116632|P3|STARTED|Treatment Period 1 (Day 1)||9
2495412|NCT00834808|6116633|P2|STARTED|Treatment Period 1 (Day 1)||9
2495413|NCT00834808|6116634|P1|STARTED|Treatment Period 1 (Day 1)||9
2495414|NCT00834795|6116656|P2|NOT COMPLETED|Second Intervention||0
2495415|NCT00834795|6116657|P1|NOT COMPLETED|Second Intervention||1
2495416|NCT00834795|6116656|P2|COMPLETED|Second Intervention||17
2495417|NCT00834795|6116657|P1|COMPLETED|Second Intervention||17
2495418|NCT00834795|6116656|P2|STARTED|Second Intervention||17
2495419|NCT00834795|6116657|P1|STARTED|Second Intervention||18
2495420|NCT00834795|6116656|P2|NOT COMPLETED|Washout: 7 Days||1
2495421|NCT00834795|6116657|P1|NOT COMPLETED|Washout: 7 Days||0
2495422|NCT00834795|6116656|P2|COMPLETED|Washout: 7 Days||17
2495423|NCT00834795|6116657|P1|COMPLETED|Washout: 7 Days||18
2495424|NCT00834795|6116656|P2|STARTED|Washout: 7 Days||18
2495425|NCT00834795|6116657|P1|STARTED|Washout: 7 Days||18
2495426|NCT00834795|6116656|P2|NOT COMPLETED|First Intervention||0
2495427|NCT00834795|6116657|P1|NOT COMPLETED|First Intervention||0
2495428|NCT00834795|6116656|P2|COMPLETED|First Intervention||18
2495429|NCT00834795|6116657|P1|COMPLETED|First Intervention||18
2495430|NCT00834795|6116656|P2|STARTED|First Intervention||18
2495431|NCT00834795|6116657|P1|STARTED|First Intervention||18
2495432|NCT00834756|6116667|P2|NOT COMPLETED|Second Intervention||0
2495433|NCT00834756|6116668|P1|NOT COMPLETED|Second Intervention||0
2495434|NCT00834756|6116667|P2|COMPLETED|Second Intervention||18
2495435|NCT00834756|6116668|P1|COMPLETED|Second Intervention||16
2495436|NCT00834756|6116667|P2|STARTED|Second Intervention||18
2495437|NCT00834756|6116668|P1|STARTED|Second Intervention||16
2495438|NCT00834756|6116667|P2|NOT COMPLETED|Washout: 21 Days||0
2495439|NCT00834756|6116668|P1|NOT COMPLETED|Washout: 21 Days||1
2495440|NCT00834756|6116667|P2|COMPLETED|Washout: 21 Days||18
2495441|NCT00834756|6116668|P1|COMPLETED|Washout: 21 Days||16
2495442|NCT00834756|6116667|P2|STARTED|Washout: 21 Days||18
2495443|NCT00834756|6116668|P1|STARTED|Washout: 21 Days||17
2495444|NCT00834756|6116667|P2|NOT COMPLETED|First Intervention||0
2495445|NCT00834756|6116668|P1|NOT COMPLETED|First Intervention||1
2495446|NCT00834756|6116667|P2|COMPLETED|First Intervention||18
2495447|NCT00834756|6116668|P1|COMPLETED|First Intervention||17
2495448|NCT00834756|6116667|P2|STARTED|First Intervention||18
2495449|NCT00834756|6116668|P1|STARTED|First Intervention||18
2495450|NCT00834743|6116678|P2|NOT COMPLETED|Second Intervention||0
2495451|NCT00834743|6116679|P1|NOT COMPLETED|Second Intervention||1
2495452|NCT00834743|6116678|P2|COMPLETED|Second Intervention||16
2495453|NCT00834743|6116679|P1|COMPLETED|Second Intervention||15
2495454|NCT00834743|6116678|P2|STARTED|Second Intervention||16
2495455|NCT00834743|6116679|P1|STARTED|Second Intervention||16
2495456|NCT00834743|6116678|P2|NOT COMPLETED|Washout of 7 Days||0
2495457|NCT00834743|6116679|P1|NOT COMPLETED|Washout of 7 Days||0
2495458|NCT00834743|6116678|P2|COMPLETED|Washout of 7 Days||16
2495459|NCT00834743|6116679|P1|COMPLETED|Washout of 7 Days||16
2495460|NCT00834743|6116678|P2|STARTED|Washout of 7 Days||16
2495461|NCT00834743|6116679|P1|STARTED|Washout of 7 Days||16
2495462|NCT00834743|6116678|P2|NOT COMPLETED|First Intervention||0
2495463|NCT00834743|6116679|P1|NOT COMPLETED|First Intervention||0
2495464|NCT00834743|6116678|P2|COMPLETED|First Intervention||16
2495465|NCT00834743|6116679|P1|COMPLETED|First Intervention||16
2495466|NCT00834743|6116678|P2|STARTED|First Intervention||16
2495467|NCT00834743|6116679|P1|STARTED|First Intervention||16
2495468|NCT00834717|6116689|P2|NOT COMPLETED|Second Intervention||0
2495469|NCT00834717|6116690|P1|NOT COMPLETED|Second Intervention||0
2495470|NCT00834717|6116689|P2|COMPLETED|Second Intervention||19
2495471|NCT00834717|6116690|P1|COMPLETED|Second Intervention||19
2495472|NCT00834717|6116689|P2|STARTED|Second Intervention||19
2495473|NCT00834717|6116690|P1|STARTED|Second Intervention||19
2495474|NCT00834717|6116689|P2|NOT COMPLETED|First Intervention||1
2495475|NCT00834717|6116690|P1|NOT COMPLETED|First Intervention||1
2495476|NCT00834717|6116689|P2|COMPLETED|First Intervention||19
2495477|NCT00834717|6116690|P1|COMPLETED|First Intervention||19
2495478|NCT00834717|6116689|P2|STARTED|First Intervention||20
2495479|NCT00834717|6116690|P1|STARTED|First Intervention||20
2495480|NCT00834678|6116698|P1|NOT COMPLETED|Overall Study||0
2495481|NCT00834678|6116698|P1|COMPLETED|Overall Study||11
2495482|NCT00834678|6116698|P1|STARTED|Overall Study||11
2495483|NCT00834652|6116712|P2|NOT COMPLETED|Overall Study||40
2495484|NCT00834652|6116713|P1|NOT COMPLETED|Overall Study||38
2495485|NCT00834652|6116712|P2|COMPLETED|Overall Study||62
2495486|NCT00834652|6116713|P1|COMPLETED|Overall Study||66
2495487|NCT00834652|6116712|P2|STARTED|Overall Study||102
2495488|NCT00834652|6116713|P1|STARTED|Overall Study||104
2495489|NCT00834639|6116721|P2|NOT COMPLETED|Second Intervention||2
2495490|NCT00834639|6116722|P1|NOT COMPLETED|Second Intervention||0
2495491|NCT00834639|6116721|P2|COMPLETED|Second Intervention||10
2495492|NCT00834639|6116722|P1|COMPLETED|Second Intervention||12
2495493|NCT00834639|6116721|P2|STARTED|Second Intervention||12
2495494|NCT00834639|6116722|P1|STARTED|Second Intervention||12
2495495|NCT00834639|6116721|P2|NOT COMPLETED|Washout of 7 Days||0
2495496|NCT00834639|6116722|P1|NOT COMPLETED|Washout of 7 Days||0
2495497|NCT00834639|6116721|P2|COMPLETED|Washout of 7 Days||12
2495498|NCT00834639|6116722|P1|COMPLETED|Washout of 7 Days||12
2495499|NCT00834639|6116721|P2|STARTED|Washout of 7 Days||12
2495500|NCT00834639|6116722|P1|STARTED|Washout of 7 Days||12
2495501|NCT00834639|6116721|P2|NOT COMPLETED|First Intervention||0
2495502|NCT00834639|6116722|P1|NOT COMPLETED|First Intervention||0
2495503|NCT00834639|6116721|P2|COMPLETED|First Intervention||12
2495504|NCT00834639|6116722|P1|COMPLETED|First Intervention||12
2495505|NCT00834639|6116721|P2|STARTED|First Intervention||12
2495506|NCT00834639|6116722|P1|STARTED|First Intervention||12
2495507|NCT00834626|6116730|P1|NOT COMPLETED|Overall Study||0
2495508|NCT00834626|6116730|P1|COMPLETED|Overall Study||30
2495509|NCT00834626|6116730|P1|1 Year Follow-up|Overall Study||30
2495510|NCT00834626|6116730|P1|STARTED|Overall Study||30
2495511|NCT00834613|6116739|P2|NOT COMPLETED|Second Intervention||0
2495512|NCT00834613|6116740|P1|NOT COMPLETED|Second Intervention||0
2495513|NCT00834613|6116739|P2|COMPLETED|Second Intervention||16
2495514|NCT00834613|6116740|P1|COMPLETED|Second Intervention||15
2495515|NCT00834613|6116739|P2|STARTED|Second Intervention||16
2495516|NCT00834613|6116740|P1|STARTED|Second Intervention||15
2495517|NCT00834613|6116739|P2|NOT COMPLETED|Washout of 7 Days||0
2495518|NCT00834613|6116740|P1|NOT COMPLETED|Washout of 7 Days||0
2495519|NCT00834613|6116739|P2|COMPLETED|Washout of 7 Days||16
2495520|NCT00834613|6116740|P1|COMPLETED|Washout of 7 Days||15
2495521|NCT00834613|6116739|P2|STARTED|Washout of 7 Days||16
2495522|NCT00834613|6116740|P1|STARTED|Washout of 7 Days||15
2495523|NCT00834613|6116739|P2|NOT COMPLETED|First Intervention||0
2495524|NCT00834613|6116740|P1|NOT COMPLETED|First Intervention||1
2495525|NCT00834613|6116739|P2|COMPLETED|First Intervention||16
2495526|NCT00834613|6116740|P1|COMPLETED|First Intervention||15
2495527|NCT00834613|6116739|P2|STARTED|First Intervention||16
2495528|NCT00834613|6116740|P1|STARTED|First Intervention||16
2495529|NCT00834587|6116750|P2|NOT COMPLETED|Second Intervention||0
2495530|NCT00834587|6116751|P1|NOT COMPLETED|Second Intervention||0
2495531|NCT00834587|6116750|P2|COMPLETED|Second Intervention||20
2495532|NCT00834587|6116751|P1|COMPLETED|Second Intervention||19
2495533|NCT00834587|6116750|P2|STARTED|Second Intervention||20
2495534|NCT00834587|6116751|P1|STARTED|Second Intervention||19
2495535|NCT00834587|6116750|P2|NOT COMPLETED|Washout: 7 Days||0
2495536|NCT00834587|6116751|P1|NOT COMPLETED|Washout: 7 Days||1
2495537|NCT00834587|6116750|P2|COMPLETED|Washout: 7 Days||20
2495538|NCT00834587|6116751|P1|COMPLETED|Washout: 7 Days||19
2495539|NCT00834587|6116750|P2|STARTED|Washout: 7 Days||20
2495540|NCT00834587|6116751|P1|STARTED|Washout: 7 Days||20
2495541|NCT00834587|6116750|P2|NOT COMPLETED|First Intervention||0
2495542|NCT00834587|6116751|P1|NOT COMPLETED|First Intervention||0
2495543|NCT00834587|6116750|P2|COMPLETED|First Intervention||20
2495544|NCT00834587|6116751|P1|COMPLETED|First Intervention||20
2495545|NCT00834587|6116750|P2|STARTED|First Intervention||20
2495546|NCT00834587|6116751|P1|STARTED|First Intervention||20
2495547|NCT00834574|6116767|P2|NOT COMPLETED|Second Intervention||0
2495548|NCT00834574|6116768|P1|NOT COMPLETED|Second Intervention||0
2495549|NCT00834574|6116767|P2|COMPLETED|Second Intervention||16
2495550|NCT00834574|6116768|P1|COMPLETED|Second Intervention||16
2495551|NCT00834574|6116767|P2|STARTED|Second Intervention||16
2495552|NCT00834574|6116768|P1|STARTED|Second Intervention||16
2495553|NCT00834574|6116767|P2|NOT COMPLETED|Washout of 7 Days||0
2495554|NCT00834574|6116768|P1|NOT COMPLETED|Washout of 7 Days||0
2495555|NCT00834574|6116767|P2|COMPLETED|Washout of 7 Days||16
2495556|NCT00834574|6116768|P1|COMPLETED|Washout of 7 Days||16
2495557|NCT00834574|6116767|P2|STARTED|Washout of 7 Days||16
2495558|NCT00834574|6116768|P1|STARTED|Washout of 7 Days||16
2495559|NCT00834574|6116767|P2|NOT COMPLETED|First Intervention||0
2495560|NCT00834574|6116768|P1|NOT COMPLETED|First Intervention||0
2495561|NCT00834574|6116767|P2|COMPLETED|First Intervention||16
2495562|NCT00834574|6116768|P1|COMPLETED|First Intervention||16
2495563|NCT00834574|6116767|P2|STARTED|First Intervention||16
2495564|NCT00834574|6116768|P1|STARTED|First Intervention||16
2495565|NCT00834561|6116778|P2|NOT COMPLETED|Second Intervention||0
2495566|NCT00834561|6116779|P1|NOT COMPLETED|Second Intervention||0
2495567|NCT00834561|6116778|P2|COMPLETED|Second Intervention||16
2495568|NCT00834561|6116779|P1|COMPLETED|Second Intervention||16
2495569|NCT00834561|6116778|P2|STARTED|Second Intervention||16
2495570|NCT00834561|6116779|P1|STARTED|Second Intervention||16
2495571|NCT00834561|6116778|P2|NOT COMPLETED|First Intervention||0
2495572|NCT00834561|6116779|P1|NOT COMPLETED|First Intervention||0
2495573|NCT00834561|6116778|P2|COMPLETED|First Intervention||16
2495574|NCT00834561|6116779|P1|COMPLETED|First Intervention||16
2495575|NCT00834561|6116778|P2|STARTED|First Intervention||16
2495576|NCT00834561|6116779|P1|STARTED|First Intervention||16
2495577|NCT00834535|6116789|P2|NOT COMPLETED|Second Intervention||0
2495578|NCT00834535|6116790|P1|NOT COMPLETED|Second Intervention||0
2495579|NCT00834535|6116789|P2|COMPLETED|Second Intervention||16
2495580|NCT00834535|6116790|P1|COMPLETED|Second Intervention||16
2495581|NCT00834535|6116789|P2|STARTED|Second Intervention||16
2495582|NCT00834535|6116790|P1|STARTED|Second Intervention||16
2495583|NCT00834535|6116789|P2|NOT COMPLETED|Washout of 7 Days||0
2495584|NCT00834535|6116790|P1|NOT COMPLETED|Washout of 7 Days||0
2495585|NCT00834535|6116789|P2|COMPLETED|Washout of 7 Days||16
2495586|NCT00834535|6116790|P1|COMPLETED|Washout of 7 Days||16
2495587|NCT00834535|6116789|P2|STARTED|Washout of 7 Days||16
2495588|NCT00834535|6116790|P1|STARTED|Washout of 7 Days||16
2495589|NCT00834535|6116789|P2|NOT COMPLETED|First Intervention||0
2495590|NCT00834535|6116790|P1|NOT COMPLETED|First Intervention||0
2495591|NCT00834535|6116789|P2|COMPLETED|First Intervention||16
2495592|NCT00834535|6116790|P1|COMPLETED|First Intervention||16
2495593|NCT00834535|6116789|P2|STARTED|First Intervention||16
2495594|NCT00834535|6116790|P1|STARTED|First Intervention||16
2495595|NCT00834522|6116800|P2|NOT COMPLETED|Second Intervention||0
2495596|NCT00834522|6116801|P1|NOT COMPLETED|Second Intervention||0
2495597|NCT00834522|6116800|P2|COMPLETED|Second Intervention||39
2495598|NCT00834522|6116801|P1|COMPLETED|Second Intervention||37
2495599|NCT00834522|6116800|P2|STARTED|Second Intervention||39
2495600|NCT00834522|6116801|P1|STARTED|Second Intervention||37
2495601|NCT00834522|6116800|P2|NOT COMPLETED|Washout||1
2495602|NCT00834522|6116801|P1|NOT COMPLETED|Washout||3
2495603|NCT00834522|6116800|P2|COMPLETED|Washout||39
2495604|NCT00834522|6116801|P1|COMPLETED|Washout||37
2495605|NCT00834522|6116800|P2|STARTED|Washout||40
2495606|NCT00834522|6116801|P1|STARTED|Washout||40
2495607|NCT00834522|6116800|P2|NOT COMPLETED|First Intervention||0
2495608|NCT00834522|6116801|P1|NOT COMPLETED|First Intervention||0
2495609|NCT00834522|6116800|P2|COMPLETED|First Intervention||40
2495610|NCT00834522|6116801|P1|COMPLETED|First Intervention||40
2495611|NCT00834522|6116800|P2|STARTED|First Intervention||40
2495612|NCT00834522|6116801|P1|STARTED|First Intervention||40
2495613|NCT00834483|6116811|P2|NOT COMPLETED|Overall Study||0
2495614|NCT00834483|6116812|P1|NOT COMPLETED|Overall Study||0
2495615|NCT00834483|6116811|P2|COMPLETED|Overall Study||29
2495616|NCT00834483|6116812|P1|COMPLETED|Overall Study||31
2495617|NCT00834483|6116811|P2|STARTED|Overall Study||29
2495618|NCT00834483|6116812|P1|STARTED|Overall Study||31
2495619|NCT00834444|6116824|P2|NOT COMPLETED|Second Intervention||0
2495620|NCT00834444|6116825|P1|NOT COMPLETED|Second Intervention||1
2495621|NCT00834444|6116824|P2|COMPLETED|Second Intervention||16
2495622|NCT00834444|6116825|P1|COMPLETED|Second Intervention||16
2495623|NCT00834444|6116824|P2|STARTED|Second Intervention||16
2495624|NCT00834444|6116825|P1|STARTED|Second Intervention||17
2495625|NCT00834444|6116824|P2|NOT COMPLETED|Washout of 7 Days||1
2495626|NCT00834444|6116825|P1|NOT COMPLETED|Washout of 7 Days||0
2495627|NCT00834444|6116824|P2|COMPLETED|Washout of 7 Days||16
2495628|NCT00834444|6116825|P1|COMPLETED|Washout of 7 Days||17
2495629|NCT00834444|6116824|P2|STARTED|Washout of 7 Days||17
2495630|NCT00834444|6116825|P1|STARTED|Washout of 7 Days||17
2495631|NCT00834444|6116824|P2|NOT COMPLETED|First Intervention||1
2495632|NCT00834444|6116825|P1|NOT COMPLETED|First Intervention||1
2495633|NCT00834444|6116824|P2|COMPLETED|First Intervention||17
2495634|NCT00834444|6116825|P1|COMPLETED|First Intervention||17
2495635|NCT00834444|6116824|P2|STARTED|First Intervention||18
2495636|NCT00834444|6116825|P1|STARTED|First Intervention||18
2495637|NCT00834431|6116835|P2|NOT COMPLETED|Second Intervention||0
2495638|NCT00834431|6116836|P1|NOT COMPLETED|Second Intervention||0
2495639|NCT00834431|6116835|P2|COMPLETED|Second Intervention||16
2495640|NCT00834431|6116836|P1|COMPLETED|Second Intervention||18
2495641|NCT00834431|6116835|P2|STARTED|Second Intervention||16
2495642|NCT00834431|6116836|P1|STARTED|Second Intervention||18
2495643|NCT00834431|6116835|P2|NOT COMPLETED|Washout of 7 Days||1
2495644|NCT00834431|6116836|P1|NOT COMPLETED|Washout of 7 Days||0
2495645|NCT00834431|6116835|P2|COMPLETED|Washout of 7 Days||16
2495646|NCT00834431|6116836|P1|COMPLETED|Washout of 7 Days||18
2495647|NCT00834431|6116835|P2|STARTED|Washout of 7 Days||17
2495648|NCT00834431|6116836|P1|STARTED|Washout of 7 Days||18
2495649|NCT00834431|6116835|P2|NOT COMPLETED|First Intervention||1
2495650|NCT00834431|6116836|P1|NOT COMPLETED|First Intervention||0
2495651|NCT00834431|6116835|P2|COMPLETED|First Intervention||17
2495652|NCT00834431|6116836|P1|COMPLETED|First Intervention||18
2495653|NCT00834431|6116835|P2|STARTED|First Intervention||18
2495654|NCT00834431|6116836|P1|STARTED|First Intervention||18
2495655|NCT00834418|6116846|P2|NOT COMPLETED|Overall Study||2
2495656|NCT00834418|6116847|P1|NOT COMPLETED|Overall Study||0
2495657|NCT00834418|6116846|P2|COMPLETED|Overall Study||40
2495658|NCT00834418|6116847|P1|COMPLETED|Overall Study||42
2495659|NCT00834418|6116846|P2|STARTED|Overall Study||42
2495660|NCT00834418|6116847|P1|STARTED|Overall Study||42
2495661|NCT00834405|6116855|P2|NOT COMPLETED|Overall Study||0
2495662|NCT00834405|6116856|P1|NOT COMPLETED|Overall Study||0
2495663|NCT00834405|6116855|P2|COMPLETED|Overall Study||17
2495664|NCT00834405|6116856|P1|COMPLETED|Overall Study||20
2495665|NCT00834405|6116855|P2|STARTED|Overall Study||17
2495666|NCT00834405|6116856|P1|STARTED|Overall Study||20
2495667|NCT00834366|6116864|P2|NOT COMPLETED|Treatment Period 2||0
2495668|NCT00834366|6116865|P1|NOT COMPLETED|Treatment Period 2||0
2495669|NCT00834366|6116864|P2|COMPLETED|Treatment Period 2||12
2495670|NCT00834366|6116865|P1|COMPLETED|Treatment Period 2||12
2495671|NCT00834366|6116864|P2|STARTED|Treatment Period 2||12
2495672|NCT00834366|6116865|P1|STARTED|Treatment Period 2||12
2495673|NCT00834366|6116864|P2|NOT COMPLETED|Treatment Period 1||1
2495674|NCT00834366|6116865|P1|NOT COMPLETED|Treatment Period 1||1
2495675|NCT00834366|6116864|P2|COMPLETED|Treatment Period 1||12
2495676|NCT00834366|6116865|P1|COMPLETED|Treatment Period 1||12
2495677|NCT00834366|6116864|P2|STARTED|Treatment Period 1||13
2495678|NCT00834366|6116865|P1|STARTED|Treatment Period 1||13
2495679|NCT00834340|6116881|P2|NOT COMPLETED|Second Intervention||0
2495680|NCT00834340|6116882|P1|NOT COMPLETED|Second Intervention||0
2495681|NCT00834340|6116881|P2|COMPLETED|Second Intervention||16
2495682|NCT00834340|6116882|P1|COMPLETED|Second Intervention||14
2495683|NCT00834340|6116881|P2|STARTED|Second Intervention||16
2495684|NCT00834340|6116882|P1|STARTED|Second Intervention||14
2495685|NCT00834340|6116881|P2|NOT COMPLETED|Washout||0
2495686|NCT00834340|6116882|P1|NOT COMPLETED|Washout||2
2495687|NCT00834340|6116881|P2|COMPLETED|Washout||16
2495688|NCT00834340|6116882|P1|COMPLETED|Washout||14
2495689|NCT00834340|6116881|P2|STARTED|Washout||16
2495690|NCT00834340|6116882|P1|STARTED|Washout||16
2495691|NCT00834340|6116881|P2|NOT COMPLETED|First Intervention||0
2495692|NCT00834340|6116882|P1|NOT COMPLETED|First Intervention||0
2495693|NCT00834340|6116881|P2|COMPLETED|First Intervention||16
2495694|NCT00834340|6116882|P1|COMPLETED|First Intervention||16
2495695|NCT00834340|6116881|P2|STARTED|First Intervention||16
2495696|NCT00834340|6116882|P1|STARTED|First Intervention||16
2495697|NCT00834288|6116892|P2|NOT COMPLETED|Treatment Phase II||0
2495698|NCT00834288|6116893|P1|NOT COMPLETED|Treatment Phase II||0
2495699|NCT00834288|6116892|P2|COMPLETED|Treatment Phase II||13
2495700|NCT00834288|6116893|P1|COMPLETED|Treatment Phase II||13
2495701|NCT00834288|6116892|P2|STARTED|Treatment Phase II||13
2495702|NCT00834288|6116893|P1|STARTED|Treatment Phase II||13
2495703|NCT00834288|6116892|P2|NOT COMPLETED|Treatment Phase I||0
2495704|NCT00834288|6116893|P1|NOT COMPLETED|Treatment Phase I||0
2495705|NCT00834288|6116892|P2|COMPLETED|Treatment Phase I||13
2495706|NCT00834288|6116893|P1|COMPLETED|Treatment Phase I||13
2495707|NCT00834288|6116892|P2|STARTED|Treatment Phase I||13
2495708|NCT00834288|6116893|P1|STARTED|Treatment Phase I||13
2495709|NCT00834275|6116915|P2|NOT COMPLETED|Second Intervention||0
2495710|NCT00834275|6116916|P1|NOT COMPLETED|Second Intervention||0
2495711|NCT00834275|6116915|P2|COMPLETED|Second Intervention||13
2495712|NCT00834275|6116916|P1|COMPLETED|Second Intervention||13
2495713|NCT00834275|6116915|P2|STARTED|Second Intervention||13
2495714|NCT00834275|6116916|P1|STARTED|Second Intervention||13
2495715|NCT00834275|6116915|P2|NOT COMPLETED|Washout of 7 Days||0
2495716|NCT00834275|6116916|P1|NOT COMPLETED|Washout of 7 Days||0
2495717|NCT00834275|6116915|P2|COMPLETED|Washout of 7 Days||13
2495718|NCT00834275|6116916|P1|COMPLETED|Washout of 7 Days||13
2495719|NCT00834275|6116915|P2|STARTED|Washout of 7 Days||13
2495720|NCT00834275|6116916|P1|STARTED|Washout of 7 Days||13
2495721|NCT00834275|6116915|P2|NOT COMPLETED|First Intervention||0
2495722|NCT00834275|6116916|P1|NOT COMPLETED|First Intervention||0
2495723|NCT00834275|6116915|P2|COMPLETED|First Intervention||13
2495724|NCT00834275|6116916|P1|COMPLETED|First Intervention||13
2495725|NCT00834275|6116915|P2|STARTED|First Intervention||13
2495726|NCT00834275|6116916|P1|STARTED|First Intervention||13
2495727|NCT00834249|6116926|P2|NOT COMPLETED|Second Intervention||0
2495728|NCT00834249|6116927|P1|NOT COMPLETED|Second Intervention||1
2495729|NCT00834249|6116926|P2|COMPLETED|Second Intervention||8
2495730|NCT00834249|6116927|P1|COMPLETED|Second Intervention||7
2495731|NCT00834249|6116926|P2|STARTED|Second Intervention||8
2495732|NCT00834249|6116927|P1|STARTED|Second Intervention||8
2495733|NCT00834249|6116926|P2|NOT COMPLETED|Washout: 7 Days||1
2495734|NCT00834249|6116927|P1|NOT COMPLETED|Washout: 7 Days||1
2495735|NCT00834249|6116926|P2|COMPLETED|Washout: 7 Days||8
2495736|NCT00834249|6116927|P1|COMPLETED|Washout: 7 Days||8
2495737|NCT00834249|6116926|P2|STARTED|Washout: 7 Days||9
2495738|NCT00834249|6116927|P1|STARTED|Washout: 7 Days||9
2495739|NCT00834249|6116926|P2|NOT COMPLETED|First Intervention||0
2495740|NCT00834249|6116927|P1|NOT COMPLETED|First Intervention||0
2495741|NCT00834249|6116926|P2|COMPLETED|First Intervention||9
2495742|NCT00834249|6116927|P1|COMPLETED|First Intervention||9
2495743|NCT00834249|6116926|P2|STARTED|First Intervention||9
2495744|NCT00834249|6116927|P1|STARTED|First Intervention||9
2495745|NCT00834236|6116943|P2|NOT COMPLETED|Overall Study||0
2495746|NCT00834236|6116944|P1|NOT COMPLETED|Overall Study||0
2495747|NCT00834236|6116943|P2|COMPLETED|Overall Study||47
2495748|NCT00834236|6116944|P1|COMPLETED|Overall Study||29
2495749|NCT00834236|6116943|P2|STARTED|Overall Study||47
2495750|NCT00834236|6116944|P1|STARTED|Overall Study||29
2495751|NCT00834210|6116952|P2|NOT COMPLETED|Overall Study||8
2495752|NCT00834210|6116953|P1|NOT COMPLETED|Overall Study||3
2495753|NCT00834210|6116952|P2|COMPLETED|Overall Study||77
2495754|NCT00834210|6116953|P1|COMPLETED|Overall Study||83
2495755|NCT00834210|6116952|P2|STARTED|Overall Study||85
2495756|NCT00834210|6116953|P1|STARTED|Overall Study||86
2495757|NCT00834197|6116967|P2|NOT COMPLETED|Second Intervention||0
2495758|NCT00834197|6116968|P1|NOT COMPLETED|Second Intervention||0
2495759|NCT00834197|6116967|P2|COMPLETED|Second Intervention||16
2495760|NCT00834197|6116968|P1|COMPLETED|Second Intervention||16
2495761|NCT00834197|6116967|P2|STARTED|Second Intervention||16
2495762|NCT00834197|6116968|P1|STARTED|Second Intervention||16
2495763|NCT00834197|6116967|P2|NOT COMPLETED|Washout of 14 Days||0
2495764|NCT00834197|6116968|P1|NOT COMPLETED|Washout of 14 Days||0
2495765|NCT00834197|6116967|P2|COMPLETED|Washout of 14 Days||16
2495766|NCT00834197|6116968|P1|COMPLETED|Washout of 14 Days||16
2495767|NCT00834197|6116967|P2|STARTED|Washout of 14 Days||16
2495768|NCT00834197|6116968|P1|STARTED|Washout of 14 Days||16
2495769|NCT00834197|6116967|P2|NOT COMPLETED|First Intervention||0
2495770|NCT00834197|6116968|P1|NOT COMPLETED|First Intervention||0
2495771|NCT00834197|6116967|P2|COMPLETED|First Intervention||16
2495772|NCT00834197|6116968|P1|COMPLETED|First Intervention||16
2495773|NCT00834197|6116967|P2|STARTED|First Intervention||16
2495774|NCT00834197|6116968|P1|STARTED|First Intervention||16
2495775|NCT00834171|6116978|P2|NOT COMPLETED|Overall Study||0
2495776|NCT00834171|6116979|P1|NOT COMPLETED|Overall Study||0
2495777|NCT00834171|6116978|P2|COMPLETED|Overall Study||7
2495778|NCT00834171|6116979|P1|COMPLETED|Overall Study||43
2495779|NCT00834171|6116978|P2|STARTED|Overall Study||7
2495780|NCT00834171|6116979|P1|STARTED|Overall Study||43
2495781|NCT00834132|6116987|P2|NOT COMPLETED|Second Intervention||0
2495782|NCT00834132|6116988|P1|NOT COMPLETED|Second Intervention||0
2495783|NCT00834132|6116987|P2|COMPLETED|Second Intervention||12
2495784|NCT00834132|6116988|P1|COMPLETED|Second Intervention||12
2495785|NCT00834132|6116987|P2|STARTED|Second Intervention||12
2495786|NCT00834132|6116988|P1|STARTED|Second Intervention||12
2495787|NCT00834132|6116987|P2|NOT COMPLETED|Washout: 21 Days||0
2495788|NCT00834132|6116988|P1|NOT COMPLETED|Washout: 21 Days||0
2495789|NCT00834132|6116987|P2|COMPLETED|Washout: 21 Days||12
2495790|NCT00834132|6116988|P1|COMPLETED|Washout: 21 Days||12
2495791|NCT00834132|6116987|P2|STARTED|Washout: 21 Days||12
2495792|NCT00834132|6116988|P1|STARTED|Washout: 21 Days||12
2495793|NCT00834132|6116987|P2|NOT COMPLETED|First Intervention||0
2495794|NCT00834132|6116988|P1|NOT COMPLETED|First Intervention||0
2495795|NCT00834132|6116987|P2|COMPLETED|First Intervention||12
2495796|NCT00834132|6116988|P1|COMPLETED|First Intervention||12
2495797|NCT00834132|6116987|P2|STARTED|First Intervention||12
2495798|NCT00834132|6116988|P1|STARTED|First Intervention||12
2495799|NCT00834106|6116998|P2|NOT COMPLETED|Extension Study (Month 42 to Month 90)||74
2495800|NCT00834106|6116999|P1|NOT COMPLETED|Extension Study (Month 42 to Month 90)||96
2495801|NCT00834106|6116998|P2|COMPLETED|Extension Study (Month 42 to Month 90)||1294
2495802|NCT00834106|6116999|P1|COMPLETED|Extension Study (Month 42 to Month 90)||1308
2495803|NCT00834106|6116998|P2|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1368
2495804|NCT00834106|6116999|P1|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1404
2495805|NCT00834106|6116998|P2|NOT COMPLETED|Base Study (Day 1 to Month 30)||145
2495806|NCT00834106|6116999|P1|NOT COMPLETED|Base Study (Day 1 to Month 30)||102
2495807|NCT00834106|6116998|P2|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1358
2495808|NCT00834106|6116999|P1|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1401
2495809|NCT00834106|6116998|P2|Completed Vaccinations|Base Study (Day 1 to Month 30)||1463
2495810|NCT00834106|6116999|P1|Completed Vaccinations|Base Study (Day 1 to Month 30)||1473
2495811|NCT00834106|6116998|P2|Vaccinated|Base Study (Day 1 to Month 30)||1503
2495812|NCT00834106|6116999|P1|Vaccinated|Base Study (Day 1 to Month 30)||1503
2495813|NCT00834106|6116998|P2|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503
2495814|NCT00834106|6116999|P1|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503
2495815|NCT00834080|6117023|P1|NOT COMPLETED|Overall Study||23
2495816|NCT00834080|6117023|P1|COMPLETED|Overall Study||15
2495817|NCT00834080|6117023|P1|STARTED|Overall Study||38
2495818|NCT00834067|6117029|P2|NOT COMPLETED|Second Intervention||0
2495819|NCT00834067|6117030|P1|NOT COMPLETED|Second Intervention||0
2495820|NCT00834067|6117029|P2|COMPLETED|Second Intervention||29
2495821|NCT00834067|6117030|P1|COMPLETED|Second Intervention||30
2495822|NCT00834067|6117029|P2|STARTED|Second Intervention||29
2495823|NCT00834067|6117030|P1|STARTED|Second Intervention||30
2495824|NCT00834067|6117029|P2|NOT COMPLETED|Washout of 21 Days||1
2495825|NCT00834067|6117030|P1|NOT COMPLETED|Washout of 21 Days||0
2495826|NCT00834067|6117029|P2|COMPLETED|Washout of 21 Days||29
2495827|NCT00834067|6117030|P1|COMPLETED|Washout of 21 Days||30
2495828|NCT00834067|6117029|P2|STARTED|Washout of 21 Days||30
2495829|NCT00834067|6117030|P1|STARTED|Washout of 21 Days||30
2495830|NCT00834067|6117029|P2|NOT COMPLETED|First Intervention||0
2495831|NCT00834067|6117030|P1|NOT COMPLETED|First Intervention||0
2495832|NCT00834067|6117029|P2|COMPLETED|First Intervention||30
2495833|NCT00834067|6117030|P1|COMPLETED|First Intervention||30
2495834|NCT00834067|6117029|P2|STARTED|First Intervention||30
2495835|NCT00834067|6117030|P1|STARTED|First Intervention||30
2495836|NCT00834041|6117052|P2|NOT COMPLETED|Overall Study||1
2495837|NCT00834041|6117053|P1|NOT COMPLETED|Overall Study||1
2495838|NCT00834041|6117052|P2|COMPLETED|Overall Study||19
2495839|NCT00834041|6117053|P1|COMPLETED|Overall Study||18
2495840|NCT00834041|6117052|P2|STARTED|Overall Study||20
2495841|NCT00834041|6117053|P1|STARTED|Overall Study||19
2495842|NCT00833989|6117071|P4|NOT COMPLETED|Overall Study||2
2495843|NCT00833989|6117072|P3|NOT COMPLETED|Overall Study||1
2495844|NCT00833989|6117073|P2|NOT COMPLETED|Overall Study||0
2495845|NCT00833989|6117074|P1|NOT COMPLETED|Overall Study||3
2495846|NCT00833989|6117071|P4|COMPLETED|Overall Study||6
2495847|NCT00833989|6117072|P3|COMPLETED|Overall Study||8
2495848|NCT00833989|6117073|P2|COMPLETED|Overall Study||8
2495849|NCT00833989|6117074|P1|COMPLETED|Overall Study||14
2495850|NCT00833989|6117071|P4|STARTED|Overall Study||8
2495851|NCT00833989|6117072|P3|STARTED|Overall Study||9
2495852|NCT00833989|6117073|P2|STARTED|Overall Study||8
2495853|NCT00833989|6117074|P1|STARTED|Overall Study||17
2495854|NCT00833976|6117178|P1|NOT COMPLETED|Overall Study||51
2495855|NCT00833976|6117178|P1|COMPLETED|Overall Study||14
2495856|NCT00833976|6117178|P1|STARTED|Overall Study||65
2495857|NCT00833937|6117186|P2|NOT COMPLETED|Second Intervention||0
2495858|NCT00833937|6117187|P1|NOT COMPLETED|Second Intervention||0
2495859|NCT00833937|6117186|P2|COMPLETED|Second Intervention||12
2495860|NCT00833937|6117187|P1|COMPLETED|Second Intervention||11
2495861|NCT00833937|6117186|P2|STARTED|Second Intervention||12
2495862|NCT00833937|6117187|P1|STARTED|Second Intervention||11
2495863|NCT00833937|6117186|P2|NOT COMPLETED|Washout||0
2495864|NCT00833937|6117187|P1|NOT COMPLETED|Washout||1
2495865|NCT00833937|6117186|P2|COMPLETED|Washout||12
2495866|NCT00833937|6117187|P1|COMPLETED|Washout||11
2495867|NCT00833937|6117186|P2|STARTED|Washout||12
2495868|NCT00833937|6117187|P1|STARTED|Washout||12
2495869|NCT00833937|6117186|P2|NOT COMPLETED|First Intervention||0
2495870|NCT00833937|6117187|P1|NOT COMPLETED|First Intervention||0
2495871|NCT00833937|6117186|P2|COMPLETED|First Intervention||12
2495872|NCT00833937|6117187|P1|COMPLETED|First Intervention||12
2495873|NCT00833937|6117186|P2|STARTED|First Intervention||12
2495874|NCT00833937|6117187|P1|STARTED|First Intervention||12
2495875|NCT00833924|6117195|P1|NOT COMPLETED|Overall Study||109
2495876|NCT00833924|6117195|P1|COMPLETED|Overall Study||11
2495877|NCT00833924|6117195|P1|12-month|Overall Study||113
2495878|NCT00833924|6117195|P1|30-day|Overall Study||120
2495879|NCT00833924|6117195|P1|STARTED|Overall Study||120
2495880|NCT00833911|6117200|P1|NOT COMPLETED|Maintenance Phase II||10
2495881|NCT00833911|6117200|P1|COMPLETED|Maintenance Phase II||166
2495882|NCT00833911|6117200|P1|STARTED|Maintenance Phase II|97 patients chose not to continue into Maintenance Phase II|176
2495883|NCT00833911|6117200|P1|NOT COMPLETED|Maintenance Phase I||98
2495884|NCT00833911|6117200|P1|COMPLETED|Maintenance Phase I||273
2495885|NCT00833911|6117200|P1|STARTED|Maintenance Phase I||371
2495886|NCT00833911|6117200|P1|NOT COMPLETED|Titration||21
2495887|NCT00833911|6117200|P1|COMPLETED|Titration||371
2495888|NCT00833911|6117200|P1|STARTED|Titration||392
2495889|NCT00833898|6117210|P2|NOT COMPLETED|Overall Study||36
2495890|NCT00833898|6117211|P1|NOT COMPLETED|Overall Study||40
2495891|NCT00833898|6117210|P2|COMPLETED|Overall Study||38
2495892|NCT00833898|6117211|P1|COMPLETED|Overall Study||34
2495893|NCT00833898|6117210|P2|Month 12 (Post Transplantation)|Overall Study||50
2495894|NCT00833898|6117211|P1|Month 12 (Post Transplantation)|Overall Study||50
2495895|NCT00833898|6117210|P2|Month 6 (Post Transplantation)|Overall Study||54
2495896|NCT00833898|6117211|P1|Month 6 (Post Transplantation)|Overall Study||59
2495897|NCT00833898|6117210|P2|Month 3 (Post Transplantation)|Overall Study||64
2495898|NCT00833898|6117211|P1|Month 3 (Post Transplantation)|Overall Study||66
2495899|NCT00833898|6117210|P2|Month 1 (Post Transplantation)|Overall Study||74
2495900|NCT00833898|6117211|P1|Month 1 (Post Transplantation)|Overall Study||72
2495901|NCT00833898|6117210|P2|STARTED|Overall Study||74
2495902|NCT00833898|6117211|P1|STARTED|Overall Study||74
2495903|NCT00833859|6117257|P1|NOT COMPLETED|Overall Study||0
2495904|NCT00833859|6117257|P1|COMPLETED|Overall Study||2
2495905|NCT00833859|6117257|P1|STARTED|Overall Study||2
2495906|NCT00833833|6117270|P6|NOT COMPLETED|Phase 2 (as of 01 April 2011)||61
2495907|NCT00833833|6117271|P5|NOT COMPLETED|Phase 2 (as of 01 April 2011)||55
2495908|NCT00833833|6117272|P4|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
2495909|NCT00833833|6117273|P3|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
2495910|NCT00833833|6117274|P2|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
2495911|NCT00833833|6117275|P1|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
2495912|NCT00833833|6117270|P6|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|47
2495913|NCT00833833|6117271|P5|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|58
2495914|NCT00833833|6117272|P4|COMPLETED|Phase 2 (as of 01 April 2011)||0
2495915|NCT00833833|6117273|P3|COMPLETED|Phase 2 (as of 01 April 2011)||0
2495916|NCT00833833|6117274|P2|COMPLETED|Phase 2 (as of 01 April 2011)||0
2495917|NCT00833833|6117275|P1|COMPLETED|Phase 2 (as of 01 April 2011)||0
2495918|NCT00833833|6117270|P6|Safety Population|Phase 2 (as of 01 April 2011)||107
2495919|NCT00833833|6117271|P5|Safety Population|Phase 2 (as of 01 April 2011)||112
2495920|NCT00833833|6117272|P4|Safety Population|Phase 2 (as of 01 April 2011)||0
2495921|NCT00833833|6117273|P3|Safety Population|Phase 2 (as of 01 April 2011)||0
2495922|NCT00833833|6117274|P2|Safety Population|Phase 2 (as of 01 April 2011)||0
2495923|NCT00833833|6117275|P1|Safety Population|Phase 2 (as of 01 April 2011)||0
2495924|NCT00833833|6117270|P6|STARTED|Phase 2 (as of 01 April 2011)||108
2495925|NCT00833833|6117271|P5|STARTED|Phase 2 (as of 01 April 2011)||113
2495926|NCT00833833|6117272|P4|STARTED|Phase 2 (as of 01 April 2011)||0
2495927|NCT00833833|6117273|P3|STARTED|Phase 2 (as of 01 April 2011)||0
2495928|NCT00833833|6117274|P2|STARTED|Phase 2 (as of 01 April 2011)||0
2495929|NCT00833833|6117275|P1|STARTED|Phase 2 (as of 01 April 2011)||0
2495930|NCT00833833|6117270|P6|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
2495931|NCT00833833|6117271|P5|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
2495932|NCT00833833|6117272|P4|NOT COMPLETED|Phase 1 (as of 01 April 2011)||6
2495933|NCT00833833|6117273|P3|NOT COMPLETED|Phase 1 (as of 01 April 2011)||9
2495934|NCT00833833|6117274|P2|NOT COMPLETED|Phase 1 (as of 01 April 2011)||5
2495935|NCT00833833|6117275|P1|NOT COMPLETED|Phase 1 (as of 01 April 2011)||4
2495936|NCT00833833|6117270|P6|COMPLETED|Phase 1 (as of 01 April 2011)||0
2495937|NCT00833833|6117271|P5|COMPLETED|Phase 1 (as of 01 April 2011)||0
2495938|NCT00833833|6117272|P4|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|4
2495939|NCT00833833|6117273|P3|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|5
2495940|NCT00833833|6117274|P2|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|3
2495941|NCT00833833|6117275|P1|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|2
2495942|NCT00833833|6117270|P6|STARTED|Phase 1 (as of 01 April 2011)||0
2495943|NCT00833833|6117271|P5|STARTED|Phase 1 (as of 01 April 2011)||0
2495944|NCT00833833|6117272|P4|STARTED|Phase 1 (as of 01 April 2011)||10
2495945|NCT00833833|6117273|P3|STARTED|Phase 1 (as of 01 April 2011)||14
2495946|NCT00833833|6117274|P2|STARTED|Phase 1 (as of 01 April 2011)||8
2495947|NCT00833833|6117275|P1|STARTED|Phase 1 (as of 01 April 2011)||6
2495948|NCT00833794|6117315|P2|NOT COMPLETED|Double-blind Phase||49
2495949|NCT00833794|6117316|P1|NOT COMPLETED|Double-blind Phase||106
2495950|NCT00833794|6117315|P2|COMPLETED|Double-blind Phase||165
2495951|NCT00833794|6117316|P1|COMPLETED|Double-blind Phase||326
2495952|NCT00833794|6117315|P2|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 214 were randomized to Placebo|214
2495953|NCT00833794|6117316|P1|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 432 were randomized to Tramadol Once A Day|432
2495954|NCT00833794|6117315|P2|NOT COMPLETED|Open-label Phase||0
2495955|NCT00833794|6117316|P1|NOT COMPLETED|Open-label Phase||382
2495956|NCT00833794|6117315|P2|COMPLETED|Open-label Phase||0
2495957|NCT00833794|6117316|P1|COMPLETED|Open-label Phase|Randomized in double-blind phase|646
2495958|NCT00833794|6117315|P2|Received Open-Label Treatment|Open-label Phase||0
2495959|NCT00833794|6117316|P1|Received Open-Label Treatment|Open-label Phase||1023
2495960|NCT00833794|6117315|P2|Entered run-in Period|Open-label Phase||0
2495961|NCT00833794|6117316|P1|Entered run-in Period|Open-label Phase||1027
2495962|NCT00833794|6117315|P2|STARTED|Open-label Phase|No Placebo arm during open-label phase.|0
2495963|NCT00833794|6117316|P1|STARTED|Open-label Phase|Enrolled. Population described in the baseline characteristics is 1023 patients (Open-Label safety).|1028
2495964|NCT00833781|6117344|P2|NOT COMPLETED|Overall Study||0
2495965|NCT00833781|6117345|P1|NOT COMPLETED|Overall Study||0
2495966|NCT00833781|6117344|P2|COMPLETED|Overall Study||5
2495967|NCT00833781|6117345|P1|COMPLETED|Overall Study||10
2495968|NCT00833781|6117344|P2|STARTED|Overall Study||5
2495969|NCT00833781|6117345|P1|STARTED|Overall Study||10
2495970|NCT00833755|6117360|P4|NOT COMPLETED|Overall Study||6
2495971|NCT00833755|6117361|P3|NOT COMPLETED|Overall Study||2
2495972|NCT00833755|6117362|P2|NOT COMPLETED|Overall Study||5
2495973|NCT00833755|6117363|P1|NOT COMPLETED|Overall Study||4
2495974|NCT00833755|6117360|P4|COMPLETED|Overall Study||17
2495975|NCT00833755|6117361|P3|COMPLETED|Overall Study||20
2495976|NCT00833755|6117362|P2|COMPLETED|Overall Study||13
2495977|NCT00833755|6117363|P1|COMPLETED|Overall Study||12
2495978|NCT00833755|6117360|P4|STARTED|Overall Study||23
2495979|NCT00833755|6117361|P3|STARTED|Overall Study||22
2495980|NCT00833755|6117362|P2|STARTED|Overall Study||18
2495981|NCT00833755|6117363|P1|STARTED|Overall Study||16
2495982|NCT00833703|6117383|P2|NOT COMPLETED|Overall Study||1
2495983|NCT00833703|6117384|P1|NOT COMPLETED|Overall Study||0
2495984|NCT00833703|6117383|P2|COMPLETED|Overall Study|Completed follow-up|25
2495985|NCT00833703|6117384|P1|COMPLETED|Overall Study|Completed follow-up|23
2495986|NCT00833703|6117383|P2|Completed Treatment|Overall Study||24
2495987|NCT00833703|6117384|P1|Completed Treatment|Overall Study||22
2495988|NCT00833703|6117383|P2|Treated|Overall Study||26
2495989|NCT00833703|6117384|P1|Treated|Overall Study||23
2495990|NCT00833703|6117383|P2|STARTED|Overall Study|Included|26
2495991|NCT00833703|6117384|P1|STARTED|Overall Study|Included|23
2495992|NCT00833690|6117397|P3|NOT COMPLETED|Overall Study||0
2495993|NCT00833690|6117398|P2|NOT COMPLETED|Overall Study||2
2495994|NCT00833690|6117399|P1|NOT COMPLETED|Overall Study||4
2495995|NCT00833690|6117397|P3|COMPLETED|Overall Study||26
2495996|NCT00833690|6117398|P2|COMPLETED|Overall Study||22
2495997|NCT00833690|6117399|P1|COMPLETED|Overall Study||21
2495998|NCT00833690|6117397|P3|STARTED|Overall Study||26
2495999|NCT00833690|6117398|P2|STARTED|Overall Study||24
2496000|NCT00833690|6117399|P1|STARTED|Overall Study||25
2496001|NCT00833664|6117523|P2|NOT COMPLETED|Second Intervention||0
2496002|NCT00833664|6117524|P1|NOT COMPLETED|Second Intervention||0
2496003|NCT00833664|6117523|P2|COMPLETED|Second Intervention||11
2496004|NCT00833664|6117524|P1|COMPLETED|Second Intervention||10
2496005|NCT00833664|6117523|P2|STARTED|Second Intervention||11
2496006|NCT00833664|6117524|P1|STARTED|Second Intervention||10
2496007|NCT00833664|6117523|P2|NOT COMPLETED|Washout: 14 Days||0
2496008|NCT00833664|6117524|P1|NOT COMPLETED|Washout: 14 Days||1
2496009|NCT00833664|6117523|P2|COMPLETED|Washout: 14 Days||11
2496010|NCT00833664|6117524|P1|COMPLETED|Washout: 14 Days||10
2496011|NCT00833664|6117523|P2|STARTED|Washout: 14 Days||11
2496012|NCT00833664|6117524|P1|STARTED|Washout: 14 Days||11
2496013|NCT00833664|6117523|P2|NOT COMPLETED|First Intervention||0
2496014|NCT00833664|6117524|P1|NOT COMPLETED|First Intervention||0
2496015|NCT00833664|6117523|P2|COMPLETED|First Intervention||11
2496016|NCT00833664|6117524|P1|COMPLETED|First Intervention||11
2496017|NCT00833664|6117523|P2|STARTED|First Intervention||11
2496018|NCT00833664|6117524|P1|STARTED|First Intervention||11
2496019|NCT00833638|6117535|P3|NOT COMPLETED|Phase 3: Open-label Extension Phase||2
2496020|NCT00833638|6117536|P2|NOT COMPLETED|Phase 3: Open-label Extension Phase||3
2496021|NCT00833638|6117537|P1|NOT COMPLETED|Phase 3: Open-label Extension Phase||1
2496022|NCT00833638|6117535|P3|COMPLETED|Phase 3: Open-label Extension Phase||122
2496023|NCT00833638|6117536|P2|COMPLETED|Phase 3: Open-label Extension Phase||105
2496024|NCT00833638|6117537|P1|COMPLETED|Phase 3: Open-label Extension Phase||110
2496025|NCT00833638|6117535|P3|STARTED|Phase 3: Open-label Extension Phase||124
2496026|NCT00833638|6117536|P2|STARTED|Phase 3: Open-label Extension Phase||108
2496027|NCT00833638|6117537|P1|STARTED|Phase 3: Open-label Extension Phase||111
2496028|NCT00833638|6117535|P3|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||9
2496029|NCT00833638|6117536|P2|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
2496030|NCT00833638|6117537|P1|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
2496031|NCT00833638|6117535|P3|COMPLETED|Phase 2: Double-blind Treatment Phase||124
2496032|NCT00833638|6117536|P2|COMPLETED|Phase 2: Double-blind Treatment Phase||108
2496033|NCT00833638|6117537|P1|COMPLETED|Phase 2: Double-blind Treatment Phase||111
2496034|NCT00833638|6117535|P3|STARTED|Phase 2: Double-blind Treatment Phase||133
2496035|NCT00833638|6117536|P2|STARTED|Phase 2: Double-blind Treatment Phase||118
2496036|NCT00833638|6117537|P1|STARTED|Phase 2: Double-blind Treatment Phase||121
2496037|NCT00833586|6117579|P2|NOT COMPLETED|Second Intervention||0
2496038|NCT00833586|6117580|P1|NOT COMPLETED|Second Intervention||0
2496039|NCT00833586|6117579|P2|COMPLETED|Second Intervention||14
2496040|NCT00833586|6117580|P1|COMPLETED|Second Intervention||14
2496041|NCT00833586|6117579|P2|STARTED|Second Intervention||14
2496042|NCT00833586|6117580|P1|STARTED|Second Intervention||14
2496043|NCT00833586|6117579|P2|NOT COMPLETED|Washout: 14 Days||0
2496044|NCT00833586|6117580|P1|NOT COMPLETED|Washout: 14 Days||0
2496045|NCT00833586|6117579|P2|COMPLETED|Washout: 14 Days||14
2496046|NCT00833586|6117580|P1|COMPLETED|Washout: 14 Days||14
2496047|NCT00833586|6117579|P2|STARTED|Washout: 14 Days||14
2496048|NCT00833586|6117580|P1|STARTED|Washout: 14 Days||14
2496049|NCT00833586|6117579|P2|NOT COMPLETED|First Intervention||0
2496050|NCT00833586|6117580|P1|NOT COMPLETED|First Intervention||0
2496051|NCT00833586|6117579|P2|COMPLETED|First Intervention||14
2496052|NCT00833586|6117580|P1|COMPLETED|First Intervention||14
2496053|NCT00833586|6117579|P2|STARTED|First Intervention||14
2496054|NCT00833586|6117580|P1|STARTED|First Intervention||14
2496055|NCT00833560|6117588|P1|NOT COMPLETED|Overall Study||42
2496056|NCT00833560|6117588|P1|COMPLETED|Overall Study||353
2496057|NCT00833560|6117588|P1|STARTED|Overall Study||395
2496058|NCT00833547|6117597|P2|NOT COMPLETED|Overall Study||2
2496059|NCT00833547|6117598|P1|NOT COMPLETED|Overall Study||2
2496060|NCT00833547|6117597|P2|COMPLETED|Overall Study||10
2496061|NCT00833547|6117598|P1|COMPLETED|Overall Study||11
2496062|NCT00833547|6117597|P2|STARTED|Overall Study||12
2496063|NCT00833547|6117598|P1|STARTED|Overall Study||13
2496064|NCT00833521|6117608|P2|NOT COMPLETED|Second Intervention||0
2496065|NCT00833521|6117609|P1|NOT COMPLETED|Second Intervention||0
2496066|NCT00833521|6117608|P2|COMPLETED|Second Intervention||19
2496067|NCT00833521|6117609|P1|COMPLETED|Second Intervention||19
2496068|NCT00833521|6117608|P2|STARTED|Second Intervention||19
2496069|NCT00833521|6117609|P1|STARTED|Second Intervention||19
2496070|NCT00833521|6117608|P2|NOT COMPLETED|First Intervention||0
2496071|NCT00833521|6117609|P1|NOT COMPLETED|First Intervention||0
2496072|NCT00833521|6117608|P2|COMPLETED|First Intervention||19
2496073|NCT00833521|6117609|P1|COMPLETED|First Intervention||19
2496074|NCT00833521|6117608|P2|STARTED|First Intervention||19
2496075|NCT00833521|6117609|P1|STARTED|First Intervention||19
2496076|NCT00833482|6117619|P6|NOT COMPLETED|Days 21-30||0
2496077|NCT00833482|6117620|P5|NOT COMPLETED|Days 21-30||1
2496078|NCT00833482|6117621|P4|NOT COMPLETED|Days 21-30||0
2496079|NCT00833482|6117622|P3|NOT COMPLETED|Days 21-30||1
2496080|NCT00833482|6117623|P2|NOT COMPLETED|Days 21-30||0
2496081|NCT00833482|6117624|P1|NOT COMPLETED|Days 21-30||0
2496082|NCT00833482|6117619|P6|COMPLETED|Days 21-30||0
2496083|NCT00833482|6117620|P5|COMPLETED|Days 21-30||7
2496084|NCT00833482|6117621|P4|COMPLETED|Days 21-30||0
2496085|NCT00833482|6117622|P3|COMPLETED|Days 21-30||20
2496086|NCT00833482|6117623|P2|COMPLETED|Days 21-30||0
2496087|NCT00833482|6117624|P1|COMPLETED|Days 21-30||0
2496088|NCT00833482|6117619|P6|STARTED|Days 21-30||0
2496089|NCT00833482|6117620|P5|STARTED|Days 21-30||8
2496090|NCT00833482|6117621|P4|STARTED|Days 21-30||0
2496091|NCT00833482|6117622|P3|STARTED|Days 21-30||21
2496092|NCT00833482|6117623|P2|STARTED|Days 21-30||0
2496093|NCT00833482|6117624|P1|STARTED|Days 21-30||0
2496094|NCT00833482|6117619|P6|NOT COMPLETED|Days 11-20||0
2496095|NCT00833482|6117620|P5|NOT COMPLETED|Days 11-20||0
2496096|NCT00833482|6117621|P4|NOT COMPLETED|Days 11-20||0
2496097|NCT00833482|6117622|P3|NOT COMPLETED|Days 11-20||0
2496098|NCT00833482|6117623|P2|NOT COMPLETED|Days 11-20||3
2496099|NCT00833482|6117624|P1|NOT COMPLETED|Days 11-20||0
2496100|NCT00833482|6117619|P6|COMPLETED|Days 11-20||8
2496101|NCT00833482|6117620|P5|COMPLETED|Days 11-20||0
2496102|NCT00833482|6117621|P4|COMPLETED|Days 11-20||0
2496103|NCT00833482|6117622|P3|COMPLETED|Days 11-20||0
2496104|NCT00833482|6117623|P2|COMPLETED|Days 11-20||21
2496105|NCT00833482|6117624|P1|COMPLETED|Days 11-20||0
2496106|NCT00833482|6117619|P6|STARTED|Days 11-20|Participants who received treatment.|8
2496107|NCT00833482|6117620|P5|STARTED|Days 11-20||0
2496108|NCT00833482|6117621|P4|STARTED|Days 11-20||0
2496109|NCT00833482|6117622|P3|STARTED|Days 11-20||0
2496110|NCT00833482|6117623|P2|STARTED|Days 11-20|Participants who received treatment.|24
2496111|NCT00833482|6117624|P1|STARTED|Days 11-20||0
2496112|NCT00833482|6117619|P6|NOT COMPLETED|Days 1-3||0
2496113|NCT00833482|6117620|P5|NOT COMPLETED|Days 1-3||0
2496114|NCT00833482|6117621|P4|NOT COMPLETED|Days 1-3||0
2496115|NCT00833482|6117622|P3|NOT COMPLETED|Days 1-3||0
2496116|NCT00833482|6117623|P2|NOT COMPLETED|Days 1-3||0
2496117|NCT00833482|6117624|P1|NOT COMPLETED|Days 1-3||0
2496118|NCT00833482|6117619|P6|COMPLETED|Days 1-3||0
2496119|NCT00833482|6117620|P5|COMPLETED|Days 1-3||0
2496120|NCT00833482|6117621|P4|COMPLETED|Days 1-3||8
2496121|NCT00833482|6117622|P3|COMPLETED|Days 1-3||0
2496122|NCT00833482|6117623|P2|COMPLETED|Days 1-3||0
2496123|NCT00833482|6117624|P1|COMPLETED|Days 1-3||24
2496124|NCT00833482|6117619|P6|STARTED|Days 1-3||0
2496125|NCT00833482|6117620|P5|STARTED|Days 1-3||0
2496126|NCT00833482|6117621|P4|STARTED|Days 1-3||8
2496127|NCT00833482|6117622|P3|STARTED|Days 1-3||0
2496128|NCT00833482|6117623|P2|STARTED|Days 1-3|Participants who received treatment|0
2496129|NCT00833482|6117624|P1|STARTED|Days 1-3|Participants who received treatment|24
2496130|NCT00833469|6117680|P1|NOT COMPLETED|Overall Study||2
2496131|NCT00833469|6117680|P1|COMPLETED|Overall Study||3
2496132|NCT00833469|6117680|P1|STARTED|Overall Study||5
2496133|NCT00833443|6117688|P2|NOT COMPLETED|Overall Study||28
2496134|NCT00833443|6117689|P1|NOT COMPLETED|Overall Study||20
2496135|NCT00833443|6117688|P2|COMPLETED|Overall Study||15
2496136|NCT00833443|6117689|P1|COMPLETED|Overall Study||21
2496137|NCT00833443|6117688|P2|STARTED|Overall Study||43
2496138|NCT00833443|6117689|P1|STARTED|Overall Study||41
2496139|NCT00833417|6117703|P2|NOT COMPLETED|Overall Study||71
2496140|NCT00833417|6117704|P1|NOT COMPLETED|Overall Study||33
2496141|NCT00833417|6117703|P2|COMPLETED|Overall Study||0
2496142|NCT00833417|6117704|P1|COMPLETED|Overall Study||0
2496143|NCT00833417|6117703|P2|STARTED|Overall Study||71
2496144|NCT00833417|6117704|P1|STARTED|Overall Study||33
2496145|NCT00833365|6117719|P2|NOT COMPLETED|Overall Study||0
2496146|NCT00833365|6117720|P1|NOT COMPLETED|Overall Study||0
2496147|NCT00833365|6117719|P2|COMPLETED|Overall Study||6
2496148|NCT00833365|6117720|P1|COMPLETED|Overall Study||9
2496149|NCT00833365|6117719|P2|STARTED|Overall Study||6
2496150|NCT00833365|6117720|P1|STARTED|Overall Study||9
2496151|NCT00833261|6117728|P1|NOT COMPLETED|Overall Study||4
2496152|NCT00833261|6117728|P1|COMPLETED|Overall Study|3 patients withdrew from the study prior to treatment & 1 receiving it did not complete the course.|33
2496153|NCT00833261|6117728|P1|STARTED|Overall Study||37
2496154|NCT00833248|6117735|P2|NOT COMPLETED|Overall Study||3
2496155|NCT00833248|6117736|P1|NOT COMPLETED|Overall Study||4
2496156|NCT00833248|6117735|P2|COMPLETED|Overall Study||62
2496157|NCT00833248|6117736|P1|COMPLETED|Overall Study||177
2496158|NCT00833248|6117735|P2|Safety Analysis Set|Overall Study||64
2496159|NCT00833248|6117736|P1|Safety Analysis Set|Overall Study||181
2496160|NCT00833248|6117735|P2|Per Protocol (PP) Analysis Set|Overall Study||57
2496161|NCT00833248|6117736|P1|Per Protocol (PP) Analysis Set|Overall Study||164
2496162|NCT00833248|6117735|P2|Full Analysis Set (FAS)|Overall Study||64
2496163|NCT00833248|6117736|P1|Full Analysis Set (FAS)|Overall Study||180
2496164|NCT00833248|6117735|P2|STARTED|Overall Study||65
2496165|NCT00833248|6117736|P1|STARTED|Overall Study||181
2496166|NCT00833105|6117758|P1|NOT COMPLETED|Overall Study||3
2496167|NCT00833105|6117758|P1|COMPLETED|Overall Study||10
2496168|NCT00833105|6117758|P1|STARTED|Overall Study||13
2496169|NCT00833092|6117776|P2|NOT COMPLETED|Overall Study||7
2496170|NCT00833092|6117777|P1|NOT COMPLETED|Overall Study||4
2496171|NCT00833092|6117776|P2|COMPLETED|Overall Study||50
2496172|NCT00833092|6117777|P1|COMPLETED|Overall Study||50
2496173|NCT00833092|6117776|P2|STARTED|Overall Study||57
2496174|NCT00833092|6117777|P1|STARTED|Overall Study||54
2496175|NCT00833053|6117785|P2|NOT COMPLETED|Overall Study||3
2496176|NCT00833053|6117786|P1|NOT COMPLETED|Overall Study||9
2496177|NCT00833053|6117785|P2|COMPLETED|Overall Study||17
2496178|NCT00833053|6117786|P1|COMPLETED|Overall Study||10
2496179|NCT00833053|6117785|P2|STARTED|Overall Study||20
2496180|NCT00833053|6117786|P1|STARTED|Overall Study||19
2496181|NCT00833040|6117804|P6|NOT COMPLETED|Overall Study||1
2496182|NCT00833040|6117805|P5|NOT COMPLETED|Overall Study||0
2496183|NCT00833040|6117806|P4|NOT COMPLETED|Overall Study||0
2496184|NCT00833040|6117807|P3|NOT COMPLETED|Overall Study||0
2496185|NCT00833040|6117808|P2|NOT COMPLETED|Overall Study||0
2496186|NCT00833040|6117809|P1|NOT COMPLETED|Overall Study||0
2496187|NCT00833040|6117804|P6|COMPLETED|Overall Study||4
2496188|NCT00833040|6117805|P5|COMPLETED|Overall Study||5
2496189|NCT00833040|6117806|P4|COMPLETED|Overall Study||6
2496190|NCT00833040|6117807|P3|COMPLETED|Overall Study||6
2496191|NCT00833040|6117808|P2|COMPLETED|Overall Study||6
2496192|NCT00833040|6117809|P1|COMPLETED|Overall Study||6
2496193|NCT00833040|6117804|P6|STARTED|Overall Study||5
2496194|NCT00833040|6117805|P5|STARTED|Overall Study||5
2496195|NCT00833040|6117806|P4|STARTED|Overall Study||6
2496196|NCT00833040|6117807|P3|STARTED|Overall Study||6
2496197|NCT00833040|6117808|P2|STARTED|Overall Study||6
2496198|NCT00833040|6117809|P1|STARTED|Overall Study||6
2496199|NCT00833027|6117814|P1|NOT COMPLETED|Overall Study||211
2496200|NCT00833027|6117814|P1|COMPLETED|Overall Study||397
2496201|NCT00833027|6117814|P1|STARTED|Overall Study||608
2496202|NCT00832975|6117819|P1|NOT COMPLETED|Overall Study||39
2496203|NCT00832975|6117819|P1|COMPLETED|Overall Study||118
2496204|NCT00832975|6117819|P1|STARTED|Overall Study||157
2496205|NCT00832871|6117824|P1|NOT COMPLETED|Overall Study||0
2496206|NCT00832871|6117824|P1|COMPLETED|Overall Study||4
2496207|NCT00832871|6117824|P1|STARTED|Overall Study||4
2496208|NCT00832819|6117833|P3|NOT COMPLETED|Overall Study||1
2496209|NCT00832819|6117834|P2|NOT COMPLETED|Overall Study||1
2496210|NCT00832819|6117835|P1|NOT COMPLETED|Overall Study||0
2496211|NCT00832819|6117833|P3|COMPLETED|Overall Study||15
2496212|NCT00832819|6117834|P2|COMPLETED|Overall Study||5
2496213|NCT00832819|6117835|P1|COMPLETED|Overall Study||6
2496214|NCT00832819|6117833|P3|STARTED|Overall Study||16
2496215|NCT00832819|6117834|P2|STARTED|Overall Study||6
2496216|NCT00832819|6117835|P1|STARTED|Overall Study||6
2496217|NCT00832780|6117841|P1|NOT COMPLETED|Overall Study||25
2496218|NCT00832780|6117841|P1|COMPLETED|Overall Study||19
2496219|NCT00832780|6117841|P1|STARTED|Overall Study||44
2496220|NCT00832767|6117851|P2|NOT COMPLETED|Overall Study||18
2496221|NCT00832767|6117852|P1|NOT COMPLETED|Overall Study||22
2496222|NCT00832767|6117851|P2|COMPLETED|Overall Study||63
2496223|NCT00832767|6117852|P1|COMPLETED|Overall Study||99
2496224|NCT00832767|6117851|P2|STARTED|Overall Study||81
2496225|NCT00832767|6117852|P1|STARTED|Overall Study||121
2496226|NCT00832650|6117883|P3|NOT COMPLETED|Overall Study||1
2496227|NCT00832650|6117884|P2|NOT COMPLETED|Overall Study||0
2496228|NCT00832650|6117885|P1|NOT COMPLETED|Overall Study||0
2496229|NCT00832650|6117883|P3|COMPLETED|Overall Study||22
2496230|NCT00832650|6117884|P2|COMPLETED|Overall Study||12
2496231|NCT00832650|6117885|P1|COMPLETED|Overall Study||25
2496232|NCT00832650|6117883|P3|Treated|Overall Study||22
2496233|NCT00832650|6117884|P2|Treated|Overall Study||12
2496234|NCT00832650|6117885|P1|Treated|Overall Study||25
2496235|NCT00832650|6117883|P3|STARTED|Overall Study||23
2496236|NCT00832650|6117884|P2|STARTED|Overall Study||12
2496237|NCT00832650|6117885|P1|STARTED|Overall Study||25
2496238|NCT00832637|6117917|P1|NOT COMPLETED|Overall Study||0
2496239|NCT00832637|6117917|P1|COMPLETED|Overall Study||33
2496240|NCT00832637|6117917|P1|STARTED|Overall Study||33
2496241|NCT00832624|6117925|P1|NOT COMPLETED|Overall Study||10
2496242|NCT00832624|6117925|P1|COMPLETED|Overall Study||0
2496243|NCT00832624|6117925|P1|STARTED|Overall Study||10
2496244|NCT00832598|6117929|P1|NOT COMPLETED|Overall Study||0
2496245|NCT00832598|6117929|P1|COMPLETED|Overall Study||13
2496246|NCT00832598|6117929|P1|STARTED|Overall Study||13
2496247|NCT00832585|6117935|P1|NOT COMPLETED|Overall Study||2
2496248|NCT00832585|6117935|P1|COMPLETED|Overall Study|Only three subjects completed all of the visits for the study as per protocol.|3
2496249|NCT00832585|6117935|P1|STARTED|Overall Study|Eight subjects were screened but only 5 started the study and received study drug.|5
2496250|NCT00832572|6117942|P2|NOT COMPLETED|Period 2||0
2496251|NCT00832572|6117943|P1|NOT COMPLETED|Period 2||0
2496252|NCT00832572|6117942|P2|COMPLETED|Period 2||2
2496253|NCT00832572|6117943|P1|COMPLETED|Period 2||3
2496254|NCT00832572|6117942|P2|STARTED|Period 2||2
2496255|NCT00832572|6117943|P1|STARTED|Period 2||3
2496256|NCT00832572|6117942|P2|NOT COMPLETED|Period 1||0
2496257|NCT00832572|6117943|P1|NOT COMPLETED|Period 1||0
2496258|NCT00832572|6117942|P2|COMPLETED|Period 1||2
2496259|NCT00832572|6117943|P1|COMPLETED|Period 1||3
2496260|NCT00832572|6117942|P2|STARTED|Period 1||2
2496261|NCT00832572|6117943|P1|STARTED|Period 1||3
2496262|NCT00832520|6117955|P1|NOT COMPLETED|Overall Study||0
2496263|NCT00832520|6117955|P1|COMPLETED|Overall Study||13
2496264|NCT00832520|6117955|P1|STARTED|Overall Study||13
2496265|NCT00832455|6117960|P1|NOT COMPLETED|Overall Study||72
2496266|NCT00832455|6117960|P1|COMPLETED|Overall Study||373
2496267|NCT00832455|6117960|P1|Week 12|Overall Study||373
2496268|NCT00832455|6117960|P1|Week 8 (Optional)|Overall Study||247
2496269|NCT00832455|6117960|P1|Week 4|Overall Study||411
2496270|NCT00832455|6117960|P1|Baseline|Overall Study|420 –patients that received at least one dose of study medication and had 1 follow-up visit (ITT)|420
2496271|NCT00832455|6117960|P1|STARTED|Overall Study|445 – number of patients that signed the informed consent form (Safety population)|445
2496272|NCT00832416|6117984|P4|NOT COMPLETED|Overall Study||83
2496273|NCT00832416|6117985|P3|NOT COMPLETED|Overall Study||61
2496274|NCT00832416|6117986|P2|NOT COMPLETED|Overall Study||53
2496275|NCT00832416|6117987|P1|NOT COMPLETED|Overall Study||46
2496276|NCT00832416|6117984|P4|COMPLETED|Overall Study||144
2496277|NCT00832416|6117985|P3|COMPLETED|Overall Study||54
2496278|NCT00832416|6117986|P2|COMPLETED|Overall Study||60
2496279|NCT00832416|6117987|P1|COMPLETED|Overall Study||64
2496280|NCT00832416|6117984|P4|STARTED|Overall Study||227
2496281|NCT00832416|6117985|P3|STARTED|Overall Study||115
2496282|NCT00832416|6117986|P2|STARTED|Overall Study||113
2496283|NCT00832416|6117987|P1|STARTED|Overall Study||110
2496284|NCT00832390|6118028|P3|NOT COMPLETED|Overall Study||0
2496285|NCT00832390|6118029|P2|NOT COMPLETED|Overall Study||0
2496286|NCT00832390|6118030|P1|NOT COMPLETED|Overall Study||0
2496287|NCT00832390|6118028|P3|COMPLETED|Overall Study||1
2496288|NCT00832390|6118029|P2|COMPLETED|Overall Study||16
2496289|NCT00832390|6118030|P1|COMPLETED|Overall Study||12
2496290|NCT00832390|6118028|P3|STARTED|Overall Study||1
2496291|NCT00832390|6118029|P2|STARTED|Overall Study||16
2496292|NCT00832390|6118030|P1|STARTED|Overall Study||12
2496293|NCT00832377|6118038|P1|NOT COMPLETED|Overall Study||1
2496294|NCT00832377|6118038|P1|COMPLETED|Overall Study||36
2496295|NCT00832377|6118038|P1|STARTED|Overall Study||37
2496296|NCT00832338|6118045|P1|NOT COMPLETED|Overall Study||0
2496297|NCT00832338|6118045|P1|COMPLETED|Overall Study||23
2496298|NCT00832338|6118045|P1|STARTED|Overall Study||23
2496299|NCT00832299|6118049|P1|NOT COMPLETED|Overall Study||0
2496300|NCT00832299|6118049|P1|COMPLETED|Overall Study||2
2496301|NCT00832299|6118049|P1|STARTED|Overall Study||2
2496302|NCT00832260|6118054|P1|NOT COMPLETED|Overall Study||0
2496303|NCT00832260|6118054|P1|COMPLETED|Overall Study||70
2496304|NCT00832260|6118054|P1|STARTED|Overall Study||70
2496305|NCT00832130|6118061|P2|NOT COMPLETED|Overall Study||0
2496306|NCT00832130|6118062|P1|NOT COMPLETED|Overall Study||0
2496307|NCT00832130|6118061|P2|COMPLETED|Overall Study||70
2496308|NCT00832130|6118062|P1|COMPLETED|Overall Study||69
2496309|NCT00832130|6118061|P2|STARTED|Overall Study||70
2496310|NCT00832130|6118062|P1|STARTED|Overall Study||69
2496311|NCT00832117|6118084|P1|NOT COMPLETED|Overall Study||12
2496312|NCT00832117|6118084|P1|COMPLETED|Overall Study||17
2496313|NCT00832117|6118084|P1|STARTED|Overall Study||29
2496314|NCT00832091|6118103|P2|NOT COMPLETED|Overall Study||2
2496315|NCT00832091|6118104|P1|NOT COMPLETED|Overall Study||5
2496316|NCT00832091|6118103|P2|COMPLETED|Overall Study||53
2496317|NCT00832091|6118104|P1|COMPLETED|Overall Study||12
2496318|NCT00832091|6118103|P2|STARTED|Overall Study||55
2496319|NCT00832091|6118104|P1|STARTED|Overall Study||17
2496320|NCT00832078|6118112|P2|NOT COMPLETED|Test Day 2 - 2 Period||0
2496321|NCT00832078|6118113|P1|NOT COMPLETED|Test Day 2 - 2 Period||1
2496322|NCT00832078|6118112|P2|COMPLETED|Test Day 2 - 2 Period||10
2496323|NCT00832078|6118113|P1|COMPLETED|Test Day 2 - 2 Period||12
2496324|NCT00832078|6118112|P2|STARTED|Test Day 2 - 2 Period||10
2496325|NCT00832078|6118113|P1|STARTED|Test Day 2 - 2 Period||13
2496326|NCT00832078|6118112|P2|NOT COMPLETED|Test Day 2 - 1 Period||0
2496327|NCT00832078|6118113|P1|NOT COMPLETED|Test Day 2 - 1 Period||0
2496328|NCT00832078|6118112|P2|COMPLETED|Test Day 2 - 1 Period||10
2496329|NCT00832078|6118113|P1|COMPLETED|Test Day 2 - 1 Period||13
2496330|NCT00832078|6118112|P2|STARTED|Test Day 2 - 1 Period||10
2496331|NCT00832078|6118113|P1|STARTED|Test Day 2 - 1 Period||13
2496332|NCT00832078|6118112|P2|NOT COMPLETED|Test Day 1-2 Period||2
2496333|NCT00832078|6118113|P1|NOT COMPLETED|Test Day 1-2 Period||0
2496334|NCT00832078|6118112|P2|COMPLETED|Test Day 1-2 Period||10
2496335|NCT00832078|6118113|P1|COMPLETED|Test Day 1-2 Period||13
2496336|NCT00832078|6118112|P2|STARTED|Test Day 1-2 Period||12
2496337|NCT00832078|6118113|P1|STARTED|Test Day 1-2 Period||13
2496338|NCT00832078|6118112|P2|NOT COMPLETED|Test Day 1- 1 Period||0
2496339|NCT00832078|6118113|P1|NOT COMPLETED|Test Day 1- 1 Period||0
2496340|NCT00832078|6118112|P2|COMPLETED|Test Day 1- 1 Period||12
2496341|NCT00832078|6118113|P1|COMPLETED|Test Day 1- 1 Period||13
2496342|NCT00832078|6118112|P2|STARTED|Test Day 1- 1 Period||12
2496343|NCT00832078|6118113|P1|STARTED|Test Day 1- 1 Period||13
2496344|NCT00832000|6118119|P2|NOT COMPLETED|Overall Study||1
2496345|NCT00832000|6118120|P1|NOT COMPLETED|Overall Study||6
2496346|NCT00832000|6118119|P2|COMPLETED|Overall Study||29
2496347|NCT00832000|6118120|P1|COMPLETED|Overall Study||23
2496348|NCT00832000|6118119|P2|Crossed Over to Opposite Intervention|Overall Study|Mexiletine 200 mg orally three times daily|29
2496349|NCT00832000|6118120|P1|Crossed Over to Opposite Intervention|Overall Study|Placebo|25
2496350|NCT00832000|6118119|P2|STARTED|Overall Study|Placebo|30
2496351|NCT00832000|6118120|P1|STARTED|Overall Study|Mexiletine 200 mg orally three times daily|29
2496352|NCT00831987|6118158|P2|NOT COMPLETED|Overall Study||0
2496353|NCT00831987|6118159|P1|NOT COMPLETED|Overall Study||0
2496354|NCT00831987|6118158|P2|COMPLETED|Overall Study||60
2496355|NCT00831987|6118159|P1|COMPLETED|Overall Study||60
2496356|NCT00831987|6118158|P2|STARTED|Overall Study||60
2496357|NCT00831987|6118159|P1|STARTED|Overall Study||60
2496358|NCT00831844|6118181|P10|NOT COMPLETED|Overall Study||0
2496359|NCT00831844|6118182|P9|NOT COMPLETED|Overall Study||9
2496360|NCT00831844|6118183|P8|NOT COMPLETED|Overall Study||10
2496361|NCT00831844|6118184|P7|NOT COMPLETED|Overall Study||10
2496362|NCT00831844|6118185|P6|NOT COMPLETED|Overall Study||19
2496363|NCT00831844|6118186|P5|NOT COMPLETED|Overall Study||14
2496364|NCT00831844|6118187|P4|NOT COMPLETED|Overall Study||10
2496365|NCT00831844|6118188|P3|NOT COMPLETED|Overall Study||20
2496366|NCT00831844|6118189|P2|NOT COMPLETED|Overall Study||12
2496367|NCT00831844|6118190|P1|NOT COMPLETED|Overall Study||10
2496368|NCT00831844|6118181|P10|COMPLETED|Overall Study||0
2496369|NCT00831844|6118182|P9|COMPLETED|Overall Study||0
2496370|NCT00831844|6118183|P8|COMPLETED|Overall Study||0
2496371|NCT00831844|6118184|P7|COMPLETED|Overall Study||0
2496372|NCT00831844|6118185|P6|COMPLETED|Overall Study||1
2496373|NCT00831844|6118186|P5|COMPLETED|Overall Study||0
2496374|NCT00831844|6118187|P4|COMPLETED|Overall Study||0
2496375|NCT00831844|6118188|P3|COMPLETED|Overall Study||1
2496376|NCT00831844|6118189|P2|COMPLETED|Overall Study||0
2496377|NCT00831844|6118190|P1|COMPLETED|Overall Study||0
2496378|NCT00831844|6118181|P10|STARTED|Overall Study||0
2496379|NCT00831844|6118182|P9|STARTED|Overall Study||9
2496380|NCT00831844|6118183|P8|STARTED|Overall Study||10
2496381|NCT00831844|6118184|P7|STARTED|Overall Study||10
2496382|NCT00831844|6118185|P6|STARTED|Overall Study||20
2496383|NCT00831844|6118186|P5|STARTED|Overall Study||14
2496384|NCT00831844|6118187|P4|STARTED|Overall Study||10
2496385|NCT00831844|6118188|P3|STARTED|Overall Study||21
2496386|NCT00831844|6118189|P2|STARTED|Overall Study||12
2496387|NCT00831844|6118190|P1|STARTED|Overall Study||10
2496388|NCT00831792|6118212|P1|NOT COMPLETED|Overall Study||6
2496389|NCT00831792|6118212|P1|COMPLETED|Overall Study||40
2496390|NCT00831792|6118212|P1|STARTED|Overall Study||46
2496391|NCT00831779|6118218|P2|NOT COMPLETED|Overall Study||1
2496392|NCT00831779|6118219|P1|NOT COMPLETED|Overall Study||1
2496393|NCT00831779|6118218|P2|COMPLETED|Overall Study||22
2496394|NCT00831779|6118219|P1|COMPLETED|Overall Study||20
2496395|NCT00831779|6118218|P2|STARTED|Overall Study||23
2496396|NCT00831779|6118219|P1|STARTED|Overall Study||21
2496403|NCT00831753|6118241|P2|NOT COMPLETED|Overall Study||0
2496404|NCT00831753|6118242|P1|NOT COMPLETED|Overall Study||0
2496405|NCT00831753|6118241|P2|COMPLETED|Overall Study||131
2496406|NCT00831753|6118242|P1|COMPLETED|Overall Study||132
2496407|NCT00831753|6118241|P2|STARTED|Overall Study||131
2496408|NCT00831753|6118242|P1|STARTED|Overall Study||132
2496409|NCT00831701|6118256|P2|NOT COMPLETED|Overall Study||5
2496410|NCT00831701|6118257|P1|NOT COMPLETED|Overall Study||5
2496411|NCT00831701|6118256|P2|COMPLETED|Overall Study||45
2496412|NCT00831701|6118257|P1|COMPLETED|Overall Study||45
2496413|NCT00831701|6118256|P2|STARTED|Overall Study||50
2496414|NCT00831701|6118257|P1|STARTED|Overall Study||50
2496415|NCT00831675|6118273|P2|NOT COMPLETED|Overall Study||0
2496416|NCT00831675|6118274|P1|NOT COMPLETED|Overall Study||0
2496417|NCT00831675|6118273|P2|COMPLETED|Overall Study||18
2496418|NCT00831675|6118274|P1|COMPLETED|Overall Study||12
2496419|NCT00831675|6118273|P2|STARTED|Overall Study||18
2496420|NCT00831675|6118274|P1|STARTED|Overall Study||12
2496421|NCT00831493|6118286|P1|NOT COMPLETED|Overall Study||1
2496422|NCT00831493|6118286|P1|COMPLETED|Overall Study||2
2496423|NCT00831493|6118286|P1|STARTED|Overall Study||3
2496424|NCT00831480|6118290|P1|NOT COMPLETED|Overall Study||2
2496425|NCT00831480|6118290|P1|COMPLETED|Overall Study||7
2496426|NCT00831480|6118290|P1|STARTED|Overall Study||9
2496427|NCT00831441|6118296|P2|NOT COMPLETED|Follow Up (30 Days)||174
2496428|NCT00831441|6118297|P1|NOT COMPLETED|Follow Up (30 Days)||133
2496429|NCT00831441|6118296|P2|COMPLETED|Follow Up (30 Days)||3355
2496430|NCT00831441|6118297|P1|COMPLETED|Follow Up (30 Days)||3375
2496431|NCT00831441|6118296|P2|STARTED|Follow Up (30 Days)|3529 participants entered the follow up period.|3529
2496432|NCT00831441|6118297|P1|STARTED|Follow Up (30 Days)|3508 participants entered the follow up period.|3508
2496433|NCT00831441|6118296|P2|NOT COMPLETED|Randomized||3705
2496434|NCT00831441|6118297|P1|NOT COMPLETED|Randomized||3687
2496435|NCT00831441|6118296|P2|COMPLETED|Randomized||0
2496436|NCT00831441|6118297|P1|COMPLETED|Randomized||0
2496437|NCT00831441|6118296|P2|Treated|Randomized||3672
2496438|NCT00831441|6118297|P1|Treated|Randomized||3643
2496439|NCT00831441|6118296|P2|STARTED|Randomized||3705
2496440|NCT00831441|6118297|P1|STARTED|Randomized||3687
2496441|NCT00831428|6118325|P1|NOT COMPLETED|Overall Study||0
2496442|NCT00831428|6118325|P1|COMPLETED|Overall Study||97
2496443|NCT00831428|6118325|P1|STARTED|Overall Study||97
2496444|NCT00831415|6118329|P1|NOT COMPLETED|Overall Study||75
2496445|NCT00831415|6118329|P1|COMPLETED|Overall Study|In addition to Completers for Study includes 2 participants who discontinued after on-therapy period|229
2496446|NCT00831415|6118329|P1|"Study Completers"|Overall Study|Defined as participants whose conclusion of study participation status was “study completed.”|227
2496447|NCT00831415|6118329|P1|"Completers for Exposure"|Overall Study|Participants with ≥ 301 days of exposure to study drug and completed study day 308 evaluations.|227
2496448|NCT00831415|6118329|P1|STARTED|Overall Study||304
2496449|NCT00831389|6118338|P2|NOT COMPLETED|Overall Study||1
2496450|NCT00831389|6118339|P1|NOT COMPLETED|Overall Study||0
2496451|NCT00831389|6118338|P2|COMPLETED|Overall Study||6
2496452|NCT00831389|6118339|P1|COMPLETED|Overall Study||6
2496453|NCT00831389|6118338|P2|STARTED|Overall Study||7
2496454|NCT00831389|6118339|P1|STARTED|Overall Study||6
2496455|NCT00831311|6118365|P2|NOT COMPLETED|Overall Study||8
2496456|NCT00831311|6118366|P1|NOT COMPLETED|Overall Study||12
2496457|NCT00831311|6118365|P2|COMPLETED|Overall Study||304
2496458|NCT00831311|6118366|P1|COMPLETED|Overall Study||300
2496459|NCT00831311|6118365|P2|STARTED|Overall Study||312
2496460|NCT00831311|6118366|P1|STARTED|Overall Study||312
2496461|NCT00831272|6118388|P4|NOT COMPLETED|Overall Study||10
2496462|NCT00831272|6118389|P3|NOT COMPLETED|Overall Study||10
2496463|NCT00831272|6118390|P2|NOT COMPLETED|Overall Study||7
2496464|NCT00831272|6118391|P1|NOT COMPLETED|Overall Study||8
2496465|NCT00831272|6118388|P4|COMPLETED|Overall Study||56
2496466|NCT00831272|6118389|P3|COMPLETED|Overall Study||63
2496467|NCT00831272|6118390|P2|COMPLETED|Overall Study||37
2496468|NCT00831272|6118391|P1|COMPLETED|Overall Study||30
2496469|NCT00831272|6118388|P4|STARTED|Overall Study||66
2496470|NCT00831272|6118389|P3|STARTED|Overall Study||73
2496471|NCT00831272|6118390|P2|STARTED|Overall Study||44
2496472|NCT00831272|6118391|P1|STARTED|Overall Study||38
2496473|NCT00831233|6118403|P2|NOT COMPLETED|Overall Study||1
2496474|NCT00831233|6118404|P1|NOT COMPLETED|Overall Study||3
2496475|NCT00831233|6118403|P2|COMPLETED|Overall Study||12
2496476|NCT00831233|6118404|P1|COMPLETED|Overall Study||26
2496477|NCT00831233|6118403|P2|Per Protocol (PP) Analysis Set|Overall Study||11
2496478|NCT00831233|6118404|P1|Per Protocol (PP) Analysis Set|Overall Study||26
2496479|NCT00831233|6118403|P2|Full Analysis Set (FAS)|Overall Study||13
2496480|NCT00831233|6118404|P1|Full Analysis Set (FAS)|Overall Study|2 participants were randomised but never treated.|27
2496481|NCT00831233|6118403|P2|STARTED|Overall Study|ITT population.|13
2496482|NCT00831233|6118404|P1|STARTED|Overall Study|Intention-to-treat (ITT) population.|29
2496483|NCT00831181|6118428|P1|NOT COMPLETED|Overall Study||12
2496484|NCT00831181|6118428|P1|COMPLETED|Overall Study||15
2496485|NCT00831181|6118428|P1|STARTED|Overall Study||27
2496486|NCT00831129|6118441|P2|NOT COMPLETED|Overall Study||10
2496487|NCT00831129|6118442|P1|NOT COMPLETED|Overall Study||0
2496488|NCT00831129|6118441|P2|COMPLETED|Overall Study||23
2496489|NCT00831129|6118442|P1|COMPLETED|Overall Study||20
2496490|NCT00831129|6118441|P2|STARTED|Overall Study||33
2496491|NCT00831129|6118442|P1|STARTED|Overall Study||20
2496492|NCT00830960|6118484|P6|NOT COMPLETED|Overall Study||37
2496493|NCT00830960|6118485|P5|NOT COMPLETED|Overall Study||32
2496494|NCT00830960|6118486|P4|NOT COMPLETED|Overall Study||32
2496495|NCT00830960|6118487|P3|NOT COMPLETED|Overall Study||29
2496496|NCT00830960|6118488|P2|NOT COMPLETED|Overall Study||28
2496497|NCT00830960|6118489|P1|NOT COMPLETED|Overall Study||33
2496498|NCT00830960|6118484|P6|COMPLETED|Overall Study||63
2496499|NCT00830960|6118485|P5|COMPLETED|Overall Study|6 participants not completed due to death; 1 additional death occurred after study discontinuation.|64
2496500|NCT00830960|6118486|P4|COMPLETED|Overall Study||106
2496501|NCT00830960|6118487|P3|COMPLETED|Overall Study||108
2496502|NCT00830960|6118488|P2|COMPLETED|Overall Study||96
2496503|NCT00830960|6118489|P1|COMPLETED|Overall Study||91
2496504|NCT00830960|6118484|P6|Received at Least 1 Dose of Study Drug|Overall Study||93
2496505|NCT00830960|6118485|P5|Received at Least 1 Dose of Study Drug|Overall Study||91
2496506|NCT00830960|6118486|P4|Received at Least 1 Dose of Study Drug|Overall Study||135
2496507|NCT00830960|6118487|P3|Received at Least 1 Dose of Study Drug|Overall Study||133
2496508|NCT00830960|6118488|P2|Received at Least 1 Dose of Study Drug|Overall Study||122
2496509|NCT00830960|6118489|P1|Received at Least 1 Dose of Study Drug|Overall Study|Baseline Characteristics (below) include those who received ≥1 dose study drug, not all who STARTED.|117
2496510|NCT00830960|6118484|P6|STARTED|Overall Study|Total 720 participants were randomized; 1 was not included in a cohort as baseline weight missing.|100
2496511|NCT00830960|6118485|P5|STARTED|Overall Study||96
2496512|NCT00830960|6118486|P4|STARTED|Overall Study||138
2496513|NCT00830960|6118487|P3|STARTED|Overall Study||137
2496514|NCT00830960|6118488|P2|STARTED|Overall Study||124
2496515|NCT00830960|6118489|P1|STARTED|Overall Study|"Number of participants STARTED equals the number of participants randomized."|124
2496516|NCT00830947|6118605|P2|NOT COMPLETED|Overall Study||4
2496517|NCT00830947|6118606|P1|NOT COMPLETED|Overall Study||4
2496518|NCT00830947|6118605|P2|COMPLETED|Overall Study||18
2496519|NCT00830947|6118606|P1|COMPLETED|Overall Study||19
2496520|NCT00830947|6118605|P2|STARTED|Overall Study||22
2496521|NCT00830947|6118606|P1|STARTED|Overall Study||23
2496522|NCT00830869|6118624|P12|NOT COMPLETED|Period 2: Part 2||20
2496523|NCT00830869|6118625|P11|NOT COMPLETED|Period 2: Part 2||11
2496524|NCT00830869|6118626|P10|NOT COMPLETED|Period 2: Part 2||20
2496525|NCT00830869|6118627|P9|NOT COMPLETED|Period 2: Part 2||22
2496526|NCT00830869|6118628|P8|NOT COMPLETED|Period 2: Part 2||20
2496527|NCT00830869|6118629|P7|NOT COMPLETED|Period 2: Part 2||0
2496528|NCT00830869|6118630|P6|NOT COMPLETED|Period 2: Part 2||0
2496529|NCT00830869|6118631|P5|NOT COMPLETED|Period 2: Part 2||0
2496530|NCT00830869|6118632|P4|NOT COMPLETED|Period 2: Part 2||0
2496531|NCT00830869|6118633|P3|NOT COMPLETED|Period 2: Part 2||0
2496532|NCT00830869|6118634|P2|NOT COMPLETED|Period 2: Part 2||0
2496533|NCT00830869|6118635|P1|NOT COMPLETED|Period 2: Part 2||0
2496534|NCT00830869|6118624|P12|COMPLETED|Period 2: Part 2||0
2496535|NCT00830869|6118625|P11|COMPLETED|Period 2: Part 2||0
2496536|NCT00830869|6118626|P10|COMPLETED|Period 2: Part 2||0
2496537|NCT00830869|6118627|P9|COMPLETED|Period 2: Part 2||0
2496538|NCT00830869|6118628|P8|COMPLETED|Period 2: Part 2||0
2496539|NCT00830869|6118629|P7|COMPLETED|Period 2: Part 2||0
2496540|NCT00830869|6118630|P6|COMPLETED|Period 2: Part 2||0
2496541|NCT00830869|6118631|P5|COMPLETED|Period 2: Part 2||0
2496542|NCT00830869|6118632|P4|COMPLETED|Period 2: Part 2||0
2496543|NCT00830869|6118633|P3|COMPLETED|Period 2: Part 2||0
2496544|NCT00830869|6118634|P2|COMPLETED|Period 2: Part 2||0
2496545|NCT00830869|6118635|P1|COMPLETED|Period 2: Part 2||0
2496546|NCT00830869|6118624|P12|STARTED|Period 2: Part 2||20
2496547|NCT00830869|6118625|P11|STARTED|Period 2: Part 2||11
2496548|NCT00830869|6118626|P10|STARTED|Period 2: Part 2||20
2496549|NCT00830869|6118627|P9|STARTED|Period 2: Part 2||22
2496550|NCT00830869|6118628|P8|STARTED|Period 2: Part 2||20
2496551|NCT00830869|6118629|P7|STARTED|Period 2: Part 2||0
2496552|NCT00830869|6118630|P6|STARTED|Period 2: Part 2||0
2496553|NCT00830869|6118631|P5|STARTED|Period 2: Part 2||0
2496554|NCT00830869|6118632|P4|STARTED|Period 2: Part 2||0
2496555|NCT00830869|6118633|P3|STARTED|Period 2: Part 2||0
2496556|NCT00830869|6118634|P2|STARTED|Period 2: Part 2||0
2496557|NCT00830869|6118635|P1|STARTED|Period 2: Part 2||0
2496558|NCT00830869|6118624|P12|NOT COMPLETED|Period 1: Part 1||0
2496559|NCT00830869|6118625|P11|NOT COMPLETED|Period 1: Part 1||0
2496560|NCT00830869|6118626|P10|NOT COMPLETED|Period 1: Part 1||0
2496561|NCT00830869|6118627|P9|NOT COMPLETED|Period 1: Part 1||0
2496562|NCT00830869|6118628|P8|NOT COMPLETED|Period 1: Part 1||0
2496563|NCT00830869|6118629|P7|NOT COMPLETED|Period 1: Part 1||3
2496564|NCT00830869|6118630|P6|NOT COMPLETED|Period 1: Part 1||6
2496565|NCT00830869|6118631|P5|NOT COMPLETED|Period 1: Part 1||4
2496566|NCT00830869|6118632|P4|NOT COMPLETED|Period 1: Part 1||7
2496567|NCT00830869|6118633|P3|NOT COMPLETED|Period 1: Part 1||1
2496568|NCT00830869|6118634|P2|NOT COMPLETED|Period 1: Part 1||1
2496569|NCT00830869|6118635|P1|NOT COMPLETED|Period 1: Part 1||1
2496570|NCT00830869|6118624|P12|COMPLETED|Period 1: Part 1||0
2496571|NCT00830869|6118625|P11|COMPLETED|Period 1: Part 1||0
2496572|NCT00830869|6118626|P10|COMPLETED|Period 1: Part 1||0
2496573|NCT00830869|6118627|P9|COMPLETED|Period 1: Part 1||0
2496574|NCT00830869|6118628|P8|COMPLETED|Period 1: Part 1||0
2496575|NCT00830869|6118629|P7|COMPLETED|Period 1: Part 1||0
2496576|NCT00830869|6118630|P6|COMPLETED|Period 1: Part 1||0
2496577|NCT00830869|6118631|P5|COMPLETED|Period 1: Part 1||0
2496578|NCT00830869|6118632|P4|COMPLETED|Period 1: Part 1||0
2496579|NCT00830869|6118633|P3|COMPLETED|Period 1: Part 1||0
2496580|NCT00830869|6118634|P2|COMPLETED|Period 1: Part 1||0
2496581|NCT00830869|6118635|P1|COMPLETED|Period 1: Part 1||0
2496582|NCT00830869|6118624|P12|STARTED|Period 1: Part 1||0
2496583|NCT00830869|6118625|P11|STARTED|Period 1: Part 1||0
2496584|NCT00830869|6118626|P10|STARTED|Period 1: Part 1||0
2496585|NCT00830869|6118627|P9|STARTED|Period 1: Part 1||0
2496586|NCT00830869|6118628|P8|STARTED|Period 1: Part 1||0
2496587|NCT00830869|6118629|P7|STARTED|Period 1: Part 1||3
2496588|NCT00830869|6118630|P6|STARTED|Period 1: Part 1||6
2496589|NCT00830869|6118631|P5|STARTED|Period 1: Part 1||4
2496590|NCT00830869|6118632|P4|STARTED|Period 1: Part 1||7
2496591|NCT00830869|6118633|P3|STARTED|Period 1: Part 1||1
2496592|NCT00830869|6118634|P2|STARTED|Period 1: Part 1||1
2496593|NCT00830869|6118635|P1|STARTED|Period 1: Part 1||1
2496594|NCT00830804|6118771|P1|NOT COMPLETED|Overall Study||15
2496595|NCT00830804|6118771|P1|COMPLETED|Overall Study||97
2496596|NCT00830804|6118771|P1|STARTED|Overall Study|113 subjects enrolled. One subject never started study treatment and was excluded in all analysis.|112
2496597|NCT00830791|6118797|P6|NOT COMPLETED|Overall Study||0
2496598|NCT00830791|6118798|P5|NOT COMPLETED|Overall Study||0
2496599|NCT00830791|6118799|P4|NOT COMPLETED|Overall Study||0
2496600|NCT00830791|6118800|P3|NOT COMPLETED|Overall Study||0
2496601|NCT00830791|6118801|P2|NOT COMPLETED|Overall Study||0
2496602|NCT00830791|6118802|P1|NOT COMPLETED|Overall Study||0
2496603|NCT00830791|6118797|P6|COMPLETED|Overall Study||0
2496604|NCT00830791|6118798|P5|COMPLETED|Overall Study||0
2496605|NCT00830791|6118799|P4|COMPLETED|Overall Study||8
2496606|NCT00830791|6118800|P3|COMPLETED|Overall Study||8
2496607|NCT00830791|6118801|P2|COMPLETED|Overall Study||8
2496608|NCT00830791|6118802|P1|COMPLETED|Overall Study||8
2496609|NCT00830791|6118797|P6|STARTED|Overall Study||0
2496610|NCT00830791|6118798|P5|STARTED|Overall Study||0
2496611|NCT00830791|6118799|P4|STARTED|Overall Study||8
2496612|NCT00830791|6118800|P3|STARTED|Overall Study||8
2496613|NCT00830791|6118801|P2|STARTED|Overall Study||8
2496614|NCT00830791|6118802|P1|STARTED|Overall Study||8
2496615|NCT00830765|6118851|P2|NOT COMPLETED|Overall Study||2
2496616|NCT00830765|6118852|P1|NOT COMPLETED|Overall Study||3
2496617|NCT00830765|6118851|P2|COMPLETED|Overall Study||69
2496618|NCT00830765|6118852|P1|COMPLETED|Overall Study||70
2496619|NCT00830765|6118851|P2|STARTED|Overall Study||71
2496620|NCT00830765|6118852|P1|STARTED|Overall Study||73
2496621|NCT00830596|6118861|P3|NOT COMPLETED|Overall Study||6
2496622|NCT00830596|6118862|P2|NOT COMPLETED|Overall Study||2
2496623|NCT00830596|6118863|P1|NOT COMPLETED|Overall Study||2
2496624|NCT00830596|6118861|P3|COMPLETED|Overall Study||67
2496625|NCT00830596|6118862|P2|COMPLETED|Overall Study||72
2496626|NCT00830596|6118863|P1|COMPLETED|Overall Study||72
2496627|NCT00830596|6118861|P3|STARTED|Overall Study||73
2496628|NCT00830596|6118862|P2|STARTED|Overall Study||74
2496629|NCT00830596|6118863|P1|STARTED|Overall Study||74
2496630|NCT00830518|6118885|P2|NOT COMPLETED|Overall Study||11
2496631|NCT00830518|6118886|P1|NOT COMPLETED|Overall Study||46
2496632|NCT00830518|6118885|P2|COMPLETED|Overall Study||0
2496633|NCT00830518|6118886|P1|COMPLETED|Overall Study|Completed = participants who completed study treatment.|0
2496634|NCT00830518|6118885|P2|STARTED|Overall Study||11
2496635|NCT00830518|6118886|P1|STARTED|Overall Study||46
2496636|NCT00830440|6118905|P2|NOT COMPLETED|Overall Study||0
2496637|NCT00830440|6118906|P1|NOT COMPLETED|Overall Study||8
2496638|NCT00830440|6118905|P2|COMPLETED|Overall Study||11
2496639|NCT00830440|6118906|P1|COMPLETED|Overall Study||24
2496640|NCT00830440|6118905|P2|Completed 24 Week Follow up|Overall Study||0
2496641|NCT00830440|6118906|P1|Completed 24 Week Follow up|Overall Study||3
2496642|NCT00830440|6118905|P2|Completed 16 Week Follow up|Overall Study||0
2496643|NCT00830440|6118906|P1|Completed 16 Week Follow up|Overall Study||4
2496644|NCT00830440|6118905|P2|Completed 12 Week Follow up|Overall Study||11
2496645|NCT00830440|6118906|P1|Completed 12 Week Follow up|Overall Study||24
2496646|NCT00830440|6118905|P2|Received Device|Overall Study||0
2496647|NCT00830440|6118906|P1|Received Device|Overall Study||26
2496648|NCT00830440|6118905|P2|STARTED|Overall Study||11
2496649|NCT00830440|6118906|P1|STARTED|Overall Study||32
2496650|NCT00830388|6118916|P1|NOT COMPLETED|Overall Study||0
2496651|NCT00830388|6118916|P1|COMPLETED|Overall Study||11
2496652|NCT00830388|6118916|P1|STARTED|Overall Study||11
2496653|NCT00830375|6118921|P1|NOT COMPLETED|Overall Study||1
2496654|NCT00830375|6118921|P1|COMPLETED|Overall Study||9
2496655|NCT00830375|6118921|P1|STARTED|Overall Study||10
2496656|NCT00830362|6118927|P2|NOT COMPLETED|Overall Study||4
2496657|NCT00830362|6118928|P1|NOT COMPLETED|Overall Study||4
2496658|NCT00830362|6118927|P2|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|20
2496659|NCT00830362|6118928|P1|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|23
2496660|NCT00830362|6118927|P2|Completed Sessions 1 and 2|Overall Study|Received palcebo and completed both Test and Retrieval sessions (Session 1 and 2).|24
2496661|NCT00830362|6118928|P1|Completed Sessions 1 and 2|Overall Study|Received propranolol and completed both Test and Retrieval sessions (Session 1 and 2).|26
2496662|NCT00830362|6118927|P2|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|24
2496754|NCT00830128|6119077|P1|NOT COMPLETED|Overall Study||19
2496663|NCT00830362|6118928|P1|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|27
2496664|NCT00830336|6118936|P2|NOT COMPLETED|Second Intervention||0
2496665|NCT00830336|6118937|P1|NOT COMPLETED|Second Intervention||0
2496666|NCT00830336|6118936|P2|COMPLETED|Second Intervention||40
2496667|NCT00830336|6118937|P1|COMPLETED|Second Intervention||39
2496668|NCT00830336|6118936|P2|STARTED|Second Intervention||40
2496669|NCT00830336|6118937|P1|STARTED|Second Intervention||39
2496670|NCT00830336|6118936|P2|NOT COMPLETED|Washout: 21 Days||0
2496671|NCT00830336|6118937|P1|NOT COMPLETED|Washout: 21 Days||1
2496672|NCT00830336|6118936|P2|COMPLETED|Washout: 21 Days||40
2496673|NCT00830336|6118937|P1|COMPLETED|Washout: 21 Days||39
2496674|NCT00830336|6118936|P2|STARTED|Washout: 21 Days||40
2496675|NCT00830336|6118937|P1|STARTED|Washout: 21 Days||40
2496676|NCT00830336|6118936|P2|NOT COMPLETED|First Intervention||0
2496677|NCT00830336|6118937|P1|NOT COMPLETED|First Intervention||0
2496678|NCT00830336|6118936|P2|COMPLETED|First Intervention||40
2496679|NCT00830336|6118937|P1|COMPLETED|First Intervention||40
2496680|NCT00830336|6118936|P2|STARTED|First Intervention||40
2496681|NCT00830336|6118937|P1|STARTED|First Intervention||40
2496682|NCT00830310|6118945|P1|NOT COMPLETED|Overall Study||13
2496683|NCT00830310|6118945|P1|COMPLETED|Overall Study||30
2496684|NCT00830310|6118945|P1|STARTED|Overall Study||43
2496685|NCT00830284|6118957|P1|NOT COMPLETED|Overall Study||2
2496686|NCT00830284|6118957|P1|COMPLETED|Overall Study||10
2496687|NCT00830284|6118957|P1|STARTED|Overall Study|The study was started in our Medical Surgical ICU October of 2008.|12
2496688|NCT00830258|6118964|P2|NOT COMPLETED|Second Intervention||0
2496689|NCT00830258|6118965|P1|NOT COMPLETED|Second Intervention||0
2496690|NCT00830258|6118964|P2|COMPLETED|Second Intervention||30
2496691|NCT00830258|6118965|P1|COMPLETED|Second Intervention||28
2496692|NCT00830258|6118964|P2|STARTED|Second Intervention||30
2496693|NCT00830258|6118965|P1|STARTED|Second Intervention||28
2496694|NCT00830258|6118964|P2|NOT COMPLETED|Washout: 7 Days||0
2496695|NCT00830258|6118965|P1|NOT COMPLETED|Washout: 7 Days||1
2496696|NCT00830258|6118964|P2|COMPLETED|Washout: 7 Days||30
2496697|NCT00830258|6118965|P1|COMPLETED|Washout: 7 Days||28
2496698|NCT00830258|6118964|P2|STARTED|Washout: 7 Days||30
2496699|NCT00830258|6118965|P1|STARTED|Washout: 7 Days||29
2496700|NCT00830258|6118964|P2|NOT COMPLETED|First Intervention||0
2496701|NCT00830258|6118965|P1|NOT COMPLETED|First Intervention||1
2496702|NCT00830258|6118964|P2|COMPLETED|First Intervention||30
2496703|NCT00830258|6118965|P1|COMPLETED|First Intervention||29
2496704|NCT00830258|6118964|P2|STARTED|First Intervention||30
2496705|NCT00830258|6118965|P1|STARTED|First Intervention||30
2496706|NCT00830232|6118975|P2|NOT COMPLETED|Overall Study||0
2496707|NCT00830232|6118976|P1|NOT COMPLETED|Overall Study||0
2496708|NCT00830232|6118975|P2|COMPLETED|Overall Study||20
2496709|NCT00830232|6118976|P1|COMPLETED|Overall Study||20
2496710|NCT00830232|6118975|P2|STARTED|Overall Study||20
2496711|NCT00830232|6118976|P1|STARTED|Overall Study||20
2496712|NCT00830219|6118984|P2|NOT COMPLETED|Second Intervention||0
2496713|NCT00830219|6118985|P1|NOT COMPLETED|Second Intervention||0
2496714|NCT00830219|6118984|P2|COMPLETED|Second Intervention||22
2496715|NCT00830219|6118985|P1|COMPLETED|Second Intervention||22
2496716|NCT00830219|6118984|P2|STARTED|Second Intervention||22
2496717|NCT00830219|6118985|P1|STARTED|Second Intervention||22
2496718|NCT00830219|6118984|P2|NOT COMPLETED|Washout of 7 Days||1
2496719|NCT00830219|6118985|P1|NOT COMPLETED|Washout of 7 Days||1
2496720|NCT00830219|6118984|P2|COMPLETED|Washout of 7 Days||22
2496721|NCT00830219|6118985|P1|COMPLETED|Washout of 7 Days||22
2496722|NCT00830219|6118984|P2|STARTED|Washout of 7 Days||23
2496723|NCT00830219|6118985|P1|STARTED|Washout of 7 Days||23
2496724|NCT00830219|6118984|P2|NOT COMPLETED|First Intervention||0
2496725|NCT00830219|6118985|P1|NOT COMPLETED|First Intervention||0
2496726|NCT00830219|6118984|P2|COMPLETED|First Intervention||23
2496727|NCT00830219|6118985|P1|COMPLETED|First Intervention||23
2496728|NCT00830219|6118984|P2|STARTED|First Intervention||23
2496729|NCT00830219|6118985|P1|STARTED|First Intervention||23
2496730|NCT00830206|6118995|P2|NOT COMPLETED|Second Intervention||0
2496731|NCT00830206|6118996|P1|NOT COMPLETED|Second Intervention||0
2496732|NCT00830206|6118995|P2|COMPLETED|Second Intervention||39
2496733|NCT00830206|6118996|P1|COMPLETED|Second Intervention||39
2496734|NCT00830206|6118995|P2|STARTED|Second Intervention||39
2496735|NCT00830206|6118996|P1|STARTED|Second Intervention||39
2496736|NCT00830206|6118995|P2|NOT COMPLETED|Washout: 21 Days||1
2496737|NCT00830206|6118996|P1|NOT COMPLETED|Washout: 21 Days||1
2496738|NCT00830206|6118995|P2|COMPLETED|Washout: 21 Days||39
2496739|NCT00830206|6118996|P1|COMPLETED|Washout: 21 Days||39
2496740|NCT00830206|6118995|P2|STARTED|Washout: 21 Days||40
2496741|NCT00830206|6118996|P1|STARTED|Washout: 21 Days||40
2496742|NCT00830206|6118995|P2|NOT COMPLETED|First Intervention||0
2496743|NCT00830206|6118996|P1|NOT COMPLETED|First Intervention||0
2496744|NCT00830206|6118995|P2|COMPLETED|First Intervention||40
2496745|NCT00830206|6118996|P1|COMPLETED|First Intervention||40
2496746|NCT00830206|6118995|P2|STARTED|First Intervention||40
2496747|NCT00830206|6118996|P1|STARTED|First Intervention||40
2496748|NCT00830167|6119006|P2|NOT COMPLETED|Overall Study||43
2496749|NCT00830167|6119007|P1|NOT COMPLETED|Overall Study||40
2496750|NCT00830167|6119006|P2|COMPLETED|Overall Study||207
2496751|NCT00830167|6119007|P1|COMPLETED|Overall Study||208
2496752|NCT00830167|6119006|P2|STARTED|Overall Study|Treated|250
2496753|NCT00830167|6119007|P1|STARTED|Overall Study|Treated|248
2496755|NCT00830128|6119077|P1|COMPLETED|Overall Study||87
2496756|NCT00830128|6119077|P1|STARTED|Overall Study||106
2496757|NCT00830115|6119092|P1|NOT COMPLETED|Overall Study||3
2496758|NCT00830115|6119092|P1|COMPLETED|Overall Study||1042
2496759|NCT00830115|6119092|P1|STARTED|Overall Study||1045
2496760|NCT00830076|6119108|P1|NOT COMPLETED|Placebo Sitagliptin + Placebo Metformin||0
2496761|NCT00830076|6119108|P1|COMPLETED|Placebo Sitagliptin + Placebo Metformin||18
2496762|NCT00830076|6119108|P1|STARTED|Placebo Sitagliptin + Placebo Metformin||18
2496763|NCT00830076|6119108|P1|NOT COMPLETED|7-day Washout||0
2496764|NCT00830076|6119108|P1|COMPLETED|7-day Washout||18
2496765|NCT00830076|6119108|P1|STARTED|7-day Washout||18
2496766|NCT00830076|6119108|P1|NOT COMPLETED|Sitagliptin + Metformin||0
2496767|NCT00830076|6119108|P1|COMPLETED|Sitagliptin + Metformin||18
2496768|NCT00830076|6119108|P1|STARTED|Sitagliptin + Metformin||18
2496769|NCT00830076|6119108|P1|NOT COMPLETED|7-day Washout||0
2496770|NCT00830076|6119108|P1|COMPLETED|7-day Washout||18
2496771|NCT00830076|6119108|P1|STARTED|7-day Washout||18
2496772|NCT00830076|6119108|P1|NOT COMPLETED|Metformin + Placebo Sitagliptin||0
2496773|NCT00830076|6119108|P1|COMPLETED|Metformin + Placebo Sitagliptin||18
2496774|NCT00830076|6119108|P1|STARTED|Metformin + Placebo Sitagliptin||18
2496775|NCT00830076|6119108|P1|NOT COMPLETED|7-day Washout||0
2496776|NCT00830076|6119108|P1|COMPLETED|7-day Washout||18
2496777|NCT00830076|6119108|P1|STARTED|7-day Washout||18
2496778|NCT00830076|6119108|P1|NOT COMPLETED|Sitagliptin + Placebo Metformin||0
2496779|NCT00830076|6119108|P1|COMPLETED|Sitagliptin + Placebo Metformin||18
2496780|NCT00830076|6119108|P1|STARTED|Sitagliptin + Placebo Metformin||18
2496781|NCT00830037|6119119|P2|NOT COMPLETED|Overall Study||19
2496782|NCT00830037|6119120|P1|NOT COMPLETED|Overall Study||18
2496783|NCT00830037|6119119|P2|COMPLETED|Overall Study||50
2496784|NCT00830037|6119120|P1|COMPLETED|Overall Study||49
2496785|NCT00830037|6119119|P2|STARTED|Overall Study||69
2496786|NCT00830037|6119120|P1|STARTED|Overall Study||67
2496787|NCT00830024|6119130|P2|NOT COMPLETED|Second Intervention||0
2496788|NCT00830024|6119131|P1|NOT COMPLETED|Second Intervention||0
2496789|NCT00830024|6119130|P2|COMPLETED|Second Intervention||18
2496790|NCT00830024|6119131|P1|COMPLETED|Second Intervention||17
2496791|NCT00830024|6119130|P2|STARTED|Second Intervention||18
2496792|NCT00830024|6119131|P1|STARTED|Second Intervention||17
2496793|NCT00830024|6119130|P2|NOT COMPLETED|Washout: 7 Days||0
2496794|NCT00830024|6119131|P1|NOT COMPLETED|Washout: 7 Days||1
2496795|NCT00830024|6119130|P2|COMPLETED|Washout: 7 Days||18
2496796|NCT00830024|6119131|P1|COMPLETED|Washout: 7 Days||17
2496797|NCT00830024|6119130|P2|STARTED|Washout: 7 Days||18
2496798|NCT00830024|6119131|P1|STARTED|Washout: 7 Days||18
2496799|NCT00830024|6119130|P2|NOT COMPLETED|First Intervention||0
2496800|NCT00830024|6119131|P1|NOT COMPLETED|First Intervention||0
2496801|NCT00830024|6119130|P2|COMPLETED|First Intervention||18
2496802|NCT00830024|6119131|P1|COMPLETED|First Intervention||18
2496803|NCT00830024|6119130|P2|STARTED|First Intervention||18
2496804|NCT00830024|6119131|P1|STARTED|First Intervention||18
2496805|NCT00829998|6119141|P2|NOT COMPLETED|Second Intervention||0
2496806|NCT00829998|6119142|P1|NOT COMPLETED|Second Intervention||0
2496807|NCT00829998|6119141|P2|COMPLETED|Second Intervention||19
2496808|NCT00829998|6119142|P1|COMPLETED|Second Intervention||21
2496809|NCT00829998|6119141|P2|STARTED|Second Intervention||19
2496810|NCT00829998|6119142|P1|STARTED|Second Intervention||21
2496811|NCT00829998|6119141|P2|NOT COMPLETED|Washout||1
2496812|NCT00829998|6119142|P1|NOT COMPLETED|Washout||0
2496813|NCT00829998|6119141|P2|COMPLETED|Washout||19
2496814|NCT00829998|6119142|P1|COMPLETED|Washout||21
2496815|NCT00829998|6119141|P2|STARTED|Washout||20
2496816|NCT00829998|6119142|P1|STARTED|Washout||21
2496817|NCT00829998|6119141|P2|NOT COMPLETED|First Intervention||0
2496818|NCT00829998|6119142|P1|NOT COMPLETED|First Intervention||0
2496819|NCT00829998|6119141|P2|COMPLETED|First Intervention||20
2496820|NCT00829998|6119142|P1|COMPLETED|First Intervention||21
2496821|NCT00829998|6119141|P2|STARTED|First Intervention||20
2496822|NCT00829998|6119142|P1|STARTED|First Intervention||21
2496823|NCT00829985|6119152|P2|NOT COMPLETED|Overall Study||4
2496824|NCT00829985|6119153|P1|NOT COMPLETED|Overall Study||9
2496825|NCT00829985|6119152|P2|COMPLETED|Overall Study||22
2496826|NCT00829985|6119153|P1|COMPLETED|Overall Study||19
2496827|NCT00829985|6119152|P2|STARTED|Overall Study||26
2496828|NCT00829985|6119153|P1|STARTED|Overall Study||28
2496829|NCT00829933|6119171|P4|NOT COMPLETED|Overall Study||14
2496830|NCT00829933|6119172|P3|NOT COMPLETED|Overall Study||13
2496831|NCT00829933|6119173|P2|NOT COMPLETED|Overall Study||13
2496832|NCT00829933|6119174|P1|NOT COMPLETED|Overall Study||14
2496833|NCT00829933|6119171|P4|COMPLETED|Overall Study||120
2496834|NCT00829933|6119172|P3|COMPLETED|Overall Study||119
2496835|NCT00829933|6119173|P2|COMPLETED|Overall Study||122
2496836|NCT00829933|6119174|P1|COMPLETED|Overall Study||121
2496837|NCT00829933|6119171|P4|Baseline Analysis Population|Overall Study||129
2496838|NCT00829933|6119172|P3|Baseline Analysis Population|Overall Study||131
2496839|NCT00829933|6119173|P2|Baseline Analysis Population|Overall Study||134
2496840|NCT00829933|6119174|P1|Baseline Analysis Population|Overall Study||131
2496841|NCT00829933|6119171|P4|STARTED|Overall Study||134
2496842|NCT00829933|6119172|P3|STARTED|Overall Study||132
2496843|NCT00829933|6119173|P2|STARTED|Overall Study||135
2496844|NCT00829933|6119174|P1|STARTED|Overall Study||135
2496845|NCT00829868|6119186|P2|NOT COMPLETED|Second Intervention||0
2496846|NCT00829868|6119187|P1|NOT COMPLETED|Second Intervention||0
2496847|NCT00829868|6119186|P2|COMPLETED|Second Intervention||21
2496848|NCT00829868|6119187|P1|COMPLETED|Second Intervention||20
2496849|NCT00829868|6119186|P2|STARTED|Second Intervention||21
2496850|NCT00829868|6119187|P1|STARTED|Second Intervention||20
2496851|NCT00829868|6119186|P2|NOT COMPLETED|Washout||0
2496852|NCT00829868|6119187|P1|NOT COMPLETED|Washout||1
2496853|NCT00829868|6119186|P2|COMPLETED|Washout||21
2496854|NCT00829868|6119187|P1|COMPLETED|Washout||20
2496855|NCT00829868|6119186|P2|STARTED|Washout||21
2496856|NCT00829868|6119187|P1|STARTED|Washout||21
2496857|NCT00829868|6119186|P2|NOT COMPLETED|First Intervention||0
2496858|NCT00829868|6119187|P1|NOT COMPLETED|First Intervention||0
2496859|NCT00829868|6119186|P2|COMPLETED|First Intervention||21
2496860|NCT00829868|6119187|P1|COMPLETED|First Intervention||21
2496861|NCT00829868|6119186|P2|STARTED|First Intervention||21
2496862|NCT00829868|6119187|P1|STARTED|First Intervention||21
2496863|NCT00829829|6119198|P3|NOT COMPLETED|Overall Study||11
2496864|NCT00829829|6119199|P2|NOT COMPLETED|Overall Study||16
2496865|NCT00829829|6119200|P1|NOT COMPLETED|Overall Study||22
2496866|NCT00829829|6119198|P3|COMPLETED|Overall Study||70
2496867|NCT00829829|6119199|P2|COMPLETED|Overall Study||64
2496868|NCT00829829|6119200|P1|COMPLETED|Overall Study||58
2496869|NCT00829829|6119198|P3|Treated|Overall Study||81
2496870|NCT00829829|6119199|P2|Treated|Overall Study||80
2496871|NCT00829829|6119200|P1|Treated|Overall Study||79
2496872|NCT00829829|6119198|P3|STARTED|Overall Study||81
2496873|NCT00829829|6119199|P2|STARTED|Overall Study||80
2496874|NCT00829829|6119200|P1|STARTED|Overall Study||80
2496875|NCT00829790|6119225|P2|NOT COMPLETED|Second Intervention||0
2496876|NCT00829790|6119226|P1|NOT COMPLETED|Second Intervention||0
2496877|NCT00829790|6119225|P2|COMPLETED|Second Intervention||14
2496878|NCT00829790|6119226|P1|COMPLETED|Second Intervention||15
2496879|NCT00829790|6119225|P2|STARTED|Second Intervention||14
2496880|NCT00829790|6119226|P1|STARTED|Second Intervention||15
2496881|NCT00829790|6119225|P2|NOT COMPLETED|Washout of 14 Days||1
2496882|NCT00829790|6119226|P1|NOT COMPLETED|Washout of 14 Days||0
2496883|NCT00829790|6119225|P2|COMPLETED|Washout of 14 Days||14
2496884|NCT00829790|6119226|P1|COMPLETED|Washout of 14 Days||15
2496885|NCT00829790|6119225|P2|STARTED|Washout of 14 Days||15
2496886|NCT00829790|6119226|P1|STARTED|Washout of 14 Days||15
2496887|NCT00829790|6119225|P2|NOT COMPLETED|First Intervention||0
2496888|NCT00829790|6119226|P1|NOT COMPLETED|First Intervention||0
2496889|NCT00829790|6119225|P2|COMPLETED|First Intervention||15
2496890|NCT00829790|6119226|P1|COMPLETED|First Intervention||15
2496891|NCT00829790|6119225|P2|STARTED|First Intervention||15
2496892|NCT00829790|6119226|P1|STARTED|First Intervention||15
2496893|NCT00829764|6119236|P2|NOT COMPLETED|Second Intervention||0
2496894|NCT00829764|6119237|P1|NOT COMPLETED|Second Intervention||0
2496895|NCT00829764|6119236|P2|COMPLETED|Second Intervention||14
2496896|NCT00829764|6119237|P1|COMPLETED|Second Intervention||13
2496897|NCT00829764|6119236|P2|STARTED|Second Intervention||14
2496898|NCT00829764|6119237|P1|STARTED|Second Intervention||13
2496899|NCT00829764|6119236|P2|NOT COMPLETED|Washout of 14 Days||0
2496900|NCT00829764|6119237|P1|NOT COMPLETED|Washout of 14 Days||0
2496901|NCT00829764|6119236|P2|COMPLETED|Washout of 14 Days||14
2496902|NCT00829764|6119237|P1|COMPLETED|Washout of 14 Days||13
2496903|NCT00829764|6119236|P2|STARTED|Washout of 14 Days||14
2496904|NCT00829764|6119237|P1|STARTED|Washout of 14 Days||13
2496905|NCT00829764|6119236|P2|NOT COMPLETED|First Intervention||1
2496906|NCT00829764|6119237|P1|NOT COMPLETED|First Intervention||2
2496907|NCT00829764|6119236|P2|COMPLETED|First Intervention||14
2496908|NCT00829764|6119237|P1|COMPLETED|First Intervention||13
2496909|NCT00829764|6119236|P2|STARTED|First Intervention||15
2496910|NCT00829764|6119237|P1|STARTED|First Intervention||15
2496911|NCT00829738|6119245|P1|NOT COMPLETED|Overall Study||8
2496912|NCT00829738|6119245|P1|COMPLETED|Overall Study||4180
2496913|NCT00829738|6119245|P1|STARTED|Overall Study||4188
2496914|NCT00829712|6119263|P2|NOT COMPLETED|Second Intervention||0
2496915|NCT00829712|6119264|P1|NOT COMPLETED|Second Intervention||0
2496916|NCT00829712|6119263|P2|COMPLETED|Second Intervention||11
2496917|NCT00829712|6119264|P1|COMPLETED|Second Intervention||12
2496918|NCT00829712|6119263|P2|STARTED|Second Intervention||11
2496919|NCT00829712|6119264|P1|STARTED|Second Intervention||12
2496920|NCT00829712|6119263|P2|NOT COMPLETED|Washout of 7 Days||1
2496921|NCT00829712|6119264|P1|NOT COMPLETED|Washout of 7 Days||0
2496922|NCT00829712|6119263|P2|COMPLETED|Washout of 7 Days||11
2496923|NCT00829712|6119264|P1|COMPLETED|Washout of 7 Days||12
2496924|NCT00829712|6119263|P2|STARTED|Washout of 7 Days||12
2496925|NCT00829712|6119264|P1|STARTED|Washout of 7 Days||12
2496926|NCT00829712|6119263|P2|NOT COMPLETED|First Intervention||0
2496927|NCT00829712|6119264|P1|NOT COMPLETED|First Intervention||0
2496928|NCT00829712|6119263|P2|COMPLETED|First Intervention||12
2496929|NCT00829712|6119264|P1|COMPLETED|First Intervention||12
2496930|NCT00829712|6119263|P2|STARTED|First Intervention||12
2496931|NCT00829712|6119264|P1|STARTED|First Intervention||12
2496932|NCT00829686|6119274|P2|NOT COMPLETED|Overall Study||0
2496933|NCT00829686|6119275|P1|NOT COMPLETED|Overall Study||0
2496934|NCT00829686|6119274|P2|COMPLETED|Overall Study||18
2496935|NCT00829686|6119275|P1|COMPLETED|Overall Study||13
2496936|NCT00829686|6119274|P2|STARTED|Overall Study||18
2496937|NCT00829686|6119275|P1|STARTED|Overall Study||13
2496938|NCT00829673|6119283|P2|NOT COMPLETED|Second Intervention||0
2496939|NCT00829673|6119284|P1|NOT COMPLETED|Second Intervention||0
2496940|NCT00829673|6119283|P2|COMPLETED|Second Intervention||12
2496941|NCT00829673|6119284|P1|COMPLETED|Second Intervention||11
2496942|NCT00829673|6119283|P2|STARTED|Second Intervention||12
2496943|NCT00829673|6119284|P1|STARTED|Second Intervention||11
2496944|NCT00829673|6119283|P2|NOT COMPLETED|Washout of 7 Days||0
2496945|NCT00829673|6119284|P1|NOT COMPLETED|Washout of 7 Days||1
2496946|NCT00829673|6119283|P2|COMPLETED|Washout of 7 Days||12
2496947|NCT00829673|6119284|P1|COMPLETED|Washout of 7 Days||11
2496948|NCT00829673|6119283|P2|STARTED|Washout of 7 Days||12
2496949|NCT00829673|6119284|P1|STARTED|Washout of 7 Days||12
2496950|NCT00829673|6119283|P2|NOT COMPLETED|First Intervention||0
2496951|NCT00829673|6119284|P1|NOT COMPLETED|First Intervention||0
2496952|NCT00829673|6119283|P2|COMPLETED|First Intervention||12
2496953|NCT00829673|6119284|P1|COMPLETED|First Intervention||12
2496954|NCT00829673|6119283|P2|STARTED|First Intervention||12
2496955|NCT00829673|6119284|P1|STARTED|First Intervention||12
2496956|NCT00829621|6119294|P2|NOT COMPLETED|Overall Study||4
2496957|NCT00829621|6119295|P1|NOT COMPLETED|Overall Study||4
2496958|NCT00829621|6119294|P2|COMPLETED|Overall Study||8
2496959|NCT00829621|6119295|P1|COMPLETED|Overall Study||4
2496960|NCT00829621|6119294|P2|STARTED|Overall Study||12
2496961|NCT00829621|6119295|P1|STARTED|Overall Study||8
2496962|NCT00829530|6119303|P2|NOT COMPLETED|Second Intervention||0
2496963|NCT00829530|6119304|P1|NOT COMPLETED|Second Intervention||1
2496964|NCT00829530|6119303|P2|COMPLETED|Second Intervention||18
2496965|NCT00829530|6119304|P1|COMPLETED|Second Intervention||19
2496966|NCT00829530|6119303|P2|STARTED|Second Intervention||18
2496967|NCT00829530|6119304|P1|STARTED|Second Intervention||20
2496968|NCT00829530|6119303|P2|NOT COMPLETED|Washout of 42 Days||0
2496969|NCT00829530|6119304|P1|NOT COMPLETED|Washout of 42 Days||0
2496970|NCT00829530|6119303|P2|COMPLETED|Washout of 42 Days||18
2496971|NCT00829530|6119304|P1|COMPLETED|Washout of 42 Days||20
2496972|NCT00829530|6119303|P2|STARTED|Washout of 42 Days||18
2496973|NCT00829530|6119304|P1|STARTED|Washout of 42 Days||20
2496974|NCT00829530|6119303|P2|NOT COMPLETED|First Intervention||2
2496975|NCT00829530|6119304|P1|NOT COMPLETED|First Intervention||0
2496976|NCT00829530|6119303|P2|COMPLETED|First Intervention||18
2496977|NCT00829530|6119304|P1|COMPLETED|First Intervention||20
2496978|NCT00829530|6119303|P2|STARTED|First Intervention||20
2496979|NCT00829530|6119304|P1|STARTED|First Intervention||20
2496980|NCT00829504|6119318|P2|NOT COMPLETED|Second Intervention||0
2496981|NCT00829504|6119319|P1|NOT COMPLETED|Second Intervention||1
2496982|NCT00829504|6119318|P2|COMPLETED|Second Intervention||22
2496983|NCT00829504|6119319|P1|COMPLETED|Second Intervention||19
2496984|NCT00829504|6119318|P2|STARTED|Second Intervention||22
2496985|NCT00829504|6119319|P1|STARTED|Second Intervention||20
2496986|NCT00829504|6119318|P2|NOT COMPLETED|Washout of 7 Days||0
2496987|NCT00829504|6119319|P1|NOT COMPLETED|Washout of 7 Days||1
2496988|NCT00829504|6119318|P2|COMPLETED|Washout of 7 Days||22
2496989|NCT00829504|6119319|P1|COMPLETED|Washout of 7 Days||20
2496990|NCT00829504|6119318|P2|STARTED|Washout of 7 Days||22
2496991|NCT00829504|6119319|P1|STARTED|Washout of 7 Days||21
2496992|NCT00829504|6119318|P2|NOT COMPLETED|First Intervention||0
2496993|NCT00829504|6119319|P1|NOT COMPLETED|First Intervention||1
2496994|NCT00829504|6119318|P2|COMPLETED|First Intervention||22
2496995|NCT00829504|6119319|P1|COMPLETED|First Intervention||21
2496996|NCT00829504|6119318|P2|STARTED|First Intervention||22
2496997|NCT00829504|6119319|P1|STARTED|First Intervention||22
2496998|NCT00829452|6119329|P2|NOT COMPLETED|Second Intervention||1
2496999|NCT00829452|6119330|P1|NOT COMPLETED|Second Intervention||0
2497000|NCT00829452|6119329|P2|COMPLETED|Second Intervention||17
2497001|NCT00829452|6119330|P1|COMPLETED|Second Intervention||20
2497002|NCT00829452|6119329|P2|STARTED|Second Intervention||18
2497003|NCT00829452|6119330|P1|STARTED|Second Intervention||20
2497004|NCT00829452|6119329|P2|NOT COMPLETED|Washout of 42 Days||1
2497005|NCT00829452|6119330|P1|NOT COMPLETED|Washout of 42 Days||0
2497006|NCT00829452|6119329|P2|COMPLETED|Washout of 42 Days||18
2497007|NCT00829452|6119330|P1|COMPLETED|Washout of 42 Days||20
2497008|NCT00829452|6119329|P2|STARTED|Washout of 42 Days||19
2497009|NCT00829452|6119330|P1|STARTED|Washout of 42 Days||20
2497010|NCT00829452|6119329|P2|NOT COMPLETED|First Intervention||1
2497011|NCT00829452|6119330|P1|NOT COMPLETED|First Intervention||0
2497012|NCT00829452|6119329|P2|COMPLETED|First Intervention||19
2497013|NCT00829452|6119330|P1|COMPLETED|First Intervention||20
2497014|NCT00829452|6119329|P2|STARTED|First Intervention||20
2497015|NCT00829452|6119330|P1|STARTED|First Intervention||20
2497016|NCT00829439|6119342|P4|NOT COMPLETED|Overall Study||0
2497017|NCT00829439|6119343|P3|NOT COMPLETED|Overall Study||1
2497018|NCT00829439|6119344|P2|NOT COMPLETED|Overall Study||0
2497019|NCT00829439|6119345|P1|NOT COMPLETED|Overall Study||0
2497020|NCT00829439|6119342|P4|COMPLETED|Overall Study||4
2497021|NCT00829439|6119343|P3|COMPLETED|Overall Study||5
2497022|NCT00829439|6119344|P2|COMPLETED|Overall Study||3
2497023|NCT00829439|6119345|P1|COMPLETED|Overall Study||3
2497024|NCT00829439|6119342|P4|STARTED|Overall Study||4
2497025|NCT00829439|6119343|P3|STARTED|Overall Study||6
2497026|NCT00829439|6119344|P2|STARTED|Overall Study||3
2497027|NCT00829439|6119345|P1|STARTED|Overall Study||3
2497028|NCT00829426|6119351|P2|NOT COMPLETED|Second Intervention||0
2497029|NCT00829426|6119352|P1|NOT COMPLETED|Second Intervention||0
2497030|NCT00829426|6119351|P2|COMPLETED|Second Intervention||16
2497031|NCT00829426|6119352|P1|COMPLETED|Second Intervention||15
2497032|NCT00829426|6119351|P2|STARTED|Second Intervention||16
2497033|NCT00829426|6119352|P1|STARTED|Second Intervention||15
2497034|NCT00829426|6119351|P2|NOT COMPLETED|Washout: 7 Days||0
2497035|NCT00829426|6119352|P1|NOT COMPLETED|Washout: 7 Days||1
2497036|NCT00829426|6119351|P2|COMPLETED|Washout: 7 Days||16
2497037|NCT00829426|6119352|P1|COMPLETED|Washout: 7 Days||15
2497038|NCT00829426|6119351|P2|STARTED|Washout: 7 Days||16
2497039|NCT00829426|6119352|P1|STARTED|Washout: 7 Days||16
2497040|NCT00829426|6119351|P2|NOT COMPLETED|First Intervention||0
2497041|NCT00829426|6119352|P1|NOT COMPLETED|First Intervention||0
2497042|NCT00829426|6119351|P2|COMPLETED|First Intervention||16
2497043|NCT00829426|6119352|P1|COMPLETED|First Intervention||16
2497044|NCT00829426|6119351|P2|STARTED|First Intervention||16
2497045|NCT00829426|6119352|P1|STARTED|First Intervention||16
2497046|NCT00829413|6119360|P1|NOT COMPLETED|Overall Study||94
2497047|NCT00829413|6119360|P1|COMPLETED|Overall Study||259
2497048|NCT00829413|6119360|P1|STARTED|Overall Study||353
2497049|NCT00829387|6119409|P2|NOT COMPLETED|Overall Study||3
2497050|NCT00829387|6119410|P1|NOT COMPLETED|Overall Study||3
2497051|NCT00829387|6119409|P2|COMPLETED|Overall Study||21
2497052|NCT00829387|6119410|P1|COMPLETED|Overall Study||20
2497053|NCT00829387|6119409|P2|STARTED|Overall Study||24
2497054|NCT00829387|6119410|P1|STARTED|Overall Study||23
2497055|NCT00829309|6119428|P2|NOT COMPLETED|Second Intervention||0
2497056|NCT00829309|6119429|P1|NOT COMPLETED|Second Intervention||0
2497057|NCT00829309|6119428|P2|COMPLETED|Second Intervention||8
2497058|NCT00829309|6119429|P1|COMPLETED|Second Intervention||7
2497059|NCT00829309|6119428|P2|STARTED|Second Intervention||8
2497060|NCT00829309|6119429|P1|STARTED|Second Intervention||7
2497061|NCT00829309|6119428|P2|NOT COMPLETED|Washout: 7 Days||0
2497062|NCT00829309|6119429|P1|NOT COMPLETED|Washout: 7 Days||1
2497063|NCT00829309|6119428|P2|COMPLETED|Washout: 7 Days||8
2497064|NCT00829309|6119429|P1|COMPLETED|Washout: 7 Days||7
2497065|NCT00829309|6119428|P2|STARTED|Washout: 7 Days||8
2497066|NCT00829309|6119429|P1|STARTED|Washout: 7 Days||8
2497067|NCT00829309|6119428|P2|NOT COMPLETED|First Intervention||0
2497068|NCT00829309|6119429|P1|NOT COMPLETED|First Intervention||0
2497069|NCT00829309|6119428|P2|COMPLETED|First Intervention||8
2497070|NCT00829309|6119429|P1|COMPLETED|First Intervention||8
2497071|NCT00829309|6119428|P2|STARTED|First Intervention||8
2497072|NCT00829309|6119429|P1|STARTED|First Intervention||8
2497073|NCT00829296|6119439|P2|NOT COMPLETED|Overall Study||4
2497074|NCT00829296|6119440|P1|NOT COMPLETED|Overall Study||5
2497075|NCT00829296|6119439|P2|COMPLETED|Overall Study||32
2497076|NCT00829296|6119440|P1|COMPLETED|Overall Study||29
2497077|NCT00829296|6119439|P2|STARTED|Overall Study||36
2497078|NCT00829296|6119440|P1|STARTED|Overall Study||34
2497079|NCT00829283|6119454|P2|NOT COMPLETED|Overall Study||25
2497080|NCT00829283|6119455|P1|NOT COMPLETED|Overall Study||7
2497081|NCT00829283|6119454|P2|COMPLETED|Overall Study||127
2497082|NCT00829283|6119455|P1|COMPLETED|Overall Study||32
2497083|NCT00829283|6119454|P2|STARTED|Overall Study||152
2497084|NCT00829283|6119455|P1|STARTED|Overall Study||39
2497085|NCT00829244|6119465|P2|NOT COMPLETED|Overall Study||21
2497086|NCT00829244|6119466|P1|NOT COMPLETED|Overall Study||14
2497087|NCT00829244|6119465|P2|COMPLETED|Overall Study||83
2497088|NCT00829244|6119466|P1|COMPLETED|Overall Study||82
2497089|NCT00829244|6119465|P2|STARTED|Overall Study||104
2497090|NCT00829244|6119466|P1|STARTED|Overall Study||96
2497091|NCT00829179|6119496|P1|NOT COMPLETED|Overall Study||1
2497092|NCT00829179|6119496|P1|COMPLETED|Overall Study||19
2497093|NCT00829179|6119496|P1|STARTED|Overall Study||20
2497094|NCT00829166|6119502|P2|NOT COMPLETED|Overall Study||496
2497095|NCT00829166|6119503|P1|NOT COMPLETED|Overall Study||495
2497096|NCT00829166|6119502|P2|COMPLETED|Overall Study||0
2497097|NCT00829166|6119503|P1|COMPLETED|Overall Study||0
2497098|NCT00829166|6119502|P2|Treated|Overall Study||488
2497099|NCT00829166|6119503|P1|Treated|Overall Study||490
2497100|NCT00829166|6119502|P2|STARTED|Overall Study||496
2497101|NCT00829166|6119503|P1|STARTED|Overall Study||495
2497102|NCT00829049|6119544|P2|NOT COMPLETED|Overall Study||20
2497103|NCT00829049|6119545|P1|NOT COMPLETED|Overall Study||17
2497104|NCT00829049|6119544|P2|COMPLETED|Overall Study||68
2497105|NCT00829049|6119545|P1|COMPLETED|Overall Study||60
2497106|NCT00829049|6119544|P2|STARTED|Overall Study||88
2497107|NCT00829049|6119545|P1|STARTED|Overall Study||77
2497108|NCT00829036|6119557|P1|NOT COMPLETED|Overall Study||0
2497109|NCT00829036|6119557|P1|COMPLETED|Overall Study||24
2497110|NCT00829036|6119557|P1|STARTED|Overall Study||24
2497111|NCT00829010|6119566|P5|NOT COMPLETED|Overall Study||2
2497112|NCT00829010|6119567|P4|NOT COMPLETED|Overall Study||8
2497113|NCT00829010|6119568|P3|NOT COMPLETED|Overall Study||3
2497114|NCT00829010|6119569|P2|NOT COMPLETED|Overall Study||9
2497115|NCT00829010|6119570|P1|NOT COMPLETED|Overall Study||10
2497116|NCT00829010|6119566|P5|COMPLETED|Overall Study||98
2497117|NCT00829010|6119567|P4|COMPLETED|Overall Study||92
2497118|NCT00829010|6119568|P3|COMPLETED|Overall Study||97
2497119|NCT00829010|6119569|P2|COMPLETED|Overall Study||92
2497120|NCT00829010|6119570|P1|COMPLETED|Overall Study||73
2497121|NCT00829010|6119566|P5|STARTED|Overall Study||100
2497122|NCT00829010|6119567|P4|STARTED|Overall Study||100
2497123|NCT00829010|6119568|P3|STARTED|Overall Study||100
2497124|NCT00829010|6119569|P2|STARTED|Overall Study||101
2497125|NCT00829010|6119570|P1|STARTED|Overall Study||83
2497126|NCT00828984|6119735|P3|NOT COMPLETED|Overall Study||9
2497127|NCT00828984|6119736|P2|NOT COMPLETED|Overall Study||16
2497128|NCT00828984|6119737|P1|NOT COMPLETED|Overall Study||14
2497129|NCT00828984|6119735|P3|COMPLETED|Overall Study||19
2497130|NCT00828984|6119736|P2|COMPLETED|Overall Study||15
2497131|NCT00828984|6119737|P1|COMPLETED|Overall Study||14
2497132|NCT00828984|6119735|P3|Post Intervention Follow-Up|Overall Study||19
2497133|NCT00828984|6119736|P2|Post Intervention Follow-Up|Overall Study||16
2497134|NCT00828984|6119737|P1|Post Intervention Follow-Up|Overall Study||15
2497135|NCT00828984|6119735|P3|Flexible Sigmoidoscopy|Overall Study||19
2497136|NCT00828984|6119736|P2|Flexible Sigmoidoscopy|Overall Study||19
2497137|NCT00828984|6119737|P1|Flexible Sigmoidoscopy|Overall Study||20
2497138|NCT00828984|6119735|P3|Treatment|Overall Study||24
2497139|NCT00828984|6119736|P2|Treatment|Overall Study||26
2497140|NCT00828984|6119737|P1|Treatment|Overall Study||24
2497141|NCT00828984|6119735|P3|Randomization|Overall Study||28
2497142|NCT00828984|6119736|P2|Randomization|Overall Study||31
2497143|NCT00828984|6119737|P1|Randomization|Overall Study||28
2497144|NCT00828984|6119735|P3|STARTED|Overall Study||28
2497145|NCT00828984|6119736|P2|STARTED|Overall Study||31
2497146|NCT00828984|6119737|P1|STARTED|Overall Study||28
2497147|NCT00828945|6119760|P1|NOT COMPLETED|Overall Study||41
2497148|NCT00828945|6119760|P1|COMPLETED|Overall Study||216
2497149|NCT00828945|6119760|P1|STARTED|Overall Study||257
2497150|NCT00828841|6119777|P3|NOT COMPLETED|Overall Study||4
2497151|NCT00828841|6119778|P2|NOT COMPLETED|Overall Study||4
2497152|NCT00828841|6119779|P1|NOT COMPLETED|Overall Study||4
2497153|NCT00828841|6119777|P3|COMPLETED|Overall Study||126
2497154|NCT00828841|6119778|P2|COMPLETED|Overall Study||232
2497155|NCT00828841|6119779|P1|COMPLETED|Overall Study||231
2497156|NCT00828841|6119777|P3|STARTED|Overall Study||130
2497157|NCT00828841|6119778|P2|STARTED|Overall Study||236
2497158|NCT00828841|6119779|P1|STARTED|Overall Study||235
2497159|NCT00828750|6119792|P1|NOT COMPLETED|Overall Study||4
2497160|NCT00828750|6119792|P1|COMPLETED|Overall Study||15
2497161|NCT00828750|6119792|P1|STARTED|Overall Study||19
2497162|NCT00828711|6119806|P3|NOT COMPLETED|Overall Study||0
2497163|NCT00828711|6119807|P2|NOT COMPLETED|Overall Study||0
2497164|NCT00828711|6119808|P1|NOT COMPLETED|Overall Study||1
2497165|NCT00828711|6119806|P3|COMPLETED|Overall Study||131
2497166|NCT00828711|6119807|P2|COMPLETED|Overall Study||125
2497167|NCT00828711|6119808|P1|COMPLETED|Overall Study||117
2497168|NCT00828711|6119806|P3|STARTED|Overall Study||131
2497169|NCT00828711|6119807|P2|STARTED|Overall Study||125
2497170|NCT00828711|6119808|P1|STARTED|Overall Study||118
2497171|NCT00828672|6119839|P2|NOT COMPLETED|Follow-up||0
2497172|NCT00828672|6119840|P1|NOT COMPLETED|Follow-up||0
2497173|NCT00828672|6119839|P2|COMPLETED|Follow-up||41
2497174|NCT00828672|6119840|P1|COMPLETED|Follow-up||42
2497175|NCT00828672|6119839|P2|STARTED|Follow-up|Patients with no central review material and with adverse event are in followup (joined this period)|41
2497176|NCT00828672|6119840|P1|STARTED|Follow-up|Patient in Arm 1 with clinical complete response and no surgery is in follow up (joined this period)|42
2497177|NCT00828672|6119839|P2|NOT COMPLETED|Post-surgery (<30 Days)||1
2497178|NCT00828672|6119840|P1|NOT COMPLETED|Post-surgery (<30 Days)||0
2497179|NCT00828672|6119839|P2|COMPLETED|Post-surgery (<30 Days)||38
2497180|NCT00828672|6119840|P1|COMPLETED|Post-surgery (<30 Days)||41
2497181|NCT00828672|6119839|P2|STARTED|Post-surgery (<30 Days)||39
2497182|NCT00828672|6119840|P1|STARTED|Post-surgery (<30 Days)||41
2497183|NCT00828672|6119839|P2|NOT COMPLETED|Study Treatment||2
2497184|NCT00828672|6119840|P1|NOT COMPLETED|Study Treatment||2
2497185|NCT00828672|6119839|P2|COMPLETED|Study Treatment||39
2497186|NCT00828672|6119840|P1|COMPLETED|Study Treatment||41
2497187|NCT00828672|6119839|P2|STARTED|Study Treatment||41
2497188|NCT00828672|6119840|P1|STARTED|Study Treatment||43
2497189|NCT00828672|6119839|P2|NOT COMPLETED|Pre-treatment (Baseline)||0
2497190|NCT00828672|6119840|P1|NOT COMPLETED|Pre-treatment (Baseline)||0
2497191|NCT00828672|6119839|P2|COMPLETED|Pre-treatment (Baseline)||41
2497192|NCT00828672|6119840|P1|COMPLETED|Pre-treatment (Baseline)||43
2497193|NCT00828672|6119839|P2|STARTED|Pre-treatment (Baseline)||41
2497194|NCT00828672|6119840|P1|STARTED|Pre-treatment (Baseline)||43
2497195|NCT00828568|6119861|P3|NOT COMPLETED|Treated - Received at Least One Dose||5
2497196|NCT00828568|6119862|P2|NOT COMPLETED|Treated - Received at Least One Dose||29
2497197|NCT00828568|6119863|P1|NOT COMPLETED|Treated - Received at Least One Dose||30
2497198|NCT00828568|6119861|P3|COMPLETED|Treated - Received at Least One Dose||55
2497199|NCT00828568|6119862|P2|COMPLETED|Treated - Received at Least One Dose||150
2497200|NCT00828568|6119863|P1|COMPLETED|Treated - Received at Least One Dose||153
2497201|NCT00828568|6119861|P3|STARTED|Treated - Received at Least One Dose||60
2497202|NCT00828568|6119862|P2|STARTED|Treated - Received at Least One Dose||179
2497203|NCT00828568|6119863|P1|STARTED|Treated - Received at Least One Dose||183
2497204|NCT00828568|6119861|P3|NOT COMPLETED|Randomized||2
2497205|NCT00828568|6119862|P2|NOT COMPLETED|Randomized||0
2497206|NCT00828568|6119863|P1|NOT COMPLETED|Randomized||1
2497207|NCT00828568|6119861|P3|COMPLETED|Randomized||60
2497208|NCT00828568|6119862|P2|COMPLETED|Randomized||179
2497209|NCT00828568|6119863|P1|COMPLETED|Randomized||183
2497210|NCT00828568|6119861|P3|STARTED|Randomized||62
2497211|NCT00828568|6119862|P2|STARTED|Randomized||179
2497212|NCT00828568|6119863|P1|STARTED|Randomized||184
2497213|NCT00828542|6119878|P2|NOT COMPLETED|Overall Study||3
2497214|NCT00828542|6119879|P1|NOT COMPLETED|Overall Study||3
2497215|NCT00828542|6119878|P2|COMPLETED|Overall Study||20
2497216|NCT00828542|6119879|P1|COMPLETED|Overall Study||20
2497217|NCT00828542|6119878|P2|STARTED|Overall Study||23
2497218|NCT00828542|6119879|P1|STARTED|Overall Study||23
2497219|NCT00828516|6119885|P1|NOT COMPLETED|Clinical Phase: Series 2||0
2497220|NCT00828516|6119885|P1|COMPLETED|Clinical Phase: Series 2||30
2497221|NCT00828516|6119885|P1|STARTED|Clinical Phase: Series 2||30
2497222|NCT00828516|6119885|P1|NOT COMPLETED|Clinical Phase: Series 1||2
2497223|NCT00828516|6119885|P1|COMPLETED|Clinical Phase: Series 1||33
2497224|NCT00828516|6119885|P1|STARTED|Clinical Phase: Series 1||35
2497225|NCT00828464|6119890|P1|NOT COMPLETED|Overall Study||1
2497226|NCT00828464|6119890|P1|COMPLETED|Overall Study||29
2497227|NCT00828464|6119890|P1|STARTED|Overall Study||30
2497228|NCT00828451|6119907|P1|NOT COMPLETED|Overall Study||11
2497229|NCT00828451|6119907|P1|COMPLETED|Overall Study||18
2497230|NCT00828451|6119907|P1|STARTED|Overall Study||29
2497231|NCT00828412|6119915|P2|NOT COMPLETED|Overall Study||2
2497232|NCT00828412|6119916|P1|NOT COMPLETED|Overall Study||9
2497233|NCT00828412|6119915|P2|COMPLETED|Overall Study||48
2497234|NCT00828412|6119916|P1|COMPLETED|Overall Study||41
2497235|NCT00828412|6119915|P2|STARTED|Overall Study||50
2497236|NCT00828412|6119916|P1|STARTED|Overall Study||50
2497237|NCT00828347|6119924|P2|NOT COMPLETED|Overall Study||0
2497238|NCT00828347|6119925|P1|NOT COMPLETED|Overall Study||0
2497239|NCT00828347|6119924|P2|COMPLETED|Overall Study||11
2497240|NCT00828347|6119925|P1|COMPLETED|Overall Study||12
2497241|NCT00828347|6119924|P2|STARTED|Overall Study||11
2497242|NCT00828347|6119925|P1|STARTED|Overall Study||12
2497243|NCT00828321|6119933|P2|NOT COMPLETED|Second Intervention||1
2497244|NCT00828321|6119934|P1|NOT COMPLETED|Second Intervention||0
2497245|NCT00828321|6119933|P2|COMPLETED|Second Intervention||19
2497246|NCT00828321|6119934|P1|COMPLETED|Second Intervention||18
2497247|NCT00828321|6119933|P2|STARTED|Second Intervention||20
2497248|NCT00828321|6119934|P1|STARTED|Second Intervention||18
2497249|NCT00828321|6119933|P2|NOT COMPLETED|Washout of 42 Days||0
2497250|NCT00828321|6119934|P1|NOT COMPLETED|Washout of 42 Days||2
2497251|NCT00828321|6119933|P2|COMPLETED|Washout of 42 Days||20
2497252|NCT00828321|6119934|P1|COMPLETED|Washout of 42 Days||18
2497253|NCT00828321|6119933|P2|STARTED|Washout of 42 Days||20
2497254|NCT00828321|6119934|P1|STARTED|Washout of 42 Days||20
2497255|NCT00828321|6119933|P2|NOT COMPLETED|First Intervention||0
2497256|NCT00828321|6119934|P1|NOT COMPLETED|First Intervention||0
2497257|NCT00828321|6119933|P2|COMPLETED|First Intervention||20
2497258|NCT00828321|6119934|P1|COMPLETED|First Intervention||20
2497259|NCT00828321|6119933|P2|STARTED|First Intervention||20
2497260|NCT00828321|6119934|P1|STARTED|First Intervention||20
2497261|NCT00828308|6119946|P1|NOT COMPLETED|Overall Study||0
2497262|NCT00828308|6119946|P1|COMPLETED|Overall Study||16
2497263|NCT00828308|6119946|P1|STARTED|Overall Study||16
2497264|NCT00828295|6119952|P2|NOT COMPLETED|Overall Study||0
2497265|NCT00828295|6119953|P1|NOT COMPLETED|Overall Study||0
2497266|NCT00828295|6119952|P2|COMPLETED|Overall Study||75
2497267|NCT00828295|6119953|P1|COMPLETED|Overall Study||75
2497268|NCT00828295|6119952|P2|STARTED|Overall Study||75
2497269|NCT00828295|6119953|P1|STARTED|Overall Study||75
2497270|NCT00828204|6119963|P2|NOT COMPLETED|Extension Study||3
2497271|NCT00828204|6119964|P1|NOT COMPLETED|Extension Study||0
2497272|NCT00828204|6119963|P2|COMPLETED|Extension Study||61
2497273|NCT00828204|6119964|P1|COMPLETED|Extension Study||0
2497274|NCT00828204|6119963|P2|STARTED|Extension Study|Participation in Extension Study was optional for Main Subset participants completing Main Study.|64
2497275|NCT00828204|6119964|P1|STARTED|Extension Study|Participation in the Extension Study was not offered to Initial Subset after completing Main Study.|0
2497276|NCT00828204|6119963|P2|NOT COMPLETED|Main Study: After Study Restart||3
2497277|NCT00828204|6119964|P1|NOT COMPLETED|Main Study: After Study Restart||0
2497278|NCT00828204|6119963|P2|COMPLETED|Main Study: After Study Restart||71
2497279|NCT00828204|6119964|P1|COMPLETED|Main Study: After Study Restart||0
2497280|NCT00828204|6119963|P2|Continued With Autoinjector Injections|Main Study: After Study Restart||72
2497281|NCT00828204|6119964|P1|Continued With Autoinjector Injections|Main Study: After Study Restart||0
2497282|NCT00828204|6119963|P2|Completed Manual Injection|Main Study: After Study Restart||74
2497283|NCT00828204|6119964|P1|Completed Manual Injection|Main Study: After Study Restart||0
2497284|NCT00828204|6119963|P2|STARTED|Main Study: After Study Restart|After a protocol amendment, the Main Subset participants were enrolled.|74
2497285|NCT00828204|6119964|P1|STARTED|Main Study: After Study Restart|Initial Subset participants did not continue after the study was suspended.|0
2497286|NCT00828204|6119963|P2|NOT COMPLETED|Main Study: Prior to Study Suspension||0
2497287|NCT00828204|6119964|P1|NOT COMPLETED|Main Study: Prior to Study Suspension||14
2497288|NCT00828204|6119963|P2|COMPLETED|Main Study: Prior to Study Suspension||0
2497289|NCT00828204|6119964|P1|COMPLETED|Main Study: Prior to Study Suspension||7
2497290|NCT00828204|6119963|P2|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||0
2497291|NCT00828204|6119964|P1|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||19
2497292|NCT00828204|6119963|P2|Completed Manual Injection|Main Study: Prior to Study Suspension||0
2497293|NCT00828204|6119964|P1|Completed Manual Injection|Main Study: Prior to Study Suspension||21
2497294|NCT00828204|6119963|P2|STARTED|Main Study: Prior to Study Suspension|Main Subset was not enrolled until after study suspension (period 2, below).|0
2497295|NCT00828204|6119964|P1|STARTED|Main Study: Prior to Study Suspension||21
2497296|NCT00828191|6119983|P2|NOT COMPLETED|Overall Study||10
2497297|NCT00828191|6119984|P1|NOT COMPLETED|Overall Study||8
2497298|NCT00828191|6119983|P2|COMPLETED|Overall Study|Patients with at least one embryo transferred.|390
2497299|NCT00828191|6119984|P1|COMPLETED|Overall Study|Patients with at least one embryo transferred.|392
2497300|NCT00828191|6119983|P2|STARTED|Overall Study|Randomized patients|400
2497301|NCT00828191|6119984|P1|STARTED|Overall Study|Randomized patients|400
2497302|NCT00828178|6119996|P2|NOT COMPLETED|Overall Study||2
2497303|NCT00828178|6119997|P1|NOT COMPLETED|Overall Study||0
2497304|NCT00828178|6119996|P2|COMPLETED|Overall Study|Two patients did not complete the study.|43
2497305|NCT00828178|6119997|P1|COMPLETED|Overall Study||42
2497306|NCT00828178|6119996|P2|STARTED|Overall Study|Eighty seven participants were randomized.|45
2497307|NCT00828178|6119997|P1|STARTED|Overall Study||42
2497308|NCT00828139|6120011|P4|NOT COMPLETED|Overall Study||51
2497309|NCT00828139|6120012|P3|NOT COMPLETED|Overall Study||55
2497310|NCT00828139|6120013|P2|NOT COMPLETED|Overall Study||41
2497311|NCT00828139|6120014|P1|NOT COMPLETED|Overall Study||41
2497312|NCT00828139|6120011|P4|COMPLETED|Overall Study||0
2497313|NCT00828139|6120012|P3|COMPLETED|Overall Study||0
2497314|NCT00828139|6120013|P2|COMPLETED|Overall Study||0
2497315|NCT00828139|6120014|P1|COMPLETED|Overall Study||1
2497316|NCT00828139|6120011|P4|STARTED|Overall Study||51
2497317|NCT00828139|6120012|P3|STARTED|Overall Study||55
2497318|NCT00828139|6120013|P2|STARTED|Overall Study||41
2497319|NCT00828139|6120014|P1|STARTED|Overall Study||42
2497320|NCT00828113|6120034|P2|NOT COMPLETED|Overall Study||31
2497321|NCT00828113|6120035|P1|NOT COMPLETED|Overall Study||30
2497322|NCT00828113|6120034|P2|COMPLETED|Overall Study||20
2497323|NCT00828113|6120035|P1|COMPLETED|Overall Study||20
2497324|NCT00828113|6120034|P2|STARTED|Overall Study||51
2497325|NCT00828113|6120035|P1|STARTED|Overall Study||50
2497326|NCT00828074|6120043|P3|NOT COMPLETED|Overall Study||0
2497327|NCT00828074|6120044|P2|NOT COMPLETED|Overall Study||0
2497328|NCT00828074|6120045|P1|NOT COMPLETED|Overall Study||0
2497329|NCT00828074|6120043|P3|COMPLETED|Overall Study||35
2497330|NCT00828074|6120044|P2|COMPLETED|Overall Study||5
2497331|NCT00828074|6120045|P1|COMPLETED|Overall Study||6
2497332|NCT00828074|6120043|P3|STARTED|Overall Study||35
2497333|NCT00828074|6120044|P2|STARTED|Overall Study||5
2497334|NCT00828074|6120045|P1|STARTED|Overall Study||6
2497335|NCT00828061|6120057|P6|NOT COMPLETED|Period 3||0
2497336|NCT00828061|6120058|P5|NOT COMPLETED|Period 3||0
2497337|NCT00828061|6120059|P4|NOT COMPLETED|Period 3||0
2497338|NCT00828061|6120060|P3|NOT COMPLETED|Period 3||0
2497339|NCT00828061|6120061|P2|NOT COMPLETED|Period 3||0
2497340|NCT00828061|6120062|P1|NOT COMPLETED|Period 3||0
2497341|NCT00828061|6120057|P6|COMPLETED|Period 3||3
2497342|NCT00828061|6120058|P5|COMPLETED|Period 3||3
2497343|NCT00828061|6120059|P4|COMPLETED|Period 3||3
2497344|NCT00828061|6120060|P3|COMPLETED|Period 3||3
2497345|NCT00828061|6120061|P2|COMPLETED|Period 3||3
2497346|NCT00828061|6120062|P1|COMPLETED|Period 3||4
2497347|NCT00828061|6120057|P6|STARTED|Period 3||3
2497348|NCT00828061|6120058|P5|STARTED|Period 3||3
2497349|NCT00828061|6120059|P4|STARTED|Period 3||3
2497350|NCT00828061|6120060|P3|STARTED|Period 3||3
2497351|NCT00828061|6120061|P2|STARTED|Period 3||3
2497352|NCT00828061|6120062|P1|STARTED|Period 3||4
2497353|NCT00828061|6120057|P6|NOT COMPLETED|Period 2||0
2497354|NCT00828061|6120058|P5|NOT COMPLETED|Period 2||0
2497355|NCT00828061|6120059|P4|NOT COMPLETED|Period 2||0
2497356|NCT00828061|6120060|P3|NOT COMPLETED|Period 2||0
2497357|NCT00828061|6120061|P2|NOT COMPLETED|Period 2||0
2497358|NCT00828061|6120062|P1|NOT COMPLETED|Period 2||0
2497359|NCT00828061|6120057|P6|COMPLETED|Period 2||3
2497360|NCT00828061|6120058|P5|COMPLETED|Period 2||3
2497361|NCT00828061|6120059|P4|COMPLETED|Period 2||3
2497362|NCT00828061|6120060|P3|COMPLETED|Period 2||3
2497363|NCT00828061|6120061|P2|COMPLETED|Period 2||3
2497364|NCT00828061|6120062|P1|COMPLETED|Period 2||4
2497365|NCT00828061|6120057|P6|STARTED|Period 2||3
2497366|NCT00828061|6120058|P5|STARTED|Period 2||3
2497367|NCT00828061|6120059|P4|STARTED|Period 2||3
2497368|NCT00828061|6120060|P3|STARTED|Period 2||3
2497369|NCT00828061|6120061|P2|STARTED|Period 2||3
2497370|NCT00828061|6120062|P1|STARTED|Period 2||4
2497371|NCT00828061|6120057|P6|NOT COMPLETED|Period 1||0
2497372|NCT00828061|6120058|P5|NOT COMPLETED|Period 1||0
2497373|NCT00828061|6120059|P4|NOT COMPLETED|Period 1||0
2497374|NCT00828061|6120060|P3|NOT COMPLETED|Period 1||0
2497375|NCT00828061|6120061|P2|NOT COMPLETED|Period 1||0
2497376|NCT00828061|6120062|P1|NOT COMPLETED|Period 1||0
2497377|NCT00828061|6120057|P6|COMPLETED|Period 1||3
2497378|NCT00828061|6120058|P5|COMPLETED|Period 1||3
2497379|NCT00828061|6120059|P4|COMPLETED|Period 1||3
2497380|NCT00828061|6120060|P3|COMPLETED|Period 1||3
2497381|NCT00828061|6120061|P2|COMPLETED|Period 1||3
2497382|NCT00828061|6120062|P1|COMPLETED|Period 1||4
2497383|NCT00828061|6120057|P6|STARTED|Period 1||3
2497384|NCT00828061|6120058|P5|STARTED|Period 1||3
2497385|NCT00828061|6120059|P4|STARTED|Period 1||3
2497386|NCT00828061|6120060|P3|STARTED|Period 1||3
2497387|NCT00828061|6120061|P2|STARTED|Period 1||3
2497388|NCT00828061|6120062|P1|STARTED|Period 1||4
2497389|NCT00828009|6120073|P1|NOT COMPLETED|Step 2 - Maintenance Therapy||33
2497390|NCT00828009|6120073|P1|COMPLETED|Step 2 - Maintenance Therapy|Max maintenance therapy was 34 cycles. No patients were off treatment due to completion of 34 cycles|0
2497391|NCT00828009|6120073|P1|STARTED|Step 2 - Maintenance Therapy|Among 39 pts with tx completion, 4 did not register to step 2 and 2 had PD at the end of step 1.|33
2497392|NCT00828009|6120073|P1|NOT COMPLETED|Step 1 - Chemo RT/Consolidation Chemo||31
2497393|NCT00828009|6120073|P1|COMPLETED|Step 1 - Chemo RT/Consolidation Chemo||39
2497394|NCT00828009|6120073|P1|STARTED|Step 1 - Chemo RT/Consolidation Chemo||70
2497395|NCT00827983|6120082|P2|NOT COMPLETED|Overall Study||16
2497396|NCT00827983|6120083|P1|NOT COMPLETED|Overall Study||18
2497397|NCT00827983|6120082|P2|COMPLETED|Overall Study|patients who performed the pregnancy test|328
2497398|NCT00827983|6120083|P1|COMPLETED|Overall Study|patients who performed the pregnancy test|321
2497399|NCT00827983|6120082|P2|STARTED|Overall Study|all randomised patients|344
2497400|NCT00827983|6120083|P1|STARTED|Overall Study|All randomised patients|339
2497401|NCT00827944|6120095|P2|NOT COMPLETED|Overall Study||59
2497402|NCT00827944|6120096|P1|NOT COMPLETED|Overall Study||63
2497403|NCT00827944|6120095|P2|COMPLETED|Overall Study||240
2497404|NCT00827944|6120096|P1|COMPLETED|Overall Study||241
2497405|NCT00827944|6120095|P2|STARTED|Overall Study||299
2497406|NCT00827944|6120096|P1|STARTED|Overall Study||304
2497407|NCT00827931|6120116|P2|NOT COMPLETED|Overall Study||6
2497408|NCT00827931|6120117|P1|NOT COMPLETED|Overall Study||6
2497409|NCT00827931|6120116|P2|COMPLETED|Overall Study||39
2497410|NCT00827931|6120117|P1|COMPLETED|Overall Study||43
2497411|NCT00827931|6120116|P2|STARTED|Overall Study||45
2497412|NCT00827931|6120117|P1|STARTED|Overall Study||49
2497413|NCT00827918|6120138|P3|NOT COMPLETED|Overall Study||21
2497414|NCT00827918|6120139|P2|NOT COMPLETED|Overall Study||9
2497415|NCT00827918|6120140|P1|NOT COMPLETED|Overall Study||28
2497416|NCT00827918|6120138|P3|COMPLETED|Overall Study||62
2497417|NCT00827918|6120139|P2|COMPLETED|Overall Study||38
2497418|NCT00827918|6120140|P1|COMPLETED|Overall Study||58
2497419|NCT00827918|6120138|P3|STARTED|Overall Study||83
2497420|NCT00827918|6120139|P2|STARTED|Overall Study||47
2497421|NCT00827918|6120140|P1|STARTED|Overall Study||86
2497422|NCT00827827|6120168|P2|NOT COMPLETED|Overall Study||0
2497423|NCT00827827|6120169|P1|NOT COMPLETED|Overall Study||8
2497424|NCT00827827|6120168|P2|COMPLETED|Overall Study||16
2497425|NCT00827827|6120169|P1|COMPLETED|Overall Study||14
2497426|NCT00827827|6120168|P2|STARTED|Overall Study||16
2497427|NCT00827827|6120169|P1|STARTED|Overall Study||22
2497428|NCT00827632|6120213|P2|NOT COMPLETED|Overall Study||23
2497429|NCT00827632|6120214|P1|NOT COMPLETED|Overall Study||22
2497430|NCT00827632|6120213|P2|COMPLETED|Overall Study||75
2497431|NCT00827632|6120214|P1|COMPLETED|Overall Study||106
2497432|NCT00827632|6120213|P2|STARTED|Overall Study||98
2497433|NCT00827632|6120214|P1|STARTED|Overall Study||128
2497434|NCT00827606|6120226|P2|NOT COMPLETED|Overall Study||38
2497435|NCT00827606|6120227|P1|NOT COMPLETED|Overall Study||27
2497436|NCT00827606|6120226|P2|COMPLETED|Overall Study||94
2497437|NCT00827606|6120227|P1|COMPLETED|Overall Study||112
2497438|NCT00827606|6120226|P2|STARTED|Overall Study||132
2497439|NCT00827606|6120227|P1|STARTED|Overall Study||139
2497440|NCT00827567|6120288|P1|NOT COMPLETED|Overall Study||4
2497441|NCT00827567|6120288|P1|COMPLETED|Overall Study|2 screen failures, 4 withdrew from study to go on to other therapies|0
2497442|NCT00827567|6120288|P1|STARTED|Overall Study||4
2497443|NCT00827541|6120294|P2|NOT COMPLETED|Overall Study||11
2497444|NCT00827541|6120295|P1|NOT COMPLETED|Overall Study||4
2497445|NCT00827541|6120294|P2|COMPLETED|Overall Study||85
2497446|NCT00827541|6120295|P1|COMPLETED|Overall Study||15
2497447|NCT00827541|6120294|P2|STARTED|Overall Study||96
2497448|NCT00827541|6120295|P1|STARTED|Overall Study||19
2497449|NCT00827502|6120307|P1|NOT COMPLETED|Overall Study||21
2497450|NCT00827502|6120307|P1|COMPLETED|Overall Study||400
2497451|NCT00827502|6120307|P1|Received Treatment (Number Treated)|Overall Study||410
2497452|NCT00827502|6120307|P1|STARTED|Overall Study||421
2497453|NCT00827372|6120313|P1|NOT COMPLETED|Overall Study||8
2497454|NCT00827372|6120313|P1|COMPLETED|Overall Study||2
2497455|NCT00827372|6120313|P1|STARTED|Overall Study||10
2497456|NCT00827255|6120321|P1|NOT COMPLETED|Overall Study||0
2497457|NCT00827255|6120321|P1|COMPLETED|Overall Study||35
2497458|NCT00827255|6120321|P1|STARTED|Overall Study||35
2497459|NCT00827242|6120328|P2|NOT COMPLETED|Overall Study||12
2497460|NCT00827242|6120329|P1|NOT COMPLETED|Overall Study||13
2497461|NCT00827242|6120328|P2|COMPLETED|Overall Study||152
2497462|NCT00827242|6120329|P1|COMPLETED|Overall Study||148
2497463|NCT00827242|6120328|P2|STARTED|Overall Study||164
2497464|NCT00827242|6120329|P1|STARTED|Overall Study||161
2497465|NCT00827112|6120367|P2|NOT COMPLETED|Overall Study||12
2497466|NCT00827112|6120368|P1|NOT COMPLETED|Overall Study||15
2497467|NCT00827112|6120367|P2|COMPLETED|Overall Study||52
2497468|NCT00827112|6120368|P1|COMPLETED|Overall Study||50
2497469|NCT00827112|6120367|P2|Treated|Overall Study||61
2497470|NCT00827112|6120368|P1|Treated|Overall Study||60
2497471|NCT00827112|6120367|P2|STARTED|Overall Study||64
2497472|NCT00827112|6120368|P1|STARTED|Overall Study||65
2497473|NCT00827099|6120401|P1|NOT COMPLETED|Overall Study||0
2497474|NCT00827099|6120401|P1|COMPLETED|Overall Study||5
2497475|NCT00827099|6120401|P1|STARTED|Overall Study||5
2497476|NCT00827073|6120412|P2|NOT COMPLETED|Overall Study||0
2497477|NCT00827073|6120413|P1|NOT COMPLETED|Overall Study||0
2497478|NCT00827073|6120412|P2|COMPLETED|Overall Study||20
2497479|NCT00827073|6120413|P1|COMPLETED|Overall Study||20
2497480|NCT00827073|6120412|P2|STARTED|Overall Study||20
2497481|NCT00827073|6120413|P1|STARTED|Overall Study||20
2497482|NCT00826943|6120421|P6|NOT COMPLETED|Overall Study||0
2497483|NCT00826943|6120422|P5|NOT COMPLETED|Overall Study||1
2497484|NCT00826943|6120423|P4|NOT COMPLETED|Overall Study||0
2497485|NCT00826943|6120424|P3|NOT COMPLETED|Overall Study||0
2497486|NCT00826943|6120425|P2|NOT COMPLETED|Overall Study||0
2497487|NCT00826943|6120426|P1|NOT COMPLETED|Overall Study||0
2497488|NCT00826943|6120421|P6|COMPLETED|Overall Study||2
2497489|NCT00826943|6120422|P5|COMPLETED|Overall Study||6
2497490|NCT00826943|6120423|P4|COMPLETED|Overall Study||5
2497491|NCT00826943|6120424|P3|COMPLETED|Overall Study||4
2497492|NCT00826943|6120425|P2|COMPLETED|Overall Study||6
2497493|NCT00826943|6120426|P1|COMPLETED|Overall Study||6
2497494|NCT00826943|6120421|P6|STARTED|Overall Study||2
2497495|NCT00826943|6120422|P5|STARTED|Overall Study||7
2497496|NCT00826943|6120423|P4|STARTED|Overall Study||5
2497497|NCT00826943|6120424|P3|STARTED|Overall Study||4
2497498|NCT00826943|6120425|P2|STARTED|Overall Study||6
2497499|NCT00826943|6120426|P1|STARTED|Overall Study||6
2497500|NCT00826800|6120440|P1|NOT COMPLETED|Overall Study||0
2497501|NCT00826800|6120440|P1|COMPLETED|Overall Study||2
2497502|NCT00826800|6120440|P1|STARTED|Overall Study||2
2497503|NCT00826748|6120447|P3|NOT COMPLETED|Overall Study||4
2497504|NCT00826748|6120448|P2|NOT COMPLETED|Overall Study||0
2497505|NCT00826748|6120449|P1|NOT COMPLETED|Overall Study||0
2497506|NCT00826748|6120447|P3|COMPLETED|Overall Study||8
2497507|NCT00826748|6120448|P2|COMPLETED|Overall Study||4
2497508|NCT00826748|6120449|P1|COMPLETED|Overall Study||6
2497509|NCT00826748|6120447|P3|STARTED|Overall Study||12
2497510|NCT00826748|6120448|P2|STARTED|Overall Study||4
2497511|NCT00826748|6120449|P1|STARTED|Overall Study||6
2497512|NCT00826618|6120457|P1|NOT COMPLETED|Overall Study||1
2497513|NCT00826618|6120457|P1|COMPLETED|Overall Study||5
2497514|NCT00826618|6120457|P1|STARTED|Overall Study||6
2497515|NCT00826540|6120461|P1|NOT COMPLETED|Overall Study||4
2497516|NCT00826540|6120461|P1|COMPLETED|Overall Study||79
2497517|NCT00826540|6120461|P1|STARTED|Overall Study||83
2497518|NCT00826449|6120467|P1|NOT COMPLETED|Overall Study||5
2497519|NCT00826449|6120467|P1|COMPLETED|Overall Study||42
2497520|NCT00826449|6120467|P1|Phase II|Overall Study||35
2497521|NCT00826449|6120467|P1|Phase I|Overall Study||12
2497522|NCT00826449|6120467|P1|STARTED|Overall Study||47
2497523|NCT00826280|6120476|P3|NOT COMPLETED|Overall Study||46
2497524|NCT00826280|6120477|P2|NOT COMPLETED|Overall Study||46
2497525|NCT00826280|6120478|P1|NOT COMPLETED|Overall Study||48
2497526|NCT00826280|6120476|P3|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|71
2497527|NCT00826280|6120477|P2|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|70
2497528|NCT00826280|6120478|P1|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|66
2497529|NCT00826280|6120476|P3|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|72
2497530|NCT00826280|6120477|P2|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|71
2497531|NCT00826280|6120478|P1|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|66
2497532|NCT00826280|6120476|P3|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
2497533|NCT00826280|6120477|P2|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
2497534|NCT00826280|6120478|P1|Safety Analysis Set|Overall Study|Safety Analysis Set (SAF) was all randomized subjects who received at least one dose of regadenoson|113
2497535|NCT00826280|6120476|P3|STARTED|Overall Study||117
2497536|NCT00826280|6120477|P2|STARTED|Overall Study||116
2497537|NCT00826280|6120478|P1|STARTED|Overall Study||114
2497538|NCT00826267|6120507|P3|NOT COMPLETED|Overall Study||0
2497539|NCT00826267|6120508|P2|NOT COMPLETED|Overall Study||0
2497540|NCT00826267|6120509|P1|NOT COMPLETED|Overall Study||1
2497541|NCT00826267|6120507|P3|COMPLETED|Overall Study||11
2497542|NCT00826267|6120508|P2|COMPLETED|Overall Study||8
2497543|NCT00826267|6120509|P1|COMPLETED|Overall Study||9
2497544|NCT00826267|6120507|P3|STARTED|Overall Study||11
2497545|NCT00826267|6120508|P2|STARTED|Overall Study||8
2497546|NCT00826267|6120509|P1|STARTED|Overall Study||10
2497547|NCT00826241|6120527|P1|NOT COMPLETED|Overall Study||27
2497548|NCT00826241|6120527|P1|COMPLETED|Overall Study||31
2497549|NCT00826241|6120527|P1|STARTED|Overall Study||58
2497550|NCT00826228|6120533|P1|NOT COMPLETED|Overall Study||1
2497551|NCT00826228|6120533|P1|COMPLETED|Overall Study||11
2497552|NCT00826228|6120533|P1|STARTED|Overall Study||12
2497553|NCT00826202|6120540|P2|NOT COMPLETED|Overall Study||13
2497554|NCT00826202|6120541|P1|NOT COMPLETED|Overall Study||10
2497555|NCT00826202|6120540|P2|COMPLETED|Overall Study||11
2497556|NCT00826202|6120541|P1|COMPLETED|Overall Study||10
2497557|NCT00826202|6120540|P2|Completed Visit 4 (1st Efficacy Visit)|Overall Study||20
2497558|NCT00826202|6120541|P1|Completed Visit 4 (1st Efficacy Visit)|Overall Study||15
2497559|NCT00826202|6120540|P2|STARTED|Overall Study||24
2497560|NCT00826202|6120541|P1|STARTED|Overall Study||20
2497561|NCT00826176|6120555|P2|NOT COMPLETED|Overall Study||0
2497562|NCT00826176|6120556|P1|NOT COMPLETED|Overall Study||13
2497563|NCT00826176|6120555|P2|COMPLETED|Overall Study|treated and completed|36
2497564|NCT00826176|6120556|P1|COMPLETED|Overall Study|treated and completed|115
2497565|NCT00826176|6120555|P2|STARTED|Overall Study|enrolled|36
2497566|NCT00826176|6120556|P1|STARTED|Overall Study|enrolled|128
2497567|NCT00826150|6120569|P3|NOT COMPLETED|Overall Study||3
2497568|NCT00826150|6120570|P2|NOT COMPLETED|Overall Study||2
2497569|NCT00826150|6120571|P1|NOT COMPLETED|Overall Study||6
2497570|NCT00826150|6120569|P3|COMPLETED|Overall Study||0
2497571|NCT00826150|6120570|P2|COMPLETED|Overall Study||1
2497572|NCT00826150|6120571|P1|COMPLETED|Overall Study||2
2497573|NCT00826150|6120569|P3|STARTED|Overall Study||3
2497574|NCT00826150|6120570|P2|STARTED|Overall Study||3
2497575|NCT00826150|6120571|P1|STARTED|Overall Study||8
2497576|NCT00826111|6120605|P2|NOT COMPLETED|Overall Study||2
2497577|NCT00826111|6120606|P1|NOT COMPLETED|Overall Study||7
2497578|NCT00826111|6120605|P2|COMPLETED|Overall Study||3
2497579|NCT00826111|6120606|P1|COMPLETED|Overall Study||7
2497580|NCT00826111|6120605|P2|STARTED|Overall Study||5
2497581|NCT00826111|6120606|P1|STARTED|Overall Study||14
2497582|NCT00826020|6120628|P1|NOT COMPLETED|Overall Study||0
2497583|NCT00826020|6120628|P1|COMPLETED|Overall Study||72
2497584|NCT00826020|6120628|P1|STARTED|Overall Study||72
2497585|NCT00826007|6120635|P2|NOT COMPLETED|Overall Study||0
2497586|NCT00826007|6120636|P1|NOT COMPLETED|Overall Study||0
2497587|NCT00826007|6120635|P2|COMPLETED|Overall Study||279
2497588|NCT00826007|6120636|P1|COMPLETED|Overall Study|Retrospective review|308
2497589|NCT00826007|6120635|P2|STARTED|Overall Study||279
2497590|NCT00826007|6120636|P1|STARTED|Overall Study|Retrospective review|308
2497591|NCT00825994|6120641|P1|NOT COMPLETED|Overall Study||5
2497592|NCT00825994|6120641|P1|COMPLETED|Overall Study||19
2497593|NCT00825994|6120641|P1|STARTED|Overall Study||24
2497594|NCT00825916|6120649|P3|NOT COMPLETED|Overall Study||1
2497595|NCT00825916|6120650|P2|NOT COMPLETED|Overall Study||2
2497596|NCT00825916|6120651|P1|NOT COMPLETED|Overall Study||4
2497597|NCT00825916|6120649|P3|COMPLETED|Overall Study||19
2497598|NCT00825916|6120650|P2|COMPLETED|Overall Study||18
2497599|NCT00825916|6120651|P1|COMPLETED|Overall Study||15
2497600|NCT00825916|6120649|P3|STARTED|Overall Study||20
2497601|NCT00825916|6120650|P2|STARTED|Overall Study||20
2497602|NCT00825916|6120651|P1|STARTED|Overall Study||19
2497603|NCT00825825|6120692|P6|NOT COMPLETED|Third Medication Period (14 Days)||2
2497604|NCT00825825|6120693|P5|NOT COMPLETED|Third Medication Period (14 Days)||0
2497605|NCT00825825|6120694|P4|NOT COMPLETED|Third Medication Period (14 Days)||0
2497606|NCT00825825|6120695|P3|NOT COMPLETED|Third Medication Period (14 Days)||0
2497607|NCT00825825|6120696|P2|NOT COMPLETED|Third Medication Period (14 Days)||2
2497608|NCT00825825|6120697|P1|NOT COMPLETED|Third Medication Period (14 Days)||0
2497609|NCT00825825|6120692|P6|COMPLETED|Third Medication Period (14 Days)||1
2497610|NCT00825825|6120693|P5|COMPLETED|Third Medication Period (14 Days)||3
2497611|NCT00825825|6120694|P4|COMPLETED|Third Medication Period (14 Days)||3
2497612|NCT00825825|6120695|P3|COMPLETED|Third Medication Period (14 Days)||2
2497613|NCT00825825|6120696|P2|COMPLETED|Third Medication Period (14 Days)||2
2497614|NCT00825825|6120697|P1|COMPLETED|Third Medication Period (14 Days)||1
2497615|NCT00825825|6120692|P6|STARTED|Third Medication Period (14 Days)||3
2497616|NCT00825825|6120693|P5|STARTED|Third Medication Period (14 Days)||3
2497617|NCT00825825|6120694|P4|STARTED|Third Medication Period (14 Days)||3
2497618|NCT00825825|6120695|P3|STARTED|Third Medication Period (14 Days)||2
2497619|NCT00825825|6120696|P2|STARTED|Third Medication Period (14 Days)||4
2497620|NCT00825825|6120697|P1|STARTED|Third Medication Period (14 Days)||1
2497621|NCT00825825|6120692|P6|NOT COMPLETED|Second Washout Period (14 Days)||0
2497622|NCT00825825|6120693|P5|NOT COMPLETED|Second Washout Period (14 Days)||0
2497623|NCT00825825|6120694|P4|NOT COMPLETED|Second Washout Period (14 Days)||0
2497624|NCT00825825|6120695|P3|NOT COMPLETED|Second Washout Period (14 Days)||0
2497625|NCT00825825|6120696|P2|NOT COMPLETED|Second Washout Period (14 Days)||0
2497626|NCT00825825|6120697|P1|NOT COMPLETED|Second Washout Period (14 Days)||0
2497627|NCT00825825|6120692|P6|COMPLETED|Second Washout Period (14 Days)||3
2497628|NCT00825825|6120693|P5|COMPLETED|Second Washout Period (14 Days)||3
2497629|NCT00825825|6120694|P4|COMPLETED|Second Washout Period (14 Days)||3
2497630|NCT00825825|6120695|P3|COMPLETED|Second Washout Period (14 Days)||2
2497631|NCT00825825|6120696|P2|COMPLETED|Second Washout Period (14 Days)||4
2497632|NCT00825825|6120697|P1|COMPLETED|Second Washout Period (14 Days)||1
2497633|NCT00825825|6120692|P6|STARTED|Second Washout Period (14 Days)||3
2497634|NCT00825825|6120693|P5|STARTED|Second Washout Period (14 Days)||3
2497635|NCT00825825|6120694|P4|STARTED|Second Washout Period (14 Days)||3
2497636|NCT00825825|6120695|P3|STARTED|Second Washout Period (14 Days)||2
2497637|NCT00825825|6120696|P2|STARTED|Second Washout Period (14 Days)||4
2497638|NCT00825825|6120697|P1|STARTED|Second Washout Period (14 Days)||1
2497639|NCT00825825|6120692|P6|NOT COMPLETED|Second Medication Period (14 Days)||0
2497640|NCT00825825|6120693|P5|NOT COMPLETED|Second Medication Period (14 Days)||1
2497641|NCT00825825|6120694|P4|NOT COMPLETED|Second Medication Period (14 Days)||2
2497642|NCT00825825|6120695|P3|NOT COMPLETED|Second Medication Period (14 Days)||0
2497643|NCT00825825|6120696|P2|NOT COMPLETED|Second Medication Period (14 Days)||0
2497644|NCT00825825|6120697|P1|NOT COMPLETED|Second Medication Period (14 Days)||2
2497645|NCT00825825|6120692|P6|COMPLETED|Second Medication Period (14 Days)||3
2497646|NCT00825825|6120693|P5|COMPLETED|Second Medication Period (14 Days)||3
2497647|NCT00825825|6120694|P4|COMPLETED|Second Medication Period (14 Days)||3
2497648|NCT00825825|6120695|P3|COMPLETED|Second Medication Period (14 Days)||2
2497649|NCT00825825|6120696|P2|COMPLETED|Second Medication Period (14 Days)||4
2497650|NCT00825825|6120697|P1|COMPLETED|Second Medication Period (14 Days)||1
2497651|NCT00825825|6120692|P6|STARTED|Second Medication Period (14 Days)||3
2497652|NCT00825825|6120693|P5|STARTED|Second Medication Period (14 Days)||4
2497653|NCT00825825|6120694|P4|STARTED|Second Medication Period (14 Days)||5
2497654|NCT00825825|6120695|P3|STARTED|Second Medication Period (14 Days)||2
2497655|NCT00825825|6120696|P2|STARTED|Second Medication Period (14 Days)||4
2497656|NCT00825825|6120697|P1|STARTED|Second Medication Period (14 Days)||3
2497657|NCT00825825|6120692|P6|NOT COMPLETED|First Washout Period (14 Days)||0
2497658|NCT00825825|6120693|P5|NOT COMPLETED|First Washout Period (14 Days)||0
2497659|NCT00825825|6120694|P4|NOT COMPLETED|First Washout Period (14 Days)||0
2497660|NCT00825825|6120695|P3|NOT COMPLETED|First Washout Period (14 Days)||0
2497661|NCT00825825|6120696|P2|NOT COMPLETED|First Washout Period (14 Days)||0
2497662|NCT00825825|6120697|P1|NOT COMPLETED|First Washout Period (14 Days)||0
2497663|NCT00825825|6120692|P6|COMPLETED|First Washout Period (14 Days)||3
2497664|NCT00825825|6120693|P5|COMPLETED|First Washout Period (14 Days)||4
2497665|NCT00825825|6120694|P4|COMPLETED|First Washout Period (14 Days)||5
2497666|NCT00825825|6120695|P3|COMPLETED|First Washout Period (14 Days)||2
2497667|NCT00825825|6120696|P2|COMPLETED|First Washout Period (14 Days)||4
2497668|NCT00825825|6120697|P1|COMPLETED|First Washout Period (14 Days)||3
2497669|NCT00825825|6120692|P6|STARTED|First Washout Period (14 Days)||3
2497670|NCT00825825|6120693|P5|STARTED|First Washout Period (14 Days)||4
2497671|NCT00825825|6120694|P4|STARTED|First Washout Period (14 Days)||5
2497672|NCT00825825|6120695|P3|STARTED|First Washout Period (14 Days)||2
2497673|NCT00825825|6120696|P2|STARTED|First Washout Period (14 Days)||4
2497674|NCT00825825|6120697|P1|STARTED|First Washout Period (14 Days)||3
2497675|NCT00825825|6120692|P6|NOT COMPLETED|First Medication Period (14 Days)||2
2497676|NCT00825825|6120693|P5|NOT COMPLETED|First Medication Period (14 Days)||0
2497677|NCT00825825|6120694|P4|NOT COMPLETED|First Medication Period (14 Days)||0
2497678|NCT00825825|6120695|P3|NOT COMPLETED|First Medication Period (14 Days)||1
2497679|NCT00825825|6120696|P2|NOT COMPLETED|First Medication Period (14 Days)||0
2497680|NCT00825825|6120697|P1|NOT COMPLETED|First Medication Period (14 Days)||3
2497681|NCT00825825|6120692|P6|COMPLETED|First Medication Period (14 Days)||3
2497682|NCT00825825|6120693|P5|COMPLETED|First Medication Period (14 Days)||4
2497683|NCT00825825|6120694|P4|COMPLETED|First Medication Period (14 Days)||5
2497684|NCT00825825|6120695|P3|COMPLETED|First Medication Period (14 Days)||2
2497685|NCT00825825|6120696|P2|COMPLETED|First Medication Period (14 Days)||4
2497686|NCT00825825|6120697|P1|COMPLETED|First Medication Period (14 Days)||3
2497687|NCT00825825|6120692|P6|STARTED|First Medication Period (14 Days)||5
2497688|NCT00825825|6120693|P5|STARTED|First Medication Period (14 Days)||4
2497689|NCT00825825|6120694|P4|STARTED|First Medication Period (14 Days)||5
2497690|NCT00825825|6120695|P3|STARTED|First Medication Period (14 Days)||3
2497691|NCT00825825|6120696|P2|STARTED|First Medication Period (14 Days)||4
2497692|NCT00825825|6120697|P1|STARTED|First Medication Period (14 Days)||6
2497693|NCT00825812|6120713|P4|NOT COMPLETED|Overall Study||10
2497694|NCT00825812|6120714|P3|NOT COMPLETED|Overall Study||6
2497695|NCT00825812|6120715|P2|NOT COMPLETED|Overall Study||1
2497696|NCT00825812|6120716|P1|NOT COMPLETED|Overall Study||0
2497697|NCT00825812|6120713|P4|COMPLETED|Overall Study||111
2497698|NCT00825812|6120714|P3|COMPLETED|Overall Study||120
2497699|NCT00825812|6120715|P2|COMPLETED|Overall Study||31
2497700|NCT00825812|6120716|P1|COMPLETED|Overall Study||29
2497701|NCT00825812|6120713|P4|TREATED|Overall Study||111
2497702|NCT00825812|6120714|P3|TREATED|Overall Study||120
2497703|NCT00825812|6120715|P2|TREATED|Overall Study||31
2497704|NCT00825812|6120716|P1|TREATED|Overall Study||29
2497705|NCT00825812|6120713|P4|STARTED|Overall Study||121
2497706|NCT00825812|6120714|P3|STARTED|Overall Study||126
2497707|NCT00825812|6120715|P2|STARTED|Overall Study||32
2497708|NCT00825812|6120716|P1|STARTED|Overall Study||29
2497709|NCT00825786|6120732|P2|NOT COMPLETED|Overall Study||0
2497710|NCT00825786|6120733|P1|NOT COMPLETED|Overall Study||0
2497711|NCT00825786|6120732|P2|COMPLETED|Overall Study||51
2497712|NCT00825786|6120733|P1|COMPLETED|Overall Study||52
2497713|NCT00825786|6120732|P2|STARTED|Overall Study||51
2497714|NCT00825786|6120733|P1|STARTED|Overall Study||52
2497715|NCT00825734|6120751|P3|NOT COMPLETED|Phase II||76
2497716|NCT00825734|6120752|P2|NOT COMPLETED|Phase II||0
2497717|NCT00825734|6120753|P1|NOT COMPLETED|Phase II||0
2497718|NCT00825734|6120751|P3|COMPLETED|Phase II||0
2497719|NCT00825734|6120752|P2|COMPLETED|Phase II||0
2497720|NCT00825734|6120753|P1|COMPLETED|Phase II||0
2497721|NCT00825734|6120751|P3|STARTED|Phase II|Includes patients treated at MTD during Phase I and 73 additional patients enrolled for Phase II|76
2497722|NCT00825734|6120752|P2|STARTED|Phase II||0
2497723|NCT00825734|6120753|P1|STARTED|Phase II||0
2497724|NCT00825734|6120751|P3|NOT COMPLETED|Phase I||0
2497725|NCT00825734|6120752|P2|NOT COMPLETED|Phase I||3
2497726|NCT00825734|6120753|P1|NOT COMPLETED|Phase I||4
2497727|NCT00825734|6120751|P3|COMPLETED|Phase I||3
2497728|NCT00825734|6120752|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
2497729|NCT00825734|6120753|P1|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
2497730|NCT00825734|6120751|P3|STARTED|Phase I||3
2497731|NCT00825734|6120752|P2|STARTED|Phase I||3
2497732|NCT00825734|6120753|P1|STARTED|Phase I||4
2497733|NCT00825682|6120763|P2|NOT COMPLETED|Overall Study||5
2497734|NCT00825682|6120764|P1|NOT COMPLETED|Overall Study||13
2497735|NCT00825682|6120763|P2|COMPLETED|Overall Study||20
2497736|NCT00825682|6120764|P1|COMPLETED|Overall Study||34
2497737|NCT00825682|6120763|P2|STARTED|Overall Study||25
2497738|NCT00825682|6120764|P1|STARTED|Overall Study||47
2497739|NCT00825630|6120778|P4|NOT COMPLETED|Overall Study||0
2497740|NCT00825630|6120779|P3|NOT COMPLETED|Overall Study||0
2497741|NCT00825630|6120780|P2|NOT COMPLETED|Overall Study||0
2497742|NCT00825630|6120781|P1|NOT COMPLETED|Overall Study||0
2497743|NCT00825630|6120778|P4|COMPLETED|Overall Study||13
2497744|NCT00825630|6120779|P3|COMPLETED|Overall Study||19
2497745|NCT00825630|6120780|P2|COMPLETED|Overall Study||62
2497746|NCT00825630|6120781|P1|COMPLETED|Overall Study||29
2497747|NCT00825630|6120778|P4|STARTED|Overall Study||13
2497748|NCT00825630|6120779|P3|STARTED|Overall Study||19
2497749|NCT00825630|6120780|P2|STARTED|Overall Study||62
2497750|NCT00825630|6120781|P1|STARTED|Overall Study||29
2497751|NCT00825565|6120791|P1|NOT COMPLETED|Overall Study||0
2497752|NCT00825565|6120791|P1|COMPLETED|Overall Study||8
2497753|NCT00825565|6120791|P1|STARTED|Overall Study||8
2497754|NCT00825500|6120804|P3|NOT COMPLETED|Overall Study||0
2497755|NCT00825500|6120805|P2|NOT COMPLETED|Overall Study||0
2497756|NCT00825500|6120806|P1|NOT COMPLETED|Overall Study||0
2497757|NCT00825500|6120804|P3|COMPLETED|Overall Study||120
2497758|NCT00825500|6120805|P2|COMPLETED|Overall Study||121
2497759|NCT00825500|6120806|P1|COMPLETED|Overall Study||125
2497760|NCT00825500|6120804|P3|STARTED|Overall Study||120
2497761|NCT00825500|6120805|P2|STARTED|Overall Study||121
2497762|NCT00825500|6120806|P1|STARTED|Overall Study||125
2497763|NCT00825370|6120819|P2|NOT COMPLETED|Overall Study||0
2497764|NCT00825370|6120820|P1|NOT COMPLETED|Overall Study||0
2497765|NCT00825370|6120819|P2|COMPLETED|Overall Study||175
2497766|NCT00825370|6120820|P1|COMPLETED|Overall Study||175
2497767|NCT00825370|6120819|P2|STARTED|Overall Study||175
2497768|NCT00825370|6120820|P1|STARTED|Overall Study||175
2497769|NCT00825344|6120834|P2|NOT COMPLETED|Overall Study||1
2497770|NCT00825344|6120835|P1|NOT COMPLETED|Overall Study||1
2497771|NCT00825344|6120834|P2|COMPLETED|Overall Study||42
2497772|NCT00825344|6120835|P1|COMPLETED|Overall Study||33
2497773|NCT00825344|6120834|P2|STARTED|Overall Study||43
2497774|NCT00825344|6120835|P1|STARTED|Overall Study||34
2497775|NCT00825318|6120845|P1|NOT COMPLETED|Overall Study||1
2497776|NCT00825318|6120845|P1|COMPLETED|Overall Study||12
2497777|NCT00825318|6120845|P1|STARTED|Overall Study||13
2497778|NCT00825305|6120855|P2|NOT COMPLETED|Overall Study||23
2497779|NCT00825305|6120856|P1|NOT COMPLETED|Overall Study||17
2497780|NCT00825305|6120855|P2|COMPLETED|Overall Study||252
2497781|NCT00825305|6120856|P1|COMPLETED|Overall Study||533
2497782|NCT00825305|6120855|P2|STARTED|Overall Study||275
2497783|NCT00825305|6120856|P1|STARTED|Overall Study||550
2497784|NCT00825266|6120870|P2|NOT COMPLETED|Overall Study||0
2497785|NCT00825266|6120871|P1|NOT COMPLETED|Overall Study||0
2497786|NCT00825266|6120870|P2|COMPLETED|Overall Study||1
2497787|NCT00825266|6120871|P1|COMPLETED|Overall Study||1
2497788|NCT00825266|6120870|P2|STARTED|Overall Study||1
2497789|NCT00825266|6120871|P1|STARTED|Overall Study||1
2497790|NCT00825227|6120883|P2|NOT COMPLETED|Overall Study||0
2497791|NCT00825227|6120884|P1|NOT COMPLETED|Overall Study||0
2497792|NCT00825227|6120883|P2|COMPLETED|Overall Study||4
2497793|NCT00825227|6120884|P1|COMPLETED|Overall Study||6
2497794|NCT00825227|6120883|P2|STARTED|Overall Study||4
2497795|NCT00825227|6120884|P1|STARTED|Overall Study||6
2497796|NCT00825175|6120896|P2|NOT COMPLETED|Overall Study||5
2497797|NCT00825175|6120897|P1|NOT COMPLETED|Overall Study||0
2497798|NCT00825175|6120896|P2|COMPLETED|Overall Study||7
2497799|NCT00825175|6120897|P1|COMPLETED|Overall Study||10
2497800|NCT00825175|6120896|P2|STARTED|Overall Study||12
2497801|NCT00825175|6120897|P1|STARTED|Overall Study||10
2497802|NCT00825162|6120906|P3|NOT COMPLETED|Overall Study||6
2497803|NCT00825162|6120907|P2|NOT COMPLETED|Overall Study||21
2497804|NCT00825162|6120908|P1|NOT COMPLETED|Overall Study||28
2497805|NCT00825162|6120906|P3|COMPLETED|Overall Study||396
2497806|NCT00825162|6120907|P2|COMPLETED|Overall Study||859
2497807|NCT00825162|6120908|P1|COMPLETED|Overall Study||682
2497808|NCT00825162|6120906|P3|STARTED|Overall Study||402
2497809|NCT00825162|6120907|P2|STARTED|Overall Study||880
2497810|NCT00825162|6120908|P1|STARTED|Overall Study||710
2497811|NCT00824993|6120934|P2|NOT COMPLETED|Overall Study||17
2497812|NCT00824993|6120935|P1|NOT COMPLETED|Overall Study||14
2497813|NCT00824993|6120934|P2|COMPLETED|Overall Study||22
2497814|NCT00824993|6120935|P1|COMPLETED|Overall Study||25
2497815|NCT00824993|6120934|P2|6 Month Follow up|Overall Study||27
2497816|NCT00824993|6120935|P1|6 Month Follow up|Overall Study||33
2497817|NCT00824993|6120934|P2|STARTED|Overall Study||39
2497818|NCT00824993|6120935|P1|STARTED|Overall Study||39
2497819|NCT00824850|6120943|P2|NOT COMPLETED|Overall Study||1
2497820|NCT00824850|6120944|P1|NOT COMPLETED|Overall Study||0
2497821|NCT00824850|6120943|P2|COMPLETED|Overall Study||36
2497822|NCT00824850|6120944|P1|COMPLETED|Overall Study||38
2497823|NCT00824850|6120943|P2|Received Vaccination 13vPnC|Overall Study||36
2497824|NCT00824850|6120944|P1|Received Vaccination 13vPnC|Overall Study||38
2497825|NCT00824850|6120943|P2|STARTED|Overall Study||37
2497826|NCT00824850|6120944|P1|STARTED|Overall Study||38
2497827|NCT00824824|6120990|P2|NOT COMPLETED|Overall Study||0
2497828|NCT00824824|6120991|P1|NOT COMPLETED|Overall Study||0
2497829|NCT00824824|6120990|P2|COMPLETED|Overall Study||3
2497830|NCT00824824|6120991|P1|COMPLETED|Overall Study||4
2497831|NCT00824824|6120990|P2|STARTED|Overall Study||3
2497832|NCT00824824|6120991|P1|STARTED|Overall Study||4
2497833|NCT00824772|6120997|P1|NOT COMPLETED|Overall Study||8
2497834|NCT00824772|6120997|P1|COMPLETED|Overall Study||196
2497835|NCT00824772|6120997|P1|STARTED|Overall Study||204
2497836|NCT00824746|6121002|P1|NOT COMPLETED|Overall Study||0
2497837|NCT00824746|6121002|P1|COMPLETED|Overall Study||23
2497838|NCT00824746|6121002|P1|STARTED|Overall Study||23
2497839|NCT00824733|6121008|P1|NOT COMPLETED|Overall Study||0
2497840|NCT00824733|6121008|P1|COMPLETED|Overall Study||6
2497841|NCT00824733|6121008|P1|STARTED|Overall Study||6
2497842|NCT00824720|6121017|P3|NOT COMPLETED|Overall Study||1
2497843|NCT00824720|6121018|P2|NOT COMPLETED|Overall Study||1
2497844|NCT00824720|6121019|P1|NOT COMPLETED|Overall Study||3
2497845|NCT00824720|6121017|P3|COMPLETED|Overall Study||19
2497846|NCT00824720|6121018|P2|COMPLETED|Overall Study||15
2497847|NCT00824720|6121019|P1|COMPLETED|Overall Study||16
2497848|NCT00824720|6121017|P3|STARTED|Overall Study||20
2497849|NCT00824720|6121018|P2|STARTED|Overall Study|1 subject in the low dose group did not receive device - unable to insert.|16
2497850|NCT00824720|6121019|P1|STARTED|Overall Study|3 subjects in the high dose group did not receive device - unable to insert.|19
2497851|NCT00824655|6121035|P2|NOT COMPLETED|Toddler Dose (12 Months of Age)||0
2497852|NCT00824655|6121036|P1|NOT COMPLETED|Toddler Dose (12 Months of Age)||2
2497853|NCT00824655|6121035|P2|COMPLETED|Toddler Dose (12 Months of Age)||116
2497854|NCT00824655|6121036|P1|COMPLETED|Toddler Dose (12 Months of Age)||116
2497855|NCT00824655|6121035|P2|STARTED|Toddler Dose (12 Months of Age)||116
2497856|NCT00824655|6121036|P1|STARTED|Toddler Dose (12 Months of Age)||118
2497857|NCT00824655|6121035|P2|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
2497858|NCT00824655|6121036|P1|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
2497859|NCT00824655|6121035|P2|COMPLETED|After Infant Dose (6 Months of Age)||0
2497860|NCT00824655|6121036|P1|COMPLETED|After Infant Dose (6 Months of Age)||118
2497861|NCT00824655|6121035|P2|STARTED|After Infant Dose (6 Months of Age)||0
2497862|NCT00824655|6121036|P1|STARTED|After Infant Dose (6 Months of Age)||118
2497863|NCT00824655|6121035|P2|NOT COMPLETED|Infant Series (5 Months of Age)||0
2497864|NCT00824655|6121036|P1|NOT COMPLETED|Infant Series (5 Months of Age)||0
2497865|NCT00824655|6121035|P2|COMPLETED|Infant Series (5 Months of Age)||0
2497866|NCT00824655|6121036|P1|COMPLETED|Infant Series (5 Months of Age)||118
2497867|NCT00824655|6121035|P2|STARTED|Infant Series (5 Months of Age)||0
2497868|NCT00824655|6121036|P1|STARTED|Infant Series (5 Months of Age)||118
2497869|NCT00824616|6121056|P2|NOT COMPLETED|Overall Study||7
2497870|NCT00824616|6121057|P1|NOT COMPLETED|Overall Study||6
2497871|NCT00824616|6121056|P2|COMPLETED|Overall Study||27
2497872|NCT00824616|6121057|P1|COMPLETED|Overall Study||28
2497873|NCT00824616|6121056|P2|STARTED|Overall Study||34
2497874|NCT00824616|6121057|P1|STARTED|Overall Study||34
2497875|NCT00824564|6121067|P2|NOT COMPLETED|Overall Study||10
2497876|NCT00824564|6121068|P1|NOT COMPLETED|Overall Study||8
2497877|NCT00824564|6121067|P2|COMPLETED|Overall Study||30
2497878|NCT00824564|6121068|P1|COMPLETED|Overall Study||34
2497879|NCT00824564|6121067|P2|Treated|Overall Study||40
2497880|NCT00824564|6121068|P1|Treated|Overall Study||41
2497881|NCT00824564|6121067|P2|STARTED|Overall Study||40
2497882|NCT00824564|6121068|P1|STARTED|Overall Study||42
2497883|NCT00824538|6121086|P1|NOT COMPLETED|Overall Study||2
2497884|NCT00824538|6121086|P1|COMPLETED|Overall Study||11
2497885|NCT00824538|6121086|P1|STARTED|Overall Study|13 patients entered the study|13
2497886|NCT00824512|6121096|P2|NOT COMPLETED|Overall Study||0
2497887|NCT00824512|6121097|P1|NOT COMPLETED|Overall Study||0
2497888|NCT00824512|6121096|P2|COMPLETED|Overall Study||11
2497889|NCT00824512|6121097|P1|COMPLETED|Overall Study||11
2497890|NCT00824512|6121096|P2|STARTED|Overall Study||11
2497891|NCT00824512|6121097|P1|STARTED|Overall Study||11
2497892|NCT00824473|6121147|P2|NOT COMPLETED|Overall Study||13
2497893|NCT00824473|6121148|P1|NOT COMPLETED|Overall Study||15
2497894|NCT00824473|6121147|P2|COMPLETED|Overall Study||238
2497895|NCT00824473|6121148|P1|COMPLETED|Overall Study||240
2497896|NCT00824473|6121147|P2|STARTED|Overall Study||251
2497897|NCT00824473|6121148|P1|STARTED|Overall Study|1 subject was randomized in error|255
2497898|NCT00824460|6121170|P6|NOT COMPLETED|Overall Study||8
2497899|NCT00824460|6121171|P5|NOT COMPLETED|Overall Study||9
2497900|NCT00824460|6121172|P4|NOT COMPLETED|Overall Study||12
2497901|NCT00824460|6121173|P3|NOT COMPLETED|Overall Study||5
2497902|NCT00824460|6121174|P2|NOT COMPLETED|Overall Study||9
2497903|NCT00824460|6121175|P1|NOT COMPLETED|Overall Study||8
2497904|NCT00824460|6121170|P6|COMPLETED|Overall Study||18
2497905|NCT00824460|6121171|P5|COMPLETED|Overall Study||15
2497906|NCT00824460|6121172|P4|COMPLETED|Overall Study||15
2497907|NCT00824460|6121173|P3|COMPLETED|Overall Study||20
2497908|NCT00824460|6121174|P2|COMPLETED|Overall Study||17
2497909|NCT00824460|6121175|P1|COMPLETED|Overall Study||18
2497910|NCT00824460|6121170|P6|STARTED|Overall Study||26
2497911|NCT00824460|6121171|P5|STARTED|Overall Study||24
2497912|NCT00824460|6121172|P4|STARTED|Overall Study||27
2497913|NCT00824460|6121173|P3|STARTED|Overall Study||25
2497914|NCT00824460|6121174|P2|STARTED|Overall Study||26
2497915|NCT00824460|6121175|P1|STARTED|Overall Study||26
2497916|NCT00824434|6121207|P1|NOT COMPLETED|Overall Study||0
2497917|NCT00824434|6121207|P1|COMPLETED|Overall Study||100
2497918|NCT00824434|6121207|P1|STARTED|Overall Study||100
2497919|NCT00824421|6121229|P3|NOT COMPLETED|Overall Study||14
2497920|NCT00824421|6121230|P2|NOT COMPLETED|Overall Study||22
2497921|NCT00824421|6121231|P1|NOT COMPLETED|Overall Study||17
2497922|NCT00824421|6121229|P3|COMPLETED|Overall Study||49
2497923|NCT00824421|6121230|P2|COMPLETED|Overall Study||44
2497924|NCT00824421|6121231|P1|COMPLETED|Overall Study||49
2497925|NCT00824421|6121229|P3|Treated|Overall Study||63
2497926|NCT00824421|6121230|P2|Treated|Overall Study||65
2497927|NCT00824421|6121231|P1|Treated|Overall Study||65
2497928|NCT00824421|6121229|P3|STARTED|Overall Study||63
2497929|NCT00824421|6121230|P2|STARTED|Overall Study||66
2497930|NCT00824421|6121231|P1|STARTED|Overall Study||66
2497931|NCT00824408|6121282|P5|NOT COMPLETED|Randomized Phase||46
2497932|NCT00824408|6121283|P4|NOT COMPLETED|Randomized Phase||46
2497933|NCT00824408|6121284|P3|NOT COMPLETED|Randomized Phase||36
2497934|NCT00824408|6121285|P2|NOT COMPLETED|Randomized Phase||0
2497935|NCT00824408|6121286|P1|NOT COMPLETED|Randomized Phase||0
2497936|NCT00824408|6121282|P5|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
2497937|NCT00824408|6121283|P4|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
2497938|NCT00824408|6121284|P3|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
2497939|NCT00824408|6121285|P2|COMPLETED|Randomized Phase||0
2497940|NCT00824408|6121286|P1|COMPLETED|Randomized Phase||0
2497941|NCT00824408|6121282|P5|STARTED|Randomized Phase||47
2497942|NCT00824408|6121283|P4|STARTED|Randomized Phase||47
2497943|NCT00824408|6121284|P3|STARTED|Randomized Phase||37
2497944|NCT00824408|6121285|P2|STARTED|Randomized Phase||0
2497945|NCT00824408|6121286|P1|STARTED|Randomized Phase||0
2497946|NCT00824408|6121282|P5|NOT COMPLETED|Run-in Phase||0
2497947|NCT00824408|6121283|P4|NOT COMPLETED|Run-in Phase||0
2497948|NCT00824408|6121284|P3|NOT COMPLETED|Run-in Phase||0
2497949|NCT00824408|6121285|P2|NOT COMPLETED|Run-in Phase||6
2497950|NCT00824408|6121286|P1|NOT COMPLETED|Run-in Phase||6
2497951|NCT00824408|6121282|P5|COMPLETED|Run-in Phase||0
2497952|NCT00824408|6121283|P4|COMPLETED|Run-in Phase||0
2497953|NCT00824408|6121284|P3|COMPLETED|Run-in Phase||0
2497954|NCT00824408|6121285|P2|COMPLETED|Run-in Phase||0
2497955|NCT00824408|6121286|P1|COMPLETED|Run-in Phase||0
2497956|NCT00824408|6121282|P5|STARTED|Run-in Phase||0
2497957|NCT00824408|6121283|P4|STARTED|Run-in Phase||0
2497958|NCT00824408|6121284|P3|STARTED|Run-in Phase||0
2497959|NCT00824408|6121285|P2|STARTED|Run-in Phase||6
2497960|NCT00824408|6121286|P1|STARTED|Run-in Phase||6
2497961|NCT00824382|6121338|P4|NOT COMPLETED|Overall Study||5
2497962|NCT00824382|6121339|P3|NOT COMPLETED|Overall Study||3
2497963|NCT00824382|6121340|P2|NOT COMPLETED|Overall Study||2
2497964|NCT00824382|6121341|P1|NOT COMPLETED|Overall Study||5
2497965|NCT00824382|6121338|P4|COMPLETED|Overall Study||81
2497966|NCT00824382|6121339|P3|COMPLETED|Overall Study||76
2497967|NCT00824382|6121340|P2|COMPLETED|Overall Study||82
2497968|NCT00824382|6121341|P1|COMPLETED|Overall Study||74
2497969|NCT00824382|6121338|P4|STARTED|Overall Study||86
2497970|NCT00824382|6121339|P3|STARTED|Overall Study||79
2497971|NCT00824382|6121340|P2|STARTED|Overall Study||84
2497972|NCT00824382|6121341|P1|STARTED|Overall Study||79
2497973|NCT00824369|6121417|P6|NOT COMPLETED|Overall Study||1
2497974|NCT00824369|6121418|P5|NOT COMPLETED|Overall Study||1
2497975|NCT00824369|6121419|P4|NOT COMPLETED|Overall Study||2
2497976|NCT00824369|6121420|P3|NOT COMPLETED|Overall Study||1
2497977|NCT00824369|6121421|P2|NOT COMPLETED|Overall Study||0
2497978|NCT00824369|6121422|P1|NOT COMPLETED|Overall Study||1
2497979|NCT00824369|6121417|P6|COMPLETED|Overall Study||16
2497980|NCT00824369|6121418|P5|COMPLETED|Overall Study||11
2497981|NCT00824369|6121419|P4|COMPLETED|Overall Study||9
2497982|NCT00824369|6121420|P3|COMPLETED|Overall Study||2
2497983|NCT00824369|6121421|P2|COMPLETED|Overall Study||4
2497984|NCT00824369|6121422|P1|COMPLETED|Overall Study||4
2497985|NCT00824369|6121417|P6|STARTED|Overall Study||17
2497986|NCT00824369|6121418|P5|STARTED|Overall Study||12
2497987|NCT00824369|6121419|P4|STARTED|Overall Study||11
2497988|NCT00824369|6121420|P3|STARTED|Overall Study||3
2497989|NCT00824369|6121421|P2|STARTED|Overall Study||4
2497990|NCT00824369|6121422|P1|STARTED|Overall Study||5
2497991|NCT00824291|6121462|P2|NOT COMPLETED|Overall Study||35
2497992|NCT00824291|6121463|P1|NOT COMPLETED|Overall Study||54
2497993|NCT00824291|6121462|P2|COMPLETED|Overall Study||107
2497994|NCT00824291|6121463|P1|COMPLETED|Overall Study||231
2497995|NCT00824291|6121462|P2|STARTED|Overall Study||142
2497996|NCT00824291|6121463|P1|STARTED|Overall Study||285
2497997|NCT00824265|6121485|P2|NOT COMPLETED|Survival Follow-up Phase||16
2497998|NCT00824265|6121486|P1|NOT COMPLETED|Survival Follow-up Phase||9
2497999|NCT00824265|6121485|P2|COMPLETED|Survival Follow-up Phase||73
2498000|NCT00824265|6121486|P1|COMPLETED|Survival Follow-up Phase||87
2498001|NCT00824265|6121485|P2|STARTED|Survival Follow-up Phase||89
2498002|NCT00824265|6121486|P1|STARTED|Survival Follow-up Phase||96
2498003|NCT00824265|6121485|P2|NOT COMPLETED|Follow-up Phase||31
2498004|NCT00824265|6121486|P1|NOT COMPLETED|Follow-up Phase||18
2498005|NCT00824265|6121485|P2|COMPLETED|Follow-up Phase||129
2498006|NCT00824265|6121486|P1|COMPLETED|Follow-up Phase||154
2498007|NCT00824265|6121485|P2|STARTED|Follow-up Phase||160
2498008|NCT00824265|6121486|P1|STARTED|Follow-up Phase||172
2498009|NCT00824265|6121485|P2|NOT COMPLETED|Treatment Phase||80
2498010|NCT00824265|6121486|P1|NOT COMPLETED|Treatment Phase||64
2498011|NCT00824265|6121485|P2|COMPLETED|Treatment Phase||102
2498012|NCT00824265|6121486|P1|COMPLETED|Treatment Phase||119
2498013|NCT00824265|6121485|P2|STARTED|Treatment Phase||182
2498014|NCT00824265|6121486|P1|STARTED|Treatment Phase||183
2498015|NCT00824161|6121547|P1|NOT COMPLETED|Overall Study||2
2498016|NCT00824161|6121547|P1|COMPLETED|Overall Study||26
2498017|NCT00824161|6121547|P1|STARTED|Overall Study||28
2498018|NCT00824070|6121556|P3|NOT COMPLETED|Overall Study||0
2498019|NCT00824070|6121557|P2|NOT COMPLETED|Overall Study||0
2498020|NCT00824070|6121558|P1|NOT COMPLETED|Overall Study||0
2498021|NCT00824070|6121556|P3|COMPLETED|Overall Study||36
2498022|NCT00824070|6121557|P2|COMPLETED|Overall Study||35
2498023|NCT00824070|6121558|P1|COMPLETED|Overall Study||34
2498024|NCT00824070|6121556|P3|STARTED|Overall Study||36
2498025|NCT00824070|6121557|P2|STARTED|Overall Study||35
2498026|NCT00824070|6121558|P1|STARTED|Overall Study||34
2498027|NCT00824044|6121568|P2|NOT COMPLETED|Overall Study||6
2498028|NCT00824044|6121569|P1|NOT COMPLETED|Overall Study||9
2498029|NCT00824044|6121568|P2|COMPLETED|Overall Study||10
2498030|NCT00824044|6121569|P1|COMPLETED|Overall Study||14
2498031|NCT00824044|6121568|P2|STARTED|Overall Study||16
2498032|NCT00824044|6121569|P1|STARTED|Overall Study||23
2498033|NCT00824005|6121613|P2|NOT COMPLETED|Overall Study||2
2498034|NCT00824005|6121614|P1|NOT COMPLETED|Overall Study||0
2498035|NCT00824005|6121613|P2|COMPLETED|Overall Study||59
2498036|NCT00824005|6121614|P1|COMPLETED|Overall Study||31
2498037|NCT00824005|6121613|P2|STARTED|Overall Study||61
2498038|NCT00824005|6121614|P1|STARTED|Overall Study||31
2498039|NCT00823979|6121649|P3|NOT COMPLETED|Overall Study||24
2498040|NCT00823979|6121650|P2|NOT COMPLETED|Overall Study||32
2498041|NCT00823979|6121651|P1|NOT COMPLETED|Overall Study||29
2498042|NCT00823979|6121649|P3|COMPLETED|Overall Study||11
2498043|NCT00823979|6121650|P2|COMPLETED|Overall Study||3
2498044|NCT00823979|6121651|P1|COMPLETED|Overall Study||6
2498045|NCT00823979|6121649|P3|Treated|Overall Study||34
2498046|NCT00823979|6121650|P2|Treated|Overall Study||32
2498047|NCT00823979|6121651|P1|Treated|Overall Study||31
2498048|NCT00823979|6121649|P3|STARTED|Overall Study||35
2498049|NCT00823979|6121650|P2|STARTED|Overall Study||35
2498050|NCT00823979|6121651|P1|STARTED|Overall Study||35
2498051|NCT00823966|6121689|P1|NOT COMPLETED|Overall Study||0
2498052|NCT00823966|6121689|P1|COMPLETED|Overall Study||3
2498053|NCT00823966|6121689|P1|STARTED|Overall Study||3
2498054|NCT00823901|6121696|P2|NOT COMPLETED|Overall Study||2
2498055|NCT00823901|6121697|P1|NOT COMPLETED|Overall Study||4
2498056|NCT00823901|6121696|P2|COMPLETED|Overall Study|Discontinued intervention (n=1) Only baseline completed (n=1)|38
2498057|NCT00823901|6121697|P1|COMPLETED|Overall Study|Discontinued intervention (n=2) Only baseline completed (n=2)|39
2498058|NCT00823901|6121696|P2|STARTED|Overall Study|Randomized to placebo gel|40
2498059|NCT00823901|6121697|P1|STARTED|Overall Study|Randomized to clindamycin/tretinoin gel|43
2498060|NCT00823836|6121705|P2|NOT COMPLETED|Long-term Phase||5
2498061|NCT00823836|6121706|P1|NOT COMPLETED|Long-term Phase||5
2498062|NCT00823836|6121705|P2|COMPLETED|Long-term Phase||79
2498063|NCT00823836|6121706|P1|COMPLETED|Long-term Phase||68
2498064|NCT00823836|6121705|P2|STARTED|Long-term Phase||84
2498065|NCT00823836|6121706|P1|STARTED|Long-term Phase||73
2498066|NCT00823836|6121705|P2|NOT COMPLETED|NV and PR/XR Switching Phases||29
2498067|NCT00823836|6121706|P1|NOT COMPLETED|NV and PR/XR Switching Phases||32
2498068|NCT00823836|6121705|P2|COMPLETED|NV and PR/XR Switching Phases||117
2498069|NCT00823836|6121706|P1|COMPLETED|NV and PR/XR Switching Phases||124
2498070|NCT00823836|6121705|P2|STARTED|NV and PR/XR Switching Phases||146
2498071|NCT00823836|6121706|P1|STARTED|NV and PR/XR Switching Phases||156
2498072|NCT00823823|6121812|P2|NOT COMPLETED|Overall Study||6
2498073|NCT00823823|6121813|P1|NOT COMPLETED|Overall Study||8
2498074|NCT00823823|6121812|P2|COMPLETED|Overall Study||101
2498075|NCT00823823|6121813|P1|COMPLETED|Overall Study||101
2498076|NCT00823823|6121812|P2|STARTED|Overall Study||107
2498077|NCT00823823|6121813|P1|STARTED|Overall Study||109
2498078|NCT00823797|6121823|P2|NOT COMPLETED|Overall Study||0
2498079|NCT00823797|6121824|P1|NOT COMPLETED|Overall Study||0
2498080|NCT00823797|6121823|P2|COMPLETED|Overall Study||16
2498081|NCT00823797|6121824|P1|COMPLETED|Overall Study||29
2498082|NCT00823797|6121823|P2|STARTED|Overall Study||16
2498083|NCT00823797|6121824|P1|STARTED|Overall Study||29
2498084|NCT00823719|6121837|P2|NOT COMPLETED|Overall Study||11
2498085|NCT00823719|6121838|P1|NOT COMPLETED|Overall Study||6
2498086|NCT00823719|6121837|P2|COMPLETED|Overall Study||24
2498087|NCT00823719|6121838|P1|COMPLETED|Overall Study||20
2498088|NCT00823719|6121837|P2|STARTED|Overall Study||35
2498089|NCT00823719|6121838|P1|STARTED|Overall Study||26
2498090|NCT00823615|6121891|P2|NOT COMPLETED|Period 2||2
2498091|NCT00823615|6121892|P1|NOT COMPLETED|Period 2||3
2498092|NCT00823615|6121891|P2|COMPLETED|Period 2||17
2498093|NCT00823615|6121892|P1|COMPLETED|Period 2||16
2498094|NCT00823615|6121891|P2|STARTED|Period 2||19
2498095|NCT00823615|6121892|P1|STARTED|Period 2||19
2498096|NCT00823615|6121891|P2|NOT COMPLETED|Period 1||0
2498097|NCT00823615|6121892|P1|NOT COMPLETED|Period 1||0
2498098|NCT00823615|6121891|P2|COMPLETED|Period 1||19
2498099|NCT00823615|6121892|P1|COMPLETED|Period 1||19
2498100|NCT00823615|6121891|P2|STARTED|Period 1||19
2498101|NCT00823615|6121892|P1|STARTED|Period 1||19
2498102|NCT00823472|6121902|P2|NOT COMPLETED|Overall Study||28
2498103|NCT00823472|6121903|P1|NOT COMPLETED|Overall Study||24
2498104|NCT00823472|6121902|P2|COMPLETED|Overall Study||39
2498105|NCT00823472|6121903|P1|COMPLETED|Overall Study||56
2498106|NCT00823472|6121902|P2|STARTED|Overall Study||67
2498107|NCT00823472|6121903|P1|STARTED|Overall Study||80
2498108|NCT00823459|6121911|P1|NOT COMPLETED|Overall Study||0
2498109|NCT00823459|6121911|P1|COMPLETED|Overall Study||58
2498110|NCT00823459|6121911|P1|STARTED|Overall Study||58
2498111|NCT00823303|6121921|P2|NOT COMPLETED|Overall Study||11
2498112|NCT00823303|6121922|P1|NOT COMPLETED|Overall Study||9
2498113|NCT00823303|6121921|P2|COMPLETED|Overall Study||45
2498114|NCT00823303|6121922|P1|COMPLETED|Overall Study||45
2498115|NCT00823303|6121921|P2|STARTED|Overall Study||56
2498116|NCT00823303|6121922|P1|STARTED|Overall Study||54
2498117|NCT00823264|6121930|P2|NOT COMPLETED|Overall Study||0
2498118|NCT00823264|6121931|P1|NOT COMPLETED|Overall Study||2
2498119|NCT00823264|6121930|P2|COMPLETED|Overall Study||7
2498120|NCT00823264|6121931|P1|COMPLETED|Overall Study||8
2498121|NCT00823264|6121930|P2|STARTED|Overall Study||7
2498122|NCT00823264|6121931|P1|STARTED|Overall Study||10
2498123|NCT00823212|6121939|P2|NOT COMPLETED|Overall Study||33
2498124|NCT00823212|6121940|P1|NOT COMPLETED|Overall Study||35
2498125|NCT00823212|6121939|P2|COMPLETED|Overall Study|12-month follow-up|735
2498126|NCT00823212|6121940|P1|COMPLETED|Overall Study|12-month follow-up|727
2498127|NCT00823212|6121939|P2|STARTED|Overall Study||768
2498128|NCT00823212|6121940|P1|STARTED|Overall Study||762
2498129|NCT00823199|6122022|P1|NOT COMPLETED|Overall Study||2
2498130|NCT00823199|6122022|P1|COMPLETED|Overall Study||8
2498131|NCT00823199|6122022|P1|STARTED|Overall Study||10
2498132|NCT00823095|6122028|P1|NOT COMPLETED|Overall Study||0
2498133|NCT00823095|6122028|P1|COMPLETED|Overall Study||7
2498134|NCT00823095|6122028|P1|STARTED|Overall Study||7
2498135|NCT00823082|6122035|P2|NOT COMPLETED|Overall Study||1
2498136|NCT00823082|6122036|P1|NOT COMPLETED|Overall Study||0
2498137|NCT00823082|6122035|P2|COMPLETED|Overall Study||99
2498138|NCT00823082|6122036|P1|COMPLETED|Overall Study||100
2498139|NCT00823082|6122035|P2|Intent-to-Treat/Per Protocol Populations|Overall Study||94
2498140|NCT00823082|6122036|P1|Intent-to-Treat/Per Protocol Populations|Overall Study||100
2498141|NCT00823082|6122035|P2|Safety Population|Overall Study||99
2498142|NCT00823082|6122036|P1|Safety Population|Overall Study||100
2498143|NCT00823082|6122035|P2|STARTED|Overall Study||100
2498144|NCT00823082|6122036|P1|STARTED|Overall Study||100
2498145|NCT00823069|6122070|P1|NOT COMPLETED|Overall Study||0
2498146|NCT00823069|6122070|P1|COMPLETED|Overall Study||60
2498147|NCT00823069|6122070|P1|STARTED|Overall Study||60
2498148|NCT00823043|6122077|P2|NOT COMPLETED|Overall Study||0
2498149|NCT00823043|6122078|P1|NOT COMPLETED|Overall Study||0
2498150|NCT00823043|6122077|P2|COMPLETED|Overall Study||39
2498151|NCT00823043|6122078|P1|COMPLETED|Overall Study||64
2498152|NCT00823043|6122077|P2|STARTED|Overall Study||39
2498153|NCT00823043|6122078|P1|STARTED|Overall Study||64
2498154|NCT00822926|6122091|P2|NOT COMPLETED|Second Injection Visit||1
2498155|NCT00822926|6122092|P1|NOT COMPLETED|Second Injection Visit||1
2498156|NCT00822926|6122091|P2|COMPLETED|Second Injection Visit||2
2498157|NCT00822926|6122092|P1|COMPLETED|Second Injection Visit||1
2498158|NCT00822926|6122091|P2|STARTED|Second Injection Visit||3
2498159|NCT00822926|6122092|P1|STARTED|Second Injection Visit||2
2498160|NCT00822926|6122091|P2|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
2498161|NCT00822926|6122092|P1|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
2498162|NCT00822926|6122091|P2|COMPLETED|Washout (Varies Based on Scheduling)||3
2498163|NCT00822926|6122092|P1|COMPLETED|Washout (Varies Based on Scheduling)||2
2498164|NCT00822926|6122091|P2|STARTED|Washout (Varies Based on Scheduling)||3
2498165|NCT00822926|6122092|P1|STARTED|Washout (Varies Based on Scheduling)||2
2498166|NCT00822926|6122091|P2|NOT COMPLETED|First Injection Visit||0
2498167|NCT00822926|6122092|P1|NOT COMPLETED|First Injection Visit||0
2498168|NCT00822926|6122091|P2|COMPLETED|First Injection Visit||3
2498169|NCT00822926|6122092|P1|COMPLETED|First Injection Visit||2
2498170|NCT00822926|6122091|P2|STARTED|First Injection Visit||3
2498171|NCT00822926|6122092|P1|STARTED|First Injection Visit||2
2498172|NCT00822900|6122106|P2|NOT COMPLETED|Overall Study||93
2498173|NCT00822900|6122107|P1|NOT COMPLETED|Overall Study||108
2498174|NCT00822900|6122106|P2|COMPLETED|Overall Study||347
2498175|NCT00822900|6122107|P1|COMPLETED|Overall Study||334
2498176|NCT00822900|6122106|P2|STARTED|Overall Study||440
2498177|NCT00822900|6122107|P1|STARTED|Overall Study||442
2498178|NCT00822770|6122135|P1|NOT COMPLETED|Overall Study||0
2498179|NCT00822770|6122135|P1|COMPLETED|Overall Study||47
2498180|NCT00822770|6122135|P1|STARTED|Overall Study||47
2498181|NCT00822757|6122141|P2|NOT COMPLETED|Overall Study||0
2498182|NCT00822757|6122142|P1|NOT COMPLETED|Overall Study||0
2498183|NCT00822757|6122141|P2|COMPLETED|Overall Study||10
2498184|NCT00822757|6122142|P1|COMPLETED|Overall Study||41
2498185|NCT00822757|6122141|P2|STARTED|Overall Study||10
2498186|NCT00822757|6122142|P1|STARTED|Overall Study||41
2498187|NCT00822692|6122154|P2|NOT COMPLETED|Overall Study||25
2498188|NCT00822692|6122155|P1|NOT COMPLETED|Overall Study||17
2498189|NCT00822692|6122154|P2|COMPLETED|Overall Study|June 1 , 2009|51
2498190|NCT00822692|6122155|P1|COMPLETED|Overall Study|June 1, 2009|46
2498191|NCT00822692|6122154|P2|STARTED|Overall Study|July 1, 2008|76
2498192|NCT00822692|6122155|P1|STARTED|Overall Study|July 1, 2008|63
2498193|NCT00822679|6122163|P2|NOT COMPLETED|Overall Study||0
2498194|NCT00822679|6122164|P1|NOT COMPLETED|Overall Study||0
2498195|NCT00822679|6122163|P2|COMPLETED|Overall Study||0
2498196|NCT00822679|6122164|P1|COMPLETED|Overall Study||0
2498197|NCT00822679|6122163|P2|STARTED|Overall Study||0
2498198|NCT00822679|6122164|P1|STARTED|Overall Study||0
2498199|NCT00822588|6122172|P2|NOT COMPLETED|Overall Study||4
2498200|NCT00822588|6122173|P1|NOT COMPLETED|Overall Study||7
2498201|NCT00822588|6122172|P2|COMPLETED|Overall Study|APT/ITT analysis set|110
2498202|NCT00822588|6122173|P1|COMPLETED|Overall Study|APT/ITT analysis set|106
2498203|NCT00822588|6122172|P2|STARTED|Overall Study|4 participants excluded before surgery. No baseline data available|114
2498204|NCT00822588|6122173|P1|STARTED|Overall Study|7 participants excluded before surgery. No baseline data available|113
2498205|NCT00822523|6122182|P3|NOT COMPLETED|Overall Study||0
2498206|NCT00822523|6122183|P2|NOT COMPLETED|Overall Study||0
2498207|NCT00822523|6122184|P1|NOT COMPLETED|Overall Study||0
2498208|NCT00822523|6122182|P3|COMPLETED|Overall Study||4
2498209|NCT00822523|6122183|P2|COMPLETED|Overall Study||4
2498210|NCT00822523|6122184|P1|COMPLETED|Overall Study||5
2498211|NCT00822523|6122182|P3|STARTED|Overall Study||4
2498212|NCT00822523|6122183|P2|STARTED|Overall Study||4
2498213|NCT00822523|6122184|P1|STARTED|Overall Study||5
2498214|NCT00822510|6122230|P2|NOT COMPLETED|Overall Study||5
2498215|NCT00822510|6122231|P1|NOT COMPLETED|Overall Study||3
2498216|NCT00822510|6122230|P2|COMPLETED|Overall Study||36
2498217|NCT00822510|6122231|P1|COMPLETED|Overall Study||35
2498218|NCT00822510|6122230|P2|STARTED|Overall Study||41
2498219|NCT00822510|6122231|P1|STARTED|Overall Study||38
2498220|NCT00822354|6122251|P2|NOT COMPLETED|Second Intervention (28 Days)||0
2498221|NCT00822354|6122252|P1|NOT COMPLETED|Second Intervention (28 Days)||1
2498222|NCT00822354|6122251|P2|COMPLETED|Second Intervention (28 Days)||5
2498223|NCT00822354|6122252|P1|COMPLETED|Second Intervention (28 Days)||3
2498224|NCT00822354|6122251|P2|STARTED|Second Intervention (28 Days)||5
2498225|NCT00822354|6122252|P1|STARTED|Second Intervention (28 Days)||4
2498226|NCT00822354|6122251|P2|NOT COMPLETED|Washout (7 Days)||0
2498227|NCT00822354|6122252|P1|NOT COMPLETED|Washout (7 Days)||0
2498228|NCT00822354|6122251|P2|COMPLETED|Washout (7 Days)||5
2498229|NCT00822354|6122252|P1|COMPLETED|Washout (7 Days)||4
2498230|NCT00822354|6122251|P2|STARTED|Washout (7 Days)||5
2498231|NCT00822354|6122252|P1|STARTED|Washout (7 Days)||4
2498232|NCT00822354|6122251|P2|NOT COMPLETED|First Intervention (28 Days)||0
2498233|NCT00822354|6122252|P1|NOT COMPLETED|First Intervention (28 Days)||1
2498234|NCT00822354|6122251|P2|COMPLETED|First Intervention (28 Days)||5
2498235|NCT00822354|6122252|P1|COMPLETED|First Intervention (28 Days)||4
2498236|NCT00822354|6122251|P2|STARTED|First Intervention (28 Days)||5
2498237|NCT00822354|6122252|P1|STARTED|First Intervention (28 Days)||5
2498238|NCT00822328|6122282|P2|NOT COMPLETED|Overall Study||0
2498239|NCT00822328|6122283|P1|NOT COMPLETED|Overall Study||0
2498240|NCT00822328|6122282|P2|COMPLETED|Overall Study||12
2498241|NCT00822328|6122283|P1|COMPLETED|Overall Study||12
2498242|NCT00822328|6122282|P2|STARTED|Overall Study||12
2498243|NCT00822328|6122283|P1|STARTED|Overall Study||12
2498244|NCT00822237|6122293|P2|NOT COMPLETED|Dose 2 Vaccination||11
2498245|NCT00822237|6122294|P1|NOT COMPLETED|Dose 2 Vaccination||4
2498246|NCT00822237|6122293|P2|COMPLETED|Dose 2 Vaccination||262
2498247|NCT00822237|6122294|P1|COMPLETED|Dose 2 Vaccination||270
2498248|NCT00822237|6122293|P2|STARTED|Dose 2 Vaccination|Number who received second dose|273
2498249|NCT00822237|6122294|P1|STARTED|Dose 2 Vaccination|Number who received second dose|274
2498250|NCT00822237|6122293|P2|NOT COMPLETED|Dose 1 Vaccination||26
2498251|NCT00822237|6122294|P1|NOT COMPLETED|Dose 1 Vaccination||25
2498252|NCT00822237|6122293|P2|COMPLETED|Dose 1 Vaccination||273
2498253|NCT00822237|6122294|P1|COMPLETED|Dose 1 Vaccination||274
2498254|NCT00822237|6122293|P2|STARTED|Dose 1 Vaccination|Number randomized|299
2498255|NCT00822237|6122294|P1|STARTED|Dose 1 Vaccination|Number randomized|299
2498256|NCT00822185|6122304|P5|NOT COMPLETED|Overall Study||0
2498257|NCT00822185|6122305|P4|NOT COMPLETED|Overall Study||0
2498258|NCT00822185|6122306|P3|NOT COMPLETED|Overall Study||0
2498259|NCT00822185|6122307|P2|NOT COMPLETED|Overall Study||0
2498260|NCT00822185|6122308|P1|NOT COMPLETED|Overall Study||0
2498261|NCT00822185|6122304|P5|COMPLETED|Overall Study||8
2498262|NCT00822185|6122305|P4|COMPLETED|Overall Study||6
2498263|NCT00822185|6122306|P3|COMPLETED|Overall Study||6
2498264|NCT00822185|6122307|P2|COMPLETED|Overall Study||6
2498265|NCT00822185|6122308|P1|COMPLETED|Overall Study||6
2498266|NCT00822185|6122304|P5|STARTED|Overall Study||8
2498267|NCT00822185|6122305|P4|STARTED|Overall Study||6
2498268|NCT00822185|6122306|P3|STARTED|Overall Study||6
2498269|NCT00822185|6122307|P2|STARTED|Overall Study||6
2498270|NCT00822185|6122308|P1|STARTED|Overall Study||6
2498271|NCT00822172|6122375|P2|NOT COMPLETED|Overall Study||19
2498272|NCT00822172|6122376|P1|NOT COMPLETED|Overall Study||15
2498273|NCT00822172|6122375|P2|COMPLETED|Overall Study||64
2498274|NCT00822172|6122376|P1|COMPLETED|Overall Study||65
2498275|NCT00822172|6122375|P2|STARTED|Overall Study||83
2498276|NCT00822172|6122376|P1|STARTED|Overall Study||80
2498277|NCT00822120|6122396|P6|NOT COMPLETED|PET-directed Therapy||0
2498278|NCT00822120|6122397|P5|NOT COMPLETED|PET-directed Therapy||0
2498279|NCT00822120|6122398|P4|NOT COMPLETED|PET-directed Therapy||10
2498280|NCT00822120|6122399|P3|NOT COMPLETED|PET-directed Therapy||0
2498281|NCT00822120|6122400|P2|NOT COMPLETED|PET-directed Therapy||0
2498282|NCT00822120|6122401|P1|NOT COMPLETED|PET-directed Therapy||0
2498283|NCT00822120|6122396|P6|COMPLETED|PET-directed Therapy||1
2498284|NCT00822120|6122397|P5|COMPLETED|PET-directed Therapy||10
2498285|NCT00822120|6122398|P4|COMPLETED|PET-directed Therapy||45
2498286|NCT00822120|6122399|P3|COMPLETED|PET-directed Therapy||270
2498287|NCT00822120|6122400|P2|COMPLETED|PET-directed Therapy||0
2498288|NCT00822120|6122401|P1|COMPLETED|PET-directed Therapy||0
2498289|NCT00822120|6122396|P6|Eligibile and Evaluable Patients|PET-directed Therapy||1
2498290|NCT00822120|6122397|P5|Eligibile and Evaluable Patients|PET-directed Therapy||10
2498291|NCT00822120|6122398|P4|Eligibile and Evaluable Patients|PET-directed Therapy||55
2498292|NCT00822120|6122399|P3|Eligibile and Evaluable Patients|PET-directed Therapy||270
2498293|NCT00822120|6122400|P2|Eligibile and Evaluable Patients|PET-directed Therapy||0
2498294|NCT00822120|6122401|P1|Eligibile and Evaluable Patients|PET-directed Therapy||0
2498295|NCT00822120|6122396|P6|STARTED|PET-directed Therapy||1
2498296|NCT00822120|6122397|P5|STARTED|PET-directed Therapy||10
2498297|NCT00822120|6122398|P4|STARTED|PET-directed Therapy||55
2498298|NCT00822120|6122399|P3|STARTED|PET-directed Therapy||270
2498299|NCT00822120|6122400|P2|STARTED|PET-directed Therapy||0
2498300|NCT00822120|6122401|P1|STARTED|PET-directed Therapy||0
2498301|NCT00822120|6122396|P6|NOT COMPLETED|Initial Registration||0
2498302|NCT00822120|6122397|P5|NOT COMPLETED|Initial Registration||0
2498303|NCT00822120|6122398|P4|NOT COMPLETED|Initial Registration||0
2498304|NCT00822120|6122399|P3|NOT COMPLETED|Initial Registration||0
2498305|NCT00822120|6122400|P2|NOT COMPLETED|Initial Registration||1
2498306|NCT00822120|6122401|P1|NOT COMPLETED|Initial Registration||26
2498307|NCT00822120|6122396|P6|COMPLETED|Initial Registration||0
2498308|NCT00822120|6122397|P5|COMPLETED|Initial Registration||0
2498309|NCT00822120|6122398|P4|COMPLETED|Initial Registration||0
2498310|NCT00822120|6122399|P3|COMPLETED|Initial Registration||0
2498311|NCT00822120|6122400|P2|COMPLETED|Initial Registration||12
2498312|NCT00822120|6122401|P1|COMPLETED|Initial Registration||332
2498313|NCT00822120|6122396|P6|Eligible and Evaluable Patients|Initial Registration||0
2498314|NCT00822120|6122397|P5|Eligible and Evaluable Patients|Initial Registration||0
2498315|NCT00822120|6122398|P4|Eligible and Evaluable Patients|Initial Registration||0
2498316|NCT00822120|6122399|P3|Eligible and Evaluable Patients|Initial Registration||0
2498317|NCT00822120|6122400|P2|Eligible and Evaluable Patients|Initial Registration||12
2498318|NCT00822120|6122401|P1|Eligible and Evaluable Patients|Initial Registration||336
2498319|NCT00822120|6122396|P6|STARTED|Initial Registration||0
2498320|NCT00822120|6122397|P5|STARTED|Initial Registration||0
2498321|NCT00822120|6122398|P4|STARTED|Initial Registration||0
2498322|NCT00822120|6122399|P3|STARTED|Initial Registration||0
2498323|NCT00822120|6122400|P2|STARTED|Initial Registration||13
2498324|NCT00822120|6122401|P1|STARTED|Initial Registration||358
2498325|NCT00822107|6122424|P1|NOT COMPLETED|Overall Study||0
2498326|NCT00822107|6122424|P1|COMPLETED|Overall Study||5
2498327|NCT00822107|6122424|P1|STARTED|Overall Study||5
2498328|NCT00822094|6122430|P2|NOT COMPLETED|Overall Study||25
2498329|NCT00822094|6122431|P1|NOT COMPLETED|Overall Study||44
2498330|NCT00822094|6122430|P2|COMPLETED|Overall Study||20
2498331|NCT00822094|6122431|P1|COMPLETED|Overall Study||37
2498332|NCT00822094|6122430|P2|STARTED|Overall Study||45
2498333|NCT00822094|6122431|P1|STARTED|Overall Study||81
2498334|NCT00821964|6122447|P1|NOT COMPLETED|Overall Study||6
2498335|NCT00821964|6122447|P1|COMPLETED|Overall Study||9
2498336|NCT00821964|6122447|P1|Evaluable for Pathologic Response|Overall Study||7
2498337|NCT00821964|6122447|P1|Evaluable for Clinical Response|Overall Study||14
2498338|NCT00821964|6122447|P1|STARTED|Overall Study||15
2498339|NCT00821951|6122456|P1|NOT COMPLETED|Overall Study||5
2498340|NCT00821951|6122456|P1|COMPLETED|Overall Study||12
2498341|NCT00821951|6122456|P1|STARTED|Overall Study||17
2498342|NCT00821886|6122460|P1|NOT COMPLETED|Overall Study||9
2498343|NCT00821886|6122460|P1|COMPLETED|Overall Study||49
2498344|NCT00821886|6122460|P1|STARTED|Overall Study|Two patients were enrolled, but subsequently found to be ineligible|58
2498345|NCT00821873|6122467|P1|NOT COMPLETED|Overall Study||4
2498346|NCT00821873|6122467|P1|COMPLETED|Overall Study||5
2498347|NCT00821873|6122467|P1|STARTED|Overall Study||9
2498348|NCT00821821|6122474|P3|NOT COMPLETED|Overall Study||0
2498349|NCT00821821|6122475|P2|NOT COMPLETED|Overall Study||0
2498350|NCT00821821|6122476|P1|NOT COMPLETED|Overall Study||0
2498351|NCT00821821|6122474|P3|COMPLETED|Overall Study||11
2498352|NCT00821821|6122475|P2|COMPLETED|Overall Study||13
2498353|NCT00821821|6122476|P1|COMPLETED|Overall Study||12
2498354|NCT00821821|6122474|P3|STARTED|Overall Study||11
2498355|NCT00821821|6122475|P2|STARTED|Overall Study||13
2498356|NCT00821821|6122476|P1|STARTED|Overall Study||12
2498357|NCT00821678|6122488|P2|NOT COMPLETED|Overall Study||14
2498358|NCT00821678|6122489|P1|NOT COMPLETED|Overall Study||21
2498359|NCT00821678|6122488|P2|COMPLETED|Overall Study||118
2498360|NCT00821678|6122489|P1|COMPLETED|Overall Study||112
2498361|NCT00821678|6122488|P2|STARTED|Overall Study||132
2498362|NCT00821678|6122489|P1|STARTED|Overall Study||133
2498363|NCT00821587|6122511|P2|NOT COMPLETED|Overall Study||1
2498364|NCT00821587|6122512|P1|NOT COMPLETED|Overall Study||0
2498365|NCT00821587|6122511|P2|COMPLETED|Overall Study||18
2498366|NCT00821587|6122512|P1|COMPLETED|Overall Study||20
2498367|NCT00821587|6122511|P2|STARTED|Overall Study||19
2498368|NCT00821587|6122512|P1|STARTED|Overall Study||20
2498369|NCT00821509|6122521|P3|NOT COMPLETED|Overall Study||34
2498370|NCT00821509|6122522|P2|NOT COMPLETED|Overall Study||11
2498371|NCT00821509|6122523|P1|NOT COMPLETED|Overall Study||12
2498372|NCT00821509|6122521|P3|COMPLETED|Overall Study|This is a result of 50 lost-to-follow-up and 16 new recruits|190
2498373|NCT00821509|6122522|P2|COMPLETED|Overall Study|This is a result of 57 lost-to-follow-up and 46 new recruits|191
2498374|NCT00821509|6122523|P1|COMPLETED|Overall Study|This is a result of 56 lost-to-follow-up and 44 new recruits|245
2498375|NCT00821509|6122521|P3|STARTED|Overall Study||224
2498376|NCT00821509|6122522|P2|STARTED|Overall Study||202
2498377|NCT00821509|6122523|P1|STARTED|Overall Study||257
2498378|NCT00821431|6122536|P2|NOT COMPLETED|Overall Study||5
2498379|NCT00821431|6122537|P1|NOT COMPLETED|Overall Study||15
2498380|NCT00821431|6122536|P2|COMPLETED|Overall Study||47
2498381|NCT00821431|6122537|P1|COMPLETED|Overall Study||23
2498382|NCT00821431|6122536|P2|STARTED|Overall Study||52
2498383|NCT00821431|6122537|P1|STARTED|Overall Study||38
2498384|NCT00821327|6122545|P1|NOT COMPLETED|Overall Study||35
2498385|NCT00821327|6122545|P1|COMPLETED|Overall Study||1
2498386|NCT00821327|6122545|P1|STARTED|Overall Study||36
2498387|NCT00821236|6122554|P1|NOT COMPLETED|Overall Study||3
2498388|NCT00821236|6122554|P1|COMPLETED|Overall Study||37
2498389|NCT00821236|6122554|P1|STARTED|Overall Study||40
2498390|NCT00821184|6122570|P2|NOT COMPLETED|Overall Study||0
2498391|NCT00821184|6122571|P1|NOT COMPLETED|Overall Study||0
2498392|NCT00821184|6122570|P2|COMPLETED|Overall Study||6
2498393|NCT00821184|6122571|P1|COMPLETED|Overall Study||6
2498394|NCT00821184|6122570|P2|STARTED|Overall Study||6
2498395|NCT00821184|6122571|P1|STARTED|Overall Study||6
2498396|NCT00821119|6122581|P2|NOT COMPLETED|Overall Study||0
2498397|NCT00821119|6122582|P1|NOT COMPLETED|Overall Study||0
2498398|NCT00821119|6122581|P2|COMPLETED|Overall Study||100
2498399|NCT00821119|6122582|P1|COMPLETED|Overall Study||100
2498400|NCT00821119|6122581|P2|STARTED|Overall Study||100
2498401|NCT00821119|6122582|P1|STARTED|Overall Study||100
2498402|NCT00821093|6122594|P2|NOT COMPLETED|Overall Study||40
2498403|NCT00821093|6122595|P1|NOT COMPLETED|Overall Study||49
2498404|NCT00821093|6122594|P2|COMPLETED|Overall Study||523
2498405|NCT00821093|6122595|P1|COMPLETED|Overall Study||511
2498406|NCT00821093|6122594|P2|Exposed to Drug|Overall Study||562
2498407|NCT00821093|6122595|P1|Exposed to Drug|Overall Study||559
2498408|NCT00821093|6122594|P2|STARTED|Overall Study||563
2498409|NCT00821093|6122595|P1|STARTED|Overall Study||560
2498410|NCT00821041|6122605|P2|NOT COMPLETED|Overall Study||0
2498411|NCT00821041|6122606|P1|NOT COMPLETED|Overall Study||0
2498412|NCT00821041|6122605|P2|COMPLETED|Overall Study||59
2498413|NCT00821041|6122606|P1|COMPLETED|Overall Study||59
2498414|NCT00821041|6122605|P2|STARTED|Overall Study||59
2498415|NCT00821041|6122606|P1|STARTED|Overall Study||59
2498416|NCT00821015|6122614|P1|NOT COMPLETED|Overall Study||12
2498417|NCT00821015|6122614|P1|COMPLETED|Overall Study||15
2498418|NCT00821015|6122614|P1|STARTED|Overall Study||27
2498419|NCT00820898|6122625|P1|NOT COMPLETED|Overall Study||1
2498420|NCT00820898|6122625|P1|COMPLETED|Overall Study||23
2498421|NCT00820898|6122625|P1|STARTED|Overall Study||24
2498422|NCT00820872|6122635|P1|NOT COMPLETED|Overall Study||0
2498423|NCT00820872|6122635|P1|COMPLETED|Overall Study||30
2498424|NCT00820872|6122635|P1|STARTED|Overall Study||30
2498425|NCT00820755|6122639|P3|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
2498426|NCT00820755|6122640|P2|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
2498427|NCT00820755|6122641|P1|NOT COMPLETED|Period 2: Maintenance Therapy Phase||0
2498428|NCT00820755|6122639|P3|COMPLETED|Period 2: Maintenance Therapy Phase||109
2498429|NCT00820755|6122640|P2|COMPLETED|Period 2: Maintenance Therapy Phase||112
2498430|NCT00820755|6122641|P1|COMPLETED|Period 2: Maintenance Therapy Phase||0
2498431|NCT00820755|6122639|P3|STARTED|Period 2: Maintenance Therapy Phase||154
2498432|NCT00820755|6122640|P2|STARTED|Period 2: Maintenance Therapy Phase||157
2498433|NCT00820755|6122641|P1|STARTED|Period 2: Maintenance Therapy Phase||0
2498434|NCT00820755|6122639|P3|NOT COMPLETED|Period 1: Combination Therapy Phase||0
2498435|NCT00820755|6122640|P2|NOT COMPLETED|Period 1: Combination Therapy Phase||0
2498436|NCT00820755|6122641|P1|NOT COMPLETED|Period 1: Combination Therapy Phase||270
2498437|NCT00820755|6122639|P3|COMPLETED|Period 1: Combination Therapy Phase||0
2498438|NCT00820755|6122640|P2|COMPLETED|Period 1: Combination Therapy Phase||0
2498439|NCT00820755|6122641|P1|COMPLETED|Period 1: Combination Therapy Phase|2 of 313 participants excluded from maintenance phase analysis (reason: not eligible)|313
2498440|NCT00820755|6122639|P3|STARTED|Period 1: Combination Therapy Phase||0
2498441|NCT00820755|6122640|P2|STARTED|Period 1: Combination Therapy Phase||0
2498442|NCT00820755|6122641|P1|STARTED|Period 1: Combination Therapy Phase||583
2498443|NCT00820664|6122665|P3|NOT COMPLETED|Overall Study||0
2498444|NCT00820664|6122666|P2|NOT COMPLETED|Overall Study||0
2498445|NCT00820664|6122667|P1|NOT COMPLETED|Overall Study||0
2498446|NCT00820664|6122665|P3|COMPLETED|Overall Study||9
2498447|NCT00820664|6122666|P2|COMPLETED|Overall Study||11
2498448|NCT00820664|6122667|P1|COMPLETED|Overall Study||9
2498449|NCT00820664|6122665|P3|STARTED|Overall Study||9
2498450|NCT00820664|6122666|P2|STARTED|Overall Study||11
2498451|NCT00820664|6122667|P1|STARTED|Overall Study||9
2498452|NCT00820612|6122677|P2|NOT COMPLETED|Overall Study||0
2498453|NCT00820612|6122678|P1|NOT COMPLETED|Overall Study||0
2498454|NCT00820612|6122677|P2|COMPLETED|Overall Study||295
2498455|NCT00820612|6122678|P1|COMPLETED|Overall Study||307
2498456|NCT00820612|6122677|P2|STARTED|Overall Study||295
2498457|NCT00820612|6122678|P1|STARTED|Overall Study||307
2498458|NCT00820573|6122688|P4|NOT COMPLETED|Overall Study||0
2498459|NCT00820573|6122689|P3|NOT COMPLETED|Overall Study||0
2498460|NCT00820573|6122690|P2|NOT COMPLETED|Overall Study||0
2498461|NCT00820573|6122691|P1|NOT COMPLETED|Overall Study||0
2498462|NCT00820573|6122688|P4|COMPLETED|Overall Study||4
2498463|NCT00820573|6122689|P3|COMPLETED|Overall Study||4
2498464|NCT00820573|6122690|P2|COMPLETED|Overall Study||4
2498465|NCT00820573|6122691|P1|COMPLETED|Overall Study||4
2498466|NCT00820573|6122688|P4|STARTED|Overall Study||4
2498467|NCT00820573|6122689|P3|STARTED|Overall Study||4
2498468|NCT00820573|6122690|P2|STARTED|Overall Study||4
2498469|NCT00820573|6122691|P1|STARTED|Overall Study||4
2498470|NCT00820534|6122715|P2|NOT COMPLETED|Overall Study||0
2498471|NCT00820534|6122716|P1|NOT COMPLETED|Overall Study||0
2498472|NCT00820534|6122715|P2|COMPLETED|Overall Study||62
2498473|NCT00820534|6122716|P1|COMPLETED|Overall Study||64
2498474|NCT00820534|6122715|P2|STARTED|Overall Study||62
2498475|NCT00820534|6122716|P1|STARTED|Overall Study||64
2498476|NCT00820443|6122724|P1|NOT COMPLETED|24 Month||43
2498477|NCT00820443|6122724|P1|COMPLETED|24 Month||202
2498478|NCT00820443|6122724|P1|STARTED|24 Month||245
2498479|NCT00820443|6122724|P1|NOT COMPLETED|12 Month||24
2498480|NCT00820443|6122724|P1|COMPLETED|12 Month||226
2498481|NCT00820443|6122724|P1|STARTED|12 Month||250
2498482|NCT00820443|6122724|P1|NOT COMPLETED|6 Month||20
2498483|NCT00820443|6122724|P1|COMPLETED|6 Month||233
2498484|NCT00820443|6122724|P1|STARTED|6 Month||253
2498485|NCT00820443|6122724|P1|NOT COMPLETED|3 Month||9
2498486|NCT00820443|6122724|P1|COMPLETED|3 Month||244
2498487|NCT00820443|6122724|P1|STARTED|3 Month||253
2498488|NCT00820443|6122724|P1|NOT COMPLETED|Immediately||5
2498489|NCT00820443|6122724|P1|COMPLETED|Immediately||248
2498490|NCT00820443|6122724|P1|STARTED|Immediately||253
2498491|NCT00820443|6122724|P1|NOT COMPLETED|Op||0
2498492|NCT00820443|6122724|P1|COMPLETED|Op||253
2498493|NCT00820443|6122724|P1|STARTED|Op||253
2498494|NCT00820443|6122724|P1|NOT COMPLETED|Pre-Op||0
2498495|NCT00820443|6122724|P1|COMPLETED|Pre-Op||253
2498496|NCT00820443|6122724|P1|STARTED|Pre-Op||253
2498497|NCT00820248|6122734|P2|NOT COMPLETED|Overall Study||1
2498498|NCT00820248|6122735|P1|NOT COMPLETED|Overall Study||4
2498499|NCT00820248|6122734|P2|COMPLETED|Overall Study||159
2498500|NCT00820248|6122735|P1|COMPLETED|Overall Study||156
2498501|NCT00820248|6122734|P2|Received Protocol Treatment|Overall Study||159
2498502|NCT00820248|6122735|P1|Received Protocol Treatment|Overall Study||156
2498503|NCT00820248|6122734|P2|STARTED|Overall Study||160
2498504|NCT00820248|6122735|P1|STARTED|Overall Study||160
2498505|NCT00820222|6122745|P2|NOT COMPLETED|Overall Study||190
2498506|NCT00820222|6122746|P1|NOT COMPLETED|Overall Study||176
2498507|NCT00820222|6122745|P2|COMPLETED|Overall Study||79
2498508|NCT00820222|6122746|P1|COMPLETED|Overall Study||95
2498509|NCT00820222|6122745|P2|STARTED|Overall Study||269
2498510|NCT00820222|6122746|P1|STARTED|Overall Study||271
2498511|NCT00820170|6122777|P5|NOT COMPLETED|Overall Study||4
2498512|NCT00820170|6122778|P4|NOT COMPLETED|Overall Study||0
2498513|NCT00820170|6122779|P3|NOT COMPLETED|Overall Study||0
2498514|NCT00820170|6122780|P2|NOT COMPLETED|Overall Study||0
2498515|NCT00820170|6122781|P1|NOT COMPLETED|Overall Study||0
2498516|NCT00820170|6122777|P5|COMPLETED|Overall Study||0
2498517|NCT00820170|6122778|P4|COMPLETED|Overall Study||40
2498518|NCT00820170|6122779|P3|COMPLETED|Overall Study||3
2498519|NCT00820170|6122780|P2|COMPLETED|Overall Study||5
2498520|NCT00820170|6122781|P1|COMPLETED|Overall Study||3
2498521|NCT00820170|6122777|P5|STARTED|Overall Study||4
2498522|NCT00820170|6122778|P4|STARTED|Overall Study||40
2498523|NCT00820170|6122779|P3|STARTED|Overall Study||3
2498524|NCT00820170|6122780|P2|STARTED|Overall Study||5
2498525|NCT00820170|6122781|P1|STARTED|Overall Study||3
2498526|NCT00819910|6122833|P4|NOT COMPLETED|Overall Study||1
2498527|NCT00819910|6122834|P3|NOT COMPLETED|Overall Study||3
2498528|NCT00819910|6122835|P2|NOT COMPLETED|Overall Study||1
2498529|NCT00819910|6122836|P1|NOT COMPLETED|Overall Study||2
2498530|NCT00819910|6122833|P4|COMPLETED|Overall Study||10
2498531|NCT00819910|6122834|P3|COMPLETED|Overall Study||7
2498532|NCT00819910|6122835|P2|COMPLETED|Overall Study||9
2498533|NCT00819910|6122836|P1|COMPLETED|Overall Study||8
2498534|NCT00819910|6122833|P4|STARTED|Overall Study||11
2498535|NCT00819910|6122834|P3|STARTED|Overall Study||10
2498536|NCT00819910|6122835|P2|STARTED|Overall Study||10
2498537|NCT00819910|6122836|P1|STARTED|Overall Study||10
2498538|NCT00819832|6122868|P6|NOT COMPLETED|Overall Study||0
2498539|NCT00819832|6122869|P5|NOT COMPLETED|Overall Study||0
2498540|NCT00819832|6122870|P4|NOT COMPLETED|Overall Study||0
2498541|NCT00819832|6122871|P3|NOT COMPLETED|Overall Study||0
2498542|NCT00819832|6122872|P2|NOT COMPLETED|Overall Study||0
2498543|NCT00819832|6122873|P1|NOT COMPLETED|Overall Study||3
2498544|NCT00819832|6122868|P6|COMPLETED|Overall Study||0
2498545|NCT00819832|6122869|P5|COMPLETED|Overall Study||0
2498546|NCT00819832|6122870|P4|COMPLETED|Overall Study||0
2498547|NCT00819832|6122871|P3|COMPLETED|Overall Study||0
2498548|NCT00819832|6122872|P2|COMPLETED|Overall Study||0
2498549|NCT00819832|6122873|P1|COMPLETED|Overall Study||0
2498550|NCT00819832|6122868|P6|STARTED|Overall Study||0
2498551|NCT00819832|6122869|P5|STARTED|Overall Study||0
2498552|NCT00819832|6122870|P4|STARTED|Overall Study||0
2498553|NCT00819832|6122871|P3|STARTED|Overall Study||0
2498554|NCT00819832|6122872|P2|STARTED|Overall Study||0
2498555|NCT00819832|6122873|P1|STARTED|Overall Study|No patient data analysis.|3
2498556|NCT00819793|6122887|P1|NOT COMPLETED|Overall Study||0
2498557|NCT00819793|6122887|P1|COMPLETED|Overall Study||32
2498558|NCT00819793|6122887|P1|STARTED|Overall Study||32
2498559|NCT00819780|6122894|P2|NOT COMPLETED|Overall Study||21
2498560|NCT00819780|6122895|P1|NOT COMPLETED|Overall Study||28
2498561|NCT00819780|6122894|P2|COMPLETED|Overall Study|Indicates participants who ended study treatment|122
2498562|NCT00819780|6122895|P1|COMPLETED|Overall Study|Indicates participants who ended study treatment|114
2498563|NCT00819780|6122894|P2|Received Study Treatment|Overall Study||139
2498564|NCT00819780|6122895|P1|Received Study Treatment|Overall Study||139
2498565|NCT00819780|6122894|P2|STARTED|Overall Study||143
2498566|NCT00819780|6122895|P1|STARTED|Overall Study||142
2498567|NCT00819767|6122929|P2|NOT COMPLETED|Overall Study||2
2498568|NCT00819767|6122930|P1|NOT COMPLETED|Overall Study||1
2498569|NCT00819767|6122929|P2|COMPLETED|Overall Study||33
2498570|NCT00819767|6122930|P1|COMPLETED|Overall Study||32
2498571|NCT00819767|6122929|P2|STARTED|Overall Study||35
2498572|NCT00819767|6122930|P1|STARTED|Overall Study||33
2498573|NCT00819741|6122942|P2|NOT COMPLETED|Overall Study||14
2498574|NCT00819741|6122943|P1|NOT COMPLETED|Overall Study||22
2498575|NCT00819741|6122942|P2|COMPLETED|Overall Study||201
2498576|NCT00819741|6122943|P1|COMPLETED|Overall Study||196
2498577|NCT00819741|6122942|P2|Exposed to Drug|Overall Study|One subject after randomisation was not exposed to the treatment due to non-compliance|214
2498578|NCT00819741|6122943|P1|Exposed to Drug|Overall Study||218
2498579|NCT00819741|6122942|P2|STARTED|Overall Study||215
2498580|NCT00819741|6122943|P1|STARTED|Overall Study||218
2498581|NCT00819637|6122980|P3|NOT COMPLETED|Overall Study||0
2498582|NCT00819637|6122981|P2|NOT COMPLETED|Overall Study||0
2498583|NCT00819637|6122982|P1|NOT COMPLETED|Overall Study||0
2498584|NCT00819637|6122980|P3|COMPLETED|Overall Study||0
2498585|NCT00819637|6122981|P2|COMPLETED|Overall Study||0
2498586|NCT00819637|6122982|P1|COMPLETED|Overall Study||2
2498587|NCT00819637|6122980|P3|STARTED|Overall Study||0
2498588|NCT00819637|6122981|P2|STARTED|Overall Study||0
2498589|NCT00819637|6122982|P1|STARTED|Overall Study||2
2498590|NCT00819585|6122997|P11|NOT COMPLETED|Extension Study||2
2498591|NCT00819585|6122998|P10|NOT COMPLETED|Extension Study||1
2498592|NCT00819585|6122999|P9|NOT COMPLETED|Extension Study||8
2498593|NCT00819585|6123000|P8|NOT COMPLETED|Extension Study||0
2498594|NCT00819585|6123001|P7|NOT COMPLETED|Extension Study||0
2498595|NCT00819585|6123002|P6|NOT COMPLETED|Extension Study||0
2498596|NCT00819585|6123003|P5|NOT COMPLETED|Extension Study||0
2498597|NCT00819585|6123004|P4|NOT COMPLETED|Extension Study||0
2498598|NCT00819585|6123005|P3|NOT COMPLETED|Extension Study||0
2498599|NCT00819585|6123006|P2|NOT COMPLETED|Extension Study||0
2498600|NCT00819585|6123007|P1|NOT COMPLETED|Extension Study||0
2498601|NCT00819585|6122997|P11|COMPLETED|Extension Study||58
2498602|NCT00819585|6122998|P10|COMPLETED|Extension Study||24
2498603|NCT00819585|6122999|P9|COMPLETED|Extension Study||173
2498604|NCT00819585|6123000|P8|COMPLETED|Extension Study||75
2498605|NCT00819585|6123001|P7|COMPLETED|Extension Study||0
2498606|NCT00819585|6123002|P6|COMPLETED|Extension Study||0
2498607|NCT00819585|6123003|P5|COMPLETED|Extension Study||0
2498608|NCT00819585|6123004|P4|COMPLETED|Extension Study||0
2498609|NCT00819585|6123005|P3|COMPLETED|Extension Study||0
2498610|NCT00819585|6123006|P2|COMPLETED|Extension Study||0
2498611|NCT00819585|6123007|P1|COMPLETED|Extension Study||0
2498612|NCT00819585|6122997|P11|STARTED|Extension Study||60
2498613|NCT00819585|6122998|P10|STARTED|Extension Study||25
2498614|NCT00819585|6122999|P9|STARTED|Extension Study||181
2498615|NCT00819585|6123000|P8|STARTED|Extension Study||75
2498616|NCT00819585|6123001|P7|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
2498617|NCT00819585|6123002|P6|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
2498618|NCT00819585|6123003|P5|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
2498619|NCT00819585|6123004|P4|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
2498620|NCT00819585|6123005|P3|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
2498621|NCT00819585|6123006|P2|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
2498622|NCT00819585|6123007|P1|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
2498623|NCT00819585|6122997|P11|NOT COMPLETED|Core Study||0
2498624|NCT00819585|6122998|P10|NOT COMPLETED|Core Study||0
2498625|NCT00819585|6122999|P9|NOT COMPLETED|Core Study||0
2498626|NCT00819585|6123000|P8|NOT COMPLETED|Core Study||0
2498627|NCT00819585|6123001|P7|NOT COMPLETED|Core Study||13
2498628|NCT00819585|6123002|P6|NOT COMPLETED|Core Study||2
2498629|NCT00819585|6123003|P5|NOT COMPLETED|Core Study||3
2498630|NCT00819585|6123004|P4|NOT COMPLETED|Core Study||5
2498631|NCT00819585|6123005|P3|NOT COMPLETED|Core Study||6
2498632|NCT00819585|6123006|P2|NOT COMPLETED|Core Study||6
2498633|NCT00819585|6123007|P1|NOT COMPLETED|Core Study||6
2498634|NCT00819585|6122997|P11|COMPLETED|Core Study||0
2498635|NCT00819585|6122998|P10|COMPLETED|Core Study||0
2498636|NCT00819585|6122999|P9|COMPLETED|Core Study||0
2498637|NCT00819585|6123000|P8|COMPLETED|Core Study||0
2498638|NCT00819585|6123001|P7|COMPLETED|Core Study||95
2498639|NCT00819585|6123002|P6|COMPLETED|Core Study||52
2498640|NCT00819585|6123003|P5|COMPLETED|Core Study||50
2498641|NCT00819585|6123004|P4|COMPLETED|Core Study||49
2498642|NCT00819585|6123005|P3|COMPLETED|Core Study||48
2498643|NCT00819585|6123006|P2|COMPLETED|Core Study||48
2498644|NCT00819585|6123007|P1|COMPLETED|Core Study||49
2498645|NCT00819585|6122997|P11|Received Study Medication|Core Study||0
2498646|NCT00819585|6122998|P10|Received Study Medication|Core Study||0
2498647|NCT00819585|6122999|P9|Received Study Medication|Core Study||0
2498648|NCT00819585|6123000|P8|Received Study Medication|Core Study||0
2498649|NCT00819585|6123001|P7|Received Study Medication|Core Study||108
2498650|NCT00819585|6123002|P6|Received Study Medication|Core Study|One participant in this treatment arm was HIV+ve and did not receive any study medication.|53
2498651|NCT00819585|6123003|P5|Received Study Medication|Core Study||53
2498652|NCT00819585|6123004|P4|Received Study Medication|Core Study||54
2498653|NCT00819585|6123005|P3|Received Study Medication|Core Study||54
2498654|NCT00819585|6123006|P2|Received Study Medication|Core Study||54
2498655|NCT00819585|6123007|P1|Received Study Medication|Core Study|Participants who received study medication are included in the safety population.|55
2498656|NCT00819585|6122997|P11|STARTED|Core Study|There were no participants in this arm during the core study.|0
2498657|NCT00819585|6122998|P10|STARTED|Core Study|There were no participants in this arm during the core study.|0
2498658|NCT00819585|6122999|P9|STARTED|Core Study|There were no participants in this arm during the core study.|0
2498659|NCT00819585|6123000|P8|STARTED|Core Study|There were no participants in this arm during the core study.|0
2498660|NCT00819585|6123001|P7|STARTED|Core Study||108
2498661|NCT00819585|6123002|P6|STARTED|Core Study||54
2498662|NCT00819585|6123003|P5|STARTED|Core Study||53
2498663|NCT00819585|6123004|P4|STARTED|Core Study||54
2498664|NCT00819585|6123005|P3|STARTED|Core Study||54
2498665|NCT00819585|6123006|P2|STARTED|Core Study||54
2498666|NCT00819585|6123007|P1|STARTED|Core Study|Participants who started the core study are included in the randomized and full analysis sets.|55
2498667|NCT00819507|6123078|P1|NOT COMPLETED|Overall Study||0
2498668|NCT00819507|6123078|P1|COMPLETED|Overall Study||25
2498669|NCT00819507|6123078|P1|STARTED|Overall Study||25
2498670|NCT00819403|6123085|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
2498671|NCT00819403|6123086|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
2498672|NCT00819403|6123085|P2|COMPLETED|Second Intervention (6 Weeks)||8
2498673|NCT00819403|6123086|P1|COMPLETED|Second Intervention (6 Weeks)||7
2498674|NCT00819403|6123085|P2|STARTED|Second Intervention (6 Weeks)||8
2498675|NCT00819403|6123086|P1|STARTED|Second Intervention (6 Weeks)||7
2498676|NCT00819403|6123085|P2|NOT COMPLETED|Washout (14 Days)||0
2498677|NCT00819403|6123086|P1|NOT COMPLETED|Washout (14 Days)||0
2498678|NCT00819403|6123085|P2|COMPLETED|Washout (14 Days)||8
2498679|NCT00819403|6123086|P1|COMPLETED|Washout (14 Days)||7
2498680|NCT00819403|6123085|P2|STARTED|Washout (14 Days)||8
2498681|NCT00819403|6123086|P1|STARTED|Washout (14 Days)||7
2498682|NCT00819403|6123085|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
2498683|NCT00819403|6123086|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
2498684|NCT00819403|6123085|P2|COMPLETED|First Intervention (6 Weeks)||8
2498685|NCT00819403|6123086|P1|COMPLETED|First Intervention (6 Weeks)||7
2498686|NCT00819403|6123085|P2|STARTED|First Intervention (6 Weeks)||8
2498687|NCT00819403|6123086|P1|STARTED|First Intervention (6 Weeks)||7
2498688|NCT00819390|6123098|P4|NOT COMPLETED|Overall Study||0
2498689|NCT00819390|6123099|P3|NOT COMPLETED|Overall Study||1
2498690|NCT00819390|6123100|P2|NOT COMPLETED|Overall Study||1
2498691|NCT00819390|6123101|P1|NOT COMPLETED|Overall Study||3
2498692|NCT00819390|6123098|P4|COMPLETED|Overall Study||19
2498693|NCT00819390|6123099|P3|COMPLETED|Overall Study||17
2498694|NCT00819390|6123100|P2|COMPLETED|Overall Study||16
2498695|NCT00819390|6123101|P1|COMPLETED|Overall Study||13
2498696|NCT00819390|6123098|P4|STARTED|Overall Study||19
2498697|NCT00819390|6123099|P3|STARTED|Overall Study||18
2498698|NCT00819390|6123100|P2|STARTED|Overall Study||17
2498699|NCT00819390|6123101|P1|STARTED|Overall Study||16
2498700|NCT00819286|6123213|P2|NOT COMPLETED|Overall Study||25
2498701|NCT00819286|6123214|P1|NOT COMPLETED|Overall Study||14
2498702|NCT00819286|6123213|P2|COMPLETED|Overall Study||45
2498703|NCT00819286|6123214|P1|COMPLETED|Overall Study||56
2498704|NCT00819286|6123213|P2|STARTED|Overall Study||70
2498705|NCT00819286|6123214|P1|STARTED|Overall Study||70
2498706|NCT00819260|6123222|P1|NOT COMPLETED|Overall Study||0
2498707|NCT00819260|6123222|P1|COMPLETED|Overall Study||31
2498708|NCT00819260|6123222|P1|STARTED|Overall Study||31
2498709|NCT00819247|6123237|P3|NOT COMPLETED|Overall Study||14
2498710|NCT00819247|6123238|P2|NOT COMPLETED|Overall Study||16
2498711|NCT00819247|6123239|P1|NOT COMPLETED|Overall Study||11
2498712|NCT00819247|6123237|P3|COMPLETED|Overall Study||26
2498713|NCT00819247|6123238|P2|COMPLETED|Overall Study||30
2498714|NCT00819247|6123239|P1|COMPLETED|Overall Study||32
2498715|NCT00819247|6123237|P3|Per Protocol Population|Overall Study|One participant - baseline testosterone outside normal range.|38
2498716|NCT00819247|6123238|P2|Per Protocol Population|Overall Study|Two participants - prohibited drugs|44
2498717|NCT00819247|6123239|P1|Per Protocol Population|Overall Study|One participant- baseline testosterone outside normal range. Three participants- prohibited drugs.|38
2498718|NCT00819247|6123237|P3|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|39
2498719|NCT00819247|6123238|P2|Intent-to-treat Population|Overall Study||46
2498720|NCT00819247|6123239|P1|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|42
2498721|NCT00819247|6123237|P3|Randomized|Overall Study||40
2498722|NCT00819247|6123238|P2|Randomized|Overall Study||46
2498723|NCT00819247|6123239|P1|Randomized|Overall Study||43
2498724|NCT00819247|6123237|P3|STARTED|Overall Study||40
2498725|NCT00819247|6123238|P2|STARTED|Overall Study||46
2498726|NCT00819247|6123239|P1|STARTED|Overall Study||43
2498727|NCT00819234|6123265|P10|NOT COMPLETED|Overall Study||7
2498728|NCT00819234|6123266|P9|NOT COMPLETED|Overall Study||6
2498729|NCT00819234|6123267|P8|NOT COMPLETED|Overall Study||9
2498730|NCT00819234|6123268|P7|NOT COMPLETED|Overall Study||5
2498731|NCT00819234|6123269|P6|NOT COMPLETED|Overall Study||7
2498732|NCT00819234|6123270|P5|NOT COMPLETED|Overall Study||1
2498733|NCT00819234|6123271|P4|NOT COMPLETED|Overall Study||6
2498734|NCT00819234|6123272|P3|NOT COMPLETED|Overall Study||8
2498735|NCT00819234|6123273|P2|NOT COMPLETED|Overall Study||15
2498736|NCT00819234|6123274|P1|NOT COMPLETED|Overall Study||10
2498737|NCT00819234|6123265|P10|COMPLETED|Overall Study||30
2498738|NCT00819234|6123266|P9|COMPLETED|Overall Study||31
2498739|NCT00819234|6123267|P8|COMPLETED|Overall Study||20
2498740|NCT00819234|6123268|P7|COMPLETED|Overall Study||8
2498741|NCT00819234|6123269|P6|COMPLETED|Overall Study||7
2498742|NCT00819234|6123270|P5|COMPLETED|Overall Study||12
2498743|NCT00819234|6123271|P4|COMPLETED|Overall Study||22
2498744|NCT00819234|6123272|P3|COMPLETED|Overall Study||28
2498745|NCT00819234|6123273|P2|COMPLETED|Overall Study||20
2498746|NCT00819234|6123274|P1|COMPLETED|Overall Study||21
2498747|NCT00819234|6123265|P10|STARTED|Overall Study||37
2498748|NCT00819234|6123266|P9|STARTED|Overall Study||37
2498749|NCT00819234|6123267|P8|STARTED|Overall Study||29
2498750|NCT00819234|6123268|P7|STARTED|Overall Study||13
2498751|NCT00819234|6123269|P6|STARTED|Overall Study||14
2498752|NCT00819234|6123270|P5|STARTED|Overall Study||13
2498753|NCT00819234|6123271|P4|STARTED|Overall Study||28
2498754|NCT00819234|6123272|P3|STARTED|Overall Study||36
2498755|NCT00819234|6123273|P2|STARTED|Overall Study||35
2498756|NCT00819234|6123274|P1|STARTED|Overall Study||31
2498757|NCT00819182|6123435|P3|NOT COMPLETED|Overall Study||1
2498758|NCT00819182|6123436|P2|NOT COMPLETED|Overall Study||8
2498759|NCT00819182|6123437|P1|NOT COMPLETED|Overall Study||13
2498760|NCT00819182|6123435|P3|COMPLETED|Overall Study||43
2498761|NCT00819182|6123436|P2|COMPLETED|Overall Study||78
2498762|NCT00819182|6123437|P1|COMPLETED|Overall Study||75
2498763|NCT00819182|6123435|P3|Week 16 Visit|Overall Study||43
2498764|NCT00819182|6123436|P2|Week 16 Visit|Overall Study||78
2498765|NCT00819182|6123437|P1|Week 16 Visit|Overall Study||75
2498766|NCT00819182|6123435|P3|STARTED|Overall Study|Consented participants allocated to this arm.|44
2498767|NCT00819182|6123436|P2|STARTED|Overall Study|Consented participants allocated to this arm.|86
2498768|NCT00819182|6123437|P1|STARTED|Overall Study|Consented participants allocated to this arm.|88
2498769|NCT00819156|6123473|P6|NOT COMPLETED|Overall Study||8
2498770|NCT00819156|6123474|P5|NOT COMPLETED|Overall Study||6
2498771|NCT00819156|6123475|P4|NOT COMPLETED|Overall Study||2
2498772|NCT00819156|6123476|P3|NOT COMPLETED|Overall Study||6
2498773|NCT00819156|6123477|P2|NOT COMPLETED|Overall Study||10
2498774|NCT00819156|6123478|P1|NOT COMPLETED|Overall Study||10
2498775|NCT00819156|6123473|P6|COMPLETED|Overall Study||23
2498776|NCT00819156|6123474|P5|COMPLETED|Overall Study||27
2498777|NCT00819156|6123475|P4|COMPLETED|Overall Study||28
2498778|NCT00819156|6123476|P3|COMPLETED|Overall Study||26
2498779|NCT00819156|6123477|P2|COMPLETED|Overall Study||23
2498780|NCT00819156|6123478|P1|COMPLETED|Overall Study||20
2498781|NCT00819156|6123473|P6|Randomised and Treated (ITT Population)|Overall Study||30
2498782|NCT00819156|6123474|P5|Randomised and Treated (ITT Population)|Overall Study||33
2498783|NCT00819156|6123475|P4|Randomised and Treated (ITT Population)|Overall Study||30
2498784|NCT00819156|6123476|P3|Randomised and Treated (ITT Population)|Overall Study||32
2498785|NCT00819156|6123477|P2|Randomised and Treated (ITT Population)|Overall Study||32
2498786|NCT00819156|6123478|P1|Randomised and Treated (ITT Population)|Overall Study||30
2498787|NCT00819156|6123473|P6|STARTED|Overall Study||31
2498788|NCT00819156|6123474|P5|STARTED|Overall Study||33
2498789|NCT00819156|6123475|P4|STARTED|Overall Study||30
2498790|NCT00819156|6123476|P3|STARTED|Overall Study||32
2498791|NCT00819156|6123477|P2|STARTED|Overall Study||33
2498792|NCT00819156|6123478|P1|STARTED|Overall Study||30
2498793|NCT00819091|6123568|P2|NOT COMPLETED|Overall Study||10
2498794|NCT00819091|6123569|P1|NOT COMPLETED|Overall Study||7
2498795|NCT00819091|6123568|P2|COMPLETED|Overall Study||151
2498796|NCT00819091|6123569|P1|COMPLETED|Overall Study||77
2498797|NCT00819091|6123568|P2|STARTED|Overall Study||161
2498798|NCT00819091|6123569|P1|STARTED|Overall Study||84
2498799|NCT00819052|6123595|P2|NOT COMPLETED|Overall Study||14
2498800|NCT00819052|6123596|P1|NOT COMPLETED|Overall Study||6
2498801|NCT00819052|6123595|P2|COMPLETED|Overall Study||281
2498802|NCT00819052|6123596|P1|COMPLETED|Overall Study||142
2498803|NCT00819052|6123595|P2|STARTED|Overall Study||295
2498804|NCT00819052|6123596|P1|STARTED|Overall Study||148
2498805|NCT00819039|6123711|P3|NOT COMPLETED|Overall Study||1
2498806|NCT00819039|6123712|P2|NOT COMPLETED|Overall Study||0
2498807|NCT00819039|6123713|P1|NOT COMPLETED|Overall Study||2
2498808|NCT00819039|6123711|P3|COMPLETED|Overall Study||24
2498809|NCT00819039|6123712|P2|COMPLETED|Overall Study||27
2498810|NCT00819039|6123713|P1|COMPLETED|Overall Study||44
2498811|NCT00819039|6123711|P3|STARTED|Overall Study||25
2498812|NCT00819039|6123712|P2|STARTED|Overall Study||27
2498813|NCT00819039|6123713|P1|STARTED|Overall Study||46
2498814|NCT00819013|6123743|P4|NOT COMPLETED|Overall Study||4
2498815|NCT00819013|6123744|P3|NOT COMPLETED|Overall Study||5
2498816|NCT00819013|6123745|P2|NOT COMPLETED|Overall Study||1
2498817|NCT00819013|6123746|P1|NOT COMPLETED|Overall Study||3
2498818|NCT00819013|6123743|P4|COMPLETED|Overall Study||17
2498819|NCT00819013|6123744|P3|COMPLETED|Overall Study||16
2498820|NCT00819013|6123745|P2|COMPLETED|Overall Study||22
2498821|NCT00819013|6123746|P1|COMPLETED|Overall Study||19
2498822|NCT00819013|6123743|P4|STARTED|Overall Study||21
2498823|NCT00819013|6123744|P3|STARTED|Overall Study||21
2498824|NCT00819013|6123745|P2|STARTED|Overall Study||23
2498825|NCT00819013|6123746|P1|STARTED|Overall Study||22
2498826|NCT00818961|6123796|P1|NOT COMPLETED|Overall Study||0
2498827|NCT00818961|6123796|P1|COMPLETED|Overall Study||36
2498828|NCT00818961|6123796|P1|STARTED|Overall Study||36
2498829|NCT00818883|6123812|P2|NOT COMPLETED|Overall Study||46
2498830|NCT00818883|6123813|P1|NOT COMPLETED|Overall Study||51
2498831|NCT00818883|6123812|P2|COMPLETED|Overall Study||260
2498832|NCT00818883|6123813|P1|COMPLETED|Overall Study||252
2498833|NCT00818883|6123812|P2|STARTED|Overall Study||306
2498834|NCT00818883|6123813|P1|STARTED|Overall Study||303
2498835|NCT00818805|6123847|P2|NOT COMPLETED|Second Intervention||0
2498836|NCT00818805|6123848|P1|NOT COMPLETED|Second Intervention||0
2498837|NCT00818805|6123847|P2|COMPLETED|Second Intervention||25
2498838|NCT00818805|6123848|P1|COMPLETED|Second Intervention||25
2498839|NCT00818805|6123847|P2|STARTED|Second Intervention||25
2498840|NCT00818805|6123848|P1|STARTED|Second Intervention||25
2498841|NCT00818805|6123847|P2|NOT COMPLETED|First Intervention||0
2498842|NCT00818805|6123848|P1|NOT COMPLETED|First Intervention||0
2498843|NCT00818805|6123847|P2|COMPLETED|First Intervention||25
2498844|NCT00818805|6123848|P1|COMPLETED|First Intervention||25
2498845|NCT00818805|6123847|P2|STARTED|First Intervention||25
2498846|NCT00818805|6123848|P1|STARTED|First Intervention||25
2498847|NCT00818779|6123860|P2|NOT COMPLETED|Overall Study||1
2498848|NCT00818779|6123861|P1|NOT COMPLETED|Overall Study||6
2498849|NCT00818779|6123860|P2|COMPLETED|Overall Study||15
2498850|NCT00818779|6123861|P1|COMPLETED|Overall Study||16
2498851|NCT00818779|6123860|P2|STARTED|Overall Study||16
2498852|NCT00818779|6123861|P1|STARTED|Overall Study||22
2498853|NCT00818766|6123877|P2|NOT COMPLETED|Overall Study||10
2498854|NCT00818766|6123878|P1|NOT COMPLETED|Overall Study||15
2498855|NCT00818766|6123877|P2|COMPLETED|Overall Study||116
2498856|NCT00818766|6123878|P1|COMPLETED|Overall Study||110
2498857|NCT00818766|6123877|P2|Intent-to-Treat Population|Overall Study|2 participants were randomized twice but only counted once (per first randomization).|124
2498858|NCT00818766|6123878|P1|Intent-to-Treat Population|Overall Study|1 participant was randomized twice but only counted once (per first randomization).|121
2498859|NCT00818766|6123877|P2|Received Allocated Intervention|Overall Study||126
2498860|NCT00818766|6123878|P1|Received Allocated Intervention|Overall Study|1 withdrew consent, 1 had active infection and 1 was given open-label antibiotic after surgery.|122
2498861|NCT00818766|6123877|P2|STARTED|Overall Study||126
2498862|NCT00818766|6123878|P1|STARTED|Overall Study||125
2498863|NCT00818753|6123907|P3|NOT COMPLETED|Overall Study||1
2498864|NCT00818753|6123908|P2|NOT COMPLETED|Overall Study||0
2498865|NCT00818753|6123909|P1|NOT COMPLETED|Overall Study||3
2498866|NCT00818753|6123907|P3|COMPLETED|Overall Study||9
2498867|NCT00818753|6123908|P2|COMPLETED|Overall Study||21
2498868|NCT00818753|6123909|P1|COMPLETED|Overall Study||19
2498869|NCT00818753|6123907|P3|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|10
2498870|NCT00818753|6123908|P2|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|21
2498871|NCT00818753|6123909|P1|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|22
2498872|NCT00818662|6123933|P4|NOT COMPLETED|Overall Study||16
2498873|NCT00818662|6123934|P3|NOT COMPLETED|Overall Study||9
2498874|NCT00818662|6123935|P2|NOT COMPLETED|Overall Study||33
2498875|NCT00818662|6123936|P1|NOT COMPLETED|Overall Study||23
2498876|NCT00818662|6123933|P4|COMPLETED|Overall Study||47
2498877|NCT00818662|6123934|P3|COMPLETED|Overall Study||49
2498878|NCT00818662|6123935|P2|COMPLETED|Overall Study||102
2498879|NCT00818662|6123936|P1|COMPLETED|Overall Study||104
2498880|NCT00818662|6123933|P4|STARTED|Overall Study||63
2498881|NCT00818662|6123934|P3|STARTED|Overall Study||58
2498882|NCT00818662|6123935|P2|STARTED|Overall Study||135
2498883|NCT00818662|6123936|P1|STARTED|Overall Study||127
2498884|NCT00818649|6124022|P1|NOT COMPLETED|Overall Study||4
2498885|NCT00818649|6124022|P1|COMPLETED|Overall Study||12
2498886|NCT00818649|6124022|P1|STARTED|Overall Study||16
2498887|NCT00818623|6124036|P8|NOT COMPLETED|Overall Study||1
2498888|NCT00818623|6124037|P7|NOT COMPLETED|Overall Study||4
2498889|NCT00818623|6124038|P6|NOT COMPLETED|Overall Study||3
2498890|NCT00818623|6124039|P5|NOT COMPLETED|Overall Study||4
2498891|NCT00818623|6124040|P4|NOT COMPLETED|Overall Study||5
2498892|NCT00818623|6124041|P3|NOT COMPLETED|Overall Study||4
2498893|NCT00818623|6124042|P2|NOT COMPLETED|Overall Study||4
2498894|NCT00818623|6124043|P1|NOT COMPLETED|Overall Study||2
2498895|NCT00818623|6124036|P8|COMPLETED|Overall Study||26
2498896|NCT00818623|6124037|P7|COMPLETED|Overall Study||23
2498897|NCT00818623|6124038|P6|COMPLETED|Overall Study||21
2498898|NCT00818623|6124039|P5|COMPLETED|Overall Study||23
2498899|NCT00818623|6124040|P4|COMPLETED|Overall Study||19
2498900|NCT00818623|6124041|P3|COMPLETED|Overall Study||9
2498901|NCT00818623|6124042|P2|COMPLETED|Overall Study||8
2498902|NCT00818623|6124043|P1|COMPLETED|Overall Study||24
2498903|NCT00818623|6124036|P8|Intent-to-treat (ITT) Population|Overall Study||27
2498904|NCT00818623|6124037|P7|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
2498905|NCT00818623|6124038|P6|Intent-to-treat (ITT) Population|Overall Study||24
2498906|NCT00818623|6124039|P5|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
2498907|NCT00818623|6124040|P4|Intent-to-treat (ITT) Population|Overall Study||24
2498908|NCT00818623|6124041|P3|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|12
2498909|NCT00818623|6124042|P2|Intent-to-treat (ITT) Population|Overall Study||12
2498910|NCT00818623|6124043|P1|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|25
2498911|NCT00818623|6124036|P8|STARTED|Overall Study||27
2498912|NCT00818623|6124037|P7|STARTED|Overall Study||27
2498913|NCT00818623|6124038|P6|STARTED|Overall Study||24
2498914|NCT00818623|6124039|P5|STARTED|Overall Study||27
2498915|NCT00818623|6124040|P4|STARTED|Overall Study||24
2498916|NCT00818623|6124041|P3|STARTED|Overall Study||13
2498917|NCT00818623|6124042|P2|STARTED|Overall Study||12
2498918|NCT00818623|6124043|P1|STARTED|Overall Study||26
2498919|NCT00818519|6124119|P2|NOT COMPLETED|Overall Study||19
2498920|NCT00818519|6124120|P1|NOT COMPLETED|Overall Study||14
2498921|NCT00818519|6124119|P2|COMPLETED|Overall Study||71
2498922|NCT00818519|6124120|P1|COMPLETED|Overall Study||75
2498923|NCT00818519|6124119|P2|Participants Received Treatment|Overall Study|= Baseline|86
2498924|NCT00818519|6124120|P1|Participants Received Treatment|Overall Study|= Baseline|87
2498925|NCT00818519|6124119|P2|STARTED|Overall Study|4 excluded from FAS because study drug intake unknown or never administered|90
2498926|NCT00818519|6124120|P1|STARTED|Overall Study|2 excluded from FAS because study drug intake unknown or never administered|89
2498927|NCT00818454|6124150|P4|NOT COMPLETED|Treatment Period 3||1
2498928|NCT00818454|6124151|P3|NOT COMPLETED|Treatment Period 3||0
2498929|NCT00818454|6124152|P2|NOT COMPLETED|Treatment Period 3||0
2498930|NCT00818454|6124153|P1|NOT COMPLETED|Treatment Period 3||0
2498931|NCT00818454|6124150|P4|COMPLETED|Treatment Period 3||138
2498932|NCT00818454|6124151|P3|COMPLETED|Treatment Period 3||26
2498933|NCT00818454|6124152|P2|COMPLETED|Treatment Period 3||0
2498934|NCT00818454|6124153|P1|COMPLETED|Treatment Period 3||0
2498935|NCT00818454|6124150|P4|STARTED|Treatment Period 3||139
2498936|NCT00818454|6124151|P3|STARTED|Treatment Period 3||26
2498937|NCT00818454|6124152|P2|STARTED|Treatment Period 3||0
2498938|NCT00818454|6124153|P1|STARTED|Treatment Period 3||0
2498939|NCT00818454|6124150|P4|NOT COMPLETED|Treatment Period 2||0
2498940|NCT00818454|6124151|P3|NOT COMPLETED|Treatment Period 2||0
2498941|NCT00818454|6124152|P2|NOT COMPLETED|Treatment Period 2||1
2498942|NCT00818454|6124153|P1|NOT COMPLETED|Treatment Period 2||2
2498943|NCT00818454|6124150|P4|COMPLETED|Treatment Period 2||0
2498944|NCT00818454|6124151|P3|COMPLETED|Treatment Period 2||0
2498945|NCT00818454|6124152|P2|COMPLETED|Treatment Period 2||106
2498946|NCT00818454|6124153|P1|COMPLETED|Treatment Period 2||106
2498947|NCT00818454|6124150|P4|STARTED|Treatment Period 2||0
2498948|NCT00818454|6124151|P3|STARTED|Treatment Period 2||0
2498949|NCT00818454|6124152|P2|STARTED|Treatment Period 2||107
2498950|NCT00818454|6124153|P1|STARTED|Treatment Period 2||108
2498951|NCT00818454|6124150|P4|NOT COMPLETED|Washout Period of 1 Week||0
2498952|NCT00818454|6124151|P3|NOT COMPLETED|Washout Period of 1 Week||0
2498953|NCT00818454|6124152|P2|NOT COMPLETED|Washout Period of 1 Week||3
2498954|NCT00818454|6124153|P1|NOT COMPLETED|Washout Period of 1 Week||4
2498955|NCT00818454|6124150|P4|COMPLETED|Washout Period of 1 Week||0
2498956|NCT00818454|6124151|P3|COMPLETED|Washout Period of 1 Week||0
2498957|NCT00818454|6124152|P2|COMPLETED|Washout Period of 1 Week||107
2498958|NCT00818454|6124153|P1|COMPLETED|Washout Period of 1 Week||108
2498959|NCT00818454|6124150|P4|STARTED|Washout Period of 1 Week||0
2498960|NCT00818454|6124151|P3|STARTED|Washout Period of 1 Week||0
2498961|NCT00818454|6124152|P2|STARTED|Washout Period of 1 Week||110
2498962|NCT00818454|6124153|P1|STARTED|Washout Period of 1 Week||112
2498963|NCT00818454|6124150|P4|NOT COMPLETED|Treatment Period 1||0
2498964|NCT00818454|6124151|P3|NOT COMPLETED|Treatment Period 1||0
2498965|NCT00818454|6124152|P2|NOT COMPLETED|Treatment Period 1||1
2498966|NCT00818454|6124153|P1|NOT COMPLETED|Treatment Period 1||3
2498967|NCT00818454|6124150|P4|COMPLETED|Treatment Period 1||0
2498968|NCT00818454|6124151|P3|COMPLETED|Treatment Period 1||0
2498969|NCT00818454|6124152|P2|COMPLETED|Treatment Period 1||110
2498970|NCT00818454|6124153|P1|COMPLETED|Treatment Period 1||112
2498971|NCT00818454|6124150|P4|STARTED|Treatment Period 1||0
2498972|NCT00818454|6124151|P3|STARTED|Treatment Period 1||0
2498973|NCT00818454|6124152|P2|STARTED|Treatment Period 1||111
2498974|NCT00818454|6124153|P1|STARTED|Treatment Period 1||115
2498975|NCT00818441|6124181|P2|NOT COMPLETED|Overall Study||30
2498976|NCT00818441|6124182|P1|NOT COMPLETED|Overall Study||89
2498977|NCT00818441|6124181|P2|COMPLETED|Overall Study||0
2498978|NCT00818441|6124182|P1|COMPLETED|Overall Study||0
2498979|NCT00818441|6124181|P2|STARTED|Overall Study||30
2498980|NCT00818441|6124182|P1|STARTED|Overall Study||89
2498981|NCT00818389|6124204|P2|NOT COMPLETED|Overall Study||6
2498982|NCT00818389|6124205|P1|NOT COMPLETED|Overall Study||4
2498983|NCT00818389|6124204|P2|COMPLETED|Overall Study|6 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|38
2498984|NCT00818389|6124205|P1|COMPLETED|Overall Study|4 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|36
2498985|NCT00818389|6124204|P2|STARTED|Overall Study||44
2498986|NCT00818389|6124205|P1|STARTED|Overall Study||40
2498987|NCT00818337|6124215|P1|NOT COMPLETED|Overall Study||0
2498988|NCT00818337|6124215|P1|COMPLETED|Overall Study||36
2498989|NCT00818337|6124215|P1|STARTED|Overall Study||36
2498990|NCT00818324|6124220|P1|NOT COMPLETED|Overall Study||27
2498991|NCT00818324|6124220|P1|COMPLETED|Overall Study||127
2498992|NCT00818324|6124220|P1|STARTED|Overall Study||154
2498993|NCT00818272|6124225|P1|NOT COMPLETED|Overall Study||74
2498994|NCT00818272|6124225|P1|COMPLETED|Overall Study||74
2498995|NCT00818272|6124225|P1|STARTED|Overall Study||148
2498996|NCT00818259|6124240|P9|NOT COMPLETED|Part V||0
2498997|NCT00818259|6124241|P8|NOT COMPLETED|Part V||1
2498998|NCT00818259|6124242|P7|NOT COMPLETED|Part V||0
2498999|NCT00818259|6124243|P6|NOT COMPLETED|Part V||0
2499000|NCT00818259|6124244|P5|NOT COMPLETED|Part V||0
2499001|NCT00818259|6124245|P4|NOT COMPLETED|Part V||0
2499002|NCT00818259|6124246|P3|NOT COMPLETED|Part V||0
2499003|NCT00818259|6124247|P2|NOT COMPLETED|Part V||0
2499004|NCT00818259|6124248|P1|NOT COMPLETED|Part V||0
2499005|NCT00818259|6124240|P9|COMPLETED|Part V||6
2499006|NCT00818259|6124241|P8|COMPLETED|Part V||16
2499007|NCT00818259|6124242|P7|COMPLETED|Part V||0
2499008|NCT00818259|6124243|P6|COMPLETED|Part V||0
2499009|NCT00818259|6124244|P5|COMPLETED|Part V||0
2499010|NCT00818259|6124245|P4|COMPLETED|Part V||0
2499011|NCT00818259|6124246|P3|COMPLETED|Part V||0
2499012|NCT00818259|6124247|P2|COMPLETED|Part V||0
2499013|NCT00818259|6124248|P1|COMPLETED|Part V||0
2499014|NCT00818259|6124240|P9|STARTED|Part V|Newly enrolled participants|6
2499015|NCT00818259|6124241|P8|STARTED|Part V|Participants continuing from Part IV|17
2499016|NCT00818259|6124242|P7|STARTED|Part V||0
2499017|NCT00818259|6124243|P6|STARTED|Part V||0
2499018|NCT00818259|6124244|P5|STARTED|Part V||0
2499019|NCT00818259|6124245|P4|STARTED|Part V||0
2499020|NCT00818259|6124246|P3|STARTED|Part V||0
2499021|NCT00818259|6124247|P2|STARTED|Part V||0
2499022|NCT00818259|6124248|P1|STARTED|Part V||0
2499023|NCT00818259|6124240|P9|NOT COMPLETED|Part IV||0
2499024|NCT00818259|6124241|P8|NOT COMPLETED|Part IV||0
2499025|NCT00818259|6124242|P7|NOT COMPLETED|Part IV||0
2499026|NCT00818259|6124243|P6|NOT COMPLETED|Part IV||1
2499027|NCT00818259|6124244|P5|NOT COMPLETED|Part IV||0
2499028|NCT00818259|6124245|P4|NOT COMPLETED|Part IV||0
2499029|NCT00818259|6124246|P3|NOT COMPLETED|Part IV||0
2499030|NCT00818259|6124247|P2|NOT COMPLETED|Part IV||0
2499031|NCT00818259|6124248|P1|NOT COMPLETED|Part IV||0
2499032|NCT00818259|6124240|P9|COMPLETED|Part IV||0
2499033|NCT00818259|6124241|P8|COMPLETED|Part IV||0
2499034|NCT00818259|6124242|P7|COMPLETED|Part IV||5
2499035|NCT00818259|6124243|P6|COMPLETED|Part IV||14
2499036|NCT00818259|6124244|P5|COMPLETED|Part IV||0
2499037|NCT00818259|6124245|P4|COMPLETED|Part IV||0
2499038|NCT00818259|6124246|P3|COMPLETED|Part IV||0
2499039|NCT00818259|6124247|P2|COMPLETED|Part IV||0
2499040|NCT00818259|6124248|P1|COMPLETED|Part IV||0
2499041|NCT00818259|6124240|P9|STARTED|Part IV||0
2499042|NCT00818259|6124241|P8|STARTED|Part IV||0
2499043|NCT00818259|6124242|P7|STARTED|Part IV|Newly enrolled participants|5
2499044|NCT00818259|6124243|P6|STARTED|Part IV|Participants continuing from Part III|15
2499045|NCT00818259|6124244|P5|STARTED|Part IV||0
2499046|NCT00818259|6124245|P4|STARTED|Part IV||0
2499047|NCT00818259|6124246|P3|STARTED|Part IV||0
2499048|NCT00818259|6124247|P2|STARTED|Part IV||0
2499049|NCT00818259|6124248|P1|STARTED|Part IV||0
2499050|NCT00818259|6124240|P9|NOT COMPLETED|Part III||0
2499051|NCT00818259|6124241|P8|NOT COMPLETED|Part III||0
2499052|NCT00818259|6124242|P7|NOT COMPLETED|Part III||0
2499053|NCT00818259|6124243|P6|NOT COMPLETED|Part III||0
2499054|NCT00818259|6124244|P5|NOT COMPLETED|Part III||0
2499055|NCT00818259|6124245|P4|NOT COMPLETED|Part III||0
2499056|NCT00818259|6124246|P3|NOT COMPLETED|Part III||0
2499057|NCT00818259|6124247|P2|NOT COMPLETED|Part III||0
2499058|NCT00818259|6124248|P1|NOT COMPLETED|Part III||0
2499059|NCT00818259|6124240|P9|COMPLETED|Part III||0
2499060|NCT00818259|6124241|P8|COMPLETED|Part III||0
2499061|NCT00818259|6124242|P7|COMPLETED|Part III||0
2499062|NCT00818259|6124243|P6|COMPLETED|Part III||0
2499063|NCT00818259|6124244|P5|COMPLETED|Part III||19
2499064|NCT00818259|6124245|P4|COMPLETED|Part III||0
2499065|NCT00818259|6124246|P3|COMPLETED|Part III||0
2499066|NCT00818259|6124247|P2|COMPLETED|Part III||0
2499067|NCT00818259|6124248|P1|COMPLETED|Part III||0
2499068|NCT00818259|6124240|P9|STARTED|Part III||0
2499069|NCT00818259|6124241|P8|STARTED|Part III||0
2499070|NCT00818259|6124242|P7|STARTED|Part III||0
2499071|NCT00818259|6124243|P6|STARTED|Part III||0
2499072|NCT00818259|6124244|P5|STARTED|Part III|Newly enrolled participants|19
2499073|NCT00818259|6124245|P4|STARTED|Part III||0
2499074|NCT00818259|6124246|P3|STARTED|Part III||0
2499075|NCT00818259|6124247|P2|STARTED|Part III||0
2499076|NCT00818259|6124248|P1|STARTED|Part III||0
2499077|NCT00818259|6124240|P9|NOT COMPLETED|Part II||0
2499078|NCT00818259|6124241|P8|NOT COMPLETED|Part II||0
2499079|NCT00818259|6124242|P7|NOT COMPLETED|Part II||0
2499080|NCT00818259|6124243|P6|NOT COMPLETED|Part II||0
2499081|NCT00818259|6124244|P5|NOT COMPLETED|Part II||0
2499082|NCT00818259|6124245|P4|NOT COMPLETED|Part II||2
2499083|NCT00818259|6124246|P3|NOT COMPLETED|Part II||1
2499084|NCT00818259|6124247|P2|NOT COMPLETED|Part II||0
2499085|NCT00818259|6124248|P1|NOT COMPLETED|Part II||0
2499086|NCT00818259|6124240|P9|COMPLETED|Part II||0
2499087|NCT00818259|6124241|P8|COMPLETED|Part II||0
2499088|NCT00818259|6124242|P7|COMPLETED|Part II||0
2499089|NCT00818259|6124243|P6|COMPLETED|Part II||0
2499090|NCT00818259|6124244|P5|COMPLETED|Part II||0
2499091|NCT00818259|6124245|P4|COMPLETED|Part II||18
2499092|NCT00818259|6124246|P3|COMPLETED|Part II||18
2499093|NCT00818259|6124247|P2|COMPLETED|Part II||0
2499094|NCT00818259|6124248|P1|COMPLETED|Part II||0
2499095|NCT00818259|6124240|P9|Treated|Part II||0
2499096|NCT00818259|6124241|P8|Treated|Part II||0
2499097|NCT00818259|6124242|P7|Treated|Part II||0
2499098|NCT00818259|6124243|P6|Treated|Part II||0
2499099|NCT00818259|6124244|P5|Treated|Part II||0
2499100|NCT00818259|6124245|P4|Treated|Part II||19
2499101|NCT00818259|6124246|P3|Treated|Part II||19
2499102|NCT00818259|6124247|P2|Treated|Part II||0
2499103|NCT00818259|6124248|P1|Treated|Part II||0
2499104|NCT00818259|6124240|P9|STARTED|Part II||0
2499105|NCT00818259|6124241|P8|STARTED|Part II||0
2499106|NCT00818259|6124242|P7|STARTED|Part II||0
2499107|NCT00818259|6124243|P6|STARTED|Part II||0
2499108|NCT00818259|6124244|P5|STARTED|Part II||0
2499109|NCT00818259|6124245|P4|STARTED|Part II|Newly enrolled participants|20
2499110|NCT00818259|6124246|P3|STARTED|Part II|Newly enrolled participants|19
2499111|NCT00818259|6124247|P2|STARTED|Part II||0
2499112|NCT00818259|6124248|P1|STARTED|Part II||0
2499113|NCT00818259|6124240|P9|NOT COMPLETED|Part I||0
2499114|NCT00818259|6124241|P8|NOT COMPLETED|Part I||0
2499115|NCT00818259|6124242|P7|NOT COMPLETED|Part I||0
2499116|NCT00818259|6124243|P6|NOT COMPLETED|Part I||0
2499117|NCT00818259|6124244|P5|NOT COMPLETED|Part I||0
2499118|NCT00818259|6124245|P4|NOT COMPLETED|Part I||0
2499119|NCT00818259|6124246|P3|NOT COMPLETED|Part I||0
2499120|NCT00818259|6124247|P2|NOT COMPLETED|Part I||0
2499121|NCT00818259|6124248|P1|NOT COMPLETED|Part I||1
2499122|NCT00818259|6124240|P9|COMPLETED|Part I||0
2499123|NCT00818259|6124241|P8|COMPLETED|Part I||0
2499124|NCT00818259|6124242|P7|COMPLETED|Part I||0
2499125|NCT00818259|6124243|P6|COMPLETED|Part I||0
2499126|NCT00818259|6124244|P5|COMPLETED|Part I||0
2499127|NCT00818259|6124245|P4|COMPLETED|Part I||0
2499128|NCT00818259|6124246|P3|COMPLETED|Part I||0
2499129|NCT00818259|6124247|P2|COMPLETED|Part I||11
2499130|NCT00818259|6124248|P1|COMPLETED|Part I||11
2499131|NCT00818259|6124240|P9|STARTED|Part I||0
2499132|NCT00818259|6124241|P8|STARTED|Part I||0
2499133|NCT00818259|6124242|P7|STARTED|Part I||0
2499134|NCT00818259|6124243|P6|STARTED|Part I||0
2499135|NCT00818259|6124244|P5|STARTED|Part I||0
2499136|NCT00818259|6124245|P4|STARTED|Part I||0
2499137|NCT00818259|6124246|P3|STARTED|Part I||0
2499138|NCT00818259|6124247|P2|STARTED|Part I|Newly enrolled participants|11
2499139|NCT00818259|6124248|P1|STARTED|Part I|Newly enrolled participants|12
2499140|NCT00818259|6124240|P9|NOT COMPLETED|Randomization||0
2499141|NCT00818259|6124241|P8|NOT COMPLETED|Randomization||0
2499142|NCT00818259|6124242|P7|NOT COMPLETED|Randomization||0
2499143|NCT00818259|6124243|P6|NOT COMPLETED|Randomization||0
2499144|NCT00818259|6124244|P5|NOT COMPLETED|Randomization||0
2499145|NCT00818259|6124245|P4|NOT COMPLETED|Randomization||0
2499146|NCT00818259|6124246|P3|NOT COMPLETED|Randomization||0
2499147|NCT00818259|6124247|P2|NOT COMPLETED|Randomization||0
2499148|NCT00818259|6124248|P1|NOT COMPLETED|Randomization||0
2499149|NCT00818259|6124240|P9|COMPLETED|Randomization||6
2499150|NCT00818259|6124241|P8|COMPLETED|Randomization||0
2499151|NCT00818259|6124242|P7|COMPLETED|Randomization||5
2499152|NCT00818259|6124243|P6|COMPLETED|Randomization||0
2499153|NCT00818259|6124244|P5|COMPLETED|Randomization||19
2499154|NCT00818259|6124245|P4|COMPLETED|Randomization||20
2499155|NCT00818259|6124246|P3|COMPLETED|Randomization||19
2499156|NCT00818259|6124247|P2|COMPLETED|Randomization||11
2499157|NCT00818259|6124248|P1|COMPLETED|Randomization||12
2499158|NCT00818259|6124240|P9|STARTED|Randomization||6
2499159|NCT00818259|6124241|P8|STARTED|Randomization||0
2499160|NCT00818259|6124242|P7|STARTED|Randomization||5
2499161|NCT00818259|6124243|P6|STARTED|Randomization||0
2499162|NCT00818259|6124244|P5|STARTED|Randomization||19
2499163|NCT00818259|6124245|P4|STARTED|Randomization||20
2499164|NCT00818259|6124246|P3|STARTED|Randomization||19
2499165|NCT00818259|6124247|P2|STARTED|Randomization||11
2499166|NCT00818259|6124248|P1|STARTED|Randomization||12
2499167|NCT00818246|6124320|P1|NOT COMPLETED|Overall Study||5
2499168|NCT00818246|6124320|P1|COMPLETED|Overall Study|split-face study|35
2499169|NCT00818246|6124320|P1|STARTED|Overall Study||40
2499170|NCT00818207|6124329|P2|NOT COMPLETED|Overall Study||267
2499171|NCT00818207|6124330|P1|NOT COMPLETED|Overall Study||222
2499172|NCT00818207|6124329|P2|COMPLETED|Overall Study||417
2499173|NCT00818207|6124330|P1|COMPLETED|Overall Study||474
2499174|NCT00818207|6124329|P2|STARTED|Overall Study||684
2499175|NCT00818207|6124330|P1|STARTED|Overall Study||696
2499176|NCT00818168|6124344|P1|NOT COMPLETED|Overall Study||70
2499177|NCT00818168|6124344|P1|COMPLETED|Overall Study|Includes 78 participants whose completer/non-completer status was not reported (missing)|250
2499178|NCT00818168|6124344|P1|STARTED|Overall Study||320
2499179|NCT00818116|6124352|P1|NOT COMPLETED|Overall Study||0
2499180|NCT00818116|6124352|P1|COMPLETED|Overall Study||34
2499181|NCT00818116|6124352|P1|STARTED|Overall Study||34
2499182|NCT00817999|6124358|P2|NOT COMPLETED|No Grapefruit Juice||0
2499183|NCT00817999|6124359|P1|NOT COMPLETED|No Grapefruit Juice||0
2499184|NCT00817999|6124358|P2|COMPLETED|No Grapefruit Juice||17
2499185|NCT00817999|6124359|P1|COMPLETED|No Grapefruit Juice||15
2499186|NCT00817999|6124358|P2|STARTED|No Grapefruit Juice||17
2499187|NCT00817999|6124359|P1|STARTED|No Grapefruit Juice||15
2499188|NCT00817999|6124358|P2|NOT COMPLETED|Grapefruit Juice||0
2499189|NCT00817999|6124359|P1|NOT COMPLETED|Grapefruit Juice||0
2499190|NCT00817999|6124358|P2|COMPLETED|Grapefruit Juice||17
2499191|NCT00817999|6124359|P1|COMPLETED|Grapefruit Juice||15
2499192|NCT00817999|6124358|P2|STARTED|Grapefruit Juice||17
2499193|NCT00817999|6124359|P1|STARTED|Grapefruit Juice||15
2499194|NCT00817843|6124367|P2|NOT COMPLETED|Second Period (6 Weeks)||1
2499195|NCT00817843|6124368|P1|NOT COMPLETED|Second Period (6 Weeks)||0
2499196|NCT00817843|6124367|P2|COMPLETED|Second Period (6 Weeks)||44
2499197|NCT00817843|6124368|P1|COMPLETED|Second Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|41
2499198|NCT00817843|6124367|P2|STARTED|Second Period (6 Weeks)||45
2499199|NCT00817843|6124368|P1|STARTED|Second Period (6 Weeks)||41
2499200|NCT00817843|6124367|P2|NOT COMPLETED|Washout Period (6 Weeks)||1
2499201|NCT00817843|6124368|P1|NOT COMPLETED|Washout Period (6 Weeks)||1
2499202|NCT00817843|6124367|P2|COMPLETED|Washout Period (6 Weeks)||45
2499203|NCT00817843|6124368|P1|COMPLETED|Washout Period (6 Weeks)||41
2499204|NCT00817843|6124367|P2|STARTED|Washout Period (6 Weeks)||46
2499205|NCT00817843|6124368|P1|STARTED|Washout Period (6 Weeks)||42
2499206|NCT00817843|6124367|P2|NOT COMPLETED|First Period (6 Weeks)||4
2499207|NCT00817843|6124368|P1|NOT COMPLETED|First Period (6 Weeks)||8
2499208|NCT00817843|6124367|P2|COMPLETED|First Period (6 Weeks)||46
2499209|NCT00817843|6124368|P1|COMPLETED|First Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|42
2499210|NCT00817843|6124367|P2|STARTED|First Period (6 Weeks)||50
2499211|NCT00817843|6124368|P1|STARTED|First Period (6 Weeks)||50
2499212|NCT00817804|6124375|P2|NOT COMPLETED|Overall Study||0
2499213|NCT00817804|6124376|P1|NOT COMPLETED|Overall Study||0
2499214|NCT00817804|6124375|P2|COMPLETED|Overall Study||2
2499215|NCT00817804|6124376|P1|COMPLETED|Overall Study||1
2499216|NCT00817804|6124375|P2|STARTED|Overall Study||2
2499217|NCT00817804|6124376|P1|STARTED|Overall Study||1
2499218|NCT00817778|6124384|P2|NOT COMPLETED|Overall Study||3
2499219|NCT00817778|6124385|P1|NOT COMPLETED|Overall Study||3
2499220|NCT00817778|6124384|P2|COMPLETED|Overall Study||5
2499221|NCT00817778|6124385|P1|COMPLETED|Overall Study||16
2499222|NCT00817778|6124384|P2|STARTED|Overall Study||8
2499223|NCT00817778|6124385|P1|STARTED|Overall Study||19
2499224|NCT00817596|6124410|P1|NOT COMPLETED|Overall Study||48
2499225|NCT00817596|6124410|P1|COMPLETED|Overall Study||62
2499226|NCT00817596|6124410|P1|STARTED|Overall Study||110
2499227|NCT00817531|6124414|P1|NOT COMPLETED|Overall Study||2
2499228|NCT00817531|6124414|P1|COMPLETED|Overall Study|20 out of 22 patients finished study treatment. 2 patients stopped the treatment after the 1st week.|20
2499229|NCT00817531|6124414|P1|STARTED|Overall Study|22 patients were eligible for this study and started the treatment.|22
2499230|NCT00817479|6124420|P2|NOT COMPLETED|Overall Study||1
2499231|NCT00817479|6124421|P1|NOT COMPLETED|Overall Study||1
2499232|NCT00817479|6124420|P2|COMPLETED|Overall Study||13
2499233|NCT00817479|6124421|P1|COMPLETED|Overall Study||5
2499234|NCT00817479|6124420|P2|STARTED|Overall Study||14
2499235|NCT00817479|6124421|P1|STARTED|Overall Study||6
2499236|NCT00817336|6124431|P2|NOT COMPLETED|Overall Study||1
2499237|NCT00817336|6124432|P1|NOT COMPLETED|Overall Study||1
2499238|NCT00817336|6124431|P2|COMPLETED|Overall Study||7
2499239|NCT00817336|6124432|P1|COMPLETED|Overall Study||7
2499240|NCT00817336|6124431|P2|STARTED|Overall Study||8
2499241|NCT00817336|6124432|P1|STARTED|Overall Study||8
2499242|NCT00817219|6124443|P1|NOT COMPLETED|Overall Study||0
2499243|NCT00817219|6124443|P1|COMPLETED|Overall Study||33
2499244|NCT00817219|6124443|P1|STARTED|Overall Study||33
2499245|NCT00817206|6124458|P2|NOT COMPLETED|Overall Study||9
2499246|NCT00817206|6124459|P1|NOT COMPLETED|Overall Study||21
2499247|NCT00817206|6124458|P2|COMPLETED|Overall Study||154
2499248|NCT00817206|6124459|P1|COMPLETED|Overall Study||142
2499249|NCT00817206|6124458|P2|STARTED|Overall Study||163
2499250|NCT00817206|6124459|P1|STARTED|Overall Study||163
2499251|NCT00817089|6124469|P4|NOT COMPLETED|Second Alcohol Challenge||0
2499252|NCT00817089|6124470|P3|NOT COMPLETED|Second Alcohol Challenge||0
2499253|NCT00817089|6124471|P2|NOT COMPLETED|Second Alcohol Challenge||1
2499254|NCT00817089|6124472|P1|NOT COMPLETED|Second Alcohol Challenge||0
2499255|NCT00817089|6124469|P4|COMPLETED|Second Alcohol Challenge||5
2499256|NCT00817089|6124470|P3|COMPLETED|Second Alcohol Challenge||4
2499257|NCT00817089|6124471|P2|COMPLETED|Second Alcohol Challenge||7
2499258|NCT00817089|6124472|P1|COMPLETED|Second Alcohol Challenge||6
2499259|NCT00817089|6124469|P4|STARTED|Second Alcohol Challenge||5
2499260|NCT00817089|6124470|P3|STARTED|Second Alcohol Challenge||4
2499261|NCT00817089|6124471|P2|STARTED|Second Alcohol Challenge||8
2499262|NCT00817089|6124472|P1|STARTED|Second Alcohol Challenge||6
2499263|NCT00817089|6124469|P4|NOT COMPLETED|First Alcohol Challenge||1
2499264|NCT00817089|6124470|P3|NOT COMPLETED|First Alcohol Challenge||0
2499265|NCT00817089|6124471|P2|NOT COMPLETED|First Alcohol Challenge||0
2499266|NCT00817089|6124472|P1|NOT COMPLETED|First Alcohol Challenge||0
2499267|NCT00817089|6124469|P4|COMPLETED|First Alcohol Challenge||5
2499268|NCT00817089|6124470|P3|COMPLETED|First Alcohol Challenge||4
2499269|NCT00817089|6124471|P2|COMPLETED|First Alcohol Challenge||8
2499270|NCT00817089|6124472|P1|COMPLETED|First Alcohol Challenge||6
2499271|NCT00817089|6124469|P4|STARTED|First Alcohol Challenge||6
2499272|NCT00817089|6124470|P3|STARTED|First Alcohol Challenge||4
2499273|NCT00817089|6124471|P2|STARTED|First Alcohol Challenge||8
2499274|NCT00817089|6124472|P1|STARTED|First Alcohol Challenge||6
2499275|NCT00817063|6124488|P2|NOT COMPLETED|Overall Study||170
2499276|NCT00817063|6124489|P1|NOT COMPLETED|Overall Study||137
2499277|NCT00817063|6124488|P2|COMPLETED|Overall Study||128
2499278|NCT00817063|6124489|P1|COMPLETED|Overall Study||161
2499279|NCT00817063|6124488|P2|STARTED|Overall Study||298
2499280|NCT00817063|6124489|P1|STARTED|Overall Study||298
2499281|NCT00816907|6124533|P2|NOT COMPLETED|Overall Study||17
2499282|NCT00816907|6124534|P1|NOT COMPLETED|Overall Study||13
2499283|NCT00816907|6124533|P2|COMPLETED|Overall Study||58
2499284|NCT00816907|6124534|P1|COMPLETED|Overall Study||58
2499285|NCT00816907|6124533|P2|STARTED|Overall Study||75
2499286|NCT00816907|6124534|P1|STARTED|Overall Study||71
2499287|NCT00816829|6124556|P2|NOT COMPLETED|Overall Study||0
2499288|NCT00816829|6124557|P1|NOT COMPLETED|Overall Study||0
2499289|NCT00816829|6124556|P2|COMPLETED|Overall Study||18
2499290|NCT00816829|6124557|P1|COMPLETED|Overall Study||16
2499291|NCT00816829|6124556|P2|STARTED|Overall Study||18
2499292|NCT00816829|6124557|P1|STARTED|Overall Study||16
2499293|NCT00816777|6124583|P2|NOT COMPLETED|Overall Study||0
2499294|NCT00816777|6124584|P1|NOT COMPLETED|Overall Study||0
2499295|NCT00816777|6124583|P2|COMPLETED|Overall Study||2
2499296|NCT00816777|6124584|P1|COMPLETED|Overall Study||2
2499297|NCT00816777|6124583|P2|STARTED|Overall Study||2
2499298|NCT00816777|6124584|P1|STARTED|Overall Study||2
2499299|NCT00816751|6124606|P2|NOT COMPLETED|Overall Study||0
2499300|NCT00816751|6124607|P1|NOT COMPLETED|Overall Study||0
2499301|NCT00816751|6124606|P2|COMPLETED|Overall Study||44
2499302|NCT00816751|6124607|P1|COMPLETED|Overall Study||45
2499303|NCT00816751|6124606|P2|STARTED|Overall Study||44
2499304|NCT00816751|6124607|P1|STARTED|Overall Study||45
2499305|NCT00816595|6124617|P2|NOT COMPLETED|Overall Study||0
2499306|NCT00816595|6124618|P1|NOT COMPLETED|Overall Study||2
2499307|NCT00816595|6124617|P2|COMPLETED|Overall Study||33
2499308|NCT00816595|6124618|P1|COMPLETED|Overall Study||33
2499309|NCT00816595|6124617|P2|STARTED|Overall Study||33
2499310|NCT00816595|6124618|P1|STARTED|Overall Study||35
2499311|NCT00816556|6124631|P3|NOT COMPLETED|Overall Study||3
2499312|NCT00816556|6124632|P2|NOT COMPLETED|Overall Study||2
2499313|NCT00816556|6124633|P1|NOT COMPLETED|Overall Study||2
2499314|NCT00816556|6124631|P3|COMPLETED|Overall Study||19
2499315|NCT00816556|6124632|P2|COMPLETED|Overall Study||19
2499316|NCT00816556|6124633|P1|COMPLETED|Overall Study||18
2499317|NCT00816556|6124631|P3|STARTED|Overall Study||22
2499318|NCT00816556|6124632|P2|STARTED|Overall Study||21
2499319|NCT00816556|6124633|P1|STARTED|Overall Study||20
2499320|NCT00816400|6124656|P9|NOT COMPLETED|Overall Study||6
2499321|NCT00816400|6124657|P8|NOT COMPLETED|Overall Study||5
2499322|NCT00816400|6124658|P7|NOT COMPLETED|Overall Study||2
2499323|NCT00816400|6124659|P6|NOT COMPLETED|Overall Study||3
2499324|NCT00816400|6124660|P5|NOT COMPLETED|Overall Study||2
2499325|NCT00816400|6124661|P4|NOT COMPLETED|Overall Study||3
2499326|NCT00816400|6124662|P3|NOT COMPLETED|Overall Study||5
2499327|NCT00816400|6124663|P2|NOT COMPLETED|Overall Study||3
2499328|NCT00816400|6124664|P1|NOT COMPLETED|Overall Study||2
2499329|NCT00816400|6124656|P9|COMPLETED|Overall Study||0
2499330|NCT00816400|6124657|P8|COMPLETED|Overall Study||1
2499331|NCT00816400|6124658|P7|COMPLETED|Overall Study||1
2499332|NCT00816400|6124659|P6|COMPLETED|Overall Study||0
2499333|NCT00816400|6124660|P5|COMPLETED|Overall Study||1
2499334|NCT00816400|6124661|P4|COMPLETED|Overall Study||0
2499335|NCT00816400|6124662|P3|COMPLETED|Overall Study||0
2499336|NCT00816400|6124663|P2|COMPLETED|Overall Study||0
2499337|NCT00816400|6124664|P1|COMPLETED|Overall Study||1
2499338|NCT00816400|6124656|P9|STARTED|Overall Study||6
2499339|NCT00816400|6124657|P8|STARTED|Overall Study||6
2499340|NCT00816400|6124658|P7|STARTED|Overall Study||3
2499341|NCT00816400|6124659|P6|STARTED|Overall Study||3
2499342|NCT00816400|6124660|P5|STARTED|Overall Study||3
2499343|NCT00816400|6124661|P4|STARTED|Overall Study||3
2499344|NCT00816400|6124662|P3|STARTED|Overall Study||5
2499345|NCT00816400|6124663|P2|STARTED|Overall Study||3
2499346|NCT00816400|6124664|P1|STARTED|Overall Study||3
2499347|NCT00816361|6124855|P9|NOT COMPLETED|Overall Study||10
2499348|NCT00816361|6124856|P8|NOT COMPLETED|Overall Study||9
2499349|NCT00816361|6124857|P7|NOT COMPLETED|Overall Study||3
2499350|NCT00816361|6124858|P6|NOT COMPLETED|Overall Study||3
2499351|NCT00816361|6124859|P5|NOT COMPLETED|Overall Study||2
2499352|NCT00816361|6124860|P4|NOT COMPLETED|Overall Study||3
2499353|NCT00816361|6124861|P3|NOT COMPLETED|Overall Study||3
2499354|NCT00816361|6124862|P2|NOT COMPLETED|Overall Study||3
2499355|NCT00816361|6124863|P1|NOT COMPLETED|Overall Study||4
2499356|NCT00816361|6124855|P9|COMPLETED|Overall Study||0
2499357|NCT00816361|6124856|P8|COMPLETED|Overall Study||1
2499358|NCT00816361|6124857|P7|COMPLETED|Overall Study||0
2499359|NCT00816361|6124858|P6|COMPLETED|Overall Study||0
2499360|NCT00816361|6124859|P5|COMPLETED|Overall Study||1
2499361|NCT00816361|6124860|P4|COMPLETED|Overall Study||0
2499362|NCT00816361|6124861|P3|COMPLETED|Overall Study||1
2499363|NCT00816361|6124862|P2|COMPLETED|Overall Study||0
2499364|NCT00816361|6124863|P1|COMPLETED|Overall Study||0
2499365|NCT00816361|6124855|P9|STARTED|Overall Study||10
2499366|NCT00816361|6124856|P8|STARTED|Overall Study||10
2499367|NCT00816361|6124857|P7|STARTED|Overall Study||3
2499368|NCT00816361|6124858|P6|STARTED|Overall Study||3
2499369|NCT00816361|6124859|P5|STARTED|Overall Study||3
2499370|NCT00816361|6124860|P4|STARTED|Overall Study||3
2499371|NCT00816361|6124861|P3|STARTED|Overall Study||4
2499372|NCT00816361|6124862|P2|STARTED|Overall Study||3
2499373|NCT00816361|6124863|P1|STARTED|Overall Study||4
2499374|NCT00816348|6125016|P1|NOT COMPLETED|Overall Study||0
2499375|NCT00816348|6125016|P1|COMPLETED|Overall Study||15
2499376|NCT00816348|6125016|P1|STARTED|Overall Study||15
2499377|NCT00816166|6125022|P2|NOT COMPLETED|Overall Study||12
2499378|NCT00816166|6125023|P1|NOT COMPLETED|Overall Study||10
2499379|NCT00816166|6125022|P2|COMPLETED|Overall Study||41
2499380|NCT00816166|6125023|P1|COMPLETED|Overall Study||49
2499381|NCT00816166|6125022|P2|ITT Population (Met Eligibility)|Overall Study||53
2499382|NCT00816166|6125023|P1|ITT Population (Met Eligibility)|Overall Study|Of 59 randomized to Stent Arm, 1 subject failed to meet eligibility and was excluded from the ITT|58
2499383|NCT00816166|6125022|P2|STARTED|Overall Study|Of 53 randomized to Medical Therapy Arm, 9 were treated with Stent+Medical Therapy|53
2499384|NCT00816166|6125023|P1|STARTED|Overall Study|Of 59 randomized to Stent Arm, 4 were treated with Medical Therapy Only|59
2499385|NCT00816101|6125032|P3|NOT COMPLETED|Overall Study||0
2499386|NCT00816101|6125033|P2|NOT COMPLETED|Overall Study||0
2499387|NCT00816101|6125034|P1|NOT COMPLETED|Overall Study||0
2499388|NCT00816101|6125032|P3|COMPLETED|Overall Study||5
2499389|NCT00816101|6125033|P2|COMPLETED|Overall Study||8
2499390|NCT00816101|6125034|P1|COMPLETED|Overall Study||13
2499391|NCT00816101|6125032|P3|STARTED|Overall Study||5
2499392|NCT00816101|6125033|P2|STARTED|Overall Study||8
2499393|NCT00816101|6125034|P1|STARTED|Overall Study||13
2499394|NCT00816062|6125048|P1|NOT COMPLETED|Overall Study||127
2499395|NCT00816062|6125048|P1|COMPLETED|Overall Study||133
2499396|NCT00816062|6125048|P1|STARTED|Overall Study||260
2499397|NCT00816036|6125055|P2|NOT COMPLETED|Overall Study||108
2499398|NCT00816036|6125056|P1|NOT COMPLETED|Overall Study||176
2499399|NCT00816036|6125055|P2|COMPLETED|Overall Study||287
2499400|NCT00816036|6125056|P1|COMPLETED|Overall Study||327
2499401|NCT00816036|6125055|P2|STARTED|Overall Study||395
2499402|NCT00816036|6125056|P1|STARTED|Overall Study||503
2499403|NCT00816023|6125070|P4|NOT COMPLETED|Overall Study||12
2499404|NCT00816023|6125071|P3|NOT COMPLETED|Overall Study||9
2499405|NCT00816023|6125072|P2|NOT COMPLETED|Overall Study||6
2499406|NCT00816023|6125073|P1|NOT COMPLETED|Overall Study||9
2499407|NCT00816023|6125070|P4|COMPLETED|Overall Study||62
2499408|NCT00816023|6125071|P3|COMPLETED|Overall Study||60
2499409|NCT00816023|6125072|P2|COMPLETED|Overall Study||56
2499410|NCT00816023|6125073|P1|COMPLETED|Overall Study||62
2499411|NCT00816023|6125070|P4|Completed Therapy|Overall Study||63
2499412|NCT00816023|6125071|P3|Completed Therapy|Overall Study||61
2499413|NCT00816023|6125072|P2|Completed Therapy|Overall Study||59
2499414|NCT00816023|6125073|P1|Completed Therapy|Overall Study||65
2499415|NCT00816023|6125070|P4|STARTED|Overall Study||74
2499416|NCT00816023|6125071|P3|STARTED|Overall Study||69
2499417|NCT00816023|6125072|P2|STARTED|Overall Study||62
2499418|NCT00816023|6125073|P1|STARTED|Overall Study||71
2499419|NCT00815997|6125089|P2|NOT COMPLETED|Overall Study||0
2499420|NCT00815997|6125090|P1|NOT COMPLETED|Overall Study||0
2499421|NCT00815997|6125089|P2|COMPLETED|Overall Study||80
2499422|NCT00815997|6125090|P1|COMPLETED|Overall Study||80
2499423|NCT00815997|6125089|P2|STARTED|Overall Study||80
2499424|NCT00815997|6125090|P1|STARTED|Overall Study||80
2499425|NCT00815919|6125110|P1|NOT COMPLETED|Overall Study||4
2499426|NCT00815919|6125110|P1|COMPLETED|Overall Study||18
2499427|NCT00815919|6125110|P1|STARTED|Overall Study||22
2499428|NCT00815776|6125121|P3|NOT COMPLETED|Overall Study||6
2499429|NCT00815776|6125122|P2|NOT COMPLETED|Overall Study||8
2499430|NCT00815776|6125123|P1|NOT COMPLETED|Overall Study||8
2499431|NCT00815776|6125121|P3|COMPLETED|Overall Study||22
2499432|NCT00815776|6125122|P2|COMPLETED|Overall Study||56
2499433|NCT00815776|6125123|P1|COMPLETED|Overall Study||52
2499434|NCT00815776|6125121|P3|STARTED|Overall Study||28
2499435|NCT00815776|6125122|P2|STARTED|Overall Study||64
2499436|NCT00815776|6125123|P1|STARTED|Overall Study||60
2499437|NCT00815698|6125139|P2|NOT COMPLETED|Overall Study||0
2499438|NCT00815698|6125140|P1|NOT COMPLETED|Overall Study||0
2499439|NCT00815698|6125139|P2|COMPLETED|Overall Study||171
2499440|NCT00815698|6125140|P1|COMPLETED|Overall Study||163
2499441|NCT00815698|6125139|P2|STARTED|Overall Study||171
2499442|NCT00815698|6125140|P1|STARTED|Overall Study||163
2499443|NCT00815685|6125148|P1|NOT COMPLETED|Overall Study||22
2499444|NCT00815685|6125148|P1|COMPLETED|Overall Study|Complete pre and post-treatment serum samples were available for 14 participants.|14
2499445|NCT00815685|6125148|P1|STARTED|Overall Study||36
2499446|NCT00815659|6125153|P1|NOT COMPLETED|Overall Study||23
2499447|NCT00815659|6125153|P1|COMPLETED|Overall Study||74
2499448|NCT00815659|6125153|P1|STARTED|Overall Study||97
2499449|NCT00815633|6125196|P1|NOT COMPLETED|Overall Study||1
2499450|NCT00815633|6125196|P1|COMPLETED|Overall Study||0
2499451|NCT00815633|6125196|P1|STARTED|Overall Study||1
2499452|NCT00815516|6125203|P2|NOT COMPLETED|Overall Study||1
2499453|NCT00815516|6125204|P1|NOT COMPLETED|Overall Study||4
2499454|NCT00815516|6125203|P2|COMPLETED|Overall Study||9
2499455|NCT00815516|6125204|P1|COMPLETED|Overall Study||16
2499456|NCT00815516|6125203|P2|STARTED|Overall Study||10
2499457|NCT00815516|6125204|P1|STARTED|Overall Study||20
2499458|NCT00815490|6125235|P2|NOT COMPLETED|Overall Study||0
2499459|NCT00815490|6125236|P1|NOT COMPLETED|Overall Study||0
2499460|NCT00815490|6125235|P2|COMPLETED|Overall Study||9
2499461|NCT00815490|6125236|P1|COMPLETED|Overall Study||9
2499462|NCT00815490|6125235|P2|STARTED|Overall Study||9
2499463|NCT00815490|6125236|P1|STARTED|Overall Study||9
2499464|NCT00815360|6125244|P2|NOT COMPLETED|Overall Study||0
2499465|NCT00815360|6125245|P1|NOT COMPLETED|Overall Study||0
2499466|NCT00815360|6125244|P2|COMPLETED|Overall Study||11
2499467|NCT00815360|6125245|P1|COMPLETED|Overall Study||11
2499468|NCT00815360|6125244|P2|STARTED|Overall Study||11
2499469|NCT00815360|6125245|P1|STARTED|Overall Study||11
2499470|NCT00815347|6125253|P1|NOT COMPLETED|Overall Study||4
2499471|NCT00815347|6125253|P1|COMPLETED|Overall Study||7
2499472|NCT00815347|6125253|P1|STARTED|Overall Study||11
2499473|NCT00815308|6125269|P1|NOT COMPLETED|Overall Study||10
2499474|NCT00815308|6125269|P1|COMPLETED|Overall Study||45
2499475|NCT00815308|6125269|P1|STARTED|Overall Study||55
2499476|NCT00815295|6125278|P3|NOT COMPLETED|Overall Study||3
2499477|NCT00815295|6125279|P2|NOT COMPLETED|Overall Study||1
2499478|NCT00815295|6125280|P1|NOT COMPLETED|Overall Study||0
2499479|NCT00815295|6125278|P3|COMPLETED|Overall Study||9
2499480|NCT00815295|6125279|P2|COMPLETED|Overall Study||7
2499481|NCT00815295|6125280|P1|COMPLETED|Overall Study||8
2499482|NCT00815295|6125278|P3|STARTED|Overall Study||12
2499483|NCT00815295|6125279|P2|STARTED|Overall Study||8
2499484|NCT00815295|6125280|P1|STARTED|Overall Study||8
2499485|NCT00815191|6125292|P2|NOT COMPLETED|Overall Study||1
2499486|NCT00815191|6125293|P1|NOT COMPLETED|Overall Study||1
2499487|NCT00815191|6125292|P2|COMPLETED|Overall Study||34
2499488|NCT00815191|6125293|P1|COMPLETED|Overall Study||37
2499489|NCT00815191|6125292|P2|STARTED|Overall Study||35
2499490|NCT00815191|6125293|P1|STARTED|Overall Study||38
2499491|NCT00815087|6125301|P2|NOT COMPLETED|Overall Study||0
2499492|NCT00815087|6125302|P1|NOT COMPLETED|Overall Study||0
2499493|NCT00815087|6125301|P2|COMPLETED|Overall Study||10
2499494|NCT00815087|6125302|P1|COMPLETED|Overall Study||10
2499495|NCT00815087|6125301|P2|STARTED|Overall Study||10
2499496|NCT00815087|6125302|P1|STARTED|Overall Study||10
2499497|NCT00815035|6125310|P3|NOT COMPLETED|Open Label Extension Phase||6
2499498|NCT00815035|6125311|P2|NOT COMPLETED|Open Label Extension Phase||0
2499499|NCT00815035|6125312|P1|NOT COMPLETED|Open Label Extension Phase||0
2499500|NCT00815035|6125310|P3|COMPLETED|Open Label Extension Phase||9
2499501|NCT00815035|6125311|P2|COMPLETED|Open Label Extension Phase||0
2499502|NCT00815035|6125312|P1|COMPLETED|Open Label Extension Phase||0
2499503|NCT00815035|6125310|P3|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|15
2499504|NCT00815035|6125311|P2|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
2499505|NCT00815035|6125312|P1|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
2499506|NCT00815035|6125310|P3|NOT COMPLETED|Blinded Phase||0
2499507|NCT00815035|6125311|P2|NOT COMPLETED|Blinded Phase||0
2499508|NCT00815035|6125312|P1|NOT COMPLETED|Blinded Phase||1
2499509|NCT00815035|6125310|P3|COMPLETED|Blinded Phase||0
2499510|NCT00815035|6125311|P2|COMPLETED|Blinded Phase||6
2499511|NCT00815035|6125312|P1|COMPLETED|Blinded Phase||9
2499512|NCT00815035|6125310|P3|STARTED|Blinded Phase||0
2499513|NCT00815035|6125311|P2|STARTED|Blinded Phase||6
2499514|NCT00815035|6125312|P1|STARTED|Blinded Phase||10
2499515|NCT00814983|6125330|P2|NOT COMPLETED|Overall Study||0
2499516|NCT00814983|6125331|P1|NOT COMPLETED|Overall Study||3
2499517|NCT00814983|6125330|P2|COMPLETED|Overall Study||0
2499518|NCT00814983|6125331|P1|COMPLETED|Overall Study||12
2499519|NCT00814983|6125330|P2|STARTED|Overall Study||0
2499520|NCT00814983|6125331|P1|STARTED|Overall Study||15
2499521|NCT00814970|6125341|P1|NOT COMPLETED|Overall Study||50
2499522|NCT00814970|6125341|P1|COMPLETED|Overall Study||146
2499523|NCT00814970|6125341|P1|STARTED|Overall Study||196
2499524|NCT00814892|6125362|P1|NOT COMPLETED|Overall Study||2
2499525|NCT00814892|6125362|P1|COMPLETED|Overall Study||0
2499526|NCT00814892|6125362|P1|STARTED|Overall Study||2
2499527|NCT00814879|6125374|P2|NOT COMPLETED|By Week 48||3
2499528|NCT00814879|6125375|P1|NOT COMPLETED|By Week 48||2
2499529|NCT00814879|6125374|P2|COMPLETED|By Week 48||26
2499530|NCT00814879|6125375|P1|COMPLETED|By Week 48||25
2499531|NCT00814879|6125374|P2|STARTED|By Week 48||29
2499532|NCT00814879|6125375|P1|STARTED|By Week 48||27
2499533|NCT00814879|6125374|P2|NOT COMPLETED|By Week 24||1
2499534|NCT00814879|6125375|P1|NOT COMPLETED|By Week 24||1
2499535|NCT00814879|6125374|P2|COMPLETED|By Week 24||29
2499536|NCT00814879|6125375|P1|COMPLETED|By Week 24||27
2499537|NCT00814879|6125374|P2|STARTED|By Week 24||30
2499538|NCT00814879|6125375|P1|STARTED|By Week 24||28
2499539|NCT00814801|6125394|P3|NOT COMPLETED|Overall Study||43
2499540|NCT00814801|6125395|P2|NOT COMPLETED|Overall Study||38
2499541|NCT00814801|6125396|P1|NOT COMPLETED|Overall Study||34
2499542|NCT00814801|6125394|P3|COMPLETED|Overall Study||151
2499543|NCT00814801|6125395|P2|COMPLETED|Overall Study||154
2499544|NCT00814801|6125396|P1|COMPLETED|Overall Study||160
2499545|NCT00814801|6125394|P3|STARTED|Overall Study||194
2499546|NCT00814801|6125395|P2|STARTED|Overall Study||192
2499547|NCT00814801|6125396|P1|STARTED|Overall Study||194
2499548|NCT00814788|6125416|P1|NOT COMPLETED|Overall Study||0
2499549|NCT00814788|6125416|P1|COMPLETED|Overall Study||24
2499550|NCT00814788|6125416|P1|STARTED|Overall Study||24
2499551|NCT00814775|6125424|P2|NOT COMPLETED|Overall Study||0
2499552|NCT00814775|6125425|P1|NOT COMPLETED|Overall Study||0
2499553|NCT00814775|6125424|P2|COMPLETED|Overall Study||20
2499554|NCT00814775|6125425|P1|COMPLETED|Overall Study||23
2499555|NCT00814775|6125424|P2|STARTED|Overall Study||20
2499556|NCT00814775|6125425|P1|STARTED|Overall Study||23
2499557|NCT00814710|6125435|P2|NOT COMPLETED|Overall Study||3
2499558|NCT00814710|6125436|P1|NOT COMPLETED|Overall Study||8
2499559|NCT00814710|6125435|P2|COMPLETED|Overall Study||117
2499560|NCT00814710|6125436|P1|COMPLETED|Overall Study||232
2499561|NCT00814710|6125435|P2|STARTED|Overall Study||120
2499562|NCT00814710|6125436|P1|STARTED|Overall Study||240
2499563|NCT00814697|6125474|P1|NOT COMPLETED|Overall Study||0
2499564|NCT00814697|6125474|P1|COMPLETED|Overall Study||12
2499565|NCT00814697|6125474|P1|STARTED|Overall Study||12
2499566|NCT00814671|6125481|P3|NOT COMPLETED|Overall Study||2
2499567|NCT00814671|6125482|P2|NOT COMPLETED|Overall Study||4
2499568|NCT00814671|6125483|P1|NOT COMPLETED|Overall Study||7
2499569|NCT00814671|6125481|P3|COMPLETED|Overall Study||49
2499570|NCT00814671|6125482|P2|COMPLETED|Overall Study||44
2499571|NCT00814671|6125483|P1|COMPLETED|Overall Study||47
2499572|NCT00814671|6125481|P3|STARTED|Overall Study||51
2499573|NCT00814671|6125482|P2|STARTED|Overall Study||48
2499574|NCT00814671|6125483|P1|STARTED|Overall Study||54
2499575|NCT00814658|6125504|P2|NOT COMPLETED|Overall Study||4
2499576|NCT00814658|6125505|P1|NOT COMPLETED|Overall Study||4
2499577|NCT00814658|6125504|P2|COMPLETED|Overall Study||8
2499578|NCT00814658|6125505|P1|COMPLETED|Overall Study||5
2499579|NCT00814658|6125504|P2|STARTED|Overall Study||12
2499580|NCT00814658|6125505|P1|STARTED|Overall Study||9
2499581|NCT00814632|6125571|P1|NOT COMPLETED|Overall Study||2
2499582|NCT00814632|6125571|P1|COMPLETED|Overall Study|Two subjects withdrew early due to lack of efficacy.|7
2499583|NCT00814632|6125571|P1|STARTED|Overall Study|Ten were allocated to treatment intervention however one was not treated due to lactose allergy.|9
2499584|NCT00814580|6125577|P2|NOT COMPLETED|Overall Study||47
2499585|NCT00814580|6125578|P1|NOT COMPLETED|Overall Study||31
2499586|NCT00814580|6125577|P2|COMPLETED|Overall Study||141
2499587|NCT00814580|6125578|P1|COMPLETED|Overall Study||163
2499588|NCT00814580|6125577|P2|STARTED|Overall Study||188
2499589|NCT00814580|6125578|P1|STARTED|Overall Study||194
2499590|NCT00814502|6125708|P2|NOT COMPLETED|Overall Study||2
2499591|NCT00814502|6125709|P1|NOT COMPLETED|Overall Study||1
2499592|NCT00814502|6125708|P2|COMPLETED|Overall Study||7
2499593|NCT00814502|6125709|P1|COMPLETED|Overall Study||7
2499594|NCT00814502|6125708|P2|STARTED|Overall Study||9
2499595|NCT00814502|6125709|P1|STARTED|Overall Study||8
2499596|NCT00814489|6125722|P3|NOT COMPLETED|Overall Study||1
2499597|NCT00814489|6125723|P2|NOT COMPLETED|Overall Study||0
2499598|NCT00814489|6125724|P1|NOT COMPLETED|Overall Study||2
2499599|NCT00814489|6125722|P3|COMPLETED|Overall Study||7
2499600|NCT00814489|6125723|P2|COMPLETED|Overall Study||17
2499601|NCT00814489|6125724|P1|COMPLETED|Overall Study||13
2499602|NCT00814489|6125722|P3|STARTED|Overall Study||8
2499603|NCT00814489|6125723|P2|STARTED|Overall Study||17
2499604|NCT00814489|6125724|P1|STARTED|Overall Study||15
2499605|NCT00814463|6125756|P1|NOT COMPLETED|Overall Study||1
2499606|NCT00814463|6125756|P1|COMPLETED|Overall Study||0
2499607|NCT00814463|6125756|P1|STARTED|Overall Study||1
2499608|NCT00814346|6125769|P2|NOT COMPLETED|Open Phase (17 Months)||0
2499609|NCT00814346|6125770|P1|NOT COMPLETED|Open Phase (17 Months)||10
2499610|NCT00814346|6125769|P2|COMPLETED|Open Phase (17 Months)||0
2499611|NCT00814346|6125770|P1|COMPLETED|Open Phase (17 Months)||31
2499612|NCT00814346|6125769|P2|AD|Open Phase (17 Months)||0
2499613|NCT00814346|6125770|P1|AD|Open Phase (17 Months)|Open period was not proposed to AD subjects.|0
2499614|NCT00814346|6125769|P2|MC|Open Phase (17 Months)||0
2499615|NCT00814346|6125770|P1|MC|Open Phase (17 Months)||20
2499616|NCT00814346|6125769|P2|CNE|Open Phase (17 Months)||0
2499617|NCT00814346|6125770|P1|CNE|Open Phase (17 Months)||21
2499618|NCT00814346|6125769|P2|STARTED|Open Phase (17 Months)|This was an open period, without placebo arm, the number of subject on placebo is 0.|0
2499619|NCT00814346|6125770|P1|STARTED|Open Phase (17 Months)|Open period was treated with EGB761®. 41 subjects accepted follow-up open period(21 in CNE,20 in MC)|41
2499620|NCT00814346|6125769|P2|NOT COMPLETED|Double-blind Phase (4 Weeks)||3
2499621|NCT00814346|6125770|P1|NOT COMPLETED|Double-blind Phase (4 Weeks)||0
2499622|NCT00814346|6125769|P2|COMPLETED|Double-blind Phase (4 Weeks)||23
2499623|NCT00814346|6125770|P1|COMPLETED|Double-blind Phase (4 Weeks)||23
2499624|NCT00814346|6125769|P2|AD|Double-blind Phase (4 Weeks)||2
2499625|NCT00814346|6125770|P1|AD|Double-blind Phase (4 Weeks)||3
2499626|NCT00814346|6125769|P2|MC|Double-blind Phase (4 Weeks)||11
2499627|NCT00814346|6125770|P1|MC|Double-blind Phase (4 Weeks)||10
2499628|NCT00814346|6125769|P2|CNE|Double-blind Phase (4 Weeks)||13
2499629|NCT00814346|6125770|P1|CNE|Double-blind Phase (4 Weeks)||10
2499630|NCT00814346|6125769|P2|STARTED|Double-blind Phase (4 Weeks)||26
2499631|NCT00814346|6125770|P1|STARTED|Double-blind Phase (4 Weeks)||23
2499632|NCT00814333|6125836|P2|NOT COMPLETED|Treatment Period||0
2499633|NCT00814333|6125837|P1|NOT COMPLETED|Treatment Period||0
2499634|NCT00814333|6125836|P2|COMPLETED|Treatment Period||0
2499635|NCT00814333|6125837|P1|COMPLETED|Treatment Period||0
2499636|NCT00814333|6125836|P2|STARTED|Treatment Period||0
2499637|NCT00814333|6125837|P1|STARTED|Treatment Period||0
2499638|NCT00814333|6125836|P2|NOT COMPLETED|Enrollment||0
2499639|NCT00814333|6125837|P1|NOT COMPLETED|Enrollment||1
2499640|NCT00814333|6125836|P2|COMPLETED|Enrollment||0
2499641|NCT00814333|6125837|P1|COMPLETED|Enrollment||0
2499642|NCT00814333|6125836|P2|STARTED|Enrollment||0
2499643|NCT00814333|6125837|P1|STARTED|Enrollment||1
2499644|NCT00814320|6125845|P2|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||10
2499645|NCT00814320|6125846|P1|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||3
2499646|NCT00814320|6125845|P2|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)|Three participants who switched to safety follow-up remained in the study.|60
2499647|NCT00814320|6125846|P1|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||8
2499648|NCT00814320|6125845|P2|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||70
2499649|NCT00814320|6125846|P1|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||11
2499650|NCT00814320|6125845|P2|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||0
2499651|NCT00814320|6125846|P1|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||2
2499652|NCT00814320|6125845|P2|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||70
2499653|NCT00814320|6125846|P1|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||11
2499654|NCT00814320|6125845|P2|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||70
2499655|NCT00814320|6125846|P1|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||13
2499656|NCT00814320|6125845|P2|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||1
2499657|NCT00814320|6125846|P1|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||0
2499658|NCT00814320|6125845|P2|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||70
2499659|NCT00814320|6125846|P1|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
2499660|NCT00814320|6125845|P2|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||71
2499661|NCT00814320|6125846|P1|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
2499662|NCT00814320|6125845|P2|NOT COMPLETED|Epoch 1 (IV Treatment)||2
2499663|NCT00814320|6125846|P1|NOT COMPLETED|Epoch 1 (IV Treatment)||1
2499664|NCT00814320|6125845|P2|COMPLETED|Epoch 1 (IV Treatment)||71
2499665|NCT00814320|6125846|P1|COMPLETED|Epoch 1 (IV Treatment)||13
2499666|NCT00814320|6125845|P2|STARTED|Epoch 1 (IV Treatment)||73
2499667|NCT00814320|6125846|P1|STARTED|Epoch 1 (IV Treatment)||14
2499668|NCT00814307|6125978|P4|NOT COMPLETED|Overall Study||10
2499669|NCT00814307|6125979|P3|NOT COMPLETED|Overall Study||7
2499670|NCT00814307|6125980|P2|NOT COMPLETED|Overall Study||27
2499671|NCT00814307|6125981|P1|NOT COMPLETED|Overall Study||12
2499672|NCT00814307|6125978|P4|COMPLETED|Overall Study||51
2499673|NCT00814307|6125979|P3|COMPLETED|Overall Study||54
2499674|NCT00814307|6125980|P2|COMPLETED|Overall Study||218
2499675|NCT00814307|6125981|P1|COMPLETED|Overall Study||232
2499676|NCT00814307|6125978|P4|Treated|Overall Study||61
2499677|NCT00814307|6125979|P3|Treated|Overall Study||61
2499678|NCT00814307|6125980|P2|Treated|Overall Study||245
2499679|NCT00814307|6125981|P1|Treated|Overall Study||243
2499680|NCT00814307|6125978|P4|STARTED|Overall Study||61
2499681|NCT00814307|6125979|P3|STARTED|Overall Study||61
2499682|NCT00814307|6125980|P2|STARTED|Overall Study||245
2499683|NCT00814307|6125981|P1|STARTED|Overall Study||244
2499684|NCT00814255|6126146|P3|NOT COMPLETED|Overall Study||1
2499685|NCT00814255|6126147|P2|NOT COMPLETED|Overall Study||0
2499686|NCT00814255|6126148|P1|NOT COMPLETED|Overall Study||1
2499687|NCT00814255|6126146|P3|COMPLETED|Overall Study||7
2499688|NCT00814255|6126147|P2|COMPLETED|Overall Study||7
2499689|NCT00814255|6126148|P1|COMPLETED|Overall Study||7
2499690|NCT00814255|6126146|P3|STARTED|Overall Study||8
2499691|NCT00814255|6126147|P2|STARTED|Overall Study||7
2499692|NCT00814255|6126148|P1|STARTED|Overall Study||8
2499693|NCT00814177|6126170|P2|NOT COMPLETED|Overall Study||0
2499694|NCT00814177|6126171|P1|NOT COMPLETED|Overall Study||0
2499695|NCT00814177|6126170|P2|COMPLETED|Overall Study||80
2499696|NCT00814177|6126171|P1|COMPLETED|Overall Study||80
2499697|NCT00814177|6126170|P2|STARTED|Overall Study||80
2499698|NCT00814177|6126171|P1|STARTED|Overall Study||80
2499699|NCT00814164|6126177|P1|NOT COMPLETED|Overall Study||19
2499700|NCT00814164|6126177|P1|COMPLETED|Overall Study||2
2499701|NCT00814164|6126177|P1|STARTED|Overall Study||21
2499702|NCT00814138|6126190|P2|NOT COMPLETED|Overall Study||7
2499703|NCT00814138|6126191|P1|NOT COMPLETED|Overall Study||1
2499704|NCT00814138|6126190|P2|COMPLETED|Overall Study||18
2499705|NCT00814138|6126191|P1|COMPLETED|Overall Study||24
2499706|NCT00814138|6126190|P2|STARTED|Overall Study||25
2499707|NCT00814138|6126191|P1|STARTED|Overall Study||25
2499708|NCT00813995|6126211|P2|NOT COMPLETED|Overall Study||16
2499709|NCT00813995|6126212|P1|NOT COMPLETED|Overall Study||23
2499710|NCT00813995|6126211|P2|COMPLETED|Overall Study||182
2499711|NCT00813995|6126212|P1|COMPLETED|Overall Study||174
2499712|NCT00813995|6126211|P2|STARTED|Overall Study||198
2499713|NCT00813995|6126212|P1|STARTED|Overall Study||197
2499714|NCT00813982|6126226|P1|NOT COMPLETED|Overall Study||0
2499715|NCT00813982|6126226|P1|COMPLETED|Overall Study||59
2499716|NCT00813982|6126226|P1|STARTED|Overall Study||59
2499717|NCT00813943|6126235|P3|NOT COMPLETED|Overall Study||3
2499718|NCT00813943|6126236|P2|NOT COMPLETED|Overall Study||5
2499719|NCT00813943|6126237|P1|NOT COMPLETED|Overall Study||5
2499720|NCT00813943|6126235|P3|COMPLETED|Overall Study||86
2499721|NCT00813943|6126236|P2|COMPLETED|Overall Study||83
2499722|NCT00813943|6126237|P1|COMPLETED|Overall Study||83
2499723|NCT00813943|6126235|P3|STARTED|Overall Study||89
2499724|NCT00813943|6126236|P2|STARTED|Overall Study||88
2499725|NCT00813943|6126237|P1|STARTED|Overall Study||88
2499726|NCT00813917|6126267|P2|NOT COMPLETED|Overall Study||6
2499727|NCT00813917|6126268|P1|NOT COMPLETED|Overall Study||6
2499728|NCT00813917|6126267|P2|COMPLETED|Overall Study||32
2499729|NCT00813917|6126268|P1|COMPLETED|Overall Study||32
2499730|NCT00813917|6126267|P2|STARTED|Overall Study||38
2499731|NCT00813917|6126268|P1|STARTED|Overall Study||38
2499732|NCT00813904|6126274|P1|NOT COMPLETED|Overall Study||1
2499733|NCT00813904|6126274|P1|COMPLETED|Overall Study||30
2499734|NCT00813904|6126274|P1|STARTED|Overall Study||31
2499735|NCT00813865|6126280|P1|NOT COMPLETED|Overall Study||7
2499736|NCT00813865|6126280|P1|COMPLETED|Overall Study||1
2499737|NCT00813865|6126280|P1|Pharmacodynamic (PD) Population|Overall Study||8
2499738|NCT00813865|6126280|P1|Safety Population|Overall Study||8
2499739|NCT00813865|6126280|P1|STARTED|Overall Study||8
2499740|NCT00813813|6126288|P2|NOT COMPLETED|Overall Study||9
2499741|NCT00813813|6126289|P1|NOT COMPLETED|Overall Study||3
2499742|NCT00813813|6126288|P2|COMPLETED|Overall Study||16
2499743|NCT00813813|6126289|P1|COMPLETED|Overall Study||4
2499744|NCT00813813|6126288|P2|STARTED|Overall Study||25
2499745|NCT00813813|6126289|P1|STARTED|Overall Study||7
2499746|NCT00813800|6126305|P1|NOT COMPLETED|Overall Study||6
2499747|NCT00813800|6126305|P1|COMPLETED|Overall Study||5
2499748|NCT00813800|6126305|P1|STARTED|Overall Study||11
2499749|NCT00813761|6126313|P4|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||5
2499750|NCT00813761|6126314|P3|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
2499751|NCT00813761|6126315|P2|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
2499752|NCT00813761|6126316|P1|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||16
2499753|NCT00813761|6126313|P4|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||100
2499754|NCT00813761|6126314|P3|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||94
2499755|NCT00813761|6126315|P2|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||91
2499756|NCT00813761|6126316|P1|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||101
2499757|NCT00813761|6126313|P4|STARTED|Phase 2 (4 Weeks to 24 Weeks)||105
2499758|NCT00813761|6126314|P3|STARTED|Phase 2 (4 Weeks to 24 Weeks)||103
2499759|NCT00813761|6126315|P2|STARTED|Phase 2 (4 Weeks to 24 Weeks)||100
2499760|NCT00813761|6126316|P1|STARTED|Phase 2 (4 Weeks to 24 Weeks)||117
2499761|NCT00813761|6126313|P4|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||2
2499762|NCT00813761|6126314|P3|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||12
2499763|NCT00813761|6126315|P2|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||3
2499764|NCT00813761|6126316|P1|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||4
2499765|NCT00813761|6126313|P4|COMPLETED|Phase 1 (Baseline to 4 Weeks)||105
2499766|NCT00813761|6126314|P3|COMPLETED|Phase 1 (Baseline to 4 Weeks)||103
2499767|NCT00813761|6126315|P2|COMPLETED|Phase 1 (Baseline to 4 Weeks)||100
2499768|NCT00813761|6126316|P1|COMPLETED|Phase 1 (Baseline to 4 Weeks)||117
2499769|NCT00813761|6126313|P4|STARTED|Phase 1 (Baseline to 4 Weeks)||107
2499770|NCT00813761|6126314|P3|STARTED|Phase 1 (Baseline to 4 Weeks)||115
2499771|NCT00813761|6126315|P2|STARTED|Phase 1 (Baseline to 4 Weeks)||103
2499772|NCT00813761|6126316|P1|STARTED|Phase 1 (Baseline to 4 Weeks)||121
2499773|NCT00813748|6126366|P2|NOT COMPLETED|Skin Test Substudy||1
2499774|NCT00813748|6126367|P1|NOT COMPLETED|Skin Test Substudy||0
2499775|NCT00813748|6126366|P2|COMPLETED|Skin Test Substudy||7
2499776|NCT00813748|6126367|P1|COMPLETED|Skin Test Substudy||3
2499777|NCT00813748|6126366|P2|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|8
2499778|NCT00813748|6126367|P1|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|3
2499779|NCT00813748|6126366|P2|NOT COMPLETED|Main Observational Study||0
2499780|NCT00813748|6126367|P1|NOT COMPLETED|Main Observational Study||0
2499781|NCT00813748|6126366|P2|COMPLETED|Main Observational Study||88
2499782|NCT00813748|6126367|P1|COMPLETED|Main Observational Study||30
2499783|NCT00813748|6126366|P2|STARTED|Main Observational Study||88
2499784|NCT00813748|6126367|P1|STARTED|Main Observational Study||30
2499785|NCT00813709|6126396|P6|NOT COMPLETED|Open Label Period||11
2499786|NCT00813709|6126397|P5|NOT COMPLETED|Open Label Period||10
2499787|NCT00813709|6126398|P4|NOT COMPLETED|Open Label Period||20
2499788|NCT00813709|6126399|P3|NOT COMPLETED|Open Label Period||0
2499789|NCT00813709|6126400|P2|NOT COMPLETED|Open Label Period||0
2499790|NCT00813709|6126401|P1|NOT COMPLETED|Open Label Period||0
2499791|NCT00813709|6126396|P6|COMPLETED|Open Label Period||35
2499792|NCT00813709|6126397|P5|COMPLETED|Open Label Period||41
2499793|NCT00813709|6126398|P4|COMPLETED|Open Label Period||38
2499794|NCT00813709|6126399|P3|COMPLETED|Open Label Period||0
2499795|NCT00813709|6126400|P2|COMPLETED|Open Label Period||0
2499796|NCT00813709|6126401|P1|COMPLETED|Open Label Period||0
2499797|NCT00813709|6126396|P6|Treated|Open Label Period||45
2499798|NCT00813709|6126397|P5|Treated|Open Label Period||51
2499799|NCT00813709|6126398|P4|Treated|Open Label Period||57
2499800|NCT00813709|6126399|P3|Treated|Open Label Period||0
2499801|NCT00813709|6126400|P2|Treated|Open Label Period||0
2499802|NCT00813709|6126401|P1|Treated|Open Label Period||0
2499803|NCT00813709|6126396|P6|STARTED|Open Label Period|28 participants in OL period initially + 18 participants from DB converted to CDMS during the study|46
2499804|NCT00813709|6126397|P5|STARTED|Open Label Period|25 participants in OL period initially + 26 participants from DB converted to CDMS during the study|51
2499805|NCT00813709|6126398|P4|STARTED|Open Label Period|49 participants in OL period initially + 9 participants from DB converted to CDMS during the study|58
2499806|NCT00813709|6126399|P3|STARTED|Open Label Period||0
2499807|NCT00813709|6126400|P2|STARTED|Open Label Period||0
2499808|NCT00813709|6126401|P1|STARTED|Open Label Period||0
2499809|NCT00813709|6126396|P6|NOT COMPLETED|Double Blind Period||0
2499810|NCT00813709|6126397|P5|NOT COMPLETED|Double Blind Period||0
2499811|NCT00813709|6126398|P4|NOT COMPLETED|Double Blind Period||0
2499812|NCT00813709|6126399|P3|NOT COMPLETED|Double Blind Period||31
2499813|NCT00813709|6126400|P2|NOT COMPLETED|Double Blind Period||41
2499814|NCT00813709|6126401|P1|NOT COMPLETED|Double Blind Period||31
2499815|NCT00813709|6126396|P6|COMPLETED|Double Blind Period||0
2499816|NCT00813709|6126397|P5|COMPLETED|Double Blind Period||0
2499817|NCT00813709|6126398|P4|COMPLETED|Double Blind Period||0
2499818|NCT00813709|6126399|P3|COMPLETED|Double Blind Period||68
2499819|NCT00813709|6126400|P2|COMPLETED|Double Blind Period||76
2499820|NCT00813709|6126401|P1|COMPLETED|Double Blind Period||53
2499821|NCT00813709|6126396|P6|Treated|Double Blind Period||0
2499822|NCT00813709|6126397|P5|Treated|Double Blind Period||0
2499823|NCT00813709|6126398|P4|Treated|Double Blind Period||0
2499824|NCT00813709|6126399|P3|Treated|Double Blind Period||98
2499825|NCT00813709|6126400|P2|Treated|Double Blind Period||114
2499826|NCT00813709|6126401|P1|Treated|Double Blind Period||83
2499827|NCT00813709|6126396|P6|STARTED|Double Blind Period||0
2499828|NCT00813709|6126397|P5|STARTED|Double Blind Period||0
2499829|NCT00813709|6126398|P4|STARTED|Double Blind Period||0
2499830|NCT00813709|6126399|P3|STARTED|Double Blind Period||99
2499831|NCT00813709|6126400|P2|STARTED|Double Blind Period||117
2499832|NCT00813709|6126401|P1|STARTED|Double Blind Period||84
2499833|NCT00813592|6126481|P1|NOT COMPLETED|Overall Study||2
2499834|NCT00813592|6126481|P1|COMPLETED|Overall Study||0
2499835|NCT00813592|6126481|P1|Response Assessment|Overall Study|One patient met the response assessment.|1
2499836|NCT00813592|6126481|P1|Treated|Overall Study|Two patients were treated.|2
2499837|NCT00813592|6126481|P1|STARTED|Overall Study||2
2499838|NCT00813488|6126490|P2|NOT COMPLETED|Open-label Extension||7
2499839|NCT00813488|6126491|P1|NOT COMPLETED|Open-label Extension||12
2499840|NCT00813488|6126490|P2|COMPLETED|Open-label Extension|This group received standard of care (including immediate-release oxycodone)|59
2499841|NCT00813488|6126491|P1|COMPLETED|Open-label Extension|This group received FBT open--label|53
2499842|NCT00813488|6126490|P2|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|66
2499843|NCT00813488|6126491|P1|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|65
2499844|NCT00813488|6126490|P2|NOT COMPLETED|Double-blind Treatment Period 2||1
2499845|NCT00813488|6126491|P1|NOT COMPLETED|Double-blind Treatment Period 2||5
2499846|NCT00813488|6126490|P2|COMPLETED|Double-blind Treatment Period 2||65
2499847|NCT00813488|6126491|P1|COMPLETED|Double-blind Treatment Period 2||66
2499848|NCT00813488|6126490|P2|STARTED|Double-blind Treatment Period 2||66
2499849|NCT00813488|6126491|P1|STARTED|Double-blind Treatment Period 2||71
2499850|NCT00813488|6126490|P2|NOT COMPLETED|Double-blind Treatment Period 1||5
2499851|NCT00813488|6126491|P1|NOT COMPLETED|Double-blind Treatment Period 1||1
2499852|NCT00813488|6126490|P2|COMPLETED|Double-blind Treatment Period 1||66
2499853|NCT00813488|6126491|P1|COMPLETED|Double-blind Treatment Period 1||71
2499854|NCT00813488|6126490|P2|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|71
2499855|NCT00813488|6126491|P1|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|72
2499856|NCT00813488|6126490|P2|NOT COMPLETED|Titration Period 2||10
2499857|NCT00813488|6126491|P1|NOT COMPLETED|Titration Period 2||16
2499858|NCT00813488|6126490|P2|COMPLETED|Titration Period 2||79
2499859|NCT00813488|6126491|P1|COMPLETED|Titration Period 2||64
2499860|NCT00813488|6126490|P2|STARTED|Titration Period 2||89
2499861|NCT00813488|6126491|P1|STARTED|Titration Period 2||80
2499862|NCT00813488|6126490|P2|NOT COMPLETED|Titration Period 1||17
2499863|NCT00813488|6126491|P1|NOT COMPLETED|Titration Period 1||27
2499864|NCT00813488|6126490|P2|COMPLETED|Titration Period 1||89
2499865|NCT00813488|6126491|P1|COMPLETED|Titration Period 1||80
2499866|NCT00813488|6126490|P2|STARTED|Titration Period 1||106
2499867|NCT00813488|6126491|P1|STARTED|Titration Period 1||107
2499868|NCT00813319|6126589|P2|NOT COMPLETED|Overall Study||0
2499869|NCT00813319|6126590|P1|NOT COMPLETED|Overall Study||0
2499870|NCT00813319|6126589|P2|COMPLETED|Overall Study|104 out of 108 have complete follow-up data, there were 4 missing charts 7 months post-randomization|108
2499871|NCT00813319|6126590|P1|COMPLETED|Overall Study|100 out of 108 have complete follow-up data, there were 8 missing charts 7 months post-randomization|108
2499872|NCT00813319|6126589|P2|STARTED|Overall Study||108
2499873|NCT00813319|6126590|P1|STARTED|Overall Study||108
2499874|NCT00813176|6126602|P2|NOT COMPLETED|Overall Study||0
2499875|NCT00813176|6126603|P1|NOT COMPLETED|Overall Study||0
2499876|NCT00813176|6126602|P2|COMPLETED|Overall Study||25
2499877|NCT00813176|6126603|P1|COMPLETED|Overall Study||25
2499878|NCT00813176|6126602|P2|STARTED|Overall Study||25
2499879|NCT00813176|6126603|P1|STARTED|Overall Study||25
2499880|NCT00813150|6126621|P2|NOT COMPLETED|Long Term Follow-up||31
2499881|NCT00813150|6126622|P1|NOT COMPLETED|Long Term Follow-up||24
2499882|NCT00813150|6126621|P2|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|0
2499883|NCT00813150|6126622|P1|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|2
2499884|NCT00813150|6126621|P2|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|31
2499885|NCT00813150|6126622|P1|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|26
2499886|NCT00813150|6126621|P2|NOT COMPLETED|Treatment Period||32
2499887|NCT00813150|6126622|P1|NOT COMPLETED|Treatment Period||32
2499888|NCT00813150|6126621|P2|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|15
2499889|NCT00813150|6126622|P1|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|14
2499890|NCT00813150|6126621|P2|Intent-to-treat Participants|Treatment Period||47
2499891|NCT00813150|6126622|P1|Intent-to-treat Participants|Treatment Period||43
2499892|NCT00813150|6126621|P2|STARTED|Treatment Period|Number of randomized and treated participants|47
2499893|NCT00813150|6126622|P1|STARTED|Treatment Period|Number of randomized and treated participants|46
2499894|NCT00813111|6126636|P2|NOT COMPLETED|Overall Study||0
2499895|NCT00813111|6126637|P1|NOT COMPLETED|Overall Study||2
2499896|NCT00813111|6126636|P2|COMPLETED|Overall Study||70
2499897|NCT00813111|6126637|P1|COMPLETED|Overall Study||64
2499898|NCT00813111|6126636|P2|STARTED|Overall Study||70
2499899|NCT00813111|6126637|P1|STARTED|Overall Study||66
2499900|NCT00813098|6126646|P3|NOT COMPLETED|Overall Study||2
2499901|NCT00813098|6126647|P2|NOT COMPLETED|Overall Study||8
2499902|NCT00813098|6126648|P1|NOT COMPLETED|Overall Study||3
2499903|NCT00813098|6126646|P3|COMPLETED|Overall Study||50
2499904|NCT00813098|6126647|P2|COMPLETED|Overall Study||46
2499905|NCT00813098|6126648|P1|COMPLETED|Overall Study||46
2499906|NCT00813098|6126646|P3|STARTED|Overall Study||52
2499907|NCT00813098|6126647|P2|STARTED|Overall Study||54
2499908|NCT00813098|6126648|P1|STARTED|Overall Study||49
2499909|NCT00812981|6126673|P2|NOT COMPLETED|Overall Study||1
2499910|NCT00812981|6126674|P1|NOT COMPLETED|Overall Study||0
2499911|NCT00812981|6126673|P2|COMPLETED|Overall Study||159
2499912|NCT00812981|6126674|P1|COMPLETED|Overall Study||160
2499913|NCT00812981|6126673|P2|STARTED|Overall Study||160
2499914|NCT00812981|6126674|P1|STARTED|Overall Study||160
2499915|NCT00812968|6126712|P1|NOT COMPLETED|Overall Study||11
2499916|NCT00812968|6126712|P1|COMPLETED|Overall Study||0
2499917|NCT00812968|6126712|P1|STARTED|Overall Study||11
2499918|NCT00812955|6126747|P4|NOT COMPLETED|Overall Study||8
2499919|NCT00812955|6126748|P3|NOT COMPLETED|Overall Study||6
2499920|NCT00812955|6126749|P2|NOT COMPLETED|Overall Study||7
2499921|NCT00812955|6126750|P1|NOT COMPLETED|Overall Study||10
2499922|NCT00812955|6126747|P4|COMPLETED|Overall Study||110
2499923|NCT00812955|6126748|P3|COMPLETED|Overall Study||113
2499924|NCT00812955|6126749|P2|COMPLETED|Overall Study||111
2499925|NCT00812955|6126750|P1|COMPLETED|Overall Study||109
2499926|NCT00812955|6126747|P4|STARTED|Overall Study||118
2499927|NCT00812955|6126748|P3|STARTED|Overall Study||119
2499928|NCT00812955|6126749|P2|STARTED|Overall Study||118
2499929|NCT00812955|6126750|P1|STARTED|Overall Study||119
2499930|NCT00812929|6126770|P10|NOT COMPLETED|Treatment Period 5||0
2499931|NCT00812929|6126771|P9|NOT COMPLETED|Treatment Period 5||0
2499932|NCT00812929|6126772|P8|NOT COMPLETED|Treatment Period 5||0
2499933|NCT00812929|6126773|P7|NOT COMPLETED|Treatment Period 5||0
2499934|NCT00812929|6126774|P6|NOT COMPLETED|Treatment Period 5||0
2499935|NCT00812929|6126775|P5|NOT COMPLETED|Treatment Period 5||0
2499936|NCT00812929|6126776|P4|NOT COMPLETED|Treatment Period 5||0
2499937|NCT00812929|6126777|P3|NOT COMPLETED|Treatment Period 5||0
2499938|NCT00812929|6126778|P2|NOT COMPLETED|Treatment Period 5||0
2499939|NCT00812929|6126779|P1|NOT COMPLETED|Treatment Period 5||0
2499940|NCT00812929|6126770|P10|COMPLETED|Treatment Period 5||4
2499941|NCT00812929|6126771|P9|COMPLETED|Treatment Period 5||4
2499942|NCT00812929|6126772|P8|COMPLETED|Treatment Period 5||5
2499943|NCT00812929|6126773|P7|COMPLETED|Treatment Period 5||5
2499944|NCT00812929|6126774|P6|COMPLETED|Treatment Period 5||4
2499945|NCT00812929|6126775|P5|COMPLETED|Treatment Period 5||5
2499946|NCT00812929|6126776|P4|COMPLETED|Treatment Period 5||4
2499947|NCT00812929|6126777|P3|COMPLETED|Treatment Period 5||4
2499948|NCT00812929|6126778|P2|COMPLETED|Treatment Period 5||4
2499949|NCT00812929|6126779|P1|COMPLETED|Treatment Period 5||5
2499950|NCT00812929|6126770|P10|STARTED|Treatment Period 5||4
2499951|NCT00812929|6126771|P9|STARTED|Treatment Period 5||4
2499952|NCT00812929|6126772|P8|STARTED|Treatment Period 5||5
2499953|NCT00812929|6126773|P7|STARTED|Treatment Period 5||5
2499954|NCT00812929|6126774|P6|STARTED|Treatment Period 5||4
2499955|NCT00812929|6126775|P5|STARTED|Treatment Period 5||5
2499956|NCT00812929|6126776|P4|STARTED|Treatment Period 5||4
2499957|NCT00812929|6126777|P3|STARTED|Treatment Period 5||4
2499958|NCT00812929|6126778|P2|STARTED|Treatment Period 5||4
2499959|NCT00812929|6126779|P1|STARTED|Treatment Period 5||5
2499960|NCT00812929|6126770|P10|NOT COMPLETED|Washout Period 4 (7 Days)||0
2499961|NCT00812929|6126771|P9|NOT COMPLETED|Washout Period 4 (7 Days)||0
2499962|NCT00812929|6126772|P8|NOT COMPLETED|Washout Period 4 (7 Days)||0
2499963|NCT00812929|6126773|P7|NOT COMPLETED|Washout Period 4 (7 Days)||0
2499964|NCT00812929|6126774|P6|NOT COMPLETED|Washout Period 4 (7 Days)||0
2499965|NCT00812929|6126775|P5|NOT COMPLETED|Washout Period 4 (7 Days)||0
2499966|NCT00812929|6126776|P4|NOT COMPLETED|Washout Period 4 (7 Days)||0
2499967|NCT00812929|6126777|P3|NOT COMPLETED|Washout Period 4 (7 Days)||0
2499968|NCT00812929|6126778|P2|NOT COMPLETED|Washout Period 4 (7 Days)||0
2499969|NCT00812929|6126779|P1|NOT COMPLETED|Washout Period 4 (7 Days)||0
2499970|NCT00812929|6126770|P10|COMPLETED|Washout Period 4 (7 Days)||4
2499971|NCT00812929|6126771|P9|COMPLETED|Washout Period 4 (7 Days)||4
2499972|NCT00812929|6126772|P8|COMPLETED|Washout Period 4 (7 Days)||5
2499973|NCT00812929|6126773|P7|COMPLETED|Washout Period 4 (7 Days)||5
2499974|NCT00812929|6126774|P6|COMPLETED|Washout Period 4 (7 Days)||4
2499975|NCT00812929|6126775|P5|COMPLETED|Washout Period 4 (7 Days)||5
2499976|NCT00812929|6126776|P4|COMPLETED|Washout Period 4 (7 Days)||4
2499977|NCT00812929|6126777|P3|COMPLETED|Washout Period 4 (7 Days)||4
2499978|NCT00812929|6126778|P2|COMPLETED|Washout Period 4 (7 Days)||4
2499979|NCT00812929|6126779|P1|COMPLETED|Washout Period 4 (7 Days)||5
2499980|NCT00812929|6126770|P10|STARTED|Washout Period 4 (7 Days)||4
2499981|NCT00812929|6126771|P9|STARTED|Washout Period 4 (7 Days)||4
2499982|NCT00812929|6126772|P8|STARTED|Washout Period 4 (7 Days)||5
2499983|NCT00812929|6126773|P7|STARTED|Washout Period 4 (7 Days)||5
2499984|NCT00812929|6126774|P6|STARTED|Washout Period 4 (7 Days)||4
2499985|NCT00812929|6126775|P5|STARTED|Washout Period 4 (7 Days)||5
2499986|NCT00812929|6126776|P4|STARTED|Washout Period 4 (7 Days)||4
2499987|NCT00812929|6126777|P3|STARTED|Washout Period 4 (7 Days)||4
2499988|NCT00812929|6126778|P2|STARTED|Washout Period 4 (7 Days)||4
2499989|NCT00812929|6126779|P1|STARTED|Washout Period 4 (7 Days)||5
2499990|NCT00812929|6126770|P10|NOT COMPLETED|Treatment Period 4||0
2499991|NCT00812929|6126771|P9|NOT COMPLETED|Treatment Period 4||0
2499992|NCT00812929|6126772|P8|NOT COMPLETED|Treatment Period 4||0
2499993|NCT00812929|6126773|P7|NOT COMPLETED|Treatment Period 4||0
2499994|NCT00812929|6126774|P6|NOT COMPLETED|Treatment Period 4||0
2499995|NCT00812929|6126775|P5|NOT COMPLETED|Treatment Period 4||0
2499996|NCT00812929|6126776|P4|NOT COMPLETED|Treatment Period 4||0
2499997|NCT00812929|6126777|P3|NOT COMPLETED|Treatment Period 4||0
2499998|NCT00812929|6126778|P2|NOT COMPLETED|Treatment Period 4||0
2499999|NCT00812929|6126779|P1|NOT COMPLETED|Treatment Period 4||0
2500000|NCT00812929|6126770|P10|COMPLETED|Treatment Period 4||4
2500001|NCT00812929|6126771|P9|COMPLETED|Treatment Period 4||4
2500002|NCT00812929|6126772|P8|COMPLETED|Treatment Period 4||5
2500003|NCT00812929|6126773|P7|COMPLETED|Treatment Period 4||5
2500004|NCT00812929|6126774|P6|COMPLETED|Treatment Period 4||4
2500005|NCT00812929|6126775|P5|COMPLETED|Treatment Period 4||5
2500006|NCT00812929|6126776|P4|COMPLETED|Treatment Period 4||4
2500007|NCT00812929|6126777|P3|COMPLETED|Treatment Period 4||4
2500008|NCT00812929|6126778|P2|COMPLETED|Treatment Period 4||4
2500009|NCT00812929|6126779|P1|COMPLETED|Treatment Period 4||5
2500010|NCT00812929|6126770|P10|STARTED|Treatment Period 4||4
2500011|NCT00812929|6126771|P9|STARTED|Treatment Period 4||4
2500012|NCT00812929|6126772|P8|STARTED|Treatment Period 4||5
2500013|NCT00812929|6126773|P7|STARTED|Treatment Period 4||5
2500014|NCT00812929|6126774|P6|STARTED|Treatment Period 4||4
2500015|NCT00812929|6126775|P5|STARTED|Treatment Period 4||5
2500016|NCT00812929|6126776|P4|STARTED|Treatment Period 4||4
2500017|NCT00812929|6126777|P3|STARTED|Treatment Period 4||4
2500018|NCT00812929|6126778|P2|STARTED|Treatment Period 4||4
2500019|NCT00812929|6126779|P1|STARTED|Treatment Period 4||5
2500020|NCT00812929|6126770|P10|NOT COMPLETED|Washout Period 3 (7 Days)||0
2500021|NCT00812929|6126771|P9|NOT COMPLETED|Washout Period 3 (7 Days)||0
2500022|NCT00812929|6126772|P8|NOT COMPLETED|Washout Period 3 (7 Days)||0
2500023|NCT00812929|6126773|P7|NOT COMPLETED|Washout Period 3 (7 Days)||0
2500024|NCT00812929|6126774|P6|NOT COMPLETED|Washout Period 3 (7 Days)||1
2500025|NCT00812929|6126775|P5|NOT COMPLETED|Washout Period 3 (7 Days)||0
2500026|NCT00812929|6126776|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
2500027|NCT00812929|6126777|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
2500028|NCT00812929|6126778|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
2500029|NCT00812929|6126779|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
2500030|NCT00812929|6126770|P10|COMPLETED|Washout Period 3 (7 Days)||4
2500031|NCT00812929|6126771|P9|COMPLETED|Washout Period 3 (7 Days)||4
2500032|NCT00812929|6126772|P8|COMPLETED|Washout Period 3 (7 Days)||5
2500033|NCT00812929|6126773|P7|COMPLETED|Washout Period 3 (7 Days)||5
2500034|NCT00812929|6126774|P6|COMPLETED|Washout Period 3 (7 Days)||4
2500035|NCT00812929|6126775|P5|COMPLETED|Washout Period 3 (7 Days)||5
2500036|NCT00812929|6126776|P4|COMPLETED|Washout Period 3 (7 Days)||4
2500037|NCT00812929|6126777|P3|COMPLETED|Washout Period 3 (7 Days)||4
2500038|NCT00812929|6126778|P2|COMPLETED|Washout Period 3 (7 Days)||4
2500039|NCT00812929|6126779|P1|COMPLETED|Washout Period 3 (7 Days)||5
2500040|NCT00812929|6126770|P10|STARTED|Washout Period 3 (7 Days)||4
2500041|NCT00812929|6126771|P9|STARTED|Washout Period 3 (7 Days)||4
2500042|NCT00812929|6126772|P8|STARTED|Washout Period 3 (7 Days)||5
2500043|NCT00812929|6126773|P7|STARTED|Washout Period 3 (7 Days)||5
2500044|NCT00812929|6126774|P6|STARTED|Washout Period 3 (7 Days)||5
2500045|NCT00812929|6126775|P5|STARTED|Washout Period 3 (7 Days)||5
2500046|NCT00812929|6126776|P4|STARTED|Washout Period 3 (7 Days)||4
2500047|NCT00812929|6126777|P3|STARTED|Washout Period 3 (7 Days)||4
2500048|NCT00812929|6126778|P2|STARTED|Washout Period 3 (7 Days)||4
2500049|NCT00812929|6126779|P1|STARTED|Washout Period 3 (7 Days)||5
2500050|NCT00812929|6126770|P10|NOT COMPLETED|Treatment Period 3||0
2500051|NCT00812929|6126771|P9|NOT COMPLETED|Treatment Period 3||0
2500052|NCT00812929|6126772|P8|NOT COMPLETED|Treatment Period 3||0
2500053|NCT00812929|6126773|P7|NOT COMPLETED|Treatment Period 3||0
2500054|NCT00812929|6126774|P6|NOT COMPLETED|Treatment Period 3||0
2500055|NCT00812929|6126775|P5|NOT COMPLETED|Treatment Period 3||0
2500056|NCT00812929|6126776|P4|NOT COMPLETED|Treatment Period 3||0
2500057|NCT00812929|6126777|P3|NOT COMPLETED|Treatment Period 3||0
2500058|NCT00812929|6126778|P2|NOT COMPLETED|Treatment Period 3||0
2500059|NCT00812929|6126779|P1|NOT COMPLETED|Treatment Period 3||0
2500060|NCT00812929|6126770|P10|COMPLETED|Treatment Period 3||4
2500061|NCT00812929|6126771|P9|COMPLETED|Treatment Period 3||4
2500062|NCT00812929|6126772|P8|COMPLETED|Treatment Period 3||5
2500063|NCT00812929|6126773|P7|COMPLETED|Treatment Period 3||5
2500064|NCT00812929|6126774|P6|COMPLETED|Treatment Period 3||5
2500065|NCT00812929|6126775|P5|COMPLETED|Treatment Period 3||5
2500066|NCT00812929|6126776|P4|COMPLETED|Treatment Period 3||4
2500067|NCT00812929|6126777|P3|COMPLETED|Treatment Period 3||4
2500068|NCT00812929|6126778|P2|COMPLETED|Treatment Period 3||4
2500069|NCT00812929|6126779|P1|COMPLETED|Treatment Period 3||5
2500070|NCT00812929|6126770|P10|STARTED|Treatment Period 3||4
2500071|NCT00812929|6126771|P9|STARTED|Treatment Period 3||4
2500072|NCT00812929|6126772|P8|STARTED|Treatment Period 3||5
2500073|NCT00812929|6126773|P7|STARTED|Treatment Period 3||5
2500074|NCT00812929|6126774|P6|STARTED|Treatment Period 3||5
2500075|NCT00812929|6126775|P5|STARTED|Treatment Period 3||5
2500076|NCT00812929|6126776|P4|STARTED|Treatment Period 3||4
2500077|NCT00812929|6126777|P3|STARTED|Treatment Period 3||4
2500078|NCT00812929|6126778|P2|STARTED|Treatment Period 3||4
2500079|NCT00812929|6126779|P1|STARTED|Treatment Period 3||5
2500080|NCT00812929|6126770|P10|NOT COMPLETED|Washout Period 2 (7 Days)||1
2500081|NCT00812929|6126771|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
2500082|NCT00812929|6126772|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
2500083|NCT00812929|6126773|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
2500084|NCT00812929|6126774|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
2500085|NCT00812929|6126775|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
2500086|NCT00812929|6126776|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
2500087|NCT00812929|6126777|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
2500088|NCT00812929|6126778|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
2500089|NCT00812929|6126779|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
2500090|NCT00812929|6126770|P10|COMPLETED|Washout Period 2 (7 Days)||4
2500091|NCT00812929|6126771|P9|COMPLETED|Washout Period 2 (7 Days)||4
2500092|NCT00812929|6126772|P8|COMPLETED|Washout Period 2 (7 Days)||5
2500093|NCT00812929|6126773|P7|COMPLETED|Washout Period 2 (7 Days)||5
2500094|NCT00812929|6126774|P6|COMPLETED|Washout Period 2 (7 Days)||5
2500095|NCT00812929|6126775|P5|COMPLETED|Washout Period 2 (7 Days)||5
2500096|NCT00812929|6126776|P4|COMPLETED|Washout Period 2 (7 Days)||4
2500097|NCT00812929|6126777|P3|COMPLETED|Washout Period 2 (7 Days)||4
2500098|NCT00812929|6126778|P2|COMPLETED|Washout Period 2 (7 Days)||4
2500099|NCT00812929|6126779|P1|COMPLETED|Washout Period 2 (7 Days)||5
2500100|NCT00812929|6126770|P10|STARTED|Washout Period 2 (7 Days)||5
2500101|NCT00812929|6126771|P9|STARTED|Washout Period 2 (7 Days)||4
2500102|NCT00812929|6126772|P8|STARTED|Washout Period 2 (7 Days)||5
2500103|NCT00812929|6126773|P7|STARTED|Washout Period 2 (7 Days)||5
2500104|NCT00812929|6126774|P6|STARTED|Washout Period 2 (7 Days)||5
2500105|NCT00812929|6126775|P5|STARTED|Washout Period 2 (7 Days)||5
2500106|NCT00812929|6126776|P4|STARTED|Washout Period 2 (7 Days)||4
2500107|NCT00812929|6126777|P3|STARTED|Washout Period 2 (7 Days)||4
2500108|NCT00812929|6126778|P2|STARTED|Washout Period 2 (7 Days)||4
2500109|NCT00812929|6126779|P1|STARTED|Washout Period 2 (7 Days)||5
2500110|NCT00812929|6126770|P10|NOT COMPLETED|Treatment Period 2||0
2500111|NCT00812929|6126771|P9|NOT COMPLETED|Treatment Period 2||0
2500112|NCT00812929|6126772|P8|NOT COMPLETED|Treatment Period 2||0
2500113|NCT00812929|6126773|P7|NOT COMPLETED|Treatment Period 2||0
2500114|NCT00812929|6126774|P6|NOT COMPLETED|Treatment Period 2||0
2500115|NCT00812929|6126775|P5|NOT COMPLETED|Treatment Period 2||0
2500116|NCT00812929|6126776|P4|NOT COMPLETED|Treatment Period 2||0
2500117|NCT00812929|6126777|P3|NOT COMPLETED|Treatment Period 2||0
2500118|NCT00812929|6126778|P2|NOT COMPLETED|Treatment Period 2||0
2500119|NCT00812929|6126779|P1|NOT COMPLETED|Treatment Period 2||0
2500120|NCT00812929|6126770|P10|COMPLETED|Treatment Period 2||5
2500121|NCT00812929|6126771|P9|COMPLETED|Treatment Period 2||4
2500122|NCT00812929|6126772|P8|COMPLETED|Treatment Period 2||5
2500123|NCT00812929|6126773|P7|COMPLETED|Treatment Period 2||5
2500124|NCT00812929|6126774|P6|COMPLETED|Treatment Period 2||5
2500125|NCT00812929|6126775|P5|COMPLETED|Treatment Period 2||5
2500126|NCT00812929|6126776|P4|COMPLETED|Treatment Period 2||4
2500127|NCT00812929|6126777|P3|COMPLETED|Treatment Period 2||4
2500128|NCT00812929|6126778|P2|COMPLETED|Treatment Period 2||4
2500129|NCT00812929|6126779|P1|COMPLETED|Treatment Period 2||5
2500130|NCT00812929|6126770|P10|STARTED|Treatment Period 2||5
2500131|NCT00812929|6126771|P9|STARTED|Treatment Period 2||4
2500132|NCT00812929|6126772|P8|STARTED|Treatment Period 2||5
2500133|NCT00812929|6126773|P7|STARTED|Treatment Period 2||5
2500134|NCT00812929|6126774|P6|STARTED|Treatment Period 2||5
2500135|NCT00812929|6126775|P5|STARTED|Treatment Period 2||5
2500136|NCT00812929|6126776|P4|STARTED|Treatment Period 2||4
2500137|NCT00812929|6126777|P3|STARTED|Treatment Period 2||4
2500138|NCT00812929|6126778|P2|STARTED|Treatment Period 2||4
2500139|NCT00812929|6126779|P1|STARTED|Treatment Period 2||5
2500140|NCT00812929|6126770|P10|NOT COMPLETED|Washout Period 1 (7 Days)||0
2500141|NCT00812929|6126771|P9|NOT COMPLETED|Washout Period 1 (7 Days)||0
2500142|NCT00812929|6126772|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
2500143|NCT00812929|6126773|P7|NOT COMPLETED|Washout Period 1 (7 Days)||0
2500144|NCT00812929|6126774|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
2500145|NCT00812929|6126775|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
2500146|NCT00812929|6126776|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
2500147|NCT00812929|6126777|P3|NOT COMPLETED|Washout Period 1 (7 Days)||1
2500148|NCT00812929|6126778|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
2500149|NCT00812929|6126779|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
2500150|NCT00812929|6126770|P10|COMPLETED|Washout Period 1 (7 Days)||5
2500151|NCT00812929|6126771|P9|COMPLETED|Washout Period 1 (7 Days)||4
2500152|NCT00812929|6126772|P8|COMPLETED|Washout Period 1 (7 Days)||5
2500153|NCT00812929|6126773|P7|COMPLETED|Washout Period 1 (7 Days)||5
2500154|NCT00812929|6126774|P6|COMPLETED|Washout Period 1 (7 Days)||5
2500155|NCT00812929|6126775|P5|COMPLETED|Washout Period 1 (7 Days)||5
2500156|NCT00812929|6126776|P4|COMPLETED|Washout Period 1 (7 Days)||4
2500157|NCT00812929|6126777|P3|COMPLETED|Washout Period 1 (7 Days)||4
2500158|NCT00812929|6126778|P2|COMPLETED|Washout Period 1 (7 Days)||4
2500159|NCT00812929|6126779|P1|COMPLETED|Washout Period 1 (7 Days)||5
2500160|NCT00812929|6126770|P10|STARTED|Washout Period 1 (7 Days)||5
2500161|NCT00812929|6126771|P9|STARTED|Washout Period 1 (7 Days)||4
2500162|NCT00812929|6126772|P8|STARTED|Washout Period 1 (7 Days)||5
2500163|NCT00812929|6126773|P7|STARTED|Washout Period 1 (7 Days)||5
2500164|NCT00812929|6126774|P6|STARTED|Washout Period 1 (7 Days)||5
2500165|NCT00812929|6126775|P5|STARTED|Washout Period 1 (7 Days)||5
2500166|NCT00812929|6126776|P4|STARTED|Washout Period 1 (7 Days)||4
2500167|NCT00812929|6126777|P3|STARTED|Washout Period 1 (7 Days)||5
2500168|NCT00812929|6126778|P2|STARTED|Washout Period 1 (7 Days)||4
2500169|NCT00812929|6126779|P1|STARTED|Washout Period 1 (7 Days)||5
2500170|NCT00812929|6126770|P10|NOT COMPLETED|Treatment Period 1||0
2500171|NCT00812929|6126771|P9|NOT COMPLETED|Treatment Period 1||0
2500172|NCT00812929|6126772|P8|NOT COMPLETED|Treatment Period 1||0
2500173|NCT00812929|6126773|P7|NOT COMPLETED|Treatment Period 1||0
2500174|NCT00812929|6126774|P6|NOT COMPLETED|Treatment Period 1||0
2500175|NCT00812929|6126775|P5|NOT COMPLETED|Treatment Period 1||0
2500176|NCT00812929|6126776|P4|NOT COMPLETED|Treatment Period 1||0
2500177|NCT00812929|6126777|P3|NOT COMPLETED|Treatment Period 1||0
2500178|NCT00812929|6126778|P2|NOT COMPLETED|Treatment Period 1||0
2500179|NCT00812929|6126779|P1|NOT COMPLETED|Treatment Period 1||0
2500180|NCT00812929|6126770|P10|COMPLETED|Treatment Period 1||5
2500181|NCT00812929|6126771|P9|COMPLETED|Treatment Period 1||4
2500182|NCT00812929|6126772|P8|COMPLETED|Treatment Period 1||5
2500183|NCT00812929|6126773|P7|COMPLETED|Treatment Period 1||5
2500184|NCT00812929|6126774|P6|COMPLETED|Treatment Period 1||5
2500185|NCT00812929|6126775|P5|COMPLETED|Treatment Period 1||5
2500186|NCT00812929|6126776|P4|COMPLETED|Treatment Period 1||4
2500187|NCT00812929|6126777|P3|COMPLETED|Treatment Period 1||5
2500188|NCT00812929|6126778|P2|COMPLETED|Treatment Period 1||4
2500189|NCT00812929|6126779|P1|COMPLETED|Treatment Period 1||5
2500190|NCT00812929|6126770|P10|STARTED|Treatment Period 1||5
2500191|NCT00812929|6126771|P9|STARTED|Treatment Period 1||4
2500192|NCT00812929|6126772|P8|STARTED|Treatment Period 1||5
2500193|NCT00812929|6126773|P7|STARTED|Treatment Period 1||5
2500194|NCT00812929|6126774|P6|STARTED|Treatment Period 1||5
2500195|NCT00812929|6126775|P5|STARTED|Treatment Period 1||5
2500196|NCT00812929|6126776|P4|STARTED|Treatment Period 1||4
2500197|NCT00812929|6126777|P3|STARTED|Treatment Period 1||5
2500198|NCT00812929|6126778|P2|STARTED|Treatment Period 1||4
2500199|NCT00812929|6126779|P1|STARTED|Treatment Period 1||5
2500200|NCT00812916|6126895|P1|NOT COMPLETED|Overall Study||3
2500201|NCT00812916|6126895|P1|COMPLETED|Overall Study||203
2500202|NCT00812916|6126895|P1|CFAE - Guided Ablation|Overall Study||203
2500203|NCT00812916|6126895|P1|Data Available|Overall Study||205
2500204|NCT00812916|6126895|P1|STARTED|Overall Study|206 enrolled (consented)|206
2500205|NCT00812877|6126906|P2|NOT COMPLETED|Overall Study||51
2500206|NCT00812877|6126907|P1|NOT COMPLETED|Overall Study||37
2500207|NCT00812877|6126906|P2|COMPLETED|Overall Study||130
2500208|NCT00812877|6126907|P1|COMPLETED|Overall Study||158
2500209|NCT00812877|6126906|P2|STARTED|Overall Study||181
2500210|NCT00812877|6126907|P1|STARTED|Overall Study||195
2500223|NCT00812812|6126934|P2|NOT COMPLETED|Overall Study||4
2500224|NCT00812812|6126935|P1|NOT COMPLETED|Overall Study||3
2500225|NCT00812812|6126934|P2|COMPLETED|Overall Study||25
2500226|NCT00812812|6126935|P1|COMPLETED|Overall Study||24
2500227|NCT00812812|6126934|P2|STARTED|Overall Study||29
2500228|NCT00812812|6126935|P1|STARTED|Overall Study||27
2500229|NCT00812708|6126948|P1|NOT COMPLETED|Overall Study||8
2500230|NCT00812708|6126948|P1|COMPLETED|Overall Study||64
2500231|NCT00812708|6126948|P1|Taken to Surgery for Device Implantation|Overall Study|2 patients could not be implanted because of intraoperative complications.|66
2500232|NCT00812708|6126948|P1|STARTED|Overall Study|6 patients withdrew from the study before being taken to the operating room.|72
2500233|NCT00812604|6126959|P2|NOT COMPLETED|Overall Study||5
2500234|NCT00812604|6126960|P1|NOT COMPLETED|Overall Study||5
2500235|NCT00812604|6126959|P2|COMPLETED|Overall Study||22
2500236|NCT00812604|6126960|P1|COMPLETED|Overall Study||23
2500237|NCT00812604|6126959|P2|STARTED|Overall Study||27
2500238|NCT00812604|6126960|P1|STARTED|Overall Study||28
2500239|NCT00812565|6126976|P8|NOT COMPLETED|Overall Study||1
2500240|NCT00812565|6126977|P7|NOT COMPLETED|Overall Study||0
2500241|NCT00812565|6126978|P6|NOT COMPLETED|Overall Study||1
2500242|NCT00812565|6126979|P5|NOT COMPLETED|Overall Study||1
2500243|NCT00812565|6126980|P4|NOT COMPLETED|Overall Study||2
2500244|NCT00812565|6126981|P3|NOT COMPLETED|Overall Study||0
2500245|NCT00812565|6126982|P2|NOT COMPLETED|Overall Study||1
2500246|NCT00812565|6126983|P1|NOT COMPLETED|Overall Study||3
2500247|NCT00812565|6126976|P8|COMPLETED|Overall Study||6
2500248|NCT00812565|6126977|P7|COMPLETED|Overall Study||8
2500249|NCT00812565|6126978|P6|COMPLETED|Overall Study||6
2500250|NCT00812565|6126979|P5|COMPLETED|Overall Study||6
2500251|NCT00812565|6126980|P4|COMPLETED|Overall Study||5
2500252|NCT00812565|6126981|P3|COMPLETED|Overall Study||7
2500253|NCT00812565|6126982|P2|COMPLETED|Overall Study||6
2500254|NCT00812565|6126983|P1|COMPLETED|Overall Study||5
2500255|NCT00812565|6126976|P8|STARTED|Overall Study||7
2500256|NCT00812565|6126977|P7|STARTED|Overall Study||8
2500257|NCT00812565|6126978|P6|STARTED|Overall Study||7
2500258|NCT00812565|6126979|P5|STARTED|Overall Study||7
2500259|NCT00812565|6126980|P4|STARTED|Overall Study||7
2500260|NCT00812565|6126981|P3|STARTED|Overall Study||7
2500261|NCT00812565|6126982|P2|STARTED|Overall Study||7
2500262|NCT00812565|6126983|P1|STARTED|Overall Study||8
2500263|NCT00812487|6127107|P2|NOT COMPLETED|Overall Study||3
2500264|NCT00812487|6127108|P1|NOT COMPLETED|Overall Study||6
2500265|NCT00812487|6127107|P2|COMPLETED|Overall Study||39
2500266|NCT00812487|6127108|P1|COMPLETED|Overall Study||26
2500267|NCT00812487|6127107|P2|STARTED|Overall Study||42
2500268|NCT00812487|6127108|P1|STARTED|Overall Study||32
2500269|NCT00812461|6127134|P2|NOT COMPLETED|All Treated Patients||147
2500270|NCT00812461|6127135|P1|NOT COMPLETED|All Treated Patients||132
2500271|NCT00812461|6127134|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|194
2500272|NCT00812461|6127135|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|205
2500273|NCT00812461|6127134|P2|STARTED|All Treated Patients||341
2500274|NCT00812461|6127135|P1|STARTED|All Treated Patients||337
2500275|NCT00812461|6127134|P2|NOT COMPLETED|All Randomised Patients||17
2500276|NCT00812461|6127135|P1|NOT COMPLETED|All Randomised Patients||23
2500277|NCT00812461|6127134|P2|COMPLETED|All Randomised Patients||341
2500278|NCT00812461|6127135|P1|COMPLETED|All Randomised Patients||337
2500279|NCT00812461|6127134|P2|STARTED|All Randomised Patients||358
2500280|NCT00812461|6127135|P1|STARTED|All Randomised Patients||360
2500281|NCT00812331|6127158|P5|NOT COMPLETED|Overall Study||0
2500282|NCT00812331|6127159|P4|NOT COMPLETED|Overall Study||0
2500283|NCT00812331|6127160|P3|NOT COMPLETED|Overall Study||0
2500284|NCT00812331|6127161|P2|NOT COMPLETED|Overall Study||0
2500285|NCT00812331|6127162|P1|NOT COMPLETED|Overall Study||1
2500286|NCT00812331|6127158|P5|COMPLETED|Overall Study||8
2500287|NCT00812331|6127159|P4|COMPLETED|Overall Study||7
2500288|NCT00812331|6127160|P3|COMPLETED|Overall Study||8
2500289|NCT00812331|6127161|P2|COMPLETED|Overall Study||8
2500290|NCT00812331|6127162|P1|COMPLETED|Overall Study||5
2500291|NCT00812331|6127158|P5|STARTED|Overall Study||8
2500292|NCT00812331|6127159|P4|STARTED|Overall Study||7
2500293|NCT00812331|6127160|P3|STARTED|Overall Study||8
2500294|NCT00812331|6127161|P2|STARTED|Overall Study||8
2500295|NCT00812331|6127162|P1|STARTED|Overall Study||6
2500296|NCT00812253|6127237|P2|NOT COMPLETED|Overall Study||3
2500297|NCT00812253|6127238|P1|NOT COMPLETED|Overall Study||6
2500298|NCT00812253|6127237|P2|COMPLETED|Overall Study||39
2500299|NCT00812253|6127238|P1|COMPLETED|Overall Study||26
2500300|NCT00812253|6127237|P2|STARTED|Overall Study||42
2500301|NCT00812253|6127238|P1|STARTED|Overall Study||32
2500302|NCT00812110|6127254|P1|NOT COMPLETED|Overall Study||0
2500303|NCT00812110|6127254|P1|COMPLETED|Overall Study||292
2500304|NCT00812110|6127254|P1|STARTED|Overall Study||292
2500305|NCT00812097|6127263|P4|NOT COMPLETED|Overall Study||35
2500306|NCT00812097|6127264|P3|NOT COMPLETED|Overall Study||57
2500307|NCT00812097|6127265|P2|NOT COMPLETED|Overall Study||89
2500308|NCT00812097|6127266|P1|NOT COMPLETED|Overall Study||245
2500309|NCT00812097|6127263|P4|COMPLETED|Overall Study||34
2500310|NCT00812097|6127264|P3|COMPLETED|Overall Study||67
2500311|NCT00812097|6127265|P2|COMPLETED|Overall Study||101
2500312|NCT00812097|6127266|P1|COMPLETED|Overall Study||327
2500313|NCT00812097|6127263|P4|STARTED|Overall Study||69
2500314|NCT00812097|6127264|P3|STARTED|Overall Study||124
2500315|NCT00812097|6127265|P2|STARTED|Overall Study||190
2500316|NCT00812097|6127266|P1|STARTED|Overall Study||572
2500317|NCT00812006|6127295|P3|NOT COMPLETED|Overall Study||6
2500318|NCT00812006|6127296|P2|NOT COMPLETED|Overall Study||3
2500319|NCT00812006|6127297|P1|NOT COMPLETED|Overall Study||6
2500320|NCT00812006|6127295|P3|COMPLETED|Overall Study||30
2500321|NCT00812006|6127296|P2|COMPLETED|Overall Study||33
2500322|NCT00812006|6127297|P1|COMPLETED|Overall Study||30
2500323|NCT00812006|6127295|P3|STARTED|Overall Study||36
2500324|NCT00812006|6127296|P2|STARTED|Overall Study||36
2500325|NCT00812006|6127297|P1|STARTED|Overall Study||36
2500326|NCT00811954|6127314|P3|NOT COMPLETED|Overall Study||101
2500327|NCT00811954|6127315|P2|NOT COMPLETED|Overall Study||72
2500328|NCT00811954|6127316|P1|NOT COMPLETED|Overall Study||89
2500329|NCT00811954|6127314|P3|COMPLETED|Overall Study||500
2500330|NCT00811954|6127315|P2|COMPLETED|Overall Study||531
2500331|NCT00811954|6127316|P1|COMPLETED|Overall Study||516
2500332|NCT00811954|6127314|P3|STARTED|Overall Study||601
2500333|NCT00811954|6127315|P2|STARTED|Overall Study||603
2500334|NCT00811954|6127316|P1|STARTED|Overall Study||605
2500335|NCT00811941|6127380|P2|NOT COMPLETED|All Treated Patients||191
2500336|NCT00811941|6127381|P1|NOT COMPLETED|All Treated Patients||52
2500337|NCT00811941|6127380|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|310
2500338|NCT00811941|6127381|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|112
2500339|NCT00811941|6127380|P2|STARTED|All Treated Patients||501
2500340|NCT00811941|6127381|P1|STARTED|All Treated Patients||164
2500341|NCT00811941|6127380|P2|NOT COMPLETED|All Randomised Patients||8
2500342|NCT00811941|6127381|P1|NOT COMPLETED|All Randomised Patients||2
2500343|NCT00811941|6127380|P2|COMPLETED|All Randomised Patients||501
2500344|NCT00811941|6127381|P1|COMPLETED|All Randomised Patients||164
2500345|NCT00811941|6127380|P2|STARTED|All Randomised Patients||509
2500346|NCT00811941|6127381|P1|STARTED|All Randomised Patients||166
2500347|NCT00811928|6127419|P2|NOT COMPLETED|Overall Study||33
2500348|NCT00811928|6127420|P1|NOT COMPLETED|Overall Study||39
2500349|NCT00811928|6127419|P2|COMPLETED|Overall Study||90
2500350|NCT00811928|6127420|P1|COMPLETED|Overall Study||90
2500351|NCT00811928|6127419|P2|STARTED|Overall Study||123
2500352|NCT00811928|6127420|P1|STARTED|Overall Study||129
2500353|NCT00811850|6127438|P1|NOT COMPLETED|Treatment Period 3: Combigan® or Cosopt®||0
2500354|NCT00811850|6127438|P1|COMPLETED|Treatment Period 3: Combigan® or Cosopt®||15
2500355|NCT00811850|6127438|P1|STARTED|Treatment Period 3: Combigan® or Cosopt®||15
2500356|NCT00811850|6127438|P1|NOT COMPLETED|Treatment Period 2: Wash Out||0
2500357|NCT00811850|6127438|P1|COMPLETED|Treatment Period 2: Wash Out||15
2500358|NCT00811850|6127438|P1|STARTED|Treatment Period 2: Wash Out||15
2500359|NCT00811850|6127438|P1|NOT COMPLETED|Treatment Period 1: Combigan® or Cosopt®||0
2500360|NCT00811850|6127438|P1|COMPLETED|Treatment Period 1: Combigan® or Cosopt®||15
2500361|NCT00811850|6127438|P1|STARTED|Treatment Period 1: Combigan® or Cosopt®||15
2500362|NCT00811798|6127458|P1|NOT COMPLETED|Overall Study||0
2500363|NCT00811798|6127458|P1|COMPLETED|Overall Study||92
2500364|NCT00811798|6127458|P1|STARTED|Overall Study||92
2500365|NCT00811733|6127464|P2|NOT COMPLETED|Overall Study||10
2500366|NCT00811733|6127465|P1|NOT COMPLETED|Overall Study||11
2500367|NCT00811733|6127464|P2|COMPLETED|Overall Study||12
2500368|NCT00811733|6127465|P1|COMPLETED|Overall Study||4
2500369|NCT00811733|6127464|P2|STARTED|Overall Study||22
2500370|NCT00811733|6127465|P1|STARTED|Overall Study||15
2500371|NCT00811720|6127513|P2|NOT COMPLETED|All Treated Patients||164
2500372|NCT00811720|6127514|P1|NOT COMPLETED|All Treated Patients||96
2500373|NCT00811720|6127513|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|138
2500374|NCT00811720|6127514|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|200
2500375|NCT00811720|6127513|P2|STARTED|All Treated Patients||302
2500376|NCT00811720|6127514|P1|STARTED|All Treated Patients||296
2500377|NCT00811720|6127513|P2|NOT COMPLETED|All Randomised Patients||4
2500378|NCT00811720|6127514|P1|NOT COMPLETED|All Randomised Patients||2
2500379|NCT00811720|6127513|P2|COMPLETED|All Randomised Patients||302
2500380|NCT00811720|6127514|P1|COMPLETED|All Randomised Patients||296
2500381|NCT00811720|6127513|P2|STARTED|All Randomised Patients||306
2500382|NCT00811720|6127514|P1|STARTED|All Randomised Patients||298
2500383|NCT00811655|6127532|P1|NOT COMPLETED|Overall Study||1
2500384|NCT00811655|6127532|P1|COMPLETED|Overall Study||5
2500385|NCT00811655|6127532|P1|STARTED|Overall Study||6
2500386|NCT00811642|6127544|P1|NOT COMPLETED|Overall Study||15
2500387|NCT00811642|6127544|P1|COMPLETED|Overall Study|The Per Protocol Set (PPS) includes the 47 participants who completed the study per protocol.|47
2500388|NCT00811642|6127544|P1|STARTED|Overall Study|63 participants were screened and enrolled; 62 participants from Safety Set (SS) started study drug.|62
2500389|NCT00811590|6127554|P1|NOT COMPLETED|Overall Study||0
2500390|NCT00811590|6127554|P1|COMPLETED|Overall Study||3
2500391|NCT00811590|6127554|P1|STARTED|Overall Study||3
2500392|NCT00811577|6127560|P2|NOT COMPLETED|Overall Study||1
2500393|NCT00811577|6127561|P1|NOT COMPLETED|Overall Study||10
2500394|NCT00811577|6127560|P2|COMPLETED|Overall Study||23
2500395|NCT00811577|6127561|P1|COMPLETED|Overall Study||116
2500396|NCT00811577|6127560|P2|STARTED|Overall Study||24
2500397|NCT00811577|6127561|P1|STARTED|Overall Study||126
2500398|NCT00811564|6127612|P2|NOT COMPLETED|Overall Study||2
2500399|NCT00811564|6127613|P1|NOT COMPLETED|Overall Study||9
2500400|NCT00811564|6127612|P2|COMPLETED|Overall Study||73
2500401|NCT00811564|6127613|P1|COMPLETED|Overall Study||64
2500402|NCT00811564|6127612|P2|STARTED|Overall Study||75
2500403|NCT00811564|6127613|P1|STARTED|Overall Study||73
2500404|NCT00811473|6127621|P2|NOT COMPLETED|Overall Study||26
2500405|NCT00811473|6127622|P1|NOT COMPLETED|Overall Study||23
2500406|NCT00811473|6127621|P2|COMPLETED|Overall Study||74
2500407|NCT00811473|6127622|P1|COMPLETED|Overall Study||70
2500408|NCT00811473|6127621|P2|STARTED|Overall Study||100
2500409|NCT00811473|6127622|P1|STARTED|Overall Study||93
2500410|NCT00811434|6127638|P2|NOT COMPLETED|Second Intervention||0
2500411|NCT00811434|6127639|P1|NOT COMPLETED|Second Intervention||0
2500412|NCT00811434|6127638|P2|COMPLETED|Second Intervention||5
2500413|NCT00811434|6127639|P1|COMPLETED|Second Intervention||4
2500414|NCT00811434|6127638|P2|STARTED|Second Intervention||5
2500415|NCT00811434|6127639|P1|STARTED|Second Intervention||4
2500416|NCT00811434|6127638|P2|NOT COMPLETED|Washout (1 Month)||0
2500417|NCT00811434|6127639|P1|NOT COMPLETED|Washout (1 Month)||0
2500418|NCT00811434|6127638|P2|COMPLETED|Washout (1 Month)||5
2500419|NCT00811434|6127639|P1|COMPLETED|Washout (1 Month)||4
2500420|NCT00811434|6127638|P2|STARTED|Washout (1 Month)||5
2500421|NCT00811434|6127639|P1|STARTED|Washout (1 Month)||4
2500422|NCT00811434|6127638|P2|NOT COMPLETED|First Intervention||0
2500423|NCT00811434|6127639|P1|NOT COMPLETED|First Intervention||3
2500424|NCT00811434|6127638|P2|COMPLETED|First Intervention||5
2500425|NCT00811434|6127639|P1|COMPLETED|First Intervention||4
2500426|NCT00811434|6127638|P2|STARTED|First Intervention||5
2500427|NCT00811434|6127639|P1|STARTED|First Intervention||7
2500428|NCT00811395|6127653|P6|NOT COMPLETED|Extension Treatment||2
2500429|NCT00811395|6127654|P5|NOT COMPLETED|Extension Treatment||0
2500430|NCT00811395|6127655|P4|NOT COMPLETED|Extension Treatment||3
2500431|NCT00811395|6127656|P3|NOT COMPLETED|Extension Treatment||3
2500432|NCT00811395|6127657|P2|NOT COMPLETED|Extension Treatment||6
2500433|NCT00811395|6127658|P1|NOT COMPLETED|Extension Treatment||2
2500434|NCT00811395|6127653|P6|COMPLETED|Extension Treatment|completed 48-week treatment|27
2500435|NCT00811395|6127654|P5|COMPLETED|Extension Treatment|completed 48-week treatment|30
2500436|NCT00811395|6127655|P4|COMPLETED|Extension Treatment|completed 48-week treatment|34
2500437|NCT00811395|6127656|P3|COMPLETED|Extension Treatment|completed 48-week treatment|24
2500438|NCT00811395|6127657|P2|COMPLETED|Extension Treatment|completed 48-week treatment|22
2500439|NCT00811395|6127658|P1|COMPLETED|Extension Treatment|completed 48-week treatment|29
2500440|NCT00811395|6127653|P6|STARTED|Extension Treatment|continued initial treatment|29
2500441|NCT00811395|6127654|P5|STARTED|Extension Treatment|continued initial treatment|30
2500442|NCT00811395|6127655|P4|STARTED|Extension Treatment|continued initial treatment|37
2500443|NCT00811395|6127656|P3|STARTED|Extension Treatment|continued initial treatment|27
2500444|NCT00811395|6127657|P2|STARTED|Extension Treatment|continued initial treatment|28
2500445|NCT00811395|6127658|P1|STARTED|Extension Treatment|continued initial treatment|31
2500446|NCT00811395|6127653|P6|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||6
2500447|NCT00811395|6127654|P5|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||5
2500448|NCT00811395|6127655|P4|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
2500449|NCT00811395|6127656|P3|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
2500450|NCT00811395|6127657|P2|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||4
2500451|NCT00811395|6127658|P1|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||3
2500452|NCT00811395|6127653|P6|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|35
2500453|NCT00811395|6127654|P5|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|37
2500454|NCT00811395|6127655|P4|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|38
2500455|NCT00811395|6127656|P3|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|36
2500456|NCT00811395|6127657|P2|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|33
2500457|NCT00811395|6127658|P1|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|38
2500458|NCT00811395|6127653|P6|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
2500459|NCT00811395|6127654|P5|STARTED|Initial Treatment (PDY6045 or PDY6046)||42
2500460|NCT00811395|6127655|P4|STARTED|Initial Treatment (PDY6045 or PDY6046)||40
2500461|NCT00811395|6127656|P3|STARTED|Initial Treatment (PDY6045 or PDY6046)||38
2500462|NCT00811395|6127657|P2|STARTED|Initial Treatment (PDY6045 or PDY6046)|One participant received 7 mg instead of 14 mg as per randomization|37
2500463|NCT00811395|6127658|P1|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
2500464|NCT00811382|6127722|P2|NOT COMPLETED|Overall Study||0
2500465|NCT00811382|6127723|P1|NOT COMPLETED|Overall Study||0
2500466|NCT00811382|6127722|P2|COMPLETED|Overall Study||75
2500467|NCT00811382|6127723|P1|COMPLETED|Overall Study||88
2500468|NCT00811382|6127722|P2|STARTED|Overall Study||75
2500469|NCT00811382|6127723|P1|STARTED|Overall Study||88
2500470|NCT00811317|6127735|P1|NOT COMPLETED|Overall Study||0
2500471|NCT00811317|6127735|P1|COMPLETED|Overall Study||11
2500472|NCT00811317|6127735|P1|STARTED|Overall Study||11
2500473|NCT00811252|6127764|P3|NOT COMPLETED|Overall Study||23
2500474|NCT00811252|6127765|P2|NOT COMPLETED|Overall Study||20
2500475|NCT00811252|6127766|P1|NOT COMPLETED|Overall Study||17
2500476|NCT00811252|6127764|P3|COMPLETED|Overall Study||128
2500477|NCT00811252|6127765|P2|COMPLETED|Overall Study||136
2500478|NCT00811252|6127766|P1|COMPLETED|Overall Study||128
2500479|NCT00811252|6127764|P3|STARTED|Overall Study||151
2500480|NCT00811252|6127765|P2|STARTED|Overall Study||156
2500481|NCT00811252|6127766|P1|STARTED|Overall Study||145
2500482|NCT00811187|6127812|P2|NOT COMPLETED|Overall Study||3
2500483|NCT00811187|6127813|P1|NOT COMPLETED|Overall Study||3
2500484|NCT00811187|6127812|P2|COMPLETED|Overall Study||37
2500485|NCT00811187|6127813|P1|COMPLETED|Overall Study||37
2500486|NCT00811187|6127812|P2|STARTED|Overall Study||40
2500487|NCT00811187|6127813|P1|STARTED|Overall Study||40
2500488|NCT00811174|6127819|P1|NOT COMPLETED|Overall Study||3
2500489|NCT00811174|6127819|P1|COMPLETED|Overall Study||2
2500490|NCT00811174|6127819|P1|STARTED|Overall Study||5
2500491|NCT00811135|6127830|P1|NOT COMPLETED|Overall Study||88
2500492|NCT00811135|6127830|P1|COMPLETED|Overall Study||0
2500493|NCT00811135|6127830|P1|STARTED|Overall Study||88
2500494|NCT00811070|6127848|P6|NOT COMPLETED|Overall Study||1
2500495|NCT00811070|6127849|P5|NOT COMPLETED|Overall Study||5
2500496|NCT00811070|6127850|P4|NOT COMPLETED|Overall Study||2
2500497|NCT00811070|6127851|P3|NOT COMPLETED|Overall Study||0
2500498|NCT00811070|6127852|P2|NOT COMPLETED|Overall Study||1
2500499|NCT00811070|6127853|P1|NOT COMPLETED|Overall Study||1
2500500|NCT00811070|6127848|P6|COMPLETED|Overall Study||10
2500501|NCT00811070|6127849|P5|COMPLETED|Overall Study||2
2500502|NCT00811070|6127850|P4|COMPLETED|Overall Study||26
2500503|NCT00811070|6127851|P3|COMPLETED|Overall Study||3
2500504|NCT00811070|6127852|P2|COMPLETED|Overall Study||6
2500505|NCT00811070|6127853|P1|COMPLETED|Overall Study||6
2500506|NCT00811070|6127848|P6|STARTED|Overall Study||11
2500507|NCT00811070|6127849|P5|STARTED|Overall Study||7
2500508|NCT00811070|6127850|P4|STARTED|Overall Study||28
2500509|NCT00811070|6127851|P3|STARTED|Overall Study||3
2500510|NCT00811070|6127852|P2|STARTED|Overall Study||7
2500511|NCT00811070|6127853|P1|STARTED|Overall Study||7
2500512|NCT00811057|6127913|P3|NOT COMPLETED|Overall Study||10
2500513|NCT00811057|6127914|P2|NOT COMPLETED|Overall Study||10
2500514|NCT00811057|6127915|P1|NOT COMPLETED|Overall Study||5
2500515|NCT00811057|6127913|P3|COMPLETED|Overall Study||87
2500516|NCT00811057|6127914|P2|COMPLETED|Overall Study||104
2500517|NCT00811057|6127915|P1|COMPLETED|Overall Study||85
2500518|NCT00811057|6127913|P3|STARTED|Overall Study||97
2500519|NCT00811057|6127914|P2|STARTED|Overall Study||114
2500520|NCT00811057|6127915|P1|STARTED|Overall Study||90
2500521|NCT00811018|6127926|P1|NOT COMPLETED|Overall Study||968
2500522|NCT00811018|6127926|P1|COMPLETED|Overall Study||224
2500523|NCT00811018|6127926|P1|STARTED|Overall Study||1192
2500524|NCT00810901|6127944|P2|NOT COMPLETED|Overall Study||58
2500525|NCT00810901|6127945|P1|NOT COMPLETED|Overall Study||88
2500526|NCT00810901|6127944|P2|COMPLETED|Overall Study||118
2500527|NCT00810901|6127945|P1|COMPLETED|Overall Study||165
2500528|NCT00810901|6127944|P2|6-month Follow-up|Overall Study||122
2500529|NCT00810901|6127945|P1|6-month Follow-up|Overall Study||181
2500530|NCT00810901|6127944|P2|1-month Follow up|Overall Study||146
2500531|NCT00810901|6127945|P1|1-month Follow up|Overall Study||242
2500532|NCT00810901|6127944|P2|STARTED|Overall Study||176
2500533|NCT00810901|6127945|P1|STARTED|Overall Study||253
2500534|NCT00810888|6127956|P3|NOT COMPLETED|Overall Study||0
2500535|NCT00810888|6127957|P2|NOT COMPLETED|Overall Study||0
2500536|NCT00810888|6127958|P1|NOT COMPLETED|Overall Study||0
2500537|NCT00810888|6127956|P3|COMPLETED|Overall Study||73
2500538|NCT00810888|6127957|P2|COMPLETED|Overall Study||9
2500539|NCT00810888|6127958|P1|COMPLETED|Overall Study||10
2500540|NCT00810888|6127956|P3|STARTED|Overall Study||73
2500541|NCT00810888|6127957|P2|STARTED|Overall Study||9
2500542|NCT00810888|6127958|P1|STARTED|Overall Study||10
2500543|NCT00810810|6127991|P4|NOT COMPLETED|Overall Study||13
2500544|NCT00810810|6127992|P3|NOT COMPLETED|Overall Study||11
2500545|NCT00810810|6127993|P2|NOT COMPLETED|Overall Study||11
2500546|NCT00810810|6127994|P1|NOT COMPLETED|Overall Study||0
2500547|NCT00810810|6127991|P4|COMPLETED|Overall Study||38
2500548|NCT00810810|6127992|P3|COMPLETED|Overall Study||45
2500549|NCT00810810|6127993|P2|COMPLETED|Overall Study||38
2500550|NCT00810810|6127994|P1|COMPLETED|Overall Study||124
2500551|NCT00810810|6127991|P4|STARTED|Overall Study||51
2500552|NCT00810810|6127992|P3|STARTED|Overall Study||56
2500553|NCT00810810|6127993|P2|STARTED|Overall Study||49
2500554|NCT00810810|6127994|P1|STARTED|Overall Study||124
2500555|NCT00810771|6128011|P3|NOT COMPLETED|Overall Study||0
2500556|NCT00810771|6128012|P2|NOT COMPLETED|Overall Study||0
2500557|NCT00810771|6128013|P1|NOT COMPLETED|Overall Study||0
2500558|NCT00810771|6128011|P3|COMPLETED|Overall Study||84
2500559|NCT00810771|6128012|P2|COMPLETED|Overall Study||234
2500560|NCT00810771|6128013|P1|COMPLETED|Overall Study||232
2500561|NCT00810771|6128011|P3|STARTED|Overall Study||84
2500562|NCT00810771|6128012|P2|STARTED|Overall Study||234
2500563|NCT00810771|6128013|P1|STARTED|Overall Study||232
2500564|NCT00810719|6128033|P1|NOT COMPLETED|Overall Study||0
2500565|NCT00810719|6128033|P1|COMPLETED|Overall Study||30
2500566|NCT00810719|6128033|P1|STARTED|Overall Study||30
2500567|NCT00810693|6128042|P3|NOT COMPLETED|Follow-up Period (FUP)||4
2500568|NCT00810693|6128043|P2|NOT COMPLETED|Follow-up Period (FUP)||3
2500569|NCT00810693|6128044|P1|NOT COMPLETED|Follow-up Period (FUP)||8
2500570|NCT00810693|6128042|P3|COMPLETED|Follow-up Period (FUP)||12
2500571|NCT00810693|6128043|P2|COMPLETED|Follow-up Period (FUP)||4
2500572|NCT00810693|6128044|P1|COMPLETED|Follow-up Period (FUP)||15
2500573|NCT00810693|6128042|P3|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|16
2500574|NCT00810693|6128043|P2|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|7
2500575|NCT00810693|6128044|P1|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|23
2500576|NCT00810693|6128042|P3|NOT COMPLETED|Treatment Period||16
2500577|NCT00810693|6128043|P2|NOT COMPLETED|Treatment Period||7
2500578|NCT00810693|6128044|P1|NOT COMPLETED|Treatment Period||17
2500579|NCT00810693|6128042|P3|COMPLETED|Treatment Period||111
2500580|NCT00810693|6128043|P2|COMPLETED|Treatment Period||57
2500581|NCT00810693|6128044|P1|COMPLETED|Treatment Period||237
2500582|NCT00810693|6128042|P3|Participants Received Treatment|Treatment Period||126
2500583|NCT00810693|6128043|P2|Participants Received Treatment|Treatment Period||63
2500584|NCT00810693|6128044|P1|Participants Received Treatment|Treatment Period||254
2500585|NCT00810693|6128042|P3|STARTED|Treatment Period|1 randomized but not treated|127
2500586|NCT00810693|6128043|P2|STARTED|Treatment Period|1 randomized but not treated|64
2500587|NCT00810693|6128044|P1|STARTED|Treatment Period||254
2500588|NCT00810641|6128076|P3|NOT COMPLETED|Overall Study||2
2500589|NCT00810641|6128077|P2|NOT COMPLETED|Overall Study||1
2500590|NCT00810641|6128078|P1|NOT COMPLETED|Overall Study||0
2500591|NCT00810641|6128076|P3|COMPLETED|Overall Study||49
2500592|NCT00810641|6128077|P2|COMPLETED|Overall Study||53
2500593|NCT00810641|6128078|P1|COMPLETED|Overall Study||52
2500594|NCT00810641|6128076|P3|STARTED|Overall Study||51
2500595|NCT00810641|6128077|P2|STARTED|Overall Study||54
2500596|NCT00810641|6128078|P1|STARTED|Overall Study||52
2500597|NCT00810615|6128088|P2|NOT COMPLETED|Overall Study||1
2500598|NCT00810615|6128089|P1|NOT COMPLETED|Overall Study||1
2500599|NCT00810615|6128088|P2|COMPLETED|Overall Study|One male withdrawal due to personal reasons.|24
2500600|NCT00810615|6128089|P1|COMPLETED|Overall Study|One male withdrawal due to personal reasons.|24
2500601|NCT00810615|6128088|P2|STARTED|Overall Study||25
2500602|NCT00810615|6128089|P1|STARTED|Overall Study||25
2500603|NCT00810602|6128139|P2|NOT COMPLETED|Overall Study||3
2500604|NCT00810602|6128140|P1|NOT COMPLETED|Overall Study||8
2500605|NCT00810602|6128139|P2|COMPLETED|Overall Study||31
2500606|NCT00810602|6128140|P1|COMPLETED|Overall Study||19
2500607|NCT00810602|6128139|P2|STARTED|Overall Study||34
2500608|NCT00810602|6128140|P1|STARTED|Overall Study||27
2500609|NCT00810576|6128147|P1|NOT COMPLETED|Overall Study||0
2500610|NCT00810576|6128147|P1|COMPLETED|Overall Study||1
2500611|NCT00810576|6128147|P1|STARTED|Overall Study||1
2500612|NCT00810511|6128153|P2|NOT COMPLETED|Overall Study||4
2500613|NCT00810511|6128154|P1|NOT COMPLETED|Overall Study||10
2500614|NCT00810511|6128153|P2|COMPLETED|Overall Study||102
2500615|NCT00810511|6128154|P1|COMPLETED|Overall Study||97
2500616|NCT00810511|6128153|P2|STARTED|Overall Study||106
2500617|NCT00810511|6128154|P1|STARTED|Overall Study||107
2500618|NCT00810446|6128160|P1|NOT COMPLETED|Overall Study||0
2500619|NCT00810446|6128160|P1|COMPLETED|Overall Study||72
2500620|NCT00810446|6128160|P1|STARTED|Overall Study||72
2500621|NCT00810407|6128172|P1|NOT COMPLETED|Overall Study||6
2500622|NCT00810407|6128172|P1|COMPLETED|Overall Study||588
2500623|NCT00810407|6128172|P1|STARTED|Overall Study||594
2500624|NCT00810394|6128184|P1|NOT COMPLETED|Overall Study||3
2500625|NCT00810394|6128184|P1|COMPLETED|Overall Study||47
2500626|NCT00810394|6128184|P1|Cycle 3 400mg Twice Daily|Overall Study||5
2500627|NCT00810394|6128184|P1|Cycle 3 800 mg Twice Daily|Overall Study||4
2500628|NCT00810394|6128184|P1|Cycle 2 400mg Once Daily|Overall Study||22
2500629|NCT00810394|6128184|P1|Cycle 2 600mg Twice Daily|Overall Study||13
2500630|NCT00810394|6128184|P1|STARTED|Overall Study||50
2500631|NCT00810368|6128192|P2|NOT COMPLETED|Overall Study||2
2500632|NCT00810368|6128193|P1|NOT COMPLETED|Overall Study||6
2500633|NCT00810368|6128192|P2|COMPLETED|Overall Study||13
2500634|NCT00810368|6128193|P1|COMPLETED|Overall Study||12
2500635|NCT00810368|6128192|P2|STARTED|Overall Study||15
2500636|NCT00810368|6128193|P1|STARTED|Overall Study||18
2500637|NCT00810355|6128214|P3|NOT COMPLETED|Overall Study||11
2500638|NCT00810355|6128215|P2|NOT COMPLETED|Overall Study||17
2500639|NCT00810355|6128216|P1|NOT COMPLETED|Overall Study||14
2500640|NCT00810355|6128214|P3|COMPLETED|Overall Study||14
2500641|NCT00810355|6128215|P2|COMPLETED|Overall Study||8
2500642|NCT00810355|6128216|P1|COMPLETED|Overall Study||11
2500643|NCT00810355|6128214|P3|STARTED|Overall Study||25
2500644|NCT00810355|6128215|P2|STARTED|Overall Study||25
2500645|NCT00810355|6128216|P1|STARTED|Overall Study||25
2500646|NCT00810342|6128232|P2|NOT COMPLETED|12-month Followup||11
2500647|NCT00810342|6128233|P1|NOT COMPLETED|12-month Followup||12
2500648|NCT00810342|6128232|P2|COMPLETED|12-month Followup||136
2500649|NCT00810342|6128233|P1|COMPLETED|12-month Followup||113
2500650|NCT00810342|6128232|P2|STARTED|12-month Followup||147
2500651|NCT00810342|6128233|P1|STARTED|12-month Followup||125
2500652|NCT00810342|6128232|P2|NOT COMPLETED|6-month Follow-up||8
2500653|NCT00810342|6128233|P1|NOT COMPLETED|6-month Follow-up||24
2500654|NCT00810342|6128232|P2|COMPLETED|6-month Follow-up||147
2500655|NCT00810342|6128233|P1|COMPLETED|6-month Follow-up||125
2500656|NCT00810342|6128232|P2|STARTED|6-month Follow-up||155
2500657|NCT00810342|6128233|P1|STARTED|6-month Follow-up||149
2500658|NCT00810342|6128232|P2|NOT COMPLETED|Month 1 Follow-up||2
2500659|NCT00810342|6128233|P1|NOT COMPLETED|Month 1 Follow-up||5
2500660|NCT00810342|6128232|P2|COMPLETED|Month 1 Follow-up||155
2500661|NCT00810342|6128233|P1|COMPLETED|Month 1 Follow-up||149
2500662|NCT00810342|6128232|P2|STARTED|Month 1 Follow-up||157
2500663|NCT00810342|6128233|P1|STARTED|Month 1 Follow-up||154
2500664|NCT00810303|6128241|P1|NOT COMPLETED|Ezetimibe and Efavirenz - Day 21-30||0
2500665|NCT00810303|6128241|P1|COMPLETED|Ezetimibe and Efavirenz - Day 21-30||12
2500666|NCT00810303|6128241|P1|STARTED|Ezetimibe and Efavirenz - Day 21-30||12
2500667|NCT00810303|6128241|P1|NOT COMPLETED|Ezetimibe and Efavirenz - Day 16-20||0
2500668|NCT00810303|6128241|P1|COMPLETED|Ezetimibe and Efavirenz - Day 16-20||12
2500669|NCT00810303|6128241|P1|STARTED|Ezetimibe and Efavirenz - Day 16-20||12
2500670|NCT00810303|6128241|P1|NOT COMPLETED|Ezetimibe Alone - Day 6-15||0
2500671|NCT00810303|6128241|P1|COMPLETED|Ezetimibe Alone - Day 6-15||12
2500672|NCT00810303|6128241|P1|STARTED|Ezetimibe Alone - Day 6-15||12
2500673|NCT00810303|6128241|P1|NOT COMPLETED|Efavirenz Alone - Day 1-5||0
2500674|NCT00810303|6128241|P1|COMPLETED|Efavirenz Alone - Day 1-5||12
2500675|NCT00810303|6128241|P1|STARTED|Efavirenz Alone - Day 1-5||12
2500676|NCT00810277|6128266|P1|NOT COMPLETED|Overall Study||1
2500677|NCT00810277|6128266|P1|COMPLETED|Overall Study||13
2500678|NCT00810277|6128266|P1|STARTED|Overall Study||14
2500679|NCT00810264|6128279|P1|NOT COMPLETED|Overall Study||1553
2500680|NCT00810264|6128279|P1|COMPLETED|Overall Study||946
2500681|NCT00810264|6128279|P1|STARTED|Overall Study||2499
2500682|NCT00810199|6128306|P2|NOT COMPLETED|Overall Study||82
2500683|NCT00810199|6128307|P1|NOT COMPLETED|Overall Study||59
2500684|NCT00810199|6128306|P2|COMPLETED|Overall Study|Completed=Completed Treatment|195
2500685|NCT00810199|6128307|P1|COMPLETED|Overall Study||220
2500686|NCT00810199|6128306|P2|Completed Week 104|Overall Study||201
2500687|NCT00810199|6128307|P1|Completed Week 104|Overall Study||222
2500688|NCT00810199|6128306|P2|Completed Week 52|Overall Study||229
2500689|NCT00810199|6128307|P1|Completed Week 52|Overall Study||243
2500690|NCT00810199|6128306|P2|Completed Week 24|Overall Study||250
2500691|NCT00810199|6128307|P1|Completed Week 24|Overall Study||259
2500692|NCT00810199|6128306|P2|Received Study Drug|Overall Study||276
2500693|NCT00810199|6128307|P1|Received Study Drug|Overall Study||277
2500694|NCT00810199|6128306|P2|STARTED|Overall Study||277
2500695|NCT00810199|6128307|P1|STARTED|Overall Study||279
2500696|NCT00810108|6128385|P2|NOT COMPLETED|Overall Study||0
2500697|NCT00810108|6128386|P1|NOT COMPLETED|Overall Study||1
2500698|NCT00810108|6128385|P2|COMPLETED|Overall Study||7
2500699|NCT00810108|6128386|P1|COMPLETED|Overall Study||5
2500700|NCT00810108|6128385|P2|STARTED|Overall Study||7
2500701|NCT00810108|6128386|P1|STARTED|Overall Study||6
2500702|NCT00810095|6128391|P1|NOT COMPLETED|Overall Study||0
2500703|NCT00810095|6128391|P1|COMPLETED|Overall Study||40
2500704|NCT00810095|6128391|P1|STARTED|Overall Study||40
2500705|NCT00810082|6128400|P2|NOT COMPLETED|Overall Study||4
2500706|NCT00810082|6128401|P1|NOT COMPLETED|Overall Study||0
2500707|NCT00810082|6128400|P2|COMPLETED|Overall Study||27
2500708|NCT00810082|6128401|P1|COMPLETED|Overall Study||34
2500709|NCT00810082|6128400|P2|STARTED|Overall Study||31
2500710|NCT00810082|6128401|P1|STARTED|Overall Study||34
2500711|NCT00810069|6128409|P3|NOT COMPLETED|Double-Blind Period II||72
2500712|NCT00810069|6128410|P2|NOT COMPLETED|Double-Blind Period II||56
2500713|NCT00810069|6128411|P1|NOT COMPLETED|Double-Blind Period II||0
2500714|NCT00810069|6128409|P3|COMPLETED|Double-Blind Period II||212
2500715|NCT00810069|6128410|P2|COMPLETED|Double-Blind Period II||226
2500716|NCT00810069|6128411|P1|COMPLETED|Double-Blind Period II||0
2500717|NCT00810069|6128409|P3|STARTED|Double-Blind Period II|At Week 8 - delayed intervention divided by response to treatment (nonresponders or responders).|284
2500718|NCT00810069|6128410|P2|STARTED|Double-Blind Period II||282
2500719|NCT00810069|6128411|P1|STARTED|Double-Blind Period II||0
2500720|NCT00810069|6128409|P3|NOT COMPLETED|Lead-in Period I||0
2500721|NCT00810069|6128410|P2|NOT COMPLETED|Lead-in Period I||0
2500722|NCT00810069|6128411|P1|NOT COMPLETED|Lead-in Period I||274
2500723|NCT00810069|6128409|P3|COMPLETED|Lead-in Period I||0
2500724|NCT00810069|6128410|P2|COMPLETED|Lead-in Period I||0
2500725|NCT00810069|6128411|P1|COMPLETED|Lead-in Period I||566
2500726|NCT00810069|6128409|P3|STARTED|Lead-in Period I||0
2500727|NCT00810069|6128410|P2|STARTED|Lead-in Period I||0
2500728|NCT00810069|6128411|P1|STARTED|Lead-in Period I||840
2500729|NCT00810043|6128456|P3|NOT COMPLETED|Overall Study||8
2500730|NCT00810043|6128457|P2|NOT COMPLETED|Overall Study||1
2500731|NCT00810043|6128458|P1|NOT COMPLETED|Overall Study||4
2500732|NCT00810043|6128456|P3|COMPLETED|Overall Study||0
2500733|NCT00810043|6128457|P2|COMPLETED|Overall Study||54
2500734|NCT00810043|6128458|P1|COMPLETED|Overall Study||53
2500735|NCT00810043|6128456|P3|STARTED|Overall Study||8
2500736|NCT00810043|6128457|P2|STARTED|Overall Study||55
2500737|NCT00810043|6128458|P1|STARTED|Overall Study||57
2500738|NCT00809965|6128480|P3|NOT COMPLETED|Overall Study||844
2500739|NCT00809965|6128481|P2|NOT COMPLETED|Overall Study||775
2500740|NCT00809965|6128482|P1|NOT COMPLETED|Overall Study||783
2500741|NCT00809965|6128480|P3|COMPLETED|Overall Study||4332
2500742|NCT00809965|6128481|P2|COMPLETED|Overall Study||4399
2500743|NCT00809965|6128482|P1|COMPLETED|Overall Study||4393
2500744|NCT00809965|6128480|P3|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5115
2500745|NCT00809965|6128481|P2|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5114
2500746|NCT00809965|6128482|P1|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5113
2500747|NCT00809965|6128480|P3|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5110
2500748|NCT00809965|6128481|P2|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5115
2500749|NCT00809965|6128482|P1|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5125
2500750|NCT00809965|6128480|P3|STARTED|Overall Study||5176
2500751|NCT00809965|6128481|P2|STARTED|Overall Study||5174
2500752|NCT00809965|6128482|P1|STARTED|Overall Study||5176
2500753|NCT00809926|6128504|P2|NOT COMPLETED|Overall Study||23
2500754|NCT00809926|6128505|P1|NOT COMPLETED|Overall Study||31
2500755|NCT00809926|6128504|P2|COMPLETED|Overall Study||196
2500756|NCT00809926|6128505|P1|COMPLETED|Overall Study||201
2500757|NCT00809926|6128504|P2|STARTED|Overall Study||219
2500758|NCT00809926|6128505|P1|STARTED|Overall Study||232
2500759|NCT00809848|6128534|P5|NOT COMPLETED|Overall Study||3
2500760|NCT00809848|6128535|P4|NOT COMPLETED|Overall Study||1
2500761|NCT00809848|6128536|P3|NOT COMPLETED|Overall Study||0
2500762|NCT00809848|6128537|P2|NOT COMPLETED|Overall Study||0
2500763|NCT00809848|6128538|P1|NOT COMPLETED|Overall Study||0
2500764|NCT00809848|6128534|P5|COMPLETED|Overall Study||34
2500765|NCT00809848|6128535|P4|COMPLETED|Overall Study||30
2500766|NCT00809848|6128536|P3|COMPLETED|Overall Study||34
2500767|NCT00809848|6128537|P2|COMPLETED|Overall Study||34
2500768|NCT00809848|6128538|P1|COMPLETED|Overall Study||36
2500769|NCT00809848|6128534|P5|STARTED|Overall Study||37
2500770|NCT00809848|6128535|P4|STARTED|Overall Study||31
2500771|NCT00809848|6128536|P3|STARTED|Overall Study||34
2500772|NCT00809848|6128537|P2|STARTED|Overall Study||34
2500773|NCT00809848|6128538|P1|STARTED|Overall Study||36
2500774|NCT00809835|6128559|P4|NOT COMPLETED|Overall Study||2
2500775|NCT00809835|6128560|P3|NOT COMPLETED|Overall Study||11
2500776|NCT00809835|6128561|P2|NOT COMPLETED|Overall Study||7
2500777|NCT00809835|6128562|P1|NOT COMPLETED|Overall Study||8
2500778|NCT00809835|6128559|P4|COMPLETED|Overall Study||25
2500779|NCT00809835|6128560|P3|COMPLETED|Overall Study||27
2500780|NCT00809835|6128561|P2|COMPLETED|Overall Study||20
2500781|NCT00809835|6128562|P1|COMPLETED|Overall Study||20
2500782|NCT00809835|6128559|P4|STARTED|Overall Study||27
2500783|NCT00809835|6128560|P3|STARTED|Overall Study||38
2500784|NCT00809835|6128561|P2|STARTED|Overall Study||27
2500785|NCT00809835|6128562|P1|STARTED|Overall Study||28
2500786|NCT00809809|6128582|P2|NOT COMPLETED|Overall Study||2
2500787|NCT00809809|6128583|P1|NOT COMPLETED|Overall Study||3
2500788|NCT00809809|6128582|P2|COMPLETED|Overall Study|2 dropped from the study when it was discovered they met the exclusion criteria|77
2500789|NCT00809809|6128583|P1|COMPLETED|Overall Study|3 dropped from the study when it was discovered they met the exclusion criteria|75
2500790|NCT00809809|6128582|P2|STARTED|Overall Study||79
2500791|NCT00809809|6128583|P1|STARTED|Overall Study||78
2500792|NCT00809757|6128592|P3|NOT COMPLETED|Overall Study||11
2500793|NCT00809757|6128593|P2|NOT COMPLETED|Overall Study||5
2500794|NCT00809757|6128594|P1|NOT COMPLETED|Overall Study||6
2500795|NCT00809757|6128592|P3|COMPLETED|Overall Study||53
2500796|NCT00809757|6128593|P2|COMPLETED|Overall Study||60
2500797|NCT00809757|6128594|P1|COMPLETED|Overall Study||62
2500798|NCT00809757|6128592|P3|STARTED|Overall Study||64
2500799|NCT00809757|6128593|P2|STARTED|Overall Study||65
2500800|NCT00809757|6128594|P1|STARTED|Overall Study||68
2500801|NCT00809614|6128679|P2|NOT COMPLETED|Overall Study||4
2500802|NCT00809614|6128680|P1|NOT COMPLETED|Overall Study||3
2500803|NCT00809614|6128679|P2|COMPLETED|Overall Study||10
2500804|NCT00809614|6128680|P1|COMPLETED|Overall Study||25
2500805|NCT00809614|6128679|P2|Pharmacodynamic (PD) Set|Overall Study||13
2500806|NCT00809614|6128680|P1|Pharmacodynamic (PD) Set|Overall Study||24
2500807|NCT00809614|6128679|P2|Pharmacokinetic Safety Set|Overall Study||14
2500808|NCT00809614|6128680|P1|Pharmacokinetic Safety Set|Overall Study||27
2500809|NCT00809614|6128679|P2|STARTED|Overall Study||14
2500810|NCT00809614|6128680|P1|STARTED|Overall Study||28
2500811|NCT00809523|6128710|P2|NOT COMPLETED|Overall Study||4
2500812|NCT00809523|6128711|P1|NOT COMPLETED|Overall Study||7
2500813|NCT00809523|6128710|P2|COMPLETED|Overall Study||48
2500814|NCT00809523|6128711|P1|COMPLETED|Overall Study||47
2500815|NCT00809523|6128710|P2|STARTED|Overall Study||52
2500816|NCT00809523|6128711|P1|STARTED|Overall Study||54
2500817|NCT00809471|6128724|P3|NOT COMPLETED|Overall Study||17
2500818|NCT00809471|6128725|P2|NOT COMPLETED|Overall Study||20
2500819|NCT00809471|6128726|P1|NOT COMPLETED|Overall Study||20
2500820|NCT00809471|6128724|P3|COMPLETED|Overall Study||114
2500821|NCT00809471|6128725|P2|COMPLETED|Overall Study||109
2500822|NCT00809471|6128726|P1|COMPLETED|Overall Study||110
2500823|NCT00809471|6128724|P3|STARTED|Overall Study||131
2500824|NCT00809471|6128725|P2|STARTED|Overall Study||129
2500825|NCT00809471|6128726|P1|STARTED|Overall Study||130
2500826|NCT00809458|6128742|P2|NOT COMPLETED|Overall Study||1
2500827|NCT00809458|6128743|P1|NOT COMPLETED|Overall Study||1
2500828|NCT00809458|6128742|P2|COMPLETED|Overall Study||5
2500829|NCT00809458|6128743|P1|COMPLETED|Overall Study||8
2500830|NCT00809458|6128742|P2|STARTED|Overall Study||6
2500831|NCT00809458|6128743|P1|STARTED|Overall Study||9
2500832|NCT00809445|6128756|P3|NOT COMPLETED|6 Month Follow-up||24
2500833|NCT00809445|6128757|P2|NOT COMPLETED|6 Month Follow-up||23
2500834|NCT00809445|6128758|P1|NOT COMPLETED|6 Month Follow-up||24
2500835|NCT00809445|6128756|P3|COMPLETED|6 Month Follow-up||395
2500836|NCT00809445|6128757|P2|COMPLETED|6 Month Follow-up||410
2500837|NCT00809445|6128758|P1|COMPLETED|6 Month Follow-up||405
2500838|NCT00809445|6128756|P3|STARTED|6 Month Follow-up||419
2500839|NCT00809445|6128757|P2|STARTED|6 Month Follow-up||433
2500840|NCT00809445|6128758|P1|STARTED|6 Month Follow-up||429
2500841|NCT00809445|6128756|P3|NOT COMPLETED|1 Month Follow-up||4
2500842|NCT00809445|6128757|P2|NOT COMPLETED|1 Month Follow-up||4
2500843|NCT00809445|6128758|P1|NOT COMPLETED|1 Month Follow-up||2
2500844|NCT00809445|6128756|P3|COMPLETED|1 Month Follow-up||415
2500845|NCT00809445|6128757|P2|COMPLETED|1 Month Follow-up||429
2500846|NCT00809445|6128758|P1|COMPLETED|1 Month Follow-up||427
2500847|NCT00809445|6128756|P3|STARTED|1 Month Follow-up||419
2500848|NCT00809445|6128757|P2|STARTED|1 Month Follow-up||433
2500849|NCT00809445|6128758|P1|STARTED|1 Month Follow-up||429
2500850|NCT00809341|6128777|P2|NOT COMPLETED|Overall Study||1
2500851|NCT00809341|6128778|P1|NOT COMPLETED|Overall Study||0
2500852|NCT00809341|6128777|P2|COMPLETED|Overall Study||4
2500853|NCT00809341|6128778|P1|COMPLETED|Overall Study||20
2500854|NCT00809341|6128777|P2|STARTED|Overall Study||5
2500855|NCT00809341|6128778|P1|STARTED|Overall Study||20
2500856|NCT00809328|6128786|P1|NOT COMPLETED|Overall Study||29
2500857|NCT00809328|6128786|P1|COMPLETED|Overall Study||73
2500858|NCT00809328|6128786|P1|STARTED|Overall Study||102
2500859|NCT00809276|6128794|P1|NOT COMPLETED|Overall Study||0
2500860|NCT00809276|6128794|P1|COMPLETED|Overall Study||92
2500861|NCT00809276|6128794|P1|STARTED|Overall Study||92
2500862|NCT00809185|6128798|P1|NOT COMPLETED|Overall Study||0
2500863|NCT00809185|6128798|P1|COMPLETED|Overall Study||7
2500864|NCT00809185|6128798|P1|STARTED|Overall Study||7
2500865|NCT00809159|6128808|P6|NOT COMPLETED|Part 1 and 2||3
2500866|NCT00809159|6128809|P5|NOT COMPLETED|Part 1 and 2||6
2500867|NCT00809159|6128810|P4|NOT COMPLETED|Part 1 and 2||5
2500868|NCT00809159|6128811|P3|NOT COMPLETED|Part 1 and 2||10
2500869|NCT00809159|6128812|P2|NOT COMPLETED|Part 1 and 2||0
2500870|NCT00809159|6128813|P1|NOT COMPLETED|Part 1 and 2||0
2500871|NCT00809159|6128808|P6|COMPLETED|Part 1 and 2||3
2500872|NCT00809159|6128809|P5|COMPLETED|Part 1 and 2||6
2500873|NCT00809159|6128810|P4|COMPLETED|Part 1 and 2||7
2500874|NCT00809159|6128811|P3|COMPLETED|Part 1 and 2||20
2500875|NCT00809159|6128812|P2|COMPLETED|Part 1 and 2||0
2500876|NCT00809159|6128813|P1|COMPLETED|Part 1 and 2||0
2500877|NCT00809159|6128808|P6|PD Analysis Set|Part 1 and 2||6
2500878|NCT00809159|6128809|P5|PD Analysis Set|Part 1 and 2||12
2500879|NCT00809159|6128810|P4|PD Analysis Set|Part 1 and 2||12
2500880|NCT00809159|6128811|P3|PD Analysis Set|Part 1 and 2||28
2500881|NCT00809159|6128812|P2|PD Analysis Set|Part 1 and 2||0
2500882|NCT00809159|6128813|P1|PD Analysis Set|Part 1 and 2||0
2500883|NCT00809159|6128808|P6|PK Analysis Set|Part 1 and 2||6
2500884|NCT00809159|6128809|P5|PK Analysis Set|Part 1 and 2||12
2500885|NCT00809159|6128810|P4|PK Analysis Set|Part 1 and 2||12
2500886|NCT00809159|6128811|P3|PK Analysis Set|Part 1 and 2||30
2500887|NCT00809159|6128812|P2|PK Analysis Set|Part 1 and 2||0
2500888|NCT00809159|6128813|P1|PK Analysis Set|Part 1 and 2||0
2500889|NCT00809159|6128808|P6|STARTED|Part 1 and 2||6
2500890|NCT00809159|6128809|P5|STARTED|Part 1 and 2||12
2500891|NCT00809159|6128810|P4|STARTED|Part 1 and 2||12
2500892|NCT00809159|6128811|P3|STARTED|Part 1 and 2||30
2500893|NCT00809159|6128812|P2|STARTED|Part 1 and 2||0
2500894|NCT00809159|6128813|P1|STARTED|Part 1 and 2||0
2500895|NCT00809159|6128808|P6|NOT COMPLETED|Part 1||0
2500896|NCT00809159|6128809|P5|NOT COMPLETED|Part 1||0
2500897|NCT00809159|6128810|P4|NOT COMPLETED|Part 1||0
2500898|NCT00809159|6128811|P3|NOT COMPLETED|Part 1||0
2500899|NCT00809159|6128812|P2|NOT COMPLETED|Part 1||3
2500900|NCT00809159|6128813|P1|NOT COMPLETED|Part 1||8
2500901|NCT00809159|6128808|P6|COMPLETED|Part 1||0
2500902|NCT00809159|6128809|P5|COMPLETED|Part 1||0
2500903|NCT00809159|6128810|P4|COMPLETED|Part 1||0
2500904|NCT00809159|6128811|P3|COMPLETED|Part 1||0
2500905|NCT00809159|6128812|P2|COMPLETED|Part 1||3
2500906|NCT00809159|6128813|P1|COMPLETED|Part 1||16
2500907|NCT00809159|6128808|P6|PD Analysis Set|Part 1||0
2500908|NCT00809159|6128809|P5|PD Analysis Set|Part 1||0
2500909|NCT00809159|6128810|P4|PD Analysis Set|Part 1||0
2500910|NCT00809159|6128811|P3|PD Analysis Set|Part 1||0
2500911|NCT00809159|6128812|P2|PD Analysis Set|Part 1||6
2500912|NCT00809159|6128813|P1|PD Analysis Set|Part 1||23
2500913|NCT00809159|6128808|P6|PK Analysis Set|Part 1||0
2500914|NCT00809159|6128809|P5|PK Analysis Set|Part 1||0
2500915|NCT00809159|6128810|P4|PK Analysis Set|Part 1||0
2500916|NCT00809159|6128811|P3|PK Analysis Set|Part 1||0
2500917|NCT00809159|6128812|P2|PK Analysis Set|Part 1||6
2500918|NCT00809159|6128813|P1|PK Analysis Set|Part 1||24
2500919|NCT00809159|6128808|P6|STARTED|Part 1||0
2500920|NCT00809159|6128809|P5|STARTED|Part 1||0
2500921|NCT00809159|6128810|P4|STARTED|Part 1||0
2500922|NCT00809159|6128811|P3|STARTED|Part 1||0
2500923|NCT00809159|6128812|P2|STARTED|Part 1||6
2500924|NCT00809159|6128813|P1|STARTED|Part 1||24
2500925|NCT00809146|6128879|P2|NOT COMPLETED|Overall Study||0
2500926|NCT00809146|6128880|P1|NOT COMPLETED|Overall Study||0
2500927|NCT00809146|6128879|P2|COMPLETED|Overall Study||445
2500928|NCT00809146|6128880|P1|COMPLETED|Overall Study||448
2500929|NCT00809146|6128879|P2|STARTED|Overall Study||445
2500930|NCT00809146|6128880|P1|STARTED|Overall Study||448
2500931|NCT00809133|6128918|P14|NOT COMPLETED|Overall Study||7
2500932|NCT00809133|6128919|P13|NOT COMPLETED|Overall Study||5
2500933|NCT00809133|6128920|P12|NOT COMPLETED|Overall Study||8
2500934|NCT00809133|6128921|P11|NOT COMPLETED|Overall Study||6
2500935|NCT00809133|6128922|P10|NOT COMPLETED|Overall Study||9
2500936|NCT00809133|6128923|P9|NOT COMPLETED|Overall Study||3
2500937|NCT00809133|6128924|P8|NOT COMPLETED|Overall Study||8
2500938|NCT00809133|6128925|P7|NOT COMPLETED|Overall Study||6
2500939|NCT00809133|6128926|P6|NOT COMPLETED|Overall Study||7
2500940|NCT00809133|6128927|P5|NOT COMPLETED|Overall Study||5
2500941|NCT00809133|6128928|P4|NOT COMPLETED|Overall Study||3
2500942|NCT00809133|6128929|P3|NOT COMPLETED|Overall Study||6
2500943|NCT00809133|6128930|P2|NOT COMPLETED|Overall Study||7
2500944|NCT00809133|6128931|P1|NOT COMPLETED|Overall Study||3
2500945|NCT00809133|6128918|P14|COMPLETED|Overall Study||0
2500946|NCT00809133|6128919|P13|COMPLETED|Overall Study||0
2500947|NCT00809133|6128920|P12|COMPLETED|Overall Study||0
2500948|NCT00809133|6128921|P11|COMPLETED|Overall Study||0
2500949|NCT00809133|6128922|P10|COMPLETED|Overall Study||0
2500950|NCT00809133|6128923|P9|COMPLETED|Overall Study||0
2500951|NCT00809133|6128924|P8|COMPLETED|Overall Study||0
2500952|NCT00809133|6128925|P7|COMPLETED|Overall Study||0
2500953|NCT00809133|6128926|P6|COMPLETED|Overall Study||0
2500954|NCT00809133|6128927|P5|COMPLETED|Overall Study||0
2500955|NCT00809133|6128928|P4|COMPLETED|Overall Study||0
2500956|NCT00809133|6128929|P3|COMPLETED|Overall Study||0
2500957|NCT00809133|6128930|P2|COMPLETED|Overall Study||0
2500958|NCT00809133|6128931|P1|COMPLETED|Overall Study||0
2500959|NCT00809133|6128918|P14|STARTED|Overall Study||7
2500960|NCT00809133|6128919|P13|STARTED|Overall Study||5
2500961|NCT00809133|6128920|P12|STARTED|Overall Study||8
2500962|NCT00809133|6128921|P11|STARTED|Overall Study||6
2500963|NCT00809133|6128922|P10|STARTED|Overall Study||9
2500964|NCT00809133|6128923|P9|STARTED|Overall Study||3
2500965|NCT00809133|6128924|P8|STARTED|Overall Study||8
2500966|NCT00809133|6128925|P7|STARTED|Overall Study||6
2500967|NCT00809133|6128926|P6|STARTED|Overall Study||7
2500968|NCT00809133|6128927|P5|STARTED|Overall Study||5
2500969|NCT00809133|6128928|P4|STARTED|Overall Study||3
2500970|NCT00809133|6128929|P3|STARTED|Overall Study||6
2500971|NCT00809133|6128930|P2|STARTED|Overall Study||7
2500972|NCT00809133|6128931|P1|STARTED|Overall Study||3
2500973|NCT00809094|6129085|P2|NOT COMPLETED|Overall Study||1
2500974|NCT00809094|6129086|P1|NOT COMPLETED|Overall Study||0
2500975|NCT00809094|6129085|P2|COMPLETED|Overall Study||33
2500976|NCT00809094|6129086|P1|COMPLETED|Overall Study||36
2500977|NCT00809094|6129085|P2|STARTED|Overall Study||34
2500978|NCT00809094|6129086|P1|STARTED|Overall Study||36
2500979|NCT00809055|6129106|P2|NOT COMPLETED|Overall Study||7
2500980|NCT00809055|6129107|P1|NOT COMPLETED|Overall Study||9
2500981|NCT00809055|6129106|P2|COMPLETED|Overall Study||30
2500982|NCT00809055|6129107|P1|COMPLETED|Overall Study||28
2500983|NCT00809055|6129106|P2|STARTED|Overall Study||37
2500984|NCT00809055|6129107|P1|STARTED|Overall Study||37
2500985|NCT00808899|6129131|P1|NOT COMPLETED|Overall Study||4
2500986|NCT00808899|6129131|P1|COMPLETED|Overall Study||0
2500987|NCT00808899|6129131|P1|STARTED|Overall Study||4
2500988|NCT00808834|6129135|P2|NOT COMPLETED|Period 2||0
2500989|NCT00808834|6129136|P1|NOT COMPLETED|Period 2||0
2500990|NCT00808834|6129135|P2|COMPLETED|Period 2||99
2500991|NCT00808834|6129136|P1|COMPLETED|Period 2||97
2500992|NCT00808834|6129135|P2|STARTED|Period 2||99
2500993|NCT00808834|6129136|P1|STARTED|Period 2||97
2500994|NCT00808834|6129135|P2|NOT COMPLETED|Period 1||0
2500995|NCT00808834|6129136|P1|NOT COMPLETED|Period 1||0
2500996|NCT00808834|6129135|P2|COMPLETED|Period 1||99
2500997|NCT00808834|6129136|P1|COMPLETED|Period 1||97
2500998|NCT00808834|6129135|P2|STARTED|Period 1||99
2500999|NCT00808834|6129136|P1|STARTED|Period 1||97
2501000|NCT00808808|6129145|P3|NOT COMPLETED|Overall Study||2557
2501001|NCT00808808|6129146|P2|NOT COMPLETED|Overall Study||2437
2501002|NCT00808808|6129147|P1|NOT COMPLETED|Overall Study||2817
2501003|NCT00808808|6129145|P3|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1830
2501004|NCT00808808|6129146|P2|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1320
2501005|NCT00808808|6129147|P1|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1261
2501006|NCT00808808|6129145|P3|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|2132
2501007|NCT00808808|6129146|P2|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1489
2501008|NCT00808808|6129147|P1|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1392
2501009|NCT00808808|6129145|P3|STARTED|Overall Study|Started includes all employees at participating sites.|4387
2501010|NCT00808808|6129146|P2|STARTED|Overall Study|Started includes all employees at participating sites|3757
2501011|NCT00808808|6129147|P1|STARTED|Overall Study|Started includes all employees at participating sites.|4078
2501012|NCT00808769|6129173|P2|NOT COMPLETED|Second Intervention||0
2501013|NCT00808769|6129174|P1|NOT COMPLETED|Second Intervention||0
2501014|NCT00808769|6129173|P2|COMPLETED|Second Intervention||15
2501015|NCT00808769|6129174|P1|COMPLETED|Second Intervention||15
2501016|NCT00808769|6129173|P2|STARTED|Second Intervention||15
2501017|NCT00808769|6129174|P1|STARTED|Second Intervention||15
2501018|NCT00808769|6129173|P2|NOT COMPLETED|First Intervention||0
2501019|NCT00808769|6129174|P1|NOT COMPLETED|First Intervention||0
2501020|NCT00808769|6129173|P2|COMPLETED|First Intervention||15
2501021|NCT00808769|6129174|P1|COMPLETED|First Intervention||15
2501022|NCT00808769|6129173|P2|STARTED|First Intervention||15
2501023|NCT00808769|6129174|P1|STARTED|First Intervention||15
2501024|NCT00808665|6129182|P2|NOT COMPLETED|Overall Study||3
2501025|NCT00808665|6129183|P1|NOT COMPLETED|Overall Study||6
2501026|NCT00808665|6129182|P2|COMPLETED|Overall Study||29
2501027|NCT00808665|6129183|P1|COMPLETED|Overall Study||25
2501028|NCT00808665|6129182|P2|Completed Post Operative Doses|Overall Study||29
2501029|NCT00808665|6129183|P1|Completed Post Operative Doses|Overall Study||25
2501030|NCT00808665|6129182|P2|Completed Intra-operative Dose|Overall Study||32
2501031|NCT00808665|6129183|P1|Completed Intra-operative Dose|Overall Study||26
2501032|NCT00808665|6129182|P2|Medication Started|Overall Study||32
2501033|NCT00808665|6129183|P1|Medication Started|Overall Study||30
2501034|NCT00808665|6129182|P2|STARTED|Overall Study||32
2501035|NCT00808665|6129183|P1|STARTED|Overall Study||31
2501036|NCT00808639|6129189|P1|NOT COMPLETED|Overall Study||1
2501037|NCT00808639|6129189|P1|COMPLETED|Overall Study|One patient went off treatment due to disease progression before surgery.|38
2501038|NCT00808639|6129189|P1|STARTED|Overall Study||39
2501039|NCT00808509|6129197|P2|NOT COMPLETED|Observation Phase||0
2501040|NCT00808509|6129198|P1|NOT COMPLETED|Observation Phase||0
2501041|NCT00808509|6129197|P2|COMPLETED|Observation Phase||15
2501042|NCT00808509|6129198|P1|COMPLETED|Observation Phase||16
2501043|NCT00808509|6129197|P2|STARTED|Observation Phase|The observation phase was open to all participants|15
2501044|NCT00808509|6129198|P1|STARTED|Observation Phase|The observation phase was open to all participants|16
2501045|NCT00808509|6129197|P2|NOT COMPLETED|Randomized Phase||5
2501046|NCT00808509|6129198|P1|NOT COMPLETED|Randomized Phase||2
2501047|NCT00808509|6129197|P2|COMPLETED|Randomized Phase|Includes participants who received rescue therapy & follow-up for 12 weeks|11
2501048|NCT00808509|6129198|P1|COMPLETED|Randomized Phase||15
2501049|NCT00808509|6129197|P2|Received Rescue Therapy|Randomized Phase||9
2501050|NCT00808509|6129198|P1|Received Rescue Therapy|Randomized Phase||0
2501051|NCT00808509|6129197|P2|STARTED|Randomized Phase||16
2501052|NCT00808509|6129198|P1|STARTED|Randomized Phase||17
2501053|NCT00808483|6129296|P2|NOT COMPLETED|From 5 Months to 12 Months||0
2501054|NCT00808483|6129297|P1|NOT COMPLETED|From 5 Months to 12 Months||1
2501055|NCT00808483|6129296|P2|COMPLETED|From 5 Months to 12 Months||32
2501056|NCT00808483|6129297|P1|COMPLETED|From 5 Months to 12 Months||32
2501057|NCT00808483|6129296|P2|STARTED|From 5 Months to 12 Months||32
2501058|NCT00808483|6129297|P1|STARTED|From 5 Months to 12 Months||33
2501059|NCT00808483|6129296|P2|NOT COMPLETED|From 3 to 5 Months After Surgery||1
2501060|NCT00808483|6129297|P1|NOT COMPLETED|From 3 to 5 Months After Surgery||2
2501061|NCT00808483|6129296|P2|COMPLETED|From 3 to 5 Months After Surgery||32
2501062|NCT00808483|6129297|P1|COMPLETED|From 3 to 5 Months After Surgery||33
2501063|NCT00808483|6129296|P2|STARTED|From 3 to 5 Months After Surgery||33
2501064|NCT00808483|6129297|P1|STARTED|From 3 to 5 Months After Surgery||35
2501065|NCT00808470|6129319|P2|NOT COMPLETED|Overall Study||0
2501066|NCT00808470|6129320|P1|NOT COMPLETED|Overall Study||2
2501067|NCT00808470|6129319|P2|COMPLETED|Overall Study||35
2501068|NCT00808470|6129320|P1|COMPLETED|Overall Study||35
2501069|NCT00808470|6129319|P2|STARTED|Overall Study||35
2501070|NCT00808470|6129320|P1|STARTED|Overall Study||37
2501071|NCT00808444|6129334|P2|NOT COMPLETED|Overall Study||1
2501072|NCT00808444|6129335|P1|NOT COMPLETED|Overall Study||1
2501073|NCT00808444|6129334|P2|COMPLETED|Overall Study||232
2501074|NCT00808444|6129335|P1|COMPLETED|Overall Study||232
2501075|NCT00808444|6129334|P2|STARTED|Overall Study||233
2501076|NCT00808444|6129335|P1|STARTED|Overall Study||233
2501077|NCT00808405|6129375|P2|NOT COMPLETED|Overall Study||0
2501078|NCT00808405|6129376|P1|NOT COMPLETED|Overall Study||0
2501079|NCT00808405|6129375|P2|COMPLETED|Overall Study||27
2501080|NCT00808405|6129376|P1|COMPLETED|Overall Study||61
2501081|NCT00808405|6129375|P2|STARTED|Overall Study||27
2501082|NCT00808405|6129376|P1|STARTED|Overall Study||61
2501083|NCT00808340|6129384|P6|NOT COMPLETED|Third Intervention||0
2501084|NCT00808340|6129385|P5|NOT COMPLETED|Third Intervention||0
2501085|NCT00808340|6129386|P4|NOT COMPLETED|Third Intervention||0
2501086|NCT00808340|6129387|P3|NOT COMPLETED|Third Intervention||0
2501087|NCT00808340|6129388|P2|NOT COMPLETED|Third Intervention||0
2501088|NCT00808340|6129389|P1|NOT COMPLETED|Third Intervention||0
2501089|NCT00808340|6129384|P6|COMPLETED|Third Intervention||6
2501090|NCT00808340|6129385|P5|COMPLETED|Third Intervention||5
2501091|NCT00808340|6129386|P4|COMPLETED|Third Intervention||3
2501092|NCT00808340|6129387|P3|COMPLETED|Third Intervention||7
2501093|NCT00808340|6129388|P2|COMPLETED|Third Intervention||9
2501094|NCT00808340|6129389|P1|COMPLETED|Third Intervention||4
2501095|NCT00808340|6129384|P6|STARTED|Third Intervention||6
2501096|NCT00808340|6129385|P5|STARTED|Third Intervention||5
2501097|NCT00808340|6129386|P4|STARTED|Third Intervention||3
2501098|NCT00808340|6129387|P3|STARTED|Third Intervention||7
2501099|NCT00808340|6129388|P2|STARTED|Third Intervention||9
2501100|NCT00808340|6129389|P1|STARTED|Third Intervention||4
2501101|NCT00808340|6129384|P6|NOT COMPLETED|Second Intervention||0
2501102|NCT00808340|6129385|P5|NOT COMPLETED|Second Intervention||0
2501103|NCT00808340|6129386|P4|NOT COMPLETED|Second Intervention||0
2501104|NCT00808340|6129387|P3|NOT COMPLETED|Second Intervention||0
2501105|NCT00808340|6129388|P2|NOT COMPLETED|Second Intervention||0
2501106|NCT00808340|6129389|P1|NOT COMPLETED|Second Intervention||0
2501107|NCT00808340|6129384|P6|COMPLETED|Second Intervention||6
2501108|NCT00808340|6129385|P5|COMPLETED|Second Intervention||5
2501109|NCT00808340|6129386|P4|COMPLETED|Second Intervention||3
2501110|NCT00808340|6129387|P3|COMPLETED|Second Intervention||7
2501111|NCT00808340|6129388|P2|COMPLETED|Second Intervention||9
2501112|NCT00808340|6129389|P1|COMPLETED|Second Intervention||4
2501113|NCT00808340|6129384|P6|STARTED|Second Intervention||6
2501114|NCT00808340|6129385|P5|STARTED|Second Intervention||5
2501115|NCT00808340|6129386|P4|STARTED|Second Intervention||3
2501116|NCT00808340|6129387|P3|STARTED|Second Intervention||7
2501117|NCT00808340|6129388|P2|STARTED|Second Intervention||9
2501118|NCT00808340|6129389|P1|STARTED|Second Intervention||4
2501119|NCT00808340|6129384|P6|NOT COMPLETED|First Intervention||0
2501120|NCT00808340|6129385|P5|NOT COMPLETED|First Intervention||0
2501121|NCT00808340|6129386|P4|NOT COMPLETED|First Intervention||0
2501122|NCT00808340|6129387|P3|NOT COMPLETED|First Intervention||0
2501123|NCT00808340|6129388|P2|NOT COMPLETED|First Intervention||0
2501124|NCT00808340|6129389|P1|NOT COMPLETED|First Intervention||0
2501125|NCT00808340|6129384|P6|COMPLETED|First Intervention||6
2501126|NCT00808340|6129385|P5|COMPLETED|First Intervention||5
2501127|NCT00808340|6129386|P4|COMPLETED|First Intervention||3
2501128|NCT00808340|6129387|P3|COMPLETED|First Intervention||7
2501129|NCT00808340|6129388|P2|COMPLETED|First Intervention||9
2501130|NCT00808340|6129389|P1|COMPLETED|First Intervention||4
2501131|NCT00808340|6129384|P6|STARTED|First Intervention||6
2501132|NCT00808340|6129385|P5|STARTED|First Intervention||5
2501133|NCT00808340|6129386|P4|STARTED|First Intervention||3
2501134|NCT00808340|6129387|P3|STARTED|First Intervention||7
2501135|NCT00808340|6129388|P2|STARTED|First Intervention||9
2501136|NCT00808340|6129389|P1|STARTED|First Intervention||4
2501137|NCT00808249|6129410|P4|NOT COMPLETED|Overall Study||16
2501138|NCT00808249|6129411|P3|NOT COMPLETED|Overall Study||22
2501139|NCT00808249|6129412|P2|NOT COMPLETED|Overall Study||15
2501140|NCT00808249|6129413|P1|NOT COMPLETED|Overall Study||17
2501141|NCT00808249|6129410|P4|COMPLETED|Overall Study||90
2501142|NCT00808249|6129411|P3|COMPLETED|Overall Study||83
2501143|NCT00808249|6129412|P2|COMPLETED|Overall Study||91
2501144|NCT00808249|6129413|P1|COMPLETED|Overall Study||90
2501145|NCT00808249|6129410|P4|STARTED|Overall Study||106
2501146|NCT00808249|6129411|P3|STARTED|Overall Study||105
2501147|NCT00808249|6129412|P2|STARTED|Overall Study||106
2501148|NCT00808249|6129413|P1|STARTED|Overall Study||107
2501149|NCT00808236|6129441|P2|NOT COMPLETED|Overall Study||91
2501150|NCT00808236|6129442|P1|NOT COMPLETED|Overall Study||82
2501151|NCT00808236|6129441|P2|COMPLETED|Overall Study||13
2501152|NCT00808236|6129442|P1|COMPLETED|Overall Study||14
2501153|NCT00808236|6129441|P2|Admitted to Hospital|Overall Study|Died during transport to hospital(1)|42
2501154|NCT00808236|6129442|P1|Admitted to Hospital|Overall Study|Died during transport to hospital(2); DNAR determination was made at hospital(1)|30
2501155|NCT00808236|6129441|P2|Achieved ROSC|Overall Study||43
2501156|NCT00808236|6129442|P1|Achieved ROSC|Overall Study||33
2501157|NCT00808236|6129441|P2|Included in Analysis|Overall Study|Crossed over & withdrawn (1); Lost to Follow-Up: taken to non-participating hospital (1)|99
2501158|NCT00808236|6129442|P1|Included in Analysis|Overall Study|Lost to Follow-Up: taken to non-participating hospital (1)|83
2501159|NCT00808236|6129441|P2|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: Terminal(1); Asphyxia(1), In-hospital(1)|101
2501247|NCT00807885|6129701|P9|COMPLETED|Overall Study||11
2501248|NCT00807885|6129702|P8|COMPLETED|Overall Study||11
2501160|NCT00808236|6129442|P1|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: DNAR(4); had pulse(2); CVA(2); Drug OD(2); On home oxygen(1); Unwitnessed(1)|84
2501161|NCT00808236|6129441|P2|STARTED|Overall Study||104
2501162|NCT00808236|6129442|P1|STARTED|Overall Study||96
2501163|NCT00808132|6129475|P5|NOT COMPLETED|Overall Study||100
2501164|NCT00808132|6129476|P4|NOT COMPLETED|Overall Study||69
2501165|NCT00808132|6129477|P3|NOT COMPLETED|Overall Study||54
2501166|NCT00808132|6129478|P2|NOT COMPLETED|Overall Study||88
2501167|NCT00808132|6129479|P1|NOT COMPLETED|Overall Study||98
2501168|NCT00808132|6129475|P5|COMPLETED|Overall Study||383
2501169|NCT00808132|6129476|P4|COMPLETED|Overall Study||159
2501170|NCT00808132|6129477|P3|COMPLETED|Overall Study||185
2501171|NCT00808132|6129478|P2|COMPLETED|Overall Study||393
2501172|NCT00808132|6129479|P1|COMPLETED|Overall Study||357
2501173|NCT00808132|6129475|P5|Treated|Overall Study||474
2501174|NCT00808132|6129476|P4|Treated|Overall Study||220
2501175|NCT00808132|6129477|P3|Treated|Overall Study||230
2501176|NCT00808132|6129478|P2|Treated|Overall Study||474
2501177|NCT00808132|6129479|P1|Treated|Overall Study||445
2501178|NCT00808132|6129475|P5|STARTED|Overall Study||483
2501179|NCT00808132|6129476|P4|STARTED|Overall Study||228
2501180|NCT00808132|6129477|P3|STARTED|Overall Study||239
2501181|NCT00808132|6129478|P2|STARTED|Overall Study||481
2501182|NCT00808132|6129479|P1|STARTED|Overall Study||455
2501183|NCT00808080|6129551|P1|NOT COMPLETED|Overall Study||6
2501184|NCT00808080|6129551|P1|COMPLETED|Overall Study||0
2501185|NCT00808080|6129551|P1|STARTED|Overall Study||6
2501186|NCT00808067|6129558|P2|NOT COMPLETED|Overall Study||518
2501187|NCT00808067|6129559|P1|NOT COMPLETED|Overall Study||481
2501188|NCT00808067|6129558|P2|COMPLETED|Overall Study||2438
2501189|NCT00808067|6129559|P1|COMPLETED|Overall Study||2446
2501190|NCT00808067|6129558|P2|STARTED|Overall Study|Number of patients which are treated.|2956
2501191|NCT00808067|6129559|P1|STARTED|Overall Study|Number of patients which are treated.|2927
2501192|NCT00808028|6129595|P4|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||23
2501193|NCT00808028|6129596|P3|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||29
2501194|NCT00808028|6129597|P2|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||0
2501195|NCT00808028|6129598|P1|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||11
2501196|NCT00808028|6129595|P4|COMPLETED|Stage 2 (Followed up to 48 Months )||128
2501197|NCT00808028|6129596|P3|COMPLETED|Stage 2 (Followed up to 48 Months )||141
2501198|NCT00808028|6129597|P2|COMPLETED|Stage 2 (Followed up to 48 Months )||0
2501199|NCT00808028|6129598|P1|COMPLETED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|69
2501200|NCT00808028|6129595|P4|STARTED|Stage 2 (Followed up to 48 Months )||151
2501201|NCT00808028|6129596|P3|STARTED|Stage 2 (Followed up to 48 Months )||170
2501202|NCT00808028|6129597|P2|STARTED|Stage 2 (Followed up to 48 Months )||0
2501203|NCT00808028|6129598|P1|STARTED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|80
2501204|NCT00808028|6129595|P4|NOT COMPLETED|Stage 1 (6 Months)||15
2501205|NCT00808028|6129596|P3|NOT COMPLETED|Stage 1 (6 Months)||7
2501206|NCT00808028|6129597|P2|NOT COMPLETED|Stage 1 (6 Months)||1
2501207|NCT00808028|6129598|P1|NOT COMPLETED|Stage 1 (6 Months)||5
2501208|NCT00808028|6129595|P4|COMPLETED|Stage 1 (6 Months)||183
2501209|NCT00808028|6129596|P3|COMPLETED|Stage 1 (6 Months)||191
2501210|NCT00808028|6129597|P2|COMPLETED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|21
2501211|NCT00808028|6129598|P1|COMPLETED|Stage 1 (6 Months)||116
2501212|NCT00808028|6129595|P4|STARTED|Stage 1 (6 Months)||198
2501213|NCT00808028|6129596|P3|STARTED|Stage 1 (6 Months)||198
2501214|NCT00808028|6129597|P2|STARTED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|22
2501215|NCT00808028|6129598|P1|STARTED|Stage 1 (6 Months)||121
2501216|NCT00808015|6129634|P1|NOT COMPLETED|Overall Study||344
2501217|NCT00808015|6129634|P1|COMPLETED|Overall Study||1033
2501218|NCT00808015|6129634|P1|Treated|Overall Study||1373
2501219|NCT00808015|6129634|P1|STARTED|Overall Study||1377
2501220|NCT00807989|6129648|P2|NOT COMPLETED|Overall Study||2
2501221|NCT00807989|6129649|P1|NOT COMPLETED|Overall Study||3
2501222|NCT00807989|6129648|P2|COMPLETED|Overall Study||98
2501223|NCT00807989|6129649|P1|COMPLETED|Overall Study||104
2501224|NCT00807989|6129648|P2|STARTED|Overall Study||100
2501225|NCT00807989|6129649|P1|STARTED|Overall Study||107
2501226|NCT00807937|6129663|P4|NOT COMPLETED|Overall Study||15
2501227|NCT00807937|6129664|P3|NOT COMPLETED|Overall Study||14
2501228|NCT00807937|6129665|P2|NOT COMPLETED|Overall Study||25
2501229|NCT00807937|6129666|P1|NOT COMPLETED|Overall Study||27
2501230|NCT00807937|6129663|P4|COMPLETED|Overall Study||77
2501231|NCT00807937|6129664|P3|COMPLETED|Overall Study||78
2501232|NCT00807937|6129665|P2|COMPLETED|Overall Study||67
2501233|NCT00807937|6129666|P1|COMPLETED|Overall Study||66
2501234|NCT00807937|6129663|P4|STARTED|Overall Study||92
2501235|NCT00807937|6129664|P3|STARTED|Overall Study||92
2501236|NCT00807937|6129665|P2|STARTED|Overall Study||92
2501237|NCT00807937|6129666|P1|STARTED|Overall Study||93
2501238|NCT00807885|6129701|P9|NOT COMPLETED|Overall Study||0
2501239|NCT00807885|6129702|P8|NOT COMPLETED|Overall Study||0
2501240|NCT00807885|6129703|P7|NOT COMPLETED|Overall Study||0
2501241|NCT00807885|6129704|P6|NOT COMPLETED|Overall Study||1
2501242|NCT00807885|6129705|P5|NOT COMPLETED|Overall Study||0
2501243|NCT00807885|6129706|P4|NOT COMPLETED|Overall Study||0
2501244|NCT00807885|6129707|P3|NOT COMPLETED|Overall Study||0
2501245|NCT00807885|6129708|P2|NOT COMPLETED|Overall Study||0
2501246|NCT00807885|6129709|P1|NOT COMPLETED|Overall Study||0
2501249|NCT00807885|6129703|P7|COMPLETED|Overall Study||12
2501250|NCT00807885|6129704|P6|COMPLETED|Overall Study|Subject completed treatment, but lost to follow-up|11
2501251|NCT00807885|6129705|P5|COMPLETED|Overall Study||12
2501252|NCT00807885|6129706|P4|COMPLETED|Overall Study||10
2501253|NCT00807885|6129707|P3|COMPLETED|Overall Study||11
2501254|NCT00807885|6129708|P2|COMPLETED|Overall Study||11
2501255|NCT00807885|6129709|P1|COMPLETED|Overall Study||10
2501256|NCT00807885|6129701|P9|STARTED|Overall Study||11
2501257|NCT00807885|6129702|P8|STARTED|Overall Study||11
2501258|NCT00807885|6129703|P7|STARTED|Overall Study||12
2501259|NCT00807885|6129704|P6|STARTED|Overall Study||12
2501260|NCT00807885|6129705|P5|STARTED|Overall Study||12
2501261|NCT00807885|6129706|P4|STARTED|Overall Study||10
2501262|NCT00807885|6129707|P3|STARTED|Overall Study||11
2501263|NCT00807885|6129708|P2|STARTED|Overall Study||11
2501264|NCT00807885|6129709|P1|STARTED|Overall Study||10
2501265|NCT00807846|6129758|P2|NOT COMPLETED|Overall Study||4
2501266|NCT00807846|6129759|P1|NOT COMPLETED|Overall Study||12
2501267|NCT00807846|6129758|P2|COMPLETED|Overall Study||94
2501268|NCT00807846|6129759|P1|COMPLETED|Overall Study||88
2501269|NCT00807846|6129758|P2|STARTED|Overall Study||98
2501270|NCT00807846|6129759|P1|STARTED|Overall Study||100
2501271|NCT00807768|6129793|P2|NOT COMPLETED|Overall Study||0
2501272|NCT00807768|6129794|P1|NOT COMPLETED|Overall Study||0
2501273|NCT00807768|6129793|P2|COMPLETED|Overall Study||300
2501274|NCT00807768|6129794|P1|COMPLETED|Overall Study||301
2501275|NCT00807768|6129793|P2|STARTED|Overall Study||300
2501276|NCT00807768|6129794|P1|STARTED|Overall Study||301
2501277|NCT00807742|6129812|P2|NOT COMPLETED|Overall Study||54
2501278|NCT00807742|6129813|P1|NOT COMPLETED|Overall Study||46
2501279|NCT00807742|6129812|P2|COMPLETED|Overall Study||114
2501280|NCT00807742|6129813|P1|COMPLETED|Overall Study||126
2501281|NCT00807742|6129812|P2|STARTED|Overall Study||168
2501282|NCT00807742|6129813|P1|STARTED|Overall Study||172
2501283|NCT00807664|6129859|P2|NOT COMPLETED|Overall Study||19
2501284|NCT00807664|6129860|P1|NOT COMPLETED|Overall Study||11
2501285|NCT00807664|6129859|P2|COMPLETED|Overall Study||75
2501286|NCT00807664|6129860|P1|COMPLETED|Overall Study||77
2501287|NCT00807664|6129859|P2|STARTED|Overall Study||94
2501288|NCT00807664|6129860|P1|STARTED|Overall Study||88
2501289|NCT00807599|6129872|P3|NOT COMPLETED|Overall Study||17
2501290|NCT00807599|6129873|P2|NOT COMPLETED|Overall Study||0
2501291|NCT00807599|6129874|P1|NOT COMPLETED|Overall Study||0
2501292|NCT00807599|6129872|P3|COMPLETED|Overall Study||0
2501293|NCT00807599|6129873|P2|COMPLETED|Overall Study||24
2501294|NCT00807599|6129874|P1|COMPLETED|Overall Study||26
2501295|NCT00807599|6129872|P3|STARTED|Overall Study||17
2501296|NCT00807599|6129873|P2|STARTED|Overall Study||24
2501297|NCT00807599|6129874|P1|STARTED|Overall Study||26
2501298|NCT00807586|6129888|P2|NOT COMPLETED|Overall Study||1
2501299|NCT00807586|6129889|P1|NOT COMPLETED|Overall Study||6
2501300|NCT00807586|6129888|P2|COMPLETED|Overall Study||58
2501301|NCT00807586|6129889|P1|COMPLETED|Overall Study||54
2501302|NCT00807586|6129888|P2|STARTED|Overall Study||59
2501303|NCT00807586|6129889|P1|STARTED|Overall Study||60
2501304|NCT00807573|6129901|P1|NOT COMPLETED|Overall Study||2
2501305|NCT00807573|6129901|P1|COMPLETED|Overall Study||42
2501306|NCT00807573|6129901|P1|STARTED|Overall Study||44
2501307|NCT00807560|6129907|P2|NOT COMPLETED|Overall Study||0
2501308|NCT00807560|6129908|P1|NOT COMPLETED|Overall Study||0
2501309|NCT00807560|6129907|P2|COMPLETED|Overall Study||39
2501310|NCT00807560|6129908|P1|COMPLETED|Overall Study||38
2501311|NCT00807560|6129907|P2|STARTED|Overall Study||39
2501312|NCT00807560|6129908|P1|STARTED|Overall Study||38
2501313|NCT00807495|6129947|P5|NOT COMPLETED|Overall Study||5
2501314|NCT00807495|6129948|P4|NOT COMPLETED|Overall Study||1
2501315|NCT00807495|6129949|P3|NOT COMPLETED|Overall Study||4
2501316|NCT00807495|6129950|P2|NOT COMPLETED|Overall Study||6
2501317|NCT00807495|6129951|P1|NOT COMPLETED|Overall Study||8
2501318|NCT00807495|6129947|P5|COMPLETED|Overall Study||2
2501319|NCT00807495|6129948|P4|COMPLETED|Overall Study||0
2501320|NCT00807495|6129949|P3|COMPLETED|Overall Study||1
2501321|NCT00807495|6129950|P2|COMPLETED|Overall Study||7
2501322|NCT00807495|6129951|P1|COMPLETED|Overall Study|Completed = participants who completed the study treatment to PD or symptomatic deterioration.|14
2501323|NCT00807495|6129947|P5|STARTED|Overall Study|An ATL participant had late on-study biopsy and was in DLBL, reducing ATL participants from 8 to 7.|7
2501324|NCT00807495|6129948|P4|STARTED|Overall Study||1
2501325|NCT00807495|6129949|P3|STARTED|Overall Study||5
2501326|NCT00807495|6129950|P2|STARTED|Overall Study||13
2501327|NCT00807495|6129951|P1|STARTED|Overall Study||22
2501328|NCT00807456|6129993|P1|NOT COMPLETED|Overall Study||0
2501329|NCT00807456|6129993|P1|COMPLETED|Overall Study||65
2501330|NCT00807456|6129993|P1|STARTED|Overall Study||65
2501331|NCT00807365|6129997|P1|NOT COMPLETED|Overall Study||5
2501332|NCT00807365|6129997|P1|COMPLETED|Overall Study||0
2501333|NCT00807365|6129997|P1|STARTED|Overall Study||5
2501334|NCT00807248|6130005|P4|NOT COMPLETED|Overall Study||14
2501335|NCT00807248|6130006|P3|NOT COMPLETED|Overall Study||18
2501336|NCT00807248|6130007|P2|NOT COMPLETED|Overall Study||12
2501337|NCT00807248|6130008|P1|NOT COMPLETED|Overall Study||21
2501338|NCT00807248|6130005|P4|COMPLETED|Overall Study||126
2501339|NCT00807248|6130006|P3|COMPLETED|Overall Study||121
2501340|NCT00807248|6130007|P2|COMPLETED|Overall Study||128
2501341|NCT00807248|6130008|P1|COMPLETED|Overall Study||50
2501342|NCT00807248|6130005|P4|STARTED|Overall Study||140
2501343|NCT00807248|6130006|P3|STARTED|Overall Study||139
2501344|NCT00807248|6130007|P2|STARTED|Overall Study||140
2501345|NCT00807248|6130008|P1|STARTED|Overall Study||71
2501346|NCT00807235|6130052|P2|NOT COMPLETED|Overall Study||0
2501347|NCT00807235|6130053|P1|NOT COMPLETED|Overall Study||1
2501348|NCT00807235|6130052|P2|COMPLETED|Overall Study||6
2501349|NCT00807235|6130053|P1|COMPLETED|Overall Study||10
2501350|NCT00807235|6130052|P2|STARTED|Overall Study||6
2501351|NCT00807235|6130053|P1|STARTED|Overall Study||11
2501352|NCT00807209|6130086|P3|NOT COMPLETED|Overall Study||0
2501353|NCT00807209|6130087|P2|NOT COMPLETED|Overall Study||0
2501354|NCT00807209|6130088|P1|NOT COMPLETED|Overall Study||0
2501355|NCT00807209|6130086|P3|COMPLETED|Overall Study||1
2501356|NCT00807209|6130087|P2|COMPLETED|Overall Study||1
2501357|NCT00807209|6130088|P1|COMPLETED|Overall Study||1
2501358|NCT00807209|6130086|P3|STARTED|Overall Study||1
2501359|NCT00807209|6130087|P2|STARTED|Overall Study||1
2501360|NCT00807209|6130088|P1|STARTED|Overall Study||1
2501361|NCT00807092|6130098|P2|NOT COMPLETED|Overall Study||4
2501362|NCT00807092|6130099|P1|NOT COMPLETED|Overall Study||1
2501363|NCT00807092|6130098|P2|COMPLETED|Overall Study||69
2501364|NCT00807092|6130099|P1|COMPLETED|Overall Study||71
2501365|NCT00807092|6130098|P2|Exposed to Drug|Overall Study||73
2501366|NCT00807092|6130099|P1|Exposed to Drug|Overall Study|Subject was randomised, but not exposed to any trial drug|71
2501367|NCT00807092|6130098|P2|STARTED|Overall Study||73
2501368|NCT00807092|6130099|P1|STARTED|Overall Study||72
2501369|NCT00807040|6130129|P2|NOT COMPLETED|Overall Study||41
2501370|NCT00807040|6130130|P1|NOT COMPLETED|Overall Study||36
2501371|NCT00807040|6130129|P2|COMPLETED|Overall Study||84
2501372|NCT00807040|6130130|P1|COMPLETED|Overall Study||90
2501373|NCT00807040|6130129|P2|STARTED|Overall Study||125
2501374|NCT00807040|6130130|P1|STARTED|Overall Study||126
2501375|NCT00807014|6130140|P2|NOT COMPLETED|Overall Study||27
2501376|NCT00807014|6130141|P1|NOT COMPLETED|Overall Study||27
2501377|NCT00807014|6130140|P2|COMPLETED|Overall Study||58
2501378|NCT00807014|6130141|P1|COMPLETED|Overall Study||56
2501379|NCT00807014|6130140|P2|STARTED|Overall Study||85
2501380|NCT00807014|6130141|P1|STARTED|Overall Study||83
2501381|NCT00807001|6130172|P5|NOT COMPLETED|Overall Study||0
2501382|NCT00807001|6130173|P4|NOT COMPLETED|Overall Study||0
2501383|NCT00807001|6130174|P3|NOT COMPLETED|Overall Study||0
2501384|NCT00807001|6130175|P2|NOT COMPLETED|Overall Study||1
2501385|NCT00807001|6130176|P1|NOT COMPLETED|Overall Study||0
2501386|NCT00807001|6130172|P5|COMPLETED|Overall Study||9
2501387|NCT00807001|6130173|P4|COMPLETED|Overall Study||8
2501388|NCT00807001|6130174|P3|COMPLETED|Overall Study||8
2501389|NCT00807001|6130175|P2|COMPLETED|Overall Study||7
2501390|NCT00807001|6130176|P1|COMPLETED|Overall Study||8
2501391|NCT00807001|6130172|P5|STARTED|Overall Study||9
2501392|NCT00807001|6130173|P4|STARTED|Overall Study||8
2501393|NCT00807001|6130174|P3|STARTED|Overall Study||8
2501394|NCT00807001|6130175|P2|STARTED|Overall Study||8
2501395|NCT00807001|6130176|P1|STARTED|Overall Study|For all groups, number of subjects who received at least one dose of study drug.|8
2501396|NCT00806988|6130195|P2|NOT COMPLETED|Overall Study||43
2501397|NCT00806988|6130196|P1|NOT COMPLETED|Overall Study||27
2501398|NCT00806988|6130195|P2|COMPLETED|Overall Study||108
2501399|NCT00806988|6130196|P1|COMPLETED|Overall Study||123
2501400|NCT00806988|6130195|P2|STARTED|Overall Study||151
2501401|NCT00806988|6130196|P1|STARTED|Overall Study||150
2501402|NCT00806819|6130206|P2|NOT COMPLETED|Overall Study||358
2501403|NCT00806819|6130207|P1|NOT COMPLETED|Overall Study||346
2501404|NCT00806819|6130206|P2|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|2
2501405|NCT00806819|6130207|P1|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|7
2501406|NCT00806819|6130206|P2|STARTED|Overall Study|randomised patients|360
2501407|NCT00806819|6130207|P1|STARTED|Overall Study|randomised patients|353
2501408|NCT00806676|6130242|P3|NOT COMPLETED|Overall Study||6
2501409|NCT00806676|6130243|P2|NOT COMPLETED|Overall Study||0
2501410|NCT00806676|6130244|P1|NOT COMPLETED|Overall Study||4
2501411|NCT00806676|6130242|P3|COMPLETED|Overall Study||23
2501412|NCT00806676|6130243|P2|COMPLETED|Overall Study||9
2501413|NCT00806676|6130244|P1|COMPLETED|Overall Study||25
2501414|NCT00806676|6130242|P3|STARTED|Overall Study||29
2501415|NCT00806676|6130243|P2|STARTED|Overall Study||9
2501416|NCT00806676|6130244|P1|STARTED|Overall Study||29
2501417|NCT00806624|6130276|P3|NOT COMPLETED|Overall Study||6
2501418|NCT00806624|6130277|P2|NOT COMPLETED|Overall Study||12
2501419|NCT00806624|6130278|P1|NOT COMPLETED|Overall Study||9
2501420|NCT00806624|6130276|P3|COMPLETED|Overall Study||69
2501421|NCT00806624|6130277|P2|COMPLETED|Overall Study||68
2501422|NCT00806624|6130278|P1|COMPLETED|Overall Study||70
2501423|NCT00806624|6130276|P3|STARTED|Overall Study||75
2501424|NCT00806624|6130277|P2|STARTED|Overall Study||80
2501425|NCT00806624|6130278|P1|STARTED|Overall Study||79
2501426|NCT00806598|6130286|P1|NOT COMPLETED|Overall Study||0
2501427|NCT00806598|6130286|P1|COMPLETED|Overall Study||48
2501428|NCT00806598|6130286|P1|STARTED|Overall Study||48
2501429|NCT00806585|6130295|P5|NOT COMPLETED|Overall Study||31
2501430|NCT00806585|6130296|P4|NOT COMPLETED|Overall Study||15
2501431|NCT00806585|6130297|P3|NOT COMPLETED|Overall Study||32
2501432|NCT00806585|6130298|P2|NOT COMPLETED|Overall Study||31
2501433|NCT00806585|6130299|P1|NOT COMPLETED|Overall Study||32
2501434|NCT00806585|6130295|P5|COMPLETED|Overall Study||106
2501435|NCT00806585|6130296|P4|COMPLETED|Overall Study||56
2501436|NCT00806585|6130297|P3|COMPLETED|Overall Study||109
2501437|NCT00806585|6130298|P2|COMPLETED|Overall Study||103
2501438|NCT00806585|6130299|P1|COMPLETED|Overall Study||105
2501439|NCT00806585|6130295|P5|STARTED|Overall Study||137
2501440|NCT00806585|6130296|P4|STARTED|Overall Study||71
2501441|NCT00806585|6130297|P3|STARTED|Overall Study||141
2501442|NCT00806585|6130298|P2|STARTED|Overall Study||134
2501443|NCT00806585|6130299|P1|STARTED|Overall Study||137
2501444|NCT00806546|6130331|P1|NOT COMPLETED|Overall Study||307
2501445|NCT00806546|6130331|P1|COMPLETED|Overall Study||207
2501446|NCT00806546|6130331|P1|STARTED|Overall Study|35 subjects were enrolled but did not treat for a total of 479 subjects in the safety population|514
2501447|NCT00806494|6130335|P1|NOT COMPLETED|Overall Study||80
2501448|NCT00806494|6130335|P1|COMPLETED|Overall Study||251
2501449|NCT00806494|6130335|P1|STARTED|Overall Study||331
2501450|NCT00806442|6130359|P2|NOT COMPLETED|Overall Study||7
2501451|NCT00806442|6130360|P1|NOT COMPLETED|Overall Study||4
2501452|NCT00806442|6130359|P2|COMPLETED|Overall Study||14
2501453|NCT00806442|6130360|P1|COMPLETED|Overall Study||14
2501454|NCT00806442|6130359|P2|Second Intervention (3 Wks)|Overall Study||14
2501455|NCT00806442|6130360|P1|Second Intervention (3 Wks)|Overall Study||15
2501456|NCT00806442|6130359|P2|Washout (3 Wks)|Overall Study||14
2501457|NCT00806442|6130360|P1|Washout (3 Wks)|Overall Study||15
2501458|NCT00806442|6130359|P2|First Intervention (3 Wks)|Overall Study||21
2501459|NCT00806442|6130360|P1|First Intervention (3 Wks)|Overall Study||18
2501460|NCT00806442|6130359|P2|STARTED|Overall Study||21
2501461|NCT00806442|6130360|P1|STARTED|Overall Study||18
2501462|NCT00806416|6130382|P4|NOT COMPLETED|Period 2 - Part II||0
2501463|NCT00806416|6130383|P3|NOT COMPLETED|Period 2 - Part II||0
2501464|NCT00806416|6130384|P2|NOT COMPLETED|Period 2 - Part II||0
2501465|NCT00806416|6130385|P1|NOT COMPLETED|Period 2 - Part II||0
2501466|NCT00806416|6130382|P4|COMPLETED|Period 2 - Part II||14
2501467|NCT00806416|6130383|P3|COMPLETED|Period 2 - Part II||14
2501468|NCT00806416|6130384|P2|COMPLETED|Period 2 - Part II||0
2501469|NCT00806416|6130385|P1|COMPLETED|Period 2 - Part II||0
2501470|NCT00806416|6130382|P4|STARTED|Period 2 - Part II||14
2501471|NCT00806416|6130383|P3|STARTED|Period 2 - Part II||14
2501472|NCT00806416|6130384|P2|STARTED|Period 2 - Part II||0
2501473|NCT00806416|6130385|P1|STARTED|Period 2 - Part II||0
2501474|NCT00806416|6130382|P4|NOT COMPLETED|Period 1 - Part II||2
2501475|NCT00806416|6130383|P3|NOT COMPLETED|Period 1 - Part II||0
2501476|NCT00806416|6130384|P2|NOT COMPLETED|Period 1 - Part II||0
2501477|NCT00806416|6130385|P1|NOT COMPLETED|Period 1 - Part II||0
2501478|NCT00806416|6130382|P4|COMPLETED|Period 1 - Part II||14
2501479|NCT00806416|6130383|P3|COMPLETED|Period 1 - Part II||14
2501480|NCT00806416|6130384|P2|COMPLETED|Period 1 - Part II||0
2501481|NCT00806416|6130385|P1|COMPLETED|Period 1 - Part II||0
2501482|NCT00806416|6130382|P4|STARTED|Period 1 - Part II||16
2501483|NCT00806416|6130383|P3|STARTED|Period 1 - Part II||14
2501484|NCT00806416|6130384|P2|STARTED|Period 1 - Part II||0
2501485|NCT00806416|6130385|P1|STARTED|Period 1 - Part II||0
2501486|NCT00806416|6130382|P4|NOT COMPLETED|Period 2 - Part I||0
2501487|NCT00806416|6130383|P3|NOT COMPLETED|Period 2 - Part I||0
2501488|NCT00806416|6130384|P2|NOT COMPLETED|Period 2 - Part I||0
2501489|NCT00806416|6130385|P1|NOT COMPLETED|Period 2 - Part I||0
2501490|NCT00806416|6130382|P4|COMPLETED|Period 2 - Part I||0
2501491|NCT00806416|6130383|P3|COMPLETED|Period 2 - Part I||0
2501492|NCT00806416|6130384|P2|COMPLETED|Period 2 - Part I||103
2501493|NCT00806416|6130385|P1|COMPLETED|Period 2 - Part I||104
2501494|NCT00806416|6130382|P4|STARTED|Period 2 - Part I||0
2501495|NCT00806416|6130383|P3|STARTED|Period 2 - Part I||0
2501496|NCT00806416|6130384|P2|STARTED|Period 2 - Part I||103
2501497|NCT00806416|6130385|P1|STARTED|Period 2 - Part I||104
2501498|NCT00806416|6130382|P4|NOT COMPLETED|Period 1 - Part I||0
2501499|NCT00806416|6130383|P3|NOT COMPLETED|Period 1 - Part I||0
2501500|NCT00806416|6130384|P2|NOT COMPLETED|Period 1 - Part I||4
2501501|NCT00806416|6130385|P1|NOT COMPLETED|Period 1 - Part I||3
2501502|NCT00806416|6130382|P4|COMPLETED|Period 1 - Part I||0
2501503|NCT00806416|6130383|P3|COMPLETED|Period 1 - Part I||0
2501504|NCT00806416|6130384|P2|COMPLETED|Period 1 - Part I||103
2501505|NCT00806416|6130385|P1|COMPLETED|Period 1 - Part I||104
2501506|NCT00806416|6130382|P4|STARTED|Period 1 - Part I||0
2501507|NCT00806416|6130383|P3|STARTED|Period 1 - Part I||0
2501508|NCT00806416|6130384|P2|STARTED|Period 1 - Part I||107
2501509|NCT00806416|6130385|P1|STARTED|Period 1 - Part I||107
2501510|NCT00806403|6130398|P2|NOT COMPLETED|Overall Study||3
2501511|NCT00806403|6130399|P1|NOT COMPLETED|Overall Study||4
2501512|NCT00806403|6130398|P2|COMPLETED|Overall Study||98
2501513|NCT00806403|6130399|P1|COMPLETED|Overall Study||100
2501514|NCT00806403|6130398|P2|STARTED|Overall Study||101
2501515|NCT00806403|6130399|P1|STARTED|Overall Study||104
2501516|NCT00806390|6130413|P2|NOT COMPLETED|Overall Study||0
2501517|NCT00806390|6130414|P1|NOT COMPLETED|Overall Study||0
2501518|NCT00806390|6130413|P2|COMPLETED|Overall Study||8
2501519|NCT00806390|6130414|P1|COMPLETED|Overall Study||7
2501520|NCT00806390|6130413|P2|STARTED|Overall Study||8
2501521|NCT00806390|6130414|P1|STARTED|Overall Study||7
2501522|NCT00806351|6130422|P2|NOT COMPLETED|Overall Study||4
2501523|NCT00806351|6130423|P1|NOT COMPLETED|Overall Study||5
2501524|NCT00806351|6130422|P2|COMPLETED|Overall Study||2
2501525|NCT00806351|6130423|P1|COMPLETED|Overall Study||10
2501526|NCT00806351|6130422|P2|STARTED|Overall Study||6
2501527|NCT00806351|6130423|P1|STARTED|Overall Study||15
2501528|NCT00806260|6130460|P6|NOT COMPLETED|Period 3||0
2501529|NCT00806260|6130461|P5|NOT COMPLETED|Period 3||0
2501530|NCT00806260|6130462|P4|NOT COMPLETED|Period 3||0
2501531|NCT00806260|6130463|P3|NOT COMPLETED|Period 3||1
2501532|NCT00806260|6130464|P2|NOT COMPLETED|Period 3||1
2501533|NCT00806260|6130465|P1|NOT COMPLETED|Period 3||1
2501534|NCT00806260|6130460|P6|COMPLETED|Period 3||0
2501535|NCT00806260|6130461|P5|COMPLETED|Period 3||0
2501536|NCT00806260|6130462|P4|COMPLETED|Period 3||12
2501537|NCT00806260|6130463|P3|COMPLETED|Period 3||5
2501538|NCT00806260|6130464|P2|COMPLETED|Period 3||7
2501539|NCT00806260|6130465|P1|COMPLETED|Period 3||12
2501540|NCT00806260|6130460|P6|STARTED|Period 3||0
2501541|NCT00806260|6130461|P5|STARTED|Period 3||0
2501542|NCT00806260|6130462|P4|STARTED|Period 3||12
2501543|NCT00806260|6130463|P3|STARTED|Period 3||6
2501544|NCT00806260|6130464|P2|STARTED|Period 3||8
2501545|NCT00806260|6130465|P1|STARTED|Period 3||13
2501546|NCT00806260|6130460|P6|NOT COMPLETED|Period 2||0
2501547|NCT00806260|6130461|P5|NOT COMPLETED|Period 2||0
2501548|NCT00806260|6130462|P4|NOT COMPLETED|Period 2||2
2501549|NCT00806260|6130463|P3|NOT COMPLETED|Period 2||2
2501550|NCT00806260|6130464|P2|NOT COMPLETED|Period 2||0
2501551|NCT00806260|6130465|P1|NOT COMPLETED|Period 2||2
2501552|NCT00806260|6130460|P6|COMPLETED|Period 2||0
2501553|NCT00806260|6130461|P5|COMPLETED|Period 2||0
2501554|NCT00806260|6130462|P4|COMPLETED|Period 2||12
2501555|NCT00806260|6130463|P3|COMPLETED|Period 2||6
2501556|NCT00806260|6130464|P2|COMPLETED|Period 2||8
2501557|NCT00806260|6130465|P1|COMPLETED|Period 2||13
2501558|NCT00806260|6130460|P6|STARTED|Period 2||0
2501559|NCT00806260|6130461|P5|STARTED|Period 2||0
2501560|NCT00806260|6130462|P4|STARTED|Period 2||14
2501561|NCT00806260|6130463|P3|STARTED|Period 2||8
2501562|NCT00806260|6130464|P2|STARTED|Period 2||8
2501563|NCT00806260|6130465|P1|STARTED|Period 2||15
2501564|NCT00806260|6130460|P6|NOT COMPLETED|Period 1 (1 Day)||0
2501565|NCT00806260|6130461|P5|NOT COMPLETED|Period 1 (1 Day)||3
2501566|NCT00806260|6130462|P4|NOT COMPLETED|Period 1 (1 Day)||0
2501567|NCT00806260|6130463|P3|NOT COMPLETED|Period 1 (1 Day)||0
2501568|NCT00806260|6130464|P2|NOT COMPLETED|Period 1 (1 Day)||0
2501569|NCT00806260|6130465|P1|NOT COMPLETED|Period 1 (1 Day)||0
2501570|NCT00806260|6130460|P6|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|17
2501571|NCT00806260|6130461|P5|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|15
2501572|NCT00806260|6130462|P4|COMPLETED|Period 1 (1 Day)||14
2501573|NCT00806260|6130463|P3|COMPLETED|Period 1 (1 Day)||8
2501574|NCT00806260|6130464|P2|COMPLETED|Period 1 (1 Day)||8
2501575|NCT00806260|6130465|P1|COMPLETED|Period 1 (1 Day)||15
2501576|NCT00806260|6130460|P6|STARTED|Period 1 (1 Day)||17
2501577|NCT00806260|6130461|P5|STARTED|Period 1 (1 Day)||18
2501578|NCT00806260|6130462|P4|STARTED|Period 1 (1 Day)||14
2501579|NCT00806260|6130463|P3|STARTED|Period 1 (1 Day)||8
2501580|NCT00806260|6130464|P2|STARTED|Period 1 (1 Day)||8
2501581|NCT00806260|6130465|P1|STARTED|Period 1 (1 Day)||15
2501582|NCT00806234|6130480|P3|NOT COMPLETED|Overall Study||12
2501583|NCT00806234|6130481|P2|NOT COMPLETED|Overall Study||12
2501584|NCT00806234|6130482|P1|NOT COMPLETED|Overall Study||13
2501585|NCT00806234|6130480|P3|COMPLETED|Overall Study||37
2501586|NCT00806234|6130481|P2|COMPLETED|Overall Study||19
2501587|NCT00806234|6130482|P1|COMPLETED|Overall Study||34
2501588|NCT00806234|6130480|P3|STARTED|Overall Study||49
2501589|NCT00806234|6130481|P2|STARTED|Overall Study||31
2501590|NCT00806234|6130482|P1|STARTED|Overall Study||47
2501591|NCT00806221|6130499|P1|NOT COMPLETED|Overall Study||2
2501592|NCT00806221|6130499|P1|COMPLETED|Overall Study||20
2501593|NCT00806221|6130499|P1|STARTED|Overall Study||22
2501594|NCT00806195|6130510|P4|NOT COMPLETED|Overall Study||106
2501595|NCT00806195|6130511|P3|NOT COMPLETED|Overall Study||270
2501596|NCT00806195|6130512|P2|NOT COMPLETED|Overall Study||162
2501597|NCT00806195|6130513|P1|NOT COMPLETED|Overall Study||514
2501598|NCT00806195|6130510|P4|COMPLETED|Overall Study||383
2501599|NCT00806195|6130511|P3|COMPLETED|Overall Study||1139
2501600|NCT00806195|6130512|P2|COMPLETED|Overall Study||1321
2501601|NCT00806195|6130513|P1|COMPLETED|Overall Study||3849
2501602|NCT00806195|6130510|P4|STARTED|Overall Study||489
2501603|NCT00806195|6130511|P3|STARTED|Overall Study||1409
2501604|NCT00806195|6130512|P2|STARTED|Overall Study||1483
2501605|NCT00806195|6130513|P1|STARTED|Overall Study||4363
2501606|NCT00806078|6130527|P2|NOT COMPLETED|Second Intervention||0
2501607|NCT00806078|6130528|P1|NOT COMPLETED|Second Intervention||0
2501608|NCT00806078|6130527|P2|COMPLETED|Second Intervention||9
2501609|NCT00806078|6130528|P1|COMPLETED|Second Intervention||9
2501610|NCT00806078|6130527|P2|STARTED|Second Intervention||9
2501611|NCT00806078|6130528|P1|STARTED|Second Intervention||9
2501612|NCT00806078|6130527|P2|NOT COMPLETED|7 Day Washout Period||0
2501613|NCT00806078|6130528|P1|NOT COMPLETED|7 Day Washout Period||0
2501614|NCT00806078|6130527|P2|COMPLETED|7 Day Washout Period||9
2501615|NCT00806078|6130528|P1|COMPLETED|7 Day Washout Period||9
2501616|NCT00806078|6130527|P2|STARTED|7 Day Washout Period||9
2501617|NCT00806078|6130528|P1|STARTED|7 Day Washout Period||9
2501618|NCT00806078|6130527|P2|NOT COMPLETED|First Intervention||0
2501619|NCT00806078|6130528|P1|NOT COMPLETED|First Intervention||0
2501620|NCT00806078|6130527|P2|COMPLETED|First Intervention||9
2501621|NCT00806078|6130528|P1|COMPLETED|First Intervention||9
2501622|NCT00806078|6130527|P2|STARTED|First Intervention||9
2501623|NCT00806078|6130528|P1|STARTED|First Intervention||9
2501624|NCT00806026|6130544|P6|NOT COMPLETED|Overall Study||32
2501625|NCT00806026|6130545|P5|NOT COMPLETED|Overall Study||30
2501626|NCT00806026|6130546|P4|NOT COMPLETED|Overall Study||29
2501627|NCT00806026|6130547|P3|NOT COMPLETED|Overall Study||93
2501628|NCT00806026|6130548|P2|NOT COMPLETED|Overall Study||101
2501629|NCT00806026|6130549|P1|NOT COMPLETED|Overall Study||92
2501630|NCT00806026|6130544|P6|COMPLETED|Overall Study||29
2501631|NCT00806026|6130545|P5|COMPLETED|Overall Study||29
2501632|NCT00806026|6130546|P4|COMPLETED|Overall Study||32
2501633|NCT00806026|6130547|P3|COMPLETED|Overall Study||89
2501634|NCT00806026|6130548|P2|COMPLETED|Overall Study||82
2501635|NCT00806026|6130549|P1|COMPLETED|Overall Study||93
2501636|NCT00806026|6130544|P6|Treated|Overall Study||61
2501637|NCT00806026|6130545|P5|Treated|Overall Study||59
2501638|NCT00806026|6130546|P4|Treated|Overall Study||59
2501639|NCT00806026|6130547|P3|Treated|Overall Study||180
2501640|NCT00806026|6130548|P2|Treated|Overall Study||178
2501641|NCT00806026|6130549|P1|Treated|Overall Study||182
2501642|NCT00806026|6130544|P6|STARTED|Overall Study||61
2501643|NCT00806026|6130545|P5|STARTED|Overall Study||59
2501644|NCT00806026|6130546|P4|STARTED|Overall Study||61
2501645|NCT00806026|6130547|P3|STARTED|Overall Study||182
2501646|NCT00806026|6130548|P2|STARTED|Overall Study||183
2501647|NCT00806026|6130549|P1|STARTED|Overall Study||185
2501648|NCT00805961|6130644|P1|NOT COMPLETED|Maintenance Treatment||34
2501649|NCT00805961|6130644|P1|COMPLETED|Maintenance Treatment||23
2501650|NCT00805961|6130644|P1|STARTED|Maintenance Treatment||57
2501651|NCT00805961|6130644|P1|NOT COMPLETED|Treatment-Free Interval||7
2501652|NCT00805961|6130644|P1|COMPLETED|Treatment-Free Interval||57
2501653|NCT00805961|6130644|P1|STARTED|Treatment-Free Interval||64
2501654|NCT00805961|6130644|P1|NOT COMPLETED|Modality Therapy||4
2501655|NCT00805961|6130644|P1|COMPLETED|Modality Therapy||64
2501656|NCT00805961|6130644|P1|STARTED|Modality Therapy||68
2501657|NCT00805948|6130652|P2|NOT COMPLETED|Overall Study||96
2501658|NCT00805948|6130653|P1|NOT COMPLETED|Overall Study||68
2501659|NCT00805948|6130652|P2|COMPLETED|Overall Study||99
2501660|NCT00805948|6130653|P1|COMPLETED|Overall Study||86
2501661|NCT00805948|6130652|P2|STARTED|Overall Study||195
2501662|NCT00805948|6130653|P1|STARTED|Overall Study||154
2501663|NCT00805935|6130668|P4|NOT COMPLETED|Overall Study||11
2501664|NCT00805935|6130669|P3|NOT COMPLETED|Overall Study||15
2501665|NCT00805935|6130670|P2|NOT COMPLETED|Overall Study||19
2501666|NCT00805935|6130671|P1|NOT COMPLETED|Overall Study||13
2501667|NCT00805935|6130668|P4|COMPLETED|Overall Study||19
2501668|NCT00805935|6130669|P3|COMPLETED|Overall Study||13
2501669|NCT00805935|6130670|P2|COMPLETED|Overall Study||8
2501670|NCT00805935|6130671|P1|COMPLETED|Overall Study||12
2501671|NCT00805935|6130668|P4|STARTED|Overall Study||30
2501672|NCT00805935|6130669|P3|STARTED|Overall Study||28
2501673|NCT00805935|6130670|P2|STARTED|Overall Study||27
2501674|NCT00805935|6130671|P1|STARTED|Overall Study||25
2501675|NCT00805870|6130725|P2|NOT COMPLETED|Overall Study||0
2501676|NCT00805870|6130726|P1|NOT COMPLETED|Overall Study||0
2501677|NCT00805870|6130725|P2|COMPLETED|Overall Study||10
2501678|NCT00805870|6130726|P1|COMPLETED|Overall Study||10
2501679|NCT00805870|6130725|P2|STARTED|Overall Study||10
2501680|NCT00805870|6130726|P1|STARTED|Overall Study||10
2501681|NCT00805792|6130738|P1|NOT COMPLETED|Overall Study||5
2501682|NCT00805792|6130738|P1|COMPLETED|Overall Study||28
2501683|NCT00805792|6130738|P1|STARTED|Overall Study||33
2501684|NCT00805766|6130746|P1|NOT COMPLETED|Increased Dose Period||13
2501685|NCT00805766|6130746|P1|COMPLETED|Increased Dose Period||26
2501686|NCT00805766|6130746|P1|STARTED|Increased Dose Period||39
2501687|NCT00805766|6130746|P1|NOT COMPLETED|Screening Period||6
2501688|NCT00805766|6130746|P1|COMPLETED|Screening Period||39
2501689|NCT00805766|6130746|P1|STARTED|Screening Period||45
2501690|NCT00805740|6130760|P2|NOT COMPLETED|Overall Study||4
2501691|NCT00805740|6130761|P1|NOT COMPLETED|Overall Study||11
2501692|NCT00805740|6130760|P2|COMPLETED|Overall Study||9
2501693|NCT00805740|6130761|P1|COMPLETED|Overall Study||17
2501694|NCT00805740|6130760|P2|Treated|Overall Study||13
2501695|NCT00805740|6130761|P1|Treated|Overall Study||26
2501696|NCT00805740|6130760|P2|STARTED|Overall Study||13
2501697|NCT00805740|6130761|P1|STARTED|Overall Study||28
2501698|NCT00805675|6130786|P3|NOT COMPLETED|Overall Study||1
2501699|NCT00805675|6130787|P2|NOT COMPLETED|Overall Study||0
2501700|NCT00805675|6130788|P1|NOT COMPLETED|Overall Study||0
2501701|NCT00805675|6130786|P3|COMPLETED|Overall Study||15
2501702|NCT00805675|6130787|P2|COMPLETED|Overall Study||14
2501703|NCT00805675|6130788|P1|COMPLETED|Overall Study||16
2501704|NCT00805675|6130786|P3|STARTED|Overall Study||16
2501705|NCT00805675|6130787|P2|STARTED|Overall Study||14
2501706|NCT00805675|6130788|P1|STARTED|Overall Study||16
2501707|NCT00805545|6130822|P2|NOT COMPLETED|Overall Study||3
2501708|NCT00805545|6130823|P1|NOT COMPLETED|Overall Study||6
2501709|NCT00805545|6130822|P2|COMPLETED|Overall Study||197
2501710|NCT00805545|6130823|P1|COMPLETED|Overall Study||194
2501711|NCT00805545|6130822|P2|STARTED|Overall Study||200
2501712|NCT00805545|6130823|P1|STARTED|Overall Study||200
2501713|NCT00805532|6130831|P2|NOT COMPLETED|Overall Study||1
2501714|NCT00805532|6130832|P1|NOT COMPLETED|Overall Study||0
2501715|NCT00805532|6130831|P2|COMPLETED|Overall Study||38
2501716|NCT00805532|6130832|P1|COMPLETED|Overall Study|We did intent-to-treat analyses so 42 participants' data were analyzed.|42
2501717|NCT00805532|6130831|P2|STARTED|Overall Study||39
2501718|NCT00805532|6130832|P1|STARTED|Overall Study||42
2501719|NCT00805493|6130849|P3|NOT COMPLETED|Overall Study||1
2501720|NCT00805493|6130850|P2|NOT COMPLETED|Overall Study||0
2501721|NCT00805493|6130851|P1|NOT COMPLETED|Overall Study||2
2501722|NCT00805493|6130849|P3|COMPLETED|Overall Study||0
2501723|NCT00805493|6130850|P2|COMPLETED|Overall Study||2
2501724|NCT00805493|6130851|P1|COMPLETED|Overall Study||1
2501725|NCT00805493|6130849|P3|STARTED|Overall Study||1
2501726|NCT00805493|6130850|P2|STARTED|Overall Study||2
2501727|NCT00805493|6130851|P1|STARTED|Overall Study||3
2501728|NCT00805480|6130866|P4|NOT COMPLETED|Overall Study||5
2501729|NCT00805480|6130867|P3|NOT COMPLETED|Overall Study||12
2501730|NCT00805480|6130868|P2|NOT COMPLETED|Overall Study||7
2501731|NCT00805480|6130869|P1|NOT COMPLETED|Overall Study||14
2501732|NCT00805480|6130866|P4|COMPLETED|Overall Study||5
2501733|NCT00805480|6130867|P3|COMPLETED|Overall Study||19
2501734|NCT00805480|6130868|P2|COMPLETED|Overall Study||22
2501735|NCT00805480|6130869|P1|COMPLETED|Overall Study||16
2501736|NCT00805480|6130866|P4|Pharmacodynamic Analysis Set|Overall Study||10
2501737|NCT00805480|6130867|P3|Pharmacodynamic Analysis Set|Overall Study||29
2501738|NCT00805480|6130868|P2|Pharmacodynamic Analysis Set|Overall Study||25
2501739|NCT00805480|6130869|P1|Pharmacodynamic Analysis Set|Overall Study||30
2501740|NCT00805480|6130866|P4|STARTED|Overall Study||10
2501741|NCT00805480|6130867|P3|STARTED|Overall Study||31
2501742|NCT00805480|6130868|P2|STARTED|Overall Study||29
2501743|NCT00805480|6130869|P1|STARTED|Overall Study||30
2501744|NCT00805467|6130898|P4|NOT COMPLETED|Overall Study||237
2501745|NCT00805467|6130899|P3|NOT COMPLETED|Overall Study||103
2501746|NCT00805467|6130900|P2|NOT COMPLETED|Overall Study||34
2501747|NCT00805467|6130901|P1|NOT COMPLETED|Overall Study||0
2501748|NCT00805467|6130898|P4|COMPLETED|Overall Study|Ongoing when study terminated|144
2501749|NCT00805467|6130899|P3|COMPLETED|Overall Study|Ongoing when study terminated|80
2501750|NCT00805467|6130900|P2|COMPLETED|Overall Study|Ongoing when study terminated|25
2501751|NCT00805467|6130901|P1|COMPLETED|Overall Study|Ongoing when study terminated|1
2501752|NCT00805467|6130898|P4|Enrolled But Did Not Receive Treatment|Overall Study||0
2501753|NCT00805467|6130899|P3|Enrolled But Did Not Receive Treatment|Overall Study||0
2501754|NCT00805467|6130900|P2|Enrolled But Did Not Receive Treatment|Overall Study||0
2501755|NCT00805467|6130901|P1|Enrolled But Did Not Receive Treatment|Overall Study||0
2501756|NCT00805467|6130898|P4|STARTED|Overall Study|Patients who received treatment|381
2501757|NCT00805467|6130899|P3|STARTED|Overall Study|Patients who received treatment|183
2501758|NCT00805467|6130900|P2|STARTED|Overall Study|Patients who received treatment|59
2501759|NCT00805467|6130901|P1|STARTED|Overall Study|Patients who received treatment|1
2501760|NCT00805441|6130921|P2|NOT COMPLETED|Overall Study||36
2501761|NCT00805441|6130922|P1|NOT COMPLETED|Overall Study||34
2501762|NCT00805441|6130921|P2|COMPLETED|Overall Study||60
2501763|NCT00805441|6130922|P1|COMPLETED|Overall Study||60
2501764|NCT00805441|6130921|P2|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|91
2501765|NCT00805441|6130922|P1|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|92
2501766|NCT00805441|6130921|P2|STARTED|Overall Study||96
2501767|NCT00805441|6130922|P1|STARTED|Overall Study||94
2501768|NCT00805389|6130957|P5|NOT COMPLETED|Overall Study||13
2501769|NCT00805389|6130958|P4|NOT COMPLETED|Overall Study||17
2501770|NCT00805389|6130959|P3|NOT COMPLETED|Overall Study||12
2501771|NCT00805389|6130960|P2|NOT COMPLETED|Overall Study||5
2501772|NCT00805389|6130961|P1|NOT COMPLETED|Overall Study||7
2501773|NCT00805389|6130957|P5|COMPLETED|Overall Study||129
2501774|NCT00805389|6130958|P4|COMPLETED|Overall Study||128
2501775|NCT00805389|6130959|P3|COMPLETED|Overall Study||129
2501776|NCT00805389|6130960|P2|COMPLETED|Overall Study||137
2501777|NCT00805389|6130961|P1|COMPLETED|Overall Study||136
2501778|NCT00805389|6130957|P5|STARTED|Overall Study||142
2501779|NCT00805389|6130958|P4|STARTED|Overall Study||145
2501780|NCT00805389|6130959|P3|STARTED|Overall Study||141
2501781|NCT00805389|6130960|P2|STARTED|Overall Study||142
2501782|NCT00805389|6130961|P1|STARTED|Overall Study||143
2501783|NCT00805285|6131208|P1|NOT COMPLETED|Overall Study||1
2501784|NCT00805285|6131208|P1|COMPLETED|Overall Study||0
2501785|NCT00805285|6131208|P1|STARTED|Overall Study||1
2501786|NCT00805207|6131225|P9|NOT COMPLETED|Overall Study||0
2501787|NCT00805207|6131226|P8|NOT COMPLETED|Overall Study||0
2501788|NCT00805207|6131227|P7|NOT COMPLETED|Overall Study||0
2501789|NCT00805207|6131228|P6|NOT COMPLETED|Overall Study||3
2501790|NCT00805207|6131229|P5|NOT COMPLETED|Overall Study||1
2501791|NCT00805207|6131230|P4|NOT COMPLETED|Overall Study||0
2501792|NCT00805207|6131231|P3|NOT COMPLETED|Overall Study||1
2501793|NCT00805207|6131232|P2|NOT COMPLETED|Overall Study||2
2501794|NCT00805207|6131233|P1|NOT COMPLETED|Overall Study||0
2501795|NCT00805207|6131225|P9|COMPLETED|Overall Study||6
2501796|NCT00805207|6131226|P8|COMPLETED|Overall Study||6
2501797|NCT00805207|6131227|P7|COMPLETED|Overall Study||6
2501798|NCT00805207|6131228|P6|COMPLETED|Overall Study||9
2501799|NCT00805207|6131229|P5|COMPLETED|Overall Study||2
2501800|NCT00805207|6131230|P4|COMPLETED|Overall Study||6
2501801|NCT00805207|6131231|P3|COMPLETED|Overall Study||11
2501802|NCT00805207|6131232|P2|COMPLETED|Overall Study||7
2501803|NCT00805207|6131233|P1|COMPLETED|Overall Study||1
2501804|NCT00805207|6131225|P9|STARTED|Overall Study||6
2501805|NCT00805207|6131226|P8|STARTED|Overall Study||6
2501806|NCT00805207|6131227|P7|STARTED|Overall Study||6
2501807|NCT00805207|6131228|P6|STARTED|Overall Study||12
2501808|NCT00805207|6131229|P5|STARTED|Overall Study||3
2501809|NCT00805207|6131230|P4|STARTED|Overall Study||6
2501810|NCT00805207|6131231|P3|STARTED|Overall Study||12
2501811|NCT00805207|6131232|P2|STARTED|Overall Study||9
2501812|NCT00805207|6131233|P1|STARTED|Overall Study||1
2501813|NCT00805194|6131291|P2|NOT COMPLETED|Overall Study||654
2501814|NCT00805194|6131292|P1|NOT COMPLETED|Overall Study||649
2501815|NCT00805194|6131291|P2|COMPLETED|Overall Study||5
2501816|NCT00805194|6131292|P1|COMPLETED|Overall Study||6
2501817|NCT00805194|6131291|P2|STARTED|Overall Study|randomised patients|659
2501818|NCT00805194|6131292|P1|STARTED|Overall Study|randomised patients|655
2501819|NCT00805142|6131326|P2|NOT COMPLETED|Maintenance Period||2
2501820|NCT00805142|6131327|P1|NOT COMPLETED|Maintenance Period||0
2501821|NCT00805142|6131326|P2|COMPLETED|Maintenance Period||30
2501822|NCT00805142|6131327|P1|COMPLETED|Maintenance Period||30
2501823|NCT00805142|6131326|P2|STARTED|Maintenance Period||32
2501824|NCT00805142|6131327|P1|STARTED|Maintenance Period||30
2501825|NCT00805142|6131326|P2|NOT COMPLETED|Titration Period||10
2501826|NCT00805142|6131327|P1|NOT COMPLETED|Titration Period||6
2501827|NCT00805142|6131326|P2|COMPLETED|Titration Period||32
2501828|NCT00805142|6131327|P1|COMPLETED|Titration Period||30
2501829|NCT00805142|6131326|P2|STARTED|Titration Period||42
2501830|NCT00805142|6131327|P1|STARTED|Titration Period||36
2501831|NCT00805038|6131353|P2|NOT COMPLETED|Overall Study||0
2501832|NCT00805038|6131354|P1|NOT COMPLETED|Overall Study||0
2501833|NCT00805038|6131353|P2|COMPLETED|Overall Study||92
2501834|NCT00805038|6131354|P1|COMPLETED|Overall Study||75
2501835|NCT00805038|6131353|P2|STARTED|Overall Study||92
2501836|NCT00805038|6131354|P1|STARTED|Overall Study||75
2501837|NCT00805025|6131360|P1|NOT COMPLETED|Overall Study||49
2501838|NCT00805025|6131360|P1|COMPLETED|Overall Study||82
2501839|NCT00805025|6131360|P1|Enrolled and Treated|Overall Study||89
2501840|NCT00805025|6131360|P1|STARTED|Overall Study||131
2501841|NCT00804999|6131370|P4|NOT COMPLETED|Overall Study||0
2501842|NCT00804999|6131371|P3|NOT COMPLETED|Overall Study||0
2501843|NCT00804999|6131372|P2|NOT COMPLETED|Overall Study||0
2501844|NCT00804999|6131373|P1|NOT COMPLETED|Overall Study||0
2501845|NCT00804999|6131370|P4|COMPLETED|Overall Study||10
2501846|NCT00804999|6131371|P3|COMPLETED|Overall Study||14
2501847|NCT00804999|6131372|P2|COMPLETED|Overall Study||12
2501848|NCT00804999|6131373|P1|COMPLETED|Overall Study||15
2501849|NCT00804999|6131370|P4|STARTED|Overall Study||10
2501850|NCT00804999|6131371|P3|STARTED|Overall Study||14
2501851|NCT00804999|6131372|P2|STARTED|Overall Study||12
2501852|NCT00804999|6131373|P1|STARTED|Overall Study||15
2501853|NCT00804986|6131389|P6|NOT COMPLETED|Overall Study||10
2501854|NCT00804986|6131390|P5|NOT COMPLETED|Overall Study||9
2501855|NCT00804986|6131391|P4|NOT COMPLETED|Overall Study||8
2501856|NCT00804986|6131392|P3|NOT COMPLETED|Overall Study||2
2501857|NCT00804986|6131393|P2|NOT COMPLETED|Overall Study||8
2501858|NCT00804986|6131394|P1|NOT COMPLETED|Overall Study||1
2501859|NCT00804986|6131389|P6|COMPLETED|Overall Study||31
2501860|NCT00804986|6131390|P5|COMPLETED|Overall Study||34
2501861|NCT00804986|6131391|P4|COMPLETED|Overall Study||34
2501862|NCT00804986|6131392|P3|COMPLETED|Overall Study||40
2501863|NCT00804986|6131393|P2|COMPLETED|Overall Study||35
2501864|NCT00804986|6131394|P1|COMPLETED|Overall Study||35
2501865|NCT00804986|6131389|P6|STARTED|Overall Study||41
2501866|NCT00804986|6131390|P5|STARTED|Overall Study||43
2501867|NCT00804986|6131391|P4|STARTED|Overall Study||42
2501868|NCT00804986|6131392|P3|STARTED|Overall Study||42
2501869|NCT00804986|6131393|P2|STARTED|Overall Study||43
2501870|NCT00804986|6131394|P1|STARTED|Overall Study||36
2501871|NCT00804908|6131489|P3|NOT COMPLETED|Overall Study||114
2501872|NCT00804908|6131490|P2|NOT COMPLETED|Overall Study||116
2501873|NCT00804908|6131491|P1|NOT COMPLETED|Overall Study||115
2501874|NCT00804908|6131489|P3|COMPLETED|Overall Study||1
2501875|NCT00804908|6131490|P2|COMPLETED|Overall Study||0
2501876|NCT00804908|6131491|P1|COMPLETED|Overall Study||0
2501877|NCT00804908|6131489|P3|STARTED|Overall Study||115
2501878|NCT00804908|6131490|P2|STARTED|Overall Study||116
2501879|NCT00804908|6131491|P1|STARTED|Overall Study||115
2501880|NCT00804843|6131522|P2|NOT COMPLETED|Overall Study||7
2501881|NCT00804843|6131523|P1|NOT COMPLETED|Overall Study||10
2501882|NCT00804843|6131522|P2|COMPLETED|Overall Study||43
2501883|NCT00804843|6131523|P1|COMPLETED|Overall Study||40
2501884|NCT00804843|6131522|P2|STARTED|Overall Study||50
2501885|NCT00804843|6131523|P1|STARTED|Overall Study||50
2501886|NCT00804713|6131533|P1|NOT COMPLETED|Overall Study||0
2501887|NCT00804713|6131533|P1|COMPLETED|Overall Study||1978
2501888|NCT00804713|6131533|P1|STARTED|Overall Study||1978
2501889|NCT00804687|6131541|P6|NOT COMPLETED|Period 5: Treatment Period||0
2501890|NCT00804687|6131542|P5|NOT COMPLETED|Period 5: Treatment Period||1
2501891|NCT00804687|6131543|P4|NOT COMPLETED|Period 5: Treatment Period||0
2501892|NCT00804687|6131544|P3|NOT COMPLETED|Period 5: Treatment Period||1
2501893|NCT00804687|6131545|P2|NOT COMPLETED|Period 5: Treatment Period||0
2501894|NCT00804687|6131546|P1|NOT COMPLETED|Period 5: Treatment Period||1
2501895|NCT00804687|6131541|P6|COMPLETED|Period 5: Treatment Period||8
2501896|NCT00804687|6131542|P5|COMPLETED|Period 5: Treatment Period||8
2501897|NCT00804687|6131543|P4|COMPLETED|Period 5: Treatment Period||8
2501898|NCT00804687|6131544|P3|COMPLETED|Period 5: Treatment Period||8
2501899|NCT00804687|6131545|P2|COMPLETED|Period 5: Treatment Period||9
2501900|NCT00804687|6131546|P1|COMPLETED|Period 5: Treatment Period||8
2501901|NCT00804687|6131541|P6|STARTED|Period 5: Treatment Period||8
2501902|NCT00804687|6131542|P5|STARTED|Period 5: Treatment Period||9
2501903|NCT00804687|6131543|P4|STARTED|Period 5: Treatment Period||8
2501904|NCT00804687|6131544|P3|STARTED|Period 5: Treatment Period||9
2501905|NCT00804687|6131545|P2|STARTED|Period 5: Treatment Period||9
2501906|NCT00804687|6131546|P1|STARTED|Period 5: Treatment Period||9
2501907|NCT00804687|6131541|P6|NOT COMPLETED|Period 4: Washout Period||0
2501908|NCT00804687|6131542|P5|NOT COMPLETED|Period 4: Washout Period||0
2501909|NCT00804687|6131543|P4|NOT COMPLETED|Period 4: Washout Period||0
2501910|NCT00804687|6131544|P3|NOT COMPLETED|Period 4: Washout Period||0
2501911|NCT00804687|6131545|P2|NOT COMPLETED|Period 4: Washout Period||0
2501912|NCT00804687|6131546|P1|NOT COMPLETED|Period 4: Washout Period||0
2501913|NCT00804687|6131541|P6|COMPLETED|Period 4: Washout Period||8
2501914|NCT00804687|6131542|P5|COMPLETED|Period 4: Washout Period||9
2501915|NCT00804687|6131543|P4|COMPLETED|Period 4: Washout Period||8
2501916|NCT00804687|6131544|P3|COMPLETED|Period 4: Washout Period||9
2501917|NCT00804687|6131545|P2|COMPLETED|Period 4: Washout Period||9
2501918|NCT00804687|6131546|P1|COMPLETED|Period 4: Washout Period||9
2501919|NCT00804687|6131541|P6|STARTED|Period 4: Washout Period||8
2501920|NCT00804687|6131542|P5|STARTED|Period 4: Washout Period||9
2501921|NCT00804687|6131543|P4|STARTED|Period 4: Washout Period||8
2501922|NCT00804687|6131544|P3|STARTED|Period 4: Washout Period||9
2501923|NCT00804687|6131545|P2|STARTED|Period 4: Washout Period||9
2501924|NCT00804687|6131546|P1|STARTED|Period 4: Washout Period||9
2501925|NCT00804687|6131541|P6|NOT COMPLETED|Period 3: Treatment Period||0
2501926|NCT00804687|6131542|P5|NOT COMPLETED|Period 3: Treatment Period||0
2501927|NCT00804687|6131543|P4|NOT COMPLETED|Period 3: Treatment Period||1
2501928|NCT00804687|6131544|P3|NOT COMPLETED|Period 3: Treatment Period||0
2501929|NCT00804687|6131545|P2|NOT COMPLETED|Period 3: Treatment Period||0
2501930|NCT00804687|6131546|P1|NOT COMPLETED|Period 3: Treatment Period||0
2501931|NCT00804687|6131541|P6|COMPLETED|Period 3: Treatment Period||8
2501932|NCT00804687|6131542|P5|COMPLETED|Period 3: Treatment Period||9
2501933|NCT00804687|6131543|P4|COMPLETED|Period 3: Treatment Period||8
2501934|NCT00804687|6131544|P3|COMPLETED|Period 3: Treatment Period||9
2501935|NCT00804687|6131545|P2|COMPLETED|Period 3: Treatment Period||9
2501936|NCT00804687|6131546|P1|COMPLETED|Period 3: Treatment Period||9
2501937|NCT00804687|6131541|P6|STARTED|Period 3: Treatment Period||8
2501938|NCT00804687|6131542|P5|STARTED|Period 3: Treatment Period||9
2501939|NCT00804687|6131543|P4|STARTED|Period 3: Treatment Period||9
2501940|NCT00804687|6131544|P3|STARTED|Period 3: Treatment Period||9
2501941|NCT00804687|6131545|P2|STARTED|Period 3: Treatment Period||9
2501942|NCT00804687|6131546|P1|STARTED|Period 3: Treatment Period||9
2501943|NCT00804687|6131541|P6|NOT COMPLETED|Period 2: Washout Period||0
2501944|NCT00804687|6131542|P5|NOT COMPLETED|Period 2: Washout Period||0
2501945|NCT00804687|6131543|P4|NOT COMPLETED|Period 2: Washout Period||0
2501946|NCT00804687|6131544|P3|NOT COMPLETED|Period 2: Washout Period||0
2501947|NCT00804687|6131545|P2|NOT COMPLETED|Period 2: Washout Period||0
2501948|NCT00804687|6131546|P1|NOT COMPLETED|Period 2: Washout Period||0
2501949|NCT00804687|6131541|P6|COMPLETED|Period 2: Washout Period||8
2501950|NCT00804687|6131542|P5|COMPLETED|Period 2: Washout Period||9
2501951|NCT00804687|6131543|P4|COMPLETED|Period 2: Washout Period||9
2501952|NCT00804687|6131544|P3|COMPLETED|Period 2: Washout Period||9
2501953|NCT00804687|6131545|P2|COMPLETED|Period 2: Washout Period||9
2501954|NCT00804687|6131546|P1|COMPLETED|Period 2: Washout Period||9
2501955|NCT00804687|6131541|P6|STARTED|Period 2: Washout Period||8
2501956|NCT00804687|6131542|P5|STARTED|Period 2: Washout Period||9
2501957|NCT00804687|6131543|P4|STARTED|Period 2: Washout Period||9
2501958|NCT00804687|6131544|P3|STARTED|Period 2: Washout Period||9
2501959|NCT00804687|6131545|P2|STARTED|Period 2: Washout Period||9
2501960|NCT00804687|6131546|P1|STARTED|Period 2: Washout Period||9
2501961|NCT00804687|6131541|P6|NOT COMPLETED|Period 1: Treatment Period||0
2501962|NCT00804687|6131542|P5|NOT COMPLETED|Period 1: Treatment Period||0
2501963|NCT00804687|6131543|P4|NOT COMPLETED|Period 1: Treatment Period||0
2501964|NCT00804687|6131544|P3|NOT COMPLETED|Period 1: Treatment Period||0
2501965|NCT00804687|6131545|P2|NOT COMPLETED|Period 1: Treatment Period||0
2501966|NCT00804687|6131546|P1|NOT COMPLETED|Period 1: Treatment Period||0
2501967|NCT00804687|6131541|P6|COMPLETED|Period 1: Treatment Period||8
2501968|NCT00804687|6131542|P5|COMPLETED|Period 1: Treatment Period||9
2501969|NCT00804687|6131543|P4|COMPLETED|Period 1: Treatment Period||9
2501970|NCT00804687|6131544|P3|COMPLETED|Period 1: Treatment Period||9
2501971|NCT00804687|6131545|P2|COMPLETED|Period 1: Treatment Period||9
2501972|NCT00804687|6131546|P1|COMPLETED|Period 1: Treatment Period||9
2501973|NCT00804687|6131541|P6|STARTED|Period 1: Treatment Period||8
2501974|NCT00804687|6131542|P5|STARTED|Period 1: Treatment Period||9
2501975|NCT00804687|6131543|P4|STARTED|Period 1: Treatment Period||9
2501976|NCT00804687|6131544|P3|STARTED|Period 1: Treatment Period||9
2501977|NCT00804687|6131545|P2|STARTED|Period 1: Treatment Period||9
2501978|NCT00804687|6131546|P1|STARTED|Period 1: Treatment Period||9
2501979|NCT00804648|6131563|P6|NOT COMPLETED|Third Invervention||0
2501980|NCT00804648|6131564|P5|NOT COMPLETED|Third Invervention||0
2501981|NCT00804648|6131565|P4|NOT COMPLETED|Third Invervention||0
2501982|NCT00804648|6131566|P3|NOT COMPLETED|Third Invervention||0
2501983|NCT00804648|6131567|P2|NOT COMPLETED|Third Invervention||0
2501984|NCT00804648|6131568|P1|NOT COMPLETED|Third Invervention||0
2501985|NCT00804648|6131563|P6|COMPLETED|Third Invervention||8
2501986|NCT00804648|6131564|P5|COMPLETED|Third Invervention||4
2501987|NCT00804648|6131565|P4|COMPLETED|Third Invervention||4
2501988|NCT00804648|6131566|P3|COMPLETED|Third Invervention||6
2501989|NCT00804648|6131567|P2|COMPLETED|Third Invervention||5
2501990|NCT00804648|6131568|P1|COMPLETED|Third Invervention||3
2501991|NCT00804648|6131563|P6|STARTED|Third Invervention||8
2501992|NCT00804648|6131564|P5|STARTED|Third Invervention||4
2501993|NCT00804648|6131565|P4|STARTED|Third Invervention||4
2501994|NCT00804648|6131566|P3|STARTED|Third Invervention||6
2501995|NCT00804648|6131567|P2|STARTED|Third Invervention||5
2501996|NCT00804648|6131568|P1|STARTED|Third Invervention||3
2501997|NCT00804648|6131563|P6|NOT COMPLETED|Second Intervention||0
2501998|NCT00804648|6131564|P5|NOT COMPLETED|Second Intervention||0
2501999|NCT00804648|6131565|P4|NOT COMPLETED|Second Intervention||0
2502000|NCT00804648|6131566|P3|NOT COMPLETED|Second Intervention||0
2502001|NCT00804648|6131567|P2|NOT COMPLETED|Second Intervention||0
2502002|NCT00804648|6131568|P1|NOT COMPLETED|Second Intervention||0
2502003|NCT00804648|6131563|P6|COMPLETED|Second Intervention||8
2502004|NCT00804648|6131564|P5|COMPLETED|Second Intervention||4
2502005|NCT00804648|6131565|P4|COMPLETED|Second Intervention||4
2502006|NCT00804648|6131566|P3|COMPLETED|Second Intervention||6
2502007|NCT00804648|6131567|P2|COMPLETED|Second Intervention||5
2502008|NCT00804648|6131568|P1|COMPLETED|Second Intervention||3
2502009|NCT00804648|6131563|P6|STARTED|Second Intervention||8
2502010|NCT00804648|6131564|P5|STARTED|Second Intervention||4
2502011|NCT00804648|6131565|P4|STARTED|Second Intervention||4
2502012|NCT00804648|6131566|P3|STARTED|Second Intervention||6
2502013|NCT00804648|6131567|P2|STARTED|Second Intervention||5
2502014|NCT00804648|6131568|P1|STARTED|Second Intervention||3
2502015|NCT00804648|6131563|P6|NOT COMPLETED|First Intervention||0
2502016|NCT00804648|6131564|P5|NOT COMPLETED|First Intervention||0
2502017|NCT00804648|6131565|P4|NOT COMPLETED|First Intervention||0
2502018|NCT00804648|6131566|P3|NOT COMPLETED|First Intervention||0
2502019|NCT00804648|6131567|P2|NOT COMPLETED|First Intervention||0
2502020|NCT00804648|6131568|P1|NOT COMPLETED|First Intervention||0
2502021|NCT00804648|6131563|P6|COMPLETED|First Intervention||8
2502022|NCT00804648|6131564|P5|COMPLETED|First Intervention||4
2502023|NCT00804648|6131565|P4|COMPLETED|First Intervention||4
2502024|NCT00804648|6131566|P3|COMPLETED|First Intervention||6
2502025|NCT00804648|6131567|P2|COMPLETED|First Intervention||5
2502026|NCT00804648|6131568|P1|COMPLETED|First Intervention||3
2502027|NCT00804648|6131563|P6|STARTED|First Intervention||8
2502028|NCT00804648|6131564|P5|STARTED|First Intervention||4
2502029|NCT00804648|6131565|P4|STARTED|First Intervention||4
2502030|NCT00804648|6131566|P3|STARTED|First Intervention||6
2502031|NCT00804648|6131567|P2|STARTED|First Intervention||5
2502032|NCT00804648|6131568|P1|STARTED|First Intervention||3
2502033|NCT00804609|6131611|P2|NOT COMPLETED|Overall Study||1
2502034|NCT00804609|6131612|P1|NOT COMPLETED|Overall Study||0
2502035|NCT00804609|6131611|P2|COMPLETED|Overall Study||14
2502036|NCT00804609|6131612|P1|COMPLETED|Overall Study||15
2502037|NCT00804609|6131611|P2|STARTED|Overall Study||15
2502038|NCT00804609|6131612|P1|STARTED|Overall Study||15
2502039|NCT00804596|6131618|P1|NOT COMPLETED|Overall Study||0
2502040|NCT00804596|6131618|P1|COMPLETED|Overall Study||74
2502041|NCT00804596|6131618|P1|STARTED|Overall Study||74
2502042|NCT00804570|6131625|P2|NOT COMPLETED|Overall Study||94
2502043|NCT00804570|6131626|P1|NOT COMPLETED|Overall Study||72
2502044|NCT00804570|6131625|P2|COMPLETED|Overall Study||94
2502045|NCT00804570|6131626|P1|COMPLETED|Overall Study||115
2502046|NCT00804570|6131625|P2|STARTED|Overall Study||188
2502047|NCT00804570|6131626|P1|STARTED|Overall Study||187
2502048|NCT00804193|6131685|P3|NOT COMPLETED|Overall Study||32
2502049|NCT00804193|6131686|P2|NOT COMPLETED|Overall Study||44
2502050|NCT00804193|6131687|P1|NOT COMPLETED|Overall Study||39
2502051|NCT00804193|6131685|P3|COMPLETED|Overall Study||77
2502052|NCT00804193|6131686|P2|COMPLETED|Overall Study||180
2502053|NCT00804193|6131687|P1|COMPLETED|Overall Study||181
2502054|NCT00804193|6131685|P3|STARTED|Overall Study||109
2502055|NCT00804193|6131686|P2|STARTED|Overall Study||224
2502056|NCT00804193|6131687|P1|STARTED|Overall Study||220
2502057|NCT00804141|6131701|P1|NOT COMPLETED|Overall Study||563
2502058|NCT00804141|6131701|P1|COMPLETED|Overall Study||477
2502059|NCT00804141|6131701|P1|Received at Least 1 Dose of Study Drug|Overall Study||1034
2502060|NCT00804141|6131701|P1|STARTED|Overall Study||1040
2502061|NCT00803959|6131708|P2|NOT COMPLETED|Overall Study||51
2502062|NCT00803959|6131709|P1|NOT COMPLETED|Overall Study||56
2502063|NCT00803959|6131708|P2|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=264).|264
2502064|NCT00803959|6131709|P1|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=259).|259
2502065|NCT00803959|6131708|P2|ITT Analysis With Primary Outcome Data|Overall Study||272
2502066|NCT00803959|6131709|P1|ITT Analysis With Primary Outcome Data|Overall Study||266
2502067|NCT00803959|6131708|P2|STARTED|Overall Study||315
2502068|NCT00803959|6131709|P1|STARTED|Overall Study||315
2502069|NCT00803790|6131741|P4|NOT COMPLETED|Period 2||1
2502070|NCT00803790|6131742|P3|NOT COMPLETED|Period 2||1
2502071|NCT00803790|6131743|P2|NOT COMPLETED|Period 2||0
2502072|NCT00803790|6131744|P1|NOT COMPLETED|Period 2||2
2502073|NCT00803790|6131741|P4|COMPLETED|Period 2||30
2502074|NCT00803790|6131742|P3|COMPLETED|Period 2||30
2502075|NCT00803790|6131743|P2|COMPLETED|Period 2||114
2502076|NCT00803790|6131744|P1|COMPLETED|Period 2||114
2502077|NCT00803790|6131741|P4|STARTED|Period 2||31
2502078|NCT00803790|6131742|P3|STARTED|Period 2||31
2502079|NCT00803790|6131743|P2|STARTED|Period 2||114
2502080|NCT00803790|6131744|P1|STARTED|Period 2||116
2502081|NCT00803790|6131741|P4|NOT COMPLETED|Period 1||4
2502082|NCT00803790|6131742|P3|NOT COMPLETED|Period 1||1
2502083|NCT00803790|6131743|P2|NOT COMPLETED|Period 1||12
2502084|NCT00803790|6131744|P1|NOT COMPLETED|Period 1||9
2502085|NCT00803790|6131741|P4|COMPLETED|Period 1||31
2502086|NCT00803790|6131742|P3|COMPLETED|Period 1||31
2502087|NCT00803790|6131743|P2|COMPLETED|Period 1||114
2502088|NCT00803790|6131744|P1|COMPLETED|Period 1||116
2502089|NCT00803790|6131741|P4|STARTED|Period 1||35
2502090|NCT00803790|6131742|P3|STARTED|Period 1||32
2502091|NCT00803790|6131743|P2|STARTED|Period 1||126
2502092|NCT00803790|6131744|P1|STARTED|Period 1||125
2502093|NCT00803777|6131755|P1|NOT COMPLETED|Overall Study||0
2502094|NCT00803777|6131755|P1|COMPLETED|Overall Study||147
2502095|NCT00803777|6131755|P1|STARTED|Overall Study||147
2502096|NCT00803751|6131765|P2|NOT COMPLETED|Overall Study||0
2502097|NCT00803751|6131766|P1|NOT COMPLETED|Overall Study||0
2502098|NCT00803751|6131765|P2|COMPLETED|Overall Study||23
2502099|NCT00803751|6131766|P1|COMPLETED|Overall Study||26
2502100|NCT00803751|6131765|P2|STARTED|Overall Study||23
2502101|NCT00803751|6131766|P1|STARTED|Overall Study||26
2502102|NCT00803738|6131784|P2|NOT COMPLETED|Overall Study||110
2502103|NCT00803738|6131785|P1|NOT COMPLETED|Overall Study||94
2502104|NCT00803738|6131784|P2|COMPLETED|Overall Study||176
2502105|NCT00803738|6131785|P1|COMPLETED|Overall Study||192
2502106|NCT00803738|6131784|P2|STARTED|Overall Study||286
2502107|NCT00803738|6131785|P1|STARTED|Overall Study||286
2502108|NCT00803712|6131797|P2|NOT COMPLETED|Overall Study||27
2502109|NCT00803712|6131798|P1|NOT COMPLETED|Overall Study||36
2502110|NCT00803712|6131797|P2|COMPLETED|Overall Study|128 participants randomized to the control group completed the study|128
2502111|NCT00803712|6131798|P1|COMPLETED|Overall Study|118 participants randomized to the cinacalcet group completed the study|118
2502112|NCT00803712|6131797|P2|Safety Analysis Set|Overall Study|Randomized to the control group|154
2502113|NCT00803712|6131798|P1|Safety Analysis Set|Overall Study|Rz'ed to cinacalcet and received at least 1 dose, or to control but received cinacalcet throughout|155
2502114|NCT00803712|6131797|P2|Full Analysis Set|Overall Study|151 participants randomized and had at least one PTH concentration available after study day 1.|151
2502115|NCT00803712|6131798|P1|Full Analysis Set|Overall Study|153 participants randomized and had at least one PTH concentration available after study day 1.|153
2502116|NCT00803712|6131797|P2|STARTED|Overall Study|155 participants were randomized to the control group|155
2502117|NCT00803712|6131798|P1|STARTED|Overall Study|154 participants were randomized to the cinacalcet group|154
2502118|NCT00803686|6131866|P4|NOT COMPLETED|Part 2, Period 3||0
2502119|NCT00803686|6131867|P3|NOT COMPLETED|Part 2, Period 3||0
2502120|NCT00803686|6131868|P2|NOT COMPLETED|Part 2, Period 3||0
2502121|NCT00803686|6131869|P1|NOT COMPLETED|Part 2, Period 3||0
2502122|NCT00803686|6131866|P4|COMPLETED|Part 2, Period 3|All who started this period completed|4
2502123|NCT00803686|6131867|P3|COMPLETED|Part 2, Period 3|All who started this period completed|5
2502124|NCT00803686|6131868|P2|COMPLETED|Part 2, Period 3|No subjects were treated in this period.|0
2502125|NCT00803686|6131869|P1|COMPLETED|Part 2, Period 3|No subjects were treated in this period|0
2502126|NCT00803686|6131866|P4|STARTED|Part 2, Period 3|Of the 6 eligible, 2 elected not to continue into Period 3.|4
2502127|NCT00803686|6131867|P3|STARTED|Part 2, Period 3|Of the 6 eligible, 1 elected not to continue into Period 3.|5
2502128|NCT00803686|6131868|P2|STARTED|Part 2, Period 3|No subjects were treated in this period.|0
2502129|NCT00803686|6131869|P1|STARTED|Part 2, Period 3|No subjects were treated in this period|0
2502130|NCT00803686|6131866|P4|NOT COMPLETED|Part 1, Period 2||0
2502131|NCT00803686|6131867|P3|NOT COMPLETED|Part 1, Period 2||0
2502132|NCT00803686|6131868|P2|NOT COMPLETED|Part 1, Period 2||0
2502133|NCT00803686|6131869|P1|NOT COMPLETED|Part 1, Period 2||0
2502134|NCT00803686|6131866|P4|COMPLETED|Part 1, Period 2|No subjects treated.|0
2502135|NCT00803686|6131867|P3|COMPLETED|Part 1, Period 2|No subjects treated.|0
2502136|NCT00803686|6131868|P2|COMPLETED|Part 1, Period 2||6
2502137|NCT00803686|6131869|P1|COMPLETED|Part 1, Period 2||6
2502138|NCT00803686|6131866|P4|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
2502139|NCT00803686|6131867|P3|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
2502140|NCT00803686|6131868|P2|STARTED|Part 1, Period 2||6
2502141|NCT00803686|6131869|P1|STARTED|Part 1, Period 2||6
2502142|NCT00803686|6131866|P4|NOT COMPLETED|Part 1, Period 1||0
2502143|NCT00803686|6131867|P3|NOT COMPLETED|Part 1, Period 1||0
2502144|NCT00803686|6131868|P2|NOT COMPLETED|Part 1, Period 1||0
2502145|NCT00803686|6131869|P1|NOT COMPLETED|Part 1, Period 1||0
2502146|NCT00803686|6131866|P4|COMPLETED|Part 1, Period 1||0
2502147|NCT00803686|6131867|P3|COMPLETED|Part 1, Period 1||0
2502148|NCT00803686|6131868|P2|COMPLETED|Part 1, Period 1||6
2502149|NCT00803686|6131869|P1|COMPLETED|Part 1, Period 1||6
2502150|NCT00803686|6131866|P4|STARTED|Part 1, Period 1||0
2502151|NCT00803686|6131867|P3|STARTED|Part 1, Period 1||0
2502152|NCT00803686|6131868|P2|STARTED|Part 1, Period 1||6
2502153|NCT00803686|6131869|P1|STARTED|Part 1, Period 1||6
2502154|NCT00803647|6131887|P1|NOT COMPLETED|Overall Study||0
2502155|NCT00803647|6131887|P1|COMPLETED|Overall Study||20
2502156|NCT00803647|6131887|P1|STARTED|Overall Study||20
2502157|NCT00803634|6131897|P2|NOT COMPLETED|Overall Study||5
2502158|NCT00803634|6131898|P1|NOT COMPLETED|Overall Study||6
2502159|NCT00803634|6131897|P2|COMPLETED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|48
2502160|NCT00803634|6131898|P1|COMPLETED|Overall Study|All patients dosed with clevidipine [Safety population]|45
2502161|NCT00803634|6131897|P2|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with SOC antihypertensive therapy and confirmed to have AHF [mITT population]|41
2502162|NCT00803634|6131898|P1|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with clevidipine and confirmed to have AHF [mITT population]|44
2502163|NCT00803634|6131897|P2|STARTED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|53
2502164|NCT00803634|6131898|P1|STARTED|Overall Study|All patients dosed with clevidipine [Safety population]|51
2502165|NCT00803595|6131927|P3|NOT COMPLETED|Overall Study||16
2502166|NCT00803595|6131928|P2|NOT COMPLETED|Overall Study||8
2502167|NCT00803595|6131929|P1|NOT COMPLETED|Overall Study||15
2502168|NCT00803595|6131927|P3|COMPLETED|Overall Study||322
2502169|NCT00803595|6131928|P2|COMPLETED|Overall Study||319
2502170|NCT00803595|6131929|P1|COMPLETED|Overall Study||322
2502171|NCT00803595|6131927|P3|STARTED|Overall Study||338
2502172|NCT00803595|6131928|P2|STARTED|Overall Study||327
2502173|NCT00803595|6131929|P1|STARTED|Overall Study||337
2502174|NCT00803569|6131940|P1|NOT COMPLETED|Overall Study||4
2502175|NCT00803569|6131940|P1|COMPLETED|Overall Study||9
2502176|NCT00803569|6131940|P1|STARTED|Overall Study||13
2502177|NCT00803543|6131950|P2|NOT COMPLETED|Overall Study||12
2502178|NCT00803543|6131951|P1|NOT COMPLETED|Overall Study||24
2502179|NCT00803543|6131950|P2|COMPLETED|Overall Study||22
2502180|NCT00803543|6131951|P1|COMPLETED|Overall Study||45
2502181|NCT00803543|6131950|P2|STARTED|Overall Study||34
2502182|NCT00803543|6131951|P1|STARTED|Overall Study||69
2502183|NCT00803517|6131965|P2|NOT COMPLETED|Overall Study||0
2502184|NCT00803517|6131966|P1|NOT COMPLETED|Overall Study||0
2502185|NCT00803517|6131965|P2|COMPLETED|Overall Study||12
2502186|NCT00803517|6131966|P1|COMPLETED|Overall Study||12
2502187|NCT00803517|6131965|P2|STARTED|Overall Study||12
2502188|NCT00803517|6131966|P1|STARTED|Overall Study||12
2502189|NCT00803452|6131974|P2|NOT COMPLETED|Overall Study||5
2502190|NCT00803452|6131975|P1|NOT COMPLETED|Overall Study||0
2502191|NCT00803452|6131974|P2|COMPLETED|Overall Study||17
2502192|NCT00803452|6131975|P1|COMPLETED|Overall Study||9
2502193|NCT00803452|6131974|P2|STARTED|Overall Study||22
2502194|NCT00803452|6131975|P1|STARTED|Overall Study||9
2502195|NCT00803413|6131985|P4|NOT COMPLETED|Overall Period||0
2502196|NCT00803413|6131986|P3|NOT COMPLETED|Overall Period||0
2502197|NCT00803413|6131987|P2|NOT COMPLETED|Overall Period||0
2502198|NCT00803413|6131988|P1|NOT COMPLETED|Overall Period||0
2502199|NCT00803413|6131985|P4|COMPLETED|Overall Period||30
2502200|NCT00803413|6131986|P3|COMPLETED|Overall Period||29
2502201|NCT00803413|6131987|P2|COMPLETED|Overall Period||32
2502202|NCT00803413|6131988|P1|COMPLETED|Overall Period||28
2502203|NCT00803413|6131985|P4|STARTED|Overall Period||30
2502204|NCT00803413|6131986|P3|STARTED|Overall Period||29
2502205|NCT00803413|6131987|P2|STARTED|Overall Period||32
2502206|NCT00803413|6131988|P1|STARTED|Overall Period||28
2502207|NCT00803400|6132000|P2|NOT COMPLETED|Overall Study||24
2502208|NCT00803400|6132001|P1|NOT COMPLETED|Overall Study||20
2502209|NCT00803400|6132000|P2|COMPLETED|Overall Study||51
2502210|NCT00803400|6132001|P1|COMPLETED|Overall Study||55
2502211|NCT00803400|6132000|P2|STARTED|Overall Study||75
2502212|NCT00803400|6132001|P1|STARTED|Overall Study||75
2502213|NCT00803361|6132013|P2|NOT COMPLETED|Overall Study||28
2502214|NCT00803361|6132014|P1|NOT COMPLETED|Overall Study||26
2502215|NCT00803361|6132013|P2|COMPLETED|Overall Study||74
2502216|NCT00803361|6132014|P1|COMPLETED|Overall Study||82
2502217|NCT00803361|6132013|P2|STARTED|Overall Study||102
2502218|NCT00803361|6132014|P1|STARTED|Overall Study||108
2502219|NCT00803283|6132034|P2|NOT COMPLETED|Overall Study||0
2502220|NCT00803283|6132035|P1|NOT COMPLETED|Overall Study||0
2502221|NCT00803283|6132034|P2|COMPLETED|Overall Study||1
2502222|NCT00803283|6132035|P1|COMPLETED|Overall Study||1
2502223|NCT00803283|6132034|P2|STARTED|Overall Study||1
2502224|NCT00803283|6132035|P1|STARTED|Overall Study||1
2502225|NCT00803270|6132061|P2|NOT COMPLETED|Overall Study||2
2502226|NCT00803270|6132062|P1|NOT COMPLETED|Overall Study||1
2502227|NCT00803270|6132061|P2|COMPLETED|Overall Study||12
2502228|NCT00803270|6132062|P1|COMPLETED|Overall Study||12
2502229|NCT00803270|6132061|P2|STARTED|Overall Study||14
2502230|NCT00803270|6132062|P1|STARTED|Overall Study||13
2502231|NCT00803244|6132072|P2|NOT COMPLETED|Overall Study||15
2502232|NCT00803244|6132073|P1|NOT COMPLETED|Overall Study||7
2502233|NCT00803244|6132072|P2|COMPLETED|Overall Study||178
2502234|NCT00803244|6132073|P1|COMPLETED|Overall Study||181
2502235|NCT00803244|6132072|P2|STARTED|Overall Study||193
2502236|NCT00803244|6132073|P1|STARTED|Overall Study||188
2502237|NCT00803179|6132081|P1|NOT COMPLETED|Overall Study||3
2502238|NCT00803179|6132081|P1|COMPLETED|Overall Study||2
2502239|NCT00803179|6132081|P1|STARTED|Overall Study||5
2502240|NCT00803114|6132087|P2|NOT COMPLETED|Overall Study||0
2502241|NCT00803114|6132088|P1|NOT COMPLETED|Overall Study||0
2502242|NCT00803114|6132087|P2|COMPLETED|Overall Study||115
2502243|NCT00803114|6132088|P1|COMPLETED|Overall Study||113
2502244|NCT00803114|6132087|P2|STARTED|Overall Study||115
2502245|NCT00803114|6132088|P1|STARTED|Overall Study||113
2502246|NCT00803101|6132100|P2|NOT COMPLETED|Overall Study||22
2502247|NCT00803101|6132101|P1|NOT COMPLETED|Overall Study||18
2502248|NCT00803101|6132100|P2|COMPLETED|Overall Study||66
2502249|NCT00803101|6132101|P1|COMPLETED|Overall Study||70
2502250|NCT00803101|6132100|P2|STARTED|Overall Study||88
2502251|NCT00803101|6132101|P1|STARTED|Overall Study||88
2502252|NCT00803062|6132123|P4|NOT COMPLETED|Overall Study||0
2502253|NCT00803062|6132124|P3|NOT COMPLETED|Overall Study||0
2502254|NCT00803062|6132125|P2|NOT COMPLETED|Overall Study||0
2502255|NCT00803062|6132126|P1|NOT COMPLETED|Overall Study||0
2502256|NCT00803062|6132123|P4|COMPLETED|Overall Study||112
2502257|NCT00803062|6132124|P3|COMPLETED|Overall Study||111
2502258|NCT00803062|6132125|P2|COMPLETED|Overall Study||115
2502259|NCT00803062|6132126|P1|COMPLETED|Overall Study||114
2502260|NCT00803062|6132123|P4|STARTED|Overall Study||112
2502261|NCT00803062|6132124|P3|STARTED|Overall Study||111
2502262|NCT00803062|6132125|P2|STARTED|Overall Study||115
2502263|NCT00803062|6132126|P1|STARTED|Overall Study||114
2502264|NCT00803049|6132152|P4|NOT COMPLETED|Overall Study||102
2502265|NCT00803049|6132153|P3|NOT COMPLETED|Overall Study||44
2502266|NCT00803049|6132154|P2|NOT COMPLETED|Overall Study||118
2502267|NCT00803049|6132155|P1|NOT COMPLETED|Overall Study||61
2502268|NCT00803049|6132152|P4|COMPLETED|Overall Study||151
2502269|NCT00803049|6132153|P3|COMPLETED|Overall Study||64
2502270|NCT00803049|6132154|P2|COMPLETED|Overall Study||134
2502271|NCT00803049|6132155|P1|COMPLETED|Overall Study||68
2502272|NCT00803049|6132152|P4|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|250
2502273|NCT00803049|6132153|P3|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|107
2502274|NCT00803049|6132154|P2|Safety Population|Overall Study|Included 1 participant from Placebo/Teriflunomide 14 mg and 1 from Teriflunomide14 mg/14 mg arm|254
2502275|NCT00803049|6132155|P1|Safety Population|Overall Study||129
2502276|NCT00803049|6132152|P4|Treated|Overall Study||251
2502277|NCT00803049|6132153|P3|Treated|Overall Study||108
2502278|NCT00803049|6132154|P2|Treated|Overall Study||252
2502279|NCT00803049|6132155|P1|Treated|Overall Study||129
2502280|NCT00803049|6132152|P4|STARTED|Overall Study|Randomized in extension study|253
2502281|NCT00803049|6132153|P3|STARTED|Overall Study|Randomized in extension study|108
2502282|NCT00803049|6132154|P2|STARTED|Overall Study|Randomized in extension study|252
2502283|NCT00803049|6132155|P1|STARTED|Overall Study|Randomized in extension study|129
2502284|NCT00803023|6132189|P4|NOT COMPLETED|Overall Study||8
2502285|NCT00803023|6132190|P3|NOT COMPLETED|Overall Study||11
2502286|NCT00803023|6132191|P2|NOT COMPLETED|Overall Study||8
2502287|NCT00803023|6132192|P1|NOT COMPLETED|Overall Study||5
2502288|NCT00803023|6132189|P4|COMPLETED|Overall Study||25
2502289|NCT00803023|6132190|P3|COMPLETED|Overall Study||20
2502290|NCT00803023|6132191|P2|COMPLETED|Overall Study||25
2502291|NCT00803023|6132192|P1|COMPLETED|Overall Study||27
2502292|NCT00803023|6132189|P4|STARTED|Overall Study||33
2502293|NCT00803023|6132190|P3|STARTED|Overall Study||31
2502294|NCT00803023|6132191|P2|STARTED|Overall Study||33
2502295|NCT00803023|6132192|P1|STARTED|Overall Study||32
2502296|NCT00803010|6132204|P2|NOT COMPLETED|Overall Study||0
2502297|NCT00803010|6132205|P1|NOT COMPLETED|Overall Study||0
2502298|NCT00803010|6132204|P2|COMPLETED|Overall Study||37
2502299|NCT00803010|6132205|P1|COMPLETED|Overall Study||37
2502300|NCT00803010|6132204|P2|STARTED|Overall Study||37
2502301|NCT00803010|6132205|P1|STARTED|Overall Study||37
2502302|NCT00802997|6132217|P2|NOT COMPLETED|6 Month to 9 Months||0
2502303|NCT00802997|6132218|P1|NOT COMPLETED|6 Month to 9 Months||2
2502304|NCT00802997|6132217|P2|COMPLETED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
2502305|NCT00802997|6132218|P1|COMPLETED|6 Month to 9 Months||25
2502306|NCT00802997|6132217|P2|STARTED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
2502307|NCT00802997|6132218|P1|STARTED|6 Month to 9 Months||27
2502308|NCT00802997|6132217|P2|NOT COMPLETED|3 Months to 6 Months||0
2502309|NCT00802997|6132218|P1|NOT COMPLETED|3 Months to 6 Months||7
2502310|NCT00802997|6132217|P2|COMPLETED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
2502311|NCT00802997|6132218|P1|COMPLETED|3 Months to 6 Months||27
2502312|NCT00802997|6132217|P2|STARTED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
2502313|NCT00802997|6132218|P1|STARTED|3 Months to 6 Months||34
2502314|NCT00802997|6132217|P2|NOT COMPLETED|Baseline to 3 Months||0
2502315|NCT00802997|6132218|P1|NOT COMPLETED|Baseline to 3 Months||0
2502316|NCT00802997|6132217|P2|COMPLETED|Baseline to 3 Months||17
2502317|NCT00802997|6132218|P1|COMPLETED|Baseline to 3 Months||34
2502318|NCT00802997|6132217|P2|STARTED|Baseline to 3 Months||17
2502319|NCT00802997|6132218|P1|STARTED|Baseline to 3 Months||34
2502320|NCT00802945|6132230|P2|NOT COMPLETED|Overall Study||35
2502321|NCT00802945|6132231|P1|NOT COMPLETED|Overall Study||35
2502322|NCT00802945|6132230|P2|COMPLETED|Overall Study||0
2502323|NCT00802945|6132231|P1|COMPLETED|Overall Study||0
2502324|NCT00802945|6132230|P2|STARTED|Overall Study||35
2502325|NCT00802945|6132231|P1|STARTED|Overall Study||35
2502326|NCT00802919|6132249|P2|NOT COMPLETED|Overall Study||1
2502327|NCT00802919|6132250|P1|NOT COMPLETED|Overall Study||3
2502328|NCT00802919|6132249|P2|COMPLETED|Overall Study||45
2502329|NCT00802919|6132250|P1|COMPLETED|Overall Study||42
2502330|NCT00802919|6132249|P2|STARTED|Overall Study||46
2502331|NCT00802919|6132250|P1|STARTED|Overall Study||45
2502332|NCT00802893|6132262|P1|NOT COMPLETED|Overall Study||3
2502333|NCT00802893|6132262|P1|COMPLETED|Overall Study||0
2502334|NCT00802893|6132262|P1|STARTED|Overall Study||3
2502335|NCT00802880|6132267|P1|NOT COMPLETED|Overall Study||0
2502336|NCT00802880|6132267|P1|COMPLETED|Overall Study||80
2502337|NCT00802880|6132267|P1|STARTED|Overall Study||80
2502338|NCT00802867|6132286|P1|NOT COMPLETED|Overall Study||13
2502339|NCT00802867|6132286|P1|COMPLETED|Overall Study||976
2502340|NCT00802867|6132286|P1|STARTED|Overall Study||989
2502341|NCT00802854|6132294|P1|NOT COMPLETED|Overall Study||0
2502342|NCT00802854|6132294|P1|COMPLETED|Overall Study||244
2502343|NCT00802854|6132294|P1|STARTED|Overall Study||244
2502344|NCT00802841|6132309|P2|NOT COMPLETED|Overall Study||95
2502345|NCT00802841|6132310|P1|NOT COMPLETED|Overall Study||96
2502346|NCT00802841|6132309|P2|COMPLETED|Overall Study||0
2502347|NCT00802841|6132310|P1|COMPLETED|Overall Study||0
2502348|NCT00802841|6132309|P2|Cross-over Set|Overall Study||56
2502349|NCT00802841|6132310|P1|Cross-over Set|Overall Study||13
2502350|NCT00802841|6132309|P2|Safety Set|Overall Study||93
2502351|NCT00802841|6132310|P1|Safety Set|Overall Study||96
2502352|NCT00802841|6132309|P2|Full Analysis Set|Overall Study||95
2502353|NCT00802841|6132310|P1|Full Analysis Set|Overall Study||96
2502354|NCT00802841|6132309|P2|STARTED|Overall Study||95
2502355|NCT00802841|6132310|P1|STARTED|Overall Study||96
2502356|NCT00802737|6132335|P3|NOT COMPLETED|Overall Study||1
2502357|NCT00802737|6132336|P2|NOT COMPLETED|Overall Study||11
2502358|NCT00802737|6132337|P1|NOT COMPLETED|Overall Study||17
2502359|NCT00802737|6132335|P3|COMPLETED|Overall Study||0
2502360|NCT00802737|6132336|P2|COMPLETED|Overall Study||0
2502361|NCT00802737|6132337|P1|COMPLETED|Overall Study||0
2502362|NCT00802737|6132335|P3|STARTED|Overall Study||1
2502363|NCT00802737|6132336|P2|STARTED|Overall Study||11
2502364|NCT00802737|6132337|P1|STARTED|Overall Study||17
2502365|NCT00802685|6132385|P2|NOT COMPLETED|Overall Study||0
2502366|NCT00802685|6132386|P1|NOT COMPLETED|Overall Study||0
2502367|NCT00802685|6132385|P2|COMPLETED|Overall Study||51
2502368|NCT00802685|6132386|P1|COMPLETED|Overall Study||54
2502369|NCT00802685|6132385|P2|STARTED|Overall Study||51
2502370|NCT00802685|6132386|P1|STARTED|Overall Study||54
2502371|NCT00802672|6132397|P3|NOT COMPLETED|Overall Study||34
2502372|NCT00802672|6132398|P2|NOT COMPLETED|Overall Study||52
2502373|NCT00802672|6132399|P1|NOT COMPLETED|Overall Study||68
2502374|NCT00802672|6132397|P3|COMPLETED|Overall Study||77
2502375|NCT00802672|6132398|P2|COMPLETED|Overall Study||174
2502376|NCT00802672|6132399|P1|COMPLETED|Overall Study||156
2502377|NCT00802672|6132397|P3|STARTED|Overall Study||111
2502378|NCT00802672|6132398|P2|STARTED|Overall Study||226
2502379|NCT00802672|6132399|P1|STARTED|Overall Study||224
2502380|NCT00802659|6132417|P4|NOT COMPLETED|Overall Study||0
2502381|NCT00802659|6132418|P3|NOT COMPLETED|Overall Study||0
2502382|NCT00802659|6132419|P2|NOT COMPLETED|Overall Study||1
2502383|NCT00802659|6132420|P1|NOT COMPLETED|Overall Study||0
2502384|NCT00802659|6132417|P4|COMPLETED|Overall Study||0
2502385|NCT00802659|6132418|P3|COMPLETED|Overall Study||0
2502386|NCT00802659|6132419|P2|COMPLETED|Overall Study||1
2502387|NCT00802659|6132420|P1|COMPLETED|Overall Study||0
2502388|NCT00802659|6132417|P4|STARTED|Overall Study||0
2502389|NCT00802659|6132418|P3|STARTED|Overall Study||0
2502390|NCT00802659|6132419|P2|STARTED|Overall Study||2
2502391|NCT00802659|6132420|P1|STARTED|Overall Study||0
2502392|NCT00802633|6132448|P2|NOT COMPLETED|Overall Study||0
2502393|NCT00802633|6132449|P1|NOT COMPLETED|Overall Study||0
2502394|NCT00802633|6132448|P2|COMPLETED|Overall Study||40
2502395|NCT00802633|6132449|P1|COMPLETED|Overall Study||40
2502396|NCT00802633|6132448|P2|STARTED|Overall Study||40
2502397|NCT00802633|6132449|P1|STARTED|Overall Study||40
2502398|NCT00802529|6132459|P2|NOT COMPLETED|Overall Study||1
2502399|NCT00802529|6132460|P1|NOT COMPLETED|Overall Study||0
2502400|NCT00802529|6132459|P2|COMPLETED|Overall Study||29
2502401|NCT00802529|6132460|P1|COMPLETED|Overall Study|2 patients crossed-over to gentamicin after steroids failed to control vertigo (as per protocol).|30
2502402|NCT00802529|6132459|P2|STARTED|Overall Study||30
2502403|NCT00802529|6132460|P1|STARTED|Overall Study||30
2502404|NCT00802503|6132472|P2|NOT COMPLETED|Overall Study||20
2502405|NCT00802503|6132473|P1|NOT COMPLETED|Overall Study||10
2502406|NCT00802503|6132472|P2|COMPLETED|Overall Study||133
2502407|NCT00802503|6132473|P1|COMPLETED|Overall Study||142
2502408|NCT00802503|6132472|P2|STARTED|Overall Study||153
2502409|NCT00802503|6132473|P1|STARTED|Overall Study||152
2502410|NCT00802464|6132499|P4|NOT COMPLETED|Month 8 - Month 14||0
2502411|NCT00802464|6132500|P3|NOT COMPLETED|Month 8 - Month 14||1
2502412|NCT00802464|6132501|P2|NOT COMPLETED|Month 8 - Month 14||2
2502413|NCT00802464|6132502|P1|NOT COMPLETED|Month 8 - Month 14||1
2502414|NCT00802464|6132499|P4|COMPLETED|Month 8 - Month 14||126
2502415|NCT00802464|6132500|P3|COMPLETED|Month 8 - Month 14||129
2502416|NCT00802464|6132501|P2|COMPLETED|Month 8 - Month 14||63
2502417|NCT00802464|6132502|P1|COMPLETED|Month 8 - Month 14||33
2502418|NCT00802464|6132499|P4|STARTED|Month 8 - Month 14||126
2502419|NCT00802464|6132500|P3|STARTED|Month 8 - Month 14||130
2502420|NCT00802464|6132501|P2|STARTED|Month 8 - Month 14||65
2502421|NCT00802464|6132502|P1|STARTED|Month 8 - Month 14||34
2502422|NCT00802464|6132499|P4|NOT COMPLETED|Month 0 - Month 8||9
2502423|NCT00802464|6132500|P3|NOT COMPLETED|Month 0 - Month 8||7
2502424|NCT00802464|6132501|P2|NOT COMPLETED|Month 0 - Month 8||3
2502425|NCT00802464|6132502|P1|NOT COMPLETED|Month 0 - Month 8||0
2502426|NCT00802464|6132499|P4|COMPLETED|Month 0 - Month 8||141
2502427|NCT00802464|6132500|P3|COMPLETED|Month 0 - Month 8||142
2502428|NCT00802464|6132501|P2|COMPLETED|Month 0 - Month 8||70
2502429|NCT00802464|6132502|P1|COMPLETED|Month 0 - Month 8||38
2502430|NCT00802464|6132499|P4|STARTED|Month 0 - Month 8||150
2502431|NCT00802464|6132500|P3|STARTED|Month 0 - Month 8||149
2502432|NCT00802464|6132501|P2|STARTED|Month 0 - Month 8||73
2502433|NCT00802464|6132502|P1|STARTED|Month 0 - Month 8||38
2502434|NCT00802438|6132588|P1|NOT COMPLETED|Overall Study||28
2502435|NCT00802438|6132588|P1|COMPLETED|Overall Study||10
2502436|NCT00802438|6132588|P1|STARTED|Overall Study||38
2502437|NCT00802412|6132595|P2|NOT COMPLETED|Overall Study||1
2502438|NCT00802412|6132596|P1|NOT COMPLETED|Overall Study||2
2502439|NCT00802412|6132595|P2|COMPLETED|Overall Study||66
2502440|NCT00802412|6132596|P1|COMPLETED|Overall Study||63
2502441|NCT00802412|6132595|P2|STARTED|Overall Study||67
2502442|NCT00802412|6132596|P1|STARTED|Overall Study||65
2502443|NCT00802360|6132608|P4|NOT COMPLETED|Overall Study||22
2502444|NCT00802360|6132609|P3|NOT COMPLETED|Overall Study||25
2502445|NCT00802360|6132610|P2|NOT COMPLETED|Overall Study||26
2502446|NCT00802360|6132611|P1|NOT COMPLETED|Overall Study||24
2502447|NCT00802360|6132608|P4|COMPLETED|Overall Study||17
2502448|NCT00802360|6132609|P3|COMPLETED|Overall Study||17
2502449|NCT00802360|6132610|P2|COMPLETED|Overall Study||16
2502450|NCT00802360|6132611|P1|COMPLETED|Overall Study||18
2502451|NCT00802360|6132608|P4|STARTED|Overall Study||39
2502452|NCT00802360|6132609|P3|STARTED|Overall Study||42
2502453|NCT00802360|6132610|P2|STARTED|Overall Study||42
2502454|NCT00802360|6132611|P1|STARTED|Overall Study||42
2502455|NCT00802204|6132653|P2|NOT COMPLETED|Overall Study||1
2502456|NCT00802204|6132654|P1|NOT COMPLETED|Overall Study||1
2502457|NCT00802204|6132653|P2|COMPLETED|Overall Study||18
2502458|NCT00802204|6132654|P1|COMPLETED|Overall Study||8
2502459|NCT00802204|6132653|P2|STARTED|Overall Study||19
2502460|NCT00802204|6132654|P1|STARTED|Overall Study||9
2502461|NCT00802178|6132678|P1|NOT COMPLETED|Overall Study||113
2502462|NCT00802178|6132678|P1|COMPLETED|Overall Study||2335
2502463|NCT00802178|6132678|P1|STARTED|Overall Study||2448
2502464|NCT00802113|6132687|P2|NOT COMPLETED|Overall Study||0
2502465|NCT00802113|6132688|P1|NOT COMPLETED|Overall Study||0
2502466|NCT00802113|6132687|P2|COMPLETED|Overall Study||17
2502467|NCT00802113|6132688|P1|COMPLETED|Overall Study||6
2502468|NCT00802113|6132687|P2|STARTED|Overall Study||17
2502469|NCT00802113|6132688|P1|STARTED|Overall Study||6
2502470|NCT00802100|6132709|P3|NOT COMPLETED|Overall Study||4
2502471|NCT00802100|6132710|P2|NOT COMPLETED|Overall Study||7
2502472|NCT00802100|6132711|P1|NOT COMPLETED|Overall Study||6
2502473|NCT00802100|6132709|P3|COMPLETED|Overall Study||2
2502474|NCT00802100|6132710|P2|COMPLETED|Overall Study||2
2502475|NCT00802100|6132711|P1|COMPLETED|Overall Study||0
2502476|NCT00802100|6132709|P3|STARTED|Overall Study||6
2502477|NCT00802100|6132710|P2|STARTED|Overall Study||9
2502478|NCT00802100|6132711|P1|STARTED|Overall Study||6
2502479|NCT00802074|6132726|P6|NOT COMPLETED|Overall Study||0
2502480|NCT00802074|6132727|P5|NOT COMPLETED|Overall Study||0
2502481|NCT00802074|6132728|P4|NOT COMPLETED|Overall Study||0
2502482|NCT00802074|6132729|P3|NOT COMPLETED|Overall Study||1
2502483|NCT00802074|6132730|P2|NOT COMPLETED|Overall Study||1
2502484|NCT00802074|6132731|P1|NOT COMPLETED|Overall Study||2
2502485|NCT00802074|6132726|P6|COMPLETED|Overall Study||7
2502486|NCT00802074|6132727|P5|COMPLETED|Overall Study||7
2502487|NCT00802074|6132728|P4|COMPLETED|Overall Study||7
2502488|NCT00802074|6132729|P3|COMPLETED|Overall Study||6
2502489|NCT00802074|6132730|P2|COMPLETED|Overall Study||7
2502490|NCT00802074|6132731|P1|COMPLETED|Overall Study||7
2502491|NCT00802074|6132726|P6|STARTED|Overall Study||7
2502492|NCT00802074|6132727|P5|STARTED|Overall Study||7
2502493|NCT00802074|6132728|P4|STARTED|Overall Study||7
2502494|NCT00802074|6132729|P3|STARTED|Overall Study||7
2502495|NCT00802074|6132730|P2|STARTED|Overall Study||8
2502496|NCT00802074|6132731|P1|STARTED|Overall Study||9
2502497|NCT00801983|6132765|P2|NOT COMPLETED|Period 2||1
2502498|NCT00801983|6132766|P1|NOT COMPLETED|Period 2||2
2502499|NCT00801983|6132765|P2|COMPLETED|Period 2||32
2502500|NCT00801983|6132766|P1|COMPLETED|Period 2||38
2502501|NCT00801983|6132765|P2|STARTED|Period 2||33
2502502|NCT00801983|6132766|P1|STARTED|Period 2||40
2502503|NCT00801983|6132765|P2|NOT COMPLETED|Period 1||8
2502504|NCT00801983|6132766|P1|NOT COMPLETED|Period 1||4
2502505|NCT00801983|6132765|P2|COMPLETED|Period 1||33
2502506|NCT00801983|6132766|P1|COMPLETED|Period 1||40
2502507|NCT00801983|6132765|P2|STARTED|Period 1||41
2502508|NCT00801983|6132766|P1|STARTED|Period 1||44
2502509|NCT00801931|6132772|P1|NOT COMPLETED|Overall Study||0
2502510|NCT00801931|6132772|P1|COMPLETED|Overall Study||1
2502511|NCT00801931|6132772|P1|STARTED|Overall Study||1
2502512|NCT00801892|6132781|P2|NOT COMPLETED|Sham Crossover Period||2
2502513|NCT00801892|6132782|P1|NOT COMPLETED|Sham Crossover Period||0
2502514|NCT00801892|6132781|P2|COMPLETED|Sham Crossover Period||5
2502515|NCT00801892|6132782|P1|COMPLETED|Sham Crossover Period||0
2502516|NCT00801892|6132781|P2|STARTED|Sham Crossover Period||7
2502517|NCT00801892|6132782|P1|STARTED|Sham Crossover Period||0
2502518|NCT00801892|6132781|P2|NOT COMPLETED|Main Study Period||1
2502519|NCT00801892|6132782|P1|NOT COMPLETED|Main Study Period||0
2502520|NCT00801892|6132781|P2|COMPLETED|Main Study Period||10
2502521|NCT00801892|6132782|P1|COMPLETED|Main Study Period||12
2502522|NCT00801892|6132781|P2|STARTED|Main Study Period||11
2502523|NCT00801892|6132782|P1|STARTED|Main Study Period||12
2502524|NCT00801827|6132798|P1|NOT COMPLETED|Overall Study||0
2502525|NCT00801827|6132798|P1|COMPLETED|Overall Study||5
2502526|NCT00801827|6132798|P1|STARTED|Overall Study|2 others consented but due to scheduling did not complete|5
2502527|NCT00801801|6132802|P1|NOT COMPLETED|Overall Study||0
2502528|NCT00801801|6132802|P1|COMPLETED|Overall Study||5
2502529|NCT00801801|6132802|P1|STARTED|Overall Study||5
2502530|NCT00801684|6132807|P1|NOT COMPLETED|Overall Study||0
2502531|NCT00801684|6132807|P1|COMPLETED|Overall Study||24
2502532|NCT00801684|6132807|P1|STARTED|Overall Study||24
2502533|NCT00801632|6132829|P1|NOT COMPLETED|Overall Study||1
2502534|NCT00801632|6132829|P1|COMPLETED|Overall Study||4
2502535|NCT00801632|6132829|P1|STARTED|Overall Study||5
2502536|NCT00801398|6132846|P6|NOT COMPLETED|Overall Study||3
2502537|NCT00801398|6132847|P5|NOT COMPLETED|Overall Study||7
2502538|NCT00801398|6132848|P4|NOT COMPLETED|Overall Study||6
2502539|NCT00801398|6132849|P3|NOT COMPLETED|Overall Study||7
2502540|NCT00801398|6132850|P2|NOT COMPLETED|Overall Study||9
2502541|NCT00801398|6132851|P1|NOT COMPLETED|Overall Study||6
2502542|NCT00801398|6132846|P6|COMPLETED|Overall Study||5
2502543|NCT00801398|6132847|P5|COMPLETED|Overall Study||1
2502544|NCT00801398|6132848|P4|COMPLETED|Overall Study||3
2502545|NCT00801398|6132849|P3|COMPLETED|Overall Study||4
2502546|NCT00801398|6132850|P2|COMPLETED|Overall Study||0
2502547|NCT00801398|6132851|P1|COMPLETED|Overall Study||7
2502548|NCT00801398|6132846|P6|STARTED|Overall Study||8
2502549|NCT00801398|6132847|P5|STARTED|Overall Study||8
2502550|NCT00801398|6132848|P4|STARTED|Overall Study||9
2502551|NCT00801398|6132849|P3|STARTED|Overall Study||11
2502552|NCT00801398|6132850|P2|STARTED|Overall Study||9
2502553|NCT00801398|6132851|P1|STARTED|Overall Study||13
2502554|NCT00801242|6132907|P1|NOT COMPLETED|Overall Study||52
2502555|NCT00801242|6132907|P1|COMPLETED|Overall Study|42, 10, and 0 participants withdrew during Cycles 1, 2, and 3 (i.e. 168 completed the trial).|168
2502556|NCT00801242|6132907|P1|Started Cycle 3|Overall Study||2
2502557|NCT00801242|6132907|P1|Started Cycle 2|Overall Study||35
2502558|NCT00801242|6132907|P1|FAS, Off-treatment Cycle 1|Overall Study|Completed 7 months induction period and were enrolled in the off-treatment period of cycle 1.|191
2502559|NCT00801242|6132907|P1|Full Analysis Set (FAS), Cycle 1|Overall Study|Randomized participants who received ≥1 dose and had ≥1 efficacy assessment.|213
2502560|NCT00801242|6132907|P1|Safety Analysis Set|Overall Study|Randomized participants who received ≥1 dose of degarelix.|216
2502561|NCT00801242|6132907|P1|STARTED|Overall Study|Randomized participants.|220
2502562|NCT00801229|6132920|P2|NOT COMPLETED|Received Study Drug/Placebo||4
2502563|NCT00801229|6132921|P1|NOT COMPLETED|Received Study Drug/Placebo||4
2502564|NCT00801229|6132920|P2|COMPLETED|Received Study Drug/Placebo||30
2502565|NCT00801229|6132921|P1|COMPLETED|Received Study Drug/Placebo||31
2502566|NCT00801229|6132920|P2|STARTED|Received Study Drug/Placebo||34
2502567|NCT00801229|6132921|P1|STARTED|Received Study Drug/Placebo||35
2502568|NCT00801229|6132920|P2|NOT COMPLETED|Signed Consent||3
2502569|NCT00801229|6132921|P1|NOT COMPLETED|Signed Consent||3
2502570|NCT00801229|6132920|P2|COMPLETED|Signed Consent||34
2502571|NCT00801229|6132921|P1|COMPLETED|Signed Consent||35
2502572|NCT00801229|6132920|P2|STARTED|Signed Consent||37
2502573|NCT00801229|6132921|P1|STARTED|Signed Consent||38
2502574|NCT00801138|6132931|P4|NOT COMPLETED|Overall Study||0
2502575|NCT00801138|6132932|P3|NOT COMPLETED|Overall Study||0
2502576|NCT00801138|6132933|P2|NOT COMPLETED|Overall Study||0
2502577|NCT00801138|6132934|P1|NOT COMPLETED|Overall Study||0
2502578|NCT00801138|6132931|P4|COMPLETED|Overall Study||54
2502579|NCT00801138|6132932|P3|COMPLETED|Overall Study||54
2502580|NCT00801138|6132933|P2|COMPLETED|Overall Study||56
2502581|NCT00801138|6132934|P1|COMPLETED|Overall Study||54
2502582|NCT00801138|6132931|P4|STARTED|Overall Study||54
2502583|NCT00801138|6132932|P3|STARTED|Overall Study||54
2502584|NCT00801138|6132933|P2|STARTED|Overall Study||56
2502585|NCT00801138|6132934|P1|STARTED|Overall Study||54
2502586|NCT00801099|6132956|P1|NOT COMPLETED|Overall Study||101
2502587|NCT00801099|6132956|P1|COMPLETED|Overall Study||175
2502588|NCT00801099|6132956|P1|STARTED|Overall Study||276
2502589|NCT00800982|6132962|P2|NOT COMPLETED|Overall Study||3
2502590|NCT00800982|6132963|P1|NOT COMPLETED|Overall Study||2
2502591|NCT00800982|6132962|P2|COMPLETED|Overall Study||12
2502592|NCT00800982|6132963|P1|COMPLETED|Overall Study||13
2502593|NCT00800982|6132962|P2|STARTED|Overall Study||15
2502594|NCT00800982|6132963|P1|STARTED|Overall Study||15
2502595|NCT00800865|6132971|P2|NOT COMPLETED|Overall Study||0
2502596|NCT00800865|6132972|P1|NOT COMPLETED|Overall Study||0
2502597|NCT00800865|6132971|P2|COMPLETED|Overall Study||16
2502598|NCT00800865|6132972|P1|COMPLETED|Overall Study||15
2502599|NCT00800865|6132971|P2|STARTED|Overall Study||16
2502600|NCT00800865|6132972|P1|STARTED|Overall Study||15
2502601|NCT00800839|6132980|P1|NOT COMPLETED|Overall Study||7
2502602|NCT00800839|6132980|P1|COMPLETED|Overall Study||49
2502603|NCT00800839|6132980|P1|STARTED|Overall Study||56
2502604|NCT00800735|6132989|P1|NOT COMPLETED|Overall Study||14
2502605|NCT00800735|6132989|P1|COMPLETED|Overall Study||16
2502606|NCT00800735|6132989|P1|STARTED|Overall Study||30
2502607|NCT00800683|6132995|P2|NOT COMPLETED|Overall Study||19
2502608|NCT00800683|6132996|P1|NOT COMPLETED|Overall Study||17
2502609|NCT00800683|6132995|P2|COMPLETED|Overall Study|Number who completed treatment|49
2502610|NCT00800683|6132996|P1|COMPLETED|Overall Study|Number who completed treatment|48
2502611|NCT00800683|6132995|P2|STARTED|Overall Study|Number who started treatment|68
2502612|NCT00800683|6132996|P1|STARTED|Overall Study|Number who started treatment|65
2502613|NCT00800540|6133042|P2|NOT COMPLETED|Period 2: 6 Weeks||1
2502614|NCT00800540|6133043|P1|NOT COMPLETED|Period 2: 6 Weeks||0
2502615|NCT00800540|6133042|P2|COMPLETED|Period 2: 6 Weeks||16
2502616|NCT00800540|6133043|P1|COMPLETED|Period 2: 6 Weeks||16
2502617|NCT00800540|6133042|P2|STARTED|Period 2: 6 Weeks||17
2502618|NCT00800540|6133043|P1|STARTED|Period 2: 6 Weeks||16
2502619|NCT00800540|6133042|P2|NOT COMPLETED|Washout: 4 Weeks||0
2502620|NCT00800540|6133043|P1|NOT COMPLETED|Washout: 4 Weeks||0
2502621|NCT00800540|6133042|P2|COMPLETED|Washout: 4 Weeks||17
2502622|NCT00800540|6133043|P1|COMPLETED|Washout: 4 Weeks||16
2502623|NCT00800540|6133042|P2|STARTED|Washout: 4 Weeks||17
2502624|NCT00800540|6133043|P1|STARTED|Washout: 4 Weeks||16
2502625|NCT00800540|6133042|P2|NOT COMPLETED|Period One: 6 Weeks||1
2502626|NCT00800540|6133043|P1|NOT COMPLETED|Period One: 6 Weeks||1
2502627|NCT00800540|6133042|P2|COMPLETED|Period One: 6 Weeks||17
2502628|NCT00800540|6133043|P1|COMPLETED|Period One: 6 Weeks||16
2502629|NCT00800540|6133042|P2|STARTED|Period One: 6 Weeks||18
2502630|NCT00800540|6133043|P1|STARTED|Period One: 6 Weeks||17
2502631|NCT00800436|6133078|P7|NOT COMPLETED|Overall Study||0
2502632|NCT00800436|6133079|P6|NOT COMPLETED|Overall Study||0
2502633|NCT00800436|6133080|P5|NOT COMPLETED|Overall Study||0
2502634|NCT00800436|6133081|P4|NOT COMPLETED|Overall Study||1
2502635|NCT00800436|6133082|P3|NOT COMPLETED|Overall Study||1
2502636|NCT00800436|6133083|P2|NOT COMPLETED|Overall Study||0
2502637|NCT00800436|6133084|P1|NOT COMPLETED|Overall Study||0
2502638|NCT00800436|6133078|P7|COMPLETED|Overall Study||20
2502639|NCT00800436|6133079|P6|COMPLETED|Overall Study||20
2502640|NCT00800436|6133080|P5|COMPLETED|Overall Study||6
2502641|NCT00800436|6133081|P4|COMPLETED|Overall Study||5
2502642|NCT00800436|6133082|P3|COMPLETED|Overall Study||5
2502643|NCT00800436|6133083|P2|COMPLETED|Overall Study||6
2502644|NCT00800436|6133084|P1|COMPLETED|Overall Study||6
2502645|NCT00800436|6133078|P7|STARTED|Overall Study||20
2502646|NCT00800436|6133079|P6|STARTED|Overall Study||20
2502647|NCT00800436|6133080|P5|STARTED|Overall Study||6
2502648|NCT00800436|6133081|P4|STARTED|Overall Study||6
2502649|NCT00800436|6133082|P3|STARTED|Overall Study||6
2502650|NCT00800436|6133083|P2|STARTED|Overall Study||6
2502651|NCT00800436|6133084|P1|STARTED|Overall Study||6
2502652|NCT00800384|6133130|P2|NOT COMPLETED|Overall Study||43
2502653|NCT00800384|6133131|P1|NOT COMPLETED|Overall Study||41
2502654|NCT00800384|6133130|P2|COMPLETED|Overall Study||1210
2502655|NCT00800384|6133131|P1|COMPLETED|Overall Study||1206
2502656|NCT00800384|6133130|P2|STARTED|Overall Study||1253
2502657|NCT00800384|6133131|P1|STARTED|Overall Study||1247
2502658|NCT00800345|6133139|P1|NOT COMPLETED|Overall Study||0
2502659|NCT00800345|6133139|P1|COMPLETED|Overall Study||33
2502660|NCT00800345|6133139|P1|STARTED|Overall Study||33
2502661|NCT00800254|6133146|P2|NOT COMPLETED|Overall Study||6
2502662|NCT00800254|6133147|P1|NOT COMPLETED|Overall Study||5
2502663|NCT00800254|6133146|P2|COMPLETED|Overall Study||25
2502664|NCT00800254|6133147|P1|COMPLETED|Overall Study||30
2502665|NCT00800254|6133146|P2|3.5 Weeks Post-operatively|Overall Study||31
2502666|NCT00800254|6133147|P1|3.5 Weeks Post-operatively|Overall Study||31
2502667|NCT00800254|6133146|P2|STARTED|Overall Study||31
2502668|NCT00800254|6133147|P1|STARTED|Overall Study||35
2502669|NCT00800202|6133169|P2|NOT COMPLETED|Overall Study||24
2502670|NCT00800202|6133170|P1|NOT COMPLETED|Overall Study||67
2502671|NCT00800202|6133169|P2|COMPLETED|Overall Study||0
2502672|NCT00800202|6133170|P1|COMPLETED|Overall Study||0
2502673|NCT00800202|6133169|P2|STARTED|Overall Study||24
2502674|NCT00800202|6133170|P1|STARTED|Overall Study||67
2502675|NCT00799903|6133190|P2|NOT COMPLETED|Overall Study||278
2502676|NCT00799903|6133191|P1|NOT COMPLETED|Overall Study||273
2502677|NCT00799903|6133190|P2|COMPLETED|Overall Study||7646
2502678|NCT00799903|6133191|P1|COMPLETED|Overall Study||7631
2502679|NCT00799903|6133190|P2|STARTED|Overall Study||7924
2502680|NCT00799903|6133191|P1|STARTED|Overall Study||7904
2502681|NCT00799825|6133211|P1|NOT COMPLETED|Overall Study||48
2502682|NCT00799825|6133211|P1|COMPLETED|Overall Study||296
2502683|NCT00799825|6133211|P1|STARTED|Overall Study||344
2502684|NCT00799773|6133219|P2|NOT COMPLETED|Overall Study||0
2502685|NCT00799773|6133220|P1|NOT COMPLETED|Overall Study||0
2502686|NCT00799773|6133219|P2|COMPLETED|Overall Study||1
2502687|NCT00799773|6133220|P1|COMPLETED|Overall Study||2
2502688|NCT00799773|6133219|P2|STARTED|Overall Study||1
2502689|NCT00799773|6133220|P1|STARTED|Overall Study||2
2502690|NCT00799708|6133251|P3|NOT COMPLETED|Overall Study||0
2502691|NCT00799708|6133252|P2|NOT COMPLETED|Overall Study||0
2502692|NCT00799708|6133253|P1|NOT COMPLETED|Overall Study||1
2502693|NCT00799708|6133251|P3|COMPLETED|Overall Study||11
2502694|NCT00799708|6133252|P2|COMPLETED|Overall Study||6
2502695|NCT00799708|6133253|P1|COMPLETED|Overall Study||9
2502696|NCT00799708|6133251|P3|STARTED|Overall Study||11
2502697|NCT00799708|6133252|P2|STARTED|Overall Study||6
2502698|NCT00799708|6133253|P1|STARTED|Overall Study||10
2502699|NCT00799643|6133265|P2|NOT COMPLETED|Overall Study||27
2502700|NCT00799643|6133266|P1|NOT COMPLETED|Overall Study||25
2502701|NCT00799643|6133265|P2|COMPLETED|Overall Study||119
2502702|NCT00799643|6133266|P1|COMPLETED|Overall Study||115
2502703|NCT00799643|6133265|P2|STARTED|Overall Study||146
2502704|NCT00799643|6133266|P1|STARTED|Overall Study||140
2502705|NCT00799617|6133276|P2|NOT COMPLETED|Anemia Trial||3
2502706|NCT00799617|6133277|P1|NOT COMPLETED|Anemia Trial||3
2502707|NCT00799617|6133276|P2|COMPLETED|Anemia Trial||32
2502708|NCT00799617|6133277|P1|COMPLETED|Anemia Trial||24
2502709|NCT00799617|6133276|P2|STARTED|Anemia Trial||35
2502710|NCT00799617|6133277|P1|STARTED|Anemia Trial||27
2502711|NCT00799617|6133276|P2|NOT COMPLETED|Cognitive Function Trial||1
2502712|NCT00799617|6133277|P1|NOT COMPLETED|Cognitive Function Trial||0
2502713|NCT00799617|6133276|P2|COMPLETED|Cognitive Function Trial||245
2502714|NCT00799617|6133277|P1|COMPLETED|Cognitive Function Trial||247
2502715|NCT00799617|6133276|P2|STARTED|Cognitive Function Trial||246
2502716|NCT00799617|6133277|P1|STARTED|Cognitive Function Trial||247
2502717|NCT00799617|6133276|P2|NOT COMPLETED|Bone Trial||16
2502718|NCT00799617|6133277|P1|NOT COMPLETED|Bone Trial||6
2502719|NCT00799617|6133276|P2|COMPLETED|Bone Trial||85
2502720|NCT00799617|6133277|P1|COMPLETED|Bone Trial||104
2502721|NCT00799617|6133276|P2|STARTED|Bone Trial||101
2502722|NCT00799617|6133277|P1|STARTED|Bone Trial||110
2502723|NCT00799617|6133276|P2|NOT COMPLETED|Cardiovascular Trial||17
2502724|NCT00799617|6133277|P1|NOT COMPLETED|Cardiovascular Trial||15
2502725|NCT00799617|6133276|P2|COMPLETED|Cardiovascular Trial||65
2502726|NCT00799617|6133277|P1|COMPLETED|Cardiovascular Trial||73
2502727|NCT00799617|6133276|P2|STARTED|Cardiovascular Trial||82
2502728|NCT00799617|6133277|P1|STARTED|Cardiovascular Trial||88
2502729|NCT00799617|6133276|P2|NOT COMPLETED|Vitality Trial||22
2502730|NCT00799617|6133277|P1|NOT COMPLETED|Vitality Trial||7
2502731|NCT00799617|6133276|P2|COMPLETED|Vitality Trial||216
2502732|NCT00799617|6133277|P1|COMPLETED|Vitality Trial||229
2502733|NCT00799617|6133276|P2|STARTED|Vitality Trial||238
2502734|NCT00799617|6133277|P1|STARTED|Vitality Trial||236
2502735|NCT00799617|6133276|P2|NOT COMPLETED|Physical Function Trial||11
2502736|NCT00799617|6133277|P1|NOT COMPLETED|Physical Function Trial||6
2502737|NCT00799617|6133276|P2|COMPLETED|Physical Function Trial||185
2502738|NCT00799617|6133277|P1|COMPLETED|Physical Function Trial||185
2502739|NCT00799617|6133276|P2|STARTED|Physical Function Trial||196
2502740|NCT00799617|6133277|P1|STARTED|Physical Function Trial||191
2502741|NCT00799617|6133276|P2|NOT COMPLETED|Sexual Funtion Trial||21
2502742|NCT00799617|6133277|P1|NOT COMPLETED|Sexual Funtion Trial||16
2502743|NCT00799617|6133276|P2|COMPLETED|Sexual Funtion Trial||215
2502744|NCT00799617|6133277|P1|COMPLETED|Sexual Funtion Trial||218
2502745|NCT00799617|6133276|P2|STARTED|Sexual Funtion Trial||236
2502746|NCT00799617|6133277|P1|STARTED|Sexual Funtion Trial||234
2502747|NCT00799617|6133276|P2|NOT COMPLETED|Main Testosterone Trial||21
2502748|NCT00799617|6133277|P1|NOT COMPLETED|Main Testosterone Trial||19
2502749|NCT00799617|6133276|P2|COMPLETED|Main Testosterone Trial||374
2502750|NCT00799617|6133277|P1|COMPLETED|Main Testosterone Trial|Participants qualified for 1 of the 3 main trials (sexual function, physical function, vitality).|376
2502751|NCT00799617|6133276|P2|STARTED|Main Testosterone Trial||395
2502752|NCT00799617|6133277|P1|STARTED|Main Testosterone Trial||395
2502753|NCT00799604|6133358|P3|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
2502754|NCT00799604|6133359|P2|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
2502755|NCT00799604|6133360|P1|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
2502756|NCT00799604|6133358|P3|COMPLETED|Bolus 2 (With Anesthesia)||3
2502757|NCT00799604|6133359|P2|COMPLETED|Bolus 2 (With Anesthesia)||12
2502758|NCT00799604|6133360|P1|COMPLETED|Bolus 2 (With Anesthesia)||6
2502759|NCT00799604|6133358|P3|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|3
2502760|NCT00799604|6133359|P2|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|12
2502761|NCT00799604|6133360|P1|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|6
2502762|NCT00799604|6133358|P3|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
2502763|NCT00799604|6133359|P2|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
2502764|NCT00799604|6133360|P1|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
2502765|NCT00799604|6133358|P3|COMPLETED|Bolus 1 (Pre-anesthesia)||10
2502766|NCT00799604|6133359|P2|COMPLETED|Bolus 1 (Pre-anesthesia)||10
2502767|NCT00799604|6133360|P1|COMPLETED|Bolus 1 (Pre-anesthesia)||10
2502768|NCT00799604|6133358|P3|STARTED|Bolus 1 (Pre-anesthesia)||10
2502769|NCT00799604|6133359|P2|STARTED|Bolus 1 (Pre-anesthesia)||10
2502770|NCT00799604|6133360|P1|STARTED|Bolus 1 (Pre-anesthesia)||10
2502771|NCT00799591|6133384|P1|NOT COMPLETED|Overall Study||66
2502772|NCT00799591|6133384|P1|COMPLETED|Overall Study||90
2502773|NCT00799591|6133384|P1|STARTED|Overall Study||156
2502774|NCT00799578|6133395|P1|NOT COMPLETED|Overall Study||2
2502775|NCT00799578|6133395|P1|COMPLETED|Overall Study||11
2502776|NCT00799578|6133395|P1|STARTED|Overall Study||13
2502777|NCT00799487|6133402|P3|NOT COMPLETED|Double-Blind Assessment Period||2
2502778|NCT00799487|6133403|P2|NOT COMPLETED|Double-Blind Assessment Period||1
2502779|NCT00799487|6133404|P1|NOT COMPLETED|Double-Blind Assessment Period||0
2502780|NCT00799487|6133402|P3|COMPLETED|Double-Blind Assessment Period||32
2502781|NCT00799487|6133403|P2|COMPLETED|Double-Blind Assessment Period||33
2502782|NCT00799487|6133404|P1|COMPLETED|Double-Blind Assessment Period||0
2502783|NCT00799487|6133402|P3|STARTED|Double-Blind Assessment Period||34
2502784|NCT00799487|6133403|P2|STARTED|Double-Blind Assessment Period||34
2502785|NCT00799487|6133404|P1|STARTED|Double-Blind Assessment Period||0
2502786|NCT00799487|6133402|P3|NOT COMPLETED|Dose Adjustment Period||0
2502787|NCT00799487|6133403|P2|NOT COMPLETED|Dose Adjustment Period||0
2502788|NCT00799487|6133404|P1|NOT COMPLETED|Dose Adjustment Period||21
2502789|NCT00799487|6133402|P3|COMPLETED|Dose Adjustment Period||34
2502790|NCT00799487|6133403|P2|COMPLETED|Dose Adjustment Period||34
2502791|NCT00799487|6133404|P1|COMPLETED|Dose Adjustment Period||0
2502792|NCT00799487|6133402|P3|STARTED|Dose Adjustment Period||34
2502793|NCT00799487|6133403|P2|STARTED|Dose Adjustment Period||34
2502794|NCT00799487|6133404|P1|STARTED|Dose Adjustment Period||21
2502795|NCT00799474|6133484|P1|NOT COMPLETED|Overall Study||0
2502796|NCT00799474|6133484|P1|COMPLETED|Overall Study||609
2502797|NCT00799474|6133484|P1|STARTED|Overall Study||609
2502798|NCT00799435|6133492|P2|NOT COMPLETED|Overall Study||0
2502799|NCT00799435|6133493|P1|NOT COMPLETED|Overall Study||0
2502800|NCT00799435|6133492|P2|COMPLETED|Overall Study||1
2502801|NCT00799435|6133493|P1|COMPLETED|Overall Study||1
2502802|NCT00799435|6133492|P2|STARTED|Overall Study||1
2502803|NCT00799435|6133493|P1|STARTED|Overall Study||1
2502804|NCT00799422|6133499|P6|NOT COMPLETED|Third Week of Wear||0
2502805|NCT00799422|6133500|P5|NOT COMPLETED|Third Week of Wear||0
2502806|NCT00799422|6133501|P4|NOT COMPLETED|Third Week of Wear||0
2502807|NCT00799422|6133502|P3|NOT COMPLETED|Third Week of Wear||0
2502808|NCT00799422|6133503|P2|NOT COMPLETED|Third Week of Wear||0
2502809|NCT00799422|6133504|P1|NOT COMPLETED|Third Week of Wear||0
2502810|NCT00799422|6133499|P6|COMPLETED|Third Week of Wear||4
2502811|NCT00799422|6133500|P5|COMPLETED|Third Week of Wear||4
2502812|NCT00799422|6133501|P4|COMPLETED|Third Week of Wear||3
2502813|NCT00799422|6133502|P3|COMPLETED|Third Week of Wear||3
2502814|NCT00799422|6133503|P2|COMPLETED|Third Week of Wear||4
2502815|NCT00799422|6133504|P1|COMPLETED|Third Week of Wear||4
2502816|NCT00799422|6133499|P6|STARTED|Third Week of Wear||4
2502817|NCT00799422|6133500|P5|STARTED|Third Week of Wear||4
2502818|NCT00799422|6133501|P4|STARTED|Third Week of Wear||3
2502819|NCT00799422|6133502|P3|STARTED|Third Week of Wear||3
2502820|NCT00799422|6133503|P2|STARTED|Third Week of Wear||4
2502821|NCT00799422|6133504|P1|STARTED|Third Week of Wear||4
2502822|NCT00799422|6133499|P6|NOT COMPLETED|Second Week of Wear||0
2502823|NCT00799422|6133500|P5|NOT COMPLETED|Second Week of Wear||0
2502824|NCT00799422|6133501|P4|NOT COMPLETED|Second Week of Wear||0
2502825|NCT00799422|6133502|P3|NOT COMPLETED|Second Week of Wear||0
2502826|NCT00799422|6133503|P2|NOT COMPLETED|Second Week of Wear||0
2502827|NCT00799422|6133504|P1|NOT COMPLETED|Second Week of Wear||0
2502828|NCT00799422|6133499|P6|COMPLETED|Second Week of Wear||4
2502829|NCT00799422|6133500|P5|COMPLETED|Second Week of Wear||4
2502830|NCT00799422|6133501|P4|COMPLETED|Second Week of Wear||3
2502831|NCT00799422|6133502|P3|COMPLETED|Second Week of Wear||3
2502832|NCT00799422|6133503|P2|COMPLETED|Second Week of Wear||4
2502833|NCT00799422|6133504|P1|COMPLETED|Second Week of Wear||4
2502834|NCT00799422|6133499|P6|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|4
2502835|NCT00799422|6133500|P5|STARTED|Second Week of Wear||4
2502836|NCT00799422|6133501|P4|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|3
2502837|NCT00799422|6133502|P3|STARTED|Second Week of Wear||3
2502838|NCT00799422|6133503|P2|STARTED|Second Week of Wear||4
2502839|NCT00799422|6133504|P1|STARTED|Second Week of Wear||4
2502840|NCT00799422|6133499|P6|NOT COMPLETED|First Week of Wear||0
2502841|NCT00799422|6133500|P5|NOT COMPLETED|First Week of Wear||0
2502842|NCT00799422|6133501|P4|NOT COMPLETED|First Week of Wear||1
2502843|NCT00799422|6133502|P3|NOT COMPLETED|First Week of Wear||1
2502844|NCT00799422|6133503|P2|NOT COMPLETED|First Week of Wear||0
2502845|NCT00799422|6133504|P1|NOT COMPLETED|First Week of Wear||0
2502846|NCT00799422|6133499|P6|COMPLETED|First Week of Wear||5
2502847|NCT00799422|6133500|P5|COMPLETED|First Week of Wear||4
2502848|NCT00799422|6133501|P4|COMPLETED|First Week of Wear||4
2502849|NCT00799422|6133502|P3|COMPLETED|First Week of Wear||3
2502850|NCT00799422|6133503|P2|COMPLETED|First Week of Wear||4
2502851|NCT00799422|6133504|P1|COMPLETED|First Week of Wear||4
2502852|NCT00799422|6133499|P6|STARTED|First Week of Wear||5
2502853|NCT00799422|6133500|P5|STARTED|First Week of Wear||4
2502854|NCT00799422|6133501|P4|STARTED|First Week of Wear||5
2502855|NCT00799422|6133502|P3|STARTED|First Week of Wear||4
2502856|NCT00799422|6133503|P2|STARTED|First Week of Wear||4
2502857|NCT00799422|6133504|P1|STARTED|First Week of Wear||4
2502858|NCT00799409|6133521|P3|NOT COMPLETED|Overall Study||0
2502859|NCT00799409|6133522|P2|NOT COMPLETED|Overall Study||0
2502860|NCT00799409|6133523|P1|NOT COMPLETED|Overall Study||7
2502861|NCT00799409|6133521|P3|COMPLETED|Overall Study||35
2502862|NCT00799409|6133522|P2|COMPLETED|Overall Study||36
2502863|NCT00799409|6133523|P1|COMPLETED|Overall Study||0
2502864|NCT00799409|6133521|P3|STARTED|Overall Study||35
2502865|NCT00799409|6133522|P2|STARTED|Overall Study||36
2502866|NCT00799409|6133523|P1|STARTED|Overall Study||7
2502867|NCT00799396|6133603|P1|NOT COMPLETED|Clopidogrel Plus Aspirin||6
2502868|NCT00799396|6133603|P1|COMPLETED|Clopidogrel Plus Aspirin||663
2502869|NCT00799396|6133603|P1|STARTED|Clopidogrel Plus Aspirin||669
2502870|NCT00799396|6133603|P1|NOT COMPLETED|Clopidogrel Treatment||13
2502871|NCT00799396|6133603|P1|COMPLETED|Clopidogrel Treatment||669
2502872|NCT00799396|6133603|P1|STARTED|Clopidogrel Treatment||682
2502873|NCT00799383|6133610|P2|NOT COMPLETED|Overall Study||6
2502874|NCT00799383|6133611|P1|NOT COMPLETED|Overall Study||3
2502875|NCT00799383|6133610|P2|COMPLETED|Overall Study||18
2502876|NCT00799383|6133611|P1|COMPLETED|Overall Study||20
2502877|NCT00799383|6133610|P2|STARTED|Overall Study||24
2502878|NCT00799383|6133611|P1|STARTED|Overall Study||23
2502879|NCT00799292|6133633|P2|NOT COMPLETED|Overall Study||0
2502880|NCT00799292|6133634|P1|NOT COMPLETED|Overall Study||0
2502881|NCT00799292|6133633|P2|COMPLETED|Overall Study||29
2502882|NCT00799292|6133634|P1|COMPLETED|Overall Study||29
2502883|NCT00799292|6133633|P2|STARTED|Overall Study||29
2502884|NCT00799292|6133634|P1|STARTED|Overall Study||29
2502885|NCT00799266|6133640|P2|NOT COMPLETED|Overall Study||1
2502886|NCT00799266|6133641|P1|NOT COMPLETED|Overall Study||3
2502887|NCT00799266|6133640|P2|COMPLETED|Overall Study||15
2502888|NCT00799266|6133641|P1|COMPLETED|Overall Study||15
2502889|NCT00799266|6133640|P2|Safety Set|Overall Study||16
2502890|NCT00799266|6133641|P1|Safety Set|Overall Study||18
2502891|NCT00799266|6133640|P2|Modified Intention-to-treat (MITT)|Overall Study||16
2502892|NCT00799266|6133641|P1|Modified Intention-to-treat (MITT)|Overall Study||17
2502893|NCT00799266|6133640|P2|STARTED|Overall Study||16
2502894|NCT00799266|6133641|P1|STARTED|Overall Study||18
2502895|NCT00799227|6133672|P1|NOT COMPLETED|Overall Study||3
2502896|NCT00799227|6133672|P1|COMPLETED|Overall Study||53
2502897|NCT00799227|6133672|P1|STARTED|Overall Study||56
2502898|NCT00798967|6133681|P2|NOT COMPLETED|Overall Study||4
2502899|NCT00798967|6133682|P1|NOT COMPLETED|Overall Study||4
2502900|NCT00798967|6133681|P2|COMPLETED|Overall Study||39
2502901|NCT00798967|6133682|P1|COMPLETED|Overall Study||39
2502902|NCT00798967|6133681|P2|Discontinued During Dosing Period|Overall Study||4
2502903|NCT00798967|6133682|P1|Discontinued During Dosing Period|Overall Study||4
2502904|NCT00798967|6133681|P2|STARTED|Overall Study||43
2502905|NCT00798967|6133682|P1|STARTED|Overall Study||43
2502906|NCT00798889|6133690|P1|NOT COMPLETED|Overall Study||314
2502907|NCT00798889|6133690|P1|COMPLETED|Overall Study||0
2502908|NCT00798889|6133690|P1|Treated|Overall Study||311
2502909|NCT00798889|6133690|P1|STARTED|Overall Study||314
2502910|NCT00798759|6133696|P2|NOT COMPLETED|Overall Study||13
2502911|NCT00798759|6133697|P1|NOT COMPLETED|Overall Study||8
2502912|NCT00798759|6133696|P2|COMPLETED|Overall Study||106
2502913|NCT00798759|6133697|P1|COMPLETED|Overall Study||109
2502914|NCT00798759|6133696|P2|STARTED|Overall Study||119
2502915|NCT00798759|6133697|P1|STARTED|Overall Study||117
2502916|NCT00798720|6133705|P1|NOT COMPLETED|Overall Study||0
2502917|NCT00798720|6133705|P1|COMPLETED|Overall Study||18
2502918|NCT00798720|6133705|P1|STARTED|Overall Study||18
2502919|NCT00798707|6133715|P3|NOT COMPLETED|Overall Study||22
2502920|NCT00798707|6133716|P2|NOT COMPLETED|Overall Study||33
2502921|NCT00798707|6133717|P1|NOT COMPLETED|Overall Study||26
2502922|NCT00798707|6133715|P3|COMPLETED|Overall Study||215
2502923|NCT00798707|6133716|P2|COMPLETED|Overall Study||204
2502924|NCT00798707|6133717|P1|COMPLETED|Overall Study||209
2502925|NCT00798707|6133715|P3|Treated|Overall Study||236
2502926|NCT00798707|6133716|P2|Treated|Overall Study||232
2502927|NCT00798707|6133717|P1|Treated|Overall Study||231
2502928|NCT00798707|6133715|P3|STARTED|Overall Study||237
2502929|NCT00798707|6133716|P2|STARTED|Overall Study||237
2502930|NCT00798707|6133717|P1|STARTED|Overall Study||235
2502931|NCT00798694|6133769|P2|NOT COMPLETED|Overall Study||1
2502932|NCT00798694|6133770|P1|NOT COMPLETED|Overall Study||2
2502933|NCT00798694|6133769|P2|COMPLETED|Overall Study||27
2502934|NCT00798694|6133770|P1|COMPLETED|Overall Study||28
2502935|NCT00798694|6133769|P2|STARTED|Overall Study||28
2502936|NCT00798694|6133770|P1|STARTED|Overall Study||30
2502937|NCT00798655|6133794|P1|NOT COMPLETED|Overall Study||2
2502938|NCT00798655|6133794|P1|COMPLETED|Overall Study||44
2502939|NCT00798655|6133794|P1|STARTED|Overall Study||46
2502940|NCT00798603|6133799|P1|NOT COMPLETED|Overall Study||35
2502941|NCT00798603|6133799|P1|COMPLETED|Overall Study||27
2502942|NCT00798603|6133799|P1|STARTED|Overall Study||62
2502943|NCT00798590|6133821|P2|NOT COMPLETED|Overall Study||8
2502944|NCT00798590|6133822|P1|NOT COMPLETED|Overall Study||11
2502945|NCT00798590|6133821|P2|COMPLETED|Overall Study||0
2502946|NCT00798590|6133822|P1|COMPLETED|Overall Study||0
2502947|NCT00798590|6133821|P2|STARTED|Overall Study||8
2502948|NCT00798590|6133822|P1|STARTED|Overall Study||11
2502949|NCT00798577|6133832|P2|NOT COMPLETED|Overall Study||0
2502950|NCT00798577|6133833|P1|NOT COMPLETED|Overall Study||0
2502951|NCT00798577|6133832|P2|COMPLETED|Overall Study||7
2502952|NCT00798577|6133833|P1|COMPLETED|Overall Study||17
2502953|NCT00798577|6133832|P2|STARTED|Overall Study||7
2502954|NCT00798577|6133833|P1|STARTED|Overall Study||17
2502955|NCT00798486|6133847|P1|NOT COMPLETED|Overall Study||0
2502956|NCT00798486|6133847|P1|COMPLETED|Overall Study||110
2502957|NCT00798486|6133847|P1|STARTED|Overall Study||110
2502958|NCT00798434|6133856|P2|NOT COMPLETED|Open-Label||32
2502959|NCT00798434|6133857|P1|NOT COMPLETED|Open-Label||42
2502960|NCT00798434|6133856|P2|COMPLETED|Open-Label||282
2502961|NCT00798434|6133857|P1|COMPLETED|Open-Label||299
2502962|NCT00798434|6133856|P2|Received Treatment|Open-Label||313
2502963|NCT00798434|6133857|P1|Received Treatment|Open-Label||341
2502964|NCT00798434|6133856|P2|STARTED|Open-Label||314
2502965|NCT00798434|6133857|P1|STARTED|Open-Label||341
2502966|NCT00798434|6133856|P2|NOT COMPLETED|Double-Blind||84
2502967|NCT00798434|6133857|P1|NOT COMPLETED|Double-Blind||55
2502968|NCT00798434|6133856|P2|COMPLETED|Double-Blind||314
2502969|NCT00798434|6133857|P1|COMPLETED|Double-Blind||341
2502970|NCT00798434|6133856|P2|Received Treatment|Double-Blind||392
2502971|NCT00798434|6133857|P1|Received Treatment|Double-Blind||393
2502972|NCT00798434|6133856|P2|STARTED|Double-Blind||398
2502973|NCT00798434|6133857|P1|STARTED|Double-Blind||396
2502974|NCT00798369|6133943|P6|NOT COMPLETED|Overall Study||3
2502975|NCT00798369|6133944|P5|NOT COMPLETED|Overall Study||1
2502976|NCT00798369|6133945|P4|NOT COMPLETED|Overall Study||1
2502977|NCT00798369|6133946|P3|NOT COMPLETED|Overall Study||2
2502978|NCT00798369|6133947|P2|NOT COMPLETED|Overall Study||1
2502979|NCT00798369|6133948|P1|NOT COMPLETED|Overall Study||1
2502980|NCT00798369|6133943|P6|COMPLETED|Overall Study||54
2502981|NCT00798369|6133944|P5|COMPLETED|Overall Study||27
2502982|NCT00798369|6133945|P4|COMPLETED|Overall Study||28
2502983|NCT00798369|6133946|P3|COMPLETED|Overall Study||27
2502984|NCT00798369|6133947|P2|COMPLETED|Overall Study||28
2502985|NCT00798369|6133948|P1|COMPLETED|Overall Study||27
2502986|NCT00798369|6133943|P6|STARTED|Overall Study||57
2502987|NCT00798369|6133944|P5|STARTED|Overall Study||28
2502988|NCT00798369|6133945|P4|STARTED|Overall Study||29
2502989|NCT00798369|6133946|P3|STARTED|Overall Study||29
2502990|NCT00798369|6133947|P2|STARTED|Overall Study||29
2502991|NCT00798369|6133948|P1|STARTED|Overall Study||28
2502992|NCT00798317|6133995|P2|NOT COMPLETED|Overall Study||7
2502993|NCT00798317|6133996|P1|NOT COMPLETED|Overall Study||10
2502994|NCT00798317|6133995|P2|COMPLETED|Overall Study||74
2502995|NCT00798317|6133996|P1|COMPLETED|Overall Study||235
2502996|NCT00798317|6133995|P2|STARTED|Overall Study||81
2502997|NCT00798317|6133996|P1|STARTED|Overall Study||245
2502998|NCT00798304|6134007|P3|NOT COMPLETED|Overall Study||10
2502999|NCT00798304|6134008|P2|NOT COMPLETED|Overall Study||22
2503000|NCT00798304|6134009|P1|NOT COMPLETED|Overall Study||14
2503001|NCT00798304|6134007|P3|COMPLETED|Overall Study||0
2503002|NCT00798304|6134008|P2|COMPLETED|Overall Study||0
2503003|NCT00798304|6134009|P1|COMPLETED|Overall Study||0
2503004|NCT00798304|6134007|P3|STARTED|Overall Study||10
2503005|NCT00798304|6134008|P2|STARTED|Overall Study||22
2503006|NCT00798304|6134009|P1|STARTED|Overall Study||14
2503007|NCT00798174|6134035|P2|NOT COMPLETED|Overall Study||3
2503008|NCT00798174|6134036|P1|NOT COMPLETED|Overall Study||4
2503009|NCT00798174|6134035|P2|COMPLETED|Overall Study||13
2503010|NCT00798174|6134036|P1|COMPLETED|Overall Study||12
2503011|NCT00798174|6134035|P2|STARTED|Overall Study||16
2503012|NCT00798174|6134036|P1|STARTED|Overall Study||16
2503013|NCT00798161|6134047|P7|NOT COMPLETED|Overall Study||10
2503014|NCT00798161|6134048|P6|NOT COMPLETED|Overall Study||11
2503015|NCT00798161|6134049|P5|NOT COMPLETED|Overall Study||16
2503016|NCT00798161|6134050|P4|NOT COMPLETED|Overall Study||21
2503017|NCT00798161|6134051|P3|NOT COMPLETED|Overall Study||21
2503018|NCT00798161|6134052|P2|NOT COMPLETED|Overall Study||17
2503019|NCT00798161|6134053|P1|NOT COMPLETED|Overall Study||18
2503020|NCT00798161|6134047|P7|COMPLETED|Overall Study||56
2503021|NCT00798161|6134048|P6|COMPLETED|Overall Study||132
2503022|NCT00798161|6134049|P5|COMPLETED|Overall Study||127
2503023|NCT00798161|6134050|P4|COMPLETED|Overall Study||121
2503024|NCT00798161|6134051|P3|COMPLETED|Overall Study||126
2503025|NCT00798161|6134052|P2|COMPLETED|Overall Study||127
2503026|NCT00798161|6134053|P1|COMPLETED|Overall Study||54
2503027|NCT00798161|6134047|P7|STARTED|Overall Study||66
2503028|NCT00798161|6134048|P6|STARTED|Overall Study||143
2503029|NCT00798161|6134049|P5|STARTED|Overall Study||143
2503030|NCT00798161|6134050|P4|STARTED|Overall Study||142
2503031|NCT00798161|6134051|P3|STARTED|Overall Study||147
2503032|NCT00798161|6134052|P2|STARTED|Overall Study||144
2503033|NCT00798161|6134053|P1|STARTED|Overall Study||72
2503034|NCT00798135|6134160|P1|NOT COMPLETED|Overall Study||13
2503035|NCT00798135|6134160|P1|COMPLETED|Overall Study||0
2503036|NCT00798135|6134160|P1|STARTED|Overall Study||13
2503037|NCT00798096|6134166|P1|NOT COMPLETED|Overall Study||2
2503038|NCT00798096|6134166|P1|COMPLETED|Overall Study|Completion of Study is defined as a minimum of 8 weeks of treatment or early disease progression|16
2503039|NCT00798096|6134166|P1|STARTED|Overall Study|Treatment with 200 mg bid, oral Fostamatanib until disease progression, toxicity or withdrawal|18
2503040|NCT00798018|6134177|P4|NOT COMPLETED|Overall Study||0
2503041|NCT00798018|6134178|P3|NOT COMPLETED|Overall Study||0
2503042|NCT00798018|6134179|P2|NOT COMPLETED|Overall Study||0
2503043|NCT00798018|6134180|P1|NOT COMPLETED|Overall Study||0
2503044|NCT00798018|6134177|P4|COMPLETED|Overall Study||25
2503045|NCT00798018|6134178|P3|COMPLETED|Overall Study||25
2503046|NCT00798018|6134179|P2|COMPLETED|Overall Study||25
2503047|NCT00798018|6134180|P1|COMPLETED|Overall Study||25
2503048|NCT00798018|6134177|P4|STARTED|Overall Study||25
2503049|NCT00798018|6134178|P3|STARTED|Overall Study||25
2503050|NCT00798018|6134179|P2|STARTED|Overall Study||25
2503051|NCT00798018|6134180|P1|STARTED|Overall Study||25
2503052|NCT00797966|6134194|P6|NOT COMPLETED|Phase A+||28
2503053|NCT00797966|6134195|P5|NOT COMPLETED|Phase A+||0
2503054|NCT00797966|6134196|P4|NOT COMPLETED|Phase A+||0
2503055|NCT00797966|6134197|P3|NOT COMPLETED|Phase A+||0
2503056|NCT00797966|6134198|P2|NOT COMPLETED|Phase A+||0
2503057|NCT00797966|6134199|P1|NOT COMPLETED|Phase A+||0
2503058|NCT00797966|6134194|P6|COMPLETED|Phase A+||207
2503059|NCT00797966|6134195|P5|COMPLETED|Phase A+||0
2503060|NCT00797966|6134196|P4|COMPLETED|Phase A+||0
2503061|NCT00797966|6134197|P3|COMPLETED|Phase A+||0
2503062|NCT00797966|6134198|P2|COMPLETED|Phase A+||0
2503063|NCT00797966|6134199|P1|COMPLETED|Phase A+||0
2503064|NCT00797966|6134194|P6|STARTED|Phase A+||235
2503065|NCT00797966|6134195|P5|STARTED|Phase A+||0
2503066|NCT00797966|6134196|P4|STARTED|Phase A+||0
2503067|NCT00797966|6134197|P3|STARTED|Phase A+||0
2503068|NCT00797966|6134198|P2|STARTED|Phase A+||0
2503069|NCT00797966|6134199|P1|STARTED|Phase A+||0
2503070|NCT00797966|6134194|P6|NOT COMPLETED|Phase B||0
2503071|NCT00797966|6134195|P5|NOT COMPLETED|Phase B||0
2503072|NCT00797966|6134196|P4|NOT COMPLETED|Phase B||16
2503073|NCT00797966|6134197|P3|NOT COMPLETED|Phase B||21
2503074|NCT00797966|6134198|P2|NOT COMPLETED|Phase B||18
2503075|NCT00797966|6134199|P1|NOT COMPLETED|Phase B||11
2503076|NCT00797966|6134194|P6|COMPLETED|Phase B||0
2503077|NCT00797966|6134195|P5|COMPLETED|Phase B||0
2503078|NCT00797966|6134196|P4|COMPLETED|Phase B||110
2503079|NCT00797966|6134197|P3|COMPLETED|Phase B||100
2503080|NCT00797966|6134198|P2|COMPLETED|Phase B||102
2503081|NCT00797966|6134199|P1|COMPLETED|Phase B||51
2503082|NCT00797966|6134194|P6|STARTED|Phase B||0
2503083|NCT00797966|6134195|P5|STARTED|Phase B||0
2503084|NCT00797966|6134196|P4|STARTED|Phase B|Randomized participants.|126
2503085|NCT00797966|6134197|P3|STARTED|Phase B|Randomized participants.|121
2503086|NCT00797966|6134198|P2|STARTED|Phase B|Randomized participants.|120
2503087|NCT00797966|6134199|P1|STARTED|Phase B|Randomized participants.|62
2503088|NCT00797966|6134194|P6|NOT COMPLETED|Phase A||0
2503089|NCT00797966|6134195|P5|NOT COMPLETED|Phase A||185
2503090|NCT00797966|6134196|P4|NOT COMPLETED|Phase A||0
2503091|NCT00797966|6134197|P3|NOT COMPLETED|Phase A||0
2503092|NCT00797966|6134198|P2|NOT COMPLETED|Phase A||0
2503093|NCT00797966|6134199|P1|NOT COMPLETED|Phase A||0
2503094|NCT00797966|6134194|P6|COMPLETED|Phase A||0
2503095|NCT00797966|6134195|P5|COMPLETED|Phase A||664
2503096|NCT00797966|6134196|P4|COMPLETED|Phase A||0
2503097|NCT00797966|6134197|P3|COMPLETED|Phase A||0
2503098|NCT00797966|6134198|P2|COMPLETED|Phase A||0
2503099|NCT00797966|6134199|P1|COMPLETED|Phase A||0
2503100|NCT00797966|6134194|P6|STARTED|Phase A||0
2503101|NCT00797966|6134195|P5|STARTED|Phase A|850 participants entered Phase A; 849 participants were treated.|849
2503102|NCT00797966|6134196|P4|STARTED|Phase A||0
2503103|NCT00797966|6134197|P3|STARTED|Phase A||0
2503104|NCT00797966|6134198|P2|STARTED|Phase A||0
2503105|NCT00797966|6134199|P1|STARTED|Phase A||0
2503106|NCT00797862|6134264|P3|NOT COMPLETED|Overall Study||86
2503107|NCT00797862|6134265|P2|NOT COMPLETED|Overall Study||68
2503108|NCT00797862|6134266|P1|NOT COMPLETED|Overall Study||124
2503109|NCT00797862|6134264|P3|COMPLETED|Overall Study||230
2503110|NCT00797862|6134265|P2|COMPLETED|Overall Study||250
2503111|NCT00797862|6134266|P1|COMPLETED|Overall Study||496
2503112|NCT00797862|6134264|P3|Entered Double-Blind Treatment (FAS)|Overall Study||315
2503113|NCT00797862|6134265|P2|Entered Double-Blind Treatment (FAS)|Overall Study||315
2503114|NCT00797862|6134266|P1|Entered Double-Blind Treatment (FAS)|Overall Study||617
2503115|NCT00797862|6134264|P3|STARTED|Overall Study|1 participant was mis-randomized and discontinued. Only 315 participants received study drug.|316
2503116|NCT00797862|6134265|P2|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 315 participants received study drug.|318
2503117|NCT00797862|6134266|P1|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 617 participants received study drug.|620
2503118|NCT00797823|6134295|P3|NOT COMPLETED|Second Period (Crossover)||0
2503119|NCT00797823|6134296|P2|NOT COMPLETED|Second Period (Crossover)||0
2503120|NCT00797823|6134297|P1|NOT COMPLETED|Second Period (Crossover)||0
2503121|NCT00797823|6134295|P3|COMPLETED|Second Period (Crossover)||0
2503122|NCT00797823|6134296|P2|COMPLETED|Second Period (Crossover)||4
2503123|NCT00797823|6134297|P1|COMPLETED|Second Period (Crossover)||3
2503124|NCT00797823|6134295|P3|STARTED|Second Period (Crossover)||0
2503125|NCT00797823|6134296|P2|STARTED|Second Period (Crossover)||4
2503126|NCT00797823|6134297|P1|STARTED|Second Period (Crossover)||3
2503127|NCT00797823|6134295|P3|NOT COMPLETED|First Period (Initial Randomization)||0
2503128|NCT00797823|6134296|P2|NOT COMPLETED|First Period (Initial Randomization)||0
2503129|NCT00797823|6134297|P1|NOT COMPLETED|First Period (Initial Randomization)||1
2503130|NCT00797823|6134295|P3|COMPLETED|First Period (Initial Randomization)||0
2503131|NCT00797823|6134296|P2|COMPLETED|First Period (Initial Randomization)||4
2503132|NCT00797823|6134297|P1|COMPLETED|First Period (Initial Randomization)||3
2503133|NCT00797823|6134295|P3|STARTED|First Period (Initial Randomization)|Pilot studies only performed during initial period.|0
2503134|NCT00797823|6134296|P2|STARTED|First Period (Initial Randomization)||4
2503135|NCT00797823|6134297|P1|STARTED|First Period (Initial Randomization)||4
2503136|NCT00797823|6134295|P3|NOT COMPLETED|Pilot Studies||0
2503137|NCT00797823|6134296|P2|NOT COMPLETED|Pilot Studies||0
2503138|NCT00797823|6134297|P1|NOT COMPLETED|Pilot Studies||0
2503139|NCT00797823|6134295|P3|COMPLETED|Pilot Studies||6
2503140|NCT00797823|6134296|P2|COMPLETED|Pilot Studies||0
2503141|NCT00797823|6134297|P1|COMPLETED|Pilot Studies||0
2503142|NCT00797823|6134295|P3|STARTED|Pilot Studies||6
2503143|NCT00797823|6134296|P2|STARTED|Pilot Studies|Not involved in pilot studies|0
2503144|NCT00797823|6134297|P1|STARTED|Pilot Studies|Not involved in pilot studies|0
2503145|NCT00797797|6134308|P2|NOT COMPLETED|Overall Study||43
2503146|NCT00797797|6134309|P1|NOT COMPLETED|Overall Study||55
2503147|NCT00797797|6134308|P2|COMPLETED|Overall Study||141
2503148|NCT00797797|6134309|P1|COMPLETED|Overall Study||123
2503149|NCT00797797|6134308|P2|STARTED|Overall Study||184
2503150|NCT00797797|6134309|P1|STARTED|Overall Study|Two patients took no background stable dose of pregabalin after randomization and are not included.|178
2503151|NCT00797732|6134319|P3|NOT COMPLETED|Overall Study||154
2503152|NCT00797732|6134320|P2|NOT COMPLETED|Overall Study||3
2503153|NCT00797732|6134321|P1|NOT COMPLETED|Overall Study||5
2503154|NCT00797732|6134319|P3|COMPLETED|Overall Study||0
2503155|NCT00797732|6134320|P2|COMPLETED|Overall Study||18
2503156|NCT00797732|6134321|P1|COMPLETED|Overall Study||16
2503157|NCT00797732|6134319|P3|Evaluable at 12 Months|Overall Study||0
2503158|NCT00797732|6134320|P2|Evaluable at 12 Months|Overall Study||18
2503159|NCT00797732|6134321|P1|Evaluable at 12 Months|Overall Study||17
2503160|NCT00797732|6134319|P3|Evaluable at 20 Weeks|Overall Study||0
2503161|NCT00797732|6134320|P2|Evaluable at 20 Weeks|Overall Study||18
2503162|NCT00797732|6134321|P1|Evaluable at 20 Weeks|Overall Study||17
2503163|NCT00797732|6134319|P3|Evaluable at Baseline|Overall Study||0
2503164|NCT00797732|6134320|P2|Evaluable at Baseline|Overall Study||18
2503165|NCT00797732|6134321|P1|Evaluable at Baseline|Overall Study||18
2503166|NCT00797732|6134319|P3|STARTED|Overall Study||154
2503167|NCT00797732|6134320|P2|STARTED|Overall Study||21
2503168|NCT00797732|6134321|P1|STARTED|Overall Study||21
2503169|NCT00797667|6134336|P3|NOT COMPLETED|Overall Study||127
2503170|NCT00797667|6134337|P2|NOT COMPLETED|Overall Study||259
2503171|NCT00797667|6134338|P1|NOT COMPLETED|Overall Study||260
2503172|NCT00797667|6134336|P3|COMPLETED|Overall Study||4
2503173|NCT00797667|6134337|P2|COMPLETED|Overall Study||5
2503174|NCT00797667|6134338|P1|COMPLETED|Overall Study||5
2503175|NCT00797667|6134336|P3|Treated|Overall Study||130
2503176|NCT00797667|6134337|P2|Treated|Overall Study||263
2503177|NCT00797667|6134338|P1|Treated|Overall Study||263
2503178|NCT00797667|6134336|P3|STARTED|Overall Study||131
2503179|NCT00797667|6134337|P2|STARTED|Overall Study||264
2503180|NCT00797667|6134338|P1|STARTED|Overall Study||265
2503181|NCT00797563|6134364|P1|NOT COMPLETED|Overall Study||1
2503182|NCT00797563|6134364|P1|COMPLETED|Overall Study||101
2503183|NCT00797563|6134364|P1|STARTED|Overall Study|number of subjects|102
2503184|NCT00797511|6134370|P1|NOT COMPLETED|Overall Study||1
2503185|NCT00797511|6134370|P1|COMPLETED|Overall Study||131
2503186|NCT00797511|6134370|P1|STARTED|Overall Study||132
2503187|NCT00797459|6134378|P1|NOT COMPLETED|Overall Study||0
2503188|NCT00797459|6134378|P1|COMPLETED|Overall Study||60
2503189|NCT00797459|6134378|P1|STARTED|Overall Study||60
2503190|NCT00797316|6134388|P2|NOT COMPLETED|Overall Study||32
2503191|NCT00797316|6134389|P1|NOT COMPLETED|Overall Study||23
2503192|NCT00797316|6134388|P2|COMPLETED|Overall Study||233
2503193|NCT00797316|6134389|P1|COMPLETED|Overall Study||244
2503194|NCT00797316|6134388|P2|STARTED|Overall Study||265
2503195|NCT00797316|6134389|P1|STARTED|Overall Study||267
2503196|NCT00797277|6134405|P2|NOT COMPLETED|Overall Study||0
2503197|NCT00797277|6134406|P1|NOT COMPLETED|Overall Study||0
2503198|NCT00797277|6134405|P2|COMPLETED|Overall Study||30
2503199|NCT00797277|6134406|P1|COMPLETED|Overall Study||37
2503200|NCT00797277|6134405|P2|STARTED|Overall Study||30
2503201|NCT00797277|6134406|P1|STARTED|Overall Study||37
2503202|NCT00797225|6134418|P8|NOT COMPLETED|Weeks 13 to 24||0
2503203|NCT00797225|6134419|P7|NOT COMPLETED|Weeks 13 to 24||2
2503204|NCT00797225|6134420|P6|NOT COMPLETED|Weeks 13 to 24||0
2503205|NCT00797225|6134421|P5|NOT COMPLETED|Weeks 13 to 24||1
2503206|NCT00797225|6134422|P4|NOT COMPLETED|Weeks 13 to 24||0
2503207|NCT00797225|6134423|P3|NOT COMPLETED|Weeks 13 to 24||2
2503208|NCT00797225|6134424|P2|NOT COMPLETED|Weeks 13 to 24||4
2503209|NCT00797225|6134425|P1|NOT COMPLETED|Weeks 13 to 24||0
2503210|NCT00797225|6134418|P8|COMPLETED|Weeks 13 to 24||22
2503211|NCT00797225|6134419|P7|COMPLETED|Weeks 13 to 24||20
2503212|NCT00797225|6134420|P6|COMPLETED|Weeks 13 to 24||21
2503213|NCT00797225|6134421|P5|COMPLETED|Weeks 13 to 24||19
2503214|NCT00797225|6134422|P4|COMPLETED|Weeks 13 to 24||0
2503215|NCT00797225|6134423|P3|COMPLETED|Weeks 13 to 24||41
2503216|NCT00797225|6134424|P2|COMPLETED|Weeks 13 to 24||38
2503217|NCT00797225|6134425|P1|COMPLETED|Weeks 13 to 24||0
2503218|NCT00797225|6134418|P8|STARTED|Weeks 13 to 24||22
2503219|NCT00797225|6134419|P7|STARTED|Weeks 13 to 24||22
2503220|NCT00797225|6134420|P6|STARTED|Weeks 13 to 24||21
2503221|NCT00797225|6134421|P5|STARTED|Weeks 13 to 24||20
2503222|NCT00797225|6134422|P4|STARTED|Weeks 13 to 24||0
2503223|NCT00797225|6134423|P3|STARTED|Weeks 13 to 24||43
2503224|NCT00797225|6134424|P2|STARTED|Weeks 13 to 24||42
2503225|NCT00797225|6134425|P1|STARTED|Weeks 13 to 24||0
2503226|NCT00797225|6134418|P8|NOT COMPLETED|Weeks 1 to 12||0
2503227|NCT00797225|6134419|P7|NOT COMPLETED|Weeks 1 to 12||0
2503228|NCT00797225|6134420|P6|NOT COMPLETED|Weeks 1 to 12||0
2503229|NCT00797225|6134421|P5|NOT COMPLETED|Weeks 1 to 12||0
2503230|NCT00797225|6134422|P4|NOT COMPLETED|Weeks 1 to 12||0
2503231|NCT00797225|6134423|P3|NOT COMPLETED|Weeks 1 to 12||1
2503232|NCT00797225|6134424|P2|NOT COMPLETED|Weeks 1 to 12||1
2503233|NCT00797225|6134425|P1|NOT COMPLETED|Weeks 1 to 12||2
2503234|NCT00797225|6134418|P8|COMPLETED|Weeks 1 to 12||0
2503235|NCT00797225|6134419|P7|COMPLETED|Weeks 1 to 12||0
2503236|NCT00797225|6134420|P6|COMPLETED|Weeks 1 to 12||0
2503237|NCT00797225|6134421|P5|COMPLETED|Weeks 1 to 12||0
2503238|NCT00797225|6134422|P4|COMPLETED|Weeks 1 to 12||44
2503239|NCT00797225|6134423|P3|COMPLETED|Weeks 1 to 12||43
2503240|NCT00797225|6134424|P2|COMPLETED|Weeks 1 to 12||42
2503241|NCT00797225|6134425|P1|COMPLETED|Weeks 1 to 12||41
2503242|NCT00797225|6134418|P8|Received Study Drug|Weeks 1 to 12||0
2503243|NCT00797225|6134419|P7|Received Study Drug|Weeks 1 to 12||0
2503244|NCT00797225|6134420|P6|Received Study Drug|Weeks 1 to 12||0
2503245|NCT00797225|6134421|P5|Received Study Drug|Weeks 1 to 12||0
2503246|NCT00797225|6134422|P4|Received Study Drug|Weeks 1 to 12||44
2503247|NCT00797225|6134423|P3|Received Study Drug|Weeks 1 to 12||44
2503248|NCT00797225|6134424|P2|Received Study Drug|Weeks 1 to 12||43
2503249|NCT00797225|6134425|P1|Received Study Drug|Weeks 1 to 12||43
2503250|NCT00797225|6134418|P8|STARTED|Weeks 1 to 12||0
2503251|NCT00797225|6134419|P7|STARTED|Weeks 1 to 12||0
2503252|NCT00797225|6134420|P6|STARTED|Weeks 1 to 12||0
2503253|NCT00797225|6134421|P5|STARTED|Weeks 1 to 12||0
2503254|NCT00797225|6134422|P4|STARTED|Weeks 1 to 12||44
2503255|NCT00797225|6134423|P3|STARTED|Weeks 1 to 12||44
2503256|NCT00797225|6134424|P2|STARTED|Weeks 1 to 12||43
2503257|NCT00797225|6134425|P1|STARTED|Weeks 1 to 12||43
2503258|NCT00797212|6134533|P1|NOT COMPLETED|Overall Study||0
2503259|NCT00797212|6134533|P1|COMPLETED|Overall Study||50
2503260|NCT00797212|6134533|P1|STARTED|Overall Study||50
2503261|NCT00797108|6134542|P3|NOT COMPLETED|Overall Study||6
2503262|NCT00797108|6134543|P2|NOT COMPLETED|Overall Study||2
2503263|NCT00797108|6134544|P1|NOT COMPLETED|Overall Study||4
2503264|NCT00797108|6134542|P3|COMPLETED|Overall Study||6
2503265|NCT00797108|6134543|P2|COMPLETED|Overall Study||9
2503266|NCT00797108|6134544|P1|COMPLETED|Overall Study||8
2503267|NCT00797108|6134542|P3|Treated|Overall Study||12
2503268|NCT00797108|6134543|P2|Treated|Overall Study||11
2503269|NCT00797108|6134544|P1|Treated|Overall Study||10
2503270|NCT00797108|6134542|P3|STARTED|Overall Study||12
2503271|NCT00797108|6134543|P2|STARTED|Overall Study||11
2503272|NCT00797108|6134544|P1|STARTED|Overall Study||12
2503273|NCT00796991|6134579|P3|NOT COMPLETED|Overall Study||14
2503274|NCT00796991|6134580|P2|NOT COMPLETED|Overall Study||12
2503275|NCT00796991|6134581|P1|NOT COMPLETED|Overall Study||15
2503276|NCT00796991|6134579|P3|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|6
2503277|NCT00796991|6134580|P2|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|7
2503278|NCT00796991|6134581|P1|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|5
2503279|NCT00796991|6134579|P3|STARTED|Overall Study||20
2503280|NCT00796991|6134580|P2|STARTED|Overall Study||19
2503281|NCT00796991|6134581|P1|STARTED|Overall Study||20
2503282|NCT00796926|6134681|P2|NOT COMPLETED|Overall Study||0
2503283|NCT00796926|6134682|P1|NOT COMPLETED|Overall Study||1
2503284|NCT00796926|6134681|P2|COMPLETED|Overall Study||15
2503285|NCT00796926|6134682|P1|COMPLETED|Overall Study||14
2503286|NCT00796926|6134681|P2|STARTED|Overall Study||15
2503287|NCT00796926|6134682|P1|STARTED|Overall Study||15
2503288|NCT00796861|6134688|P1|NOT COMPLETED|Overall Study||4
2503289|NCT00796861|6134688|P1|COMPLETED|Overall Study||0
2503290|NCT00796861|6134688|P1|STARTED|Overall Study||4
2503291|NCT00796822|6134694|P2|NOT COMPLETED|Overall Study||0
2503292|NCT00796822|6134695|P1|NOT COMPLETED|Overall Study||3
2503293|NCT00796822|6134694|P2|COMPLETED|Overall Study||13
2503294|NCT00796822|6134695|P1|COMPLETED|Overall Study||10
2503295|NCT00796822|6134694|P2|STARTED|Overall Study||13
2503296|NCT00796822|6134695|P1|STARTED|Overall Study||13
2503297|NCT00796757|6134703|P1|NOT COMPLETED|Overall Study||86
2503298|NCT00796757|6134703|P1|COMPLETED|Overall Study||60
2503299|NCT00796757|6134703|P1|STARTED|Overall Study||146
2503300|NCT00796744|6134718|P3|NOT COMPLETED|Overall Study||1
2503301|NCT00796744|6134719|P2|NOT COMPLETED|Overall Study||0
2503302|NCT00796744|6134720|P1|NOT COMPLETED|Overall Study||0
2503303|NCT00796744|6134718|P3|COMPLETED|Overall Study||27
2503304|NCT00796744|6134719|P2|COMPLETED|Overall Study||26
2503305|NCT00796744|6134720|P1|COMPLETED|Overall Study||24
2503306|NCT00796744|6134718|P3|STARTED|Overall Study||28
2503307|NCT00796744|6134719|P2|STARTED|Overall Study||26
2503308|NCT00796744|6134720|P1|STARTED|Overall Study||24
2503309|NCT00796718|6134737|P1|NOT COMPLETED|Overall Study||9
2503310|NCT00796718|6134737|P1|COMPLETED|Overall Study||53
2503311|NCT00796718|6134737|P1|STARTED|Overall Study||62
2503312|NCT00796705|6134748|P4|NOT COMPLETED|Overall Study||0
2503313|NCT00796705|6134749|P3|NOT COMPLETED|Overall Study||0
2503314|NCT00796705|6134750|P2|NOT COMPLETED|Overall Study||0
2503315|NCT00796705|6134751|P1|NOT COMPLETED|Overall Study||0
2503316|NCT00796705|6134748|P4|COMPLETED|Overall Study||2
2503317|NCT00796705|6134749|P3|COMPLETED|Overall Study||4
2503318|NCT00796705|6134750|P2|COMPLETED|Overall Study||4
2503319|NCT00796705|6134751|P1|COMPLETED|Overall Study||3
2503320|NCT00796705|6134748|P4|STARTED|Overall Study||2
2503321|NCT00796705|6134749|P3|STARTED|Overall Study||4
2503322|NCT00796705|6134750|P2|STARTED|Overall Study||4
2503323|NCT00796705|6134751|P1|STARTED|Overall Study||3
2503324|NCT00796666|6134789|P2|NOT COMPLETED|Overall Study||64
2503325|NCT00796666|6134790|P1|NOT COMPLETED|Overall Study||67
2503326|NCT00796666|6134789|P2|COMPLETED|Overall Study||0
2503327|NCT00796666|6134790|P1|COMPLETED|Overall Study||0
2503328|NCT00796666|6134789|P2|Randomized and Not Treated|Overall Study||0
2503329|NCT00796666|6134790|P1|Randomized and Not Treated|Overall Study||1
2503330|NCT00796666|6134789|P2|Treated|Overall Study||64
2503331|NCT00796666|6134790|P1|Treated|Overall Study||66
2503332|NCT00796666|6134789|P2|STARTED|Overall Study||64
2503333|NCT00796666|6134790|P1|STARTED|Overall Study||67
2503334|NCT00796653|6134824|P4|NOT COMPLETED|Overall Study||40
2503335|NCT00796653|6134825|P3|NOT COMPLETED|Overall Study||36
2503336|NCT00796653|6134826|P2|NOT COMPLETED|Overall Study||37
2503337|NCT00796653|6134827|P1|NOT COMPLETED|Overall Study||51
2503338|NCT00796653|6134824|P4|COMPLETED|Overall Study||193
2503339|NCT00796653|6134825|P3|COMPLETED|Overall Study||198
2503340|NCT00796653|6134826|P2|COMPLETED|Overall Study||195
2503341|NCT00796653|6134827|P1|COMPLETED|Overall Study||184
2503342|NCT00796653|6134824|P4|STARTED|Overall Study||233
2503343|NCT00796653|6134825|P3|STARTED|Overall Study||234
2503344|NCT00796653|6134826|P2|STARTED|Overall Study||232
2503345|NCT00796653|6134827|P1|STARTED|Overall Study||235
2503346|NCT00796627|6135095|P2|NOT COMPLETED|Overall Study||0
2503347|NCT00796627|6135096|P1|NOT COMPLETED|Overall Study||0
2503348|NCT00796627|6135095|P2|COMPLETED|Overall Study||31
2503349|NCT00796627|6135096|P1|COMPLETED|Overall Study||10
2503350|NCT00796627|6135095|P2|STARTED|Overall Study||31
2503351|NCT00796627|6135096|P1|STARTED|Overall Study||10
2503352|NCT00796614|6135112|P4|NOT COMPLETED|Overall Study||1
2503353|NCT00796614|6135113|P3|NOT COMPLETED|Overall Study||3
2503354|NCT00796614|6135114|P2|NOT COMPLETED|Overall Study||4
2503355|NCT00796614|6135115|P1|NOT COMPLETED|Overall Study||5
2503356|NCT00796614|6135112|P4|COMPLETED|Overall Study||40
2503357|NCT00796614|6135113|P3|COMPLETED|Overall Study||36
2503358|NCT00796614|6135114|P2|COMPLETED|Overall Study||36
2503359|NCT00796614|6135115|P1|COMPLETED|Overall Study||36
2503360|NCT00796614|6135112|P4|Not Treated|Overall Study||0
2503361|NCT00796614|6135113|P3|Not Treated|Overall Study||1
2503362|NCT00796614|6135114|P2|Not Treated|Overall Study||0
2503363|NCT00796614|6135115|P1|Not Treated|Overall Study||0
2503364|NCT00796614|6135112|P4|STARTED|Overall Study||41
2503365|NCT00796614|6135113|P3|STARTED|Overall Study||39
2503366|NCT00796614|6135114|P2|STARTED|Overall Study||40
2503367|NCT00796614|6135115|P1|STARTED|Overall Study||41
2503368|NCT00796562|6135157|P1|NOT COMPLETED|Overall Study||49
2503369|NCT00796562|6135157|P1|COMPLETED|Overall Study||47
2503370|NCT00796562|6135157|P1|STARTED|Overall Study||96
2503371|NCT00796549|6135166|P1|NOT COMPLETED|Overall Study||218
2503372|NCT00796549|6135166|P1|COMPLETED|Overall Study||0
2503373|NCT00796549|6135166|P1|Entered|Overall Study|entered and treated|69
2503374|NCT00796549|6135166|P1|STARTED|Overall Study|Excluding duplicate records for 5 patients who were screened twice|218
2503375|NCT00796523|6135183|P2|NOT COMPLETED|Overall Study||7
2503376|NCT00796523|6135184|P1|NOT COMPLETED|Overall Study||9
2503377|NCT00796523|6135183|P2|COMPLETED|Overall Study||17
2503378|NCT00796523|6135184|P1|COMPLETED|Overall Study||18
2503379|NCT00796523|6135183|P2|STARTED|Overall Study||24
2503380|NCT00796523|6135184|P1|STARTED|Overall Study||27
2503381|NCT00796510|6135194|P2|NOT COMPLETED|Overall Study||0
2503382|NCT00796510|6135195|P1|NOT COMPLETED|Overall Study||3
2503383|NCT00796510|6135194|P2|COMPLETED|Overall Study||0
2503384|NCT00796510|6135195|P1|COMPLETED|Overall Study||0
2503385|NCT00796510|6135194|P2|STARTED|Overall Study||0
2503386|NCT00796510|6135195|P1|STARTED|Overall Study||3
2503387|NCT00796445|6135207|P2|NOT COMPLETED|Overall Study||292
2503388|NCT00796445|6135208|P1|NOT COMPLETED|Overall Study||584
2503389|NCT00796445|6135207|P2|COMPLETED|Overall Study||158
2503390|NCT00796445|6135208|P1|COMPLETED|Overall Study||310
2503391|NCT00796445|6135207|P2|STARTED|Overall Study||450
2503392|NCT00796445|6135208|P1|STARTED|Overall Study||894
2503393|NCT00796419|6135260|P2|NOT COMPLETED|Overall Study||1
2503394|NCT00796419|6135261|P1|NOT COMPLETED|Overall Study||0
2503395|NCT00796419|6135260|P2|COMPLETED|Overall Study||13
2503396|NCT00796419|6135261|P1|COMPLETED|Overall Study||13
2503397|NCT00796419|6135260|P2|STARTED|Overall Study||14
2503398|NCT00796419|6135261|P1|STARTED|Overall Study||13
2503399|NCT00796367|6135274|P3|NOT COMPLETED|Overall Study||47
2503400|NCT00796367|6135275|P2|NOT COMPLETED|Overall Study||25
2503401|NCT00796367|6135276|P1|NOT COMPLETED|Overall Study||30
2503402|NCT00796367|6135274|P3|COMPLETED|Overall Study||248
2503403|NCT00796367|6135275|P2|COMPLETED|Overall Study||129
2503404|NCT00796367|6135276|P1|COMPLETED|Overall Study||197
2503405|NCT00796367|6135274|P3|STARTED|Overall Study||295
2503406|NCT00796367|6135275|P2|STARTED|Overall Study|one participant signed ICF but withdrew from study prior to first dosing in OB-305|154
2503407|NCT00796367|6135276|P1|STARTED|Overall Study||227
2503408|NCT00796328|6135287|P1|NOT COMPLETED|Overall Study||6
2503409|NCT00796328|6135287|P1|COMPLETED|Overall Study||40
2503410|NCT00796328|6135287|P1|STARTED|Overall Study||46
2503411|NCT00796315|6135291|P3|NOT COMPLETED|Overall Study||0
2503412|NCT00796315|6135292|P2|NOT COMPLETED|Overall Study||1
2503413|NCT00796315|6135293|P1|NOT COMPLETED|Overall Study||0
2503414|NCT00796315|6135291|P3|COMPLETED|Overall Study||15
2503415|NCT00796315|6135292|P2|COMPLETED|Overall Study||16
2503416|NCT00796315|6135293|P1|COMPLETED|Overall Study||9
2503417|NCT00796315|6135291|P3|STARTED|Overall Study||15
2503418|NCT00796315|6135292|P2|STARTED|Overall Study||17
2503419|NCT00796315|6135293|P1|STARTED|Overall Study||9
2503420|NCT00796302|6135306|P2|NOT COMPLETED|Overall Study||18
2503421|NCT00796302|6135307|P1|NOT COMPLETED|Overall Study||13
2503422|NCT00796302|6135306|P2|COMPLETED|Overall Study||66
2503423|NCT00796302|6135307|P1|COMPLETED|Overall Study||71
2503424|NCT00796302|6135306|P2|STARTED|Overall Study||84
2503425|NCT00796302|6135307|P1|STARTED|Overall Study||84
2503426|NCT00796224|6135321|P2|NOT COMPLETED|Overall Study||1
2503427|NCT00796224|6135322|P1|NOT COMPLETED|Overall Study||1
2503428|NCT00796224|6135321|P2|COMPLETED|Overall Study||18
2503429|NCT00796224|6135322|P1|COMPLETED|Overall Study||18
2503430|NCT00796224|6135321|P2|STARTED|Overall Study||19
2503431|NCT00796224|6135322|P1|STARTED|Overall Study||19
2503432|NCT00796120|6135342|P2|NOT COMPLETED|Overall Study||60
2503433|NCT00796120|6135343|P1|NOT COMPLETED|Overall Study||61
2503434|NCT00796120|6135342|P2|COMPLETED|Overall Study||0
2503435|NCT00796120|6135343|P1|COMPLETED|Overall Study||0
2503436|NCT00796120|6135342|P2|Treated|Overall Study||57
2503437|NCT00796120|6135343|P1|Treated|Overall Study||61
2503438|NCT00796120|6135342|P2|STARTED|Overall Study||60
2503439|NCT00796120|6135343|P1|STARTED|Overall Study||61
2503440|NCT00796003|6135359|P2|NOT COMPLETED|Overall Study||29
2503441|NCT00796003|6135360|P1|NOT COMPLETED|Overall Study||3
2503442|NCT00796003|6135359|P2|COMPLETED|Overall Study|Includes 2 participants from Phase I (20 mg/m2) group|7
2503443|NCT00796003|6135360|P1|COMPLETED|Overall Study||0
2503444|NCT00796003|6135359|P2|Treated|Overall Study|Number of participants treated|34
2503445|NCT00796003|6135360|P1|Treated|Overall Study|Number of participants treated|3
2503446|NCT00796003|6135359|P2|STARTED|Overall Study|Number of participants enrolled. Includes 6 participants from Phase I (20 mg/m2) group|36
2503447|NCT00796003|6135360|P1|STARTED|Overall Study|Number of participants enrolled|3
2503448|NCT00795951|6135381|P1|NOT COMPLETED|Overall Study||2
2503449|NCT00795951|6135381|P1|COMPLETED|Overall Study||100
2503450|NCT00795951|6135381|P1|STARTED|Overall Study||102
2503451|NCT00795886|6135418|P1|NOT COMPLETED|Overall Study||10
2503452|NCT00795886|6135418|P1|COMPLETED|Overall Study||53
2503453|NCT00795886|6135418|P1|STARTED|Overall Study||63
2503454|NCT00795821|6135426|P2|NOT COMPLETED|Taper Phase||0
2503455|NCT00795821|6135427|P1|NOT COMPLETED|Taper Phase||9
2503456|NCT00795821|6135426|P2|COMPLETED|Taper Phase|N=6 participants completed only Acute Taper Phase; N=0 participants entered Extension Taper Phase.|6
2503457|NCT00795821|6135427|P1|COMPLETED|Taper Phase|N=231 participants completed Taper Phases: N=3 from Acute Phase; N=228 from Extension Phase.|231
2503458|NCT00795821|6135426|P2|STARTED|Taper Phase|N=6 participants entered only Acute Taper Phase.|6
2503459|NCT00795821|6135427|P1|STARTED|Taper Phase|N=240 participants entered Taper Phases: N=4 from Acute Phase; N=236 from Extension Phase.|240
2503460|NCT00795821|6135426|P2|NOT COMPLETED|Long-term Extension Phase||92
2503461|NCT00795821|6135427|P1|NOT COMPLETED|Long-term Extension Phase||90
2503462|NCT00795821|6135426|P2|COMPLETED|Long-term Extension Phase||115
2503463|NCT00795821|6135427|P1|COMPLETED|Long-term Extension Phase||100
2503464|NCT00795821|6135426|P2|STARTED|Long-term Extension Phase|All placebo-treated participants received LY2216684 in the Long-term Extension Phase.|207
2503465|NCT00795821|6135427|P1|STARTED|Long-term Extension Phase||190
2503466|NCT00795821|6135426|P2|NOT COMPLETED|Acute Treatment Phase||31
2503467|NCT00795821|6135427|P1|NOT COMPLETED|Acute Treatment Phase||56
2503468|NCT00795821|6135426|P2|COMPLETED|Acute Treatment Phase|7 placebo-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|214
2503469|NCT00795821|6135427|P1|COMPLETED|Acute Treatment Phase|4 LY-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|194
2503470|NCT00795821|6135426|P2|STARTED|Acute Treatment Phase||245
2503471|NCT00795821|6135427|P1|STARTED|Acute Treatment Phase||250
2503472|NCT00795769|6135496|P1|NOT COMPLETED|Overall Study||0
2503473|NCT00795769|6135496|P1|COMPLETED|Overall Study||49
2503474|NCT00795769|6135496|P1|STARTED|Overall Study||49
2503475|NCT00795717|6135502|P2|NOT COMPLETED|Phase II||1
2503476|NCT00795717|6135503|P1|NOT COMPLETED|Phase II||0
2503477|NCT00795717|6135502|P2|COMPLETED|Phase II||18
2503478|NCT00795717|6135503|P1|COMPLETED|Phase II||18
2503479|NCT00795717|6135502|P2|STARTED|Phase II||19
2503480|NCT00795717|6135503|P1|STARTED|Phase II||18
2503481|NCT00795717|6135502|P2|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
2503482|NCT00795717|6135503|P1|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
2503483|NCT00795717|6135502|P2|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||19
2503484|NCT00795717|6135503|P1|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||18
2503485|NCT00795717|6135502|P2|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to placebo first|21
2503486|NCT00795717|6135503|P1|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to treatment first|20
2503487|NCT00795704|6135515|P2|NOT COMPLETED|Overall Study||3
2503488|NCT00795704|6135516|P1|NOT COMPLETED|Overall Study||4
2503489|NCT00795704|6135515|P2|COMPLETED|Overall Study||9
2503490|NCT00795704|6135516|P1|COMPLETED|Overall Study||8
2503491|NCT00795704|6135515|P2|STARTED|Overall Study||12
2503492|NCT00795704|6135516|P1|STARTED|Overall Study||12
2503493|NCT00795639|6135528|P2|NOT COMPLETED|Overall Study||26
2503494|NCT00795639|6135529|P1|NOT COMPLETED|Overall Study||21
2503495|NCT00795639|6135528|P2|COMPLETED|Overall Study||66
2503496|NCT00795639|6135529|P1|COMPLETED|Overall Study||70
2503497|NCT00795639|6135528|P2|Randomized and Not Treated|Overall Study||1
2503498|NCT00795639|6135529|P1|Randomized and Not Treated|Overall Study||0
2503499|NCT00795639|6135528|P2|STARTED|Overall Study||92
2503500|NCT00795639|6135529|P1|STARTED|Overall Study||91
2503501|NCT00795600|6135541|P2|NOT COMPLETED|Overall Study||4
2503502|NCT00795600|6135542|P1|NOT COMPLETED|Overall Study||4
2503503|NCT00795600|6135541|P2|COMPLETED|Overall Study||31
2503504|NCT00795600|6135542|P1|COMPLETED|Overall Study||21
2503505|NCT00795600|6135541|P2|Exposed to Drug|Overall Study||35
2503506|NCT00795600|6135542|P1|Exposed to Drug|Overall Study|1 patient did not take study medication because the patient withdrew consent|24
2503507|NCT00795600|6135541|P2|STARTED|Overall Study||35
2503508|NCT00795600|6135542|P1|STARTED|Overall Study||25
2503509|NCT00795535|6135662|P1|NOT COMPLETED|Overall Study||20
2503510|NCT00795535|6135662|P1|COMPLETED|Overall Study||75
2503511|NCT00795535|6135662|P1|STARTED|Overall Study||95
2503512|NCT00795509|6135669|P1|NOT COMPLETED|Overall Study||31
2503513|NCT00795509|6135669|P1|COMPLETED|Overall Study||343
2503514|NCT00795509|6135669|P1|STARTED|Overall Study||374
2503515|NCT00795366|6135676|P2|NOT COMPLETED|Overall Study||0
2503516|NCT00795366|6135677|P1|NOT COMPLETED|Overall Study||0
2503517|NCT00795366|6135676|P2|COMPLETED|Overall Study||54
2503518|NCT00795366|6135677|P1|COMPLETED|Overall Study||42
2503519|NCT00795366|6135676|P2|STARTED|Overall Study||54
2503520|NCT00795366|6135677|P1|STARTED|Overall Study||42
2503521|NCT00795340|6135685|P2|NOT COMPLETED|Overall Study||0
2503522|NCT00795340|6135686|P1|NOT COMPLETED|Overall Study||7
2503523|NCT00795340|6135685|P2|COMPLETED|Overall Study||153
2503524|NCT00795340|6135686|P1|COMPLETED|Overall Study||146
2503525|NCT00795340|6135685|P2|STARTED|Overall Study||153
2503526|NCT00795340|6135686|P1|STARTED|Overall Study||153
2503527|NCT00795288|6135698|P2|NOT COMPLETED|Overall Study||0
2503528|NCT00795288|6135699|P1|NOT COMPLETED|Overall Study||0
2503529|NCT00795288|6135698|P2|COMPLETED|Overall Study||21
2503530|NCT00795288|6135699|P1|COMPLETED|Overall Study||21
2503531|NCT00795288|6135698|P2|STARTED|Overall Study||21
2503532|NCT00795288|6135699|P1|STARTED|Overall Study||21
2503533|NCT00795236|6135711|P2|NOT COMPLETED|Overall Study||0
2503534|NCT00795236|6135712|P1|NOT COMPLETED|Overall Study||0
2503535|NCT00795236|6135711|P2|COMPLETED|Overall Study||0
2503536|NCT00795236|6135712|P1|COMPLETED|Overall Study|Unable to consistently obtain saliva DLMO in subjects and thus couldn't measure circadian period|0
2503537|NCT00795236|6135711|P2|STARTED|Overall Study||0
2503538|NCT00795236|6135712|P1|STARTED|Overall Study||0
2503539|NCT00795210|6135725|P3|NOT COMPLETED|Overall Study||2
2503540|NCT00795210|6135726|P2|NOT COMPLETED|Overall Study||1
2503541|NCT00795210|6135727|P1|NOT COMPLETED|Overall Study||0
2503542|NCT00795210|6135725|P3|COMPLETED|Overall Study||3
2503543|NCT00795210|6135726|P2|COMPLETED|Overall Study||11
2503544|NCT00795210|6135727|P1|COMPLETED|Overall Study||8
2503545|NCT00795210|6135725|P3|STARTED|Overall Study||5
2503546|NCT00795210|6135726|P2|STARTED|Overall Study||12
2503547|NCT00795210|6135727|P1|STARTED|Overall Study||8
2503548|NCT00795184|6135738|P2|NOT COMPLETED|Overall Study||13
2503549|NCT00795184|6135739|P1|NOT COMPLETED|Overall Study||8
2503550|NCT00795184|6135738|P2|COMPLETED|Overall Study|44 patients analysable, completed all 3 imaging procedures|44
2503551|NCT00795184|6135739|P1|COMPLETED|Overall Study|57 patients analysable, completed all 3 imaging procedures|57
2503552|NCT00795184|6135738|P2|STARTED|Overall Study||57
2503553|NCT00795184|6135739|P1|STARTED|Overall Study||65
2503554|NCT00795145|6135750|P7|NOT COMPLETED|Cohort 2||0
2503555|NCT00795145|6135751|P6|NOT COMPLETED|Cohort 2||0
2503556|NCT00795145|6135752|P5|NOT COMPLETED|Cohort 2||0
2503557|NCT00795145|6135753|P4|NOT COMPLETED|Cohort 2||0
2503558|NCT00795145|6135754|P3|NOT COMPLETED|Cohort 2||0
2503559|NCT00795145|6135755|P2|NOT COMPLETED|Cohort 2||0
2503560|NCT00795145|6135756|P1|NOT COMPLETED|Cohort 2||0
2503561|NCT00795145|6135750|P7|COMPLETED|Cohort 2||10
2503562|NCT00795145|6135751|P6|COMPLETED|Cohort 2||10
2503563|NCT00795145|6135752|P5|COMPLETED|Cohort 2||10
2503564|NCT00795145|6135753|P4|COMPLETED|Cohort 2||10
2503565|NCT00795145|6135754|P3|COMPLETED|Cohort 2||0
2503566|NCT00795145|6135755|P2|COMPLETED|Cohort 2||0
2503567|NCT00795145|6135756|P1|COMPLETED|Cohort 2||0
2503568|NCT00795145|6135750|P7|STARTED|Cohort 2||10
2503569|NCT00795145|6135751|P6|STARTED|Cohort 2||10
2503570|NCT00795145|6135752|P5|STARTED|Cohort 2||10
2503571|NCT00795145|6135753|P4|STARTED|Cohort 2||10
2503572|NCT00795145|6135754|P3|STARTED|Cohort 2||0
2503573|NCT00795145|6135755|P2|STARTED|Cohort 2||0
2503574|NCT00795145|6135756|P1|STARTED|Cohort 2||0
2503575|NCT00795145|6135750|P7|NOT COMPLETED|Cohort 1||0
2503576|NCT00795145|6135751|P6|NOT COMPLETED|Cohort 1||0
2503577|NCT00795145|6135752|P5|NOT COMPLETED|Cohort 1||0
2503578|NCT00795145|6135753|P4|NOT COMPLETED|Cohort 1||0
2503579|NCT00795145|6135754|P3|NOT COMPLETED|Cohort 1||0
2503580|NCT00795145|6135755|P2|NOT COMPLETED|Cohort 1||0
2503581|NCT00795145|6135756|P1|NOT COMPLETED|Cohort 1||0
2503582|NCT00795145|6135750|P7|COMPLETED|Cohort 1||0
2503583|NCT00795145|6135751|P6|COMPLETED|Cohort 1||0
2503584|NCT00795145|6135752|P5|COMPLETED|Cohort 1||0
2503585|NCT00795145|6135753|P4|COMPLETED|Cohort 1||0
2503586|NCT00795145|6135754|P3|COMPLETED|Cohort 1||3
2503587|NCT00795145|6135755|P2|COMPLETED|Cohort 1||3
2503588|NCT00795145|6135756|P1|COMPLETED|Cohort 1||3
2503589|NCT00795145|6135750|P7|STARTED|Cohort 1||0
2503590|NCT00795145|6135751|P6|STARTED|Cohort 1||0
2503591|NCT00795145|6135752|P5|STARTED|Cohort 1||0
2503592|NCT00795145|6135753|P4|STARTED|Cohort 1||0
2503593|NCT00795145|6135754|P3|STARTED|Cohort 1||3
2503594|NCT00795145|6135755|P2|STARTED|Cohort 1||3
2503595|NCT00795145|6135756|P1|STARTED|Cohort 1||3
2503596|NCT00795132|6135800|P1|NOT COMPLETED|Overall Study||3
2503597|NCT00795132|6135800|P1|COMPLETED|Overall Study||44
2503598|NCT00795132|6135800|P1|STARTED|Overall Study||47
2503599|NCT00795002|6135814|P2|NOT COMPLETED|Overall Study||0
2503600|NCT00795002|6135815|P1|NOT COMPLETED|Overall Study||0
2503601|NCT00795002|6135814|P2|COMPLETED|Overall Study||37
2503602|NCT00795002|6135815|P1|COMPLETED|Overall Study||37
2503603|NCT00795002|6135814|P2|STARTED|Overall Study||37
2503604|NCT00795002|6135815|P1|STARTED|Overall Study||37
2503605|NCT00794963|6135827|P2|NOT COMPLETED|Overall Study||4
2503606|NCT00794963|6135828|P1|NOT COMPLETED|Overall Study||1
2503607|NCT00794963|6135827|P2|COMPLETED|Overall Study||0
2503608|NCT00794963|6135828|P1|COMPLETED|Overall Study||3
2503609|NCT00794963|6135827|P2|STARTED|Overall Study||4
2503610|NCT00794963|6135828|P1|STARTED|Overall Study||4
2503611|NCT00794950|6135834|P1|NOT COMPLETED|Beginning Sunitinib Treatment||12
2503612|NCT00794950|6135834|P1|COMPLETED|Beginning Sunitinib Treatment||24
2503613|NCT00794950|6135834|P1|STARTED|Beginning Sunitinib Treatment||36
2503614|NCT00794950|6135834|P1|NOT COMPLETED|BCG Induction||7
2503615|NCT00794950|6135834|P1|COMPLETED|BCG Induction||36
2503616|NCT00794950|6135834|P1|STARTED|BCG Induction||43
2503617|NCT00794924|6135843|P2|NOT COMPLETED|Overall Study||70
2503618|NCT00794924|6135844|P1|NOT COMPLETED|Overall Study||60
2503619|NCT00794924|6135843|P2|COMPLETED|Overall Study||101
2503620|NCT00794924|6135844|P1|COMPLETED|Overall Study||114
2503621|NCT00794924|6135843|P2|STARTED|Overall Study|14 patients refused to start the study|171
2503622|NCT00794924|6135844|P1|STARTED|Overall Study|14 patients refused to start the study|174
2503623|NCT00794820|6135848|P1|NOT COMPLETED|Overall Study||16
2503624|NCT00794820|6135848|P1|COMPLETED|Overall Study||50
2503625|NCT00794820|6135848|P1|STARTED|Overall Study||66
2503626|NCT00794677|6135856|P2|NOT COMPLETED|Second Intervention||0
2503627|NCT00794677|6135857|P1|NOT COMPLETED|Second Intervention||0
2503628|NCT00794677|6135856|P2|COMPLETED|Second Intervention||13
2503629|NCT00794677|6135857|P1|COMPLETED|Second Intervention||11
2503630|NCT00794677|6135856|P2|STARTED|Second Intervention||13
2503631|NCT00794677|6135857|P1|STARTED|Second Intervention||11
2503632|NCT00794677|6135856|P2|NOT COMPLETED|First Intervention||0
2503633|NCT00794677|6135857|P1|NOT COMPLETED|First Intervention||2
2503634|NCT00794677|6135856|P2|COMPLETED|First Intervention||13
2503635|NCT00794677|6135857|P1|COMPLETED|First Intervention||11
2503636|NCT00794677|6135856|P2|STARTED|First Intervention||13
2503637|NCT00794677|6135857|P1|STARTED|First Intervention||13
2503638|NCT00794664|6135879|P2|NOT COMPLETED|Follow-up Period||5
2503639|NCT00794664|6135880|P1|NOT COMPLETED|Follow-up Period||1
2503640|NCT00794664|6135879|P2|COMPLETED|Follow-up Period||28
2503641|NCT00794664|6135880|P1|COMPLETED|Follow-up Period||15
2503642|NCT00794664|6135879|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|33
2503643|NCT00794664|6135880|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|16
2503644|NCT00794664|6135879|P2|NOT COMPLETED|Treatment Period||12
2503645|NCT00794664|6135880|P1|NOT COMPLETED|Treatment Period||1
2503646|NCT00794664|6135879|P2|COMPLETED|Treatment Period|6 participants enrolled in open-label extension study NCT00694109|27
2503647|NCT00794664|6135880|P1|COMPLETED|Treatment Period|3 participants enrolled in open-label extension study NCT00694109|18
2503648|NCT00794664|6135879|P2|STARTED|Treatment Period||39
2503649|NCT00794664|6135880|P1|STARTED|Treatment Period||19
2503650|NCT00794573|6135926|P2|NOT COMPLETED|Overall Study||45
2503651|NCT00794573|6135927|P1|NOT COMPLETED|Overall Study||38
2503652|NCT00794573|6135926|P2|COMPLETED|Overall Study||106
2503653|NCT00794573|6135927|P1|COMPLETED|Overall Study||113
2503654|NCT00794573|6135926|P2|STARTED|Overall Study||151
2503655|NCT00794573|6135927|P1|STARTED|Overall Study||151
2503656|NCT00794560|6135959|P4|NOT COMPLETED|Overall Study||4
2503657|NCT00794560|6135960|P3|NOT COMPLETED|Overall Study||4
2503658|NCT00794560|6135961|P2|NOT COMPLETED|Overall Study||4
2503659|NCT00794560|6135962|P1|NOT COMPLETED|Overall Study||3
2503660|NCT00794560|6135959|P4|COMPLETED|Overall Study||34
2503661|NCT00794560|6135960|P3|COMPLETED|Overall Study||40
2503662|NCT00794560|6135961|P2|COMPLETED|Overall Study||32
2503663|NCT00794560|6135962|P1|COMPLETED|Overall Study||33
2503664|NCT00794560|6135959|P4|STARTED|Overall Study||38
2503665|NCT00794560|6135960|P3|STARTED|Overall Study||44
2503666|NCT00794560|6135961|P2|STARTED|Overall Study||36
2503667|NCT00794560|6135962|P1|STARTED|Overall Study||36
2503668|NCT00794547|6135976|P2|NOT COMPLETED|Overall Study||0
2503669|NCT00794547|6135977|P1|NOT COMPLETED|Overall Study||0
2503670|NCT00794547|6135976|P2|COMPLETED|Overall Study||16
2503671|NCT00794547|6135977|P1|COMPLETED|Overall Study||18
2503672|NCT00794547|6135976|P2|STARTED|Overall Study||16
2503673|NCT00794547|6135977|P1|STARTED|Overall Study||18
2503674|NCT00794508|6135985|P1|NOT COMPLETED|Overall Study||0
2503675|NCT00794508|6135985|P1|COMPLETED|Overall Study||10
2503676|NCT00794508|6135985|P1|STARTED|Overall Study||10
2503677|NCT00794469|6135991|P1|NOT COMPLETED|Overall Study||0
2503678|NCT00794469|6135991|P1|COMPLETED|Overall Study||21
2503679|NCT00794469|6135991|P1|STARTED|Overall Study||21
2503680|NCT00794365|6135996|P1|NOT COMPLETED|Overall Study||79
2503681|NCT00794365|6135996|P1|COMPLETED|Overall Study||251
2503682|NCT00794365|6135996|P1|STARTED|Overall Study||330
2503683|NCT00794313|6136002|P3|NOT COMPLETED|Overall Study||0
2503684|NCT00794313|6136003|P2|NOT COMPLETED|Overall Study||0
2503685|NCT00794313|6136004|P1|NOT COMPLETED|Overall Study||0
2503686|NCT00794313|6136002|P3|COMPLETED|Overall Study||1
2503687|NCT00794313|6136003|P2|COMPLETED|Overall Study||1
2503688|NCT00794313|6136004|P1|COMPLETED|Overall Study||1
2503689|NCT00794313|6136002|P3|STARTED|Overall Study||1
2503690|NCT00794313|6136003|P2|STARTED|Overall Study||1
2503691|NCT00794313|6136004|P1|STARTED|Overall Study||1
2503692|NCT00794196|6136017|P2|NOT COMPLETED|Overall Study||23
2503693|NCT00794196|6136018|P1|NOT COMPLETED|Overall Study||5
2503694|NCT00794196|6136017|P2|COMPLETED|Overall Study||64
2503695|NCT00794196|6136018|P1|COMPLETED|Overall Study||87
2503696|NCT00794196|6136017|P2|STARTED|Overall Study||87
2503697|NCT00794196|6136018|P1|STARTED|Overall Study||92
2503698|NCT00794170|6136028|P2|NOT COMPLETED|Overall Study||3
2503699|NCT00794170|6136029|P1|NOT COMPLETED|Overall Study||7
2503700|NCT00794170|6136028|P2|COMPLETED|Overall Study||152
2503701|NCT00794170|6136029|P1|COMPLETED|Overall Study||150
2503702|NCT00794170|6136028|P2|STARTED|Overall Study||155
2503703|NCT00794170|6136029|P1|STARTED|Overall Study||157
2503704|NCT00794157|6136038|P3|NOT COMPLETED|Overall Study||19
2503705|NCT00794157|6136039|P2|NOT COMPLETED|Overall Study||10
2503706|NCT00794157|6136040|P1|NOT COMPLETED|Overall Study||10
2503707|NCT00794157|6136038|P3|COMPLETED|Overall Study||98
2503708|NCT00794157|6136039|P2|COMPLETED|Overall Study||106
2503709|NCT00794157|6136040|P1|COMPLETED|Overall Study||104
2503710|NCT00794157|6136038|P3|STARTED|Overall Study||117
2503711|NCT00794157|6136039|P2|STARTED|Overall Study||116
2503712|NCT00794157|6136040|P1|STARTED|Overall Study||114
2503713|NCT00794144|6136062|P2|NOT COMPLETED|Overall Study||3
2503714|NCT00794144|6136063|P1|NOT COMPLETED|Overall Study||3
2503715|NCT00794144|6136062|P2|COMPLETED|Overall Study||63
2503716|NCT00794144|6136063|P1|COMPLETED|Overall Study||63
2503717|NCT00794144|6136062|P2|STARTED|Overall Study||66
2503718|NCT00794144|6136063|P1|STARTED|Overall Study||66
2503719|NCT00794118|6136069|P1|NOT COMPLETED|Overall Study||27
2503720|NCT00794118|6136069|P1|COMPLETED|Overall Study||272
2503721|NCT00794118|6136069|P1|STARTED|Overall Study||299
2503722|NCT00794040|6136129|P2|NOT COMPLETED|Overall Study||5
2503723|NCT00794040|6136130|P1|NOT COMPLETED|Overall Study||3
2503724|NCT00794040|6136129|P2|COMPLETED|Overall Study||23
2503725|NCT00794040|6136130|P1|COMPLETED|Overall Study||22
2503726|NCT00794040|6136129|P2|STARTED|Overall Study||28
2503727|NCT00794040|6136130|P1|STARTED|Overall Study||25
2503728|NCT00793910|6136146|P2|NOT COMPLETED|Overall Study||7
2503729|NCT00793910|6136147|P1|NOT COMPLETED|Overall Study||5
2503730|NCT00793910|6136146|P2|COMPLETED|Overall Study||46
2503731|NCT00793910|6136147|P1|COMPLETED|Overall Study||48
2503732|NCT00793910|6136146|P2|STARTED|Overall Study||53
2503733|NCT00793910|6136147|P1|STARTED|Overall Study||53
2503734|NCT00793871|6136161|P1|NOT COMPLETED|Overall Study||60
2503735|NCT00793871|6136161|P1|COMPLETED|Overall Study||0
2503736|NCT00793871|6136161|P1|Received Treatment|Overall Study||59
2503737|NCT00793871|6136161|P1|STARTED|Overall Study||60
2503738|NCT00793819|6136175|P2|NOT COMPLETED|Overall Study||9
2503739|NCT00793819|6136176|P1|NOT COMPLETED|Overall Study||14
2503740|NCT00793819|6136175|P2|COMPLETED|Overall Study||89
2503741|NCT00793819|6136176|P1|COMPLETED|Overall Study||97
2503742|NCT00793819|6136175|P2|STARTED|Overall Study||98
2503743|NCT00793819|6136176|P1|STARTED|Overall Study||111
2503744|NCT00793793|6136194|P12|NOT COMPLETED|Overall Study||6
2503745|NCT00793793|6136195|P11|NOT COMPLETED|Overall Study||3
2503746|NCT00793793|6136196|P10|NOT COMPLETED|Overall Study||9
2503747|NCT00793793|6136197|P9|NOT COMPLETED|Overall Study||9
2503748|NCT00793793|6136198|P8|NOT COMPLETED|Overall Study||0
2503749|NCT00793793|6136199|P7|NOT COMPLETED|Overall Study||4
2503750|NCT00793793|6136200|P6|NOT COMPLETED|Overall Study||2
2503751|NCT00793793|6136201|P5|NOT COMPLETED|Overall Study||2
2503752|NCT00793793|6136202|P4|NOT COMPLETED|Overall Study||3
2503753|NCT00793793|6136203|P3|NOT COMPLETED|Overall Study||2
2503754|NCT00793793|6136204|P2|NOT COMPLETED|Overall Study||1
2503755|NCT00793793|6136205|P1|NOT COMPLETED|Overall Study||0
2503756|NCT00793793|6136194|P12|COMPLETED|Overall Study||1
2503757|NCT00793793|6136195|P11|COMPLETED|Overall Study||3
2503758|NCT00793793|6136196|P10|COMPLETED|Overall Study||6
2503759|NCT00793793|6136197|P9|COMPLETED|Overall Study||6
2503760|NCT00793793|6136198|P8|COMPLETED|Overall Study||6
2503761|NCT00793793|6136199|P7|COMPLETED|Overall Study||3
2503762|NCT00793793|6136200|P6|COMPLETED|Overall Study||4
2503763|NCT00793793|6136201|P5|COMPLETED|Overall Study||4
2503764|NCT00793793|6136202|P4|COMPLETED|Overall Study||4
2503765|NCT00793793|6136203|P3|COMPLETED|Overall Study||5
2503766|NCT00793793|6136204|P2|COMPLETED|Overall Study||5
2503767|NCT00793793|6136205|P1|COMPLETED|Overall Study||8
2503768|NCT00793793|6136194|P12|STARTED|Overall Study||7
2503769|NCT00793793|6136195|P11|STARTED|Overall Study||6
2503770|NCT00793793|6136196|P10|STARTED|Overall Study||15
2503771|NCT00793793|6136197|P9|STARTED|Overall Study||15
2503772|NCT00793793|6136198|P8|STARTED|Overall Study||6
2503773|NCT00793793|6136199|P7|STARTED|Overall Study||7
2503774|NCT00793793|6136200|P6|STARTED|Overall Study||6
2503775|NCT00793793|6136201|P5|STARTED|Overall Study||6
2503776|NCT00793793|6136202|P4|STARTED|Overall Study||7
2503777|NCT00793793|6136203|P3|STARTED|Overall Study||7
2503778|NCT00793793|6136204|P2|STARTED|Overall Study||6
2503779|NCT00793793|6136205|P1|STARTED|Overall Study||8
2503780|NCT00793780|6136580|P2|NOT COMPLETED|Overall Study||1
2503781|NCT00793780|6136581|P1|NOT COMPLETED|Overall Study||2
2503782|NCT00793780|6136580|P2|COMPLETED|Overall Study||11
2503783|NCT00793780|6136581|P1|COMPLETED|Overall Study||10
2503784|NCT00793780|6136580|P2|Collected Baseline Data|Overall Study||12
2503785|NCT00793780|6136581|P1|Collected Baseline Data|Overall Study||11
2503786|NCT00793780|6136580|P2|Randomization|Overall Study||12
2503787|NCT00793780|6136581|P1|Randomization|Overall Study||12
2503788|NCT00793780|6136580|P2|STARTED|Overall Study||12
2503789|NCT00793780|6136581|P1|STARTED|Overall Study||12
2503790|NCT00793650|6136599|P2|NOT COMPLETED|Overall Study||0
2503791|NCT00793650|6136600|P1|NOT COMPLETED|Overall Study||0
2503792|NCT00793650|6136599|P2|COMPLETED|Overall Study||20
2503793|NCT00793650|6136600|P1|COMPLETED|Overall Study||19
2503794|NCT00793650|6136599|P2|STARTED|Overall Study||20
2503795|NCT00793650|6136600|P1|STARTED|Overall Study||19
2503796|NCT00793624|6136612|P4|NOT COMPLETED|Overall Study||43
2503797|NCT00793624|6136613|P3|NOT COMPLETED|Overall Study||39
2503798|NCT00793624|6136614|P2|NOT COMPLETED|Overall Study||36
2503799|NCT00793624|6136615|P1|NOT COMPLETED|Overall Study||57
2503800|NCT00793624|6136612|P4|COMPLETED|Overall Study||184
2503801|NCT00793624|6136613|P3|COMPLETED|Overall Study||186
2503802|NCT00793624|6136614|P2|COMPLETED|Overall Study||191
2503803|NCT00793624|6136615|P1|COMPLETED|Overall Study||168
2503804|NCT00793624|6136612|P4|STARTED|Overall Study||227
2503805|NCT00793624|6136613|P3|STARTED|Overall Study||225
2503806|NCT00793624|6136614|P2|STARTED|Overall Study||227
2503807|NCT00793624|6136615|P1|STARTED|Overall Study||225
2503808|NCT00793611|6136883|P2|NOT COMPLETED|Overall Study||0
2503809|NCT00793611|6136884|P1|NOT COMPLETED|Overall Study||0
2503810|NCT00793611|6136883|P2|COMPLETED|Overall Study||10
2503811|NCT00793611|6136884|P1|COMPLETED|Overall Study||10
2503812|NCT00793611|6136883|P2|STARTED|Overall Study||10
2503813|NCT00793611|6136884|P1|STARTED|Overall Study||10
2503814|NCT00793585|6136896|P2|NOT COMPLETED|Overall Study||3
2503815|NCT00793585|6136897|P1|NOT COMPLETED|Overall Study||2
2503816|NCT00793585|6136896|P2|COMPLETED|Overall Study||18
2503817|NCT00793585|6136897|P1|COMPLETED|Overall Study||17
2503818|NCT00793585|6136896|P2|STARTED|Overall Study||21
2503819|NCT00793585|6136897|P1|STARTED|Overall Study||19
2503820|NCT00793572|6136905|P1|NOT COMPLETED|Overall Study||0
2503821|NCT00793572|6136905|P1|COMPLETED|Overall Study||32
2503822|NCT00793572|6136905|P1|STARTED|Overall Study||32
2503823|NCT00793546|6136916|P2|NOT COMPLETED|Overall Study||28
2503824|NCT00793546|6136917|P1|NOT COMPLETED|Overall Study||14
2503825|NCT00793546|6136916|P2|COMPLETED|Overall Study||0
2503826|NCT00793546|6136917|P1|COMPLETED|Overall Study||0
2503827|NCT00793546|6136916|P2|STARTED|Overall Study||28
2503828|NCT00793546|6136917|P1|STARTED|Overall Study||14
2503829|NCT00793520|6136947|P2|NOT COMPLETED|Placebo Crossover to Milnacipran||1
2503830|NCT00793520|6136948|P1|NOT COMPLETED|Placebo Crossover to Milnacipran||0
2503831|NCT00793520|6136947|P2|COMPLETED|Placebo Crossover to Milnacipran||0
2503832|NCT00793520|6136948|P1|COMPLETED|Placebo Crossover to Milnacipran||0
2503833|NCT00793520|6136947|P2|STARTED|Placebo Crossover to Milnacipran||1
2503834|NCT00793520|6136948|P1|STARTED|Placebo Crossover to Milnacipran||0
2503835|NCT00793520|6136947|P2|NOT COMPLETED|Milnacipran Crossover to Placebo||0
2503836|NCT00793520|6136948|P1|NOT COMPLETED|Milnacipran Crossover to Placebo||1
2503837|NCT00793520|6136947|P2|COMPLETED|Milnacipran Crossover to Placebo||0
2503838|NCT00793520|6136948|P1|COMPLETED|Milnacipran Crossover to Placebo||0
2503839|NCT00793520|6136947|P2|STARTED|Milnacipran Crossover to Placebo||0
2503840|NCT00793520|6136948|P1|STARTED|Milnacipran Crossover to Placebo||1
2503841|NCT00793455|6136958|P2|NOT COMPLETED|Overall Study||0
2503842|NCT00793455|6136959|P1|NOT COMPLETED|Overall Study||0
2503843|NCT00793455|6136958|P2|COMPLETED|Overall Study||314
2503844|NCT00793455|6136959|P1|COMPLETED|Overall Study||314
2503845|NCT00793455|6136958|P2|STARTED|Overall Study||314
2503846|NCT00793455|6136959|P1|STARTED|Overall Study||314
2503847|NCT00793403|6136967|P1|NOT COMPLETED|Overall Study||73
2503848|NCT00793403|6136967|P1|COMPLETED|Overall Study||220
2503849|NCT00793403|6136967|P1|STARTED|Overall Study||293
2503850|NCT00793325|6137014|P1|NOT COMPLETED|Overall Study||19
2503851|NCT00793325|6137014|P1|COMPLETED|Overall Study||890
2503852|NCT00793325|6137014|P1|STARTED|Overall Study||909
2503853|NCT00793182|6137040|P2|NOT COMPLETED|Overall Study||1
2503854|NCT00793182|6137041|P1|NOT COMPLETED|Overall Study||0
2503855|NCT00793182|6137040|P2|COMPLETED|Overall Study||3
2503856|NCT00793182|6137041|P1|COMPLETED|Overall Study||2
2503857|NCT00793182|6137040|P2|STARTED|Overall Study||4
2503858|NCT00793182|6137041|P1|STARTED|Overall Study||2
2503859|NCT00793169|6137047|P1|NOT COMPLETED|Overall Study||0
2503860|NCT00793169|6137047|P1|COMPLETED|Overall Study||19
2503861|NCT00793169|6137047|P1|STARTED|Overall Study||19
2503862|NCT00793104|6137051|P1|NOT COMPLETED|Overall Study||1
2503863|NCT00793104|6137051|P1|COMPLETED|Overall Study||9
2503864|NCT00793104|6137051|P1|STARTED|Overall Study||10
2503868|NCT00792935|6137070|P2|NOT COMPLETED|Overall Study||3
2503869|NCT00792935|6137071|P1|NOT COMPLETED|Overall Study||4
2503870|NCT00792935|6137070|P2|COMPLETED|Overall Study||68
2503871|NCT00792935|6137071|P1|COMPLETED|Overall Study||68
2503872|NCT00792935|6137070|P2|STARTED|Overall Study||71
2503873|NCT00792935|6137071|P1|STARTED|Overall Study||72
2503874|NCT00792922|6137083|P4|NOT COMPLETED|At 3 Years||0
2503875|NCT00792922|6137084|P3|NOT COMPLETED|At 3 Years||0
2503876|NCT00792922|6137085|P2|NOT COMPLETED|At 3 Years||0
2503877|NCT00792922|6137086|P1|NOT COMPLETED|At 3 Years||0
2503878|NCT00792922|6137083|P4|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
2503879|NCT00792922|6137084|P3|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
2503880|NCT00792922|6137085|P2|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
2503881|NCT00792922|6137086|P1|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
2503882|NCT00792922|6137083|P4|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
2503883|NCT00792922|6137084|P3|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
2503884|NCT00792922|6137085|P2|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
2503885|NCT00792922|6137086|P1|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
2503886|NCT00792922|6137083|P4|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
2503887|NCT00792922|6137084|P3|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
2503888|NCT00792922|6137085|P2|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
2503889|NCT00792922|6137086|P1|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
2503890|NCT00792922|6137083|P4|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
2503891|NCT00792922|6137084|P3|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
2503892|NCT00792922|6137085|P2|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
2503959|NCT00792688|6137188|P3|STARTED|Overall Study||9
2503893|NCT00792922|6137086|P1|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
2503894|NCT00792922|6137083|P4|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|0
2503895|NCT00792922|6137084|P3|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|0
2503896|NCT00792922|6137085|P2|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|0
2503897|NCT00792922|6137086|P1|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|0
2503898|NCT00792922|6137083|P4|NOT COMPLETED|At Baseline||0
2503899|NCT00792922|6137084|P3|NOT COMPLETED|At Baseline||0
2503900|NCT00792922|6137085|P2|NOT COMPLETED|At Baseline||0
2503901|NCT00792922|6137086|P1|NOT COMPLETED|At Baseline||0
2503902|NCT00792922|6137083|P4|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
2503903|NCT00792922|6137084|P3|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
2503904|NCT00792922|6137085|P2|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
2503905|NCT00792922|6137086|P1|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
2503906|NCT00792922|6137083|P4|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
2503907|NCT00792922|6137084|P3|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
2503908|NCT00792922|6137085|P2|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
2503909|NCT00792922|6137086|P1|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
2503910|NCT00792922|6137083|P4|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
2503911|NCT00792922|6137084|P3|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
2503912|NCT00792922|6137085|P2|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
2503913|NCT00792922|6137086|P1|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
2503914|NCT00792922|6137083|P4|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
2503915|NCT00792922|6137084|P3|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
2503916|NCT00792922|6137085|P2|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
2503917|NCT00792922|6137086|P1|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
2503918|NCT00792922|6137083|P4|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
2503919|NCT00792922|6137084|P3|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
2503920|NCT00792922|6137085|P2|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
2503921|NCT00792922|6137086|P1|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
2503922|NCT00792909|6137103|P3|NOT COMPLETED|Overall Study||0
2503923|NCT00792909|6137104|P2|NOT COMPLETED|Overall Study||1
2503924|NCT00792909|6137105|P1|NOT COMPLETED|Overall Study||0
2503925|NCT00792909|6137103|P3|COMPLETED|Overall Study||62
2503926|NCT00792909|6137104|P2|COMPLETED|Overall Study||58
2503927|NCT00792909|6137105|P1|COMPLETED|Overall Study||51
2503928|NCT00792909|6137103|P3|STARTED|Overall Study||62
2503929|NCT00792909|6137104|P2|STARTED|Overall Study||59
2503930|NCT00792909|6137105|P1|STARTED|Overall Study||51
2503931|NCT00792805|6137161|P3|NOT COMPLETED|Overall Study||33
2503932|NCT00792805|6137162|P2|NOT COMPLETED|Overall Study||26
2503933|NCT00792805|6137163|P1|NOT COMPLETED|Overall Study||22
2503934|NCT00792805|6137161|P3|COMPLETED|Overall Study||154
2503935|NCT00792805|6137162|P2|COMPLETED|Overall Study||162
2503936|NCT00792805|6137163|P1|COMPLETED|Overall Study||166
2503937|NCT00792805|6137161|P3|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|186
2503938|NCT00792805|6137162|P2|Exposed to Study Medication or Placebo|Overall Study||188
2503939|NCT00792805|6137163|P1|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|187
2503940|NCT00792805|6137161|P3|STARTED|Overall Study||187
2503941|NCT00792805|6137162|P2|STARTED|Overall Study||188
2503942|NCT00792805|6137163|P1|STARTED|Overall Study||188
2503943|NCT00792701|6137173|P2|NOT COMPLETED|Overall Study||44
2503944|NCT00792701|6137174|P1|NOT COMPLETED|Overall Study||19
2503945|NCT00792701|6137173|P2|COMPLETED|Overall Study||22
2503946|NCT00792701|6137174|P1|COMPLETED|Overall Study||0
2503947|NCT00792701|6137173|P2|Eligible and Analyzable|Overall Study||44
2503948|NCT00792701|6137174|P1|Eligible and Analyzable|Overall Study||17
2503949|NCT00792701|6137173|P2|Eligible|Overall Study||63
2503950|NCT00792701|6137174|P1|Eligible|Overall Study||18
2503951|NCT00792701|6137173|P2|STARTED|Overall Study||66
2503952|NCT00792701|6137174|P1|STARTED|Overall Study||19
2503953|NCT00792688|6137188|P3|NOT COMPLETED|Overall Study||0
2503954|NCT00792688|6137189|P2|NOT COMPLETED|Overall Study||0
2503955|NCT00792688|6137190|P1|NOT COMPLETED|Overall Study||0
2503956|NCT00792688|6137188|P3|COMPLETED|Overall Study||9
2503957|NCT00792688|6137189|P2|COMPLETED|Overall Study||8
2503958|NCT00792688|6137190|P1|COMPLETED|Overall Study||9
2503960|NCT00792688|6137189|P2|STARTED|Overall Study||8
2503961|NCT00792688|6137190|P1|STARTED|Overall Study||9
2503962|NCT00792636|6137204|P3|NOT COMPLETED|Overall Study||81
2503963|NCT00792636|6137205|P2|NOT COMPLETED|Overall Study||81
2503964|NCT00792636|6137206|P1|NOT COMPLETED|Overall Study||68
2503965|NCT00792636|6137204|P3|COMPLETED|Overall Study||55
2503966|NCT00792636|6137205|P2|COMPLETED|Overall Study||55
2503967|NCT00792636|6137206|P1|COMPLETED|Overall Study||67
2503968|NCT00792636|6137204|P3|STARTED|Overall Study||136
2503969|NCT00792636|6137205|P2|STARTED|Overall Study||136
2503970|NCT00792636|6137206|P1|STARTED|Overall Study||135
2503971|NCT00792623|6137243|P1|NOT COMPLETED|Overall Study||7
2503972|NCT00792623|6137243|P1|COMPLETED|Overall Study||22
2503973|NCT00792623|6137243|P1|STARTED|Overall Study||29
2503974|NCT00792610|6137256|P1|NOT COMPLETED|Overall Study||0
2503975|NCT00792610|6137256|P1|COMPLETED|Overall Study||127
2503976|NCT00792610|6137256|P1|Youths|Overall Study||127
2503977|NCT00792610|6137256|P1|STARTED|Overall Study||127
2503978|NCT00792571|6137260|P1|NOT COMPLETED|Overall Study||10
2503979|NCT00792571|6137260|P1|COMPLETED|Overall Study||8
2503980|NCT00792571|6137260|P1|STARTED|Overall Study||18
2503981|NCT00792428|6137271|P2|NOT COMPLETED|Overall Study||0
2503982|NCT00792428|6137272|P1|NOT COMPLETED|Overall Study||0
2503983|NCT00792428|6137271|P2|COMPLETED|Overall Study||10
2503984|NCT00792428|6137272|P1|COMPLETED|Overall Study||10
2503985|NCT00792428|6137271|P2|STARTED|Overall Study||10
2503986|NCT00792428|6137272|P1|STARTED|Overall Study||10
2503987|NCT00792298|6137280|P8|NOT COMPLETED|Treatment Period 2||2
2503988|NCT00792298|6137281|P7|NOT COMPLETED|Treatment Period 2||1
2503989|NCT00792298|6137282|P6|NOT COMPLETED|Treatment Period 2||0
2503990|NCT00792298|6137283|P5|NOT COMPLETED|Treatment Period 2||2
2503991|NCT00792298|6137284|P4|NOT COMPLETED|Treatment Period 2||2
2503992|NCT00792298|6137285|P3|NOT COMPLETED|Treatment Period 2||1
2503993|NCT00792298|6137286|P2|NOT COMPLETED|Treatment Period 2||1
2503994|NCT00792298|6137287|P1|NOT COMPLETED|Treatment Period 2||1
2503995|NCT00792298|6137280|P8|COMPLETED|Treatment Period 2||28
2503996|NCT00792298|6137281|P7|COMPLETED|Treatment Period 2||28
2503997|NCT00792298|6137282|P6|COMPLETED|Treatment Period 2||27
2503998|NCT00792298|6137283|P5|COMPLETED|Treatment Period 2||30
2503999|NCT00792298|6137284|P4|COMPLETED|Treatment Period 2||26
2504000|NCT00792298|6137285|P3|COMPLETED|Treatment Period 2||30
2504001|NCT00792298|6137286|P2|COMPLETED|Treatment Period 2||30
2504002|NCT00792298|6137287|P1|COMPLETED|Treatment Period 2||29
2504003|NCT00792298|6137280|P8|STARTED|Treatment Period 2||30
2504004|NCT00792298|6137281|P7|STARTED|Treatment Period 2||29
2504005|NCT00792298|6137282|P6|STARTED|Treatment Period 2||27
2504006|NCT00792298|6137283|P5|STARTED|Treatment Period 2||32
2504007|NCT00792298|6137284|P4|STARTED|Treatment Period 2||28
2504008|NCT00792298|6137285|P3|STARTED|Treatment Period 2||31
2504009|NCT00792298|6137286|P2|STARTED|Treatment Period 2||31
2504010|NCT00792298|6137287|P1|STARTED|Treatment Period 2||30
2504011|NCT00792298|6137280|P8|NOT COMPLETED|Washout||0
2504012|NCT00792298|6137281|P7|NOT COMPLETED|Washout||0
2504013|NCT00792298|6137282|P6|NOT COMPLETED|Washout||2
2504014|NCT00792298|6137283|P5|NOT COMPLETED|Washout||0
2504015|NCT00792298|6137284|P4|NOT COMPLETED|Washout||0
2504016|NCT00792298|6137285|P3|NOT COMPLETED|Washout||1
2504017|NCT00792298|6137286|P2|NOT COMPLETED|Washout||0
2504018|NCT00792298|6137287|P1|NOT COMPLETED|Washout||0
2504019|NCT00792298|6137280|P8|COMPLETED|Washout||30
2504020|NCT00792298|6137281|P7|COMPLETED|Washout||29
2504021|NCT00792298|6137282|P6|COMPLETED|Washout||27
2504022|NCT00792298|6137283|P5|COMPLETED|Washout||32
2504023|NCT00792298|6137284|P4|COMPLETED|Washout||28
2504024|NCT00792298|6137285|P3|COMPLETED|Washout||31
2504025|NCT00792298|6137286|P2|COMPLETED|Washout||31
2504026|NCT00792298|6137287|P1|COMPLETED|Washout||30
2504027|NCT00792298|6137280|P8|STARTED|Washout||30
2504028|NCT00792298|6137281|P7|STARTED|Washout|2 participants discontinued therapy during Period 1 but entered the Washout as allowed per protocol|29
2504029|NCT00792298|6137282|P6|STARTED|Washout||29
2504030|NCT00792298|6137283|P5|STARTED|Washout||32
2504031|NCT00792298|6137284|P4|STARTED|Washout||28
2504032|NCT00792298|6137285|P3|STARTED|Washout|1 participant discontinued therapy during Period 1 but entered the Washout as allowed per protocol|32
2504033|NCT00792298|6137286|P2|STARTED|Washout||31
2504034|NCT00792298|6137287|P1|STARTED|Washout||30
2504035|NCT00792298|6137280|P8|NOT COMPLETED|Treatment Period 1||1
2504036|NCT00792298|6137281|P7|NOT COMPLETED|Treatment Period 1||4
2504037|NCT00792298|6137282|P6|NOT COMPLETED|Treatment Period 1||3
2504038|NCT00792298|6137283|P5|NOT COMPLETED|Treatment Period 1||0
2504039|NCT00792298|6137284|P4|NOT COMPLETED|Treatment Period 1||4
2504040|NCT00792298|6137285|P3|NOT COMPLETED|Treatment Period 1||2
2504041|NCT00792298|6137286|P2|NOT COMPLETED|Treatment Period 1||1
2504042|NCT00792298|6137287|P1|NOT COMPLETED|Treatment Period 1||1
2504043|NCT00792298|6137280|P8|COMPLETED|Treatment Period 1||30
2504044|NCT00792298|6137281|P7|COMPLETED|Treatment Period 1||27
2504045|NCT00792298|6137282|P6|COMPLETED|Treatment Period 1||29
2504046|NCT00792298|6137283|P5|COMPLETED|Treatment Period 1||32
2504047|NCT00792298|6137284|P4|COMPLETED|Treatment Period 1||28
2504048|NCT00792298|6137285|P3|COMPLETED|Treatment Period 1||31
2504049|NCT00792298|6137286|P2|COMPLETED|Treatment Period 1||31
2504050|NCT00792298|6137287|P1|COMPLETED|Treatment Period 1||30
2504051|NCT00792298|6137280|P8|STARTED|Treatment Period 1||31
2504052|NCT00792298|6137281|P7|STARTED|Treatment Period 1||31
2504053|NCT00792298|6137282|P6|STARTED|Treatment Period 1||32
2504054|NCT00792298|6137283|P5|STARTED|Treatment Period 1||32
2504055|NCT00792298|6137284|P4|STARTED|Treatment Period 1||32
2504056|NCT00792298|6137285|P3|STARTED|Treatment Period 1||33
2504057|NCT00792298|6137286|P2|STARTED|Treatment Period 1||32
2504058|NCT00792298|6137287|P1|STARTED|Treatment Period 1||31
2504059|NCT00792259|6137317|P3|NOT COMPLETED|Overall Study||0
2504060|NCT00792259|6137318|P2|NOT COMPLETED|Overall Study||0
2504061|NCT00792259|6137319|P1|NOT COMPLETED|Overall Study||1
2504062|NCT00792259|6137317|P3|COMPLETED|Overall Study||13
2504063|NCT00792259|6137318|P2|COMPLETED|Overall Study||20
2504064|NCT00792259|6137319|P1|COMPLETED|Overall Study||14
2504065|NCT00792259|6137317|P3|STARTED|Overall Study||13
2504066|NCT00792259|6137318|P2|STARTED|Overall Study||20
2504067|NCT00792259|6137319|P1|STARTED|Overall Study||15
2504068|NCT00792116|6137329|P2|NOT COMPLETED|Overall Study||1
2504069|NCT00792116|6137330|P1|NOT COMPLETED|Overall Study||1
2504070|NCT00792116|6137329|P2|COMPLETED|Overall Study||54
2504071|NCT00792116|6137330|P1|COMPLETED|Overall Study||52
2504072|NCT00792116|6137329|P2|STARTED|Overall Study||55
2504073|NCT00792116|6137330|P1|STARTED|Overall Study||53
2504074|NCT00792103|6137340|P1|NOT COMPLETED|Overall Study||133
2504075|NCT00792103|6137340|P1|COMPLETED|Overall Study||65
2504076|NCT00792103|6137340|P1|STARTED|Overall Study|15 subjects were enrolled but did not treat for a total of 183 subjects in the safety population|198
2504077|NCT00791999|6137352|P4|NOT COMPLETED|Overall Study||52
2504078|NCT00791999|6137353|P3|NOT COMPLETED|Overall Study||20
2504079|NCT00791999|6137354|P2|NOT COMPLETED|Overall Study||16
2504080|NCT00791999|6137355|P1|NOT COMPLETED|Overall Study||21
2504081|NCT00791999|6137352|P4|COMPLETED|Overall Study||25
2504082|NCT00791999|6137353|P3|COMPLETED|Overall Study||65
2504083|NCT00791999|6137354|P2|COMPLETED|Overall Study||66
2504084|NCT00791999|6137355|P1|COMPLETED|Overall Study||51
2504085|NCT00791999|6137352|P4|STARTED|Overall Study||77
2504086|NCT00791999|6137353|P3|STARTED|Overall Study||85
2504087|NCT00791999|6137354|P2|STARTED|Overall Study||82
2504088|NCT00791999|6137355|P1|STARTED|Overall Study||72
2504089|NCT00791973|6137371|P2|NOT COMPLETED|Second Intervention (1 Week)||0
2504090|NCT00791973|6137372|P1|NOT COMPLETED|Second Intervention (1 Week)||0
2504091|NCT00791973|6137371|P2|COMPLETED|Second Intervention (1 Week)||7
2504092|NCT00791973|6137372|P1|COMPLETED|Second Intervention (1 Week)||8
2504093|NCT00791973|6137371|P2|STARTED|Second Intervention (1 Week)||7
2504094|NCT00791973|6137372|P1|STARTED|Second Intervention (1 Week)||8
2504095|NCT00791973|6137371|P2|NOT COMPLETED|Washout (1 Week)||0
2504096|NCT00791973|6137372|P1|NOT COMPLETED|Washout (1 Week)||0
2504097|NCT00791973|6137371|P2|COMPLETED|Washout (1 Week)||7
2504098|NCT00791973|6137372|P1|COMPLETED|Washout (1 Week)||8
2504099|NCT00791973|6137371|P2|STARTED|Washout (1 Week)||7
2504100|NCT00791973|6137372|P1|STARTED|Washout (1 Week)||8
2504101|NCT00791973|6137371|P2|NOT COMPLETED|First Intervention (1 Week)||0
2504102|NCT00791973|6137372|P1|NOT COMPLETED|First Intervention (1 Week)||0
2504103|NCT00791973|6137371|P2|COMPLETED|First Intervention (1 Week)||7
2504104|NCT00791973|6137372|P1|COMPLETED|First Intervention (1 Week)||8
2504105|NCT00791973|6137371|P2|STARTED|First Intervention (1 Week)||7
2504106|NCT00791973|6137372|P1|STARTED|First Intervention (1 Week)||8
2504107|NCT00791934|6137380|P1|NOT COMPLETED|Overall Study||15
2504108|NCT00791934|6137380|P1|COMPLETED|Overall Study|Follow-up extended to 1 yr. 13 subjects chose not to participate in the extension.|48
2504109|NCT00791934|6137380|P1|STARTED|Overall Study||63
2504110|NCT00791921|6137390|P2|NOT COMPLETED|Overall Study||96
2504111|NCT00791921|6137391|P1|NOT COMPLETED|Overall Study||34
2504112|NCT00791921|6137390|P2|COMPLETED|Overall Study||18
2504113|NCT00791921|6137391|P1|COMPLETED|Overall Study||82
2504114|NCT00791921|6137390|P2|STARTED|Overall Study||114
2504115|NCT00791921|6137391|P1|STARTED|Overall Study||116
2504116|NCT00791908|6137399|P1|NOT COMPLETED|Overall Study||0
2504117|NCT00791908|6137399|P1|COMPLETED|Overall Study||15
2504118|NCT00791908|6137399|P1|STARTED|Overall Study||15
2504119|NCT00791843|6137407|P1|NOT COMPLETED|Overall Study||0
2504120|NCT00791843|6137407|P1|COMPLETED|Overall Study|Data unavailable for the study|0
2504121|NCT00791843|6137407|P1|STARTED|Overall Study|Data unavailable for the study|0
2504122|NCT00791817|6137413|P2|NOT COMPLETED|2: Single Dose||0
2504123|NCT00791817|6137414|P1|NOT COMPLETED|2: Single Dose||0
2504124|NCT00791817|6137413|P2|COMPLETED|2: Single Dose||5
2504125|NCT00791817|6137414|P1|COMPLETED|2: Single Dose||5
2504126|NCT00791817|6137413|P2|STARTED|2: Single Dose||5
2504127|NCT00791817|6137414|P1|STARTED|2: Single Dose||5
2504128|NCT00791817|6137413|P2|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
2504129|NCT00791817|6137414|P1|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
2504130|NCT00791817|6137413|P2|COMPLETED|1: Single Dose Followed by Week Washout||5
2504131|NCT00791817|6137414|P1|COMPLETED|1: Single Dose Followed by Week Washout||5
2504132|NCT00791817|6137413|P2|STARTED|1: Single Dose Followed by Week Washout||5
2504133|NCT00791817|6137414|P1|STARTED|1: Single Dose Followed by Week Washout||5
2504134|NCT00791778|6137422|P2|NOT COMPLETED|Follow-up||1
2504135|NCT00791778|6137423|P1|NOT COMPLETED|Follow-up||5
2504136|NCT00791778|6137422|P2|COMPLETED|Follow-up|Includes 78 participants with study follow-up terminated by sponsor and 12 deaths|90
2504137|NCT00791778|6137423|P1|COMPLETED|Follow-up|Includes 79 participants with study follow-up terminated by sponsor and 16 deaths|95
2504138|NCT00791778|6137422|P2|STARTED|Follow-up||91
2504139|NCT00791778|6137423|P1|STARTED|Follow-up||100
2504140|NCT00791778|6137422|P2|NOT COMPLETED|Double-blind Treatment||48
2504141|NCT00791778|6137423|P1|NOT COMPLETED|Double-blind Treatment||77
2504142|NCT00791778|6137422|P2|COMPLETED|Double-blind Treatment|includes: 75 subjects with progression|75
2504143|NCT00791778|6137423|P1|COMPLETED|Double-blind Treatment|includes: 42 subjects with progression, 4 subjects transferred to a continuation study|46
2504144|NCT00791778|6137422|P2|STARTED|Double-blind Treatment||123
2504145|NCT00791778|6137423|P1|STARTED|Double-blind Treatment||123
2504146|NCT00791765|6137477|P2|NOT COMPLETED|Weeks 13 to 24||8
2504147|NCT00791765|6137478|P1|NOT COMPLETED|Weeks 13 to 24||5
2504148|NCT00791765|6137477|P2|COMPLETED|Weeks 13 to 24||49
2504149|NCT00791765|6137478|P1|COMPLETED|Weeks 13 to 24||49
2504150|NCT00791765|6137477|P2|STARTED|Weeks 13 to 24|1 participant discontinued due to an adverse event after completing 12 weeks.|57
2504151|NCT00791765|6137478|P1|STARTED|Weeks 13 to 24||54
2504152|NCT00791765|6137477|P2|NOT COMPLETED|Weeks 1 to 12||4
2504153|NCT00791765|6137478|P1|NOT COMPLETED|Weeks 1 to 12||8
2504154|NCT00791765|6137477|P2|COMPLETED|Weeks 1 to 12||58
2504155|NCT00791765|6137478|P1|COMPLETED|Weeks 1 to 12||54
2504156|NCT00791765|6137477|P2|Treated|Weeks 1 to 12||59
2504157|NCT00791765|6137478|P1|Treated|Weeks 1 to 12||62
2504158|NCT00791765|6137477|P2|STARTED|Weeks 1 to 12||62
2504159|NCT00791765|6137478|P1|STARTED|Weeks 1 to 12||62
2504160|NCT00791700|6137493|P4|NOT COMPLETED|Overall Study||18
2504161|NCT00791700|6137494|P3|NOT COMPLETED|Overall Study||4
2504162|NCT00791700|6137495|P2|NOT COMPLETED|Overall Study||5
2504163|NCT00791700|6137496|P1|NOT COMPLETED|Overall Study||4
2504164|NCT00791700|6137493|P4|COMPLETED|Overall Study|Two participants discontinued treatment after the lower bound (days 313 and 314) of Week 48 window.|25
2504165|NCT00791700|6137494|P3|COMPLETED|Overall Study||9
2504166|NCT00791700|6137495|P2|COMPLETED|Overall Study||26
2504167|NCT00791700|6137496|P1|COMPLETED|Overall Study||12
2504168|NCT00791700|6137493|P4|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|43
2504169|NCT00791700|6137494|P3|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|13
2504170|NCT00791700|6137495|P2|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|31
2504171|NCT00791700|6137496|P1|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|16
2504172|NCT00791661|6137584|P3|NOT COMPLETED|Period 3||0
2504173|NCT00791661|6137585|P2|NOT COMPLETED|Period 3||0
2504174|NCT00791661|6137586|P1|NOT COMPLETED|Period 3||0
2504175|NCT00791661|6137584|P3|COMPLETED|Period 3||6
2504176|NCT00791661|6137585|P2|COMPLETED|Period 3||8
2504177|NCT00791661|6137586|P1|COMPLETED|Period 3||8
2504178|NCT00791661|6137584|P3|Received Matching Placebo to MK-1006|Period 3||1
2504179|NCT00791661|6137585|P2|Received Matching Placebo to MK-1006|Period 3||2
2504180|NCT00791661|6137586|P1|Received Matching Placebo to MK-1006|Period 3||2
2504181|NCT00791661|6137584|P3|Received MK-1006|Period 3||5
2504182|NCT00791661|6137585|P2|Received MK-1006|Period 3||6
2504183|NCT00791661|6137586|P1|Received MK-1006|Period 3||6
2504184|NCT00791661|6137584|P3|STARTED|Period 3||6
2504185|NCT00791661|6137585|P2|STARTED|Period 3||8
2504186|NCT00791661|6137586|P1|STARTED|Period 3||8
2504187|NCT00791661|6137584|P3|NOT COMPLETED|7 Day Wash-out||0
2504188|NCT00791661|6137585|P2|NOT COMPLETED|7 Day Wash-out||0
2504189|NCT00791661|6137586|P1|NOT COMPLETED|7 Day Wash-out||0
2504190|NCT00791661|6137584|P3|COMPLETED|7 Day Wash-out||6
2504191|NCT00791661|6137585|P2|COMPLETED|7 Day Wash-out||8
2504192|NCT00791661|6137586|P1|COMPLETED|7 Day Wash-out||8
2504193|NCT00791661|6137584|P3|STARTED|7 Day Wash-out||6
2504194|NCT00791661|6137585|P2|STARTED|7 Day Wash-out||8
2504195|NCT00791661|6137586|P1|STARTED|7 Day Wash-out||8
2504196|NCT00791661|6137584|P3|NOT COMPLETED|Period 2||0
2504197|NCT00791661|6137585|P2|NOT COMPLETED|Period 2||0
2504198|NCT00791661|6137586|P1|NOT COMPLETED|Period 2||0
2504199|NCT00791661|6137584|P3|COMPLETED|Period 2||6
2504200|NCT00791661|6137585|P2|COMPLETED|Period 2||8
2504201|NCT00791661|6137586|P1|COMPLETED|Period 2||8
2504202|NCT00791661|6137584|P3|Received Matching Placebo to MK-1006|Period 2||2
2504203|NCT00791661|6137585|P2|Received Matching Placebo to MK-1006|Period 2||2
2504204|NCT00791661|6137586|P1|Received Matching Placebo to MK-1006|Period 2||2
2504205|NCT00791661|6137584|P3|Received MK-1006|Period 2||4
2504206|NCT00791661|6137585|P2|Received MK-1006|Period 2||6
2504207|NCT00791661|6137586|P1|Received MK-1006|Period 2||6
2504208|NCT00791661|6137584|P3|STARTED|Period 2||6
2504209|NCT00791661|6137585|P2|STARTED|Period 2||8
2504210|NCT00791661|6137586|P1|STARTED|Period 2||8
2504211|NCT00791661|6137584|P3|NOT COMPLETED|7 Day Wash-out||2
2504212|NCT00791661|6137585|P2|NOT COMPLETED|7 Day Wash-out||0
2504213|NCT00791661|6137586|P1|NOT COMPLETED|7 Day Wash-out||0
2504214|NCT00791661|6137584|P3|COMPLETED|7 Day Wash-out||6
2504215|NCT00791661|6137585|P2|COMPLETED|7 Day Wash-out||8
2504216|NCT00791661|6137586|P1|COMPLETED|7 Day Wash-out||8
2504217|NCT00791661|6137584|P3|STARTED|7 Day Wash-out||8
2504218|NCT00791661|6137585|P2|STARTED|7 Day Wash-out||8
2504219|NCT00791661|6137586|P1|STARTED|7 Day Wash-out||8
2504220|NCT00791661|6137584|P3|NOT COMPLETED|Period 1||0
2504221|NCT00791661|6137585|P2|NOT COMPLETED|Period 1||0
2504222|NCT00791661|6137586|P1|NOT COMPLETED|Period 1||0
2504223|NCT00791661|6137584|P3|COMPLETED|Period 1||8
2504224|NCT00791661|6137585|P2|COMPLETED|Period 1||8
2504225|NCT00791661|6137586|P1|COMPLETED|Period 1||8
2504226|NCT00791661|6137584|P3|Received Matching Placebo to MK-1006|Period 1||2
2504227|NCT00791661|6137585|P2|Received Matching Placebo to MK-1006|Period 1||2
2504228|NCT00791661|6137586|P1|Received Matching Placebo to MK-1006|Period 1||2
2504229|NCT00791661|6137584|P3|Received MK-1006|Period 1||6
2504230|NCT00791661|6137585|P2|Received MK-1006|Period 1||6
2504231|NCT00791661|6137586|P1|Received MK-1006|Period 1||6
2504232|NCT00791661|6137584|P3|STARTED|Period 1||8
2504233|NCT00791661|6137585|P2|STARTED|Period 1||8
2504234|NCT00791661|6137586|P1|STARTED|Period 1||8
2504235|NCT00791648|6137679|P2|NOT COMPLETED|Overall Study||2
2504236|NCT00791648|6137680|P1|NOT COMPLETED|Overall Study||0
2504237|NCT00791648|6137679|P2|COMPLETED|Overall Study||307
2504238|NCT00791648|6137680|P1|COMPLETED|Overall Study||308
2504239|NCT00791648|6137679|P2|STARTED|Overall Study||309
2504240|NCT00791648|6137680|P1|STARTED|Overall Study||308
2504241|NCT00791557|6137716|P1|NOT COMPLETED|Overall Study||1
2504242|NCT00791557|6137716|P1|COMPLETED|Overall Study||1
2504243|NCT00791557|6137716|P1|STARTED|Overall Study||2
2504244|NCT00791518|6137720|P1|NOT COMPLETED|Overall Study||93
2504245|NCT00791518|6137720|P1|COMPLETED|Overall Study||991
2504246|NCT00791518|6137720|P1|STARTED|Overall Study||1084
2504247|NCT00791492|6137748|P2|NOT COMPLETED|Overall Study||3
2504248|NCT00791492|6137749|P1|NOT COMPLETED|Overall Study||6
2504249|NCT00791492|6137748|P2|COMPLETED|Overall Study||38
2504250|NCT00791492|6137749|P1|COMPLETED|Overall Study||39
2504251|NCT00791492|6137748|P2|TREATED|Overall Study||41
2504252|NCT00791492|6137749|P1|TREATED|Overall Study||44
2504253|NCT00791492|6137748|P2|STARTED|Overall Study||41
2504254|NCT00791492|6137749|P1|STARTED|Overall Study||45
2504255|NCT00791479|6137797|P6|NOT COMPLETED|Overall Study||3
2504256|NCT00791479|6137798|P5|NOT COMPLETED|Overall Study||3
2504257|NCT00791479|6137799|P4|NOT COMPLETED|Overall Study||4
2504258|NCT00791479|6137800|P3|NOT COMPLETED|Overall Study||0
2504259|NCT00791479|6137801|P2|NOT COMPLETED|Overall Study||3
2504260|NCT00791479|6137802|P1|NOT COMPLETED|Overall Study||2
2504261|NCT00791479|6137797|P6|COMPLETED|Overall Study||29
2504262|NCT00791479|6137798|P5|COMPLETED|Overall Study||0
2504263|NCT00791479|6137799|P4|COMPLETED|Overall Study||25
2504264|NCT00791479|6137800|P3|COMPLETED|Overall Study||34
2504265|NCT00791479|6137801|P2|COMPLETED|Overall Study||31
2504266|NCT00791479|6137802|P1|COMPLETED|Overall Study||33
2504267|NCT00791479|6137797|P6|Received at Least One Dose of Study Drug|Overall Study||32
2504268|NCT00791479|6137798|P5|Received at Least One Dose of Study Drug|Overall Study||3
2504269|NCT00791479|6137799|P4|Received at Least One Dose of Study Drug|Overall Study||29
2504270|NCT00791479|6137800|P3|Received at Least One Dose of Study Drug|Overall Study||34
2504271|NCT00791479|6137801|P2|Received at Least One Dose of Study Drug|Overall Study||34
2504272|NCT00791479|6137802|P1|Received at Least One Dose of Study Drug|Overall Study||35
2504273|NCT00791479|6137797|P6|STARTED|Overall Study||32
2504274|NCT00791479|6137798|P5|STARTED|Overall Study|3mg LY2189265 discont. Replaced with 1.5mg dose based on dose finding Study H9X-MC-GBCF; NCT00734474|3
2504275|NCT00791479|6137799|P4|STARTED|Overall Study||29
2504276|NCT00791479|6137800|P3|STARTED|Overall Study||34
2504277|NCT00791479|6137801|P2|STARTED|Overall Study||34
2504278|NCT00791479|6137802|P1|STARTED|Overall Study||35
2504279|NCT00791388|6137901|P5|NOT COMPLETED|Period 4 - 400 mg Dose Group||4
2504280|NCT00791388|6137902|P4|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
2504281|NCT00791388|6137903|P3|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
2504282|NCT00791388|6137904|P2|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
2504283|NCT00791388|6137905|P1|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
2504284|NCT00791388|6137901|P5|COMPLETED|Period 4 - 400 mg Dose Group||4
2504285|NCT00791388|6137902|P4|COMPLETED|Period 4 - 400 mg Dose Group||0
2504286|NCT00791388|6137903|P3|COMPLETED|Period 4 - 400 mg Dose Group||0
2504287|NCT00791388|6137904|P2|COMPLETED|Period 4 - 400 mg Dose Group||0
2504288|NCT00791388|6137905|P1|COMPLETED|Period 4 - 400 mg Dose Group||4
2504289|NCT00791388|6137901|P5|STARTED|Period 4 - 400 mg Dose Group||8
2504290|NCT00791388|6137902|P4|STARTED|Period 4 - 400 mg Dose Group||0
2504291|NCT00791388|6137903|P3|STARTED|Period 4 - 400 mg Dose Group||0
2504292|NCT00791388|6137904|P2|STARTED|Period 4 - 400 mg Dose Group||0
2504293|NCT00791388|6137905|P1|STARTED|Period 4 - 400 mg Dose Group||4
2504294|NCT00791388|6137901|P5|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
2504295|NCT00791388|6137902|P4|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
2504296|NCT00791388|6137903|P3|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
2504297|NCT00791388|6137904|P2|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
2504298|NCT00791388|6137905|P1|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
2504299|NCT00791388|6137901|P5|COMPLETED|Period 3 - 200 mg Dose Group||0
2504300|NCT00791388|6137902|P4|COMPLETED|Period 3 - 200 mg Dose Group||8
2504301|NCT00791388|6137903|P3|COMPLETED|Period 3 - 200 mg Dose Group||0
2504302|NCT00791388|6137904|P2|COMPLETED|Period 3 - 200 mg Dose Group||0
2504303|NCT00791388|6137905|P1|COMPLETED|Period 3 - 200 mg Dose Group||3
2504304|NCT00791388|6137901|P5|STARTED|Period 3 - 200 mg Dose Group||0
2504305|NCT00791388|6137902|P4|STARTED|Period 3 - 200 mg Dose Group||8
2504306|NCT00791388|6137903|P3|STARTED|Period 3 - 200 mg Dose Group||0
2504307|NCT00791388|6137904|P2|STARTED|Period 3 - 200 mg Dose Group||0
2504308|NCT00791388|6137905|P1|STARTED|Period 3 - 200 mg Dose Group||3
2504309|NCT00791388|6137901|P5|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
2504310|NCT00791388|6137902|P4|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
2504311|NCT00791388|6137903|P3|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
2504312|NCT00791388|6137904|P2|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
2504313|NCT00791388|6137905|P1|NOT COMPLETED|Period 2 - 100 mg Dose Group||1
2504314|NCT00791388|6137901|P5|COMPLETED|Period 2 - 100 mg Dose Group||0
2504315|NCT00791388|6137902|P4|COMPLETED|Period 2 - 100 mg Dose Group||0
2504316|NCT00791388|6137903|P3|COMPLETED|Period 2 - 100 mg Dose Group||8
2504317|NCT00791388|6137904|P2|COMPLETED|Period 2 - 100 mg Dose Group||0
2504318|NCT00791388|6137905|P1|COMPLETED|Period 2 - 100 mg Dose Group||2
2504319|NCT00791388|6137901|P5|STARTED|Period 2 - 100 mg Dose Group||0
2504320|NCT00791388|6137902|P4|STARTED|Period 2 - 100 mg Dose Group||0
2504321|NCT00791388|6137903|P3|STARTED|Period 2 - 100 mg Dose Group||8
2504322|NCT00791388|6137904|P2|STARTED|Period 2 - 100 mg Dose Group||0
2504323|NCT00791388|6137905|P1|STARTED|Period 2 - 100 mg Dose Group||3
2504324|NCT00791388|6137901|P5|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
2504325|NCT00791388|6137902|P4|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
2504326|NCT00791388|6137903|P3|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
2504327|NCT00791388|6137904|P2|NOT COMPLETED|Period 1 - 50 mg Dose Group||1
2504328|NCT00791388|6137905|P1|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
2504329|NCT00791388|6137901|P5|COMPLETED|Period 1 - 50 mg Dose Group||0
2504330|NCT00791388|6137902|P4|COMPLETED|Period 1 - 50 mg Dose Group||0
2504331|NCT00791388|6137903|P3|COMPLETED|Period 1 - 50 mg Dose Group||0
2504332|NCT00791388|6137904|P2|COMPLETED|Period 1 - 50 mg Dose Group||7
2504333|NCT00791388|6137905|P1|COMPLETED|Period 1 - 50 mg Dose Group||3
2504334|NCT00791388|6137901|P5|STARTED|Period 1 - 50 mg Dose Group||0
2504335|NCT00791388|6137902|P4|STARTED|Period 1 - 50 mg Dose Group||0
2504336|NCT00791388|6137903|P3|STARTED|Period 1 - 50 mg Dose Group||0
2504337|NCT00791388|6137904|P2|STARTED|Period 1 - 50 mg Dose Group||8
2504338|NCT00791388|6137905|P1|STARTED|Period 1 - 50 mg Dose Group||3
2504339|NCT00791336|6137932|P1|NOT COMPLETED|Overall Study||0
2504340|NCT00791336|6137932|P1|COMPLETED|Overall Study||1
2504341|NCT00791336|6137932|P1|STARTED|Overall Study||1
2504342|NCT00791323|6137940|P2|NOT COMPLETED|Overall Study||0
2504343|NCT00791323|6137941|P1|NOT COMPLETED|Overall Study||0
2504344|NCT00791323|6137940|P2|COMPLETED|Overall Study||3
2504345|NCT00791323|6137941|P1|COMPLETED|Overall Study||6
2504346|NCT00791323|6137940|P2|STARTED|Overall Study||3
2504347|NCT00791323|6137941|P1|STARTED|Overall Study||6
2504348|NCT00791258|6137947|P1|NOT COMPLETED|Overall Study||263
2504349|NCT00791258|6137947|P1|COMPLETED|Overall Study||736
2504350|NCT00791258|6137947|P1|STARTED|Overall Study||999
2504351|NCT00791128|6138009|P1|NOT COMPLETED|Overall Study||9
2504352|NCT00791128|6138009|P1|COMPLETED|Overall Study||13
2504353|NCT00791128|6138009|P1|STARTED|Overall Study||22
2504354|NCT00791102|6138014|P2|NOT COMPLETED|Period 2||0
2504355|NCT00791102|6138015|P1|NOT COMPLETED|Period 2||0
2504356|NCT00791102|6138014|P2|COMPLETED|Period 2||10
2504357|NCT00791102|6138015|P1|COMPLETED|Period 2||10
2504358|NCT00791102|6138014|P2|STARTED|Period 2||10
2504359|NCT00791102|6138015|P1|STARTED|Period 2||10
2504360|NCT00791102|6138014|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
2504361|NCT00791102|6138015|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
2504362|NCT00791102|6138014|P2|COMPLETED|Washout Period of 2 Weeks||10
2504363|NCT00791102|6138015|P1|COMPLETED|Washout Period of 2 Weeks||10
2504364|NCT00791102|6138014|P2|STARTED|Washout Period of 2 Weeks||10
2504365|NCT00791102|6138015|P1|STARTED|Washout Period of 2 Weeks||10
2504366|NCT00791102|6138014|P2|NOT COMPLETED|Period 1||0
2504367|NCT00791102|6138015|P1|NOT COMPLETED|Period 1||0
2504368|NCT00791102|6138014|P2|COMPLETED|Period 1||10
2504369|NCT00791102|6138015|P1|COMPLETED|Period 1||10
2504370|NCT00791102|6138014|P2|STARTED|Period 1||10
2504371|NCT00791102|6138015|P1|STARTED|Period 1||10
2504372|NCT00791089|6138033|P2|NOT COMPLETED|Overall Study||6
2504373|NCT00791089|6138034|P1|NOT COMPLETED|Overall Study||6
2504374|NCT00791089|6138033|P2|COMPLETED|Overall Study||0
2504375|NCT00791089|6138034|P1|COMPLETED|Overall Study||0
2504376|NCT00791089|6138033|P2|Six-month Data Collected|Overall Study||5
2504377|NCT00791089|6138034|P1|Six-month Data Collected|Overall Study||6
2504378|NCT00791089|6138033|P2|Began Actually Taking Fish Oil or Placeb|Overall Study||5
2504379|NCT00791089|6138034|P1|Began Actually Taking Fish Oil or Placeb|Overall Study||6
2504380|NCT00791089|6138033|P2|STARTED|Overall Study||6
2504381|NCT00791089|6138034|P1|STARTED|Overall Study||6
2504382|NCT00791076|6138040|P1|NOT COMPLETED|Overall Study||8
2504383|NCT00791076|6138040|P1|COMPLETED|Overall Study||0
2504384|NCT00791076|6138040|P1|STARTED|Overall Study||8
2504385|NCT00791037|6138048|P1|NOT COMPLETED|Overall Study||0
2504386|NCT00791037|6138048|P1|COMPLETED|Overall Study||23
2504387|NCT00791037|6138048|P1|Skeletal or Bone-only Disease by FDG-PET|Overall Study||1
2504388|NCT00791037|6138048|P1|Primary Outcome|Overall Study||19
2504389|NCT00791037|6138048|P1|STARTED|Overall Study||23
2504390|NCT00790933|6138060|P5|NOT COMPLETED|Overall Study||276
2504391|NCT00790933|6138061|P4|NOT COMPLETED|Overall Study||14
2504392|NCT00790933|6138062|P3|NOT COMPLETED|Overall Study||269
2504393|NCT00790933|6138063|P2|NOT COMPLETED|Overall Study||480
2504394|NCT00790933|6138064|P1|NOT COMPLETED|Overall Study||438
2504395|NCT00790933|6138060|P5|COMPLETED|Overall Study||145
2504396|NCT00790933|6138061|P4|COMPLETED|Overall Study||23
2504397|NCT00790933|6138062|P3|COMPLETED|Overall Study||115
2504398|NCT00790933|6138063|P2|COMPLETED|Overall Study||246
2504399|NCT00790933|6138064|P1|COMPLETED|Overall Study||237
2504400|NCT00790933|6138060|P5|STARTED|Overall Study||421
2504401|NCT00790933|6138061|P4|STARTED|Overall Study||37
2504402|NCT00790933|6138062|P3|STARTED|Overall Study||384
2504403|NCT00790933|6138063|P2|STARTED|Overall Study||726
2504404|NCT00790933|6138064|P1|STARTED|Overall Study||675
2504405|NCT00790907|6138595|P3|NOT COMPLETED|Overall Study||339
2504406|NCT00790907|6138596|P2|NOT COMPLETED|Overall Study||340
2504407|NCT00790907|6138597|P1|NOT COMPLETED|Overall Study||455
2504408|NCT00790907|6138595|P3|COMPLETED|Overall Study||663
2504409|NCT00790907|6138596|P2|COMPLETED|Overall Study||684
2504410|NCT00790907|6138597|P1|COMPLETED|Overall Study||754
2504411|NCT00790907|6138595|P3|STARTED|Overall Study||1002
2504412|NCT00790907|6138596|P2|STARTED|Overall Study||1024
2504413|NCT00790907|6138597|P1|STARTED|Overall Study||1209
2504414|NCT00790868|6138620|P2|NOT COMPLETED|Overall Study||17
2504415|NCT00790868|6138621|P1|NOT COMPLETED|Overall Study||6
2504416|NCT00790868|6138620|P2|COMPLETED|Overall Study||75
2504417|NCT00790868|6138621|P1|COMPLETED|Overall Study||82
2504418|NCT00790868|6138620|P2|STARTED|Overall Study||92
2504419|NCT00790868|6138621|P1|STARTED|Overall Study||88
2504420|NCT00790855|6138635|P1|NOT COMPLETED|Overall Study||0
2504421|NCT00790855|6138635|P1|COMPLETED|Overall Study||25
2504422|NCT00790855|6138635|P1|STARTED|Overall Study||25
2504423|NCT00790842|6138643|P11|NOT COMPLETED|Expansion Cohort||0
2504424|NCT00790842|6138644|P10|NOT COMPLETED|Expansion Cohort||0
2504425|NCT00790842|6138645|P9|NOT COMPLETED|Expansion Cohort||0
2504426|NCT00790842|6138646|P8|NOT COMPLETED|Expansion Cohort||0
2504427|NCT00790842|6138647|P7|NOT COMPLETED|Expansion Cohort||1
2504428|NCT00790842|6138648|P6|NOT COMPLETED|Expansion Cohort||0
2504429|NCT00790842|6138649|P5|NOT COMPLETED|Expansion Cohort||0
2504430|NCT00790842|6138650|P4|NOT COMPLETED|Expansion Cohort||0
2504431|NCT00790842|6138651|P3|NOT COMPLETED|Expansion Cohort||7
2504432|NCT00790842|6138652|P2|NOT COMPLETED|Expansion Cohort||0
2504433|NCT00790842|6138653|P1|NOT COMPLETED|Expansion Cohort||0
2504434|NCT00790842|6138643|P11|COMPLETED|Expansion Cohort||0
2504435|NCT00790842|6138644|P10|COMPLETED|Expansion Cohort||0
2504436|NCT00790842|6138645|P9|COMPLETED|Expansion Cohort||0
2504437|NCT00790842|6138646|P8|COMPLETED|Expansion Cohort||0
2504438|NCT00790842|6138647|P7|COMPLETED|Expansion Cohort||1
2504439|NCT00790842|6138648|P6|COMPLETED|Expansion Cohort||0
2504440|NCT00790842|6138649|P5|COMPLETED|Expansion Cohort||0
2504441|NCT00790842|6138650|P4|COMPLETED|Expansion Cohort||0
2504442|NCT00790842|6138651|P3|COMPLETED|Expansion Cohort||7
2504443|NCT00790842|6138652|P2|COMPLETED|Expansion Cohort||0
2504444|NCT00790842|6138653|P1|COMPLETED|Expansion Cohort||0
2504445|NCT00790842|6138643|P11|Began Treatment|Expansion Cohort||0
2504446|NCT00790842|6138644|P10|Began Treatment|Expansion Cohort||0
2504447|NCT00790842|6138645|P9|Began Treatment|Expansion Cohort||0
2504448|NCT00790842|6138646|P8|Began Treatment|Expansion Cohort||0
2504449|NCT00790842|6138647|P7|Began Treatment|Expansion Cohort||2
2504450|NCT00790842|6138648|P6|Began Treatment|Expansion Cohort||0
2504451|NCT00790842|6138649|P5|Began Treatment|Expansion Cohort||0
2504452|NCT00790842|6138650|P4|Began Treatment|Expansion Cohort||0
2504453|NCT00790842|6138651|P3|Began Treatment|Expansion Cohort||14
2504454|NCT00790842|6138652|P2|Began Treatment|Expansion Cohort||0
2504455|NCT00790842|6138653|P1|Began Treatment|Expansion Cohort||0
2504456|NCT00790842|6138643|P11|STARTED|Expansion Cohort||0
2504457|NCT00790842|6138644|P10|STARTED|Expansion Cohort||0
2504458|NCT00790842|6138645|P9|STARTED|Expansion Cohort||0
2504459|NCT00790842|6138646|P8|STARTED|Expansion Cohort||0
2504460|NCT00790842|6138647|P7|STARTED|Expansion Cohort||2
2504461|NCT00790842|6138648|P6|STARTED|Expansion Cohort||0
2504462|NCT00790842|6138649|P5|STARTED|Expansion Cohort||0
2504463|NCT00790842|6138650|P4|STARTED|Expansion Cohort||0
2504464|NCT00790842|6138651|P3|STARTED|Expansion Cohort||14
2504465|NCT00790842|6138652|P2|STARTED|Expansion Cohort||0
2504466|NCT00790842|6138653|P1|STARTED|Expansion Cohort||0
2504467|NCT00790842|6138643|P11|NOT COMPLETED|Dose Level 4||2
2504468|NCT00790842|6138644|P10|NOT COMPLETED|Dose Level 4||0
2504469|NCT00790842|6138645|P9|NOT COMPLETED|Dose Level 4||0
2504470|NCT00790842|6138646|P8|NOT COMPLETED|Dose Level 4||0
2504471|NCT00790842|6138647|P7|NOT COMPLETED|Dose Level 4||2
2504472|NCT00790842|6138648|P6|NOT COMPLETED|Dose Level 4||0
2504473|NCT00790842|6138649|P5|NOT COMPLETED|Dose Level 4||0
2504474|NCT00790842|6138650|P4|NOT COMPLETED|Dose Level 4||0
2504475|NCT00790842|6138651|P3|NOT COMPLETED|Dose Level 4||0
2504476|NCT00790842|6138652|P2|NOT COMPLETED|Dose Level 4||0
2504477|NCT00790842|6138653|P1|NOT COMPLETED|Dose Level 4||0
2504478|NCT00790842|6138643|P11|COMPLETED|Dose Level 4||3
2504479|NCT00790842|6138644|P10|COMPLETED|Dose Level 4||0
2504480|NCT00790842|6138645|P9|COMPLETED|Dose Level 4||0
2504481|NCT00790842|6138646|P8|COMPLETED|Dose Level 4||0
2504482|NCT00790842|6138647|P7|COMPLETED|Dose Level 4||6
2504483|NCT00790842|6138648|P6|COMPLETED|Dose Level 4||0
2504484|NCT00790842|6138649|P5|COMPLETED|Dose Level 4||0
2504485|NCT00790842|6138650|P4|COMPLETED|Dose Level 4||0
2504486|NCT00790842|6138651|P3|COMPLETED|Dose Level 4||0
2504487|NCT00790842|6138652|P2|COMPLETED|Dose Level 4||0
2504488|NCT00790842|6138653|P1|COMPLETED|Dose Level 4||0
2504489|NCT00790842|6138643|P11|Began Treatment|Dose Level 4||5
2504490|NCT00790842|6138644|P10|Began Treatment|Dose Level 4||0
2504491|NCT00790842|6138645|P9|Began Treatment|Dose Level 4||0
2504492|NCT00790842|6138646|P8|Began Treatment|Dose Level 4||0
2504493|NCT00790842|6138647|P7|Began Treatment|Dose Level 4||8
2504494|NCT00790842|6138648|P6|Began Treatment|Dose Level 4||0
2504495|NCT00790842|6138649|P5|Began Treatment|Dose Level 4||0
2504496|NCT00790842|6138650|P4|Began Treatment|Dose Level 4||0
2504497|NCT00790842|6138651|P3|Began Treatment|Dose Level 4||0
2504498|NCT00790842|6138652|P2|Began Treatment|Dose Level 4||0
2504499|NCT00790842|6138653|P1|Began Treatment|Dose Level 4||0
2504500|NCT00790842|6138643|P11|STARTED|Dose Level 4||5
2504501|NCT00790842|6138644|P10|STARTED|Dose Level 4||0
2504502|NCT00790842|6138645|P9|STARTED|Dose Level 4||0
2504503|NCT00790842|6138646|P8|STARTED|Dose Level 4||0
2504504|NCT00790842|6138647|P7|STARTED|Dose Level 4||8
2504505|NCT00790842|6138648|P6|STARTED|Dose Level 4||0
2504506|NCT00790842|6138649|P5|STARTED|Dose Level 4||0
2504507|NCT00790842|6138650|P4|STARTED|Dose Level 4||0
2504508|NCT00790842|6138651|P3|STARTED|Dose Level 4||0
2504509|NCT00790842|6138652|P2|STARTED|Dose Level 4||0
2504510|NCT00790842|6138653|P1|STARTED|Dose Level 4||0
2504511|NCT00790842|6138643|P11|NOT COMPLETED|Dose Level 3||0
2504512|NCT00790842|6138644|P10|NOT COMPLETED|Dose Level 3||2
2504513|NCT00790842|6138645|P9|NOT COMPLETED|Dose Level 3||0
2504514|NCT00790842|6138646|P8|NOT COMPLETED|Dose Level 3||0
2504515|NCT00790842|6138647|P7|NOT COMPLETED|Dose Level 3||0
2504516|NCT00790842|6138648|P6|NOT COMPLETED|Dose Level 3||1
2504517|NCT00790842|6138649|P5|NOT COMPLETED|Dose Level 3||0
2504518|NCT00790842|6138650|P4|NOT COMPLETED|Dose Level 3||0
2504519|NCT00790842|6138651|P3|NOT COMPLETED|Dose Level 3||5
2504520|NCT00790842|6138652|P2|NOT COMPLETED|Dose Level 3||0
2504521|NCT00790842|6138653|P1|NOT COMPLETED|Dose Level 3||0
2504522|NCT00790842|6138643|P11|COMPLETED|Dose Level 3||0
2504523|NCT00790842|6138644|P10|COMPLETED|Dose Level 3||1
2504524|NCT00790842|6138645|P9|COMPLETED|Dose Level 3||0
2504525|NCT00790842|6138646|P8|COMPLETED|Dose Level 3||0
2504526|NCT00790842|6138647|P7|COMPLETED|Dose Level 3||0
2504527|NCT00790842|6138648|P6|COMPLETED|Dose Level 3||2
2504528|NCT00790842|6138649|P5|COMPLETED|Dose Level 3||0
2504529|NCT00790842|6138650|P4|COMPLETED|Dose Level 3||0
2504530|NCT00790842|6138651|P3|COMPLETED|Dose Level 3||2
2504531|NCT00790842|6138652|P2|COMPLETED|Dose Level 3||0
2504532|NCT00790842|6138653|P1|COMPLETED|Dose Level 3||0
2504533|NCT00790842|6138643|P11|Began Treatment|Dose Level 3||0
2504534|NCT00790842|6138644|P10|Began Treatment|Dose Level 3||3
2504535|NCT00790842|6138645|P9|Began Treatment|Dose Level 3||0
2504536|NCT00790842|6138646|P8|Began Treatment|Dose Level 3||0
2504537|NCT00790842|6138647|P7|Began Treatment|Dose Level 3||0
2504538|NCT00790842|6138648|P6|Began Treatment|Dose Level 3||3
2504539|NCT00790842|6138649|P5|Began Treatment|Dose Level 3||0
2504540|NCT00790842|6138650|P4|Began Treatment|Dose Level 3||0
2504541|NCT00790842|6138651|P3|Began Treatment|Dose Level 3||6
2504542|NCT00790842|6138652|P2|Began Treatment|Dose Level 3||0
2504543|NCT00790842|6138653|P1|Began Treatment|Dose Level 3||0
2504544|NCT00790842|6138643|P11|STARTED|Dose Level 3||0
2504545|NCT00790842|6138644|P10|STARTED|Dose Level 3||3
2504546|NCT00790842|6138645|P9|STARTED|Dose Level 3||0
2504547|NCT00790842|6138646|P8|STARTED|Dose Level 3||0
2504548|NCT00790842|6138647|P7|STARTED|Dose Level 3||0
2504549|NCT00790842|6138648|P6|STARTED|Dose Level 3||3
2504550|NCT00790842|6138649|P5|STARTED|Dose Level 3||0
2504551|NCT00790842|6138650|P4|STARTED|Dose Level 3||0
2504552|NCT00790842|6138651|P3|STARTED|Dose Level 3||7
2504553|NCT00790842|6138652|P2|STARTED|Dose Level 3||0
2504554|NCT00790842|6138653|P1|STARTED|Dose Level 3||0
2504555|NCT00790842|6138643|P11|NOT COMPLETED|Dose Level 2||0
2504556|NCT00790842|6138644|P10|NOT COMPLETED|Dose Level 2||0
2504557|NCT00790842|6138645|P9|NOT COMPLETED|Dose Level 2||2
2504558|NCT00790842|6138646|P8|NOT COMPLETED|Dose Level 2||0
2504559|NCT00790842|6138647|P7|NOT COMPLETED|Dose Level 2||0
2504560|NCT00790842|6138648|P6|NOT COMPLETED|Dose Level 2||0
2504561|NCT00790842|6138649|P5|NOT COMPLETED|Dose Level 2||1
2504562|NCT00790842|6138650|P4|NOT COMPLETED|Dose Level 2||0
2504563|NCT00790842|6138651|P3|NOT COMPLETED|Dose Level 2||0
2504564|NCT00790842|6138652|P2|NOT COMPLETED|Dose Level 2||3
2504565|NCT00790842|6138653|P1|NOT COMPLETED|Dose Level 2||0
2504566|NCT00790842|6138643|P11|COMPLETED|Dose Level 2||0
2504567|NCT00790842|6138644|P10|COMPLETED|Dose Level 2||0
2504568|NCT00790842|6138645|P9|COMPLETED|Dose Level 2||1
2504569|NCT00790842|6138646|P8|COMPLETED|Dose Level 2||0
2504570|NCT00790842|6138647|P7|COMPLETED|Dose Level 2||0
2504571|NCT00790842|6138648|P6|COMPLETED|Dose Level 2||0
2504572|NCT00790842|6138649|P5|COMPLETED|Dose Level 2||2
2504573|NCT00790842|6138650|P4|COMPLETED|Dose Level 2||0
2504574|NCT00790842|6138651|P3|COMPLETED|Dose Level 2||0
2504575|NCT00790842|6138652|P2|COMPLETED|Dose Level 2||0
2504576|NCT00790842|6138653|P1|COMPLETED|Dose Level 2||0
2504577|NCT00790842|6138643|P11|Began Treatment|Dose Level 2||0
2504578|NCT00790842|6138644|P10|Began Treatment|Dose Level 2||0
2504579|NCT00790842|6138645|P9|Began Treatment|Dose Level 2||3
2504580|NCT00790842|6138646|P8|Began Treatment|Dose Level 2||0
2504581|NCT00790842|6138647|P7|Began Treatment|Dose Level 2||0
2504582|NCT00790842|6138648|P6|Began Treatment|Dose Level 2||0
2504583|NCT00790842|6138649|P5|Began Treatment|Dose Level 2||3
2504584|NCT00790842|6138650|P4|Began Treatment|Dose Level 2||0
2504585|NCT00790842|6138651|P3|Began Treatment|Dose Level 2||0
2504586|NCT00790842|6138652|P2|Began Treatment|Dose Level 2||3
2504587|NCT00790842|6138653|P1|Began Treatment|Dose Level 2||0
2504588|NCT00790842|6138643|P11|STARTED|Dose Level 2||0
2504589|NCT00790842|6138644|P10|STARTED|Dose Level 2||0
2504590|NCT00790842|6138645|P9|STARTED|Dose Level 2||3
2504591|NCT00790842|6138646|P8|STARTED|Dose Level 2||0
2504592|NCT00790842|6138647|P7|STARTED|Dose Level 2||0
2504593|NCT00790842|6138648|P6|STARTED|Dose Level 2||0
2504594|NCT00790842|6138649|P5|STARTED|Dose Level 2||3
2504595|NCT00790842|6138650|P4|STARTED|Dose Level 2||0
2504596|NCT00790842|6138651|P3|STARTED|Dose Level 2||0
2504597|NCT00790842|6138652|P2|STARTED|Dose Level 2||3
2504598|NCT00790842|6138653|P1|STARTED|Dose Level 2||0
2504599|NCT00790842|6138643|P11|NOT COMPLETED|Dose Level 1||0
2504600|NCT00790842|6138644|P10|NOT COMPLETED|Dose Level 1||0
2504601|NCT00790842|6138645|P9|NOT COMPLETED|Dose Level 1||0
2504602|NCT00790842|6138646|P8|NOT COMPLETED|Dose Level 1||2
2504603|NCT00790842|6138647|P7|NOT COMPLETED|Dose Level 1||0
2504604|NCT00790842|6138648|P6|NOT COMPLETED|Dose Level 1||0
2504605|NCT00790842|6138649|P5|NOT COMPLETED|Dose Level 1||0
2504606|NCT00790842|6138650|P4|NOT COMPLETED|Dose Level 1||2
2504607|NCT00790842|6138651|P3|NOT COMPLETED|Dose Level 1||0
2504608|NCT00790842|6138652|P2|NOT COMPLETED|Dose Level 1||0
2504609|NCT00790842|6138653|P1|NOT COMPLETED|Dose Level 1||3
2504610|NCT00790842|6138643|P11|COMPLETED|Dose Level 1||0
2504611|NCT00790842|6138644|P10|COMPLETED|Dose Level 1||0
2504612|NCT00790842|6138645|P9|COMPLETED|Dose Level 1||0
2504613|NCT00790842|6138646|P8|COMPLETED|Dose Level 1||1
2504614|NCT00790842|6138647|P7|COMPLETED|Dose Level 1||0
2504615|NCT00790842|6138648|P6|COMPLETED|Dose Level 1||0
2504616|NCT00790842|6138649|P5|COMPLETED|Dose Level 1||0
2504617|NCT00790842|6138650|P4|COMPLETED|Dose Level 1||1
2504618|NCT00790842|6138651|P3|COMPLETED|Dose Level 1||0
2504619|NCT00790842|6138652|P2|COMPLETED|Dose Level 1||0
2504620|NCT00790842|6138653|P1|COMPLETED|Dose Level 1||3
2504621|NCT00790842|6138643|P11|Began Treatment|Dose Level 1||0
2504622|NCT00790842|6138644|P10|Began Treatment|Dose Level 1||0
2504623|NCT00790842|6138645|P9|Began Treatment|Dose Level 1||0
2504624|NCT00790842|6138646|P8|Began Treatment|Dose Level 1||3
2504625|NCT00790842|6138647|P7|Began Treatment|Dose Level 1||0
2504626|NCT00790842|6138648|P6|Began Treatment|Dose Level 1||0
2504627|NCT00790842|6138649|P5|Began Treatment|Dose Level 1||0
2504628|NCT00790842|6138650|P4|Began Treatment|Dose Level 1||3
2504629|NCT00790842|6138651|P3|Began Treatment|Dose Level 1||0
2504630|NCT00790842|6138652|P2|Began Treatment|Dose Level 1||0
2504631|NCT00790842|6138653|P1|Began Treatment|Dose Level 1||6
2504632|NCT00790842|6138643|P11|STARTED|Dose Level 1||0
2504633|NCT00790842|6138644|P10|STARTED|Dose Level 1||0
2504634|NCT00790842|6138645|P9|STARTED|Dose Level 1||0
2504635|NCT00790842|6138646|P8|STARTED|Dose Level 1||3
2504636|NCT00790842|6138647|P7|STARTED|Dose Level 1||0
2504637|NCT00790842|6138648|P6|STARTED|Dose Level 1||0
2504638|NCT00790842|6138649|P5|STARTED|Dose Level 1||0
2504639|NCT00790842|6138650|P4|STARTED|Dose Level 1||3
2504640|NCT00790842|6138651|P3|STARTED|Dose Level 1||0
2504641|NCT00790842|6138652|P2|STARTED|Dose Level 1||0
2504642|NCT00790842|6138653|P1|STARTED|Dose Level 1||6
2504643|NCT00790803|6138710|P1|NOT COMPLETED|Overall Study||0
2504644|NCT00790803|6138710|P1|COMPLETED|Overall Study||5
2504645|NCT00790803|6138710|P1|STARTED|Overall Study||5
2504646|NCT00790790|6138721|P3|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
2504647|NCT00790790|6138722|P2|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
2504648|NCT00790790|6138723|P1|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
2504649|NCT00790790|6138721|P3|COMPLETED|Study Period 3: 1-Week Washout Phase||26
2504650|NCT00790790|6138722|P2|COMPLETED|Study Period 3: 1-Week Washout Phase||31
2504651|NCT00790790|6138723|P1|COMPLETED|Study Period 3: 1-Week Washout Phase||37
2504652|NCT00790790|6138721|P3|STARTED|Study Period 3: 1-Week Washout Phase||27
2504653|NCT00790790|6138722|P2|STARTED|Study Period 3: 1-Week Washout Phase||32
2504654|NCT00790790|6138723|P1|STARTED|Study Period 3: 1-Week Washout Phase||37
2504655|NCT00790790|6138721|P3|NOT COMPLETED|Study Period 2: Therapy Phase||21
2504656|NCT00790790|6138722|P2|NOT COMPLETED|Study Period 2: Therapy Phase||18
2504657|NCT00790790|6138723|P1|NOT COMPLETED|Study Period 2: Therapy Phase||12
2504658|NCT00790790|6138721|P3|COMPLETED|Study Period 2: Therapy Phase||27
2504659|NCT00790790|6138722|P2|COMPLETED|Study Period 2: Therapy Phase||32
2504660|NCT00790790|6138723|P1|COMPLETED|Study Period 2: Therapy Phase||37
2504661|NCT00790790|6138721|P3|STARTED|Study Period 2: Therapy Phase||48
2504662|NCT00790790|6138722|P2|STARTED|Study Period 2: Therapy Phase||50
2504663|NCT00790790|6138723|P1|STARTED|Study Period 2: Therapy Phase||49
2504664|NCT00790751|6138800|P4|NOT COMPLETED|Overall Study||21
2504665|NCT00790751|6138801|P3|NOT COMPLETED|Overall Study||20
2504666|NCT00790751|6138802|P2|NOT COMPLETED|Overall Study||30
2504667|NCT00790751|6138803|P1|NOT COMPLETED|Overall Study||25
2504668|NCT00790751|6138800|P4|COMPLETED|Overall Study||141
2504669|NCT00790751|6138801|P3|COMPLETED|Overall Study||141
2504670|NCT00790751|6138802|P2|COMPLETED|Overall Study||131
2504671|NCT00790751|6138803|P1|COMPLETED|Overall Study||137
2504672|NCT00790751|6138800|P4|STARTED|Overall Study||162
2504673|NCT00790751|6138801|P3|STARTED|Overall Study||161
2504674|NCT00790751|6138802|P2|STARTED|Overall Study||161
2504675|NCT00790751|6138803|P1|STARTED|Overall Study||162
2504676|NCT00790738|6138823|P2|NOT COMPLETED|Overall Study||3
2504677|NCT00790738|6138824|P1|NOT COMPLETED|Overall Study||2
2504678|NCT00790738|6138823|P2|COMPLETED|Overall Study||3
2504679|NCT00790738|6138824|P1|COMPLETED|Overall Study||3
2504680|NCT00790738|6138823|P2|STARTED|Overall Study||6
2504681|NCT00790738|6138824|P1|STARTED|Overall Study||5
2504682|NCT00790673|6138838|P4|NOT COMPLETED|Overall Study||0
2504683|NCT00790673|6138839|P3|NOT COMPLETED|Overall Study||0
2504684|NCT00790673|6138840|P2|NOT COMPLETED|Overall Study||0
2504685|NCT00790673|6138841|P1|NOT COMPLETED|Overall Study||0
2504686|NCT00790673|6138838|P4|COMPLETED|Overall Study||8
2504687|NCT00790673|6138839|P3|COMPLETED|Overall Study||12
2504688|NCT00790673|6138840|P2|COMPLETED|Overall Study||6
2504689|NCT00790673|6138841|P1|COMPLETED|Overall Study||6
2504690|NCT00790673|6138838|P4|STARTED|Overall Study||8
2504691|NCT00790673|6138839|P3|STARTED|Overall Study||12
2504692|NCT00790673|6138840|P2|STARTED|Overall Study||6
2504693|NCT00790673|6138841|P1|STARTED|Overall Study||6
2504694|NCT00790647|6138851|P1|NOT COMPLETED|Overall Study||1
2504695|NCT00790647|6138851|P1|COMPLETED|Overall Study||9
2504696|NCT00790647|6138851|P1|STARTED|Overall Study||10
2504697|NCT00790569|6138861|P3|NOT COMPLETED|End of Study (12 Month Interview)||50
2504698|NCT00790569|6138862|P2|NOT COMPLETED|End of Study (12 Month Interview)||19
2504699|NCT00790569|6138863|P1|NOT COMPLETED|End of Study (12 Month Interview)||66
2504700|NCT00790569|6138861|P3|COMPLETED|End of Study (12 Month Interview)||83
2504701|NCT00790569|6138862|P2|COMPLETED|End of Study (12 Month Interview)||26
2504702|NCT00790569|6138863|P1|COMPLETED|End of Study (12 Month Interview)||71
2504703|NCT00790569|6138861|P3|STARTED|End of Study (12 Month Interview)||133
2504704|NCT00790569|6138862|P2|STARTED|End of Study (12 Month Interview)||45
2504705|NCT00790569|6138863|P1|STARTED|End of Study (12 Month Interview)||137
2504706|NCT00790569|6138861|P3|NOT COMPLETED|End of Treatment (6 Month Interview)||26
2504707|NCT00790569|6138862|P2|NOT COMPLETED|End of Treatment (6 Month Interview)||10
2504708|NCT00790569|6138863|P1|NOT COMPLETED|End of Treatment (6 Month Interview)||22
2504709|NCT00790569|6138861|P3|COMPLETED|End of Treatment (6 Month Interview)||107
2504710|NCT00790569|6138862|P2|COMPLETED|End of Treatment (6 Month Interview)||35
2504711|NCT00790569|6138863|P1|COMPLETED|End of Treatment (6 Month Interview)||115
2504712|NCT00790569|6138861|P3|STARTED|End of Treatment (6 Month Interview)||133
2504713|NCT00790569|6138862|P2|STARTED|End of Treatment (6 Month Interview)||45
2504714|NCT00790569|6138863|P1|STARTED|End of Treatment (6 Month Interview)||137
2504715|NCT00790556|6138904|P2|NOT COMPLETED|Treatment Period 2||0
2504716|NCT00790556|6138905|P1|NOT COMPLETED|Treatment Period 2||0
2504717|NCT00790556|6138904|P2|COMPLETED|Treatment Period 2||6
2504718|NCT00790556|6138905|P1|COMPLETED|Treatment Period 2||6
2504719|NCT00790556|6138904|P2|STARTED|Treatment Period 2||6
2504720|NCT00790556|6138905|P1|STARTED|Treatment Period 2||6
2504721|NCT00790556|6138904|P2|NOT COMPLETED|Washout After Period 1||0
2504722|NCT00790556|6138905|P1|NOT COMPLETED|Washout After Period 1||0
2504723|NCT00790556|6138904|P2|COMPLETED|Washout After Period 1||6
2504724|NCT00790556|6138905|P1|COMPLETED|Washout After Period 1||6
2504725|NCT00790556|6138904|P2|STARTED|Washout After Period 1||6
2504726|NCT00790556|6138905|P1|STARTED|Washout After Period 1||6
2504727|NCT00790556|6138904|P2|NOT COMPLETED|Treatment Period 1||0
2504728|NCT00790556|6138905|P1|NOT COMPLETED|Treatment Period 1||2
2504729|NCT00790556|6138904|P2|COMPLETED|Treatment Period 1||6
2504730|NCT00790556|6138905|P1|COMPLETED|Treatment Period 1||6
2504731|NCT00790556|6138904|P2|STARTED|Treatment Period 1||6
2504732|NCT00790556|6138905|P1|STARTED|Treatment Period 1||8
2504733|NCT00790452|6138917|P2|NOT COMPLETED|Overall Study||0
2504734|NCT00790452|6138918|P1|NOT COMPLETED|Overall Study||1
2504735|NCT00790452|6138917|P2|COMPLETED|Overall Study||0
2504736|NCT00790452|6138918|P1|COMPLETED|Overall Study||0
2504737|NCT00790452|6138917|P2|STARTED|Overall Study||0
2504738|NCT00790452|6138918|P1|STARTED|Overall Study||1
2504739|NCT00790400|6138926|P2|NOT COMPLETED|Everolimus Period (Core or Extension)||0
2504740|NCT00790400|6138927|P1|NOT COMPLETED|Everolimus Period (Core or Extension)||29
2504741|NCT00790400|6138926|P2|COMPLETED|Everolimus Period (Core or Extension)||0
2504742|NCT00790400|6138927|P1|COMPLETED|Everolimus Period (Core or Extension)|Treatment duration completed as per protocol|83
2504743|NCT00790400|6138926|P2|STARTED|Everolimus Period (Core or Extension)|"Placebo randomized patients who switched to Everolimus are reported in Everolimus arm."|0
2504744|NCT00790400|6138927|P1|STARTED|Everolimus Period (Core or Extension)|112 pts had Everolimus during core and/or extension (6 from placebo did not switch to Eve. in ext.)|112
2504745|NCT00790400|6138926|P2|NOT COMPLETED|Double-blind Period (Core Phase)||13
2504746|NCT00790400|6138927|P1|NOT COMPLETED|Double-blind Period (Core Phase)||7
2504747|NCT00790400|6138926|P2|COMPLETED|Double-blind Period (Core Phase)|Completed = 1st received Placebo in the Core phase, switched to Everolimus in Extension phase|26
2504748|NCT00790400|6138927|P1|COMPLETED|Double-blind Period (Core Phase)|Completed = Completed the Core phase & moved to Extension phase|72
2504749|NCT00790400|6138926|P2|STARTED|Double-blind Period (Core Phase)||39
2504750|NCT00790400|6138927|P1|STARTED|Double-blind Period (Core Phase)||79
2504751|NCT00790335|6138956|P2|NOT COMPLETED|Overall Study||112
2504752|NCT00790335|6138957|P1|NOT COMPLETED|Overall Study||80
2504753|NCT00790335|6138956|P2|COMPLETED|Overall Study||243
2504754|NCT00790335|6138957|P1|COMPLETED|Overall Study||257
2504755|NCT00790335|6138956|P2|STARTED|Overall Study||355
2504756|NCT00790335|6138957|P1|STARTED|Overall Study||337
2504757|NCT00790296|6139017|P2|NOT COMPLETED|Overall Study||2
2504758|NCT00790296|6139018|P1|NOT COMPLETED|Overall Study||1
2504759|NCT00790296|6139017|P2|COMPLETED|Overall Study||4
2504760|NCT00790296|6139018|P1|COMPLETED|Overall Study||4
2504761|NCT00790296|6139017|P2|STARTED|Overall Study||6
2504762|NCT00790296|6139018|P1|STARTED|Overall Study||5
2504763|NCT00790270|6139027|P3|NOT COMPLETED|Overall Study||0
2504764|NCT00790270|6139028|P2|NOT COMPLETED|Overall Study||0
2504765|NCT00790270|6139029|P1|NOT COMPLETED|Overall Study||0
2504766|NCT00790270|6139027|P3|COMPLETED|Overall Study||20
2504767|NCT00790270|6139028|P2|COMPLETED|Overall Study||20
2504768|NCT00790270|6139029|P1|COMPLETED|Overall Study||21
2504769|NCT00790270|6139027|P3|STARTED|Overall Study||20
2504770|NCT00790270|6139028|P2|STARTED|Overall Study||20
2504771|NCT00790270|6139029|P1|STARTED|Overall Study||21
2504772|NCT00790218|6139040|P3|NOT COMPLETED|Overall Study||0
2504773|NCT00790218|6139041|P2|NOT COMPLETED|Overall Study||0
2504774|NCT00790218|6139042|P1|NOT COMPLETED|Overall Study||1
2504775|NCT00790218|6139040|P3|COMPLETED|Overall Study||7
2504776|NCT00790218|6139041|P2|COMPLETED|Overall Study||6
2504777|NCT00790218|6139042|P1|COMPLETED|Overall Study||5
2504778|NCT00790218|6139040|P3|STARTED|Overall Study||7
2504779|NCT00790218|6139041|P2|STARTED|Overall Study||6
2504780|NCT00790218|6139042|P1|STARTED|Overall Study||6
2504781|NCT00790205|6139052|P2|NOT COMPLETED|Overall Study||434
2504782|NCT00790205|6139053|P1|NOT COMPLETED|Overall Study||360
2504783|NCT00790205|6139052|P2|COMPLETED|Overall Study||6905
2504784|NCT00790205|6139053|P1|COMPLETED|Overall Study||6972
2504785|NCT00790205|6139052|P2|Treated|Overall Study||7274
2504786|NCT00790205|6139053|P1|Treated|Overall Study||7266
2504787|NCT00790205|6139052|P2|STARTED|Overall Study||7339
2504788|NCT00790205|6139053|P1|STARTED|Overall Study||7332
2504789|NCT00790192|6139097|P4|NOT COMPLETED|Overall Study||48
2504790|NCT00790192|6139098|P3|NOT COMPLETED|Overall Study||23
2504791|NCT00790192|6139099|P2|NOT COMPLETED|Overall Study||28
2504792|NCT00790192|6139100|P1|NOT COMPLETED|Overall Study||36
2504793|NCT00790192|6139097|P4|COMPLETED|Overall Study||74
2504794|NCT00790192|6139098|P3|COMPLETED|Overall Study||97
2504795|NCT00790192|6139099|P2|COMPLETED|Overall Study||93
2504796|NCT00790192|6139100|P1|COMPLETED|Overall Study||89
2504797|NCT00790192|6139097|P4|STARTED|Overall Study||122
2504798|NCT00790192|6139098|P3|STARTED|Overall Study||120
2504799|NCT00790192|6139099|P2|STARTED|Overall Study||121
2504800|NCT00790192|6139100|P1|STARTED|Overall Study||125
2504801|NCT00790088|6139114|P1|NOT COMPLETED|Overall Study||39
2504802|NCT00790088|6139114|P1|COMPLETED|Overall Study||235
2504803|NCT00790088|6139114|P1|Eligible for Data Analysis|Overall Study|Number of participants minus 11 protocol violation|263
2504804|NCT00790088|6139114|P1|STARTED|Overall Study||274
2504805|NCT00790062|6139127|P3|NOT COMPLETED|Overall Study||0
2504806|NCT00790062|6139128|P2|NOT COMPLETED|Overall Study||0
2504807|NCT00790062|6139129|P1|NOT COMPLETED|Overall Study||0
2504808|NCT00790062|6139127|P3|COMPLETED|Overall Study||658
2504809|NCT00790062|6139128|P2|COMPLETED|Overall Study||481
2504810|NCT00790062|6139129|P1|COMPLETED|Overall Study||659
2504811|NCT00790062|6139127|P3|STARTED|Overall Study||658
2504812|NCT00790062|6139128|P2|STARTED|Overall Study||481
2504813|NCT00790062|6139129|P1|STARTED|Overall Study||659
2504814|NCT00790036|6139160|P2|NOT COMPLETED|Overall Study||121
2504815|NCT00790036|6139161|P1|NOT COMPLETED|Overall Study||195
2504816|NCT00790036|6139160|P2|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|249
2504817|NCT00790036|6139161|P1|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|177
2504818|NCT00790036|6139160|P2|Untreated Participants|Overall Study|not treated due to administrative problems and subject withdrawal of consent.|6
2504819|NCT00790036|6139161|P1|Untreated Participants|Overall Study|not treated due to administrative problems, protocol deviation, and subject withdrawal of consent.|4
2504820|NCT00790036|6139160|P2|STARTED|Overall Study||370
2504821|NCT00790036|6139161|P1|STARTED|Overall Study||372
2504822|NCT00790023|6139175|P3|NOT COMPLETED|Overall Study||21
2504823|NCT00790023|6139176|P2|NOT COMPLETED|Overall Study||10
2504824|NCT00790023|6139177|P1|NOT COMPLETED|Overall Study||11
2504825|NCT00790023|6139175|P3|COMPLETED|Overall Study||214
2504826|NCT00790023|6139176|P2|COMPLETED|Overall Study||225
2504827|NCT00790023|6139177|P1|COMPLETED|Overall Study||226
2504828|NCT00790023|6139175|P3|STARTED|Overall Study||235
2504829|NCT00790023|6139176|P2|STARTED|Overall Study||235
2504830|NCT00790023|6139177|P1|STARTED|Overall Study||237
2504831|NCT00789997|6139267|P2|NOT COMPLETED|Overall Study||2
2504832|NCT00789997|6139268|P1|NOT COMPLETED|Overall Study||1
2504833|NCT00789997|6139267|P2|COMPLETED|Overall Study||38
2504834|NCT00789997|6139268|P1|COMPLETED|Overall Study||40
2504835|NCT00789997|6139267|P2|STARTED|Overall Study||40
2504836|NCT00789997|6139268|P1|STARTED|Overall Study||41
2504837|NCT00789958|6139276|P1|NOT COMPLETED|Overall Study||37
2504838|NCT00789958|6139276|P1|COMPLETED|Overall Study||68
2504839|NCT00789958|6139276|P1|Eligible and Analyzable|Overall Study||79
2504840|NCT00789958|6139276|P1|STARTED|Overall Study||105
2504841|NCT00789880|6139295|P6|NOT COMPLETED|Overall Study||0
2504842|NCT00789880|6139296|P5|NOT COMPLETED|Overall Study||3
2504843|NCT00789880|6139297|P4|NOT COMPLETED|Overall Study||1
2504844|NCT00789880|6139298|P3|NOT COMPLETED|Overall Study||0
2504845|NCT00789880|6139299|P2|NOT COMPLETED|Overall Study||1
2504846|NCT00789880|6139300|P1|NOT COMPLETED|Overall Study||1
2504847|NCT00789880|6139295|P6|COMPLETED|Overall Study||8
2504848|NCT00789880|6139296|P5|COMPLETED|Overall Study||15
2504849|NCT00789880|6139297|P4|COMPLETED|Overall Study||15
2504850|NCT00789880|6139298|P3|COMPLETED|Overall Study||8
2504851|NCT00789880|6139299|P2|COMPLETED|Overall Study||15
2504852|NCT00789880|6139300|P1|COMPLETED|Overall Study||15
2504853|NCT00789880|6139295|P6|STARTED|Overall Study||8
2504854|NCT00789880|6139296|P5|STARTED|Overall Study||18
2504855|NCT00789880|6139297|P4|STARTED|Overall Study||16
2504856|NCT00789880|6139298|P3|STARTED|Overall Study||8
2504857|NCT00789880|6139299|P2|STARTED|Overall Study||16
2504858|NCT00789880|6139300|P1|STARTED|Overall Study||16
2504859|NCT00789867|6139329|P3|NOT COMPLETED|Overall Study||0
2504860|NCT00789867|6139330|P2|NOT COMPLETED|Overall Study||0
2504861|NCT00789867|6139331|P1|NOT COMPLETED|Overall Study||0
2504862|NCT00789867|6139329|P3|COMPLETED|Overall Study||8
2504863|NCT00789867|6139330|P2|COMPLETED|Overall Study||10
2504864|NCT00789867|6139331|P1|COMPLETED|Overall Study||17
2504865|NCT00789867|6139329|P3|STARTED|Overall Study||8
2504866|NCT00789867|6139330|P2|STARTED|Overall Study||10
2504867|NCT00789867|6139331|P1|STARTED|Overall Study||17
2504868|NCT00789854|6139357|P3|NOT COMPLETED|Overall Study||47
2504869|NCT00789854|6139358|P2|NOT COMPLETED|Overall Study||35
2504870|NCT00789854|6139359|P1|NOT COMPLETED|Overall Study||49
2504871|NCT00789854|6139357|P3|COMPLETED|Overall Study||182
2504872|NCT00789854|6139358|P2|COMPLETED|Overall Study||196
2504873|NCT00789854|6139359|P1|COMPLETED|Overall Study||179
2504874|NCT00789854|6139357|P3|STARTED|Overall Study||229
2504875|NCT00789854|6139358|P2|STARTED|Overall Study||231
2504876|NCT00789854|6139359|P1|STARTED|Overall Study||228
2504877|NCT00789828|6139456|P2|NOT COMPLETED|Open-label Extension Period (4 Years)||0
2504878|NCT00789828|6139457|P1|NOT COMPLETED|Open-label Extension Period (4 Years)||29
2504879|NCT00789828|6139456|P2|COMPLETED|Open-label Extension Period (4 Years)||0
2504880|NCT00789828|6139457|P1|COMPLETED|Open-label Extension Period (4 Years)||82
2504881|NCT00789828|6139456|P2|STARTED|Open-label Extension Period (4 Years)|No participant received placebo.|0
2504882|NCT00789828|6139457|P1|STARTED|Open-label Extension Period (4 Years)|Of 117 participants only 111 completed the core period and continued in the extension period|111
2504883|NCT00789828|6139456|P2|NOT COMPLETED|Core Period (48 Weeks)||6
2504884|NCT00789828|6139457|P1|NOT COMPLETED|Core Period (48 Weeks)||0
2504885|NCT00789828|6139456|P2|COMPLETED|Core Period (48 Weeks)||33
2504886|NCT00789828|6139457|P1|COMPLETED|Core Period (48 Weeks)||78
2504887|NCT00789828|6139456|P2|STARTED|Core Period (48 Weeks)||39
2504888|NCT00789828|6139457|P1|STARTED|Core Period (48 Weeks)||78
2504889|NCT00789815|6139491|P2|NOT COMPLETED|Overall Study||1
2504890|NCT00789815|6139492|P1|NOT COMPLETED|Overall Study||7
2504891|NCT00789815|6139491|P2|COMPLETED|Overall Study||249
2504892|NCT00789815|6139492|P1|COMPLETED|Overall Study||243
2504893|NCT00789815|6139491|P2|STARTED|Overall Study||250
2504894|NCT00789815|6139492|P1|STARTED|Overall Study||250
2504895|NCT00789802|6139515|P3|NOT COMPLETED|Overall Study||6
2504896|NCT00789802|6139516|P2|NOT COMPLETED|Overall Study||7
2504897|NCT00789802|6139517|P1|NOT COMPLETED|Overall Study||10
2504898|NCT00789802|6139515|P3|COMPLETED|Overall Study||37
2504899|NCT00789802|6139516|P2|COMPLETED|Overall Study||35
2504900|NCT00789802|6139517|P1|COMPLETED|Overall Study||34
2504901|NCT00789802|6139515|P3|STARTED|Overall Study||43
2504902|NCT00789802|6139516|P2|STARTED|Overall Study||42
2504903|NCT00789802|6139517|P1|STARTED|Overall Study||44
2504904|NCT00789776|6139536|P2|NOT COMPLETED|Overall Study||1
2504905|NCT00789776|6139537|P1|NOT COMPLETED|Overall Study||0
2504906|NCT00789776|6139536|P2|COMPLETED|Overall Study||35
2504907|NCT00789776|6139537|P1|COMPLETED|Overall Study||5
2504908|NCT00789776|6139536|P2|STARTED|Overall Study||36
2504909|NCT00789776|6139537|P1|STARTED|Overall Study||5
2504910|NCT00789750|6139557|P2|NOT COMPLETED|Overall Study||60
2504911|NCT00789750|6139558|P1|NOT COMPLETED|Overall Study||59
2504912|NCT00789750|6139557|P2|COMPLETED|Overall Study||222
2504913|NCT00789750|6139558|P1|COMPLETED|Overall Study||221
2504914|NCT00789750|6139557|P2|Intent to Treat Set|Overall Study||276
2504915|NCT00789750|6139558|P1|Intent to Treat Set|Overall Study||271
2504916|NCT00789750|6139557|P2|Safety Set|Overall Study||277
2504917|NCT00789750|6139558|P1|Safety Set|Overall Study||274
2504918|NCT00789750|6139557|P2|Dropped During run-in Period|Overall Study||5
2504919|NCT00789750|6139558|P1|Dropped During run-in Period|Overall Study||6
2504920|NCT00789750|6139557|P2|STARTED|Overall Study||282
2504921|NCT00789750|6139558|P1|STARTED|Overall Study||280
2504922|NCT00789737|6139602|P2|NOT COMPLETED|Overall Study||55
2504923|NCT00789737|6139603|P1|NOT COMPLETED|Overall Study||48
2504924|NCT00789737|6139602|P2|COMPLETED|Overall Study||126
2504925|NCT00789737|6139603|P1|COMPLETED|Overall Study||128
2504926|NCT00789737|6139602|P2|STARTED|Overall Study||181
2504927|NCT00789737|6139603|P1|STARTED|Overall Study||176
2504928|NCT00789724|6139635|P2|NOT COMPLETED|Overall Study||0
2504929|NCT00789724|6139636|P1|NOT COMPLETED|Overall Study||0
2504930|NCT00789724|6139635|P2|COMPLETED|Overall Study||5
2504931|NCT00789724|6139636|P1|COMPLETED|Overall Study||5
2504932|NCT00789724|6139635|P2|STARTED|Overall Study||5
2504933|NCT00789724|6139636|P1|STARTED|Overall Study||5
2504934|NCT00789698|6139646|P4|NOT COMPLETED|Overall Study||52
2504935|NCT00789698|6139647|P3|NOT COMPLETED|Overall Study||27
2504936|NCT00789698|6139648|P2|NOT COMPLETED|Overall Study||33
2504937|NCT00789698|6139649|P1|NOT COMPLETED|Overall Study||40
2504938|NCT00789698|6139646|P4|COMPLETED|Overall Study||33
2504939|NCT00789698|6139647|P3|COMPLETED|Overall Study||29
2504940|NCT00789698|6139648|P2|COMPLETED|Overall Study||46
2504941|NCT00789698|6139649|P1|COMPLETED|Overall Study||32
2504942|NCT00789698|6139646|P4|STARTED|Overall Study||85
2504943|NCT00789698|6139647|P3|STARTED|Overall Study||56
2504944|NCT00789698|6139648|P2|STARTED|Overall Study||79
2504945|NCT00789698|6139649|P1|STARTED|Overall Study||72
2504946|NCT00789685|6139663|P1|NOT COMPLETED|Overall Study||12
2504947|NCT00789685|6139663|P1|COMPLETED|Overall Study|Completed the study to Day 28|25
2504948|NCT00789685|6139663|P1|STARTED|Overall Study||37
2504949|NCT00789672|6139671|P2|NOT COMPLETED|Overall Study||0
2504950|NCT00789672|6139672|P1|NOT COMPLETED|Overall Study||0
2504951|NCT00789672|6139671|P2|COMPLETED|Overall Study||17
2504952|NCT00789672|6139672|P1|COMPLETED|Overall Study||16
2504953|NCT00789672|6139671|P2|STARTED|Overall Study||17
2504954|NCT00789672|6139672|P1|STARTED|Overall Study||16
2504955|NCT00789581|6139704|P2|NOT COMPLETED|Adjuvant Therapy||57
2504956|NCT00789581|6139705|P1|NOT COMPLETED|Adjuvant Therapy||40
2504957|NCT00789581|6139704|P2|COMPLETED|Adjuvant Therapy||234
2504958|NCT00789581|6139705|P1|COMPLETED|Adjuvant Therapy||255
2504959|NCT00789581|6139704|P2|STARTED|Adjuvant Therapy||291
2504960|NCT00789581|6139705|P1|STARTED|Adjuvant Therapy||295
2504961|NCT00789581|6139704|P2|NOT COMPLETED|AC Therapy||17
2504962|NCT00789581|6139705|P1|NOT COMPLETED|AC Therapy||11
2504963|NCT00789581|6139704|P2|COMPLETED|AC Therapy||291
2504964|NCT00789581|6139705|P1|COMPLETED|AC Therapy||295
2504965|NCT00789581|6139704|P2|STARTED|AC Therapy||308
2504966|NCT00789581|6139705|P1|STARTED|AC Therapy||306
2504967|NCT00789555|6139716|P3|NOT COMPLETED|Overall Study||159
2504968|NCT00789555|6139717|P2|NOT COMPLETED|Overall Study||139
2504969|NCT00789555|6139718|P1|NOT COMPLETED|Overall Study||159
2504970|NCT00789555|6139716|P3|COMPLETED|Overall Study||263
2504971|NCT00789555|6139717|P2|COMPLETED|Overall Study||278
2504972|NCT00789555|6139718|P1|COMPLETED|Overall Study||262
2504973|NCT00789555|6139716|P3|STARTED|Overall Study||422
2504974|NCT00789555|6139717|P2|STARTED|Overall Study||417
2504975|NCT00789555|6139718|P1|STARTED|Overall Study||421
2504976|NCT00789529|6139743|P2|NOT COMPLETED|Overall Study||1
2504977|NCT00789529|6139744|P1|NOT COMPLETED|Overall Study||1
2504978|NCT00789529|6139743|P2|COMPLETED|Overall Study||15
2504979|NCT00789529|6139744|P1|COMPLETED|Overall Study||15
2504980|NCT00789529|6139743|P2|STARTED|Overall Study||16
2504981|NCT00789529|6139744|P1|STARTED|Overall Study||16
2504982|NCT00789477|6139757|P5|NOT COMPLETED|Overall Study||7
2504983|NCT00789477|6139758|P4|NOT COMPLETED|Overall Study||10
2504984|NCT00789477|6139759|P3|NOT COMPLETED|Overall Study||11
2504985|NCT00789477|6139760|P2|NOT COMPLETED|Overall Study||6
2504986|NCT00789477|6139761|P1|NOT COMPLETED|Overall Study||11
2504987|NCT00789477|6139757|P5|COMPLETED|Overall Study||38
2504988|NCT00789477|6139758|P4|COMPLETED|Overall Study||34
2504989|NCT00789477|6139759|P3|COMPLETED|Overall Study||33
2504990|NCT00789477|6139760|P2|COMPLETED|Overall Study||38
2504991|NCT00789477|6139761|P1|COMPLETED|Overall Study||33
2504992|NCT00789477|6139757|P5|Participants Received Treatment|Overall Study|SAF|45
2504993|NCT00789477|6139758|P4|Participants Received Treatment|Overall Study|SAF|42
2504994|NCT00789477|6139759|P3|Participants Received Treatment|Overall Study|SAF|44
2504995|NCT00789477|6139760|P2|Participants Received Treatment|Overall Study|SAF|44
2504996|NCT00789477|6139761|P1|Participants Received Treatment|Overall Study|safety analysis set (SAF)|44
2504997|NCT00789477|6139757|P5|STARTED|Overall Study|randomized|45
2504998|NCT00789477|6139758|P4|STARTED|Overall Study|randomized|44
2504999|NCT00789477|6139759|P3|STARTED|Overall Study|randomized|44
2505000|NCT00789477|6139760|P2|STARTED|Overall Study|randomized|44
2505001|NCT00789477|6139761|P1|STARTED|Overall Study|randomized|44
2505002|NCT00789438|6139796|P3|NOT COMPLETED|Overall Study||0
2505003|NCT00789438|6139797|P2|NOT COMPLETED|Overall Study||0
2505004|NCT00789438|6139798|P1|NOT COMPLETED|Overall Study||0
2505005|NCT00789438|6139796|P3|COMPLETED|Overall Study||28
2505006|NCT00789438|6139797|P2|COMPLETED|Overall Study||20
2505007|NCT00789438|6139798|P1|COMPLETED|Overall Study||21
2505008|NCT00789438|6139796|P3|STARTED|Overall Study||28
2505009|NCT00789438|6139797|P2|STARTED|Overall Study||20
2505010|NCT00789438|6139798|P1|STARTED|Overall Study||21
2505011|NCT00789373|6139806|P3|NOT COMPLETED|Maintenance||180
2505012|NCT00789373|6139807|P2|NOT COMPLETED|Maintenance||359
2505013|NCT00789373|6139808|P1|NOT COMPLETED|Maintenance||0
2505014|NCT00789373|6139806|P3|COMPLETED|Maintenance||0
2505015|NCT00789373|6139807|P2|COMPLETED|Maintenance||0
2505016|NCT00789373|6139808|P1|COMPLETED|Maintenance||0
2505017|NCT00789373|6139806|P3|STARTED|Maintenance||180
2505018|NCT00789373|6139807|P2|STARTED|Maintenance||359
2505019|NCT00789373|6139808|P1|STARTED|Maintenance||0
2505020|NCT00789373|6139806|P3|NOT COMPLETED|Induction||0
2505021|NCT00789373|6139807|P2|NOT COMPLETED|Induction||0
2505022|NCT00789373|6139808|P1|NOT COMPLETED|Induction||399
2505023|NCT00789373|6139806|P3|COMPLETED|Induction||0
2505024|NCT00789373|6139807|P2|COMPLETED|Induction||0
2505025|NCT00789373|6139808|P1|COMPLETED|Induction|1 patient received maintenance therapy post-induction but was never randomized.|540
2505026|NCT00789373|6139806|P3|STARTED|Induction||0
2505027|NCT00789373|6139807|P2|STARTED|Induction||0
2505028|NCT00789373|6139808|P1|STARTED|Induction||939
2505029|NCT00789360|6139835|P2|NOT COMPLETED|Overall Study||1
2505030|NCT00789360|6139836|P1|NOT COMPLETED|Overall Study||3
2505031|NCT00789360|6139835|P2|COMPLETED|Overall Study||14
2505032|NCT00789360|6139836|P1|COMPLETED|Overall Study||12
2505033|NCT00789360|6139835|P2|STARTED|Overall Study||15
2505034|NCT00789360|6139836|P1|STARTED|Overall Study||15
2505035|NCT00789321|6139846|P2|NOT COMPLETED|Overall Study||1
2505036|NCT00789321|6139847|P1|NOT COMPLETED|Overall Study||0
2505037|NCT00789321|6139846|P2|COMPLETED|Overall Study||22
2505038|NCT00789321|6139847|P1|COMPLETED|Overall Study||24
2505039|NCT00789321|6139846|P2|STARTED|Overall Study||23
2505040|NCT00789321|6139847|P1|STARTED|Overall Study||24
2505041|NCT00789256|6139857|P2|NOT COMPLETED|Overall Study||0
2505042|NCT00789256|6139858|P1|NOT COMPLETED|Overall Study||0
2505043|NCT00789256|6139857|P2|COMPLETED|Overall Study||12
2505044|NCT00789256|6139858|P1|COMPLETED|Overall Study|Strata 1 had 5 responders and continued accrual, but the study was closed due to low accrual.|14
2505045|NCT00789256|6139857|P2|STARTED|Overall Study||12
2505046|NCT00789256|6139858|P1|STARTED|Overall Study||14
2505047|NCT00789191|6139869|P2|NOT COMPLETED|Overall Study||19
2505048|NCT00789191|6139870|P1|NOT COMPLETED|Overall Study||14
2505049|NCT00789191|6139869|P2|COMPLETED|Overall Study||92
2505050|NCT00789191|6139870|P1|COMPLETED|Overall Study||97
2505051|NCT00789191|6139869|P2|Exposed|Overall Study|1 non-compliance|110
2505052|NCT00789191|6139870|P1|Exposed|Overall Study|2 withdrew informed consent. 1 randomised by mistake. 1 non-compliance|107
2505053|NCT00789191|6139869|P2|STARTED|Overall Study||111
2505054|NCT00789191|6139870|P1|STARTED|Overall Study||111
2505055|NCT00789113|6139898|P1|NOT COMPLETED|Overall Study||0
2505056|NCT00789113|6139898|P1|COMPLETED|Overall Study||12
2505057|NCT00789113|6139898|P1|STARTED|Overall Study||12
2505058|NCT00789074|6139905|P2|NOT COMPLETED|Overall Study||13
2505059|NCT00789074|6139906|P1|NOT COMPLETED|Overall Study||11
2505060|NCT00789074|6139905|P2|COMPLETED|Overall Study||35
2505061|NCT00789074|6139906|P1|COMPLETED|Overall Study||42
2505062|NCT00789074|6139905|P2|STARTED|Overall Study||48
2505063|NCT00789074|6139906|P1|STARTED|Overall Study||53
2505064|NCT00789035|6139927|P5|NOT COMPLETED|Overall Study||6
2505065|NCT00789035|6139928|P4|NOT COMPLETED|Overall Study||1
2505066|NCT00789035|6139929|P3|NOT COMPLETED|Overall Study||1
2505067|NCT00789035|6139930|P2|NOT COMPLETED|Overall Study||7
2505068|NCT00789035|6139931|P1|NOT COMPLETED|Overall Study||6
2505069|NCT00789035|6139927|P5|COMPLETED|Overall Study||74
2505070|NCT00789035|6139928|P4|COMPLETED|Overall Study||81
2505071|NCT00789035|6139929|P3|COMPLETED|Overall Study||80
2505072|NCT00789035|6139930|P2|COMPLETED|Overall Study||74
2505073|NCT00789035|6139931|P1|COMPLETED|Overall Study||76
2505074|NCT00789035|6139927|P5|STARTED|Overall Study||80
2505075|NCT00789035|6139928|P4|STARTED|Overall Study||82
2505076|NCT00789035|6139929|P3|STARTED|Overall Study||81
2505077|NCT00789035|6139930|P2|STARTED|Overall Study||81
2505078|NCT00789035|6139931|P1|STARTED|Overall Study||82
2505079|NCT00788957|6139990|P6|NOT COMPLETED|Part 3||11
2505080|NCT00788957|6139991|P5|NOT COMPLETED|Part 3||9
2505081|NCT00788957|6139992|P4|NOT COMPLETED|Part 3||0
2505082|NCT00788957|6139993|P3|NOT COMPLETED|Part 3||0
2505083|NCT00788957|6139994|P2|NOT COMPLETED|Part 3||0
2505084|NCT00788957|6139995|P1|NOT COMPLETED|Part 3||0
2505085|NCT00788957|6139990|P6|COMPLETED|Part 3|Completed the safety follow-up visit|1
2505086|NCT00788957|6139991|P5|COMPLETED|Part 3|Completed the safety follow-up visit|4
2505087|NCT00788957|6139992|P4|COMPLETED|Part 3||0
2505088|NCT00788957|6139993|P3|COMPLETED|Part 3||0
2505089|NCT00788957|6139994|P2|COMPLETED|Part 3||0
2505090|NCT00788957|6139995|P1|COMPLETED|Part 3||0
2505091|NCT00788957|6139990|P6|STARTED|Part 3||12
2505092|NCT00788957|6139991|P5|STARTED|Part 3||13
2505093|NCT00788957|6139992|P4|STARTED|Part 3||0
2505094|NCT00788957|6139993|P3|STARTED|Part 3||0
2505095|NCT00788957|6139994|P2|STARTED|Part 3||0
2505096|NCT00788957|6139995|P1|STARTED|Part 3||0
2505097|NCT00788957|6139990|P6|NOT COMPLETED|Part 2||0
2505098|NCT00788957|6139991|P5|NOT COMPLETED|Part 2||0
2505099|NCT00788957|6139992|P4|NOT COMPLETED|Part 2||41
2505100|NCT00788957|6139993|P3|NOT COMPLETED|Part 2||44
2505101|NCT00788957|6139994|P2|NOT COMPLETED|Part 2||42
2505102|NCT00788957|6139995|P1|NOT COMPLETED|Part 2||0
2505103|NCT00788957|6139990|P6|COMPLETED|Part 2||0
2505104|NCT00788957|6139991|P5|COMPLETED|Part 2||0
2505105|NCT00788957|6139992|P4|COMPLETED|Part 2|Completed the safety follow-up visit|5
2505106|NCT00788957|6139993|P3|COMPLETED|Part 2|Completed the safety follow-up visit|4
2505107|NCT00788957|6139994|P2|COMPLETED|Part 2|Completed the safety follow-up visit at the end of the study|6
2505108|NCT00788957|6139995|P1|COMPLETED|Part 2||0
2505109|NCT00788957|6139990|P6|STARTED|Part 2||0
2505110|NCT00788957|6139991|P5|STARTED|Part 2||0
2505111|NCT00788957|6139992|P4|STARTED|Part 2||46
2505112|NCT00788957|6139993|P3|STARTED|Part 2||48
2505113|NCT00788957|6139994|P2|STARTED|Part 2||48
2505114|NCT00788957|6139995|P1|STARTED|Part 2||0
2505115|NCT00788957|6139990|P6|NOT COMPLETED|Part 1||0
2505116|NCT00788957|6139991|P5|NOT COMPLETED|Part 1||0
2505117|NCT00788957|6139992|P4|NOT COMPLETED|Part 1||0
2505118|NCT00788957|6139993|P3|NOT COMPLETED|Part 1||0
2505119|NCT00788957|6139994|P2|NOT COMPLETED|Part 1||0
2505120|NCT00788957|6139995|P1|NOT COMPLETED|Part 1||9
2505121|NCT00788957|6139990|P6|COMPLETED|Part 1||0
2505122|NCT00788957|6139991|P5|COMPLETED|Part 1||0
2505123|NCT00788957|6139992|P4|COMPLETED|Part 1||0
2505124|NCT00788957|6139993|P3|COMPLETED|Part 1||0
2505125|NCT00788957|6139994|P2|COMPLETED|Part 1||0
2505126|NCT00788957|6139995|P1|COMPLETED|Part 1|Completed the safety follow-up visit|2
2505127|NCT00788957|6139990|P6|STARTED|Part 1||0
2505128|NCT00788957|6139991|P5|STARTED|Part 1||0
2505129|NCT00788957|6139992|P4|STARTED|Part 1||0
2505130|NCT00788957|6139993|P3|STARTED|Part 1||0
2505131|NCT00788957|6139994|P2|STARTED|Part 1||0
2505132|NCT00788957|6139995|P1|STARTED|Part 1||11
2505133|NCT00788892|6140051|P2|NOT COMPLETED|Overall Study||23
2505134|NCT00788892|6140052|P1|NOT COMPLETED|Overall Study||49
2505135|NCT00788892|6140051|P2|COMPLETED|Overall Study||18
2505136|NCT00788892|6140052|P1|COMPLETED|Overall Study||36
2505137|NCT00788892|6140051|P2|STARTED|Overall Study||41
2505138|NCT00788892|6140052|P1|STARTED|Overall Study||85
2505139|NCT00788827|6140068|P1|NOT COMPLETED|Overall Study||2
2505140|NCT00788827|6140068|P1|COMPLETED|Overall Study||5
2505141|NCT00788827|6140068|P1|STARTED|Overall Study||7
2505142|NCT00788775|6140082|P2|NOT COMPLETED|Overall Study||8
2505143|NCT00788775|6140083|P1|NOT COMPLETED|Overall Study||10
2505144|NCT00788775|6140082|P2|COMPLETED|Overall Study||1
2505145|NCT00788775|6140083|P1|COMPLETED|Overall Study||1
2505146|NCT00788775|6140082|P2|Treated|Overall Study||8
2505147|NCT00788775|6140083|P1|Treated|Overall Study||11
2505148|NCT00788775|6140082|P2|STARTED|Overall Study||9
2505149|NCT00788775|6140083|P1|STARTED|Overall Study||11
2505150|NCT00788710|6140098|P3|NOT COMPLETED|Overall Study||6
2505151|NCT00788710|6140099|P2|NOT COMPLETED|Overall Study||8
2505152|NCT00788710|6140100|P1|NOT COMPLETED|Overall Study||5
2505153|NCT00788710|6140098|P3|COMPLETED|Overall Study||138
2505154|NCT00788710|6140099|P2|COMPLETED|Overall Study||134
2505155|NCT00788710|6140100|P1|COMPLETED|Overall Study||139
2505156|NCT00788710|6140098|P3|STARTED|Overall Study||144
2505157|NCT00788710|6140099|P2|STARTED|Overall Study||142
2505158|NCT00788710|6140100|P1|STARTED|Overall Study||144
2505159|NCT00788697|6140114|P1|NOT COMPLETED|Overall Study||109
2505160|NCT00788697|6140114|P1|COMPLETED|Overall Study||240
2505161|NCT00788697|6140114|P1|STARTED|Overall Study||349
2505162|NCT00788593|6140161|P3|NOT COMPLETED|Second Intervention Period||1
2505163|NCT00788593|6140162|P2|NOT COMPLETED|Second Intervention Period||1
2505164|NCT00788593|6140163|P1|NOT COMPLETED|Second Intervention Period||0
2505165|NCT00788593|6140161|P3|COMPLETED|Second Intervention Period||36
2505166|NCT00788593|6140162|P2|COMPLETED|Second Intervention Period||37
2505167|NCT00788593|6140163|P1|COMPLETED|Second Intervention Period||0
2505168|NCT00788593|6140161|P3|STARTED|Second Intervention Period||37
2505169|NCT00788593|6140162|P2|STARTED|Second Intervention Period||38
2505170|NCT00788593|6140163|P1|STARTED|Second Intervention Period||0
2505171|NCT00788593|6140161|P3|NOT COMPLETED|First Intervention Period||0
2505172|NCT00788593|6140162|P2|NOT COMPLETED|First Intervention Period||1
2505173|NCT00788593|6140163|P1|NOT COMPLETED|First Intervention Period||0
2505174|NCT00788593|6140161|P3|COMPLETED|First Intervention Period||37
2505175|NCT00788593|6140162|P2|COMPLETED|First Intervention Period||38
2505176|NCT00788593|6140163|P1|COMPLETED|First Intervention Period||0
2505177|NCT00788593|6140161|P3|STARTED|First Intervention Period||37
2505178|NCT00788593|6140162|P2|STARTED|First Intervention Period||39
2505179|NCT00788593|6140163|P1|STARTED|First Intervention Period||0
2505180|NCT00788593|6140161|P3|NOT COMPLETED|Placebo Run-in Phase||0
2505181|NCT00788593|6140162|P2|NOT COMPLETED|Placebo Run-in Phase||0
2505182|NCT00788593|6140163|P1|NOT COMPLETED|Placebo Run-in Phase||6
2505183|NCT00788593|6140161|P3|COMPLETED|Placebo Run-in Phase||0
2505184|NCT00788593|6140162|P2|COMPLETED|Placebo Run-in Phase||0
2505185|NCT00788593|6140163|P1|COMPLETED|Placebo Run-in Phase||76
2505186|NCT00788593|6140161|P3|STARTED|Placebo Run-in Phase||0
2505187|NCT00788593|6140162|P2|STARTED|Placebo Run-in Phase||0
2505188|NCT00788593|6140163|P1|STARTED|Placebo Run-in Phase||82
2505189|NCT00788372|6140180|P1|NOT COMPLETED|Period 2 (Week 4 to Week 52)||32
2505190|NCT00788372|6140180|P1|COMPLETED|Period 2 (Week 4 to Week 52)||79
2505191|NCT00788372|6140180|P1|STARTED|Period 2 (Week 4 to Week 52)||111
2505192|NCT00788372|6140180|P1|NOT COMPLETED|Period 1 (up to 4 Weeks)||31
2505193|NCT00788372|6140180|P1|COMPLETED|Period 1 (up to 4 Weeks)||111
2505194|NCT00788372|6140180|P1|STARTED|Period 1 (up to 4 Weeks)||142
2505195|NCT00788255|6140194|P1|NOT COMPLETED|Overall Study||0
2505196|NCT00788255|6140194|P1|COMPLETED|Overall Study||25
2505197|NCT00788255|6140194|P1|Oxytocin: 0 μU/mL|Overall Study||25
2505198|NCT00788255|6140194|P1|Oxytocin Infusion 3: 32.9μU/mL|Overall Study||25
2505199|NCT00788255|6140194|P1|Oxytocin Infusion 2: 30.1μU/mL|Overall Study||25
2505200|NCT00788255|6140194|P1|Oxytocin Infusion 1: 22.5 μU/mL|Overall Study||25
2505201|NCT00788255|6140194|P1|STARTED|Overall Study||25
2505202|NCT00788151|6140209|P2|NOT COMPLETED|Overall Study||10
2505203|NCT00788151|6140210|P1|NOT COMPLETED|Overall Study||14
2505204|NCT00788151|6140209|P2|COMPLETED|Overall Study||90
2505205|NCT00788151|6140210|P1|COMPLETED|Overall Study||186
2505206|NCT00788151|6140209|P2|Received Vaccination 3|Overall Study||90
2505207|NCT00788151|6140210|P1|Received Vaccination 3|Overall Study||186
2505208|NCT00788151|6140209|P2|Received Vaccination 2|Overall Study||92
2505209|NCT00788151|6140210|P1|Received Vaccination 2|Overall Study||188
2505210|NCT00788151|6140209|P2|Received Vaccination 1|Overall Study||99
2505211|NCT00788151|6140210|P1|Received Vaccination 1|Overall Study||199
2505212|NCT00788151|6140209|P2|STARTED|Overall Study||100
2505213|NCT00788151|6140210|P1|STARTED|Overall Study||200
2505214|NCT00788073|6140254|P2|NOT COMPLETED|Placebo Then STX209||1
2505215|NCT00788073|6140255|P1|NOT COMPLETED|Placebo Then STX209||2
2505216|NCT00788073|6140254|P2|COMPLETED|Placebo Then STX209||29
2505217|NCT00788073|6140255|P1|COMPLETED|Placebo Then STX209||27
2505218|NCT00788073|6140254|P2|STARTED|Placebo Then STX209||30
2505219|NCT00788073|6140255|P1|STARTED|Placebo Then STX209||29
2505220|NCT00788073|6140254|P2|NOT COMPLETED|STX209 Then Placebo||3
2505221|NCT00788073|6140255|P1|NOT COMPLETED|STX209 Then Placebo||1
2505222|NCT00788073|6140254|P2|COMPLETED|STX209 Then Placebo||30
2505223|NCT00788073|6140255|P1|COMPLETED|STX209 Then Placebo||29
2505224|NCT00788073|6140254|P2|STARTED|STX209 Then Placebo||33
2505225|NCT00788073|6140255|P1|STARTED|STX209 Then Placebo||30
2505226|NCT00788008|6140265|P2|NOT COMPLETED|Overall Study||0
2505227|NCT00788008|6140266|P1|NOT COMPLETED|Overall Study||0
2505228|NCT00788008|6140265|P2|COMPLETED|Overall Study||101
2505229|NCT00788008|6140266|P1|COMPLETED|Overall Study||98
2505230|NCT00788008|6140265|P2|STARTED|Overall Study||101
2505231|NCT00788008|6140266|P1|STARTED|Overall Study||98
2505232|NCT00787943|6140272|P1|NOT COMPLETED|Overall Study||0
2505233|NCT00787943|6140272|P1|COMPLETED|Overall Study||10
2505234|NCT00787943|6140272|P1|STARTED|Overall Study||10
2505235|NCT00787930|6140280|P1|NOT COMPLETED|Continuation Treatment -- up to 12 Month||3
2505236|NCT00787930|6140280|P1|COMPLETED|Continuation Treatment -- up to 12 Month||16
2505237|NCT00787930|6140280|P1|STARTED|Continuation Treatment -- up to 12 Month||19
2505238|NCT00787930|6140280|P1|NOT COMPLETED|Acute Treatment -- 3 Weeks||0
2505239|NCT00787930|6140280|P1|COMPLETED|Acute Treatment -- 3 Weeks||19
2505240|NCT00787930|6140280|P1|STARTED|Acute Treatment -- 3 Weeks||19
2505241|NCT00787917|6140295|P2|NOT COMPLETED|Open Label||0
2505242|NCT00787917|6140296|P1|NOT COMPLETED|Open Label||4
2505243|NCT00787917|6140295|P2|COMPLETED|Open Label||0
2505244|NCT00787917|6140296|P1|COMPLETED|Open Label||3
2505245|NCT00787917|6140295|P2|STARTED|Open Label|"Placebo was not an arm in open label treatment."|0
2505246|NCT00787917|6140296|P1|STARTED|Open Label||7
2505247|NCT00787917|6140295|P2|NOT COMPLETED|Blinded Treatment||2
2505248|NCT00787917|6140296|P1|NOT COMPLETED|Blinded Treatment||5
2505249|NCT00787917|6140295|P2|COMPLETED|Blinded Treatment||3
2505250|NCT00787917|6140296|P1|COMPLETED|Blinded Treatment||4
2505251|NCT00787917|6140295|P2|STARTED|Blinded Treatment||5
2505252|NCT00787917|6140296|P1|STARTED|Blinded Treatment||9
2505253|NCT00787904|6140315|P2|NOT COMPLETED|Overall Study||0
2505254|NCT00787904|6140316|P1|NOT COMPLETED|Overall Study||0
2505255|NCT00787904|6140315|P2|COMPLETED|Overall Study||13
2505256|NCT00787904|6140316|P1|COMPLETED|Overall Study||6
2505257|NCT00787904|6140315|P2|STARTED|Overall Study||13
2505258|NCT00787904|6140316|P1|STARTED|Overall Study||6
2505259|NCT00787891|6140326|P2|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
2505260|NCT00787891|6140327|P1|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
2505261|NCT00787891|6140326|P2|COMPLETED|Maintenance Double-blind Phase (Part 2)||24
2505262|NCT00787891|6140327|P1|COMPLETED|Maintenance Double-blind Phase (Part 2)||26
2505263|NCT00787891|6140326|P2|STARTED|Maintenance Double-blind Phase (Part 2)||31
2505264|NCT00787891|6140327|P1|STARTED|Maintenance Double-blind Phase (Part 2)||33
2505265|NCT00787891|6140326|P2|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||9
2505266|NCT00787891|6140327|P1|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||10
2505267|NCT00787891|6140326|P2|COMPLETED|Short-term Double-blind Phase (Part 1)||53
2505268|NCT00787891|6140327|P1|COMPLETED|Short-term Double-blind Phase (Part 1)||55
2505269|NCT00787891|6140326|P2|STARTED|Short-term Double-blind Phase (Part 1)||62
2505270|NCT00787891|6140327|P1|STARTED|Short-term Double-blind Phase (Part 1)||65
2505271|NCT00787852|6140347|P2|NOT COMPLETED|Overall Study||0
2505272|NCT00787852|6140348|P1|NOT COMPLETED|Overall Study||1
2505273|NCT00787852|6140347|P2|COMPLETED|Overall Study||5
2505274|NCT00787852|6140348|P1|COMPLETED|Overall Study|1 patient withdrew consent prior to starting|5
2505275|NCT00787852|6140347|P2|STARTED|Overall Study|The study was terminated prior to enrolled to group 2|5
2505276|NCT00787852|6140348|P1|STARTED|Overall Study||6
2505277|NCT00787839|6140354|P1|NOT COMPLETED|Overall Study||404
2505278|NCT00787839|6140354|P1|COMPLETED|Overall Study||1535
2505279|NCT00787839|6140354|P1|Complete GCT, OGTT, A1c, Demographics|Overall Study||1535
2505280|NCT00787839|6140354|P1|Completed GCT Screening|Overall Study||1876
2505281|NCT00787839|6140354|P1|Consented|Overall Study|consented|1939
2505282|NCT00787839|6140354|P1|STARTED|Overall Study||1939
2505283|NCT00787800|6140377|P2|NOT COMPLETED|Overall Study||7
2505284|NCT00787800|6140378|P1|NOT COMPLETED|Overall Study||3
2505285|NCT00787800|6140377|P2|COMPLETED|Overall Study||43
2505286|NCT00787800|6140378|P1|COMPLETED|Overall Study||47
2505287|NCT00787800|6140377|P2|STARTED|Overall Study||50
2505288|NCT00787800|6140378|P1|STARTED|Overall Study||50
2505289|NCT00787787|6140394|P1|NOT COMPLETED|Overall Study||7
2505290|NCT00787787|6140394|P1|COMPLETED|Overall Study||0
2505291|NCT00787787|6140394|P1|STARTED|Overall Study||7
2505292|NCT00787761|6140400|P1|NOT COMPLETED|Overall Study||0
2505293|NCT00787761|6140400|P1|COMPLETED|Overall Study||24
2505294|NCT00787761|6140400|P1|STARTED|Overall Study||24
2505295|NCT00787644|6140413|P2|NOT COMPLETED|Overall Study||2
2505296|NCT00787644|6140414|P1|NOT COMPLETED|Overall Study||2
2505297|NCT00787644|6140413|P2|COMPLETED|Overall Study||9
2505298|NCT00787644|6140414|P1|COMPLETED|Overall Study||10
2505299|NCT00787644|6140413|P2|STARTED|Overall Study||11
2505300|NCT00787644|6140414|P1|STARTED|Overall Study||12
2505301|NCT00787618|6140423|P3|NOT COMPLETED|Overall Study||0
2505302|NCT00787618|6140424|P2|NOT COMPLETED|Overall Study||0
2505303|NCT00787618|6140425|P1|NOT COMPLETED|Overall Study||0
2505304|NCT00787618|6140423|P3|COMPLETED|Overall Study||3
2505305|NCT00787618|6140424|P2|COMPLETED|Overall Study||0
2505306|NCT00787618|6140425|P1|COMPLETED|Overall Study||3
2505307|NCT00787618|6140423|P3|STARTED|Overall Study||3
2505308|NCT00787618|6140424|P2|STARTED|Overall Study||0
2505309|NCT00787618|6140425|P1|STARTED|Overall Study||3
2505310|NCT00787605|6140435|P2|NOT COMPLETED|Overall Study||56
2505311|NCT00787605|6140436|P1|NOT COMPLETED|Overall Study||46
2505312|NCT00787605|6140435|P2|COMPLETED|Overall Study||376
2505313|NCT00787605|6140436|P1|COMPLETED|Overall Study||382
2505314|NCT00787605|6140435|P2|STARTED|Overall Study||432
2505315|NCT00787605|6140436|P1|STARTED|Overall Study||428
2505316|NCT00787566|6140455|P3|NOT COMPLETED|Overall Study||0
2505317|NCT00787566|6140456|P2|NOT COMPLETED|Overall Study||1
2505318|NCT00787566|6140457|P1|NOT COMPLETED|Overall Study||0
2505319|NCT00787566|6140455|P3|COMPLETED|Overall Study||22
2505320|NCT00787566|6140456|P2|COMPLETED|Overall Study|1 patient withdrew from the study due to an AE related to chemotherapy agent administration.|24
2505321|NCT00787566|6140457|P1|COMPLETED|Overall Study||21
2505322|NCT00787566|6140455|P3|STARTED|Overall Study||22
2505323|NCT00787566|6140456|P2|STARTED|Overall Study||25
2505324|NCT00787566|6140457|P1|STARTED|Overall Study||21
2505325|NCT00787527|6140465|P1|NOT COMPLETED|Overall Study||3
2505326|NCT00787527|6140465|P1|COMPLETED|Overall Study||11
2505327|NCT00787527|6140465|P1|STARTED|Overall Study||14
2505328|NCT00787332|6140475|P2|NOT COMPLETED|Overall Study||0
2505329|NCT00787332|6140476|P1|NOT COMPLETED|Overall Study||0
2505330|NCT00787332|6140475|P2|COMPLETED|Overall Study||8
2505331|NCT00787332|6140476|P1|COMPLETED|Overall Study||8
2505332|NCT00787332|6140475|P2|STARTED|Overall Study||8
2505333|NCT00787332|6140476|P1|STARTED|Overall Study||8
2505334|NCT00787319|6140482|P1|NOT COMPLETED|Overall Study||63
2505335|NCT00787319|6140482|P1|COMPLETED|Overall Study||45
2505336|NCT00787319|6140482|P1|STARTED|Overall Study||108
2505337|NCT00787267|6140494|P1|NOT COMPLETED|Overall Study||12
2505338|NCT00787267|6140494|P1|COMPLETED|Overall Study|Received at least one dose of study drug|25
2505339|NCT00787267|6140494|P1|STARTED|Overall Study|Signed a consent form|37
2505340|NCT00787254|6140504|P2|NOT COMPLETED|Overall Study||82
2505341|NCT00787254|6140505|P1|NOT COMPLETED|Overall Study||76
2505342|NCT00787254|6140504|P2|COMPLETED|Overall Study||99
2505343|NCT00787254|6140505|P1|COMPLETED|Overall Study||109
2505344|NCT00787254|6140504|P2|STARTED|Overall Study||181
2505345|NCT00787254|6140505|P1|STARTED|Overall Study||185
2505346|NCT00787241|6140608|P3|NOT COMPLETED|Overall Study||0
2505347|NCT00787241|6140609|P2|NOT COMPLETED|Overall Study||0
2505348|NCT00787241|6140610|P1|NOT COMPLETED|Overall Study||0
2505349|NCT00787241|6140608|P3|COMPLETED|Overall Study||41
2505350|NCT00787241|6140609|P2|COMPLETED|Overall Study||143
2505351|NCT00787241|6140610|P1|COMPLETED|Overall Study||261
2505352|NCT00787241|6140608|P3|STARTED|Overall Study||41
2505353|NCT00787241|6140609|P2|STARTED|Overall Study||143
2505354|NCT00787241|6140610|P1|STARTED|Overall Study||261
2505355|NCT00787202|6140629|P5|NOT COMPLETED|Overall Study||4
2505356|NCT00787202|6140630|P4|NOT COMPLETED|Overall Study||2
2505357|NCT00787202|6140631|P3|NOT COMPLETED|Overall Study||7
2505358|NCT00787202|6140632|P2|NOT COMPLETED|Overall Study||11
2505359|NCT00787202|6140633|P1|NOT COMPLETED|Overall Study||14
2505360|NCT00787202|6140629|P5|COMPLETED|Overall Study||45
2505361|NCT00787202|6140630|P4|COMPLETED|Overall Study||31
2505362|NCT00787202|6140631|P3|COMPLETED|Overall Study||26
2505363|NCT00787202|6140632|P2|COMPLETED|Overall Study||20
2505364|NCT00787202|6140633|P1|COMPLETED|Overall Study||35
2505365|NCT00787202|6140629|P5|Treated|Overall Study||49
2505366|NCT00787202|6140630|P4|Treated|Overall Study||33
2505367|NCT00787202|6140631|P3|Treated|Overall Study||33
2505368|NCT00787202|6140632|P2|Treated|Overall Study||31
2505369|NCT00787202|6140633|P1|Treated|Overall Study||48
2505370|NCT00787202|6140629|P5|STARTED|Overall Study||49
2505371|NCT00787202|6140630|P4|STARTED|Overall Study||33
2505372|NCT00787202|6140631|P3|STARTED|Overall Study||33
2505373|NCT00787202|6140632|P2|STARTED|Overall Study||31
2505374|NCT00787202|6140633|P1|STARTED|Overall Study||49
2505375|NCT00787189|6140686|P2|NOT COMPLETED|Overall Study||2
2505376|NCT00787189|6140687|P1|NOT COMPLETED|Overall Study||2
2505377|NCT00787189|6140686|P2|COMPLETED|Overall Study|To study end point.|30
2505378|NCT00787189|6140687|P1|COMPLETED|Overall Study|To study end point.|30
2505379|NCT00787189|6140686|P2|STARTED|Overall Study||32
2505380|NCT00787189|6140687|P1|STARTED|Overall Study||32
2505381|NCT00787150|6140696|P3|NOT COMPLETED|Overall Study||5
2505382|NCT00787150|6140697|P2|NOT COMPLETED|Overall Study||7
2505383|NCT00787150|6140698|P1|NOT COMPLETED|Overall Study||9
2505384|NCT00787150|6140696|P3|COMPLETED|Overall Study||66
2505385|NCT00787150|6140697|P2|COMPLETED|Overall Study||65
2505386|NCT00787150|6140698|P1|COMPLETED|Overall Study||66
2505387|NCT00787150|6140696|P3|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|71
2505388|NCT00787150|6140697|P2|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|72
2505389|NCT00787150|6140698|P1|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|75
2505390|NCT00787137|6140743|P3|NOT COMPLETED|Overall Study||1
2505391|NCT00787137|6140744|P2|NOT COMPLETED|Overall Study||0
2505392|NCT00787137|6140745|P1|NOT COMPLETED|Overall Study||0
2505393|NCT00787137|6140743|P3|COMPLETED|Overall Study||4
2505394|NCT00787137|6140744|P2|COMPLETED|Overall Study||6
2505395|NCT00787137|6140745|P1|COMPLETED|Overall Study||6
2505396|NCT00787137|6140743|P3|STARTED|Overall Study||5
2505397|NCT00787137|6140744|P2|STARTED|Overall Study||6
2505398|NCT00787137|6140745|P1|STARTED|Overall Study||6
2505399|NCT00787124|6140767|P2|NOT COMPLETED|Overall Study||0
2505400|NCT00787124|6140768|P1|NOT COMPLETED|Overall Study||0
2505401|NCT00787124|6140767|P2|COMPLETED|Overall Study||4
2505402|NCT00787124|6140768|P1|COMPLETED|Overall Study||4
2505403|NCT00787124|6140767|P2|STARTED|Overall Study||4
2505404|NCT00787124|6140768|P1|STARTED|Overall Study||4
2505405|NCT00787020|6140778|P2|NOT COMPLETED|Overall Study||0
2505406|NCT00787020|6140779|P1|NOT COMPLETED|Overall Study||0
2505407|NCT00787020|6140778|P2|COMPLETED|Overall Study||13
2505408|NCT00787020|6140779|P1|COMPLETED|Overall Study||24
2505409|NCT00787020|6140778|P2|STARTED|Overall Study||13
2505410|NCT00787020|6140779|P1|STARTED|Overall Study||24
2505411|NCT00786994|6140793|P4|NOT COMPLETED|Overall Study||6
2505412|NCT00786994|6140794|P3|NOT COMPLETED|Overall Study||2
2505413|NCT00786994|6140795|P2|NOT COMPLETED|Overall Study||15
2505414|NCT00786994|6140796|P1|NOT COMPLETED|Overall Study||10
2505415|NCT00786994|6140793|P4|COMPLETED|Overall Study||22
2505416|NCT00786994|6140794|P3|COMPLETED|Overall Study||24
2505417|NCT00786994|6140795|P2|COMPLETED|Overall Study||39
2505418|NCT00786994|6140796|P1|COMPLETED|Overall Study||47
2505419|NCT00786994|6140793|P4|ITT|Overall Study||28
2505420|NCT00786994|6140794|P3|ITT|Overall Study||25
2505421|NCT00786994|6140795|P2|ITT|Overall Study||51
2505422|NCT00786994|6140796|P1|ITT|Overall Study||53
2505423|NCT00786994|6140793|P4|STARTED|Overall Study||28
2505424|NCT00786994|6140794|P3|STARTED|Overall Study||26
2505425|NCT00786994|6140795|P2|STARTED|Overall Study||54
2505426|NCT00786994|6140796|P1|STARTED|Overall Study||57
2505427|NCT00786916|6140808|P3|NOT COMPLETED|Overall Study||0
2505428|NCT00786916|6140809|P2|NOT COMPLETED|Overall Study||0
2505429|NCT00786916|6140810|P1|NOT COMPLETED|Overall Study||0
2505430|NCT00786916|6140808|P3|COMPLETED|Overall Study||34
2505431|NCT00786916|6140809|P2|COMPLETED|Overall Study||36
2505432|NCT00786916|6140810|P1|COMPLETED|Overall Study||39
2505433|NCT00786916|6140808|P3|STARTED|Overall Study||34
2505434|NCT00786916|6140809|P2|STARTED|Overall Study||36
2505435|NCT00786916|6140810|P1|STARTED|Overall Study||39
2505436|NCT00786864|6140820|P2|NOT COMPLETED|Overall Study||1
2505437|NCT00786864|6140821|P1|NOT COMPLETED|Overall Study||1
2505438|NCT00786864|6140820|P2|COMPLETED|Overall Study|1 child lost to study immediately post-intervention as she left the school|32
2505439|NCT00786864|6140821|P1|COMPLETED|Overall Study|1 child excluded at the 3 month follow-up, as he sustained a serious back injury|38
2505440|NCT00786864|6140820|P2|STARTED|Overall Study||33
2505441|NCT00786864|6140821|P1|STARTED|Overall Study||39
2505442|NCT00786838|6140833|P1|NOT COMPLETED|Overall Study||49
2505443|NCT00786838|6140833|P1|COMPLETED|Overall Study||26
2505444|NCT00786838|6140833|P1|STARTED|Overall Study||75
2505445|NCT00786825|6140860|P2|NOT COMPLETED|Overall Study||0
2505446|NCT00786825|6140861|P1|NOT COMPLETED|Overall Study||0
2505447|NCT00786825|6140860|P2|COMPLETED|Overall Study||5
2505448|NCT00786825|6140861|P1|COMPLETED|Overall Study||5
2505449|NCT00786825|6140860|P2|STARTED|Overall Study||5
2505450|NCT00786825|6140861|P1|STARTED|Overall Study||5
2505451|NCT00786799|6140869|P2|NOT COMPLETED|Overall Study||1
2505452|NCT00786799|6140870|P1|NOT COMPLETED|Overall Study||1
2505453|NCT00786799|6140869|P2|COMPLETED|Overall Study||12
2505454|NCT00786799|6140870|P1|COMPLETED|Overall Study||13
2505455|NCT00786799|6140869|P2|STARTED|Overall Study||13
2505456|NCT00786799|6140870|P1|STARTED|Overall Study||14
2505457|NCT00786682|6140881|P1|NOT COMPLETED|Overall Study||0
2505458|NCT00786682|6140881|P1|COMPLETED|Overall Study||11
2505459|NCT00786682|6140881|P1|STARTED|Overall Study||11
2505460|NCT00786643|6140889|P2|NOT COMPLETED|Overall Study||0
2505461|NCT00786643|6140890|P1|NOT COMPLETED|Overall Study||0
2505462|NCT00786643|6140889|P2|COMPLETED|Overall Study||28
2505463|NCT00786643|6140890|P1|COMPLETED|Overall Study||20
2505464|NCT00786643|6140889|P2|STARTED|Overall Study||28
2505465|NCT00786643|6140890|P1|STARTED|Overall Study||20
2505466|NCT00786565|6140900|P1|NOT COMPLETED|Post Surgery||2
2505467|NCT00786565|6140900|P1|COMPLETED|Post Surgery|67 Participants (134 eyes) completed the study.|67
2505468|NCT00786565|6140900|P1|STARTED|Post Surgery||69
2505469|NCT00786565|6140900|P1|NOT COMPLETED|Enrollment Prior to Surgery||6
2505470|NCT00786565|6140900|P1|COMPLETED|Enrollment Prior to Surgery|69 participants - Akreos Advanced Optic Lens in one eye and Akreos Adapt Lens in the fellow eye.|69
2505471|NCT00786565|6140900|P1|STARTED|Enrollment Prior to Surgery||75
2505472|NCT00786487|6140942|P4|NOT COMPLETED|Overall Study||0
2505473|NCT00786487|6140943|P3|NOT COMPLETED|Overall Study||0
2505474|NCT00786487|6140944|P2|NOT COMPLETED|Overall Study||0
2505475|NCT00786487|6140945|P1|NOT COMPLETED|Overall Study||0
2505476|NCT00786487|6140942|P4|COMPLETED|Overall Study||7
2505477|NCT00786487|6140943|P3|COMPLETED|Overall Study||9
2505478|NCT00786487|6140944|P2|COMPLETED|Overall Study||7
2505479|NCT00786487|6140945|P1|COMPLETED|Overall Study||10
2505480|NCT00786487|6140942|P4|STARTED|Overall Study||7
2505481|NCT00786487|6140943|P3|STARTED|Overall Study||9
2505482|NCT00786487|6140944|P2|STARTED|Overall Study||7
2505483|NCT00786487|6140945|P1|STARTED|Overall Study||10
2505484|NCT00786474|6140957|P2|NOT COMPLETED|Overall Study||43
2505485|NCT00786474|6140958|P1|NOT COMPLETED|Overall Study||37
2505486|NCT00786474|6140957|P2|COMPLETED|Overall Study||891
2505487|NCT00786474|6140958|P1|COMPLETED|Overall Study||913
2505488|NCT00786474|6140957|P2|STARTED|Overall Study||934
2505489|NCT00786474|6140958|P1|STARTED|Overall Study||950
2505490|NCT00786422|6140970|P1|NOT COMPLETED|Follow-up Period||3
2505491|NCT00786422|6140970|P1|COMPLETED|Follow-up Period||17
2505492|NCT00786422|6140970|P1|STARTED|Follow-up Period|Participants entered follow-up period. No reason documents for those not entering this period|20
2505493|NCT00786422|6140970|P1|NOT COMPLETED|Rivaroxaban Treatment||11
2505494|NCT00786422|6140970|P1|COMPLETED|Rivaroxaban Treatment||14
2505495|NCT00786422|6140970|P1|STARTED|Rivaroxaban Treatment||25
2505496|NCT00786409|6140986|P1|NOT COMPLETED|Overall Study||7
2505497|NCT00786409|6140986|P1|COMPLETED|Overall Study||20
2505498|NCT00786409|6140986|P1|STARTED|Overall Study||27
2505499|NCT00786188|6141003|P2|NOT COMPLETED|Overall Study||1
2505500|NCT00786188|6141004|P1|NOT COMPLETED|Overall Study||5
2505501|NCT00786188|6141003|P2|COMPLETED|Overall Study||51
2505502|NCT00786188|6141004|P1|COMPLETED|Overall Study||45
2505503|NCT00786188|6141003|P2|STARTED|Overall Study||52
2505504|NCT00786188|6141004|P1|STARTED|Overall Study||50
2505505|NCT00786032|6141030|P1|NOT COMPLETED|Overall Study||24
2505506|NCT00786032|6141030|P1|COMPLETED|Overall Study||3
2505507|NCT00786032|6141030|P1|Independent Users|Overall Study|All data analyses were based on the 14 independent users.|14
2505508|NCT00786032|6141030|P1|STARTED|Overall Study||27
2505509|NCT00786019|6141042|P2|NOT COMPLETED|Overall Study||10
2505510|NCT00786019|6141043|P1|NOT COMPLETED|Overall Study||5
2505511|NCT00786019|6141042|P2|COMPLETED|Overall Study||17
2505512|NCT00786019|6141043|P1|COMPLETED|Overall Study||15
2505513|NCT00786019|6141042|P2|STARTED|Overall Study||27
2505514|NCT00786019|6141043|P1|STARTED|Overall Study||20
2505515|NCT00785980|6141051|P1|NOT COMPLETED|Quinine Sulfate With Ciprofloxacin||0
2505516|NCT00785980|6141051|P1|COMPLETED|Quinine Sulfate With Ciprofloxacin||21
2505517|NCT00785980|6141051|P1|STARTED|Quinine Sulfate With Ciprofloxacin||21
2505518|NCT00785980|6141051|P1|NOT COMPLETED|Ciprofloxacin Alone||0
2505519|NCT00785980|6141051|P1|COMPLETED|Ciprofloxacin Alone||21
2505520|NCT00785980|6141051|P1|STARTED|Ciprofloxacin Alone||21
2505521|NCT00785980|6141051|P1|NOT COMPLETED|7 Day Washout Period||3
2505522|NCT00785980|6141051|P1|COMPLETED|7 Day Washout Period||21
2505523|NCT00785980|6141051|P1|STARTED|7 Day Washout Period||24
2505524|NCT00785980|6141051|P1|NOT COMPLETED|Quinine Sulfate Alone||0
2505525|NCT00785980|6141051|P1|COMPLETED|Quinine Sulfate Alone||24
2505526|NCT00785980|6141051|P1|STARTED|Quinine Sulfate Alone||24
2505527|NCT00785928|6141069|P7|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||5
2505528|NCT00785928|6141070|P6|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||0
2505529|NCT00785928|6141071|P5|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||2
2505530|NCT00785928|6141072|P4|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||0
2505531|NCT00785928|6141073|P3|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||2
2505532|NCT00785928|6141074|P2|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||3
2505533|NCT00785928|6141075|P1|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||1
2505534|NCT00785928|6141069|P7|COMPLETED|Follow-up Phases (Weeks 24-72)||9
2505535|NCT00785928|6141070|P6|COMPLETED|Follow-up Phases (Weeks 24-72)||0
2505536|NCT00785928|6141071|P5|COMPLETED|Follow-up Phases (Weeks 24-72)||4
2505537|NCT00785928|6141072|P4|COMPLETED|Follow-up Phases (Weeks 24-72)||4
2505538|NCT00785928|6141073|P3|COMPLETED|Follow-up Phases (Weeks 24-72)||4
2505539|NCT00785928|6141074|P2|COMPLETED|Follow-up Phases (Weeks 24-72)||5
2505540|NCT00785928|6141075|P1|COMPLETED|Follow-up Phases (Weeks 24-72)||7
2505541|NCT00785928|6141069|P7|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|14
2505542|NCT00785928|6141070|P6|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|0
2505543|NCT00785928|6141071|P5|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|6
2505544|NCT00785928|6141072|P4|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|4
2505545|NCT00785928|6141073|P3|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|6
2505546|NCT00785928|6141074|P2|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|8
2505547|NCT00785928|6141075|P1|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|8
2505548|NCT00785928|6141069|P7|NOT COMPLETED|Treatment Phase||3
2505549|NCT00785928|6141070|P6|NOT COMPLETED|Treatment Phase||0
2505550|NCT00785928|6141071|P5|NOT COMPLETED|Treatment Phase||2
2505551|NCT00785928|6141072|P4|NOT COMPLETED|Treatment Phase||0
2505552|NCT00785928|6141073|P3|NOT COMPLETED|Treatment Phase||3
2505553|NCT00785928|6141074|P2|NOT COMPLETED|Treatment Phase||5
2505554|NCT00785928|6141075|P1|NOT COMPLETED|Treatment Phase||3
2505555|NCT00785928|6141069|P7|COMPLETED|Treatment Phase||23
2505556|NCT00785928|6141070|P6|COMPLETED|Treatment Phase||13
2505557|NCT00785928|6141071|P5|COMPLETED|Treatment Phase||16
2505558|NCT00785928|6141072|P4|COMPLETED|Treatment Phase||15
2505559|NCT00785928|6141073|P3|COMPLETED|Treatment Phase||17
2505560|NCT00785928|6141074|P2|COMPLETED|Treatment Phase||25
2505561|NCT00785928|6141075|P1|COMPLETED|Treatment Phase||33
2505562|NCT00785928|6141069|P7|STARTED|Treatment Phase||26
2505563|NCT00785928|6141070|P6|STARTED|Treatment Phase||13
2505564|NCT00785928|6141071|P5|STARTED|Treatment Phase||18
2505565|NCT00785928|6141072|P4|STARTED|Treatment Phase||15
2505566|NCT00785928|6141073|P3|STARTED|Treatment Phase||20
2505567|NCT00785928|6141074|P2|STARTED|Treatment Phase||30
2505568|NCT00785928|6141075|P1|STARTED|Treatment Phase||36
2505569|NCT00785798|6141215|P1|NOT COMPLETED|Overall Study||1
2505570|NCT00785798|6141215|P1|COMPLETED|Overall Study||16
2505571|NCT00785798|6141215|P1|STARTED|Overall Study||17
2505572|NCT00785785|6141222|P2|NOT COMPLETED|Optional Extension Phase||125
2505573|NCT00785785|6141223|P1|NOT COMPLETED|Optional Extension Phase||39
2505574|NCT00785785|6141222|P2|COMPLETED|Optional Extension Phase||0
2505575|NCT00785785|6141223|P1|COMPLETED|Optional Extension Phase||0
2505576|NCT00785785|6141222|P2|STARTED|Optional Extension Phase|crossover extension phase was optional|125
2505577|NCT00785785|6141223|P1|STARTED|Optional Extension Phase|crossover extension phase was optional|39
2505578|NCT00785785|6141222|P2|NOT COMPLETED|Core Phase up to 36 Months||320
2505579|NCT00785785|6141223|P1|NOT COMPLETED|Core Phase up to 36 Months||324
2505580|NCT00785785|6141222|P2|COMPLETED|Core Phase up to 36 Months||0
2505581|NCT00785785|6141223|P1|COMPLETED|Core Phase up to 36 Months||0
2505582|NCT00785785|6141222|P2|STARTED|Core Phase up to 36 Months||320
2505583|NCT00785785|6141223|P1|STARTED|Core Phase up to 36 Months||324
2505584|NCT00785772|6141231|P1|NOT COMPLETED|Overall Study||0
2505585|NCT00785772|6141231|P1|COMPLETED|Overall Study||1
2505586|NCT00785772|6141231|P1|STARTED|Overall Study||1
2505587|NCT00785707|6141237|P1|NOT COMPLETED|Overall Study||7
2505588|NCT00785707|6141237|P1|COMPLETED|Overall Study||24
2505589|NCT00785707|6141237|P1|STARTED|Overall Study||31
2505590|NCT00785629|6141246|P4|NOT COMPLETED|Overall Study||16
2505591|NCT00785629|6141247|P3|NOT COMPLETED|Overall Study||10
2505592|NCT00785629|6141248|P2|NOT COMPLETED|Overall Study||5
2505593|NCT00785629|6141249|P1|NOT COMPLETED|Overall Study||8
2505594|NCT00785629|6141246|P4|COMPLETED|Overall Study|16 not completed|41
2505595|NCT00785629|6141247|P3|COMPLETED|Overall Study|10 not completed|18
2505596|NCT00785629|6141248|P2|COMPLETED|Overall Study|5 not completed|25
2505597|NCT00785629|6141249|P1|COMPLETED|Overall Study|8 not completed|22
2505598|NCT00785629|6141246|P4|STARTED|Overall Study||57
2505599|NCT00785629|6141247|P3|STARTED|Overall Study||28
2505600|NCT00785629|6141248|P2|STARTED|Overall Study||30
2505601|NCT00785629|6141249|P1|STARTED|Overall Study||30
2505602|NCT00785577|6141262|P5|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
2505603|NCT00785577|6141263|P4|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
2505604|NCT00785577|6141264|P3|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
2505605|NCT00785577|6141265|P2|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
2505606|NCT00785577|6141266|P1|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
2505607|NCT00785577|6141262|P5|COMPLETED|Study Period 3: 1-Week Washout Phase||26
2505608|NCT00785577|6141263|P4|COMPLETED|Study Period 3: 1-Week Washout Phase||35
2505609|NCT00785577|6141264|P3|COMPLETED|Study Period 3: 1-Week Washout Phase||25
2505610|NCT00785577|6141265|P2|COMPLETED|Study Period 3: 1-Week Washout Phase||36
2505611|NCT00785577|6141266|P1|COMPLETED|Study Period 3: 1-Week Washout Phase||78
2505612|NCT00785577|6141262|P5|STARTED|Study Period 3: 1-Week Washout Phase||27
2505613|NCT00785577|6141263|P4|STARTED|Study Period 3: 1-Week Washout Phase||36
2505614|NCT00785577|6141264|P3|STARTED|Study Period 3: 1-Week Washout Phase||25
2505615|NCT00785577|6141265|P2|STARTED|Study Period 3: 1-Week Washout Phase||36
2505616|NCT00785577|6141266|P1|STARTED|Study Period 3: 1-Week Washout Phase||78
2505617|NCT00785577|6141262|P5|NOT COMPLETED|Study Period 2: Therapy Phase||20
2505618|NCT00785577|6141263|P4|NOT COMPLETED|Study Period 2: Therapy Phase||13
2505619|NCT00785577|6141264|P3|NOT COMPLETED|Study Period 2: Therapy Phase||18
2505620|NCT00785577|6141265|P2|NOT COMPLETED|Study Period 2: Therapy Phase||9
2505621|NCT00785577|6141266|P1|NOT COMPLETED|Study Period 2: Therapy Phase||11
2505622|NCT00785577|6141262|P5|COMPLETED|Study Period 2: Therapy Phase||27
2505623|NCT00785577|6141263|P4|COMPLETED|Study Period 2: Therapy Phase||36
2505624|NCT00785577|6141264|P3|COMPLETED|Study Period 2: Therapy Phase||25
2505625|NCT00785577|6141265|P2|COMPLETED|Study Period 2: Therapy Phase||36
2505626|NCT00785577|6141266|P1|COMPLETED|Study Period 2: Therapy Phase||78
2505627|NCT00785577|6141262|P5|STARTED|Study Period 2: Therapy Phase||47
2505628|NCT00785577|6141263|P4|STARTED|Study Period 2: Therapy Phase||49
2505629|NCT00785577|6141264|P3|STARTED|Study Period 2: Therapy Phase||43
2505630|NCT00785577|6141265|P2|STARTED|Study Period 2: Therapy Phase||45
2505631|NCT00785577|6141266|P1|STARTED|Study Period 2: Therapy Phase||89
2505632|NCT00785538|6141406|P4|NOT COMPLETED|Treatment Period||1
2505633|NCT00785538|6141407|P3|NOT COMPLETED|Treatment Period||2
2505634|NCT00785538|6141408|P2|NOT COMPLETED|Treatment Period||2
2505635|NCT00785538|6141409|P1|NOT COMPLETED|Treatment Period||1
2505636|NCT00785538|6141406|P4|COMPLETED|Treatment Period||1
2505637|NCT00785538|6141407|P3|COMPLETED|Treatment Period||4
2505638|NCT00785538|6141408|P2|COMPLETED|Treatment Period||7
2505639|NCT00785538|6141409|P1|COMPLETED|Treatment Period||6
2505640|NCT00785538|6141406|P4|Received at Least 1 Dose of Study Drug|Treatment Period||2
2505641|NCT00785538|6141407|P3|Received at Least 1 Dose of Study Drug|Treatment Period||6
2505642|NCT00785538|6141408|P2|Received at Least 1 Dose of Study Drug|Treatment Period||9
2505643|NCT00785538|6141409|P1|Received at Least 1 Dose of Study Drug|Treatment Period||7
2505644|NCT00785538|6141406|P4|STARTED|Treatment Period||2
2505645|NCT00785538|6141407|P3|STARTED|Treatment Period||6
2505646|NCT00785538|6141408|P2|STARTED|Treatment Period||9
2505647|NCT00785538|6141409|P1|STARTED|Treatment Period||7
2505648|NCT00785538|6141406|P4|NOT COMPLETED|PK Period||0
2505649|NCT00785538|6141407|P3|NOT COMPLETED|PK Period||0
2505650|NCT00785538|6141408|P2|NOT COMPLETED|PK Period||0
2505651|NCT00785538|6141409|P1|NOT COMPLETED|PK Period||0
2505652|NCT00785538|6141406|P4|COMPLETED|PK Period||0
2505653|NCT00785538|6141407|P3|COMPLETED|PK Period||1
2505654|NCT00785538|6141408|P2|COMPLETED|PK Period||1
2505655|NCT00785538|6141409|P1|COMPLETED|PK Period||7
2505656|NCT00785538|6141406|P4|STARTED|PK Period||0
2505657|NCT00785538|6141407|P3|STARTED|PK Period||1
2505658|NCT00785538|6141408|P2|STARTED|PK Period||1
2505659|NCT00785538|6141409|P1|STARTED|PK Period||7
2505660|NCT00785512|6141457|P2|NOT COMPLETED|Overall Study||4
2505661|NCT00785512|6141458|P1|NOT COMPLETED|Overall Study||3
2505662|NCT00785512|6141457|P2|COMPLETED|Overall Study||101
2505663|NCT00785512|6141458|P1|COMPLETED|Overall Study||99
2505664|NCT00785512|6141457|P2|STARTED|Overall Study||105
2505665|NCT00785512|6141458|P1|STARTED|Overall Study||102
2505666|NCT00785486|6141467|P1|NOT COMPLETED|Midazolam With Qualaquin at Steady State||0
2505667|NCT00785486|6141467|P1|COMPLETED|Midazolam With Qualaquin at Steady State||23
2505668|NCT00785486|6141467|P1|STARTED|Midazolam With Qualaquin at Steady State||23
2505669|NCT00785486|6141467|P1|NOT COMPLETED|Qualaquin Alone at Steady State||0
2505670|NCT00785486|6141467|P1|COMPLETED|Qualaquin Alone at Steady State||23
2505671|NCT00785486|6141467|P1|STARTED|Qualaquin Alone at Steady State||23
2505672|NCT00785486|6141467|P1|NOT COMPLETED|3 Day Washout||0
2505673|NCT00785486|6141467|P1|COMPLETED|3 Day Washout||23
2505674|NCT00785486|6141467|P1|STARTED|3 Day Washout||23
2505675|NCT00785486|6141467|P1|NOT COMPLETED|Midazolam Alone||1
2505676|NCT00785486|6141467|P1|COMPLETED|Midazolam Alone|one participant withdrew for personal reasons after first midazolam dose|23
2505677|NCT00785486|6141467|P1|STARTED|Midazolam Alone||24
2505678|NCT00785356|6141491|P1|NOT COMPLETED|Overall Study||8
2505679|NCT00785356|6141491|P1|COMPLETED|Overall Study||0
2505680|NCT00785356|6141491|P1|STARTED|Overall Study||8
2505690|NCT00785213|6141524|P1|NOT COMPLETED|Rosiglitazone With Quinine Sulfate||1
2505691|NCT00785213|6141524|P1|COMPLETED|Rosiglitazone With Quinine Sulfate||18
2505692|NCT00785213|6141524|P1|STARTED|Rosiglitazone With Quinine Sulfate||19
2505693|NCT00785213|6141524|P1|NOT COMPLETED|Quinine Sulfate Alone||4
2505694|NCT00785213|6141524|P1|COMPLETED|Quinine Sulfate Alone||19
2505695|NCT00785213|6141524|P1|STARTED|Quinine Sulfate Alone||23
2505696|NCT00785213|6141524|P1|NOT COMPLETED|2 Day Washout Period||0
2505697|NCT00785213|6141524|P1|COMPLETED|2 Day Washout Period||23
2505698|NCT00785213|6141524|P1|STARTED|2 Day Washout Period||23
2505699|NCT00785213|6141524|P1|NOT COMPLETED|Rosiglitazone Alone||0
2505700|NCT00785213|6141524|P1|COMPLETED|Rosiglitazone Alone||23
2505701|NCT00785213|6141524|P1|STARTED|Rosiglitazone Alone||23
2505702|NCT00785044|6141535|P1|NOT COMPLETED|Overall Study||496
2505703|NCT00785044|6141535|P1|COMPLETED|Overall Study|Data for 471 participants (MBG313) combined with data from MBG311 and MBG312 for efficacy analysis|468
2505704|NCT00785044|6141535|P1|Enrolled Participants|Overall Study|Out of 964 from MBG311 and MBG312 HF participants, 471 enrolled into the extension MBG313 study.|471
2505705|NCT00785044|6141535|P1|STARTED|Overall Study|Eligible to participate in MBG313|964
2505706|NCT00784979|6141540|P1|NOT COMPLETED|Overall Study||6
2505707|NCT00784979|6141540|P1|COMPLETED|Overall Study||20
2505708|NCT00784979|6141540|P1|STARTED|Overall Study||26
2505709|NCT00784927|6141544|P1|NOT COMPLETED|Overall Study||3
2505710|NCT00784927|6141544|P1|COMPLETED|Overall Study||33
2505711|NCT00784927|6141544|P1|STARTED|Overall Study||36
2505712|NCT00784875|6141556|P4|NOT COMPLETED|Period D||1
2505713|NCT00784875|6141557|P3|NOT COMPLETED|Period D||6
2505714|NCT00784875|6141558|P2|NOT COMPLETED|Period D||4
2505715|NCT00784875|6141559|P1|NOT COMPLETED|Period D||5
2505716|NCT00784875|6141556|P4|COMPLETED|Period D||87
2505717|NCT00784875|6141557|P3|COMPLETED|Period D||88
2505718|NCT00784875|6141558|P2|COMPLETED|Period D||85
2505719|NCT00784875|6141559|P1|COMPLETED|Period D||86
2505720|NCT00784875|6141556|P4|STARTED|Period D||88
2505721|NCT00784875|6141557|P3|STARTED|Period D||94
2505722|NCT00784875|6141558|P2|STARTED|Period D||89
2505723|NCT00784875|6141559|P1|STARTED|Period D||91
2505724|NCT00784875|6141556|P4|NOT COMPLETED|Period C||7
2505725|NCT00784875|6141557|P3|NOT COMPLETED|Period C||13
2505726|NCT00784875|6141558|P2|NOT COMPLETED|Period C||6
2505727|NCT00784875|6141559|P1|NOT COMPLETED|Period C||7
2505728|NCT00784875|6141556|P4|COMPLETED|Period C||91
2505729|NCT00784875|6141557|P3|COMPLETED|Period C||84
2505730|NCT00784875|6141558|P2|COMPLETED|Period C||91
2505731|NCT00784875|6141559|P1|COMPLETED|Period C||96
2505732|NCT00784875|6141556|P4|STARTED|Period C||98
2505733|NCT00784875|6141557|P3|STARTED|Period C||97
2505734|NCT00784875|6141558|P2|STARTED|Period C||97
2505735|NCT00784875|6141559|P1|STARTED|Period C||103
2505736|NCT00784875|6141556|P4|NOT COMPLETED|Period B - Efficacy Endpoint||19
2505737|NCT00784875|6141557|P3|NOT COMPLETED|Period B - Efficacy Endpoint||21
2505738|NCT00784875|6141558|P2|NOT COMPLETED|Period B - Efficacy Endpoint||12
2505739|NCT00784875|6141559|P1|NOT COMPLETED|Period B - Efficacy Endpoint||14
2505740|NCT00784875|6141556|P4|COMPLETED|Period B - Efficacy Endpoint||98
2505741|NCT00784875|6141557|P3|COMPLETED|Period B - Efficacy Endpoint||96
2505742|NCT00784875|6141558|P2|COMPLETED|Period B - Efficacy Endpoint||101
2505743|NCT00784875|6141559|P1|COMPLETED|Period B - Efficacy Endpoint||100
2505744|NCT00784875|6141556|P4|Cohort 2|Period B - Efficacy Endpoint||101
2505745|NCT00784875|6141557|P3|Cohort 2|Period B - Efficacy Endpoint||102
2505746|NCT00784875|6141558|P2|Cohort 2|Period B - Efficacy Endpoint||102
2505747|NCT00784875|6141559|P1|Cohort 2|Period B - Efficacy Endpoint||102
2505748|NCT00784875|6141556|P4|STARTED|Period B - Efficacy Endpoint||117
2505749|NCT00784875|6141557|P3|STARTED|Period B - Efficacy Endpoint||117
2505750|NCT00784875|6141558|P2|STARTED|Period B - Efficacy Endpoint||113
2505751|NCT00784875|6141559|P1|STARTED|Period B - Efficacy Endpoint||114
2505752|NCT00784875|6141556|P4|NOT COMPLETED|Period A - Baseline||182
2505753|NCT00784875|6141557|P3|NOT COMPLETED|Period A - Baseline||0
2505754|NCT00784875|6141558|P2|NOT COMPLETED|Period A - Baseline||0
2505755|NCT00784875|6141559|P1|NOT COMPLETED|Period A - Baseline||0
2505756|NCT00784875|6141556|P4|COMPLETED|Period A - Baseline||461
2505757|NCT00784875|6141557|P3|COMPLETED|Period A - Baseline||0
2505758|NCT00784875|6141558|P2|COMPLETED|Period A - Baseline||0
2505759|NCT00784875|6141559|P1|COMPLETED|Period A - Baseline||0
2505760|NCT00784875|6141556|P4|STARTED|Period A - Baseline||643
2505761|NCT00784875|6141557|P3|STARTED|Period A - Baseline||0
2505762|NCT00784875|6141558|P2|STARTED|Period A - Baseline||0
2505763|NCT00784875|6141559|P1|STARTED|Period A - Baseline||0
2505764|NCT00784849|6141673|P1|NOT COMPLETED|Overall Study||0
2505765|NCT00784849|6141673|P1|COMPLETED|Overall Study||62
2505766|NCT00784849|6141673|P1|STARTED|Overall Study||62
2505767|NCT00784836|6141679|P1|NOT COMPLETED|Overall Study||3
2505768|NCT00784836|6141679|P1|COMPLETED|Overall Study|The study was terminated early by the Sponsor for business reason not related to safety.|0
2505769|NCT00784836|6141679|P1|STARTED|Overall Study||3
2505770|NCT00784810|6141686|P2|NOT COMPLETED|Overall Study||49
2505771|NCT00784810|6141687|P1|NOT COMPLETED|Overall Study||63
2505772|NCT00784810|6141686|P2|COMPLETED|Overall Study||74
2505773|NCT00784810|6141687|P1|COMPLETED|Overall Study||61
2505774|NCT00784810|6141686|P2|STARTED|Overall Study||123
2505775|NCT00784810|6141687|P1|STARTED|Overall Study||124
2505776|NCT00784784|6141697|P2|NOT COMPLETED|Overall Study||2
2505777|NCT00784784|6141698|P1|NOT COMPLETED|Overall Study||2
2505778|NCT00784784|6141697|P2|COMPLETED|Overall Study||40
2505779|NCT00784784|6141698|P1|COMPLETED|Overall Study||20
2505780|NCT00784784|6141697|P2|STARTED|Overall Study||42
2505781|NCT00784784|6141698|P1|STARTED|Overall Study||22
2505782|NCT00784758|6141708|P2|NOT COMPLETED|Overall Study||0
2505783|NCT00784758|6141709|P1|NOT COMPLETED|Overall Study||4
2505784|NCT00784758|6141708|P2|COMPLETED|Overall Study||39
2505785|NCT00784758|6141709|P1|COMPLETED|Overall Study||38
2505786|NCT00784758|6141708|P2|Completed Treatment|Overall Study||39
2505787|NCT00784758|6141709|P1|Completed Treatment|Overall Study||40
2505788|NCT00784758|6141708|P2|Began Treatment|Overall Study||39
2505789|NCT00784758|6141709|P1|Began Treatment|Overall Study||41
2505790|NCT00784758|6141708|P2|STARTED|Overall Study||39
2505791|NCT00784758|6141709|P1|STARTED|Overall Study||42
2505792|NCT00784719|6141758|P7|NOT COMPLETED|Overall Study||5
2505793|NCT00784719|6141759|P6|NOT COMPLETED|Overall Study||3
2505794|NCT00784719|6141760|P5|NOT COMPLETED|Overall Study||6
2505795|NCT00784719|6141761|P4|NOT COMPLETED|Overall Study||0
2505796|NCT00784719|6141762|P3|NOT COMPLETED|Overall Study||1
2505797|NCT00784719|6141763|P2|NOT COMPLETED|Overall Study||3
2505798|NCT00784719|6141764|P1|NOT COMPLETED|Overall Study||3
2505799|NCT00784719|6141758|P7|COMPLETED|Overall Study||42
2505800|NCT00784719|6141759|P6|COMPLETED|Overall Study||41
2505801|NCT00784719|6141760|P5|COMPLETED|Overall Study||42
2505802|NCT00784719|6141761|P4|COMPLETED|Overall Study||48
2505803|NCT00784719|6141762|P3|COMPLETED|Overall Study||46
2505804|NCT00784719|6141763|P2|COMPLETED|Overall Study||43
2505805|NCT00784719|6141764|P1|COMPLETED|Overall Study||44
2505806|NCT00784719|6141758|P7|STARTED|Overall Study||47
2505807|NCT00784719|6141759|P6|STARTED|Overall Study||44
2505808|NCT00784719|6141760|P5|STARTED|Overall Study||48
2505809|NCT00784719|6141761|P4|STARTED|Overall Study||48
2505810|NCT00784719|6141762|P3|STARTED|Overall Study||47
2505811|NCT00784719|6141763|P2|STARTED|Overall Study||46
2505812|NCT00784719|6141764|P1|STARTED|Overall Study||47
2505813|NCT00784654|6141934|P3|NOT COMPLETED|Randomized Withdrawal Period||63
2505814|NCT00784654|6141935|P2|NOT COMPLETED|Randomized Withdrawal Period||18
2505815|NCT00784654|6141936|P1|NOT COMPLETED|Randomized Withdrawal Period||0
2505816|NCT00784654|6141934|P3|COMPLETED|Randomized Withdrawal Period||16
2505817|NCT00784654|6141935|P2|COMPLETED|Randomized Withdrawal Period||60
2505818|NCT00784654|6141936|P1|COMPLETED|Randomized Withdrawal Period||0
2505819|NCT00784654|6141934|P3|STARTED|Randomized Withdrawal Period||79
2505820|NCT00784654|6141935|P2|STARTED|Randomized Withdrawal Period||78
2505821|NCT00784654|6141936|P1|STARTED|Randomized Withdrawal Period||0
2505822|NCT00784654|6141934|P3|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
2505823|NCT00784654|6141935|P2|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
2505824|NCT00784654|6141936|P1|NOT COMPLETED|Open-Label Period (Non-Randomized)||111
2505825|NCT00784654|6141934|P3|COMPLETED|Open-Label Period (Non-Randomized)||0
2505826|NCT00784654|6141935|P2|COMPLETED|Open-Label Period (Non-Randomized)||0
2505827|NCT00784654|6141936|P1|COMPLETED|Open-Label Period (Non-Randomized)||165
2505828|NCT00784654|6141934|P3|STARTED|Open-Label Period (Non-Randomized)||0
2505829|NCT00784654|6141935|P2|STARTED|Open-Label Period (Non-Randomized)||0
2505830|NCT00784654|6141936|P1|STARTED|Open-Label Period (Non-Randomized)||276
2505831|NCT00784563|6141971|P3|NOT COMPLETED|Year 3||3
2505832|NCT00784563|6141972|P2|NOT COMPLETED|Year 3||0
2505833|NCT00784563|6141973|P1|NOT COMPLETED|Year 3||0
2505834|NCT00784563|6141971|P3|COMPLETED|Year 3||14
2505835|NCT00784563|6141972|P2|COMPLETED|Year 3||0
2505836|NCT00784563|6141973|P1|COMPLETED|Year 3||0
2505837|NCT00784563|6141971|P3|STARTED|Year 3||17
2505838|NCT00784563|6141972|P2|STARTED|Year 3||0
2505839|NCT00784563|6141973|P1|STARTED|Year 3||0
2505840|NCT00784563|6141971|P3|NOT COMPLETED|Years 1 & 2||0
2505841|NCT00784563|6141972|P2|NOT COMPLETED|Years 1 & 2||5
2505842|NCT00784563|6141973|P1|NOT COMPLETED|Years 1 & 2||3
2505843|NCT00784563|6141971|P3|COMPLETED|Years 1 & 2||0
2505844|NCT00784563|6141972|P2|COMPLETED|Years 1 & 2||17
2505845|NCT00784563|6141973|P1|COMPLETED|Years 1 & 2||18
2505846|NCT00784563|6141971|P3|STARTED|Years 1 & 2||0
2505847|NCT00784563|6141972|P2|STARTED|Years 1 & 2||22
2505848|NCT00784563|6141973|P1|STARTED|Years 1 & 2||21
2505849|NCT00784550|6141991|P2|NOT COMPLETED|Overall Study||42
2505850|NCT00784550|6141992|P1|NOT COMPLETED|Overall Study||36
2505851|NCT00784550|6141991|P2|COMPLETED|Overall Study||127
2505852|NCT00784550|6141992|P1|COMPLETED|Overall Study||137
2505853|NCT00784550|6141991|P2|STARTED|Overall Study||169
2505854|NCT00784550|6141992|P1|STARTED|Overall Study||173
2505855|NCT00784524|6142008|P1|NOT COMPLETED|Overall Study||0
2505856|NCT00784524|6142008|P1|COMPLETED|Overall Study||14
2505857|NCT00784524|6142008|P1|STARTED|Overall Study||14
2505858|NCT00784459|6142018|P2|NOT COMPLETED|Overall Study||2
2505859|NCT00784459|6142019|P1|NOT COMPLETED|Overall Study||0
2505860|NCT00784459|6142018|P2|COMPLETED|Overall Study||11
2505861|NCT00784459|6142019|P1|COMPLETED|Overall Study||11
2505862|NCT00784459|6142018|P2|STARTED|Overall Study||13
2505863|NCT00784459|6142019|P1|STARTED|Overall Study||11
2505864|NCT00784368|6142030|P3|NOT COMPLETED|Overall Study||11
2505865|NCT00784368|6142031|P2|NOT COMPLETED|Overall Study||11
2505866|NCT00784368|6142032|P1|NOT COMPLETED|Overall Study||8
2505867|NCT00784368|6142030|P3|COMPLETED|Overall Study||12
2505868|NCT00784368|6142031|P2|COMPLETED|Overall Study||5
2505869|NCT00784368|6142032|P1|COMPLETED|Overall Study||8
2505870|NCT00784368|6142030|P3|STARTED|Overall Study||23
2505871|NCT00784368|6142031|P2|STARTED|Overall Study||16
2505872|NCT00784368|6142032|P1|STARTED|Overall Study||16
2505873|NCT00784303|6142068|P2|NOT COMPLETED|Overall Study||15
2505874|NCT00784303|6142069|P1|NOT COMPLETED|Overall Study||17
2505875|NCT00784303|6142068|P2|COMPLETED|Overall Study||44
2505876|NCT00784303|6142069|P1|COMPLETED|Overall Study||41
2505877|NCT00784303|6142068|P2|Discontinued Due to Disease Progression|Overall Study||15
2505878|NCT00784303|6142069|P1|Discontinued Due to Disease Progression|Overall Study||18
2505879|NCT00784303|6142068|P2|Continued Treatment in Extension Phase|Overall Study|Participants continued in extension phase at data cutoff date (11 April 2011)|29
2505880|NCT00784303|6142069|P1|Continued Treatment in Extension Phase|Overall Study|Participants continued in extension phase at data cutoff date (11 April 2011)|23
2505881|NCT00784303|6142068|P2|STARTED|Overall Study||59
2505882|NCT00784303|6142069|P1|STARTED|Overall Study||58
2505883|NCT00784277|6142108|P7|NOT COMPLETED|ER Treatment||15
2505884|NCT00784277|6142109|P6|NOT COMPLETED|ER Treatment||24
2505885|NCT00784277|6142110|P5|NOT COMPLETED|ER Treatment||9
2505886|NCT00784277|6142111|P4|NOT COMPLETED|ER Treatment||0
2505887|NCT00784277|6142112|P3|NOT COMPLETED|ER Treatment||0
2505888|NCT00784277|6142113|P2|NOT COMPLETED|ER Treatment||0
2505889|NCT00784277|6142114|P1|NOT COMPLETED|ER Treatment||0
2505890|NCT00784277|6142108|P7|COMPLETED|ER Treatment||76
2505891|NCT00784277|6142109|P6|COMPLETED|ER Treatment||226
2505892|NCT00784277|6142110|P5|COMPLETED|ER Treatment||113
2505893|NCT00784277|6142111|P4|COMPLETED|ER Treatment||0
2505894|NCT00784277|6142112|P3|COMPLETED|ER Treatment||0
2505895|NCT00784277|6142113|P2|COMPLETED|ER Treatment||0
2505896|NCT00784277|6142114|P1|COMPLETED|ER Treatment||0
2505897|NCT00784277|6142108|P7|STARTED|ER Treatment|9 participants who had completed IR treatment have not taken any ER treatment.|91
2505898|NCT00784277|6142109|P6|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|250
2505899|NCT00784277|6142110|P5|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|122
2505900|NCT00784277|6142111|P4|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
2505901|NCT00784277|6142112|P3|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
2505902|NCT00784277|6142113|P2|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
2505903|NCT00784277|6142114|P1|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
2505904|NCT00784277|6142108|P7|NOT COMPLETED|IR Treatment||0
2505905|NCT00784277|6142109|P6|NOT COMPLETED|IR Treatment||0
2505906|NCT00784277|6142110|P5|NOT COMPLETED|IR Treatment||0
2505907|NCT00784277|6142111|P4|NOT COMPLETED|IR Treatment||43
2505908|NCT00784277|6142112|P3|NOT COMPLETED|IR Treatment||28
2505909|NCT00784277|6142113|P2|NOT COMPLETED|IR Treatment||17
2505910|NCT00784277|6142114|P1|NOT COMPLETED|IR Treatment||16
2505911|NCT00784277|6142108|P7|COMPLETED|IR Treatment||0
2505912|NCT00784277|6142109|P6|COMPLETED|IR Treatment||0
2505913|NCT00784277|6142110|P5|COMPLETED|IR Treatment||0
2505914|NCT00784277|6142111|P4|COMPLETED|IR Treatment||100
2505915|NCT00784277|6142112|P3|COMPLETED|IR Treatment||126
2505916|NCT00784277|6142113|P2|COMPLETED|IR Treatment||134
2505917|NCT00784277|6142114|P1|COMPLETED|IR Treatment||132
2505918|NCT00784277|6142108|P7|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
2505919|NCT00784277|6142109|P6|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
2505920|NCT00784277|6142110|P5|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
2505921|NCT00784277|6142111|P4|STARTED|IR Treatment||143
2505922|NCT00784277|6142112|P3|STARTED|IR Treatment||154
2505923|NCT00784277|6142113|P2|STARTED|IR Treatment||151
2505924|NCT00784277|6142114|P1|STARTED|IR Treatment||148
2505925|NCT00784238|6142131|P1|NOT COMPLETED|Overall Study||119
2505926|NCT00784238|6142131|P1|COMPLETED|Overall Study||170
2505927|NCT00784238|6142131|P1|STARTED|Overall Study||289
2505928|NCT00784225|6142176|P4|NOT COMPLETED|Overall Study||0
2505929|NCT00784225|6142177|P3|NOT COMPLETED|Overall Study||0
2505930|NCT00784225|6142178|P2|NOT COMPLETED|Overall Study||0
2505931|NCT00784225|6142179|P1|NOT COMPLETED|Overall Study||0
2505932|NCT00784225|6142176|P4|COMPLETED|Overall Study||3374
2505933|NCT00784225|6142177|P3|COMPLETED|Overall Study||3369
2505934|NCT00784225|6142178|P2|COMPLETED|Overall Study||3357
2505935|NCT00784225|6142179|P1|COMPLETED|Overall Study||3375
2505936|NCT00784225|6142176|P4|STARTED|Overall Study||3374
2505937|NCT00784225|6142177|P3|STARTED|Overall Study||3369
2505938|NCT00784225|6142178|P2|STARTED|Overall Study||3357
2505939|NCT00784225|6142179|P1|STARTED|Overall Study||3375
2505940|NCT00784147|6142203|P2|NOT COMPLETED|Overall Study||9
2505941|NCT00784147|6142204|P1|NOT COMPLETED|Overall Study||8
2505942|NCT00784147|6142203|P2|COMPLETED|Overall Study||45
2505943|NCT00784147|6142204|P1|COMPLETED|Overall Study||51
2505944|NCT00784147|6142203|P2|STARTED|Overall Study||54
2505945|NCT00784147|6142204|P1|STARTED|Overall Study||59
2505946|NCT00784134|6142224|P2|NOT COMPLETED|Overall Study||6
2505947|NCT00784134|6142225|P1|NOT COMPLETED|Overall Study||3
2505948|NCT00784134|6142224|P2|COMPLETED|Overall Study||245
2505949|NCT00784134|6142225|P1|COMPLETED|Overall Study||246
2505950|NCT00784134|6142224|P2|STARTED|Overall Study||251
2505951|NCT00784134|6142225|P1|STARTED|Overall Study||249
2505952|NCT00784095|6142324|P3|NOT COMPLETED|Overall Study||1
2505953|NCT00784095|6142325|P2|NOT COMPLETED|Overall Study||1
2505954|NCT00784095|6142326|P1|NOT COMPLETED|Overall Study||0
2505955|NCT00784095|6142324|P3|COMPLETED|Overall Study||11
2505956|NCT00784095|6142325|P2|COMPLETED|Overall Study||11
2505957|NCT00784095|6142326|P1|COMPLETED|Overall Study||12
2505958|NCT00784095|6142324|P3|STARTED|Overall Study||12
2505959|NCT00784095|6142325|P2|STARTED|Overall Study||12
2505960|NCT00784095|6142326|P1|STARTED|Overall Study||12
2505961|NCT00784043|6142348|P2|NOT COMPLETED|Overall Study||6
2505962|NCT00784043|6142349|P1|NOT COMPLETED|Overall Study||31
2505963|NCT00784043|6142348|P2|COMPLETED|Overall Study||0
2505964|NCT00784043|6142349|P1|COMPLETED|Overall Study||0
2505965|NCT00784043|6142348|P2|STARTED|Overall Study||6
2505966|NCT00784043|6142349|P1|STARTED|Overall Study||31
2505967|NCT00784030|6142361|P2|NOT COMPLETED|Overall Study||0
2505968|NCT00784030|6142362|P1|NOT COMPLETED|Overall Study||0
2505969|NCT00784030|6142361|P2|COMPLETED|Overall Study||10
2505970|NCT00784030|6142362|P1|COMPLETED|Overall Study||13
2505971|NCT00784030|6142361|P2|STARTED|Overall Study||10
2505972|NCT00784030|6142362|P1|STARTED|Overall Study||13
2505973|NCT00783965|6142370|P2|NOT COMPLETED|Second Intervention (24 Months)||9
2505974|NCT00783965|6142371|P1|NOT COMPLETED|Second Intervention (24 Months)||0
2505975|NCT00783965|6142370|P2|COMPLETED|Second Intervention (24 Months)||16
2505976|NCT00783965|6142371|P1|COMPLETED|Second Intervention (24 Months)||2
2505977|NCT00783965|6142370|P2|STARTED|Second Intervention (24 Months)||25
2505978|NCT00783965|6142371|P1|STARTED|Second Intervention (24 Months)||2
2505979|NCT00783965|6142370|P2|NOT COMPLETED|First Intervention (12 Months)||4
2505980|NCT00783965|6142371|P1|NOT COMPLETED|First Intervention (12 Months)||3
2505981|NCT00783965|6142370|P2|COMPLETED|First Intervention (12 Months)||25
2505982|NCT00783965|6142371|P1|COMPLETED|First Intervention (12 Months)||2
2505983|NCT00783965|6142370|P2|STARTED|First Intervention (12 Months)||29
2505984|NCT00783965|6142371|P1|STARTED|First Intervention (12 Months)||5
2505985|NCT00783952|6142379|P1|NOT COMPLETED|Overall Study||0
2505986|NCT00783952|6142379|P1|COMPLETED|Overall Study||8
2505987|NCT00783952|6142379|P1|STARTED|Overall Study||8
2505988|NCT00783835|6142384|P1|NOT COMPLETED|Overall Study||10
2505989|NCT00783835|6142384|P1|COMPLETED|Overall Study||50
2505990|NCT00783835|6142384|P1|STARTED|Overall Study||60
2505991|NCT00783796|6142396|P1|NOT COMPLETED|Overall Study||6
2505992|NCT00783796|6142396|P1|COMPLETED|Overall Study||144
2505993|NCT00783796|6142396|P1|STARTED|Overall Study||150
2505994|NCT00783718|6142501|P7|NOT COMPLETED|Maintenance Phase||195
2505995|NCT00783718|6142502|P6|NOT COMPLETED|Maintenance Phase||41
2505996|NCT00783718|6142503|P5|NOT COMPLETED|Maintenance Phase||45
2505997|NCT00783718|6142504|P4|NOT COMPLETED|Maintenance Phase||78
2505998|NCT00783718|6142505|P3|NOT COMPLETED|Maintenance Phase||0
2505999|NCT00783718|6142506|P2|NOT COMPLETED|Maintenance Phase||0
2506000|NCT00783718|6142507|P1|NOT COMPLETED|Maintenance Phase||105
2506001|NCT00783718|6142501|P7|COMPLETED|Maintenance Phase||135
2506002|NCT00783718|6142502|P6|COMPLETED|Maintenance Phase||84
2506003|NCT00783718|6142503|P5|COMPLETED|Maintenance Phase||77
2506004|NCT00783718|6142504|P4|COMPLETED|Maintenance Phase||48
2506005|NCT00783718|6142505|P3|COMPLETED|Maintenance Phase||0
2506006|NCT00783718|6142506|P2|COMPLETED|Maintenance Phase||0
2506007|NCT00783718|6142507|P1|COMPLETED|Maintenance Phase||30
2506008|NCT00783718|6142501|P7|STARTED|Maintenance Phase||330
2506009|NCT00783718|6142502|P6|STARTED|Maintenance Phase||125
2506010|NCT00783718|6142503|P5|STARTED|Maintenance Phase||122
2506011|NCT00783718|6142504|P4|STARTED|Maintenance Phase||126
2506012|NCT00783718|6142505|P3|STARTED|Maintenance Phase||0
2506013|NCT00783718|6142506|P2|STARTED|Maintenance Phase||0
2506014|NCT00783718|6142507|P1|STARTED|Maintenance Phase||135
2506015|NCT00783718|6142501|P7|NOT COMPLETED|Induction Phase||0
2506016|NCT00783718|6142502|P6|NOT COMPLETED|Induction Phase||0
2506017|NCT00783718|6142503|P5|NOT COMPLETED|Induction Phase||0
2506018|NCT00783718|6142504|P4|NOT COMPLETED|Induction Phase||0
2506019|NCT00783718|6142505|P3|NOT COMPLETED|Induction Phase||36
2506020|NCT00783718|6142506|P2|NOT COMPLETED|Induction Phase||7
2506021|NCT00783718|6142507|P1|NOT COMPLETED|Induction Phase||14
2506022|NCT00783718|6142501|P7|COMPLETED|Induction Phase||0
2506023|NCT00783718|6142502|P6|COMPLETED|Induction Phase||0
2506024|NCT00783718|6142503|P5|COMPLETED|Induction Phase||0
2506025|NCT00783718|6142504|P4|COMPLETED|Induction Phase||0
2506026|NCT00783718|6142505|P3|COMPLETED|Induction Phase||485
2506027|NCT00783718|6142506|P2|COMPLETED|Induction Phase||218
2506028|NCT00783718|6142507|P1|COMPLETED|Induction Phase||135
2506029|NCT00783718|6142501|P7|STARTED|Induction Phase||0
2506030|NCT00783718|6142502|P6|STARTED|Induction Phase||0
2506031|NCT00783718|6142503|P5|STARTED|Induction Phase||0
2506032|NCT00783718|6142504|P4|STARTED|Induction Phase||0
2506033|NCT00783718|6142505|P3|STARTED|Induction Phase||521
2506034|NCT00783718|6142506|P2|STARTED|Induction Phase||225
2506035|NCT00783718|6142507|P1|STARTED|Induction Phase||149
2506036|NCT00783705|6142535|P2|NOT COMPLETED|Overall Study||5
2506037|NCT00783705|6142536|P1|NOT COMPLETED|Overall Study||6
2506038|NCT00783705|6142535|P2|COMPLETED|Overall Study||36
2506039|NCT00783705|6142536|P1|COMPLETED|Overall Study||38
2506040|NCT00783705|6142535|P2|STARTED|Overall Study||41
2506041|NCT00783705|6142536|P1|STARTED|Overall Study||44
2506042|NCT00783692|6142583|P7|NOT COMPLETED|Maintenance Phase||249
2506043|NCT00783692|6142584|P6|NOT COMPLETED|Maintenance Phase||72
2506044|NCT00783692|6142585|P5|NOT COMPLETED|Maintenance Phase||81
2506045|NCT00783692|6142586|P4|NOT COMPLETED|Maintenance Phase||89
2506046|NCT00783692|6142587|P3|NOT COMPLETED|Maintenance Phase||0
2506047|NCT00783692|6142588|P2|NOT COMPLETED|Maintenance Phase||0
2506048|NCT00783692|6142589|P1|NOT COMPLETED|Maintenance Phase||95
2506049|NCT00783692|6142583|P7|COMPLETED|Maintenance Phase||163
2506050|NCT00783692|6142584|P6|COMPLETED|Maintenance Phase||82
2506051|NCT00783692|6142585|P5|COMPLETED|Maintenance Phase||73
2506052|NCT00783692|6142586|P4|COMPLETED|Maintenance Phase||64
2506053|NCT00783692|6142587|P3|COMPLETED|Maintenance Phase||0
2506054|NCT00783692|6142588|P2|COMPLETED|Maintenance Phase||0
2506055|NCT00783692|6142589|P1|COMPLETED|Maintenance Phase||42
2506056|NCT00783692|6142583|P7|STARTED|Maintenance Phase||412
2506057|NCT00783692|6142584|P6|STARTED|Maintenance Phase||154
2506058|NCT00783692|6142585|P5|STARTED|Maintenance Phase||154
2506059|NCT00783692|6142586|P4|STARTED|Maintenance Phase||153
2506060|NCT00783692|6142587|P3|STARTED|Maintenance Phase||0
2506061|NCT00783692|6142588|P2|STARTED|Maintenance Phase||0
2506062|NCT00783692|6142589|P1|STARTED|Maintenance Phase||137
2506063|NCT00783692|6142583|P7|NOT COMPLETED|Induction Phase||0
2506064|NCT00783692|6142584|P6|NOT COMPLETED|Induction Phase||0
2506065|NCT00783692|6142585|P5|NOT COMPLETED|Induction Phase||0
2506066|NCT00783692|6142586|P4|NOT COMPLETED|Induction Phase||0
2506067|NCT00783692|6142587|P3|NOT COMPLETED|Induction Phase||74
2506068|NCT00783692|6142588|P2|NOT COMPLETED|Induction Phase||21
2506069|NCT00783692|6142589|P1|NOT COMPLETED|Induction Phase||11
2506070|NCT00783692|6142583|P7|COMPLETED|Induction Phase||0
2506071|NCT00783692|6142584|P6|COMPLETED|Induction Phase||0
2506072|NCT00783692|6142585|P5|COMPLETED|Induction Phase||0
2506073|NCT00783692|6142586|P4|COMPLETED|Induction Phase||0
2506074|NCT00783692|6142587|P3|COMPLETED|Induction Phase||674
2506075|NCT00783692|6142588|P2|COMPLETED|Induction Phase||199
2506076|NCT00783692|6142589|P1|COMPLETED|Induction Phase||137
2506077|NCT00783692|6142583|P7|Treated|Induction Phase||0
2506078|NCT00783692|6142584|P6|Treated|Induction Phase||0
2506079|NCT00783692|6142585|P5|Treated|Induction Phase||0
2506080|NCT00783692|6142586|P4|Treated|Induction Phase||0
2506081|NCT00783692|6142587|P3|Treated|Induction Phase||747
2506082|NCT00783692|6142588|P2|Treated|Induction Phase||220
2506083|NCT00783692|6142589|P1|Treated|Induction Phase||148
2506084|NCT00783692|6142583|P7|STARTED|Induction Phase||0
2506085|NCT00783692|6142584|P6|STARTED|Induction Phase||0
2506086|NCT00783692|6142585|P5|STARTED|Induction Phase||0
2506087|NCT00783692|6142586|P4|STARTED|Induction Phase||0
2506088|NCT00783692|6142587|P3|STARTED|Induction Phase||748
2506089|NCT00783692|6142588|P2|STARTED|Induction Phase||220
2506090|NCT00783692|6142589|P1|STARTED|Induction Phase||148
2506091|NCT00783614|6142616|P4|NOT COMPLETED|Overall Study||0
2506092|NCT00783614|6142617|P3|NOT COMPLETED|Overall Study||0
2506093|NCT00783614|6142618|P2|NOT COMPLETED|Overall Study||0
2506094|NCT00783614|6142619|P1|NOT COMPLETED|Overall Study||0
2506095|NCT00783614|6142616|P4|COMPLETED|Overall Study||5
2506096|NCT00783614|6142617|P3|COMPLETED|Overall Study||5
2506097|NCT00783614|6142618|P2|COMPLETED|Overall Study||6
2506098|NCT00783614|6142619|P1|COMPLETED|Overall Study||6
2506099|NCT00783614|6142616|P4|STARTED|Overall Study||5
2506100|NCT00783614|6142617|P3|STARTED|Overall Study||5
2506101|NCT00783614|6142618|P2|STARTED|Overall Study||6
2506102|NCT00783614|6142619|P1|STARTED|Overall Study||6
2506103|NCT00783432|6142635|P2|NOT COMPLETED|Overall Study||78
2506104|NCT00783432|6142636|P1|NOT COMPLETED|Overall Study||85
2506105|NCT00783432|6142635|P2|COMPLETED|Overall Study||354
2506106|NCT00783432|6142636|P1|COMPLETED|Overall Study||345
2506107|NCT00783432|6142635|P2|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|432
2506108|NCT00783432|6142636|P1|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|430
2506109|NCT00783302|6142646|P1|NOT COMPLETED|Overall Study||35
2506110|NCT00783302|6142646|P1|COMPLETED|Overall Study||850
2506111|NCT00783302|6142646|P1|STARTED|Overall Study||885
2506112|NCT00783289|6142668|P4|NOT COMPLETED|Overall Study||0
2506113|NCT00783289|6142669|P3|NOT COMPLETED|Overall Study||0
2506114|NCT00783289|6142670|P2|NOT COMPLETED|Overall Study||1
2506115|NCT00783289|6142671|P1|NOT COMPLETED|Overall Study||0
2506116|NCT00783289|6142668|P4|COMPLETED|Overall Study||6
2506117|NCT00783289|6142669|P3|COMPLETED|Overall Study||6
2506118|NCT00783289|6142670|P2|COMPLETED|Overall Study||6
2506119|NCT00783289|6142671|P1|COMPLETED|Overall Study||6
2506120|NCT00783289|6142668|P4|STARTED|Overall Study||6
2506121|NCT00783289|6142669|P3|STARTED|Overall Study||6
2506122|NCT00783289|6142670|P2|STARTED|Overall Study||7
2506123|NCT00783289|6142671|P1|STARTED|Overall Study||6
2506124|NCT00783263|6142701|P4|NOT COMPLETED|Overall Study||3
2506125|NCT00783263|6142702|P3|NOT COMPLETED|Overall Study||3
2506126|NCT00783263|6142703|P2|NOT COMPLETED|Overall Study||2
2506127|NCT00783263|6142704|P1|NOT COMPLETED|Overall Study||4
2506128|NCT00783263|6142701|P4|COMPLETED|Overall Study||118
2506129|NCT00783263|6142702|P3|COMPLETED|Overall Study||119
2506130|NCT00783263|6142703|P2|COMPLETED|Overall Study||96
2506131|NCT00783263|6142704|P1|COMPLETED|Overall Study||95
2506132|NCT00783263|6142701|P4|STARTED|Overall Study||121
2506133|NCT00783263|6142702|P3|STARTED|Overall Study||122
2506134|NCT00783263|6142703|P2|STARTED|Overall Study||98
2506135|NCT00783263|6142704|P1|STARTED|Overall Study||99
2506136|NCT00783224|6142734|P4|NOT COMPLETED|Overall Study||2
2506137|NCT00783224|6142735|P3|NOT COMPLETED|Overall Study||1
2506138|NCT00783224|6142736|P2|NOT COMPLETED|Overall Study||0
2506139|NCT00783224|6142737|P1|NOT COMPLETED|Overall Study||0
2506140|NCT00783224|6142734|P4|COMPLETED|Overall Study||140
2506141|NCT00783224|6142735|P3|COMPLETED|Overall Study||142
2506142|NCT00783224|6142736|P2|COMPLETED|Overall Study||34
2506143|NCT00783224|6142737|P1|COMPLETED|Overall Study||32
2506144|NCT00783224|6142734|P4|STARTED|Overall Study||142
2506145|NCT00783224|6142735|P3|STARTED|Overall Study||143
2506146|NCT00783224|6142736|P2|STARTED|Overall Study||34
2506147|NCT00783224|6142737|P1|STARTED|Overall Study||32
2506148|NCT00783198|6142749|P3|NOT COMPLETED|Overall Study||42
2506149|NCT00783198|6142750|P2|NOT COMPLETED|Overall Study||43
2506150|NCT00783198|6142751|P1|NOT COMPLETED|Overall Study||57
2506151|NCT00783198|6142749|P3|COMPLETED|Overall Study||146
2506152|NCT00783198|6142750|P2|COMPLETED|Overall Study||144
2506153|NCT00783198|6142751|P1|COMPLETED|Overall Study||133
2506154|NCT00783198|6142749|P3|STARTED|Overall Study||188
2506155|NCT00783198|6142750|P2|STARTED|Overall Study||187
2506156|NCT00783198|6142751|P1|STARTED|Overall Study||190
2506157|NCT00783094|6142774|P3|NOT COMPLETED|Open-Label Extension Period||30
2506158|NCT00783094|6142775|P2|NOT COMPLETED|Open-Label Extension Period||19
2506159|NCT00783094|6142776|P1|NOT COMPLETED|Open-Label Extension Period||22
2506160|NCT00783094|6142774|P3|COMPLETED|Open-Label Extension Period||101
2506161|NCT00783094|6142775|P2|COMPLETED|Open-Label Extension Period||109
2506162|NCT00783094|6142776|P1|COMPLETED|Open-Label Extension Period||113
2506163|NCT00783094|6142774|P3|STARTED|Open-Label Extension Period||131
2506164|NCT00783094|6142775|P2|STARTED|Open-Label Extension Period||128
2506165|NCT00783094|6142776|P1|STARTED|Open-Label Extension Period||135
2506166|NCT00783094|6142774|P3|NOT COMPLETED|Randomized Double-Blind Treatment Period||9
2506167|NCT00783094|6142775|P2|NOT COMPLETED|Randomized Double-Blind Treatment Period||12
2506168|NCT00783094|6142776|P1|NOT COMPLETED|Randomized Double-Blind Treatment Period||7
2506169|NCT00783094|6142774|P3|COMPLETED|Randomized Double-Blind Treatment Period||131
2506170|NCT00783094|6142775|P2|COMPLETED|Randomized Double-Blind Treatment Period||128
2506171|NCT00783094|6142776|P1|COMPLETED|Randomized Double-Blind Treatment Period||135
2506172|NCT00783094|6142774|P3|STARTED|Randomized Double-Blind Treatment Period||140
2506173|NCT00783094|6142775|P2|STARTED|Randomized Double-Blind Treatment Period||140
2506174|NCT00783094|6142776|P1|STARTED|Randomized Double-Blind Treatment Period||142
2506175|NCT00782834|6142852|P1|NOT COMPLETED|Treatment Phase||1
2506176|NCT00782834|6142852|P1|COMPLETED|Treatment Phase||13
2506177|NCT00782834|6142852|P1|STARTED|Treatment Phase||14
2506178|NCT00782834|6142852|P1|NOT COMPLETED|Screened Patients||1
2506179|NCT00782834|6142852|P1|COMPLETED|Screened Patients|1 pt ineligible d/t arrhythmia|14
2506180|NCT00782834|6142852|P1|STARTED|Screened Patients||15
2506181|NCT00782821|6142861|P4|NOT COMPLETED|Overall Study||2
2506182|NCT00782821|6142862|P3|NOT COMPLETED|Overall Study||1
2506183|NCT00782821|6142863|P2|NOT COMPLETED|Overall Study||0
2506184|NCT00782821|6142864|P1|NOT COMPLETED|Overall Study||0
2506185|NCT00782821|6142861|P4|COMPLETED|Overall Study||8
2506186|NCT00782821|6142862|P3|COMPLETED|Overall Study||9
2506187|NCT00782821|6142863|P2|COMPLETED|Overall Study||10
2506188|NCT00782821|6142864|P1|COMPLETED|Overall Study||10
2506189|NCT00782821|6142861|P4|STARTED|Overall Study||10
2506190|NCT00782821|6142862|P3|STARTED|Overall Study||10
2506191|NCT00782821|6142863|P2|STARTED|Overall Study||10
2506192|NCT00782821|6142864|P1|STARTED|Overall Study||10
2506193|NCT00782795|6142892|P2|NOT COMPLETED|Overall Study||2
2506194|NCT00782795|6142893|P1|NOT COMPLETED|Overall Study||1
2506195|NCT00782795|6142892|P2|COMPLETED|Overall Study||6
2506196|NCT00782795|6142893|P1|COMPLETED|Overall Study||16
2506197|NCT00782795|6142892|P2|24 Week Appointment|Overall Study||7
2506198|NCT00782795|6142893|P1|24 Week Appointment|Overall Study||16
2506199|NCT00782795|6142892|P2|6 Weeks (1st Apptment)|Overall Study||7
2506200|NCT00782795|6142893|P1|6 Weeks (1st Apptment)|Overall Study||16
2506201|NCT00782795|6142892|P2|STARTED|Overall Study||8
2506202|NCT00782795|6142893|P1|STARTED|Overall Study||17
2506203|NCT00782756|6142925|P1|NOT COMPLETED|Overall Study||0
2506204|NCT00782756|6142925|P1|COMPLETED|Overall Study||40
2506205|NCT00782756|6142925|P1|STARTED|Overall Study||40
2506206|NCT00782717|6142933|P2|NOT COMPLETED|Overall Study||28
2506207|NCT00782717|6142934|P1|NOT COMPLETED|Overall Study||15
2506208|NCT00782717|6142933|P2|COMPLETED|Overall Study||102
2506209|NCT00782717|6142934|P1|COMPLETED|Overall Study||118
2506210|NCT00782717|6142933|P2|STARTED|Overall Study||130
2506211|NCT00782717|6142934|P1|STARTED|Overall Study||133
2506212|NCT00782639|6142944|P2|NOT COMPLETED|Overall Study||0
2506213|NCT00782639|6142945|P1|NOT COMPLETED|Overall Study||0
2506214|NCT00782639|6142944|P2|COMPLETED|Overall Study|This study was terminated due to low enrollment.|11
2506215|NCT00782639|6142945|P1|COMPLETED|Overall Study|This study was terminated due to low enrollment.|12
2506216|NCT00782639|6142944|P2|STARTED|Overall Study||11
2506217|NCT00782639|6142945|P1|STARTED|Overall Study||12
2506218|NCT00782626|6142961|P1|NOT COMPLETED|Overall Study||7
2506219|NCT00782626|6142961|P1|COMPLETED|Overall Study||16
2506220|NCT00782626|6142961|P1|STARTED|Overall Study||23
2506221|NCT00782509|6142968|P3|NOT COMPLETED|Overall Study||36
2506222|NCT00782509|6142969|P2|NOT COMPLETED|Overall Study||24
2506223|NCT00782509|6142970|P1|NOT COMPLETED|Overall Study||41
2506224|NCT00782509|6142968|P3|COMPLETED|Overall Study||181
2506225|NCT00782509|6142969|P2|COMPLETED|Overall Study||185
2506226|NCT00782509|6142970|P1|COMPLETED|Overall Study||175
2506227|NCT00782509|6142968|P3|STARTED|Overall Study||217
2506228|NCT00782509|6142969|P2|STARTED|Overall Study||209
2506229|NCT00782509|6142970|P1|STARTED|Overall Study||216
2506230|NCT00782496|6143163|P2|NOT COMPLETED|Overall Study||15
2506231|NCT00782496|6143164|P1|NOT COMPLETED|Overall Study||14
2506232|NCT00782496|6143163|P2|COMPLETED|Overall Study||90
2506233|NCT00782496|6143164|P1|COMPLETED|Overall Study||92
2506234|NCT00782496|6143163|P2|STARTED|Overall Study||105
2506235|NCT00782496|6143164|P1|STARTED|Overall Study||106
2506236|NCT00782483|6143171|P1|NOT COMPLETED|Overall Study||6
2506237|NCT00782483|6143171|P1|COMPLETED|Overall Study||0
2506238|NCT00782483|6143171|P1|STARTED|Overall Study|6 subjects enrolled beginning on 04/27/2009 with last enrollment on 04/13/2010.|6
2506239|NCT00782418|6143175|P7|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
2506240|NCT00782418|6143176|P6|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
2506241|NCT00782418|6143177|P5|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
2506242|NCT00782418|6143178|P4|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
2506243|NCT00782418|6143179|P3|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
2506244|NCT00782418|6143180|P2|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
2506245|NCT00782418|6143181|P1|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
2506246|NCT00782418|6143175|P7|COMPLETED|Period 2 Procedure/Treatment Groups||4
2506247|NCT00782418|6143176|P6|COMPLETED|Period 2 Procedure/Treatment Groups||4
2506248|NCT00782418|6143177|P5|COMPLETED|Period 2 Procedure/Treatment Groups||3
2506249|NCT00782418|6143178|P4|COMPLETED|Period 2 Procedure/Treatment Groups||1
2506250|NCT00782418|6143179|P3|COMPLETED|Period 2 Procedure/Treatment Groups||4
2506251|NCT00782418|6143180|P2|COMPLETED|Period 2 Procedure/Treatment Groups||4
2506252|NCT00782418|6143181|P1|COMPLETED|Period 2 Procedure/Treatment Groups||3
2506253|NCT00782418|6143175|P7|STARTED|Period 2 Procedure/Treatment Groups||4
2506254|NCT00782418|6143176|P6|STARTED|Period 2 Procedure/Treatment Groups||4
2506255|NCT00782418|6143177|P5|STARTED|Period 2 Procedure/Treatment Groups||3
2506256|NCT00782418|6143178|P4|STARTED|Period 2 Procedure/Treatment Groups||1
2506257|NCT00782418|6143179|P3|STARTED|Period 2 Procedure/Treatment Groups||4
2506258|NCT00782418|6143180|P2|STARTED|Period 2 Procedure/Treatment Groups||4
2506259|NCT00782418|6143181|P1|STARTED|Period 2 Procedure/Treatment Groups||3
2506260|NCT00782418|6143175|P7|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
2506261|NCT00782418|6143176|P6|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
2506262|NCT00782418|6143177|P5|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
2506263|NCT00782418|6143178|P4|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
2506264|NCT00782418|6143179|P3|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
2506265|NCT00782418|6143180|P2|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
2506266|NCT00782418|6143181|P1|NOT COMPLETED|Period 1 Procedure/Treatment Groups||2
2506267|NCT00782418|6143175|P7|COMPLETED|Period 1 Procedure/Treatment Groups||4
2506268|NCT00782418|6143176|P6|COMPLETED|Period 1 Procedure/Treatment Groups||4
2506269|NCT00782418|6143177|P5|COMPLETED|Period 1 Procedure/Treatment Groups||4
2506270|NCT00782418|6143178|P4|COMPLETED|Period 1 Procedure/Treatment Groups||2
2506271|NCT00782418|6143179|P3|COMPLETED|Period 1 Procedure/Treatment Groups||4
2506272|NCT00782418|6143180|P2|COMPLETED|Period 1 Procedure/Treatment Groups||4
2506273|NCT00782418|6143181|P1|COMPLETED|Period 1 Procedure/Treatment Groups||1
2506274|NCT00782418|6143175|P7|STARTED|Period 1 Procedure/Treatment Groups||4
2506275|NCT00782418|6143176|P6|STARTED|Period 1 Procedure/Treatment Groups||5
2506276|NCT00782418|6143177|P5|STARTED|Period 1 Procedure/Treatment Groups||5
2506277|NCT00782418|6143178|P4|STARTED|Period 1 Procedure/Treatment Groups||2
2506278|NCT00782418|6143179|P3|STARTED|Period 1 Procedure/Treatment Groups||4
2506279|NCT00782418|6143180|P2|STARTED|Period 1 Procedure/Treatment Groups||4
2506280|NCT00782418|6143181|P1|STARTED|Period 1 Procedure/Treatment Groups||3
2506281|NCT00782379|6143201|P1|NOT COMPLETED|Overall Study||0
2506282|NCT00782379|6143201|P1|COMPLETED|Overall Study||20
2506283|NCT00782379|6143201|P1|STARTED|Overall Study||20
2506284|NCT00782340|6143218|P3|NOT COMPLETED|Randomized Double Blind||0
2506285|NCT00782340|6143219|P2|NOT COMPLETED|Randomized Double Blind||0
2506286|NCT00782340|6143220|P1|NOT COMPLETED|Randomized Double Blind||0
2506287|NCT00782340|6143218|P3|COMPLETED|Randomized Double Blind||80
2506288|NCT00782340|6143219|P2|COMPLETED|Randomized Double Blind||82
2506289|NCT00782340|6143220|P1|COMPLETED|Randomized Double Blind||0
2506290|NCT00782340|6143218|P3|STARTED|Randomized Double Blind||80
2506291|NCT00782340|6143219|P2|STARTED|Randomized Double Blind||82
2506292|NCT00782340|6143220|P1|STARTED|Randomized Double Blind||0
2506293|NCT00782340|6143218|P3|NOT COMPLETED|Open Label Titration||0
2506294|NCT00782340|6143219|P2|NOT COMPLETED|Open Label Titration||0
2506295|NCT00782340|6143220|P1|NOT COMPLETED|Open Label Titration||101
2506296|NCT00782340|6143218|P3|COMPLETED|Open Label Titration||0
2506297|NCT00782340|6143219|P2|COMPLETED|Open Label Titration||0
2506298|NCT00782340|6143220|P1|COMPLETED|Open Label Titration||162
2506299|NCT00782340|6143218|P3|STARTED|Open Label Titration||0
2506300|NCT00782340|6143219|P2|STARTED|Open Label Titration||0
2506301|NCT00782340|6143220|P1|STARTED|Open Label Titration||263
2506302|NCT00782288|6143246|P3|NOT COMPLETED|Overall Study||0
2506303|NCT00782288|6143247|P2|NOT COMPLETED|Overall Study||0
2506304|NCT00782288|6143248|P1|NOT COMPLETED|Overall Study||0
2506305|NCT00782288|6143246|P3|COMPLETED|Overall Study||8
2506306|NCT00782288|6143247|P2|COMPLETED|Overall Study||8
2506307|NCT00782288|6143248|P1|COMPLETED|Overall Study||8
2506308|NCT00782288|6143246|P3|STARTED|Overall Study||8
2506309|NCT00782288|6143247|P2|STARTED|Overall Study||8
2506310|NCT00782288|6143248|P1|STARTED|Overall Study||8
2506311|NCT00782275|6143290|P1|NOT COMPLETED|Overall Study||41
2506312|NCT00782275|6143290|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
2506313|NCT00782275|6143290|P1|Prior VEGFR Response Evaluable|Overall Study|One patient was unevaluable and therefore excluded from related subgroup analyses.|39
2506314|NCT00782275|6143290|P1|Treated|Overall Study||40
2506315|NCT00782275|6143290|P1|STARTED|Overall Study||41
2506316|NCT00782210|6143299|P3|NOT COMPLETED|Overall Study||35
2506317|NCT00782210|6143300|P2|NOT COMPLETED|Overall Study||35
2506318|NCT00782210|6143301|P1|NOT COMPLETED|Overall Study||50
2506319|NCT00782210|6143299|P3|COMPLETED|Overall Study||172
2506320|NCT00782210|6143300|P2|COMPLETED|Overall Study||173
2506321|NCT00782210|6143301|P1|COMPLETED|Overall Study||159
2506322|NCT00782210|6143299|P3|STARTED|Overall Study||207
2506323|NCT00782210|6143300|P2|STARTED|Overall Study||208
2506324|NCT00782210|6143301|P1|STARTED|Overall Study||209
2506325|NCT00782184|6143494|P2|NOT COMPLETED|Overall Study||5
2506326|NCT00782184|6143495|P1|NOT COMPLETED|Overall Study||4
2506327|NCT00782184|6143494|P2|COMPLETED|Overall Study||125
2506328|NCT00782184|6143495|P1|COMPLETED|Overall Study||116
2506329|NCT00782184|6143494|P2|STARTED|Overall Study||130
2506330|NCT00782184|6143495|P1|STARTED|Overall Study||120
2506331|NCT00782171|6143532|P2|NOT COMPLETED|Overall Study||19
2506332|NCT00782171|6143533|P1|NOT COMPLETED|Overall Study||22
2506333|NCT00782171|6143532|P2|COMPLETED|Overall Study||115
2506334|NCT00782171|6143533|P1|COMPLETED|Overall Study||124
2506335|NCT00782171|6143532|P2|Surgery (Baseline)|Overall Study||128
2506336|NCT00782171|6143533|P1|Surgery (Baseline)|Overall Study||138
2506337|NCT00782171|6143532|P2|1 Year|Overall Study||120
2506338|NCT00782171|6143533|P1|1 Year|Overall Study||131
2506339|NCT00782171|6143532|P2|20-23 Weeks|Overall Study||124
2506340|NCT00782171|6143533|P1|20-23 Weeks|Overall Study||135
2506341|NCT00782171|6143532|P2|STARTED|Overall Study||134
2506342|NCT00782171|6143533|P1|STARTED|Overall Study||146
2506343|NCT00782067|6143565|P1|NOT COMPLETED|Overall Study||116
2506344|NCT00782067|6143565|P1|COMPLETED|Overall Study||0
2506345|NCT00782067|6143565|P1|Primary Efficacy Population (PEP)|Overall Study||89
2506346|NCT00782067|6143565|P1|Safety Set (SS)|Overall Study||116
2506347|NCT00782067|6143565|P1|STARTED|Overall Study||116
2506348|NCT00781963|6143577|P2|NOT COMPLETED|Overall Study||2
2506349|NCT00781963|6143578|P1|NOT COMPLETED|Overall Study||17
2506350|NCT00781963|6143577|P2|COMPLETED|Overall Study||51
2506351|NCT00781963|6143578|P1|COMPLETED|Overall Study||89
2506352|NCT00781963|6143577|P2|STARTED|Overall Study||53
2506353|NCT00781963|6143578|P1|STARTED|Overall Study||106
2506354|NCT00781950|6143596|P2|NOT COMPLETED|Overall Study||13
2506355|NCT00781950|6143597|P1|NOT COMPLETED|Overall Study||11
2506356|NCT00781950|6143596|P2|COMPLETED|Overall Study||45
2506357|NCT00781950|6143597|P1|COMPLETED|Overall Study||41
2506358|NCT00781950|6143596|P2|STARTED|Overall Study||58
2506359|NCT00781950|6143597|P1|STARTED|Overall Study||52
2506360|NCT00781937|6143607|P2|NOT COMPLETED|Follow up Period (Week 56-68)||5
2506361|NCT00781937|6143608|P1|NOT COMPLETED|Follow up Period (Week 56-68)||6
2506362|NCT00781937|6143607|P2|COMPLETED|Follow up Period (Week 56-68)||141
2506363|NCT00781937|6143608|P1|COMPLETED|Follow up Period (Week 56-68)||153
2506364|NCT00781937|6143607|P2|STARTED|Follow up Period (Week 56-68)||146
2506365|NCT00781937|6143608|P1|STARTED|Follow up Period (Week 56-68)||159
2506366|NCT00781937|6143607|P2|NOT COMPLETED|Main Trial Period Through Week 56||64
2506367|NCT00781937|6143608|P1|NOT COMPLETED|Main Trial Period Through Week 56||53
2506368|NCT00781937|6143607|P2|COMPLETED|Main Trial Period Through Week 56||146
2506369|NCT00781937|6143608|P1|COMPLETED|Main Trial Period Through Week 56||159
2506370|NCT00781937|6143607|P2|STARTED|Main Trial Period Through Week 56||210
2506371|NCT00781937|6143608|P1|STARTED|Main Trial Period Through Week 56||212
2506372|NCT00781911|6143666|P2|NOT COMPLETED|Overall Study||8
2506373|NCT00781911|6143667|P1|NOT COMPLETED|Overall Study||6
2506374|NCT00781911|6143666|P2|COMPLETED|Overall Study||4
2506375|NCT00781911|6143667|P1|COMPLETED|Overall Study||25
2506376|NCT00781911|6143666|P2|Received at Least 1 Dose of Study Drug|Overall Study||12
2506377|NCT00781911|6143667|P1|Received at Least 1 Dose of Study Drug|Overall Study||31
2506378|NCT00781911|6143666|P2|STARTED|Overall Study||12
2506379|NCT00781911|6143667|P1|STARTED|Overall Study||31
2506380|NCT00781898|6143695|P2|NOT COMPLETED|Overall Study||29
2506381|NCT00781898|6143696|P1|NOT COMPLETED|Overall Study||34
2506382|NCT00781898|6143695|P2|COMPLETED|Overall Study||126
2506383|NCT00781898|6143696|P1|COMPLETED|Overall Study||119
2506384|NCT00781898|6143695|P2|STARTED|Overall Study||155
2506385|NCT00781898|6143696|P1|STARTED|Overall Study||153
2506386|NCT00781859|6143704|P2|NOT COMPLETED|Overall Study||9
2506387|NCT00781859|6143705|P1|NOT COMPLETED|Overall Study||19
2506388|NCT00781859|6143704|P2|COMPLETED|Overall Study||98
2506389|NCT00781859|6143705|P1|COMPLETED|Overall Study||200
2506390|NCT00781859|6143704|P2|STARTED|Overall Study||107
2506391|NCT00781859|6143705|P1|STARTED|Overall Study||219
2506392|NCT00781768|6143715|P2|NOT COMPLETED|Overall Study||2
2506393|NCT00781768|6143716|P1|NOT COMPLETED|Overall Study||0
2506394|NCT00781768|6143715|P2|COMPLETED|Overall Study||90
2506395|NCT00781768|6143716|P1|COMPLETED|Overall Study||89
2506396|NCT00781768|6143715|P2|STARTED|Overall Study||92
2506397|NCT00781768|6143716|P1|STARTED|Overall Study||89
2506398|NCT00781599|6143724|P2|NOT COMPLETED|Overall Study||4
2506399|NCT00781599|6143725|P1|NOT COMPLETED|Overall Study||7
2506400|NCT00781599|6143724|P2|COMPLETED|Overall Study||32
2506401|NCT00781599|6143725|P1|COMPLETED|Overall Study||29
2506402|NCT00781599|6143724|P2|STARTED|Overall Study||36
2506403|NCT00781599|6143725|P1|STARTED|Overall Study||36
2506404|NCT00781508|6143739|P2|NOT COMPLETED|Overall Study||0
2506405|NCT00781508|6143740|P1|NOT COMPLETED|Overall Study||0
2506406|NCT00781508|6143739|P2|COMPLETED|Overall Study||5
2506407|NCT00781508|6143740|P1|COMPLETED|Overall Study||5
2506408|NCT00781508|6143739|P2|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
2506409|NCT00781508|6143740|P1|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
2506410|NCT00781456|6143750|P2|NOT COMPLETED|Overall Study||16
2506411|NCT00781456|6143751|P1|NOT COMPLETED|Overall Study||21
2506412|NCT00781456|6143750|P2|COMPLETED|Overall Study||35
2506413|NCT00781456|6143751|P1|COMPLETED|Overall Study||37
2506414|NCT00781456|6143750|P2|Received Study Drug|Overall Study||49
2506415|NCT00781456|6143751|P1|Received Study Drug|Overall Study||57
2506416|NCT00781456|6143750|P2|STARTED|Overall Study||51
2506417|NCT00781456|6143751|P1|STARTED|Overall Study||58
2506418|NCT00781391|6143774|P3|NOT COMPLETED|Overall Study||784
2506419|NCT00781391|6143775|P2|NOT COMPLETED|Overall Study||807
2506420|NCT00781391|6143776|P1|NOT COMPLETED|Overall Study||879
2506421|NCT00781391|6143774|P3|COMPLETED|Overall Study||6250
2506422|NCT00781391|6143775|P2|COMPLETED|Overall Study||6228
2506423|NCT00781391|6143776|P1|COMPLETED|Overall Study||6157
2506424|NCT00781391|6143774|P3|Per Protocol Analysis Set|Overall Study||6982
2506425|NCT00781391|6143775|P2|Per Protocol Analysis Set|Overall Study||6995
2506426|NCT00781391|6143776|P1|Per Protocol Analysis Set|Overall Study||6993
2506427|NCT00781391|6143774|P3|mITT Analysis Set (Received Drug)|Overall Study||7002
2506428|NCT00781391|6143775|P2|mITT Analysis Set (Received Drug)|Overall Study||7012
2506429|NCT00781391|6143776|P1|mITT Analysis Set (Received Drug)|Overall Study||7012
2506430|NCT00781391|6143774|P3|Safety Analysis Set (Received Drug)|Overall Study||7002
2506431|NCT00781391|6143775|P2|Safety Analysis Set (Received Drug)|Overall Study||7012
2506432|NCT00781391|6143776|P1|Safety Analysis Set (Received Drug)|Overall Study||7012
2506433|NCT00781391|6143774|P3|STARTED|Overall Study||7034
2506434|NCT00781391|6143775|P2|STARTED|Overall Study||7035
2506435|NCT00781391|6143776|P1|STARTED|Overall Study||7036
2506436|NCT00781365|6143810|P2|NOT COMPLETED|Overall Study||36
2506437|NCT00781365|6143811|P1|NOT COMPLETED|Overall Study||34
2506438|NCT00781365|6143810|P2|COMPLETED|Overall Study|completed both 6 and 12 month follow up|186
2506439|NCT00781365|6143811|P1|COMPLETED|Overall Study|completed both 6 and 12 month follow up|194
2506440|NCT00781365|6143810|P2|STARTED|Overall Study||222
2506441|NCT00781365|6143811|P1|STARTED|Overall Study||228
2506442|NCT00781326|6143821|P1|NOT COMPLETED|Phase 2||0
2506443|NCT00781326|6143821|P1|COMPLETED|Phase 2||0
2506444|NCT00781326|6143821|P1|STARTED|Phase 2|Study terminated prior to enrollment into Phase II|0
2506445|NCT00781326|6143821|P1|NOT COMPLETED|Phase I||4
2506446|NCT00781326|6143821|P1|COMPLETED|Phase I||2
2506447|NCT00781326|6143821|P1|STARTED|Phase I|Nine subjects consented; 3 did not meet eligibility criteria. 6 started antidepressant treatment.|6
2506448|NCT00781274|6143825|P1|NOT COMPLETED|Overall Study||2
2506449|NCT00781274|6143825|P1|COMPLETED|Overall Study||30
2506450|NCT00781274|6143825|P1|STARTED|Overall Study||32
2506451|NCT00781079|6143831|P2|NOT COMPLETED|Overall Study||17
2506452|NCT00781079|6143832|P1|NOT COMPLETED|Overall Study||27
2506453|NCT00781079|6143831|P2|COMPLETED|Overall Study||116
2506454|NCT00781079|6143832|P1|COMPLETED|Overall Study||122
2506455|NCT00781079|6143831|P2|STARTED|Overall Study||133
2506456|NCT00781079|6143832|P1|STARTED|Overall Study||149
2506457|NCT00780962|6143850|P2|NOT COMPLETED|Overall Study||27
2506458|NCT00780962|6143851|P1|NOT COMPLETED|Overall Study||15
2506459|NCT00780962|6143850|P2|COMPLETED|Overall Study||172
2506460|NCT00780962|6143851|P1|COMPLETED|Overall Study||185
2506461|NCT00780962|6143850|P2|Second Blood Draw (Outcome Measurement)|Overall Study||172
2506462|NCT00780962|6143851|P1|Second Blood Draw (Outcome Measurement)|Overall Study||185
2506463|NCT00780962|6143850|P2|STARTED|Overall Study||199
2506464|NCT00780962|6143851|P1|STARTED|Overall Study||200
2506465|NCT00780910|6143857|P1|NOT COMPLETED|Overall Study||2
2506466|NCT00780910|6143857|P1|COMPLETED|Overall Study||107
2506467|NCT00780910|6143857|P1|STARTED|Overall Study||109
2506468|NCT00780741|6143863|P2|NOT COMPLETED|Overall Study||10
2506469|NCT00780741|6143864|P1|NOT COMPLETED|Overall Study||7
2506470|NCT00780741|6143863|P2|COMPLETED|Overall Study|18 months of age (±4 weeks)|71
2506471|NCT00780741|6143864|P1|COMPLETED|Overall Study|18 months of age (±4 weeks)|75
2506472|NCT00780741|6143863|P2|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|67
2506473|NCT00780741|6143864|P1|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|73
2506474|NCT00780741|6143863|P2|STARTED|Overall Study|randomized|81
2506475|NCT00780741|6143864|P1|STARTED|Overall Study|randomized|82
2506476|NCT00780715|6143880|P4|NOT COMPLETED|Overall Study||0
2506477|NCT00780715|6143881|P3|NOT COMPLETED|Overall Study||0
2506478|NCT00780715|6143882|P2|NOT COMPLETED|Overall Study||0
2506479|NCT00780715|6143883|P1|NOT COMPLETED|Overall Study||0
2506480|NCT00780715|6143880|P4|COMPLETED|Overall Study||11
2506481|NCT00780715|6143881|P3|COMPLETED|Overall Study||6
2506482|NCT00780715|6143882|P2|COMPLETED|Overall Study||6
2506483|NCT00780715|6143883|P1|COMPLETED|Overall Study||6
2506484|NCT00780715|6143880|P4|STARTED|Overall Study||11
2506485|NCT00780715|6143881|P3|STARTED|Overall Study||6
2506486|NCT00780715|6143882|P2|STARTED|Overall Study||6
2506487|NCT00780715|6143883|P1|STARTED|Overall Study||6
2506488|NCT00780676|6143898|P5|NOT COMPLETED|Overall Study||0
2506489|NCT00780676|6143899|P4|NOT COMPLETED|Overall Study||0
2506490|NCT00780676|6143900|P3|NOT COMPLETED|Overall Study||0
2506491|NCT00780676|6143901|P2|NOT COMPLETED|Overall Study||0
2506492|NCT00780676|6143902|P1|NOT COMPLETED|Overall Study||0
2506493|NCT00780676|6143898|P5|COMPLETED|Overall Study||0
2506494|NCT00780676|6143899|P4|COMPLETED|Overall Study||0
2506495|NCT00780676|6143900|P3|COMPLETED|Overall Study||13
2506496|NCT00780676|6143901|P2|COMPLETED|Overall Study||8
2506497|NCT00780676|6143902|P1|COMPLETED|Overall Study||9
2506498|NCT00780676|6143898|P5|STARTED|Overall Study||0
2506499|NCT00780676|6143899|P4|STARTED|Overall Study||0
2506500|NCT00780676|6143900|P3|STARTED|Overall Study||13
2506501|NCT00780676|6143901|P2|STARTED|Overall Study||8
2506502|NCT00780676|6143902|P1|STARTED|Overall Study||9
2506503|NCT00780572|6143910|P2|NOT COMPLETED|Overall Study||0
2506504|NCT00780572|6143911|P1|NOT COMPLETED|Overall Study||0
2506505|NCT00780572|6143910|P2|COMPLETED|Overall Study||298
2506506|NCT00780572|6143911|P1|COMPLETED|Overall Study||297
2506507|NCT00780572|6143910|P2|STARTED|Overall Study||298
2506508|NCT00780572|6143911|P1|STARTED|Overall Study||297
2506509|NCT00780559|6143919|P2|NOT COMPLETED|Overall Study||7
2506510|NCT00780559|6143920|P1|NOT COMPLETED|Overall Study||3
2506511|NCT00780559|6143919|P2|COMPLETED|Overall Study||33
2506512|NCT00780559|6143920|P1|COMPLETED|Overall Study||29
2506513|NCT00780559|6143919|P2|STARTED|Overall Study||40
2506514|NCT00780559|6143920|P1|STARTED|Overall Study||32
2506515|NCT00780494|6143934|P1|NOT COMPLETED|Overall Study||0
2506516|NCT00780494|6143934|P1|COMPLETED|Overall Study||35
2506517|NCT00780494|6143934|P1|STARTED|Overall Study||35
2506518|NCT00780481|6143943|P1|NOT COMPLETED|Overall Study||0
2506519|NCT00780481|6143943|P1|COMPLETED|Overall Study||13
2506520|NCT00780481|6143943|P1|STARTED|Overall Study||13
2506521|NCT00780455|6143952|P2|NOT COMPLETED|Overall Study||0
2506522|NCT00780455|6143953|P1|NOT COMPLETED|Overall Study||0
2506523|NCT00780455|6143952|P2|COMPLETED|Overall Study||2
2506524|NCT00780455|6143953|P1|COMPLETED|Overall Study||2
2506525|NCT00780455|6143952|P2|STARTED|Overall Study||2
2506526|NCT00780455|6143953|P1|STARTED|Overall Study||2
2506527|NCT00780442|6143979|P2|NOT COMPLETED|Overall Study||0
2506528|NCT00780442|6143980|P1|NOT COMPLETED|Overall Study||0
2506529|NCT00780442|6143979|P2|COMPLETED|Overall Study||15
2506530|NCT00780442|6143980|P1|COMPLETED|Overall Study||12
2506531|NCT00780442|6143979|P2|STARTED|Overall Study||15
2506532|NCT00780442|6143980|P1|STARTED|Overall Study||12
2506533|NCT00780416|6143988|P2|NOT COMPLETED|Overall Study||9
2506534|NCT00780416|6143989|P1|NOT COMPLETED|Overall Study||12
2506535|NCT00780416|6143988|P2|COMPLETED|Overall Study||54
2506536|NCT00780416|6143989|P1|COMPLETED|Overall Study||114
2506537|NCT00780416|6143988|P2|STARTED|Overall Study||63
2506538|NCT00780416|6143989|P1|STARTED|Overall Study||126
2506539|NCT00780403|6143995|P2|NOT COMPLETED|Second Intervention||0
2506540|NCT00780403|6143996|P1|NOT COMPLETED|Second Intervention||0
2506541|NCT00780403|6143995|P2|COMPLETED|Second Intervention||111
2506542|NCT00780403|6143996|P1|COMPLETED|Second Intervention||109
2506543|NCT00780403|6143995|P2|STARTED|Second Intervention||111
2506544|NCT00780403|6143996|P1|STARTED|Second Intervention||109
2506545|NCT00780403|6143995|P2|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
2506546|NCT00780403|6143996|P1|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
2506547|NCT00780403|6143995|P2|COMPLETED|Interval Between Doses (8-10 Minutes)||111
2506548|NCT00780403|6143996|P1|COMPLETED|Interval Between Doses (8-10 Minutes)||109
2506549|NCT00780403|6143995|P2|STARTED|Interval Between Doses (8-10 Minutes)||111
2506550|NCT00780403|6143996|P1|STARTED|Interval Between Doses (8-10 Minutes)||109
2506551|NCT00780403|6143995|P2|NOT COMPLETED|First Intervention||0
2506552|NCT00780403|6143996|P1|NOT COMPLETED|First Intervention||0
2506553|NCT00780403|6143995|P2|COMPLETED|First Intervention||111
2506554|NCT00780403|6143996|P1|COMPLETED|First Intervention||109
2506555|NCT00780403|6143995|P2|STARTED|First Intervention||111
2506556|NCT00780403|6143996|P1|STARTED|First Intervention||109
2506557|NCT00780338|6144005|P2|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||5
2506558|NCT00780338|6144006|P1|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||13
2506559|NCT00780338|6144005|P2|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||159
2506560|NCT00780338|6144006|P1|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||156
2506561|NCT00780338|6144005|P2|STARTED|Mid to Post (1 Year; 2 Years in Total)||164
2506562|NCT00780338|6144006|P1|STARTED|Mid to Post (1 Year; 2 Years in Total)||169
2506563|NCT00780338|6144005|P2|NOT COMPLETED|Baseline to Mid (1 Year)||38
2506564|NCT00780338|6144006|P1|NOT COMPLETED|Baseline to Mid (1 Year)||5
2506565|NCT00780338|6144005|P2|COMPLETED|Baseline to Mid (1 Year)||164
2506566|NCT00780338|6144006|P1|COMPLETED|Baseline to Mid (1 Year)||169
2506567|NCT00780338|6144005|P2|STARTED|Baseline to Mid (1 Year)||202
2506568|NCT00780338|6144006|P1|STARTED|Baseline to Mid (1 Year)||174
2506569|NCT00780273|6144034|P1|NOT COMPLETED|Overall Study||2
2506570|NCT00780273|6144034|P1|COMPLETED|Overall Study||17
2506571|NCT00780273|6144034|P1|STARTED|Overall Study||19
2506572|NCT00780234|6144045|P2|NOT COMPLETED|Overall Study||8
2506573|NCT00780234|6144046|P1|NOT COMPLETED|Overall Study||8
2506574|NCT00780234|6144045|P2|COMPLETED|Overall Study||37
2506575|NCT00780234|6144046|P1|COMPLETED|Overall Study||39
2506576|NCT00780234|6144045|P2|STARTED|Overall Study||45
2506577|NCT00780234|6144046|P1|STARTED|Overall Study||47
2506578|NCT00780208|6144052|P1|NOT COMPLETED|Overall Study||6
2506579|NCT00780208|6144052|P1|COMPLETED|Overall Study||8
2506580|NCT00780208|6144052|P1|STARTED|Overall Study||14
2506581|NCT00780143|6144057|P1|NOT COMPLETED|Overall Study||3
2506582|NCT00780143|6144057|P1|COMPLETED|Overall Study||0
2506583|NCT00780143|6144057|P1|STARTED|Overall Study||3
2506584|NCT00780026|6144065|P2|NOT COMPLETED|Overall Study||0
2506585|NCT00780026|6144066|P1|NOT COMPLETED|Overall Study||0
2506586|NCT00780026|6144065|P2|COMPLETED|Overall Study||50
2506587|NCT00780026|6144066|P1|COMPLETED|Overall Study||50
2506588|NCT00780026|6144065|P2|STARTED|Overall Study||50
2506589|NCT00780026|6144066|P1|STARTED|Overall Study||50
2506590|NCT00779909|6144088|P4|NOT COMPLETED|Overall Study||1
2506591|NCT00779909|6144089|P3|NOT COMPLETED|Overall Study||0
2506592|NCT00779909|6144090|P2|NOT COMPLETED|Overall Study||1
2506593|NCT00779909|6144091|P1|NOT COMPLETED|Overall Study||1
2506594|NCT00779909|6144088|P4|COMPLETED|Overall Study||7
2506595|NCT00779909|6144089|P3|COMPLETED|Overall Study||8
2506596|NCT00779909|6144090|P2|COMPLETED|Overall Study||8
2506597|NCT00779909|6144091|P1|COMPLETED|Overall Study||9
2506598|NCT00779909|6144088|P4|STARTED|Overall Study||8
2506599|NCT00779909|6144089|P3|STARTED|Overall Study||8
2506600|NCT00779909|6144090|P2|STARTED|Overall Study||9
2506601|NCT00779909|6144091|P1|STARTED|Overall Study||10
2506602|NCT00779870|6144136|P3|NOT COMPLETED|Overall Study||0
2506603|NCT00779870|6144137|P2|NOT COMPLETED|Overall Study||0
2506604|NCT00779870|6144138|P1|NOT COMPLETED|Overall Study||0
2506605|NCT00779870|6144136|P3|COMPLETED|Overall Study||7
2506606|NCT00779870|6144137|P2|COMPLETED|Overall Study||6
2506607|NCT00779870|6144138|P1|COMPLETED|Overall Study||5
2506608|NCT00779870|6144136|P3|STARTED|Overall Study||7
2506609|NCT00779870|6144137|P2|STARTED|Overall Study||6
2506610|NCT00779870|6144138|P1|STARTED|Overall Study||5
2506611|NCT00779857|6144155|P1|NOT COMPLETED|Overall Study||6
2506612|NCT00779857|6144155|P1|COMPLETED|Overall Study|12 Month Post procedure, 64 subjects available for evaluation|64
2506613|NCT00779857|6144155|P1|3 Month Post Procedure|Overall Study|3 month follow-up, 65 of the subjects were available for evaluation.|65
2506614|NCT00779857|6144155|P1|30 Day Post Procedure|Overall Study|2 missed Visit|68
2506615|NCT00779857|6144155|P1|STARTED|Overall Study|70 patients treated|70
2506616|NCT00779779|6144160|P1|NOT COMPLETED|Overall Study||24
2506617|NCT00779779|6144160|P1|COMPLETED|Overall Study||498
2506618|NCT00779779|6144160|P1|STARTED|Overall Study||522
2506619|NCT00779766|6144169|P2|NOT COMPLETED|Month 72||189
2506620|NCT00779766|6144170|P1|NOT COMPLETED|Month 72||185
2506621|NCT00779766|6144169|P2|COMPLETED|Month 72||2158
2506622|NCT00779766|6144170|P1|COMPLETED|Month 72||2134
2506623|NCT00779766|6144169|P2|STARTED|Month 72||2347
2506624|NCT00779766|6144170|P1|STARTED|Month 72||2319
2506625|NCT00779766|6144169|P2|NOT COMPLETED|Month 48||168
2506626|NCT00779766|6144170|P1|NOT COMPLETED|Month 48||174
2506627|NCT00779766|6144169|P2|COMPLETED|Month 48||2559
2506628|NCT00779766|6144170|P1|COMPLETED|Month 48||2529
2506629|NCT00779766|6144169|P2|STARTED|Month 48||2727
2506630|NCT00779766|6144170|P1|STARTED|Month 48||2703
2506631|NCT00779766|6144169|P2|NOT COMPLETED|Month 24||332
2506632|NCT00779766|6144170|P1|NOT COMPLETED|Month 24||332
2506633|NCT00779766|6144169|P2|COMPLETED|Month 24||2693
2506634|NCT00779766|6144170|P1|COMPLETED|Month 24||2694
2506635|NCT00779766|6144169|P2|STARTED|Month 24||3025
2506636|NCT00779766|6144170|P1|STARTED|Month 24||3026
2506637|NCT00779701|6144254|P1|NOT COMPLETED|Overall Study||0
2506638|NCT00779701|6144254|P1|COMPLETED|Overall Study||27
2506639|NCT00779701|6144254|P1|STARTED|Overall Study||27
2506640|NCT00779675|6144258|P1|NOT COMPLETED|Extended Treatment Period||46
2506641|NCT00779675|6144258|P1|COMPLETED|Extended Treatment Period||147
2506642|NCT00779675|6144258|P1|STARTED|Extended Treatment Period|Clinical responders during the treatment period could enter the extended treatment period.|193
2506643|NCT00779675|6144258|P1|NOT COMPLETED|Treatment Period||332
2506644|NCT00779675|6144258|P1|COMPLETED|Treatment Period||328
2506645|NCT00779675|6144258|P1|STARTED|Treatment Period|One of the 660 participants did not receive study treatment.|660
2506646|NCT00779584|6144286|P9|NOT COMPLETED|Overall Study||2
2506647|NCT00779584|6144287|P8|NOT COMPLETED|Overall Study||3
2506648|NCT00779584|6144288|P7|NOT COMPLETED|Overall Study||8
2506649|NCT00779584|6144289|P6|NOT COMPLETED|Overall Study||6
2506650|NCT00779584|6144290|P5|NOT COMPLETED|Overall Study||7
2506651|NCT00779584|6144291|P4|NOT COMPLETED|Overall Study||6
2506652|NCT00779584|6144292|P3|NOT COMPLETED|Overall Study||7
2506653|NCT00779584|6144293|P2|NOT COMPLETED|Overall Study||3
2506654|NCT00779584|6144294|P1|NOT COMPLETED|Overall Study||3
2506655|NCT00779584|6144286|P9|COMPLETED|Overall Study||0
2506656|NCT00779584|6144287|P8|COMPLETED|Overall Study||0
2506657|NCT00779584|6144288|P7|COMPLETED|Overall Study||0
2506658|NCT00779584|6144289|P6|COMPLETED|Overall Study||0
2506659|NCT00779584|6144290|P5|COMPLETED|Overall Study||0
2506660|NCT00779584|6144291|P4|COMPLETED|Overall Study||0
2506661|NCT00779584|6144292|P3|COMPLETED|Overall Study||0
2506662|NCT00779584|6144293|P2|COMPLETED|Overall Study||0
2506663|NCT00779584|6144294|P1|COMPLETED|Overall Study||0
2506664|NCT00779584|6144286|P9|Treated|Overall Study||2
2506665|NCT00779584|6144287|P8|Treated|Overall Study||3
2506666|NCT00779584|6144288|P7|Treated|Overall Study||8
2506667|NCT00779584|6144289|P6|Treated|Overall Study||4
2506668|NCT00779584|6144290|P5|Treated|Overall Study||7
2506669|NCT00779584|6144291|P4|Treated|Overall Study||6
2506670|NCT00779584|6144292|P3|Treated|Overall Study||7
2506671|NCT00779584|6144293|P2|Treated|Overall Study||3
2506672|NCT00779584|6144294|P1|Treated|Overall Study||3
2506673|NCT00779584|6144286|P9|STARTED|Overall Study||2
2506674|NCT00779584|6144287|P8|STARTED|Overall Study||3
2506675|NCT00779584|6144288|P7|STARTED|Overall Study||8
2506676|NCT00779584|6144289|P6|STARTED|Overall Study||6
2506677|NCT00779584|6144290|P5|STARTED|Overall Study||7
2506678|NCT00779584|6144291|P4|STARTED|Overall Study||6
2506679|NCT00779584|6144292|P3|STARTED|Overall Study||7
2506680|NCT00779584|6144293|P2|STARTED|Overall Study||3
2506681|NCT00779584|6144294|P1|STARTED|Overall Study||3
2506682|NCT00779558|6144370|P2|NOT COMPLETED|Overall Study||7
2506683|NCT00779558|6144371|P1|NOT COMPLETED|Overall Study||4
2506684|NCT00779558|6144370|P2|COMPLETED|Overall Study||37
2506685|NCT00779558|6144371|P1|COMPLETED|Overall Study||53
2506686|NCT00779558|6144370|P2|STARTED|Overall Study||44
2506687|NCT00779558|6144371|P1|STARTED|Overall Study||57
2506688|NCT00779506|6144385|P1|NOT COMPLETED|Overall Study||29
2506689|NCT00779506|6144385|P1|COMPLETED|Overall Study||67
2506690|NCT00779506|6144385|P1|Withdrawal Treatment|Overall Study||27
2506691|NCT00779506|6144385|P1|Treatment Complete|Overall Study||67
2506692|NCT00779506|6144385|P1|MITT|Overall Study||89
2506693|NCT00779506|6144385|P1|Assigned|Overall Study||94
2506694|NCT00779506|6144385|P1|Screen Failed|Overall Study||2
2506695|NCT00779506|6144385|P1|Enrolled|Overall Study||96
2506696|NCT00779506|6144385|P1|STARTED|Overall Study||96
2506697|NCT00779467|6144399|P4|NOT COMPLETED|Overall Study||19
2506698|NCT00779467|6144400|P3|NOT COMPLETED|Overall Study||10
2506699|NCT00779467|6144401|P2|NOT COMPLETED|Overall Study||5
2506700|NCT00779467|6144402|P1|NOT COMPLETED|Overall Study||15
2506701|NCT00779467|6144399|P4|COMPLETED|Overall Study||35
2506702|NCT00779467|6144400|P3|COMPLETED|Overall Study||38
2506703|NCT00779467|6144401|P2|COMPLETED|Overall Study||40
2506704|NCT00779467|6144402|P1|COMPLETED|Overall Study||38
2506705|NCT00779467|6144399|P4|STARTED|Overall Study||54
2506706|NCT00779467|6144400|P3|STARTED|Overall Study||48
2506707|NCT00779467|6144401|P2|STARTED|Overall Study||45
2506708|NCT00779467|6144402|P1|STARTED|Overall Study||53
2506709|NCT00779402|6144442|P2|NOT COMPLETED|Long-term Follow-up||6
2506710|NCT00779402|6144443|P1|NOT COMPLETED|Long-term Follow-up||21
2506711|NCT00779402|6144442|P2|COMPLETED|Long-term Follow-up||7
2506712|NCT00779402|6144443|P1|COMPLETED|Long-term Follow-up||20
2506713|NCT00779402|6144442|P2|STARTED|Long-term Follow-up||13
2506714|NCT00779402|6144443|P1|STARTED|Long-term Follow-up||41
2506715|NCT00779402|6144442|P2|NOT COMPLETED|Surveillance Phase||31
2506716|NCT00779402|6144443|P1|NOT COMPLETED|Surveillance Phase||43
2506717|NCT00779402|6144442|P2|COMPLETED|Surveillance Phase||13
2506718|NCT00779402|6144443|P1|COMPLETED|Surveillance Phase||41
2506719|NCT00779402|6144442|P2|STARTED|Surveillance Phase||44
2506720|NCT00779402|6144443|P1|STARTED|Surveillance Phase||84
2506721|NCT00779402|6144442|P2|NOT COMPLETED|Treatment Phase 1||15
2506722|NCT00779402|6144443|P1|NOT COMPLETED|Treatment Phase 1||33
2506723|NCT00779402|6144442|P2|COMPLETED|Treatment Phase 1||44
2506724|NCT00779402|6144443|P1|COMPLETED|Treatment Phase 1||84
2506725|NCT00779402|6144442|P2|Received Booster Infusion|Treatment Phase 1||30
2506726|NCT00779402|6144443|P1|Received Booster Infusion|Treatment Phase 1||50
2506727|NCT00779402|6144442|P2|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||59
2506728|NCT00779402|6144443|P1|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||113
2506729|NCT00779402|6144442|P2|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||59
2506730|NCT00779402|6144443|P1|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||116
2506731|NCT00779402|6144442|P2|STARTED|Treatment Phase 1||59
2506732|NCT00779402|6144443|P1|STARTED|Treatment Phase 1||117
2506733|NCT00779311|6144456|P5|NOT COMPLETED|Overall Study||0
2506734|NCT00779311|6144457|P4|NOT COMPLETED|Overall Study||0
2506735|NCT00779311|6144458|P3|NOT COMPLETED|Overall Study||0
2506736|NCT00779311|6144459|P2|NOT COMPLETED|Overall Study||0
2506737|NCT00779311|6144460|P1|NOT COMPLETED|Overall Study||0
2506738|NCT00779311|6144456|P5|COMPLETED|Overall Study||0
2506739|NCT00779311|6144457|P4|COMPLETED|Overall Study||0
2506740|NCT00779311|6144458|P3|COMPLETED|Overall Study||0
2506741|NCT00779311|6144459|P2|COMPLETED|Overall Study||0
2506742|NCT00779311|6144460|P1|COMPLETED|Overall Study||8
2506743|NCT00779311|6144456|P5|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
2506744|NCT00779311|6144457|P4|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
2506745|NCT00779311|6144458|P3|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
2506746|NCT00779311|6144459|P2|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
2506747|NCT00779311|6144460|P1|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||6
2506748|NCT00779311|6144456|P5|STARTED|Overall Study||0
2506749|NCT00779311|6144457|P4|STARTED|Overall Study||0
2506750|NCT00779311|6144458|P3|STARTED|Overall Study||0
2506751|NCT00779311|6144459|P2|STARTED|Overall Study||0
2506752|NCT00779311|6144460|P1|STARTED|Overall Study|2 of 6 patients were not evaluable for DLT assessment and were replaced for a total of 8 enrolled.|8
2506753|NCT00779285|6144482|P1|NOT COMPLETED|Overall Study||0
2506754|NCT00779285|6144482|P1|COMPLETED|Overall Study||1
2506755|NCT00779285|6144482|P1|STARTED|Overall Study||1
2506756|NCT00779259|6144486|P1|NOT COMPLETED|Theophylline With Quinine||0
2506757|NCT00779259|6144486|P1|COMPLETED|Theophylline With Quinine||22
2506758|NCT00779259|6144486|P1|STARTED|Theophylline With Quinine||22
2506759|NCT00779259|6144486|P1|NOT COMPLETED|Quinine Alone||2
2506760|NCT00779259|6144486|P1|COMPLETED|Quinine Alone||22
2506761|NCT00779259|6144486|P1|STARTED|Quinine Alone||24
2506762|NCT00779259|6144486|P1|NOT COMPLETED|4 Day Washout Period||0
2506763|NCT00779259|6144486|P1|COMPLETED|4 Day Washout Period||24
2506764|NCT00779259|6144486|P1|STARTED|4 Day Washout Period||24
2506765|NCT00779259|6144486|P1|NOT COMPLETED|Theophylline Alone||0
2506766|NCT00779259|6144486|P1|COMPLETED|Theophylline Alone||24
2506767|NCT00779259|6144486|P1|STARTED|Theophylline Alone||24
2506768|NCT00779246|6144507|P2|NOT COMPLETED|Overall Study||53
2506769|NCT00779246|6144508|P1|NOT COMPLETED|Overall Study||33
2506770|NCT00779246|6144507|P2|COMPLETED|Overall Study||715
2506771|NCT00779246|6144508|P1|COMPLETED|Overall Study||717
2506772|NCT00779246|6144507|P2|STARTED|Overall Study||768
2506773|NCT00779246|6144508|P1|STARTED|Overall Study||750
2506774|NCT00779155|6144520|P2|NOT COMPLETED|Overall Study||0
2506775|NCT00779155|6144521|P1|NOT COMPLETED|Overall Study||0
2506776|NCT00779155|6144520|P2|COMPLETED|Overall Study||6
2506777|NCT00779155|6144521|P1|COMPLETED|Overall Study||6
2506778|NCT00779155|6144520|P2|STARTED|Overall Study||6
2506779|NCT00779155|6144521|P1|STARTED|Overall Study||6
2506780|NCT00779142|6144527|P1|NOT COMPLETED|Overall Study||3
2506781|NCT00779142|6144527|P1|COMPLETED|Overall Study|Only 2 patients were actually enrolled.|2
2506782|NCT00779142|6144527|P1|STARTED|Overall Study|5 patients signed consent and were screened.|5
2506783|NCT00779116|6144533|P2|NOT COMPLETED|Second Intervention||0
2506784|NCT00779116|6144534|P1|NOT COMPLETED|Second Intervention||0
2506785|NCT00779116|6144533|P2|COMPLETED|Second Intervention||108
2506786|NCT00779116|6144534|P1|COMPLETED|Second Intervention||109
2506787|NCT00779116|6144533|P2|STARTED|Second Intervention||108
2506788|NCT00779116|6144534|P1|STARTED|Second Intervention||109
2506789|NCT00779116|6144533|P2|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
2506790|NCT00779116|6144534|P1|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
2506791|NCT00779116|6144533|P2|COMPLETED|Interval Between Doses (8-10 Minutes)||108
2506792|NCT00779116|6144534|P1|COMPLETED|Interval Between Doses (8-10 Minutes)||109
2506793|NCT00779116|6144533|P2|STARTED|Interval Between Doses (8-10 Minutes)||108
2506794|NCT00779116|6144534|P1|STARTED|Interval Between Doses (8-10 Minutes)||109
2506795|NCT00779116|6144533|P2|NOT COMPLETED|First Intervention||0
2506796|NCT00779116|6144534|P1|NOT COMPLETED|First Intervention||0
2506797|NCT00779116|6144533|P2|COMPLETED|First Intervention||108
2506798|NCT00779116|6144534|P1|COMPLETED|First Intervention||109
2506799|NCT00779116|6144533|P2|STARTED|First Intervention||108
2506800|NCT00779116|6144534|P1|STARTED|First Intervention||109
2506801|NCT00779038|6144541|P1|NOT COMPLETED|Overall Study||13
2506802|NCT00779038|6144541|P1|COMPLETED|Overall Study||0
2506803|NCT00779038|6144541|P1|STARTED|Overall Study||13
2506804|NCT00779025|6144550|P1|NOT COMPLETED|Overall Study||1
2506805|NCT00779025|6144550|P1|COMPLETED|Overall Study||81
2506806|NCT00779025|6144550|P1|STARTED|Overall Study||82
2506807|NCT00778999|6144561|P2|NOT COMPLETED|Overall Study||34
2506808|NCT00778999|6144562|P1|NOT COMPLETED|Overall Study||28
2506809|NCT00778999|6144561|P2|COMPLETED|Overall Study||185
2506810|NCT00778999|6144562|P1|COMPLETED|Overall Study||195
2506811|NCT00778999|6144561|P2|STARTED|Overall Study||219
2506812|NCT00778999|6144562|P1|STARTED|Overall Study||223
2506813|NCT00778921|6144571|P3|NOT COMPLETED|Overall Study||28
2506814|NCT00778921|6144572|P2|NOT COMPLETED|Overall Study||19
2506815|NCT00778921|6144573|P1|NOT COMPLETED|Overall Study||18
2506816|NCT00778921|6144571|P3|COMPLETED|Overall Study||255
2506817|NCT00778921|6144572|P2|COMPLETED|Overall Study||266
2506818|NCT00778921|6144573|P1|COMPLETED|Overall Study||261
2506819|NCT00778921|6144571|P3|STARTED|Overall Study||283
2506820|NCT00778921|6144572|P2|STARTED|Overall Study||285
2506821|NCT00778921|6144573|P1|STARTED|Overall Study||279
2506822|NCT00778895|6144590|P3|NOT COMPLETED|ESFU Phase||2
2506823|NCT00778895|6144591|P2|NOT COMPLETED|ESFU Phase||12
2506824|NCT00778895|6144592|P1|NOT COMPLETED|ESFU Phase||11
2506825|NCT00778895|6144590|P3|COMPLETED|ESFU Phase||41
2506826|NCT00778895|6144591|P2|COMPLETED|ESFU Phase||155
2506827|NCT00778895|6144592|P1|COMPLETED|ESFU Phase||153
2506828|NCT00778895|6144590|P3|STARTED|ESFU Phase||43
2506829|NCT00778895|6144591|P2|STARTED|ESFU Phase||167
2506830|NCT00778895|6144592|P1|STARTED|ESFU Phase||164
2506831|NCT00778895|6144590|P3|NOT COMPLETED|Active Phase||0
2506832|NCT00778895|6144591|P2|NOT COMPLETED|Active Phase||6
2506833|NCT00778895|6144592|P1|NOT COMPLETED|Active Phase||7
2506834|NCT00778895|6144590|P3|COMPLETED|Active Phase||43
2506835|NCT00778895|6144591|P2|COMPLETED|Active Phase||161
2506836|NCT00778895|6144592|P1|COMPLETED|Active Phase||157
2506837|NCT00778895|6144590|P3|STARTED|Active Phase||43
2506838|NCT00778895|6144591|P2|STARTED|Active Phase||167
2506839|NCT00778895|6144592|P1|STARTED|Active Phase||164
2506840|NCT00778869|6144630|P1|NOT COMPLETED|Overall Study||0
2506841|NCT00778869|6144630|P1|COMPLETED|Overall Study||10
2506842|NCT00778869|6144630|P1|STARTED|Overall Study||10
2506843|NCT00778830|6144636|P2|NOT COMPLETED|Overall Study||1
2506844|NCT00778830|6144637|P1|NOT COMPLETED|Overall Study||0
2506845|NCT00778830|6144636|P2|COMPLETED|Overall Study||187
2506846|NCT00778830|6144637|P1|COMPLETED|Overall Study||101
2506847|NCT00778830|6144636|P2|STARTED|Overall Study||188
2506848|NCT00778830|6144637|P1|STARTED|Overall Study||101
2506849|NCT00778817|6144649|P1|NOT COMPLETED|Overall Study||4
2506850|NCT00778817|6144649|P1|COMPLETED|Overall Study||16
2506851|NCT00778817|6144649|P1|STARTED|Overall Study||20
2506852|NCT00778648|6144666|P2|NOT COMPLETED|Overall Study||5
2506853|NCT00778648|6144667|P1|NOT COMPLETED|Overall Study||9
2506854|NCT00778648|6144666|P2|COMPLETED|Overall Study||266
2506855|NCT00778648|6144667|P1|COMPLETED|Overall Study||263
2506856|NCT00778648|6144666|P2|STARTED|Overall Study||271
2506857|NCT00778648|6144667|P1|STARTED|Overall Study||272
2506858|NCT00778622|6144676|P3|NOT COMPLETED|Overall Study||15
2506859|NCT00778622|6144677|P2|NOT COMPLETED|Overall Study||15
2506860|NCT00778622|6144678|P1|NOT COMPLETED|Overall Study||16
2506861|NCT00778622|6144676|P3|COMPLETED|Overall Study||109
2506862|NCT00778622|6144677|P2|COMPLETED|Overall Study||107
2506863|NCT00778622|6144678|P1|COMPLETED|Overall Study||109
2506864|NCT00778622|6144676|P3|STARTED|Overall Study||124
2506865|NCT00778622|6144677|P2|STARTED|Overall Study||122
2506866|NCT00778622|6144678|P1|STARTED|Overall Study||125
2506867|NCT00778375|6144731|P1|NOT COMPLETED|Overall Study||3
2506868|NCT00778375|6144731|P1|COMPLETED|Overall Study||119
2506869|NCT00778375|6144731|P1|STARTED|Overall Study||122
2506870|NCT00778336|6144745|P4|NOT COMPLETED|3 Month Follow Up||0
2506871|NCT00778336|6144746|P3|NOT COMPLETED|3 Month Follow Up||5
2506872|NCT00778336|6144747|P2|NOT COMPLETED|3 Month Follow Up||23
2506873|NCT00778336|6144748|P1|NOT COMPLETED|3 Month Follow Up||23
2506874|NCT00778336|6144745|P4|COMPLETED|3 Month Follow Up||12
2506875|NCT00778336|6144746|P3|COMPLETED|3 Month Follow Up||65
2506876|NCT00778336|6144747|P2|COMPLETED|3 Month Follow Up||144
2506877|NCT00778336|6144748|P1|COMPLETED|3 Month Follow Up||169
2506878|NCT00778336|6144745|P4|STARTED|3 Month Follow Up||12
2506879|NCT00778336|6144746|P3|STARTED|3 Month Follow Up||70
2506880|NCT00778336|6144747|P2|STARTED|3 Month Follow Up||167
2506881|NCT00778336|6144748|P1|STARTED|3 Month Follow Up||192
2506882|NCT00778336|6144745|P4|NOT COMPLETED|Index Procedure-Discharge||0
2506883|NCT00778336|6144746|P3|NOT COMPLETED|Index Procedure-Discharge||2
2506884|NCT00778336|6144747|P2|NOT COMPLETED|Index Procedure-Discharge||3
2506885|NCT00778336|6144748|P1|NOT COMPLETED|Index Procedure-Discharge||6
2506886|NCT00778336|6144745|P4|COMPLETED|Index Procedure-Discharge||12
2506887|NCT00778336|6144746|P3|COMPLETED|Index Procedure-Discharge||70
2506888|NCT00778336|6144747|P2|COMPLETED|Index Procedure-Discharge||167
2506889|NCT00778336|6144748|P1|COMPLETED|Index Procedure-Discharge||192
2506890|NCT00778336|6144745|P4|STARTED|Index Procedure-Discharge||12
2506891|NCT00778336|6144746|P3|STARTED|Index Procedure-Discharge||72
2506892|NCT00778336|6144747|P2|STARTED|Index Procedure-Discharge||170
2506893|NCT00778336|6144748|P1|STARTED|Index Procedure-Discharge||198
2506894|NCT00778310|6144768|P2|NOT COMPLETED|Overall Study||0
2506895|NCT00778310|6144769|P1|NOT COMPLETED|Overall Study||0
2506896|NCT00778310|6144768|P2|COMPLETED|Overall Study||26
2506897|NCT00778310|6144769|P1|COMPLETED|Overall Study||17
2506898|NCT00778310|6144768|P2|Usable Data|Overall Study||21
2506899|NCT00778310|6144769|P1|Usable Data|Overall Study||14
2506900|NCT00778310|6144768|P2|STARTED|Overall Study||26
2506901|NCT00778310|6144769|P1|STARTED|Overall Study||17
2506902|NCT00778258|6144786|P9|NOT COMPLETED|Overall Study||4
2506903|NCT00778258|6144787|P8|NOT COMPLETED|Overall Study||15
2506904|NCT00778258|6144788|P7|NOT COMPLETED|Overall Study||15
2506905|NCT00778258|6144789|P6|NOT COMPLETED|Overall Study||10
2506906|NCT00778258|6144790|P5|NOT COMPLETED|Overall Study||0
2506907|NCT00778258|6144791|P4|NOT COMPLETED|Overall Study||3
2506908|NCT00778258|6144792|P3|NOT COMPLETED|Overall Study||10
2506909|NCT00778258|6144793|P2|NOT COMPLETED|Overall Study||2
2506910|NCT00778258|6144794|P1|NOT COMPLETED|Overall Study||7
2506911|NCT00778258|6144786|P9|COMPLETED|Overall Study||6
2506912|NCT00778258|6144787|P8|COMPLETED|Overall Study||26
2506913|NCT00778258|6144788|P7|COMPLETED|Overall Study||19
2506914|NCT00778258|6144789|P6|COMPLETED|Overall Study||13
2506915|NCT00778258|6144790|P5|COMPLETED|Overall Study||6
2506916|NCT00778258|6144791|P4|COMPLETED|Overall Study||12
2506917|NCT00778258|6144792|P3|COMPLETED|Overall Study||10
2506918|NCT00778258|6144793|P2|COMPLETED|Overall Study||3
2506919|NCT00778258|6144794|P1|COMPLETED|Overall Study||9
2506920|NCT00778258|6144786|P9|STARTED|Overall Study||10
2506921|NCT00778258|6144787|P8|STARTED|Overall Study||41
2506922|NCT00778258|6144788|P7|STARTED|Overall Study||34
2506923|NCT00778258|6144789|P6|STARTED|Overall Study||23
2506924|NCT00778258|6144790|P5|STARTED|Overall Study||6
2506925|NCT00778258|6144791|P4|STARTED|Overall Study||15
2506926|NCT00778258|6144792|P3|STARTED|Overall Study||20
2506927|NCT00778258|6144793|P2|STARTED|Overall Study||5
2506928|NCT00778258|6144794|P1|STARTED|Overall Study||16
2506929|NCT00778167|6144849|P3|NOT COMPLETED|Overall Study||0
2506930|NCT00778167|6144850|P2|NOT COMPLETED|Overall Study||0
2506931|NCT00778167|6144851|P1|NOT COMPLETED|Overall Study||0
2506932|NCT00778167|6144849|P3|COMPLETED|Overall Study||4
2506933|NCT00778167|6144850|P2|COMPLETED|Overall Study||8
2506934|NCT00778167|6144851|P1|COMPLETED|Overall Study||6
2506935|NCT00778167|6144849|P3|STARTED|Overall Study||4
2506936|NCT00778167|6144850|P2|STARTED|Overall Study||8
2506937|NCT00778167|6144851|P1|STARTED|Overall Study||6
2506938|NCT00778102|6144861|P2|NOT COMPLETED|Overall Study||22
2506939|NCT00778102|6144862|P1|NOT COMPLETED|Overall Study||21
2506940|NCT00778102|6144861|P2|COMPLETED|Overall Study||19
2506941|NCT00778102|6144862|P1|COMPLETED|Overall Study||18
2506942|NCT00778102|6144861|P2|STARTED|Overall Study||41
2506943|NCT00778102|6144862|P1|STARTED|Overall Study||39
2506944|NCT00777946|6144897|P3|NOT COMPLETED|Overall Study||16
2506945|NCT00777946|6144898|P2|NOT COMPLETED|Overall Study||6
2506946|NCT00777946|6144899|P1|NOT COMPLETED|Overall Study||21
2506947|NCT00777946|6144897|P3|COMPLETED|Overall Study||244
2506948|NCT00777946|6144898|P2|COMPLETED|Overall Study||271
2506949|NCT00777946|6144899|P1|COMPLETED|Overall Study||262
2506950|NCT00777946|6144897|P3|Safety & Full Analysis Sets|Overall Study||260
2506951|NCT00777946|6144898|P2|Safety & Full Analysis Sets|Overall Study||276
2506952|NCT00777946|6144899|P1|Safety & Full Analysis Sets|Overall Study||282
2506953|NCT00777946|6144897|P3|STARTED|Overall Study||260
2506954|NCT00777946|6144898|P2|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 5 mg group was randomized in error.|277
2506955|NCT00777946|6144899|P1|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 10 mg group was randomized in error.|283
2506956|NCT00777855|6144922|P2|NOT COMPLETED|Second Intervention||0
2506957|NCT00777855|6144923|P1|NOT COMPLETED|Second Intervention||0
2506958|NCT00777855|6144922|P2|COMPLETED|Second Intervention||5
2506959|NCT00777855|6144923|P1|COMPLETED|Second Intervention||5
2506960|NCT00777855|6144922|P2|STARTED|Second Intervention||5
2506961|NCT00777855|6144923|P1|STARTED|Second Intervention||5
2506962|NCT00777855|6144922|P2|NOT COMPLETED|Washout Period (>= 14 Days)||0
2506963|NCT00777855|6144923|P1|NOT COMPLETED|Washout Period (>= 14 Days)||0
2506964|NCT00777855|6144922|P2|COMPLETED|Washout Period (>= 14 Days)||5
2506965|NCT00777855|6144923|P1|COMPLETED|Washout Period (>= 14 Days)||5
2506966|NCT00777855|6144922|P2|STARTED|Washout Period (>= 14 Days)||5
2506967|NCT00777855|6144923|P1|STARTED|Washout Period (>= 14 Days)||5
2506968|NCT00777855|6144922|P2|NOT COMPLETED|First Intervention||0
2506969|NCT00777855|6144923|P1|NOT COMPLETED|First Intervention||0
2506970|NCT00777855|6144922|P2|COMPLETED|First Intervention||5
2506971|NCT00777855|6144923|P1|COMPLETED|First Intervention||5
2506972|NCT00777855|6144922|P2|STARTED|First Intervention||5
2506973|NCT00777855|6144923|P1|STARTED|First Intervention||5
2506974|NCT00777803|6144934|P2|NOT COMPLETED|Overall Study||7
2506975|NCT00777803|6144935|P1|NOT COMPLETED|Overall Study||15
2506976|NCT00777803|6144934|P2|COMPLETED|Overall Study||90
2506977|NCT00777803|6144935|P1|COMPLETED|Overall Study||269
2506978|NCT00777803|6144934|P2|STARTED|Overall Study||97
2506979|NCT00777803|6144935|P1|STARTED|Overall Study||284
2506980|NCT00777790|6144970|P3|NOT COMPLETED|Overall Study||0
2506981|NCT00777790|6144971|P2|NOT COMPLETED|Overall Study||0
2506982|NCT00777790|6144972|P1|NOT COMPLETED|Overall Study||0
2506983|NCT00777790|6144970|P3|COMPLETED|Overall Study||88
2506984|NCT00777790|6144971|P2|COMPLETED|Overall Study||77
2506985|NCT00777790|6144972|P1|COMPLETED|Overall Study||76
2506986|NCT00777790|6144970|P3|STARTED|Overall Study||88
2506987|NCT00777790|6144971|P2|STARTED|Overall Study||77
2506988|NCT00777790|6144972|P1|STARTED|Overall Study||76
2506989|NCT00777764|6144982|P2|NOT COMPLETED|Overall Study||1
2506990|NCT00777764|6144983|P1|NOT COMPLETED|Overall Study||0
2506991|NCT00777764|6144982|P2|COMPLETED|Overall Study||29
2506992|NCT00777764|6144983|P1|COMPLETED|Overall Study||30
2506993|NCT00777764|6144982|P2|STARTED|Overall Study||30
2506994|NCT00777764|6144983|P1|STARTED|Overall Study||30
2506995|NCT00777634|6144995|P2|NOT COMPLETED|Overall Study||1
2506996|NCT00777634|6144996|P1|NOT COMPLETED|Overall Study||5
2506997|NCT00777634|6144995|P2|COMPLETED|Overall Study||133
2506998|NCT00777634|6144996|P1|COMPLETED|Overall Study||129
2506999|NCT00777634|6144995|P2|STARTED|Overall Study||134
2507000|NCT00777634|6144996|P1|STARTED|Overall Study||134
2507001|NCT00777608|6145014|P2|NOT COMPLETED|Overall Study||6
2507002|NCT00777608|6145015|P1|NOT COMPLETED|Overall Study||4
2507003|NCT00777608|6145014|P2|COMPLETED|Overall Study||47
2507004|NCT00777608|6145015|P1|COMPLETED|Overall Study||49
2507005|NCT00777608|6145014|P2|STARTED|Overall Study||53
2507006|NCT00777608|6145015|P1|STARTED|Overall Study||53
2507007|NCT00777556|6145025|P1|NOT COMPLETED|Overall Study||66
2507008|NCT00777556|6145025|P1|COMPLETED|Overall Study|Completed all 3 follow-up visits|277
2507009|NCT00777556|6145025|P1|Used Product|Overall Study||297
2507010|NCT00777556|6145025|P1|Safety Population|Overall Study|Participants who used the product; two were given product in error (inappropriately self-selected)|299
2507011|NCT00777556|6145025|P1|Dispensed Product|Overall Study||307
2507012|NCT00777556|6145025|P1|STARTED|Overall Study|Enrolled; signed informed consent|343
2507013|NCT00777491|6145034|P2|NOT COMPLETED|Overall Study||2
2507014|NCT00777491|6145035|P1|NOT COMPLETED|Overall Study||2
2507015|NCT00777491|6145034|P2|COMPLETED|Overall Study||33
2507016|NCT00777491|6145035|P1|COMPLETED|Overall Study||33
2507017|NCT00777491|6145034|P2|Has 3 Year AUASI Data|Overall Study||6
2507018|NCT00777491|6145035|P1|Has 3 Year AUASI Data|Overall Study||6
2507019|NCT00777491|6145034|P2|Has Adverse Event Data (Late)|Overall Study||31
2507020|NCT00777491|6145035|P1|Has Adverse Event Data (Late)|Overall Study||32
2507021|NCT00777491|6145034|P2|Has Adverse Event Data (Treatment)|Overall Study||33
2507022|NCT00777491|6145035|P1|Has Adverse Event Data (Treatment)|Overall Study||33
2507023|NCT00777491|6145034|P2|Started Adjuvant Therapy|Overall Study||31
2507024|NCT00777491|6145035|P1|Started Adjuvant Therapy|Overall Study||32
2507025|NCT00777491|6145034|P2|Started Consolidation Therapy|Overall Study||25
2507026|NCT00777491|6145035|P1|Started Consolidation Therapy|Overall Study||29
2507027|NCT00777491|6145034|P2|Started Induction Therapy|Overall Study||33
2507028|NCT00777491|6145035|P1|Started Induction Therapy|Overall Study||33
2507029|NCT00777491|6145034|P2|Has 3-year Efficacy Data|Overall Study||25
2507030|NCT00777491|6145035|P1|Has 3-year Efficacy Data|Overall Study||27
2507031|NCT00777491|6145034|P2|Eligible|Overall Study||33
2507032|NCT00777491|6145035|P1|Eligible|Overall Study||33
2507033|NCT00777491|6145034|P2|STARTED|Overall Study||35
2507034|NCT00777491|6145035|P1|STARTED|Overall Study||35
2507035|NCT00777335|6145055|P2|NOT COMPLETED|Overall Study||0
2507036|NCT00777335|6145056|P1|NOT COMPLETED|Overall Study||0
2507037|NCT00777335|6145055|P2|COMPLETED|Overall Study||2
2507038|NCT00777335|6145056|P1|COMPLETED|Overall Study||2
2507039|NCT00777335|6145055|P2|STARTED|Overall Study||2
2507040|NCT00777335|6145056|P1|STARTED|Overall Study||2
2507041|NCT00777296|6145068|P4|NOT COMPLETED|Overall Study||1
2507042|NCT00777296|6145069|P3|NOT COMPLETED|Overall Study||2
2507043|NCT00777296|6145070|P2|NOT COMPLETED|Overall Study||1
2507044|NCT00777296|6145071|P1|NOT COMPLETED|Overall Study||1
2507045|NCT00777296|6145068|P4|COMPLETED|Overall Study||10
2507046|NCT00777296|6145069|P3|COMPLETED|Overall Study||21
2507047|NCT00777296|6145070|P2|COMPLETED|Overall Study||10
2507048|NCT00777296|6145071|P1|COMPLETED|Overall Study||20
2507049|NCT00777296|6145068|P4|STARTED|Overall Study||11
2507050|NCT00777296|6145069|P3|STARTED|Overall Study||23
2507051|NCT00777296|6145070|P2|STARTED|Overall Study||11
2507052|NCT00777296|6145071|P1|STARTED|Overall Study||21
2507053|NCT00777257|6145113|P3|NOT COMPLETED|Overall Study||9
2507054|NCT00777257|6145114|P2|NOT COMPLETED|Overall Study||12
2507055|NCT00777257|6145115|P1|NOT COMPLETED|Overall Study||11
2507056|NCT00777257|6145113|P3|COMPLETED|Overall Study||442
2507057|NCT00777257|6145114|P2|COMPLETED|Overall Study||438
2507058|NCT00777257|6145115|P1|COMPLETED|Overall Study||433
2507059|NCT00777257|6145113|P3|STARTED|Overall Study||451
2507060|NCT00777257|6145114|P2|STARTED|Overall Study||450
2507061|NCT00777257|6145115|P1|STARTED|Overall Study||444
2507062|NCT00777205|6145134|P2|NOT COMPLETED|Overall Study||71
2507063|NCT00777205|6145135|P1|NOT COMPLETED|Overall Study||31
2507064|NCT00777205|6145134|P2|COMPLETED|Overall Study||129
2507065|NCT00777205|6145135|P1|COMPLETED|Overall Study||212
2507066|NCT00777205|6145134|P2|Intervention Interruption|Overall Study|56 participants excluded from main analyses due to 2 mos interruption in study intervention|56
2507067|NCT00777205|6145135|P1|Intervention Interruption|Overall Study||0
2507068|NCT00777205|6145134|P2|STARTED|Overall Study||200
2507069|NCT00777205|6145135|P1|STARTED|Overall Study||243
2507070|NCT00777179|6145151|P2|NOT COMPLETED|Overall Study||0
2507071|NCT00777179|6145152|P1|NOT COMPLETED|Overall Study||0
2507072|NCT00777179|6145151|P2|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|42
2507073|NCT00777179|6145152|P1|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|75
2507074|NCT00777179|6145151|P2|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|42
2507075|NCT00777179|6145152|P1|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|75
2507076|NCT00777153|6145169|P3|NOT COMPLETED|Overall Study||37
2507077|NCT00777153|6145170|P2|NOT COMPLETED|Overall Study||83
2507078|NCT00777153|6145171|P1|NOT COMPLETED|Overall Study||90
2507079|NCT00777153|6145169|P3|COMPLETED|Overall Study||28
2507080|NCT00777153|6145170|P2|COMPLETED|Overall Study||46
2507081|NCT00777153|6145171|P1|COMPLETED|Overall Study||41
2507082|NCT00777153|6145169|P3|STARTED|Overall Study||65
2507083|NCT00777153|6145170|P2|STARTED|Overall Study||129
2507084|NCT00777153|6145171|P1|STARTED|Overall Study||131
2507085|NCT00777101|6145196|P2|NOT COMPLETED|Overall Study||51
2507086|NCT00777101|6145197|P1|NOT COMPLETED|Overall Study||62
2507087|NCT00777101|6145196|P2|COMPLETED|Overall Study||65
2507088|NCT00777101|6145197|P1|COMPLETED|Overall Study||55
2507089|NCT00777101|6145196|P2|Treated|Overall Study||115
2507090|NCT00777101|6145197|P1|Treated|Overall Study||116
2507091|NCT00777101|6145196|P2|STARTED|Overall Study||116
2507092|NCT00777101|6145197|P1|STARTED|Overall Study||117
2507093|NCT00777088|6145215|P1|NOT COMPLETED|Overall Study||1
2507094|NCT00777088|6145215|P1|COMPLETED|Overall Study||107
2507095|NCT00777088|6145215|P1|STARTED|Overall Study||108
2507096|NCT00777062|6145229|P2|NOT COMPLETED|Overall Study||5
2507097|NCT00777062|6145230|P1|NOT COMPLETED|Overall Study||3
2507098|NCT00777062|6145229|P2|COMPLETED|Overall Study||36
2507099|NCT00777062|6145230|P1|COMPLETED|Overall Study||36
2507100|NCT00777062|6145229|P2|STARTED|Overall Study||41
2507101|NCT00777062|6145230|P1|STARTED|Overall Study||39
2507102|NCT00777049|6145240|P2|NOT COMPLETED|Overall Study||1
2507103|NCT00777049|6145241|P1|NOT COMPLETED|Overall Study||1
2507104|NCT00777049|6145240|P2|COMPLETED|Overall Study||20
2507105|NCT00777049|6145241|P1|COMPLETED|Overall Study||32
2507106|NCT00777049|6145240|P2|STARTED|Overall Study||21
2507107|NCT00777049|6145241|P1|STARTED|Overall Study||33
2507108|NCT00777036|6145250|P3|NOT COMPLETED|Follow-Up||4
2507109|NCT00777036|6145251|P2|NOT COMPLETED|Follow-Up||8
2507110|NCT00777036|6145252|P1|NOT COMPLETED|Follow-Up||5
2507111|NCT00777036|6145250|P3|COMPLETED|Follow-Up|Completed = Still in Follow-up|19
2507112|NCT00777036|6145251|P2|COMPLETED|Follow-Up|Completed = Still in Follow-up|5
2507113|NCT00777036|6145252|P1|COMPLETED|Follow-Up|Completed = Still in Follow-up|9
2507202|NCT00776009|6145616|P2|NOT COMPLETED|Period 3: Third Intervention||0
2507114|NCT00777036|6145250|P3|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|23
2507115|NCT00777036|6145251|P2|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|13
2507116|NCT00777036|6145252|P1|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|14
2507117|NCT00777036|6145250|P3|NOT COMPLETED|On Treatment||23
2507118|NCT00777036|6145251|P2|NOT COMPLETED|On Treatment||16
2507119|NCT00777036|6145252|P1|NOT COMPLETED|On Treatment||15
2507120|NCT00777036|6145250|P3|COMPLETED|On Treatment|Completed = Still on treatment|61
2507121|NCT00777036|6145251|P2|COMPLETED|On Treatment|Completed = Still on treatment|1
2507122|NCT00777036|6145252|P1|COMPLETED|On Treatment|Completed = Still on treatment|14
2507123|NCT00777036|6145250|P3|STARTED|On Treatment||84
2507124|NCT00777036|6145251|P2|STARTED|On Treatment||17
2507125|NCT00777036|6145252|P1|STARTED|On Treatment||29
2507126|NCT00777023|6145348|P3|NOT COMPLETED|Overall Study||37
2507127|NCT00777023|6145349|P2|NOT COMPLETED|Overall Study||41
2507128|NCT00777023|6145350|P1|NOT COMPLETED|Overall Study||35
2507129|NCT00777023|6145348|P3|COMPLETED|Overall Study||146
2507130|NCT00777023|6145349|P2|COMPLETED|Overall Study||149
2507131|NCT00777023|6145350|P1|COMPLETED|Overall Study||151
2507132|NCT00777023|6145348|P3|STARTED|Overall Study|183 patients were randomized, and 183 received study treatment.|183
2507133|NCT00777023|6145349|P2|STARTED|Overall Study|190 patients were randomized, and 190 received study treatment.|190
2507134|NCT00777023|6145350|P1|STARTED|Overall Study|192 patients were randomized, but only 186 received study treatment.|186
2507135|NCT00776997|6145367|P1|NOT COMPLETED|Overall Study||2
2507136|NCT00776997|6145367|P1|COMPLETED|Overall Study|98 subjects evaluated at 12-months. Endpoint analysis based on all subjects treated (n=100)|98
2507137|NCT00776997|6145367|P1|STARTED|Overall Study||100
2507138|NCT00776984|6145376|P2|NOT COMPLETED|Overall Study||21
2507139|NCT00776984|6145377|P1|NOT COMPLETED|Overall Study||31
2507140|NCT00776984|6145376|P2|COMPLETED|Overall Study||198
2507141|NCT00776984|6145377|P1|COMPLETED|Overall Study||203
2507142|NCT00776984|6145376|P2|STARTED|Overall Study||219
2507143|NCT00776984|6145377|P1|STARTED|Overall Study||234
2507144|NCT00776919|6145451|P4|NOT COMPLETED|Overall Study||39
2507145|NCT00776919|6145452|P3|NOT COMPLETED|Overall Study||32
2507146|NCT00776919|6145453|P2|NOT COMPLETED|Overall Study||33
2507147|NCT00776919|6145454|P1|NOT COMPLETED|Overall Study||27
2507148|NCT00776919|6145451|P4|COMPLETED|Overall Study||293
2507149|NCT00776919|6145452|P3|COMPLETED|Overall Study||296
2507150|NCT00776919|6145453|P2|COMPLETED|Overall Study||295
2507151|NCT00776919|6145454|P1|COMPLETED|Overall Study||300
2507152|NCT00776919|6145451|P4|STARTED|Overall Study||332
2507153|NCT00776919|6145452|P3|STARTED|Overall Study||328
2507154|NCT00776919|6145453|P2|STARTED|Overall Study||328
2507155|NCT00776919|6145454|P1|STARTED|Overall Study||327
2507156|NCT00776789|6145518|P2|NOT COMPLETED|Overall Study||3
2507157|NCT00776789|6145519|P1|NOT COMPLETED|Overall Study||3
2507158|NCT00776789|6145518|P2|COMPLETED|Overall Study||18
2507159|NCT00776789|6145519|P1|COMPLETED|Overall Study||17
2507160|NCT00776789|6145518|P2|STARTED|Overall Study||21
2507161|NCT00776789|6145519|P1|STARTED|Overall Study||20
2507162|NCT00776659|6145531|P1|NOT COMPLETED|Overall Study||26
2507163|NCT00776659|6145531|P1|COMPLETED|Overall Study||13
2507164|NCT00776659|6145531|P1|STARTED|Overall Study||39
2507165|NCT00776594|6145543|P2|NOT COMPLETED|Overall Study||2
2507166|NCT00776594|6145544|P1|NOT COMPLETED|Overall Study||4
2507167|NCT00776594|6145543|P2|COMPLETED|Overall Study||34
2507168|NCT00776594|6145544|P1|COMPLETED|Overall Study||62
2507169|NCT00776594|6145543|P2|STARTED|Overall Study||36
2507170|NCT00776594|6145544|P1|STARTED|Overall Study||66
2507171|NCT00776555|6145558|P2|NOT COMPLETED|Overall Study||0
2507172|NCT00776555|6145559|P1|NOT COMPLETED|Overall Study||3
2507173|NCT00776555|6145558|P2|COMPLETED|Overall Study||0
2507174|NCT00776555|6145559|P1|COMPLETED|Overall Study||0
2507175|NCT00776555|6145558|P2|STARTED|Overall Study||0
2507176|NCT00776555|6145559|P1|STARTED|Overall Study||3
2507177|NCT00776295|6145569|P1|NOT COMPLETED|Overall Study||0
2507178|NCT00776295|6145569|P1|COMPLETED|Overall Study||2
2507179|NCT00776295|6145569|P1|STARTED|Overall Study||2
2507180|NCT00776230|6145577|P3|NOT COMPLETED|Overall Study||5
2507181|NCT00776230|6145578|P2|NOT COMPLETED|Overall Study||3
2507182|NCT00776230|6145579|P1|NOT COMPLETED|Overall Study||3
2507183|NCT00776230|6145577|P3|COMPLETED|Overall Study||97
2507184|NCT00776230|6145578|P2|COMPLETED|Overall Study||100
2507185|NCT00776230|6145579|P1|COMPLETED|Overall Study||96
2507186|NCT00776230|6145577|P3|Enrolled and Vaccinated at Day 0|Overall Study||102
2507187|NCT00776230|6145578|P2|Enrolled and Vaccinated at Day 0|Overall Study||103
2507188|NCT00776230|6145579|P1|Enrolled and Vaccinated at Day 0|Overall Study||98
2507189|NCT00776230|6145577|P3|STARTED|Overall Study||102
2507190|NCT00776230|6145578|P2|STARTED|Overall Study||103
2507191|NCT00776230|6145579|P1|STARTED|Overall Study||99
2507192|NCT00776100|6145589|P2|NOT COMPLETED|Overall Study||0
2507193|NCT00776100|6145590|P1|NOT COMPLETED|Overall Study||1
2507194|NCT00776100|6145589|P2|COMPLETED|Overall Study||1
2507195|NCT00776100|6145590|P1|COMPLETED|Overall Study||0
2507196|NCT00776100|6145589|P2|STARTED|Overall Study||1
2507197|NCT00776100|6145590|P1|STARTED|Overall Study||1
2507198|NCT00776009|6145612|P6|NOT COMPLETED|Period 3: Third Intervention||0
2507199|NCT00776009|6145613|P5|NOT COMPLETED|Period 3: Third Intervention||0
2507200|NCT00776009|6145614|P4|NOT COMPLETED|Period 3: Third Intervention||0
2507201|NCT00776009|6145615|P3|NOT COMPLETED|Period 3: Third Intervention||0
2507203|NCT00776009|6145617|P1|NOT COMPLETED|Period 3: Third Intervention||1
2507204|NCT00776009|6145612|P6|COMPLETED|Period 3: Third Intervention||26
2507205|NCT00776009|6145613|P5|COMPLETED|Period 3: Third Intervention||26
2507206|NCT00776009|6145614|P4|COMPLETED|Period 3: Third Intervention||27
2507207|NCT00776009|6145615|P3|COMPLETED|Period 3: Third Intervention||27
2507208|NCT00776009|6145616|P2|COMPLETED|Period 3: Third Intervention||27
2507209|NCT00776009|6145617|P1|COMPLETED|Period 3: Third Intervention||24
2507210|NCT00776009|6145612|P6|STARTED|Period 3: Third Intervention||26
2507211|NCT00776009|6145613|P5|STARTED|Period 3: Third Intervention||26
2507212|NCT00776009|6145614|P4|STARTED|Period 3: Third Intervention||27
2507213|NCT00776009|6145615|P3|STARTED|Period 3: Third Intervention||27
2507214|NCT00776009|6145616|P2|STARTED|Period 3: Third Intervention||27
2507215|NCT00776009|6145617|P1|STARTED|Period 3: Third Intervention||25
2507216|NCT00776009|6145612|P6|NOT COMPLETED|Period 2: Second Intervention||1
2507217|NCT00776009|6145613|P5|NOT COMPLETED|Period 2: Second Intervention||0
2507218|NCT00776009|6145614|P4|NOT COMPLETED|Period 2: Second Intervention||0
2507219|NCT00776009|6145615|P3|NOT COMPLETED|Period 2: Second Intervention||1
2507220|NCT00776009|6145616|P2|NOT COMPLETED|Period 2: Second Intervention||0
2507221|NCT00776009|6145617|P1|NOT COMPLETED|Period 2: Second Intervention||1
2507222|NCT00776009|6145612|P6|COMPLETED|Period 2: Second Intervention||26
2507223|NCT00776009|6145613|P5|COMPLETED|Period 2: Second Intervention||26
2507224|NCT00776009|6145614|P4|COMPLETED|Period 2: Second Intervention||27
2507225|NCT00776009|6145615|P3|COMPLETED|Period 2: Second Intervention||27
2507226|NCT00776009|6145616|P2|COMPLETED|Period 2: Second Intervention||27
2507227|NCT00776009|6145617|P1|COMPLETED|Period 2: Second Intervention||25
2507228|NCT00776009|6145612|P6|STARTED|Period 2: Second Intervention||27
2507229|NCT00776009|6145613|P5|STARTED|Period 2: Second Intervention||26
2507230|NCT00776009|6145614|P4|STARTED|Period 2: Second Intervention||27
2507231|NCT00776009|6145615|P3|STARTED|Period 2: Second Intervention||28
2507232|NCT00776009|6145616|P2|STARTED|Period 2: Second Intervention||27
2507233|NCT00776009|6145617|P1|STARTED|Period 2: Second Intervention||26
2507234|NCT00776009|6145612|P6|NOT COMPLETED|Period 1: First Intervention||0
2507235|NCT00776009|6145613|P5|NOT COMPLETED|Period 1: First Intervention||2
2507236|NCT00776009|6145614|P4|NOT COMPLETED|Period 1: First Intervention||0
2507237|NCT00776009|6145615|P3|NOT COMPLETED|Period 1: First Intervention||1
2507238|NCT00776009|6145616|P2|NOT COMPLETED|Period 1: First Intervention||1
2507239|NCT00776009|6145617|P1|NOT COMPLETED|Period 1: First Intervention||0
2507240|NCT00776009|6145612|P6|COMPLETED|Period 1: First Intervention||27
2507241|NCT00776009|6145613|P5|COMPLETED|Period 1: First Intervention||26
2507242|NCT00776009|6145614|P4|COMPLETED|Period 1: First Intervention||27
2507243|NCT00776009|6145615|P3|COMPLETED|Period 1: First Intervention||28
2507244|NCT00776009|6145616|P2|COMPLETED|Period 1: First Intervention||27
2507245|NCT00776009|6145617|P1|COMPLETED|Period 1: First Intervention||26
2507246|NCT00776009|6145612|P6|STARTED|Period 1: First Intervention||27
2507247|NCT00776009|6145613|P5|STARTED|Period 1: First Intervention||28
2507248|NCT00776009|6145614|P4|STARTED|Period 1: First Intervention||27
2507249|NCT00776009|6145615|P3|STARTED|Period 1: First Intervention||29
2507250|NCT00776009|6145616|P2|STARTED|Period 1: First Intervention||28
2507251|NCT00776009|6145617|P1|STARTED|Period 1: First Intervention||26
2507252|NCT00775983|6145639|P2|NOT COMPLETED|Overall Study||2
2507253|NCT00775983|6145640|P1|NOT COMPLETED|Overall Study||1
2507254|NCT00775983|6145639|P2|COMPLETED|Overall Study||34
2507255|NCT00775983|6145640|P1|COMPLETED|Overall Study||35
2507256|NCT00775983|6145639|P2|STARTED|Overall Study||36
2507257|NCT00775983|6145640|P1|STARTED|Overall Study||36
2507258|NCT00775944|6145652|P4|NOT COMPLETED|Overall Study||16
2507259|NCT00775944|6145653|P3|NOT COMPLETED|Overall Study||16
2507260|NCT00775944|6145654|P2|NOT COMPLETED|Overall Study||9
2507261|NCT00775944|6145655|P1|NOT COMPLETED|Overall Study||15
2507262|NCT00775944|6145652|P4|COMPLETED|Overall Study|16 participants withdrew consent|632
2507263|NCT00775944|6145653|P3|COMPLETED|Overall Study|16 participants withdrew consent|632
2507264|NCT00775944|6145654|P2|COMPLETED|Overall Study|9 participants withdrew consent|638
2507265|NCT00775944|6145655|P1|COMPLETED|Overall Study|15 participants withdrew consent|633
2507266|NCT00775944|6145652|P4|STARTED|Overall Study||648
2507267|NCT00775944|6145653|P3|STARTED|Overall Study||648
2507268|NCT00775944|6145654|P2|STARTED|Overall Study||647
2507269|NCT00775944|6145655|P1|STARTED|Overall Study||648
2507270|NCT00775931|6145683|P2|NOT COMPLETED|Overall Study||0
2507271|NCT00775931|6145684|P1|NOT COMPLETED|Overall Study||0
2507272|NCT00775931|6145683|P2|COMPLETED|Overall Study||1
2507273|NCT00775931|6145684|P1|COMPLETED|Overall Study||6
2507274|NCT00775931|6145683|P2|STARTED|Overall Study||1
2507275|NCT00775931|6145684|P1|STARTED|Overall Study||6
2507276|NCT00775684|6145699|P3|NOT COMPLETED|Overall Study||3
2507277|NCT00775684|6145700|P2|NOT COMPLETED|Overall Study||1
2507278|NCT00775684|6145701|P1|NOT COMPLETED|Overall Study||3
2507279|NCT00775684|6145699|P3|COMPLETED|Overall Study||14
2507280|NCT00775684|6145700|P2|COMPLETED|Overall Study||12
2507281|NCT00775684|6145701|P1|COMPLETED|Overall Study||14
2507282|NCT00775684|6145699|P3|STARTED|Overall Study||17
2507283|NCT00775684|6145700|P2|STARTED|Overall Study||13
2507284|NCT00775684|6145701|P1|STARTED|Overall Study||17
2507285|NCT00775671|6145723|P2|NOT COMPLETED|Overall Study||0
2507286|NCT00775671|6145724|P1|NOT COMPLETED|Overall Study||0
2507287|NCT00775671|6145723|P2|COMPLETED|Overall Study||23
2507288|NCT00775671|6145724|P1|COMPLETED|Overall Study||23
2507289|NCT00775671|6145723|P2|STARTED|Overall Study||23
2507290|NCT00775671|6145724|P1|STARTED|Overall Study||23
2507291|NCT00775658|6145732|P2|NOT COMPLETED|Second Intervention||0
2507292|NCT00775658|6145733|P1|NOT COMPLETED|Second Intervention||0
2507293|NCT00775658|6145732|P2|COMPLETED|Second Intervention||11
2507294|NCT00775658|6145733|P1|COMPLETED|Second Intervention||10
2507295|NCT00775658|6145732|P2|STARTED|Second Intervention||11
2507296|NCT00775658|6145733|P1|STARTED|Second Intervention||10
2507297|NCT00775658|6145732|P2|NOT COMPLETED|First Intervention||0
2507298|NCT00775658|6145733|P1|NOT COMPLETED|First Intervention||0
2507299|NCT00775658|6145732|P2|COMPLETED|First Intervention||11
2507300|NCT00775658|6145733|P1|COMPLETED|First Intervention||10
2507301|NCT00775658|6145732|P2|STARTED|First Intervention||11
2507302|NCT00775658|6145733|P1|STARTED|First Intervention||10
2507303|NCT00775645|6145743|P2|NOT COMPLETED|Overall Study||20
2507304|NCT00775645|6145744|P1|NOT COMPLETED|Overall Study||17
2507305|NCT00775645|6145743|P2|COMPLETED|Overall Study||181
2507306|NCT00775645|6145744|P1|COMPLETED|Overall Study||191
2507307|NCT00775645|6145743|P2|STARTED|Overall Study||201
2507308|NCT00775645|6145744|P1|STARTED|Overall Study||208
2507309|NCT00775606|6145766|P2|NOT COMPLETED|Overall Study||0
2507310|NCT00775606|6145767|P1|NOT COMPLETED|Overall Study||3
2507311|NCT00775606|6145766|P2|COMPLETED|Overall Study||5
2507312|NCT00775606|6145767|P1|COMPLETED|Overall Study||5
2507313|NCT00775606|6145766|P2|STARTED|Overall Study||5
2507314|NCT00775606|6145767|P1|STARTED|Overall Study||8
2507315|NCT00775593|6145777|P1|NOT COMPLETED|Overall Study||7
2507316|NCT00775593|6145777|P1|COMPLETED|Overall Study||53
2507317|NCT00775593|6145777|P1|STARTED|Overall Study||60
2507318|NCT00775528|6145784|P1|NOT COMPLETED|Overall Study||1
2507319|NCT00775528|6145784|P1|COMPLETED|Overall Study||18
2507320|NCT00775528|6145784|P1|STARTED|Overall Study|Started means number of patients who consented|19
2507321|NCT00775463|6145793|P2|NOT COMPLETED|Overall Study||13
2507322|NCT00775463|6145794|P1|NOT COMPLETED|Overall Study||11
2507323|NCT00775463|6145793|P2|COMPLETED|Overall Study||59
2507324|NCT00775463|6145794|P1|COMPLETED|Overall Study||65
2507325|NCT00775463|6145793|P2|STARTED|Overall Study||72
2507326|NCT00775463|6145794|P1|STARTED|Overall Study||76
2507327|NCT00775450|6145831|P5|NOT COMPLETED|Overall Study||2
2507328|NCT00775450|6145832|P4|NOT COMPLETED|Overall Study||0
2507329|NCT00775450|6145833|P3|NOT COMPLETED|Overall Study||0
2507330|NCT00775450|6145834|P2|NOT COMPLETED|Overall Study||0
2507331|NCT00775450|6145835|P1|NOT COMPLETED|Overall Study||3
2507332|NCT00775450|6145831|P5|COMPLETED|Overall Study||199
2507333|NCT00775450|6145832|P4|COMPLETED|Overall Study||108
2507334|NCT00775450|6145833|P3|COMPLETED|Overall Study||105
2507335|NCT00775450|6145834|P2|COMPLETED|Overall Study||98
2507336|NCT00775450|6145835|P1|COMPLETED|Overall Study||292
2507337|NCT00775450|6145831|P5|STARTED|Overall Study||201
2507338|NCT00775450|6145832|P4|STARTED|Overall Study||108
2507339|NCT00775450|6145833|P3|STARTED|Overall Study||105
2507340|NCT00775450|6145834|P2|STARTED|Overall Study||98
2507341|NCT00775450|6145835|P1|STARTED|Overall Study||295
2507342|NCT00775437|6145862|P1|NOT COMPLETED|Overall Study||6
2507343|NCT00775437|6145862|P1|COMPLETED|Overall Study||26
2507344|NCT00775437|6145862|P1|STARTED|Overall Study||32
2507345|NCT00775411|6145912|P1|NOT COMPLETED|Overall Study||1
2507346|NCT00775411|6145912|P1|COMPLETED|Overall Study||43
2507347|NCT00775411|6145912|P1|STARTED|Overall Study||44
2507348|NCT00775346|6145918|P1|NOT COMPLETED|Overall Study||0
2507349|NCT00775346|6145918|P1|COMPLETED|Overall Study||92
2507350|NCT00775346|6145918|P1|STARTED|Overall Study||92
2507351|NCT00775229|6145924|P2|NOT COMPLETED|Overall Study||2
2507352|NCT00775229|6145925|P1|NOT COMPLETED|Overall Study||5
2507353|NCT00775229|6145924|P2|COMPLETED|Overall Study||24
2507354|NCT00775229|6145925|P1|COMPLETED|Overall Study||20
2507355|NCT00775229|6145924|P2|STARTED|Overall Study||26
2507356|NCT00775229|6145925|P1|STARTED|Overall Study||25
2507357|NCT00775203|6145937|P2|NOT COMPLETED|Overall Study||43
2507358|NCT00775203|6145938|P1|NOT COMPLETED|Overall Study||62
2507359|NCT00775203|6145937|P2|COMPLETED|Overall Study||163
2507360|NCT00775203|6145938|P1|COMPLETED|Overall Study||144
2507361|NCT00775203|6145937|P2|Received Study Medication|Overall Study||204
2507362|NCT00775203|6145938|P1|Received Study Medication|Overall Study||202
2507363|NCT00775203|6145937|P2|STARTED|Overall Study||206
2507364|NCT00775203|6145938|P1|STARTED|Overall Study||206
2507365|NCT00775190|6145972|P2|NOT COMPLETED|Overall Study||5
2507366|NCT00775190|6145973|P1|NOT COMPLETED|Overall Study||4
2507367|NCT00775190|6145972|P2|COMPLETED|Overall Study||0
2507368|NCT00775190|6145973|P1|COMPLETED|Overall Study||3
2507369|NCT00775190|6145972|P2|STARTED|Overall Study||5
2507370|NCT00775190|6145973|P1|STARTED|Overall Study||7
2507371|NCT00775138|6145999|P4|NOT COMPLETED|Overall Study||2
2507372|NCT00775138|6146000|P3|NOT COMPLETED|Overall Study||3
2507373|NCT00775138|6146001|P2|NOT COMPLETED|Overall Study||0
2507374|NCT00775138|6146002|P1|NOT COMPLETED|Overall Study||0
2507375|NCT00775138|6145999|P4|COMPLETED|Overall Study||8
2507376|NCT00775138|6146000|P3|COMPLETED|Overall Study||17
2507377|NCT00775138|6146001|P2|COMPLETED|Overall Study||10
2507378|NCT00775138|6146002|P1|COMPLETED|Overall Study||24
2507379|NCT00775138|6145999|P4|STARTED|Overall Study||10
2507380|NCT00775138|6146000|P3|STARTED|Overall Study||20
2507381|NCT00775138|6146001|P2|STARTED|Overall Study||10
2507382|NCT00775138|6146002|P1|STARTED|Overall Study||24
2507383|NCT00775021|6146048|P2|NOT COMPLETED|Second Intervention||1
2507384|NCT00775021|6146049|P1|NOT COMPLETED|Second Intervention||0
2507385|NCT00775021|6146048|P2|COMPLETED|Second Intervention||59
2507386|NCT00775021|6146049|P1|COMPLETED|Second Intervention||62
2507387|NCT00775021|6146048|P2|STARTED|Second Intervention||60
2507388|NCT00775021|6146049|P1|STARTED|Second Intervention||62
2507389|NCT00775021|6146048|P2|NOT COMPLETED|First Intervention||0
2507390|NCT00775021|6146049|P1|NOT COMPLETED|First Intervention||1
2507391|NCT00775021|6146048|P2|COMPLETED|First Intervention||60
2507392|NCT00775021|6146049|P1|COMPLETED|First Intervention||62
2507393|NCT00775021|6146048|P2|STARTED|First Intervention||60
2507394|NCT00775021|6146049|P1|STARTED|First Intervention||63
2507395|NCT00774995|6146067|P4|NOT COMPLETED|Overall Study||0
2507396|NCT00774995|6146068|P3|NOT COMPLETED|Overall Study||1
2507397|NCT00774995|6146069|P2|NOT COMPLETED|Overall Study||0
2507398|NCT00774995|6146070|P1|NOT COMPLETED|Overall Study||0
2507399|NCT00774995|6146067|P4|COMPLETED|Overall Study||16
2507400|NCT00774995|6146068|P3|COMPLETED|Overall Study||7
2507401|NCT00774995|6146069|P2|COMPLETED|Overall Study||16
2507402|NCT00774995|6146070|P1|COMPLETED|Overall Study||9
2507403|NCT00774995|6146067|P4|STARTED|Overall Study||16
2507404|NCT00774995|6146068|P3|STARTED|Overall Study||8
2507405|NCT00774995|6146069|P2|STARTED|Overall Study||16
2507406|NCT00774995|6146070|P1|STARTED|Overall Study||9
2507407|NCT00774930|6146110|P2|NOT COMPLETED|LTOLE Phase||17
2507408|NCT00774930|6146111|P1|NOT COMPLETED|LTOLE Phase||15
2507409|NCT00774930|6146110|P2|COMPLETED|LTOLE Phase||8
2507410|NCT00774930|6146111|P1|COMPLETED|LTOLE Phase||17
2507411|NCT00774930|6146110|P2|STARTED|LTOLE Phase|20 subjects from IOL did not enter LTOLE (12 completed IOL, 8 did not complete IOL).|25
2507412|NCT00774930|6146111|P1|STARTED|LTOLE Phase|24 subjects from IOL did not enter LTOLE (11 completed IOL, 13 did not complete IOL).|32
2507413|NCT00774930|6146110|P2|NOT COMPLETED|IOL Phase||9
2507414|NCT00774930|6146111|P1|NOT COMPLETED|IOL Phase||13
2507415|NCT00774930|6146110|P2|COMPLETED|IOL Phase||37
2507416|NCT00774930|6146111|P1|COMPLETED|IOL Phase||43
2507417|NCT00774930|6146110|P2|STARTED|IOL Phase|Includes 1 subject listed as completing and withdrawing from the DB phase due to brain radiation|46
2507418|NCT00774930|6146111|P1|STARTED|IOL Phase||56
2507419|NCT00774930|6146110|P2|NOT COMPLETED|DB Phase||22
2507420|NCT00774930|6146111|P1|NOT COMPLETED|DB Phase||14
2507421|NCT00774930|6146110|P2|COMPLETED|DB Phase|had diary data at least up to day 21 after 4th dose, regardless of missing diary data before day 21.|34
2507422|NCT00774930|6146111|P1|COMPLETED|DB Phase|Received 4 DB study injections AND continued to IOL phase OR|45
2507423|NCT00774930|6146110|P2|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|56
2507424|NCT00774930|6146111|P1|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|59
2507425|NCT00774852|6146139|P2|NOT COMPLETED|Overall Study||41
2507426|NCT00774852|6146140|P1|NOT COMPLETED|Overall Study||45
2507427|NCT00774852|6146139|P2|COMPLETED|Overall Study||27
2507428|NCT00774852|6146140|P1|COMPLETED|Overall Study||24
2507429|NCT00774852|6146139|P2|STARTED|Overall Study||68
2507430|NCT00774852|6146140|P1|STARTED|Overall Study||69
2507431|NCT00774800|6146188|P1|NOT COMPLETED|Intervention 4||1
2507432|NCT00774800|6146188|P1|COMPLETED|Intervention 4||21
2507433|NCT00774800|6146188|P1|Received at Least One Dose of Study Drug|Intervention 4||21
2507434|NCT00774800|6146188|P1|STARTED|Intervention 4||22
2507435|NCT00774800|6146188|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
2507436|NCT00774800|6146188|P1|COMPLETED|Washout (3 to 10 Days)||22
2507437|NCT00774800|6146188|P1|STARTED|Washout (3 to 10 Days)||22
2507438|NCT00774800|6146188|P1|NOT COMPLETED|Intervention 3||0
2507439|NCT00774800|6146188|P1|COMPLETED|Intervention 3||22
2507440|NCT00774800|6146188|P1|Received at Least One Dose of Study Drug|Intervention 3||22
2507441|NCT00774800|6146188|P1|STARTED|Intervention 3||22
2507442|NCT00774800|6146188|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
2507443|NCT00774800|6146188|P1|COMPLETED|Washout (3 to 10 Days)||22
2507444|NCT00774800|6146188|P1|STARTED|Washout (3 to 10 Days)||22
2507445|NCT00774800|6146188|P1|NOT COMPLETED|Intervention 2||0
2507446|NCT00774800|6146188|P1|COMPLETED|Intervention 2||22
2507447|NCT00774800|6146188|P1|Received at Least One Dose of Study Drug|Intervention 2||22
2507448|NCT00774800|6146188|P1|STARTED|Intervention 2||22
2507449|NCT00774800|6146188|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
2507450|NCT00774800|6146188|P1|COMPLETED|Washout (3 to 10 Days)||22
2507451|NCT00774800|6146188|P1|STARTED|Washout (3 to 10 Days)||22
2507452|NCT00774800|6146188|P1|NOT COMPLETED|Intervention 1||0
2507453|NCT00774800|6146188|P1|COMPLETED|Intervention 1||22
2507454|NCT00774800|6146188|P1|Received at Least One Dose of Study Drug|Intervention 1||22
2507455|NCT00774800|6146188|P1|STARTED|Intervention 1||22
2507456|NCT00774787|6146210|P1|NOT COMPLETED|Overall Study||1
2507457|NCT00774787|6146210|P1|COMPLETED|Overall Study||26
2507458|NCT00774787|6146210|P1|STARTED|Overall Study||27
2507459|NCT00774748|6146217|P1|NOT COMPLETED|Overall Study||3
2507460|NCT00774748|6146217|P1|COMPLETED|Overall Study||18
2507461|NCT00774748|6146217|P1|STARTED|Overall Study||21
2507462|NCT00774579|6146227|P2|NOT COMPLETED|Overall Study||0
2507463|NCT00774579|6146228|P1|NOT COMPLETED|Overall Study||0
2507464|NCT00774579|6146227|P2|COMPLETED|Overall Study||9
2507465|NCT00774579|6146228|P1|COMPLETED|Overall Study||9
2507466|NCT00774579|6146227|P2|STARTED|Overall Study||9
2507467|NCT00774579|6146228|P1|STARTED|Overall Study||9
2507468|NCT00774397|6146243|P7|NOT COMPLETED|Overall Study||30
2507469|NCT00774397|6146244|P6|NOT COMPLETED|Overall Study||22
2507470|NCT00774397|6146245|P5|NOT COMPLETED|Overall Study||46
2507471|NCT00774397|6146246|P4|NOT COMPLETED|Overall Study||17
2507472|NCT00774397|6146247|P3|NOT COMPLETED|Overall Study||30
2507473|NCT00774397|6146248|P2|NOT COMPLETED|Overall Study||13
2507474|NCT00774397|6146249|P1|NOT COMPLETED|Overall Study||14
2507475|NCT00774397|6146243|P7|COMPLETED|Overall Study||41
2507476|NCT00774397|6146244|P6|COMPLETED|Overall Study||54
2507477|NCT00774397|6146245|P5|COMPLETED|Overall Study||97
2507478|NCT00774397|6146246|P4|COMPLETED|Overall Study||129
2507479|NCT00774397|6146247|P3|COMPLETED|Overall Study||113
2507480|NCT00774397|6146248|P2|COMPLETED|Overall Study||56
2507481|NCT00774397|6146249|P1|COMPLETED|Overall Study||57
2507482|NCT00774397|6146243|P7|STARTED|Overall Study||71
2507483|NCT00774397|6146244|P6|STARTED|Overall Study||76
2507484|NCT00774397|6146245|P5|STARTED|Overall Study||143
2507485|NCT00774397|6146246|P4|STARTED|Overall Study||146
2507486|NCT00774397|6146247|P3|STARTED|Overall Study||143
2507487|NCT00774397|6146248|P2|STARTED|Overall Study||69
2507488|NCT00774397|6146249|P1|STARTED|Overall Study||71
2507489|NCT00774306|6146485|P4|NOT COMPLETED|Overall Study||5
2507490|NCT00774306|6146486|P3|NOT COMPLETED|Overall Study||8
2507491|NCT00774306|6146487|P2|NOT COMPLETED|Overall Study||2
2507492|NCT00774306|6146488|P1|NOT COMPLETED|Overall Study||18
2507493|NCT00774306|6146485|P4|COMPLETED|Overall Study||2
2507494|NCT00774306|6146486|P3|COMPLETED|Overall Study||8
2507495|NCT00774306|6146487|P2|COMPLETED|Overall Study||3
2507496|NCT00774306|6146488|P1|COMPLETED|Overall Study||6
2507497|NCT00774306|6146485|P4|STARTED|Overall Study||7
2507498|NCT00774306|6146486|P3|STARTED|Overall Study||16
2507499|NCT00774306|6146487|P2|STARTED|Overall Study||5
2507500|NCT00774306|6146488|P1|STARTED|Overall Study||24
2507501|NCT00774267|6146502|P4|NOT COMPLETED|Overall Study||0
2507502|NCT00774267|6146503|P3|NOT COMPLETED|Overall Study||0
2507503|NCT00774267|6146504|P2|NOT COMPLETED|Overall Study||0
2507504|NCT00774267|6146505|P1|NOT COMPLETED|Overall Study||0
2507505|NCT00774267|6146502|P4|COMPLETED|Overall Study||135
2507506|NCT00774267|6146503|P3|COMPLETED|Overall Study||129
2507507|NCT00774267|6146504|P2|COMPLETED|Overall Study||111
2507508|NCT00774267|6146505|P1|COMPLETED|Overall Study||132
2507509|NCT00774267|6146502|P4|STARTED|Overall Study||135
2507510|NCT00774267|6146503|P3|STARTED|Overall Study||129
2507511|NCT00774267|6146504|P2|STARTED|Overall Study||111
2507512|NCT00774267|6146505|P1|STARTED|Overall Study||132
2507513|NCT00774202|6146517|P2|NOT COMPLETED|Overall Study||0
2507514|NCT00774202|6146518|P1|NOT COMPLETED|Overall Study||0
2507515|NCT00774202|6146517|P2|COMPLETED|Overall Study||8
2507516|NCT00774202|6146518|P1|COMPLETED|Overall Study||9
2507517|NCT00774202|6146517|P2|STARTED|Overall Study||8
2507518|NCT00774202|6146518|P1|STARTED|Overall Study||9
2507519|NCT00774163|6146530|P2|NOT COMPLETED|Overall Study||0
2507520|NCT00774163|6146531|P1|NOT COMPLETED|Overall Study||0
2507521|NCT00774163|6146530|P2|COMPLETED|Overall Study||15
2507522|NCT00774163|6146531|P1|COMPLETED|Overall Study||30
2507523|NCT00774163|6146530|P2|STARTED|Overall Study||15
2507524|NCT00774163|6146531|P1|STARTED|Overall Study||30
2507525|NCT00774046|6146569|P1|NOT COMPLETED|Autologous Transplant||0
2507526|NCT00774046|6146569|P1|COMPLETED|Autologous Transplant||4
2507527|NCT00774046|6146569|P1|STARTED|Autologous Transplant|2 patients died in remission and 1 relapsed without having received transplant|4
2507528|NCT00774046|6146569|P1|NOT COMPLETED|Stem Cell Mobilization||3
2507529|NCT00774046|6146569|P1|COMPLETED|Stem Cell Mobilization||7
2507530|NCT00774046|6146569|P1|STARTED|Stem Cell Mobilization|For mobilization, the patient must have had a CR and not been a candidate for allogeneic transplant|10
2507531|NCT00774046|6146569|P1|NOT COMPLETED|Induction Therapy||0
2507532|NCT00774046|6146569|P1|COMPLETED|Induction Therapy||32
2507533|NCT00774046|6146569|P1|STARTED|Induction Therapy||32
2507534|NCT00774046|6146569|P1|NOT COMPLETED|Enrollment||28
2507535|NCT00774046|6146569|P1|COMPLETED|Enrollment||32
2507536|NCT00774046|6146569|P1|STARTED|Enrollment||60
2507537|NCT00774046|6146569|P1|NOT COMPLETED|Screening||56
2507538|NCT00774046|6146569|P1|COMPLETED|Screening||60
2507539|NCT00774046|6146569|P1|STARTED|Screening||116
2507540|NCT00773968|6146579|P1|NOT COMPLETED|Overall Study||45
2507541|NCT00773968|6146579|P1|COMPLETED|Overall Study||95
2507542|NCT00773968|6146579|P1|Treated|Overall Study||111
2507543|NCT00773968|6146579|P1|STARTED|Overall Study||140
2507544|NCT00773955|6146588|P1|NOT COMPLETED|Overall Study||0
2507545|NCT00773955|6146588|P1|COMPLETED|Overall Study||15
2507546|NCT00773955|6146588|P1|STARTED|Overall Study||15
2507547|NCT00773786|6146595|P2|NOT COMPLETED|Second Intervention (1 Week)||0
2507548|NCT00773786|6146596|P1|NOT COMPLETED|Second Intervention (1 Week)||0
2507549|NCT00773786|6146595|P2|COMPLETED|Second Intervention (1 Week)||10
2507550|NCT00773786|6146596|P1|COMPLETED|Second Intervention (1 Week)||10
2507551|NCT00773786|6146595|P2|STARTED|Second Intervention (1 Week)||10
2507552|NCT00773786|6146596|P1|STARTED|Second Intervention (1 Week)||10
2507553|NCT00773786|6146595|P2|NOT COMPLETED|Washout (1 Week)||0
2507554|NCT00773786|6146596|P1|NOT COMPLETED|Washout (1 Week)||0
2507555|NCT00773786|6146595|P2|COMPLETED|Washout (1 Week)||10
2507556|NCT00773786|6146596|P1|COMPLETED|Washout (1 Week)||10
2507557|NCT00773786|6146595|P2|STARTED|Washout (1 Week)||10
2507558|NCT00773786|6146596|P1|STARTED|Washout (1 Week)||10
2507559|NCT00773786|6146595|P2|NOT COMPLETED|First Intervention (1 Week)||0
2507560|NCT00773786|6146596|P1|NOT COMPLETED|First Intervention (1 Week)||0
2507561|NCT00773786|6146595|P2|COMPLETED|First Intervention (1 Week)||10
2507562|NCT00773786|6146596|P1|COMPLETED|First Intervention (1 Week)||10
2507563|NCT00773786|6146595|P2|STARTED|First Intervention (1 Week)||10
2507564|NCT00773786|6146596|P1|STARTED|First Intervention (1 Week)||10
2507565|NCT00773734|6146610|P6|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
2507566|NCT00773734|6146611|P5|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
2507567|NCT00773734|6146612|P4|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
2507568|NCT00773734|6146613|P3|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
2507569|NCT00773734|6146614|P2|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
2507570|NCT00773734|6146615|P1|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
2507571|NCT00773734|6146610|P6|COMPLETED|LTE Period: Week 52 to 6 Years||0
2507572|NCT00773734|6146611|P5|COMPLETED|LTE Period: Week 52 to 6 Years||0
2507573|NCT00773734|6146612|P4|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|5
2507574|NCT00773734|6146613|P3|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|4
2507575|NCT00773734|6146614|P2|COMPLETED|LTE Period: Week 52 to 6 Years||0
2507576|NCT00773734|6146615|P1|COMPLETED|LTE Period: Week 52 to 6 Years||0
2507577|NCT00773734|6146610|P6|STARTED|LTE Period: Week 52 to 6 Years||0
2507578|NCT00773734|6146611|P5|STARTED|LTE Period: Week 52 to 6 Years||0
2507579|NCT00773734|6146612|P4|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|17
2507580|NCT00773734|6146613|P3|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|16
2507581|NCT00773734|6146614|P2|STARTED|LTE Period: Week 52 to 6 Years||0
2507582|NCT00773734|6146615|P1|STARTED|LTE Period: Week 52 to 6 Years||0
2507583|NCT00773734|6146610|P6|NOT COMPLETED|Extension: Active Treatment Week 24-52||8
2507584|NCT00773734|6146611|P5|NOT COMPLETED|Extension: Active Treatment Week 24-52||5
2507585|NCT00773734|6146612|P4|NOT COMPLETED|Extension: Active Treatment Week 24-52||10
2507586|NCT00773734|6146613|P3|NOT COMPLETED|Extension: Active Treatment Week 24-52||17
2507587|NCT00773734|6146614|P2|NOT COMPLETED|Extension: Active Treatment Week 24-52||13
2507588|NCT00773734|6146615|P1|NOT COMPLETED|Extension: Active Treatment Week 24-52||0
2507589|NCT00773734|6146610|P6|COMPLETED|Extension: Active Treatment Week 24-52||19
2507590|NCT00773734|6146611|P5|COMPLETED|Extension: Active Treatment Week 24-52||22
2507591|NCT00773734|6146612|P4|COMPLETED|Extension: Active Treatment Week 24-52||48
2507592|NCT00773734|6146613|P3|COMPLETED|Extension: Active Treatment Week 24-52||33
2507593|NCT00773734|6146614|P2|COMPLETED|Extension: Active Treatment Week 24-52|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|34
2507594|NCT00773734|6146615|P1|COMPLETED|Extension: Active Treatment Week 24-52||0
2507595|NCT00773734|6146610|P6|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
2507596|NCT00773734|6146611|P5|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
2507597|NCT00773734|6146612|P4|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
2507598|NCT00773734|6146613|P3|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
2507599|NCT00773734|6146614|P2|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||5
2507600|NCT00773734|6146615|P1|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||0
2507601|NCT00773734|6146610|P6|STARTED|Extension: Active Treatment Week 24-52||27
2507602|NCT00773734|6146611|P5|STARTED|Extension: Active Treatment Week 24-52||27
2507603|NCT00773734|6146612|P4|STARTED|Extension: Active Treatment Week 24-52||58
2507604|NCT00773734|6146613|P3|STARTED|Extension: Active Treatment Week 24-52||50
2507605|NCT00773734|6146614|P2|STARTED|Extension: Active Treatment Week 24-52||47
2507606|NCT00773734|6146615|P1|STARTED|Extension: Active Treatment Week 24-52||0
2507607|NCT00773734|6146610|P6|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||5
2507608|NCT00773734|6146611|P5|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||1
2507609|NCT00773734|6146612|P4|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||2
2507610|NCT00773734|6146613|P3|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||7
2507611|NCT00773734|6146614|P2|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||12
2507612|NCT00773734|6146615|P1|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||0
2507613|NCT00773734|6146610|P6|COMPLETED|Core: Active Treatment Phase Week 16-24||31
2507614|NCT00773734|6146611|P5|COMPLETED|Core: Active Treatment Phase Week 16-24||33
2507615|NCT00773734|6146612|P4|COMPLETED|Core: Active Treatment Phase Week 16-24||65
2507616|NCT00773734|6146613|P3|COMPLETED|Core: Active Treatment Phase Week 16-24||59
2507617|NCT00773734|6146614|P2|COMPLETED|Core: Active Treatment Phase Week 16-24||65
2507618|NCT00773734|6146615|P1|COMPLETED|Core: Active Treatment Phase Week 16-24||0
2507619|NCT00773734|6146610|P6|STARTED|Core: Active Treatment Phase Week 16-24||36
2507620|NCT00773734|6146611|P5|STARTED|Core: Active Treatment Phase Week 16-24||34
2507621|NCT00773734|6146612|P4|STARTED|Core: Active Treatment Phase Week 16-24|3 participants elected not to continue from previous period|67
2507622|NCT00773734|6146613|P3|STARTED|Core: Active Treatment Phase Week 16-24||66
2507623|NCT00773734|6146614|P2|STARTED|Core: Active Treatment Phase Week 16-24|2 participants elected not to continue from previous period|77
2507624|NCT00773734|6146615|P1|STARTED|Core: Active Treatment Phase Week 16-24|Placebo participants were re-randomized at Week 16 to receive apremilast 20mg or 30mg PO BID.|0
2507625|NCT00773734|6146610|P6|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
2507626|NCT00773734|6146611|P5|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
2507627|NCT00773734|6146612|P4|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||18
2507628|NCT00773734|6146613|P3|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||21
2507629|NCT00773734|6146614|P2|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||10
2507630|NCT00773734|6146615|P1|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||16
2507631|NCT00773734|6146610|P6|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
2507632|NCT00773734|6146611|P5|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
2507633|NCT00773734|6146612|P4|COMPLETED|Core: Placebo Controlled Phase Week 0-16|3 participants completed placebo controlled phase but elected not to continue|70
2507634|NCT00773734|6146613|P3|COMPLETED|Core: Placebo Controlled Phase Week 0-16||66
2507635|NCT00773734|6146614|P2|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|79
2507636|NCT00773734|6146615|P1|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|72
2507637|NCT00773734|6146610|P6|STARTED|Core: Placebo Controlled Phase Week 0-16||0
2507638|NCT00773734|6146611|P5|STARTED|Core: Placebo Controlled Phase Week 0-16||0
2507639|NCT00773734|6146612|P4|STARTED|Core: Placebo Controlled Phase Week 0-16||88
2507640|NCT00773734|6146613|P3|STARTED|Core: Placebo Controlled Phase Week 0-16||87
2507641|NCT00773734|6146614|P2|STARTED|Core: Placebo Controlled Phase Week 0-16||89
2507642|NCT00773734|6146615|P1|STARTED|Core: Placebo Controlled Phase Week 0-16||88
2507643|NCT00773604|6147177|P1|NOT COMPLETED|Overall Study||0
2507644|NCT00773604|6147177|P1|COMPLETED|Overall Study||9
2507645|NCT00773604|6147177|P1|STARTED|Overall Study||9
2507646|NCT00773513|6147183|P2|NOT COMPLETED|Overall Study||1109
2507647|NCT00773513|6147184|P1|NOT COMPLETED|Overall Study||1101
2507648|NCT00773513|6147183|P2|COMPLETED|Overall Study||303
2507649|NCT00773513|6147184|P1|COMPLETED|Overall Study||312
2507650|NCT00773513|6147183|P2|Received Study Treatment|Overall Study||1409
2507651|NCT00773513|6147184|P1|Received Study Treatment|Overall Study||1409
2507652|NCT00773513|6147183|P2|STARTED|Overall Study||1412
2507653|NCT00773513|6147184|P1|STARTED|Overall Study||1413
2507654|NCT00773474|6147204|P1|NOT COMPLETED|Overall Study||0
2507655|NCT00773474|6147204|P1|COMPLETED|Overall Study||29
2507656|NCT00773474|6147204|P1|STARTED|Overall Study||29
2507657|NCT00773461|6147213|P2|NOT COMPLETED|Overall Study||4
2507658|NCT00773461|6147214|P1|NOT COMPLETED|Overall Study||5
2507659|NCT00773461|6147213|P2|COMPLETED|Overall Study||135
2507660|NCT00773461|6147214|P1|COMPLETED|Overall Study||65
2507661|NCT00773461|6147213|P2|STARTED|Overall Study||139
2507662|NCT00773461|6147214|P1|STARTED|Overall Study||70
2507663|NCT00773422|6147255|P3|NOT COMPLETED|Overall Study||0
2507664|NCT00773422|6147256|P2|NOT COMPLETED|Overall Study||0
2507665|NCT00773422|6147257|P1|NOT COMPLETED|Overall Study||0
2507666|NCT00773422|6147255|P3|COMPLETED|Overall Study||10
2507667|NCT00773422|6147256|P2|COMPLETED|Overall Study||9
2507668|NCT00773422|6147257|P1|COMPLETED|Overall Study||11
2507669|NCT00773422|6147255|P3|STARTED|Overall Study||10
2507670|NCT00773422|6147256|P2|STARTED|Overall Study||9
2507671|NCT00773422|6147257|P1|STARTED|Overall Study||11
2507672|NCT00773383|6147268|P1|NOT COMPLETED|Overall Study||31
2507673|NCT00773383|6147268|P1|COMPLETED|Overall Study|this includes at the time of clinical cut-off (2/23/2010) there were 4 patients ongoing|4
2507674|NCT00773383|6147268|P1|Received Study Drug|Overall Study||34
2507675|NCT00773383|6147268|P1|STARTED|Overall Study||35
2507676|NCT00773370|6147290|P2|NOT COMPLETED|Overall Study||10
2507677|NCT00773370|6147291|P1|NOT COMPLETED|Overall Study||18
2507678|NCT00773370|6147290|P2|COMPLETED|Overall Study||23
2507679|NCT00773370|6147291|P1|COMPLETED|Overall Study||25
2507680|NCT00773370|6147290|P2|STARTED|Overall Study||33
2507681|NCT00773370|6147291|P1|STARTED|Overall Study||43
2507682|NCT00773279|6147303|P2|NOT COMPLETED|Period 2||6
2507683|NCT00773279|6147304|P1|NOT COMPLETED|Period 2||3
2507684|NCT00773279|6147303|P2|COMPLETED|Period 2||111
2507685|NCT00773279|6147304|P1|COMPLETED|Period 2||111
2507686|NCT00773279|6147303|P2|STARTED|Period 2||117
2507687|NCT00773279|6147304|P1|STARTED|Period 2||114
2507688|NCT00773279|6147303|P2|NOT COMPLETED|Period 1||4
2507689|NCT00773279|6147304|P1|NOT COMPLETED|Period 1||7
2507690|NCT00773279|6147303|P2|COMPLETED|Period 1||117
2507691|NCT00773279|6147304|P1|COMPLETED|Period 1||114
2507692|NCT00773279|6147303|P2|STARTED|Period 1||121
2507693|NCT00773279|6147304|P1|STARTED|Period 1||121
2507694|NCT00773253|6147325|P2|NOT COMPLETED|Second Intervention (Week 24-48)||0
2507695|NCT00773253|6147326|P1|NOT COMPLETED|Second Intervention (Week 24-48)||0
2507696|NCT00773253|6147325|P2|COMPLETED|Second Intervention (Week 24-48)||4
2507697|NCT00773253|6147326|P1|COMPLETED|Second Intervention (Week 24-48)||5
2507698|NCT00773253|6147325|P2|STARTED|Second Intervention (Week 24-48)||4
2507699|NCT00773253|6147326|P1|STARTED|Second Intervention (Week 24-48)||5
2507700|NCT00773253|6147325|P2|NOT COMPLETED|First Intervention (Week 0-24)||1
2507701|NCT00773253|6147326|P1|NOT COMPLETED|First Intervention (Week 0-24)||0
2507702|NCT00773253|6147325|P2|COMPLETED|First Intervention (Week 0-24)||4
2507703|NCT00773253|6147326|P1|COMPLETED|First Intervention (Week 0-24)||5
2507704|NCT00773253|6147325|P2|STARTED|First Intervention (Week 0-24)||5
2507705|NCT00773253|6147326|P1|STARTED|First Intervention (Week 0-24)||5
2507706|NCT00773175|6147334|P2|NOT COMPLETED|Overall Study||2
2507707|NCT00773175|6147335|P1|NOT COMPLETED|Overall Study||2
2507708|NCT00773175|6147334|P2|COMPLETED|Overall Study||73
2507709|NCT00773175|6147335|P1|COMPLETED|Overall Study||71
2507710|NCT00773175|6147334|P2|No Fluids Received|Overall Study||1
2507711|NCT00773175|6147335|P1|No Fluids Received|Overall Study||0
2507712|NCT00773175|6147334|P2|Initial Fluids Via Subcutaneous Rescue|Overall Study||15
2507713|NCT00773175|6147335|P1|Initial Fluids Via Subcutaneous Rescue|Overall Study||0
2507714|NCT00773175|6147334|P2|Initial Fluids Via Randomized Route|Overall Study||59
2507715|NCT00773175|6147335|P1|Initial Fluids Via Randomized Route|Overall Study||73
2507716|NCT00773175|6147334|P2|STARTED|Overall Study||75
2507717|NCT00773175|6147335|P1|STARTED|Overall Study||73
2507718|NCT00773136|6147427|P1|NOT COMPLETED|Overall Study||2
2507719|NCT00773136|6147427|P1|COMPLETED|Overall Study||19
2507720|NCT00773136|6147427|P1|STARTED|Overall Study||21
2507721|NCT00773097|6147432|P1|NOT COMPLETED|Overall Study||7
2507722|NCT00773097|6147432|P1|COMPLETED|Overall Study||39
2507723|NCT00773097|6147432|P1|STARTED|Overall Study||46
2507724|NCT00772967|6147438|P6|NOT COMPLETED|Crossover Treatment 3||0
2507725|NCT00772967|6147439|P5|NOT COMPLETED|Crossover Treatment 3||1
2507726|NCT00772967|6147440|P4|NOT COMPLETED|Crossover Treatment 3||0
2507727|NCT00772967|6147441|P3|NOT COMPLETED|Crossover Treatment 3||0
2507728|NCT00772967|6147442|P2|NOT COMPLETED|Crossover Treatment 3||0
2507729|NCT00772967|6147443|P1|NOT COMPLETED|Crossover Treatment 3||0
2507730|NCT00772967|6147438|P6|COMPLETED|Crossover Treatment 3||3
2507731|NCT00772967|6147439|P5|COMPLETED|Crossover Treatment 3||3
2507732|NCT00772967|6147440|P4|COMPLETED|Crossover Treatment 3||3
2507733|NCT00772967|6147441|P3|COMPLETED|Crossover Treatment 3||3
2507734|NCT00772967|6147442|P2|COMPLETED|Crossover Treatment 3||4
2507735|NCT00772967|6147443|P1|COMPLETED|Crossover Treatment 3||3
2507736|NCT00772967|6147438|P6|STARTED|Crossover Treatment 3||3
2507737|NCT00772967|6147439|P5|STARTED|Crossover Treatment 3||4
2507738|NCT00772967|6147440|P4|STARTED|Crossover Treatment 3||3
2507739|NCT00772967|6147441|P3|STARTED|Crossover Treatment 3||3
2507740|NCT00772967|6147442|P2|STARTED|Crossover Treatment 3||4
2507741|NCT00772967|6147443|P1|STARTED|Crossover Treatment 3||3
2507742|NCT00772967|6147438|P6|NOT COMPLETED|Break 2 (4-7 Days)||0
2507743|NCT00772967|6147439|P5|NOT COMPLETED|Break 2 (4-7 Days)||0
2507744|NCT00772967|6147440|P4|NOT COMPLETED|Break 2 (4-7 Days)||0
2507745|NCT00772967|6147441|P3|NOT COMPLETED|Break 2 (4-7 Days)||0
2507746|NCT00772967|6147442|P2|NOT COMPLETED|Break 2 (4-7 Days)||0
2507747|NCT00772967|6147443|P1|NOT COMPLETED|Break 2 (4-7 Days)||0
2507748|NCT00772967|6147438|P6|COMPLETED|Break 2 (4-7 Days)||3
2507749|NCT00772967|6147439|P5|COMPLETED|Break 2 (4-7 Days)||4
2507750|NCT00772967|6147440|P4|COMPLETED|Break 2 (4-7 Days)||3
2507751|NCT00772967|6147441|P3|COMPLETED|Break 2 (4-7 Days)||3
2507752|NCT00772967|6147442|P2|COMPLETED|Break 2 (4-7 Days)||4
2507753|NCT00772967|6147443|P1|COMPLETED|Break 2 (4-7 Days)||3
2507754|NCT00772967|6147438|P6|STARTED|Break 2 (4-7 Days)||3
2507755|NCT00772967|6147439|P5|STARTED|Break 2 (4-7 Days)||4
2507756|NCT00772967|6147440|P4|STARTED|Break 2 (4-7 Days)||3
2507757|NCT00772967|6147441|P3|STARTED|Break 2 (4-7 Days)||3
2507758|NCT00772967|6147442|P2|STARTED|Break 2 (4-7 Days)||4
2507759|NCT00772967|6147443|P1|STARTED|Break 2 (4-7 Days)||3
2507760|NCT00772967|6147438|P6|NOT COMPLETED|Crossover Treatment 2||0
2507761|NCT00772967|6147439|P5|NOT COMPLETED|Crossover Treatment 2||0
2507762|NCT00772967|6147440|P4|NOT COMPLETED|Crossover Treatment 2||0
2507763|NCT00772967|6147441|P3|NOT COMPLETED|Crossover Treatment 2||0
2507764|NCT00772967|6147442|P2|NOT COMPLETED|Crossover Treatment 2||0
2507765|NCT00772967|6147443|P1|NOT COMPLETED|Crossover Treatment 2||0
2507766|NCT00772967|6147438|P6|COMPLETED|Crossover Treatment 2||3
2507767|NCT00772967|6147439|P5|COMPLETED|Crossover Treatment 2||4
2507768|NCT00772967|6147440|P4|COMPLETED|Crossover Treatment 2||3
2507769|NCT00772967|6147441|P3|COMPLETED|Crossover Treatment 2||3
2507770|NCT00772967|6147442|P2|COMPLETED|Crossover Treatment 2||4
2507771|NCT00772967|6147443|P1|COMPLETED|Crossover Treatment 2||3
2507772|NCT00772967|6147438|P6|STARTED|Crossover Treatment 2||3
2507773|NCT00772967|6147439|P5|STARTED|Crossover Treatment 2||4
2507774|NCT00772967|6147440|P4|STARTED|Crossover Treatment 2||3
2507775|NCT00772967|6147441|P3|STARTED|Crossover Treatment 2||3
2507776|NCT00772967|6147442|P2|STARTED|Crossover Treatment 2||4
2507777|NCT00772967|6147443|P1|STARTED|Crossover Treatment 2||3
2507778|NCT00772967|6147438|P6|NOT COMPLETED|Break 1 (4-7 Days)||0
2507779|NCT00772967|6147439|P5|NOT COMPLETED|Break 1 (4-7 Days)||0
2507780|NCT00772967|6147440|P4|NOT COMPLETED|Break 1 (4-7 Days)||0
2507781|NCT00772967|6147441|P3|NOT COMPLETED|Break 1 (4-7 Days)||0
2507782|NCT00772967|6147442|P2|NOT COMPLETED|Break 1 (4-7 Days)||1
2507783|NCT00772967|6147443|P1|NOT COMPLETED|Break 1 (4-7 Days)||0
2507784|NCT00772967|6147438|P6|COMPLETED|Break 1 (4-7 Days)||3
2507785|NCT00772967|6147439|P5|COMPLETED|Break 1 (4-7 Days)||4
2507786|NCT00772967|6147440|P4|COMPLETED|Break 1 (4-7 Days)||3
2507787|NCT00772967|6147441|P3|COMPLETED|Break 1 (4-7 Days)||3
2507788|NCT00772967|6147442|P2|COMPLETED|Break 1 (4-7 Days)||4
2507789|NCT00772967|6147443|P1|COMPLETED|Break 1 (4-7 Days)||3
2507790|NCT00772967|6147438|P6|STARTED|Break 1 (4-7 Days)||3
2507791|NCT00772967|6147439|P5|STARTED|Break 1 (4-7 Days)||4
2507792|NCT00772967|6147440|P4|STARTED|Break 1 (4-7 Days)||3
2507793|NCT00772967|6147441|P3|STARTED|Break 1 (4-7 Days)||3
2507794|NCT00772967|6147442|P2|STARTED|Break 1 (4-7 Days)||5
2507795|NCT00772967|6147443|P1|STARTED|Break 1 (4-7 Days)||3
2507796|NCT00772967|6147438|P6|NOT COMPLETED|Crossover Treatment 1||0
2507797|NCT00772967|6147439|P5|NOT COMPLETED|Crossover Treatment 1||0
2507798|NCT00772967|6147440|P4|NOT COMPLETED|Crossover Treatment 1||1
2507799|NCT00772967|6147441|P3|NOT COMPLETED|Crossover Treatment 1||0
2507800|NCT00772967|6147442|P2|NOT COMPLETED|Crossover Treatment 1||0
2507801|NCT00772967|6147443|P1|NOT COMPLETED|Crossover Treatment 1||0
2507802|NCT00772967|6147438|P6|COMPLETED|Crossover Treatment 1||3
2507803|NCT00772967|6147439|P5|COMPLETED|Crossover Treatment 1||4
2507804|NCT00772967|6147440|P4|COMPLETED|Crossover Treatment 1|The withdrawal is not included in any outcomes; but is part of the Adverse Event group for placebo|3
2507805|NCT00772967|6147441|P3|COMPLETED|Crossover Treatment 1||3
2507806|NCT00772967|6147442|P2|COMPLETED|Crossover Treatment 1||5
2507807|NCT00772967|6147443|P1|COMPLETED|Crossover Treatment 1||3
2507808|NCT00772967|6147438|P6|STARTED|Crossover Treatment 1||3
2507809|NCT00772967|6147439|P5|STARTED|Crossover Treatment 1||4
2507810|NCT00772967|6147440|P4|STARTED|Crossover Treatment 1||4
2507811|NCT00772967|6147441|P3|STARTED|Crossover Treatment 1||3
2507812|NCT00772967|6147442|P2|STARTED|Crossover Treatment 1||5
2507813|NCT00772967|6147443|P1|STARTED|Crossover Treatment 1||3
2507814|NCT00772954|6147463|P3|NOT COMPLETED|Overall Study||1
2507815|NCT00772954|6147464|P2|NOT COMPLETED|Overall Study||0
2507816|NCT00772954|6147465|P1|NOT COMPLETED|Overall Study||0
2507817|NCT00772954|6147463|P3|COMPLETED|Overall Study||11
2507818|NCT00772954|6147464|P2|COMPLETED|Overall Study||12
2507819|NCT00772954|6147465|P1|COMPLETED|Overall Study||12
2507820|NCT00772954|6147463|P3|STARTED|Overall Study||12
2507821|NCT00772954|6147464|P2|STARTED|Overall Study||12
2507822|NCT00772954|6147465|P1|STARTED|Overall Study||12
2507823|NCT00772941|6147473|P1|NOT COMPLETED|Overall Study||682
2507824|NCT00772941|6147473|P1|COMPLETED|Overall Study||3257
2507825|NCT00772941|6147473|P1|STARTED|Overall Study||3939
2507826|NCT00772928|6147504|P2|NOT COMPLETED|Overall Study||41
2507827|NCT00772928|6147505|P1|NOT COMPLETED|Overall Study||44
2507828|NCT00772928|6147504|P2|COMPLETED|Overall Study||538
2507829|NCT00772928|6147505|P1|COMPLETED|Overall Study||543
2507830|NCT00772928|6147504|P2|STARTED|Overall Study||579
2507831|NCT00772928|6147505|P1|STARTED|Overall Study||587
2507832|NCT00772915|6147515|P1|NOT COMPLETED|Overall Study||15
2507833|NCT00772915|6147515|P1|COMPLETED|Overall Study||23
2507834|NCT00772915|6147515|P1|STARTED|Overall Study||38
2507835|NCT00772889|6147526|P3|NOT COMPLETED|Overall Study||16
2507836|NCT00772889|6147527|P2|NOT COMPLETED|Overall Study||18
2507837|NCT00772889|6147528|P1|NOT COMPLETED|Overall Study||22
2507838|NCT00772889|6147526|P3|COMPLETED|Overall Study||187
2507839|NCT00772889|6147527|P2|COMPLETED|Overall Study||375
2507840|NCT00772889|6147528|P1|COMPLETED|Overall Study||353
2507841|NCT00772889|6147526|P3|Completed at Day 21|Overall Study||203
2507842|NCT00772889|6147527|P2|Completed at Day 21|Overall Study||390
2507843|NCT00772889|6147528|P1|Completed at Day 21|Overall Study||374
2507844|NCT00772889|6147526|P3|STARTED|Overall Study||203
2507845|NCT00772889|6147527|P2|STARTED|Overall Study||393
2507846|NCT00772889|6147528|P1|STARTED|Overall Study||375
2507847|NCT00772772|6147581|P1|NOT COMPLETED|Overall Study||0
2507848|NCT00772772|6147581|P1|COMPLETED|Overall Study||12
2507849|NCT00772772|6147581|P1|STARTED|Overall Study||12
2507850|NCT00772707|6147586|P1|NOT COMPLETED|Overall Study||3
2507851|NCT00772707|6147586|P1|COMPLETED|Overall Study||111
2507852|NCT00772707|6147586|P1|STARTED|Overall Study||114
2507853|NCT00772668|6147591|P1|NOT COMPLETED|Overall Study||3
2507854|NCT00772668|6147591|P1|COMPLETED|Overall Study||0
2507855|NCT00772668|6147591|P1|STARTED|Overall Study||3
2507856|NCT00772629|6147600|P2|NOT COMPLETED|Overall Study||0
2507857|NCT00772629|6147601|P1|NOT COMPLETED|Overall Study||1
2507858|NCT00772629|6147600|P2|COMPLETED|Overall Study||1
2507859|NCT00772629|6147601|P1|COMPLETED|Overall Study||16
2507860|NCT00772629|6147600|P2|STARTED|Overall Study||1
2507861|NCT00772629|6147601|P1|STARTED|Overall Study||17
2507862|NCT00772603|6147610|P3|NOT COMPLETED|Overall Study||26
2507863|NCT00772603|6147611|P2|NOT COMPLETED|Overall Study||40
2507864|NCT00772603|6147612|P1|NOT COMPLETED|Overall Study||52
2507865|NCT00772603|6147610|P3|COMPLETED|Overall Study||95
2507866|NCT00772603|6147611|P2|COMPLETED|Overall Study||82
2507867|NCT00772603|6147612|P1|COMPLETED|Overall Study||71
2507868|NCT00772603|6147610|P3|STARTED|Overall Study||121
2507869|NCT00772603|6147611|P2|STARTED|Overall Study||122
2507870|NCT00772603|6147612|P1|STARTED|Overall Study||123
2507871|NCT00772590|6147636|P4|NOT COMPLETED|Overall Study||0
2507872|NCT00772590|6147637|P3|NOT COMPLETED|Overall Study||0
2507873|NCT00772590|6147638|P2|NOT COMPLETED|Overall Study||0
2507874|NCT00772590|6147639|P1|NOT COMPLETED|Overall Study||0
2507875|NCT00772590|6147636|P4|COMPLETED|Overall Study||17
2507876|NCT00772590|6147637|P3|COMPLETED|Overall Study||18
2507877|NCT00772590|6147638|P2|COMPLETED|Overall Study||19
2507878|NCT00772590|6147639|P1|COMPLETED|Overall Study||19
2507879|NCT00772590|6147636|P4|STARTED|Overall Study||17
2507880|NCT00772590|6147637|P3|STARTED|Overall Study||18
2507881|NCT00772590|6147638|P2|STARTED|Overall Study||19
2507882|NCT00772590|6147639|P1|STARTED|Overall Study||19
2507883|NCT00772577|6147651|P2|NOT COMPLETED|Overall Study||23
2507884|NCT00772577|6147652|P1|NOT COMPLETED|Overall Study||23
2507885|NCT00772577|6147651|P2|COMPLETED|Overall Study||170
2507886|NCT00772577|6147652|P1|COMPLETED|Overall Study||170
2507887|NCT00772577|6147651|P2|STARTED|Overall Study||193
2507888|NCT00772577|6147652|P1|STARTED|Overall Study||193
2507889|NCT00772538|6147668|P2|NOT COMPLETED|Overall Study||26
2507890|NCT00772538|6147669|P1|NOT COMPLETED|Overall Study||20
2507891|NCT00772538|6147668|P2|COMPLETED|Overall Study||211
2507892|NCT00772538|6147669|P1|COMPLETED|Overall Study||202
2507893|NCT00772538|6147668|P2|STARTED|Overall Study||237
2507894|NCT00772538|6147669|P1|STARTED|Overall Study||222
2507895|NCT00772447|6147741|P2|NOT COMPLETED|Overall Study||24
2507896|NCT00772447|6147742|P1|NOT COMPLETED|Overall Study||20
2507897|NCT00772447|6147741|P2|COMPLETED|Overall Study||110
2507898|NCT00772447|6147742|P1|COMPLETED|Overall Study||111
2507899|NCT00772447|6147741|P2|STARTED|Overall Study||134
2507900|NCT00772447|6147742|P1|STARTED|Overall Study||131
2507901|NCT00772382|6147770|P1|NOT COMPLETED|Overall Study||55
2507902|NCT00772382|6147770|P1|COMPLETED|Overall Study||61
2507903|NCT00772382|6147770|P1|STARTED|Overall Study||116
2507904|NCT00772369|6147775|P1|NOT COMPLETED|Overall Study||1
2507905|NCT00772369|6147775|P1|COMPLETED|Overall Study||3213
2507906|NCT00772369|6147775|P1|STARTED|Overall Study||3214
2507907|NCT00772304|6147780|P1|NOT COMPLETED|Overall Study||0
2507908|NCT00772304|6147780|P1|COMPLETED|Overall Study||102
2507909|NCT00772304|6147780|P1|STARTED|Overall Study||102
2507910|NCT00772148|6147786|P2|NOT COMPLETED|Maintenance Phase (Week 52)||5
2507911|NCT00772148|6147787|P1|NOT COMPLETED|Maintenance Phase (Week 52)||4
2507912|NCT00772148|6147786|P2|COMPLETED|Maintenance Phase (Week 52)||18
2507913|NCT00772148|6147787|P1|COMPLETED|Maintenance Phase (Week 52)||17
2507914|NCT00772148|6147786|P2|STARTED|Maintenance Phase (Week 52)||23
2507915|NCT00772148|6147787|P1|STARTED|Maintenance Phase (Week 52)||21
2507916|NCT00772148|6147786|P2|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||6
2507917|NCT00772148|6147787|P1|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||8
2507918|NCT00772148|6147786|P2|COMPLETED|Pharmacokinetic Phase (14 Days)||23
2507919|NCT00772148|6147787|P1|COMPLETED|Pharmacokinetic Phase (14 Days)||21
2507920|NCT00772148|6147786|P2|STARTED|Pharmacokinetic Phase (14 Days)||29
2507921|NCT00772148|6147787|P1|STARTED|Pharmacokinetic Phase (14 Days)||29
2507922|NCT00772109|6147807|P4|NOT COMPLETED|Overall Study||31
2507923|NCT00772109|6147808|P3|NOT COMPLETED|Overall Study||19
2507924|NCT00772109|6147809|P2|NOT COMPLETED|Overall Study||19
2507925|NCT00772109|6147810|P1|NOT COMPLETED|Overall Study||21
2507926|NCT00772109|6147807|P4|COMPLETED|Overall Study||1397
2507927|NCT00772109|6147808|P3|COMPLETED|Overall Study||936
2507928|NCT00772109|6147809|P2|COMPLETED|Overall Study||934
2507929|NCT00772109|6147810|P1|COMPLETED|Overall Study||935
2507930|NCT00772109|6147807|P4|STARTED|Overall Study||1428
2507931|NCT00772109|6147808|P3|STARTED|Overall Study||955
2507932|NCT00772109|6147809|P2|STARTED|Overall Study||953
2507933|NCT00772109|6147810|P1|STARTED|Overall Study||956
2507934|NCT00772070|6147834|P2|NOT COMPLETED|Overall Study||10
2507935|NCT00772070|6147835|P1|NOT COMPLETED|Overall Study||2
2507936|NCT00772070|6147834|P2|COMPLETED|Overall Study||61
2507937|NCT00772070|6147835|P1|COMPLETED|Overall Study|Two participants had vaccination errors, they were removed from analysis.|100
2507938|NCT00772070|6147834|P2|STARTED|Overall Study||71
2507939|NCT00772070|6147835|P1|STARTED|Overall Study||102
2507940|NCT00772031|6147847|P2|NOT COMPLETED|Overall Study||43
2507941|NCT00772031|6147848|P1|NOT COMPLETED|Overall Study||32
2507942|NCT00772031|6147847|P2|COMPLETED|Overall Study||52
2507943|NCT00772031|6147848|P1|COMPLETED|Overall Study||64
2507944|NCT00772031|6147847|P2|STARTED|Overall Study||95
2507945|NCT00772031|6147848|P1|STARTED|Overall Study||96
2507946|NCT00772005|6147874|P4|NOT COMPLETED|Overall Study||26
2507947|NCT00772005|6147875|P3|NOT COMPLETED|Overall Study||28
2507948|NCT00772005|6147876|P2|NOT COMPLETED|Overall Study||30
2507949|NCT00772005|6147877|P1|NOT COMPLETED|Overall Study||25
2507950|NCT00772005|6147874|P4|COMPLETED|Overall Study||46
2507951|NCT00772005|6147875|P3|COMPLETED|Overall Study||44
2507952|NCT00772005|6147876|P2|COMPLETED|Overall Study||40
2507953|NCT00772005|6147877|P1|COMPLETED|Overall Study||46
2507954|NCT00772005|6147874|P4|STARTED|Overall Study|Two patients withdrew before taking any study drug.|72
2507955|NCT00772005|6147875|P3|STARTED|Overall Study|One patient withdrew before taking any study drug.|72
2507956|NCT00772005|6147876|P2|STARTED|Overall Study|One patient withdrew before taking any study drug.|70
2507957|NCT00772005|6147877|P1|STARTED|Overall Study||71
2507958|NCT00771953|6148565|P2|NOT COMPLETED|Overall Study||10
2507959|NCT00771953|6148566|P1|NOT COMPLETED|Overall Study||10
2507960|NCT00771953|6148565|P2|COMPLETED|Overall Study||26
2507961|NCT00771953|6148566|P1|COMPLETED|Overall Study||26
2507962|NCT00771953|6148565|P2|STARTED|Overall Study||36
2507963|NCT00771953|6148566|P1|STARTED|Overall Study||36
2507964|NCT00771927|6148576|P2|NOT COMPLETED|Overall Study||237
2507965|NCT00771927|6148577|P1|NOT COMPLETED|Overall Study||255
2507966|NCT00771927|6148576|P2|COMPLETED|Overall Study||256
2507967|NCT00771927|6148577|P1|COMPLETED|Overall Study||256
2507968|NCT00771927|6148576|P2|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|493
2507969|NCT00771927|6148577|P1|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|511
2507970|NCT00771914|6148589|P4|NOT COMPLETED|Overall Study||2
2507971|NCT00771914|6148590|P3|NOT COMPLETED|Overall Study||0
2507972|NCT00771914|6148591|P2|NOT COMPLETED|Overall Study||0
2507973|NCT00771914|6148592|P1|NOT COMPLETED|Overall Study||0
2507974|NCT00771914|6148589|P4|COMPLETED|Overall Study||6
2507975|NCT00771914|6148590|P3|COMPLETED|Overall Study||6
2507976|NCT00771914|6148591|P2|COMPLETED|Overall Study||6
2507977|NCT00771914|6148592|P1|COMPLETED|Overall Study||7
2507978|NCT00771914|6148589|P4|STARTED|Overall Study||8
2507979|NCT00771914|6148590|P3|STARTED|Overall Study||6
2507980|NCT00771914|6148591|P2|STARTED|Overall Study||6
2507981|NCT00771914|6148592|P1|STARTED|Overall Study||7
2507982|NCT00771901|6148605|P3|NOT COMPLETED|Overall Study||4
2507983|NCT00771901|6148606|P2|NOT COMPLETED|Overall Study||0
2507984|NCT00771901|6148607|P1|NOT COMPLETED|Overall Study||0
2507985|NCT00771901|6148605|P3|COMPLETED|Overall Study||6
2507986|NCT00771901|6148606|P2|COMPLETED|Overall Study||10
2507987|NCT00771901|6148607|P1|COMPLETED|Overall Study||10
2507988|NCT00771901|6148605|P3|STARTED|Overall Study||10
2507989|NCT00771901|6148606|P2|STARTED|Overall Study||10
2507990|NCT00771901|6148607|P1|STARTED|Overall Study||10
2507991|NCT00771875|6148624|P3|NOT COMPLETED|Overall Study||0
2507992|NCT00771875|6148625|P2|NOT COMPLETED|Overall Study||1
2507993|NCT00771875|6148626|P1|NOT COMPLETED|Overall Study||0
2507994|NCT00771875|6148624|P3|COMPLETED|Overall Study||10
2507995|NCT00771875|6148625|P2|COMPLETED|Overall Study||9
2507996|NCT00771875|6148626|P1|COMPLETED|Overall Study||10
2507997|NCT00771875|6148624|P3|STARTED|Overall Study||10
2507998|NCT00771875|6148625|P2|STARTED|Overall Study||10
2507999|NCT00771875|6148626|P1|STARTED|Overall Study||10
2508000|NCT00771849|6148654|P2|NOT COMPLETED|Overall Study||4
2508001|NCT00771849|6148655|P1|NOT COMPLETED|Overall Study||2
2508002|NCT00771849|6148654|P2|COMPLETED|Overall Study||47
2508003|NCT00771849|6148655|P1|COMPLETED|Overall Study||50
2508004|NCT00771849|6148654|P2|STARTED|Overall Study|One subject was not vaccinated|51
2508005|NCT00771849|6148655|P1|STARTED|Overall Study||52
2508006|NCT00771810|6148666|P3|NOT COMPLETED|Overall Study||7
2508007|NCT00771810|6148667|P2|NOT COMPLETED|Overall Study||5
2508008|NCT00771810|6148668|P1|NOT COMPLETED|Overall Study||5
2508009|NCT00771810|6148666|P3|COMPLETED|Overall Study||6
2508010|NCT00771810|6148667|P2|COMPLETED|Overall Study||6
2508011|NCT00771810|6148668|P1|COMPLETED|Overall Study||5
2508012|NCT00771810|6148666|P3|STARTED|Overall Study||13
2508013|NCT00771810|6148667|P2|STARTED|Overall Study||11
2508014|NCT00771810|6148668|P1|STARTED|Overall Study||10
2508015|NCT00771758|6148706|P3|NOT COMPLETED|Overall Study||2
2508016|NCT00771758|6148707|P2|NOT COMPLETED|Overall Study||12
2508017|NCT00771758|6148708|P1|NOT COMPLETED|Overall Study||8
2508018|NCT00771758|6148706|P3|COMPLETED|Overall Study||19
2508019|NCT00771758|6148707|P2|COMPLETED|Overall Study||31
2508020|NCT00771758|6148708|P1|COMPLETED|Overall Study||36
2508021|NCT00771758|6148706|P3|STARTED|Overall Study||21
2508022|NCT00771758|6148707|P2|STARTED|Overall Study||43
2508023|NCT00771758|6148708|P1|STARTED|Overall Study||44
2508024|NCT00771745|6148858|P2|NOT COMPLETED|Overall Study||0
2508025|NCT00771745|6148859|P1|NOT COMPLETED|Overall Study||0
2508026|NCT00771745|6148858|P2|COMPLETED|Overall Study||5
2508027|NCT00771745|6148859|P1|COMPLETED|Overall Study||6
2508028|NCT00771745|6148858|P2|STARTED|Overall Study||5
2508029|NCT00771745|6148859|P1|STARTED|Overall Study||6
2508030|NCT00771667|6148869|P10|NOT COMPLETED|Maintenance Phase||17
2508031|NCT00771667|6148870|P9|NOT COMPLETED|Maintenance Phase||22
2508032|NCT00771667|6148871|P8|NOT COMPLETED|Maintenance Phase||5
2508033|NCT00771667|6148872|P7|NOT COMPLETED|Maintenance Phase||10
2508034|NCT00771667|6148873|P6|NOT COMPLETED|Maintenance Phase||7
2508035|NCT00771667|6148874|P5|NOT COMPLETED|Maintenance Phase||2
2508036|NCT00771667|6148875|P4|NOT COMPLETED|Maintenance Phase||0
2508037|NCT00771667|6148876|P3|NOT COMPLETED|Maintenance Phase||0
2508038|NCT00771667|6148877|P2|NOT COMPLETED|Maintenance Phase||0
2508039|NCT00771667|6148878|P1|NOT COMPLETED|Maintenance Phase||0
2508040|NCT00771667|6148869|P10|COMPLETED|Maintenance Phase||92
2508041|NCT00771667|6148870|P9|COMPLETED|Maintenance Phase||88
2508042|NCT00771667|6148871|P8|COMPLETED|Maintenance Phase||67
2508043|NCT00771667|6148872|P7|COMPLETED|Maintenance Phase||63
2508044|NCT00771667|6148873|P6|COMPLETED|Maintenance Phase||78
2508045|NCT00771667|6148874|P5|COMPLETED|Maintenance Phase||26
2508046|NCT00771667|6148875|P4|COMPLETED|Maintenance Phase||0
2508047|NCT00771667|6148876|P3|COMPLETED|Maintenance Phase||0
2508048|NCT00771667|6148877|P2|COMPLETED|Maintenance Phase||0
2508049|NCT00771667|6148878|P1|COMPLETED|Maintenance Phase||0
2508050|NCT00771667|6148869|P10|STARTED|Maintenance Phase||109
2508051|NCT00771667|6148870|P9|STARTED|Maintenance Phase||110
2508052|NCT00771667|6148871|P8|STARTED|Maintenance Phase||72
2508053|NCT00771667|6148872|P7|STARTED|Maintenance Phase||73
2508054|NCT00771667|6148873|P6|STARTED|Maintenance Phase||85
2508055|NCT00771667|6148874|P5|STARTED|Maintenance Phase||28
2508056|NCT00771667|6148875|P4|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
2508057|NCT00771667|6148876|P3|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
2508058|NCT00771667|6148877|P2|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
2508059|NCT00771667|6148878|P1|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
2508060|NCT00771667|6148869|P10|NOT COMPLETED|Induction Phase||0
2508061|NCT00771667|6148870|P9|NOT COMPLETED|Induction Phase||0
2508062|NCT00771667|6148871|P8|NOT COMPLETED|Induction Phase||0
2508063|NCT00771667|6148872|P7|NOT COMPLETED|Induction Phase||0
2508064|NCT00771667|6148873|P6|NOT COMPLETED|Induction Phase||0
2508065|NCT00771667|6148874|P5|NOT COMPLETED|Induction Phase||0
2508066|NCT00771667|6148875|P4|NOT COMPLETED|Induction Phase||8
2508067|NCT00771667|6148876|P3|NOT COMPLETED|Induction Phase||12
2508068|NCT00771667|6148877|P2|NOT COMPLETED|Induction Phase||10
2508069|NCT00771667|6148878|P1|NOT COMPLETED|Induction Phase||19
2508070|NCT00771667|6148869|P10|COMPLETED|Induction Phase||0
2508071|NCT00771667|6148870|P9|COMPLETED|Induction Phase||0
2508072|NCT00771667|6148871|P8|COMPLETED|Induction Phase||0
2508073|NCT00771667|6148872|P7|COMPLETED|Induction Phase||0
2508074|NCT00771667|6148873|P6|COMPLETED|Induction Phase||0
2508075|NCT00771667|6148874|P5|COMPLETED|Induction Phase||0
2508076|NCT00771667|6148875|P4|COMPLETED|Induction Phase||123
2508077|NCT00771667|6148876|P3|COMPLETED|Induction Phase||120
2508078|NCT00771667|6148877|P2|COMPLETED|Induction Phase||121
2508079|NCT00771667|6148878|P1|COMPLETED|Induction Phase||113
2508080|NCT00771667|6148869|P10|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
2508081|NCT00771667|6148870|P9|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
2508082|NCT00771667|6148871|P8|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
2508083|NCT00771667|6148872|P7|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
2508084|NCT00771667|6148873|P6|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
2508085|NCT00771667|6148874|P5|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
2508086|NCT00771667|6148875|P4|STARTED|Induction Phase||131
2508087|NCT00771667|6148876|P3|STARTED|Induction Phase||132
2508088|NCT00771667|6148877|P2|STARTED|Induction Phase||131
2508089|NCT00771667|6148878|P1|STARTED|Induction Phase||132
2508090|NCT00771615|6148923|P9|NOT COMPLETED|Overall Study||0
2508091|NCT00771615|6148924|P8|NOT COMPLETED|Overall Study||1
2508092|NCT00771615|6148925|P7|NOT COMPLETED|Overall Study||1
2508093|NCT00771615|6148926|P6|NOT COMPLETED|Overall Study||1
2508094|NCT00771615|6148927|P5|NOT COMPLETED|Overall Study||0
2508095|NCT00771615|6148928|P4|NOT COMPLETED|Overall Study||1
2508096|NCT00771615|6148929|P3|NOT COMPLETED|Overall Study||1
2508097|NCT00771615|6148930|P2|NOT COMPLETED|Overall Study||2
2508098|NCT00771615|6148931|P1|NOT COMPLETED|Overall Study||1
2508099|NCT00771615|6148923|P9|COMPLETED|Overall Study|Up to Day 364|41
2508100|NCT00771615|6148924|P8|COMPLETED|Overall Study|Up to Day 364|58
2508101|NCT00771615|6148925|P7|COMPLETED|Overall Study|Up to Day 364|45
2508102|NCT00771615|6148926|P6|COMPLETED|Overall Study|Up to Day 364|60
2508103|NCT00771615|6148927|P5|COMPLETED|Overall Study|Up to Day 364|40
2508104|NCT00771615|6148928|P4|COMPLETED|Overall Study|Up to Day 364|59
2508105|NCT00771615|6148929|P3|COMPLETED|Overall Study|Up to Day 364|40
2508106|NCT00771615|6148930|P2|COMPLETED|Overall Study|Up to Day 364|70
2508107|NCT00771615|6148931|P1|COMPLETED|Overall Study|Up to Day 364|48
2508108|NCT00771615|6148923|P9|STARTED|Overall Study||41
2508109|NCT00771615|6148924|P8|STARTED|Overall Study||59
2508110|NCT00771615|6148925|P7|STARTED|Overall Study||46
2508111|NCT00771615|6148926|P6|STARTED|Overall Study||61
2508112|NCT00771615|6148927|P5|STARTED|Overall Study||40
2508113|NCT00771615|6148928|P4|STARTED|Overall Study||60
2508114|NCT00771615|6148929|P3|STARTED|Overall Study||41
2508115|NCT00771615|6148930|P2|STARTED|Overall Study||72
2508116|NCT00771615|6148931|P1|STARTED|Overall Study||49
2508117|NCT00771602|6149125|P3|NOT COMPLETED|Overall Study||0
2508118|NCT00771602|6149126|P2|NOT COMPLETED|Overall Study||0
2508119|NCT00771602|6149127|P1|NOT COMPLETED|Overall Study||0
2508120|NCT00771602|6149125|P3|COMPLETED|Overall Study||0
2508121|NCT00771602|6149126|P2|COMPLETED|Overall Study||0
2508122|NCT00771602|6149127|P1|COMPLETED|Overall Study||1
2508123|NCT00771602|6149125|P3|STARTED|Overall Study||0
2508124|NCT00771602|6149126|P2|STARTED|Overall Study||0
2508125|NCT00771602|6149127|P1|STARTED|Overall Study||1
2508126|NCT00771537|6149151|P16|NOT COMPLETED|Overall Study||0
2508127|NCT00771537|6149152|P15|NOT COMPLETED|Overall Study||0
2508128|NCT00771537|6149153|P14|NOT COMPLETED|Overall Study||0
2508129|NCT00771537|6149154|P13|NOT COMPLETED|Overall Study||0
2508130|NCT00771537|6149155|P12|NOT COMPLETED|Overall Study||0
2508131|NCT00771537|6149156|P11|NOT COMPLETED|Overall Study||0
2508132|NCT00771537|6149157|P10|NOT COMPLETED|Overall Study||0
2508133|NCT00771537|6149158|P9|NOT COMPLETED|Overall Study||0
2508134|NCT00771537|6149159|P8|NOT COMPLETED|Overall Study||0
2508135|NCT00771537|6149160|P7|NOT COMPLETED|Overall Study||0
2508136|NCT00771537|6149161|P6|NOT COMPLETED|Overall Study||0
2508137|NCT00771537|6149162|P5|NOT COMPLETED|Overall Study||0
2508138|NCT00771537|6149163|P4|NOT COMPLETED|Overall Study||0
2508139|NCT00771537|6149164|P3|NOT COMPLETED|Overall Study||0
2508140|NCT00771537|6149165|P2|NOT COMPLETED|Overall Study||0
2508141|NCT00771537|6149166|P1|NOT COMPLETED|Overall Study||0
2508142|NCT00771537|6149151|P16|COMPLETED|Overall Study||122
2508143|NCT00771537|6149152|P15|COMPLETED|Overall Study||124
2508144|NCT00771537|6149153|P14|COMPLETED|Overall Study||124
2508145|NCT00771537|6149154|P13|COMPLETED|Overall Study||128
2508146|NCT00771537|6149155|P12|COMPLETED|Overall Study||137
2508147|NCT00771537|6149156|P11|COMPLETED|Overall Study||133
2508148|NCT00771537|6149157|P10|COMPLETED|Overall Study||119
2508149|NCT00771537|6149158|P9|COMPLETED|Overall Study||115
2508150|NCT00771537|6149159|P8|COMPLETED|Overall Study||132
2508151|NCT00771537|6149160|P7|COMPLETED|Overall Study||128
2508152|NCT00771537|6149161|P6|COMPLETED|Overall Study||118
2508153|NCT00771537|6149162|P5|COMPLETED|Overall Study||127
2508154|NCT00771537|6149163|P4|COMPLETED|Overall Study||114
2508155|NCT00771537|6149164|P3|COMPLETED|Overall Study||151
2508156|NCT00771537|6149165|P2|COMPLETED|Overall Study||124
2508157|NCT00771537|6149166|P1|COMPLETED|Overall Study||135
2508158|NCT00771537|6149151|P16|STARTED|Overall Study||122
2508159|NCT00771537|6149152|P15|STARTED|Overall Study||124
2508160|NCT00771537|6149153|P14|STARTED|Overall Study||124
2508161|NCT00771537|6149154|P13|STARTED|Overall Study||128
2508162|NCT00771537|6149155|P12|STARTED|Overall Study||137
2508163|NCT00771537|6149156|P11|STARTED|Overall Study||133
2508164|NCT00771537|6149157|P10|STARTED|Overall Study||119
2508165|NCT00771537|6149158|P9|STARTED|Overall Study||115
2508166|NCT00771537|6149159|P8|STARTED|Overall Study||132
2508167|NCT00771537|6149160|P7|STARTED|Overall Study||128
2508168|NCT00771537|6149161|P6|STARTED|Overall Study||118
2508169|NCT00771537|6149162|P5|STARTED|Overall Study||127
2508170|NCT00771537|6149163|P4|STARTED|Overall Study||114
2508171|NCT00771537|6149164|P3|STARTED|Overall Study||151
2508172|NCT00771537|6149165|P2|STARTED|Overall Study||124
2508173|NCT00771537|6149166|P1|STARTED|Overall Study||135
2508174|NCT00771472|6149192|P2|NOT COMPLETED|Overall Study||4
2508175|NCT00771472|6149193|P1|NOT COMPLETED|Overall Study||6
2508176|NCT00771472|6149192|P2|COMPLETED|Overall Study||0
2508177|NCT00771472|6149193|P1|COMPLETED|Overall Study||0
2508178|NCT00771472|6149192|P2|STARTED|Overall Study||4
2508179|NCT00771472|6149193|P1|STARTED|Overall Study||6
2508180|NCT00771407|6149204|P2|NOT COMPLETED|Overall Study||25
2508181|NCT00771407|6149205|P1|NOT COMPLETED|Overall Study||20
2508182|NCT00771407|6149204|P2|COMPLETED|Overall Study||35
2508183|NCT00771407|6149205|P1|COMPLETED|Overall Study||40
2508184|NCT00771407|6149204|P2|STARTED|Overall Study||60
2508185|NCT00771407|6149205|P1|STARTED|Overall Study||60
2508186|NCT00771316|6149213|P2|NOT COMPLETED|Overall Study||1
2508187|NCT00771316|6149214|P1|NOT COMPLETED|Overall Study||2
2508188|NCT00771316|6149213|P2|COMPLETED|Overall Study||1
2508189|NCT00771316|6149214|P1|COMPLETED|Overall Study||2
2508190|NCT00771316|6149213|P2|STARTED|Overall Study||2
2508191|NCT00771316|6149214|P1|STARTED|Overall Study||4
2508192|NCT00771277|6149224|P1|NOT COMPLETED|Overall Study||0
2508193|NCT00771277|6149224|P1|COMPLETED|Overall Study||6
2508194|NCT00771277|6149224|P1|STARTED|Overall Study||6
2508195|NCT00771264|6149232|P2|NOT COMPLETED|Overall Study||5
2508196|NCT00771264|6149233|P1|NOT COMPLETED|Overall Study||7
2508197|NCT00771264|6149232|P2|COMPLETED|Overall Study||105
2508198|NCT00771264|6149233|P1|COMPLETED|Overall Study||103
2508199|NCT00771264|6149232|P2|STARTED|Overall Study||110
2508200|NCT00771264|6149233|P1|STARTED|Overall Study||110
2508201|NCT00771238|6149241|P2|NOT COMPLETED|Overall Study||0
2508202|NCT00771238|6149242|P1|NOT COMPLETED|Overall Study||0
2508203|NCT00771238|6149241|P2|COMPLETED|Overall Study||21
2508204|NCT00771238|6149242|P1|COMPLETED|Overall Study||31
2508205|NCT00771238|6149241|P2|STARTED|Overall Study||21
2508206|NCT00771238|6149242|P1|STARTED|Overall Study||31
2508207|NCT00771173|6149252|P2|NOT COMPLETED|Overall Study||17
2508208|NCT00771173|6149253|P1|NOT COMPLETED|Overall Study||22
2508209|NCT00771173|6149252|P2|COMPLETED|Overall Study||112
2508210|NCT00771173|6149253|P1|COMPLETED|Overall Study||107
2508211|NCT00771173|6149252|P2|STARTED|Overall Study||129
2508212|NCT00771173|6149253|P1|STARTED|Overall Study||129
2508213|NCT00771056|6149259|P1|NOT COMPLETED|Overall Study||5
2508214|NCT00771056|6149259|P1|COMPLETED|Overall Study||18
2508215|NCT00771056|6149259|P1|STARTED|Overall Study||23
2508216|NCT00770991|6149266|P2|NOT COMPLETED|Overall Study||5
2508217|NCT00770991|6149267|P1|NOT COMPLETED|Overall Study||5
2508218|NCT00770991|6149266|P2|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
2508219|NCT00770991|6149267|P1|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
2508220|NCT00770991|6149266|P2|STARTED|Overall Study|We anticipated 26-30 subjects with FAP 18 year or olders would need to be enrolled to randomize 18|12
2508221|NCT00770991|6149267|P1|STARTED|Overall Study|34 participants enrolled (signed informed consent). 24 subjects were eligible to be randomized.|12
2508222|NCT00770965|6149283|P4|NOT COMPLETED|Excluded Set||13
2508223|NCT00770965|6149284|P3|NOT COMPLETED|Excluded Set||14
2508224|NCT00770965|6149285|P2|NOT COMPLETED|Excluded Set||13
2508225|NCT00770965|6149286|P1|NOT COMPLETED|Excluded Set||15
2508226|NCT00770965|6149283|P4|COMPLETED|Excluded Set||2
2508227|NCT00770965|6149284|P3|COMPLETED|Excluded Set||2
2508228|NCT00770965|6149285|P2|COMPLETED|Excluded Set||3
2508229|NCT00770965|6149286|P1|COMPLETED|Excluded Set||3
2508230|NCT00770965|6149283|P4|STARTED|Excluded Set||15
2508231|NCT00770965|6149284|P3|STARTED|Excluded Set||16
2508232|NCT00770965|6149285|P2|STARTED|Excluded Set||16
2508233|NCT00770965|6149286|P1|STARTED|Excluded Set||18
2508234|NCT00770965|6149283|P4|NOT COMPLETED|Safety Set||1
2508235|NCT00770965|6149284|P3|NOT COMPLETED|Safety Set||1
2508236|NCT00770965|6149285|P2|NOT COMPLETED|Safety Set||0
2508237|NCT00770965|6149286|P1|NOT COMPLETED|Safety Set||0
2508238|NCT00770965|6149283|P4|COMPLETED|Safety Set||4
2508239|NCT00770965|6149284|P3|COMPLETED|Safety Set||3
2508240|NCT00770965|6149285|P2|COMPLETED|Safety Set||4
2508241|NCT00770965|6149286|P1|COMPLETED|Safety Set||2
2508242|NCT00770965|6149283|P4|STARTED|Safety Set||5
2508243|NCT00770965|6149284|P3|STARTED|Safety Set||4
2508244|NCT00770965|6149285|P2|STARTED|Safety Set||4
2508245|NCT00770965|6149286|P1|STARTED|Safety Set||2
2508246|NCT00770913|6149307|P3|NOT COMPLETED|Overall Study||13
2508247|NCT00770913|6149308|P2|NOT COMPLETED|Overall Study||8
2508248|NCT00770913|6149309|P1|NOT COMPLETED|Overall Study||11
2508249|NCT00770913|6149307|P3|COMPLETED|Overall Study||100
2508250|NCT00770913|6149308|P2|COMPLETED|Overall Study||103
2508251|NCT00770913|6149309|P1|COMPLETED|Overall Study||102
2508252|NCT00770913|6149307|P3|STARTED|Overall Study||113
2508253|NCT00770913|6149308|P2|STARTED|Overall Study||111
2508254|NCT00770913|6149309|P1|STARTED|Overall Study||113
2508255|NCT00770874|6149319|P2|NOT COMPLETED|Overall Study||0
2508256|NCT00770874|6149320|P1|NOT COMPLETED|Overall Study||0
2508257|NCT00770874|6149319|P2|COMPLETED|Overall Study||176
2508258|NCT00770874|6149320|P1|COMPLETED|Overall Study||188
2508259|NCT00770874|6149319|P2|STARTED|Overall Study||176
2508260|NCT00770874|6149320|P1|STARTED|Overall Study||188
2508261|NCT00770861|6149330|P2|NOT COMPLETED|Overall Study||16
2508262|NCT00770861|6149331|P1|NOT COMPLETED|Overall Study||10
2508263|NCT00770861|6149330|P2|COMPLETED|Overall Study||120
2508264|NCT00770861|6149331|P1|COMPLETED|Overall Study||131
2508265|NCT00770861|6149330|P2|STARTED|Overall Study||136
2508266|NCT00770861|6149331|P1|STARTED|Overall Study||141
2508267|NCT00770809|6149342|P3|NOT COMPLETED|Overall Study||23
2508268|NCT00770809|6149343|P2|NOT COMPLETED|Overall Study||10
2508269|NCT00770809|6149344|P1|NOT COMPLETED|Overall Study||17
2508270|NCT00770809|6149342|P3|COMPLETED|Overall Study||44
2508271|NCT00770809|6149343|P2|COMPLETED|Overall Study||110
2508272|NCT00770809|6149344|P1|COMPLETED|Overall Study||101
2508273|NCT00770809|6149342|P3|STARTED|Overall Study||67
2508274|NCT00770809|6149343|P2|STARTED|Overall Study||120
2508275|NCT00770809|6149344|P1|STARTED|Overall Study||118
2508276|NCT00770770|6149354|P2|NOT COMPLETED|Overall Study||1
2508277|NCT00770770|6149355|P1|NOT COMPLETED|Overall Study||10
2508278|NCT00770770|6149354|P2|COMPLETED|Overall Study||5
2508279|NCT00770770|6149355|P1|COMPLETED|Overall Study||4
2508280|NCT00770770|6149354|P2|STARTED|Overall Study||6
2508281|NCT00770770|6149355|P1|STARTED|Overall Study||14
2508282|NCT00770757|6149361|P1|NOT COMPLETED|Overall Study||0
2508283|NCT00770757|6149361|P1|COMPLETED|Overall Study||13
2508284|NCT00770757|6149361|P1|STARTED|Overall Study||13
2508285|NCT00770692|6149373|P4|NOT COMPLETED|Overall Study||11
2508286|NCT00770692|6149374|P3|NOT COMPLETED|Overall Study||14
2508287|NCT00770692|6149375|P2|NOT COMPLETED|Overall Study||9
2508288|NCT00770692|6149376|P1|NOT COMPLETED|Overall Study||12
2508289|NCT00770692|6149373|P4|COMPLETED|Overall Study||66
2508290|NCT00770692|6149374|P3|COMPLETED|Overall Study||70
2508291|NCT00770692|6149375|P2|COMPLETED|Overall Study||74
2508292|NCT00770692|6149376|P1|COMPLETED|Overall Study||69
2508293|NCT00770692|6149373|P4|STARTED|Overall Study||77
2508294|NCT00770692|6149374|P3|STARTED|Overall Study||84
2508295|NCT00770692|6149375|P2|STARTED|Overall Study||83
2508296|NCT00770692|6149376|P1|STARTED|Overall Study|"1 participant whose compliance was unknown, was regarded as a treatment compliance unknown"|81
2508297|NCT00770679|6149402|P1|NOT COMPLETED|Overall Study||6
2508298|NCT00770679|6149402|P1|COMPLETED|Overall Study||10
2508299|NCT00770679|6149402|P1|STARTED|Overall Study||16
2508300|NCT00770653|6149410|P2|NOT COMPLETED|Overall Study||29
2508301|NCT00770653|6149411|P1|NOT COMPLETED|Overall Study||32
2508302|NCT00770653|6149410|P2|COMPLETED|Overall Study||121
2508303|NCT00770653|6149411|P1|COMPLETED|Overall Study||123
2508304|NCT00770653|6149410|P2|STARTED|Overall Study||150
2508305|NCT00770653|6149411|P1|STARTED|Overall Study||155
2508306|NCT00770588|6149481|P2|NOT COMPLETED|Overall Study||95
2508307|NCT00770588|6149482|P1|NOT COMPLETED|Overall Study||81
2508308|NCT00770588|6149481|P2|COMPLETED|Overall Study||53
2508309|NCT00770588|6149482|P1|COMPLETED|Overall Study||67
2508310|NCT00770588|6149481|P2|STARTED|Overall Study||148
2508311|NCT00770588|6149482|P1|STARTED|Overall Study||148
2508312|NCT00770562|6149498|P2|NOT COMPLETED|Overall Study||1
2508313|NCT00770562|6149499|P1|NOT COMPLETED|Overall Study||1
2508314|NCT00770562|6149498|P2|COMPLETED|Overall Study||49
2508315|NCT00770562|6149499|P1|COMPLETED|Overall Study||52
2508316|NCT00770562|6149498|P2|STARTED|Overall Study||50
2508317|NCT00770562|6149499|P1|STARTED|Overall Study||53
2508318|NCT00770510|6149510|P1|NOT COMPLETED|Overall Study||5
2508319|NCT00770510|6149510|P1|COMPLETED|Overall Study||67
2508320|NCT00770510|6149510|P1|STARTED|Overall Study||72
2508321|NCT00770484|6149549|P2|NOT COMPLETED|Overall Study||0
2508322|NCT00770484|6149550|P1|NOT COMPLETED|Overall Study||1
2508323|NCT00770484|6149549|P2|COMPLETED|Overall Study||4
2508324|NCT00770484|6149550|P1|COMPLETED|Overall Study||7
2508325|NCT00770484|6149549|P2|STARTED|Overall Study||4
2508326|NCT00770484|6149550|P1|STARTED|Overall Study||8
2508327|NCT00770432|6149558|P2|NOT COMPLETED|Overall Study||7
2508328|NCT00770432|6149559|P1|NOT COMPLETED|Overall Study||4
2508329|NCT00770432|6149558|P2|COMPLETED|Overall Study||94
2508330|NCT00770432|6149559|P1|COMPLETED|Overall Study||98
2508331|NCT00770432|6149558|P2|STARTED|Overall Study||101
2508332|NCT00770432|6149559|P1|STARTED|Overall Study||102
2508333|NCT00770367|6149567|P2|NOT COMPLETED|Second Intervention||0
2508334|NCT00770367|6149568|P1|NOT COMPLETED|Second Intervention||2
2508335|NCT00770367|6149567|P2|COMPLETED|Second Intervention||15
2508336|NCT00770367|6149568|P1|COMPLETED|Second Intervention||16
2508337|NCT00770367|6149567|P2|STARTED|Second Intervention||15
2508338|NCT00770367|6149568|P1|STARTED|Second Intervention||18
2508339|NCT00770367|6149567|P2|NOT COMPLETED|Washout Period of 4 Weeks||1
2508340|NCT00770367|6149568|P1|NOT COMPLETED|Washout Period of 4 Weeks||0
2508341|NCT00770367|6149567|P2|COMPLETED|Washout Period of 4 Weeks||15
2508342|NCT00770367|6149568|P1|COMPLETED|Washout Period of 4 Weeks||18
2508343|NCT00770367|6149567|P2|STARTED|Washout Period of 4 Weeks||16
2508344|NCT00770367|6149568|P1|STARTED|Washout Period of 4 Weeks||18
2508345|NCT00770367|6149567|P2|NOT COMPLETED|First Intervention||2
2508346|NCT00770367|6149568|P1|NOT COMPLETED|First Intervention||0
2508347|NCT00770367|6149567|P2|COMPLETED|First Intervention||16
2508348|NCT00770367|6149568|P1|COMPLETED|First Intervention||18
2508349|NCT00770367|6149567|P2|STARTED|First Intervention||18
2508350|NCT00770367|6149568|P1|STARTED|First Intervention||18
2508351|NCT00770341|6149579|P3|NOT COMPLETED|Overall Study||3
2508352|NCT00770341|6149580|P2|NOT COMPLETED|Overall Study||5
2508353|NCT00770341|6149581|P1|NOT COMPLETED|Overall Study||12
2508354|NCT00770341|6149579|P3|COMPLETED|Overall Study||8
2508355|NCT00770341|6149580|P2|COMPLETED|Overall Study||17
2508356|NCT00770341|6149581|P1|COMPLETED|Overall Study||77
2508357|NCT00770341|6149579|P3|STARTED|Overall Study|Number randomized|11
2508358|NCT00770341|6149580|P2|STARTED|Overall Study|Number randomized|22
2508359|NCT00770341|6149581|P1|STARTED|Overall Study|Number randomized|89
2508360|NCT00770328|6149607|P2|NOT COMPLETED|Overall Study||4
2508361|NCT00770328|6149608|P1|NOT COMPLETED|Overall Study||13
2508362|NCT00770328|6149607|P2|COMPLETED|Overall Study||11
2508363|NCT00770328|6149608|P1|COMPLETED|Overall Study||9
2508364|NCT00770328|6149607|P2|STARTED|Overall Study||15
2508365|NCT00770328|6149608|P1|STARTED|Overall Study||22
2508366|NCT00770315|6149624|P4|NOT COMPLETED|Overall Study||38
2508367|NCT00770315|6149625|P3|NOT COMPLETED|Overall Study||57
2508368|NCT00770315|6149626|P2|NOT COMPLETED|Overall Study||43
2508369|NCT00770315|6149627|P1|NOT COMPLETED|Overall Study||40
2508370|NCT00770315|6149624|P4|COMPLETED|Overall Study||160
2508371|NCT00770315|6149625|P3|COMPLETED|Overall Study||137
2508372|NCT00770315|6149626|P2|COMPLETED|Overall Study||152
2508373|NCT00770315|6149627|P1|COMPLETED|Overall Study||157
2508374|NCT00770315|6149624|P4|STARTED|Overall Study||198
2508375|NCT00770315|6149625|P3|STARTED|Overall Study||194
2508376|NCT00770315|6149626|P2|STARTED|Overall Study||195
2508377|NCT00770315|6149627|P1|STARTED|Overall Study||197
2508378|NCT00770289|6149653|P1|NOT COMPLETED|Overall Study||6
2508379|NCT00770289|6149653|P1|COMPLETED|Overall Study||845
2508380|NCT00770289|6149653|P1|STARTED|Overall Study||851
2508381|NCT00770224|6149662|P2|NOT COMPLETED|Step 2: Maintenance||30
2508382|NCT00770224|6149663|P1|NOT COMPLETED|Step 2: Maintenance||0
2508383|NCT00770224|6149662|P2|COMPLETED|Step 2: Maintenance||41
2508384|NCT00770224|6149663|P1|COMPLETED|Step 2: Maintenance||0
2508385|NCT00770224|6149662|P2|Eligible and Evaluable|Step 2: Maintenance||69
2508386|NCT00770224|6149663|P1|Eligible and Evaluable|Step 2: Maintenance||0
2508387|NCT00770224|6149662|P2|STARTED|Step 2: Maintenance||71
2508388|NCT00770224|6149663|P1|STARTED|Step 2: Maintenance||0
2508389|NCT00770224|6149662|P2|NOT COMPLETED|Step 1: Induction||0
2508390|NCT00770224|6149663|P1|NOT COMPLETED|Step 1: Induction||14
2508391|NCT00770224|6149662|P2|COMPLETED|Step 1: Induction||0
2508392|NCT00770224|6149663|P1|COMPLETED|Step 1: Induction||73
2508393|NCT00770224|6149662|P2|Eligible and Evaluable|Step 1: Induction||0
2508394|NCT00770224|6149663|P1|Eligible and Evaluable|Step 1: Induction||84
2508395|NCT00770224|6149662|P2|STARTED|Step 1: Induction||0
2508396|NCT00770224|6149663|P1|STARTED|Step 1: Induction||87
2508397|NCT00770211|6149675|P2|NOT COMPLETED|Overall Study||2
2508398|NCT00770211|6149676|P1|NOT COMPLETED|Overall Study||1
2508399|NCT00770211|6149675|P2|COMPLETED|Overall Study||87
2508400|NCT00770211|6149676|P1|COMPLETED|Overall Study||181
2508401|NCT00770211|6149675|P2|STARTED|Overall Study||89
2508402|NCT00770211|6149676|P1|STARTED|Overall Study||182
2508403|NCT00770146|6149692|P2|NOT COMPLETED|Follow-up Period||20
2508404|NCT00770146|6149693|P1|NOT COMPLETED|Follow-up Period||11
2508405|NCT00770146|6149692|P2|COMPLETED|Follow-up Period||85
2508406|NCT00770146|6149693|P1|COMPLETED|Follow-up Period||42
2508407|NCT00770146|6149692|P2|STARTED|Follow-up Period||105
2508408|NCT00770146|6149693|P1|STARTED|Follow-up Period||53
2508409|NCT00770146|6149692|P2|NOT COMPLETED|Treatment Period||45
2508410|NCT00770146|6149693|P1|NOT COMPLETED|Treatment Period||9
2508411|NCT00770146|6149692|P2|COMPLETED|Treatment Period||60
2508412|NCT00770146|6149693|P1|COMPLETED|Treatment Period||44
2508413|NCT00770146|6149692|P2|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|101
2508414|NCT00770146|6149693|P1|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|50
2508415|NCT00770146|6149692|P2|Treated|Treatment Period||105
2508416|NCT00770146|6149693|P1|Treated|Treatment Period||52
2508417|NCT00770146|6149692|P2|STARTED|Treatment Period||105
2508418|NCT00770146|6149693|P1|STARTED|Treatment Period||53
2508419|NCT00770120|6149737|P1|NOT COMPLETED|Overall Study||61
2508420|NCT00770120|6149737|P1|COMPLETED|Overall Study||0
2508421|NCT00770120|6149737|P1|Not Analyzable|Overall Study||1
2508422|NCT00770120|6149737|P1|Eligible|Overall Study||60
2508423|NCT00770120|6149737|P1|STARTED|Overall Study||61
2508424|NCT00770029|6149746|P2|NOT COMPLETED|Overall Study||3
2508425|NCT00770029|6149747|P1|NOT COMPLETED|Overall Study||6
2508426|NCT00770029|6149746|P2|COMPLETED|Overall Study||89
2508427|NCT00770029|6149747|P1|COMPLETED|Overall Study||178
2508428|NCT00770029|6149746|P2|STARTED|Overall Study||92
2508429|NCT00770029|6149747|P1|STARTED|Overall Study||184
2508430|NCT00769860|6149763|P2|NOT COMPLETED|Overall Study||0
2508431|NCT00769860|6149764|P1|NOT COMPLETED|Overall Study||2
2508432|NCT00769860|6149763|P2|COMPLETED|Overall Study||8
2508433|NCT00769860|6149764|P1|COMPLETED|Overall Study||14
2508434|NCT00769860|6149763|P2|Month 8|Overall Study||8
2508435|NCT00769860|6149764|P1|Month 8|Overall Study||14
2508436|NCT00769860|6149763|P2|Month 4|Overall Study||8
2508437|NCT00769860|6149764|P1|Month 4|Overall Study||16
2508438|NCT00769860|6149763|P2|STARTED|Overall Study||8
2508439|NCT00769860|6149764|P1|STARTED|Overall Study||16
2508440|NCT00769704|6149792|P2|NOT COMPLETED|Overall Study||199
2508441|NCT00769704|6149793|P1|NOT COMPLETED|Overall Study||111
2508442|NCT00769704|6149792|P2|COMPLETED|Overall Study||97
2508443|NCT00769704|6149793|P1|COMPLETED|Overall Study||30
2508444|NCT00769704|6149792|P2|Received Treatment|Overall Study||292
2508445|NCT00769704|6149793|P1|Received Treatment|Overall Study||127
2508446|NCT00769704|6149792|P2|Intent-to-treat Population|Overall Study|Participants who were randomized once to study treatment; excludes 1 participant randomized 3 times|295
2508447|NCT00769704|6149793|P1|Intent-to-treat Population|Overall Study|All participants who were randomized once to study treatment|141
2508448|NCT00769704|6149792|P2|STARTED|Overall Study||296
2508449|NCT00769704|6149793|P1|STARTED|Overall Study||141
2508450|NCT00769652|6149813|P2|NOT COMPLETED|Overall Study||0
2508451|NCT00769652|6149814|P1|NOT COMPLETED|Overall Study||0
2508452|NCT00769652|6149813|P2|COMPLETED|Overall Study||1
2508453|NCT00769652|6149814|P1|COMPLETED|Overall Study||6
2508454|NCT00769652|6149813|P2|STARTED|Overall Study||1
2508455|NCT00769652|6149814|P1|STARTED|Overall Study||6
2508456|NCT00769600|6149826|P2|NOT COMPLETED|Overall Study||0
2508457|NCT00769600|6149827|P1|NOT COMPLETED|Overall Study||0
2508458|NCT00769600|6149826|P2|COMPLETED|Overall Study||8
2508459|NCT00769600|6149827|P1|COMPLETED|Overall Study||15
2508460|NCT00769600|6149826|P2|STARTED|Overall Study||8
2508461|NCT00769600|6149827|P1|STARTED|Overall Study||15
2508462|NCT00769561|6149843|P2|NOT COMPLETED|Overall Study||5
2508463|NCT00769561|6149844|P1|NOT COMPLETED|Overall Study||3
2508464|NCT00769561|6149843|P2|COMPLETED|Overall Study||24
2508465|NCT00769561|6149844|P1|COMPLETED|Overall Study||26
2508466|NCT00769561|6149843|P2|STARTED|Overall Study||29
2508467|NCT00769561|6149844|P1|STARTED|Overall Study||29
2508468|NCT00769483|6149870|P6|NOT COMPLETED|Overall Study||0
2508469|NCT00769483|6149871|P5|NOT COMPLETED|Overall Study||1
2508470|NCT00769483|6149872|P4|NOT COMPLETED|Overall Study||0
2508471|NCT00769483|6149873|P3|NOT COMPLETED|Overall Study||0
2508472|NCT00769483|6149874|P2|NOT COMPLETED|Overall Study||1
2508473|NCT00769483|6149875|P1|NOT COMPLETED|Overall Study||0
2508474|NCT00769483|6149870|P6|COMPLETED|Overall Study||9
2508475|NCT00769483|6149871|P5|COMPLETED|Overall Study||15
2508476|NCT00769483|6149872|P4|COMPLETED|Overall Study||15
2508477|NCT00769483|6149873|P3|COMPLETED|Overall Study||15
2508478|NCT00769483|6149874|P2|COMPLETED|Overall Study||12
2508479|NCT00769483|6149875|P1|COMPLETED|Overall Study||9
2508480|NCT00769483|6149870|P6|STARTED|Overall Study||9
2508481|NCT00769483|6149871|P5|STARTED|Overall Study||16
2508482|NCT00769483|6149872|P4|STARTED|Overall Study||15
2508483|NCT00769483|6149873|P3|STARTED|Overall Study||15
2508484|NCT00769483|6149874|P2|STARTED|Overall Study||13
2508485|NCT00769483|6149875|P1|STARTED|Overall Study||9
2508486|NCT00769392|6149913|P1|NOT COMPLETED|Overall Study||4
2508487|NCT00769392|6149913|P1|COMPLETED|Overall Study||24
2508488|NCT00769392|6149913|P1|STARTED|Overall Study||28
2508489|NCT00769314|6149920|P2|NOT COMPLETED|Overall Study||13
2508490|NCT00769314|6149921|P1|NOT COMPLETED|Overall Study||17
2508491|NCT00769314|6149920|P2|COMPLETED|Overall Study||384
2508492|NCT00769314|6149921|P1|COMPLETED|Overall Study||361
2508493|NCT00769314|6149920|P2|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|397
2508494|NCT00769314|6149921|P1|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|378
2508495|NCT00769184|6149947|P2|NOT COMPLETED|No Treatment (6 Weeks)||1
2508496|NCT00769184|6149948|P1|NOT COMPLETED|No Treatment (6 Weeks)||1
2508497|NCT00769184|6149947|P2|COMPLETED|No Treatment (6 Weeks)||6
2508498|NCT00769184|6149948|P1|COMPLETED|No Treatment (6 Weeks)||5
2508499|NCT00769184|6149947|P2|STARTED|No Treatment (6 Weeks)||7
2508500|NCT00769184|6149948|P1|STARTED|No Treatment (6 Weeks)||6
2508501|NCT00769184|6149947|P2|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
2508502|NCT00769184|6149948|P1|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
2508503|NCT00769184|6149947|P2|COMPLETED|+LCD / +Placebo Only (4 Weeks)||7
2508504|NCT00769184|6149948|P1|COMPLETED|+LCD / +Placebo Only (4 Weeks)||6
2508505|NCT00769184|6149947|P2|STARTED|+LCD / +Placebo Only (4 Weeks)||7
2508506|NCT00769184|6149948|P1|STARTED|+LCD / +Placebo Only (4 Weeks)||6
2508507|NCT00769184|6149947|P2|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
2508508|NCT00769184|6149948|P1|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
2508509|NCT00769184|6149947|P2|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
2508510|NCT00769184|6149948|P1|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||6
2508511|NCT00769184|6149947|P2|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||8
2508512|NCT00769184|6149948|P1|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
2508513|NCT00769132|6149956|P4|NOT COMPLETED|Period 4||0
2508514|NCT00769132|6149957|P3|NOT COMPLETED|Period 4||0
2508515|NCT00769132|6149958|P2|NOT COMPLETED|Period 4||1
2508516|NCT00769132|6149959|P1|NOT COMPLETED|Period 4||0
2508517|NCT00769132|6149956|P4|COMPLETED|Period 4||5
2508518|NCT00769132|6149957|P3|COMPLETED|Period 4||6
2508519|NCT00769132|6149958|P2|COMPLETED|Period 4||5
2508520|NCT00769132|6149959|P1|COMPLETED|Period 4||5
2508521|NCT00769132|6149956|P4|STARTED|Period 4||5
2508522|NCT00769132|6149957|P3|STARTED|Period 4||6
2508523|NCT00769132|6149958|P2|STARTED|Period 4||6
2508524|NCT00769132|6149959|P1|STARTED|Period 4||5
2508525|NCT00769132|6149956|P4|NOT COMPLETED|Period 3||0
2508526|NCT00769132|6149957|P3|NOT COMPLETED|Period 3||0
2508527|NCT00769132|6149958|P2|NOT COMPLETED|Period 3||0
2508528|NCT00769132|6149959|P1|NOT COMPLETED|Period 3||1
2508529|NCT00769132|6149956|P4|COMPLETED|Period 3||5
2508530|NCT00769132|6149957|P3|COMPLETED|Period 3||6
2508531|NCT00769132|6149958|P2|COMPLETED|Period 3||6
2508532|NCT00769132|6149959|P1|COMPLETED|Period 3||5
2508533|NCT00769132|6149956|P4|STARTED|Period 3||5
2508534|NCT00769132|6149957|P3|STARTED|Period 3||6
2508535|NCT00769132|6149958|P2|STARTED|Period 3||6
2508536|NCT00769132|6149959|P1|STARTED|Period 3||6
2508537|NCT00769132|6149956|P4|NOT COMPLETED|Period 2||1
2508538|NCT00769132|6149957|P3|NOT COMPLETED|Period 2||0
2508539|NCT00769132|6149958|P2|NOT COMPLETED|Period 2||0
2508540|NCT00769132|6149959|P1|NOT COMPLETED|Period 2||0
2508541|NCT00769132|6149956|P4|COMPLETED|Period 2||5
2508542|NCT00769132|6149957|P3|COMPLETED|Period 2||6
2508543|NCT00769132|6149958|P2|COMPLETED|Period 2||6
2508544|NCT00769132|6149959|P1|COMPLETED|Period 2||6
2508545|NCT00769132|6149956|P4|STARTED|Period 2||6
2508546|NCT00769132|6149957|P3|STARTED|Period 2||6
2508547|NCT00769132|6149958|P2|STARTED|Period 2||6
2508548|NCT00769132|6149959|P1|STARTED|Period 2||6
2508549|NCT00769132|6149956|P4|NOT COMPLETED|Period 1||1
2508550|NCT00769132|6149957|P3|NOT COMPLETED|Period 1||0
2508551|NCT00769132|6149958|P2|NOT COMPLETED|Period 1||0
2508552|NCT00769132|6149959|P1|NOT COMPLETED|Period 1||1
2508553|NCT00769132|6149956|P4|COMPLETED|Period 1||6
2508554|NCT00769132|6149957|P3|COMPLETED|Period 1||6
2508555|NCT00769132|6149958|P2|COMPLETED|Period 1||6
2508556|NCT00769132|6149959|P1|COMPLETED|Period 1||6
2508557|NCT00769132|6149956|P4|STARTED|Period 1||7
2508558|NCT00769132|6149957|P3|STARTED|Period 1||6
2508559|NCT00769132|6149958|P2|STARTED|Period 1||6
2508560|NCT00769132|6149959|P1|STARTED|Period 1||7
2508561|NCT00769119|6149975|P2|NOT COMPLETED|Overall Study||3
2508562|NCT00769119|6149976|P1|NOT COMPLETED|Overall Study||2
2508563|NCT00769119|6149975|P2|COMPLETED|Overall Study||13
2508564|NCT00769119|6149976|P1|COMPLETED|Overall Study||20
2508565|NCT00769119|6149975|P2|STARTED|Overall Study||16
2508566|NCT00769119|6149976|P1|STARTED|Overall Study||22
2508567|NCT00769067|6150022|P2|NOT COMPLETED|Overall Study||94
2508568|NCT00769067|6150023|P1|NOT COMPLETED|Overall Study||94
2508569|NCT00769067|6150022|P2|COMPLETED|Overall Study||0
2508570|NCT00769067|6150023|P1|COMPLETED|Overall Study||0
2508571|NCT00769067|6150022|P2|Treated|Overall Study|One participant was not treated: refused treatment for reason other than an adverse event (AE).|93
2508572|NCT00769067|6150023|P1|Treated|Overall Study||94
2508573|NCT00769067|6150022|P2|STARTED|Overall Study||94
2508574|NCT00769067|6150023|P1|STARTED|Overall Study||94
2508575|NCT00769015|6150050|P2|NOT COMPLETED|Overall Study||16
2508576|NCT00769015|6150051|P1|NOT COMPLETED|Overall Study||9
2508577|NCT00769015|6150050|P2|COMPLETED|Overall Study||76
2508578|NCT00769015|6150051|P1|COMPLETED|Overall Study||87
2508579|NCT00769015|6150050|P2|STARTED|Overall Study||92
2508580|NCT00769015|6150051|P1|STARTED|Overall Study||96
2508581|NCT00768989|6150071|P2|NOT COMPLETED|On or After Week 36||27
2508582|NCT00768989|6150072|P1|NOT COMPLETED|On or After Week 36||51
2508583|NCT00768989|6150071|P2|COMPLETED|On or After Week 36||0
2508584|NCT00768989|6150072|P1|COMPLETED|On or After Week 36||0
2508585|NCT00768989|6150071|P2|STARTED|On or After Week 36||27
2508586|NCT00768989|6150072|P1|STARTED|On or After Week 36||51
2508587|NCT00768989|6150071|P2|NOT COMPLETED|Week 24 to Prior to Week 36||0
2508588|NCT00768989|6150072|P1|NOT COMPLETED|Week 24 to Prior to Week 36||8
2508589|NCT00768989|6150071|P2|COMPLETED|Week 24 to Prior to Week 36||27
2508590|NCT00768989|6150072|P1|COMPLETED|Week 24 to Prior to Week 36||51
2508591|NCT00768989|6150071|P2|STARTED|Week 24 to Prior to Week 36||27
2508592|NCT00768989|6150072|P1|STARTED|Week 24 to Prior to Week 36||59
2508593|NCT00768989|6150071|P2|NOT COMPLETED|Prior to Week 24||3
2508594|NCT00768989|6150072|P1|NOT COMPLETED|Prior to Week 24||4
2508595|NCT00768989|6150071|P2|COMPLETED|Prior to Week 24||27
2508596|NCT00768989|6150072|P1|COMPLETED|Prior to Week 24||59
2508597|NCT00768989|6150071|P2|STARTED|Prior to Week 24||30
2508598|NCT00768989|6150072|P1|STARTED|Prior to Week 24||63
2508599|NCT00768898|6150120|P1|NOT COMPLETED|Overall Study||2
2508600|NCT00768898|6150120|P1|COMPLETED|Overall Study||28
2508601|NCT00768898|6150120|P1|STARTED|Overall Study||30
2508602|NCT00768755|6150144|P4|NOT COMPLETED|Phase 2||57
2508603|NCT00768755|6150145|P3|NOT COMPLETED|Phase 2||58
2508604|NCT00768755|6150146|P2|NOT COMPLETED|Phase 2||55
2508605|NCT00768755|6150147|P1|NOT COMPLETED|Phase 2||0
2508606|NCT00768755|6150144|P4|COMPLETED|Phase 2||0
2508607|NCT00768755|6150145|P3|COMPLETED|Phase 2||0
2508608|NCT00768755|6150146|P2|COMPLETED|Phase 2||0
2508609|NCT00768755|6150147|P1|COMPLETED|Phase 2||0
2508610|NCT00768755|6150144|P4|Treated|Phase 2||55
2508611|NCT00768755|6150145|P3|Treated|Phase 2||58
2508612|NCT00768755|6150146|P2|Treated|Phase 2||55
2508613|NCT00768755|6150147|P1|Treated|Phase 2||0
2508614|NCT00768755|6150144|P4|STARTED|Phase 2||57
2508615|NCT00768755|6150145|P3|STARTED|Phase 2||58
2508616|NCT00768755|6150146|P2|STARTED|Phase 2||55
2508617|NCT00768755|6150147|P1|STARTED|Phase 2||0
2508618|NCT00768755|6150144|P4|NOT COMPLETED|Phase 1||0
2508619|NCT00768755|6150145|P3|NOT COMPLETED|Phase 1||0
2508620|NCT00768755|6150146|P2|NOT COMPLETED|Phase 1||0
2508621|NCT00768755|6150147|P1|NOT COMPLETED|Phase 1||10
2508622|NCT00768755|6150144|P4|COMPLETED|Phase 1||0
2508623|NCT00768755|6150145|P3|COMPLETED|Phase 1||0
2508624|NCT00768755|6150146|P2|COMPLETED|Phase 1||0
2508625|NCT00768755|6150147|P1|COMPLETED|Phase 1||0
2508626|NCT00768755|6150144|P4|STARTED|Phase 1||0
2508627|NCT00768755|6150145|P3|STARTED|Phase 1||0
2508628|NCT00768755|6150146|P2|STARTED|Phase 1||0
2508629|NCT00768755|6150147|P1|STARTED|Phase 1||10
2508630|NCT00768716|6150173|P2|NOT COMPLETED|Overall Study||0
2508631|NCT00768716|6150174|P1|NOT COMPLETED|Overall Study||0
2508632|NCT00768716|6150173|P2|COMPLETED|Overall Study||41
2508633|NCT00768716|6150174|P1|COMPLETED|Overall Study||54
2508634|NCT00768716|6150173|P2|STARTED|Overall Study||41
2508635|NCT00768716|6150174|P1|STARTED|Overall Study||54
2508636|NCT00768651|6150195|P1|NOT COMPLETED|Overall Study||1
2508637|NCT00768651|6150195|P1|COMPLETED|Overall Study||7
2508638|NCT00768651|6150195|P1|STARTED|Overall Study||8
2508639|NCT00768599|6150203|P3|NOT COMPLETED|Overall Study||12
2508640|NCT00768599|6150204|P2|NOT COMPLETED|Overall Study||16
2508641|NCT00768599|6150205|P1|NOT COMPLETED|Overall Study||11
2508642|NCT00768599|6150203|P3|COMPLETED|Overall Study||35
2508643|NCT00768599|6150204|P2|COMPLETED|Overall Study||27
2508644|NCT00768599|6150205|P1|COMPLETED|Overall Study||34
2508645|NCT00768599|6150203|P3|STARTED|Overall Study||47
2508646|NCT00768599|6150204|P2|STARTED|Overall Study||43
2508647|NCT00768599|6150205|P1|STARTED|Overall Study||45
2508648|NCT00768560|6150234|P6|NOT COMPLETED|Intervention Set 3||0
2508649|NCT00768560|6150235|P5|NOT COMPLETED|Intervention Set 3||0
2508650|NCT00768560|6150236|P4|NOT COMPLETED|Intervention Set 3||0
2508651|NCT00768560|6150237|P3|NOT COMPLETED|Intervention Set 3||0
2508652|NCT00768560|6150238|P2|NOT COMPLETED|Intervention Set 3||0
2508653|NCT00768560|6150239|P1|NOT COMPLETED|Intervention Set 3||0
2508654|NCT00768560|6150234|P6|COMPLETED|Intervention Set 3||6
2508655|NCT00768560|6150235|P5|COMPLETED|Intervention Set 3||6
2508656|NCT00768560|6150236|P4|COMPLETED|Intervention Set 3||6
2508657|NCT00768560|6150237|P3|COMPLETED|Intervention Set 3||6
2508658|NCT00768560|6150238|P2|COMPLETED|Intervention Set 3||5
2508659|NCT00768560|6150239|P1|COMPLETED|Intervention Set 3||5
2508660|NCT00768560|6150234|P6|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
2508661|NCT00768560|6150235|P5|STARTED|Intervention Set 3|40 mg BID for 2 weeks|6
2508662|NCT00768560|6150236|P4|STARTED|Intervention Set 3|80 mg OD for 2 weeks|6
2508663|NCT00768560|6150237|P3|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
2508664|NCT00768560|6150238|P2|STARTED|Intervention Set 3|40 mg BID for 2 weeks|5
2508665|NCT00768560|6150239|P1|STARTED|Intervention Set 3|80 mg OD for 2 weeks|5
2508666|NCT00768560|6150234|P6|NOT COMPLETED|Intervention Set 2||0
2508667|NCT00768560|6150235|P5|NOT COMPLETED|Intervention Set 2||0
2508668|NCT00768560|6150236|P4|NOT COMPLETED|Intervention Set 2||0
2508669|NCT00768560|6150237|P3|NOT COMPLETED|Intervention Set 2||0
2508670|NCT00768560|6150238|P2|NOT COMPLETED|Intervention Set 2||0
2508671|NCT00768560|6150239|P1|NOT COMPLETED|Intervention Set 2||0
2508672|NCT00768560|6150234|P6|COMPLETED|Intervention Set 2||6
2508673|NCT00768560|6150235|P5|COMPLETED|Intervention Set 2||6
2508674|NCT00768560|6150236|P4|COMPLETED|Intervention Set 2||6
2508675|NCT00768560|6150237|P3|COMPLETED|Intervention Set 2||6
2508676|NCT00768560|6150238|P2|COMPLETED|Intervention Set 2||5
2508677|NCT00768560|6150239|P1|COMPLETED|Intervention Set 2||5
2508678|NCT00768560|6150234|P6|STARTED|Intervention Set 2|40 mg BID for 2 weeks|6
2508679|NCT00768560|6150235|P5|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
2508680|NCT00768560|6150236|P4|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
2508681|NCT00768560|6150237|P3|STARTED|Intervention Set 2|80 mg OD for 2 weeks|6
2508682|NCT00768560|6150238|P2|STARTED|Intervention Set 2|80 mg OD for 2 weeks|5
2508683|NCT00768560|6150239|P1|STARTED|Intervention Set 2|40 mg BID for 2 weeks|5
2508684|NCT00768560|6150234|P6|NOT COMPLETED|Intervention Set 1||0
2508685|NCT00768560|6150235|P5|NOT COMPLETED|Intervention Set 1||0
2508686|NCT00768560|6150236|P4|NOT COMPLETED|Intervention Set 1||0
2508687|NCT00768560|6150237|P3|NOT COMPLETED|Intervention Set 1||0
2508688|NCT00768560|6150238|P2|NOT COMPLETED|Intervention Set 1||1
2508689|NCT00768560|6150239|P1|NOT COMPLETED|Intervention Set 1||0
2508690|NCT00768560|6150234|P6|COMPLETED|Intervention Set 1||6
2508691|NCT00768560|6150235|P5|COMPLETED|Intervention Set 1||6
2508692|NCT00768560|6150236|P4|COMPLETED|Intervention Set 1||6
2508693|NCT00768560|6150237|P3|COMPLETED|Intervention Set 1||6
2508694|NCT00768560|6150238|P2|COMPLETED|Intervention Set 1||5
2508695|NCT00768560|6150239|P1|COMPLETED|Intervention Set 1||5
2508696|NCT00768560|6150234|P6|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
2508697|NCT00768560|6150235|P5|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
2508698|NCT00768560|6150236|P4|Subjects Received Treatment|Intervention Set 1|40 mg BID for 2 weeks|6
2508699|NCT00768560|6150237|P3|Subjects Received Treatment|Intervention Set 1|40 mg twice daily (BID) for 2 weeks|6
2508700|NCT00768560|6150238|P2|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|6
2508701|NCT00768560|6150239|P1|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|5
2508702|NCT00768560|6150234|P6|STARTED|Intervention Set 1|3-period/treatment crossover|6
2508703|NCT00768560|6150235|P5|STARTED|Intervention Set 1|3-period/treatment crossover|6
2508704|NCT00768560|6150236|P4|STARTED|Intervention Set 1|3-period/treatment crossover|6
2508705|NCT00768560|6150237|P3|STARTED|Intervention Set 1|3-period/treatment crossover|6
2508706|NCT00768560|6150238|P2|STARTED|Intervention Set 1|3-period/treatment crossover|6
2508707|NCT00768560|6150239|P1|STARTED|Intervention Set 1|3-period/treatment crossover|5
2508708|NCT00768521|6150265|P2|NOT COMPLETED|Period 2||0
2508709|NCT00768521|6150266|P1|NOT COMPLETED|Period 2||0
2508710|NCT00768521|6150265|P2|COMPLETED|Period 2||11
2508711|NCT00768521|6150266|P1|COMPLETED|Period 2||9
2508712|NCT00768521|6150265|P2|STARTED|Period 2||11
2508713|NCT00768521|6150266|P1|STARTED|Period 2||9
2508714|NCT00768521|6150265|P2|NOT COMPLETED|Period 1||0
2508715|NCT00768521|6150266|P1|NOT COMPLETED|Period 1||0
2508716|NCT00768521|6150265|P2|COMPLETED|Period 1||11
2508717|NCT00768521|6150266|P1|COMPLETED|Period 1||9
2508718|NCT00768521|6150265|P2|STARTED|Period 1||11
2508719|NCT00768521|6150266|P1|STARTED|Period 1||9
2508720|NCT00768469|6150276|P2|NOT COMPLETED|Overall Study||7
2508721|NCT00768469|6150277|P1|NOT COMPLETED|Overall Study||3
2508722|NCT00768469|6150276|P2|COMPLETED|Overall Study||0
2508723|NCT00768469|6150277|P1|COMPLETED|Overall Study||0
2508724|NCT00768469|6150276|P2|STARTED|Overall Study||7
2508725|NCT00768469|6150277|P1|STARTED|Overall Study||3
2508726|NCT00768430|6150292|P2|NOT COMPLETED|7 Day Endpoint||3
2508727|NCT00768430|6150293|P1|NOT COMPLETED|7 Day Endpoint||2
2508728|NCT00768430|6150292|P2|COMPLETED|7 Day Endpoint||22
2508729|NCT00768430|6150293|P1|COMPLETED|7 Day Endpoint||45
2508730|NCT00768430|6150292|P2|STARTED|7 Day Endpoint||25
2508731|NCT00768430|6150293|P1|STARTED|7 Day Endpoint||47
2508732|NCT00768430|6150292|P2|NOT COMPLETED|24 Hour Endpoint||0
2508733|NCT00768430|6150293|P1|NOT COMPLETED|24 Hour Endpoint||1
2508734|NCT00768430|6150292|P2|COMPLETED|24 Hour Endpoint||25
2508735|NCT00768430|6150293|P1|COMPLETED|24 Hour Endpoint||47
2508736|NCT00768430|6150292|P2|STARTED|24 Hour Endpoint||25
2508737|NCT00768430|6150293|P1|STARTED|24 Hour Endpoint||48
2508738|NCT00768300|6150301|P2|NOT COMPLETED|Overall Study||163
2508739|NCT00768300|6150302|P1|NOT COMPLETED|Overall Study||329
2508740|NCT00768300|6150301|P2|COMPLETED|Overall Study||1
2508741|NCT00768300|6150302|P1|COMPLETED|Overall Study||1
2508742|NCT00768300|6150301|P2|Randomized and Treated|Overall Study||163
2508743|NCT00768300|6150302|P1|Randomized and Treated|Overall Study||329
2508744|NCT00768300|6150301|P2|STARTED|Overall Study||164
2508745|NCT00768300|6150302|P1|STARTED|Overall Study||330
2508746|NCT00768287|6150324|P6|NOT COMPLETED|Surgical Sub-study||0
2508747|NCT00768287|6150325|P5|NOT COMPLETED|Surgical Sub-study||0
2508748|NCT00768287|6150326|P4|NOT COMPLETED|Surgical Sub-study||0
2508749|NCT00768287|6150327|P3|NOT COMPLETED|Surgical Sub-study||0
2508750|NCT00768287|6150328|P2|NOT COMPLETED|Surgical Sub-study||0
2508751|NCT00768287|6150329|P1|NOT COMPLETED|Surgical Sub-study||0
2508752|NCT00768287|6150324|P6|COMPLETED|Surgical Sub-study||17
2508753|NCT00768287|6150325|P5|COMPLETED|Surgical Sub-study||0
2508754|NCT00768287|6150326|P4|COMPLETED|Surgical Sub-study||0
2508755|NCT00768287|6150327|P3|COMPLETED|Surgical Sub-study||0
2508756|NCT00768287|6150328|P2|COMPLETED|Surgical Sub-study||0
2508757|NCT00768287|6150329|P1|COMPLETED|Surgical Sub-study||0
2508758|NCT00768287|6150324|P6|STARTED|Surgical Sub-study|1 female subject was excluded from the efficacy analysis. She was included in the safety population.|17
2508759|NCT00768287|6150325|P5|STARTED|Surgical Sub-study||0
2508760|NCT00768287|6150326|P4|STARTED|Surgical Sub-study||0
2508761|NCT00768287|6150327|P3|STARTED|Surgical Sub-study||0
2508762|NCT00768287|6150328|P2|STARTED|Surgical Sub-study||0
2508763|NCT00768287|6150329|P1|STARTED|Surgical Sub-study||0
2508764|NCT00768287|6150324|P6|NOT COMPLETED|Treatment Study||0
2508765|NCT00768287|6150325|P5|NOT COMPLETED|Treatment Study||0
2508766|NCT00768287|6150326|P4|NOT COMPLETED|Treatment Study||0
2508767|NCT00768287|6150327|P3|NOT COMPLETED|Treatment Study||0
2508768|NCT00768287|6150328|P2|NOT COMPLETED|Treatment Study||0
2508769|NCT00768287|6150329|P1|NOT COMPLETED|Treatment Study||0
2508770|NCT00768287|6150324|P6|COMPLETED|Treatment Study||0
2508771|NCT00768287|6150325|P5|COMPLETED|Treatment Study||9
2508772|NCT00768287|6150326|P4|COMPLETED|Treatment Study||58
2508773|NCT00768287|6150327|P3|COMPLETED|Treatment Study||0
2508774|NCT00768287|6150328|P2|COMPLETED|Treatment Study||0
2508775|NCT00768287|6150329|P1|COMPLETED|Treatment Study||0
2508776|NCT00768287|6150324|P6|Treated|Treatment Study||0
2508777|NCT00768287|6150325|P5|Treated|Treatment Study|Subjects could switch treatment regimens. 3 subjects switched from Prophylaxis to On Demand.|12
2508778|NCT00768287|6150326|P4|Treated|Treatment Study|Subjects could switch treatment regimens. 3 subjects switched from On Demand to Prophylaxis.|61
2508779|NCT00768287|6150327|P3|Treated|Treatment Study||0
2508780|NCT00768287|6150328|P2|Treated|Treatment Study||0
2508781|NCT00768287|6150329|P1|Treated|Treatment Study||0
2508782|NCT00768287|6150324|P6|STARTED|Treatment Study||0
2508783|NCT00768287|6150325|P5|STARTED|Treatment Study|1 subject was not assigned a regimen at the start of the study.|9
2508784|NCT00768287|6150326|P4|STARTED|Treatment Study|1 subject was not assigned a regimen at the start of the study.|58
2508785|NCT00768287|6150327|P3|STARTED|Treatment Study||0
2508786|NCT00768287|6150328|P2|STARTED|Treatment Study||0
2508787|NCT00768287|6150329|P1|STARTED|Treatment Study||0
2508788|NCT00768287|6150324|P6|NOT COMPLETED|Repeat Pharmacokinetic Study||0
2508789|NCT00768287|6150325|P5|NOT COMPLETED|Repeat Pharmacokinetic Study||0
2508790|NCT00768287|6150326|P4|NOT COMPLETED|Repeat Pharmacokinetic Study||0
2508791|NCT00768287|6150327|P3|NOT COMPLETED|Repeat Pharmacokinetic Study||0
2508792|NCT00768287|6150328|P2|NOT COMPLETED|Repeat Pharmacokinetic Study||0
2508793|NCT00768287|6150329|P1|NOT COMPLETED|Repeat Pharmacokinetic Study||0
2508794|NCT00768287|6150324|P6|COMPLETED|Repeat Pharmacokinetic Study||0
2508795|NCT00768287|6150325|P5|COMPLETED|Repeat Pharmacokinetic Study||0
2508796|NCT00768287|6150326|P4|COMPLETED|Repeat Pharmacokinetic Study||0
2508797|NCT00768287|6150327|P3|COMPLETED|Repeat Pharmacokinetic Study||14
2508798|NCT00768287|6150328|P2|COMPLETED|Repeat Pharmacokinetic Study||0
2508799|NCT00768287|6150329|P1|COMPLETED|Repeat Pharmacokinetic Study||0
2508800|NCT00768287|6150324|P6|STARTED|Repeat Pharmacokinetic Study||0
2508801|NCT00768287|6150325|P5|STARTED|Repeat Pharmacokinetic Study||0
2508802|NCT00768287|6150326|P4|STARTED|Repeat Pharmacokinetic Study||0
2508803|NCT00768287|6150327|P3|STARTED|Repeat Pharmacokinetic Study|Eight subjects were part of the IB1001 first group; 6 were from the nonacog alfa first group.|14
2508804|NCT00768287|6150328|P2|STARTED|Repeat Pharmacokinetic Study||0
2508805|NCT00768287|6150329|P1|STARTED|Repeat Pharmacokinetic Study||0
2508806|NCT00768287|6150324|P6|NOT COMPLETED|Pharmacokinetic Study||0
2508807|NCT00768287|6150325|P5|NOT COMPLETED|Pharmacokinetic Study||0
2508808|NCT00768287|6150326|P4|NOT COMPLETED|Pharmacokinetic Study||0
2508809|NCT00768287|6150327|P3|NOT COMPLETED|Pharmacokinetic Study||0
2508810|NCT00768287|6150328|P2|NOT COMPLETED|Pharmacokinetic Study||0
2508811|NCT00768287|6150329|P1|NOT COMPLETED|Pharmacokinetic Study||0
2508812|NCT00768287|6150324|P6|COMPLETED|Pharmacokinetic Study||0
2508813|NCT00768287|6150325|P5|COMPLETED|Pharmacokinetic Study||0
2508814|NCT00768287|6150326|P4|COMPLETED|Pharmacokinetic Study||0
2508815|NCT00768287|6150327|P3|COMPLETED|Pharmacokinetic Study||0
2508816|NCT00768287|6150328|P2|COMPLETED|Pharmacokinetic Study||16
2508817|NCT00768287|6150329|P1|COMPLETED|Pharmacokinetic Study||16
2508818|NCT00768287|6150324|P6|STARTED|Pharmacokinetic Study||0
2508819|NCT00768287|6150325|P5|STARTED|Pharmacokinetic Study||0
2508820|NCT00768287|6150326|P4|STARTED|Pharmacokinetic Study||0
2508821|NCT00768287|6150327|P3|STARTED|Pharmacokinetic Study||0
2508822|NCT00768287|6150328|P2|STARTED|Pharmacokinetic Study||16
2508823|NCT00768287|6150329|P1|STARTED|Pharmacokinetic Study||16
2508824|NCT00768261|6150368|P4|NOT COMPLETED|Overall Study||0
2508825|NCT00768261|6150369|P3|NOT COMPLETED|Overall Study||25
2508826|NCT00768261|6150370|P2|NOT COMPLETED|Overall Study||0
2508827|NCT00768261|6150371|P1|NOT COMPLETED|Overall Study||0
2508828|NCT00768261|6150368|P4|COMPLETED|Overall Study||56
2508829|NCT00768261|6150369|P3|COMPLETED|Overall Study||14
2508830|NCT00768261|6150370|P2|COMPLETED|Overall Study||18
2508831|NCT00768261|6150371|P1|COMPLETED|Overall Study||14
2508832|NCT00768261|6150368|P4|STARTED|Overall Study||56
2508833|NCT00768261|6150369|P3|STARTED|Overall Study||39
2508834|NCT00768261|6150370|P2|STARTED|Overall Study||18
2508835|NCT00768261|6150371|P1|STARTED|Overall Study||14
2508836|NCT00768248|6150386|P2|NOT COMPLETED|Overall Study||1
2508837|NCT00768248|6150387|P1|NOT COMPLETED|Overall Study||1
2508838|NCT00768248|6150386|P2|COMPLETED|Overall Study||0
2508839|NCT00768248|6150387|P1|COMPLETED|Overall Study||0
2508840|NCT00768248|6150386|P2|STARTED|Overall Study||1
2508841|NCT00768248|6150387|P1|STARTED|Overall Study||1
2508842|NCT00768222|6150403|P2|NOT COMPLETED|Overall Study||4
2508843|NCT00768222|6150404|P1|NOT COMPLETED|Overall Study||4
2508844|NCT00768222|6150403|P2|COMPLETED|Overall Study||47
2508845|NCT00768222|6150404|P1|COMPLETED|Overall Study||46
2508846|NCT00768222|6150403|P2|STARTED|Overall Study||51
2508847|NCT00768222|6150404|P1|STARTED|Overall Study||50
2508848|NCT00768144|6150426|P1|NOT COMPLETED|Overall Study||36
2508849|NCT00768144|6150426|P1|COMPLETED|Overall Study||0
2508850|NCT00768144|6150426|P1|STARTED|Overall Study||36
2508851|NCT00768118|6150432|P1|NOT COMPLETED|Overall Study||0
2508852|NCT00768118|6150432|P1|COMPLETED|Overall Study||11
2508853|NCT00768118|6150432|P1|STARTED|Overall Study||11
2508854|NCT00768066|6150439|P3|NOT COMPLETED|Overall Study||0
2508855|NCT00768066|6150440|P2|NOT COMPLETED|Overall Study||3
2508856|NCT00768066|6150441|P1|NOT COMPLETED|Overall Study||3
2508857|NCT00768066|6150439|P3|COMPLETED|Overall Study||21
2508858|NCT00768066|6150440|P2|COMPLETED|Overall Study||19
2508859|NCT00768066|6150441|P1|COMPLETED|Overall Study||19
2508860|NCT00768066|6150439|P3|STARTED|Overall Study||21
2508861|NCT00768066|6150440|P2|STARTED|Overall Study||22
2508862|NCT00768066|6150441|P1|STARTED|Overall Study||22
2508863|NCT00768053|6150473|P1|NOT COMPLETED|Overall Study||11
2508864|NCT00768053|6150473|P1|COMPLETED|Overall Study||97
2508865|NCT00768053|6150473|P1|STARTED|Overall Study||108
2508866|NCT00768040|6150504|P2|NOT COMPLETED|Overall Study||3
2508867|NCT00768040|6150505|P1|NOT COMPLETED|Overall Study||4
2508868|NCT00768040|6150504|P2|COMPLETED|Overall Study||16
2508869|NCT00768040|6150505|P1|COMPLETED|Overall Study||16
2508870|NCT00768040|6150504|P2|STARTED|Overall Study||19
2508871|NCT00768040|6150505|P1|STARTED|Overall Study|"Started indicates randomized, safety and full analysis set."|20
2508872|NCT00767819|6150514|P3|NOT COMPLETED|Overall Study||0
2508873|NCT00767819|6150515|P2|NOT COMPLETED|Overall Study||19
2508874|NCT00767819|6150516|P1|NOT COMPLETED|Overall Study||25
2508875|NCT00767819|6150514|P3|COMPLETED|Overall Study||10
2508876|NCT00767819|6150515|P2|COMPLETED|Overall Study||5
2508877|NCT00767819|6150516|P1|COMPLETED|Overall Study||12
2508878|NCT00767819|6150514|P3|Safety Analysis Set (SAF)|Overall Study||10
2508879|NCT00767819|6150515|P2|Safety Analysis Set (SAF)|Overall Study||24
2508880|NCT00767819|6150516|P1|Safety Analysis Set (SAF)|Overall Study||37
2508881|NCT00767819|6150514|P3|Intent to Treat (ITT) Analysis Set|Overall Study||10
2508882|NCT00767819|6150515|P2|Intent to Treat (ITT) Analysis Set|Overall Study||24
2508883|NCT00767819|6150516|P1|Intent to Treat (ITT) Analysis Set|Overall Study||37
2508884|NCT00767819|6150514|P3|STARTED|Overall Study||10
2508885|NCT00767819|6150515|P2|STARTED|Overall Study||24
2508886|NCT00767819|6150516|P1|STARTED|Overall Study||37
2508887|NCT00767806|6150541|P2|NOT COMPLETED|Overall Study||47
2508888|NCT00767806|6150542|P1|NOT COMPLETED|Overall Study||51
2508889|NCT00767806|6150541|P2|COMPLETED|Overall Study||156
2508890|NCT00767806|6150542|P1|COMPLETED|Overall Study||147
2508891|NCT00767806|6150541|P2|STARTED|Overall Study||203
2508892|NCT00767806|6150542|P1|STARTED|Overall Study||198
2508893|NCT00767767|6150603|P5|NOT COMPLETED|Overall Study||0
2508894|NCT00767767|6150604|P4|NOT COMPLETED|Overall Study||0
2508895|NCT00767767|6150605|P3|NOT COMPLETED|Overall Study||0
2508896|NCT00767767|6150606|P2|NOT COMPLETED|Overall Study||0
2508897|NCT00767767|6150607|P1|NOT COMPLETED|Overall Study||0
2508898|NCT00767767|6150603|P5|COMPLETED|Overall Study||3
2508899|NCT00767767|6150604|P4|COMPLETED|Overall Study||3
2508900|NCT00767767|6150605|P3|COMPLETED|Overall Study||20
2508901|NCT00767767|6150606|P2|COMPLETED|Overall Study||20
2508902|NCT00767767|6150607|P1|COMPLETED|Overall Study||21
2508903|NCT00767767|6150603|P5|STARTED|Overall Study||3
2508904|NCT00767767|6150604|P4|STARTED|Overall Study||3
2508905|NCT00767767|6150605|P3|STARTED|Overall Study||20
2508906|NCT00767767|6150606|P2|STARTED|Overall Study||20
2508907|NCT00767767|6150607|P1|STARTED|Overall Study||21
2508908|NCT00767676|6150619|P1|NOT COMPLETED|Overall Study||54
2508909|NCT00767676|6150619|P1|COMPLETED|Overall Study||205
2508910|NCT00767676|6150619|P1|STARTED|Overall Study||259
2508911|NCT00767624|6150625|P2|NOT COMPLETED|Overall Study||17
2508912|NCT00767624|6150626|P1|NOT COMPLETED|Overall Study||24
2508913|NCT00767624|6150625|P2|COMPLETED|Overall Study||58
2508914|NCT00767624|6150626|P1|COMPLETED|Overall Study||51
2508915|NCT00767624|6150625|P2|STARTED|Overall Study||75
2508916|NCT00767624|6150626|P1|STARTED|Overall Study||75
2508917|NCT00767572|6150634|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
2508918|NCT00767572|6150634|P1|COMPLETED|Second Intervention (12 Weeks)||12
2508919|NCT00767572|6150634|P1|STARTED|Second Intervention (12 Weeks)||12
2508920|NCT00767572|6150634|P1|NOT COMPLETED|Washout (4 Weeks)||0
2508921|NCT00767572|6150634|P1|COMPLETED|Washout (4 Weeks)||12
2508922|NCT00767572|6150634|P1|STARTED|Washout (4 Weeks)||12
2508923|NCT00767572|6150634|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
2508924|NCT00767572|6150634|P1|COMPLETED|First Intervention (12 Weeks)||12
2508925|NCT00767572|6150634|P1|STARTED|First Intervention (12 Weeks)||12
2508926|NCT00767520|6150642|P2|NOT COMPLETED|Overall Study||17
2508927|NCT00767520|6150643|P1|NOT COMPLETED|Overall Study||11
2508928|NCT00767520|6150642|P2|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-56, study drug toxicity-2,AE-1,Death-1|61
2508929|NCT00767520|6150643|P1|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-50, study drug toxicity-10,AE-3,Death-2|68
2508930|NCT00767520|6150642|P2|STARTED|Overall Study||78
2508931|NCT00767520|6150643|P1|STARTED|Overall Study||79
2508932|NCT00767507|6150669|P4|NOT COMPLETED|Overall Study||3
2508933|NCT00767507|6150670|P3|NOT COMPLETED|Overall Study||0
2508934|NCT00767507|6150671|P2|NOT COMPLETED|Overall Study||0
2508935|NCT00767507|6150672|P1|NOT COMPLETED|Overall Study||0
2508936|NCT00767507|6150669|P4|COMPLETED|Overall Study||101
2508937|NCT00767507|6150670|P3|COMPLETED|Overall Study||106
2508938|NCT00767507|6150671|P2|COMPLETED|Overall Study||6
2508939|NCT00767507|6150672|P1|COMPLETED|Overall Study||5
2508940|NCT00767507|6150669|P4|STARTED|Overall Study||104
2508941|NCT00767507|6150670|P3|STARTED|Overall Study||106
2508942|NCT00767507|6150671|P2|STARTED|Overall Study||6
2508943|NCT00767507|6150672|P1|STARTED|Overall Study||5
2508944|NCT00767455|6150696|P1|NOT COMPLETED|Overall Study||19
2508945|NCT00767455|6150696|P1|COMPLETED|Overall Study||40
2508946|NCT00767455|6150696|P1|STARTED|Overall Study||59
2508947|NCT00767364|6150704|P2|NOT COMPLETED|Overall Study||0
2508948|NCT00767364|6150705|P1|NOT COMPLETED|Overall Study||0
2508949|NCT00767364|6150704|P2|COMPLETED|Overall Study||3
2508950|NCT00767364|6150705|P1|COMPLETED|Overall Study||5
2508951|NCT00767364|6150704|P2|STARTED|Overall Study||3
2508952|NCT00767364|6150705|P1|STARTED|Overall Study||5
2508953|NCT00767338|6150717|P4|NOT COMPLETED|Overall Study||0
2508954|NCT00767338|6150718|P3|NOT COMPLETED|Overall Study||0
2508955|NCT00767338|6150719|P2|NOT COMPLETED|Overall Study||2
2508956|NCT00767338|6150720|P1|NOT COMPLETED|Overall Study||1
2508957|NCT00767338|6150717|P4|COMPLETED|Overall Study||0
2508958|NCT00767338|6150718|P3|COMPLETED|Overall Study||0
2508959|NCT00767338|6150719|P2|COMPLETED|Overall Study||0
2508960|NCT00767338|6150720|P1|COMPLETED|Overall Study||0
2508961|NCT00767338|6150717|P4|STARTED|Overall Study||0
2508962|NCT00767338|6150718|P3|STARTED|Overall Study||0
2508963|NCT00767338|6150719|P2|STARTED|Overall Study||2
2508964|NCT00767338|6150720|P1|STARTED|Overall Study||1
2508965|NCT00767325|6150730|P1|NOT COMPLETED|Overall Study||15
2508966|NCT00767325|6150730|P1|COMPLETED|Overall Study||89
2508967|NCT00767325|6150730|P1|STARTED|Overall Study||104
2508968|NCT00767104|6150741|P2|NOT COMPLETED|Overall Study||2
2508969|NCT00767104|6150742|P1|NOT COMPLETED|Overall Study||1
2508970|NCT00767104|6150741|P2|COMPLETED|Overall Study||18
2508971|NCT00767104|6150742|P1|COMPLETED|Overall Study||19
2508972|NCT00767104|6150741|P2|STARTED|Overall Study||20
2508973|NCT00767104|6150742|P1|STARTED|Overall Study||20
2508974|NCT00767039|6150752|P2|NOT COMPLETED|Overall Study||2
2508975|NCT00767039|6150753|P1|NOT COMPLETED|Overall Study||5
2508976|NCT00767039|6150752|P2|COMPLETED|Overall Study||23
2508977|NCT00767039|6150753|P1|COMPLETED|Overall Study||22
2508978|NCT00767039|6150752|P2|STARTED|Overall Study||25
2508979|NCT00767039|6150753|P1|STARTED|Overall Study|Two early deaths and 3 late deaths occurred in this group|27
2508980|NCT00767000|6150784|P5|NOT COMPLETED|Optional 104-week Extension||4
2508981|NCT00767000|6150785|P4|NOT COMPLETED|Optional 104-week Extension||2
2508982|NCT00767000|6150786|P3|NOT COMPLETED|Optional 104-week Extension||7
2508983|NCT00767000|6150787|P2|NOT COMPLETED|Optional 104-week Extension||3
2508984|NCT00767000|6150788|P1|NOT COMPLETED|Optional 104-week Extension||7
2508985|NCT00767000|6150784|P5|COMPLETED|Optional 104-week Extension||0
2508986|NCT00767000|6150785|P4|COMPLETED|Optional 104-week Extension||0
2508987|NCT00767000|6150786|P3|COMPLETED|Optional 104-week Extension||0
2508988|NCT00767000|6150787|P2|COMPLETED|Optional 104-week Extension||0
2508989|NCT00767000|6150788|P1|COMPLETED|Optional 104-week Extension||0
2508990|NCT00767000|6150784|P5|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|4
2508991|NCT00767000|6150785|P4|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|2
2508992|NCT00767000|6150786|P3|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
2508993|NCT00767000|6150787|P2|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|3
2508994|NCT00767000|6150788|P1|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
2508995|NCT00767000|6150784|P5|NOT COMPLETED|54-week Study||224
2508996|NCT00767000|6150785|P4|NOT COMPLETED|54-week Study||225
2508997|NCT00767000|6150786|P3|NOT COMPLETED|54-week Study||109
2508998|NCT00767000|6150787|P2|NOT COMPLETED|54-week Study||113
2508999|NCT00767000|6150788|P1|NOT COMPLETED|54-week Study||108
2509000|NCT00767000|6150784|P5|COMPLETED|54-week Study||7
2509001|NCT00767000|6150785|P4|COMPLETED|54-week Study||4
2509002|NCT00767000|6150786|P3|COMPLETED|54-week Study||8
2509003|NCT00767000|6150787|P2|COMPLETED|54-week Study||4
2509004|NCT00767000|6150788|P1|COMPLETED|54-week Study||11
2509005|NCT00767000|6150784|P5|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|231
2509006|NCT00767000|6150785|P4|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|229
2509007|NCT00767000|6150786|P3|STARTED|54-week Study||117
2509008|NCT00767000|6150787|P2|STARTED|54-week Study||117
2509009|NCT00767000|6150788|P1|STARTED|54-week Study||119
2509010|NCT00766831|6150830|P1|NOT COMPLETED|Overall Study||115
2509011|NCT00766831|6150830|P1|COMPLETED|Overall Study||75
2509012|NCT00766831|6150830|P1|STARTED|Overall Study||190
2509013|NCT00766753|6150848|P2|NOT COMPLETED|Overall Study||0
2509014|NCT00766753|6150849|P1|NOT COMPLETED|Overall Study||0
2509015|NCT00766753|6150848|P2|COMPLETED|Overall Study||11
2509016|NCT00766753|6150849|P1|COMPLETED|Overall Study||11
2509017|NCT00766753|6150848|P2|Completed at Least Four Vaccines|Overall Study||9
2509018|NCT00766753|6150849|P1|Completed at Least Four Vaccines|Overall Study||10
2509019|NCT00766753|6150848|P2|Received at Least One Vaccine|Overall Study||11
2509020|NCT00766753|6150849|P1|Received at Least One Vaccine|Overall Study||11
2509021|NCT00766753|6150848|P2|STARTED|Overall Study||11
2509022|NCT00766753|6150849|P1|STARTED|Overall Study||11
2509023|NCT00766675|6150860|P1|NOT COMPLETED|Overall Study||40
2509024|NCT00766675|6150860|P1|COMPLETED|Overall Study||40
2509025|NCT00766675|6150860|P1|STARTED|Overall Study||80
2509026|NCT00766649|6150873|P1|NOT COMPLETED|Overall Study||10
2509027|NCT00766649|6150873|P1|COMPLETED|Overall Study||1
2509028|NCT00766649|6150873|P1|STARTED|Overall Study||11
2509029|NCT00766636|6150887|P2|NOT COMPLETED|Overall Study||2
2509030|NCT00766636|6150888|P1|NOT COMPLETED|Overall Study||3
2509031|NCT00766636|6150887|P2|COMPLETED|Overall Study||0
2509032|NCT00766636|6150888|P1|COMPLETED|Overall Study|Number that completed pre- and post-operative therapy as well as surgery.|0
2509033|NCT00766636|6150887|P2|STARTED|Overall Study||2
2509034|NCT00766636|6150888|P1|STARTED|Overall Study||3
2509035|NCT00766597|6150894|P1|NOT COMPLETED|Overall Study||9
2509036|NCT00766597|6150894|P1|COMPLETED|Overall Study|Treatment duration is 48 weeks plus 5 years of follow-up|0
2509037|NCT00766597|6150894|P1|Completed Week 48|Overall Study|Week 48 is the second primary time point of analysis|0
2509038|NCT00766597|6150894|P1|Completed Week 24|Overall Study|Week 24 is the first primary time point of analysis|1
2509039|NCT00766597|6150894|P1|Without CCR5-tropic Virus|Overall Study|Not evaluable participants, did not receive the study drug|5
2509040|NCT00766597|6150894|P1|With CCR5-tropic Virus|Overall Study|Evaluable participants, received the study drug|4
2509041|NCT00766597|6150894|P1|STARTED|Overall Study|Screened participants who were evaluated for co-receptor tropism|9
2509042|NCT00766532|6150906|P1|NOT COMPLETED|Overall Study||2
2509043|NCT00766532|6150906|P1|COMPLETED|Overall Study||10
2509044|NCT00766532|6150906|P1|STARTED|Overall Study||12
2509045|NCT00766506|6150912|P2|NOT COMPLETED|Overall Study||2
2509046|NCT00766506|6150913|P1|NOT COMPLETED|Overall Study||5
2509047|NCT00766506|6150912|P2|COMPLETED|Overall Study||48
2509048|NCT00766506|6150913|P1|COMPLETED|Overall Study||53
2509049|NCT00766506|6150912|P2|STARTED|Overall Study||50
2509050|NCT00766506|6150913|P1|STARTED|Overall Study||58
2509051|NCT00766493|6150937|P1|NOT COMPLETED|30 Days Post-Procedure||12
2509052|NCT00766493|6150937|P1|COMPLETED|30 Days Post-Procedure||238
2509053|NCT00766493|6150937|P1|STARTED|30 Days Post-Procedure||250
2509054|NCT00766493|6150937|P1|NOT COMPLETED|Pre-Discharge||0
2509055|NCT00766493|6150937|P1|COMPLETED|Pre-Discharge||250
2509056|NCT00766493|6150937|P1|STARTED|Pre-Discharge||250
2509057|NCT00766467|6150947|P2|NOT COMPLETED|Overall Study||8
2509058|NCT00766467|6150948|P1|NOT COMPLETED|Overall Study||11
2509059|NCT00766467|6150947|P2|COMPLETED|Overall Study||31
2509060|NCT00766467|6150948|P1|COMPLETED|Overall Study||31
2509061|NCT00766467|6150947|P2|Initiated Treatment|Overall Study||38
2509062|NCT00766467|6150948|P1|Initiated Treatment|Overall Study||39
2509063|NCT00766467|6150947|P2|STARTED|Overall Study||39
2509064|NCT00766467|6150948|P1|STARTED|Overall Study||42
2509065|NCT00766415|6150960|P2|NOT COMPLETED|Overall Study||1
2509066|NCT00766415|6150961|P1|NOT COMPLETED|Overall Study||0
2509067|NCT00766415|6150960|P2|COMPLETED|Overall Study||26
2509068|NCT00766415|6150961|P1|COMPLETED|Overall Study||25
2509069|NCT00766415|6150960|P2|STARTED|Overall Study||27
2509070|NCT00766415|6150961|P1|STARTED|Overall Study||25
2509071|NCT00766376|6151009|P1|NOT COMPLETED|Overall Study||27
2509072|NCT00766376|6151009|P1|COMPLETED|Overall Study||124
2509073|NCT00766376|6151009|P1|STARTED|Overall Study||151
2509074|NCT00766363|6151018|P4|NOT COMPLETED|Overall Study||0
2509075|NCT00766363|6151019|P3|NOT COMPLETED|Overall Study||0
2509076|NCT00766363|6151020|P2|NOT COMPLETED|Overall Study||1
2509077|NCT00766363|6151021|P1|NOT COMPLETED|Overall Study||1
2509078|NCT00766363|6151018|P4|COMPLETED|Overall Study||12
2509079|NCT00766363|6151019|P3|COMPLETED|Overall Study||12
2509080|NCT00766363|6151020|P2|COMPLETED|Overall Study||12
2509081|NCT00766363|6151021|P1|COMPLETED|Overall Study||11
2509082|NCT00766363|6151018|P4|PK POPULATION|Overall Study||13
2509083|NCT00766363|6151019|P3|PK POPULATION|Overall Study||10
2509084|NCT00766363|6151020|P2|PK POPULATION|Overall Study||13
2509085|NCT00766363|6151021|P1|PK POPULATION|Overall Study||12
2509086|NCT00766363|6151018|P4|SAFETY POPULATION|Overall Study|Increased by one subject who took placebo due to treatment assignment error.|13
2509087|NCT00766363|6151019|P3|SAFETY POPULATION|Overall Study|Decreased by one subject who took placebo instead due to treatment assignment error.|11
2509088|NCT00766363|6151020|P2|SAFETY POPULATION|Overall Study||13
2509089|NCT00766363|6151021|P1|SAFETY POPULATION|Overall Study||12
2509090|NCT00766363|6151018|P4|STARTED|Overall Study|Number randomized.|12
2509091|NCT00766363|6151019|P3|STARTED|Overall Study|Number randomized.|12
2509092|NCT00766363|6151020|P2|STARTED|Overall Study||13
2509093|NCT00766363|6151021|P1|STARTED|Overall Study||12
2509094|NCT00766116|6151058|P1|NOT COMPLETED|Overall Study||0
2509095|NCT00766116|6151058|P1|COMPLETED|Overall Study||50
2509096|NCT00766116|6151058|P1|STARTED|Overall Study||50
2509097|NCT00766090|6151067|P12|NOT COMPLETED|Treatment Period 3 (28 Days)||1
2509098|NCT00766090|6151068|P11|NOT COMPLETED|Treatment Period 3 (28 Days)||0
2509099|NCT00766090|6151069|P10|NOT COMPLETED|Treatment Period 3 (28 Days)||0
2509100|NCT00766090|6151070|P9|NOT COMPLETED|Treatment Period 3 (28 Days)||0
2509101|NCT00766090|6151071|P8|NOT COMPLETED|Treatment Period 3 (28 Days)||0
2509102|NCT00766090|6151072|P7|NOT COMPLETED|Treatment Period 3 (28 Days)||0
2509103|NCT00766090|6151073|P6|NOT COMPLETED|Treatment Period 3 (28 Days)||1
2509104|NCT00766090|6151074|P5|NOT COMPLETED|Treatment Period 3 (28 Days)||1
2509105|NCT00766090|6151075|P4|NOT COMPLETED|Treatment Period 3 (28 Days)||1
2509106|NCT00766090|6151076|P3|NOT COMPLETED|Treatment Period 3 (28 Days)||0
2509107|NCT00766090|6151077|P2|NOT COMPLETED|Treatment Period 3 (28 Days)||1
2509108|NCT00766090|6151078|P1|NOT COMPLETED|Treatment Period 3 (28 Days)||0
2509109|NCT00766090|6151067|P12|COMPLETED|Treatment Period 3 (28 Days)||6
2509110|NCT00766090|6151068|P11|COMPLETED|Treatment Period 3 (28 Days)||7
2509111|NCT00766090|6151069|P10|COMPLETED|Treatment Period 3 (28 Days)||8
2509112|NCT00766090|6151070|P9|COMPLETED|Treatment Period 3 (28 Days)||6
2509113|NCT00766090|6151071|P8|COMPLETED|Treatment Period 3 (28 Days)||8
2509114|NCT00766090|6151072|P7|COMPLETED|Treatment Period 3 (28 Days)||6
2509115|NCT00766090|6151073|P6|COMPLETED|Treatment Period 3 (28 Days)||22
2509116|NCT00766090|6151074|P5|COMPLETED|Treatment Period 3 (28 Days)||20
2509117|NCT00766090|6151075|P4|COMPLETED|Treatment Period 3 (28 Days)||24
2509118|NCT00766090|6151076|P3|COMPLETED|Treatment Period 3 (28 Days)||20
2509119|NCT00766090|6151077|P2|COMPLETED|Treatment Period 3 (28 Days)||26
2509120|NCT00766090|6151078|P1|COMPLETED|Treatment Period 3 (28 Days)||22
2509121|NCT00766090|6151067|P12|STARTED|Treatment Period 3 (28 Days)||7
2509122|NCT00766090|6151068|P11|STARTED|Treatment Period 3 (28 Days)||7
2509123|NCT00766090|6151069|P10|STARTED|Treatment Period 3 (28 Days)||8
2509124|NCT00766090|6151070|P9|STARTED|Treatment Period 3 (28 Days)||6
2509125|NCT00766090|6151071|P8|STARTED|Treatment Period 3 (28 Days)||8
2509126|NCT00766090|6151072|P7|STARTED|Treatment Period 3 (28 Days)||6
2509127|NCT00766090|6151073|P6|STARTED|Treatment Period 3 (28 Days)||23
2509128|NCT00766090|6151074|P5|STARTED|Treatment Period 3 (28 Days)||21
2509129|NCT00766090|6151075|P4|STARTED|Treatment Period 3 (28 Days)||25
2509130|NCT00766090|6151076|P3|STARTED|Treatment Period 3 (28 Days)||20
2509131|NCT00766090|6151077|P2|STARTED|Treatment Period 3 (28 Days)||27
2509132|NCT00766090|6151078|P1|STARTED|Treatment Period 3 (28 Days)||22
2509133|NCT00766090|6151067|P12|NOT COMPLETED|Washout Period 2 (14 Days)||0
2509134|NCT00766090|6151068|P11|NOT COMPLETED|Washout Period 2 (14 Days)||0
2509135|NCT00766090|6151069|P10|NOT COMPLETED|Washout Period 2 (14 Days)||0
2509136|NCT00766090|6151070|P9|NOT COMPLETED|Washout Period 2 (14 Days)||0
2509137|NCT00766090|6151071|P8|NOT COMPLETED|Washout Period 2 (14 Days)||0
2509138|NCT00766090|6151072|P7|NOT COMPLETED|Washout Period 2 (14 Days)||0
2509139|NCT00766090|6151073|P6|NOT COMPLETED|Washout Period 2 (14 Days)||0
2509140|NCT00766090|6151074|P5|NOT COMPLETED|Washout Period 2 (14 Days)||0
2509141|NCT00766090|6151075|P4|NOT COMPLETED|Washout Period 2 (14 Days)||0
2509142|NCT00766090|6151076|P3|NOT COMPLETED|Washout Period 2 (14 Days)||1
2509143|NCT00766090|6151077|P2|NOT COMPLETED|Washout Period 2 (14 Days)||0
2509144|NCT00766090|6151078|P1|NOT COMPLETED|Washout Period 2 (14 Days)||0
2509145|NCT00766090|6151067|P12|COMPLETED|Washout Period 2 (14 Days)||7
2509146|NCT00766090|6151068|P11|COMPLETED|Washout Period 2 (14 Days)||7
2509147|NCT00766090|6151069|P10|COMPLETED|Washout Period 2 (14 Days)||8
2509148|NCT00766090|6151070|P9|COMPLETED|Washout Period 2 (14 Days)||6
2509149|NCT00766090|6151071|P8|COMPLETED|Washout Period 2 (14 Days)||8
2509150|NCT00766090|6151072|P7|COMPLETED|Washout Period 2 (14 Days)||6
2509151|NCT00766090|6151073|P6|COMPLETED|Washout Period 2 (14 Days)||23
2509152|NCT00766090|6151074|P5|COMPLETED|Washout Period 2 (14 Days)||21
2509153|NCT00766090|6151075|P4|COMPLETED|Washout Period 2 (14 Days)||25
2509154|NCT00766090|6151076|P3|COMPLETED|Washout Period 2 (14 Days)||20
2509155|NCT00766090|6151077|P2|COMPLETED|Washout Period 2 (14 Days)||27
2509156|NCT00766090|6151078|P1|COMPLETED|Washout Period 2 (14 Days)||22
2509157|NCT00766090|6151067|P12|STARTED|Washout Period 2 (14 Days)||7
2509158|NCT00766090|6151068|P11|STARTED|Washout Period 2 (14 Days)||7
2509159|NCT00766090|6151069|P10|STARTED|Washout Period 2 (14 Days)||8
2509160|NCT00766090|6151070|P9|STARTED|Washout Period 2 (14 Days)||6
2509161|NCT00766090|6151071|P8|STARTED|Washout Period 2 (14 Days)||8
2509162|NCT00766090|6151072|P7|STARTED|Washout Period 2 (14 Days)||6
2509163|NCT00766090|6151073|P6|STARTED|Washout Period 2 (14 Days)||23
2509164|NCT00766090|6151074|P5|STARTED|Washout Period 2 (14 Days)||21
2509165|NCT00766090|6151075|P4|STARTED|Washout Period 2 (14 Days)||25
2509166|NCT00766090|6151076|P3|STARTED|Washout Period 2 (14 Days)||21
2509167|NCT00766090|6151077|P2|STARTED|Washout Period 2 (14 Days)||27
2509168|NCT00766090|6151078|P1|STARTED|Washout Period 2 (14 Days)||22
2509169|NCT00766090|6151067|P12|NOT COMPLETED|Treatment Period 2 (28 Days)||0
2509170|NCT00766090|6151068|P11|NOT COMPLETED|Treatment Period 2 (28 Days)||0
2509171|NCT00766090|6151069|P10|NOT COMPLETED|Treatment Period 2 (28 Days)||0
2509172|NCT00766090|6151070|P9|NOT COMPLETED|Treatment Period 2 (28 Days)||0
2509173|NCT00766090|6151071|P8|NOT COMPLETED|Treatment Period 2 (28 Days)||0
2509174|NCT00766090|6151072|P7|NOT COMPLETED|Treatment Period 2 (28 Days)||0
2509175|NCT00766090|6151073|P6|NOT COMPLETED|Treatment Period 2 (28 Days)||0
2509176|NCT00766090|6151074|P5|NOT COMPLETED|Treatment Period 2 (28 Days)||2
2509177|NCT00766090|6151075|P4|NOT COMPLETED|Treatment Period 2 (28 Days)||0
2509178|NCT00766090|6151076|P3|NOT COMPLETED|Treatment Period 2 (28 Days)||1
2509179|NCT00766090|6151077|P2|NOT COMPLETED|Treatment Period 2 (28 Days)||0
2509180|NCT00766090|6151078|P1|NOT COMPLETED|Treatment Period 2 (28 Days)||0
2509181|NCT00766090|6151067|P12|COMPLETED|Treatment Period 2 (28 Days)||7
2509182|NCT00766090|6151068|P11|COMPLETED|Treatment Period 2 (28 Days)||7
2509183|NCT00766090|6151069|P10|COMPLETED|Treatment Period 2 (28 Days)||8
2509184|NCT00766090|6151070|P9|COMPLETED|Treatment Period 2 (28 Days)||6
2509185|NCT00766090|6151071|P8|COMPLETED|Treatment Period 2 (28 Days)||8
2509186|NCT00766090|6151072|P7|COMPLETED|Treatment Period 2 (28 Days)||6
2509187|NCT00766090|6151073|P6|COMPLETED|Treatment Period 2 (28 Days)||23
2509188|NCT00766090|6151074|P5|COMPLETED|Treatment Period 2 (28 Days)||21
2509189|NCT00766090|6151075|P4|COMPLETED|Treatment Period 2 (28 Days)||25
2509190|NCT00766090|6151076|P3|COMPLETED|Treatment Period 2 (28 Days)||21
2509191|NCT00766090|6151077|P2|COMPLETED|Treatment Period 2 (28 Days)||27
2509192|NCT00766090|6151078|P1|COMPLETED|Treatment Period 2 (28 Days)||22
2509193|NCT00766090|6151067|P12|STARTED|Treatment Period 2 (28 Days)||7
2509194|NCT00766090|6151068|P11|STARTED|Treatment Period 2 (28 Days)||7
2509195|NCT00766090|6151069|P10|STARTED|Treatment Period 2 (28 Days)||8
2509196|NCT00766090|6151070|P9|STARTED|Treatment Period 2 (28 Days)||6
2509197|NCT00766090|6151071|P8|STARTED|Treatment Period 2 (28 Days)||8
2509198|NCT00766090|6151072|P7|STARTED|Treatment Period 2 (28 Days)||6
2509199|NCT00766090|6151073|P6|STARTED|Treatment Period 2 (28 Days)||23
2509200|NCT00766090|6151074|P5|STARTED|Treatment Period 2 (28 Days)||23
2509201|NCT00766090|6151075|P4|STARTED|Treatment Period 2 (28 Days)||25
2509202|NCT00766090|6151076|P3|STARTED|Treatment Period 2 (28 Days)||22
2509203|NCT00766090|6151077|P2|STARTED|Treatment Period 2 (28 Days)||27
2509204|NCT00766090|6151078|P1|STARTED|Treatment Period 2 (28 Days)||22
2509205|NCT00766090|6151067|P12|NOT COMPLETED|Washout Period 1 (14 Days)||0
2509206|NCT00766090|6151068|P11|NOT COMPLETED|Washout Period 1 (14 Days)||0
2509207|NCT00766090|6151069|P10|NOT COMPLETED|Washout Period 1 (14 Days)||0
2509208|NCT00766090|6151070|P9|NOT COMPLETED|Washout Period 1 (14 Days)||0
2509209|NCT00766090|6151071|P8|NOT COMPLETED|Washout Period 1 (14 Days)||0
2509210|NCT00766090|6151072|P7|NOT COMPLETED|Washout Period 1 (14 Days)||0
2509211|NCT00766090|6151073|P6|NOT COMPLETED|Washout Period 1 (14 Days)||0
2509212|NCT00766090|6151074|P5|NOT COMPLETED|Washout Period 1 (14 Days)||0
2509213|NCT00766090|6151075|P4|NOT COMPLETED|Washout Period 1 (14 Days)||0
2509214|NCT00766090|6151076|P3|NOT COMPLETED|Washout Period 1 (14 Days)||1
2509215|NCT00766090|6151077|P2|NOT COMPLETED|Washout Period 1 (14 Days)||0
2509216|NCT00766090|6151078|P1|NOT COMPLETED|Washout Period 1 (14 Days)||0
2509217|NCT00766090|6151067|P12|COMPLETED|Washout Period 1 (14 Days)||7
2509218|NCT00766090|6151068|P11|COMPLETED|Washout Period 1 (14 Days)||7
2509219|NCT00766090|6151069|P10|COMPLETED|Washout Period 1 (14 Days)||8
2509220|NCT00766090|6151070|P9|COMPLETED|Washout Period 1 (14 Days)||6
2509221|NCT00766090|6151071|P8|COMPLETED|Washout Period 1 (14 Days)||8
2509222|NCT00766090|6151072|P7|COMPLETED|Washout Period 1 (14 Days)||6
2509223|NCT00766090|6151073|P6|COMPLETED|Washout Period 1 (14 Days)||23
2509224|NCT00766090|6151074|P5|COMPLETED|Washout Period 1 (14 Days)||23
2509225|NCT00766090|6151075|P4|COMPLETED|Washout Period 1 (14 Days)||25
2509226|NCT00766090|6151076|P3|COMPLETED|Washout Period 1 (14 Days)||22
2509227|NCT00766090|6151077|P2|COMPLETED|Washout Period 1 (14 Days)||27
2509228|NCT00766090|6151078|P1|COMPLETED|Washout Period 1 (14 Days)||22
2509229|NCT00766090|6151067|P12|STARTED|Washout Period 1 (14 Days)||7
2509230|NCT00766090|6151068|P11|STARTED|Washout Period 1 (14 Days)||7
2509231|NCT00766090|6151069|P10|STARTED|Washout Period 1 (14 Days)||8
2509232|NCT00766090|6151070|P9|STARTED|Washout Period 1 (14 Days)||6
2509233|NCT00766090|6151071|P8|STARTED|Washout Period 1 (14 Days)||8
2509234|NCT00766090|6151072|P7|STARTED|Washout Period 1 (14 Days)||6
2509235|NCT00766090|6151073|P6|STARTED|Washout Period 1 (14 Days)||23
2509236|NCT00766090|6151074|P5|STARTED|Washout Period 1 (14 Days)||23
2509237|NCT00766090|6151075|P4|STARTED|Washout Period 1 (14 Days)||25
2509238|NCT00766090|6151076|P3|STARTED|Washout Period 1 (14 Days)||23
2509239|NCT00766090|6151077|P2|STARTED|Washout Period 1 (14 Days)||27
2509240|NCT00766090|6151078|P1|STARTED|Washout Period 1 (14 Days)||22
2509241|NCT00766090|6151067|P12|NOT COMPLETED|Treatment Period 1 (28 Days)||0
2509242|NCT00766090|6151068|P11|NOT COMPLETED|Treatment Period 1 (28 Days)||0
2509243|NCT00766090|6151069|P10|NOT COMPLETED|Treatment Period 1 (28 Days)||0
2509244|NCT00766090|6151070|P9|NOT COMPLETED|Treatment Period 1 (28 Days)||1
2509245|NCT00766090|6151071|P8|NOT COMPLETED|Treatment Period 1 (28 Days)||0
2509246|NCT00766090|6151072|P7|NOT COMPLETED|Treatment Period 1 (28 Days)||0
2509247|NCT00766090|6151073|P6|NOT COMPLETED|Treatment Period 1 (28 Days)||0
2509248|NCT00766090|6151074|P5|NOT COMPLETED|Treatment Period 1 (28 Days)||0
2509249|NCT00766090|6151075|P4|NOT COMPLETED|Treatment Period 1 (28 Days)||1
2509250|NCT00766090|6151076|P3|NOT COMPLETED|Treatment Period 1 (28 Days)||0
2509251|NCT00766090|6151077|P2|NOT COMPLETED|Treatment Period 1 (28 Days)||0
2509252|NCT00766090|6151078|P1|NOT COMPLETED|Treatment Period 1 (28 Days)||3
2509253|NCT00766090|6151067|P12|COMPLETED|Treatment Period 1 (28 Days)||7
2509254|NCT00766090|6151068|P11|COMPLETED|Treatment Period 1 (28 Days)||7
2509255|NCT00766090|6151069|P10|COMPLETED|Treatment Period 1 (28 Days)||8
2509256|NCT00766090|6151070|P9|COMPLETED|Treatment Period 1 (28 Days)||6
2509257|NCT00766090|6151071|P8|COMPLETED|Treatment Period 1 (28 Days)||8
2509258|NCT00766090|6151072|P7|COMPLETED|Treatment Period 1 (28 Days)||6
2509259|NCT00766090|6151073|P6|COMPLETED|Treatment Period 1 (28 Days)||23
2509260|NCT00766090|6151074|P5|COMPLETED|Treatment Period 1 (28 Days)||23
2509261|NCT00766090|6151075|P4|COMPLETED|Treatment Period 1 (28 Days)||25
2509262|NCT00766090|6151076|P3|COMPLETED|Treatment Period 1 (28 Days)||23
2509263|NCT00766090|6151077|P2|COMPLETED|Treatment Period 1 (28 Days)||27
2509264|NCT00766090|6151078|P1|COMPLETED|Treatment Period 1 (28 Days)||22
2509265|NCT00766090|6151067|P12|STARTED|Treatment Period 1 (28 Days)||7
2509266|NCT00766090|6151068|P11|STARTED|Treatment Period 1 (28 Days)||7
2509267|NCT00766090|6151069|P10|STARTED|Treatment Period 1 (28 Days)||8
2509268|NCT00766090|6151070|P9|STARTED|Treatment Period 1 (28 Days)||7
2509269|NCT00766090|6151071|P8|STARTED|Treatment Period 1 (28 Days)||8
2509270|NCT00766090|6151072|P7|STARTED|Treatment Period 1 (28 Days)||6
2509271|NCT00766090|6151073|P6|STARTED|Treatment Period 1 (28 Days)||23
2509272|NCT00766090|6151074|P5|STARTED|Treatment Period 1 (28 Days)||23
2509273|NCT00766090|6151075|P4|STARTED|Treatment Period 1 (28 Days)||26
2509274|NCT00766090|6151076|P3|STARTED|Treatment Period 1 (28 Days)||23
2509275|NCT00766090|6151077|P2|STARTED|Treatment Period 1 (28 Days)||27
2509276|NCT00766090|6151078|P1|STARTED|Treatment Period 1 (28 Days)||25
2509277|NCT00766051|6151119|P2|NOT COMPLETED|Overall Study||0
2509278|NCT00766051|6151120|P1|NOT COMPLETED|Overall Study||2
2509279|NCT00766051|6151119|P2|COMPLETED|Overall Study||10
2509280|NCT00766051|6151120|P1|COMPLETED|Overall Study||10
2509281|NCT00766051|6151119|P2|STARTED|Overall Study||10
2509282|NCT00766051|6151120|P1|STARTED|Overall Study||12
2509283|NCT00766038|6151132|P2|NOT COMPLETED|Overall Study||14
2509284|NCT00766038|6151133|P1|NOT COMPLETED|Overall Study||15
2509285|NCT00766038|6151132|P2|COMPLETED|Overall Study||18
2509286|NCT00766038|6151133|P1|COMPLETED|Overall Study||16
2509287|NCT00766038|6151132|P2|STARTED|Overall Study||32
2509288|NCT00766038|6151133|P1|STARTED|Overall Study||31
2509289|NCT00765999|6151149|P1|NOT COMPLETED|Overall Study||784
2509290|NCT00765999|6151149|P1|COMPLETED|Overall Study||770
2509291|NCT00765999|6151149|P1|STARTED|Overall Study||1554
2509292|NCT00765947|6151155|P1|NOT COMPLETED|Overall Study||24
2509293|NCT00765947|6151155|P1|COMPLETED|Overall Study||232
2509294|NCT00765947|6151155|P1|STARTED|Overall Study||256
2509295|NCT00765895|6151166|P2|NOT COMPLETED|Overall Study||0
2509296|NCT00765895|6151167|P1|NOT COMPLETED|Overall Study||0
2509297|NCT00765895|6151166|P2|COMPLETED|Overall Study||65
2509298|NCT00765895|6151167|P1|COMPLETED|Overall Study||65
2509299|NCT00765895|6151166|P2|STARTED|Overall Study||65
2509300|NCT00765895|6151167|P1|STARTED|Overall Study||65
2509301|NCT00765882|6151176|P3|NOT COMPLETED|Overall Study||36
2509302|NCT00765882|6151177|P2|NOT COMPLETED|Overall Study||40
2509303|NCT00765882|6151178|P1|NOT COMPLETED|Overall Study||24
2509304|NCT00765882|6151176|P3|COMPLETED|Overall Study||169
2509305|NCT00765882|6151177|P2|COMPLETED|Overall Study||173
2509306|NCT00765882|6151178|P1|COMPLETED|Overall Study||191
2509307|NCT00765882|6151176|P3|STARTED|Overall Study||205
2509308|NCT00765882|6151177|P2|STARTED|Overall Study||213
2509309|NCT00765882|6151178|P1|STARTED|Overall Study||215
2509310|NCT00765843|6151210|P3|NOT COMPLETED|Overall Study||3
2509311|NCT00765843|6151211|P2|NOT COMPLETED|Overall Study||4
2509312|NCT00765843|6151212|P1|NOT COMPLETED|Overall Study||1
2509313|NCT00765843|6151210|P3|COMPLETED|Overall Study||23
2509314|NCT00765843|6151211|P2|COMPLETED|Overall Study||21
2509315|NCT00765843|6151212|P1|COMPLETED|Overall Study||25
2509316|NCT00765843|6151210|P3|STARTED|Overall Study||26
2509317|NCT00765843|6151211|P2|STARTED|Overall Study||25
2509318|NCT00765843|6151212|P1|STARTED|Overall Study||26
2509319|NCT00765817|6151222|P2|NOT COMPLETED|Overall Study||22
2509320|NCT00765817|6151223|P1|NOT COMPLETED|Overall Study||26
2509321|NCT00765817|6151222|P2|COMPLETED|Overall Study||101
2509322|NCT00765817|6151223|P1|COMPLETED|Overall Study||112
2509323|NCT00765817|6151222|P2|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|123
2509324|NCT00765817|6151223|P1|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|138
2509325|NCT00765765|6151261|P1|NOT COMPLETED|Overall Study||0
2509326|NCT00765765|6151261|P1|COMPLETED|Overall Study||6
2509327|NCT00765765|6151261|P1|STARTED|Overall Study||6
2509328|NCT00765726|6151271|P1|NOT COMPLETED|Overall Study||9
2509329|NCT00765726|6151271|P1|COMPLETED|Overall Study||3
2509330|NCT00765726|6151271|P1|STARTED|Overall Study||12
2509331|NCT00765674|6151279|P4|NOT COMPLETED|Overall Study||25
2509332|NCT00765674|6151280|P3|NOT COMPLETED|Overall Study||17
2509333|NCT00765674|6151281|P2|NOT COMPLETED|Overall Study||22
2509334|NCT00765674|6151282|P1|NOT COMPLETED|Overall Study||21
2509335|NCT00765674|6151279|P4|COMPLETED|Overall Study||285
2509336|NCT00765674|6151280|P3|COMPLETED|Overall Study||279
2509337|NCT00765674|6151281|P2|COMPLETED|Overall Study||276
2509338|NCT00765674|6151282|P1|COMPLETED|Overall Study||266
2509339|NCT00765674|6151279|P4|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|310
2509340|NCT00765674|6151280|P3|STARTED|Overall Study||296
2509341|NCT00765674|6151281|P2|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|298
2509342|NCT00765674|6151282|P1|STARTED|Overall Study||287
2509343|NCT00765661|6151306|P2|NOT COMPLETED|Overall Study||0
2509344|NCT00765661|6151307|P1|NOT COMPLETED|Overall Study||0
2509345|NCT00765661|6151306|P2|COMPLETED|Overall Study||31
2509346|NCT00765661|6151307|P1|COMPLETED|Overall Study||32
2509347|NCT00765661|6151306|P2|STARTED|Overall Study||31
2509348|NCT00765661|6151307|P1|STARTED|Overall Study||32
2509349|NCT00765648|6151321|P2|NOT COMPLETED|Overall Study||2
2509350|NCT00765648|6151322|P1|NOT COMPLETED|Overall Study||1
2509351|NCT00765648|6151321|P2|COMPLETED|Overall Study||114
2509352|NCT00765648|6151322|P1|COMPLETED|Overall Study||109
2509353|NCT00765648|6151321|P2|STARTED|Overall Study||116
2509354|NCT00765648|6151322|P1|STARTED|Overall Study||110
2509355|NCT00765570|6151340|P2|NOT COMPLETED|Overall Study||0
2509356|NCT00765570|6151341|P1|NOT COMPLETED|Overall Study||2
2509357|NCT00765570|6151340|P2|COMPLETED|Overall Study||3
2509358|NCT00765570|6151341|P1|COMPLETED|Overall Study||7
2509359|NCT00765570|6151340|P2|STARTED|Overall Study||3
2509360|NCT00765570|6151341|P1|STARTED|Overall Study||9
2509361|NCT00765388|6151349|P2|NOT COMPLETED|Period 2||0
2509362|NCT00765388|6151350|P1|NOT COMPLETED|Period 2||0
2509363|NCT00765388|6151349|P2|COMPLETED|Period 2||6
2509364|NCT00765388|6151350|P1|COMPLETED|Period 2||15
2509365|NCT00765388|6151349|P2|STARTED|Period 2||6
2509366|NCT00765388|6151350|P1|STARTED|Period 2||15
2509367|NCT00765388|6151349|P2|NOT COMPLETED|Period 1||5
2509368|NCT00765388|6151350|P1|NOT COMPLETED|Period 1||1
2509369|NCT00765388|6151349|P2|COMPLETED|Period 1||6
2509370|NCT00765388|6151350|P1|COMPLETED|Period 1||15
2509371|NCT00765388|6151349|P2|STARTED|Period 1||11
2509372|NCT00765388|6151350|P1|STARTED|Period 1|A cross-over study|16
2509373|NCT00765375|6151378|P1|NOT COMPLETED|Overall Study||0
2509374|NCT00765375|6151378|P1|COMPLETED|Overall Study||5
2509375|NCT00765375|6151378|P1|STARTED|Overall Study||5
2509376|NCT00765362|6151384|P1|NOT COMPLETED|Overall Study||137
2509377|NCT00765362|6151384|P1|COMPLETED|Overall Study||282
2509378|NCT00765362|6151384|P1|STARTED|Overall Study||419
2509379|NCT00765336|6151392|P2|NOT COMPLETED|Overall Study||16
2509380|NCT00765336|6151393|P1|NOT COMPLETED|Overall Study||19
2509381|NCT00765336|6151392|P2|COMPLETED|Overall Study||73
2509382|NCT00765336|6151393|P1|COMPLETED|Overall Study||72
2509383|NCT00765336|6151392|P2|STARTED|Overall Study||89
2509384|NCT00765336|6151393|P1|STARTED|Overall Study||91
2509385|NCT00765245|6151401|P2|NOT COMPLETED|Overall Study||2
2509386|NCT00765245|6151402|P1|NOT COMPLETED|Overall Study||13
2509387|NCT00765245|6151401|P2|COMPLETED|Overall Study||20
2509388|NCT00765245|6151402|P1|COMPLETED|Overall Study||9
2509389|NCT00765245|6151401|P2|STARTED|Overall Study||22
2509390|NCT00765245|6151402|P1|STARTED|Overall Study||22
2509391|NCT00765232|6151414|P2|NOT COMPLETED|Overall Study||0
2509392|NCT00765232|6151415|P1|NOT COMPLETED|Overall Study||0
2509393|NCT00765232|6151414|P2|COMPLETED|Overall Study||54
2509394|NCT00765232|6151415|P1|COMPLETED|Overall Study||57
2509395|NCT00765232|6151414|P2|STARTED|Overall Study||54
2509396|NCT00765232|6151415|P1|STARTED|Overall Study||57
2509397|NCT00765206|6151423|P4|NOT COMPLETED|Second Intervention||0
2509398|NCT00765206|6151424|P3|NOT COMPLETED|Second Intervention||0
2509399|NCT00765206|6151425|P2|NOT COMPLETED|Second Intervention||0
2509400|NCT00765206|6151426|P1|NOT COMPLETED|Second Intervention||0
2509401|NCT00765206|6151423|P4|COMPLETED|Second Intervention||15
2509402|NCT00765206|6151424|P3|COMPLETED|Second Intervention||15
2509403|NCT00765206|6151425|P2|COMPLETED|Second Intervention||15
2509404|NCT00765206|6151426|P1|COMPLETED|Second Intervention||15
2509405|NCT00765206|6151423|P4|STARTED|Second Intervention||15
2509406|NCT00765206|6151424|P3|STARTED|Second Intervention||15
2509407|NCT00765206|6151425|P2|STARTED|Second Intervention||15
2509408|NCT00765206|6151426|P1|STARTED|Second Intervention||15
2509409|NCT00765206|6151423|P4|NOT COMPLETED|Washout Period of 14 Days||0
2509410|NCT00765206|6151424|P3|NOT COMPLETED|Washout Period of 14 Days||0
2509411|NCT00765206|6151425|P2|NOT COMPLETED|Washout Period of 14 Days||0
2509412|NCT00765206|6151426|P1|NOT COMPLETED|Washout Period of 14 Days||0
2509413|NCT00765206|6151423|P4|COMPLETED|Washout Period of 14 Days||15
2509414|NCT00765206|6151424|P3|COMPLETED|Washout Period of 14 Days||15
2509415|NCT00765206|6151425|P2|COMPLETED|Washout Period of 14 Days||15
2509416|NCT00765206|6151426|P1|COMPLETED|Washout Period of 14 Days||15
2509417|NCT00765206|6151423|P4|STARTED|Washout Period of 14 Days||15
2509418|NCT00765206|6151424|P3|STARTED|Washout Period of 14 Days||15
2509419|NCT00765206|6151425|P2|STARTED|Washout Period of 14 Days||15
2509420|NCT00765206|6151426|P1|STARTED|Washout Period of 14 Days||15
2509421|NCT00765206|6151423|P4|NOT COMPLETED|First Intervention||0
2509422|NCT00765206|6151424|P3|NOT COMPLETED|First Intervention||0
2509423|NCT00765206|6151425|P2|NOT COMPLETED|First Intervention||0
2509424|NCT00765206|6151426|P1|NOT COMPLETED|First Intervention||0
2509425|NCT00765206|6151423|P4|COMPLETED|First Intervention||15
2509426|NCT00765206|6151424|P3|COMPLETED|First Intervention||15
2509427|NCT00765206|6151425|P2|COMPLETED|First Intervention||15
2509428|NCT00765206|6151426|P1|COMPLETED|First Intervention||15
2509429|NCT00765206|6151423|P4|STARTED|First Intervention||15
2509430|NCT00765206|6151424|P3|STARTED|First Intervention||15
2509431|NCT00765206|6151425|P2|STARTED|First Intervention||15
2509432|NCT00765206|6151426|P1|STARTED|First Intervention||15
2509433|NCT00765193|6151432|P1|NOT COMPLETED|Full Body Examination||0
2509434|NCT00765193|6151432|P1|COMPLETED|Full Body Examination||14381
2509435|NCT00765193|6151432|P1|STARTED|Full Body Examination||14381
2509436|NCT00765193|6151432|P1|NOT COMPLETED|Problem Area Examination||0
2509437|NCT00765193|6151432|P1|COMPLETED|Problem Area Examination||14381
2509438|NCT00765193|6151432|P1|STARTED|Problem Area Examination||14381
2509439|NCT00765128|6151439|P2|NOT COMPLETED|Overall Study||0
2509440|NCT00765128|6151440|P1|NOT COMPLETED|Overall Study||0
2509441|NCT00765128|6151439|P2|COMPLETED|Overall Study||9
2509442|NCT00765128|6151440|P1|COMPLETED|Overall Study||8
2509443|NCT00765128|6151439|P2|STARTED|Overall Study||9
2509444|NCT00765128|6151440|P1|STARTED|Overall Study||8
2509445|NCT00765102|6151448|P1|NOT COMPLETED|Overall Study||31
2509446|NCT00765102|6151448|P1|COMPLETED|Overall Study|Completed 8 cycles of treatment|1
2509447|NCT00765102|6151448|P1|STARTED|Overall Study||32
2509448|NCT00765076|6151473|P3|NOT COMPLETED|Overall Study||1
2509449|NCT00765076|6151474|P2|NOT COMPLETED|Overall Study||0
2509450|NCT00765076|6151475|P1|NOT COMPLETED|Overall Study||1
2509451|NCT00765076|6151473|P3|COMPLETED|Overall Study||49
2509452|NCT00765076|6151474|P2|COMPLETED|Overall Study||73
2509453|NCT00765076|6151475|P1|COMPLETED|Overall Study||68
2509454|NCT00765076|6151473|P3|STARTED|Overall Study||50
2509455|NCT00765076|6151474|P2|STARTED|Overall Study||73
2509456|NCT00765076|6151475|P1|STARTED|Overall Study||69
2509457|NCT00765063|6151528|P1|NOT COMPLETED|Overall Study||32
2509458|NCT00765063|6151528|P1|COMPLETED|Overall Study||30
2509459|NCT00765063|6151528|P1|STARTED|Overall Study||62
2509460|NCT00765037|6151544|P1|NOT COMPLETED|Overall Study||6
2509461|NCT00765037|6151544|P1|COMPLETED|Overall Study|Subjects who came in for 1 year visit.|13
2509462|NCT00765037|6151544|P1|STARTED|Overall Study|Original number of eligible subjects who signed a consent form.|19
2509463|NCT00764946|6151551|P3|NOT COMPLETED|Overall Study||4
2509464|NCT00764946|6151552|P2|NOT COMPLETED|Overall Study||17
2509465|NCT00764946|6151553|P1|NOT COMPLETED|Overall Study||13
2509466|NCT00764946|6151551|P3|COMPLETED|Overall Study||18
2509467|NCT00764946|6151552|P2|COMPLETED|Overall Study||72
2509468|NCT00764946|6151553|P1|COMPLETED|Overall Study||85
2509469|NCT00764946|6151551|P3|TREATED|Overall Study||21
2509470|NCT00764946|6151552|P2|TREATED|Overall Study||88
2509471|NCT00764946|6151553|P1|TREATED|Overall Study||97
2509472|NCT00764946|6151551|P3|STARTED|Overall Study||22
2509473|NCT00764946|6151552|P2|STARTED|Overall Study||89
2509474|NCT00764946|6151553|P1|STARTED|Overall Study||98
2509475|NCT00764881|6151581|P2|NOT COMPLETED|Overall Study||10
2509476|NCT00764881|6151582|P1|NOT COMPLETED|Overall Study||16
2509477|NCT00764881|6151581|P2|COMPLETED|Overall Study||99
2509478|NCT00764881|6151582|P1|COMPLETED|Overall Study||92
2509479|NCT00764881|6151581|P2|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|107
2509480|NCT00764881|6151582|P1|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|106
2509481|NCT00764881|6151581|P2|STARTED|Overall Study||109
2509482|NCT00764881|6151582|P1|STARTED|Overall Study||108
2509483|NCT00764868|6151806|P1|NOT COMPLETED|Overall Study||113
2509484|NCT00764868|6151806|P1|COMPLETED|Overall Study||156
2509485|NCT00764868|6151806|P1|STARTED|Overall Study||269
2509486|NCT00764790|6151815|P3|NOT COMPLETED|Overall Study||30
2509487|NCT00764790|6151816|P2|NOT COMPLETED|Overall Study||41
2509488|NCT00764790|6151817|P1|NOT COMPLETED|Overall Study||38
2509489|NCT00764790|6151815|P3|COMPLETED|Overall Study||1074
2509490|NCT00764790|6151816|P2|COMPLETED|Overall Study||1065
2509491|NCT00764790|6151817|P1|COMPLETED|Overall Study||1069
2509492|NCT00764790|6151815|P3|STARTED|Overall Study||1104
2509493|NCT00764790|6151816|P2|STARTED|Overall Study||1106
2509494|NCT00764790|6151817|P1|STARTED|Overall Study||1107
2509495|NCT00764751|6151851|P2|NOT COMPLETED|Overall Study||1
2509496|NCT00764751|6151852|P1|NOT COMPLETED|Overall Study||2
2509497|NCT00764751|6151851|P2|COMPLETED|Overall Study||11
2509498|NCT00764751|6151852|P1|COMPLETED|Overall Study||37
2509499|NCT00764751|6151851|P2|STARTED|Overall Study||12
2509500|NCT00764751|6151852|P1|STARTED|Overall Study||39
2509501|NCT00764699|6151886|P1|NOT COMPLETED|Overall Study||3
2509502|NCT00764699|6151886|P1|COMPLETED|Overall Study||0
2509503|NCT00764699|6151886|P1|STARTED|Overall Study||3
2509504|NCT00764673|6151890|P1|NOT COMPLETED|Overall Study||12
2509505|NCT00764673|6151890|P1|COMPLETED|Overall Study||59
2509506|NCT00764673|6151890|P1|STARTED|Overall Study||71
2509507|NCT00764660|6151900|P2|NOT COMPLETED|Overall Study||11
2509508|NCT00764660|6151901|P1|NOT COMPLETED|Overall Study||22
2509509|NCT00764660|6151900|P2|COMPLETED|Overall Study||55
2509510|NCT00764660|6151901|P1|COMPLETED|Overall Study||53
2509511|NCT00764660|6151900|P2|STARTED|Overall Study||66
2509512|NCT00764660|6151901|P1|STARTED|Overall Study||75
2509513|NCT00764517|6151935|P2|NOT COMPLETED|Overall Study||14
2509514|NCT00764517|6151936|P1|NOT COMPLETED|Overall Study||15
2509515|NCT00764517|6151935|P2|COMPLETED|Overall Study||4
2509516|NCT00764517|6151936|P1|COMPLETED|Overall Study||24
2509517|NCT00764517|6151935|P2|STARTED|Overall Study||18
2509518|NCT00764517|6151936|P1|STARTED|Overall Study||39
2509519|NCT00764504|6151957|P3|NOT COMPLETED|Overall Study||103
2509520|NCT00764504|6151958|P2|NOT COMPLETED|Overall Study||70
2509521|NCT00764504|6151959|P1|NOT COMPLETED|Overall Study||66
2509522|NCT00764504|6151957|P3|COMPLETED|Overall Study||131
2509523|NCT00764504|6151958|P2|COMPLETED|Overall Study||71
2509524|NCT00764504|6151959|P1|COMPLETED|Overall Study||75
2509525|NCT00764504|6151957|P3|STARTED|Overall Study||234
2509526|NCT00764504|6151958|P2|STARTED|Overall Study||141
2509527|NCT00764504|6151959|P1|STARTED|Overall Study||141
2509528|NCT00764478|6151988|P3|NOT COMPLETED|Overall Study||8
2509529|NCT00764478|6151989|P2|NOT COMPLETED|Overall Study||22
2509530|NCT00764478|6151990|P1|NOT COMPLETED|Overall Study||15
2509531|NCT00764478|6151988|P3|COMPLETED|Overall Study||118
2509532|NCT00764478|6151989|P2|COMPLETED|Overall Study||97
2509533|NCT00764478|6151990|P1|COMPLETED|Overall Study||107
2509534|NCT00764478|6151988|P3|STARTED|Overall Study||126
2509535|NCT00764478|6151989|P2|STARTED|Overall Study||119
2509536|NCT00764478|6151990|P1|STARTED|Overall Study||122
2509537|NCT00764465|6152070|P6|NOT COMPLETED|Overall Study||1
2509538|NCT00764465|6152071|P5|NOT COMPLETED|Overall Study||1
2509539|NCT00764465|6152072|P4|NOT COMPLETED|Overall Study||1
2509540|NCT00764465|6152073|P3|NOT COMPLETED|Overall Study||1
2509541|NCT00764465|6152074|P2|NOT COMPLETED|Overall Study||1
2509542|NCT00764465|6152075|P1|NOT COMPLETED|Overall Study||2
2509543|NCT00764465|6152070|P6|COMPLETED|Overall Study||7
2509544|NCT00764465|6152071|P5|COMPLETED|Overall Study||6
2509545|NCT00764465|6152072|P4|COMPLETED|Overall Study||6
2509546|NCT00764465|6152073|P3|COMPLETED|Overall Study||6
2509547|NCT00764465|6152074|P2|COMPLETED|Overall Study||6
2509548|NCT00764465|6152075|P1|COMPLETED|Overall Study||7
2509549|NCT00764465|6152070|P6|STARTED|Overall Study||8
2509550|NCT00764465|6152071|P5|STARTED|Overall Study||7
2509551|NCT00764465|6152072|P4|STARTED|Overall Study||7
2509552|NCT00764465|6152073|P3|STARTED|Overall Study||7
2509553|NCT00764465|6152074|P2|STARTED|Overall Study||7
2509554|NCT00764465|6152075|P1|STARTED|Overall Study||9
2509555|NCT00764361|6152103|P2|NOT COMPLETED|Overall Study||4
2509556|NCT00764361|6152104|P1|NOT COMPLETED|Overall Study||2
2509557|NCT00764361|6152103|P2|COMPLETED|Overall Study||3
2509558|NCT00764361|6152104|P1|COMPLETED|Overall Study||6
2509559|NCT00764361|6152103|P2|STARTED|Overall Study||7
2509560|NCT00764361|6152104|P1|STARTED|Overall Study||8
2509561|NCT00764322|6152112|P1|NOT COMPLETED|Overall Study||20
2509562|NCT00764322|6152112|P1|COMPLETED|Overall Study||480
2509563|NCT00764322|6152112|P1|STARTED|Overall Study||500
2509564|NCT00764309|6152129|P1|NOT COMPLETED|Overall Study||0
2509565|NCT00764309|6152129|P1|COMPLETED|Overall Study|Completed=off study. Major Reasons for off study: AE-13; withdrawn by sponsor-10; Lack of efficacy-3|31
2509566|NCT00764309|6152129|P1|STARTED|Overall Study|Number of participants treated.|31
2509567|NCT00763971|6152139|P3|NOT COMPLETED|Overall Study||69
2509568|NCT00763971|6152140|P2|NOT COMPLETED|Overall Study||38
2509569|NCT00763971|6152141|P1|NOT COMPLETED|Overall Study||33
2509570|NCT00763971|6152139|P3|COMPLETED|Overall Study||42
2509571|NCT00763971|6152140|P2|COMPLETED|Overall Study||74
2509572|NCT00763971|6152141|P1|COMPLETED|Overall Study||80
2509573|NCT00763971|6152139|P3|STARTED|Overall Study||111
2509574|NCT00763971|6152140|P2|STARTED|Overall Study||112
2509575|NCT00763971|6152141|P1|STARTED|Overall Study||113
2509576|NCT00763958|6152172|P2|NOT COMPLETED|Overall Study||11
2509577|NCT00763958|6152173|P1|NOT COMPLETED|Overall Study||14
2509578|NCT00763958|6152172|P2|COMPLETED|Overall Study||5
2509579|NCT00763958|6152173|P1|COMPLETED|Overall Study||14
2509580|NCT00763958|6152172|P2|STARTED|Overall Study||16
2509581|NCT00763958|6152173|P1|STARTED|Overall Study||28
2509582|NCT00763919|6152183|P1|NOT COMPLETED|Overall Study||13
2509583|NCT00763919|6152183|P1|COMPLETED|Overall Study||30
2509584|NCT00763919|6152183|P1|STARTED|Overall Study||43
2509585|NCT00763867|6152211|P2|NOT COMPLETED|Overall Study||12
2509586|NCT00763867|6152212|P1|NOT COMPLETED|Overall Study||5
2509587|NCT00763867|6152211|P2|COMPLETED|Overall Study||101
2509588|NCT00763867|6152212|P1|COMPLETED|Overall Study||98
2509589|NCT00763867|6152211|P2|STARTED|Overall Study||113
2509590|NCT00763867|6152212|P1|STARTED|Overall Study||103
2509591|NCT00763815|6152308|P2|NOT COMPLETED|Overall Study||84
2509592|NCT00763815|6152309|P1|NOT COMPLETED|Overall Study||52
2509593|NCT00763815|6152308|P2|COMPLETED|Overall Study||239
2509594|NCT00763815|6152309|P1|COMPLETED|Overall Study||109
2509595|NCT00763815|6152308|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||320
2509596|NCT00763815|6152309|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|159
2509597|NCT00763815|6152308|P2|Treated/Safety Population|Overall Study||323
2509598|NCT00763815|6152309|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|161
2509599|NCT00763815|6152308|P2|STARTED|Overall Study||323
2509600|NCT00763815|6152309|P1|STARTED|Overall Study|Randomized.|161
2509604|NCT00763698|6152337|P1|NOT COMPLETED|Overall Study||10
2509605|NCT00763698|6152337|P1|COMPLETED|Overall Study||76
2509606|NCT00763698|6152337|P1|STARTED|Overall Study||86
2509607|NCT00763490|6152343|P1|NOT COMPLETED|Overall Study||0
2509608|NCT00763490|6152343|P1|COMPLETED|Overall Study||20
2509609|NCT00763490|6152343|P1|STARTED|Overall Study||20
2509610|NCT00763451|6152354|P4|NOT COMPLETED|Overall Study||30
2509611|NCT00763451|6152355|P3|NOT COMPLETED|Overall Study||40
2509612|NCT00763451|6152356|P2|NOT COMPLETED|Overall Study||22
2509613|NCT00763451|6152357|P1|NOT COMPLETED|Overall Study||13
2509614|NCT00763451|6152354|P4|COMPLETED|Overall Study||131
2509615|NCT00763451|6152355|P3|COMPLETED|Overall Study||121
2509616|NCT00763451|6152356|P2|COMPLETED|Overall Study||60
2509617|NCT00763451|6152357|P1|COMPLETED|Overall Study||67
2509618|NCT00763451|6152354|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||160
2509619|NCT00763451|6152355|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||160
2509620|NCT00763451|6152356|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||80
2509621|NCT00763451|6152357|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|79
2509622|NCT00763451|6152354|P4|Treated/Safety Population|Overall Study||161
2509623|NCT00763451|6152355|P3|Treated/Safety Population|Overall Study||161
2509624|NCT00763451|6152356|P2|Treated/Safety Population|Overall Study||81
2509625|NCT00763451|6152357|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|79
2509626|NCT00763451|6152354|P4|STARTED|Overall Study||161
2509627|NCT00763451|6152355|P3|STARTED|Overall Study||161
2509628|NCT00763451|6152356|P2|STARTED|Overall Study||82
2509629|NCT00763451|6152357|P1|STARTED|Overall Study|Randomized.|80
2509630|NCT00763412|6152391|P2|NOT COMPLETED|Overall Study||4
2509631|NCT00763412|6152392|P1|NOT COMPLETED|Overall Study||4
2509632|NCT00763412|6152391|P2|COMPLETED|Overall Study||4
2509633|NCT00763412|6152392|P1|COMPLETED|Overall Study||4
2509634|NCT00763412|6152391|P2|STARTED|Overall Study||8
2509635|NCT00763412|6152392|P1|STARTED|Overall Study||8
2509636|NCT00763386|6152416|P2|NOT COMPLETED|Overall Study||40
2509637|NCT00763386|6152417|P1|NOT COMPLETED|Overall Study||48
2509638|NCT00763386|6152416|P2|COMPLETED|Overall Study||127
2509639|NCT00763386|6152417|P1|COMPLETED|Overall Study||116
2509640|NCT00763386|6152416|P2|STARTED|Overall Study||167
2509641|NCT00763386|6152417|P1|STARTED|Overall Study||164
2509642|NCT00763360|6152428|P3|NOT COMPLETED|Overall Study||0
2509643|NCT00763360|6152429|P2|NOT COMPLETED|Overall Study||2
2509644|NCT00763360|6152430|P1|NOT COMPLETED|Overall Study||0
2509645|NCT00763360|6152428|P3|COMPLETED|Overall Study||63
2509646|NCT00763360|6152429|P2|COMPLETED|Overall Study||58
2509647|NCT00763360|6152430|P1|COMPLETED|Overall Study||61
2509648|NCT00763360|6152428|P3|STARTED|Overall Study||63
2509649|NCT00763360|6152429|P2|STARTED|Overall Study||60
2509650|NCT00763360|6152430|P1|STARTED|Overall Study||61
2509651|NCT00763321|6152450|P3|NOT COMPLETED|Double-blind Period||29
2509652|NCT00763321|6152451|P2|NOT COMPLETED|Double-blind Period||21
2509653|NCT00763321|6152452|P1|NOT COMPLETED|Double-blind Period||0
2509654|NCT00763321|6152450|P3|COMPLETED|Double-blind Period||84
2509655|NCT00763321|6152451|P2|COMPLETED|Double-blind Period||88
2509656|NCT00763321|6152452|P1|COMPLETED|Double-blind Period||0
2509657|NCT00763321|6152450|P3|STARTED|Double-blind Period||113
2509658|NCT00763321|6152451|P2|STARTED|Double-blind Period||109
2509659|NCT00763321|6152452|P1|STARTED|Double-blind Period||0
2509660|NCT00763321|6152450|P3|NOT COMPLETED|Open-label Period||0
2509661|NCT00763321|6152451|P2|NOT COMPLETED|Open-label Period||0
2509662|NCT00763321|6152452|P1|NOT COMPLETED|Open-label Period||63
2509663|NCT00763321|6152450|P3|COMPLETED|Open-label Period||0
2509664|NCT00763321|6152451|P2|COMPLETED|Open-label Period||0
2509665|NCT00763321|6152452|P1|COMPLETED|Open-label Period||222
2509666|NCT00763321|6152450|P3|STARTED|Open-label Period||0
2509667|NCT00763321|6152451|P2|STARTED|Open-label Period||0
2509668|NCT00763321|6152452|P1|STARTED|Open-label Period||285
2509669|NCT00763282|6152463|P2|NOT COMPLETED|Overall Study||34
2509670|NCT00763282|6152464|P1|NOT COMPLETED|Overall Study||32
2509671|NCT00763282|6152463|P2|COMPLETED|Overall Study||38
2509672|NCT00763282|6152464|P1|COMPLETED|Overall Study||40
2509673|NCT00763282|6152463|P2|STARTED|Overall Study||72
2509674|NCT00763282|6152464|P1|STARTED|Overall Study||72
2509675|NCT00763269|6152480|P2|NOT COMPLETED|Overall Study||13
2509676|NCT00763269|6152481|P1|NOT COMPLETED|Overall Study||12
2509677|NCT00763269|6152480|P2|COMPLETED|Overall Study||299
2509678|NCT00763269|6152481|P1|COMPLETED|Overall Study||302
2509679|NCT00763269|6152480|P2|STARTED|Overall Study||312
2509680|NCT00763269|6152481|P1|STARTED|Overall Study||314
2509681|NCT00763256|6152495|P2|NOT COMPLETED|Overall Study||10
2509682|NCT00763256|6152496|P1|NOT COMPLETED|Overall Study||7
2509683|NCT00763256|6152495|P2|COMPLETED|Overall Study||8
2509684|NCT00763256|6152496|P1|COMPLETED|Overall Study||8
2509685|NCT00763256|6152495|P2|STARTED|Overall Study||18
2509686|NCT00763256|6152496|P1|STARTED|Overall Study||15
2509687|NCT00763243|6152510|P1|NOT COMPLETED|6-Month Follow-Up Period||0
2509688|NCT00763243|6152510|P1|COMPLETED|6-Month Follow-Up Period||9
2509689|NCT00763243|6152510|P1|STARTED|6-Month Follow-Up Period||9
2509690|NCT00763243|6152510|P1|NOT COMPLETED|1-Month Follow-Up Period||0
2509691|NCT00763243|6152510|P1|COMPLETED|1-Month Follow-Up Period||9
2509692|NCT00763243|6152510|P1|STARTED|1-Month Follow-Up Period||9
2509693|NCT00763243|6152510|P1|NOT COMPLETED|Training Period||0
2509694|NCT00763243|6152510|P1|COMPLETED|Training Period||9
2509695|NCT00763243|6152510|P1|STARTED|Training Period||9
2509696|NCT00763243|6152510|P1|NOT COMPLETED|Waiting Period||0
2509697|NCT00763243|6152510|P1|COMPLETED|Waiting Period||9
2509698|NCT00763243|6152510|P1|STARTED|Waiting Period||9
2509699|NCT00763139|6152532|P2|NOT COMPLETED|Overall Study||3
2509700|NCT00763139|6152533|P1|NOT COMPLETED|Overall Study||5
2509701|NCT00763139|6152532|P2|COMPLETED|Overall Study||14
2509702|NCT00763139|6152533|P1|COMPLETED|Overall Study||12
2509703|NCT00763139|6152532|P2|STARTED|Overall Study||17
2509704|NCT00763139|6152533|P1|STARTED|Overall Study||17
2509705|NCT00763061|6152555|P2|NOT COMPLETED|Overall Study||13
2509706|NCT00763061|6152556|P1|NOT COMPLETED|Overall Study||5
2509707|NCT00763061|6152555|P2|COMPLETED|Overall Study||44
2509708|NCT00763061|6152556|P1|COMPLETED|Overall Study||49
2509709|NCT00763061|6152555|P2|STARTED|Overall Study||57
2509710|NCT00763061|6152556|P1|STARTED|Overall Study||54
2509711|NCT00763048|6152570|P2|NOT COMPLETED|Overall Study||0
2509712|NCT00763048|6152571|P1|NOT COMPLETED|Overall Study||0
2509713|NCT00763048|6152570|P2|COMPLETED|Overall Study||18
2509714|NCT00763048|6152571|P1|COMPLETED|Overall Study||21
2509715|NCT00763048|6152570|P2|STARTED|Overall Study||18
2509716|NCT00763048|6152571|P1|STARTED|Overall Study||21
2509717|NCT00763035|6152595|P2|NOT COMPLETED|Second Intervention||0
2509718|NCT00763035|6152596|P1|NOT COMPLETED|Second Intervention||3
2509719|NCT00763035|6152595|P2|COMPLETED|Second Intervention||3
2509720|NCT00763035|6152596|P1|COMPLETED|Second Intervention||6
2509721|NCT00763035|6152595|P2|STARTED|Second Intervention||3
2509722|NCT00763035|6152596|P1|STARTED|Second Intervention||9
2509723|NCT00763035|6152595|P2|NOT COMPLETED|First Intervention||1
2509724|NCT00763035|6152596|P1|NOT COMPLETED|First Intervention||1
2509725|NCT00763035|6152595|P2|COMPLETED|First Intervention||3
2509726|NCT00763035|6152596|P1|COMPLETED|First Intervention||9
2509727|NCT00763035|6152595|P2|STARTED|First Intervention||4
2509728|NCT00763035|6152596|P1|STARTED|First Intervention||10
2509729|NCT00763009|6152614|P1|NOT COMPLETED|Overall Study||1
2509730|NCT00763009|6152614|P1|COMPLETED|Overall Study||7
2509731|NCT00763009|6152614|P1|STARTED|Overall Study||8
2509732|NCT00762996|6152619|P4|NOT COMPLETED|Period Two||0
2509733|NCT00762996|6152620|P3|NOT COMPLETED|Period Two||0
2509734|NCT00762996|6152621|P2|NOT COMPLETED|Period Two||0
2509735|NCT00762996|6152622|P1|NOT COMPLETED|Period Two||0
2509736|NCT00762996|6152619|P4|COMPLETED|Period Two||16
2509737|NCT00762996|6152620|P3|COMPLETED|Period Two||13
2509738|NCT00762996|6152621|P2|COMPLETED|Period Two||16
2509739|NCT00762996|6152622|P1|COMPLETED|Period Two||15
2509740|NCT00762996|6152619|P4|STARTED|Period Two||16
2509741|NCT00762996|6152620|P3|STARTED|Period Two||13
2509742|NCT00762996|6152621|P2|STARTED|Period Two||16
2509743|NCT00762996|6152622|P1|STARTED|Period Two||15
2509744|NCT00762996|6152619|P4|NOT COMPLETED|Period One||1
2509745|NCT00762996|6152620|P3|NOT COMPLETED|Period One||4
2509746|NCT00762996|6152621|P2|NOT COMPLETED|Period One||0
2509747|NCT00762996|6152622|P1|NOT COMPLETED|Period One||0
2509748|NCT00762996|6152619|P4|COMPLETED|Period One||16
2509749|NCT00762996|6152620|P3|COMPLETED|Period One||13
2509750|NCT00762996|6152621|P2|COMPLETED|Period One||16
2509751|NCT00762996|6152622|P1|COMPLETED|Period One||15
2509752|NCT00762996|6152619|P4|STARTED|Period One||17
2509753|NCT00762996|6152620|P3|STARTED|Period One||17
2509754|NCT00762996|6152621|P2|STARTED|Period One||16
2509755|NCT00762996|6152622|P1|STARTED|Period One||15
2509756|NCT00762970|6152635|P3|NOT COMPLETED|Overall Study||1
2509757|NCT00762970|6152636|P2|NOT COMPLETED|Overall Study||9
2509758|NCT00762970|6152637|P1|NOT COMPLETED|Overall Study||12
2509759|NCT00762970|6152635|P3|COMPLETED|Overall Study||46
2509760|NCT00762970|6152636|P2|COMPLETED|Overall Study||35
2509761|NCT00762970|6152637|P1|COMPLETED|Overall Study||34
2509762|NCT00762970|6152635|P3|STARTED|Overall Study||47
2509763|NCT00762970|6152636|P2|STARTED|Overall Study||44
2509764|NCT00762970|6152637|P1|STARTED|Overall Study||46
2509765|NCT00762931|6152648|P1|NOT COMPLETED|Overall Study||2
2509766|NCT00762931|6152648|P1|COMPLETED|Overall Study||23
2509767|NCT00762931|6152648|P1|STARTED|Overall Study||25
2509768|NCT00762892|6152655|P2|NOT COMPLETED|Overall Study||6
2509769|NCT00762892|6152656|P1|NOT COMPLETED|Overall Study||5
2509770|NCT00762892|6152655|P2|COMPLETED|Overall Study||8
2509771|NCT00762892|6152656|P1|COMPLETED|Overall Study||9
2509772|NCT00762892|6152655|P2|STARTED|Overall Study||14
2509773|NCT00762892|6152656|P1|STARTED|Overall Study||14
2509774|NCT00762853|6152672|P2|NOT COMPLETED|Second Treatment Period||0
2509775|NCT00762853|6152673|P1|NOT COMPLETED|Second Treatment Period||0
2509776|NCT00762853|6152672|P2|COMPLETED|Second Treatment Period||10
2509777|NCT00762853|6152673|P1|COMPLETED|Second Treatment Period||10
2509778|NCT00762853|6152672|P2|STARTED|Second Treatment Period||10
2509779|NCT00762853|6152673|P1|STARTED|Second Treatment Period||10
2509780|NCT00762853|6152672|P2|NOT COMPLETED|1 Week Washout After Treatment 1||0
2509781|NCT00762853|6152673|P1|NOT COMPLETED|1 Week Washout After Treatment 1||0
2509782|NCT00762853|6152672|P2|COMPLETED|1 Week Washout After Treatment 1||10
2509783|NCT00762853|6152673|P1|COMPLETED|1 Week Washout After Treatment 1||10
2509784|NCT00762853|6152672|P2|STARTED|1 Week Washout After Treatment 1||10
2509785|NCT00762853|6152673|P1|STARTED|1 Week Washout After Treatment 1||10
2509786|NCT00762853|6152672|P2|NOT COMPLETED|First Treatment Period||0
2509787|NCT00762853|6152673|P1|NOT COMPLETED|First Treatment Period||0
2509788|NCT00762853|6152672|P2|COMPLETED|First Treatment Period||10
2509789|NCT00762853|6152673|P1|COMPLETED|First Treatment Period||10
2509790|NCT00762853|6152672|P2|STARTED|First Treatment Period||10
2509791|NCT00762853|6152673|P1|STARTED|First Treatment Period||10
2509792|NCT00762788|6152685|P6|NOT COMPLETED|Overall Study||21
2509793|NCT00762788|6152686|P5|NOT COMPLETED|Overall Study||13
2509794|NCT00762788|6152687|P4|NOT COMPLETED|Overall Study||26
2509795|NCT00762788|6152688|P3|NOT COMPLETED|Overall Study||21
2509796|NCT00762788|6152689|P2|NOT COMPLETED|Overall Study||37
2509797|NCT00762788|6152690|P1|NOT COMPLETED|Overall Study||26
2509798|NCT00762788|6152685|P6|COMPLETED|Overall Study||31
2509799|NCT00762788|6152686|P5|COMPLETED|Overall Study||30
2509800|NCT00762788|6152687|P4|COMPLETED|Overall Study||38
2509801|NCT00762788|6152688|P3|COMPLETED|Overall Study||21
2509802|NCT00762788|6152689|P2|COMPLETED|Overall Study||21
2509803|NCT00762788|6152690|P1|COMPLETED|Overall Study||29
2509804|NCT00762788|6152685|P6|STARTED|Overall Study||52
2509805|NCT00762788|6152686|P5|STARTED|Overall Study||43
2509806|NCT00762788|6152687|P4|STARTED|Overall Study||64
2509807|NCT00762788|6152688|P3|STARTED|Overall Study||42
2509808|NCT00762788|6152689|P2|STARTED|Overall Study||58
2509809|NCT00762788|6152690|P1|STARTED|Overall Study||55
2509810|NCT00762762|6152712|P2|NOT COMPLETED|Overall Study||10
2509811|NCT00762762|6152713|P1|NOT COMPLETED|Overall Study||8
2509812|NCT00762762|6152712|P2|COMPLETED|Overall Study||20
2509813|NCT00762762|6152713|P1|COMPLETED|Overall Study||22
2509814|NCT00762762|6152712|P2|STARTED|Overall Study||30
2509815|NCT00762762|6152713|P1|STARTED|Overall Study||30
2509816|NCT00762723|6152730|P3|NOT COMPLETED|Overall Study||3
2509817|NCT00762723|6152731|P2|NOT COMPLETED|Overall Study||5
2509818|NCT00762723|6152732|P1|NOT COMPLETED|Overall Study||5
2509819|NCT00762723|6152730|P3|COMPLETED|Overall Study||0
2509820|NCT00762723|6152731|P2|COMPLETED|Overall Study||6
2509821|NCT00762723|6152732|P1|COMPLETED|Overall Study||0
2509822|NCT00762723|6152730|P3|STARTED|Overall Study||3
2509823|NCT00762723|6152731|P2|STARTED|Overall Study||11
2509824|NCT00762723|6152732|P1|STARTED|Overall Study||5
2509825|NCT00762645|6152742|P2|NOT COMPLETED|Overall Study||2
2509826|NCT00762645|6152743|P1|NOT COMPLETED|Overall Study||4
2509827|NCT00762645|6152742|P2|COMPLETED|Overall Study||12
2509828|NCT00762645|6152743|P1|COMPLETED|Overall Study||12
2509829|NCT00762645|6152742|P2|STARTED|Overall Study||14
2509830|NCT00762645|6152743|P1|STARTED|Overall Study||16
2509831|NCT00762619|6152753|P2|NOT COMPLETED|Overall Study||0
2509832|NCT00762619|6152754|P1|NOT COMPLETED|Overall Study||0
2509833|NCT00762619|6152753|P2|COMPLETED|Overall Study||50
2509834|NCT00762619|6152754|P1|COMPLETED|Overall Study||55
2509835|NCT00762619|6152753|P2|STARTED|Overall Study||50
2509836|NCT00762619|6152754|P1|STARTED|Overall Study||55
2509837|NCT00762606|6152896|P2|NOT COMPLETED|Overall Study||13
2509838|NCT00762606|6152897|P1|NOT COMPLETED|Overall Study||18
2509839|NCT00762606|6152896|P2|COMPLETED|Overall Study||38
2509840|NCT00762606|6152897|P1|COMPLETED|Overall Study||37
2509841|NCT00762606|6152896|P2|STARTED|Overall Study||51
2509842|NCT00762606|6152897|P1|STARTED|Overall Study||55
2509843|NCT00762528|6152907|P2|NOT COMPLETED|Overall Study||0
2509844|NCT00762528|6152908|P1|NOT COMPLETED|Overall Study||0
2509845|NCT00762528|6152907|P2|COMPLETED|Overall Study||25
2509846|NCT00762528|6152908|P1|COMPLETED|Overall Study||24
2509847|NCT00762528|6152907|P2|STARTED|Overall Study||25
2509848|NCT00762528|6152908|P1|STARTED|Overall Study||24
2509849|NCT00762515|6152930|P2|NOT COMPLETED|Overall Study||0
2509850|NCT00762515|6152931|P1|NOT COMPLETED|Overall Study||0
2509851|NCT00762515|6152930|P2|COMPLETED|Overall Study||22
2509852|NCT00762515|6152931|P1|COMPLETED|Overall Study||22
2509853|NCT00762515|6152930|P2|STARTED|Overall Study||22
2509854|NCT00762515|6152931|P1|STARTED|Overall Study||22
2509855|NCT00762502|6152942|P3|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
2509856|NCT00762502|6152943|P2|NOT COMPLETED|Month 3 to Month 6 (Period 2)||1
2509857|NCT00762502|6152944|P1|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
2509858|NCT00762502|6152942|P3|COMPLETED|Month 3 to Month 6 (Period 2)||23
2509859|NCT00762502|6152943|P2|COMPLETED|Month 3 to Month 6 (Period 2)||4
2509860|NCT00762502|6152944|P1|COMPLETED|Month 3 to Month 6 (Period 2)||9
2509861|NCT00762502|6152942|P3|STARTED|Month 3 to Month 6 (Period 2)||23
2509862|NCT00762502|6152943|P2|STARTED|Month 3 to Month 6 (Period 2)||5
2509863|NCT00762502|6152944|P1|STARTED|Month 3 to Month 6 (Period 2)||9
2509864|NCT00762502|6152942|P3|NOT COMPLETED|Baseline to Month 3 (Period 1)||19
2509865|NCT00762502|6152943|P2|NOT COMPLETED|Baseline to Month 3 (Period 1)||6
2509866|NCT00762502|6152944|P1|NOT COMPLETED|Baseline to Month 3 (Period 1)||10
2509867|NCT00762502|6152942|P3|COMPLETED|Baseline to Month 3 (Period 1)||32
2509868|NCT00762502|6152943|P2|COMPLETED|Baseline to Month 3 (Period 1)||19
2509869|NCT00762502|6152944|P1|COMPLETED|Baseline to Month 3 (Period 1)||26
2509870|NCT00762502|6152942|P3|STARTED|Baseline to Month 3 (Period 1)||51
2509871|NCT00762502|6152943|P2|STARTED|Baseline to Month 3 (Period 1)||25
2509872|NCT00762502|6152944|P1|STARTED|Baseline to Month 3 (Period 1)||36
2509873|NCT00762476|6152958|P2|NOT COMPLETED|Overall Study||36
2509874|NCT00762476|6152959|P1|NOT COMPLETED|Overall Study||23
2509875|NCT00762476|6152958|P2|COMPLETED|Overall Study||169
2509876|NCT00762476|6152959|P1|COMPLETED|Overall Study||183
2509877|NCT00762476|6152958|P2|STARTED|Overall Study||205
2509878|NCT00762476|6152959|P1|STARTED|Overall Study||206
2509879|NCT00762463|6152971|P4|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||2
2509880|NCT00762463|6152972|P3|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||4
2509881|NCT00762463|6152973|P2|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||1
2509882|NCT00762463|6152974|P1|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||3
2509883|NCT00762463|6152971|P4|COMPLETED|Extension Phase (Week 6 to Week 12)||52
2509884|NCT00762463|6152972|P3|COMPLETED|Extension Phase (Week 6 to Week 12)||50
2509885|NCT00762463|6152973|P2|COMPLETED|Extension Phase (Week 6 to Week 12)||54
2509886|NCT00762463|6152974|P1|COMPLETED|Extension Phase (Week 6 to Week 12)||52
2509887|NCT00762463|6152971|P4|STARTED|Extension Phase (Week 6 to Week 12)||54
2509888|NCT00762463|6152972|P3|STARTED|Extension Phase (Week 6 to Week 12)||54
2509889|NCT00762463|6152973|P2|STARTED|Extension Phase (Week 6 to Week 12)||55
2509890|NCT00762463|6152974|P1|STARTED|Extension Phase (Week 6 to Week 12)||55
2509891|NCT00762463|6152971|P4|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
2509892|NCT00762463|6152972|P3|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
2509893|NCT00762463|6152973|P2|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||1
2509894|NCT00762463|6152974|P1|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||4
2509895|NCT00762463|6152971|P4|COMPLETED|Enrollment in Extension Phase (Week 6)||0
2509896|NCT00762463|6152972|P3|COMPLETED|Enrollment in Extension Phase (Week 6)||0
2509897|NCT00762463|6152973|P2|COMPLETED|Enrollment in Extension Phase (Week 6)||109
2509898|NCT00762463|6152974|P1|COMPLETED|Enrollment in Extension Phase (Week 6)||109
2509899|NCT00762463|6152971|P4|STARTED|Enrollment in Extension Phase (Week 6)||0
2509900|NCT00762463|6152972|P3|STARTED|Enrollment in Extension Phase (Week 6)||0
2509901|NCT00762463|6152973|P2|STARTED|Enrollment in Extension Phase (Week 6)||110
2509902|NCT00762463|6152974|P1|STARTED|Enrollment in Extension Phase (Week 6)||113
2509903|NCT00762463|6152971|P4|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
2509904|NCT00762463|6152972|P3|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
2509905|NCT00762463|6152973|P2|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||10
2509906|NCT00762463|6152974|P1|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||7
2509907|NCT00762463|6152971|P4|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
2509908|NCT00762463|6152972|P3|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
2509909|NCT00762463|6152973|P2|COMPLETED|Double-blind Phase (Baseline to Week 6)||110
2509910|NCT00762463|6152974|P1|COMPLETED|Double-blind Phase (Baseline to Week 6)||113
2509911|NCT00762463|6152971|P4|STARTED|Double-blind Phase (Baseline to Week 6)||0
2509912|NCT00762463|6152972|P3|STARTED|Double-blind Phase (Baseline to Week 6)||0
2509913|NCT00762463|6152973|P2|STARTED|Double-blind Phase (Baseline to Week 6)||120
2509914|NCT00762463|6152974|P1|STARTED|Double-blind Phase (Baseline to Week 6)||120
2509915|NCT00762450|6153059|P3|NOT COMPLETED|3rd Treatment Period||0
2509916|NCT00762450|6153060|P2|NOT COMPLETED|3rd Treatment Period||0
2509917|NCT00762450|6153061|P1|NOT COMPLETED|3rd Treatment Period||0
2509918|NCT00762450|6153059|P3|COMPLETED|3rd Treatment Period||2
2509919|NCT00762450|6153060|P2|COMPLETED|3rd Treatment Period||2
2509920|NCT00762450|6153061|P1|COMPLETED|3rd Treatment Period||2
2509921|NCT00762450|6153059|P3|STARTED|3rd Treatment Period||2
2509922|NCT00762450|6153060|P2|STARTED|3rd Treatment Period||2
2509923|NCT00762450|6153061|P1|STARTED|3rd Treatment Period||2
2509924|NCT00762450|6153059|P3|NOT COMPLETED|Washout After 2nd Treatment Period||0
2509925|NCT00762450|6153060|P2|NOT COMPLETED|Washout After 2nd Treatment Period||0
2509926|NCT00762450|6153061|P1|NOT COMPLETED|Washout After 2nd Treatment Period||0
2509927|NCT00762450|6153059|P3|COMPLETED|Washout After 2nd Treatment Period||2
2509928|NCT00762450|6153060|P2|COMPLETED|Washout After 2nd Treatment Period||2
2509929|NCT00762450|6153061|P1|COMPLETED|Washout After 2nd Treatment Period||2
2509930|NCT00762450|6153059|P3|STARTED|Washout After 2nd Treatment Period||2
2509931|NCT00762450|6153060|P2|STARTED|Washout After 2nd Treatment Period||2
2509932|NCT00762450|6153061|P1|STARTED|Washout After 2nd Treatment Period||2
2509933|NCT00762450|6153059|P3|NOT COMPLETED|2nd Treatment Period||0
2509934|NCT00762450|6153060|P2|NOT COMPLETED|2nd Treatment Period||0
2509935|NCT00762450|6153061|P1|NOT COMPLETED|2nd Treatment Period||0
2509936|NCT00762450|6153059|P3|COMPLETED|2nd Treatment Period||2
2509937|NCT00762450|6153060|P2|COMPLETED|2nd Treatment Period||2
2509938|NCT00762450|6153061|P1|COMPLETED|2nd Treatment Period||2
2509939|NCT00762450|6153059|P3|STARTED|2nd Treatment Period||2
2509940|NCT00762450|6153060|P2|STARTED|2nd Treatment Period||2
2509941|NCT00762450|6153061|P1|STARTED|2nd Treatment Period||2
2509942|NCT00762450|6153059|P3|NOT COMPLETED|Washout After 1st Treatment Period||0
2509943|NCT00762450|6153060|P2|NOT COMPLETED|Washout After 1st Treatment Period||0
2509944|NCT00762450|6153061|P1|NOT COMPLETED|Washout After 1st Treatment Period||0
2509945|NCT00762450|6153059|P3|COMPLETED|Washout After 1st Treatment Period||2
2509946|NCT00762450|6153060|P2|COMPLETED|Washout After 1st Treatment Period||2
2509947|NCT00762450|6153061|P1|COMPLETED|Washout After 1st Treatment Period||2
2509948|NCT00762450|6153059|P3|STARTED|Washout After 1st Treatment Period||2
2509949|NCT00762450|6153060|P2|STARTED|Washout After 1st Treatment Period||2
2509950|NCT00762450|6153061|P1|STARTED|Washout After 1st Treatment Period||2
2509951|NCT00762450|6153059|P3|NOT COMPLETED|1st Treatment Period||0
2509952|NCT00762450|6153060|P2|NOT COMPLETED|1st Treatment Period||0
2509953|NCT00762450|6153061|P1|NOT COMPLETED|1st Treatment Period||0
2509954|NCT00762450|6153059|P3|COMPLETED|1st Treatment Period||2
2509955|NCT00762450|6153060|P2|COMPLETED|1st Treatment Period||2
2509956|NCT00762450|6153061|P1|COMPLETED|1st Treatment Period||2
2509957|NCT00762450|6153059|P3|STARTED|1st Treatment Period||2
2509958|NCT00762450|6153060|P2|STARTED|1st Treatment Period||2
2509959|NCT00762450|6153061|P1|STARTED|1st Treatment Period||2
2509960|NCT00762424|6153071|P2|NOT COMPLETED|Overall Study||0
2509961|NCT00762424|6153072|P1|NOT COMPLETED|Overall Study||0
2509962|NCT00762424|6153071|P2|COMPLETED|Overall Study||25
2509963|NCT00762424|6153072|P1|COMPLETED|Overall Study||28
2509964|NCT00762424|6153071|P2|STARTED|Overall Study||25
2509965|NCT00762424|6153072|P1|STARTED|Overall Study||28
2509966|NCT00762411|6153080|P2|NOT COMPLETED|Safety Follow Up (SFU)-Optional||118
2509967|NCT00762411|6153081|P1|NOT COMPLETED|Safety Follow Up (SFU)-Optional||84
2509968|NCT00762411|6153080|P2|COMPLETED|Safety Follow Up (SFU)-Optional||312
2509969|NCT00762411|6153081|P1|COMPLETED|Safety Follow Up (SFU)-Optional||228
2509970|NCT00762411|6153080|P2|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|430
2509971|NCT00762411|6153081|P1|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|312
2509972|NCT00762411|6153080|P2|NOT COMPLETED|Delayed Start||26
2509973|NCT00762411|6153081|P1|NOT COMPLETED|Delayed Start||17
2509974|NCT00762411|6153080|P2|COMPLETED|Delayed Start||8
2509975|NCT00762411|6153081|P1|COMPLETED|Delayed Start||5
2509976|NCT00762411|6153080|P2|STARTED|Delayed Start||34
2509977|NCT00762411|6153081|P1|STARTED|Delayed Start||22
2509978|NCT00762411|6153080|P2|NOT COMPLETED|Initial Treatment||521
2509979|NCT00762411|6153081|P1|NOT COMPLETED|Initial Treatment||534
2509980|NCT00762411|6153080|P2|COMPLETED|Initial Treatment||34
2509981|NCT00762411|6153081|P1|COMPLETED|Initial Treatment||22
2509982|NCT00762411|6153080|P2|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who received at least 1 dose of study drug.|553
2509983|NCT00762411|6153081|P1|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants(pts) who received at least 1 dose of study drug.|555
2509984|NCT00762411|6153080|P2|STARTED|Initial Treatment||555
2509985|NCT00762411|6153081|P1|STARTED|Initial Treatment||556
2509986|NCT00762385|6153145|P2|NOT COMPLETED|Second Intervention||3
2509987|NCT00762385|6153146|P1|NOT COMPLETED|Second Intervention||3
2509988|NCT00762385|6153145|P2|COMPLETED|Second Intervention||39
2509989|NCT00762385|6153146|P1|COMPLETED|Second Intervention||46
2509990|NCT00762385|6153145|P2|STARTED|Second Intervention||42
2509991|NCT00762385|6153146|P1|STARTED|Second Intervention||49
2509992|NCT00762385|6153145|P2|NOT COMPLETED|First Intervention||4
2509993|NCT00762385|6153146|P1|NOT COMPLETED|First Intervention||2
2509994|NCT00762385|6153145|P2|COMPLETED|First Intervention||42
2509995|NCT00762385|6153146|P1|COMPLETED|First Intervention||49
2509996|NCT00762385|6153145|P2|STARTED|First Intervention||46
2509997|NCT00762385|6153146|P1|STARTED|First Intervention||51
2509998|NCT00762372|6153159|P3|NOT COMPLETED|Overall Study||0
2509999|NCT00762372|6153160|P2|NOT COMPLETED|Overall Study||0
2510000|NCT00762372|6153161|P1|NOT COMPLETED|Overall Study||1
2510001|NCT00762372|6153159|P3|COMPLETED|Overall Study||50
2510002|NCT00762372|6153160|P2|COMPLETED|Overall Study||55
2510003|NCT00762372|6153161|P1|COMPLETED|Overall Study||110
2510004|NCT00762372|6153159|P3|STARTED|Overall Study|N=53 enrolled but 3 participant's discontinued before start of study drug administration.|50
2510005|NCT00762372|6153160|P2|STARTED|Overall Study|N=57 enrolled but 2 participant's discontinued before start of study drug administration.|55
2510006|NCT00762372|6153161|P1|STARTED|Overall Study|N=114 enrolled but 3 participant's discontinued before start of study drug administration.|111
2510007|NCT00762359|6153237|P2|NOT COMPLETED|Overall Study||57
2510008|NCT00762359|6153238|P1|NOT COMPLETED|Overall Study||59
2510009|NCT00762359|6153237|P2|COMPLETED|Overall Study||178
2510010|NCT00762359|6153238|P1|COMPLETED|Overall Study||167
2510011|NCT00762359|6153237|P2|STARTED|Overall Study||235
2510012|NCT00762359|6153238|P1|STARTED|Overall Study||226
2510013|NCT00762320|6153338|P1|NOT COMPLETED|Overall Study||0
2510014|NCT00762320|6153338|P1|COMPLETED|Overall Study||8
2510015|NCT00762320|6153338|P1|STARTED|Overall Study||8
2510016|NCT00762268|6153355|P2|NOT COMPLETED|Overall Study||3
2510017|NCT00762268|6153356|P1|NOT COMPLETED|Overall Study||3
2510018|NCT00762268|6153355|P2|COMPLETED|Overall Study||8
2510019|NCT00762268|6153356|P1|COMPLETED|Overall Study||9
2510020|NCT00762268|6153355|P2|STARTED|Overall Study||11
2510021|NCT00762268|6153356|P1|STARTED|Overall Study||12
2510022|NCT00762229|6153368|P2|NOT COMPLETED|Overall Study||2
2510023|NCT00762229|6153369|P1|NOT COMPLETED|Overall Study||1
2510024|NCT00762229|6153368|P2|COMPLETED|Overall Study||22
2510025|NCT00762229|6153369|P1|COMPLETED|Overall Study||14
2510026|NCT00762229|6153368|P2|STARTED|Overall Study||24
2510027|NCT00762229|6153369|P1|STARTED|Overall Study||15
2510028|NCT00762216|6153377|P1|NOT COMPLETED|Overall Study||0
2510029|NCT00762216|6153377|P1|COMPLETED|Overall Study||71
2510030|NCT00762216|6153377|P1|STARTED|Overall Study||71
2510031|NCT00762177|6153385|P3|NOT COMPLETED|3rd Treatment Period||0
2510032|NCT00762177|6153386|P2|NOT COMPLETED|3rd Treatment Period||0
2510033|NCT00762177|6153387|P1|NOT COMPLETED|3rd Treatment Period||0
2510034|NCT00762177|6153385|P3|COMPLETED|3rd Treatment Period||8
2510035|NCT00762177|6153386|P2|COMPLETED|3rd Treatment Period||8
2510036|NCT00762177|6153387|P1|COMPLETED|3rd Treatment Period||8
2510037|NCT00762177|6153385|P3|STARTED|3rd Treatment Period||8
2510038|NCT00762177|6153386|P2|STARTED|3rd Treatment Period||8
2510039|NCT00762177|6153387|P1|STARTED|3rd Treatment Period||8
2510040|NCT00762177|6153385|P3|NOT COMPLETED|Washout After 2nd Treatment||0
2510041|NCT00762177|6153386|P2|NOT COMPLETED|Washout After 2nd Treatment||0
2510042|NCT00762177|6153387|P1|NOT COMPLETED|Washout After 2nd Treatment||0
2510043|NCT00762177|6153385|P3|COMPLETED|Washout After 2nd Treatment||8
2510044|NCT00762177|6153386|P2|COMPLETED|Washout After 2nd Treatment||8
2510045|NCT00762177|6153387|P1|COMPLETED|Washout After 2nd Treatment||8
2510046|NCT00762177|6153385|P3|STARTED|Washout After 2nd Treatment||8
2510047|NCT00762177|6153386|P2|STARTED|Washout After 2nd Treatment||8
2510048|NCT00762177|6153387|P1|STARTED|Washout After 2nd Treatment||8
2510049|NCT00762177|6153385|P3|NOT COMPLETED|2nd Treatment Period||0
2510050|NCT00762177|6153386|P2|NOT COMPLETED|2nd Treatment Period||0
2510051|NCT00762177|6153387|P1|NOT COMPLETED|2nd Treatment Period||0
2510052|NCT00762177|6153385|P3|COMPLETED|2nd Treatment Period||8
2510053|NCT00762177|6153386|P2|COMPLETED|2nd Treatment Period||8
2510054|NCT00762177|6153387|P1|COMPLETED|2nd Treatment Period||8
2510055|NCT00762177|6153385|P3|STARTED|2nd Treatment Period||8
2510056|NCT00762177|6153386|P2|STARTED|2nd Treatment Period||8
2510057|NCT00762177|6153387|P1|STARTED|2nd Treatment Period||8
2510058|NCT00762177|6153385|P3|NOT COMPLETED|Washout After 1st Treatment||0
2510059|NCT00762177|6153386|P2|NOT COMPLETED|Washout After 1st Treatment||0
2510060|NCT00762177|6153387|P1|NOT COMPLETED|Washout After 1st Treatment||0
2510061|NCT00762177|6153385|P3|COMPLETED|Washout After 1st Treatment||8
2510062|NCT00762177|6153386|P2|COMPLETED|Washout After 1st Treatment||8
2510063|NCT00762177|6153387|P1|COMPLETED|Washout After 1st Treatment||8
2510064|NCT00762177|6153385|P3|STARTED|Washout After 1st Treatment||8
2510065|NCT00762177|6153386|P2|STARTED|Washout After 1st Treatment||8
2510066|NCT00762177|6153387|P1|STARTED|Washout After 1st Treatment||8
2510067|NCT00762177|6153385|P3|NOT COMPLETED|1st Treatment Period||0
2510068|NCT00762177|6153386|P2|NOT COMPLETED|1st Treatment Period||0
2510069|NCT00762177|6153387|P1|NOT COMPLETED|1st Treatment Period||0
2510070|NCT00762177|6153385|P3|COMPLETED|1st Treatment Period||8
2510071|NCT00762177|6153386|P2|COMPLETED|1st Treatment Period||8
2510072|NCT00762177|6153387|P1|COMPLETED|1st Treatment Period||8
2510073|NCT00762177|6153385|P3|STARTED|1st Treatment Period||8
2510074|NCT00762177|6153386|P2|STARTED|1st Treatment Period||8
2510075|NCT00762177|6153387|P1|STARTED|1st Treatment Period||8
2510076|NCT00762164|6153466|P2|NOT COMPLETED|Overall Study||2
2510077|NCT00762164|6153467|P1|NOT COMPLETED|Overall Study||3
2510078|NCT00762164|6153466|P2|COMPLETED|Overall Study||15
2510079|NCT00762164|6153467|P1|COMPLETED|Overall Study||14
2510080|NCT00762164|6153466|P2|STARTED|Overall Study||17
2510081|NCT00762164|6153467|P1|STARTED|Overall Study||17
2510082|NCT00762086|6153477|P2|NOT COMPLETED|Overall Study||4
2510083|NCT00762086|6153478|P1|NOT COMPLETED|Overall Study||6
2510084|NCT00762086|6153477|P2|COMPLETED|Overall Study||24
2510085|NCT00762086|6153478|P1|COMPLETED|Overall Study||33
2510086|NCT00762086|6153477|P2|STARTED|Overall Study||28
2510087|NCT00762086|6153478|P1|STARTED|Overall Study||39
2510088|NCT00762073|6153488|P4|NOT COMPLETED|Overall Study||3
2510089|NCT00762073|6153489|P3|NOT COMPLETED|Overall Study||2
2510090|NCT00762073|6153490|P2|NOT COMPLETED|Overall Study||4
2510091|NCT00762073|6153491|P1|NOT COMPLETED|Overall Study||4
2510092|NCT00762073|6153488|P4|COMPLETED|Overall Study||17
2510093|NCT00762073|6153489|P3|COMPLETED|Overall Study|One participant was enrolled and randomized then withdrew consent and did not receive study drug.|18
2510094|NCT00762073|6153490|P2|COMPLETED|Overall Study||17
2510095|NCT00762073|6153491|P1|COMPLETED|Overall Study||17
2510096|NCT00762073|6153488|P4|STARTED|Overall Study||20
2510097|NCT00762073|6153489|P3|STARTED|Overall Study||20
2510098|NCT00762073|6153490|P2|STARTED|Overall Study||21
2510099|NCT00762073|6153491|P1|STARTED|Overall Study||21
2510100|NCT00762034|6153555|P2|NOT COMPLETED|Maintenance Period||298
2510101|NCT00762034|6153556|P1|NOT COMPLETED|Maintenance Period||294
2510102|NCT00762034|6153555|P2|COMPLETED|Maintenance Period||0
2510103|NCT00762034|6153556|P1|COMPLETED|Maintenance Period||0
2510104|NCT00762034|6153555|P2|Received at Least 1 Dose of Study Drug|Maintenance Period||298
2510105|NCT00762034|6153556|P1|Received at Least 1 Dose of Study Drug|Maintenance Period||294
2510106|NCT00762034|6153555|P2|STARTED|Maintenance Period||298
2510107|NCT00762034|6153556|P1|STARTED|Maintenance Period||294
2510108|NCT00762034|6153555|P2|NOT COMPLETED|Induction Period||169
2510109|NCT00762034|6153556|P1|NOT COMPLETED|Induction Period||178
2510110|NCT00762034|6153555|P2|COMPLETED|Induction Period||298
2510111|NCT00762034|6153556|P1|COMPLETED|Induction Period||294
2510112|NCT00762034|6153555|P2|Received at Least 1 Dose of Study Drug|Induction Period||443
2510113|NCT00762034|6153556|P1|Received at Least 1 Dose of Study Drug|Induction Period||442
2510114|NCT00762034|6153555|P2|STARTED|Induction Period||467
2510115|NCT00762034|6153556|P1|STARTED|Induction Period||472
2510116|NCT00762021|6153615|P2|NOT COMPLETED|Overall Study||8
2510117|NCT00762021|6153616|P1|NOT COMPLETED|Overall Study||8
2510118|NCT00762021|6153615|P2|COMPLETED|Overall Study||44
2510119|NCT00762021|6153616|P1|COMPLETED|Overall Study||44
2510120|NCT00762021|6153615|P2|STARTED|Overall Study||52
2510121|NCT00762021|6153616|P1|STARTED|Overall Study||52
2510122|NCT00761969|6153628|P2|NOT COMPLETED|Overall Study||140
2510123|NCT00761969|6153629|P1|NOT COMPLETED|Overall Study||200
2510124|NCT00761969|6153628|P2|COMPLETED|Overall Study||573
2510125|NCT00761969|6153629|P1|COMPLETED|Overall Study||542
2510126|NCT00761969|6153628|P2|STARTED|Overall Study||713
2510127|NCT00761969|6153629|P1|STARTED|Overall Study||742
2510128|NCT00761956|6153639|P2|NOT COMPLETED|Overall Study||54
2510129|NCT00761956|6153640|P1|NOT COMPLETED|Overall Study||35
2510130|NCT00761956|6153639|P2|COMPLETED|Overall Study||48
2510131|NCT00761956|6153640|P1|COMPLETED|Overall Study||52
2510132|NCT00761956|6153639|P2|STARTED|Overall Study||102
2510133|NCT00761956|6153640|P1|STARTED|Overall Study||87
2510134|NCT00761930|6153651|P3|NOT COMPLETED|Overall Study||0
2510135|NCT00761930|6153652|P2|NOT COMPLETED|Overall Study||0
2510136|NCT00761930|6153653|P1|NOT COMPLETED|Overall Study||0
2510137|NCT00761930|6153651|P3|COMPLETED|Overall Study||35
2510138|NCT00761930|6153652|P2|COMPLETED|Overall Study||34
2510139|NCT00761930|6153653|P1|COMPLETED|Overall Study||34
2510140|NCT00761930|6153651|P3|STARTED|Overall Study||35
2510141|NCT00761930|6153652|P2|STARTED|Overall Study||34
2510142|NCT00761930|6153653|P1|STARTED|Overall Study||34
2510143|NCT00761891|6153667|P1|NOT COMPLETED|Overall Study||10
2510144|NCT00761891|6153667|P1|COMPLETED|Overall Study||54
2510145|NCT00761891|6153667|P1|STARTED|Overall Study||64
2510146|NCT00761865|6153674|P2|NOT COMPLETED|Overall Study||7
2510147|NCT00761865|6153675|P1|NOT COMPLETED|Overall Study||8
2510148|NCT00761865|6153674|P2|COMPLETED|Overall Study||11
2510149|NCT00761865|6153675|P1|COMPLETED|Overall Study||8
2510150|NCT00761865|6153674|P2|STARTED|Overall Study||18
2510151|NCT00761865|6153675|P1|STARTED|Overall Study||16
2510152|NCT00761813|6153685|P2|NOT COMPLETED|Overall Study||14
2510153|NCT00761813|6153686|P1|NOT COMPLETED|Overall Study||15
2510154|NCT00761813|6153685|P2|COMPLETED|Overall Study||537
2510155|NCT00761813|6153686|P1|COMPLETED|Overall Study||542
2510156|NCT00761813|6153685|P2|STARTED|Overall Study||551
2510157|NCT00761813|6153686|P1|STARTED|Overall Study||557
2510158|NCT00761774|6153696|P1|NOT COMPLETED|Overall Study||79
2510159|NCT00761774|6153696|P1|COMPLETED|Overall Study||29
2510160|NCT00761774|6153696|P1|STARTED|Overall Study||108
2510161|NCT00761761|6153707|P2|NOT COMPLETED|Overall Study||1
2510162|NCT00761761|6153708|P1|NOT COMPLETED|Overall Study||6
2510163|NCT00761761|6153707|P2|COMPLETED|Overall Study||29
2510164|NCT00761761|6153708|P1|COMPLETED|Overall Study||24
2510165|NCT00761761|6153707|P2|STARTED|Overall Study||30
2510166|NCT00761761|6153708|P1|STARTED|Overall Study||30
2510167|NCT00761748|6153720|P2|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
2510168|NCT00761748|6153721|P1|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
2510169|NCT00761748|6153720|P2|COMPLETED|Second Intervention (21 +/- 3 Days)||7
2510170|NCT00761748|6153721|P1|COMPLETED|Second Intervention (21 +/- 3 Days)||17
2510171|NCT00761748|6153720|P2|STARTED|Second Intervention (21 +/- 3 Days)||7
2510172|NCT00761748|6153721|P1|STARTED|Second Intervention (21 +/- 3 Days)||17
2510173|NCT00761748|6153720|P2|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
2510174|NCT00761748|6153721|P1|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
2510175|NCT00761748|6153720|P2|COMPLETED|First Intervention (21 +/- 3 Days)||7
2510176|NCT00761748|6153721|P1|COMPLETED|First Intervention (21 +/- 3 Days)||17
2510177|NCT00761748|6153720|P2|STARTED|First Intervention (21 +/- 3 Days)||10
2510178|NCT00761748|6153721|P1|STARTED|First Intervention (21 +/- 3 Days)||20
2510179|NCT00761735|6153727|P1|NOT COMPLETED|Overall Study||14
2510180|NCT00761735|6153727|P1|COMPLETED|Overall Study||80
2510181|NCT00761735|6153727|P1|STARTED|Overall Study||94
2510182|NCT00761631|6153743|P6|NOT COMPLETED|Overall Study||5
2510183|NCT00761631|6153744|P5|NOT COMPLETED|Overall Study||22
2510184|NCT00761631|6153745|P4|NOT COMPLETED|Overall Study||3
2510185|NCT00761631|6153746|P3|NOT COMPLETED|Overall Study||16
2510186|NCT00761631|6153747|P2|NOT COMPLETED|Overall Study||7
2510187|NCT00761631|6153748|P1|NOT COMPLETED|Overall Study||15
2510188|NCT00761631|6153743|P6|COMPLETED|Overall Study||294
2510189|NCT00761631|6153744|P5|COMPLETED|Overall Study||277
2510190|NCT00761631|6153745|P4|COMPLETED|Overall Study||116
2510191|NCT00761631|6153746|P3|COMPLETED|Overall Study||160
2510192|NCT00761631|6153747|P2|COMPLETED|Overall Study||174
2510193|NCT00761631|6153748|P1|COMPLETED|Overall Study||111
2510194|NCT00761631|6153743|P6|Vaccinated Dose 2|Overall Study||0
2510195|NCT00761631|6153744|P5|Vaccinated Dose 2|Overall Study||0
2510196|NCT00761631|6153745|P4|Vaccinated Dose 2|Overall Study||0
2510197|NCT00761631|6153746|P3|Vaccinated Dose 2|Overall Study||165
2510198|NCT00761631|6153747|P2|Vaccinated Dose 2|Overall Study||0
2510199|NCT00761631|6153748|P1|Vaccinated Dose 2|Overall Study||112
2510200|NCT00761631|6153743|P6|Vaccinated Dose 1|Overall Study||298
2510201|NCT00761631|6153744|P5|Vaccinated Dose 1|Overall Study||294
2510202|NCT00761631|6153745|P4|Vaccinated Dose 1|Overall Study||118
2510203|NCT00761631|6153746|P3|Vaccinated Dose 1|Overall Study||175
2510204|NCT00761631|6153747|P2|Vaccinated Dose 1|Overall Study||179
2510205|NCT00761631|6153748|P1|Vaccinated Dose 1|Overall Study||124
2510206|NCT00761631|6153743|P6|STARTED|Overall Study||299
2510207|NCT00761631|6153744|P5|STARTED|Overall Study||299
2510208|NCT00761631|6153745|P4|STARTED|Overall Study||119
2510209|NCT00761631|6153746|P3|STARTED|Overall Study||176
2510210|NCT00761631|6153747|P2|STARTED|Overall Study||181
2510211|NCT00761631|6153748|P1|STARTED|Overall Study||126
2510212|NCT00761605|6153783|P1|NOT COMPLETED|Overall Study||141
2510213|NCT00761605|6153783|P1|COMPLETED|Overall Study||246
2510214|NCT00761605|6153783|P1|STARTED|Overall Study||387
2510215|NCT00761592|6153812|P2|NOT COMPLETED|Overall Study||1
2510216|NCT00761592|6153813|P1|NOT COMPLETED|Overall Study||1
2510217|NCT00761592|6153812|P2|COMPLETED|Overall Study||32
2510218|NCT00761592|6153813|P1|COMPLETED|Overall Study||31
2510219|NCT00761592|6153812|P2|STARTED|Overall Study||33
2510220|NCT00761592|6153813|P1|STARTED|Overall Study||32
2510221|NCT00761579|6153827|P1|NOT COMPLETED|Overall Study||92
2510222|NCT00761579|6153827|P1|COMPLETED|Overall Study||98
2510223|NCT00761579|6153827|P1|STARTED|Overall Study||190
2510224|NCT00761527|6153860|P1|NOT COMPLETED|Overall Study||22
2510225|NCT00761527|6153860|P1|COMPLETED|Overall Study||2958
2510226|NCT00761527|6153860|P1|Received One Dose of Study Medication|Overall Study||2978
2510227|NCT00761527|6153860|P1|STARTED|Overall Study||2980
2510228|NCT00761514|6153867|P1|NOT COMPLETED|Overall Study||7
2510229|NCT00761514|6153867|P1|COMPLETED|Overall Study||7
2510230|NCT00761514|6153867|P1|STARTED|Overall Study||14
2510231|NCT00761462|6153874|P2|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||51
2510232|NCT00761462|6153875|P1|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||154
2510233|NCT00761462|6153874|P2|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 2 year safety Follow-up.|456
2510234|NCT00761462|6153875|P1|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 5 year safety Follow-up.|333
2510235|NCT00761462|6153874|P2|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||507
2510236|NCT00761462|6153875|P1|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||485
2510237|NCT00761462|6153874|P2|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||507
2510238|NCT00761462|6153875|P1|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||487
2510239|NCT00761462|6153874|P2|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|507
2510240|NCT00761462|6153875|P1|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|487
2510241|NCT00761462|6153874|P2|NOT COMPLETED|Treatment||12
2510242|NCT00761462|6153875|P1|NOT COMPLETED|Treatment||23
2510243|NCT00761462|6153874|P2|COMPLETED|Treatment|Patients with confirmed intake of study drug|507
2510244|NCT00761462|6153875|P1|COMPLETED|Treatment|Patients with confirmed intake of study drug|487
2510245|NCT00761462|6153874|P2|STARTED|Treatment|Patients enrolled in study group|519
2510246|NCT00761462|6153875|P1|STARTED|Treatment|Patients enrolled in study group|510
2510247|NCT00761345|6153883|P1|NOT COMPLETED|Overall Study||3
2510248|NCT00761345|6153883|P1|COMPLETED|Overall Study||24
2510249|NCT00761345|6153883|P1|STARTED|Overall Study||27
2510250|NCT00761319|6153889|P2|NOT COMPLETED|Overall Study||34
2510251|NCT00761319|6153890|P1|NOT COMPLETED|Overall Study||48
2510252|NCT00761319|6153889|P2|COMPLETED|Overall Study||318
2510253|NCT00761319|6153890|P1|COMPLETED|Overall Study||305
2510254|NCT00761319|6153889|P2|STARTED|Overall Study||352
2510255|NCT00761319|6153890|P1|STARTED|Overall Study||353
2510256|NCT00761306|6153898|P1|NOT COMPLETED|Overall Study||20
2510257|NCT00761306|6153898|P1|COMPLETED|Overall Study||54
2510258|NCT00761306|6153898|P1|STARTED|Overall Study||74
2510259|NCT00761280|6153909|P2|NOT COMPLETED|First Dose to End of Study||11
2510260|NCT00761280|6153910|P1|NOT COMPLETED|First Dose to End of Study||12
2510261|NCT00761280|6153909|P2|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
2510262|NCT00761280|6153910|P1|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
2510263|NCT00761280|6153909|P2|STARTED|First Dose to End of Study||11
2510264|NCT00761280|6153910|P1|STARTED|First Dose to End of Study||12
2510265|NCT00761280|6153909|P2|NOT COMPLETED|Randomization to First Dose||2
2510266|NCT00761280|6153910|P1|NOT COMPLETED|Randomization to First Dose||2
2510267|NCT00761280|6153909|P2|COMPLETED|Randomization to First Dose||11
2510268|NCT00761280|6153910|P1|COMPLETED|Randomization to First Dose||12
2510269|NCT00761280|6153909|P2|First Dose of Study Drug / Chemotherapy|Randomization to First Dose|Safety population|11
2510270|NCT00761280|6153910|P1|First Dose of Study Drug / Chemotherapy|Randomization to First Dose||12
2510271|NCT00761280|6153909|P2|Catheter Surgery|Randomization to First Dose|Not applicable to control group|0
2510272|NCT00761280|6153910|P1|Catheter Surgery|Randomization to First Dose|Safety population|13
2510273|NCT00761280|6153909|P2|STARTED|Randomization to First Dose||13
2510274|NCT00761280|6153910|P1|STARTED|Randomization to First Dose||14
2510275|NCT00761267|6153941|P3|NOT COMPLETED|Overall Study||6
2510276|NCT00761267|6153942|P2|NOT COMPLETED|Overall Study||4
2510277|NCT00761267|6153943|P1|NOT COMPLETED|Overall Study||2
2510278|NCT00761267|6153941|P3|COMPLETED|Overall Study||24
2510279|NCT00761267|6153942|P2|COMPLETED|Overall Study||16
2510280|NCT00761267|6153943|P1|COMPLETED|Overall Study||18
2510281|NCT00761267|6153941|P3|Treated|Overall Study||30
2510282|NCT00761267|6153942|P2|Treated|Overall Study||19
2510283|NCT00761267|6153943|P1|Treated|Overall Study||19
2510284|NCT00761267|6153941|P3|STARTED|Overall Study||30
2510285|NCT00761267|6153942|P2|STARTED|Overall Study||20
2510286|NCT00761267|6153943|P1|STARTED|Overall Study||20
2510287|NCT00761215|6153994|P3|NOT COMPLETED|Overall Study||8
2510288|NCT00761215|6153995|P2|NOT COMPLETED|Overall Study||4
2510289|NCT00761215|6153996|P1|NOT COMPLETED|Overall Study||9
2510290|NCT00761215|6153994|P3|COMPLETED|Overall Study||56
2510291|NCT00761215|6153995|P2|COMPLETED|Overall Study||60
2510292|NCT00761215|6153996|P1|COMPLETED|Overall Study||55
2510293|NCT00761215|6153994|P3|STARTED|Overall Study||64
2510294|NCT00761215|6153995|P2|STARTED|Overall Study||64
2510295|NCT00761215|6153996|P1|STARTED|Overall Study||64
2510296|NCT00761202|6154021|P2|NOT COMPLETED|Overall Study||2
2510297|NCT00761202|6154022|P1|NOT COMPLETED|Overall Study||1
2510298|NCT00761202|6154021|P2|COMPLETED|Overall Study||26
2510299|NCT00761202|6154022|P1|COMPLETED|Overall Study||21
2510300|NCT00761202|6154021|P2|STARTED|Overall Study||28
2510301|NCT00761202|6154022|P1|STARTED|Overall Study||22
2510302|NCT00761189|6154038|P1|NOT COMPLETED|Overall Study||185
2510303|NCT00761189|6154038|P1|COMPLETED|Overall Study||306
2510304|NCT00761189|6154038|P1|STARTED|Overall Study||491
2510305|NCT00761176|6154055|P2|NOT COMPLETED|Overall Study||1
2510306|NCT00761176|6154056|P1|NOT COMPLETED|Overall Study||2
2510307|NCT00761176|6154055|P2|COMPLETED|Overall Study||3
2510308|NCT00761176|6154056|P1|COMPLETED|Overall Study||2
2510309|NCT00761176|6154055|P2|STARTED|Overall Study||4
2510310|NCT00761176|6154056|P1|STARTED|Overall Study||4
2510311|NCT00761150|6154065|P3|NOT COMPLETED|Double-blind Period||29
2510312|NCT00761150|6154066|P2|NOT COMPLETED|Double-blind Period||14
2510313|NCT00761150|6154067|P1|NOT COMPLETED|Double-blind Period||0
2510314|NCT00761150|6154065|P3|COMPLETED|Double-blind Period||89
2510315|NCT00761150|6154066|P2|COMPLETED|Double-blind Period||106
2510316|NCT00761150|6154067|P1|COMPLETED|Double-blind Period||0
2510317|NCT00761150|6154065|P3|STARTED|Double-blind Period||118
2510318|NCT00761150|6154066|P2|STARTED|Double-blind Period||120
2510319|NCT00761150|6154067|P1|STARTED|Double-blind Period||0
2510320|NCT00761150|6154065|P3|NOT COMPLETED|Open-label Period||0
2510321|NCT00761150|6154066|P2|NOT COMPLETED|Open-label Period||0
2510322|NCT00761150|6154067|P1|NOT COMPLETED|Open-label Period||70
2510323|NCT00761150|6154065|P3|COMPLETED|Open-label Period||0
2510324|NCT00761150|6154066|P2|COMPLETED|Open-label Period||0
2510325|NCT00761150|6154067|P1|COMPLETED|Open-label Period||238
2510326|NCT00761150|6154065|P3|STARTED|Open-label Period||0
2510327|NCT00761150|6154066|P2|STARTED|Open-label Period||0
2510328|NCT00761150|6154067|P1|STARTED|Open-label Period||308
2510329|NCT00761137|6154076|P1|NOT COMPLETED|Overall Study||0
2510330|NCT00761137|6154076|P1|COMPLETED|Overall Study||19
2510331|NCT00761137|6154076|P1|3 mg Tropicamide|Overall Study||19
2510332|NCT00761137|6154076|P1|1 mg Tropicamide|Overall Study||19
2510333|NCT00761137|6154076|P1|0.3 mg Tropicamide|Overall Study||19
2510334|NCT00761137|6154076|P1|Placebo|Overall Study||19
2510335|NCT00761137|6154076|P1|STARTED|Overall Study||19
2510336|NCT00761085|6154091|P4|NOT COMPLETED|Overall Study||4
2510337|NCT00761085|6154092|P3|NOT COMPLETED|Overall Study||0
2510338|NCT00761085|6154093|P2|NOT COMPLETED|Overall Study||6
2510339|NCT00761085|6154094|P1|NOT COMPLETED|Overall Study||0
2510340|NCT00761085|6154091|P4|COMPLETED|Overall Study||8
2510341|NCT00761085|6154092|P3|COMPLETED|Overall Study||11
2510342|NCT00761085|6154093|P2|COMPLETED|Overall Study||6
2510343|NCT00761085|6154094|P1|COMPLETED|Overall Study||12
2510344|NCT00761085|6154091|P4|STARTED|Overall Study||12
2510345|NCT00761085|6154092|P3|STARTED|Overall Study||11
2510346|NCT00761085|6154093|P2|STARTED|Overall Study||12
2510347|NCT00761085|6154094|P1|STARTED|Overall Study||12
2510348|NCT00761007|6154112|P4|NOT COMPLETED|Overall Study||7
2510349|NCT00761007|6154113|P3|NOT COMPLETED|Overall Study||18
2510350|NCT00761007|6154114|P2|NOT COMPLETED|Overall Study||11
2510351|NCT00761007|6154115|P1|NOT COMPLETED|Overall Study||13
2510352|NCT00761007|6154112|P4|COMPLETED|Overall Study||131
2510353|NCT00761007|6154113|P3|COMPLETED|Overall Study||121
2510354|NCT00761007|6154114|P2|COMPLETED|Overall Study||124
2510355|NCT00761007|6154115|P1|COMPLETED|Overall Study||129
2510356|NCT00761007|6154112|P4|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||136
2510357|NCT00761007|6154113|P3|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||135
2510358|NCT00761007|6154114|P2|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||133
2510359|NCT00761007|6154115|P1|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||140
2510360|NCT00761007|6154112|P4|Safety (>=1 Dose of Study Medication)|Overall Study||137
2510361|NCT00761007|6154113|P3|Safety (>=1 Dose of Study Medication)|Overall Study||139
2510362|NCT00761007|6154114|P2|Safety (>=1 Dose of Study Medication)|Overall Study||135
2510363|NCT00761007|6154115|P1|Safety (>=1 Dose of Study Medication)|Overall Study||140
2510364|NCT00761007|6154112|P4|STARTED|Overall Study||138
2510365|NCT00761007|6154113|P3|STARTED|Overall Study||139
2510366|NCT00761007|6154114|P2|STARTED|Overall Study||135
2510367|NCT00761007|6154115|P1|STARTED|Overall Study||142
2510368|NCT00760877|6154139|P2|NOT COMPLETED|Overall Study||26
2510369|NCT00760877|6154140|P1|NOT COMPLETED|Overall Study||45
2510370|NCT00760877|6154139|P2|COMPLETED|Overall Study||77
2510371|NCT00760877|6154140|P1|COMPLETED|Overall Study||59
2510372|NCT00760877|6154139|P2|Safety Set|Overall Study||103
2510373|NCT00760877|6154140|P1|Safety Set|Overall Study||101
2510374|NCT00760877|6154139|P2|Cross-over to Nilotinib|Overall Study||46
2510375|NCT00760877|6154140|P1|Cross-over to Nilotinib|Overall Study|Not applicable: cross-over occurred from imatinib to nilotinib only.|0
2510376|NCT00760877|6154139|P2|STARTED|Overall Study||103
2510377|NCT00760877|6154140|P1|STARTED|Overall Study||104
2510378|NCT00760838|6154158|P2|NOT COMPLETED|Overall Study||2
2510379|NCT00760838|6154159|P1|NOT COMPLETED|Overall Study||5
2510380|NCT00760838|6154158|P2|COMPLETED|Overall Study||53
2510381|NCT00760838|6154159|P1|COMPLETED|Overall Study||49
2510382|NCT00760838|6154158|P2|STARTED|Overall Study||55
2510383|NCT00760838|6154159|P1|STARTED|Overall Study||54
2510384|NCT00760747|6154177|P2|NOT COMPLETED|Study Period III||3
2510385|NCT00760747|6154178|P1|NOT COMPLETED|Study Period III||3
2510386|NCT00760747|6154177|P2|COMPLETED|Study Period III||38
2510387|NCT00760747|6154178|P1|COMPLETED|Study Period III||41
2510388|NCT00760747|6154177|P2|STARTED|Study Period III||41
2510389|NCT00760747|6154178|P1|STARTED|Study Period III||44
2510390|NCT00760747|6154177|P2|NOT COMPLETED|Study Period II||14
2510391|NCT00760747|6154178|P1|NOT COMPLETED|Study Period II||13
2510392|NCT00760747|6154177|P2|COMPLETED|Study Period II||41
2510393|NCT00760747|6154178|P1|COMPLETED|Study Period II||44
2510394|NCT00760747|6154177|P2|Received at Least One Dose of Study Drug|Study Period II||54
2510395|NCT00760747|6154178|P1|Received at Least One Dose of Study Drug|Study Period II||57
2510396|NCT00760747|6154177|P2|STARTED|Study Period II||55
2510397|NCT00760747|6154178|P1|STARTED|Study Period II||57
2510398|NCT00760669|6154206|P1|NOT COMPLETED|Overall Study||30
2510399|NCT00760669|6154206|P1|COMPLETED|Overall Study||1031
2510400|NCT00760669|6154206|P1|STARTED|Overall Study||1061
2510401|NCT00760617|6154223|P3|NOT COMPLETED|Overall Study||5
2510402|NCT00760617|6154224|P2|NOT COMPLETED|Overall Study||2
2510403|NCT00760617|6154225|P1|NOT COMPLETED|Overall Study||5
2510404|NCT00760617|6154223|P3|COMPLETED|Overall Study||111
2510405|NCT00760617|6154224|P2|COMPLETED|Overall Study||142
2510406|NCT00760617|6154225|P1|COMPLETED|Overall Study||261
2510407|NCT00760617|6154223|P3|STARTED|Overall Study||116
2510408|NCT00760617|6154224|P2|STARTED|Overall Study||144
2510409|NCT00760617|6154225|P1|STARTED|Overall Study||266
2510410|NCT00760578|6154300|P4|NOT COMPLETED|Overall Study||4
2510411|NCT00760578|6154301|P3|NOT COMPLETED|Overall Study||5
2510412|NCT00760578|6154302|P2|NOT COMPLETED|Overall Study||2
2510413|NCT00760578|6154303|P1|NOT COMPLETED|Overall Study||3
2510414|NCT00760578|6154300|P4|COMPLETED|Overall Study||18
2510415|NCT00760578|6154301|P3|COMPLETED|Overall Study||16
2510416|NCT00760578|6154302|P2|COMPLETED|Overall Study||19
2510417|NCT00760578|6154303|P1|COMPLETED|Overall Study||19
2510418|NCT00760578|6154300|P4|Entered Drug Treatment Period|Overall Study||22
2510419|NCT00760578|6154301|P3|Entered Drug Treatment Period|Overall Study||19
2510420|NCT00760578|6154302|P2|Entered Drug Treatment Period|Overall Study||20
2510421|NCT00760578|6154303|P1|Entered Drug Treatment Period|Overall Study||21
2510422|NCT00760578|6154300|P4|STARTED|Overall Study||22
2510423|NCT00760578|6154301|P3|STARTED|Overall Study||21
2510424|NCT00760578|6154302|P2|STARTED|Overall Study||21
2510425|NCT00760578|6154303|P1|STARTED|Overall Study||22
2510426|NCT00760552|6154339|P2|NOT COMPLETED|Overall Study||10
2510427|NCT00760552|6154340|P1|NOT COMPLETED|Overall Study||13
2510428|NCT00760552|6154339|P2|COMPLETED|Overall Study||52
2510429|NCT00760552|6154340|P1|COMPLETED|Overall Study||48
2510430|NCT00760552|6154339|P2|STARTED|Overall Study||62
2510431|NCT00760552|6154340|P1|STARTED|Overall Study||61
2510432|NCT00760526|6154348|P2|NOT COMPLETED|Overall Study||4
2510433|NCT00760526|6154349|P1|NOT COMPLETED|Overall Study||5
2510434|NCT00760526|6154348|P2|COMPLETED|Overall Study||68
2510435|NCT00760526|6154349|P1|COMPLETED|Overall Study||69
2510436|NCT00760526|6154348|P2|STARTED|Overall Study||72
2510437|NCT00760526|6154349|P1|STARTED|Overall Study||74
2510438|NCT00760513|6154376|P2|NOT COMPLETED|Overall Study||7
2510439|NCT00760513|6154377|P1|NOT COMPLETED|Overall Study||5
2510440|NCT00760513|6154376|P2|COMPLETED|Overall Study||45
2510441|NCT00760513|6154377|P1|COMPLETED|Overall Study||46
2510442|NCT00760513|6154376|P2|STARTED|Overall Study||52
2510443|NCT00760513|6154377|P1|STARTED|Overall Study||51
2510444|NCT00760487|6154387|P1|NOT COMPLETED|Overall Study||3
2510445|NCT00760487|6154387|P1|COMPLETED|Overall Study||117
2510446|NCT00760487|6154387|P1|STARTED|Overall Study||120
2510447|NCT00760474|6154393|P2|NOT COMPLETED|Period 2 (P2)||1
2510448|NCT00760474|6154394|P1|NOT COMPLETED|Period 2 (P2)||1
2510449|NCT00760474|6154393|P2|COMPLETED|Period 2 (P2)||11
2510450|NCT00760474|6154394|P1|COMPLETED|Period 2 (P2)||11
2510451|NCT00760474|6154393|P2|STARTED|Period 2 (P2)||12
2510452|NCT00760474|6154394|P1|STARTED|Period 2 (P2)||12
2510453|NCT00760474|6154393|P2|NOT COMPLETED|Placebo Washout Period||1
2510454|NCT00760474|6154394|P1|NOT COMPLETED|Placebo Washout Period||0
2510455|NCT00760474|6154393|P2|COMPLETED|Placebo Washout Period||12
2510456|NCT00760474|6154394|P1|COMPLETED|Placebo Washout Period||12
2510457|NCT00760474|6154393|P2|STARTED|Placebo Washout Period||13
2510458|NCT00760474|6154394|P1|STARTED|Placebo Washout Period||12
2510459|NCT00760474|6154393|P2|NOT COMPLETED|Period 1 (P1)||1
2510460|NCT00760474|6154394|P1|NOT COMPLETED|Period 1 (P1)||1
2510461|NCT00760474|6154393|P2|COMPLETED|Period 1 (P1)||13
2510462|NCT00760474|6154394|P1|COMPLETED|Period 1 (P1)||12
2510463|NCT00760474|6154393|P2|Overall Number of Unique Participants|Period 1 (P1)||13
2510464|NCT00760474|6154394|P1|Overall Number of Unique Participants|Period 1 (P1)||12
2510465|NCT00760474|6154393|P2|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|14
2510466|NCT00760474|6154394|P1|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|13
2510467|NCT00760474|6154393|P2|STARTED|Period 1 (P1)||14
2510468|NCT00760474|6154394|P1|STARTED|Period 1 (P1)||13
2510469|NCT00760461|6154430|P1|NOT COMPLETED|Overall Study||44
2510470|NCT00760461|6154430|P1|COMPLETED|Overall Study||0
2510471|NCT00760461|6154430|P1|STARTED|Overall Study||44
2510472|NCT00760435|6154436|P2|NOT COMPLETED|Overall Study||5
2510473|NCT00760435|6154437|P1|NOT COMPLETED|Overall Study||4
2510474|NCT00760435|6154436|P2|COMPLETED|Overall Study||93
2510475|NCT00760435|6154437|P1|COMPLETED|Overall Study||94
2510476|NCT00760435|6154436|P2|STARTED|Overall Study||98
2510477|NCT00760435|6154437|P1|STARTED|Overall Study||98
2510478|NCT00760383|6154451|P2|NOT COMPLETED|Overall Study||7
2510479|NCT00760383|6154452|P1|NOT COMPLETED|Overall Study||5
2510480|NCT00760383|6154451|P2|COMPLETED|Overall Study||12
2510481|NCT00760383|6154452|P1|COMPLETED|Overall Study||16
2510482|NCT00760383|6154451|P2|STARTED|Overall Study||19
2510483|NCT00760383|6154452|P1|STARTED|Overall Study||21
2510484|NCT00760266|6154464|P2|NOT COMPLETED|Overall Study||18
2510485|NCT00760266|6154465|P1|NOT COMPLETED|Overall Study||24
2510486|NCT00760266|6154464|P2|COMPLETED|Overall Study||205
2510487|NCT00760266|6154465|P1|COMPLETED|Overall Study||204
2510488|NCT00760266|6154464|P2|STARTED|Overall Study||223
2510489|NCT00760266|6154465|P1|STARTED|Overall Study||228
2510490|NCT00760214|6154482|P3|NOT COMPLETED|Overall Study||41
2510491|NCT00760214|6154483|P2|NOT COMPLETED|Overall Study||30
2510492|NCT00760214|6154484|P1|NOT COMPLETED|Overall Study||30
2510493|NCT00760214|6154482|P3|COMPLETED|Overall Study||255
2510494|NCT00760214|6154483|P2|COMPLETED|Overall Study||264
2510495|NCT00760214|6154484|P1|COMPLETED|Overall Study||265
2510496|NCT00760214|6154482|P3|STARTED|Overall Study||296
2510497|NCT00760214|6154483|P2|STARTED|Overall Study||294
2510498|NCT00760214|6154484|P1|STARTED|Overall Study||295
2510499|NCT00760084|6154525|P1|NOT COMPLETED|Overall Study||10
2510500|NCT00760084|6154525|P1|COMPLETED|Overall Study||0
2510501|NCT00760084|6154525|P1|STARTED|Overall Study||10
2510502|NCT00760019|6154531|P4|NOT COMPLETED|Overall Study||0
2510503|NCT00760019|6154532|P3|NOT COMPLETED|Overall Study||0
2510504|NCT00760019|6154533|P2|NOT COMPLETED|Overall Study||0
2510505|NCT00760019|6154534|P1|NOT COMPLETED|Overall Study||0
2510506|NCT00760019|6154531|P4|COMPLETED|Overall Study||14
2510507|NCT00760019|6154532|P3|COMPLETED|Overall Study||14
2510508|NCT00760019|6154533|P2|COMPLETED|Overall Study||15
2510509|NCT00760019|6154534|P1|COMPLETED|Overall Study||15
2510510|NCT00760019|6154531|P4|STARTED|Overall Study||14
2510511|NCT00760019|6154532|P3|STARTED|Overall Study||14
2510512|NCT00760019|6154533|P2|STARTED|Overall Study||15
2510513|NCT00760019|6154534|P1|STARTED|Overall Study||15
2510514|NCT00760006|6154542|P2|NOT COMPLETED|Overall Study||0
2510515|NCT00760006|6154543|P1|NOT COMPLETED|Overall Study||0
2510516|NCT00760006|6154542|P2|COMPLETED|Overall Study||138
2510517|NCT00760006|6154543|P1|COMPLETED|Overall Study||86
2510518|NCT00760006|6154542|P2|STARTED|Overall Study||138
2510519|NCT00760006|6154543|P1|STARTED|Overall Study||86
2510520|NCT00759967|6154549|P2|NOT COMPLETED|Second Intervention||0
2510521|NCT00759967|6154550|P1|NOT COMPLETED|Second Intervention||2
2510522|NCT00759967|6154549|P2|COMPLETED|Second Intervention||9
2510523|NCT00759967|6154550|P1|COMPLETED|Second Intervention||8
2510524|NCT00759967|6154549|P2|STARTED|Second Intervention||9
2510525|NCT00759967|6154550|P1|STARTED|Second Intervention||10
2510526|NCT00759967|6154549|P2|NOT COMPLETED|First Intervention||0
2510527|NCT00759967|6154550|P1|NOT COMPLETED|First Intervention||0
2510528|NCT00759967|6154549|P2|COMPLETED|First Intervention||9
2510529|NCT00759967|6154550|P1|COMPLETED|First Intervention||10
2510530|NCT00759967|6154549|P2|STARTED|First Intervention||9
2510531|NCT00759967|6154550|P1|STARTED|First Intervention||10
2510532|NCT00759954|6154568|P2|NOT COMPLETED|Overall Study||2
2510533|NCT00759954|6154569|P1|NOT COMPLETED|Overall Study||2
2510534|NCT00759954|6154568|P2|COMPLETED|Overall Study|Two participants (#202 and #228) did not enter Period 2.|16
2510535|NCT00759954|6154569|P1|COMPLETED|Overall Study|One participant(#225) did not enter Period 2 and one participant (#203)dropped out during Period 2|16
2510536|NCT00759954|6154568|P2|STARTED|Overall Study|All assigned participants entered trial|18
2510537|NCT00759954|6154569|P1|STARTED|Overall Study|All assigned participants entered trial|18
2510538|NCT00759941|6154583|P2|NOT COMPLETED|Overall Study||1
2510539|NCT00759941|6154584|P1|NOT COMPLETED|Overall Study||3
2510540|NCT00759941|6154583|P2|COMPLETED|Overall Study||43
2510541|NCT00759941|6154584|P1|COMPLETED|Overall Study||39
2510542|NCT00759941|6154583|P2|STARTED|Overall Study||44
2510543|NCT00759941|6154584|P1|STARTED|Overall Study||42
2510544|NCT00759915|6154598|P2|NOT COMPLETED|Overall Study||1
2510545|NCT00759915|6154599|P1|NOT COMPLETED|Overall Study||1
2510546|NCT00759915|6154598|P2|COMPLETED|Overall Study||17
2510547|NCT00759915|6154599|P1|COMPLETED|Overall Study||17
2510548|NCT00759915|6154598|P2|STARTED|Overall Study||18
2510549|NCT00759915|6154599|P1|STARTED|Overall Study||18
2510550|NCT00759902|6154613|P2|NOT COMPLETED|Overall Study||1
2510551|NCT00759902|6154614|P1|NOT COMPLETED|Overall Study||0
2510552|NCT00759902|6154613|P2|COMPLETED|Overall Study||17
2510553|NCT00759902|6154614|P1|COMPLETED|Overall Study||18
2510554|NCT00759902|6154613|P2|STARTED|Overall Study||18
2510555|NCT00759902|6154614|P1|STARTED|Overall Study||18
2510556|NCT00759863|6154628|P2|NOT COMPLETED|Overall Study||18
2510557|NCT00759863|6154629|P1|NOT COMPLETED|Overall Study||20
2510558|NCT00759863|6154628|P2|COMPLETED|Overall Study||80
2510559|NCT00759863|6154629|P1|COMPLETED|Overall Study||124
2510560|NCT00759863|6154628|P2|STARTED|Overall Study||98
2510561|NCT00759863|6154629|P1|STARTED|Overall Study||144
2510562|NCT00759811|6154641|P2|NOT COMPLETED|Overall Study||1
2510563|NCT00759811|6154642|P1|NOT COMPLETED|Overall Study||2
2510564|NCT00759811|6154641|P2|COMPLETED|Overall Study||24
2510565|NCT00759811|6154642|P1|COMPLETED|Overall Study||23
2510566|NCT00759811|6154641|P2|STARTED|Overall Study||25
2510567|NCT00759811|6154642|P1|STARTED|Overall Study||25
2510568|NCT00759785|6154650|P2|NOT COMPLETED|Overall Study||5
2510569|NCT00759785|6154651|P1|NOT COMPLETED|Overall Study||12
2510570|NCT00759785|6154650|P2|COMPLETED|Overall Study||17
2510571|NCT00759785|6154651|P1|COMPLETED|Overall Study||14
2510572|NCT00759785|6154650|P2|Treated|Overall Study||20
2510573|NCT00759785|6154651|P1|Treated|Overall Study||25
2510574|NCT00759785|6154650|P2|STARTED|Overall Study||22
2510575|NCT00759785|6154651|P1|STARTED|Overall Study||26
2510576|NCT00759772|6154665|P2|NOT COMPLETED|Overall Study||0
2510577|NCT00759772|6154666|P1|NOT COMPLETED|Overall Study||0
2510578|NCT00759772|6154665|P2|COMPLETED|Overall Study||11
2510579|NCT00759772|6154666|P1|COMPLETED|Overall Study||12
2510580|NCT00759772|6154665|P2|STARTED|Overall Study||11
2510581|NCT00759772|6154666|P1|STARTED|Overall Study||12
2510582|NCT00759759|6154674|P2|NOT COMPLETED|Overall Study||1
2510583|NCT00759759|6154675|P1|NOT COMPLETED|Overall Study||4
2510584|NCT00759759|6154674|P2|COMPLETED|Overall Study||17
2510585|NCT00759759|6154675|P1|COMPLETED|Overall Study||14
2510586|NCT00759759|6154674|P2|STARTED|Overall Study||18
2510587|NCT00759759|6154675|P1|STARTED|Overall Study||18
2510588|NCT00759707|6154687|P1|NOT COMPLETED|Overall Study||0
2510589|NCT00759707|6154687|P1|COMPLETED|Overall Study||19
2510590|NCT00759707|6154687|P1|STARTED|Overall Study||19
2510591|NCT00759681|6154693|P2|NOT COMPLETED|Overall Study||10
2510592|NCT00759681|6154694|P1|NOT COMPLETED|Overall Study||10
2510593|NCT00759681|6154693|P2|COMPLETED|Overall Study||100
2510594|NCT00759681|6154694|P1|COMPLETED|Overall Study||97
2510595|NCT00759681|6154693|P2|STARTED|Overall Study||110
2510596|NCT00759681|6154694|P1|STARTED|Overall Study||107
2510597|NCT00759668|6154704|P2|NOT COMPLETED|Overall Study||3
2510598|NCT00759668|6154705|P1|NOT COMPLETED|Overall Study||1
2510599|NCT00759668|6154704|P2|COMPLETED|Overall Study||15
2510600|NCT00759668|6154705|P1|COMPLETED|Overall Study||16
2510601|NCT00759668|6154704|P2|STARTED|Overall Study||18
2510602|NCT00759668|6154705|P1|STARTED|Overall Study||17
2510603|NCT00759655|6154721|P1|NOT COMPLETED|Overall Study||1
2510604|NCT00759655|6154721|P1|COMPLETED|Overall Study||0
2510605|NCT00759655|6154721|P1|STARTED|Overall Study||1
2510606|NCT00759642|6154732|P1|NOT COMPLETED|Overall Study||0
2510607|NCT00759642|6154732|P1|COMPLETED|Overall Study||33
2510608|NCT00759642|6154732|P1|STARTED|Overall Study||33
2510609|NCT00759603|6154736|P1|NOT COMPLETED|Overall Study||0
2510610|NCT00759603|6154736|P1|COMPLETED|Overall Study||59
2510611|NCT00759603|6154736|P1|STARTED|Overall Study||59
2510612|NCT00759577|6154740|P1|NOT COMPLETED|Overall Study||0
2510613|NCT00759577|6154740|P1|COMPLETED|Overall Study||36
2510614|NCT00759577|6154740|P1|STARTED|Overall Study||36
2510615|NCT00759564|6154749|P5|NOT COMPLETED|Second Intervention Period (4 Days)||0
2510616|NCT00759564|6154750|P4|NOT COMPLETED|Second Intervention Period (4 Days)||0
2510617|NCT00759564|6154751|P3|NOT COMPLETED|Second Intervention Period (4 Days)||0
2510618|NCT00759564|6154752|P2|NOT COMPLETED|Second Intervention Period (4 Days)||0
2510619|NCT00759564|6154753|P1|NOT COMPLETED|Second Intervention Period (4 Days)||0
2510620|NCT00759564|6154749|P5|COMPLETED|Second Intervention Period (4 Days)||3
2510621|NCT00759564|6154750|P4|COMPLETED|Second Intervention Period (4 Days)||1
2510622|NCT00759564|6154751|P3|COMPLETED|Second Intervention Period (4 Days)||8
2510623|NCT00759564|6154752|P2|COMPLETED|Second Intervention Period (4 Days)||8
2510624|NCT00759564|6154753|P1|COMPLETED|Second Intervention Period (4 Days)||8
2510625|NCT00759564|6154749|P5|STARTED|Second Intervention Period (4 Days)||3
2510626|NCT00759564|6154750|P4|STARTED|Second Intervention Period (4 Days)||1
2510627|NCT00759564|6154751|P3|STARTED|Second Intervention Period (4 Days)||8
2510628|NCT00759564|6154752|P2|STARTED|Second Intervention Period (4 Days)||8
2510629|NCT00759564|6154753|P1|STARTED|Second Intervention Period (4 Days)||8
2510630|NCT00759564|6154749|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||1
2510631|NCT00759564|6154750|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2510632|NCT00759564|6154751|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2510633|NCT00759564|6154752|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2510634|NCT00759564|6154753|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
2510635|NCT00759564|6154749|P5|COMPLETED|Washout Period (at Least 14 Days)||3
2510636|NCT00759564|6154750|P4|COMPLETED|Washout Period (at Least 14 Days)||1
2510637|NCT00759564|6154751|P3|COMPLETED|Washout Period (at Least 14 Days)||8
2510638|NCT00759564|6154752|P2|COMPLETED|Washout Period (at Least 14 Days)||8
2510639|NCT00759564|6154753|P1|COMPLETED|Washout Period (at Least 14 Days)||8
2510640|NCT00759564|6154749|P5|STARTED|Washout Period (at Least 14 Days)||4
2510641|NCT00759564|6154750|P4|STARTED|Washout Period (at Least 14 Days)||1
2510642|NCT00759564|6154751|P3|STARTED|Washout Period (at Least 14 Days)||8
2510643|NCT00759564|6154752|P2|STARTED|Washout Period (at Least 14 Days)||8
2510644|NCT00759564|6154753|P1|STARTED|Washout Period (at Least 14 Days)||8
2510645|NCT00759564|6154749|P5|NOT COMPLETED|First Intervention Period (4 Days)||0
2510646|NCT00759564|6154750|P4|NOT COMPLETED|First Intervention Period (4 Days)||0
2510647|NCT00759564|6154751|P3|NOT COMPLETED|First Intervention Period (4 Days)||0
2510648|NCT00759564|6154752|P2|NOT COMPLETED|First Intervention Period (4 Days)||0
2510649|NCT00759564|6154753|P1|NOT COMPLETED|First Intervention Period (4 Days)||0
2510650|NCT00759564|6154749|P5|COMPLETED|First Intervention Period (4 Days)||4
2510651|NCT00759564|6154750|P4|COMPLETED|First Intervention Period (4 Days)||1
2510652|NCT00759564|6154751|P3|COMPLETED|First Intervention Period (4 Days)||8
2510653|NCT00759564|6154752|P2|COMPLETED|First Intervention Period (4 Days)||8
2510654|NCT00759564|6154753|P1|COMPLETED|First Intervention Period (4 Days)||8
2510655|NCT00759564|6154749|P5|STARTED|First Intervention Period (4 Days)||4
2510656|NCT00759564|6154750|P4|STARTED|First Intervention Period (4 Days)||1
2510657|NCT00759564|6154751|P3|STARTED|First Intervention Period (4 Days)||8
2510658|NCT00759564|6154752|P2|STARTED|First Intervention Period (4 Days)||8
2510659|NCT00759564|6154753|P1|STARTED|First Intervention Period (4 Days)||8
2510660|NCT00759525|6154893|P2|NOT COMPLETED|Second Intervention (14 Days)||0
2510661|NCT00759525|6154894|P1|NOT COMPLETED|Second Intervention (14 Days)||0
2510662|NCT00759525|6154893|P2|COMPLETED|Second Intervention (14 Days)||8
2510663|NCT00759525|6154894|P1|COMPLETED|Second Intervention (14 Days)||7
2510664|NCT00759525|6154893|P2|STARTED|Second Intervention (14 Days)||8
2510665|NCT00759525|6154894|P1|STARTED|Second Intervention (14 Days)||7
2510666|NCT00759525|6154893|P2|NOT COMPLETED|Washout (14 Days)||0
2510667|NCT00759525|6154894|P1|NOT COMPLETED|Washout (14 Days)||0
2510668|NCT00759525|6154893|P2|COMPLETED|Washout (14 Days)||8
2510669|NCT00759525|6154894|P1|COMPLETED|Washout (14 Days)||7
2510670|NCT00759525|6154893|P2|STARTED|Washout (14 Days)||8
2510671|NCT00759525|6154894|P1|STARTED|Washout (14 Days)||7
2510672|NCT00759525|6154893|P2|NOT COMPLETED|First Intervention (14 Days)||0
2510673|NCT00759525|6154894|P1|NOT COMPLETED|First Intervention (14 Days)||0
2510674|NCT00759525|6154893|P2|COMPLETED|First Intervention (14 Days)||8
2510675|NCT00759525|6154894|P1|COMPLETED|First Intervention (14 Days)||7
2510676|NCT00759525|6154893|P2|STARTED|First Intervention (14 Days)||8
2510677|NCT00759525|6154894|P1|STARTED|First Intervention (14 Days)||7
2510678|NCT00759473|6154905|P5|NOT COMPLETED|Overall Study||0
2510679|NCT00759473|6154906|P4|NOT COMPLETED|Overall Study||0
2510680|NCT00759473|6154907|P3|NOT COMPLETED|Overall Study||0
2510681|NCT00759473|6154908|P2|NOT COMPLETED|Overall Study||0
2510682|NCT00759473|6154909|P1|NOT COMPLETED|Overall Study||0
2510683|NCT00759473|6154905|P5|COMPLETED|Overall Study||24
2510684|NCT00759473|6154906|P4|COMPLETED|Overall Study||23
2510685|NCT00759473|6154907|P3|COMPLETED|Overall Study||12
2510686|NCT00759473|6154908|P2|COMPLETED|Overall Study||10
2510687|NCT00759473|6154909|P1|COMPLETED|Overall Study||10
2510688|NCT00759473|6154905|P5|STARTED|Overall Study||24
2510689|NCT00759473|6154906|P4|STARTED|Overall Study||23
2510690|NCT00759473|6154907|P3|STARTED|Overall Study||12
2510691|NCT00759473|6154908|P2|STARTED|Overall Study||10
2510692|NCT00759473|6154909|P1|STARTED|Overall Study||10
2510693|NCT00759408|6154921|P1|NOT COMPLETED|Overall Study||19
2510694|NCT00759408|6154921|P1|COMPLETED|Overall Study||19
2510695|NCT00759408|6154921|P1|STARTED|Overall Study||38
2510696|NCT00759395|6154930|P2|NOT COMPLETED|Overall Study||2
2510697|NCT00759395|6154931|P1|NOT COMPLETED|Overall Study||2
2510698|NCT00759395|6154930|P2|COMPLETED|Overall Study||7
2510699|NCT00759395|6154931|P1|COMPLETED|Overall Study||11
2510700|NCT00759395|6154930|P2|STARTED|Overall Study||9
2510701|NCT00759395|6154931|P1|STARTED|Overall Study||13
2510702|NCT00759356|6154947|P2|NOT COMPLETED|Overall Study||3
2510703|NCT00759356|6154948|P1|NOT COMPLETED|Overall Study||1
2510704|NCT00759356|6154947|P2|COMPLETED|Overall Study||15
2510705|NCT00759356|6154948|P1|COMPLETED|Overall Study||17
2510706|NCT00759356|6154947|P2|STARTED|Overall Study||18
2510707|NCT00759356|6154948|P1|STARTED|Overall Study||18
2510708|NCT00759330|6154964|P4|NOT COMPLETED|Overall Study||2
2510709|NCT00759330|6154965|P3|NOT COMPLETED|Overall Study||0
2510710|NCT00759330|6154966|P2|NOT COMPLETED|Overall Study||1
2510711|NCT00759330|6154967|P1|NOT COMPLETED|Overall Study||1
2510712|NCT00759330|6154964|P4|COMPLETED|Overall Study||41
2510713|NCT00759330|6154965|P3|COMPLETED|Overall Study||22
2510714|NCT00759330|6154966|P2|COMPLETED|Overall Study||41
2510715|NCT00759330|6154967|P1|COMPLETED|Overall Study||19
2510716|NCT00759330|6154964|P4|STARTED|Overall Study||43
2510717|NCT00759330|6154965|P3|STARTED|Overall Study||22
2510718|NCT00759330|6154966|P2|STARTED|Overall Study||42
2510719|NCT00759330|6154967|P1|STARTED|Overall Study||20
2510720|NCT00759187|6155016|P3|NOT COMPLETED|Overall Study||0
2510721|NCT00759187|6155017|P2|NOT COMPLETED|Overall Study||0
2510722|NCT00759187|6155018|P1|NOT COMPLETED|Overall Study||0
2510723|NCT00759187|6155016|P3|COMPLETED|Overall Study||9
2510724|NCT00759187|6155017|P2|COMPLETED|Overall Study||8
2510725|NCT00759187|6155018|P1|COMPLETED|Overall Study||8
2510726|NCT00759187|6155016|P3|STARTED|Overall Study||9
2510727|NCT00759187|6155017|P2|STARTED|Overall Study||8
2510728|NCT00759187|6155018|P1|STARTED|Overall Study||8
2510729|NCT00759174|6155028|P2|NOT COMPLETED|Overall Study||2
2510730|NCT00759174|6155029|P1|NOT COMPLETED|Overall Study||0
2510731|NCT00759174|6155028|P2|COMPLETED|Overall Study||595
2510732|NCT00759174|6155029|P1|COMPLETED|Overall Study||76
2510733|NCT00759174|6155028|P2|STARTED|Overall Study||597
2510734|NCT00759174|6155029|P1|STARTED|Overall Study||76
2510735|NCT00759161|6155038|P1|NOT COMPLETED|Overall Study||0
2510736|NCT00759161|6155038|P1|COMPLETED|Overall Study||35
2510737|NCT00759161|6155038|P1|STARTED|Overall Study||35
2510738|NCT00759148|6155053|P2|NOT COMPLETED|Overall Study||32
2510739|NCT00759148|6155054|P1|NOT COMPLETED|Overall Study||14
2510740|NCT00759148|6155053|P2|COMPLETED|Overall Study||554
2510741|NCT00759148|6155054|P1|COMPLETED|Overall Study||579
2510742|NCT00759148|6155053|P2|STARTED|Overall Study||586
2510743|NCT00759148|6155054|P1|STARTED|Overall Study||593
2510744|NCT00759109|6155064|P2|NOT COMPLETED|Overall Study||35
2510745|NCT00759109|6155065|P1|NOT COMPLETED|Overall Study||39
2510746|NCT00759109|6155064|P2|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|41
2510747|NCT00759109|6155065|P1|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|35
2510748|NCT00759109|6155064|P2|STARTED|Overall Study||76
2510749|NCT00759109|6155065|P1|STARTED|Overall Study||74
2510750|NCT00759096|6155081|P1|NOT COMPLETED|Overall Study||0
2510751|NCT00759096|6155081|P1|COMPLETED|Overall Study||30
2510752|NCT00759096|6155081|P1|STARTED|Overall Study||30
2510753|NCT00759031|6155087|P2|NOT COMPLETED|Second Intervention (1 Day)||0
2510754|NCT00759031|6155088|P1|NOT COMPLETED|Second Intervention (1 Day)||0
2510755|NCT00759031|6155087|P2|COMPLETED|Second Intervention (1 Day)||8
2510756|NCT00759031|6155088|P1|COMPLETED|Second Intervention (1 Day)||8
2510757|NCT00759031|6155087|P2|STARTED|Second Intervention (1 Day)||8
2510758|NCT00759031|6155088|P1|STARTED|Second Intervention (1 Day)||8
2510759|NCT00759031|6155087|P2|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
2510760|NCT00759031|6155088|P1|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
2510761|NCT00759031|6155087|P2|COMPLETED|Washout After 1st Intervention (1 Week)||8
2510762|NCT00759031|6155088|P1|COMPLETED|Washout After 1st Intervention (1 Week)||8
2510763|NCT00759031|6155087|P2|STARTED|Washout After 1st Intervention (1 Week)||8
2510764|NCT00759031|6155088|P1|STARTED|Washout After 1st Intervention (1 Week)||8
2510765|NCT00759031|6155087|P2|NOT COMPLETED|First Intervention (1 Day)||1
2510766|NCT00759031|6155088|P1|NOT COMPLETED|First Intervention (1 Day)||2
2510767|NCT00759031|6155087|P2|COMPLETED|First Intervention (1 Day)||8
2510768|NCT00759031|6155088|P1|COMPLETED|First Intervention (1 Day)||8
2510769|NCT00759031|6155087|P2|STARTED|First Intervention (1 Day)||9
2510770|NCT00759031|6155088|P1|STARTED|First Intervention (1 Day)||10
2510771|NCT00758862|6155094|P1|NOT COMPLETED|Overall Study||1
2510772|NCT00758862|6155094|P1|COMPLETED|Overall Study||19
2510773|NCT00758862|6155094|P1|STARTED|Overall Study||20
2510774|NCT00758836|6155114|P4|NOT COMPLETED|Overall Study||32
2510775|NCT00758836|6155115|P3|NOT COMPLETED|Overall Study||38
2510776|NCT00758836|6155116|P2|NOT COMPLETED|Overall Study||26
2510777|NCT00758836|6155117|P1|NOT COMPLETED|Overall Study||24
2510778|NCT00758836|6155114|P4|COMPLETED|Overall Study||138
2510779|NCT00758836|6155115|P3|COMPLETED|Overall Study||133
2510780|NCT00758836|6155116|P2|COMPLETED|Overall Study||145
2510781|NCT00758836|6155117|P1|COMPLETED|Overall Study||147
2510782|NCT00758836|6155114|P4|Treated|Overall Study||138
2510783|NCT00758836|6155115|P3|Treated|Overall Study||133
2510784|NCT00758836|6155116|P2|Treated|Overall Study||145
2510785|NCT00758836|6155117|P1|Treated|Overall Study||147
2510786|NCT00758836|6155114|P4|STARTED|Overall Study||170
2510787|NCT00758836|6155115|P3|STARTED|Overall Study||171
2510788|NCT00758836|6155116|P2|STARTED|Overall Study||171
2510789|NCT00758836|6155117|P1|STARTED|Overall Study||171
2510790|NCT00758771|6155141|P2|NOT COMPLETED|Overall Study||5
2510791|NCT00758771|6155142|P1|NOT COMPLETED|Overall Study||3
2510792|NCT00758771|6155141|P2|COMPLETED|Overall Study||15
2510793|NCT00758771|6155142|P1|COMPLETED|Overall Study||15
2510794|NCT00758771|6155141|P2|STARTED|Overall Study||20
2510795|NCT00758771|6155142|P1|STARTED|Overall Study||18
2510796|NCT00758758|6155156|P8|NOT COMPLETED|Overall Study||0
2510797|NCT00758758|6155157|P7|NOT COMPLETED|Overall Study||14
2510798|NCT00758758|6155158|P6|NOT COMPLETED|Overall Study||14
2510799|NCT00758758|6155159|P5|NOT COMPLETED|Overall Study||2
2510800|NCT00758758|6155160|P4|NOT COMPLETED|Overall Study||2
2510801|NCT00758758|6155161|P3|NOT COMPLETED|Overall Study||18
2510802|NCT00758758|6155162|P2|NOT COMPLETED|Overall Study||25
2510803|NCT00758758|6155163|P1|NOT COMPLETED|Overall Study||3
2510804|NCT00758758|6155156|P8|COMPLETED|Overall Study||0
2510805|NCT00758758|6155157|P7|COMPLETED|Overall Study||17
2510806|NCT00758758|6155158|P6|COMPLETED|Overall Study||36
2510807|NCT00758758|6155159|P5|COMPLETED|Overall Study||1
2510808|NCT00758758|6155160|P4|COMPLETED|Overall Study||4
2510809|NCT00758758|6155161|P3|COMPLETED|Overall Study||35
2510810|NCT00758758|6155162|P2|COMPLETED|Overall Study||49
2510811|NCT00758758|6155163|P1|COMPLETED|Overall Study||11
2510812|NCT00758758|6155156|P8|STARTED|Overall Study||0
2510813|NCT00758758|6155157|P7|STARTED|Overall Study||31
2510814|NCT00758758|6155158|P6|STARTED|Overall Study||50
2510815|NCT00758758|6155159|P5|STARTED|Overall Study||3
2510816|NCT00758758|6155160|P4|STARTED|Overall Study||6
2510817|NCT00758758|6155161|P3|STARTED|Overall Study||53
2510818|NCT00758758|6155162|P2|STARTED|Overall Study||74
2510819|NCT00758758|6155163|P1|STARTED|Overall Study||14
2510820|NCT00758745|6155191|P2|NOT COMPLETED|Overall Study||21
2510821|NCT00758745|6155192|P1|NOT COMPLETED|Overall Study||21
2510822|NCT00758745|6155191|P2|COMPLETED|Overall Study||60
2510823|NCT00758745|6155192|P1|COMPLETED|Overall Study||60
2510824|NCT00758745|6155191|P2|STARTED|Overall Study||81
2510825|NCT00758745|6155192|P1|STARTED|Overall Study||81
2510826|NCT00758706|6155200|P2|NOT COMPLETED|Overall Study||4
2510827|NCT00758706|6155201|P1|NOT COMPLETED|Overall Study||4
2510828|NCT00758706|6155200|P2|COMPLETED|Overall Study||25
2510829|NCT00758706|6155201|P1|COMPLETED|Overall Study||22
2510830|NCT00758706|6155200|P2|STARTED|Overall Study||29
2510831|NCT00758706|6155201|P1|STARTED|Overall Study||26
2510832|NCT00758680|6155237|P10|NOT COMPLETED|Overall Study||1
2510833|NCT00758680|6155238|P9|NOT COMPLETED|Overall Study||2
2510834|NCT00758680|6155239|P8|NOT COMPLETED|Overall Study||1
2510835|NCT00758680|6155240|P7|NOT COMPLETED|Overall Study||1
2510836|NCT00758680|6155241|P6|NOT COMPLETED|Overall Study||0
2510837|NCT00758680|6155242|P5|NOT COMPLETED|Overall Study||0
2510838|NCT00758680|6155243|P4|NOT COMPLETED|Overall Study||0
2510839|NCT00758680|6155244|P3|NOT COMPLETED|Overall Study||0
2510840|NCT00758680|6155245|P2|NOT COMPLETED|Overall Study||0
2510841|NCT00758680|6155246|P1|NOT COMPLETED|Overall Study||0
2510842|NCT00758680|6155237|P10|COMPLETED|Overall Study||28
2510843|NCT00758680|6155238|P9|COMPLETED|Overall Study||18
2510844|NCT00758680|6155239|P8|COMPLETED|Overall Study||19
2510845|NCT00758680|6155240|P7|COMPLETED|Overall Study||6
2510846|NCT00758680|6155241|P6|COMPLETED|Overall Study||6
2510847|NCT00758680|6155242|P5|COMPLETED|Overall Study||6
2510848|NCT00758680|6155243|P4|COMPLETED|Overall Study||6
2510849|NCT00758680|6155244|P3|COMPLETED|Overall Study||6
2510850|NCT00758680|6155245|P2|COMPLETED|Overall Study||6
2510851|NCT00758680|6155246|P1|COMPLETED|Overall Study||6
2510852|NCT00758680|6155237|P10|STARTED|Overall Study||29
2510853|NCT00758680|6155238|P9|STARTED|Overall Study||20
2510854|NCT00758680|6155239|P8|STARTED|Overall Study||20
2510855|NCT00758680|6155240|P7|STARTED|Overall Study||7
2510856|NCT00758680|6155241|P6|STARTED|Overall Study||6
2510857|NCT00758680|6155242|P5|STARTED|Overall Study||6
2510858|NCT00758680|6155243|P4|STARTED|Overall Study||6
2510859|NCT00758680|6155244|P3|STARTED|Overall Study||6
2510860|NCT00758680|6155245|P2|STARTED|Overall Study||6
2510861|NCT00758680|6155246|P1|STARTED|Overall Study||6
2510862|NCT00758667|6155288|P2|NOT COMPLETED|Overall Study||0
2510863|NCT00758667|6155289|P1|NOT COMPLETED|Overall Study||0
2510864|NCT00758667|6155288|P2|COMPLETED|Overall Study||11
2510865|NCT00758667|6155289|P1|COMPLETED|Overall Study||9
2510866|NCT00758667|6155288|P2|STARTED|Overall Study||11
2510867|NCT00758667|6155289|P1|STARTED|Overall Study||9
2510868|NCT00758602|6155299|P2|NOT COMPLETED|Overall Study||22
2510869|NCT00758602|6155300|P1|NOT COMPLETED|Overall Study||19
2510870|NCT00758602|6155299|P2|COMPLETED|Overall Study||84
2510871|NCT00758602|6155300|P1|COMPLETED|Overall Study||85
2510872|NCT00758602|6155299|P2|STARTED|Overall Study||106
2510873|NCT00758602|6155300|P1|STARTED|Overall Study||104
2510874|NCT00758589|6155326|P4|NOT COMPLETED|Overall Study||6
2510875|NCT00758589|6155327|P3|NOT COMPLETED|Overall Study||6
2510876|NCT00758589|6155328|P2|NOT COMPLETED|Overall Study||3
2510877|NCT00758589|6155329|P1|NOT COMPLETED|Overall Study||3
2510878|NCT00758589|6155326|P4|COMPLETED|Overall Study||85
2510879|NCT00758589|6155327|P3|COMPLETED|Overall Study||86
2510880|NCT00758589|6155328|P2|COMPLETED|Overall Study||87
2510881|NCT00758589|6155329|P1|COMPLETED|Overall Study||92
2510882|NCT00758589|6155326|P4|STARTED|Overall Study||91
2510883|NCT00758589|6155327|P3|STARTED|Overall Study||92
2510884|NCT00758589|6155328|P2|STARTED|Overall Study||90
2510885|NCT00758589|6155329|P1|STARTED|Overall Study||95
2510886|NCT00758576|6155395|P1|NOT COMPLETED|Overall Study||1
2510887|NCT00758576|6155395|P1|COMPLETED|Overall Study||63
2510888|NCT00758576|6155395|P1|STARTED|Overall Study||64
2510889|NCT00758563|6155403|P2|NOT COMPLETED|Overall Study||0
2510890|NCT00758563|6155404|P1|NOT COMPLETED|Overall Study||0
2510891|NCT00758563|6155403|P2|COMPLETED|Overall Study||8
2510892|NCT00758563|6155404|P1|COMPLETED|Overall Study||7
2510893|NCT00758563|6155403|P2|STARTED|Overall Study||8
2510894|NCT00758563|6155404|P1|STARTED|Overall Study||7
2510895|NCT00758550|6155410|P2|NOT COMPLETED|Overall Study||0
2510896|NCT00758550|6155411|P1|NOT COMPLETED|Overall Study||0
2510897|NCT00758550|6155410|P2|COMPLETED|Overall Study||30
2510898|NCT00758550|6155411|P1|COMPLETED|Overall Study||30
2510899|NCT00758550|6155410|P2|STARTED|Overall Study||30
2510900|NCT00758550|6155411|P1|STARTED|Overall Study||30
2510901|NCT00758498|6155422|P3|NOT COMPLETED|Overall Study||5
2510902|NCT00758498|6155423|P2|NOT COMPLETED|Overall Study||2
2510903|NCT00758498|6155424|P1|NOT COMPLETED|Overall Study||3
2510904|NCT00758498|6155422|P3|COMPLETED|Overall Study||137
2510905|NCT00758498|6155423|P2|COMPLETED|Overall Study||141
2510906|NCT00758498|6155424|P1|COMPLETED|Overall Study||139
2510907|NCT00758498|6155422|P3|STARTED|Overall Study||142
2510908|NCT00758498|6155423|P2|STARTED|Overall Study||143
2510909|NCT00758498|6155424|P1|STARTED|Overall Study||142
2510910|NCT00758485|6155509|P2|NOT COMPLETED|Overall Study||3
2510911|NCT00758485|6155510|P1|NOT COMPLETED|Overall Study||1
2510912|NCT00758485|6155509|P2|COMPLETED|Overall Study||67
2510913|NCT00758485|6155510|P1|COMPLETED|Overall Study||69
2510914|NCT00758485|6155509|P2|TREATED|Overall Study||68
2510915|NCT00758485|6155510|P1|TREATED|Overall Study||69
2510916|NCT00758485|6155509|P2|STARTED|Overall Study||70
2510917|NCT00758485|6155510|P1|STARTED|Overall Study||70
2510918|NCT00758459|6155522|P2|NOT COMPLETED|Overall Study||4
2510919|NCT00758459|6155523|P1|NOT COMPLETED|Overall Study||3
2510920|NCT00758459|6155522|P2|COMPLETED|Overall Study||35
2510921|NCT00758459|6155523|P1|COMPLETED|Overall Study||32
2510922|NCT00758459|6155522|P2|STARTED|Overall Study||39
2510923|NCT00758459|6155523|P1|STARTED|Overall Study||35
2510924|NCT00758420|6155557|P2|NOT COMPLETED|Overall Study||0
2510925|NCT00758420|6155558|P1|NOT COMPLETED|Overall Study||0
2510926|NCT00758420|6155557|P2|COMPLETED|Overall Study||38
2510927|NCT00758420|6155558|P1|COMPLETED|Overall Study||39
2510928|NCT00758420|6155557|P2|STARTED|Overall Study||38
2510929|NCT00758420|6155558|P1|STARTED|Overall Study||39
2510930|NCT00758394|6155568|P4|NOT COMPLETED|4th Intervention||0
2510931|NCT00758394|6155569|P3|NOT COMPLETED|4th Intervention||0
2510932|NCT00758394|6155570|P2|NOT COMPLETED|4th Intervention||0
2510933|NCT00758394|6155571|P1|NOT COMPLETED|4th Intervention||0
2510934|NCT00758394|6155568|P4|COMPLETED|4th Intervention||7
2510935|NCT00758394|6155569|P3|COMPLETED|4th Intervention||6
2510936|NCT00758394|6155570|P2|COMPLETED|4th Intervention||6
2510937|NCT00758394|6155571|P1|COMPLETED|4th Intervention||7
2510938|NCT00758394|6155568|P4|STARTED|4th Intervention||7
2510939|NCT00758394|6155569|P3|STARTED|4th Intervention||6
2510940|NCT00758394|6155570|P2|STARTED|4th Intervention||6
2510941|NCT00758394|6155571|P1|STARTED|4th Intervention||7
2510942|NCT00758394|6155568|P4|NOT COMPLETED|Washout After 3rd Intervention||0
2510943|NCT00758394|6155569|P3|NOT COMPLETED|Washout After 3rd Intervention||0
2510944|NCT00758394|6155570|P2|NOT COMPLETED|Washout After 3rd Intervention||0
2510945|NCT00758394|6155571|P1|NOT COMPLETED|Washout After 3rd Intervention||0
2510946|NCT00758394|6155568|P4|COMPLETED|Washout After 3rd Intervention||7
2510947|NCT00758394|6155569|P3|COMPLETED|Washout After 3rd Intervention||6
2510948|NCT00758394|6155570|P2|COMPLETED|Washout After 3rd Intervention||6
2510949|NCT00758394|6155571|P1|COMPLETED|Washout After 3rd Intervention||7
2510950|NCT00758394|6155568|P4|STARTED|Washout After 3rd Intervention||7
2510951|NCT00758394|6155569|P3|STARTED|Washout After 3rd Intervention||6
2510952|NCT00758394|6155570|P2|STARTED|Washout After 3rd Intervention||6
2510953|NCT00758394|6155571|P1|STARTED|Washout After 3rd Intervention||7
2510954|NCT00758394|6155568|P4|NOT COMPLETED|3rd Intervention||1
2510955|NCT00758394|6155569|P3|NOT COMPLETED|3rd Intervention||0
2510956|NCT00758394|6155570|P2|NOT COMPLETED|3rd Intervention||0
2510957|NCT00758394|6155571|P1|NOT COMPLETED|3rd Intervention||1
2510958|NCT00758394|6155568|P4|COMPLETED|3rd Intervention||7
2510959|NCT00758394|6155569|P3|COMPLETED|3rd Intervention||6
2510960|NCT00758394|6155570|P2|COMPLETED|3rd Intervention||6
2510961|NCT00758394|6155571|P1|COMPLETED|3rd Intervention||7
2510962|NCT00758394|6155568|P4|STARTED|3rd Intervention||8
2510963|NCT00758394|6155569|P3|STARTED|3rd Intervention||6
2510964|NCT00758394|6155570|P2|STARTED|3rd Intervention||6
2510965|NCT00758394|6155571|P1|STARTED|3rd Intervention||8
2510966|NCT00758394|6155568|P4|NOT COMPLETED|Washout After 2nd Intervention||0
2510967|NCT00758394|6155569|P3|NOT COMPLETED|Washout After 2nd Intervention||0
2510968|NCT00758394|6155570|P2|NOT COMPLETED|Washout After 2nd Intervention||0
2510969|NCT00758394|6155571|P1|NOT COMPLETED|Washout After 2nd Intervention||0
2510970|NCT00758394|6155568|P4|COMPLETED|Washout After 2nd Intervention||8
2510971|NCT00758394|6155569|P3|COMPLETED|Washout After 2nd Intervention||6
2510972|NCT00758394|6155570|P2|COMPLETED|Washout After 2nd Intervention||6
2510973|NCT00758394|6155571|P1|COMPLETED|Washout After 2nd Intervention||8
2510974|NCT00758394|6155568|P4|STARTED|Washout After 2nd Intervention||8
2510975|NCT00758394|6155569|P3|STARTED|Washout After 2nd Intervention||6
2510976|NCT00758394|6155570|P2|STARTED|Washout After 2nd Intervention||6
2510977|NCT00758394|6155571|P1|STARTED|Washout After 2nd Intervention||8
2510978|NCT00758394|6155568|P4|NOT COMPLETED|2nd Intervention Order||0
2510979|NCT00758394|6155569|P3|NOT COMPLETED|2nd Intervention Order||0
2510980|NCT00758394|6155570|P2|NOT COMPLETED|2nd Intervention Order||1
2510981|NCT00758394|6155571|P1|NOT COMPLETED|2nd Intervention Order||0
2510982|NCT00758394|6155568|P4|COMPLETED|2nd Intervention Order||8
2510983|NCT00758394|6155569|P3|COMPLETED|2nd Intervention Order||6
2510984|NCT00758394|6155570|P2|COMPLETED|2nd Intervention Order||6
2510985|NCT00758394|6155571|P1|COMPLETED|2nd Intervention Order||8
2510986|NCT00758394|6155568|P4|STARTED|2nd Intervention Order||8
2510987|NCT00758394|6155569|P3|STARTED|2nd Intervention Order||6
2510988|NCT00758394|6155570|P2|STARTED|2nd Intervention Order||7
2510989|NCT00758394|6155571|P1|STARTED|2nd Intervention Order||8
2510990|NCT00758394|6155568|P4|NOT COMPLETED|Washout After 1st Intervention||0
2510991|NCT00758394|6155569|P3|NOT COMPLETED|Washout After 1st Intervention||0
2510992|NCT00758394|6155570|P2|NOT COMPLETED|Washout After 1st Intervention||0
2510993|NCT00758394|6155571|P1|NOT COMPLETED|Washout After 1st Intervention||0
2510994|NCT00758394|6155568|P4|COMPLETED|Washout After 1st Intervention||8
2510995|NCT00758394|6155569|P3|COMPLETED|Washout After 1st Intervention||6
2510996|NCT00758394|6155570|P2|COMPLETED|Washout After 1st Intervention||7
2510997|NCT00758394|6155571|P1|COMPLETED|Washout After 1st Intervention||8
2510998|NCT00758394|6155568|P4|STARTED|Washout After 1st Intervention||8
2510999|NCT00758394|6155569|P3|STARTED|Washout After 1st Intervention||6
2511000|NCT00758394|6155570|P2|STARTED|Washout After 1st Intervention||7
2511001|NCT00758394|6155571|P1|STARTED|Washout After 1st Intervention||8
2511002|NCT00758394|6155568|P4|NOT COMPLETED|1st Intervention||0
2511003|NCT00758394|6155569|P3|NOT COMPLETED|1st Intervention||0
2511004|NCT00758394|6155570|P2|NOT COMPLETED|1st Intervention||0
2511005|NCT00758394|6155571|P1|NOT COMPLETED|1st Intervention||0
2511006|NCT00758394|6155568|P4|COMPLETED|1st Intervention||8
2511007|NCT00758394|6155569|P3|COMPLETED|1st Intervention||6
2511008|NCT00758394|6155570|P2|COMPLETED|1st Intervention||7
2511009|NCT00758394|6155571|P1|COMPLETED|1st Intervention||8
2511010|NCT00758394|6155568|P4|STARTED|1st Intervention||8
2511011|NCT00758394|6155569|P3|STARTED|1st Intervention||6
2511012|NCT00758394|6155570|P2|STARTED|1st Intervention||7
2511013|NCT00758394|6155571|P1|STARTED|1st Intervention||8
2511014|NCT00758342|6155583|P2|NOT COMPLETED|Overall Study||1
2511015|NCT00758342|6155584|P1|NOT COMPLETED|Overall Study||4
2511016|NCT00758342|6155583|P2|COMPLETED|Overall Study||17
2511017|NCT00758342|6155584|P1|COMPLETED|Overall Study||15
2511018|NCT00758342|6155583|P2|STARTED|Overall Study||18
2511019|NCT00758342|6155584|P1|STARTED|Overall Study||19
2511020|NCT00758290|6155592|P2|NOT COMPLETED|Overall Study||0
2511021|NCT00758290|6155593|P1|NOT COMPLETED|Overall Study||0
2511022|NCT00758290|6155592|P2|COMPLETED|Overall Study||12
2511023|NCT00758290|6155593|P1|COMPLETED|Overall Study||11
2511024|NCT00758290|6155592|P2|STARTED|Overall Study||12
2511025|NCT00758290|6155593|P1|STARTED|Overall Study||11
2511026|NCT00758264|6155600|P3|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
2511027|NCT00758264|6155601|P2|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
2511028|NCT00758264|6155602|P1|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
2511029|NCT00758264|6155600|P3|COMPLETED|Extended Safety Follow Up (ESFU) Phase||89
2511030|NCT00758264|6155601|P2|COMPLETED|Extended Safety Follow Up (ESFU) Phase||90
2511031|NCT00758264|6155602|P1|COMPLETED|Extended Safety Follow Up (ESFU) Phase||181
2511032|NCT00758264|6155600|P3|STARTED|Extended Safety Follow Up (ESFU) Phase||89
2511033|NCT00758264|6155601|P2|STARTED|Extended Safety Follow Up (ESFU) Phase||90
2511034|NCT00758264|6155602|P1|STARTED|Extended Safety Follow Up (ESFU) Phase||181
2511035|NCT00758264|6155600|P3|NOT COMPLETED|Active Phase||5
2511036|NCT00758264|6155601|P2|NOT COMPLETED|Active Phase||0
2511037|NCT00758264|6155602|P1|NOT COMPLETED|Active Phase||1
2511038|NCT00758264|6155600|P3|COMPLETED|Active Phase||85
2511039|NCT00758264|6155601|P2|COMPLETED|Active Phase||91
2511040|NCT00758264|6155602|P1|COMPLETED|Active Phase||181
2511041|NCT00758264|6155600|P3|STARTED|Active Phase||90
2511042|NCT00758264|6155601|P2|STARTED|Active Phase||91
2511043|NCT00758264|6155602|P1|STARTED|Active Phase||182
2511044|NCT00758160|6155661|P1|NOT COMPLETED|Overall Study||66
2511045|NCT00758160|6155661|P1|COMPLETED|Overall Study||230
2511046|NCT00758160|6155661|P1|STARTED|Overall Study||296
2511047|NCT00758069|6155682|P3|NOT COMPLETED|Overall Study||1
2511048|NCT00758069|6155683|P2|NOT COMPLETED|Overall Study||0
2511049|NCT00758069|6155684|P1|NOT COMPLETED|Overall Study||1
2511050|NCT00758069|6155682|P3|COMPLETED|Overall Study||27
2511051|NCT00758069|6155683|P2|COMPLETED|Overall Study||25
2511052|NCT00758069|6155684|P1|COMPLETED|Overall Study||26
2511053|NCT00758069|6155682|P3|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|28
2511054|NCT00758069|6155683|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|25
2511055|NCT00758069|6155684|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|27
2511056|NCT00758043|6155699|P4|NOT COMPLETED|Overall Study||100
2511057|NCT00758043|6155700|P3|NOT COMPLETED|Overall Study||39
2511058|NCT00758043|6155701|P2|NOT COMPLETED|Overall Study||41
2511059|NCT00758043|6155702|P1|NOT COMPLETED|Overall Study||1
2511060|NCT00758043|6155699|P4|COMPLETED|Overall Study||0
2511061|NCT00758043|6155700|P3|COMPLETED|Overall Study||79
2511062|NCT00758043|6155701|P2|COMPLETED|Overall Study||119
2511063|NCT00758043|6155702|P1|COMPLETED|Overall Study||161
2511064|NCT00758043|6155699|P4|STARTED|Overall Study||100
2511065|NCT00758043|6155700|P3|STARTED|Overall Study||118
2511066|NCT00758043|6155701|P2|STARTED|Overall Study||160
2511067|NCT00758043|6155702|P1|STARTED|Overall Study||162
2511068|NCT00757848|6155730|P2|NOT COMPLETED|Overall Study||2
2511069|NCT00757848|6155731|P1|NOT COMPLETED|Overall Study||3
2511070|NCT00757848|6155730|P2|COMPLETED|Overall Study||27
2511071|NCT00757848|6155731|P1|COMPLETED|Overall Study||24
2511072|NCT00757848|6155730|P2|STARTED|Overall Study||29
2511073|NCT00757848|6155731|P1|STARTED|Overall Study||27
2511074|NCT00757822|6155777|P2|NOT COMPLETED|Overall Study||31
2511075|NCT00757822|6155778|P1|NOT COMPLETED|Overall Study||28
2511076|NCT00757822|6155777|P2|COMPLETED|Overall Study||57
2511077|NCT00757822|6155778|P1|COMPLETED|Overall Study||64
2511078|NCT00757822|6155777|P2|Data Lock, Unblinding Analysis|Overall Study||57
2511079|NCT00757822|6155778|P1|Data Lock, Unblinding Analysis|Overall Study||64
2511080|NCT00757822|6155777|P2|Withdrawn-protocol Deviation|Overall Study||8
2511081|NCT00757822|6155778|P1|Withdrawn-protocol Deviation|Overall Study||9
2511082|NCT00757822|6155777|P2|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk < 2|9
2511083|NCT00757822|6155778|P1|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk<2|12
2511084|NCT00757822|6155777|P2|Data Entry, QC Assessment|Overall Study||74
2511085|NCT00757822|6155778|P1|Data Entry, QC Assessment|Overall Study||85
2511086|NCT00757822|6155777|P2|2-6 wk Post-op Assessment|Overall Study||74
2511087|NCT00757822|6155778|P1|2-6 wk Post-op Assessment|Overall Study||85
2511088|NCT00757822|6155777|P2|24-48 hr Telephone Assessment|Overall Study||74
2511089|NCT00757822|6155778|P1|24-48 hr Telephone Assessment|Overall Study||85
2511090|NCT00757822|6155777|P2|DOS: Post-operative Assessments|Overall Study||74
2511091|NCT00757822|6155778|P1|DOS: Post-operative Assessments|Overall Study||85
2511092|NCT00757822|6155777|P2|Received Study Intervention|Overall Study||74
2511093|NCT00757822|6155778|P1|Received Study Intervention|Overall Study||85
2511094|NCT00757822|6155777|P2|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|11
2511095|NCT00757822|6155778|P1|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|6
2511096|NCT00757822|6155777|P2|Withdrawal by Subject-no Intervention|Overall Study||3
2511097|NCT00757822|6155778|P1|Withdrawal by Subject-no Intervention|Overall Study||1
2511098|NCT00757822|6155777|P2|Day of Surgery (DOS) Assessment|Overall Study||88
2511099|NCT00757822|6155778|P1|Day of Surgery (DOS) Assessment|Overall Study||92
2511100|NCT00757822|6155777|P2|STARTED|Overall Study||88
2511101|NCT00757822|6155778|P1|STARTED|Overall Study||92
2511102|NCT00757783|6155800|P2|NOT COMPLETED|Overall Study||6
2511103|NCT00757783|6155801|P1|NOT COMPLETED|Overall Study||5
2511104|NCT00757783|6155800|P2|COMPLETED|Overall Study||25
2511105|NCT00757783|6155801|P1|COMPLETED|Overall Study||29
2511106|NCT00757783|6155800|P2|STARTED|Overall Study||31
2511107|NCT00757783|6155801|P1|STARTED|Overall Study||34
2511108|NCT00757705|6155837|P1|NOT COMPLETED|Overall Study||121
2511109|NCT00757705|6155837|P1|COMPLETED|Overall Study||178
2511110|NCT00757705|6155837|P1|STARTED|Overall Study||299
2511111|NCT00757666|6155851|P2|NOT COMPLETED|Overall Study||23
2511112|NCT00757666|6155852|P1|NOT COMPLETED|Overall Study||22
2511113|NCT00757666|6155851|P2|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|11
2511114|NCT00757666|6155852|P1|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|12
2511115|NCT00757666|6155851|P2|STARTED|Overall Study||34
2511116|NCT00757666|6155852|P1|STARTED|Overall Study||34
2511117|NCT00757627|6155866|P1|NOT COMPLETED|Overall Study||81
2511118|NCT00757627|6155866|P1|COMPLETED|Overall Study||419
2511119|NCT00757627|6155866|P1|STARTED|Overall Study||500
2511120|NCT00757601|6155879|P12|NOT COMPLETED|Period 5||0
2511121|NCT00757601|6155880|P11|NOT COMPLETED|Period 5||0
2511122|NCT00757601|6155881|P10|NOT COMPLETED|Period 5||0
2511123|NCT00757601|6155882|P9|NOT COMPLETED|Period 5||0
2511124|NCT00757601|6155883|P8|NOT COMPLETED|Period 5||0
2511125|NCT00757601|6155884|P7|NOT COMPLETED|Period 5||0
2511126|NCT00757601|6155885|P6|NOT COMPLETED|Period 5||0
2511127|NCT00757601|6155886|P5|NOT COMPLETED|Period 5||0
2511128|NCT00757601|6155887|P4|NOT COMPLETED|Period 5||0
2511129|NCT00757601|6155888|P3|NOT COMPLETED|Period 5||0
2511130|NCT00757601|6155889|P2|NOT COMPLETED|Period 5||0
2511131|NCT00757601|6155890|P1|NOT COMPLETED|Period 5||0
2511132|NCT00757601|6155879|P12|COMPLETED|Period 5||1
2511133|NCT00757601|6155880|P11|COMPLETED|Period 5||2
2511134|NCT00757601|6155881|P10|COMPLETED|Period 5||1
2511135|NCT00757601|6155882|P9|COMPLETED|Period 5||2
2511136|NCT00757601|6155883|P8|COMPLETED|Period 5||2
2511137|NCT00757601|6155884|P7|COMPLETED|Period 5||2
2511138|NCT00757601|6155885|P6|COMPLETED|Period 5||2
2511139|NCT00757601|6155886|P5|COMPLETED|Period 5||2
2511140|NCT00757601|6155887|P4|COMPLETED|Period 5||2
2511141|NCT00757601|6155888|P3|COMPLETED|Period 5||2
2511142|NCT00757601|6155889|P2|COMPLETED|Period 5||2
2511143|NCT00757601|6155890|P1|COMPLETED|Period 5||2
2511144|NCT00757601|6155879|P12|STARTED|Period 5||1
2511145|NCT00757601|6155880|P11|STARTED|Period 5||2
2511146|NCT00757601|6155881|P10|STARTED|Period 5||1
2511147|NCT00757601|6155882|P9|STARTED|Period 5||2
2511148|NCT00757601|6155883|P8|STARTED|Period 5||2
2511149|NCT00757601|6155884|P7|STARTED|Period 5||2
2511150|NCT00757601|6155885|P6|STARTED|Period 5||2
2511151|NCT00757601|6155886|P5|STARTED|Period 5||2
2511152|NCT00757601|6155887|P4|STARTED|Period 5||2
2511153|NCT00757601|6155888|P3|STARTED|Period 5||2
2511154|NCT00757601|6155889|P2|STARTED|Period 5||2
2511155|NCT00757601|6155890|P1|STARTED|Period 5||2
2511156|NCT00757601|6155879|P12|NOT COMPLETED|Period 4||1
2511157|NCT00757601|6155880|P11|NOT COMPLETED|Period 4||0
2511158|NCT00757601|6155881|P10|NOT COMPLETED|Period 4||1
2511159|NCT00757601|6155882|P9|NOT COMPLETED|Period 4||0
2511160|NCT00757601|6155883|P8|NOT COMPLETED|Period 4||0
2511161|NCT00757601|6155884|P7|NOT COMPLETED|Period 4||0
2511162|NCT00757601|6155885|P6|NOT COMPLETED|Period 4||0
2511163|NCT00757601|6155886|P5|NOT COMPLETED|Period 4||0
2511164|NCT00757601|6155887|P4|NOT COMPLETED|Period 4||0
2511165|NCT00757601|6155888|P3|NOT COMPLETED|Period 4||0
2511166|NCT00757601|6155889|P2|NOT COMPLETED|Period 4||0
2511167|NCT00757601|6155890|P1|NOT COMPLETED|Period 4||0
2511168|NCT00757601|6155879|P12|COMPLETED|Period 4|Replacement participant discontinued after receiving placebo to 230mg MK1006 and was not replaced|1
2511169|NCT00757601|6155880|P11|COMPLETED|Period 4||2
2511170|NCT00757601|6155881|P10|COMPLETED|Period 4|One participant discontinued after receiving the 230 mg dose of MK1006 and was not replaced|1
2511171|NCT00757601|6155882|P9|COMPLETED|Period 4||2
2511172|NCT00757601|6155883|P8|COMPLETED|Period 4||2
2511173|NCT00757601|6155884|P7|COMPLETED|Period 4||2
2511174|NCT00757601|6155885|P6|COMPLETED|Period 4||2
2511175|NCT00757601|6155886|P5|COMPLETED|Period 4||2
2511176|NCT00757601|6155887|P4|COMPLETED|Period 4||2
2511177|NCT00757601|6155888|P3|COMPLETED|Period 4||2
2511178|NCT00757601|6155889|P2|COMPLETED|Period 4||2
2511179|NCT00757601|6155890|P1|COMPLETED|Period 4||2
2511180|NCT00757601|6155879|P12|STARTED|Period 4||2
2511181|NCT00757601|6155880|P11|STARTED|Period 4||2
2511182|NCT00757601|6155881|P10|STARTED|Period 4||2
2511183|NCT00757601|6155882|P9|STARTED|Period 4||2
2511184|NCT00757601|6155883|P8|STARTED|Period 4||2
2511185|NCT00757601|6155884|P7|STARTED|Period 4||2
2511186|NCT00757601|6155885|P6|STARTED|Period 4||2
2511187|NCT00757601|6155886|P5|STARTED|Period 4||2
2511188|NCT00757601|6155887|P4|STARTED|Period 4||2
2511189|NCT00757601|6155888|P3|STARTED|Period 4||2
2511190|NCT00757601|6155889|P2|STARTED|Period 4||2
2511191|NCT00757601|6155890|P1|STARTED|Period 4||2
2511192|NCT00757601|6155879|P12|NOT COMPLETED|Period 3||0
2511193|NCT00757601|6155880|P11|NOT COMPLETED|Period 3||0
2511194|NCT00757601|6155881|P10|NOT COMPLETED|Period 3||0
2511195|NCT00757601|6155882|P9|NOT COMPLETED|Period 3||0
2511196|NCT00757601|6155883|P8|NOT COMPLETED|Period 3||0
2511197|NCT00757601|6155884|P7|NOT COMPLETED|Period 3||0
2511198|NCT00757601|6155885|P6|NOT COMPLETED|Period 3||0
2511199|NCT00757601|6155886|P5|NOT COMPLETED|Period 3||0
2511200|NCT00757601|6155887|P4|NOT COMPLETED|Period 3||0
2511201|NCT00757601|6155888|P3|NOT COMPLETED|Period 3||0
2511202|NCT00757601|6155889|P2|NOT COMPLETED|Period 3||0
2511203|NCT00757601|6155890|P1|NOT COMPLETED|Period 3||0
2511204|NCT00757601|6155879|P12|COMPLETED|Period 3||2
2511205|NCT00757601|6155880|P11|COMPLETED|Period 3||2
2511206|NCT00757601|6155881|P10|COMPLETED|Period 3||2
2511207|NCT00757601|6155882|P9|COMPLETED|Period 3||2
2511208|NCT00757601|6155883|P8|COMPLETED|Period 3||2
2511209|NCT00757601|6155884|P7|COMPLETED|Period 3||2
2511210|NCT00757601|6155885|P6|COMPLETED|Period 3||2
2511211|NCT00757601|6155886|P5|COMPLETED|Period 3||2
2511212|NCT00757601|6155887|P4|COMPLETED|Period 3||2
2511213|NCT00757601|6155888|P3|COMPLETED|Period 3||2
2511214|NCT00757601|6155889|P2|COMPLETED|Period 3||2
2511215|NCT00757601|6155890|P1|COMPLETED|Period 3||2
2511216|NCT00757601|6155879|P12|STARTED|Period 3||2
2511217|NCT00757601|6155880|P11|STARTED|Period 3||2
2511218|NCT00757601|6155881|P10|STARTED|Period 3||2
2511219|NCT00757601|6155882|P9|STARTED|Period 3||2
2511220|NCT00757601|6155883|P8|STARTED|Period 3||2
2511221|NCT00757601|6155884|P7|STARTED|Period 3||2
2511222|NCT00757601|6155885|P6|STARTED|Period 3||2
2511223|NCT00757601|6155886|P5|STARTED|Period 3||2
2511224|NCT00757601|6155887|P4|STARTED|Period 3||2
2511225|NCT00757601|6155888|P3|STARTED|Period 3||2
2511226|NCT00757601|6155889|P2|STARTED|Period 3||2
2511227|NCT00757601|6155890|P1|STARTED|Period 3||2
2511228|NCT00757601|6155879|P12|NOT COMPLETED|Period 2||1
2511229|NCT00757601|6155880|P11|NOT COMPLETED|Period 2||0
2511230|NCT00757601|6155881|P10|NOT COMPLETED|Period 2||0
2511231|NCT00757601|6155882|P9|NOT COMPLETED|Period 2||0
2511232|NCT00757601|6155883|P8|NOT COMPLETED|Period 2||0
2511233|NCT00757601|6155884|P7|NOT COMPLETED|Period 2||0
2511234|NCT00757601|6155885|P6|NOT COMPLETED|Period 2||0
2511235|NCT00757601|6155886|P5|NOT COMPLETED|Period 2||0
2511236|NCT00757601|6155887|P4|NOT COMPLETED|Period 2||0
2511237|NCT00757601|6155888|P3|NOT COMPLETED|Period 2||0
2511238|NCT00757601|6155889|P2|NOT COMPLETED|Period 2||0
2511239|NCT00757601|6155890|P1|NOT COMPLETED|Period 2||0
2511240|NCT00757601|6155879|P12|COMPLETED|Period 2|One participant discontinued the study after Period 2 and was replaced by another participant.|2
2511241|NCT00757601|6155880|P11|COMPLETED|Period 2||2
2511242|NCT00757601|6155881|P10|COMPLETED|Period 2||2
2511243|NCT00757601|6155882|P9|COMPLETED|Period 2||2
2511244|NCT00757601|6155883|P8|COMPLETED|Period 2||2
2511245|NCT00757601|6155884|P7|COMPLETED|Period 2||2
2511246|NCT00757601|6155885|P6|COMPLETED|Period 2||2
2511247|NCT00757601|6155886|P5|COMPLETED|Period 2||2
2511248|NCT00757601|6155887|P4|COMPLETED|Period 2||2
2511249|NCT00757601|6155888|P3|COMPLETED|Period 2||2
2511250|NCT00757601|6155889|P2|COMPLETED|Period 2||2
2511251|NCT00757601|6155890|P1|COMPLETED|Period 2||2
2511252|NCT00757601|6155879|P12|STARTED|Period 2||3
2511253|NCT00757601|6155880|P11|STARTED|Period 2||2
2511254|NCT00757601|6155881|P10|STARTED|Period 2||2
2511255|NCT00757601|6155882|P9|STARTED|Period 2||2
2511256|NCT00757601|6155883|P8|STARTED|Period 2||2
2511257|NCT00757601|6155884|P7|STARTED|Period 2||2
2511258|NCT00757601|6155885|P6|STARTED|Period 2||2
2511259|NCT00757601|6155886|P5|STARTED|Period 2||2
2511260|NCT00757601|6155887|P4|STARTED|Period 2||2
2511261|NCT00757601|6155888|P3|STARTED|Period 2||2
2511262|NCT00757601|6155889|P2|STARTED|Period 2||2
2511263|NCT00757601|6155890|P1|STARTED|Period 2||2
2511264|NCT00757601|6155879|P12|NOT COMPLETED|Period 1||0
2511265|NCT00757601|6155880|P11|NOT COMPLETED|Period 1||0
2511266|NCT00757601|6155881|P10|NOT COMPLETED|Period 1||0
2511267|NCT00757601|6155882|P9|NOT COMPLETED|Period 1||0
2511268|NCT00757601|6155883|P8|NOT COMPLETED|Period 1||0
2511269|NCT00757601|6155884|P7|NOT COMPLETED|Period 1||0
2511270|NCT00757601|6155885|P6|NOT COMPLETED|Period 1||0
2511271|NCT00757601|6155886|P5|NOT COMPLETED|Period 1||0
2511272|NCT00757601|6155887|P4|NOT COMPLETED|Period 1||0
2511273|NCT00757601|6155888|P3|NOT COMPLETED|Period 1||0
2511274|NCT00757601|6155889|P2|NOT COMPLETED|Period 1||0
2511275|NCT00757601|6155890|P1|NOT COMPLETED|Period 1||0
2511276|NCT00757601|6155879|P12|COMPLETED|Period 1||3
2511277|NCT00757601|6155880|P11|COMPLETED|Period 1||2
2511278|NCT00757601|6155881|P10|COMPLETED|Period 1||2
2511279|NCT00757601|6155882|P9|COMPLETED|Period 1||2
2511280|NCT00757601|6155883|P8|COMPLETED|Period 1||2
2511281|NCT00757601|6155884|P7|COMPLETED|Period 1||2
2511282|NCT00757601|6155885|P6|COMPLETED|Period 1||2
2511283|NCT00757601|6155886|P5|COMPLETED|Period 1||2
2511284|NCT00757601|6155887|P4|COMPLETED|Period 1||2
2511285|NCT00757601|6155888|P3|COMPLETED|Period 1||2
2511286|NCT00757601|6155889|P2|COMPLETED|Period 1||2
2511287|NCT00757601|6155890|P1|COMPLETED|Period 1||2
2511288|NCT00757601|6155879|P12|STARTED|Period 1||3
2511289|NCT00757601|6155880|P11|STARTED|Period 1||2
2511290|NCT00757601|6155881|P10|STARTED|Period 1||2
2511291|NCT00757601|6155882|P9|STARTED|Period 1||2
2511292|NCT00757601|6155883|P8|STARTED|Period 1||2
2511293|NCT00757601|6155884|P7|STARTED|Period 1||2
2511294|NCT00757601|6155885|P6|STARTED|Period 1||2
2511295|NCT00757601|6155886|P5|STARTED|Period 1||2
2511296|NCT00757601|6155887|P4|STARTED|Period 1||2
2511297|NCT00757601|6155888|P3|STARTED|Period 1||2
2511298|NCT00757601|6155889|P2|STARTED|Period 1||2
2511299|NCT00757601|6155890|P1|STARTED|Period 1||2
2511300|NCT00757588|6156001|P2|NOT COMPLETED|Period 2: Long-term (52-week) Phase||9
2511301|NCT00757588|6156002|P1|NOT COMPLETED|Period 2: Long-term (52-week) Phase||22
2511302|NCT00757588|6156001|P2|COMPLETED|Period 2: Long-term (52-week) Phase||125
2511303|NCT00757588|6156002|P1|COMPLETED|Period 2: Long-term (52-week) Phase||246
2511304|NCT00757588|6156001|P2|STARTED|Period 2: Long-term (52-week) Phase||134
2511305|NCT00757588|6156002|P1|STARTED|Period 2: Long-term (52-week) Phase|270 participants completed short-term phase; 2 of these did not enter long-term phase.|268
2511306|NCT00757588|6156001|P2|NOT COMPLETED|Period 1: Short-term (24-week) Phase||17
2511307|NCT00757588|6156002|P1|NOT COMPLETED|Period 1: Short-term (24-week) Phase||36
2511308|NCT00757588|6156001|P2|COMPLETED|Period 1: Short-term (24-week) Phase||134
2511309|NCT00757588|6156002|P1|COMPLETED|Period 1: Short-term (24-week) Phase|Does not include 2 who completed Period 1 but were erroneously reported in the CSR as noncompleters.|268
2511310|NCT00757588|6156001|P2|STARTED|Period 1: Short-term (24-week) Phase||151
2511311|NCT00757588|6156002|P1|STARTED|Period 1: Short-term (24-week) Phase||304
2511312|NCT00757484|6156034|P1|NOT COMPLETED|Overall Study||0
2511313|NCT00757484|6156034|P1|COMPLETED|Overall Study||491
2511314|NCT00757484|6156034|P1|STARTED|Overall Study||491
2511315|NCT00757237|6156043|P2|NOT COMPLETED|Overall Study||25
2511316|NCT00757237|6156044|P1|NOT COMPLETED|Overall Study||13
2511317|NCT00757237|6156043|P2|COMPLETED|Overall Study||111
2511318|NCT00757237|6156044|P1|COMPLETED|Overall Study||124
2511319|NCT00757237|6156043|P2|Treated|Overall Study||132
2511320|NCT00757237|6156044|P1|Treated|Overall Study||136
2511321|NCT00757237|6156043|P2|STARTED|Overall Study||136
2511322|NCT00757237|6156044|P1|STARTED|Overall Study||137
2511323|NCT00757172|6156072|P1|NOT COMPLETED|Overall Study||11
2511324|NCT00757172|6156072|P1|COMPLETED|Overall Study|Participants underwent surgery.|54
2511325|NCT00757172|6156072|P1|STARTED|Overall Study||65
2511326|NCT00757003|6156080|P1|NOT COMPLETED|Overall Study||49
2511327|NCT00757003|6156080|P1|COMPLETED|Overall Study||51
2511328|NCT00757003|6156080|P1|STARTED|Overall Study||100
2511329|NCT00756977|6156088|P2|NOT COMPLETED|Overall Study||11
2511330|NCT00756977|6156089|P1|NOT COMPLETED|Overall Study||21
2511331|NCT00756977|6156088|P2|COMPLETED|Overall Study||187
2511332|NCT00756977|6156089|P1|COMPLETED|Overall Study||175
2511333|NCT00756977|6156088|P2|STARTED|Overall Study||198
2511334|NCT00756977|6156089|P1|STARTED|Overall Study||196
2511335|NCT00756964|6156117|P2|NOT COMPLETED|Overall Study||0
2511336|NCT00756964|6156118|P1|NOT COMPLETED|Overall Study||0
2511337|NCT00756964|6156117|P2|COMPLETED|Overall Study||13
2511338|NCT00756964|6156118|P1|COMPLETED|Overall Study||13
2511339|NCT00756964|6156117|P2|STARTED|Overall Study||13
2511340|NCT00756964|6156118|P1|STARTED|Overall Study||13
2511341|NCT00756938|6156127|P4|NOT COMPLETED|Optional Extension||37
2511342|NCT00756938|6156128|P3|NOT COMPLETED|Optional Extension||0
2511343|NCT00756938|6156129|P2|NOT COMPLETED|Optional Extension||0
2511344|NCT00756938|6156130|P1|NOT COMPLETED|Optional Extension||0
2511345|NCT00756938|6156127|P4|COMPLETED|Optional Extension||53
2511346|NCT00756938|6156128|P3|COMPLETED|Optional Extension||0
2511347|NCT00756938|6156129|P2|COMPLETED|Optional Extension||0
2511348|NCT00756938|6156130|P1|COMPLETED|Optional Extension||0
2511349|NCT00756938|6156127|P4|STARTED|Optional Extension|7 participants who completed base study opted not to enter extension|90
2511350|NCT00756938|6156128|P3|STARTED|Optional Extension||0
2511351|NCT00756938|6156129|P2|STARTED|Optional Extension||0
2511352|NCT00756938|6156130|P1|STARTED|Optional Extension||0
2511353|NCT00756938|6156127|P4|NOT COMPLETED|12-week Base Study||0
2511354|NCT00756938|6156128|P3|NOT COMPLETED|12-week Base Study||2
2511355|NCT00756938|6156129|P2|NOT COMPLETED|12-week Base Study||0
2511356|NCT00756938|6156130|P1|NOT COMPLETED|12-week Base Study||2
2511357|NCT00756938|6156127|P4|COMPLETED|12-week Base Study||0
2511358|NCT00756938|6156128|P3|COMPLETED|12-week Base Study||32
2511359|NCT00756938|6156129|P2|COMPLETED|12-week Base Study||34
2511360|NCT00756938|6156130|P1|COMPLETED|12-week Base Study||31
2511361|NCT00756938|6156127|P4|STARTED|12-week Base Study||0
2511362|NCT00756938|6156128|P3|STARTED|12-week Base Study||34
2511363|NCT00756938|6156129|P2|STARTED|12-week Base Study||34
2511364|NCT00756938|6156130|P1|STARTED|12-week Base Study||33
2511365|NCT00756886|6156158|P2|NOT COMPLETED|Overall Study||7
2511366|NCT00756886|6156159|P1|NOT COMPLETED|Overall Study||11
2511367|NCT00756886|6156158|P2|COMPLETED|Overall Study||25
2511368|NCT00756886|6156159|P1|COMPLETED|Overall Study||30
2511369|NCT00756886|6156158|P2|STARTED|Overall Study||32
2511370|NCT00756886|6156159|P1|STARTED|Overall Study||41
2511371|NCT00756730|6156167|P2|NOT COMPLETED|Overall Study||2
2511372|NCT00756730|6156168|P1|NOT COMPLETED|Overall Study||0
2511373|NCT00756730|6156167|P2|COMPLETED|Overall Study||22
2511374|NCT00756730|6156168|P1|COMPLETED|Overall Study||25
2511375|NCT00756730|6156167|P2|STARTED|Overall Study||24
2511376|NCT00756730|6156168|P1|STARTED|Overall Study||25
2511377|NCT00756717|6156188|P1|NOT COMPLETED|Overall Study||2
2511378|NCT00756717|6156188|P1|COMPLETED|Overall Study||20
2511379|NCT00756717|6156188|P1|STARTED|Overall Study||22
2511380|NCT00756678|6156192|P1|NOT COMPLETED|Overall Study||1
2511381|NCT00756678|6156192|P1|COMPLETED|Overall Study||50
2511382|NCT00756678|6156192|P1|STARTED|Overall Study||51
2511383|NCT00756613|6156205|P2|NOT COMPLETED|Overall Study||70
2511384|NCT00756613|6156206|P1|NOT COMPLETED|Overall Study||86
2511385|NCT00756613|6156205|P2|COMPLETED|Overall Study||462
2511386|NCT00756613|6156206|P1|COMPLETED|Overall Study||426
2511387|NCT00756613|6156205|P2|STARTED|Overall Study||532
2511388|NCT00756613|6156206|P1|STARTED|Overall Study||512
2511389|NCT00756574|6156221|P2|NOT COMPLETED|Overall Study||11
2511390|NCT00756574|6156222|P1|NOT COMPLETED|Overall Study||13
2511391|NCT00756574|6156221|P2|COMPLETED|Overall Study||210
2511392|NCT00756574|6156222|P1|COMPLETED|Overall Study||212
2511393|NCT00756574|6156221|P2|STARTED|Overall Study||221
2511394|NCT00756574|6156222|P1|STARTED|Overall Study||225
2511395|NCT00756561|6156232|P1|NOT COMPLETED|Overall Study||0
2511396|NCT00756561|6156232|P1|COMPLETED|Overall Study||10
2511397|NCT00756561|6156232|P1|STARTED|Overall Study||10
2511398|NCT00756548|6156239|P2|NOT COMPLETED|Overall Study||0
2511399|NCT00756548|6156240|P1|NOT COMPLETED|Overall Study||2
2511400|NCT00756548|6156239|P2|COMPLETED|Overall Study||185
2511401|NCT00756548|6156240|P1|COMPLETED|Overall Study||184
2511402|NCT00756548|6156239|P2|STARTED|Overall Study||185
2511403|NCT00756548|6156240|P1|STARTED|Overall Study||186
2511404|NCT00756470|6156266|P1|NOT COMPLETED|Overall Study||5
2511405|NCT00756470|6156266|P1|COMPLETED|Overall Study||10
2511406|NCT00756470|6156266|P1|STARTED|Overall Study||15
2511407|NCT00756457|6156273|P2|NOT COMPLETED|Overall Study||2
2511408|NCT00756457|6156274|P1|NOT COMPLETED|Overall Study||1
2511409|NCT00756457|6156273|P2|COMPLETED|Overall Study|One participant moved overseas; the other participant resumed cancer treatment|17
2511499|NCT00756002|6156387|P1|STARTED|Double-Blind Treatment Period||129
2511410|NCT00756457|6156274|P1|COMPLETED|Overall Study|One participant in the Active treatment group decided to have surgery after the 2 week follow-up.|19
2511411|NCT00756457|6156273|P2|STARTED|Overall Study||19
2511412|NCT00756457|6156274|P1|STARTED|Overall Study||20
2511413|NCT00756444|6156304|P2|NOT COMPLETED|Overall Study||21
2511414|NCT00756444|6156305|P1|NOT COMPLETED|Overall Study||15
2511415|NCT00756444|6156304|P2|COMPLETED|Overall Study||13
2511416|NCT00756444|6156305|P1|COMPLETED|Overall Study||18
2511417|NCT00756444|6156304|P2|STARTED|Overall Study||34
2511418|NCT00756444|6156305|P1|STARTED|Overall Study||33
2511419|NCT00756314|6156316|P2|NOT COMPLETED|Overall Study||59
2511420|NCT00756314|6156317|P1|NOT COMPLETED|Overall Study||2
2511421|NCT00756314|6156316|P2|COMPLETED|Overall Study|"4 participants did not do the follow up, 55 discontinued and were analyzed by intention to treat"|64
2511422|NCT00756314|6156317|P1|COMPLETED|Overall Study|"2 participants discontinued the intervention and were analyzed by intention to treat analysis."|121
2511423|NCT00756314|6156316|P2|STARTED|Overall Study||123
2511424|NCT00756314|6156317|P1|STARTED|Overall Study||123
2511425|NCT00756275|6156333|P2|NOT COMPLETED|Overall Study||28
2511426|NCT00756275|6156334|P1|NOT COMPLETED|Overall Study||29
2511427|NCT00756275|6156333|P2|COMPLETED|Overall Study||49
2511428|NCT00756275|6156334|P1|COMPLETED|Overall Study||31
2511429|NCT00756275|6156333|P2|STARTED|Overall Study||77
2511430|NCT00756275|6156334|P1|STARTED|Overall Study||60
2511431|NCT00756236|6156361|P3|NOT COMPLETED|Overall Study||0
2511432|NCT00756236|6156362|P2|NOT COMPLETED|Overall Study||0
2511433|NCT00756236|6156363|P1|NOT COMPLETED|Overall Study||0
2511434|NCT00756236|6156361|P3|COMPLETED|Overall Study||20
2511435|NCT00756236|6156362|P2|COMPLETED|Overall Study||20
2511436|NCT00756236|6156363|P1|COMPLETED|Overall Study||20
2511437|NCT00756236|6156361|P3|STARTED|Overall Study||20
2511438|NCT00756236|6156362|P2|STARTED|Overall Study||20
2511439|NCT00756236|6156363|P1|STARTED|Overall Study||20
2511440|NCT00756093|6156371|P4|NOT COMPLETED|Fourth Intervention||0
2511441|NCT00756093|6156372|P3|NOT COMPLETED|Fourth Intervention||0
2511442|NCT00756093|6156373|P2|NOT COMPLETED|Fourth Intervention||0
2511443|NCT00756093|6156374|P1|NOT COMPLETED|Fourth Intervention||0
2511444|NCT00756093|6156371|P4|COMPLETED|Fourth Intervention||5
2511445|NCT00756093|6156372|P3|COMPLETED|Fourth Intervention||5
2511446|NCT00756093|6156373|P2|COMPLETED|Fourth Intervention||5
2511447|NCT00756093|6156374|P1|COMPLETED|Fourth Intervention||5
2511448|NCT00756093|6156371|P4|STARTED|Fourth Intervention||5
2511449|NCT00756093|6156372|P3|STARTED|Fourth Intervention||5
2511450|NCT00756093|6156373|P2|STARTED|Fourth Intervention||5
2511451|NCT00756093|6156374|P1|STARTED|Fourth Intervention||5
2511452|NCT00756093|6156371|P4|NOT COMPLETED|Third Intervention||0
2511453|NCT00756093|6156372|P3|NOT COMPLETED|Third Intervention||0
2511454|NCT00756093|6156373|P2|NOT COMPLETED|Third Intervention||0
2511455|NCT00756093|6156374|P1|NOT COMPLETED|Third Intervention||0
2511456|NCT00756093|6156371|P4|COMPLETED|Third Intervention||5
2511457|NCT00756093|6156372|P3|COMPLETED|Third Intervention||5
2511458|NCT00756093|6156373|P2|COMPLETED|Third Intervention||5
2511459|NCT00756093|6156374|P1|COMPLETED|Third Intervention||5
2511460|NCT00756093|6156371|P4|STARTED|Third Intervention||5
2511461|NCT00756093|6156372|P3|STARTED|Third Intervention||5
2511462|NCT00756093|6156373|P2|STARTED|Third Intervention||5
2511463|NCT00756093|6156374|P1|STARTED|Third Intervention||5
2511464|NCT00756093|6156371|P4|NOT COMPLETED|Second Intervention||0
2511465|NCT00756093|6156372|P3|NOT COMPLETED|Second Intervention||0
2511466|NCT00756093|6156373|P2|NOT COMPLETED|Second Intervention||0
2511467|NCT00756093|6156374|P1|NOT COMPLETED|Second Intervention||0
2511468|NCT00756093|6156371|P4|COMPLETED|Second Intervention||5
2511469|NCT00756093|6156372|P3|COMPLETED|Second Intervention||5
2511470|NCT00756093|6156373|P2|COMPLETED|Second Intervention||5
2511471|NCT00756093|6156374|P1|COMPLETED|Second Intervention||5
2511472|NCT00756093|6156371|P4|STARTED|Second Intervention||5
2511473|NCT00756093|6156372|P3|STARTED|Second Intervention||5
2511474|NCT00756093|6156373|P2|STARTED|Second Intervention||5
2511475|NCT00756093|6156374|P1|STARTED|Second Intervention||5
2511476|NCT00756093|6156371|P4|NOT COMPLETED|First Intervention||0
2511477|NCT00756093|6156372|P3|NOT COMPLETED|First Intervention||0
2511478|NCT00756093|6156373|P2|NOT COMPLETED|First Intervention||0
2511479|NCT00756093|6156374|P1|NOT COMPLETED|First Intervention||0
2511480|NCT00756093|6156371|P4|COMPLETED|First Intervention||5
2511481|NCT00756093|6156372|P3|COMPLETED|First Intervention||5
2511482|NCT00756093|6156373|P2|COMPLETED|First Intervention||5
2511483|NCT00756093|6156374|P1|COMPLETED|First Intervention||5
2511484|NCT00756093|6156371|P4|STARTED|First Intervention||5
2511485|NCT00756093|6156372|P3|STARTED|First Intervention||5
2511486|NCT00756093|6156373|P2|STARTED|First Intervention||5
2511487|NCT00756093|6156374|P1|STARTED|First Intervention||5
2511488|NCT00756002|6156386|P2|NOT COMPLETED|Placebo Run-out||0
2511489|NCT00756002|6156387|P1|NOT COMPLETED|Placebo Run-out||0
2511490|NCT00756002|6156386|P2|COMPLETED|Placebo Run-out||0
2511491|NCT00756002|6156387|P1|COMPLETED|Placebo Run-out||114
2511492|NCT00756002|6156386|P2|STARTED|Placebo Run-out||0
2511493|NCT00756002|6156387|P1|STARTED|Placebo Run-out||114
2511494|NCT00756002|6156386|P2|NOT COMPLETED|Double-Blind Treatment Period||15
2511495|NCT00756002|6156387|P1|NOT COMPLETED|Double-Blind Treatment Period||15
2511496|NCT00756002|6156386|P2|COMPLETED|Double-Blind Treatment Period||115
2511497|NCT00756002|6156387|P1|COMPLETED|Double-Blind Treatment Period||114
2511498|NCT00756002|6156386|P2|STARTED|Double-Blind Treatment Period||130
2511500|NCT00756002|6156386|P2|NOT COMPLETED|Placebo Run-in||0
2511501|NCT00756002|6156387|P1|NOT COMPLETED|Placebo Run-in||229
2511502|NCT00756002|6156386|P2|COMPLETED|Placebo Run-in||0
2511503|NCT00756002|6156387|P1|COMPLETED|Placebo Run-in||259
2511504|NCT00756002|6156386|P2|STARTED|Placebo Run-in||0
2511505|NCT00756002|6156387|P1|STARTED|Placebo Run-in||488
2511506|NCT00755937|6156481|P1|NOT COMPLETED|Observational Follow-up||148
2511507|NCT00755937|6156481|P1|COMPLETED|Observational Follow-up|Subjects followed until end of study/subjects for whom end of participation data were collected|244
2511508|NCT00755937|6156481|P1|STARTED|Observational Follow-up||392
2511509|NCT00755937|6156481|P1|NOT COMPLETED|Recruitment||164
2511510|NCT00755937|6156481|P1|COMPLETED|Recruitment|Subjects who had a baseline visit and at least 1 additional follow-up visit (analyzed population)|392
2511511|NCT00755937|6156481|P1|STARTED|Recruitment|Subjects registered in the program|556
2511512|NCT00755911|6156493|P2|NOT COMPLETED|Overall Study||0
2511513|NCT00755911|6156494|P1|NOT COMPLETED|Overall Study||0
2511514|NCT00755911|6156493|P2|COMPLETED|Overall Study||12
2511515|NCT00755911|6156494|P1|COMPLETED|Overall Study||12
2511516|NCT00755911|6156493|P2|STARTED|Overall Study||12
2511517|NCT00755911|6156494|P1|STARTED|Overall Study||12
2511518|NCT00755846|6156508|P6|NOT COMPLETED|Overall Study||14
2511519|NCT00755846|6156509|P5|NOT COMPLETED|Overall Study||17
2511520|NCT00755846|6156510|P4|NOT COMPLETED|Overall Study||13
2511521|NCT00755846|6156511|P3|NOT COMPLETED|Overall Study||12
2511522|NCT00755846|6156512|P2|NOT COMPLETED|Overall Study||17
2511523|NCT00755846|6156513|P1|NOT COMPLETED|Overall Study||25
2511524|NCT00755846|6156508|P6|COMPLETED|Overall Study||31
2511525|NCT00755846|6156509|P5|COMPLETED|Overall Study||27
2511526|NCT00755846|6156510|P4|COMPLETED|Overall Study||32
2511527|NCT00755846|6156511|P3|COMPLETED|Overall Study||32
2511528|NCT00755846|6156512|P2|COMPLETED|Overall Study||27
2511529|NCT00755846|6156513|P1|COMPLETED|Overall Study||18
2511530|NCT00755846|6156508|P6|STARTED|Overall Study||45
2511531|NCT00755846|6156509|P5|STARTED|Overall Study||44
2511532|NCT00755846|6156510|P4|STARTED|Overall Study||45
2511533|NCT00755846|6156511|P3|STARTED|Overall Study||44
2511534|NCT00755846|6156512|P2|STARTED|Overall Study||44
2511535|NCT00755846|6156513|P1|STARTED|Overall Study||43
2511536|NCT00755807|6156613|P2|NOT COMPLETED|Open-label Extension Phase||16
2511537|NCT00755807|6156614|P1|NOT COMPLETED|Open-label Extension Phase||18
2511538|NCT00755807|6156613|P2|COMPLETED|Open-label Extension Phase||93
2511539|NCT00755807|6156614|P1|COMPLETED|Open-label Extension Phase||82
2511540|NCT00755807|6156613|P2|STARTED|Open-label Extension Phase||109
2511541|NCT00755807|6156614|P1|STARTED|Open-label Extension Phase||100
2511542|NCT00755807|6156613|P2|NOT COMPLETED|Acute Phase||12
2511543|NCT00755807|6156614|P1|NOT COMPLETED|Acute Phase||18
2511544|NCT00755807|6156613|P2|COMPLETED|Acute Phase||109
2511545|NCT00755807|6156614|P1|COMPLETED|Acute Phase||100
2511546|NCT00755807|6156613|P2|STARTED|Acute Phase||121
2511547|NCT00755807|6156614|P1|STARTED|Acute Phase||118
2511548|NCT00755755|6156678|P3|NOT COMPLETED|Overall Study||3
2511549|NCT00755755|6156679|P2|NOT COMPLETED|Overall Study||8
2511550|NCT00755755|6156680|P1|NOT COMPLETED|Overall Study||6
2511551|NCT00755755|6156678|P3|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|45
2511552|NCT00755755|6156679|P2|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|90
2511553|NCT00755755|6156680|P1|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|89
2511554|NCT00755755|6156678|P3|STARTED|Overall Study|Safety population|48
2511555|NCT00755755|6156679|P2|STARTED|Overall Study|Safety population|98
2511556|NCT00755755|6156680|P1|STARTED|Overall Study|Safety population|95
2511557|NCT00755716|6156694|P3|NOT COMPLETED|Overall Study||3
2511558|NCT00755716|6156695|P2|NOT COMPLETED|Overall Study||8
2511559|NCT00755716|6156696|P1|NOT COMPLETED|Overall Study||8
2511560|NCT00755716|6156694|P3|COMPLETED|Overall Study||16
2511561|NCT00755716|6156695|P2|COMPLETED|Overall Study||11
2511562|NCT00755716|6156696|P1|COMPLETED|Overall Study||11
2511563|NCT00755716|6156694|P3|STARTED|Overall Study||19
2511564|NCT00755716|6156695|P2|STARTED|Overall Study||19
2511565|NCT00755716|6156696|P1|STARTED|Overall Study||19
2511566|NCT00755417|6156710|P3|NOT COMPLETED|Overall Study||42
2511567|NCT00755417|6156711|P2|NOT COMPLETED|Overall Study||55
2511568|NCT00755417|6156712|P1|NOT COMPLETED|Overall Study||62
2511569|NCT00755417|6156710|P3|COMPLETED|Overall Study||135
2511570|NCT00755417|6156711|P2|COMPLETED|Overall Study||126
2511571|NCT00755417|6156712|P1|COMPLETED|Overall Study||112
2511572|NCT00755417|6156710|P3|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|177
2511573|NCT00755417|6156711|P2|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|181
2511574|NCT00755417|6156712|P1|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|174
2511575|NCT00755326|6156731|P2|NOT COMPLETED|Overall Study||3
2511576|NCT00755326|6156732|P1|NOT COMPLETED|Overall Study||2
2511577|NCT00755326|6156731|P2|COMPLETED|Overall Study||42
2511578|NCT00755326|6156732|P1|COMPLETED|Overall Study||45
2511579|NCT00755326|6156731|P2|STARTED|Overall Study||45
2511580|NCT00755326|6156732|P1|STARTED|Overall Study||47
2511581|NCT00755274|6156744|P2|NOT COMPLETED|Overall Study||0
2511582|NCT00755274|6156745|P1|NOT COMPLETED|Overall Study||0
2511583|NCT00755274|6156744|P2|COMPLETED|Overall Study||8
2511584|NCT00755274|6156745|P1|COMPLETED|Overall Study||24
2511585|NCT00755274|6156744|P2|STARTED|Overall Study||8
2511586|NCT00755274|6156745|P1|STARTED|Overall Study||24
2511587|NCT00755261|6156765|P1|NOT COMPLETED|Overall Study||2
2511588|NCT00755261|6156765|P1|COMPLETED|Overall Study||4
2511589|NCT00755261|6156765|P1|STARTED|Overall Study||6
2511590|NCT00755235|6156771|P2|NOT COMPLETED|Overall Study||9
2511591|NCT00755235|6156772|P1|NOT COMPLETED|Overall Study||2
2511592|NCT00755235|6156771|P2|COMPLETED|Overall Study||93
2511593|NCT00755235|6156772|P1|COMPLETED|Overall Study||104
2511594|NCT00755235|6156771|P2|STARTED|Overall Study||102
2511595|NCT00755235|6156772|P1|STARTED|Overall Study||106
2511596|NCT00755222|6156782|P2|NOT COMPLETED|Overall Study||2
2511597|NCT00755222|6156783|P1|NOT COMPLETED|Overall Study||8
2511598|NCT00755222|6156782|P2|COMPLETED|Overall Study||34
2511599|NCT00755222|6156783|P1|COMPLETED|Overall Study||103
2511600|NCT00755222|6156782|P2|STARTED|Overall Study||36
2511601|NCT00755222|6156783|P1|STARTED|Overall Study||111
2511602|NCT00755196|6156797|P1|NOT COMPLETED|Overall Study||2
2511603|NCT00755196|6156797|P1|COMPLETED|Overall Study||28
2511604|NCT00755196|6156797|P1|STARTED|Overall Study||30
2511605|NCT00755131|6156804|P2|NOT COMPLETED|Overall Study||0
2511606|NCT00755131|6156805|P1|NOT COMPLETED|Overall Study||0
2511607|NCT00755131|6156804|P2|COMPLETED|Overall Study||38
2511608|NCT00755131|6156805|P1|COMPLETED|Overall Study||37
2511609|NCT00755131|6156804|P2|STARTED|Overall Study||38
2511610|NCT00755131|6156805|P1|STARTED|Overall Study||37
2511611|NCT00755105|6156818|P3|NOT COMPLETED|Overall Study||4
2511612|NCT00755105|6156819|P2|NOT COMPLETED|Overall Study||11
2511613|NCT00755105|6156820|P1|NOT COMPLETED|Overall Study||9
2511614|NCT00755105|6156818|P3|COMPLETED|Overall Study||5
2511615|NCT00755105|6156819|P2|COMPLETED|Overall Study||19
2511616|NCT00755105|6156820|P1|COMPLETED|Overall Study||29
2511617|NCT00755105|6156818|P3|STARTED|Overall Study||9
2511618|NCT00755105|6156819|P2|STARTED|Overall Study||30
2511619|NCT00755105|6156820|P1|STARTED|Overall Study||38
2511620|NCT00755079|6156830|P2|NOT COMPLETED|Overall Study||6
2511621|NCT00755079|6156831|P1|NOT COMPLETED|Overall Study||1
2511622|NCT00755079|6156830|P2|COMPLETED|Overall Study||16
2511623|NCT00755079|6156831|P1|COMPLETED|Overall Study||17
2511624|NCT00755079|6156830|P2|STARTED|Overall Study||22
2511625|NCT00755079|6156831|P1|STARTED|Overall Study||18
2511626|NCT00755040|6156841|P2|NOT COMPLETED|Overall Study||34
2511627|NCT00755040|6156842|P1|NOT COMPLETED|Overall Study||43
2511628|NCT00755040|6156841|P2|COMPLETED|Overall Study||47
2511629|NCT00755040|6156842|P1|COMPLETED|Overall Study||40
2511630|NCT00755040|6156841|P2|STARTED|Overall Study||81
2511631|NCT00755040|6156842|P1|STARTED|Overall Study||83
2511632|NCT00754936|6156850|P1|NOT COMPLETED|Overall Study||12
2511633|NCT00754936|6156850|P1|COMPLETED|Overall Study||59
2511634|NCT00754936|6156850|P1|STARTED|Overall Study||71
2511635|NCT00754923|6156855|P1|NOT COMPLETED|Overall Study||0
2511636|NCT00754923|6156855|P1|COMPLETED|Overall Study||11
2511637|NCT00754923|6156855|P1|STARTED|Overall Study||11
2511638|NCT00754845|6156864|P2|NOT COMPLETED|Overall Study||0
2511639|NCT00754845|6156865|P1|NOT COMPLETED|Overall Study||0
2511640|NCT00754845|6156864|P2|COMPLETED|Overall Study||959
2511641|NCT00754845|6156865|P1|COMPLETED|Overall Study||959
2511642|NCT00754845|6156864|P2|STARTED|Overall Study||959
2511643|NCT00754845|6156865|P1|STARTED|Overall Study||959
2511644|NCT00754832|6156877|P2|NOT COMPLETED|Second 6 Weeks Intervention||2
2511645|NCT00754832|6156878|P1|NOT COMPLETED|Second 6 Weeks Intervention||0
2511646|NCT00754832|6156877|P2|COMPLETED|Second 6 Weeks Intervention||24
2511647|NCT00754832|6156878|P1|COMPLETED|Second 6 Weeks Intervention||17
2511648|NCT00754832|6156877|P2|STARTED|Second 6 Weeks Intervention||26
2511649|NCT00754832|6156878|P1|STARTED|Second 6 Weeks Intervention||17
2511650|NCT00754832|6156877|P2|NOT COMPLETED|2 Weeks Washout||2
2511651|NCT00754832|6156878|P1|NOT COMPLETED|2 Weeks Washout||1
2511652|NCT00754832|6156877|P2|COMPLETED|2 Weeks Washout||26
2511653|NCT00754832|6156878|P1|COMPLETED|2 Weeks Washout||17
2511654|NCT00754832|6156877|P2|STARTED|2 Weeks Washout||28
2511655|NCT00754832|6156878|P1|STARTED|2 Weeks Washout||18
2511656|NCT00754832|6156877|P2|NOT COMPLETED|First 6 Weeks Intervention||2
2511657|NCT00754832|6156878|P1|NOT COMPLETED|First 6 Weeks Intervention||8
2511658|NCT00754832|6156877|P2|COMPLETED|First 6 Weeks Intervention||28
2511659|NCT00754832|6156878|P1|COMPLETED|First 6 Weeks Intervention||18
2511660|NCT00754832|6156877|P2|STARTED|First 6 Weeks Intervention||30
2511661|NCT00754832|6156878|P1|STARTED|First 6 Weeks Intervention||26
2511662|NCT00754793|6156890|P2|NOT COMPLETED|Overall Study||1
2511663|NCT00754793|6156891|P1|NOT COMPLETED|Overall Study||0
2511664|NCT00754793|6156890|P2|COMPLETED|Overall Study||1
2511665|NCT00754793|6156891|P1|COMPLETED|Overall Study||1
2511666|NCT00754793|6156890|P2|STARTED|Overall Study||2
2511667|NCT00754793|6156891|P1|STARTED|Overall Study||1
2511668|NCT00754767|6156899|P2|NOT COMPLETED|Overall Study||0
2511669|NCT00754767|6156900|P1|NOT COMPLETED|Overall Study||0
2511670|NCT00754767|6156899|P2|COMPLETED|Overall Study||0
2511671|NCT00754767|6156900|P1|COMPLETED|Overall Study||2
2511672|NCT00754767|6156899|P2|STARTED|Overall Study||0
2511673|NCT00754767|6156900|P1|STARTED|Overall Study||2
2511674|NCT00754741|6156909|P3|NOT COMPLETED|Overall Study||54
2511675|NCT00754741|6156910|P2|NOT COMPLETED|Overall Study||69
2511676|NCT00754741|6156911|P1|NOT COMPLETED|Overall Study||57
2511677|NCT00754741|6156909|P3|COMPLETED|Overall Study||502
2511678|NCT00754741|6156910|P2|COMPLETED|Overall Study||500
2511679|NCT00754741|6156911|P1|COMPLETED|Overall Study||510
2511680|NCT00754741|6156909|P3|STARTED|Overall Study||556
2511681|NCT00754741|6156910|P2|STARTED|Overall Study||569
2511682|NCT00754741|6156911|P1|STARTED|Overall Study||567
2511683|NCT00754650|6156958|P1|NOT COMPLETED|Overall Study||2
2511684|NCT00754650|6156958|P1|COMPLETED|Overall Study||0
2511685|NCT00754650|6156958|P1|STARTED|Overall Study||2
2511686|NCT00754624|6156963|P1|NOT COMPLETED|Overall Study||69
2511687|NCT00754624|6156963|P1|COMPLETED|Overall Study||160
2511688|NCT00754624|6156963|P1|STARTED|Overall Study||229
2511689|NCT00754572|6156973|P1|NOT COMPLETED|Overall Study||71
2511690|NCT00754572|6156973|P1|COMPLETED|Overall Study||347
2511691|NCT00754572|6156973|P1|STARTED|Overall Study||418
2511692|NCT00754559|6157000|P1|NOT COMPLETED|Overall Study||47
2511693|NCT00754559|6157000|P1|COMPLETED|Overall Study||239
2511694|NCT00754559|6157000|P1|STARTED|Overall Study||286
2511695|NCT00754546|6157024|P1|NOT COMPLETED|Overall Study||0
2511696|NCT00754546|6157024|P1|COMPLETED|Overall Study||20
2511697|NCT00754546|6157024|P1|STARTED|Overall Study||20
2511698|NCT00754494|6157041|P3|NOT COMPLETED|Overall Study||1
2511699|NCT00754494|6157042|P2|NOT COMPLETED|Overall Study||0
2511700|NCT00754494|6157043|P1|NOT COMPLETED|Overall Study||2
2511701|NCT00754494|6157041|P3|COMPLETED|Overall Study||14
2511702|NCT00754494|6157042|P2|COMPLETED|Overall Study||15
2511703|NCT00754494|6157043|P1|COMPLETED|Overall Study||13
2511704|NCT00754494|6157041|P3|STARTED|Overall Study||15
2511705|NCT00754494|6157042|P2|STARTED|Overall Study||15
2511706|NCT00754494|6157043|P1|STARTED|Overall Study||15
2511707|NCT00754468|6157089|P2|NOT COMPLETED|Overall Study||0
2511708|NCT00754468|6157090|P1|NOT COMPLETED|Overall Study||0
2511709|NCT00754468|6157089|P2|COMPLETED|Overall Study||3
2511710|NCT00754468|6157090|P1|COMPLETED|Overall Study||4
2511711|NCT00754468|6157089|P2|STARTED|Overall Study||3
2511712|NCT00754468|6157090|P1|STARTED|Overall Study||4
2511713|NCT00754442|6157100|P2|NOT COMPLETED|Overall Study||3
2511714|NCT00754442|6157101|P1|NOT COMPLETED|Overall Study||5
2511715|NCT00754442|6157100|P2|COMPLETED|Overall Study||6
2511716|NCT00754442|6157101|P1|COMPLETED|Overall Study||6
2511717|NCT00754442|6157100|P2|STARTED|Overall Study|patients 9|9
2511718|NCT00754442|6157101|P1|STARTED|Overall Study|controls 11|11
2511719|NCT00754390|6157108|P1|NOT COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||1
2511720|NCT00754390|6157108|P1|COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||10
2511721|NCT00754390|6157108|P1|STARTED|Ca/Phytate Test Meal 4 (Randomized)||11
2511722|NCT00754390|6157108|P1|NOT COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||1
2511723|NCT00754390|6157108|P1|COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||11
2511724|NCT00754390|6157108|P1|STARTED|Ca/Phytate Test Meal 3 (Randomized)||12
2511725|NCT00754390|6157108|P1|NOT COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||0
2511726|NCT00754390|6157108|P1|COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||12
2511727|NCT00754390|6157108|P1|STARTED|Ca/Phytate Test Meal 2 (Randomized)||12
2511728|NCT00754390|6157108|P1|NOT COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||5
2511729|NCT00754390|6157108|P1|COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||12
2511730|NCT00754390|6157108|P1|STARTED|Ca/Phytate Test Meal 1 (Randomized)||17
2511731|NCT00754377|6157117|P2|NOT COMPLETED|Overall Study||0
2511732|NCT00754377|6157118|P1|NOT COMPLETED|Overall Study||0
2511733|NCT00754377|6157117|P2|COMPLETED|Overall Study||42
2511734|NCT00754377|6157118|P1|COMPLETED|Overall Study||50
2511735|NCT00754377|6157117|P2|STARTED|Overall Study||42
2511736|NCT00754377|6157118|P1|STARTED|Overall Study||50
2511737|NCT00754338|6157130|P4|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
2511738|NCT00754338|6157131|P3|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
2511739|NCT00754338|6157132|P2|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
2511740|NCT00754338|6157133|P1|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
2511741|NCT00754338|6157130|P4|COMPLETED|Second Intervention for Phase1&Phase2||18
2511742|NCT00754338|6157131|P3|COMPLETED|Second Intervention for Phase1&Phase2||16
2511743|NCT00754338|6157132|P2|COMPLETED|Second Intervention for Phase1&Phase2||17
2511744|NCT00754338|6157133|P1|COMPLETED|Second Intervention for Phase1&Phase2||17
2511745|NCT00754338|6157130|P4|STARTED|Second Intervention for Phase1&Phase2||19
2511746|NCT00754338|6157131|P3|STARTED|Second Intervention for Phase1&Phase2||16
2511747|NCT00754338|6157132|P2|STARTED|Second Intervention for Phase1&Phase2||18
2511748|NCT00754338|6157133|P1|STARTED|Second Intervention for Phase1&Phase2||17
2511749|NCT00754338|6157130|P4|NOT COMPLETED|First Intervention for Phase1&Phase2||0
2511750|NCT00754338|6157131|P3|NOT COMPLETED|First Intervention for Phase1&Phase2||3
2511751|NCT00754338|6157132|P2|NOT COMPLETED|First Intervention for Phase1&Phase2||3
2511752|NCT00754338|6157133|P1|NOT COMPLETED|First Intervention for Phase1&Phase2||0
2511753|NCT00754338|6157130|P4|COMPLETED|First Intervention for Phase1&Phase2||19
2511754|NCT00754338|6157131|P3|COMPLETED|First Intervention for Phase1&Phase2||16
2511755|NCT00754338|6157132|P2|COMPLETED|First Intervention for Phase1&Phase2||18
2511756|NCT00754338|6157133|P1|COMPLETED|First Intervention for Phase1&Phase2||17
2511757|NCT00754338|6157130|P4|STARTED|First Intervention for Phase1&Phase2||19
2511758|NCT00754338|6157131|P3|STARTED|First Intervention for Phase1&Phase2||19
2511759|NCT00754338|6157132|P2|STARTED|First Intervention for Phase1&Phase2||21
2511760|NCT00754338|6157133|P1|STARTED|First Intervention for Phase1&Phase2||17
2511761|NCT00754325|6157165|P2|NOT COMPLETED|Progression and Cross-over||21
2511762|NCT00754325|6157166|P1|NOT COMPLETED|Progression and Cross-over||0
2511763|NCT00754325|6157165|P2|COMPLETED|Progression and Cross-over||0
2511764|NCT00754325|6157166|P1|COMPLETED|Progression and Cross-over||0
2511765|NCT00754325|6157165|P2|STARTED|Progression and Cross-over|Progressive disease participants in Arm 2 could add dasatinib (Arm 2b) at investigator discretion.|21
2511766|NCT00754325|6157166|P1|STARTED|Progression and Cross-over|Arm 1 participants with dasatinib-related toxicity stop dasatinib, continue fulvestrant (Arm 1b).|0
2511767|NCT00754325|6157165|P2|NOT COMPLETED|Initial Treatment||49
2511768|NCT00754325|6157166|P1|NOT COMPLETED|Initial Treatment||50
2511769|NCT00754325|6157165|P2|COMPLETED|Initial Treatment||0
2511770|NCT00754325|6157166|P1|COMPLETED|Initial Treatment||0
2511771|NCT00754325|6157165|P2|STARTED|Initial Treatment||49
2511772|NCT00754325|6157166|P1|STARTED|Initial Treatment||50
2511773|NCT00754247|6157188|P3|NOT COMPLETED|Overall Study||5
2511774|NCT00754247|6157189|P2|NOT COMPLETED|Overall Study||5
2511775|NCT00754247|6157190|P1|NOT COMPLETED|Overall Study||5
2511776|NCT00754247|6157188|P3|COMPLETED|Overall Study||5
2511777|NCT00754247|6157189|P2|COMPLETED|Overall Study||5
2511778|NCT00754247|6157190|P1|COMPLETED|Overall Study||5
2511779|NCT00754247|6157188|P3|STARTED|Overall Study||10
2511780|NCT00754247|6157189|P2|STARTED|Overall Study||10
2511781|NCT00754247|6157190|P1|STARTED|Overall Study||10
2511782|NCT00754234|6157219|P1|NOT COMPLETED|Overall Study||3
2511783|NCT00754234|6157219|P1|COMPLETED|Overall Study|2 participants did not receive the Day 1,4,5,6 menu and 1 did not receive the Day 2 menu|13
2511784|NCT00754234|6157219|P1|STARTED|Overall Study|7 Menus were consumed in randomized order|16
2511785|NCT00754208|6157223|P1|NOT COMPLETED|Overall Study||0
2511786|NCT00754208|6157223|P1|COMPLETED|Overall Study||7
2511787|NCT00754208|6157223|P1|STARTED|Overall Study||7
2511788|NCT00754156|6157232|P2|NOT COMPLETED|Overall Study||0
2511789|NCT00754156|6157233|P1|NOT COMPLETED|Overall Study||0
2511790|NCT00754156|6157232|P2|COMPLETED|Overall Study||6
2511791|NCT00754156|6157233|P1|COMPLETED|Overall Study||8
2511792|NCT00754156|6157232|P2|STARTED|Overall Study||6
2511793|NCT00754156|6157233|P1|STARTED|Overall Study||8
2511794|NCT00754130|6157257|P6|NOT COMPLETED|Period 2 (5 Days)||0
2511795|NCT00754130|6157258|P5|NOT COMPLETED|Period 2 (5 Days)||0
2511796|NCT00754130|6157259|P4|NOT COMPLETED|Period 2 (5 Days)||0
2511797|NCT00754130|6157260|P3|NOT COMPLETED|Period 2 (5 Days)||0
2511798|NCT00754130|6157261|P2|NOT COMPLETED|Period 2 (5 Days)||0
2511799|NCT00754130|6157262|P1|NOT COMPLETED|Period 2 (5 Days)||0
2511800|NCT00754130|6157257|P6|COMPLETED|Period 2 (5 Days)||4
2511801|NCT00754130|6157258|P5|COMPLETED|Period 2 (5 Days)||2
2511802|NCT00754130|6157259|P4|COMPLETED|Period 2 (5 Days)||2
2511803|NCT00754130|6157260|P3|COMPLETED|Period 2 (5 Days)||4
2511804|NCT00754130|6157261|P2|COMPLETED|Period 2 (5 Days)||2
2511805|NCT00754130|6157262|P1|COMPLETED|Period 2 (5 Days)||2
2511806|NCT00754130|6157257|P6|STARTED|Period 2 (5 Days)|One participant received MK-0941 35 mg starting with Dose 3 on Day 3.|4
2511807|NCT00754130|6157258|P5|STARTED|Period 2 (5 Days)||2
2511808|NCT00754130|6157259|P4|STARTED|Period 2 (5 Days)||2
2511809|NCT00754130|6157260|P3|STARTED|Period 2 (5 Days)||4
2511810|NCT00754130|6157261|P2|STARTED|Period 2 (5 Days)||2
2511811|NCT00754130|6157262|P1|STARTED|Period 2 (5 Days)|One participant received MK-0941 15 mg starting with Dose 2 on Day 2.|2
2511812|NCT00754130|6157257|P6|NOT COMPLETED|Washout Period (>=8 Days)||0
2511813|NCT00754130|6157258|P5|NOT COMPLETED|Washout Period (>=8 Days)||0
2511814|NCT00754130|6157259|P4|NOT COMPLETED|Washout Period (>=8 Days)||0
2511815|NCT00754130|6157260|P3|NOT COMPLETED|Washout Period (>=8 Days)||0
2511816|NCT00754130|6157261|P2|NOT COMPLETED|Washout Period (>=8 Days)||0
2511817|NCT00754130|6157262|P1|NOT COMPLETED|Washout Period (>=8 Days)||0
2511818|NCT00754130|6157257|P6|COMPLETED|Washout Period (>=8 Days)||4
2511819|NCT00754130|6157258|P5|COMPLETED|Washout Period (>=8 Days)||2
2511820|NCT00754130|6157259|P4|COMPLETED|Washout Period (>=8 Days)||2
2511821|NCT00754130|6157260|P3|COMPLETED|Washout Period (>=8 Days)||4
2511822|NCT00754130|6157261|P2|COMPLETED|Washout Period (>=8 Days)||2
2511823|NCT00754130|6157262|P1|COMPLETED|Washout Period (>=8 Days)||2
2511824|NCT00754130|6157257|P6|STARTED|Washout Period (>=8 Days)||4
2511825|NCT00754130|6157258|P5|STARTED|Washout Period (>=8 Days)||2
2511826|NCT00754130|6157259|P4|STARTED|Washout Period (>=8 Days)||2
2511827|NCT00754130|6157260|P3|STARTED|Washout Period (>=8 Days)||4
2511828|NCT00754130|6157261|P2|STARTED|Washout Period (>=8 Days)||2
2511829|NCT00754130|6157262|P1|STARTED|Washout Period (>=8 Days)||2
2511830|NCT00754130|6157257|P6|NOT COMPLETED|Period 1 (5 Days)||0
2511831|NCT00754130|6157258|P5|NOT COMPLETED|Period 1 (5 Days)||0
2511832|NCT00754130|6157259|P4|NOT COMPLETED|Period 1 (5 Days)||0
2511833|NCT00754130|6157260|P3|NOT COMPLETED|Period 1 (5 Days)||0
2511834|NCT00754130|6157261|P2|NOT COMPLETED|Period 1 (5 Days)||0
2511835|NCT00754130|6157262|P1|NOT COMPLETED|Period 1 (5 Days)||0
2511836|NCT00754130|6157257|P6|COMPLETED|Period 1 (5 Days)||4
2511837|NCT00754130|6157258|P5|COMPLETED|Period 1 (5 Days)||2
2511838|NCT00754130|6157259|P4|COMPLETED|Period 1 (5 Days)||2
2511839|NCT00754130|6157260|P3|COMPLETED|Period 1 (5 Days)||4
2511840|NCT00754130|6157261|P2|COMPLETED|Period 1 (5 Days)||2
2511841|NCT00754130|6157262|P1|COMPLETED|Period 1 (5 Days)||2
2511842|NCT00754130|6157257|P6|STARTED|Period 1 (5 Days)|One participant received MK-0941 10 mg in both Periods 1 and 2.|4
2511843|NCT00754130|6157258|P5|STARTED|Period 1 (5 Days)||2
2511844|NCT00754130|6157259|P4|STARTED|Period 1 (5 Days)||2
2511845|NCT00754130|6157260|P3|STARTED|Period 1 (5 Days)||4
2511846|NCT00754130|6157261|P2|STARTED|Period 1 (5 Days)||2
2511847|NCT00754130|6157262|P1|STARTED|Period 1 (5 Days)||2
2511848|NCT00754065|6157305|P2|NOT COMPLETED|Overall Study||80
2511849|NCT00754065|6157306|P1|NOT COMPLETED|Overall Study||81
2511850|NCT00754065|6157305|P2|COMPLETED|Overall Study||126
2511851|NCT00754065|6157306|P1|COMPLETED|Overall Study||122
2511852|NCT00754065|6157305|P2|Cycle 6|Overall Study||153
2511853|NCT00754065|6157306|P1|Cycle 6|Overall Study||141
2511854|NCT00754065|6157305|P2|Participants Received Treatment|Overall Study||204
2511855|NCT00754065|6157306|P1|Participants Received Treatment|Overall Study||191
2511856|NCT00754065|6157305|P2|STARTED|Overall Study||206
2511857|NCT00754065|6157306|P1|STARTED|Overall Study||203
2511858|NCT00754052|6157546|P2|NOT COMPLETED|Overall Study||3
2511859|NCT00754052|6157547|P1|NOT COMPLETED|Overall Study||5
2511860|NCT00754052|6157546|P2|COMPLETED|Overall Study||0
2511861|NCT00754052|6157547|P1|COMPLETED|Overall Study||0
2511862|NCT00754052|6157546|P2|STARTED|Overall Study||3
2511863|NCT00754052|6157547|P1|STARTED|Overall Study||5
2511864|NCT00754013|6157561|P2|NOT COMPLETED|Overall Study||5
2511865|NCT00754013|6157562|P1|NOT COMPLETED|Overall Study||4
2511866|NCT00754013|6157561|P2|COMPLETED|Overall Study||0
2511867|NCT00754013|6157562|P1|COMPLETED|Overall Study||0
2511868|NCT00754013|6157561|P2|STARTED|Overall Study||5
2511869|NCT00754013|6157562|P1|STARTED|Overall Study||4
2511879|NCT00753935|6157585|P2|NOT COMPLETED|Overall Study||0
2511880|NCT00753935|6157586|P1|NOT COMPLETED|Overall Study||0
2511881|NCT00753935|6157585|P2|COMPLETED|Overall Study||47
2511882|NCT00753935|6157586|P1|COMPLETED|Overall Study||45
2511883|NCT00753935|6157585|P2|STARTED|Overall Study||47
2511884|NCT00753935|6157586|P1|STARTED|Overall Study||45
2511885|NCT00753922|6157596|P4|NOT COMPLETED|Overall Study||23
2511886|NCT00753922|6157597|P3|NOT COMPLETED|Overall Study||63
2511887|NCT00753922|6157598|P2|NOT COMPLETED|Overall Study||94
2511888|NCT00753922|6157599|P1|NOT COMPLETED|Overall Study||246
2511889|NCT00753922|6157596|P4|COMPLETED|Overall Study||37
2511890|NCT00753922|6157597|P3|COMPLETED|Overall Study||82
2511891|NCT00753922|6157598|P2|COMPLETED|Overall Study||157
2511892|NCT00753922|6157599|P1|COMPLETED|Overall Study||306
2511893|NCT00753922|6157596|P4|STARTED|Overall Study||60
2511894|NCT00753922|6157597|P3|STARTED|Overall Study||145
2511895|NCT00753922|6157598|P2|STARTED|Overall Study||251
2511896|NCT00753922|6157599|P1|STARTED|Overall Study||552
2511897|NCT00753896|6157629|P1|NOT COMPLETED|Overall Study||16
2511898|NCT00753896|6157629|P1|COMPLETED|Overall Study||118
2511899|NCT00753896|6157629|P1|STARTED|Overall Study||134
2511900|NCT00753766|6157645|P2|NOT COMPLETED|Overall Study||0
2511901|NCT00753766|6157646|P1|NOT COMPLETED|Overall Study||1
2511902|NCT00753766|6157645|P2|COMPLETED|Overall Study||0
2511903|NCT00753766|6157646|P1|COMPLETED|Overall Study||0
2511904|NCT00753766|6157645|P2|STARTED|Overall Study||0
2511905|NCT00753766|6157646|P1|STARTED|Overall Study||1
2511906|NCT00753714|6157668|P2|NOT COMPLETED|Overall Study||62
2511907|NCT00753714|6157669|P1|NOT COMPLETED|Overall Study||60
2511908|NCT00753714|6157668|P2|COMPLETED|Overall Study||1
2511909|NCT00753714|6157669|P1|COMPLETED|Overall Study||1
2511910|NCT00753714|6157668|P2|STARTED|Overall Study||63
2511911|NCT00753714|6157669|P1|STARTED|Overall Study||61
2511912|NCT00753688|6157685|P2|NOT COMPLETED|Overall Study||246
2511913|NCT00753688|6157686|P1|NOT COMPLETED|Overall Study||123
2511914|NCT00753688|6157685|P2|COMPLETED|Overall Study||0
2511915|NCT00753688|6157686|P1|COMPLETED|Overall Study||0
2511916|NCT00753688|6157685|P2|Ongoing - in Follow-up|Overall Study||31
2511917|NCT00753688|6157686|P1|Ongoing - in Follow-up|Overall Study||15
2511918|NCT00753688|6157685|P2|STARTED|Overall Study||246
2511919|NCT00753688|6157686|P1|STARTED|Overall Study||123
2511920|NCT00753675|6157715|P3|NOT COMPLETED|Overall Study||56
2511921|NCT00753675|6157716|P2|NOT COMPLETED|Overall Study||59
2511922|NCT00753675|6157717|P1|NOT COMPLETED|Overall Study||59
2511923|NCT00753675|6157715|P3|COMPLETED|Overall Study||0
2511924|NCT00753675|6157716|P2|COMPLETED|Overall Study||0
2511925|NCT00753675|6157717|P1|COMPLETED|Overall Study||0
2511926|NCT00753675|6157715|P3|STARTED|Overall Study||56
2511927|NCT00753675|6157716|P2|STARTED|Overall Study||59
2511928|NCT00753675|6157717|P1|STARTED|Overall Study||59
2511929|NCT00753649|6157739|P2|NOT COMPLETED|Overall Study||0
2511930|NCT00753649|6157740|P1|NOT COMPLETED|Overall Study||7
2511931|NCT00753649|6157739|P2|COMPLETED|Overall Study||112
2511932|NCT00753649|6157740|P1|COMPLETED|Overall Study||105
2511933|NCT00753649|6157739|P2|STARTED|Overall Study||112
2511934|NCT00753649|6157740|P1|STARTED|Overall Study||112
2511935|NCT00753636|6157760|P1|NOT COMPLETED|Overall Study||6
2511936|NCT00753636|6157760|P1|COMPLETED|Overall Study||25
2511937|NCT00753636|6157760|P1|STARTED|Overall Study||31
2511938|NCT00753623|6157772|P2|NOT COMPLETED|Phase II (14 Days)||1
2511939|NCT00753623|6157773|P1|NOT COMPLETED|Phase II (14 Days)||0
2511940|NCT00753623|6157772|P2|COMPLETED|Phase II (14 Days)||7
2511941|NCT00753623|6157773|P1|COMPLETED|Phase II (14 Days)||8
2511942|NCT00753623|6157772|P2|STARTED|Phase II (14 Days)||8
2511943|NCT00753623|6157773|P1|STARTED|Phase II (14 Days)||8
2511944|NCT00753623|6157772|P2|NOT COMPLETED|Washout (7 Days)||0
2511945|NCT00753623|6157773|P1|NOT COMPLETED|Washout (7 Days)||1
2511946|NCT00753623|6157772|P2|COMPLETED|Washout (7 Days)||8
2511947|NCT00753623|6157773|P1|COMPLETED|Washout (7 Days)||8
2511948|NCT00753623|6157772|P2|STARTED|Washout (7 Days)||8
2511949|NCT00753623|6157773|P1|STARTED|Washout (7 Days)||9
2511950|NCT00753623|6157772|P2|NOT COMPLETED|Phase I (14 Days)||4
2511951|NCT00753623|6157773|P1|NOT COMPLETED|Phase I (14 Days)||2
2511952|NCT00753623|6157772|P2|COMPLETED|Phase I (14 Days)||8
2511953|NCT00753623|6157773|P1|COMPLETED|Phase I (14 Days)||9
2511954|NCT00753623|6157772|P2|STARTED|Phase I (14 Days)||12
2511955|NCT00753623|6157773|P1|STARTED|Phase I (14 Days)||11
2511956|NCT00753545|6157781|P2|NOT COMPLETED|Overall Study||118
2511957|NCT00753545|6157782|P1|NOT COMPLETED|Overall Study||108
2511958|NCT00753545|6157781|P2|COMPLETED|Overall Study|Patients completing the Study|11
2511959|NCT00753545|6157782|P1|COMPLETED|Overall Study|Patients completing the Study|28
2511960|NCT00753545|6157781|P2|STARTED|Overall Study|Patients randomized|129
2511961|NCT00753545|6157782|P1|STARTED|Overall Study|Patients randomized|136
2511962|NCT00753519|6157820|P2|NOT COMPLETED|Overall Study||2
2511963|NCT00753519|6157821|P1|NOT COMPLETED|Overall Study||0
2511964|NCT00753519|6157820|P2|COMPLETED|Overall Study||13
2511965|NCT00753519|6157821|P1|COMPLETED|Overall Study||13
2511966|NCT00753519|6157820|P2|STARTED|Overall Study||15
2511967|NCT00753519|6157821|P1|STARTED|Overall Study||13
2511968|NCT00753506|6157843|P2|NOT COMPLETED|Overall Study||2
2511969|NCT00753506|6157844|P1|NOT COMPLETED|Overall Study||7
2511970|NCT00753506|6157843|P2|COMPLETED|Overall Study||31
2511971|NCT00753506|6157844|P1|COMPLETED|Overall Study||26
2511972|NCT00753506|6157843|P2|STARTED|Overall Study||33
2511973|NCT00753506|6157844|P1|STARTED|Overall Study||33
2511974|NCT00753454|6157850|P1|NOT COMPLETED|Overall Study||14
2511975|NCT00753454|6157850|P1|COMPLETED|Overall Study||154
2511976|NCT00753454|6157850|P1|STARTED|Overall Study||168
2511977|NCT00753415|6157884|P10|NOT COMPLETED|Part B||1
2511978|NCT00753415|6157885|P9|NOT COMPLETED|Part B||3
2511979|NCT00753415|6157886|P8|NOT COMPLETED|Part B||1
2511980|NCT00753415|6157887|P7|NOT COMPLETED|Part B||0
2511981|NCT00753415|6157888|P6|NOT COMPLETED|Part B||0
2511982|NCT00753415|6157889|P5|NOT COMPLETED|Part B||0
2511983|NCT00753415|6157890|P4|NOT COMPLETED|Part B||0
2511984|NCT00753415|6157891|P3|NOT COMPLETED|Part B||0
2511985|NCT00753415|6157892|P2|NOT COMPLETED|Part B||0
2511986|NCT00753415|6157893|P1|NOT COMPLETED|Part B||0
2511987|NCT00753415|6157884|P10|COMPLETED|Part B||8
2511988|NCT00753415|6157885|P9|COMPLETED|Part B||6
2511989|NCT00753415|6157886|P8|COMPLETED|Part B||6
2511990|NCT00753415|6157887|P7|COMPLETED|Part B||2
2511991|NCT00753415|6157888|P6|COMPLETED|Part B||1
2511992|NCT00753415|6157889|P5|COMPLETED|Part B||0
2511993|NCT00753415|6157890|P4|COMPLETED|Part B||0
2511994|NCT00753415|6157891|P3|COMPLETED|Part B||0
2511995|NCT00753415|6157892|P2|COMPLETED|Part B||0
2511996|NCT00753415|6157893|P1|COMPLETED|Part B||0
2511997|NCT00753415|6157884|P10|STARTED|Part B|Of 10 eligible participants who completed Part A, 9 chose to enter Part B|9
2511998|NCT00753415|6157885|P9|STARTED|Part B|9 participants who completed Part A were eligible and enrolled in Part B|9
2511999|NCT00753415|6157886|P8|STARTED|Part B|Of 8 eligible participants who completed Part A, 7 chose to enter Part B|7
2512000|NCT00753415|6157887|P7|STARTED|Part B|Of 3 eligible participants who completed Part A, 2 chose to enter Part B|2
2512001|NCT00753415|6157888|P6|STARTED|Part B|Of 2 eligible participants who completed Part A, 1 chose to enter Part B|1
2512002|NCT00753415|6157889|P5|STARTED|Part B||0
2512003|NCT00753415|6157890|P4|STARTED|Part B||0
2512004|NCT00753415|6157891|P3|STARTED|Part B||0
2512005|NCT00753415|6157892|P2|STARTED|Part B||0
2512006|NCT00753415|6157893|P1|STARTED|Part B||0
2512007|NCT00753415|6157884|P10|NOT COMPLETED|Part A||0
2512008|NCT00753415|6157885|P9|NOT COMPLETED|Part A||0
2512009|NCT00753415|6157886|P8|NOT COMPLETED|Part A||0
2512010|NCT00753415|6157887|P7|NOT COMPLETED|Part A||0
2512011|NCT00753415|6157888|P6|NOT COMPLETED|Part A||0
2512012|NCT00753415|6157889|P5|NOT COMPLETED|Part A||0
2512013|NCT00753415|6157890|P4|NOT COMPLETED|Part A||2
2512014|NCT00753415|6157891|P3|NOT COMPLETED|Part A||2
2512015|NCT00753415|6157892|P2|NOT COMPLETED|Part A||0
2512016|NCT00753415|6157893|P1|NOT COMPLETED|Part A||1
2512017|NCT00753415|6157884|P10|COMPLETED|Part A||0
2512018|NCT00753415|6157885|P9|COMPLETED|Part A||0
2512019|NCT00753415|6157886|P8|COMPLETED|Part A||0
2512020|NCT00753415|6157887|P7|COMPLETED|Part A||0
2512021|NCT00753415|6157888|P6|COMPLETED|Part A||0
2512022|NCT00753415|6157889|P5|COMPLETED|Part A||10
2512023|NCT00753415|6157890|P4|COMPLETED|Part A||9
2512024|NCT00753415|6157891|P3|COMPLETED|Part A||8
2512025|NCT00753415|6157892|P2|COMPLETED|Part A||3
2512026|NCT00753415|6157893|P1|COMPLETED|Part A||2
2512027|NCT00753415|6157884|P10|STARTED|Part A||0
2512028|NCT00753415|6157885|P9|STARTED|Part A||0
2512029|NCT00753415|6157886|P8|STARTED|Part A||0
2512030|NCT00753415|6157887|P7|STARTED|Part A||0
2512031|NCT00753415|6157888|P6|STARTED|Part A||0
2512032|NCT00753415|6157889|P5|STARTED|Part A||10
2512033|NCT00753415|6157890|P4|STARTED|Part A||11
2512034|NCT00753415|6157891|P3|STARTED|Part A||10
2512035|NCT00753415|6157892|P2|STARTED|Part A||3
2512036|NCT00753415|6157893|P1|STARTED|Part A||3
2512037|NCT00753363|6157937|P2|NOT COMPLETED|Overall Study||39
2512038|NCT00753363|6157938|P1|NOT COMPLETED|Overall Study||40
2512039|NCT00753363|6157937|P2|COMPLETED|Overall Study||21
2512040|NCT00753363|6157938|P1|COMPLETED|Overall Study||19
2512041|NCT00753363|6157937|P2|STARTED|Overall Study||60
2512042|NCT00753363|6157938|P1|STARTED|Overall Study||59
2512043|NCT00753337|6157948|P1|NOT COMPLETED|Overall Study||0
2512044|NCT00753337|6157948|P1|COMPLETED|Overall Study||123
2512045|NCT00753337|6157948|P1|STARTED|Overall Study||123
2512046|NCT00753298|6157964|P2|NOT COMPLETED|Overall Study||4
2512047|NCT00753298|6157965|P1|NOT COMPLETED|Overall Study||8
2512048|NCT00753298|6157964|P2|COMPLETED|Overall Study||94
2512049|NCT00753298|6157965|P1|COMPLETED|Overall Study||89
2512050|NCT00753298|6157964|P2|STARTED|Overall Study||98
2512051|NCT00753298|6157965|P1|STARTED|Overall Study||97
2512052|NCT00753272|6157983|P2|NOT COMPLETED|Overall Study||4907
2512053|NCT00753272|6157984|P1|NOT COMPLETED|Overall Study||4982
2512054|NCT00753272|6157983|P2|COMPLETED|Overall Study||16895
2512055|NCT00753272|6157984|P1|COMPLETED|Overall Study||16911
2512056|NCT00753272|6157983|P2|STARTED|Overall Study||21802
2512057|NCT00753272|6157984|P1|STARTED|Overall Study||21893
2512058|NCT00753220|6158046|P1|NOT COMPLETED|Overall Study||5
2512059|NCT00753220|6158046|P1|COMPLETED|Overall Study||2
2512060|NCT00753220|6158046|P1|STARTED|Overall Study||7
2512061|NCT00753142|6158053|P3|NOT COMPLETED|Overall Study||0
2512062|NCT00753142|6158054|P2|NOT COMPLETED|Overall Study||0
2512063|NCT00753142|6158055|P1|NOT COMPLETED|Overall Study||0
2512064|NCT00753142|6158053|P3|COMPLETED|Overall Study||13
2512065|NCT00753142|6158054|P2|COMPLETED|Overall Study||7
2512066|NCT00753142|6158055|P1|COMPLETED|Overall Study||8
2512067|NCT00753142|6158053|P3|STARTED|Overall Study||13
2512068|NCT00753142|6158054|P2|STARTED|Overall Study||7
2512069|NCT00753142|6158055|P1|STARTED|Overall Study||8
2512070|NCT00753012|6158068|P2|NOT COMPLETED|Overall Study||1
2512071|NCT00753012|6158069|P1|NOT COMPLETED|Overall Study||8
2512072|NCT00753012|6158068|P2|COMPLETED|Overall Study||8
2512073|NCT00753012|6158069|P1|COMPLETED|Overall Study||7
2512074|NCT00753012|6158068|P2|STARTED|Overall Study||9
2512075|NCT00753012|6158069|P1|STARTED|Overall Study||15
2512076|NCT00752986|6158082|P3|NOT COMPLETED|Overall Study||2
2512077|NCT00752986|6158083|P2|NOT COMPLETED|Overall Study||1
2512078|NCT00752986|6158084|P1|NOT COMPLETED|Overall Study||5
2512079|NCT00752986|6158082|P3|COMPLETED|Overall Study||9
2512080|NCT00752986|6158083|P2|COMPLETED|Overall Study||11
2512081|NCT00752986|6158084|P1|COMPLETED|Overall Study||11
2512082|NCT00752986|6158082|P3|STARTED|Overall Study||11
2512083|NCT00752986|6158083|P2|STARTED|Overall Study||12
2512084|NCT00752986|6158084|P1|STARTED|Overall Study||16
2512085|NCT00752973|6158101|P1|NOT COMPLETED|Overall Study||0
2512086|NCT00752973|6158101|P1|COMPLETED|Overall Study||12
2512087|NCT00752973|6158101|P1|STARTED|Overall Study||12
2512088|NCT00752908|6158113|P2|NOT COMPLETED|Overall Study||0
2512089|NCT00752908|6158114|P1|NOT COMPLETED|Overall Study||0
2512090|NCT00752908|6158113|P2|COMPLETED|Overall Study||13
2512091|NCT00752908|6158114|P1|COMPLETED|Overall Study||14
2512092|NCT00752908|6158113|P2|STARTED|Overall Study||13
2512093|NCT00752908|6158114|P1|STARTED|Overall Study||14
2512094|NCT00752895|6158124|P2|NOT COMPLETED|Overall Study||3
2512095|NCT00752895|6158125|P1|NOT COMPLETED|Overall Study||8
2512096|NCT00752895|6158124|P2|COMPLETED|Overall Study||143
2512097|NCT00752895|6158125|P1|COMPLETED|Overall Study||139
2512098|NCT00752895|6158124|P2|STARTED|Overall Study||146
2512099|NCT00752895|6158125|P1|STARTED|Overall Study||147
2512100|NCT00752791|6158133|P1|NOT COMPLETED|Overall Study||16
2512101|NCT00752791|6158133|P1|COMPLETED|Overall Study||43
2512102|NCT00752791|6158133|P1|STARTED|Overall Study||59
2512103|NCT00752726|6158145|P2|NOT COMPLETED|Overall Study||13
2512104|NCT00752726|6158146|P1|NOT COMPLETED|Overall Study||11
2512105|NCT00752726|6158145|P2|COMPLETED|Overall Study||53
2512106|NCT00752726|6158146|P1|COMPLETED|Overall Study||54
2512107|NCT00752726|6158145|P2|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|61
2512108|NCT00752726|6158146|P1|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|62
2512109|NCT00752726|6158145|P2|Safety Population|Overall Study|2 participants were never dosed with the study medication.|64
2512110|NCT00752726|6158146|P1|Safety Population|Overall Study|2 participants were never dosed with the study medication.|63
2512111|NCT00752726|6158145|P2|STARTED|Overall Study||66
2512112|NCT00752726|6158146|P1|STARTED|Overall Study||65
2512113|NCT00752622|6158171|P1|NOT COMPLETED|Interventional Phase||8
2512114|NCT00752622|6158171|P1|COMPLETED|Interventional Phase|8 participants received at least 1 infusion of interventional treatment, but none completed trial|0
2512115|NCT00752622|6158171|P1|STARTED|Interventional Phase|5 participants randomized into increased dose group and 3 randomized into shortened interval group|8
2512116|NCT00752622|6158171|P1|NOT COMPLETED|Observational Phase||43
2512117|NCT00752622|6158171|P1|COMPLETED|Observational Phase|14 completed without loss of response 8 had loss of response & randomized into interventional phase|22
2512118|NCT00752622|6158171|P1|STARTED|Observational Phase||65
2512119|NCT00752622|6158171|P1|NOT COMPLETED|Induction Phase||35
2512120|NCT00752622|6158171|P1|COMPLETED|Induction Phase||65
2512121|NCT00752622|6158171|P1|STARTED|Induction Phase|The ELIG population comprised of 98 participants|100
2512122|NCT00752609|6158184|P2|NOT COMPLETED|Overall Study||2
2512123|NCT00752609|6158185|P1|NOT COMPLETED|Overall Study||9
2512124|NCT00752609|6158184|P2|COMPLETED|Overall Study||47
2512125|NCT00752609|6158185|P1|COMPLETED|Overall Study||44
2512126|NCT00752609|6158184|P2|Full Analysis Set|Overall Study||49
2512127|NCT00752609|6158185|P1|Full Analysis Set|Overall Study|One patient withdrew consent before receiving any study medication.|52
2512128|NCT00752609|6158184|P2|STARTED|Overall Study||49
2512129|NCT00752609|6158185|P1|STARTED|Overall Study||53
2512130|NCT00752232|6158211|P7|NOT COMPLETED|Overall Study||0
2512131|NCT00752232|6158212|P6|NOT COMPLETED|Overall Study||1
2512132|NCT00752232|6158213|P5|NOT COMPLETED|Overall Study||3
2512133|NCT00752232|6158214|P4|NOT COMPLETED|Overall Study||1
2512134|NCT00752232|6158215|P3|NOT COMPLETED|Overall Study||1
2512135|NCT00752232|6158216|P2|NOT COMPLETED|Overall Study||0
2512136|NCT00752232|6158217|P1|NOT COMPLETED|Overall Study||2
2512137|NCT00752232|6158211|P7|COMPLETED|Overall Study||4
2512138|NCT00752232|6158212|P6|COMPLETED|Overall Study||5
2512139|NCT00752232|6158213|P5|COMPLETED|Overall Study||3
2512140|NCT00752232|6158214|P4|COMPLETED|Overall Study||5
2512141|NCT00752232|6158215|P3|COMPLETED|Overall Study||5
2512142|NCT00752232|6158216|P2|COMPLETED|Overall Study||6
2512143|NCT00752232|6158217|P1|COMPLETED|Overall Study||4
2512144|NCT00752232|6158211|P7|STARTED|Overall Study||4
2512145|NCT00752232|6158212|P6|STARTED|Overall Study||6
2512146|NCT00752232|6158213|P5|STARTED|Overall Study||6
2512147|NCT00752232|6158214|P4|STARTED|Overall Study||6
2512148|NCT00752232|6158215|P3|STARTED|Overall Study||6
2512149|NCT00752232|6158216|P2|STARTED|Overall Study||6
2512150|NCT00752232|6158217|P1|STARTED|Overall Study||6
2512151|NCT00752219|6158291|P2|NOT COMPLETED|Overall Study||6
2512152|NCT00752219|6158292|P1|NOT COMPLETED|Overall Study||11
2512153|NCT00752219|6158291|P2|COMPLETED|Overall Study||96
2512154|NCT00752219|6158292|P1|COMPLETED|Overall Study||91
2512155|NCT00752219|6158291|P2|Treated|Overall Study||102
2512156|NCT00752219|6158292|P1|Treated|Overall Study||101
2512157|NCT00752219|6158291|P2|STARTED|Overall Study||102
2512158|NCT00752219|6158292|P1|STARTED|Overall Study||102
2512159|NCT00752206|6158318|P2|NOT COMPLETED|Overall Study||11
2512160|NCT00752206|6158319|P1|NOT COMPLETED|Overall Study||9
2512161|NCT00752206|6158318|P2|COMPLETED|Overall Study||8
2512162|NCT00752206|6158319|P1|COMPLETED|Overall Study||10
2512163|NCT00752206|6158318|P2|STARTED|Overall Study||19
2512164|NCT00752206|6158319|P1|STARTED|Overall Study||19
2512165|NCT00752128|6158337|P1|NOT COMPLETED|Overall Study||4
2512166|NCT00752128|6158337|P1|COMPLETED|Overall Study||2345
2512167|NCT00752128|6158337|P1|STARTED|Overall Study||2349
2512168|NCT00752102|6158344|P2|NOT COMPLETED|Overall Study||1
2512169|NCT00752102|6158345|P1|NOT COMPLETED|Overall Study||3
2512170|NCT00752102|6158344|P2|COMPLETED|Overall Study||21
2512171|NCT00752102|6158345|P1|COMPLETED|Overall Study||19
2512172|NCT00752102|6158344|P2|STARTED|Overall Study||22
2512173|NCT00752102|6158345|P1|STARTED|Overall Study||22
2512174|NCT00752089|6158351|P1|NOT COMPLETED|Overall Study||6
2512175|NCT00752089|6158351|P1|COMPLETED|Overall Study||14
2512176|NCT00752089|6158351|P1|Received Placebo|Overall Study||18
2512177|NCT00752089|6158351|P1|Received NaF|Overall Study||18
2512178|NCT00752089|6158351|P1|Received NaF/KNO3/ 0% Isopentane|Overall Study||17
2512179|NCT00752089|6158351|P1|Received NaF/ KNO3/ 2% Isopentane|Overall Study||19
2512180|NCT00752089|6158351|P1|STARTED|Overall Study||20
2512181|NCT00751998|6158365|P1|NOT COMPLETED|Overall Study||20
2512182|NCT00751998|6158365|P1|COMPLETED|Overall Study||277
2512183|NCT00751998|6158365|P1|STARTED|Overall Study||297
2512184|NCT00751972|6158371|P2|NOT COMPLETED|Overall Study||0
2512185|NCT00751972|6158372|P1|NOT COMPLETED|Overall Study||0
2512186|NCT00751972|6158371|P2|COMPLETED|Overall Study||499
2512187|NCT00751972|6158372|P1|COMPLETED|Overall Study||140
2512188|NCT00751972|6158371|P2|STARTED|Overall Study||499
2512189|NCT00751972|6158372|P1|STARTED|Overall Study||140
2512190|NCT00751933|6158384|P4|NOT COMPLETED|Overall Study||1
2512191|NCT00751933|6158385|P3|NOT COMPLETED|Overall Study||1
2512192|NCT00751933|6158386|P2|NOT COMPLETED|Overall Study||1
2512193|NCT00751933|6158387|P1|NOT COMPLETED|Overall Study||0
2512194|NCT00751933|6158384|P4|COMPLETED|Overall Study||0
2512195|NCT00751933|6158385|P3|COMPLETED|Overall Study||0
2512196|NCT00751933|6158386|P2|COMPLETED|Overall Study||0
2512197|NCT00751933|6158387|P1|COMPLETED|Overall Study||0
2512198|NCT00751933|6158384|P4|STARTED|Overall Study||1
2512199|NCT00751933|6158385|P3|STARTED|Overall Study||1
2512200|NCT00751933|6158386|P2|STARTED|Overall Study||1
2512201|NCT00751933|6158387|P1|STARTED|Overall Study||0
2512202|NCT00751881|6158395|P3|NOT COMPLETED|Extension Study Period||66
2512203|NCT00751881|6158396|P2|NOT COMPLETED|Extension Study Period||71
2512204|NCT00751881|6158397|P1|NOT COMPLETED|Extension Study Period||65
2512205|NCT00751881|6158395|P3|COMPLETED|Extension Study Period||167
2512206|NCT00751881|6158396|P2|COMPLETED|Extension Study Period||194
2512207|NCT00751881|6158397|P1|COMPLETED|Extension Study Period||188
2512208|NCT00751881|6158395|P3|STARTED|Extension Study Period|11 participants completed core treatment period but did not enter in extension treatment period.|233
2512209|NCT00751881|6158396|P2|STARTED|Extension Study Period|8 participants completed core treatment period but did not enter in extension treatment period.|265
2512210|NCT00751881|6158397|P1|STARTED|Extension Study Period|10 participants completed core treatment period but did not enter in extension treatment period.|253
2512211|NCT00751881|6158395|P3|NOT COMPLETED|Core Treatment Period||128
2512212|NCT00751881|6158396|P2|NOT COMPLETED|Core Treatment Period||135
2512213|NCT00751881|6158397|P1|NOT COMPLETED|Core Treatment Period||126
2512214|NCT00751881|6158395|P3|COMPLETED|Core Treatment Period||244
2512215|NCT00751881|6158396|P2|COMPLETED|Core Treatment Period||273
2512216|NCT00751881|6158397|P1|COMPLETED|Core Treatment Period||263
2512217|NCT00751881|6158395|P3|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 1 participant placebo (at least 1 dose)|370
2512218|NCT00751881|6158396|P2|Treated|Core Treatment Period|1 participant received placebo (at least 1 dose)|407
2512219|NCT00751881|6158397|P1|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 2 participants teriflunomide 14 mg (at least 1 dose)|388
2512220|NCT00751881|6158395|P3|STARTED|Core Treatment Period|Randomized|372
2512221|NCT00751881|6158396|P2|STARTED|Core Treatment Period|Randomized|408
2512222|NCT00751881|6158397|P1|STARTED|Core Treatment Period|Randomized|389
2512223|NCT00751790|6158444|P1|NOT COMPLETED|Overall Study||5
2512224|NCT00751790|6158444|P1|COMPLETED|Overall Study||115
2512225|NCT00751790|6158444|P1|STARTED|Overall Study||120
2512226|NCT00751777|6158450|P2|NOT COMPLETED|Overall Study||3
2512227|NCT00751777|6158451|P1|NOT COMPLETED|Overall Study||11
2512228|NCT00751777|6158450|P2|COMPLETED|Overall Study|Day 194: study completion for placebo group|36
2512229|NCT00751777|6158451|P1|COMPLETED|Overall Study|Day 380: study completion for LT group|70
2512230|NCT00751777|6158450|P2|STARTED|Overall Study||39
2512231|NCT00751777|6158451|P1|STARTED|Overall Study||81
2512232|NCT00751634|6158467|P1|NOT COMPLETED|Overall Study||0
2512233|NCT00751634|6158467|P1|COMPLETED|Overall Study||20
2512234|NCT00751634|6158467|P1|STARTED|Overall Study||20
2512235|NCT00751621|6158475|P1|NOT COMPLETED|Overall Study||4
2512236|NCT00751621|6158475|P1|COMPLETED|Overall Study||36
2512237|NCT00751621|6158475|P1|STARTED|Overall Study||40
2512238|NCT00751530|6158494|P2|NOT COMPLETED|Overall Study||0
2512239|NCT00751530|6158495|P1|NOT COMPLETED|Overall Study||0
2512240|NCT00751530|6158494|P2|COMPLETED|Overall Study||110
2512241|NCT00751530|6158495|P1|COMPLETED|Overall Study||332
2512242|NCT00751530|6158494|P2|STARTED|Overall Study||110
2512243|NCT00751530|6158495|P1|STARTED|Overall Study||332
2512244|NCT00751400|6158509|P1|NOT COMPLETED|Overall Study||10
2512245|NCT00751400|6158509|P1|COMPLETED|Overall Study||487
2512246|NCT00751400|6158509|P1|Subjects Provided Detailed Use Data|Overall Study||467
2512247|NCT00751400|6158509|P1|Subjects Consumed Drug|Overall Study||485
2512248|NCT00751400|6158509|P1|Subjects Provided Drug|Overall Study||497
2512249|NCT00751400|6158509|P1|STARTED|Overall Study||497
2512250|NCT00751348|6158524|P2|NOT COMPLETED|Overall Study||2
2512251|NCT00751348|6158525|P1|NOT COMPLETED|Overall Study||6
2512252|NCT00751348|6158524|P2|COMPLETED|Overall Study||159
2512253|NCT00751348|6158525|P1|COMPLETED|Overall Study||307
2512254|NCT00751348|6158524|P2|STARTED|Overall Study||161
2512255|NCT00751348|6158525|P1|STARTED|Overall Study||313
2512256|NCT00751296|6158547|P1|NOT COMPLETED|Overall Study||2
2512257|NCT00751296|6158547|P1|COMPLETED|Overall Study||25
2512258|NCT00751296|6158547|P1|STARTED|Overall Study|The start date of the study was 25 August 2006.|27
2512259|NCT00751179|6158554|P2|NOT COMPLETED|Overall Study||15
2512260|NCT00751179|6158555|P1|NOT COMPLETED|Overall Study||14
2512261|NCT00751179|6158554|P2|COMPLETED|Overall Study||70
2512262|NCT00751179|6158555|P1|COMPLETED|Overall Study||62
2512263|NCT00751179|6158554|P2|STARTED|Overall Study|5 of 85 randomized were not treated with succinylcholine|85
2512264|NCT00751179|6158555|P1|STARTED|Overall Study|10 of 76 randomized were not treated with sugammadex; 4 of these 10 received rocuronium only|76
2512265|NCT00751140|6158575|P1|NOT COMPLETED|Overall Study||1
2512266|NCT00751140|6158575|P1|COMPLETED|Overall Study||19
2512267|NCT00751140|6158575|P1|STARTED|Overall Study||20
2512268|NCT00751114|6158585|P2|NOT COMPLETED|Overall Study||32
2512269|NCT00751114|6158586|P1|NOT COMPLETED|Overall Study||38
2512270|NCT00751114|6158585|P2|COMPLETED|Overall Study||233
2512271|NCT00751114|6158586|P1|COMPLETED|Overall Study||212
2512272|NCT00751114|6158585|P2|mITT Population|Overall Study||253
2512273|NCT00751114|6158586|P1|mITT Population|Overall Study|modified Intent-To-Treat population: treated patients with at least 1 on-treatment efficacy measure|227
2512274|NCT00751114|6158585|P2|TREATED = Safety Population|Overall Study||264
2512275|NCT00751114|6158586|P1|TREATED = Safety Population|Overall Study|safety population: randomized patients who received at least one dose of investigational product|237
2512276|NCT00751114|6158585|P2|STARTED|Overall Study||265
2512277|NCT00751114|6158586|P1|STARTED|Overall Study|randomized|250
2512278|NCT00751036|6158611|P2|NOT COMPLETED|Overall Study||46
2512279|NCT00751036|6158612|P1|NOT COMPLETED|Overall Study||48
2512280|NCT00751036|6158611|P2|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
2512281|NCT00751036|6158612|P1|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
2512282|NCT00751036|6158611|P2|STARTED|Overall Study|Started = Treated|46
2512283|NCT00751036|6158612|P1|STARTED|Overall Study|Started = Treated|48
2512284|NCT00751023|6158626|P2|NOT COMPLETED|Overall Study||7
2512285|NCT00751023|6158627|P1|NOT COMPLETED|Overall Study||11
2512286|NCT00751023|6158626|P2|COMPLETED|Overall Study||13
2512287|NCT00751023|6158627|P1|COMPLETED|Overall Study||9
2512288|NCT00751023|6158626|P2|STARTED|Overall Study||20
2512289|NCT00751023|6158627|P1|STARTED|Overall Study||20
2512290|NCT00750919|6158647|P1|NOT COMPLETED|Overall Study||58
2512291|NCT00750919|6158647|P1|COMPLETED|Overall Study||126
2512292|NCT00750919|6158647|P1|STARTED|Overall Study||184
2512293|NCT00750893|6158655|P1|NOT COMPLETED|Overall Study||542
2512294|NCT00750893|6158655|P1|COMPLETED|Overall Study||2569
2512295|NCT00750893|6158655|P1|STARTED|Overall Study||3111
2512296|NCT00750880|6158667|P1|NOT COMPLETED|Overall Study||215
2512297|NCT00750880|6158667|P1|COMPLETED|Overall Study||1466
2512298|NCT00750880|6158667|P1|STARTED|Overall Study||1681
2512299|NCT00750867|6158690|P1|NOT COMPLETED|Overall Study||2
2512300|NCT00750867|6158690|P1|COMPLETED|Overall Study||7
2512301|NCT00750867|6158690|P1|STARTED|Overall Study||9
2512302|NCT00750815|6158697|P2|NOT COMPLETED|Overall Study||0
2512303|NCT00750815|6158698|P1|NOT COMPLETED|Overall Study||0
2512304|NCT00750815|6158697|P2|COMPLETED|Overall Study||46
2512305|NCT00750815|6158698|P1|COMPLETED|Overall Study||12
2512306|NCT00750815|6158697|P2|STARTED|Overall Study||46
2512307|NCT00750815|6158698|P1|STARTED|Overall Study||12
2512308|NCT00750737|6158711|P2|NOT COMPLETED|Overall Study||3
2512309|NCT00750737|6158712|P1|NOT COMPLETED|Overall Study||3
2512310|NCT00750737|6158711|P2|COMPLETED|Overall Study||19
2512311|NCT00750737|6158712|P1|COMPLETED|Overall Study||21
2512312|NCT00750737|6158711|P2|STARTED|Overall Study||22
2512313|NCT00750737|6158712|P1|STARTED|Overall Study||24
2512314|NCT00750555|6158720|P1|NOT COMPLETED|Overall Study||0
2512315|NCT00750555|6158720|P1|COMPLETED|Overall Study||0
2512316|NCT00750555|6158720|P1|STARTED|Overall Study||0
2512317|NCT00750438|6158727|P2|NOT COMPLETED|Overall Study||4
2512318|NCT00750438|6158728|P1|NOT COMPLETED|Overall Study||7
2512319|NCT00750438|6158727|P2|COMPLETED|Overall Study||25
2512320|NCT00750438|6158728|P1|COMPLETED|Overall Study||24
2512321|NCT00750438|6158727|P2|STARTED|Overall Study||29
2512322|NCT00750438|6158728|P1|STARTED|Overall Study||31
2512323|NCT00750373|6158744|P2|NOT COMPLETED|Overall Study||0
2512324|NCT00750373|6158745|P1|NOT COMPLETED|Overall Study||0
2512325|NCT00750373|6158744|P2|COMPLETED|Overall Study||37
2512326|NCT00750373|6158745|P1|COMPLETED|Overall Study||39
2512327|NCT00750373|6158744|P2|STARTED|Overall Study||37
2512328|NCT00750373|6158745|P1|STARTED|Overall Study||39
2512329|NCT00750360|6158757|P6|NOT COMPLETED|Overall Study||0
2512330|NCT00750360|6158758|P5|NOT COMPLETED|Overall Study||0
2512331|NCT00750360|6158759|P4|NOT COMPLETED|Overall Study||0
2512332|NCT00750360|6158760|P3|NOT COMPLETED|Overall Study||0
2512333|NCT00750360|6158761|P2|NOT COMPLETED|Overall Study||0
2512334|NCT00750360|6158762|P1|NOT COMPLETED|Overall Study||0
2512335|NCT00750360|6158757|P6|COMPLETED|Overall Study||71
2512336|NCT00750360|6158758|P5|COMPLETED|Overall Study||46
2512337|NCT00750360|6158759|P4|COMPLETED|Overall Study||79
2512338|NCT00750360|6158760|P3|COMPLETED|Overall Study||384
2512339|NCT00750360|6158761|P2|COMPLETED|Overall Study||1
2512340|NCT00750360|6158762|P1|COMPLETED|Overall Study||294
2512341|NCT00750360|6158757|P6|STARTED|Overall Study||71
2512342|NCT00750360|6158758|P5|STARTED|Overall Study||46
2512343|NCT00750360|6158759|P4|STARTED|Overall Study||79
2512344|NCT00750360|6158760|P3|STARTED|Overall Study||384
2512345|NCT00750360|6158761|P2|STARTED|Overall Study|"One subject enrolled in this group was not vaccinated and as such not included as STARTED."|1
2512346|NCT00750360|6158762|P1|STARTED|Overall Study|"Seven subjects enrolled in this group were not vaccinated and as such not included as STARTED."|294
2512347|NCT00750308|6158794|P12|NOT COMPLETED|Fourth Treatment||0
2512348|NCT00750308|6158795|P11|NOT COMPLETED|Fourth Treatment||0
2512349|NCT00750308|6158796|P10|NOT COMPLETED|Fourth Treatment||0
2512350|NCT00750308|6158797|P9|NOT COMPLETED|Fourth Treatment||0
2512351|NCT00750308|6158798|P8|NOT COMPLETED|Fourth Treatment||0
2512352|NCT00750308|6158799|P7|NOT COMPLETED|Fourth Treatment||0
2512353|NCT00750308|6158800|P6|NOT COMPLETED|Fourth Treatment||0
2512354|NCT00750308|6158801|P5|NOT COMPLETED|Fourth Treatment||0
2512355|NCT00750308|6158802|P4|NOT COMPLETED|Fourth Treatment||0
2512356|NCT00750308|6158803|P3|NOT COMPLETED|Fourth Treatment||0
2512357|NCT00750308|6158804|P2|NOT COMPLETED|Fourth Treatment||0
2512358|NCT00750308|6158805|P1|NOT COMPLETED|Fourth Treatment||0
2512359|NCT00750308|6158794|P12|COMPLETED|Fourth Treatment||1
2512360|NCT00750308|6158795|P11|COMPLETED|Fourth Treatment||1
2512361|NCT00750308|6158796|P10|COMPLETED|Fourth Treatment||2
2512362|NCT00750308|6158797|P9|COMPLETED|Fourth Treatment||1
2512363|NCT00750308|6158798|P8|COMPLETED|Fourth Treatment||2
2512364|NCT00750308|6158799|P7|COMPLETED|Fourth Treatment||2
2512365|NCT00750308|6158800|P6|COMPLETED|Fourth Treatment||2
2512366|NCT00750308|6158801|P5|COMPLETED|Fourth Treatment||1
2512367|NCT00750308|6158802|P4|COMPLETED|Fourth Treatment||1
2512368|NCT00750308|6158803|P3|COMPLETED|Fourth Treatment||2
2512369|NCT00750308|6158804|P2|COMPLETED|Fourth Treatment||1
2512370|NCT00750308|6158805|P1|COMPLETED|Fourth Treatment||2
2512371|NCT00750308|6158794|P12|STARTED|Fourth Treatment||1
2512372|NCT00750308|6158795|P11|STARTED|Fourth Treatment||1
2512373|NCT00750308|6158796|P10|STARTED|Fourth Treatment||2
2512374|NCT00750308|6158797|P9|STARTED|Fourth Treatment||1
2512375|NCT00750308|6158798|P8|STARTED|Fourth Treatment||2
2512376|NCT00750308|6158799|P7|STARTED|Fourth Treatment||2
2512377|NCT00750308|6158800|P6|STARTED|Fourth Treatment||2
2512378|NCT00750308|6158801|P5|STARTED|Fourth Treatment||1
2512379|NCT00750308|6158802|P4|STARTED|Fourth Treatment||1
2512380|NCT00750308|6158803|P3|STARTED|Fourth Treatment||2
2512381|NCT00750308|6158804|P2|STARTED|Fourth Treatment||1
2512382|NCT00750308|6158805|P1|STARTED|Fourth Treatment||2
2512383|NCT00750308|6158794|P12|NOT COMPLETED|Washout||0
2512384|NCT00750308|6158795|P11|NOT COMPLETED|Washout||0
2512385|NCT00750308|6158796|P10|NOT COMPLETED|Washout||0
2512386|NCT00750308|6158797|P9|NOT COMPLETED|Washout||0
2512387|NCT00750308|6158798|P8|NOT COMPLETED|Washout||0
2512388|NCT00750308|6158799|P7|NOT COMPLETED|Washout||0
2512389|NCT00750308|6158800|P6|NOT COMPLETED|Washout||0
2512390|NCT00750308|6158801|P5|NOT COMPLETED|Washout||0
2512391|NCT00750308|6158802|P4|NOT COMPLETED|Washout||0
2512392|NCT00750308|6158803|P3|NOT COMPLETED|Washout||0
2512393|NCT00750308|6158804|P2|NOT COMPLETED|Washout||0
2512394|NCT00750308|6158805|P1|NOT COMPLETED|Washout||0
2512395|NCT00750308|6158794|P12|COMPLETED|Washout||1
2512396|NCT00750308|6158795|P11|COMPLETED|Washout||1
2512397|NCT00750308|6158796|P10|COMPLETED|Washout||2
2512398|NCT00750308|6158797|P9|COMPLETED|Washout||1
2512399|NCT00750308|6158798|P8|COMPLETED|Washout||2
2512400|NCT00750308|6158799|P7|COMPLETED|Washout||2
2512401|NCT00750308|6158800|P6|COMPLETED|Washout||2
2512402|NCT00750308|6158801|P5|COMPLETED|Washout||1
2512403|NCT00750308|6158802|P4|COMPLETED|Washout||1
2512404|NCT00750308|6158803|P3|COMPLETED|Washout||2
2512405|NCT00750308|6158804|P2|COMPLETED|Washout||1
2512406|NCT00750308|6158805|P1|COMPLETED|Washout||2
2512407|NCT00750308|6158794|P12|STARTED|Washout||1
2512408|NCT00750308|6158795|P11|STARTED|Washout||1
2512409|NCT00750308|6158796|P10|STARTED|Washout||2
2512410|NCT00750308|6158797|P9|STARTED|Washout||1
2512411|NCT00750308|6158798|P8|STARTED|Washout||2
2512412|NCT00750308|6158799|P7|STARTED|Washout||2
2512413|NCT00750308|6158800|P6|STARTED|Washout||2
2512414|NCT00750308|6158801|P5|STARTED|Washout||1
2512415|NCT00750308|6158802|P4|STARTED|Washout||1
2512416|NCT00750308|6158803|P3|STARTED|Washout||2
2512417|NCT00750308|6158804|P2|STARTED|Washout||1
2512418|NCT00750308|6158805|P1|STARTED|Washout||2
2512419|NCT00750308|6158794|P12|NOT COMPLETED|Third Treatment||0
2512420|NCT00750308|6158795|P11|NOT COMPLETED|Third Treatment||0
2512421|NCT00750308|6158796|P10|NOT COMPLETED|Third Treatment||0
2512422|NCT00750308|6158797|P9|NOT COMPLETED|Third Treatment||0
2512423|NCT00750308|6158798|P8|NOT COMPLETED|Third Treatment||0
2512424|NCT00750308|6158799|P7|NOT COMPLETED|Third Treatment||0
2512425|NCT00750308|6158800|P6|NOT COMPLETED|Third Treatment||0
2512426|NCT00750308|6158801|P5|NOT COMPLETED|Third Treatment||0
2512427|NCT00750308|6158802|P4|NOT COMPLETED|Third Treatment||0
2512428|NCT00750308|6158803|P3|NOT COMPLETED|Third Treatment||0
2512429|NCT00750308|6158804|P2|NOT COMPLETED|Third Treatment||1
2512430|NCT00750308|6158805|P1|NOT COMPLETED|Third Treatment||0
2512431|NCT00750308|6158794|P12|COMPLETED|Third Treatment||1
2512432|NCT00750308|6158795|P11|COMPLETED|Third Treatment||1
2512433|NCT00750308|6158796|P10|COMPLETED|Third Treatment||2
2512434|NCT00750308|6158797|P9|COMPLETED|Third Treatment||1
2512435|NCT00750308|6158798|P8|COMPLETED|Third Treatment||2
2512436|NCT00750308|6158799|P7|COMPLETED|Third Treatment||2
2512437|NCT00750308|6158800|P6|COMPLETED|Third Treatment||2
2512438|NCT00750308|6158801|P5|COMPLETED|Third Treatment||1
2512439|NCT00750308|6158802|P4|COMPLETED|Third Treatment||1
2512440|NCT00750308|6158803|P3|COMPLETED|Third Treatment||2
2512441|NCT00750308|6158804|P2|COMPLETED|Third Treatment||1
2512442|NCT00750308|6158805|P1|COMPLETED|Third Treatment||2
2512443|NCT00750308|6158794|P12|STARTED|Third Treatment||1
2512444|NCT00750308|6158795|P11|STARTED|Third Treatment||1
2512445|NCT00750308|6158796|P10|STARTED|Third Treatment||2
2512446|NCT00750308|6158797|P9|STARTED|Third Treatment||1
2512447|NCT00750308|6158798|P8|STARTED|Third Treatment||2
2512448|NCT00750308|6158799|P7|STARTED|Third Treatment||2
2512449|NCT00750308|6158800|P6|STARTED|Third Treatment||2
2512450|NCT00750308|6158801|P5|STARTED|Third Treatment||1
2512451|NCT00750308|6158802|P4|STARTED|Third Treatment||1
2512452|NCT00750308|6158803|P3|STARTED|Third Treatment||2
2512453|NCT00750308|6158804|P2|STARTED|Third Treatment||2
2512454|NCT00750308|6158805|P1|STARTED|Third Treatment||2
2512455|NCT00750308|6158794|P12|NOT COMPLETED|Washout||0
2512456|NCT00750308|6158795|P11|NOT COMPLETED|Washout||0
2512457|NCT00750308|6158796|P10|NOT COMPLETED|Washout||0
2512458|NCT00750308|6158797|P9|NOT COMPLETED|Washout||0
2512459|NCT00750308|6158798|P8|NOT COMPLETED|Washout||0
2512460|NCT00750308|6158799|P7|NOT COMPLETED|Washout||0
2512461|NCT00750308|6158800|P6|NOT COMPLETED|Washout||0
2512462|NCT00750308|6158801|P5|NOT COMPLETED|Washout||0
2512463|NCT00750308|6158802|P4|NOT COMPLETED|Washout||0
2512464|NCT00750308|6158803|P3|NOT COMPLETED|Washout||0
2512465|NCT00750308|6158804|P2|NOT COMPLETED|Washout||0
2512466|NCT00750308|6158805|P1|NOT COMPLETED|Washout||0
2512467|NCT00750308|6158794|P12|COMPLETED|Washout||1
2512468|NCT00750308|6158795|P11|COMPLETED|Washout||1
2512469|NCT00750308|6158796|P10|COMPLETED|Washout||2
2512470|NCT00750308|6158797|P9|COMPLETED|Washout||1
2512471|NCT00750308|6158798|P8|COMPLETED|Washout||2
2512472|NCT00750308|6158799|P7|COMPLETED|Washout||2
2512473|NCT00750308|6158800|P6|COMPLETED|Washout||2
2512474|NCT00750308|6158801|P5|COMPLETED|Washout||1
2512475|NCT00750308|6158802|P4|COMPLETED|Washout||1
2512476|NCT00750308|6158803|P3|COMPLETED|Washout||2
2512477|NCT00750308|6158804|P2|COMPLETED|Washout||2
2512478|NCT00750308|6158805|P1|COMPLETED|Washout||2
2512479|NCT00750308|6158794|P12|STARTED|Washout||1
2512480|NCT00750308|6158795|P11|STARTED|Washout||1
2512481|NCT00750308|6158796|P10|STARTED|Washout||2
2512482|NCT00750308|6158797|P9|STARTED|Washout||1
2512483|NCT00750308|6158798|P8|STARTED|Washout||2
2512484|NCT00750308|6158799|P7|STARTED|Washout||2
2512485|NCT00750308|6158800|P6|STARTED|Washout||2
2512486|NCT00750308|6158801|P5|STARTED|Washout||1
2512487|NCT00750308|6158802|P4|STARTED|Washout||1
2512488|NCT00750308|6158803|P3|STARTED|Washout||2
2512489|NCT00750308|6158804|P2|STARTED|Washout||2
2512490|NCT00750308|6158805|P1|STARTED|Washout||2
2512491|NCT00750308|6158794|P12|NOT COMPLETED|Second Treatment||0
2512492|NCT00750308|6158795|P11|NOT COMPLETED|Second Treatment||0
2512493|NCT00750308|6158796|P10|NOT COMPLETED|Second Treatment||0
2512494|NCT00750308|6158797|P9|NOT COMPLETED|Second Treatment||1
2512495|NCT00750308|6158798|P8|NOT COMPLETED|Second Treatment||0
2512496|NCT00750308|6158799|P7|NOT COMPLETED|Second Treatment||0
2512497|NCT00750308|6158800|P6|NOT COMPLETED|Second Treatment||1
2512498|NCT00750308|6158801|P5|NOT COMPLETED|Second Treatment||1
2512499|NCT00750308|6158802|P4|NOT COMPLETED|Second Treatment||0
2512500|NCT00750308|6158803|P3|NOT COMPLETED|Second Treatment||0
2512501|NCT00750308|6158804|P2|NOT COMPLETED|Second Treatment||0
2512502|NCT00750308|6158805|P1|NOT COMPLETED|Second Treatment||0
2512503|NCT00750308|6158794|P12|COMPLETED|Second Treatment||1
2512504|NCT00750308|6158795|P11|COMPLETED|Second Treatment||1
2512505|NCT00750308|6158796|P10|COMPLETED|Second Treatment||2
2512506|NCT00750308|6158797|P9|COMPLETED|Second Treatment||1
2512507|NCT00750308|6158798|P8|COMPLETED|Second Treatment||2
2512508|NCT00750308|6158799|P7|COMPLETED|Second Treatment||2
2512509|NCT00750308|6158800|P6|COMPLETED|Second Treatment||2
2512510|NCT00750308|6158801|P5|COMPLETED|Second Treatment||1
2512511|NCT00750308|6158802|P4|COMPLETED|Second Treatment||1
2512512|NCT00750308|6158803|P3|COMPLETED|Second Treatment||2
2512513|NCT00750308|6158804|P2|COMPLETED|Second Treatment||2
2512514|NCT00750308|6158805|P1|COMPLETED|Second Treatment||2
2512515|NCT00750308|6158794|P12|STARTED|Second Treatment||1
2512516|NCT00750308|6158795|P11|STARTED|Second Treatment||1
2512517|NCT00750308|6158796|P10|STARTED|Second Treatment||2
2512518|NCT00750308|6158797|P9|STARTED|Second Treatment||2
2512519|NCT00750308|6158798|P8|STARTED|Second Treatment||2
2512520|NCT00750308|6158799|P7|STARTED|Second Treatment||2
2512521|NCT00750308|6158800|P6|STARTED|Second Treatment||3
2512522|NCT00750308|6158801|P5|STARTED|Second Treatment||2
2512523|NCT00750308|6158802|P4|STARTED|Second Treatment||1
2512524|NCT00750308|6158803|P3|STARTED|Second Treatment||2
2512525|NCT00750308|6158804|P2|STARTED|Second Treatment||2
2512526|NCT00750308|6158805|P1|STARTED|Second Treatment||2
2512527|NCT00750308|6158794|P12|NOT COMPLETED|Washout||0
2512528|NCT00750308|6158795|P11|NOT COMPLETED|Washout||0
2512529|NCT00750308|6158796|P10|NOT COMPLETED|Washout||0
2512530|NCT00750308|6158797|P9|NOT COMPLETED|Washout||0
2512531|NCT00750308|6158798|P8|NOT COMPLETED|Washout||0
2512532|NCT00750308|6158799|P7|NOT COMPLETED|Washout||0
2512533|NCT00750308|6158800|P6|NOT COMPLETED|Washout||0
2512534|NCT00750308|6158801|P5|NOT COMPLETED|Washout||0
2512535|NCT00750308|6158802|P4|NOT COMPLETED|Washout||0
2512536|NCT00750308|6158803|P3|NOT COMPLETED|Washout||0
2512537|NCT00750308|6158804|P2|NOT COMPLETED|Washout||0
2512538|NCT00750308|6158805|P1|NOT COMPLETED|Washout||0
2512539|NCT00750308|6158794|P12|COMPLETED|Washout||1
2512540|NCT00750308|6158795|P11|COMPLETED|Washout||1
2512541|NCT00750308|6158796|P10|COMPLETED|Washout||2
2512542|NCT00750308|6158797|P9|COMPLETED|Washout||2
2512543|NCT00750308|6158798|P8|COMPLETED|Washout||2
2512544|NCT00750308|6158799|P7|COMPLETED|Washout||2
2512545|NCT00750308|6158800|P6|COMPLETED|Washout||3
2512546|NCT00750308|6158801|P5|COMPLETED|Washout||2
2512547|NCT00750308|6158802|P4|COMPLETED|Washout||1
2512548|NCT00750308|6158803|P3|COMPLETED|Washout||2
2512549|NCT00750308|6158804|P2|COMPLETED|Washout||2
2512550|NCT00750308|6158805|P1|COMPLETED|Washout||2
2512551|NCT00750308|6158794|P12|STARTED|Washout||1
2512552|NCT00750308|6158795|P11|STARTED|Washout||1
2512553|NCT00750308|6158796|P10|STARTED|Washout||2
2512554|NCT00750308|6158797|P9|STARTED|Washout||2
2512555|NCT00750308|6158798|P8|STARTED|Washout||2
2512556|NCT00750308|6158799|P7|STARTED|Washout||2
2512557|NCT00750308|6158800|P6|STARTED|Washout||3
2512558|NCT00750308|6158801|P5|STARTED|Washout||2
2512559|NCT00750308|6158802|P4|STARTED|Washout||1
2512560|NCT00750308|6158803|P3|STARTED|Washout||2
2512561|NCT00750308|6158804|P2|STARTED|Washout||2
2512562|NCT00750308|6158805|P1|STARTED|Washout||2
2512563|NCT00750308|6158794|P12|NOT COMPLETED|First Treatment||1
2512564|NCT00750308|6158795|P11|NOT COMPLETED|First Treatment||1
2512565|NCT00750308|6158796|P10|NOT COMPLETED|First Treatment||0
2512566|NCT00750308|6158797|P9|NOT COMPLETED|First Treatment||0
2512567|NCT00750308|6158798|P8|NOT COMPLETED|First Treatment||1
2512568|NCT00750308|6158799|P7|NOT COMPLETED|First Treatment||0
2512569|NCT00750308|6158800|P6|NOT COMPLETED|First Treatment||0
2512570|NCT00750308|6158801|P5|NOT COMPLETED|First Treatment||0
2512571|NCT00750308|6158802|P4|NOT COMPLETED|First Treatment||1
2512572|NCT00750308|6158803|P3|NOT COMPLETED|First Treatment||0
2512573|NCT00750308|6158804|P2|NOT COMPLETED|First Treatment||1
2512574|NCT00750308|6158805|P1|NOT COMPLETED|First Treatment||0
2512575|NCT00750308|6158794|P12|COMPLETED|First Treatment||1
2512576|NCT00750308|6158795|P11|COMPLETED|First Treatment||1
2512577|NCT00750308|6158796|P10|COMPLETED|First Treatment||2
2512578|NCT00750308|6158797|P9|COMPLETED|First Treatment||2
2512579|NCT00750308|6158798|P8|COMPLETED|First Treatment||2
2512580|NCT00750308|6158799|P7|COMPLETED|First Treatment||2
2512581|NCT00750308|6158800|P6|COMPLETED|First Treatment||3
2512582|NCT00750308|6158801|P5|COMPLETED|First Treatment||2
2512583|NCT00750308|6158802|P4|COMPLETED|First Treatment||1
2512584|NCT00750308|6158803|P3|COMPLETED|First Treatment||2
2512585|NCT00750308|6158804|P2|COMPLETED|First Treatment||2
2512586|NCT00750308|6158805|P1|COMPLETED|First Treatment||2
2512587|NCT00750308|6158794|P12|STARTED|First Treatment||2
2512588|NCT00750308|6158795|P11|STARTED|First Treatment||2
2512589|NCT00750308|6158796|P10|STARTED|First Treatment||2
2512590|NCT00750308|6158797|P9|STARTED|First Treatment||2
2512591|NCT00750308|6158798|P8|STARTED|First Treatment||3
2512592|NCT00750308|6158799|P7|STARTED|First Treatment||2
2512593|NCT00750308|6158800|P6|STARTED|First Treatment||3
2512594|NCT00750308|6158801|P5|STARTED|First Treatment||2
2512595|NCT00750308|6158802|P4|STARTED|First Treatment||2
2512596|NCT00750308|6158803|P3|STARTED|First Treatment||2
2512597|NCT00750308|6158804|P2|STARTED|First Treatment||3
2512685|NCT00749957|6158991|P2|STARTED|Overall Study||6
2512598|NCT00750308|6158805|P1|STARTED|First Treatment|One female withdrew due to muscle pain|2
2512599|NCT00750282|6158823|P4|NOT COMPLETED|Overall Study||1
2512600|NCT00750282|6158824|P3|NOT COMPLETED|Overall Study||1
2512601|NCT00750282|6158825|P2|NOT COMPLETED|Overall Study||1
2512602|NCT00750282|6158826|P1|NOT COMPLETED|Overall Study||0
2512603|NCT00750282|6158823|P4|COMPLETED|Overall Study||147
2512604|NCT00750282|6158824|P3|COMPLETED|Overall Study||125
2512605|NCT00750282|6158825|P2|COMPLETED|Overall Study||81
2512606|NCT00750282|6158826|P1|COMPLETED|Overall Study||69
2512607|NCT00750282|6158823|P4|STARTED|Overall Study||148
2512608|NCT00750282|6158824|P3|STARTED|Overall Study||126
2512609|NCT00750282|6158825|P2|STARTED|Overall Study||82
2512610|NCT00750282|6158826|P1|STARTED|Overall Study||69
2512611|NCT00750269|6158855|P5|NOT COMPLETED|Overall Study||10
2512612|NCT00750269|6158856|P4|NOT COMPLETED|Overall Study||5
2512613|NCT00750269|6158857|P3|NOT COMPLETED|Overall Study||4
2512614|NCT00750269|6158858|P2|NOT COMPLETED|Overall Study||1
2512615|NCT00750269|6158859|P1|NOT COMPLETED|Overall Study||0
2512616|NCT00750269|6158855|P5|COMPLETED|Overall Study||33
2512617|NCT00750269|6158856|P4|COMPLETED|Overall Study||38
2512618|NCT00750269|6158857|P3|COMPLETED|Overall Study||14
2512619|NCT00750269|6158858|P2|COMPLETED|Overall Study||7
2512620|NCT00750269|6158859|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|8
2512621|NCT00750269|6158855|P5|STARTED|Overall Study||43
2512622|NCT00750269|6158856|P4|STARTED|Overall Study||43
2512623|NCT00750269|6158857|P3|STARTED|Overall Study||18
2512624|NCT00750269|6158858|P2|STARTED|Overall Study||8
2512625|NCT00750269|6158859|P1|STARTED|Overall Study||8
2512626|NCT00750204|6158906|P2|NOT COMPLETED|Overall Study||1
2512627|NCT00750204|6158907|P1|NOT COMPLETED|Overall Study||1
2512628|NCT00750204|6158906|P2|COMPLETED|Overall Study||0
2512629|NCT00750204|6158907|P1|COMPLETED|Overall Study||0
2512630|NCT00750204|6158906|P2|STARTED|Overall Study||1
2512631|NCT00750204|6158907|P1|STARTED|Overall Study||1
2512632|NCT00750191|6158915|P2|NOT COMPLETED|Overall Study||10
2512633|NCT00750191|6158916|P1|NOT COMPLETED|Overall Study||5
2512634|NCT00750191|6158915|P2|COMPLETED|Overall Study||20
2512635|NCT00750191|6158916|P1|COMPLETED|Overall Study||22
2512636|NCT00750191|6158915|P2|STARTED|Overall Study||30
2512637|NCT00750191|6158916|P1|STARTED|Overall Study||27
2512638|NCT00750165|6158928|P1|NOT COMPLETED|Overall Study||11
2512639|NCT00750165|6158928|P1|COMPLETED|Overall Study||21
2512640|NCT00750165|6158928|P1|STARTED|Overall Study||32
2512641|NCT00750152|6158937|P2|NOT COMPLETED|Overall Study||27
2512642|NCT00750152|6158938|P1|NOT COMPLETED|Overall Study||22
2512643|NCT00750152|6158937|P2|COMPLETED|Overall Study||141
2512644|NCT00750152|6158938|P1|COMPLETED|Overall Study||144
2512645|NCT00750152|6158937|P2|STARTED|Overall Study||168
2512646|NCT00750152|6158938|P1|STARTED|Overall Study||166
2512647|NCT00750139|6158950|P4|NOT COMPLETED|Overall Study||46
2512648|NCT00750139|6158951|P3|NOT COMPLETED|Overall Study||101
2512649|NCT00750139|6158952|P2|NOT COMPLETED|Overall Study||59
2512650|NCT00750139|6158953|P1|NOT COMPLETED|Overall Study||89
2512651|NCT00750139|6158950|P4|COMPLETED|Overall Study||73
2512652|NCT00750139|6158951|P3|COMPLETED|Overall Study||135
2512653|NCT00750139|6158952|P2|COMPLETED|Overall Study||59
2512654|NCT00750139|6158953|P1|COMPLETED|Overall Study||145
2512655|NCT00750139|6158950|P4|STARTED|Overall Study||119
2512656|NCT00750139|6158951|P3|STARTED|Overall Study||236
2512657|NCT00750139|6158952|P2|STARTED|Overall Study||118
2512658|NCT00750139|6158953|P1|STARTED|Overall Study||234
2512659|NCT00750061|6158969|P2|NOT COMPLETED|Overall Study||2
2512660|NCT00750061|6158970|P1|NOT COMPLETED|Overall Study||2
2512661|NCT00750061|6158969|P2|COMPLETED|Overall Study||18
2512662|NCT00750061|6158970|P1|COMPLETED|Overall Study||18
2512663|NCT00750061|6158969|P2|STARTED|Overall Study||20
2512664|NCT00750061|6158970|P1|STARTED|Overall Study||20
2512665|NCT00749996|6158980|P2|NOT COMPLETED|Overall Study||13
2512666|NCT00749996|6158981|P1|NOT COMPLETED|Overall Study||18
2512667|NCT00749996|6158980|P2|COMPLETED|Overall Study||58
2512668|NCT00749996|6158981|P1|COMPLETED|Overall Study||57
2512669|NCT00749996|6158980|P2|24 Months Follow up|Overall Study|Withdrawn (n=3). Lost to follow-up (n=3)|58
2512670|NCT00749996|6158981|P1|24 Months Follow up|Overall Study|Withdrawn (n=5) Accidental death (n=1) Lost to follow up (n=7)|57
2512671|NCT00749996|6158980|P2|12 Months Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=4). Lost to follow-up (n=1)|60
2512672|NCT00749996|6158981|P1|12 Months Follow-up|Overall Study|Withdrawn(n=4). Visit not done (n=2)|68
2512673|NCT00749996|6158980|P2|6 Months Follow-up|Overall Study|Withdrawn (n=3). Visit not done (n=3)|63
2512674|NCT00749996|6158981|P1|6 Months Follow-up|Overall Study|Visit not done (n=3)|71
2512675|NCT00749996|6158980|P2|3 Months Follow-up|Overall Study|Visit not done (n=1)|68
2512676|NCT00749996|6158981|P1|3 Months Follow-up|Overall Study|Visit not done (n=2)|72
2512677|NCT00749996|6158980|P2|6 Weeks Follow-up|Overall Study|Withdrawn (n=2). Visit not done (n=2)|67
2512678|NCT00749996|6158981|P1|6 Weeks Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=2)|72
2512679|NCT00749996|6158980|P2|STARTED|Overall Study|5 pts were removed due to compliance issue. 1 pt was randomized but not treated (Non-eligible)|71
2512680|NCT00749996|6158981|P1|STARTED|Overall Study|4 pts were removed due to compliance issue. 2 pts were randomized but not treated (non-eligible)|75
2512681|NCT00749957|6158991|P2|NOT COMPLETED|Overall Study||0
2512682|NCT00749957|6158992|P1|NOT COMPLETED|Overall Study||0
2512683|NCT00749957|6158991|P2|COMPLETED|Overall Study||6
2512684|NCT00749957|6158992|P1|COMPLETED|Overall Study||6
2512686|NCT00749957|6158992|P1|STARTED|Overall Study||6
2512687|NCT00749944|6159004|P2|NOT COMPLETED|Overall Study||1
2512688|NCT00749944|6159005|P1|NOT COMPLETED|Overall Study||5
2512689|NCT00749944|6159004|P2|COMPLETED|Overall Study||54
2512690|NCT00749944|6159005|P1|COMPLETED|Overall Study||50
2512691|NCT00749944|6159004|P2|STARTED|Overall Study||55
2512692|NCT00749944|6159005|P1|STARTED|Overall Study||55
2512693|NCT00749931|6159073|P3|NOT COMPLETED|Overall Study||0
2512694|NCT00749931|6159074|P2|NOT COMPLETED|Overall Study||0
2512695|NCT00749931|6159075|P1|NOT COMPLETED|Overall Study||0
2512696|NCT00749931|6159073|P3|COMPLETED|Overall Study||68
2512697|NCT00749931|6159074|P2|COMPLETED|Overall Study||298
2512698|NCT00749931|6159075|P1|COMPLETED|Overall Study||298
2512699|NCT00749931|6159073|P3|STARTED|Overall Study||68
2512700|NCT00749931|6159074|P2|STARTED|Overall Study||298
2512701|NCT00749931|6159075|P1|STARTED|Overall Study||298
2512702|NCT00749879|6159084|P1|NOT COMPLETED|Overall Study||0
2512703|NCT00749879|6159084|P1|COMPLETED|Overall Study||12
2512704|NCT00749879|6159084|P1|STARTED|Overall Study||12
2512705|NCT00749775|6159116|P1|NOT COMPLETED|Overall Study||107
2512706|NCT00749775|6159116|P1|COMPLETED|Overall Study||3210
2512707|NCT00749775|6159116|P1|STARTED|Overall Study||3317
2512708|NCT00749684|6159132|P1|NOT COMPLETED|Overall Study||82
2512709|NCT00749684|6159132|P1|COMPLETED|Overall Study||56
2512710|NCT00749684|6159132|P1|STARTED|Overall Study||138
2512711|NCT00749671|6159139|P2|NOT COMPLETED|Overall Study||0
2512712|NCT00749671|6159140|P1|NOT COMPLETED|Overall Study||0
2512713|NCT00749671|6159139|P2|COMPLETED|Overall Study||9
2512714|NCT00749671|6159140|P1|COMPLETED|Overall Study||11
2512715|NCT00749671|6159139|P2|STARTED|Overall Study||9
2512716|NCT00749671|6159140|P1|STARTED|Overall Study||11
2512717|NCT00749606|6159150|P2|NOT COMPLETED|Year 3 (Observation)||3
2512718|NCT00749606|6159151|P1|NOT COMPLETED|Year 3 (Observation)||0
2512719|NCT00749606|6159150|P2|COMPLETED|Year 3 (Observation)||69
2512720|NCT00749606|6159151|P1|COMPLETED|Year 3 (Observation)||63
2512721|NCT00749606|6159150|P2|STARTED|Year 3 (Observation)||72
2512722|NCT00749606|6159151|P1|STARTED|Year 3 (Observation)||63
2512723|NCT00749606|6159150|P2|NOT COMPLETED|Year 2||8
2512724|NCT00749606|6159151|P1|NOT COMPLETED|Year 2||11
2512725|NCT00749606|6159150|P2|COMPLETED|Year 2||72
2512726|NCT00749606|6159151|P1|COMPLETED|Year 2||63
2512727|NCT00749606|6159150|P2|STARTED|Year 2||80
2512728|NCT00749606|6159151|P1|STARTED|Year 2||74
2512729|NCT00749606|6159150|P2|NOT COMPLETED|Year 1||48
2512730|NCT00749606|6159151|P1|NOT COMPLETED|Year 1||55
2512731|NCT00749606|6159150|P2|COMPLETED|Year 1||80
2512732|NCT00749606|6159151|P1|COMPLETED|Year 1||74
2512733|NCT00749606|6159150|P2|STARTED|Year 1||128
2512734|NCT00749606|6159151|P1|STARTED|Year 1||129
2512735|NCT00749580|6159171|P2|NOT COMPLETED|Overall Study||9
2512736|NCT00749580|6159172|P1|NOT COMPLETED|Overall Study||4
2512737|NCT00749580|6159171|P2|COMPLETED|Overall Study||16
2512738|NCT00749580|6159172|P1|COMPLETED|Overall Study|December 2010|17
2512739|NCT00749580|6159171|P2|STARTED|Overall Study||25
2512740|NCT00749580|6159172|P1|STARTED|Overall Study|September 2008|21
2512741|NCT00749515|6159182|P2|NOT COMPLETED|Overall Study||0
2512742|NCT00749515|6159183|P1|NOT COMPLETED|Overall Study||0
2512743|NCT00749515|6159182|P2|COMPLETED|Overall Study||5
2512744|NCT00749515|6159183|P1|COMPLETED|Overall Study||10
2512745|NCT00749515|6159182|P2|STARTED|Overall Study||5
2512746|NCT00749515|6159183|P1|STARTED|Overall Study||10
2512747|NCT00749476|6159199|P1|NOT COMPLETED|Overall Study||0
2512748|NCT00749476|6159199|P1|COMPLETED|Overall Study||1
2512749|NCT00749476|6159199|P1|STARTED|Overall Study||1
2512750|NCT00749463|6159206|P3|NOT COMPLETED|Overall Study||1
2512751|NCT00749463|6159207|P2|NOT COMPLETED|Overall Study||4
2512752|NCT00749463|6159208|P1|NOT COMPLETED|Overall Study||1
2512753|NCT00749463|6159206|P3|COMPLETED|Overall Study||149
2512754|NCT00749463|6159207|P2|COMPLETED|Overall Study||60
2512755|NCT00749463|6159208|P1|COMPLETED|Overall Study||85
2512756|NCT00749463|6159206|P3|STARTED|Overall Study||150
2512757|NCT00749463|6159207|P2|STARTED|Overall Study||64
2512758|NCT00749463|6159208|P1|STARTED|Overall Study||86
2512759|NCT00749398|6159234|P1|NOT COMPLETED|Overall Study||53
2512760|NCT00749398|6159234|P1|COMPLETED|Overall Study||71
2512761|NCT00749398|6159234|P1|STARTED|Overall Study|Nine participants were excluded because they did not fulfill the inclusion criteria.|124
2512762|NCT00749268|6159252|P2|NOT COMPLETED|Overall Study||36
2512763|NCT00749268|6159253|P1|NOT COMPLETED|Overall Study||34
2512764|NCT00749268|6159252|P2|COMPLETED|Overall Study||74
2512765|NCT00749268|6159253|P1|COMPLETED|Overall Study||72
2512766|NCT00749268|6159252|P2|STARTED|Overall Study||110
2512767|NCT00749268|6159253|P1|STARTED|Overall Study||106
2512768|NCT00749203|6159277|P2|NOT COMPLETED|Second Infusion at 2 Weeks||2
2512769|NCT00749203|6159278|P1|NOT COMPLETED|Second Infusion at 2 Weeks||0
2512770|NCT00749203|6159277|P2|COMPLETED|Second Infusion at 2 Weeks||13
2512771|NCT00749203|6159278|P1|COMPLETED|Second Infusion at 2 Weeks||16
2512772|NCT00749203|6159277|P2|STARTED|Second Infusion at 2 Weeks||15
2512773|NCT00749203|6159278|P1|STARTED|Second Infusion at 2 Weeks|N=6 completed the study at 2 wks due to CAPS scores < 50, precluding 2nd infusion.|16
2512774|NCT00749203|6159277|P2|NOT COMPLETED|no Infusion at Week 1||4
2512775|NCT00749203|6159278|P1|NOT COMPLETED|no Infusion at Week 1||0
2512776|NCT00749203|6159277|P2|COMPLETED|no Infusion at Week 1||15
2512777|NCT00749203|6159278|P1|COMPLETED|no Infusion at Week 1||22
2512778|NCT00749203|6159277|P2|STARTED|no Infusion at Week 1||19
2512779|NCT00749203|6159278|P1|STARTED|no Infusion at Week 1||22
2512780|NCT00749203|6159277|P2|NOT COMPLETED|First Infusion Day 1||0
2512781|NCT00749203|6159278|P1|NOT COMPLETED|First Infusion Day 1||0
2512782|NCT00749203|6159277|P2|COMPLETED|First Infusion Day 1||19
2512783|NCT00749203|6159278|P1|COMPLETED|First Infusion Day 1||22
2512784|NCT00749203|6159277|P2|STARTED|First Infusion Day 1||19
2512785|NCT00749203|6159278|P1|STARTED|First Infusion Day 1||22
2512786|NCT00749190|6159299|P7|NOT COMPLETED|Overall Study||1
2512787|NCT00749190|6159300|P6|NOT COMPLETED|Overall Study||5
2512788|NCT00749190|6159301|P5|NOT COMPLETED|Overall Study||0
2512789|NCT00749190|6159302|P4|NOT COMPLETED|Overall Study||5
2512790|NCT00749190|6159303|P3|NOT COMPLETED|Overall Study||1
2512791|NCT00749190|6159304|P2|NOT COMPLETED|Overall Study||5
2512792|NCT00749190|6159305|P1|NOT COMPLETED|Overall Study||5
2512793|NCT00749190|6159299|P7|COMPLETED|Overall Study||70
2512794|NCT00749190|6159300|P6|COMPLETED|Overall Study||65
2512795|NCT00749190|6159301|P5|COMPLETED|Overall Study||70
2512796|NCT00749190|6159302|P4|COMPLETED|Overall Study||66
2512797|NCT00749190|6159303|P3|COMPLETED|Overall Study||70
2512798|NCT00749190|6159304|P2|COMPLETED|Overall Study||66
2512799|NCT00749190|6159305|P1|COMPLETED|Overall Study||66
2512800|NCT00749190|6159299|P7|STARTED|Overall Study||71
2512801|NCT00749190|6159300|P6|STARTED|Overall Study||70
2512802|NCT00749190|6159301|P5|STARTED|Overall Study||70
2512803|NCT00749190|6159302|P4|STARTED|Overall Study||71
2512804|NCT00749190|6159303|P3|STARTED|Overall Study||71
2512805|NCT00749190|6159304|P2|STARTED|Overall Study||71
2512806|NCT00749190|6159305|P1|STARTED|Overall Study||71
2512807|NCT00749125|6159384|P2|NOT COMPLETED|Overall Study||18
2512808|NCT00749125|6159385|P1|NOT COMPLETED|Overall Study||11
2512809|NCT00749125|6159384|P2|COMPLETED|Overall Study||34
2512810|NCT00749125|6159385|P1|COMPLETED|Overall Study||36
2512811|NCT00749125|6159384|P2|STARTED|Overall Study||52
2512812|NCT00749125|6159385|P1|STARTED|Overall Study||47
2512813|NCT00749073|6159391|P1|NOT COMPLETED|Overall Study||0
2512814|NCT00749073|6159391|P1|COMPLETED|Overall Study||10
2512815|NCT00749073|6159391|P1|STARTED|Overall Study||10
2512816|NCT00748982|6159399|P2|NOT COMPLETED|Overall Study||0
2512817|NCT00748982|6159400|P1|NOT COMPLETED|Overall Study||0
2512818|NCT00748982|6159399|P2|COMPLETED|Overall Study||4
2512819|NCT00748982|6159400|P1|COMPLETED|Overall Study||12
2512820|NCT00748982|6159399|P2|STARTED|Overall Study||4
2512821|NCT00748982|6159400|P1|STARTED|Overall Study||12
2512822|NCT00748969|6159414|P2|NOT COMPLETED|Overall Study||1
2512823|NCT00748969|6159415|P1|NOT COMPLETED|Overall Study||1
2512824|NCT00748969|6159414|P2|COMPLETED|Overall Study||0
2512825|NCT00748969|6159415|P1|COMPLETED|Overall Study||0
2512826|NCT00748969|6159414|P2|STARTED|Overall Study|Subject withdrew from study due to randomization to no treatment|1
2512827|NCT00748969|6159415|P1|STARTED|Overall Study|Subject withdrew from study due to worsening sleep apnea|1
2512828|NCT00748956|6159426|P3|NOT COMPLETED|Overall Study||0
2512829|NCT00748956|6159427|P2|NOT COMPLETED|Overall Study||0
2512830|NCT00748956|6159428|P1|NOT COMPLETED|Overall Study||0
2512831|NCT00748956|6159426|P3|COMPLETED|Overall Study||5
2512832|NCT00748956|6159427|P2|COMPLETED|Overall Study||5
2512833|NCT00748956|6159428|P1|COMPLETED|Overall Study||0
2512834|NCT00748956|6159426|P3|STARTED|Overall Study||5
2512835|NCT00748956|6159427|P2|STARTED|Overall Study||5
2512836|NCT00748956|6159428|P1|STARTED|Overall Study||0
2512837|NCT00748865|6159451|P2|NOT COMPLETED|Overall Study||0
2512838|NCT00748865|6159452|P1|NOT COMPLETED|Overall Study||0
2512839|NCT00748865|6159451|P2|COMPLETED|Overall Study||10
2512840|NCT00748865|6159452|P1|COMPLETED|Overall Study||10
2512841|NCT00748865|6159451|P2|STARTED|Overall Study||10
2512842|NCT00748865|6159452|P1|STARTED|Overall Study||10
2512843|NCT00748826|6159458|P1|NOT COMPLETED|Overall Study||301
2512844|NCT00748826|6159458|P1|COMPLETED|Overall Study||207
2512845|NCT00748826|6159458|P1|STARTED|Overall Study|Of 576 total enrolled, 68 out of scope participants were not used for analyses|508
2512846|NCT00748709|6159465|P1|NOT COMPLETED|Overall Study||20
2512847|NCT00748709|6159465|P1|COMPLETED|Overall Study||0
2512848|NCT00748709|6159465|P1|STARTED|Overall Study|Treated|20
2512849|NCT00748657|6159477|P1|NOT COMPLETED|Overall Study||0
2512850|NCT00748657|6159477|P1|COMPLETED|Overall Study||36
2512851|NCT00748657|6159477|P1|STARTED|Overall Study||36
2512852|NCT00748579|6159491|P2|NOT COMPLETED|Overall Study||0
2512853|NCT00748579|6159492|P1|NOT COMPLETED|Overall Study||0
2512854|NCT00748579|6159491|P2|COMPLETED|Overall Study||0
2512855|NCT00748579|6159492|P1|COMPLETED|Overall Study||2
2512856|NCT00748579|6159491|P2|STARTED|Overall Study||0
2512857|NCT00748579|6159492|P1|STARTED|Overall Study||2
2512858|NCT00748566|6159508|P1|NOT COMPLETED|Overall Study||112
2512859|NCT00748566|6159508|P1|COMPLETED|Overall Study||60
2512860|NCT00748566|6159508|P1|STARTED|Overall Study||172
2512861|NCT00748553|6159538|P2|NOT COMPLETED|Overall Study||1
2512862|NCT00748553|6159539|P1|NOT COMPLETED|Overall Study||3
2512863|NCT00748553|6159538|P2|COMPLETED|Overall Study||13
2512864|NCT00748553|6159539|P1|COMPLETED|Overall Study||13
2512865|NCT00748553|6159538|P2|STARTED|Overall Study||14
2512866|NCT00748553|6159539|P1|STARTED|Overall Study||16
2512867|NCT00748540|6159546|P1|NOT COMPLETED|Overall Study||1
2512868|NCT00748540|6159546|P1|COMPLETED|Overall Study||49
2512869|NCT00748540|6159546|P1|STARTED|Overall Study||50
2512870|NCT00748410|6159555|P2|NOT COMPLETED|Overall Study||0
2512871|NCT00748410|6159556|P1|NOT COMPLETED|Overall Study||0
2512872|NCT00748410|6159555|P2|COMPLETED|Overall Study||2
2512873|NCT00748410|6159556|P1|COMPLETED|Overall Study||1
2512874|NCT00748410|6159555|P2|STARTED|Overall Study||2
2512875|NCT00748410|6159556|P1|STARTED|Overall Study||1
2512876|NCT00748241|6159572|P1|NOT COMPLETED|Overall Study||8
2512877|NCT00748241|6159572|P1|COMPLETED|Overall Study||11
2512878|NCT00748241|6159572|P1|STARTED|Overall Study||19
2512879|NCT00748189|6159582|P2|NOT COMPLETED|Overall Study||212
2512880|NCT00748189|6159583|P1|NOT COMPLETED|Overall Study||216
2512881|NCT00748189|6159582|P2|COMPLETED|Overall Study||9
2512882|NCT00748189|6159583|P1|COMPLETED|Overall Study||10
2512883|NCT00748189|6159582|P2|STARTED|Overall Study||221
2512884|NCT00748189|6159583|P1|STARTED|Overall Study||226
2512885|NCT00748098|6159638|P2|NOT COMPLETED|Second Taper Period||0
2512886|NCT00748098|6159639|P1|NOT COMPLETED|Second Taper Period||0
2512887|NCT00748098|6159638|P2|COMPLETED|Second Taper Period||61
2512888|NCT00748098|6159639|P1|COMPLETED|Second Taper Period||53
2512889|NCT00748098|6159638|P2|STARTED|Second Taper Period||61
2512890|NCT00748098|6159639|P1|STARTED|Second Taper Period||53
2512891|NCT00748098|6159638|P2|NOT COMPLETED|Second Treatment Intervention Period||3
2512892|NCT00748098|6159639|P1|NOT COMPLETED|Second Treatment Intervention Period||6
2512893|NCT00748098|6159638|P2|COMPLETED|Second Treatment Intervention Period||61
2512894|NCT00748098|6159639|P1|COMPLETED|Second Treatment Intervention Period||53
2512895|NCT00748098|6159638|P2|STARTED|Second Treatment Intervention Period||64
2512896|NCT00748098|6159639|P1|STARTED|Second Treatment Intervention Period||59
2512897|NCT00748098|6159638|P2|NOT COMPLETED|1-Week Washout Period||1
2512898|NCT00748098|6159639|P1|NOT COMPLETED|1-Week Washout Period||2
2512899|NCT00748098|6159638|P2|COMPLETED|1-Week Washout Period||64
2512900|NCT00748098|6159639|P1|COMPLETED|1-Week Washout Period||59
2512901|NCT00748098|6159638|P2|STARTED|1-Week Washout Period||65
2512902|NCT00748098|6159639|P1|STARTED|1-Week Washout Period||61
2512903|NCT00748098|6159638|P2|NOT COMPLETED|First Taper Period||1
2512904|NCT00748098|6159639|P1|NOT COMPLETED|First Taper Period||3
2512905|NCT00748098|6159638|P2|COMPLETED|First Taper Period||65
2512906|NCT00748098|6159639|P1|COMPLETED|First Taper Period||61
2512907|NCT00748098|6159638|P2|STARTED|First Taper Period||66
2512908|NCT00748098|6159639|P1|STARTED|First Taper Period||64
2512909|NCT00748098|6159638|P2|NOT COMPLETED|First Treatment Intervention Period||1
2512910|NCT00748098|6159639|P1|NOT COMPLETED|First Treatment Intervention Period||5
2512911|NCT00748098|6159638|P2|COMPLETED|First Treatment Intervention Period||66
2512912|NCT00748098|6159639|P1|COMPLETED|First Treatment Intervention Period||64
2512913|NCT00748098|6159638|P2|STARTED|First Treatment Intervention Period||67
2512914|NCT00748098|6159639|P1|STARTED|First Treatment Intervention Period||69
2512915|NCT00748085|6159699|P1|NOT COMPLETED|Overall Study||0
2512916|NCT00748085|6159699|P1|COMPLETED|Overall Study|No analysis -study terminated for business reasons.|5
2512917|NCT00748085|6159699|P1|STARTED|Overall Study||5
2512918|NCT00748072|6159706|P2|NOT COMPLETED|Overall Study||0
2512919|NCT00748072|6159707|P1|NOT COMPLETED|Overall Study||0
2512920|NCT00748072|6159706|P2|COMPLETED|Overall Study||80
2512921|NCT00748072|6159707|P1|COMPLETED|Overall Study||82
2512922|NCT00748072|6159706|P2|STARTED|Overall Study||80
2512923|NCT00748072|6159707|P1|STARTED|Overall Study||82
2512924|NCT00747916|6159713|P1|NOT COMPLETED|Overall Study||0
2512925|NCT00747916|6159713|P1|COMPLETED|Overall Study||3
2512926|NCT00747916|6159713|P1|STARTED|Overall Study||3
2512927|NCT00747812|6159720|P2|NOT COMPLETED|Overall Study||3
2512928|NCT00747812|6159721|P1|NOT COMPLETED|Overall Study||5
2512929|NCT00747812|6159720|P2|COMPLETED|Overall Study||0
2512930|NCT00747812|6159721|P1|COMPLETED|Overall Study||0
2512931|NCT00747812|6159720|P2|STARTED|Overall Study|4 subjects were randomized to the Control Group; 1 was not implanted due to early enrollment closure|3
2512932|NCT00747812|6159721|P1|STARTED|Overall Study||5
2512933|NCT00747747|6159732|P3|NOT COMPLETED|Overall Study||0
2512934|NCT00747747|6159733|P2|NOT COMPLETED|Overall Study||0
2512935|NCT00747747|6159734|P1|NOT COMPLETED|Overall Study||0
2512936|NCT00747747|6159732|P3|COMPLETED|Overall Study|17 with acute episode + 4 with recurrent episode|21
2512937|NCT00747747|6159733|P2|COMPLETED|Overall Study|11 with acute episode + 3 with recurrent episode|14
2512938|NCT00747747|6159734|P1|COMPLETED|Overall Study|13 with acute episode + 1 with recurrent episode|14
2512939|NCT00747747|6159732|P3|STARTED|Overall Study||21
2512940|NCT00747747|6159733|P2|STARTED|Overall Study||14
2512941|NCT00747747|6159734|P1|STARTED|Overall Study||14
2512942|NCT00747643|6159759|P2|NOT COMPLETED|Overall Study||27
2512943|NCT00747643|6159760|P1|NOT COMPLETED|Overall Study||36
2512944|NCT00747643|6159759|P2|COMPLETED|Overall Study||54
2512945|NCT00747643|6159760|P1|COMPLETED|Overall Study||46
2512946|NCT00747643|6159759|P2|STARTED|Overall Study||81
2512947|NCT00747643|6159760|P1|STARTED|Overall Study||82
2512948|NCT00747617|6159774|P2|NOT COMPLETED|Overall Study||1
2512949|NCT00747617|6159775|P1|NOT COMPLETED|Overall Study||3
2512950|NCT00747617|6159774|P2|COMPLETED|Overall Study||11
2512951|NCT00747617|6159775|P1|COMPLETED|Overall Study||10
2512952|NCT00747617|6159774|P2|STARTED|Overall Study||12
2512953|NCT00747617|6159775|P1|STARTED|Overall Study||13
2512954|NCT00747565|6159785|P2|NOT COMPLETED|Overall Study||7
2512955|NCT00747565|6159786|P1|NOT COMPLETED|Overall Study||14
2512956|NCT00747565|6159785|P2|COMPLETED|Overall Study||116
2512957|NCT00747565|6159786|P1|COMPLETED|Overall Study|118 multifocal subjects in the original study plus 215 multifocal subejcts in the expansion study.|333
2512958|NCT00747565|6159785|P2|STARTED|Overall Study||123
2512959|NCT00747565|6159786|P1|STARTED|Overall Study|125 multifocal subjects in original study plus 222 multifocal subjects in the expansion study.|347
2512960|NCT00747552|6159794|P1|NOT COMPLETED|Overall Study||0
2512961|NCT00747552|6159794|P1|COMPLETED|Overall Study||30
2512962|NCT00747552|6159794|P1|STARTED|Overall Study|This number does not include the 2 who were enrolled but had no data collected on them.|30
2512963|NCT00747474|6159799|P12|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2512964|NCT00747474|6159800|P11|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2512965|NCT00747474|6159801|P10|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2512966|NCT00747474|6159802|P9|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2512967|NCT00747474|6159803|P8|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2512968|NCT00747474|6159804|P7|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2512969|NCT00747474|6159805|P6|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2512970|NCT00747474|6159806|P5|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2512971|NCT00747474|6159807|P4|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2512972|NCT00747474|6159808|P3|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2512973|NCT00747474|6159809|P2|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2512974|NCT00747474|6159810|P1|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2512975|NCT00747474|6159799|P12|COMPLETED|Cohort 12 (60 mg/m^2) Period||6
2512976|NCT00747474|6159800|P11|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2512977|NCT00747474|6159801|P10|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2512978|NCT00747474|6159802|P9|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2512979|NCT00747474|6159803|P8|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2512980|NCT00747474|6159804|P7|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2512981|NCT00747474|6159805|P6|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2512982|NCT00747474|6159806|P5|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2512983|NCT00747474|6159807|P4|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2512984|NCT00747474|6159808|P3|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2512985|NCT00747474|6159809|P2|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2512986|NCT00747474|6159810|P1|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
2512987|NCT00747474|6159799|P12|STARTED|Cohort 12 (60 mg/m^2) Period||6
2512988|NCT00747474|6159800|P11|STARTED|Cohort 12 (60 mg/m^2) Period||0
2512989|NCT00747474|6159801|P10|STARTED|Cohort 12 (60 mg/m^2) Period||0
2512990|NCT00747474|6159802|P9|STARTED|Cohort 12 (60 mg/m^2) Period||0
2512991|NCT00747474|6159803|P8|STARTED|Cohort 12 (60 mg/m^2) Period||0
2512992|NCT00747474|6159804|P7|STARTED|Cohort 12 (60 mg/m^2) Period||0
2512993|NCT00747474|6159805|P6|STARTED|Cohort 12 (60 mg/m^2) Period||0
2512994|NCT00747474|6159806|P5|STARTED|Cohort 12 (60 mg/m^2) Period||0
2512995|NCT00747474|6159807|P4|STARTED|Cohort 12 (60 mg/m^2) Period||0
2512996|NCT00747474|6159808|P3|STARTED|Cohort 12 (60 mg/m^2) Period||0
2512997|NCT00747474|6159809|P2|STARTED|Cohort 12 (60 mg/m^2) Period||0
2512998|NCT00747474|6159810|P1|STARTED|Cohort 12 (60 mg/m^2) Period||0
2512999|NCT00747474|6159799|P12|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2513000|NCT00747474|6159800|P11|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2513001|NCT00747474|6159801|P10|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2513002|NCT00747474|6159802|P9|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2513003|NCT00747474|6159803|P8|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2513004|NCT00747474|6159804|P7|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2513005|NCT00747474|6159805|P6|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2513006|NCT00747474|6159806|P5|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2513007|NCT00747474|6159807|P4|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2513008|NCT00747474|6159808|P3|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2513009|NCT00747474|6159809|P2|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2513010|NCT00747474|6159810|P1|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2513011|NCT00747474|6159799|P12|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2513012|NCT00747474|6159800|P11|COMPLETED|Cohort 11 (50 mg/m^2) Period||5
2513013|NCT00747474|6159801|P10|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2513014|NCT00747474|6159802|P9|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2513015|NCT00747474|6159803|P8|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2513016|NCT00747474|6159804|P7|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2513017|NCT00747474|6159805|P6|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2513018|NCT00747474|6159806|P5|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2513019|NCT00747474|6159807|P4|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2513020|NCT00747474|6159808|P3|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2513021|NCT00747474|6159809|P2|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2513022|NCT00747474|6159810|P1|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
2513023|NCT00747474|6159799|P12|STARTED|Cohort 11 (50 mg/m^2) Period||0
2513024|NCT00747474|6159800|P11|STARTED|Cohort 11 (50 mg/m^2) Period||5
2513025|NCT00747474|6159801|P10|STARTED|Cohort 11 (50 mg/m^2) Period||0
2513026|NCT00747474|6159802|P9|STARTED|Cohort 11 (50 mg/m^2) Period||0
2513027|NCT00747474|6159803|P8|STARTED|Cohort 11 (50 mg/m^2) Period||0
2513028|NCT00747474|6159804|P7|STARTED|Cohort 11 (50 mg/m^2) Period||0
2513029|NCT00747474|6159805|P6|STARTED|Cohort 11 (50 mg/m^2) Period||0
2513030|NCT00747474|6159806|P5|STARTED|Cohort 11 (50 mg/m^2) Period||0
2513031|NCT00747474|6159807|P4|STARTED|Cohort 11 (50 mg/m^2) Period||0
2513032|NCT00747474|6159808|P3|STARTED|Cohort 11 (50 mg/m^2) Period||0
2513033|NCT00747474|6159809|P2|STARTED|Cohort 11 (50 mg/m^2) Period||0
2513034|NCT00747474|6159810|P1|STARTED|Cohort 11 (50 mg/m^2) Period||0
2513035|NCT00747474|6159799|P12|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2513036|NCT00747474|6159800|P11|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2513037|NCT00747474|6159801|P10|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2513038|NCT00747474|6159802|P9|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2513039|NCT00747474|6159803|P8|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2513040|NCT00747474|6159804|P7|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2513041|NCT00747474|6159805|P6|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2513042|NCT00747474|6159806|P5|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2513043|NCT00747474|6159807|P4|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2513044|NCT00747474|6159808|P3|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2513045|NCT00747474|6159809|P2|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2513046|NCT00747474|6159810|P1|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2513047|NCT00747474|6159799|P12|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2513048|NCT00747474|6159800|P11|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2513049|NCT00747474|6159801|P10|COMPLETED|Cohort 10 (40 mg/m^2) Period||7
2513050|NCT00747474|6159802|P9|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2513051|NCT00747474|6159803|P8|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2513052|NCT00747474|6159804|P7|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2513053|NCT00747474|6159805|P6|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2513054|NCT00747474|6159806|P5|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2513055|NCT00747474|6159807|P4|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2513056|NCT00747474|6159808|P3|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2513057|NCT00747474|6159809|P2|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2513058|NCT00747474|6159810|P1|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
2513059|NCT00747474|6159799|P12|STARTED|Cohort 10 (40 mg/m^2) Period||0
2513060|NCT00747474|6159800|P11|STARTED|Cohort 10 (40 mg/m^2) Period||0
2513061|NCT00747474|6159801|P10|STARTED|Cohort 10 (40 mg/m^2) Period||7
2513062|NCT00747474|6159802|P9|STARTED|Cohort 10 (40 mg/m^2) Period||0
2513063|NCT00747474|6159803|P8|STARTED|Cohort 10 (40 mg/m^2) Period||0
2513064|NCT00747474|6159804|P7|STARTED|Cohort 10 (40 mg/m^2) Period||0
2513065|NCT00747474|6159805|P6|STARTED|Cohort 10 (40 mg/m^2) Period||0
2513066|NCT00747474|6159806|P5|STARTED|Cohort 10 (40 mg/m^2) Period||0
2513067|NCT00747474|6159807|P4|STARTED|Cohort 10 (40 mg/m^2) Period||0
2513068|NCT00747474|6159808|P3|STARTED|Cohort 10 (40 mg/m^2) Period||0
2513069|NCT00747474|6159809|P2|STARTED|Cohort 10 (40 mg/m^2) Period||0
2513070|NCT00747474|6159810|P1|STARTED|Cohort 10 (40 mg/m^2) Period||0
2513071|NCT00747474|6159799|P12|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2513072|NCT00747474|6159800|P11|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2513073|NCT00747474|6159801|P10|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2513074|NCT00747474|6159802|P9|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2513075|NCT00747474|6159803|P8|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2513076|NCT00747474|6159804|P7|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2513077|NCT00747474|6159805|P6|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2513078|NCT00747474|6159806|P5|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2513079|NCT00747474|6159807|P4|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2513080|NCT00747474|6159808|P3|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2513081|NCT00747474|6159809|P2|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2513082|NCT00747474|6159810|P1|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2513083|NCT00747474|6159799|P12|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2513084|NCT00747474|6159800|P11|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2513085|NCT00747474|6159801|P10|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2513086|NCT00747474|6159802|P9|COMPLETED|Cohort 9 (35 mg/m^2) Period||4
2513087|NCT00747474|6159803|P8|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2513088|NCT00747474|6159804|P7|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2513089|NCT00747474|6159805|P6|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2513090|NCT00747474|6159806|P5|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2513091|NCT00747474|6159807|P4|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2513092|NCT00747474|6159808|P3|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2513093|NCT00747474|6159809|P2|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2513094|NCT00747474|6159810|P1|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
2513095|NCT00747474|6159799|P12|STARTED|Cohort 9 (35 mg/m^2) Period||0
2513096|NCT00747474|6159800|P11|STARTED|Cohort 9 (35 mg/m^2) Period||0
2513097|NCT00747474|6159801|P10|STARTED|Cohort 9 (35 mg/m^2) Period||0
2513098|NCT00747474|6159802|P9|STARTED|Cohort 9 (35 mg/m^2) Period||4
2513099|NCT00747474|6159803|P8|STARTED|Cohort 9 (35 mg/m^2) Period||0
2513100|NCT00747474|6159804|P7|STARTED|Cohort 9 (35 mg/m^2) Period||0
2513101|NCT00747474|6159805|P6|STARTED|Cohort 9 (35 mg/m^2) Period||0
2513102|NCT00747474|6159806|P5|STARTED|Cohort 9 (35 mg/m^2) Period||0
2513103|NCT00747474|6159807|P4|STARTED|Cohort 9 (35 mg/m^2) Period||0
2513104|NCT00747474|6159808|P3|STARTED|Cohort 9 (35 mg/m^2) Period||0
2513105|NCT00747474|6159809|P2|STARTED|Cohort 9 (35 mg/m^2) Period||0
2513106|NCT00747474|6159810|P1|STARTED|Cohort 9 (35 mg/m^2) Period||0
2513107|NCT00747474|6159799|P12|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2513108|NCT00747474|6159800|P11|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2513109|NCT00747474|6159801|P10|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2513110|NCT00747474|6159802|P9|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2513111|NCT00747474|6159803|P8|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||1
2513112|NCT00747474|6159804|P7|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2513113|NCT00747474|6159805|P6|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2513114|NCT00747474|6159806|P5|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2513115|NCT00747474|6159807|P4|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2513116|NCT00747474|6159808|P3|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2513117|NCT00747474|6159809|P2|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2513118|NCT00747474|6159810|P1|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2513119|NCT00747474|6159799|P12|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2513120|NCT00747474|6159800|P11|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2513121|NCT00747474|6159801|P10|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2513122|NCT00747474|6159802|P9|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2513123|NCT00747474|6159803|P8|COMPLETED|Cohort 8 (40 mg/m^2) Period||5
2513124|NCT00747474|6159804|P7|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2513125|NCT00747474|6159805|P6|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2513126|NCT00747474|6159806|P5|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2513127|NCT00747474|6159807|P4|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2513128|NCT00747474|6159808|P3|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2513129|NCT00747474|6159809|P2|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2513130|NCT00747474|6159810|P1|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
2513131|NCT00747474|6159799|P12|STARTED|Cohort 8 (40 mg/m^2) Period||0
2513132|NCT00747474|6159800|P11|STARTED|Cohort 8 (40 mg/m^2) Period||0
2513133|NCT00747474|6159801|P10|STARTED|Cohort 8 (40 mg/m^2) Period||0
2513134|NCT00747474|6159802|P9|STARTED|Cohort 8 (40 mg/m^2) Period||0
2513135|NCT00747474|6159803|P8|STARTED|Cohort 8 (40 mg/m^2) Period||6
2513136|NCT00747474|6159804|P7|STARTED|Cohort 8 (40 mg/m^2) Period||0
2513137|NCT00747474|6159805|P6|STARTED|Cohort 8 (40 mg/m^2) Period||0
2513138|NCT00747474|6159806|P5|STARTED|Cohort 8 (40 mg/m^2) Period||0
2513139|NCT00747474|6159807|P4|STARTED|Cohort 8 (40 mg/m^2) Period||0
2513140|NCT00747474|6159808|P3|STARTED|Cohort 8 (40 mg/m^2) Period||0
2513141|NCT00747474|6159809|P2|STARTED|Cohort 8 (40 mg/m^2) Period||0
2513142|NCT00747474|6159810|P1|STARTED|Cohort 8 (40 mg/m^2) Period||0
2513143|NCT00747474|6159799|P12|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2513144|NCT00747474|6159800|P11|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2513145|NCT00747474|6159801|P10|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2513146|NCT00747474|6159802|P9|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2513147|NCT00747474|6159803|P8|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2513148|NCT00747474|6159804|P7|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2513149|NCT00747474|6159805|P6|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2513150|NCT00747474|6159806|P5|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2513151|NCT00747474|6159807|P4|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2513152|NCT00747474|6159808|P3|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2513153|NCT00747474|6159809|P2|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2513154|NCT00747474|6159810|P1|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2513155|NCT00747474|6159799|P12|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2513156|NCT00747474|6159800|P11|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2513157|NCT00747474|6159801|P10|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2513158|NCT00747474|6159802|P9|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2513159|NCT00747474|6159803|P8|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2513160|NCT00747474|6159804|P7|COMPLETED|Cohort 7 (30 mg/m^2) Period||4
2513161|NCT00747474|6159805|P6|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2513162|NCT00747474|6159806|P5|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2513163|NCT00747474|6159807|P4|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2513164|NCT00747474|6159808|P3|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2513165|NCT00747474|6159809|P2|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2513166|NCT00747474|6159810|P1|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
2513167|NCT00747474|6159799|P12|STARTED|Cohort 7 (30 mg/m^2) Period||0
2513168|NCT00747474|6159800|P11|STARTED|Cohort 7 (30 mg/m^2) Period||0
2513169|NCT00747474|6159801|P10|STARTED|Cohort 7 (30 mg/m^2) Period||0
2513170|NCT00747474|6159802|P9|STARTED|Cohort 7 (30 mg/m^2) Period||0
2513171|NCT00747474|6159803|P8|STARTED|Cohort 7 (30 mg/m^2) Period||0
2513172|NCT00747474|6159804|P7|STARTED|Cohort 7 (30 mg/m^2) Period||4
2513173|NCT00747474|6159805|P6|STARTED|Cohort 7 (30 mg/m^2) Period||0
2513174|NCT00747474|6159806|P5|STARTED|Cohort 7 (30 mg/m^2) Period||0
2513175|NCT00747474|6159807|P4|STARTED|Cohort 7 (30 mg/m^2) Period||0
2513176|NCT00747474|6159808|P3|STARTED|Cohort 7 (30 mg/m^2) Period||0
2513177|NCT00747474|6159809|P2|STARTED|Cohort 7 (30 mg/m^2) Period||0
2513178|NCT00747474|6159810|P1|STARTED|Cohort 7 (30 mg/m^2) Period||0
2513179|NCT00747474|6159799|P12|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2513180|NCT00747474|6159800|P11|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2513181|NCT00747474|6159801|P10|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2513182|NCT00747474|6159802|P9|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2513183|NCT00747474|6159803|P8|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2513184|NCT00747474|6159804|P7|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2513185|NCT00747474|6159805|P6|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2513186|NCT00747474|6159806|P5|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2513187|NCT00747474|6159807|P4|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2513188|NCT00747474|6159808|P3|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2513189|NCT00747474|6159809|P2|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2513190|NCT00747474|6159810|P1|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2513191|NCT00747474|6159799|P12|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2513192|NCT00747474|6159800|P11|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2513193|NCT00747474|6159801|P10|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2513194|NCT00747474|6159802|P9|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2513195|NCT00747474|6159803|P8|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2513196|NCT00747474|6159804|P7|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2513197|NCT00747474|6159805|P6|COMPLETED|Cohort 6 (20 mg/m^2) Period||4
2513198|NCT00747474|6159806|P5|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2513199|NCT00747474|6159807|P4|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2513200|NCT00747474|6159808|P3|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2513201|NCT00747474|6159809|P2|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2513202|NCT00747474|6159810|P1|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
2513203|NCT00747474|6159799|P12|STARTED|Cohort 6 (20 mg/m^2) Period||0
2513204|NCT00747474|6159800|P11|STARTED|Cohort 6 (20 mg/m^2) Period||0
2513205|NCT00747474|6159801|P10|STARTED|Cohort 6 (20 mg/m^2) Period||0
2513206|NCT00747474|6159802|P9|STARTED|Cohort 6 (20 mg/m^2) Period||0
2513207|NCT00747474|6159803|P8|STARTED|Cohort 6 (20 mg/m^2) Period||0
2513208|NCT00747474|6159804|P7|STARTED|Cohort 6 (20 mg/m^2) Period||0
2513209|NCT00747474|6159805|P6|STARTED|Cohort 6 (20 mg/m^2) Period||4
2513210|NCT00747474|6159806|P5|STARTED|Cohort 6 (20 mg/m^2) Period||0
2513211|NCT00747474|6159807|P4|STARTED|Cohort 6 (20 mg/m^2) Period||0
2513212|NCT00747474|6159808|P3|STARTED|Cohort 6 (20 mg/m^2) Period||0
2513213|NCT00747474|6159809|P2|STARTED|Cohort 6 (20 mg/m^2) Period||0
2513214|NCT00747474|6159810|P1|STARTED|Cohort 6 (20 mg/m^2) Period||0
2513215|NCT00747474|6159799|P12|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2513216|NCT00747474|6159800|P11|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2513217|NCT00747474|6159801|P10|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2513218|NCT00747474|6159802|P9|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2513219|NCT00747474|6159803|P8|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2513220|NCT00747474|6159804|P7|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2513221|NCT00747474|6159805|P6|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2513222|NCT00747474|6159806|P5|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2513223|NCT00747474|6159807|P4|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2513224|NCT00747474|6159808|P3|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2513225|NCT00747474|6159809|P2|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2513226|NCT00747474|6159810|P1|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2513227|NCT00747474|6159799|P12|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2513228|NCT00747474|6159800|P11|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2513229|NCT00747474|6159801|P10|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2513230|NCT00747474|6159802|P9|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2513231|NCT00747474|6159803|P8|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2513232|NCT00747474|6159804|P7|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2513233|NCT00747474|6159805|P6|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2513234|NCT00747474|6159806|P5|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||4
2513235|NCT00747474|6159807|P4|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2513236|NCT00747474|6159808|P3|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2513237|NCT00747474|6159809|P2|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2513238|NCT00747474|6159810|P1|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
2513239|NCT00747474|6159799|P12|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
2513240|NCT00747474|6159800|P11|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
2513241|NCT00747474|6159801|P10|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
2513242|NCT00747474|6159802|P9|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
2513243|NCT00747474|6159803|P8|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
2513244|NCT00747474|6159804|P7|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
2513245|NCT00747474|6159805|P6|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
2513246|NCT00747474|6159806|P5|STARTED|Cohort 5 (13.5 mg/m^2) Period||4
2513247|NCT00747474|6159807|P4|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
2513248|NCT00747474|6159808|P3|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
2513249|NCT00747474|6159809|P2|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
2513250|NCT00747474|6159810|P1|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
2513251|NCT00747474|6159799|P12|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2513252|NCT00747474|6159800|P11|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2513253|NCT00747474|6159801|P10|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2513254|NCT00747474|6159802|P9|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2513255|NCT00747474|6159803|P8|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2513256|NCT00747474|6159804|P7|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2513257|NCT00747474|6159805|P6|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2513258|NCT00747474|6159806|P5|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2513259|NCT00747474|6159807|P4|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2513260|NCT00747474|6159808|P3|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2513261|NCT00747474|6159809|P2|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2513262|NCT00747474|6159810|P1|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2513263|NCT00747474|6159799|P12|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2513264|NCT00747474|6159800|P11|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2513265|NCT00747474|6159801|P10|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2513266|NCT00747474|6159802|P9|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2513267|NCT00747474|6159803|P8|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2513268|NCT00747474|6159804|P7|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2513269|NCT00747474|6159805|P6|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2513270|NCT00747474|6159806|P5|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2513271|NCT00747474|6159807|P4|COMPLETED|Cohort 4 (9 mg/m^2) Period||4
2513272|NCT00747474|6159808|P3|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2513273|NCT00747474|6159809|P2|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2513274|NCT00747474|6159810|P1|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
2513275|NCT00747474|6159799|P12|STARTED|Cohort 4 (9 mg/m^2) Period||0
2513276|NCT00747474|6159800|P11|STARTED|Cohort 4 (9 mg/m^2) Period||0
2513277|NCT00747474|6159801|P10|STARTED|Cohort 4 (9 mg/m^2) Period||0
2513278|NCT00747474|6159802|P9|STARTED|Cohort 4 (9 mg/m^2) Period||0
2513279|NCT00747474|6159803|P8|STARTED|Cohort 4 (9 mg/m^2) Period||0
2513280|NCT00747474|6159804|P7|STARTED|Cohort 4 (9 mg/m^2) Period||0
2513281|NCT00747474|6159805|P6|STARTED|Cohort 4 (9 mg/m^2) Period||0
2513282|NCT00747474|6159806|P5|STARTED|Cohort 4 (9 mg/m^2) Period||0
2513283|NCT00747474|6159807|P4|STARTED|Cohort 4 (9 mg/m^2) Period||4
2513284|NCT00747474|6159808|P3|STARTED|Cohort 4 (9 mg/m^2) Period||0
2513285|NCT00747474|6159809|P2|STARTED|Cohort 4 (9 mg/m^2) Period||0
2513286|NCT00747474|6159810|P1|STARTED|Cohort 4 (9 mg/m^2) Period||0
2513287|NCT00747474|6159799|P12|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2513288|NCT00747474|6159800|P11|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2513289|NCT00747474|6159801|P10|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2513290|NCT00747474|6159802|P9|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2513291|NCT00747474|6159803|P8|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2513292|NCT00747474|6159804|P7|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2513293|NCT00747474|6159805|P6|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2513294|NCT00747474|6159806|P5|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2513295|NCT00747474|6159807|P4|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2513296|NCT00747474|6159808|P3|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2513297|NCT00747474|6159809|P2|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2513298|NCT00747474|6159810|P1|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2513299|NCT00747474|6159799|P12|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2513300|NCT00747474|6159800|P11|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2513301|NCT00747474|6159801|P10|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2513302|NCT00747474|6159802|P9|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2513303|NCT00747474|6159803|P8|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2513304|NCT00747474|6159804|P7|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2513305|NCT00747474|6159805|P6|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2513306|NCT00747474|6159806|P5|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2513307|NCT00747474|6159807|P4|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2513308|NCT00747474|6159808|P3|COMPLETED|Cohort 3 (6 mg/m^2) Period||3
2513309|NCT00747474|6159809|P2|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2513310|NCT00747474|6159810|P1|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
2513311|NCT00747474|6159799|P12|STARTED|Cohort 3 (6 mg/m^2) Period||0
2513312|NCT00747474|6159800|P11|STARTED|Cohort 3 (6 mg/m^2) Period||0
2513313|NCT00747474|6159801|P10|STARTED|Cohort 3 (6 mg/m^2) Period||0
2513314|NCT00747474|6159802|P9|STARTED|Cohort 3 (6 mg/m^2) Period||0
2513315|NCT00747474|6159803|P8|STARTED|Cohort 3 (6 mg/m^2) Period||0
2513316|NCT00747474|6159804|P7|STARTED|Cohort 3 (6 mg/m^2) Period||0
2513317|NCT00747474|6159805|P6|STARTED|Cohort 3 (6 mg/m^2) Period||0
2513318|NCT00747474|6159806|P5|STARTED|Cohort 3 (6 mg/m^2) Period||0
2513319|NCT00747474|6159807|P4|STARTED|Cohort 3 (6 mg/m^2) Period||0
2513320|NCT00747474|6159808|P3|STARTED|Cohort 3 (6 mg/m^2) Period||3
2513321|NCT00747474|6159809|P2|STARTED|Cohort 3 (6 mg/m^2) Period||0
2513322|NCT00747474|6159810|P1|STARTED|Cohort 3 (6 mg/m^2) Period||0
2513323|NCT00747474|6159799|P12|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2513324|NCT00747474|6159800|P11|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2513325|NCT00747474|6159801|P10|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2513326|NCT00747474|6159802|P9|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2513327|NCT00747474|6159803|P8|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2513328|NCT00747474|6159804|P7|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2513329|NCT00747474|6159805|P6|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2513330|NCT00747474|6159806|P5|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2513331|NCT00747474|6159807|P4|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2513332|NCT00747474|6159808|P3|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2513333|NCT00747474|6159809|P2|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2513334|NCT00747474|6159810|P1|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2513335|NCT00747474|6159799|P12|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2513336|NCT00747474|6159800|P11|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2513337|NCT00747474|6159801|P10|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2513338|NCT00747474|6159802|P9|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2513339|NCT00747474|6159803|P8|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2513340|NCT00747474|6159804|P7|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2513341|NCT00747474|6159805|P6|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2513342|NCT00747474|6159806|P5|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2513343|NCT00747474|6159807|P4|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2513344|NCT00747474|6159808|P3|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2513345|NCT00747474|6159809|P2|COMPLETED|Cohort 2 (3 mg/m^2) Period||4
2513346|NCT00747474|6159810|P1|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
2513347|NCT00747474|6159799|P12|STARTED|Cohort 2 (3 mg/m^2) Period||0
2513348|NCT00747474|6159800|P11|STARTED|Cohort 2 (3 mg/m^2) Period||0
2513349|NCT00747474|6159801|P10|STARTED|Cohort 2 (3 mg/m^2) Period||0
2513350|NCT00747474|6159802|P9|STARTED|Cohort 2 (3 mg/m^2) Period||0
2513351|NCT00747474|6159803|P8|STARTED|Cohort 2 (3 mg/m^2) Period||0
2513352|NCT00747474|6159804|P7|STARTED|Cohort 2 (3 mg/m^2) Period||0
2513353|NCT00747474|6159805|P6|STARTED|Cohort 2 (3 mg/m^2) Period||0
2513354|NCT00747474|6159806|P5|STARTED|Cohort 2 (3 mg/m^2) Period||0
2513355|NCT00747474|6159807|P4|STARTED|Cohort 2 (3 mg/m^2) Period||0
2513356|NCT00747474|6159808|P3|STARTED|Cohort 2 (3 mg/m^2) Period||0
2513357|NCT00747474|6159809|P2|STARTED|Cohort 2 (3 mg/m^2) Period||4
2513358|NCT00747474|6159810|P1|STARTED|Cohort 2 (3 mg/m^2) Period||0
2513359|NCT00747474|6159799|P12|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2513360|NCT00747474|6159800|P11|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2513361|NCT00747474|6159801|P10|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2513362|NCT00747474|6159802|P9|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2513363|NCT00747474|6159803|P8|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2513364|NCT00747474|6159804|P7|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2513365|NCT00747474|6159805|P6|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2513366|NCT00747474|6159806|P5|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2513367|NCT00747474|6159807|P4|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2513368|NCT00747474|6159808|P3|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2513369|NCT00747474|6159809|P2|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2513370|NCT00747474|6159810|P1|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2513371|NCT00747474|6159799|P12|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2513372|NCT00747474|6159800|P11|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2513373|NCT00747474|6159801|P10|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2513374|NCT00747474|6159802|P9|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2513375|NCT00747474|6159803|P8|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2513376|NCT00747474|6159804|P7|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2513377|NCT00747474|6159805|P6|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2513378|NCT00747474|6159806|P5|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2513379|NCT00747474|6159807|P4|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2513380|NCT00747474|6159808|P3|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2513381|NCT00747474|6159809|P2|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
2513382|NCT00747474|6159810|P1|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||3
2513383|NCT00747474|6159799|P12|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
2513384|NCT00747474|6159800|P11|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
2513385|NCT00747474|6159801|P10|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
2513386|NCT00747474|6159802|P9|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
2513387|NCT00747474|6159803|P8|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
2513388|NCT00747474|6159804|P7|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
2513389|NCT00747474|6159805|P6|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
2513390|NCT00747474|6159806|P5|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
2513391|NCT00747474|6159807|P4|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
2513392|NCT00747474|6159808|P3|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
2513393|NCT00747474|6159809|P2|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
2513394|NCT00747474|6159810|P1|STARTED|Cohort 1 (1.5 mg/m^2) Period||3
2513395|NCT00747461|6159836|P1|NOT COMPLETED|Overall Study||5
2513396|NCT00747461|6159836|P1|COMPLETED|Overall Study||0
2513397|NCT00747461|6159836|P1|STARTED|Overall Study||5
2513398|NCT00747435|6159841|P1|NOT COMPLETED|Overall Study||6
2513399|NCT00747435|6159841|P1|COMPLETED|Overall Study||67
2513400|NCT00747435|6159841|P1|STARTED|Overall Study||73
2513401|NCT00747344|6159851|P4|NOT COMPLETED|After Controlled Period||1
2513402|NCT00747344|6159852|P3|NOT COMPLETED|After Controlled Period||0
2513403|NCT00747344|6159853|P2|NOT COMPLETED|After Controlled Period||0
2513404|NCT00747344|6159854|P1|NOT COMPLETED|After Controlled Period||0
2513405|NCT00747344|6159851|P4|COMPLETED|After Controlled Period||56
2513406|NCT00747344|6159852|P3|COMPLETED|After Controlled Period||55
2513407|NCT00747344|6159853|P2|COMPLETED|After Controlled Period||0
2513408|NCT00747344|6159854|P1|COMPLETED|After Controlled Period||0
2513409|NCT00747344|6159851|P4|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|57
2513410|NCT00747344|6159852|P3|STARTED|After Controlled Period||55
2513411|NCT00747344|6159853|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
2513412|NCT00747344|6159854|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
2513413|NCT00747344|6159851|P4|NOT COMPLETED|Controlled Period||0
2513414|NCT00747344|6159852|P3|NOT COMPLETED|Controlled Period||0
2513415|NCT00747344|6159853|P2|NOT COMPLETED|Controlled Period||4
2513416|NCT00747344|6159854|P1|NOT COMPLETED|Controlled Period||5
2513417|NCT00747344|6159851|P4|COMPLETED|Controlled Period||0
2513418|NCT00747344|6159852|P3|COMPLETED|Controlled Period||0
2513419|NCT00747344|6159853|P2|COMPLETED|Controlled Period||57
2513420|NCT00747344|6159854|P1|COMPLETED|Controlled Period||55
2513421|NCT00747344|6159851|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
2513422|NCT00747344|6159852|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
2513423|NCT00747344|6159853|P2|STARTED|Controlled Period||61
2513424|NCT00747344|6159854|P1|STARTED|Controlled Period||60
2513425|NCT00747227|6159868|P2|NOT COMPLETED|Overall Study||4
2513426|NCT00747227|6159869|P1|NOT COMPLETED|Overall Study||6
2513427|NCT00747227|6159868|P2|COMPLETED|Overall Study||120
2513428|NCT00747227|6159869|P1|COMPLETED|Overall Study||120
2513429|NCT00747227|6159868|P2|STARTED|Overall Study||124
2513430|NCT00747227|6159869|P1|STARTED|Overall Study||126
2513431|NCT00747214|6159883|P2|NOT COMPLETED|Overall Study||3
2513432|NCT00747214|6159884|P1|NOT COMPLETED|Overall Study||8
2513433|NCT00747214|6159883|P2|COMPLETED|Overall Study||29
2513434|NCT00747214|6159884|P1|COMPLETED|Overall Study||19
2513435|NCT00747214|6159883|P2|STARTED|Overall Study||32
2513436|NCT00747214|6159884|P1|STARTED|Overall Study||27
2513437|NCT00747149|6159898|P2|NOT COMPLETED|Overall Study||43
2513438|NCT00747149|6159899|P1|NOT COMPLETED|Overall Study||1
2513439|NCT00747149|6159898|P2|COMPLETED|Overall Study||401
2513440|NCT00747149|6159899|P1|COMPLETED|Overall Study||153
2513441|NCT00747149|6159898|P2|STARTED|Overall Study||444
2513442|NCT00747149|6159899|P1|STARTED|Overall Study||154
2513443|NCT00747006|6159914|P3|NOT COMPLETED|Overall Study||1
2513444|NCT00747006|6159915|P2|NOT COMPLETED|Overall Study||1
2513445|NCT00747006|6159916|P1|NOT COMPLETED|Overall Study||3
2513446|NCT00747006|6159914|P3|COMPLETED|Overall Study||2
2513447|NCT00747006|6159915|P2|COMPLETED|Overall Study||7
2513448|NCT00747006|6159916|P1|COMPLETED|Overall Study||4
2513449|NCT00747006|6159914|P3|STARTED|Overall Study||3
2513450|NCT00747006|6159915|P2|STARTED|Overall Study||8
2513451|NCT00747006|6159916|P1|STARTED|Overall Study||7
2513452|NCT00746954|6159982|P3|NOT COMPLETED|Overall Study||0
2513453|NCT00746954|6159983|P2|NOT COMPLETED|Overall Study||0
2513454|NCT00746954|6159984|P1|NOT COMPLETED|Overall Study||0
2513455|NCT00746954|6159982|P3|COMPLETED|Overall Study||2
2513456|NCT00746954|6159983|P2|COMPLETED|Overall Study||3
2513457|NCT00746954|6159984|P1|COMPLETED|Overall Study||3
2513458|NCT00746954|6159982|P3|STARTED|Overall Study||2
2513459|NCT00746954|6159983|P2|STARTED|Overall Study||3
2513460|NCT00746954|6159984|P1|STARTED|Overall Study||3
2513461|NCT00746941|6159994|P4|NOT COMPLETED|Overall Study||13
2513462|NCT00746941|6159995|P3|NOT COMPLETED|Overall Study||2
2513463|NCT00746941|6159996|P2|NOT COMPLETED|Overall Study||4
2513464|NCT00746941|6159997|P1|NOT COMPLETED|Overall Study||7
2513465|NCT00746941|6159994|P4|COMPLETED|Overall Study||7
2513466|NCT00746941|6159995|P3|COMPLETED|Overall Study||3
2513467|NCT00746941|6159996|P2|COMPLETED|Overall Study||1
2513468|NCT00746941|6159997|P1|COMPLETED|Overall Study||0
2513469|NCT00746941|6159994|P4|STARTED|Overall Study||20
2513470|NCT00746941|6159995|P3|STARTED|Overall Study||5
2513471|NCT00746941|6159996|P2|STARTED|Overall Study||5
2513472|NCT00746941|6159997|P1|STARTED|Overall Study||7
2513473|NCT00746889|6160025|P2|NOT COMPLETED|Overall Study||4
2513474|NCT00746889|6160026|P1|NOT COMPLETED|Overall Study||4
2513475|NCT00746889|6160025|P2|COMPLETED|Overall Study||35
2513476|NCT00746889|6160026|P1|COMPLETED|Overall Study||36
2513477|NCT00746889|6160025|P2|STARTED|Overall Study||39
2513478|NCT00746889|6160026|P1|STARTED|Overall Study||40
2513479|NCT00746863|6160036|P2|NOT COMPLETED|Overall Study||0
2513480|NCT00746863|6160037|P1|NOT COMPLETED|Overall Study||0
2513481|NCT00746863|6160036|P2|COMPLETED|Overall Study||21
2513482|NCT00746863|6160037|P1|COMPLETED|Overall Study||21
2513483|NCT00746863|6160036|P2|STARTED|Overall Study||21
2513484|NCT00746863|6160037|P1|STARTED|Overall Study||21
2513485|NCT00746798|6160055|P4|NOT COMPLETED|Overall Study||0
2513486|NCT00746798|6160056|P3|NOT COMPLETED|Overall Study||3
2513487|NCT00746798|6160057|P2|NOT COMPLETED|Overall Study||2
2513488|NCT00746798|6160058|P1|NOT COMPLETED|Overall Study||1
2513489|NCT00746798|6160055|P4|COMPLETED|Overall Study||120
2513490|NCT00746798|6160056|P3|COMPLETED|Overall Study||110
2513491|NCT00746798|6160057|P2|COMPLETED|Overall Study||122
2513492|NCT00746798|6160058|P1|COMPLETED|Overall Study||121
2513493|NCT00746798|6160055|P4|STARTED|Overall Study||120
2513494|NCT00746798|6160056|P3|STARTED|Overall Study||113
2513495|NCT00746798|6160057|P2|STARTED|Overall Study||124
2513496|NCT00746798|6160058|P1|STARTED|Overall Study||122
2513497|NCT00746785|6160083|P3|NOT COMPLETED|Overall Study||27
2513498|NCT00746785|6160084|P2|NOT COMPLETED|Overall Study||25
2513499|NCT00746785|6160085|P1|NOT COMPLETED|Overall Study||29
2513500|NCT00746785|6160083|P3|COMPLETED|Overall Study||13
2513501|NCT00746785|6160084|P2|COMPLETED|Overall Study||21
2513502|NCT00746785|6160085|P1|COMPLETED|Overall Study||14
2513503|NCT00746785|6160083|P3|STARTED|Overall Study||40
2513504|NCT00746785|6160084|P2|STARTED|Overall Study||46
2513505|NCT00746785|6160085|P1|STARTED|Overall Study||43
2513506|NCT00746733|6160093|P2|NOT COMPLETED|Fourth Intervention||0
2513507|NCT00746733|6160094|P1|NOT COMPLETED|Fourth Intervention||0
2513508|NCT00746733|6160093|P2|COMPLETED|Fourth Intervention||11
2513509|NCT00746733|6160094|P1|COMPLETED|Fourth Intervention||10
2513510|NCT00746733|6160093|P2|STARTED|Fourth Intervention||11
2513511|NCT00746733|6160094|P1|STARTED|Fourth Intervention||10
2513512|NCT00746733|6160093|P2|NOT COMPLETED|Third Intervention||1
2513513|NCT00746733|6160094|P1|NOT COMPLETED|Third Intervention||1
2513514|NCT00746733|6160093|P2|COMPLETED|Third Intervention||11
2513515|NCT00746733|6160094|P1|COMPLETED|Third Intervention||10
2513516|NCT00746733|6160093|P2|STARTED|Third Intervention||12
2513517|NCT00746733|6160094|P1|STARTED|Third Intervention||11
2513518|NCT00746733|6160093|P2|NOT COMPLETED|Second Intervention||0
2513519|NCT00746733|6160094|P1|NOT COMPLETED|Second Intervention||1
2513520|NCT00746733|6160093|P2|COMPLETED|Second Intervention||12
2513521|NCT00746733|6160094|P1|COMPLETED|Second Intervention||11
2513522|NCT00746733|6160093|P2|STARTED|Second Intervention||12
2513523|NCT00746733|6160094|P1|STARTED|Second Intervention||12
2513524|NCT00746733|6160093|P2|NOT COMPLETED|First Intervention||0
2513525|NCT00746733|6160094|P1|NOT COMPLETED|First Intervention||0
2513526|NCT00746733|6160093|P2|COMPLETED|First Intervention||12
2513527|NCT00746733|6160094|P1|COMPLETED|First Intervention||12
2513528|NCT00746733|6160093|P2|STARTED|First Intervention||12
2513529|NCT00746733|6160094|P1|STARTED|First Intervention||12
2513530|NCT00746694|6160154|P1|NOT COMPLETED|Overall Study||0
2513531|NCT00746694|6160154|P1|COMPLETED|Overall Study||154
2513532|NCT00746694|6160154|P1|STARTED|Overall Study||154
2513533|NCT00746668|6160159|P7|NOT COMPLETED|Overall Study||0
2513534|NCT00746668|6160160|P6|NOT COMPLETED|Overall Study||0
2513535|NCT00746668|6160161|P5|NOT COMPLETED|Overall Study||0
2513536|NCT00746668|6160162|P4|NOT COMPLETED|Overall Study||0
2513537|NCT00746668|6160163|P3|NOT COMPLETED|Overall Study||0
2513538|NCT00746668|6160164|P2|NOT COMPLETED|Overall Study||0
2513539|NCT00746668|6160165|P1|NOT COMPLETED|Overall Study||0
2513540|NCT00746668|6160159|P7|COMPLETED|Overall Study||5
2513541|NCT00746668|6160160|P6|COMPLETED|Overall Study||5
2513542|NCT00746668|6160161|P5|COMPLETED|Overall Study||5
2513543|NCT00746668|6160162|P4|COMPLETED|Overall Study||5
2513544|NCT00746668|6160163|P3|COMPLETED|Overall Study||5
2513545|NCT00746668|6160164|P2|COMPLETED|Overall Study||5
2513546|NCT00746668|6160165|P1|COMPLETED|Overall Study||6
2513547|NCT00746668|6160159|P7|STARTED|Overall Study||5
2513548|NCT00746668|6160160|P6|STARTED|Overall Study||5
2513549|NCT00746668|6160161|P5|STARTED|Overall Study||5
2513550|NCT00746668|6160162|P4|STARTED|Overall Study||5
2513551|NCT00746668|6160163|P3|STARTED|Overall Study||5
2513552|NCT00746668|6160164|P2|STARTED|Overall Study||5
2513553|NCT00746668|6160165|P1|STARTED|Overall Study||6
2513554|NCT00746590|6160178|P1|NOT COMPLETED|Overall Study||1
2513555|NCT00746590|6160178|P1|COMPLETED|Overall Study||0
2513556|NCT00746590|6160178|P1|STARTED|Overall Study||1
2513557|NCT00746564|6160182|P1|NOT COMPLETED|Overall Study||2
2513558|NCT00746564|6160182|P1|COMPLETED|Overall Study||73
2513559|NCT00746564|6160182|P1|STARTED|Overall Study||75
2513560|NCT00746551|6160197|P2|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
2513561|NCT00746551|6160198|P1|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
2513562|NCT00746551|6160197|P2|COMPLETED|At Delivery (GA of 39 Weeks)||25
2513563|NCT00746551|6160198|P1|COMPLETED|At Delivery (GA of 39 Weeks)||25
2513564|NCT00746551|6160197|P2|STARTED|At Delivery (GA of 39 Weeks)||40
2513565|NCT00746551|6160198|P1|STARTED|At Delivery (GA of 39 Weeks)||40
2513566|NCT00746551|6160197|P2|NOT COMPLETED|At Gestational Age of 36 Weeks||4
2513567|NCT00746551|6160198|P1|NOT COMPLETED|At Gestational Age of 36 Weeks||2
2513568|NCT00746551|6160197|P2|COMPLETED|At Gestational Age of 36 Weeks||36
2513569|NCT00746551|6160198|P1|COMPLETED|At Gestational Age of 36 Weeks||38
2513570|NCT00746551|6160197|P2|STARTED|At Gestational Age of 36 Weeks||40
2513571|NCT00746551|6160198|P1|STARTED|At Gestational Age of 36 Weeks||40
2513572|NCT00746512|6160210|P4|NOT COMPLETED|Overall Study||0
2513573|NCT00746512|6160211|P3|NOT COMPLETED|Overall Study||0
2513574|NCT00746512|6160212|P2|NOT COMPLETED|Overall Study||0
2513575|NCT00746512|6160213|P1|NOT COMPLETED|Overall Study||0
2513576|NCT00746512|6160210|P4|COMPLETED|Overall Study||9
2513577|NCT00746512|6160211|P3|COMPLETED|Overall Study||18
2513578|NCT00746512|6160212|P2|COMPLETED|Overall Study||10
2513579|NCT00746512|6160213|P1|COMPLETED|Overall Study||8
2513580|NCT00746512|6160210|P4|STARTED|Overall Study||9
2513581|NCT00746512|6160211|P3|STARTED|Overall Study||18
2513582|NCT00746512|6160212|P2|STARTED|Overall Study||10
2513583|NCT00746512|6160213|P1|STARTED|Overall Study||8
2513584|NCT00746421|6160229|P2|NOT COMPLETED|Overall Study||2
2513585|NCT00746421|6160230|P1|NOT COMPLETED|Overall Study||7
2513586|NCT00746421|6160229|P2|COMPLETED|Overall Study||9
2513587|NCT00746421|6160230|P1|COMPLETED|Overall Study||5
2513588|NCT00746421|6160229|P2|STARTED|Overall Study||11
2513589|NCT00746421|6160230|P1|STARTED|Overall Study||12
2513590|NCT00746395|6160240|P2|NOT COMPLETED|Overall Study||0
2513591|NCT00746395|6160241|P1|NOT COMPLETED|Overall Study||0
2513592|NCT00746395|6160240|P2|COMPLETED|Overall Study||20
2513593|NCT00746395|6160241|P1|COMPLETED|Overall Study||20
2513594|NCT00746395|6160240|P2|STARTED|Overall Study||20
2513595|NCT00746395|6160241|P1|STARTED|Overall Study||20
2513596|NCT00746356|6160249|P2|NOT COMPLETED|Overall Study||7
2513597|NCT00746356|6160250|P1|NOT COMPLETED|Overall Study||11
2513598|NCT00746356|6160249|P2|COMPLETED|Overall Study||40
2513599|NCT00746356|6160250|P1|COMPLETED|Overall Study||70
2513600|NCT00746356|6160249|P2|STARTED|Overall Study||47
2513601|NCT00746356|6160250|P1|STARTED|Overall Study||81
2513602|NCT00746330|6160262|P4|NOT COMPLETED|Period 4||0
2513603|NCT00746330|6160263|P3|NOT COMPLETED|Period 4||0
2513604|NCT00746330|6160264|P2|NOT COMPLETED|Period 4||0
2513605|NCT00746330|6160265|P1|NOT COMPLETED|Period 4||0
2513606|NCT00746330|6160262|P4|COMPLETED|Period 4||7
2513607|NCT00746330|6160263|P3|COMPLETED|Period 4||8
2513608|NCT00746330|6160264|P2|COMPLETED|Period 4||9
2513609|NCT00746330|6160265|P1|COMPLETED|Period 4||7
2513610|NCT00746330|6160262|P4|STARTED|Period 4||7
2513611|NCT00746330|6160263|P3|STARTED|Period 4||8
2513612|NCT00746330|6160264|P2|STARTED|Period 4||9
2513613|NCT00746330|6160265|P1|STARTED|Period 4||7
2513614|NCT00746330|6160262|P4|NOT COMPLETED|Period 3||0
2513615|NCT00746330|6160263|P3|NOT COMPLETED|Period 3||0
2513616|NCT00746330|6160264|P2|NOT COMPLETED|Period 3||0
2513617|NCT00746330|6160265|P1|NOT COMPLETED|Period 3||0
2513618|NCT00746330|6160262|P4|COMPLETED|Period 3||7
2513619|NCT00746330|6160263|P3|COMPLETED|Period 3||8
2513620|NCT00746330|6160264|P2|COMPLETED|Period 3||9
2513621|NCT00746330|6160265|P1|COMPLETED|Period 3||7
2513622|NCT00746330|6160262|P4|STARTED|Period 3||7
2513623|NCT00746330|6160263|P3|STARTED|Period 3||8
2513624|NCT00746330|6160264|P2|STARTED|Period 3||9
2513625|NCT00746330|6160265|P1|STARTED|Period 3||7
2513626|NCT00746330|6160262|P4|NOT COMPLETED|Period 2||0
2513627|NCT00746330|6160263|P3|NOT COMPLETED|Period 2||0
2513628|NCT00746330|6160264|P2|NOT COMPLETED|Period 2||0
2513629|NCT00746330|6160265|P1|NOT COMPLETED|Period 2||0
2513630|NCT00746330|6160262|P4|COMPLETED|Period 2||7
2513631|NCT00746330|6160263|P3|COMPLETED|Period 2||8
2513632|NCT00746330|6160264|P2|COMPLETED|Period 2||9
2513633|NCT00746330|6160265|P1|COMPLETED|Period 2||7
2513634|NCT00746330|6160262|P4|STARTED|Period 2||7
2513635|NCT00746330|6160263|P3|STARTED|Period 2||8
2513636|NCT00746330|6160264|P2|STARTED|Period 2||9
2513637|NCT00746330|6160265|P1|STARTED|Period 2||7
2513638|NCT00746330|6160262|P4|NOT COMPLETED|Period 1||0
2513639|NCT00746330|6160263|P3|NOT COMPLETED|Period 1||1
2513640|NCT00746330|6160264|P2|NOT COMPLETED|Period 1||0
2513641|NCT00746330|6160265|P1|NOT COMPLETED|Period 1||0
2513642|NCT00746330|6160262|P4|COMPLETED|Period 1||7
2513643|NCT00746330|6160263|P3|COMPLETED|Period 1||8
2513644|NCT00746330|6160264|P2|COMPLETED|Period 1||9
2513645|NCT00746330|6160265|P1|COMPLETED|Period 1||7
2513646|NCT00746330|6160262|P4|STARTED|Period 1||7
2513647|NCT00746330|6160263|P3|STARTED|Period 1||9
2513648|NCT00746330|6160264|P2|STARTED|Period 1||9
2513649|NCT00746330|6160265|P1|STARTED|Period 1||7
2513650|NCT00746252|6160295|P2|NOT COMPLETED|Overall Study||2
2513651|NCT00746252|6160296|P1|NOT COMPLETED|Overall Study||1
2513652|NCT00746252|6160295|P2|COMPLETED|Overall Study||0
2513653|NCT00746252|6160296|P1|COMPLETED|Overall Study||0
2513654|NCT00746252|6160295|P2|STARTED|Overall Study||2
2513655|NCT00746252|6160296|P1|STARTED|Overall Study||1
2513656|NCT00746239|6160302|P1|NOT COMPLETED|Overall Study||6
2513657|NCT00746239|6160302|P1|COMPLETED|Overall Study|11 subjects total were enrolled - 6 withdrew from study and 5 competed|5
2513658|NCT00746239|6160302|P1|STARTED|Overall Study||11
2513659|NCT00746187|6160309|P2|NOT COMPLETED|Overall Study||2
2513660|NCT00746187|6160310|P1|NOT COMPLETED|Overall Study||3
2513661|NCT00746187|6160309|P2|COMPLETED|Overall Study||16
2513662|NCT00746187|6160310|P1|COMPLETED|Overall Study||15
2513663|NCT00746187|6160309|P2|STARTED|Overall Study||18
2513664|NCT00746187|6160310|P1|STARTED|Overall Study||18
2513665|NCT00746122|6160318|P2|NOT COMPLETED|Overall Study||0
2513666|NCT00746122|6160319|P1|NOT COMPLETED|Overall Study||0
2513667|NCT00746122|6160318|P2|COMPLETED|Overall Study||316
2513668|NCT00746122|6160319|P1|COMPLETED|Overall Study||297
2513669|NCT00746122|6160318|P2|STARTED|Overall Study|After 600 recruitment target 13 more patients were randomised before sites could be closed down.|316
2513670|NCT00746122|6160319|P1|STARTED|Overall Study||297
2513671|NCT00746096|6160331|P2|NOT COMPLETED|Overall Study||3
2513672|NCT00746096|6160332|P1|NOT COMPLETED|Overall Study||10
2513673|NCT00746096|6160331|P2|COMPLETED|Overall Study||54
2513674|NCT00746096|6160332|P1|COMPLETED|Overall Study||48
2513675|NCT00746096|6160331|P2|STARTED|Overall Study||57
2513676|NCT00746096|6160332|P1|STARTED|Overall Study||58
2513677|NCT00746018|6160340|P1|NOT COMPLETED|Overall Study||0
2513678|NCT00746018|6160340|P1|COMPLETED|Overall Study||39
2513679|NCT00746018|6160340|P1|STARTED|Overall Study||39
2513680|NCT00745940|6160346|P2|NOT COMPLETED|Overall Study||10
2513681|NCT00745940|6160347|P1|NOT COMPLETED|Overall Study||19
2513682|NCT00745940|6160346|P2|COMPLETED|Overall Study||38
2513683|NCT00745940|6160347|P1|COMPLETED|Overall Study||38
2513684|NCT00745940|6160346|P2|STARTED|Overall Study||48
2513685|NCT00745940|6160347|P1|STARTED|Overall Study||57
2513686|NCT00745901|6160363|P2|NOT COMPLETED|Overall Study||21
2513687|NCT00745901|6160364|P1|NOT COMPLETED|Overall Study||24
2513688|NCT00745901|6160363|P2|COMPLETED|Overall Study||156
2513689|NCT00745901|6160364|P1|COMPLETED|Overall Study||154
2513690|NCT00745901|6160363|P2|STARTED|Overall Study|Number of Patients Randomized|177
2513691|NCT00745901|6160364|P1|STARTED|Overall Study|Number of Patients Randomized|178
2513692|NCT00745875|6160410|P2|NOT COMPLETED|Overall Study||4
2513693|NCT00745875|6160411|P1|NOT COMPLETED|Overall Study||4
2513694|NCT00745875|6160410|P2|COMPLETED|Overall Study|Completed – Number of patients discontinued study treatment at data cut-off (17th January 2010)|26
2513695|NCT00745875|6160411|P1|COMPLETED|Overall Study|Completed – Number of patients discontinued study treatment at data cut-off (17th January 2010)|32
2513696|NCT00745875|6160410|P2|STARTED|Overall Study|Started – Number of patients randomised|30
2513697|NCT00745875|6160411|P1|STARTED|Overall Study|Started – Number of patients randomised|36
2513698|NCT00745849|6160419|P2|NOT COMPLETED|Second Intervention||1
2513699|NCT00745849|6160420|P1|NOT COMPLETED|Second Intervention||2
2513700|NCT00745849|6160419|P2|COMPLETED|Second Intervention||19
2513701|NCT00745849|6160420|P1|COMPLETED|Second Intervention||18
2513702|NCT00745849|6160419|P2|STARTED|Second Intervention||20
2513703|NCT00745849|6160420|P1|STARTED|Second Intervention||20
2513704|NCT00745849|6160419|P2|NOT COMPLETED|Washout Period||0
2513705|NCT00745849|6160420|P1|NOT COMPLETED|Washout Period||0
2513706|NCT00745849|6160419|P2|COMPLETED|Washout Period||20
2513707|NCT00745849|6160420|P1|COMPLETED|Washout Period||20
2513708|NCT00745849|6160419|P2|STARTED|Washout Period||20
2513709|NCT00745849|6160420|P1|STARTED|Washout Period||20
2513710|NCT00745849|6160419|P2|NOT COMPLETED|First Intervention||2
2513711|NCT00745849|6160420|P1|NOT COMPLETED|First Intervention||1
2513712|NCT00745849|6160419|P2|COMPLETED|First Intervention||20
2513713|NCT00745849|6160420|P1|COMPLETED|First Intervention||20
2513714|NCT00745849|6160419|P2|STARTED|First Intervention||22
2513715|NCT00745849|6160420|P1|STARTED|First Intervention||21
2513716|NCT00745823|6160428|P2|NOT COMPLETED|Overall Study||386
2513717|NCT00745823|6160429|P1|NOT COMPLETED|Overall Study||385
2513718|NCT00745823|6160428|P2|COMPLETED|Overall Study||3
2513719|NCT00745823|6160429|P1|COMPLETED|Overall Study||1
2513720|NCT00745823|6160428|P2|TREATED Week 0 - 96|Overall Study||388
2513721|NCT00745823|6160429|P1|TREATED Week 0 - 96|Overall Study||382
2513722|NCT00745823|6160428|P2|STARTED|Overall Study||389
2513723|NCT00745823|6160429|P1|STARTED|Overall Study||386
2513724|NCT00745615|6160457|P6|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||108
2513725|NCT00745615|6160458|P5|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||91
2513726|NCT00745615|6160459|P4|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
2513727|NCT00745615|6160460|P3|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
2513728|NCT00745615|6160461|P2|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
2513729|NCT00745615|6160462|P1|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
2513730|NCT00745615|6160457|P6|COMPLETED|Open-Label (up to Approx 10.5 Years)||5
2513731|NCT00745615|6160458|P5|COMPLETED|Open-Label (up to Approx 10.5 Years)||5
2513732|NCT00745615|6160459|P4|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
2513733|NCT00745615|6160460|P3|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
2513734|NCT00745615|6160461|P2|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
2513824|NCT00744978|6160627|P1|NOT COMPLETED|Placebo Washout||0
2513735|NCT00745615|6160462|P1|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
2513736|NCT00745615|6160457|P6|STARTED|Open-Label (up to Approx 10.5 Years)||113
2513737|NCT00745615|6160458|P5|STARTED|Open-Label (up to Approx 10.5 Years)||96
2513738|NCT00745615|6160459|P4|STARTED|Open-Label (up to Approx 10.5 Years)||0
2513739|NCT00745615|6160460|P3|STARTED|Open-Label (up to Approx 10.5 Years)||0
2513740|NCT00745615|6160461|P2|STARTED|Open-Label (up to Approx 10.5 Years)||0
2513741|NCT00745615|6160462|P1|STARTED|Open-Label (up to Approx 10.5 Years)||0
2513742|NCT00745615|6160457|P6|NOT COMPLETED|Double-Blind Extension (36 Weeks)||0
2513743|NCT00745615|6160458|P5|NOT COMPLETED|Double-Blind Extension (36 Weeks)||0
2513744|NCT00745615|6160459|P4|NOT COMPLETED|Double-Blind Extension (36 Weeks)||5
2513745|NCT00745615|6160460|P3|NOT COMPLETED|Double-Blind Extension (36 Weeks)||1
2513746|NCT00745615|6160461|P2|NOT COMPLETED|Double-Blind Extension (36 Weeks)||7
2513747|NCT00745615|6160462|P1|NOT COMPLETED|Double-Blind Extension (36 Weeks)||5
2513748|NCT00745615|6160457|P6|COMPLETED|Double-Blind Extension (36 Weeks)||0
2513749|NCT00745615|6160458|P5|COMPLETED|Double-Blind Extension (36 Weeks)||0
2513750|NCT00745615|6160459|P4|COMPLETED|Double-Blind Extension (36 Weeks)||39
2513751|NCT00745615|6160460|P3|COMPLETED|Double-Blind Extension (36 Weeks)||38
2513752|NCT00745615|6160461|P2|COMPLETED|Double-Blind Extension (36 Weeks)||87
2513753|NCT00745615|6160462|P1|COMPLETED|Double-Blind Extension (36 Weeks)||75
2513754|NCT00745615|6160457|P6|STARTED|Double-Blind Extension (36 Weeks)||0
2513755|NCT00745615|6160458|P5|STARTED|Double-Blind Extension (36 Weeks)||0
2513756|NCT00745615|6160459|P4|STARTED|Double-Blind Extension (36 Weeks)||44
2513757|NCT00745615|6160460|P3|STARTED|Double-Blind Extension (36 Weeks)||39
2513758|NCT00745615|6160461|P2|STARTED|Double-Blind Extension (36 Weeks)||94
2513759|NCT00745615|6160462|P1|STARTED|Double-Blind Extension (36 Weeks)||80
2513760|NCT00745498|6160511|P3|NOT COMPLETED|Overall Study||8
2513761|NCT00745498|6160512|P2|NOT COMPLETED|Overall Study||6
2513762|NCT00745498|6160513|P1|NOT COMPLETED|Overall Study||5
2513763|NCT00745498|6160511|P3|COMPLETED|Overall Study||34
2513764|NCT00745498|6160512|P2|COMPLETED|Overall Study||37
2513765|NCT00745498|6160513|P1|COMPLETED|Overall Study||36
2513766|NCT00745498|6160511|P3|STARTED|Overall Study||42
2513767|NCT00745498|6160512|P2|STARTED|Overall Study||43
2513768|NCT00745498|6160513|P1|STARTED|Overall Study||41
2513769|NCT00745420|6160527|P1|NOT COMPLETED|Overall Study||1
2513770|NCT00745420|6160527|P1|COMPLETED|Overall Study||29
2513771|NCT00745420|6160527|P1|STARTED|Overall Study||30
2513772|NCT00745368|6160544|P1|NOT COMPLETED|Overall Study||3
2513773|NCT00745368|6160544|P1|COMPLETED|Overall Study|3 male subjects were unable to provide a sample and are not included in the results|16
2513774|NCT00745368|6160544|P1|STARTED|Overall Study|Of the 28 subjects who enrolled, 19 participated in a study visit|19
2513775|NCT00745290|6160557|P2|NOT COMPLETED|Overall Study||0
2513776|NCT00745290|6160558|P1|NOT COMPLETED|Overall Study||0
2513777|NCT00745290|6160557|P2|COMPLETED|Overall Study||122
2513778|NCT00745290|6160558|P1|COMPLETED|Overall Study||123
2513779|NCT00745290|6160557|P2|STARTED|Overall Study||122
2513780|NCT00745290|6160558|P1|STARTED|Overall Study||123
2513781|NCT00745251|6160566|P2|NOT COMPLETED|Overall Study||3
2513782|NCT00745251|6160567|P1|NOT COMPLETED|Overall Study||2
2513783|NCT00745251|6160566|P2|COMPLETED|Overall Study||19
2513784|NCT00745251|6160567|P1|COMPLETED|Overall Study||21
2513785|NCT00745251|6160566|P2|STARTED|Overall Study||22
2513786|NCT00745251|6160567|P1|STARTED|Overall Study||23
2513787|NCT00745121|6160577|P2|NOT COMPLETED|Overall Study||2
2513788|NCT00745121|6160578|P1|NOT COMPLETED|Overall Study||9
2513789|NCT00745121|6160577|P2|COMPLETED|Overall Study||26
2513790|NCT00745121|6160578|P1|COMPLETED|Overall Study||11
2513791|NCT00745121|6160577|P2|STARTED|Overall Study||28
2513792|NCT00745121|6160578|P1|STARTED|Overall Study||20
2513793|NCT00745095|6160590|P6|NOT COMPLETED|Overall Study||123
2513794|NCT00745095|6160591|P5|NOT COMPLETED|Overall Study||122
2513795|NCT00745095|6160592|P4|NOT COMPLETED|Overall Study||3
2513796|NCT00745095|6160593|P3|NOT COMPLETED|Overall Study||3
2513797|NCT00745095|6160594|P2|NOT COMPLETED|Overall Study||2
2513798|NCT00745095|6160595|P1|NOT COMPLETED|Overall Study||1
2513799|NCT00745095|6160590|P6|COMPLETED|Overall Study||27
2513800|NCT00745095|6160591|P5|COMPLETED|Overall Study||28
2513801|NCT00745095|6160592|P4|COMPLETED|Overall Study||12
2513802|NCT00745095|6160593|P3|COMPLETED|Overall Study||12
2513803|NCT00745095|6160594|P2|COMPLETED|Overall Study||13
2513804|NCT00745095|6160595|P1|COMPLETED|Overall Study||14
2513805|NCT00745095|6160590|P6|STARTED|Overall Study||150
2513806|NCT00745095|6160591|P5|STARTED|Overall Study||150
2513807|NCT00745095|6160592|P4|STARTED|Overall Study||15
2513808|NCT00745095|6160593|P3|STARTED|Overall Study||15
2513809|NCT00745095|6160594|P2|STARTED|Overall Study||15
2513810|NCT00745095|6160595|P1|STARTED|Overall Study||15
2513811|NCT00745030|6160617|P2|NOT COMPLETED|Overall Study||0
2513812|NCT00745030|6160618|P1|NOT COMPLETED|Overall Study||0
2513813|NCT00745030|6160617|P2|COMPLETED|Overall Study||2
2513814|NCT00745030|6160618|P1|COMPLETED|Overall Study||1
2513815|NCT00745030|6160617|P2|STARTED|Overall Study||2
2513816|NCT00745030|6160618|P1|STARTED|Overall Study||1
2513817|NCT00744978|6160626|P2|NOT COMPLETED|Period 2||1
2513818|NCT00744978|6160627|P1|NOT COMPLETED|Period 2||0
2513819|NCT00744978|6160626|P2|COMPLETED|Period 2||28
2513820|NCT00744978|6160627|P1|COMPLETED|Period 2||26
2513821|NCT00744978|6160626|P2|STARTED|Period 2||29
2513822|NCT00744978|6160627|P1|STARTED|Period 2||26
2513823|NCT00744978|6160626|P2|NOT COMPLETED|Placebo Washout||0
2513825|NCT00744978|6160626|P2|COMPLETED|Placebo Washout||29
2513826|NCT00744978|6160627|P1|COMPLETED|Placebo Washout||26
2513827|NCT00744978|6160626|P2|STARTED|Placebo Washout||29
2513828|NCT00744978|6160627|P1|STARTED|Placebo Washout||26
2513829|NCT00744978|6160626|P2|NOT COMPLETED|Period 1||5
2513830|NCT00744978|6160627|P1|NOT COMPLETED|Period 1||6
2513831|NCT00744978|6160626|P2|COMPLETED|Period 1||29
2513832|NCT00744978|6160627|P1|COMPLETED|Period 1||26
2513833|NCT00744978|6160626|P2|Treated|Period 1||33
2513834|NCT00744978|6160627|P1|Treated|Period 1||31
2513835|NCT00744978|6160626|P2|STARTED|Period 1||34
2513836|NCT00744978|6160627|P1|STARTED|Period 1||32
2513837|NCT00744939|6160679|P1|NOT COMPLETED|Overall Study||91
2513838|NCT00744939|6160679|P1|COMPLETED|Overall Study||77
2513839|NCT00744939|6160679|P1|Treatment Received|Overall Study||141
2513840|NCT00744939|6160679|P1|STARTED|Overall Study||168
2513841|NCT00744874|6160715|P1|NOT COMPLETED|Overall Study||4
2513842|NCT00744874|6160715|P1|COMPLETED|Overall Study||51
2513843|NCT00744874|6160715|P1|STARTED|Overall Study||55
2513844|NCT00744848|6160733|P2|NOT COMPLETED|Overall Study||0
2513845|NCT00744848|6160734|P1|NOT COMPLETED|Overall Study||0
2513846|NCT00744848|6160733|P2|COMPLETED|Overall Study||101
2513847|NCT00744848|6160734|P1|COMPLETED|Overall Study||103
2513848|NCT00744848|6160733|P2|STARTED|Overall Study||101
2513849|NCT00744848|6160734|P1|STARTED|Overall Study||103
2513850|NCT00744757|6160740|P1|NOT COMPLETED|Overall Study||21
2513851|NCT00744757|6160740|P1|COMPLETED|Overall Study||16
2513852|NCT00744757|6160740|P1|STARTED|Overall Study||37
2513853|NCT00744692|6160753|P1|NOT COMPLETED|Overall Study||0
2513854|NCT00744692|6160753|P1|COMPLETED|Overall Study||22
2513855|NCT00744692|6160753|P1|STARTED|Overall Study||22
2513856|NCT00744653|6160765|P1|NOT COMPLETED|Overall Study||16
2513857|NCT00744653|6160765|P1|COMPLETED|Overall Study||1
2513858|NCT00744653|6160765|P1|STARTED|Overall Study||17
2513859|NCT00744627|6160773|P2|NOT COMPLETED|Overall Study||22
2513860|NCT00744627|6160774|P1|NOT COMPLETED|Overall Study||25
2513861|NCT00744627|6160773|P2|COMPLETED|Overall Study||128
2513862|NCT00744627|6160774|P1|COMPLETED|Overall Study||126
2513863|NCT00744627|6160773|P2|Treated|Overall Study||150
2513864|NCT00744627|6160774|P1|Treated|Overall Study||150
2513865|NCT00744627|6160773|P2|STARTED|Overall Study||150
2513866|NCT00744627|6160774|P1|STARTED|Overall Study||151
2513867|NCT00744523|6160830|P2|NOT COMPLETED|30 Days After the Procedure||5
2513868|NCT00744523|6160831|P1|NOT COMPLETED|30 Days After the Procedure||0
2513869|NCT00744523|6160830|P2|COMPLETED|30 Days After the Procedure||220
2513870|NCT00744523|6160831|P1|COMPLETED|30 Days After the Procedure||37
2513871|NCT00744523|6160830|P2|STARTED|30 Days After the Procedure||225
2513872|NCT00744523|6160831|P1|STARTED|30 Days After the Procedure||37
2513873|NCT00744523|6160830|P2|NOT COMPLETED|Procedure||0
2513874|NCT00744523|6160831|P1|NOT COMPLETED|Procedure||0
2513875|NCT00744523|6160830|P2|COMPLETED|Procedure||225
2513876|NCT00744523|6160831|P1|COMPLETED|Procedure||37
2513877|NCT00744523|6160830|P2|STARTED|Procedure||225
2513878|NCT00744523|6160831|P1|STARTED|Procedure||37
2513879|NCT00744497|6160851|P2|NOT COMPLETED|Overall Study||762
2513880|NCT00744497|6160852|P1|NOT COMPLETED|Overall Study||760
2513881|NCT00744497|6160851|P2|COMPLETED|Overall Study||0
2513882|NCT00744497|6160852|P1|COMPLETED|Overall Study||0
2513883|NCT00744497|6160851|P2|Received Treatment|Overall Study||761
2513884|NCT00744497|6160852|P1|Received Treatment|Overall Study||757
2513885|NCT00744497|6160851|P2|STARTED|Overall Study|Randomized|762
2513886|NCT00744497|6160852|P1|STARTED|Overall Study|Randomized|760
2513887|NCT00744380|6160888|P2|NOT COMPLETED|Overall Study||0
2513888|NCT00744380|6160889|P1|NOT COMPLETED|Overall Study||0
2513889|NCT00744380|6160888|P2|COMPLETED|Overall Study||11
2513890|NCT00744380|6160889|P1|COMPLETED|Overall Study||12
2513891|NCT00744380|6160888|P2|STARTED|Overall Study||11
2513892|NCT00744380|6160889|P1|STARTED|Overall Study||12
2513893|NCT00744328|6160912|P3|NOT COMPLETED|Overall Study||8
2513894|NCT00744328|6160913|P2|NOT COMPLETED|Overall Study||8
2513895|NCT00744328|6160914|P1|NOT COMPLETED|Overall Study||7
2513896|NCT00744328|6160912|P3|COMPLETED|Overall Study||21
2513897|NCT00744328|6160913|P2|COMPLETED|Overall Study||22
2513898|NCT00744328|6160914|P1|COMPLETED|Overall Study||19
2513899|NCT00744328|6160912|P3|STARTED|Overall Study||29
2513900|NCT00744328|6160913|P2|STARTED|Overall Study||30
2513901|NCT00744328|6160914|P1|STARTED|Overall Study||26
2513902|NCT00744263|6160927|P2|NOT COMPLETED|Overall Study||5320
2513903|NCT00744263|6160928|P1|NOT COMPLETED|Overall Study||5236
2513904|NCT00744263|6160927|P2|COMPLETED|Overall Study||36936
2513905|NCT00744263|6160928|P1|COMPLETED|Overall Study||37004
2513906|NCT00744263|6160927|P2|STARTED|Overall Study||42256
2513907|NCT00744263|6160928|P1|STARTED|Overall Study||42240
2513908|NCT00744237|6160951|P3|NOT COMPLETED|Overall Study||15
2513909|NCT00744237|6160952|P2|NOT COMPLETED|Overall Study||27
2513910|NCT00744237|6160953|P1|NOT COMPLETED|Overall Study||27
2513911|NCT00744237|6160951|P3|COMPLETED|Overall Study||59
2513912|NCT00744237|6160952|P2|COMPLETED|Overall Study||46
2513913|NCT00744237|6160953|P1|COMPLETED|Overall Study||56
2513914|NCT00744237|6160951|P3|STARTED|Overall Study||74
2513915|NCT00744237|6160952|P2|STARTED|Overall Study||73
2513916|NCT00744237|6160953|P1|STARTED|Overall Study||83
2513917|NCT00744211|6160967|P3|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
2513918|NCT00744211|6160968|P2|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
2513919|NCT00744211|6160969|P1|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
2513920|NCT00744211|6160967|P3|COMPLETED|24 Hours After Cardiopulmonary Bypass||10
2513921|NCT00744211|6160968|P2|COMPLETED|24 Hours After Cardiopulmonary Bypass||9
2513922|NCT00744211|6160969|P1|COMPLETED|24 Hours After Cardiopulmonary Bypass||10
2513923|NCT00744211|6160967|P3|STARTED|24 Hours After Cardiopulmonary Bypass||10
2513924|NCT00744211|6160968|P2|STARTED|24 Hours After Cardiopulmonary Bypass||9
2513925|NCT00744211|6160969|P1|STARTED|24 Hours After Cardiopulmonary Bypass||10
2513926|NCT00744211|6160967|P3|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
2513927|NCT00744211|6160968|P2|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
2513928|NCT00744211|6160969|P1|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
2513929|NCT00744211|6160967|P3|COMPLETED|12 Hours After Cardiopulmonary Bypass||10
2513930|NCT00744211|6160968|P2|COMPLETED|12 Hours After Cardiopulmonary Bypass||9
2513931|NCT00744211|6160969|P1|COMPLETED|12 Hours After Cardiopulmonary Bypass||10
2513932|NCT00744211|6160967|P3|STARTED|12 Hours After Cardiopulmonary Bypass||10
2513933|NCT00744211|6160968|P2|STARTED|12 Hours After Cardiopulmonary Bypass||9
2513934|NCT00744211|6160969|P1|STARTED|12 Hours After Cardiopulmonary Bypass||10
2513935|NCT00744211|6160967|P3|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
2513936|NCT00744211|6160968|P2|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
2513937|NCT00744211|6160969|P1|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
2513938|NCT00744211|6160967|P3|COMPLETED|6 Hours After Cardiopulmonary Bypass||10
2513939|NCT00744211|6160968|P2|COMPLETED|6 Hours After Cardiopulmonary Bypass||9
2513940|NCT00744211|6160969|P1|COMPLETED|6 Hours After Cardiopulmonary Bypass||10
2513941|NCT00744211|6160967|P3|STARTED|6 Hours After Cardiopulmonary Bypass||10
2513942|NCT00744211|6160968|P2|STARTED|6 Hours After Cardiopulmonary Bypass||9
2513943|NCT00744211|6160969|P1|STARTED|6 Hours After Cardiopulmonary Bypass||10
2513944|NCT00744211|6160967|P3|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
2513945|NCT00744211|6160968|P2|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
2513946|NCT00744211|6160969|P1|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
2513947|NCT00744211|6160967|P3|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10
2513948|NCT00744211|6160968|P2|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||9
2513949|NCT00744211|6160969|P1|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10
2513950|NCT00744211|6160967|P3|STARTED|0.5 Hours After Cardiopulmonary Bypass||10
2513951|NCT00744211|6160968|P2|STARTED|0.5 Hours After Cardiopulmonary Bypass||9
2513952|NCT00744211|6160969|P1|STARTED|0.5 Hours After Cardiopulmonary Bypass||10
2513953|NCT00744211|6160967|P3|NOT COMPLETED|Baseline||0
2513954|NCT00744211|6160968|P2|NOT COMPLETED|Baseline||0
2513955|NCT00744211|6160969|P1|NOT COMPLETED|Baseline||0
2513956|NCT00744211|6160967|P3|COMPLETED|Baseline||10
2513957|NCT00744211|6160968|P2|COMPLETED|Baseline||9
2513958|NCT00744211|6160969|P1|COMPLETED|Baseline||10
2513959|NCT00744211|6160967|P3|STARTED|Baseline||10
2513960|NCT00744211|6160968|P2|STARTED|Baseline||9
2513961|NCT00744211|6160969|P1|STARTED|Baseline||10
2513962|NCT00744055|6160987|P2|NOT COMPLETED|Overall Study||14
2513963|NCT00744055|6160988|P1|NOT COMPLETED|Overall Study||7
2513964|NCT00744055|6160987|P2|COMPLETED|Overall Study||32
2513965|NCT00744055|6160988|P1|COMPLETED|Overall Study||43
2513966|NCT00744055|6160987|P2|STARTED|Overall Study||46
2513967|NCT00744055|6160988|P1|STARTED|Overall Study||50
2513968|NCT00744042|6160996|P1|NOT COMPLETED|Overall Study||1
2513969|NCT00744042|6160996|P1|COMPLETED|Overall Study||10
2513970|NCT00744042|6160996|P1|STARTED|Overall Study||11
2513971|NCT00743730|6161012|P3|NOT COMPLETED|Overall Study||5
2513972|NCT00743730|6161013|P2|NOT COMPLETED|Overall Study||4
2513973|NCT00743730|6161014|P1|NOT COMPLETED|Overall Study||5
2513974|NCT00743730|6161012|P3|COMPLETED|Overall Study||28
2513975|NCT00743730|6161013|P2|COMPLETED|Overall Study||30
2513976|NCT00743730|6161014|P1|COMPLETED|Overall Study||22
2513977|NCT00743730|6161012|P3|STARTED|Overall Study||33
2513978|NCT00743730|6161013|P2|STARTED|Overall Study||34
2513979|NCT00743730|6161014|P1|STARTED|Overall Study||27
2513980|NCT00743717|6161030|P2|NOT COMPLETED|Overall Study||0
2513981|NCT00743717|6161031|P1|NOT COMPLETED|Overall Study||0
2513982|NCT00743717|6161030|P2|COMPLETED|Overall Study||2
2513983|NCT00743717|6161031|P1|COMPLETED|Overall Study||2
2513984|NCT00743717|6161030|P2|STARTED|Overall Study||2
2513985|NCT00743717|6161031|P1|STARTED|Overall Study||2
2513986|NCT00743652|6161042|P5|NOT COMPLETED|Overall Study||0
2513987|NCT00743652|6161043|P4|NOT COMPLETED|Overall Study||4
2513988|NCT00743652|6161044|P3|NOT COMPLETED|Overall Study||2
2513989|NCT00743652|6161045|P2|NOT COMPLETED|Overall Study||3
2513990|NCT00743652|6161046|P1|NOT COMPLETED|Overall Study||10
2513991|NCT00743652|6161042|P5|COMPLETED|Overall Study||79
2513992|NCT00743652|6161043|P4|COMPLETED|Overall Study||63
2513993|NCT00743652|6161044|P3|COMPLETED|Overall Study||23
2513994|NCT00743652|6161045|P2|COMPLETED|Overall Study||48
2513995|NCT00743652|6161046|P1|COMPLETED|Overall Study||141
2513996|NCT00743652|6161042|P5|Toddler Dose|Overall Study||0
2513997|NCT00743652|6161043|P4|Toddler Dose|Overall Study||0
2513998|NCT00743652|6161044|P3|Toddler Dose|Overall Study||16
2513999|NCT00743652|6161045|P2|Toddler Dose|Overall Study||23
2514000|NCT00743652|6161046|P1|Toddler Dose|Overall Study||15
2514001|NCT00743652|6161042|P5|Vaccinated Dose 3|Overall Study||0
2514002|NCT00743652|6161043|P4|Vaccinated Dose 3|Overall Study||0
2514003|NCT00743652|6161044|P3|Vaccinated Dose 3|Overall Study||0
2514004|NCT00743652|6161045|P2|Vaccinated Dose 3|Overall Study||0
2514005|NCT00743652|6161046|P1|Vaccinated Dose 3|Overall Study||74
2514006|NCT00743652|6161042|P5|Vaccinated Dose 2|Overall Study||0
2514007|NCT00743652|6161043|P4|Vaccinated Dose 2|Overall Study||49
2514008|NCT00743652|6161044|P3|Vaccinated Dose 2|Overall Study||0
2514009|NCT00743652|6161045|P2|Vaccinated Dose 2|Overall Study||41
2514010|NCT00743652|6161046|P1|Vaccinated Dose 2|Overall Study||112
2514011|NCT00743652|6161042|P5|Vaccinated Dose 1|Overall Study||79
2514012|NCT00743652|6161043|P4|Vaccinated Dose 1|Overall Study||66
2514013|NCT00743652|6161044|P3|Vaccinated Dose 1|Overall Study||25
2514014|NCT00743652|6161045|P2|Vaccinated Dose 1|Overall Study||51
2514015|NCT00743652|6161046|P1|Vaccinated Dose 1|Overall Study||151
2514016|NCT00743652|6161042|P5|STARTED|Overall Study||79
2514017|NCT00743652|6161043|P4|STARTED|Overall Study||67
2514018|NCT00743652|6161044|P3|STARTED|Overall Study||25
2514019|NCT00743652|6161045|P2|STARTED|Overall Study||51
2514020|NCT00743652|6161046|P1|STARTED|Overall Study||151
2514021|NCT00743574|6161121|P1|NOT COMPLETED|Overall Study||24
2514022|NCT00743574|6161121|P1|COMPLETED|Overall Study||12
2514023|NCT00743574|6161121|P1|Dropped Out After Initiating Trial|Overall Study||3
2514024|NCT00743574|6161121|P1|Further Exclusions|Overall Study||8
2514025|NCT00743574|6161121|P1|Dropped Out Before Eligibility Testing|Overall Study||13
2514026|NCT00743574|6161121|P1|STARTED|Overall Study||36
2514027|NCT00743509|6161130|P1|NOT COMPLETED|Overall Study||2
2514028|NCT00743509|6161130|P1|COMPLETED|Overall Study||47
2514029|NCT00743509|6161130|P1|STARTED|Overall Study||49
2514030|NCT00743483|6161135|P1|NOT COMPLETED|Treatment Period||1
2514031|NCT00743483|6161135|P1|COMPLETED|Treatment Period||13
2514032|NCT00743483|6161135|P1|STARTED|Treatment Period||14
2514033|NCT00743483|6161135|P1|NOT COMPLETED|Baseline Period||1
2514034|NCT00743483|6161135|P1|COMPLETED|Baseline Period||14
2514035|NCT00743483|6161135|P1|STARTED|Baseline Period||15
2514036|NCT00743444|6161139|P2|NOT COMPLETED|Second Intervention||0
2514037|NCT00743444|6161140|P1|NOT COMPLETED|Second Intervention||0
2514038|NCT00743444|6161139|P2|COMPLETED|Second Intervention||11
2514039|NCT00743444|6161140|P1|COMPLETED|Second Intervention||14
2514040|NCT00743444|6161139|P2|STARTED|Second Intervention||11
2514041|NCT00743444|6161140|P1|STARTED|Second Intervention||14
2514042|NCT00743444|6161139|P2|NOT COMPLETED|Washout Period||1
2514043|NCT00743444|6161140|P1|NOT COMPLETED|Washout Period||0
2514044|NCT00743444|6161139|P2|COMPLETED|Washout Period||11
2514045|NCT00743444|6161140|P1|COMPLETED|Washout Period||14
2514046|NCT00743444|6161139|P2|STARTED|Washout Period||12
2514047|NCT00743444|6161140|P1|STARTED|Washout Period||14
2514048|NCT00743444|6161139|P2|NOT COMPLETED|First Intervention||1
2514049|NCT00743444|6161140|P1|NOT COMPLETED|First Intervention||0
2514050|NCT00743444|6161139|P2|COMPLETED|First Intervention||12
2514051|NCT00743444|6161140|P1|COMPLETED|First Intervention||14
2514052|NCT00743444|6161139|P2|STARTED|First Intervention||13
2514053|NCT00743444|6161140|P1|STARTED|First Intervention||14
2514054|NCT00743431|6161149|P1|NOT COMPLETED|Overall Study||126
2514055|NCT00743431|6161149|P1|COMPLETED|Overall Study||98
2514056|NCT00743431|6161149|P1|STARTED|Overall Study||224
2514057|NCT00743366|6161153|P2|NOT COMPLETED|Intervention 2 (8 Days)||0
2514058|NCT00743366|6161154|P1|NOT COMPLETED|Intervention 2 (8 Days)||0
2514059|NCT00743366|6161153|P2|COMPLETED|Intervention 2 (8 Days)||7
2514060|NCT00743366|6161154|P1|COMPLETED|Intervention 2 (8 Days)||7
2514061|NCT00743366|6161153|P2|STARTED|Intervention 2 (8 Days)||7
2514062|NCT00743366|6161154|P1|STARTED|Intervention 2 (8 Days)||7
2514063|NCT00743366|6161153|P2|NOT COMPLETED|Intervention 1 (8 Days)||3
2514064|NCT00743366|6161154|P1|NOT COMPLETED|Intervention 1 (8 Days)||3
2514065|NCT00743366|6161153|P2|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
2514066|NCT00743366|6161154|P1|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
2514067|NCT00743366|6161153|P2|STARTED|Intervention 1 (8 Days)||10
2514068|NCT00743366|6161154|P1|STARTED|Intervention 1 (8 Days)||10
2514069|NCT00743340|6161160|P1|NOT COMPLETED|Overall Study||41
2514070|NCT00743340|6161160|P1|COMPLETED|Overall Study||9
2514071|NCT00743340|6161160|P1|STARTED|Overall Study||50
2514072|NCT00743288|6161164|P7|NOT COMPLETED|Overall Study||9
2514073|NCT00743288|6161165|P6|NOT COMPLETED|Overall Study||5
2514074|NCT00743288|6161166|P5|NOT COMPLETED|Overall Study||6
2514075|NCT00743288|6161167|P4|NOT COMPLETED|Overall Study||7
2514076|NCT00743288|6161168|P3|NOT COMPLETED|Overall Study||5
2514077|NCT00743288|6161169|P2|NOT COMPLETED|Overall Study||3
2514078|NCT00743288|6161170|P1|NOT COMPLETED|Overall Study||3
2514079|NCT00743288|6161164|P7|COMPLETED|Overall Study||0
2514080|NCT00743288|6161165|P6|COMPLETED|Overall Study||1
2514081|NCT00743288|6161166|P5|COMPLETED|Overall Study||0
2514082|NCT00743288|6161167|P4|COMPLETED|Overall Study||0
2514083|NCT00743288|6161168|P3|COMPLETED|Overall Study||1
2514084|NCT00743288|6161169|P2|COMPLETED|Overall Study||0
2514085|NCT00743288|6161170|P1|COMPLETED|Overall Study||0
2514086|NCT00743288|6161164|P7|STARTED|Overall Study|6 subjects were enrolled in phase 1 and 3 subjects were enrolled as part of the phase 2 expansion.|9
2514087|NCT00743288|6161165|P6|STARTED|Overall Study||6
2514088|NCT00743288|6161166|P5|STARTED|Overall Study||6
2514089|NCT00743288|6161167|P4|STARTED|Overall Study||7
2514090|NCT00743288|6161168|P3|STARTED|Overall Study||6
2514091|NCT00743288|6161169|P2|STARTED|Overall Study||3
2514092|NCT00743288|6161170|P1|STARTED|Overall Study||3
2514093|NCT00743275|6161184|P2|NOT COMPLETED|Overall Study||1
2514094|NCT00743275|6161185|P1|NOT COMPLETED|Overall Study||0
2514095|NCT00743275|6161184|P2|COMPLETED|Overall Study||60
2514096|NCT00743275|6161185|P1|COMPLETED|Overall Study||59
2514097|NCT00743275|6161184|P2|STARTED|Overall Study||61
2514098|NCT00743275|6161185|P1|STARTED|Overall Study||59
2514099|NCT00743262|6161197|P1|NOT COMPLETED|Overall Study||0
2514100|NCT00743262|6161197|P1|COMPLETED|Overall Study||15
2514101|NCT00743262|6161197|P1|STARTED|Overall Study||15
2514102|NCT00743249|6161205|P2|NOT COMPLETED|Overall Study||6
2514103|NCT00743249|6161206|P1|NOT COMPLETED|Overall Study||2
2514104|NCT00743249|6161205|P2|COMPLETED|Overall Study||24
2514105|NCT00743249|6161206|P1|COMPLETED|Overall Study||28
2514106|NCT00743249|6161205|P2|STARTED|Overall Study||30
2514107|NCT00743249|6161206|P1|STARTED|Overall Study||30
2514108|NCT00743197|6161216|P2|NOT COMPLETED|Overall Study||2
2514109|NCT00743197|6161217|P1|NOT COMPLETED|Overall Study||1
2514110|NCT00743197|6161216|P2|COMPLETED|Overall Study||0
2514111|NCT00743197|6161217|P1|COMPLETED|Overall Study||0
2514112|NCT00743197|6161216|P2|STARTED|Overall Study||2
2514113|NCT00743197|6161217|P1|STARTED|Overall Study||1
2514114|NCT00743145|6161223|P1|NOT COMPLETED|Overall Study||4
2514115|NCT00743145|6161223|P1|COMPLETED|Overall Study||19
2514116|NCT00743145|6161223|P1|STARTED|Overall Study||23
2514117|NCT00743119|6161237|P1|NOT COMPLETED|Overall Study||4
2514118|NCT00743119|6161237|P1|COMPLETED|Overall Study||30
2514119|NCT00743119|6161237|P1|STARTED|Overall Study||34
2514120|NCT00743106|6161251|P2|NOT COMPLETED|Overall Study||5
2514121|NCT00743106|6161252|P1|NOT COMPLETED|Overall Study||8
2514122|NCT00743106|6161251|P2|COMPLETED|Overall Study||43
2514123|NCT00743106|6161252|P1|COMPLETED|Overall Study||34
2514124|NCT00743106|6161251|P2|STARTED|Overall Study||48
2514125|NCT00743106|6161252|P1|STARTED|Overall Study||42
2514126|NCT00743093|6161262|P2|NOT COMPLETED|Extended Dosing Period||0
2514127|NCT00743093|6161263|P1|NOT COMPLETED|Extended Dosing Period||3
2514128|NCT00743093|6161262|P2|COMPLETED|Extended Dosing Period||1
2514129|NCT00743093|6161263|P1|COMPLETED|Extended Dosing Period||48
2514130|NCT00743093|6161262|P2|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|1
2514131|NCT00743093|6161263|P1|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|51
2514132|NCT00743093|6161262|P2|NOT COMPLETED|Base Study Period||5
2514133|NCT00743093|6161263|P1|NOT COMPLETED|Base Study Period||19
2514134|NCT00743093|6161262|P2|COMPLETED|Base Study Period||47
2514135|NCT00743093|6161263|P1|COMPLETED|Base Study Period||205
2514136|NCT00743093|6161262|P2|STARTED|Base Study Period||52
2514137|NCT00743093|6161263|P1|STARTED|Base Study Period||224
2514138|NCT00742963|6161271|P1|NOT COMPLETED|Overall Study||33
2514139|NCT00742963|6161271|P1|COMPLETED|Overall Study||68
2514140|NCT00742963|6161271|P1|Completed All Treatment Cycles|Overall Study||68
2514141|NCT00742963|6161271|P1|STARTED|Overall Study||101
2514142|NCT00742924|6161279|P4|NOT COMPLETED|Overall Study||6
2514143|NCT00742924|6161280|P3|NOT COMPLETED|Overall Study||4
2514144|NCT00742924|6161281|P2|NOT COMPLETED|Overall Study||2
2514145|NCT00742924|6161282|P1|NOT COMPLETED|Overall Study||5
2514146|NCT00742924|6161279|P4|COMPLETED|Overall Study||0
2514147|NCT00742924|6161280|P3|COMPLETED|Overall Study||2
2514148|NCT00742924|6161281|P2|COMPLETED|Overall Study||4
2514149|NCT00742924|6161282|P1|COMPLETED|Overall Study||1
2514150|NCT00742924|6161279|P4|STARTED|Overall Study||6
2514151|NCT00742924|6161280|P3|STARTED|Overall Study||6
2514152|NCT00742924|6161281|P2|STARTED|Overall Study||6
2514153|NCT00742924|6161282|P1|STARTED|Overall Study||6
2514154|NCT00742885|6161294|P2|NOT COMPLETED|Overall Study||0
2514155|NCT00742885|6161295|P1|NOT COMPLETED|Overall Study||1
2514156|NCT00742885|6161294|P2|COMPLETED|Overall Study|to Day 182|50
2514157|NCT00742885|6161295|P1|COMPLETED|Overall Study|to Day 182|49
2514158|NCT00742885|6161294|P2|STARTED|Overall Study||50
2514159|NCT00742885|6161295|P1|STARTED|Overall Study||50
2514160|NCT00742872|6161343|P2|NOT COMPLETED|Overall Study||8
2514161|NCT00742872|6161344|P1|NOT COMPLETED|Overall Study||12
2514162|NCT00742872|6161343|P2|COMPLETED|Overall Study||12
2514163|NCT00742872|6161344|P1|COMPLETED|Overall Study||9
2514164|NCT00742872|6161343|P2|STARTED|Overall Study||20
2514165|NCT00742872|6161344|P1|STARTED|Overall Study||21
2514166|NCT00742859|6161354|P4|NOT COMPLETED|Overall Study||8
2514167|NCT00742859|6161355|P3|NOT COMPLETED|Overall Study||11
2514168|NCT00742859|6161356|P2|NOT COMPLETED|Overall Study||12
2514169|NCT00742859|6161357|P1|NOT COMPLETED|Overall Study||11
2514170|NCT00742859|6161354|P4|COMPLETED|Overall Study||119
2514171|NCT00742859|6161355|P3|COMPLETED|Overall Study||116
2514172|NCT00742859|6161356|P2|COMPLETED|Overall Study||115
2514173|NCT00742859|6161357|P1|COMPLETED|Overall Study||116
2514174|NCT00742859|6161354|P4|STARTED|Overall Study||127
2514175|NCT00742859|6161355|P3|STARTED|Overall Study||127
2514176|NCT00742859|6161356|P2|STARTED|Overall Study||127
2514177|NCT00742859|6161357|P1|STARTED|Overall Study||127
2514178|NCT00742781|6161371|P1|NOT COMPLETED|Overall Study||3
2514179|NCT00742781|6161371|P1|COMPLETED|Overall Study||18
2514180|NCT00742781|6161371|P1|STARTED|Overall Study||21
2514181|NCT00742625|6161380|P1|NOT COMPLETED|Consolidation||21
2514182|NCT00742625|6161380|P1|COMPLETED|Consolidation||20
2514183|NCT00742625|6161380|P1|STARTED|Consolidation||41
2514184|NCT00742625|6161380|P1|NOT COMPLETED|Remission Induction||54
2514185|NCT00742625|6161380|P1|COMPLETED|Remission Induction||41
2514186|NCT00742625|6161380|P1|STARTED|Remission Induction||95
2514187|NCT00742560|6161394|P5|NOT COMPLETED|Overall Study||37
2514188|NCT00742560|6161395|P4|NOT COMPLETED|Overall Study||36
2514189|NCT00742560|6161396|P3|NOT COMPLETED|Overall Study||22
2514190|NCT00742560|6161397|P2|NOT COMPLETED|Overall Study||3
2514191|NCT00742560|6161398|P1|NOT COMPLETED|Overall Study||3
2514192|NCT00742560|6161394|P5|COMPLETED|Overall Study||0
2514193|NCT00742560|6161395|P4|COMPLETED|Overall Study||0
2514194|NCT00742560|6161396|P3|COMPLETED|Overall Study||0
2514195|NCT00742560|6161397|P2|COMPLETED|Overall Study||0
2514196|NCT00742560|6161398|P1|COMPLETED|Overall Study||0
2514197|NCT00742560|6161394|P5|STARTED|Overall Study||37
2514198|NCT00742560|6161395|P4|STARTED|Overall Study||36
2514199|NCT00742560|6161396|P3|STARTED|Overall Study||22
2514200|NCT00742560|6161397|P2|STARTED|Overall Study||3
2514201|NCT00742560|6161398|P1|STARTED|Overall Study||3
2514202|NCT00742508|6161472|P2|NOT COMPLETED|4-Week Exploratory Evaluation Period||1
2514203|NCT00742508|6161473|P1|NOT COMPLETED|4-Week Exploratory Evaluation Period||0
2514204|NCT00742508|6161472|P2|COMPLETED|4-Week Exploratory Evaluation Period||7
2514205|NCT00742508|6161473|P1|COMPLETED|4-Week Exploratory Evaluation Period||0
2514206|NCT00742508|6161472|P2|STARTED|4-Week Exploratory Evaluation Period||8
2514207|NCT00742508|6161473|P1|STARTED|4-Week Exploratory Evaluation Period||0
2514208|NCT00742508|6161472|P2|NOT COMPLETED|8-Week Primary Evaluation Period||11
2514209|NCT00742508|6161473|P1|NOT COMPLETED|8-Week Primary Evaluation Period||11
2514210|NCT00742508|6161472|P2|COMPLETED|8-Week Primary Evaluation Period||8
2514211|NCT00742508|6161473|P1|COMPLETED|8-Week Primary Evaluation Period||11
2514212|NCT00742508|6161472|P2|STARTED|8-Week Primary Evaluation Period||19
2514213|NCT00742508|6161473|P1|STARTED|8-Week Primary Evaluation Period||22
2514214|NCT00742469|6161537|P2|NOT COMPLETED|Overall Study||35
2514215|NCT00742469|6161538|P1|NOT COMPLETED|Overall Study||18
2514216|NCT00742469|6161537|P2|COMPLETED|Overall Study||69
2514217|NCT00742469|6161538|P1|COMPLETED|Overall Study||88
2514218|NCT00742469|6161537|P2|STARTED|Overall Study||104
2514219|NCT00742469|6161538|P1|STARTED|Overall Study||106
2514220|NCT00742417|6161546|P2|NOT COMPLETED|Maintenance II||0
2514221|NCT00742417|6161547|P1|NOT COMPLETED|Maintenance II||0
2514222|NCT00742417|6161546|P2|COMPLETED|Maintenance II||19
2514223|NCT00742417|6161547|P1|COMPLETED|Maintenance II||16
2514224|NCT00742417|6161546|P2|STARTED|Maintenance II||19
2514225|NCT00742417|6161547|P1|STARTED|Maintenance II||16
2514226|NCT00742417|6161546|P2|NOT COMPLETED|Maintenance I||0
2514227|NCT00742417|6161547|P1|NOT COMPLETED|Maintenance I||0
2514228|NCT00742417|6161546|P2|COMPLETED|Maintenance I||19
2514229|NCT00742417|6161547|P1|COMPLETED|Maintenance I||16
2514230|NCT00742417|6161546|P2|STARTED|Maintenance I||19
2514231|NCT00742417|6161547|P1|STARTED|Maintenance I||16
2514232|NCT00742417|6161546|P2|NOT COMPLETED|Intensive Period||1
2514233|NCT00742417|6161547|P1|NOT COMPLETED|Intensive Period||3
2514234|NCT00742417|6161546|P2|COMPLETED|Intensive Period|19 control patients completed all the 6 plasma exchange during the Intensive Period|19
2514235|NCT00742417|6161547|P1|COMPLETED|Intensive Period|16 patients completed all the 6 plasma exchange with Albutein 5% during the Intensive Period|16
2514236|NCT00742417|6161546|P2|STARTED|Intensive Period||20
2514237|NCT00742417|6161547|P1|STARTED|Intensive Period||19
2514238|NCT00742417|6161546|P2|NOT COMPLETED|Randomized||1
2514239|NCT00742417|6161547|P1|NOT COMPLETED|Randomized||2
2514240|NCT00742417|6161546|P2|COMPLETED|Randomized||20
2514241|NCT00742417|6161547|P1|COMPLETED|Randomized||19
2514242|NCT00742417|6161546|P2|STARTED|Randomized||21
2514243|NCT00742417|6161547|P1|STARTED|Randomized||21
2514244|NCT00742391|6161571|P2|NOT COMPLETED|Overall Study||1
2514245|NCT00742391|6161572|P1|NOT COMPLETED|Overall Study||4
2514246|NCT00742391|6161571|P2|COMPLETED|Overall Study||128
2514247|NCT00742391|6161572|P1|COMPLETED|Overall Study||122
2514248|NCT00742391|6161571|P2|STARTED|Overall Study||129
2514249|NCT00742391|6161572|P1|STARTED|Overall Study||126
2514250|NCT00742326|6161582|P2|NOT COMPLETED|Overall Study||1
2514251|NCT00742326|6161583|P1|NOT COMPLETED|Overall Study||0
2514252|NCT00742326|6161582|P2|COMPLETED|Overall Study||6
2514253|NCT00742326|6161583|P1|COMPLETED|Overall Study||6
2514254|NCT00742326|6161582|P2|STARTED|Overall Study||7
2514255|NCT00742326|6161583|P1|STARTED|Overall Study||6
2514256|NCT00742313|6161593|P2|NOT COMPLETED|Overall Study||0
2514257|NCT00742313|6161594|P1|NOT COMPLETED|Overall Study||1
2514258|NCT00742313|6161593|P2|COMPLETED|Overall Study||19
2514259|NCT00742313|6161594|P1|COMPLETED|Overall Study||24
2514260|NCT00742313|6161593|P2|STARTED|Overall Study||19
2514261|NCT00742313|6161594|P1|STARTED|Overall Study||25
2514262|NCT00742274|6161602|P2|NOT COMPLETED|Overall Study||3
2514263|NCT00742274|6161603|P1|NOT COMPLETED|Overall Study||3
2514264|NCT00742274|6161602|P2|COMPLETED|Overall Study||28
2514265|NCT00742274|6161603|P1|COMPLETED|Overall Study||27
2514266|NCT00742274|6161602|P2|STARTED|Overall Study||31
2514267|NCT00742274|6161603|P1|STARTED|Overall Study||30
2514268|NCT00742235|6161611|P2|NOT COMPLETED|Overall Study||31
2514269|NCT00742235|6161612|P1|NOT COMPLETED|Overall Study||0
2514270|NCT00742235|6161611|P2|COMPLETED|Overall Study||36
2514271|NCT00742235|6161612|P1|COMPLETED|Overall Study||32
2514272|NCT00742235|6161611|P2|STARTED|Overall Study||67
2514273|NCT00742235|6161612|P1|STARTED|Overall Study||32
2514274|NCT00742209|6161625|P5|NOT COMPLETED|Overall Study||25
2514275|NCT00742209|6161626|P4|NOT COMPLETED|Overall Study||37
2514276|NCT00742209|6161627|P3|NOT COMPLETED|Overall Study||46
2514277|NCT00742209|6161628|P2|NOT COMPLETED|Overall Study||18
2514278|NCT00742209|6161629|P1|NOT COMPLETED|Overall Study||34
2514279|NCT00742209|6161625|P5|COMPLETED|Overall Study||37
2514280|NCT00742209|6161626|P4|COMPLETED|Overall Study||97
2514281|NCT00742209|6161627|P3|COMPLETED|Overall Study||88
2514282|NCT00742209|6161628|P2|COMPLETED|Overall Study||49
2514283|NCT00742209|6161629|P1|COMPLETED|Overall Study||95
2514284|NCT00742209|6161625|P5|STARTED|Overall Study||62
2514285|NCT00742209|6161626|P4|STARTED|Overall Study||134
2514286|NCT00742209|6161627|P3|STARTED|Overall Study||134
2514287|NCT00742209|6161628|P2|STARTED|Overall Study||67
2514288|NCT00742209|6161629|P1|STARTED|Overall Study||129
2514289|NCT00742183|6161732|P2|NOT COMPLETED|Overall Study||12
2514290|NCT00742183|6161733|P1|NOT COMPLETED|Overall Study||9
2514291|NCT00742183|6161732|P2|COMPLETED|Overall Study||39
2514292|NCT00742183|6161733|P1|COMPLETED|Overall Study||40
2514293|NCT00742183|6161732|P2|STARTED|Overall Study||51
2514294|NCT00742183|6161733|P1|STARTED|Overall Study|50 subjects randomised, one of them did not receive any treatment.|49
2514295|NCT00742170|6161741|P2|NOT COMPLETED|Overall Study||5
2514296|NCT00742170|6161742|P1|NOT COMPLETED|Overall Study||2
2514297|NCT00742170|6161741|P2|COMPLETED|Overall Study||24
2514298|NCT00742170|6161742|P1|COMPLETED|Overall Study||24
2514299|NCT00742170|6161741|P2|STARTED|Overall Study||29
2514300|NCT00742170|6161742|P1|STARTED|Overall Study||26
2514301|NCT00742079|6161752|P2|NOT COMPLETED|Overall Study||1
2514302|NCT00742079|6161753|P1|NOT COMPLETED|Overall Study||0
2514303|NCT00742079|6161752|P2|COMPLETED|Overall Study||9
2514304|NCT00742079|6161753|P1|COMPLETED|Overall Study||11
2514305|NCT00742079|6161752|P2|Week 2 (Received Dose 2)|Overall Study||9
2514306|NCT00742079|6161753|P1|Week 2 (Received Dose 2)|Overall Study||11
2514307|NCT00742079|6161752|P2|Baseline/Week 1 (Received Dose 1)|Overall Study||9
2514308|NCT00742079|6161753|P1|Baseline/Week 1 (Received Dose 1)|Overall Study||11
2514309|NCT00742079|6161752|P2|STARTED|Overall Study||10
2514310|NCT00742079|6161753|P1|STARTED|Overall Study||11
2514311|NCT00742053|6161767|P1|NOT COMPLETED|Overall Study||0
2514312|NCT00742053|6161767|P1|COMPLETED|Overall Study||7
2514313|NCT00742053|6161767|P1|STARTED|Overall Study||7
2514314|NCT00742001|6161774|P3|NOT COMPLETED|Overall Study||1
2514315|NCT00742001|6161775|P2|NOT COMPLETED|Overall Study||0
2514316|NCT00742001|6161776|P1|NOT COMPLETED|Overall Study||0
2514317|NCT00742001|6161774|P3|COMPLETED|Overall Study||3
2514318|NCT00742001|6161775|P2|COMPLETED|Overall Study||4
2514319|NCT00742001|6161776|P1|COMPLETED|Overall Study||4
2514320|NCT00742001|6161774|P3|STARTED|Overall Study||4
2514321|NCT00742001|6161775|P2|STARTED|Overall Study||4
2514322|NCT00742001|6161776|P1|STARTED|Overall Study||4
2514323|NCT00741988|6161792|P2|NOT COMPLETED|Overall Study||4
2514324|NCT00741988|6161793|P1|NOT COMPLETED|Overall Study||4
2514325|NCT00741988|6161792|P2|COMPLETED|Overall Study||36
2514326|NCT00741988|6161793|P1|COMPLETED|Overall Study||38
2514327|NCT00741988|6161792|P2|STARTED|Overall Study||40
2514328|NCT00741988|6161793|P1|STARTED|Overall Study||42
2514329|NCT00741936|6161805|P2|NOT COMPLETED|Overall Study||8
2514330|NCT00741936|6161806|P1|NOT COMPLETED|Overall Study||9
2514331|NCT00741936|6161805|P2|COMPLETED|Overall Study||52
2514332|NCT00741936|6161806|P1|COMPLETED|Overall Study||51
2514333|NCT00741936|6161805|P2|STARTED|Overall Study||60
2514334|NCT00741936|6161806|P1|STARTED|Overall Study||60
2514335|NCT00741858|6161834|P2|NOT COMPLETED|Overall Study||0
2514336|NCT00741858|6161835|P1|NOT COMPLETED|Overall Study||0
2514337|NCT00741858|6161834|P2|COMPLETED|Overall Study||18
2514338|NCT00741858|6161835|P1|COMPLETED|Overall Study||16
2514339|NCT00741858|6161834|P2|STARTED|Overall Study||18
2514340|NCT00741858|6161835|P1|STARTED|Overall Study||16
2514341|NCT00741819|6161841|P1|NOT COMPLETED|Overall Study||8
2514342|NCT00741819|6161841|P1|COMPLETED|Overall Study||65
2514343|NCT00741819|6161841|P1|STARTED|Overall Study||73
2514344|NCT00741611|6161855|P3|NOT COMPLETED|Overall Study||3
2514345|NCT00741611|6161856|P2|NOT COMPLETED|Overall Study||2
2514346|NCT00741611|6161857|P1|NOT COMPLETED|Overall Study||0
2514347|NCT00741611|6161855|P3|COMPLETED|Overall Study||26
2514348|NCT00741611|6161856|P2|COMPLETED|Overall Study||1
2514349|NCT00741611|6161857|P1|COMPLETED|Overall Study||4
2514350|NCT00741611|6161855|P3|STARTED|Overall Study||29
2514351|NCT00741611|6161856|P2|STARTED|Overall Study||3
2514352|NCT00741611|6161857|P1|STARTED|Overall Study||4
2514353|NCT00741598|6161876|P2|NOT COMPLETED|Overall Study||9
2514354|NCT00741598|6161877|P1|NOT COMPLETED|Overall Study||9
2514355|NCT00741598|6161876|P2|COMPLETED|Overall Study||30
2514356|NCT00741598|6161877|P1|COMPLETED|Overall Study||24
2514357|NCT00741598|6161876|P2|STARTED|Overall Study||39
2514358|NCT00741598|6161877|P1|STARTED|Overall Study||33
2514359|NCT00741468|6161891|P1|NOT COMPLETED|Overall Study||0
2514360|NCT00741468|6161891|P1|COMPLETED|Overall Study||18
2514361|NCT00741468|6161891|P1|STARTED|Overall Study||18
2514362|NCT00741390|6161899|P4|NOT COMPLETED|Visit 2||1
2514363|NCT00741390|6161900|P3|NOT COMPLETED|Visit 2||1
2514364|NCT00741390|6161901|P2|NOT COMPLETED|Visit 2||0
2514365|NCT00741390|6161902|P1|NOT COMPLETED|Visit 2||0
2514366|NCT00741390|6161899|P4|COMPLETED|Visit 2||60
2514367|NCT00741390|6161900|P3|COMPLETED|Visit 2||54
2514368|NCT00741390|6161901|P2|COMPLETED|Visit 2||61
2514369|NCT00741390|6161902|P1|COMPLETED|Visit 2||59
2514370|NCT00741390|6161899|P4|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|61
2514371|NCT00741390|6161900|P3|STARTED|Visit 2||55
2514372|NCT00741390|6161901|P2|STARTED|Visit 2|2 subjects lost to follow-up between Visit 1 and Visit 2.|61
2514373|NCT00741390|6161902|P1|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|59
2514374|NCT00741390|6161899|P4|NOT COMPLETED|Visit 1||1
2514375|NCT00741390|6161900|P3|NOT COMPLETED|Visit 1||7
2514376|NCT00741390|6161901|P2|NOT COMPLETED|Visit 1||0
2514377|NCT00741390|6161902|P1|NOT COMPLETED|Visit 1||2
2514378|NCT00741390|6161899|P4|COMPLETED|Visit 1||62
2514379|NCT00741390|6161900|P3|COMPLETED|Visit 1||55
2514380|NCT00741390|6161901|P2|COMPLETED|Visit 1||63
2514381|NCT00741390|6161902|P1|COMPLETED|Visit 1||60
2514382|NCT00741390|6161899|P4|STARTED|Visit 1||63
2514383|NCT00741390|6161900|P3|STARTED|Visit 1||62
2514384|NCT00741390|6161901|P2|STARTED|Visit 1||63
2514385|NCT00741390|6161902|P1|STARTED|Visit 1||62
2514386|NCT00741338|6161923|P2|NOT COMPLETED|Overall Study||1
2514387|NCT00741338|6161924|P1|NOT COMPLETED|Overall Study||0
2514388|NCT00741338|6161923|P2|COMPLETED|Overall Study||2
2514389|NCT00741338|6161924|P1|COMPLETED|Overall Study||3
2514390|NCT00741338|6161923|P2|STARTED|Overall Study||3
2514391|NCT00741338|6161924|P1|STARTED|Overall Study||3
2514392|NCT00741286|6161934|P2|NOT COMPLETED|Overall Study||19
2514393|NCT00741286|6161935|P1|NOT COMPLETED|Overall Study||20
2514394|NCT00741286|6161934|P2|COMPLETED|Overall Study||81
2514395|NCT00741286|6161935|P1|COMPLETED|Overall Study||83
2514396|NCT00741286|6161934|P2|STARTED|Overall Study||100
2514397|NCT00741286|6161935|P1|STARTED|Overall Study||103
2514398|NCT00741273|6161945|P2|NOT COMPLETED|Overall Study||0
2514399|NCT00741273|6161946|P1|NOT COMPLETED|Overall Study||0
2514400|NCT00741273|6161945|P2|COMPLETED|Overall Study||8
2514401|NCT00741273|6161946|P1|COMPLETED|Overall Study||8
2514402|NCT00741273|6161945|P2|STARTED|Overall Study||8
2514403|NCT00741273|6161946|P1|STARTED|Overall Study||8
2514404|NCT00741260|6161969|P7|NOT COMPLETED|Overall Study||7
2514405|NCT00741260|6161970|P6|NOT COMPLETED|Overall Study||45
2514406|NCT00741260|6161971|P5|NOT COMPLETED|Overall Study||9
2514407|NCT00741260|6161972|P4|NOT COMPLETED|Overall Study||6
2514408|NCT00741260|6161973|P3|NOT COMPLETED|Overall Study||4
2514409|NCT00741260|6161974|P2|NOT COMPLETED|Overall Study||8
2514410|NCT00741260|6161975|P1|NOT COMPLETED|Overall Study||6
2514411|NCT00741260|6161969|P7|COMPLETED|Overall Study||0
2514412|NCT00741260|6161970|P6|COMPLETED|Overall Study||20
2514413|NCT00741260|6161971|P5|COMPLETED|Overall Study||0
2514414|NCT00741260|6161972|P4|COMPLETED|Overall Study||0
2514415|NCT00741260|6161973|P3|COMPLETED|Overall Study||0
2514416|NCT00741260|6161974|P2|COMPLETED|Overall Study||0
2514417|NCT00741260|6161975|P1|COMPLETED|Overall Study||0
2514418|NCT00741260|6161969|P7|STARTED|Overall Study||7
2514419|NCT00741260|6161970|P6|STARTED|Overall Study||65
2514420|NCT00741260|6161971|P5|STARTED|Overall Study||9
2514421|NCT00741260|6161972|P4|STARTED|Overall Study||6
2514422|NCT00741260|6161973|P3|STARTED|Overall Study||4
2514423|NCT00741260|6161974|P2|STARTED|Overall Study||8
2514424|NCT00741260|6161975|P1|STARTED|Overall Study||6
2514425|NCT00741156|6162002|P1|NOT COMPLETED|Overall Study||0
2514426|NCT00741156|6162002|P1|COMPLETED|Overall Study||12
2514427|NCT00741156|6162002|P1|STARTED|Overall Study||12
2514428|NCT00741104|6162017|P1|NOT COMPLETED|Overall Study||0
2514429|NCT00741104|6162017|P1|COMPLETED|Overall Study||363
2514430|NCT00741104|6162017|P1|STARTED|Overall Study||363
2514431|NCT00741091|6162024|P1|NOT COMPLETED|Overall Study||57
2514432|NCT00741091|6162024|P1|COMPLETED|Overall Study||1040
2514433|NCT00741091|6162024|P1|STARTED|Overall Study||1097
2514434|NCT00741039|6162034|P2|NOT COMPLETED|Overall Study||0
2514435|NCT00741039|6162035|P1|NOT COMPLETED|Overall Study||2
2514436|NCT00741039|6162034|P2|COMPLETED|Overall Study||25
2514437|NCT00741039|6162035|P1|COMPLETED|Overall Study||100
2514438|NCT00741039|6162034|P2|STARTED|Overall Study||25
2514439|NCT00741039|6162035|P1|STARTED|Overall Study||102
2514440|NCT00741026|6162041|P1|NOT COMPLETED|Overall Study||0
2514441|NCT00741026|6162041|P1|COMPLETED|Overall Study||15
2514442|NCT00741026|6162041|P1|STARTED|Overall Study||15
2514443|NCT00741013|6162072|P3|NOT COMPLETED|Overall Study||1
2514444|NCT00741013|6162073|P2|NOT COMPLETED|Overall Study||2
2514445|NCT00741013|6162074|P1|NOT COMPLETED|Overall Study||1
2514446|NCT00741013|6162072|P3|COMPLETED|Overall Study||6
2514447|NCT00741013|6162073|P2|COMPLETED|Overall Study||6
2514448|NCT00741013|6162074|P1|COMPLETED|Overall Study||6
2514449|NCT00741013|6162072|P3|STARTED|Overall Study||7
2514450|NCT00741013|6162073|P2|STARTED|Overall Study||8
2514451|NCT00741013|6162074|P1|STARTED|Overall Study||7
2514452|NCT00740870|6162085|P1|NOT COMPLETED|Overall Study||21
2514453|NCT00740870|6162085|P1|COMPLETED|Overall Study||150
2514454|NCT00740870|6162085|P1|STARTED|Overall Study||171
2514455|NCT00740857|6162100|P3|NOT COMPLETED|Overall Study||0
2514456|NCT00740857|6162101|P2|NOT COMPLETED|Overall Study||0
2514457|NCT00740857|6162102|P1|NOT COMPLETED|Overall Study||1
2514458|NCT00740857|6162100|P3|COMPLETED|Overall Study||90
2514459|NCT00740857|6162101|P2|COMPLETED|Overall Study||88
2514460|NCT00740857|6162102|P1|COMPLETED|Overall Study||32
2514461|NCT00740857|6162100|P3|STARTED|Overall Study||90
2514462|NCT00740857|6162101|P2|STARTED|Overall Study||88
2514463|NCT00740857|6162102|P1|STARTED|Overall Study||33
2514464|NCT00740831|6162134|P3|NOT COMPLETED|Overall Study||6
2514465|NCT00740831|6162135|P2|NOT COMPLETED|Overall Study||3
2514466|NCT00740831|6162136|P1|NOT COMPLETED|Overall Study||4
2514467|NCT00740831|6162134|P3|COMPLETED|Overall Study|Patients who completed part A (visit 6)|95
2514468|NCT00740831|6162135|P2|COMPLETED|Overall Study|Patients who completed part A (visit 6)|100
2514469|NCT00740831|6162136|P1|COMPLETED|Overall Study|Patients who completed part A (visit 6)|93
2514470|NCT00740831|6162134|P3|STARTED|Overall Study|Safety population|101
2514471|NCT00740831|6162135|P2|STARTED|Overall Study|Safety population|103
2514472|NCT00740831|6162136|P1|STARTED|Overall Study|Safety population|97
2514473|NCT00740792|6162157|P4|NOT COMPLETED|Overall Study||10
2514474|NCT00740792|6162158|P3|NOT COMPLETED|Overall Study||9
2514475|NCT00740792|6162159|P2|NOT COMPLETED|Overall Study||8
2514476|NCT00740792|6162160|P1|NOT COMPLETED|Overall Study||10
2514477|NCT00740792|6162157|P4|COMPLETED|Overall Study||190
2514478|NCT00740792|6162158|P3|COMPLETED|Overall Study||180
2514479|NCT00740792|6162159|P2|COMPLETED|Overall Study||186
2514480|NCT00740792|6162160|P1|COMPLETED|Overall Study||183
2514481|NCT00740792|6162157|P4|STARTED|Overall Study||200
2514482|NCT00740792|6162158|P3|STARTED|Overall Study||189
2514483|NCT00740792|6162159|P2|STARTED|Overall Study||194
2514484|NCT00740792|6162160|P1|STARTED|Overall Study||193
2514485|NCT00740779|6162181|P3|NOT COMPLETED|Overall Study||13
2514486|NCT00740779|6162182|P2|NOT COMPLETED|Overall Study||14
2514487|NCT00740779|6162183|P1|NOT COMPLETED|Overall Study||9
2514488|NCT00740779|6162181|P3|COMPLETED|Overall Study||41
2514489|NCT00740779|6162182|P2|COMPLETED|Overall Study||31
2514490|NCT00740779|6162183|P1|COMPLETED|Overall Study||43
2514491|NCT00740779|6162181|P3|STARTED|Overall Study||54
2514492|NCT00740779|6162182|P2|STARTED|Overall Study||45
2514493|NCT00740779|6162183|P1|STARTED|Overall Study||52
2514494|NCT00740727|6162191|P1|NOT COMPLETED|Overall Study||0
2514495|NCT00740727|6162191|P1|COMPLETED|Overall Study||18
2514496|NCT00740727|6162191|P1|STARTED|Overall Study||18
2514497|NCT00740714|6162200|P3|NOT COMPLETED|Overall Study||29
2514498|NCT00740714|6162201|P2|NOT COMPLETED|Overall Study||19
2514499|NCT00740714|6162202|P1|NOT COMPLETED|Overall Study||17
2514500|NCT00740714|6162200|P3|COMPLETED|Overall Study||174
2514501|NCT00740714|6162201|P2|COMPLETED|Overall Study||182
2514502|NCT00740714|6162202|P1|COMPLETED|Overall Study||179
2514503|NCT00740714|6162200|P3|Active Patients at Study Termination|Overall Study||33
2514504|NCT00740714|6162201|P2|Active Patients at Study Termination|Overall Study||12
2514505|NCT00740714|6162202|P1|Active Patients at Study Termination|Overall Study||24
2514506|NCT00740714|6162200|P3|Reaching Endpoint Before May 6, 2011|Overall Study||94
2514507|NCT00740714|6162201|P2|Reaching Endpoint Before May 6, 2011|Overall Study||87
2514508|NCT00740714|6162202|P1|Reaching Endpoint Before May 6, 2011|Overall Study||86
2514509|NCT00740714|6162200|P3|STARTED|Overall Study|Randomized throughout the recruitment period|203
2514510|NCT00740714|6162201|P2|STARTED|Overall Study|Randomized throughout the recruitment period|201
2514511|NCT00740714|6162202|P1|STARTED|Overall Study|Randomized throughout the recruitment period|196
2514512|NCT00740636|6162278|P2|NOT COMPLETED|Overall Study||4
2514513|NCT00740636|6162279|P1|NOT COMPLETED|Overall Study||2
2514514|NCT00740636|6162278|P2|COMPLETED|Overall Study||63
2514515|NCT00740636|6162279|P1|COMPLETED|Overall Study||23
2514516|NCT00740636|6162278|P2|STARTED|Overall Study||67
2514517|NCT00740636|6162279|P1|STARTED|Overall Study||25
2514518|NCT00740597|6162285|P1|NOT COMPLETED|Overall Study||1
2514519|NCT00740597|6162285|P1|COMPLETED|Overall Study||0
2514520|NCT00740597|6162285|P1|STARTED|Overall Study||1
2514521|NCT00740584|6162289|P1|NOT COMPLETED|Overall Study||1
2514522|NCT00740584|6162289|P1|COMPLETED|Overall Study||11
2514523|NCT00740584|6162289|P1|STARTED|Overall Study||12
2514524|NCT00740480|6162294|P1|NOT COMPLETED|Overall Study||2
2514525|NCT00740480|6162294|P1|COMPLETED|Overall Study||23
2514526|NCT00740480|6162294|P1|STARTED|Overall Study||25
2514527|NCT00740376|6162300|P2|NOT COMPLETED|Overall Study||3
2514528|NCT00740376|6162301|P1|NOT COMPLETED|Overall Study||3
2514529|NCT00740376|6162300|P2|COMPLETED|Overall Study||12
2514530|NCT00740376|6162301|P1|COMPLETED|Overall Study||19
2514531|NCT00740376|6162300|P2|STARTED|Overall Study||15
2514532|NCT00740376|6162301|P1|STARTED|Overall Study||22
2514533|NCT00740220|6162319|P1|NOT COMPLETED|Overall Study||9
2514534|NCT00740220|6162319|P1|COMPLETED|Overall Study||88
2514535|NCT00740220|6162319|P1|STARTED|Overall Study||97
2514536|NCT00740207|6162325|P2|NOT COMPLETED|Overall Study||0
2514537|NCT00740207|6162326|P1|NOT COMPLETED|Overall Study||0
2514538|NCT00740207|6162325|P2|COMPLETED|Overall Study||16
2514539|NCT00740207|6162326|P1|COMPLETED|Overall Study||17
2514540|NCT00740207|6162325|P2|STARTED|Overall Study||16
2514541|NCT00740207|6162326|P1|STARTED|Overall Study||17
2514542|NCT00740181|6162338|P1|NOT COMPLETED|Overall Study||0
2514543|NCT00740181|6162338|P1|COMPLETED|Overall Study||9
2514544|NCT00740181|6162338|P1|STARTED|Overall Study||9
2514545|NCT00740051|6162344|P2|NOT COMPLETED|Overall Study||32
2514546|NCT00740051|6162345|P1|NOT COMPLETED|Overall Study||18
2514547|NCT00740051|6162344|P2|COMPLETED|Overall Study||119
2514548|NCT00740051|6162345|P1|COMPLETED|Overall Study||58
2514549|NCT00740051|6162344|P2|STARTED|Overall Study||151
2514550|NCT00740051|6162345|P1|STARTED|Overall Study||76
2514551|NCT00739999|6162367|P2|NOT COMPLETED|Overall Study||0
2514552|NCT00739999|6162368|P1|NOT COMPLETED|Overall Study||0
2514553|NCT00739999|6162367|P2|COMPLETED|Overall Study||24
2514554|NCT00739999|6162368|P1|COMPLETED|Overall Study||15
2514555|NCT00739999|6162367|P2|STARTED|Overall Study||24
2514556|NCT00739999|6162368|P1|STARTED|Overall Study||15
2514557|NCT00739973|6162448|P9|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||14
2514558|NCT00739973|6162449|P8|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||10
2514559|NCT00739973|6162450|P7|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||13
2514560|NCT00739973|6162451|P6|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
2514561|NCT00739973|6162452|P5|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
2514562|NCT00739973|6162453|P4|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
2514563|NCT00739973|6162454|P3|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
2514564|NCT00739973|6162455|P2|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||20
2514565|NCT00739973|6162456|P1|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||30
2514566|NCT00739973|6162448|P9|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
2514567|NCT00739973|6162449|P8|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
2514568|NCT00739973|6162450|P7|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
2514569|NCT00739973|6162451|P6|COMPLETED|Double-blind:Randomized Period (8 Weeks)||169
2514570|NCT00739973|6162452|P5|COMPLETED|Double-blind:Randomized Period (8 Weeks)||162
2514571|NCT00739973|6162453|P4|COMPLETED|Double-blind:Randomized Period (8 Weeks)||173
2514572|NCT00739973|6162454|P3|COMPLETED|Double-blind:Randomized Period (8 Weeks)||184
2514573|NCT00739973|6162455|P2|COMPLETED|Double-blind:Randomized Period (8 Weeks)||175
2514574|NCT00739973|6162456|P1|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
2514575|NCT00739973|6162448|P9|STARTED|Double-blind:Randomized Period (8 Weeks)||184
2514576|NCT00739973|6162449|P8|STARTED|Double-blind:Randomized Period (8 Weeks)||178
2514577|NCT00739973|6162450|P7|STARTED|Double-blind:Randomized Period (8 Weeks)|2 pts. were mis-randomized, so discontinued from single-blind and were untreated in double-blind.|183
2514578|NCT00739973|6162451|P6|STARTED|Double-blind:Randomized Period (8 Weeks)||181
2514579|NCT00739973|6162452|P5|STARTED|Double-blind:Randomized Period (8 Weeks)||181
2514580|NCT00739973|6162453|P4|STARTED|Double-blind:Randomized Period (8 Weeks)||185
2514581|NCT00739973|6162454|P3|STARTED|Double-blind:Randomized Period (8 Weeks)||203
2514582|NCT00739973|6162455|P2|STARTED|Double-blind:Randomized Period (8 Weeks)|One pt. was mis-randomized, so discontinued from single-blind and was untreated in the double-blind.|195
2514583|NCT00739973|6162456|P1|STARTED|Double-blind:Randomized Period (8 Weeks)||198
2514584|NCT00739973|6162448|P9|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
2514585|NCT00739973|6162449|P8|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
2514586|NCT00739973|6162450|P7|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
2514587|NCT00739973|6162451|P6|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
2514588|NCT00739973|6162452|P5|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
2514589|NCT00739973|6162453|P4|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
2514590|NCT00739973|6162454|P3|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
2514591|NCT00739973|6162455|P2|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
2514592|NCT00739973|6162456|P1|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||1009
2514593|NCT00739973|6162448|P9|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
2514594|NCT00739973|6162449|P8|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
2514595|NCT00739973|6162450|P7|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
2514596|NCT00739973|6162451|P6|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
2514597|NCT00739973|6162452|P5|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
2514598|NCT00739973|6162453|P4|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
2514599|NCT00739973|6162454|P3|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
2514600|NCT00739973|6162455|P2|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
2514601|NCT00739973|6162456|P1|COMPLETED|Single-blind Period (2 to 4 Weeks)||1685
2514602|NCT00739973|6162448|P9|STARTED|Single-blind Period (2 to 4 Weeks)||0
2514603|NCT00739973|6162449|P8|STARTED|Single-blind Period (2 to 4 Weeks)||0
2514604|NCT00739973|6162450|P7|STARTED|Single-blind Period (2 to 4 Weeks)||0
2514605|NCT00739973|6162451|P6|STARTED|Single-blind Period (2 to 4 Weeks)||0
2514606|NCT00739973|6162452|P5|STARTED|Single-blind Period (2 to 4 Weeks)||0
2514607|NCT00739973|6162453|P4|STARTED|Single-blind Period (2 to 4 Weeks)||0
2514608|NCT00739973|6162454|P3|STARTED|Single-blind Period (2 to 4 Weeks)||0
2514609|NCT00739973|6162455|P2|STARTED|Single-blind Period (2 to 4 Weeks)||0
2514610|NCT00739973|6162456|P1|STARTED|Single-blind Period (2 to 4 Weeks)|In this period, participants were enrolled to only Placebo arm.|2694
2514611|NCT00739934|6162542|P1|NOT COMPLETED|Voriconazole Oral||3
2514612|NCT00739934|6162542|P1|COMPLETED|Voriconazole Oral||31
2514613|NCT00739934|6162542|P1|STARTED|Voriconazole Oral||34
2514614|NCT00739934|6162542|P1|NOT COMPLETED|Voriconazole IV||6
2514615|NCT00739934|6162542|P1|COMPLETED|Voriconazole IV||34
2514616|NCT00739934|6162542|P1|STARTED|Voriconazole IV||40
2514617|NCT00739908|6162564|P2|NOT COMPLETED|Overall Study||25
2514618|NCT00739908|6162565|P1|NOT COMPLETED|Overall Study||25
2514619|NCT00739908|6162564|P2|COMPLETED|Overall Study||118
2514620|NCT00739908|6162565|P1|COMPLETED|Overall Study||117
2514621|NCT00739908|6162564|P2|STARTED|Overall Study||143
2514622|NCT00739908|6162565|P1|STARTED|Overall Study||142
2514623|NCT00739882|6162585|P2|NOT COMPLETED|Open-label Period||5
2514624|NCT00739882|6162586|P1|NOT COMPLETED|Open-label Period||10
2514625|NCT00739882|6162585|P2|COMPLETED|Open-label Period||9
2514626|NCT00739882|6162586|P1|COMPLETED|Open-label Period||7
2514627|NCT00739882|6162585|P2|STARTED|Open-label Period||14
2514628|NCT00739882|6162586|P1|STARTED|Open-label Period||17
2514629|NCT00739882|6162585|P2|NOT COMPLETED|Double-blind Period||11
2514630|NCT00739882|6162586|P1|NOT COMPLETED|Double-blind Period||19
2514631|NCT00739882|6162585|P2|COMPLETED|Double-blind Period||14
2514632|NCT00739882|6162586|P1|COMPLETED|Double-blind Period||32
2514633|NCT00739882|6162585|P2|STARTED|Double-blind Period||25
2514634|NCT00739882|6162586|P1|STARTED|Double-blind Period||51
2514635|NCT00739765|6162607|P3|NOT COMPLETED|Overall Study||11
2514636|NCT00739765|6162608|P2|NOT COMPLETED|Overall Study||11
2514637|NCT00739765|6162609|P1|NOT COMPLETED|Overall Study||6
2514638|NCT00739765|6162607|P3|COMPLETED|Overall Study||21
2514639|NCT00739765|6162608|P2|COMPLETED|Overall Study||27
2514640|NCT00739765|6162609|P1|COMPLETED|Overall Study||34
2514641|NCT00739765|6162607|P3|STARTED|Overall Study||32
2514642|NCT00739765|6162608|P2|STARTED|Overall Study||38
2514643|NCT00739765|6162609|P1|STARTED|Overall Study||40
2514644|NCT00739752|6162626|P6|NOT COMPLETED|Overall Study||0
2514645|NCT00739752|6162627|P5|NOT COMPLETED|Overall Study||0
2514646|NCT00739752|6162628|P4|NOT COMPLETED|Overall Study||0
2514647|NCT00739752|6162629|P3|NOT COMPLETED|Overall Study||0
2514648|NCT00739752|6162630|P2|NOT COMPLETED|Overall Study||0
2514649|NCT00739752|6162631|P1|NOT COMPLETED|Overall Study||0
2514650|NCT00739752|6162626|P6|COMPLETED|Overall Study||293
2514651|NCT00739752|6162627|P5|COMPLETED|Overall Study||291
2514652|NCT00739752|6162628|P4|COMPLETED|Overall Study||288
2514653|NCT00739752|6162629|P3|COMPLETED|Overall Study||292
2514654|NCT00739752|6162630|P2|COMPLETED|Overall Study||284
2514655|NCT00739752|6162631|P1|COMPLETED|Overall Study||299
2514656|NCT00739752|6162626|P6|STARTED|Overall Study||293
2514657|NCT00739752|6162627|P5|STARTED|Overall Study||291
2514658|NCT00739752|6162628|P4|STARTED|Overall Study||288
2514659|NCT00739752|6162629|P3|STARTED|Overall Study||292
2514660|NCT00739752|6162630|P2|STARTED|Overall Study||284
2514661|NCT00739752|6162631|P1|STARTED|Overall Study||299
2514662|NCT00739674|6162647|P2|NOT COMPLETED|Overall Study||122
2514663|NCT00739674|6162648|P1|NOT COMPLETED|Overall Study||181
2514664|NCT00739674|6162647|P2|COMPLETED|Overall Study||335
2514665|NCT00739674|6162648|P1|COMPLETED|Overall Study||354
2514666|NCT00739674|6162647|P2|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|400
2514667|NCT00739674|6162648|P1|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|463
2514668|NCT00739674|6162647|P2|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|9
2514669|NCT00739674|6162648|P1|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|1
2514670|NCT00739674|6162647|P2|No Follow-up Data|Overall Study||18
2514671|NCT00739674|6162648|P1|No Follow-up Data|Overall Study||33
2514672|NCT00739674|6162647|P2|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|13
2514673|NCT00739674|6162648|P1|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|19
2514674|NCT00739674|6162647|P2|Screening Failures|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|17
2514675|NCT00739674|6162648|P1|Screening Failures|Overall Study||19
2514676|NCT00739674|6162647|P2|STARTED|Overall Study||457
2514677|NCT00739674|6162648|P1|STARTED|Overall Study||535
2514678|NCT00739661|6162676|P2|NOT COMPLETED|Overall Study||42
2514679|NCT00739661|6162677|P1|NOT COMPLETED|Overall Study||46
2514680|NCT00739661|6162676|P2|COMPLETED|Overall Study||10
2514681|NCT00739661|6162677|P1|COMPLETED|Overall Study||6
2514682|NCT00739661|6162676|P2|STARTED|Overall Study||52
2514683|NCT00739661|6162677|P1|STARTED|Overall Study||52
2514684|NCT00739648|6162689|P2|NOT COMPLETED|Overall Study||53
2514685|NCT00739648|6162690|P1|NOT COMPLETED|Overall Study||26
2514686|NCT00739648|6162689|P2|COMPLETED|Overall Study||161
2514687|NCT00739648|6162690|P1|COMPLETED|Overall Study||82
2514688|NCT00739648|6162689|P2|STARTED|Overall Study||214
2514689|NCT00739648|6162690|P1|STARTED|Overall Study||108
2514690|NCT00739596|6162704|P2|NOT COMPLETED|Overall Study||17
2514691|NCT00739596|6162705|P1|NOT COMPLETED|Overall Study||25
2514692|NCT00739596|6162704|P2|COMPLETED|Overall Study||149
2514693|NCT00739596|6162705|P1|COMPLETED|Overall Study||141
2514694|NCT00739596|6162704|P2|STARTED|Overall Study||166
2514695|NCT00739596|6162705|P1|STARTED|Overall Study||166
2514696|NCT00739583|6162721|P2|NOT COMPLETED|Overall Study||0
2514697|NCT00739583|6162722|P1|NOT COMPLETED|Overall Study||0
2514698|NCT00739583|6162721|P2|COMPLETED|Overall Study||10
2514699|NCT00739583|6162722|P1|COMPLETED|Overall Study||10
2514700|NCT00739583|6162721|P2|STARTED|Overall Study||10
2514701|NCT00739583|6162722|P1|STARTED|Overall Study||10
2514702|NCT00739336|6162734|P2|NOT COMPLETED|Overall Study||0
2514703|NCT00739336|6162735|P1|NOT COMPLETED|Overall Study||4
2514704|NCT00739336|6162734|P2|COMPLETED|Overall Study||24
2514705|NCT00739336|6162735|P1|COMPLETED|Overall Study||17
2514706|NCT00739336|6162734|P2|STARTED|Overall Study||24
2514707|NCT00739336|6162735|P1|STARTED|Overall Study||21
2514708|NCT00739310|6162747|P1|NOT COMPLETED|Overall Study||7
2514709|NCT00739310|6162747|P1|COMPLETED|Overall Study||22
2514710|NCT00739310|6162747|P1|STARTED|Overall Study||29
2514711|NCT00739297|6162752|P7|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
2514712|NCT00739297|6162753|P6|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
2514713|NCT00739297|6162754|P5|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
2514714|NCT00739297|6162755|P4|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
2514715|NCT00739297|6162756|P3|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
2514716|NCT00739297|6162757|P2|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
2514717|NCT00739297|6162758|P1|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
2514718|NCT00739297|6162752|P7|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||65
2514719|NCT00739297|6162753|P6|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
2514720|NCT00739297|6162754|P5|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||7
2514721|NCT00739297|6162755|P4|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||15
2514722|NCT00739297|6162756|P3|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
2514723|NCT00739297|6162757|P2|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||11
2514724|NCT00739297|6162758|P1|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||16
2514725|NCT00739297|6162752|P7|STARTED|Fourth Intervention(Visit 9 to Visit 10)||66
2514726|NCT00739297|6162753|P6|STARTED|Fourth Intervention(Visit 9 to Visit 10)||9
2514727|NCT00739297|6162754|P5|STARTED|Fourth Intervention(Visit 9 to Visit 10)||7
2514728|NCT00739297|6162755|P4|STARTED|Fourth Intervention(Visit 9 to Visit 10)||15
2514729|NCT00739297|6162756|P3|STARTED|Fourth Intervention(Visit 9 to Visit 10)||8
2514730|NCT00739297|6162757|P2|STARTED|Fourth Intervention(Visit 9 to Visit 10)||11
2514731|NCT00739297|6162758|P1|STARTED|Fourth Intervention(Visit 9 to Visit 10)||16
2514732|NCT00739297|6162752|P7|NOT COMPLETED|Third Washout Period of 4-7 Days||0
2514733|NCT00739297|6162753|P6|NOT COMPLETED|Third Washout Period of 4-7 Days||0
2514734|NCT00739297|6162754|P5|NOT COMPLETED|Third Washout Period of 4-7 Days||0
2514735|NCT00739297|6162755|P4|NOT COMPLETED|Third Washout Period of 4-7 Days||0
2514736|NCT00739297|6162756|P3|NOT COMPLETED|Third Washout Period of 4-7 Days||0
2514737|NCT00739297|6162757|P2|NOT COMPLETED|Third Washout Period of 4-7 Days||0
2514738|NCT00739297|6162758|P1|NOT COMPLETED|Third Washout Period of 4-7 Days||0
2514739|NCT00739297|6162752|P7|COMPLETED|Third Washout Period of 4-7 Days||66
2514740|NCT00739297|6162753|P6|COMPLETED|Third Washout Period of 4-7 Days||8
2514741|NCT00739297|6162754|P5|COMPLETED|Third Washout Period of 4-7 Days||6
2514742|NCT00739297|6162755|P4|COMPLETED|Third Washout Period of 4-7 Days||18
2514743|NCT00739297|6162756|P3|COMPLETED|Third Washout Period of 4-7 Days||6
2514744|NCT00739297|6162757|P2|COMPLETED|Third Washout Period of 4-7 Days||12
2514745|NCT00739297|6162758|P1|COMPLETED|Third Washout Period of 4-7 Days||16
2514746|NCT00739297|6162752|P7|STARTED|Third Washout Period of 4-7 Days||66
2514747|NCT00739297|6162753|P6|STARTED|Third Washout Period of 4-7 Days||8
2514748|NCT00739297|6162754|P5|STARTED|Third Washout Period of 4-7 Days||6
2514749|NCT00739297|6162755|P4|STARTED|Third Washout Period of 4-7 Days||18
2514750|NCT00739297|6162756|P3|STARTED|Third Washout Period of 4-7 Days||6
2514751|NCT00739297|6162757|P2|STARTED|Third Washout Period of 4-7 Days||12
2514752|NCT00739297|6162758|P1|STARTED|Third Washout Period of 4-7 Days||16
2514753|NCT00739297|6162752|P7|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
2514754|NCT00739297|6162753|P6|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
2514755|NCT00739297|6162754|P5|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
2514756|NCT00739297|6162755|P4|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
2514757|NCT00739297|6162756|P3|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
2514758|NCT00739297|6162757|P2|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
2514759|NCT00739297|6162758|P1|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
2514760|NCT00739297|6162752|P7|COMPLETED|Third Intervention (Visit 7 to Visit 8)||66
2514761|NCT00739297|6162753|P6|COMPLETED|Third Intervention (Visit 7 to Visit 8)||8
2514762|NCT00739297|6162754|P5|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
2514763|NCT00739297|6162755|P4|COMPLETED|Third Intervention (Visit 7 to Visit 8)||18
2514764|NCT00739297|6162756|P3|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
2514765|NCT00739297|6162757|P2|COMPLETED|Third Intervention (Visit 7 to Visit 8)||12
2514766|NCT00739297|6162758|P1|COMPLETED|Third Intervention (Visit 7 to Visit 8)||16
2514767|NCT00739297|6162752|P7|STARTED|Third Intervention (Visit 7 to Visit 8)||66
2514768|NCT00739297|6162753|P6|STARTED|Third Intervention (Visit 7 to Visit 8)||8
2514769|NCT00739297|6162754|P5|STARTED|Third Intervention (Visit 7 to Visit 8)||6
2514770|NCT00739297|6162755|P4|STARTED|Third Intervention (Visit 7 to Visit 8)||18
2514771|NCT00739297|6162756|P3|STARTED|Third Intervention (Visit 7 to Visit 8)||6
2514772|NCT00739297|6162757|P2|STARTED|Third Intervention (Visit 7 to Visit 8)||12
2514773|NCT00739297|6162758|P1|STARTED|Third Intervention (Visit 7 to Visit 8)||16
2514774|NCT00739297|6162752|P7|NOT COMPLETED|Second Washout Period of 4-7 Days||0
2514775|NCT00739297|6162753|P6|NOT COMPLETED|Second Washout Period of 4-7 Days||0
2514776|NCT00739297|6162754|P5|NOT COMPLETED|Second Washout Period of 4-7 Days||0
2514777|NCT00739297|6162755|P4|NOT COMPLETED|Second Washout Period of 4-7 Days||0
2514778|NCT00739297|6162756|P3|NOT COMPLETED|Second Washout Period of 4-7 Days||0
2514779|NCT00739297|6162757|P2|NOT COMPLETED|Second Washout Period of 4-7 Days||0
2514780|NCT00739297|6162758|P1|NOT COMPLETED|Second Washout Period of 4-7 Days||0
2514781|NCT00739297|6162752|P7|COMPLETED|Second Washout Period of 4-7 Days||66
2514782|NCT00739297|6162753|P6|COMPLETED|Second Washout Period of 4-7 Days||10
2514783|NCT00739297|6162754|P5|COMPLETED|Second Washout Period of 4-7 Days||6
2514784|NCT00739297|6162755|P4|COMPLETED|Second Washout Period of 4-7 Days||14
2514785|NCT00739297|6162756|P3|COMPLETED|Second Washout Period of 4-7 Days||10
2514786|NCT00739297|6162757|P2|COMPLETED|Second Washout Period of 4-7 Days||8
2514787|NCT00739297|6162758|P1|COMPLETED|Second Washout Period of 4-7 Days||18
2514788|NCT00739297|6162752|P7|STARTED|Second Washout Period of 4-7 Days||66
2514789|NCT00739297|6162753|P6|STARTED|Second Washout Period of 4-7 Days||10
2514790|NCT00739297|6162754|P5|STARTED|Second Washout Period of 4-7 Days||6
2514791|NCT00739297|6162755|P4|STARTED|Second Washout Period of 4-7 Days||14
2514792|NCT00739297|6162756|P3|STARTED|Second Washout Period of 4-7 Days||10
2514793|NCT00739297|6162757|P2|STARTED|Second Washout Period of 4-7 Days||8
2514794|NCT00739297|6162758|P1|STARTED|Second Washout Period of 4-7 Days||18
2514795|NCT00739297|6162752|P7|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
2514796|NCT00739297|6162753|P6|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
2514797|NCT00739297|6162754|P5|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
2514798|NCT00739297|6162755|P4|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
2514799|NCT00739297|6162756|P3|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
2514800|NCT00739297|6162757|P2|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
2514801|NCT00739297|6162758|P1|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
2514802|NCT00739297|6162752|P7|COMPLETED|Second Intervention (Visit 5 to Visit 6)||66
2514803|NCT00739297|6162753|P6|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
2514804|NCT00739297|6162754|P5|COMPLETED|Second Intervention (Visit 5 to Visit 6)||6
2514805|NCT00739297|6162755|P4|COMPLETED|Second Intervention (Visit 5 to Visit 6)||14
2514806|NCT00739297|6162756|P3|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
2514807|NCT00739297|6162757|P2|COMPLETED|Second Intervention (Visit 5 to Visit 6)||8
2514808|NCT00739297|6162758|P1|COMPLETED|Second Intervention (Visit 5 to Visit 6)||18
2514809|NCT00739297|6162752|P7|STARTED|Second Intervention (Visit 5 to Visit 6)||66
2514810|NCT00739297|6162753|P6|STARTED|Second Intervention (Visit 5 to Visit 6)||10
2514811|NCT00739297|6162754|P5|STARTED|Second Intervention (Visit 5 to Visit 6)||6
2514812|NCT00739297|6162755|P4|STARTED|Second Intervention (Visit 5 to Visit 6)||14
2514813|NCT00739297|6162756|P3|STARTED|Second Intervention (Visit 5 to Visit 6)||10
2514814|NCT00739297|6162757|P2|STARTED|Second Intervention (Visit 5 to Visit 6)||8
2514815|NCT00739297|6162758|P1|STARTED|Second Intervention (Visit 5 to Visit 6)||18
2514816|NCT00739297|6162752|P7|NOT COMPLETED|First Washout Period of 4-7 Days||2
2514817|NCT00739297|6162753|P6|NOT COMPLETED|First Washout Period of 4-7 Days||0
2514818|NCT00739297|6162754|P5|NOT COMPLETED|First Washout Period of 4-7 Days||0
2514819|NCT00739297|6162755|P4|NOT COMPLETED|First Washout Period of 4-7 Days||2
2514820|NCT00739297|6162756|P3|NOT COMPLETED|First Washout Period of 4-7 Days||0
2514821|NCT00739297|6162757|P2|NOT COMPLETED|First Washout Period of 4-7 Days||0
2514822|NCT00739297|6162758|P1|NOT COMPLETED|First Washout Period of 4-7 Days||0
2514823|NCT00739297|6162752|P7|COMPLETED|First Washout Period of 4-7 Days||66
2514824|NCT00739297|6162753|P6|COMPLETED|First Washout Period of 4-7 Days||9
2514825|NCT00739297|6162754|P5|COMPLETED|First Washout Period of 4-7 Days||6
2514826|NCT00739297|6162755|P4|COMPLETED|First Washout Period of 4-7 Days||17
2514827|NCT00739297|6162756|P3|COMPLETED|First Washout Period of 4-7 Days||6
2514828|NCT00739297|6162757|P2|COMPLETED|First Washout Period of 4-7 Days||11
2514829|NCT00739297|6162758|P1|COMPLETED|First Washout Period of 4-7 Days||17
2514830|NCT00739297|6162752|P7|STARTED|First Washout Period of 4-7 Days||68
2514831|NCT00739297|6162753|P6|STARTED|First Washout Period of 4-7 Days||9
2514832|NCT00739297|6162754|P5|STARTED|First Washout Period of 4-7 Days||6
2514833|NCT00739297|6162755|P4|STARTED|First Washout Period of 4-7 Days||19
2514834|NCT00739297|6162756|P3|STARTED|First Washout Period of 4-7 Days||6
2514835|NCT00739297|6162757|P2|STARTED|First Washout Period of 4-7 Days||11
2514836|NCT00739297|6162758|P1|STARTED|First Washout Period of 4-7 Days||17
2514837|NCT00739297|6162752|P7|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
2514838|NCT00739297|6162753|P6|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
2514839|NCT00739297|6162754|P5|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
2514840|NCT00739297|6162755|P4|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
2514841|NCT00739297|6162756|P3|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
2514842|NCT00739297|6162757|P2|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
2514843|NCT00739297|6162758|P1|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
2514844|NCT00739297|6162752|P7|COMPLETED|First Intervention (Visit 3 to Visit 4)||68
2514845|NCT00739297|6162753|P6|COMPLETED|First Intervention (Visit 3 to Visit 4)||9
2514846|NCT00739297|6162754|P5|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
2514847|NCT00739297|6162755|P4|COMPLETED|First Intervention (Visit 3 to Visit 4)||19
2514848|NCT00739297|6162756|P3|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
2514849|NCT00739297|6162757|P2|COMPLETED|First Intervention (Visit 3 to Visit 4)||11
2514850|NCT00739297|6162758|P1|COMPLETED|First Intervention (Visit 3 to Visit 4)||17
2514851|NCT00739297|6162752|P7|STARTED|First Intervention (Visit 3 to Visit 4)||68
2514852|NCT00739297|6162753|P6|STARTED|First Intervention (Visit 3 to Visit 4)||9
2514853|NCT00739297|6162754|P5|STARTED|First Intervention (Visit 3 to Visit 4)||6
2514854|NCT00739297|6162755|P4|STARTED|First Intervention (Visit 3 to Visit 4)||19
2514855|NCT00739297|6162756|P3|STARTED|First Intervention (Visit 3 to Visit 4)||6
2514856|NCT00739297|6162757|P2|STARTED|First Intervention (Visit 3 to Visit 4)||11
2514857|NCT00739297|6162758|P1|STARTED|First Intervention (Visit 3 to Visit 4)||17
2514858|NCT00739102|6162786|P1|NOT COMPLETED|Overall Study||15
2514859|NCT00739102|6162786|P1|COMPLETED|Overall Study|Completed 12-Month Follow-up|235
2514860|NCT00739102|6162786|P1|STARTED|Overall Study||250
2514861|NCT00739063|6162802|P1|NOT COMPLETED|Overall Study||8
2514862|NCT00739063|6162802|P1|COMPLETED|Overall Study||3
2514863|NCT00739063|6162802|P1|STARTED|Overall Study||11
2514864|NCT00739050|6162806|P2|NOT COMPLETED|Overall Study||0
2514865|NCT00739050|6162807|P1|NOT COMPLETED|Overall Study||1
2514866|NCT00739050|6162806|P2|COMPLETED|Overall Study||0
2514867|NCT00739050|6162807|P1|COMPLETED|Overall Study|These 3 patients completing treatment did not complete the required procedures during the trial.|3
2514868|NCT00739050|6162806|P2|STARTED|Overall Study||0
2514869|NCT00739050|6162807|P1|STARTED|Overall Study||4
2514870|NCT00739024|6162821|P2|NOT COMPLETED|Overall Study||0
2514871|NCT00739024|6162822|P1|NOT COMPLETED|Overall Study||0
2514872|NCT00739024|6162821|P2|COMPLETED|Overall Study||6
2514873|NCT00739024|6162822|P1|COMPLETED|Overall Study||7
2514874|NCT00739024|6162821|P2|STARTED|Overall Study||6
2514875|NCT00739024|6162822|P1|STARTED|Overall Study||7
2514876|NCT00738972|6162832|P4|NOT COMPLETED|Overall Study||1
2514877|NCT00738972|6162833|P3|NOT COMPLETED|Overall Study||0
2514878|NCT00738972|6162834|P2|NOT COMPLETED|Overall Study||0
2514879|NCT00738972|6162835|P1|NOT COMPLETED|Overall Study||0
2514880|NCT00738972|6162832|P4|COMPLETED|Overall Study||2
2514881|NCT00738972|6162833|P3|COMPLETED|Overall Study||3
2514882|NCT00738972|6162834|P2|COMPLETED|Overall Study||3
2514883|NCT00738972|6162835|P1|COMPLETED|Overall Study||3
2514884|NCT00738972|6162832|P4|STARTED|Overall Study||3
2514885|NCT00738972|6162833|P3|STARTED|Overall Study||3
2514886|NCT00738972|6162834|P2|STARTED|Overall Study||3
2514887|NCT00738972|6162835|P1|STARTED|Overall Study||3
2514888|NCT00738894|6162847|P2|NOT COMPLETED|Overall Study||33
2514889|NCT00738894|6162848|P1|NOT COMPLETED|Overall Study||39
2514890|NCT00738894|6162847|P2|COMPLETED|Overall Study||190
2514891|NCT00738894|6162848|P1|COMPLETED|Overall Study||402
2514892|NCT00738894|6162847|P2|STARTED|Overall Study||223
2514893|NCT00738894|6162848|P1|STARTED|Overall Study||441
2514894|NCT00738881|6162861|P2|NOT COMPLETED|Overall Study||2
2514895|NCT00738881|6162862|P1|NOT COMPLETED|Overall Study||0
2514896|NCT00738881|6162861|P2|COMPLETED|Overall Study||10
2514897|NCT00738881|6162862|P1|COMPLETED|Overall Study||11
2514898|NCT00738881|6162861|P2|STARTED|Overall Study||12
2514899|NCT00738881|6162862|P1|STARTED|Overall Study||11
2514900|NCT00738699|6162876|P2|NOT COMPLETED|Overall Study||140
2514901|NCT00738699|6162877|P1|NOT COMPLETED|Overall Study||275
2514902|NCT00738699|6162876|P2|COMPLETED|Overall Study||0
2514903|NCT00738699|6162877|P1|COMPLETED|Overall Study||0
2514904|NCT00738699|6162876|P2|Participants Treated|Overall Study||139
2514905|NCT00738699|6162877|P1|Participants Treated|Overall Study||273
2514906|NCT00738699|6162876|P2|Participants Not Treated|Overall Study||1
2514907|NCT00738699|6162877|P1|Participants Not Treated|Overall Study||2
2514908|NCT00738699|6162876|P2|STARTED|Overall Study||140
2514909|NCT00738699|6162877|P1|STARTED|Overall Study||275
2514910|NCT00738673|6162895|P2|NOT COMPLETED|Overall Study||11
2514911|NCT00738673|6162896|P1|NOT COMPLETED|Overall Study||24
2514912|NCT00738673|6162895|P2|COMPLETED|Overall Study||1
2514913|NCT00738673|6162896|P1|COMPLETED|Overall Study||1
2514914|NCT00738673|6162895|P2|Intent to Treat Population|Overall Study||12
2514915|NCT00738673|6162896|P1|Intent to Treat Population|Overall Study||24
2514916|NCT00738673|6162895|P2|STARTED|Overall Study||12
2514917|NCT00738673|6162896|P1|STARTED|Overall Study||25
2514918|NCT00738543|6162924|P1|NOT COMPLETED|Control||0
2514919|NCT00738543|6162924|P1|COMPLETED|Control||48
2514920|NCT00738543|6162924|P1|STARTED|Control||48
2514921|NCT00738543|6162924|P1|NOT COMPLETED|Sodium Hypochlorite||0
2514922|NCT00738543|6162924|P1|COMPLETED|Sodium Hypochlorite||48
2514923|NCT00738543|6162924|P1|STARTED|Sodium Hypochlorite||48
2514924|NCT00738543|6162924|P1|NOT COMPLETED|Povidone Iodine||0
2514925|NCT00738543|6162924|P1|COMPLETED|Povidone Iodine||48
2514926|NCT00738543|6162924|P1|STARTED|Povidone Iodine||48
2514927|NCT00738530|6162934|P2|NOT COMPLETED|Overall Study||238
2514928|NCT00738530|6162935|P1|NOT COMPLETED|Overall Study||234
2514929|NCT00738530|6162934|P2|COMPLETED|Overall Study||84
2514930|NCT00738530|6162935|P1|COMPLETED|Overall Study||93
2514931|NCT00738530|6162934|P2|Treated|Overall Study||316
2514932|NCT00738530|6162935|P1|Treated|Overall Study||325
2514933|NCT00738530|6162934|P2|STARTED|Overall Study||322
2514934|NCT00738530|6162935|P1|STARTED|Overall Study||327
2514935|NCT00738426|6162961|P2|NOT COMPLETED|Overall Study||3
2514936|NCT00738426|6162962|P1|NOT COMPLETED|Overall Study||2
2514937|NCT00738426|6162961|P2|COMPLETED|Overall Study||32
2514938|NCT00738426|6162962|P1|COMPLETED|Overall Study||35
2514939|NCT00738426|6162961|P2|STARTED|Overall Study||35
2514940|NCT00738426|6162962|P1|STARTED|Overall Study||37
2514941|NCT00738400|6162970|P2|NOT COMPLETED|Overall Study||7
2514942|NCT00738400|6162971|P1|NOT COMPLETED|Overall Study||4
2514943|NCT00738400|6162970|P2|COMPLETED|Overall Study||67
2514944|NCT00738400|6162971|P1|COMPLETED|Overall Study||72
2514945|NCT00738400|6162970|P2|ITT (Intent To Treatment) Population|Overall Study|No post-baseline efficacy measurement in 2 participants|70
2514946|NCT00738400|6162971|P1|ITT (Intent To Treatment) Population|Overall Study||75
2514947|NCT00738400|6162970|P2|Received Treatment, Safety Population|Overall Study|Two invalid participants (no evidence that these randomized participants took study medication).|72
2514948|NCT00738400|6162971|P1|Received Treatment, Safety Population|Overall Study|One invalid participant (no evidence that this randomized participant took study medication).|75
2514949|NCT00738400|6162970|P2|STARTED|Overall Study||74
2514950|NCT00738400|6162971|P1|STARTED|Overall Study||76
2514951|NCT00738374|6162992|P4|NOT COMPLETED|Maintenance Treatment/Observation Phase||12
2514952|NCT00738374|6162993|P3|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
2514953|NCT00738374|6162994|P2|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
2514954|NCT00738374|6162995|P1|NOT COMPLETED|Maintenance Treatment/Observation Phase||0
2514955|NCT00738374|6162992|P4|COMPLETED|Maintenance Treatment/Observation Phase||20
2514956|NCT00738374|6162993|P3|COMPLETED|Maintenance Treatment/Observation Phase||27
2514957|NCT00738374|6162994|P2|COMPLETED|Maintenance Treatment/Observation Phase||0
2514958|NCT00738374|6162995|P1|COMPLETED|Maintenance Treatment/Observation Phase||0
2514959|NCT00738374|6162992|P4|STARTED|Maintenance Treatment/Observation Phase||32
2514960|NCT00738374|6162993|P3|STARTED|Maintenance Treatment/Observation Phase||34
2514961|NCT00738374|6162994|P2|STARTED|Maintenance Treatment/Observation Phase||7
2514962|NCT00738374|6162995|P1|STARTED|Maintenance Treatment/Observation Phase|Participants were randomized to either maintenance therapy or observation at the end of induction.|0
2514963|NCT00738374|6162992|P4|NOT COMPLETED|Induction Treatment Phase||0
2514964|NCT00738374|6162993|P3|NOT COMPLETED|Induction Treatment Phase||0
2514965|NCT00738374|6162994|P2|NOT COMPLETED|Induction Treatment Phase||0
2514966|NCT00738374|6162995|P1|NOT COMPLETED|Induction Treatment Phase||24
2514967|NCT00738374|6162992|P4|COMPLETED|Induction Treatment Phase||0
2514968|NCT00738374|6162993|P3|COMPLETED|Induction Treatment Phase||0
2514969|NCT00738374|6162994|P2|COMPLETED|Induction Treatment Phase||0
2514970|NCT00738374|6162995|P1|COMPLETED|Induction Treatment Phase||73
2514971|NCT00738374|6162992|P4|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
2514972|NCT00738374|6162993|P3|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
2514973|NCT00738374|6162994|P2|STARTED|Induction Treatment Phase||0
2514974|NCT00738374|6162995|P1|STARTED|Induction Treatment Phase||97
2514975|NCT00738361|6163027|P1|NOT COMPLETED|Overall Study||0
2514976|NCT00738361|6163027|P1|COMPLETED|Overall Study||4
2514977|NCT00738361|6163027|P1|STARTED|Overall Study||4
2514978|NCT00738283|6163033|P1|NOT COMPLETED|Overall Study||4
2514979|NCT00738283|6163033|P1|COMPLETED|Overall Study||13
2514980|NCT00738283|6163033|P1|STARTED|Overall Study||17
2514981|NCT00738062|6163040|P3|NOT COMPLETED|Open-Label Extension||0
2514982|NCT00738062|6163041|P2|NOT COMPLETED|Open-Label Extension||0
2514983|NCT00738062|6163042|P1|NOT COMPLETED|Open-Label Extension||17
2514984|NCT00738062|6163040|P3|COMPLETED|Open-Label Extension||0
2514985|NCT00738062|6163041|P2|COMPLETED|Open-Label Extension||0
2514986|NCT00738062|6163042|P1|COMPLETED|Open-Label Extension||57
2514987|NCT00738062|6163040|P3|STARTED|Open-Label Extension||0
2514988|NCT00738062|6163041|P2|STARTED|Open-Label Extension||0
2514989|NCT00738062|6163042|P1|STARTED|Open-Label Extension|One patient completed double blind randomization but did not enter the open label extension|74
2514990|NCT00738062|6163040|P3|NOT COMPLETED|2 Week Randomized Withdrawal||0
2514991|NCT00738062|6163041|P2|NOT COMPLETED|2 Week Randomized Withdrawal||0
2514992|NCT00738062|6163042|P1|NOT COMPLETED|2 Week Randomized Withdrawal||0
2514993|NCT00738062|6163040|P3|COMPLETED|2 Week Randomized Withdrawal||37
2514994|NCT00738062|6163041|P2|COMPLETED|2 Week Randomized Withdrawal||38
2514995|NCT00738062|6163042|P1|COMPLETED|2 Week Randomized Withdrawal||0
2514996|NCT00738062|6163040|P3|STARTED|2 Week Randomized Withdrawal||37
2514997|NCT00738062|6163041|P2|STARTED|2 Week Randomized Withdrawal||38
2514998|NCT00738062|6163042|P1|STARTED|2 Week Randomized Withdrawal|Patients completing the open label titration phase were randomized to either Droxidopa or Placebo|0
2514999|NCT00738062|6163040|P3|NOT COMPLETED|Open Label Treatment||0
2515000|NCT00738062|6163041|P2|NOT COMPLETED|Open Label Treatment||0
2515001|NCT00738062|6163042|P1|NOT COMPLETED|Open Label Treatment||28
2515002|NCT00738062|6163040|P3|COMPLETED|Open Label Treatment||0
2515003|NCT00738062|6163041|P2|COMPLETED|Open Label Treatment||0
2515004|NCT00738062|6163042|P1|COMPLETED|Open Label Treatment||75
2515005|NCT00738062|6163040|P3|STARTED|Open Label Treatment||0
2515006|NCT00738062|6163041|P2|STARTED|Open Label Treatment||0
2515007|NCT00738062|6163042|P1|STARTED|Open Label Treatment||103
2515008|NCT00738049|6163069|P2|NOT COMPLETED|Washout||0
2515009|NCT00738049|6163070|P1|NOT COMPLETED|Washout||0
2515010|NCT00738049|6163069|P2|COMPLETED|Washout||7
2515011|NCT00738049|6163070|P1|COMPLETED|Washout||13
2515012|NCT00738049|6163069|P2|STARTED|Washout||7
2515013|NCT00738049|6163070|P1|STARTED|Washout||13
2515014|NCT00738049|6163069|P2|NOT COMPLETED|2nd Intervention(14 Days)||0
2515015|NCT00738049|6163070|P1|NOT COMPLETED|2nd Intervention(14 Days)||0
2515016|NCT00738049|6163069|P2|COMPLETED|2nd Intervention(14 Days)||7
2515017|NCT00738049|6163070|P1|COMPLETED|2nd Intervention(14 Days)||13
2515018|NCT00738049|6163069|P2|STARTED|2nd Intervention(14 Days)||7
2515019|NCT00738049|6163070|P1|STARTED|2nd Intervention(14 Days)||13
2515020|NCT00738049|6163069|P2|NOT COMPLETED|1st Intervention(14 Days)||0
2515021|NCT00738049|6163070|P1|NOT COMPLETED|1st Intervention(14 Days)||0
2515022|NCT00738049|6163069|P2|COMPLETED|1st Intervention(14 Days)||7
2515023|NCT00738049|6163070|P1|COMPLETED|1st Intervention(14 Days)||13
2515024|NCT00738049|6163069|P2|STARTED|1st Intervention(14 Days)||7
2515025|NCT00738049|6163070|P1|STARTED|1st Intervention(14 Days)||13
2515026|NCT00738023|6163084|P2|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
2515027|NCT00738023|6163085|P1|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
2515028|NCT00738023|6163084|P2|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
2515029|NCT00738023|6163085|P1|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||19
2515030|NCT00738023|6163084|P2|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||0
2515031|NCT00738023|6163085|P1|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||19
2515032|NCT00738023|6163084|P2|NOT COMPLETED|Saline Infusion||0
2515033|NCT00738023|6163085|P1|NOT COMPLETED|Saline Infusion||0
2515034|NCT00738023|6163084|P2|COMPLETED|Saline Infusion||0
2515035|NCT00738023|6163085|P1|COMPLETED|Saline Infusion||19
2515036|NCT00738023|6163084|P2|STARTED|Saline Infusion||0
2515037|NCT00738023|6163085|P1|STARTED|Saline Infusion||19
2515038|NCT00738023|6163084|P2|NOT COMPLETED|Intralipid Infusion||0
2515039|NCT00738023|6163085|P1|NOT COMPLETED|Intralipid Infusion||0
2515040|NCT00738023|6163084|P2|COMPLETED|Intralipid Infusion||13
2515041|NCT00738023|6163085|P1|COMPLETED|Intralipid Infusion||19
2515042|NCT00738023|6163084|P2|STARTED|Intralipid Infusion||13
2515043|NCT00738023|6163085|P1|STARTED|Intralipid Infusion||19
2515044|NCT00737737|6163095|P2|NOT COMPLETED|Overall Study||0
2515045|NCT00737737|6163096|P1|NOT COMPLETED|Overall Study||0
2515046|NCT00737737|6163095|P2|COMPLETED|Overall Study||2
2515047|NCT00737737|6163096|P1|COMPLETED|Overall Study||2
2515048|NCT00737737|6163095|P2|STARTED|Overall Study||2
2515049|NCT00737737|6163096|P1|STARTED|Overall Study||2
2515050|NCT00737711|6163104|P1|NOT COMPLETED|Overall Study||31
2515051|NCT00737711|6163104|P1|COMPLETED|Overall Study||158
2515052|NCT00737711|6163104|P1|STARTED|Overall Study||189
2515053|NCT00737698|6163138|P3|NOT COMPLETED|Overall Study||4
2515054|NCT00737698|6163139|P2|NOT COMPLETED|Overall Study||5
2515055|NCT00737698|6163140|P1|NOT COMPLETED|Overall Study||6
2515056|NCT00737698|6163138|P3|COMPLETED|Overall Study||17
2515057|NCT00737698|6163139|P2|COMPLETED|Overall Study||37
2515058|NCT00737698|6163140|P1|COMPLETED|Overall Study||17
2515059|NCT00737698|6163138|P3|STARTED|Overall Study||21
2515060|NCT00737698|6163139|P2|STARTED|Overall Study||42
2515061|NCT00737698|6163140|P1|STARTED|Overall Study||23
2515062|NCT00737672|6163150|P2|NOT COMPLETED|Overall Study||83
2515063|NCT00737672|6163151|P1|NOT COMPLETED|Overall Study||80
2515064|NCT00737672|6163150|P2|COMPLETED|Overall Study||65
2515065|NCT00737672|6163151|P1|COMPLETED|Overall Study||65
2515066|NCT00737672|6163150|P2|Per Protocol Population|Overall Study||138
2515067|NCT00737672|6163151|P1|Per Protocol Population|Overall Study||131
2515068|NCT00737672|6163150|P2|Exclusions Due to Protocol Deviations|Overall Study||10
2515069|NCT00737672|6163151|P1|Exclusions Due to Protocol Deviations|Overall Study||14
2515070|NCT00737672|6163150|P2|STARTED|Overall Study||148
2515071|NCT00737672|6163151|P1|STARTED|Overall Study||145
2515072|NCT00737633|6163189|P2|NOT COMPLETED|Overall Study||57
2515073|NCT00737633|6163190|P1|NOT COMPLETED|Overall Study||44
2515074|NCT00737633|6163189|P2|COMPLETED|Overall Study||0
2515075|NCT00737633|6163190|P1|COMPLETED|Overall Study||0
2515076|NCT00737633|6163189|P2|STARTED|Overall Study||57
2515077|NCT00737633|6163190|P1|STARTED|Overall Study||44
2515078|NCT00737594|6163201|P3|NOT COMPLETED|Overall Study||0
2515079|NCT00737594|6163202|P2|NOT COMPLETED|Overall Study||0
2515080|NCT00737594|6163203|P1|NOT COMPLETED|Overall Study||0
2515081|NCT00737594|6163201|P3|COMPLETED|Overall Study||0
2515082|NCT00737594|6163202|P2|COMPLETED|Overall Study||0
2515083|NCT00737594|6163203|P1|COMPLETED|Overall Study||0
2515084|NCT00737594|6163201|P3|STARTED|Overall Study||0
2515085|NCT00737594|6163202|P2|STARTED|Overall Study||0
2515086|NCT00737594|6163203|P1|STARTED|Overall Study||0
2515087|NCT00737568|6163213|P2|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||18
2515088|NCT00737568|6163214|P1|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||26
2515089|NCT00737568|6163213|P2|COMPLETED|Treatment-Free Follow-up (TFFU) Period||19
2515090|NCT00737568|6163214|P1|COMPLETED|Treatment-Free Follow-up (TFFU) Period||12
2515091|NCT00737568|6163213|P2|STARTED|Treatment-Free Follow-up (TFFU) Period|4 participants not completing the 240 week treatment period enrolled in the TFFU period.|37
2515092|NCT00737568|6163214|P1|STARTED|Treatment-Free Follow-up (TFFU) Period|1 participant not completing the 240 week treatment period enrolled in the TFFU period.|38
2515093|NCT00737568|6163213|P2|NOT COMPLETED|Treatment Period Through Week 240||21
2515094|NCT00737568|6163214|P1|NOT COMPLETED|Treatment Period Through Week 240||20
2515095|NCT00737568|6163213|P2|COMPLETED|Treatment Period Through Week 240||118
2515096|NCT00737568|6163214|P1|COMPLETED|Treatment Period Through Week 240||121
2515097|NCT00737568|6163213|P2|STARTED|Treatment Period Through Week 240||139
2515098|NCT00737568|6163214|P1|STARTED|Treatment Period Through Week 240||141
2515099|NCT00737529|6163244|P1|NOT COMPLETED|Overall Study||133
2515100|NCT00737529|6163244|P1|COMPLETED|Overall Study|Completed equals participants ongoing on treatment at the time of the data cut-off of 30 March 2017|1
2515101|NCT00737529|6163244|P1|STARTED|Overall Study||134
2515102|NCT00737477|6163258|P1|NOT COMPLETED|Overall Study||34
2515103|NCT00737477|6163258|P1|COMPLETED|Overall Study||62
2515104|NCT00737477|6163258|P1|STARTED|Overall Study||96
2515105|NCT00737464|6163274|P1|NOT COMPLETED|Overall Study||18
2515106|NCT00737464|6163274|P1|COMPLETED|Overall Study||114
2515107|NCT00737464|6163274|P1|STARTED|Overall Study||132
2515108|NCT00737438|6163295|P1|NOT COMPLETED|Overall Study||3
2515109|NCT00737438|6163295|P1|COMPLETED|Overall Study||20
2515110|NCT00737438|6163295|P1|STARTED|Overall Study||23
2515111|NCT00737360|6163299|P1|NOT COMPLETED|Overall Study||0
2515112|NCT00737360|6163299|P1|COMPLETED|Overall Study||27
2515113|NCT00737360|6163299|P1|STARTED|Overall Study||27
2515114|NCT00737282|6163308|P1|NOT COMPLETED|Overall Study||175
2515115|NCT00737282|6163308|P1|COMPLETED|Overall Study||0
2515116|NCT00737282|6163308|P1|STARTED|Overall Study||175
2515117|NCT00737243|6163314|P1|NOT COMPLETED|Overall Study||95
2515118|NCT00737243|6163314|P1|COMPLETED|Overall Study||194
2515119|NCT00737243|6163314|P1|Empiric CUP Therapy|Overall Study||29
2515120|NCT00737243|6163314|P1|Site Specific Therapy Less Responsive|Overall Study||79
2515121|NCT00737243|6163314|P1|Site Specific Therapy More Responsive|Overall Study||115
2515122|NCT00737243|6163314|P1|Not Treated|Overall Study|16 pts no longer met eligibility criteria; 13 came off study due to physician or pt preference.|29
2515123|NCT00737243|6163314|P1|Treated|Overall Study||223
2515124|NCT00737243|6163314|P1|Insufficient Tissue for Assay, Withdrawn|Overall Study||37
2515125|NCT00737243|6163314|P1|Successful Assay Performed|Overall Study||252
2515126|NCT00737243|6163314|P1|STARTED|Overall Study||289
2515127|NCT00737204|6163322|P2|NOT COMPLETED|Overall Study||6
2515128|NCT00737204|6163323|P1|NOT COMPLETED|Overall Study||0
2515129|NCT00737204|6163322|P2|COMPLETED|Overall Study||28
2515130|NCT00737204|6163323|P1|COMPLETED|Overall Study||36
2515131|NCT00737204|6163322|P2|STARTED|Overall Study||34
2515132|NCT00737204|6163323|P1|STARTED|Overall Study||36
2515133|NCT00737178|6163337|P2|NOT COMPLETED|Overall Study||9
2515134|NCT00737178|6163338|P1|NOT COMPLETED|Overall Study||5
2515135|NCT00737178|6163337|P2|COMPLETED|Overall Study||76
2515136|NCT00737178|6163338|P1|COMPLETED|Overall Study||66
2515137|NCT00737178|6163337|P2|STARTED|Overall Study||85
2515138|NCT00737178|6163338|P1|STARTED|Overall Study||71
2515139|NCT00737100|6163351|P3|NOT COMPLETED|Overall Study||7
2515140|NCT00737100|6163352|P2|NOT COMPLETED|Overall Study||7
2515141|NCT00737100|6163353|P1|NOT COMPLETED|Overall Study||7
2515142|NCT00737100|6163351|P3|COMPLETED|Overall Study||169
2515143|NCT00737100|6163352|P2|COMPLETED|Overall Study||159
2515144|NCT00737100|6163353|P1|COMPLETED|Overall Study||161
2515145|NCT00737100|6163351|P3|STARTED|Overall Study||176
2515146|NCT00737100|6163352|P2|STARTED|Overall Study||166
2515147|NCT00737100|6163353|P1|STARTED|Overall Study||168
2515148|NCT00737061|6163397|P1|NOT COMPLETED|1 Year Wearing Period||17
2515149|NCT00737061|6163397|P1|COMPLETED|1 Year Wearing Period||553
2515150|NCT00737061|6163397|P1|STARTED|1 Year Wearing Period||570
2515151|NCT00737061|6163397|P1|NOT COMPLETED|Waiting Period||75
2515152|NCT00737061|6163397|P1|COMPLETED|Waiting Period||570
2515153|NCT00737061|6163397|P1|STARTED|Waiting Period||645
2515154|NCT00737048|6163414|P3|NOT COMPLETED|Overall Study||4
2515155|NCT00737048|6163415|P2|NOT COMPLETED|Overall Study||6
2515156|NCT00737048|6163416|P1|NOT COMPLETED|Overall Study||3
2515157|NCT00737048|6163414|P3|COMPLETED|Overall Study||126
2515158|NCT00737048|6163415|P2|COMPLETED|Overall Study||60
2515159|NCT00737048|6163416|P1|COMPLETED|Overall Study||129
2515160|NCT00737048|6163414|P3|STARTED|Overall Study||130
2515161|NCT00737048|6163415|P2|STARTED|Overall Study||66
2515162|NCT00737048|6163416|P1|STARTED|Overall Study||132
2515163|NCT00736996|6163460|P3|NOT COMPLETED|Overall Study||2
2515164|NCT00736996|6163461|P2|NOT COMPLETED|Overall Study||9
2515165|NCT00736996|6163462|P1|NOT COMPLETED|Overall Study||1
2515166|NCT00736996|6163460|P3|COMPLETED|Overall Study||25
2515167|NCT00736996|6163461|P2|COMPLETED|Overall Study||17
2515168|NCT00736996|6163462|P1|COMPLETED|Overall Study||24
2515169|NCT00736996|6163460|P3|STARTED|Overall Study||27
2515170|NCT00736996|6163461|P2|STARTED|Overall Study||26
2515171|NCT00736996|6163462|P1|STARTED|Overall Study||25
2515172|NCT00736957|6163476|P1|NOT COMPLETED|Overall Study||122
2515173|NCT00736957|6163476|P1|COMPLETED|Overall Study||97
2515174|NCT00736957|6163476|P1|Treated|Overall Study||190
2515175|NCT00736957|6163476|P1|STARTED|Overall Study||219
2515182|NCT00736879|6163517|P4|NOT COMPLETED|Follow up Period - No Drug Treatment||0
2515183|NCT00736879|6163518|P3|NOT COMPLETED|Follow up Period - No Drug Treatment||0
2515184|NCT00736879|6163519|P2|NOT COMPLETED|Follow up Period - No Drug Treatment||3
2515185|NCT00736879|6163520|P1|NOT COMPLETED|Follow up Period - No Drug Treatment||1
2515186|NCT00736879|6163517|P4|COMPLETED|Follow up Period - No Drug Treatment||62
2515187|NCT00736879|6163518|P3|COMPLETED|Follow up Period - No Drug Treatment||66
2515188|NCT00736879|6163519|P2|COMPLETED|Follow up Period - No Drug Treatment||67
2515189|NCT00736879|6163520|P1|COMPLETED|Follow up Period - No Drug Treatment||65
2515190|NCT00736879|6163517|P4|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|62
2515191|NCT00736879|6163518|P3|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
2515192|NCT00736879|6163519|P2|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|70
2515193|NCT00736879|6163520|P1|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
2515194|NCT00736879|6163517|P4|NOT COMPLETED|Double Blind Treatment Period||5
2515195|NCT00736879|6163518|P3|NOT COMPLETED|Double Blind Treatment Period||7
2515196|NCT00736879|6163519|P2|NOT COMPLETED|Double Blind Treatment Period||4
2515197|NCT00736879|6163520|P1|NOT COMPLETED|Double Blind Treatment Period||3
2515198|NCT00736879|6163517|P4|COMPLETED|Double Blind Treatment Period||63
2515199|NCT00736879|6163518|P3|COMPLETED|Double Blind Treatment Period||67
2515200|NCT00736879|6163519|P2|COMPLETED|Double Blind Treatment Period||68
2515201|NCT00736879|6163520|P1|COMPLETED|Double Blind Treatment Period||65
2515202|NCT00736879|6163517|P4|STARTED|Double Blind Treatment Period||68
2515203|NCT00736879|6163518|P3|STARTED|Double Blind Treatment Period||74
2515204|NCT00736879|6163519|P2|STARTED|Double Blind Treatment Period||72
2515205|NCT00736879|6163520|P1|STARTED|Double Blind Treatment Period||68
2515206|NCT00736853|6163574|P3|NOT COMPLETED|Double-Blind Period||48
2515207|NCT00736853|6163575|P2|NOT COMPLETED|Double-Blind Period||24
2515208|NCT00736853|6163576|P1|NOT COMPLETED|Double-Blind Period||0
2515209|NCT00736853|6163574|P3|COMPLETED|Double-Blind Period||45
2515210|NCT00736853|6163575|P2|COMPLETED|Double-Blind Period||70
2515211|NCT00736853|6163576|P1|COMPLETED|Double-Blind Period||0
2515212|NCT00736853|6163574|P3|STARTED|Double-Blind Period||93
2515213|NCT00736853|6163575|P2|STARTED|Double-Blind Period||94
2515214|NCT00736853|6163576|P1|STARTED|Double-Blind Period||0
2515215|NCT00736853|6163574|P3|NOT COMPLETED|Open-Label Period||0
2515216|NCT00736853|6163575|P2|NOT COMPLETED|Open-Label Period||0
2515217|NCT00736853|6163576|P1|NOT COMPLETED|Open-Label Period||132
2515218|NCT00736853|6163574|P3|COMPLETED|Open-Label Period||0
2515219|NCT00736853|6163575|P2|COMPLETED|Open-Label Period||0
2515220|NCT00736853|6163576|P1|COMPLETED|Open-Label Period||187
2515221|NCT00736853|6163574|P3|Treated|Open-Label Period||0
2515222|NCT00736853|6163575|P2|Treated|Open-Label Period||0
2515223|NCT00736853|6163576|P1|Treated|Open-Label Period||277
2515224|NCT00736853|6163574|P3|STARTED|Open-Label Period||0
2515225|NCT00736853|6163575|P2|STARTED|Open-Label Period||0
2515226|NCT00736853|6163576|P1|STARTED|Open-Label Period||319
2515227|NCT00736840|6163616|P1|NOT COMPLETED|Overall Study||13
2515228|NCT00736840|6163616|P1|COMPLETED|Overall Study|9 subjects-no biopsy results, 2-no breath test, 2 no biopsy results and no complete breath test|401
2515229|NCT00736840|6163616|P1|STARTED|Overall Study||414
2515230|NCT00736723|6163623|P2|NOT COMPLETED|Overall Study||3
2515231|NCT00736723|6163624|P1|NOT COMPLETED|Overall Study||4
2515232|NCT00736723|6163623|P2|COMPLETED|Overall Study||18
2515233|NCT00736723|6163624|P1|COMPLETED|Overall Study||26
2515234|NCT00736723|6163623|P2|STARTED|Overall Study||21
2515235|NCT00736723|6163624|P1|STARTED|Overall Study||30
2515236|NCT00736645|6163634|P4|NOT COMPLETED|Overall Study||0
2515237|NCT00736645|6163635|P3|NOT COMPLETED|Overall Study||0
2515238|NCT00736645|6163636|P2|NOT COMPLETED|Overall Study||2
2515239|NCT00736645|6163637|P1|NOT COMPLETED|Overall Study||0
2515240|NCT00736645|6163634|P4|COMPLETED|Overall Study||13
2515241|NCT00736645|6163635|P3|COMPLETED|Overall Study||14
2515242|NCT00736645|6163636|P2|COMPLETED|Overall Study||13
2515243|NCT00736645|6163637|P1|COMPLETED|Overall Study||13
2515244|NCT00736645|6163634|P4|STARTED|Overall Study||13
2515245|NCT00736645|6163635|P3|STARTED|Overall Study||14
2515246|NCT00736645|6163636|P2|STARTED|Overall Study||15
2515247|NCT00736645|6163637|P1|STARTED|Overall Study||13
2515248|NCT00736632|6163654|P3|NOT COMPLETED|Overall Study||0
2515249|NCT00736632|6163655|P2|NOT COMPLETED|Overall Study||0
2515250|NCT00736632|6163656|P1|NOT COMPLETED|Overall Study||0
2515251|NCT00736632|6163654|P3|COMPLETED|Overall Study||31
2515252|NCT00736632|6163655|P2|COMPLETED|Overall Study||50
2515253|NCT00736632|6163656|P1|COMPLETED|Overall Study||44
2515254|NCT00736632|6163654|P3|STARTED|Overall Study||31
2515255|NCT00736632|6163655|P2|STARTED|Overall Study||50
2515256|NCT00736632|6163656|P1|STARTED|Overall Study||44
2515257|NCT00736580|6163680|P2|NOT COMPLETED|Overall Study||0
2515258|NCT00736580|6163681|P1|NOT COMPLETED|Overall Study||0
2515259|NCT00736580|6163680|P2|COMPLETED|Overall Study||123
2515260|NCT00736580|6163681|P1|COMPLETED|Overall Study||117
2515261|NCT00736580|6163680|P2|STARTED|Overall Study||123
2515262|NCT00736580|6163681|P1|STARTED|Overall Study||117
2515263|NCT00736502|6163687|P1|NOT COMPLETED|Overall Study||65
2515264|NCT00736502|6163687|P1|COMPLETED|Overall Study||213
2515265|NCT00736502|6163687|P1|STARTED|Overall Study|Entered and treated.|278
2515266|NCT00736489|6163693|P6|NOT COMPLETED|Period 6||0
2515267|NCT00736489|6163694|P5|NOT COMPLETED|Period 6||0
2515268|NCT00736489|6163695|P4|NOT COMPLETED|Period 6||0
2515269|NCT00736489|6163696|P3|NOT COMPLETED|Period 6||0
2515270|NCT00736489|6163697|P2|NOT COMPLETED|Period 6||0
2515271|NCT00736489|6163698|P1|NOT COMPLETED|Period 6||0
2515272|NCT00736489|6163693|P6|COMPLETED|Period 6||5
2515273|NCT00736489|6163694|P5|COMPLETED|Period 6||7
2515274|NCT00736489|6163695|P4|COMPLETED|Period 6||7
2515275|NCT00736489|6163696|P3|COMPLETED|Period 6||6
2515276|NCT00736489|6163697|P2|COMPLETED|Period 6||5
2515277|NCT00736489|6163698|P1|COMPLETED|Period 6||5
2515278|NCT00736489|6163693|P6|STARTED|Period 6||5
2515279|NCT00736489|6163694|P5|STARTED|Period 6||7
2515280|NCT00736489|6163695|P4|STARTED|Period 6||7
2515281|NCT00736489|6163696|P3|STARTED|Period 6||6
2515282|NCT00736489|6163697|P2|STARTED|Period 6||5
2515283|NCT00736489|6163698|P1|STARTED|Period 6||5
2515284|NCT00736489|6163693|P6|NOT COMPLETED|Period 5||0
2515285|NCT00736489|6163694|P5|NOT COMPLETED|Period 5||0
2515286|NCT00736489|6163695|P4|NOT COMPLETED|Period 5||0
2515287|NCT00736489|6163696|P3|NOT COMPLETED|Period 5||0
2515288|NCT00736489|6163697|P2|NOT COMPLETED|Period 5||0
2515289|NCT00736489|6163698|P1|NOT COMPLETED|Period 5||0
2515290|NCT00736489|6163693|P6|COMPLETED|Period 5||5
2515291|NCT00736489|6163694|P5|COMPLETED|Period 5||7
2515292|NCT00736489|6163695|P4|COMPLETED|Period 5||7
2515293|NCT00736489|6163696|P3|COMPLETED|Period 5||6
2515294|NCT00736489|6163697|P2|COMPLETED|Period 5||5
2515295|NCT00736489|6163698|P1|COMPLETED|Period 5||5
2515296|NCT00736489|6163693|P6|STARTED|Period 5||5
2515297|NCT00736489|6163694|P5|STARTED|Period 5||7
2515298|NCT00736489|6163695|P4|STARTED|Period 5||7
2515299|NCT00736489|6163696|P3|STARTED|Period 5||6
2515300|NCT00736489|6163697|P2|STARTED|Period 5||5
2515301|NCT00736489|6163698|P1|STARTED|Period 5||5
2515302|NCT00736489|6163693|P6|NOT COMPLETED|Period 4||0
2515303|NCT00736489|6163694|P5|NOT COMPLETED|Period 4||0
2515304|NCT00736489|6163695|P4|NOT COMPLETED|Period 4||0
2515305|NCT00736489|6163696|P3|NOT COMPLETED|Period 4||0
2515306|NCT00736489|6163697|P2|NOT COMPLETED|Period 4||0
2515307|NCT00736489|6163698|P1|NOT COMPLETED|Period 4||0
2515308|NCT00736489|6163693|P6|COMPLETED|Period 4||5
2515309|NCT00736489|6163694|P5|COMPLETED|Period 4||7
2515310|NCT00736489|6163695|P4|COMPLETED|Period 4||7
2515311|NCT00736489|6163696|P3|COMPLETED|Period 4||6
2515312|NCT00736489|6163697|P2|COMPLETED|Period 4||5
2515313|NCT00736489|6163698|P1|COMPLETED|Period 4||5
2515314|NCT00736489|6163693|P6|STARTED|Period 4||5
2515315|NCT00736489|6163694|P5|STARTED|Period 4||7
2515316|NCT00736489|6163695|P4|STARTED|Period 4||7
2515317|NCT00736489|6163696|P3|STARTED|Period 4||6
2515318|NCT00736489|6163697|P2|STARTED|Period 4||5
2515319|NCT00736489|6163698|P1|STARTED|Period 4||5
2515320|NCT00736489|6163693|P6|NOT COMPLETED|Period 3||0
2515321|NCT00736489|6163694|P5|NOT COMPLETED|Period 3||0
2515322|NCT00736489|6163695|P4|NOT COMPLETED|Period 3||0
2515323|NCT00736489|6163696|P3|NOT COMPLETED|Period 3||0
2515324|NCT00736489|6163697|P2|NOT COMPLETED|Period 3||0
2515325|NCT00736489|6163698|P1|NOT COMPLETED|Period 3||0
2515326|NCT00736489|6163693|P6|COMPLETED|Period 3||5
2515327|NCT00736489|6163694|P5|COMPLETED|Period 3||7
2515328|NCT00736489|6163695|P4|COMPLETED|Period 3||7
2515329|NCT00736489|6163696|P3|COMPLETED|Period 3||6
2515330|NCT00736489|6163697|P2|COMPLETED|Period 3||5
2515331|NCT00736489|6163698|P1|COMPLETED|Period 3||5
2515332|NCT00736489|6163693|P6|STARTED|Period 3||5
2515333|NCT00736489|6163694|P5|STARTED|Period 3||7
2515334|NCT00736489|6163695|P4|STARTED|Period 3||7
2515335|NCT00736489|6163696|P3|STARTED|Period 3||6
2515336|NCT00736489|6163697|P2|STARTED|Period 3||5
2515337|NCT00736489|6163698|P1|STARTED|Period 3||5
2515338|NCT00736489|6163693|P6|NOT COMPLETED|Period 2||0
2515339|NCT00736489|6163694|P5|NOT COMPLETED|Period 2||0
2515340|NCT00736489|6163695|P4|NOT COMPLETED|Period 2||0
2515341|NCT00736489|6163696|P3|NOT COMPLETED|Period 2||0
2515342|NCT00736489|6163697|P2|NOT COMPLETED|Period 2||0
2515343|NCT00736489|6163698|P1|NOT COMPLETED|Period 2||0
2515344|NCT00736489|6163693|P6|COMPLETED|Period 2||5
2515345|NCT00736489|6163694|P5|COMPLETED|Period 2||7
2515346|NCT00736489|6163695|P4|COMPLETED|Period 2||7
2515347|NCT00736489|6163696|P3|COMPLETED|Period 2||6
2515348|NCT00736489|6163697|P2|COMPLETED|Period 2||5
2515349|NCT00736489|6163698|P1|COMPLETED|Period 2||5
2515350|NCT00736489|6163693|P6|STARTED|Period 2||5
2515351|NCT00736489|6163694|P5|STARTED|Period 2||7
2515352|NCT00736489|6163695|P4|STARTED|Period 2||7
2515353|NCT00736489|6163696|P3|STARTED|Period 2||6
2515354|NCT00736489|6163697|P2|STARTED|Period 2||5
2515355|NCT00736489|6163698|P1|STARTED|Period 2||5
2515356|NCT00736489|6163693|P6|NOT COMPLETED|Period 1||1
2515357|NCT00736489|6163694|P5|NOT COMPLETED|Period 1||0
2515358|NCT00736489|6163695|P4|NOT COMPLETED|Period 1||0
2515359|NCT00736489|6163696|P3|NOT COMPLETED|Period 1||0
2515360|NCT00736489|6163697|P2|NOT COMPLETED|Period 1||0
2515361|NCT00736489|6163698|P1|NOT COMPLETED|Period 1||1
2515362|NCT00736489|6163693|P6|COMPLETED|Period 1||5
2515363|NCT00736489|6163694|P5|COMPLETED|Period 1||7
2515364|NCT00736489|6163695|P4|COMPLETED|Period 1||7
2515365|NCT00736489|6163696|P3|COMPLETED|Period 1||6
2515366|NCT00736489|6163697|P2|COMPLETED|Period 1||5
2515367|NCT00736489|6163698|P1|COMPLETED|Period 1||5
2515368|NCT00736489|6163693|P6|STARTED|Period 1||6
2515369|NCT00736489|6163694|P5|STARTED|Period 1||7
2515370|NCT00736489|6163695|P4|STARTED|Period 1||7
2515371|NCT00736489|6163696|P3|STARTED|Period 1||6
2515372|NCT00736489|6163697|P2|STARTED|Period 1||5
2515373|NCT00736489|6163698|P1|STARTED|Period 1|Cross-over study|6
2515374|NCT00736476|6163852|P2|NOT COMPLETED|Overall Study||0
2515375|NCT00736476|6163853|P1|NOT COMPLETED|Overall Study||1
2515376|NCT00736476|6163852|P2|COMPLETED|Overall Study||27
2515377|NCT00736476|6163853|P1|COMPLETED|Overall Study||35
2515378|NCT00736476|6163852|P2|STARTED|Overall Study||27
2515379|NCT00736476|6163853|P1|STARTED|Overall Study||36
2515380|NCT00736450|6163873|P1|NOT COMPLETED|Overall Study||25
2515381|NCT00736450|6163873|P1|COMPLETED|Overall Study||12
2515382|NCT00736450|6163873|P1|STARTED|Overall Study||37
2515383|NCT00736385|6163881|P2|NOT COMPLETED|Overall Study||3
2515384|NCT00736385|6163882|P1|NOT COMPLETED|Overall Study||2
2515385|NCT00736385|6163881|P2|COMPLETED|Overall Study||2
2515386|NCT00736385|6163882|P1|COMPLETED|Overall Study||2
2515387|NCT00736385|6163881|P2|STARTED|Overall Study||5
2515388|NCT00736385|6163882|P1|STARTED|Overall Study||4
2515389|NCT00736333|6163894|P1|NOT COMPLETED|Overall Study||111
2515390|NCT00736333|6163894|P1|COMPLETED|Overall Study||56
2515391|NCT00736333|6163894|P1|STARTED|Overall Study||167
2515392|NCT00736255|6163905|P2|NOT COMPLETED|Overall Study||1
2515393|NCT00736255|6163906|P1|NOT COMPLETED|Overall Study||3
2515394|NCT00736255|6163905|P2|COMPLETED|Overall Study||14
2515395|NCT00736255|6163906|P1|COMPLETED|Overall Study||14
2515396|NCT00736255|6163905|P2|STARTED|Overall Study||15
2515397|NCT00736255|6163906|P1|STARTED|Overall Study||17
2515398|NCT00736242|6163924|P1|NOT COMPLETED|Overall Study||125
2515399|NCT00736242|6163924|P1|COMPLETED|Overall Study||107
2515400|NCT00736242|6163924|P1|Participants in Safety Analysis Set|Overall Study||229
2515401|NCT00736242|6163924|P1|STARTED|Overall Study||232
2515402|NCT00736229|6163938|P3|NOT COMPLETED|Overall Study||0
2515403|NCT00736229|6163939|P2|NOT COMPLETED|Overall Study||0
2515404|NCT00736229|6163940|P1|NOT COMPLETED|Overall Study||0
2515405|NCT00736229|6163938|P3|COMPLETED|Overall Study||84
2515406|NCT00736229|6163939|P2|COMPLETED|Overall Study||71
2515407|NCT00736229|6163940|P1|COMPLETED|Overall Study|All patients received bolus and fixed infusion of study drug, thus completed the study|40
2515408|NCT00736229|6163938|P3|STARTED|Overall Study|Historic Control|84
2515409|NCT00736229|6163939|P2|STARTED|Overall Study|Historic control|71
2515410|NCT00736229|6163940|P1|STARTED|Overall Study|Actively Enrolled|40
2515411|NCT00736190|6163953|P1|NOT COMPLETED|Overall Study||3
2515412|NCT00736190|6163953|P1|COMPLETED|Overall Study||87
2515413|NCT00736190|6163953|P1|STARTED|Overall Study||90
2515414|NCT00736125|6163968|P2|NOT COMPLETED|Overall Study||2
2515415|NCT00736125|6163969|P1|NOT COMPLETED|Overall Study||1
2515416|NCT00736125|6163968|P2|COMPLETED|Overall Study||8
2515417|NCT00736125|6163969|P1|COMPLETED|Overall Study||9
2515418|NCT00736125|6163968|P2|STARTED|Overall Study||10
2515419|NCT00736125|6163969|P1|STARTED|Overall Study||10
2515420|NCT00736099|6163983|P2|NOT COMPLETED|Overall Study||58
2515421|NCT00736099|6163984|P1|NOT COMPLETED|Overall Study||183
2515422|NCT00736099|6163983|P2|COMPLETED|Overall Study|Number who completed treatment.|531
2515423|NCT00736099|6163984|P1|COMPLETED|Overall Study|Number who completed treatment.|1349
2515424|NCT00736099|6163983|P2|STARTED|Overall Study|Number who started treatment.|589
2515425|NCT00736099|6163984|P1|STARTED|Overall Study|Number who started treatment.|1532
2515426|NCT00736073|6164082|P2|NOT COMPLETED|Overall Study||0
2515427|NCT00736073|6164083|P1|NOT COMPLETED|Overall Study||0
2515428|NCT00736073|6164082|P2|COMPLETED|Overall Study||39
2515429|NCT00736073|6164083|P1|COMPLETED|Overall Study||34
2515430|NCT00736073|6164082|P2|STARTED|Overall Study||39
2515431|NCT00736073|6164083|P1|STARTED|Overall Study||34
2515432|NCT00736034|6164093|P1|NOT COMPLETED|Overall Study||2
2515433|NCT00736034|6164093|P1|COMPLETED|Overall Study||16
2515434|NCT00736034|6164093|P1|STARTED|Overall Study||18
2515435|NCT00735969|6164097|P1|NOT COMPLETED|Overall Study||0
2515436|NCT00735969|6164097|P1|COMPLETED|Overall Study||21
2515437|NCT00735969|6164097|P1|STARTED|Overall Study||21
2515438|NCT00735943|6164101|P1|NOT COMPLETED|Overall Study||2
2515439|NCT00735943|6164101|P1|COMPLETED|Overall Study||20
2515440|NCT00735943|6164101|P1|STARTED|Overall Study||22
2515441|NCT00735917|6164118|P1|NOT COMPLETED|Overall Study||0
2515442|NCT00735917|6164118|P1|COMPLETED|Overall Study||19
2515443|NCT00735917|6164118|P1|STARTED|Overall Study||19
2515444|NCT00735904|6164126|P1|NOT COMPLETED|Overall Study||38
2515445|NCT00735904|6164126|P1|COMPLETED|Overall Study||0
2515446|NCT00735904|6164126|P1|STARTED|Overall Study||38
2515447|NCT00735878|6164136|P3|NOT COMPLETED|Phase II- Determined Dose||0
2515448|NCT00735878|6164137|P2|NOT COMPLETED|Phase II- Determined Dose||0
2515449|NCT00735878|6164138|P1|NOT COMPLETED|Phase II- Determined Dose||0
2515450|NCT00735878|6164136|P3|COMPLETED|Phase II- Determined Dose||0
2515451|NCT00735878|6164137|P2|COMPLETED|Phase II- Determined Dose||7
2515452|NCT00735878|6164138|P1|COMPLETED|Phase II- Determined Dose|Seven subjects completed therapy within the Phase II portion of the trial.|0
2515453|NCT00735878|6164136|P3|STARTED|Phase II- Determined Dose||0
2515454|NCT00735878|6164137|P2|STARTED|Phase II- Determined Dose||7
2515455|NCT00735878|6164138|P1|STARTED|Phase II- Determined Dose||0
2515456|NCT00735878|6164136|P3|NOT COMPLETED|Phase I- Dose Determination||1
2515457|NCT00735878|6164137|P2|NOT COMPLETED|Phase I- Dose Determination||0
2515458|NCT00735878|6164138|P1|NOT COMPLETED|Phase I- Dose Determination||0
2515459|NCT00735878|6164136|P3|COMPLETED|Phase I- Dose Determination||4
2515460|NCT00735878|6164137|P2|COMPLETED|Phase I- Dose Determination||7
2515461|NCT00735878|6164138|P1|COMPLETED|Phase I- Dose Determination|12 subjects received at least one cycle of treatment and were evaluable per the protocol.|1
2515462|NCT00735878|6164136|P3|STARTED|Phase I- Dose Determination||5
2515463|NCT00735878|6164137|P2|STARTED|Phase I- Dose Determination||7
2515464|NCT00735878|6164138|P1|STARTED|Phase I- Dose Determination|13 subjects enrolled. One subject withdrew consent prior to receiving therapy & was replaced.|1
2515465|NCT00735839|6164151|P2|NOT COMPLETED|Overall Study||0
2515466|NCT00735839|6164152|P1|NOT COMPLETED|Overall Study||0
2515467|NCT00735839|6164151|P2|COMPLETED|Overall Study||10
2515468|NCT00735839|6164152|P1|COMPLETED|Overall Study||30
2515469|NCT00735839|6164151|P2|STARTED|Overall Study||10
2515470|NCT00735839|6164152|P1|STARTED|Overall Study||30
2515471|NCT00735826|6164160|P1|NOT COMPLETED|Overall Study||0
2515472|NCT00735826|6164160|P1|COMPLETED|Overall Study||10
2515473|NCT00735826|6164160|P1|STARTED|Overall Study||10
2515474|NCT00735787|6164168|P2|NOT COMPLETED|Period 2||1
2515475|NCT00735787|6164169|P1|NOT COMPLETED|Period 2||5
2515476|NCT00735787|6164168|P2|COMPLETED|Period 2||40
2515477|NCT00735787|6164169|P1|COMPLETED|Period 2||13
2515478|NCT00735787|6164168|P2|STARTED|Period 2||41
2515479|NCT00735787|6164169|P1|STARTED|Period 2||18
2515480|NCT00735787|6164168|P2|NOT COMPLETED|Period 1||8
2515481|NCT00735787|6164169|P1|NOT COMPLETED|Period 1||6
2515482|NCT00735787|6164168|P2|COMPLETED|Period 1||41
2515483|NCT00735787|6164169|P1|COMPLETED|Period 1|Per visit window, 18 completed; 17 completed per subject case report form.|17
2515484|NCT00735787|6164168|P2|STARTED|Period 1||49
2515485|NCT00735787|6164169|P1|STARTED|Period 1||23
2515486|NCT00735709|6164217|P4|NOT COMPLETED|Overall Study||18
2515487|NCT00735709|6164218|P3|NOT COMPLETED|Overall Study||11
2515488|NCT00735709|6164219|P2|NOT COMPLETED|Overall Study||13
2515489|NCT00735709|6164220|P1|NOT COMPLETED|Overall Study||13
2515490|NCT00735709|6164217|P4|COMPLETED|Overall Study||122
2515491|NCT00735709|6164218|P3|COMPLETED|Overall Study||129
2515492|NCT00735709|6164219|P2|COMPLETED|Overall Study||127
2515493|NCT00735709|6164220|P1|COMPLETED|Overall Study||127
2515494|NCT00735709|6164217|P4|Treated|Overall Study||139
2515495|NCT00735709|6164218|P3|Treated|Overall Study||140
2515496|NCT00735709|6164219|P2|Treated|Overall Study||140
2515497|NCT00735709|6164220|P1|Treated|Overall Study||140
2515498|NCT00735709|6164217|P4|STARTED|Overall Study||140
2515499|NCT00735709|6164218|P3|STARTED|Overall Study||140
2515500|NCT00735709|6164219|P2|STARTED|Overall Study||140
2515501|NCT00735709|6164220|P1|STARTED|Overall Study||140
2515502|NCT00735696|6164330|P1|NOT COMPLETED|Overall Study||2
2515503|NCT00735696|6164330|P1|COMPLETED|Overall Study||39
2515504|NCT00735696|6164330|P1|Received Any Quantity of Study Drug|Overall Study||40
2515505|NCT00735696|6164330|P1|STARTED|Overall Study||41
2515506|NCT00735670|6164344|P2|NOT COMPLETED|Overall Study||5
2515507|NCT00735670|6164345|P1|NOT COMPLETED|Overall Study||4
2515508|NCT00735670|6164344|P2|COMPLETED|Overall Study||6
2515509|NCT00735670|6164345|P1|COMPLETED|Overall Study||6
2515510|NCT00735670|6164344|P2|STARTED|Overall Study||11
2515511|NCT00735670|6164345|P1|STARTED|Overall Study||10
2515512|NCT00735644|6164358|P5|NOT COMPLETED|Overall Study||0
2515513|NCT00735644|6164359|P4|NOT COMPLETED|Overall Study||1
2515514|NCT00735644|6164360|P3|NOT COMPLETED|Overall Study||1
2515515|NCT00735644|6164361|P2|NOT COMPLETED|Overall Study||2
2515516|NCT00735644|6164362|P1|NOT COMPLETED|Overall Study||0
2515517|NCT00735644|6164358|P5|COMPLETED|Overall Study||102
2515518|NCT00735644|6164359|P4|COMPLETED|Overall Study||198
2515519|NCT00735644|6164360|P3|COMPLETED|Overall Study||295
2515520|NCT00735644|6164361|P2|COMPLETED|Overall Study||298
2515521|NCT00735644|6164362|P1|COMPLETED|Overall Study||303
2515522|NCT00735644|6164358|P5|STARTED|Overall Study||102
2515523|NCT00735644|6164359|P4|STARTED|Overall Study||199
2515524|NCT00735644|6164360|P3|STARTED|Overall Study||296
2515525|NCT00735644|6164361|P2|STARTED|Overall Study||300
2515526|NCT00735644|6164362|P1|STARTED|Overall Study||303
2515527|NCT00735618|6164399|P1|NOT COMPLETED|Overall Study||0
2515528|NCT00735618|6164399|P1|COMPLETED|Overall Study||19
2515529|NCT00735618|6164399|P1|STARTED|Overall Study||19
2515530|NCT00735553|6164406|P1|NOT COMPLETED|Overall Study||77
2515531|NCT00735553|6164406|P1|COMPLETED|Overall Study||0
2515532|NCT00735553|6164406|P1|STARTED|Overall Study||77
2515533|NCT00735475|6164416|P2|NOT COMPLETED|Overall Study||11
2515534|NCT00735475|6164417|P1|NOT COMPLETED|Overall Study||8
2515535|NCT00735475|6164416|P2|COMPLETED|Overall Study||626
2515536|NCT00735475|6164417|P1|COMPLETED|Overall Study||623
2515537|NCT00735475|6164416|P2|STARTED|Overall Study||637
2515538|NCT00735475|6164417|P1|STARTED|Overall Study||631
2515539|NCT00735462|6164438|P3|NOT COMPLETED|Overall Study||28
2515540|NCT00735462|6164439|P2|NOT COMPLETED|Overall Study||55
2515541|NCT00735462|6164440|P1|NOT COMPLETED|Overall Study||63
2515542|NCT00735462|6164438|P3|COMPLETED|Overall Study||77
2515543|NCT00735462|6164439|P2|COMPLETED|Overall Study||149
2515544|NCT00735462|6164440|P1|COMPLETED|Overall Study||139
2515545|NCT00735462|6164438|P3|STARTED|Overall Study||105
2515546|NCT00735462|6164439|P2|STARTED|Overall Study||204
2515547|NCT00735462|6164440|P1|STARTED|Overall Study||202
2515548|NCT00735449|6164453|P2|NOT COMPLETED|Overall Study||6
2515549|NCT00735449|6164454|P1|NOT COMPLETED|Overall Study||7
2515550|NCT00735449|6164453|P2|COMPLETED|Overall Study||96
2515551|NCT00735449|6164454|P1|COMPLETED|Overall Study||95
2515552|NCT00735449|6164453|P2|STARTED|Overall Study||102
2515553|NCT00735449|6164454|P1|STARTED|Overall Study||102
2515554|NCT00735436|6164468|P1|NOT COMPLETED|Overall Study||0
2515555|NCT00735436|6164468|P1|COMPLETED|Overall Study||18
2515556|NCT00735436|6164468|P1|STARTED|Overall Study||18
2515557|NCT00735397|6164477|P1|NOT COMPLETED|Overall Study||1183
2515558|NCT00735397|6164477|P1|COMPLETED|Overall Study||35
2515559|NCT00735397|6164477|P1|STARTED|Overall Study||1218
2515560|NCT00735371|6164491|P4|NOT COMPLETED|Overall Study||10
2515561|NCT00735371|6164492|P3|NOT COMPLETED|Overall Study||11
2515562|NCT00735371|6164493|P2|NOT COMPLETED|Overall Study||13
2515563|NCT00735371|6164494|P1|NOT COMPLETED|Overall Study||15
2515564|NCT00735371|6164491|P4|COMPLETED|Overall Study||69
2515565|NCT00735371|6164492|P3|COMPLETED|Overall Study||67
2515566|NCT00735371|6164493|P2|COMPLETED|Overall Study||66
2515567|NCT00735371|6164494|P1|COMPLETED|Overall Study||63
2515568|NCT00735371|6164491|P4|STARTED|Overall Study||79
2515569|NCT00735371|6164492|P3|STARTED|Overall Study||78
2515570|NCT00735371|6164493|P2|STARTED|Overall Study||79
2515571|NCT00735371|6164494|P1|STARTED|Overall Study||78
2515572|NCT00735306|6164512|P1|NOT COMPLETED|Overall Study||0
2515573|NCT00735306|6164512|P1|COMPLETED|Overall Study||12
2515574|NCT00735306|6164512|P1|STARTED|Overall Study||12
2515575|NCT00735254|6164522|P4|NOT COMPLETED|Overall Study||0
2515576|NCT00735254|6164523|P3|NOT COMPLETED|Overall Study||1
2515577|NCT00735254|6164524|P2|NOT COMPLETED|Overall Study||1
2515578|NCT00735254|6164525|P1|NOT COMPLETED|Overall Study||1
2515579|NCT00735254|6164522|P4|COMPLETED|Overall Study||0
2515580|NCT00735254|6164523|P3|COMPLETED|Overall Study||0
2515581|NCT00735254|6164524|P2|COMPLETED|Overall Study||0
2515582|NCT00735254|6164525|P1|COMPLETED|Overall Study||0
2515583|NCT00735254|6164522|P4|STARTED|Overall Study||0
2515584|NCT00735254|6164523|P3|STARTED|Overall Study||1
2515585|NCT00735254|6164524|P2|STARTED|Overall Study||1
2515586|NCT00735254|6164525|P1|STARTED|Overall Study||1
2515587|NCT00735072|6164537|P2|NOT COMPLETED|Overall Study||1
2515588|NCT00735072|6164538|P1|NOT COMPLETED|Overall Study||1
2515589|NCT00735072|6164537|P2|COMPLETED|Overall Study||21
2515590|NCT00735072|6164538|P1|COMPLETED|Overall Study||22
2515591|NCT00735072|6164537|P2|STARTED|Overall Study||22
2515592|NCT00735072|6164538|P1|STARTED|Overall Study||23
2515593|NCT00735007|6164544|P1|NOT COMPLETED|Overall Study||5
2515594|NCT00735007|6164544|P1|COMPLETED|Overall Study||101
2515595|NCT00735007|6164544|P1|STARTED|Overall Study||106
2515596|NCT00734994|6164569|P1|NOT COMPLETED|Overall Study||1
2515597|NCT00734994|6164569|P1|COMPLETED|Overall Study||14
2515598|NCT00734994|6164569|P1|STARTED|Overall Study||15
2515599|NCT00734968|6164576|P2|NOT COMPLETED|Overall Study||1
2515600|NCT00734968|6164577|P1|NOT COMPLETED|Overall Study||1
2515601|NCT00734968|6164576|P2|COMPLETED|Overall Study||75
2515602|NCT00734968|6164577|P1|COMPLETED|Overall Study||76
2515603|NCT00734968|6164576|P2|STARTED|Overall Study||76
2515604|NCT00734968|6164577|P1|STARTED|Overall Study||77
2515605|NCT00734929|6164589|P2|NOT COMPLETED|Overall Study||5
2515606|NCT00734929|6164590|P1|NOT COMPLETED|Overall Study||6
2515607|NCT00734929|6164589|P2|COMPLETED|Overall Study||53
2515608|NCT00734929|6164590|P1|COMPLETED|Overall Study||51
2515609|NCT00734929|6164589|P2|STARTED|Overall Study||58
2515610|NCT00734929|6164590|P1|STARTED|Overall Study||57
2515611|NCT00734903|6164620|P2|NOT COMPLETED|Overall Study||1
2515612|NCT00734903|6164621|P1|NOT COMPLETED|Overall Study||3
2515613|NCT00734903|6164620|P2|COMPLETED|Overall Study||32
2515614|NCT00734903|6164621|P1|COMPLETED|Overall Study||30
2515615|NCT00734903|6164620|P2|Completed 3-month Followup|Overall Study||15
2515616|NCT00734903|6164621|P1|Completed 3-month Followup|Overall Study||14
2515617|NCT00734903|6164620|P2|Completed End of Treatment Assessment|Overall Study||23
2515618|NCT00734903|6164621|P1|Completed End of Treatment Assessment|Overall Study||21
2515619|NCT00734903|6164620|P2|STARTED|Overall Study||33
2515620|NCT00734903|6164621|P1|STARTED|Overall Study||33
2515621|NCT00734851|6164647|P1|NOT COMPLETED|Overall Study||21
2515622|NCT00734851|6164647|P1|COMPLETED|Overall Study||13
2515623|NCT00734851|6164647|P1|STARTED|Overall Study||34
2515624|NCT00734799|6164659|P2|NOT COMPLETED|Overall Study||4
2515625|NCT00734799|6164660|P1|NOT COMPLETED|Overall Study||0
2515626|NCT00734799|6164659|P2|COMPLETED|Overall Study||9
2515627|NCT00734799|6164660|P1|COMPLETED|Overall Study||9
2515628|NCT00734799|6164659|P2|STARTED|Overall Study||13
2515629|NCT00734799|6164660|P1|STARTED|Overall Study||9
2515630|NCT00734747|6164668|P1|NOT COMPLETED|6 Month Follow-up||3
2515631|NCT00734747|6164668|P1|COMPLETED|6 Month Follow-up||66
2515632|NCT00734747|6164668|P1|STARTED|6 Month Follow-up||69
2515633|NCT00734747|6164668|P1|NOT COMPLETED|SRS Procedure||3
2515634|NCT00734747|6164668|P1|COMPLETED|SRS Procedure||69
2515635|NCT00734747|6164668|P1|STARTED|SRS Procedure||72
2515636|NCT00734734|6164675|P1|NOT COMPLETED|Overall Study||0
2515637|NCT00734734|6164675|P1|COMPLETED|Overall Study||64
2515638|NCT00734734|6164675|P1|STARTED|Overall Study||64
2515639|NCT00734656|6164682|P4|NOT COMPLETED|Lab Session 4||1
2515640|NCT00734656|6164683|P3|NOT COMPLETED|Lab Session 4||0
2515641|NCT00734656|6164684|P2|NOT COMPLETED|Lab Session 4||0
2515642|NCT00734656|6164685|P1|NOT COMPLETED|Lab Session 4||0
2515643|NCT00734656|6164682|P4|COMPLETED|Lab Session 4||19
2515644|NCT00734656|6164683|P3|COMPLETED|Lab Session 4||16
2515645|NCT00734656|6164684|P2|COMPLETED|Lab Session 4||18
2515646|NCT00734656|6164685|P1|COMPLETED|Lab Session 4||20
2515647|NCT00734656|6164682|P4|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
2515648|NCT00734656|6164683|P3|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|16
2515649|NCT00734656|6164684|P2|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|18
2515650|NCT00734656|6164685|P1|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
2515651|NCT00734656|6164682|P4|NOT COMPLETED|Washout 3||1
2515652|NCT00734656|6164683|P3|NOT COMPLETED|Washout 3||0
2515653|NCT00734656|6164684|P2|NOT COMPLETED|Washout 3||0
2515654|NCT00734656|6164685|P1|NOT COMPLETED|Washout 3||1
2515655|NCT00734656|6164682|P4|COMPLETED|Washout 3||18
2515656|NCT00734656|6164683|P3|COMPLETED|Washout 3||20
2515657|NCT00734656|6164684|P2|COMPLETED|Washout 3||19
2515658|NCT00734656|6164685|P1|COMPLETED|Washout 3||17
2515659|NCT00734656|6164682|P4|STARTED|Washout 3||19
2515660|NCT00734656|6164683|P3|STARTED|Washout 3||20
2515661|NCT00734656|6164684|P2|STARTED|Washout 3||19
2515662|NCT00734656|6164685|P1|STARTED|Washout 3||18
2515663|NCT00734656|6164682|P4|NOT COMPLETED|Lab Session 3||0
2515664|NCT00734656|6164683|P3|NOT COMPLETED|Lab Session 3||0
2515665|NCT00734656|6164684|P2|NOT COMPLETED|Lab Session 3||0
2515666|NCT00734656|6164685|P1|NOT COMPLETED|Lab Session 3||0
2515667|NCT00734656|6164682|P4|COMPLETED|Lab Session 3||19
2515668|NCT00734656|6164683|P3|COMPLETED|Lab Session 3||20
2515669|NCT00734656|6164684|P2|COMPLETED|Lab Session 3||19
2515670|NCT00734656|6164685|P1|COMPLETED|Lab Session 3||18
2515671|NCT00734656|6164682|P4|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
2515672|NCT00734656|6164683|P3|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|20
2515673|NCT00734656|6164684|P2|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
2515674|NCT00734656|6164685|P1|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|18
2515675|NCT00734656|6164682|P4|NOT COMPLETED|Washout 2||0
2515676|NCT00734656|6164683|P3|NOT COMPLETED|Washout 2||1
2515677|NCT00734656|6164684|P2|NOT COMPLETED|Washout 2||1
2515678|NCT00734656|6164685|P1|NOT COMPLETED|Washout 2||1
2515679|NCT00734656|6164682|P4|COMPLETED|Washout 2||19
2515680|NCT00734656|6164683|P3|COMPLETED|Washout 2||20
2515681|NCT00734656|6164684|P2|COMPLETED|Washout 2||20
2515682|NCT00734656|6164685|P1|COMPLETED|Washout 2||17
2515683|NCT00734656|6164682|P4|STARTED|Washout 2||19
2515684|NCT00734656|6164683|P3|STARTED|Washout 2||21
2515685|NCT00734656|6164684|P2|STARTED|Washout 2||21
2515686|NCT00734656|6164685|P1|STARTED|Washout 2||18
2515687|NCT00734656|6164682|P4|NOT COMPLETED|Lab Session 2||1
2515688|NCT00734656|6164683|P3|NOT COMPLETED|Lab Session 2||0
2515689|NCT00734656|6164684|P2|NOT COMPLETED|Lab Session 2||0
2515690|NCT00734656|6164685|P1|NOT COMPLETED|Lab Session 2||1
2515691|NCT00734656|6164682|P4|COMPLETED|Lab Session 2||19
2515692|NCT00734656|6164683|P3|COMPLETED|Lab Session 2||21
2515693|NCT00734656|6164684|P2|COMPLETED|Lab Session 2||21
2515694|NCT00734656|6164685|P1|COMPLETED|Lab Session 2||18
2515695|NCT00734656|6164682|P4|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|20
2515696|NCT00734656|6164683|P3|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
2515697|NCT00734656|6164684|P2|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
2515698|NCT00734656|6164685|P1|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|19
2515699|NCT00734656|6164682|P4|NOT COMPLETED|Washout 1||3
2515700|NCT00734656|6164683|P3|NOT COMPLETED|Washout 1||2
2515701|NCT00734656|6164684|P2|NOT COMPLETED|Washout 1||5
2515702|NCT00734656|6164685|P1|NOT COMPLETED|Washout 1||1
2515703|NCT00734656|6164682|P4|COMPLETED|Washout 1||18
2515704|NCT00734656|6164683|P3|COMPLETED|Washout 1||24
2515705|NCT00734656|6164684|P2|COMPLETED|Washout 1||18
2515706|NCT00734656|6164685|P1|COMPLETED|Washout 1||21
2515707|NCT00734656|6164682|P4|STARTED|Washout 1||21
2515708|NCT00734656|6164683|P3|STARTED|Washout 1||26
2515709|NCT00734656|6164684|P2|STARTED|Washout 1||23
2515710|NCT00734656|6164685|P1|STARTED|Washout 1||22
2515711|NCT00734656|6164682|P4|NOT COMPLETED|Lab Session 1||0
2515712|NCT00734656|6164683|P3|NOT COMPLETED|Lab Session 1||0
2515713|NCT00734656|6164684|P2|NOT COMPLETED|Lab Session 1||0
2515714|NCT00734656|6164685|P1|NOT COMPLETED|Lab Session 1||2
2515715|NCT00734656|6164682|P4|COMPLETED|Lab Session 1||21
2515716|NCT00734656|6164683|P3|COMPLETED|Lab Session 1||26
2515717|NCT00734656|6164684|P2|COMPLETED|Lab Session 1||23
2515718|NCT00734656|6164685|P1|COMPLETED|Lab Session 1||22
2515719|NCT00734656|6164682|P4|STARTED|Lab Session 1||21
2515720|NCT00734656|6164683|P3|STARTED|Lab Session 1||26
2515721|NCT00734656|6164684|P2|STARTED|Lab Session 1||23
2515722|NCT00734656|6164685|P1|STARTED|Lab Session 1||24
2515723|NCT00734630|6164709|P2|NOT COMPLETED|Overall Study||33
2515724|NCT00734630|6164710|P1|NOT COMPLETED|Overall Study||29
2515725|NCT00734630|6164709|P2|COMPLETED|Overall Study||200
2515726|NCT00734630|6164710|P1|COMPLETED|Overall Study||229
2515727|NCT00734630|6164709|P2|STARTED|Overall Study||233
2515728|NCT00734630|6164710|P1|STARTED|Overall Study||258
2515729|NCT00734617|6164720|P2|NOT COMPLETED|Overall Study||102
2515730|NCT00734617|6164721|P1|NOT COMPLETED|Overall Study||107
2515731|NCT00734617|6164720|P2|COMPLETED|Overall Study||128
2515732|NCT00734617|6164721|P1|COMPLETED|Overall Study||142
2515733|NCT00734617|6164720|P2|STARTED|Overall Study||230
2515734|NCT00734617|6164721|P1|STARTED|Overall Study||249
2515735|NCT00734604|6164733|P6|NOT COMPLETED|Overall Study||6
2515736|NCT00734604|6164734|P5|NOT COMPLETED|Overall Study||8
2515737|NCT00734604|6164735|P4|NOT COMPLETED|Overall Study||9
2515738|NCT00734604|6164736|P3|NOT COMPLETED|Overall Study||6
2515739|NCT00734604|6164737|P2|NOT COMPLETED|Overall Study||12
2515740|NCT00734604|6164738|P1|NOT COMPLETED|Overall Study||3
2515741|NCT00734604|6164733|P6|COMPLETED|Overall Study||58
2515742|NCT00734604|6164734|P5|COMPLETED|Overall Study||55
2515743|NCT00734604|6164735|P4|COMPLETED|Overall Study||54
2515744|NCT00734604|6164736|P3|COMPLETED|Overall Study||57
2515745|NCT00734604|6164737|P2|COMPLETED|Overall Study||51
2515746|NCT00734604|6164738|P1|COMPLETED|Overall Study||59
2515747|NCT00734604|6164733|P6|STARTED|Overall Study||64
2515748|NCT00734604|6164734|P5|STARTED|Overall Study||63
2515749|NCT00734604|6164735|P4|STARTED|Overall Study||63
2515750|NCT00734604|6164736|P3|STARTED|Overall Study||63
2515751|NCT00734604|6164737|P2|STARTED|Overall Study||63
2515752|NCT00734604|6164738|P1|STARTED|Overall Study||62
2515753|NCT00734591|6164788|P2|NOT COMPLETED|Prospective Period||44
2515754|NCT00734591|6164789|P1|NOT COMPLETED|Prospective Period||51
2515755|NCT00734591|6164788|P2|COMPLETED|Prospective Period||1229
2515756|NCT00734591|6164789|P1|COMPLETED|Prospective Period||1307
2515757|NCT00734591|6164788|P2|STARTED|Prospective Period||1273
2515758|NCT00734591|6164789|P1|STARTED|Prospective Period||1358
2515759|NCT00734591|6164788|P2|NOT COMPLETED|Screening for Prospective Period||2291
2515760|NCT00734591|6164789|P1|NOT COMPLETED|Screening for Prospective Period||2517
2515761|NCT00734591|6164788|P2|COMPLETED|Screening for Prospective Period||1273
2515762|NCT00734591|6164789|P1|COMPLETED|Screening for Prospective Period||1358
2515763|NCT00734591|6164788|P2|STARTED|Screening for Prospective Period||3564
2515764|NCT00734591|6164789|P1|STARTED|Screening for Prospective Period||3875
2515765|NCT00734591|6164788|P2|NOT COMPLETED|Retrospective Period||0
2515766|NCT00734591|6164789|P1|NOT COMPLETED|Retrospective Period||0
2515767|NCT00734591|6164788|P2|COMPLETED|Retrospective Period||3564
2515768|NCT00734591|6164789|P1|COMPLETED|Retrospective Period||3875
2515769|NCT00734591|6164788|P2|STARTED|Retrospective Period||3564
2515770|NCT00734591|6164789|P1|STARTED|Retrospective Period||3875
2515771|NCT00734578|6164804|P3|NOT COMPLETED|Overall Study||25
2515772|NCT00734578|6164805|P2|NOT COMPLETED|Overall Study||25
2515773|NCT00734578|6164806|P1|NOT COMPLETED|Overall Study||33
2515774|NCT00734578|6164804|P3|COMPLETED|Overall Study||129
2515775|NCT00734578|6164805|P2|COMPLETED|Overall Study||128
2515776|NCT00734578|6164806|P1|COMPLETED|Overall Study||121
2515777|NCT00734578|6164804|P3|STARTED|Overall Study||154
2515778|NCT00734578|6164805|P2|STARTED|Overall Study||153
2515779|NCT00734578|6164806|P1|STARTED|Overall Study||154
2515780|NCT00734539|6164840|P2|NOT COMPLETED|Long Term Follow up||31
2515781|NCT00734539|6164841|P1|NOT COMPLETED|Long Term Follow up||34
2515782|NCT00734539|6164840|P2|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|107
2515783|NCT00734539|6164841|P1|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|118
2515784|NCT00734539|6164840|P2|STARTED|Long Term Follow up||138
2515785|NCT00734539|6164841|P1|STARTED|Long Term Follow up||152
2515786|NCT00734539|6164840|P2|NOT COMPLETED|Main Study||35
2515787|NCT00734539|6164841|P1|NOT COMPLETED|Main Study||37
2515788|NCT00734539|6164840|P2|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|138
2515789|NCT00734539|6164841|P1|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|152
2515790|NCT00734539|6164840|P2|STARTED|Main Study||173
2515791|NCT00734539|6164841|P1|STARTED|Main Study||189
2515792|NCT00734500|6164869|P1|NOT COMPLETED|Overall Study||1
2515793|NCT00734500|6164869|P1|COMPLETED|Overall Study||14
2515794|NCT00734500|6164869|P1|STARTED|Overall Study||15
2515795|NCT00734474|6164883|P9|NOT COMPLETED|Overall Study||82
2515796|NCT00734474|6164884|P8|NOT COMPLETED|Overall Study||129
2515797|NCT00734474|6164885|P7|NOT COMPLETED|Overall Study||24
2515798|NCT00734474|6164886|P6|NOT COMPLETED|Overall Study||25
2515799|NCT00734474|6164887|P5|NOT COMPLETED|Overall Study||118
2515800|NCT00734474|6164888|P4|NOT COMPLETED|Overall Study||10
2515801|NCT00734474|6164889|P3|NOT COMPLETED|Overall Study||112
2515802|NCT00734474|6164890|P2|NOT COMPLETED|Overall Study||30
2515803|NCT00734474|6164891|P1|NOT COMPLETED|Overall Study||15
2515804|NCT00734474|6164883|P9|COMPLETED|Overall Study||95
2515805|NCT00734474|6164884|P8|COMPLETED|Overall Study||186
2515806|NCT00734474|6164885|P7|COMPLETED|Overall Study||0
2515807|NCT00734474|6164886|P6|COMPLETED|Overall Study||0
2515808|NCT00734474|6164887|P5|COMPLETED|Overall Study||184
2515809|NCT00734474|6164888|P4|COMPLETED|Overall Study||0
2515810|NCT00734474|6164889|P3|COMPLETED|Overall Study||192
2515811|NCT00734474|6164890|P2|COMPLETED|Overall Study||0
2515812|NCT00734474|6164891|P1|COMPLETED|Overall Study||0
2515813|NCT00734474|6164883|P9|Completed 52-Week Visit|Overall Study||112
2515814|NCT00734474|6164884|P8|Completed 52-Week Visit|Overall Study||238
2515815|NCT00734474|6164885|P7|Completed 52-Week Visit|Overall Study||0
2515816|NCT00734474|6164886|P6|Completed 52-Week Visit|Overall Study||0
2515817|NCT00734474|6164887|P5|Completed 52-Week Visit|Overall Study||243
2515818|NCT00734474|6164888|P4|Completed 52-Week Visit|Overall Study||0
2515819|NCT00734474|6164889|P3|Completed 52-Week Visit|Overall Study||238
2515820|NCT00734474|6164890|P2|Completed 52-Week Visit|Overall Study||0
2515821|NCT00734474|6164891|P1|Completed 52-Week Visit|Overall Study||0
2515822|NCT00734474|6164883|P9|Completed 26-Week Visit|Overall Study||124
2515823|NCT00734474|6164884|P8|Completed 26-Week Visit|Overall Study||270
2515824|NCT00734474|6164885|P7|Completed 26-Week Visit|Overall Study||2
2515825|NCT00734474|6164886|P6|Completed 26-Week Visit|Overall Study||2
2515826|NCT00734474|6164887|P5|Completed 26-Week Visit|Overall Study||268
2515827|NCT00734474|6164888|P4|Completed 26-Week Visit|Overall Study||2
2515828|NCT00734474|6164889|P3|Completed 26-Week Visit|Overall Study||258
2515829|NCT00734474|6164890|P2|Completed 26-Week Visit|Overall Study||0
2515830|NCT00734474|6164891|P1|Completed 26-Week Visit|Overall Study||0
2515831|NCT00734474|6164883|P9|Entered Study After Dose Decision Point|Overall Study||139
2515832|NCT00734474|6164884|P8|Entered Study After Dose Decision Point|Overall Study||273
2515833|NCT00734474|6164885|P7|Entered Study After Dose Decision Point|Overall Study||0
2515834|NCT00734474|6164886|P6|Entered Study After Dose Decision Point|Overall Study||0
2515835|NCT00734474|6164887|P5|Entered Study After Dose Decision Point|Overall Study||281
2515836|NCT00734474|6164888|P4|Entered Study After Dose Decision Point|Overall Study||0
2515837|NCT00734474|6164889|P3|Entered Study After Dose Decision Point|Overall Study||279
2515838|NCT00734474|6164890|P2|Entered Study After Dose Decision Point|Overall Study||0
2515839|NCT00734474|6164891|P1|Entered Study After Dose Decision Point|Overall Study||0
2515840|NCT00734474|6164883|P9|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|34
2515841|NCT00734474|6164884|P8|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|42
2515842|NCT00734474|6164885|P7|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|23
2515843|NCT00734474|6164886|P6|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|21
2515844|NCT00734474|6164887|P5|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|21
2515845|NCT00734474|6164888|P4|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
2515846|NCT00734474|6164889|P3|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|24
2515847|NCT00734474|6164890|P2|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|25
2515848|NCT00734474|6164891|P1|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
2515849|NCT00734474|6164883|P9|Entered Study Before Dose Decision Point|Overall Study||38
2515850|NCT00734474|6164884|P8|Entered Study Before Dose Decision Point|Overall Study||42
2515851|NCT00734474|6164885|P7|Entered Study Before Dose Decision Point|Overall Study||24
2515852|NCT00734474|6164886|P6|Entered Study Before Dose Decision Point|Overall Study||25
2515853|NCT00734474|6164887|P5|Entered Study Before Dose Decision Point|Overall Study||21
2515854|NCT00734474|6164888|P4|Entered Study Before Dose Decision Point|Overall Study||10
2515855|NCT00734474|6164889|P3|Entered Study Before Dose Decision Point|Overall Study||25
2515856|NCT00734474|6164890|P2|Entered Study Before Dose Decision Point|Overall Study||30
2515857|NCT00734474|6164891|P1|Entered Study Before Dose Decision Point|Overall Study||15
2515858|NCT00734474|6164883|P9|Received at Least 1 Dose of Study Drug|Overall Study||177
2515859|NCT00734474|6164884|P8|Received at Least 1 Dose of Study Drug|Overall Study||315
2515860|NCT00734474|6164885|P7|Received at Least 1 Dose of Study Drug|Overall Study||24
2515861|NCT00734474|6164886|P6|Received at Least 1 Dose of Study Drug|Overall Study||25
2515862|NCT00734474|6164887|P5|Received at Least 1 Dose of Study Drug|Overall Study||302
2515863|NCT00734474|6164888|P4|Received at Least 1 Dose of Study Drug|Overall Study||10
2515864|NCT00734474|6164889|P3|Received at Least 1 Dose of Study Drug|Overall Study||304
2515865|NCT00734474|6164890|P2|Received at Least 1 Dose of Study Drug|Overall Study||30
2515866|NCT00734474|6164891|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
2515867|NCT00734474|6164883|P9|STARTED|Overall Study||177
2515868|NCT00734474|6164884|P8|STARTED|Overall Study||315
2515869|NCT00734474|6164885|P7|STARTED|Overall Study||24
2515870|NCT00734474|6164886|P6|STARTED|Overall Study||25
2515871|NCT00734474|6164887|P5|STARTED|Overall Study||302
2515872|NCT00734474|6164888|P4|STARTED|Overall Study||10
2515873|NCT00734474|6164889|P3|STARTED|Overall Study||304
2515874|NCT00734474|6164890|P2|STARTED|Overall Study||30
2515875|NCT00734474|6164891|P1|STARTED|Overall Study||15
2515876|NCT00734409|6165060|P2|NOT COMPLETED|Overall Study||0
2515877|NCT00734409|6165061|P1|NOT COMPLETED|Overall Study||0
2515878|NCT00734409|6165060|P2|COMPLETED|Overall Study||145
2515879|NCT00734409|6165061|P1|COMPLETED|Overall Study||155
2515880|NCT00734409|6165060|P2|STARTED|Overall Study||145
2515881|NCT00734409|6165061|P1|STARTED|Overall Study||155
2515882|NCT00734344|6165073|P2|NOT COMPLETED|Overall Study||0
2515883|NCT00734344|6165074|P1|NOT COMPLETED|Overall Study||0
2515884|NCT00734344|6165073|P2|COMPLETED|Overall Study||9
2515885|NCT00734344|6165074|P1|COMPLETED|Overall Study||9
2515886|NCT00734344|6165073|P2|STARTED|Overall Study||9
2515887|NCT00734344|6165074|P1|STARTED|Overall Study||9
2515888|NCT00734305|6165144|P7|NOT COMPLETED|Overall Study||0
2515889|NCT00734305|6165145|P6|NOT COMPLETED|Overall Study||0
2515890|NCT00734305|6165146|P5|NOT COMPLETED|Overall Study||0
2515891|NCT00734305|6165147|P4|NOT COMPLETED|Overall Study||0
2515892|NCT00734305|6165148|P3|NOT COMPLETED|Overall Study||0
2515893|NCT00734305|6165149|P2|NOT COMPLETED|Overall Study||0
2515894|NCT00734305|6165150|P1|NOT COMPLETED|Overall Study||1
2515895|NCT00734305|6165144|P7|COMPLETED|Overall Study||18
2515896|NCT00734305|6165145|P6|COMPLETED|Overall Study||4
2515897|NCT00734305|6165146|P5|COMPLETED|Overall Study||5
2515898|NCT00734305|6165147|P4|COMPLETED|Overall Study||3
2515899|NCT00734305|6165148|P3|COMPLETED|Overall Study||4
2515900|NCT00734305|6165149|P2|COMPLETED|Overall Study||3
2515901|NCT00734305|6165150|P1|COMPLETED|Overall Study|1 patient was enrolled but did not meet eligibility criteria at C1W1, and thus was never dosed|6
2515902|NCT00734305|6165144|P7|STARTED|Overall Study||18
2515903|NCT00734305|6165145|P6|STARTED|Overall Study||4
2515904|NCT00734305|6165146|P5|STARTED|Overall Study||5
2515905|NCT00734305|6165147|P4|STARTED|Overall Study||3
2515906|NCT00734305|6165148|P3|STARTED|Overall Study||4
2515907|NCT00734305|6165149|P2|STARTED|Overall Study||3
2515908|NCT00734305|6165150|P1|STARTED|Overall Study||7
2515909|NCT00734214|6165181|P2|NOT COMPLETED|Overall Study||4
2515910|NCT00734214|6165182|P1|NOT COMPLETED|Overall Study||4
2515911|NCT00734214|6165181|P2|COMPLETED|Overall Study||126
2515912|NCT00734214|6165182|P1|COMPLETED|Overall Study||124
2515913|NCT00734214|6165181|P2|STARTED|Overall Study||130
2515914|NCT00734214|6165182|P1|STARTED|Overall Study||128
2515915|NCT00734162|6165192|P4|NOT COMPLETED|Open-Label Phase||3
2515916|NCT00734162|6165193|P3|NOT COMPLETED|Open-Label Phase||1
2515917|NCT00734162|6165194|P2|NOT COMPLETED|Open-Label Phase||2
2515918|NCT00734162|6165195|P1|NOT COMPLETED|Open-Label Phase||3
2515919|NCT00734162|6165192|P4|COMPLETED|Open-Label Phase||36
2515920|NCT00734162|6165193|P3|COMPLETED|Open-Label Phase||12
2515921|NCT00734162|6165194|P2|COMPLETED|Open-Label Phase||39
2515922|NCT00734162|6165195|P1|COMPLETED|Open-Label Phase||7
2515923|NCT00734162|6165192|P4|STARTED|Open-Label Phase|2 participants switched to open-label treatment before completing double-blind period (elevated ALT)|39
2515924|NCT00734162|6165193|P3|STARTED|Open-Label Phase||13
2515925|NCT00734162|6165194|P2|STARTED|Open-Label Phase||41
2515926|NCT00734162|6165195|P1|STARTED|Open-Label Phase||10
2515927|NCT00734162|6165192|P4|NOT COMPLETED|Randomized Phase (Through Week 72)||4
2515928|NCT00734162|6165193|P3|NOT COMPLETED|Randomized Phase (Through Week 72)||0
2515929|NCT00734162|6165194|P2|NOT COMPLETED|Randomized Phase (Through Week 72)||1
2515930|NCT00734162|6165195|P1|NOT COMPLETED|Randomized Phase (Through Week 72)||0
2515931|NCT00734162|6165192|P4|COMPLETED|Randomized Phase (Through Week 72)||37
2515932|NCT00734162|6165193|P3|COMPLETED|Randomized Phase (Through Week 72)||13
2515933|NCT00734162|6165194|P2|COMPLETED|Randomized Phase (Through Week 72)||41
2515934|NCT00734162|6165195|P1|COMPLETED|Randomized Phase (Through Week 72)||10
2515935|NCT00734162|6165192|P4|STARTED|Randomized Phase (Through Week 72)||41
2515936|NCT00734162|6165193|P3|STARTED|Randomized Phase (Through Week 72)||13
2515937|NCT00734162|6165194|P2|STARTED|Randomized Phase (Through Week 72)||42
2515938|NCT00734162|6165195|P1|STARTED|Randomized Phase (Through Week 72)||10
2515939|NCT00734149|6165419|P1|NOT COMPLETED|Overall Study||1
2515940|NCT00734149|6165419|P1|COMPLETED|Overall Study||44
2515941|NCT00734149|6165419|P1|STARTED|Overall Study||45
2515942|NCT00734097|6165426|P1|NOT COMPLETED|Open Label||16
2515943|NCT00734097|6165426|P1|COMPLETED|Open Label|16 patients discontinued after randomization|301
2515944|NCT00734097|6165426|P1|Per Protocol|Open Label||301
2515945|NCT00734097|6165426|P1|Full Analysis|Open Label||311
2515946|NCT00734097|6165426|P1|Safety Analysis|Open Label||317
2515947|NCT00734097|6165426|P1|STARTED|Open Label|Full analysis performed in 311|317
2515948|NCT00734097|6165426|P1|NOT COMPLETED|Screening||20
2515949|NCT00734097|6165426|P1|COMPLETED|Screening|20 participants were screening failure.|317
2515950|NCT00734097|6165426|P1|STARTED|Screening||337
2515951|NCT00734071|6165443|P2|NOT COMPLETED|Overall Study||27
2515952|NCT00734071|6165444|P1|NOT COMPLETED|Overall Study||38
2515953|NCT00734071|6165443|P2|COMPLETED|Overall Study||125
2515954|NCT00734071|6165444|P1|COMPLETED|Overall Study||114
2515955|NCT00734071|6165443|P2|Treated|Overall Study||148
2515956|NCT00734071|6165444|P1|Treated|Overall Study||151
2515957|NCT00734071|6165443|P2|STARTED|Overall Study||152
2515958|NCT00734071|6165444|P1|STARTED|Overall Study||152
2515959|NCT00734032|6165502|P4|NOT COMPLETED|Overall Study||0
2515960|NCT00734032|6165503|P3|NOT COMPLETED|Overall Study||0
2515961|NCT00734032|6165504|P2|NOT COMPLETED|Overall Study||1
2515962|NCT00734032|6165505|P1|NOT COMPLETED|Overall Study||0
2515963|NCT00734032|6165502|P4|COMPLETED|Overall Study||26
2515964|NCT00734032|6165503|P3|COMPLETED|Overall Study||28
2515965|NCT00734032|6165504|P2|COMPLETED|Overall Study||27
2515966|NCT00734032|6165505|P1|COMPLETED|Overall Study||25
2515967|NCT00734032|6165502|P4|STARTED|Overall Study||26
2515968|NCT00734032|6165503|P3|STARTED|Overall Study||28
2515969|NCT00734032|6165504|P2|STARTED|Overall Study||28
2515970|NCT00734032|6165505|P1|STARTED|Overall Study||25
2515971|NCT00733993|6165525|P2|NOT COMPLETED|Overall Study||0
2515972|NCT00733993|6165526|P1|NOT COMPLETED|Overall Study||0
2515973|NCT00733993|6165525|P2|COMPLETED|Overall Study||10
2515974|NCT00733993|6165526|P1|COMPLETED|Overall Study||13
2515975|NCT00733993|6165525|P2|STARTED|Overall Study||10
2515976|NCT00733993|6165526|P1|STARTED|Overall Study||13
2515977|NCT00733980|6165561|P2|NOT COMPLETED|Overall Study||21
2515978|NCT00733980|6165562|P1|NOT COMPLETED|Overall Study||22
2515979|NCT00733980|6165561|P2|COMPLETED|Overall Study||55
2515980|NCT00733980|6165562|P1|COMPLETED|Overall Study||52
2515981|NCT00733980|6165561|P2|STARTED|Overall Study||76
2515982|NCT00733980|6165562|P1|STARTED|Overall Study||74
2515983|NCT00733954|6165606|P2|NOT COMPLETED|Overall Study||2
2515984|NCT00733954|6165607|P1|NOT COMPLETED|Overall Study||8
2515985|NCT00733954|6165606|P2|COMPLETED|Overall Study||123
2515986|NCT00733954|6165607|P1|COMPLETED|Overall Study||116
2515987|NCT00733954|6165606|P2|STARTED|Overall Study||125
2515988|NCT00733954|6165607|P1|STARTED|Overall Study||124
2515989|NCT00733824|6165654|P5|NOT COMPLETED|Phase II||0
2515990|NCT00733824|6165655|P4|NOT COMPLETED|Phase II||0
2515991|NCT00733824|6165656|P3|NOT COMPLETED|Phase II||0
2515992|NCT00733824|6165657|P2|NOT COMPLETED|Phase II||0
2515993|NCT00733824|6165658|P1|NOT COMPLETED|Phase II||0
2515994|NCT00733824|6165654|P5|COMPLETED|Phase II||36
2515995|NCT00733824|6165655|P4|COMPLETED|Phase II||0
2515996|NCT00733824|6165656|P3|COMPLETED|Phase II||0
2515997|NCT00733824|6165657|P2|COMPLETED|Phase II||0
2515998|NCT00733824|6165658|P1|COMPLETED|Phase II||0
2515999|NCT00733824|6165654|P5|STARTED|Phase II||36
2516000|NCT00733824|6165655|P4|STARTED|Phase II||0
2516001|NCT00733824|6165656|P3|STARTED|Phase II||0
2516002|NCT00733824|6165657|P2|STARTED|Phase II||0
2516003|NCT00733824|6165658|P1|STARTED|Phase II||0
2516004|NCT00733824|6165654|P5|NOT COMPLETED|Phase I||0
2516005|NCT00733824|6165655|P4|NOT COMPLETED|Phase I||0
2516006|NCT00733824|6165656|P3|NOT COMPLETED|Phase I||0
2516007|NCT00733824|6165657|P2|NOT COMPLETED|Phase I||0
2516008|NCT00733824|6165658|P1|NOT COMPLETED|Phase I||1
2516009|NCT00733824|6165654|P5|COMPLETED|Phase I||0
2516010|NCT00733824|6165655|P4|COMPLETED|Phase I||6
2516011|NCT00733824|6165656|P3|COMPLETED|Phase I||6
2516012|NCT00733824|6165657|P2|COMPLETED|Phase I||3
2516013|NCT00733824|6165658|P1|COMPLETED|Phase I||9
2516014|NCT00733824|6165654|P5|STARTED|Phase I||0
2516015|NCT00733824|6165655|P4|STARTED|Phase I||6
2516016|NCT00733824|6165656|P3|STARTED|Phase I||6
2516017|NCT00733824|6165657|P2|STARTED|Phase I||3
2516018|NCT00733824|6165658|P1|STARTED|Phase I||10
2516019|NCT00733746|6165677|P1|NOT COMPLETED|Overall Study||5
2516020|NCT00733746|6165677|P1|COMPLETED|Overall Study||114
2516021|NCT00733746|6165677|P1|STARTED|Overall Study||119
2516022|NCT00733512|6165685|P1|NOT COMPLETED|Overall Study||0
2516023|NCT00733512|6165685|P1|COMPLETED|Overall Study||146
2516024|NCT00733512|6165685|P1|STARTED|Overall Study||146
2516025|NCT00733499|6165692|P2|NOT COMPLETED|10 Year Followup||19
2516026|NCT00733499|6165693|P1|NOT COMPLETED|10 Year Followup||20
2516027|NCT00733499|6165692|P2|COMPLETED|10 Year Followup||13
2516028|NCT00733499|6165693|P1|COMPLETED|10 Year Followup||26
2516029|NCT00733499|6165692|P2|STARTED|10 Year Followup||32
2516030|NCT00733499|6165693|P1|STARTED|10 Year Followup||46
2516031|NCT00733499|6165692|P2|NOT COMPLETED|5 Year Followup||25
2516032|NCT00733499|6165693|P1|NOT COMPLETED|5 Year Followup||21
2516033|NCT00733499|6165692|P2|COMPLETED|5 Year Followup||53
2516034|NCT00733499|6165693|P1|COMPLETED|5 Year Followup||70
2516035|NCT00733499|6165692|P2|STARTED|5 Year Followup||78
2516036|NCT00733499|6165693|P1|STARTED|5 Year Followup||91
2516037|NCT00733499|6165692|P2|NOT COMPLETED|24 Months Follow-up||1
2516038|NCT00733499|6165693|P1|NOT COMPLETED|24 Months Follow-up||0
2516039|NCT00733499|6165692|P2|COMPLETED|24 Months Follow-up||95
2516040|NCT00733499|6165693|P1|COMPLETED|24 Months Follow-up||99
2516041|NCT00733499|6165692|P2|STARTED|24 Months Follow-up||96
2516042|NCT00733499|6165693|P1|STARTED|24 Months Follow-up||99
2516043|NCT00733499|6165692|P2|NOT COMPLETED|12 Months Follow-up||1
2516044|NCT00733499|6165693|P1|NOT COMPLETED|12 Months Follow-up||2
2516045|NCT00733499|6165692|P2|COMPLETED|12 Months Follow-up||96
2516046|NCT00733499|6165693|P1|COMPLETED|12 Months Follow-up||99
2516047|NCT00733499|6165692|P2|STARTED|12 Months Follow-up||97
2516048|NCT00733499|6165693|P1|STARTED|12 Months Follow-up||101
2516049|NCT00733499|6165692|P2|NOT COMPLETED|6 Months Follow-up||3
2516050|NCT00733499|6165693|P1|NOT COMPLETED|6 Months Follow-up||0
2516051|NCT00733499|6165692|P2|COMPLETED|6 Months Follow-up||97
2516052|NCT00733499|6165693|P1|COMPLETED|6 Months Follow-up||101
2516053|NCT00733499|6165692|P2|STARTED|6 Months Follow-up||100
2516054|NCT00733499|6165693|P1|STARTED|6 Months Follow-up||101
2516055|NCT00733499|6165692|P2|NOT COMPLETED|3 Months Follow-up||2
2516056|NCT00733499|6165693|P1|NOT COMPLETED|3 Months Follow-up||1
2516057|NCT00733499|6165692|P2|COMPLETED|3 Months Follow-up||100
2516058|NCT00733499|6165693|P1|COMPLETED|3 Months Follow-up||101
2516059|NCT00733499|6165692|P2|STARTED|3 Months Follow-up||102
2516060|NCT00733499|6165693|P1|STARTED|3 Months Follow-up||102
2516061|NCT00733499|6165692|P2|NOT COMPLETED|Pre-operative||1
2516062|NCT00733499|6165693|P1|NOT COMPLETED|Pre-operative||0
2516063|NCT00733499|6165692|P2|COMPLETED|Pre-operative||102
2516064|NCT00733499|6165693|P1|COMPLETED|Pre-operative||102
2516065|NCT00733499|6165692|P2|STARTED|Pre-operative|A death occurred prior to surgery which left a total of 102 participants|103
2516066|NCT00733499|6165693|P1|STARTED|Pre-operative||102
2516067|NCT00733421|6165753|P2|NOT COMPLETED|Overall Study||1
2516068|NCT00733421|6165754|P1|NOT COMPLETED|Overall Study||1
2516069|NCT00733421|6165753|P2|COMPLETED|Overall Study|All but one randomised patient|49
2516070|NCT00733421|6165754|P1|COMPLETED|Overall Study|All but one randomsied patient|49
2516071|NCT00733421|6165753|P2|STARTED|Overall Study|November 2008|50
2516072|NCT00733421|6165754|P1|STARTED|Overall Study|November 2008|50
2516073|NCT00733408|6165776|P1|NOT COMPLETED|Overall Study||4
2516074|NCT00733408|6165776|P1|COMPLETED|Overall Study||55
2516075|NCT00733408|6165776|P1|STARTED|Overall Study||59
2516076|NCT00733369|6165788|P2|NOT COMPLETED|Overall Study||9
2516077|NCT00733369|6165789|P1|NOT COMPLETED|Overall Study||10
2516078|NCT00733369|6165788|P2|COMPLETED|Overall Study||47
2516079|NCT00733369|6165789|P1|COMPLETED|Overall Study||40
2516080|NCT00733369|6165788|P2|STARTED|Overall Study||56
2516081|NCT00733369|6165789|P1|STARTED|Overall Study||50
2516082|NCT00733356|6165905|P1|NOT COMPLETED|Modified Lab School, Reading Evaluation||0
2516083|NCT00733356|6165905|P1|COMPLETED|Modified Lab School, Reading Evaluation||26
2516084|NCT00733356|6165905|P1|STARTED|Modified Lab School, Reading Evaluation||26
2516085|NCT00733356|6165905|P1|NOT COMPLETED|Vyvanse Dose Titration||2
2516086|NCT00733356|6165905|P1|COMPLETED|Vyvanse Dose Titration||26
2516087|NCT00733356|6165905|P1|STARTED|Vyvanse Dose Titration||28
2516088|NCT00733330|6165911|P2|NOT COMPLETED|Overall Study||4
2516089|NCT00733330|6165912|P1|NOT COMPLETED|Overall Study||2
2516090|NCT00733330|6165911|P2|COMPLETED|Overall Study||48
2516091|NCT00733330|6165912|P1|COMPLETED|Overall Study||30
2516092|NCT00733330|6165911|P2|STARTED|Overall Study||52
2516093|NCT00733330|6165912|P1|STARTED|Overall Study||32
2516094|NCT00733304|6165997|P3|NOT COMPLETED|Overall Study||5
2516095|NCT00733304|6165998|P2|NOT COMPLETED|Overall Study||3
2516096|NCT00733304|6165999|P1|NOT COMPLETED|Overall Study||7
2516097|NCT00733304|6165997|P3|COMPLETED|Overall Study||3
2516098|NCT00733304|6165998|P2|COMPLETED|Overall Study||12
2516099|NCT00733304|6165999|P1|COMPLETED|Overall Study||12
2516100|NCT00733304|6165997|P3|STARTED|Overall Study||8
2516101|NCT00733304|6165998|P2|STARTED|Overall Study||15
2516102|NCT00733304|6165999|P1|STARTED|Overall Study||19
2516103|NCT00733291|6166081|P4|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
2516104|NCT00733291|6166082|P3|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
2516105|NCT00733291|6166083|P2|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
2516106|NCT00733291|6166084|P1|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
2516107|NCT00733291|6166081|P4|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
2516108|NCT00733291|6166082|P3|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
2516109|NCT00733291|6166083|P2|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
2516110|NCT00733291|6166084|P1|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||12
2516111|NCT00733291|6166081|P4|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
2516112|NCT00733291|6166082|P3|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
2516113|NCT00733291|6166083|P2|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
2516114|NCT00733291|6166084|P1|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||12
2516115|NCT00733291|6166081|P4|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
2516116|NCT00733291|6166082|P3|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
2516117|NCT00733291|6166083|P2|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
2516118|NCT00733291|6166084|P1|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||1
2516119|NCT00733291|6166081|P4|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
2516120|NCT00733291|6166082|P3|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
2516121|NCT00733291|6166083|P2|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
2516122|NCT00733291|6166084|P1|COMPLETED|Washout Period, 3 Days (+/-1 Day)||12
2516123|NCT00733291|6166081|P4|STARTED|Washout Period, 3 Days (+/-1 Day)||17
2516124|NCT00733291|6166082|P3|STARTED|Washout Period, 3 Days (+/-1 Day)||17
2516125|NCT00733291|6166083|P2|STARTED|Washout Period, 3 Days (+/-1 Day)||17
2516126|NCT00733291|6166084|P1|STARTED|Washout Period, 3 Days (+/-1 Day)||13
2516127|NCT00733291|6166081|P4|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
2516128|NCT00733291|6166082|P3|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
2516129|NCT00733291|6166083|P2|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
2516130|NCT00733291|6166084|P1|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
2516131|NCT00733291|6166081|P4|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
2516132|NCT00733291|6166082|P3|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
2516133|NCT00733291|6166083|P2|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
2516134|NCT00733291|6166084|P1|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||13
2516135|NCT00733291|6166081|P4|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
2516136|NCT00733291|6166082|P3|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
2516137|NCT00733291|6166083|P2|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
2516138|NCT00733291|6166084|P1|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||13
2516139|NCT00733278|6166106|P1|NOT COMPLETED|Overall Study||0
2516140|NCT00733278|6166106|P1|COMPLETED|Overall Study||7
2516141|NCT00733278|6166106|P1|STARTED|Overall Study||7
2516142|NCT00733226|6166113|P2|NOT COMPLETED|Overall Study||0
2516143|NCT00733226|6166114|P1|NOT COMPLETED|Overall Study||5
2516144|NCT00733226|6166113|P2|COMPLETED|Overall Study||40
2516145|NCT00733226|6166114|P1|COMPLETED|Overall Study||35
2516146|NCT00733226|6166113|P2|STARTED|Overall Study||40
2516147|NCT00733226|6166114|P1|STARTED|Overall Study||40
2516148|NCT00733135|6166130|P1|NOT COMPLETED|Overall Study||2
2516149|NCT00733135|6166130|P1|COMPLETED|Overall Study||131
2516150|NCT00733135|6166130|P1|STARTED|Overall Study||133
2516151|NCT00733096|6166142|P3|NOT COMPLETED|Overall Study||0
2516152|NCT00733096|6166143|P2|NOT COMPLETED|Overall Study||0
2516153|NCT00733096|6166144|P1|NOT COMPLETED|Overall Study||0
2516154|NCT00733096|6166142|P3|COMPLETED|Overall Study||30
2516155|NCT00733096|6166143|P2|COMPLETED|Overall Study||26
2516156|NCT00733096|6166144|P1|COMPLETED|Overall Study||28
2516157|NCT00733096|6166142|P3|STARTED|Overall Study||30
2516158|NCT00733096|6166143|P2|STARTED|Overall Study||26
2516159|NCT00733096|6166144|P1|STARTED|Overall Study||28
2516160|NCT00733005|6166163|P2|NOT COMPLETED|Overall Study||3
2516161|NCT00733005|6166164|P1|NOT COMPLETED|Overall Study||2
2516162|NCT00733005|6166163|P2|COMPLETED|Overall Study||159
2516163|NCT00733005|6166164|P1|COMPLETED|Overall Study||160
2516164|NCT00733005|6166163|P2|STARTED|Overall Study||162
2516165|NCT00733005|6166164|P1|STARTED|Overall Study||162
2516166|NCT00732992|6166174|P2|NOT COMPLETED|Overall Study||6
2516167|NCT00732992|6166175|P1|NOT COMPLETED|Overall Study||6
2516168|NCT00732992|6166174|P2|COMPLETED|Overall Study||0
2516169|NCT00732992|6166175|P1|COMPLETED|Overall Study||0
2516170|NCT00732992|6166174|P2|STARTED|Overall Study||6
2516171|NCT00732992|6166175|P1|STARTED|Overall Study||6
2516172|NCT00732940|6166194|P2|NOT COMPLETED|Overall Study||3
2516173|NCT00732940|6166195|P1|NOT COMPLETED|Overall Study||2
2516174|NCT00732940|6166194|P2|COMPLETED|Overall Study||25
2516175|NCT00732940|6166195|P1|COMPLETED|Overall Study||26
2516176|NCT00732940|6166194|P2|STARTED|Overall Study||28
2516177|NCT00732940|6166195|P1|STARTED|Overall Study||28
2516178|NCT00732901|6166265|P2|NOT COMPLETED|Overall Study||0
2516179|NCT00732901|6166266|P1|NOT COMPLETED|Overall Study||0
2516180|NCT00732901|6166265|P2|COMPLETED|Overall Study||12
2516181|NCT00732901|6166266|P1|COMPLETED|Overall Study||11
2516182|NCT00732901|6166265|P2|STARTED|Overall Study||12
2516183|NCT00732901|6166266|P1|STARTED|Overall Study||11
2516184|NCT00732875|6166276|P1|NOT COMPLETED|Overall Study||35
2516185|NCT00732875|6166276|P1|COMPLETED|Overall Study|These participants continued treatment until trial was completed by Sponsor.|57
2516186|NCT00732875|6166276|P1|STARTED|Overall Study||92
2516187|NCT00732758|6166284|P2|NOT COMPLETED|Overall Study||16
2516188|NCT00732758|6166285|P1|NOT COMPLETED|Overall Study||8
2516189|NCT00732758|6166284|P2|COMPLETED|Overall Study||63
2516190|NCT00732758|6166285|P1|COMPLETED|Overall Study||70
2516191|NCT00732758|6166284|P2|STARTED|Overall Study||79
2516192|NCT00732758|6166285|P1|STARTED|Overall Study||78
2516193|NCT00732680|6166297|P1|NOT COMPLETED|Overall Study||0
2516194|NCT00732680|6166297|P1|COMPLETED|Overall Study||9
2516195|NCT00732680|6166297|P1|STARTED|Overall Study||9
2516196|NCT00732654|6166304|P3|NOT COMPLETED|Overall Study||0
2516197|NCT00732654|6166305|P2|NOT COMPLETED|Overall Study||1
2516198|NCT00732654|6166306|P1|NOT COMPLETED|Overall Study||0
2516199|NCT00732654|6166304|P3|COMPLETED|Overall Study||10
2516200|NCT00732654|6166305|P2|COMPLETED|Overall Study||9
2516201|NCT00732654|6166306|P1|COMPLETED|Overall Study||10
2516202|NCT00732654|6166304|P3|STARTED|Overall Study||10
2516203|NCT00732654|6166305|P2|STARTED|Overall Study||10
2516204|NCT00732654|6166306|P1|STARTED|Overall Study||10
2516205|NCT00732641|6166325|P2|NOT COMPLETED|Overall Study||112
2516206|NCT00732641|6166326|P1|NOT COMPLETED|Overall Study||106
2516207|NCT00732641|6166325|P2|COMPLETED|Overall Study||9
2516208|NCT00732641|6166326|P1|COMPLETED|Overall Study||17
2516209|NCT00732641|6166325|P2|STARTED|Overall Study||121
2516210|NCT00732641|6166326|P1|STARTED|Overall Study||123
2516211|NCT00732615|6166346|P2|NOT COMPLETED|Overall Study||5
2516212|NCT00732615|6166347|P1|NOT COMPLETED|Overall Study||7
2516213|NCT00732615|6166346|P2|COMPLETED|Overall Study||79
2516214|NCT00732615|6166347|P1|COMPLETED|Overall Study||33
2516215|NCT00732615|6166346|P2|STARTED|Overall Study||84
2516216|NCT00732615|6166347|P1|STARTED|Overall Study||40
2516217|NCT00732498|6166359|P1|NOT COMPLETED|Overall Study||6
2516218|NCT00732498|6166359|P1|COMPLETED|Overall Study||22
2516219|NCT00732498|6166359|P1|STARTED|Overall Study||28
2516220|NCT00732472|6166370|P4|NOT COMPLETED|Overall Study||3
2516221|NCT00732472|6166371|P3|NOT COMPLETED|Overall Study||1
2516222|NCT00732472|6166372|P2|NOT COMPLETED|Overall Study||3
2516223|NCT00732472|6166373|P1|NOT COMPLETED|Overall Study||0
2516224|NCT00732472|6166370|P4|COMPLETED|Overall Study||6
2516225|NCT00732472|6166371|P3|COMPLETED|Overall Study||9
2516226|NCT00732472|6166372|P2|COMPLETED|Overall Study||7
2516227|NCT00732472|6166373|P1|COMPLETED|Overall Study||9
2516228|NCT00732472|6166370|P4|STARTED|Overall Study||9
2516229|NCT00732472|6166371|P3|STARTED|Overall Study||10
2516230|NCT00732472|6166372|P2|STARTED|Overall Study|One par. (counted as 2 on outputs) was randomized/dosed with UMEC 250 µg on 2 separate occasions.|10
2516231|NCT00732472|6166373|P1|STARTED|Overall Study||9
2516232|NCT00732381|6166473|P2|NOT COMPLETED|Overall Study||1
2516233|NCT00732381|6166474|P1|NOT COMPLETED|Overall Study||2
2516234|NCT00732381|6166473|P2|COMPLETED|Overall Study||174
2516235|NCT00732381|6166474|P1|COMPLETED|Overall Study||174
2516236|NCT00732381|6166473|P2|STARTED|Overall Study||175
2516237|NCT00732381|6166474|P1|STARTED|Overall Study||176
2516238|NCT00732303|6166482|P1|NOT COMPLETED|Overall Study||2
2516239|NCT00732303|6166482|P1|COMPLETED|Overall Study||6
2516240|NCT00732303|6166482|P1|STARTED|Overall Study||8
2516241|NCT00732251|6166488|P1|NOT COMPLETED|Overall Study||7
2516242|NCT00732251|6166488|P1|COMPLETED|Overall Study||1
2516243|NCT00732251|6166488|P1|STARTED|Overall Study||8
2516244|NCT00732238|6166496|P2|NOT COMPLETED|Overall Study||1
2516245|NCT00732238|6166497|P1|NOT COMPLETED|Overall Study||5
2516246|NCT00732238|6166496|P2|COMPLETED|Overall Study||27
2516247|NCT00732238|6166497|P1|COMPLETED|Overall Study||28
2516248|NCT00732238|6166496|P2|STARTED|Overall Study||28
2516249|NCT00732238|6166497|P1|STARTED|Overall Study||33
2516250|NCT00732225|6166510|P5|NOT COMPLETED|Overall Study||6
2516251|NCT00732225|6166511|P4|NOT COMPLETED|Overall Study||4
2516252|NCT00732225|6166512|P3|NOT COMPLETED|Overall Study||3
2516253|NCT00732225|6166513|P2|NOT COMPLETED|Overall Study||8
2516254|NCT00732225|6166514|P1|NOT COMPLETED|Overall Study||11
2516255|NCT00732225|6166510|P5|COMPLETED|Overall Study|48 eyes of 48 patients|48
2516256|NCT00732225|6166511|P4|COMPLETED|Overall Study|29 eyes of 29 patients|29
2516257|NCT00732225|6166512|P3|COMPLETED|Overall Study|23 eyes of 23 patients|23
2516258|NCT00732225|6166513|P2|COMPLETED|Overall Study|33 eyes of 32 patients|32
2516259|NCT00732225|6166514|P1|COMPLETED|Overall Study|64 eyes of 60 patients|60
2516260|NCT00732225|6166510|P5|STARTED|Overall Study|55 eyes of 54 patients|54
2516261|NCT00732225|6166511|P4|STARTED|Overall Study|33 eyes of 33 patients|33
2516262|NCT00732225|6166512|P3|STARTED|Overall Study|26 eyes of 26 patients|26
2516263|NCT00732225|6166513|P2|STARTED|Overall Study|41 eyes of 40 patients|40
2516264|NCT00732225|6166514|P1|STARTED|Overall Study|76 eyes of 71 patients|71
2516273|NCT00732199|6166598|P2|NOT COMPLETED|Overall Study||26
2516274|NCT00732199|6166599|P1|NOT COMPLETED|Overall Study||34
2516275|NCT00732199|6166598|P2|COMPLETED|Overall Study||16
2516276|NCT00732199|6166599|P1|COMPLETED|Overall Study||16
2516277|NCT00732199|6166598|P2|STARTED|Overall Study||42
2516278|NCT00732199|6166599|P1|STARTED|Overall Study||50
2516279|NCT00732160|6166614|P4|NOT COMPLETED|Overall Study||2
2516280|NCT00732160|6166615|P3|NOT COMPLETED|Overall Study||3
2516281|NCT00732160|6166616|P2|NOT COMPLETED|Overall Study||4
2516282|NCT00732160|6166617|P1|NOT COMPLETED|Overall Study||5
2516283|NCT00732160|6166614|P4|COMPLETED|Overall Study||3
2516284|NCT00732160|6166615|P3|COMPLETED|Overall Study||3
2516285|NCT00732160|6166616|P2|COMPLETED|Overall Study||1
2516286|NCT00732160|6166617|P1|COMPLETED|Overall Study||2
2516287|NCT00732160|6166614|P4|LS Aldosterone|Overall Study||5
2516288|NCT00732160|6166615|P3|LS Aldosterone|Overall Study||6
2516289|NCT00732160|6166616|P2|LS Aldosterone|Overall Study||1
2516290|NCT00732160|6166617|P1|LS Aldosterone|Overall Study||2
2516291|NCT00732160|6166614|P4|LS Vehicle|Overall Study||5
2516292|NCT00732160|6166615|P3|LS Vehicle|Overall Study||6
2516293|NCT00732160|6166616|P2|LS Vehicle|Overall Study||1
2516294|NCT00732160|6166617|P1|LS Vehicle|Overall Study||2
2516295|NCT00732160|6166614|P4|HS Aldosterone|Overall Study||3
2516296|NCT00732160|6166615|P3|HS Aldosterone|Overall Study||3
2516297|NCT00732160|6166616|P2|HS Aldosterone|Overall Study||5
2516298|NCT00732160|6166617|P1|HS Aldosterone|Overall Study||7
2516299|NCT00732160|6166614|P4|HS Vehicle|Overall Study||3
2516300|NCT00732160|6166615|P3|HS Vehicle|Overall Study||3
2516301|NCT00732160|6166616|P2|HS Vehicle|Overall Study||5
2516302|NCT00732160|6166617|P1|HS Vehicle|Overall Study||7
2516303|NCT00732160|6166614|P4|STARTED|Overall Study||5
2516304|NCT00732160|6166615|P3|STARTED|Overall Study||6
2516305|NCT00732160|6166616|P2|STARTED|Overall Study||5
2516306|NCT00732160|6166617|P1|STARTED|Overall Study||7
2516307|NCT00732069|6166631|P6|NOT COMPLETED|Third Study Drug||0
2516308|NCT00732069|6166632|P5|NOT COMPLETED|Third Study Drug||0
2516309|NCT00732069|6166633|P4|NOT COMPLETED|Third Study Drug||0
2516310|NCT00732069|6166634|P3|NOT COMPLETED|Third Study Drug||0
2516311|NCT00732069|6166635|P2|NOT COMPLETED|Third Study Drug||0
2516312|NCT00732069|6166636|P1|NOT COMPLETED|Third Study Drug||0
2516313|NCT00732069|6166631|P6|COMPLETED|Third Study Drug||2
2516314|NCT00732069|6166632|P5|COMPLETED|Third Study Drug||3
2516315|NCT00732069|6166633|P4|COMPLETED|Third Study Drug||2
2516316|NCT00732069|6166634|P3|COMPLETED|Third Study Drug||3
2516317|NCT00732069|6166635|P2|COMPLETED|Third Study Drug||3
2516318|NCT00732069|6166636|P1|COMPLETED|Third Study Drug||2
2516319|NCT00732069|6166631|P6|STARTED|Third Study Drug||2
2516320|NCT00732069|6166632|P5|STARTED|Third Study Drug||3
2516321|NCT00732069|6166633|P4|STARTED|Third Study Drug||2
2516322|NCT00732069|6166634|P3|STARTED|Third Study Drug||3
2516323|NCT00732069|6166635|P2|STARTED|Third Study Drug||3
2516324|NCT00732069|6166636|P1|STARTED|Third Study Drug||2
2516325|NCT00732069|6166631|P6|NOT COMPLETED|Washout After Second Study Drug||0
2516326|NCT00732069|6166632|P5|NOT COMPLETED|Washout After Second Study Drug||0
2516327|NCT00732069|6166633|P4|NOT COMPLETED|Washout After Second Study Drug||0
2516328|NCT00732069|6166634|P3|NOT COMPLETED|Washout After Second Study Drug||0
2516329|NCT00732069|6166635|P2|NOT COMPLETED|Washout After Second Study Drug||0
2516330|NCT00732069|6166636|P1|NOT COMPLETED|Washout After Second Study Drug||0
2516331|NCT00732069|6166631|P6|COMPLETED|Washout After Second Study Drug||2
2516332|NCT00732069|6166632|P5|COMPLETED|Washout After Second Study Drug||3
2516333|NCT00732069|6166633|P4|COMPLETED|Washout After Second Study Drug||2
2516334|NCT00732069|6166634|P3|COMPLETED|Washout After Second Study Drug||3
2516335|NCT00732069|6166635|P2|COMPLETED|Washout After Second Study Drug||3
2516336|NCT00732069|6166636|P1|COMPLETED|Washout After Second Study Drug||2
2516337|NCT00732069|6166631|P6|STARTED|Washout After Second Study Drug||2
2516338|NCT00732069|6166632|P5|STARTED|Washout After Second Study Drug||3
2516339|NCT00732069|6166633|P4|STARTED|Washout After Second Study Drug||2
2516340|NCT00732069|6166634|P3|STARTED|Washout After Second Study Drug||3
2516341|NCT00732069|6166635|P2|STARTED|Washout After Second Study Drug||3
2516342|NCT00732069|6166636|P1|STARTED|Washout After Second Study Drug||2
2516343|NCT00732069|6166631|P6|NOT COMPLETED|Second Study Drug||0
2516344|NCT00732069|6166632|P5|NOT COMPLETED|Second Study Drug||0
2516345|NCT00732069|6166633|P4|NOT COMPLETED|Second Study Drug||0
2516346|NCT00732069|6166634|P3|NOT COMPLETED|Second Study Drug||0
2516347|NCT00732069|6166635|P2|NOT COMPLETED|Second Study Drug||0
2516348|NCT00732069|6166636|P1|NOT COMPLETED|Second Study Drug||0
2516349|NCT00732069|6166631|P6|COMPLETED|Second Study Drug||2
2516350|NCT00732069|6166632|P5|COMPLETED|Second Study Drug||3
2516351|NCT00732069|6166633|P4|COMPLETED|Second Study Drug||2
2516352|NCT00732069|6166634|P3|COMPLETED|Second Study Drug||3
2516353|NCT00732069|6166635|P2|COMPLETED|Second Study Drug||3
2516354|NCT00732069|6166636|P1|COMPLETED|Second Study Drug||2
2516355|NCT00732069|6166631|P6|STARTED|Second Study Drug||2
2516356|NCT00732069|6166632|P5|STARTED|Second Study Drug||3
2516357|NCT00732069|6166633|P4|STARTED|Second Study Drug||2
2516358|NCT00732069|6166634|P3|STARTED|Second Study Drug||3
2516359|NCT00732069|6166635|P2|STARTED|Second Study Drug||3
2516360|NCT00732069|6166636|P1|STARTED|Second Study Drug||2
2516361|NCT00732069|6166631|P6|NOT COMPLETED|Washout After First Study Drug||0
2516362|NCT00732069|6166632|P5|NOT COMPLETED|Washout After First Study Drug||0
2516363|NCT00732069|6166633|P4|NOT COMPLETED|Washout After First Study Drug||0
2516364|NCT00732069|6166634|P3|NOT COMPLETED|Washout After First Study Drug||0
2516365|NCT00732069|6166635|P2|NOT COMPLETED|Washout After First Study Drug||0
2516366|NCT00732069|6166636|P1|NOT COMPLETED|Washout After First Study Drug||1
2516367|NCT00732069|6166631|P6|COMPLETED|Washout After First Study Drug||2
2516368|NCT00732069|6166632|P5|COMPLETED|Washout After First Study Drug||3
2516369|NCT00732069|6166633|P4|COMPLETED|Washout After First Study Drug||2
2516370|NCT00732069|6166634|P3|COMPLETED|Washout After First Study Drug||3
2516371|NCT00732069|6166635|P2|COMPLETED|Washout After First Study Drug||3
2516372|NCT00732069|6166636|P1|COMPLETED|Washout After First Study Drug||2
2516373|NCT00732069|6166631|P6|STARTED|Washout After First Study Drug||2
2516374|NCT00732069|6166632|P5|STARTED|Washout After First Study Drug||3
2516375|NCT00732069|6166633|P4|STARTED|Washout After First Study Drug||2
2516376|NCT00732069|6166634|P3|STARTED|Washout After First Study Drug||3
2516377|NCT00732069|6166635|P2|STARTED|Washout After First Study Drug||3
2516378|NCT00732069|6166636|P1|STARTED|Washout After First Study Drug||3
2516379|NCT00732069|6166631|P6|NOT COMPLETED|First Study Drug||0
2516380|NCT00732069|6166632|P5|NOT COMPLETED|First Study Drug||0
2516381|NCT00732069|6166633|P4|NOT COMPLETED|First Study Drug||0
2516382|NCT00732069|6166634|P3|NOT COMPLETED|First Study Drug||0
2516383|NCT00732069|6166635|P2|NOT COMPLETED|First Study Drug||0
2516384|NCT00732069|6166636|P1|NOT COMPLETED|First Study Drug||0
2516385|NCT00732069|6166631|P6|COMPLETED|First Study Drug||2
2516386|NCT00732069|6166632|P5|COMPLETED|First Study Drug||3
2516387|NCT00732069|6166633|P4|COMPLETED|First Study Drug||2
2516388|NCT00732069|6166634|P3|COMPLETED|First Study Drug||3
2516389|NCT00732069|6166635|P2|COMPLETED|First Study Drug||3
2516390|NCT00732069|6166636|P1|COMPLETED|First Study Drug||3
2516391|NCT00732069|6166631|P6|STARTED|First Study Drug||2
2516392|NCT00732069|6166632|P5|STARTED|First Study Drug||3
2516393|NCT00732069|6166633|P4|STARTED|First Study Drug||2
2516394|NCT00732069|6166634|P3|STARTED|First Study Drug||3
2516395|NCT00732069|6166635|P2|STARTED|First Study Drug||3
2516396|NCT00732069|6166636|P1|STARTED|First Study Drug||3
2516397|NCT00732030|6166647|P1|NOT COMPLETED|Overall Study||2
2516398|NCT00732030|6166647|P1|COMPLETED|Overall Study||24
2516399|NCT00732030|6166647|P1|STARTED|Overall Study||26
2516400|NCT00731939|6166654|P1|NOT COMPLETED|Overall Study||34
2516401|NCT00731939|6166654|P1|COMPLETED|Overall Study||90
2516402|NCT00731939|6166654|P1|STARTED|Overall Study||124
2516403|NCT00731874|6166704|P2|NOT COMPLETED|Overall Study||0
2516404|NCT00731874|6166705|P1|NOT COMPLETED|Overall Study||0
2516405|NCT00731874|6166704|P2|COMPLETED|Overall Study||13
2516406|NCT00731874|6166705|P1|COMPLETED|Overall Study||10
2516407|NCT00731874|6166704|P2|STARTED|Overall Study||13
2516408|NCT00731874|6166705|P1|STARTED|Overall Study||10
2516409|NCT00731822|6166731|P2|NOT COMPLETED|Overall Study||1
2516410|NCT00731822|6166732|P1|NOT COMPLETED|Overall Study||4
2516411|NCT00731822|6166731|P2|COMPLETED|Overall Study||39
2516412|NCT00731822|6166732|P1|COMPLETED|Overall Study||16
2516413|NCT00731822|6166731|P2|STARTED|Overall Study||40
2516414|NCT00731822|6166732|P1|STARTED|Overall Study||20
2516415|NCT00731783|6166746|P2|NOT COMPLETED|12 Month Follow-Up Visit||7
2516416|NCT00731783|6166747|P1|NOT COMPLETED|12 Month Follow-Up Visit||6
2516417|NCT00731783|6166746|P2|COMPLETED|12 Month Follow-Up Visit||58
2516418|NCT00731783|6166747|P1|COMPLETED|12 Month Follow-Up Visit||68
2516419|NCT00731783|6166746|P2|STARTED|12 Month Follow-Up Visit||65
2516420|NCT00731783|6166747|P1|STARTED|12 Month Follow-Up Visit||74
2516421|NCT00731783|6166746|P2|NOT COMPLETED|Six Month Follow-Up Visit||3
2516422|NCT00731783|6166747|P1|NOT COMPLETED|Six Month Follow-Up Visit||6
2516423|NCT00731783|6166746|P2|COMPLETED|Six Month Follow-Up Visit||64
2516424|NCT00731783|6166747|P1|COMPLETED|Six Month Follow-Up Visit||71
2516425|NCT00731783|6166746|P2|STARTED|Six Month Follow-Up Visit||67
2516426|NCT00731783|6166747|P1|STARTED|Six Month Follow-Up Visit||77
2516427|NCT00731783|6166746|P2|NOT COMPLETED|Three Month Follow-Up Visit||16
2516428|NCT00731783|6166747|P1|NOT COMPLETED|Three Month Follow-Up Visit||7
2516429|NCT00731783|6166746|P2|COMPLETED|Three Month Follow-Up Visit||57
2516430|NCT00731783|6166747|P1|COMPLETED|Three Month Follow-Up Visit||72
2516431|NCT00731783|6166746|P2|STARTED|Three Month Follow-Up Visit||73
2516432|NCT00731783|6166747|P1|STARTED|Three Month Follow-Up Visit||79
2516433|NCT00731783|6166746|P2|NOT COMPLETED|One Month Follow-Up Visit||22
2516434|NCT00731783|6166747|P1|NOT COMPLETED|One Month Follow-Up Visit||14
2516435|NCT00731783|6166746|P2|COMPLETED|One Month Follow-Up Visit||69
2516436|NCT00731783|6166747|P1|COMPLETED|One Month Follow-Up Visit||78
2516437|NCT00731783|6166746|P2|STARTED|One Month Follow-Up Visit||91
2516438|NCT00731783|6166747|P1|STARTED|One Month Follow-Up Visit||92
2516439|NCT00731770|6166769|P2|NOT COMPLETED|Overall Study||0
2516440|NCT00731770|6166770|P1|NOT COMPLETED|Overall Study||0
2516441|NCT00731770|6166769|P2|COMPLETED|Overall Study||5
2516442|NCT00731770|6166770|P1|COMPLETED|Overall Study||5
2516443|NCT00731770|6166769|P2|STARTED|Overall Study||5
2516444|NCT00731770|6166770|P1|STARTED|Overall Study||5
2516445|NCT00731731|6166781|P3|NOT COMPLETED|Overall Study||3
2516446|NCT00731731|6166782|P2|NOT COMPLETED|Overall Study||0
2516447|NCT00731731|6166783|P1|NOT COMPLETED|Overall Study||0
2516448|NCT00731731|6166781|P3|COMPLETED|Overall Study||107
2516449|NCT00731731|6166782|P2|COMPLETED|Overall Study||3
2516450|NCT00731731|6166783|P1|COMPLETED|Overall Study||12
2516451|NCT00731731|6166781|P3|STARTED|Overall Study||110
2516452|NCT00731731|6166782|P2|STARTED|Overall Study||3
2516453|NCT00731731|6166783|P1|STARTED|Overall Study||12
2516454|NCT00731692|6166801|P3|NOT COMPLETED|Extension Phase||301
2516455|NCT00731692|6166802|P2|NOT COMPLETED|Extension Phase||196
2516456|NCT00731692|6166803|P1|NOT COMPLETED|Extension Phase||74
2516457|NCT00731692|6166801|P3|COMPLETED|Extension Phase||0
2516458|NCT00731692|6166802|P2|COMPLETED|Extension Phase||0
2516459|NCT00731692|6166803|P1|COMPLETED|Extension Phase||0
2516460|NCT00731692|6166801|P3|STARTED|Extension Phase||301
2516461|NCT00731692|6166802|P2|STARTED|Extension Phase||196
2516462|NCT00731692|6166803|P1|STARTED|Extension Phase||74
2516463|NCT00731692|6166801|P3|NOT COMPLETED|Core Study (36 Months)||170
2516464|NCT00731692|6166802|P2|NOT COMPLETED|Core Study (36 Months)||116
2516465|NCT00731692|6166803|P1|NOT COMPLETED|Core Study (36 Months)||68
2516466|NCT00731692|6166801|P3|COMPLETED|Core Study (36 Months)||317
2516467|NCT00731692|6166802|P2|COMPLETED|Core Study (36 Months)||220
2516468|NCT00731692|6166803|P1|COMPLETED|Core Study (36 Months)||79
2516469|NCT00731692|6166801|P3|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
2516470|NCT00731692|6166802|P2|Post Protocol Amendment 5 Switch|Core Study (36 Months)|post protocol amendment 121 patients switch to 0.5 mg dose from 125mg dose|121
2516471|NCT00731692|6166803|P1|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
2516472|NCT00731692|6166801|P3|Pharmacokinetic Analysis Set|Core Study (36 Months)||0
2516473|NCT00731692|6166802|P2|Pharmacokinetic Analysis Set|Core Study (36 Months)||249
2516474|NCT00731692|6166803|P1|Pharmacokinetic Analysis Set|Core Study (36 Months)||102
2516475|NCT00731692|6166801|P3|Full Analysis Set (FAS)|Core Study (36 Months)||487
2516476|NCT00731692|6166802|P2|Full Analysis Set (FAS)|Core Study (36 Months)||336
2516477|NCT00731692|6166803|P1|Full Analysis Set (FAS)|Core Study (36 Months)||0
2516478|NCT00731692|6166801|P3|Safety Set (SAF)|Core Study (36 Months)||487
2516479|NCT00731692|6166802|P2|Safety Set (SAF)|Core Study (36 Months)||336
2516480|NCT00731692|6166803|P1|Safety Set (SAF)|Core Study (36 Months)||0
2516481|NCT00731692|6166801|P3|STARTED|Core Study (36 Months)||487
2516482|NCT00731692|6166802|P2|STARTED|Core Study (36 Months)||336
2516483|NCT00731692|6166803|P1|STARTED|Core Study (36 Months)||147
2516484|NCT00731679|6166849|P2|NOT COMPLETED|Overall Study||26
2516485|NCT00731679|6166850|P1|NOT COMPLETED|Overall Study||22
2516486|NCT00731679|6166849|P2|COMPLETED|Overall Study||283
2516487|NCT00731679|6166850|P1|COMPLETED|Overall Study||292
2516488|NCT00731679|6166849|P2|STARTED|Overall Study||309
2516489|NCT00731679|6166850|P1|STARTED|Overall Study||314
2516490|NCT00731666|6166858|P1|NOT COMPLETED|Overall Study||12
2516491|NCT00731666|6166858|P1|COMPLETED|Overall Study||28
2516492|NCT00731666|6166858|P1|STARTED|Overall Study||40
2516493|NCT00731653|6166864|P1|NOT COMPLETED|Overall Study||9
2516494|NCT00731653|6166864|P1|COMPLETED|Overall Study||72
2516495|NCT00731653|6166864|P1|STARTED|Overall Study||81
2516496|NCT00731640|6166870|P2|NOT COMPLETED|Overall Study||0
2516497|NCT00731640|6166871|P1|NOT COMPLETED|Overall Study||0
2516498|NCT00731640|6166870|P2|COMPLETED|Overall Study||32
2516499|NCT00731640|6166871|P1|COMPLETED|Overall Study||20
2516500|NCT00731640|6166870|P2|STARTED|Overall Study||32
2516501|NCT00731640|6166871|P1|STARTED|Overall Study||20
2516502|NCT00731614|6166885|P2|NOT COMPLETED|Overall Study||13
2516503|NCT00731614|6166886|P1|NOT COMPLETED|Overall Study||7
2516504|NCT00731614|6166885|P2|COMPLETED|Overall Study||18
2516505|NCT00731614|6166886|P1|COMPLETED|Overall Study||16
2516506|NCT00731614|6166885|P2|12 Weeks Posttreatment|Overall Study||23
2516507|NCT00731614|6166886|P1|12 Weeks Posttreatment|Overall Study||18
2516508|NCT00731614|6166885|P2|End of Treatment|Overall Study||24
2516509|NCT00731614|6166886|P1|End of Treatment|Overall Study||16
2516510|NCT00731614|6166885|P2|STARTED|Overall Study||31
2516511|NCT00731614|6166886|P1|STARTED|Overall Study||23
2516512|NCT00731549|6166894|P1|NOT COMPLETED|Overall Study||223
2516513|NCT00731549|6166894|P1|COMPLETED|Overall Study||858
2516514|NCT00731549|6166894|P1|STARTED|Overall Study||1081
2516515|NCT00731484|6166907|P1|NOT COMPLETED|Overall Study||0
2516516|NCT00731484|6166907|P1|COMPLETED|Overall Study||233
2516517|NCT00731484|6166907|P1|STARTED|Overall Study||233
2516518|NCT00731341|6166911|P1|NOT COMPLETED|Overall Study||0
2516519|NCT00731341|6166911|P1|COMPLETED|Overall Study||3
2516520|NCT00731341|6166911|P1|STARTED|Overall Study||3
2516521|NCT00731211|6166920|P1|NOT COMPLETED|Overall Study||0
2516522|NCT00731211|6166920|P1|COMPLETED|Overall Study||55
2516523|NCT00731211|6166920|P1|STARTED|Overall Study|2 patients ineligible (papillary histologic type-1 pt. Previous treatment with everolimus alone-1 pt|55
2516524|NCT00731198|6166927|P2|NOT COMPLETED|Overall Study||6
2516525|NCT00731198|6166928|P1|NOT COMPLETED|Overall Study||6
2516526|NCT00731198|6166927|P2|COMPLETED|Overall Study||319
2516527|NCT00731198|6166928|P1|COMPLETED|Overall Study||319
2516528|NCT00731198|6166927|P2|STARTED|Overall Study||325
2516529|NCT00731198|6166928|P1|STARTED|Overall Study||325
2516530|NCT00731133|6166934|P1|NOT COMPLETED|Overall Study||10
2516531|NCT00731133|6166934|P1|COMPLETED|Overall Study||5
2516532|NCT00731133|6166934|P1|STARTED|Overall Study||15
2516533|NCT00731120|6166942|P3|NOT COMPLETED|Overall Study||36
2516534|NCT00731120|6166943|P2|NOT COMPLETED|Overall Study||43
2516535|NCT00731120|6166944|P1|NOT COMPLETED|Overall Study||42
2516536|NCT00731120|6166942|P3|COMPLETED|Overall Study||116
2516537|NCT00731120|6166943|P2|COMPLETED|Overall Study||109
2516538|NCT00731120|6166944|P1|COMPLETED|Overall Study||111
2516539|NCT00731120|6166942|P3|Treated|Overall Study||152
2516540|NCT00731120|6166943|P2|Treated|Overall Study||151
2516541|NCT00731120|6166944|P1|Treated|Overall Study||153
2516542|NCT00731120|6166942|P3|STARTED|Overall Study||152
2516543|NCT00731120|6166943|P2|STARTED|Overall Study||152
2516544|NCT00731120|6166944|P1|STARTED|Overall Study||153
2516545|NCT00731094|6166981|P2|NOT COMPLETED|Overall Study||11
2516546|NCT00731094|6166982|P1|NOT COMPLETED|Overall Study||18
2516547|NCT00731094|6166981|P2|COMPLETED|Overall Study||105
2516548|NCT00731094|6166982|P1|COMPLETED|Overall Study||98
2516549|NCT00731094|6166981|P2|Month 6|Overall Study||107
2516550|NCT00731094|6166982|P1|Month 6|Overall Study||101
2516551|NCT00731094|6166981|P2|STARTED|Overall Study||116
2516552|NCT00731094|6166982|P1|STARTED|Overall Study||116
2516553|NCT00731055|6167052|P1|NOT COMPLETED|Overall Study||0
2516554|NCT00731055|6167052|P1|COMPLETED|Overall Study||16
2516555|NCT00731055|6167052|P1|Received Varenicline 2.0 mg|Overall Study||16
2516556|NCT00731055|6167052|P1|Received Varenicline 1.0 mg|Overall Study||16
2516557|NCT00731055|6167052|P1|Received Varenicline 0.5 mg|Overall Study||16
2516558|NCT00731055|6167052|P1|Received Placebo|Overall Study||16
2516559|NCT00731055|6167052|P1|STARTED|Overall Study|This is a within-subjects study design.|16
2516560|NCT00731042|6167061|P2|NOT COMPLETED|Second Intervention||2
2516561|NCT00731042|6167062|P1|NOT COMPLETED|Second Intervention||0
2516562|NCT00731042|6167061|P2|COMPLETED|Second Intervention|2 subjects did not met inclusion criteria for Period 2 Visual scoring skin condition|15
2516563|NCT00731042|6167062|P1|COMPLETED|Second Intervention||16
2516564|NCT00731042|6167061|P2|STARTED|Second Intervention||17
2516565|NCT00731042|6167062|P1|STARTED|Second Intervention||16
2516566|NCT00731042|6167061|P2|NOT COMPLETED|Wash-out||0
2516567|NCT00731042|6167062|P1|NOT COMPLETED|Wash-out||0
2516568|NCT00731042|6167061|P2|COMPLETED|Wash-out||17
2516569|NCT00731042|6167062|P1|COMPLETED|Wash-out||16
2516570|NCT00731042|6167061|P2|STARTED|Wash-out||17
2516571|NCT00731042|6167062|P1|STARTED|Wash-out||16
2516572|NCT00731042|6167061|P2|NOT COMPLETED|First Intervention||0
2516573|NCT00731042|6167062|P1|NOT COMPLETED|First Intervention||0
2516574|NCT00731042|6167061|P2|COMPLETED|First Intervention||17
2516575|NCT00731042|6167062|P1|COMPLETED|First Intervention||16
2516576|NCT00731042|6167061|P2|STARTED|First Intervention||17
2516577|NCT00731042|6167062|P1|STARTED|First Intervention||16
2516578|NCT00730964|6167068|P1|NOT COMPLETED|Overall Study||0
2516579|NCT00730964|6167068|P1|COMPLETED|Overall Study||1039
2516580|NCT00730964|6167068|P1|STARTED|Overall Study||1039
2516581|NCT00730925|6167073|P1|NOT COMPLETED|Overall Study||41
2516582|NCT00730925|6167073|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date|0
2516583|NCT00730925|6167073|P1|STARTED|Overall Study||41
2516584|NCT00730912|6167083|P3|NOT COMPLETED|Overall Study||1
2516585|NCT00730912|6167084|P2|NOT COMPLETED|Overall Study||0
2516586|NCT00730912|6167085|P1|NOT COMPLETED|Overall Study||0
2516587|NCT00730912|6167083|P3|COMPLETED|Overall Study||103
2516588|NCT00730912|6167084|P2|COMPLETED|Overall Study||104
2516589|NCT00730912|6167085|P1|COMPLETED|Overall Study||53
2516590|NCT00730912|6167083|P3|STARTED|Overall Study||104
2516591|NCT00730912|6167084|P2|STARTED|Overall Study||104
2516592|NCT00730912|6167085|P1|STARTED|Overall Study||53
2516593|NCT00730886|6167098|P2|NOT COMPLETED|Overall Study||0
2516594|NCT00730886|6167099|P1|NOT COMPLETED|Overall Study||2
2516595|NCT00730886|6167098|P2|COMPLETED|Overall Study|no subjects enrolled in this arm. Study enrollment terminated early.|0
2516596|NCT00730886|6167099|P1|COMPLETED|Overall Study||0
2516597|NCT00730886|6167098|P2|STARTED|Overall Study|no subjects enrolled in this arm. Study enrollment terminated early.|0
2516598|NCT00730886|6167099|P1|STARTED|Overall Study||2
2516599|NCT00730847|6167123|P1|NOT COMPLETED|Overall Study||131
2516600|NCT00730847|6167123|P1|COMPLETED|Overall Study||465
2516601|NCT00730847|6167123|P1|STARTED|Overall Study||596
2516602|NCT00730756|6167132|P2|NOT COMPLETED|Overall Study||5
2516603|NCT00730756|6167133|P1|NOT COMPLETED|Overall Study||4
2516604|NCT00730756|6167132|P2|COMPLETED|Overall Study||48
2516605|NCT00730756|6167133|P1|COMPLETED|Overall Study||45
2516606|NCT00730756|6167132|P2|STARTED|Overall Study||53
2516607|NCT00730756|6167133|P1|STARTED|Overall Study||49
2516608|NCT00730730|6167155|P1|NOT COMPLETED|Overall Study||0
2516609|NCT00730730|6167155|P1|COMPLETED|Overall Study||50
2516610|NCT00730730|6167155|P1|STARTED|Overall Study||50
2516611|NCT00730691|6167167|P5|NOT COMPLETED|Overall Study||50
2516612|NCT00730691|6167168|P4|NOT COMPLETED|Overall Study||45
2516613|NCT00730691|6167169|P3|NOT COMPLETED|Overall Study||39
2516614|NCT00730691|6167170|P2|NOT COMPLETED|Overall Study||36
2516615|NCT00730691|6167171|P1|NOT COMPLETED|Overall Study||36
2516616|NCT00730691|6167167|P5|COMPLETED|Overall Study||106
2516617|NCT00730691|6167168|P4|COMPLETED|Overall Study||111
2516618|NCT00730691|6167169|P3|COMPLETED|Overall Study||117
2516619|NCT00730691|6167170|P2|COMPLETED|Overall Study||120
2516620|NCT00730691|6167171|P1|COMPLETED|Overall Study||121
2516621|NCT00730691|6167167|P5|STARTED|Overall Study||156
2516622|NCT00730691|6167168|P4|STARTED|Overall Study||156
2516623|NCT00730691|6167169|P3|STARTED|Overall Study|One participant was randomized by error. Reason not completed is reported as Other.|156
2516624|NCT00730691|6167170|P2|STARTED|Overall Study||156
2516625|NCT00730691|6167171|P1|STARTED|Overall Study||157
2516626|NCT00730639|6167263|P5|NOT COMPLETED|Overall Study||131
2516627|NCT00730639|6167264|P4|NOT COMPLETED|Overall Study||54
2516628|NCT00730639|6167265|P3|NOT COMPLETED|Overall Study||86
2516629|NCT00730639|6167266|P2|NOT COMPLETED|Overall Study||18
2516630|NCT00730639|6167267|P1|NOT COMPLETED|Overall Study||17
2516631|NCT00730639|6167263|P5|COMPLETED|Overall Study||0
2516632|NCT00730639|6167264|P4|COMPLETED|Overall Study||0
2516633|NCT00730639|6167265|P3|COMPLETED|Overall Study||0
2516634|NCT00730639|6167266|P2|COMPLETED|Overall Study||0
2516635|NCT00730639|6167267|P1|COMPLETED|Overall Study||0
2516636|NCT00730639|6167263|P5|STARTED|Overall Study||131
2516637|NCT00730639|6167264|P4|STARTED|Overall Study||54
2516638|NCT00730639|6167265|P3|STARTED|Overall Study||86
2516639|NCT00730639|6167266|P2|STARTED|Overall Study||18
2516640|NCT00730639|6167267|P1|STARTED|Overall Study||17
2516641|NCT00730483|6167331|P1|NOT COMPLETED|Overall Study||7
2516642|NCT00730483|6167331|P1|COMPLETED|Overall Study||6
2516643|NCT00730483|6167331|P1|6 Months After First DEB-TACE|Overall Study||10
2516644|NCT00730483|6167331|P1|1 Month After First DEB-TACE|Overall Study||13
2516645|NCT00730483|6167331|P1|STARTED|Overall Study||13
2516646|NCT00730405|6167344|P5|NOT COMPLETED|Overall Study-follow-up Phase||22
2516647|NCT00730405|6167345|P4|NOT COMPLETED|Overall Study-follow-up Phase||17
2516648|NCT00730405|6167346|P3|NOT COMPLETED|Overall Study-follow-up Phase||23
2516649|NCT00730405|6167347|P2|NOT COMPLETED|Overall Study-follow-up Phase||21
2516650|NCT00730405|6167348|P1|NOT COMPLETED|Overall Study-follow-up Phase||21
2516651|NCT00730405|6167344|P5|COMPLETED|Overall Study-follow-up Phase||93
2516652|NCT00730405|6167345|P4|COMPLETED|Overall Study-follow-up Phase||100
2516653|NCT00730405|6167346|P3|COMPLETED|Overall Study-follow-up Phase||94
2516654|NCT00730405|6167347|P2|COMPLETED|Overall Study-follow-up Phase||96
2516655|NCT00730405|6167348|P1|COMPLETED|Overall Study-follow-up Phase||95
2516656|NCT00730405|6167344|P5|STARTED|Overall Study-follow-up Phase||115
2516657|NCT00730405|6167345|P4|STARTED|Overall Study-follow-up Phase||117
2516658|NCT00730405|6167346|P3|STARTED|Overall Study-follow-up Phase||117
2516659|NCT00730405|6167347|P2|STARTED|Overall Study-follow-up Phase||117
2516660|NCT00730405|6167348|P1|STARTED|Overall Study-follow-up Phase||116
2516661|NCT00730405|6167344|P5|NOT COMPLETED|Overall Study-Treatment Phase||20
2516662|NCT00730405|6167345|P4|NOT COMPLETED|Overall Study-Treatment Phase||19
2516663|NCT00730405|6167346|P3|NOT COMPLETED|Overall Study-Treatment Phase||21
2516664|NCT00730405|6167347|P2|NOT COMPLETED|Overall Study-Treatment Phase||21
2516665|NCT00730405|6167348|P1|NOT COMPLETED|Overall Study-Treatment Phase||19
2516666|NCT00730405|6167344|P5|COMPLETED|Overall Study-Treatment Phase||95
2516667|NCT00730405|6167345|P4|COMPLETED|Overall Study-Treatment Phase||98
2516668|NCT00730405|6167346|P3|COMPLETED|Overall Study-Treatment Phase||96
2516669|NCT00730405|6167347|P2|COMPLETED|Overall Study-Treatment Phase||96
2516670|NCT00730405|6167348|P1|COMPLETED|Overall Study-Treatment Phase||97
2516671|NCT00730405|6167344|P5|STARTED|Overall Study-Treatment Phase||115
2516672|NCT00730405|6167345|P4|STARTED|Overall Study-Treatment Phase||117
2516673|NCT00730405|6167346|P3|STARTED|Overall Study-Treatment Phase||117
2516674|NCT00730405|6167347|P2|STARTED|Overall Study-Treatment Phase||117
2516675|NCT00730405|6167348|P1|STARTED|Overall Study-Treatment Phase||116
2516676|NCT00730353|6167385|P1|NOT COMPLETED|Overall Study||0
2516677|NCT00730353|6167385|P1|COMPLETED|Overall Study||28
2516678|NCT00730353|6167385|P1|STARTED|Overall Study||28
2516679|NCT00730327|6167395|P2|NOT COMPLETED|Overall Study||37
2516680|NCT00730327|6167396|P1|NOT COMPLETED|Overall Study||27
2516681|NCT00730327|6167395|P2|COMPLETED|Overall Study||93
2516682|NCT00730327|6167396|P1|COMPLETED|Overall Study|Completed defined as subjects who completed the Week 52 follow-up visit.|98
2516683|NCT00730327|6167395|P2|Completed Week 26|Overall Study||99
2516684|NCT00730327|6167396|P1|Completed Week 26|Overall Study|Week 26 was halfway through the study, at which point the BIB group had their balloon removed.|125
2516685|NCT00730327|6167395|P2|STARTED|Overall Study||130
2516686|NCT00730327|6167396|P1|STARTED|Overall Study|Started is defined as subjects that began treatment.|125
2516687|NCT00730275|6167421|P4|NOT COMPLETED|Overall Study||1
2516688|NCT00730275|6167422|P3|NOT COMPLETED|Overall Study||0
2516689|NCT00730275|6167423|P2|NOT COMPLETED|Overall Study||0
2516690|NCT00730275|6167424|P1|NOT COMPLETED|Overall Study||0
2516691|NCT00730275|6167421|P4|COMPLETED|Overall Study||8
2516692|NCT00730275|6167422|P3|COMPLETED|Overall Study||8
2516693|NCT00730275|6167423|P2|COMPLETED|Overall Study||9
2516694|NCT00730275|6167424|P1|COMPLETED|Overall Study||9
2516695|NCT00730275|6167421|P4|STARTED|Overall Study||9
2516696|NCT00730275|6167422|P3|STARTED|Overall Study||8
2516697|NCT00730275|6167423|P2|STARTED|Overall Study||9
2516698|NCT00730275|6167424|P1|STARTED|Overall Study||9
2516699|NCT00730236|6167450|P1|NOT COMPLETED|Overall Study||6
2516700|NCT00730236|6167450|P1|COMPLETED|Overall Study||23
2516701|NCT00730236|6167450|P1|STARTED|Overall Study||29
2516702|NCT00730171|6167465|P1|NOT COMPLETED|Overall Study||771
2516703|NCT00730171|6167465|P1|COMPLETED|Overall Study||954
2516704|NCT00730171|6167465|P1|IBS-C Safety Population|Overall Study||1119
2516705|NCT00730171|6167465|P1|CC Safety Population|Overall Study||607
2516706|NCT00730171|6167465|P1|STARTED|Overall Study||1725
2516707|NCT00730158|6167475|P2|NOT COMPLETED|Overall Study||1
2516708|NCT00730158|6167476|P1|NOT COMPLETED|Overall Study||1
2516709|NCT00730158|6167475|P2|COMPLETED|Overall Study||15
2516710|NCT00730158|6167476|P1|COMPLETED|Overall Study||16
2516711|NCT00730158|6167475|P2|STARTED|Overall Study||16
2516712|NCT00730158|6167476|P1|STARTED|Overall Study||17
2516713|NCT00730132|6167514|P1|NOT COMPLETED|Overall Study||155
2516714|NCT00730132|6167514|P1|COMPLETED|Overall Study||557
2516715|NCT00730132|6167514|P1|STARTED|Overall Study||712
2516716|NCT00730041|6167532|P2|NOT COMPLETED|Overall Study||2
2516717|NCT00730041|6167533|P1|NOT COMPLETED|Overall Study||0
2516718|NCT00730041|6167532|P2|COMPLETED|Overall Study|One subject did not return for the final PSG or final visit, and one missed only the final visit.|23
2516719|NCT00730041|6167533|P1|COMPLETED|Overall Study||26
2516720|NCT00730041|6167532|P2|STARTED|Overall Study|4/25 (16.0%) female, 21/25 (84.0%) male|25
2516721|NCT00730041|6167533|P1|STARTED|Overall Study|4/26 (15.4%) female, 22/26 (84.6%) male|26
2516722|NCT00730028|6167556|P5|NOT COMPLETED|Overall Study||82
2516723|NCT00730028|6167557|P4|NOT COMPLETED|Overall Study||56
2516724|NCT00730028|6167558|P3|NOT COMPLETED|Overall Study||45
2516725|NCT00730028|6167559|P2|NOT COMPLETED|Overall Study||66
2516726|NCT00730028|6167560|P1|NOT COMPLETED|Overall Study||60
2516727|NCT00730028|6167556|P5|COMPLETED|Overall Study||175
2516728|NCT00730028|6167557|P4|COMPLETED|Overall Study||207
2516729|NCT00730028|6167558|P3|COMPLETED|Overall Study||221
2516730|NCT00730028|6167559|P2|COMPLETED|Overall Study||194
2516731|NCT00730028|6167560|P1|COMPLETED|Overall Study||204
2516732|NCT00730028|6167556|P5|STARTED|Overall Study||257
2516733|NCT00730028|6167557|P4|STARTED|Overall Study||263
2516734|NCT00730028|6167558|P3|STARTED|Overall Study||266
2516735|NCT00730028|6167559|P2|STARTED|Overall Study||260
2516736|NCT00730028|6167560|P1|STARTED|Overall Study||264
2516737|NCT00730015|6167610|P3|NOT COMPLETED|Overall Study||32
2516738|NCT00730015|6167611|P2|NOT COMPLETED|Overall Study||40
2516739|NCT00730015|6167612|P1|NOT COMPLETED|Overall Study||31
2516740|NCT00730015|6167610|P3|COMPLETED|Overall Study||177
2516741|NCT00730015|6167611|P2|COMPLETED|Overall Study||177
2516742|NCT00730015|6167612|P1|COMPLETED|Overall Study||186
2516743|NCT00730015|6167610|P3|STARTED|Overall Study||209
2516744|NCT00730015|6167611|P2|STARTED|Overall Study||217
2516745|NCT00730015|6167612|P1|STARTED|Overall Study||217
2516746|NCT00729937|6167652|P6|NOT COMPLETED|Overall Study||37
2516747|NCT00729937|6167653|P5|NOT COMPLETED|Overall Study||28
2516748|NCT00729937|6167654|P4|NOT COMPLETED|Overall Study||34
2516749|NCT00729937|6167655|P3|NOT COMPLETED|Overall Study||29
2516750|NCT00729937|6167656|P2|NOT COMPLETED|Overall Study||88
2516751|NCT00729937|6167657|P1|NOT COMPLETED|Overall Study||74
2516752|NCT00729937|6167652|P6|COMPLETED|Overall Study||214
2516753|NCT00729937|6167653|P5|COMPLETED|Overall Study||221
2516754|NCT00729937|6167654|P4|COMPLETED|Overall Study||215
2516755|NCT00729937|6167655|P3|COMPLETED|Overall Study||222
2516756|NCT00729937|6167656|P2|COMPLETED|Overall Study||548
2516757|NCT00729937|6167657|P1|COMPLETED|Overall Study||555
2516758|NCT00729937|6167652|P6|STARTED|Overall Study||251
2516759|NCT00729937|6167653|P5|STARTED|Overall Study||249
2516760|NCT00729937|6167654|P4|STARTED|Overall Study||249
2516761|NCT00729937|6167655|P3|STARTED|Overall Study||251
2516762|NCT00729937|6167656|P2|STARTED|Overall Study||636
2516763|NCT00729937|6167657|P1|STARTED|Overall Study||629
2516764|NCT00729924|6167851|P1|NOT COMPLETED|Overall Study||0
2516765|NCT00729924|6167851|P1|COMPLETED|Overall Study||40
2516766|NCT00729924|6167851|P1|STARTED|Overall Study||40
2516767|NCT00729859|6167861|P3|NOT COMPLETED|Overall Study||0
2516768|NCT00729859|6167862|P2|NOT COMPLETED|Overall Study||2
2516769|NCT00729859|6167863|P1|NOT COMPLETED|Overall Study||0
2516770|NCT00729859|6167861|P3|COMPLETED|Overall Study||8
2516771|NCT00729859|6167862|P2|COMPLETED|Overall Study||6
2516772|NCT00729859|6167863|P1|COMPLETED|Overall Study||8
2516773|NCT00729859|6167861|P3|STARTED|Overall Study||8
2516774|NCT00729859|6167862|P2|STARTED|Overall Study||8
2516775|NCT00729859|6167863|P1|STARTED|Overall Study||8
2516776|NCT00729846|6167900|P2|NOT COMPLETED|Overall Study||0
2516777|NCT00729846|6167901|P1|NOT COMPLETED|Overall Study||0
2516778|NCT00729846|6167900|P2|COMPLETED|Overall Study||11
2516779|NCT00729846|6167901|P1|COMPLETED|Overall Study||11
2516780|NCT00729846|6167900|P2|STARTED|Overall Study||11
2516781|NCT00729846|6167901|P1|STARTED|Overall Study||11
2516782|NCT00729833|6167907|P4|NOT COMPLETED|Overall Study||6
2516783|NCT00729833|6167908|P3|NOT COMPLETED|Overall Study||12
2516784|NCT00729833|6167909|P2|NOT COMPLETED|Overall Study||7
2516785|NCT00729833|6167910|P1|NOT COMPLETED|Overall Study||20
2516786|NCT00729833|6167907|P4|COMPLETED|Overall Study||0
2516787|NCT00729833|6167908|P3|COMPLETED|Overall Study||0
2516788|NCT00729833|6167909|P2|COMPLETED|Overall Study||0
2516789|NCT00729833|6167910|P1|COMPLETED|Overall Study||0
2516790|NCT00729833|6167907|P4|STARTED|Overall Study||6
2516791|NCT00729833|6167908|P3|STARTED|Overall Study||12
2516792|NCT00729833|6167909|P2|STARTED|Overall Study||7
2516793|NCT00729833|6167910|P1|STARTED|Overall Study||20
2516794|NCT00729807|6167949|P1|NOT COMPLETED|Overall Study||0
2516795|NCT00729807|6167949|P1|COMPLETED|Overall Study||6
2516796|NCT00729807|6167949|P1|STARTED|Overall Study||6
2516797|NCT00729781|6167959|P1|NOT COMPLETED|Long-term Follow-up Study||0
2516798|NCT00729781|6167959|P1|COMPLETED|Long-term Follow-up Study|All subjects completed the original study, but 3 did not consent to enroll in the follow-up study.|42
2516799|NCT00729781|6167959|P1|STARTED|Long-term Follow-up Study|Enrollment in the long-term follow-up required contact and a new Informed Consent.|42
2516800|NCT00729781|6167959|P1|NOT COMPLETED|Original Study||0
2516801|NCT00729781|6167959|P1|COMPLETED|Original Study||45
2516802|NCT00729781|6167959|P1|STARTED|Original Study||45
2516803|NCT00729690|6167968|P3|NOT COMPLETED|Overall Study||2
2516804|NCT00729690|6167969|P2|NOT COMPLETED|Overall Study||2
2516805|NCT00729690|6167970|P1|NOT COMPLETED|Overall Study||0
2516806|NCT00729690|6167968|P3|COMPLETED|Overall Study||14
2516807|NCT00729690|6167969|P2|COMPLETED|Overall Study||14
2516808|NCT00729690|6167970|P1|COMPLETED|Overall Study||16
2516809|NCT00729690|6167968|P3|STARTED|Overall Study||16
2516810|NCT00729690|6167969|P2|STARTED|Overall Study||16
2516811|NCT00729690|6167970|P1|STARTED|Overall Study||16
2516812|NCT00729677|6167987|P1|NOT COMPLETED|Overall Study||0
2516813|NCT00729677|6167987|P1|COMPLETED|Overall Study||64
2516814|NCT00729677|6167987|P1|STARTED|Overall Study||64
2516815|NCT00729651|6168000|P2|NOT COMPLETED|Overall Study||18
2516816|NCT00729651|6168001|P1|NOT COMPLETED|Overall Study||19
2516817|NCT00729651|6168000|P2|COMPLETED|Overall Study||152
2516818|NCT00729651|6168001|P1|COMPLETED|Overall Study||154
2516819|NCT00729651|6168000|P2|STARTED|Overall Study||170
2516820|NCT00729651|6168001|P1|STARTED|Overall Study||173
2516821|NCT00729612|6168013|P1|NOT COMPLETED|Overall Study||10
2516822|NCT00729612|6168013|P1|COMPLETED|Overall Study||53
2516823|NCT00729612|6168013|P1|Died After Cycle 2 Before Response Eval|Overall Study||1
2516824|NCT00729612|6168013|P1|Received Cycle 2|Overall Study||54
2516825|NCT00729612|6168013|P1|Did Not Receive Cycle 2|Overall Study||7
2516826|NCT00729612|6168013|P1|Received Cycle 1|Overall Study||62
2516827|NCT00729612|6168013|P1|Died Before Cycle 1|Overall Study||1
2516828|NCT00729612|6168013|P1|STARTED|Overall Study||63
2516829|NCT00729586|6168022|P2|NOT COMPLETED|Overall Study||1
2516830|NCT00729586|6168023|P1|NOT COMPLETED|Overall Study||1
2516831|NCT00729586|6168022|P2|COMPLETED|Overall Study|Eligible and treated patients|21
2516832|NCT00729586|6168023|P1|COMPLETED|Overall Study|Eligible and treated patients|50
2516833|NCT00729586|6168022|P2|STARTED|Overall Study||22
2516834|NCT00729586|6168023|P1|STARTED|Overall Study||51
2516835|NCT00729560|6168036|P1|NOT COMPLETED|Overall Study||3
2516836|NCT00729560|6168036|P1|COMPLETED|Overall Study||5
2516837|NCT00729560|6168036|P1|STARTED|Overall Study|Arm assignment can not be determined as study was ended prior to unblinding and no key found.|8
2516838|NCT00729521|6168043|P3|NOT COMPLETED|Overall Study||0
2516839|NCT00729521|6168044|P2|NOT COMPLETED|Overall Study||0
2516840|NCT00729521|6168045|P1|NOT COMPLETED|Overall Study||0
2516841|NCT00729521|6168043|P3|COMPLETED|Overall Study|Average annual population over 65 years old.|7701
2516842|NCT00729521|6168044|P2|COMPLETED|Overall Study|Average annual population over 65 years old.|14842
2516843|NCT00729521|6168045|P1|COMPLETED|Overall Study|Average annual population over 65 years old.|12494
2516844|NCT00729521|6168043|P3|STARTED|Overall Study|5 communities in Facilitative System with average annual pop. of 7,701 residents over 65 years.|7701
2516845|NCT00729521|6168044|P2|STARTED|Overall Study|Five communities with average annual population of 14,842 residents over 65 years old.|14842
2516846|NCT00729521|6168045|P1|STARTED|Overall Study|10 communities in Control with average annual population of 12,494 residents over 65 years old.|12494
2516847|NCT00729482|6168053|P1|NOT COMPLETED|Overall Study||0
2516848|NCT00729482|6168053|P1|COMPLETED|Overall Study||54
2516849|NCT00729482|6168053|P1|STARTED|Overall Study||54
2516850|NCT00729469|6168062|P2|NOT COMPLETED|Overall Study||47
2516851|NCT00729469|6168063|P1|NOT COMPLETED|Overall Study||53
2516852|NCT00729469|6168062|P2|COMPLETED|Overall Study||416
2516853|NCT00729469|6168063|P1|COMPLETED|Overall Study||403
2516854|NCT00729469|6168062|P2|STARTED|Overall Study||463
2516855|NCT00729469|6168063|P1|STARTED|Overall Study||456
2516856|NCT00729430|6168101|P2|NOT COMPLETED|Overall Study||50
2516857|NCT00729430|6168102|P1|NOT COMPLETED|Overall Study||47
2516858|NCT00729430|6168101|P2|COMPLETED|Overall Study||128
2516859|NCT00729430|6168102|P1|COMPLETED|Overall Study||133
2516860|NCT00729430|6168101|P2|STARTED|Overall Study||178
2516861|NCT00729430|6168102|P1|STARTED|Overall Study||180
2516862|NCT00729378|6168116|P2|NOT COMPLETED|36-months||6
2516863|NCT00729378|6168117|P1|NOT COMPLETED|36-months||15
2516864|NCT00729378|6168116|P2|COMPLETED|36-months||95
2516865|NCT00729378|6168117|P1|COMPLETED|36-months||105
2516866|NCT00729378|6168116|P2|STARTED|36-months||101
2516867|NCT00729378|6168117|P1|STARTED|36-months||120
2516868|NCT00729378|6168116|P2|NOT COMPLETED|24-months||51
2516869|NCT00729378|6168117|P1|NOT COMPLETED|24-months||72
2516870|NCT00729378|6168116|P2|COMPLETED|24-months||101
2516871|NCT00729378|6168117|P1|COMPLETED|24-months||120
2516872|NCT00729378|6168116|P2|STARTED|24-months||152
2516873|NCT00729378|6168117|P1|STARTED|24-months||192
2516874|NCT00729378|6168116|P2|NOT COMPLETED|12-months||65
2516875|NCT00729378|6168117|P1|NOT COMPLETED|12-months||100
2516876|NCT00729378|6168116|P2|COMPLETED|12-months||152
2516877|NCT00729378|6168117|P1|COMPLETED|12-months||192
2516878|NCT00729378|6168116|P2|STARTED|12-months||217
2516879|NCT00729378|6168117|P1|STARTED|12-months||292
2516880|NCT00729378|6168116|P2|NOT COMPLETED|Baseline||92
2516881|NCT00729378|6168117|P1|NOT COMPLETED|Baseline||138
2516882|NCT00729378|6168116|P2|COMPLETED|Baseline||217
2516883|NCT00729378|6168117|P1|COMPLETED|Baseline||292
2516884|NCT00729378|6168116|P2|STARTED|Baseline||309
2516885|NCT00729378|6168117|P1|STARTED|Baseline||430
2516886|NCT00729365|6168316|P3|NOT COMPLETED|Overall Study||7
2516887|NCT00729365|6168317|P2|NOT COMPLETED|Overall Study||6
2516888|NCT00729365|6168318|P1|NOT COMPLETED|Overall Study||33
2516889|NCT00729365|6168316|P3|COMPLETED|Overall Study|Study terminated|0
2516890|NCT00729365|6168317|P2|COMPLETED|Overall Study|Study Terminated|0
2516891|NCT00729365|6168318|P1|COMPLETED|Overall Study|Study terminated|0
2516892|NCT00729365|6168316|P3|STARTED|Overall Study||7
2516893|NCT00729365|6168317|P2|STARTED|Overall Study||6
2516894|NCT00729365|6168318|P1|STARTED|Overall Study||33
2516895|NCT00729326|6168331|P2|NOT COMPLETED|Overall Study||9
2516896|NCT00729326|6168332|P1|NOT COMPLETED|Overall Study||10
2516897|NCT00729326|6168331|P2|COMPLETED|Overall Study||33
2516898|NCT00729326|6168332|P1|COMPLETED|Overall Study||31
2516899|NCT00729326|6168331|P2|STARTED|Overall Study||42
2516900|NCT00729326|6168332|P1|STARTED|Overall Study||41
2516901|NCT00729248|6168374|P1|NOT COMPLETED|Overall Study||2
2516902|NCT00729248|6168374|P1|COMPLETED|Overall Study||10
2516903|NCT00729248|6168374|P1|STARTED|Overall Study||12
2516904|NCT00729183|6168381|P2|NOT COMPLETED|Overall Study||15
2516905|NCT00729183|6168382|P1|NOT COMPLETED|Overall Study||25
2516906|NCT00729183|6168381|P2|COMPLETED|Overall Study|Completed 24 month visit|90
2516907|NCT00729183|6168382|P1|COMPLETED|Overall Study|Completed 24 month visit|84
2516908|NCT00729183|6168381|P2|STARTED|Overall Study||105
2516909|NCT00729183|6168382|P1|STARTED|Overall Study||109
2516910|NCT00729157|6168414|P1|NOT COMPLETED|Overall Study||1
2516911|NCT00729157|6168414|P1|COMPLETED|Overall Study||40
2516912|NCT00729157|6168414|P1|STARTED|Overall Study||41
2516913|NCT00729053|6168426|P4|NOT COMPLETED|Overall Study||0
2516914|NCT00729053|6168427|P3|NOT COMPLETED|Overall Study||0
2516915|NCT00729053|6168428|P2|NOT COMPLETED|Overall Study||0
2516916|NCT00729053|6168429|P1|NOT COMPLETED|Overall Study||0
2516917|NCT00729053|6168426|P4|COMPLETED|Overall Study||23
2516918|NCT00729053|6168427|P3|COMPLETED|Overall Study||23
2516919|NCT00729053|6168428|P2|COMPLETED|Overall Study||23
2516920|NCT00729053|6168429|P1|COMPLETED|Overall Study||23
2516921|NCT00729053|6168426|P4|STARTED|Overall Study||23
2516922|NCT00729053|6168427|P3|STARTED|Overall Study||23
2516923|NCT00729053|6168428|P2|STARTED|Overall Study||23
2516924|NCT00729053|6168429|P1|STARTED|Overall Study||23
2516925|NCT00728988|6168457|P2|NOT COMPLETED|Overall Study||88
2516926|NCT00728988|6168458|P1|NOT COMPLETED|Overall Study||93
2516927|NCT00728988|6168457|P2|COMPLETED|Overall Study||164
2516928|NCT00728988|6168458|P1|COMPLETED|Overall Study||154
2516929|NCT00728988|6168457|P2|Full Analysis Set|Overall Study||172
2516930|NCT00728988|6168458|P1|Full Analysis Set|Overall Study||163
2516931|NCT00728988|6168457|P2|Treated|Overall Study||250
2516932|NCT00728988|6168458|P1|Treated|Overall Study||245
2516933|NCT00728988|6168457|P2|STARTED|Overall Study||252
2516934|NCT00728988|6168458|P1|STARTED|Overall Study||247
2516935|NCT00728962|6168476|P1|NOT COMPLETED|Two Year Post Placement Follow-up||3
2516936|NCT00728962|6168476|P1|COMPLETED|Two Year Post Placement Follow-up||59
2516937|NCT00728962|6168476|P1|STARTED|Two Year Post Placement Follow-up||62
2516938|NCT00728962|6168476|P1|NOT COMPLETED|One Year Post Placement Follow-up||0
2516939|NCT00728962|6168476|P1|COMPLETED|One Year Post Placement Follow-up||62
2516940|NCT00728962|6168476|P1|STARTED|One Year Post Placement Follow-up||62
2516941|NCT00728962|6168476|P1|NOT COMPLETED|Permanent Prosthesis Placement||3
2516942|NCT00728962|6168476|P1|COMPLETED|Permanent Prosthesis Placement||62
2516943|NCT00728962|6168476|P1|STARTED|Permanent Prosthesis Placement||65
2516944|NCT00728962|6168476|P1|NOT COMPLETED|Implant Placement Surgery||10
2516945|NCT00728962|6168476|P1|COMPLETED|Implant Placement Surgery||65
2516946|NCT00728962|6168476|P1|STARTED|Implant Placement Surgery||75
2516947|NCT00728949|6168482|P2|NOT COMPLETED|Overall Study||4
2516948|NCT00728949|6168483|P1|NOT COMPLETED|Overall Study||11
2516949|NCT00728949|6168482|P2|COMPLETED|Overall Study||27
2516950|NCT00728949|6168483|P1|COMPLETED|Overall Study||51
2516951|NCT00728949|6168482|P2|STARTED|Overall Study||31
2516952|NCT00728949|6168483|P1|STARTED|Overall Study||62
2516953|NCT00728936|6168508|P7|NOT COMPLETED|Overall Study||0
2516954|NCT00728936|6168509|P6|NOT COMPLETED|Overall Study||1
2516955|NCT00728936|6168510|P5|NOT COMPLETED|Overall Study||0
2516956|NCT00728936|6168511|P4|NOT COMPLETED|Overall Study||0
2516957|NCT00728936|6168512|P3|NOT COMPLETED|Overall Study||0
2516958|NCT00728936|6168513|P2|NOT COMPLETED|Overall Study||0
2516959|NCT00728936|6168514|P1|NOT COMPLETED|Overall Study||0
2516960|NCT00728936|6168508|P7|COMPLETED|Overall Study||7
2516961|NCT00728936|6168509|P6|COMPLETED|Overall Study||7
2516962|NCT00728936|6168510|P5|COMPLETED|Overall Study||8
2516963|NCT00728936|6168511|P4|COMPLETED|Overall Study||8
2516964|NCT00728936|6168512|P3|COMPLETED|Overall Study||9
2516965|NCT00728936|6168513|P2|COMPLETED|Overall Study||8
2516966|NCT00728936|6168514|P1|COMPLETED|Overall Study||10
2516967|NCT00728936|6168508|P7|STARTED|Overall Study||7
2516968|NCT00728936|6168509|P6|STARTED|Overall Study||8
2516969|NCT00728936|6168510|P5|STARTED|Overall Study||8
2516970|NCT00728936|6168511|P4|STARTED|Overall Study||8
2516971|NCT00728936|6168512|P3|STARTED|Overall Study||9
2516972|NCT00728936|6168513|P2|STARTED|Overall Study||8
2516973|NCT00728936|6168514|P1|STARTED|Overall Study||10
2516974|NCT00728923|6168530|P1|NOT COMPLETED|Overall Study||0
2516975|NCT00728923|6168530|P1|COMPLETED|Overall Study||9
2516976|NCT00728923|6168530|P1|STARTED|Overall Study||9
2516977|NCT00728910|6168535|P1|NOT COMPLETED|Atorvastatin+ABT335+ER Niacin||0
2516978|NCT00728910|6168535|P1|COMPLETED|Atorvastatin+ABT335+ER Niacin||22
2516979|NCT00728910|6168535|P1|STARTED|Atorvastatin+ABT335+ER Niacin||22
2516980|NCT00728910|6168535|P1|NOT COMPLETED|Atorvastatin+ABT335||0
2516981|NCT00728910|6168535|P1|COMPLETED|Atorvastatin+ABT335||22
2516982|NCT00728910|6168535|P1|STARTED|Atorvastatin+ABT335||22
2516983|NCT00728910|6168535|P1|NOT COMPLETED|Atorvastatin||3
2516984|NCT00728910|6168535|P1|COMPLETED|Atorvastatin||22
2516985|NCT00728910|6168535|P1|STARTED|Atorvastatin||25
2516986|NCT00728884|6168547|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
2516987|NCT00728884|6168547|P1|COMPLETED|Two Year Post Placement Follow-up||145
2516988|NCT00728884|6168547|P1|STARTED|Two Year Post Placement Follow-up||145
2516989|NCT00728884|6168547|P1|NOT COMPLETED|One Year Post Placement Follow-up||4
2516990|NCT00728884|6168547|P1|COMPLETED|One Year Post Placement Follow-up||145
2516991|NCT00728884|6168547|P1|STARTED|One Year Post Placement Follow-up||149
2516992|NCT00728884|6168547|P1|NOT COMPLETED|Permanent Prosthesis Placement||13
2516993|NCT00728884|6168547|P1|COMPLETED|Permanent Prosthesis Placement||149
2516994|NCT00728884|6168547|P1|STARTED|Permanent Prosthesis Placement||162
2516995|NCT00728884|6168547|P1|NOT COMPLETED|Implant Placement Surgery||0
2516996|NCT00728884|6168547|P1|COMPLETED|Implant Placement Surgery||162
2516997|NCT00728884|6168547|P1|STARTED|Implant Placement Surgery||162
2516998|NCT00728845|6168553|P2|NOT COMPLETED|Overall Study||0
2516999|NCT00728845|6168554|P1|NOT COMPLETED|Overall Study||0
2517000|NCT00728845|6168553|P2|COMPLETED|Overall Study||0
2517001|NCT00728845|6168554|P1|COMPLETED|Overall Study||8
2517002|NCT00728845|6168553|P2|STARTED|Overall Study||0
2517003|NCT00728845|6168554|P1|STARTED|Overall Study||8
2517004|NCT00728819|6168570|P2|NOT COMPLETED|Overall Study||29
2517005|NCT00728819|6168571|P1|NOT COMPLETED|Overall Study||36
2517006|NCT00728819|6168570|P2|COMPLETED|Overall Study||139
2517007|NCT00728819|6168571|P1|COMPLETED|Overall Study||135
2517008|NCT00728819|6168570|P2|STARTED|Overall Study||168
2517009|NCT00728819|6168571|P1|STARTED|Overall Study||171
2517010|NCT00728754|6168583|P2|NOT COMPLETED|Two Year Post Placement Follow-up||0
2517011|NCT00728754|6168584|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
2517012|NCT00728754|6168583|P2|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 68|28
2517013|NCT00728754|6168584|P1|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 65|24
2517014|NCT00728754|6168583|P2|STARTED|Two Year Post Placement Follow-up|individual control implant units is 68|28
2517015|NCT00728754|6168584|P1|STARTED|Two Year Post Placement Follow-up|individual test implant units is 65|24
2517016|NCT00728754|6168583|P2|NOT COMPLETED|One Year Post Placement Follow-up||0
2517017|NCT00728754|6168584|P1|NOT COMPLETED|One Year Post Placement Follow-up||1
2517018|NCT00728754|6168583|P2|COMPLETED|One Year Post Placement Follow-up|individual control implant units completed= 68|28
2517019|NCT00728754|6168584|P1|COMPLETED|One Year Post Placement Follow-up|individual test implant units completing is 65|24
2517104|NCT00727909|6168767|P1|NOT COMPLETED|Overall Study||5
2517020|NCT00728754|6168583|P2|STARTED|One Year Post Placement Follow-up|individual control implant units is 68|28
2517021|NCT00728754|6168584|P1|STARTED|One Year Post Placement Follow-up|individual test implant units is 66|25
2517022|NCT00728754|6168583|P2|NOT COMPLETED|Permanent Prosthesis Placement||4
2517023|NCT00728754|6168584|P1|NOT COMPLETED|Permanent Prosthesis Placement||4
2517024|NCT00728754|6168583|P2|COMPLETED|Permanent Prosthesis Placement|Individual control implant units completed = 68|28
2517025|NCT00728754|6168584|P1|COMPLETED|Permanent Prosthesis Placement|Individual test implant units completed = 66|25
2517026|NCT00728754|6168583|P2|STARTED|Permanent Prosthesis Placement|Individual control implant units is 78|32
2517027|NCT00728754|6168584|P1|STARTED|Permanent Prosthesis Placement|Individual test implant units is 75|29
2517028|NCT00728754|6168583|P2|NOT COMPLETED|Implant Placement Surgery||0
2517029|NCT00728754|6168584|P1|NOT COMPLETED|Implant Placement Surgery||0
2517030|NCT00728754|6168583|P2|COMPLETED|Implant Placement Surgery|Individual control implant units completed = 78|32
2517031|NCT00728754|6168584|P1|COMPLETED|Implant Placement Surgery|Individual test implant units completed = 75|29
2517032|NCT00728754|6168583|P2|STARTED|Implant Placement Surgery|Individual control implant units is 78|32
2517033|NCT00728754|6168584|P1|STARTED|Implant Placement Surgery|Individual test implant units is 75|29
2517034|NCT00728728|6168592|P2|NOT COMPLETED|Overall Study||12
2517035|NCT00728728|6168593|P1|NOT COMPLETED|Overall Study||4
2517036|NCT00728728|6168592|P2|COMPLETED|Overall Study||34
2517037|NCT00728728|6168593|P1|COMPLETED|Overall Study||38
2517038|NCT00728728|6168592|P2|STARTED|Overall Study||46
2517039|NCT00728728|6168593|P1|STARTED|Overall Study||42
2517040|NCT00728689|6168613|P2|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
2517041|NCT00728689|6168614|P1|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
2517042|NCT00728689|6168613|P2|COMPLETED|Second Intervention (Days 11 - 13)||6
2517043|NCT00728689|6168614|P1|COMPLETED|Second Intervention (Days 11 - 13)||5
2517044|NCT00728689|6168613|P2|STARTED|Second Intervention (Days 11 - 13)||6
2517045|NCT00728689|6168614|P1|STARTED|Second Intervention (Days 11 - 13)||5
2517046|NCT00728689|6168613|P2|NOT COMPLETED|Washout Period (Days 4 - 10)||0
2517047|NCT00728689|6168614|P1|NOT COMPLETED|Washout Period (Days 4 - 10)||1
2517048|NCT00728689|6168613|P2|COMPLETED|Washout Period (Days 4 - 10)||6
2517049|NCT00728689|6168614|P1|COMPLETED|Washout Period (Days 4 - 10)|Death in family during the Washout period. Completed First Intervention period with ST-246 Form I.|5
2517050|NCT00728689|6168613|P2|STARTED|Washout Period (Days 4 - 10)||6
2517051|NCT00728689|6168614|P1|STARTED|Washout Period (Days 4 - 10)||6
2517052|NCT00728689|6168613|P2|NOT COMPLETED|First Intervention (Days 1 - 3)||0
2517053|NCT00728689|6168614|P1|NOT COMPLETED|First Intervention (Days 1 - 3)||0
2517054|NCT00728689|6168613|P2|COMPLETED|First Intervention (Days 1 - 3)||6
2517055|NCT00728689|6168614|P1|COMPLETED|First Intervention (Days 1 - 3)||6
2517056|NCT00728689|6168613|P2|STARTED|First Intervention (Days 1 - 3)||6
2517057|NCT00728689|6168614|P1|STARTED|First Intervention (Days 1 - 3)||6
2517058|NCT00728507|6168632|P2|NOT COMPLETED|Overall Study||8
2517059|NCT00728507|6168633|P1|NOT COMPLETED|Overall Study||2
2517060|NCT00728507|6168632|P2|COMPLETED|Overall Study||51
2517061|NCT00728507|6168633|P1|COMPLETED|Overall Study||60
2517062|NCT00728507|6168632|P2|STARTED|Overall Study||59
2517063|NCT00728507|6168633|P1|STARTED|Overall Study||62
2517064|NCT00728494|6168643|P2|NOT COMPLETED|Overall Study||7
2517065|NCT00728494|6168644|P1|NOT COMPLETED|Overall Study||9
2517066|NCT00728494|6168643|P2|COMPLETED|Overall Study||32
2517067|NCT00728494|6168644|P1|COMPLETED|Overall Study||51
2517068|NCT00728494|6168643|P2|STARTED|Overall Study||39
2517069|NCT00728494|6168644|P1|STARTED|Overall Study||60
2517070|NCT00728481|6168662|P2|NOT COMPLETED|Overall Study||4
2517071|NCT00728481|6168663|P1|NOT COMPLETED|Overall Study||1
2517072|NCT00728481|6168662|P2|COMPLETED|Overall Study||28
2517073|NCT00728481|6168663|P1|COMPLETED|Overall Study||18
2517074|NCT00728481|6168662|P2|STARTED|Overall Study||32
2517075|NCT00728481|6168663|P1|STARTED|Overall Study||19
2517076|NCT00728468|6168679|P1|NOT COMPLETED|Overall Study||16
2517077|NCT00728468|6168679|P1|COMPLETED|Overall Study||0
2517078|NCT00728468|6168679|P1|Treated|Overall Study||15
2517079|NCT00728468|6168679|P1|STARTED|Overall Study||16
2517080|NCT00728416|6168703|P2|NOT COMPLETED|Overall Study||2
2517081|NCT00728416|6168704|P1|NOT COMPLETED|Overall Study||2
2517082|NCT00728416|6168703|P2|COMPLETED|Overall Study||163
2517083|NCT00728416|6168704|P1|COMPLETED|Overall Study||166
2517084|NCT00728416|6168703|P2|STARTED|Overall Study||165
2517085|NCT00728416|6168704|P1|STARTED|Overall Study||168
2517086|NCT00728260|6168712|P1|NOT COMPLETED|Overall Study||0
2517087|NCT00728260|6168712|P1|COMPLETED|Overall Study||1421
2517088|NCT00728260|6168712|P1|STARTED|Overall Study||1421
2517089|NCT00728182|6168720|P2|NOT COMPLETED|Overall Study||3
2517090|NCT00728182|6168721|P1|NOT COMPLETED|Overall Study||3
2517091|NCT00728182|6168720|P2|COMPLETED|Overall Study||90
2517092|NCT00728182|6168721|P1|COMPLETED|Overall Study||89
2517093|NCT00728182|6168720|P2|STARTED|Overall Study||93
2517094|NCT00728182|6168721|P1|STARTED|Overall Study||92
2517095|NCT00728130|6168749|P1|NOT COMPLETED|Overall Study||3
2517096|NCT00728130|6168749|P1|COMPLETED|Overall Study||19
2517097|NCT00728130|6168749|P1|STARTED|Overall Study||22
2517098|NCT00727961|6168754|P1|NOT COMPLETED|Overall Study||37
2517099|NCT00727961|6168754|P1|COMPLETED|Overall Study||21
2517100|NCT00727961|6168754|P1|STARTED|Overall Study||58
2517101|NCT00727909|6168764|P4|NOT COMPLETED|Overall Study||5
2517102|NCT00727909|6168765|P3|NOT COMPLETED|Overall Study||9
2517103|NCT00727909|6168766|P2|NOT COMPLETED|Overall Study||11
2517105|NCT00727909|6168764|P4|COMPLETED|Overall Study||70
2517106|NCT00727909|6168765|P3|COMPLETED|Overall Study||58
2517107|NCT00727909|6168766|P2|COMPLETED|Overall Study||61
2517108|NCT00727909|6168767|P1|COMPLETED|Overall Study||60
2517109|NCT00727909|6168764|P4|STARTED|Overall Study||75
2517110|NCT00727909|6168765|P3|STARTED|Overall Study||67
2517111|NCT00727909|6168766|P2|STARTED|Overall Study||72
2517112|NCT00727909|6168767|P1|STARTED|Overall Study||65
2517113|NCT00727857|6168774|P3|NOT COMPLETED|Overall Study||68
2517114|NCT00727857|6168775|P2|NOT COMPLETED|Overall Study||64
2517115|NCT00727857|6168776|P1|NOT COMPLETED|Overall Study||44
2517116|NCT00727857|6168774|P3|COMPLETED|Overall Study||142
2517117|NCT00727857|6168775|P2|COMPLETED|Overall Study||125
2517118|NCT00727857|6168776|P1|COMPLETED|Overall Study||157
2517119|NCT00727857|6168774|P3|STARTED|Overall Study||210
2517120|NCT00727857|6168775|P2|STARTED|Overall Study||189
2517121|NCT00727857|6168776|P1|STARTED|Overall Study||201
2517122|NCT00727844|6168864|P4|NOT COMPLETED|Second Randomization||0
2517123|NCT00727844|6168865|P3|NOT COMPLETED|Second Randomization||0
2517124|NCT00727844|6168866|P2|NOT COMPLETED|Second Randomization||0
2517125|NCT00727844|6168867|P1|NOT COMPLETED|Second Randomization||0
2517126|NCT00727844|6168864|P4|COMPLETED|Second Randomization||16
2517127|NCT00727844|6168865|P3|COMPLETED|Second Randomization||17
2517128|NCT00727844|6168866|P2|COMPLETED|Second Randomization||0
2517129|NCT00727844|6168867|P1|COMPLETED|Second Randomization||0
2517130|NCT00727844|6168864|P4|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|16
2517131|NCT00727844|6168865|P3|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|17
2517132|NCT00727844|6168866|P2|STARTED|Second Randomization||0
2517133|NCT00727844|6168867|P1|STARTED|Second Randomization||0
2517134|NCT00727844|6168864|P4|NOT COMPLETED|Initial Randomization||0
2517135|NCT00727844|6168865|P3|NOT COMPLETED|Initial Randomization||0
2517136|NCT00727844|6168866|P2|NOT COMPLETED|Initial Randomization||0
2517137|NCT00727844|6168867|P1|NOT COMPLETED|Initial Randomization||2
2517138|NCT00727844|6168864|P4|COMPLETED|Initial Randomization||0
2517139|NCT00727844|6168865|P3|COMPLETED|Initial Randomization||0
2517140|NCT00727844|6168866|P2|COMPLETED|Initial Randomization||20
2517141|NCT00727844|6168867|P1|COMPLETED|Initial Randomization||19
2517142|NCT00727844|6168864|P4|Included in MITT Analysis|Initial Randomization||0
2517143|NCT00727844|6168865|P3|Included in MITT Analysis|Initial Randomization||0
2517144|NCT00727844|6168866|P2|Included in MITT Analysis|Initial Randomization||20
2517145|NCT00727844|6168867|P1|Included in MITT Analysis|Initial Randomization||19
2517146|NCT00727844|6168864|P4|STARTED|Initial Randomization||0
2517147|NCT00727844|6168865|P3|STARTED|Initial Randomization||0
2517148|NCT00727844|6168866|P2|STARTED|Initial Randomization||20
2517149|NCT00727844|6168867|P1|STARTED|Initial Randomization|2 patients withdrawn before receiving any linezolid owing to baseline neuropathy|21
2517150|NCT00727740|6168874|P2|NOT COMPLETED|Overall Study||0
2517151|NCT00727740|6168875|P1|NOT COMPLETED|Overall Study||0
2517152|NCT00727740|6168874|P2|COMPLETED|Overall Study||61
2517153|NCT00727740|6168875|P1|COMPLETED|Overall Study||56
2517154|NCT00727740|6168874|P2|STARTED|Overall Study||61
2517155|NCT00727740|6168875|P1|STARTED|Overall Study||56
2517156|NCT00727714|6168881|P1|NOT COMPLETED|Overall Study||2
2517157|NCT00727714|6168881|P1|COMPLETED|Overall Study||93
2517158|NCT00727714|6168881|P1|STARTED|Overall Study||95
2517159|NCT00727649|6168891|P2|NOT COMPLETED|Second Intervention (4-weeks)||3
2517160|NCT00727649|6168892|P1|NOT COMPLETED|Second Intervention (4-weeks)||1
2517161|NCT00727649|6168891|P2|COMPLETED|Second Intervention (4-weeks)||34
2517162|NCT00727649|6168892|P1|COMPLETED|Second Intervention (4-weeks)||29
2517163|NCT00727649|6168891|P2|STARTED|Second Intervention (4-weeks)||37
2517164|NCT00727649|6168892|P1|STARTED|Second Intervention (4-weeks)||30
2517165|NCT00727649|6168891|P2|NOT COMPLETED|Wash-out (2-weeks)||3
2517166|NCT00727649|6168892|P1|NOT COMPLETED|Wash-out (2-weeks)||4
2517167|NCT00727649|6168891|P2|COMPLETED|Wash-out (2-weeks)||37
2517168|NCT00727649|6168892|P1|COMPLETED|Wash-out (2-weeks)||30
2517169|NCT00727649|6168891|P2|STARTED|Wash-out (2-weeks)||40
2517170|NCT00727649|6168892|P1|STARTED|Wash-out (2-weeks)||34
2517171|NCT00727649|6168891|P2|NOT COMPLETED|First Intervention (4-weeks)||3
2517172|NCT00727649|6168892|P1|NOT COMPLETED|First Intervention (4-weeks)||3
2517173|NCT00727649|6168891|P2|COMPLETED|First Intervention (4-weeks)||40
2517174|NCT00727649|6168892|P1|COMPLETED|First Intervention (4-weeks)||34
2517175|NCT00727649|6168891|P2|STARTED|First Intervention (4-weeks)||43
2517176|NCT00727649|6168892|P1|STARTED|First Intervention (4-weeks)||37
2517177|NCT00727636|6168906|P2|NOT COMPLETED|Overall Study||0
2517178|NCT00727636|6168907|P1|NOT COMPLETED|Overall Study||4
2517179|NCT00727636|6168906|P2|COMPLETED|Overall Study||15
2517180|NCT00727636|6168907|P1|COMPLETED|Overall Study||33
2517181|NCT00727636|6168906|P2|STARTED|Overall Study||15
2517182|NCT00727636|6168907|P1|STARTED|Overall Study||37
2517183|NCT00727597|6168921|P2|NOT COMPLETED|Overall Study||0
2517184|NCT00727597|6168922|P1|NOT COMPLETED|Overall Study||0
2517185|NCT00727597|6168921|P2|COMPLETED|Overall Study||50
2517186|NCT00727597|6168922|P1|COMPLETED|Overall Study||51
2517187|NCT00727597|6168921|P2|STARTED|Overall Study||50
2517188|NCT00727597|6168922|P1|STARTED|Overall Study||51
2517189|NCT00727571|6168934|P4|NOT COMPLETED|Overall Study||6
2517190|NCT00727571|6168935|P3|NOT COMPLETED|Overall Study||30
2517191|NCT00727571|6168936|P2|NOT COMPLETED|Overall Study||55
2517192|NCT00727571|6168937|P1|NOT COMPLETED|Overall Study||1
2517193|NCT00727571|6168934|P4|COMPLETED|Overall Study||163
2517194|NCT00727571|6168935|P3|COMPLETED|Overall Study||135
2517195|NCT00727571|6168936|P2|COMPLETED|Overall Study||173
2517196|NCT00727571|6168937|P1|COMPLETED|Overall Study||231
2517197|NCT00727571|6168934|P4|STARTED|Overall Study||169
2517198|NCT00727571|6168935|P3|STARTED|Overall Study||165
2517199|NCT00727571|6168936|P2|STARTED|Overall Study||228
2517200|NCT00727571|6168937|P1|STARTED|Overall Study||232
2517201|NCT00727558|6168964|P2|NOT COMPLETED|Overall Study||3
2517202|NCT00727558|6168965|P1|NOT COMPLETED|Overall Study||2
2517203|NCT00727558|6168964|P2|COMPLETED|Overall Study||118
2517204|NCT00727558|6168965|P1|COMPLETED|Overall Study||125
2517205|NCT00727558|6168964|P2|STARTED|Overall Study||121
2517206|NCT00727558|6168965|P1|STARTED|Overall Study||127
2517207|NCT00727532|6168983|P1|NOT COMPLETED|Overall Study||2
2517208|NCT00727532|6168983|P1|COMPLETED|Overall Study||7
2517209|NCT00727532|6168983|P1|STARTED|Overall Study||9
2517210|NCT00727506|6168995|P6|NOT COMPLETED|Overall Study||39
2517211|NCT00727506|6168996|P5|NOT COMPLETED|Overall Study||41
2517212|NCT00727506|6168997|P4|NOT COMPLETED|Overall Study||39
2517213|NCT00727506|6168998|P3|NOT COMPLETED|Overall Study||18
2517214|NCT00727506|6168999|P2|NOT COMPLETED|Overall Study||8
2517215|NCT00727506|6169000|P1|NOT COMPLETED|Overall Study||6
2517216|NCT00727506|6168995|P6|COMPLETED|Overall Study||0
2517217|NCT00727506|6168996|P5|COMPLETED|Overall Study||0
2517218|NCT00727506|6168997|P4|COMPLETED|Overall Study||0
2517219|NCT00727506|6168998|P3|COMPLETED|Overall Study||0
2517220|NCT00727506|6168999|P2|COMPLETED|Overall Study||0
2517221|NCT00727506|6169000|P1|COMPLETED|Overall Study||0
2517222|NCT00727506|6168995|P6|STARTED|Overall Study|Randomized|39
2517223|NCT00727506|6168996|P5|STARTED|Overall Study|Randomized|41
2517224|NCT00727506|6168997|P4|STARTED|Overall Study|Randomized|39
2517225|NCT00727506|6168998|P3|STARTED|Overall Study|Entered|18
2517226|NCT00727506|6168999|P2|STARTED|Overall Study|Entered|8
2517227|NCT00727506|6169000|P1|STARTED|Overall Study|Entered|6
2517237|NCT00727415|6169118|P1|NOT COMPLETED|Phase II||0
2517238|NCT00727415|6169118|P1|COMPLETED|Phase II||33
2517239|NCT00727415|6169118|P1|STARTED|Phase II||33
2517240|NCT00727415|6169118|P1|NOT COMPLETED|Phase I||2
2517241|NCT00727415|6169118|P1|COMPLETED|Phase I||7
2517242|NCT00727415|6169118|P1|STARTED|Phase I||9
2517243|NCT00727402|6169127|P1|NOT COMPLETED|Overall Study||116
2517244|NCT00727402|6169127|P1|COMPLETED|Overall Study||89
2517245|NCT00727402|6169127|P1|STARTED|Overall Study||205
2517246|NCT00727337|6169135|P4|NOT COMPLETED|Overall Study||9
2517247|NCT00727337|6169136|P3|NOT COMPLETED|Overall Study||10
2517248|NCT00727337|6169137|P2|NOT COMPLETED|Overall Study||10
2517249|NCT00727337|6169138|P1|NOT COMPLETED|Overall Study||7
2517250|NCT00727337|6169135|P4|COMPLETED|Overall Study||64
2517251|NCT00727337|6169136|P3|COMPLETED|Overall Study||63
2517252|NCT00727337|6169137|P2|COMPLETED|Overall Study||55
2517253|NCT00727337|6169138|P1|COMPLETED|Overall Study||61
2517254|NCT00727337|6169135|P4|STARTED|Overall Study||73
2517255|NCT00727337|6169136|P3|STARTED|Overall Study||73
2517256|NCT00727337|6169137|P2|STARTED|Overall Study||65
2517257|NCT00727337|6169138|P1|STARTED|Overall Study||68
2517258|NCT00727311|6169156|P1|NOT COMPLETED|Overall Study||1107
2517259|NCT00727311|6169156|P1|COMPLETED|Overall Study||1195
2517260|NCT00727311|6169156|P1|STARTED|Overall Study||2302
2517261|NCT00727298|6169163|P1|NOT COMPLETED|Overall Study||1257
2517262|NCT00727298|6169163|P1|COMPLETED|Overall Study||3228
2517263|NCT00727298|6169163|P1|STARTED|Overall Study||4485
2517264|NCT00727272|6169169|P3|NOT COMPLETED|Period III||0
2517265|NCT00727272|6169170|P2|NOT COMPLETED|Period III||0
2517266|NCT00727272|6169171|P1|NOT COMPLETED|Period III||0
2517267|NCT00727272|6169169|P3|COMPLETED|Period III||7
2517268|NCT00727272|6169170|P2|COMPLETED|Period III||9
2517269|NCT00727272|6169171|P1|COMPLETED|Period III||9
2517270|NCT00727272|6169169|P3|STARTED|Period III||7
2517271|NCT00727272|6169170|P2|STARTED|Period III||9
2517272|NCT00727272|6169171|P1|STARTED|Period III||9
2517273|NCT00727272|6169169|P3|NOT COMPLETED|Washout Period B||1
2517274|NCT00727272|6169170|P2|NOT COMPLETED|Washout Period B||0
2517275|NCT00727272|6169171|P1|NOT COMPLETED|Washout Period B||0
2517276|NCT00727272|6169169|P3|COMPLETED|Washout Period B|personal reasons|7
2517277|NCT00727272|6169170|P2|COMPLETED|Washout Period B||9
2517278|NCT00727272|6169171|P1|COMPLETED|Washout Period B||9
2517279|NCT00727272|6169169|P3|STARTED|Washout Period B||8
2517280|NCT00727272|6169170|P2|STARTED|Washout Period B||9
2517281|NCT00727272|6169171|P1|STARTED|Washout Period B||9
2517282|NCT00727272|6169169|P3|NOT COMPLETED|Period II||0
2517283|NCT00727272|6169170|P2|NOT COMPLETED|Period II||0
2517284|NCT00727272|6169171|P1|NOT COMPLETED|Period II||0
2517285|NCT00727272|6169169|P3|COMPLETED|Period II||8
2517286|NCT00727272|6169170|P2|COMPLETED|Period II||9
2517287|NCT00727272|6169171|P1|COMPLETED|Period II||9
2517288|NCT00727272|6169169|P3|STARTED|Period II||8
2517289|NCT00727272|6169170|P2|STARTED|Period II||9
2517290|NCT00727272|6169171|P1|STARTED|Period II||9
2517291|NCT00727272|6169169|P3|NOT COMPLETED|Washout Period A||1
2517292|NCT00727272|6169170|P2|NOT COMPLETED|Washout Period A||0
2517293|NCT00727272|6169171|P1|NOT COMPLETED|Washout Period A||0
2517294|NCT00727272|6169169|P3|COMPLETED|Washout Period A|positive pregnancy test - recorded as an adverse event|8
2517295|NCT00727272|6169170|P2|COMPLETED|Washout Period A||9
2517296|NCT00727272|6169171|P1|COMPLETED|Washout Period A||9
2517297|NCT00727272|6169169|P3|STARTED|Washout Period A||9
2517298|NCT00727272|6169170|P2|STARTED|Washout Period A||9
2517299|NCT00727272|6169171|P1|STARTED|Washout Period A||9
2517300|NCT00727272|6169169|P3|NOT COMPLETED|Period I||0
2517301|NCT00727272|6169170|P2|NOT COMPLETED|Period I||0
2517302|NCT00727272|6169171|P1|NOT COMPLETED|Period I||0
2517303|NCT00727272|6169169|P3|COMPLETED|Period I||9
2517304|NCT00727272|6169170|P2|COMPLETED|Period I||9
2517305|NCT00727272|6169171|P1|COMPLETED|Period I||9
2517306|NCT00727272|6169169|P3|STARTED|Period I||9
2517307|NCT00727272|6169170|P2|STARTED|Period I||9
2517308|NCT00727272|6169171|P1|STARTED|Period I||9
2517309|NCT00727259|6169188|P1|NOT COMPLETED|Overall Study||1055
2517310|NCT00727259|6169188|P1|COMPLETED|Overall Study||940
2517311|NCT00727259|6169188|P1|STARTED|Overall Study||1995
2517312|NCT00727246|6169197|P4|NOT COMPLETED|Overall Study||2
2517313|NCT00727246|6169198|P3|NOT COMPLETED|Overall Study||1
2517314|NCT00727246|6169199|P2|NOT COMPLETED|Overall Study||1
2517315|NCT00727246|6169200|P1|NOT COMPLETED|Overall Study||0
2517316|NCT00727246|6169197|P4|COMPLETED|Overall Study||3
2517317|NCT00727246|6169198|P3|COMPLETED|Overall Study||7
2517318|NCT00727246|6169199|P2|COMPLETED|Overall Study||2
2517319|NCT00727246|6169200|P1|COMPLETED|Overall Study||3
2517320|NCT00727246|6169197|P4|STARTED|Overall Study||5
2517321|NCT00727246|6169198|P3|STARTED|Overall Study||8
2517322|NCT00727246|6169199|P2|STARTED|Overall Study||3
2517323|NCT00727246|6169200|P1|STARTED|Overall Study||3
2517324|NCT00727220|6169216|P2|NOT COMPLETED|Overall Study||4
2517325|NCT00727220|6169217|P1|NOT COMPLETED|Overall Study||1
2517326|NCT00727220|6169216|P2|COMPLETED|Overall Study||17
2517327|NCT00727220|6169217|P1|COMPLETED|Overall Study||20
2517328|NCT00727220|6169216|P2|STARTED|Overall Study||21
2517329|NCT00727220|6169217|P1|STARTED|Overall Study||21
2517330|NCT00727194|6169223|P3|NOT COMPLETED|Treatment Period 2||0
2517331|NCT00727194|6169224|P2|NOT COMPLETED|Treatment Period 2||1
2517332|NCT00727194|6169225|P1|NOT COMPLETED|Treatment Period 2||0
2517333|NCT00727194|6169223|P3|COMPLETED|Treatment Period 2||0
2517334|NCT00727194|6169224|P2|COMPLETED|Treatment Period 2||5
2517335|NCT00727194|6169225|P1|COMPLETED|Treatment Period 2||6
2517336|NCT00727194|6169223|P3|STARTED|Treatment Period 2||0
2517337|NCT00727194|6169224|P2|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
2517338|NCT00727194|6169225|P1|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
2517339|NCT00727194|6169223|P3|NOT COMPLETED|Washout Period||0
2517340|NCT00727194|6169224|P2|NOT COMPLETED|Washout Period||0
2517341|NCT00727194|6169225|P1|NOT COMPLETED|Washout Period||0
2517342|NCT00727194|6169223|P3|COMPLETED|Washout Period||0
2517343|NCT00727194|6169224|P2|COMPLETED|Washout Period||7
2517344|NCT00727194|6169225|P1|COMPLETED|Washout Period||7
2517345|NCT00727194|6169223|P3|STARTED|Washout Period||0
2517346|NCT00727194|6169224|P2|STARTED|Washout Period||7
2517347|NCT00727194|6169225|P1|STARTED|Washout Period||7
2517348|NCT00727194|6169223|P3|NOT COMPLETED|Treatment Period 1||0
2517349|NCT00727194|6169224|P2|NOT COMPLETED|Treatment Period 1||0
2517350|NCT00727194|6169225|P1|NOT COMPLETED|Treatment Period 1||0
2517351|NCT00727194|6169223|P3|COMPLETED|Treatment Period 1||0
2517352|NCT00727194|6169224|P2|COMPLETED|Treatment Period 1||7
2517353|NCT00727194|6169225|P1|COMPLETED|Treatment Period 1||7
2517354|NCT00727194|6169223|P3|STARTED|Treatment Period 1||0
2517355|NCT00727194|6169224|P2|STARTED|Treatment Period 1||7
2517356|NCT00727194|6169225|P1|STARTED|Treatment Period 1||7
2517357|NCT00727194|6169223|P3|NOT COMPLETED|Screening Period||16
2517358|NCT00727194|6169224|P2|NOT COMPLETED|Screening Period||0
2517359|NCT00727194|6169225|P1|NOT COMPLETED|Screening Period||0
2517360|NCT00727194|6169223|P3|COMPLETED|Screening Period||0
2517361|NCT00727194|6169224|P2|COMPLETED|Screening Period||7
2517362|NCT00727194|6169225|P1|COMPLETED|Screening Period||7
2517363|NCT00727194|6169223|P3|STARTED|Screening Period||16
2517364|NCT00727194|6169224|P2|STARTED|Screening Period||7
2517365|NCT00727194|6169225|P1|STARTED|Screening Period||7
2517366|NCT00727090|6169261|P2|NOT COMPLETED|Overall Study||0
2517367|NCT00727090|6169262|P1|NOT COMPLETED|Overall Study||0
2517368|NCT00727090|6169261|P2|COMPLETED|Overall Study||3
2517369|NCT00727090|6169262|P1|COMPLETED|Overall Study||3
2517370|NCT00727090|6169261|P2|STARTED|Overall Study||3
2517371|NCT00727090|6169262|P1|STARTED|Overall Study||3
2517372|NCT00727064|6169280|P2|NOT COMPLETED|Overall Study||0
2517373|NCT00727064|6169281|P1|NOT COMPLETED|Overall Study||0
2517374|NCT00727064|6169280|P2|COMPLETED|Overall Study||7
2517375|NCT00727064|6169281|P1|COMPLETED|Overall Study||7
2517376|NCT00727064|6169280|P2|STARTED|Overall Study||7
2517377|NCT00727064|6169281|P1|STARTED|Overall Study||7
2517378|NCT00727025|6169297|P1|NOT COMPLETED|Overall Study||23
2517379|NCT00727025|6169297|P1|COMPLETED|Overall Study||51
2517380|NCT00727025|6169297|P1|STARTED|Overall Study||74
2517381|NCT00726999|6169309|P2|NOT COMPLETED|Overall Study||1
2517382|NCT00726999|6169310|P1|NOT COMPLETED|Overall Study||3
2517383|NCT00726999|6169309|P2|COMPLETED|Overall Study||30
2517384|NCT00726999|6169310|P1|COMPLETED|Overall Study||29
2517385|NCT00726999|6169309|P2|STARTED|Overall Study||31
2517386|NCT00726999|6169310|P1|STARTED|Overall Study||32
2517387|NCT00726986|6169322|P1|NOT COMPLETED|Maintenance Phase||3
2517388|NCT00726986|6169322|P1|COMPLETED|Maintenance Phase||0
2517389|NCT00726986|6169322|P1|STARTED|Maintenance Phase||3
2517390|NCT00726986|6169322|P1|NOT COMPLETED|Induction Phase||15
2517391|NCT00726986|6169322|P1|COMPLETED|Induction Phase||3
2517392|NCT00726986|6169322|P1|Maintance|Induction Phase||3
2517393|NCT00726986|6169322|P1|STARTED|Induction Phase||18
2517394|NCT00726895|6169329|P2|NOT COMPLETED|Second Intervention||0
2517395|NCT00726895|6169330|P1|NOT COMPLETED|Second Intervention||0
2517396|NCT00726895|6169329|P2|COMPLETED|Second Intervention||11
2517397|NCT00726895|6169330|P1|COMPLETED|Second Intervention||12
2517398|NCT00726895|6169329|P2|STARTED|Second Intervention||11
2517399|NCT00726895|6169330|P1|STARTED|Second Intervention||12
2517400|NCT00726895|6169329|P2|NOT COMPLETED|Washout Period of 7 Days||1
2517401|NCT00726895|6169330|P1|NOT COMPLETED|Washout Period of 7 Days||0
2517402|NCT00726895|6169329|P2|COMPLETED|Washout Period of 7 Days||11
2517403|NCT00726895|6169330|P1|COMPLETED|Washout Period of 7 Days||12
2517404|NCT00726895|6169329|P2|STARTED|Washout Period of 7 Days||12
2517405|NCT00726895|6169330|P1|STARTED|Washout Period of 7 Days||12
2517406|NCT00726895|6169329|P2|NOT COMPLETED|First Intervention||0
2517407|NCT00726895|6169330|P1|NOT COMPLETED|First Intervention||0
2517408|NCT00726895|6169329|P2|COMPLETED|First Intervention||12
2517409|NCT00726895|6169330|P1|COMPLETED|First Intervention||12
2517410|NCT00726895|6169329|P2|STARTED|First Intervention||12
2517411|NCT00726895|6169330|P1|STARTED|First Intervention||12
2517412|NCT00726882|6169343|P1|NOT COMPLETED|Overall Study||22
2517413|NCT00726882|6169343|P1|COMPLETED|Overall Study||13
2517414|NCT00726882|6169343|P1|Received ABT-333 in Study M10-351|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00696904/M10-351).|6
2517415|NCT00726882|6169343|P1|Received ABT-333 in Study M10-380|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00851890/M10-380).|22
2517416|NCT00726882|6169343|P1|STARTED|Overall Study||35
2517417|NCT00726830|6169351|P2|NOT COMPLETED|Overall Study||0
2517418|NCT00726830|6169352|P1|NOT COMPLETED|Overall Study||0
2517419|NCT00726830|6169351|P2|COMPLETED|Overall Study||0
2517420|NCT00726830|6169352|P1|COMPLETED|Overall Study||1
2517421|NCT00726830|6169351|P2|STARTED|Overall Study||0
2517422|NCT00726830|6169352|P1|STARTED|Overall Study||1
2517423|NCT00726752|6169358|P1|NOT COMPLETED|Overall Study||6
2517424|NCT00726752|6169358|P1|COMPLETED|Overall Study||0
2517425|NCT00726752|6169358|P1|STARTED|Overall Study||6
2517426|NCT00726739|6169374|P2|NOT COMPLETED|Overall Study||0
2517427|NCT00726739|6169375|P1|NOT COMPLETED|Overall Study||1
2517428|NCT00726739|6169374|P2|COMPLETED|Overall Study||10
2517429|NCT00726739|6169375|P1|COMPLETED|Overall Study|1 patient failed during screening due to brain metastasis.|10
2517430|NCT00726739|6169374|P2|STARTED|Overall Study||10
2517431|NCT00726739|6169375|P1|STARTED|Overall Study||11
2517432|NCT00726713|6169391|P2|NOT COMPLETED|Overall Study||7
2517433|NCT00726713|6169392|P1|NOT COMPLETED|Overall Study||7
2517434|NCT00726713|6169391|P2|COMPLETED|Overall Study||101
2517435|NCT00726713|6169392|P1|COMPLETED|Overall Study||99
2517436|NCT00726713|6169391|P2|STARTED|Overall Study||108
2517437|NCT00726713|6169392|P1|STARTED|Overall Study||106
2517438|NCT00726661|6169420|P2|NOT COMPLETED|Overall Study||418
2517439|NCT00726661|6169421|P1|NOT COMPLETED|Overall Study||814
2517440|NCT00726661|6169420|P2|COMPLETED|Overall Study||17
2517441|NCT00726661|6169421|P1|COMPLETED|Overall Study||18
2517442|NCT00726661|6169420|P2|STARTED|Overall Study||435
2517443|NCT00726661|6169421|P1|STARTED|Overall Study||832
2517444|NCT00726622|6169438|P2|NOT COMPLETED|Overall Study||3
2517445|NCT00726622|6169439|P1|NOT COMPLETED|Overall Study||18
2517446|NCT00726622|6169438|P2|COMPLETED|Overall Study||240
2517447|NCT00726622|6169439|P1|COMPLETED|Overall Study||225
2517448|NCT00726622|6169438|P2|STARTED|Overall Study||243
2517449|NCT00726622|6169439|P1|STARTED|Overall Study||243
2517450|NCT00726609|6169457|P1|NOT COMPLETED|Overall Study||98
2517451|NCT00726609|6169457|P1|COMPLETED|Overall Study|For 26 participants in the Missing category, it is unknown if they completed the study.|116
2517452|NCT00726609|6169457|P1|STARTED|Overall Study||214
2517453|NCT00726557|6169461|P1|NOT COMPLETED|Overall Study||128
2517454|NCT00726557|6169461|P1|COMPLETED|Overall Study|Completed is defined as those who finished the follow-up period.|118
2517455|NCT00726557|6169461|P1|STARTED|Overall Study||246
2517456|NCT00726453|6169468|P2|NOT COMPLETED|38 mm Length Group||3
2517457|NCT00726453|6169469|P1|NOT COMPLETED|38 mm Length Group||0
2517458|NCT00726453|6169468|P2|COMPLETED|38 mm Length Group|This sub-study completed the primary endpoint in March 2012 results not yet available.|111
2517459|NCT00726453|6169469|P1|COMPLETED|38 mm Length Group||0
2517460|NCT00726453|6169468|P2|STARTED|38 mm Length Group||114
2517461|NCT00726453|6169469|P1|STARTED|38 mm Length Group||0
2517462|NCT00726453|6169468|P2|NOT COMPLETED|Primary Enrollment Group||0
2517463|NCT00726453|6169469|P1|NOT COMPLETED|Primary Enrollment Group||31
2517464|NCT00726453|6169468|P2|COMPLETED|Primary Enrollment Group||0
2517465|NCT00726453|6169469|P1|COMPLETED|Primary Enrollment Group||1371
2517466|NCT00726453|6169468|P2|STARTED|Primary Enrollment Group||0
2517467|NCT00726453|6169469|P1|STARTED|Primary Enrollment Group||1402
2517468|NCT00726414|6169479|P2|NOT COMPLETED|Second Intervention||0
2517469|NCT00726414|6169480|P1|NOT COMPLETED|Second Intervention||0
2517470|NCT00726414|6169479|P2|COMPLETED|Second Intervention||11
2517471|NCT00726414|6169480|P1|COMPLETED|Second Intervention||11
2517472|NCT00726414|6169479|P2|STARTED|Second Intervention||11
2517473|NCT00726414|6169480|P1|STARTED|Second Intervention||11
2517474|NCT00726414|6169479|P2|NOT COMPLETED|Washout Period of 7 Days||0
2517475|NCT00726414|6169480|P1|NOT COMPLETED|Washout Period of 7 Days||0
2517476|NCT00726414|6169479|P2|COMPLETED|Washout Period of 7 Days||11
2517477|NCT00726414|6169480|P1|COMPLETED|Washout Period of 7 Days||11
2517478|NCT00726414|6169479|P2|STARTED|Washout Period of 7 Days||11
2517479|NCT00726414|6169480|P1|STARTED|Washout Period of 7 Days||11
2517480|NCT00726414|6169479|P2|NOT COMPLETED|First Intervention||0
2517481|NCT00726414|6169480|P1|NOT COMPLETED|First Intervention||0
2517482|NCT00726414|6169479|P2|COMPLETED|First Intervention||11
2517483|NCT00726414|6169480|P1|COMPLETED|First Intervention||11
2517484|NCT00726414|6169479|P2|STARTED|First Intervention||11
2517485|NCT00726414|6169480|P1|STARTED|First Intervention||11
2517486|NCT00726375|6169490|P1|NOT COMPLETED|Overall Study||0
2517487|NCT00726375|6169490|P1|COMPLETED|Overall Study||34
2517488|NCT00726375|6169490|P1|STARTED|Overall Study||34
2517489|NCT00726323|6169497|P2|NOT COMPLETED|Overall Study||31
2517490|NCT00726323|6169498|P1|NOT COMPLETED|Overall Study||37
2517491|NCT00726323|6169497|P2|COMPLETED|Overall Study||6
2517492|NCT00726323|6169498|P1|COMPLETED|Overall Study||0
2517493|NCT00726323|6169497|P2|STARTED|Overall Study||37
2517494|NCT00726323|6169498|P1|STARTED|Overall Study||37
2517495|NCT00726232|6169528|P8|NOT COMPLETED|Expansion Phase||38
2517496|NCT00726232|6169529|P7|NOT COMPLETED|Expansion Phase||24
2517497|NCT00726232|6169530|P6|NOT COMPLETED|Expansion Phase||0
2517498|NCT00726232|6169531|P5|NOT COMPLETED|Expansion Phase||0
2517499|NCT00726232|6169532|P4|NOT COMPLETED|Expansion Phase||0
2517500|NCT00726232|6169533|P3|NOT COMPLETED|Expansion Phase||0
2517501|NCT00726232|6169534|P2|NOT COMPLETED|Expansion Phase||0
2517502|NCT00726232|6169535|P1|NOT COMPLETED|Expansion Phase||0
2517503|NCT00726232|6169528|P8|COMPLETED|Expansion Phase||1
2517504|NCT00726232|6169529|P7|COMPLETED|Expansion Phase||10
2517505|NCT00726232|6169530|P6|COMPLETED|Expansion Phase||0
2517506|NCT00726232|6169531|P5|COMPLETED|Expansion Phase||0
2517507|NCT00726232|6169532|P4|COMPLETED|Expansion Phase||0
2517508|NCT00726232|6169533|P3|COMPLETED|Expansion Phase||0
2517509|NCT00726232|6169534|P2|COMPLETED|Expansion Phase||0
2517510|NCT00726232|6169535|P1|COMPLETED|Expansion Phase||0
2517511|NCT00726232|6169528|P8|ITT Participants|Expansion Phase||39
2517512|NCT00726232|6169529|P7|ITT Participants|Expansion Phase||34
2517513|NCT00726232|6169530|P6|ITT Participants|Expansion Phase||0
2517514|NCT00726232|6169531|P5|ITT Participants|Expansion Phase||0
2517515|NCT00726232|6169532|P4|ITT Participants|Expansion Phase||0
2517516|NCT00726232|6169533|P3|ITT Participants|Expansion Phase||0
2517517|NCT00726232|6169534|P2|ITT Participants|Expansion Phase||0
2517518|NCT00726232|6169535|P1|ITT Participants|Expansion Phase||0
2517519|NCT00726232|6169528|P8|Safety Evaluable Participants|Expansion Phase||39
2517520|NCT00726232|6169529|P7|Safety Evaluable Participants|Expansion Phase||34
2517521|NCT00726232|6169530|P6|Safety Evaluable Participants|Expansion Phase||0
2517522|NCT00726232|6169531|P5|Safety Evaluable Participants|Expansion Phase||0
2517523|NCT00726232|6169532|P4|Safety Evaluable Participants|Expansion Phase||0
2517524|NCT00726232|6169533|P3|Safety Evaluable Participants|Expansion Phase||0
2517525|NCT00726232|6169534|P2|Safety Evaluable Participants|Expansion Phase||0
2517526|NCT00726232|6169535|P1|Safety Evaluable Participants|Expansion Phase||0
2517527|NCT00726232|6169528|P8|STARTED|Expansion Phase||39
2517528|NCT00726232|6169529|P7|STARTED|Expansion Phase||34
2517529|NCT00726232|6169530|P6|STARTED|Expansion Phase||0
2517530|NCT00726232|6169531|P5|STARTED|Expansion Phase||0
2517531|NCT00726232|6169532|P4|STARTED|Expansion Phase||0
2517532|NCT00726232|6169533|P3|STARTED|Expansion Phase||0
2517533|NCT00726232|6169534|P2|STARTED|Expansion Phase||0
2517534|NCT00726232|6169535|P1|STARTED|Expansion Phase||0
2517535|NCT00726232|6169528|P8|NOT COMPLETED|Initial Phase (Dose-finding)||0
2517536|NCT00726232|6169529|P7|NOT COMPLETED|Initial Phase (Dose-finding)||0
2517537|NCT00726232|6169530|P6|NOT COMPLETED|Initial Phase (Dose-finding)||9
2517538|NCT00726232|6169531|P5|NOT COMPLETED|Initial Phase (Dose-finding)||21
2517539|NCT00726232|6169532|P4|NOT COMPLETED|Initial Phase (Dose-finding)||8
2517540|NCT00726232|6169533|P3|NOT COMPLETED|Initial Phase (Dose-finding)||5
2517541|NCT00726232|6169534|P2|NOT COMPLETED|Initial Phase (Dose-finding)||6
2517542|NCT00726232|6169535|P1|NOT COMPLETED|Initial Phase (Dose-finding)||13
2517543|NCT00726232|6169528|P8|COMPLETED|Initial Phase (Dose-finding)||0
2517544|NCT00726232|6169529|P7|COMPLETED|Initial Phase (Dose-finding)||0
2517545|NCT00726232|6169530|P6|COMPLETED|Initial Phase (Dose-finding)||0
2517546|NCT00726232|6169531|P5|COMPLETED|Initial Phase (Dose-finding)||1
2517547|NCT00726232|6169532|P4|COMPLETED|Initial Phase (Dose-finding)||0
2517548|NCT00726232|6169533|P3|COMPLETED|Initial Phase (Dose-finding)||2
2517549|NCT00726232|6169534|P2|COMPLETED|Initial Phase (Dose-finding)||2
2517550|NCT00726232|6169535|P1|COMPLETED|Initial Phase (Dose-finding)||6
2517551|NCT00726232|6169528|P8|ITT Participants|Initial Phase (Dose-finding)||0
2517552|NCT00726232|6169529|P7|ITT Participants|Initial Phase (Dose-finding)||0
2517553|NCT00726232|6169530|P6|ITT Participants|Initial Phase (Dose-finding)||9
2517554|NCT00726232|6169531|P5|ITT Participants|Initial Phase (Dose-finding)||22
2517555|NCT00726232|6169532|P4|ITT Participants|Initial Phase (Dose-finding)||8
2517556|NCT00726232|6169533|P3|ITT Participants|Initial Phase (Dose-finding)||7
2517557|NCT00726232|6169534|P2|ITT Participants|Initial Phase (Dose-finding)||8
2517558|NCT00726232|6169535|P1|ITT Participants|Initial Phase (Dose-finding)||19
2517559|NCT00726232|6169528|P8|Safety Evaluable Participants|Initial Phase (Dose-finding)||0
2517560|NCT00726232|6169529|P7|Safety Evaluable Participants|Initial Phase (Dose-finding)||0
2517561|NCT00726232|6169530|P6|Safety Evaluable Participants|Initial Phase (Dose-finding)||9
2517562|NCT00726232|6169531|P5|Safety Evaluable Participants|Initial Phase (Dose-finding)||22
2517563|NCT00726232|6169532|P4|Safety Evaluable Participants|Initial Phase (Dose-finding)||8
2517564|NCT00726232|6169533|P3|Safety Evaluable Participants|Initial Phase (Dose-finding)||7
2517565|NCT00726232|6169534|P2|Safety Evaluable Participants|Initial Phase (Dose-finding)||8
2517566|NCT00726232|6169535|P1|Safety Evaluable Participants|Initial Phase (Dose-finding)||19
2517567|NCT00726232|6169528|P8|STARTED|Initial Phase (Dose-finding)||0
2517568|NCT00726232|6169529|P7|STARTED|Initial Phase (Dose-finding)||0
2517569|NCT00726232|6169530|P6|STARTED|Initial Phase (Dose-finding)||9
2517570|NCT00726232|6169531|P5|STARTED|Initial Phase (Dose-finding)|The starting dose selected for the ET expansion cohort was 25 mg bid hence the sample size is larger|22
2517571|NCT00726232|6169532|P4|STARTED|Initial Phase (Dose-finding)||8
2517572|NCT00726232|6169533|P3|STARTED|Initial Phase (Dose-finding)||7
2517573|NCT00726232|6169534|P2|STARTED|Initial Phase (Dose-finding)||8
2517574|NCT00726232|6169535|P1|STARTED|Initial Phase (Dose-finding)|The starting dose selected for the PV expansion cohort was 10 mg bid hence the sample size is larger|19
2517575|NCT00726180|6169581|P1|NOT COMPLETED|Overall Study||0
2517576|NCT00726180|6169581|P1|COMPLETED|Overall Study||1
2517577|NCT00726180|6169581|P1|STARTED|Overall Study||1
2517578|NCT00726063|6169587|P2|NOT COMPLETED|Overall Study||7
2517579|NCT00726063|6169588|P1|NOT COMPLETED|Overall Study||9
2517580|NCT00726063|6169587|P2|COMPLETED|Overall Study|Number of implants = 239|112
2517581|NCT00726063|6169588|P1|COMPLETED|Overall Study|Number of implants =230|113
2517582|NCT00726063|6169587|P2|STARTED|Overall Study|Number of implants= 246|119
2517583|NCT00726063|6169588|P1|STARTED|Overall Study|Number of implants= 239|122
2517584|NCT00726037|6169594|P1|NOT COMPLETED|Overall Study||0
2517585|NCT00726037|6169594|P1|COMPLETED|Overall Study||7
2517586|NCT00726037|6169594|P1|STARTED|Overall Study||7
2517587|NCT00725985|6169602|P12|NOT COMPLETED|LTFU (No Cladribine Treatment)||14
2517588|NCT00725985|6169603|P11|NOT COMPLETED|LTFU (No Cladribine Treatment)||36
2517589|NCT00725985|6169604|P10|NOT COMPLETED|LTFU (No Cladribine Treatment)||34
2517590|NCT00725985|6169605|P9|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
2517591|NCT00725985|6169606|P8|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
2517592|NCT00725985|6169607|P7|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
2517593|NCT00725985|6169608|P6|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
2517594|NCT00725985|6169609|P5|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
2517595|NCT00725985|6169610|P4|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
2517596|NCT00725985|6169611|P3|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
2517597|NCT00725985|6169612|P2|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
2517598|NCT00725985|6169613|P1|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
2517599|NCT00725985|6169602|P12|COMPLETED|LTFU (No Cladribine Treatment)||0
2517600|NCT00725985|6169603|P11|COMPLETED|LTFU (No Cladribine Treatment)||0
2517601|NCT00725985|6169604|P10|COMPLETED|LTFU (No Cladribine Treatment)||0
2517602|NCT00725985|6169605|P9|COMPLETED|LTFU (No Cladribine Treatment)||0
2517603|NCT00725985|6169606|P8|COMPLETED|LTFU (No Cladribine Treatment)||0
2517604|NCT00725985|6169607|P7|COMPLETED|LTFU (No Cladribine Treatment)||0
2517605|NCT00725985|6169608|P6|COMPLETED|LTFU (No Cladribine Treatment)||0
2517606|NCT00725985|6169609|P5|COMPLETED|LTFU (No Cladribine Treatment)||0
2517607|NCT00725985|6169610|P4|COMPLETED|LTFU (No Cladribine Treatment)||0
2517608|NCT00725985|6169611|P3|COMPLETED|LTFU (No Cladribine Treatment)||0
2517609|NCT00725985|6169612|P2|COMPLETED|LTFU (No Cladribine Treatment)||0
2517610|NCT00725985|6169613|P1|COMPLETED|LTFU (No Cladribine Treatment)||0
2517611|NCT00725985|6169602|P12|STARTED|LTFU (No Cladribine Treatment)||14
2517612|NCT00725985|6169603|P11|STARTED|LTFU (No Cladribine Treatment)||36
2517613|NCT00725985|6169604|P10|STARTED|LTFU (No Cladribine Treatment)||34
2517614|NCT00725985|6169605|P9|STARTED|LTFU (No Cladribine Treatment)||0
2517615|NCT00725985|6169606|P8|STARTED|LTFU (No Cladribine Treatment)||0
2517616|NCT00725985|6169607|P7|STARTED|LTFU (No Cladribine Treatment)||0
2517617|NCT00725985|6169608|P6|STARTED|LTFU (No Cladribine Treatment)||0
2517618|NCT00725985|6169609|P5|STARTED|LTFU (No Cladribine Treatment)||0
2517619|NCT00725985|6169610|P4|STARTED|LTFU (No Cladribine Treatment)||0
2517620|NCT00725985|6169611|P3|STARTED|LTFU (No Cladribine Treatment)||0
2517621|NCT00725985|6169612|P2|STARTED|LTFU (No Cladribine Treatment)||0
2517622|NCT00725985|6169613|P1|STARTED|LTFU (No Cladribine Treatment)||0
2517623|NCT00725985|6169602|P12|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
2517624|NCT00725985|6169603|P11|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
2517625|NCT00725985|6169604|P10|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
2517626|NCT00725985|6169605|P9|NOT COMPLETED|LTFU (With Cladribine Treatment)||17
2517627|NCT00725985|6169606|P8|NOT COMPLETED|LTFU (With Cladribine Treatment)||9
2517628|NCT00725985|6169607|P7|NOT COMPLETED|LTFU (With Cladribine Treatment)||9
2517629|NCT00725985|6169608|P6|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
2517630|NCT00725985|6169609|P5|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
2517631|NCT00725985|6169610|P4|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
2517632|NCT00725985|6169611|P3|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
2517633|NCT00725985|6169612|P2|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
2517634|NCT00725985|6169613|P1|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
2517635|NCT00725985|6169602|P12|COMPLETED|LTFU (With Cladribine Treatment)||0
2517636|NCT00725985|6169603|P11|COMPLETED|LTFU (With Cladribine Treatment)||0
2517637|NCT00725985|6169604|P10|COMPLETED|LTFU (With Cladribine Treatment)||0
2517638|NCT00725985|6169605|P9|COMPLETED|LTFU (With Cladribine Treatment)||0
2517639|NCT00725985|6169606|P8|COMPLETED|LTFU (With Cladribine Treatment)||0
2517640|NCT00725985|6169607|P7|COMPLETED|LTFU (With Cladribine Treatment)||0
2517641|NCT00725985|6169608|P6|COMPLETED|LTFU (With Cladribine Treatment)||0
2517642|NCT00725985|6169609|P5|COMPLETED|LTFU (With Cladribine Treatment)||0
2517643|NCT00725985|6169610|P4|COMPLETED|LTFU (With Cladribine Treatment)||0
2517644|NCT00725985|6169611|P3|COMPLETED|LTFU (With Cladribine Treatment)||0
2517645|NCT00725985|6169612|P2|COMPLETED|LTFU (With Cladribine Treatment)||0
2517646|NCT00725985|6169613|P1|COMPLETED|LTFU (With Cladribine Treatment)||0
2517647|NCT00725985|6169602|P12|STARTED|LTFU (With Cladribine Treatment)||0
2517648|NCT00725985|6169603|P11|STARTED|LTFU (With Cladribine Treatment)||0
2517649|NCT00725985|6169604|P10|STARTED|LTFU (With Cladribine Treatment)||0
2517650|NCT00725985|6169605|P9|STARTED|LTFU (With Cladribine Treatment)||17
2517651|NCT00725985|6169606|P8|STARTED|LTFU (With Cladribine Treatment)||9
2517652|NCT00725985|6169607|P7|STARTED|LTFU (With Cladribine Treatment)||9
2517653|NCT00725985|6169608|P6|STARTED|LTFU (With Cladribine Treatment)||0
2517654|NCT00725985|6169609|P5|STARTED|LTFU (With Cladribine Treatment)||0
2517655|NCT00725985|6169610|P4|STARTED|LTFU (With Cladribine Treatment)||0
2517656|NCT00725985|6169611|P3|STARTED|LTFU (With Cladribine Treatment)||0
2517657|NCT00725985|6169612|P2|STARTED|LTFU (With Cladribine Treatment)||0
2517658|NCT00725985|6169613|P1|STARTED|LTFU (With Cladribine Treatment)||0
2517659|NCT00725985|6169602|P12|NOT COMPLETED|OLMP||0
2517660|NCT00725985|6169603|P11|NOT COMPLETED|OLMP||0
2517661|NCT00725985|6169604|P10|NOT COMPLETED|OLMP||0
2517662|NCT00725985|6169605|P9|NOT COMPLETED|OLMP||0
2517663|NCT00725985|6169606|P8|NOT COMPLETED|OLMP||0
2517664|NCT00725985|6169607|P7|NOT COMPLETED|OLMP||0
2517665|NCT00725985|6169608|P6|NOT COMPLETED|OLMP||53
2517666|NCT00725985|6169609|P5|NOT COMPLETED|OLMP||23
2517667|NCT00725985|6169610|P4|NOT COMPLETED|OLMP||18
2517668|NCT00725985|6169611|P3|NOT COMPLETED|OLMP||0
2517669|NCT00725985|6169612|P2|NOT COMPLETED|OLMP||0
2517670|NCT00725985|6169613|P1|NOT COMPLETED|OLMP||0
2517671|NCT00725985|6169602|P12|COMPLETED|OLMP||0
2517672|NCT00725985|6169603|P11|COMPLETED|OLMP||0
2517673|NCT00725985|6169604|P10|COMPLETED|OLMP||0
2517674|NCT00725985|6169605|P9|COMPLETED|OLMP||0
2517675|NCT00725985|6169606|P8|COMPLETED|OLMP||0
2517676|NCT00725985|6169607|P7|COMPLETED|OLMP||0
2517677|NCT00725985|6169608|P6|COMPLETED|OLMP||7
2517678|NCT00725985|6169609|P5|COMPLETED|OLMP||2
2517679|NCT00725985|6169610|P4|COMPLETED|OLMP||6
2517680|NCT00725985|6169611|P3|COMPLETED|OLMP||0
2517681|NCT00725985|6169612|P2|COMPLETED|OLMP||0
2517682|NCT00725985|6169613|P1|COMPLETED|OLMP||0
2517683|NCT00725985|6169602|P12|STARTED|OLMP||0
2517684|NCT00725985|6169603|P11|STARTED|OLMP||0
2517685|NCT00725985|6169604|P10|STARTED|OLMP||0
2517686|NCT00725985|6169605|P9|STARTED|OLMP||0
2517687|NCT00725985|6169606|P8|STARTED|OLMP||0
2517688|NCT00725985|6169607|P7|STARTED|OLMP||0
2517689|NCT00725985|6169608|P6|STARTED|OLMP||60
2517690|NCT00725985|6169609|P5|STARTED|OLMP||25
2517691|NCT00725985|6169610|P4|STARTED|OLMP||24
2517692|NCT00725985|6169611|P3|STARTED|OLMP||0
2517693|NCT00725985|6169612|P2|STARTED|OLMP||0
2517694|NCT00725985|6169613|P1|STARTED|OLMP||0
2517695|NCT00725985|6169602|P12|NOT COMPLETED|ITP (Up to 96 Weeks)||0
2517696|NCT00725985|6169603|P11|NOT COMPLETED|ITP (Up to 96 Weeks)||0
2517697|NCT00725985|6169604|P10|NOT COMPLETED|ITP (Up to 96 Weeks)||0
2517698|NCT00725985|6169605|P9|NOT COMPLETED|ITP (Up to 96 Weeks)||0
2517699|NCT00725985|6169606|P8|NOT COMPLETED|ITP (Up to 96 Weeks)||0
2517700|NCT00725985|6169607|P7|NOT COMPLETED|ITP (Up to 96 Weeks)||0
2517701|NCT00725985|6169608|P6|NOT COMPLETED|ITP (Up to 96 Weeks)||0
2517702|NCT00725985|6169609|P5|NOT COMPLETED|ITP (Up to 96 Weeks)||0
2517703|NCT00725985|6169610|P4|NOT COMPLETED|ITP (Up to 96 Weeks)||0
2517704|NCT00725985|6169611|P3|NOT COMPLETED|ITP (Up to 96 Weeks)||102
2517705|NCT00725985|6169612|P2|NOT COMPLETED|ITP (Up to 96 Weeks)||75
2517706|NCT00725985|6169613|P1|NOT COMPLETED|ITP (Up to 96 Weeks)||101
2517707|NCT00725985|6169602|P12|COMPLETED|ITP (Up to 96 Weeks)||0
2517708|NCT00725985|6169603|P11|COMPLETED|ITP (Up to 96 Weeks)||0
2517709|NCT00725985|6169604|P10|COMPLETED|ITP (Up to 96 Weeks)||0
2517710|NCT00725985|6169605|P9|COMPLETED|ITP (Up to 96 Weeks)||0
2517711|NCT00725985|6169606|P8|COMPLETED|ITP (Up to 96 Weeks)||0
2517712|NCT00725985|6169607|P7|COMPLETED|ITP (Up to 96 Weeks)||0
2517713|NCT00725985|6169608|P6|COMPLETED|ITP (Up to 96 Weeks)||0
2517714|NCT00725985|6169609|P5|COMPLETED|ITP (Up to 96 Weeks)||0
2517715|NCT00725985|6169610|P4|COMPLETED|ITP (Up to 96 Weeks)||0
2517716|NCT00725985|6169611|P3|COMPLETED|ITP (Up to 96 Weeks)||104
2517717|NCT00725985|6169612|P2|COMPLETED|ITP (Up to 96 Weeks)||131
2517718|NCT00725985|6169613|P1|COMPLETED|ITP (Up to 96 Weeks)||104
2517719|NCT00725985|6169602|P12|Treated|ITP (Up to 96 Weeks)||0
2517720|NCT00725985|6169603|P11|Treated|ITP (Up to 96 Weeks)||0
2517721|NCT00725985|6169604|P10|Treated|ITP (Up to 96 Weeks)||0
2517722|NCT00725985|6169605|P9|Treated|ITP (Up to 96 Weeks)||0
2517723|NCT00725985|6169606|P8|Treated|ITP (Up to 96 Weeks)||0
2517724|NCT00725985|6169607|P7|Treated|ITP (Up to 96 Weeks)||0
2517725|NCT00725985|6169608|P6|Treated|ITP (Up to 96 Weeks)||0
2517726|NCT00725985|6169609|P5|Treated|ITP (Up to 96 Weeks)||0
2517727|NCT00725985|6169610|P4|Treated|ITP (Up to 96 Weeks)||0
2517728|NCT00725985|6169611|P3|Treated|ITP (Up to 96 Weeks)||206
2517729|NCT00725985|6169612|P2|Treated|ITP (Up to 96 Weeks)||206
2517730|NCT00725985|6169613|P1|Treated|ITP (Up to 96 Weeks)||204
2517731|NCT00725985|6169602|P12|STARTED|ITP (Up to 96 Weeks)||0
2517732|NCT00725985|6169603|P11|STARTED|ITP (Up to 96 Weeks)||0
2517733|NCT00725985|6169604|P10|STARTED|ITP (Up to 96 Weeks)||0
2517734|NCT00725985|6169605|P9|STARTED|ITP (Up to 96 Weeks)||0
2517735|NCT00725985|6169606|P8|STARTED|ITP (Up to 96 Weeks)||0
2517736|NCT00725985|6169607|P7|STARTED|ITP (Up to 96 Weeks)||0
2517737|NCT00725985|6169608|P6|STARTED|ITP (Up to 96 Weeks)||0
2517738|NCT00725985|6169609|P5|STARTED|ITP (Up to 96 Weeks)||0
2517739|NCT00725985|6169610|P4|STARTED|ITP (Up to 96 Weeks)||0
2517740|NCT00725985|6169611|P3|STARTED|ITP (Up to 96 Weeks)||206
2517741|NCT00725985|6169612|P2|STARTED|ITP (Up to 96 Weeks)||206
2517742|NCT00725985|6169613|P1|STARTED|ITP (Up to 96 Weeks)||205
2517743|NCT00725959|6169641|P2|NOT COMPLETED|Overall Study||197
2517744|NCT00725959|6169642|P1|NOT COMPLETED|Overall Study||289
2517745|NCT00725959|6169641|P2|COMPLETED|Overall Study||439
2517746|NCT00725959|6169642|P1|COMPLETED|Overall Study||653
2517747|NCT00725959|6169641|P2|STARTED|Overall Study||636
2517748|NCT00725959|6169642|P1|STARTED|Overall Study||942
2517749|NCT00725920|6169650|P2|NOT COMPLETED|Overall Study||6
2517750|NCT00725920|6169651|P1|NOT COMPLETED|Overall Study||3
2517751|NCT00725920|6169650|P2|COMPLETED|Overall Study||12
2517752|NCT00725920|6169651|P1|COMPLETED|Overall Study||14
2517753|NCT00725920|6169650|P2|STARTED|Overall Study||18
2517754|NCT00725920|6169651|P1|STARTED|Overall Study||17
2517755|NCT00725842|6169657|P1|NOT COMPLETED|Overall Study||40
2517756|NCT00725842|6169657|P1|COMPLETED|Overall Study||57
2517757|NCT00725842|6169657|P1|Participants Eligible for Analysis|Overall Study||90
2517758|NCT00725842|6169657|P1|STARTED|Overall Study||97
2517759|NCT00725764|6169664|P1|NOT COMPLETED|Overall Study||14
2517760|NCT00725764|6169664|P1|COMPLETED|Overall Study||0
2517761|NCT00725764|6169664|P1|STARTED|Overall Study||14
2517762|NCT00725751|6169684|P2|NOT COMPLETED|Overall Study||108
2517763|NCT00725751|6169685|P1|NOT COMPLETED|Overall Study||34
2517764|NCT00725751|6169684|P2|COMPLETED|Overall Study||150
2517765|NCT00725751|6169685|P1|COMPLETED|Overall Study||56
2517766|NCT00725751|6169684|P2|STARTED|Overall Study||258
2517767|NCT00725751|6169685|P1|STARTED|Overall Study||90
2517768|NCT00725725|6169697|P3|NOT COMPLETED|Overall Study||5
2517769|NCT00725725|6169698|P2|NOT COMPLETED|Overall Study||4
2517770|NCT00725725|6169699|P1|NOT COMPLETED|Overall Study||4
2517771|NCT00725725|6169697|P3|COMPLETED|Overall Study||12
2517772|NCT00725725|6169698|P2|COMPLETED|Overall Study||11
2517773|NCT00725725|6169699|P1|COMPLETED|Overall Study||10
2517774|NCT00725725|6169697|P3|Treated|Overall Study||14
2517775|NCT00725725|6169698|P2|Treated|Overall Study||15
2517776|NCT00725725|6169699|P1|Treated|Overall Study||11
2517777|NCT00725725|6169697|P3|STARTED|Overall Study||17
2517778|NCT00725725|6169698|P2|STARTED|Overall Study||15
2517779|NCT00725725|6169699|P1|STARTED|Overall Study||14
2517780|NCT00725712|6169742|P2|NOT COMPLETED|Overall Study||26
2517781|NCT00725712|6169743|P1|NOT COMPLETED|Overall Study||48
2517782|NCT00725712|6169742|P2|COMPLETED|Overall Study||0
2517783|NCT00725712|6169743|P1|COMPLETED|Overall Study||0
2517784|NCT00725712|6169742|P2|STARTED|Overall Study||26
2517785|NCT00725712|6169743|P1|STARTED|Overall Study||48
2517786|NCT00725621|6169779|P1|NOT COMPLETED|Overall Study||271
2517787|NCT00725621|6169779|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|245
2517788|NCT00725621|6169779|P1|STARTED|Overall Study|Started was defined as the number of participants who received at least one infusion of Remicade.|516
2517789|NCT00725608|6169802|P1|NOT COMPLETED|Overall Study||167
2517790|NCT00725608|6169802|P1|COMPLETED|Overall Study|1 patient terminated treatment at day 368 and was counted as dropout|140
2517791|NCT00725608|6169802|P1|STARTED|Overall Study|339 patients enrolled, 32 non-eligible datasets excluded from final general and safety analysis|307
2517792|NCT00725543|6169808|P1|NOT COMPLETED|Overall Study||153
2517793|NCT00725543|6169808|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|205
2517794|NCT00725543|6169808|P1|STARTED|Overall Study||358
2517795|NCT00725530|6169817|P2|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
2517796|NCT00725530|6169818|P1|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
2517797|NCT00725530|6169817|P2|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
2517798|NCT00725530|6169818|P1|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
2517799|NCT00725530|6169817|P2|STARTED|Second Intervention, 7 Days (+0/-1)||27
2517800|NCT00725530|6169818|P1|STARTED|Second Intervention, 7 Days (+0/-1)||27
2517801|NCT00725530|6169817|P2|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
2517802|NCT00725530|6169818|P1|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
2517803|NCT00725530|6169817|P2|COMPLETED|First Intervention, 7 Days (+0/-1)||27
2517804|NCT00725530|6169818|P1|COMPLETED|First Intervention, 7 Days (+0/-1)||27
2517805|NCT00725530|6169817|P2|STARTED|First Intervention, 7 Days (+0/-1)||27
2517806|NCT00725530|6169818|P1|STARTED|First Intervention, 7 Days (+0/-1)||27
2517807|NCT00725504|6169824|P1|NOT COMPLETED|Overall Study||0
2517808|NCT00725504|6169824|P1|COMPLETED|Overall Study||71
2517809|NCT00725504|6169824|P1|STARTED|Overall Study||71
2517810|NCT00725491|6169833|P2|NOT COMPLETED|Overall Study||18
2517811|NCT00725491|6169834|P1|NOT COMPLETED|Overall Study||9
2517812|NCT00725491|6169833|P2|COMPLETED|Overall Study||102
2517813|NCT00725491|6169834|P1|COMPLETED|Overall Study||104
2517814|NCT00725491|6169833|P2|STARTED|Overall Study|Intent-to-Treat Group|120
2517815|NCT00725491|6169834|P1|STARTED|Overall Study|Intent-to-Treat Group|113
2517816|NCT00725452|6169840|P1|NOT COMPLETED|Overall Study||11
2517817|NCT00725452|6169840|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Infliximab infusions.|15
2517818|NCT00725452|6169840|P1|STARTED|Overall Study||26
2517819|NCT00725361|6169849|P1|NOT COMPLETED|Overall Study||4
2517820|NCT00725361|6169849|P1|COMPLETED|Overall Study||16
2517821|NCT00725361|6169849|P1|STARTED|Overall Study||20
2517822|NCT00725322|6169859|P2|NOT COMPLETED|Second Injection Visit||0
2517823|NCT00725322|6169860|P1|NOT COMPLETED|Second Injection Visit||0
2517824|NCT00725322|6169859|P2|COMPLETED|Second Injection Visit||14
2517825|NCT00725322|6169860|P1|COMPLETED|Second Injection Visit||13
2517826|NCT00725322|6169859|P2|STARTED|Second Injection Visit||14
2517827|NCT00725322|6169860|P1|STARTED|Second Injection Visit||13
2517828|NCT00725322|6169859|P2|NOT COMPLETED|Washout (28 Days)||1
2517829|NCT00725322|6169860|P1|NOT COMPLETED|Washout (28 Days)||2
2517830|NCT00725322|6169859|P2|COMPLETED|Washout (28 Days)||14
2517831|NCT00725322|6169860|P1|COMPLETED|Washout (28 Days)||13
2517832|NCT00725322|6169859|P2|STARTED|Washout (28 Days)||15
2517833|NCT00725322|6169860|P1|STARTED|Washout (28 Days)||15
2517834|NCT00725322|6169859|P2|NOT COMPLETED|First Injection Visit||0
2517835|NCT00725322|6169860|P1|NOT COMPLETED|First Injection Visit||0
2517836|NCT00725322|6169859|P2|COMPLETED|First Injection Visit||15
2517837|NCT00725322|6169860|P1|COMPLETED|First Injection Visit||15
2517838|NCT00725322|6169859|P2|STARTED|First Injection Visit||15
2517839|NCT00725322|6169860|P1|STARTED|First Injection Visit||15
2517840|NCT00725296|6169868|P1|NOT COMPLETED|Overall Study||62
2517841|NCT00725296|6169868|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive infusions.|101
2517842|NCT00725296|6169868|P1|STARTED|Overall Study|163 of the 178 enrolled participants received at least one dose of Infliximab.|163
2517843|NCT00725283|6169877|P1|NOT COMPLETED|Overall Study||24
2517844|NCT00725283|6169877|P1|COMPLETED|Overall Study||10
2517845|NCT00725283|6169877|P1|STARTED|Overall Study||34
2517846|NCT00725270|6169889|P2|NOT COMPLETED|Overall Study||0
2517847|NCT00725270|6169890|P1|NOT COMPLETED|Overall Study||0
2517848|NCT00725270|6169889|P2|COMPLETED|Overall Study||7
2517849|NCT00725270|6169890|P1|COMPLETED|Overall Study||5
2517850|NCT00725270|6169889|P2|STARTED|Overall Study||7
2517851|NCT00725270|6169890|P1|STARTED|Overall Study||5
2517852|NCT00725205|6169898|P1|NOT COMPLETED|Overall Study||87
2517853|NCT00725205|6169898|P1|COMPLETED|Overall Study||207
2517854|NCT00725205|6169898|P1|STARTED|Overall Study||294
2517855|NCT00725153|6169904|P2|NOT COMPLETED|Period Two, 10 Hours of Wear||0
2517856|NCT00725153|6169905|P1|NOT COMPLETED|Period Two, 10 Hours of Wear||0
2517857|NCT00725153|6169904|P2|COMPLETED|Period Two, 10 Hours of Wear||28
2517858|NCT00725153|6169905|P1|COMPLETED|Period Two, 10 Hours of Wear||27
2517859|NCT00725153|6169904|P2|STARTED|Period Two, 10 Hours of Wear||28
2517860|NCT00725153|6169905|P1|STARTED|Period Two, 10 Hours of Wear||27
2517861|NCT00725153|6169904|P2|NOT COMPLETED|Period One, 10 Hours of Wear||0
2517862|NCT00725153|6169905|P1|NOT COMPLETED|Period One, 10 Hours of Wear||0
2517863|NCT00725153|6169904|P2|COMPLETED|Period One, 10 Hours of Wear||28
2517864|NCT00725153|6169905|P1|COMPLETED|Period One, 10 Hours of Wear||27
2517865|NCT00725153|6169904|P2|STARTED|Period One, 10 Hours of Wear||28
2517866|NCT00725153|6169905|P1|STARTED|Period One, 10 Hours of Wear||27
2517867|NCT00725101|6169911|P1|NOT COMPLETED|Overall Study||495
2517868|NCT00725101|6169911|P1|COMPLETED|Overall Study||1205
2517869|NCT00725101|6169911|P1|STARTED|Overall Study||1700
2517870|NCT00725075|6169934|P3|NOT COMPLETED|Overall Study||9
2517871|NCT00725075|6169935|P2|NOT COMPLETED|Overall Study||8
2517872|NCT00725075|6169936|P1|NOT COMPLETED|Overall Study||11
2517873|NCT00725075|6169934|P3|COMPLETED|Overall Study||61
2517874|NCT00725075|6169935|P2|COMPLETED|Overall Study||65
2517875|NCT00725075|6169936|P1|COMPLETED|Overall Study||61
2517876|NCT00725075|6169934|P3|Treated|Overall Study||70
2517877|NCT00725075|6169935|P2|Treated|Overall Study||73
2517878|NCT00725075|6169936|P1|Treated|Overall Study||71
2517879|NCT00725075|6169934|P3|STARTED|Overall Study||70
2517880|NCT00725075|6169935|P2|STARTED|Overall Study||73
2517881|NCT00725075|6169936|P1|STARTED|Overall Study||72
2517882|NCT00725049|6169982|P2|NOT COMPLETED|Overall Study||0
2517883|NCT00725049|6169983|P1|NOT COMPLETED|Overall Study||0
2517884|NCT00725049|6169982|P2|COMPLETED|Overall Study||20
2517885|NCT00725049|6169983|P1|COMPLETED|Overall Study||17
2517886|NCT00725049|6169982|P2|STARTED|Overall Study||20
2517887|NCT00725049|6169983|P1|STARTED|Overall Study||17
2517888|NCT00725010|6169989|P1|NOT COMPLETED|Overall Study||25
2517889|NCT00725010|6169989|P1|COMPLETED|Overall Study||25
2517890|NCT00725010|6169989|P1|STARTED|Overall Study|Only in 50 of 64 participants the documentation of therapy and follow-up was received and evaluated.|50
2517891|NCT00724984|6170003|P6|NOT COMPLETED|Overall Study||5
2517892|NCT00724984|6170004|P5|NOT COMPLETED|Overall Study||4
2517893|NCT00724984|6170005|P4|NOT COMPLETED|Overall Study||2
2517894|NCT00724984|6170006|P3|NOT COMPLETED|Overall Study||0
2517895|NCT00724984|6170007|P2|NOT COMPLETED|Overall Study||1
2517896|NCT00724984|6170008|P1|NOT COMPLETED|Overall Study||1
2517897|NCT00724984|6170003|P6|COMPLETED|Overall Study||9
2517898|NCT00724984|6170004|P5|COMPLETED|Overall Study||12
2517899|NCT00724984|6170005|P4|COMPLETED|Overall Study||7
2517900|NCT00724984|6170006|P3|COMPLETED|Overall Study||3
2517901|NCT00724984|6170007|P2|COMPLETED|Overall Study||7
2517902|NCT00724984|6170008|P1|COMPLETED|Overall Study||4
2517903|NCT00724984|6170003|P6|STARTED|Overall Study||14
2517904|NCT00724984|6170004|P5|STARTED|Overall Study||16
2517905|NCT00724984|6170005|P4|STARTED|Overall Study||9
2517906|NCT00724984|6170006|P3|STARTED|Overall Study||3
2517907|NCT00724984|6170007|P2|STARTED|Overall Study||8
2517908|NCT00724984|6170008|P1|STARTED|Overall Study||5
2517909|NCT00724971|6170022|P1|NOT COMPLETED|Overall Study||6
2517910|NCT00724971|6170022|P1|COMPLETED|Overall Study||4
2517911|NCT00724971|6170022|P1|STARTED|Overall Study||10
2517912|NCT00724958|6170037|P1|NOT COMPLETED|Overall Study||182
2517913|NCT00724958|6170037|P1|COMPLETED|Overall Study||166
2517914|NCT00724958|6170037|P1|STARTED|Overall Study||348
2517915|NCT00724945|6170046|P2|NOT COMPLETED|Period 2||0
2517916|NCT00724945|6170047|P1|NOT COMPLETED|Period 2||4
2517917|NCT00724945|6170046|P2|COMPLETED|Period 2||54
2517918|NCT00724945|6170047|P1|COMPLETED|Period 2||51
2517919|NCT00724945|6170046|P2|STARTED|Period 2||54
2517920|NCT00724945|6170047|P1|STARTED|Period 2||55
2517921|NCT00724945|6170046|P2|NOT COMPLETED|Period 1||1
2517922|NCT00724945|6170047|P1|NOT COMPLETED|Period 1||3
2517923|NCT00724945|6170046|P2|COMPLETED|Period 1||54
2517924|NCT00724945|6170047|P1|COMPLETED|Period 1||55
2517925|NCT00724945|6170046|P2|STARTED|Period 1||55
2517926|NCT00724945|6170047|P1|STARTED|Period 1||58
2517927|NCT00724932|6170059|P2|NOT COMPLETED|Overall Study||3
2517928|NCT00724932|6170060|P1|NOT COMPLETED|Overall Study||5
2517929|NCT00724932|6170059|P2|COMPLETED|Overall Study||67
2517930|NCT00724932|6170060|P1|COMPLETED|Overall Study||65
2517931|NCT00724932|6170059|P2|STARTED|Overall Study||70
2517932|NCT00724932|6170060|P1|STARTED|Overall Study||70
2517933|NCT00724893|6170131|P2|NOT COMPLETED|Overall Study||458
2517934|NCT00724893|6170132|P1|NOT COMPLETED|Overall Study||364
2517935|NCT00724893|6170131|P2|COMPLETED|Overall Study||670
2517936|NCT00724893|6170132|P1|COMPLETED|Overall Study||938
2517937|NCT00724893|6170131|P2|STARTED|Overall Study||1128
2517938|NCT00724893|6170132|P1|STARTED|Overall Study||1302
2517939|NCT00724867|6170200|P1|NOT COMPLETED|Overall Study||128
2517940|NCT00724867|6170200|P1|COMPLETED|Overall Study||140
2517941|NCT00724867|6170200|P1|STARTED|Overall Study||268
2517942|NCT00724854|6170240|P2|NOT COMPLETED|Overall Study||31
2517943|NCT00724854|6170241|P1|NOT COMPLETED|Overall Study||403
2517944|NCT00724854|6170240|P2|COMPLETED|Overall Study||41
2517945|NCT00724854|6170241|P1|COMPLETED|Overall Study||607
2517946|NCT00724854|6170240|P2|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|72
2517947|NCT00724854|6170241|P1|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|1010
2517948|NCT00724815|6170258|P2|NOT COMPLETED|Overall Study||39
2517949|NCT00724815|6170259|P1|NOT COMPLETED|Overall Study||43
2517950|NCT00724815|6170258|P2|COMPLETED|Overall Study||226
2517951|NCT00724815|6170259|P1|COMPLETED|Overall Study||222
2517952|NCT00724815|6170258|P2|STARTED|Overall Study|subjects randomized|265
2517953|NCT00724815|6170259|P1|STARTED|Overall Study|subjects randomized|265
2517954|NCT00724750|6170273|P2|NOT COMPLETED|Overall Study||0
2517955|NCT00724750|6170274|P1|NOT COMPLETED|Overall Study||0
2517956|NCT00724750|6170273|P2|COMPLETED|Overall Study||42
2517957|NCT00724750|6170274|P1|COMPLETED|Overall Study||45
2517958|NCT00724750|6170273|P2|STARTED|Overall Study||42
2517959|NCT00724750|6170274|P1|STARTED|Overall Study||45
2517960|NCT00724711|6170292|P2|NOT COMPLETED|Overall Study||17
2517961|NCT00724711|6170293|P1|NOT COMPLETED|Overall Study||17
2517962|NCT00724711|6170292|P2|COMPLETED|Overall Study||139
2517963|NCT00724711|6170293|P1|COMPLETED|Overall Study||138
2517964|NCT00724711|6170292|P2|STARTED|Overall Study||156
2517965|NCT00724711|6170293|P1|STARTED|Overall Study||155
2517966|NCT00724698|6170325|P1|NOT COMPLETED|Overall Study||90
2517967|NCT00724698|6170325|P1|COMPLETED|Overall Study||2921
2517968|NCT00724698|6170325|P1|STARTED|Overall Study||3011
2517969|NCT00724594|6170332|P4|NOT COMPLETED|Overall Study||1
2517970|NCT00724594|6170333|P3|NOT COMPLETED|Overall Study||0
2517971|NCT00724594|6170334|P2|NOT COMPLETED|Overall Study||0
2517972|NCT00724594|6170335|P1|NOT COMPLETED|Overall Study||0
2517973|NCT00724594|6170332|P4|COMPLETED|Overall Study||10
2517974|NCT00724594|6170333|P3|COMPLETED|Overall Study||11
2517975|NCT00724594|6170334|P2|COMPLETED|Overall Study||12
2517976|NCT00724594|6170335|P1|COMPLETED|Overall Study||12
2517977|NCT00724594|6170332|P4|STARTED|Overall Study||11
2517978|NCT00724594|6170333|P3|STARTED|Overall Study||11
2517979|NCT00724594|6170334|P2|STARTED|Overall Study||12
2517980|NCT00724594|6170335|P1|STARTED|Overall Study||12
2517981|NCT00724568|6170370|P2|NOT COMPLETED|Overall Study||0
2517982|NCT00724568|6170371|P1|NOT COMPLETED|Overall Study||0
2517983|NCT00724568|6170370|P2|COMPLETED|Overall Study||32
2517984|NCT00724568|6170371|P1|COMPLETED|Overall Study||42
2517985|NCT00724568|6170370|P2|STARTED|Overall Study||32
2517986|NCT00724568|6170371|P1|STARTED|Overall Study||42
2517987|NCT00724503|6170378|P2|NOT COMPLETED|Overall Study||220
2517988|NCT00724503|6170379|P1|NOT COMPLETED|Overall Study||210
2517989|NCT00724503|6170378|P2|COMPLETED|Overall Study||43
2517990|NCT00724503|6170379|P1|COMPLETED|Overall Study||57
2517991|NCT00724503|6170378|P2|STARTED|Overall Study||263
2517992|NCT00724503|6170379|P1|STARTED|Overall Study||267
2517993|NCT00724477|6170387|P1|NOT COMPLETED|Overall Study||0
2517994|NCT00724477|6170387|P1|COMPLETED|Overall Study||1663
2517995|NCT00724477|6170387|P1|STARTED|Overall Study|This safety population (SAF)analysed consisted of all patients who took at least one tablet of INEGY|1663
2517996|NCT00724464|6170391|P1|NOT COMPLETED|Overall Study||23
2517997|NCT00724464|6170391|P1|COMPLETED|Overall Study||309
2517998|NCT00724464|6170391|P1|STARTED|Overall Study||332
2517999|NCT00724451|6170403|P1|NOT COMPLETED|Overall Study||802
2518000|NCT00724451|6170403|P1|COMPLETED|Overall Study|Completed defined as participants who completed anti-viral treatment.|326
2518001|NCT00724451|6170403|P1|Received Antiviral Treatment|Overall Study||500
2518002|NCT00724451|6170403|P1|STARTED|Overall Study||1128
2518003|NCT00724373|6170409|P1|NOT COMPLETED|Overall Study||171
2518004|NCT00724373|6170409|P1|COMPLETED|Overall Study||271
2518005|NCT00724373|6170409|P1|STARTED|Overall Study||442
2518006|NCT00724347|6170413|P1|NOT COMPLETED|Overall Study||2
2518007|NCT00724347|6170413|P1|COMPLETED|Overall Study||16
2518008|NCT00724347|6170413|P1|Baseline Testing|Overall Study||18
2518009|NCT00724347|6170413|P1|STARTED|Overall Study|Training was the final step in the program, once the outcome tests had been developed.|18
2518010|NCT00724308|6170419|P2|NOT COMPLETED|Overall Study||97
2518011|NCT00724308|6170420|P1|NOT COMPLETED|Overall Study||80
2518012|NCT00724308|6170419|P2|COMPLETED|Overall Study||210
2518013|NCT00724308|6170420|P1|COMPLETED|Overall Study||190
2518014|NCT00724308|6170419|P2|STARTED|Overall Study||307
2518015|NCT00724308|6170420|P1|STARTED|Overall Study||270
2518016|NCT00724282|6170426|P1|NOT COMPLETED|Overall Study||4
2518017|NCT00724282|6170426|P1|COMPLETED|Overall Study||16
2518018|NCT00724282|6170426|P1|STARTED|Overall Study||20
2518019|NCT00724243|6170430|P1|NOT COMPLETED|Overall Study||15
2518020|NCT00724243|6170430|P1|COMPLETED|Overall Study||18
2518021|NCT00724243|6170430|P1|STARTED|Overall Study||33
2518022|NCT00724152|6170440|P3|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
2518023|NCT00724152|6170441|P2|NOT COMPLETED|Three-arm Study Period (+Standard Care)||2
2518024|NCT00724152|6170442|P1|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
2518025|NCT00724152|6170440|P3|COMPLETED|Three-arm Study Period (+Standard Care)||1
2518026|NCT00724152|6170441|P2|COMPLETED|Three-arm Study Period (+Standard Care)||0
2518027|NCT00724152|6170442|P1|COMPLETED|Three-arm Study Period (+Standard Care)||3
2518028|NCT00724152|6170440|P3|STARTED|Three-arm Study Period (+Standard Care)|3-group randomization began|2
2518029|NCT00724152|6170441|P2|STARTED|Three-arm Study Period (+Standard Care)||2
2518030|NCT00724152|6170442|P1|STARTED|Three-arm Study Period (+Standard Care)||4
2518031|NCT00724152|6170440|P3|NOT COMPLETED|Two-arm Study Period||0
2518032|NCT00724152|6170441|P2|NOT COMPLETED|Two-arm Study Period||2
2518033|NCT00724152|6170442|P1|NOT COMPLETED|Two-arm Study Period||3
2518034|NCT00724152|6170440|P3|COMPLETED|Two-arm Study Period||0
2518035|NCT00724152|6170441|P2|COMPLETED|Two-arm Study Period||9
2518036|NCT00724152|6170442|P1|COMPLETED|Two-arm Study Period||11
2518037|NCT00724152|6170440|P3|STARTED|Two-arm Study Period|Standard Care arm was added later (Period 2)|0
2518038|NCT00724152|6170441|P2|STARTED|Two-arm Study Period||11
2518039|NCT00724152|6170442|P1|STARTED|Two-arm Study Period||14
2518040|NCT00724126|6170459|P2|NOT COMPLETED|Overall Study||15
2518041|NCT00724126|6170460|P1|NOT COMPLETED|Overall Study||19
2518042|NCT00724126|6170459|P2|COMPLETED|Overall Study||301
2518043|NCT00724126|6170460|P1|COMPLETED|Overall Study||302
2518044|NCT00724126|6170459|P2|STARTED|Overall Study||316
2518045|NCT00724126|6170460|P1|STARTED|Overall Study||321
2518046|NCT00724061|6170468|P1|NOT COMPLETED|Maintenance Therapy||0
2518047|NCT00724061|6170468|P1|COMPLETED|Maintenance Therapy||2
2518048|NCT00724061|6170468|P1|STARTED|Maintenance Therapy||2
2518049|NCT00724061|6170468|P1|NOT COMPLETED|Dose Escalation Phase||5
2518050|NCT00724061|6170468|P1|COMPLETED|Dose Escalation Phase||2
2518051|NCT00724061|6170468|P1|STARTED|Dose Escalation Phase||7
2518052|NCT00724009|6170475|P1|NOT COMPLETED|Overall Study||0
2518053|NCT00724009|6170475|P1|COMPLETED|Overall Study|One patient underwent conditioning but died 1 day before stem cell infusion due to sepsis.|29
2518054|NCT00724009|6170475|P1|STARTED|Overall Study||29
2518055|NCT00723957|6170488|P2|NOT COMPLETED|Overall Study||53
2518056|NCT00723957|6170489|P1|NOT COMPLETED|Overall Study||51
2518057|NCT00723957|6170488|P2|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|46
2518058|NCT00723957|6170489|P1|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|47
2518059|NCT00723957|6170488|P2|STARTED|Overall Study|Randomized|99
2518060|NCT00723957|6170489|P1|STARTED|Overall Study|Randomized|98
2518061|NCT00723944|6170513|P2|NOT COMPLETED|Two Year Post Placement Follow-up||0
2518062|NCT00723944|6170514|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
2518063|NCT00723944|6170513|P2|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 108|37
2518064|NCT00723944|6170514|P1|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 130|48
2518065|NCT00723944|6170513|P2|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 108|37
2518066|NCT00723944|6170514|P1|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 130|48
2518067|NCT00723944|6170513|P2|NOT COMPLETED|One Year Post Placement Follow-up||4
2518068|NCT00723944|6170514|P1|NOT COMPLETED|One Year Post Placement Follow-up||1
2518069|NCT00723944|6170513|P2|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 108|37
2518070|NCT00723944|6170514|P1|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 130|48
2518071|NCT00723944|6170513|P2|STARTED|One Year Post Placement Follow-up|number of individual implant units is 112|41
2518072|NCT00723944|6170514|P1|STARTED|One Year Post Placement Follow-up|number of individual implant units is 134|49
2518238|NCT00723255|6170896|P1|STARTED|Overall Study||53
2518073|NCT00723944|6170513|P2|NOT COMPLETED|Permanent Prosthesis Placement||9
2518074|NCT00723944|6170514|P1|NOT COMPLETED|Permanent Prosthesis Placement||3
2518075|NCT00723944|6170513|P2|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 112|41
2518076|NCT00723944|6170514|P1|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 134|49
2518077|NCT00723944|6170513|P2|STARTED|Permanent Prosthesis Placement|number of individual implant units is 138|50
2518078|NCT00723944|6170514|P1|STARTED|Permanent Prosthesis Placement|number of individual implant units is 148|52
2518079|NCT00723944|6170513|P2|NOT COMPLETED|Implant Placement Surgery||0
2518080|NCT00723944|6170514|P1|NOT COMPLETED|Implant Placement Surgery||0
2518081|NCT00723944|6170513|P2|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 138|50
2518082|NCT00723944|6170514|P1|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 148|52
2518083|NCT00723944|6170513|P2|STARTED|Implant Placement Surgery|number of individual implant units is 138|50
2518084|NCT00723944|6170514|P1|STARTED|Implant Placement Surgery|number of individual implant units is 148|52
2518085|NCT00723931|6170520|P1|NOT COMPLETED|Overall Study||0
2518086|NCT00723931|6170520|P1|COMPLETED|Overall Study||1267
2518087|NCT00723931|6170520|P1|STARTED|Overall Study||1267
2518088|NCT00723892|6170527|P2|NOT COMPLETED|Overall Study||87
2518089|NCT00723892|6170528|P1|NOT COMPLETED|Overall Study||107
2518090|NCT00723892|6170527|P2|COMPLETED|Overall Study||168
2518091|NCT00723892|6170528|P1|COMPLETED|Overall Study||206
2518092|NCT00723892|6170527|P2|STARTED|Overall Study||255
2518093|NCT00723892|6170528|P1|STARTED|Overall Study||313
2518094|NCT00723840|6170535|P1|NOT COMPLETED|Overall Study||82
2518095|NCT00723840|6170535|P1|COMPLETED|Overall Study||163
2518096|NCT00723840|6170535|P1|STARTED|Overall Study||245
2518097|NCT00723827|6170546|P1|NOT COMPLETED|Overall Study||0
2518098|NCT00723827|6170546|P1|COMPLETED|Overall Study||682
2518099|NCT00723827|6170546|P1|STARTED|Overall Study||682
2518100|NCT00723801|6170556|P2|NOT COMPLETED|Overall Study||3
2518101|NCT00723801|6170557|P1|NOT COMPLETED|Overall Study||3
2518102|NCT00723801|6170556|P2|COMPLETED|Overall Study||17
2518103|NCT00723801|6170557|P1|COMPLETED|Overall Study||17
2518104|NCT00723801|6170556|P2|STARTED|Overall Study||20
2518105|NCT00723801|6170557|P1|STARTED|Overall Study||20
2518106|NCT00723788|6170565|P1|NOT COMPLETED|Overall Study||0
2518107|NCT00723788|6170565|P1|COMPLETED|Overall Study||21
2518108|NCT00723788|6170565|P1|STARTED|Overall Study||21
2518109|NCT00723749|6170571|P1|NOT COMPLETED|Overall Study||163
2518110|NCT00723749|6170571|P1|COMPLETED|Overall Study||182
2518111|NCT00723749|6170571|P1|STARTED|Overall Study|384 patients were enrolled, 36 non-eligible datasets were excluded from analysis|345
2518112|NCT00723736|6170578|P1|NOT COMPLETED|Overall Study||1
2518113|NCT00723736|6170578|P1|COMPLETED|Overall Study|Subject's caregiver did not wish to continue, reasons unrelated.|99
2518114|NCT00723736|6170578|P1|STARTED|Overall Study||100
2518115|NCT00723710|6170582|P1|NOT COMPLETED|Overall Study||174
2518116|NCT00723710|6170582|P1|COMPLETED|Overall Study||120
2518117|NCT00723710|6170582|P1|STARTED|Overall Study||294
2518118|NCT00723697|6170586|P1|NOT COMPLETED|Overall Study||18
2518119|NCT00723697|6170586|P1|COMPLETED|Overall Study||1289
2518120|NCT00723697|6170586|P1|STARTED|Overall Study||1307
2518121|NCT00723645|6170594|P1|NOT COMPLETED|Visit 3 (Week 72 Post-treatment)||0
2518122|NCT00723645|6170594|P1|COMPLETED|Visit 3 (Week 72 Post-treatment)||187
2518123|NCT00723645|6170594|P1|STARTED|Visit 3 (Week 72 Post-treatment)|61 discontinued before V3; 26 lost to followup, 34 HCV RNA+ at Wk 24,1 death,1 HCV RNA not available|187
2518124|NCT00723645|6170594|P1|NOT COMPLETED|Visit 2 (Week 24 Post-treatment)||0
2518125|NCT00723645|6170594|P1|COMPLETED|Visit 2 (Week 24 Post-treatment)||248
2518126|NCT00723645|6170594|P1|STARTED|Visit 2 (Week 24 Post-treatment)|10 discontinued before Visit 2; 7 lost to follow-up and 3 were HCV RNA+ before Wk 24|248
2518127|NCT00723645|6170594|P1|NOT COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||0
2518128|NCT00723645|6170594|P1|COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||258
2518129|NCT00723645|6170594|P1|STARTED|Visit 1 (≤4 Weeks Post-treatment)||258
2518130|NCT00723632|6170599|P1|NOT COMPLETED|Overall Study||203
2518131|NCT00723632|6170599|P1|COMPLETED|Overall Study|Completed initial exam form and >= 1 follow up visit form; end of treatment and SVR status recorded|698
2518132|NCT00723632|6170599|P1|STARTED|Overall Study||901
2518133|NCT00723606|6170607|P2|NOT COMPLETED|Overall Study||7
2518134|NCT00723606|6170608|P1|NOT COMPLETED|Overall Study||4
2518135|NCT00723606|6170607|P2|COMPLETED|Overall Study||180
2518136|NCT00723606|6170608|P1|COMPLETED|Overall Study||185
2518137|NCT00723606|6170607|P2|STARTED|Overall Study||187
2518138|NCT00723606|6170608|P1|STARTED|Overall Study||189
2518139|NCT00723580|6170624|P1|NOT COMPLETED|Overall Study||0
2518140|NCT00723580|6170624|P1|COMPLETED|Overall Study|Completion of repeated Measurements|1
2518141|NCT00723580|6170624|P1|Baseline Measurements|Overall Study|Actigraphic, Psychometric and Observational Baseline Data Collected.|1
2518142|NCT00723580|6170624|P1|STARTED|Overall Study|Study was extended with continued repeated measurements.|1
2518143|NCT00723554|6170628|P1|NOT COMPLETED|Overall Study||29
2518144|NCT00723554|6170628|P1|COMPLETED|Overall Study||34
2518145|NCT00723554|6170628|P1|STARTED|Overall Study||63
2518146|NCT00723528|6170678|P7|NOT COMPLETED|Period 2: After Controlled Period||4
2518147|NCT00723528|6170679|P6|NOT COMPLETED|Period 2: After Controlled Period||6
2518148|NCT00723528|6170680|P5|NOT COMPLETED|Period 2: After Controlled Period||2
2518149|NCT00723528|6170681|P4|NOT COMPLETED|Period 2: After Controlled Period||1
2518150|NCT00723528|6170682|P3|NOT COMPLETED|Period 2: After Controlled Period||0
2518151|NCT00723528|6170683|P2|NOT COMPLETED|Period 2: After Controlled Period||0
2518152|NCT00723528|6170684|P1|NOT COMPLETED|Period 2: After Controlled Period||0
2518153|NCT00723528|6170678|P7|COMPLETED|Period 2: After Controlled Period||54
2518154|NCT00723528|6170679|P6|COMPLETED|Period 2: After Controlled Period||58
2518155|NCT00723528|6170680|P5|COMPLETED|Period 2: After Controlled Period||11
2518156|NCT00723528|6170681|P4|COMPLETED|Period 2: After Controlled Period||14
2518157|NCT00723528|6170682|P3|COMPLETED|Period 2: After Controlled Period||0
2518158|NCT00723528|6170683|P2|COMPLETED|Period 2: After Controlled Period||0
2518159|NCT00723528|6170684|P1|COMPLETED|Period 2: After Controlled Period||0
2518160|NCT00723528|6170678|P7|STARTED|Period 2: After Controlled Period||58
2518161|NCT00723528|6170679|P6|STARTED|Period 2: After Controlled Period||64
2518162|NCT00723528|6170680|P5|STARTED|Period 2: After Controlled Period||13
2518163|NCT00723528|6170681|P4|STARTED|Period 2: After Controlled Period||15
2518164|NCT00723528|6170682|P3|STARTED|Period 2: After Controlled Period||0
2518165|NCT00723528|6170683|P2|STARTED|Period 2: After Controlled Period||0
2518166|NCT00723528|6170684|P1|STARTED|Period 2: After Controlled Period||0
2518167|NCT00723528|6170678|P7|NOT COMPLETED|Period 1: Controlled Period (CP)||0
2518168|NCT00723528|6170679|P6|NOT COMPLETED|Period 1: Controlled Period (CP)||0
2518169|NCT00723528|6170680|P5|NOT COMPLETED|Period 1: Controlled Period (CP)||0
2518170|NCT00723528|6170681|P4|NOT COMPLETED|Period 1: Controlled Period (CP)||0
2518171|NCT00723528|6170682|P3|NOT COMPLETED|Period 1: Controlled Period (CP)||4
2518172|NCT00723528|6170683|P2|NOT COMPLETED|Period 1: Controlled Period (CP)||0
2518173|NCT00723528|6170684|P1|NOT COMPLETED|Period 1: Controlled Period (CP)||4
2518174|NCT00723528|6170678|P7|COMPLETED|Period 1: Controlled Period (CP)||0
2518175|NCT00723528|6170679|P6|COMPLETED|Period 1: Controlled Period (CP)||0
2518176|NCT00723528|6170680|P5|COMPLETED|Period 1: Controlled Period (CP)||0
2518177|NCT00723528|6170681|P4|COMPLETED|Period 1: Controlled Period (CP)||0
2518178|NCT00723528|6170682|P3|COMPLETED|Period 1: Controlled Period (CP)||58
2518179|NCT00723528|6170683|P2|COMPLETED|Period 1: Controlled Period (CP)||64
2518180|NCT00723528|6170684|P1|COMPLETED|Period 1: Controlled Period (CP)||28
2518181|NCT00723528|6170678|P7|STARTED|Period 1: Controlled Period (CP)||0
2518182|NCT00723528|6170679|P6|STARTED|Period 1: Controlled Period (CP)||0
2518183|NCT00723528|6170680|P5|STARTED|Period 1: Controlled Period (CP)||0
2518184|NCT00723528|6170681|P4|STARTED|Period 1: Controlled Period (CP)||0
2518185|NCT00723528|6170682|P3|STARTED|Period 1: Controlled Period (CP)||62
2518186|NCT00723528|6170683|P2|STARTED|Period 1: Controlled Period (CP)||64
2518187|NCT00723528|6170684|P1|STARTED|Period 1: Controlled Period (CP)||32
2518188|NCT00723489|6170746|P4|NOT COMPLETED|Overall Study||3
2518189|NCT00723489|6170747|P3|NOT COMPLETED|Overall Study||0
2518190|NCT00723489|6170748|P2|NOT COMPLETED|Overall Study||4
2518191|NCT00723489|6170749|P1|NOT COMPLETED|Overall Study||1
2518192|NCT00723489|6170746|P4|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
2518193|NCT00723489|6170747|P3|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|19
2518194|NCT00723489|6170748|P2|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|15
2518195|NCT00723489|6170749|P1|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
2518196|NCT00723489|6170746|P4|STARTED|Overall Study||23
2518197|NCT00723489|6170747|P3|STARTED|Overall Study||19
2518198|NCT00723489|6170748|P2|STARTED|Overall Study||19
2518199|NCT00723489|6170749|P1|STARTED|Overall Study||21
2518200|NCT00723450|6170777|P3|NOT COMPLETED|Randomized Phase||67
2518201|NCT00723450|6170778|P2|NOT COMPLETED|Randomized Phase||65
2518202|NCT00723450|6170779|P1|NOT COMPLETED|Randomized Phase||0
2518203|NCT00723450|6170777|P3|COMPLETED|Randomized Phase||20
2518204|NCT00723450|6170778|P2|COMPLETED|Randomized Phase||21
2518205|NCT00723450|6170779|P1|COMPLETED|Randomized Phase||0
2518206|NCT00723450|6170777|P3|STARTED|Randomized Phase||87
2518207|NCT00723450|6170778|P2|STARTED|Randomized Phase||86
2518208|NCT00723450|6170779|P1|STARTED|Randomized Phase||0
2518209|NCT00723450|6170777|P3|NOT COMPLETED|Open-Label Phase||0
2518210|NCT00723450|6170778|P2|NOT COMPLETED|Open-Label Phase||0
2518211|NCT00723450|6170779|P1|NOT COMPLETED|Open-Label Phase||125
2518212|NCT00723450|6170777|P3|COMPLETED|Open-Label Phase||0
2518213|NCT00723450|6170778|P2|COMPLETED|Open-Label Phase||0
2518214|NCT00723450|6170779|P1|COMPLETED|Open-Label Phase||173
2518215|NCT00723450|6170777|P3|STARTED|Open-Label Phase||0
2518216|NCT00723450|6170778|P2|STARTED|Open-Label Phase||0
2518217|NCT00723450|6170779|P1|STARTED|Open-Label Phase||298
2518218|NCT00723398|6170825|P5|NOT COMPLETED|Overall Study||9
2518219|NCT00723398|6170826|P4|NOT COMPLETED|Overall Study||5
2518220|NCT00723398|6170827|P3|NOT COMPLETED|Overall Study||17
2518221|NCT00723398|6170828|P2|NOT COMPLETED|Overall Study||15
2518222|NCT00723398|6170829|P1|NOT COMPLETED|Overall Study||6
2518223|NCT00723398|6170825|P5|COMPLETED|Overall Study||44
2518224|NCT00723398|6170826|P4|COMPLETED|Overall Study||49
2518225|NCT00723398|6170827|P3|COMPLETED|Overall Study||36
2518226|NCT00723398|6170828|P2|COMPLETED|Overall Study||38
2518227|NCT00723398|6170829|P1|COMPLETED|Overall Study||47
2518228|NCT00723398|6170825|P5|STARTED|Overall Study||53
2518229|NCT00723398|6170826|P4|STARTED|Overall Study||54
2518230|NCT00723398|6170827|P3|STARTED|Overall Study||53
2518231|NCT00723398|6170828|P2|STARTED|Overall Study||53
2518232|NCT00723398|6170829|P1|STARTED|Overall Study||53
2518233|NCT00723294|6170891|P1|NOT COMPLETED|Overall Study||13
2518234|NCT00723294|6170891|P1|COMPLETED|Overall Study||86
2518235|NCT00723294|6170891|P1|STARTED|Overall Study||99
2518236|NCT00723255|6170896|P1|NOT COMPLETED|Overall Study||4
2518237|NCT00723255|6170896|P1|COMPLETED|Overall Study|Eligible and treated patients|49
2518239|NCT00723229|6170923|P2|NOT COMPLETED|Second Intervention||0
2518240|NCT00723229|6170924|P1|NOT COMPLETED|Second Intervention||0
2518241|NCT00723229|6170923|P2|COMPLETED|Second Intervention||20
2518242|NCT00723229|6170924|P1|COMPLETED|Second Intervention||18
2518243|NCT00723229|6170923|P2|STARTED|Second Intervention||20
2518244|NCT00723229|6170924|P1|STARTED|Second Intervention||18
2518245|NCT00723229|6170923|P2|NOT COMPLETED|First Intervention||3
2518246|NCT00723229|6170924|P1|NOT COMPLETED|First Intervention||7
2518247|NCT00723229|6170923|P2|COMPLETED|First Intervention||20
2518248|NCT00723229|6170924|P1|COMPLETED|First Intervention||18
2518249|NCT00723229|6170923|P2|STARTED|First Intervention||23
2518250|NCT00723229|6170924|P1|STARTED|First Intervention||25
2518251|NCT00723203|6170936|P1|NOT COMPLETED|Overall Study||3
2518252|NCT00723203|6170936|P1|COMPLETED|Overall Study||13
2518253|NCT00723203|6170936|P1|STARTED|Overall Study||16
2518254|NCT00723190|6170940|P1|NOT COMPLETED|Overall Study||142
2518255|NCT00723190|6170940|P1|COMPLETED|Overall Study|53 participants completed 6-month protocol and 108 participants completed 12-month protocol|161
2518256|NCT00723190|6170940|P1|SAFETY POPULATION|Overall Study||301
2518257|NCT00723190|6170940|P1|STARTED|Overall Study|Study CLON-301 (168 participants) and Study CLON-302 (135 participants)|303
2518258|NCT00723177|6170958|P3|NOT COMPLETED|Overall Study||5
2518259|NCT00723177|6170959|P2|NOT COMPLETED|Overall Study||4
2518260|NCT00723177|6170960|P1|NOT COMPLETED|Overall Study||5
2518261|NCT00723177|6170958|P3|COMPLETED|Overall Study||10
2518262|NCT00723177|6170959|P2|COMPLETED|Overall Study||10
2518263|NCT00723177|6170960|P1|COMPLETED|Overall Study||10
2518264|NCT00723177|6170958|P3|STARTED|Overall Study||15
2518265|NCT00723177|6170959|P2|STARTED|Overall Study||14
2518266|NCT00723177|6170960|P1|STARTED|Overall Study||15
2518267|NCT00723125|6170973|P2|NOT COMPLETED|Overall Study||6
2518268|NCT00723125|6170974|P1|NOT COMPLETED|Overall Study||18
2518269|NCT00723125|6170973|P2|COMPLETED|Overall Study||21
2518270|NCT00723125|6170974|P1|COMPLETED|Overall Study||15
2518271|NCT00723125|6170973|P2|STARTED|Overall Study|27 evaluable Neo-adjuvant Of 27 patients neo-adjuvant, 24 DDAC Of 24 DDAC, 21 Avastin post-op|27
2518272|NCT00723125|6170974|P1|STARTED|Overall Study|33 pts Neo-adjuvant, 28 evaluable,DDAC: Of 28 pts,27 treated DDAC Avastin:Of 27,15 Avastin post-op|33
2518273|NCT00723099|6170984|P1|NOT COMPLETED|Overall Study||1
2518274|NCT00723099|6170984|P1|COMPLETED|Overall Study||72
2518275|NCT00723099|6170984|P1|STARTED|Overall Study||73
2518276|NCT00723073|6170998|P2|NOT COMPLETED|Overall Study||0
2518277|NCT00723073|6170999|P1|NOT COMPLETED|Overall Study||0
2518278|NCT00723073|6170998|P2|COMPLETED|Overall Study||174
2518279|NCT00723073|6170999|P1|COMPLETED|Overall Study||149
2518280|NCT00723073|6170998|P2|STARTED|Overall Study||174
2518281|NCT00723073|6170999|P1|STARTED|Overall Study||149
2518282|NCT00723021|6171023|P5|NOT COMPLETED|Intervention Period 5||0
2518283|NCT00723021|6171024|P4|NOT COMPLETED|Intervention Period 5||0
2518284|NCT00723021|6171025|P3|NOT COMPLETED|Intervention Period 5||0
2518285|NCT00723021|6171026|P2|NOT COMPLETED|Intervention Period 5||0
2518286|NCT00723021|6171027|P1|NOT COMPLETED|Intervention Period 5||0
2518287|NCT00723021|6171023|P5|COMPLETED|Intervention Period 5||2
2518288|NCT00723021|6171024|P4|COMPLETED|Intervention Period 5||3
2518289|NCT00723021|6171025|P3|COMPLETED|Intervention Period 5||3
2518290|NCT00723021|6171026|P2|COMPLETED|Intervention Period 5||3
2518291|NCT00723021|6171027|P1|COMPLETED|Intervention Period 5||3
2518292|NCT00723021|6171023|P5|STARTED|Intervention Period 5||2
2518293|NCT00723021|6171024|P4|STARTED|Intervention Period 5||3
2518294|NCT00723021|6171025|P3|STARTED|Intervention Period 5||3
2518295|NCT00723021|6171026|P2|STARTED|Intervention Period 5||3
2518296|NCT00723021|6171027|P1|STARTED|Intervention Period 5||3
2518297|NCT00723021|6171023|P5|NOT COMPLETED|Intervention Period 4||1
2518298|NCT00723021|6171024|P4|NOT COMPLETED|Intervention Period 4||0
2518299|NCT00723021|6171025|P3|NOT COMPLETED|Intervention Period 4||0
2518300|NCT00723021|6171026|P2|NOT COMPLETED|Intervention Period 4||0
2518301|NCT00723021|6171027|P1|NOT COMPLETED|Intervention Period 4||0
2518302|NCT00723021|6171023|P5|COMPLETED|Intervention Period 4||2
2518303|NCT00723021|6171024|P4|COMPLETED|Intervention Period 4||3
2518304|NCT00723021|6171025|P3|COMPLETED|Intervention Period 4||3
2518305|NCT00723021|6171026|P2|COMPLETED|Intervention Period 4||3
2518306|NCT00723021|6171027|P1|COMPLETED|Intervention Period 4||3
2518307|NCT00723021|6171023|P5|STARTED|Intervention Period 4||3
2518308|NCT00723021|6171024|P4|STARTED|Intervention Period 4||3
2518309|NCT00723021|6171025|P3|STARTED|Intervention Period 4||3
2518310|NCT00723021|6171026|P2|STARTED|Intervention Period 4||3
2518311|NCT00723021|6171027|P1|STARTED|Intervention Period 4||3
2518312|NCT00723021|6171023|P5|NOT COMPLETED|Intervention Period 3||0
2518313|NCT00723021|6171024|P4|NOT COMPLETED|Intervention Period 3||0
2518314|NCT00723021|6171025|P3|NOT COMPLETED|Intervention Period 3||0
2518315|NCT00723021|6171026|P2|NOT COMPLETED|Intervention Period 3||0
2518316|NCT00723021|6171027|P1|NOT COMPLETED|Intervention Period 3||0
2518317|NCT00723021|6171023|P5|COMPLETED|Intervention Period 3||3
2518318|NCT00723021|6171024|P4|COMPLETED|Intervention Period 3||3
2518319|NCT00723021|6171025|P3|COMPLETED|Intervention Period 3||3
2518320|NCT00723021|6171026|P2|COMPLETED|Intervention Period 3||3
2518321|NCT00723021|6171027|P1|COMPLETED|Intervention Period 3||3
2518322|NCT00723021|6171023|P5|STARTED|Intervention Period 3||3
2518323|NCT00723021|6171024|P4|STARTED|Intervention Period 3||3
2518324|NCT00723021|6171025|P3|STARTED|Intervention Period 3||3
2518325|NCT00723021|6171026|P2|STARTED|Intervention Period 3||3
2518326|NCT00723021|6171027|P1|STARTED|Intervention Period 3||3
2518327|NCT00723021|6171023|P5|NOT COMPLETED|Intervention Period 2||0
2518328|NCT00723021|6171024|P4|NOT COMPLETED|Intervention Period 2||0
2518329|NCT00723021|6171025|P3|NOT COMPLETED|Intervention Period 2||0
2518330|NCT00723021|6171026|P2|NOT COMPLETED|Intervention Period 2||0
2518331|NCT00723021|6171027|P1|NOT COMPLETED|Intervention Period 2||0
2518332|NCT00723021|6171023|P5|COMPLETED|Intervention Period 2||3
2518333|NCT00723021|6171024|P4|COMPLETED|Intervention Period 2||3
2518334|NCT00723021|6171025|P3|COMPLETED|Intervention Period 2||3
2518335|NCT00723021|6171026|P2|COMPLETED|Intervention Period 2||3
2518336|NCT00723021|6171027|P1|COMPLETED|Intervention Period 2||3
2518337|NCT00723021|6171023|P5|STARTED|Intervention Period 2||3
2518338|NCT00723021|6171024|P4|STARTED|Intervention Period 2||3
2518339|NCT00723021|6171025|P3|STARTED|Intervention Period 2||3
2518340|NCT00723021|6171026|P2|STARTED|Intervention Period 2||3
2518341|NCT00723021|6171027|P1|STARTED|Intervention Period 2||3
2518342|NCT00723021|6171023|P5|NOT COMPLETED|Intervention Period 1||0
2518343|NCT00723021|6171024|P4|NOT COMPLETED|Intervention Period 1||0
2518344|NCT00723021|6171025|P3|NOT COMPLETED|Intervention Period 1||0
2518345|NCT00723021|6171026|P2|NOT COMPLETED|Intervention Period 1||0
2518346|NCT00723021|6171027|P1|NOT COMPLETED|Intervention Period 1||0
2518347|NCT00723021|6171023|P5|COMPLETED|Intervention Period 1||3
2518348|NCT00723021|6171024|P4|COMPLETED|Intervention Period 1||3
2518349|NCT00723021|6171025|P3|COMPLETED|Intervention Period 1||3
2518350|NCT00723021|6171026|P2|COMPLETED|Intervention Period 1||3
2518351|NCT00723021|6171027|P1|COMPLETED|Intervention Period 1||3
2518352|NCT00723021|6171023|P5|STARTED|Intervention Period 1||3
2518353|NCT00723021|6171024|P4|STARTED|Intervention Period 1||3
2518354|NCT00723021|6171025|P3|STARTED|Intervention Period 1||3
2518355|NCT00723021|6171026|P2|STARTED|Intervention Period 1||3
2518356|NCT00723021|6171027|P1|STARTED|Intervention Period 1||3
2518357|NCT00723008|6171081|P2|NOT COMPLETED|4-Week Unblinded Treatment||1
2518358|NCT00723008|6171082|P1|NOT COMPLETED|4-Week Unblinded Treatment||1
2518359|NCT00723008|6171081|P2|COMPLETED|4-Week Unblinded Treatment||3
2518360|NCT00723008|6171082|P1|COMPLETED|4-Week Unblinded Treatment||4
2518361|NCT00723008|6171081|P2|STARTED|4-Week Unblinded Treatment||4
2518362|NCT00723008|6171082|P1|STARTED|4-Week Unblinded Treatment||5
2518363|NCT00723008|6171081|P2|NOT COMPLETED|4-Week Double Blinded||5
2518364|NCT00723008|6171082|P1|NOT COMPLETED|4-Week Double Blinded||5
2518365|NCT00723008|6171081|P2|COMPLETED|4-Week Double Blinded||4
2518366|NCT00723008|6171082|P1|COMPLETED|4-Week Double Blinded||5
2518367|NCT00723008|6171081|P2|STARTED|4-Week Double Blinded||9
2518368|NCT00723008|6171082|P1|STARTED|4-Week Double Blinded||10
2518369|NCT00723008|6171081|P2|NOT COMPLETED|Enrollment||0
2518370|NCT00723008|6171082|P1|NOT COMPLETED|Enrollment||1
2518371|NCT00723008|6171081|P2|COMPLETED|Enrollment||9
2518372|NCT00723008|6171082|P1|COMPLETED|Enrollment||10
2518373|NCT00723008|6171081|P2|STARTED|Enrollment||9
2518374|NCT00723008|6171082|P1|STARTED|Enrollment||11
2518375|NCT00722865|6171104|P1|NOT COMPLETED|Overall Study||2
2518376|NCT00722865|6171104|P1|COMPLETED|Overall Study||23
2518377|NCT00722865|6171104|P1|STARTED|Overall Study||25
2518378|NCT00722800|6171114|P2|NOT COMPLETED|Overall Study||0
2518379|NCT00722800|6171115|P1|NOT COMPLETED|Overall Study||2
2518380|NCT00722800|6171114|P2|COMPLETED|Overall Study||2
2518381|NCT00722800|6171115|P1|COMPLETED|Overall Study||0
2518382|NCT00722800|6171114|P2|STARTED|Overall Study||2
2518383|NCT00722800|6171115|P1|STARTED|Overall Study||2
2518384|NCT00722761|6171127|P2|NOT COMPLETED|Overall Study||6
2518385|NCT00722761|6171128|P1|NOT COMPLETED|Overall Study||6
2518386|NCT00722761|6171127|P2|COMPLETED|Overall Study||8
2518387|NCT00722761|6171128|P1|COMPLETED|Overall Study||10
2518388|NCT00722761|6171127|P2|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||10
2518389|NCT00722761|6171128|P1|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||15
2518390|NCT00722761|6171127|P2|STARTED|Overall Study||14
2518391|NCT00722761|6171128|P1|STARTED|Overall Study||16
2518392|NCT00722722|6171139|P3|NOT COMPLETED|Overall Study||0
2518393|NCT00722722|6171140|P2|NOT COMPLETED|Overall Study||0
2518394|NCT00722722|6171141|P1|NOT COMPLETED|Overall Study||0
2518395|NCT00722722|6171139|P3|COMPLETED|Overall Study||10
2518396|NCT00722722|6171140|P2|COMPLETED|Overall Study||5
2518397|NCT00722722|6171141|P1|COMPLETED|Overall Study||3
2518398|NCT00722722|6171139|P3|STARTED|Overall Study||10
2518399|NCT00722722|6171140|P2|STARTED|Overall Study||5
2518400|NCT00722722|6171141|P1|STARTED|Overall Study||3
2518401|NCT00722566|6171151|P2|NOT COMPLETED|Overall Study||35
2518402|NCT00722566|6171152|P1|NOT COMPLETED|Overall Study||67
2518403|NCT00722566|6171151|P2|COMPLETED|Overall Study|Completed 8 cycles|39
2518404|NCT00722566|6171152|P1|COMPLETED|Overall Study|Completed 8 cycles|81
2518405|NCT00722566|6171151|P2|STARTED|Overall Study||74
2518406|NCT00722566|6171152|P1|STARTED|Overall Study|One patient randomized and not dosed|148
2518407|NCT00722553|6171160|P1|NOT COMPLETED|Overall Study||0
2518408|NCT00722553|6171160|P1|COMPLETED|Overall Study||30
2518409|NCT00722553|6171160|P1|STARTED|Overall Study||30
2518410|NCT00722436|6171170|P2|NOT COMPLETED|Overall Study||0
2518411|NCT00722436|6171171|P1|NOT COMPLETED|Overall Study||0
2518412|NCT00722436|6171170|P2|COMPLETED|Overall Study||11
2518413|NCT00722436|6171171|P1|COMPLETED|Overall Study||9
2518414|NCT00722436|6171170|P2|STARTED|Overall Study||11
2518415|NCT00722436|6171171|P1|STARTED|Overall Study||9
2518416|NCT00722423|6171185|P2|NOT COMPLETED|Overall Study||1
2518417|NCT00722423|6171186|P1|NOT COMPLETED|Overall Study||0
2518418|NCT00722423|6171185|P2|COMPLETED|Overall Study||181
2518419|NCT00722423|6171186|P1|COMPLETED|Overall Study||182
2518420|NCT00722423|6171185|P2|STARTED|Overall Study||182
2518421|NCT00722423|6171186|P1|STARTED|Overall Study||182
2518422|NCT00722371|6171201|P7|NOT COMPLETED|Overall Study||51
2518423|NCT00722371|6171202|P6|NOT COMPLETED|Overall Study||53
2518424|NCT00722371|6171203|P5|NOT COMPLETED|Overall Study||48
2518425|NCT00722371|6171204|P4|NOT COMPLETED|Overall Study||63
2518426|NCT00722371|6171205|P3|NOT COMPLETED|Overall Study||65
2518427|NCT00722371|6171206|P2|NOT COMPLETED|Overall Study||72
2518428|NCT00722371|6171207|P1|NOT COMPLETED|Overall Study||56
2518429|NCT00722371|6171201|P7|COMPLETED|Overall Study||179
2518430|NCT00722371|6171202|P6|COMPLETED|Overall Study||178
2518431|NCT00722371|6171203|P5|COMPLETED|Overall Study||182
2518432|NCT00722371|6171204|P4|COMPLETED|Overall Study||167
2518433|NCT00722371|6171205|P3|COMPLETED|Overall Study||168
2518434|NCT00722371|6171206|P2|COMPLETED|Overall Study||158
2518435|NCT00722371|6171207|P1|COMPLETED|Overall Study||175
2518436|NCT00722371|6171201|P7|STARTED|Overall Study||230
2518437|NCT00722371|6171202|P6|STARTED|Overall Study||231
2518438|NCT00722371|6171203|P5|STARTED|Overall Study||230
2518439|NCT00722371|6171204|P4|STARTED|Overall Study||230
2518440|NCT00722371|6171205|P3|STARTED|Overall Study||233
2518441|NCT00722371|6171206|P2|STARTED|Overall Study||230
2518442|NCT00722371|6171207|P1|STARTED|Overall Study||231
2518443|NCT00722137|6171260|P2|NOT COMPLETED|Overall Study||48
2518444|NCT00722137|6171261|P1|NOT COMPLETED|Overall Study||45
2518445|NCT00722137|6171260|P2|COMPLETED|Overall Study||195
2518446|NCT00722137|6171261|P1|COMPLETED|Overall Study||199
2518447|NCT00722137|6171260|P2|STARTED|Overall Study||243
2518448|NCT00722137|6171261|P1|STARTED|Overall Study||244
2518449|NCT00722124|6171290|P3|NOT COMPLETED|Overall Study||20
2518450|NCT00722124|6171291|P2|NOT COMPLETED|Overall Study||14
2518451|NCT00722124|6171292|P1|NOT COMPLETED|Overall Study||17
2518452|NCT00722124|6171290|P3|COMPLETED|Overall Study||20
2518453|NCT00722124|6171291|P2|COMPLETED|Overall Study||26
2518454|NCT00722124|6171292|P1|COMPLETED|Overall Study||23
2518455|NCT00722124|6171290|P3|STARTED|Overall Study||40
2518456|NCT00722124|6171291|P2|STARTED|Overall Study||40
2518457|NCT00722124|6171292|P1|STARTED|Overall Study||40
2518458|NCT00722111|6171302|P2|NOT COMPLETED|Overall Study||0
2518459|NCT00722111|6171303|P1|NOT COMPLETED|Overall Study||0
2518460|NCT00722111|6171302|P2|COMPLETED|Overall Study||72
2518461|NCT00722111|6171303|P1|COMPLETED|Overall Study||11
2518462|NCT00722111|6171302|P2|STARTED|Overall Study||72
2518463|NCT00722111|6171303|P1|STARTED|Overall Study||11
2518464|NCT00722072|6171310|P1|NOT COMPLETED|Overall Study||3
2518465|NCT00722072|6171310|P1|COMPLETED|Overall Study||9
2518466|NCT00722072|6171310|P1|STARTED|Overall Study||12
2518467|NCT00722020|6171320|P2|NOT COMPLETED|Overall Study||0
2518468|NCT00722020|6171321|P1|NOT COMPLETED|Overall Study||0
2518469|NCT00722020|6171320|P2|COMPLETED|Overall Study||24
2518470|NCT00722020|6171321|P1|COMPLETED|Overall Study||19
2518471|NCT00722020|6171320|P2|STARTED|Overall Study||24
2518472|NCT00722020|6171321|P1|STARTED|Overall Study||19
2518473|NCT00722007|6171329|P1|NOT COMPLETED|Overall Study||30
2518474|NCT00722007|6171329|P1|COMPLETED|Overall Study||117
2518475|NCT00722007|6171329|P1|STARTED|Overall Study||147
2518476|NCT00721968|6171339|P2|NOT COMPLETED|Overall Study||0
2518477|NCT00721968|6171340|P1|NOT COMPLETED|Overall Study||2
2518478|NCT00721968|6171339|P2|COMPLETED|Overall Study||17
2518479|NCT00721968|6171340|P1|COMPLETED|Overall Study||25
2518480|NCT00721968|6171339|P2|STARTED|Overall Study||17
2518481|NCT00721968|6171340|P1|STARTED|Overall Study||27
2518482|NCT00721955|6171351|P3|NOT COMPLETED|Overall Study||2
2518483|NCT00721955|6171352|P2|NOT COMPLETED|Overall Study||0
2518484|NCT00721955|6171353|P1|NOT COMPLETED|Overall Study||0
2518485|NCT00721955|6171351|P3|COMPLETED|Overall Study||103
2518486|NCT00721955|6171352|P2|COMPLETED|Overall Study||104
2518487|NCT00721955|6171353|P1|COMPLETED|Overall Study||105
2518488|NCT00721955|6171351|P3|STARTED|Overall Study||105
2518489|NCT00721955|6171352|P2|STARTED|Overall Study||104
2518490|NCT00721955|6171353|P1|STARTED|Overall Study||105
2518491|NCT00721799|6171367|P1|NOT COMPLETED|Overall Study||8
2518492|NCT00721799|6171367|P1|COMPLETED|Overall Study||25
2518493|NCT00721799|6171367|P1|Received FLT PET Scan #2|Overall Study||25
2518494|NCT00721799|6171367|P1|Recieved FLT PET Scan 1|Overall Study||26
2518495|NCT00721799|6171367|P1|STARTED|Overall Study||33
2518496|NCT00721734|6171407|P5|NOT COMPLETED|Overall Study||6
2518497|NCT00721734|6171408|P4|NOT COMPLETED|Overall Study||6
2518498|NCT00721734|6171409|P3|NOT COMPLETED|Overall Study||8
2518499|NCT00721734|6171410|P2|NOT COMPLETED|Overall Study||12
2518500|NCT00721734|6171411|P1|NOT COMPLETED|Overall Study||8
2518501|NCT00721734|6171407|P5|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
2518502|NCT00721734|6171408|P4|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
2518503|NCT00721734|6171409|P3|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
2518504|NCT00721734|6171410|P2|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|0
2518505|NCT00721734|6171411|P1|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|4
2518506|NCT00721734|6171407|P5|STARTED|Overall Study||8
2518507|NCT00721734|6171408|P4|STARTED|Overall Study||8
2518508|NCT00721734|6171409|P3|STARTED|Overall Study||10
2518509|NCT00721734|6171410|P2|STARTED|Overall Study||12
2518510|NCT00721734|6171411|P1|STARTED|Overall Study||12
2518511|NCT00721630|6171523|P1|NOT COMPLETED|Overall Study||1
2518512|NCT00721630|6171523|P1|COMPLETED|Overall Study||23
2518513|NCT00721630|6171523|P1|STARTED|Overall Study||24
2518514|NCT00721617|6171528|P1|NOT COMPLETED|8 Hours Into Intralipid/Dextrose||0
2518515|NCT00721617|6171528|P1|COMPLETED|8 Hours Into Intralipid/Dextrose||12
2518516|NCT00721617|6171528|P1|STARTED|8 Hours Into Intralipid/Dextrose||12
2518517|NCT00721617|6171528|P1|NOT COMPLETED|4 Hours Into Intralipid/Dextrose||0
2518518|NCT00721617|6171528|P1|COMPLETED|4 Hours Into Intralipid/Dextrose||12
2518519|NCT00721617|6171528|P1|STARTED|4 Hours Into Intralipid/Dextrose||12
2518520|NCT00721617|6171528|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||0
2518521|NCT00721617|6171528|P1|COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||12
2518522|NCT00721617|6171528|P1|STARTED|0 Hour (Baseline) of Intralipid/Dextrose||12
2518523|NCT00721617|6171528|P1|NOT COMPLETED|8 Hours Into Dextrose Infusion||0
2518524|NCT00721617|6171528|P1|COMPLETED|8 Hours Into Dextrose Infusion||12
2518525|NCT00721617|6171528|P1|STARTED|8 Hours Into Dextrose Infusion||12
2518526|NCT00721617|6171528|P1|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
2518527|NCT00721617|6171528|P1|COMPLETED|4 Hours Into Dextrose Infusion||12
2518528|NCT00721617|6171528|P1|STARTED|4 Hours Into Dextrose Infusion||12
2518529|NCT00721617|6171528|P1|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
2518530|NCT00721617|6171528|P1|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
2518531|NCT00721617|6171528|P1|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
2518532|NCT00721617|6171528|P1|NOT COMPLETED|8 Hours Into Intralipid Infusion||0
2518533|NCT00721617|6171528|P1|COMPLETED|8 Hours Into Intralipid Infusion||12
2518534|NCT00721617|6171528|P1|STARTED|8 Hours Into Intralipid Infusion||12
2518535|NCT00721617|6171528|P1|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
2518536|NCT00721617|6171528|P1|COMPLETED|4 Hours Into Intralipid Infusion||12
2518537|NCT00721617|6171528|P1|STARTED|4 Hours Into Intralipid Infusion||12
2518538|NCT00721617|6171528|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
2518539|NCT00721617|6171528|P1|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
2518540|NCT00721617|6171528|P1|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
2518541|NCT00721617|6171528|P1|NOT COMPLETED|8 Hours Into Saline Infusion||0
2518542|NCT00721617|6171528|P1|COMPLETED|8 Hours Into Saline Infusion||12
2518543|NCT00721617|6171528|P1|STARTED|8 Hours Into Saline Infusion||12
2518544|NCT00721617|6171528|P1|NOT COMPLETED|4 Hours Into Saline Infusion||0
2518545|NCT00721617|6171528|P1|COMPLETED|4 Hours Into Saline Infusion||12
2518546|NCT00721617|6171528|P1|STARTED|4 Hours Into Saline Infusion||12
2518547|NCT00721617|6171528|P1|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
2518548|NCT00721617|6171528|P1|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
2518549|NCT00721617|6171528|P1|STARTED|0 Hour (Baseline) of Saline Infusion||12
2518550|NCT00721578|6171552|P2|NOT COMPLETED|Overall Study||2
2518551|NCT00721578|6171553|P1|NOT COMPLETED|Overall Study||2
2518552|NCT00721578|6171552|P2|COMPLETED|Overall Study||9
2518553|NCT00721578|6171553|P1|COMPLETED|Overall Study||10
2518554|NCT00721578|6171552|P2|STARTED|Overall Study||11
2518555|NCT00721578|6171553|P1|STARTED|Overall Study||12
2518556|NCT00721539|6171565|P1|NOT COMPLETED|Overall Study||0
2518557|NCT00721539|6171565|P1|COMPLETED|Overall Study||9
2518558|NCT00721539|6171565|P1|STARTED|Overall Study||9
2518559|NCT00721513|6171572|P1|NOT COMPLETED|Overall Study||0
2518560|NCT00721513|6171572|P1|COMPLETED|Overall Study||20
2518561|NCT00721513|6171572|P1|STARTED|Overall Study||20
2518562|NCT00721500|6171584|P4|NOT COMPLETED|Period Three||0
2518563|NCT00721500|6171585|P3|NOT COMPLETED|Period Three||0
2518564|NCT00721500|6171586|P2|NOT COMPLETED|Period Three||0
2518565|NCT00721500|6171587|P1|NOT COMPLETED|Period Three||0
2518566|NCT00721500|6171584|P4|COMPLETED|Period Three||6
2518567|NCT00721500|6171585|P3|COMPLETED|Period Three||6
2518568|NCT00721500|6171586|P2|COMPLETED|Period Three||7
2518569|NCT00721500|6171587|P1|COMPLETED|Period Three||6
2518570|NCT00721500|6171584|P4|STARTED|Period Three||6
2518571|NCT00721500|6171585|P3|STARTED|Period Three||6
2518572|NCT00721500|6171586|P2|STARTED|Period Three||7
2518573|NCT00721500|6171587|P1|STARTED|Period Three||6
2518574|NCT00721500|6171584|P4|NOT COMPLETED|Period Two||0
2518575|NCT00721500|6171585|P3|NOT COMPLETED|Period Two||0
2518576|NCT00721500|6171586|P2|NOT COMPLETED|Period Two||0
2518577|NCT00721500|6171587|P1|NOT COMPLETED|Period Two||0
2518578|NCT00721500|6171584|P4|COMPLETED|Period Two||6
2518579|NCT00721500|6171585|P3|COMPLETED|Period Two||6
2518580|NCT00721500|6171586|P2|COMPLETED|Period Two||7
2518581|NCT00721500|6171587|P1|COMPLETED|Period Two||6
2518582|NCT00721500|6171584|P4|STARTED|Period Two||6
2518583|NCT00721500|6171585|P3|STARTED|Period Two||6
2518584|NCT00721500|6171586|P2|STARTED|Period Two||7
2518585|NCT00721500|6171587|P1|STARTED|Period Two||6
2518586|NCT00721500|6171584|P4|NOT COMPLETED|Period One||0
2518587|NCT00721500|6171585|P3|NOT COMPLETED|Period One||0
2518588|NCT00721500|6171586|P2|NOT COMPLETED|Period One||0
2518589|NCT00721500|6171587|P1|NOT COMPLETED|Period One||0
2518590|NCT00721500|6171584|P4|COMPLETED|Period One||6
2518591|NCT00721500|6171585|P3|COMPLETED|Period One||6
2518592|NCT00721500|6171586|P2|COMPLETED|Period One||7
2518593|NCT00721500|6171587|P1|COMPLETED|Period One||6
2518594|NCT00721500|6171584|P4|STARTED|Period One||6
2518595|NCT00721500|6171585|P3|STARTED|Period One||6
2518596|NCT00721500|6171586|P2|STARTED|Period One||7
2518597|NCT00721500|6171587|P1|STARTED|Period One||6
2518598|NCT00721409|6171608|P3|NOT COMPLETED|Overall Study||79
2518599|NCT00721409|6171609|P2|NOT COMPLETED|Overall Study||82
2518600|NCT00721409|6171610|P1|NOT COMPLETED|Overall Study||12
2518601|NCT00721409|6171608|P3|COMPLETED|Overall Study||2
2518602|NCT00721409|6171609|P2|COMPLETED|Overall Study||2
2518603|NCT00721409|6171610|P1|COMPLETED|Overall Study||0
2518604|NCT00721409|6171608|P3|Treated|Overall Study||77
2518605|NCT00721409|6171609|P2|Treated|Overall Study||83
2518606|NCT00721409|6171610|P1|Treated|Overall Study||12
2518607|NCT00721409|6171608|P3|STARTED|Overall Study||81
2518608|NCT00721409|6171609|P2|STARTED|Overall Study||84
2518609|NCT00721409|6171610|P1|STARTED|Overall Study||12
2518610|NCT00721396|6171737|P4|NOT COMPLETED|Overall Study||10
2518611|NCT00721396|6171738|P3|NOT COMPLETED|Overall Study||10
2518612|NCT00721396|6171739|P2|NOT COMPLETED|Overall Study||36
2518613|NCT00721396|6171740|P1|NOT COMPLETED|Overall Study||30
2518614|NCT00721396|6171737|P4|COMPLETED|Overall Study||302
2518615|NCT00721396|6171738|P3|COMPLETED|Overall Study||308
2518616|NCT00721396|6171739|P2|COMPLETED|Overall Study||592
2518617|NCT00721396|6171740|P1|COMPLETED|Overall Study||597
2518618|NCT00721396|6171737|P4|STARTED|Overall Study||312
2518619|NCT00721396|6171738|P3|STARTED|Overall Study||318
2518620|NCT00721396|6171739|P2|STARTED|Overall Study||628
2518621|NCT00721396|6171740|P1|STARTED|Overall Study||627
2518622|NCT00721357|6171778|P2|NOT COMPLETED|Overall Study||0
2518623|NCT00721357|6171779|P1|NOT COMPLETED|Overall Study||0
2518624|NCT00721357|6171778|P2|COMPLETED|Overall Study||15
2518625|NCT00721357|6171779|P1|COMPLETED|Overall Study||15
2518626|NCT00721357|6171778|P2|STARTED|Overall Study||15
2518627|NCT00721357|6171779|P1|STARTED|Overall Study||15
2518628|NCT00721279|6171791|P2|NOT COMPLETED|Overall Study||24
2518629|NCT00721279|6171792|P1|NOT COMPLETED|Overall Study||36
2518630|NCT00721279|6171791|P2|COMPLETED|Overall Study||73
2518631|NCT00721279|6171792|P1|COMPLETED|Overall Study||416
2518632|NCT00721279|6171791|P2|STARTED|Overall Study||97
2518633|NCT00721279|6171792|P1|STARTED|Overall Study||452
2518634|NCT00721253|6171806|P3|NOT COMPLETED|Overall Study||0
2518635|NCT00721253|6171807|P2|NOT COMPLETED|Overall Study||0
2518636|NCT00721253|6171808|P1|NOT COMPLETED|Overall Study||0
2518637|NCT00721253|6171806|P3|COMPLETED|Overall Study||0
2518638|NCT00721253|6171807|P2|COMPLETED|Overall Study||22
2518639|NCT00721253|6171808|P1|COMPLETED|Overall Study||20
2518640|NCT00721253|6171806|P3|STARTED|Overall Study|There were no subjects that were implanted with the Tecnis lens.|0
2518641|NCT00721253|6171807|P2|STARTED|Overall Study||22
2518642|NCT00721253|6171808|P1|STARTED|Overall Study||20
2518643|NCT00721227|6171820|P2|NOT COMPLETED|Overall Study||0
2518644|NCT00721227|6171821|P1|NOT COMPLETED|Overall Study||4
2518645|NCT00721227|6171820|P2|COMPLETED|Overall Study||6
2518646|NCT00721227|6171821|P1|COMPLETED|Overall Study|3 subjects lost to follow up; 1 subject did not complete due to noncompliance of scheduled visits.|5
2518647|NCT00721227|6171820|P2|STARTED|Overall Study||6
2518648|NCT00721227|6171821|P1|STARTED|Overall Study||9
2518649|NCT00721214|6171831|P1|NOT COMPLETED|Overall Study||4
2518650|NCT00721214|6171831|P1|COMPLETED|Overall Study||12
2518651|NCT00721214|6171831|P1|STARTED|Overall Study||16
2518652|NCT00721188|6171842|P1|NOT COMPLETED|Overall Study||0
2518653|NCT00721188|6171842|P1|COMPLETED|Overall Study||11
2518654|NCT00721188|6171842|P1|STARTED|Overall Study||11
2518655|NCT00721175|6171859|P2|NOT COMPLETED|Overall Study||0
2518656|NCT00721175|6171860|P1|NOT COMPLETED|Overall Study||0
2518657|NCT00721175|6171859|P2|COMPLETED|Overall Study||54
2518658|NCT00721175|6171860|P1|COMPLETED|Overall Study||54
2518659|NCT00721175|6171859|P2|STARTED|Overall Study||54
2518660|NCT00721175|6171860|P1|STARTED|Overall Study||54
2518661|NCT00721162|6171872|P1|NOT COMPLETED|Overall Study||0
2518662|NCT00721162|6171872|P1|COMPLETED|Overall Study||60
2518663|NCT00721162|6171872|P1|Received Any Amount of Study Drug|Overall Study||60
2518664|NCT00721162|6171872|P1|STARTED|Overall Study||60
2518665|NCT00721149|6171881|P1|NOT COMPLETED|Overall Study||1
2518666|NCT00721149|6171881|P1|COMPLETED|Overall Study||9
2518667|NCT00721149|6171881|P1|STARTED|Overall Study|Enrollment was stopped after 10 subjects entered the trial.|10
2518668|NCT00721136|6171894|P4|NOT COMPLETED|Overall Study||0
2518669|NCT00721136|6171895|P3|NOT COMPLETED|Overall Study||0
2518670|NCT00721136|6171896|P2|NOT COMPLETED|Overall Study||0
2518671|NCT00721136|6171897|P1|NOT COMPLETED|Overall Study||0
2518672|NCT00721136|6171894|P4|COMPLETED|Overall Study||8
2518673|NCT00721136|6171895|P3|COMPLETED|Overall Study||8
2518674|NCT00721136|6171896|P2|COMPLETED|Overall Study||42
2518675|NCT00721136|6171897|P1|COMPLETED|Overall Study||42
2518676|NCT00721136|6171894|P4|STARTED|Overall Study||8
2518677|NCT00721136|6171895|P3|STARTED|Overall Study||8
2518678|NCT00721136|6171896|P2|STARTED|Overall Study||42
2518679|NCT00721136|6171897|P1|STARTED|Overall Study||42
2518680|NCT00721123|6171915|P1|NOT COMPLETED|Overall Study||183
2518681|NCT00721123|6171915|P1|COMPLETED|Overall Study||355
2518682|NCT00721123|6171915|P1|STARTED|Overall Study||538
2518683|NCT00721110|6171993|P4|NOT COMPLETED|Overall Study||0
2518684|NCT00721110|6171994|P3|NOT COMPLETED|Overall Study||1
2518685|NCT00721110|6171995|P2|NOT COMPLETED|Overall Study||0
2518686|NCT00721110|6171996|P1|NOT COMPLETED|Overall Study||1
2518687|NCT00721110|6171993|P4|COMPLETED|Overall Study||16
2518688|NCT00721110|6171994|P3|COMPLETED|Overall Study||15
2518689|NCT00721110|6171995|P2|COMPLETED|Overall Study||16
2518690|NCT00721110|6171996|P1|COMPLETED|Overall Study||15
2518691|NCT00721110|6171993|P4|STARTED|Overall Study||16
2518692|NCT00721110|6171994|P3|STARTED|Overall Study||16
2518693|NCT00721110|6171995|P2|STARTED|Overall Study||16
2518694|NCT00721110|6171996|P1|STARTED|Overall Study||16
2518703|NCT00720876|6172065|P1|NOT COMPLETED|Overall Study||2
2518704|NCT00720876|6172065|P1|COMPLETED|Overall Study||28
2518705|NCT00720876|6172065|P1|STARTED|Overall Study||30
2518706|NCT00720798|6172071|P1|NOT COMPLETED|Overall Study||756
2518707|NCT00720798|6172071|P1|COMPLETED|Overall Study||1311
2518708|NCT00720798|6172071|P1|STARTED|Overall Study||2067
2518709|NCT00720759|6172094|P4|NOT COMPLETED|Overall Study||0
2518710|NCT00720759|6172095|P3|NOT COMPLETED|Overall Study||1
2518711|NCT00720759|6172096|P2|NOT COMPLETED|Overall Study||1
2518712|NCT00720759|6172097|P1|NOT COMPLETED|Overall Study||0
2518713|NCT00720759|6172094|P4|COMPLETED|Overall Study||6
2518714|NCT00720759|6172095|P3|COMPLETED|Overall Study||5
2518715|NCT00720759|6172096|P2|COMPLETED|Overall Study||5
2518716|NCT00720759|6172097|P1|COMPLETED|Overall Study||6
2518717|NCT00720759|6172094|P4|STARTED|Overall Study||6
2518718|NCT00720759|6172095|P3|STARTED|Overall Study||6
2518719|NCT00720759|6172096|P2|STARTED|Overall Study||6
2518720|NCT00720759|6172097|P1|STARTED|Overall Study||6
2518721|NCT00720629|6172107|P1|NOT COMPLETED|Overall Study||0
2518722|NCT00720629|6172107|P1|COMPLETED|Overall Study||8
2518723|NCT00720629|6172107|P1|STARTED|Overall Study||8
2518724|NCT00720499|6172117|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||3
2518725|NCT00720499|6172118|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||2
2518726|NCT00720499|6172117|P2|COMPLETED|Treatment Period 2 (4 Weeks)||67
2518727|NCT00720499|6172118|P1|COMPLETED|Treatment Period 2 (4 Weeks)||64
2518728|NCT00720499|6172117|P2|STARTED|Treatment Period 2 (4 Weeks)||70
2518729|NCT00720499|6172118|P1|STARTED|Treatment Period 2 (4 Weeks)||66
2518730|NCT00720499|6172117|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
2518731|NCT00720499|6172118|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
2518732|NCT00720499|6172117|P2|COMPLETED|Washout Period (2 Weeks)||70
2518733|NCT00720499|6172118|P1|COMPLETED|Washout Period (2 Weeks)||66
2518734|NCT00720499|6172117|P2|STARTED|Washout Period (2 Weeks)||70
2518735|NCT00720499|6172118|P1|STARTED|Washout Period (2 Weeks)||66
2518736|NCT00720499|6172117|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||2
2518737|NCT00720499|6172118|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||3
2518738|NCT00720499|6172117|P2|COMPLETED|Treatment Period 1 (4 Weeks)||70
2518739|NCT00720499|6172118|P1|COMPLETED|Treatment Period 1 (4 Weeks)||66
2518740|NCT00720499|6172117|P2|STARTED|Treatment Period 1 (4 Weeks)||72
2518741|NCT00720499|6172118|P1|STARTED|Treatment Period 1 (4 Weeks)||69
2518742|NCT00720473|6172182|P2|NOT COMPLETED|Overall Study||8
2518743|NCT00720473|6172183|P1|NOT COMPLETED|Overall Study||30
2518744|NCT00720473|6172182|P2|COMPLETED|Overall Study||16
2518745|NCT00720473|6172183|P1|COMPLETED|Overall Study||15
2518746|NCT00720473|6172182|P2|STARTED|Overall Study||24
2518747|NCT00720473|6172183|P1|STARTED|Overall Study||45
2518748|NCT00720434|6172211|P4|NOT COMPLETED|Open-Label Period (Week 5-72)||4
2518749|NCT00720434|6172212|P3|NOT COMPLETED|Open-Label Period (Week 5-72)||4
2518750|NCT00720434|6172213|P2|NOT COMPLETED|Open-Label Period (Week 5-72)||3
2518751|NCT00720434|6172214|P1|NOT COMPLETED|Open-Label Period (Week 5-72)||6
2518752|NCT00720434|6172211|P4|COMPLETED|Open-Label Period (Week 5-72)||4
2518753|NCT00720434|6172212|P3|COMPLETED|Open-Label Period (Week 5-72)||4
2518754|NCT00720434|6172213|P2|COMPLETED|Open-Label Period (Week 5-72)||5
2518755|NCT00720434|6172214|P1|COMPLETED|Open-Label Period (Week 5-72)||4
2518756|NCT00720434|6172211|P4|STARTED|Open-Label Period (Week 5-72)||8
2518757|NCT00720434|6172212|P3|STARTED|Open-Label Period (Week 5-72)||8
2518758|NCT00720434|6172213|P2|STARTED|Open-Label Period (Week 5-72)||8
2518759|NCT00720434|6172214|P1|STARTED|Open-Label Period (Week 5-72)||10
2518760|NCT00720434|6172211|P4|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
2518761|NCT00720434|6172212|P3|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
2518762|NCT00720434|6172213|P2|NOT COMPLETED|Double-Blind Period (Week 1-4)||1
2518763|NCT00720434|6172214|P1|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
2518764|NCT00720434|6172211|P4|COMPLETED|Double-Blind Period (Week 1-4)||8
2518765|NCT00720434|6172212|P3|COMPLETED|Double-Blind Period (Week 1-4)||8
2518766|NCT00720434|6172213|P2|COMPLETED|Double-Blind Period (Week 1-4)||8
2518767|NCT00720434|6172214|P1|COMPLETED|Double-Blind Period (Week 1-4)||10
2518768|NCT00720434|6172211|P4|STARTED|Double-Blind Period (Week 1-4)||8
2518769|NCT00720434|6172212|P3|STARTED|Double-Blind Period (Week 1-4)||8
2518770|NCT00720434|6172213|P2|STARTED|Double-Blind Period (Week 1-4)||9
2518771|NCT00720434|6172214|P1|STARTED|Double-Blind Period (Week 1-4)||10
2518772|NCT00720382|6172238|P2|NOT COMPLETED|Overall Study||59
2518773|NCT00720382|6172239|P1|NOT COMPLETED|Overall Study||176
2518774|NCT00720382|6172238|P2|COMPLETED|Overall Study||178
2518775|NCT00720382|6172239|P1|COMPLETED|Overall Study||290
2518776|NCT00720382|6172238|P2|STARTED|Overall Study||237
2518777|NCT00720382|6172239|P1|STARTED|Overall Study||466
2518778|NCT00720369|6172249|P2|NOT COMPLETED|Overall Study||0
2518779|NCT00720369|6172250|P1|NOT COMPLETED|Overall Study||1
2518780|NCT00720369|6172249|P2|COMPLETED|Overall Study||8
2518781|NCT00720369|6172250|P1|COMPLETED|Overall Study|one subject discontinued due to an adverse event.|10
2518782|NCT00720369|6172249|P2|STARTED|Overall Study||8
2518783|NCT00720369|6172250|P1|STARTED|Overall Study||11
2518784|NCT00720356|6172258|P1|NOT COMPLETED|Follow up Until Death||5
2518785|NCT00720356|6172258|P1|COMPLETED|Follow up Until Death||43
2518786|NCT00720356|6172258|P1|STARTED|Follow up Until Death|All patients that are treated on study go into the follow up period|48
2518787|NCT00720356|6172258|P1|NOT COMPLETED|Went on to be Treated Cycle 3||2
2518788|NCT00720356|6172258|P1|COMPLETED|Went on to be Treated Cycle 3||44
2518789|NCT00720356|6172258|P1|STARTED|Went on to be Treated Cycle 3||46
2518790|NCT00720356|6172258|P1|NOT COMPLETED|Reached 1st Response/2 Cycles||2
2518791|NCT00720356|6172258|P1|COMPLETED|Reached 1st Response/2 Cycles||46
2518792|NCT00720356|6172258|P1|STARTED|Reached 1st Response/2 Cycles||48
2518793|NCT00720356|6172258|P1|NOT COMPLETED|Registration to Study||67
2518794|NCT00720356|6172258|P1|COMPLETED|Registration to Study||48
2518795|NCT00720356|6172258|P1|Completed Registration Step 2|Registration to Study||48
2518796|NCT00720356|6172258|P1|Completed Registration Step 1|Registration to Study||115
2518797|NCT00720356|6172258|P1|STARTED|Registration to Study||115
2518798|NCT00720343|6172272|P1|NOT COMPLETED|Overall Study||6
2518799|NCT00720343|6172272|P1|COMPLETED|Overall Study|3 removed by physician. 3 unable to be determined; Columbia will never have access to this data.|48
2518800|NCT00720343|6172272|P1|STARTED|Overall Study||54
2518801|NCT00720330|6172281|P3|NOT COMPLETED|Overall Study||0
2518802|NCT00720330|6172282|P2|NOT COMPLETED|Overall Study||0
2518803|NCT00720330|6172283|P1|NOT COMPLETED|Overall Study||0
2518804|NCT00720330|6172281|P3|COMPLETED|Overall Study||3
2518805|NCT00720330|6172282|P2|COMPLETED|Overall Study||4
2518806|NCT00720330|6172283|P1|COMPLETED|Overall Study||5
2518807|NCT00720330|6172281|P3|STARTED|Overall Study||3
2518808|NCT00720330|6172282|P2|STARTED|Overall Study||4
2518809|NCT00720330|6172283|P1|STARTED|Overall Study||5
2518810|NCT00720278|6172306|P3|NOT COMPLETED|Overall Study||6
2518811|NCT00720278|6172307|P2|NOT COMPLETED|Overall Study||4
2518812|NCT00720278|6172308|P1|NOT COMPLETED|Overall Study||7
2518813|NCT00720278|6172306|P3|COMPLETED|Overall Study||172
2518814|NCT00720278|6172307|P2|COMPLETED|Overall Study||166
2518815|NCT00720278|6172308|P1|COMPLETED|Overall Study||171
2518816|NCT00720278|6172306|P3|STARTED|Overall Study|1 subject was randomized in error|178
2518817|NCT00720278|6172307|P2|STARTED|Overall Study|1 subject was randomized in error|170
2518818|NCT00720278|6172308|P1|STARTED|Overall Study|1 subject was randomized in error|178
2518819|NCT00720226|6172330|P2|NOT COMPLETED|Overall Study||4
2518820|NCT00720226|6172331|P1|NOT COMPLETED|Overall Study||7
2518821|NCT00720226|6172330|P2|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|48
2518822|NCT00720226|6172331|P1|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|47
2518823|NCT00720226|6172330|P2|STARTED|Overall Study||52
2518824|NCT00720226|6172331|P1|STARTED|Overall Study||54
2518825|NCT00720213|6172339|P3|NOT COMPLETED|Treatment Period||0
2518826|NCT00720213|6172340|P2|NOT COMPLETED|Treatment Period||0
2518827|NCT00720213|6172341|P1|NOT COMPLETED|Treatment Period||0
2518828|NCT00720213|6172339|P3|COMPLETED|Treatment Period||17
2518829|NCT00720213|6172340|P2|COMPLETED|Treatment Period||20
2518830|NCT00720213|6172341|P1|COMPLETED|Treatment Period||0
2518831|NCT00720213|6172339|P3|STARTED|Treatment Period||17
2518832|NCT00720213|6172340|P2|STARTED|Treatment Period||20
2518833|NCT00720213|6172341|P1|STARTED|Treatment Period||0
2518834|NCT00720213|6172339|P3|NOT COMPLETED|Screening Phase With Diagnostic PSG||0
2518835|NCT00720213|6172340|P2|NOT COMPLETED|Screening Phase With Diagnostic PSG||0
2518836|NCT00720213|6172341|P1|NOT COMPLETED|Screening Phase With Diagnostic PSG||7
2518837|NCT00720213|6172339|P3|COMPLETED|Screening Phase With Diagnostic PSG||0
2518838|NCT00720213|6172340|P2|COMPLETED|Screening Phase With Diagnostic PSG||0
2518839|NCT00720213|6172341|P1|COMPLETED|Screening Phase With Diagnostic PSG||37
2518840|NCT00720213|6172339|P3|STARTED|Screening Phase With Diagnostic PSG||0
2518841|NCT00720213|6172340|P2|STARTED|Screening Phase With Diagnostic PSG||0
2518842|NCT00720213|6172341|P1|STARTED|Screening Phase With Diagnostic PSG||44
2518843|NCT00720122|6172379|P1|NOT COMPLETED|Overall Study||9
2518844|NCT00720122|6172379|P1|COMPLETED|Overall Study||19
2518845|NCT00720122|6172379|P1|STARTED|Overall Study||28
2518846|NCT00720109|6172383|P3|NOT COMPLETED|Risk Stratification Period||8
2518847|NCT00720109|6172384|P2|NOT COMPLETED|Risk Stratification Period||15
2518848|NCT00720109|6172385|P1|NOT COMPLETED|Risk Stratification Period||0
2518849|NCT00720109|6172383|P3|COMPLETED|Risk Stratification Period||1
2518850|NCT00720109|6172384|P2|COMPLETED|Risk Stratification Period||33
2518851|NCT00720109|6172385|P1|COMPLETED|Risk Stratification Period||0
2518852|NCT00720109|6172383|P3|STARTED|Risk Stratification Period||9
2518853|NCT00720109|6172384|P2|STARTED|Risk Stratification Period||48
2518854|NCT00720109|6172385|P1|STARTED|Risk Stratification Period||0
2518855|NCT00720109|6172383|P3|NOT COMPLETED|Induction Period||0
2518856|NCT00720109|6172384|P2|NOT COMPLETED|Induction Period||0
2518857|NCT00720109|6172385|P1|NOT COMPLETED|Induction Period||6
2518858|NCT00720109|6172383|P3|COMPLETED|Induction Period||0
2518859|NCT00720109|6172384|P2|COMPLETED|Induction Period||0
2518860|NCT00720109|6172385|P1|COMPLETED|Induction Period||57
2518861|NCT00720109|6172383|P3|STARTED|Induction Period||0
2518862|NCT00720109|6172384|P2|STARTED|Induction Period||0
2518863|NCT00720109|6172385|P1|STARTED|Induction Period||63
2518864|NCT00720096|6172405|P2|NOT COMPLETED|Overall Study||2
2518865|NCT00720096|6172406|P1|NOT COMPLETED|Overall Study||0
2518866|NCT00720096|6172405|P2|COMPLETED|Overall Study||0
2518867|NCT00720096|6172406|P1|COMPLETED|Overall Study||2
2518868|NCT00720096|6172405|P2|STARTED|Overall Study||2
2518869|NCT00720096|6172406|P1|STARTED|Overall Study||2
2518870|NCT00720083|6172418|P2|NOT COMPLETED|Overall Study||2
2518871|NCT00720083|6172419|P1|NOT COMPLETED|Overall Study||1
2518872|NCT00720083|6172418|P2|COMPLETED|Overall Study||13
2518873|NCT00720083|6172419|P1|COMPLETED|Overall Study|Subjects with data for the primary analysis are considered to have completed the study.|16
2518874|NCT00720083|6172418|P2|STARTED|Overall Study||15
2518875|NCT00720083|6172419|P1|STARTED|Overall Study||17
2518876|NCT00720057|6172427|P2|NOT COMPLETED|Overall Study||3
2518877|NCT00720057|6172428|P1|NOT COMPLETED|Overall Study||1
2518878|NCT00720057|6172427|P2|COMPLETED|Overall Study||156
2518879|NCT00720057|6172428|P1|COMPLETED|Overall Study||152
2518880|NCT00720057|6172427|P2|STARTED|Overall Study||159
2518881|NCT00720057|6172428|P1|STARTED|Overall Study||153
2518882|NCT00719953|6172444|P1|NOT COMPLETED|Overall Study||4
2518883|NCT00719953|6172444|P1|COMPLETED|Overall Study||26
2518884|NCT00719953|6172444|P1|STARTED|Overall Study||30
2518885|NCT00719914|6172450|P2|NOT COMPLETED|Overall Study||0
2518886|NCT00719914|6172451|P1|NOT COMPLETED|Overall Study||0
2518887|NCT00719914|6172450|P2|COMPLETED|Overall Study||7
2518888|NCT00719914|6172451|P1|COMPLETED|Overall Study||10
2518889|NCT00719914|6172450|P2|STARTED|Overall Study||7
2518890|NCT00719914|6172451|P1|STARTED|Overall Study||10
2518891|NCT00719901|6172457|P1|NOT COMPLETED|Overall Study||11
2518892|NCT00719901|6172457|P1|COMPLETED|Overall Study||0
2518893|NCT00719901|6172457|P1|STARTED|Overall Study||11
2518894|NCT00719862|6172469|P2|NOT COMPLETED|Overall Study||6
2518895|NCT00719862|6172470|P1|NOT COMPLETED|Overall Study||8
2518896|NCT00719862|6172469|P2|COMPLETED|Overall Study||233
2518897|NCT00719862|6172470|P1|COMPLETED|Overall Study||234
2518898|NCT00719862|6172469|P2|STARTED|Overall Study|1 subject was randomized in error|239
2518899|NCT00719862|6172470|P1|STARTED|Overall Study||242
2518900|NCT00719849|6172488|P2|NOT COMPLETED|Overall Study||1
2518901|NCT00719849|6172489|P1|NOT COMPLETED|Overall Study||0
2518902|NCT00719849|6172488|P2|COMPLETED|Overall Study||8
2518903|NCT00719849|6172489|P1|COMPLETED|Overall Study||4
2518904|NCT00719849|6172488|P2|STARTED|Overall Study||9
2518905|NCT00719849|6172489|P1|STARTED|Overall Study||4
2518906|NCT00719810|6172528|P3|NOT COMPLETED|Overall Study||8
2518907|NCT00719810|6172529|P2|NOT COMPLETED|Overall Study||4
2518908|NCT00719810|6172530|P1|NOT COMPLETED|Overall Study||3
2518909|NCT00719810|6172528|P3|COMPLETED|Overall Study||42
2518910|NCT00719810|6172529|P2|COMPLETED|Overall Study||47
2518911|NCT00719810|6172530|P1|COMPLETED|Overall Study||46
2518912|NCT00719810|6172528|P3|STARTED|Overall Study||50
2518913|NCT00719810|6172529|P2|STARTED|Overall Study||51
2518914|NCT00719810|6172530|P1|STARTED|Overall Study||49
2518915|NCT00719732|6172541|P1|NOT COMPLETED|Overall Study||22
2518916|NCT00719732|6172541|P1|COMPLETED|Overall Study||196
2518917|NCT00719732|6172541|P1|STARTED|Overall Study||218
2518918|NCT00719706|6172547|P2|NOT COMPLETED|Overall Study||6
2518919|NCT00719706|6172548|P1|NOT COMPLETED|Overall Study||9
2518920|NCT00719706|6172547|P2|COMPLETED|Overall Study||14
2518921|NCT00719706|6172548|P1|COMPLETED|Overall Study||11
2518922|NCT00719706|6172547|P2|STARTED|Overall Study||20
2518923|NCT00719706|6172548|P1|STARTED|Overall Study||20
2518924|NCT00719680|6172562|P1|NOT COMPLETED|Overall Study||5
2518925|NCT00719680|6172562|P1|COMPLETED|Overall Study||16
2518926|NCT00719680|6172562|P1|STARTED|Overall Study||21
2518927|NCT00719615|6172585|P3|NOT COMPLETED|Overall Study||0
2518928|NCT00719615|6172586|P2|NOT COMPLETED|Overall Study||0
2518929|NCT00719615|6172587|P1|NOT COMPLETED|Overall Study||0
2518930|NCT00719615|6172585|P3|COMPLETED|Overall Study||24
2518931|NCT00719615|6172586|P2|COMPLETED|Overall Study||45
2518932|NCT00719615|6172587|P1|COMPLETED|Overall Study||42
2518933|NCT00719615|6172585|P3|STARTED|Overall Study||24
2518934|NCT00719615|6172586|P2|STARTED|Overall Study||45
2518935|NCT00719615|6172587|P1|STARTED|Overall Study||42
2518936|NCT00719576|6172597|P2|NOT COMPLETED|Overall Study||5
2518937|NCT00719576|6172598|P1|NOT COMPLETED|Overall Study||2
2518938|NCT00719576|6172597|P2|COMPLETED|Overall Study||67
2518939|NCT00719576|6172598|P1|COMPLETED|Overall Study||70
2518940|NCT00719576|6172597|P2|STARTED|Overall Study||72
2518941|NCT00719576|6172598|P1|STARTED|Overall Study||72
2518942|NCT00719563|6172618|P2|NOT COMPLETED|Overall Study||42
2518943|NCT00719563|6172619|P1|NOT COMPLETED|Overall Study||38
2518944|NCT00719563|6172618|P2|COMPLETED|Overall Study||128
2518945|NCT00719563|6172619|P1|COMPLETED|Overall Study||133
2518946|NCT00719563|6172618|P2|STARTED|Overall Study||170
2518947|NCT00719563|6172619|P1|STARTED|Overall Study||171
2518948|NCT00719537|6172651|P2|NOT COMPLETED|Overall Study||1
2518949|NCT00719537|6172652|P1|NOT COMPLETED|Overall Study||1
2518950|NCT00719537|6172651|P2|COMPLETED|Overall Study||0
2518951|NCT00719537|6172652|P1|COMPLETED|Overall Study||1
2518952|NCT00719537|6172651|P2|STARTED|Overall Study||1
2518953|NCT00719537|6172652|P1|STARTED|Overall Study||2
2518954|NCT00719472|6172658|P1|NOT COMPLETED|Received Cycle 2 Treatment||68
2518955|NCT00719472|6172658|P1|COMPLETED|Received Cycle 2 Treatment||304
2518956|NCT00719472|6172658|P1|STARTED|Received Cycle 2 Treatment||372
2518957|NCT00719472|6172658|P1|NOT COMPLETED|Received Cycle 1 Treatment||53
2518958|NCT00719472|6172658|P1|COMPLETED|Received Cycle 1 Treatment||372
2518959|NCT00719472|6172658|P1|STARTED|Received Cycle 1 Treatment||425
2518960|NCT00719472|6172658|P1|NOT COMPLETED|Enrolled in Study||26
2518961|NCT00719472|6172658|P1|COMPLETED|Enrolled in Study||425
2518962|NCT00719472|6172658|P1|STARTED|Enrolled in Study||451
2518963|NCT00719355|6172669|P2|NOT COMPLETED|Overall Study||13
2518964|NCT00719355|6172670|P1|NOT COMPLETED|Overall Study||18
2518965|NCT00719355|6172669|P2|COMPLETED|Overall Study||39
2518966|NCT00719355|6172670|P1|COMPLETED|Overall Study||33
2518967|NCT00719355|6172669|P2|Completed 32 Weeks|Overall Study||39
2518968|NCT00719355|6172670|P1|Completed 32 Weeks|Overall Study||33
2518969|NCT00719355|6172669|P2|Completed 24 Weeks|Overall Study||43
2518970|NCT00719355|6172670|P1|Completed 24 Weeks|Overall Study||34
2518971|NCT00719355|6172669|P2|Completed 12 Weeks|Overall Study||46
2518972|NCT00719355|6172670|P1|Completed 12 Weeks|Overall Study||43
2518973|NCT00719355|6172669|P2|Completed 6 Weeks|Overall Study||48
2518974|NCT00719355|6172670|P1|Completed 6 Weeks|Overall Study||49
2518975|NCT00719355|6172669|P2|STARTED|Overall Study||52
2518976|NCT00719355|6172670|P1|STARTED|Overall Study||51
2518977|NCT00719329|6172681|P3|NOT COMPLETED|Overall Study||1
2518978|NCT00719329|6172682|P2|NOT COMPLETED|Overall Study||2
2518979|NCT00719329|6172683|P1|NOT COMPLETED|Overall Study||0
2518980|NCT00719329|6172681|P3|COMPLETED|Overall Study||646
2518981|NCT00719329|6172682|P2|COMPLETED|Overall Study||569
2518982|NCT00719329|6172683|P1|COMPLETED|Overall Study||705
2518983|NCT00719329|6172681|P3|Day 7 Swab|Overall Study||561
2518984|NCT00719329|6172682|P2|Day 7 Swab|Overall Study||467
2518985|NCT00719329|6172683|P1|Day 7 Swab|Overall Study||593
2518986|NCT00719329|6172681|P3|Day 3 Swab|Overall Study||578
2518987|NCT00719329|6172682|P2|Day 3 Swab|Overall Study||501
2518988|NCT00719329|6172683|P1|Day 3 Swab|Overall Study||614
2518989|NCT00719329|6172681|P3|Day 1 Swab|Overall Study||646
2518990|NCT00719329|6172682|P2|Day 1 Swab|Overall Study||569
2518991|NCT00719329|6172683|P1|Day 1 Swab|Overall Study||705
2518992|NCT00719329|6172681|P3|STARTED|Overall Study||647
2518993|NCT00719329|6172682|P2|STARTED|Overall Study||571
2518994|NCT00719329|6172683|P1|STARTED|Overall Study||705
2518995|NCT00719264|6172699|P2|NOT COMPLETED|Overall Study||183
2518996|NCT00719264|6172700|P1|NOT COMPLETED|Overall Study||182
2518997|NCT00719264|6172699|P2|COMPLETED|Overall Study||0
2518998|NCT00719264|6172700|P1|COMPLETED|Overall Study||0
2518999|NCT00719264|6172699|P2|Safety Set|Overall Study||181
2519000|NCT00719264|6172700|P1|Safety Set|Overall Study||180
2519001|NCT00719264|6172699|P2|Full Analysis Set|Overall Study||183
2519002|NCT00719264|6172700|P1|Full Analysis Set|Overall Study||182
2519003|NCT00719264|6172699|P2|STARTED|Overall Study||183
2519004|NCT00719264|6172700|P1|STARTED|Overall Study||182
2519005|NCT00719212|6172719|P1|NOT COMPLETED|Overall Study||44
2519006|NCT00719212|6172719|P1|COMPLETED|Overall Study||17
2519007|NCT00719212|6172719|P1|STARTED|Overall Study||61
2519008|NCT00719186|6172731|P2|NOT COMPLETED|Overall Study||0
2519009|NCT00719186|6172732|P1|NOT COMPLETED|Overall Study||0
2519010|NCT00719186|6172731|P2|COMPLETED|Overall Study||374
2519011|NCT00719186|6172732|P1|COMPLETED|Overall Study||376
2519012|NCT00719186|6172731|P2|STARTED|Overall Study||374
2519013|NCT00719186|6172732|P1|STARTED|Overall Study||376
2519014|NCT00719160|6172746|P2|NOT COMPLETED|Overall Study||0
2519015|NCT00719160|6172747|P1|NOT COMPLETED|Overall Study||0
2519016|NCT00719160|6172746|P2|COMPLETED|Overall Study||6
2519017|NCT00719160|6172747|P1|COMPLETED|Overall Study||6
2519018|NCT00719160|6172746|P2|STARTED|Overall Study||6
2519019|NCT00719160|6172747|P1|STARTED|Overall Study||6
2519020|NCT00719134|6172754|P1|NOT COMPLETED|Overall Study||10
2519021|NCT00719134|6172754|P1|COMPLETED|Overall Study||66
2519022|NCT00719134|6172754|P1|STARTED|Overall Study||76
2519023|NCT00719043|6172767|P7|NOT COMPLETED|Overall Study||28
2519024|NCT00719043|6172768|P6|NOT COMPLETED|Overall Study||34
2519025|NCT00719043|6172769|P5|NOT COMPLETED|Overall Study||27
2519026|NCT00719043|6172770|P4|NOT COMPLETED|Overall Study||23
2519027|NCT00719043|6172771|P3|NOT COMPLETED|Overall Study||20
2519028|NCT00719043|6172772|P2|NOT COMPLETED|Overall Study||25
2519029|NCT00719043|6172773|P1|NOT COMPLETED|Overall Study||32
2519030|NCT00719043|6172767|P7|COMPLETED|Overall Study|Up to Day 909|92
2519031|NCT00719043|6172768|P6|COMPLETED|Overall Study|Up to Day 909|86
2519032|NCT00719043|6172769|P5|COMPLETED|Overall Study|Up to Day 909|95
2519033|NCT00719043|6172770|P4|COMPLETED|Overall Study|Up to Day 909|96
2519034|NCT00719043|6172771|P3|COMPLETED|Overall Study|Up to Day 909|99
2519035|NCT00719043|6172772|P2|COMPLETED|Overall Study|Up to Day 909|96
2519036|NCT00719043|6172773|P1|COMPLETED|Overall Study|Up to Day 909|88
2519037|NCT00719043|6172767|P7|STARTED|Overall Study||120
2519038|NCT00719043|6172768|P6|STARTED|Overall Study||120
2519039|NCT00719043|6172769|P5|STARTED|Overall Study||122
2519040|NCT00719043|6172770|P4|STARTED|Overall Study||119
2519041|NCT00719043|6172771|P3|STARTED|Overall Study||119
2519042|NCT00719043|6172772|P2|STARTED|Overall Study||121
2519043|NCT00719043|6172773|P1|STARTED|Overall Study||120
2519044|NCT00718887|6172897|P2|NOT COMPLETED|Overall Study||9
2519045|NCT00718887|6172898|P1|NOT COMPLETED|Overall Study||5
2519046|NCT00718887|6172897|P2|COMPLETED|Overall Study||68
2519047|NCT00718887|6172898|P1|COMPLETED|Overall Study|Continued in study after 48 weeks|84
2519048|NCT00718887|6172897|P2|STARTED|Overall Study|Participants who received treatment.|77
2519049|NCT00718887|6172898|P1|STARTED|Overall Study|Participants who received treatment.|89
2519050|NCT00718861|6172922|P2|NOT COMPLETED|Overall Study||18
2519051|NCT00718861|6172923|P1|NOT COMPLETED|Overall Study||21
2519052|NCT00718861|6172922|P2|COMPLETED|Overall Study||77
2519053|NCT00718861|6172923|P1|COMPLETED|Overall Study||74
2519054|NCT00718861|6172922|P2|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|69
2519055|NCT00718861|6172923|P1|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|67
2519056|NCT00718861|6172922|P2|Safety Set|Overall Study||95
2519057|NCT00718861|6172923|P1|Safety Set|Overall Study|3 patients randomized but never received study drug|92
2519058|NCT00718861|6172922|P2|STARTED|Overall Study||95
2519059|NCT00718861|6172923|P1|STARTED|Overall Study|"Started indicates Randomized and Intent-to Treat (ITT) population"|95
2519060|NCT00718809|6172951|P2|NOT COMPLETED|Overall Study||9
2519061|NCT00718809|6172952|P1|NOT COMPLETED|Overall Study||12
2519062|NCT00718809|6172951|P2|COMPLETED|Overall Study||0
2519063|NCT00718809|6172952|P1|COMPLETED|Overall Study||0
2519064|NCT00718809|6172951|P2|STARTED|Overall Study||9
2519065|NCT00718809|6172952|P1|STARTED|Overall Study||12
2519066|NCT00718770|6172966|P1|NOT COMPLETED|Overall Study||8
2519067|NCT00718770|6172966|P1|COMPLETED|Overall Study||2
2519068|NCT00718770|6172966|P1|STARTED|Overall Study||10
2519069|NCT00718718|6172977|P10|NOT COMPLETED|Week 12 to End of Study||0
2519070|NCT00718718|6172978|P9|NOT COMPLETED|Week 12 to End of Study||1
2519071|NCT00718718|6172979|P8|NOT COMPLETED|Week 12 to End of Study||1
2519072|NCT00718718|6172980|P7|NOT COMPLETED|Week 12 to End of Study||2
2519073|NCT00718718|6172981|P6|NOT COMPLETED|Week 12 to End of Study||3
2519074|NCT00718718|6172982|P5|NOT COMPLETED|Week 12 to End of Study||0
2519075|NCT00718718|6172983|P4|NOT COMPLETED|Week 12 to End of Study||1
2519076|NCT00718718|6172984|P3|NOT COMPLETED|Week 12 to End of Study||0
2519077|NCT00718718|6172985|P2|NOT COMPLETED|Week 12 to End of Study||1
2519078|NCT00718718|6172986|P1|NOT COMPLETED|Week 12 to End of Study||0
2519079|NCT00718718|6172977|P10|COMPLETED|Week 12 to End of Study||31
2519080|NCT00718718|6172978|P9|COMPLETED|Week 12 to End of Study||27
2519081|NCT00718718|6172979|P8|COMPLETED|Week 12 to End of Study||27
2519082|NCT00718718|6172980|P7|COMPLETED|Week 12 to End of Study||27
2519083|NCT00718718|6172981|P6|COMPLETED|Week 12 to End of Study||24
2519084|NCT00718718|6172982|P5|COMPLETED|Week 12 to End of Study||0
2519085|NCT00718718|6172983|P4|COMPLETED|Week 12 to End of Study||15
2519086|NCT00718718|6172984|P3|COMPLETED|Week 12 to End of Study||0
2519087|NCT00718718|6172985|P2|COMPLETED|Week 12 to End of Study||17
2519088|NCT00718718|6172986|P1|COMPLETED|Week 12 to End of Study||0
2519089|NCT00718718|6172977|P10|Treated|Week 12 to End of Study||31
2519090|NCT00718718|6172978|P9|Treated|Week 12 to End of Study||28
2519091|NCT00718718|6172979|P8|Treated|Week 12 to End of Study||28
2519092|NCT00718718|6172980|P7|Treated|Week 12 to End of Study||29
2519093|NCT00718718|6172981|P6|Treated|Week 12 to End of Study||26
2519094|NCT00718718|6172982|P5|Treated|Week 12 to End of Study||0
2519095|NCT00718718|6172983|P4|Treated|Week 12 to End of Study||16
2519096|NCT00718718|6172984|P3|Treated|Week 12 to End of Study||0
2519097|NCT00718718|6172985|P2|Treated|Week 12 to End of Study||18
2519098|NCT00718718|6172986|P1|Treated|Week 12 to End of Study||0
2519099|NCT00718718|6172977|P10|STARTED|Week 12 to End of Study||31
2519100|NCT00718718|6172978|P9|STARTED|Week 12 to End of Study||28
2519101|NCT00718718|6172979|P8|STARTED|Week 12 to End of Study||28
2519102|NCT00718718|6172980|P7|STARTED|Week 12 to End of Study||29
2519103|NCT00718718|6172981|P6|STARTED|Week 12 to End of Study||27
2519104|NCT00718718|6172982|P5|STARTED|Week 12 to End of Study||0
2519105|NCT00718718|6172983|P4|STARTED|Week 12 to End of Study||16
2519106|NCT00718718|6172984|P3|STARTED|Week 12 to End of Study||0
2519107|NCT00718718|6172985|P2|STARTED|Week 12 to End of Study||18
2519108|NCT00718718|6172986|P1|STARTED|Week 12 to End of Study||0
2519109|NCT00718718|6172977|P10|NOT COMPLETED|Prior to Week 12||0
2519110|NCT00718718|6172978|P9|NOT COMPLETED|Prior to Week 12||2
2519111|NCT00718718|6172979|P8|NOT COMPLETED|Prior to Week 12||2
2519112|NCT00718718|6172980|P7|NOT COMPLETED|Prior to Week 12||1
2519113|NCT00718718|6172981|P6|NOT COMPLETED|Prior to Week 12||0
2519114|NCT00718718|6172982|P5|NOT COMPLETED|Prior to Week 12||3
2519115|NCT00718718|6172983|P4|NOT COMPLETED|Prior to Week 12||0
2519116|NCT00718718|6172984|P3|NOT COMPLETED|Prior to Week 12||1
2519117|NCT00718718|6172985|P2|NOT COMPLETED|Prior to Week 12||0
2519118|NCT00718718|6172986|P1|NOT COMPLETED|Prior to Week 12||1
2519119|NCT00718718|6172977|P10|COMPLETED|Prior to Week 12||31
2519120|NCT00718718|6172978|P9|COMPLETED|Prior to Week 12||28
2519121|NCT00718718|6172979|P8|COMPLETED|Prior to Week 12||28
2519122|NCT00718718|6172980|P7|COMPLETED|Prior to Week 12||29
2519123|NCT00718718|6172981|P6|COMPLETED|Prior to Week 12||0
2519124|NCT00718718|6172982|P5|COMPLETED|Prior to Week 12||27
2519125|NCT00718718|6172983|P4|COMPLETED|Prior to Week 12||0
2519126|NCT00718718|6172984|P3|COMPLETED|Prior to Week 12||16
2519127|NCT00718718|6172985|P2|COMPLETED|Prior to Week 12||0
2519128|NCT00718718|6172986|P1|COMPLETED|Prior to Week 12||18
2519129|NCT00718718|6172977|P10|STARTED|Prior to Week 12||31
2519130|NCT00718718|6172978|P9|STARTED|Prior to Week 12||30
2519131|NCT00718718|6172979|P8|STARTED|Prior to Week 12||30
2519132|NCT00718718|6172980|P7|STARTED|Prior to Week 12||30
2519133|NCT00718718|6172981|P6|STARTED|Prior to Week 12||0
2519134|NCT00718718|6172982|P5|STARTED|Prior to Week 12||30
2519135|NCT00718718|6172983|P4|STARTED|Prior to Week 12||0
2519136|NCT00718718|6172984|P3|STARTED|Prior to Week 12||17
2519137|NCT00718718|6172985|P2|STARTED|Prior to Week 12||0
2519138|NCT00718718|6172986|P1|STARTED|Prior to Week 12||19
2519139|NCT00718666|6173029|P3|NOT COMPLETED|Booster Phase Year 5||6
2519140|NCT00718666|6173030|P2|NOT COMPLETED|Booster Phase Year 5||0
2519141|NCT00718666|6173031|P1|NOT COMPLETED|Booster Phase Year 5||2
2519142|NCT00718666|6173029|P3|COMPLETED|Booster Phase Year 5||94
2519143|NCT00718666|6173030|P2|COMPLETED|Booster Phase Year 5||46
2519144|NCT00718666|6173031|P1|COMPLETED|Booster Phase Year 5||36
2519145|NCT00718666|6173029|P3|STARTED|Booster Phase Year 5||100
2519146|NCT00718666|6173030|P2|STARTED|Booster Phase Year 5||46
2519147|NCT00718666|6173031|P1|STARTED|Booster Phase Year 5||38
2519148|NCT00718666|6173029|P3|NOT COMPLETED|Persistence Phase Year 5||0
2519149|NCT00718666|6173030|P2|NOT COMPLETED|Persistence Phase Year 5||0
2519150|NCT00718666|6173031|P1|NOT COMPLETED|Persistence Phase Year 5||0
2519151|NCT00718666|6173029|P3|COMPLETED|Persistence Phase Year 5|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
2519152|NCT00718666|6173030|P2|COMPLETED|Persistence Phase Year 5||82
2519153|NCT00718666|6173031|P1|COMPLETED|Persistence Phase Year 5||70
2519154|NCT00718666|6173029|P3|STARTED|Persistence Phase Year 5||0
2519155|NCT00718666|6173030|P2|STARTED|Persistence Phase Year 5||82
2519156|NCT00718666|6173031|P1|STARTED|Persistence Phase Year 5||70
2519157|NCT00718666|6173029|P3|NOT COMPLETED|Persistence Phase Year 3||0
2519158|NCT00718666|6173030|P2|NOT COMPLETED|Persistence Phase Year 3||0
2519159|NCT00718666|6173031|P1|NOT COMPLETED|Persistence Phase Year 3||0
2519160|NCT00718666|6173029|P3|COMPLETED|Persistence Phase Year 3|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
2519161|NCT00718666|6173030|P2|COMPLETED|Persistence Phase Year 3||104
2519162|NCT00718666|6173031|P1|COMPLETED|Persistence Phase Year 3||98
2519163|NCT00718666|6173029|P3|STARTED|Persistence Phase Year 3||0
2519164|NCT00718666|6173030|P2|STARTED|Persistence Phase Year 3||104
2519165|NCT00718666|6173031|P1|STARTED|Persistence Phase Year 3||98
2519166|NCT00718666|6173029|P3|NOT COMPLETED|Persistence Phase Year 1||0
2519167|NCT00718666|6173030|P2|NOT COMPLETED|Persistence Phase Year 1||0
2519168|NCT00718666|6173031|P1|NOT COMPLETED|Persistence Phase Year 1||0
2519169|NCT00718666|6173029|P3|COMPLETED|Persistence Phase Year 1|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
2519170|NCT00718666|6173030|P2|COMPLETED|Persistence Phase Year 1||130
2519171|NCT00718666|6173031|P1|COMPLETED|Persistence Phase Year 1||118
2519172|NCT00718666|6173029|P3|STARTED|Persistence Phase Year 1||0
2519173|NCT00718666|6173030|P2|STARTED|Persistence Phase Year 1||130
2519174|NCT00718666|6173031|P1|STARTED|Persistence Phase Year 1||118
2519175|NCT00718640|6173115|P1|NOT COMPLETED|Overall Study||7
2519176|NCT00718640|6173115|P1|COMPLETED|Overall Study||3
2519177|NCT00718640|6173115|P1|STARTED|Overall Study||10
2519178|NCT00718549|6173127|P3|NOT COMPLETED|Maintenance/ Observation Phase||30
2519179|NCT00718549|6173128|P2|NOT COMPLETED|Maintenance/ Observation Phase||28
2519180|NCT00718549|6173129|P1|NOT COMPLETED|Maintenance/ Observation Phase||0
2519181|NCT00718549|6173127|P3|COMPLETED|Maintenance/ Observation Phase||3
2519182|NCT00718549|6173128|P2|COMPLETED|Maintenance/ Observation Phase||5
2519183|NCT00718549|6173129|P1|COMPLETED|Maintenance/ Observation Phase||0
2519184|NCT00718549|6173127|P3|STARTED|Maintenance/ Observation Phase||33
2519185|NCT00718549|6173128|P2|STARTED|Maintenance/ Observation Phase||33
2519186|NCT00718549|6173129|P1|STARTED|Maintenance/ Observation Phase||0
2519187|NCT00718549|6173127|P3|NOT COMPLETED|Induction Phase||0
2519188|NCT00718549|6173128|P2|NOT COMPLETED|Induction Phase||0
2519189|NCT00718549|6173129|P1|NOT COMPLETED|Induction Phase||62
2519190|NCT00718549|6173127|P3|COMPLETED|Induction Phase||0
2519191|NCT00718549|6173128|P2|COMPLETED|Induction Phase||0
2519192|NCT00718549|6173129|P1|COMPLETED|Induction Phase||66
2519193|NCT00718549|6173127|P3|STARTED|Induction Phase||0
2519194|NCT00718549|6173128|P2|STARTED|Induction Phase||0
2519195|NCT00718549|6173129|P1|STARTED|Induction Phase||128
2519196|NCT00718523|6173154|P2|NOT COMPLETED|Overall Study||24
2519197|NCT00718523|6173155|P1|NOT COMPLETED|Overall Study||18
2519198|NCT00718523|6173154|P2|COMPLETED|Overall Study||62
2519199|NCT00718523|6173155|P1|COMPLETED|Overall Study||66
2519200|NCT00718523|6173154|P2|STARTED|Overall Study||86
2519201|NCT00718523|6173155|P1|STARTED|Overall Study||84
2519202|NCT00718510|6173167|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
2519203|NCT00718510|6173168|P1|NOT COMPLETED|Second Intervention (3 Weeks)||1
2519204|NCT00718510|6173167|P2|COMPLETED|Second Intervention (3 Weeks)||7
2519205|NCT00718510|6173168|P1|COMPLETED|Second Intervention (3 Weeks)||6
2519206|NCT00718510|6173167|P2|STARTED|Second Intervention (3 Weeks)||7
2519207|NCT00718510|6173168|P1|STARTED|Second Intervention (3 Weeks)||7
2519208|NCT00718510|6173167|P2|NOT COMPLETED|Washout (5 Days)||0
2519209|NCT00718510|6173168|P1|NOT COMPLETED|Washout (5 Days)||0
2519210|NCT00718510|6173167|P2|COMPLETED|Washout (5 Days)||7
2519211|NCT00718510|6173168|P1|COMPLETED|Washout (5 Days)||7
2519212|NCT00718510|6173167|P2|STARTED|Washout (5 Days)||7
2519213|NCT00718510|6173168|P1|STARTED|Washout (5 Days)||7
2519214|NCT00718510|6173167|P2|NOT COMPLETED|First Intervention (3 Weeks)||1
2519215|NCT00718510|6173168|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
2519216|NCT00718510|6173167|P2|COMPLETED|First Intervention (3 Weeks)||7
2519217|NCT00718510|6173168|P1|COMPLETED|First Intervention (3 Weeks)||7
2519218|NCT00718510|6173167|P2|Received Intervention|First Intervention (3 Weeks)||7
2519219|NCT00718510|6173168|P1|Received Intervention|First Intervention (3 Weeks)||7
2519220|NCT00718510|6173167|P2|STARTED|First Intervention (3 Weeks)||8
2519221|NCT00718510|6173168|P1|STARTED|First Intervention (3 Weeks)||7
2519222|NCT00718328|6173180|P2|NOT COMPLETED|Overall Study||0
2519223|NCT00718328|6173181|P1|NOT COMPLETED|Overall Study||1
2519224|NCT00718328|6173180|P2|COMPLETED|Overall Study|Terminated due to poor enrollment|0
2519225|NCT00718328|6173181|P1|COMPLETED|Overall Study|Prematurely terminated due to poor enrollment|0
2519226|NCT00718328|6173180|P2|STARTED|Overall Study||0
2519227|NCT00718328|6173181|P1|STARTED|Overall Study||1
2519228|NCT00718315|6173190|P3|NOT COMPLETED|Overall Study||21
2519229|NCT00718315|6173191|P2|NOT COMPLETED|Overall Study||22
2519230|NCT00718315|6173192|P1|NOT COMPLETED|Overall Study||19
2519231|NCT00718315|6173190|P3|COMPLETED|Overall Study||46
2519232|NCT00718315|6173191|P2|COMPLETED|Overall Study||45
2519233|NCT00718315|6173192|P1|COMPLETED|Overall Study||48
2519234|NCT00718315|6173190|P3|STARTED|Overall Study||67
2519235|NCT00718315|6173191|P2|STARTED|Overall Study||67
2519236|NCT00718315|6173192|P1|STARTED|Overall Study||67
2519237|NCT00718302|6173226|P2|NOT COMPLETED|Overall Study||0
2519238|NCT00718302|6173227|P1|NOT COMPLETED|Overall Study||0
2519239|NCT00718302|6173226|P2|COMPLETED|Overall Study||114
2519240|NCT00718302|6173227|P1|COMPLETED|Overall Study||119
2519241|NCT00718302|6173226|P2|STARTED|Overall Study||114
2519242|NCT00718302|6173227|P1|STARTED|Overall Study||119
2519243|NCT00718237|6173243|P2|NOT COMPLETED|Overall Study||15
2519244|NCT00718237|6173244|P1|NOT COMPLETED|Overall Study||13
2519245|NCT00718237|6173243|P2|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|366
2519246|NCT00718237|6173244|P1|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|368
2519247|NCT00718237|6173243|P2|Vaccinated at Visit 3|Overall Study||369
2519248|NCT00718237|6173244|P1|Vaccinated at Visit 3|Overall Study||371
2519249|NCT00718237|6173243|P2|Vaccinated at Visit 2|Overall Study||374
2519250|NCT00718237|6173244|P1|Vaccinated at Visit 2|Overall Study||373
2519251|NCT00718237|6173243|P2|Vaccinated at Visit 1|Overall Study||381
2519252|NCT00718237|6173244|P1|Vaccinated at Visit 1|Overall Study||380
2519253|NCT00718237|6173243|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
2519254|NCT00718237|6173244|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
2519255|NCT00718159|6173261|P7|NOT COMPLETED|Overall Study||1
2519256|NCT00718159|6173262|P6|NOT COMPLETED|Overall Study||1
2519257|NCT00718159|6173263|P5|NOT COMPLETED|Overall Study||8
2519258|NCT00718159|6173264|P4|NOT COMPLETED|Overall Study||4
2519259|NCT00718159|6173265|P3|NOT COMPLETED|Overall Study||3
2519260|NCT00718159|6173266|P2|NOT COMPLETED|Overall Study||3
2519261|NCT00718159|6173267|P1|NOT COMPLETED|Overall Study||3
2519262|NCT00718159|6173261|P7|COMPLETED|Overall Study||0
2519263|NCT00718159|6173262|P6|COMPLETED|Overall Study||0
2519264|NCT00718159|6173263|P5|COMPLETED|Overall Study||0
2519265|NCT00718159|6173264|P4|COMPLETED|Overall Study||0
2519266|NCT00718159|6173265|P3|COMPLETED|Overall Study||0
2519267|NCT00718159|6173266|P2|COMPLETED|Overall Study||0
2519268|NCT00718159|6173267|P1|COMPLETED|Overall Study||0
2519269|NCT00718159|6173261|P7|Received at Least 1 Dose of Study Drug|Overall Study||1
2519270|NCT00718159|6173262|P6|Received at Least 1 Dose of Study Drug|Overall Study||1
2519271|NCT00718159|6173263|P5|Received at Least 1 Dose of Study Drug|Overall Study||8
2519272|NCT00718159|6173264|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
2519273|NCT00718159|6173265|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
2519274|NCT00718159|6173266|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
2519275|NCT00718159|6173267|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
2519276|NCT00718159|6173261|P7|STARTED|Overall Study||1
2519277|NCT00718159|6173262|P6|STARTED|Overall Study||1
2519278|NCT00718159|6173263|P5|STARTED|Overall Study||8
2519279|NCT00718159|6173264|P4|STARTED|Overall Study||4
2519280|NCT00718159|6173265|P3|STARTED|Overall Study||3
2519281|NCT00718159|6173266|P2|STARTED|Overall Study||3
2519282|NCT00718159|6173267|P1|STARTED|Overall Study||3
2519283|NCT00718120|6173293|P2|NOT COMPLETED|Overall Study||0
2519284|NCT00718120|6173294|P1|NOT COMPLETED|Overall Study||0
2519285|NCT00718120|6173293|P2|COMPLETED|Overall Study||55
2519286|NCT00718120|6173294|P1|COMPLETED|Overall Study||55
2519287|NCT00718120|6173293|P2|STARTED|Overall Study||55
2519288|NCT00718120|6173294|P1|STARTED|Overall Study||55
2519289|NCT00718094|6173314|P2|NOT COMPLETED|Overall Study||0
2519290|NCT00718094|6173315|P1|NOT COMPLETED|Overall Study||0
2519291|NCT00718094|6173314|P2|COMPLETED|Overall Study||5
2519292|NCT00718094|6173315|P1|COMPLETED|Overall Study||15
2519293|NCT00718094|6173314|P2|STARTED|Overall Study||5
2519294|NCT00718094|6173315|P1|STARTED|Overall Study||15
2519295|NCT00718081|6173324|P3|NOT COMPLETED|Overall Study||21
2519296|NCT00718081|6173325|P2|NOT COMPLETED|Overall Study||4
2519297|NCT00718081|6173326|P1|NOT COMPLETED|Overall Study||7
2519298|NCT00718081|6173324|P3|COMPLETED|Overall Study||9
2519299|NCT00718081|6173325|P2|COMPLETED|Overall Study||25
2519300|NCT00718081|6173326|P1|COMPLETED|Overall Study||22
2519301|NCT00718081|6173324|P3|STARTED|Overall Study||30
2519302|NCT00718081|6173325|P2|STARTED|Overall Study||29
2519303|NCT00718081|6173326|P1|STARTED|Overall Study||29
2519304|NCT00718042|6173343|P6|NOT COMPLETED|Donor Follow-up||0
2519305|NCT00718042|6173344|P5|NOT COMPLETED|Donor Follow-up||19
2519306|NCT00718042|6173345|P4|NOT COMPLETED|Donor Follow-up||0
2519307|NCT00718042|6173346|P3|NOT COMPLETED|Donor Follow-up||0
2519308|NCT00718042|6173347|P2|NOT COMPLETED|Donor Follow-up||0
2519309|NCT00718042|6173348|P1|NOT COMPLETED|Donor Follow-up||13
2519310|NCT00718042|6173343|P6|COMPLETED|Donor Follow-up||0
2519311|NCT00718042|6173344|P5|COMPLETED|Donor Follow-up||24
2519312|NCT00718042|6173345|P4|COMPLETED|Donor Follow-up||0
2519313|NCT00718042|6173346|P3|COMPLETED|Donor Follow-up||0
2519314|NCT00718042|6173347|P2|COMPLETED|Donor Follow-up||0
2519315|NCT00718042|6173348|P1|COMPLETED|Donor Follow-up||23
2519316|NCT00718042|6173343|P6|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
2519317|NCT00718042|6173344|P5|STARTED|Donor Follow-up||43
2519318|NCT00718042|6173345|P4|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
2519319|NCT00718042|6173346|P3|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
2519320|NCT00718042|6173347|P2|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
2519321|NCT00718042|6173348|P1|STARTED|Donor Follow-up||36
2519322|NCT00718042|6173343|P6|NOT COMPLETED|ESA Chagas Testing||0
2519323|NCT00718042|6173344|P5|NOT COMPLETED|ESA Chagas Testing||0
2519324|NCT00718042|6173345|P4|NOT COMPLETED|ESA Chagas Testing||0
2519325|NCT00718042|6173346|P3|NOT COMPLETED|ESA Chagas Testing||0
2519326|NCT00718042|6173347|P2|NOT COMPLETED|ESA Chagas Testing||0
2519327|NCT00718042|6173348|P1|NOT COMPLETED|ESA Chagas Testing||0
2519328|NCT00718042|6173343|P6|COMPLETED|ESA Chagas Testing||330
2519329|NCT00718042|6173344|P5|COMPLETED|ESA Chagas Testing||43
2519330|NCT00718042|6173345|P4|COMPLETED|ESA Chagas Testing||110
2519331|NCT00718042|6173346|P3|COMPLETED|ESA Chagas Testing||524
2519332|NCT00718042|6173347|P2|COMPLETED|ESA Chagas Testing||287
2519333|NCT00718042|6173348|P1|COMPLETED|ESA Chagas Testing||36
2519334|NCT00718042|6173343|P6|STARTED|ESA Chagas Testing|Specimens only tested with ESA Chagas|330
2519335|NCT00718042|6173344|P5|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|43
2519336|NCT00718042|6173345|P4|STARTED|ESA Chagas Testing||110
2519337|NCT00718042|6173346|P3|STARTED|ESA Chagas Testing||524
2519338|NCT00718042|6173347|P2|STARTED|ESA Chagas Testing||287
2519339|NCT00718042|6173348|P1|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|36
2519340|NCT00718042|6173343|P6|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
2519341|NCT00718042|6173344|P5|NOT COMPLETED|ABBOTT PRISM Chagas Testing||38
2519342|NCT00718042|6173345|P4|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
2519343|NCT00718042|6173346|P3|NOT COMPLETED|ABBOTT PRISM Chagas Testing||1
2519344|NCT00718042|6173347|P2|NOT COMPLETED|ABBOTT PRISM Chagas Testing||2
2519345|NCT00718042|6173348|P1|NOT COMPLETED|ABBOTT PRISM Chagas Testing||64
2519346|NCT00718042|6173343|P6|COMPLETED|ABBOTT PRISM Chagas Testing||0
2519347|NCT00718042|6173344|P5|COMPLETED|ABBOTT PRISM Chagas Testing||25511
2519348|NCT00718042|6173345|P4|COMPLETED|ABBOTT PRISM Chagas Testing||110
2519349|NCT00718042|6173346|P3|COMPLETED|ABBOTT PRISM Chagas Testing||524
2519350|NCT00718042|6173347|P2|COMPLETED|ABBOTT PRISM Chagas Testing||287
2519351|NCT00718042|6173348|P1|COMPLETED|ABBOTT PRISM Chagas Testing||16249
2519352|NCT00718042|6173343|P6|STARTED|ABBOTT PRISM Chagas Testing|Specimens not screened with PRISM Chagas assay per protocol.|0
2519353|NCT00718042|6173344|P5|STARTED|ABBOTT PRISM Chagas Testing||25549
2519354|NCT00718042|6173345|P4|STARTED|ABBOTT PRISM Chagas Testing||110
2519355|NCT00718042|6173346|P3|STARTED|ABBOTT PRISM Chagas Testing||525
2519356|NCT00718042|6173347|P2|STARTED|ABBOTT PRISM Chagas Testing||289
2519357|NCT00718042|6173348|P1|STARTED|ABBOTT PRISM Chagas Testing||16313
2519358|NCT00717977|6173360|P1|NOT COMPLETED|Overall Study||0
2519359|NCT00717977|6173360|P1|COMPLETED|Overall Study||74
2519360|NCT00717977|6173360|P1|STARTED|Overall Study||74
2519361|NCT00717912|6173388|P6|NOT COMPLETED|Overall Study||0
2519362|NCT00717912|6173389|P5|NOT COMPLETED|Overall Study||0
2519363|NCT00717912|6173390|P4|NOT COMPLETED|Overall Study||0
2519364|NCT00717912|6173391|P3|NOT COMPLETED|Overall Study||0
2519365|NCT00717912|6173392|P2|NOT COMPLETED|Overall Study||0
2519366|NCT00717912|6173393|P1|NOT COMPLETED|Overall Study||0
2519367|NCT00717912|6173388|P6|COMPLETED|Overall Study||1
2519368|NCT00717912|6173389|P5|COMPLETED|Overall Study||1
2519369|NCT00717912|6173390|P4|COMPLETED|Overall Study||1
2519370|NCT00717912|6173391|P3|COMPLETED|Overall Study||1
2519371|NCT00717912|6173392|P2|COMPLETED|Overall Study||1
2519372|NCT00717912|6173393|P1|COMPLETED|Overall Study||1
2519373|NCT00717912|6173388|P6|STARTED|Overall Study||1
2519374|NCT00717912|6173389|P5|STARTED|Overall Study||1
2519375|NCT00717912|6173390|P4|STARTED|Overall Study||1
2519376|NCT00717912|6173391|P3|STARTED|Overall Study||1
2519377|NCT00717912|6173392|P2|STARTED|Overall Study||1
2519378|NCT00717912|6173393|P1|STARTED|Overall Study||1
2519379|NCT00717886|6173404|P1|NOT COMPLETED|Overall Study||4
2519380|NCT00717886|6173404|P1|COMPLETED|Overall Study||9
2519381|NCT00717886|6173404|P1|STARTED|Overall Study||13
2519382|NCT00717873|6173410|P2|NOT COMPLETED|Overall Study||0
2519383|NCT00717873|6173411|P1|NOT COMPLETED|Overall Study||0
2519384|NCT00717873|6173410|P2|COMPLETED|Overall Study||59
2519385|NCT00717873|6173411|P1|COMPLETED|Overall Study||46
2519386|NCT00717873|6173410|P2|STARTED|Overall Study||59
2519387|NCT00717873|6173411|P1|STARTED|Overall Study||46
2519388|NCT00717860|6173419|P2|NOT COMPLETED|Overall Study||28
2519389|NCT00717860|6173420|P1|NOT COMPLETED|Overall Study||27
2519390|NCT00717860|6173419|P2|COMPLETED|Overall Study||32
2519391|NCT00717860|6173420|P1|COMPLETED|Overall Study||34
2519392|NCT00717860|6173419|P2|STARTED|Overall Study||60
2519393|NCT00717860|6173420|P1|STARTED|Overall Study||61
2519397|NCT00717574|6173436|P2|NOT COMPLETED|Overall Study||2
2519398|NCT00717574|6173437|P1|NOT COMPLETED|Overall Study||2
2519399|NCT00717574|6173436|P2|COMPLETED|Overall Study||14
2519400|NCT00717574|6173437|P1|COMPLETED|Overall Study||14
2519401|NCT00717574|6173436|P2|STARTED|Overall Study||16
2519402|NCT00717574|6173437|P1|STARTED|Overall Study||16
2519403|NCT00717522|6173443|P1|NOT COMPLETED|Overall Study||7
2519404|NCT00717522|6173443|P1|COMPLETED|Overall Study||0
2519405|NCT00717522|6173443|P1|STARTED|Overall Study||7
2519406|NCT00717418|6173452|P4|NOT COMPLETED|1-Year Follow-Up||4
2519407|NCT00717418|6173453|P3|NOT COMPLETED|1-Year Follow-Up||434
2519408|NCT00717418|6173454|P2|NOT COMPLETED|1-Year Follow-Up||51
2519409|NCT00717418|6173455|P1|NOT COMPLETED|1-Year Follow-Up||147
2519410|NCT00717418|6173452|P4|COMPLETED|1-Year Follow-Up||0
2519411|NCT00717418|6173453|P3|COMPLETED|1-Year Follow-Up||74
2519412|NCT00717418|6173454|P2|COMPLETED|1-Year Follow-Up||23
2519413|NCT00717418|6173455|P1|COMPLETED|1-Year Follow-Up||33
2519414|NCT00717418|6173452|P4|STARTED|1-Year Follow-Up||4
2519415|NCT00717418|6173453|P3|STARTED|1-Year Follow-Up||508
2519416|NCT00717418|6173454|P2|STARTED|1-Year Follow-Up||74
2519417|NCT00717418|6173455|P1|STARTED|1-Year Follow-Up||180
2519418|NCT00717418|6173452|P4|NOT COMPLETED|Baseline||15
2519419|NCT00717418|6173453|P3|NOT COMPLETED|Baseline||0
2519420|NCT00717418|6173454|P2|NOT COMPLETED|Baseline||0
2519421|NCT00717418|6173455|P1|NOT COMPLETED|Baseline||0
2519422|NCT00717418|6173452|P4|COMPLETED|Baseline||4
2519423|NCT00717418|6173453|P3|COMPLETED|Baseline||508
2519424|NCT00717418|6173454|P2|COMPLETED|Baseline||74
2519425|NCT00717418|6173455|P1|COMPLETED|Baseline||180
2519426|NCT00717418|6173452|P4|STARTED|Baseline||19
2519427|NCT00717418|6173453|P3|STARTED|Baseline||508
2519428|NCT00717418|6173454|P2|STARTED|Baseline||74
2519429|NCT00717418|6173455|P1|STARTED|Baseline||180
2519430|NCT00717405|6173460|P1|NOT COMPLETED|Overall Study||0
2519431|NCT00717405|6173460|P1|COMPLETED|Overall Study||52
2519432|NCT00717405|6173460|P1|STARTED|Overall Study||52
2519433|NCT00717366|6173479|P2|NOT COMPLETED|Extension Period (52 Weeks)||16
2519434|NCT00717366|6173480|P1|NOT COMPLETED|Extension Period (52 Weeks)||4
2519435|NCT00717366|6173479|P2|COMPLETED|Extension Period (52 Weeks)||12
2519436|NCT00717366|6173480|P1|COMPLETED|Extension Period (52 Weeks)||5
2519437|NCT00717366|6173479|P2|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||28
2519438|NCT00717366|6173480|P1|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||8
2519439|NCT00717366|6173479|P2|STARTED|Extension Period (52 Weeks)||28
2519440|NCT00717366|6173480|P1|STARTED|Extension Period (52 Weeks)||9
2519441|NCT00717366|6173479|P2|NOT COMPLETED|Core Study Period (20 Weeks)||13
2519442|NCT00717366|6173480|P1|NOT COMPLETED|Core Study Period (20 Weeks)||4
2519443|NCT00717366|6173479|P2|COMPLETED|Core Study Period (20 Weeks)||35
2519444|NCT00717366|6173480|P1|COMPLETED|Core Study Period (20 Weeks)||12
2519445|NCT00717366|6173479|P2|STARTED|Core Study Period (20 Weeks)||48
2519446|NCT00717366|6173480|P1|STARTED|Core Study Period (20 Weeks)||16
2519447|NCT00717314|6173504|P2|NOT COMPLETED|Overall Study||10
2519448|NCT00717314|6173505|P1|NOT COMPLETED|Overall Study||6
2519449|NCT00717314|6173504|P2|COMPLETED|Overall Study||34
2519450|NCT00717314|6173505|P1|COMPLETED|Overall Study||37
2519451|NCT00717314|6173504|P2|STARTED|Overall Study||44
2519452|NCT00717314|6173505|P1|STARTED|Overall Study||43
2519453|NCT00717288|6173526|P3|NOT COMPLETED|Overall Study||0
2519454|NCT00717288|6173527|P2|NOT COMPLETED|Overall Study||0
2519455|NCT00717288|6173528|P1|NOT COMPLETED|Overall Study||0
2519456|NCT00717288|6173526|P3|COMPLETED|Overall Study||25
2519457|NCT00717288|6173527|P2|COMPLETED|Overall Study||29
2519458|NCT00717288|6173528|P1|COMPLETED|Overall Study||28
2519459|NCT00717288|6173526|P3|STARTED|Overall Study||25
2519460|NCT00717288|6173527|P2|STARTED|Overall Study||29
2519461|NCT00717288|6173528|P1|STARTED|Overall Study||28
2519462|NCT00717275|6173542|P1|NOT COMPLETED|Overall Study||3
2519463|NCT00717275|6173542|P1|COMPLETED|Overall Study||0
2519464|NCT00717275|6173542|P1|STARTED|Overall Study||3
2519465|NCT00717249|6173548|P2|NOT COMPLETED|Overall Study||15
2519466|NCT00717249|6173549|P1|NOT COMPLETED|Overall Study||22
2519467|NCT00717249|6173548|P2|COMPLETED|Overall Study||150
2519468|NCT00717249|6173549|P1|COMPLETED|Overall Study||304
2519469|NCT00717249|6173548|P2|STARTED|Overall Study||165
2519470|NCT00717249|6173549|P1|STARTED|Overall Study||326
2519471|NCT00717236|6173563|P2|NOT COMPLETED|Open-Label Period||21
2519472|NCT00717236|6173564|P1|NOT COMPLETED|Open-Label Period||125
2519473|NCT00717236|6173563|P2|COMPLETED|Open-Label Period||163
2519474|NCT00717236|6173564|P1|COMPLETED|Open-Label Period||646
2519475|NCT00717236|6173563|P2|STARTED|Open-Label Period||184
2519476|NCT00717236|6173564|P1|STARTED|Open-Label Period||771
2519477|NCT00717236|6173563|P2|NOT COMPLETED|Double-Blind Period||28
2519478|NCT00717236|6173564|P1|NOT COMPLETED|Double-Blind Period||80
2519479|NCT00717236|6173563|P2|COMPLETED|Double-Blind Period||184
2519480|NCT00717236|6173564|P1|COMPLETED|Double-Blind Period||771
2519481|NCT00717236|6173563|P2|STARTED|Double-Blind Period||212
2519482|NCT00717236|6173564|P1|STARTED|Double-Blind Period||851
2519483|NCT00717197|6173633|P1|NOT COMPLETED|Overall Study||7
2519484|NCT00717197|6173633|P1|COMPLETED|Overall Study||23
2519485|NCT00717197|6173633|P1|STARTED|Overall Study||30
2519486|NCT00717093|6173639|P2|NOT COMPLETED|Overall Study||48
2519487|NCT00717093|6173640|P1|NOT COMPLETED|Overall Study||44
2519488|NCT00717093|6173639|P2|COMPLETED|Overall Study||170
2519489|NCT00717093|6173640|P1|COMPLETED|Overall Study||170
2519490|NCT00717093|6173639|P2|Received Treatment|Overall Study||218
2519491|NCT00717093|6173640|P1|Received Treatment|Overall Study||213
2519492|NCT00717093|6173639|P2|STARTED|Overall Study||218
2519493|NCT00717093|6173640|P1|STARTED|Overall Study||214
2519494|NCT00717067|6173657|P5|NOT COMPLETED|Part 2: End Stage Renal Disease||0
2519495|NCT00717067|6173658|P4|NOT COMPLETED|Part 2: End Stage Renal Disease||0
2519496|NCT00717067|6173659|P3|NOT COMPLETED|Part 2: End Stage Renal Disease||0
2519497|NCT00717067|6173660|P2|NOT COMPLETED|Part 2: End Stage Renal Disease||0
2519498|NCT00717067|6173661|P1|NOT COMPLETED|Part 2: End Stage Renal Disease||0
2519499|NCT00717067|6173657|P5|COMPLETED|Part 2: End Stage Renal Disease||6
2519500|NCT00717067|6173658|P4|COMPLETED|Part 2: End Stage Renal Disease||0
2519501|NCT00717067|6173659|P3|COMPLETED|Part 2: End Stage Renal Disease||0
2519502|NCT00717067|6173660|P2|COMPLETED|Part 2: End Stage Renal Disease||0
2519503|NCT00717067|6173661|P1|COMPLETED|Part 2: End Stage Renal Disease||0
2519504|NCT00717067|6173657|P5|STARTED|Part 2: End Stage Renal Disease||6
2519505|NCT00717067|6173658|P4|STARTED|Part 2: End Stage Renal Disease||0
2519506|NCT00717067|6173659|P3|STARTED|Part 2: End Stage Renal Disease||0
2519507|NCT00717067|6173660|P2|STARTED|Part 2: End Stage Renal Disease||0
2519508|NCT00717067|6173661|P1|STARTED|Part 2: End Stage Renal Disease||0
2519509|NCT00717067|6173657|P5|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
2519510|NCT00717067|6173658|P4|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
2519511|NCT00717067|6173659|P3|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
2519512|NCT00717067|6173660|P2|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
2519513|NCT00717067|6173661|P1|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
2519514|NCT00717067|6173657|P5|COMPLETED|Part 1b: Severe Renal Impairment||0
2519515|NCT00717067|6173658|P4|COMPLETED|Part 1b: Severe Renal Impairment||6
2519516|NCT00717067|6173659|P3|COMPLETED|Part 1b: Severe Renal Impairment||0
2519517|NCT00717067|6173660|P2|COMPLETED|Part 1b: Severe Renal Impairment||0
2519518|NCT00717067|6173661|P1|COMPLETED|Part 1b: Severe Renal Impairment||0
2519519|NCT00717067|6173657|P5|STARTED|Part 1b: Severe Renal Impairment||0
2519520|NCT00717067|6173658|P4|STARTED|Part 1b: Severe Renal Impairment||6
2519521|NCT00717067|6173659|P3|STARTED|Part 1b: Severe Renal Impairment||0
2519522|NCT00717067|6173660|P2|STARTED|Part 1b: Severe Renal Impairment||0
2519523|NCT00717067|6173661|P1|STARTED|Part 1b: Severe Renal Impairment||0
2519524|NCT00717067|6173657|P5|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
2519525|NCT00717067|6173658|P4|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
2519526|NCT00717067|6173659|P3|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||1
2519527|NCT00717067|6173660|P2|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
2519528|NCT00717067|6173661|P1|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
2519529|NCT00717067|6173657|P5|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
2519530|NCT00717067|6173658|P4|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
2519531|NCT00717067|6173659|P3|COMPLETED|Part 1a: Normal/Mild/Moderate Group||5
2519532|NCT00717067|6173660|P2|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
2519533|NCT00717067|6173661|P1|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
2519534|NCT00717067|6173657|P5|STARTED|Part 1a: Normal/Mild/Moderate Group||0
2519535|NCT00717067|6173658|P4|STARTED|Part 1a: Normal/Mild/Moderate Group||0
2519536|NCT00717067|6173659|P3|STARTED|Part 1a: Normal/Mild/Moderate Group||6
2519537|NCT00717067|6173660|P2|STARTED|Part 1a: Normal/Mild/Moderate Group||6
2519538|NCT00717067|6173661|P1|STARTED|Part 1a: Normal/Mild/Moderate Group||6
2519539|NCT00717054|6173745|P2|NOT COMPLETED|Overall Study||0
2519540|NCT00717054|6173746|P1|NOT COMPLETED|Overall Study||0
2519541|NCT00717054|6173745|P2|COMPLETED|Overall Study||57
2519542|NCT00717054|6173746|P1|COMPLETED|Overall Study||58
2519543|NCT00717054|6173745|P2|STARTED|Overall Study||57
2519544|NCT00717054|6173746|P1|STARTED|Overall Study||58
2519545|NCT00717041|6173758|P1|NOT COMPLETED|Overall Study||0
2519546|NCT00717041|6173758|P1|COMPLETED|Overall Study||1206
2519547|NCT00717041|6173758|P1|STARTED|Overall Study||1206
2519548|NCT00716976|6173768|P2|NOT COMPLETED|Overall Study||9
2519549|NCT00716976|6173769|P1|NOT COMPLETED|Overall Study||20
2519550|NCT00716976|6173768|P2|COMPLETED|Overall Study||57
2519551|NCT00716976|6173769|P1|COMPLETED|Overall Study||45
2519552|NCT00716976|6173768|P2|STARTED|Overall Study||66
2519553|NCT00716976|6173769|P1|STARTED|Overall Study||65
2519554|NCT00716963|6173791|P6|NOT COMPLETED|Overall Study||0
2519555|NCT00716963|6173792|P5|NOT COMPLETED|Overall Study||0
2519556|NCT00716963|6173793|P4|NOT COMPLETED|Overall Study||0
2519557|NCT00716963|6173794|P3|NOT COMPLETED|Overall Study||0
2519558|NCT00716963|6173795|P2|NOT COMPLETED|Overall Study||0
2519559|NCT00716963|6173796|P1|NOT COMPLETED|Overall Study||1
2519560|NCT00716963|6173791|P6|COMPLETED|Overall Study||1
2519561|NCT00716963|6173792|P5|COMPLETED|Overall Study||1
2519562|NCT00716963|6173793|P4|COMPLETED|Overall Study||1
2519563|NCT00716963|6173794|P3|COMPLETED|Overall Study||1
2519564|NCT00716963|6173795|P2|COMPLETED|Overall Study||1
2519565|NCT00716963|6173796|P1|COMPLETED|Overall Study||1
2519566|NCT00716963|6173791|P6|STARTED|Overall Study||1
2519567|NCT00716963|6173792|P5|STARTED|Overall Study||1
2519568|NCT00716963|6173793|P4|STARTED|Overall Study||1
2519569|NCT00716963|6173794|P3|STARTED|Overall Study||1
2519570|NCT00716963|6173795|P2|STARTED|Overall Study||1
2519571|NCT00716963|6173796|P1|STARTED|Overall Study||2
2519572|NCT00716859|6173809|P2|NOT COMPLETED|Overall Study||5
2519573|NCT00716859|6173810|P1|NOT COMPLETED|Overall Study||9
2519574|NCT00716859|6173809|P2|COMPLETED|Overall Study||64
2519575|NCT00716859|6173810|P1|COMPLETED|Overall Study||61
2519576|NCT00716859|6173809|P2|Received Treatment|Overall Study||68
2519577|NCT00716859|6173810|P1|Received Treatment|Overall Study||69
2519578|NCT00716859|6173809|P2|STARTED|Overall Study||69
2519579|NCT00716859|6173810|P1|STARTED|Overall Study||70
2519580|NCT00716820|6173834|P1|NOT COMPLETED|Overall Study||0
2519581|NCT00716820|6173834|P1|COMPLETED|Overall Study||472
2519582|NCT00716820|6173834|P1|STARTED|Overall Study||472
2519583|NCT00716807|6173869|P4|NOT COMPLETED|Overall Study||0
2519584|NCT00716807|6173870|P3|NOT COMPLETED|Overall Study||0
2519585|NCT00716807|6173871|P2|NOT COMPLETED|Overall Study||0
2519586|NCT00716807|6173872|P1|NOT COMPLETED|Overall Study||0
2519587|NCT00716807|6173869|P4|COMPLETED|Overall Study||15
2519588|NCT00716807|6173870|P3|COMPLETED|Overall Study||18
2519589|NCT00716807|6173871|P2|COMPLETED|Overall Study||5
2519590|NCT00716807|6173872|P1|COMPLETED|Overall Study||8
2519591|NCT00716807|6173869|P4|STARTED|Overall Study||15
2519592|NCT00716807|6173870|P3|STARTED|Overall Study||18
2519593|NCT00716807|6173871|P2|STARTED|Overall Study||5
2519594|NCT00716807|6173872|P1|STARTED|Overall Study||8
2519595|NCT00716742|6173885|P3|NOT COMPLETED|3 Year Follow-up||21
2519596|NCT00716742|6173886|P2|NOT COMPLETED|3 Year Follow-up||32
2519597|NCT00716742|6173887|P1|NOT COMPLETED|3 Year Follow-up||30
2519598|NCT00716742|6173885|P3|COMPLETED|3 Year Follow-up||29
2519599|NCT00716742|6173886|P2|COMPLETED|3 Year Follow-up||35
2519600|NCT00716742|6173887|P1|COMPLETED|3 Year Follow-up||26
2519601|NCT00716742|6173885|P3|STARTED|3 Year Follow-up||50
2519602|NCT00716742|6173886|P2|STARTED|3 Year Follow-up||67
2519603|NCT00716742|6173887|P1|STARTED|3 Year Follow-up||56
2519604|NCT00716742|6173885|P3|NOT COMPLETED|2 Year Follow-up||102
2519605|NCT00716742|6173886|P2|NOT COMPLETED|2 Year Follow-up||96
2519606|NCT00716742|6173887|P1|NOT COMPLETED|2 Year Follow-up||104
2519607|NCT00716742|6173885|P3|COMPLETED|2 Year Follow-up||50
2519608|NCT00716742|6173886|P2|COMPLETED|2 Year Follow-up||67
2519609|NCT00716742|6173887|P1|COMPLETED|2 Year Follow-up||56
2519610|NCT00716742|6173885|P3|STARTED|2 Year Follow-up||152
2519611|NCT00716742|6173886|P2|STARTED|2 Year Follow-up||163
2519612|NCT00716742|6173887|P1|STARTED|2 Year Follow-up||160
2519613|NCT00716742|6173885|P3|NOT COMPLETED|1 Year Follow-up||200
2519614|NCT00716742|6173886|P2|NOT COMPLETED|1 Year Follow-up||193
2519615|NCT00716742|6173887|P1|NOT COMPLETED|1 Year Follow-up||187
2519616|NCT00716742|6173885|P3|COMPLETED|1 Year Follow-up||152
2519617|NCT00716742|6173886|P2|COMPLETED|1 Year Follow-up||163
2519618|NCT00716742|6173887|P1|COMPLETED|1 Year Follow-up||160
2519619|NCT00716742|6173885|P3|STARTED|1 Year Follow-up||352
2519620|NCT00716742|6173886|P2|STARTED|1 Year Follow-up||356
2519621|NCT00716742|6173887|P1|STARTED|1 Year Follow-up||347
2519622|NCT00716742|6173885|P3|NOT COMPLETED|Baseline||13
2519623|NCT00716742|6173886|P2|NOT COMPLETED|Baseline||14
2519624|NCT00716742|6173887|P1|NOT COMPLETED|Baseline||17
2519625|NCT00716742|6173885|P3|COMPLETED|Baseline||352
2519626|NCT00716742|6173886|P2|COMPLETED|Baseline||356
2519627|NCT00716742|6173887|P1|COMPLETED|Baseline||347
2519628|NCT00716742|6173885|P3|STARTED|Baseline||365
2519629|NCT00716742|6173886|P2|STARTED|Baseline||370
2519630|NCT00716742|6173887|P1|STARTED|Baseline||364
2519631|NCT00716625|6173895|P1|NOT COMPLETED|Overall Study||1
2519632|NCT00716625|6173895|P1|COMPLETED|Overall Study||1673
2519633|NCT00716625|6173895|P1|STARTED|Overall Study||1674
2519634|NCT00716482|6173920|P1|NOT COMPLETED|Overall Study||119
2519635|NCT00716482|6173920|P1|COMPLETED|Overall Study||1562
2519636|NCT00716482|6173920|P1|STARTED|Overall Study||1681
2519637|NCT00716456|6173933|P3|NOT COMPLETED|Overall Study||0
2519638|NCT00716456|6173934|P2|NOT COMPLETED|Overall Study||2
2519639|NCT00716456|6173935|P1|NOT COMPLETED|Overall Study||0
2519640|NCT00716456|6173933|P3|COMPLETED|Overall Study||13
2519641|NCT00716456|6173934|P2|COMPLETED|Overall Study||3
2519642|NCT00716456|6173935|P1|COMPLETED|Overall Study||3
2519643|NCT00716456|6173933|P3|STARTED|Overall Study||13
2519644|NCT00716456|6173934|P2|STARTED|Overall Study||5
2519645|NCT00716456|6173935|P1|STARTED|Overall Study||3
2519646|NCT00716443|6173943|P1|NOT COMPLETED|Overall Study||0
2519647|NCT00716443|6173943|P1|COMPLETED|Overall Study||51
2519648|NCT00716443|6173943|P1|STARTED|Overall Study||51
2519649|NCT00716417|6173986|P10|NOT COMPLETED|Overall Study||3
2519650|NCT00716417|6173987|P9|NOT COMPLETED|Overall Study||5
2519651|NCT00716417|6173988|P8|NOT COMPLETED|Overall Study||3
2519652|NCT00716417|6173989|P7|NOT COMPLETED|Overall Study||7
2519653|NCT00716417|6173990|P6|NOT COMPLETED|Overall Study||3
2519654|NCT00716417|6173991|P5|NOT COMPLETED|Overall Study||1
2519655|NCT00716417|6173992|P4|NOT COMPLETED|Overall Study||11
2519656|NCT00716417|6173993|P3|NOT COMPLETED|Overall Study||5
2519657|NCT00716417|6173994|P2|NOT COMPLETED|Overall Study||6
2519658|NCT00716417|6173995|P1|NOT COMPLETED|Overall Study||3
2519659|NCT00716417|6173986|P10|COMPLETED|Overall Study||0
2519660|NCT00716417|6173987|P9|COMPLETED|Overall Study||0
2519661|NCT00716417|6173988|P8|COMPLETED|Overall Study||0
2519662|NCT00716417|6173989|P7|COMPLETED|Overall Study||0
2519663|NCT00716417|6173990|P6|COMPLETED|Overall Study||0
2519664|NCT00716417|6173991|P5|COMPLETED|Overall Study||0
2519665|NCT00716417|6173992|P4|COMPLETED|Overall Study||0
2519666|NCT00716417|6173993|P3|COMPLETED|Overall Study||0
2519667|NCT00716417|6173994|P2|COMPLETED|Overall Study||0
2519668|NCT00716417|6173995|P1|COMPLETED|Overall Study||0
2519669|NCT00716417|6173986|P10|STARTED|Overall Study||3
2519670|NCT00716417|6173987|P9|STARTED|Overall Study||5
2519671|NCT00716417|6173988|P8|STARTED|Overall Study||3
2519672|NCT00716417|6173989|P7|STARTED|Overall Study||7
2519673|NCT00716417|6173990|P6|STARTED|Overall Study||3
2519674|NCT00716417|6173991|P5|STARTED|Overall Study||1
2519675|NCT00716417|6173992|P4|STARTED|Overall Study||11
2519676|NCT00716417|6173993|P3|STARTED|Overall Study||5
2519677|NCT00716417|6173994|P2|STARTED|Overall Study||6
2519678|NCT00716417|6173995|P1|STARTED|Overall Study||3
2519679|NCT00716274|6174042|P6|NOT COMPLETED|Study Period III (16-Weeks)||0
2519680|NCT00716274|6174043|P5|NOT COMPLETED|Study Period III (16-Weeks)||3
2519681|NCT00716274|6174044|P4|NOT COMPLETED|Study Period III (16-Weeks)||1
2519682|NCT00716274|6174045|P3|NOT COMPLETED|Study Period III (16-Weeks)||2
2519683|NCT00716274|6174046|P2|NOT COMPLETED|Study Period III (16-Weeks)||0
2519684|NCT00716274|6174047|P1|NOT COMPLETED|Study Period III (16-Weeks)||0
2519685|NCT00716274|6174042|P6|COMPLETED|Study Period III (16-Weeks)||19
2519686|NCT00716274|6174043|P5|COMPLETED|Study Period III (16-Weeks)||32
2519687|NCT00716274|6174044|P4|COMPLETED|Study Period III (16-Weeks)||17
2519688|NCT00716274|6174045|P3|COMPLETED|Study Period III (16-Weeks)||16
2519689|NCT00716274|6174046|P2|COMPLETED|Study Period III (16-Weeks)||0
2519690|NCT00716274|6174047|P1|COMPLETED|Study Period III (16-Weeks)||0
2519691|NCT00716274|6174042|P6|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|19
2519692|NCT00716274|6174043|P5|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|35
2519693|NCT00716274|6174044|P4|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18
2519694|NCT00716274|6174045|P3|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18
2519695|NCT00716274|6174046|P2|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0
2519696|NCT00716274|6174047|P1|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0
2519697|NCT00716274|6174042|P6|NOT COMPLETED|Study Period II (16-Weeks)||2
2519698|NCT00716274|6174043|P5|NOT COMPLETED|Study Period II (16-Weeks)||0
2519699|NCT00716274|6174044|P4|NOT COMPLETED|Study Period II (16-Weeks)||0
2519700|NCT00716274|6174045|P3|NOT COMPLETED|Study Period II (16-Weeks)||0
2519701|NCT00716274|6174046|P2|NOT COMPLETED|Study Period II (16-Weeks)||9
2519702|NCT00716274|6174047|P1|NOT COMPLETED|Study Period II (16-Weeks)||9
2519703|NCT00716274|6174042|P6|COMPLETED|Study Period II (16-Weeks)||19
2519704|NCT00716274|6174043|P5|COMPLETED|Study Period II (16-Weeks)||0
2519705|NCT00716274|6174044|P4|COMPLETED|Study Period II (16-Weeks)||0
2519706|NCT00716274|6174045|P3|COMPLETED|Study Period II (16-Weeks)||0
2519707|NCT00716274|6174046|P2|COMPLETED|Study Period II (16-Weeks)||35
2519708|NCT00716274|6174047|P1|COMPLETED|Study Period II (16-Weeks)||36
2519709|NCT00716274|6174042|P6|STARTED|Study Period II (16-Weeks)||21
2519710|NCT00716274|6174043|P5|STARTED|Study Period II (16-Weeks)||0
2519711|NCT00716274|6174044|P4|STARTED|Study Period II (16-Weeks)||0
2519712|NCT00716274|6174045|P3|STARTED|Study Period II (16-Weeks)||0
2519713|NCT00716274|6174046|P2|STARTED|Study Period II (16-Weeks)||44
2519714|NCT00716274|6174047|P1|STARTED|Study Period II (16-Weeks)||45
2519715|NCT00716144|6174181|P4|NOT COMPLETED|Overall Study||12
2519716|NCT00716144|6174182|P3|NOT COMPLETED|Overall Study||12
2519717|NCT00716144|6174183|P2|NOT COMPLETED|Overall Study||7
2519718|NCT00716144|6174184|P1|NOT COMPLETED|Overall Study||9
2519719|NCT00716144|6174181|P4|COMPLETED|Overall Study||33
2519720|NCT00716144|6174182|P3|COMPLETED|Overall Study||33
2519721|NCT00716144|6174183|P2|COMPLETED|Overall Study||38
2519722|NCT00716144|6174184|P1|COMPLETED|Overall Study||32
2519723|NCT00716144|6174181|P4|STARTED|Overall Study||45
2519724|NCT00716144|6174182|P3|STARTED|Overall Study||45
2519725|NCT00716144|6174183|P2|STARTED|Overall Study||45
2519726|NCT00716144|6174184|P1|STARTED|Overall Study||41
2519727|NCT00716092|6174209|P3|NOT COMPLETED|Overall Study||0
2519728|NCT00716092|6174210|P2|NOT COMPLETED|Overall Study||1
2519729|NCT00716092|6174211|P1|NOT COMPLETED|Overall Study||2
2519730|NCT00716092|6174209|P3|COMPLETED|Overall Study||41
2519731|NCT00716092|6174210|P2|COMPLETED|Overall Study||39
2519732|NCT00716092|6174211|P1|COMPLETED|Overall Study||38
2519733|NCT00716092|6174209|P3|STARTED|Overall Study||41
2519734|NCT00716092|6174210|P2|STARTED|Overall Study||40
2519735|NCT00716092|6174211|P1|STARTED|Overall Study||40
2519736|NCT00716079|6174242|P2|NOT COMPLETED|Overall Study||15
2519737|NCT00716079|6174243|P1|NOT COMPLETED|Overall Study||9
2519738|NCT00716079|6174242|P2|COMPLETED|Overall Study||1421
2519739|NCT00716079|6174243|P1|COMPLETED|Overall Study||1394
2519740|NCT00716079|6174242|P2|STARTED|Overall Study||1436
2519741|NCT00716079|6174243|P1|STARTED|Overall Study||1403
2519742|NCT00715962|6174253|P2|NOT COMPLETED|Overall Study||2
2519743|NCT00715962|6174254|P1|NOT COMPLETED|Overall Study||6
2519744|NCT00715962|6174253|P2|COMPLETED|Overall Study||48
2519745|NCT00715962|6174254|P1|COMPLETED|Overall Study||44
2519746|NCT00715962|6174253|P2|STARTED|Overall Study||50
2519747|NCT00715962|6174254|P1|STARTED|Overall Study||50
2519748|NCT00715949|6174264|P1|NOT COMPLETED|Overall Study||4
2519749|NCT00715949|6174264|P1|COMPLETED|Overall Study|116 patients completed first test|116
2519750|NCT00715949|6174264|P1|STARTED|Overall Study|4 dropped because could not finish first test|120
2519751|NCT00715910|6174272|P6|NOT COMPLETED|Booster and ESFU Phase||13
2519752|NCT00715910|6174273|P5|NOT COMPLETED|Booster and ESFU Phase||2
2519753|NCT00715910|6174274|P4|NOT COMPLETED|Booster and ESFU Phase||11
2519754|NCT00715910|6174275|P3|NOT COMPLETED|Booster and ESFU Phase||0
2519755|NCT00715910|6174276|P2|NOT COMPLETED|Booster and ESFU Phase||0
2519756|NCT00715910|6174277|P1|NOT COMPLETED|Booster and ESFU Phase||0
2519757|NCT00715910|6174272|P6|COMPLETED|Booster and ESFU Phase||88
2519758|NCT00715910|6174273|P5|COMPLETED|Booster and ESFU Phase||36
2519759|NCT00715910|6174274|P4|COMPLETED|Booster and ESFU Phase||172
2519760|NCT00715910|6174275|P3|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
2519761|NCT00715910|6174276|P2|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
2519762|NCT00715910|6174277|P1|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
2519763|NCT00715910|6174272|P6|STARTED|Booster and ESFU Phase||101
2519764|NCT00715910|6174273|P5|STARTED|Booster and ESFU Phase||38
2519765|NCT00715910|6174274|P4|STARTED|Booster and ESFU Phase||183
2519766|NCT00715910|6174275|P3|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
2519767|NCT00715910|6174276|P2|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
2519768|NCT00715910|6174277|P1|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
2519769|NCT00715910|6174272|P6|NOT COMPLETED|Year 5||0
2519770|NCT00715910|6174273|P5|NOT COMPLETED|Year 5||0
2519771|NCT00715910|6174274|P4|NOT COMPLETED|Year 5||0
2519772|NCT00715910|6174275|P3|NOT COMPLETED|Year 5||0
2519773|NCT00715910|6174276|P2|NOT COMPLETED|Year 5||0
2519774|NCT00715910|6174277|P1|NOT COMPLETED|Year 5||0
2519775|NCT00715910|6174272|P6|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
2519776|NCT00715910|6174273|P5|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
2519777|NCT00715910|6174274|P4|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
2519778|NCT00715910|6174275|P3|COMPLETED|Year 5||38
2519779|NCT00715910|6174276|P2|COMPLETED|Year 5||56
2519780|NCT00715910|6174277|P1|COMPLETED|Year 5||218
2519781|NCT00715910|6174272|P6|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
2519782|NCT00715910|6174273|P5|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
2519783|NCT00715910|6174274|P4|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
2519784|NCT00715910|6174275|P3|STARTED|Year 5||38
2519785|NCT00715910|6174276|P2|STARTED|Year 5||56
2519786|NCT00715910|6174277|P1|STARTED|Year 5||218
2519787|NCT00715910|6174272|P6|NOT COMPLETED|Year 3||0
2519788|NCT00715910|6174273|P5|NOT COMPLETED|Year 3||0
2519789|NCT00715910|6174274|P4|NOT COMPLETED|Year 3||0
2519790|NCT00715910|6174275|P3|NOT COMPLETED|Year 3||0
2519791|NCT00715910|6174276|P2|NOT COMPLETED|Year 3||0
2519792|NCT00715910|6174277|P1|NOT COMPLETED|Year 3||0
2519793|NCT00715910|6174272|P6|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
2519794|NCT00715910|6174273|P5|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
2519795|NCT00715910|6174274|P4|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
2519796|NCT00715910|6174275|P3|COMPLETED|Year 3||56
2519797|NCT00715910|6174276|P2|COMPLETED|Year 3||86
2519798|NCT00715910|6174277|P1|COMPLETED|Year 3||345
2519799|NCT00715910|6174272|P6|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
2519800|NCT00715910|6174273|P5|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
2519801|NCT00715910|6174274|P4|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
2519802|NCT00715910|6174275|P3|STARTED|Year 3||56
2519803|NCT00715910|6174276|P2|STARTED|Year 3||86
2519804|NCT00715910|6174277|P1|STARTED|Year 3||345
2519805|NCT00715910|6174272|P6|NOT COMPLETED|Year 1||0
2519806|NCT00715910|6174273|P5|NOT COMPLETED|Year 1||0
2519807|NCT00715910|6174274|P4|NOT COMPLETED|Year 1||0
2519808|NCT00715910|6174275|P3|NOT COMPLETED|Year 1||0
2519809|NCT00715910|6174276|P2|NOT COMPLETED|Year 1||0
2519810|NCT00715910|6174277|P1|NOT COMPLETED|Year 1||0
2519811|NCT00715910|6174272|P6|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
2519812|NCT00715910|6174273|P5|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
2519813|NCT00715910|6174274|P4|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
2519814|NCT00715910|6174275|P3|COMPLETED|Year 1||68
2519815|NCT00715910|6174276|P2|COMPLETED|Year 1||147
2519816|NCT00715910|6174277|P1|COMPLETED|Year 1||433
2519817|NCT00715910|6174272|P6|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
2519818|NCT00715910|6174273|P5|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
2519819|NCT00715910|6174274|P4|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
2519820|NCT00715910|6174275|P3|STARTED|Year 1||68
2519821|NCT00715910|6174276|P2|STARTED|Year 1||147
2519822|NCT00715910|6174277|P1|STARTED|Year 1||433
2519823|NCT00715884|6174353|P2|NOT COMPLETED|Overall Study||1
2519824|NCT00715884|6174354|P1|NOT COMPLETED|Overall Study||8
2519825|NCT00715884|6174353|P2|COMPLETED|Overall Study||225
2519826|NCT00715884|6174354|P1|COMPLETED|Overall Study||444
2519827|NCT00715884|6174353|P2|STARTED|Overall Study||226
2519828|NCT00715884|6174354|P1|STARTED|Overall Study||452
2519829|NCT00715793|6174396|P2|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||2
2519830|NCT00715793|6174397|P1|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
2519831|NCT00715793|6174396|P2|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||27
2519832|NCT00715793|6174397|P1|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
2519833|NCT00715793|6174396|P2|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||29
2519834|NCT00715793|6174397|P1|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
2519835|NCT00715793|6174396|P2|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||0
2519836|NCT00715793|6174397|P1|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||1
2519837|NCT00715793|6174396|P2|COMPLETED|Phase 1 RP2D DAC + TMZ||6
2519838|NCT00715793|6174397|P1|COMPLETED|Phase 1 RP2D DAC + TMZ||3
2519839|NCT00715793|6174396|P2|STARTED|Phase 1 RP2D DAC + TMZ||6
2519840|NCT00715793|6174397|P1|STARTED|Phase 1 RP2D DAC + TMZ||4
2519841|NCT00715754|6174409|P1|NOT COMPLETED|Overall Study||0
2519842|NCT00715754|6174409|P1|COMPLETED|Overall Study||47
2519843|NCT00715754|6174409|P1|STARTED|Overall Study||47
2519844|NCT00715741|6174419|P4|NOT COMPLETED|Overall Study||0
2519845|NCT00715741|6174420|P3|NOT COMPLETED|Overall Study||0
2519846|NCT00715741|6174421|P2|NOT COMPLETED|Overall Study||0
2519847|NCT00715741|6174422|P1|NOT COMPLETED|Overall Study||0
2519848|NCT00715741|6174419|P4|COMPLETED|Overall Study||25
2519849|NCT00715741|6174420|P3|COMPLETED|Overall Study||25
2519850|NCT00715741|6174421|P2|COMPLETED|Overall Study||25
2519851|NCT00715741|6174422|P1|COMPLETED|Overall Study||25
2519852|NCT00715741|6174419|P4|STARTED|Overall Study||25
2519853|NCT00715741|6174420|P3|STARTED|Overall Study||25
2519854|NCT00715741|6174421|P2|STARTED|Overall Study||25
2519855|NCT00715741|6174422|P1|STARTED|Overall Study||25
2519856|NCT00715728|6174446|P2|NOT COMPLETED|Overall Study||0
2519857|NCT00715728|6174447|P1|NOT COMPLETED|Overall Study||0
2519858|NCT00715728|6174446|P2|COMPLETED|Overall Study||14
2519859|NCT00715728|6174447|P1|COMPLETED|Overall Study||14
2519860|NCT00715728|6174446|P2|STARTED|Overall Study||14
2519861|NCT00715728|6174447|P1|STARTED|Overall Study||14
2519862|NCT00715676|6174458|P3|NOT COMPLETED|Overall Study||32
2519863|NCT00715676|6174459|P2|NOT COMPLETED|Overall Study||11
2519864|NCT00715676|6174460|P1|NOT COMPLETED|Overall Study||6
2519865|NCT00715676|6174458|P3|COMPLETED|Overall Study||21
2519866|NCT00715676|6174459|P2|COMPLETED|Overall Study||43
2519867|NCT00715676|6174460|P1|COMPLETED|Overall Study||43
2519868|NCT00715676|6174458|P3|STARTED|Overall Study||53
2519869|NCT00715676|6174459|P2|STARTED|Overall Study||54
2519870|NCT00715676|6174460|P1|STARTED|Overall Study|1 additional subject was enrolled in the placebo group but discontinued before taking any study drug|49
2519871|NCT00715650|6174488|P2|NOT COMPLETED|Follow-up||5
2519872|NCT00715650|6174489|P1|NOT COMPLETED|Follow-up||13
2519873|NCT00715650|6174488|P2|COMPLETED|Follow-up||37
2519874|NCT00715650|6174489|P1|COMPLETED|Follow-up||29
2519875|NCT00715650|6174488|P2|Completed Month 6 Follow-up|Follow-up||37
2519876|NCT00715650|6174489|P1|Completed Month 6 Follow-up|Follow-up||29
2519877|NCT00715650|6174488|P2|Completed Month 3 Follow-up|Follow-up||40
2519878|NCT00715650|6174489|P1|Completed Month 3 Follow-up|Follow-up||35
2519879|NCT00715650|6174488|P2|Completed Month 1 Follow-up|Follow-up||38
2519880|NCT00715650|6174489|P1|Completed Month 1 Follow-up|Follow-up||40
2519881|NCT00715650|6174488|P2|STARTED|Follow-up||42
2519882|NCT00715650|6174489|P1|STARTED|Follow-up||42
2519883|NCT00715650|6174488|P2|NOT COMPLETED|Intervention||3
2519884|NCT00715650|6174489|P1|NOT COMPLETED|Intervention||5
2519885|NCT00715650|6174488|P2|COMPLETED|Intervention||42
2519886|NCT00715650|6174489|P1|COMPLETED|Intervention||42
2519887|NCT00715650|6174488|P2|Attended ≥ 3 Sessions|Intervention||17
2519888|NCT00715650|6174489|P1|Attended ≥ 3 Sessions|Intervention||23
2519889|NCT00715650|6174488|P2|Attended ≥ 2 Sessions|Intervention||33
2519890|NCT00715650|6174489|P1|Attended ≥ 2 Sessions|Intervention||36
2519891|NCT00715650|6174488|P2|Received Any Session|Intervention||38
2519892|NCT00715650|6174489|P1|Received Any Session|Intervention||39
2519893|NCT00715650|6174488|P2|STARTED|Intervention||45
2519894|NCT00715650|6174489|P1|STARTED|Intervention||47
2519895|NCT00715624|6174503|P2|NOT COMPLETED|Overall Study||116
2519896|NCT00715624|6174504|P1|NOT COMPLETED|Overall Study||52
2519897|NCT00715624|6174503|P2|COMPLETED|Overall Study||213
2519898|NCT00715624|6174504|P1|COMPLETED|Overall Study||115
2519899|NCT00715624|6174503|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||327
2519900|NCT00715624|6174504|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|166
2519901|NCT00715624|6174503|P2|Treated/Safety Population|Overall Study||328
2519902|NCT00715624|6174504|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|167
2519903|NCT00715624|6174503|P2|STARTED|Overall Study||329
2519904|NCT00715624|6174504|P1|STARTED|Overall Study|Randomized|167
2519905|NCT00715559|6174532|P1|NOT COMPLETED|Overall Study||1
2519906|NCT00715559|6174532|P1|COMPLETED|Overall Study||2
2519907|NCT00715559|6174532|P1|STARTED|Overall Study||3
2519908|NCT00715520|6174542|P3|NOT COMPLETED|Overall Study||2
2519909|NCT00715520|6174543|P2|NOT COMPLETED|Overall Study||1
2519910|NCT00715520|6174544|P1|NOT COMPLETED|Overall Study||10
2519911|NCT00715520|6174542|P3|COMPLETED|Overall Study||1
2519912|NCT00715520|6174543|P2|COMPLETED|Overall Study||9
2519913|NCT00715520|6174544|P1|COMPLETED|Overall Study||10
2519914|NCT00715520|6174542|P3|STARTED|Overall Study||3
2519915|NCT00715520|6174543|P2|STARTED|Overall Study||10
2519916|NCT00715520|6174544|P1|STARTED|Overall Study||20
2519917|NCT00715429|6174559|P2|NOT COMPLETED|Overall Study||1
2519918|NCT00715429|6174560|P1|NOT COMPLETED|Overall Study||0
2519919|NCT00715429|6174559|P2|COMPLETED|Overall Study||6
2519920|NCT00715429|6174560|P1|COMPLETED|Overall Study||7
2519921|NCT00715429|6174559|P2|STARTED|Overall Study||7
2519922|NCT00715429|6174560|P1|STARTED|Overall Study||7
2519923|NCT00715403|6174575|P7|NOT COMPLETED|Overall Study||1
2519924|NCT00715403|6174576|P6|NOT COMPLETED|Overall Study||19
2519925|NCT00715403|6174577|P5|NOT COMPLETED|Overall Study||6
2519926|NCT00715403|6174578|P4|NOT COMPLETED|Overall Study||9
2519927|NCT00715403|6174579|P3|NOT COMPLETED|Overall Study||4
2519928|NCT00715403|6174580|P2|NOT COMPLETED|Overall Study||1
2519929|NCT00715403|6174581|P1|NOT COMPLETED|Overall Study||1
2519930|NCT00715403|6174575|P7|COMPLETED|Overall Study||0
2519931|NCT00715403|6174576|P6|COMPLETED|Overall Study||0
2519932|NCT00715403|6174577|P5|COMPLETED|Overall Study||0
2519933|NCT00715403|6174578|P4|COMPLETED|Overall Study||0
2519934|NCT00715403|6174579|P3|COMPLETED|Overall Study||0
2519935|NCT00715403|6174580|P2|COMPLETED|Overall Study||0
2519936|NCT00715403|6174581|P1|COMPLETED|Overall Study||0
2519937|NCT00715403|6174575|P7|STARTED|Overall Study||1
2519938|NCT00715403|6174576|P6|STARTED|Overall Study||19
2519939|NCT00715403|6174577|P5|STARTED|Overall Study||6
2519940|NCT00715403|6174578|P4|STARTED|Overall Study||9
2519941|NCT00715403|6174579|P3|STARTED|Overall Study||4
2519942|NCT00715403|6174580|P2|STARTED|Overall Study||1
2519943|NCT00715403|6174581|P1|STARTED|Overall Study||1
2519944|NCT00715390|6174716|P1|NOT COMPLETED|Overall Study||0
2519945|NCT00715390|6174716|P1|COMPLETED|Overall Study|These were broken down to different types of dysrhythymia.|234
2519946|NCT00715390|6174716|P1|Eligible|Overall Study||234
2519947|NCT00715390|6174716|P1|STARTED|Overall Study|114,209 Anesthetic records were screened to identify 234 records.|234
2519948|NCT00715299|6174720|P1|NOT COMPLETED|Overall Study||6
2519949|NCT00715299|6174720|P1|COMPLETED|Overall Study||30
2519950|NCT00715299|6174720|P1|STARTED|Overall Study|A total of 38 participants were consented to the study, but only 36 made it to day one of testing.|36
2519951|NCT00715208|6174726|P2|NOT COMPLETED|Overall Study||9
2519952|NCT00715208|6174727|P1|NOT COMPLETED|Overall Study||1
2519953|NCT00715208|6174726|P2|COMPLETED|Overall Study||39
2519954|NCT00715208|6174727|P1|COMPLETED|Overall Study||6
2519955|NCT00715208|6174726|P2|STARTED|Overall Study||48
2519956|NCT00715208|6174727|P1|STARTED|Overall Study||7
2519957|NCT00715117|6174743|P2|NOT COMPLETED|Overall Study||1
2519958|NCT00715117|6174744|P1|NOT COMPLETED|Overall Study||0
2519959|NCT00715117|6174743|P2|COMPLETED|Overall Study|One subject flared and was rescued with steroids|5
2519960|NCT00715117|6174744|P1|COMPLETED|Overall Study||6
2519961|NCT00715117|6174743|P2|Completion fo 8 Week Study|Overall Study||6
2519962|NCT00715117|6174744|P1|Completion fo 8 Week Study|Overall Study||6
2519963|NCT00715117|6174743|P2|STARTED|Overall Study||6
2519964|NCT00715117|6174744|P1|STARTED|Overall Study||6
2519965|NCT00715104|6174758|P3|NOT COMPLETED|Overall Study||0
2519966|NCT00715104|6174759|P2|NOT COMPLETED|Overall Study||0
2519967|NCT00715104|6174760|P1|NOT COMPLETED|Overall Study||0
2519968|NCT00715104|6174758|P3|COMPLETED|Overall Study||8
2519969|NCT00715104|6174759|P2|COMPLETED|Overall Study||16
2519970|NCT00715104|6174760|P1|COMPLETED|Overall Study||18
2519971|NCT00715104|6174758|P3|STARTED|Overall Study||8
2519972|NCT00715104|6174759|P2|STARTED|Overall Study||16
2519973|NCT00715104|6174760|P1|STARTED|Overall Study||18
2519974|NCT00715078|6174812|P3|NOT COMPLETED|Overall Study||38
2519975|NCT00715078|6174813|P2|NOT COMPLETED|Overall Study||36
2519976|NCT00715078|6174814|P1|NOT COMPLETED|Overall Study||30
2519977|NCT00715078|6174812|P3|COMPLETED|Overall Study||3
2519978|NCT00715078|6174813|P2|COMPLETED|Overall Study||4
2519979|NCT00715078|6174814|P1|COMPLETED|Overall Study||11
2519980|NCT00715078|6174812|P3|Received ≥ 1 Leukapheresis|Overall Study||40
2519981|NCT00715078|6174813|P2|Received ≥ 1 Leukapheresis|Overall Study||40
2519982|NCT00715078|6174814|P1|Received ≥ 1 Leukapheresis|Overall Study||40
2519983|NCT00715078|6174812|P3|Received ≥ 1 Study Infusion|Overall Study||39
2519984|NCT00715078|6174813|P2|Received ≥ 1 Study Infusion|Overall Study||40
2519985|NCT00715078|6174814|P1|Received ≥ 1 Study Infusion|Overall Study||40
2519986|NCT00715078|6174812|P3|STARTED|Overall Study||41
2519987|NCT00715078|6174813|P2|STARTED|Overall Study||40
2519988|NCT00715078|6174814|P1|STARTED|Overall Study||41
2519989|NCT00715026|6174822|P1|NOT COMPLETED|Overall Study||10
2519990|NCT00715026|6174822|P1|COMPLETED|Overall Study|20 unilateral subjects and 1 bilateral|21
2519991|NCT00715026|6174822|P1|Subjects That Received Surgery|Overall Study|24 unilateral subjects and 1 bilateral|25
2519992|NCT00715026|6174822|P1|STARTED|Overall Study|30 unilateral subjects and 1 bilateral|31
2519993|NCT00714948|6174827|P1|NOT COMPLETED|Overall Study||2
2519994|NCT00714948|6174827|P1|COMPLETED|Overall Study||0
2519995|NCT00714948|6174827|P1|STARTED|Overall Study||2
2519996|NCT00714870|6174833|P2|NOT COMPLETED|Overall Study||5
2519997|NCT00714870|6174834|P1|NOT COMPLETED|Overall Study||27
2519998|NCT00714870|6174833|P2|COMPLETED|Overall Study||22
2519999|NCT00714870|6174834|P1|COMPLETED|Overall Study||22
2520000|NCT00714870|6174833|P2|STARTED|Overall Study||27
2520001|NCT00714870|6174834|P1|STARTED|Overall Study||49
2520002|NCT00714792|6174842|P2|NOT COMPLETED|Overall Study||0
2520003|NCT00714792|6174843|P1|NOT COMPLETED|Overall Study||0
2520004|NCT00714792|6174842|P2|COMPLETED|Overall Study||8
2520005|NCT00714792|6174843|P1|COMPLETED|Overall Study||10
2520006|NCT00714792|6174842|P2|STARTED|Overall Study||8
2520007|NCT00714792|6174843|P1|STARTED|Overall Study||10
2520008|NCT00714753|6174849|P1|NOT COMPLETED|Overall Study||0
2520009|NCT00714753|6174849|P1|COMPLETED|Overall Study||5
2520010|NCT00714753|6174849|P1|External Beam Radiotherapy (EBRT)|Overall Study||1
2520011|NCT00714753|6174849|P1|HDR Brachytherapy|Overall Study||5
2520012|NCT00714753|6174849|P1|STARTED|Overall Study||5
2520013|NCT00714714|6174858|P1|NOT COMPLETED|Overall Study||1
2520014|NCT00714714|6174858|P1|COMPLETED|Overall Study||24
2520015|NCT00714714|6174858|P1|STARTED|Overall Study||25
2520016|NCT00714688|6174867|P3|NOT COMPLETED|Overall Study||37
2520017|NCT00714688|6174868|P2|NOT COMPLETED|Overall Study||35
2520018|NCT00714688|6174869|P1|NOT COMPLETED|Overall Study||29
2520019|NCT00714688|6174867|P3|COMPLETED|Overall Study||55
2520020|NCT00714688|6174868|P2|COMPLETED|Overall Study||55
2520021|NCT00714688|6174869|P1|COMPLETED|Overall Study||68
2520022|NCT00714688|6174867|P3|STARTED|Overall Study||92
2520023|NCT00714688|6174868|P2|STARTED|Overall Study||90
2520024|NCT00714688|6174869|P1|STARTED|Overall Study||97
2520025|NCT00714571|6174892|P6|NOT COMPLETED|Stage 2||0
2520026|NCT00714571|6174893|P5|NOT COMPLETED|Stage 2||0
2520027|NCT00714571|6174894|P4|NOT COMPLETED|Stage 2||0
2520028|NCT00714571|6174895|P3|NOT COMPLETED|Stage 2||0
2520029|NCT00714571|6174896|P2|NOT COMPLETED|Stage 2||0
2520030|NCT00714571|6174897|P1|NOT COMPLETED|Stage 2||0
2520031|NCT00714571|6174892|P6|COMPLETED|Stage 2||15
2520032|NCT00714571|6174893|P5|COMPLETED|Stage 2||15
2520033|NCT00714571|6174894|P4|COMPLETED|Stage 2||0
2520034|NCT00714571|6174895|P3|COMPLETED|Stage 2||0
2520035|NCT00714571|6174896|P2|COMPLETED|Stage 2||0
2520036|NCT00714571|6174897|P1|COMPLETED|Stage 2||0
2520037|NCT00714571|6174892|P6|STARTED|Stage 2||15
2520038|NCT00714571|6174893|P5|STARTED|Stage 2||15
2520039|NCT00714571|6174894|P4|STARTED|Stage 2||0
2520040|NCT00714571|6174895|P3|STARTED|Stage 2||0
2520041|NCT00714571|6174896|P2|STARTED|Stage 2||0
2520042|NCT00714571|6174897|P1|STARTED|Stage 2||0
2520043|NCT00714571|6174892|P6|NOT COMPLETED|Stage 1||0
2520044|NCT00714571|6174893|P5|NOT COMPLETED|Stage 1||0
2520045|NCT00714571|6174894|P4|NOT COMPLETED|Stage 1||0
2520046|NCT00714571|6174895|P3|NOT COMPLETED|Stage 1||1
2520047|NCT00714571|6174896|P2|NOT COMPLETED|Stage 1||0
2520048|NCT00714571|6174897|P1|NOT COMPLETED|Stage 1||0
2520049|NCT00714571|6174892|P6|COMPLETED|Stage 1||0
2520050|NCT00714571|6174893|P5|COMPLETED|Stage 1||0
2520051|NCT00714571|6174894|P4|COMPLETED|Stage 1||14
2520052|NCT00714571|6174895|P3|COMPLETED|Stage 1||10
2520053|NCT00714571|6174896|P2|COMPLETED|Stage 1||15
2520054|NCT00714571|6174897|P1|COMPLETED|Stage 1|1 patient excluded who completed training but did not disclose ongoing chemotherapy for cancer|12
2520055|NCT00714571|6174892|P6|STARTED|Stage 1||0
2520056|NCT00714571|6174893|P5|STARTED|Stage 1||0
2520057|NCT00714571|6174894|P4|STARTED|Stage 1||14
2520058|NCT00714571|6174895|P3|STARTED|Stage 1||11
2520059|NCT00714571|6174896|P2|STARTED|Stage 1|11 allocated to intervention, but 1 withdrew before the first intervention session|15
2520060|NCT00714571|6174897|P1|STARTED|Stage 1||12
2520061|NCT00714493|6174911|P1|NOT COMPLETED|Overall Study||49
2520062|NCT00714493|6174911|P1|COMPLETED|Overall Study||154
2520063|NCT00714493|6174911|P1|STARTED|Overall Study||203
2520064|NCT00714415|6174923|P2|NOT COMPLETED|Overall Study||0
2520065|NCT00714415|6174924|P1|NOT COMPLETED|Overall Study||2
2520066|NCT00714415|6174923|P2|COMPLETED|Overall Study||55
2520067|NCT00714415|6174924|P1|COMPLETED|Overall Study||23
2520068|NCT00714415|6174923|P2|STARTED|Overall Study||55
2520069|NCT00714415|6174924|P1|STARTED|Overall Study||25
2520070|NCT00714389|6174956|P1|NOT COMPLETED|Overall Study||0
2520071|NCT00714389|6174956|P1|COMPLETED|Overall Study||12
2520072|NCT00714389|6174956|P1|STARTED|Overall Study||12
2520073|NCT00714311|6174963|P2|NOT COMPLETED|Overall Study||22
2520074|NCT00714311|6174964|P1|NOT COMPLETED|Overall Study||13
2520075|NCT00714311|6174963|P2|COMPLETED|Overall Study||30
2520076|NCT00714311|6174964|P1|COMPLETED|Overall Study||39
2520077|NCT00714311|6174963|P2|STARTED|Overall Study||52
2520078|NCT00714311|6174964|P1|STARTED|Overall Study||52
2520079|NCT00714285|6174974|P4|NOT COMPLETED|Overall Study||1
2520080|NCT00714285|6174975|P3|NOT COMPLETED|Overall Study||0
2520081|NCT00714285|6174976|P2|NOT COMPLETED|Overall Study||3
2520082|NCT00714285|6174977|P1|NOT COMPLETED|Overall Study||0
2520083|NCT00714285|6174974|P4|COMPLETED|Overall Study|Completed upto Day 180|104
2520084|NCT00714285|6174975|P3|COMPLETED|Overall Study|Completed upto Day 180|105
2520085|NCT00714285|6174976|P2|COMPLETED|Overall Study|Completed upto Day 180|102
2520086|NCT00714285|6174977|P1|COMPLETED|Overall Study|Completed upto Day 180|105
2520087|NCT00714285|6174974|P4|STARTED|Overall Study||105
2520088|NCT00714285|6174975|P3|STARTED|Overall Study||105
2520089|NCT00714285|6174976|P2|STARTED|Overall Study||105
2520090|NCT00714285|6174977|P1|STARTED|Overall Study||105
2520091|NCT00714259|6175027|P1|NOT COMPLETED|Overall Study||2
2520092|NCT00714259|6175027|P1|COMPLETED|Overall Study||3
2520093|NCT00714259|6175027|P1|STARTED|Overall Study||5
2520094|NCT00714233|6175041|P4|NOT COMPLETED|Overall Study||4
2520095|NCT00714233|6175042|P3|NOT COMPLETED|Overall Study||1
2520096|NCT00714233|6175043|P2|NOT COMPLETED|Overall Study||1
2520097|NCT00714233|6175044|P1|NOT COMPLETED|Overall Study||4
2520098|NCT00714233|6175041|P4|COMPLETED|Overall Study||6
2520099|NCT00714233|6175042|P3|COMPLETED|Overall Study||10
2520100|NCT00714233|6175043|P2|COMPLETED|Overall Study||10
2520101|NCT00714233|6175044|P1|COMPLETED|Overall Study||6
2520102|NCT00714233|6175041|P4|STARTED|Overall Study||10
2520103|NCT00714233|6175042|P3|STARTED|Overall Study||11
2520104|NCT00714233|6175043|P2|STARTED|Overall Study||11
2520105|NCT00714233|6175044|P1|STARTED|Overall Study||10
2520106|NCT00714168|6175073|P2|NOT COMPLETED|Overall Study||59
2520107|NCT00714168|6175074|P1|NOT COMPLETED|Overall Study||44
2520108|NCT00714168|6175073|P2|COMPLETED|Overall Study||139
2520109|NCT00714168|6175074|P1|COMPLETED|Overall Study||121
2520110|NCT00714168|6175073|P2|STARTED|Overall Study||198
2520111|NCT00714168|6175074|P1|STARTED|Overall Study||165
2520112|NCT00714051|6175090|P2|NOT COMPLETED|Overall Study||1
2520113|NCT00714051|6175091|P1|NOT COMPLETED|Overall Study||1
2520114|NCT00714051|6175090|P2|COMPLETED|Overall Study||27
2520115|NCT00714051|6175091|P1|COMPLETED|Overall Study||26
2520116|NCT00714051|6175090|P2|STARTED|Overall Study||28
2520117|NCT00714051|6175091|P1|STARTED|Overall Study||27
2520118|NCT00713830|6175099|P2|NOT COMPLETED|Overall Study||177
2520119|NCT00713830|6175100|P1|NOT COMPLETED|Overall Study||82
2520120|NCT00713830|6175099|P2|COMPLETED|Overall Study||396
2520121|NCT00713830|6175100|P1|COMPLETED|Overall Study||204
2520122|NCT00713830|6175099|P2|Subgroup for Standardized Meal Test|Overall Study||313
2520123|NCT00713830|6175100|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal challenge test was performed.|155
2520124|NCT00713830|6175099|P2|Safety Population|Overall Study|1 patient randomized to placebo received Lixisenatide (at least one dose)|574
2520125|NCT00713830|6175100|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|285
2520126|NCT00713830|6175099|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||570
2520127|NCT00713830|6175100|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|286
2520128|NCT00713830|6175099|P2|STARTED|Overall Study||573
2520129|NCT00713830|6175100|P1|STARTED|Overall Study|Randomized.|286
2520130|NCT00713817|6175138|P2|NOT COMPLETED|Overall Study||0
2520131|NCT00713817|6175139|P1|NOT COMPLETED|Overall Study||0
2520132|NCT00713817|6175138|P2|COMPLETED|Overall Study||9
2520133|NCT00713817|6175139|P1|COMPLETED|Overall Study||10
2520134|NCT00713817|6175138|P2|STARTED|Overall Study||9
2520135|NCT00713817|6175139|P1|STARTED|Overall Study||10
2520136|NCT00713700|6175157|P1|NOT COMPLETED|Overall Study||4
2520137|NCT00713700|6175157|P1|COMPLETED|Overall Study||188
2520138|NCT00713700|6175157|P1|STARTED|Overall Study||192
2520139|NCT00713661|6175166|P4|NOT COMPLETED|Overall Study||0
2520140|NCT00713661|6175167|P3|NOT COMPLETED|Overall Study||0
2520141|NCT00713661|6175168|P2|NOT COMPLETED|Overall Study||0
2520142|NCT00713661|6175169|P1|NOT COMPLETED|Overall Study||0
2520143|NCT00713661|6175166|P4|COMPLETED|Overall Study||5
2520144|NCT00713661|6175167|P3|COMPLETED|Overall Study||4
2520145|NCT00713661|6175168|P2|COMPLETED|Overall Study||9
2520146|NCT00713661|6175169|P1|COMPLETED|Overall Study||7
2520147|NCT00713661|6175166|P4|STARTED|Overall Study||5
2520148|NCT00713661|6175167|P3|STARTED|Overall Study||4
2520149|NCT00713661|6175168|P2|STARTED|Overall Study||9
2520150|NCT00713661|6175169|P1|STARTED|Overall Study||7
2520151|NCT00713648|6175183|P1|NOT COMPLETED|Overall Study||8
2520152|NCT00713648|6175183|P1|COMPLETED|Overall Study||33
2520153|NCT00713648|6175183|P1|STARTED|Overall Study||41
2520154|NCT00713609|6175196|P6|NOT COMPLETED|Overall Study||8
2520155|NCT00713609|6175197|P5|NOT COMPLETED|Overall Study||19
2520156|NCT00713609|6175198|P4|NOT COMPLETED|Overall Study||9
2520157|NCT00713609|6175199|P3|NOT COMPLETED|Overall Study||15
2520158|NCT00713609|6175200|P2|NOT COMPLETED|Overall Study||15
2520159|NCT00713609|6175201|P1|NOT COMPLETED|Overall Study||21
2520160|NCT00713609|6175196|P6|COMPLETED|Overall Study||47
2520161|NCT00713609|6175197|P5|COMPLETED|Overall Study||87
2520162|NCT00713609|6175198|P4|COMPLETED|Overall Study||99
2520163|NCT00713609|6175199|P3|COMPLETED|Overall Study||92
2520164|NCT00713609|6175200|P2|COMPLETED|Overall Study||90
2520165|NCT00713609|6175201|P1|COMPLETED|Overall Study||85
2520166|NCT00713609|6175196|P6|STARTED|Overall Study||55
2520167|NCT00713609|6175197|P5|STARTED|Overall Study||106
2520168|NCT00713609|6175198|P4|STARTED|Overall Study||108
2520169|NCT00713609|6175199|P3|STARTED|Overall Study||107
2520170|NCT00713609|6175200|P2|STARTED|Overall Study||105
2520171|NCT00713609|6175201|P1|STARTED|Overall Study||106
2520172|NCT00713596|6175236|P3|NOT COMPLETED|Overall Study||2
2520173|NCT00713596|6175237|P2|NOT COMPLETED|Overall Study||3
2520174|NCT00713596|6175238|P1|NOT COMPLETED|Overall Study||2
2520175|NCT00713596|6175236|P3|COMPLETED|Overall Study||6
2520176|NCT00713596|6175237|P2|COMPLETED|Overall Study||5
2520177|NCT00713596|6175238|P1|COMPLETED|Overall Study||7
2520178|NCT00713596|6175236|P3|STARTED|Overall Study||8
2520179|NCT00713596|6175237|P2|STARTED|Overall Study||8
2520180|NCT00713596|6175238|P1|STARTED|Overall Study||9
2520181|NCT00713583|6175251|P2|NOT COMPLETED|Overall Study||0
2520182|NCT00713583|6175252|P1|NOT COMPLETED|Overall Study||0
2520183|NCT00713583|6175251|P2|COMPLETED|Overall Study||40
2520184|NCT00713583|6175252|P1|COMPLETED|Overall Study||45
2520185|NCT00713583|6175251|P2|STARTED|Overall Study||40
2520186|NCT00713583|6175252|P1|STARTED|Overall Study||45
2520187|NCT00713544|6175264|P6|NOT COMPLETED|Overall Study||9
2520188|NCT00713544|6175265|P5|NOT COMPLETED|Overall Study||8
2520189|NCT00713544|6175266|P4|NOT COMPLETED|Overall Study||10
2520190|NCT00713544|6175267|P3|NOT COMPLETED|Overall Study||11
2520191|NCT00713544|6175268|P2|NOT COMPLETED|Overall Study||6
2520192|NCT00713544|6175269|P1|NOT COMPLETED|Overall Study||7
2520193|NCT00713544|6175264|P6|COMPLETED|Overall Study||67
2520194|NCT00713544|6175265|P5|COMPLETED|Overall Study||57
2520195|NCT00713544|6175266|P4|COMPLETED|Overall Study||66
2520196|NCT00713544|6175267|P3|COMPLETED|Overall Study||41
2520197|NCT00713544|6175268|P2|COMPLETED|Overall Study||46
2520198|NCT00713544|6175269|P1|COMPLETED|Overall Study||45
2520199|NCT00713544|6175264|P6|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|76
2520200|NCT00713544|6175265|P5|STARTED|Overall Study||65
2520201|NCT00713544|6175266|P4|STARTED|Overall Study||76
2520202|NCT00713544|6175267|P3|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|52
2520203|NCT00713544|6175268|P2|STARTED|Overall Study||52
2520204|NCT00713544|6175269|P1|STARTED|Overall Study||52
2520205|NCT00713479|6175307|P2|NOT COMPLETED|Next Medication Condition||0
2520206|NCT00713479|6175308|P1|NOT COMPLETED|Next Medication Condition||0
2520207|NCT00713479|6175307|P2|COMPLETED|Next Medication Condition||6
2520208|NCT00713479|6175308|P1|COMPLETED|Next Medication Condition||2
2520209|NCT00713479|6175307|P2|STARTED|Next Medication Condition||6
2520210|NCT00713479|6175308|P1|STARTED|Next Medication Condition||2
2520211|NCT00713479|6175307|P2|NOT COMPLETED|Washout||0
2520212|NCT00713479|6175308|P1|NOT COMPLETED|Washout||0
2520213|NCT00713479|6175307|P2|COMPLETED|Washout||6
2520214|NCT00713479|6175308|P1|COMPLETED|Washout||2
2520215|NCT00713479|6175307|P2|STARTED|Washout||6
2520216|NCT00713479|6175308|P1|STARTED|Washout||2
2520217|NCT00713479|6175307|P2|NOT COMPLETED|First Medication Condition||0
2520218|NCT00713479|6175308|P1|NOT COMPLETED|First Medication Condition||4
2520219|NCT00713479|6175307|P2|COMPLETED|First Medication Condition||6
2520220|NCT00713479|6175308|P1|COMPLETED|First Medication Condition||2
2520221|NCT00713479|6175307|P2|STARTED|First Medication Condition||6
2520222|NCT00713479|6175308|P1|STARTED|First Medication Condition||6
2520223|NCT00713349|6175320|P1|NOT COMPLETED|Overall Study||1
2520224|NCT00713349|6175320|P1|COMPLETED|Overall Study||24
2520225|NCT00713349|6175320|P1|STARTED|Overall Study||25
2520226|NCT00713323|6175326|P1|NOT COMPLETED|Overall Study||146
2520227|NCT00713323|6175326|P1|COMPLETED|Overall Study||234
2520228|NCT00713323|6175326|P1|STARTED|Overall Study||380
2520229|NCT00713310|6175339|P2|NOT COMPLETED|Overall Study||6
2520230|NCT00713310|6175340|P1|NOT COMPLETED|Overall Study||5
2520231|NCT00713310|6175339|P2|COMPLETED|Overall Study||36
2520232|NCT00713310|6175340|P1|COMPLETED|Overall Study||36
2520233|NCT00713310|6175339|P2|mITT Population|Overall Study|1 subject randomized to high dose not dosed so not included in the mITT population.|41
2520234|NCT00713310|6175340|P1|mITT Population|Overall Study||41
2520235|NCT00713310|6175339|P2|STARTED|Overall Study||42
2520236|NCT00713310|6175340|P1|STARTED|Overall Study||41
2520237|NCT00713258|6175350|P2|NOT COMPLETED|Overall Study||6
2520238|NCT00713258|6175351|P1|NOT COMPLETED|Overall Study||5
2520239|NCT00713258|6175350|P2|COMPLETED|Overall Study||28
2520240|NCT00713258|6175351|P1|COMPLETED|Overall Study||36
2520241|NCT00713258|6175350|P2|STARTED|Overall Study||34
2520242|NCT00713258|6175351|P1|STARTED|Overall Study||41
2520243|NCT00713219|6175359|P1|NOT COMPLETED|Overall Study||2
2520244|NCT00713219|6175359|P1|COMPLETED|Overall Study||12
2520245|NCT00713219|6175359|P1|STARTED|Overall Study||14
2520246|NCT00713206|6175365|P2|NOT COMPLETED|Overall Study||3
2520247|NCT00713206|6175366|P1|NOT COMPLETED|Overall Study||7
2520248|NCT00713206|6175365|P2|COMPLETED|Overall Study||27
2520249|NCT00713206|6175366|P1|COMPLETED|Overall Study||55
2520250|NCT00713206|6175365|P2|STARTED|Overall Study||30
2520251|NCT00713206|6175366|P1|STARTED|Overall Study||62
2520252|NCT00712985|6175372|P1|NOT COMPLETED|Overall Study||5
2520253|NCT00712985|6175372|P1|COMPLETED|Overall Study||13
2520254|NCT00712985|6175372|P1|STARTED|Overall Study||18
2520255|NCT00712959|6175378|P2|NOT COMPLETED|Overall Study||3
2520256|NCT00712959|6175379|P1|NOT COMPLETED|Overall Study||19
2520257|NCT00712959|6175378|P2|COMPLETED|Overall Study||404
2520258|NCT00712959|6175379|P1|COMPLETED|Overall Study||342
2520259|NCT00712959|6175378|P2|STARTED|Overall Study||407
2520260|NCT00712959|6175379|P1|STARTED|Overall Study||361
2520261|NCT00712933|6175397|P1|NOT COMPLETED|Overall Study||367
2520262|NCT00712933|6175397|P1|COMPLETED|Overall Study||368
2520263|NCT00712933|6175397|P1|STARTED|Overall Study||735
2520264|NCT00712920|6175427|P3|NOT COMPLETED|Overall Study||12
2520265|NCT00712920|6175428|P2|NOT COMPLETED|Overall Study||17
2520266|NCT00712920|6175429|P1|NOT COMPLETED|Overall Study||17
2520267|NCT00712920|6175427|P3|COMPLETED|Overall Study||180
2520268|NCT00712920|6175428|P2|COMPLETED|Overall Study||180
2520269|NCT00712920|6175429|P1|COMPLETED|Overall Study||175
2520270|NCT00712920|6175427|P3|STARTED|Overall Study||192
2520271|NCT00712920|6175428|P2|STARTED|Overall Study|3 subjects were randomized in error|197
2520272|NCT00712920|6175429|P1|STARTED|Overall Study||192
2520273|NCT00712725|6175457|P8|NOT COMPLETED|Overall Study||11
2520274|NCT00712725|6175458|P7|NOT COMPLETED|Overall Study||22
2520275|NCT00712725|6175459|P6|NOT COMPLETED|Overall Study||16
2520276|NCT00712725|6175460|P5|NOT COMPLETED|Overall Study||19
2520277|NCT00712725|6175461|P4|NOT COMPLETED|Overall Study||17
2520278|NCT00712725|6175462|P3|NOT COMPLETED|Overall Study||10
2520279|NCT00712725|6175463|P2|NOT COMPLETED|Overall Study||6
2520280|NCT00712725|6175464|P1|NOT COMPLETED|Overall Study||29
2520281|NCT00712725|6175457|P8|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|63
2520282|NCT00712725|6175458|P7|COMPLETED|Overall Study|One patient received study drug. The remaining patients discontinued prior to receiving study drug.|61
2520283|NCT00712725|6175459|P6|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|68
2520284|NCT00712725|6175460|P5|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
2520285|NCT00712725|6175461|P4|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
2520286|NCT00712725|6175462|P3|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|47
2520287|NCT00712725|6175463|P2|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|33
2520288|NCT00712725|6175464|P1|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|140
2520289|NCT00712725|6175457|P8|STARTED|Overall Study||74
2520290|NCT00712725|6175458|P7|STARTED|Overall Study||83
2520291|NCT00712725|6175459|P6|STARTED|Overall Study||84
2520292|NCT00712725|6175460|P5|STARTED|Overall Study||86
2520293|NCT00712725|6175461|P4|STARTED|Overall Study||84
2520294|NCT00712725|6175462|P3|STARTED|Overall Study||57
2520295|NCT00712725|6175463|P2|STARTED|Overall Study||39
2520296|NCT00712725|6175464|P1|STARTED|Overall Study||169
2520297|NCT00712673|6175525|P4|NOT COMPLETED|Overall Study||70
2520298|NCT00712673|6175526|P3|NOT COMPLETED|Overall Study||57
2520299|NCT00712673|6175527|P2|NOT COMPLETED|Overall Study||21
2520300|NCT00712673|6175528|P1|NOT COMPLETED|Overall Study||21
2520301|NCT00712673|6175525|P4|COMPLETED|Overall Study||185
2520302|NCT00712673|6175526|P3|COMPLETED|Overall Study||198
2520303|NCT00712673|6175527|P2|COMPLETED|Overall Study||64
2520304|NCT00712673|6175528|P1|COMPLETED|Overall Study||64
2520305|NCT00712673|6175525|P4|Subgroup for Standardized Meal Test|Overall Study||0
2520306|NCT00712673|6175526|P3|Subgroup for Standardized Meal Test|Overall Study||255
2520307|NCT00712673|6175527|P2|Subgroup for Standardized Meal Test|Overall Study||0
2520308|NCT00712673|6175528|P1|Subgroup for Standardized Meal Test|Overall Study|Patients from morning injection arms where standardized meal test was performed.|85
2520309|NCT00712673|6175525|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||255
2520310|NCT00712673|6175526|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||255
2520311|NCT00712673|6175527|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||85
2520312|NCT00712673|6175528|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|85
2520313|NCT00712673|6175525|P4|Safety Population|Overall Study||255
2520314|NCT00712673|6175526|P3|Safety Population|Overall Study||255
2520315|NCT00712673|6175527|P2|Safety Population|Overall Study||85
2520316|NCT00712673|6175528|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|85
2520317|NCT00712673|6175525|P4|STARTED|Overall Study||255
2520318|NCT00712673|6175526|P3|STARTED|Overall Study||255
2520319|NCT00712673|6175527|P2|STARTED|Overall Study||85
2520320|NCT00712673|6175528|P1|STARTED|Overall Study|Randomized.|85
2520321|NCT00712543|6175592|P2|NOT COMPLETED|Day 8-14||2
2520322|NCT00712543|6175593|P1|NOT COMPLETED|Day 8-14||0
2520323|NCT00712543|6175592|P2|COMPLETED|Day 8-14||25
2520324|NCT00712543|6175593|P1|COMPLETED|Day 8-14||23
2520325|NCT00712543|6175592|P2|STARTED|Day 8-14||27
2520326|NCT00712543|6175593|P1|STARTED|Day 8-14||23
2520327|NCT00712543|6175592|P2|NOT COMPLETED|Day 1-7||0
2520328|NCT00712543|6175593|P1|NOT COMPLETED|Day 1-7||0
2520329|NCT00712543|6175592|P2|COMPLETED|Day 1-7||27
2520330|NCT00712543|6175593|P1|COMPLETED|Day 1-7||23
2520331|NCT00712543|6175592|P2|STARTED|Day 1-7||27
2520332|NCT00712543|6175593|P1|STARTED|Day 1-7||23
2520333|NCT00712530|6175602|P3|NOT COMPLETED|Overall Study||0
2520334|NCT00712530|6175603|P2|NOT COMPLETED|Overall Study||0
2520335|NCT00712530|6175604|P1|NOT COMPLETED|Overall Study||0
2520336|NCT00712530|6175602|P3|COMPLETED|Overall Study||3
2520337|NCT00712530|6175603|P2|COMPLETED|Overall Study||3
2520338|NCT00712530|6175604|P1|COMPLETED|Overall Study||3
2520339|NCT00712530|6175602|P3|STARTED|Overall Study|Screened 4 patients, but one failed to meet entry criteria due to a history of bleeding and diabetes|3
2520340|NCT00712530|6175603|P2|STARTED|Overall Study||3
2520341|NCT00712530|6175604|P1|STARTED|Overall Study||3
2520342|NCT00712348|6175627|P1|NOT COMPLETED|Overall Study||1
2520343|NCT00712348|6175627|P1|COMPLETED|Overall Study||30
2520344|NCT00712348|6175627|P1|STARTED|Overall Study||31
2520345|NCT00712335|6175639|P5|NOT COMPLETED|Overall Study||0
2520346|NCT00712335|6175640|P4|NOT COMPLETED|Overall Study||5
2520347|NCT00712335|6175641|P3|NOT COMPLETED|Overall Study||5
2520348|NCT00712335|6175642|P2|NOT COMPLETED|Overall Study||17
2520349|NCT00712335|6175643|P1|NOT COMPLETED|Overall Study||3
2520350|NCT00712335|6175639|P5|COMPLETED|Overall Study||30
2520351|NCT00712335|6175640|P4|COMPLETED|Overall Study||19
2520352|NCT00712335|6175641|P3|COMPLETED|Overall Study||6
2520353|NCT00712335|6175642|P2|COMPLETED|Overall Study||15
2520354|NCT00712335|6175643|P1|COMPLETED|Overall Study||5
2520355|NCT00712335|6175639|P5|STARTED|Overall Study||30
2520356|NCT00712335|6175640|P4|STARTED|Overall Study||24
2520357|NCT00712335|6175641|P3|STARTED|Overall Study||11
2520358|NCT00712335|6175642|P2|STARTED|Overall Study||32
2520359|NCT00712335|6175643|P1|STARTED|Overall Study||8
2520360|NCT00712270|6175688|P1|NOT COMPLETED|Overall Study||14
2520361|NCT00712270|6175688|P1|COMPLETED|Overall Study||7
2520362|NCT00712270|6175688|P1|STARTED|Overall Study||21
2520363|NCT00712244|6175701|P4|NOT COMPLETED|Overall Study||1
2520364|NCT00712244|6175702|P3|NOT COMPLETED|Overall Study||2
2520365|NCT00712244|6175703|P2|NOT COMPLETED|Overall Study||1
2520366|NCT00712244|6175704|P1|NOT COMPLETED|Overall Study||4
2520367|NCT00712244|6175701|P4|COMPLETED|Overall Study||26
2520368|NCT00712244|6175702|P3|COMPLETED|Overall Study||25
2520369|NCT00712244|6175703|P2|COMPLETED|Overall Study||28
2520370|NCT00712244|6175704|P1|COMPLETED|Overall Study||25
2520371|NCT00712244|6175701|P4|STARTED|Overall Study||27
2520372|NCT00712244|6175702|P3|STARTED|Overall Study||27
2520373|NCT00712244|6175703|P2|STARTED|Overall Study||29
2520374|NCT00712244|6175704|P1|STARTED|Overall Study||29
2520375|NCT00712179|6175746|P1|NOT COMPLETED|Overall Study||12
2520376|NCT00712179|6175746|P1|COMPLETED|Overall Study|Data from 4 subjects was excluded due to noise in recorded EMG signal, so 33 subjects were analysed.|37
2520377|NCT00712179|6175746|P1|STARTED|Overall Study||49
2520378|NCT00712166|6175752|P2|NOT COMPLETED|Overall Study||1
2520379|NCT00712166|6175753|P1|NOT COMPLETED|Overall Study||0
2520380|NCT00712166|6175752|P2|COMPLETED|Overall Study||75
2520381|NCT00712166|6175753|P1|COMPLETED|Overall Study||81
2520382|NCT00712166|6175752|P2|STARTED|Overall Study||76
2520383|NCT00712166|6175753|P1|STARTED|Overall Study||81
2520384|NCT00712075|6175780|P3|NOT COMPLETED|Overall Study||11
2520385|NCT00712075|6175781|P2|NOT COMPLETED|Overall Study||4
2520386|NCT00712075|6175782|P1|NOT COMPLETED|Overall Study||5
2520387|NCT00712075|6175780|P3|COMPLETED|Overall Study||14
2520388|NCT00712075|6175781|P2|COMPLETED|Overall Study||26
2520389|NCT00712075|6175782|P1|COMPLETED|Overall Study||17
2520390|NCT00712075|6175780|P3|STARTED|Overall Study||25
2520391|NCT00712075|6175781|P2|STARTED|Overall Study||30
2520392|NCT00712075|6175782|P1|STARTED|Overall Study||22
2520393|NCT00712010|6175796|P1|NOT COMPLETED|7th and Last Protein Testing (1 Day)||0
2520394|NCT00712010|6175796|P1|COMPLETED|7th and Last Protein Testing (1 Day)||23
2520395|NCT00712010|6175796|P1|STARTED|7th and Last Protein Testing (1 Day)||23
2520396|NCT00712010|6175796|P1|NOT COMPLETED|Washout (7 Days)||0
2520397|NCT00712010|6175796|P1|COMPLETED|Washout (7 Days)||23
2520398|NCT00712010|6175796|P1|STARTED|Washout (7 Days)||23
2520399|NCT00712010|6175796|P1|NOT COMPLETED|6th Protein Testing (1 Day)||0
2520400|NCT00712010|6175796|P1|COMPLETED|6th Protein Testing (1 Day)||23
2520401|NCT00712010|6175796|P1|STARTED|6th Protein Testing (1 Day)||23
2520402|NCT00712010|6175796|P1|NOT COMPLETED|Washout (7 Days)||0
2520403|NCT00712010|6175796|P1|COMPLETED|Washout (7 Days)||23
2520404|NCT00712010|6175796|P1|STARTED|Washout (7 Days)||23
2520405|NCT00712010|6175796|P1|NOT COMPLETED|5th Protein Testing (1 Day)||0
2520406|NCT00712010|6175796|P1|COMPLETED|5th Protein Testing (1 Day)||23
2520407|NCT00712010|6175796|P1|STARTED|5th Protein Testing (1 Day)||23
2520408|NCT00712010|6175796|P1|NOT COMPLETED|Washout (7 Days)||1
2520409|NCT00712010|6175796|P1|COMPLETED|Washout (7 Days)||23
2520410|NCT00712010|6175796|P1|STARTED|Washout (7 Days)||24
2520411|NCT00712010|6175796|P1|NOT COMPLETED|4th Protein Testing (1 Day)||0
2520412|NCT00712010|6175796|P1|COMPLETED|4th Protein Testing (1 Day)||24
2520413|NCT00712010|6175796|P1|STARTED|4th Protein Testing (1 Day)||24
2520414|NCT00712010|6175796|P1|NOT COMPLETED|Washout (7 Days)||0
2520415|NCT00712010|6175796|P1|COMPLETED|Washout (7 Days)||24
2520416|NCT00712010|6175796|P1|STARTED|Washout (7 Days)||24
2520417|NCT00712010|6175796|P1|NOT COMPLETED|3rd Protein Testing (1 Day)||0
2520418|NCT00712010|6175796|P1|COMPLETED|3rd Protein Testing (1 Day)||24
2520419|NCT00712010|6175796|P1|STARTED|3rd Protein Testing (1 Day)||24
2520420|NCT00712010|6175796|P1|NOT COMPLETED|Washout (7 Days)||0
2520421|NCT00712010|6175796|P1|COMPLETED|Washout (7 Days)||24
2520422|NCT00712010|6175796|P1|STARTED|Washout (7 Days)||24
2520423|NCT00712010|6175796|P1|NOT COMPLETED|2nd Protein Testing (1 Day)||0
2520424|NCT00712010|6175796|P1|COMPLETED|2nd Protein Testing (1 Day)||24
2520425|NCT00712010|6175796|P1|STARTED|2nd Protein Testing (1 Day)||24
2520426|NCT00712010|6175796|P1|NOT COMPLETED|Washout (7 Days)||0
2520427|NCT00712010|6175796|P1|COMPLETED|Washout (7 Days)||24
2520428|NCT00712010|6175796|P1|STARTED|Washout (7 Days)||24
2520429|NCT00712010|6175796|P1|NOT COMPLETED|1st Protein Testing (1 Day)||0
2520430|NCT00712010|6175796|P1|COMPLETED|1st Protein Testing (1 Day)||24
2520431|NCT00712010|6175796|P1|STARTED|1st Protein Testing (1 Day)|1 subject withdrew his consent form before to starting the 1st intervention|24
2520432|NCT00711997|6175821|P2|NOT COMPLETED|Overall Study||0
2520433|NCT00711997|6175822|P1|NOT COMPLETED|Overall Study||0
2520434|NCT00711997|6175821|P2|COMPLETED|Overall Study||6
2520435|NCT00711997|6175822|P1|COMPLETED|Overall Study||3
2520436|NCT00711997|6175821|P2|STARTED|Overall Study||6
2520437|NCT00711997|6175822|P1|STARTED|Overall Study||3
2520438|NCT00711971|6175835|P3|NOT COMPLETED|Overall Study||1
2520439|NCT00711971|6175836|P2|NOT COMPLETED|Overall Study||4
2520440|NCT00711971|6175837|P1|NOT COMPLETED|Overall Study||3
2520441|NCT00711971|6175835|P3|COMPLETED|Overall Study||41
2520442|NCT00711971|6175836|P2|COMPLETED|Overall Study||38
2520443|NCT00711971|6175837|P1|COMPLETED|Overall Study||39
2520444|NCT00711971|6175835|P3|STARTED|Overall Study||42
2520445|NCT00711971|6175836|P2|STARTED|Overall Study||42
2520446|NCT00711971|6175837|P1|STARTED|Overall Study||42
2520447|NCT00711958|6175871|P2|NOT COMPLETED|Overall Study||23
2520448|NCT00711958|6175872|P1|NOT COMPLETED|Overall Study||33
2520449|NCT00711958|6175871|P2|COMPLETED|Overall Study||17
2520450|NCT00711958|6175872|P1|COMPLETED|Overall Study||41
2520451|NCT00711958|6175871|P2|STARTED|Overall Study||40
2520452|NCT00711958|6175872|P1|STARTED|Overall Study||74
2520453|NCT00711880|6175880|P2|NOT COMPLETED|Overall Study||7
2520454|NCT00711880|6175881|P1|NOT COMPLETED|Overall Study||13
2520455|NCT00711880|6175880|P2|COMPLETED|Overall Study||55
2520456|NCT00711880|6175881|P1|COMPLETED|Overall Study||50
2520457|NCT00711880|6175880|P2|STARTED|Overall Study||62
2520458|NCT00711880|6175881|P1|STARTED|Overall Study||63
2520459|NCT00711867|6175919|P2|NOT COMPLETED|Overall Study||4
2520460|NCT00711867|6175920|P1|NOT COMPLETED|Overall Study||5
2520461|NCT00711867|6175919|P2|COMPLETED|Overall Study|3 received additional warming. 1 missing primary measure.|21
2520462|NCT00711867|6175920|P1|COMPLETED|Overall Study|2 received additional warming. 3 missing primary measure.|25
2520463|NCT00711867|6175919|P2|STARTED|Overall Study||25
2520464|NCT00711867|6175920|P1|STARTED|Overall Study||30
2520465|NCT00711828|6175926|P1|NOT COMPLETED|Overall Study||0
2520466|NCT00711828|6175926|P1|COMPLETED|Overall Study||21
2520467|NCT00711828|6175926|P1|STARTED|Overall Study||21
2520468|NCT00711802|6175943|P8|NOT COMPLETED|Overall Study||2
2520469|NCT00711802|6175944|P7|NOT COMPLETED|Overall Study||5
2520470|NCT00711802|6175945|P6|NOT COMPLETED|Overall Study||8
2520471|NCT00711802|6175946|P5|NOT COMPLETED|Overall Study||14
2520472|NCT00711802|6175947|P4|NOT COMPLETED|Overall Study||3
2520473|NCT00711802|6175948|P3|NOT COMPLETED|Overall Study||6
2520474|NCT00711802|6175949|P2|NOT COMPLETED|Overall Study||6
2520475|NCT00711802|6175950|P1|NOT COMPLETED|Overall Study||2
2520476|NCT00711802|6175943|P8|COMPLETED|Overall Study||13
2520477|NCT00711802|6175944|P7|COMPLETED|Overall Study||25
2520478|NCT00711802|6175945|P6|COMPLETED|Overall Study||34
2520479|NCT00711802|6175946|P5|COMPLETED|Overall Study||69
2520480|NCT00711802|6175947|P4|COMPLETED|Overall Study||35
2520481|NCT00711802|6175948|P3|COMPLETED|Overall Study||69
2520482|NCT00711802|6175949|P2|COMPLETED|Overall Study||32
2520483|NCT00711802|6175950|P1|COMPLETED|Overall Study||73
2520484|NCT00711802|6175943|P8|Received at Least 1 Dose of Study Drug|Overall Study||15
2520485|NCT00711802|6175944|P7|Received at Least 1 Dose of Study Drug|Overall Study||30
2520486|NCT00711802|6175945|P6|Received at Least 1 Dose of Study Drug|Overall Study||42
2520487|NCT00711802|6175946|P5|Received at Least 1 Dose of Study Drug|Overall Study||81
2520488|NCT00711802|6175947|P4|Received at Least 1 Dose of Study Drug|Overall Study||38
2520489|NCT00711802|6175948|P3|Received at Least 1 Dose of Study Drug|Overall Study||73
2520490|NCT00711802|6175949|P2|Received at Least 1 Dose of Study Drug|Overall Study||37
2520491|NCT00711802|6175950|P1|Received at Least 1 Dose of Study Drug|Overall Study||73
2520492|NCT00711802|6175943|P8|STARTED|Overall Study||15
2520493|NCT00711802|6175944|P7|STARTED|Overall Study||30
2520494|NCT00711802|6175945|P6|STARTED|Overall Study||42
2520495|NCT00711802|6175946|P5|STARTED|Overall Study||83
2520496|NCT00711802|6175947|P4|STARTED|Overall Study||38
2520497|NCT00711802|6175948|P3|STARTED|Overall Study||75
2520498|NCT00711802|6175949|P2|STARTED|Overall Study||38
2520499|NCT00711802|6175950|P1|STARTED|Overall Study||75
2520500|NCT00711711|6175982|P2|NOT COMPLETED|Overall Study||6
2520501|NCT00711711|6175983|P1|NOT COMPLETED|Overall Study||1
2520502|NCT00711711|6175982|P2|COMPLETED|Overall Study||24
2520503|NCT00711711|6175983|P1|COMPLETED|Overall Study||29
2520504|NCT00711711|6175982|P2|Seventh Postsurgical Day|Overall Study||27
2520505|NCT00711711|6175983|P1|Seventh Postsurgical Day|Overall Study||29
2520506|NCT00711711|6175982|P2|Second Postsurgical Day|Overall Study||30
2520507|NCT00711711|6175983|P1|Second Postsurgical Day|Overall Study||30
2520508|NCT00711711|6175982|P2|STARTED|Overall Study||30
2520509|NCT00711711|6175983|P1|STARTED|Overall Study||30
2520510|NCT00711646|6175993|P2|NOT COMPLETED|Overall Study||3
2520511|NCT00711646|6175994|P1|NOT COMPLETED|Overall Study||12
2520512|NCT00711646|6175993|P2|COMPLETED|Overall Study||62
2520513|NCT00711646|6175994|P1|COMPLETED|Overall Study||112
2520514|NCT00711646|6175993|P2|STARTED|Overall Study||65
2520515|NCT00711646|6175994|P1|STARTED|Overall Study||124
2520516|NCT00711594|6176016|P4|NOT COMPLETED|Overall Study||62
2520517|NCT00711594|6176017|P3|NOT COMPLETED|Overall Study||6
2520518|NCT00711594|6176018|P2|NOT COMPLETED|Overall Study||3
2520519|NCT00711594|6176019|P1|NOT COMPLETED|Overall Study||3
2520520|NCT00711594|6176016|P4|COMPLETED|Overall Study||0
2520521|NCT00711594|6176017|P3|COMPLETED|Overall Study||0
2520522|NCT00711594|6176018|P2|COMPLETED|Overall Study||0
2520523|NCT00711594|6176019|P1|COMPLETED|Overall Study||0
2520524|NCT00711594|6176016|P4|STARTED|Overall Study||62
2520525|NCT00711594|6176017|P3|STARTED|Overall Study||6
2520526|NCT00711594|6176018|P2|STARTED|Overall Study||3
2520527|NCT00711594|6176019|P1|STARTED|Overall Study||3
2520528|NCT00711555|6176056|P1|NOT COMPLETED|Overall Study||3
2520529|NCT00711555|6176056|P1|COMPLETED|Overall Study||19
2520530|NCT00711555|6176056|P1|STARTED|Overall Study||22
2520531|NCT00711529|6176065|P2|NOT COMPLETED|Overall Study||6
2520532|NCT00711529|6176066|P1|NOT COMPLETED|Overall Study||4
2520533|NCT00711529|6176065|P2|COMPLETED|Overall Study||8
2520534|NCT00711529|6176066|P1|COMPLETED|Overall Study|2 women lost their hot flash diary, so only 7 patients were evaluable for primary endpoint.|9
2520535|NCT00711529|6176065|P2|STARTED|Overall Study||14
2520536|NCT00711529|6176066|P1|STARTED|Overall Study||13
2520537|NCT00711516|6176090|P2|NOT COMPLETED|Overall Study||3
2520538|NCT00711516|6176091|P1|NOT COMPLETED|Overall Study||1
2520539|NCT00711516|6176090|P2|COMPLETED|Overall Study||16
2520540|NCT00711516|6176091|P1|COMPLETED|Overall Study||20
2520541|NCT00711516|6176090|P2|STARTED|Overall Study||19
2520542|NCT00711516|6176091|P1|STARTED|Overall Study||21
2520543|NCT00711490|6176185|P1|NOT COMPLETED|Overall Study||0
2520544|NCT00711490|6176185|P1|COMPLETED|Overall Study||5
2520545|NCT00711490|6176185|P1|STARTED|Overall Study||5
2520546|NCT00711477|6176198|P2|NOT COMPLETED|Overall Study||3
2520547|NCT00711477|6176199|P1|NOT COMPLETED|Overall Study||3
2520548|NCT00711477|6176198|P2|COMPLETED|Overall Study||20
2520549|NCT00711477|6176199|P1|COMPLETED|Overall Study||20
2520550|NCT00711477|6176198|P2|STARTED|Overall Study||23
2520551|NCT00711477|6176199|P1|STARTED|Overall Study||23
2520552|NCT00711464|6176227|P1|NOT COMPLETED|Overall Study||0
2520553|NCT00711464|6176227|P1|COMPLETED|Overall Study||29
2520554|NCT00711464|6176227|P1|STARTED|Overall Study||29
2520555|NCT00711425|6176245|P1|NOT COMPLETED|Overall Study||4
2520556|NCT00711425|6176245|P1|COMPLETED|Overall Study||41
2520557|NCT00711425|6176245|P1|STARTED|Overall Study|Implant placement in 45 patients. Implant loading (baseline) in 44 patients.|45
2520558|NCT00711412|6176251|P1|NOT COMPLETED|Survival Follow up Until Death||12
2520559|NCT00711412|6176251|P1|COMPLETED|Survival Follow up Until Death||26
2520560|NCT00711412|6176251|P1|STARTED|Survival Follow up Until Death|All patients that received treatment went into follow up period.|38
2520561|NCT00711412|6176251|P1|NOT COMPLETED|Evaluation for Response and Surgery||6
2520562|NCT00711412|6176251|P1|COMPLETED|Evaluation for Response and Surgery||28
2520563|NCT00711412|6176251|P1|STARTED|Evaluation for Response and Surgery|1 patient only completed 2 cycles of therapy was evaluated and eligible for surgical resection.|34
2520564|NCT00711412|6176251|P1|NOT COMPLETED|Combination Treatment||1
2520565|NCT00711412|6176251|P1|COMPLETED|Combination Treatment||33
2520566|NCT00711412|6176251|P1|STARTED|Combination Treatment||34
2520567|NCT00711412|6176251|P1|NOT COMPLETED|Evaluated for Combination Treatment||6
2520568|NCT00711412|6176251|P1|COMPLETED|Evaluated for Combination Treatment||34
2520569|NCT00711412|6176251|P1|STARTED|Evaluated for Combination Treatment||40
2520570|NCT00711412|6176251|P1|NOT COMPLETED|Induction Treatment||4
2520571|NCT00711412|6176251|P1|COMPLETED|Induction Treatment||40
2520572|NCT00711412|6176251|P1|Started Induction Treatment|Induction Treatment||43
2520573|NCT00711412|6176251|P1|Registered to Study|Induction Treatment||44
2520574|NCT00711412|6176251|P1|STARTED|Induction Treatment||44
2520575|NCT00711347|6176265|P2|NOT COMPLETED|Overall Study||0
2520576|NCT00711347|6176266|P1|NOT COMPLETED|Overall Study||0
2520577|NCT00711347|6176265|P2|COMPLETED|Overall Study||14
2520578|NCT00711347|6176266|P1|COMPLETED|Overall Study||14
2520579|NCT00711347|6176265|P2|STARTED|Overall Study||14
2520580|NCT00711347|6176266|P1|STARTED|Overall Study||14
2520581|NCT00711269|6176286|P4|NOT COMPLETED|Overall Study||14
2520582|NCT00711269|6176287|P3|NOT COMPLETED|Overall Study||50
2520583|NCT00711269|6176288|P2|NOT COMPLETED|Overall Study||48
2520584|NCT00711269|6176289|P1|NOT COMPLETED|Overall Study||44
2520585|NCT00711269|6176286|P4|COMPLETED|Overall Study||51
2520586|NCT00711269|6176287|P3|COMPLETED|Overall Study||83
2520587|NCT00711269|6176288|P2|COMPLETED|Overall Study||83
2520588|NCT00711269|6176289|P1|COMPLETED|Overall Study||87
2520589|NCT00711269|6176286|P4|STARTED|Overall Study||65
2520590|NCT00711269|6176287|P3|STARTED|Overall Study||133
2520591|NCT00711269|6176288|P2|STARTED|Overall Study||131
2520592|NCT00711269|6176289|P1|STARTED|Overall Study||131
2520593|NCT00711243|6176329|P6|NOT COMPLETED|Follow up Every 3 Months Until Death||2
2520594|NCT00711243|6176330|P5|NOT COMPLETED|Follow up Every 3 Months Until Death||0
2520595|NCT00711243|6176331|P4|NOT COMPLETED|Follow up Every 3 Months Until Death||0
2520596|NCT00711243|6176332|P3|NOT COMPLETED|Follow up Every 3 Months Until Death||0
2520597|NCT00711243|6176333|P2|NOT COMPLETED|Follow up Every 3 Months Until Death||0
2520598|NCT00711243|6176334|P1|NOT COMPLETED|Follow up Every 3 Months Until Death||0
2520599|NCT00711243|6176329|P6|COMPLETED|Follow up Every 3 Months Until Death||37
2520600|NCT00711243|6176330|P5|COMPLETED|Follow up Every 3 Months Until Death||3
2520601|NCT00711243|6176331|P4|COMPLETED|Follow up Every 3 Months Until Death||3
2520602|NCT00711243|6176332|P3|COMPLETED|Follow up Every 3 Months Until Death||3
2520603|NCT00711243|6176333|P2|COMPLETED|Follow up Every 3 Months Until Death||3
2520604|NCT00711243|6176334|P1|COMPLETED|Follow up Every 3 Months Until Death||3
2520605|NCT00711243|6176329|P6|STARTED|Follow up Every 3 Months Until Death|4 patients died whilst on study and 1 patient did not get treated on study|39
2520606|NCT00711243|6176330|P5|STARTED|Follow up Every 3 Months Until Death||3
2520607|NCT00711243|6176331|P4|STARTED|Follow up Every 3 Months Until Death||3
2520608|NCT00711243|6176332|P3|STARTED|Follow up Every 3 Months Until Death||3
2520609|NCT00711243|6176333|P2|STARTED|Follow up Every 3 Months Until Death||3
2520610|NCT00711243|6176334|P1|STARTED|Follow up Every 3 Months Until Death||3
2520611|NCT00711243|6176329|P6|NOT COMPLETED|Treated Cycle 5 After First Response||4
2520612|NCT00711243|6176330|P5|NOT COMPLETED|Treated Cycle 5 After First Response||1
2520613|NCT00711243|6176331|P4|NOT COMPLETED|Treated Cycle 5 After First Response||0
2520614|NCT00711243|6176332|P3|NOT COMPLETED|Treated Cycle 5 After First Response||0
2520615|NCT00711243|6176333|P2|NOT COMPLETED|Treated Cycle 5 After First Response||2
2520616|NCT00711243|6176334|P1|NOT COMPLETED|Treated Cycle 5 After First Response||1
2520617|NCT00711243|6176329|P6|COMPLETED|Treated Cycle 5 After First Response||37
2520618|NCT00711243|6176330|P5|COMPLETED|Treated Cycle 5 After First Response||2
2520619|NCT00711243|6176331|P4|COMPLETED|Treated Cycle 5 After First Response||2
2520620|NCT00711243|6176332|P3|COMPLETED|Treated Cycle 5 After First Response||3
2520621|NCT00711243|6176333|P2|COMPLETED|Treated Cycle 5 After First Response||1
2520622|NCT00711243|6176334|P1|COMPLETED|Treated Cycle 5 After First Response||2
2520623|NCT00711243|6176329|P6|STARTED|Treated Cycle 5 After First Response||41
2520624|NCT00711243|6176330|P5|STARTED|Treated Cycle 5 After First Response||3
2520625|NCT00711243|6176331|P4|STARTED|Treated Cycle 5 After First Response||2
2520626|NCT00711243|6176332|P3|STARTED|Treated Cycle 5 After First Response||3
2520627|NCT00711243|6176333|P2|STARTED|Treated Cycle 5 After First Response||3
2520628|NCT00711243|6176334|P1|STARTED|Treated Cycle 5 After First Response||3
2520629|NCT00711243|6176329|P6|NOT COMPLETED|Reached First Response/4 Cycles||2
2520630|NCT00711243|6176330|P5|NOT COMPLETED|Reached First Response/4 Cycles||0
2520631|NCT00711243|6176331|P4|NOT COMPLETED|Reached First Response/4 Cycles||1
2520632|NCT00711243|6176332|P3|NOT COMPLETED|Reached First Response/4 Cycles||0
2520633|NCT00711243|6176333|P2|NOT COMPLETED|Reached First Response/4 Cycles||0
2520634|NCT00711243|6176334|P1|NOT COMPLETED|Reached First Response/4 Cycles||0
2520635|NCT00711243|6176329|P6|COMPLETED|Reached First Response/4 Cycles||41
2520636|NCT00711243|6176330|P5|COMPLETED|Reached First Response/4 Cycles||3
2520637|NCT00711243|6176331|P4|COMPLETED|Reached First Response/4 Cycles||2
2520638|NCT00711243|6176332|P3|COMPLETED|Reached First Response/4 Cycles||3
2520639|NCT00711243|6176333|P2|COMPLETED|Reached First Response/4 Cycles||3
2520640|NCT00711243|6176334|P1|COMPLETED|Reached First Response/4 Cycles||3
2520641|NCT00711243|6176329|P6|STARTED|Reached First Response/4 Cycles||43
2520642|NCT00711243|6176330|P5|STARTED|Reached First Response/4 Cycles||3
2520643|NCT00711243|6176331|P4|STARTED|Reached First Response/4 Cycles||3
2520644|NCT00711243|6176332|P3|STARTED|Reached First Response/4 Cycles||3
2520645|NCT00711243|6176333|P2|STARTED|Reached First Response/4 Cycles||3
2520646|NCT00711243|6176334|P1|STARTED|Reached First Response/4 Cycles||3
2520647|NCT00711243|6176329|P6|NOT COMPLETED|Registed and Started Treatment||1
2520648|NCT00711243|6176330|P5|NOT COMPLETED|Registed and Started Treatment||0
2520649|NCT00711243|6176331|P4|NOT COMPLETED|Registed and Started Treatment||0
2520650|NCT00711243|6176332|P3|NOT COMPLETED|Registed and Started Treatment||0
2520651|NCT00711243|6176333|P2|NOT COMPLETED|Registed and Started Treatment||0
2520652|NCT00711243|6176334|P1|NOT COMPLETED|Registed and Started Treatment||0
2520653|NCT00711243|6176329|P6|COMPLETED|Registed and Started Treatment||43
2520654|NCT00711243|6176330|P5|COMPLETED|Registed and Started Treatment||3
2520655|NCT00711243|6176331|P4|COMPLETED|Registed and Started Treatment||3
2520656|NCT00711243|6176332|P3|COMPLETED|Registed and Started Treatment||3
2520657|NCT00711243|6176333|P2|COMPLETED|Registed and Started Treatment||3
2520658|NCT00711243|6176334|P1|COMPLETED|Registed and Started Treatment||3
2520659|NCT00711243|6176329|P6|Started Treatment|Registed and Started Treatment||43
2520660|NCT00711243|6176330|P5|Started Treatment|Registed and Started Treatment||3
2520661|NCT00711243|6176331|P4|Started Treatment|Registed and Started Treatment||3
2520662|NCT00711243|6176332|P3|Started Treatment|Registed and Started Treatment||3
2520663|NCT00711243|6176333|P2|Started Treatment|Registed and Started Treatment||3
2520664|NCT00711243|6176334|P1|Started Treatment|Registed and Started Treatment||3
2520665|NCT00711243|6176329|P6|Registered to Study|Registed and Started Treatment||44
2520666|NCT00711243|6176330|P5|Registered to Study|Registed and Started Treatment||3
2520667|NCT00711243|6176331|P4|Registered to Study|Registed and Started Treatment||3
2520668|NCT00711243|6176332|P3|Registered to Study|Registed and Started Treatment||3
2520669|NCT00711243|6176333|P2|Registered to Study|Registed and Started Treatment||3
2520670|NCT00711243|6176334|P1|Registered to Study|Registed and Started Treatment||3
2520671|NCT00711243|6176329|P6|STARTED|Registed and Started Treatment||44
2520672|NCT00711243|6176330|P5|STARTED|Registed and Started Treatment||3
2520673|NCT00711243|6176331|P4|STARTED|Registed and Started Treatment||3
2520674|NCT00711243|6176332|P3|STARTED|Registed and Started Treatment||3
2520675|NCT00711243|6176333|P2|STARTED|Registed and Started Treatment||3
2520676|NCT00711243|6176334|P1|STARTED|Registed and Started Treatment||3
2520677|NCT00711191|6176357|P3|NOT COMPLETED|Overall Study||12
2520678|NCT00711191|6176358|P2|NOT COMPLETED|Overall Study||5
2520679|NCT00711191|6176359|P1|NOT COMPLETED|Overall Study||3
2520680|NCT00711191|6176357|P3|COMPLETED|Overall Study||1
2520681|NCT00711191|6176358|P2|COMPLETED|Overall Study||1
2520682|NCT00711191|6176359|P1|COMPLETED|Overall Study||0
2520683|NCT00711191|6176357|P3|STARTED|Overall Study||13
2520684|NCT00711191|6176358|P2|STARTED|Overall Study||6
2520685|NCT00711191|6176359|P1|STARTED|Overall Study||3
2520686|NCT00711113|6176396|P1|NOT COMPLETED|Overall Study||11
2520687|NCT00711113|6176396|P1|COMPLETED|Overall Study||36
2520688|NCT00711113|6176396|P1|STARTED|Overall Study||47
2520689|NCT00711100|6176402|P1|NOT COMPLETED|Overall Study||13
2520690|NCT00711100|6176402|P1|COMPLETED|Overall Study||91
2520691|NCT00711100|6176402|P1|STARTED|Overall Study||104
2520692|NCT00711087|6176420|P2|NOT COMPLETED|Overall Study||0
2520693|NCT00711087|6176421|P1|NOT COMPLETED|Overall Study||1
2520694|NCT00711087|6176420|P2|COMPLETED|Overall Study||0
2520695|NCT00711087|6176421|P1|COMPLETED|Overall Study||0
2520696|NCT00711087|6176420|P2|STARTED|Overall Study||0
2520697|NCT00711087|6176421|P1|STARTED|Overall Study||1
2520698|NCT00711022|6176427|P1|NOT COMPLETED|Overall Study||11
2520699|NCT00711022|6176427|P1|COMPLETED|Overall Study||40
2520700|NCT00711022|6176427|P1|STARTED|Overall Study||51
2520701|NCT00711009|6176433|P2|NOT COMPLETED|Overall Study||19
2520702|NCT00711009|6176434|P1|NOT COMPLETED|Overall Study||15
2520703|NCT00711009|6176433|P2|COMPLETED|Overall Study||82
2520704|NCT00711009|6176434|P1|COMPLETED|Overall Study||90
2520705|NCT00711009|6176433|P2|STARTED|Overall Study||101
2520706|NCT00711009|6176434|P1|STARTED|Overall Study||105
2520707|NCT00710996|6176605|P3|NOT COMPLETED|Overall Study||0
2520708|NCT00710996|6176606|P2|NOT COMPLETED|Overall Study||4
2520709|NCT00710996|6176607|P1|NOT COMPLETED|Overall Study||1
2520710|NCT00710996|6176605|P3|COMPLETED|Overall Study||21
2520711|NCT00710996|6176606|P2|COMPLETED|Overall Study||16
2520712|NCT00710996|6176607|P1|COMPLETED|Overall Study||16
2520713|NCT00710996|6176605|P3|STARTED|Overall Study||21
2520714|NCT00710996|6176606|P2|STARTED|Overall Study||20
2520715|NCT00710996|6176607|P1|STARTED|Overall Study||17
2520716|NCT00710970|6176615|P1|NOT COMPLETED|Overall Study||10
2520717|NCT00710970|6176615|P1|COMPLETED|Overall Study||18
2520718|NCT00710970|6176615|P1|STARTED|Overall Study||28
2520719|NCT00710944|6176622|P3|NOT COMPLETED|Overall Study||2
2520720|NCT00710944|6176623|P2|NOT COMPLETED|Overall Study||9
2520721|NCT00710944|6176624|P1|NOT COMPLETED|Overall Study||10
2520722|NCT00710944|6176622|P3|COMPLETED|Overall Study||17
2520723|NCT00710944|6176623|P2|COMPLETED|Overall Study||49
2520724|NCT00710944|6176624|P1|COMPLETED|Overall Study||45
2520725|NCT00710944|6176622|P3|STARTED|Overall Study||19
2520726|NCT00710944|6176623|P2|STARTED|Overall Study||58
2520727|NCT00710944|6176624|P1|STARTED|Overall Study||55
2520728|NCT00710931|6176632|P1|NOT COMPLETED|Overall Study||5
2520729|NCT00710931|6176632|P1|COMPLETED|Overall Study||29
2520730|NCT00710931|6176632|P1|STARTED|Overall Study||34
2520731|NCT00710905|6176636|P1|NOT COMPLETED|Overall Study||16
2520732|NCT00710905|6176636|P1|COMPLETED|Overall Study||34
2520733|NCT00710905|6176636|P1|STARTED|Overall Study||50
2520734|NCT00710879|6176642|P2|NOT COMPLETED|Overall Study||4
2520735|NCT00710879|6176643|P1|NOT COMPLETED|Overall Study||2
2520736|NCT00710879|6176642|P2|COMPLETED|Overall Study||113
2520737|NCT00710879|6176643|P1|COMPLETED|Overall Study||58
2520738|NCT00710879|6176642|P2|STARTED|Overall Study||117
2520739|NCT00710879|6176643|P1|STARTED|Overall Study||60
2520740|NCT00710866|6176655|P2|NOT COMPLETED|Overall Study||6
2520741|NCT00710866|6176656|P1|NOT COMPLETED|Overall Study||9
2520742|NCT00710866|6176655|P2|COMPLETED|Overall Study||128
2520743|NCT00710866|6176656|P1|COMPLETED|Overall Study||124
2520744|NCT00710866|6176655|P2|STARTED|Overall Study||134
2520745|NCT00710866|6176656|P1|STARTED|Overall Study||133
2520746|NCT00710840|6176678|P2|NOT COMPLETED|Overall Study||3
2520747|NCT00710840|6176679|P1|NOT COMPLETED|Overall Study||0
2520748|NCT00710840|6176678|P2|COMPLETED|Overall Study||19
2520749|NCT00710840|6176679|P1|COMPLETED|Overall Study||22
2520750|NCT00710840|6176678|P2|STARTED|Overall Study||22
2520751|NCT00710840|6176679|P1|STARTED|Overall Study||22
2520752|NCT00710814|6176693|P2|NOT COMPLETED|Overall Study||3
2520753|NCT00710814|6176694|P1|NOT COMPLETED|Overall Study||1
2520754|NCT00710814|6176693|P2|COMPLETED|Overall Study||13
2520755|NCT00710814|6176694|P1|COMPLETED|Overall Study||14
2520756|NCT00710814|6176693|P2|STARTED|Overall Study||16
2520757|NCT00710814|6176694|P1|STARTED|Overall Study||15
2520758|NCT00710762|6176702|P2|NOT COMPLETED|Overall Study||40
2520759|NCT00710762|6176703|P1|NOT COMPLETED|Overall Study||39
2520760|NCT00710762|6176702|P2|COMPLETED|Overall Study||0
2520761|NCT00710762|6176703|P1|COMPLETED|Overall Study||5
2520762|NCT00710762|6176702|P2|STARTED|Overall Study||40
2520763|NCT00710762|6176703|P1|STARTED|Overall Study||44
2520764|NCT00710749|6176719|P2|NOT COMPLETED|Second Intervention||0
2520765|NCT00710749|6176720|P1|NOT COMPLETED|Second Intervention||0
2520766|NCT00710749|6176719|P2|COMPLETED|Second Intervention||30
2520767|NCT00710749|6176720|P1|COMPLETED|Second Intervention||29
2520768|NCT00710749|6176719|P2|STARTED|Second Intervention||30
2520769|NCT00710749|6176720|P1|STARTED|Second Intervention||29
2520770|NCT00710749|6176719|P2|NOT COMPLETED|First Intervention||0
2520771|NCT00710749|6176720|P1|NOT COMPLETED|First Intervention||1
2520772|NCT00710749|6176719|P2|COMPLETED|First Intervention||30
2520773|NCT00710749|6176720|P1|COMPLETED|First Intervention||29
2520774|NCT00710749|6176719|P2|STARTED|First Intervention||30
2520775|NCT00710749|6176720|P1|STARTED|First Intervention||30
2520776|NCT00710749|6176719|P2|NOT COMPLETED|Clinic Baseline Recording||0
2520777|NCT00710749|6176720|P1|NOT COMPLETED|Clinic Baseline Recording||0
2520778|NCT00710749|6176719|P2|COMPLETED|Clinic Baseline Recording||30
2520779|NCT00710749|6176720|P1|COMPLETED|Clinic Baseline Recording||30
2520780|NCT00710749|6176719|P2|STARTED|Clinic Baseline Recording||30
2520781|NCT00710749|6176720|P1|STARTED|Clinic Baseline Recording||30
2520782|NCT00710684|6176731|P3|NOT COMPLETED|Overall Study||64
2520783|NCT00710684|6176732|P2|NOT COMPLETED|Overall Study||74
2520784|NCT00710684|6176733|P1|NOT COMPLETED|Overall Study||74
2520785|NCT00710684|6176731|P3|COMPLETED|Overall Study||172
2520786|NCT00710684|6176732|P2|COMPLETED|Overall Study||147
2520787|NCT00710684|6176733|P1|COMPLETED|Overall Study||151
2520788|NCT00710684|6176731|P3|STARTED|Overall Study||236
2520789|NCT00710684|6176732|P2|STARTED|Overall Study||221
2520790|NCT00710684|6176733|P1|STARTED|Overall Study||225
2520791|NCT00710606|6176790|P2|NOT COMPLETED|Overall Study||2
2520792|NCT00710606|6176791|P1|NOT COMPLETED|Overall Study||0
2520793|NCT00710606|6176790|P2|COMPLETED|Overall Study||18
2520794|NCT00710606|6176791|P1|COMPLETED|Overall Study||20
2520795|NCT00710606|6176790|P2|STARTED|Overall Study||20
2520796|NCT00710606|6176791|P1|STARTED|Overall Study||20
2520797|NCT00710593|6176803|P2|NOT COMPLETED|Overall Study||5
2520798|NCT00710593|6176804|P1|NOT COMPLETED|Overall Study||15
2520799|NCT00710593|6176803|P2|COMPLETED|Overall Study|25 completed study and vaccine. 2 did not receive all vaccine, but completed all study visits.|25
2520800|NCT00710593|6176804|P1|COMPLETED|Overall Study|54 completed study and vaccine. 6 did not receive all vaccine, but completed all study visits.|54
2520801|NCT00710593|6176803|P2|STARTED|Overall Study||30
2520802|NCT00710593|6176804|P1|STARTED|Overall Study||69
2520803|NCT00710554|6176847|P2|NOT COMPLETED|Overall Study||24
2520804|NCT00710554|6176848|P1|NOT COMPLETED|Overall Study||49
2520805|NCT00710554|6176847|P2|COMPLETED|Overall Study||94
2520806|NCT00710554|6176848|P1|COMPLETED|Overall Study||79
2520807|NCT00710554|6176847|P2|STARTED|Overall Study||118
2520808|NCT00710554|6176848|P1|STARTED|Overall Study||128
2520809|NCT00710424|6176876|P2|NOT COMPLETED|Overall Study||23
2520810|NCT00710424|6176877|P1|NOT COMPLETED|Overall Study||44
2520811|NCT00710424|6176876|P2|COMPLETED|Overall Study||125
2520812|NCT00710424|6176877|P1|COMPLETED|Overall Study||105
2520813|NCT00710424|6176876|P2|STARTED|Overall Study||148
2520814|NCT00710424|6176877|P1|STARTED|Overall Study||149
2520815|NCT00710385|6176901|P1|NOT COMPLETED|Overall Study||5
2520816|NCT00710385|6176901|P1|COMPLETED|Overall Study||12
2520817|NCT00710385|6176901|P1|STARTED|Overall Study|19 participants signed consent for the study 2 withdrew before any study procedures were initiated.|17
2520818|NCT00710203|6176918|P1|NOT COMPLETED|Overall Study||0
2520819|NCT00710203|6176918|P1|COMPLETED|Overall Study||10
2520820|NCT00710203|6176918|P1|STARTED|Overall Study||10
2520821|NCT00710034|6176946|P2|NOT COMPLETED|Completed 12 Weeks of Treatment||11
2520822|NCT00710034|6176947|P1|NOT COMPLETED|Completed 12 Weeks of Treatment||13
2520823|NCT00710034|6176946|P2|COMPLETED|Completed 12 Weeks of Treatment||138
2520824|NCT00710034|6176947|P1|COMPLETED|Completed 12 Weeks of Treatment||141
2520825|NCT00710034|6176946|P2|STARTED|Completed 12 Weeks of Treatment||149
2520826|NCT00710034|6176947|P1|STARTED|Completed 12 Weeks of Treatment||154
2520827|NCT00710034|6176946|P2|NOT COMPLETED|Completed 6 Weeks of Treatment||47
2520828|NCT00710034|6176947|P1|NOT COMPLETED|Completed 6 Weeks of Treatment||41
2520829|NCT00710034|6176946|P2|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=149|149
2520830|NCT00710034|6176947|P1|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=154|154
2520831|NCT00710034|6176946|P2|STARTED|Completed 6 Weeks of Treatment||196
2520832|NCT00710034|6176947|P1|STARTED|Completed 6 Weeks of Treatment||195
2520833|NCT00710021|6176964|P3|NOT COMPLETED|Overall Study||1
2520834|NCT00710021|6176965|P2|NOT COMPLETED|Overall Study||3
2520835|NCT00710021|6176966|P1|NOT COMPLETED|Overall Study||1
2520836|NCT00710021|6176964|P3|COMPLETED|Overall Study||18
2520837|NCT00710021|6176965|P2|COMPLETED|Overall Study||16
2520838|NCT00710021|6176966|P1|COMPLETED|Overall Study||18
2520839|NCT00710021|6176964|P3|Modified Intent-to-Treat (mITT)|Overall Study|1 subject who did not take study drug was excluded from mITT|18
2520840|NCT00710021|6176965|P2|Modified Intent-to-Treat (mITT)|Overall Study|2 subjects who did not take study drug were excluded from mITT|17
2520841|NCT00710021|6176966|P1|Modified Intent-to-Treat (mITT)|Overall Study||19
2520842|NCT00710021|6176964|P3|STARTED|Overall Study||19
2520843|NCT00710021|6176965|P2|STARTED|Overall Study||19
2520844|NCT00710021|6176966|P1|STARTED|Overall Study||19
2520845|NCT00709995|6177081|P2|NOT COMPLETED|Overall Study||5
2520846|NCT00709995|6177082|P1|NOT COMPLETED|Overall Study||5
2520847|NCT00709995|6177081|P2|COMPLETED|Overall Study||1
2520848|NCT00709995|6177082|P1|COMPLETED|Overall Study||6
2520849|NCT00709995|6177081|P2|Progressive Disease|Overall Study||1
2520850|NCT00709995|6177082|P1|Progressive Disease|Overall Study||6
2520851|NCT00709995|6177081|P2|STARTED|Overall Study||6
2520852|NCT00709995|6177082|P1|STARTED|Overall Study||11
2520853|NCT00709956|6177100|P2|NOT COMPLETED|Overall Study||4
2520854|NCT00709956|6177101|P1|NOT COMPLETED|Overall Study||3
2520855|NCT00709956|6177100|P2|COMPLETED|Overall Study||33
2520856|NCT00709956|6177101|P1|COMPLETED|Overall Study||30
2520857|NCT00709956|6177100|P2|Double-blind Crossover-period|Overall Study|Days 2 and 3|33
2520858|NCT00709956|6177101|P1|Double-blind Crossover-period|Overall Study|Days 2 and 3|31
2520859|NCT00709956|6177100|P2|STARTED|Overall Study|Day 1 Single-blind placebo run-in|37
2520860|NCT00709956|6177101|P1|STARTED|Overall Study|Day 1 Single-blind placebo run-in|33
2520861|NCT00709891|6177109|P1|NOT COMPLETED|Longitudinal Follow-up Phase||4982
2520862|NCT00709891|6177109|P1|COMPLETED|Longitudinal Follow-up Phase||5020
2520863|NCT00709891|6177109|P1|STARTED|Longitudinal Follow-up Phase|Only participants who met study criteria in the Baseline phase started the Follow-up phase.|10002
2520864|NCT00709891|6177109|P1|NOT COMPLETED|Baseline, Cross-sectional Phase||1450
2520865|NCT00709891|6177109|P1|COMPLETED|Baseline, Cross-sectional Phase||45758
2520866|NCT00709891|6177109|P1|STARTED|Baseline, Cross-sectional Phase||47208
2520867|NCT00709878|6177118|P4|NOT COMPLETED|Overall Study||0
2520868|NCT00709878|6177119|P3|NOT COMPLETED|Overall Study||0
2520869|NCT00709878|6177120|P2|NOT COMPLETED|Overall Study||0
2520870|NCT00709878|6177121|P1|NOT COMPLETED|Overall Study||0
2520871|NCT00709878|6177118|P4|COMPLETED|Overall Study||8
2520872|NCT00709878|6177119|P3|COMPLETED|Overall Study||8
2520873|NCT00709878|6177120|P2|COMPLETED|Overall Study||8
2520874|NCT00709878|6177121|P1|COMPLETED|Overall Study||8
2520875|NCT00709878|6177118|P4|STARTED|Overall Study||8
2520876|NCT00709878|6177119|P3|STARTED|Overall Study||8
2520877|NCT00709878|6177120|P2|STARTED|Overall Study||8
2520878|NCT00709878|6177121|P1|STARTED|Overall Study||8
2520879|NCT00709852|6177131|P2|NOT COMPLETED|Period 2||2
2520880|NCT00709852|6177132|P1|NOT COMPLETED|Period 2||9
2520881|NCT00709852|6177131|P2|COMPLETED|Period 2||169
2520882|NCT00709852|6177132|P1|COMPLETED|Period 2||211
2520883|NCT00709852|6177131|P2|STARTED|Period 2||171
2520884|NCT00709852|6177132|P1|STARTED|Period 2||220
2520885|NCT00709852|6177131|P2|NOT COMPLETED|Period 1||3
2520886|NCT00709852|6177132|P1|NOT COMPLETED|Period 1||8
2520887|NCT00709852|6177131|P2|COMPLETED|Period 1||171
2520888|NCT00709852|6177132|P1|COMPLETED|Period 1||220
2520889|NCT00709852|6177131|P2|STARTED|Period 1||174
2520890|NCT00709852|6177132|P1|STARTED|Period 1||228
2520891|NCT00709826|6177287|P2|NOT COMPLETED|Overall Study||1
2520892|NCT00709826|6177288|P1|NOT COMPLETED|Overall Study||2
2520893|NCT00709826|6177287|P2|COMPLETED|Overall Study||38
2520894|NCT00709826|6177288|P1|COMPLETED|Overall Study||68
2520895|NCT00709826|6177287|P2|STARTED|Overall Study||39
2520896|NCT00709826|6177288|P1|STARTED|Overall Study||70
2520897|NCT00709761|6177296|P1|NOT COMPLETED|Overall Study||27
2520898|NCT00709761|6177296|P1|COMPLETED|Overall Study||33
2520899|NCT00709761|6177296|P1|STARTED|Overall Study||60
2520900|NCT00709735|6177307|P2|NOT COMPLETED|Overall Study||2
2520901|NCT00709735|6177308|P1|NOT COMPLETED|Overall Study||3
2520902|NCT00709735|6177307|P2|COMPLETED|Overall Study||10
2520903|NCT00709735|6177308|P1|COMPLETED|Overall Study||8
2520904|NCT00709735|6177307|P2|STARTED|Overall Study||12
2520905|NCT00709735|6177308|P1|STARTED|Overall Study||11
2520906|NCT00709722|6177316|P1|NOT COMPLETED|Overall Study||1
2520907|NCT00709722|6177316|P1|COMPLETED|Overall Study||20
2520908|NCT00709722|6177316|P1|STARTED|Overall Study||21
2520909|NCT00709696|6177324|P2|NOT COMPLETED|Overall Study||0
2520910|NCT00709696|6177325|P1|NOT COMPLETED|Overall Study||0
2520911|NCT00709696|6177324|P2|COMPLETED|Overall Study||3
2520912|NCT00709696|6177325|P1|COMPLETED|Overall Study||4
2520913|NCT00709696|6177324|P2|STARTED|Overall Study||3
2520914|NCT00709696|6177325|P1|STARTED|Overall Study||4
2520915|NCT00709618|6177331|P1|NOT COMPLETED|Overall Study||30
2520916|NCT00709618|6177331|P1|COMPLETED|Overall Study||14
2520917|NCT00709618|6177331|P1|STARTED|Overall Study||44
2520918|NCT00709592|6177343|P2|NOT COMPLETED|Overall Study||1
2520919|NCT00709592|6177344|P1|NOT COMPLETED|Overall Study||0
2520920|NCT00709592|6177343|P2|COMPLETED|Overall Study||22
2520921|NCT00709592|6177344|P1|COMPLETED|Overall Study||19
2520922|NCT00709592|6177343|P2|STARTED|Overall Study||23
2520923|NCT00709592|6177344|P1|STARTED|Overall Study||19
2520924|NCT00709319|6177366|P1|NOT COMPLETED|Overall Study||6
2520925|NCT00709319|6177366|P1|COMPLETED|Overall Study||81
2520926|NCT00709319|6177366|P1|STARTED|Overall Study||87
2520927|NCT00709306|6177378|P4|NOT COMPLETED|Overall Study||10
2520928|NCT00709306|6177379|P3|NOT COMPLETED|Overall Study||10
2520929|NCT00709306|6177380|P2|NOT COMPLETED|Overall Study||14
2520930|NCT00709306|6177381|P1|NOT COMPLETED|Overall Study||9
2520931|NCT00709306|6177378|P4|COMPLETED|Overall Study||37
2520932|NCT00709306|6177379|P3|COMPLETED|Overall Study||48
2520933|NCT00709306|6177380|P2|COMPLETED|Overall Study||30
2520934|NCT00709306|6177381|P1|COMPLETED|Overall Study||39
2520935|NCT00709306|6177378|P4|STARTED|Overall Study||47
2520936|NCT00709306|6177379|P3|STARTED|Overall Study||58
2520937|NCT00709306|6177380|P2|STARTED|Overall Study||44
2520938|NCT00709306|6177381|P1|STARTED|Overall Study||48
2520939|NCT00709228|6177395|P1|NOT COMPLETED|Overall Study||332
2520940|NCT00709228|6177395|P1|COMPLETED|Overall Study|Number completed is defined as participants who completed the follow-up period.|164
2520941|NCT00709228|6177395|P1|STARTED|Overall Study||496
2520942|NCT00709202|6177401|P2|NOT COMPLETED|Overall Study||6
2520943|NCT00709202|6177402|P1|NOT COMPLETED|Overall Study||6
2520944|NCT00709202|6177401|P2|COMPLETED|Overall Study||15
2520945|NCT00709202|6177402|P1|COMPLETED|Overall Study||13
2520946|NCT00709202|6177401|P2|STARTED|Overall Study||21
2520947|NCT00709202|6177402|P1|STARTED|Overall Study||19
2520948|NCT00709124|6177430|P2|NOT COMPLETED|Overall Study||1
2520949|NCT00709124|6177431|P1|NOT COMPLETED|Overall Study||4
2520950|NCT00709124|6177430|P2|COMPLETED|Overall Study||17
2520951|NCT00709124|6177431|P1|COMPLETED|Overall Study||12
2520952|NCT00709124|6177430|P2|STARTED|Overall Study||18
2520953|NCT00709124|6177431|P1|STARTED|Overall Study||16
2520954|NCT00709111|6177465|P1|NOT COMPLETED|Overall Study||2
2520955|NCT00709111|6177465|P1|COMPLETED|Overall Study||32
2520956|NCT00709111|6177465|P1|Week 22/24|Overall Study||33
2520957|NCT00709111|6177465|P1|STARTED|Overall Study||34
2520958|NCT00709098|6177506|P3|NOT COMPLETED|Open-label Period||14
2520959|NCT00709098|6177507|P2|NOT COMPLETED|Open-label Period||0
2520960|NCT00709098|6177508|P1|NOT COMPLETED|Open-label Period||0
2520961|NCT00709098|6177506|P3|COMPLETED|Open-label Period||18
2520962|NCT00709098|6177507|P2|COMPLETED|Open-label Period||0
2520963|NCT00709098|6177508|P1|COMPLETED|Open-label Period||0
2520964|NCT00709098|6177506|P3|STARTED|Open-label Period|The open-label period was only made available to patients in US centers|32
2520965|NCT00709098|6177507|P2|STARTED|Open-label Period||0
2520966|NCT00709098|6177508|P1|STARTED|Open-label Period||0
2520967|NCT00709098|6177506|P3|NOT COMPLETED|Double-blind Period||0
2520968|NCT00709098|6177507|P2|NOT COMPLETED|Double-blind Period||8
2520969|NCT00709098|6177508|P1|NOT COMPLETED|Double-blind Period||6
2520970|NCT00709098|6177506|P3|COMPLETED|Double-blind Period||0
2520971|NCT00709098|6177507|P2|COMPLETED|Double-blind Period||16
2520972|NCT00709098|6177508|P1|COMPLETED|Double-blind Period||19
2520973|NCT00709098|6177506|P3|STARTED|Double-blind Period||0
2520974|NCT00709098|6177507|P2|STARTED|Double-blind Period||24
2520975|NCT00709098|6177508|P1|STARTED|Double-blind Period||25
2520976|NCT00709059|6177527|P1|NOT COMPLETED|Overall Study||94
2520977|NCT00709059|6177527|P1|COMPLETED|Overall Study||444
2520978|NCT00709059|6177527|P1|STARTED|Overall Study||538
2520979|NCT00708942|6177536|P5|NOT COMPLETED|Overall Study||1
2520980|NCT00708942|6177537|P4|NOT COMPLETED|Overall Study||0
2520981|NCT00708942|6177538|P3|NOT COMPLETED|Overall Study||2
2520982|NCT00708942|6177539|P2|NOT COMPLETED|Overall Study||1
2520983|NCT00708942|6177540|P1|NOT COMPLETED|Overall Study||7
2520984|NCT00708942|6177536|P5|COMPLETED|Overall Study||2
2520985|NCT00708942|6177537|P4|COMPLETED|Overall Study||10
2520986|NCT00708942|6177538|P3|COMPLETED|Overall Study||9
2520987|NCT00708942|6177539|P2|COMPLETED|Overall Study||11
2520988|NCT00708942|6177540|P1|COMPLETED|Overall Study||40
2520989|NCT00708942|6177536|P5|STARTED|Overall Study||3
2520990|NCT00708942|6177537|P4|STARTED|Overall Study||10
2520991|NCT00708942|6177538|P3|STARTED|Overall Study||11
2520992|NCT00708942|6177539|P2|STARTED|Overall Study||12
2520993|NCT00708942|6177540|P1|STARTED|Overall Study||47
2520994|NCT00708877|6177562|P1|NOT COMPLETED|Overall Study||0
2520995|NCT00708877|6177562|P1|COMPLETED|Overall Study||5
2520996|NCT00708877|6177562|P1|STARTED|Overall Study||5
2520997|NCT00708851|6177566|P1|NOT COMPLETED|Overall Study||0
2520998|NCT00708851|6177566|P1|COMPLETED|Overall Study||12
2520999|NCT00708851|6177566|P1|STARTED|Overall Study||12
2521000|NCT00708734|6177574|P1|NOT COMPLETED|Overall Study||7
2521001|NCT00708734|6177574|P1|COMPLETED|Overall Study|Ten subjects enrolled, three completed the intervention and all follow up sessions.|3
2521002|NCT00708734|6177574|P1|STARTED|Overall Study|94 subjects were screened, 45 did not meet criteria, and 39 declined participation after screening.|10
2521003|NCT00708721|6177578|P4|NOT COMPLETED|Overall Study||0
2521004|NCT00708721|6177579|P3|NOT COMPLETED|Overall Study||0
2521005|NCT00708721|6177580|P2|NOT COMPLETED|Overall Study||0
2521006|NCT00708721|6177581|P1|NOT COMPLETED|Overall Study||0
2521007|NCT00708721|6177578|P4|COMPLETED|Overall Study||2
2521008|NCT00708721|6177579|P3|COMPLETED|Overall Study||3
2521009|NCT00708721|6177580|P2|COMPLETED|Overall Study||4
2521010|NCT00708721|6177581|P1|COMPLETED|Overall Study||2
2521011|NCT00708721|6177578|P4|STARTED|Overall Study||2
2521012|NCT00708721|6177579|P3|STARTED|Overall Study||3
2521013|NCT00708721|6177580|P2|STARTED|Overall Study||4
2521014|NCT00708721|6177581|P1|STARTED|Overall Study||2
2521015|NCT00708708|6177594|P1|NOT COMPLETED|Overall Study||742
2521016|NCT00708708|6177594|P1|COMPLETED|Overall Study|Included participants completed total observation period and participants with planned study end.|213
2521017|NCT00708708|6177594|P1|STARTED|Overall Study||955
2521018|NCT00708682|6177642|P1|NOT COMPLETED|Toddler Dose||8
2521019|NCT00708682|6177642|P1|COMPLETED|Toddler Dose||183
2521020|NCT00708682|6177642|P1|STARTED|Toddler Dose||191
2521021|NCT00708682|6177642|P1|NOT COMPLETED|After Infant Series||1
2521022|NCT00708682|6177642|P1|COMPLETED|After Infant Series||191
2521023|NCT00708682|6177642|P1|STARTED|After Infant Series||192
2521024|NCT00708682|6177642|P1|NOT COMPLETED|Infant Series||33
2521025|NCT00708682|6177642|P1|COMPLETED|Infant Series||192
2521026|NCT00708682|6177642|P1|Vaccinated Dose 3|Infant Series||194
2521027|NCT00708682|6177642|P1|Vaccinated Dose 2|Infant Series||214
2521028|NCT00708682|6177642|P1|Vaccinated Dose 1|Infant Series||223
2521029|NCT00708682|6177642|P1|STARTED|Infant Series||225
2521030|NCT00708643|6177663|P2|NOT COMPLETED|Overall Study||1
2521031|NCT00708643|6177664|P1|NOT COMPLETED|Overall Study||0
2521032|NCT00708643|6177663|P2|COMPLETED|Overall Study||39
2521033|NCT00708643|6177664|P1|COMPLETED|Overall Study||40
2521034|NCT00708643|6177663|P2|STARTED|Overall Study||40
2521035|NCT00708643|6177664|P1|STARTED|Overall Study||40
2521036|NCT00708552|6177684|P4|NOT COMPLETED|Overall Study||21
2521037|NCT00708552|6177685|P3|NOT COMPLETED|Overall Study||15
2521038|NCT00708552|6177686|P2|NOT COMPLETED|Overall Study||18
2521039|NCT00708552|6177687|P1|NOT COMPLETED|Overall Study||27
2521040|NCT00708552|6177684|P4|COMPLETED|Overall Study||130
2521041|NCT00708552|6177685|P3|COMPLETED|Overall Study||118
2521042|NCT00708552|6177686|P2|COMPLETED|Overall Study||127
2521043|NCT00708552|6177687|P1|COMPLETED|Overall Study||118
2521044|NCT00708552|6177684|P4|STARTED|Overall Study||151
2521045|NCT00708552|6177685|P3|STARTED|Overall Study||133
2521046|NCT00708552|6177686|P2|STARTED|Overall Study||145
2521047|NCT00708552|6177687|P1|STARTED|Overall Study||145
2521048|NCT00708526|6177837|P2|NOT COMPLETED|Return of Cognitive Function||0
2521049|NCT00708526|6177838|P1|NOT COMPLETED|Return of Cognitive Function||0
2521050|NCT00708526|6177837|P2|COMPLETED|Return of Cognitive Function||11
2521051|NCT00708526|6177838|P1|COMPLETED|Return of Cognitive Function||11
2521052|NCT00708526|6177837|P2|STARTED|Return of Cognitive Function||11
2521053|NCT00708526|6177838|P1|STARTED|Return of Cognitive Function||11
2521054|NCT00708526|6177837|P2|NOT COMPLETED|Wake up After Anesthesia||0
2521055|NCT00708526|6177838|P1|NOT COMPLETED|Wake up After Anesthesia||0
2521056|NCT00708526|6177837|P2|COMPLETED|Wake up After Anesthesia||11
2521057|NCT00708526|6177838|P1|COMPLETED|Wake up After Anesthesia||11
2521058|NCT00708526|6177837|P2|STARTED|Wake up After Anesthesia||11
2521059|NCT00708526|6177838|P1|STARTED|Wake up After Anesthesia||11
2521060|NCT00708500|6177849|P3|NOT COMPLETED|FOLLOWUP||15
2521061|NCT00708500|6177850|P2|NOT COMPLETED|FOLLOWUP||15
2521062|NCT00708500|6177851|P1|NOT COMPLETED|FOLLOWUP||40
2521063|NCT00708500|6177849|P3|COMPLETED|FOLLOWUP||143
2521064|NCT00708500|6177850|P2|COMPLETED|FOLLOWUP||136
2521065|NCT00708500|6177851|P1|COMPLETED|FOLLOWUP||37
2521066|NCT00708500|6177849|P3|STARTED|FOLLOWUP||158
2521067|NCT00708500|6177850|P2|STARTED|FOLLOWUP||151
2521068|NCT00708500|6177851|P1|STARTED|FOLLOWUP||77
2521069|NCT00708500|6177849|P3|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
2521070|NCT00708500|6177850|P2|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||52
2521071|NCT00708500|6177851|P1|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
2521072|NCT00708500|6177849|P3|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||105
2521073|NCT00708500|6177850|P2|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||104
2521074|NCT00708500|6177851|P1|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||23
2521075|NCT00708500|6177849|P3|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||160
2521076|NCT00708500|6177850|P2|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||156
2521077|NCT00708500|6177851|P1|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||78
2521078|NCT00708500|6177849|P3|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
2521079|NCT00708500|6177850|P2|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||6
2521080|NCT00708500|6177851|P1|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
2521081|NCT00708500|6177849|P3|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||160
2521082|NCT00708500|6177850|P2|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||156
2521083|NCT00708500|6177851|P1|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||78
2521084|NCT00708500|6177849|P3|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||161
2521085|NCT00708500|6177850|P2|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
2521086|NCT00708500|6177851|P1|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
2521087|NCT00708500|6177849|P3|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
2521088|NCT00708500|6177850|P2|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
2521089|NCT00708500|6177851|P1|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
2521090|NCT00708461|6177870|P2|NOT COMPLETED|Overall Study||200
2521091|NCT00708461|6177871|P1|NOT COMPLETED|Overall Study||141
2521092|NCT00708461|6177870|P2|COMPLETED|Overall Study||795
2521093|NCT00708461|6177871|P1|COMPLETED|Overall Study||611
2521094|NCT00708461|6177870|P2|STARTED|Overall Study||995
2521095|NCT00708461|6177871|P1|STARTED|Overall Study||752
2521096|NCT00708435|6177879|P2|NOT COMPLETED|Overall Study||17
2521097|NCT00708435|6177880|P1|NOT COMPLETED|Overall Study||25
2521098|NCT00708435|6177879|P2|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|92
2521099|NCT00708435|6177880|P1|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|82
2521100|NCT00708435|6177879|P2|STARTED|Overall Study||109
2521101|NCT00708435|6177880|P1|STARTED|Overall Study||107
2521102|NCT00708422|6177907|P2|NOT COMPLETED|Overall Study||1
2521103|NCT00708422|6177908|P1|NOT COMPLETED|Overall Study||4
2521104|NCT00708422|6177907|P2|COMPLETED|Overall Study||114
2521105|NCT00708422|6177908|P1|COMPLETED|Overall Study||112
2521106|NCT00708422|6177907|P2|STARTED|Overall Study||115
2521107|NCT00708422|6177908|P1|STARTED|Overall Study||116
2521108|NCT00708305|6177916|P4|NOT COMPLETED|Period 4||0
2521109|NCT00708305|6177917|P3|NOT COMPLETED|Period 4||0
2521110|NCT00708305|6177918|P2|NOT COMPLETED|Period 4||0
2521111|NCT00708305|6177919|P1|NOT COMPLETED|Period 4||0
2521112|NCT00708305|6177916|P4|COMPLETED|Period 4||14
2521113|NCT00708305|6177917|P3|COMPLETED|Period 4||14
2521114|NCT00708305|6177918|P2|COMPLETED|Period 4||14
2521115|NCT00708305|6177919|P1|COMPLETED|Period 4||12
2521116|NCT00708305|6177916|P4|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
2521117|NCT00708305|6177917|P3|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
2521118|NCT00708305|6177918|P2|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
2521119|NCT00708305|6177919|P1|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
2521120|NCT00708305|6177916|P4|NOT COMPLETED|Period 3||0
2521121|NCT00708305|6177917|P3|NOT COMPLETED|Period 3||0
2521122|NCT00708305|6177918|P2|NOT COMPLETED|Period 3||2
2521123|NCT00708305|6177919|P1|NOT COMPLETED|Period 3||1
2521124|NCT00708305|6177916|P4|COMPLETED|Period 3||14
2521125|NCT00708305|6177917|P3|COMPLETED|Period 3||14
2521126|NCT00708305|6177918|P2|COMPLETED|Period 3||12
2521127|NCT00708305|6177919|P1|COMPLETED|Period 3||14
2521128|NCT00708305|6177916|P4|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
2521129|NCT00708305|6177917|P3|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
2521130|NCT00708305|6177918|P2|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
2521131|NCT00708305|6177919|P1|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|15
2521132|NCT00708305|6177916|P4|NOT COMPLETED|Period 2||1
2521133|NCT00708305|6177917|P3|NOT COMPLETED|Period 2||0
2521134|NCT00708305|6177918|P2|NOT COMPLETED|Period 2||2
2521135|NCT00708305|6177919|P1|NOT COMPLETED|Period 2||1
2521136|NCT00708305|6177916|P4|COMPLETED|Period 2||14
2521137|NCT00708305|6177917|P3|COMPLETED|Period 2||16
2521138|NCT00708305|6177918|P2|COMPLETED|Period 2||13
2521139|NCT00708305|6177919|P1|COMPLETED|Period 2||14
2521140|NCT00708305|6177916|P4|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
2521141|NCT00708305|6177917|P3|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|16
2521142|NCT00708305|6177918|P2|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
2521143|NCT00708305|6177919|P1|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
2521144|NCT00708305|6177916|P4|NOT COMPLETED|Period 1||2
2521145|NCT00708305|6177917|P3|NOT COMPLETED|Period 1||1
2521146|NCT00708305|6177918|P2|NOT COMPLETED|Period 1||0
2521147|NCT00708305|6177919|P1|NOT COMPLETED|Period 1||1
2521148|NCT00708305|6177916|P4|COMPLETED|Period 1||14
2521149|NCT00708305|6177917|P3|COMPLETED|Period 1||16
2521150|NCT00708305|6177918|P2|COMPLETED|Period 1||16
2521151|NCT00708305|6177919|P1|COMPLETED|Period 1||15
2521152|NCT00708305|6177916|P4|STARTED|Period 1||16
2521153|NCT00708305|6177917|P3|STARTED|Period 1||17
2521154|NCT00708305|6177918|P2|STARTED|Period 1||16
2521155|NCT00708305|6177919|P1|STARTED|Period 1||16
2521156|NCT00708227|6177955|P4|NOT COMPLETED|Overall Study||3
2521157|NCT00708227|6177956|P3|NOT COMPLETED|Overall Study||1
2521158|NCT00708227|6177957|P2|NOT COMPLETED|Overall Study||5
2521159|NCT00708227|6177958|P1|NOT COMPLETED|Overall Study||1
2521160|NCT00708227|6177955|P4|COMPLETED|Overall Study||22
2521161|NCT00708227|6177956|P3|COMPLETED|Overall Study||17
2521162|NCT00708227|6177957|P2|COMPLETED|Overall Study||21
2521163|NCT00708227|6177958|P1|COMPLETED|Overall Study||18
2521164|NCT00708227|6177955|P4|STARTED|Overall Study||25
2521165|NCT00708227|6177956|P3|STARTED|Overall Study||18
2521166|NCT00708227|6177957|P2|STARTED|Overall Study||26
2521167|NCT00708227|6177958|P1|STARTED|Overall Study||19
2521168|NCT00708214|6177991|P3|NOT COMPLETED|Overall Study||8
2521169|NCT00708214|6177992|P2|NOT COMPLETED|Overall Study||13
2521170|NCT00708214|6177993|P1|NOT COMPLETED|Overall Study||7
2521171|NCT00708214|6177991|P3|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
2521172|NCT00708214|6177992|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
2521173|NCT00708214|6177993|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
2521174|NCT00708214|6177991|P3|STARTED|Overall Study||8
2521175|NCT00708214|6177992|P2|STARTED|Overall Study||13
2521176|NCT00708214|6177993|P1|STARTED|Overall Study||7
2521177|NCT00708201|6178036|P2|NOT COMPLETED|Overall Study||6
2521178|NCT00708201|6178037|P1|NOT COMPLETED|Overall Study||7
2521179|NCT00708201|6178036|P2|COMPLETED|Overall Study||137
2521180|NCT00708201|6178037|P1|COMPLETED|Overall Study||130
2521181|NCT00708201|6178036|P2|Received at Least 1 Dose of Study Drug|Overall Study||137
2521182|NCT00708201|6178037|P1|Received at Least 1 Dose of Study Drug|Overall Study||130
2521183|NCT00708201|6178036|P2|STARTED|Overall Study||143
2521184|NCT00708201|6178037|P1|STARTED|Overall Study||137
2521185|NCT00708175|6178061|P2|NOT COMPLETED|Overall Study||21
2521186|NCT00708175|6178062|P1|NOT COMPLETED|Overall Study||18
2521187|NCT00708175|6178061|P2|COMPLETED|Overall Study||57
2521188|NCT00708175|6178062|P1|COMPLETED|Overall Study||60
2521189|NCT00708175|6178061|P2|STARTED|Overall Study||78
2521190|NCT00708175|6178062|P1|STARTED|Overall Study||78
2521191|NCT00708162|6178078|P2|NOT COMPLETED|Open-Label Phase||30
2521192|NCT00708162|6178079|P1|NOT COMPLETED|Open-Label Phase||44
2521193|NCT00708162|6178078|P2|COMPLETED|Open-Label Phase||121
2521194|NCT00708162|6178079|P1|COMPLETED|Open-Label Phase||152
2521195|NCT00708162|6178078|P2|STARTED|Open-Label Phase|58 participants completing the Randomized Phase did not continue to the Open-Label Phase.|151
2521196|NCT00708162|6178079|P1|STARTED|Open-Label Phase|9 participants completing the Randomized Phase did not continue to the Open-Label Phase.|196
2521197|NCT00708162|6178078|P2|NOT COMPLETED|Randomized Phase||154
2521198|NCT00708162|6178079|P1|NOT COMPLETED|Randomized Phase||156
2521199|NCT00708162|6178078|P2|COMPLETED|Randomized Phase||209
2521200|NCT00708162|6178079|P1|COMPLETED|Randomized Phase||205
2521201|NCT00708162|6178078|P2|Randomized and Treated|Randomized Phase||358
2521202|NCT00708162|6178079|P1|Randomized and Treated|Randomized Phase||354
2521203|NCT00708162|6178078|P2|STARTED|Randomized Phase||363
2521204|NCT00708162|6178079|P1|STARTED|Randomized Phase||361
2521205|NCT00708123|6178120|P5|NOT COMPLETED|Period 5||0
2521206|NCT00708123|6178121|P4|NOT COMPLETED|Period 5||0
2521207|NCT00708123|6178122|P3|NOT COMPLETED|Period 5||0
2521208|NCT00708123|6178123|P2|NOT COMPLETED|Period 5||0
2521209|NCT00708123|6178124|P1|NOT COMPLETED|Period 5||0
2521210|NCT00708123|6178120|P5|COMPLETED|Period 5||10
2521211|NCT00708123|6178121|P4|COMPLETED|Period 5||11
2521212|NCT00708123|6178122|P3|COMPLETED|Period 5||11
2521213|NCT00708123|6178123|P2|COMPLETED|Period 5||10
2521214|NCT00708123|6178124|P1|COMPLETED|Period 5||10
2521215|NCT00708123|6178120|P5|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
2521216|NCT00708123|6178121|P4|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
2521217|NCT00708123|6178122|P3|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
2521218|NCT00708123|6178123|P2|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
2521219|NCT00708123|6178124|P1|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
2521220|NCT00708123|6178120|P5|NOT COMPLETED|Period 4||0
2521221|NCT00708123|6178121|P4|NOT COMPLETED|Period 4||0
2521222|NCT00708123|6178122|P3|NOT COMPLETED|Period 4||0
2521223|NCT00708123|6178123|P2|NOT COMPLETED|Period 4||1
2521224|NCT00708123|6178124|P1|NOT COMPLETED|Period 4||0
2521225|NCT00708123|6178120|P5|COMPLETED|Period 4||11
2521226|NCT00708123|6178121|P4|COMPLETED|Period 4||10
2521227|NCT00708123|6178122|P3|COMPLETED|Period 4||10
2521228|NCT00708123|6178123|P2|COMPLETED|Period 4||11
2521229|NCT00708123|6178124|P1|COMPLETED|Period 4||10
2521230|NCT00708123|6178120|P5|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|11
2521231|NCT00708123|6178121|P4|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
2521232|NCT00708123|6178122|P3|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
2521233|NCT00708123|6178123|P2|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
2521234|NCT00708123|6178124|P1|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
2521235|NCT00708123|6178120|P5|NOT COMPLETED|Period 3||0
2521236|NCT00708123|6178121|P4|NOT COMPLETED|Period 3||1
2521237|NCT00708123|6178122|P3|NOT COMPLETED|Period 3||1
2521238|NCT00708123|6178123|P2|NOT COMPLETED|Period 3||0
2521239|NCT00708123|6178124|P1|NOT COMPLETED|Period 3||0
2521240|NCT00708123|6178120|P5|COMPLETED|Period 3||10
2521241|NCT00708123|6178121|P4|COMPLETED|Period 3||11
2521242|NCT00708123|6178122|P3|COMPLETED|Period 3||10
2521243|NCT00708123|6178123|P2|COMPLETED|Period 3||10
2521244|NCT00708123|6178124|P1|COMPLETED|Period 3||12
2521245|NCT00708123|6178120|P5|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
2521246|NCT00708123|6178121|P4|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
2521247|NCT00708123|6178122|P3|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|11
2521330|NCT00708097|6178260|P2|COMPLETED|Period 3||11
2521248|NCT00708123|6178123|P2|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
2521249|NCT00708123|6178124|P1|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
2521250|NCT00708123|6178120|P5|NOT COMPLETED|Period 2||0
2521251|NCT00708123|6178121|P4|NOT COMPLETED|Period 2||1
2521252|NCT00708123|6178122|P3|NOT COMPLETED|Period 2||0
2521253|NCT00708123|6178123|P2|NOT COMPLETED|Period 2||0
2521254|NCT00708123|6178124|P1|NOT COMPLETED|Period 2||1
2521255|NCT00708123|6178120|P5|COMPLETED|Period 2||11
2521256|NCT00708123|6178121|P4|COMPLETED|Period 2||10
2521257|NCT00708123|6178122|P3|COMPLETED|Period 2||12
2521258|NCT00708123|6178123|P2|COMPLETED|Period 2||12
2521259|NCT00708123|6178124|P1|COMPLETED|Period 2||10
2521260|NCT00708123|6178120|P5|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
2521261|NCT00708123|6178121|P4|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
2521262|NCT00708123|6178122|P3|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
2521263|NCT00708123|6178123|P2|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
2521264|NCT00708123|6178124|P1|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
2521265|NCT00708123|6178120|P5|NOT COMPLETED|Period 1||0
2521266|NCT00708123|6178121|P4|NOT COMPLETED|Period 1||1
2521267|NCT00708123|6178122|P3|NOT COMPLETED|Period 1||1
2521268|NCT00708123|6178123|P2|NOT COMPLETED|Period 1||1
2521269|NCT00708123|6178124|P1|NOT COMPLETED|Period 1||0
2521270|NCT00708123|6178120|P5|COMPLETED|Period 1||12
2521271|NCT00708123|6178121|P4|COMPLETED|Period 1||11
2521272|NCT00708123|6178122|P3|COMPLETED|Period 1||11
2521273|NCT00708123|6178123|P2|COMPLETED|Period 1||11
2521274|NCT00708123|6178124|P1|COMPLETED|Period 1||12
2521275|NCT00708123|6178120|P5|STARTED|Period 1||12
2521276|NCT00708123|6178121|P4|STARTED|Period 1||12
2521277|NCT00708123|6178122|P3|STARTED|Period 1||12
2521278|NCT00708123|6178123|P2|STARTED|Period 1||12
2521279|NCT00708123|6178124|P1|STARTED|Period 1||12
2521280|NCT00708110|6178148|P4|NOT COMPLETED|Overall Study||0
2521281|NCT00708110|6178149|P3|NOT COMPLETED|Overall Study||0
2521282|NCT00708110|6178150|P2|NOT COMPLETED|Overall Study||0
2521283|NCT00708110|6178151|P1|NOT COMPLETED|Overall Study||0
2521284|NCT00708110|6178148|P4|COMPLETED|Overall Study||10
2521285|NCT00708110|6178149|P3|COMPLETED|Overall Study||9
2521286|NCT00708110|6178150|P2|COMPLETED|Overall Study||9
2521287|NCT00708110|6178151|P1|COMPLETED|Overall Study||7
2521288|NCT00708110|6178148|P4|STARTED|Overall Study||10
2521289|NCT00708110|6178149|P3|STARTED|Overall Study||9
2521290|NCT00708110|6178150|P2|STARTED|Overall Study||9
2521291|NCT00708110|6178151|P1|STARTED|Overall Study||7
2521292|NCT00708097|6178257|P5|NOT COMPLETED|Period 5||0
2521293|NCT00708097|6178258|P4|NOT COMPLETED|Period 5||0
2521294|NCT00708097|6178259|P3|NOT COMPLETED|Period 5||0
2521295|NCT00708097|6178260|P2|NOT COMPLETED|Period 5||0
2521296|NCT00708097|6178261|P1|NOT COMPLETED|Period 5||0
2521297|NCT00708097|6178257|P5|COMPLETED|Period 5||12
2521298|NCT00708097|6178258|P4|COMPLETED|Period 5||10
2521299|NCT00708097|6178259|P3|COMPLETED|Period 5||11
2521300|NCT00708097|6178260|P2|COMPLETED|Period 5||9
2521301|NCT00708097|6178261|P1|COMPLETED|Period 5||8
2521302|NCT00708097|6178257|P5|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|12
2521303|NCT00708097|6178258|P4|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|10
2521304|NCT00708097|6178259|P3|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|11
2521305|NCT00708097|6178260|P2|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|9
2521306|NCT00708097|6178261|P1|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|8
2521307|NCT00708097|6178257|P5|NOT COMPLETED|Period 4||0
2521308|NCT00708097|6178258|P4|NOT COMPLETED|Period 4||0
2521309|NCT00708097|6178259|P3|NOT COMPLETED|Period 4||0
2521310|NCT00708097|6178260|P2|NOT COMPLETED|Period 4||0
2521311|NCT00708097|6178261|P1|NOT COMPLETED|Period 4||0
2521312|NCT00708097|6178257|P5|COMPLETED|Period 4||8
2521313|NCT00708097|6178258|P4|COMPLETED|Period 4||11
2521314|NCT00708097|6178259|P3|COMPLETED|Period 4||10
2521315|NCT00708097|6178260|P2|COMPLETED|Period 4||9
2521316|NCT00708097|6178261|P1|COMPLETED|Period 4||12
2521317|NCT00708097|6178257|P5|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|8
2521318|NCT00708097|6178258|P4|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|11
2521319|NCT00708097|6178259|P3|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|10
2521320|NCT00708097|6178260|P2|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|9
2521321|NCT00708097|6178261|P1|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|12
2521322|NCT00708097|6178257|P5|NOT COMPLETED|Period 3||0
2521323|NCT00708097|6178258|P4|NOT COMPLETED|Period 3||0
2521324|NCT00708097|6178259|P3|NOT COMPLETED|Period 3||0
2521325|NCT00708097|6178260|P2|NOT COMPLETED|Period 3||0
2521326|NCT00708097|6178261|P1|NOT COMPLETED|Period 3||0
2521327|NCT00708097|6178257|P5|COMPLETED|Period 3||10
2521328|NCT00708097|6178258|P4|COMPLETED|Period 3||10
2521329|NCT00708097|6178259|P3|COMPLETED|Period 3||10
2521331|NCT00708097|6178261|P1|COMPLETED|Period 3||9
2521332|NCT00708097|6178257|P5|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
2521333|NCT00708097|6178258|P4|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
2521334|NCT00708097|6178259|P3|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
2521335|NCT00708097|6178260|P2|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|11
2521336|NCT00708097|6178261|P1|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|9
2521337|NCT00708097|6178257|P5|NOT COMPLETED|Period 2||0
2521338|NCT00708097|6178258|P4|NOT COMPLETED|Period 2||1
2521339|NCT00708097|6178259|P3|NOT COMPLETED|Period 2||1
2521340|NCT00708097|6178260|P2|NOT COMPLETED|Period 2||1
2521341|NCT00708097|6178261|P1|NOT COMPLETED|Period 2||0
2521342|NCT00708097|6178257|P5|COMPLETED|Period 2||10
2521343|NCT00708097|6178258|P4|COMPLETED|Period 2||10
2521344|NCT00708097|6178259|P3|COMPLETED|Period 2||9
2521345|NCT00708097|6178260|P2|COMPLETED|Period 2||11
2521346|NCT00708097|6178261|P1|COMPLETED|Period 2||10
2521347|NCT00708097|6178257|P5|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
2521348|NCT00708097|6178258|P4|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|11
2521349|NCT00708097|6178259|P3|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
2521350|NCT00708097|6178260|P2|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|12
2521351|NCT00708097|6178261|P1|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
2521352|NCT00708097|6178257|P5|NOT COMPLETED|Period 1||1
2521353|NCT00708097|6178258|P4|NOT COMPLETED|Period 1||2
2521354|NCT00708097|6178259|P3|NOT COMPLETED|Period 1||0
2521355|NCT00708097|6178260|P2|NOT COMPLETED|Period 1||1
2521356|NCT00708097|6178261|P1|NOT COMPLETED|Period 1||0
2521357|NCT00708097|6178257|P5|COMPLETED|Period 1||10
2521358|NCT00708097|6178258|P4|COMPLETED|Period 1||9
2521359|NCT00708097|6178259|P3|COMPLETED|Period 1||12
2521360|NCT00708097|6178260|P2|COMPLETED|Period 1||11
2521361|NCT00708097|6178261|P1|COMPLETED|Period 1||11
2521362|NCT00708097|6178257|P5|STARTED|Period 1||11
2521363|NCT00708097|6178258|P4|STARTED|Period 1||11
2521364|NCT00708097|6178259|P3|STARTED|Period 1||12
2521365|NCT00708097|6178260|P2|STARTED|Period 1||12
2521366|NCT00708097|6178261|P1|STARTED|Period 1||11
2521367|NCT00708071|6178291|P1|NOT COMPLETED|Overall Study||0
2521368|NCT00708071|6178291|P1|COMPLETED|Overall Study||45
2521369|NCT00708071|6178291|P1|STARTED|Overall Study|Randomized and treated|45
2521370|NCT00708032|6178371|P2|NOT COMPLETED|Overall Study||16
2521371|NCT00708032|6178372|P1|NOT COMPLETED|Overall Study||10
2521372|NCT00708032|6178371|P2|COMPLETED|Overall Study||22
2521373|NCT00708032|6178372|P1|COMPLETED|Overall Study||26
2521374|NCT00708032|6178371|P2|STARTED|Overall Study||38
2521375|NCT00708032|6178372|P1|STARTED|Overall Study||36
2521376|NCT00708019|6178388|P2|NOT COMPLETED|Overall Study||15
2521377|NCT00708019|6178389|P1|NOT COMPLETED|Overall Study||15
2521378|NCT00708019|6178388|P2|COMPLETED|Overall Study||78
2521379|NCT00708019|6178389|P1|COMPLETED|Overall Study||77
2521380|NCT00708019|6178388|P2|STARTED|Overall Study||93
2521381|NCT00708019|6178389|P1|STARTED|Overall Study||92
2521382|NCT00707993|6178399|P2|NOT COMPLETED|Overall Study||94
2521383|NCT00707993|6178400|P1|NOT COMPLETED|Overall Study||89
2521384|NCT00707993|6178399|P2|COMPLETED|Overall Study||125
2521385|NCT00707993|6178400|P1|COMPLETED|Overall Study||133
2521386|NCT00707993|6178399|P2|STARTED|Overall Study||219
2521387|NCT00707993|6178400|P1|STARTED|Overall Study||222
2521388|NCT00707980|6178442|P1|NOT COMPLETED|Overall Study||310
2521389|NCT00707980|6178442|P1|COMPLETED|Overall Study||526
2521390|NCT00707980|6178442|P1|Received Treatment|Overall Study||834
2521391|NCT00707980|6178442|P1|STARTED|Overall Study||836
2521392|NCT00707967|6178460|P3|NOT COMPLETED|Overall Study||0
2521393|NCT00707967|6178461|P2|NOT COMPLETED|Overall Study||0
2521394|NCT00707967|6178462|P1|NOT COMPLETED|Overall Study||0
2521395|NCT00707967|6178460|P3|COMPLETED|Overall Study||7
2521396|NCT00707967|6178461|P2|COMPLETED|Overall Study||8
2521397|NCT00707967|6178462|P1|COMPLETED|Overall Study||22
2521398|NCT00707967|6178460|P3|STARTED|Overall Study||7
2521399|NCT00707967|6178461|P2|STARTED|Overall Study||8
2521400|NCT00707967|6178462|P1|STARTED|Overall Study||22
2521401|NCT00707954|6178526|P5|NOT COMPLETED|Overall Study||1
2521402|NCT00707954|6178527|P4|NOT COMPLETED|Overall Study||0
2521403|NCT00707954|6178528|P3|NOT COMPLETED|Overall Study||0
2521404|NCT00707954|6178529|P2|NOT COMPLETED|Overall Study||0
2521405|NCT00707954|6178530|P1|NOT COMPLETED|Overall Study||0
2521406|NCT00707954|6178526|P5|COMPLETED|Overall Study||9
2521407|NCT00707954|6178527|P4|COMPLETED|Overall Study||13
2521408|NCT00707954|6178528|P3|COMPLETED|Overall Study||14
2521409|NCT00707954|6178529|P2|COMPLETED|Overall Study||12
2521410|NCT00707954|6178530|P1|COMPLETED|Overall Study||12
2521411|NCT00707954|6178526|P5|STARTED|Overall Study||10
2521412|NCT00707954|6178527|P4|STARTED|Overall Study||13
2521413|NCT00707954|6178528|P3|STARTED|Overall Study||14
2521414|NCT00707954|6178529|P2|STARTED|Overall Study||12
2521415|NCT00707954|6178530|P1|STARTED|Overall Study||12
2521416|NCT00707915|6178542|P1|NOT COMPLETED|Overall Study||0
2521417|NCT00707915|6178542|P1|COMPLETED|Overall Study||30
2521418|NCT00707915|6178542|P1|Effects of Discontinuing Benzodiazepine|Overall Study||30
2521419|NCT00707915|6178542|P1|STARTED|Overall Study||30
2521420|NCT00707863|6178553|P2|NOT COMPLETED|Overall Study||3
2521421|NCT00707863|6178554|P1|NOT COMPLETED|Overall Study||0
2521422|NCT00707863|6178553|P2|COMPLETED|Overall Study||8
2521423|NCT00707863|6178554|P1|COMPLETED|Overall Study||6
2521424|NCT00707863|6178553|P2|STARTED|Overall Study||11
2521425|NCT00707863|6178554|P1|STARTED|Overall Study||6
2521426|NCT00707759|6178562|P2|NOT COMPLETED|Overall Study||2
2521427|NCT00707759|6178563|P1|NOT COMPLETED|Overall Study||2
2521428|NCT00707759|6178562|P2|COMPLETED|Overall Study||12
2521429|NCT00707759|6178563|P1|COMPLETED|Overall Study||12
2521430|NCT00707759|6178562|P2|STARTED|Overall Study||14
2521431|NCT00707759|6178563|P1|STARTED|Overall Study||14
2521432|NCT00707746|6178571|P2|NOT COMPLETED|Follow-up Period||0
2521433|NCT00707746|6178572|P1|NOT COMPLETED|Follow-up Period||0
2521434|NCT00707746|6178571|P2|COMPLETED|Follow-up Period||21
2521435|NCT00707746|6178572|P1|COMPLETED|Follow-up Period||12
2521436|NCT00707746|6178571|P2|STARTED|Follow-up Period||21
2521437|NCT00707746|6178572|P1|STARTED|Follow-up Period||12
2521438|NCT00707746|6178571|P2|NOT COMPLETED|Treatment Period||5
2521439|NCT00707746|6178572|P1|NOT COMPLETED|Treatment Period||2
2521440|NCT00707746|6178571|P2|COMPLETED|Treatment Period||17
2521441|NCT00707746|6178572|P1|COMPLETED|Treatment Period||10
2521442|NCT00707746|6178571|P2|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|21
2521443|NCT00707746|6178572|P1|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|12
2521444|NCT00707746|6178571|P2|STARTED|Treatment Period||22
2521445|NCT00707746|6178572|P1|STARTED|Treatment Period||12
2521446|NCT00707655|6178620|P2|NOT COMPLETED|Overall Study||2
2521447|NCT00707655|6178621|P1|NOT COMPLETED|Overall Study||0
2521448|NCT00707655|6178620|P2|COMPLETED|Overall Study||3
2521449|NCT00707655|6178621|P1|COMPLETED|Overall Study||3
2521450|NCT00707655|6178620|P2|STARTED|Overall Study||5
2521451|NCT00707655|6178621|P1|STARTED|Overall Study||3
2521452|NCT00707577|6178633|P2|NOT COMPLETED|Overall Study||38
2521453|NCT00707577|6178634|P1|NOT COMPLETED|Overall Study||54
2521454|NCT00707577|6178633|P2|COMPLETED|Overall Study||118
2521455|NCT00707577|6178634|P1|COMPLETED|Overall Study||120
2521456|NCT00707577|6178633|P2|STARTED|Overall Study||156
2521457|NCT00707577|6178634|P1|STARTED|Overall Study||174
2521458|NCT00707486|6178640|P1|NOT COMPLETED|Overall Study||1
2521459|NCT00707486|6178640|P1|COMPLETED|Overall Study||71
2521460|NCT00707486|6178640|P1|STARTED|Overall Study||72
2521461|NCT00707447|6178651|P2|NOT COMPLETED|Overall Study||8
2521462|NCT00707447|6178652|P1|NOT COMPLETED|Overall Study||8
2521463|NCT00707447|6178651|P2|COMPLETED|Overall Study||85
2521464|NCT00707447|6178652|P1|COMPLETED|Overall Study||81
2521465|NCT00707447|6178651|P2|STARTED|Overall Study||93
2521466|NCT00707447|6178652|P1|STARTED|Overall Study||89
2521467|NCT00707343|6178676|P1|NOT COMPLETED|Overall Study||0
2521468|NCT00707343|6178676|P1|COMPLETED|Overall Study||15
2521469|NCT00707343|6178676|P1|STARTED|Overall Study||15
2521470|NCT00707239|6178683|P3|NOT COMPLETED|Overall Study||14
2521471|NCT00707239|6178684|P2|NOT COMPLETED|Overall Study||11
2521472|NCT00707239|6178685|P1|NOT COMPLETED|Overall Study||19
2521473|NCT00707239|6178683|P3|COMPLETED|Overall Study||21
2521474|NCT00707239|6178684|P2|COMPLETED|Overall Study||25
2521475|NCT00707239|6178685|P1|COMPLETED|Overall Study||18
2521476|NCT00707239|6178683|P3|Treated|Overall Study||34
2521477|NCT00707239|6178684|P2|Treated|Overall Study||35
2521478|NCT00707239|6178685|P1|Treated|Overall Study||36
2521479|NCT00707239|6178683|P3|STARTED|Overall Study||35
2521480|NCT00707239|6178684|P2|STARTED|Overall Study||36
2521481|NCT00707239|6178685|P1|STARTED|Overall Study||37
2521482|NCT00707174|6178733|P2|NOT COMPLETED|Overall Study||7
2521483|NCT00707174|6178734|P1|NOT COMPLETED|Overall Study||5
2521484|NCT00707174|6178733|P2|COMPLETED|Overall Study||37
2521485|NCT00707174|6178734|P1|COMPLETED|Overall Study||41
2521486|NCT00707174|6178733|P2|STARTED|Overall Study||44
2521487|NCT00707174|6178734|P1|STARTED|Overall Study||46
2521488|NCT00707161|6178740|P1|NOT COMPLETED|Overall Study||6
2521489|NCT00707161|6178740|P1|COMPLETED|Overall Study||0
2521490|NCT00707161|6178740|P1|STARTED|Overall Study|3 deceased (1-Huntsman Cancer Institute, 2- LDS Hospital).|6
2521491|NCT00707057|6178746|P2|NOT COMPLETED|Overall Study||4
2521492|NCT00707057|6178747|P1|NOT COMPLETED|Overall Study||8
2521493|NCT00707057|6178746|P2|COMPLETED|Overall Study||83
2521494|NCT00707057|6178747|P1|COMPLETED|Overall Study||161
2521495|NCT00707057|6178746|P2|STARTED|Overall Study||87
2521496|NCT00707057|6178747|P1|STARTED|Overall Study||169
2521497|NCT00707031|6178781|P2|NOT COMPLETED|Overall Study||99
2521498|NCT00707031|6178782|P1|NOT COMPLETED|Overall Study||104
2521499|NCT00707031|6178781|P2|COMPLETED|Overall Study||220
2521500|NCT00707031|6178782|P1|COMPLETED|Overall Study||216
2521501|NCT00707031|6178781|P2|Modified Intent-to-Treat Population|Overall Study||315
2521502|NCT00707031|6178782|P1|Modified Intent-to-Treat Population|Overall Study|All patients who received at least 1 dose;had baseline;at least 1 post-baseline efficacy assessment.|315
2521503|NCT00707031|6178781|P2|Treated/Safety Population|Overall Study||316
2521504|NCT00707031|6178782|P1|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|318
2521505|NCT00707031|6178781|P2|STARTED|Overall Study||319
2521506|NCT00707031|6178782|P1|STARTED|Overall Study|Randomized|320
2521507|NCT00706992|6178811|P7|NOT COMPLETED|Overall Study||3
2521508|NCT00706992|6178812|P6|NOT COMPLETED|Overall Study||2
2521509|NCT00706992|6178813|P5|NOT COMPLETED|Overall Study||4
2521510|NCT00706992|6178814|P4|NOT COMPLETED|Overall Study||2
2521511|NCT00706992|6178815|P3|NOT COMPLETED|Overall Study||6
2521512|NCT00706992|6178816|P2|NOT COMPLETED|Overall Study||5
2521513|NCT00706992|6178817|P1|NOT COMPLETED|Overall Study||5
2521514|NCT00706992|6178811|P7|COMPLETED|Overall Study||3
2521515|NCT00706992|6178812|P6|COMPLETED|Overall Study||3
2521516|NCT00706992|6178813|P5|COMPLETED|Overall Study||2
2521517|NCT00706992|6178814|P4|COMPLETED|Overall Study||6
2521518|NCT00706992|6178815|P3|COMPLETED|Overall Study||3
2521519|NCT00706992|6178816|P2|COMPLETED|Overall Study||3
2521520|NCT00706992|6178817|P1|COMPLETED|Overall Study||3
2521521|NCT00706992|6178811|P7|STARTED|Overall Study||6
2521522|NCT00706992|6178812|P6|STARTED|Overall Study||5
2521523|NCT00706992|6178813|P5|STARTED|Overall Study||6
2521524|NCT00706992|6178814|P4|STARTED|Overall Study||8
2521525|NCT00706992|6178815|P3|STARTED|Overall Study||9
2521526|NCT00706992|6178816|P2|STARTED|Overall Study||8
2521527|NCT00706992|6178817|P1|STARTED|Overall Study||8
2521528|NCT00706979|6178836|P2|NOT COMPLETED|Overall Study||0
2521529|NCT00706979|6178837|P1|NOT COMPLETED|Overall Study||0
2521530|NCT00706979|6178836|P2|COMPLETED|Overall Study||423
2521531|NCT00706979|6178837|P1|COMPLETED|Overall Study||426
2521532|NCT00706979|6178836|P2|STARTED|Overall Study||423
2521533|NCT00706979|6178837|P1|STARTED|Overall Study||426
2521534|NCT00706966|6178849|P1|NOT COMPLETED|Overall Study||1
2521535|NCT00706966|6178849|P1|COMPLETED|Overall Study||9
2521536|NCT00706966|6178849|P1|STARTED|Overall Study||10
2521537|NCT00706914|6178885|P3|NOT COMPLETED|Overall Study||1
2521538|NCT00706914|6178886|P2|NOT COMPLETED|Overall Study||4
2521539|NCT00706914|6178887|P1|NOT COMPLETED|Overall Study||6
2521540|NCT00706914|6178885|P3|COMPLETED|Overall Study||30
2521541|NCT00706914|6178886|P2|COMPLETED|Overall Study||58
2521542|NCT00706914|6178887|P1|COMPLETED|Overall Study||57
2521543|NCT00706914|6178885|P3|STARTED|Overall Study||31
2521544|NCT00706914|6178886|P2|STARTED|Overall Study||62
2521545|NCT00706914|6178887|P1|STARTED|Overall Study||63
2521546|NCT00706901|6178910|P3|NOT COMPLETED|Overall Study||8
2521547|NCT00706901|6178911|P2|NOT COMPLETED|Overall Study||5
2521548|NCT00706901|6178912|P1|NOT COMPLETED|Overall Study||8
2521549|NCT00706901|6178910|P3|COMPLETED|Overall Study||51
2521550|NCT00706901|6178911|P2|COMPLETED|Overall Study||57
2521551|NCT00706901|6178912|P1|COMPLETED|Overall Study||51
2521552|NCT00706901|6178910|P3|STARTED|Overall Study||59
2521553|NCT00706901|6178911|P2|STARTED|Overall Study||62
2521554|NCT00706901|6178912|P1|STARTED|Overall Study||59
2521555|NCT00706849|6178937|P2|NOT COMPLETED|Follow-up Period||3
2521556|NCT00706849|6178938|P1|NOT COMPLETED|Follow-up Period||0
2521557|NCT00706849|6178937|P2|COMPLETED|Follow-up Period||25
2521558|NCT00706849|6178938|P1|COMPLETED|Follow-up Period||3
2521559|NCT00706849|6178937|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|28
2521560|NCT00706849|6178938|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|3
2521561|NCT00706849|6178937|P2|NOT COMPLETED|Treatment Period||10
2521562|NCT00706849|6178938|P1|NOT COMPLETED|Treatment Period||0
2521563|NCT00706849|6178937|P2|COMPLETED|Treatment Period|55 patients entered the open-label extension study (301012-CS6; NCT00694109).|73
2521564|NCT00706849|6178938|P1|COMPLETED|Treatment Period|38 patients entered the open-label extension study (301012-CS6; NCT00694109).|41
2521565|NCT00706849|6178937|P2|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement.|82
2521566|NCT00706849|6178938|P1|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|41
2521567|NCT00706849|6178937|P2|STARTED|Treatment Period||83
2521568|NCT00706849|6178938|P1|STARTED|Treatment Period||41
2521569|NCT00706836|6178982|P1|NOT COMPLETED|Overall Study||0
2521570|NCT00706836|6178982|P1|COMPLETED|Overall Study||16
2521571|NCT00706836|6178982|P1|STARTED|Overall Study||16
2521572|NCT00706823|6178992|P2|NOT COMPLETED|Overall Study||0
2521573|NCT00706823|6178993|P1|NOT COMPLETED|Overall Study||0
2521574|NCT00706823|6178992|P2|COMPLETED|Overall Study||25
2521575|NCT00706823|6178993|P1|COMPLETED|Overall Study||25
2521576|NCT00706823|6178992|P2|STARTED|Overall Study||25
2521577|NCT00706823|6178993|P1|STARTED|Overall Study||25
2521578|NCT00706810|6179009|P1|NOT COMPLETED|Overall Study||1
2521579|NCT00706810|6179009|P1|COMPLETED|Overall Study||7
2521580|NCT00706810|6179009|P1|STARTED|Overall Study||8
2521581|NCT00706797|6179016|P2|NOT COMPLETED|Overall Study||71
2521582|NCT00706797|6179017|P1|NOT COMPLETED|Overall Study||69
2521583|NCT00706797|6179016|P2|COMPLETED|Overall Study||0
2521584|NCT00706797|6179017|P1|COMPLETED|Overall Study||1
2521585|NCT00706797|6179016|P2|Safety Population|Overall Study||71
2521586|NCT00706797|6179017|P1|Safety Population|Overall Study|Safety population=all randomly assigned subjects who had at least 1 dose of study treatment.|63
2521587|NCT00706797|6179016|P2|STARTED|Overall Study||71
2521588|NCT00706797|6179017|P1|STARTED|Overall Study||70
2521589|NCT00706784|6179059|P2|NOT COMPLETED|Overall Study||0
2521590|NCT00706784|6179060|P1|NOT COMPLETED|Overall Study||0
2521591|NCT00706784|6179059|P2|COMPLETED|Overall Study||3
2521592|NCT00706784|6179060|P1|COMPLETED|Overall Study||3
2521593|NCT00706784|6179059|P2|STARTED|Overall Study||3
2521594|NCT00706784|6179060|P1|STARTED|Overall Study||3
2521595|NCT00706719|6179069|P3|NOT COMPLETED|Overall Study||4
2521596|NCT00706719|6179070|P2|NOT COMPLETED|Overall Study||1
2521597|NCT00706719|6179071|P1|NOT COMPLETED|Overall Study||0
2521598|NCT00706719|6179069|P3|COMPLETED|Overall Study||1
2521599|NCT00706719|6179070|P2|COMPLETED|Overall Study||6
2521600|NCT00706719|6179071|P1|COMPLETED|Overall Study||5
2521601|NCT00706719|6179069|P3|STARTED|Overall Study||5
2521602|NCT00706719|6179070|P2|STARTED|Overall Study||7
2521603|NCT00706719|6179071|P1|STARTED|Overall Study||5
2521604|NCT00706706|6179086|P1|NOT COMPLETED|Overall Study||105
2521605|NCT00706706|6179086|P1|COMPLETED|Overall Study||0
2521606|NCT00706706|6179086|P1|STARTED|Overall Study||105
2521607|NCT00706654|6179096|P4|NOT COMPLETED|Depot Maintenance Phase||70
2521608|NCT00706654|6179097|P3|NOT COMPLETED|Depot Maintenance Phase||88
2521609|NCT00706654|6179098|P2|NOT COMPLETED|Depot Maintenance Phase||69
2521610|NCT00706654|6179099|P1|NOT COMPLETED|Depot Maintenance Phase||0
2521611|NCT00706654|6179096|P4|COMPLETED|Depot Maintenance Phase||61
2521612|NCT00706654|6179097|P3|COMPLETED|Depot Maintenance Phase||178
2521613|NCT00706654|6179098|P2|COMPLETED|Depot Maintenance Phase||196
2521614|NCT00706654|6179099|P1|COMPLETED|Depot Maintenance Phase||0
2521615|NCT00706654|6179096|P4|STARTED|Depot Maintenance Phase||131
2521616|NCT00706654|6179097|P3|STARTED|Depot Maintenance Phase||266
2521617|NCT00706654|6179098|P2|STARTED|Depot Maintenance Phase||265
2521618|NCT00706654|6179099|P1|STARTED|Depot Maintenance Phase|Patients were randomized into the 3 aripiprazole treatment groups in this phase of the study.|0
2521619|NCT00706654|6179096|P4|NOT COMPLETED|Oral Stabilization Phase||0
2521620|NCT00706654|6179097|P3|NOT COMPLETED|Oral Stabilization Phase||0
2521621|NCT00706654|6179098|P2|NOT COMPLETED|Oral Stabilization Phase||0
2521622|NCT00706654|6179099|P1|NOT COMPLETED|Oral Stabilization Phase||180
2521623|NCT00706654|6179096|P4|COMPLETED|Oral Stabilization Phase||0
2521624|NCT00706654|6179097|P3|COMPLETED|Oral Stabilization Phase||0
2521625|NCT00706654|6179098|P2|COMPLETED|Oral Stabilization Phase||0
2521626|NCT00706654|6179099|P1|COMPLETED|Oral Stabilization Phase||662
2521627|NCT00706654|6179096|P4|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
2521628|NCT00706654|6179097|P3|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
2521629|NCT00706654|6179098|P2|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
2521630|NCT00706654|6179099|P1|STARTED|Oral Stabilization Phase|228 of the 842 patients who started this phase enrolled directly into this phase of the study.|842
2521631|NCT00706654|6179096|P4|NOT COMPLETED|Conversion Phase||0
2521632|NCT00706654|6179097|P3|NOT COMPLETED|Conversion Phase||0
2521633|NCT00706654|6179098|P2|NOT COMPLETED|Conversion Phase||0
2521634|NCT00706654|6179099|P1|NOT COMPLETED|Conversion Phase||95
2521635|NCT00706654|6179096|P4|COMPLETED|Conversion Phase||0
2521636|NCT00706654|6179097|P3|COMPLETED|Conversion Phase||0
2521637|NCT00706654|6179098|P2|COMPLETED|Conversion Phase||0
2521638|NCT00706654|6179099|P1|COMPLETED|Conversion Phase||614
2521639|NCT00706654|6179096|P4|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
2521640|NCT00706654|6179097|P3|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
2521641|NCT00706654|6179098|P2|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
2521642|NCT00706654|6179099|P1|STARTED|Conversion Phase||709
2521643|NCT00706641|6179118|P1|NOT COMPLETED|Radical Cystectomy||1
2521644|NCT00706641|6179118|P1|COMPLETED|Radical Cystectomy||22
2521645|NCT00706641|6179118|P1|STARTED|Radical Cystectomy||23
2521646|NCT00706641|6179118|P1|NOT COMPLETED|Dasatinib Administration||2
2521647|NCT00706641|6179118|P1|COMPLETED|Dasatinib Administration||23
2521648|NCT00706641|6179118|P1|Toxicity Evaluation|Dasatinib Administration||24
2521649|NCT00706641|6179118|P1|STARTED|Dasatinib Administration||25
2521650|NCT00706628|6179132|P4|NOT COMPLETED|Overall Study||3
2521651|NCT00706628|6179133|P3|NOT COMPLETED|Overall Study||16
2521652|NCT00706628|6179134|P2|NOT COMPLETED|Overall Study||21
2521653|NCT00706628|6179135|P1|NOT COMPLETED|Overall Study||47
2521654|NCT00706628|6179132|P4|COMPLETED|Overall Study||0
2521655|NCT00706628|6179133|P3|COMPLETED|Overall Study||0
2521656|NCT00706628|6179134|P2|COMPLETED|Overall Study||0
2521657|NCT00706628|6179135|P1|COMPLETED|Overall Study||0
2521658|NCT00706628|6179132|P4|STARTED|Overall Study||3
2521659|NCT00706628|6179133|P3|STARTED|Overall Study||16
2521660|NCT00706628|6179134|P2|STARTED|Overall Study||21
2521661|NCT00706628|6179135|P1|STARTED|Overall Study||47
2521662|NCT00706589|6179185|P2|NOT COMPLETED|Overall Study||4
2521663|NCT00706589|6179186|P1|NOT COMPLETED|Overall Study||3
2521664|NCT00706589|6179185|P2|COMPLETED|Overall Study||25
2521665|NCT00706589|6179186|P1|COMPLETED|Overall Study||29
2521666|NCT00706589|6179185|P2|STARTED|Overall Study||29
2521667|NCT00706589|6179186|P1|STARTED|Overall Study||32
2521668|NCT00706563|6179194|P2|NOT COMPLETED|Overall Study||0
2521669|NCT00706563|6179195|P1|NOT COMPLETED|Overall Study||0
2521670|NCT00706563|6179194|P2|COMPLETED|Overall Study||59
2521671|NCT00706563|6179195|P1|COMPLETED|Overall Study||61
2521672|NCT00706563|6179194|P2|STARTED|Overall Study||59
2521673|NCT00706563|6179195|P1|STARTED|Overall Study||61
2521674|NCT00706550|6179219|P2|NOT COMPLETED|Overall Study||28
2521675|NCT00706550|6179220|P1|NOT COMPLETED|Overall Study||7
2521676|NCT00706550|6179219|P2|COMPLETED|Overall Study||36
2521677|NCT00706550|6179220|P1|COMPLETED|Overall Study||36
2521678|NCT00706550|6179219|P2|STARTED|Overall Study||64
2521679|NCT00706550|6179220|P1|STARTED|Overall Study||43
2521680|NCT00706485|6179236|P1|NOT COMPLETED|Overall Study||0
2521681|NCT00706485|6179236|P1|COMPLETED|Overall Study||5
2521682|NCT00706485|6179236|P1|STARTED|Overall Study||5
2521683|NCT00706446|6179248|P6|NOT COMPLETED|Overall Study||38
2521684|NCT00706446|6179249|P5|NOT COMPLETED|Overall Study||44
2521685|NCT00706446|6179250|P4|NOT COMPLETED|Overall Study||22
2521686|NCT00706446|6179251|P3|NOT COMPLETED|Overall Study||37
2521687|NCT00706446|6179252|P2|NOT COMPLETED|Overall Study||49
2521688|NCT00706446|6179253|P1|NOT COMPLETED|Overall Study||26
2521689|NCT00706446|6179248|P6|COMPLETED|Overall Study||7
2521690|NCT00706446|6179249|P5|COMPLETED|Overall Study||10
2521691|NCT00706446|6179250|P4|COMPLETED|Overall Study||4
2521692|NCT00706446|6179251|P3|COMPLETED|Overall Study||7
2521693|NCT00706446|6179252|P2|COMPLETED|Overall Study||8
2521694|NCT00706446|6179253|P1|COMPLETED|Overall Study||3
2521695|NCT00706446|6179248|P6|STARTED|Overall Study||45
2521696|NCT00706446|6179249|P5|STARTED|Overall Study||54
2521697|NCT00706446|6179250|P4|STARTED|Overall Study||26
2521698|NCT00706446|6179251|P3|STARTED|Overall Study||44
2521699|NCT00706446|6179252|P2|STARTED|Overall Study||57
2521700|NCT00706446|6179253|P1|STARTED|Overall Study||29
2521701|NCT00706433|6179295|P4|NOT COMPLETED|Overall Study||2
2521702|NCT00706433|6179296|P3|NOT COMPLETED|Overall Study||10
2521703|NCT00706433|6179297|P2|NOT COMPLETED|Overall Study||3
2521704|NCT00706433|6179298|P1|NOT COMPLETED|Overall Study||5
2521705|NCT00706433|6179295|P4|COMPLETED|Overall Study||64
2521706|NCT00706433|6179296|P3|COMPLETED|Overall Study||57
2521707|NCT00706433|6179297|P2|COMPLETED|Overall Study||62
2521708|NCT00706433|6179298|P1|COMPLETED|Overall Study||63
2521709|NCT00706433|6179295|P4|STARTED|Overall Study||66
2521710|NCT00706433|6179296|P3|STARTED|Overall Study||67
2521711|NCT00706433|6179297|P2|STARTED|Overall Study||65
2521712|NCT00706433|6179298|P1|STARTED|Overall Study||68
2521713|NCT00706407|6179614|P1|NOT COMPLETED|Overall Study||9
2521714|NCT00706407|6179614|P1|COMPLETED|Overall Study||33
2521715|NCT00706407|6179614|P1|STARTED|Overall Study||42
2521716|NCT00706355|6179625|P4|NOT COMPLETED|Period 4: PF-04217903 150 mg||4
2521717|NCT00706355|6179626|P3|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
2521718|NCT00706355|6179627|P2|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
2521719|NCT00706355|6179628|P1|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
2521720|NCT00706355|6179625|P4|COMPLETED|Period 4: PF-04217903 150 mg||0
2521721|NCT00706355|6179626|P3|COMPLETED|Period 4: PF-04217903 150 mg||0
2521722|NCT00706355|6179627|P2|COMPLETED|Period 4: PF-04217903 150 mg||0
2521723|NCT00706355|6179628|P1|COMPLETED|Period 4: PF-04217903 150 mg||0
2521724|NCT00706355|6179625|P4|STARTED|Period 4: PF-04217903 150 mg||4
2521725|NCT00706355|6179626|P3|STARTED|Period 4: PF-04217903 150 mg||0
2521726|NCT00706355|6179627|P2|STARTED|Period 4: PF-04217903 150 mg||0
2521727|NCT00706355|6179628|P1|STARTED|Period 4: PF-04217903 150 mg||0
2521728|NCT00706355|6179625|P4|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
2521729|NCT00706355|6179626|P3|NOT COMPLETED|Period 3: PF-04217903 200 mg||2
2521730|NCT00706355|6179627|P2|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
2521731|NCT00706355|6179628|P1|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
2521732|NCT00706355|6179625|P4|COMPLETED|Period 3: PF-04217903 200 mg||0
2521733|NCT00706355|6179626|P3|COMPLETED|Period 3: PF-04217903 200 mg||0
2521734|NCT00706355|6179627|P2|COMPLETED|Period 3: PF-04217903 200 mg||0
2521735|NCT00706355|6179628|P1|COMPLETED|Period 3: PF-04217903 200 mg||0
2521736|NCT00706355|6179625|P4|STARTED|Period 3: PF-04217903 200 mg||0
2521737|NCT00706355|6179626|P3|STARTED|Period 3: PF-04217903 200 mg||2
2521738|NCT00706355|6179627|P2|STARTED|Period 3: PF-04217903 200 mg||0
2521739|NCT00706355|6179628|P1|STARTED|Period 3: PF-04217903 200 mg||0
2521740|NCT00706355|6179625|P4|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
2521741|NCT00706355|6179626|P3|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
2521742|NCT00706355|6179627|P2|NOT COMPLETED|Period 2: PF-04217903 100 mg||7
2521743|NCT00706355|6179628|P1|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
2521744|NCT00706355|6179625|P4|COMPLETED|Period 2: PF-04217903 100 mg||0
2521745|NCT00706355|6179626|P3|COMPLETED|Period 2: PF-04217903 100 mg||0
2521746|NCT00706355|6179627|P2|COMPLETED|Period 2: PF-04217903 100 mg||0
2521747|NCT00706355|6179628|P1|COMPLETED|Period 2: PF-04217903 100 mg||0
2521748|NCT00706355|6179625|P4|STARTED|Period 2: PF-04217903 100 mg||0
2521749|NCT00706355|6179626|P3|STARTED|Period 2: PF-04217903 100 mg||0
2521750|NCT00706355|6179627|P2|STARTED|Period 2: PF-04217903 100 mg||7
2521751|NCT00706355|6179628|P1|STARTED|Period 2: PF-04217903 100 mg||0
2521752|NCT00706355|6179625|P4|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
2521753|NCT00706355|6179626|P3|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
2521754|NCT00706355|6179627|P2|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
2521755|NCT00706355|6179628|P1|NOT COMPLETED|Period 1: PF-04217903 50 mg||3
2521756|NCT00706355|6179625|P4|COMPLETED|Period 1: PF-04217903 50 mg||0
2521757|NCT00706355|6179626|P3|COMPLETED|Period 1: PF-04217903 50 mg||0
2521758|NCT00706355|6179627|P2|COMPLETED|Period 1: PF-04217903 50 mg||0
2521759|NCT00706355|6179628|P1|COMPLETED|Period 1: PF-04217903 50 mg||0
2521760|NCT00706355|6179625|P4|STARTED|Period 1: PF-04217903 50 mg||0
2521761|NCT00706355|6179626|P3|STARTED|Period 1: PF-04217903 50 mg||0
2521762|NCT00706355|6179627|P2|STARTED|Period 1: PF-04217903 50 mg||0
2521763|NCT00706355|6179628|P1|STARTED|Period 1: PF-04217903 50 mg||3
2521764|NCT00706342|6179680|P1|NOT COMPLETED|Overall Study||18
2521765|NCT00706342|6179680|P1|COMPLETED|Overall Study||0
2521766|NCT00706342|6179680|P1|STARTED|Overall Study||18
2521767|NCT00706329|6179689|P1|NOT COMPLETED|Overall Study||0
2521768|NCT00706329|6179689|P1|COMPLETED|Overall Study||25
2521769|NCT00706329|6179689|P1|STARTED|Overall Study||25
2521770|NCT00706238|6179693|P1|NOT COMPLETED|Overall Study||5
2521771|NCT00706238|6179693|P1|COMPLETED|Overall Study||0
2521772|NCT00706238|6179693|P1|STARTED|Overall Study||5
2521773|NCT00706134|6179710|P4|NOT COMPLETED|Overall Study||11
2521774|NCT00706134|6179711|P3|NOT COMPLETED|Overall Study||6
2521775|NCT00706134|6179712|P2|NOT COMPLETED|Overall Study||19
2521776|NCT00706134|6179713|P1|NOT COMPLETED|Overall Study||20
2521777|NCT00706134|6179710|P4|COMPLETED|Overall Study||175
2521778|NCT00706134|6179711|P3|COMPLETED|Overall Study||183
2521779|NCT00706134|6179712|P2|COMPLETED|Overall Study||173
2521780|NCT00706134|6179713|P1|COMPLETED|Overall Study||169
2521781|NCT00706134|6179710|P4|Entered Double-blind Period|Overall Study||186
2521782|NCT00706134|6179711|P3|Entered Double-blind Period|Overall Study||189
2521783|NCT00706134|6179712|P2|Entered Double-blind Period|Overall Study||192
2521784|NCT00706134|6179713|P1|Entered Double-blind Period|Overall Study||187
2521785|NCT00706134|6179710|P4|STARTED|Overall Study||186
2521786|NCT00706134|6179711|P3|STARTED|Overall Study||189
2521787|NCT00706134|6179712|P2|STARTED|Overall Study||192
2521788|NCT00706134|6179713|P1|STARTED|Overall Study||189
2521789|NCT00706121|6179747|P4|NOT COMPLETED|Overall Study||352
2521790|NCT00706121|6179748|P3|NOT COMPLETED|Overall Study||404
2521791|NCT00706121|6179749|P2|NOT COMPLETED|Overall Study||396
2521792|NCT00706121|6179750|P1|NOT COMPLETED|Overall Study||396
2521793|NCT00706121|6179747|P4|COMPLETED|Overall Study||1577
2521794|NCT00706121|6179748|P3|COMPLETED|Overall Study||1626
2521795|NCT00706121|6179749|P2|COMPLETED|Overall Study||1700
2521796|NCT00706121|6179750|P1|COMPLETED|Overall Study||1643
2521797|NCT00706121|6179747|P4|STARTED|Overall Study||1929
2521798|NCT00706121|6179748|P3|STARTED|Overall Study||2030
2521799|NCT00706121|6179749|P2|STARTED|Overall Study||2096
2521800|NCT00706121|6179750|P1|STARTED|Overall Study||2039
2521801|NCT00706095|6179779|P3|NOT COMPLETED|Overall Study||5
2521802|NCT00706095|6179780|P2|NOT COMPLETED|Overall Study||7
2521803|NCT00706095|6179781|P1|NOT COMPLETED|Overall Study||6
2521804|NCT00706095|6179779|P3|COMPLETED|Overall Study||0
2521805|NCT00706095|6179780|P2|COMPLETED|Overall Study||0
2521806|NCT00706095|6179781|P1|COMPLETED|Overall Study||0
2521807|NCT00706095|6179779|P3|STARTED|Overall Study||5
2521808|NCT00706095|6179780|P2|STARTED|Overall Study||7
2521809|NCT00706095|6179781|P1|STARTED|Overall Study||6
2521810|NCT00706030|6179799|P4|NOT COMPLETED|Overall Study||16
2521811|NCT00706030|6179800|P3|NOT COMPLETED|Overall Study||60
2521812|NCT00706030|6179801|P2|NOT COMPLETED|Overall Study||6
2521813|NCT00706030|6179802|P1|NOT COMPLETED|Overall Study||6
2521814|NCT00706030|6179799|P4|COMPLETED|Overall Study||0
2521815|NCT00706030|6179800|P3|COMPLETED|Overall Study||4
2521816|NCT00706030|6179801|P2|COMPLETED|Overall Study||0
2521817|NCT00706030|6179802|P1|COMPLETED|Overall Study||0
2521818|NCT00706030|6179799|P4|Treated|Overall Study||15
2521819|NCT00706030|6179800|P3|Treated|Overall Study||64
2521820|NCT00706030|6179801|P2|Treated|Overall Study||6
2521821|NCT00706030|6179802|P1|Treated|Overall Study||6
2521822|NCT00706030|6179799|P4|STARTED|Overall Study||16
2521823|NCT00706030|6179800|P3|STARTED|Overall Study||64
2521824|NCT00706030|6179801|P2|STARTED|Overall Study||6
2521825|NCT00706030|6179802|P1|STARTED|Overall Study||6
2521826|NCT00706004|6179817|P1|NOT COMPLETED|Overall Study||2
2521827|NCT00706004|6179817|P1|COMPLETED|Overall Study||7
2521828|NCT00706004|6179817|P1|STARTED|Overall Study||9
2521829|NCT00705939|6179845|P3|NOT COMPLETED|Overall Study||4
2521830|NCT00705939|6179846|P2|NOT COMPLETED|Overall Study||2
2521831|NCT00705939|6179847|P1|NOT COMPLETED|Overall Study||0
2521832|NCT00705939|6179845|P3|COMPLETED|Overall Study||14
2521833|NCT00705939|6179846|P2|COMPLETED|Overall Study||12
2521834|NCT00705939|6179847|P1|COMPLETED|Overall Study||12
2521835|NCT00705939|6179845|P3|STARTED|Overall Study|1 subject enrolled but not treated in this protocol.|18
2521836|NCT00705939|6179846|P2|STARTED|Overall Study||14
2521837|NCT00705939|6179847|P1|STARTED|Overall Study||12
2521838|NCT00705874|6179877|P7|NOT COMPLETED|Overall Study||0
2521839|NCT00705874|6179878|P6|NOT COMPLETED|Overall Study||4
2521840|NCT00705874|6179879|P5|NOT COMPLETED|Overall Study||12
2521841|NCT00705874|6179880|P4|NOT COMPLETED|Overall Study||1
2521842|NCT00705874|6179881|P3|NOT COMPLETED|Overall Study||2
2521843|NCT00705874|6179882|P2|NOT COMPLETED|Overall Study||1
2521844|NCT00705874|6179883|P1|NOT COMPLETED|Overall Study||2
2521845|NCT00705874|6179877|P7|COMPLETED|Overall Study||3
2521846|NCT00705874|6179878|P6|COMPLETED|Overall Study||28
2521847|NCT00705874|6179879|P5|COMPLETED|Overall Study||36
2521848|NCT00705874|6179880|P4|COMPLETED|Overall Study||33
2521849|NCT00705874|6179881|P3|COMPLETED|Overall Study||32
2521850|NCT00705874|6179882|P2|COMPLETED|Overall Study||8
2521851|NCT00705874|6179883|P1|COMPLETED|Overall Study||10
2521852|NCT00705874|6179877|P7|STARTED|Overall Study||3
2521853|NCT00705874|6179878|P6|STARTED|Overall Study||32
2521854|NCT00705874|6179879|P5|STARTED|Overall Study||48
2521855|NCT00705874|6179880|P4|STARTED|Overall Study||34
2521856|NCT00705874|6179881|P3|STARTED|Overall Study||34
2521857|NCT00705874|6179882|P2|STARTED|Overall Study||9
2521858|NCT00705874|6179883|P1|STARTED|Overall Study||12
2521859|NCT00705783|6179901|P3|NOT COMPLETED|Depot Maintenance Phase||131
2521860|NCT00705783|6179902|P2|NOT COMPLETED|Depot Maintenance Phase||246
2521861|NCT00705783|6179903|P1|NOT COMPLETED|Depot Maintenance Phase||0
2521862|NCT00705783|6179901|P3|COMPLETED|Depot Maintenance Phase||3
2521863|NCT00705783|6179902|P2|COMPLETED|Depot Maintenance Phase||23
2521864|NCT00705783|6179903|P1|COMPLETED|Depot Maintenance Phase||0
2521865|NCT00705783|6179901|P3|STARTED|Depot Maintenance Phase||134
2521866|NCT00705783|6179902|P2|STARTED|Depot Maintenance Phase||269
2521867|NCT00705783|6179903|P1|STARTED|Depot Maintenance Phase|Patients were randomized into the aripiprazole and placebo depot groups in this phase of the study.|0
2521868|NCT00705783|6179901|P3|NOT COMPLETED|Depot Stabilization Phase||0
2521869|NCT00705783|6179902|P2|NOT COMPLETED|Depot Stabilization Phase||0
2521870|NCT00705783|6179903|P1|NOT COMPLETED|Depot Stabilization Phase||173
2521871|NCT00705783|6179901|P3|COMPLETED|Depot Stabilization Phase||0
2521872|NCT00705783|6179902|P2|COMPLETED|Depot Stabilization Phase||0
2521873|NCT00705783|6179903|P1|COMPLETED|Depot Stabilization Phase||403
2521874|NCT00705783|6179901|P3|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
2521875|NCT00705783|6179902|P2|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
2521876|NCT00705783|6179903|P1|STARTED|Depot Stabilization Phase||576
2521877|NCT00705783|6179901|P3|NOT COMPLETED|Oral Stabilization Phase||0
2521878|NCT00705783|6179902|P2|NOT COMPLETED|Oral Stabilization Phase||0
2521879|NCT00705783|6179903|P1|NOT COMPLETED|Oral Stabilization Phase||134
2521880|NCT00705783|6179901|P3|COMPLETED|Oral Stabilization Phase||0
2521881|NCT00705783|6179902|P2|COMPLETED|Oral Stabilization Phase||0
2521882|NCT00705783|6179903|P1|COMPLETED|Oral Stabilization Phase||576
2521883|NCT00705783|6179901|P3|Received Study Medication|Oral Stabilization Phase||0
2521884|NCT00705783|6179902|P2|Received Study Medication|Oral Stabilization Phase||0
2521885|NCT00705783|6179903|P1|Received Study Medication|Oral Stabilization Phase||709
2521886|NCT00705783|6179901|P3|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
2521887|NCT00705783|6179902|P2|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
2521888|NCT00705783|6179903|P1|STARTED|Oral Stabilization Phase|210 of the 710 patients who started this phase enrolled in this study directly into this phase.|710
2521889|NCT00705783|6179901|P3|NOT COMPLETED|Conversion Phase||0
2521890|NCT00705783|6179902|P2|NOT COMPLETED|Conversion Phase||0
2521891|NCT00705783|6179903|P1|NOT COMPLETED|Conversion Phase||133
2521892|NCT00705783|6179901|P3|COMPLETED|Conversion Phase||0
2521893|NCT00705783|6179902|P2|COMPLETED|Conversion Phase||0
2521894|NCT00705783|6179903|P1|COMPLETED|Conversion Phase||500
2521895|NCT00705783|6179901|P3|Received Study Medication|Conversion Phase||0
2521896|NCT00705783|6179902|P2|Received Study Medication|Conversion Phase||0
2521897|NCT00705783|6179903|P1|Received Study Medication|Conversion Phase||632
2521898|NCT00705783|6179901|P3|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
2521899|NCT00705783|6179902|P2|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
2521900|NCT00705783|6179903|P1|STARTED|Conversion Phase||633
2521901|NCT00705757|6179933|P3|NOT COMPLETED|Overall Study||11
2521902|NCT00705757|6179934|P2|NOT COMPLETED|Overall Study||8
2521903|NCT00705757|6179935|P1|NOT COMPLETED|Overall Study||13
2521904|NCT00705757|6179933|P3|COMPLETED|Overall Study||17
2521905|NCT00705757|6179934|P2|COMPLETED|Overall Study||21
2521906|NCT00705757|6179935|P1|COMPLETED|Overall Study||19
2521907|NCT00705757|6179933|P3|STARTED|Overall Study||28
2521908|NCT00705757|6179934|P2|STARTED|Overall Study||29
2521909|NCT00705757|6179935|P1|STARTED|Overall Study||32
2521910|NCT00705718|6179945|P2|NOT COMPLETED|Overall Study||22
2521911|NCT00705718|6179946|P1|NOT COMPLETED|Overall Study||7
2521912|NCT00705718|6179945|P2|COMPLETED|Overall Study||128
2521913|NCT00705718|6179946|P1|COMPLETED|Overall Study||37
2521914|NCT00705718|6179945|P2|12 Month Follow up|Overall Study|4 Deaths, 12 Subjects Not due for next visit, 4 Subjects Missed Visit|128
2521915|NCT00705718|6179946|P1|12 Month Follow up|Overall Study|2 Deaths|37
2521916|NCT00705718|6179945|P2|6 Month Follow up|Overall Study|2 Deaths, 5 Subjects Missed Visit|143
2521917|NCT00705718|6179946|P1|6 Month Follow up|Overall Study|3 Deaths|40
2521918|NCT00705718|6179945|P2|1 Month Follow up|Overall Study|1 Subject Missed Visit|149
2521919|NCT00705718|6179946|P1|1 Month Follow up|Overall Study|1 Death|43
2521920|NCT00705718|6179945|P2|STARTED|Overall Study||150
2521921|NCT00705718|6179946|P1|STARTED|Overall Study||44
2521922|NCT00705679|6179967|P5|NOT COMPLETED|Overall Study||69
2521923|NCT00705679|6179968|P4|NOT COMPLETED|Overall Study||80
2521924|NCT00705679|6179969|P3|NOT COMPLETED|Overall Study||115
2521925|NCT00705679|6179970|P2|NOT COMPLETED|Overall Study||139
2521926|NCT00705679|6179971|P1|NOT COMPLETED|Overall Study||65
2521927|NCT00705679|6179967|P5|COMPLETED|Overall Study||934
2521928|NCT00705679|6179968|P4|COMPLETED|Overall Study||927
2521929|NCT00705679|6179969|P3|COMPLETED|Overall Study||894
2521930|NCT00705679|6179970|P2|COMPLETED|Overall Study||864
2521931|NCT00705679|6179971|P1|COMPLETED|Overall Study||942
2521932|NCT00705679|6179967|P5|STARTED|Overall Study||1003
2521933|NCT00705679|6179968|P4|STARTED|Overall Study||1007
2521934|NCT00705679|6179969|P3|STARTED|Overall Study||1009
2521935|NCT00705679|6179970|P2|STARTED|Overall Study||1003
2521936|NCT00705679|6179971|P1|STARTED|Overall Study||1007
2521937|NCT00705666|6180006|P1|NOT COMPLETED|Overall Study||339
2521938|NCT00705666|6180006|P1|COMPLETED|Overall Study||450
2521939|NCT00705666|6180006|P1|STARTED|Overall Study||789
2521940|NCT00705653|6180010|P1|NOT COMPLETED|Overall Study||0
2521941|NCT00705653|6180010|P1|COMPLETED|Overall Study||46
2521942|NCT00705653|6180010|P1|STARTED|Overall Study||46
2521943|NCT00705614|6180017|P2|NOT COMPLETED|Switch to Remicade||49
2521944|NCT00705614|6180018|P1|NOT COMPLETED|Switch to Remicade||0
2521945|NCT00705614|6180017|P2|COMPLETED|Switch to Remicade||249
2521946|NCT00705614|6180018|P1|COMPLETED|Switch to Remicade||0
2521947|NCT00705614|6180017|P2|STARTED|Switch to Remicade||298
2521948|NCT00705614|6180018|P1|STARTED|Switch to Remicade||0
2521949|NCT00705614|6180017|P2|NOT COMPLETED|Initial Intervention||321
2521950|NCT00705614|6180018|P1|NOT COMPLETED|Initial Intervention||518
2521951|NCT00705614|6180017|P2|COMPLETED|Initial Intervention||800
2521952|NCT00705614|6180018|P1|COMPLETED|Initial Intervention||1023
2521953|NCT00705614|6180017|P2|STARTED|Initial Intervention||1121
2521954|NCT00705614|6180018|P1|STARTED|Initial Intervention||1541
2521955|NCT00705575|6180067|P2|NOT COMPLETED|Overall Study||46
2521956|NCT00705575|6180068|P1|NOT COMPLETED|Overall Study||23
2521957|NCT00705575|6180067|P2|COMPLETED|Overall Study||293
2521958|NCT00705575|6180068|P1|COMPLETED|Overall Study||326
2521959|NCT00705575|6180067|P2|STARTED|Overall Study||339
2521960|NCT00705575|6180068|P1|STARTED|Overall Study||349
2521961|NCT00705536|6180082|P4|NOT COMPLETED|Completed Study||0
2521962|NCT00705536|6180083|P3|NOT COMPLETED|Completed Study||0
2521963|NCT00705536|6180084|P2|NOT COMPLETED|Completed Study||0
2521964|NCT00705536|6180085|P1|NOT COMPLETED|Completed Study||0
2521965|NCT00705536|6180082|P4|COMPLETED|Completed Study||6
2521966|NCT00705536|6180083|P3|COMPLETED|Completed Study||7
2521967|NCT00705536|6180084|P2|COMPLETED|Completed Study||6
2521968|NCT00705536|6180085|P1|COMPLETED|Completed Study||6
2521969|NCT00705536|6180082|P4|STARTED|Completed Study||6
2521970|NCT00705536|6180083|P3|STARTED|Completed Study||7
2521971|NCT00705536|6180084|P2|STARTED|Completed Study||6
2521972|NCT00705536|6180085|P1|STARTED|Completed Study||6
2521973|NCT00705536|6180082|P4|NOT COMPLETED|Start Period 2||0
2521974|NCT00705536|6180083|P3|NOT COMPLETED|Start Period 2||0
2521975|NCT00705536|6180084|P2|NOT COMPLETED|Start Period 2||0
2521976|NCT00705536|6180085|P1|NOT COMPLETED|Start Period 2||0
2521977|NCT00705536|6180082|P4|COMPLETED|Start Period 2||6
2521978|NCT00705536|6180083|P3|COMPLETED|Start Period 2||7
2521979|NCT00705536|6180084|P2|COMPLETED|Start Period 2||6
2521980|NCT00705536|6180085|P1|COMPLETED|Start Period 2||6
2521981|NCT00705536|6180082|P4|STARTED|Start Period 2||6
2521982|NCT00705536|6180083|P3|STARTED|Start Period 2||7
2521983|NCT00705536|6180084|P2|STARTED|Start Period 2||6
2521984|NCT00705536|6180085|P1|STARTED|Start Period 2||6
2521985|NCT00705536|6180082|P4|NOT COMPLETED|Washout Period of at Least 6 Days||0
2521986|NCT00705536|6180083|P3|NOT COMPLETED|Washout Period of at Least 6 Days||0
2521987|NCT00705536|6180084|P2|NOT COMPLETED|Washout Period of at Least 6 Days||0
2521988|NCT00705536|6180085|P1|NOT COMPLETED|Washout Period of at Least 6 Days||0
2521989|NCT00705536|6180082|P4|COMPLETED|Washout Period of at Least 6 Days||6
2521990|NCT00705536|6180083|P3|COMPLETED|Washout Period of at Least 6 Days||7
2521991|NCT00705536|6180084|P2|COMPLETED|Washout Period of at Least 6 Days||6
2521992|NCT00705536|6180085|P1|COMPLETED|Washout Period of at Least 6 Days||6
2521993|NCT00705536|6180082|P4|STARTED|Washout Period of at Least 6 Days||6
2521994|NCT00705536|6180083|P3|STARTED|Washout Period of at Least 6 Days||7
2521995|NCT00705536|6180084|P2|STARTED|Washout Period of at Least 6 Days||6
2521996|NCT00705536|6180085|P1|STARTED|Washout Period of at Least 6 Days||6
2521997|NCT00705536|6180082|P4|NOT COMPLETED|Start Period 1||1
2521998|NCT00705536|6180083|P3|NOT COMPLETED|Start Period 1||0
2521999|NCT00705536|6180084|P2|NOT COMPLETED|Start Period 1||0
2522000|NCT00705536|6180085|P1|NOT COMPLETED|Start Period 1||0
2522001|NCT00705536|6180082|P4|COMPLETED|Start Period 1||6
2522002|NCT00705536|6180083|P3|COMPLETED|Start Period 1||7
2522003|NCT00705536|6180084|P2|COMPLETED|Start Period 1||6
2522004|NCT00705536|6180085|P1|COMPLETED|Start Period 1||6
2522005|NCT00705536|6180082|P4|Received at Least 1 Dose of Study Drug|Start Period 1||7
2522006|NCT00705536|6180083|P3|Received at Least 1 Dose of Study Drug|Start Period 1||7
2522007|NCT00705536|6180084|P2|Received at Least 1 Dose of Study Drug|Start Period 1||6
2522008|NCT00705536|6180085|P1|Received at Least 1 Dose of Study Drug|Start Period 1||6
2522009|NCT00705536|6180082|P4|STARTED|Start Period 1||7
2522010|NCT00705536|6180083|P3|STARTED|Start Period 1||7
2522011|NCT00705536|6180084|P2|STARTED|Start Period 1||6
2522012|NCT00705536|6180085|P1|STARTED|Start Period 1||6
2522013|NCT00705523|6180146|P2|NOT COMPLETED|Overall Study||3
2522014|NCT00705523|6180147|P1|NOT COMPLETED|Overall Study||2
2522015|NCT00705523|6180146|P2|COMPLETED|Overall Study||18
2522016|NCT00705523|6180147|P1|COMPLETED|Overall Study||17
2522017|NCT00705523|6180146|P2|STARTED|Overall Study||21
2522018|NCT00705523|6180147|P1|STARTED|Overall Study||19
2522019|NCT00705484|6180157|P2|NOT COMPLETED|Overall Study||408
2522020|NCT00705484|6180158|P1|NOT COMPLETED|Overall Study||382
2522021|NCT00705484|6180157|P2|COMPLETED|Overall Study||772
2522022|NCT00705484|6180158|P1|COMPLETED|Overall Study||677
2522023|NCT00705484|6180157|P2|Follow-up Period|Overall Study|Switched From Standard Therapy to Remicade|296
2522024|NCT00705484|6180158|P1|Follow-up Period|Overall Study||1059
2522025|NCT00705484|6180157|P2|STARTED|Overall Study|Number Enrolled|1180
2522026|NCT00705484|6180158|P1|STARTED|Overall Study|Number Enrolled|1059
2522027|NCT00705432|6180172|P6|NOT COMPLETED|Follow-up Period (Upto Week 72)||7
2522028|NCT00705432|6180173|P5|NOT COMPLETED|Follow-up Period (Upto Week 72)||6
2522029|NCT00705432|6180174|P4|NOT COMPLETED|Follow-up Period (Upto Week 72)||14
2522030|NCT00705432|6180175|P3|NOT COMPLETED|Follow-up Period (Upto Week 72)||25
2522031|NCT00705432|6180176|P2|NOT COMPLETED|Follow-up Period (Upto Week 72)||43
2522032|NCT00705432|6180177|P1|NOT COMPLETED|Follow-up Period (Upto Week 72)||71
2522033|NCT00705432|6180172|P6|COMPLETED|Follow-up Period (Upto Week 72)||46
2522034|NCT00705432|6180173|P5|COMPLETED|Follow-up Period (Upto Week 72)||38
2522035|NCT00705432|6180174|P4|COMPLETED|Follow-up Period (Upto Week 72)||28
2522036|NCT00705432|6180175|P3|COMPLETED|Follow-up Period (Upto Week 72)||266
2522037|NCT00705432|6180176|P2|COMPLETED|Follow-up Period (Upto Week 72)||252
2522038|NCT00705432|6180177|P1|COMPLETED|Follow-up Period (Upto Week 72)||207
2522039|NCT00705432|6180172|P6|STARTED|Follow-up Period (Upto Week 72)||53
2522040|NCT00705432|6180173|P5|STARTED|Follow-up Period (Upto Week 72)||44
2522041|NCT00705432|6180174|P4|STARTED|Follow-up Period (Upto Week 72)||42
2522042|NCT00705432|6180175|P3|STARTED|Follow-up Period (Upto Week 72)||291
2522043|NCT00705432|6180176|P2|STARTED|Follow-up Period (Upto Week 72)||295
2522044|NCT00705432|6180177|P1|STARTED|Follow-up Period (Upto Week 72)||278
2522045|NCT00705432|6180172|P6|NOT COMPLETED|Treatment Period||30
2522046|NCT00705432|6180173|P5|NOT COMPLETED|Treatment Period||28
2522047|NCT00705432|6180174|P4|NOT COMPLETED|Treatment Period||41
2522048|NCT00705432|6180175|P3|NOT COMPLETED|Treatment Period||121
2522049|NCT00705432|6180176|P2|NOT COMPLETED|Treatment Period||111
2522050|NCT00705432|6180177|P1|NOT COMPLETED|Treatment Period||163
2522051|NCT00705432|6180172|P6|COMPLETED|Treatment Period||25
2522052|NCT00705432|6180173|P5|COMPLETED|Treatment Period||24
2522053|NCT00705432|6180174|P4|COMPLETED|Treatment Period||11
2522054|NCT00705432|6180175|P3|COMPLETED|Treatment Period||190
2522055|NCT00705432|6180176|P2|COMPLETED|Treatment Period||205
2522056|NCT00705432|6180177|P1|COMPLETED|Treatment Period||148
2522057|NCT00705432|6180172|P6|STARTED BOCEPREVIR/PLACEBO|Treatment Period||55
2522058|NCT00705432|6180173|P5|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
2522059|NCT00705432|6180174|P4|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
2522060|NCT00705432|6180175|P3|STARTED BOCEPREVIR/PLACEBO|Treatment Period||299
2522061|NCT00705432|6180176|P2|STARTED BOCEPREVIR/PLACEBO|Treatment Period||303
2522062|NCT00705432|6180177|P1|STARTED BOCEPREVIR/PLACEBO|Treatment Period||297
2522063|NCT00705432|6180172|P6|STARTED|Treatment Period||55
2522064|NCT00705432|6180173|P5|STARTED|Treatment Period||52
2522065|NCT00705432|6180174|P4|STARTED|Treatment Period||52
2522066|NCT00705432|6180175|P3|STARTED|Treatment Period||311
2522067|NCT00705432|6180176|P2|STARTED|Treatment Period||316
2522068|NCT00705432|6180177|P1|STARTED|Treatment Period||311
2522069|NCT00705406|6180214|P2|NOT COMPLETED|Overall Study||5
2522070|NCT00705406|6180215|P1|NOT COMPLETED|Overall Study||4
2522071|NCT00705406|6180214|P2|COMPLETED|Overall Study||197
2522072|NCT00705406|6180215|P1|COMPLETED|Overall Study||199
2522073|NCT00705406|6180214|P2|STARTED|Overall Study||202
2522074|NCT00705406|6180215|P1|STARTED|Overall Study||203
2522075|NCT00705367|6180239|P2|NOT COMPLETED|Long-term Extension Period||0
2522076|NCT00705367|6180240|P1|NOT COMPLETED|Long-term Extension Period||9
2522077|NCT00705367|6180239|P2|COMPLETED|Long-term Extension Period||0
2522078|NCT00705367|6180240|P1|COMPLETED|Long-term Extension Period||0
2522079|NCT00705367|6180239|P2|STARTED|Long-term Extension Period||0
2522080|NCT00705367|6180240|P1|STARTED|Long-term Extension Period||9
2522081|NCT00705367|6180239|P2|NOT COMPLETED|Short-term Period||0
2522082|NCT00705367|6180240|P1|NOT COMPLETED|Short-term Period||0
2522083|NCT00705367|6180239|P2|COMPLETED|Short-term Period||3
2522084|NCT00705367|6180240|P1|COMPLETED|Short-term Period||6
2522085|NCT00705367|6180239|P2|STARTED|Short-term Period||3
2522086|NCT00705367|6180240|P1|STARTED|Short-term Period||6
2522087|NCT00705341|6180267|P4|NOT COMPLETED|Phase 2: Trial||4
2522088|NCT00705341|6180268|P3|NOT COMPLETED|Phase 2: Trial||7
2522089|NCT00705341|6180269|P2|NOT COMPLETED|Phase 2: Trial||0
2522090|NCT00705341|6180270|P1|NOT COMPLETED|Phase 2: Trial||0
2522091|NCT00705341|6180267|P4|COMPLETED|Phase 2: Trial||28
2522092|NCT00705341|6180268|P3|COMPLETED|Phase 2: Trial||23
2522093|NCT00705341|6180269|P2|COMPLETED|Phase 2: Trial||0
2522094|NCT00705341|6180270|P1|COMPLETED|Phase 2: Trial||0
2522095|NCT00705341|6180267|P4|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|32
2522096|NCT00705341|6180268|P3|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|30
2522097|NCT00705341|6180269|P2|STARTED|Phase 2: Trial||0
2522098|NCT00705341|6180270|P1|STARTED|Phase 2: Trial||0
2522099|NCT00705341|6180267|P4|NOT COMPLETED|Phase 1:Control Challenge||0
2522100|NCT00705341|6180268|P3|NOT COMPLETED|Phase 1:Control Challenge||0
2522101|NCT00705341|6180269|P2|NOT COMPLETED|Phase 1:Control Challenge||0
2522102|NCT00705341|6180270|P1|NOT COMPLETED|Phase 1:Control Challenge||0
2522103|NCT00705341|6180267|P4|COMPLETED|Phase 1:Control Challenge||0
2522104|NCT00705341|6180268|P3|COMPLETED|Phase 1:Control Challenge||0
2522105|NCT00705341|6180269|P2|COMPLETED|Phase 1:Control Challenge|Nonasthmatic controls did not advance to phase 2 due to design of study|93
2522106|NCT00705341|6180270|P1|COMPLETED|Phase 1:Control Challenge|If participants in this group met criteria, they were randomized into phase 2|126
2522107|NCT00705341|6180267|P4|STARTED|Phase 1:Control Challenge||0
2522108|NCT00705341|6180268|P3|STARTED|Phase 1:Control Challenge||0
2522109|NCT00705341|6180269|P2|STARTED|Phase 1:Control Challenge||93
2522110|NCT00705341|6180270|P1|STARTED|Phase 1:Control Challenge||126
2522111|NCT00705289|6180278|P1|NOT COMPLETED|Overall Study||131
2522112|NCT00705289|6180278|P1|COMPLETED|Overall Study||597
2522113|NCT00705289|6180278|P1|STARTED|Overall Study||728
2522114|NCT00705263|6180302|P1|NOT COMPLETED|Overall Study||2
2522115|NCT00705263|6180302|P1|COMPLETED|Overall Study||108
2522116|NCT00705263|6180302|P1|STARTED|Overall Study|113 patients started the treatment; however, data were available for only 110 patients.|110
2522117|NCT00705250|6180306|P1|NOT COMPLETED|Overall Study||2
2522118|NCT00705250|6180306|P1|COMPLETED|Overall Study||34
2522119|NCT00705250|6180306|P1|STARTED|Overall Study||36
2522120|NCT00705224|6180310|P1|NOT COMPLETED|Overall Study||11
2522121|NCT00705224|6180310|P1|COMPLETED|Overall Study||239
2522122|NCT00705224|6180310|P1|STARTED|Overall Study||250
2522123|NCT00705159|6180326|P4|NOT COMPLETED|Overall Study||4
2522124|NCT00705159|6180327|P3|NOT COMPLETED|Overall Study||5
2522125|NCT00705159|6180328|P2|NOT COMPLETED|Overall Study||2
2522126|NCT00705159|6180329|P1|NOT COMPLETED|Overall Study||0
2522127|NCT00705159|6180326|P4|COMPLETED|Overall Study||30
2522128|NCT00705159|6180327|P3|COMPLETED|Overall Study||29
2522129|NCT00705159|6180328|P2|COMPLETED|Overall Study||33
2522130|NCT00705159|6180329|P1|COMPLETED|Overall Study||34
2522131|NCT00705159|6180326|P4|STARTED|Overall Study||34
2522132|NCT00705159|6180327|P3|STARTED|Overall Study||34
2522133|NCT00705159|6180328|P2|STARTED|Overall Study||35
2522134|NCT00705159|6180329|P1|STARTED|Overall Study||34
2522135|NCT00705146|6180349|P2|NOT COMPLETED|Overall Study||1
2522136|NCT00705146|6180350|P1|NOT COMPLETED|Overall Study||1
2522137|NCT00705146|6180349|P2|COMPLETED|Overall Study||23
2522138|NCT00705146|6180350|P1|COMPLETED|Overall Study||31
2522139|NCT00705146|6180349|P2|STARTED|Overall Study||24
2522140|NCT00705146|6180350|P1|STARTED|Overall Study||32
2522141|NCT00705107|6180358|P1|NOT COMPLETED|Overall Study||49
2522142|NCT00705107|6180358|P1|COMPLETED|Overall Study||218
2522143|NCT00705107|6180358|P1|STARTED|Overall Study||267
2522144|NCT00705081|6180365|P2|NOT COMPLETED|Overall Study||0
2522145|NCT00705081|6180366|P1|NOT COMPLETED|Overall Study||0
2522146|NCT00705081|6180365|P2|COMPLETED|Overall Study||198
2522147|NCT00705081|6180366|P1|COMPLETED|Overall Study||255
2522148|NCT00705081|6180365|P2|STARTED|Overall Study||198
2522149|NCT00705081|6180366|P1|STARTED|Overall Study||255
2522150|NCT00705016|6180379|P3|NOT COMPLETED|Overall Study||58
2522151|NCT00705016|6180380|P2|NOT COMPLETED|Overall Study||58
2522152|NCT00705016|6180381|P1|NOT COMPLETED|Overall Study||60
2522153|NCT00705016|6180379|P3|COMPLETED|Overall Study||4
2522154|NCT00705016|6180380|P2|COMPLETED|Overall Study||2
2522155|NCT00705016|6180381|P1|COMPLETED|Overall Study||2
2522156|NCT00705016|6180379|P3|STARTED|Overall Study||62
2522157|NCT00705016|6180380|P2|STARTED|Overall Study||60
2522158|NCT00705016|6180381|P1|STARTED|Overall Study||62
2522159|NCT00705003|6180410|P3|NOT COMPLETED|Treated||3
2522160|NCT00705003|6180411|P2|NOT COMPLETED|Treated||6
2522161|NCT00705003|6180412|P1|NOT COMPLETED|Treated||13
2522162|NCT00705003|6180410|P3|COMPLETED|Treated||30
2522163|NCT00705003|6180411|P2|COMPLETED|Treated||28
2522164|NCT00705003|6180412|P1|COMPLETED|Treated||54
2522165|NCT00705003|6180410|P3|STARTED|Treated||33
2522166|NCT00705003|6180411|P2|STARTED|Treated||34
2522167|NCT00705003|6180412|P1|STARTED|Treated||67
2522168|NCT00705003|6180410|P3|NOT COMPLETED|Enrolled||1
2522169|NCT00705003|6180411|P2|NOT COMPLETED|Enrolled||3
2522170|NCT00705003|6180412|P1|NOT COMPLETED|Enrolled||4
2522171|NCT00705003|6180410|P3|COMPLETED|Enrolled||33
2522172|NCT00705003|6180411|P2|COMPLETED|Enrolled||34
2522173|NCT00705003|6180412|P1|COMPLETED|Enrolled||67
2522174|NCT00705003|6180410|P3|STARTED|Enrolled||34
2522175|NCT00705003|6180411|P2|STARTED|Enrolled||37
2522176|NCT00705003|6180412|P1|STARTED|Enrolled||71
2522177|NCT00704964|6180432|P1|NOT COMPLETED|Overall Study||328
2522178|NCT00704964|6180432|P1|COMPLETED|Overall Study|Number of participants who completed therapy as scheduled.|418
2522179|NCT00704964|6180432|P1|STARTED|Overall Study|Number of participants who took at least one dose of study medication.|746
2522180|NCT00704938|6180439|P2|NOT COMPLETED|Overall Study||0
2522181|NCT00704938|6180440|P1|NOT COMPLETED|Overall Study||0
2522182|NCT00704938|6180439|P2|COMPLETED|Overall Study||1
2522183|NCT00704938|6180440|P1|COMPLETED|Overall Study||2
2522184|NCT00704938|6180439|P2|STARTED|Overall Study||1
2522185|NCT00704938|6180440|P1|STARTED|Overall Study||2
2522186|NCT00704912|6180451|P3|NOT COMPLETED|Overall Study||7
2522187|NCT00704912|6180452|P2|NOT COMPLETED|Overall Study||4
2522188|NCT00704912|6180453|P1|NOT COMPLETED|Overall Study||6
2522189|NCT00704912|6180451|P3|COMPLETED|Overall Study||43
2522190|NCT00704912|6180452|P2|COMPLETED|Overall Study||45
2522191|NCT00704912|6180453|P1|COMPLETED|Overall Study||44
2522192|NCT00704912|6180451|P3|STARTED|Overall Study||50
2522193|NCT00704912|6180452|P2|STARTED|Overall Study||49
2522194|NCT00704912|6180453|P1|STARTED|Overall Study||50
2522195|NCT00704847|6180472|P2|NOT COMPLETED|Overall Study||170
2522196|NCT00704847|6180473|P1|NOT COMPLETED|Overall Study||221
2522197|NCT00704847|6180472|P2|COMPLETED|Overall Study||339
2522198|NCT00704847|6180473|P1|COMPLETED|Overall Study||300
2522199|NCT00704847|6180472|P2|STARTED|Overall Study||509
2522200|NCT00704847|6180473|P1|STARTED|Overall Study||521
2522201|NCT00704808|6180493|P1|NOT COMPLETED|Overall Study||131
2522202|NCT00704808|6180493|P1|COMPLETED|Overall Study||49
2522203|NCT00704808|6180493|P1|STARTED|Overall Study||180
2522204|NCT00704769|6180497|P1|NOT COMPLETED|Overall Study||0
2522205|NCT00704769|6180497|P1|COMPLETED|Overall Study||591
2522206|NCT00704769|6180497|P1|STARTED|Overall Study||591
2522207|NCT00704730|6180504|P2|NOT COMPLETED|Overall Study||96
2522208|NCT00704730|6180505|P1|NOT COMPLETED|Overall Study||121
2522209|NCT00704730|6180504|P2|COMPLETED|Overall Study|Continuing study treatment at the time of data cut-off.|15
2522210|NCT00704730|6180505|P1|COMPLETED|Overall Study|Continuing study treatment at the time of data cut-off.|98
2522211|NCT00704730|6180504|P2|STARTED|Overall Study|Randomized|111
2522212|NCT00704730|6180505|P1|STARTED|Overall Study|Randomized|219
2522213|NCT00704717|6180521|P1|NOT COMPLETED|Overall Study||0
2522214|NCT00704717|6180521|P1|COMPLETED|Overall Study||185
2522215|NCT00704717|6180521|P1|STARTED|Overall Study||185
2522216|NCT00704535|6180525|P1|NOT COMPLETED|Overall Study||146
2522217|NCT00704535|6180525|P1|COMPLETED|Overall Study||3959
2522218|NCT00704535|6180525|P1|STARTED|Overall Study||4105
2522219|NCT00704522|6180538|P2|NOT COMPLETED|Overall Study||45
2522220|NCT00704522|6180539|P1|NOT COMPLETED|Overall Study||183
2522221|NCT00704522|6180538|P2|COMPLETED|Overall Study||75
2522222|NCT00704522|6180539|P1|COMPLETED|Overall Study||298
2522223|NCT00704522|6180538|P2|STARTED|Overall Study||120
2522224|NCT00704522|6180539|P1|STARTED|Overall Study||481
2522225|NCT00704496|6180548|P2|NOT COMPLETED|Overall Study||0
2522226|NCT00704496|6180549|P1|NOT COMPLETED|Overall Study||0
2522227|NCT00704496|6180548|P2|COMPLETED|Overall Study||0
2522228|NCT00704496|6180549|P1|COMPLETED|Overall Study||0
2522229|NCT00704496|6180548|P2|STARTED|Overall Study||0
2522230|NCT00704496|6180549|P1|STARTED|Overall Study||0
2522231|NCT00704418|6180559|P2|NOT COMPLETED|Overall Study||6
2522232|NCT00704418|6180560|P1|NOT COMPLETED|Overall Study||5
2522233|NCT00704418|6180559|P2|COMPLETED|Overall Study||72
2522234|NCT00704418|6180560|P1|COMPLETED|Overall Study||73
2522235|NCT00704418|6180559|P2|STARTED|Overall Study||78
2522236|NCT00704418|6180560|P1|STARTED|Overall Study||78
2522237|NCT00704405|6180573|P5|NOT COMPLETED|Overall Study (C Population)||0
2522238|NCT00704405|6180574|P4|NOT COMPLETED|Overall Study (C Population)||1
2522239|NCT00704405|6180575|P3|NOT COMPLETED|Overall Study (C Population)||1
2522240|NCT00704405|6180576|P2|NOT COMPLETED|Overall Study (C Population)||3
2522241|NCT00704405|6180577|P1|NOT COMPLETED|Overall Study (C Population)||1
2522242|NCT00704405|6180573|P5|COMPLETED|Overall Study (C Population)||14
2522243|NCT00704405|6180574|P4|COMPLETED|Overall Study (C Population)||14
2522244|NCT00704405|6180575|P3|COMPLETED|Overall Study (C Population)||14
2522245|NCT00704405|6180576|P2|COMPLETED|Overall Study (C Population)||11
2522246|NCT00704405|6180577|P1|COMPLETED|Overall Study (C Population)||15
2522247|NCT00704405|6180573|P5|STARTED|Overall Study (C Population)||14
2522248|NCT00704405|6180574|P4|STARTED|Overall Study (C Population)||15
2522249|NCT00704405|6180575|P3|STARTED|Overall Study (C Population)||15
2522250|NCT00704405|6180576|P2|STARTED|Overall Study (C Population)||14
2522251|NCT00704405|6180577|P1|STARTED|Overall Study (C Population)||16
2522252|NCT00704405|6180573|P5|NOT COMPLETED|Overall Study (NC Population)||5
2522253|NCT00704405|6180574|P4|NOT COMPLETED|Overall Study (NC Population)||4
2522254|NCT00704405|6180575|P3|NOT COMPLETED|Overall Study (NC Population)||3
2522255|NCT00704405|6180576|P2|NOT COMPLETED|Overall Study (NC Population)||4
2522256|NCT00704405|6180577|P1|NOT COMPLETED|Overall Study (NC Population)||5
2522257|NCT00704405|6180573|P5|COMPLETED|Overall Study (NC Population)||37
2522258|NCT00704405|6180574|P4|COMPLETED|Overall Study (NC Population)||38
2522259|NCT00704405|6180575|P3|COMPLETED|Overall Study (NC Population)||38
2522260|NCT00704405|6180576|P2|COMPLETED|Overall Study (NC Population)||40
2522261|NCT00704405|6180577|P1|COMPLETED|Overall Study (NC Population)||37
2522262|NCT00704405|6180573|P5|STARTED|Overall Study (NC Population)||42
2522263|NCT00704405|6180574|P4|STARTED|Overall Study (NC Population)||42
2522264|NCT00704405|6180575|P3|STARTED|Overall Study (NC Population)||41
2522265|NCT00704405|6180576|P2|STARTED|Overall Study (NC Population)||44
2522266|NCT00704405|6180577|P1|STARTED|Overall Study (NC Population)||42
2522267|NCT00704379|6180607|P2|NOT COMPLETED|Overall Study||7
2522268|NCT00704379|6180608|P1|NOT COMPLETED|Overall Study||7
2522269|NCT00704379|6180607|P2|COMPLETED|Overall Study||41
2522270|NCT00704379|6180608|P1|COMPLETED|Overall Study||39
2522271|NCT00704379|6180607|P2|STARTED|Overall Study||48
2522272|NCT00704379|6180608|P1|STARTED|Overall Study||46
2522273|NCT00704353|6180626|P2|NOT COMPLETED|Overall Study||114
2522274|NCT00704353|6180627|P1|NOT COMPLETED|Overall Study||98
2522275|NCT00704353|6180626|P2|COMPLETED|Overall Study||255
2522276|NCT00704353|6180627|P1|COMPLETED|Overall Study||268
2522277|NCT00704353|6180626|P2|STARTED|Overall Study||369
2522278|NCT00704353|6180627|P1|STARTED|Overall Study||366
2522279|NCT00704340|6180635|P2|NOT COMPLETED|Overall Study||2
2522280|NCT00704340|6180636|P1|NOT COMPLETED|Overall Study||2
2522281|NCT00704340|6180635|P2|COMPLETED|Overall Study||115
2522282|NCT00704340|6180636|P1|COMPLETED|Overall Study||118
2522283|NCT00704340|6180635|P2|STARTED|Overall Study||117
2522284|NCT00704340|6180636|P1|STARTED|Overall Study||120
2522285|NCT00704184|6180651|P5|NOT COMPLETED|Open-Label Treatment||3
2522286|NCT00704184|6180652|P4|NOT COMPLETED|Open-Label Treatment||5
2522287|NCT00704184|6180653|P3|NOT COMPLETED|Open-Label Treatment||4
2522288|NCT00704184|6180654|P2|NOT COMPLETED|Open-Label Treatment||2
2522289|NCT00704184|6180655|P1|NOT COMPLETED|Open-Label Treatment||1
2522290|NCT00704184|6180651|P5|COMPLETED|Open-Label Treatment||16
2522291|NCT00704184|6180652|P4|COMPLETED|Open-Label Treatment||13
2522292|NCT00704184|6180653|P3|COMPLETED|Open-Label Treatment||16
2522293|NCT00704184|6180654|P2|COMPLETED|Open-Label Treatment||16
2522294|NCT00704184|6180655|P1|COMPLETED|Open-Label Treatment||18
2522295|NCT00704184|6180651|P5|STARTED|Open-Label Treatment||19
2522296|NCT00704184|6180652|P4|STARTED|Open-Label Treatment||18
2522297|NCT00704184|6180653|P3|STARTED|Open-Label Treatment||20
2522298|NCT00704184|6180654|P2|STARTED|Open-Label Treatment||18
2522299|NCT00704184|6180655|P1|STARTED|Open-Label Treatment||19
2522300|NCT00704184|6180651|P5|NOT COMPLETED|Double-Blind Treatment||0
2522301|NCT00704184|6180652|P4|NOT COMPLETED|Double-Blind Treatment||0
2522302|NCT00704184|6180653|P3|NOT COMPLETED|Double-Blind Treatment||0
2522303|NCT00704184|6180654|P2|NOT COMPLETED|Double-Blind Treatment||0
2522304|NCT00704184|6180655|P1|NOT COMPLETED|Double-Blind Treatment||1
2522305|NCT00704184|6180651|P5|COMPLETED|Double-Blind Treatment||19
2522306|NCT00704184|6180652|P4|COMPLETED|Double-Blind Treatment||18
2522307|NCT00704184|6180653|P3|COMPLETED|Double-Blind Treatment||20
2522308|NCT00704184|6180654|P2|COMPLETED|Double-Blind Treatment||18
2522309|NCT00704184|6180655|P1|COMPLETED|Double-Blind Treatment||19
2522310|NCT00704184|6180651|P5|Treated|Double-Blind Treatment||19
2522311|NCT00704184|6180652|P4|Treated|Double-Blind Treatment||18
2522312|NCT00704184|6180653|P3|Treated|Double-Blind Treatment||20
2522313|NCT00704184|6180654|P2|Treated|Double-Blind Treatment||18
2522314|NCT00704184|6180655|P1|Treated|Double-Blind Treatment|One participant was randomized to placebo but withdrew prior to receiving study medication.|19
2522315|NCT00704184|6180651|P5|STARTED|Double-Blind Treatment||19
2522316|NCT00704184|6180652|P4|STARTED|Double-Blind Treatment||18
2522317|NCT00704184|6180653|P3|STARTED|Double-Blind Treatment||20
2522318|NCT00704184|6180654|P2|STARTED|Double-Blind Treatment||18
2522319|NCT00704184|6180655|P1|STARTED|Double-Blind Treatment||20
2522320|NCT00704171|6180694|P2|NOT COMPLETED|Overall Study||0
2522321|NCT00704171|6180695|P1|NOT COMPLETED|Overall Study||1
2522322|NCT00704171|6180694|P2|COMPLETED|Overall Study|All control subjects completed the study.|59
2522323|NCT00704171|6180695|P1|COMPLETED|Overall Study|One subject withdrew consent prior to study completion. No reason given.|61
2522324|NCT00704171|6180694|P2|STARTED|Overall Study||59
2522325|NCT00704171|6180695|P1|STARTED|Overall Study||62
2522326|NCT00704132|6180713|P2|NOT COMPLETED|Overall Study||2
2522327|NCT00704132|6180714|P1|NOT COMPLETED|Overall Study||1
2522328|NCT00704132|6180713|P2|COMPLETED|Overall Study||22
2522329|NCT00704132|6180714|P1|COMPLETED|Overall Study||25
2522330|NCT00704132|6180713|P2|STARTED|Overall Study||24
2522331|NCT00704132|6180714|P1|STARTED|Overall Study||26
2522332|NCT00704028|6180722|P2|NOT COMPLETED|Overall Study||21
2522333|NCT00704028|6180723|P1|NOT COMPLETED|Overall Study||12
2522334|NCT00704028|6180722|P2|COMPLETED|Overall Study||57
2522335|NCT00704028|6180723|P1|COMPLETED|Overall Study||70
2522336|NCT00704028|6180722|P2|STARTED|Overall Study|A subject randomized to iron dextran never received study drug and was d/c due to subject request.|78
2522337|NCT00704028|6180723|P1|STARTED|Overall Study||82
2522338|NCT00703976|6180731|P2|NOT COMPLETED|Overall Study||0
2522339|NCT00703976|6180732|P1|NOT COMPLETED|Overall Study||0
2522340|NCT00703976|6180731|P2|COMPLETED|Overall Study||41
2522341|NCT00703976|6180732|P1|COMPLETED|Overall Study||37
2522342|NCT00703976|6180731|P2|STARTED|Overall Study||41
2522343|NCT00703976|6180732|P1|STARTED|Overall Study||37
2522344|NCT00703963|6180742|P2|NOT COMPLETED|Overall Study||14
2522345|NCT00703963|6180743|P1|NOT COMPLETED|Overall Study||7
2522346|NCT00703963|6180742|P2|COMPLETED|Overall Study||86
2522347|NCT00703963|6180743|P1|COMPLETED|Overall Study||93
2522348|NCT00703963|6180742|P2|STARTED|Overall Study||100
2522349|NCT00703963|6180743|P1|STARTED|Overall Study||100
2522350|NCT00703937|6180755|P2|NOT COMPLETED|Overall Study||93
2522351|NCT00703937|6180756|P1|NOT COMPLETED|Overall Study||65
2522352|NCT00703937|6180755|P2|COMPLETED|Overall Study||267
2522353|NCT00703937|6180756|P1|COMPLETED|Overall Study||278
2522354|NCT00703937|6180755|P2|STARTED|Overall Study||360
2522355|NCT00703937|6180756|P1|STARTED|Overall Study||343
2522356|NCT00703924|6180764|P2|NOT COMPLETED|Overall Study||1
2522357|NCT00703924|6180765|P1|NOT COMPLETED|Overall Study||1
2522358|NCT00703924|6180764|P2|COMPLETED|Overall Study||41
2522359|NCT00703924|6180765|P1|COMPLETED|Overall Study||49
2522360|NCT00703924|6180764|P2|STARTED|Overall Study||42
2522361|NCT00703924|6180765|P1|STARTED|Overall Study||50
2522362|NCT00703911|6180781|P1|NOT COMPLETED|Overall Study||10
2522363|NCT00703911|6180781|P1|COMPLETED|Overall Study||92
2522364|NCT00703911|6180781|P1|STARTED|Overall Study||102
2522365|NCT00703885|6180809|P1|NOT COMPLETED|Overall Study||0
2522366|NCT00703885|6180809|P1|COMPLETED|Overall Study||16
2522367|NCT00703885|6180809|P1|STARTED|Overall Study||16
2522368|NCT00703846|6180814|P1|NOT COMPLETED|Overall Study||137
2522369|NCT00703846|6180814|P1|COMPLETED|Overall Study||363
2522370|NCT00703846|6180814|P1|STARTED|Overall Study||500
2522371|NCT00703820|6180830|P2|NOT COMPLETED|Overall Study||34
2522372|NCT00703820|6180831|P1|NOT COMPLETED|Overall Study||35
2522373|NCT00703820|6180830|P2|COMPLETED|Overall Study||95
2522374|NCT00703820|6180831|P1|COMPLETED|Overall Study||98
2522375|NCT00703820|6180830|P2|STARTED|Overall Study||129
2522376|NCT00703820|6180831|P1|STARTED|Overall Study||133
2522377|NCT00703781|6180840|P2|NOT COMPLETED|Overall Study||2
2522378|NCT00703781|6180841|P1|NOT COMPLETED|Overall Study||2
2522379|NCT00703781|6180840|P2|COMPLETED|Overall Study||61
2522380|NCT00703781|6180841|P1|COMPLETED|Overall Study||61
2522381|NCT00703781|6180840|P2|STARTED|Overall Study||63
2522382|NCT00703781|6180841|P1|STARTED|Overall Study||63
2522383|NCT00703729|6180851|P2|NOT COMPLETED|Overall Study||3
2522384|NCT00703729|6180852|P1|NOT COMPLETED|Overall Study||0
2522385|NCT00703729|6180851|P2|COMPLETED|Overall Study||21
2522386|NCT00703729|6180852|P1|COMPLETED|Overall Study||25
2522387|NCT00703729|6180851|P2|STARTED|Overall Study||24
2522388|NCT00703729|6180852|P1|STARTED|Overall Study||25
2522389|NCT00703677|6180886|P1|NOT COMPLETED|Overall Study||3
2522390|NCT00703677|6180886|P1|COMPLETED|Overall Study||14
2522391|NCT00703677|6180886|P1|STARTED|Overall Study||17
2522392|NCT00703664|6180902|P3|NOT COMPLETED|Overall Study||0
2522393|NCT00703664|6180903|P2|NOT COMPLETED|Overall Study||0
2522394|NCT00703664|6180904|P1|NOT COMPLETED|Overall Study||0
2522395|NCT00703664|6180902|P3|COMPLETED|Overall Study||39
2522396|NCT00703664|6180903|P2|COMPLETED|Overall Study||4
2522397|NCT00703664|6180904|P1|COMPLETED|Overall Study||22
2522398|NCT00703664|6180902|P3|STARTED|Overall Study||39
2522399|NCT00703664|6180903|P2|STARTED|Overall Study||4
2522400|NCT00703664|6180904|P1|STARTED|Overall Study||22
2522401|NCT00703534|6180926|P2|NOT COMPLETED|Overall Study||25
2522402|NCT00703534|6180927|P1|NOT COMPLETED|Overall Study||30
2522403|NCT00703534|6180926|P2|COMPLETED|Overall Study||218
2522404|NCT00703534|6180927|P1|COMPLETED|Overall Study||205
2522405|NCT00703534|6180926|P2|STARTED|Overall Study||243
2522406|NCT00703534|6180927|P1|STARTED|Overall Study||235
2522407|NCT00703508|6180933|P1|NOT COMPLETED|Overall Study||0
2522408|NCT00703508|6180933|P1|COMPLETED|Overall Study||26
2522409|NCT00703508|6180933|P1|STARTED|Overall Study||26
2522410|NCT00703391|6180947|P2|NOT COMPLETED|Overall Study||0
2522411|NCT00703391|6180948|P1|NOT COMPLETED|Overall Study||0
2522412|NCT00703391|6180947|P2|COMPLETED|Overall Study||6
2522413|NCT00703391|6180948|P1|COMPLETED|Overall Study||12
2522414|NCT00703391|6180947|P2|STARTED|Overall Study||6
2522415|NCT00703391|6180948|P1|STARTED|Overall Study||12
2522416|NCT00703339|6180992|P1|NOT COMPLETED|Overall Study||0
2522417|NCT00703339|6180992|P1|COMPLETED|Overall Study||1
2522418|NCT00703339|6180992|P1|STARTED|Overall Study||1
2522419|NCT00703326|6180999|P2|NOT COMPLETED|Overall Study||225
2522420|NCT00703326|6181000|P1|NOT COMPLETED|Overall Study||447
2522421|NCT00703326|6180999|P2|COMPLETED|Overall Study||160
2522422|NCT00703326|6181000|P1|COMPLETED|Overall Study||312
2522423|NCT00703326|6180999|P2|Received at Least 1 Dose of Study Drug|Overall Study||382
2522424|NCT00703326|6181000|P1|Received at Least 1 Dose of Study Drug|Overall Study||752
2522425|NCT00703326|6180999|P2|STARTED|Overall Study||385
2522426|NCT00703326|6181000|P1|STARTED|Overall Study||759
2522427|NCT00703261|6181022|P2|NOT COMPLETED|Overall Study||6
2522428|NCT00703261|6181023|P1|NOT COMPLETED|Overall Study||6
2522429|NCT00703261|6181022|P2|COMPLETED|Overall Study||35
2522430|NCT00703261|6181023|P1|COMPLETED|Overall Study||36
2522431|NCT00703261|6181022|P2|STARTED|Overall Study||41
2522432|NCT00703261|6181023|P1|STARTED|Overall Study||42
2522433|NCT00703157|6181032|P2|NOT COMPLETED|Overall Study||2
2522434|NCT00703157|6181033|P1|NOT COMPLETED|Overall Study||4
2522435|NCT00703157|6181032|P2|COMPLETED|Overall Study||24
2522436|NCT00703157|6181033|P1|COMPLETED|Overall Study||22
2522437|NCT00703157|6181032|P2|24 Months FU|Overall Study||24
2522438|NCT00703157|6181033|P1|24 Months FU|Overall Study||22
2522439|NCT00703157|6181032|P2|6 Months FU|Overall Study||25
2522440|NCT00703157|6181033|P1|6 Months FU|Overall Study||25
2522441|NCT00703157|6181032|P2|STARTED|Overall Study||26
2522442|NCT00703157|6181033|P1|STARTED|Overall Study||26
2522443|NCT00703118|6181067|P3|NOT COMPLETED|Overall Study||22
2522444|NCT00703118|6181068|P2|NOT COMPLETED|Overall Study||16
2522445|NCT00703118|6181069|P1|NOT COMPLETED|Overall Study||21
2522446|NCT00703118|6181067|P3|COMPLETED|Overall Study||110
2522447|NCT00703118|6181068|P2|COMPLETED|Overall Study||248
2522448|NCT00703118|6181069|P1|COMPLETED|Overall Study||245
2522449|NCT00703118|6181067|P3|STARTED|Overall Study||132
2522450|NCT00703118|6181068|P2|STARTED|Overall Study||264
2522451|NCT00703118|6181069|P1|STARTED|Overall Study||266
2522452|NCT00703092|6181100|P1|NOT COMPLETED|Overall Study||2
2522453|NCT00703092|6181100|P1|COMPLETED|Overall Study||0
2522454|NCT00703092|6181100|P1|STARTED|Overall Study||2
2522455|NCT00703053|6181114|P9|NOT COMPLETED|Overall Study||1
2522456|NCT00703053|6181115|P8|NOT COMPLETED|Overall Study||6
2522457|NCT00703053|6181116|P7|NOT COMPLETED|Overall Study||7
2522458|NCT00703053|6181117|P6|NOT COMPLETED|Overall Study||6
2522459|NCT00703053|6181118|P5|NOT COMPLETED|Overall Study||1
2522460|NCT00703053|6181119|P4|NOT COMPLETED|Overall Study||3
2522461|NCT00703053|6181120|P3|NOT COMPLETED|Overall Study||3
2522462|NCT00703053|6181121|P2|NOT COMPLETED|Overall Study||2
2522463|NCT00703053|6181122|P1|NOT COMPLETED|Overall Study||1
2522464|NCT00703053|6181114|P9|COMPLETED|Overall Study||102
2522465|NCT00703053|6181115|P8|COMPLETED|Overall Study||91
2522466|NCT00703053|6181116|P7|COMPLETED|Overall Study||45
2522467|NCT00703053|6181117|P6|COMPLETED|Overall Study||43
2522468|NCT00703053|6181118|P5|COMPLETED|Overall Study||50
2522469|NCT00703053|6181119|P4|COMPLETED|Overall Study||46
2522470|NCT00703053|6181120|P3|COMPLETED|Overall Study||48
2522471|NCT00703053|6181121|P2|COMPLETED|Overall Study||24
2522472|NCT00703053|6181122|P1|COMPLETED|Overall Study||26
2522473|NCT00703053|6181114|P9|STARTED|Overall Study||103
2522474|NCT00703053|6181115|P8|STARTED|Overall Study||97
2522475|NCT00703053|6181116|P7|STARTED|Overall Study||52
2522476|NCT00703053|6181117|P6|STARTED|Overall Study||49
2522477|NCT00703053|6181118|P5|STARTED|Overall Study||51
2522478|NCT00703053|6181119|P4|STARTED|Overall Study||49
2522479|NCT00703053|6181120|P3|STARTED|Overall Study||51
2522480|NCT00703053|6181121|P2|STARTED|Overall Study||26
2522481|NCT00703053|6181122|P1|STARTED|Overall Study||27
2522482|NCT00703014|6181308|P4|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||42
2522483|NCT00703014|6181309|P3|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||47
2522484|NCT00703014|6181310|P2|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
2522485|NCT00703014|6181311|P1|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
2522486|NCT00703014|6181308|P4|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|284
2522555|NCT00702845|6181394|P1|NOT COMPLETED|Overall Study||22
2522487|NCT00703014|6181309|P3|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|305
2522488|NCT00703014|6181310|P2|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
2522489|NCT00703014|6181311|P1|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
2522490|NCT00703014|6181308|P4|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|315
2522491|NCT00703014|6181309|P3|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|344
2522492|NCT00703014|6181310|P2|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
2522493|NCT00703014|6181311|P1|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
2522494|NCT00703014|6181308|P4|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|326
2522495|NCT00703014|6181309|P3|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|352
2522496|NCT00703014|6181310|P2|STARTED|Fetuses/Infants Follow Up Trial P05712||0
2522497|NCT00703014|6181311|P1|STARTED|Fetuses/Infants Follow Up Trial P05712||0
2522498|NCT00703014|6181308|P4|NOT COMPLETED|Mothers Follow Up Trial P05712||0
2522499|NCT00703014|6181309|P3|NOT COMPLETED|Mothers Follow Up Trial P05712||0
2522500|NCT00703014|6181310|P2|NOT COMPLETED|Mothers Follow Up Trial P05712||32
2522501|NCT00703014|6181311|P1|NOT COMPLETED|Mothers Follow Up Trial P05712||33
2522502|NCT00703014|6181308|P4|COMPLETED|Mothers Follow Up Trial P05712||0
2522503|NCT00703014|6181309|P3|COMPLETED|Mothers Follow Up Trial P05712||0
2522504|NCT00703014|6181310|P2|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|235
2522505|NCT00703014|6181311|P1|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|241
2522506|NCT00703014|6181308|P4|STARTED|Mothers Follow Up Trial P05712||0
2522507|NCT00703014|6181309|P3|STARTED|Mothers Follow Up Trial P05712||0
2522508|NCT00703014|6181310|P2|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|267
2522509|NCT00703014|6181311|P1|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|274
2522510|NCT00703014|6181308|P4|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
2522511|NCT00703014|6181309|P3|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
2522512|NCT00703014|6181310|P2|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||466
2522513|NCT00703014|6181311|P1|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||462
2522514|NCT00703014|6181308|P4|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
2522515|NCT00703014|6181309|P3|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
2522516|NCT00703014|6181310|P2|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|286
2522517|NCT00703014|6181311|P1|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|295
2522518|NCT00703014|6181308|P4|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
2522519|NCT00703014|6181309|P3|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
2522520|NCT00703014|6181310|P2|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|704
2522521|NCT00703014|6181311|P1|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|672
2522522|NCT00703014|6181308|P4|Treated|Mothers Base Trial P05787 (NCT00696800)||0
2522523|NCT00703014|6181309|P3|Treated|Mothers Base Trial P05787 (NCT00696800)||0
2522524|NCT00703014|6181310|P2|Treated|Mothers Base Trial P05787 (NCT00696800)|ITT group in Base Trial P05787 (NCT006968000)|750
2522525|NCT00703014|6181311|P1|Treated|Mothers Base Trial P05787 (NCT00696800)|Intent-To-Treat (ITT) group in Base Trial P05787 (NCT00696800)|756
2522526|NCT00703014|6181308|P4|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
2522527|NCT00703014|6181309|P3|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
2522528|NCT00703014|6181310|P2|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|752
2522529|NCT00703014|6181311|P1|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|757
2522530|NCT00702962|6181331|P2|NOT COMPLETED|Overall Study||1
2522531|NCT00702962|6181332|P1|NOT COMPLETED|Overall Study||1
2522532|NCT00702962|6181331|P2|COMPLETED|Overall Study|Two completed all required cycles. One experienced progressive disease after 2 cycles|2
2522533|NCT00702962|6181332|P1|COMPLETED|Overall Study|The one participant off treatment after 2 doses due to concurrent health disorder.|0
2522534|NCT00702962|6181331|P2|STARTED|Overall Study|Three treated. Milestone not met as Phase I closed prematurely as NCI research established the MTD.|3
2522535|NCT00702962|6181332|P1|STARTED|Overall Study|One initiated treatment. Milestones not achieved due to premature closing due to low accrual.|1
2522536|NCT00702949|6181343|P3|NOT COMPLETED|Overall Study||8
2522537|NCT00702949|6181344|P2|NOT COMPLETED|Overall Study||9
2522538|NCT00702949|6181345|P1|NOT COMPLETED|Overall Study||5
2522539|NCT00702949|6181343|P3|COMPLETED|Overall Study||54
2522540|NCT00702949|6181344|P2|COMPLETED|Overall Study||57
2522541|NCT00702949|6181345|P1|COMPLETED|Overall Study||58
2522542|NCT00702949|6181343|P3|Evaluable for Primary Endpoint|Overall Study||51
2522543|NCT00702949|6181344|P2|Evaluable for Primary Endpoint|Overall Study||56
2522544|NCT00702949|6181345|P1|Evaluable for Primary Endpoint|Overall Study||56
2522545|NCT00702949|6181343|P3|STARTED|Overall Study||62
2522546|NCT00702949|6181344|P2|STARTED|Overall Study||66
2522547|NCT00702949|6181345|P1|STARTED|Overall Study||63
2522548|NCT00702923|6181370|P1|NOT COMPLETED|Overall Study||1
2522549|NCT00702923|6181370|P1|COMPLETED|Overall Study||11
2522550|NCT00702923|6181370|P1|STARTED|Overall Study||12
2522551|NCT00702884|6181379|P1|NOT COMPLETED|Overall Study||0
2522552|NCT00702884|6181379|P1|COMPLETED|Overall Study||25
2522553|NCT00702884|6181379|P1|STARTED|Overall Study||25
2522554|NCT00702845|6181393|P2|NOT COMPLETED|Overall Study||8
2522556|NCT00702845|6181393|P2|COMPLETED|Overall Study||121
2522557|NCT00702845|6181394|P1|COMPLETED|Overall Study||246
2522558|NCT00702845|6181393|P2|Randomized|Overall Study||128
2522559|NCT00702845|6181394|P1|Randomized|Overall Study||268
2522560|NCT00702845|6181393|P2|STARTED|Overall Study|Includes one treated participant who was not randomized|129
2522561|NCT00702845|6181394|P1|STARTED|Overall Study||268
2522562|NCT00702780|6181434|P2|NOT COMPLETED|Overall Study||8
2522563|NCT00702780|6181435|P1|NOT COMPLETED|Overall Study||9
2522564|NCT00702780|6181434|P2|COMPLETED|Overall Study||29
2522565|NCT00702780|6181435|P1|COMPLETED|Overall Study||28
2522566|NCT00702780|6181434|P2|STARTED|Overall Study||37
2522567|NCT00702780|6181435|P1|STARTED|Overall Study||37
2522568|NCT00702754|6181443|P1|NOT COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||24
2522569|NCT00702754|6181443|P1|COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||329
2522570|NCT00702754|6181443|P1|STARTED|MYOBLOC Treatment Session 8 (App 84 Wks)||353
2522571|NCT00702754|6181443|P1|NOT COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||24
2522572|NCT00702754|6181443|P1|COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||353
2522573|NCT00702754|6181443|P1|STARTED|MYOBLOC Treatment Session 7 (App 72 Wks)||377
2522574|NCT00702754|6181443|P1|NOT COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||19
2522575|NCT00702754|6181443|P1|COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||377
2522576|NCT00702754|6181443|P1|STARTED|MYOBLOC Treatment Session 6 (App 60 Wks)||396
2522577|NCT00702754|6181443|P1|NOT COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||32
2522578|NCT00702754|6181443|P1|COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||396
2522579|NCT00702754|6181443|P1|STARTED|MYOBLOC Treatment Session 5 (App 48 Wks)||428
2522580|NCT00702754|6181443|P1|NOT COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||22
2522581|NCT00702754|6181443|P1|COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||428
2522582|NCT00702754|6181443|P1|STARTED|MYOBLOC Treatment Session 4 (App 36 Wks)||450
2522583|NCT00702754|6181443|P1|NOT COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||25
2522584|NCT00702754|6181443|P1|COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||450
2522585|NCT00702754|6181443|P1|STARTED|MYOBLOC Treatment Session 3 (App 24 Wks)||475
2522586|NCT00702754|6181443|P1|NOT COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||20
2522587|NCT00702754|6181443|P1|COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||475
2522588|NCT00702754|6181443|P1|STARTED|MYOBLOC Treatment Session 2 (App 12 Wks)||495
2522589|NCT00702754|6181443|P1|NOT COMPLETED|MYOBLOC Treatment Session 1 (Time 0)||7
2522590|NCT00702754|6181443|P1|COMPLETED|MYOBLOC Treatment Session 1 (Time 0)|Approximately 70% of subjects completed at least 2 years of treatment.|495
2522591|NCT00702754|6181443|P1|STARTED|MYOBLOC Treatment Session 1 (Time 0)||502
2522592|NCT00702715|6181456|P2|NOT COMPLETED|Overall Study||0
2522593|NCT00702715|6181457|P1|NOT COMPLETED|Overall Study||1
2522594|NCT00702715|6181456|P2|COMPLETED|Overall Study||33
2522595|NCT00702715|6181457|P1|COMPLETED|Overall Study||34
2522596|NCT00702715|6181456|P2|STARTED|Overall Study|One subject was enrolled but did not start study|33
2522597|NCT00702715|6181457|P1|STARTED|Overall Study||35
2522598|NCT00702702|6181470|P1|NOT COMPLETED|Overall Study||56
2522599|NCT00702702|6181470|P1|COMPLETED|Overall Study||0
2522600|NCT00702702|6181470|P1|STARTED|Overall Study||56
2522601|NCT00702689|6181478|P1|NOT COMPLETED|Overall Study||6
2522602|NCT00702689|6181478|P1|COMPLETED|Overall Study||14
2522603|NCT00702689|6181478|P1|STARTED|Overall Study||20
2522604|NCT00702650|6181489|P1|NOT COMPLETED|Overall Study||20
2522605|NCT00702650|6181489|P1|COMPLETED|Overall Study||135
2522606|NCT00702650|6181489|P1|STARTED|Overall Study||155
2522607|NCT00702624|6181509|P4|NOT COMPLETED|Fetuses/Infant Follow-up||0
2522608|NCT00702624|6181510|P3|NOT COMPLETED|Fetuses/Infant Follow-up||10
2522609|NCT00702624|6181511|P2|NOT COMPLETED|Fetuses/Infant Follow-up||0
2522610|NCT00702624|6181512|P1|NOT COMPLETED|Fetuses/Infant Follow-up||0
2522611|NCT00702624|6181509|P4|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|55
2522612|NCT00702624|6181510|P3|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|78
2522613|NCT00702624|6181511|P2|COMPLETED|Fetuses/Infant Follow-up||0
2522614|NCT00702624|6181512|P1|COMPLETED|Fetuses/Infant Follow-up||0
2522615|NCT00702624|6181509|P4|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy.|55
2522616|NCT00702624|6181510|P3|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy|80
2522617|NCT00702624|6181511|P2|Live Born Infants|Fetuses/Infant Follow-up||0
2522618|NCT00702624|6181512|P1|Live Born Infants|Fetuses/Infant Follow-up||0
2522619|NCT00702624|6181509|P4|STARTED|Fetuses/Infant Follow-up||55
2522620|NCT00702624|6181510|P3|STARTED|Fetuses/Infant Follow-up||88
2522621|NCT00702624|6181511|P2|STARTED|Fetuses/Infant Follow-up||0
2522622|NCT00702624|6181512|P1|STARTED|Fetuses/Infant Follow-up||0
2522623|NCT00702624|6181509|P4|NOT COMPLETED|Expectant Mother Follow-up||0
2522624|NCT00702624|6181510|P3|NOT COMPLETED|Expectant Mother Follow-up||0
2522625|NCT00702624|6181511|P2|NOT COMPLETED|Expectant Mother Follow-up||0
2522626|NCT00702624|6181512|P1|NOT COMPLETED|Expectant Mother Follow-up||7
2522627|NCT00702624|6181509|P4|COMPLETED|Expectant Mother Follow-up||0
2522628|NCT00702624|6181510|P3|COMPLETED|Expectant Mother Follow-up||0
2522629|NCT00702624|6181511|P2|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|45
2522630|NCT00702624|6181512|P1|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|61
2522631|NCT00702624|6181509|P4|STARTED|Expectant Mother Follow-up||0
2522632|NCT00702624|6181510|P3|STARTED|Expectant Mother Follow-up||0
2522633|NCT00702624|6181511|P2|STARTED|Expectant Mother Follow-up||45
2522634|NCT00702624|6181512|P1|STARTED|Expectant Mother Follow-up||68
2522635|NCT00702624|6181509|P4|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
2522636|NCT00702624|6181510|P3|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
2522637|NCT00702624|6181511|P2|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
2522638|NCT00702624|6181512|P1|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
2522639|NCT00702624|6181509|P4|COMPLETED|Base Study P05690 (NCT00702845)||0
2522640|NCT00702624|6181510|P3|COMPLETED|Base Study P05690 (NCT00702845)||0
2522641|NCT00702624|6181511|P2|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
2522642|NCT00702624|6181512|P1|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
2522643|NCT00702624|6181509|P4|STARTED|Base Study P05690 (NCT00702845)||0
2522644|NCT00702624|6181510|P3|STARTED|Base Study P05690 (NCT00702845)||0
2522645|NCT00702624|6181511|P2|STARTED|Base Study P05690 (NCT00702845)||128
2522646|NCT00702624|6181512|P1|STARTED|Base Study P05690 (NCT00702845)||268
2522647|NCT00702546|6181530|P2|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||1
2522648|NCT00702546|6181531|P1|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||5
2522649|NCT00702546|6181530|P2|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|24
2522650|NCT00702546|6181531|P1|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|72
2522651|NCT00702546|6181530|P2|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|25
2522652|NCT00702546|6181531|P1|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|77
2522653|NCT00702546|6181530|P2|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
2522654|NCT00702546|6181531|P1|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
2522655|NCT00702546|6181530|P2|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
2522656|NCT00702546|6181531|P1|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
2522657|NCT00702546|6181530|P2|STARTED|Base Study P05690 (NCT00702845)||128
2522658|NCT00702546|6181531|P1|STARTED|Base Study P05690 (NCT00702845)||268
2522659|NCT00702520|6181551|P4|NOT COMPLETED|Follow-up Study P05783||0
2522660|NCT00702520|6181552|P3|NOT COMPLETED|Follow-up Study P05783||0
2522661|NCT00702520|6181553|P2|NOT COMPLETED|Follow-up Study P05783||0
2522662|NCT00702520|6181554|P1|NOT COMPLETED|Follow-up Study P05783||0
2522663|NCT00702520|6181551|P4|COMPLETED|Follow-up Study P05783||11
2522664|NCT00702520|6181552|P3|COMPLETED|Follow-up Study P05783||8
2522665|NCT00702520|6181553|P2|COMPLETED|Follow-up Study P05783||8
2522666|NCT00702520|6181554|P1|COMPLETED|Follow-up Study P05783||7
2522667|NCT00702520|6181551|P4|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 150 ug.|11
2522668|NCT00702520|6181552|P3|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 100 ug.|8
2522669|NCT00702520|6181553|P2|STARTED|Follow-up Study P05783||8
2522670|NCT00702520|6181554|P1|STARTED|Follow-up Study P05783||7
2522671|NCT00702520|6181551|P4|NOT COMPLETED|Base Study P05788 - Follow-Up||0
2522672|NCT00702520|6181552|P3|NOT COMPLETED|Base Study P05788 - Follow-Up||0
2522673|NCT00702520|6181553|P2|NOT COMPLETED|Base Study P05788 - Follow-Up||10
2522674|NCT00702520|6181554|P1|NOT COMPLETED|Base Study P05788 - Follow-Up||15
2522675|NCT00702520|6181551|P4|COMPLETED|Base Study P05788 - Follow-Up||0
2522676|NCT00702520|6181552|P3|COMPLETED|Base Study P05788 - Follow-Up||0
2522677|NCT00702520|6181553|P2|COMPLETED|Base Study P05788 - Follow-Up||8
2522678|NCT00702520|6181554|P1|COMPLETED|Base Study P05788 - Follow-Up||7
2522679|NCT00702520|6181551|P4|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
2522680|NCT00702520|6181552|P3|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
2522681|NCT00702520|6181553|P2|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||8
2522682|NCT00702520|6181554|P1|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||7
2522683|NCT00702520|6181551|P4|STARTED|Base Study P05788 - Follow-Up||0
2522684|NCT00702520|6181552|P3|STARTED|Base Study P05788 - Follow-Up||0
2522685|NCT00702520|6181553|P2|STARTED|Base Study P05788 - Follow-Up||18
2522686|NCT00702520|6181554|P1|STARTED|Base Study P05788 - Follow-Up||22
2522687|NCT00702520|6181551|P4|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
2522688|NCT00702520|6181552|P3|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
2522689|NCT00702520|6181553|P2|NOT COMPLETED|Base Study P05788 - Embryo Transfer||6
2522690|NCT00702520|6181554|P1|NOT COMPLETED|Base Study P05788 - Embryo Transfer||3
2522691|NCT00702520|6181551|P4|COMPLETED|Base Study P05788 - Embryo Transfer||0
2522692|NCT00702520|6181552|P3|COMPLETED|Base Study P05788 - Embryo Transfer||0
2522693|NCT00702520|6181553|P2|COMPLETED|Base Study P05788 - Embryo Transfer||18
2522694|NCT00702520|6181554|P1|COMPLETED|Base Study P05788 - Embryo Transfer||22
2522695|NCT00702520|6181551|P4|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
2522696|NCT00702520|6181552|P3|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
2522697|NCT00702520|6181553|P2|Embryo Transfer|Base Study P05788 - Embryo Transfer||18
2522698|NCT00702520|6181554|P1|Embryo Transfer|Base Study P05788 - Embryo Transfer||22
2522699|NCT00702520|6181551|P4|STARTED|Base Study P05788 - Embryo Transfer||0
2522700|NCT00702520|6181552|P3|STARTED|Base Study P05788 - Embryo Transfer||0
2522701|NCT00702520|6181553|P2|STARTED|Base Study P05788 - Embryo Transfer||24
2522702|NCT00702520|6181554|P1|STARTED|Base Study P05788 - Embryo Transfer||25
2522703|NCT00702520|6181551|P4|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
2522704|NCT00702520|6181552|P3|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
2522705|NCT00702520|6181553|P2|NOT COMPLETED|Base Study P05788 - Assigned Treatment||1
2522706|NCT00702520|6181554|P1|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
2522707|NCT00702520|6181551|P4|COMPLETED|Base Study P05788 - Assigned Treatment||0
2522708|NCT00702520|6181552|P3|COMPLETED|Base Study P05788 - Assigned Treatment||0
2522709|NCT00702520|6181553|P2|COMPLETED|Base Study P05788 - Assigned Treatment||24
2522710|NCT00702520|6181554|P1|COMPLETED|Base Study P05788 - Assigned Treatment||25
2522711|NCT00702520|6181551|P4|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
2522712|NCT00702520|6181552|P3|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
2522713|NCT00702520|6181553|P2|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||24
2522714|NCT00702520|6181554|P1|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||25
2522715|NCT00702520|6181551|P4|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
2522716|NCT00702520|6181552|P3|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
2522717|NCT00702520|6181553|P2|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||24
2522718|NCT00702520|6181554|P1|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||25
2522719|NCT00702520|6181551|P4|STARTED|Base Study P05788 - Assigned Treatment||0
2522720|NCT00702520|6181552|P3|STARTED|Base Study P05788 - Assigned Treatment||0
2522721|NCT00702520|6181553|P2|STARTED|Base Study P05788 - Assigned Treatment||25
2522722|NCT00702520|6181554|P1|STARTED|Base Study P05788 - Assigned Treatment||25
2522723|NCT00702507|6181570|P1|NOT COMPLETED|Follow-up Phase||27
2522724|NCT00702507|6181570|P1|COMPLETED|Follow-up Phase||132
2522725|NCT00702507|6181570|P1|STARTED|Follow-up Phase||159
2522726|NCT00702507|6181570|P1|NOT COMPLETED|Initial Treatment Phase||41
2522727|NCT00702507|6181570|P1|COMPLETED|Initial Treatment Phase||159
2522728|NCT00702507|6181570|P1|STARTED|Initial Treatment Phase||200
2522729|NCT00702468|6181584|P2|NOT COMPLETED|Overall Study||16
2522730|NCT00702468|6181585|P1|NOT COMPLETED|Overall Study||3
2522731|NCT00702468|6181584|P2|COMPLETED|Overall Study||2
2522732|NCT00702468|6181585|P1|COMPLETED|Overall Study||15
2522733|NCT00702468|6181584|P2|STARTED|Overall Study||18
2522734|NCT00702468|6181585|P1|STARTED|Overall Study||18
2522735|NCT00702403|6181607|P1|NOT COMPLETED|From Engraftment to Study Completion||27
2522736|NCT00702403|6181607|P1|COMPLETED|From Engraftment to Study Completion||13
2522737|NCT00702403|6181607|P1|Patient Drop-outs|From Engraftment to Study Completion||27
2522738|NCT00702403|6181607|P1|STARTED|From Engraftment to Study Completion||40
2522739|NCT00702403|6181607|P1|NOT COMPLETED|From Consent to Engraftment||17
2522740|NCT00702403|6181607|P1|COMPLETED|From Consent to Engraftment|40 of 57 originally consented subjects remained eligible at engraftment (= the 2nd ITT population)|40
2522741|NCT00702403|6181607|P1|Ineligible for Study Drug|From Consent to Engraftment||17
2522742|NCT00702403|6181607|P1|STARTED|From Consent to Engraftment|"57 agreed to participate and completed informed consent (= the 1st intention to treat population)"|57
2522743|NCT00702377|6181617|P2|NOT COMPLETED|Overall Study||3
2522744|NCT00702377|6181618|P1|NOT COMPLETED|Overall Study||1
2522745|NCT00702377|6181617|P2|COMPLETED|Overall Study||53
2522746|NCT00702377|6181618|P1|COMPLETED|Overall Study||52
2522747|NCT00702377|6181617|P2|STARTED|Overall Study||56
2522748|NCT00702377|6181618|P1|STARTED|Overall Study||53
2522749|NCT00702364|6181630|P2|NOT COMPLETED|Overall Study||4
2522750|NCT00702364|6181631|P1|NOT COMPLETED|Overall Study||2
2522751|NCT00702364|6181630|P2|COMPLETED|Overall Study||25
2522752|NCT00702364|6181631|P1|COMPLETED|Overall Study||24
2522753|NCT00702364|6181630|P2|STARTED|Overall Study||29
2522754|NCT00702364|6181631|P1|STARTED|Overall Study||26
2522755|NCT00702338|6181643|P3|NOT COMPLETED|Follow-up Study: Infant FU||2
2522756|NCT00702338|6181644|P2|NOT COMPLETED|Follow-up Study: Infant FU||0
2522757|NCT00702338|6181645|P1|NOT COMPLETED|Follow-up Study: Infant FU||0
2522758|NCT00702338|6181643|P3|COMPLETED|Follow-up Study: Infant FU||0
2522759|NCT00702338|6181644|P2|COMPLETED|Follow-up Study: Infant FU||0
2522760|NCT00702338|6181645|P1|COMPLETED|Follow-up Study: Infant FU||0
2522761|NCT00702338|6181643|P3|STARTED|Follow-up Study: Infant FU|Participants died on day of delivery, did not complete follow-up visit at 4-12 weeks postpartum.|2
2522762|NCT00702338|6181644|P2|STARTED|Follow-up Study: Infant FU||0
2522763|NCT00702338|6181645|P1|STARTED|Follow-up Study: Infant FU||0
2522764|NCT00702338|6181643|P3|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
2522765|NCT00702338|6181644|P2|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||1
2522766|NCT00702338|6181645|P1|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
2522767|NCT00702338|6181643|P3|COMPLETED|Follow-up Study: Expectant Mothers FU||0
2522768|NCT00702338|6181644|P2|COMPLETED|Follow-up Study: Expectant Mothers FU|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|0
2522769|NCT00702338|6181645|P1|COMPLETED|Follow-up Study: Expectant Mothers FU||0
2522770|NCT00702338|6181643|P3|STARTED|Follow-up Study: Expectant Mothers FU||0
2522771|NCT00702338|6181644|P2|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|1
2522772|NCT00702338|6181645|P1|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|0
2522773|NCT00702338|6181643|P3|NOT COMPLETED|Base Study (NCT00697255)||0
2522774|NCT00702338|6181644|P2|NOT COMPLETED|Base Study (NCT00697255)||2
2522775|NCT00702338|6181645|P1|NOT COMPLETED|Base Study (NCT00697255)||3
2522776|NCT00702338|6181643|P3|COMPLETED|Base Study (NCT00697255)||0
2522848|NCT00701935|6181791|P1|STARTED|Overall Study||43
2522777|NCT00702338|6181644|P2|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|1
2522778|NCT00702338|6181645|P1|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|2
2522779|NCT00702338|6181643|P3|STARTED|Base Study (NCT00697255)||0
2522780|NCT00702338|6181644|P2|STARTED|Base Study (NCT00697255)||3
2522781|NCT00702338|6181645|P1|STARTED|Base Study (NCT00697255)||5
2522782|NCT00702325|6181661|P2|NOT COMPLETED|Overall Study||53
2522783|NCT00702325|6181662|P1|NOT COMPLETED|Overall Study||38
2522784|NCT00702325|6181661|P2|COMPLETED|Overall Study|Completed participants based on randomized population (155) minus discontinued participants (53).|102
2522785|NCT00702325|6181662|P1|COMPLETED|Overall Study|Completed participants based on randomized population (156) minus discontinued participants (38).|118
2522786|NCT00702325|6181661|P2|STARTED|Overall Study|Randomized|155
2522787|NCT00702325|6181662|P1|STARTED|Overall Study|Randomized|156
2522788|NCT00702299|6181714|P1|NOT COMPLETED|Overall Study||0
2522789|NCT00702299|6181714|P1|COMPLETED|Overall Study||15
2522790|NCT00702299|6181714|P1|STARTED|Overall Study||15
2522791|NCT00702273|6181727|P2|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||29
2522792|NCT00702273|6181728|P1|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||20
2522793|NCT00702273|6181727|P2|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|147
2522794|NCT00702273|6181728|P1|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|148
2522795|NCT00702273|6181727|P2|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study, who had at least one embryo thawed for a FTET cycle|176
2522796|NCT00702273|6181728|P1|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study,who had at least one embryo thawed for a FTET cycle.|168
2522797|NCT00702273|6181727|P2|NOT COMPLETED|Base Study P05787 (NCT00696800)||48
2522798|NCT00702273|6181728|P1|NOT COMPLETED|Base Study P05787 (NCT00696800)||85
2522799|NCT00702273|6181727|P2|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|704
2522800|NCT00702273|6181728|P1|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|672
2522801|NCT00702273|6181727|P2|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|750
2522802|NCT00702273|6181728|P1|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|756
2522803|NCT00702273|6181727|P2|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|752
2522804|NCT00702273|6181728|P1|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|757
2522805|NCT00702234|6181746|P2|NOT COMPLETED|Follow-up Study: Fetuses/Infants||27
2522806|NCT00702234|6181747|P1|NOT COMPLETED|Follow-up Study: Fetuses/Infants||0
2522807|NCT00702234|6181746|P2|COMPLETED|Follow-up Study: Fetuses/Infants|All 288 who completed were live born infants|288
2522808|NCT00702234|6181747|P1|COMPLETED|Follow-up Study: Fetuses/Infants||0
2522809|NCT00702234|6181746|P2|Live Born Infants|Follow-up Study: Fetuses/Infants|Of the 11 that were not live born infants, outcome is known for 8 (fetus was lost) and unknown for 3|304
2522810|NCT00702234|6181747|P1|Live Born Infants|Follow-up Study: Fetuses/Infants||0
2522811|NCT00702234|6181746|P2|STARTED|Follow-up Study: Fetuses/Infants|Fetuses present 10 weeks after fresh ET and/or at enrollment of expectant mother in follow-up study|315
2522812|NCT00702234|6181747|P1|STARTED|Follow-up Study: Fetuses/Infants||0
2522813|NCT00702234|6181746|P2|NOT COMPLETED|Follow-up Study: Expectant Mothers||0
2522814|NCT00702234|6181747|P1|NOT COMPLETED|Follow-up Study: Expectant Mothers||22
2522815|NCT00702234|6181746|P2|COMPLETED|Follow-up Study: Expectant Mothers||0
2522816|NCT00702234|6181747|P1|COMPLETED|Follow-up Study: Expectant Mothers||246
2522817|NCT00702234|6181746|P2|STARTED|Follow-up Study: Expectant Mothers||0
2522818|NCT00702234|6181747|P1|STARTED|Follow-up Study: Expectant Mothers|"A participant could enter follow-up study without meeting definition for Completion of base study"|268
2522819|NCT00702234|6181746|P2|NOT COMPLETED|Base Study (NCT00696878)||0
2522820|NCT00702234|6181747|P1|NOT COMPLETED|Base Study (NCT00696878)||504
2522821|NCT00702234|6181746|P2|COMPLETED|Base Study (NCT00696878)||0
2522822|NCT00702234|6181747|P1|COMPLETED|Base Study (NCT00696878)||178
2522823|NCT00702234|6181746|P2|STARTED|Base Study (NCT00696878)||0
2522824|NCT00702234|6181747|P1|STARTED|Base Study (NCT00696878)||682
2522825|NCT00702221|6181758|P2|NOT COMPLETED|Overall Study||3
2522826|NCT00702221|6181759|P1|NOT COMPLETED|Overall Study||4
2522827|NCT00702221|6181758|P2|COMPLETED|Overall Study||7
2522828|NCT00702221|6181759|P1|COMPLETED|Overall Study||6
2522829|NCT00702221|6181758|P2|STARTED|Overall Study||10
2522830|NCT00702221|6181759|P1|STARTED|Overall Study||10
2522831|NCT00702208|6181765|P1|NOT COMPLETED|Overall Study||31
2522832|NCT00702208|6181765|P1|COMPLETED|Overall Study||167
2522833|NCT00702208|6181765|P1|STARTED|Overall Study||198
2522834|NCT00702143|6181774|P3|NOT COMPLETED|Overall Study||1
2522835|NCT00702143|6181775|P2|NOT COMPLETED|Overall Study||0
2522836|NCT00702143|6181776|P1|NOT COMPLETED|Overall Study||0
2522837|NCT00702143|6181774|P3|COMPLETED|Overall Study||78
2522838|NCT00702143|6181775|P2|COMPLETED|Overall Study||60
2522839|NCT00702143|6181776|P1|COMPLETED|Overall Study||45
2522840|NCT00702143|6181774|P3|STARTED|Overall Study||79
2522841|NCT00702143|6181775|P2|STARTED|Overall Study||60
2522842|NCT00702143|6181776|P1|STARTED|Overall Study||45
2522843|NCT00701935|6181790|P2|NOT COMPLETED|Overall Study||11
2522844|NCT00701935|6181791|P1|NOT COMPLETED|Overall Study||16
2522845|NCT00701935|6181790|P2|COMPLETED|Overall Study||26
2522846|NCT00701935|6181791|P1|COMPLETED|Overall Study||27
2522847|NCT00701935|6181790|P2|STARTED|Overall Study||37
2522849|NCT00701805|6181825|P4|NOT COMPLETED|Overall Study||4
2522850|NCT00701805|6181826|P3|NOT COMPLETED|Overall Study||7
2522851|NCT00701805|6181827|P2|NOT COMPLETED|Overall Study||4
2522852|NCT00701805|6181828|P1|NOT COMPLETED|Overall Study||3
2522853|NCT00701805|6181825|P4|COMPLETED|Overall Study||22
2522854|NCT00701805|6181826|P3|COMPLETED|Overall Study||16
2522855|NCT00701805|6181827|P2|COMPLETED|Overall Study||25
2522856|NCT00701805|6181828|P1|COMPLETED|Overall Study||23
2522857|NCT00701805|6181825|P4|STARTED|Overall Study||26
2522858|NCT00701805|6181826|P3|STARTED|Overall Study||23
2522859|NCT00701805|6181827|P2|STARTED|Overall Study||29
2522860|NCT00701805|6181828|P1|STARTED|Overall Study||26
2522861|NCT00701779|6181878|P1|NOT COMPLETED|Overall Study||9
2522862|NCT00701779|6181878|P1|COMPLETED|Overall Study||54
2522863|NCT00701779|6181878|P1|12 Month|Overall Study||54
2522864|NCT00701779|6181878|P1|9 Month|Overall Study||56
2522865|NCT00701779|6181878|P1|6 Month|Overall Study||58
2522866|NCT00701779|6181878|P1|3 Month|Overall Study||60
2522867|NCT00701779|6181878|P1|STARTED|Overall Study||63
2522868|NCT00701727|6181890|P2|NOT COMPLETED|Second Treatment Period||0
2522869|NCT00701727|6181891|P1|NOT COMPLETED|Second Treatment Period||2
2522870|NCT00701727|6181890|P2|COMPLETED|Second Treatment Period||13
2522871|NCT00701727|6181891|P1|COMPLETED|Second Treatment Period||13
2522872|NCT00701727|6181890|P2|STARTED|Second Treatment Period||13
2522873|NCT00701727|6181891|P1|STARTED|Second Treatment Period||15
2522874|NCT00701727|6181890|P2|NOT COMPLETED|First Treatment Period||2
2522875|NCT00701727|6181891|P1|NOT COMPLETED|First Treatment Period||1
2522876|NCT00701727|6181890|P2|COMPLETED|First Treatment Period||13
2522877|NCT00701727|6181891|P1|COMPLETED|First Treatment Period||15
2522878|NCT00701727|6181890|P2|STARTED|First Treatment Period||15
2522879|NCT00701727|6181891|P1|STARTED|First Treatment Period||16
2522880|NCT00701714|6181911|P2|NOT COMPLETED|Safety Follow-up Period (6 Months)||7
2522881|NCT00701714|6181912|P1|NOT COMPLETED|Safety Follow-up Period (6 Months)||7
2522882|NCT00701714|6181911|P2|COMPLETED|Safety Follow-up Period (6 Months)||112
2522883|NCT00701714|6181912|P1|COMPLETED|Safety Follow-up Period (6 Months)||144
2522884|NCT00701714|6181911|P2|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|119
2522885|NCT00701714|6181912|P1|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|151
2522886|NCT00701714|6181911|P2|NOT COMPLETED|Treatment Period (up to 1 Year)||134
2522887|NCT00701714|6181912|P1|NOT COMPLETED|Treatment Period (up to 1 Year)||137
2522888|NCT00701714|6181911|P2|COMPLETED|Treatment Period (up to 1 Year)||29
2522889|NCT00701714|6181912|P1|COMPLETED|Treatment Period (up to 1 Year)||37
2522890|NCT00701714|6181911|P2|STARTED|Treatment Period (up to 1 Year)||163
2522891|NCT00701714|6181912|P1|STARTED|Treatment Period (up to 1 Year)||174
2522892|NCT00701675|6181927|P3|NOT COMPLETED|Overall Study||7
2522893|NCT00701675|6181928|P2|NOT COMPLETED|Overall Study||8
2522894|NCT00701675|6181929|P1|NOT COMPLETED|Overall Study||4
2522895|NCT00701675|6181927|P3|COMPLETED|Overall Study||7
2522896|NCT00701675|6181928|P2|COMPLETED|Overall Study||6
2522897|NCT00701675|6181929|P1|COMPLETED|Overall Study||10
2522898|NCT00701675|6181927|P3|STARTED|Overall Study||14
2522899|NCT00701675|6181928|P2|STARTED|Overall Study||14
2522900|NCT00701675|6181929|P1|STARTED|Overall Study||14
2522901|NCT00701662|6181937|P1|NOT COMPLETED|Overall Study||1
2522902|NCT00701662|6181937|P1|COMPLETED|Overall Study||7
2522903|NCT00701662|6181937|P1|STARTED|Overall Study||8
2522904|NCT00701636|6181956|P2|NOT COMPLETED|Overall Study||0
2522905|NCT00701636|6181957|P1|NOT COMPLETED|Overall Study||0
2522906|NCT00701636|6181956|P2|COMPLETED|Overall Study||15
2522907|NCT00701636|6181957|P1|COMPLETED|Overall Study||15
2522908|NCT00701636|6181956|P2|STARTED|Overall Study||15
2522909|NCT00701636|6181957|P1|STARTED|Overall Study||15
2522910|NCT00701558|6181962|P1|NOT COMPLETED|Overall Study||15
2522911|NCT00701558|6181962|P1|COMPLETED|Overall Study||4
2522912|NCT00701558|6181962|P1|STARTED|Overall Study||19
2522913|NCT00701441|6181970|P2|NOT COMPLETED|Overall Study||4
2522914|NCT00701441|6181971|P1|NOT COMPLETED|Overall Study||0
2522915|NCT00701441|6181970|P2|COMPLETED|Overall Study||12
2522916|NCT00701441|6181971|P1|COMPLETED|Overall Study||9
2522917|NCT00701441|6181970|P2|STARTED|Overall Study||16
2522918|NCT00701441|6181971|P1|STARTED|Overall Study||9
2522919|NCT00701415|6181983|P2|NOT COMPLETED|Overall Study||1
2522920|NCT00701415|6181984|P1|NOT COMPLETED|Overall Study||1
2522921|NCT00701415|6181983|P2|COMPLETED|Overall Study||14
2522922|NCT00701415|6181984|P1|COMPLETED|Overall Study||15
2522923|NCT00701415|6181983|P2|STARTED|Overall Study||15
2522924|NCT00701415|6181984|P1|STARTED|Overall Study||16
2522925|NCT00701389|6181994|P4|NOT COMPLETED|Period 4||0
2522926|NCT00701389|6181995|P3|NOT COMPLETED|Period 4||0
2522927|NCT00701389|6181996|P2|NOT COMPLETED|Period 4||0
2522928|NCT00701389|6181997|P1|NOT COMPLETED|Period 4||0
2522929|NCT00701389|6181994|P4|COMPLETED|Period 4||6
2522930|NCT00701389|6181995|P3|COMPLETED|Period 4||6
2522931|NCT00701389|6181996|P2|COMPLETED|Period 4||6
2522932|NCT00701389|6181997|P1|COMPLETED|Period 4||6
2522933|NCT00701389|6181994|P4|STARTED|Period 4||6
2522934|NCT00701389|6181995|P3|STARTED|Period 4||6
2522935|NCT00701389|6181996|P2|STARTED|Period 4||6
2522936|NCT00701389|6181997|P1|STARTED|Period 4||6
2522937|NCT00701389|6181994|P4|NOT COMPLETED|Period 3||0
2522938|NCT00701389|6181995|P3|NOT COMPLETED|Period 3||0
2522939|NCT00701389|6181996|P2|NOT COMPLETED|Period 3||0
2522940|NCT00701389|6181997|P1|NOT COMPLETED|Period 3||0
2522941|NCT00701389|6181994|P4|COMPLETED|Period 3||6
2522942|NCT00701389|6181995|P3|COMPLETED|Period 3||6
2522943|NCT00701389|6181996|P2|COMPLETED|Period 3||6
2522944|NCT00701389|6181997|P1|COMPLETED|Period 3||6
2522945|NCT00701389|6181994|P4|STARTED|Period 3||6
2522946|NCT00701389|6181995|P3|STARTED|Period 3||6
2522947|NCT00701389|6181996|P2|STARTED|Period 3||6
2522948|NCT00701389|6181997|P1|STARTED|Period 3||6
2522949|NCT00701389|6181994|P4|NOT COMPLETED|Period 2||0
2522950|NCT00701389|6181995|P3|NOT COMPLETED|Period 2||0
2522951|NCT00701389|6181996|P2|NOT COMPLETED|Period 2||0
2522952|NCT00701389|6181997|P1|NOT COMPLETED|Period 2||0
2522953|NCT00701389|6181994|P4|COMPLETED|Period 2||6
2522954|NCT00701389|6181995|P3|COMPLETED|Period 2||6
2522955|NCT00701389|6181996|P2|COMPLETED|Period 2||6
2522956|NCT00701389|6181997|P1|COMPLETED|Period 2||6
2522957|NCT00701389|6181994|P4|STARTED|Period 2||6
2522958|NCT00701389|6181995|P3|STARTED|Period 2||6
2522959|NCT00701389|6181996|P2|STARTED|Period 2||6
2522960|NCT00701389|6181997|P1|STARTED|Period 2||6
2522961|NCT00701389|6181994|P4|NOT COMPLETED|Period 1||0
2522962|NCT00701389|6181995|P3|NOT COMPLETED|Period 1||0
2522963|NCT00701389|6181996|P2|NOT COMPLETED|Period 1||0
2522964|NCT00701389|6181997|P1|NOT COMPLETED|Period 1||0
2522965|NCT00701389|6181994|P4|COMPLETED|Period 1||6
2522966|NCT00701389|6181995|P3|COMPLETED|Period 1||6
2522967|NCT00701389|6181996|P2|COMPLETED|Period 1||6
2522968|NCT00701389|6181997|P1|COMPLETED|Period 1||6
2522969|NCT00701389|6181994|P4|STARTED|Period 1||6
2522970|NCT00701389|6181995|P3|STARTED|Period 1||6
2522971|NCT00701389|6181996|P2|STARTED|Period 1||6
2522972|NCT00701389|6181997|P1|STARTED|Period 1||6
2522973|NCT00701363|6182019|P4|NOT COMPLETED|Treatment Phase 2||0
2522974|NCT00701363|6182020|P3|NOT COMPLETED|Treatment Phase 2||2
2522975|NCT00701363|6182021|P2|NOT COMPLETED|Treatment Phase 2||0
2522976|NCT00701363|6182022|P1|NOT COMPLETED|Treatment Phase 2||0
2522977|NCT00701363|6182019|P4|COMPLETED|Treatment Phase 2||26
2522978|NCT00701363|6182020|P3|COMPLETED|Treatment Phase 2||68
2522979|NCT00701363|6182021|P2|COMPLETED|Treatment Phase 2||13
2522980|NCT00701363|6182022|P1|COMPLETED|Treatment Phase 2||0
2522981|NCT00701363|6182019|P4|STARTED|Treatment Phase 2||26
2522982|NCT00701363|6182020|P3|STARTED|Treatment Phase 2||70
2522983|NCT00701363|6182021|P2|STARTED|Treatment Phase 2||13
2522984|NCT00701363|6182022|P1|STARTED|Treatment Phase 2||0
2522985|NCT00701363|6182019|P4|NOT COMPLETED|Treatment Phase 1||0
2522986|NCT00701363|6182020|P3|NOT COMPLETED|Treatment Phase 1||0
2522987|NCT00701363|6182021|P2|NOT COMPLETED|Treatment Phase 1||0
2522988|NCT00701363|6182022|P1|NOT COMPLETED|Treatment Phase 1||15
2522989|NCT00701363|6182019|P4|COMPLETED|Treatment Phase 1||0
2522990|NCT00701363|6182020|P3|COMPLETED|Treatment Phase 1||0
2522991|NCT00701363|6182021|P2|COMPLETED|Treatment Phase 1||0
2522992|NCT00701363|6182022|P1|COMPLETED|Treatment Phase 1||109
2522993|NCT00701363|6182019|P4|STARTED|Treatment Phase 1||0
2522994|NCT00701363|6182020|P3|STARTED|Treatment Phase 1||0
2522995|NCT00701363|6182021|P2|STARTED|Treatment Phase 1||0
2522996|NCT00701363|6182022|P1|STARTED|Treatment Phase 1||124
2522997|NCT00701363|6182019|P4|NOT COMPLETED|Screening (Pre-assignment) Phase||0
2522998|NCT00701363|6182020|P3|NOT COMPLETED|Screening (Pre-assignment) Phase||0
2522999|NCT00701363|6182021|P2|NOT COMPLETED|Screening (Pre-assignment) Phase||0
2523000|NCT00701363|6182022|P1|NOT COMPLETED|Screening (Pre-assignment) Phase||4
2523001|NCT00701363|6182019|P4|COMPLETED|Screening (Pre-assignment) Phase||0
2523002|NCT00701363|6182020|P3|COMPLETED|Screening (Pre-assignment) Phase||0
2523003|NCT00701363|6182021|P2|COMPLETED|Screening (Pre-assignment) Phase||0
2523004|NCT00701363|6182022|P1|COMPLETED|Screening (Pre-assignment) Phase||124
2523005|NCT00701363|6182019|P4|STARTED|Screening (Pre-assignment) Phase||0
2523006|NCT00701363|6182020|P3|STARTED|Screening (Pre-assignment) Phase||0
2523007|NCT00701363|6182021|P2|STARTED|Screening (Pre-assignment) Phase||0
2523008|NCT00701363|6182022|P1|STARTED|Screening (Pre-assignment) Phase||128
2523009|NCT00701311|6182062|P1|NOT COMPLETED|Overall Study||8
2523010|NCT00701311|6182062|P1|COMPLETED|Overall Study|Eight subjects did not complete full period of treatment but their data was included in analysis.|9
2523011|NCT00701311|6182062|P1|STARTED|Overall Study||17
2523012|NCT00701129|6182066|P1|NOT COMPLETED|Overall Study||2
2523013|NCT00701129|6182066|P1|COMPLETED|Overall Study||2
2523014|NCT00701129|6182066|P1|Full Analysis Set (FAS)|Overall Study|All enrolled patients who signed informed consent, received at least 1 dose of alglucosidase alfa.|4
2523015|NCT00701129|6182066|P1|STARTED|Overall Study||4
2523016|NCT00701103|6182088|P11|NOT COMPLETED|Overall Study||11
2523017|NCT00701103|6182089|P10|NOT COMPLETED|Overall Study||11
2523018|NCT00701103|6182090|P9|NOT COMPLETED|Overall Study||9
2523019|NCT00701103|6182091|P8|NOT COMPLETED|Overall Study||7
2523020|NCT00701103|6182092|P7|NOT COMPLETED|Overall Study||8
2523021|NCT00701103|6182093|P6|NOT COMPLETED|Overall Study||6
2523022|NCT00701103|6182094|P5|NOT COMPLETED|Overall Study||6
2523023|NCT00701103|6182095|P4|NOT COMPLETED|Overall Study||6
2523024|NCT00701103|6182096|P3|NOT COMPLETED|Overall Study||8
2523025|NCT00701103|6182097|P2|NOT COMPLETED|Overall Study||3
2523026|NCT00701103|6182098|P1|NOT COMPLETED|Overall Study||5
2523027|NCT00701103|6182088|P11|COMPLETED|Overall Study||0
2523028|NCT00701103|6182089|P10|COMPLETED|Overall Study||0
2523029|NCT00701103|6182090|P9|COMPLETED|Overall Study||0
2523030|NCT00701103|6182091|P8|COMPLETED|Overall Study||0
2523031|NCT00701103|6182092|P7|COMPLETED|Overall Study||0
2523032|NCT00701103|6182093|P6|COMPLETED|Overall Study||0
2523033|NCT00701103|6182094|P5|COMPLETED|Overall Study||0
2523034|NCT00701103|6182095|P4|COMPLETED|Overall Study||0
2523035|NCT00701103|6182096|P3|COMPLETED|Overall Study||0
2523036|NCT00701103|6182097|P2|COMPLETED|Overall Study||0
2523037|NCT00701103|6182098|P1|COMPLETED|Overall Study||0
2523038|NCT00701103|6182088|P11|STARTED|Overall Study||11
2523039|NCT00701103|6182089|P10|STARTED|Overall Study||11
2523040|NCT00701103|6182090|P9|STARTED|Overall Study||9
2523041|NCT00701103|6182091|P8|STARTED|Overall Study||7
2523042|NCT00701103|6182092|P7|STARTED|Overall Study||8
2523043|NCT00701103|6182093|P6|STARTED|Overall Study||6
2523044|NCT00701103|6182094|P5|STARTED|Overall Study||6
2523045|NCT00701103|6182095|P4|STARTED|Overall Study||6
2523046|NCT00701103|6182096|P3|STARTED|Overall Study||8
2523047|NCT00701103|6182097|P2|STARTED|Overall Study||3
2523048|NCT00701103|6182098|P1|STARTED|Overall Study||5
2523049|NCT00701090|6182204|P2|NOT COMPLETED|Overall Study||51
2523050|NCT00701090|6182205|P1|NOT COMPLETED|Overall Study||48
2523051|NCT00701090|6182204|P2|COMPLETED|Overall Study||468
2523052|NCT00701090|6182205|P1|COMPLETED|Overall Study||468
2523053|NCT00701090|6182204|P2|STARTED|Overall Study||519
2523054|NCT00701090|6182205|P1|STARTED|Overall Study||516
2523055|NCT00701064|6182223|P2|NOT COMPLETED|Overall Study||4
2523056|NCT00701064|6182224|P1|NOT COMPLETED|Overall Study||4
2523057|NCT00701064|6182223|P2|COMPLETED|Overall Study||32
2523058|NCT00701064|6182224|P1|COMPLETED|Overall Study||31
2523059|NCT00701064|6182223|P2|STARTED|Overall Study||36
2523060|NCT00701064|6182224|P1|STARTED|Overall Study||35
2523061|NCT00701051|6182236|P3|NOT COMPLETED|Detraining Intervention (Optional)||0
2523062|NCT00701051|6182237|P2|NOT COMPLETED|Detraining Intervention (Optional)||0
2523063|NCT00701051|6182238|P1|NOT COMPLETED|Detraining Intervention (Optional)||0
2523064|NCT00701051|6182236|P3|COMPLETED|Detraining Intervention (Optional)||6
2523065|NCT00701051|6182237|P2|COMPLETED|Detraining Intervention (Optional)||6
2523066|NCT00701051|6182238|P1|COMPLETED|Detraining Intervention (Optional)||0
2523067|NCT00701051|6182236|P3|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
2523068|NCT00701051|6182237|P2|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
2523069|NCT00701051|6182238|P1|STARTED|Detraining Intervention (Optional)||0
2523070|NCT00701051|6182236|P3|NOT COMPLETED|Exercise Intervention||3
2523071|NCT00701051|6182237|P2|NOT COMPLETED|Exercise Intervention||5
2523072|NCT00701051|6182238|P1|NOT COMPLETED|Exercise Intervention||0
2523073|NCT00701051|6182236|P3|COMPLETED|Exercise Intervention||9
2523074|NCT00701051|6182237|P2|COMPLETED|Exercise Intervention||14
2523075|NCT00701051|6182238|P1|COMPLETED|Exercise Intervention||0
2523076|NCT00701051|6182236|P3|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|12
2523077|NCT00701051|6182237|P2|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|19
2523078|NCT00701051|6182238|P1|STARTED|Exercise Intervention|Participants assigned to Normal or Impaired glucose tolerance arm after screening.|0
2523079|NCT00701051|6182236|P3|NOT COMPLETED|Screening||0
2523080|NCT00701051|6182237|P2|NOT COMPLETED|Screening||0
2523081|NCT00701051|6182238|P1|NOT COMPLETED|Screening||59
2523082|NCT00701051|6182236|P3|COMPLETED|Screening||0
2523083|NCT00701051|6182237|P2|COMPLETED|Screening||0
2523084|NCT00701051|6182238|P1|COMPLETED|Screening|Arm assignment not known until baseline testing; both arms included in this number|31
2523085|NCT00701051|6182236|P3|STARTED|Screening||0
2523086|NCT00701051|6182237|P2|STARTED|Screening||0
2523087|NCT00701051|6182238|P1|STARTED|Screening|Arm assignment not known until baseline testing; both arms included in this number|90
2523088|NCT00701038|6182256|P2|NOT COMPLETED|Overall Study||4
2523089|NCT00701038|6182257|P1|NOT COMPLETED|Overall Study||4
2523090|NCT00701038|6182256|P2|COMPLETED|Overall Study||23
2523091|NCT00701038|6182257|P1|COMPLETED|Overall Study||23
2523092|NCT00701038|6182256|P2|STARTED|Overall Study||27
2523093|NCT00701038|6182257|P1|STARTED|Overall Study||27
2523094|NCT00700999|6182265|P2|NOT COMPLETED|Overall Study||9
2523095|NCT00700999|6182266|P1|NOT COMPLETED|Overall Study||15
2523096|NCT00700999|6182265|P2|COMPLETED|Overall Study||20
2523097|NCT00700999|6182266|P1|COMPLETED|Overall Study||21
2523098|NCT00700999|6182265|P2|Second MRI Scan|Overall Study||18
2523099|NCT00700999|6182266|P1|Second MRI Scan|Overall Study||19
2523100|NCT00700999|6182265|P2|First MRI Scan|Overall Study||22
2523101|NCT00700999|6182266|P1|First MRI Scan|Overall Study||29
2523102|NCT00700999|6182265|P2|STARTED|Overall Study||29
2523103|NCT00700999|6182266|P1|STARTED|Overall Study||36
2523104|NCT00700973|6182274|P2|NOT COMPLETED|Overall Study||7
2523105|NCT00700973|6182275|P1|NOT COMPLETED|Overall Study||8
2523106|NCT00700973|6182274|P2|COMPLETED|Overall Study||63
2523107|NCT00700973|6182275|P1|COMPLETED|Overall Study||63
2523108|NCT00700973|6182274|P2|STARTED|Overall Study||70
2523109|NCT00700973|6182275|P1|STARTED|Overall Study||71
2523116|NCT00700817|6182290|P5|NOT COMPLETED|Week 52-78 (Extension Period 2)||5
2523117|NCT00700817|6182291|P4|NOT COMPLETED|Week 52-78 (Extension Period 2)||8
2523118|NCT00700817|6182292|P3|NOT COMPLETED|Week 52-78 (Extension Period 2)||0
2523119|NCT00700817|6182293|P2|NOT COMPLETED|Week 52-78 (Extension Period 2)||15
2523120|NCT00700817|6182294|P1|NOT COMPLETED|Week 52-78 (Extension Period 2)||10
2523121|NCT00700817|6182290|P5|COMPLETED|Week 52-78 (Extension Period 2)||63
2523122|NCT00700817|6182291|P4|COMPLETED|Week 52-78 (Extension Period 2)||59
2523123|NCT00700817|6182292|P3|COMPLETED|Week 52-78 (Extension Period 2)||0
2523124|NCT00700817|6182293|P2|COMPLETED|Week 52-78 (Extension Period 2)||135
2523125|NCT00700817|6182294|P1|COMPLETED|Week 52-78 (Extension Period 2)||124
2523126|NCT00700817|6182290|P5|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|68
2523127|NCT00700817|6182291|P4|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|67
2523128|NCT00700817|6182292|P3|STARTED|Week 52-78 (Extension Period 2)|Re-randomised to lira 1.2 or 1.8 mg|0
2523129|NCT00700817|6182293|P2|STARTED|Week 52-78 (Extension Period 2)||150
2523130|NCT00700817|6182294|P1|STARTED|Week 52-78 (Extension Period 2)|Subject withdrew before entry to extension period 2|134
2523131|NCT00700817|6182290|P5|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
2523132|NCT00700817|6182291|P4|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
2523133|NCT00700817|6182292|P3|NOT COMPLETED|Week 26-52 (Extension Period 1)||15
2523134|NCT00700817|6182293|P2|NOT COMPLETED|Week 26-52 (Extension Period 1)||26
2523135|NCT00700817|6182294|P1|NOT COMPLETED|Week 26-52 (Extension Period 1)||20
2523136|NCT00700817|6182290|P5|COMPLETED|Week 26-52 (Extension Period 1)||0
2523137|NCT00700817|6182291|P4|COMPLETED|Week 26-52 (Extension Period 1)||0
2523138|NCT00700817|6182292|P3|COMPLETED|Week 26-52 (Extension Period 1)||151
2523139|NCT00700817|6182293|P2|COMPLETED|Week 26-52 (Extension Period 1)||150
2523140|NCT00700817|6182294|P1|COMPLETED|Week 26-52 (Extension Period 1)||135
2523141|NCT00700817|6182290|P5|STARTED|Week 26-52 (Extension Period 1)||0
2523142|NCT00700817|6182291|P4|STARTED|Week 26-52 (Extension Period 1)||0
2523143|NCT00700817|6182292|P3|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|166
2523144|NCT00700817|6182293|P2|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|176
2523145|NCT00700817|6182294|P1|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|155
2523146|NCT00700817|6182290|P5|NOT COMPLETED|Week 0-26 (Main Period)||0
2523147|NCT00700817|6182291|P4|NOT COMPLETED|Week 0-26 (Main Period)||0
2523148|NCT00700817|6182292|P3|NOT COMPLETED|Week 0-26 (Main Period)||25
2523149|NCT00700817|6182293|P2|NOT COMPLETED|Week 0-26 (Main Period)||30
2523150|NCT00700817|6182294|P1|NOT COMPLETED|Week 0-26 (Main Period)||56
2523151|NCT00700817|6182290|P5|COMPLETED|Week 0-26 (Main Period)||0
2523152|NCT00700817|6182291|P4|COMPLETED|Week 0-26 (Main Period)||0
2523153|NCT00700817|6182292|P3|COMPLETED|Week 0-26 (Main Period)||194
2523154|NCT00700817|6182293|P2|COMPLETED|Week 0-26 (Main Period)||191
2523155|NCT00700817|6182294|P1|COMPLETED|Week 0-26 (Main Period)||169
2523156|NCT00700817|6182290|P5|Exposed|Week 0-26 (Main Period)||0
2523157|NCT00700817|6182291|P4|Exposed|Week 0-26 (Main Period)||0
2523158|NCT00700817|6182292|P3|Exposed|Week 0-26 (Main Period)||219
2523159|NCT00700817|6182293|P2|Exposed|Week 0-26 (Main Period)|3 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|218
2523160|NCT00700817|6182294|P1|Exposed|Week 0-26 (Main Period)|4 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|221
2523161|NCT00700817|6182290|P5|STARTED|Week 0-26 (Main Period)||0
2523162|NCT00700817|6182291|P4|STARTED|Week 0-26 (Main Period)||0
2523163|NCT00700817|6182292|P3|STARTED|Week 0-26 (Main Period)|Randomised|219
2523164|NCT00700817|6182293|P2|STARTED|Week 0-26 (Main Period)|Randomised|221
2523165|NCT00700817|6182294|P1|STARTED|Week 0-26 (Main Period)|Randomised|225
2523166|NCT00700804|6182676|P2|NOT COMPLETED|Overall Study||4
2523167|NCT00700804|6182677|P1|NOT COMPLETED|Overall Study||3
2523168|NCT00700804|6182676|P2|COMPLETED|Overall Study||13
2523169|NCT00700804|6182677|P1|COMPLETED|Overall Study||14
2523170|NCT00700804|6182676|P2|STARTED|Overall Study||17
2523171|NCT00700804|6182677|P1|STARTED|Overall Study||17
2523172|NCT00700752|6182685|P2|NOT COMPLETED|Second Intervention||0
2523173|NCT00700752|6182686|P1|NOT COMPLETED|Second Intervention||0
2523174|NCT00700752|6182685|P2|COMPLETED|Second Intervention||18
2523175|NCT00700752|6182686|P1|COMPLETED|Second Intervention||20
2523176|NCT00700752|6182685|P2|STARTED|Second Intervention||18
2523177|NCT00700752|6182686|P1|STARTED|Second Intervention||20
2523178|NCT00700752|6182685|P2|NOT COMPLETED|First Intervention||2
2523179|NCT00700752|6182686|P1|NOT COMPLETED|First Intervention||0
2523180|NCT00700752|6182685|P2|COMPLETED|First Intervention||18
2523181|NCT00700752|6182686|P1|COMPLETED|First Intervention||20
2523182|NCT00700752|6182685|P2|STARTED|First Intervention||20
2523183|NCT00700752|6182686|P1|STARTED|First Intervention||20
2523184|NCT00700739|6182694|P2|NOT COMPLETED|Overall Study||4
2523185|NCT00700739|6182695|P1|NOT COMPLETED|Overall Study||4
2523186|NCT00700739|6182694|P2|COMPLETED|Overall Study||12
2523187|NCT00700739|6182695|P1|COMPLETED|Overall Study||18
2523188|NCT00700739|6182694|P2|STARTED|Overall Study||16
2523189|NCT00700739|6182695|P1|STARTED|Overall Study||22
2523190|NCT00700713|6182734|P3|NOT COMPLETED|Overall Study||2
2523191|NCT00700713|6182735|P2|NOT COMPLETED|Overall Study||0
2523192|NCT00700713|6182736|P1|NOT COMPLETED|Overall Study||1
2523193|NCT00700713|6182734|P3|COMPLETED|Overall Study||65
2523194|NCT00700713|6182735|P2|COMPLETED|Overall Study||66
2523195|NCT00700713|6182736|P1|COMPLETED|Overall Study||47
2523196|NCT00700713|6182734|P3|STARTED|Overall Study||67
2523197|NCT00700713|6182735|P2|STARTED|Overall Study||66
2523198|NCT00700713|6182736|P1|STARTED|Overall Study||48
2523199|NCT00700635|6182753|P3|NOT COMPLETED|Overall Study||1
2523200|NCT00700635|6182754|P2|NOT COMPLETED|Overall Study||8
2523201|NCT00700635|6182755|P1|NOT COMPLETED|Overall Study||11
2523202|NCT00700635|6182753|P3|COMPLETED|Overall Study||110
2523203|NCT00700635|6182754|P2|COMPLETED|Overall Study||103
2523204|NCT00700635|6182755|P1|COMPLETED|Overall Study||100
2523205|NCT00700635|6182753|P3|STARTED|Overall Study||111
2523206|NCT00700635|6182754|P2|STARTED|Overall Study||111
2523207|NCT00700635|6182755|P1|STARTED|Overall Study||111
2523208|NCT00700622|6182777|P2|NOT COMPLETED|Overall Study||5
2523209|NCT00700622|6182778|P1|NOT COMPLETED|Overall Study||13
2523210|NCT00700622|6182777|P2|COMPLETED|Overall Study||60
2523211|NCT00700622|6182778|P1|COMPLETED|Overall Study||52
2523212|NCT00700622|6182777|P2|STARTED|Overall Study||65
2523213|NCT00700622|6182778|P1|STARTED|Overall Study||65
2523214|NCT00700570|6182786|P2|NOT COMPLETED|Overall Study||26
2523215|NCT00700570|6182787|P1|NOT COMPLETED|Overall Study||11
2523216|NCT00700570|6182786|P2|COMPLETED|Overall Study||0
2523217|NCT00700570|6182787|P1|COMPLETED|Overall Study||8
2523218|NCT00700570|6182786|P2|STARTED|Overall Study||26
2523219|NCT00700570|6182787|P1|STARTED|Overall Study||19
2523220|NCT00700440|6182799|P1|NOT COMPLETED|Overall Study||0
2523221|NCT00700440|6182799|P1|COMPLETED|Overall Study||100
2523222|NCT00700440|6182799|P1|STARTED|Overall Study||100
2523223|NCT00700427|6182803|P5|NOT COMPLETED|Study Period 4 (Open-Label Extension)||84
2523224|NCT00700427|6182804|P4|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
2523225|NCT00700427|6182805|P3|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
2523226|NCT00700427|6182806|P2|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
2523227|NCT00700427|6182807|P1|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
2523228|NCT00700427|6182803|P5|COMPLETED|Study Period 4 (Open-Label Extension)||96
2523229|NCT00700427|6182804|P4|COMPLETED|Study Period 4 (Open-Label Extension)||0
2523230|NCT00700427|6182805|P3|COMPLETED|Study Period 4 (Open-Label Extension)||0
2523231|NCT00700427|6182806|P2|COMPLETED|Study Period 4 (Open-Label Extension)||0
2523232|NCT00700427|6182807|P1|COMPLETED|Study Period 4 (Open-Label Extension)||0
2523233|NCT00700427|6182803|P5|STARTED|Study Period 4 (Open-Label Extension)||180
2523234|NCT00700427|6182804|P4|STARTED|Study Period 4 (Open-Label Extension)||0
2523235|NCT00700427|6182805|P3|STARTED|Study Period 4 (Open-Label Extension)||0
2523236|NCT00700427|6182806|P2|STARTED|Study Period 4 (Open-Label Extension)||0
2523237|NCT00700427|6182807|P1|STARTED|Study Period 4 (Open-Label Extension)||0
2523238|NCT00700427|6182803|P5|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
2523239|NCT00700427|6182804|P4|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||93
2523240|NCT00700427|6182805|P3|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||82
2523241|NCT00700427|6182806|P2|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
2523242|NCT00700427|6182807|P1|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
2523243|NCT00700427|6182803|P5|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
2523244|NCT00700427|6182804|P4|COMPLETED|Study Period 3B (Randomized Withdrawal)||165
2523245|NCT00700427|6182805|P3|COMPLETED|Study Period 3B (Randomized Withdrawal)||184
2523246|NCT00700427|6182806|P2|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
2523247|NCT00700427|6182807|P1|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
2523248|NCT00700427|6182803|P5|STARTED|Study Period 3B (Randomized Withdrawal)||0
2523249|NCT00700427|6182804|P4|STARTED|Study Period 3B (Randomized Withdrawal)||258
2523250|NCT00700427|6182805|P3|STARTED|Study Period 3B (Randomized Withdrawal)||266
2523251|NCT00700427|6182806|P2|STARTED|Study Period 3B (Randomized Withdrawal)||0
2523252|NCT00700427|6182807|P1|STARTED|Study Period 3B (Randomized Withdrawal)||0
2523253|NCT00700427|6182803|P5|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
2523254|NCT00700427|6182804|P4|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
2523255|NCT00700427|6182805|P3|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
2523256|NCT00700427|6182806|P2|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||481
2523257|NCT00700427|6182807|P1|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
2523258|NCT00700427|6182803|P5|COMPLETED|Study Period 3A (Blinded Maintenance)||0
2523259|NCT00700427|6182804|P4|COMPLETED|Study Period 3A (Blinded Maintenance)||0
2523260|NCT00700427|6182805|P3|COMPLETED|Study Period 3A (Blinded Maintenance)||0
2523261|NCT00700427|6182806|P2|COMPLETED|Study Period 3A (Blinded Maintenance)||524
2523262|NCT00700427|6182807|P1|COMPLETED|Study Period 3A (Blinded Maintenance)||0
2523263|NCT00700427|6182803|P5|STARTED|Study Period 3A (Blinded Maintenance)||0
2523264|NCT00700427|6182804|P4|STARTED|Study Period 3A (Blinded Maintenance)||0
2523265|NCT00700427|6182805|P3|STARTED|Study Period 3A (Blinded Maintenance)||0
2523266|NCT00700427|6182806|P2|STARTED|Study Period 3A (Blinded Maintenance)||1005
2523267|NCT00700427|6182807|P1|STARTED|Study Period 3A (Blinded Maintenance)||0
2523268|NCT00700427|6182803|P5|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
2523269|NCT00700427|6182804|P4|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
2523270|NCT00700427|6182805|P3|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
2523271|NCT00700427|6182806|P2|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
2523272|NCT00700427|6182807|P1|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||1011
2523273|NCT00700427|6182803|P5|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
2523274|NCT00700427|6182804|P4|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
2523275|NCT00700427|6182805|P3|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
2523276|NCT00700427|6182806|P2|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
2523277|NCT00700427|6182807|P1|COMPLETED|Study Period 2 (Open-Label Acute Trx)|One participant was mistakenly recorded as completed. The reason for discontinuation is unknown.|1006
2523278|NCT00700427|6182803|P5|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
2523370|NCT00700011|6183086|P2|STARTED|Overall Study||2
2523279|NCT00700427|6182804|P4|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
2523280|NCT00700427|6182805|P3|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
2523281|NCT00700427|6182806|P2|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
2523282|NCT00700427|6182807|P1|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||2011
2523283|NCT00700427|6182803|P5|STARTED|Study Period 2 (Open-Label Acute Trx)||0
2523284|NCT00700427|6182804|P4|STARTED|Study Period 2 (Open-Label Acute Trx)||0
2523285|NCT00700427|6182805|P3|STARTED|Study Period 2 (Open-Label Acute Trx)||0
2523286|NCT00700427|6182806|P2|STARTED|Study Period 2 (Open-Label Acute Trx)||0
2523287|NCT00700427|6182807|P1|STARTED|Study Period 2 (Open-Label Acute Trx)||2017
2523288|NCT00700401|6182829|P1|NOT COMPLETED|Overall Study||94
2523289|NCT00700401|6182829|P1|COMPLETED|Overall Study||168
2523290|NCT00700401|6182829|P1|STARTED|Overall Study||262
2523291|NCT00700375|6182842|P2|NOT COMPLETED|Overall Study||0
2523292|NCT00700375|6182843|P1|NOT COMPLETED|Overall Study||0
2523293|NCT00700375|6182842|P2|COMPLETED|Overall Study||29
2523294|NCT00700375|6182843|P1|COMPLETED|Overall Study||30
2523295|NCT00700375|6182842|P2|2 Days After Creatinine Mesurement|Overall Study||29
2523296|NCT00700375|6182843|P1|2 Days After Creatinine Mesurement|Overall Study||30
2523297|NCT00700375|6182842|P2|STARTED|Overall Study||29
2523298|NCT00700375|6182843|P1|STARTED|Overall Study||30
2523299|NCT00700310|6182853|P4|NOT COMPLETED|Overall Study||26
2523300|NCT00700310|6182854|P3|NOT COMPLETED|Overall Study||16
2523301|NCT00700310|6182855|P2|NOT COMPLETED|Overall Study||26
2523302|NCT00700310|6182856|P1|NOT COMPLETED|Overall Study||21
2523303|NCT00700310|6182853|P4|COMPLETED|Overall Study||145
2523304|NCT00700310|6182854|P3|COMPLETED|Overall Study||158
2523305|NCT00700310|6182855|P2|COMPLETED|Overall Study||154
2523306|NCT00700310|6182856|P1|COMPLETED|Overall Study||166
2523307|NCT00700310|6182853|P4|STARTED|Overall Study||171
2523308|NCT00700310|6182854|P3|STARTED|Overall Study||174
2523309|NCT00700310|6182855|P2|STARTED|Overall Study||180
2523310|NCT00700310|6182856|P1|STARTED|Overall Study||187
2523311|NCT00700271|6182876|P2|NOT COMPLETED|Overall Study||12
2523312|NCT00700271|6182877|P1|NOT COMPLETED|Overall Study||14
2523313|NCT00700271|6182876|P2|COMPLETED|Overall Study||256
2523314|NCT00700271|6182877|P1|COMPLETED|Overall Study||264
2523315|NCT00700271|6182876|P2|STARTED|Overall Study||268
2523316|NCT00700271|6182877|P1|STARTED|Overall Study||278
2523317|NCT00700180|6182905|P2|NOT COMPLETED|Overall Study||149
2523318|NCT00700180|6182906|P1|NOT COMPLETED|Overall Study||154
2523319|NCT00700180|6182905|P2|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
2523320|NCT00700180|6182906|P1|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
2523321|NCT00700180|6182905|P2|STARTED|Overall Study||149
2523322|NCT00700180|6182906|P1|STARTED|Overall Study||154
2523323|NCT00700141|6182928|P1|NOT COMPLETED|Overall Study||0
2523324|NCT00700141|6182928|P1|COMPLETED|Overall Study||482
2523325|NCT00700141|6182928|P1|STARTED|Overall Study||482
2523326|NCT00700115|6182935|P2|NOT COMPLETED|Overall Study||1
2523327|NCT00700115|6182936|P1|NOT COMPLETED|Overall Study||1
2523328|NCT00700115|6182935|P2|COMPLETED|Overall Study||19
2523329|NCT00700115|6182936|P1|COMPLETED|Overall Study||39
2523330|NCT00700115|6182935|P2|STARTED|Overall Study||20
2523331|NCT00700115|6182936|P1|STARTED|Overall Study||40
2523332|NCT00700102|6182946|P2|NOT COMPLETED|Overall Study||395
2523333|NCT00700102|6182947|P1|NOT COMPLETED|Overall Study||402
2523334|NCT00700102|6182946|P2|COMPLETED|Overall Study||14
2523335|NCT00700102|6182947|P1|COMPLETED|Overall Study||9
2523336|NCT00700102|6182946|P2|Received at Least One Dose|Overall Study||403
2523337|NCT00700102|6182947|P1|Received at Least One Dose|Overall Study||407
2523338|NCT00700102|6182946|P2|Intention to Treat|Overall Study||409
2523339|NCT00700102|6182947|P1|Intention to Treat|Overall Study||410
2523340|NCT00700102|6182946|P2|STARTED|Overall Study||409
2523341|NCT00700102|6182947|P1|STARTED|Overall Study||411
2523342|NCT00700063|6182971|P8|NOT COMPLETED|Overall Study||0
2523343|NCT00700063|6182972|P7|NOT COMPLETED|Overall Study||0
2523344|NCT00700063|6182973|P6|NOT COMPLETED|Overall Study||0
2523345|NCT00700063|6182974|P5|NOT COMPLETED|Overall Study||2
2523346|NCT00700063|6182975|P4|NOT COMPLETED|Overall Study||2
2523347|NCT00700063|6182976|P3|NOT COMPLETED|Overall Study||0
2523348|NCT00700063|6182977|P2|NOT COMPLETED|Overall Study||0
2523349|NCT00700063|6182978|P1|NOT COMPLETED|Overall Study||1
2523350|NCT00700063|6182971|P8|COMPLETED|Overall Study||33
2523351|NCT00700063|6182972|P7|COMPLETED|Overall Study||32
2523352|NCT00700063|6182973|P6|COMPLETED|Overall Study||34
2523353|NCT00700063|6182974|P5|COMPLETED|Overall Study||31
2523354|NCT00700063|6182975|P4|COMPLETED|Overall Study||31
2523355|NCT00700063|6182976|P3|COMPLETED|Overall Study||33
2523356|NCT00700063|6182977|P2|COMPLETED|Overall Study||34
2523357|NCT00700063|6182978|P1|COMPLETED|Overall Study||32
2523358|NCT00700063|6182971|P8|STARTED|Overall Study||33
2523359|NCT00700063|6182972|P7|STARTED|Overall Study||32
2523360|NCT00700063|6182973|P6|STARTED|Overall Study||34
2523361|NCT00700063|6182974|P5|STARTED|Overall Study||33
2523362|NCT00700063|6182975|P4|STARTED|Overall Study||33
2523363|NCT00700063|6182976|P3|STARTED|Overall Study||33
2523364|NCT00700063|6182977|P2|STARTED|Overall Study||34
2523365|NCT00700063|6182978|P1|STARTED|Overall Study||33
2523366|NCT00700011|6183086|P2|NOT COMPLETED|Overall Study||1
2523367|NCT00700011|6183087|P1|NOT COMPLETED|Overall Study||0
2523368|NCT00700011|6183086|P2|COMPLETED|Overall Study||1
2523369|NCT00700011|6183087|P1|COMPLETED|Overall Study||8
2523371|NCT00700011|6183087|P1|STARTED|Overall Study||8
2523372|NCT00699998|6183103|P4|NOT COMPLETED|Overall Study||82
2523373|NCT00699998|6183104|P3|NOT COMPLETED|Overall Study||206
2523374|NCT00699998|6183105|P2|NOT COMPLETED|Overall Study||86
2523375|NCT00699998|6183106|P1|NOT COMPLETED|Overall Study||199
2523376|NCT00699998|6183103|P4|COMPLETED|Overall Study||958
2523377|NCT00699998|6183104|P3|COMPLETED|Overall Study||3417
2523378|NCT00699998|6183105|P2|COMPLETED|Overall Study||957
2523379|NCT00699998|6183106|P1|COMPLETED|Overall Study||3421
2523380|NCT00699998|6183103|P4|Received at Least 1 Dose of Study Drug|Overall Study||1027
2523381|NCT00699998|6183104|P3|Received at Least 1 Dose of Study Drug|Overall Study||3590
2523382|NCT00699998|6183105|P2|Received at Least 1 Dose of Study Drug|Overall Study||1033
2523383|NCT00699998|6183106|P1|Received at Least 1 Dose of Study Drug|Overall Study||3590
2523384|NCT00699998|6183103|P4|STARTED|Overall Study||1040
2523385|NCT00699998|6183104|P3|STARTED|Overall Study||3623
2523386|NCT00699998|6183105|P2|STARTED|Overall Study||1043
2523387|NCT00699998|6183106|P1|STARTED|Overall Study||3620
2523388|NCT00699972|6183151|P3|NOT COMPLETED|Overall Study||35
2523389|NCT00699972|6183152|P2|NOT COMPLETED|Overall Study||19
2523390|NCT00699972|6183153|P1|NOT COMPLETED|Overall Study||16
2523391|NCT00699972|6183151|P3|COMPLETED|Overall Study||100
2523392|NCT00699972|6183152|P2|COMPLETED|Overall Study||114
2523393|NCT00699972|6183153|P1|COMPLETED|Overall Study||106
2523394|NCT00699972|6183151|P3|STARTED|Overall Study||135
2523395|NCT00699972|6183152|P2|STARTED|Overall Study||133
2523396|NCT00699972|6183153|P1|STARTED|Overall Study||122
2523397|NCT00699907|6183170|P3|NOT COMPLETED|Overall Study||8
2523398|NCT00699907|6183171|P2|NOT COMPLETED|Overall Study||10
2523399|NCT00699907|6183172|P1|NOT COMPLETED|Overall Study||2
2523400|NCT00699907|6183170|P3|COMPLETED|Overall Study||48
2523401|NCT00699907|6183171|P2|COMPLETED|Overall Study||47
2523402|NCT00699907|6183172|P1|COMPLETED|Overall Study||12
2523403|NCT00699907|6183170|P3|STARTED|Overall Study||56
2523404|NCT00699907|6183171|P2|STARTED|Overall Study||57
2523405|NCT00699907|6183172|P1|STARTED|Overall Study||14
2523406|NCT00699842|6183207|P3|NOT COMPLETED|Overall Study||0
2523407|NCT00699842|6183208|P2|NOT COMPLETED|Overall Study||1
2523408|NCT00699842|6183209|P1|NOT COMPLETED|Overall Study||0
2523409|NCT00699842|6183207|P3|COMPLETED|Overall Study||0
2523410|NCT00699842|6183208|P2|COMPLETED|Overall Study||4
2523411|NCT00699842|6183209|P1|COMPLETED|Overall Study||3
2523412|NCT00699842|6183207|P3|STARTED|Overall Study||0
2523413|NCT00699842|6183208|P2|STARTED|Overall Study||5
2523414|NCT00699842|6183209|P1|STARTED|Overall Study||3
2523415|NCT00699816|6183222|P2|NOT COMPLETED|Overall Study||3
2523416|NCT00699816|6183223|P1|NOT COMPLETED|Overall Study||1
2523417|NCT00699816|6183222|P2|COMPLETED|Overall Study||112
2523418|NCT00699816|6183223|P1|COMPLETED|Overall Study||114
2523419|NCT00699816|6183222|P2|STARTED|Overall Study||115
2523420|NCT00699816|6183223|P1|STARTED|Overall Study||115
2523421|NCT00699751|6183241|P2|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||9
2523422|NCT00699751|6183242|P1|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||0
2523423|NCT00699751|6183241|P2|COMPLETED|Period 2:Switched From Placebo to Xofigo|Completed all 6 injections|17
2523424|NCT00699751|6183242|P1|COMPLETED|Period 2:Switched From Placebo to Xofigo||0
2523425|NCT00699751|6183241|P2|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
2523426|NCT00699751|6183242|P1|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
2523427|NCT00699751|6183241|P2|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||15
2523428|NCT00699751|6183242|P1|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
2523429|NCT00699751|6183241|P2|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||24
2523430|NCT00699751|6183242|P1|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||0
2523431|NCT00699751|6183241|P2|STARTED|Period 2:Switched From Placebo to Xofigo|Participants in the placebo group switched to Xofigo treatment|26
2523432|NCT00699751|6183242|P1|STARTED|Period 2:Switched From Placebo to Xofigo||0
2523433|NCT00699751|6183241|P2|NOT COMPLETED|Period 1: Without/Before Drug Switch||162
2523434|NCT00699751|6183242|P1|NOT COMPLETED|Period 1: Without/Before Drug Switch||225
2523435|NCT00699751|6183241|P2|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|145
2523436|NCT00699751|6183242|P1|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|389
2523437|NCT00699751|6183241|P2|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||12
2523438|NCT00699751|6183242|P1|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||49
2523439|NCT00699751|6183241|P2|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|168
2523440|NCT00699751|6183242|P1|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|407
2523441|NCT00699751|6183241|P2|Participants Received Treatment|Period 1: Without/Before Drug Switch||301
2523442|NCT00699751|6183242|P1|Participants Received Treatment|Period 1: Without/Before Drug Switch||600
2523443|NCT00699751|6183241|P2|STARTED|Period 1: Without/Before Drug Switch||307
2523444|NCT00699751|6183242|P1|STARTED|Period 1: Without/Before Drug Switch||614
2523445|NCT00699699|6183327|P1|NOT COMPLETED|Overall Study||57
2523446|NCT00699699|6183327|P1|COMPLETED|Overall Study||1223
2523447|NCT00699699|6183327|P1|STARTED|Overall Study||1280
2523448|NCT00699660|6183336|P2|NOT COMPLETED|Overall Study||8
2523449|NCT00699660|6183337|P1|NOT COMPLETED|Overall Study||14
2523450|NCT00699660|6183336|P2|COMPLETED|Overall Study||208
2523451|NCT00699660|6183337|P1|COMPLETED|Overall Study||176
2523452|NCT00699660|6183336|P2|STARTED|Overall Study||216
2523453|NCT00699660|6183337|P1|STARTED|Overall Study||190
2523454|NCT00699608|6183349|P6|NOT COMPLETED|Third Intervention||0
2523455|NCT00699608|6183350|P5|NOT COMPLETED|Third Intervention||0
2523456|NCT00699608|6183351|P4|NOT COMPLETED|Third Intervention||0
2523457|NCT00699608|6183352|P3|NOT COMPLETED|Third Intervention||0
2523458|NCT00699608|6183353|P2|NOT COMPLETED|Third Intervention||0
2523459|NCT00699608|6183354|P1|NOT COMPLETED|Third Intervention||0
2523460|NCT00699608|6183349|P6|COMPLETED|Third Intervention||15
2523461|NCT00699608|6183350|P5|COMPLETED|Third Intervention||14
2523462|NCT00699608|6183351|P4|COMPLETED|Third Intervention||14
2523463|NCT00699608|6183352|P3|COMPLETED|Third Intervention||13
2523464|NCT00699608|6183353|P2|COMPLETED|Third Intervention||15
2523465|NCT00699608|6183354|P1|COMPLETED|Third Intervention||16
2523466|NCT00699608|6183349|P6|STARTED|Third Intervention||15
2523467|NCT00699608|6183350|P5|STARTED|Third Intervention||14
2523468|NCT00699608|6183351|P4|STARTED|Third Intervention||14
2523469|NCT00699608|6183352|P3|STARTED|Third Intervention||13
2523470|NCT00699608|6183353|P2|STARTED|Third Intervention||15
2523471|NCT00699608|6183354|P1|STARTED|Third Intervention||16
2523472|NCT00699608|6183349|P6|NOT COMPLETED|Second 4-14 Day Washout Period||0
2523473|NCT00699608|6183350|P5|NOT COMPLETED|Second 4-14 Day Washout Period||0
2523474|NCT00699608|6183351|P4|NOT COMPLETED|Second 4-14 Day Washout Period||0
2523475|NCT00699608|6183352|P3|NOT COMPLETED|Second 4-14 Day Washout Period||0
2523476|NCT00699608|6183353|P2|NOT COMPLETED|Second 4-14 Day Washout Period||0
2523477|NCT00699608|6183354|P1|NOT COMPLETED|Second 4-14 Day Washout Period||0
2523478|NCT00699608|6183349|P6|COMPLETED|Second 4-14 Day Washout Period||15
2523479|NCT00699608|6183350|P5|COMPLETED|Second 4-14 Day Washout Period||14
2523480|NCT00699608|6183351|P4|COMPLETED|Second 4-14 Day Washout Period||14
2523481|NCT00699608|6183352|P3|COMPLETED|Second 4-14 Day Washout Period||13
2523482|NCT00699608|6183353|P2|COMPLETED|Second 4-14 Day Washout Period||15
2523483|NCT00699608|6183354|P1|COMPLETED|Second 4-14 Day Washout Period||16
2523484|NCT00699608|6183349|P6|STARTED|Second 4-14 Day Washout Period||15
2523485|NCT00699608|6183350|P5|STARTED|Second 4-14 Day Washout Period||14
2523486|NCT00699608|6183351|P4|STARTED|Second 4-14 Day Washout Period||14
2523487|NCT00699608|6183352|P3|STARTED|Second 4-14 Day Washout Period||13
2523488|NCT00699608|6183353|P2|STARTED|Second 4-14 Day Washout Period||15
2523489|NCT00699608|6183354|P1|STARTED|Second 4-14 Day Washout Period||16
2523490|NCT00699608|6183349|P6|NOT COMPLETED|Second Intervention||0
2523491|NCT00699608|6183350|P5|NOT COMPLETED|Second Intervention||0
2523492|NCT00699608|6183351|P4|NOT COMPLETED|Second Intervention||1
2523493|NCT00699608|6183352|P3|NOT COMPLETED|Second Intervention||1
2523494|NCT00699608|6183353|P2|NOT COMPLETED|Second Intervention||0
2523495|NCT00699608|6183354|P1|NOT COMPLETED|Second Intervention||0
2523496|NCT00699608|6183349|P6|COMPLETED|Second Intervention||15
2523497|NCT00699608|6183350|P5|COMPLETED|Second Intervention||14
2523498|NCT00699608|6183351|P4|COMPLETED|Second Intervention||14
2523499|NCT00699608|6183352|P3|COMPLETED|Second Intervention||13
2523500|NCT00699608|6183353|P2|COMPLETED|Second Intervention||15
2523501|NCT00699608|6183354|P1|COMPLETED|Second Intervention||16
2523502|NCT00699608|6183349|P6|STARTED|Second Intervention||15
2523503|NCT00699608|6183350|P5|STARTED|Second Intervention||14
2523504|NCT00699608|6183351|P4|STARTED|Second Intervention||15
2523505|NCT00699608|6183352|P3|STARTED|Second Intervention||14
2523506|NCT00699608|6183353|P2|STARTED|Second Intervention||15
2523507|NCT00699608|6183354|P1|STARTED|Second Intervention||16
2523508|NCT00699608|6183349|P6|NOT COMPLETED|First 4-14 Day Washout Period||0
2523509|NCT00699608|6183350|P5|NOT COMPLETED|First 4-14 Day Washout Period||0
2523510|NCT00699608|6183351|P4|NOT COMPLETED|First 4-14 Day Washout Period||0
2523511|NCT00699608|6183352|P3|NOT COMPLETED|First 4-14 Day Washout Period||0
2523512|NCT00699608|6183353|P2|NOT COMPLETED|First 4-14 Day Washout Period||0
2523513|NCT00699608|6183354|P1|NOT COMPLETED|First 4-14 Day Washout Period||0
2523514|NCT00699608|6183349|P6|COMPLETED|First 4-14 Day Washout Period||15
2523515|NCT00699608|6183350|P5|COMPLETED|First 4-14 Day Washout Period||14
2523516|NCT00699608|6183351|P4|COMPLETED|First 4-14 Day Washout Period||15
2523517|NCT00699608|6183352|P3|COMPLETED|First 4-14 Day Washout Period||14
2523518|NCT00699608|6183353|P2|COMPLETED|First 4-14 Day Washout Period||15
2523519|NCT00699608|6183354|P1|COMPLETED|First 4-14 Day Washout Period||16
2523520|NCT00699608|6183349|P6|STARTED|First 4-14 Day Washout Period||15
2523521|NCT00699608|6183350|P5|STARTED|First 4-14 Day Washout Period||14
2523522|NCT00699608|6183351|P4|STARTED|First 4-14 Day Washout Period||15
2523523|NCT00699608|6183352|P3|STARTED|First 4-14 Day Washout Period||14
2523524|NCT00699608|6183353|P2|STARTED|First 4-14 Day Washout Period||15
2523525|NCT00699608|6183354|P1|STARTED|First 4-14 Day Washout Period||16
2523526|NCT00699608|6183349|P6|NOT COMPLETED|First Intervention||0
2523527|NCT00699608|6183350|P5|NOT COMPLETED|First Intervention||1
2523528|NCT00699608|6183351|P4|NOT COMPLETED|First Intervention||0
2523529|NCT00699608|6183352|P3|NOT COMPLETED|First Intervention||1
2523530|NCT00699608|6183353|P2|NOT COMPLETED|First Intervention||0
2523531|NCT00699608|6183354|P1|NOT COMPLETED|First Intervention||0
2523532|NCT00699608|6183349|P6|COMPLETED|First Intervention||15
2523533|NCT00699608|6183350|P5|COMPLETED|First Intervention||14
2523534|NCT00699608|6183351|P4|COMPLETED|First Intervention||15
2523535|NCT00699608|6183352|P3|COMPLETED|First Intervention||14
2523536|NCT00699608|6183353|P2|COMPLETED|First Intervention||15
2523537|NCT00699608|6183354|P1|COMPLETED|First Intervention||16
2523538|NCT00699608|6183349|P6|STARTED|First Intervention||15
2523539|NCT00699608|6183350|P5|STARTED|First Intervention||15
2523540|NCT00699608|6183351|P4|STARTED|First Intervention||15
2523541|NCT00699608|6183352|P3|STARTED|First Intervention||15
2523542|NCT00699608|6183353|P2|STARTED|First Intervention||15
2523543|NCT00699608|6183354|P1|STARTED|First Intervention||16
2523544|NCT00699582|6183407|P3|NOT COMPLETED|Overall Study||28
2523545|NCT00699582|6183408|P2|NOT COMPLETED|Overall Study||22
2523546|NCT00699582|6183409|P1|NOT COMPLETED|Overall Study||18
2523547|NCT00699582|6183407|P3|COMPLETED|Overall Study||93
2523548|NCT00699582|6183408|P2|COMPLETED|Overall Study||108
2523549|NCT00699582|6183409|P1|COMPLETED|Overall Study||120
2523550|NCT00699582|6183407|P3|STARTED|Overall Study||121
2523551|NCT00699582|6183408|P2|STARTED|Overall Study||130
2523552|NCT00699582|6183409|P1|STARTED|Overall Study||138
2523553|NCT00699556|6183423|P2|NOT COMPLETED|Second Intervention (1 Day)||0
2523554|NCT00699556|6183424|P1|NOT COMPLETED|Second Intervention (1 Day)||0
2523555|NCT00699556|6183423|P2|COMPLETED|Second Intervention (1 Day)||11
2523556|NCT00699556|6183424|P1|COMPLETED|Second Intervention (1 Day)||11
2523557|NCT00699556|6183423|P2|STARTED|Second Intervention (1 Day)||11
2523558|NCT00699556|6183424|P1|STARTED|Second Intervention (1 Day)||11
2523559|NCT00699556|6183423|P2|NOT COMPLETED|First Intervention (1 Day)||0
2523560|NCT00699556|6183424|P1|NOT COMPLETED|First Intervention (1 Day)||0
2523561|NCT00699556|6183423|P2|COMPLETED|First Intervention (1 Day)||11
2523562|NCT00699556|6183424|P1|COMPLETED|First Intervention (1 Day)||11
2523563|NCT00699556|6183423|P2|STARTED|First Intervention (1 Day)||11
2523564|NCT00699556|6183424|P1|STARTED|First Intervention (1 Day)||11
2523565|NCT00699491|6183438|P6|NOT COMPLETED|Overall Study||0
2523566|NCT00699491|6183439|P5|NOT COMPLETED|Overall Study||0
2523567|NCT00699491|6183440|P4|NOT COMPLETED|Overall Study||0
2523568|NCT00699491|6183441|P3|NOT COMPLETED|Overall Study||0
2523569|NCT00699491|6183442|P2|NOT COMPLETED|Overall Study||0
2523570|NCT00699491|6183443|P1|NOT COMPLETED|Overall Study||0
2523571|NCT00699491|6183438|P6|COMPLETED|Overall Study||22
2523572|NCT00699491|6183439|P5|COMPLETED|Overall Study||8
2523573|NCT00699491|6183440|P4|COMPLETED|Overall Study||6
2523574|NCT00699491|6183441|P3|COMPLETED|Overall Study||7
2523575|NCT00699491|6183442|P2|COMPLETED|Overall Study||2
2523576|NCT00699491|6183443|P1|COMPLETED|Overall Study||3
2523577|NCT00699491|6183438|P6|STARTED|Overall Study||22
2523578|NCT00699491|6183439|P5|STARTED|Overall Study||8
2523579|NCT00699491|6183440|P4|STARTED|Overall Study||6
2523580|NCT00699491|6183441|P3|STARTED|Overall Study||7
2523581|NCT00699491|6183442|P2|STARTED|Overall Study||2
2523582|NCT00699491|6183443|P1|STARTED|Overall Study||3
2523583|NCT00699413|6183464|P2|NOT COMPLETED|Overall Study||4
2523584|NCT00699413|6183465|P1|NOT COMPLETED|Overall Study||4
2523585|NCT00699413|6183464|P2|COMPLETED|Overall Study||0
2523586|NCT00699413|6183465|P1|COMPLETED|Overall Study||0
2523587|NCT00699413|6183464|P2|STARTED|Overall Study||4
2523588|NCT00699413|6183465|P1|STARTED|Overall Study||4
2523589|NCT00699400|6183480|P6|NOT COMPLETED|Overall Study||11
2523590|NCT00699400|6183481|P5|NOT COMPLETED|Overall Study||0
2523591|NCT00699400|6183482|P4|NOT COMPLETED|Overall Study||0
2523592|NCT00699400|6183483|P3|NOT COMPLETED|Overall Study||0
2523593|NCT00699400|6183484|P2|NOT COMPLETED|Overall Study||0
2523594|NCT00699400|6183485|P1|NOT COMPLETED|Overall Study||0
2523595|NCT00699400|6183480|P6|COMPLETED|Overall Study||0
2523596|NCT00699400|6183481|P5|COMPLETED|Overall Study||4
2523597|NCT00699400|6183482|P4|COMPLETED|Overall Study||6
2523598|NCT00699400|6183483|P3|COMPLETED|Overall Study||138
2523599|NCT00699400|6183484|P2|COMPLETED|Overall Study||3
2523600|NCT00699400|6183485|P1|COMPLETED|Overall Study||42
2523601|NCT00699400|6183480|P6|STARTED|Overall Study||11
2523602|NCT00699400|6183481|P5|STARTED|Overall Study||4
2523603|NCT00699400|6183482|P4|STARTED|Overall Study||6
2523604|NCT00699400|6183483|P3|STARTED|Overall Study||138
2523605|NCT00699400|6183484|P2|STARTED|Overall Study||3
2523606|NCT00699400|6183485|P1|STARTED|Overall Study||42
2523607|NCT00699374|6183519|P2|NOT COMPLETED|Overall Study||544
2523608|NCT00699374|6183520|P1|NOT COMPLETED|Overall Study||530
2523609|NCT00699374|6183519|P2|COMPLETED|Overall Study||0
2523610|NCT00699374|6183520|P1|COMPLETED|Overall Study||0
2523611|NCT00699374|6183519|P2|Treated|Overall Study||542
2523612|NCT00699374|6183520|P1|Treated|Overall Study||526
2523613|NCT00699374|6183519|P2|STARTED|Overall Study||544
2523614|NCT00699374|6183520|P1|STARTED|Overall Study||530
2523615|NCT00699348|6183532|P1|NOT COMPLETED|Overall Study||90
2523616|NCT00699348|6183532|P1|COMPLETED|Overall Study||261
2523617|NCT00699348|6183532|P1|STARTED|Overall Study||351
2523618|NCT00699335|6183541|P1|NOT COMPLETED|Overall Study||228
2523619|NCT00699335|6183541|P1|COMPLETED|Overall Study||5080
2523620|NCT00699335|6183541|P1|STARTED|Overall Study||5308
2523621|NCT00699283|6183574|P2|NOT COMPLETED|Overall Study||8
2523622|NCT00699283|6183575|P1|NOT COMPLETED|Overall Study||33
2523623|NCT00699283|6183574|P2|COMPLETED|Overall Study||7
2523624|NCT00699283|6183575|P1|COMPLETED|Overall Study||14
2523625|NCT00699283|6183574|P2|STARTED|Overall Study||15
2523626|NCT00699283|6183575|P1|STARTED|Overall Study||47
2523627|NCT00699218|6183580|P1|NOT COMPLETED|Overall Study||0
2523628|NCT00699218|6183580|P1|COMPLETED|Overall Study||15
2523629|NCT00699218|6183580|P1|STARTED|Overall Study||15
2523630|NCT00699192|6183588|P3|NOT COMPLETED|Overall Study||11
2523631|NCT00699192|6183589|P2|NOT COMPLETED|Overall Study||12
2523632|NCT00699192|6183590|P1|NOT COMPLETED|Overall Study||16
2523633|NCT00699192|6183588|P3|COMPLETED|Overall Study||261
2523634|NCT00699192|6183589|P2|COMPLETED|Overall Study||260
2523635|NCT00699192|6183590|P1|COMPLETED|Overall Study||259
2523636|NCT00699192|6183588|P3|STARTED|Overall Study||272
2523637|NCT00699192|6183589|P2|STARTED|Overall Study||272
2523638|NCT00699192|6183590|P1|STARTED|Overall Study||275
2523639|NCT00699153|6183612|P2|NOT COMPLETED|Overall Study||2
2523640|NCT00699153|6183613|P1|NOT COMPLETED|Overall Study||3
2523641|NCT00699153|6183612|P2|COMPLETED|Overall Study||200
2523642|NCT00699153|6183613|P1|COMPLETED|Overall Study||200
2523643|NCT00699153|6183612|P2|STARTED|Overall Study|Intent to treat population|202
2523644|NCT00699153|6183613|P1|STARTED|Overall Study|Intent to treat population|203
2523645|NCT00699140|6183625|P1|NOT COMPLETED|Overall Study||0
2523646|NCT00699140|6183625|P1|COMPLETED|Overall Study||18
2523647|NCT00699140|6183625|P1|STARTED|Overall Study||18
2523648|NCT00699010|6183639|P2|NOT COMPLETED|Overall Study||0
2523649|NCT00699010|6183640|P1|NOT COMPLETED|Overall Study||0
2523650|NCT00699010|6183639|P2|COMPLETED|Overall Study||15
2523651|NCT00699010|6183640|P1|COMPLETED|Overall Study||15
2523652|NCT00699010|6183639|P2|STARTED|Overall Study||15
2523653|NCT00699010|6183640|P1|STARTED|Overall Study||15
2523660|NCT00698932|6183663|P2|NOT COMPLETED|Overall Study||36
2523661|NCT00698932|6183664|P1|NOT COMPLETED|Overall Study||22
2523662|NCT00698932|6183663|P2|COMPLETED|Overall Study|Completed 24 Weeks of treatment|248
2523663|NCT00698932|6183664|P1|COMPLETED|Overall Study|Completed 24 Weeks of treatment|262
2523664|NCT00698932|6183663|P2|STARTED|Overall Study|Randomized and treated|284
2523665|NCT00698932|6183664|P1|STARTED|Overall Study|Randomized and treated|284
2523666|NCT00698867|6183680|P1|NOT COMPLETED|Overall Study||91
2523667|NCT00698867|6183680|P1|COMPLETED|Overall Study||27
2523668|NCT00698867|6183680|P1|Subjects With 4 Year Data|Overall Study||34
2523669|NCT00698867|6183680|P1|Subjects With 3 Year Data|Overall Study||35
2523670|NCT00698867|6183680|P1|Subjects With 2 Year Data|Overall Study||55
2523671|NCT00698867|6183680|P1|Subjects With 1 Year Data|Overall Study||68
2523672|NCT00698867|6183680|P1|STARTED|Overall Study||118
2523673|NCT00698841|6183690|P1|NOT COMPLETED|Overall Study||18
2523674|NCT00698841|6183690|P1|COMPLETED|Overall Study||33
2523675|NCT00698841|6183690|P1|STARTED|Overall Study||51
2523676|NCT00698815|6183704|P3|NOT COMPLETED|Overall Study||10
2523677|NCT00698815|6183705|P2|NOT COMPLETED|Overall Study||14
2523678|NCT00698815|6183706|P1|NOT COMPLETED|Overall Study||10
2523679|NCT00698815|6183704|P3|COMPLETED|Overall Study||31
2523680|NCT00698815|6183705|P2|COMPLETED|Overall Study||33
2523681|NCT00698815|6183706|P1|COMPLETED|Overall Study||32
2523682|NCT00698815|6183704|P3|STARTED|Overall Study||41
2523683|NCT00698815|6183705|P2|STARTED|Overall Study||47
2523684|NCT00698815|6183706|P1|STARTED|Overall Study||42
2523685|NCT00698685|6183723|P1|NOT COMPLETED|Overall Study||2
2523686|NCT00698685|6183723|P1|COMPLETED|Overall Study||12
2523687|NCT00698685|6183723|P1|STARTED|Overall Study||14
2523688|NCT00698646|6183731|P3|NOT COMPLETED|Overall Study||29
2523689|NCT00698646|6183732|P2|NOT COMPLETED|Overall Study||31
2523690|NCT00698646|6183733|P1|NOT COMPLETED|Overall Study||36
2523691|NCT00698646|6183731|P3|COMPLETED|Overall Study||99
2523692|NCT00698646|6183732|P2|COMPLETED|Overall Study||97
2523693|NCT00698646|6183733|P1|COMPLETED|Overall Study||92
2523694|NCT00698646|6183731|P3|STARTED|Overall Study||128
2523695|NCT00698646|6183732|P2|STARTED|Overall Study||128
2523696|NCT00698646|6183733|P1|STARTED|Overall Study||128
2523697|NCT00698581|6183758|P2|NOT COMPLETED|Overall Study||12
2523698|NCT00698581|6183759|P1|NOT COMPLETED|Overall Study||45
2523699|NCT00698581|6183758|P2|COMPLETED|Overall Study||8
2523700|NCT00698581|6183759|P1|COMPLETED|Overall Study||23
2523701|NCT00698581|6183758|P2|STARTED|Overall Study||20
2523702|NCT00698581|6183759|P1|STARTED|Overall Study||68
2523703|NCT00698516|6183770|P1|NOT COMPLETED|Overall Study||5
2523704|NCT00698516|6183770|P1|COMPLETED|Overall Study||45
2523705|NCT00698516|6183770|P1|STARTED|Overall Study||50
2523706|NCT00698451|6183788|P1|NOT COMPLETED|Overall Study||39
2523707|NCT00698451|6183788|P1|COMPLETED|Overall Study||15
2523708|NCT00698451|6183788|P1|STARTED|Overall Study||54
2523709|NCT00698204|6183795|P2|NOT COMPLETED|Overall Study||0
2523710|NCT00698204|6183796|P1|NOT COMPLETED|Overall Study||1
2523711|NCT00698204|6183795|P2|COMPLETED|Overall Study||20
2523712|NCT00698204|6183796|P1|COMPLETED|Overall Study||19
2523713|NCT00698204|6183795|P2|STARTED|Overall Study||20
2523714|NCT00698204|6183796|P1|STARTED|Overall Study||20
2523715|NCT00698139|6183807|P3|NOT COMPLETED|Overall Study||0
2523716|NCT00698139|6183808|P2|NOT COMPLETED|Overall Study||0
2523717|NCT00698139|6183809|P1|NOT COMPLETED|Overall Study||0
2523718|NCT00698139|6183807|P3|COMPLETED|Overall Study||1
2523719|NCT00698139|6183808|P2|COMPLETED|Overall Study||1
2523720|NCT00698139|6183809|P1|COMPLETED|Overall Study||1
2523721|NCT00698139|6183807|P3|2nd Visit|Overall Study|1 subject in the Intervention Group did not have a 2nd visit (per design).|0
2523722|NCT00698139|6183808|P2|2nd Visit|Overall Study||1
2523723|NCT00698139|6183809|P1|2nd Visit|Overall Study||1
2523724|NCT00698139|6183807|P3|STARTED|Overall Study||1
2523725|NCT00698139|6183808|P2|STARTED|Overall Study||1
2523726|NCT00698139|6183809|P1|STARTED|Overall Study||1
2523727|NCT00698035|6183825|P2|NOT COMPLETED|Overall Study||2
2523728|NCT00698035|6183826|P1|NOT COMPLETED|Overall Study||4
2523729|NCT00698035|6183825|P2|COMPLETED|Overall Study||34
2523730|NCT00698035|6183826|P1|COMPLETED|Overall Study||35
2523731|NCT00698035|6183825|P2|STARTED|Overall Study||36
2523732|NCT00698035|6183826|P1|STARTED|Overall Study||39
2523733|NCT00698022|6183846|P3|NOT COMPLETED|Overall Study||2
2523734|NCT00698022|6183847|P2|NOT COMPLETED|Overall Study||10
2523735|NCT00698022|6183848|P1|NOT COMPLETED|Overall Study||16
2523736|NCT00698022|6183846|P3|COMPLETED|Overall Study||14
2523737|NCT00698022|6183847|P2|COMPLETED|Overall Study||20
2523738|NCT00698022|6183848|P1|COMPLETED|Overall Study||14
2523739|NCT00698022|6183846|P3|STARTED|Overall Study||16
2523740|NCT00698022|6183847|P2|STARTED|Overall Study||30
2523741|NCT00698022|6183848|P1|STARTED|Overall Study||30
2523742|NCT00698009|6183856|P1|NOT COMPLETED|Overall Study||1
2523743|NCT00698009|6183856|P1|COMPLETED|Overall Study||0
2523744|NCT00698009|6183856|P1|STARTED|Overall Study||1
2523745|NCT00697827|6183862|P2|NOT COMPLETED|Overall Study||1
2523746|NCT00697827|6183863|P1|NOT COMPLETED|Overall Study||2
2523747|NCT00697827|6183862|P2|COMPLETED|Overall Study||15
2523748|NCT00697827|6183863|P1|COMPLETED|Overall Study||26
2523749|NCT00697827|6183862|P2|STARTED|Overall Study||16
2523750|NCT00697827|6183863|P1|STARTED|Overall Study||28
2523751|NCT00697801|6183874|P3|NOT COMPLETED|Overall Study||24
2523752|NCT00697801|6183875|P2|NOT COMPLETED|Overall Study||12
2523753|NCT00697801|6183876|P1|NOT COMPLETED|Overall Study||12
2523754|NCT00697801|6183874|P3|COMPLETED|Overall Study||45
2523755|NCT00697801|6183875|P2|COMPLETED|Overall Study||58
2523756|NCT00697801|6183876|P1|COMPLETED|Overall Study||57
2523757|NCT00697801|6183874|P3|STARTED|Overall Study||69
2523758|NCT00697801|6183875|P2|STARTED|Overall Study||70
2523759|NCT00697801|6183876|P1|STARTED|Overall Study||69
2523760|NCT00697788|6183890|P8|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2523761|NCT00697788|6183891|P7|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2523762|NCT00697788|6183892|P6|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2523763|NCT00697788|6183893|P5|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2523764|NCT00697788|6183894|P4|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2523765|NCT00697788|6183895|P3|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2523766|NCT00697788|6183896|P2|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2523767|NCT00697788|6183897|P1|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2523768|NCT00697788|6183890|P8|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
2523769|NCT00697788|6183891|P7|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2523770|NCT00697788|6183892|P6|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2523771|NCT00697788|6183893|P5|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2523772|NCT00697788|6183894|P4|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2523773|NCT00697788|6183895|P3|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2523774|NCT00697788|6183896|P2|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2523775|NCT00697788|6183897|P1|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2523776|NCT00697788|6183890|P8|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
2523777|NCT00697788|6183891|P7|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2523778|NCT00697788|6183892|P6|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2523779|NCT00697788|6183893|P5|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2523780|NCT00697788|6183894|P4|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2523781|NCT00697788|6183895|P3|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2523782|NCT00697788|6183896|P2|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2523783|NCT00697788|6183897|P1|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
2523784|NCT00697788|6183890|P8|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2523785|NCT00697788|6183891|P7|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2523786|NCT00697788|6183892|P6|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2523787|NCT00697788|6183893|P5|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2523788|NCT00697788|6183894|P4|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2523789|NCT00697788|6183895|P3|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2523790|NCT00697788|6183896|P2|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2523791|NCT00697788|6183897|P1|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2523792|NCT00697788|6183890|P8|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2523793|NCT00697788|6183891|P7|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
2523794|NCT00697788|6183892|P6|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2523795|NCT00697788|6183893|P5|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2523796|NCT00697788|6183894|P4|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2523797|NCT00697788|6183895|P3|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2523798|NCT00697788|6183896|P2|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2523799|NCT00697788|6183897|P1|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2523800|NCT00697788|6183890|P8|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2523801|NCT00697788|6183891|P7|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
2523802|NCT00697788|6183892|P6|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2523803|NCT00697788|6183893|P5|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2523804|NCT00697788|6183894|P4|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2523805|NCT00697788|6183895|P3|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2523806|NCT00697788|6183896|P2|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2523807|NCT00697788|6183897|P1|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
2523808|NCT00697788|6183890|P8|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2523809|NCT00697788|6183891|P7|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2523810|NCT00697788|6183892|P6|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2523811|NCT00697788|6183893|P5|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2523812|NCT00697788|6183894|P4|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2523813|NCT00697788|6183895|P3|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2523814|NCT00697788|6183896|P2|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2523815|NCT00697788|6183897|P1|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2523816|NCT00697788|6183890|P8|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2523817|NCT00697788|6183891|P7|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2523818|NCT00697788|6183892|P6|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
2523819|NCT00697788|6183893|P5|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2523820|NCT00697788|6183894|P4|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2523821|NCT00697788|6183895|P3|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2523822|NCT00697788|6183896|P2|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2523823|NCT00697788|6183897|P1|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2523824|NCT00697788|6183890|P8|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2523825|NCT00697788|6183891|P7|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2523826|NCT00697788|6183892|P6|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
2523827|NCT00697788|6183893|P5|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2523828|NCT00697788|6183894|P4|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2523829|NCT00697788|6183895|P3|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2523830|NCT00697788|6183896|P2|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2523831|NCT00697788|6183897|P1|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
2523832|NCT00697788|6183890|P8|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2523833|NCT00697788|6183891|P7|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2523834|NCT00697788|6183892|P6|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2523835|NCT00697788|6183893|P5|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||1
2523836|NCT00697788|6183894|P4|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2523837|NCT00697788|6183895|P3|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2523838|NCT00697788|6183896|P2|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2523839|NCT00697788|6183897|P1|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2523840|NCT00697788|6183890|P8|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2523841|NCT00697788|6183891|P7|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2523842|NCT00697788|6183892|P6|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2523843|NCT00697788|6183893|P5|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||2
2523844|NCT00697788|6183894|P4|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2523845|NCT00697788|6183895|P3|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2523846|NCT00697788|6183896|P2|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2523847|NCT00697788|6183897|P1|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2523848|NCT00697788|6183890|P8|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2523849|NCT00697788|6183891|P7|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2523850|NCT00697788|6183892|P6|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2523851|NCT00697788|6183893|P5|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||3
2523852|NCT00697788|6183894|P4|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2523853|NCT00697788|6183895|P3|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2523854|NCT00697788|6183896|P2|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2523855|NCT00697788|6183897|P1|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
2523856|NCT00697788|6183890|P8|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2523857|NCT00697788|6183891|P7|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2523858|NCT00697788|6183892|P6|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2523859|NCT00697788|6183893|P5|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2523860|NCT00697788|6183894|P4|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2523861|NCT00697788|6183895|P3|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2523862|NCT00697788|6183896|P2|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2523863|NCT00697788|6183897|P1|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2523864|NCT00697788|6183890|P8|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2523865|NCT00697788|6183891|P7|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2523866|NCT00697788|6183892|P6|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2523867|NCT00697788|6183893|P5|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2523868|NCT00697788|6183894|P4|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
2523869|NCT00697788|6183895|P3|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2523870|NCT00697788|6183896|P2|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2523871|NCT00697788|6183897|P1|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2523872|NCT00697788|6183890|P8|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2523873|NCT00697788|6183891|P7|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2523874|NCT00697788|6183892|P6|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2523875|NCT00697788|6183893|P5|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2523876|NCT00697788|6183894|P4|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
2523877|NCT00697788|6183895|P3|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2523878|NCT00697788|6183896|P2|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2523879|NCT00697788|6183897|P1|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
2523880|NCT00697788|6183890|P8|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2523881|NCT00697788|6183891|P7|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2523882|NCT00697788|6183892|P6|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2523883|NCT00697788|6183893|P5|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2523884|NCT00697788|6183894|P4|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2523885|NCT00697788|6183895|P3|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2523886|NCT00697788|6183896|P2|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2523887|NCT00697788|6183897|P1|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2523888|NCT00697788|6183890|P8|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2523889|NCT00697788|6183891|P7|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2523890|NCT00697788|6183892|P6|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2523891|NCT00697788|6183893|P5|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2523892|NCT00697788|6183894|P4|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2523893|NCT00697788|6183895|P3|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||3
2523894|NCT00697788|6183896|P2|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2523895|NCT00697788|6183897|P1|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2523896|NCT00697788|6183890|P8|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2523897|NCT00697788|6183891|P7|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2523898|NCT00697788|6183892|P6|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2523899|NCT00697788|6183893|P5|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2523900|NCT00697788|6183894|P4|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2523901|NCT00697788|6183895|P3|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion|2 participants did not begin this infusion due to hypotension (MAP<50)|3
2523902|NCT00697788|6183896|P2|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2523903|NCT00697788|6183897|P1|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
2523904|NCT00697788|6183890|P8|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2523905|NCT00697788|6183891|P7|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2523906|NCT00697788|6183892|P6|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2523907|NCT00697788|6183893|P5|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2523908|NCT00697788|6183894|P4|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2523909|NCT00697788|6183895|P3|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2523910|NCT00697788|6183896|P2|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||2
2523911|NCT00697788|6183897|P1|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2523912|NCT00697788|6183890|P8|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2523913|NCT00697788|6183891|P7|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2523914|NCT00697788|6183892|P6|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2523915|NCT00697788|6183893|P5|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2523916|NCT00697788|6183894|P4|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2523917|NCT00697788|6183895|P3|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2523918|NCT00697788|6183896|P2|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||5
2523919|NCT00697788|6183897|P1|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2523920|NCT00697788|6183890|P8|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2523921|NCT00697788|6183891|P7|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2523922|NCT00697788|6183892|P6|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2523923|NCT00697788|6183893|P5|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2523924|NCT00697788|6183894|P4|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2523925|NCT00697788|6183895|P3|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2523926|NCT00697788|6183896|P2|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion|1 participant did not begin infusion due to hypotension (MAP<50)|7
2523927|NCT00697788|6183897|P1|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
2523928|NCT00697788|6183890|P8|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
2523929|NCT00697788|6183891|P7|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
2523930|NCT00697788|6183892|P6|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
2523931|NCT00697788|6183893|P5|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
2523932|NCT00697788|6183894|P4|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
2523933|NCT00697788|6183895|P3|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
2523934|NCT00697788|6183896|P2|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
2523935|NCT00697788|6183897|P1|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
2523936|NCT00697788|6183890|P8|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
2523937|NCT00697788|6183891|P7|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
2523938|NCT00697788|6183892|P6|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
2523939|NCT00697788|6183893|P5|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
2523940|NCT00697788|6183894|P4|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
2523941|NCT00697788|6183895|P3|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
2523942|NCT00697788|6183896|P2|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
2523943|NCT00697788|6183897|P1|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||8
2523944|NCT00697788|6183890|P8|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
2523945|NCT00697788|6183891|P7|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
2523946|NCT00697788|6183892|P6|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
2523947|NCT00697788|6183893|P5|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
2523948|NCT00697788|6183894|P4|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
2523949|NCT00697788|6183895|P3|STARTED|Dexmedetomidine Bolus 1 mcg/kg|2 participants did not begin the ascending (1.0 mcg/kg/hr) due to MAP<50|0
2523950|NCT00697788|6183896|P2|STARTED|Dexmedetomidine Bolus 1 mcg/kg|One participant did not begin infusion due to hypotension (mean pressure <50)|0
2523951|NCT00697788|6183897|P1|STARTED|Dexmedetomidine Bolus 1 mcg/kg||8
2523952|NCT00697697|6183941|P2|NOT COMPLETED|Overall Study||54
2523953|NCT00697697|6183942|P1|NOT COMPLETED|Overall Study||49
2523954|NCT00697697|6183941|P2|COMPLETED|Overall Study||44
2523955|NCT00697697|6183942|P1|COMPLETED|Overall Study||45
2523956|NCT00697697|6183941|P2|STARTED|Overall Study||98
2523957|NCT00697697|6183942|P1|STARTED|Overall Study||94
2523958|NCT00697619|6183952|P2|NOT COMPLETED|Overall Study||8
2523959|NCT00697619|6183953|P1|NOT COMPLETED|Overall Study||6
2523960|NCT00697619|6183952|P2|COMPLETED|Overall Study||22
2523961|NCT00697619|6183953|P1|COMPLETED|Overall Study||24
2523962|NCT00697619|6183952|P2|STARTED|Overall Study||30
2523963|NCT00697619|6183953|P1|STARTED|Overall Study||30
2523964|NCT00697593|6183959|P1|NOT COMPLETED|Overall Study||19
2523965|NCT00697593|6183959|P1|COMPLETED|Overall Study||51
2523966|NCT00697593|6183959|P1|STARTED|Overall Study||70
2523967|NCT00697541|6183992|P2|NOT COMPLETED|Overall Study||1
2523968|NCT00697541|6183993|P1|NOT COMPLETED|Overall Study||2
2523969|NCT00697541|6183992|P2|COMPLETED|Overall Study||9
2523970|NCT00697541|6183993|P1|COMPLETED|Overall Study||8
2523971|NCT00697541|6183992|P2|STARTED|Overall Study||10
2523972|NCT00697541|6183993|P1|STARTED|Overall Study||10
2523973|NCT00697515|6184003|P2|NOT COMPLETED|Second Intervention (Crossover Period)||1
2523974|NCT00697515|6184004|P1|NOT COMPLETED|Second Intervention (Crossover Period)||1
2523975|NCT00697515|6184003|P2|COMPLETED|Second Intervention (Crossover Period)||51
2523976|NCT00697515|6184004|P1|COMPLETED|Second Intervention (Crossover Period)||52
2523977|NCT00697515|6184003|P2|STARTED|Second Intervention (Crossover Period)||52
2523978|NCT00697515|6184004|P1|STARTED|Second Intervention (Crossover Period)||53
2523979|NCT00697515|6184003|P2|NOT COMPLETED|First Intervention (Crossover Period)||12
2523980|NCT00697515|6184004|P1|NOT COMPLETED|First Intervention (Crossover Period)||10
2523981|NCT00697515|6184003|P2|COMPLETED|First Intervention (Crossover Period)||52
2523982|NCT00697515|6184004|P1|COMPLETED|First Intervention (Crossover Period)||53
2523983|NCT00697515|6184003|P2|STARTED|First Intervention (Crossover Period)||64
2523984|NCT00697515|6184004|P1|STARTED|First Intervention (Crossover Period)||63
2523985|NCT00697515|6184003|P2|NOT COMPLETED|Dose Optimization Period||0
2523986|NCT00697515|6184004|P1|NOT COMPLETED|Dose Optimization Period||15
2523987|NCT00697515|6184003|P2|COMPLETED|Dose Optimization Period||0
2523988|NCT00697515|6184004|P1|COMPLETED|Dose Optimization Period||127
2523989|NCT00697515|6184003|P2|STARTED|Dose Optimization Period||0
2523990|NCT00697515|6184004|P1|STARTED|Dose Optimization Period||142
2523991|NCT00697463|6184032|P1|NOT COMPLETED|Overall Study||1
2523992|NCT00697463|6184032|P1|COMPLETED|Overall Study||21
2523993|NCT00697463|6184032|P1|STARTED|Overall Study||22
2523994|NCT00697346|6184039|P3|NOT COMPLETED|Overall Study||1
2523995|NCT00697346|6184040|P2|NOT COMPLETED|Overall Study||26
2523996|NCT00697346|6184041|P1|NOT COMPLETED|Overall Study||28
2523997|NCT00697346|6184039|P3|COMPLETED|Overall Study|1 participant was ongoing as of primary completion date 27 Dec 2011 and has now completed.|1
2523998|NCT00697346|6184040|P2|COMPLETED|Overall Study|2 participants were ongoing as of primary completion date 27 Dec 2011 and have now completed.|2
2523999|NCT00697346|6184041|P1|COMPLETED|Overall Study|Completed = participants who completed study treatment.|0
2524000|NCT00697346|6184039|P3|STARTED|Overall Study||2
2524001|NCT00697346|6184040|P2|STARTED|Overall Study||28
2524002|NCT00697346|6184041|P1|STARTED|Overall Study||28
2524003|NCT00697255|6184149|P2|NOT COMPLETED|Stage 1b||2
2524004|NCT00697255|6184150|P1|NOT COMPLETED|Stage 1b||0
2524005|NCT00697255|6184149|P2|COMPLETED|Stage 1b|Participants who completed 1b received hCG bolus injection and did not proceed further in the trial|1
2524006|NCT00697255|6184150|P1|COMPLETED|Stage 1b||0
2524007|NCT00697255|6184149|P2|STARTED|Stage 1b|After enrollment in Stage 1a completed, a new cohort of participants enrolled in Stage 1b.|3
2524008|NCT00697255|6184150|P1|STARTED|Stage 1b||0
2524009|NCT00697255|6184149|P2|NOT COMPLETED|Stage 1a||0
2524010|NCT00697255|6184150|P1|NOT COMPLETED|Stage 1a||3
2524011|NCT00697255|6184149|P2|COMPLETED|Stage 1a||0
2524012|NCT00697255|6184150|P1|COMPLETED|Stage 1a|Participants who completed 1a received hCG bolus injection and did not proceed further in the trial|2
2524013|NCT00697255|6184149|P2|STARTED|Stage 1a||0
2524014|NCT00697255|6184150|P1|STARTED|Stage 1a||5
2524015|NCT00697203|6184170|P4|NOT COMPLETED|Overall Study||7
2524016|NCT00697203|6184171|P3|NOT COMPLETED|Overall Study||8
2524017|NCT00697203|6184172|P2|NOT COMPLETED|Overall Study||6
2524018|NCT00697203|6184173|P1|NOT COMPLETED|Overall Study||9
2524019|NCT00697203|6184170|P4|COMPLETED|Overall Study||67
2524020|NCT00697203|6184171|P3|COMPLETED|Overall Study||66
2524021|NCT00697203|6184172|P2|COMPLETED|Overall Study||62
2524022|NCT00697203|6184173|P1|COMPLETED|Overall Study||67
2524023|NCT00697203|6184170|P4|STARTED|Overall Study||74
2524024|NCT00697203|6184171|P3|STARTED|Overall Study||74
2524025|NCT00697203|6184172|P2|STARTED|Overall Study||68
2524026|NCT00697203|6184173|P1|STARTED|Overall Study||76
2524027|NCT00697190|6184203|P2|NOT COMPLETED|Second Intervention||0
2524028|NCT00697190|6184204|P1|NOT COMPLETED|Second Intervention||0
2524029|NCT00697190|6184203|P2|COMPLETED|Second Intervention||20
2524030|NCT00697190|6184204|P1|COMPLETED|Second Intervention||18
2524031|NCT00697190|6184203|P2|STARTED|Second Intervention||20
2524032|NCT00697190|6184204|P1|STARTED|Second Intervention|one subject moved away between the first period and second period.|18
2524033|NCT00697190|6184203|P2|NOT COMPLETED|First Intervention||0
2524034|NCT00697190|6184204|P1|NOT COMPLETED|First Intervention||0
2524035|NCT00697190|6184203|P2|COMPLETED|First Intervention||20
2524036|NCT00697190|6184204|P1|COMPLETED|First Intervention||19
2524037|NCT00697190|6184203|P2|STARTED|First Intervention||20
2524038|NCT00697190|6184204|P1|STARTED|First Intervention||19
2524039|NCT00697112|6184238|P1|NOT COMPLETED|Overall Study||10
2524040|NCT00697112|6184238|P1|COMPLETED|Overall Study||43
2524041|NCT00697112|6184238|P1|Met the Inclusion Criteria|Overall Study||52
2524042|NCT00697112|6184238|P1|STARTED|Overall Study||53
2524043|NCT00697073|6184262|P1|NOT COMPLETED|Overall Study||9
2524044|NCT00697073|6184262|P1|COMPLETED|Overall Study||59
2524045|NCT00697073|6184262|P1|STARTED|Overall Study||68
2524046|NCT00696878|6184266|P1|NOT COMPLETED|Overall Study||504
2524047|NCT00696878|6184266|P1|COMPLETED|Overall Study||178
2524048|NCT00696878|6184266|P1|STARTED|Overall Study||682
2524049|NCT00696800|6184340|P2|NOT COMPLETED|Overall Study||48
2524050|NCT00696800|6184341|P1|NOT COMPLETED|Overall Study||85
2524051|NCT00696800|6184340|P2|COMPLETED|Overall Study|Participants who had embryos transferred|704
2524052|NCT00696800|6184341|P1|COMPLETED|Overall Study|Participants who had embryos transferred|672
2524053|NCT00696800|6184340|P2|Treated (ITT)|Overall Study|The ITT group|750
2524054|NCT00696800|6184341|P1|Treated (ITT)|Overall Study|The ITT group|756
2524055|NCT00696800|6184340|P2|STARTED|Overall Study||752
2524056|NCT00696800|6184341|P1|STARTED|Overall Study||757
2524057|NCT00696787|6184394|P3|NOT COMPLETED|Overall Study||26
2524058|NCT00696787|6184395|P2|NOT COMPLETED|Overall Study||20
2524059|NCT00696787|6184396|P1|NOT COMPLETED|Overall Study||15
2524060|NCT00696787|6184394|P3|COMPLETED|Overall Study||17
2524061|NCT00696787|6184395|P2|COMPLETED|Overall Study||22
2524062|NCT00696787|6184396|P1|COMPLETED|Overall Study||25
2524063|NCT00696787|6184394|P3|STARTED|Overall Study||43
2524064|NCT00696787|6184395|P2|STARTED|Overall Study||42
2524065|NCT00696787|6184396|P1|STARTED|Overall Study||40
2524066|NCT00696774|6184410|P3|NOT COMPLETED|Period III||0
2524067|NCT00696774|6184411|P2|NOT COMPLETED|Period III||7
2524068|NCT00696774|6184412|P1|NOT COMPLETED|Period III||7
2524069|NCT00696774|6184410|P3|COMPLETED|Period III||0
2524070|NCT00696774|6184411|P2|COMPLETED|Period III|82 participants were reported at Week 8; 81 completed Week 8 as 1 participant decided to withdraw.|81
2524071|NCT00696774|6184412|P1|COMPLETED|Period III||106
2524072|NCT00696774|6184410|P3|STARTED|Period III||0
2524073|NCT00696774|6184411|P2|STARTED|Period III|91 reported at Week 4; 88 start Period 3 (1 adverse event, 1 protocol violation, 1 lack of efficacy)|88
2524074|NCT00696774|6184412|P1|STARTED|Period III|115 reported at Week 4; 113 started Period 3 (1 lost to follow-up and 1 protocol violation).|113
2524075|NCT00696774|6184410|P3|NOT COMPLETED|Period II||36
2524076|NCT00696774|6184411|P2|NOT COMPLETED|Period II||0
2524077|NCT00696774|6184412|P1|NOT COMPLETED|Period II||0
2524078|NCT00696774|6184410|P3|COMPLETED|Period II||0
2524079|NCT00696774|6184411|P2|COMPLETED|Period II||91
2524080|NCT00696774|6184412|P1|COMPLETED|Period II||115
2524081|NCT00696774|6184410|P3|STARTED|Period II|1 participant did not receive study drug and was not included in the safety analyses.|36
2524082|NCT00696774|6184411|P2|STARTED|Period II||91
2524083|NCT00696774|6184412|P1|STARTED|Period II||115
2524084|NCT00696761|6184450|P4|NOT COMPLETED|Overall Study||10
2524085|NCT00696761|6184451|P3|NOT COMPLETED|Overall Study||11
2524086|NCT00696761|6184452|P2|NOT COMPLETED|Overall Study||26
2524087|NCT00696761|6184453|P1|NOT COMPLETED|Overall Study||20
2524088|NCT00696761|6184450|P4|COMPLETED|Overall Study||44
2524089|NCT00696761|6184451|P3|COMPLETED|Overall Study||30
2524090|NCT00696761|6184452|P2|COMPLETED|Overall Study||50
2524091|NCT00696761|6184453|P1|COMPLETED|Overall Study||41
2524092|NCT00696761|6184450|P4|STARTED|Overall Study||54
2524093|NCT00696761|6184451|P3|STARTED|Overall Study||41
2524094|NCT00696761|6184452|P2|STARTED|Overall Study||76
2524095|NCT00696761|6184453|P1|STARTED|Overall Study||61
2524096|NCT00696709|6184472|P5|NOT COMPLETED|Overall Study||3
2524097|NCT00696709|6184473|P4|NOT COMPLETED|Overall Study||5
2524098|NCT00696709|6184474|P3|NOT COMPLETED|Overall Study||1
2524099|NCT00696709|6184475|P2|NOT COMPLETED|Overall Study||3
2524100|NCT00696709|6184476|P1|NOT COMPLETED|Overall Study||3
2524101|NCT00696709|6184472|P5|COMPLETED|Overall Study||62
2524102|NCT00696709|6184473|P4|COMPLETED|Overall Study||59
2524103|NCT00696709|6184474|P3|COMPLETED|Overall Study||32
2524104|NCT00696709|6184475|P2|COMPLETED|Overall Study||60
2524105|NCT00696709|6184476|P1|COMPLETED|Overall Study||62
2524106|NCT00696709|6184472|P5|Vaccination 4 (~Day 90)|Overall Study||63
2524107|NCT00696709|6184473|P4|Vaccination 4 (~Day 90)|Overall Study||59
2524108|NCT00696709|6184474|P3|Vaccination 4 (~Day 90)|Overall Study||32
2524109|NCT00696709|6184475|P2|Vaccination 4 (~Day 90)|Overall Study||60
2524110|NCT00696709|6184476|P1|Vaccination 4 (~Day 90)|Overall Study||62
2524111|NCT00696709|6184472|P5|Vaccination 3 (~Day 60)|Overall Study||63
2524112|NCT00696709|6184473|P4|Vaccination 3 (~Day 60)|Overall Study||59
2524113|NCT00696709|6184474|P3|Vaccination 3 (~Day 60)|Overall Study||32
2524114|NCT00696709|6184475|P2|Vaccination 3 (~Day 60)|Overall Study||60
2524115|NCT00696709|6184476|P1|Vaccination 3 (~Day 60)|Overall Study||64
2524116|NCT00696709|6184472|P5|Vaccination 2 (~Day 30)|Overall Study||64
2524117|NCT00696709|6184473|P4|Vaccination 2 (~Day 30)|Overall Study||61
2524118|NCT00696709|6184474|P3|Vaccination 2 (~Day 30)|Overall Study||32
2524119|NCT00696709|6184475|P2|Vaccination 2 (~Day 30)|Overall Study||60
2524120|NCT00696709|6184476|P1|Vaccination 2 (~Day 30)|Overall Study||64
2524121|NCT00696709|6184472|P5|Vaccination 1 (Day 1)|Overall Study||65
2524122|NCT00696709|6184473|P4|Vaccination 1 (Day 1)|Overall Study||64
2524123|NCT00696709|6184474|P3|Vaccination 1 (Day 1)|Overall Study||32
2524124|NCT00696709|6184475|P2|Vaccination 1 (Day 1)|Overall Study||63
2524125|NCT00696709|6184476|P1|Vaccination 1 (Day 1)|Overall Study||65
2524126|NCT00696709|6184472|P5|STARTED|Overall Study||65
2524127|NCT00696709|6184473|P4|STARTED|Overall Study||64
2524128|NCT00696709|6184474|P3|STARTED|Overall Study||33
2524129|NCT00696709|6184475|P2|STARTED|Overall Study||63
2524130|NCT00696709|6184476|P1|STARTED|Overall Study||65
2524131|NCT00696696|6184512|P1|NOT COMPLETED|Overall Study||18
2524132|NCT00696696|6184512|P1|COMPLETED|Overall Study|number of patients off treatment due to progression of disease only|26
2524133|NCT00696696|6184512|P1|STARTED|Overall Study||44
2524134|NCT00696657|6184527|P9|NOT COMPLETED|Overall Study||9
2524135|NCT00696657|6184528|P8|NOT COMPLETED|Overall Study||3
2524136|NCT00696657|6184529|P7|NOT COMPLETED|Overall Study||15
2524137|NCT00696657|6184530|P6|NOT COMPLETED|Overall Study||12
2524138|NCT00696657|6184531|P5|NOT COMPLETED|Overall Study||10
2524139|NCT00696657|6184532|P4|NOT COMPLETED|Overall Study||11
2524140|NCT00696657|6184533|P3|NOT COMPLETED|Overall Study||8
2524141|NCT00696657|6184534|P2|NOT COMPLETED|Overall Study||5
2524142|NCT00696657|6184535|P1|NOT COMPLETED|Overall Study||1
2524143|NCT00696657|6184527|P9|COMPLETED|Overall Study||41
2524144|NCT00696657|6184528|P8|COMPLETED|Overall Study||42
2524145|NCT00696657|6184529|P7|COMPLETED|Overall Study||30
2524146|NCT00696657|6184530|P6|COMPLETED|Overall Study||33
2524147|NCT00696657|6184531|P5|COMPLETED|Overall Study||34
2524148|NCT00696657|6184532|P4|COMPLETED|Overall Study||38
2524149|NCT00696657|6184533|P3|COMPLETED|Overall Study||36
2524150|NCT00696657|6184534|P2|COMPLETED|Overall Study||42
2524151|NCT00696657|6184535|P1|COMPLETED|Overall Study||45
2524152|NCT00696657|6184527|P9|EXPOSED|Overall Study||50
2524153|NCT00696657|6184528|P8|EXPOSED|Overall Study||45
2524154|NCT00696657|6184529|P7|EXPOSED|Overall Study||45
2524155|NCT00696657|6184530|P6|EXPOSED|Overall Study||43
2524156|NCT00696657|6184531|P5|EXPOSED|Overall Study||44
2524157|NCT00696657|6184532|P4|EXPOSED|Overall Study||48
2524158|NCT00696657|6184533|P3|EXPOSED|Overall Study||43
2524159|NCT00696657|6184534|P2|EXPOSED|Overall Study||47
2524160|NCT00696657|6184535|P1|EXPOSED|Overall Study||46
2524161|NCT00696657|6184527|P9|STARTED|Overall Study||50
2524162|NCT00696657|6184528|P8|STARTED|Overall Study||45
2524163|NCT00696657|6184529|P7|STARTED|Overall Study||45
2524164|NCT00696657|6184530|P6|STARTED|Overall Study||45
2524165|NCT00696657|6184531|P5|STARTED|Overall Study||44
2524166|NCT00696657|6184532|P4|STARTED|Overall Study||49
2524167|NCT00696657|6184533|P3|STARTED|Overall Study||44
2524168|NCT00696657|6184534|P2|STARTED|Overall Study||47
2524169|NCT00696657|6184535|P1|STARTED|Overall Study||46
2524170|NCT00696618|6184862|P3|NOT COMPLETED|Overall Study||0
2524171|NCT00696618|6184863|P2|NOT COMPLETED|Overall Study||0
2524172|NCT00696618|6184864|P1|NOT COMPLETED|Overall Study||0
2524173|NCT00696618|6184862|P3|COMPLETED|Overall Study||3
2524174|NCT00696618|6184863|P2|COMPLETED|Overall Study||3
2524175|NCT00696618|6184864|P1|COMPLETED|Overall Study||3
2524176|NCT00696618|6184862|P3|STARTED|Overall Study||3
2524177|NCT00696618|6184863|P2|STARTED|Overall Study||3
2524178|NCT00696618|6184864|P1|STARTED|Overall Study||3
2524179|NCT00696488|6184878|P1|NOT COMPLETED|Overall Study||0
2524180|NCT00696488|6184878|P1|COMPLETED|Overall Study||20
2524181|NCT00696488|6184878|P1|STARTED|Overall Study||20
2524182|NCT00696449|6184886|P4|NOT COMPLETED|Overall Study||3
2524183|NCT00696449|6184887|P3|NOT COMPLETED|Overall Study||1
2524184|NCT00696449|6184888|P2|NOT COMPLETED|Overall Study||6
2524185|NCT00696449|6184889|P1|NOT COMPLETED|Overall Study||3
2524186|NCT00696449|6184886|P4|COMPLETED|Overall Study||13
2524187|NCT00696449|6184887|P3|COMPLETED|Overall Study||14
2524188|NCT00696449|6184888|P2|COMPLETED|Overall Study||9
2524189|NCT00696449|6184889|P1|COMPLETED|Overall Study||12
2524190|NCT00696449|6184886|P4|STARTED|Overall Study||16
2524191|NCT00696449|6184887|P3|STARTED|Overall Study||15
2524192|NCT00696449|6184888|P2|STARTED|Overall Study||15
2524193|NCT00696449|6184889|P1|STARTED|Overall Study||15
2524194|NCT00696436|6184904|P5|NOT COMPLETED|Overall Study||13
2524195|NCT00696436|6184905|P4|NOT COMPLETED|Overall Study||22
2524196|NCT00696436|6184906|P3|NOT COMPLETED|Overall Study||28
2524197|NCT00696436|6184907|P2|NOT COMPLETED|Overall Study||30
2524198|NCT00696436|6184908|P1|NOT COMPLETED|Overall Study||23
2524199|NCT00696436|6184904|P5|COMPLETED|Overall Study||141
2524200|NCT00696436|6184905|P4|COMPLETED|Overall Study||268
2524201|NCT00696436|6184906|P3|COMPLETED|Overall Study||254
2524202|NCT00696436|6184907|P2|COMPLETED|Overall Study||255
2524203|NCT00696436|6184908|P1|COMPLETED|Overall Study||257
2524204|NCT00696436|6184904|P5|STARTED|Overall Study|Randomized participants only.|154
2524205|NCT00696436|6184905|P4|STARTED|Overall Study|Randomized participants only.|290
2524206|NCT00696436|6184906|P3|STARTED|Overall Study|Randomized participants only.|282
2524207|NCT00696436|6184907|P2|STARTED|Overall Study|Randomized participants only. One participant treated but not randomized and is not included.|285
2524208|NCT00696436|6184908|P1|STARTED|Overall Study|Randomized participants only.|280
2524209|NCT00696423|6184992|P2|NOT COMPLETED|Overall Study||5
2524210|NCT00696423|6184993|P1|NOT COMPLETED|Overall Study||0
2524211|NCT00696423|6184992|P2|COMPLETED|Overall Study||218
2524212|NCT00696423|6184993|P1|COMPLETED|Overall Study||244
2524213|NCT00696423|6184992|P2|STARTED|Overall Study||223
2524214|NCT00696423|6184993|P1|STARTED|Overall Study||244
2524215|NCT00696410|6185025|P2|NOT COMPLETED|Overall Study||0
2524216|NCT00696410|6185026|P1|NOT COMPLETED|Overall Study||13
2524217|NCT00696410|6185025|P2|COMPLETED|Overall Study||10
2524218|NCT00696410|6185026|P1|COMPLETED|Overall Study||25
2524219|NCT00696410|6185025|P2|STARTED|Overall Study||10
2524220|NCT00696410|6185026|P1|STARTED|Overall Study||38
2524221|NCT00696384|6185040|P3|NOT COMPLETED|Double Blind Phase||6
2524222|NCT00696384|6185041|P2|NOT COMPLETED|Double Blind Phase||11
2524223|NCT00696384|6185042|P1|NOT COMPLETED|Double Blind Phase||0
2524224|NCT00696384|6185040|P3|COMPLETED|Double Blind Phase||145
2524225|NCT00696384|6185041|P2|COMPLETED|Double Blind Phase||137
2524226|NCT00696384|6185042|P1|COMPLETED|Double Blind Phase||0
2524227|NCT00696384|6185040|P3|STARTED|Double Blind Phase||151
2524228|NCT00696384|6185041|P2|STARTED|Double Blind Phase||148
2524229|NCT00696384|6185042|P1|STARTED|Double Blind Phase||0
2524230|NCT00696384|6185040|P3|NOT COMPLETED|Open Label Phase||0
2524231|NCT00696384|6185041|P2|NOT COMPLETED|Open Label Phase||0
2524232|NCT00696384|6185042|P1|NOT COMPLETED|Open Label Phase||119
2524233|NCT00696384|6185040|P3|COMPLETED|Open Label Phase||0
2524234|NCT00696384|6185041|P2|COMPLETED|Open Label Phase||0
2524235|NCT00696384|6185042|P1|COMPLETED|Open Label Phase||299
2524236|NCT00696384|6185040|P3|STARTED|Open Label Phase||0
2524237|NCT00696384|6185041|P2|STARTED|Open Label Phase||0
2524238|NCT00696384|6185042|P1|STARTED|Open Label Phase||418
2524239|NCT00696293|6185056|P1|NOT COMPLETED|Overall Study||2
2524240|NCT00696293|6185056|P1|COMPLETED|Overall Study||28
2524241|NCT00696293|6185056|P1|STARTED|Overall Study||30
2524242|NCT00696241|6185066|P5|NOT COMPLETED|Overall Study||12
2524243|NCT00696241|6185067|P4|NOT COMPLETED|Overall Study||14
2524244|NCT00696241|6185068|P3|NOT COMPLETED|Overall Study||24
2524245|NCT00696241|6185069|P2|NOT COMPLETED|Overall Study||22
2524246|NCT00696241|6185070|P1|NOT COMPLETED|Overall Study||24
2524247|NCT00696241|6185066|P5|COMPLETED|Overall Study||130
2524248|NCT00696241|6185067|P4|COMPLETED|Overall Study||268
2524249|NCT00696241|6185068|P3|COMPLETED|Overall Study||261
2524250|NCT00696241|6185069|P2|COMPLETED|Overall Study||261
2524251|NCT00696241|6185070|P1|COMPLETED|Overall Study||259
2524252|NCT00696241|6185066|P5|STARTED|Overall Study||142
2524253|NCT00696241|6185067|P4|STARTED|Overall Study||282
2524254|NCT00696241|6185068|P3|STARTED|Overall Study||285
2524255|NCT00696241|6185069|P2|STARTED|Overall Study||283
2524256|NCT00696241|6185070|P1|STARTED|Overall Study||283
2524257|NCT00696137|6185152|P1|NOT COMPLETED|Overall Study||2
2524258|NCT00696137|6185152|P1|COMPLETED|Overall Study||3
2524259|NCT00696137|6185152|P1|STARTED|Overall Study||5
2524260|NCT00696072|6185158|P2|NOT COMPLETED|Overall Study||63
2524261|NCT00696072|6185159|P1|NOT COMPLETED|Overall Study||57
2524262|NCT00696072|6185158|P2|COMPLETED|Overall Study||0
2524263|NCT00696072|6185159|P1|COMPLETED|Overall Study||0
2524264|NCT00696072|6185158|P2|STARTED|Overall Study||63
2524265|NCT00696072|6185159|P1|STARTED|Overall Study||57
2524266|NCT00696020|6185180|P4|NOT COMPLETED|Overall Study||4
2524267|NCT00696020|6185181|P3|NOT COMPLETED|Overall Study||3
2524268|NCT00696020|6185182|P2|NOT COMPLETED|Overall Study||2
2524269|NCT00696020|6185183|P1|NOT COMPLETED|Overall Study||4
2524270|NCT00696020|6185180|P4|COMPLETED|Overall Study||84
2524271|NCT00696020|6185181|P3|COMPLETED|Overall Study||90
2524272|NCT00696020|6185182|P2|COMPLETED|Overall Study||87
2524273|NCT00696020|6185183|P1|COMPLETED|Overall Study||86
2524274|NCT00696020|6185180|P4|STARTED|Overall Study||88
2524275|NCT00696020|6185181|P3|STARTED|Overall Study||93
2524276|NCT00696020|6185182|P2|STARTED|Overall Study||89
2524277|NCT00696020|6185183|P1|STARTED|Overall Study||90
2524278|NCT00695955|6185291|P1|NOT COMPLETED|Cohort 2||104
2524279|NCT00695955|6185291|P1|COMPLETED|Cohort 2||203
2524280|NCT00695955|6185291|P1|STARTED|Cohort 2||307
2524281|NCT00695955|6185291|P1|NOT COMPLETED|Cohort 1||102
2524282|NCT00695955|6185291|P1|COMPLETED|Cohort 1||260
2524283|NCT00695955|6185291|P1|STARTED|Cohort 1||362
2524284|NCT00695903|6185303|P2|NOT COMPLETED|Had Test of Cure (TOC) Assessment||1
2524285|NCT00695903|6185304|P1|NOT COMPLETED|Had Test of Cure (TOC) Assessment||2
2524286|NCT00695903|6185303|P2|COMPLETED|Had Test of Cure (TOC) Assessment||3
2524287|NCT00695903|6185304|P1|COMPLETED|Had Test of Cure (TOC) Assessment||5
2524288|NCT00695903|6185303|P2|STARTED|Had Test of Cure (TOC) Assessment||4
2524289|NCT00695903|6185304|P1|STARTED|Had Test of Cure (TOC) Assessment||7
2524290|NCT00695903|6185303|P2|NOT COMPLETED|Had End of Therapy (EOT) Assessment||15
2524291|NCT00695903|6185304|P1|NOT COMPLETED|Had End of Therapy (EOT) Assessment||12
2524292|NCT00695903|6185303|P2|COMPLETED|Had End of Therapy (EOT) Assessment||4
2524293|NCT00695903|6185304|P1|COMPLETED|Had End of Therapy (EOT) Assessment||7
2524294|NCT00695903|6185303|P2|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||6
2524295|NCT00695903|6185304|P1|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||9
2524296|NCT00695903|6185303|P2|STARTED|Had End of Therapy (EOT) Assessment||19
2524297|NCT00695903|6185304|P1|STARTED|Had End of Therapy (EOT) Assessment||19
2524298|NCT00695864|6185316|P1|NOT COMPLETED|Ondansetron||5
2524299|NCT00695864|6185316|P1|COMPLETED|Ondansetron||9
2524300|NCT00695864|6185316|P1|STARTED|Ondansetron||14
2524301|NCT00695864|6185316|P1|NOT COMPLETED|Placebo||5
2524302|NCT00695864|6185316|P1|COMPLETED|Placebo||9
2524303|NCT00695864|6185316|P1|STARTED|Placebo||14
2524304|NCT00695669|6185326|P4|NOT COMPLETED|Overall Study||4
2524305|NCT00695669|6185327|P3|NOT COMPLETED|Overall Study||3
2524306|NCT00695669|6185328|P2|NOT COMPLETED|Overall Study||4
2524307|NCT00695669|6185329|P1|NOT COMPLETED|Overall Study||4
2524308|NCT00695669|6185326|P4|COMPLETED|Overall Study||74
2524309|NCT00695669|6185327|P3|COMPLETED|Overall Study||75
2524310|NCT00695669|6185328|P2|COMPLETED|Overall Study||74
2524311|NCT00695669|6185329|P1|COMPLETED|Overall Study||74
2524312|NCT00695669|6185326|P4|STARTED|Overall Study||78
2524313|NCT00695669|6185327|P3|STARTED|Overall Study||78
2524314|NCT00695669|6185328|P2|STARTED|Overall Study||78
2524315|NCT00695669|6185329|P1|STARTED|Overall Study||78
2524316|NCT00695578|6185405|P2|NOT COMPLETED|Overall Study||0
2524317|NCT00695578|6185406|P1|NOT COMPLETED|Overall Study||0
2524318|NCT00695578|6185405|P2|COMPLETED|Overall Study||10
2524319|NCT00695578|6185406|P1|COMPLETED|Overall Study||10
2524320|NCT00695578|6185405|P2|STARTED|Overall Study||10
2524321|NCT00695578|6185406|P1|STARTED|Overall Study||10
2524322|NCT00695565|6185414|P2|NOT COMPLETED|Overall Study||9
2524323|NCT00695565|6185415|P1|NOT COMPLETED|Overall Study||13
2524324|NCT00695565|6185414|P2|COMPLETED|Overall Study||81
2524325|NCT00695565|6185415|P1|COMPLETED|Overall Study||77
2524326|NCT00695565|6185414|P2|STARTED|Overall Study||90
2524327|NCT00695565|6185415|P1|STARTED|Overall Study||90
2524328|NCT00695500|6185449|P2|NOT COMPLETED|Overall Study||5
2524329|NCT00695500|6185450|P1|NOT COMPLETED|Overall Study||3
2524330|NCT00695500|6185449|P2|COMPLETED|Overall Study||17
2524331|NCT00695500|6185450|P1|COMPLETED|Overall Study||21
2524332|NCT00695500|6185449|P2|STARTED|Overall Study||22
2524333|NCT00695500|6185450|P1|STARTED|Overall Study||24
2524334|NCT00695435|6185460|P3|NOT COMPLETED|Overall Study||0
2524335|NCT00695435|6185461|P2|NOT COMPLETED|Overall Study||0
2524336|NCT00695435|6185462|P1|NOT COMPLETED|Overall Study||0
2524337|NCT00695435|6185460|P3|COMPLETED|Overall Study||7
2524338|NCT00695435|6185461|P2|COMPLETED|Overall Study||7
2524339|NCT00695435|6185462|P1|COMPLETED|Overall Study||7
2524340|NCT00695435|6185460|P3|STARTED|Overall Study||7
2524341|NCT00695435|6185461|P2|STARTED|Overall Study||7
2524342|NCT00695435|6185462|P1|STARTED|Overall Study||7
2524343|NCT00695409|6185473|P1|NOT COMPLETED|Overall Study||0
2524344|NCT00695409|6185473|P1|COMPLETED|Overall Study||122
2524345|NCT00695409|6185473|P1|STARTED|Overall Study||122
2524346|NCT00695396|6185488|P3|NOT COMPLETED|Overall Study||8
2524347|NCT00695396|6185489|P2|NOT COMPLETED|Overall Study||8
2524348|NCT00695396|6185490|P1|NOT COMPLETED|Overall Study||7
2524349|NCT00695396|6185488|P3|COMPLETED|Overall Study||1
2524350|NCT00695396|6185489|P2|COMPLETED|Overall Study||0
2524351|NCT00695396|6185490|P1|COMPLETED|Overall Study||1
2524352|NCT00695396|6185488|P3|STARTED|Overall Study||9
2524353|NCT00695396|6185489|P2|STARTED|Overall Study||8
2524354|NCT00695396|6185490|P1|STARTED|Overall Study||8
2524355|NCT00695318|6185506|P2|NOT COMPLETED|Overall Study||1
2524356|NCT00695318|6185507|P1|NOT COMPLETED|Overall Study||5
2524357|NCT00695318|6185506|P2|COMPLETED|Overall Study||6
2524358|NCT00695318|6185507|P1|COMPLETED|Overall Study||5
2524359|NCT00695318|6185506|P2|STARTED|Overall Study||7
2524360|NCT00695318|6185507|P1|STARTED|Overall Study||10
2524361|NCT00695292|6185518|P1|NOT COMPLETED|Overall Study||0
2524362|NCT00695292|6185518|P1|COMPLETED|Overall Study||37
2524363|NCT00695292|6185518|P1|STARTED|Overall Study||37
2524364|NCT00695188|6185525|P2|NOT COMPLETED|Overall Study||0
2524365|NCT00695188|6185526|P1|NOT COMPLETED|Overall Study||0
2524366|NCT00695188|6185525|P2|COMPLETED|Overall Study||9
2524367|NCT00695188|6185526|P1|COMPLETED|Overall Study||10
2524368|NCT00695188|6185525|P2|STARTED|Overall Study||9
2524369|NCT00695188|6185526|P1|STARTED|Overall Study||10
2524370|NCT00695136|6185532|P1|NOT COMPLETED|Overall Study||2
2524371|NCT00695136|6185532|P1|COMPLETED|Overall Study||5
2524372|NCT00695136|6185532|P1|STARTED|Overall Study|7|7
2524373|NCT00695097|6185538|P2|NOT COMPLETED|Overall Study||0
2524374|NCT00695097|6185539|P1|NOT COMPLETED|Overall Study||1
2524375|NCT00695097|6185538|P2|COMPLETED|Overall Study||5
2524376|NCT00695097|6185539|P1|COMPLETED|Overall Study||9
2524377|NCT00695097|6185538|P2|STARTED|Overall Study||5
2524378|NCT00695097|6185539|P1|STARTED|Overall Study||10
2524379|NCT00695019|6185548|P3|NOT COMPLETED|Overall Study||10
2524380|NCT00695019|6185549|P2|NOT COMPLETED|Overall Study||14
2524381|NCT00695019|6185550|P1|NOT COMPLETED|Overall Study||13
2524382|NCT00695019|6185548|P3|COMPLETED|Overall Study||47
2524383|NCT00695019|6185549|P2|COMPLETED|Overall Study||39
2524384|NCT00695019|6185550|P1|COMPLETED|Overall Study||46
2524385|NCT00695019|6185548|P3|STARTED|Overall Study||57
2524386|NCT00695019|6185549|P2|STARTED|Overall Study||53
2524387|NCT00695019|6185550|P1|STARTED|Overall Study||59
2524388|NCT00694707|6185584|P5|NOT COMPLETED|Overall Study||40
2524389|NCT00694707|6185585|P4|NOT COMPLETED|Overall Study||50
2524390|NCT00694707|6185586|P3|NOT COMPLETED|Overall Study||51
2524391|NCT00694707|6185587|P2|NOT COMPLETED|Overall Study||55
2524392|NCT00694707|6185588|P1|NOT COMPLETED|Overall Study||72
2524393|NCT00694707|6185584|P5|COMPLETED|Overall Study||101
2524394|NCT00694707|6185585|P4|COMPLETED|Overall Study||98
2524395|NCT00694707|6185586|P3|COMPLETED|Overall Study||96
2524396|NCT00694707|6185587|P2|COMPLETED|Overall Study||90
2524397|NCT00694707|6185588|P1|COMPLETED|Overall Study||79
2524398|NCT00694707|6185584|P5|STARTED|Overall Study||141
2524399|NCT00694707|6185585|P4|STARTED|Overall Study||148
2524400|NCT00694707|6185586|P3|STARTED|Overall Study||147
2524401|NCT00694707|6185587|P2|STARTED|Overall Study||145
2524402|NCT00694707|6185588|P1|STARTED|Overall Study||151
2524403|NCT00694603|6185605|P1|NOT COMPLETED|Overall Study||0
2524404|NCT00694603|6185605|P1|COMPLETED|Overall Study||18
2524405|NCT00694603|6185605|P1|STARTED|Overall Study||18
2524406|NCT00694564|6185610|P1|NOT COMPLETED|Overall Study||2
2524407|NCT00694564|6185610|P1|COMPLETED|Overall Study||6
2524408|NCT00694564|6185610|P1|STARTED|Overall Study||8
2524409|NCT00694551|6185617|P3|NOT COMPLETED|Overall Study||1
2524410|NCT00694551|6185618|P2|NOT COMPLETED|Overall Study||0
2524411|NCT00694551|6185619|P1|NOT COMPLETED|Overall Study||1
2524412|NCT00694551|6185617|P3|COMPLETED|Overall Study||8
2524413|NCT00694551|6185618|P2|COMPLETED|Overall Study||10
2524414|NCT00694551|6185619|P1|COMPLETED|Overall Study||9
2524415|NCT00694551|6185617|P3|STARTED|Overall Study||9
2524416|NCT00694551|6185618|P2|STARTED|Overall Study||10
2524417|NCT00694551|6185619|P1|STARTED|Overall Study||10
2524418|NCT00694473|6185633|P1|NOT COMPLETED|Overall Study||7
2524419|NCT00694473|6185633|P1|COMPLETED|Overall Study|Dec 2010|69
2524420|NCT00694473|6185633|P1|STARTED|Overall Study|Aug 2008|76
2524421|NCT00694369|6185648|P5|NOT COMPLETED|Overall Study||6
2524422|NCT00694369|6185649|P4|NOT COMPLETED|Overall Study||3
2524423|NCT00694369|6185650|P3|NOT COMPLETED|Overall Study||2
2524424|NCT00694369|6185651|P2|NOT COMPLETED|Overall Study||3
2524425|NCT00694369|6185652|P1|NOT COMPLETED|Overall Study||1
2524426|NCT00694369|6185648|P5|COMPLETED|Overall Study||56
2524427|NCT00694369|6185649|P4|COMPLETED|Overall Study||189
2524428|NCT00694369|6185650|P3|COMPLETED|Overall Study||95
2524429|NCT00694369|6185651|P2|COMPLETED|Overall Study||188
2524430|NCT00694369|6185652|P1|COMPLETED|Overall Study||45
2524431|NCT00694369|6185648|P5|STARTED|Overall Study||62
2524432|NCT00694369|6185649|P4|STARTED|Overall Study||192
2524433|NCT00694369|6185650|P3|STARTED|Overall Study||97
2524434|NCT00694369|6185651|P2|STARTED|Overall Study||191
2524435|NCT00694369|6185652|P1|STARTED|Overall Study||46
2524436|NCT00694356|6185672|P3|NOT COMPLETED|Overall Study||6
2524437|NCT00694356|6185673|P2|NOT COMPLETED|Overall Study||6
2524438|NCT00694356|6185674|P1|NOT COMPLETED|Overall Study||3
2524439|NCT00694356|6185672|P3|COMPLETED|Overall Study||0
2524440|NCT00694356|6185673|P2|COMPLETED|Overall Study||0
2524441|NCT00694356|6185674|P1|COMPLETED|Overall Study||0
2524442|NCT00694356|6185672|P3|STARTED|Overall Study||6
2524443|NCT00694356|6185673|P2|STARTED|Overall Study||6
2524444|NCT00694356|6185674|P1|STARTED|Overall Study||3
2524445|NCT00694304|6185709|P1|NOT COMPLETED|Overall Study||207
2524446|NCT00694304|6185709|P1|COMPLETED|Overall Study||328
2524447|NCT00694304|6185709|P1|STARTED|Overall Study||535
2524448|NCT00694161|6185722|P1|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||3
2524449|NCT00694161|6185722|P1|COMPLETED|Part 2 (After Week 6 up to Month 12)||32
2524450|NCT00694161|6185722|P1|STARTED|Part 2 (After Week 6 up to Month 12)||35
2524451|NCT00694161|6185722|P1|NOT COMPLETED|Part 1 (up to Week 6)||0
2524452|NCT00694161|6185722|P1|COMPLETED|Part 1 (up to Week 6)||35
2524453|NCT00694161|6185722|P1|STARTED|Part 1 (up to Week 6)||35
2524454|NCT00694122|6185761|P2|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
2524455|NCT00694122|6185762|P1|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
2524456|NCT00694122|6185761|P2|COMPLETED|Second Intervention (3-4 Weeks)||5
2524457|NCT00694122|6185762|P1|COMPLETED|Second Intervention (3-4 Weeks)||10
2524458|NCT00694122|6185761|P2|STARTED|Second Intervention (3-4 Weeks)||5
2524459|NCT00694122|6185762|P1|STARTED|Second Intervention (3-4 Weeks)||10
2524460|NCT00694122|6185761|P2|NOT COMPLETED|Washout (1 Day)||0
2524461|NCT00694122|6185762|P1|NOT COMPLETED|Washout (1 Day)||0
2524462|NCT00694122|6185761|P2|COMPLETED|Washout (1 Day)||5
2524463|NCT00694122|6185762|P1|COMPLETED|Washout (1 Day)||10
2524464|NCT00694122|6185761|P2|STARTED|Washout (1 Day)||5
2524465|NCT00694122|6185762|P1|STARTED|Washout (1 Day)||10
2524466|NCT00694122|6185761|P2|NOT COMPLETED|First Intervention (3-4 Weeks)||2
2524467|NCT00694122|6185762|P1|NOT COMPLETED|First Intervention (3-4 Weeks)||10
2524468|NCT00694122|6185761|P2|COMPLETED|First Intervention (3-4 Weeks)||5
2524469|NCT00694122|6185762|P1|COMPLETED|First Intervention (3-4 Weeks)||10
2524470|NCT00694122|6185761|P2|STARTED|First Intervention (3-4 Weeks)|Started on NPH then on Lantus.|7
2524471|NCT00694122|6185762|P1|STARTED|First Intervention (3-4 Weeks)|Started Lantus then on NPH.|20
2524472|NCT00694109|6185778|P1|NOT COMPLETED|Overall Study||117
2524473|NCT00694109|6185778|P1|COMPLETED|Overall Study||25
2524474|NCT00694109|6185778|P1|Completed Consented Length of Treatment|Overall Study||60
2524475|NCT00694109|6185778|P1|Consented 2 Years Additional Treatment|Overall Study||42
2524476|NCT00694109|6185778|P1|Treated|Overall Study||141
2524477|NCT00694109|6185778|P1|STARTED|Overall Study|This does not include 2 patients from phase 2 trial with very different treatment experience.|142
2524478|NCT00694096|6185802|P1|NOT COMPLETED|Overall Study||5
2524479|NCT00694096|6185802|P1|COMPLETED|Overall Study||20
2524480|NCT00694096|6185802|P1|STARTED|Overall Study||25
2524481|NCT00694070|6185808|P1|NOT COMPLETED|Overall Study||0
2524482|NCT00694070|6185808|P1|COMPLETED|Overall Study||51
2524483|NCT00694070|6185808|P1|STARTED|Overall Study||51
2524484|NCT00694018|6185816|P2|NOT COMPLETED|Overall Study||9
2524485|NCT00694018|6185817|P1|NOT COMPLETED|Overall Study||13
2524486|NCT00694018|6185816|P2|COMPLETED|Overall Study||102
2524487|NCT00694018|6185817|P1|COMPLETED|Overall Study||105
2524488|NCT00694018|6185816|P2|6 Months|Overall Study||101
2524489|NCT00694018|6185817|P1|6 Months|Overall Study||106
2524490|NCT00694018|6185816|P2|STARTED|Overall Study||111
2524491|NCT00694018|6185817|P1|STARTED|Overall Study||118
2524492|NCT00693992|6185825|P2|NOT COMPLETED|Overall Study||0
2524493|NCT00693992|6185826|P1|NOT COMPLETED|Overall Study||0
2524494|NCT00693992|6185825|P2|COMPLETED|Overall Study||104
2524495|NCT00693992|6185826|P1|COMPLETED|Overall Study||106
2524496|NCT00693992|6185825|P2|STARTED|Overall Study||104
2524497|NCT00693992|6185826|P1|STARTED|Overall Study||106
2524498|NCT00693784|6185842|P1|NOT COMPLETED|Overall Study||4
2524499|NCT00693784|6185842|P1|COMPLETED|Overall Study||11
2524500|NCT00693784|6185842|P1|104-week Extended Follow-up|Overall Study||11
2524501|NCT00693784|6185842|P1|52-week Extended Follow-up|Overall Study||13
2524502|NCT00693784|6185842|P1|26-Week Primary Endpoint|Overall Study||15
2524503|NCT00693784|6185842|P1|STARTED|Overall Study||15
2524504|NCT00693719|6185848|P1|NOT COMPLETED|Overall Study||0
2524505|NCT00693719|6185848|P1|COMPLETED|Overall Study||31
2524506|NCT00693719|6185848|P1|STARTED|Overall Study||31
2524507|NCT00693706|6185855|P2|NOT COMPLETED|Overall Study||1
2524508|NCT00693706|6185856|P1|NOT COMPLETED|Overall Study||0
2524509|NCT00693706|6185855|P2|COMPLETED|Overall Study||98
2524510|NCT00693706|6185856|P1|COMPLETED|Overall Study||101
2524511|NCT00693706|6185855|P2|STARTED|Overall Study||99
2524512|NCT00693706|6185856|P1|STARTED|Overall Study||101
2524513|NCT00693693|6185883|P3|NOT COMPLETED|Overall Study||2
2524514|NCT00693693|6185884|P2|NOT COMPLETED|Overall Study||1
2524515|NCT00693693|6185885|P1|NOT COMPLETED|Overall Study||1
2524516|NCT00693693|6185883|P3|COMPLETED|Overall Study||7
2524517|NCT00693693|6185884|P2|COMPLETED|Overall Study||8
2524518|NCT00693693|6185885|P1|COMPLETED|Overall Study||6
2524519|NCT00693693|6185883|P3|STARTED|Overall Study||9
2524520|NCT00693693|6185884|P2|STARTED|Overall Study||9
2524521|NCT00693693|6185885|P1|STARTED|Overall Study||7
2524522|NCT00693654|6185895|P2|NOT COMPLETED|Overall Study||0
2524523|NCT00693654|6185896|P1|NOT COMPLETED|Overall Study||0
2524524|NCT00693654|6185895|P2|COMPLETED|Overall Study||14
2524525|NCT00693654|6185896|P1|COMPLETED|Overall Study||14
2524526|NCT00693654|6185895|P2|STARTED|Overall Study||14
2524527|NCT00693654|6185896|P1|STARTED|Overall Study||14
2524528|NCT00693628|6185906|P2|NOT COMPLETED|Overall Study||0
2524529|NCT00693628|6185907|P1|NOT COMPLETED|Overall Study||0
2524530|NCT00693628|6185906|P2|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment.|0
2524531|NCT00693628|6185907|P1|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment|0
2524532|NCT00693628|6185906|P2|STARTED|Overall Study|No data is available indicating to which group patients were assigned .|0
2524533|NCT00693628|6185907|P1|STARTED|Overall Study|No data is available indicating to which group patients were assigned.|0
2524534|NCT00693498|6185915|P2|NOT COMPLETED|Overall Study||0
2524535|NCT00693498|6185916|P1|NOT COMPLETED|Overall Study||0
2524536|NCT00693498|6185915|P2|COMPLETED|Overall Study||81
2524537|NCT00693498|6185916|P1|COMPLETED|Overall Study||81
2524538|NCT00693498|6185915|P2|STARTED|Overall Study||81
2524539|NCT00693498|6185916|P1|STARTED|Overall Study||81
2524540|NCT00693485|6185927|P3|NOT COMPLETED|Overall Study||0
2524541|NCT00693485|6185928|P2|NOT COMPLETED|Overall Study||2
2524542|NCT00693485|6185929|P1|NOT COMPLETED|Overall Study||0
2524543|NCT00693485|6185927|P3|COMPLETED|Overall Study||24
2524544|NCT00693485|6185928|P2|COMPLETED|Overall Study||19
2524545|NCT00693485|6185929|P1|COMPLETED|Overall Study||25
2524546|NCT00693485|6185927|P3|STARTED|Overall Study||24
2524547|NCT00693485|6185928|P2|STARTED|Overall Study||21
2524548|NCT00693485|6185929|P1|STARTED|Overall Study||25
2524549|NCT00693472|6185944|P4|NOT COMPLETED|Part 2||2
2524550|NCT00693472|6185945|P3|NOT COMPLETED|Part 2||2
2524551|NCT00693472|6185946|P2|NOT COMPLETED|Part 2||0
2524552|NCT00693472|6185947|P1|NOT COMPLETED|Part 2||0
2524553|NCT00693472|6185944|P4|COMPLETED|Part 2||4
2524554|NCT00693472|6185945|P3|COMPLETED|Part 2||6
2524555|NCT00693472|6185946|P2|COMPLETED|Part 2||0
2524556|NCT00693472|6185947|P1|COMPLETED|Part 2||0
2524557|NCT00693472|6185944|P4|STARTED|Part 2||6
2524558|NCT00693472|6185945|P3|STARTED|Part 2||8
2524559|NCT00693472|6185946|P2|STARTED|Part 2||0
2524560|NCT00693472|6185947|P1|STARTED|Part 2||0
2524561|NCT00693472|6185944|P4|NOT COMPLETED|Part 1||0
2524562|NCT00693472|6185945|P3|NOT COMPLETED|Part 1||0
2524563|NCT00693472|6185946|P2|NOT COMPLETED|Part 1||4
2524564|NCT00693472|6185947|P1|NOT COMPLETED|Part 1||6
2524565|NCT00693472|6185944|P4|COMPLETED|Part 1||0
2524566|NCT00693472|6185945|P3|COMPLETED|Part 1||0
2524567|NCT00693472|6185946|P2|COMPLETED|Part 1||9
2524568|NCT00693472|6185947|P1|COMPLETED|Part 1||13
2524569|NCT00693472|6185944|P4|STARTED|Part 1||0
2524570|NCT00693472|6185945|P3|STARTED|Part 1||0
2524571|NCT00693472|6185946|P2|STARTED|Part 1||13
2524572|NCT00693472|6185947|P1|STARTED|Part 1||19
2524573|NCT00693420|6185967|P2|NOT COMPLETED|Overall Study||15
2524574|NCT00693420|6185968|P1|NOT COMPLETED|Overall Study||6
2524575|NCT00693420|6185967|P2|COMPLETED|Overall Study||126
2524576|NCT00693420|6185968|P1|COMPLETED|Overall Study||131
2524577|NCT00693420|6185967|P2|STARTED|Overall Study||141
2524578|NCT00693420|6185968|P1|STARTED|Overall Study||137
2524579|NCT00693303|6185992|P1|NOT COMPLETED|Overall Study||0
2524580|NCT00693303|6185992|P1|COMPLETED|Overall Study||21
2524581|NCT00693303|6185992|P1|STARTED|Overall Study||21
2524582|NCT00693238|6185998|P2|NOT COMPLETED|Overall Study||0
2524583|NCT00693238|6185999|P1|NOT COMPLETED|Overall Study||0
2524584|NCT00693238|6185998|P2|COMPLETED|Overall Study||106
2524585|NCT00693238|6185999|P1|COMPLETED|Overall Study||122
2524586|NCT00693238|6185998|P2|STARTED|Overall Study||106
2524587|NCT00693238|6185999|P1|STARTED|Overall Study||122
2524588|NCT00693225|6186007|P2|NOT COMPLETED|Overall Study||5
2524589|NCT00693225|6186008|P1|NOT COMPLETED|Overall Study||2
2524590|NCT00693225|6186007|P2|COMPLETED|Overall Study||43
2524591|NCT00693225|6186008|P1|COMPLETED|Overall Study||41
2524592|NCT00693225|6186007|P2|STARTED|Overall Study||48
2524593|NCT00693225|6186008|P1|STARTED|Overall Study||43
2524594|NCT00693160|6186020|P2|NOT COMPLETED|Overall Study||0
2524595|NCT00693160|6186021|P1|NOT COMPLETED|Overall Study||0
2524596|NCT00693160|6186020|P2|COMPLETED|Overall Study||16
2524597|NCT00693160|6186021|P1|COMPLETED|Overall Study||14
2524598|NCT00693160|6186020|P2|STARTED|Overall Study||16
2524599|NCT00693160|6186021|P1|STARTED|Overall Study||14
2524600|NCT00693017|6186031|P2|NOT COMPLETED|Overall Study||2
2524601|NCT00693017|6186032|P1|NOT COMPLETED|Overall Study||2
2524602|NCT00693017|6186031|P2|COMPLETED|Overall Study||0
2524603|NCT00693017|6186032|P1|COMPLETED|Overall Study||0
2524604|NCT00693017|6186031|P2|STARTED|Overall Study||2
2524605|NCT00693017|6186032|P1|STARTED|Overall Study||2
2524606|NCT00692913|6186042|P2|NOT COMPLETED|Overall Study||30
2524607|NCT00692913|6186043|P1|NOT COMPLETED|Overall Study||29
2524608|NCT00692913|6186042|P2|COMPLETED|Overall Study||228
2524609|NCT00692913|6186043|P1|COMPLETED|Overall Study||228
2524610|NCT00692913|6186042|P2|STARTED|Overall Study||258
2524611|NCT00692913|6186043|P1|STARTED|Overall Study||257
2524612|NCT00692770|6186065|P2|NOT COMPLETED|Overall Study||558
2524613|NCT00692770|6186066|P1|NOT COMPLETED|Overall Study||556
2524614|NCT00692770|6186065|P2|COMPLETED|Overall Study||0
2524615|NCT00692770|6186066|P1|COMPLETED|Overall Study||0
2524616|NCT00692770|6186065|P2|Participants Received Treatment|Overall Study||554
2524617|NCT00692770|6186066|P1|Participants Received Treatment|Overall Study||553
2524618|NCT00692770|6186065|P2|STARTED|Overall Study||558
2524619|NCT00692770|6186066|P1|STARTED|Overall Study||556
2524620|NCT00692692|6186090|P2|NOT COMPLETED|Overall Study||0
2524621|NCT00692692|6186091|P1|NOT COMPLETED|Overall Study||0
2524622|NCT00692692|6186090|P2|COMPLETED|Overall Study||16
2524623|NCT00692692|6186091|P1|COMPLETED|Overall Study||20
2524624|NCT00692692|6186090|P2|STARTED|Overall Study||16
2524625|NCT00692692|6186091|P1|STARTED|Overall Study||20
2524626|NCT00692419|6186101|P2|NOT COMPLETED|Overall Study||18
2524627|NCT00692419|6186102|P1|NOT COMPLETED|Overall Study||16
2524628|NCT00692419|6186101|P2|COMPLETED|Overall Study||102
2524629|NCT00692419|6186102|P1|COMPLETED|Overall Study||84
2524630|NCT00692419|6186101|P2|STARTED|Overall Study||120
2524631|NCT00692419|6186102|P1|STARTED|Overall Study||100
2524632|NCT00692406|6186112|P1|NOT COMPLETED|Overall Study||57
2524633|NCT00692406|6186112|P1|COMPLETED|Overall Study|This group quit smoking before their second scan.|23
2524634|NCT00692406|6186112|P1|STARTED|Overall Study|Initially this group was assigned to quit smoking before the second scan.|80
2524635|NCT00692341|6186126|P3|NOT COMPLETED|Overall Study||0
2524636|NCT00692341|6186127|P2|NOT COMPLETED|Overall Study||0
2524637|NCT00692341|6186128|P1|NOT COMPLETED|Overall Study||0
2524638|NCT00692341|6186126|P3|COMPLETED|Overall Study||8
2524639|NCT00692341|6186127|P2|COMPLETED|Overall Study||8
2524640|NCT00692341|6186128|P1|COMPLETED|Overall Study||8
2524641|NCT00692341|6186126|P3|STARTED|Overall Study||8
2524642|NCT00692341|6186127|P2|STARTED|Overall Study||8
2524643|NCT00692341|6186128|P1|STARTED|Overall Study||8
2524644|NCT00692237|6186174|P2|NOT COMPLETED|Overall Study||4
2524645|NCT00692237|6186175|P1|NOT COMPLETED|Overall Study||1
2524646|NCT00692237|6186174|P2|COMPLETED|Overall Study||25
2524647|NCT00692237|6186175|P1|COMPLETED|Overall Study||29
2524648|NCT00692237|6186174|P2|STARTED|Overall Study||29
2524649|NCT00692237|6186175|P1|STARTED|Overall Study||30
2524650|NCT00692211|6186185|P2|NOT COMPLETED|Overall Study||0
2524651|NCT00692211|6186186|P1|NOT COMPLETED|Overall Study||0
2524652|NCT00692211|6186185|P2|COMPLETED|Overall Study||202
2524653|NCT00692211|6186186|P1|COMPLETED|Overall Study||202
2524654|NCT00692211|6186185|P2|STARTED|Overall Study||202
2524655|NCT00692211|6186186|P1|STARTED|Overall Study||202
2524656|NCT00692198|6186194|P2|NOT COMPLETED|Overall Study||0
2524657|NCT00692198|6186195|P1|NOT COMPLETED|Overall Study||0
2524658|NCT00692198|6186194|P2|COMPLETED|Overall Study||370
2524659|NCT00692198|6186195|P1|COMPLETED|Overall Study||368
2524660|NCT00692198|6186194|P2|STARTED|Overall Study||370
2524661|NCT00692198|6186195|P1|STARTED|Overall Study||368
2524662|NCT00692185|6186230|P2|NOT COMPLETED|Overall Study||3
2524663|NCT00692185|6186231|P1|NOT COMPLETED|Overall Study||3
2524664|NCT00692185|6186230|P2|COMPLETED|Overall Study||9
2524665|NCT00692185|6186231|P1|COMPLETED|Overall Study||8
2524666|NCT00692185|6186230|P2|STARTED|Overall Study||12
2524667|NCT00692185|6186231|P1|STARTED|Overall Study||11
2524668|NCT00692094|6186243|P4|NOT COMPLETED|Overall Study||0
2524669|NCT00692094|6186244|P3|NOT COMPLETED|Overall Study||0
2524670|NCT00692094|6186245|P2|NOT COMPLETED|Overall Study||0
2524671|NCT00692094|6186246|P1|NOT COMPLETED|Overall Study||0
2524672|NCT00692094|6186243|P4|COMPLETED|Overall Study||0
2524673|NCT00692094|6186244|P3|COMPLETED|Overall Study||0
2524674|NCT00692094|6186245|P2|COMPLETED|Overall Study||0
2524675|NCT00692094|6186246|P1|COMPLETED|Overall Study||0
2524676|NCT00692094|6186243|P4|STARTED|Overall Study||0
2524677|NCT00692094|6186244|P3|STARTED|Overall Study||0
2524678|NCT00692094|6186245|P2|STARTED|Overall Study||0
2524679|NCT00692094|6186246|P1|STARTED|Overall Study||0
2524680|NCT00692003|6186262|P2|NOT COMPLETED|Overall Study||1
2524681|NCT00692003|6186263|P1|NOT COMPLETED|Overall Study||5
2524682|NCT00692003|6186262|P2|COMPLETED|Overall Study||0
2524683|NCT00692003|6186263|P1|COMPLETED|Overall Study||0
2524684|NCT00692003|6186262|P2|STARTED|Overall Study||1
2524685|NCT00692003|6186263|P1|STARTED|Overall Study||5
2524686|NCT00691938|6186278|P7|NOT COMPLETED|Overall Study||0
2524687|NCT00691938|6186279|P6|NOT COMPLETED|Overall Study||0
2524688|NCT00691938|6186280|P5|NOT COMPLETED|Overall Study||0
2524689|NCT00691938|6186281|P4|NOT COMPLETED|Overall Study||0
2524690|NCT00691938|6186282|P3|NOT COMPLETED|Overall Study||0
2524691|NCT00691938|6186283|P2|NOT COMPLETED|Overall Study||0
2524692|NCT00691938|6186284|P1|NOT COMPLETED|Overall Study||1
2524693|NCT00691938|6186278|P7|COMPLETED|Overall Study||14
2524694|NCT00691938|6186279|P6|COMPLETED|Overall Study||6
2524695|NCT00691938|6186280|P5|COMPLETED|Overall Study||10
2524696|NCT00691938|6186281|P4|COMPLETED|Overall Study||8
2524697|NCT00691938|6186282|P3|COMPLETED|Overall Study||6
2524698|NCT00691938|6186283|P2|COMPLETED|Overall Study||3
2524699|NCT00691938|6186284|P1|COMPLETED|Overall Study||4
2524700|NCT00691938|6186278|P7|STARTED|Overall Study||14
2524701|NCT00691938|6186279|P6|STARTED|Overall Study||6
2524702|NCT00691938|6186280|P5|STARTED|Overall Study||10
2524703|NCT00691938|6186281|P4|STARTED|Overall Study||8
2524704|NCT00691938|6186282|P3|STARTED|Overall Study||6
2524705|NCT00691938|6186283|P2|STARTED|Overall Study||3
2524706|NCT00691938|6186284|P1|STARTED|Overall Study||5
2524707|NCT00691808|6186308|P3|NOT COMPLETED|Overall Study||0
2524708|NCT00691808|6186309|P2|NOT COMPLETED|Overall Study||1
2524709|NCT00691808|6186310|P1|NOT COMPLETED|Overall Study||0
2524710|NCT00691808|6186308|P3|COMPLETED|Overall Study||32
2524711|NCT00691808|6186309|P2|COMPLETED|Overall Study||35
2524712|NCT00691808|6186310|P1|COMPLETED|Overall Study||35
2524713|NCT00691808|6186308|P3|STARTED|Overall Study||32
2524714|NCT00691808|6186309|P2|STARTED|Overall Study||36
2524715|NCT00691808|6186310|P1|STARTED|Overall Study||35
2524716|NCT00691704|6186351|P1|NOT COMPLETED|Two Years of Maintenance Therapy||13
2524717|NCT00691704|6186351|P1|COMPLETED|Two Years of Maintenance Therapy||3
2524718|NCT00691704|6186351|P1|STARTED|Two Years of Maintenance Therapy||16
2524719|NCT00691704|6186351|P1|NOT COMPLETED|Induction Therapy||2
2524720|NCT00691704|6186351|P1|COMPLETED|Induction Therapy||16
2524721|NCT00691704|6186351|P1|STARTED|Induction Therapy||18
2524722|NCT00691665|6186361|P2|NOT COMPLETED|Overall Study||0
2524723|NCT00691665|6186362|P1|NOT COMPLETED|Overall Study||0
2524724|NCT00691665|6186361|P2|COMPLETED|Overall Study||65
2524725|NCT00691665|6186362|P1|COMPLETED|Overall Study||65
2524726|NCT00691665|6186361|P2|STARTED|Overall Study||65
2524727|NCT00691665|6186362|P1|STARTED|Overall Study||65
2524728|NCT00691652|6186374|P1|NOT COMPLETED|Overall Study||1
2524729|NCT00691652|6186374|P1|COMPLETED|Overall Study||1
2524730|NCT00691652|6186374|P1|STARTED|Overall Study||2
2524731|NCT00691574|6186386|P2|NOT COMPLETED|Overall Study||0
2524732|NCT00691574|6186387|P1|NOT COMPLETED|Overall Study||0
2524733|NCT00691574|6186386|P2|COMPLETED|Overall Study||0
2524734|NCT00691574|6186387|P1|COMPLETED|Overall Study||0
2524735|NCT00691574|6186386|P2|STARTED|Overall Study||0
2524736|NCT00691574|6186387|P1|STARTED|Overall Study||0
2524737|NCT00691483|6186399|P2|NOT COMPLETED|Overall Study||25
2524738|NCT00691483|6186400|P1|NOT COMPLETED|Overall Study||68
2524739|NCT00691483|6186399|P2|COMPLETED|Overall Study||141
2524740|NCT00691483|6186400|P1|COMPLETED|Overall Study|Completed refers to completion of the study.|425
2524741|NCT00691483|6186399|P2|Received Treatment|Overall Study||165
2524742|NCT00691483|6186400|P1|Received Treatment|Overall Study||486
2524743|NCT00691483|6186399|P2|STARTED|Overall Study||166
2524744|NCT00691483|6186400|P1|STARTED|Overall Study||493
2524745|NCT00691444|6186419|P3|NOT COMPLETED|Overall Study||0
2524746|NCT00691444|6186420|P2|NOT COMPLETED|Overall Study||0
2524747|NCT00691444|6186421|P1|NOT COMPLETED|Overall Study||0
2524748|NCT00691444|6186419|P3|COMPLETED|Overall Study||0
2524749|NCT00691444|6186420|P2|COMPLETED|Overall Study||0
2524750|NCT00691444|6186421|P1|COMPLETED|Overall Study||0
2524751|NCT00691444|6186419|P3|STARTED|Overall Study||0
2524752|NCT00691444|6186420|P2|STARTED|Overall Study||0
2524753|NCT00691444|6186421|P1|STARTED|Overall Study||0
2524754|NCT00691327|6186434|P2|NOT COMPLETED|Overall Study||2508
2524755|NCT00691327|6186435|P1|NOT COMPLETED|Overall Study||2841
2524756|NCT00691327|6186434|P2|COMPLETED|Overall Study||36766
2524757|NCT00691327|6186435|P1|COMPLETED|Overall Study||42214
2524758|NCT00691327|6186434|P2|STARTED|Overall Study||39274
2524759|NCT00691327|6186435|P1|STARTED|Overall Study||45055
2524760|NCT00691301|6186443|P1|NOT COMPLETED|Overall Study||54
2524761|NCT00691301|6186443|P1|COMPLETED|Overall Study||1
2524762|NCT00691301|6186443|P1|STARTED|Overall Study||55
2524763|NCT00691210|6186463|P8|NOT COMPLETED|Overall Study||0
2524764|NCT00691210|6186464|P7|NOT COMPLETED|Overall Study||0
2524765|NCT00691210|6186465|P6|NOT COMPLETED|Overall Study||1
2524766|NCT00691210|6186466|P5|NOT COMPLETED|Overall Study||0
2524767|NCT00691210|6186467|P4|NOT COMPLETED|Overall Study||3
2524768|NCT00691210|6186468|P3|NOT COMPLETED|Overall Study||0
2524769|NCT00691210|6186469|P2|NOT COMPLETED|Overall Study||0
2524770|NCT00691210|6186470|P1|NOT COMPLETED|Overall Study||0
2524771|NCT00691210|6186463|P8|COMPLETED|Overall Study||0
2524772|NCT00691210|6186464|P7|COMPLETED|Overall Study||6
2524773|NCT00691210|6186465|P6|COMPLETED|Overall Study||6
2524774|NCT00691210|6186466|P5|COMPLETED|Overall Study||5
2524775|NCT00691210|6186467|P4|COMPLETED|Overall Study||6
2524776|NCT00691210|6186468|P3|COMPLETED|Overall Study||3
2524777|NCT00691210|6186469|P2|COMPLETED|Overall Study||5
2524778|NCT00691210|6186470|P1|COMPLETED|Overall Study||3
2524779|NCT00691210|6186463|P8|STARTED|Overall Study||0
2524780|NCT00691210|6186464|P7|STARTED|Overall Study||6
2524781|NCT00691210|6186465|P6|STARTED|Overall Study||7
2524782|NCT00691210|6186466|P5|STARTED|Overall Study||5
2524783|NCT00691210|6186467|P4|STARTED|Overall Study||9
2524784|NCT00691210|6186468|P3|STARTED|Overall Study||3
2524785|NCT00691210|6186469|P2|STARTED|Overall Study||5
2524786|NCT00691210|6186470|P1|STARTED|Overall Study||3
2524787|NCT00691197|6186490|P2|NOT COMPLETED|Overall Study||5
2524788|NCT00691197|6186491|P1|NOT COMPLETED|Overall Study||11
2524789|NCT00691197|6186490|P2|COMPLETED|Overall Study||75
2524790|NCT00691197|6186491|P1|COMPLETED|Overall Study||155
2524791|NCT00691197|6186490|P2|STARTED|Overall Study||80
2524792|NCT00691197|6186491|P1|STARTED|Overall Study||166
2524793|NCT00691132|6186505|P2|NOT COMPLETED|Overall Study||13
2524794|NCT00691132|6186506|P1|NOT COMPLETED|Overall Study||12
2524795|NCT00691132|6186505|P2|COMPLETED|Overall Study|45 completed, but 4 excluded b/c urinary measures indicated they did not smoke study cigarettes.|41
2524796|NCT00691132|6186506|P1|COMPLETED|Overall Study||41
2524797|NCT00691132|6186505|P2|STARTED|Overall Study|107 total randomized. Approximately 1/2 per arm.|54
2524798|NCT00691132|6186506|P1|STARTED|Overall Study||53
2524799|NCT00691093|6186525|P1|NOT COMPLETED|Overall Study||7
2524800|NCT00691093|6186525|P1|COMPLETED|Overall Study||816
2524801|NCT00691093|6186525|P1|STARTED|Overall Study||823
2524802|NCT00691054|6186559|P1|NOT COMPLETED|Overall Study||1
2524803|NCT00691054|6186559|P1|COMPLETED|Overall Study||19
2524804|NCT00691054|6186559|P1|STARTED|Overall Study||20
2524805|NCT00691028|6186571|P4|NOT COMPLETED|Double-blind Period||0
2524806|NCT00691028|6186572|P3|NOT COMPLETED|Double-blind Period||9
2524807|NCT00691028|6186573|P2|NOT COMPLETED|Double-blind Period||13
2524808|NCT00691028|6186574|P1|NOT COMPLETED|Double-blind Period||13
2524809|NCT00691028|6186571|P4|COMPLETED|Double-blind Period||0
2524810|NCT00691028|6186572|P3|COMPLETED|Double-blind Period||95
2524811|NCT00691028|6186573|P2|COMPLETED|Double-blind Period||91
2524812|NCT00691028|6186574|P1|COMPLETED|Double-blind Period||86
2524813|NCT00691028|6186571|P4|STARTED|Double-blind Period||0
2524814|NCT00691028|6186572|P3|STARTED|Double-blind Period||104
2524815|NCT00691028|6186573|P2|STARTED|Double-blind Period||104
2524816|NCT00691028|6186574|P1|STARTED|Double-blind Period||99
2524817|NCT00691028|6186571|P4|NOT COMPLETED|Open-label Period||20
2524818|NCT00691028|6186572|P3|NOT COMPLETED|Open-label Period||0
2524819|NCT00691028|6186573|P2|NOT COMPLETED|Open-label Period||0
2524820|NCT00691028|6186574|P1|NOT COMPLETED|Open-label Period||0
2524821|NCT00691028|6186571|P4|COMPLETED|Open-label Period||307
2524822|NCT00691028|6186572|P3|COMPLETED|Open-label Period||0
2524823|NCT00691028|6186573|P2|COMPLETED|Open-label Period||0
2524824|NCT00691028|6186574|P1|COMPLETED|Open-label Period||0
2524825|NCT00691028|6186571|P4|STARTED|Open-label Period||327
2524826|NCT00691028|6186572|P3|STARTED|Open-label Period||0
2524827|NCT00691028|6186573|P2|STARTED|Open-label Period||0
2524828|NCT00691028|6186574|P1|STARTED|Open-label Period||0
2524829|NCT00691015|6186607|P1|NOT COMPLETED|Overall Study||1
2524830|NCT00691015|6186607|P1|COMPLETED|Overall Study||47
2524831|NCT00691015|6186607|P1|STARTED|Overall Study||48
2524832|NCT00690924|6186618|P1|NOT COMPLETED|Overall Study||0
2524833|NCT00690924|6186618|P1|COMPLETED|Overall Study||16
2524834|NCT00690924|6186618|P1|STARTED|Overall Study||16
2524835|NCT00690898|6186622|P1|NOT COMPLETED|TREATMENT||26
2524836|NCT00690898|6186622|P1|COMPLETED|TREATMENT||64
2524837|NCT00690898|6186622|P1|STARTED|TREATMENT|Total number of patients treated.|90
2524838|NCT00690898|6186622|P1|NOT COMPLETED|SCREENING||18
2524839|NCT00690898|6186622|P1|COMPLETED|SCREENING|Number of patients included in the study.|90
2524840|NCT00690898|6186622|P1|STARTED|SCREENING|Total of patients screened for the study.|108
2524841|NCT00690833|6186636|P1|NOT COMPLETED|Overall Study||2
2524842|NCT00690833|6186636|P1|COMPLETED|Overall Study||39
2524843|NCT00690833|6186636|P1|STARTED|Overall Study||41
2524844|NCT00690820|6186642|P2|NOT COMPLETED|Period 2||0
2524845|NCT00690820|6186643|P1|NOT COMPLETED|Period 2||0
2524846|NCT00690820|6186642|P2|COMPLETED|Period 2||8
2524847|NCT00690820|6186643|P1|COMPLETED|Period 2||8
2524848|NCT00690820|6186642|P2|STARTED|Period 2||8
2524849|NCT00690820|6186643|P1|STARTED|Period 2||8
2524850|NCT00690820|6186642|P2|NOT COMPLETED|Period 1||1
2524851|NCT00690820|6186643|P1|NOT COMPLETED|Period 1||0
2524852|NCT00690820|6186642|P2|COMPLETED|Period 1||8
2524853|NCT00690820|6186643|P1|COMPLETED|Period 1||8
2524854|NCT00690820|6186642|P2|STARTED|Period 1||9
2524855|NCT00690820|6186643|P1|STARTED|Period 1||8
2524856|NCT00690794|6186665|P2|NOT COMPLETED|Overall Study||35
2524857|NCT00690794|6186666|P1|NOT COMPLETED|Overall Study||21
2524858|NCT00690794|6186665|P2|COMPLETED|Overall Study||328
2524859|NCT00690794|6186666|P1|COMPLETED|Overall Study||342
2524860|NCT00690794|6186665|P2|STARTED|Overall Study||363
2524861|NCT00690794|6186666|P1|STARTED|Overall Study||363
2524862|NCT00690755|6186681|P7|NOT COMPLETED|Overall Study||0
2524863|NCT00690755|6186682|P6|NOT COMPLETED|Overall Study||4
2524864|NCT00690755|6186683|P5|NOT COMPLETED|Overall Study||0
2524865|NCT00690755|6186684|P4|NOT COMPLETED|Overall Study||5
2524866|NCT00690755|6186685|P3|NOT COMPLETED|Overall Study||46
2524867|NCT00690755|6186686|P2|NOT COMPLETED|Overall Study||0
2524868|NCT00690755|6186687|P1|NOT COMPLETED|Overall Study||2
2524869|NCT00690755|6186681|P7|COMPLETED|Overall Study||0
2524870|NCT00690755|6186682|P6|COMPLETED|Overall Study||6
2524871|NCT00690755|6186683|P5|COMPLETED|Overall Study||0
2524872|NCT00690755|6186684|P4|COMPLETED|Overall Study||15
2524873|NCT00690755|6186685|P3|COMPLETED|Overall Study||51
2524874|NCT00690755|6186686|P2|COMPLETED|Overall Study||0
2524875|NCT00690755|6186687|P1|COMPLETED|Overall Study|Patient recruitment ended on 12/31/2010|28
2524876|NCT00690755|6186681|P7|STARTED|Overall Study||0
2524877|NCT00690755|6186682|P6|STARTED|Overall Study||10
2524878|NCT00690755|6186683|P5|STARTED|Overall Study||0
2524879|NCT00690755|6186684|P4|STARTED|Overall Study||20
2524880|NCT00690755|6186685|P3|STARTED|Overall Study||97
2524881|NCT00690755|6186686|P2|STARTED|Overall Study||0
2524882|NCT00690755|6186687|P1|STARTED|Overall Study||30
2524883|NCT00690612|6186703|P1|NOT COMPLETED|Overall Study||3
2524884|NCT00690612|6186703|P1|COMPLETED|Overall Study||32
2524885|NCT00690612|6186703|P1|STARTED|Overall Study||35
2524886|NCT00690573|6186708|P1|NOT COMPLETED|Overall Study||9
2524887|NCT00690573|6186708|P1|COMPLETED|Overall Study||16
2524888|NCT00690573|6186708|P1|STARTED|Overall Study||25
2524889|NCT00690495|6186718|P2|NOT COMPLETED|Overall Study||0
2524890|NCT00690495|6186719|P1|NOT COMPLETED|Overall Study||0
2524891|NCT00690495|6186718|P2|COMPLETED|Overall Study||50
2524892|NCT00690495|6186719|P1|COMPLETED|Overall Study||50
2524893|NCT00690495|6186718|P2|Primary Endpoint|Overall Study||50
2524894|NCT00690495|6186719|P1|Primary Endpoint|Overall Study||50
2524895|NCT00690495|6186718|P2|STARTED|Overall Study||50
2524896|NCT00690495|6186719|P1|STARTED|Overall Study||50
2524897|NCT00690482|6186727|P2|NOT COMPLETED|Overall Study||3
2524898|NCT00690482|6186728|P1|NOT COMPLETED|Overall Study||4
2524899|NCT00690482|6186727|P2|COMPLETED|Overall Study||54
2524900|NCT00690482|6186728|P1|COMPLETED|Overall Study||57
2524901|NCT00690482|6186727|P2|STARTED|Overall Study||57
2524902|NCT00690482|6186728|P1|STARTED|Overall Study||61
2524903|NCT00690443|6186762|P2|NOT COMPLETED|Overall Study||2
2524904|NCT00690443|6186763|P1|NOT COMPLETED|Overall Study||1
2524905|NCT00690443|6186762|P2|COMPLETED|Overall Study||19
2524906|NCT00690443|6186763|P1|COMPLETED|Overall Study||22
2524907|NCT00690443|6186762|P2|STARTED|Overall Study||21
2524908|NCT00690443|6186763|P1|STARTED|Overall Study||23
2524909|NCT00690430|6186773|P3|NOT COMPLETED|Extension Phase||13
2524910|NCT00690430|6186774|P2|NOT COMPLETED|Extension Phase||5
2524911|NCT00690430|6186775|P1|NOT COMPLETED|Extension Phase||18
2524912|NCT00690430|6186773|P3|COMPLETED|Extension Phase||2
2524913|NCT00690430|6186774|P2|COMPLETED|Extension Phase||1
2524914|NCT00690430|6186775|P1|COMPLETED|Extension Phase||2
2524915|NCT00690430|6186773|P3|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|15
2524916|NCT00690430|6186774|P2|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|6
2524917|NCT00690430|6186775|P1|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|20
2524918|NCT00690430|6186773|P3|NOT COMPLETED|Core Phase||0
2524919|NCT00690430|6186774|P2|NOT COMPLETED|Core Phase||23
2524920|NCT00690430|6186775|P1|NOT COMPLETED|Core Phase||18
2524921|NCT00690430|6186773|P3|COMPLETED|Core Phase||0
2524922|NCT00690430|6186774|P2|COMPLETED|Core Phase||34
2524923|NCT00690430|6186775|P1|COMPLETED|Core Phase||35
2524924|NCT00690430|6186773|P3|STARTED|Core Phase|This arm belongs to Extension Phase.|0
2524925|NCT00690430|6186774|P2|STARTED|Core Phase||57
2524926|NCT00690430|6186775|P1|STARTED|Core Phase|"Started indicates Full Analysis Set (FAS) and Safety Set."|53
2524927|NCT00690378|6186804|P2|NOT COMPLETED|Overall Study||14
2524928|NCT00690378|6186805|P1|NOT COMPLETED|Overall Study||20
2524929|NCT00690378|6186804|P2|COMPLETED|Overall Study|Up to LFU visit|54
2524930|NCT00690378|6186805|P1|COMPLETED|Overall Study|Up to Late follow up (LFU) visit|49
2524931|NCT00690378|6186804|P2|Treated|Overall Study||67
2524932|NCT00690378|6186805|P1|Treated|Overall Study||68
2524933|NCT00690378|6186804|P2|STARTED|Overall Study|Randomized|68
2524934|NCT00690378|6186805|P1|STARTED|Overall Study|Randomized|69
2524935|NCT00690339|6186853|P4|NOT COMPLETED|Overall Study||25
2524936|NCT00690339|6186854|P3|NOT COMPLETED|Overall Study||57
2524937|NCT00690339|6186855|P2|NOT COMPLETED|Overall Study||81
2524938|NCT00690339|6186856|P1|NOT COMPLETED|Overall Study||117
2524939|NCT00690339|6186853|P4|COMPLETED|Overall Study||43
2524940|NCT00690339|6186854|P3|COMPLETED|Overall Study||99
2524941|NCT00690339|6186855|P2|COMPLETED|Overall Study||144
2524942|NCT00690339|6186856|P1|COMPLETED|Overall Study||375
2524943|NCT00690339|6186853|P4|STARTED|Overall Study||68
2524944|NCT00690339|6186854|P3|STARTED|Overall Study||156
2524945|NCT00690339|6186855|P2|STARTED|Overall Study||225
2524946|NCT00690339|6186856|P1|STARTED|Overall Study||492
2524947|NCT00690274|6186872|P2|NOT COMPLETED|Overall Study||8
2524948|NCT00690274|6186873|P1|NOT COMPLETED|Overall Study||6
2524949|NCT00690274|6186872|P2|COMPLETED|Overall Study||15
2524950|NCT00690274|6186873|P1|COMPLETED|Overall Study||23
2524951|NCT00690274|6186872|P2|STARTED|Overall Study||23
2524952|NCT00690274|6186873|P1|STARTED|Overall Study||29
2524953|NCT00690235|6186883|P2|NOT COMPLETED|Overall Study||4
2524954|NCT00690235|6186884|P1|NOT COMPLETED|Overall Study||5
2524955|NCT00690235|6186883|P2|COMPLETED|Overall Study||12
2524956|NCT00690235|6186884|P1|COMPLETED|Overall Study||12
2524957|NCT00690235|6186883|P2|STARTED|Overall Study||16
2524958|NCT00690235|6186884|P1|STARTED|Overall Study||17
2524959|NCT00690040|6186892|P2|NOT COMPLETED|Overall Study||0
2524960|NCT00690040|6186893|P1|NOT COMPLETED|Overall Study||0
2524961|NCT00690040|6186892|P2|COMPLETED|Overall Study||148
2524962|NCT00690040|6186893|P1|COMPLETED|Overall Study||145
2524963|NCT00690040|6186892|P2|STARTED|Overall Study||148
2524964|NCT00690040|6186893|P1|STARTED|Overall Study||145
2524965|NCT00689936|6186902|P3|NOT COMPLETED|Long-Term Follow Up Phase||144
2524966|NCT00689936|6186903|P2|NOT COMPLETED|Long-Term Follow Up Phase||188
2524967|NCT00689936|6186904|P1|NOT COMPLETED|Long-Term Follow Up Phase||127
2524968|NCT00689936|6186902|P3|COMPLETED|Long-Term Follow Up Phase||315
2524969|NCT00689936|6186903|P2|COMPLETED|Long-Term Follow Up Phase||275
2524970|NCT00689936|6186904|P1|COMPLETED|Long-Term Follow Up Phase||255
2524971|NCT00689936|6186902|P3|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|459
2524972|NCT00689936|6186903|P2|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|463
2524973|NCT00689936|6186904|P1|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|382
2524974|NCT00689936|6186902|P3|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
2524975|NCT00689936|6186903|P2|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
2524976|NCT00689936|6186904|P1|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
2524977|NCT00689936|6186902|P3|COMPLETED|Progression Free Survival-PFS-Follow-Up||273
2524978|NCT00689936|6186903|P2|COMPLETED|Progression Free Survival-PFS-Follow-Up||300
2524979|NCT00689936|6186904|P1|COMPLETED|Progression Free Survival-PFS-Follow-Up||87
2524980|NCT00689936|6186902|P3|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 12 cycles MPT and did not experience progressive disease.|273
2524981|NCT00689936|6186903|P2|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 18 cycles (Rd18) and did not experience progressive disease.|300
2524982|NCT00689936|6186904|P1|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who discontinued treatment for reasons other than progressive disease.|87
2524983|NCT00689936|6186902|P3|NOT COMPLETED|Active Treatment Phase||547
2524984|NCT00689936|6186903|P2|NOT COMPLETED|Active Treatment Phase||541
2524985|NCT00689936|6186904|P1|NOT COMPLETED|Active Treatment Phase||535
2524986|NCT00689936|6186902|P3|COMPLETED|Active Treatment Phase||0
2524987|NCT00689936|6186903|P2|COMPLETED|Active Treatment Phase||0
2524988|NCT00689936|6186904|P1|COMPLETED|Active Treatment Phase||0
2524989|NCT00689936|6186902|P3|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|6
2524990|NCT00689936|6186903|P2|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|1
2524991|NCT00689936|6186904|P1|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|3
2524992|NCT00689936|6186902|P3|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|541
2524993|NCT00689936|6186903|P2|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|540
2524994|NCT00689936|6186904|P1|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|532
2524995|NCT00689936|6186902|P3|STARTED|Active Treatment Phase||547
2524996|NCT00689936|6186903|P2|STARTED|Active Treatment Phase||541
2524997|NCT00689936|6186904|P1|STARTED|Active Treatment Phase||535
2524998|NCT00689884|6187044|P1|NOT COMPLETED|Overall Study||0
2524999|NCT00689884|6187044|P1|COMPLETED|Overall Study||7
2525000|NCT00689884|6187044|P1|STARTED|Overall Study||7
2525001|NCT00689871|6187053|P4|NOT COMPLETED|Overall Study||7
2525002|NCT00689871|6187054|P3|NOT COMPLETED|Overall Study||73
2525003|NCT00689871|6187055|P2|NOT COMPLETED|Overall Study||52
2525004|NCT00689871|6187056|P1|NOT COMPLETED|Overall Study||175
2525005|NCT00689871|6187053|P4|COMPLETED|Overall Study|4 Patients discontinued|8
2525006|NCT00689871|6187054|P3|COMPLETED|Overall Study|28 Patients discontinued|74
2525007|NCT00689871|6187055|P2|COMPLETED|Overall Study|35 Patients discontinued|46
2525008|NCT00689871|6187056|P1|COMPLETED|Overall Study|35 Patients discontinued|280
2525009|NCT00689871|6187053|P4|STARTED|Overall Study|25 Implants|15
2525010|NCT00689871|6187054|P3|STARTED|Overall Study|288 Implants|147
2525011|NCT00689871|6187055|P2|STARTED|Overall Study|127 Implants|98
2525012|NCT00689871|6187056|P1|STARTED|Overall Study|908 Implants|455
2525013|NCT00689819|6187072|P2|NOT COMPLETED|Overall Study||15
2525014|NCT00689819|6187073|P1|NOT COMPLETED|Overall Study||20
2525015|NCT00689819|6187072|P2|COMPLETED|Overall Study||43
2525016|NCT00689819|6187073|P1|COMPLETED|Overall Study||45
2525017|NCT00689819|6187072|P2|STARTED|Overall Study||58
2525018|NCT00689819|6187073|P1|STARTED|Overall Study||65
2525019|NCT00689793|6187083|P2|NOT COMPLETED|Overall Study||5
2525020|NCT00689793|6187084|P1|NOT COMPLETED|Overall Study||4
2525021|NCT00689793|6187083|P2|COMPLETED|Overall Study||71
2525022|NCT00689793|6187084|P1|COMPLETED|Overall Study||74
2525023|NCT00689793|6187083|P2|STARTED|Overall Study||76
2525024|NCT00689793|6187084|P1|STARTED|Overall Study||78
2525025|NCT00689728|6187103|P3|NOT COMPLETED|Optional Follow-Up||6
2525026|NCT00689728|6187104|P2|NOT COMPLETED|Optional Follow-Up||6
2525027|NCT00689728|6187105|P1|NOT COMPLETED|Optional Follow-Up||3
2525028|NCT00689728|6187103|P3|COMPLETED|Optional Follow-Up||4
2525029|NCT00689728|6187104|P2|COMPLETED|Optional Follow-Up||5
2525030|NCT00689728|6187105|P1|COMPLETED|Optional Follow-Up||6
2525031|NCT00689728|6187103|P3|STARTED|Optional Follow-Up|19 participants who completed the rescue period did not enter the optional follow-up period.|10
2525032|NCT00689728|6187104|P2|STARTED|Optional Follow-Up|13 participants who completed the rescue period did not enter the optional follow-up period.|11
2525033|NCT00689728|6187105|P1|STARTED|Optional Follow-Up|21 participants who completed the rescue period did not enter the optional follow-up period.|9
2525034|NCT00689728|6187103|P3|NOT COMPLETED|Rescue||1
2525035|NCT00689728|6187104|P2|NOT COMPLETED|Rescue||2
2525036|NCT00689728|6187105|P1|NOT COMPLETED|Rescue||1
2525037|NCT00689728|6187103|P3|COMPLETED|Rescue||29
2525038|NCT00689728|6187104|P2|COMPLETED|Rescue||24
2525039|NCT00689728|6187105|P1|COMPLETED|Rescue||30
2525040|NCT00689728|6187103|P3|STARTED|Rescue||30
2525041|NCT00689728|6187104|P2|STARTED|Rescue||26
2525042|NCT00689728|6187105|P1|STARTED|Rescue||31
2525043|NCT00689728|6187103|P3|NOT COMPLETED|Double-Blind Treatment||5
2525044|NCT00689728|6187104|P2|NOT COMPLETED|Double-Blind Treatment||4
2525045|NCT00689728|6187105|P1|NOT COMPLETED|Double-Blind Treatment||4
2525046|NCT00689728|6187103|P3|COMPLETED|Double-Blind Treatment||30
2525047|NCT00689728|6187104|P2|COMPLETED|Double-Blind Treatment||26
2525048|NCT00689728|6187105|P1|COMPLETED|Double-Blind Treatment||31
2525049|NCT00689728|6187103|P3|STARTED|Double-Blind Treatment||35
2525050|NCT00689728|6187104|P2|STARTED|Double-Blind Treatment||30
2525051|NCT00689728|6187105|P1|STARTED|Double-Blind Treatment||35
2525052|NCT00689611|6187188|P2|NOT COMPLETED|Overall Study||46
2525053|NCT00689611|6187189|P1|NOT COMPLETED|Overall Study||41
2525054|NCT00689611|6187188|P2|COMPLETED|Overall Study||146
2525055|NCT00689611|6187189|P1|COMPLETED|Overall Study||159
2525056|NCT00689611|6187188|P2|STARTED|Overall Study||192
2525057|NCT00689611|6187189|P1|STARTED|Overall Study||200
2525058|NCT00689481|6187199|P2|NOT COMPLETED|Overall Study||14
2525059|NCT00689481|6187200|P1|NOT COMPLETED|Overall Study||24
2525060|NCT00689481|6187199|P2|COMPLETED|Overall Study||95
2525061|NCT00689481|6187200|P1|COMPLETED|Overall Study||190
2525062|NCT00689481|6187199|P2|STARTED|Overall Study||109
2525063|NCT00689481|6187200|P1|STARTED|Overall Study||214
2525064|NCT00689390|6187218|P2|NOT COMPLETED|Overall Study||10
2525065|NCT00689390|6187219|P1|NOT COMPLETED|Overall Study||426
2525066|NCT00689390|6187218|P2|COMPLETED|Overall Study||37
2525067|NCT00689390|6187219|P1|COMPLETED|Overall Study||1481
2525068|NCT00689390|6187218|P2|STARTED|Overall Study||47
2525069|NCT00689390|6187219|P1|STARTED|Overall Study||1907
2525070|NCT00689351|6187237|P2|NOT COMPLETED|Toddler Dose||0
2525071|NCT00689351|6187238|P1|NOT COMPLETED|Toddler Dose||0
2525072|NCT00689351|6187237|P2|COMPLETED|Toddler Dose||88
2525073|NCT00689351|6187238|P1|COMPLETED|Toddler Dose||84
2525074|NCT00689351|6187237|P2|STARTED|Toddler Dose||88
2525075|NCT00689351|6187238|P1|STARTED|Toddler Dose||84
2525076|NCT00689351|6187237|P2|NOT COMPLETED|After Infant Series||0
2525077|NCT00689351|6187238|P1|NOT COMPLETED|After Infant Series||1
2525078|NCT00689351|6187237|P2|COMPLETED|After Infant Series||88
2525079|NCT00689351|6187238|P1|COMPLETED|After Infant Series||84
2525080|NCT00689351|6187237|P2|STARTED|After Infant Series||88
2525081|NCT00689351|6187238|P1|STARTED|After Infant Series||85
2525082|NCT00689351|6187237|P2|NOT COMPLETED|Infant Series of Dosing||1
2525083|NCT00689351|6187238|P1|NOT COMPLETED|Infant Series of Dosing||6
2525084|NCT00689351|6187237|P2|COMPLETED|Infant Series of Dosing||88
2525085|NCT00689351|6187238|P1|COMPLETED|Infant Series of Dosing||85
2525086|NCT00689351|6187237|P2|Vaccinated Dose 3|Infant Series of Dosing||88
2525087|NCT00689351|6187238|P1|Vaccinated Dose 3|Infant Series of Dosing||85
2525088|NCT00689351|6187237|P2|Vaccinated Dose 2|Infant Series of Dosing||88
2525089|NCT00689351|6187238|P1|Vaccinated Dose 2|Infant Series of Dosing||86
2525090|NCT00689351|6187237|P2|Vaccinated Dose 1|Infant Series of Dosing||89
2525091|NCT00689351|6187238|P1|Vaccinated Dose 1|Infant Series of Dosing||88
2525092|NCT00689351|6187237|P2|STARTED|Infant Series of Dosing||89
2525093|NCT00689351|6187238|P1|STARTED|Infant Series of Dosing||91
2525094|NCT00689338|6187270|P1|NOT COMPLETED|Overall Study||143
2525095|NCT00689338|6187270|P1|COMPLETED|Overall Study||73
2525096|NCT00689338|6187270|P1|STARTED|Overall Study||216
2525097|NCT00689299|6187283|P3|NOT COMPLETED|Overall Study||5
2525098|NCT00689299|6187284|P2|NOT COMPLETED|Overall Study||3
2525099|NCT00689299|6187285|P1|NOT COMPLETED|Overall Study||7
2525100|NCT00689299|6187283|P3|COMPLETED|Overall Study||49
2525101|NCT00689299|6187284|P2|COMPLETED|Overall Study||54
2525102|NCT00689299|6187285|P1|COMPLETED|Overall Study||51
2525103|NCT00689299|6187283|P3|STARTED|Overall Study||54
2525104|NCT00689299|6187284|P2|STARTED|Overall Study||57
2525105|NCT00689299|6187285|P1|STARTED|Overall Study||58
2525106|NCT00689260|6187295|P2|NOT COMPLETED|Overall Study||0
2525107|NCT00689260|6187296|P1|NOT COMPLETED|Overall Study||2
2525108|NCT00689260|6187295|P2|COMPLETED|Overall Study||21
2525109|NCT00689260|6187296|P1|COMPLETED|Overall Study||19
2525110|NCT00689260|6187295|P2|STARTED|Overall Study||21
2525111|NCT00689260|6187296|P1|STARTED|Overall Study||21
2525112|NCT00689221|6187314|P2|NOT COMPLETED|Overall Study||36
2525113|NCT00689221|6187315|P1|NOT COMPLETED|Overall Study||39
2525114|NCT00689221|6187314|P2|COMPLETED|Overall Study||237
2525115|NCT00689221|6187315|P1|COMPLETED|Overall Study||233
2525116|NCT00689221|6187314|P2|STARTED|Overall Study||273
2525117|NCT00689221|6187315|P1|STARTED|Overall Study||272
2525118|NCT00689117|6187344|P4|NOT COMPLETED|Overall Study||31
2525119|NCT00689117|6187345|P3|NOT COMPLETED|Overall Study||59
2525120|NCT00689117|6187346|P2|NOT COMPLETED|Overall Study||51
2525121|NCT00689117|6187347|P1|NOT COMPLETED|Overall Study||62
2525122|NCT00689117|6187344|P4|COMPLETED|Overall Study||211
2525123|NCT00689117|6187345|P3|COMPLETED|Overall Study||405
2525124|NCT00689117|6187346|P2|COMPLETED|Overall Study||416
2525125|NCT00689117|6187347|P1|COMPLETED|Overall Study||414
2525126|NCT00689117|6187344|P4|STARTED|Overall Study||242
2525127|NCT00689117|6187345|P3|STARTED|Overall Study||464
2525128|NCT00689117|6187346|P2|STARTED|Overall Study||467
2525129|NCT00689117|6187347|P1|STARTED|Overall Study||476
2525130|NCT00689104|6187377|P4|NOT COMPLETED|Overall Study||50
2525131|NCT00689104|6187378|P3|NOT COMPLETED|Overall Study||45
2525132|NCT00689104|6187379|P2|NOT COMPLETED|Overall Study||57
2525133|NCT00689104|6187380|P1|NOT COMPLETED|Overall Study||44
2525134|NCT00689104|6187377|P4|COMPLETED|Overall Study||445
2525135|NCT00689104|6187378|P3|COMPLETED|Overall Study||453
2525136|NCT00689104|6187379|P2|COMPLETED|Overall Study||440
2525137|NCT00689104|6187380|P1|COMPLETED|Overall Study||453
2525138|NCT00689104|6187377|P4|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|300
2525139|NCT00689104|6187378|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|281
2525140|NCT00689104|6187379|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|293
2525141|NCT00689104|6187380|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|291
2525142|NCT00689104|6187377|P4|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|475
2525143|NCT00689104|6187378|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|478
2525144|NCT00689104|6187379|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|473
2525145|NCT00689104|6187380|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|480
2525146|NCT00689104|6187377|P4|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|495
2525147|NCT00689104|6187378|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|496
2525148|NCT00689104|6187379|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|493
2525149|NCT00689104|6187380|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|494
2525150|NCT00689104|6187377|P4|STARTED|Overall Study||495
2525151|NCT00689104|6187378|P3|STARTED|Overall Study||498
2525152|NCT00689104|6187379|P2|STARTED|Overall Study||497
2525153|NCT00689104|6187380|P1|STARTED|Overall Study||497
2525154|NCT00689091|6187512|P2|NOT COMPLETED|Overall Study||1394
2525155|NCT00689091|6187513|P1|NOT COMPLETED|Overall Study||1371
2525156|NCT00689091|6187512|P2|COMPLETED|Overall Study||9376
2525157|NCT00689091|6187513|P1|COMPLETED|Overall Study||9460
2525158|NCT00689091|6187512|P2|STARTED|Overall Study||10770
2525159|NCT00689091|6187513|P1|STARTED|Overall Study||10831
2525160|NCT00689078|6187535|P4|NOT COMPLETED|Overall Study||1
2525161|NCT00689078|6187536|P3|NOT COMPLETED|Overall Study||1
2525162|NCT00689078|6187537|P2|NOT COMPLETED|Overall Study||2
2525163|NCT00689078|6187538|P1|NOT COMPLETED|Overall Study||0
2525164|NCT00689078|6187535|P4|COMPLETED|Overall Study||8
2525165|NCT00689078|6187536|P3|COMPLETED|Overall Study||8
2525166|NCT00689078|6187537|P2|COMPLETED|Overall Study||7
2525167|NCT00689078|6187538|P1|COMPLETED|Overall Study||9
2525168|NCT00689078|6187535|P4|STARTED|Overall Study||9
2525169|NCT00689078|6187536|P3|STARTED|Overall Study||9
2525170|NCT00689078|6187537|P2|STARTED|Overall Study||9
2525171|NCT00689078|6187538|P1|STARTED|Overall Study||9
2525172|NCT00689052|6187586|P2|NOT COMPLETED|Overall Study||30
2525173|NCT00689052|6187587|P1|NOT COMPLETED|Overall Study||31
2525174|NCT00689052|6187586|P2|COMPLETED|Overall Study||0
2525175|NCT00689052|6187587|P1|COMPLETED|Overall Study||0
2525176|NCT00689052|6187586|P2|STARTED|Overall Study||30
2525177|NCT00689052|6187587|P1|STARTED|Overall Study||31
2525178|NCT00689026|6187619|P2|NOT COMPLETED|Overall Study||6
2525179|NCT00689026|6187620|P1|NOT COMPLETED|Overall Study||13
2525180|NCT00689026|6187619|P2|COMPLETED|Overall Study||24
2525181|NCT00689026|6187620|P1|COMPLETED|Overall Study||17
2525182|NCT00689026|6187619|P2|STARTED|Overall Study||30
2525183|NCT00689026|6187620|P1|STARTED|Overall Study||30
2525184|NCT00688935|6187626|P1|NOT COMPLETED|Overall Study||0
2525185|NCT00688935|6187626|P1|COMPLETED|Overall Study||0
2525186|NCT00688935|6187626|P1|STARTED|Overall Study||0
2525187|NCT00688870|6187633|P2|NOT COMPLETED|Toddler Dose||0
2525188|NCT00688870|6187634|P1|NOT COMPLETED|Toddler Dose||0
2525189|NCT00688870|6187633|P2|COMPLETED|Toddler Dose||84
2525190|NCT00688870|6187634|P1|COMPLETED|Toddler Dose||80
2525191|NCT00688870|6187633|P2|STARTED|Toddler Dose||84
2525192|NCT00688870|6187634|P1|STARTED|Toddler Dose||80
2525193|NCT00688870|6187633|P2|NOT COMPLETED|After Infant Series||0
2525194|NCT00688870|6187634|P1|NOT COMPLETED|After Infant Series||0
2525195|NCT00688870|6187633|P2|COMPLETED|After Infant Series||84
2525196|NCT00688870|6187634|P1|COMPLETED|After Infant Series||80
2525197|NCT00688870|6187633|P2|STARTED|After Infant Series||84
2525198|NCT00688870|6187634|P1|STARTED|After Infant Series||80
2525199|NCT00688870|6187633|P2|NOT COMPLETED|Infant Series||0
2525200|NCT00688870|6187634|P1|NOT COMPLETED|Infant Series||4
2525201|NCT00688870|6187633|P2|COMPLETED|Infant Series||84
2525202|NCT00688870|6187634|P1|COMPLETED|Infant Series||80
2525203|NCT00688870|6187633|P2|Vaccinated Dose 3|Infant Series||84
2525204|NCT00688870|6187634|P1|Vaccinated Dose 3|Infant Series||80
2525205|NCT00688870|6187633|P2|Vaccinated Dose 2|Infant Series||84
2525206|NCT00688870|6187634|P1|Vaccinated Dose 2|Infant Series||80
2525207|NCT00688870|6187633|P2|Vaccinated Dose 1|Infant Series||84
2525208|NCT00688870|6187634|P1|Vaccinated Dose 1|Infant Series||83
2525209|NCT00688870|6187633|P2|STARTED|Infant Series||84
2525210|NCT00688870|6187634|P1|STARTED|Infant Series||84
2525211|NCT00688844|6187666|P1|NOT COMPLETED|Overall Study||10
2525212|NCT00688844|6187666|P1|COMPLETED|Overall Study||48
2525213|NCT00688844|6187666|P1|STARTED|Overall Study||58
2525214|NCT00688753|6187676|P1|NOT COMPLETED|Overall Study||92
2525215|NCT00688753|6187676|P1|COMPLETED|Overall Study||0
2525216|NCT00688753|6187676|P1|STARTED|Overall Study||92
2525217|NCT00688740|6187687|P2|NOT COMPLETED|Overall Study||35
2525218|NCT00688740|6187688|P1|NOT COMPLETED|Overall Study||66
2525219|NCT00688740|6187687|P2|COMPLETED|Overall Study||711
2525220|NCT00688740|6187688|P1|COMPLETED|Overall Study||679
2525221|NCT00688740|6187687|P2|STARTED|Overall Study||746
2525222|NCT00688740|6187688|P1|STARTED|Overall Study||745
2525223|NCT00688701|6187701|P4|NOT COMPLETED|Overall Study||11
2525224|NCT00688701|6187702|P3|NOT COMPLETED|Overall Study||10
2525225|NCT00688701|6187703|P2|NOT COMPLETED|Overall Study||5
2525226|NCT00688701|6187704|P1|NOT COMPLETED|Overall Study||4
2525227|NCT00688701|6187701|P4|COMPLETED|Overall Study||108
2525228|NCT00688701|6187702|P3|COMPLETED|Overall Study||110
2525229|NCT00688701|6187703|P2|COMPLETED|Overall Study||56
2525230|NCT00688701|6187704|P1|COMPLETED|Overall Study||57
2525231|NCT00688701|6187701|P4|Subgroup for Standardized Meal Test|Overall Study||65
2525232|NCT00688701|6187702|P3|Subgroup for Standardized Meal Test|Overall Study||60
2525233|NCT00688701|6187703|P2|Subgroup for Standardized Meal Test|Overall Study||35
2525234|NCT00688701|6187704|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|27
2525235|NCT00688701|6187701|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||118
2525236|NCT00688701|6187702|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||120
2525237|NCT00688701|6187703|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||60
2525238|NCT00688701|6187704|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|61
2525239|NCT00688701|6187701|P4|Treated/Safety Population|Overall Study||119
2525240|NCT00688701|6187702|P3|Treated/Safety Population|Overall Study||120
2525241|NCT00688701|6187703|P2|Treated/Safety Population|Overall Study||61
2525242|NCT00688701|6187704|P1|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|61
2525243|NCT00688701|6187701|P4|STARTED|Overall Study||119
2525244|NCT00688701|6187702|P3|STARTED|Overall Study||120
2525245|NCT00688701|6187703|P2|STARTED|Overall Study||61
2525246|NCT00688701|6187704|P1|STARTED|Overall Study|Randomized|61
2525247|NCT00688688|6187745|P3|NOT COMPLETED|Overall Study||192
2525248|NCT00688688|6187746|P2|NOT COMPLETED|Overall Study||179
2525249|NCT00688688|6187747|P1|NOT COMPLETED|Overall Study||186
2525250|NCT00688688|6187745|P3|COMPLETED|Overall Study||621
2525251|NCT00688688|6187746|P2|COMPLETED|Overall Study||645
2525252|NCT00688688|6187747|P1|COMPLETED|Overall Study||629
2525253|NCT00688688|6187745|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|488
2525254|NCT00688688|6187746|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|483
2525255|NCT00688688|6187747|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|479
2525256|NCT00688688|6187745|P3|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|791
2525257|NCT00688688|6187746|P2|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|802
2525258|NCT00688688|6187747|P1|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|789
2525259|NCT00688688|6187745|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
2525260|NCT00688688|6187746|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|820
2525261|NCT00688688|6187747|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
2525262|NCT00688688|6187745|P3|STARTED|Overall Study||813
2525263|NCT00688688|6187746|P2|STARTED|Overall Study||824
2525264|NCT00688688|6187747|P1|STARTED|Overall Study||815
2525265|NCT00688662|6187838|P2|NOT COMPLETED|Overall Study||18
2525266|NCT00688662|6187839|P1|NOT COMPLETED|Overall Study||23
2525267|NCT00688662|6187838|P2|COMPLETED|Overall Study||55
2525268|NCT00688662|6187839|P1|COMPLETED|Overall Study||118
2525269|NCT00688662|6187838|P2|STARTED|Overall Study||73
2525270|NCT00688662|6187839|P1|STARTED|Overall Study||141
2525271|NCT00688636|6187849|P2|NOT COMPLETED|Overall Study||1
2525272|NCT00688636|6187850|P1|NOT COMPLETED|Overall Study||2
2525273|NCT00688636|6187849|P2|COMPLETED|Overall Study||12
2525274|NCT00688636|6187850|P1|COMPLETED|Overall Study||9
2525275|NCT00688636|6187849|P2|STARTED|Overall Study||13
2525276|NCT00688636|6187850|P1|STARTED|Overall Study||11
2525277|NCT00688623|6187864|P1|NOT COMPLETED|Overall Study||55
2525278|NCT00688623|6187864|P1|COMPLETED|Overall Study||18
2525279|NCT00688623|6187864|P1|Per Protocol (PP)|Overall Study|no major protocol deviation and 50% of planned dose of 8 weeks or d/c due to disease progression|60
2525280|NCT00688623|6187864|P1|Safety Analysis Set|Overall Study|received at least one dose of study drug and had at least one post-baseline safety assessment|73
2525281|NCT00688623|6187864|P1|STARTED|Overall Study|Intent to treat (ITT)|73
2525282|NCT00688597|6187878|P3|NOT COMPLETED|Overall Study||0
2525283|NCT00688597|6187879|P2|NOT COMPLETED|Overall Study||0
2525284|NCT00688597|6187880|P1|NOT COMPLETED|Overall Study||3
2525285|NCT00688597|6187878|P3|COMPLETED|Overall Study||0
2525286|NCT00688597|6187879|P2|COMPLETED|Overall Study||0
2525287|NCT00688597|6187880|P1|COMPLETED|Overall Study||0
2525288|NCT00688597|6187878|P3|Received at Least 1 Dose of Study Drug|Overall Study||0
2525289|NCT00688597|6187879|P2|Received at Least 1 Dose of Study Drug|Overall Study||0
2525290|NCT00688597|6187880|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
2525291|NCT00688597|6187878|P3|STARTED|Overall Study||0
2525292|NCT00688597|6187879|P2|STARTED|Overall Study||0
2525293|NCT00688597|6187880|P1|STARTED|Overall Study||3
2525294|NCT00688545|6187893|P2|NOT COMPLETED|Overall Study||15
2525295|NCT00688545|6187894|P1|NOT COMPLETED|Overall Study||5
2525296|NCT00688545|6187893|P2|COMPLETED|Overall Study||204
2525297|NCT00688545|6187894|P1|COMPLETED|Overall Study||50
2525298|NCT00688545|6187893|P2|Switched Treatment at Least Once|Overall Study||13
2525299|NCT00688545|6187894|P1|Switched Treatment at Least Once|Overall Study||6
2525300|NCT00688545|6187893|P2|STARTED|Overall Study||219
2525301|NCT00688545|6187894|P1|STARTED|Overall Study||55
2525302|NCT00688519|6187904|P2|NOT COMPLETED|Overall Study||15
2525303|NCT00688519|6187905|P1|NOT COMPLETED|Overall Study||19
2525304|NCT00688519|6187904|P2|COMPLETED|Overall Study||98
2525305|NCT00688519|6187905|P1|COMPLETED|Overall Study||204
2525306|NCT00688519|6187904|P2|STARTED|Overall Study||113
2525307|NCT00688519|6187905|P1|STARTED|Overall Study||223
2525308|NCT00688467|6187923|P2|NOT COMPLETED|Treatment Period 2||2
2525309|NCT00688467|6187924|P1|NOT COMPLETED|Treatment Period 2||0
2525310|NCT00688467|6187923|P2|COMPLETED|Treatment Period 2||6
2525311|NCT00688467|6187924|P1|COMPLETED|Treatment Period 2||7
2525312|NCT00688467|6187923|P2|STARTED|Treatment Period 2||8
2525313|NCT00688467|6187924|P1|STARTED|Treatment Period 2||7
2525314|NCT00688467|6187923|P2|NOT COMPLETED|Treatment Period 1||2
2525315|NCT00688467|6187924|P1|NOT COMPLETED|Treatment Period 1||2
2525316|NCT00688467|6187923|P2|COMPLETED|Treatment Period 1||8
2525317|NCT00688467|6187924|P1|COMPLETED|Treatment Period 1||7
2525318|NCT00688467|6187923|P2|STARTED|Treatment Period 1||10
2525319|NCT00688467|6187924|P1|STARTED|Treatment Period 1||9
2525320|NCT00688324|6187954|P1|NOT COMPLETED|Overall Study||8
2525321|NCT00688324|6187954|P1|COMPLETED|Overall Study||28
2525322|NCT00688324|6187954|P1|STARTED|Overall Study||36
2525323|NCT00688259|6187999|P2|NOT COMPLETED|Overall Study||8
2525324|NCT00688259|6188000|P1|NOT COMPLETED|Overall Study||7
2525325|NCT00688259|6187999|P2|COMPLETED|Overall Study||36
2525326|NCT00688259|6188000|P1|COMPLETED|Overall Study||37
2525327|NCT00688259|6187999|P2|End to Active Treatment,|Overall Study||37
2525328|NCT00688259|6188000|P1|End to Active Treatment,|Overall Study||37
2525329|NCT00688259|6187999|P2|STARTED|Overall Study||44
2525330|NCT00688259|6188000|P1|STARTED|Overall Study||44
2525331|NCT00688155|6188020|P4|NOT COMPLETED|Overall Study||1
2525332|NCT00688155|6188021|P3|NOT COMPLETED|Overall Study||1
2525333|NCT00688155|6188022|P2|NOT COMPLETED|Overall Study||2
2525334|NCT00688155|6188023|P1|NOT COMPLETED|Overall Study||2
2525335|NCT00688155|6188020|P4|COMPLETED|Overall Study||17
2525336|NCT00688155|6188021|P3|COMPLETED|Overall Study||18
2525337|NCT00688155|6188022|P2|COMPLETED|Overall Study||16
2525338|NCT00688155|6188023|P1|COMPLETED|Overall Study||16
2525339|NCT00688155|6188020|P4|STARTED|Overall Study||18
2525340|NCT00688155|6188021|P3|STARTED|Overall Study||19
2525341|NCT00688155|6188022|P2|STARTED|Overall Study||18
2525342|NCT00688155|6188023|P1|STARTED|Overall Study||18
2525343|NCT00688103|6188043|P2|NOT COMPLETED|Overall Study||13
2525344|NCT00688103|6188044|P1|NOT COMPLETED|Overall Study||30
2525345|NCT00688103|6188043|P2|COMPLETED|Overall Study||64
2525346|NCT00688103|6188044|P1|COMPLETED|Overall Study||44
2525347|NCT00688103|6188043|P2|Actually Treated|Overall Study||76
2525348|NCT00688103|6188044|P1|Actually Treated|Overall Study||71
2525349|NCT00688103|6188043|P2|STARTED|Overall Study||77
2525350|NCT00688103|6188044|P1|STARTED|Overall Study||74
2525351|NCT00688064|6188056|P2|NOT COMPLETED|Overall Study||26
2525352|NCT00688064|6188057|P1|NOT COMPLETED|Overall Study||21
2525353|NCT00688064|6188056|P2|COMPLETED|Overall Study||201
2525354|NCT00688064|6188057|P1|COMPLETED|Overall Study||211
2525355|NCT00688064|6188056|P2|STARTED|Overall Study||227
2525356|NCT00688064|6188057|P1|STARTED|Overall Study||232
2525357|NCT00687973|6188073|P2|NOT COMPLETED|Overall Study||38
2525358|NCT00687973|6188074|P1|NOT COMPLETED|Overall Study||24
2525359|NCT00687973|6188073|P2|COMPLETED|Overall Study||162
2525360|NCT00687973|6188074|P1|COMPLETED|Overall Study||169
2525361|NCT00687973|6188073|P2|STARTED|Overall Study||200
2525362|NCT00687973|6188074|P1|STARTED|Overall Study||193
2525363|NCT00687908|6188103|P2|NOT COMPLETED|Overall Study||42
2525364|NCT00687908|6188104|P1|NOT COMPLETED|Overall Study||18
2525365|NCT00687908|6188103|P2|COMPLETED|Overall Study||78
2525366|NCT00687908|6188104|P1|COMPLETED|Overall Study||105
2525367|NCT00687908|6188103|P2|STARTED|Overall Study||120
2525368|NCT00687908|6188104|P1|STARTED|Overall Study||123
2525369|NCT00687856|6188118|P1|NOT COMPLETED|Overall Study||0
2525370|NCT00687856|6188118|P1|COMPLETED|Overall Study||211
2525371|NCT00687856|6188118|P1|STARTED|Overall Study||211
2525372|NCT00687830|6188124|P2|NOT COMPLETED|Overall Study||0
2525373|NCT00687830|6188125|P1|NOT COMPLETED|Overall Study||0
2525374|NCT00687830|6188124|P2|COMPLETED|Overall Study||68
2525375|NCT00687830|6188125|P1|COMPLETED|Overall Study||68
2525376|NCT00687830|6188124|P2|STARTED|Overall Study||68
2525377|NCT00687830|6188125|P1|STARTED|Overall Study||68
2525378|NCT00687804|6188136|P3|NOT COMPLETED|Open-Label Extension Study||11
2525379|NCT00687804|6188137|P2|NOT COMPLETED|Open-Label Extension Study||11
2525380|NCT00687804|6188138|P1|NOT COMPLETED|Open-Label Extension Study||10
2525381|NCT00687804|6188136|P3|COMPLETED|Open-Label Extension Study||63
2525382|NCT00687804|6188137|P2|COMPLETED|Open-Label Extension Study||72
2525383|NCT00687804|6188138|P1|COMPLETED|Open-Label Extension Study||73
2525384|NCT00687804|6188136|P3|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||15
2525385|NCT00687804|6188137|P2|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||21
2525386|NCT00687804|6188138|P1|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||16
2525387|NCT00687804|6188136|P3|STARTED|Open-Label Extension Study||74
2525388|NCT00687804|6188137|P2|STARTED|Open-Label Extension Study||83
2525389|NCT00687804|6188138|P1|STARTED|Open-Label Extension Study||83
2525390|NCT00687804|6188136|P3|NOT COMPLETED|Core Study||13
2525391|NCT00687804|6188137|P2|NOT COMPLETED|Core Study||15
2525392|NCT00687804|6188138|P1|NOT COMPLETED|Core Study||14
2525393|NCT00687804|6188136|P3|COMPLETED|Core Study||98
2525394|NCT00687804|6188137|P2|COMPLETED|Core Study||103
2525395|NCT00687804|6188138|P1|COMPLETED|Core Study||102
2525396|NCT00687804|6188136|P3|STARTED|Core Study||111
2525397|NCT00687804|6188137|P2|STARTED|Core Study||118
2525398|NCT00687804|6188138|P1|STARTED|Core Study||116
2525399|NCT00687739|6188185|P4|NOT COMPLETED|Overall Study||2
2525400|NCT00687739|6188186|P3|NOT COMPLETED|Overall Study||2
2525401|NCT00687739|6188187|P2|NOT COMPLETED|Overall Study||3
2525402|NCT00687739|6188188|P1|NOT COMPLETED|Overall Study||2
2525403|NCT00687739|6188185|P4|COMPLETED|Overall Study||12
2525404|NCT00687739|6188186|P3|COMPLETED|Overall Study||23
2525405|NCT00687739|6188187|P2|COMPLETED|Overall Study||12
2525406|NCT00687739|6188188|P1|COMPLETED|Overall Study||23
2525407|NCT00687739|6188185|P4|STARTED|Overall Study||14
2525408|NCT00687739|6188186|P3|STARTED|Overall Study||25
2525409|NCT00687739|6188187|P2|STARTED|Overall Study||15
2525410|NCT00687739|6188188|P1|STARTED|Overall Study||25
2525411|NCT00687713|6188214|P2|NOT COMPLETED|Overall Study||40
2525412|NCT00687713|6188215|P1|NOT COMPLETED|Overall Study||32
2525413|NCT00687713|6188214|P2|COMPLETED|Overall Study||64
2525414|NCT00687713|6188215|P1|COMPLETED|Overall Study||68
2525415|NCT00687713|6188214|P2|STARTED|Overall Study||104
2525416|NCT00687713|6188215|P1|STARTED|Overall Study||100
2525417|NCT00687674|6188223|P1|NOT COMPLETED|Overall Study||2
2525418|NCT00687674|6188223|P1|COMPLETED|Overall Study||11
2525419|NCT00687674|6188223|P1|STARTED|Overall Study||13
2525420|NCT00687609|6188230|P1|NOT COMPLETED|Overall Study||3
2525421|NCT00687609|6188230|P1|COMPLETED|Overall Study||4
2525422|NCT00687609|6188230|P1|STARTED|Overall Study||7
2525423|NCT00687544|6188244|P1|NOT COMPLETED|Overall Study||11
2525424|NCT00687544|6188244|P1|COMPLETED|Overall Study||0
2525425|NCT00687544|6188244|P1|STARTED|Overall Study||11
2525426|NCT00687531|6188253|P1|NOT COMPLETED|Overall Study||135
2525427|NCT00687531|6188253|P1|COMPLETED|Overall Study||250
2525428|NCT00687531|6188253|P1|RECEIVED TREATMENT|Overall Study||281
2525429|NCT00687531|6188253|P1|STARTED|Overall Study|Completed screening procedures|385
2525430|NCT00687453|6188269|P2|NOT COMPLETED|Overall Study||6
2525431|NCT00687453|6188270|P1|NOT COMPLETED|Overall Study||3
2525432|NCT00687453|6188269|P2|COMPLETED|Overall Study||7
2525433|NCT00687453|6188270|P1|COMPLETED|Overall Study||8
2525434|NCT00687453|6188269|P2|STARTED|Overall Study||13
2525435|NCT00687453|6188270|P1|STARTED|Overall Study||11
2525436|NCT00687440|6188276|P1|NOT COMPLETED|Overall Study||12
2525437|NCT00687440|6188276|P1|COMPLETED|Overall Study||15
2525438|NCT00687440|6188276|P1|STARTED|Overall Study|Number of screened participants|27
2525439|NCT00687401|6188280|P1|NOT COMPLETED|Overall Study||30
2525440|NCT00687401|6188280|P1|COMPLETED|Overall Study||129
2525441|NCT00687401|6188280|P1|STARTED|Overall Study|215 participants enrolled in the study, of which 56 failed screening and did not receive study drug.|159
2525442|NCT00687362|6188285|P1|NOT COMPLETED|Overall Study||3
2525443|NCT00687362|6188285|P1|COMPLETED|Overall Study|Completed protocol at Week 24|19
2525444|NCT00687362|6188285|P1|STARTED|Overall Study||22
2525445|NCT00687323|6188289|P1|NOT COMPLETED|Overall Study||180
2525446|NCT00687323|6188289|P1|COMPLETED|Overall Study|Number of participants alive at one year|15
2525447|NCT00687323|6188289|P1|Received Treatment|Overall Study||47
2525448|NCT00687323|6188289|P1|STARTED|Overall Study|Number of screened participants|195
2525449|NCT00687297|6188305|P2|NOT COMPLETED|Maintenance||1
2525450|NCT00687297|6188306|P1|NOT COMPLETED|Maintenance||3
2525451|NCT00687297|6188305|P2|COMPLETED|Maintenance||25
2525452|NCT00687297|6188306|P1|COMPLETED|Maintenance||29
2525453|NCT00687297|6188305|P2|STARTED|Maintenance||26
2525454|NCT00687297|6188306|P1|STARTED|Maintenance||32
2525455|NCT00687297|6188305|P2|NOT COMPLETED|Induction||55
2525456|NCT00687297|6188306|P1|NOT COMPLETED|Induction||45
2525457|NCT00687297|6188305|P2|COMPLETED|Induction||26
2525458|NCT00687297|6188306|P1|COMPLETED|Induction||32
2525459|NCT00687297|6188305|P2|STARTED|Induction||81
2525460|NCT00687297|6188306|P1|STARTED|Induction||77
2525461|NCT00687297|6188305|P2|NOT COMPLETED|Randomization||1
2525462|NCT00687297|6188306|P1|NOT COMPLETED|Randomization||3
2525463|NCT00687297|6188305|P2|COMPLETED|Randomization||81
2525464|NCT00687297|6188306|P1|COMPLETED|Randomization||77
2525465|NCT00687297|6188305|P2|STARTED|Randomization||82
2525466|NCT00687297|6188306|P1|STARTED|Randomization||80
2525467|NCT00687271|6188320|P4|NOT COMPLETED|Overall Study||0
2525468|NCT00687271|6188321|P3|NOT COMPLETED|Overall Study||5
2525469|NCT00687271|6188322|P2|NOT COMPLETED|Overall Study||6
2525470|NCT00687271|6188323|P1|NOT COMPLETED|Overall Study||3
2525471|NCT00687271|6188320|P4|COMPLETED|Overall Study||48
2525472|NCT00687271|6188321|P3|COMPLETED|Overall Study||91
2525473|NCT00687271|6188322|P2|COMPLETED|Overall Study||90
2525474|NCT00687271|6188323|P1|COMPLETED|Overall Study||91
2525475|NCT00687271|6188320|P4|Treated|Overall Study||48
2525476|NCT00687271|6188321|P3|Treated|Overall Study||96
2525477|NCT00687271|6188322|P2|Treated|Overall Study||95
2525478|NCT00687271|6188323|P1|Treated|Overall Study||94
2525479|NCT00687271|6188320|P4|STARTED|Overall Study||48
2525480|NCT00687271|6188321|P3|STARTED|Overall Study||96
2525481|NCT00687271|6188322|P2|STARTED|Overall Study||96
2525482|NCT00687271|6188323|P1|STARTED|Overall Study||94
2525483|NCT00687219|6188361|P1|NOT COMPLETED|Overall Study||51
2525484|NCT00687219|6188361|P1|COMPLETED|Overall Study||51
2525485|NCT00687219|6188361|P1|STARTED|Overall Study||102
2525486|NCT00687193|6188373|P6|NOT COMPLETED|Overall Study||4
2525487|NCT00687193|6188374|P5|NOT COMPLETED|Overall Study||2
2525488|NCT00687193|6188375|P4|NOT COMPLETED|Overall Study||4
2525489|NCT00687193|6188376|P3|NOT COMPLETED|Overall Study||2
2525490|NCT00687193|6188377|P2|NOT COMPLETED|Overall Study||4
2525491|NCT00687193|6188378|P1|NOT COMPLETED|Overall Study||2
2525492|NCT00687193|6188373|P6|COMPLETED|Overall Study||48
2525493|NCT00687193|6188374|P5|COMPLETED|Overall Study||52
2525494|NCT00687193|6188375|P4|COMPLETED|Overall Study||49
2525495|NCT00687193|6188376|P3|COMPLETED|Overall Study||50
2525496|NCT00687193|6188377|P2|COMPLETED|Overall Study||49
2525497|NCT00687193|6188378|P1|COMPLETED|Overall Study||51
2525498|NCT00687193|6188373|P6|STARTED|Overall Study|One participant withdrew after randomization but prior to treatment.|52
2525499|NCT00687193|6188374|P5|STARTED|Overall Study||54
2525500|NCT00687193|6188375|P4|STARTED|Overall Study||53
2525501|NCT00687193|6188376|P3|STARTED|Overall Study||52
2525502|NCT00687193|6188377|P2|STARTED|Overall Study||53
2525503|NCT00687193|6188378|P1|STARTED|Overall Study||53
2525504|NCT00687167|6188542|P2|NOT COMPLETED|Second Intervention||0
2525505|NCT00687167|6188543|P1|NOT COMPLETED|Second Intervention||0
2525506|NCT00687167|6188542|P2|COMPLETED|Second Intervention||17
2525507|NCT00687167|6188543|P1|COMPLETED|Second Intervention||17
2525508|NCT00687167|6188542|P2|STARTED|Second Intervention||17
2525509|NCT00687167|6188543|P1|STARTED|Second Intervention||17
2525510|NCT00687167|6188542|P2|NOT COMPLETED|Washout Period of 28 Days||0
2525511|NCT00687167|6188543|P1|NOT COMPLETED|Washout Period of 28 Days||0
2525512|NCT00687167|6188542|P2|COMPLETED|Washout Period of 28 Days||17
2525513|NCT00687167|6188543|P1|COMPLETED|Washout Period of 28 Days||17
2525514|NCT00687167|6188542|P2|STARTED|Washout Period of 28 Days||17
2525515|NCT00687167|6188543|P1|STARTED|Washout Period of 28 Days||17
2525516|NCT00687167|6188542|P2|NOT COMPLETED|First Intervention||0
2525517|NCT00687167|6188543|P1|NOT COMPLETED|First Intervention||0
2525518|NCT00687167|6188542|P2|COMPLETED|First Intervention||17
2525519|NCT00687167|6188543|P1|COMPLETED|First Intervention||17
2525520|NCT00687167|6188542|P2|STARTED|First Intervention||17
2525521|NCT00687167|6188543|P1|STARTED|First Intervention||17
2525522|NCT00687102|6188553|P2|NOT COMPLETED|Overall Study||0
2525523|NCT00687102|6188554|P1|NOT COMPLETED|Overall Study||0
2525524|NCT00687102|6188553|P2|COMPLETED|Overall Study||765
2525525|NCT00687102|6188554|P1|COMPLETED|Overall Study||733
2525526|NCT00687102|6188553|P2|STARTED|Overall Study||765
2525527|NCT00687102|6188554|P1|STARTED|Overall Study||733
2525528|NCT00687076|6188576|P2|NOT COMPLETED|Overall Study||30
2525529|NCT00687076|6188577|P1|NOT COMPLETED|Overall Study||32
2525530|NCT00687076|6188576|P2|COMPLETED|Overall Study||21
2525531|NCT00687076|6188577|P1|COMPLETED|Overall Study||19
2525532|NCT00687076|6188576|P2|STARTED|Overall Study||51
2525533|NCT00687076|6188577|P1|STARTED|Overall Study||51
2525534|NCT00686998|6188588|P3|NOT COMPLETED|Overall Study||4
2525535|NCT00686998|6188589|P2|NOT COMPLETED|Overall Study||8
2525536|NCT00686998|6188590|P1|NOT COMPLETED|Overall Study||13
2525537|NCT00686998|6188588|P3|COMPLETED|Overall Study||18
2525538|NCT00686998|6188589|P2|COMPLETED|Overall Study||33
2525539|NCT00686998|6188590|P1|COMPLETED|Overall Study||30
2525540|NCT00686998|6188588|P3|Completed Scheduled Treatment|Overall Study||18
2525541|NCT00686998|6188589|P2|Completed Scheduled Treatment|Overall Study||33
2525542|NCT00686998|6188590|P1|Completed Scheduled Treatment|Overall Study||30
2525543|NCT00686998|6188588|P3|Eligible for Efficacy Analysis|Overall Study||21
2525544|NCT00686998|6188589|P2|Eligible for Efficacy Analysis|Overall Study||39
2525545|NCT00686998|6188590|P1|Eligible for Efficacy Analysis|Overall Study||42
2525546|NCT00686998|6188588|P3|Received Treatment|Overall Study||22
2525547|NCT00686998|6188589|P2|Received Treatment|Overall Study||41
2525548|NCT00686998|6188590|P1|Received Treatment|Overall Study||43
2525549|NCT00686998|6188588|P3|Randomized|Overall Study||22
2525550|NCT00686998|6188589|P2|Randomized|Overall Study||41
2525551|NCT00686998|6188590|P1|Randomized|Overall Study||43
2525552|NCT00686998|6188588|P3|STARTED|Overall Study|Randomized & received study medication|22
2525553|NCT00686998|6188589|P2|STARTED|Overall Study|Randomized & received study medication|41
2525554|NCT00686998|6188590|P1|STARTED|Overall Study|Randomized & received study medication|43
2525555|NCT00686972|6188598|P1|NOT COMPLETED|Overall Study||51
2525556|NCT00686972|6188598|P1|COMPLETED|Overall Study||0
2525557|NCT00686972|6188598|P1|STARTED|Overall Study||51
2525558|NCT00686959|6188604|P2|NOT COMPLETED|Overall Study||117
2525559|NCT00686959|6188605|P1|NOT COMPLETED|Overall Study||124
2525560|NCT00686959|6188604|P2|COMPLETED|Overall Study|Study completion includes death due to any cause.|180
2525561|NCT00686959|6188605|P1|COMPLETED|Overall Study|Study completion includes death due to any cause|177
2525562|NCT00686959|6188604|P2|Entered Consolidation Phase|Overall Study||202
2525563|NCT00686959|6188605|P1|Entered Consolidation Phase|Overall Study||229
2525564|NCT00686959|6188604|P2|Received at Least One Dose of Study Drug|Overall Study||272
2525565|NCT00686959|6188605|P1|Received at Least One Dose of Study Drug|Overall Study||283
2525566|NCT00686959|6188604|P2|STARTED|Overall Study||297
2525567|NCT00686959|6188605|P1|STARTED|Overall Study||301
2525568|NCT00686920|6188625|P2|NOT COMPLETED|Overall Study||36
2525569|NCT00686920|6188626|P1|NOT COMPLETED|Overall Study||132
2525570|NCT00686920|6188625|P2|COMPLETED|Overall Study||34
2525571|NCT00686920|6188626|P1|COMPLETED|Overall Study||120
2525572|NCT00686920|6188625|P2|Received At Least 1 Dose Of Study Drug|Overall Study||70
2525573|NCT00686920|6188626|P1|Received At Least 1 Dose Of Study Drug|Overall Study||252
2525574|NCT00686920|6188625|P2|STARTED|Overall Study||70
2525575|NCT00686920|6188626|P1|STARTED|Overall Study||252
2525576|NCT00686894|6188638|P1|NOT COMPLETED|Overall Study||6
2525577|NCT00686894|6188638|P1|COMPLETED|Overall Study||1
2525578|NCT00686894|6188638|P1|STARTED|Overall Study||7
2525579|NCT00686881|6188644|P2|NOT COMPLETED|Overall Study||81
2525580|NCT00686881|6188645|P1|NOT COMPLETED|Overall Study||82
2525581|NCT00686881|6188644|P2|COMPLETED|Overall Study||53
2525582|NCT00686881|6188645|P1|COMPLETED|Overall Study||45
2525583|NCT00686881|6188644|P2|STARTED|Overall Study|After randomization, 6 participants withdrew consent and did not receive study drug.|134
2525584|NCT00686881|6188645|P1|STARTED|Overall Study|After randomization, 2 participants withdrew consent and did not receive study drug.|127
2525585|NCT00686855|6188657|P2|NOT COMPLETED|Overall Study||1
2525586|NCT00686855|6188658|P1|NOT COMPLETED|Overall Study||1
2525587|NCT00686855|6188657|P2|COMPLETED|Overall Study||17
2525588|NCT00686855|6188658|P1|COMPLETED|Overall Study||27
2525589|NCT00686855|6188657|P2|STARTED|Overall Study||18
2525590|NCT00686855|6188658|P1|STARTED|Overall Study||28
2525591|NCT00686842|6188664|P1|NOT COMPLETED|Overall Study||0
2525592|NCT00686842|6188664|P1|COMPLETED|Overall Study||17
2525593|NCT00686842|6188664|P1|STARTED|Overall Study||17
2525594|NCT00686803|6188671|P3|NOT COMPLETED|Overall Study||0
2525595|NCT00686803|6188672|P2|NOT COMPLETED|Overall Study||0
2525596|NCT00686803|6188673|P1|NOT COMPLETED|Overall Study||0
2525597|NCT00686803|6188671|P3|COMPLETED|Overall Study||3
2525598|NCT00686803|6188672|P2|COMPLETED|Overall Study||12
2525599|NCT00686803|6188673|P1|COMPLETED|Overall Study||6
2525600|NCT00686803|6188671|P3|STARTED|Overall Study||3
2525601|NCT00686803|6188672|P2|STARTED|Overall Study||12
2525602|NCT00686803|6188673|P1|STARTED|Overall Study||6
2525603|NCT00686790|6188684|P1|NOT COMPLETED|Overall Study||16
2525604|NCT00686790|6188684|P1|COMPLETED|Overall Study||32
2525605|NCT00686790|6188684|P1|STARTED|Overall Study||48
2525606|NCT00686777|6188692|P1|NOT COMPLETED|Overall Study||10
2525607|NCT00686777|6188692|P1|COMPLETED|Overall Study|Of 10 noncompleters, 6 had AEs including 4 meeting protocol prespecified AE discontinuance criteria.|65
2525608|NCT00686777|6188692|P1|Completed 24 Weeks of Follow-up|Overall Study||70
2525609|NCT00686777|6188692|P1|Included in Follow-up (All Treated)|Overall Study||75
2525610|NCT00686777|6188692|P1|Completed 48 Weeks of Treatment|Overall Study||65
2525611|NCT00686777|6188692|P1|Completed 24 Weeks of Treatment|Overall Study||69
2525612|NCT00686777|6188692|P1|STARTED|Overall Study||75
2525613|NCT00686725|6188700|P2|NOT COMPLETED|Overall Study||42
2525614|NCT00686725|6188701|P1|NOT COMPLETED|Overall Study||46
2525615|NCT00686725|6188700|P2|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|10
2525616|NCT00686725|6188701|P1|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|1
2525617|NCT00686725|6188700|P2|STARTED|Overall Study||52
2525618|NCT00686725|6188701|P1|STARTED|Overall Study||47
2525619|NCT00686712|6188726|P3|NOT COMPLETED|Overall Study||13
2525620|NCT00686712|6188727|P2|NOT COMPLETED|Overall Study||11
2525621|NCT00686712|6188728|P1|NOT COMPLETED|Overall Study||10
2525622|NCT00686712|6188726|P3|COMPLETED|Overall Study||17
2525623|NCT00686712|6188727|P2|COMPLETED|Overall Study||14
2525624|NCT00686712|6188728|P1|COMPLETED|Overall Study||20
2525625|NCT00686712|6188726|P3|STARTED|Overall Study||30
2525626|NCT00686712|6188727|P2|STARTED|Overall Study||25
2525627|NCT00686712|6188728|P1|STARTED|Overall Study||30
2525628|NCT00686699|6188756|P2|NOT COMPLETED|Treatment Period 2||0
2525629|NCT00686699|6188757|P1|NOT COMPLETED|Treatment Period 2||0
2525630|NCT00686699|6188756|P2|COMPLETED|Treatment Period 2||5
2525631|NCT00686699|6188757|P1|COMPLETED|Treatment Period 2||4
2525632|NCT00686699|6188756|P2|STARTED|Treatment Period 2||5
2525633|NCT00686699|6188757|P1|STARTED|Treatment Period 2||4
2525634|NCT00686699|6188756|P2|NOT COMPLETED|Treatment Period 1||2
2525635|NCT00686699|6188757|P1|NOT COMPLETED|Treatment Period 1||0
2525636|NCT00686699|6188756|P2|COMPLETED|Treatment Period 1||5
2525637|NCT00686699|6188757|P1|COMPLETED|Treatment Period 1||4
2525638|NCT00686699|6188756|P2|STARTED|Treatment Period 1||7
2525639|NCT00686699|6188757|P1|STARTED|Treatment Period 1||4
2525640|NCT00686686|6188781|P1|NOT COMPLETED|Overall Study||6
2525641|NCT00686686|6188781|P1|COMPLETED|Overall Study||17
2525642|NCT00686686|6188781|P1|STARTED|Overall Study||23
2525643|NCT00686647|6188789|P1|NOT COMPLETED|Overall Study||2
2525644|NCT00686647|6188789|P1|COMPLETED|Overall Study||91
2525645|NCT00686647|6188789|P1|STARTED|Overall Study||93
2525646|NCT00686634|6188795|P1|NOT COMPLETED|Overall Study||6
2525647|NCT00686634|6188795|P1|COMPLETED|Overall Study||102
2525648|NCT00686634|6188795|P1|STARTED|Overall Study||108
2525649|NCT00686595|6188802|P1|NOT COMPLETED|Overall Study||7
2525650|NCT00686595|6188802|P1|COMPLETED|Overall Study||31
2525651|NCT00686595|6188802|P1|STARTED|Overall Study||38
2525652|NCT00686582|6188830|P3|NOT COMPLETED|Overall Study||0
2525653|NCT00686582|6188831|P2|NOT COMPLETED|Overall Study||14
2525654|NCT00686582|6188832|P1|NOT COMPLETED|Overall Study||18
2525655|NCT00686582|6188830|P3|COMPLETED|Overall Study||121
2525656|NCT00686582|6188831|P2|COMPLETED|Overall Study||77
2525657|NCT00686582|6188832|P1|COMPLETED|Overall Study||74
2525658|NCT00686582|6188830|P3|Booster Vaccination|Overall Study||0
2525659|NCT00686582|6188831|P2|Booster Vaccination|Overall Study||77
2525660|NCT00686582|6188832|P1|Booster Vaccination|Overall Study||75
2525661|NCT00686582|6188830|P3|STARTED|Overall Study||121
2525662|NCT00686582|6188831|P2|STARTED|Overall Study||91
2525663|NCT00686582|6188832|P1|STARTED|Overall Study||92
2525664|NCT00686543|6188862|P4|NOT COMPLETED|Overall Study||3
2525665|NCT00686543|6188863|P3|NOT COMPLETED|Overall Study||5
2525666|NCT00686543|6188864|P2|NOT COMPLETED|Overall Study||1
2525667|NCT00686543|6188865|P1|NOT COMPLETED|Overall Study||14
2525668|NCT00686543|6188862|P4|COMPLETED|Overall Study||17
2525669|NCT00686543|6188863|P3|COMPLETED|Overall Study||15
2525670|NCT00686543|6188864|P2|COMPLETED|Overall Study||20
2525671|NCT00686543|6188865|P1|COMPLETED|Overall Study||0
2525672|NCT00686543|6188862|P4|STARTED|Overall Study||20
2525673|NCT00686543|6188863|P3|STARTED|Overall Study||20
2525674|NCT00686543|6188864|P2|STARTED|Overall Study||21
2525675|NCT00686543|6188865|P1|STARTED|Overall Study||14
2525676|NCT00686517|6188886|P3|NOT COMPLETED|Follow-up||10
2525677|NCT00686517|6188887|P2|NOT COMPLETED|Follow-up||10
2525678|NCT00686517|6188888|P1|NOT COMPLETED|Follow-up||8
2525679|NCT00686517|6188886|P3|COMPLETED|Follow-up||29
2525680|NCT00686517|6188887|P2|COMPLETED|Follow-up||28
2525681|NCT00686517|6188888|P1|COMPLETED|Follow-up||29
2525682|NCT00686517|6188886|P3|STARTED|Follow-up||39
2525683|NCT00686517|6188887|P2|STARTED|Follow-up||38
2525684|NCT00686517|6188888|P1|STARTED|Follow-up||37
2525685|NCT00686517|6188886|P3|NOT COMPLETED|Treatment||1
2525686|NCT00686517|6188887|P2|NOT COMPLETED|Treatment||3
2525687|NCT00686517|6188888|P1|NOT COMPLETED|Treatment||6
2525688|NCT00686517|6188886|P3|COMPLETED|Treatment||42
2525689|NCT00686517|6188887|P2|COMPLETED|Treatment||40
2525690|NCT00686517|6188888|P1|COMPLETED|Treatment||38
2525691|NCT00686517|6188886|P3|Completed Final Treatment Visit|Treatment|Included 1 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
2525692|NCT00686517|6188887|P2|Completed Final Treatment Visit|Treatment|Included 3 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
2525693|NCT00686517|6188888|P1|Completed Final Treatment Visit|Treatment|Included 6 that discontinued the treatment before completion,but performed the Final Treatment Visit|44
2525694|NCT00686517|6188886|P3|STARTED|Treatment||43
2525695|NCT00686517|6188887|P2|STARTED|Treatment||43
2525696|NCT00686517|6188888|P1|STARTED|Treatment||44
2525697|NCT00686374|6188911|P1|NOT COMPLETED|Overall Study||61
2525698|NCT00686374|6188911|P1|COMPLETED|Overall Study||39
2525699|NCT00686374|6188911|P1|STARTED|Overall Study||100
2525700|NCT00686335|6188922|P1|NOT COMPLETED|Treatment Period||0
2525701|NCT00686335|6188922|P1|COMPLETED|Treatment Period||7
2525702|NCT00686335|6188922|P1|STARTED|Treatment Period||7
2525703|NCT00686335|6188922|P1|NOT COMPLETED|Run-in Period||5
2525704|NCT00686335|6188922|P1|COMPLETED|Run-in Period||7
2525705|NCT00686335|6188922|P1|STARTED|Run-in Period||12
2525706|NCT00686257|6188930|P2|NOT COMPLETED|Overall Study||0
2525707|NCT00686257|6188931|P1|NOT COMPLETED|Overall Study||0
2525708|NCT00686257|6188930|P2|COMPLETED|Overall Study||31
2525709|NCT00686257|6188931|P1|COMPLETED|Overall Study||29
2525710|NCT00686257|6188930|P2|STARTED|Overall Study||31
2525711|NCT00686257|6188931|P1|STARTED|Overall Study||29
2525712|NCT00686231|6188954|P3|NOT COMPLETED|Overall Study||0
2525713|NCT00686231|6188955|P2|NOT COMPLETED|Overall Study||0
2525714|NCT00686231|6188956|P1|NOT COMPLETED|Overall Study||0
2525715|NCT00686231|6188954|P3|COMPLETED|Overall Study||20
2525716|NCT00686231|6188955|P2|COMPLETED|Overall Study||20
2525717|NCT00686231|6188956|P1|COMPLETED|Overall Study||20
2525718|NCT00686231|6188954|P3|STARTED|Overall Study||20
2525719|NCT00686231|6188955|P2|STARTED|Overall Study||20
2525720|NCT00686231|6188956|P1|STARTED|Overall Study||20
2525721|NCT00686205|6188966|P2|NOT COMPLETED|Overall Study||981
2525722|NCT00686205|6188967|P1|NOT COMPLETED|Overall Study||6007
2525723|NCT00686205|6188966|P2|COMPLETED|Overall Study||1524
2525724|NCT00686205|6188967|P1|COMPLETED|Overall Study||15599
2525725|NCT00686205|6188966|P2|STARTED|Overall Study||2505
2525726|NCT00686205|6188967|P1|STARTED|Overall Study||21606
2525727|NCT00686166|6188973|P1|NOT COMPLETED|Overall Study||20
2525728|NCT00686166|6188973|P1|COMPLETED|Overall Study||63
2525729|NCT00686166|6188973|P1|Eligible and Began Protocol Therapy|Overall Study||74
2525730|NCT00686166|6188973|P1|Eligible|Overall Study||78
2525731|NCT00686166|6188973|P1|STARTED|Overall Study||83
2525732|NCT00686127|6188985|P2|NOT COMPLETED|Overall Study||6
2525733|NCT00686127|6188986|P1|NOT COMPLETED|Overall Study||14
2525734|NCT00686127|6188985|P2|COMPLETED|Overall Study||1
2525735|NCT00686127|6188986|P1|COMPLETED|Overall Study|Patients withdrew from the study because they did not like wearing the patch.|0
2525736|NCT00686127|6188985|P2|STARTED|Overall Study||7
2525737|NCT00686127|6188986|P1|STARTED|Overall Study||14
2525738|NCT00686075|6189002|P10|NOT COMPLETED|Overall Study||10
2525739|NCT00686075|6189003|P9|NOT COMPLETED|Overall Study||6
2525740|NCT00686075|6189004|P8|NOT COMPLETED|Overall Study||2
2525741|NCT00686075|6189005|P7|NOT COMPLETED|Overall Study||0
2525742|NCT00686075|6189006|P6|NOT COMPLETED|Overall Study||3
2525743|NCT00686075|6189007|P5|NOT COMPLETED|Overall Study||4
2525744|NCT00686075|6189008|P4|NOT COMPLETED|Overall Study||9
2525745|NCT00686075|6189009|P3|NOT COMPLETED|Overall Study||6
2525746|NCT00686075|6189010|P2|NOT COMPLETED|Overall Study||10
2525747|NCT00686075|6189011|P1|NOT COMPLETED|Overall Study||8
2525748|NCT00686075|6189002|P10|COMPLETED|Overall Study||69
2525749|NCT00686075|6189003|P9|COMPLETED|Overall Study||75
2525750|NCT00686075|6189004|P8|COMPLETED|Overall Study||76
2525751|NCT00686075|6189005|P7|COMPLETED|Overall Study||82
2525752|NCT00686075|6189006|P6|COMPLETED|Overall Study||37
2525753|NCT00686075|6189007|P5|COMPLETED|Overall Study||36
2525754|NCT00686075|6189008|P4|COMPLETED|Overall Study||71
2525755|NCT00686075|6189009|P3|COMPLETED|Overall Study||74
2525756|NCT00686075|6189010|P2|COMPLETED|Overall Study||71
2525757|NCT00686075|6189011|P1|COMPLETED|Overall Study||71
2525758|NCT00686075|6189002|P10|Treated|Overall Study||78
2525759|NCT00686075|6189003|P9|Treated|Overall Study||80
2525760|NCT00686075|6189004|P8|Treated|Overall Study||77
2525761|NCT00686075|6189005|P7|Treated|Overall Study||82
2525762|NCT00686075|6189006|P6|Treated|Overall Study||40
2525763|NCT00686075|6189007|P5|Treated|Overall Study||40
2525764|NCT00686075|6189008|P4|Treated|Overall Study||80
2525765|NCT00686075|6189009|P3|Treated|Overall Study||80
2525766|NCT00686075|6189010|P2|Treated|Overall Study||79
2525767|NCT00686075|6189011|P1|Treated|Overall Study||78
2525768|NCT00686075|6189002|P10|STARTED|Overall Study||79
2525769|NCT00686075|6189003|P9|STARTED|Overall Study||81
2525770|NCT00686075|6189004|P8|STARTED|Overall Study||78
2525771|NCT00686075|6189005|P7|STARTED|Overall Study||82
2525772|NCT00686075|6189006|P6|STARTED|Overall Study||40
2525773|NCT00686075|6189007|P5|STARTED|Overall Study||40
2525774|NCT00686075|6189008|P4|STARTED|Overall Study||80
2525775|NCT00686075|6189009|P3|STARTED|Overall Study||80
2525776|NCT00686075|6189010|P2|STARTED|Overall Study||81
2525777|NCT00686075|6189011|P1|STARTED|Overall Study||79
2525778|NCT00686036|6189205|P2|NOT COMPLETED|Overall Study||6
2525779|NCT00686036|6189206|P1|NOT COMPLETED|Overall Study||9
2525780|NCT00686036|6189205|P2|COMPLETED|Overall Study||2
2525781|NCT00686036|6189206|P1|COMPLETED|Overall Study||0
2525782|NCT00686036|6189205|P2|STARTED|Overall Study||8
2525783|NCT00686036|6189206|P1|STARTED|Overall Study||9
2525784|NCT00685945|6189218|P1|NOT COMPLETED|Sildenafil + L-NMMA + Bradykinin||0
2525785|NCT00685945|6189218|P1|COMPLETED|Sildenafil + L-NMMA + Bradykinin||12
2525786|NCT00685945|6189218|P1|STARTED|Sildenafil + L-NMMA + Bradykinin||12
2525787|NCT00685945|6189218|P1|NOT COMPLETED|Isosorbide + L-NMMA + Bradykinin||0
2525788|NCT00685945|6189218|P1|COMPLETED|Isosorbide + L-NMMA + Bradykinin||11
2525789|NCT00685945|6189218|P1|STARTED|Isosorbide + L-NMMA + Bradykinin||11
2525790|NCT00685945|6189218|P1|NOT COMPLETED|L-NMMA + Bradykinin||1
2525791|NCT00685945|6189218|P1|COMPLETED|L-NMMA + Bradykinin||23
2525792|NCT00685945|6189218|P1|STARTED|L-NMMA + Bradykinin||24
2525793|NCT00685945|6189218|P1|NOT COMPLETED|Control (Bradykinin Infusion)||0
2525794|NCT00685945|6189218|P1|COMPLETED|Control (Bradykinin Infusion)||24
2525795|NCT00685945|6189218|P1|STARTED|Control (Bradykinin Infusion)|A total of 24 subjects received an infusion of bradykinin|24
2525796|NCT00685932|6189235|P2|NOT COMPLETED|Overall Study||20
2525797|NCT00685932|6189236|P1|NOT COMPLETED|Overall Study||21
2525798|NCT00685932|6189235|P2|COMPLETED|Overall Study||58
2525799|NCT00685932|6189236|P1|COMPLETED|Overall Study||55
2525800|NCT00685932|6189235|P2|STARTED|Overall Study||78
2525801|NCT00685932|6189236|P1|STARTED|Overall Study||76
2525802|NCT00685880|6189246|P2|NOT COMPLETED|Overall Study||0
2525803|NCT00685880|6189247|P1|NOT COMPLETED|Overall Study||0
2525804|NCT00685880|6189246|P2|COMPLETED|Overall Study||2
2525805|NCT00685880|6189247|P1|COMPLETED|Overall Study||0
2525806|NCT00685880|6189246|P2|STARTED|Overall Study||2
2525807|NCT00685880|6189247|P1|STARTED|Overall Study||0
2525808|NCT00685802|6189253|P2|NOT COMPLETED|Second Intervention||0
2525809|NCT00685802|6189254|P1|NOT COMPLETED|Second Intervention||0
2525810|NCT00685802|6189253|P2|COMPLETED|Second Intervention||15
2525811|NCT00685802|6189254|P1|COMPLETED|Second Intervention||14
2525812|NCT00685802|6189253|P2|STARTED|Second Intervention||15
2525813|NCT00685802|6189254|P1|STARTED|Second Intervention||14
2525814|NCT00685802|6189253|P2|NOT COMPLETED|Washout Period of 7 Days||1
2525815|NCT00685802|6189254|P1|NOT COMPLETED|Washout Period of 7 Days||2
2525816|NCT00685802|6189253|P2|COMPLETED|Washout Period of 7 Days||15
2525817|NCT00685802|6189254|P1|COMPLETED|Washout Period of 7 Days||14
2525818|NCT00685802|6189253|P2|STARTED|Washout Period of 7 Days||16
2525819|NCT00685802|6189254|P1|STARTED|Washout Period of 7 Days||16
2525820|NCT00685802|6189253|P2|NOT COMPLETED|First Intervention||0
2525821|NCT00685802|6189254|P1|NOT COMPLETED|First Intervention||0
2525822|NCT00685802|6189253|P2|COMPLETED|First Intervention||16
2525823|NCT00685802|6189254|P1|COMPLETED|First Intervention||16
2525824|NCT00685802|6189253|P2|STARTED|First Intervention||16
2525825|NCT00685802|6189254|P1|STARTED|First Intervention||16
2525826|NCT00685763|6189264|P1|NOT COMPLETED|Overall Study||2
2525827|NCT00685763|6189264|P1|COMPLETED|Overall Study||11
2525828|NCT00685763|6189264|P1|STARTED|Overall Study||13
2525829|NCT00685750|6189275|P7|NOT COMPLETED|Overall Study||1
2525830|NCT00685750|6189276|P6|NOT COMPLETED|Overall Study||0
2525831|NCT00685750|6189277|P5|NOT COMPLETED|Overall Study||0
2525832|NCT00685750|6189278|P4|NOT COMPLETED|Overall Study||0
2525833|NCT00685750|6189279|P3|NOT COMPLETED|Overall Study||2
2525834|NCT00685750|6189280|P2|NOT COMPLETED|Overall Study||0
2525835|NCT00685750|6189281|P1|NOT COMPLETED|Overall Study||0
2525836|NCT00685750|6189275|P7|COMPLETED|Overall Study||9
2525837|NCT00685750|6189276|P6|COMPLETED|Overall Study||20
2525838|NCT00685750|6189277|P5|COMPLETED|Overall Study||15
2525839|NCT00685750|6189278|P4|COMPLETED|Overall Study||2
2525840|NCT00685750|6189279|P3|COMPLETED|Overall Study||19
2525841|NCT00685750|6189280|P2|COMPLETED|Overall Study||3
2525842|NCT00685750|6189281|P1|COMPLETED|Overall Study||17
2525843|NCT00685750|6189275|P7|STARTED|Overall Study||10
2525844|NCT00685750|6189276|P6|STARTED|Overall Study||20
2525845|NCT00685750|6189277|P5|STARTED|Overall Study||15
2525846|NCT00685750|6189278|P4|STARTED|Overall Study||2
2525847|NCT00685750|6189279|P3|STARTED|Overall Study||21
2525848|NCT00685750|6189280|P2|STARTED|Overall Study||3
2525849|NCT00685750|6189281|P1|STARTED|Overall Study||17
2525850|NCT00685698|6189309|P1|NOT COMPLETED|Overall Study||13
2525851|NCT00685698|6189309|P1|COMPLETED|Overall Study||25
2525852|NCT00685698|6189309|P1|STARTED|Overall Study||38
2525853|NCT00685685|6189344|P2|NOT COMPLETED|Second Intervention||0
2525854|NCT00685685|6189345|P1|NOT COMPLETED|Second Intervention||0
2525855|NCT00685685|6189344|P2|COMPLETED|Second Intervention||26
2525856|NCT00685685|6189345|P1|COMPLETED|Second Intervention||25
2525857|NCT00685685|6189344|P2|STARTED|Second Intervention||26
2525858|NCT00685685|6189345|P1|STARTED|Second Intervention||25
2525859|NCT00685685|6189344|P2|NOT COMPLETED|Washout Period of 7 Days||1
2525860|NCT00685685|6189345|P1|NOT COMPLETED|Washout Period of 7 Days||2
2525861|NCT00685685|6189344|P2|COMPLETED|Washout Period of 7 Days||26
2525862|NCT00685685|6189345|P1|COMPLETED|Washout Period of 7 Days||25
2525863|NCT00685685|6189344|P2|STARTED|Washout Period of 7 Days||27
2525864|NCT00685685|6189345|P1|STARTED|Washout Period of 7 Days||27
2525865|NCT00685685|6189344|P2|NOT COMPLETED|First Intervention||0
2525866|NCT00685685|6189345|P1|NOT COMPLETED|First Intervention||0
2525867|NCT00685685|6189344|P2|COMPLETED|First Intervention||27
2525868|NCT00685685|6189345|P1|COMPLETED|First Intervention||27
2525869|NCT00685685|6189344|P2|STARTED|First Intervention||27
2525870|NCT00685685|6189345|P1|STARTED|First Intervention||27
2525871|NCT00685659|6189358|P3|NOT COMPLETED|Overall Study||15
2525872|NCT00685659|6189359|P2|NOT COMPLETED|Overall Study||25
2525873|NCT00685659|6189360|P1|NOT COMPLETED|Overall Study||31
2525874|NCT00685659|6189358|P3|COMPLETED|Overall Study||92
2525875|NCT00685659|6189359|P2|COMPLETED|Overall Study||81
2525876|NCT00685659|6189360|P1|COMPLETED|Overall Study||77
2525877|NCT00685659|6189358|P3|STARTED|Overall Study||107
2525878|NCT00685659|6189359|P2|STARTED|Overall Study||106
2525879|NCT00685659|6189360|P1|STARTED|Overall Study||108
2525880|NCT00685516|6189458|P3|NOT COMPLETED|Overall Study||7
2525881|NCT00685516|6189459|P2|NOT COMPLETED|Overall Study||5
2525882|NCT00685516|6189460|P1|NOT COMPLETED|Overall Study||8
2525883|NCT00685516|6189458|P3|COMPLETED|Overall Study||26
2525884|NCT00685516|6189459|P2|COMPLETED|Overall Study||33
2525885|NCT00685516|6189460|P1|COMPLETED|Overall Study||34
2525886|NCT00685516|6189458|P3|STARTED|Overall Study||33
2525887|NCT00685516|6189459|P2|STARTED|Overall Study||38
2525888|NCT00685516|6189460|P1|STARTED|Overall Study||42
2525889|NCT00685477|6189477|P6|NOT COMPLETED|Overall Study||0
2525890|NCT00685477|6189478|P5|NOT COMPLETED|Overall Study||0
2525891|NCT00685477|6189479|P4|NOT COMPLETED|Overall Study||0
2525892|NCT00685477|6189480|P3|NOT COMPLETED|Overall Study||0
2525893|NCT00685477|6189481|P2|NOT COMPLETED|Overall Study||0
2525894|NCT00685477|6189482|P1|NOT COMPLETED|Overall Study||0
2525895|NCT00685477|6189477|P6|COMPLETED|Overall Study||10
2525896|NCT00685477|6189478|P5|COMPLETED|Overall Study||10
2525897|NCT00685477|6189479|P4|COMPLETED|Overall Study||10
2525898|NCT00685477|6189480|P3|COMPLETED|Overall Study||10
2525899|NCT00685477|6189481|P2|COMPLETED|Overall Study||10
2525900|NCT00685477|6189482|P1|COMPLETED|Overall Study||10
2525901|NCT00685477|6189477|P6|STARTED|Overall Study||10
2525902|NCT00685477|6189478|P5|STARTED|Overall Study||10
2525903|NCT00685477|6189479|P4|STARTED|Overall Study||10
2525904|NCT00685477|6189480|P3|STARTED|Overall Study||10
2525905|NCT00685477|6189481|P2|STARTED|Overall Study||10
2525906|NCT00685477|6189482|P1|STARTED|Overall Study||10
2525907|NCT00685399|6189498|P8|NOT COMPLETED|Extension||0
2525908|NCT00685399|6189499|P7|NOT COMPLETED|Extension||0
2525909|NCT00685399|6189500|P6|NOT COMPLETED|Extension||0
2525910|NCT00685399|6189501|P5|NOT COMPLETED|Extension||0
2525911|NCT00685399|6189502|P4|NOT COMPLETED|Extension||7
2525912|NCT00685399|6189503|P3|NOT COMPLETED|Extension||0
2525913|NCT00685399|6189504|P2|NOT COMPLETED|Extension||0
2525914|NCT00685399|6189505|P1|NOT COMPLETED|Extension||0
2525915|NCT00685399|6189498|P8|COMPLETED|Extension||0
2525916|NCT00685399|6189499|P7|COMPLETED|Extension||0
2525917|NCT00685399|6189500|P6|COMPLETED|Extension||0
2525918|NCT00685399|6189501|P5|COMPLETED|Extension||0
2525919|NCT00685399|6189502|P4|COMPLETED|Extension||21
2525920|NCT00685399|6189503|P3|COMPLETED|Extension||0
2525921|NCT00685399|6189504|P2|COMPLETED|Extension||0
2525922|NCT00685399|6189505|P1|COMPLETED|Extension||0
2525923|NCT00685399|6189498|P8|STARTED|Extension||0
2525924|NCT00685399|6189499|P7|STARTED|Extension||0
2525925|NCT00685399|6189500|P6|STARTED|Extension||0
2525926|NCT00685399|6189501|P5|STARTED|Extension||0
2525927|NCT00685399|6189502|P4|STARTED|Extension||28
2525928|NCT00685399|6189503|P3|STARTED|Extension||0
2525929|NCT00685399|6189504|P2|STARTED|Extension||0
2525930|NCT00685399|6189505|P1|STARTED|Extension||0
2525931|NCT00685399|6189498|P8|NOT COMPLETED|Treatment Period 2||2
2525932|NCT00685399|6189499|P7|NOT COMPLETED|Treatment Period 2||0
2525933|NCT00685399|6189500|P6|NOT COMPLETED|Treatment Period 2||2
2525934|NCT00685399|6189501|P5|NOT COMPLETED|Treatment Period 2||0
2525935|NCT00685399|6189502|P4|NOT COMPLETED|Treatment Period 2||0
2525936|NCT00685399|6189503|P3|NOT COMPLETED|Treatment Period 2||3
2525937|NCT00685399|6189504|P2|NOT COMPLETED|Treatment Period 2||12
2525938|NCT00685399|6189505|P1|NOT COMPLETED|Treatment Period 2||0
2525939|NCT00685399|6189498|P8|COMPLETED|Treatment Period 2||10
2525940|NCT00685399|6189499|P7|COMPLETED|Treatment Period 2||13
2525941|NCT00685399|6189500|P6|COMPLETED|Treatment Period 2||10
2525942|NCT00685399|6189501|P5|COMPLETED|Treatment Period 2||4
2525943|NCT00685399|6189502|P4|COMPLETED|Treatment Period 2|in extension period only|0
2525944|NCT00685399|6189503|P3|COMPLETED|Treatment Period 2||2
2525945|NCT00685399|6189504|P2|COMPLETED|Treatment Period 2||2
2525946|NCT00685399|6189505|P1|COMPLETED|Treatment Period 2||0
2525947|NCT00685399|6189498|P8|STARTED|Treatment Period 2||12
2525948|NCT00685399|6189499|P7|STARTED|Treatment Period 2||13
2525949|NCT00685399|6189500|P6|STARTED|Treatment Period 2||12
2525950|NCT00685399|6189501|P5|STARTED|Treatment Period 2||4
2525951|NCT00685399|6189502|P4|STARTED|Treatment Period 2|in extension period only|0
2525952|NCT00685399|6189503|P3|STARTED|Treatment Period 2||5
2525953|NCT00685399|6189504|P2|STARTED|Treatment Period 2||14
2525954|NCT00685399|6189505|P1|STARTED|Treatment Period 2||0
2525955|NCT00685399|6189498|P8|NOT COMPLETED|Treatment Period 1||0
2525956|NCT00685399|6189499|P7|NOT COMPLETED|Treatment Period 1||0
2525957|NCT00685399|6189500|P6|NOT COMPLETED|Treatment Period 1||0
2525958|NCT00685399|6189501|P5|NOT COMPLETED|Treatment Period 1||0
2525959|NCT00685399|6189502|P4|NOT COMPLETED|Treatment Period 1||0
2525960|NCT00685399|6189503|P3|NOT COMPLETED|Treatment Period 1||0
2525961|NCT00685399|6189504|P2|NOT COMPLETED|Treatment Period 1||0
2525962|NCT00685399|6189505|P1|NOT COMPLETED|Treatment Period 1||6
2525963|NCT00685399|6189498|P8|COMPLETED|Treatment Period 1||0
2525964|NCT00685399|6189499|P7|COMPLETED|Treatment Period 1||0
2525965|NCT00685399|6189500|P6|COMPLETED|Treatment Period 1||0
2525966|NCT00685399|6189501|P5|COMPLETED|Treatment Period 1||0
2525967|NCT00685399|6189502|P4|COMPLETED|Treatment Period 1||0
2525968|NCT00685399|6189503|P3|COMPLETED|Treatment Period 1||0
2525969|NCT00685399|6189504|P2|COMPLETED|Treatment Period 1||0
2525970|NCT00685399|6189505|P1|COMPLETED|Treatment Period 1||10
2525971|NCT00685399|6189498|P8|STARTED|Treatment Period 1||0
2525972|NCT00685399|6189499|P7|STARTED|Treatment Period 1||0
2525973|NCT00685399|6189500|P6|STARTED|Treatment Period 1||0
2525974|NCT00685399|6189501|P5|STARTED|Treatment Period 1||0
2525975|NCT00685399|6189502|P4|STARTED|Treatment Period 1||0
2525976|NCT00685399|6189503|P3|STARTED|Treatment Period 1||0
2525977|NCT00685399|6189504|P2|STARTED|Treatment Period 1||0
2525978|NCT00685399|6189505|P1|STARTED|Treatment Period 1||16
2525979|NCT00685373|6189538|P1|NOT COMPLETED|Overall Study||15
2525980|NCT00685373|6189538|P1|COMPLETED|Overall Study||151
2525981|NCT00685373|6189538|P1|STARTED|Overall Study||166
2525982|NCT00685334|6189547|P2|NOT COMPLETED|Overall Study||7
2525983|NCT00685334|6189548|P1|NOT COMPLETED|Overall Study||10
2525984|NCT00685334|6189547|P2|COMPLETED|Overall Study||3
2525985|NCT00685334|6189548|P1|COMPLETED|Overall Study||2
2525986|NCT00685334|6189547|P2|STARTED|Overall Study||10
2525987|NCT00685334|6189548|P1|STARTED|Overall Study||12
2525988|NCT00685295|6189558|P2|NOT COMPLETED|Overall Study||0
2525989|NCT00685295|6189559|P1|NOT COMPLETED|Overall Study||0
2525990|NCT00685295|6189558|P2|COMPLETED|Overall Study||30
2525991|NCT00685295|6189559|P1|COMPLETED|Overall Study||30
2525992|NCT00685295|6189558|P2|STARTED|Overall Study||30
2525993|NCT00685295|6189559|P1|STARTED|Overall Study||30
2525994|NCT00685178|6189573|P4|NOT COMPLETED|Overall Study||14
2525995|NCT00685178|6189574|P3|NOT COMPLETED|Overall Study||12
2525996|NCT00685178|6189575|P2|NOT COMPLETED|Overall Study||19
2525997|NCT00685178|6189576|P1|NOT COMPLETED|Overall Study||13
2525998|NCT00685178|6189573|P4|COMPLETED|Overall Study||33
2525999|NCT00685178|6189574|P3|COMPLETED|Overall Study||27
2526000|NCT00685178|6189575|P2|COMPLETED|Overall Study||26
2526001|NCT00685178|6189576|P1|COMPLETED|Overall Study||27
2526002|NCT00685178|6189573|P4|STARTED|Overall Study||47
2526003|NCT00685178|6189574|P3|STARTED|Overall Study||39
2526004|NCT00685178|6189575|P2|STARTED|Overall Study||45
2526005|NCT00685178|6189576|P1|STARTED|Overall Study||40
2526006|NCT00685165|6189590|P2|NOT COMPLETED|Second Intervention||0
2526007|NCT00685165|6189591|P1|NOT COMPLETED|Second Intervention||0
2526008|NCT00685165|6189590|P2|COMPLETED|Second Intervention||11
2526009|NCT00685165|6189591|P1|COMPLETED|Second Intervention||10
2526010|NCT00685165|6189590|P2|STARTED|Second Intervention||11
2526011|NCT00685165|6189591|P1|STARTED|Second Intervention||10
2526012|NCT00685165|6189590|P2|NOT COMPLETED|Washout Period of 14 Days||0
2526013|NCT00685165|6189591|P1|NOT COMPLETED|Washout Period of 14 Days||1
2526014|NCT00685165|6189590|P2|COMPLETED|Washout Period of 14 Days||11
2526015|NCT00685165|6189591|P1|COMPLETED|Washout Period of 14 Days|adverse event- possible upper respiratory infection|10
2526016|NCT00685165|6189590|P2|STARTED|Washout Period of 14 Days||11
2526017|NCT00685165|6189591|P1|STARTED|Washout Period of 14 Days||11
2526018|NCT00685165|6189590|P2|NOT COMPLETED|First Intervention||0
2526019|NCT00685165|6189591|P1|NOT COMPLETED|First Intervention||0
2526020|NCT00685165|6189590|P2|COMPLETED|First Intervention||11
2526021|NCT00685165|6189591|P1|COMPLETED|First Intervention||11
2526022|NCT00685165|6189590|P2|STARTED|First Intervention||11
2526023|NCT00685165|6189591|P1|STARTED|First Intervention||11
2526024|NCT00685139|6189601|P2|NOT COMPLETED|Second Intervention||0
2526025|NCT00685139|6189602|P1|NOT COMPLETED|Second Intervention||0
2526026|NCT00685139|6189601|P2|COMPLETED|Second Intervention||17
2526027|NCT00685139|6189602|P1|COMPLETED|Second Intervention||17
2526028|NCT00685139|6189601|P2|STARTED|Second Intervention||17
2526029|NCT00685139|6189602|P1|STARTED|Second Intervention||17
2526030|NCT00685139|6189601|P2|NOT COMPLETED|Washout Period of 28 Days||0
2526031|NCT00685139|6189602|P1|NOT COMPLETED|Washout Period of 28 Days||0
2526032|NCT00685139|6189601|P2|COMPLETED|Washout Period of 28 Days||17
2526033|NCT00685139|6189602|P1|COMPLETED|Washout Period of 28 Days||17
2526034|NCT00685139|6189601|P2|STARTED|Washout Period of 28 Days||17
2526035|NCT00685139|6189602|P1|STARTED|Washout Period of 28 Days||17
2526036|NCT00685139|6189601|P2|NOT COMPLETED|First Intervention||0
2526037|NCT00685139|6189602|P1|NOT COMPLETED|First Intervention||0
2526038|NCT00685139|6189601|P2|COMPLETED|First Intervention||17
2526039|NCT00685139|6189602|P1|COMPLETED|First Intervention||17
2526040|NCT00685139|6189601|P2|STARTED|First Intervention||17
2526041|NCT00685139|6189602|P1|STARTED|First Intervention||17
2526042|NCT00685035|6189610|P2|NOT COMPLETED|Period 3: 2nd Intervention||0
2526043|NCT00685035|6189611|P1|NOT COMPLETED|Period 3: 2nd Intervention||0
2526044|NCT00685035|6189610|P2|COMPLETED|Period 3: 2nd Intervention||8
2526045|NCT00685035|6189611|P1|COMPLETED|Period 3: 2nd Intervention||8
2526046|NCT00685035|6189610|P2|STARTED|Period 3: 2nd Intervention||8
2526047|NCT00685035|6189611|P1|STARTED|Period 3: 2nd Intervention||8
2526048|NCT00685035|6189610|P2|NOT COMPLETED|Period 2: 2-day Washout||0
2526049|NCT00685035|6189611|P1|NOT COMPLETED|Period 2: 2-day Washout||0
2526050|NCT00685035|6189610|P2|COMPLETED|Period 2: 2-day Washout||8
2526051|NCT00685035|6189611|P1|COMPLETED|Period 2: 2-day Washout||8
2526052|NCT00685035|6189610|P2|STARTED|Period 2: 2-day Washout||8
2526053|NCT00685035|6189611|P1|STARTED|Period 2: 2-day Washout||8
2526054|NCT00685035|6189610|P2|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||0
2526055|NCT00685035|6189611|P1|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||1
2526056|NCT00685035|6189610|P2|COMPLETED|Period 1: First Intervention: 30 Minutes||8
2526057|NCT00685035|6189611|P1|COMPLETED|Period 1: First Intervention: 30 Minutes||8
2526058|NCT00685035|6189610|P2|STARTED|Period 1: First Intervention: 30 Minutes||8
2526059|NCT00685035|6189611|P1|STARTED|Period 1: First Intervention: 30 Minutes||9
2526060|NCT00684996|6189635|P1|NOT COMPLETED|Overall Study||5
2526061|NCT00684996|6189635|P1|COMPLETED|Overall Study||0
2526062|NCT00684996|6189635|P1|Eligible|Overall Study||5
2526063|NCT00684996|6189635|P1|STARTED|Overall Study||5
2526064|NCT00684983|6189650|P2|NOT COMPLETED|Overall Study||0
2526065|NCT00684983|6189651|P1|NOT COMPLETED|Overall Study||0
2526066|NCT00684983|6189650|P2|COMPLETED|Overall Study|One major violation patient in Arm B is included in the primary analysis per protocol.|45
2526067|NCT00684983|6189651|P1|COMPLETED|Overall Study||19
2526068|NCT00684983|6189650|P2|STARTED|Overall Study||45
2526069|NCT00684983|6189651|P1|STARTED|Overall Study||19
2526070|NCT00684814|6189667|P2|NOT COMPLETED|Second Intervention||0
2526071|NCT00684814|6189668|P1|NOT COMPLETED|Second Intervention||1
2526072|NCT00684814|6189667|P2|COMPLETED|Second Intervention||15
2526073|NCT00684814|6189668|P1|COMPLETED|Second Intervention||16
2526074|NCT00684814|6189667|P2|STARTED|Second Intervention||15
2526075|NCT00684814|6189668|P1|STARTED|Second Intervention||17
2526076|NCT00684814|6189667|P2|NOT COMPLETED|Washout Period of 7 Days||4
2526077|NCT00684814|6189668|P1|NOT COMPLETED|Washout Period of 7 Days||2
2526078|NCT00684814|6189667|P2|COMPLETED|Washout Period of 7 Days||15
2526079|NCT00684814|6189668|P1|COMPLETED|Washout Period of 7 Days||17
2526080|NCT00684814|6189667|P2|STARTED|Washout Period of 7 Days||19
2526081|NCT00684814|6189668|P1|STARTED|Washout Period of 7 Days||19
2526082|NCT00684814|6189667|P2|NOT COMPLETED|First Intervention||0
2526083|NCT00684814|6189668|P1|NOT COMPLETED|First Intervention||0
2526084|NCT00684814|6189667|P2|COMPLETED|First Intervention||19
2526085|NCT00684814|6189668|P1|COMPLETED|First Intervention||19
2526086|NCT00684814|6189667|P2|STARTED|First Intervention||19
2526087|NCT00684814|6189668|P1|STARTED|First Intervention||19
2526088|NCT00684788|6189680|P2|NOT COMPLETED|Overall Study||0
2526089|NCT00684788|6189681|P1|NOT COMPLETED|Overall Study||0
2526090|NCT00684788|6189680|P2|COMPLETED|Overall Study||18
2526091|NCT00684788|6189681|P1|COMPLETED|Overall Study||17
2526092|NCT00684788|6189680|P2|STARTED|Overall Study||18
2526093|NCT00684788|6189681|P1|STARTED|Overall Study||17
2526094|NCT00684775|6189701|P2|NOT COMPLETED|Overall Study||0
2526095|NCT00684775|6189702|P1|NOT COMPLETED|Overall Study||0
2526096|NCT00684775|6189701|P2|COMPLETED|Overall Study||19
2526097|NCT00684775|6189702|P1|COMPLETED|Overall Study||19
2526098|NCT00684775|6189701|P2|STARTED|Overall Study||19
2526099|NCT00684775|6189702|P1|STARTED|Overall Study||19
2526100|NCT00684762|6189720|P2|NOT COMPLETED|Second Intervention||0
2526101|NCT00684762|6189721|P1|NOT COMPLETED|Second Intervention||0
2526102|NCT00684762|6189720|P2|COMPLETED|Second Intervention||14
2526103|NCT00684762|6189721|P1|COMPLETED|Second Intervention||14
2526104|NCT00684762|6189720|P2|STARTED|Second Intervention||14
2526105|NCT00684762|6189721|P1|STARTED|Second Intervention||14
2526106|NCT00684762|6189720|P2|NOT COMPLETED|Washout Period of 7 Days||2
2526107|NCT00684762|6189721|P1|NOT COMPLETED|Washout Period of 7 Days||2
2526108|NCT00684762|6189720|P2|COMPLETED|Washout Period of 7 Days||14
2526109|NCT00684762|6189721|P1|COMPLETED|Washout Period of 7 Days||14
2526110|NCT00684762|6189720|P2|STARTED|Washout Period of 7 Days||16
2526111|NCT00684762|6189721|P1|STARTED|Washout Period of 7 Days||16
2526112|NCT00684762|6189720|P2|NOT COMPLETED|First Intervention||0
2526113|NCT00684762|6189721|P1|NOT COMPLETED|First Intervention||0
2526114|NCT00684762|6189720|P2|COMPLETED|First Intervention||16
2526115|NCT00684762|6189721|P1|COMPLETED|First Intervention||16
2526116|NCT00684762|6189720|P2|STARTED|First Intervention||16
2526117|NCT00684762|6189721|P1|STARTED|First Intervention||16
2526118|NCT00684749|6189731|P1|NOT COMPLETED|Overall Study||0
2526119|NCT00684749|6189731|P1|COMPLETED|Overall Study||142
2526120|NCT00684749|6189731|P1|STARTED|Overall Study||142
2526121|NCT00684723|6189735|P2|NOT COMPLETED|Second Intervention||0
2526122|NCT00684723|6189736|P1|NOT COMPLETED|Second Intervention||0
2526123|NCT00684723|6189735|P2|COMPLETED|Second Intervention||27
2526124|NCT00684723|6189736|P1|COMPLETED|Second Intervention||27
2526125|NCT00684723|6189735|P2|STARTED|Second Intervention||27
2526126|NCT00684723|6189736|P1|STARTED|Second Intervention||27
2526127|NCT00684723|6189735|P2|NOT COMPLETED|Washout Period of 7 Days||0
2526128|NCT00684723|6189736|P1|NOT COMPLETED|Washout Period of 7 Days||0
2526129|NCT00684723|6189735|P2|COMPLETED|Washout Period of 7 Days||27
2526130|NCT00684723|6189736|P1|COMPLETED|Washout Period of 7 Days||27
2526131|NCT00684723|6189735|P2|STARTED|Washout Period of 7 Days||27
2526132|NCT00684723|6189736|P1|STARTED|Washout Period of 7 Days||27
2526133|NCT00684723|6189735|P2|NOT COMPLETED|First Intervention||0
2526134|NCT00684723|6189736|P1|NOT COMPLETED|First Intervention||0
2526135|NCT00684723|6189735|P2|COMPLETED|First Intervention||27
2526136|NCT00684723|6189736|P1|COMPLETED|First Intervention||27
2526137|NCT00684723|6189735|P2|STARTED|First Intervention||27
2526138|NCT00684723|6189736|P1|STARTED|First Intervention||27
2526139|NCT00684671|6189749|P3|NOT COMPLETED|Overall Study||0
2526140|NCT00684671|6189750|P2|NOT COMPLETED|Overall Study||0
2526141|NCT00684671|6189751|P1|NOT COMPLETED|Overall Study||3
2526142|NCT00684671|6189749|P3|COMPLETED|Overall Study||164
2526143|NCT00684671|6189750|P2|COMPLETED|Overall Study||170
2526144|NCT00684671|6189751|P1|COMPLETED|Overall Study||169
2526145|NCT00684671|6189749|P3|STARTED|Overall Study||164
2526146|NCT00684671|6189750|P2|STARTED|Overall Study||170
2526147|NCT00684671|6189751|P1|STARTED|Overall Study||172
2526148|NCT00684645|6189780|P1|NOT COMPLETED|Overall Study||114
2526149|NCT00684645|6189780|P1|COMPLETED|Overall Study||72
2526150|NCT00684645|6189780|P1|STARTED|Overall Study||186
2526151|NCT00684593|6189800|P2|NOT COMPLETED|Overall Study||2
2526152|NCT00684593|6189801|P1|NOT COMPLETED|Overall Study||0
2526153|NCT00684593|6189800|P2|COMPLETED|Overall Study||8
2526154|NCT00684593|6189801|P1|COMPLETED|Overall Study||21
2526155|NCT00684593|6189800|P2|STARTED|Overall Study||10
2526156|NCT00684593|6189801|P1|STARTED|Overall Study||21
2526157|NCT00684567|6189813|P1|NOT COMPLETED|Monotherapy Period||14
2526158|NCT00684567|6189813|P1|COMPLETED|Monotherapy Period||9
2526159|NCT00684567|6189813|P1|STARTED|Monotherapy Period|5 subjects completed radiotherapy combined therapy phase but did not proceed to monotherapy phase.|23
2526160|NCT00684567|6189813|P1|NOT COMPLETED|Concomitant Radiotherapy Period||2
2526161|NCT00684567|6189813|P1|COMPLETED|Concomitant Radiotherapy Period||28
2526162|NCT00684567|6189813|P1|STARTED|Concomitant Radiotherapy Period||30
2526163|NCT00684554|6189823|P2|NOT COMPLETED|Overall Study||0
2526164|NCT00684554|6189824|P1|NOT COMPLETED|Overall Study||0
2526165|NCT00684554|6189823|P2|COMPLETED|Overall Study||10
2526166|NCT00684554|6189824|P1|COMPLETED|Overall Study||10
2526167|NCT00684554|6189823|P2|STARTED|Overall Study||10
2526168|NCT00684554|6189824|P1|STARTED|Overall Study||10
2526169|NCT00684541|6189834|P2|NOT COMPLETED|Overall Study||3
2526170|NCT00684541|6189835|P1|NOT COMPLETED|Overall Study||3
2526171|NCT00684541|6189834|P2|COMPLETED|Overall Study||23
2526172|NCT00684541|6189835|P1|COMPLETED|Overall Study||20
2526173|NCT00684541|6189834|P2|STARTED|Overall Study||26
2526174|NCT00684541|6189835|P1|STARTED|Overall Study||23
2526175|NCT00684515|6189846|P3|NOT COMPLETED|Overall Study||1
2526176|NCT00684515|6189847|P2|NOT COMPLETED|Overall Study||3
2526177|NCT00684515|6189848|P1|NOT COMPLETED|Overall Study||4
2526178|NCT00684515|6189846|P3|COMPLETED|Overall Study||27
2526179|NCT00684515|6189847|P2|COMPLETED|Overall Study||26
2526180|NCT00684515|6189848|P1|COMPLETED|Overall Study||29
2526181|NCT00684515|6189846|P3|STARTED|Overall Study||28
2526182|NCT00684515|6189847|P2|STARTED|Overall Study||29
2526183|NCT00684515|6189848|P1|STARTED|Overall Study||33
2526184|NCT00684424|6189871|P1|NOT COMPLETED|Overall Study||5
2526185|NCT00684424|6189871|P1|COMPLETED|Overall Study||194
2526186|NCT00684424|6189871|P1|STARTED|Overall Study||199
2526187|NCT00684411|6189886|P1|NOT COMPLETED|Overall Study||12
2526188|NCT00684411|6189886|P1|COMPLETED|Overall Study||0
2526189|NCT00684411|6189886|P1|Disease Evaluable|Overall Study||11
2526190|NCT00684411|6189886|P1|STARTED|Overall Study||12
2526191|NCT00684320|6189894|P2|NOT COMPLETED|Overall Study||0
2526192|NCT00684320|6189895|P1|NOT COMPLETED|Overall Study||4
2526193|NCT00684320|6189894|P2|COMPLETED|Overall Study||22
2526194|NCT00684320|6189895|P1|COMPLETED|Overall Study||22
2526195|NCT00684320|6189894|P2|STARTED|Overall Study||22
2526196|NCT00684320|6189895|P1|STARTED|Overall Study||26
2526197|NCT00684307|6189908|P5|NOT COMPLETED|Overall Study||25
2526198|NCT00684307|6189909|P4|NOT COMPLETED|Overall Study||32
2526199|NCT00684307|6189910|P3|NOT COMPLETED|Overall Study||28
2526200|NCT00684307|6189911|P2|NOT COMPLETED|Overall Study||22
2526201|NCT00684307|6189912|P1|NOT COMPLETED|Overall Study||24
2526202|NCT00684307|6189908|P5|COMPLETED|Overall Study||293
2526203|NCT00684307|6189909|P4|COMPLETED|Overall Study||128
2526204|NCT00684307|6189910|P3|COMPLETED|Overall Study||128
2526205|NCT00684307|6189911|P2|COMPLETED|Overall Study||129
2526206|NCT00684307|6189912|P1|COMPLETED|Overall Study||140
2526207|NCT00684307|6189908|P5|On Treatment Period Completed|Overall Study||293
2526208|NCT00684307|6189909|P4|On Treatment Period Completed|Overall Study||128
2526209|NCT00684307|6189910|P3|On Treatment Period Completed|Overall Study||128
2526210|NCT00684307|6189911|P2|On Treatment Period Completed|Overall Study||129
2526211|NCT00684307|6189912|P1|On Treatment Period Completed|Overall Study|Patients who completed treatment|140
2526212|NCT00684307|6189908|P5|On Treatment Period Started|Overall Study||318
2526213|NCT00684307|6189909|P4|On Treatment Period Started|Overall Study||160
2526214|NCT00684307|6189910|P3|On Treatment Period Started|Overall Study||156
2526215|NCT00684307|6189911|P2|On Treatment Period Started|Overall Study||151
2526216|NCT00684307|6189912|P1|On Treatment Period Started|Overall Study||164
2526217|NCT00684307|6189908|P5|STARTED|Overall Study||318
2526218|NCT00684307|6189909|P4|STARTED|Overall Study||160
2526219|NCT00684307|6189910|P3|STARTED|Overall Study||156
2526220|NCT00684307|6189911|P2|STARTED|Overall Study||151
2526221|NCT00684307|6189912|P1|STARTED|Overall Study|Patients who received treatment|164
2526222|NCT00684255|6189979|P1|NOT COMPLETED|Overall Study||0
2526223|NCT00684255|6189979|P1|COMPLETED|Overall Study||1
2526224|NCT00684255|6189979|P1|STARTED|Overall Study||1
2526225|NCT00684242|6189984|P1|NOT COMPLETED|Overall Study||0
2526226|NCT00684242|6189984|P1|COMPLETED|Overall Study||3
2526227|NCT00684242|6189984|P1|STARTED|Overall Study||3
2526228|NCT00684203|6189994|P6|NOT COMPLETED|Overall Study||0
2526229|NCT00684203|6189995|P5|NOT COMPLETED|Overall Study||0
2526230|NCT00684203|6189996|P4|NOT COMPLETED|Overall Study||0
2526231|NCT00684203|6189997|P3|NOT COMPLETED|Overall Study||9
2526232|NCT00684203|6189998|P2|NOT COMPLETED|Overall Study||8
2526233|NCT00684203|6189999|P1|NOT COMPLETED|Overall Study||9
2526234|NCT00684203|6189994|P6|COMPLETED|Overall Study||2
2526235|NCT00684203|6189995|P5|COMPLETED|Overall Study||17
2526236|NCT00684203|6189996|P4|COMPLETED|Overall Study||6
2526237|NCT00684203|6189997|P3|COMPLETED|Overall Study||12
2526238|NCT00684203|6189998|P2|COMPLETED|Overall Study||23
2526239|NCT00684203|6189999|P1|COMPLETED|Overall Study||31
2526240|NCT00684203|6189994|P6|STARTED|Overall Study||2
2526241|NCT00684203|6189995|P5|STARTED|Overall Study||17
2526242|NCT00684203|6189996|P4|STARTED|Overall Study||6
2526243|NCT00684203|6189997|P3|STARTED|Overall Study||21
2526244|NCT00684203|6189998|P2|STARTED|Overall Study||31
2526245|NCT00684203|6189999|P1|STARTED|Overall Study||40
2526246|NCT00684177|6190060|P2|NOT COMPLETED|Overall Study||23
2526247|NCT00684177|6190061|P1|NOT COMPLETED|Overall Study||21
2526248|NCT00684177|6190060|P2|COMPLETED|Overall Study||141
2526249|NCT00684177|6190061|P1|COMPLETED|Overall Study||322
2526250|NCT00684177|6190060|P2|STARTED|Overall Study||164
2526251|NCT00684177|6190061|P1|STARTED|Overall Study||343
2526252|NCT00684138|6190079|P2|NOT COMPLETED|Overall Study||8
2526253|NCT00684138|6190080|P1|NOT COMPLETED|Overall Study||3
2526254|NCT00684138|6190079|P2|COMPLETED|Overall Study||131
2526255|NCT00684138|6190080|P1|COMPLETED|Overall Study||138
2526256|NCT00684138|6190079|P2|STARTED|Overall Study||139
2526257|NCT00684138|6190080|P1|STARTED|Overall Study||141
2526258|NCT00684073|6190096|P1|NOT COMPLETED|Treatment (Days 1 Through 5)||1
2526259|NCT00684073|6190096|P1|COMPLETED|Treatment (Days 1 Through 5)|number of subjects who had a Day 5 visit (and therefore completed study)|52
2526260|NCT00684073|6190096|P1|STARTED|Treatment (Days 1 Through 5)|number of subjects who had a Day 1 visit|53
2526261|NCT00684073|6190096|P1|NOT COMPLETED|Selection||7
2526262|NCT00684073|6190096|P1|COMPLETED|Selection|number of subjects who had a Day 1 visit|53
2526263|NCT00684073|6190096|P1|STARTED|Selection||60
2526264|NCT00684060|6190106|P2|NOT COMPLETED|Overall Study||3
2526265|NCT00684060|6190107|P1|NOT COMPLETED|Overall Study||3
2526266|NCT00684060|6190106|P2|COMPLETED|Overall Study||26
2526267|NCT00684060|6190107|P1|COMPLETED|Overall Study||55
2526268|NCT00684060|6190106|P2|STARTED|Overall Study||29
2526269|NCT00684060|6190107|P1|STARTED|Overall Study||58
2526270|NCT00684047|6190130|P3|NOT COMPLETED|Overall Study||5
2526271|NCT00684047|6190131|P2|NOT COMPLETED|Overall Study||16
2526272|NCT00684047|6190132|P1|NOT COMPLETED|Overall Study||13
2526273|NCT00684047|6190130|P3|COMPLETED|Overall Study||52
2526274|NCT00684047|6190131|P2|COMPLETED|Overall Study||94
2526275|NCT00684047|6190132|P1|COMPLETED|Overall Study||59
2526276|NCT00684047|6190130|P3|STARTED|Overall Study||57
2526277|NCT00684047|6190131|P2|STARTED|Overall Study||110
2526278|NCT00684047|6190132|P1|STARTED|Overall Study||72
2526279|NCT00684021|6190146|P4|NOT COMPLETED|Overall Study||2
2526280|NCT00684021|6190147|P3|NOT COMPLETED|Overall Study||2
2526281|NCT00684021|6190148|P2|NOT COMPLETED|Overall Study||2
2526282|NCT00684021|6190149|P1|NOT COMPLETED|Overall Study||2
2526283|NCT00684021|6190146|P4|COMPLETED|Overall Study||15
2526284|NCT00684021|6190147|P3|COMPLETED|Overall Study||34
2526285|NCT00684021|6190148|P2|COMPLETED|Overall Study||22
2526286|NCT00684021|6190149|P1|COMPLETED|Overall Study||41
2526287|NCT00684021|6190146|P4|STARTED|Overall Study||17
2526288|NCT00684021|6190147|P3|STARTED|Overall Study||36
2526289|NCT00684021|6190148|P2|STARTED|Overall Study||24
2526290|NCT00684021|6190149|P1|STARTED|Overall Study||43
2526291|NCT00683930|6190190|P3|NOT COMPLETED|Overall Study||9
2526292|NCT00683930|6190191|P2|NOT COMPLETED|Overall Study||3
2526293|NCT00683930|6190192|P1|NOT COMPLETED|Overall Study||7
2526294|NCT00683930|6190190|P3|COMPLETED|Overall Study||28
2526295|NCT00683930|6190191|P2|COMPLETED|Overall Study||18
2526296|NCT00683930|6190192|P1|COMPLETED|Overall Study||29
2526297|NCT00683930|6190190|P3|STARTED|Overall Study||37
2526298|NCT00683930|6190191|P2|STARTED|Overall Study|One subject not included: no study drug dispensed.|21
2526299|NCT00683930|6190192|P1|STARTED|Overall Study|One subject not included: no study drug dispensed.|36
2526300|NCT00683917|6190210|P1|NOT COMPLETED|Overall Study||10
2526301|NCT00683917|6190210|P1|COMPLETED|Overall Study||0
2526302|NCT00683917|6190210|P1|STARTED|Overall Study||10
2526303|NCT00683904|6190220|P2|NOT COMPLETED|Dose Level 2||2
2526304|NCT00683904|6190221|P1|NOT COMPLETED|Dose Level 2||0
2526305|NCT00683904|6190220|P2|COMPLETED|Dose Level 2||4
2526306|NCT00683904|6190221|P1|COMPLETED|Dose Level 2||0
2526307|NCT00683904|6190220|P2|STARTED|Dose Level 2||6
2526308|NCT00683904|6190221|P1|STARTED|Dose Level 2||0
2526309|NCT00683904|6190220|P2|NOT COMPLETED|Dose Level 1||0
2526310|NCT00683904|6190221|P1|NOT COMPLETED|Dose Level 1||3
2526311|NCT00683904|6190220|P2|COMPLETED|Dose Level 1||0
2526312|NCT00683904|6190221|P1|COMPLETED|Dose Level 1||3
2526313|NCT00683904|6190220|P2|STARTED|Dose Level 1||0
2526314|NCT00683904|6190221|P1|STARTED|Dose Level 1||6
2526315|NCT00683878|6190257|P3|NOT COMPLETED|Overall Study||14
2526316|NCT00683878|6190258|P2|NOT COMPLETED|Overall Study||16
2526317|NCT00683878|6190259|P1|NOT COMPLETED|Overall Study||23
2526318|NCT00683878|6190257|P3|COMPLETED|Overall Study||126
2526319|NCT00683878|6190258|P2|COMPLETED|Overall Study||125
2526320|NCT00683878|6190259|P1|COMPLETED|Overall Study||116
2526321|NCT00683878|6190257|P3|STARTED|Overall Study||140
2526322|NCT00683878|6190258|P2|STARTED|Overall Study||141
2526323|NCT00683878|6190259|P1|STARTED|Overall Study||139
2526324|NCT00683852|6190287|P3|NOT COMPLETED|30-Day Phase 2 Period||9
2526325|NCT00683852|6190288|P2|NOT COMPLETED|30-Day Phase 2 Period||5
2526326|NCT00683852|6190289|P1|NOT COMPLETED|30-Day Phase 2 Period||6
2526327|NCT00683852|6190287|P3|COMPLETED|30-Day Phase 2 Period||75
2526328|NCT00683852|6190288|P2|COMPLETED|30-Day Phase 2 Period||78
2526329|NCT00683852|6190289|P1|COMPLETED|30-Day Phase 2 Period||48
2526330|NCT00683852|6190287|P3|STARTED|30-Day Phase 2 Period||84
2526331|NCT00683852|6190288|P2|STARTED|30-Day Phase 2 Period||83
2526332|NCT00683852|6190289|P1|STARTED|30-Day Phase 2 Period||54
2526333|NCT00683852|6190287|P3|NOT COMPLETED|30-Day Phase 1 Period||1
2526334|NCT00683852|6190288|P2|NOT COMPLETED|30-Day Phase 1 Period||1
2526335|NCT00683852|6190289|P1|NOT COMPLETED|30-Day Phase 1 Period||2
2526336|NCT00683852|6190287|P3|COMPLETED|30-Day Phase 1 Period||84
2526337|NCT00683852|6190288|P2|COMPLETED|30-Day Phase 1 Period||83
2526338|NCT00683852|6190289|P1|COMPLETED|30-Day Phase 1 Period||54
2526339|NCT00683852|6190287|P3|STARTED|30-Day Phase 1 Period||85
2526340|NCT00683852|6190288|P2|STARTED|30-Day Phase 1 Period||84
2526341|NCT00683852|6190289|P1|STARTED|30-Day Phase 1 Period||56
2526342|NCT00683826|6190323|P1|NOT COMPLETED|Overall Study||1
2526343|NCT00683826|6190323|P1|COMPLETED|Overall Study||7
2526344|NCT00683826|6190323|P1|4g Leucine|Overall Study||7
2526345|NCT00683826|6190323|P1|8g Leucine|Overall Study||8
2526346|NCT00683826|6190323|P1|0g Leucine|Overall Study||8
2526347|NCT00683826|6190323|P1|STARTED|Overall Study||8
2526348|NCT00683800|6190333|P2|NOT COMPLETED|Overall Study||366
2526349|NCT00683800|6190334|P1|NOT COMPLETED|Overall Study||432
2526350|NCT00683800|6190333|P2|COMPLETED|Overall Study||719
2526351|NCT00683800|6190334|P1|COMPLETED|Overall Study||669
2526352|NCT00683800|6190333|P2|Treated|Overall Study||1052
2526353|NCT00683800|6190334|P1|Treated|Overall Study||1066
2526354|NCT00683800|6190333|P2|STARTED|Overall Study||1085
2526355|NCT00683800|6190334|P1|STARTED|Overall Study||1101
2526356|NCT00683787|6190401|P3|NOT COMPLETED|Overall Study||2
2526357|NCT00683787|6190402|P2|NOT COMPLETED|Overall Study||3
2526358|NCT00683787|6190403|P1|NOT COMPLETED|Overall Study||3
2526359|NCT00683787|6190401|P3|COMPLETED|Overall Study||0
2526360|NCT00683787|6190402|P2|COMPLETED|Overall Study||0
2526361|NCT00683787|6190403|P1|COMPLETED|Overall Study||0
2526362|NCT00683787|6190401|P3|STARTED|Overall Study||2
2526363|NCT00683787|6190402|P2|STARTED|Overall Study||3
2526364|NCT00683787|6190403|P1|STARTED|Overall Study||3
2526365|NCT00683774|6190422|P2|NOT COMPLETED|Overall Study||1
2526366|NCT00683774|6190423|P1|NOT COMPLETED|Overall Study||3
2526367|NCT00683774|6190422|P2|COMPLETED|Overall Study||9
2526368|NCT00683774|6190423|P1|COMPLETED|Overall Study||8
2526369|NCT00683774|6190422|P2|STARTED|Overall Study||10
2526370|NCT00683774|6190423|P1|STARTED|Overall Study||11
2526371|NCT00683696|6190433|P2|NOT COMPLETED|Overall Study||405
2526372|NCT00683696|6190434|P1|NOT COMPLETED|Overall Study||404
2526373|NCT00683696|6190433|P2|COMPLETED|Overall Study||0
2526374|NCT00683696|6190434|P1|COMPLETED|Overall Study||0
2526375|NCT00683696|6190433|P2|STARTED|Overall Study||405
2526376|NCT00683696|6190434|P1|STARTED|Overall Study||404
2526377|NCT00683657|6190453|P2|NOT COMPLETED|Overall Study||1
2526378|NCT00683657|6190454|P1|NOT COMPLETED|Overall Study||1
2526379|NCT00683657|6190453|P2|COMPLETED|Overall Study||46
2526380|NCT00683657|6190454|P1|COMPLETED|Overall Study||45
2526381|NCT00683657|6190453|P2|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|47
2526382|NCT00683657|6190454|P1|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|46
2526383|NCT00683657|6190453|P2|STARTED|Overall Study||47
2526384|NCT00683657|6190454|P1|STARTED|Overall Study||46
2526385|NCT00683644|6190470|P2|NOT COMPLETED|Overall Study||14
2526386|NCT00683644|6190471|P1|NOT COMPLETED|Overall Study||13
2526387|NCT00683644|6190470|P2|COMPLETED|Overall Study||44
2526388|NCT00683644|6190471|P1|COMPLETED|Overall Study||45
2526389|NCT00683644|6190470|P2|STARTED|Overall Study||58
2526390|NCT00683644|6190471|P1|STARTED|Overall Study||58
2526391|NCT00683618|6190484|P3|NOT COMPLETED|Extension Treatment Period||0
2526392|NCT00683618|6190485|P2|NOT COMPLETED|Extension Treatment Period||0
2526393|NCT00683618|6190486|P1|NOT COMPLETED|Extension Treatment Period||3
2526394|NCT00683618|6190484|P3|COMPLETED|Extension Treatment Period||0
2526395|NCT00683618|6190485|P2|COMPLETED|Extension Treatment Period||23
2526396|NCT00683618|6190486|P1|COMPLETED|Extension Treatment Period||33
2526397|NCT00683618|6190484|P3|STARTED|Extension Treatment Period||0
2526398|NCT00683618|6190485|P2|STARTED|Extension Treatment Period||23
2526399|NCT00683618|6190486|P1|STARTED|Extension Treatment Period||36
2526400|NCT00683618|6190484|P3|NOT COMPLETED|Randomised Treatment Period||6
2526401|NCT00683618|6190485|P2|NOT COMPLETED|Randomised Treatment Period||2
2526402|NCT00683618|6190486|P1|NOT COMPLETED|Randomised Treatment Period||6
2526403|NCT00683618|6190484|P3|COMPLETED|Randomised Treatment Period||140
2526404|NCT00683618|6190485|P2|COMPLETED|Randomised Treatment Period||143
2526405|NCT00683618|6190486|P1|COMPLETED|Randomised Treatment Period||139
2526406|NCT00683618|6190484|P3|STARTED|Randomised Treatment Period||146
2526407|NCT00683618|6190485|P2|STARTED|Randomised Treatment Period||145
2526408|NCT00683618|6190486|P1|STARTED|Randomised Treatment Period||145
2526409|NCT00683592|6190536|P2|NOT COMPLETED|Overall Study||46
2526410|NCT00683592|6190537|P1|NOT COMPLETED|Overall Study||47
2526411|NCT00683592|6190536|P2|COMPLETED|Overall Study||195
2526412|NCT00683592|6190537|P1|COMPLETED|Overall Study||193
2526413|NCT00683592|6190536|P2|Safety Population|Overall Study||233
2526414|NCT00683592|6190537|P1|Safety Population|Overall Study||235
2526415|NCT00683592|6190536|P2|Intent to Treat Population|Overall Study||232
2526416|NCT00683592|6190537|P1|Intent to Treat Population|Overall Study||231
2526417|NCT00683592|6190536|P2|STARTED|Overall Study||241
2526418|NCT00683592|6190537|P1|STARTED|Overall Study||240
2526419|NCT00683475|6190555|P2|NOT COMPLETED|Overall Study||3
2526420|NCT00683475|6190556|P1|NOT COMPLETED|Overall Study||4
2526421|NCT00683475|6190555|P2|COMPLETED|Overall Study||66
2526422|NCT00683475|6190556|P1|COMPLETED|Overall Study||65
2526423|NCT00683475|6190555|P2|Received Any Quantity of Study Drug|Overall Study||66
2526424|NCT00683475|6190556|P1|Received Any Quantity of Study Drug|Overall Study||66
2526425|NCT00683475|6190555|P2|STARTED|Overall Study||69
2526426|NCT00683475|6190556|P1|STARTED|Overall Study||69
2526427|NCT00683449|6190591|P5|NOT COMPLETED|Overall Study||0
2526428|NCT00683449|6190592|P4|NOT COMPLETED|Overall Study||0
2526429|NCT00683449|6190593|P3|NOT COMPLETED|Overall Study||0
2526430|NCT00683449|6190594|P2|NOT COMPLETED|Overall Study||1
2526431|NCT00683449|6190595|P1|NOT COMPLETED|Overall Study||0
2526432|NCT00683449|6190591|P5|COMPLETED|Overall Study||2
2526433|NCT00683449|6190592|P4|COMPLETED|Overall Study||6
2526434|NCT00683449|6190593|P3|COMPLETED|Overall Study||3
2526435|NCT00683449|6190594|P2|COMPLETED|Overall Study||12
2526436|NCT00683449|6190595|P1|COMPLETED|Overall Study||5
2526437|NCT00683449|6190591|P5|STARTED|Overall Study||2
2526438|NCT00683449|6190592|P4|STARTED|Overall Study||6
2526439|NCT00683449|6190593|P3|STARTED|Overall Study||3
2526440|NCT00683449|6190594|P2|STARTED|Overall Study||13
2526441|NCT00683449|6190595|P1|STARTED|Overall Study||5
2526442|NCT00683410|6190617|P1|NOT COMPLETED|Overall Study||0
2526443|NCT00683410|6190617|P1|COMPLETED|Overall Study||3366
2526444|NCT00683410|6190617|P1|Vaccinated Dose 4|Overall Study||175
2526445|NCT00683410|6190617|P1|Vaccinated Dose 3|Overall Study||817
2526446|NCT00683410|6190617|P1|Vaccinated Dose 2|Overall Study||1623
2526447|NCT00683410|6190617|P1|Vaccinated Dose 1|Overall Study||3240
2526448|NCT00683410|6190617|P1|STARTED|Overall Study||3366
2526449|NCT00683384|6190621|P1|NOT COMPLETED|Overall Study||2
2526450|NCT00683384|6190621|P1|COMPLETED|Overall Study||91
2526451|NCT00683384|6190621|P1|STARTED|Overall Study||93
2526452|NCT00683332|6190625|P1|NOT COMPLETED|Overall Study||0
2526453|NCT00683332|6190625|P1|COMPLETED|Overall Study||621
2526454|NCT00683332|6190625|P1|STARTED|Overall Study||621
2526455|NCT00683293|6190631|P2|NOT COMPLETED|Overall Study||3
2526456|NCT00683293|6190632|P1|NOT COMPLETED|Overall Study||2
2526457|NCT00683293|6190631|P2|COMPLETED|Overall Study||47
2526458|NCT00683293|6190632|P1|COMPLETED|Overall Study||48
2526459|NCT00683293|6190631|P2|STARTED|Overall Study||50
2526460|NCT00683293|6190632|P1|STARTED|Overall Study||50
2526461|NCT00683163|6190642|P2|NOT COMPLETED|Overall Study||0
2526462|NCT00683163|6190643|P1|NOT COMPLETED|Overall Study||0
2526463|NCT00683163|6190642|P2|COMPLETED|Overall Study||22
2526464|NCT00683163|6190643|P1|COMPLETED|Overall Study||22
2526465|NCT00683163|6190642|P2|STARTED|Overall Study||22
2526466|NCT00683163|6190643|P1|STARTED|Overall Study||22
2526467|NCT00683085|6190651|P1|NOT COMPLETED|Overall Study||0
2526468|NCT00683085|6190651|P1|COMPLETED|Overall Study||2
2526469|NCT00683085|6190651|P1|STARTED|Overall Study||2
2526470|NCT00683046|6190656|P1|NOT COMPLETED|Overall Study||0
2526471|NCT00683046|6190656|P1|COMPLETED|Overall Study||204
2526472|NCT00683046|6190656|P1|STARTED|Overall Study||204
2526473|NCT00683020|6190663|P2|NOT COMPLETED|Overall Study||55
2526474|NCT00683020|6190664|P1|NOT COMPLETED|Overall Study||55
2526475|NCT00683020|6190663|P2|COMPLETED|Overall Study||125
2526476|NCT00683020|6190664|P1|COMPLETED|Overall Study||127
2526477|NCT00683020|6190663|P2|STARTED|Overall Study||180
2526478|NCT00683020|6190664|P1|STARTED|Overall Study||182
2526479|NCT00682929|6190695|P3|NOT COMPLETED|Overall Study||2
2526480|NCT00682929|6190696|P2|NOT COMPLETED|Overall Study||5
2526481|NCT00682929|6190697|P1|NOT COMPLETED|Overall Study||6
2526482|NCT00682929|6190695|P3|COMPLETED|Overall Study||12
2526483|NCT00682929|6190696|P2|COMPLETED|Overall Study||9
2526484|NCT00682929|6190697|P1|COMPLETED|Overall Study||7
2526485|NCT00682929|6190695|P3|STARTED|Overall Study||14
2526486|NCT00682929|6190696|P2|STARTED|Overall Study||14
2526487|NCT00682929|6190697|P1|STARTED|Overall Study||13
2526488|NCT00682890|6190866|P2|NOT COMPLETED|Overall Study||2
2526489|NCT00682890|6190867|P1|NOT COMPLETED|Overall Study||2
2526490|NCT00682890|6190866|P2|COMPLETED|Overall Study||9
2526491|NCT00682890|6190867|P1|COMPLETED|Overall Study||10
2526492|NCT00682890|6190866|P2|STARTED|Overall Study||11
2526493|NCT00682890|6190867|P1|STARTED|Overall Study||12
2526494|NCT00682851|6190877|P2|NOT COMPLETED|Overall Study||0
2526495|NCT00682851|6190878|P1|NOT COMPLETED|Overall Study||0
2526496|NCT00682851|6190877|P2|COMPLETED|Overall Study||268
2526497|NCT00682851|6190878|P1|COMPLETED|Overall Study||251
2526498|NCT00682851|6190877|P2|STARTED|Overall Study||268
2526499|NCT00682851|6190878|P1|STARTED|Overall Study||251
2526500|NCT00682838|6190894|P4|NOT COMPLETED|Overall Study||0
2526501|NCT00682838|6190895|P3|NOT COMPLETED|Overall Study||0
2526502|NCT00682838|6190896|P2|NOT COMPLETED|Overall Study||0
2526503|NCT00682838|6190897|P1|NOT COMPLETED|Overall Study||0
2526504|NCT00682838|6190894|P4|COMPLETED|Overall Study||73
2526505|NCT00682838|6190895|P3|COMPLETED|Overall Study||75
2526506|NCT00682838|6190896|P2|COMPLETED|Overall Study||67
2526507|NCT00682838|6190897|P1|COMPLETED|Overall Study||65
2526508|NCT00682838|6190894|P4|STARTED|Overall Study||73
2526509|NCT00682838|6190895|P3|STARTED|Overall Study||75
2526510|NCT00682838|6190896|P2|STARTED|Overall Study||67
2526511|NCT00682838|6190897|P1|STARTED|Overall Study||65
2526512|NCT00682786|6190909|P2|NOT COMPLETED|Overall Study||3
2526513|NCT00682786|6190910|P1|NOT COMPLETED|Overall Study||2
2526514|NCT00682786|6190909|P2|COMPLETED|Overall Study||34
2526515|NCT00682786|6190910|P1|COMPLETED|Overall Study||96
2526516|NCT00682786|6190909|P2|STARTED|Overall Study||37
2526517|NCT00682786|6190910|P1|STARTED|Overall Study||98
2526518|NCT00682734|6190947|P3|NOT COMPLETED|48 Hour Follow-up||11
2526519|NCT00682734|6190948|P2|NOT COMPLETED|48 Hour Follow-up||6
2526520|NCT00682734|6190949|P1|NOT COMPLETED|48 Hour Follow-up||6
2526521|NCT00682734|6190947|P3|COMPLETED|48 Hour Follow-up||106
2526522|NCT00682734|6190948|P2|COMPLETED|48 Hour Follow-up||111
2526523|NCT00682734|6190949|P1|COMPLETED|48 Hour Follow-up||107
2526524|NCT00682734|6190947|P3|STARTED|48 Hour Follow-up||117
2526525|NCT00682734|6190948|P2|STARTED|48 Hour Follow-up||117
2526526|NCT00682734|6190949|P1|STARTED|48 Hour Follow-up||113
2526527|NCT00682734|6190947|P3|NOT COMPLETED|Emergency Department Portion||1
2526528|NCT00682734|6190948|P2|NOT COMPLETED|Emergency Department Portion||1
2526529|NCT00682734|6190949|P1|NOT COMPLETED|Emergency Department Portion||0
2526530|NCT00682734|6190947|P3|COMPLETED|Emergency Department Portion||117
2526531|NCT00682734|6190948|P2|COMPLETED|Emergency Department Portion||117
2526532|NCT00682734|6190949|P1|COMPLETED|Emergency Department Portion||113
2526533|NCT00682734|6190947|P3|STARTED|Emergency Department Portion||118
2526534|NCT00682734|6190948|P2|STARTED|Emergency Department Portion||118
2526535|NCT00682734|6190949|P1|STARTED|Emergency Department Portion||113
2526536|NCT00682643|6190959|P2|NOT COMPLETED|Overall Study||169
2526537|NCT00682643|6190960|P1|NOT COMPLETED|Overall Study||78
2526538|NCT00682643|6190959|P2|COMPLETED|Overall Study||199
2526539|NCT00682643|6190960|P1|COMPLETED|Overall Study||104
2526540|NCT00682643|6190959|P2|STARTED|Overall Study||368
2526541|NCT00682643|6190960|P1|STARTED|Overall Study||182
2526542|NCT00682565|6190995|P3|NOT COMPLETED|Overall Study||0
2526543|NCT00682565|6190996|P2|NOT COMPLETED|Overall Study||3
2526544|NCT00682565|6190997|P1|NOT COMPLETED|Overall Study||1
2526545|NCT00682565|6190995|P3|COMPLETED|Overall Study||29
2526546|NCT00682565|6190996|P2|COMPLETED|Overall Study||32
2526547|NCT00682565|6190997|P1|COMPLETED|Overall Study||30
2526548|NCT00682565|6190995|P3|STARTED|Overall Study||29
2526549|NCT00682565|6190996|P2|STARTED|Overall Study||35
2526550|NCT00682565|6190997|P1|STARTED|Overall Study||31
2526551|NCT00682539|6191021|P3|NOT COMPLETED|Ranibizumab vs Triamcinolone||8
2526552|NCT00682539|6191022|P2|NOT COMPLETED|Ranibizumab vs Triamcinolone||3
2526553|NCT00682539|6191023|P1|NOT COMPLETED|Ranibizumab vs Triamcinolone||0
2526554|NCT00682539|6191021|P3|COMPLETED|Ranibizumab vs Triamcinolone||10
2526555|NCT00682539|6191022|P2|COMPLETED|Ranibizumab vs Triamcinolone||15
2526556|NCT00682539|6191023|P1|COMPLETED|Ranibizumab vs Triamcinolone||0
2526557|NCT00682539|6191021|P3|STARTED|Ranibizumab vs Triamcinolone|Both periods recruited independently following the same criteria.|18
2526558|NCT00682539|6191022|P2|STARTED|Ranibizumab vs Triamcinolone|None of the patients of the 1st period was included in the second period.|18
2526559|NCT00682539|6191023|P1|STARTED|Ranibizumab vs Triamcinolone|Two independent periods.|0
2526560|NCT00682539|6191021|P3|NOT COMPLETED|Bevacizumab vs Triamcinolone||0
2526561|NCT00682539|6191022|P2|NOT COMPLETED|Bevacizumab vs Triamcinolone||1
2526562|NCT00682539|6191023|P1|NOT COMPLETED|Bevacizumab vs Triamcinolone||3
2526563|NCT00682539|6191021|P3|COMPLETED|Bevacizumab vs Triamcinolone||0
2526564|NCT00682539|6191022|P2|COMPLETED|Bevacizumab vs Triamcinolone||15
2526565|NCT00682539|6191023|P1|COMPLETED|Bevacizumab vs Triamcinolone||15
2526566|NCT00682539|6191021|P3|STARTED|Bevacizumab vs Triamcinolone||0
2526567|NCT00682539|6191022|P2|STARTED|Bevacizumab vs Triamcinolone||16
2526568|NCT00682539|6191023|P1|STARTED|Bevacizumab vs Triamcinolone||18
2526569|NCT00682461|6191036|P2|NOT COMPLETED|Overall Study||31
2526570|NCT00682461|6191037|P1|NOT COMPLETED|Overall Study||25
2526571|NCT00682461|6191036|P2|COMPLETED|Overall Study||69
2526572|NCT00682461|6191037|P1|COMPLETED|Overall Study||75
2526573|NCT00682461|6191036|P2|STARTED|Overall Study||100
2526574|NCT00682461|6191037|P1|STARTED|Overall Study||100
2526575|NCT00682435|6191051|P1|NOT COMPLETED|Overall Study||7
2526576|NCT00682435|6191051|P1|COMPLETED|Overall Study||223
2526577|NCT00682435|6191051|P1|Sufficient Data to Carry Out Analysis|Overall Study||223
2526578|NCT00682435|6191051|P1|Ensured Enrolled Only Once|Overall Study||228
2526579|NCT00682435|6191051|P1|STARTED|Overall Study||230
2526580|NCT00682357|6191061|P3|NOT COMPLETED|Overall Study||0
2526581|NCT00682357|6191062|P2|NOT COMPLETED|Overall Study||0
2526582|NCT00682357|6191063|P1|NOT COMPLETED|Overall Study||0
2526583|NCT00682357|6191061|P3|COMPLETED|Overall Study||5
2526584|NCT00682357|6191062|P2|COMPLETED|Overall Study||10
2526585|NCT00682357|6191063|P1|COMPLETED|Overall Study||10
2526586|NCT00682357|6191061|P3|STARTED|Overall Study||5
2526587|NCT00682357|6191062|P2|STARTED|Overall Study||10
2526588|NCT00682357|6191063|P1|STARTED|Overall Study||10
2526589|NCT00681889|6191080|P1|NOT COMPLETED|Overall Study||0
2526590|NCT00681889|6191080|P1|COMPLETED|Overall Study||9
2526591|NCT00681889|6191080|P1|STARTED|Overall Study||9
2526592|NCT00681863|6191084|P1|NOT COMPLETED|Overall Study||23
2526593|NCT00681863|6191084|P1|COMPLETED|Overall Study||22
2526594|NCT00681863|6191084|P1|STARTED|Overall Study||45
2526595|NCT00681824|6191132|P3|NOT COMPLETED|Overall Study||1
2526596|NCT00681824|6191133|P2|NOT COMPLETED|Overall Study||1
2526597|NCT00681824|6191134|P1|NOT COMPLETED|Overall Study||1
2526598|NCT00681824|6191132|P3|COMPLETED|Overall Study||33
2526599|NCT00681824|6191133|P2|COMPLETED|Overall Study||12
2526600|NCT00681824|6191134|P1|COMPLETED|Overall Study||27
2526601|NCT00681824|6191132|P3|STARTED|Overall Study||34
2526602|NCT00681824|6191133|P2|STARTED|Overall Study||13
2526603|NCT00681824|6191134|P1|STARTED|Overall Study||28
2526604|NCT00681811|6191152|P2|NOT COMPLETED|Overall Study||4
2526605|NCT00681811|6191153|P1|NOT COMPLETED|Overall Study||3
2526606|NCT00681811|6191152|P2|COMPLETED|Overall Study||1
2526607|NCT00681811|6191153|P1|COMPLETED|Overall Study||3
2526608|NCT00681811|6191152|P2|STARTED|Overall Study||5
2526609|NCT00681811|6191153|P1|STARTED|Overall Study||6
2526610|NCT00681668|6191181|P1|NOT COMPLETED|Overall Study||2
2526611|NCT00681668|6191181|P1|COMPLETED|Overall Study||3
2526612|NCT00681668|6191181|P1|STARTED|Overall Study||5
2526613|NCT00681629|6191190|P2|NOT COMPLETED|Overall Study||2
2526614|NCT00681629|6191191|P1|NOT COMPLETED|Overall Study||5
2526615|NCT00681629|6191190|P2|COMPLETED|Overall Study||0
2526616|NCT00681629|6191191|P1|COMPLETED|Overall Study||0
2526617|NCT00681629|6191190|P2|STARTED|Overall Study|It was planned to recruit 100 patient|2
2526618|NCT00681629|6191191|P1|STARTED|Overall Study|It was planned to recruit 100 patient|5
2526619|NCT00681590|6191237|P2|NOT COMPLETED|Overall Study||12
2526620|NCT00681590|6191238|P1|NOT COMPLETED|Overall Study||2
2526621|NCT00681590|6191237|P2|COMPLETED|Overall Study||59
2526622|NCT00681590|6191238|P1|COMPLETED|Overall Study||32
2526623|NCT00681590|6191237|P2|STARTED|Overall Study||71
2526624|NCT00681590|6191238|P1|STARTED|Overall Study||34
2526625|NCT00681564|6191248|P2|NOT COMPLETED|Overall Study||8
2526626|NCT00681564|6191249|P1|NOT COMPLETED|Overall Study||6
2526627|NCT00681564|6191248|P2|COMPLETED|Overall Study||47
2526628|NCT00681564|6191249|P1|COMPLETED|Overall Study||41
2526629|NCT00681564|6191248|P2|STARTED|Overall Study||55
2526630|NCT00681564|6191249|P1|STARTED|Overall Study||47
2526631|NCT00681538|6191279|P2|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||2
2526632|NCT00681538|6191280|P1|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||15
2526633|NCT00681538|6191279|P2|COMPLETED|Phase B- Responders;12 Week Double-blind||115
2526634|NCT00681538|6191280|P1|COMPLETED|Phase B- Responders;12 Week Double-blind||109
2526635|NCT00681538|6191279|P2|STARTED|Phase B- Responders;12 Week Double-blind||117
2526636|NCT00681538|6191280|P1|STARTED|Phase B- Responders;12 Week Double-blind||124
2526637|NCT00681538|6191279|P2|NOT COMPLETED|Phase A- 4 Weeks Single Blind||0
2526638|NCT00681538|6191280|P1|NOT COMPLETED|Phase A- 4 Weeks Single Blind||34
2526639|NCT00681538|6191279|P2|COMPLETED|Phase A- 4 Weeks Single Blind||0
2526640|NCT00681538|6191280|P1|COMPLETED|Phase A- 4 Weeks Single Blind||538
2526641|NCT00681538|6191279|P2|STARTED|Phase A- 4 Weeks Single Blind||0
2526642|NCT00681538|6191280|P1|STARTED|Phase A- 4 Weeks Single Blind||572
2526643|NCT00681473|6191310|P1|NOT COMPLETED|Overall Study||0
2526644|NCT00681473|6191310|P1|COMPLETED|Overall Study|All 20 patients completed RT and tolerated treatment well.|20
2526645|NCT00681473|6191310|P1|STARTED|Overall Study|20 patients with WHO Grade 2 Glioma were enrolled.|20
2526646|NCT00681291|6191318|P2|NOT COMPLETED|Overall Study||27
2526647|NCT00681291|6191319|P1|NOT COMPLETED|Overall Study||13
2526648|NCT00681291|6191318|P2|COMPLETED|Overall Study||57
2526649|NCT00681291|6191319|P1|COMPLETED|Overall Study||75
2526650|NCT00681291|6191318|P2|STARTED|Overall Study||84
2526651|NCT00681291|6191319|P1|STARTED|Overall Study||88
2526652|NCT00681265|6191331|P1|NOT COMPLETED|Overall Study||0
2526653|NCT00681265|6191331|P1|COMPLETED|Overall Study||16
2526654|NCT00681265|6191331|P1|STARTED|Overall Study||16
2526655|NCT00681187|6191341|P2|NOT COMPLETED|Overall Study||2
2526656|NCT00681187|6191342|P1|NOT COMPLETED|Overall Study||1
2526657|NCT00681187|6191341|P2|COMPLETED|Overall Study||13
2526658|NCT00681187|6191342|P1|COMPLETED|Overall Study||10
2526659|NCT00681187|6191341|P2|STARTED|Overall Study||15
2526660|NCT00681187|6191342|P1|STARTED|Overall Study||11
2526661|NCT00681109|6191377|P3|NOT COMPLETED|Overall Study||0
2526662|NCT00681109|6191378|P2|NOT COMPLETED|Overall Study||6
2526663|NCT00681109|6191379|P1|NOT COMPLETED|Overall Study||2
2526664|NCT00681109|6191377|P3|COMPLETED|Overall Study||15
2526665|NCT00681109|6191378|P2|COMPLETED|Overall Study||24
2526666|NCT00681109|6191379|P1|COMPLETED|Overall Study||28
2526667|NCT00681109|6191377|P3|STARTED|Overall Study||15
2526668|NCT00681109|6191378|P2|STARTED|Overall Study||30
2526669|NCT00681109|6191379|P1|STARTED|Overall Study||30
2526670|NCT00681083|6191396|P2|NOT COMPLETED|Night 2 (Crossover of Night 1)||0
2526671|NCT00681083|6191397|P1|NOT COMPLETED|Night 2 (Crossover of Night 1)||0
2526672|NCT00681083|6191396|P2|COMPLETED|Night 2 (Crossover of Night 1)||10
2526673|NCT00681083|6191397|P1|COMPLETED|Night 2 (Crossover of Night 1)||10
2526674|NCT00681083|6191396|P2|STARTED|Night 2 (Crossover of Night 1)||10
2526675|NCT00681083|6191397|P1|STARTED|Night 2 (Crossover of Night 1)||10
2526676|NCT00681083|6191396|P2|NOT COMPLETED|Night 1||3
2526677|NCT00681083|6191397|P1|NOT COMPLETED|Night 1||3
2526678|NCT00681083|6191396|P2|COMPLETED|Night 1|20 in total completed study. 10 randomized to arm 1 and arm 2 then crossed over to other arm.|10
2526679|NCT00681083|6191397|P1|COMPLETED|Night 1|20 in total completed study. 10 randomized to arm 1 and arm 2 then crossed over to other arm.|10
2526680|NCT00681083|6191396|P2|STARTED|Night 1|26 participants were initially consented (this is the total for the study).|13
2526681|NCT00681083|6191397|P1|STARTED|Night 1|26 participants were initially consented (this is the total for the study).|13
2526682|NCT00681044|6191405|P1|NOT COMPLETED|Overall Study||0
2526683|NCT00681044|6191405|P1|COMPLETED|Overall Study||4
2526684|NCT00681044|6191405|P1|STARTED|Overall Study||4
2526685|NCT00681031|6191413|P1|NOT COMPLETED|Overall Study||0
2526686|NCT00681031|6191413|P1|COMPLETED|Overall Study||96
2526687|NCT00681031|6191413|P1|STARTED|Overall Study||96
2526688|NCT00680992|6191420|P3|NOT COMPLETED|Overall Study||12
2526689|NCT00680992|6191421|P2|NOT COMPLETED|Overall Study||252
2526690|NCT00680992|6191422|P1|NOT COMPLETED|Overall Study||268
2526691|NCT00680992|6191420|P3|COMPLETED|Overall Study||0
2526692|NCT00680992|6191421|P2|COMPLETED|Overall Study||0
2526693|NCT00680992|6191422|P1|COMPLETED|Overall Study||0
2526694|NCT00680992|6191420|P3|Efficacy Analysis Set|Overall Study||11
2526695|NCT00680992|6191421|P2|Efficacy Analysis Set|Overall Study||242
2526696|NCT00680992|6191422|P1|Efficacy Analysis Set|Overall Study||260
2526697|NCT00680992|6191420|P3|Safety Analysis Set|Overall Study||12
2526698|NCT00680992|6191421|P2|Safety Analysis Set|Overall Study||249
2526699|NCT00680992|6191422|P1|Safety Analysis Set|Overall Study||265
2526700|NCT00680992|6191420|P3|STARTED|Overall Study||12
2526701|NCT00680992|6191421|P2|STARTED|Overall Study||252
2526702|NCT00680992|6191422|P1|STARTED|Overall Study||268
2526703|NCT00680953|6191438|P3|NOT COMPLETED|Overall Study||47
2526704|NCT00680953|6191439|P2|NOT COMPLETED|Overall Study||95
2526705|NCT00680953|6191440|P1|NOT COMPLETED|Overall Study||86
2526706|NCT00680953|6191438|P3|COMPLETED|Overall Study||204
2526707|NCT00680953|6191439|P2|COMPLETED|Overall Study||416
2526708|NCT00680953|6191440|P1|COMPLETED|Overall Study||414
2526709|NCT00680953|6191438|P3|STARTED|Overall Study||251
2526710|NCT00680953|6191439|P2|STARTED|Overall Study||511
2526711|NCT00680953|6191440|P1|STARTED|Overall Study||500
2526712|NCT00680914|6191456|P2|NOT COMPLETED|Overall Study||4
2526713|NCT00680914|6191457|P1|NOT COMPLETED|Overall Study||10
2526714|NCT00680914|6191456|P2|COMPLETED|Overall Study||125
2526715|NCT00680914|6191457|P1|COMPLETED|Overall Study||364
2526716|NCT00680914|6191456|P2|STARTED|Overall Study||129
2526717|NCT00680914|6191457|P1|STARTED|Overall Study||374
2526718|NCT00680901|6191491|P2|NOT COMPLETED|Overall Study||76
2526719|NCT00680901|6191492|P1|NOT COMPLETED|Overall Study||73
2526720|NCT00680901|6191491|P2|COMPLETED|Overall Study||197
2526721|NCT00680901|6191492|P1|COMPLETED|Overall Study||199
2526722|NCT00680901|6191491|P2|Ongoing: In Follow Up|Overall Study||41
2526723|NCT00680901|6191492|P1|Ongoing: In Follow Up|Overall Study||45
2526724|NCT00680901|6191491|P2|Ongoing: On Study Treatment|Overall Study||13
2526725|NCT00680901|6191492|P1|Ongoing: On Study Treatment|Overall Study||16
2526726|NCT00680901|6191491|P2|STARTED|Overall Study||273
2526727|NCT00680901|6191492|P1|STARTED|Overall Study||272
2526728|NCT00680862|6191524|P1|NOT COMPLETED|Overall Study||0
2526729|NCT00680862|6191524|P1|COMPLETED|Overall Study||25
2526730|NCT00680862|6191524|P1|STARTED|Overall Study||25
2526731|NCT00680836|6191530|P2|NOT COMPLETED|Overall Study||2
2526732|NCT00680836|6191531|P1|NOT COMPLETED|Overall Study||8
2526733|NCT00680836|6191530|P2|COMPLETED|Overall Study||25
2526734|NCT00680836|6191531|P1|COMPLETED|Overall Study||19
2526735|NCT00680836|6191530|P2|STARTED|Overall Study||27
2526736|NCT00680836|6191531|P1|STARTED|Overall Study||27
2526737|NCT00680823|6191550|P3|NOT COMPLETED|Overall Study||0
2526738|NCT00680823|6191551|P2|NOT COMPLETED|Overall Study||0
2526739|NCT00680823|6191552|P1|NOT COMPLETED|Overall Study||0
2526740|NCT00680823|6191550|P3|COMPLETED|Overall Study||50
2526741|NCT00680823|6191551|P2|COMPLETED|Overall Study||50
2526742|NCT00680823|6191552|P1|COMPLETED|Overall Study||50
2526743|NCT00680823|6191550|P3|STARTED|Overall Study||50
2526744|NCT00680823|6191551|P2|STARTED|Overall Study||50
2526745|NCT00680823|6191552|P1|STARTED|Overall Study||50
2526746|NCT00680797|6191570|P4|NOT COMPLETED|Overall Study||0
2526747|NCT00680797|6191571|P3|NOT COMPLETED|Overall Study||0
2526748|NCT00680797|6191572|P2|NOT COMPLETED|Overall Study||0
2526749|NCT00680797|6191573|P1|NOT COMPLETED|Overall Study||0
2526750|NCT00680797|6191570|P4|COMPLETED|Overall Study||8
2526751|NCT00680797|6191571|P3|COMPLETED|Overall Study||8
2526752|NCT00680797|6191572|P2|COMPLETED|Overall Study||8
2526753|NCT00680797|6191573|P1|COMPLETED|Overall Study||9
2526754|NCT00680797|6191570|P4|STARTED|Overall Study||8
2526755|NCT00680797|6191571|P3|STARTED|Overall Study||8
2526756|NCT00680797|6191572|P2|STARTED|Overall Study||8
2526757|NCT00680797|6191573|P1|STARTED|Overall Study||9
2526758|NCT00680771|6191585|P2|NOT COMPLETED|Overall Study||2
2526759|NCT00680771|6191586|P1|NOT COMPLETED|Overall Study||6
2526760|NCT00680771|6191585|P2|COMPLETED|Overall Study||11
2526761|NCT00680771|6191586|P1|COMPLETED|Overall Study||9
2526762|NCT00680771|6191585|P2|STARTED|Overall Study||13
2526763|NCT00680771|6191586|P1|STARTED|Overall Study||15
2526764|NCT00680745|6191596|P4|NOT COMPLETED|Overall Study||13
2526765|NCT00680745|6191597|P3|NOT COMPLETED|Overall Study||10
2526766|NCT00680745|6191598|P2|NOT COMPLETED|Overall Study||13
2526767|NCT00680745|6191599|P1|NOT COMPLETED|Overall Study||14
2526768|NCT00680745|6191596|P4|COMPLETED|Overall Study||133
2526769|NCT00680745|6191597|P3|COMPLETED|Overall Study||141
2526770|NCT00680745|6191598|P2|COMPLETED|Overall Study||132
2526771|NCT00680745|6191599|P1|COMPLETED|Overall Study||140
2526772|NCT00680745|6191596|P4|STARTED|Overall Study|Safety Analysis Set|146
2526773|NCT00680745|6191597|P3|STARTED|Overall Study|Safety Analysis Set|151
2526774|NCT00680745|6191598|P2|STARTED|Overall Study|Safety Analysis Set|145
2526775|NCT00680745|6191599|P1|STARTED|Overall Study|Safety Analysis Set|154
2526776|NCT00680706|6191631|P2|NOT COMPLETED|Overall Study||5
2526777|NCT00680706|6191632|P1|NOT COMPLETED|Overall Study||7
2526778|NCT00680706|6191631|P2|COMPLETED|Overall Study||55
2526779|NCT00680706|6191632|P1|COMPLETED|Overall Study||63
2526780|NCT00680706|6191631|P2|STARTED|Overall Study||60
2526781|NCT00680706|6191632|P1|STARTED|Overall Study||70
2526782|NCT00680628|6191642|P2|NOT COMPLETED|Overall Study||0
2526783|NCT00680628|6191643|P1|NOT COMPLETED|Overall Study||0
2526784|NCT00680628|6191642|P2|COMPLETED|Overall Study||40
2526785|NCT00680628|6191643|P1|COMPLETED|Overall Study||43
2526786|NCT00680628|6191642|P2|STARTED|Overall Study||40
2526787|NCT00680628|6191643|P1|STARTED|Overall Study||43
2526788|NCT00680524|6191653|P1|NOT COMPLETED|Overall Study||3
2526789|NCT00680524|6191653|P1|COMPLETED|Overall Study||17
2526790|NCT00680524|6191653|P1|STARTED|Overall Study||20
2526791|NCT00680459|6191659|P2|NOT COMPLETED|Overall Study||0
2526792|NCT00680459|6191660|P1|NOT COMPLETED|Overall Study||0
2526793|NCT00680459|6191659|P2|COMPLETED|Overall Study||6
2526794|NCT00680459|6191660|P1|COMPLETED|Overall Study||7
2526795|NCT00680459|6191659|P2|STARTED|Overall Study||6
2526796|NCT00680459|6191660|P1|STARTED|Overall Study||7
2526797|NCT00680407|6191673|P3|NOT COMPLETED|Overall Study||3
2526798|NCT00680407|6191674|P2|NOT COMPLETED|Overall Study||5
2526799|NCT00680407|6191675|P1|NOT COMPLETED|Overall Study||8
2526800|NCT00680407|6191673|P3|COMPLETED|Overall Study||22
2526801|NCT00680407|6191674|P2|COMPLETED|Overall Study||22
2526802|NCT00680407|6191675|P1|COMPLETED|Overall Study||18
2526803|NCT00680407|6191673|P3|STARTED|Overall Study||25
2526804|NCT00680407|6191674|P2|STARTED|Overall Study||27
2526805|NCT00680407|6191675|P1|STARTED|Overall Study||26
2526806|NCT00680368|6191689|P1|NOT COMPLETED|Overall Study||15
2526807|NCT00680368|6191689|P1|COMPLETED|Overall Study|15 residents excluded because their attending physician was not participating in the study|97
2526808|NCT00680368|6191689|P1|STARTED|Overall Study||112
2526809|NCT00680316|6191697|P2|NOT COMPLETED|Overall Study||0
2526810|NCT00680316|6191698|P1|NOT COMPLETED|Overall Study||0
2526811|NCT00680316|6191697|P2|COMPLETED|Overall Study||2
2526812|NCT00680316|6191698|P1|COMPLETED|Overall Study||1
2526813|NCT00680316|6191697|P2|STARTED|Overall Study||2
2526814|NCT00680316|6191698|P1|STARTED|Overall Study||1
2526815|NCT00680225|6191710|P1|NOT COMPLETED|Overall Study||2
2526816|NCT00680225|6191710|P1|COMPLETED|Overall Study||8
2526817|NCT00680225|6191710|P1|STARTED|Overall Study||10
2526818|NCT00680186|6191717|P2|NOT COMPLETED|Overall Study||116
2526819|NCT00680186|6191718|P1|NOT COMPLETED|Overall Study||125
2526820|NCT00680186|6191717|P2|COMPLETED|Overall Study|Completed planned observation time.|1172
2526821|NCT00680186|6191718|P1|COMPLETED|Overall Study|Completed planned observation time.|1155
2526822|NCT00680186|6191717|P2|STARTED|Overall Study|Started treatment.|1288
2526823|NCT00680186|6191718|P1|STARTED|Overall Study|Started treatment.|1280
2526824|NCT00680121|6191744|P2|NOT COMPLETED|Overall Study||23
2526825|NCT00680121|6191745|P1|NOT COMPLETED|Overall Study||27
2526826|NCT00680121|6191744|P2|COMPLETED|Overall Study||37
2526827|NCT00680121|6191745|P1|COMPLETED|Overall Study||33
2526828|NCT00680121|6191744|P2|STARTED|Overall Study||60
2526829|NCT00680121|6191745|P1|STARTED|Overall Study||60
2526830|NCT00680056|6191759|P2|NOT COMPLETED|Second Intervention||1
2526831|NCT00680056|6191760|P1|NOT COMPLETED|Second Intervention||3
2526832|NCT00680056|6191759|P2|COMPLETED|Second Intervention||14
2526833|NCT00680056|6191760|P1|COMPLETED|Second Intervention||12
2526834|NCT00680056|6191759|P2|STARTED|Second Intervention||15
2526835|NCT00680056|6191760|P1|STARTED|Second Intervention||15
2526836|NCT00680056|6191759|P2|NOT COMPLETED|Washout Period of One Week||0
2526837|NCT00680056|6191760|P1|NOT COMPLETED|Washout Period of One Week||0
2526838|NCT00680056|6191759|P2|COMPLETED|Washout Period of One Week||15
2526839|NCT00680056|6191760|P1|COMPLETED|Washout Period of One Week||15
2526840|NCT00680056|6191759|P2|STARTED|Washout Period of One Week||15
2526841|NCT00680056|6191760|P1|STARTED|Washout Period of One Week||15
2526842|NCT00680056|6191759|P2|NOT COMPLETED|First Intervention||2
2526843|NCT00680056|6191760|P1|NOT COMPLETED|First Intervention||1
2526844|NCT00680056|6191759|P2|COMPLETED|First Intervention||15
2526845|NCT00680056|6191760|P1|COMPLETED|First Intervention||15
2526846|NCT00680056|6191759|P2|STARTED|First Intervention||17
2526847|NCT00680056|6191760|P1|STARTED|First Intervention||16
2526848|NCT00680043|6191771|P3|NOT COMPLETED|Overall Study||4
2526849|NCT00680043|6191772|P2|NOT COMPLETED|Overall Study||1
2526850|NCT00680043|6191773|P1|NOT COMPLETED|Overall Study||2
2526851|NCT00680043|6191771|P3|COMPLETED|Overall Study||34
2526852|NCT00680043|6191772|P2|COMPLETED|Overall Study||36
2526853|NCT00680043|6191773|P1|COMPLETED|Overall Study||37
2526854|NCT00680043|6191771|P3|STARTED|Overall Study||38
2526855|NCT00680043|6191772|P2|STARTED|Overall Study||37
2526856|NCT00680043|6191773|P1|STARTED|Overall Study||39
2526857|NCT00680017|6191789|P2|NOT COMPLETED|Overall Study||12
2526858|NCT00680017|6191790|P1|NOT COMPLETED|Overall Study||17
2526859|NCT00680017|6191789|P2|COMPLETED|Overall Study||128
2526860|NCT00680017|6191790|P1|COMPLETED|Overall Study||123
2526861|NCT00680017|6191789|P2|STARTED|Overall Study||140
2526862|NCT00680017|6191790|P1|STARTED|Overall Study||140
2526863|NCT00679952|6191800|P2|NOT COMPLETED|Overall Study||0
2526864|NCT00679952|6191801|P1|NOT COMPLETED|Overall Study||0
2526865|NCT00679952|6191800|P2|COMPLETED|Overall Study||82
2526866|NCT00679952|6191801|P1|COMPLETED|Overall Study||86
2526867|NCT00679952|6191800|P2|STARTED|Overall Study||82
2526868|NCT00679952|6191801|P1|STARTED|Overall Study||86
2526869|NCT00679939|6191809|P2|NOT COMPLETED|24-Week Open-Label (OL) Period||4
2526870|NCT00679939|6191810|P1|NOT COMPLETED|24-Week Open-Label (OL) Period||7
2526871|NCT00679939|6191809|P2|COMPLETED|24-Week Open-Label (OL) Period||80
2526872|NCT00679939|6191810|P1|COMPLETED|24-Week Open-Label (OL) Period||69
2526873|NCT00679939|6191809|P2|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|84
2526874|NCT00679939|6191810|P1|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|76
2526875|NCT00679939|6191809|P2|NOT COMPLETED|52-Week Double-Blind (DB) Period||27
2526876|NCT00679939|6191810|P1|NOT COMPLETED|52-Week Double-Blind (DB) Period||37
2526877|NCT00679939|6191809|P2|COMPLETED|52-Week Double-Blind (DB) Period||85
2526878|NCT00679939|6191810|P1|COMPLETED|52-Week Double-Blind (DB) Period||77
2526879|NCT00679939|6191809|P2|STARTED|52-Week Double-Blind (DB) Period||112
2526880|NCT00679939|6191810|P1|STARTED|52-Week Double-Blind (DB) Period||114
2526881|NCT00679913|6191961|P2|NOT COMPLETED|Overall Study||13
2526882|NCT00679913|6191962|P1|NOT COMPLETED|Overall Study||18
2526883|NCT00679913|6191961|P2|COMPLETED|Overall Study||86
2526884|NCT00679913|6191962|P1|COMPLETED|Overall Study||83
2526885|NCT00679913|6191961|P2|STARTED|Overall Study||99
2526886|NCT00679913|6191962|P1|STARTED|Overall Study||101
2526887|NCT00679783|6191977|P7|NOT COMPLETED|Overall Study||1
2526888|NCT00679783|6191978|P6|NOT COMPLETED|Overall Study||0
2526889|NCT00679783|6191979|P5|NOT COMPLETED|Overall Study||1
2526890|NCT00679783|6191980|P4|NOT COMPLETED|Overall Study||20
2526891|NCT00679783|6191981|P3|NOT COMPLETED|Overall Study||1
2526892|NCT00679783|6191982|P2|NOT COMPLETED|Overall Study||3
2526893|NCT00679783|6191983|P1|NOT COMPLETED|Overall Study||2
2526894|NCT00679783|6191977|P7|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|15
2526895|NCT00679783|6191978|P6|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|5
2526896|NCT00679783|6191979|P5|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|4
2526897|NCT00679783|6191980|P4|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|25
2526898|NCT00679783|6191981|P3|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
2526899|NCT00679783|6191982|P2|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|10
2526900|NCT00679783|6191983|P1|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
2526901|NCT00679783|6191977|P7|STARTED|Overall Study|Gave Informed consent and passed screening|16
2526902|NCT00679783|6191978|P6|STARTED|Overall Study|Gave Informed consent and passed screening|5
2526903|NCT00679783|6191979|P5|STARTED|Overall Study|Gave Informed consent and passed screening|5
2526904|NCT00679783|6191980|P4|STARTED|Overall Study|Gave Informed consent and passed screening|45
2526905|NCT00679783|6191981|P3|STARTED|Overall Study|Gave Informed consent and passed screening|3
2526906|NCT00679783|6191982|P2|STARTED|Overall Study|Gave Informed consent and passed screening|13
2526907|NCT00679783|6191983|P1|STARTED|Overall Study|Gave Informed consent and passed screening|4
2526908|NCT00679627|6192036|P2|NOT COMPLETED|Overall Study||685
2526909|NCT00679627|6192037|P1|NOT COMPLETED|Overall Study||699
2526910|NCT00679627|6192036|P2|COMPLETED|Overall Study||339
2526911|NCT00679627|6192037|P1|COMPLETED|Overall Study||322
2526912|NCT00679627|6192036|P2|STARTED|Overall Study||1024
2526913|NCT00679627|6192037|P1|STARTED|Overall Study||1021
2526914|NCT00679549|6192061|P2|NOT COMPLETED|Overall Study||9
2526915|NCT00679549|6192062|P1|NOT COMPLETED|Overall Study||6
2526916|NCT00679549|6192061|P2|COMPLETED|Overall Study|4 dropouts in the control arm; 5 missing echocardiograms in the control arm|66
2526917|NCT00679549|6192062|P1|COMPLETED|Overall Study||69
2526918|NCT00679549|6192061|P2|STARTED|Overall Study||75
2526919|NCT00679549|6192062|P1|STARTED|Overall Study||75
2526920|NCT00679432|6192072|P4|NOT COMPLETED|Overall Study||32
2526921|NCT00679432|6192073|P3|NOT COMPLETED|Overall Study||53
2526922|NCT00679432|6192074|P2|NOT COMPLETED|Overall Study||38
2526923|NCT00679432|6192075|P1|NOT COMPLETED|Overall Study||37
2526924|NCT00679432|6192072|P4|COMPLETED|Overall Study||95
2526925|NCT00679432|6192073|P3|COMPLETED|Overall Study||76
2526926|NCT00679432|6192074|P2|COMPLETED|Overall Study||89
2526927|NCT00679432|6192075|P1|COMPLETED|Overall Study||89
2526928|NCT00679432|6192072|P4|STARTED|Overall Study||127
2526929|NCT00679432|6192073|P3|STARTED|Overall Study||129
2526930|NCT00679432|6192074|P2|STARTED|Overall Study||127
2526931|NCT00679432|6192075|P1|STARTED|Overall Study||126
2526932|NCT00679380|6192097|P4|NOT COMPLETED|Overall Study||28
2526933|NCT00679380|6192098|P3|NOT COMPLETED|Overall Study||35
2526934|NCT00679380|6192099|P2|NOT COMPLETED|Overall Study||33
2526935|NCT00679380|6192100|P1|NOT COMPLETED|Overall Study||42
2526936|NCT00679380|6192097|P4|COMPLETED|Overall Study||61
2526937|NCT00679380|6192098|P3|COMPLETED|Overall Study||68
2526938|NCT00679380|6192099|P2|COMPLETED|Overall Study||76
2526939|NCT00679380|6192100|P1|COMPLETED|Overall Study||67
2526940|NCT00679380|6192097|P4|STARTED|Overall Study||89
2526941|NCT00679380|6192098|P3|STARTED|Overall Study||103
2526942|NCT00679380|6192099|P2|STARTED|Overall Study||109
2526943|NCT00679380|6192100|P1|STARTED|Overall Study||109
2526944|NCT00679367|6192118|P1|NOT COMPLETED|Overall Study||12
2526945|NCT00679367|6192118|P1|COMPLETED|Overall Study||4
2526946|NCT00679367|6192118|P1|STARTED|Overall Study||16
2526947|NCT00679354|6192124|P1|NOT COMPLETED|Overall Study||30
2526948|NCT00679354|6192124|P1|COMPLETED|Overall Study||0
2526949|NCT00679354|6192124|P1|STARTED|Overall Study||30
2526950|NCT00679341|6192142|P2|NOT COMPLETED|Overall Study||51
2526951|NCT00679341|6192143|P1|NOT COMPLETED|Overall Study||53
2526952|NCT00679341|6192142|P2|COMPLETED|Overall Study||19
2526953|NCT00679341|6192143|P1|COMPLETED|Overall Study||14
2526954|NCT00679341|6192142|P2|STARTED|Overall Study||70
2526955|NCT00679341|6192143|P1|STARTED|Overall Study||67
2526956|NCT00679302|6192163|P2|NOT COMPLETED|Overall Study||4
2526957|NCT00679302|6192164|P1|NOT COMPLETED|Overall Study||8
2526958|NCT00679302|6192163|P2|COMPLETED|Overall Study||73
2526959|NCT00679302|6192164|P1|COMPLETED|Overall Study||76
2526960|NCT00679302|6192163|P2|STARTED|Overall Study||77
2526961|NCT00679302|6192164|P1|STARTED|Overall Study||84
2526962|NCT00679289|6192175|P3|NOT COMPLETED|Overall Study||23
2526963|NCT00679289|6192176|P2|NOT COMPLETED|Overall Study||6
2526964|NCT00679289|6192177|P1|NOT COMPLETED|Overall Study||5
2526965|NCT00679289|6192175|P3|COMPLETED|Overall Study||1
2526966|NCT00679289|6192176|P2|COMPLETED|Overall Study||0
2526967|NCT00679289|6192177|P1|COMPLETED|Overall Study||1
2526968|NCT00679289|6192175|P3|STARTED|Overall Study||24
2526969|NCT00679289|6192176|P2|STARTED|Overall Study||6
2526970|NCT00679289|6192177|P1|STARTED|Overall Study||6
2526971|NCT00679263|6192199|P3|NOT COMPLETED|Visit 2/Dose 1||0
2526972|NCT00679263|6192200|P2|NOT COMPLETED|Visit 2/Dose 1||1
2526973|NCT00679263|6192201|P1|NOT COMPLETED|Visit 2/Dose 1||2
2526974|NCT00679263|6192199|P3|COMPLETED|Visit 2/Dose 1||11
2526975|NCT00679263|6192200|P2|COMPLETED|Visit 2/Dose 1||5
2526976|NCT00679263|6192201|P1|COMPLETED|Visit 2/Dose 1||9
2526977|NCT00679263|6192199|P3|STARTED|Visit 2/Dose 1||11
2526978|NCT00679263|6192200|P2|STARTED|Visit 2/Dose 1||6
2526979|NCT00679263|6192201|P1|STARTED|Visit 2/Dose 1||11
2526980|NCT00679263|6192199|P3|NOT COMPLETED|Visit 3/Dose 2||0
2526981|NCT00679263|6192200|P2|NOT COMPLETED|Visit 3/Dose 2||5
2526982|NCT00679263|6192201|P1|NOT COMPLETED|Visit 3/Dose 2||1
2526983|NCT00679263|6192199|P3|COMPLETED|Visit 3/Dose 2||11
2526984|NCT00679263|6192200|P2|COMPLETED|Visit 3/Dose 2||6
2526985|NCT00679263|6192201|P1|COMPLETED|Visit 3/Dose 2||9
2526986|NCT00679263|6192199|P3|STARTED|Visit 3/Dose 2||11
2526987|NCT00679263|6192200|P2|STARTED|Visit 3/Dose 2||11
2526988|NCT00679263|6192201|P1|STARTED|Visit 3/Dose 2||10
2526989|NCT00679211|6192212|P1|NOT COMPLETED|Overall Study||110
2526990|NCT00679211|6192212|P1|COMPLETED|Overall Study||0
2526991|NCT00679211|6192212|P1|STARTED|Overall Study||110
2526992|NCT00679172|6192229|P5|NOT COMPLETED|Overall Study||0
2526993|NCT00679172|6192230|P4|NOT COMPLETED|Overall Study||1
2526994|NCT00679172|6192231|P3|NOT COMPLETED|Overall Study||1
2526995|NCT00679172|6192232|P2|NOT COMPLETED|Overall Study||1
2526996|NCT00679172|6192233|P1|NOT COMPLETED|Overall Study||1
2526997|NCT00679172|6192229|P5|COMPLETED|Overall Study||37
2526998|NCT00679172|6192230|P4|COMPLETED|Overall Study||38
2526999|NCT00679172|6192231|P3|COMPLETED|Overall Study||35
2527000|NCT00679172|6192232|P2|COMPLETED|Overall Study||37
2527001|NCT00679172|6192233|P1|COMPLETED|Overall Study||36
2527002|NCT00679172|6192229|P5|STARTED|Overall Study||37
2527003|NCT00679172|6192230|P4|STARTED|Overall Study||39
2527004|NCT00679172|6192231|P3|STARTED|Overall Study||36
2527005|NCT00679172|6192232|P2|STARTED|Overall Study||38
2527006|NCT00679172|6192233|P1|STARTED|Overall Study||37
2527007|NCT00679081|6192296|P1|NOT COMPLETED|Overall Study||1
2527008|NCT00679081|6192296|P1|COMPLETED|Overall Study||14
2527009|NCT00679081|6192296|P1|STARTED|Overall Study|Study design was within-subject control.|15
2527010|NCT00679055|6192306|P2|NOT COMPLETED|Overall Study||5
2527011|NCT00679055|6192307|P1|NOT COMPLETED|Overall Study||2
2527012|NCT00679055|6192306|P2|COMPLETED|Overall Study||1
2527013|NCT00679055|6192307|P1|COMPLETED|Overall Study||6
2527014|NCT00679055|6192306|P2|STARTED|Overall Study||6
2527015|NCT00679055|6192307|P1|STARTED|Overall Study||8
2527016|NCT00679029|6192317|P1|NOT COMPLETED|Overall Study||5
2527017|NCT00679029|6192317|P1|COMPLETED|Overall Study||10
2527018|NCT00679029|6192317|P1|STARTED|Overall Study||15
2527019|NCT00678899|6192324|P1|NOT COMPLETED|Overall Study||1
2527020|NCT00678899|6192324|P1|COMPLETED|Overall Study||49
2527021|NCT00678899|6192324|P1|STARTED|Overall Study||50
2527022|NCT00678886|6192333|P4|NOT COMPLETED|Overall Study||9
2527023|NCT00678886|6192334|P3|NOT COMPLETED|Overall Study||9
2527024|NCT00678886|6192335|P2|NOT COMPLETED|Overall Study||0
2527025|NCT00678886|6192336|P1|NOT COMPLETED|Overall Study||0
2527026|NCT00678886|6192333|P4|COMPLETED|Overall Study||153
2527027|NCT00678886|6192334|P3|COMPLETED|Overall Study||72
2527028|NCT00678886|6192335|P2|COMPLETED|Overall Study||19
2527029|NCT00678886|6192336|P1|COMPLETED|Overall Study||10
2527030|NCT00678886|6192333|P4|STARTED|Overall Study||162
2527031|NCT00678886|6192334|P3|STARTED|Overall Study||81
2527032|NCT00678886|6192335|P2|STARTED|Overall Study||19
2527033|NCT00678886|6192336|P1|STARTED|Overall Study||10
2527034|NCT00678834|6192383|P3|NOT COMPLETED|Overall Study||9
2527035|NCT00678834|6192384|P2|NOT COMPLETED|Overall Study||0
2527036|NCT00678834|6192385|P1|NOT COMPLETED|Overall Study||16
2527037|NCT00678834|6192383|P3|COMPLETED|Overall Study||16
2527038|NCT00678834|6192384|P2|COMPLETED|Overall Study||15
2527039|NCT00678834|6192385|P1|COMPLETED|Overall Study||24
2527040|NCT00678834|6192383|P3|STARTED|Overall Study||25
2527041|NCT00678834|6192384|P2|STARTED|Overall Study||15
2527042|NCT00678834|6192385|P1|STARTED|Overall Study||40
2527043|NCT00678795|6192405|P2|NOT COMPLETED|Overall Study||6
2527044|NCT00678795|6192406|P1|NOT COMPLETED|Overall Study||11
2527045|NCT00678795|6192405|P2|COMPLETED|Overall Study||62
2527046|NCT00678795|6192406|P1|COMPLETED|Overall Study||56
2527047|NCT00678795|6192405|P2|STARTED|Overall Study||68
2527048|NCT00678795|6192406|P1|STARTED|Overall Study||67
2527049|NCT00678691|6192428|P2|NOT COMPLETED|Overall Study||4
2527050|NCT00678691|6192429|P1|NOT COMPLETED|Overall Study||6
2527051|NCT00678691|6192428|P2|COMPLETED|Overall Study||24
2527052|NCT00678691|6192429|P1|COMPLETED|Overall Study||21
2527053|NCT00678691|6192428|P2|STARTED|Overall Study||28
2527054|NCT00678691|6192429|P1|STARTED|Overall Study||27
2527055|NCT00678652|6192439|P4|NOT COMPLETED|Overall Study||0
2527056|NCT00678652|6192440|P3|NOT COMPLETED|Overall Study||1
2527057|NCT00678652|6192441|P2|NOT COMPLETED|Overall Study||0
2527058|NCT00678652|6192442|P1|NOT COMPLETED|Overall Study||3
2527059|NCT00678652|6192439|P4|COMPLETED|Overall Study||9
2527060|NCT00678652|6192440|P3|COMPLETED|Overall Study||8
2527061|NCT00678652|6192441|P2|COMPLETED|Overall Study||9
2527062|NCT00678652|6192442|P1|COMPLETED|Overall Study||6
2527063|NCT00678652|6192439|P4|STARTED|Overall Study||9
2527064|NCT00678652|6192440|P3|STARTED|Overall Study||9
2527065|NCT00678652|6192441|P2|STARTED|Overall Study||9
2527066|NCT00678652|6192442|P1|STARTED|Overall Study||9
2527067|NCT00678639|6192466|P2|NOT COMPLETED|Overall Study||0
2527068|NCT00678639|6192467|P1|NOT COMPLETED|Overall Study||2
2527069|NCT00678639|6192466|P2|COMPLETED|Overall Study||57
2527070|NCT00678639|6192467|P1|COMPLETED|Overall Study||51
2527071|NCT00678639|6192466|P2|Hospital Discharge|Overall Study||57
2527072|NCT00678639|6192467|P1|Hospital Discharge|Overall Study||53
2527073|NCT00678639|6192466|P2|STARTED|Overall Study||57
2527074|NCT00678639|6192467|P1|STARTED|Overall Study||53
2527075|NCT00678587|6192482|P2|NOT COMPLETED|Overall Study||18
2527076|NCT00678587|6192483|P1|NOT COMPLETED|Overall Study||20
2527077|NCT00678587|6192482|P2|COMPLETED|Overall Study||127
2527078|NCT00678587|6192483|P1|COMPLETED|Overall Study||127
2527079|NCT00678587|6192482|P2|STARTED|Overall Study||145
2527080|NCT00678587|6192483|P1|STARTED|Overall Study||147
2527081|NCT00678574|6192517|P2|NOT COMPLETED|Overall Study||0
2527082|NCT00678574|6192518|P1|NOT COMPLETED|Overall Study||0
2527083|NCT00678574|6192517|P2|COMPLETED|Overall Study||27
2527084|NCT00678574|6192518|P1|COMPLETED|Overall Study||18
2527085|NCT00678574|6192517|P2|STARTED|Overall Study||27
2527086|NCT00678574|6192518|P1|STARTED|Overall Study||18
2527087|NCT00678535|6192526|P2|NOT COMPLETED|Overall Study||98
2527088|NCT00678535|6192527|P1|NOT COMPLETED|Overall Study||93
2527089|NCT00678535|6192526|P2|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|351
2527090|NCT00678535|6192527|P1|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|362
2527091|NCT00678535|6192526|P2|STARTED|Overall Study|ITT population|449
2527092|NCT00678535|6192527|P1|STARTED|Overall Study|ITT population|455
2527093|NCT00678470|6192543|P1|NOT COMPLETED|Overall Study||4
2527094|NCT00678470|6192543|P1|COMPLETED|Overall Study||14
2527095|NCT00678470|6192543|P1|STARTED|Overall Study||18
2527096|NCT00678444|6192549|P2|NOT COMPLETED|Overall Study||0
2527097|NCT00678444|6192550|P1|NOT COMPLETED|Overall Study||0
2527098|NCT00678444|6192549|P2|COMPLETED|Overall Study||99
2527099|NCT00678444|6192550|P1|COMPLETED|Overall Study||100
2527100|NCT00678444|6192549|P2|STARTED|Overall Study||99
2527101|NCT00678444|6192550|P1|STARTED|Overall Study||100
2527102|NCT00678418|6192560|P2|NOT COMPLETED|Part B (Open Label)||0
2527103|NCT00678418|6192561|P1|NOT COMPLETED|Part B (Open Label)||43
2527104|NCT00678418|6192560|P2|COMPLETED|Part B (Open Label)||0
2527105|NCT00678418|6192561|P1|COMPLETED|Part B (Open Label)||71
2527106|NCT00678418|6192560|P2|STARTED|Part B (Open Label)||0
2527107|NCT00678418|6192561|P1|STARTED|Part B (Open Label)|All participants who received placebo in Part A were switched to open-label VIVITROL in Part B.|114
2527108|NCT00678418|6192560|P2|NOT COMPLETED|Part A (Double Blind)||77
2527109|NCT00678418|6192561|P1|NOT COMPLETED|Part A (Double Blind)||59
2527110|NCT00678418|6192560|P2|COMPLETED|Part A (Double Blind)||47
2527111|NCT00678418|6192561|P1|COMPLETED|Part A (Double Blind)||67
2527112|NCT00678418|6192560|P2|STARTED|Part A (Double Blind)||124
2527113|NCT00678418|6192561|P1|STARTED|Part A (Double Blind)||126
2527114|NCT00678392|6192577|P2|NOT COMPLETED|Overall Study||362
2527115|NCT00678392|6192578|P1|NOT COMPLETED|Overall Study||361
2527116|NCT00678392|6192577|P2|COMPLETED|Overall Study||0
2527117|NCT00678392|6192578|P1|COMPLETED|Overall Study||0
2527118|NCT00678392|6192577|P2|Treated|Overall Study||355
2527119|NCT00678392|6192578|P1|Treated|Overall Study||359
2527120|NCT00678392|6192577|P2|STARTED|Overall Study||362
2527121|NCT00678392|6192578|P1|STARTED|Overall Study||361
2527122|NCT00678379|6192613|P3|NOT COMPLETED|Overall Study||4
2527123|NCT00678379|6192614|P2|NOT COMPLETED|Overall Study||3
2527124|NCT00678379|6192615|P1|NOT COMPLETED|Overall Study||6
2527125|NCT00678379|6192613|P3|COMPLETED|Overall Study||36
2527126|NCT00678379|6192614|P2|COMPLETED|Overall Study||37
2527127|NCT00678379|6192615|P1|COMPLETED|Overall Study||34
2527128|NCT00678379|6192613|P3|STARTED|Overall Study||40
2527129|NCT00678379|6192614|P2|STARTED|Overall Study||40
2527130|NCT00678379|6192615|P1|STARTED|Overall Study||40
2527131|NCT00678301|6192643|P2|NOT COMPLETED|Overall Study||2
2527132|NCT00678301|6192644|P1|NOT COMPLETED|Overall Study||8
2527133|NCT00678301|6192643|P2|COMPLETED|Overall Study||116
2527134|NCT00678301|6192644|P1|COMPLETED|Overall Study||231
2527135|NCT00678301|6192643|P2|STARTED|Overall Study||118
2527136|NCT00678301|6192644|P1|STARTED|Overall Study||239
2527137|NCT00678288|6192702|P2|NOT COMPLETED|Overall Study||6
2527138|NCT00678288|6192703|P1|NOT COMPLETED|Overall Study||10
2527139|NCT00678288|6192702|P2|COMPLETED|Overall Study||0
2527140|NCT00678288|6192703|P1|COMPLETED|Overall Study||0
2527141|NCT00678288|6192702|P2|STARTED|Overall Study||6
2527142|NCT00678288|6192703|P1|STARTED|Overall Study||10
2527143|NCT00678249|6192720|P3|NOT COMPLETED|Overall Study||0
2527144|NCT00678249|6192721|P2|NOT COMPLETED|Overall Study||0
2527145|NCT00678249|6192722|P1|NOT COMPLETED|Overall Study||0
2527146|NCT00678249|6192720|P3|COMPLETED|Overall Study||37
2527147|NCT00678249|6192721|P2|COMPLETED|Overall Study||93
2527148|NCT00678249|6192722|P1|COMPLETED|Overall Study||97
2527149|NCT00678249|6192720|P3|STARTED|Overall Study||37
2527150|NCT00678249|6192721|P2|STARTED|Overall Study||93
2527151|NCT00678249|6192722|P1|STARTED|Overall Study||97
2527152|NCT00678210|6192758|P4|NOT COMPLETED|Overall Study||20
2527153|NCT00678210|6192759|P3|NOT COMPLETED|Overall Study||6
2527154|NCT00678210|6192760|P2|NOT COMPLETED|Overall Study||11
2527155|NCT00678210|6192761|P1|NOT COMPLETED|Overall Study||11
2527156|NCT00678210|6192758|P4|COMPLETED|Overall Study||30
2527157|NCT00678210|6192759|P3|COMPLETED|Overall Study||43
2527158|NCT00678210|6192760|P2|COMPLETED|Overall Study||38
2527159|NCT00678210|6192761|P1|COMPLETED|Overall Study||38
2527160|NCT00678210|6192758|P4|STARTED|Overall Study||50
2527161|NCT00678210|6192759|P3|STARTED|Overall Study||49
2527162|NCT00678210|6192760|P2|STARTED|Overall Study||49
2527163|NCT00678210|6192761|P1|STARTED|Overall Study||49
2527164|NCT00678080|6192797|P2|NOT COMPLETED|Overall Study||1
2527165|NCT00678080|6192798|P1|NOT COMPLETED|Overall Study||3
2527166|NCT00678080|6192797|P2|COMPLETED|Overall Study||13
2527167|NCT00678080|6192798|P1|COMPLETED|Overall Study||8
2527168|NCT00678080|6192797|P2|STARTED|Overall Study||14
2527169|NCT00678080|6192798|P1|STARTED|Overall Study||11
2527170|NCT00678041|6192824|P2|NOT COMPLETED|Overall Study||5
2527171|NCT00678041|6192825|P1|NOT COMPLETED|Overall Study||5
2527172|NCT00678041|6192824|P2|COMPLETED|Overall Study||0
2527173|NCT00678041|6192825|P1|COMPLETED|Overall Study||0
2527174|NCT00678041|6192824|P2|STARTED|Overall Study||5
2527175|NCT00678041|6192825|P1|STARTED|Overall Study||5
2527176|NCT00678015|6192837|P1|NOT COMPLETED|Overall Study||0
2527177|NCT00678015|6192837|P1|COMPLETED|Overall Study||12
2527178|NCT00678015|6192837|P1|STARTED|Overall Study||12
2527179|NCT00677924|6192846|P2|NOT COMPLETED|Overall Study||0
2527180|NCT00677924|6192847|P1|NOT COMPLETED|Overall Study||0
2527181|NCT00677924|6192846|P2|COMPLETED|Overall Study||6
2527182|NCT00677924|6192847|P1|COMPLETED|Overall Study||3
2527183|NCT00677924|6192846|P2|STARTED|Overall Study||6
2527184|NCT00677924|6192847|P1|STARTED|Overall Study||3
2527185|NCT00677898|6192857|P2|NOT COMPLETED|Overall Study||18
2527186|NCT00677898|6192858|P1|NOT COMPLETED|Overall Study||20
2527187|NCT00677898|6192857|P2|COMPLETED|Overall Study||102
2527188|NCT00677898|6192858|P1|COMPLETED|Overall Study||99
2527189|NCT00677898|6192857|P2|STARTED|Overall Study||120
2527190|NCT00677898|6192858|P1|STARTED|Overall Study||119
2527191|NCT00677833|6192878|P4|NOT COMPLETED|Overall Study||3
2527192|NCT00677833|6192879|P3|NOT COMPLETED|Overall Study||2
2527193|NCT00677833|6192880|P2|NOT COMPLETED|Overall Study||0
2527194|NCT00677833|6192881|P1|NOT COMPLETED|Overall Study||4
2527195|NCT00677833|6192878|P4|COMPLETED|Overall Study||128
2527196|NCT00677833|6192879|P3|COMPLETED|Overall Study||122
2527197|NCT00677833|6192880|P2|COMPLETED|Overall Study||51
2527198|NCT00677833|6192881|P1|COMPLETED|Overall Study||51
2527199|NCT00677833|6192878|P4|STARTED|Overall Study||131
2527200|NCT00677833|6192879|P3|STARTED|Overall Study||124
2527201|NCT00677833|6192880|P2|STARTED|Overall Study||51
2527202|NCT00677833|6192881|P1|STARTED|Overall Study||55
2527203|NCT00677820|6192931|P2|NOT COMPLETED|Overall Study||0
2527204|NCT00677820|6192932|P1|NOT COMPLETED|Overall Study||1
2527205|NCT00677820|6192931|P2|COMPLETED|Overall Study||60
2527206|NCT00677820|6192932|P1|COMPLETED|Overall Study||239
2527207|NCT00677820|6192931|P2|STARTED|Overall Study||60
2527208|NCT00677820|6192932|P1|STARTED|Overall Study||240
2527209|NCT00677807|6192953|P3|NOT COMPLETED|Overall Study||20
2527210|NCT00677807|6192954|P2|NOT COMPLETED|Overall Study||11
2527211|NCT00677807|6192955|P1|NOT COMPLETED|Overall Study||18
2527212|NCT00677807|6192953|P3|COMPLETED|Overall Study||105
2527213|NCT00677807|6192954|P2|COMPLETED|Overall Study||135
2527214|NCT00677807|6192955|P1|COMPLETED|Overall Study||126
2527215|NCT00677807|6192953|P3|Safety/ITT: Received Study Drug|Overall Study|One patient did not take study medication.|124
2527216|NCT00677807|6192954|P2|Safety/ITT: Received Study Drug|Overall Study||146
2527217|NCT00677807|6192955|P1|Safety/ITT: Received Study Drug|Overall Study||144
2527218|NCT00677807|6192953|P3|STARTED|Overall Study||125
2527219|NCT00677807|6192954|P2|STARTED|Overall Study||146
2527220|NCT00677807|6192955|P1|STARTED|Overall Study||144
2527221|NCT00677690|6192986|P2|NOT COMPLETED|Overall Study||0
2527222|NCT00677690|6192987|P1|NOT COMPLETED|Overall Study||0
2527223|NCT00677690|6192986|P2|COMPLETED|Overall Study||41
2527224|NCT00677690|6192987|P1|COMPLETED|Overall Study||42
2527225|NCT00677690|6192986|P2|STARTED|Overall Study||41
2527226|NCT00677690|6192987|P1|STARTED|Overall Study||42
2527227|NCT00677534|6193001|P1|NOT COMPLETED|After Paricalcitol Restart (Weeks 13-14)||0
2527228|NCT00677534|6193001|P1|COMPLETED|After Paricalcitol Restart (Weeks 13-14)||7
2527229|NCT00677534|6193001|P1|STARTED|After Paricalcitol Restart (Weeks 13-14)||7
2527230|NCT00677534|6193001|P1|NOT COMPLETED|Cholecalciferol (Weeks 5-12)||0
2527231|NCT00677534|6193001|P1|COMPLETED|Cholecalciferol (Weeks 5-12)||7
2527232|NCT00677534|6193001|P1|STARTED|Cholecalciferol (Weeks 5-12)||7
2527233|NCT00677534|6193001|P1|NOT COMPLETED|Washout (Weeks 1-4)||3
2527234|NCT00677534|6193001|P1|COMPLETED|Washout (Weeks 1-4)||7
2527235|NCT00677534|6193001|P1|STARTED|Washout (Weeks 1-4)||10
2527236|NCT00677365|6193009|P4|NOT COMPLETED|Overall Study||3
2527237|NCT00677365|6193010|P3|NOT COMPLETED|Overall Study||2
2527238|NCT00677365|6193011|P2|NOT COMPLETED|Overall Study||1
2527239|NCT00677365|6193012|P1|NOT COMPLETED|Overall Study||2
2527240|NCT00677365|6193009|P4|COMPLETED|Overall Study||36
2527241|NCT00677365|6193010|P3|COMPLETED|Overall Study||35
2527242|NCT00677365|6193011|P2|COMPLETED|Overall Study||37
2527243|NCT00677365|6193012|P1|COMPLETED|Overall Study||35
2527244|NCT00677365|6193009|P4|STARTED|Overall Study||39
2527245|NCT00677365|6193010|P3|STARTED|Overall Study||37
2527246|NCT00677365|6193011|P2|STARTED|Overall Study||38
2527247|NCT00677365|6193012|P1|STARTED|Overall Study||37
2527248|NCT00677352|6193044|P2|NOT COMPLETED|Tapering Phase||10
2527249|NCT00677352|6193045|P1|NOT COMPLETED|Tapering Phase||6
2527250|NCT00677352|6193044|P2|COMPLETED|Tapering Phase||112
2527251|NCT00677352|6193045|P1|COMPLETED|Tapering Phase||126
2527252|NCT00677352|6193044|P2|STARTED|Tapering Phase||122
2527253|NCT00677352|6193045|P1|STARTED|Tapering Phase||132
2527254|NCT00677352|6193044|P2|NOT COMPLETED|Treatment Phase||42
2527255|NCT00677352|6193045|P1|NOT COMPLETED|Treatment Phase||25
2527256|NCT00677352|6193044|P2|COMPLETED|Treatment Phase||122
2527257|NCT00677352|6193045|P1|COMPLETED|Treatment Phase||132
2527258|NCT00677352|6193044|P2|STARTED|Treatment Phase|2 subjects were not teated, therefore 162 subjects were treated with paroxetine.|164
2527259|NCT00677352|6193045|P1|STARTED|Treatment Phase|All 157 subjects were treated with Sertraline.|157
2527260|NCT00677235|6193065|P2|NOT COMPLETED|Overall Study||38
2527261|NCT00677235|6193066|P1|NOT COMPLETED|Overall Study||41
2527262|NCT00677235|6193065|P2|COMPLETED|Overall Study||94
2527263|NCT00677235|6193066|P1|COMPLETED|Overall Study||97
2527264|NCT00677235|6193065|P2|STARTED|Overall Study||132
2527265|NCT00677235|6193066|P1|STARTED|Overall Study||138
2527266|NCT00677092|6193106|P1|NOT COMPLETED|Overall Study||6
2527267|NCT00677092|6193106|P1|COMPLETED|Overall Study||6
2527268|NCT00677092|6193106|P1|Received Study Treatment|Overall Study||11
2527269|NCT00677092|6193106|P1|STARTED|Overall Study||12
2527270|NCT00677040|6193115|P1|NOT COMPLETED|Overall Study||0
2527271|NCT00677040|6193115|P1|COMPLETED|Overall Study||20
2527272|NCT00677040|6193115|P1|STARTED|Overall Study||20
2527273|NCT00677014|6193123|P3|NOT COMPLETED|Overall Study||49
2527274|NCT00677014|6193124|P2|NOT COMPLETED|Overall Study||41
2527275|NCT00677014|6193125|P1|NOT COMPLETED|Overall Study||44
2527276|NCT00677014|6193123|P3|COMPLETED|Overall Study||283
2527277|NCT00677014|6193124|P2|COMPLETED|Overall Study||282
2527278|NCT00677014|6193125|P1|COMPLETED|Overall Study||281
2527279|NCT00677014|6193123|P3|STARTED|Overall Study||332
2527280|NCT00677014|6193124|P2|STARTED|Overall Study||323
2527281|NCT00677014|6193125|P1|STARTED|Overall Study||325
2527282|NCT00676897|6193135|P2|NOT COMPLETED|Overall Study||0
2527283|NCT00676897|6193136|P1|NOT COMPLETED|Overall Study||0
2527284|NCT00676897|6193135|P2|COMPLETED|Overall Study||10
2527285|NCT00676897|6193136|P1|COMPLETED|Overall Study||8
2527286|NCT00676897|6193135|P2|STARTED|Overall Study||10
2527287|NCT00676897|6193136|P1|STARTED|Overall Study||8
2527288|NCT00676806|6193146|P2|NOT COMPLETED|Overall Study||0
2527289|NCT00676806|6193147|P1|NOT COMPLETED|Overall Study||0
2527290|NCT00676806|6193146|P2|COMPLETED|Overall Study||3
2527291|NCT00676806|6193147|P1|COMPLETED|Overall Study||3
2527292|NCT00676806|6193146|P2|STARTED|Overall Study||3
2527293|NCT00676806|6193147|P1|STARTED|Overall Study||3
2527294|NCT00676793|6193163|P1|NOT COMPLETED|Overall Study||13
2527295|NCT00676793|6193163|P1|COMPLETED|Overall Study||19
2527296|NCT00676793|6193163|P1|STARTED|Overall Study||32
2527297|NCT00676780|6193168|P1|NOT COMPLETED|Overall Study||7
2527298|NCT00676780|6193168|P1|COMPLETED|Overall Study||26
2527299|NCT00676780|6193168|P1|STARTED|Overall Study||33
2527300|NCT00676715|6193178|P4|NOT COMPLETED|Overall Study||40
2527301|NCT00676715|6193179|P3|NOT COMPLETED|Overall Study||41
2527302|NCT00676715|6193180|P2|NOT COMPLETED|Overall Study||47
2527303|NCT00676715|6193181|P1|NOT COMPLETED|Overall Study||40
2527304|NCT00676715|6193178|P4|COMPLETED|Overall Study||14
2527305|NCT00676715|6193179|P3|COMPLETED|Overall Study||14
2527306|NCT00676715|6193180|P2|COMPLETED|Overall Study||8
2527307|NCT00676715|6193181|P1|COMPLETED|Overall Study||14
2527308|NCT00676715|6193178|P4|STARTED|Overall Study||54
2527309|NCT00676715|6193179|P3|STARTED|Overall Study||55
2527310|NCT00676715|6193180|P2|STARTED|Overall Study||55
2527311|NCT00676715|6193181|P1|STARTED|Overall Study||54
2527318|NCT00676676|6193217|P1|NOT COMPLETED|Overall Study||0
2527319|NCT00676676|6193217|P1|COMPLETED|Overall Study||9
2527320|NCT00676676|6193217|P1|STARTED|Overall Study||9
2527321|NCT00676663|6193223|P2|NOT COMPLETED|Overall Study||38
2527322|NCT00676663|6193224|P1|NOT COMPLETED|Overall Study||45
2527323|NCT00676663|6193223|P2|COMPLETED|Overall Study||26
2527324|NCT00676663|6193224|P1|COMPLETED|Overall Study||21
2527325|NCT00676663|6193223|P2|STARTED|Overall Study||64
2527326|NCT00676663|6193224|P1|STARTED|Overall Study||66
2527327|NCT00676650|6193240|P2|NOT COMPLETED|Overall Study||289
2527328|NCT00676650|6193241|P1|NOT COMPLETED|Overall Study||584
2527329|NCT00676650|6193240|P2|COMPLETED|Overall Study||0
2527330|NCT00676650|6193241|P1|COMPLETED|Overall Study||0
2527331|NCT00676650|6193240|P2|Treated|Overall Study||285
2527332|NCT00676650|6193241|P1|Treated|Overall Study||581
2527333|NCT00676650|6193240|P2|STARTED|Overall Study||289
2527334|NCT00676650|6193241|P1|STARTED|Overall Study||584
2527335|NCT00676585|6193261|P2|NOT COMPLETED|Overall Study||0
2527336|NCT00676585|6193262|P1|NOT COMPLETED|Overall Study||0
2527337|NCT00676585|6193261|P2|COMPLETED|Overall Study||25
2527338|NCT00676585|6193262|P1|COMPLETED|Overall Study||25
2527339|NCT00676585|6193261|P2|STARTED|Overall Study||25
2527340|NCT00676585|6193262|P1|STARTED|Overall Study||25
2527341|NCT00676572|6193274|P2|NOT COMPLETED|Overall Study||0
2527342|NCT00676572|6193275|P1|NOT COMPLETED|Overall Study||0
2527343|NCT00676572|6193274|P2|COMPLETED|Overall Study||6
2527344|NCT00676572|6193275|P1|COMPLETED|Overall Study||6
2527345|NCT00676572|6193274|P2|STARTED|Overall Study||6
2527346|NCT00676572|6193275|P1|STARTED|Overall Study||6
2527347|NCT00676520|6193283|P1|NOT COMPLETED|Overall Study||731
2527348|NCT00676520|6193283|P1|COMPLETED|Overall Study||7309
2527349|NCT00676520|6193283|P1|STARTED|Overall Study||8040
2527350|NCT00676494|6193340|P1|NOT COMPLETED|Overall Study||14
2527351|NCT00676494|6193340|P1|COMPLETED|Overall Study||158
2527352|NCT00676494|6193340|P1|STARTED|Overall Study||172
2527353|NCT00676455|6193346|P1|NOT COMPLETED|Overall Study||0
2527354|NCT00676455|6193346|P1|COMPLETED|Overall Study||14
2527355|NCT00676455|6193346|P1|STARTED|Overall Study||14
2527356|NCT00676403|6193357|P6|NOT COMPLETED|Overall Study||5
2527357|NCT00676403|6193358|P5|NOT COMPLETED|Overall Study||1
2527358|NCT00676403|6193359|P4|NOT COMPLETED|Overall Study||5
2527359|NCT00676403|6193360|P3|NOT COMPLETED|Overall Study||1
2527360|NCT00676403|6193361|P2|NOT COMPLETED|Overall Study||2
2527361|NCT00676403|6193362|P1|NOT COMPLETED|Overall Study||2
2527362|NCT00676403|6193357|P6|COMPLETED|Overall Study||18
2527363|NCT00676403|6193358|P5|COMPLETED|Overall Study||23
2527364|NCT00676403|6193359|P4|COMPLETED|Overall Study||17
2527365|NCT00676403|6193360|P3|COMPLETED|Overall Study||22
2527366|NCT00676403|6193361|P2|COMPLETED|Overall Study||20
2527367|NCT00676403|6193362|P1|COMPLETED|Overall Study||21
2527368|NCT00676403|6193357|P6|STARTED|Overall Study||23
2527369|NCT00676403|6193358|P5|STARTED|Overall Study||24
2527370|NCT00676403|6193359|P4|STARTED|Overall Study||22
2527371|NCT00676403|6193360|P3|STARTED|Overall Study||23
2527372|NCT00676403|6193361|P2|STARTED|Overall Study||22
2527373|NCT00676403|6193362|P1|STARTED|Overall Study||23
2527374|NCT00676364|6193492|P2|NOT COMPLETED|Overall Study||0
2527375|NCT00676364|6193493|P1|NOT COMPLETED|Overall Study||0
2527376|NCT00676364|6193492|P2|COMPLETED|Overall Study||57
2527377|NCT00676364|6193493|P1|COMPLETED|Overall Study||57
2527378|NCT00676364|6193492|P2|STARTED|Overall Study||57
2527379|NCT00676364|6193493|P1|STARTED|Overall Study||57
2527380|NCT00676338|6193505|P4|NOT COMPLETED|Overall Study||23
2527381|NCT00676338|6193506|P3|NOT COMPLETED|Overall Study||30
2527382|NCT00676338|6193507|P2|NOT COMPLETED|Overall Study||33
2527383|NCT00676338|6193508|P1|NOT COMPLETED|Overall Study||38
2527384|NCT00676338|6193505|P4|COMPLETED|Overall Study||140
2527385|NCT00676338|6193506|P3|COMPLETED|Overall Study||133
2527386|NCT00676338|6193507|P2|COMPLETED|Overall Study||213
2527387|NCT00676338|6193508|P1|COMPLETED|Overall Study||210
2527388|NCT00676338|6193505|P4|STARTED|Overall Study||163
2527389|NCT00676338|6193506|P3|STARTED|Overall Study||163
2527390|NCT00676338|6193507|P2|STARTED|Overall Study||246
2527391|NCT00676338|6193508|P1|STARTED|Overall Study||248
2527392|NCT00676208|6193560|P2|NOT COMPLETED|Overall Study||6
2527393|NCT00676208|6193561|P1|NOT COMPLETED|Overall Study||2
2527394|NCT00676208|6193560|P2|COMPLETED|Overall Study||13
2527395|NCT00676208|6193561|P1|COMPLETED|Overall Study||12
2527396|NCT00676208|6193560|P2|STARTED|Overall Study||19
2527397|NCT00676208|6193561|P1|STARTED|Overall Study||14
2527398|NCT00676195|6193569|P1|NOT COMPLETED|Overall Study||3
2527399|NCT00676195|6193569|P1|COMPLETED|Overall Study||21
2527400|NCT00676195|6193569|P1|STARTED|Overall Study||24
2527401|NCT00676182|6193579|P1|NOT COMPLETED|Overall Study||0
2527402|NCT00676182|6193579|P1|COMPLETED|Overall Study||75
2527403|NCT00676182|6193579|P1|STARTED|Overall Study||75
2527404|NCT00676143|6193594|P2|NOT COMPLETED|Overall Study||260
2527405|NCT00676143|6193595|P1|NOT COMPLETED|Overall Study||156
2527406|NCT00676143|6193594|P2|COMPLETED|Overall Study||398
2527407|NCT00676143|6193595|P1|COMPLETED|Overall Study||285
2527408|NCT00676143|6193594|P2|Treated|Overall Study||654
2527409|NCT00676143|6193595|P1|Treated|Overall Study||439
2527410|NCT00676143|6193594|P2|STARTED|Overall Study||658
2527411|NCT00676143|6193595|P1|STARTED|Overall Study||441
2527412|NCT00676130|6193635|P2|NOT COMPLETED|Overall Study||4
2527413|NCT00676130|6193636|P1|NOT COMPLETED|Overall Study||3
2527414|NCT00676130|6193635|P2|COMPLETED|Overall Study||73
2527415|NCT00676130|6193636|P1|COMPLETED|Overall Study||73
2527416|NCT00676130|6193635|P2|STARTED|Overall Study||77
2527417|NCT00676130|6193636|P1|STARTED|Overall Study||76
2527418|NCT00676091|6193646|P2|NOT COMPLETED|Toddler Dose||0
2527419|NCT00676091|6193647|P1|NOT COMPLETED|Toddler Dose||3
2527420|NCT00676091|6193646|P2|COMPLETED|Toddler Dose||156
2527421|NCT00676091|6193647|P1|COMPLETED|Toddler Dose||153
2527422|NCT00676091|6193646|P2|STARTED|Toddler Dose||156
2527423|NCT00676091|6193647|P1|STARTED|Toddler Dose||156
2527424|NCT00676091|6193646|P2|NOT COMPLETED|After Infant Series||3
2527425|NCT00676091|6193647|P1|NOT COMPLETED|After Infant Series||1
2527426|NCT00676091|6193646|P2|COMPLETED|After Infant Series||156
2527427|NCT00676091|6193647|P1|COMPLETED|After Infant Series||156
2527428|NCT00676091|6193646|P2|STARTED|After Infant Series||159
2527429|NCT00676091|6193647|P1|STARTED|After Infant Series||157
2527430|NCT00676091|6193646|P2|NOT COMPLETED|Infant Series||18
2527431|NCT00676091|6193647|P1|NOT COMPLETED|Infant Series||20
2527432|NCT00676091|6193646|P2|COMPLETED|Infant Series||159
2527433|NCT00676091|6193647|P1|COMPLETED|Infant Series||157
2527434|NCT00676091|6193646|P2|Vaccinated Dose 3|Infant Series||161
2527435|NCT00676091|6193647|P1|Vaccinated Dose 3|Infant Series||158
2527436|NCT00676091|6193646|P2|Vaccinated Dose 2|Infant Series||162
2527437|NCT00676091|6193647|P1|Vaccinated Dose 2|Infant Series||159
2527438|NCT00676091|6193646|P2|Vaccinated Dose 1|Infant Series||162
2527439|NCT00676091|6193647|P1|Vaccinated Dose 1|Infant Series||163
2527440|NCT00676091|6193646|P2|STARTED|Infant Series||177
2527441|NCT00676091|6193647|P1|STARTED|Infant Series||177
2527442|NCT00676065|6193682|P3|NOT COMPLETED|Overall Study||0
2527443|NCT00676065|6193683|P2|NOT COMPLETED|Overall Study||0
2527444|NCT00676065|6193684|P1|NOT COMPLETED|Overall Study||0
2527445|NCT00676065|6193682|P3|COMPLETED|Overall Study||26341
2527446|NCT00676065|6193683|P2|COMPLETED|Overall Study||15428
2527447|NCT00676065|6193684|P1|COMPLETED|Overall Study||16534
2527448|NCT00676065|6193682|P3|STARTED|Overall Study||26341
2527449|NCT00676065|6193683|P2|STARTED|Overall Study||15428
2527450|NCT00676065|6193684|P1|STARTED|Overall Study||16534
2527451|NCT00676052|6193704|P6|NOT COMPLETED|Overall Study||6
2527452|NCT00676052|6193705|P5|NOT COMPLETED|Overall Study||6
2527453|NCT00676052|6193706|P4|NOT COMPLETED|Overall Study||5
2527454|NCT00676052|6193707|P3|NOT COMPLETED|Overall Study||6
2527455|NCT00676052|6193708|P2|NOT COMPLETED|Overall Study||7
2527456|NCT00676052|6193709|P1|NOT COMPLETED|Overall Study||9
2527457|NCT00676052|6193704|P6|COMPLETED|Overall Study||91
2527458|NCT00676052|6193705|P5|COMPLETED|Overall Study||89
2527459|NCT00676052|6193706|P4|COMPLETED|Overall Study||92
2527460|NCT00676052|6193707|P3|COMPLETED|Overall Study||90
2527461|NCT00676052|6193708|P2|COMPLETED|Overall Study||88
2527462|NCT00676052|6193709|P1|COMPLETED|Overall Study||87
2527463|NCT00676052|6193704|P6|STARTED|Overall Study||97
2527464|NCT00676052|6193705|P5|STARTED|Overall Study||95
2527465|NCT00676052|6193706|P4|STARTED|Overall Study||97
2527466|NCT00676052|6193707|P3|STARTED|Overall Study||96
2527467|NCT00676052|6193708|P2|STARTED|Overall Study||95
2527468|NCT00676052|6193709|P1|STARTED|Overall Study||96
2527469|NCT00676026|6193741|P1|NOT COMPLETED|Overall Study||0
2527470|NCT00676026|6193741|P1|COMPLETED|Overall Study||8
2527471|NCT00676026|6193741|P1|STARTED|Overall Study||8
2527472|NCT00676013|6193745|P1|NOT COMPLETED|Overall Study||1
2527473|NCT00676013|6193745|P1|COMPLETED|Overall Study||157
2527474|NCT00676013|6193745|P1|STARTED|Overall Study||158
2527475|NCT00675987|6193754|P2|NOT COMPLETED|Overall Study||0
2527476|NCT00675987|6193755|P1|NOT COMPLETED|Overall Study||0
2527477|NCT00675987|6193754|P2|COMPLETED|Overall Study||27
2527478|NCT00675987|6193755|P1|COMPLETED|Overall Study||26
2527479|NCT00675987|6193754|P2|STARTED|Overall Study||27
2527480|NCT00675987|6193755|P1|STARTED|Overall Study||26
2527481|NCT00675948|6193779|P2|NOT COMPLETED|Overall Study||3
2527482|NCT00675948|6193780|P1|NOT COMPLETED|Overall Study||39
2527483|NCT00675948|6193779|P2|COMPLETED|Overall Study||1
2527484|NCT00675948|6193780|P1|COMPLETED|Overall Study||0
2527485|NCT00675948|6193779|P2|STARTED|Overall Study||4
2527486|NCT00675948|6193780|P1|STARTED|Overall Study||39
2527487|NCT00675922|6193790|P1|NOT COMPLETED|Overall Study||0
2527488|NCT00675922|6193790|P1|COMPLETED|Overall Study||98
2527489|NCT00675922|6193790|P1|STARTED|Overall Study||98
2527490|NCT00675909|6193798|P3|NOT COMPLETED|Overall Study||0
2527491|NCT00675909|6193799|P2|NOT COMPLETED|Overall Study||0
2527492|NCT00675909|6193800|P1|NOT COMPLETED|Overall Study||0
2527493|NCT00675909|6193798|P3|COMPLETED|Overall Study||60
2527494|NCT00675909|6193799|P2|COMPLETED|Overall Study||60
2527495|NCT00675909|6193800|P1|COMPLETED|Overall Study||60
2527496|NCT00675909|6193798|P3|STARTED|Overall Study||60
2527497|NCT00675909|6193799|P2|STARTED|Overall Study||60
2527498|NCT00675909|6193800|P1|STARTED|Overall Study||60
2527499|NCT00675792|6193822|P2|NOT COMPLETED|Overall Study||0
2527500|NCT00675792|6193823|P1|NOT COMPLETED|Overall Study||0
2527501|NCT00675792|6193822|P2|COMPLETED|Overall Study||49
2527502|NCT00675792|6193823|P1|COMPLETED|Overall Study||51
2527503|NCT00675792|6193822|P2|STARTED|Overall Study||49
2527504|NCT00675792|6193823|P1|STARTED|Overall Study||51
2527505|NCT00675766|6193843|P4|NOT COMPLETED|Overall Study||26
2527506|NCT00675766|6193844|P3|NOT COMPLETED|Overall Study||21
2527507|NCT00675766|6193845|P2|NOT COMPLETED|Overall Study||5
2527508|NCT00675766|6193846|P1|NOT COMPLETED|Overall Study||6
2527509|NCT00675766|6193843|P4|COMPLETED|Overall Study||11
2527510|NCT00675766|6193844|P3|COMPLETED|Overall Study||29
2527511|NCT00675766|6193845|P2|COMPLETED|Overall Study||25
2527512|NCT00675766|6193846|P1|COMPLETED|Overall Study||100
2527513|NCT00675766|6193843|P4|Year 3|Overall Study||11
2527514|NCT00675766|6193844|P3|Year 3|Overall Study||29
2527515|NCT00675766|6193845|P2|Year 3|Overall Study||25
2527516|NCT00675766|6193846|P1|Year 3|Overall Study||100
2527517|NCT00675766|6193843|P4|Year 2|Overall Study||20
2527518|NCT00675766|6193844|P3|Year 2|Overall Study||34
2527519|NCT00675766|6193845|P2|Year 2|Overall Study||28
2527520|NCT00675766|6193846|P1|Year 2|Overall Study||105
2527521|NCT00675766|6193843|P4|STARTED|Overall Study||37
2527522|NCT00675766|6193844|P3|STARTED|Overall Study||50
2527523|NCT00675766|6193845|P2|STARTED|Overall Study||30
2527524|NCT00675766|6193846|P1|STARTED|Overall Study||106
2527525|NCT00675597|6193856|P1|NOT COMPLETED|Overall Study||3
2527526|NCT00675597|6193856|P1|COMPLETED|Overall Study||23
2527527|NCT00675597|6193856|P1|STARTED|Overall Study||26
2527528|NCT00675584|6193862|P2|NOT COMPLETED|Overall Study||26
2527529|NCT00675584|6193863|P1|NOT COMPLETED|Overall Study||39
2527530|NCT00675584|6193862|P2|COMPLETED|Overall Study||113
2527531|NCT00675584|6193863|P1|COMPLETED|Overall Study||100
2527532|NCT00675584|6193862|P2|STARTED|Overall Study||139
2527533|NCT00675584|6193863|P1|STARTED|Overall Study||139
2527534|NCT00675558|6193892|P3|NOT COMPLETED|Second Operation||0
2527535|NCT00675558|6193893|P2|NOT COMPLETED|Second Operation||0
2527536|NCT00675558|6193894|P1|NOT COMPLETED|Second Operation||0
2527537|NCT00675558|6193892|P3|COMPLETED|Second Operation||10
2527538|NCT00675558|6193893|P2|COMPLETED|Second Operation||0
2527539|NCT00675558|6193894|P1|COMPLETED|Second Operation||0
2527540|NCT00675558|6193892|P3|STARTED|Second Operation|As predicted, only 10 SMO patients medically required a second operation, and thus met study goals.|10
2527541|NCT00675558|6193893|P2|STARTED|Second Operation|No medical reason, and none for the goals of the study, for MO pts to have a second procedure .|0
2527542|NCT00675558|6193894|P1|STARTED|Second Operation|No medical reason, and no study-related reason for non-obese pts to have a second procedure.|0
2527543|NCT00675558|6193892|P3|NOT COMPLETED|Surgery||0
2527544|NCT00675558|6193893|P2|NOT COMPLETED|Surgery||0
2527545|NCT00675558|6193894|P1|NOT COMPLETED|Surgery||0
2527546|NCT00675558|6193892|P3|COMPLETED|Surgery||30
2527547|NCT00675558|6193893|P2|COMPLETED|Surgery||10
2527548|NCT00675558|6193894|P1|COMPLETED|Surgery||10
2527549|NCT00675558|6193892|P3|STARTED|Surgery||30
2527550|NCT00675558|6193893|P2|STARTED|Surgery||10
2527551|NCT00675558|6193894|P1|STARTED|Surgery||10
2527552|NCT00675506|6193910|P2|NOT COMPLETED|Overall Study||12
2527553|NCT00675506|6193911|P1|NOT COMPLETED|Overall Study||12
2527554|NCT00675506|6193910|P2|COMPLETED|Overall Study||17
2527555|NCT00675506|6193911|P1|COMPLETED|Overall Study||19
2527556|NCT00675506|6193910|P2|Received Intervention|Overall Study||29
2527557|NCT00675506|6193911|P1|Received Intervention|Overall Study|Two subjects did not start treatment: 1) disclosed cancer history, 2) declined participation.|29
2527558|NCT00675506|6193910|P2|STARTED|Overall Study||29
2527559|NCT00675506|6193911|P1|STARTED|Overall Study||31
2527560|NCT00675441|6193927|P1|NOT COMPLETED|Overall Study||3
2527561|NCT00675441|6193927|P1|COMPLETED|Overall Study||2
2527562|NCT00675441|6193927|P1|STARTED|Overall Study||5
2527563|NCT00675428|6193933|P2|NOT COMPLETED|Overall Study||3
2527564|NCT00675428|6193934|P1|NOT COMPLETED|Overall Study||3
2527565|NCT00675428|6193933|P2|COMPLETED|Overall Study||0
2527566|NCT00675428|6193934|P1|COMPLETED|Overall Study||0
2527567|NCT00675428|6193933|P2|STARTED|Overall Study||3
2527568|NCT00675428|6193934|P1|STARTED|Overall Study||3
2527569|NCT00675415|6193954|P2|NOT COMPLETED|Overall Study||8
2527570|NCT00675415|6193955|P1|NOT COMPLETED|Overall Study||8
2527571|NCT00675415|6193954|P2|COMPLETED|Overall Study||123
2527572|NCT00675415|6193955|P1|COMPLETED|Overall Study||124
2527573|NCT00675415|6193954|P2|STARTED|Overall Study||131
2527574|NCT00675415|6193955|P1|STARTED|Overall Study||132
2527575|NCT00675259|6193967|P1|NOT COMPLETED|Overall Study||14
2527576|NCT00675259|6193967|P1|COMPLETED|Overall Study||19
2527577|NCT00675259|6193967|P1|STARTED|Overall Study||33
2527578|NCT00675103|6193976|P1|NOT COMPLETED|Overall Study||3
2527579|NCT00675103|6193976|P1|COMPLETED|Overall Study||4
2527580|NCT00675103|6193976|P1|STARTED|Overall Study||7
2527581|NCT00674986|6193983|P2|NOT COMPLETED|Overall Study||81
2527582|NCT00674986|6193984|P1|NOT COMPLETED|Overall Study||43
2527583|NCT00674986|6193983|P2|COMPLETED|Overall Study||188
2527584|NCT00674986|6193984|P1|COMPLETED|Overall Study||187
2527585|NCT00674986|6193983|P2|Intent to Treat Population|Overall Study||256
2527586|NCT00674986|6193984|P1|Intent to Treat Population|Overall Study||227
2527587|NCT00674986|6193983|P2|STARTED|Overall Study||269
2527588|NCT00674986|6193984|P1|STARTED|Overall Study||230
2527589|NCT00674973|6194005|P2|NOT COMPLETED|Overall Study||102
2527590|NCT00674973|6194006|P1|NOT COMPLETED|Overall Study||100
2527591|NCT00674973|6194005|P2|COMPLETED|Overall Study|Completed double-blind treatment.|2
2527592|NCT00674973|6194006|P1|COMPLETED|Overall Study|Completed double-blind treatment.|3
2527593|NCT00674973|6194005|P2|Switch to Open-Label Erlotinib|Overall Study||0
2527594|NCT00674973|6194006|P1|Switch to Open-Label Erlotinib|Overall Study|Participants with PD were given opportunity to switch.|57
2527595|NCT00674973|6194005|P2|STARTED|Overall Study||104
2527596|NCT00674973|6194006|P1|STARTED|Overall Study||103
2527597|NCT00674817|6194020|P1|NOT COMPLETED|Period 6||0
2527598|NCT00674817|6194020|P1|COMPLETED|Period 6||38
2527599|NCT00674817|6194020|P1|STARTED|Period 6||38
2527600|NCT00674817|6194020|P1|NOT COMPLETED|Period 5||0
2527601|NCT00674817|6194020|P1|COMPLETED|Period 5||38
2527602|NCT00674817|6194020|P1|STARTED|Period 5||38
2527603|NCT00674817|6194020|P1|NOT COMPLETED|Period 4||1
2527604|NCT00674817|6194020|P1|COMPLETED|Period 4||38
2527605|NCT00674817|6194020|P1|STARTED|Period 4||39
2527606|NCT00674817|6194020|P1|NOT COMPLETED|Period 3||2
2527607|NCT00674817|6194020|P1|COMPLETED|Period 3||39
2527608|NCT00674817|6194020|P1|STARTED|Period 3||41
2527609|NCT00674817|6194020|P1|NOT COMPLETED|Period 2||0
2527610|NCT00674817|6194020|P1|COMPLETED|Period 2||41
2527611|NCT00674817|6194020|P1|STARTED|Period 2||41
2527612|NCT00674817|6194020|P1|NOT COMPLETED|Period 1||3
2527613|NCT00674817|6194020|P1|COMPLETED|Period 1||41
2527614|NCT00674817|6194020|P1|STARTED|Period 1||44
2527615|NCT00674765|6194168|P2|NOT COMPLETED|Overall Study||29
2527616|NCT00674765|6194169|P1|NOT COMPLETED|Overall Study||36
2527617|NCT00674765|6194168|P2|COMPLETED|Overall Study||46
2527618|NCT00674765|6194169|P1|COMPLETED|Overall Study||45
2527619|NCT00674765|6194168|P2|STARTED|Overall Study||75
2527620|NCT00674765|6194169|P1|STARTED|Overall Study||81
2527621|NCT00674739|6194178|P3|NOT COMPLETED|Overall Study||32
2527622|NCT00674739|6194179|P2|NOT COMPLETED|Overall Study||59
2527623|NCT00674739|6194180|P1|NOT COMPLETED|Overall Study||57
2527624|NCT00674739|6194178|P3|COMPLETED|Overall Study||65
2527625|NCT00674739|6194179|P2|COMPLETED|Overall Study||136
2527626|NCT00674739|6194180|P1|COMPLETED|Overall Study||121
2527627|NCT00674739|6194178|P3|STARTED|Overall Study||97
2527628|NCT00674739|6194179|P2|STARTED|Overall Study||195
2527629|NCT00674739|6194180|P1|STARTED|Overall Study||178
2527630|NCT00674700|6194197|P3|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
2527631|NCT00674700|6194198|P2|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
2527632|NCT00674700|6194199|P1|NOT COMPLETED|Year 2 Follow-up Without Treatment||6
2527633|NCT00674700|6194197|P3|COMPLETED|Year 2 Follow-up Without Treatment||141
2527634|NCT00674700|6194198|P2|COMPLETED|Year 2 Follow-up Without Treatment||123
2527635|NCT00674700|6194199|P1|COMPLETED|Year 2 Follow-up Without Treatment||133
2527636|NCT00674700|6194197|P3|STARTED|Year 2 Follow-up Without Treatment||153
2527637|NCT00674700|6194198|P2|STARTED|Year 2 Follow-up Without Treatment||135
2527638|NCT00674700|6194199|P1|STARTED|Year 2 Follow-up Without Treatment||139
2527639|NCT00674700|6194197|P3|NOT COMPLETED|Year 1||17
2527640|NCT00674700|6194198|P2|NOT COMPLETED|Year 1||34
2527641|NCT00674700|6194199|P1|NOT COMPLETED|Year 1||31
2527642|NCT00674700|6194197|P3|COMPLETED|Year 1||153
2527643|NCT00674700|6194198|P2|COMPLETED|Year 1||135
2527644|NCT00674700|6194199|P1|COMPLETED|Year 1||139
2527645|NCT00674700|6194197|P3|STARTED|Year 1||170
2527646|NCT00674700|6194198|P2|STARTED|Year 1||169
2527647|NCT00674700|6194199|P1|STARTED|Year 1||170
2527648|NCT00674661|6194212|P2|NOT COMPLETED|Overall Study||15
2527649|NCT00674661|6194213|P1|NOT COMPLETED|Overall Study||11
2527650|NCT00674661|6194212|P2|COMPLETED|Overall Study||48
2527651|NCT00674661|6194213|P1|COMPLETED|Overall Study||56
2527652|NCT00674661|6194212|P2|STARTED|Overall Study||63
2527653|NCT00674661|6194213|P1|STARTED|Overall Study||67
2527654|NCT00674622|6194222|P3|NOT COMPLETED|Overall Study||0
2527655|NCT00674622|6194223|P2|NOT COMPLETED|Overall Study||4
2527656|NCT00674622|6194224|P1|NOT COMPLETED|Overall Study||1
2527657|NCT00674622|6194222|P3|COMPLETED|Overall Study||22
2527658|NCT00674622|6194223|P2|COMPLETED|Overall Study||18
2527659|NCT00674622|6194224|P1|COMPLETED|Overall Study||21
2527660|NCT00674622|6194222|P3|STARTED|Overall Study||22
2527661|NCT00674622|6194223|P2|STARTED|Overall Study||22
2527662|NCT00674622|6194224|P1|STARTED|Overall Study||22
2527663|NCT00674609|6194247|P3|NOT COMPLETED|Overall Study||8
2527664|NCT00674609|6194248|P2|NOT COMPLETED|Overall Study||13
2527665|NCT00674609|6194249|P1|NOT COMPLETED|Overall Study||12
2527666|NCT00674609|6194247|P3|COMPLETED|Overall Study||51
2527667|NCT00674609|6194248|P2|COMPLETED|Overall Study||45
2527668|NCT00674609|6194249|P1|COMPLETED|Overall Study||48
2527669|NCT00674609|6194247|P3|STARTED|Overall Study||59
2527670|NCT00674609|6194248|P2|STARTED|Overall Study||58
2527671|NCT00674609|6194249|P1|STARTED|Overall Study||60
2527672|NCT00674583|6194283|P2|NOT COMPLETED|Overall Study||0
2527673|NCT00674583|6194284|P1|NOT COMPLETED|Overall Study||0
2527674|NCT00674583|6194283|P2|COMPLETED|Overall Study||103
2527675|NCT00674583|6194284|P1|COMPLETED|Overall Study||311
2527676|NCT00674583|6194283|P2|STARTED|Overall Study||103
2527677|NCT00674583|6194284|P1|STARTED|Overall Study||311
2527678|NCT00674570|6194311|P3|NOT COMPLETED|Overall Study||0
2527679|NCT00674570|6194312|P2|NOT COMPLETED|Overall Study||2
2527680|NCT00674570|6194313|P1|NOT COMPLETED|Overall Study||0
2527681|NCT00674570|6194311|P3|COMPLETED|Overall Study||35
2527682|NCT00674570|6194312|P2|COMPLETED|Overall Study||32
2527683|NCT00674570|6194313|P1|COMPLETED|Overall Study||37
2527684|NCT00674570|6194311|P3|STARTED|Overall Study||35
2527685|NCT00674570|6194312|P2|STARTED|Overall Study||34
2527686|NCT00674570|6194313|P1|STARTED|Overall Study||37
2527687|NCT00674492|6194321|P1|NOT COMPLETED|Overall Study||0
2527688|NCT00674492|6194321|P1|COMPLETED|Overall Study||21
2527689|NCT00674492|6194321|P1|STARTED|Overall Study||21
2527693|NCT00674466|6194334|P3|NOT COMPLETED|Overall Study||9
2527694|NCT00674466|6194335|P2|NOT COMPLETED|Overall Study||8
2527695|NCT00674466|6194336|P1|NOT COMPLETED|Overall Study||7
2527696|NCT00674466|6194334|P3|COMPLETED|Overall Study||21
2527697|NCT00674466|6194335|P2|COMPLETED|Overall Study||22
2527698|NCT00674466|6194336|P1|COMPLETED|Overall Study||23
2527699|NCT00674466|6194334|P3|STARTED|Overall Study||30
2527700|NCT00674466|6194335|P2|STARTED|Overall Study||30
2527701|NCT00674466|6194336|P1|STARTED|Overall Study||30
2527702|NCT00674362|6194352|P2|NOT COMPLETED|Open Label||0
2527703|NCT00674362|6194353|P1|NOT COMPLETED|Open Label||2
2527704|NCT00674362|6194352|P2|COMPLETED|Open Label||7
2527705|NCT00674362|6194353|P1|COMPLETED|Open Label||18
2527706|NCT00674362|6194352|P2|STARTED|Open Label||7
2527707|NCT00674362|6194353|P1|STARTED|Open Label||20
2527708|NCT00674362|6194352|P2|NOT COMPLETED|Double Blind||18
2527709|NCT00674362|6194353|P1|NOT COMPLETED|Double Blind||12
2527710|NCT00674362|6194352|P2|COMPLETED|Double Blind||80
2527711|NCT00674362|6194353|P1|COMPLETED|Double Blind||84
2527712|NCT00674362|6194352|P2|STARTED|Double Blind||98
2527713|NCT00674362|6194353|P1|STARTED|Double Blind||96
2527714|NCT00674323|6194421|P3|NOT COMPLETED|Overall Study||0
2527715|NCT00674323|6194422|P2|NOT COMPLETED|Overall Study||1
2527716|NCT00674323|6194423|P1|NOT COMPLETED|Overall Study||1
2527717|NCT00674323|6194421|P3|COMPLETED|Overall Study||21
2527718|NCT00674323|6194422|P2|COMPLETED|Overall Study||20
2527719|NCT00674323|6194423|P1|COMPLETED|Overall Study||18
2527720|NCT00674323|6194421|P3|STARTED|Overall Study||21
2527721|NCT00674323|6194422|P2|STARTED|Overall Study||21
2527722|NCT00674323|6194423|P1|STARTED|Overall Study||19
2527723|NCT00674297|6194440|P4|NOT COMPLETED|Overall Study||3
2527724|NCT00674297|6194441|P3|NOT COMPLETED|Overall Study||4
2527725|NCT00674297|6194442|P2|NOT COMPLETED|Overall Study||0
2527726|NCT00674297|6194443|P1|NOT COMPLETED|Overall Study||10
2527727|NCT00674297|6194440|P4|COMPLETED|Overall Study||4
2527728|NCT00674297|6194441|P3|COMPLETED|Overall Study||5
2527729|NCT00674297|6194442|P2|COMPLETED|Overall Study||7
2527730|NCT00674297|6194443|P1|COMPLETED|Overall Study||8
2527731|NCT00674297|6194440|P4|STARTED|Overall Study||7
2527732|NCT00674297|6194441|P3|STARTED|Overall Study||9
2527733|NCT00674297|6194442|P2|STARTED|Overall Study||7
2527734|NCT00674297|6194443|P1|STARTED|Overall Study||18
2527735|NCT00674219|6194460|P2|NOT COMPLETED|Overall Study||0
2527736|NCT00674219|6194461|P1|NOT COMPLETED|Overall Study||0
2527737|NCT00674219|6194460|P2|COMPLETED|Overall Study||7
2527738|NCT00674219|6194461|P1|COMPLETED|Overall Study||10
2527739|NCT00674219|6194460|P2|STARTED|Overall Study||7
2527740|NCT00674219|6194461|P1|STARTED|Overall Study||10
2527741|NCT00674206|6194467|P1|NOT COMPLETED|Overall Study||0
2527742|NCT00674206|6194467|P1|COMPLETED|Overall Study||6
2527743|NCT00674206|6194467|P1|STARTED|Overall Study||6
2527744|NCT00674154|6194474|P2|NOT COMPLETED|Overall Study||3
2527745|NCT00674154|6194475|P1|NOT COMPLETED|Overall Study||3
2527746|NCT00674154|6194474|P2|COMPLETED|Overall Study||20
2527747|NCT00674154|6194475|P1|COMPLETED|Overall Study||20
2527748|NCT00674154|6194474|P2|STARTED|Overall Study||23
2527749|NCT00674154|6194475|P1|STARTED|Overall Study||23
2527750|NCT00674128|6194483|P2|NOT COMPLETED|Overall Study||23
2527751|NCT00674128|6194484|P1|NOT COMPLETED|Overall Study||25
2527752|NCT00674128|6194483|P2|COMPLETED|Overall Study||21
2527753|NCT00674128|6194484|P1|COMPLETED|Overall Study||25
2527754|NCT00674128|6194483|P2|STARTED|Overall Study||44
2527755|NCT00674128|6194484|P1|STARTED|Overall Study||50
2527756|NCT00674115|6194490|P4|NOT COMPLETED|Third Intervention||0
2527757|NCT00674115|6194491|P3|NOT COMPLETED|Third Intervention||0
2527758|NCT00674115|6194492|P2|NOT COMPLETED|Third Intervention||0
2527759|NCT00674115|6194493|P1|NOT COMPLETED|Third Intervention||0
2527760|NCT00674115|6194490|P4|COMPLETED|Third Intervention||0
2527761|NCT00674115|6194491|P3|COMPLETED|Third Intervention||0
2527762|NCT00674115|6194492|P2|COMPLETED|Third Intervention||16
2527763|NCT00674115|6194493|P1|COMPLETED|Third Intervention||14
2527764|NCT00674115|6194490|P4|STARTED|Third Intervention||0
2527765|NCT00674115|6194491|P3|STARTED|Third Intervention||0
2527766|NCT00674115|6194492|P2|STARTED|Third Intervention||16
2527767|NCT00674115|6194493|P1|STARTED|Third Intervention||14
2527768|NCT00674115|6194490|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
2527769|NCT00674115|6194491|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
2527770|NCT00674115|6194492|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
2527771|NCT00674115|6194493|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
2527772|NCT00674115|6194490|P4|COMPLETED|Washout Period of 2 Weeks||0
2527773|NCT00674115|6194491|P3|COMPLETED|Washout Period of 2 Weeks||0
2527774|NCT00674115|6194492|P2|COMPLETED|Washout Period of 2 Weeks||16
2527775|NCT00674115|6194493|P1|COMPLETED|Washout Period of 2 Weeks||14
2527776|NCT00674115|6194490|P4|STARTED|Washout Period of 2 Weeks||0
2527777|NCT00674115|6194491|P3|STARTED|Washout Period of 2 Weeks||0
2527778|NCT00674115|6194492|P2|STARTED|Washout Period of 2 Weeks||16
2527779|NCT00674115|6194493|P1|STARTED|Washout Period of 2 Weeks||14
2527780|NCT00674115|6194490|P4|NOT COMPLETED|Second Intervention||0
2527781|NCT00674115|6194491|P3|NOT COMPLETED|Second Intervention||0
2527782|NCT00674115|6194492|P2|NOT COMPLETED|Second Intervention||0
2527783|NCT00674115|6194493|P1|NOT COMPLETED|Second Intervention||0
2527784|NCT00674115|6194490|P4|COMPLETED|Second Intervention||16
2527785|NCT00674115|6194491|P3|COMPLETED|Second Intervention||14
2527786|NCT00674115|6194492|P2|COMPLETED|Second Intervention||16
2527787|NCT00674115|6194493|P1|COMPLETED|Second Intervention||14
2527788|NCT00674115|6194490|P4|STARTED|Second Intervention||16
2527789|NCT00674115|6194491|P3|STARTED|Second Intervention||14
2527790|NCT00674115|6194492|P2|STARTED|Second Intervention||16
2527791|NCT00674115|6194493|P1|STARTED|Second Intervention||14
2527792|NCT00674115|6194490|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
2527793|NCT00674115|6194491|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
2527794|NCT00674115|6194492|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
2527795|NCT00674115|6194493|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
2527796|NCT00674115|6194490|P4|COMPLETED|Washout Period of 2 Weeks||16
2527797|NCT00674115|6194491|P3|COMPLETED|Washout Period of 2 Weeks||14
2527798|NCT00674115|6194492|P2|COMPLETED|Washout Period of 2 Weeks||16
2527799|NCT00674115|6194493|P1|COMPLETED|Washout Period of 2 Weeks||14
2527800|NCT00674115|6194490|P4|STARTED|Washout Period of 2 Weeks||16
2527801|NCT00674115|6194491|P3|STARTED|Washout Period of 2 Weeks||14
2527802|NCT00674115|6194492|P2|STARTED|Washout Period of 2 Weeks||16
2527803|NCT00674115|6194493|P1|STARTED|Washout Period of 2 Weeks||14
2527804|NCT00674115|6194490|P4|NOT COMPLETED|First Intervention||0
2527805|NCT00674115|6194491|P3|NOT COMPLETED|First Intervention||0
2527806|NCT00674115|6194492|P2|NOT COMPLETED|First Intervention||0
2527807|NCT00674115|6194493|P1|NOT COMPLETED|First Intervention||0
2527808|NCT00674115|6194490|P4|COMPLETED|First Intervention||16
2527809|NCT00674115|6194491|P3|COMPLETED|First Intervention||14
2527810|NCT00674115|6194492|P2|COMPLETED|First Intervention||16
2527811|NCT00674115|6194493|P1|COMPLETED|First Intervention||14
2527812|NCT00674115|6194490|P4|STARTED|First Intervention||16
2527813|NCT00674115|6194491|P3|STARTED|First Intervention||14
2527814|NCT00674115|6194492|P2|STARTED|First Intervention||16
2527815|NCT00674115|6194493|P1|STARTED|First Intervention||14
2527816|NCT00673959|6194502|P2|NOT COMPLETED|Overall Study||0
2527817|NCT00673959|6194503|P1|NOT COMPLETED|Overall Study||0
2527818|NCT00673959|6194502|P2|COMPLETED|Overall Study||10
2527819|NCT00673959|6194503|P1|COMPLETED|Overall Study||10
2527820|NCT00673959|6194502|P2|STARTED|Overall Study||10
2527821|NCT00673959|6194503|P1|STARTED|Overall Study||10
2527822|NCT00673933|6194509|P1|NOT COMPLETED|Overall Study||3
2527823|NCT00673933|6194509|P1|COMPLETED|Overall Study||17
2527824|NCT00673933|6194509|P1|STARTED|Overall Study||20
2527825|NCT00673894|6194527|P2|NOT COMPLETED|Second Intervention 4 Weeks||0
2527826|NCT00673894|6194528|P1|NOT COMPLETED|Second Intervention 4 Weeks||0
2527827|NCT00673894|6194527|P2|COMPLETED|Second Intervention 4 Weeks||7
2527828|NCT00673894|6194528|P1|COMPLETED|Second Intervention 4 Weeks||6
2527829|NCT00673894|6194527|P2|STARTED|Second Intervention 4 Weeks||7
2527830|NCT00673894|6194528|P1|STARTED|Second Intervention 4 Weeks||6
2527831|NCT00673894|6194527|P2|NOT COMPLETED|Washout 4-6 Weeks||0
2527832|NCT00673894|6194528|P1|NOT COMPLETED|Washout 4-6 Weeks||0
2527833|NCT00673894|6194527|P2|COMPLETED|Washout 4-6 Weeks||7
2527834|NCT00673894|6194528|P1|COMPLETED|Washout 4-6 Weeks||6
2527835|NCT00673894|6194527|P2|STARTED|Washout 4-6 Weeks||7
2527836|NCT00673894|6194528|P1|STARTED|Washout 4-6 Weeks||6
2527837|NCT00673894|6194527|P2|NOT COMPLETED|First Intervention 4 Weeks||0
2527838|NCT00673894|6194528|P1|NOT COMPLETED|First Intervention 4 Weeks||2
2527839|NCT00673894|6194527|P2|COMPLETED|First Intervention 4 Weeks||7
2527840|NCT00673894|6194528|P1|COMPLETED|First Intervention 4 Weeks||6
2527841|NCT00673894|6194527|P2|STARTED|First Intervention 4 Weeks||7
2527842|NCT00673894|6194528|P1|STARTED|First Intervention 4 Weeks||8
2527843|NCT00673881|6194536|P1|NOT COMPLETED|Overall Study||1
2527844|NCT00673881|6194536|P1|COMPLETED|Overall Study||24
2527845|NCT00673881|6194536|P1|STARTED|Overall Study||25
2527846|NCT00673855|6194543|P2|NOT COMPLETED|Second Intervention||0
2527847|NCT00673855|6194544|P1|NOT COMPLETED|Second Intervention||0
2527848|NCT00673855|6194543|P2|COMPLETED|Second Intervention||10
2527849|NCT00673855|6194544|P1|COMPLETED|Second Intervention||10
2527850|NCT00673855|6194543|P2|STARTED|Second Intervention||10
2527851|NCT00673855|6194544|P1|STARTED|Second Intervention||10
2527852|NCT00673855|6194543|P2|NOT COMPLETED|First Intervention||0
2527853|NCT00673855|6194544|P1|NOT COMPLETED|First Intervention||0
2527854|NCT00673855|6194543|P2|COMPLETED|First Intervention||10
2527855|NCT00673855|6194544|P1|COMPLETED|First Intervention||10
2527856|NCT00673855|6194543|P2|STARTED|First Intervention||10
2527857|NCT00673855|6194544|P1|STARTED|First Intervention||10
2527858|NCT00673816|6194550|P1|NOT COMPLETED|Overall Study||2
2527859|NCT00673816|6194550|P1|COMPLETED|Overall Study||0
2527860|NCT00673816|6194550|P1|STARTED|Overall Study||2
2527861|NCT00673764|6194557|P2|NOT COMPLETED|Overall Study||0
2527862|NCT00673764|6194558|P1|NOT COMPLETED|Overall Study||0
2527863|NCT00673764|6194557|P2|COMPLETED|Overall Study||24
2527864|NCT00673764|6194558|P1|COMPLETED|Overall Study||24
2527865|NCT00673764|6194557|P2|STARTED|Overall Study||24
2527866|NCT00673764|6194558|P1|STARTED|Overall Study||24
2527867|NCT00673738|6194566|P1|NOT COMPLETED|Overall Study||0
2527868|NCT00673738|6194566|P1|COMPLETED|Overall Study||27
2527869|NCT00673738|6194566|P1|STARTED|Overall Study||27
2527870|NCT00673712|6194574|P2|NOT COMPLETED|Overall Study||0
2527871|NCT00673712|6194575|P1|NOT COMPLETED|Overall Study||0
2527872|NCT00673712|6194574|P2|COMPLETED|Overall Study||326
2527873|NCT00673712|6194575|P1|COMPLETED|Overall Study||321
2527874|NCT00673712|6194574|P2|STARTED|Overall Study||326
2527875|NCT00673712|6194575|P1|STARTED|Overall Study||321
2527876|NCT00673673|6194585|P1|NOT COMPLETED|Overall Study||36
2527877|NCT00673673|6194585|P1|COMPLETED|Overall Study||3
2527878|NCT00673673|6194585|P1|STARTED|Overall Study||39
2527879|NCT00673660|6194591|P1|NOT COMPLETED|Overall Study||107
2527880|NCT00673660|6194591|P1|COMPLETED|Overall Study||268
2527881|NCT00673660|6194591|P1|STARTED|Overall Study||375
2527882|NCT00673595|6194604|P2|NOT COMPLETED|Overall Study||0
2527883|NCT00673595|6194605|P1|NOT COMPLETED|Overall Study||0
2527884|NCT00673595|6194604|P2|COMPLETED|Overall Study||11
2527885|NCT00673595|6194605|P1|COMPLETED|Overall Study||8
2527886|NCT00673595|6194604|P2|STARTED|Overall Study||11
2527887|NCT00673595|6194605|P1|STARTED|Overall Study||8
2527888|NCT00673465|6194613|P12|NOT COMPLETED|Part 2 (India)||0
2527889|NCT00673465|6194614|P11|NOT COMPLETED|Part 2 (India)||0
2527890|NCT00673465|6194615|P10|NOT COMPLETED|Part 2 (India)||0
2527891|NCT00673465|6194616|P9|NOT COMPLETED|Part 2 (India)||0
2527892|NCT00673465|6194617|P8|NOT COMPLETED|Part 2 (India)||0
2527893|NCT00673465|6194618|P7|NOT COMPLETED|Part 2 (India)||0
2527894|NCT00673465|6194619|P6|NOT COMPLETED|Part 2 (India)||0
2527895|NCT00673465|6194620|P5|NOT COMPLETED|Part 2 (India)||0
2527896|NCT00673465|6194621|P4|NOT COMPLETED|Part 2 (India)||0
2527897|NCT00673465|6194622|P3|NOT COMPLETED|Part 2 (India)||0
2527898|NCT00673465|6194623|P2|NOT COMPLETED|Part 2 (India)||0
2527899|NCT00673465|6194624|P1|NOT COMPLETED|Part 2 (India)||0
2527900|NCT00673465|6194613|P12|COMPLETED|Part 2 (India)||0
2527901|NCT00673465|6194614|P11|COMPLETED|Part 2 (India)||0
2527902|NCT00673465|6194615|P10|COMPLETED|Part 2 (India)||0
2527903|NCT00673465|6194616|P9|COMPLETED|Part 2 (India)||0
2527904|NCT00673465|6194617|P8|COMPLETED|Part 2 (India)||0
2527905|NCT00673465|6194618|P7|COMPLETED|Part 2 (India)||0
2527906|NCT00673465|6194619|P6|COMPLETED|Part 2 (India)||0
2527907|NCT00673465|6194620|P5|COMPLETED|Part 2 (India)||0
2527908|NCT00673465|6194621|P4|COMPLETED|Part 2 (India)||0
2527909|NCT00673465|6194622|P3|COMPLETED|Part 2 (India)||0
2527910|NCT00673465|6194623|P2|COMPLETED|Part 2 (India)||0
2527911|NCT00673465|6194624|P1|COMPLETED|Part 2 (India)||0
2527912|NCT00673465|6194613|P12|STARTED|Part 2 (India)||0
2527913|NCT00673465|6194614|P11|STARTED|Part 2 (India)||0
2527914|NCT00673465|6194615|P10|STARTED|Part 2 (India)||0
2527915|NCT00673465|6194616|P9|STARTED|Part 2 (India)||0
2527916|NCT00673465|6194617|P8|STARTED|Part 2 (India)||0
2527917|NCT00673465|6194618|P7|STARTED|Part 2 (India)||0
2527918|NCT00673465|6194619|P6|STARTED|Part 2 (India)||0
2527919|NCT00673465|6194620|P5|STARTED|Part 2 (India)||0
2527920|NCT00673465|6194621|P4|STARTED|Part 2 (India)||0
2527921|NCT00673465|6194622|P3|STARTED|Part 2 (India)||0
2527922|NCT00673465|6194623|P2|STARTED|Part 2 (India)||0
2527923|NCT00673465|6194624|P1|STARTED|Part 2 (India)||0
2527924|NCT00673465|6194613|P12|NOT COMPLETED|Part 1/Period 3 (United States)||0
2527925|NCT00673465|6194614|P11|NOT COMPLETED|Part 1/Period 3 (United States)||0
2527926|NCT00673465|6194615|P10|NOT COMPLETED|Part 1/Period 3 (United States)||0
2527927|NCT00673465|6194616|P9|NOT COMPLETED|Part 1/Period 3 (United States)||0
2527928|NCT00673465|6194617|P8|NOT COMPLETED|Part 1/Period 3 (United States)||0
2527929|NCT00673465|6194618|P7|NOT COMPLETED|Part 1/Period 3 (United States)||0
2527930|NCT00673465|6194619|P6|NOT COMPLETED|Part 1/Period 3 (United States)||0
2527931|NCT00673465|6194620|P5|NOT COMPLETED|Part 1/Period 3 (United States)||0
2527932|NCT00673465|6194621|P4|NOT COMPLETED|Part 1/Period 3 (United States)||0
2527933|NCT00673465|6194622|P3|NOT COMPLETED|Part 1/Period 3 (United States)||0
2527934|NCT00673465|6194623|P2|NOT COMPLETED|Part 1/Period 3 (United States)||0
2527935|NCT00673465|6194624|P1|NOT COMPLETED|Part 1/Period 3 (United States)||0
2527936|NCT00673465|6194613|P12|COMPLETED|Part 1/Period 3 (United States)||0
2527937|NCT00673465|6194614|P11|COMPLETED|Part 1/Period 3 (United States)||0
2527938|NCT00673465|6194615|P10|COMPLETED|Part 1/Period 3 (United States)||0
2527939|NCT00673465|6194616|P9|COMPLETED|Part 1/Period 3 (United States)||0
2527940|NCT00673465|6194617|P8|COMPLETED|Part 1/Period 3 (United States)||0
2527941|NCT00673465|6194618|P7|COMPLETED|Part 1/Period 3 (United States)||0
2527942|NCT00673465|6194619|P6|COMPLETED|Part 1/Period 3 (United States)||1
2527943|NCT00673465|6194620|P5|COMPLETED|Part 1/Period 3 (United States)||1
2527944|NCT00673465|6194621|P4|COMPLETED|Part 1/Period 3 (United States)||3
2527945|NCT00673465|6194622|P3|COMPLETED|Part 1/Period 3 (United States)||3
2527946|NCT00673465|6194623|P2|COMPLETED|Part 1/Period 3 (United States)||3
2527947|NCT00673465|6194624|P1|COMPLETED|Part 1/Period 3 (United States)||3
2527948|NCT00673465|6194613|P12|STARTED|Part 1/Period 3 (United States)||0
2527949|NCT00673465|6194614|P11|STARTED|Part 1/Period 3 (United States)||0
2527950|NCT00673465|6194615|P10|STARTED|Part 1/Period 3 (United States)||0
2527951|NCT00673465|6194616|P9|STARTED|Part 1/Period 3 (United States)||0
2527952|NCT00673465|6194617|P8|STARTED|Part 1/Period 3 (United States)||0
2527953|NCT00673465|6194618|P7|STARTED|Part 1/Period 3 (United States)||0
2527954|NCT00673465|6194619|P6|STARTED|Part 1/Period 3 (United States)||1
2527955|NCT00673465|6194620|P5|STARTED|Part 1/Period 3 (United States)||1
2527956|NCT00673465|6194621|P4|STARTED|Part 1/Period 3 (United States)||3
2527957|NCT00673465|6194622|P3|STARTED|Part 1/Period 3 (United States)||3
2527958|NCT00673465|6194623|P2|STARTED|Part 1/Period 3 (United States)||3
2527959|NCT00673465|6194624|P1|STARTED|Part 1/Period 3 (United States)||3
2527960|NCT00673465|6194613|P12|NOT COMPLETED|Part 1/Period 2 (United States)||0
2527961|NCT00673465|6194614|P11|NOT COMPLETED|Part 1/Period 2 (United States)||0
2527962|NCT00673465|6194615|P10|NOT COMPLETED|Part 1/Period 2 (United States)||0
2527963|NCT00673465|6194616|P9|NOT COMPLETED|Part 1/Period 2 (United States)||0
2527964|NCT00673465|6194617|P8|NOT COMPLETED|Part 1/Period 2 (United States)||0
2527965|NCT00673465|6194618|P7|NOT COMPLETED|Part 1/Period 2 (United States)||0
2527966|NCT00673465|6194619|P6|NOT COMPLETED|Part 1/Period 2 (United States)||0
2527967|NCT00673465|6194620|P5|NOT COMPLETED|Part 1/Period 2 (United States)||1
2527968|NCT00673465|6194621|P4|NOT COMPLETED|Part 1/Period 2 (United States)||0
2527969|NCT00673465|6194622|P3|NOT COMPLETED|Part 1/Period 2 (United States)||0
2527970|NCT00673465|6194623|P2|NOT COMPLETED|Part 1/Period 2 (United States)||0
2527971|NCT00673465|6194624|P1|NOT COMPLETED|Part 1/Period 2 (United States)||0
2527972|NCT00673465|6194613|P12|COMPLETED|Part 1/Period 2 (United States)||0
2527973|NCT00673465|6194614|P11|COMPLETED|Part 1/Period 2 (United States)||0
2527974|NCT00673465|6194615|P10|COMPLETED|Part 1/Period 2 (United States)||0
2527975|NCT00673465|6194616|P9|COMPLETED|Part 1/Period 2 (United States)||0
2527976|NCT00673465|6194617|P8|COMPLETED|Part 1/Period 2 (United States)||0
2527977|NCT00673465|6194618|P7|COMPLETED|Part 1/Period 2 (United States)||0
2527978|NCT00673465|6194619|P6|COMPLETED|Part 1/Period 2 (United States)||1
2527979|NCT00673465|6194620|P5|COMPLETED|Part 1/Period 2 (United States)||1
2527980|NCT00673465|6194621|P4|COMPLETED|Part 1/Period 2 (United States)||3
2527981|NCT00673465|6194622|P3|COMPLETED|Part 1/Period 2 (United States)||3
2527982|NCT00673465|6194623|P2|COMPLETED|Part 1/Period 2 (United States)||3
2527983|NCT00673465|6194624|P1|COMPLETED|Part 1/Period 2 (United States)||3
2527984|NCT00673465|6194613|P12|STARTED|Part 1/Period 2 (United States)||0
2527985|NCT00673465|6194614|P11|STARTED|Part 1/Period 2 (United States)||0
2527986|NCT00673465|6194615|P10|STARTED|Part 1/Period 2 (United States)||0
2527987|NCT00673465|6194616|P9|STARTED|Part 1/Period 2 (United States)||0
2527988|NCT00673465|6194617|P8|STARTED|Part 1/Period 2 (United States)||0
2527989|NCT00673465|6194618|P7|STARTED|Part 1/Period 2 (United States)||0
2527990|NCT00673465|6194619|P6|STARTED|Part 1/Period 2 (United States)||1
2527991|NCT00673465|6194620|P5|STARTED|Part 1/Period 2 (United States)||2
2527992|NCT00673465|6194621|P4|STARTED|Part 1/Period 2 (United States)||3
2527993|NCT00673465|6194622|P3|STARTED|Part 1/Period 2 (United States)||3
2527994|NCT00673465|6194623|P2|STARTED|Part 1/Period 2 (United States)||3
2527995|NCT00673465|6194624|P1|STARTED|Part 1/Period 2 (United States)||3
2527996|NCT00673465|6194613|P12|NOT COMPLETED|Part 1/Period 1 (United States)||0
2527997|NCT00673465|6194614|P11|NOT COMPLETED|Part 1/Period 1 (United States)||0
2527998|NCT00673465|6194615|P10|NOT COMPLETED|Part 1/Period 1 (United States)||0
2527999|NCT00673465|6194616|P9|NOT COMPLETED|Part 1/Period 1 (United States)||0
2528000|NCT00673465|6194617|P8|NOT COMPLETED|Part 1/Period 1 (United States)||0
2528001|NCT00673465|6194618|P7|NOT COMPLETED|Part 1/Period 1 (United States)||0
2528002|NCT00673465|6194619|P6|NOT COMPLETED|Part 1/Period 1 (United States)||1
2528003|NCT00673465|6194620|P5|NOT COMPLETED|Part 1/Period 1 (United States)||1
2528004|NCT00673465|6194621|P4|NOT COMPLETED|Part 1/Period 1 (United States)||0
2528005|NCT00673465|6194622|P3|NOT COMPLETED|Part 1/Period 1 (United States)||0
2528006|NCT00673465|6194623|P2|NOT COMPLETED|Part 1/Period 1 (United States)||0
2528007|NCT00673465|6194624|P1|NOT COMPLETED|Part 1/Period 1 (United States)||0
2528008|NCT00673465|6194613|P12|COMPLETED|Part 1/Period 1 (United States)||0
2528009|NCT00673465|6194614|P11|COMPLETED|Part 1/Period 1 (United States)||0
2528010|NCT00673465|6194615|P10|COMPLETED|Part 1/Period 1 (United States)||0
2528011|NCT00673465|6194616|P9|COMPLETED|Part 1/Period 1 (United States)||0
2528012|NCT00673465|6194617|P8|COMPLETED|Part 1/Period 1 (United States)||0
2528013|NCT00673465|6194618|P7|COMPLETED|Part 1/Period 1 (United States)||0
2528014|NCT00673465|6194619|P6|COMPLETED|Part 1/Period 1 (United States)||1
2528015|NCT00673465|6194620|P5|COMPLETED|Part 1/Period 1 (United States)||2
2528016|NCT00673465|6194621|P4|COMPLETED|Part 1/Period 1 (United States)||3
2528017|NCT00673465|6194622|P3|COMPLETED|Part 1/Period 1 (United States)||3
2528018|NCT00673465|6194623|P2|COMPLETED|Part 1/Period 1 (United States)||3
2528019|NCT00673465|6194624|P1|COMPLETED|Part 1/Period 1 (United States)||3
2528020|NCT00673465|6194613|P12|STARTED|Part 1/Period 1 (United States)||0
2528021|NCT00673465|6194614|P11|STARTED|Part 1/Period 1 (United States)||0
2528022|NCT00673465|6194615|P10|STARTED|Part 1/Period 1 (United States)||0
2528023|NCT00673465|6194616|P9|STARTED|Part 1/Period 1 (United States)||0
2528024|NCT00673465|6194617|P8|STARTED|Part 1/Period 1 (United States)||0
2528025|NCT00673465|6194618|P7|STARTED|Part 1/Period 1 (United States)||0
2528026|NCT00673465|6194619|P6|STARTED|Part 1/Period 1 (United States)||2
2528027|NCT00673465|6194620|P5|STARTED|Part 1/Period 1 (United States)||3
2528028|NCT00673465|6194621|P4|STARTED|Part 1/Period 1 (United States)||3
2528029|NCT00673465|6194622|P3|STARTED|Part 1/Period 1 (United States)||3
2528030|NCT00673465|6194623|P2|STARTED|Part 1/Period 1 (United States)||3
2528031|NCT00673465|6194624|P1|STARTED|Part 1/Period 1 (United States)||3
2528032|NCT00673452|6194673|P2|NOT COMPLETED|Continuation Double-Blind Phase||34
2528033|NCT00673452|6194674|P1|NOT COMPLETED|Continuation Double-Blind Phase||25
2528034|NCT00673452|6194673|P2|COMPLETED|Continuation Double-Blind Phase||153
2528035|NCT00673452|6194674|P1|COMPLETED|Continuation Double-Blind Phase||151
2528036|NCT00673452|6194673|P2|STARTED|Continuation Double-Blind Phase|Patients on placebo in acute phase received 60 mg duloxetine during the continuation phase.|187
2528037|NCT00673452|6194674|P1|STARTED|Continuation Double-Blind Phase||176
2528038|NCT00673452|6194673|P2|NOT COMPLETED|Acute Double-Blind Phase||80
2528039|NCT00673452|6194674|P1|NOT COMPLETED|Acute Double-Blind Phase||87
2528040|NCT00673452|6194673|P2|COMPLETED|Acute Double-Blind Phase||187
2528041|NCT00673452|6194674|P1|COMPLETED|Acute Double-Blind Phase||176
2528042|NCT00673452|6194673|P2|STARTED|Acute Double-Blind Phase||267
2528043|NCT00673452|6194674|P1|STARTED|Acute Double-Blind Phase||263
2528044|NCT00673439|6194708|P1|NOT COMPLETED|Overall Study||0
2528045|NCT00673439|6194708|P1|COMPLETED|Overall Study||3
2528046|NCT00673439|6194708|P1|STARTED|Overall Study||3
2528047|NCT00673400|6194713|P1|NOT COMPLETED|Overall Study||0
2528048|NCT00673400|6194713|P1|COMPLETED|Overall Study||52
2528049|NCT00673400|6194713|P1|STARTED|Overall Study||52
2528050|NCT00673387|6194738|P8|NOT COMPLETED|Overall Study||35
2528051|NCT00673387|6194739|P7|NOT COMPLETED|Overall Study||30
2528052|NCT00673387|6194740|P6|NOT COMPLETED|Overall Study||34
2528053|NCT00673387|6194741|P5|NOT COMPLETED|Overall Study||30
2528054|NCT00673387|6194742|P4|NOT COMPLETED|Overall Study||26
2528055|NCT00673387|6194743|P3|NOT COMPLETED|Overall Study||31
2528056|NCT00673387|6194744|P2|NOT COMPLETED|Overall Study||23
2528057|NCT00673387|6194745|P1|NOT COMPLETED|Overall Study||29
2528058|NCT00673387|6194738|P8|COMPLETED|Overall Study||40
2528059|NCT00673387|6194739|P7|COMPLETED|Overall Study||48
2528060|NCT00673387|6194740|P6|COMPLETED|Overall Study||44
2528061|NCT00673387|6194741|P5|COMPLETED|Overall Study||48
2528062|NCT00673387|6194742|P4|COMPLETED|Overall Study||49
2528063|NCT00673387|6194743|P3|COMPLETED|Overall Study||41
2528064|NCT00673387|6194744|P2|COMPLETED|Overall Study||54
2528065|NCT00673387|6194745|P1|COMPLETED|Overall Study||46
2528066|NCT00673387|6194738|P8|STARTED|Overall Study||75
2528067|NCT00673387|6194739|P7|STARTED|Overall Study||78
2528068|NCT00673387|6194740|P6|STARTED|Overall Study||78
2528069|NCT00673387|6194741|P5|STARTED|Overall Study||78
2528070|NCT00673387|6194742|P4|STARTED|Overall Study||75
2528071|NCT00673387|6194743|P3|STARTED|Overall Study||72
2528072|NCT00673387|6194744|P2|STARTED|Overall Study||77
2528073|NCT00673387|6194745|P1|STARTED|Overall Study||75
2528074|NCT00673361|6194961|P1|NOT COMPLETED|Overall Study||2
2528075|NCT00673361|6194961|P1|COMPLETED|Overall Study||7
2528076|NCT00673361|6194961|P1|STARTED|Overall Study||9
2528077|NCT00673309|6194975|P10|NOT COMPLETED|Overall Study||0
2528078|NCT00673309|6194976|P9|NOT COMPLETED|Overall Study||0
2528079|NCT00673309|6194977|P8|NOT COMPLETED|Overall Study||0
2528080|NCT00673309|6194978|P7|NOT COMPLETED|Overall Study||0
2528081|NCT00673309|6194979|P6|NOT COMPLETED|Overall Study||0
2528082|NCT00673309|6194980|P5|NOT COMPLETED|Overall Study||0
2528083|NCT00673309|6194981|P4|NOT COMPLETED|Overall Study||0
2528084|NCT00673309|6194982|P3|NOT COMPLETED|Overall Study||0
2528085|NCT00673309|6194983|P2|NOT COMPLETED|Overall Study||0
2528086|NCT00673309|6194984|P1|NOT COMPLETED|Overall Study||0
2528087|NCT00673309|6194975|P10|COMPLETED|Overall Study||30
2528088|NCT00673309|6194976|P9|COMPLETED|Overall Study||17
2528089|NCT00673309|6194977|P8|COMPLETED|Overall Study||13
2528090|NCT00673309|6194978|P7|COMPLETED|Overall Study||14
2528091|NCT00673309|6194979|P6|COMPLETED|Overall Study||35
2528092|NCT00673309|6194980|P5|COMPLETED|Overall Study||18
2528093|NCT00673309|6194981|P4|COMPLETED|Overall Study||25
2528094|NCT00673309|6194982|P3|COMPLETED|Overall Study||14
2528095|NCT00673309|6194983|P2|COMPLETED|Overall Study||14
2528096|NCT00673309|6194984|P1|COMPLETED|Overall Study||64
2528097|NCT00673309|6194975|P10|STARTED|Overall Study||30
2528098|NCT00673309|6194976|P9|STARTED|Overall Study||17
2528099|NCT00673309|6194977|P8|STARTED|Overall Study||13
2528100|NCT00673309|6194978|P7|STARTED|Overall Study||14
2528101|NCT00673309|6194979|P6|STARTED|Overall Study||35
2528102|NCT00673309|6194980|P5|STARTED|Overall Study||18
2528103|NCT00673309|6194981|P4|STARTED|Overall Study||25
2528104|NCT00673309|6194982|P3|STARTED|Overall Study||14
2528105|NCT00673309|6194983|P2|STARTED|Overall Study||14
2528106|NCT00673309|6194984|P1|STARTED|Overall Study||64
2528107|NCT00673257|6194997|P1|NOT COMPLETED|Overall Study||5
2528108|NCT00673257|6194997|P1|COMPLETED|Overall Study||102
2528109|NCT00673257|6194997|P1|STARTED|Overall Study||107
2528110|NCT00673231|6195006|P4|NOT COMPLETED|Overall Study||18
2528111|NCT00673231|6195007|P3|NOT COMPLETED|Overall Study||26
2528112|NCT00673231|6195008|P2|NOT COMPLETED|Overall Study||22
2528113|NCT00673231|6195009|P1|NOT COMPLETED|Overall Study||29
2528114|NCT00673231|6195006|P4|COMPLETED|Overall Study||178
2528115|NCT00673231|6195007|P3|COMPLETED|Overall Study||186
2528116|NCT00673231|6195008|P2|COMPLETED|Overall Study||180
2528117|NCT00673231|6195009|P1|COMPLETED|Overall Study||168
2528118|NCT00673231|6195006|P4|STARTED|Overall Study|Of the 196 randomized participants only 194 were included in the full analysis set|196
2528119|NCT00673231|6195007|P3|STARTED|Overall Study|Of the 212 randomized participants only 211 were included in the full analysis set|212
2528120|NCT00673231|6195008|P2|STARTED|Overall Study|All 202 were included in the full analysis set|202
2528121|NCT00673231|6195009|P1|STARTED|Overall Study|Of the 197 randomized participants only 193 were included in the full analysis set|197
2528122|NCT00673179|6195041|P2|NOT COMPLETED|Overall Study||0
2528123|NCT00673179|6195042|P1|NOT COMPLETED|Overall Study||3
2528124|NCT00673179|6195041|P2|COMPLETED|Overall Study||0
2528125|NCT00673179|6195042|P1|COMPLETED|Overall Study||4
2528126|NCT00673179|6195041|P2|STARTED|Overall Study||0
2528127|NCT00673179|6195042|P1|STARTED|Overall Study||7
2528128|NCT00673153|6195048|P1|NOT COMPLETED|Overall Study||1
2528129|NCT00673153|6195048|P1|COMPLETED|Overall Study||30
2528130|NCT00673153|6195048|P1|STARTED|Overall Study||31
2528131|NCT00673127|6195056|P1|NOT COMPLETED|Overall Study||0
2528132|NCT00673127|6195056|P1|COMPLETED|Overall Study||57
2528133|NCT00673127|6195056|P1|STARTED|Overall Study||57
2528134|NCT00673114|6195061|P1|NOT COMPLETED|Overall Study||0
2528135|NCT00673114|6195061|P1|COMPLETED|Overall Study||3
2528136|NCT00673114|6195061|P1|STARTED|Overall Study||3
2528137|NCT00673075|6195074|P2|NOT COMPLETED|Overall Study||7
2528138|NCT00673075|6195075|P1|NOT COMPLETED|Overall Study||9
2528139|NCT00673075|6195074|P2|COMPLETED|Overall Study||11
2528140|NCT00673075|6195075|P1|COMPLETED|Overall Study||12
2528141|NCT00673075|6195074|P2|STARTED|Overall Study||18
2528142|NCT00673075|6195075|P1|STARTED|Overall Study||21
2528143|NCT00673049|6195091|P4|NOT COMPLETED|After Progression on Erlotinib||83
2528144|NCT00673049|6195092|P3|NOT COMPLETED|After Progression on Erlotinib||0
2528145|NCT00673049|6195093|P2|NOT COMPLETED|After Progression on Erlotinib||0
2528146|NCT00673049|6195094|P1|NOT COMPLETED|After Progression on Erlotinib||0
2528147|NCT00673049|6195091|P4|COMPLETED|After Progression on Erlotinib||0
2528148|NCT00673049|6195092|P3|COMPLETED|After Progression on Erlotinib||0
2528149|NCT00673049|6195093|P2|COMPLETED|After Progression on Erlotinib||0
2528150|NCT00673049|6195094|P1|COMPLETED|After Progression on Erlotinib||0
2528151|NCT00673049|6195091|P4|STARTED|After Progression on Erlotinib||83
2528152|NCT00673049|6195092|P3|STARTED|After Progression on Erlotinib||0
2528153|NCT00673049|6195093|P2|STARTED|After Progression on Erlotinib||0
2528154|NCT00673049|6195094|P1|STARTED|After Progression on Erlotinib||0
2528155|NCT00673049|6195091|P4|NOT COMPLETED|Before Progression on Erlotinib||0
2528156|NCT00673049|6195092|P3|NOT COMPLETED|Before Progression on Erlotinib||1
2528157|NCT00673049|6195093|P2|NOT COMPLETED|Before Progression on Erlotinib||290
2528158|NCT00673049|6195094|P1|NOT COMPLETED|Before Progression on Erlotinib||292
2528159|NCT00673049|6195091|P4|COMPLETED|Before Progression on Erlotinib||0
2528160|NCT00673049|6195092|P3|COMPLETED|Before Progression on Erlotinib||0
2528161|NCT00673049|6195093|P2|COMPLETED|Before Progression on Erlotinib||0
2528162|NCT00673049|6195094|P1|COMPLETED|Before Progression on Erlotinib||0
2528163|NCT00673049|6195091|P4|Treated|Before Progression on Erlotinib||0
2528164|NCT00673049|6195092|P3|Treated|Before Progression on Erlotinib||1
2528165|NCT00673049|6195093|P2|Treated|Before Progression on Erlotinib||289
2528166|NCT00673049|6195094|P1|Treated|Before Progression on Erlotinib||289
2528167|NCT00673049|6195091|P4|STARTED|Before Progression on Erlotinib|Participants treated with erlo alone who subsequently received figi upon disease progression.|0
2528168|NCT00673049|6195092|P3|STARTED|Before Progression on Erlotinib||1
2528169|NCT00673049|6195093|P2|STARTED|Before Progression on Erlotinib||290
2528170|NCT00673049|6195094|P1|STARTED|Before Progression on Erlotinib||292
2528171|NCT00672984|6195118|P3|NOT COMPLETED|Third Intervention||1
2528172|NCT00672984|6195119|P2|NOT COMPLETED|Third Intervention||0
2528173|NCT00672984|6195120|P1|NOT COMPLETED|Third Intervention||1
2528174|NCT00672984|6195118|P3|COMPLETED|Third Intervention||23
2528175|NCT00672984|6195119|P2|COMPLETED|Third Intervention||17
2528176|NCT00672984|6195120|P1|COMPLETED|Third Intervention||21
2528177|NCT00672984|6195118|P3|STARTED|Third Intervention||24
2528178|NCT00672984|6195119|P2|STARTED|Third Intervention||17
2528179|NCT00672984|6195120|P1|STARTED|Third Intervention||22
2528180|NCT00672984|6195118|P3|NOT COMPLETED|Second Intervention||1
2528181|NCT00672984|6195119|P2|NOT COMPLETED|Second Intervention||6
2528182|NCT00672984|6195120|P1|NOT COMPLETED|Second Intervention||0
2528183|NCT00672984|6195118|P3|COMPLETED|Second Intervention||24
2528184|NCT00672984|6195119|P2|COMPLETED|Second Intervention||17
2528185|NCT00672984|6195120|P1|COMPLETED|Second Intervention||22
2528186|NCT00672984|6195118|P3|STARTED|Second Intervention||25
2528187|NCT00672984|6195119|P2|STARTED|Second Intervention||23
2528188|NCT00672984|6195120|P1|STARTED|Second Intervention||22
2528189|NCT00672984|6195118|P3|NOT COMPLETED|First Intervention||2
2528190|NCT00672984|6195119|P2|NOT COMPLETED|First Intervention||2
2528191|NCT00672984|6195120|P1|NOT COMPLETED|First Intervention||9
2528192|NCT00672984|6195118|P3|COMPLETED|First Intervention||25
2528193|NCT00672984|6195119|P2|COMPLETED|First Intervention||23
2528194|NCT00672984|6195120|P1|COMPLETED|First Intervention||22
2528195|NCT00672984|6195118|P3|STARTED|First Intervention||27
2528196|NCT00672984|6195119|P2|STARTED|First Intervention||25
2528197|NCT00672984|6195120|P1|STARTED|First Intervention||31
2528198|NCT00672958|6195171|P2|NOT COMPLETED|Overall Study||56
2528199|NCT00672958|6195172|P1|NOT COMPLETED|Overall Study||64
2528200|NCT00672958|6195171|P2|COMPLETED|Overall Study||244
2528201|NCT00672958|6195172|P1|COMPLETED|Overall Study||236
2528202|NCT00672958|6195171|P2|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|292
2528203|NCT00672958|6195172|P1|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|286
2528204|NCT00672958|6195171|P2|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|299
2528205|NCT00672958|6195172|P1|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|298
2528206|NCT00672958|6195171|P2|STARTED|Overall Study||300
2528207|NCT00672958|6195172|P1|STARTED|Overall Study||300
2528208|NCT00672932|6195204|P2|NOT COMPLETED|Overall Study||0
2528209|NCT00672932|6195205|P1|NOT COMPLETED|Overall Study||0
2528210|NCT00672932|6195204|P2|COMPLETED|Overall Study||9
2528211|NCT00672932|6195205|P1|COMPLETED|Overall Study||9
2528212|NCT00672932|6195204|P2|Rolled Over to Raltegravir|Overall Study|6 subjects randomized to no drug later rolled over to receive raltegravir|6
2528213|NCT00672932|6195205|P1|Rolled Over to Raltegravir|Overall Study||0
2528214|NCT00672932|6195204|P2|Provided Analyzable Blood and CSF Sample|Overall Study||9
2528215|NCT00672932|6195205|P1|Provided Analyzable Blood and CSF Sample|Overall Study|one subject was censored when pharmacological study showed no drug in plasma or CSF|8
2528216|NCT00672932|6195204|P2|Completed Initial 12-week Assignment|Overall Study||9
2528217|NCT00672932|6195205|P1|Completed Initial 12-week Assignment|Overall Study||9
2528218|NCT00672932|6195204|P2|STARTED|Overall Study||9
2528219|NCT00672932|6195205|P1|STARTED|Overall Study||9
2528220|NCT00672854|6195215|P2|NOT COMPLETED|Overall Study||0
2528221|NCT00672854|6195216|P1|NOT COMPLETED|Overall Study||0
2528222|NCT00672854|6195215|P2|COMPLETED|Overall Study||51
2528223|NCT00672854|6195216|P1|COMPLETED|Overall Study||49
2528224|NCT00672854|6195215|P2|STARTED|Overall Study||51
2528225|NCT00672854|6195216|P1|STARTED|Overall Study||49
2528226|NCT00672841|6195238|P2|NOT COMPLETED|Overall Study||15
2528227|NCT00672841|6195239|P1|NOT COMPLETED|Overall Study||1
2528228|NCT00672841|6195238|P2|COMPLETED|Overall Study||32
2528229|NCT00672841|6195239|P1|COMPLETED|Overall Study||16
2528230|NCT00672841|6195238|P2|STARTED|Overall Study||47
2528231|NCT00672841|6195239|P1|STARTED|Overall Study||17
2528232|NCT00672737|6195251|P1|NOT COMPLETED|Overall Study||8
2528233|NCT00672737|6195251|P1|COMPLETED|Overall Study||48
2528234|NCT00672737|6195251|P1|STARTED|Overall Study||56
2528235|NCT00672646|6195261|P3|NOT COMPLETED|Overall Study||3
2528236|NCT00672646|6195262|P2|NOT COMPLETED|Overall Study||1
2528237|NCT00672646|6195263|P1|NOT COMPLETED|Overall Study||0
2528238|NCT00672646|6195261|P3|COMPLETED|Overall Study||37
2528239|NCT00672646|6195262|P2|COMPLETED|Overall Study||22
2528240|NCT00672646|6195263|P1|COMPLETED|Overall Study||40
2528241|NCT00672646|6195261|P3|STARTED|Overall Study||40
2528242|NCT00672646|6195262|P2|STARTED|Overall Study||23
2528243|NCT00672646|6195263|P1|STARTED|Overall Study||40
2528244|NCT00672633|6195288|P2|NOT COMPLETED|Overall Study||1
2528245|NCT00672633|6195289|P1|NOT COMPLETED|Overall Study||0
2528246|NCT00672633|6195288|P2|COMPLETED|Overall Study||12
2528247|NCT00672633|6195289|P1|COMPLETED|Overall Study||12
2528248|NCT00672633|6195288|P2|STARTED|Overall Study||13
2528249|NCT00672633|6195289|P1|STARTED|Overall Study||12
2528250|NCT00672620|6195303|P4|NOT COMPLETED|Overall Study||42
2528251|NCT00672620|6195304|P3|NOT COMPLETED|Overall Study||31
2528252|NCT00672620|6195305|P2|NOT COMPLETED|Overall Study||54
2528253|NCT00672620|6195306|P1|NOT COMPLETED|Overall Study||33
2528254|NCT00672620|6195303|P4|COMPLETED|Overall Study||110
2528255|NCT00672620|6195304|P3|COMPLETED|Overall Study||122
2528256|NCT00672620|6195305|P2|COMPLETED|Overall Study||99
2528257|NCT00672620|6195306|P1|COMPLETED|Overall Study||120
2528258|NCT00672620|6195303|P4|Treated|Overall Study||150
2528259|NCT00672620|6195304|P3|Treated|Overall Study||153
2528260|NCT00672620|6195305|P2|Treated|Overall Study||149
2528261|NCT00672620|6195306|P1|Treated|Overall Study||151
2528262|NCT00672620|6195303|P4|STARTED|Overall Study||152
2528263|NCT00672620|6195304|P3|STARTED|Overall Study||153
2528264|NCT00672620|6195305|P2|STARTED|Overall Study||153
2528265|NCT00672620|6195306|P1|STARTED|Overall Study||153
2528266|NCT00672594|6195360|P1|NOT COMPLETED|Overall Study||3
2528267|NCT00672594|6195360|P1|COMPLETED|Overall Study||27
2528268|NCT00672594|6195360|P1|STARTED|Overall Study||30
2528269|NCT00672555|6195371|P1|NOT COMPLETED|Overall Study||6
2528270|NCT00672555|6195371|P1|COMPLETED|Overall Study|All patients were seen at 3 weeks in the outpatient clinic.|64
2528271|NCT00672555|6195371|P1|STARTED|Overall Study||70
2528272|NCT00672490|6195382|P2|NOT COMPLETED|Overall Study||32
2528273|NCT00672490|6195383|P1|NOT COMPLETED|Overall Study||24
2528274|NCT00672490|6195382|P2|COMPLETED|Overall Study||157
2528275|NCT00672490|6195383|P1|COMPLETED|Overall Study||163
2528276|NCT00672490|6195382|P2|STARTED|Overall Study||189
2528277|NCT00672490|6195383|P1|STARTED|Overall Study||187
2528278|NCT00672477|6195407|P2|NOT COMPLETED|Overall Study||26
2528279|NCT00672477|6195408|P1|NOT COMPLETED|Overall Study||27
2528280|NCT00672477|6195407|P2|COMPLETED|Overall Study||88
2528281|NCT00672477|6195408|P1|COMPLETED|Overall Study|One subject had missing data as reason for study termination - not counted as early termination.|89
2528282|NCT00672477|6195407|P2|STARTED|Overall Study|117 subjects were randomized to this group, but only 114 subjects received study drug.|114
2528283|NCT00672477|6195408|P1|STARTED|Overall Study|120 subjects were randomized to this group, but only 116 subjects received study drug.|116
2528284|NCT00672451|6195418|P2|NOT COMPLETED|Overall Study||0
2528285|NCT00672451|6195419|P1|NOT COMPLETED|Overall Study||0
2528286|NCT00672451|6195418|P2|COMPLETED|Overall Study||2
2528287|NCT00672451|6195419|P1|COMPLETED|Overall Study||1
2528288|NCT00672451|6195418|P2|STARTED|Overall Study||2
2528289|NCT00672451|6195419|P1|STARTED|Overall Study||1
2528290|NCT00672438|6195429|P2|NOT COMPLETED|Infusion 2||0
2528291|NCT00672438|6195430|P1|NOT COMPLETED|Infusion 2||0
2528292|NCT00672438|6195429|P2|COMPLETED|Infusion 2||118
2528293|NCT00672438|6195430|P1|COMPLETED|Infusion 2||119
2528294|NCT00672438|6195429|P2|STARTED|Infusion 2||118
2528295|NCT00672438|6195430|P1|STARTED|Infusion 2||119
2528296|NCT00672438|6195429|P2|NOT COMPLETED|Washout||0
2528297|NCT00672438|6195430|P1|NOT COMPLETED|Washout||0
2528298|NCT00672438|6195429|P2|COMPLETED|Washout||118
2528299|NCT00672438|6195430|P1|COMPLETED|Washout||119
2528300|NCT00672438|6195429|P2|STARTED|Washout||118
2528301|NCT00672438|6195430|P1|STARTED|Washout||119
2528302|NCT00672438|6195429|P2|NOT COMPLETED|Infusion 1||0
2528303|NCT00672438|6195430|P1|NOT COMPLETED|Infusion 1||0
2528304|NCT00672438|6195429|P2|COMPLETED|Infusion 1||118
2528305|NCT00672438|6195430|P1|COMPLETED|Infusion 1||119
2528306|NCT00672438|6195429|P2|STARTED|Infusion 1||118
2528307|NCT00672438|6195430|P1|STARTED|Infusion 1||119
2528308|NCT00672256|6195461|P1|NOT COMPLETED|Overall Study||44
2528309|NCT00672256|6195461|P1|COMPLETED|Overall Study||18
2528310|NCT00672256|6195461|P1|STARTED|Overall Study|January 2007|62
2528311|NCT00672243|6195468|P1|NOT COMPLETED|Overall Study||0
2528312|NCT00672243|6195468|P1|COMPLETED|Overall Study||32
2528313|NCT00672243|6195468|P1|STARTED|Overall Study||32
2528314|NCT00672204|6195476|P1|NOT COMPLETED|Overall Study||20
2528315|NCT00672204|6195476|P1|COMPLETED|Overall Study||3
2528316|NCT00672204|6195476|P1|STARTED|Overall Study||23
2528317|NCT00672178|6195480|P1|NOT COMPLETED|Overall Study||0
2528318|NCT00672178|6195480|P1|COMPLETED|Overall Study||1
2528319|NCT00672178|6195480|P1|STARTED|Overall Study||1
2528320|NCT00672139|6195486|P2|NOT COMPLETED|Overall Study||45
2528321|NCT00672139|6195487|P1|NOT COMPLETED|Overall Study||30
2528322|NCT00672139|6195486|P2|COMPLETED|Overall Study||47
2528323|NCT00672139|6195487|P1|COMPLETED|Overall Study||27
2528324|NCT00672139|6195486|P2|STARTED|Overall Study|Four of 96 enrolled subjects did not receive study drug.|92
2528325|NCT00672139|6195487|P1|STARTED|Overall Study|Three of 60 enrolled subjects did not receive study drug.|57
2528326|NCT00672100|6195496|P3|NOT COMPLETED|Overall Study||0
2528327|NCT00672100|6195497|P2|NOT COMPLETED|Overall Study||0
2528328|NCT00672100|6195498|P1|NOT COMPLETED|Overall Study||0
2528329|NCT00672100|6195496|P3|COMPLETED|Overall Study||12
2528330|NCT00672100|6195497|P2|COMPLETED|Overall Study||12
2528331|NCT00672100|6195498|P1|COMPLETED|Overall Study||12
2528332|NCT00672100|6195496|P3|PACU (Within 8 Hours)|Overall Study||12
2528333|NCT00672100|6195497|P2|PACU (Within 8 Hours)|Overall Study||12
2528334|NCT00672100|6195498|P1|PACU (Within 8 Hours)|Overall Study||12
2528335|NCT00672100|6195496|P3|STARTED|Overall Study||12
2528336|NCT00672100|6195497|P2|STARTED|Overall Study||12
2528337|NCT00672100|6195498|P1|STARTED|Overall Study||12
2528338|NCT00671970|6195515|P2|NOT COMPLETED|Overall Study||0
2528339|NCT00671970|6195516|P1|NOT COMPLETED|Overall Study||0
2528340|NCT00671970|6195515|P2|COMPLETED|Overall Study||25
2528341|NCT00671970|6195516|P1|COMPLETED|Overall Study||32
2528342|NCT00671970|6195515|P2|STARTED|Overall Study||25
2528343|NCT00671970|6195516|P1|STARTED|Overall Study||32
2528344|NCT00671931|6195544|P5|NOT COMPLETED|Overall Study||1
2528345|NCT00671931|6195545|P4|NOT COMPLETED|Overall Study||2
2528346|NCT00671931|6195546|P3|NOT COMPLETED|Overall Study||0
2528347|NCT00671931|6195547|P2|NOT COMPLETED|Overall Study||0
2528348|NCT00671931|6195548|P1|NOT COMPLETED|Overall Study||1
2528349|NCT00671931|6195544|P5|COMPLETED|Overall Study|Low heart rate requiring treatment|7
2528350|NCT00671931|6195545|P4|COMPLETED|Overall Study|Prepositioning - Neuromonitoring required|8
2528351|NCT00671931|6195546|P3|COMPLETED|Overall Study|all completed|9
2528352|NCT00671931|6195547|P2|COMPLETED|Overall Study|All completed|8
2528353|NCT00671931|6195548|P1|COMPLETED|Overall Study|Nueromonitoring equipment falure|8
2528354|NCT00671931|6195544|P5|STARTED|Overall Study||8
2528355|NCT00671931|6195545|P4|STARTED|Overall Study||10
2528356|NCT00671931|6195546|P3|STARTED|Overall Study||9
2528357|NCT00671931|6195547|P2|STARTED|Overall Study||8
2528358|NCT00671931|6195548|P1|STARTED|Overall Study||9
2528359|NCT00671918|6195560|P1|NOT COMPLETED|Overall Study||17
2528360|NCT00671918|6195560|P1|COMPLETED|Overall Study||169
2528361|NCT00671918|6195560|P1|STARTED|Overall Study||186
2528362|NCT00671879|6195568|P3|NOT COMPLETED|Overall Study||6
2528363|NCT00671879|6195569|P2|NOT COMPLETED|Overall Study||4
2528364|NCT00671879|6195570|P1|NOT COMPLETED|Overall Study||0
2528365|NCT00671879|6195568|P3|COMPLETED|Overall Study||274
2528366|NCT00671879|6195569|P2|COMPLETED|Overall Study||275
2528367|NCT00671879|6195570|P1|COMPLETED|Overall Study||281
2528368|NCT00671879|6195568|P3|STARTED|Overall Study||280
2528369|NCT00671879|6195569|P2|STARTED|Overall Study||279
2528370|NCT00671879|6195570|P1|STARTED|Overall Study||281
2528371|NCT00671853|6195583|P2|NOT COMPLETED|Overall Study||27
2528372|NCT00671853|6195584|P1|NOT COMPLETED|Overall Study||20
2528373|NCT00671853|6195583|P2|COMPLETED|Overall Study||18
2528374|NCT00671853|6195584|P1|COMPLETED|Overall Study||26
2528375|NCT00671853|6195583|P2|STARTED|Overall Study||45
2528376|NCT00671853|6195584|P1|STARTED|Overall Study||46
2528377|NCT00671788|6195600|P1|NOT COMPLETED|Overall Study||14
2528378|NCT00671788|6195600|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|21
2528379|NCT00671788|6195600|P1|STARTED|Overall Study||35
2528380|NCT00671749|6195607|P1|NOT COMPLETED|Overall Study||8
2528381|NCT00671749|6195607|P1|COMPLETED|Overall Study||92
2528382|NCT00671749|6195607|P1|STARTED|Overall Study||100
2528383|NCT00671723|6195620|P3|NOT COMPLETED|Overall Study||0
2528384|NCT00671723|6195621|P2|NOT COMPLETED|Overall Study||0
2528385|NCT00671723|6195622|P1|NOT COMPLETED|Overall Study||0
2528386|NCT00671723|6195620|P3|COMPLETED|Overall Study||11
2528387|NCT00671723|6195621|P2|COMPLETED|Overall Study||11
2528388|NCT00671723|6195622|P1|COMPLETED|Overall Study||11
2528389|NCT00671723|6195620|P3|STARTED|Overall Study||11
2528390|NCT00671723|6195621|P2|STARTED|Overall Study||11
2528391|NCT00671723|6195622|P1|STARTED|Overall Study||11
2528392|NCT00671671|6195635|P2|NOT COMPLETED|Overall Study||0
2528393|NCT00671671|6195636|P1|NOT COMPLETED|Overall Study||0
2528394|NCT00671671|6195635|P2|COMPLETED|Overall Study||10
2528395|NCT00671671|6195636|P1|COMPLETED|Overall Study||10
2528396|NCT00671671|6195635|P2|STARTED|Overall Study||10
2528397|NCT00671671|6195636|P1|STARTED|Overall Study||10
2528398|NCT00671606|6195662|P1|NOT COMPLETED|Overall Study||0
2528399|NCT00671606|6195662|P1|COMPLETED|Overall Study||5
2528400|NCT00671606|6195662|P1|STARTED|Overall Study||5
2528401|NCT00671554|6195666|P1|NOT COMPLETED|Overall Study||3
2528402|NCT00671554|6195666|P1|COMPLETED|Overall Study||0
2528403|NCT00671554|6195666|P1|STARTED|Overall Study||3
2528404|NCT00671528|6195674|P3|NOT COMPLETED|Overall Study||0
2528405|NCT00671528|6195675|P2|NOT COMPLETED|Overall Study||0
2528406|NCT00671528|6195676|P1|NOT COMPLETED|Overall Study||0
2528407|NCT00671528|6195674|P3|COMPLETED|Overall Study||1
2528408|NCT00671528|6195675|P2|COMPLETED|Overall Study||1
2528409|NCT00671528|6195676|P1|COMPLETED|Overall Study||1
2528410|NCT00671528|6195674|P3|STARTED|Overall Study||1
2528411|NCT00671528|6195675|P2|STARTED|Overall Study||1
2528412|NCT00671528|6195676|P1|STARTED|Overall Study||1
2528413|NCT00671515|6195687|P1|NOT COMPLETED|Phase 2||4
2528414|NCT00671515|6195687|P1|COMPLETED|Phase 2||9
2528415|NCT00671515|6195687|P1|STARTED|Phase 2||13
2528416|NCT00671515|6195687|P1|NOT COMPLETED|Phase 1||3
2528417|NCT00671515|6195687|P1|COMPLETED|Phase 1||20
2528418|NCT00671515|6195687|P1|STARTED|Phase 1||23
2528419|NCT00671502|6195695|P3|NOT COMPLETED|Overall Study||27
2528420|NCT00671502|6195696|P2|NOT COMPLETED|Overall Study||39
2528421|NCT00671502|6195697|P1|NOT COMPLETED|Overall Study||39
2528422|NCT00671502|6195695|P3|COMPLETED|Overall Study||252
2528423|NCT00671502|6195696|P2|COMPLETED|Overall Study||241
2528424|NCT00671502|6195697|P1|COMPLETED|Overall Study||242
2528425|NCT00671502|6195695|P3|STARTED|Overall Study||279
2528426|NCT00671502|6195696|P2|STARTED|Overall Study||280
2528427|NCT00671502|6195697|P1|STARTED|Overall Study||281
2528428|NCT00671437|6195705|P1|NOT COMPLETED|Overall Study||15
2528429|NCT00671437|6195705|P1|COMPLETED|Overall Study||27
2528430|NCT00671437|6195705|P1|STARTED|Overall Study||42
2528431|NCT00671177|6195726|P2|NOT COMPLETED|Overall Study||1
2528432|NCT00671177|6195727|P1|NOT COMPLETED|Overall Study||2
2528433|NCT00671177|6195726|P2|COMPLETED|Overall Study||114
2528434|NCT00671177|6195727|P1|COMPLETED|Overall Study||112
2528435|NCT00671177|6195726|P2|STARTED|Overall Study||115
2528436|NCT00671177|6195727|P1|STARTED|Overall Study||114
2528437|NCT00671060|6195739|P2|NOT COMPLETED|Overall Study||1
2528438|NCT00671060|6195740|P1|NOT COMPLETED|Overall Study||1
2528439|NCT00671060|6195739|P2|COMPLETED|Overall Study|1 woman was withdrawn from the study due to preeclampsia.|75
2528440|NCT00671060|6195740|P1|COMPLETED|Overall Study|1 woman completed study but was excluded from analysis because gestational age <14 weeks.|76
2528441|NCT00671060|6195739|P2|STARTED|Overall Study||76
2528442|NCT00671060|6195740|P1|STARTED|Overall Study||77
2528443|NCT00671034|6195749|P3|NOT COMPLETED|Overall Study||24
2528444|NCT00671034|6195750|P2|NOT COMPLETED|Overall Study||20
2528445|NCT00671034|6195751|P1|NOT COMPLETED|Overall Study||39
2528446|NCT00671034|6195749|P3|COMPLETED|Overall Study||31
2528447|NCT00671034|6195750|P2|COMPLETED|Overall Study||22
2528448|NCT00671034|6195751|P1|COMPLETED|Overall Study||30
2528449|NCT00671034|6195749|P3|STARTED|Overall Study||55
2528450|NCT00671034|6195750|P2|STARTED|Overall Study||42
2528451|NCT00671034|6195751|P1|STARTED|Overall Study||69
2528452|NCT00670982|6195788|P2|NOT COMPLETED|Overall Study||0
2528453|NCT00670982|6195789|P1|NOT COMPLETED|Overall Study||0
2528454|NCT00670982|6195788|P2|COMPLETED|Overall Study||7
2528455|NCT00670982|6195789|P1|COMPLETED|Overall Study||22
2528456|NCT00670982|6195788|P2|STARTED|Overall Study||7
2528457|NCT00670982|6195789|P1|STARTED|Overall Study||22
2528458|NCT00670956|6195798|P1|NOT COMPLETED|Overall Study||0
2528459|NCT00670956|6195798|P1|COMPLETED|Overall Study||1
2528460|NCT00670956|6195798|P1|STARTED|Overall Study||1
2528461|NCT00670930|6195806|P2|NOT COMPLETED|Overall Study||1
2528462|NCT00670930|6195807|P1|NOT COMPLETED|Overall Study||1
2528463|NCT00670930|6195806|P2|COMPLETED|Overall Study||12
2528464|NCT00670930|6195807|P1|COMPLETED|Overall Study||22
2528465|NCT00670930|6195806|P2|Intent to Treat (ITT) Population|Overall Study||12
2528466|NCT00670930|6195807|P1|Intent to Treat (ITT) Population|Overall Study||23
2528467|NCT00670930|6195806|P2|STARTED|Overall Study||13
2528468|NCT00670930|6195807|P1|STARTED|Overall Study|"Started indicates Randomized and Safety populaiton"|23
2528469|NCT00670800|6195823|P2|NOT COMPLETED|Overall Study||2
2528470|NCT00670800|6195824|P1|NOT COMPLETED|Overall Study||0
2528471|NCT00670800|6195823|P2|COMPLETED|Overall Study|Two controls were found to have insulin resistance and were excluded from analysis.|5
2528472|NCT00670800|6195824|P1|COMPLETED|Overall Study||7
2528473|NCT00670800|6195823|P2|STARTED|Overall Study||7
2528474|NCT00670800|6195824|P1|STARTED|Overall Study||7
2528475|NCT00670774|6195840|P1|NOT COMPLETED|Overall Study||0
2528476|NCT00670774|6195840|P1|COMPLETED|Overall Study||26
2528477|NCT00670774|6195840|P1|STARTED|Overall Study||26
2528478|NCT00670748|6195855|P4|NOT COMPLETED|Overall Study||1
2528479|NCT00670748|6195856|P3|NOT COMPLETED|Overall Study||2
2528480|NCT00670748|6195857|P2|NOT COMPLETED|Overall Study||2
2528481|NCT00670748|6195858|P1|NOT COMPLETED|Overall Study||3
2528482|NCT00670748|6195855|P4|COMPLETED|Overall Study||4
2528483|NCT00670748|6195856|P3|COMPLETED|Overall Study||5
2528484|NCT00670748|6195857|P2|COMPLETED|Overall Study||14
2528485|NCT00670748|6195858|P1|COMPLETED|Overall Study||14
2528486|NCT00670748|6195855|P4|STARTED|Overall Study||5
2528487|NCT00670748|6195856|P3|STARTED|Overall Study||7
2528488|NCT00670748|6195857|P2|STARTED|Overall Study||16
2528489|NCT00670748|6195858|P1|STARTED|Overall Study||17
2528490|NCT00670709|6195878|P2|NOT COMPLETED|Overall Study||0
2528491|NCT00670709|6195879|P1|NOT COMPLETED|Overall Study||0
2528492|NCT00670709|6195878|P2|COMPLETED|Overall Study||15
2528493|NCT00670709|6195879|P1|COMPLETED|Overall Study||27
2528494|NCT00670709|6195878|P2|STARTED|Overall Study||15
2528495|NCT00670709|6195879|P1|STARTED|Overall Study||27
2528496|NCT00670631|6195887|P1|NOT COMPLETED|Overall Study||0
2528497|NCT00670631|6195887|P1|COMPLETED|Overall Study||0
2528498|NCT00670631|6195887|P1|STARTED|Overall Study||0
2528499|NCT00670540|6195893|P1|NOT COMPLETED|Overall Study||3325
2528500|NCT00670540|6195893|P1|COMPLETED|Overall Study|total recruited for the follow up|4931
2528501|NCT00670540|6195893|P1|STARTED|Overall Study||8256
2528502|NCT00670488|6195913|P10|NOT COMPLETED|Overall Study||2
2528503|NCT00670488|6195914|P9|NOT COMPLETED|Overall Study||3
2528504|NCT00670488|6195915|P8|NOT COMPLETED|Overall Study||3
2528505|NCT00670488|6195916|P7|NOT COMPLETED|Overall Study||17
2528506|NCT00670488|6195917|P6|NOT COMPLETED|Overall Study||5
2528507|NCT00670488|6195918|P5|NOT COMPLETED|Overall Study||3
2528508|NCT00670488|6195919|P4|NOT COMPLETED|Overall Study||7
2528509|NCT00670488|6195920|P3|NOT COMPLETED|Overall Study||3
2528510|NCT00670488|6195921|P2|NOT COMPLETED|Overall Study||58
2528511|NCT00670488|6195922|P1|NOT COMPLETED|Overall Study||3
2528512|NCT00670488|6195913|P10|COMPLETED|Overall Study||0
2528513|NCT00670488|6195914|P9|COMPLETED|Overall Study||0
2528514|NCT00670488|6195915|P8|COMPLETED|Overall Study||0
2528515|NCT00670488|6195916|P7|COMPLETED|Overall Study||0
2528516|NCT00670488|6195917|P6|COMPLETED|Overall Study||0
2528517|NCT00670488|6195918|P5|COMPLETED|Overall Study||0
2528518|NCT00670488|6195919|P4|COMPLETED|Overall Study||0
2528519|NCT00670488|6195920|P3|COMPLETED|Overall Study||0
2528520|NCT00670488|6195921|P2|COMPLETED|Overall Study||0
2528521|NCT00670488|6195922|P1|COMPLETED|Overall Study||0
2528522|NCT00670488|6195913|P10|STARTED|Overall Study||2
2528523|NCT00670488|6195914|P9|STARTED|Overall Study||3
2528524|NCT00670488|6195915|P8|STARTED|Overall Study||3
2528525|NCT00670488|6195916|P7|STARTED|Overall Study||17
2528526|NCT00670488|6195917|P6|STARTED|Overall Study||5
2528527|NCT00670488|6195918|P5|STARTED|Overall Study||3
2528528|NCT00670488|6195919|P4|STARTED|Overall Study||7
2528529|NCT00670488|6195920|P3|STARTED|Overall Study||3
2528530|NCT00670488|6195921|P2|STARTED|Overall Study||58
2528531|NCT00670488|6195922|P1|STARTED|Overall Study||3
2528532|NCT00670462|6196076|P2|NOT COMPLETED|Overall Study||31
2528533|NCT00670462|6196077|P1|NOT COMPLETED|Overall Study||30
2528534|NCT00670462|6196076|P2|COMPLETED|Overall Study||76
2528535|NCT00670462|6196077|P1|COMPLETED|Overall Study||76
2528536|NCT00670462|6196076|P2|STARTED|Overall Study||107
2528537|NCT00670462|6196077|P1|STARTED|Overall Study||106
2528538|NCT00670449|6196109|P4|NOT COMPLETED|Overall Study||8
2528539|NCT00670449|6196110|P3|NOT COMPLETED|Overall Study||9
2528540|NCT00670449|6196111|P2|NOT COMPLETED|Overall Study||10
2528541|NCT00670449|6196112|P1|NOT COMPLETED|Overall Study||9
2528542|NCT00670449|6196109|P4|COMPLETED|Overall Study||15
2528543|NCT00670449|6196110|P3|COMPLETED|Overall Study||18
2528544|NCT00670449|6196111|P2|COMPLETED|Overall Study||36
2528545|NCT00670449|6196112|P1|COMPLETED|Overall Study||38
2528546|NCT00670449|6196109|P4|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|17
2528547|NCT00670449|6196110|P3|Switched to 0.5mg (Open Label)|Overall Study||23
2528548|NCT00670449|6196111|P2|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|41
2528549|NCT00670449|6196112|P1|Switched to 0.5mg (Open Label)|Overall Study||45
2528550|NCT00670449|6196109|P4|STARTED|Overall Study||23
2528551|NCT00670449|6196110|P3|STARTED|Overall Study||27
2528552|NCT00670449|6196111|P2|STARTED|Overall Study||46
2528553|NCT00670449|6196112|P1|STARTED|Overall Study||47
2528554|NCT00670306|6196136|P1|NOT COMPLETED|Overall Study||55
2528555|NCT00670306|6196136|P1|COMPLETED|Overall Study||473
2528556|NCT00670306|6196136|P1|STARTED|Overall Study||528
2528557|NCT00670267|6196140|P1|NOT COMPLETED|Overall Study||1
2528558|NCT00670267|6196140|P1|COMPLETED|Overall Study||9
2528559|NCT00670267|6196140|P1|STARTED|Overall Study||10
2528560|NCT00670241|6196151|P3|NOT COMPLETED|Overall Study||27
2528561|NCT00670241|6196152|P2|NOT COMPLETED|Overall Study||21
2528562|NCT00670241|6196153|P1|NOT COMPLETED|Overall Study||12
2528563|NCT00670241|6196151|P3|COMPLETED|Overall Study||64
2528564|NCT00670241|6196152|P2|COMPLETED|Overall Study||163
2528565|NCT00670241|6196153|P1|COMPLETED|Overall Study||171
2528566|NCT00670241|6196151|P3|STARTED|Overall Study||91
2528567|NCT00670241|6196152|P2|STARTED|Overall Study||184
2528568|NCT00670241|6196153|P1|STARTED|Overall Study||183
2528569|NCT00670228|6196175|P2|NOT COMPLETED|Overall Study||3
2528570|NCT00670228|6196176|P1|NOT COMPLETED|Overall Study||5
2528571|NCT00670228|6196175|P2|COMPLETED|Overall Study||12
2528572|NCT00670228|6196176|P1|COMPLETED|Overall Study||13
2528573|NCT00670228|6196175|P2|STARTED|Overall Study||15
2528574|NCT00670228|6196176|P1|STARTED|Overall Study||18
2528575|NCT00670202|6196190|P2|NOT COMPLETED|Overall Study||0
2528576|NCT00670202|6196191|P1|NOT COMPLETED|Overall Study||0
2528577|NCT00670202|6196190|P2|COMPLETED|Overall Study||0
2528578|NCT00670202|6196191|P1|COMPLETED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
2528579|NCT00670202|6196190|P2|STARTED|Overall Study||0
2528580|NCT00670202|6196191|P1|STARTED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
2528581|NCT00670111|6196200|P3|NOT COMPLETED|Six Months to Twelve Months||0
2528582|NCT00670111|6196201|P2|NOT COMPLETED|Six Months to Twelve Months||0
2528583|NCT00670111|6196202|P1|NOT COMPLETED|Six Months to Twelve Months||0
2528584|NCT00670111|6196200|P3|COMPLETED|Six Months to Twelve Months||0
2528585|NCT00670111|6196201|P2|COMPLETED|Six Months to Twelve Months||8
2528586|NCT00670111|6196202|P1|COMPLETED|Six Months to Twelve Months||4
2528587|NCT00670111|6196200|P3|STARTED|Six Months to Twelve Months||0
2528588|NCT00670111|6196201|P2|STARTED|Six Months to Twelve Months||8
2528589|NCT00670111|6196202|P1|STARTED|Six Months to Twelve Months||4
2528590|NCT00670111|6196200|P3|NOT COMPLETED|One Month to Six Months||0
2528591|NCT00670111|6196201|P2|NOT COMPLETED|One Month to Six Months||0
2528592|NCT00670111|6196202|P1|NOT COMPLETED|One Month to Six Months||0
2528593|NCT00670111|6196200|P3|COMPLETED|One Month to Six Months||0
2528594|NCT00670111|6196201|P2|COMPLETED|One Month to Six Months|8 patients in this group completed the 1 month visit; 4 had data eligible for endpoint analysis.|8
2528595|NCT00670111|6196202|P1|COMPLETED|One Month to Six Months|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
2528596|NCT00670111|6196200|P3|STARTED|One Month to Six Months||0
2528597|NCT00670111|6196201|P2|STARTED|One Month to Six Months||8
2528598|NCT00670111|6196202|P1|STARTED|One Month to Six Months||4
2528599|NCT00670111|6196200|P3|NOT COMPLETED|One Month Period B||0
2528600|NCT00670111|6196201|P2|NOT COMPLETED|One Month Period B||0
2528601|NCT00670111|6196202|P1|NOT COMPLETED|One Month Period B||0
2528602|NCT00670111|6196200|P3|COMPLETED|One Month Period B||0
2528603|NCT00670111|6196201|P2|COMPLETED|One Month Period B|8 patients in this group completed the 1 month visit; 6 had data eligible for endpoint analysis.|8
2528604|NCT00670111|6196202|P1|COMPLETED|One Month Period B|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
2528605|NCT00670111|6196200|P3|STARTED|One Month Period B||0
2528606|NCT00670111|6196201|P2|STARTED|One Month Period B||8
2528607|NCT00670111|6196202|P1|STARTED|One Month Period B||4
2528608|NCT00670111|6196200|P3|NOT COMPLETED|One Month Period A||0
2528609|NCT00670111|6196201|P2|NOT COMPLETED|One Month Period A||0
2528610|NCT00670111|6196202|P1|NOT COMPLETED|One Month Period A||0
2528611|NCT00670111|6196200|P3|COMPLETED|One Month Period A||0
2528612|NCT00670111|6196201|P2|COMPLETED|One Month Period A||8
2528613|NCT00670111|6196202|P1|COMPLETED|One Month Period A||4
2528614|NCT00670111|6196200|P3|STARTED|One Month Period A||0
2528615|NCT00670111|6196201|P2|STARTED|One Month Period A||8
2528616|NCT00670111|6196202|P1|STARTED|One Month Period A||4
2528617|NCT00670111|6196200|P3|NOT COMPLETED|Enrollment to One Month||19
2528618|NCT00670111|6196201|P2|NOT COMPLETED|Enrollment to One Month||0
2528619|NCT00670111|6196202|P1|NOT COMPLETED|Enrollment to One Month||1
2528620|NCT00670111|6196200|P3|COMPLETED|Enrollment to One Month||0
2528621|NCT00670111|6196201|P2|COMPLETED|Enrollment to One Month||8
2528622|NCT00670111|6196202|P1|COMPLETED|Enrollment to One Month||4
2528623|NCT00670111|6196200|P3|STARTED|Enrollment to One Month||19
2528624|NCT00670111|6196201|P2|STARTED|Enrollment to One Month||8
2528625|NCT00670111|6196202|P1|STARTED|Enrollment to One Month||5
2528626|NCT00670046|6196212|P2|NOT COMPLETED|Overall Study||2
2528627|NCT00670046|6196213|P1|NOT COMPLETED|Overall Study||1
2528628|NCT00670046|6196212|P2|COMPLETED|Overall Study||6
2528629|NCT00670046|6196213|P1|COMPLETED|Overall Study||6
2528630|NCT00670046|6196212|P2|STARTED|Overall Study||8
2528631|NCT00670046|6196213|P1|STARTED|Overall Study||7
2528632|NCT00670007|6196227|P1|NOT COMPLETED|Overall Study||9
2528633|NCT00670007|6196227|P1|COMPLETED|Overall Study||131
2528634|NCT00670007|6196227|P1|STARTED|Overall Study||140
2528635|NCT00669955|6196254|P2|NOT COMPLETED|Overall Study||27
2528636|NCT00669955|6196255|P1|NOT COMPLETED|Overall Study||14
2528637|NCT00669955|6196254|P2|COMPLETED|Overall Study||195
2528638|NCT00669955|6196255|P1|COMPLETED|Overall Study||204
2528639|NCT00669955|6196254|P2|STARTED|Overall Study||222
2528640|NCT00669955|6196255|P1|STARTED|Overall Study|216 patients received study drug. 2 patients were dispensed study drug but did not take it|218
2528641|NCT00669942|6196285|P12|NOT COMPLETED|Healthy Volunteers||0
2528642|NCT00669942|6196286|P11|NOT COMPLETED|Healthy Volunteers||1
2528643|NCT00669942|6196287|P10|NOT COMPLETED|Healthy Volunteers||0
2528644|NCT00669942|6196288|P9|NOT COMPLETED|Healthy Volunteers||0
2528645|NCT00669942|6196289|P8|NOT COMPLETED|Healthy Volunteers||0
2528646|NCT00669942|6196290|P7|NOT COMPLETED|Healthy Volunteers||0
2528647|NCT00669942|6196291|P6|NOT COMPLETED|Healthy Volunteers||0
2528648|NCT00669942|6196292|P5|NOT COMPLETED|Healthy Volunteers||0
2528649|NCT00669942|6196293|P4|NOT COMPLETED|Healthy Volunteers||0
2528650|NCT00669942|6196294|P3|NOT COMPLETED|Healthy Volunteers||0
2528651|NCT00669942|6196295|P2|NOT COMPLETED|Healthy Volunteers||0
2528652|NCT00669942|6196296|P1|NOT COMPLETED|Healthy Volunteers||0
2528653|NCT00669942|6196285|P12|COMPLETED|Healthy Volunteers||2
2528654|NCT00669942|6196286|P11|COMPLETED|Healthy Volunteers||2
2528655|NCT00669942|6196287|P10|COMPLETED|Healthy Volunteers||3
2528656|NCT00669942|6196288|P9|COMPLETED|Healthy Volunteers||0
2528657|NCT00669942|6196289|P8|COMPLETED|Healthy Volunteers||0
2528658|NCT00669942|6196290|P7|COMPLETED|Healthy Volunteers||0
2528659|NCT00669942|6196291|P6|COMPLETED|Healthy Volunteers||0
2528660|NCT00669942|6196292|P5|COMPLETED|Healthy Volunteers||0
2528661|NCT00669942|6196293|P4|COMPLETED|Healthy Volunteers||0
2528662|NCT00669942|6196294|P3|COMPLETED|Healthy Volunteers||0
2528663|NCT00669942|6196295|P2|COMPLETED|Healthy Volunteers||0
2528664|NCT00669942|6196296|P1|COMPLETED|Healthy Volunteers||0
2528665|NCT00669942|6196285|P12|STARTED|Healthy Volunteers||2
2528666|NCT00669942|6196286|P11|STARTED|Healthy Volunteers||3
2528667|NCT00669942|6196287|P10|STARTED|Healthy Volunteers||3
2528668|NCT00669942|6196288|P9|STARTED|Healthy Volunteers||0
2528669|NCT00669942|6196289|P8|STARTED|Healthy Volunteers||0
2528670|NCT00669942|6196290|P7|STARTED|Healthy Volunteers||0
2528671|NCT00669942|6196291|P6|STARTED|Healthy Volunteers||0
2528672|NCT00669942|6196292|P5|STARTED|Healthy Volunteers||0
2528673|NCT00669942|6196293|P4|STARTED|Healthy Volunteers||0
2528674|NCT00669942|6196294|P3|STARTED|Healthy Volunteers||0
2528675|NCT00669942|6196295|P2|STARTED|Healthy Volunteers||0
2528676|NCT00669942|6196296|P1|STARTED|Healthy Volunteers||0
2528677|NCT00669942|6196285|P12|NOT COMPLETED|Parts 2 and 3||0
2528678|NCT00669942|6196286|P11|NOT COMPLETED|Parts 2 and 3||0
2528679|NCT00669942|6196287|P10|NOT COMPLETED|Parts 2 and 3||0
2528680|NCT00669942|6196288|P9|NOT COMPLETED|Parts 2 and 3||3
2528681|NCT00669942|6196289|P8|NOT COMPLETED|Parts 2 and 3||2
2528682|NCT00669942|6196290|P7|NOT COMPLETED|Parts 2 and 3||0
2528683|NCT00669942|6196291|P6|NOT COMPLETED|Parts 2 and 3||2
2528684|NCT00669942|6196292|P5|NOT COMPLETED|Parts 2 and 3||0
2528685|NCT00669942|6196293|P4|NOT COMPLETED|Parts 2 and 3||0
2528686|NCT00669942|6196294|P3|NOT COMPLETED|Parts 2 and 3||0
2528687|NCT00669942|6196295|P2|NOT COMPLETED|Parts 2 and 3||0
2528688|NCT00669942|6196296|P1|NOT COMPLETED|Parts 2 and 3||0
2528689|NCT00669942|6196285|P12|COMPLETED|Parts 2 and 3||0
2528690|NCT00669942|6196286|P11|COMPLETED|Parts 2 and 3||0
2528691|NCT00669942|6196287|P10|COMPLETED|Parts 2 and 3||0
2528692|NCT00669942|6196288|P9|COMPLETED|Parts 2 and 3||23
2528693|NCT00669942|6196289|P8|COMPLETED|Parts 2 and 3||24
2528694|NCT00669942|6196290|P7|COMPLETED|Parts 2 and 3||6
2528695|NCT00669942|6196291|P6|COMPLETED|Parts 2 and 3||4
2528696|NCT00669942|6196292|P5|COMPLETED|Parts 2 and 3||0
2528697|NCT00669942|6196293|P4|COMPLETED|Parts 2 and 3||0
2528698|NCT00669942|6196294|P3|COMPLETED|Parts 2 and 3||0
2528699|NCT00669942|6196295|P2|COMPLETED|Parts 2 and 3||0
2528700|NCT00669942|6196296|P1|COMPLETED|Parts 2 and 3||0
2528701|NCT00669942|6196285|P12|STARTED|Parts 2 and 3||0
2528702|NCT00669942|6196286|P11|STARTED|Parts 2 and 3||0
2528703|NCT00669942|6196287|P10|STARTED|Parts 2 and 3||0
2528704|NCT00669942|6196288|P9|STARTED|Parts 2 and 3||26
2528705|NCT00669942|6196289|P8|STARTED|Parts 2 and 3||26
2528706|NCT00669942|6196290|P7|STARTED|Parts 2 and 3||6
2528707|NCT00669942|6196291|P6|STARTED|Parts 2 and 3||6
2528708|NCT00669942|6196292|P5|STARTED|Parts 2 and 3||0
2528709|NCT00669942|6196293|P4|STARTED|Parts 2 and 3||0
2528710|NCT00669942|6196294|P3|STARTED|Parts 2 and 3||0
2528711|NCT00669942|6196295|P2|STARTED|Parts 2 and 3||0
2528712|NCT00669942|6196296|P1|STARTED|Parts 2 and 3||0
2528713|NCT00669942|6196285|P12|NOT COMPLETED|Part 1||0
2528714|NCT00669942|6196286|P11|NOT COMPLETED|Part 1||0
2528715|NCT00669942|6196287|P10|NOT COMPLETED|Part 1||0
2528716|NCT00669942|6196288|P9|NOT COMPLETED|Part 1||0
2528717|NCT00669942|6196289|P8|NOT COMPLETED|Part 1||0
2528718|NCT00669942|6196290|P7|NOT COMPLETED|Part 1||0
2528719|NCT00669942|6196291|P6|NOT COMPLETED|Part 1||0
2528720|NCT00669942|6196292|P5|NOT COMPLETED|Part 1||0
2528721|NCT00669942|6196293|P4|NOT COMPLETED|Part 1||0
2528722|NCT00669942|6196294|P3|NOT COMPLETED|Part 1||0
2528723|NCT00669942|6196295|P2|NOT COMPLETED|Part 1||0
2528724|NCT00669942|6196296|P1|NOT COMPLETED|Part 1||0
2528725|NCT00669942|6196285|P12|COMPLETED|Part 1||0
2528726|NCT00669942|6196286|P11|COMPLETED|Part 1||0
2528727|NCT00669942|6196287|P10|COMPLETED|Part 1||0
2528728|NCT00669942|6196288|P9|COMPLETED|Part 1||0
2528729|NCT00669942|6196289|P8|COMPLETED|Part 1||0
2528730|NCT00669942|6196290|P7|COMPLETED|Part 1||0
2528731|NCT00669942|6196291|P6|COMPLETED|Part 1||0
2528732|NCT00669942|6196292|P5|COMPLETED|Part 1||8
2528733|NCT00669942|6196293|P4|COMPLETED|Part 1||6
2528734|NCT00669942|6196294|P3|COMPLETED|Part 1||6
2528735|NCT00669942|6196295|P2|COMPLETED|Part 1||6
2528736|NCT00669942|6196296|P1|COMPLETED|Part 1||6
2528737|NCT00669942|6196285|P12|STARTED|Part 1||0
2528738|NCT00669942|6196286|P11|STARTED|Part 1||0
2528739|NCT00669942|6196287|P10|STARTED|Part 1||0
2528740|NCT00669942|6196288|P9|STARTED|Part 1||0
2528741|NCT00669942|6196289|P8|STARTED|Part 1||0
2528742|NCT00669942|6196290|P7|STARTED|Part 1||0
2528743|NCT00669942|6196291|P6|STARTED|Part 1||0
2528744|NCT00669942|6196292|P5|STARTED|Part 1||8
2528745|NCT00669942|6196293|P4|STARTED|Part 1||6
2528746|NCT00669942|6196294|P3|STARTED|Part 1||6
2528747|NCT00669942|6196295|P2|STARTED|Part 1||6
2528748|NCT00669942|6196296|P1|STARTED|Part 1||6
2528749|NCT00669916|6196360|P2|NOT COMPLETED|Overall Study||0
2528750|NCT00669916|6196361|P1|NOT COMPLETED|Overall Study||0
2528751|NCT00669916|6196360|P2|COMPLETED|Overall Study||18
2528752|NCT00669916|6196361|P1|COMPLETED|Overall Study||18
2528753|NCT00669916|6196360|P2|STARTED|Overall Study||18
2528754|NCT00669916|6196361|P1|STARTED|Overall Study||18
2528755|NCT00669903|6196379|P4|NOT COMPLETED|Overall Study||4
2528756|NCT00669903|6196380|P3|NOT COMPLETED|Overall Study||5
2528757|NCT00669903|6196381|P2|NOT COMPLETED|Overall Study||5
2528758|NCT00669903|6196382|P1|NOT COMPLETED|Overall Study||1
2528759|NCT00669903|6196379|P4|COMPLETED|Overall Study||18
2528760|NCT00669903|6196380|P3|COMPLETED|Overall Study||13
2528761|NCT00669903|6196381|P2|COMPLETED|Overall Study||32
2528762|NCT00669903|6196382|P1|COMPLETED|Overall Study||22
2528763|NCT00669903|6196379|P4|Completed Treatment Period|Overall Study||19
2528764|NCT00669903|6196380|P3|Completed Treatment Period|Overall Study||13
2528765|NCT00669903|6196381|P2|Completed Treatment Period|Overall Study||33
2528766|NCT00669903|6196382|P1|Completed Treatment Period|Overall Study||23
2528767|NCT00669903|6196379|P4|STARTED|Overall Study||22
2528768|NCT00669903|6196380|P3|STARTED|Overall Study||18
2528769|NCT00669903|6196381|P2|STARTED|Overall Study||37
2528770|NCT00669903|6196382|P1|STARTED|Overall Study||23
2528771|NCT00669877|6196412|P1|NOT COMPLETED|Overall Study||4
2528772|NCT00669877|6196412|P1|COMPLETED|Overall Study||52
2528773|NCT00669877|6196412|P1|STARTED|Overall Study||56
2528774|NCT00669864|6196417|P1|NOT COMPLETED|Overall Study||9
2528775|NCT00669864|6196417|P1|COMPLETED|Overall Study||284
2528776|NCT00669864|6196417|P1|STARTED|Overall Study||293
2528777|NCT00669682|6196426|P1|NOT COMPLETED|Overall Study||0
2528778|NCT00669682|6196426|P1|COMPLETED|Overall Study||9
2528779|NCT00669682|6196426|P1|STARTED|Overall Study||9
2528780|NCT00669669|6196431|P1|NOT COMPLETED|Overall Study||1
2528781|NCT00669669|6196431|P1|COMPLETED|Overall Study||11
2528782|NCT00669669|6196431|P1|STARTED|Overall Study||12
2528783|NCT00669617|6196436|P5|NOT COMPLETED|Period 5||0
2528784|NCT00669617|6196437|P4|NOT COMPLETED|Period 5||0
2528785|NCT00669617|6196438|P3|NOT COMPLETED|Period 5||0
2528786|NCT00669617|6196439|P2|NOT COMPLETED|Period 5||0
2528787|NCT00669617|6196440|P1|NOT COMPLETED|Period 5||0
2528788|NCT00669617|6196436|P5|COMPLETED|Period 5||17
2528789|NCT00669617|6196437|P4|COMPLETED|Period 5||18
2528790|NCT00669617|6196438|P3|COMPLETED|Period 5||17
2528791|NCT00669617|6196439|P2|COMPLETED|Period 5||17
2528792|NCT00669617|6196440|P1|COMPLETED|Period 5||17
2528793|NCT00669617|6196436|P5|STARTED|Period 5||17
2528794|NCT00669617|6196437|P4|STARTED|Period 5||18
2528795|NCT00669617|6196438|P3|STARTED|Period 5||17
2528796|NCT00669617|6196439|P2|STARTED|Period 5||17
2528797|NCT00669617|6196440|P1|STARTED|Period 5||17
2528798|NCT00669617|6196436|P5|NOT COMPLETED|Period 4||0
2528799|NCT00669617|6196437|P4|NOT COMPLETED|Period 4||0
2528800|NCT00669617|6196438|P3|NOT COMPLETED|Period 4||0
2528801|NCT00669617|6196439|P2|NOT COMPLETED|Period 4||0
2528802|NCT00669617|6196440|P1|NOT COMPLETED|Period 4||0
2528803|NCT00669617|6196436|P5|COMPLETED|Period 4||17
2528804|NCT00669617|6196437|P4|COMPLETED|Period 4||18
2528805|NCT00669617|6196438|P3|COMPLETED|Period 4||17
2528806|NCT00669617|6196439|P2|COMPLETED|Period 4||17
2528807|NCT00669617|6196440|P1|COMPLETED|Period 4||17
2528808|NCT00669617|6196436|P5|STARTED|Period 4||17
2528809|NCT00669617|6196437|P4|STARTED|Period 4||18
2528810|NCT00669617|6196438|P3|STARTED|Period 4||17
2528811|NCT00669617|6196439|P2|STARTED|Period 4||17
2528812|NCT00669617|6196440|P1|STARTED|Period 4||17
2528813|NCT00669617|6196436|P5|NOT COMPLETED|Period 3||0
2528814|NCT00669617|6196437|P4|NOT COMPLETED|Period 3||0
2528815|NCT00669617|6196438|P3|NOT COMPLETED|Period 3||0
2528816|NCT00669617|6196439|P2|NOT COMPLETED|Period 3||0
2528817|NCT00669617|6196440|P1|NOT COMPLETED|Period 3||1
2528818|NCT00669617|6196436|P5|COMPLETED|Period 3||17
2528819|NCT00669617|6196437|P4|COMPLETED|Period 3||18
2528820|NCT00669617|6196438|P3|COMPLETED|Period 3||17
2528821|NCT00669617|6196439|P2|COMPLETED|Period 3||17
2528822|NCT00669617|6196440|P1|COMPLETED|Period 3||17
2528823|NCT00669617|6196436|P5|STARTED|Period 3||17
2528824|NCT00669617|6196437|P4|STARTED|Period 3||18
2528825|NCT00669617|6196438|P3|STARTED|Period 3||17
2528826|NCT00669617|6196439|P2|STARTED|Period 3||17
2528827|NCT00669617|6196440|P1|STARTED|Period 3||18
2528828|NCT00669617|6196436|P5|NOT COMPLETED|Period 2||0
2528829|NCT00669617|6196437|P4|NOT COMPLETED|Period 2||0
2528830|NCT00669617|6196438|P3|NOT COMPLETED|Period 2||0
2528831|NCT00669617|6196439|P2|NOT COMPLETED|Period 2||0
2528832|NCT00669617|6196440|P1|NOT COMPLETED|Period 2||0
2528833|NCT00669617|6196436|P5|COMPLETED|Period 2||17
2528834|NCT00669617|6196437|P4|COMPLETED|Period 2||18
2528835|NCT00669617|6196438|P3|COMPLETED|Period 2||17
2528836|NCT00669617|6196439|P2|COMPLETED|Period 2||17
2528837|NCT00669617|6196440|P1|COMPLETED|Period 2||18
2528838|NCT00669617|6196436|P5|STARTED|Period 2||17
2528839|NCT00669617|6196437|P4|STARTED|Period 2||18
2528840|NCT00669617|6196438|P3|STARTED|Period 2||17
2528841|NCT00669617|6196439|P2|STARTED|Period 2||17
2528842|NCT00669617|6196440|P1|STARTED|Period 2||18
2528843|NCT00669617|6196436|P5|NOT COMPLETED|Period 1||1
2528844|NCT00669617|6196437|P4|NOT COMPLETED|Period 1||0
2528845|NCT00669617|6196438|P3|NOT COMPLETED|Period 1||1
2528846|NCT00669617|6196439|P2|NOT COMPLETED|Period 1||0
2528847|NCT00669617|6196440|P1|NOT COMPLETED|Period 1||0
2528848|NCT00669617|6196436|P5|COMPLETED|Period 1||17
2528849|NCT00669617|6196437|P4|COMPLETED|Period 1||18
2528850|NCT00669617|6196438|P3|COMPLETED|Period 1||17
2528851|NCT00669617|6196439|P2|COMPLETED|Period 1||17
2528852|NCT00669617|6196440|P1|COMPLETED|Period 1||18
2528853|NCT00669617|6196436|P5|STARTED|Period 1||18
2528854|NCT00669617|6196437|P4|STARTED|Period 1||18
2528855|NCT00669617|6196438|P3|STARTED|Period 1||18
2528856|NCT00669617|6196439|P2|STARTED|Period 1||17
2528857|NCT00669617|6196440|P1|STARTED|Period 1||18
2528858|NCT00669578|6196454|P2|NOT COMPLETED|Overall Study||0
2528859|NCT00669578|6196455|P1|NOT COMPLETED|Overall Study||0
2528860|NCT00669578|6196454|P2|COMPLETED|Overall Study||65
2528861|NCT00669578|6196455|P1|COMPLETED|Overall Study||12
2528862|NCT00669578|6196454|P2|STARTED|Overall Study||65
2528863|NCT00669578|6196455|P1|STARTED|Overall Study||12
2528864|NCT00669552|6196468|P1|NOT COMPLETED|Overall Study||0
2528865|NCT00669552|6196468|P1|COMPLETED|Overall Study||11
2528866|NCT00669552|6196468|P1|STARTED|Overall Study||11
2528867|NCT00669539|6196474|P2|NOT COMPLETED|Overall Study||9
2528868|NCT00669539|6196475|P1|NOT COMPLETED|Overall Study||8
2528869|NCT00669539|6196474|P2|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|43
2528870|NCT00669539|6196475|P1|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|86
2528871|NCT00669539|6196474|P2|STARTED|Overall Study||52
2528872|NCT00669539|6196475|P1|STARTED|Overall Study||94
2528873|NCT00669461|6196481|P1|NOT COMPLETED|Overall Study||0
2528874|NCT00669461|6196481|P1|COMPLETED|Overall Study||1
2528875|NCT00669461|6196481|P1|STARTED|Overall Study||1
2528876|NCT00669396|6196488|P2|NOT COMPLETED|Overall Study||12
2528877|NCT00669396|6196489|P1|NOT COMPLETED|Overall Study||10
2528878|NCT00669396|6196488|P2|COMPLETED|Overall Study||22
2528879|NCT00669396|6196489|P1|COMPLETED|Overall Study||13
2528880|NCT00669396|6196488|P2|STARTED|Overall Study||34
2528881|NCT00669396|6196489|P1|STARTED|Overall Study||23
2528882|NCT00669383|6196503|P2|NOT COMPLETED|Overall Study||0
2528883|NCT00669383|6196504|P1|NOT COMPLETED|Overall Study||0
2528884|NCT00669383|6196503|P2|COMPLETED|Overall Study||41
2528885|NCT00669383|6196504|P1|COMPLETED|Overall Study||44
2528886|NCT00669383|6196503|P2|STARTED|Overall Study||41
2528887|NCT00669383|6196504|P1|STARTED|Overall Study||44
2528888|NCT00669331|6196516|P2|NOT COMPLETED|Blinded Treatment Period||39
2528889|NCT00669331|6196517|P1|NOT COMPLETED|Blinded Treatment Period||42
2528890|NCT00669331|6196516|P2|COMPLETED|Blinded Treatment Period||189
2528891|NCT00669331|6196517|P1|COMPLETED|Blinded Treatment Period||191
2528892|NCT00669331|6196516|P2|STARTED|Blinded Treatment Period||228
2528893|NCT00669331|6196517|P1|STARTED|Blinded Treatment Period||233
2528894|NCT00669331|6196516|P2|NOT COMPLETED|Randomisation to First Dose||13
2528895|NCT00669331|6196517|P1|NOT COMPLETED|Randomisation to First Dose||11
2528896|NCT00669331|6196516|P2|COMPLETED|Randomisation to First Dose||228
2528897|NCT00669331|6196517|P1|COMPLETED|Randomisation to First Dose||233
2528898|NCT00669331|6196516|P2|STARTED|Randomisation to First Dose||241
2528899|NCT00669331|6196517|P1|STARTED|Randomisation to First Dose||244
2528900|NCT00669318|6196559|P1|NOT COMPLETED|Overall Study||2
2528901|NCT00669318|6196559|P1|COMPLETED|Overall Study||39
2528902|NCT00669318|6196559|P1|STARTED|Overall Study||41
2528903|NCT00669279|6196569|P2|NOT COMPLETED|Overall Study||0
2528904|NCT00669279|6196570|P1|NOT COMPLETED|Overall Study||0
2528905|NCT00669279|6196569|P2|COMPLETED|Overall Study||19
2528906|NCT00669279|6196570|P1|COMPLETED|Overall Study||22
2528907|NCT00669279|6196569|P2|STARTED|Overall Study||19
2528908|NCT00669279|6196570|P1|STARTED|Overall Study||22
2528909|NCT00669240|6196576|P1|NOT COMPLETED|Overall Study||165
2528910|NCT00669240|6196576|P1|COMPLETED|Overall Study||402
2528911|NCT00669240|6196576|P1|Received Treatment|Overall Study||551
2528912|NCT00669240|6196576|P1|Assigned to Treatment|Overall Study||566
2528913|NCT00669240|6196576|P1|STARTED|Overall Study||567
2528914|NCT00669214|6196592|P2|NOT COMPLETED|Open-Label Treatment Period (Week 24)||9
2528915|NCT00669214|6196593|P1|NOT COMPLETED|Open-Label Treatment Period (Week 24)||4
2528916|NCT00669214|6196592|P2|COMPLETED|Open-Label Treatment Period (Week 24)||46
2528917|NCT00669214|6196593|P1|COMPLETED|Open-Label Treatment Period (Week 24)||18
2528918|NCT00669214|6196592|P2|STARTED|Open-Label Treatment Period (Week 24)||55
2528919|NCT00669214|6196593|P1|STARTED|Open-Label Treatment Period (Week 24)||22
2528920|NCT00669214|6196592|P2|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||7
2528921|NCT00669214|6196593|P1|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||5
2528922|NCT00669214|6196592|P2|COMPLETED|Double-Blind Treatment Period (Week 12)||55
2528923|NCT00669214|6196593|P1|COMPLETED|Double-Blind Treatment Period (Week 12)||22
2528924|NCT00669214|6196592|P2|STARTED|Double-Blind Treatment Period (Week 12)||62
2528925|NCT00669214|6196593|P1|STARTED|Double-Blind Treatment Period (Week 12)||27
2528926|NCT00669162|6196625|P1|NOT COMPLETED|Overall Study||1
2528927|NCT00669162|6196625|P1|COMPLETED|Overall Study||26
2528928|NCT00669162|6196625|P1|STARTED|Overall Study||27
2528929|NCT00669110|6196631|P2|NOT COMPLETED|Overall Study||13
2528930|NCT00669110|6196632|P1|NOT COMPLETED|Overall Study||8
2528931|NCT00669110|6196631|P2|COMPLETED|Overall Study||7
2528932|NCT00669110|6196632|P1|COMPLETED|Overall Study||12
2528933|NCT00669110|6196631|P2|STARTED|Overall Study||20
2528934|NCT00669110|6196632|P1|STARTED|Overall Study||20
2528935|NCT00669071|6196668|P1|NOT COMPLETED|Overall Study||4
2528936|NCT00669071|6196668|P1|COMPLETED|Overall Study||52
2528937|NCT00669071|6196668|P1|STARTED|Overall Study||56
2528938|NCT00669032|6196689|P2|NOT COMPLETED|Overall Study||59
2528939|NCT00669032|6196690|P1|NOT COMPLETED|Overall Study||44
2528940|NCT00669032|6196689|P2|COMPLETED|Overall Study||94
2528941|NCT00669032|6196690|P1|COMPLETED|Overall Study||109
2528942|NCT00669032|6196689|P2|STARTED|Overall Study||153
2528943|NCT00669032|6196690|P1|STARTED|Overall Study||153
2528944|NCT00669019|6196718|P1|NOT COMPLETED|Overall Study||0
2528945|NCT00669019|6196718|P1|COMPLETED|Overall Study||23
2528946|NCT00669019|6196718|P1|STARTED|Overall Study||23
2528947|NCT00668902|6196726|P3|NOT COMPLETED|Overall Study||0
2528948|NCT00668902|6196727|P2|NOT COMPLETED|Overall Study||0
2528949|NCT00668902|6196728|P1|NOT COMPLETED|Overall Study||0
2528950|NCT00668902|6196726|P3|COMPLETED|Overall Study||5
2528951|NCT00668902|6196727|P2|COMPLETED|Overall Study||10
2528952|NCT00668902|6196728|P1|COMPLETED|Overall Study||10
2528953|NCT00668902|6196726|P3|STARTED|Overall Study||5
2528954|NCT00668902|6196727|P2|STARTED|Overall Study||10
2528955|NCT00668902|6196728|P1|STARTED|Overall Study||10
2528956|NCT00668863|6196736|P1|NOT COMPLETED|Overall Study||71
2528957|NCT00668863|6196736|P1|COMPLETED|Overall Study||0
2528958|NCT00668863|6196736|P1|STARTED|Overall Study||71
2528959|NCT00668811|6196755|P1|NOT COMPLETED|Overall Study||0
2528960|NCT00668811|6196755|P1|COMPLETED|Overall Study||23
2528961|NCT00668811|6196755|P1|STARTED|Overall Study||23
2528962|NCT00668785|6196760|P1|NOT COMPLETED|Overall Study||0
2528963|NCT00668785|6196760|P1|COMPLETED|Overall Study||6
2528964|NCT00668785|6196760|P1|STARTED|Overall Study||6
2528965|NCT00668746|6196768|P2|NOT COMPLETED|Overall Study||1
2528966|NCT00668746|6196769|P1|NOT COMPLETED|Overall Study||2
2528967|NCT00668746|6196768|P2|COMPLETED|Overall Study||11
2528968|NCT00668746|6196769|P1|COMPLETED|Overall Study||21
2528969|NCT00668746|6196768|P2|STARTED|Overall Study||12
2528970|NCT00668746|6196769|P1|STARTED|Overall Study||23
2528971|NCT00668733|6196789|P2|NOT COMPLETED|Overall Study||7
2528972|NCT00668733|6196790|P1|NOT COMPLETED|Overall Study||2
2528973|NCT00668733|6196789|P2|COMPLETED|Overall Study||83
2528974|NCT00668733|6196790|P1|COMPLETED|Overall Study||87
2528975|NCT00668733|6196789|P2|STARTED|Overall Study||90
2528976|NCT00668733|6196790|P1|STARTED|Overall Study||89
2528977|NCT00668564|6196796|P1|NOT COMPLETED|Overall Study||0
2528978|NCT00668564|6196796|P1|COMPLETED|Overall Study||18
2528979|NCT00668564|6196796|P1|STARTED|Overall Study||18
2528980|NCT00668525|6196804|P3|NOT COMPLETED|Overall Study||53
2528981|NCT00668525|6196805|P2|NOT COMPLETED|Overall Study||93
2528982|NCT00668525|6196806|P1|NOT COMPLETED|Overall Study||77
2528983|NCT00668525|6196804|P3|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|167
2528984|NCT00668525|6196805|P2|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|239
2528985|NCT00668525|6196806|P1|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|248
2528986|NCT00668525|6196804|P3|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|220
2528987|NCT00668525|6196805|P2|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|332
2528988|NCT00668525|6196806|P1|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|325
2528989|NCT00668434|6196819|P2|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||11
2528990|NCT00668434|6196820|P1|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||22
2528991|NCT00668434|6196819|P2|COMPLETED|Secondary Outcome Time Point (52 Weeks)||77
2528992|NCT00668434|6196820|P1|COMPLETED|Secondary Outcome Time Point (52 Weeks)||157
2528993|NCT00668434|6196819|P2|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|88
2528994|NCT00668434|6196820|P1|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|179
2528995|NCT00668434|6196819|P2|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||0
2528996|NCT00668434|6196820|P1|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||2
2528997|NCT00668434|6196819|P2|COMPLETED|Primary Outcome Time Point (3 Weeks)||88
2528998|NCT00668434|6196820|P1|COMPLETED|Primary Outcome Time Point (3 Weeks)||179
2528999|NCT00668434|6196819|P2|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|88
2529000|NCT00668434|6196820|P1|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|181
2529001|NCT00668395|6196835|P3|NOT COMPLETED|Overall Study||1
2529002|NCT00668395|6196836|P2|NOT COMPLETED|Overall Study||6
2529003|NCT00668395|6196837|P1|NOT COMPLETED|Overall Study||6
2529004|NCT00668395|6196835|P3|COMPLETED|Overall Study||5
2529005|NCT00668395|6196836|P2|COMPLETED|Overall Study||16
2529006|NCT00668395|6196837|P1|COMPLETED|Overall Study||39
2529007|NCT00668395|6196835|P3|STARTED|Overall Study||6
2529008|NCT00668395|6196836|P2|STARTED|Overall Study||22
2529009|NCT00668395|6196837|P1|STARTED|Overall Study||45
2529010|NCT00668382|6196845|P1|NOT COMPLETED|Overall Study||0
2529011|NCT00668382|6196845|P1|COMPLETED|Overall Study||11
2529012|NCT00668382|6196845|P1|STARTED|Overall Study|beginning of trial|11
2529013|NCT00668317|6196849|P1|NOT COMPLETED|Overall Study||2
2529014|NCT00668317|6196849|P1|COMPLETED|Overall Study||3
2529015|NCT00668317|6196849|P1|STARTED|Overall Study||5
2529016|NCT00668265|6196855|P2|NOT COMPLETED|Overall Study||5
2529017|NCT00668265|6196856|P1|NOT COMPLETED|Overall Study||9
2529018|NCT00668265|6196855|P2|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
2529019|NCT00668265|6196856|P1|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
2529020|NCT00668265|6196855|P2|STARTED|Overall Study||5
2529021|NCT00668265|6196856|P1|STARTED|Overall Study||9
2529022|NCT00668200|6196864|P1|NOT COMPLETED|Overall Study||3
2529023|NCT00668200|6196864|P1|COMPLETED|Overall Study||77
2529024|NCT00668200|6196864|P1|Intent to Treat (ITT)|Overall Study||80
2529025|NCT00668200|6196864|P1|Safety Population|Overall Study|1 patient was not included in the ITT patient was enrolled in error|81
2529026|NCT00668200|6196864|P1|STARTED|Overall Study||80
2529027|NCT00668148|6196870|P1|NOT COMPLETED|Overall Study||10
2529028|NCT00668148|6196870|P1|COMPLETED|Overall Study||103
2529029|NCT00668148|6196870|P1|Received at Least 1 Dose of Study Drug|Overall Study||111
2529030|NCT00668148|6196870|P1|STARTED|Overall Study||113
2529031|NCT00667992|6196909|P2|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
2529032|NCT00667992|6196910|P1|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
2529033|NCT00667992|6196909|P2|COMPLETED|Forth Intervention 400 Mcg Twice Daily||35
2529034|NCT00667992|6196910|P1|COMPLETED|Forth Intervention 400 Mcg Twice Daily||33
2529035|NCT00667992|6196909|P2|STARTED|Forth Intervention 400 Mcg Twice Daily||35
2529036|NCT00667992|6196910|P1|STARTED|Forth Intervention 400 Mcg Twice Daily||33
2529037|NCT00667992|6196909|P2|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
2529038|NCT00667992|6196910|P1|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
2529039|NCT00667992|6196909|P2|COMPLETED|Third Intervention 100 Mcg Twice Daily||35
2529040|NCT00667992|6196910|P1|COMPLETED|Third Intervention 100 Mcg Twice Daily||33
2529041|NCT00667992|6196909|P2|STARTED|Third Intervention 100 Mcg Twice Daily||36
2529042|NCT00667992|6196910|P1|STARTED|Third Intervention 100 Mcg Twice Daily||34
2529043|NCT00667992|6196909|P2|NOT COMPLETED|Wash-out||5
2529044|NCT00667992|6196910|P1|NOT COMPLETED|Wash-out||7
2529045|NCT00667992|6196909|P2|COMPLETED|Wash-out||36
2529046|NCT00667992|6196910|P1|COMPLETED|Wash-out||34
2529047|NCT00667992|6196909|P2|STARTED|Wash-out||41
2529048|NCT00667992|6196910|P1|STARTED|Wash-out||41
2529049|NCT00667992|6196909|P2|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||4
2529050|NCT00667992|6196910|P1|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||3
2529051|NCT00667992|6196909|P2|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
2529052|NCT00667992|6196910|P1|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
2529053|NCT00667992|6196909|P2|STARTED|Second Intervention 400 Mcg Twice Daily||45
2529054|NCT00667992|6196910|P1|STARTED|Second Intervention 400 Mcg Twice Daily||44
2529055|NCT00667992|6196909|P2|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
2529056|NCT00667992|6196910|P1|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
2529057|NCT00667992|6196909|P2|COMPLETED|First Intervention 100 Mcg Twice Daily||45
2529058|NCT00667992|6196910|P1|COMPLETED|First Intervention 100 Mcg Twice Daily||44
2529059|NCT00667992|6196909|P2|STARTED|First Intervention 100 Mcg Twice Daily||50
2529060|NCT00667992|6196910|P1|STARTED|First Intervention 100 Mcg Twice Daily||49
2529061|NCT00667875|6196967|P3|NOT COMPLETED|Overall Study||13
2529062|NCT00667875|6196968|P2|NOT COMPLETED|Overall Study||11
2529063|NCT00667875|6196969|P1|NOT COMPLETED|Overall Study||10
2529064|NCT00667875|6196967|P3|COMPLETED|Overall Study||8
2529065|NCT00667875|6196968|P2|COMPLETED|Overall Study||10
2529066|NCT00667875|6196969|P1|COMPLETED|Overall Study|Subjects who dropped out during treatment are considered completed if they provide end of study data|13
2529067|NCT00667875|6196967|P3|Subjects Included in Analysisd|Overall Study||19
2529068|NCT00667875|6196968|P2|Subjects Included in Analysisd|Overall Study||21
2529069|NCT00667875|6196969|P1|Subjects Included in Analysisd|Overall Study||20
2529070|NCT00667875|6196967|P3|STARTED|Overall Study|2 subjects had no data following randomization and were excluded from the analysis.|21
2529071|NCT00667875|6196968|P2|STARTED|Overall Study||21
2529072|NCT00667875|6196969|P1|STARTED|Overall Study|3 subjects had no data after randomization and were excluded from analysis|23
2529073|NCT00667849|6196988|P2|NOT COMPLETED|Overall Study||121
2529074|NCT00667849|6196989|P1|NOT COMPLETED|Overall Study||108
2529075|NCT00667849|6196988|P2|COMPLETED|Overall Study||130
2529076|NCT00667849|6196989|P1|COMPLETED|Overall Study||142
2529077|NCT00667849|6196988|P2|STARTED|Overall Study||251
2529078|NCT00667849|6196989|P1|STARTED|Overall Study||250
2529079|NCT00667810|6197003|P4|NOT COMPLETED|Overall Study||2
2529080|NCT00667810|6197004|P3|NOT COMPLETED|Overall Study||222
2529081|NCT00667810|6197005|P2|NOT COMPLETED|Overall Study||170
2529082|NCT00667810|6197006|P1|NOT COMPLETED|Overall Study||167
2529083|NCT00667810|6197003|P4|COMPLETED|Overall Study||9
2529084|NCT00667810|6197004|P3|COMPLETED|Overall Study||124
2529085|NCT00667810|6197005|P2|COMPLETED|Overall Study||94
2529086|NCT00667810|6197006|P1|COMPLETED|Overall Study||102
2529087|NCT00667810|6197003|P4|Treated|Overall Study||11
2529088|NCT00667810|6197004|P3|Treated|Overall Study||344
2529089|NCT00667810|6197005|P2|Treated|Overall Study||263
2529090|NCT00667810|6197006|P1|Treated|Overall Study||267
2529091|NCT00667810|6197003|P4|STARTED|Overall Study||11
2529092|NCT00667810|6197004|P3|STARTED|Overall Study||346
2529093|NCT00667810|6197005|P2|STARTED|Overall Study||264
2529094|NCT00667810|6197006|P1|STARTED|Overall Study||269
2529095|NCT00667745|6197065|P2|NOT COMPLETED|Overall Study||21
2529096|NCT00667745|6197066|P1|NOT COMPLETED|Overall Study||25
2529097|NCT00667745|6197065|P2|COMPLETED|Overall Study||121
2529098|NCT00667745|6197066|P1|COMPLETED|Overall Study||116
2529099|NCT00667745|6197065|P2|STARTED|Overall Study||142
2529100|NCT00667745|6197066|P1|STARTED|Overall Study||141
2529101|NCT00667732|6197082|P3|NOT COMPLETED|Extension (26 Weeks)||0
2529102|NCT00667732|6197083|P2|NOT COMPLETED|Extension (26 Weeks)||0
2529103|NCT00667732|6197084|P1|NOT COMPLETED|Extension (26 Weeks)||0
2529104|NCT00667732|6197082|P3|COMPLETED|Extension (26 Weeks)||17
2529105|NCT00667732|6197083|P2|COMPLETED|Extension (26 Weeks)||14
2529106|NCT00667732|6197084|P1|COMPLETED|Extension (26 Weeks)||0
2529107|NCT00667732|6197082|P3|STARTED|Extension (26 Weeks)||17
2529108|NCT00667732|6197083|P2|STARTED|Extension (26 Weeks)||14
2529109|NCT00667732|6197084|P1|STARTED|Extension (26 Weeks)||0
2529110|NCT00667732|6197082|P3|NOT COMPLETED|Randomization (24 Weeks)||0
2529111|NCT00667732|6197083|P2|NOT COMPLETED|Randomization (24 Weeks)||1
2529112|NCT00667732|6197084|P1|NOT COMPLETED|Randomization (24 Weeks)||0
2529113|NCT00667732|6197082|P3|COMPLETED|Randomization (24 Weeks)||17
2529114|NCT00667732|6197083|P2|COMPLETED|Randomization (24 Weeks)||16
2529115|NCT00667732|6197084|P1|COMPLETED|Randomization (24 Weeks)||0
2529116|NCT00667732|6197082|P3|Participants Enrolled in Substudy|Randomization (24 Weeks)||9
2529117|NCT00667732|6197083|P2|Participants Enrolled in Substudy|Randomization (24 Weeks)||11
2529118|NCT00667732|6197084|P1|Participants Enrolled in Substudy|Randomization (24 Weeks)||0
2529119|NCT00667732|6197082|P3|STARTED|Randomization (24 Weeks)||17
2529120|NCT00667732|6197083|P2|STARTED|Randomization (24 Weeks)||17
2529121|NCT00667732|6197084|P1|STARTED|Randomization (24 Weeks)||0
2529122|NCT00667732|6197082|P3|NOT COMPLETED|Run -In (8 Weeks)||0
2529123|NCT00667732|6197083|P2|NOT COMPLETED|Run -In (8 Weeks)||0
2529124|NCT00667732|6197084|P1|NOT COMPLETED|Run -In (8 Weeks)||7
2529125|NCT00667732|6197082|P3|COMPLETED|Run -In (8 Weeks)||0
2529126|NCT00667732|6197083|P2|COMPLETED|Run -In (8 Weeks)||0
2529127|NCT00667732|6197084|P1|COMPLETED|Run -In (8 Weeks)||34
2529128|NCT00667732|6197082|P3|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
2529129|NCT00667732|6197083|P2|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
2529130|NCT00667732|6197084|P1|Participants Enrolled in Substudy|Run -In (8 Weeks)||20
2529131|NCT00667732|6197082|P3|STARTED|Run -In (8 Weeks)||0
2529132|NCT00667732|6197083|P2|STARTED|Run -In (8 Weeks)||0
2529133|NCT00667732|6197084|P1|STARTED|Run -In (8 Weeks)||41
2529134|NCT00667693|6197097|P2|NOT COMPLETED|Overall Study||2
2529135|NCT00667693|6197098|P1|NOT COMPLETED|Overall Study||0
2529136|NCT00667693|6197097|P2|COMPLETED|Overall Study||50
2529137|NCT00667693|6197098|P1|COMPLETED|Overall Study||49
2529138|NCT00667693|6197097|P2|STARTED|Overall Study||52
2529139|NCT00667693|6197098|P1|STARTED|Overall Study||49
2529140|NCT00667615|6197112|P1|NOT COMPLETED|Overall Study||0
2529141|NCT00667615|6197112|P1|COMPLETED|Overall Study||30
2529142|NCT00667615|6197112|P1|STARTED|Overall Study||30
2529143|NCT00667602|6197120|P3|NOT COMPLETED|Overall Study||18
2529144|NCT00667602|6197121|P2|NOT COMPLETED|Overall Study||15
2529145|NCT00667602|6197122|P1|NOT COMPLETED|Overall Study||8
2529146|NCT00667602|6197120|P3|COMPLETED|Overall Study||197
2529147|NCT00667602|6197121|P2|COMPLETED|Overall Study||213
2529148|NCT00667602|6197122|P1|COMPLETED|Overall Study||211
2529149|NCT00667602|6197120|P3|STARTED|Overall Study||215
2529150|NCT00667602|6197121|P2|STARTED|Overall Study||228
2529151|NCT00667602|6197122|P1|STARTED|Overall Study||219
2529152|NCT00667589|6197172|P4|NOT COMPLETED|Overall Study||1
2529153|NCT00667589|6197173|P3|NOT COMPLETED|Overall Study||3
2529154|NCT00667589|6197174|P2|NOT COMPLETED|Overall Study||0
2529155|NCT00667589|6197175|P1|NOT COMPLETED|Overall Study||1
2529156|NCT00667589|6197172|P4|COMPLETED|Overall Study||1
2529157|NCT00667589|6197173|P3|COMPLETED|Overall Study||0
2529158|NCT00667589|6197174|P2|COMPLETED|Overall Study||0
2529159|NCT00667589|6197175|P1|COMPLETED|Overall Study||0
2529160|NCT00667589|6197172|P4|STARTED|Overall Study||2
2529161|NCT00667589|6197173|P3|STARTED|Overall Study||3
2529162|NCT00667589|6197174|P2|STARTED|Overall Study||0
2529163|NCT00667589|6197175|P1|STARTED|Overall Study||1
2529164|NCT00667576|6197190|P5|NOT COMPLETED|Overall Study||1
2529165|NCT00667576|6197191|P4|NOT COMPLETED|Overall Study||4
2529166|NCT00667576|6197192|P3|NOT COMPLETED|Overall Study||2
2529167|NCT00667576|6197193|P2|NOT COMPLETED|Overall Study||1
2529168|NCT00667576|6197194|P1|NOT COMPLETED|Overall Study||2
2529169|NCT00667576|6197190|P5|COMPLETED|Overall Study||29
2529170|NCT00667576|6197191|P4|COMPLETED|Overall Study||27
2529171|NCT00667576|6197192|P3|COMPLETED|Overall Study||29
2529172|NCT00667576|6197193|P2|COMPLETED|Overall Study||30
2529173|NCT00667576|6197194|P1|COMPLETED|Overall Study||28
2529174|NCT00667576|6197190|P5|STARTED|Overall Study||30
2529175|NCT00667576|6197191|P4|STARTED|Overall Study||31
2529176|NCT00667576|6197192|P3|STARTED|Overall Study||31
2529177|NCT00667576|6197193|P2|STARTED|Overall Study||31
2529178|NCT00667576|6197194|P1|STARTED|Overall Study||30
2529179|NCT00667563|6197241|P1|NOT COMPLETED|Overall Study||24
2529180|NCT00667563|6197241|P1|COMPLETED|Overall Study||126
2529181|NCT00667563|6197241|P1|STARTED|Overall Study||150
2529182|NCT00667511|6197251|P1|NOT COMPLETED|Intervention 2: Home NHD||4
2529183|NCT00667511|6197251|P1|COMPLETED|Intervention 2: Home NHD||39
2529184|NCT00667511|6197251|P1|STARTED|Intervention 2: Home NHD||43
2529185|NCT00667511|6197251|P1|NOT COMPLETED|Training/Transition Period||8
2529186|NCT00667511|6197251|P1|COMPLETED|Training/Transition Period||43
2529187|NCT00667511|6197251|P1|STARTED|Training/Transition Period||51
2529188|NCT00667511|6197251|P1|NOT COMPLETED|Intervention 1: Home DHD||7
2529189|NCT00667511|6197251|P1|COMPLETED|Intervention 1: Home DHD||51
2529190|NCT00667511|6197251|P1|STARTED|Intervention 1: Home DHD||58
2529191|NCT00667459|6197261|P2|NOT COMPLETED|Overall Study||45
2529192|NCT00667459|6197262|P1|NOT COMPLETED|Overall Study||8
2529193|NCT00667459|6197261|P2|COMPLETED|Overall Study||220
2529194|NCT00667459|6197262|P1|COMPLETED|Overall Study||272
2529195|NCT00667459|6197261|P2|STARTED|Overall Study||265
2529196|NCT00667459|6197262|P1|STARTED|Overall Study||280
2529197|NCT00667446|6197304|P2|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||1
2529198|NCT00667446|6197305|P1|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||0
2529199|NCT00667446|6197304|P2|COMPLETED|Safety Follow-up Period (12 Weeks)||25
2529200|NCT00667446|6197305|P1|COMPLETED|Safety Follow-up Period (12 Weeks)||28
2529201|NCT00667446|6197304|P2|STARTED|Safety Follow-up Period (12 Weeks)||26
2529202|NCT00667446|6197305|P1|STARTED|Safety Follow-up Period (12 Weeks)||28
2529203|NCT00667446|6197304|P2|NOT COMPLETED|Treatment Period (36 Months)||25
2529204|NCT00667446|6197305|P1|NOT COMPLETED|Treatment Period (36 Months)||23
2529205|NCT00667446|6197304|P2|COMPLETED|Treatment Period (36 Months)||13
2529206|NCT00667446|6197305|P1|COMPLETED|Treatment Period (36 Months)||11
2529207|NCT00667446|6197304|P2|STARTED|Treatment Period (36 Months)||38
2529208|NCT00667446|6197305|P1|STARTED|Treatment Period (36 Months)||34
2529209|NCT00667420|6197327|P1|NOT COMPLETED|Overall Study||10
2529210|NCT00667420|6197327|P1|COMPLETED|Overall Study||7
2529211|NCT00667420|6197327|P1|Completion of Surgery/Re-staging|Overall Study||11
2529212|NCT00667420|6197327|P1|Completion of Pre-operative EOX-P|Overall Study||15
2529213|NCT00667420|6197327|P1|STARTED|Overall Study||17
2529214|NCT00667394|6197337|P2|NOT COMPLETED|Overall Study||0
2529215|NCT00667394|6197338|P1|NOT COMPLETED|Overall Study||4
2529216|NCT00667394|6197337|P2|COMPLETED|Overall Study||1
2529217|NCT00667394|6197338|P1|COMPLETED|Overall Study||37
2529218|NCT00667394|6197337|P2|STARTED|Overall Study||1
2529219|NCT00667394|6197338|P1|STARTED|Overall Study||41
2529220|NCT00667381|6197348|P2|NOT COMPLETED|Overall Study||0
2529221|NCT00667381|6197349|P1|NOT COMPLETED|Overall Study||0
2529222|NCT00667381|6197348|P2|COMPLETED|Overall Study||503
2529223|NCT00667381|6197349|P1|COMPLETED|Overall Study||501
2529224|NCT00667381|6197348|P2|STARTED|Overall Study||503
2529225|NCT00667381|6197349|P1|STARTED|Overall Study||501
2529232|NCT00667355|6197374|P1|NOT COMPLETED|Overall Study||11
2529233|NCT00667355|6197374|P1|COMPLETED|Overall Study||30
2529234|NCT00667355|6197374|P1|STARTED|Overall Study||41
2529235|NCT00667342|6197399|P3|NOT COMPLETED|Overall Study||9
2529236|NCT00667342|6197400|P2|NOT COMPLETED|Overall Study||0
2529237|NCT00667342|6197401|P1|NOT COMPLETED|Overall Study||14
2529238|NCT00667342|6197399|P3|COMPLETED|Overall Study||3
2529239|NCT00667342|6197400|P2|COMPLETED|Overall Study||0
2529240|NCT00667342|6197401|P1|COMPLETED|Overall Study||17
2529241|NCT00667342|6197399|P3|STARTED|Overall Study||12
2529242|NCT00667342|6197400|P2|STARTED|Overall Study||0
2529243|NCT00667342|6197401|P1|STARTED|Overall Study||31
2529244|NCT00667277|6197439|P1|NOT COMPLETED|Overall Study||2
2529245|NCT00667277|6197439|P1|COMPLETED|Overall Study||11
2529246|NCT00667277|6197439|P1|STARTED|Overall Study||13
2529259|NCT00667225|6197473|P2|NOT COMPLETED|Overall Study||1
2529260|NCT00667225|6197474|P1|NOT COMPLETED|Overall Study||1
2529261|NCT00667225|6197473|P2|COMPLETED|Overall Study||12
2529262|NCT00667225|6197474|P1|COMPLETED|Overall Study||15
2529263|NCT00667225|6197473|P2|STARTED|Overall Study||13
2529264|NCT00667225|6197474|P1|STARTED|Overall Study||16
2529265|NCT00667186|6197484|P2|NOT COMPLETED|Overall Study||0
2529266|NCT00667186|6197485|P1|NOT COMPLETED|Overall Study||0
2529267|NCT00667186|6197484|P2|COMPLETED|Overall Study||4880
2529268|NCT00667186|6197485|P1|COMPLETED|Overall Study||4692
2529269|NCT00667186|6197484|P2|STARTED|Overall Study||4880
2529270|NCT00667186|6197485|P1|STARTED|Overall Study||4692
2529271|NCT00667095|6197495|P2|NOT COMPLETED|Overall Study||1
2529272|NCT00667095|6197496|P1|NOT COMPLETED|Overall Study||0
2529273|NCT00667095|6197495|P2|COMPLETED|Overall Study||9
2529274|NCT00667095|6197496|P1|COMPLETED|Overall Study||11
2529275|NCT00667095|6197495|P2|STARTED|Overall Study||10
2529276|NCT00667095|6197496|P1|STARTED|Overall Study||11
2529277|NCT00667017|6197512|P1|NOT COMPLETED|Overall Study||1
2529278|NCT00667017|6197512|P1|COMPLETED|Overall Study||0
2529279|NCT00667017|6197512|P1|STARTED|Overall Study||1
2529280|NCT00666978|6197518|P2|NOT COMPLETED|Overall Study||83
2529281|NCT00666978|6197519|P1|NOT COMPLETED|Overall Study||78
2529282|NCT00666978|6197518|P2|COMPLETED|Overall Study||187
2529283|NCT00666978|6197519|P1|COMPLETED|Overall Study||192
2529284|NCT00666978|6197518|P2|STARTED|Overall Study||270
2529285|NCT00666978|6197519|P1|STARTED|Overall Study||270
2529286|NCT00666965|6197532|P4|NOT COMPLETED|Overall Study||15
2529287|NCT00666965|6197533|P3|NOT COMPLETED|Overall Study||2
2529288|NCT00666965|6197534|P2|NOT COMPLETED|Overall Study||4
2529289|NCT00666965|6197535|P1|NOT COMPLETED|Overall Study||3
2529290|NCT00666965|6197532|P4|COMPLETED|Overall Study||42
2529291|NCT00666965|6197533|P3|COMPLETED|Overall Study||56
2529292|NCT00666965|6197534|P2|COMPLETED|Overall Study||53
2529293|NCT00666965|6197535|P1|COMPLETED|Overall Study||55
2529294|NCT00666965|6197532|P4|STARTED|Overall Study||57
2529295|NCT00666965|6197533|P3|STARTED|Overall Study||58
2529296|NCT00666965|6197534|P2|STARTED|Overall Study||57
2529297|NCT00666965|6197535|P1|STARTED|Overall Study||58
2529298|NCT00666926|6197565|P16|NOT COMPLETED|Overall Study||8
2529299|NCT00666926|6197566|P15|NOT COMPLETED|Overall Study||7
2529300|NCT00666926|6197567|P14|NOT COMPLETED|Overall Study||4
2529301|NCT00666926|6197568|P13|NOT COMPLETED|Overall Study||3
2529302|NCT00666926|6197569|P12|NOT COMPLETED|Overall Study||33
2529303|NCT00666926|6197570|P11|NOT COMPLETED|Overall Study||6
2529304|NCT00666926|6197571|P10|NOT COMPLETED|Overall Study||10
2529305|NCT00666926|6197572|P9|NOT COMPLETED|Overall Study||3
2529306|NCT00666926|6197573|P8|NOT COMPLETED|Overall Study||1
2529307|NCT00666926|6197574|P7|NOT COMPLETED|Overall Study||4
2529308|NCT00666926|6197575|P6|NOT COMPLETED|Overall Study||4
2529309|NCT00666926|6197576|P5|NOT COMPLETED|Overall Study||3
2529310|NCT00666926|6197577|P4|NOT COMPLETED|Overall Study||4
2529311|NCT00666926|6197578|P3|NOT COMPLETED|Overall Study||3
2529312|NCT00666926|6197579|P2|NOT COMPLETED|Overall Study||4
2529313|NCT00666926|6197580|P1|NOT COMPLETED|Overall Study||2
2529314|NCT00666926|6197565|P16|COMPLETED|Overall Study||0
2529315|NCT00666926|6197566|P15|COMPLETED|Overall Study||0
2529316|NCT00666926|6197567|P14|COMPLETED|Overall Study||0
2529317|NCT00666926|6197568|P13|COMPLETED|Overall Study||0
2529318|NCT00666926|6197569|P12|COMPLETED|Overall Study||0
2529319|NCT00666926|6197570|P11|COMPLETED|Overall Study||0
2529320|NCT00666926|6197571|P10|COMPLETED|Overall Study||0
2529321|NCT00666926|6197572|P9|COMPLETED|Overall Study||0
2529322|NCT00666926|6197573|P8|COMPLETED|Overall Study||0
2529323|NCT00666926|6197574|P7|COMPLETED|Overall Study||0
2529324|NCT00666926|6197575|P6|COMPLETED|Overall Study||0
2529325|NCT00666926|6197576|P5|COMPLETED|Overall Study||0
2529326|NCT00666926|6197577|P4|COMPLETED|Overall Study||0
2529327|NCT00666926|6197578|P3|COMPLETED|Overall Study||0
2529328|NCT00666926|6197579|P2|COMPLETED|Overall Study||0
2529329|NCT00666926|6197580|P1|COMPLETED|Overall Study||0
2529330|NCT00666926|6197565|P16|STARTED|Overall Study||8
2529331|NCT00666926|6197566|P15|STARTED|Overall Study||7
2529332|NCT00666926|6197567|P14|STARTED|Overall Study||4
2529333|NCT00666926|6197568|P13|STARTED|Overall Study||3
2529334|NCT00666926|6197569|P12|STARTED|Overall Study||33
2529335|NCT00666926|6197570|P11|STARTED|Overall Study||6
2529336|NCT00666926|6197571|P10|STARTED|Overall Study||10
2529337|NCT00666926|6197572|P9|STARTED|Overall Study||3
2529338|NCT00666926|6197573|P8|STARTED|Overall Study||1
2529339|NCT00666926|6197574|P7|STARTED|Overall Study||4
2529340|NCT00666926|6197575|P6|STARTED|Overall Study||4
2529341|NCT00666926|6197576|P5|STARTED|Overall Study||3
2529342|NCT00666926|6197577|P4|STARTED|Overall Study||4
2529343|NCT00666926|6197578|P3|STARTED|Overall Study||3
2529344|NCT00666926|6197579|P2|STARTED|Overall Study||4
2529345|NCT00666926|6197580|P1|STARTED|Overall Study||2
2529346|NCT00666848|6197874|P3|NOT COMPLETED|Overall Study||0
2529347|NCT00666848|6197875|P2|NOT COMPLETED|Overall Study||0
2529348|NCT00666848|6197876|P1|NOT COMPLETED|Overall Study||0
2529349|NCT00666848|6197874|P3|COMPLETED|Overall Study|finished Aim 3|7
2529350|NCT00666848|6197875|P2|COMPLETED|Overall Study|finished Aim 1|9
2529351|NCT00666848|6197876|P1|COMPLETED|Overall Study|finished Aim 2|8
2529352|NCT00666848|6197874|P3|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|7
2529353|NCT00666848|6197875|P2|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|9
2529354|NCT00666848|6197876|P1|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|8
2529355|NCT00666835|6197889|P2|NOT COMPLETED|Overall Study||22
2529356|NCT00666835|6197890|P1|NOT COMPLETED|Overall Study||53
2529357|NCT00666835|6197889|P2|COMPLETED|Overall Study||142
2529358|NCT00666835|6197890|P1|COMPLETED|Overall Study||261
2529359|NCT00666835|6197889|P2|STARTED|Overall Study||164
2529360|NCT00666835|6197890|P1|STARTED|Overall Study||314
2529361|NCT00666757|6197900|P2|NOT COMPLETED|Overall Study||97
2529362|NCT00666757|6197901|P1|NOT COMPLETED|Overall Study||100
2529363|NCT00666757|6197900|P2|COMPLETED|Overall Study||281
2529364|NCT00666757|6197901|P1|COMPLETED|Overall Study||272
2529365|NCT00666757|6197900|P2|STARTED|Overall Study||378
2529366|NCT00666757|6197901|P1|STARTED|Overall Study||372
2529367|NCT00666718|6197960|P2|NOT COMPLETED|Overall Study||18
2529368|NCT00666718|6197961|P1|NOT COMPLETED|Overall Study||12
2529369|NCT00666718|6197960|P2|COMPLETED|Overall Study||169
2529370|NCT00666718|6197961|P1|COMPLETED|Overall Study||175
2529371|NCT00666718|6197960|P2|STARTED|Overall Study||187
2529372|NCT00666718|6197961|P1|STARTED|Overall Study||187
2529373|NCT00666705|6197987|P1|NOT COMPLETED|Overall Study||1
2529374|NCT00666705|6197987|P1|COMPLETED|Overall Study||17
2529375|NCT00666705|6197987|P1|Raltegravir + Maraviroc (Days 12 - 14)|Overall Study|400 mg Raltegravir every 12 hours plus 300 mg Maraviroc every 12 hours (AM doses only on Day 14)|17
2529376|NCT00666705|6197987|P1|Maraviroc Alone (Days 6 - 11)|Overall Study|300 mg Maraviroc every 12 hours|18
2529377|NCT00666705|6197987|P1|Washout (Days 4 - 5)|Overall Study||18
2529378|NCT00666705|6197987|P1|Raltegravir Alone (Days 1 - 3)|Overall Study|400 mg Raltegravir every 12 hours (AM dose on Day 3)|18
2529379|NCT00666705|6197987|P1|STARTED|Overall Study||18
2529380|NCT00666679|6198006|P2|NOT COMPLETED|Second Intervention||1
2529381|NCT00666679|6198007|P1|NOT COMPLETED|Second Intervention||1
2529382|NCT00666679|6198006|P2|COMPLETED|Second Intervention||64
2529383|NCT00666679|6198007|P1|COMPLETED|Second Intervention||61
2529384|NCT00666679|6198006|P2|STARTED|Second Intervention||65
2529385|NCT00666679|6198007|P1|STARTED|Second Intervention||62
2529386|NCT00666679|6198006|P2|NOT COMPLETED|Washout Period of 1 Week||2
2529387|NCT00666679|6198007|P1|NOT COMPLETED|Washout Period of 1 Week||0
2529388|NCT00666679|6198006|P2|COMPLETED|Washout Period of 1 Week||65
2529389|NCT00666679|6198007|P1|COMPLETED|Washout Period of 1 Week||62
2529390|NCT00666679|6198006|P2|STARTED|Washout Period of 1 Week||67
2529391|NCT00666679|6198007|P1|STARTED|Washout Period of 1 Week||62
2529392|NCT00666679|6198006|P2|NOT COMPLETED|First Intervention||1
2529393|NCT00666679|6198007|P1|NOT COMPLETED|First Intervention||4
2529394|NCT00666679|6198006|P2|COMPLETED|First Intervention||67
2529395|NCT00666679|6198007|P1|COMPLETED|First Intervention||62
2529396|NCT00666679|6198006|P2|STARTED|First Intervention||68
2529397|NCT00666679|6198007|P1|STARTED|First Intervention||66
2529398|NCT00666666|6198027|P1|NOT COMPLETED|Overall Study||0
2529399|NCT00666666|6198027|P1|COMPLETED|Overall Study||55
2529400|NCT00666666|6198027|P1|STARTED|Overall Study||55
2529401|NCT00666588|6198037|P4|NOT COMPLETED|Overall Study||2
2529402|NCT00666588|6198038|P3|NOT COMPLETED|Overall Study||0
2529403|NCT00666588|6198039|P2|NOT COMPLETED|Overall Study||0
2529404|NCT00666588|6198040|P1|NOT COMPLETED|Overall Study||4
2529405|NCT00666588|6198037|P4|COMPLETED|Overall Study||20
2529406|NCT00666588|6198038|P3|COMPLETED|Overall Study||6
2529407|NCT00666588|6198039|P2|COMPLETED|Overall Study||6
2529408|NCT00666588|6198040|P1|COMPLETED|Overall Study||14
2529409|NCT00666588|6198037|P4|STARTED|Overall Study||22
2529410|NCT00666588|6198038|P3|STARTED|Overall Study||6
2529411|NCT00666588|6198039|P2|STARTED|Overall Study||6
2529412|NCT00666588|6198040|P1|STARTED|Overall Study||18
2529413|NCT00666562|6198073|P3|NOT COMPLETED|Overall Study||0
2529414|NCT00666562|6198074|P2|NOT COMPLETED|Overall Study||2
2529415|NCT00666562|6198075|P1|NOT COMPLETED|Overall Study||0
2529416|NCT00666562|6198073|P3|COMPLETED|Overall Study||10
2529417|NCT00666562|6198074|P2|COMPLETED|Overall Study||8
2529418|NCT00666562|6198075|P1|COMPLETED|Overall Study||11
2529419|NCT00666562|6198073|P3|STARTED|Overall Study||10
2529420|NCT00666562|6198074|P2|STARTED|Overall Study||10
2529421|NCT00666562|6198075|P1|STARTED|Overall Study||11
2529422|NCT00666536|6198122|P2|NOT COMPLETED|Overall Study||37
2529423|NCT00666536|6198123|P1|NOT COMPLETED|Overall Study||33
2529424|NCT00666536|6198122|P2|COMPLETED|Overall Study||322
2529425|NCT00666536|6198123|P1|COMPLETED|Overall Study||336
2529426|NCT00666536|6198122|P2|STARTED|Overall Study||359
2529427|NCT00666536|6198123|P1|STARTED|Overall Study||369
2529428|NCT00666458|6198141|P2|NOT COMPLETED|Overall Study||24
2529429|NCT00666458|6198142|P1|NOT COMPLETED|Overall Study||38
2529430|NCT00666458|6198141|P2|COMPLETED|Overall Study|Completed 18 weeks of treatment|374
2529431|NCT00666458|6198142|P1|COMPLETED|Overall Study|Completed 18 weeks of treatment|365
2529432|NCT00666458|6198141|P2|STARTED|Overall Study|Randomized and treated|398
2529433|NCT00666458|6198142|P1|STARTED|Overall Study|Randomized and treated|403
2529434|NCT00666406|6198154|P2|NOT COMPLETED|Second PK Infusion||0
2529435|NCT00666406|6198155|P1|NOT COMPLETED|Second PK Infusion||0
2529436|NCT00666406|6198154|P2|COMPLETED|Second PK Infusion||3
2529437|NCT00666406|6198155|P1|COMPLETED|Second PK Infusion||6
2529438|NCT00666406|6198154|P2|STARTED|Second PK Infusion||3
2529439|NCT00666406|6198155|P1|STARTED|Second PK Infusion||6
2529440|NCT00666406|6198154|P2|NOT COMPLETED|First PK Infusion||0
2529441|NCT00666406|6198155|P1|NOT COMPLETED|First PK Infusion||0
2529442|NCT00666406|6198154|P2|COMPLETED|First PK Infusion||3
2529443|NCT00666406|6198155|P1|COMPLETED|First PK Infusion||6
2529444|NCT00666406|6198154|P2|STARTED|First PK Infusion||3
2529445|NCT00666406|6198155|P1|STARTED|First PK Infusion||6
2529446|NCT00666328|6198230|P1|NOT COMPLETED|Overall Study||5
2529447|NCT00666328|6198230|P1|COMPLETED|Overall Study|30/35 completed the study within the Safety population; 28/33 completed within the mITT population.|30
2529448|NCT00666328|6198230|P1|Modified Intent To Treat (mITT)|Overall Study|mITT population: participants dosed and in whom all inclusion and no exclusion criteria were met|33
2529449|NCT00666328|6198230|P1|STARTED|Overall Study|Safety population: participants dosed with study drug (primary population for Safety analyses)|35
2529450|NCT00666276|6198243|P1|NOT COMPLETED|Overall Study||34
2529451|NCT00666276|6198243|P1|COMPLETED|Overall Study||970
2529452|NCT00666276|6198243|P1|STARTED|Overall Study||1004
2529453|NCT00666263|6198267|P2|NOT COMPLETED|End of Study Visit||0
2529454|NCT00666263|6198268|P1|NOT COMPLETED|End of Study Visit||0
2529455|NCT00666263|6198267|P2|COMPLETED|End of Study Visit||22
2529456|NCT00666263|6198268|P1|COMPLETED|End of Study Visit||22
2529457|NCT00666263|6198267|P2|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
2529458|NCT00666263|6198268|P1|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
2529459|NCT00666263|6198267|P2|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||1
2529460|NCT00666263|6198268|P1|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||0
2529461|NCT00666263|6198267|P2|COMPLETED|Study Part 5 (Stabilization Phase 3)||20
2529462|NCT00666263|6198268|P1|COMPLETED|Study Part 5 (Stabilization Phase 3)||21
2529463|NCT00666263|6198267|P2|STARTED|Study Part 5 (Stabilization Phase 3)||21
2529464|NCT00666263|6198268|P1|STARTED|Study Part 5 (Stabilization Phase 3)||21
2529465|NCT00666263|6198267|P2|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||0
2529466|NCT00666263|6198268|P1|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||1
2529467|NCT00666263|6198267|P2|COMPLETED|Study Part 4 (Cross-over Period 2)||21
2529468|NCT00666263|6198268|P1|COMPLETED|Study Part 4 (Cross-over Period 2)||21
2529469|NCT00666263|6198267|P2|STARTED|Study Part 4 (Cross-over Period 2)||21
2529470|NCT00666263|6198268|P1|STARTED|Study Part 4 (Cross-over Period 2)||22
2529471|NCT00666263|6198267|P2|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
2529472|NCT00666263|6198268|P1|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
2529473|NCT00666263|6198267|P2|COMPLETED|Study Part 3 (Stabilization Phase 2)||21
2529474|NCT00666263|6198268|P1|COMPLETED|Study Part 3 (Stabilization Phase 2)||22
2529475|NCT00666263|6198267|P2|STARTED|Study Part 3 (Stabilization Phase 2)||21
2529476|NCT00666263|6198268|P1|STARTED|Study Part 3 (Stabilization Phase 2)||22
2529477|NCT00666263|6198267|P2|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
2529478|NCT00666263|6198268|P1|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
2529479|NCT00666263|6198267|P2|COMPLETED|Study Part 2 (Cross-over Period 1)||21
2529480|NCT00666263|6198268|P1|COMPLETED|Study Part 2 (Cross-over Period 1)||22
2529481|NCT00666263|6198267|P2|STARTED|Study Part 2 (Cross-over Period 1)||21
2529482|NCT00666263|6198268|P1|STARTED|Study Part 2 (Cross-over Period 1)||22
2529483|NCT00666263|6198267|P2|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||1
2529484|NCT00666263|6198268|P1|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||0
2529485|NCT00666263|6198267|P2|COMPLETED|Study Part 1 (Stabilization Phase 1)||21
2529486|NCT00666263|6198268|P1|COMPLETED|Study Part 1 (Stabilization Phase 1)||22
2529487|NCT00666263|6198267|P2|STARTED|Study Part 1 (Stabilization Phase 1)||22
2529488|NCT00666263|6198268|P1|STARTED|Study Part 1 (Stabilization Phase 1)||22
2529489|NCT00666224|6198412|P2|NOT COMPLETED|Open-Label||85
2529490|NCT00666224|6198413|P1|NOT COMPLETED|Open-Label||35
2529491|NCT00666224|6198412|P2|COMPLETED|Open-Label||126
2529492|NCT00666224|6198413|P1|COMPLETED|Open-Label||163
2529493|NCT00666224|6198412|P2|STARTED|Open-Label||211
2529494|NCT00666224|6198413|P1|STARTED|Open-Label|454 participants took at least one dose of GA including 45 who didn't continue into the OL.|198
2529495|NCT00666224|6198412|P2|NOT COMPLETED|Double-Blind||27
2529496|NCT00666224|6198413|P1|NOT COMPLETED|Double-Blind||45
2529497|NCT00666224|6198412|P2|COMPLETED|Double-Blind|55 completed 3 years treatment, 109 converted to CDMS, 47 switched to OL as per DMC|211
2529498|NCT00666224|6198413|P1|COMPLETED|Double-Blind|78 completed 3 years treatment, 66 converted to CDMS, 54 switched to OL as per DMC|198
2529499|NCT00666224|6198412|P2|STARTED|Double-Blind||238
2529500|NCT00666224|6198413|P1|STARTED|Double-Blind||243
2529501|NCT00666211|6198432|P2|NOT COMPLETED|Overall Study||38
2529502|NCT00666211|6198433|P1|NOT COMPLETED|Overall Study||20
2529503|NCT00666211|6198432|P2|COMPLETED|Overall Study||18
2529504|NCT00666211|6198433|P1|COMPLETED|Overall Study||22
2529505|NCT00666211|6198432|P2|STARTED|Overall Study||56
2529506|NCT00666211|6198433|P1|STARTED|Overall Study||42
2529507|NCT00666198|6198451|P1|NOT COMPLETED|Overall Study||33
2529508|NCT00666198|6198451|P1|COMPLETED|Overall Study||3304
2529509|NCT00666198|6198451|P1|STARTED|Overall Study||3337
2529510|NCT00666029|6198466|P2|NOT COMPLETED|Overall Study||0
2529511|NCT00666029|6198467|P1|NOT COMPLETED|Overall Study||1
2529512|NCT00666029|6198466|P2|COMPLETED|Overall Study||20
2529513|NCT00666029|6198467|P1|COMPLETED|Overall Study||19
2529514|NCT00666029|6198466|P2|STARTED|Overall Study||20
2529515|NCT00666029|6198467|P1|STARTED|Overall Study||20
2529516|NCT00665925|6198479|P4|NOT COMPLETED|Overall Study||21
2529517|NCT00665925|6198480|P3|NOT COMPLETED|Overall Study||26
2529518|NCT00665925|6198481|P2|NOT COMPLETED|Overall Study||17
2529519|NCT00665925|6198482|P1|NOT COMPLETED|Overall Study||15
2529520|NCT00665925|6198479|P4|COMPLETED|Overall Study|Participants completed the study|131
2529521|NCT00665925|6198480|P3|COMPLETED|Overall Study|Participants completed the study|126
2529522|NCT00665925|6198481|P2|COMPLETED|Overall Study|Participants completed the study|59
2529523|NCT00665925|6198482|P1|COMPLETED|Overall Study|Participants completed the study|62
2529524|NCT00665925|6198479|P4|STARTED|Overall Study|Participants randomized|152
2529525|NCT00665925|6198480|P3|STARTED|Overall Study|Participants randomized|152
2529526|NCT00665925|6198481|P2|STARTED|Overall Study|Participants randomized|76
2529527|NCT00665925|6198482|P1|STARTED|Overall Study|Participants randomized|77
2529528|NCT00665847|6198893|P1|NOT COMPLETED|Overall Study||25
2529529|NCT00665847|6198893|P1|COMPLETED|Overall Study||76
2529530|NCT00665847|6198893|P1|STARTED|Overall Study||101
2529531|NCT00665704|6198905|P1|NOT COMPLETED|Overall Study||0
2529532|NCT00665704|6198905|P1|COMPLETED|Overall Study||9
2529533|NCT00665704|6198905|P1|STARTED|Overall Study||9
2529534|NCT00665652|6198910|P1|NOT COMPLETED|Overall Study||6
2529535|NCT00665652|6198910|P1|COMPLETED|Overall Study||2
2529536|NCT00665652|6198910|P1|STARTED|Overall Study||8
2529537|NCT00665626|6198916|P2|NOT COMPLETED|Overall Study||22
2529538|NCT00665626|6198917|P1|NOT COMPLETED|Overall Study||10
2529539|NCT00665626|6198916|P2|COMPLETED|Overall Study|Participants completed the study|124
2529540|NCT00665626|6198917|P1|COMPLETED|Overall Study|Participants completed the study|63
2529541|NCT00665626|6198916|P2|STARTED|Overall Study|Participants randomized|146
2529542|NCT00665626|6198917|P1|STARTED|Overall Study|Participants randomized|73
2529543|NCT00665470|6198985|P2|NOT COMPLETED|Overall Study||0
2529544|NCT00665470|6198986|P1|NOT COMPLETED|Overall Study||0
2529545|NCT00665470|6198985|P2|COMPLETED|Overall Study||0
2529546|NCT00665470|6198986|P1|COMPLETED|Overall Study||10
2529547|NCT00665470|6198985|P2|STARTED|Overall Study||0
2529548|NCT00665470|6198986|P1|STARTED|Overall Study||10
2529549|NCT00665457|6198994|P1|NOT COMPLETED|Overall Study||0
2529550|NCT00665457|6198994|P1|COMPLETED|Overall Study||3
2529551|NCT00665457|6198994|P1|STARTED|Overall Study||3
2529552|NCT00665444|6198999|P1|NOT COMPLETED|Overall Study||2
2529553|NCT00665444|6198999|P1|COMPLETED|Overall Study||1
2529554|NCT00665444|6198999|P1|STARTED|Overall Study||3
2529555|NCT00665431|6199011|P3|NOT COMPLETED|Overall Study||24
2529556|NCT00665431|6199012|P2|NOT COMPLETED|Overall Study||57
2529557|NCT00665431|6199013|P1|NOT COMPLETED|Overall Study||40
2529558|NCT00665431|6199011|P3|COMPLETED|Overall Study||98
2529559|NCT00665431|6199012|P2|COMPLETED|Overall Study||188
2529560|NCT00665431|6199013|P1|COMPLETED|Overall Study||203
2529561|NCT00665431|6199011|P3|STARTED|Overall Study|Safety population|122
2529562|NCT00665431|6199012|P2|STARTED|Overall Study|Safety population|245
2529563|NCT00665431|6199013|P1|STARTED|Overall Study|Safety population|243
2529564|NCT00665366|6199056|P2|NOT COMPLETED|Overall Study||59
2529565|NCT00665366|6199057|P1|NOT COMPLETED|Overall Study||58
2529566|NCT00665366|6199056|P2|COMPLETED|Overall Study||122
2529567|NCT00665366|6199057|P1|COMPLETED|Overall Study||131
2529568|NCT00665366|6199056|P2|STARTED|Overall Study|Participants randomized|181
2529569|NCT00665366|6199057|P1|STARTED|Overall Study|Participants randomized|189
2529570|NCT00665353|6199085|P1|NOT COMPLETED|Study Step 2||14
2529571|NCT00665353|6199085|P1|COMPLETED|Study Step 2||2
2529572|NCT00665353|6199085|P1|STARTED|Study Step 2||16
2529573|NCT00665353|6199085|P1|NOT COMPLETED|Study Step 1||3
2529574|NCT00665353|6199085|P1|COMPLETED|Study Step 1||16
2529575|NCT00665353|6199085|P1|STARTED|Study Step 1||19
2529576|NCT00665132|6199095|P1|NOT COMPLETED|Overall Study||0
2529577|NCT00665132|6199095|P1|COMPLETED|Overall Study||10
2529578|NCT00665132|6199095|P1|STARTED|Overall Study||10
2529579|NCT00665002|6199102|P1|NOT COMPLETED|Overall Study||12
2529580|NCT00665002|6199102|P1|COMPLETED|Overall Study||4
2529581|NCT00665002|6199102|P1|STARTED|Overall Study||16
2529582|NCT00664755|6199109|P2|NOT COMPLETED|Overall Study||0
2529583|NCT00664755|6199110|P1|NOT COMPLETED|Overall Study||0
2529584|NCT00664755|6199109|P2|COMPLETED|Overall Study||73
2529585|NCT00664755|6199110|P1|COMPLETED|Overall Study||67
2529586|NCT00664755|6199109|P2|STARTED|Overall Study||73
2529587|NCT00664755|6199110|P1|STARTED|Overall Study||67
2529588|NCT00664742|6199116|P1|NOT COMPLETED|Overall Study||126
2529589|NCT00664742|6199116|P1|COMPLETED|Overall Study||481
2529590|NCT00664742|6199116|P1|STARTED|Overall Study||607
2529591|NCT00664560|6199124|P3|NOT COMPLETED|Overall Study||19
2529592|NCT00664560|6199125|P2|NOT COMPLETED|Overall Study||35
2529593|NCT00664560|6199126|P1|NOT COMPLETED|Overall Study||39
2529594|NCT00664560|6199124|P3|COMPLETED|Overall Study||105
2529595|NCT00664560|6199125|P2|COMPLETED|Overall Study||208
2529596|NCT00664560|6199126|P1|COMPLETED|Overall Study||208
2529597|NCT00664560|6199124|P3|STARTED|Overall Study|Safety Population|124
2529598|NCT00664560|6199125|P2|STARTED|Overall Study|Safety Population|243
2529599|NCT00664560|6199126|P1|STARTED|Overall Study|Safety Population|247
2529600|NCT00664534|6199169|P2|NOT COMPLETED|Overall Study||33
2529601|NCT00664534|6199170|P1|NOT COMPLETED|Overall Study||41
2529602|NCT00664534|6199169|P2|COMPLETED|Overall Study||138
2529603|NCT00664534|6199170|P1|COMPLETED|Overall Study||132
2529604|NCT00664534|6199169|P2|STARTED|Overall Study||171
2529605|NCT00664534|6199170|P1|STARTED|Overall Study||173
2529606|NCT00664521|6199198|P2|NOT COMPLETED|Overall Study||1
2529607|NCT00664521|6199199|P1|NOT COMPLETED|Overall Study||6
2529608|NCT00664521|6199198|P2|COMPLETED|Overall Study||8
2529609|NCT00664521|6199199|P1|COMPLETED|Overall Study||12
2529610|NCT00664521|6199198|P2|STARTED|Overall Study||9
2529611|NCT00664521|6199199|P1|STARTED|Overall Study||18
2529612|NCT00664430|6199219|P1|NOT COMPLETED|Overall Study||13
2529613|NCT00664430|6199219|P1|COMPLETED|Overall Study|Study terminated early due to low enrollment rate.|0
2529614|NCT00664430|6199219|P1|STARTED|Overall Study||13
2529615|NCT00664326|6199225|P1|NOT COMPLETED|Overall Study||24
2529616|NCT00664326|6199225|P1|COMPLETED|Overall Study||25
2529617|NCT00664326|6199225|P1|STARTED|Overall Study||49
2529618|NCT00664209|6199244|P1|NOT COMPLETED|Study Treatment Period||6
2529619|NCT00664209|6199244|P1|COMPLETED|Study Treatment Period||0
2529620|NCT00664209|6199244|P1|STARTED|Study Treatment Period||6
2529621|NCT00664209|6199244|P1|NOT COMPLETED|Motor Fluctuations Screen||7
2529622|NCT00664209|6199244|P1|COMPLETED|Motor Fluctuations Screen||6
2529623|NCT00664209|6199244|P1|STARTED|Motor Fluctuations Screen||13
2529624|NCT00664105|6199252|P1|NOT COMPLETED|Overall Study||24
2529625|NCT00664105|6199252|P1|COMPLETED|Overall Study||39
2529626|NCT00664105|6199252|P1|STARTED|Overall Study||63
2529627|NCT00664066|6199259|P1|NOT COMPLETED|Overall Study||3
2529628|NCT00664066|6199259|P1|COMPLETED|Overall Study||0
2529629|NCT00664066|6199259|P1|STARTED|Overall Study||3
2529630|NCT00663962|6199265|P2|NOT COMPLETED|Overall Study||0
2529631|NCT00663962|6199266|P1|NOT COMPLETED|Overall Study||1
2529632|NCT00663962|6199265|P2|COMPLETED|Overall Study||8
2529633|NCT00663962|6199266|P1|COMPLETED|Overall Study|1 patient excluded for somnolence and unblinded--in 300mg group|6
2529634|NCT00663962|6199265|P2|STARTED|Overall Study||8
2529635|NCT00663962|6199266|P1|STARTED|Overall Study||7
2529636|NCT00663923|6199272|P1|NOT COMPLETED|Overall Study||2
2529637|NCT00663923|6199272|P1|COMPLETED|Overall Study||48
2529638|NCT00663923|6199272|P1|STARTED|Overall Study||50
2529639|NCT00663858|6199289|P3|NOT COMPLETED|Overall Study||20
2529640|NCT00663858|6199290|P2|NOT COMPLETED|Overall Study||10
2529641|NCT00663858|6199291|P1|NOT COMPLETED|Overall Study||34
2529642|NCT00663858|6199289|P3|COMPLETED|Overall Study||82
2529643|NCT00663858|6199290|P2|COMPLETED|Overall Study||96
2529644|NCT00663858|6199291|P1|COMPLETED|Overall Study||178
2529645|NCT00663858|6199289|P3|STARTED|Overall Study||102
2529646|NCT00663858|6199290|P2|STARTED|Overall Study||106
2529647|NCT00663858|6199291|P1|STARTED|Overall Study||212
2529648|NCT00663819|6199301|P2|NOT COMPLETED|Overall Study||0
2529649|NCT00663819|6199302|P1|NOT COMPLETED|Overall Study||0
2529650|NCT00663819|6199301|P2|COMPLETED|Overall Study||135
2529651|NCT00663819|6199302|P1|COMPLETED|Overall Study||123
2529652|NCT00663819|6199301|P2|STARTED|Overall Study||135
2529653|NCT00663819|6199302|P1|STARTED|Overall Study||123
2529654|NCT00663793|6199316|P2|NOT COMPLETED|Overall Study||0
2529655|NCT00663793|6199317|P1|NOT COMPLETED|Overall Study||0
2529656|NCT00663793|6199316|P2|COMPLETED|Overall Study||8
2529657|NCT00663793|6199317|P1|COMPLETED|Overall Study||8
2529658|NCT00663793|6199316|P2|STARTED|Overall Study||8
2529659|NCT00663793|6199317|P1|STARTED|Overall Study||8
2529660|NCT00663702|6199329|P2|NOT COMPLETED|Overall Study||10
2529661|NCT00663702|6199330|P1|NOT COMPLETED|Overall Study||18
2529662|NCT00663702|6199329|P2|COMPLETED|Overall Study||61
2529663|NCT00663702|6199330|P1|COMPLETED|Overall Study||34
2529664|NCT00663702|6199329|P2|STARTED|Overall Study||71
2529665|NCT00663702|6199330|P1|STARTED|Overall Study||52
2529666|NCT00663403|6199353|P1|NOT COMPLETED|Overall Study||0
2529667|NCT00663403|6199353|P1|COMPLETED|Overall Study||8
2529668|NCT00663403|6199353|P1|STARTED|Overall Study||8
2529669|NCT00663260|6199366|P3|NOT COMPLETED|Overall Study||16
2529670|NCT00663260|6199367|P2|NOT COMPLETED|Overall Study||11
2529671|NCT00663260|6199368|P1|NOT COMPLETED|Overall Study||21
2529672|NCT00663260|6199366|P3|COMPLETED|Overall Study||69
2529673|NCT00663260|6199367|P2|COMPLETED|Overall Study||72
2529674|NCT00663260|6199368|P1|COMPLETED|Overall Study||63
2529675|NCT00663260|6199366|P3|STARTED|Overall Study||85
2529676|NCT00663260|6199367|P2|STARTED|Overall Study||83
2529677|NCT00663260|6199368|P1|STARTED|Overall Study||84
2529678|NCT00663234|6199382|P1|NOT COMPLETED|Overall Study||1
2529679|NCT00663234|6199382|P1|COMPLETED|Overall Study||27
2529680|NCT00663234|6199382|P1|Dose Increased to 20 mg at Week 8|Overall Study||10
2529681|NCT00663234|6199382|P1|STARTED|Overall Study||28
2529682|NCT00663208|6199415|P7|NOT COMPLETED|Follow-up Period||1
2529683|NCT00663208|6199416|P6|NOT COMPLETED|Follow-up Period||0
2529684|NCT00663208|6199417|P5|NOT COMPLETED|Follow-up Period||0
2529685|NCT00663208|6199418|P4|NOT COMPLETED|Follow-up Period||2
2529686|NCT00663208|6199419|P3|NOT COMPLETED|Follow-up Period||3
2529687|NCT00663208|6199420|P2|NOT COMPLETED|Follow-up Period||0
2529688|NCT00663208|6199421|P1|NOT COMPLETED|Follow-up Period||3
2529689|NCT00663208|6199415|P7|COMPLETED|Follow-up Period||5
2529690|NCT00663208|6199416|P6|COMPLETED|Follow-up Period||4
2529691|NCT00663208|6199417|P5|COMPLETED|Follow-up Period||4
2529692|NCT00663208|6199418|P4|COMPLETED|Follow-up Period||2
2529693|NCT00663208|6199419|P3|COMPLETED|Follow-up Period||1
2529694|NCT00663208|6199420|P2|COMPLETED|Follow-up Period||3
2529695|NCT00663208|6199421|P1|COMPLETED|Follow-up Period||1
2529696|NCT00663208|6199415|P7|STARTED|Follow-up Period||6
2529697|NCT00663208|6199416|P6|STARTED|Follow-up Period||4
2529698|NCT00663208|6199417|P5|STARTED|Follow-up Period||4
2529699|NCT00663208|6199418|P4|STARTED|Follow-up Period||4
2529700|NCT00663208|6199419|P3|STARTED|Follow-up Period||4
2529701|NCT00663208|6199420|P2|STARTED|Follow-up Period||3
2529702|NCT00663208|6199421|P1|STARTED|Follow-up Period||4
2529703|NCT00663208|6199415|P7|NOT COMPLETED|Treatment Period||0
2529704|NCT00663208|6199416|P6|NOT COMPLETED|Treatment Period||0
2529705|NCT00663208|6199417|P5|NOT COMPLETED|Treatment Period||0
2529706|NCT00663208|6199418|P4|NOT COMPLETED|Treatment Period||0
2529707|NCT00663208|6199419|P3|NOT COMPLETED|Treatment Period||0
2529708|NCT00663208|6199420|P2|NOT COMPLETED|Treatment Period||1
2529709|NCT00663208|6199421|P1|NOT COMPLETED|Treatment Period||0
2529710|NCT00663208|6199415|P7|COMPLETED|Treatment Period||6
2529711|NCT00663208|6199416|P6|COMPLETED|Treatment Period||4
2529712|NCT00663208|6199417|P5|COMPLETED|Treatment Period||4
2529713|NCT00663208|6199418|P4|COMPLETED|Treatment Period||4
2529714|NCT00663208|6199419|P3|COMPLETED|Treatment Period||4
2529715|NCT00663208|6199420|P2|COMPLETED|Treatment Period||3
2529716|NCT00663208|6199421|P1|COMPLETED|Treatment Period||4
2529717|NCT00663208|6199415|P7|STARTED|Treatment Period||6
2529718|NCT00663208|6199416|P6|STARTED|Treatment Period||4
2529719|NCT00663208|6199417|P5|STARTED|Treatment Period||4
2529720|NCT00663208|6199418|P4|STARTED|Treatment Period||4
2529721|NCT00663208|6199419|P3|STARTED|Treatment Period||4
2529722|NCT00663208|6199420|P2|STARTED|Treatment Period||4
2529723|NCT00663208|6199421|P1|STARTED|Treatment Period||4
2529724|NCT00663169|6199573|P2|NOT COMPLETED|Overall Study||0
2529725|NCT00663169|6199574|P1|NOT COMPLETED|Overall Study||0
2529726|NCT00663169|6199573|P2|COMPLETED|Overall Study||3
2529727|NCT00663169|6199574|P1|COMPLETED|Overall Study||3
2529728|NCT00663169|6199573|P2|STARTED|Overall Study||3
2529729|NCT00663169|6199574|P1|STARTED|Overall Study||3
2529730|NCT00663117|6199599|P2|NOT COMPLETED|Overall Study||0
2529731|NCT00663117|6199600|P1|NOT COMPLETED|Overall Study||1
2529732|NCT00663117|6199599|P2|COMPLETED|Overall Study||20
2529733|NCT00663117|6199600|P1|COMPLETED|Overall Study|One patient in placebo flared and was unblinded and crossed over to active drug|19
2529734|NCT00663117|6199599|P2|STARTED|Overall Study||20
2529735|NCT00663117|6199600|P1|STARTED|Overall Study||20
2529736|NCT00663052|6199614|P2|NOT COMPLETED|Overall Study||10
2529737|NCT00663052|6199615|P1|NOT COMPLETED|Overall Study||12
2529738|NCT00663052|6199614|P2|COMPLETED|Overall Study||127
2529739|NCT00663052|6199615|P1|COMPLETED|Overall Study||124
2529740|NCT00663052|6199614|P2|STARTED|Overall Study||137
2529741|NCT00663052|6199615|P1|STARTED|Overall Study||136
2529742|NCT00663039|6199695|P2|NOT COMPLETED|Overall Study||4
2529743|NCT00663039|6199696|P1|NOT COMPLETED|Overall Study||4
2529744|NCT00663039|6199695|P2|COMPLETED|Overall Study||9
2529745|NCT00663039|6199696|P1|COMPLETED|Overall Study||10
2529746|NCT00663039|6199695|P2|STARTED|Overall Study||13
2529747|NCT00663039|6199696|P1|STARTED|Overall Study||14
2529748|NCT00663026|6199721|P3|NOT COMPLETED|Overall Study||4
2529749|NCT00663026|6199722|P2|NOT COMPLETED|Overall Study||6
2529750|NCT00663026|6199723|P1|NOT COMPLETED|Overall Study||2
2529751|NCT00663026|6199721|P3|COMPLETED|Overall Study||27
2529752|NCT00663026|6199722|P2|COMPLETED|Overall Study||23
2529753|NCT00663026|6199723|P1|COMPLETED|Overall Study||17
2529754|NCT00663026|6199721|P3|STARTED|Overall Study||31
2529755|NCT00663026|6199722|P2|STARTED|Overall Study||29
2529756|NCT00663026|6199723|P1|STARTED|Overall Study||19
2529757|NCT00662909|6199746|P3|NOT COMPLETED|Overall Study||53
2529758|NCT00662909|6199747|P2|NOT COMPLETED|Overall Study||59
2529759|NCT00662909|6199748|P1|NOT COMPLETED|Overall Study||69
2529760|NCT00662909|6199746|P3|COMPLETED|Overall Study||380
2529761|NCT00662909|6199747|P2|COMPLETED|Overall Study||383
2529762|NCT00662909|6199748|P1|COMPLETED|Overall Study||385
2529763|NCT00662909|6199746|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|296
2529764|NCT00662909|6199747|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|312
2529765|NCT00662909|6199748|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|325
2529766|NCT00662909|6199746|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|412
2529767|NCT00662909|6199747|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|425
2529768|NCT00662909|6199748|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|433
2529769|NCT00662909|6199746|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
2529770|NCT00662909|6199747|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|442
2529771|NCT00662909|6199748|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|453
2529772|NCT00662909|6199746|P3|STARTED|Overall Study||433
2529773|NCT00662909|6199747|P2|STARTED|Overall Study||442
2529774|NCT00662909|6199748|P1|STARTED|Overall Study||454
2529775|NCT00662857|6199846|P2|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
2529776|NCT00662857|6199847|P1|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
2529777|NCT00662857|6199846|P2|COMPLETED|Lispro Dosing Period (1 Day)||14
2529778|NCT00662857|6199847|P1|COMPLETED|Lispro Dosing Period (1 Day)||12
2529779|NCT00662857|6199846|P2|STARTED|Lispro Dosing Period (1 Day)||14
2529780|NCT00662857|6199847|P1|STARTED|Lispro Dosing Period (1 Day)||12
2529781|NCT00662857|6199846|P2|NOT COMPLETED|Washout 2 (3 - 14 Days)||0
2529782|NCT00662857|6199847|P1|NOT COMPLETED|Washout 2 (3 - 14 Days)||1
2529783|NCT00662857|6199846|P2|COMPLETED|Washout 2 (3 - 14 Days)||14
2529784|NCT00662857|6199847|P1|COMPLETED|Washout 2 (3 - 14 Days)||12
2529785|NCT00662857|6199846|P2|STARTED|Washout 2 (3 - 14 Days)||14
2529786|NCT00662857|6199847|P1|STARTED|Washout 2 (3 - 14 Days)||13
2529787|NCT00662857|6199846|P2|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
2529788|NCT00662857|6199847|P1|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
2529789|NCT00662857|6199846|P2|COMPLETED|TI Dosing Period 2 (1 Day)||14
2529790|NCT00662857|6199847|P1|COMPLETED|TI Dosing Period 2 (1 Day)||13
2529791|NCT00662857|6199846|P2|STARTED|TI Dosing Period 2 (1 Day)||14
2529792|NCT00662857|6199847|P1|STARTED|TI Dosing Period 2 (1 Day)||13
2529793|NCT00662857|6199846|P2|NOT COMPLETED|Washout 1 (3 - 14 Days)||2
2529794|NCT00662857|6199847|P1|NOT COMPLETED|Washout 1 (3 - 14 Days)||0
2529795|NCT00662857|6199846|P2|COMPLETED|Washout 1 (3 - 14 Days)||14
2529796|NCT00662857|6199847|P1|COMPLETED|Washout 1 (3 - 14 Days)||13
2529797|NCT00662857|6199846|P2|STARTED|Washout 1 (3 - 14 Days)||16
2529798|NCT00662857|6199847|P1|STARTED|Washout 1 (3 - 14 Days)||13
2529799|NCT00662857|6199846|P2|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
2529800|NCT00662857|6199847|P1|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
2529801|NCT00662857|6199846|P2|COMPLETED|TI Dosing Period 1 (1 Day)||16
2529802|NCT00662857|6199847|P1|COMPLETED|TI Dosing Period 1 (1 Day)||13
2529803|NCT00662857|6199846|P2|STARTED|TI Dosing Period 1 (1 Day)||16
2529804|NCT00662857|6199847|P1|STARTED|TI Dosing Period 1 (1 Day)||13
2529805|NCT00662831|6199862|P2|NOT COMPLETED|Overall Study||59
2529806|NCT00662831|6199863|P1|NOT COMPLETED|Overall Study||106
2529807|NCT00662831|6199862|P2|COMPLETED|Overall Study||33
2529808|NCT00662831|6199863|P1|COMPLETED|Overall Study||78
2529809|NCT00662831|6199862|P2|STARTED|Overall Study||92
2529810|NCT00662831|6199863|P1|STARTED|Overall Study||184
2529811|NCT00662818|6199903|P2|NOT COMPLETED|Period 2 (6 Weeks)||12
2529812|NCT00662818|6199904|P1|NOT COMPLETED|Period 2 (6 Weeks)||13
2529813|NCT00662818|6199903|P2|COMPLETED|Period 2 (6 Weeks)||41
2529814|NCT00662818|6199904|P1|COMPLETED|Period 2 (6 Weeks)||38
2529815|NCT00662818|6199903|P2|STARTED|Period 2 (6 Weeks)||53
2529816|NCT00662818|6199904|P1|STARTED|Period 2 (6 Weeks)||51
2529817|NCT00662818|6199903|P2|NOT COMPLETED|Wash-Out (14 Days)||5
2529818|NCT00662818|6199904|P1|NOT COMPLETED|Wash-Out (14 Days)||5
2529819|NCT00662818|6199903|P2|COMPLETED|Wash-Out (14 Days)||53
2529820|NCT00662818|6199904|P1|COMPLETED|Wash-Out (14 Days)||51
2529821|NCT00662818|6199903|P2|STARTED|Wash-Out (14 Days)||58
2529822|NCT00662818|6199904|P1|STARTED|Wash-Out (14 Days)||56
2529823|NCT00662818|6199903|P2|NOT COMPLETED|Period 1 (6 Weeks)||23
2529824|NCT00662818|6199904|P1|NOT COMPLETED|Period 1 (6 Weeks)||28
2529825|NCT00662818|6199903|P2|COMPLETED|Period 1 (6 Weeks)||58
2529826|NCT00662818|6199904|P1|COMPLETED|Period 1 (6 Weeks)||56
2529827|NCT00662818|6199903|P2|Treated|Period 1 (6 Weeks)||58
2529828|NCT00662818|6199904|P1|Treated|Period 1 (6 Weeks)||56
2529829|NCT00662818|6199903|P2|STARTED|Period 1 (6 Weeks)||81
2529830|NCT00662818|6199904|P1|STARTED|Period 1 (6 Weeks)||84
2529831|NCT00662675|6199928|P2|NOT COMPLETED|Overall Study||0
2529832|NCT00662675|6199929|P1|NOT COMPLETED|Overall Study||0
2529833|NCT00662675|6199928|P2|COMPLETED|Overall Study||20
2529834|NCT00662675|6199929|P1|COMPLETED|Overall Study||20
2529835|NCT00662675|6199928|P2|STARTED|Overall Study||20
2529836|NCT00662675|6199929|P1|STARTED|Overall Study||20
2529837|NCT00662649|6199943|P5|NOT COMPLETED|Extension Study (Month 24 to 60)||29
2529838|NCT00662649|6199944|P4|NOT COMPLETED|Extension Study (Month 24 to 60)||33
2529839|NCT00662649|6199945|P3|NOT COMPLETED|Extension Study (Month 24 to 60)||0
2529840|NCT00662649|6199946|P2|NOT COMPLETED|Extension Study (Month 24 to 60)||41
2529841|NCT00662649|6199947|P1|NOT COMPLETED|Extension Study (Month 24 to 60)||44
2529842|NCT00662649|6199943|P5|COMPLETED|Extension Study (Month 24 to 60)||126
2529843|NCT00662649|6199944|P4|COMPLETED|Extension Study (Month 24 to 60)||112
2529844|NCT00662649|6199945|P3|COMPLETED|Extension Study (Month 24 to 60)||0
2529845|NCT00662649|6199946|P2|COMPLETED|Extension Study (Month 24 to 60)||290
2529846|NCT00662649|6199947|P1|COMPLETED|Extension Study (Month 24 to 60)|"completed refers to patients that completed extension study in different time points."|245
2529847|NCT00662649|6199943|P5|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||13
2529848|NCT00662649|6199944|P4|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||11
2529849|NCT00662649|6199945|P3|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||0
2529850|NCT00662649|6199946|P2|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||32
2529851|NCT00662649|6199947|P1|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||31
2529852|NCT00662649|6199943|P5|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||67
2529853|NCT00662649|6199944|P4|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||58
2529854|NCT00662649|6199945|P3|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||0
2529855|NCT00662649|6199946|P2|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||152
2529856|NCT00662649|6199947|P1|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||125
2529857|NCT00662649|6199943|P5|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||136
2529858|NCT00662649|6199944|P4|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||120
2529859|NCT00662649|6199945|P3|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||0
2529860|NCT00662649|6199946|P2|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||301
2529861|NCT00662649|6199947|P1|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||254
2529862|NCT00662649|6199943|P5|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||145
2529863|NCT00662649|6199944|P4|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||130
2529864|NCT00662649|6199945|P3|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||0
2529865|NCT00662649|6199946|P2|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||311
2529866|NCT00662649|6199947|P1|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||270
2529867|NCT00662649|6199943|P5|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||152
2529868|NCT00662649|6199944|P4|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||136
2529869|NCT00662649|6199945|P3|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||0
2529870|NCT00662649|6199946|P2|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||324
2529871|NCT00662649|6199947|P1|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||276
2529872|NCT00662649|6199943|P5|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||155
2529873|NCT00662649|6199944|P4|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||145
2529874|NCT00662649|6199945|P3|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||0
2529875|NCT00662649|6199946|P2|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||331
2529876|NCT00662649|6199947|P1|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||289
2529877|NCT00662649|6199943|P5|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||154
2529878|NCT00662649|6199944|P4|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||145
2529879|NCT00662649|6199945|P3|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||0
2529880|NCT00662649|6199946|P2|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||330
2529881|NCT00662649|6199947|P1|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||287
2529882|NCT00662649|6199943|P5|STARTED|Extension Study (Month 24 to 60)||155
2529883|NCT00662649|6199944|P4|STARTED|Extension Study (Month 24 to 60)||145
2529884|NCT00662649|6199945|P3|STARTED|Extension Study (Month 24 to 60)|This reporting group is used only for core study|0
2529885|NCT00662649|6199946|P2|STARTED|Extension Study (Month 24 to 60)||331
2529886|NCT00662649|6199947|P1|STARTED|Extension Study (Month 24 to 60)||289
2529887|NCT00662649|6199943|P5|NOT COMPLETED|Core Study (24 Months)||0
2529888|NCT00662649|6199944|P4|NOT COMPLETED|Core Study (24 Months)||0
2529889|NCT00662649|6199945|P3|NOT COMPLETED|Core Study (24 Months)||86
2529890|NCT00662649|6199946|P2|NOT COMPLETED|Core Study (24 Months)||56
2529891|NCT00662649|6199947|P1|NOT COMPLETED|Core Study (24 Months)||97
2529892|NCT00662649|6199943|P5|COMPLETED|Core Study (24 Months)||0
2529893|NCT00662649|6199944|P4|COMPLETED|Core Study (24 Months)||0
2529894|NCT00662649|6199945|P3|COMPLETED|Core Study (24 Months)||332
2529895|NCT00662649|6199946|P2|COMPLETED|Core Study (24 Months)||369
2529896|NCT00662649|6199947|P1|COMPLETED|Core Study (24 Months)||332
2529897|NCT00662649|6199943|P5|Intent to Treat (ITT)|Core Study (24 Months)||0
2529898|NCT00662649|6199944|P4|Intent to Treat (ITT)|Core Study (24 Months)||0
2529899|NCT00662649|6199945|P3|Intent to Treat (ITT)|Core Study (24 Months)||418
2529900|NCT00662649|6199946|P2|Intent to Treat (ITT)|Core Study (24 Months)||425
2529901|NCT00662649|6199947|P1|Intent to Treat (ITT)|Core Study (24 Months)||429
2529902|NCT00662649|6199943|P5|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
2529903|NCT00662649|6199944|P4|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
2529904|NCT00662649|6199945|P3|STARTED|Core Study (24 Months)||418
2529905|NCT00662649|6199946|P2|STARTED|Core Study (24 Months)||425
2529906|NCT00662649|6199947|P1|STARTED|Core Study (24 Months)||429
2529907|NCT00662558|6199987|P2|NOT COMPLETED|Overall Study||110
2529908|NCT00662558|6199988|P1|NOT COMPLETED|Overall Study||56
2529909|NCT00662558|6199987|P2|COMPLETED|Overall Study||294
2529910|NCT00662558|6199988|P1|COMPLETED|Overall Study||342
2529911|NCT00662558|6199987|P2|Received Treatment|Overall Study||396
2529912|NCT00662558|6199988|P1|Received Treatment|Overall Study||396
2529913|NCT00662558|6199987|P2|STARTED|Overall Study||404
2529914|NCT00662558|6199988|P1|STARTED|Overall Study||398
2529915|NCT00662545|6200022|P2|NOT COMPLETED|Overall Study||0
2529916|NCT00662545|6200023|P1|NOT COMPLETED|Overall Study||0
2529917|NCT00662545|6200022|P2|COMPLETED|Overall Study||5
2529918|NCT00662545|6200023|P1|COMPLETED|Overall Study||5
2529919|NCT00662545|6200022|P2|STARTED|Overall Study||5
2529920|NCT00662545|6200023|P1|STARTED|Overall Study||5
2529921|NCT00662532|6200039|P2|NOT COMPLETED|Overall Study||2
2529922|NCT00662532|6200040|P1|NOT COMPLETED|Overall Study||0
2529923|NCT00662532|6200039|P2|COMPLETED|Overall Study||20
2529924|NCT00662532|6200040|P1|COMPLETED|Overall Study||22
2529925|NCT00662532|6200039|P2|STARTED|Overall Study||22
2529926|NCT00662532|6200040|P1|STARTED|Overall Study||22
2529927|NCT00662389|6200050|P1|NOT COMPLETED|Overall Study||0
2529928|NCT00662389|6200050|P1|COMPLETED|Overall Study||4
2529929|NCT00662389|6200050|P1|STARTED|Overall Study||4
2529930|NCT00662363|6200055|P2|NOT COMPLETED|Overall Study||10
2529931|NCT00662363|6200056|P1|NOT COMPLETED|Overall Study||11
2529932|NCT00662363|6200055|P2|COMPLETED|Overall Study|one subject died before receiving any study med 2 subjects withdrew before taking any study med|22
2529933|NCT00662363|6200056|P1|COMPLETED|Overall Study|1 subject withdrew before taking any study medication|21
2529934|NCT00662363|6200055|P2|STARTED|Overall Study||32
2529935|NCT00662363|6200056|P1|STARTED|Overall Study||32
2529936|NCT00662311|6200067|P3|NOT COMPLETED|Overall Study||0
2529937|NCT00662311|6200068|P2|NOT COMPLETED|Overall Study||0
2529938|NCT00662311|6200069|P1|NOT COMPLETED|Overall Study||1
2529939|NCT00662311|6200067|P3|COMPLETED|Overall Study||0
2529940|NCT00662311|6200068|P2|COMPLETED|Overall Study||0
2529941|NCT00662311|6200069|P1|COMPLETED|Overall Study||4
2529942|NCT00662311|6200067|P3|STARTED|Overall Study||0
2529943|NCT00662311|6200068|P2|STARTED|Overall Study||0
2529944|NCT00662311|6200069|P1|STARTED|Overall Study||5
2529945|NCT00662298|6200092|P1|NOT COMPLETED|Overall Study||0
2529946|NCT00662298|6200092|P1|COMPLETED|Overall Study||5
2529947|NCT00662298|6200092|P1|STARTED|Overall Study||5
2529948|NCT00662259|6200104|P2|NOT COMPLETED|Overall Study||0
2529949|NCT00662259|6200105|P1|NOT COMPLETED|Overall Study||2
2529950|NCT00662259|6200104|P2|COMPLETED|Overall Study||11
2529951|NCT00662259|6200105|P1|COMPLETED|Overall Study||19
2529952|NCT00662259|6200104|P2|STARTED|Overall Study||11
2529953|NCT00662259|6200105|P1|STARTED|Overall Study||21
2529954|NCT00662207|6200119|P1|NOT COMPLETED|Overall Study||0
2529955|NCT00662207|6200119|P1|COMPLETED|Overall Study||3
2529956|NCT00662207|6200119|P1|STARTED|Overall Study||3
2529957|NCT00662155|6200130|P4|NOT COMPLETED|Overall Study||4
2529958|NCT00662155|6200131|P3|NOT COMPLETED|Overall Study||7
2529959|NCT00662155|6200132|P2|NOT COMPLETED|Overall Study||5
2529960|NCT00662155|6200133|P1|NOT COMPLETED|Overall Study||3
2529961|NCT00662155|6200130|P4|COMPLETED|Overall Study||14
2529962|NCT00662155|6200131|P3|COMPLETED|Overall Study||13
2529963|NCT00662155|6200132|P2|COMPLETED|Overall Study||15
2529964|NCT00662155|6200133|P1|COMPLETED|Overall Study||13
2529965|NCT00662155|6200130|P4|STARTED|Overall Study||18
2529966|NCT00662155|6200131|P3|STARTED|Overall Study||20
2529967|NCT00662155|6200132|P2|STARTED|Overall Study||20
2529968|NCT00662155|6200133|P1|STARTED|Overall Study||16
2529969|NCT00662129|6200147|P1|NOT COMPLETED|Overall Study||3
2529970|NCT00662129|6200147|P1|COMPLETED|Overall Study||47
2529971|NCT00662129|6200147|P1|STARTED|Overall Study||50
2529972|NCT00662038|6200157|P1|NOT COMPLETED|Overall Study||631
2529973|NCT00662038|6200157|P1|COMPLETED|Overall Study||427
2529974|NCT00662038|6200157|P1|STARTED|Overall Study||1058
2529975|NCT00662025|6200161|P1|NOT COMPLETED|Overall Study||63
2529976|NCT00662025|6200161|P1|COMPLETED|Overall Study||0
2529977|NCT00662025|6200161|P1|STARTED|Overall Study|All 63 participants were included in Full Analysis Set population.|63
2529978|NCT00662012|6200181|P1|NOT COMPLETED|Overall Study||87
2529979|NCT00662012|6200181|P1|COMPLETED|Overall Study||327
2529980|NCT00662012|6200181|P1|STARTED|Overall Study||414
2529981|NCT00661999|6200189|P3|NOT COMPLETED|Overall Study||57
2529982|NCT00661999|6200190|P2|NOT COMPLETED|Overall Study||50
2529983|NCT00661999|6200191|P1|NOT COMPLETED|Overall Study||59
2529984|NCT00661999|6200189|P3|COMPLETED|Overall Study||106
2529985|NCT00661999|6200190|P2|COMPLETED|Overall Study||113
2529986|NCT00661999|6200191|P1|COMPLETED|Overall Study||105
2529987|NCT00661999|6200189|P3|STARTED|Overall Study||163
2529988|NCT00661999|6200190|P2|STARTED|Overall Study||163
2529989|NCT00661999|6200191|P1|STARTED|Overall Study||164
2529990|NCT00661960|6200247|P3|NOT COMPLETED|Overall Study||1
2529991|NCT00661960|6200248|P2|NOT COMPLETED|Overall Study||3
2529992|NCT00661960|6200249|P1|NOT COMPLETED|Overall Study||0
2529993|NCT00661960|6200247|P3|COMPLETED|Overall Study||9
2529994|NCT00661960|6200248|P2|COMPLETED|Overall Study||7
2529995|NCT00661960|6200249|P1|COMPLETED|Overall Study||5
2529996|NCT00661960|6200247|P3|STARTED|Overall Study||10
2529997|NCT00661960|6200248|P2|STARTED|Overall Study||10
2529998|NCT00661960|6200249|P1|STARTED|Overall Study||5
2529999|NCT00661895|6200259|P2|NOT COMPLETED|Overall Study||0
2530000|NCT00661895|6200260|P1|NOT COMPLETED|Overall Study||0
2530001|NCT00661895|6200259|P2|COMPLETED|Overall Study||50
2530002|NCT00661895|6200260|P1|COMPLETED|Overall Study||49
2530003|NCT00661895|6200259|P2|STARTED|Overall Study||50
2530004|NCT00661895|6200260|P1|STARTED|Overall Study||49
2530005|NCT00661830|6200268|P2|NOT COMPLETED|Overall Study||42
2530006|NCT00661830|6200269|P1|NOT COMPLETED|Overall Study||40
2530007|NCT00661830|6200268|P2|COMPLETED|Overall Study||6
2530008|NCT00661830|6200269|P1|COMPLETED|Overall Study||9
2530009|NCT00661830|6200268|P2|STARTED|Overall Study||48
2530010|NCT00661830|6200269|P1|STARTED|Overall Study||49
2530011|NCT00661778|6200281|P1|NOT COMPLETED|Overall Study||50
2530012|NCT00661778|6200281|P1|COMPLETED|Overall Study||0
2530013|NCT00661778|6200281|P1|STARTED|Overall Study||50
2530014|NCT00661726|6200288|P1|NOT COMPLETED|Overall Study||1
2530015|NCT00661726|6200288|P1|COMPLETED|Overall Study||5
2530016|NCT00661726|6200288|P1|STARTED|Overall Study||6
2530017|NCT00661713|6200311|P8|NOT COMPLETED|Overall Study||11
2530018|NCT00661713|6200312|P7|NOT COMPLETED|Overall Study||64
2530019|NCT00661713|6200313|P6|NOT COMPLETED|Overall Study||37
2530020|NCT00661713|6200314|P5|NOT COMPLETED|Overall Study||20
2530021|NCT00661713|6200315|P4|NOT COMPLETED|Overall Study||28
2530022|NCT00661713|6200316|P3|NOT COMPLETED|Overall Study||17
2530023|NCT00661713|6200317|P2|NOT COMPLETED|Overall Study||39
2530024|NCT00661713|6200318|P1|NOT COMPLETED|Overall Study||16
2530025|NCT00661713|6200311|P8|COMPLETED|Overall Study||117
2530026|NCT00661713|6200312|P7|COMPLETED|Overall Study||309
2530027|NCT00661713|6200313|P6|COMPLETED|Overall Study||216
2530028|NCT00661713|6200314|P5|COMPLETED|Overall Study||107
2530029|NCT00661713|6200315|P4|COMPLETED|Overall Study||219
2530030|NCT00661713|6200316|P3|COMPLETED|Overall Study||111
2530031|NCT00661713|6200317|P2|COMPLETED|Overall Study||208
2530032|NCT00661713|6200318|P1|COMPLETED|Overall Study||112
2530033|NCT00661713|6200311|P8|STARTED|Overall Study||128
2530034|NCT00661713|6200312|P7|STARTED|Overall Study||373
2530035|NCT00661713|6200313|P6|STARTED|Overall Study||253
2530036|NCT00661713|6200314|P5|STARTED|Overall Study||127
2530037|NCT00661713|6200315|P4|STARTED|Overall Study||247
2530038|NCT00661713|6200316|P3|STARTED|Overall Study||128
2530039|NCT00661713|6200317|P2|STARTED|Overall Study||247
2530040|NCT00661713|6200318|P1|STARTED|Overall Study||128
2530041|NCT00661687|6200410|P1|NOT COMPLETED|Overall Study||15
2530042|NCT00661687|6200410|P1|COMPLETED|Overall Study|Number indicates number of subjects successfully completing study.|189
2530043|NCT00661687|6200410|P1|STARTED|Overall Study|Contralateral study design, numbers indicate number of subjects.|204
2530044|NCT00661674|6200420|P6|NOT COMPLETED|Overall Study||0
2530045|NCT00661674|6200421|P5|NOT COMPLETED|Overall Study||0
2530046|NCT00661674|6200422|P4|NOT COMPLETED|Overall Study||0
2530047|NCT00661674|6200423|P3|NOT COMPLETED|Overall Study||0
2530048|NCT00661674|6200424|P2|NOT COMPLETED|Overall Study||0
2530049|NCT00661674|6200425|P1|NOT COMPLETED|Overall Study||0
2530050|NCT00661674|6200420|P6|COMPLETED|Overall Study|Participant 9 completed sequence 6|1
2530051|NCT00661674|6200421|P5|COMPLETED|Overall Study|Participants 6 & 8 completed sequence 5|2
2530052|NCT00661674|6200422|P4|COMPLETED|Overall Study|Participant 5 completed sequence 4|1
2530053|NCT00661674|6200423|P3|COMPLETED|Overall Study|Participants 4 & 7 completed sequence 3|2
2530054|NCT00661674|6200424|P2|COMPLETED|Overall Study|Participants 2 & 3 completed sequence 2|2
2530055|NCT00661674|6200425|P1|COMPLETED|Overall Study|Participants 1 & 10 completed sequence 1|2
2530056|NCT00661674|6200420|P6|STARTED|Overall Study|Participant 9 was assigned to sequence 6|1
2530057|NCT00661674|6200421|P5|STARTED|Overall Study|Participants 6 & 8 were assigned to sequence 5|2
2530058|NCT00661674|6200422|P4|STARTED|Overall Study|Participant 5 was assigned to sequence 4|1
2530059|NCT00661674|6200423|P3|STARTED|Overall Study|Participants 4 & 7 were assigned to sequence 3|2
2530060|NCT00661674|6200424|P2|STARTED|Overall Study|Participants 2 & 3 were assigned to sequence 2|2
2530061|NCT00661674|6200425|P1|STARTED|Overall Study|Participants 1 & 10 were assigned to sequence 1|2
2530062|NCT00661661|6200438|P2|NOT COMPLETED|Overall Study||39
2530063|NCT00661661|6200439|P1|NOT COMPLETED|Overall Study||140
2530064|NCT00661661|6200438|P2|COMPLETED|Overall Study||66
2530065|NCT00661661|6200439|P1|COMPLETED|Overall Study||242
2530066|NCT00661661|6200438|P2|STARTED|Overall Study||105
2530067|NCT00661661|6200439|P1|STARTED|Overall Study||382
2530068|NCT00661622|6200515|P2|NOT COMPLETED|Overall Study||0
2530069|NCT00661622|6200516|P1|NOT COMPLETED|Overall Study||1
2530070|NCT00661622|6200515|P2|COMPLETED|Overall Study||27
2530071|NCT00661622|6200516|P1|COMPLETED|Overall Study||25
2530072|NCT00661622|6200515|P2|STARTED|Overall Study||27
2530073|NCT00661622|6200516|P1|STARTED|Overall Study||26
2530074|NCT00661609|6200530|P1|NOT COMPLETED|Overall Study||41
2530075|NCT00661609|6200530|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
2530076|NCT00661609|6200530|P1|STARTED|Overall Study|All dosed patients|41
2530077|NCT00661583|6200540|P3|NOT COMPLETED|Overall Study||0
2530078|NCT00661583|6200541|P2|NOT COMPLETED|Overall Study||0
2530079|NCT00661583|6200542|P1|NOT COMPLETED|Overall Study||0
2530080|NCT00661583|6200540|P3|COMPLETED|Overall Study||10
2530081|NCT00661583|6200541|P2|COMPLETED|Overall Study||10
2530082|NCT00661583|6200542|P1|COMPLETED|Overall Study||10
2530083|NCT00661583|6200540|P3|STARTED|Overall Study||10
2530084|NCT00661583|6200541|P2|STARTED|Overall Study||10
2530085|NCT00661583|6200542|P1|STARTED|Overall Study||10
2530086|NCT00661570|6200559|P1|NOT COMPLETED|Overall Study||0
2530087|NCT00661570|6200559|P1|COMPLETED|Overall Study||26
2530088|NCT00661570|6200559|P1|STARTED|Overall Study||26
2530089|NCT00661557|6200568|P2|NOT COMPLETED|Overall Study||0
2530090|NCT00661557|6200569|P1|NOT COMPLETED|Overall Study||9
2530091|NCT00661557|6200568|P2|COMPLETED|Overall Study||79
2530092|NCT00661557|6200569|P1|COMPLETED|Overall Study||183
2530093|NCT00661557|6200568|P2|STARTED|Overall Study||79
2530094|NCT00661557|6200569|P1|STARTED|Overall Study||192
2530095|NCT00661544|6200593|P1|NOT COMPLETED|Overall Study||0
2530096|NCT00661544|6200593|P1|COMPLETED|Overall Study||48
2530097|NCT00661544|6200593|P1|STARTED|Overall Study||48
2530098|NCT00661531|6200597|P1|NOT COMPLETED|Overall Study||3
2530099|NCT00661531|6200597|P1|COMPLETED|Overall Study||8
2530100|NCT00661531|6200597|P1|STARTED|Overall Study||11
2530101|NCT00661505|6200602|P1|NOT COMPLETED|Overall Study||30
2530102|NCT00661505|6200602|P1|COMPLETED|Overall Study||102
2530103|NCT00661505|6200602|P1|STARTED|Overall Study||132
2530104|NCT00661492|6200630|P2|NOT COMPLETED|Overall Study||29
2530105|NCT00661492|6200631|P1|NOT COMPLETED|Overall Study||68
2530106|NCT00661492|6200630|P2|COMPLETED|Overall Study||11
2530107|NCT00661492|6200631|P1|COMPLETED|Overall Study||7
2530108|NCT00661492|6200630|P2|STARTED|Overall Study||40
2530109|NCT00661492|6200631|P1|STARTED|Overall Study||75
2530110|NCT00661479|6200655|P4|NOT COMPLETED|Overall Study||0
2530111|NCT00661479|6200656|P3|NOT COMPLETED|Overall Study||0
2530112|NCT00661479|6200657|P2|NOT COMPLETED|Overall Study||0
2530113|NCT00661479|6200658|P1|NOT COMPLETED|Overall Study||0
2530114|NCT00661479|6200655|P4|COMPLETED|Overall Study||3
2530115|NCT00661479|6200656|P3|COMPLETED|Overall Study||3
2530116|NCT00661479|6200657|P2|COMPLETED|Overall Study||3
2530117|NCT00661479|6200658|P1|COMPLETED|Overall Study||12
2530118|NCT00661479|6200655|P4|STARTED|Overall Study||3
2530119|NCT00661479|6200656|P3|STARTED|Overall Study||3
2530120|NCT00661479|6200657|P2|STARTED|Overall Study||3
2530121|NCT00661479|6200658|P1|STARTED|Overall Study||12
2530122|NCT00661453|6200671|P1|NOT COMPLETED|Overall Study||13
2530123|NCT00661453|6200671|P1|COMPLETED|Overall Study||25
2530124|NCT00661453|6200671|P1|STARTED|Overall Study||38
2530125|NCT00661427|6200677|P2|NOT COMPLETED|Overall Study||7
2530126|NCT00661427|6200678|P1|NOT COMPLETED|Overall Study||5
2530127|NCT00661427|6200677|P2|COMPLETED|Overall Study||19
2530128|NCT00661427|6200678|P1|COMPLETED|Overall Study||30
2530129|NCT00661427|6200677|P2|STARTED|Overall Study||26
2530130|NCT00661427|6200678|P1|STARTED|Overall Study||35
2530131|NCT00661388|6200686|P1|NOT COMPLETED|Overall Study||24
2530132|NCT00661388|6200686|P1|COMPLETED|Overall Study||51
2530133|NCT00661388|6200686|P1|STARTED|Overall Study||75
2530134|NCT00661362|6200709|P2|NOT COMPLETED|Overall Study||40
2530135|NCT00661362|6200710|P1|NOT COMPLETED|Overall Study||29
2530136|NCT00661362|6200709|P2|COMPLETED|Overall Study|Completed 24 Weeks of treatment|247
2530137|NCT00661362|6200710|P1|COMPLETED|Overall Study|Completed 24 Weeks of treatment|254
2530138|NCT00661362|6200709|P2|STARTED|Overall Study|Randomized and treated|287
2530139|NCT00661362|6200710|P1|STARTED|Overall Study|Randomized and treated|283
2530140|NCT00661271|6200728|P2|NOT COMPLETED|Overall Study||25
2530141|NCT00661271|6200729|P1|NOT COMPLETED|Overall Study||28
2530142|NCT00661271|6200728|P2|COMPLETED|Overall Study||20
2530143|NCT00661271|6200729|P1|COMPLETED|Overall Study||20
2530144|NCT00661271|6200728|P2|STARTED|Overall Study||45
2530145|NCT00661271|6200729|P1|STARTED|Overall Study||48
2530146|NCT00661258|6200739|P2|NOT COMPLETED|Overall Study||1
2530147|NCT00661258|6200740|P1|NOT COMPLETED|Overall Study||3
2530148|NCT00661258|6200739|P2|COMPLETED|Overall Study||33
2530149|NCT00661258|6200740|P1|COMPLETED|Overall Study||31
2530150|NCT00661258|6200739|P2|STARTED|Overall Study||34
2530151|NCT00661258|6200740|P1|STARTED|Overall Study||34
2530158|NCT00661141|6200762|P6|NOT COMPLETED|Overall Study||0
2530159|NCT00661141|6200763|P5|NOT COMPLETED|Overall Study||0
2530160|NCT00661141|6200764|P4|NOT COMPLETED|Overall Study||0
2530161|NCT00661141|6200765|P3|NOT COMPLETED|Overall Study||0
2530162|NCT00661141|6200766|P2|NOT COMPLETED|Overall Study||0
2530163|NCT00661141|6200767|P1|NOT COMPLETED|Overall Study||0
2530164|NCT00661141|6200762|P6|COMPLETED|Overall Study||4
2530165|NCT00661141|6200763|P5|COMPLETED|Overall Study||4
2530166|NCT00661141|6200764|P4|COMPLETED|Overall Study||4
2530167|NCT00661141|6200765|P3|COMPLETED|Overall Study||4
2530168|NCT00661141|6200766|P2|COMPLETED|Overall Study||8
2530169|NCT00661141|6200767|P1|COMPLETED|Overall Study||8
2530170|NCT00661141|6200762|P6|Administered 30 Minutes After Ethanol|Overall Study||0
2530171|NCT00661141|6200763|P5|Administered 30 Minutes After Ethanol|Overall Study||0
2530172|NCT00661141|6200764|P4|Administered 30 Minutes After Ethanol|Overall Study||2
2530173|NCT00661141|6200765|P3|Administered 30 Minutes After Ethanol|Overall Study||2
2530174|NCT00661141|6200766|P2|Administered 30 Minutes After Ethanol|Overall Study||2
2530175|NCT00661141|6200767|P1|Administered 30 Minutes After Ethanol|Overall Study||2
2530176|NCT00661141|6200762|P6|Administered 30 Minutes Prior to Ethanol|Overall Study||4
2530177|NCT00661141|6200763|P5|Administered 30 Minutes Prior to Ethanol|Overall Study||4
2530178|NCT00661141|6200764|P4|Administered 30 Minutes Prior to Ethanol|Overall Study||2
2530179|NCT00661141|6200765|P3|Administered 30 Minutes Prior to Ethanol|Overall Study||2
2530180|NCT00661141|6200766|P2|Administered 30 Minutes Prior to Ethanol|Overall Study||6
2530181|NCT00661141|6200767|P1|Administered 30 Minutes Prior to Ethanol|Overall Study||6
2530182|NCT00661141|6200762|P6|STARTED|Overall Study||4
2530183|NCT00661141|6200763|P5|STARTED|Overall Study||4
2530184|NCT00661141|6200764|P4|STARTED|Overall Study||4
2530185|NCT00661141|6200765|P3|STARTED|Overall Study||4
2530186|NCT00661141|6200766|P2|STARTED|Overall Study||8
2530187|NCT00661141|6200767|P1|STARTED|Overall Study||8
2530188|NCT00661089|6200976|P2|NOT COMPLETED|Overall Study||2
2530189|NCT00661089|6200977|P1|NOT COMPLETED|Overall Study||0
2530190|NCT00661089|6200976|P2|COMPLETED|Overall Study||9
2530191|NCT00661089|6200977|P1|COMPLETED|Overall Study||10
2530192|NCT00661089|6200976|P2|STARTED|Overall Study||11
2530193|NCT00661089|6200977|P1|STARTED|Overall Study||10
2530194|NCT00661037|6200987|P2|NOT COMPLETED|Overall Study||257
2530195|NCT00661037|6200988|P1|NOT COMPLETED|Overall Study||154
2530196|NCT00661037|6200987|P2|COMPLETED|Overall Study||1027
2530197|NCT00661037|6200988|P1|COMPLETED|Overall Study||682
2530198|NCT00661037|6200987|P2|Deaths|Overall Study||188
2530199|NCT00661037|6200988|P1|Deaths|Overall Study||108
2530200|NCT00661037|6200987|P2|Witdrawn|Overall Study||68
2530201|NCT00661037|6200988|P1|Witdrawn|Overall Study||47
2530202|NCT00661037|6200987|P2|STARTED|Overall Study||1284
2530203|NCT00661037|6200988|P1|STARTED|Overall Study||836
2530204|NCT00660985|6201000|P2|NOT COMPLETED|Overall Study||0
2530205|NCT00660985|6201001|P1|NOT COMPLETED|Overall Study||1
2530206|NCT00660985|6201000|P2|COMPLETED|Overall Study||25
2530207|NCT00660985|6201001|P1|COMPLETED|Overall Study||25
2530208|NCT00660985|6201000|P2|STARTED|Overall Study||25
2530209|NCT00660985|6201001|P1|STARTED|Overall Study||26
2530210|NCT00660907|6201025|P2|NOT COMPLETED|Overall Study||94
2530211|NCT00660907|6201026|P1|NOT COMPLETED|Overall Study||84
2530212|NCT00660907|6201025|P2|COMPLETED|Overall Study||314
2530213|NCT00660907|6201026|P1|COMPLETED|Overall Study||322
2530214|NCT00660907|6201025|P2|STARTED|Overall Study|Of the 408 randomized participants only 401 were included in the full analysis set.|408
2530215|NCT00660907|6201026|P1|STARTED|Overall Study|Of the 406 randomized participants only 400 were included in the full analysis set.|406
2530216|NCT00660829|6201040|P2|NOT COMPLETED|Overall Study||19
2530217|NCT00660829|6201041|P1|NOT COMPLETED|Overall Study||18
2530218|NCT00660829|6201040|P2|COMPLETED|Overall Study||249
2530219|NCT00660829|6201041|P1|COMPLETED|Overall Study||250
2530220|NCT00660829|6201040|P2|STARTED|Overall Study|2 subjects were randomized in error|268
2530221|NCT00660829|6201041|P1|STARTED|Overall Study|2 subjects were randomized in error|268
2530222|NCT00660816|6201059|P2|NOT COMPLETED|Overall Study||19
2530223|NCT00660816|6201060|P1|NOT COMPLETED|Overall Study||20
2530224|NCT00660816|6201059|P2|COMPLETED|Overall Study||3
2530225|NCT00660816|6201060|P1|COMPLETED|Overall Study||4
2530226|NCT00660816|6201059|P2|STARTED|Overall Study||22
2530227|NCT00660816|6201060|P1|STARTED|Overall Study||24
2530228|NCT00660699|6201072|P1|NOT COMPLETED|Overall Study||2
2530229|NCT00660699|6201072|P1|COMPLETED|Overall Study||48
2530230|NCT00660699|6201072|P1|STARTED|Overall Study||50
2530231|NCT00660660|6201088|P2|NOT COMPLETED|Overall Study||9
2530232|NCT00660660|6201089|P1|NOT COMPLETED|Overall Study||5
2530233|NCT00660660|6201088|P2|COMPLETED|Overall Study|Number of completed patients is based on randomized population (133) minus withdrawals (9).|124
2530234|NCT00660660|6201089|P1|COMPLETED|Overall Study|Number of completed patients is based on randomized population (143) minus withdrawals (5).|138
2530235|NCT00660660|6201088|P2|Met Criteria for MITT Population|Overall Study||125
2530236|NCT00660660|6201089|P1|Met Criteria for MITT Population|Overall Study||137
2530237|NCT00660660|6201088|P2|STARTED|Overall Study|Randomized|133
2530238|NCT00660660|6201089|P1|STARTED|Overall Study|Randomized|143
2530239|NCT00660595|6201189|P2|NOT COMPLETED|Overall Study||9
2530240|NCT00660595|6201190|P1|NOT COMPLETED|Overall Study||18
2530241|NCT00660595|6201189|P2|COMPLETED|Overall Study|One of the two was lost to follow-up|1
2530242|NCT00660595|6201190|P1|COMPLETED|Overall Study||1
2530243|NCT00660595|6201189|P2|STARTED|Overall Study||10
2530244|NCT00660595|6201190|P1|STARTED|Overall Study||19
2530245|NCT00660543|6201202|P1|NOT COMPLETED|Overall Study||0
2530246|NCT00660543|6201202|P1|COMPLETED|Overall Study||14
2530247|NCT00660543|6201202|P1|STARTED|Overall Study||14
2530248|NCT00660517|6201215|P4|NOT COMPLETED|Overall Study||7
2530249|NCT00660517|6201216|P3|NOT COMPLETED|Overall Study||7
2530250|NCT00660517|6201217|P2|NOT COMPLETED|Overall Study||8
2530251|NCT00660517|6201218|P1|NOT COMPLETED|Overall Study||8
2530252|NCT00660517|6201215|P4|COMPLETED|Overall Study||144
2530253|NCT00660517|6201216|P3|COMPLETED|Overall Study||144
2530254|NCT00660517|6201217|P2|COMPLETED|Overall Study||144
2530255|NCT00660517|6201218|P1|COMPLETED|Overall Study||145
2530256|NCT00660517|6201215|P4|STARTED|Overall Study||151
2530257|NCT00660517|6201216|P3|STARTED|Overall Study||151
2530258|NCT00660517|6201217|P2|STARTED|Overall Study||152
2530259|NCT00660517|6201218|P1|STARTED|Overall Study||153
2530260|NCT00660504|6201238|P2|NOT COMPLETED|Overall Study||1
2530261|NCT00660504|6201239|P1|NOT COMPLETED|Overall Study||0
2530262|NCT00660504|6201238|P2|COMPLETED|Overall Study||150
2530263|NCT00660504|6201239|P1|COMPLETED|Overall Study||149
2530264|NCT00660504|6201238|P2|STARTED|Overall Study||151
2530265|NCT00660504|6201239|P1|STARTED|Overall Study||149
2530266|NCT00660400|6201251|P1|NOT COMPLETED|Overall Study||4
2530267|NCT00660400|6201251|P1|COMPLETED|Overall Study||21
2530268|NCT00660400|6201251|P1|STARTED|Overall Study||25
2530269|NCT00660387|6201260|P2|NOT COMPLETED|Overall Study||3
2530270|NCT00660387|6201261|P1|NOT COMPLETED|Overall Study||2
2530271|NCT00660387|6201260|P2|COMPLETED|Overall Study||31
2530272|NCT00660387|6201261|P1|COMPLETED|Overall Study||35
2530273|NCT00660387|6201260|P2|STARTED|Overall Study||34
2530274|NCT00660387|6201261|P1|STARTED|Overall Study||37
2530275|NCT00660348|6201315|P2|NOT COMPLETED|Overall Study||0
2530276|NCT00660348|6201316|P1|NOT COMPLETED|Overall Study||1
2530277|NCT00660348|6201315|P2|COMPLETED|Overall Study||0
2530278|NCT00660348|6201316|P1|COMPLETED|Overall Study||0
2530279|NCT00660348|6201315|P2|STARTED|Overall Study||0
2530280|NCT00660348|6201316|P1|STARTED|Overall Study||1
2530281|NCT00660309|6201324|P2|NOT COMPLETED|Overall Study||3
2530282|NCT00660309|6201325|P1|NOT COMPLETED|Overall Study||2
2530283|NCT00660309|6201324|P2|COMPLETED|Overall Study||19
2530284|NCT00660309|6201325|P1|COMPLETED|Overall Study||21
2530285|NCT00660309|6201324|P2|Pharmacodynamic Analysis Set|Overall Study||20
2530286|NCT00660309|6201325|P1|Pharmacodynamic Analysis Set|Overall Study||22
2530287|NCT00660309|6201324|P2|Treated With Aliskiren or Irbesartan|Overall Study||21
2530288|NCT00660309|6201325|P1|Treated With Aliskiren or Irbesartan|Overall Study||22
2530289|NCT00660309|6201324|P2|STARTED|Overall Study|Represents participants who received one dose of Captopril.|22
2530290|NCT00660309|6201325|P1|STARTED|Overall Study|Represents participants who received one dose of Captopril.|23
2530291|NCT00660192|6201366|P2|NOT COMPLETED|Overall Study||3
2530292|NCT00660192|6201367|P1|NOT COMPLETED|Overall Study||2
2530293|NCT00660192|6201366|P2|COMPLETED|Overall Study||10
2530294|NCT00660192|6201367|P1|COMPLETED|Overall Study||10
2530295|NCT00660192|6201366|P2|STARTED|Overall Study||13
2530296|NCT00660192|6201367|P1|STARTED|Overall Study||12
2530297|NCT00660179|6201378|P3|NOT COMPLETED|Overall Study||41
2530298|NCT00660179|6201379|P2|NOT COMPLETED|Overall Study||58
2530299|NCT00660179|6201380|P1|NOT COMPLETED|Overall Study||56
2530300|NCT00660179|6201378|P3|COMPLETED|Overall Study||201
2530301|NCT00660179|6201379|P2|COMPLETED|Overall Study||192
2530302|NCT00660179|6201380|P1|COMPLETED|Overall Study||194
2530303|NCT00660179|6201378|P3|STARTED|Overall Study||242
2530304|NCT00660179|6201379|P2|STARTED|Overall Study||250
2530305|NCT00660179|6201380|P1|STARTED|Overall Study||250
2530306|NCT00660075|6201414|P2|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
2530307|NCT00660075|6201415|P1|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
2530308|NCT00660075|6201414|P2|COMPLETED|Second Intervention (Week 11 to Week 16||18
2530309|NCT00660075|6201415|P1|COMPLETED|Second Intervention (Week 11 to Week 16||18
2530310|NCT00660075|6201414|P2|STARTED|Second Intervention (Week 11 to Week 16||18
2530311|NCT00660075|6201415|P1|STARTED|Second Intervention (Week 11 to Week 16||18
2530312|NCT00660075|6201414|P2|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
2530313|NCT00660075|6201415|P1|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
2530314|NCT00660075|6201414|P2|COMPLETED|Washout Period (Week 7 to Week 10)||18
2530315|NCT00660075|6201415|P1|COMPLETED|Washout Period (Week 7 to Week 10)||18
2530316|NCT00660075|6201414|P2|STARTED|Washout Period (Week 7 to Week 10)||18
2530317|NCT00660075|6201415|P1|STARTED|Washout Period (Week 7 to Week 10)||18
2530318|NCT00660075|6201414|P2|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
2530319|NCT00660075|6201415|P1|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
2530320|NCT00660075|6201414|P2|COMPLETED|First Intervention (Week 1 to Week 6)||18
2530321|NCT00660075|6201415|P1|COMPLETED|First Intervention (Week 1 to Week 6)||18
2530322|NCT00660075|6201414|P2|STARTED|First Intervention (Week 1 to Week 6)||18
2530323|NCT00660075|6201415|P1|STARTED|First Intervention (Week 1 to Week 6)||18
2530324|NCT00660049|6201421|P1|NOT COMPLETED|Overall Study||6
2530325|NCT00660049|6201421|P1|COMPLETED|Overall Study||6
2530326|NCT00660049|6201421|P1|STARTED|Overall Study||12
2530327|NCT00660023|6201425|P1|NOT COMPLETED|Overall Study||29
2530328|NCT00660023|6201425|P1|COMPLETED|Overall Study||95
2530329|NCT00660023|6201425|P1|Treated|Overall Study||114
2530330|NCT00660023|6201425|P1|STARTED|Overall Study||124
2530331|NCT00660010|6201436|P1|NOT COMPLETED|Overall Study||9
2530332|NCT00660010|6201436|P1|COMPLETED|Overall Study||46
2530333|NCT00660010|6201436|P1|STARTED|Overall Study||55
2530334|NCT00659984|6201450|P1|NOT COMPLETED|Overall Study||1
2530335|NCT00659984|6201450|P1|COMPLETED|Overall Study||14
2530336|NCT00659984|6201450|P1|STARTED|Overall Study||15
2530337|NCT00659945|6201463|P2|NOT COMPLETED|Overall Study||0
2530338|NCT00659945|6201464|P1|NOT COMPLETED|Overall Study||0
2530339|NCT00659945|6201463|P2|COMPLETED|Overall Study||75
2530340|NCT00659945|6201464|P1|COMPLETED|Overall Study||75
2530341|NCT00659945|6201463|P2|STARTED|Overall Study||75
2530342|NCT00659945|6201464|P1|STARTED|Overall Study||75
2530343|NCT00659880|6201470|P1|NOT COMPLETED|Overall Study||5
2530344|NCT00659880|6201470|P1|COMPLETED|Overall Study|60 months|4
2530345|NCT00659880|6201470|P1|24 Months|Overall Study||6
2530346|NCT00659880|6201470|P1|12 Months|Overall Study||7
2530347|NCT00659880|6201470|P1|6 Months|Overall Study||9
2530348|NCT00659880|6201470|P1|6 Weeks|Overall Study||9
2530349|NCT00659880|6201470|P1|STARTED|Overall Study||9
2530350|NCT00659828|6201475|P1|NOT COMPLETED|Overall Study||0
2530351|NCT00659828|6201475|P1|COMPLETED|Overall Study||1
2530352|NCT00659828|6201475|P1|STARTED|Overall Study||1
2530353|NCT00659815|6201483|P2|NOT COMPLETED|Overall Study||4
2530354|NCT00659815|6201484|P1|NOT COMPLETED|Overall Study||4
2530355|NCT00659815|6201483|P2|COMPLETED|Overall Study||147
2530356|NCT00659815|6201484|P1|COMPLETED|Overall Study||153
2530357|NCT00659815|6201483|P2|STARTED|Overall Study||151
2530358|NCT00659815|6201484|P1|STARTED|Overall Study||157
2530359|NCT00659789|6201496|P2|NOT COMPLETED|Overall Study||7
2530360|NCT00659789|6201497|P1|NOT COMPLETED|Overall Study||7
2530361|NCT00659789|6201496|P2|COMPLETED|Overall Study||36
2530362|NCT00659789|6201497|P1|COMPLETED|Overall Study||86
2530363|NCT00659789|6201496|P2|STARTED|Overall Study||43
2530364|NCT00659789|6201497|P1|STARTED|Overall Study||93
2530365|NCT00659737|6201515|P2|NOT COMPLETED|Overall Study||0
2530366|NCT00659737|6201516|P1|NOT COMPLETED|Overall Study||0
2530367|NCT00659737|6201515|P2|COMPLETED|Overall Study||58
2530368|NCT00659737|6201516|P1|COMPLETED|Overall Study||57
2530369|NCT00659737|6201515|P2|STARTED|Overall Study||58
2530370|NCT00659737|6201516|P1|STARTED|Overall Study||57
2530371|NCT00659724|6201522|P1|NOT COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||0
2530372|NCT00659724|6201522|P1|COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||33
2530373|NCT00659724|6201522|P1|STARTED|Weeks 3-4: Assessment of HD-C4 Big||33
2530374|NCT00659724|6201522|P1|NOT COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||0
2530375|NCT00659724|6201522|P1|COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||33
2530376|NCT00659724|6201522|P1|STARTED|Weeks 1-2: Assessment of 180NR or 200NR||33
2530377|NCT00659633|6201540|P1|NOT COMPLETED|Overall Study||0
2530378|NCT00659633|6201540|P1|COMPLETED|Overall Study||10
2530379|NCT00659633|6201540|P1|STARTED|Overall Study||10
2530380|NCT00659607|6201544|P1|NOT COMPLETED|Overall Study||316
2530381|NCT00659607|6201544|P1|COMPLETED|Overall Study||3616
2530382|NCT00659607|6201544|P1|STARTED|Overall Study||3932
2530383|NCT00659581|6201562|P1|NOT COMPLETED|Overall Study||8582
2530384|NCT00659581|6201562|P1|COMPLETED|Overall Study||12412
2530385|NCT00659581|6201562|P1|STARTED|Overall Study||20994
2530386|NCT00659529|6201574|P1|NOT COMPLETED|Overall Study||16
2530387|NCT00659529|6201574|P1|COMPLETED|Overall Study|4 patients withdrew as a result of side effects. 3 subjects were withdrawn by the investigator.|20
2530388|NCT00659529|6201574|P1|Received at Least One Dose of Study Drug|Overall Study|Received at least one dose of study drug|27
2530389|NCT00659529|6201574|P1|STARTED|Overall Study|There were 9 screen failures (subjects who did not meet inclusion/exclusion criteria)|36
2530390|NCT00659490|6201581|P3|NOT COMPLETED|Overall Study||1
2530391|NCT00659490|6201582|P2|NOT COMPLETED|Overall Study||0
2530392|NCT00659490|6201583|P1|NOT COMPLETED|Overall Study||2
2530393|NCT00659490|6201581|P3|COMPLETED|Overall Study||30
2530394|NCT00659490|6201582|P2|COMPLETED|Overall Study||59
2530395|NCT00659490|6201583|P1|COMPLETED|Overall Study||59
2530396|NCT00659490|6201581|P3|STARTED|Overall Study||31
2530397|NCT00659490|6201582|P2|STARTED|Overall Study||59
2530398|NCT00659490|6201583|P1|STARTED|Overall Study||61
2530399|NCT00659438|6201656|P2|NOT COMPLETED|Overall Study||8
2530400|NCT00659438|6201657|P1|NOT COMPLETED|Overall Study||14
2530401|NCT00659438|6201656|P2|COMPLETED|Overall Study||40
2530402|NCT00659438|6201657|P1|COMPLETED|Overall Study||33
2530403|NCT00659438|6201656|P2|Safety Analysis Set|Overall Study||47
2530404|NCT00659438|6201657|P1|Safety Analysis Set|Overall Study|One patient randomized to placebo was accounted in vandetanib group as he mistakenly received drug|48
2530405|NCT00659438|6201656|P2|Secondary Analysis Set|Overall Study||48
2530406|NCT00659438|6201657|P1|Secondary Analysis Set|Overall Study||47
2530407|NCT00659438|6201656|P2|Assessable Set : Primary Analysis|Overall Study||45
2530408|NCT00659438|6201657|P1|Assessable Set : Primary Analysis|Overall Study||44
2530409|NCT00659438|6201656|P2|STARTED|Overall Study||48
2530410|NCT00659438|6201657|P1|STARTED|Overall Study||47
2530411|NCT00659425|6201689|P10|NOT COMPLETED|Overall Study||13
2530412|NCT00659425|6201690|P9|NOT COMPLETED|Overall Study||6
2530413|NCT00659425|6201691|P8|NOT COMPLETED|Overall Study||11
2530414|NCT00659425|6201692|P7|NOT COMPLETED|Overall Study||8
2530415|NCT00659425|6201693|P6|NOT COMPLETED|Overall Study||4
2530416|NCT00659425|6201694|P5|NOT COMPLETED|Overall Study||4
2530417|NCT00659425|6201695|P4|NOT COMPLETED|Overall Study||4
2530418|NCT00659425|6201696|P3|NOT COMPLETED|Overall Study||1
2530419|NCT00659425|6201697|P2|NOT COMPLETED|Overall Study||1
2530420|NCT00659425|6201698|P1|NOT COMPLETED|Overall Study||1
2530421|NCT00659425|6201689|P10|COMPLETED|Overall Study||1
2530422|NCT00659425|6201690|P9|COMPLETED|Overall Study||0
2530423|NCT00659425|6201691|P8|COMPLETED|Overall Study||0
2530424|NCT00659425|6201692|P7|COMPLETED|Overall Study||0
2530425|NCT00659425|6201693|P6|COMPLETED|Overall Study||1
2530426|NCT00659425|6201694|P5|COMPLETED|Overall Study||0
2530427|NCT00659425|6201695|P4|COMPLETED|Overall Study||0
2530428|NCT00659425|6201696|P3|COMPLETED|Overall Study||0
2530429|NCT00659425|6201697|P2|COMPLETED|Overall Study||0
2530430|NCT00659425|6201698|P1|COMPLETED|Overall Study||0
2530431|NCT00659425|6201689|P10|STARTED|Overall Study||14
2530432|NCT00659425|6201690|P9|STARTED|Overall Study||6
2530433|NCT00659425|6201691|P8|STARTED|Overall Study||11
2530434|NCT00659425|6201692|P7|STARTED|Overall Study||8
2530435|NCT00659425|6201693|P6|STARTED|Overall Study||5
2530436|NCT00659425|6201694|P5|STARTED|Overall Study||4
2530437|NCT00659425|6201695|P4|STARTED|Overall Study||4
2530438|NCT00659425|6201696|P3|STARTED|Overall Study||1
2530439|NCT00659425|6201697|P2|STARTED|Overall Study||1
2530440|NCT00659425|6201698|P1|STARTED|Overall Study||1
2530441|NCT00659373|6201929|P2|NOT COMPLETED|Overall Study||7
2530442|NCT00659373|6201930|P1|NOT COMPLETED|Overall Study||5
2530443|NCT00659373|6201929|P2|COMPLETED|Overall Study||54
2530444|NCT00659373|6201930|P1|COMPLETED|Overall Study||20
2530445|NCT00659373|6201929|P2|STARTED|Overall Study||61
2530446|NCT00659373|6201930|P1|STARTED|Overall Study||25
2530447|NCT00659360|6201936|P1|NOT COMPLETED|Overall Study||0
2530448|NCT00659360|6201936|P1|COMPLETED|Overall Study||17
2530449|NCT00659360|6201936|P1|STARTED|Overall Study||17
2530450|NCT00659334|6201952|P7|NOT COMPLETED|Overall Study||1
2530451|NCT00659334|6201953|P6|NOT COMPLETED|Overall Study||0
2530452|NCT00659334|6201954|P5|NOT COMPLETED|Overall Study||0
2530453|NCT00659334|6201955|P4|NOT COMPLETED|Overall Study||0
2530454|NCT00659334|6201956|P3|NOT COMPLETED|Overall Study||0
2530455|NCT00659334|6201957|P2|NOT COMPLETED|Overall Study||5
2530456|NCT00659334|6201958|P1|NOT COMPLETED|Overall Study||8
2530457|NCT00659334|6201952|P7|COMPLETED|Overall Study|1 screen failure|20
2530458|NCT00659334|6201953|P6|COMPLETED|Overall Study||0
2530459|NCT00659334|6201954|P5|COMPLETED|Overall Study||1
2530460|NCT00659334|6201955|P4|COMPLETED|Overall Study||2
2530461|NCT00659334|6201956|P3|COMPLETED|Overall Study||5
2530462|NCT00659334|6201957|P2|COMPLETED|Overall Study|5 Screen failures|36
2530463|NCT00659334|6201958|P1|COMPLETED|Overall Study|8 Screen failures|38
2530464|NCT00659334|6201952|P7|STARTED|Overall Study||21
2530465|NCT00659334|6201953|P6|STARTED|Overall Study||0
2530466|NCT00659334|6201954|P5|STARTED|Overall Study||1
2530467|NCT00659334|6201955|P4|STARTED|Overall Study||2
2530468|NCT00659334|6201956|P3|STARTED|Overall Study||5
2530469|NCT00659334|6201957|P2|STARTED|Overall Study||41
2530470|NCT00659334|6201958|P1|STARTED|Overall Study||46
2530471|NCT00659295|6201976|P2|NOT COMPLETED|Overall Study||5603
2530472|NCT00659295|6201977|P1|NOT COMPLETED|Overall Study||2708
2530473|NCT00659295|6201976|P2|COMPLETED|Overall Study||32038
2530474|NCT00659295|6201977|P1|COMPLETED|Overall Study||10821
2530475|NCT00659295|6201976|P2|STARTED|Overall Study||37641
2530476|NCT00659295|6201977|P1|STARTED|Overall Study||13529
2530477|NCT00659269|6201985|P2|NOT COMPLETED|Overall Study||1
2530478|NCT00659269|6201986|P1|NOT COMPLETED|Overall Study||1
2530479|NCT00659269|6201985|P2|COMPLETED|Overall Study||161
2530480|NCT00659269|6201986|P1|COMPLETED|Overall Study||156
2530481|NCT00659269|6201985|P2|Group 3 (Taxanes)|Overall Study||97
2530482|NCT00659269|6201986|P1|Group 3 (Taxanes)|Overall Study||92
2530483|NCT00659269|6201985|P2|Group 2 (Vinca Alkaloids)|Overall Study||12
2530484|NCT00659269|6201986|P1|Group 2 (Vinca Alkaloids)|Overall Study||12
2530485|NCT00659269|6201985|P2|Group 1 (Heavy Metals)|Overall Study||52
2530486|NCT00659269|6201986|P1|Group 1 (Heavy Metals)|Overall Study||52
2530487|NCT00659269|6201985|P2|STARTED|Overall Study||162
2530488|NCT00659269|6201986|P1|STARTED|Overall Study||157
2530489|NCT00659230|6202016|P2|NOT COMPLETED|Overall Study||12
2530490|NCT00659230|6202017|P1|NOT COMPLETED|Overall Study||9
2530491|NCT00659230|6202016|P2|COMPLETED|Overall Study||37
2530492|NCT00659230|6202017|P1|COMPLETED|Overall Study||42
2530493|NCT00659230|6202016|P2|STARTED|Overall Study|3 did not return post-randomization, 4 lost source documents, thus 7 excluded from results analysis|49
2530494|NCT00659230|6202017|P1|STARTED|Overall Study|2 did not return post-randomization, 5 lost source documents, thus 7 excluded from results analysis|51
2530495|NCT00659165|6202031|P2|NOT COMPLETED|Overall Study||0
2530496|NCT00659165|6202032|P1|NOT COMPLETED|Overall Study||0
2530497|NCT00659165|6202031|P2|COMPLETED|Overall Study||5
2530498|NCT00659165|6202032|P1|COMPLETED|Overall Study||5
2530499|NCT00659165|6202031|P2|STARTED|Overall Study||5
2530500|NCT00659165|6202032|P1|STARTED|Overall Study||5
2530501|NCT00659061|6202040|P2|NOT COMPLETED|Overall Study||15
2530502|NCT00659061|6202041|P1|NOT COMPLETED|Overall Study||21
2530503|NCT00659061|6202040|P2|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
2530504|NCT00659061|6202041|P1|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
2530505|NCT00659061|6202040|P2|STARTED|Overall Study||302
2530506|NCT00659061|6202041|P1|STARTED|Overall Study||308
2530507|NCT00658996|6202059|P2|NOT COMPLETED|Second Intervention||1
2530508|NCT00658996|6202060|P1|NOT COMPLETED|Second Intervention||1
2530509|NCT00658996|6202059|P2|COMPLETED|Second Intervention||104
2530510|NCT00658996|6202060|P1|COMPLETED|Second Intervention||105
2530511|NCT00658996|6202059|P2|STARTED|Second Intervention||105
2530512|NCT00658996|6202060|P1|STARTED|Second Intervention||106
2530513|NCT00658996|6202059|P2|NOT COMPLETED|Crossover Period||1
2530514|NCT00658996|6202060|P1|NOT COMPLETED|Crossover Period||2
2530515|NCT00658996|6202059|P2|COMPLETED|Crossover Period||105
2530516|NCT00658996|6202060|P1|COMPLETED|Crossover Period||106
2530517|NCT00658996|6202059|P2|STARTED|Crossover Period||106
2530518|NCT00658996|6202060|P1|STARTED|Crossover Period||108
2530519|NCT00658996|6202059|P2|NOT COMPLETED|First Intervention||1
2530520|NCT00658996|6202060|P1|NOT COMPLETED|First Intervention||1
2530521|NCT00658996|6202059|P2|COMPLETED|First Intervention||106
2530522|NCT00658996|6202060|P1|COMPLETED|First Intervention||108
2530523|NCT00658996|6202059|P2|STARTED|First Intervention||107
2530524|NCT00658996|6202060|P1|STARTED|First Intervention||109
2530525|NCT00658879|6202070|P1|NOT COMPLETED|Overall Study||1
2530526|NCT00658879|6202070|P1|COMPLETED|Overall Study||250
2530527|NCT00658879|6202070|P1|STARTED|Overall Study||251
2530554|NCT00658788|6202102|P1|NOT COMPLETED|Overall Study||74
2530555|NCT00658788|6202102|P1|COMPLETED|Overall Study||231
2530556|NCT00658788|6202102|P1|STARTED|Overall Study||305
2530557|NCT00658775|6202157|P2|NOT COMPLETED|Overall Study||43
2530558|NCT00658775|6202158|P1|NOT COMPLETED|Overall Study||42
2530559|NCT00658775|6202157|P2|COMPLETED|Overall Study||485
2530560|NCT00658775|6202158|P1|COMPLETED|Overall Study||495
2530561|NCT00658775|6202157|P2|STARTED|Overall Study|Treated|528
2530562|NCT00658775|6202158|P1|STARTED|Overall Study|Treated|537
2530563|NCT00658736|6202170|P2|NOT COMPLETED|Overall Study||2
2530564|NCT00658736|6202171|P1|NOT COMPLETED|Overall Study||6
2530565|NCT00658736|6202170|P2|COMPLETED|Overall Study||19
2530566|NCT00658736|6202171|P1|COMPLETED|Overall Study||13
2530567|NCT00658736|6202170|P2|STARTED|Overall Study||21
2530568|NCT00658736|6202171|P1|STARTED|Overall Study||19
2530569|NCT00658723|6202181|P3|NOT COMPLETED|Overall Study||7
2530570|NCT00658723|6202182|P2|NOT COMPLETED|Overall Study||4
2530571|NCT00658723|6202183|P1|NOT COMPLETED|Overall Study||4
2530572|NCT00658723|6202181|P3|COMPLETED|Overall Study||44
2530573|NCT00658723|6202182|P2|COMPLETED|Overall Study||26
2530574|NCT00658723|6202183|P1|COMPLETED|Overall Study||56
2530575|NCT00658723|6202181|P3|STARTED|Overall Study||51
2530576|NCT00658723|6202182|P2|STARTED|Overall Study||30
2530577|NCT00658723|6202183|P1|STARTED|Overall Study||60
2530578|NCT00658697|6202210|P1|NOT COMPLETED|Overall Study||0
2530579|NCT00658697|6202210|P1|COMPLETED|Overall Study||41
2530580|NCT00658697|6202210|P1|STARTED|Overall Study||41
2530581|NCT00658684|6202221|P4|NOT COMPLETED|Overall Study||1
2530582|NCT00658684|6202222|P3|NOT COMPLETED|Overall Study||3
2530583|NCT00658684|6202223|P2|NOT COMPLETED|Overall Study||15
2530584|NCT00658684|6202224|P1|NOT COMPLETED|Overall Study||19
2530585|NCT00658684|6202221|P4|COMPLETED|Overall Study||27
2530586|NCT00658684|6202222|P3|COMPLETED|Overall Study||22
2530587|NCT00658684|6202223|P2|COMPLETED|Overall Study||84
2530588|NCT00658684|6202224|P1|COMPLETED|Overall Study||133
2530589|NCT00658684|6202221|P4|STARTED|Overall Study||28
2530590|NCT00658684|6202222|P3|STARTED|Overall Study||25
2530591|NCT00658684|6202223|P2|STARTED|Overall Study||99
2530592|NCT00658684|6202224|P1|STARTED|Overall Study||152
2530593|NCT00658658|6202279|P5|NOT COMPLETED|Overall Study||5
2530594|NCT00658658|6202280|P4|NOT COMPLETED|Overall Study||2
2530595|NCT00658658|6202281|P3|NOT COMPLETED|Overall Study||0
2530596|NCT00658658|6202282|P2|NOT COMPLETED|Overall Study||2
2530597|NCT00658658|6202283|P1|NOT COMPLETED|Overall Study||5
2530598|NCT00658658|6202279|P5|COMPLETED|Overall Study||3
2530599|NCT00658658|6202280|P4|COMPLETED|Overall Study||4
2530600|NCT00658658|6202281|P3|COMPLETED|Overall Study||4
2530601|NCT00658658|6202282|P2|COMPLETED|Overall Study||5
2530602|NCT00658658|6202283|P1|COMPLETED|Overall Study||1
2530603|NCT00658658|6202279|P5|STARTED|Overall Study||8
2530604|NCT00658658|6202280|P4|STARTED|Overall Study||6
2530605|NCT00658658|6202281|P3|STARTED|Overall Study||4
2530606|NCT00658658|6202282|P2|STARTED|Overall Study||7
2530607|NCT00658658|6202283|P1|STARTED|Overall Study||6
2530608|NCT00658632|6202342|P2|NOT COMPLETED|Overall Study||65
2530609|NCT00658632|6202343|P1|NOT COMPLETED|Overall Study||64
2530610|NCT00658632|6202342|P2|COMPLETED|Overall Study||633
2530611|NCT00658632|6202343|P1|COMPLETED|Overall Study||618
2530612|NCT00658632|6202342|P2|STARTED|Overall Study|Treated|698
2530613|NCT00658632|6202343|P1|STARTED|Overall Study|Treated|682
2530614|NCT00658619|6202358|P5|NOT COMPLETED|Overall Study||2
2530615|NCT00658619|6202359|P4|NOT COMPLETED|Overall Study||12
2530616|NCT00658619|6202360|P3|NOT COMPLETED|Overall Study||10
2530617|NCT00658619|6202361|P2|NOT COMPLETED|Overall Study||1
2530618|NCT00658619|6202362|P1|NOT COMPLETED|Overall Study||0
2530619|NCT00658619|6202358|P5|COMPLETED|Overall Study||21
2530620|NCT00658619|6202359|P4|COMPLETED|Overall Study||37
2530621|NCT00658619|6202360|P3|COMPLETED|Overall Study||31
2530622|NCT00658619|6202361|P2|COMPLETED|Overall Study||2
2530623|NCT00658619|6202362|P1|COMPLETED|Overall Study||3
2530624|NCT00658619|6202358|P5|STARTED|Overall Study||23
2530625|NCT00658619|6202359|P4|STARTED|Overall Study||49
2530626|NCT00658619|6202360|P3|STARTED|Overall Study||41
2530627|NCT00658619|6202361|P2|STARTED|Overall Study||3
2530628|NCT00658619|6202362|P1|STARTED|Overall Study||3
2530629|NCT00658606|6202384|P2|NOT COMPLETED|Overall Study||23
2530630|NCT00658606|6202385|P1|NOT COMPLETED|Overall Study||16
2530631|NCT00658606|6202384|P2|COMPLETED|Overall Study|Represents patients who completed follow-up|26
2530632|NCT00658606|6202385|P1|COMPLETED|Overall Study|Represents patients who completed follow-up|33
2530633|NCT00658606|6202384|P2|Completed Treatment|Overall Study||44
2530634|NCT00658606|6202385|P1|Completed Treatment|Overall Study||42
2530635|NCT00658606|6202384|P2|STARTED|Overall Study||49
2530636|NCT00658606|6202385|P1|STARTED|Overall Study||49
2530637|NCT00658567|6202414|P3|NOT COMPLETED|Overall Study||6
2530638|NCT00658567|6202415|P2|NOT COMPLETED|Overall Study||4
2530639|NCT00658567|6202416|P1|NOT COMPLETED|Overall Study||8
2530640|NCT00658567|6202414|P3|COMPLETED|Overall Study||35
2530641|NCT00658567|6202415|P2|COMPLETED|Overall Study||38
2530642|NCT00658567|6202416|P1|COMPLETED|Overall Study||32
2530643|NCT00658567|6202414|P3|STARTED|Overall Study||41
2530644|NCT00658567|6202415|P2|STARTED|Overall Study||42
2530645|NCT00658567|6202416|P1|STARTED|Overall Study||40
2530646|NCT00658541|6202427|P2|NOT COMPLETED|Second Intervention||0
2530647|NCT00658541|6202428|P1|NOT COMPLETED|Second Intervention||0
2530648|NCT00658541|6202427|P2|COMPLETED|Second Intervention||17
2530649|NCT00658541|6202428|P1|COMPLETED|Second Intervention||18
2530650|NCT00658541|6202427|P2|STARTED|Second Intervention||17
2530651|NCT00658541|6202428|P1|STARTED|Second Intervention||18
2530652|NCT00658541|6202427|P2|NOT COMPLETED|Washout Period of 7 Days||2
2530653|NCT00658541|6202428|P1|NOT COMPLETED|Washout Period of 7 Days||1
2530654|NCT00658541|6202427|P2|COMPLETED|Washout Period of 7 Days||17
2530655|NCT00658541|6202428|P1|COMPLETED|Washout Period of 7 Days||18
2530656|NCT00658541|6202427|P2|STARTED|Washout Period of 7 Days||19
2530657|NCT00658541|6202428|P1|STARTED|Washout Period of 7 Days||19
2530658|NCT00658541|6202427|P2|NOT COMPLETED|First Intervention||0
2530659|NCT00658541|6202428|P1|NOT COMPLETED|First Intervention||0
2530660|NCT00658541|6202427|P2|COMPLETED|First Intervention||19
2530661|NCT00658541|6202428|P1|COMPLETED|First Intervention||19
2530662|NCT00658541|6202427|P2|STARTED|First Intervention||19
2530663|NCT00658541|6202428|P1|STARTED|First Intervention||19
2530664|NCT00658528|6202440|P2|NOT COMPLETED|Overall Study||45
2530665|NCT00658528|6202441|P1|NOT COMPLETED|Overall Study||40
2530666|NCT00658528|6202440|P2|COMPLETED|Overall Study||479
2530667|NCT00658528|6202441|P1|COMPLETED|Overall Study||491
2530668|NCT00658528|6202440|P2|STARTED|Overall Study|Treated|524
2530669|NCT00658528|6202441|P1|STARTED|Overall Study|Treated|531
2530670|NCT00658515|6202453|P2|NOT COMPLETED|Overall Study||265
2530671|NCT00658515|6202454|P1|NOT COMPLETED|Overall Study||312
2530672|NCT00658515|6202453|P2|COMPLETED|Overall Study||7668
2530673|NCT00658515|6202454|P1|COMPLETED|Overall Study||7626
2530674|NCT00658515|6202453|P2|STARTED|Overall Study||7933
2530675|NCT00658515|6202454|P1|STARTED|Overall Study||7938
2530676|NCT00658411|6202466|P1|NOT COMPLETED|Overall Study||0
2530677|NCT00658411|6202466|P1|COMPLETED|Overall Study||5
2530678|NCT00658411|6202466|P1|STARTED|Overall Study||5
2530679|NCT00658385|6202474|P1|NOT COMPLETED|Overall Study||0
2530680|NCT00658385|6202474|P1|COMPLETED|Overall Study||5
2530681|NCT00658385|6202474|P1|STARTED|Overall Study||5
2530682|NCT00658359|6202481|P3|NOT COMPLETED|Overall Study||46
2530683|NCT00658359|6202482|P2|NOT COMPLETED|Overall Study||45
2530684|NCT00658359|6202483|P1|NOT COMPLETED|Overall Study||28
2530685|NCT00658359|6202481|P3|COMPLETED|Overall Study||8
2530686|NCT00658359|6202482|P2|COMPLETED|Overall Study||15
2530687|NCT00658359|6202483|P1|COMPLETED|Overall Study||36
2530688|NCT00658359|6202481|P3|STARTED|Overall Study||54
2530689|NCT00658359|6202482|P2|STARTED|Overall Study||60
2530690|NCT00658359|6202483|P1|STARTED|Overall Study||64
2530691|NCT00658333|6202571|P2|NOT COMPLETED|Overall Study||1
2530692|NCT00658333|6202572|P1|NOT COMPLETED|Overall Study||2
2530693|NCT00658333|6202571|P2|COMPLETED|Overall Study||14
2530694|NCT00658333|6202572|P1|COMPLETED|Overall Study||13
2530695|NCT00658333|6202571|P2|STARTED|Overall Study||15
2530696|NCT00658333|6202572|P1|STARTED|Overall Study||15
2530697|NCT00658320|6202582|P2|NOT COMPLETED|Extension Study: After Month 24||0
2530698|NCT00658320|6202583|P1|NOT COMPLETED|Extension Study: After Month 24||2
2530699|NCT00658320|6202582|P2|COMPLETED|Extension Study: After Month 24||0
2530700|NCT00658320|6202583|P1|COMPLETED|Extension Study: After Month 24||42
2530701|NCT00658320|6202582|P2|STARTED|Extension Study: After Month 24||0
2530702|NCT00658320|6202583|P1|STARTED|Extension Study: After Month 24||44
2530703|NCT00658320|6202582|P2|NOT COMPLETED|Extension Study: Month 12 to Month 24||7
2530704|NCT00658320|6202583|P1|NOT COMPLETED|Extension Study: Month 12 to Month 24||6
2530705|NCT00658320|6202582|P2|COMPLETED|Extension Study: Month 12 to Month 24||50
2530706|NCT00658320|6202583|P1|COMPLETED|Extension Study: Month 12 to Month 24||47
2530707|NCT00658320|6202582|P2|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
2530708|NCT00658320|6202583|P1|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
2530709|NCT00658320|6202582|P2|STARTED|Extension Study: Month 12 to Month 24||57
2530710|NCT00658320|6202583|P1|STARTED|Extension Study: Month 12 to Month 24||53
2530711|NCT00658320|6202582|P2|NOT COMPLETED|Core Study: 12 Months||3
2530712|NCT00658320|6202583|P1|NOT COMPLETED|Core Study: 12 Months||5
2530713|NCT00658320|6202582|P2|COMPLETED|Core Study: 12 Months||58
2530714|NCT00658320|6202583|P1|COMPLETED|Core Study: 12 Months||56
2530715|NCT00658320|6202582|P2|STARTED|Core Study: 12 Months||61
2530716|NCT00658320|6202583|P1|STARTED|Core Study: 12 Months||61
2530717|NCT00658138|6202606|P1|NOT COMPLETED|Overall Study||21
2530718|NCT00658138|6202606|P1|COMPLETED|Overall Study||40
2530719|NCT00658138|6202606|P1|STARTED|Overall Study||61
2530720|NCT00658112|6202611|P1|NOT COMPLETED|Overall Study||9
2530721|NCT00658112|6202611|P1|COMPLETED|Overall Study||11
2530722|NCT00658112|6202611|P1|STARTED|Overall Study||20
2530723|NCT00657917|6202615|P1|NOT COMPLETED|Overall Study||0
2530724|NCT00657917|6202615|P1|COMPLETED|Overall Study||1
2530725|NCT00657917|6202615|P1|STARTED|Overall Study||1
2530726|NCT00657709|6202626|P5|NOT COMPLETED|Overall Study||33
2530727|NCT00657709|6202627|P4|NOT COMPLETED|Overall Study||14
2530728|NCT00657709|6202628|P3|NOT COMPLETED|Overall Study||28
2530729|NCT00657709|6202629|P2|NOT COMPLETED|Overall Study||33
2530730|NCT00657709|6202630|P1|NOT COMPLETED|Overall Study||23
2530731|NCT00657709|6202626|P5|COMPLETED|Overall Study||457
2530732|NCT00657709|6202627|P4|COMPLETED|Overall Study||645
2530733|NCT00657709|6202628|P3|COMPLETED|Overall Study||792
2530734|NCT00657709|6202629|P2|COMPLETED|Overall Study||795
2530735|NCT00657709|6202630|P1|COMPLETED|Overall Study||810
2530736|NCT00657709|6202626|P5|STARTED|Overall Study||490
2530737|NCT00657709|6202627|P4|STARTED|Overall Study||659
2530738|NCT00657709|6202628|P3|STARTED|Overall Study||820
2530739|NCT00657709|6202629|P2|STARTED|Overall Study||828
2530740|NCT00657709|6202630|P1|STARTED|Overall Study||833
2530741|NCT00657657|6202671|P1|NOT COMPLETED|Overall Study||0
2530742|NCT00657657|6202671|P1|COMPLETED|Overall Study||29
2530743|NCT00657657|6202671|P1|STARTED|Overall Study||29
2530744|NCT00657618|6202679|P1|NOT COMPLETED|Overall Study||43
2530745|NCT00657618|6202679|P1|COMPLETED|Overall Study||34
2530746|NCT00657618|6202679|P1|STARTED|Overall Study||77
2530747|NCT00657605|6202684|P1|NOT COMPLETED|Overall Study||0
2530748|NCT00657605|6202684|P1|COMPLETED|Overall Study||3
2530749|NCT00657605|6202684|P1|STARTED|Overall Study||3
2530750|NCT00657553|6202691|P2|NOT COMPLETED|Overall Study||5
2530751|NCT00657553|6202692|P1|NOT COMPLETED|Overall Study||5
2530752|NCT00657553|6202691|P2|COMPLETED|Overall Study||0
2530753|NCT00657553|6202692|P1|COMPLETED|Overall Study||0
2530754|NCT00657553|6202691|P2|STARTED|Overall Study||5
2530755|NCT00657553|6202692|P1|STARTED|Overall Study||5
2530756|NCT00657540|6202700|P2|NOT COMPLETED|Overall Study||4
2530757|NCT00657540|6202701|P1|NOT COMPLETED|Overall Study||1
2530758|NCT00657540|6202700|P2|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|27
2530759|NCT00657540|6202701|P1|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|28
2530760|NCT00657540|6202700|P2|STARTED|Overall Study||31
2530761|NCT00657540|6202701|P1|STARTED|Overall Study||29
2530762|NCT00657371|6202715|P1|NOT COMPLETED|Overall Study||39
2530763|NCT00657371|6202715|P1|COMPLETED|Overall Study||249
2530764|NCT00657371|6202715|P1|STARTED|Overall Study||288
2530765|NCT00657358|6202720|P1|NOT COMPLETED|Overall Study||6
2530766|NCT00657358|6202720|P1|COMPLETED|Overall Study||16
2530767|NCT00657358|6202720|P1|STARTED|Overall Study||22
2530768|NCT00657280|6202728|P1|NOT COMPLETED|Overall Study||0
2530769|NCT00657280|6202728|P1|COMPLETED|Overall Study||16
2530770|NCT00657280|6202728|P1|STARTED|Overall Study||16
2530771|NCT00657267|6202732|P1|NOT COMPLETED|Overall Study||54
2530772|NCT00657267|6202732|P1|COMPLETED|Overall Study||4
2530773|NCT00657267|6202732|P1|STARTED|Overall Study||58
2530774|NCT00657150|6202742|P2|NOT COMPLETED|Treatment||97
2530775|NCT00657150|6202743|P1|NOT COMPLETED|Treatment||107
2530776|NCT00657150|6202742|P2|COMPLETED|Treatment||906
2530777|NCT00657150|6202743|P1|COMPLETED|Treatment||903
2530778|NCT00657150|6202742|P2|STARTED|Treatment||1003
2530779|NCT00657150|6202743|P1|STARTED|Treatment||1010
2530780|NCT00657150|6202742|P2|NOT COMPLETED|Overall Study||93
2530781|NCT00657150|6202743|P1|NOT COMPLETED|Overall Study||115
2530782|NCT00657150|6202742|P2|COMPLETED|Overall Study||910
2530783|NCT00657150|6202743|P1|COMPLETED|Overall Study||895
2530784|NCT00657150|6202742|P2|STARTED|Overall Study||1003
2530785|NCT00657150|6202743|P1|STARTED|Overall Study||1010
2530786|NCT00657046|6202774|P3|NOT COMPLETED|Overall Study||2
2530787|NCT00657046|6202775|P2|NOT COMPLETED|Overall Study||3
2530788|NCT00657046|6202776|P1|NOT COMPLETED|Overall Study||4
2530789|NCT00657046|6202774|P3|COMPLETED|Overall Study||21
2530790|NCT00657046|6202775|P2|COMPLETED|Overall Study||29
2530791|NCT00657046|6202776|P1|COMPLETED|Overall Study||26
2530792|NCT00657046|6202774|P3|Had Visits up to Visit 18|Overall Study||23
2530793|NCT00657046|6202775|P2|Had Visits up to Visit 18|Overall Study||30
2530794|NCT00657046|6202776|P1|Had Visits up to Visit 18|Overall Study||28
2530795|NCT00657046|6202774|P3|Had at Least 1 Post Baseline Visit|Overall Study||23
2530796|NCT00657046|6202775|P2|Had at Least 1 Post Baseline Visit|Overall Study||31
2530797|NCT00657046|6202776|P1|Had at Least 1 Post Baseline Visit|Overall Study||30
2530798|NCT00657046|6202774|P3|STARTED|Overall Study||23
2530799|NCT00657046|6202775|P2|STARTED|Overall Study||32
2530800|NCT00657046|6202776|P1|STARTED|Overall Study||30
2530801|NCT00657020|6202808|P2|NOT COMPLETED|PERIOD 2||0
2530802|NCT00657020|6202809|P1|NOT COMPLETED|PERIOD 2||0
2530803|NCT00657020|6202808|P2|COMPLETED|PERIOD 2||11
2530804|NCT00657020|6202809|P1|COMPLETED|PERIOD 2||11
2530805|NCT00657020|6202808|P2|STARTED|PERIOD 2||11
2530806|NCT00657020|6202809|P1|STARTED|PERIOD 2||11
2530807|NCT00657020|6202808|P2|NOT COMPLETED|PERIOD 1||1
2530808|NCT00657020|6202809|P1|NOT COMPLETED|PERIOD 1||0
2530809|NCT00657020|6202808|P2|COMPLETED|PERIOD 1||11
2530810|NCT00657020|6202809|P1|COMPLETED|PERIOD 1||11
2530811|NCT00657020|6202808|P2|STARTED|PERIOD 1||12
2530812|NCT00657020|6202809|P1|STARTED|PERIOD 1||11
2530813|NCT00656968|6202839|P2|NOT COMPLETED|Overall Study||0
2530814|NCT00656968|6202840|P1|NOT COMPLETED|Overall Study||0
2530815|NCT00656968|6202839|P2|COMPLETED|Overall Study||117
2530816|NCT00656968|6202840|P1|COMPLETED|Overall Study||115
2530817|NCT00656968|6202839|P2|STARTED|Overall Study||117
2530818|NCT00656968|6202840|P1|STARTED|Overall Study||115
2530819|NCT00656916|6202850|P2|NOT COMPLETED|Overall Study||0
2530820|NCT00656916|6202851|P1|NOT COMPLETED|Overall Study||0
2530821|NCT00656916|6202850|P2|COMPLETED|Overall Study||0
2530822|NCT00656916|6202851|P1|COMPLETED|Overall Study||1
2530823|NCT00656916|6202850|P2|STARTED|Overall Study||0
2530824|NCT00656916|6202851|P1|STARTED|Overall Study||1
2530825|NCT00656851|6202859|P2|NOT COMPLETED|Overall Study||4
2530826|NCT00656851|6202860|P1|NOT COMPLETED|Overall Study||0
2530827|NCT00656851|6202859|P2|COMPLETED|Overall Study||8
2530828|NCT00656851|6202860|P1|COMPLETED|Overall Study||12
2530829|NCT00656851|6202859|P2|STARTED|Overall Study||12
2530830|NCT00656851|6202860|P1|STARTED|Overall Study||12
2530831|NCT00656799|6202882|P1|NOT COMPLETED|Overall Study||2
2530832|NCT00656799|6202882|P1|COMPLETED|Overall Study||4
2530833|NCT00656799|6202882|P1|STARTED|Overall Study||6
2530834|NCT00656669|6202904|P1|NOT COMPLETED|AC (Cycles 6-9)||2
2530835|NCT00656669|6202904|P1|COMPLETED|AC (Cycles 6-9)||15
2530836|NCT00656669|6202904|P1|STARTED|AC (Cycles 6-9)||17
2530837|NCT00656669|6202904|P1|NOT COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||6
2530838|NCT00656669|6202904|P1|COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||17
2530839|NCT00656669|6202904|P1|STARTED|Paclitaxel/Sunitinib (Cycles 2-5)||23
2530840|NCT00656669|6202904|P1|NOT COMPLETED|Single Agent Sunitinib (Cycle 1)||0
2530841|NCT00656669|6202904|P1|COMPLETED|Single Agent Sunitinib (Cycle 1)||23
2530842|NCT00656669|6202904|P1|STARTED|Single Agent Sunitinib (Cycle 1)||23
2530843|NCT00656656|6202913|P1|NOT COMPLETED|Overall Study||0
2530844|NCT00656656|6202913|P1|COMPLETED|Overall Study||23
2530845|NCT00656656|6202913|P1|STARTED|Overall Study||23
2530846|NCT00656630|6202921|P3|NOT COMPLETED|Overall Study||2
2530847|NCT00656630|6202922|P2|NOT COMPLETED|Overall Study||2
2530848|NCT00656630|6202923|P1|NOT COMPLETED|Overall Study||2
2530849|NCT00656630|6202921|P3|COMPLETED|Overall Study||17
2530850|NCT00656630|6202922|P2|COMPLETED|Overall Study||25
2530851|NCT00656630|6202923|P1|COMPLETED|Overall Study||20
2530852|NCT00656630|6202921|P3|STARTED|Overall Study||19
2530853|NCT00656630|6202922|P2|STARTED|Overall Study||27
2530854|NCT00656630|6202923|P1|STARTED|Overall Study||22
2530855|NCT00656617|6202943|P1|NOT COMPLETED|Overall Study||7
2530856|NCT00656617|6202943|P1|COMPLETED|Overall Study||99
2530857|NCT00656617|6202943|P1|Induction Phase|Overall Study|Induction phase following determination of safe combination Vorinostat with Idarubicin.|103
2530858|NCT00656617|6202943|P1|Run-in Induction Phase|Overall Study|Initial run-in: Vorinostat induction dose 500 mg orally three times daily for 3 days.|3
2530859|NCT00656617|6202943|P1|STARTED|Overall Study||106
2530860|NCT00656513|6202952|P3|NOT COMPLETED|Overall Study||22
2530861|NCT00656513|6202953|P2|NOT COMPLETED|Overall Study||30
2530862|NCT00656513|6202954|P1|NOT COMPLETED|Overall Study||4
2530863|NCT00656513|6202952|P3|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|53
2530864|NCT00656513|6202953|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|43
2530865|NCT00656513|6202954|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
2530866|NCT00656513|6202952|P3|STARTED|Overall Study||75
2530867|NCT00656513|6202953|P2|STARTED|Overall Study||73
2530868|NCT00656513|6202954|P1|STARTED|Overall Study||48
2530869|NCT00656487|6202976|P3|NOT COMPLETED|Overall Study||0
2530870|NCT00656487|6202977|P2|NOT COMPLETED|Overall Study||4
2530871|NCT00656487|6202978|P1|NOT COMPLETED|Overall Study||2
2530872|NCT00656487|6202976|P3|COMPLETED|Overall Study||20
2530873|NCT00656487|6202977|P2|COMPLETED|Overall Study||19
2530874|NCT00656487|6202978|P1|COMPLETED|Overall Study||21
2530875|NCT00656487|6202976|P3|STARTED|Overall Study||20
2530876|NCT00656487|6202977|P2|STARTED|Overall Study||23
2530877|NCT00656487|6202978|P1|STARTED|Overall Study||23
2530878|NCT00656474|6203001|P1|NOT COMPLETED|Overall Study||1
2530879|NCT00656474|6203001|P1|COMPLETED|Overall Study||11
2530880|NCT00656474|6203001|P1|STARTED|Overall Study||12
2530881|NCT00656448|6203010|P2|NOT COMPLETED|Overall Study||0
2530882|NCT00656448|6203011|P1|NOT COMPLETED|Overall Study||0
2530883|NCT00656448|6203010|P2|COMPLETED|Overall Study||25
2530884|NCT00656448|6203011|P1|COMPLETED|Overall Study||25
2530885|NCT00656448|6203010|P2|STARTED|Overall Study||25
2530886|NCT00656448|6203011|P1|STARTED|Overall Study||25
2530887|NCT00656370|6203019|P1|NOT COMPLETED|Overall Study||10
2530888|NCT00656370|6203019|P1|COMPLETED|Overall Study|15 subjects were randomized and completed stage 1 (received both NS and LR).|15
2530889|NCT00656370|6203019|P1|STARTED|Overall Study|25 subjects were assessed for eligibility and signed an Informed Consent Form.|25
2530890|NCT00656305|6203035|P2|NOT COMPLETED|Overall Study||7
2530891|NCT00656305|6203036|P1|NOT COMPLETED|Overall Study||22
2530892|NCT00656305|6203035|P2|COMPLETED|Overall Study||21
2530893|NCT00656305|6203036|P1|COMPLETED|Overall Study||65
2530894|NCT00656305|6203035|P2|STARTED|Overall Study||28
2530895|NCT00656305|6203036|P1|STARTED|Overall Study||87
2530896|NCT00656292|6203048|P2|NOT COMPLETED|Overall Study||5
2530897|NCT00656292|6203049|P1|NOT COMPLETED|Overall Study||3
2530898|NCT00656292|6203048|P2|COMPLETED|Overall Study||24
2530899|NCT00656292|6203049|P1|COMPLETED|Overall Study||29
2530900|NCT00656292|6203048|P2|STARTED|Overall Study||29
2530901|NCT00656292|6203049|P1|STARTED|Overall Study||32
2530902|NCT00656201|6203067|P2|NOT COMPLETED|Overall Study||32
2530903|NCT00656201|6203068|P1|NOT COMPLETED|Overall Study||29
2530904|NCT00656201|6203067|P2|COMPLETED|Overall Study||201
2530905|NCT00656201|6203068|P1|COMPLETED|Overall Study||206
2530906|NCT00656201|6203067|P2|STARTED|Overall Study||233
2530907|NCT00656201|6203068|P1|STARTED|Overall Study||235
2530908|NCT00656175|6203076|P2|NOT COMPLETED|Overall Study||1
2530909|NCT00656175|6203077|P1|NOT COMPLETED|Overall Study||1
2530910|NCT00656175|6203076|P2|COMPLETED|Overall Study||20
2530911|NCT00656175|6203077|P1|COMPLETED|Overall Study||17
2530912|NCT00656175|6203076|P2|STARTED|Overall Study||21
2530913|NCT00656175|6203077|P1|STARTED|Overall Study||18
2530914|NCT00656136|6203085|P2|NOT COMPLETED|Overall Study||390
2530915|NCT00656136|6203086|P1|NOT COMPLETED|Overall Study||195
2530916|NCT00656136|6203085|P2|COMPLETED|Overall Study||0
2530917|NCT00656136|6203086|P1|COMPLETED|Overall Study||0
2530918|NCT00656136|6203085|P2|STARTED|Overall Study|Randomised patients.|390
2530919|NCT00656136|6203086|P1|STARTED|Overall Study|Randomised patients.|195
2530920|NCT00656084|6203096|P1|NOT COMPLETED|Overall Study||7
2530921|NCT00656084|6203096|P1|COMPLETED|Overall Study||9
2530922|NCT00656084|6203096|P1|STARTED|Overall Study||16
2530923|NCT00656058|6203103|P1|NOT COMPLETED|Overall Study||6
2530924|NCT00656058|6203103|P1|COMPLETED|Overall Study||19
2530925|NCT00656058|6203103|P1|STARTED|Overall Study||25
2530926|NCT00656019|6203116|P4|NOT COMPLETED|Overall Study||0
2530927|NCT00656019|6203117|P3|NOT COMPLETED|Overall Study||0
2530928|NCT00656019|6203118|P2|NOT COMPLETED|Overall Study||1
2530929|NCT00656019|6203119|P1|NOT COMPLETED|Overall Study||14
2530930|NCT00656019|6203116|P4|COMPLETED|Overall Study||4
2530931|NCT00656019|6203117|P3|COMPLETED|Overall Study||11
2530932|NCT00656019|6203118|P2|COMPLETED|Overall Study||18
2530933|NCT00656019|6203119|P1|COMPLETED|Overall Study||15
2530934|NCT00656019|6203116|P4|STARTED|Overall Study||4
2530935|NCT00656019|6203117|P3|STARTED|Overall Study||11
2530936|NCT00656019|6203118|P2|STARTED|Overall Study||19
2530937|NCT00656019|6203119|P1|STARTED|Overall Study||29
2530938|NCT00655928|6203131|P2|NOT COMPLETED|Overall Study||2
2530939|NCT00655928|6203132|P1|NOT COMPLETED|Overall Study||3
2530940|NCT00655928|6203131|P2|COMPLETED|Overall Study||24
2530941|NCT00655928|6203132|P1|COMPLETED|Overall Study||23
2530942|NCT00655928|6203131|P2|STARTED|Overall Study||26
2530943|NCT00655928|6203132|P1|STARTED|Overall Study||26
2530944|NCT00655889|6203138|P1|NOT COMPLETED|Overall Study||2
2530945|NCT00655889|6203138|P1|COMPLETED|Overall Study||11
2530946|NCT00655889|6203138|P1|STARTED|Overall Study||13
2530947|NCT00655876|6203145|P2|NOT COMPLETED|Overall Study||7
2530948|NCT00655876|6203146|P1|NOT COMPLETED|Overall Study||9
2530949|NCT00655876|6203145|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|169
2530950|NCT00655876|6203146|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|159
2530951|NCT00655876|6203145|P2|STARTED|Overall Study||176
2530952|NCT00655876|6203146|P1|STARTED|Overall Study||168
2530953|NCT00655863|6203165|P3|NOT COMPLETED|Overall Study||1
2530954|NCT00655863|6203166|P2|NOT COMPLETED|Overall Study||0
2530955|NCT00655863|6203167|P1|NOT COMPLETED|Overall Study||0
2530956|NCT00655863|6203165|P3|COMPLETED|Overall Study||21
2530957|NCT00655863|6203166|P2|COMPLETED|Overall Study||25
2530958|NCT00655863|6203167|P1|COMPLETED|Overall Study||24
2530959|NCT00655863|6203165|P3|STARTED|Overall Study||22
2530960|NCT00655863|6203166|P2|STARTED|Overall Study||25
2530961|NCT00655863|6203167|P1|STARTED|Overall Study||24
2530962|NCT00655850|6203226|P1|NOT COMPLETED|Overall Study||3
2530963|NCT00655850|6203226|P1|COMPLETED|Overall Study||36
2530964|NCT00655850|6203226|P1|STARTED|Overall Study||39
2530965|NCT00655824|6203233|P1|NOT COMPLETED|Overall Study||84
2530966|NCT00655824|6203233|P1|COMPLETED|Overall Study||8
2530967|NCT00655824|6203233|P1|STARTED|Overall Study||92
2530968|NCT00655811|6203267|P1|NOT COMPLETED|Overall Study||0
2530969|NCT00655811|6203267|P1|COMPLETED|Overall Study||40
2530970|NCT00655811|6203267|P1|STARTED|Overall Study||40
2530971|NCT00655746|6203281|P1|NOT COMPLETED|Overall Study||1
2530972|NCT00655746|6203281|P1|COMPLETED|Overall Study||13
2530973|NCT00655746|6203281|P1|STARTED|Overall Study||14
2530974|NCT00655733|6203300|P2|NOT COMPLETED|Overall Study||8
2530975|NCT00655733|6203301|P1|NOT COMPLETED|Overall Study||7
2530976|NCT00655733|6203300|P2|COMPLETED|Overall Study||42
2530977|NCT00655733|6203301|P1|COMPLETED|Overall Study||44
2530978|NCT00655733|6203300|P2|STARTED|Overall Study||50
2530979|NCT00655733|6203301|P1|STARTED|Overall Study||51
2530980|NCT00655707|6203329|P1|NOT COMPLETED|Overall Study||0
2530981|NCT00655707|6203329|P1|COMPLETED|Overall Study||5
2530982|NCT00655707|6203329|P1|STARTED|Overall Study||5
2530983|NCT00655668|6203334|P1|NOT COMPLETED|Overall Study||54
2530984|NCT00655668|6203334|P1|COMPLETED|Overall Study|Participants dosed up to 24 months, disease progression or unacceptable adverse events developed.|0
2530985|NCT00655668|6203334|P1|STARTED|Overall Study|Planned enrollment: 80 participants|54
2530986|NCT00655642|6203346|P4|NOT COMPLETED|Overall Study||2
2530987|NCT00655642|6203347|P3|NOT COMPLETED|Overall Study||2
2530988|NCT00655642|6203348|P2|NOT COMPLETED|Overall Study||3
2530989|NCT00655642|6203349|P1|NOT COMPLETED|Overall Study||1
2530990|NCT00655642|6203346|P4|COMPLETED|Overall Study|1 patient's initial Visual analog scale (VAS)<40; 1 patient was withdrawn by treating physician|39
2530991|NCT00655642|6203347|P3|COMPLETED|Overall Study|1 patient left the ED prior to receiving drug; 1 patient's nausea resolved prior to receiving drug|43
2530992|NCT00655642|6203348|P2|COMPLETED|Overall Study|1 patient given drug orally rather than intravenous(iv);1 patient refused iv; 1 pt lost to follow-up|40
2530993|NCT00655642|6203349|P1|COMPLETED|Overall Study|1 patient withdrawn by treating physician after consent|41
2530994|NCT00655642|6203346|P4|STARTED|Overall Study||41
2530995|NCT00655642|6203347|P3|STARTED|Overall Study||45
2530996|NCT00655642|6203348|P2|STARTED|Overall Study||43
2530997|NCT00655642|6203349|P1|STARTED|Overall Study||42
2530998|NCT00655629|6203361|P2|NOT COMPLETED|Overall Study||23
2530999|NCT00655629|6203362|P1|NOT COMPLETED|Overall Study||21
2531000|NCT00655629|6203361|P2|COMPLETED|Overall Study||144
2531001|NCT00655629|6203362|P1|COMPLETED|Overall Study||151
2531002|NCT00655629|6203361|P2|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion.(safety population)|166
2531003|NCT00655629|6203362|P1|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion. (safety population)|171
2531004|NCT00655629|6203361|P2|STARTED|Overall Study||167
2531005|NCT00655629|6203362|P1|STARTED|Overall Study||172
2531006|NCT00655564|6203398|P1|NOT COMPLETED|Overall Study||3
2531007|NCT00655564|6203398|P1|COMPLETED|Overall Study||12
2531008|NCT00655564|6203398|P1|STARTED|Overall Study||15
2531009|NCT00655551|6203406|P3|NOT COMPLETED|Period 4 (up to 7 Days)||0
2531010|NCT00655551|6203407|P2|NOT COMPLETED|Period 4 (up to 7 Days)||2
2531011|NCT00655551|6203408|P1|NOT COMPLETED|Period 4 (up to 7 Days)||0
2531012|NCT00655551|6203406|P3|COMPLETED|Period 4 (up to 7 Days)||0
2531013|NCT00655551|6203407|P2|COMPLETED|Period 4 (up to 7 Days)||23
2531014|NCT00655551|6203408|P1|COMPLETED|Period 4 (up to 7 Days)||0
2531015|NCT00655551|6203406|P3|STARTED|Period 4 (up to 7 Days)||0
2531016|NCT00655551|6203407|P2|STARTED|Period 4 (up to 7 Days)||25
2531017|NCT00655551|6203408|P1|STARTED|Period 4 (up to 7 Days)||0
2531018|NCT00655551|6203406|P3|NOT COMPLETED|Period 3 (up to 7 Days)||4
2531019|NCT00655551|6203407|P2|NOT COMPLETED|Period 3 (up to 7 Days)||0
2531020|NCT00655551|6203408|P1|NOT COMPLETED|Period 3 (up to 7 Days)||0
2531021|NCT00655551|6203406|P3|COMPLETED|Period 3 (up to 7 Days)||21
2531022|NCT00655551|6203407|P2|COMPLETED|Period 3 (up to 7 Days)||0
2531023|NCT00655551|6203408|P1|COMPLETED|Period 3 (up to 7 Days)||0
2531024|NCT00655551|6203406|P3|STARTED|Period 3 (up to 7 Days)||25
2531025|NCT00655551|6203407|P2|STARTED|Period 3 (up to 7 Days)||0
2531026|NCT00655551|6203408|P1|STARTED|Period 3 (up to 7 Days)||0
2531027|NCT00655551|6203406|P3|NOT COMPLETED|Period 2 (up to 7 Days)||0
2531028|NCT00655551|6203407|P2|NOT COMPLETED|Period 2 (up to 7 Days)||1
2531029|NCT00655551|6203408|P1|NOT COMPLETED|Period 2 (up to 7 Days)||0
2531030|NCT00655551|6203406|P3|COMPLETED|Period 2 (up to 7 Days)||0
2531031|NCT00655551|6203407|P2|COMPLETED|Period 2 (up to 7 Days)||24
2531032|NCT00655551|6203408|P1|COMPLETED|Period 2 (up to 7 Days)||0
2531033|NCT00655551|6203406|P3|STARTED|Period 2 (up to 7 Days)||0
2531034|NCT00655551|6203407|P2|STARTED|Period 2 (up to 7 Days)||25
2531035|NCT00655551|6203408|P1|STARTED|Period 2 (up to 7 Days)||0
2531036|NCT00655551|6203406|P3|NOT COMPLETED|Period 1 (up to 7 Days)||0
2531037|NCT00655551|6203407|P2|NOT COMPLETED|Period 1 (up to 7 Days)||0
2531038|NCT00655551|6203408|P1|NOT COMPLETED|Period 1 (up to 7 Days)||0
2531039|NCT00655551|6203406|P3|COMPLETED|Period 1 (up to 7 Days)||0
2531040|NCT00655551|6203407|P2|COMPLETED|Period 1 (up to 7 Days)||0
2531041|NCT00655551|6203408|P1|COMPLETED|Period 1 (up to 7 Days)||25
2531042|NCT00655551|6203406|P3|STARTED|Period 1 (up to 7 Days)||0
2531043|NCT00655551|6203407|P2|STARTED|Period 1 (up to 7 Days)||0
2531044|NCT00655551|6203408|P1|STARTED|Period 1 (up to 7 Days)||25
2531045|NCT00655551|6203406|P3|NOT COMPLETED|All Periods Combined||4
2531046|NCT00655551|6203407|P2|NOT COMPLETED|All Periods Combined||3
2531047|NCT00655551|6203408|P1|NOT COMPLETED|All Periods Combined||0
2531048|NCT00655551|6203406|P3|COMPLETED|All Periods Combined||21
2531049|NCT00655551|6203407|P2|COMPLETED|All Periods Combined||47
2531050|NCT00655551|6203408|P1|COMPLETED|All Periods Combined||25
2531051|NCT00655551|6203406|P3|STARTED|All Periods Combined||25
2531052|NCT00655551|6203407|P2|STARTED|All Periods Combined||50
2531053|NCT00655551|6203408|P1|STARTED|All Periods Combined||25
2531054|NCT00655538|6203424|P2|NOT COMPLETED|Overall Study||27
2531055|NCT00655538|6203425|P1|NOT COMPLETED|Overall Study||24
2531056|NCT00655538|6203424|P2|COMPLETED|Overall Study||211
2531057|NCT00655538|6203425|P1|COMPLETED|Overall Study||214
2531058|NCT00655538|6203424|P2|STARTED|Overall Study||238
2531059|NCT00655538|6203425|P1|STARTED|Overall Study||238
2531060|NCT00655486|6203445|P1|NOT COMPLETED|Overall Study||28
2531061|NCT00655486|6203445|P1|COMPLETED|Overall Study||69
2531062|NCT00655486|6203445|P1|STARTED|Overall Study||97
2531063|NCT00655473|6203452|P2|NOT COMPLETED|Overall Study||15
2531064|NCT00655473|6203453|P1|NOT COMPLETED|Overall Study||11
2531065|NCT00655473|6203452|P2|COMPLETED|Overall Study||51
2531066|NCT00655473|6203453|P1|COMPLETED|Overall Study||53
2531067|NCT00655473|6203452|P2|STARTED|Overall Study||66
2531068|NCT00655473|6203453|P1|STARTED|Overall Study||64
2531069|NCT00655356|6203473|P2|NOT COMPLETED|Overall Study||10
2531070|NCT00655356|6203474|P1|NOT COMPLETED|Overall Study||17
2531071|NCT00655356|6203473|P2|COMPLETED|Overall Study||98
2531072|NCT00655356|6203474|P1|COMPLETED|Overall Study||93
2531073|NCT00655356|6203473|P2|STARTED|Overall Study||108
2531074|NCT00655356|6203474|P1|STARTED|Overall Study||110
2531075|NCT00655083|6203488|P2|NOT COMPLETED|Overall Study||0
2531076|NCT00655083|6203489|P1|NOT COMPLETED|Overall Study||0
2531077|NCT00655083|6203488|P2|COMPLETED|Overall Study||8
2531078|NCT00655083|6203489|P1|COMPLETED|Overall Study||12
2531079|NCT00655083|6203488|P2|STARTED|Overall Study||8
2531080|NCT00655083|6203489|P1|STARTED|Overall Study||12
2531081|NCT00654992|6203503|P2|NOT COMPLETED|Overall Study||0
2531082|NCT00654992|6203504|P1|NOT COMPLETED|Overall Study||0
2531083|NCT00654992|6203503|P2|COMPLETED|Overall Study||35
2531084|NCT00654992|6203504|P1|COMPLETED|Overall Study||36
2531085|NCT00654992|6203503|P2|STARTED|Overall Study||35
2531086|NCT00654992|6203504|P1|STARTED|Overall Study||36
2531087|NCT00654953|6203513|P3|NOT COMPLETED|Overall Study||22
2531088|NCT00654953|6203514|P2|NOT COMPLETED|Overall Study||28
2531089|NCT00654953|6203515|P1|NOT COMPLETED|Overall Study||30
2531090|NCT00654953|6203513|P3|COMPLETED|Overall Study||8
2531091|NCT00654953|6203514|P2|COMPLETED|Overall Study||8
2531092|NCT00654953|6203515|P1|COMPLETED|Overall Study||6
2531093|NCT00654953|6203513|P3|STARTED|Overall Study||30
2531094|NCT00654953|6203514|P2|STARTED|Overall Study||36
2531095|NCT00654953|6203515|P1|STARTED|Overall Study||36
2531096|NCT00654940|6203525|P2|NOT COMPLETED|Period 2||0
2531097|NCT00654940|6203526|P1|NOT COMPLETED|Period 2||0
2531098|NCT00654940|6203525|P2|COMPLETED|Period 2||11
2531099|NCT00654940|6203526|P1|COMPLETED|Period 2||12
2531100|NCT00654940|6203525|P2|STARTED|Period 2||11
2531101|NCT00654940|6203526|P1|STARTED|Period 2||12
2531102|NCT00654940|6203525|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
2531103|NCT00654940|6203526|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
2531104|NCT00654940|6203525|P2|COMPLETED|Washout Period of 2 Weeks||11
2531105|NCT00654940|6203526|P1|COMPLETED|Washout Period of 2 Weeks||12
2531106|NCT00654940|6203525|P2|STARTED|Washout Period of 2 Weeks||11
2531107|NCT00654940|6203526|P1|STARTED|Washout Period of 2 Weeks||12
2531108|NCT00654940|6203525|P2|NOT COMPLETED|Period 1||1
2531109|NCT00654940|6203526|P1|NOT COMPLETED|Period 1||1
2531110|NCT00654940|6203525|P2|COMPLETED|Period 1||11
2531111|NCT00654940|6203526|P1|COMPLETED|Period 1||12
2531112|NCT00654940|6203525|P2|Received Study Treatment|Period 1||12
2531113|NCT00654940|6203526|P1|Received Study Treatment|Period 1||12
2531114|NCT00654940|6203525|P2|STARTED|Period 1|Assigned to study treatment.|12
2531115|NCT00654940|6203526|P1|STARTED|Period 1|Assigned to study treatment.|13
2531116|NCT00654927|6203538|P1|NOT COMPLETED|Overall Study||107
2531117|NCT00654927|6203538|P1|COMPLETED|Overall Study||70
2531118|NCT00654927|6203538|P1|STARTED|Overall Study||177
2531119|NCT00654901|6203550|P4|NOT COMPLETED|Overall Study||0
2531120|NCT00654901|6203551|P3|NOT COMPLETED|Overall Study||2
2531121|NCT00654901|6203552|P2|NOT COMPLETED|Overall Study||0
2531122|NCT00654901|6203553|P1|NOT COMPLETED|Overall Study||4
2531123|NCT00654901|6203550|P4|COMPLETED|Overall Study||113
2531124|NCT00654901|6203551|P3|COMPLETED|Overall Study||250
2531125|NCT00654901|6203552|P2|COMPLETED|Overall Study||262
2531126|NCT00654901|6203553|P1|COMPLETED|Overall Study||250
2531127|NCT00654901|6203550|P4|STARTED|Overall Study||113
2531128|NCT00654901|6203551|P3|STARTED|Overall Study||252
2531129|NCT00654901|6203552|P2|STARTED|Overall Study||262
2531130|NCT00654901|6203553|P1|STARTED|Overall Study||254
2531131|NCT00654875|6203573|P2|NOT COMPLETED|Overall Study||17
2531132|NCT00654875|6203574|P1|NOT COMPLETED|Overall Study||17
2531133|NCT00654875|6203573|P2|COMPLETED|Overall Study||147
2531134|NCT00654875|6203574|P1|COMPLETED|Overall Study||147
2531135|NCT00654875|6203573|P2|STARTED|Overall Study||164
2531136|NCT00654875|6203574|P1|STARTED|Overall Study||164
2531137|NCT00654836|6203592|P1|NOT COMPLETED|Overall Study||0
2531138|NCT00654836|6203592|P1|COMPLETED|Overall Study||32
2531139|NCT00654836|6203592|P1|STARTED|Overall Study||32
2531140|NCT00654784|6203600|P2|NOT COMPLETED|Overall Study||0
2531141|NCT00654784|6203601|P1|NOT COMPLETED|Overall Study||0
2531142|NCT00654784|6203600|P2|COMPLETED|Overall Study||8
2531143|NCT00654784|6203601|P1|COMPLETED|Overall Study||13
2531144|NCT00654784|6203600|P2|STARTED|Overall Study||8
2531145|NCT00654784|6203601|P1|STARTED|Overall Study||13
2531146|NCT00654745|6203607|P1|NOT COMPLETED|Overall Study||43
2531147|NCT00654745|6203607|P1|COMPLETED|Overall Study||164
2531148|NCT00654745|6203607|P1|STARTED|Overall Study|This is single group study in which subjects were titrated to the next of 7 arms if BP goal not met.|207
2531149|NCT00654654|6203645|P1|NOT COMPLETED|Overall Study||7
2531150|NCT00654654|6203645|P1|COMPLETED|Overall Study||43
2531151|NCT00654654|6203645|P1|STARTED|Overall Study||50
2531152|NCT00654641|6203652|P2|NOT COMPLETED|Overall Study||3
2531153|NCT00654641|6203653|P1|NOT COMPLETED|Overall Study||2
2531154|NCT00654641|6203652|P2|COMPLETED|Overall Study||23
2531155|NCT00654641|6203653|P1|COMPLETED|Overall Study||26
2531156|NCT00654641|6203652|P2|STARTED|Overall Study||26
2531157|NCT00654641|6203653|P1|STARTED|Overall Study||28
2531158|NCT00654628|6203659|P1|NOT COMPLETED|6 –Week Extension Period (Single Site)||5
2531159|NCT00654628|6203659|P1|COMPLETED|6 –Week Extension Period (Single Site)||55
2531160|NCT00654628|6203659|P1|STARTED|6 –Week Extension Period (Single Site)|Subjects who completed the first 6-week period and participated in the second 6-week study period.|60
2531161|NCT00654628|6203659|P1|NOT COMPLETED|6-week Active Treatment Period||21
2531162|NCT00654628|6203659|P1|COMPLETED|6-week Active Treatment Period||152
2531163|NCT00654628|6203659|P1|STARTED|6-week Active Treatment Period||173
2531164|NCT00654615|6203676|P2|NOT COMPLETED|Overall Study||7
2531165|NCT00654615|6203677|P1|NOT COMPLETED|Overall Study||8
2531166|NCT00654615|6203676|P2|COMPLETED|Overall Study||23
2531167|NCT00654615|6203677|P1|COMPLETED|Overall Study||22
2531168|NCT00654615|6203676|P2|STARTED|Overall Study||30
2531169|NCT00654615|6203677|P1|STARTED|Overall Study||30
2531170|NCT00654511|6203689|P4|NOT COMPLETED|Overall Study||0
2531171|NCT00654511|6203690|P3|NOT COMPLETED|Overall Study||0
2531172|NCT00654511|6203691|P2|NOT COMPLETED|Overall Study||0
2531173|NCT00654511|6203692|P1|NOT COMPLETED|Overall Study||0
2531174|NCT00654511|6203689|P4|COMPLETED|Overall Study||25
2531175|NCT00654511|6203690|P3|COMPLETED|Overall Study||25
2531176|NCT00654511|6203691|P2|COMPLETED|Overall Study||25
2531177|NCT00654511|6203692|P1|COMPLETED|Overall Study||26
2531178|NCT00654511|6203689|P4|STARTED|Overall Study||25
2531179|NCT00654511|6203690|P3|STARTED|Overall Study||25
2531180|NCT00654511|6203691|P2|STARTED|Overall Study||25
2531181|NCT00654511|6203692|P1|STARTED|Overall Study||26
2531182|NCT00654498|6203708|P2|NOT COMPLETED|Overall Study||12
2531183|NCT00654498|6203709|P1|NOT COMPLETED|Overall Study||14
2531184|NCT00654498|6203708|P2|COMPLETED|Overall Study||91
2531185|NCT00654498|6203709|P1|COMPLETED|Overall Study||189
2531186|NCT00654498|6203708|P2|STARTED|Overall Study||103
2531187|NCT00654498|6203709|P1|STARTED|Overall Study||203
2531188|NCT00654420|6203741|P4|NOT COMPLETED|Phase II||38
2531189|NCT00654420|6203742|P3|NOT COMPLETED|Phase II||37
2531190|NCT00654420|6203743|P2|NOT COMPLETED|Phase II||0
2531191|NCT00654420|6203744|P1|NOT COMPLETED|Phase II||0
2531192|NCT00654420|6203741|P4|COMPLETED|Phase II||0
2531193|NCT00654420|6203742|P3|COMPLETED|Phase II||0
2531194|NCT00654420|6203743|P2|COMPLETED|Phase II||0
2531195|NCT00654420|6203744|P1|COMPLETED|Phase II||0
2531196|NCT00654420|6203741|P4|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|38
2531197|NCT00654420|6203742|P3|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|37
2531198|NCT00654420|6203743|P2|STARTED|Phase II||0
2531199|NCT00654420|6203744|P1|STARTED|Phase II||0
2531200|NCT00654420|6203741|P4|NOT COMPLETED|Phase I (Dose Escalation)||0
2531201|NCT00654420|6203742|P3|NOT COMPLETED|Phase I (Dose Escalation)||0
2531202|NCT00654420|6203743|P2|NOT COMPLETED|Phase I (Dose Escalation)||16
2531203|NCT00654420|6203744|P1|NOT COMPLETED|Phase I (Dose Escalation)||4
2531204|NCT00654420|6203741|P4|COMPLETED|Phase I (Dose Escalation)||0
2531205|NCT00654420|6203742|P3|COMPLETED|Phase I (Dose Escalation)||0
2531206|NCT00654420|6203743|P2|COMPLETED|Phase I (Dose Escalation)||0
2531207|NCT00654420|6203744|P1|COMPLETED|Phase I (Dose Escalation)||0
2531208|NCT00654420|6203741|P4|STARTED|Phase I (Dose Escalation)||0
2531209|NCT00654420|6203742|P3|STARTED|Phase I (Dose Escalation)||0
2531210|NCT00654420|6203743|P2|STARTED|Phase I (Dose Escalation)||16
2531211|NCT00654420|6203744|P1|STARTED|Phase I (Dose Escalation)||4
2531212|NCT00654381|6203770|P6|NOT COMPLETED|Extension Stage||3
2531213|NCT00654381|6203771|P5|NOT COMPLETED|Extension Stage||3
2531214|NCT00654381|6203772|P4|NOT COMPLETED|Extension Stage||9
2531215|NCT00654381|6203773|P3|NOT COMPLETED|Extension Stage||11
2531216|NCT00654381|6203774|P2|NOT COMPLETED|Extension Stage||2
2531217|NCT00654381|6203775|P1|NOT COMPLETED|Extension Stage||1
2531218|NCT00654381|6203770|P6|COMPLETED|Extension Stage||73
2531219|NCT00654381|6203771|P5|COMPLETED|Extension Stage||68
2531220|NCT00654381|6203772|P4|COMPLETED|Extension Stage||142
2531221|NCT00654381|6203773|P3|COMPLETED|Extension Stage||142
2531222|NCT00654381|6203774|P2|COMPLETED|Extension Stage||36
2531223|NCT00654381|6203775|P1|COMPLETED|Extension Stage||33
2531224|NCT00654381|6203770|P6|STARTED|Extension Stage||76
2531225|NCT00654381|6203771|P5|STARTED|Extension Stage||71
2531226|NCT00654381|6203772|P4|STARTED|Extension Stage||151
2531227|NCT00654381|6203773|P3|STARTED|Extension Stage||153
2531228|NCT00654381|6203774|P2|STARTED|Extension Stage||38
2531229|NCT00654381|6203775|P1|STARTED|Extension Stage||34
2531230|NCT00654381|6203770|P6|NOT COMPLETED|2nd Stage||3
2531231|NCT00654381|6203771|P5|NOT COMPLETED|2nd Stage||8
2531232|NCT00654381|6203772|P4|NOT COMPLETED|2nd Stage||4
2531233|NCT00654381|6203773|P3|NOT COMPLETED|2nd Stage||3
2531234|NCT00654381|6203774|P2|NOT COMPLETED|2nd Stage||0
2531235|NCT00654381|6203775|P1|NOT COMPLETED|2nd Stage||2
2531236|NCT00654381|6203770|P6|COMPLETED|2nd Stage||76
2531237|NCT00654381|6203771|P5|COMPLETED|2nd Stage||71
2531238|NCT00654381|6203772|P4|COMPLETED|2nd Stage||151
2531239|NCT00654381|6203773|P3|COMPLETED|2nd Stage||153
2531240|NCT00654381|6203774|P2|COMPLETED|2nd Stage||38
2531241|NCT00654381|6203775|P1|COMPLETED|2nd Stage||34
2531242|NCT00654381|6203770|P6|STARTED|2nd Stage||79
2531243|NCT00654381|6203771|P5|STARTED|2nd Stage||79
2531244|NCT00654381|6203772|P4|STARTED|2nd Stage||155
2531245|NCT00654381|6203773|P3|STARTED|2nd Stage||156
2531246|NCT00654381|6203774|P2|STARTED|2nd Stage||38
2531247|NCT00654381|6203775|P1|STARTED|2nd Stage||36
2531248|NCT00654381|6203770|P6|NOT COMPLETED|1st Stage||2
2531249|NCT00654381|6203771|P5|NOT COMPLETED|1st Stage||2
2531250|NCT00654381|6203772|P4|NOT COMPLETED|1st Stage||5
2531251|NCT00654381|6203773|P3|NOT COMPLETED|1st Stage||3
2531252|NCT00654381|6203774|P2|NOT COMPLETED|1st Stage||3
2531253|NCT00654381|6203775|P1|NOT COMPLETED|1st Stage||3
2531254|NCT00654381|6203770|P6|COMPLETED|1st Stage||79
2531255|NCT00654381|6203771|P5|COMPLETED|1st Stage||79
2531256|NCT00654381|6203772|P4|COMPLETED|1st Stage||155
2531257|NCT00654381|6203773|P3|COMPLETED|1st Stage||156
2531258|NCT00654381|6203774|P2|COMPLETED|1st Stage||38
2531259|NCT00654381|6203775|P1|COMPLETED|1st Stage||36
2531260|NCT00654381|6203770|P6|STARTED|1st Stage||81
2531261|NCT00654381|6203771|P5|STARTED|1st Stage||81
2531262|NCT00654381|6203772|P4|STARTED|1st Stage||160
2531263|NCT00654381|6203773|P3|STARTED|1st Stage||159
2531264|NCT00654381|6203774|P2|STARTED|1st Stage||41
2531265|NCT00654381|6203775|P1|STARTED|1st Stage||39
2531266|NCT00654368|6203812|P3|NOT COMPLETED|Overall Study||32
2531267|NCT00654368|6203813|P2|NOT COMPLETED|Overall Study||48
2531268|NCT00654368|6203814|P1|NOT COMPLETED|Overall Study||53
2531269|NCT00654368|6203812|P3|COMPLETED|Overall Study||75
2531270|NCT00654368|6203813|P2|COMPLETED|Overall Study||50
2531271|NCT00654368|6203814|P1|COMPLETED|Overall Study||0
2531272|NCT00654368|6203812|P3|STARTED|Overall Study||107
2531273|NCT00654368|6203813|P2|STARTED|Overall Study||98
2531274|NCT00654368|6203814|P1|STARTED|Overall Study||53
2531275|NCT00654355|6203847|P2|NOT COMPLETED|Overall Study||2
2531276|NCT00654355|6203848|P1|NOT COMPLETED|Overall Study||2
2531277|NCT00654355|6203847|P2|COMPLETED|Overall Study||13
2531278|NCT00654355|6203848|P1|COMPLETED|Overall Study||13
2531279|NCT00654355|6203847|P2|STARTED|Overall Study||15
2531280|NCT00654355|6203848|P1|STARTED|Overall Study||15
2531281|NCT00654329|6203862|P4|NOT COMPLETED|Overall Study||0
2531282|NCT00654329|6203863|P3|NOT COMPLETED|Overall Study||0
2531283|NCT00654329|6203864|P2|NOT COMPLETED|Overall Study||0
2531284|NCT00654329|6203865|P1|NOT COMPLETED|Overall Study||0
2531285|NCT00654329|6203862|P4|COMPLETED|Overall Study||27
2531286|NCT00654329|6203863|P3|COMPLETED|Overall Study||23
2531287|NCT00654329|6203864|P2|COMPLETED|Overall Study||28
2531288|NCT00654329|6203865|P1|COMPLETED|Overall Study||23
2531289|NCT00654329|6203862|P4|STARTED|Overall Study||27
2531290|NCT00654329|6203863|P3|STARTED|Overall Study||23
2531291|NCT00654329|6203864|P2|STARTED|Overall Study||28
2531292|NCT00654329|6203865|P1|STARTED|Overall Study||23
2531293|NCT00654238|6203879|P1|NOT COMPLETED|Overall Study||4
2531294|NCT00654238|6203879|P1|COMPLETED|Overall Study||55
2531295|NCT00654238|6203879|P1|STARTED|Overall Study||59
2531296|NCT00654186|6203884|P1|NOT COMPLETED|Overall Study||5
2531297|NCT00654186|6203884|P1|COMPLETED|Overall Study||27
2531298|NCT00654186|6203884|P1|STARTED|Overall Study||32
2531299|NCT00654147|6203892|P2|NOT COMPLETED|Overall Study||4
2531300|NCT00654147|6203893|P1|NOT COMPLETED|Overall Study||2
2531301|NCT00654147|6203892|P2|COMPLETED|Overall Study||19
2531302|NCT00654147|6203893|P1|COMPLETED|Overall Study||19
2531303|NCT00654147|6203892|P2|STARTED|Overall Study||23
2531304|NCT00654147|6203893|P1|STARTED|Overall Study||21
2531305|NCT00654095|6203909|P1|NOT COMPLETED|Overall Study||32
2531306|NCT00654095|6203909|P1|COMPLETED|Overall Study||114
2531307|NCT00654095|6203909|P1|STARTED|Overall Study||146
2531308|NCT00654069|6203916|P3|NOT COMPLETED|Overall Study||18
2531309|NCT00654069|6203917|P2|NOT COMPLETED|Overall Study||11
2531310|NCT00654069|6203918|P1|NOT COMPLETED|Overall Study||17
2531311|NCT00654069|6203916|P3|COMPLETED|Overall Study||116
2531312|NCT00654069|6203917|P2|COMPLETED|Overall Study||124
2531313|NCT00654069|6203918|P1|COMPLETED|Overall Study||119
2531314|NCT00654069|6203916|P3|STARTED|Overall Study||134
2531315|NCT00654069|6203917|P2|STARTED|Overall Study||135
2531316|NCT00654069|6203918|P1|STARTED|Overall Study||136
2531317|NCT00654030|6203926|P1|NOT COMPLETED|Overall Study||1
2531318|NCT00654030|6203926|P1|COMPLETED|Overall Study||11
2531319|NCT00654030|6203926|P1|STARTED|Overall Study||12
2531320|NCT00654004|6203932|P2|NOT COMPLETED|Overall Study||0
2531321|NCT00654004|6203933|P1|NOT COMPLETED|Overall Study||1
2531322|NCT00654004|6203932|P2|COMPLETED|Overall Study||12
2531323|NCT00654004|6203933|P1|COMPLETED|Overall Study||13
2531324|NCT00654004|6203932|P2|STARTED|Overall Study||12
2531325|NCT00654004|6203933|P1|STARTED|Overall Study||14
2531326|NCT00653991|6203949|P2|NOT COMPLETED|6 Month Follow-up||141
2531327|NCT00653991|6203950|P1|NOT COMPLETED|6 Month Follow-up||133
2531328|NCT00653991|6203949|P2|COMPLETED|6 Month Follow-up||350
2531329|NCT00653991|6203950|P1|COMPLETED|6 Month Follow-up||311
2531330|NCT00653991|6203949|P2|STARTED|6 Month Follow-up|Completion of 3 month follow-up was not required for 6-month eligibility.|491
2531331|NCT00653991|6203950|P1|STARTED|6 Month Follow-up|Completion of 3 month follow-up was not required for 6-month eligibility.|444
2531332|NCT00653991|6203949|P2|NOT COMPLETED|3 Month Follow-up||157
2531333|NCT00653991|6203950|P1|NOT COMPLETED|3 Month Follow-up||150
2531334|NCT00653991|6203949|P2|COMPLETED|3 Month Follow-up||334
2531335|NCT00653991|6203950|P1|COMPLETED|3 Month Follow-up||294
2531336|NCT00653991|6203949|P2|STARTED|3 Month Follow-up||491
2531337|NCT00653991|6203950|P1|STARTED|3 Month Follow-up||444
2531338|NCT00653939|6203962|P2|NOT COMPLETED|Overall Study||15
2531339|NCT00653939|6203963|P1|NOT COMPLETED|Overall Study||12
2531340|NCT00653939|6203962|P2|COMPLETED|Overall Study||17
2531341|NCT00653939|6203963|P1|COMPLETED|Overall Study||19
2531342|NCT00653939|6203962|P2|STARTED|Overall Study|1 patient randomized did not receive treatment due to acute renal failure.|32
2531343|NCT00653939|6203963|P1|STARTED|Overall Study|2 patients randomized did not receive treatment due to brain metastasis or consent withdrawal.|31
2531344|NCT00653861|6203979|P1|NOT COMPLETED|Overall Study||0
2531345|NCT00653861|6203979|P1|COMPLETED|Overall Study||72
2531346|NCT00653861|6203979|P1|STARTED|Overall Study||72
2531347|NCT00653523|6203988|P1|NOT COMPLETED|Overall Study||19
2531348|NCT00653523|6203988|P1|COMPLETED|Overall Study||132
2531349|NCT00653523|6203988|P1|STARTED|Overall Study||151
2531350|NCT00653328|6203992|P1|NOT COMPLETED|Overall Study||15
2531351|NCT00653328|6203992|P1|COMPLETED|Overall Study||0
2531352|NCT00653328|6203992|P1|STARTED|Overall Study||15
2531353|NCT00653263|6203999|P1|NOT COMPLETED|Overall Study||2
2531354|NCT00653263|6203999|P1|COMPLETED|Overall Study||6
2531355|NCT00653263|6203999|P1|STARTED|Overall Study|1 dropped out of treatment and the other had untreated hypertension|8
2531356|NCT00653224|6204007|P2|NOT COMPLETED|Overall Study||7
2531357|NCT00653224|6204008|P1|NOT COMPLETED|Overall Study||7
2531358|NCT00653224|6204007|P2|COMPLETED|Overall Study||280
2531359|NCT00653224|6204008|P1|COMPLETED|Overall Study||286
2531360|NCT00653224|6204007|P2|STARTED|Overall Study||287
2531361|NCT00653224|6204008|P1|STARTED|Overall Study||293
2531362|NCT00653159|6204194|P2|NOT COMPLETED|Overall Study||3
2531363|NCT00653159|6204195|P1|NOT COMPLETED|Overall Study||5
2531364|NCT00653159|6204194|P2|COMPLETED|Overall Study||9
2531365|NCT00653159|6204195|P1|COMPLETED|Overall Study||6
2531366|NCT00653159|6204194|P2|STARTED|Overall Study||12
2531367|NCT00653159|6204195|P1|STARTED|Overall Study||11
2531368|NCT00653133|6204211|P2|NOT COMPLETED|Overall Study||0
2531369|NCT00653133|6204212|P1|NOT COMPLETED|Overall Study||0
2531370|NCT00653133|6204211|P2|COMPLETED|Overall Study||497
2531371|NCT00653133|6204212|P1|COMPLETED|Overall Study||1324
2531372|NCT00653133|6204211|P2|STARTED|Overall Study||497
2531373|NCT00653133|6204212|P1|STARTED|Overall Study||1324
2531374|NCT00653068|6204222|P1|NOT COMPLETED|Overall Study||50
2531375|NCT00653068|6204222|P1|COMPLETED|Overall Study||20
2531376|NCT00653068|6204222|P1|STARTED|Overall Study||70
2531377|NCT00652951|6204236|P3|NOT COMPLETED|Booster Phase||0
2531378|NCT00652951|6204237|P2|NOT COMPLETED|Booster Phase||1
2531379|NCT00652951|6204238|P1|NOT COMPLETED|Booster Phase||1
2531380|NCT00652951|6204236|P3|COMPLETED|Booster Phase||258
2531381|NCT00652951|6204237|P2|COMPLETED|Booster Phase||258
2531382|NCT00652951|6204238|P1|COMPLETED|Booster Phase||256
2531383|NCT00652951|6204236|P3|STARTED|Booster Phase||258
2531384|NCT00652951|6204237|P2|STARTED|Booster Phase||259
2531385|NCT00652951|6204238|P1|STARTED|Booster Phase||257
2531386|NCT00652951|6204236|P3|NOT COMPLETED|Primary Phase||0
2531387|NCT00652951|6204237|P2|NOT COMPLETED|Primary Phase||0
2531388|NCT00652951|6204238|P1|NOT COMPLETED|Primary Phase||0
2531389|NCT00652951|6204236|P3|COMPLETED|Primary Phase||260
2531390|NCT00652951|6204237|P2|COMPLETED|Primary Phase||260
2531391|NCT00652951|6204238|P1|COMPLETED|Primary Phase||260
2531392|NCT00652951|6204236|P3|STARTED|Primary Phase||260
2531393|NCT00652951|6204237|P2|STARTED|Primary Phase||260
2531394|NCT00652951|6204238|P1|STARTED|Primary Phase||260
2531395|NCT00652938|6204375|P3|NOT COMPLETED|Overall Study||5
2531396|NCT00652938|6204376|P2|NOT COMPLETED|Overall Study||7
2531397|NCT00652938|6204377|P1|NOT COMPLETED|Overall Study||1
2531398|NCT00652938|6204375|P3|COMPLETED|Overall Study||242
2531399|NCT00652938|6204376|P2|COMPLETED|Overall Study||240
2531400|NCT00652938|6204377|P1|COMPLETED|Overall Study||246
2531401|NCT00652938|6204375|P3|STARTED|Overall Study||247
2531402|NCT00652938|6204376|P2|STARTED|Overall Study||247
2531403|NCT00652938|6204377|P1|STARTED|Overall Study||247
2531404|NCT00652899|6204442|P1|NOT COMPLETED|Overall Study||2
2531405|NCT00652899|6204442|P1|COMPLETED|Overall Study||12
2531406|NCT00652899|6204442|P1|STARTED|Overall Study||14
2531407|NCT00652834|6204452|P1|NOT COMPLETED|Overall Study||5
2531408|NCT00652834|6204452|P1|COMPLETED|Overall Study|3 subjects withdrew after completing baseline questionnaire. 2 did not complete 30-day visit.|18
2531409|NCT00652834|6204452|P1|STARTED|Overall Study||23
2531410|NCT00652743|6204459|P3|NOT COMPLETED|Months 42-48||0
2531411|NCT00652743|6204460|P2|NOT COMPLETED|Months 42-48||0
2531412|NCT00652743|6204461|P1|NOT COMPLETED|Months 42-48||0
2531413|NCT00652743|6204459|P3|COMPLETED|Months 42-48||367
2531414|NCT00652743|6204460|P2|COMPLETED|Months 42-48||170
2531415|NCT00652743|6204461|P1|COMPLETED|Months 42-48||196
2531416|NCT00652743|6204459|P3|STARTED|Months 42-48||367
2531417|NCT00652743|6204460|P2|STARTED|Months 42-48||170
2531418|NCT00652743|6204461|P1|STARTED|Months 42-48||196
2531419|NCT00652743|6204459|P3|NOT COMPLETED|Months 36-42||9
2531420|NCT00652743|6204460|P2|NOT COMPLETED|Months 36-42||5
2531421|NCT00652743|6204461|P1|NOT COMPLETED|Months 36-42||6
2531422|NCT00652743|6204459|P3|COMPLETED|Months 36-42||381
2531423|NCT00652743|6204460|P2|COMPLETED|Months 36-42||180
2531424|NCT00652743|6204461|P1|COMPLETED|Months 36-42||210
2531425|NCT00652743|6204459|P3|STARTED|Months 36-42||390
2531426|NCT00652743|6204460|P2|STARTED|Months 36-42||185
2531427|NCT00652743|6204461|P1|STARTED|Months 36-42||216
2531428|NCT00652743|6204459|P3|NOT COMPLETED|Months 24-30||11
2531429|NCT00652743|6204460|P2|NOT COMPLETED|Months 24-30||1
2531430|NCT00652743|6204461|P1|NOT COMPLETED|Months 24-30||5
2531431|NCT00652743|6204459|P3|COMPLETED|Months 24-30||422
2531432|NCT00652743|6204460|P2|COMPLETED|Months 24-30||185
2531433|NCT00652743|6204461|P1|COMPLETED|Months 24-30||207
2531434|NCT00652743|6204459|P3|STARTED|Months 24-30||433
2531435|NCT00652743|6204460|P2|STARTED|Months 24-30||186
2531436|NCT00652743|6204461|P1|STARTED|Months 24-30||212
2531437|NCT00652743|6204459|P3|NOT COMPLETED|Months 12-18||7
2531438|NCT00652743|6204460|P2|NOT COMPLETED|Months 12-18||2
2531439|NCT00652743|6204461|P1|NOT COMPLETED|Months 12-18||1
2531440|NCT00652743|6204459|P3|COMPLETED|Months 12-18||430
2531441|NCT00652743|6204460|P2|COMPLETED|Months 12-18||186
2531442|NCT00652743|6204461|P1|COMPLETED|Months 12-18||218
2531443|NCT00652743|6204459|P3|STARTED|Months 12-18||437
2531444|NCT00652743|6204460|P2|STARTED|Months 12-18||188
2531445|NCT00652743|6204461|P1|STARTED|Months 12-18||219
2531446|NCT00652626|6204543|P7|NOT COMPLETED|Extension Phase||3
2531447|NCT00652626|6204544|P6|NOT COMPLETED|Extension Phase||12
2531448|NCT00652626|6204545|P5|NOT COMPLETED|Extension Phase||0
2531449|NCT00652626|6204546|P4|NOT COMPLETED|Extension Phase||0
2531450|NCT00652626|6204547|P3|NOT COMPLETED|Extension Phase||0
2531451|NCT00652626|6204548|P2|NOT COMPLETED|Extension Phase||0
2531452|NCT00652626|6204549|P1|NOT COMPLETED|Extension Phase||0
2531453|NCT00652626|6204543|P7|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|1
2531454|NCT00652626|6204544|P6|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|2
2531455|NCT00652626|6204545|P5|COMPLETED|Extension Phase||0
2531456|NCT00652626|6204546|P4|COMPLETED|Extension Phase||0
2531457|NCT00652626|6204547|P3|COMPLETED|Extension Phase||0
2531458|NCT00652626|6204548|P2|COMPLETED|Extension Phase||0
2531459|NCT00652626|6204549|P1|COMPLETED|Extension Phase||0
2531460|NCT00652626|6204543|P7|STARTED|Extension Phase||4
2531461|NCT00652626|6204544|P6|STARTED|Extension Phase||14
2531462|NCT00652626|6204545|P5|STARTED|Extension Phase||0
2531463|NCT00652626|6204546|P4|STARTED|Extension Phase||0
2531464|NCT00652626|6204547|P3|STARTED|Extension Phase||0
2531465|NCT00652626|6204548|P2|STARTED|Extension Phase||0
2531466|NCT00652626|6204549|P1|STARTED|Extension Phase||0
2531467|NCT00652626|6204543|P7|NOT COMPLETED|Initial Treatment Phase||0
2531468|NCT00652626|6204544|P6|NOT COMPLETED|Initial Treatment Phase||0
2531469|NCT00652626|6204545|P5|NOT COMPLETED|Initial Treatment Phase||3
2531470|NCT00652626|6204546|P4|NOT COMPLETED|Initial Treatment Phase||1
2531471|NCT00652626|6204547|P3|NOT COMPLETED|Initial Treatment Phase||1
2531472|NCT00652626|6204548|P2|NOT COMPLETED|Initial Treatment Phase||0
2531473|NCT00652626|6204549|P1|NOT COMPLETED|Initial Treatment Phase||0
2531474|NCT00652626|6204543|P7|COMPLETED|Initial Treatment Phase||0
2531475|NCT00652626|6204544|P6|COMPLETED|Initial Treatment Phase||0
2531476|NCT00652626|6204545|P5|COMPLETED|Initial Treatment Phase||5
2531477|NCT00652626|6204546|P4|COMPLETED|Initial Treatment Phase||5
2531478|NCT00652626|6204547|P3|COMPLETED|Initial Treatment Phase||6
2531479|NCT00652626|6204548|P2|COMPLETED|Initial Treatment Phase||5
2531480|NCT00652626|6204549|P1|COMPLETED|Initial Treatment Phase||5
2531481|NCT00652626|6204543|P7|Received Study Drug|Initial Treatment Phase||0
2531482|NCT00652626|6204544|P6|Received Study Drug|Initial Treatment Phase||0
2531483|NCT00652626|6204545|P5|Received Study Drug|Initial Treatment Phase||6
2531484|NCT00652626|6204546|P4|Received Study Drug|Initial Treatment Phase||5
2531485|NCT00652626|6204547|P3|Received Study Drug|Initial Treatment Phase||6
2531486|NCT00652626|6204548|P2|Received Study Drug|Initial Treatment Phase||5
2531487|NCT00652626|6204549|P1|Received Study Drug|Initial Treatment Phase||5
2531488|NCT00652626|6204543|P7|STARTED|Initial Treatment Phase||0
2531489|NCT00652626|6204544|P6|STARTED|Initial Treatment Phase||0
2531490|NCT00652626|6204545|P5|STARTED|Initial Treatment Phase||8
2531491|NCT00652626|6204546|P4|STARTED|Initial Treatment Phase||6
2531492|NCT00652626|6204547|P3|STARTED|Initial Treatment Phase||7
2531493|NCT00652626|6204548|P2|STARTED|Initial Treatment Phase||5
2531494|NCT00652626|6204549|P1|STARTED|Initial Treatment Phase||5
2531495|NCT00652366|6204618|P5|NOT COMPLETED|Overall Study||36
2531496|NCT00652366|6204619|P4|NOT COMPLETED|Overall Study||179
2531497|NCT00652366|6204620|P3|NOT COMPLETED|Overall Study||71
2531498|NCT00652366|6204621|P2|NOT COMPLETED|Overall Study||75
2531499|NCT00652366|6204622|P1|NOT COMPLETED|Overall Study||106
2531500|NCT00652366|6204618|P5|COMPLETED|Overall Study||0
2531501|NCT00652366|6204619|P4|COMPLETED|Overall Study||0
2531502|NCT00652366|6204620|P3|COMPLETED|Overall Study||0
2531503|NCT00652366|6204621|P2|COMPLETED|Overall Study||0
2531504|NCT00652366|6204622|P1|COMPLETED|Overall Study||0
2531505|NCT00652366|6204618|P5|STARTED|Overall Study||36
2531506|NCT00652366|6204619|P4|STARTED|Overall Study||179
2531507|NCT00652366|6204620|P3|STARTED|Overall Study||71
2531508|NCT00652366|6204621|P2|STARTED|Overall Study||75
2531509|NCT00652366|6204622|P1|STARTED|Overall Study||106
2531510|NCT00652340|6204657|P2|NOT COMPLETED|Overall Study||3
2531511|NCT00652340|6204658|P1|NOT COMPLETED|Overall Study||4
2531512|NCT00652340|6204657|P2|COMPLETED|Overall Study|3 patients remained on study at database lock.|39
2531513|NCT00652340|6204658|P1|COMPLETED|Overall Study|4 patients remained on study at database lock.|74
2531514|NCT00652340|6204657|P2|STARTED|Overall Study||42
2531515|NCT00652340|6204658|P1|STARTED|Overall Study||78
2531516|NCT00652327|6204668|P2|NOT COMPLETED|Overall Study||5
2531517|NCT00652327|6204669|P1|NOT COMPLETED|Overall Study||0
2531518|NCT00652327|6204668|P2|COMPLETED|Overall Study||36
2531519|NCT00652327|6204669|P1|COMPLETED|Overall Study||42
2531520|NCT00652327|6204668|P2|STARTED|Overall Study|Participants who recieved randomized treatment assignment to double the dose of ongoing statin|41
2531521|NCT00652327|6204669|P1|STARTED|Overall Study|Participants who recieved randomized treatment assignment to ezetimibe and ongoing statin|42
2531522|NCT00652314|6204677|P2|NOT COMPLETED|Overall Study||9
2531523|NCT00652314|6204678|P1|NOT COMPLETED|Overall Study||9
2531524|NCT00652314|6204677|P2|COMPLETED|Overall Study||26
2531525|NCT00652314|6204678|P1|COMPLETED|Overall Study||53
2531526|NCT00652314|6204677|P2|STARTED|Overall Study||35
2531527|NCT00652314|6204678|P1|STARTED|Overall Study||62
2531528|NCT00652145|6204694|P2|NOT COMPLETED|Overall Study||0
2531529|NCT00652145|6204695|P1|NOT COMPLETED|Overall Study||0
2531530|NCT00652145|6204694|P2|COMPLETED|Overall Study||26
2531531|NCT00652145|6204695|P1|COMPLETED|Overall Study||26
2531532|NCT00652145|6204694|P2|STARTED|Overall Study||26
2531533|NCT00652145|6204695|P1|STARTED|Overall Study||26
2531534|NCT00652093|6204711|P6|NOT COMPLETED|Overall Study||0
2531535|NCT00652093|6204712|P5|NOT COMPLETED|Overall Study||2
2531536|NCT00652093|6204713|P4|NOT COMPLETED|Overall Study||0
2531537|NCT00652093|6204714|P3|NOT COMPLETED|Overall Study||1
2531538|NCT00652093|6204715|P2|NOT COMPLETED|Overall Study||0
2531539|NCT00652093|6204716|P1|NOT COMPLETED|Overall Study||0
2531540|NCT00652093|6204711|P6|COMPLETED|Overall Study||4
2531541|NCT00652093|6204712|P5|COMPLETED|Overall Study||2
2531542|NCT00652093|6204713|P4|COMPLETED|Overall Study||4
2531543|NCT00652093|6204714|P3|COMPLETED|Overall Study||3
2531544|NCT00652093|6204715|P2|COMPLETED|Overall Study||4
2531545|NCT00652093|6204716|P1|COMPLETED|Overall Study||4
2531546|NCT00652093|6204711|P6|STARTED|Overall Study||4
2531547|NCT00652093|6204712|P5|STARTED|Overall Study||4
2531548|NCT00652093|6204713|P4|STARTED|Overall Study||4
2531549|NCT00652093|6204714|P3|STARTED|Overall Study||4
2531550|NCT00652093|6204715|P2|STARTED|Overall Study||4
2531551|NCT00652093|6204716|P1|STARTED|Overall Study||4
2531552|NCT00652080|6204796|P1|NOT COMPLETED|Overall Study||4
2531553|NCT00652080|6204796|P1|COMPLETED|Overall Study||31
2531554|NCT00652080|6204796|P1|STARTED|Overall Study||35
2531555|NCT00652028|6204806|P4|NOT COMPLETED|Overall Study||0
2531556|NCT00652028|6204807|P3|NOT COMPLETED|Overall Study||1
2531557|NCT00652028|6204808|P2|NOT COMPLETED|Overall Study||1
2531558|NCT00652028|6204809|P1|NOT COMPLETED|Overall Study||1
2531559|NCT00652028|6204806|P4|COMPLETED|Overall Study||14
2531560|NCT00652028|6204807|P3|COMPLETED|Overall Study||14
2531561|NCT00652028|6204808|P2|COMPLETED|Overall Study||13
2531562|NCT00652028|6204809|P1|COMPLETED|Overall Study||15
2531563|NCT00652028|6204806|P4|STARTED|Overall Study||14
2531564|NCT00652028|6204807|P3|STARTED|Overall Study||15
2531565|NCT00652028|6204808|P2|STARTED|Overall Study||14
2531566|NCT00652028|6204809|P1|STARTED|Overall Study||16
2531567|NCT00651937|6204853|P2|NOT COMPLETED|Overall Study||1
2531568|NCT00651937|6204854|P1|NOT COMPLETED|Overall Study||4
2531569|NCT00651937|6204853|P2|COMPLETED|Overall Study||40
2531570|NCT00651937|6204854|P1|COMPLETED|Overall Study||35
2531571|NCT00651937|6204853|P2|STARTED|Overall Study||41
2531572|NCT00651937|6204854|P1|STARTED|Overall Study||39
2531573|NCT00651924|6204864|P2|NOT COMPLETED|Overall Study||7
2531574|NCT00651924|6204865|P1|NOT COMPLETED|Overall Study||0
2531575|NCT00651924|6204864|P2|COMPLETED|Overall Study||2
2531576|NCT00651924|6204865|P1|COMPLETED|Overall Study||18
2531577|NCT00651924|6204864|P2|STARTED|Overall Study||9
2531578|NCT00651924|6204865|P1|STARTED|Overall Study||18
2531579|NCT00651820|6204871|P1|NOT COMPLETED|Overall Study||2
2531580|NCT00651820|6204871|P1|COMPLETED|Overall Study||26
2531581|NCT00651820|6204871|P1|STARTED|Overall Study||28
2531582|NCT00651794|6204881|P3|NOT COMPLETED|Overall Study||21
2531583|NCT00651794|6204882|P2|NOT COMPLETED|Overall Study||22
2531584|NCT00651794|6204883|P1|NOT COMPLETED|Overall Study||21
2531585|NCT00651794|6204881|P3|COMPLETED|Overall Study||10
2531586|NCT00651794|6204882|P2|COMPLETED|Overall Study||9
2531587|NCT00651794|6204883|P1|COMPLETED|Overall Study||15
2531588|NCT00651794|6204881|P3|STARTED|Overall Study||31
2531589|NCT00651794|6204882|P2|STARTED|Overall Study||31
2531590|NCT00651794|6204883|P1|STARTED|Overall Study||36
2531591|NCT00651755|6204903|P2|NOT COMPLETED|Cycle 2 (Second 21 Days)||1
2531592|NCT00651755|6204904|P1|NOT COMPLETED|Cycle 2 (Second 21 Days)||0
2531593|NCT00651755|6204903|P2|COMPLETED|Cycle 2 (Second 21 Days)||8
2531594|NCT00651755|6204904|P1|COMPLETED|Cycle 2 (Second 21 Days)||10
2531595|NCT00651755|6204903|P2|STARTED|Cycle 2 (Second 21 Days)||9
2531596|NCT00651755|6204904|P1|STARTED|Cycle 2 (Second 21 Days)||10
2531597|NCT00651755|6204903|P2|NOT COMPLETED|Cycle 1 (First 21 Days)||0
2531598|NCT00651755|6204904|P1|NOT COMPLETED|Cycle 1 (First 21 Days)||1
2531599|NCT00651755|6204903|P2|COMPLETED|Cycle 1 (First 21 Days)||9
2531600|NCT00651755|6204904|P1|COMPLETED|Cycle 1 (First 21 Days)||10
2531601|NCT00651755|6204903|P2|STARTED|Cycle 1 (First 21 Days)||9
2531602|NCT00651755|6204904|P1|STARTED|Cycle 1 (First 21 Days)||11
2531603|NCT00651664|6204930|P10|NOT COMPLETED|Overall Study||7
2531604|NCT00651664|6204931|P9|NOT COMPLETED|Overall Study||7
2531605|NCT00651664|6204932|P8|NOT COMPLETED|Overall Study||7
2531606|NCT00651664|6204933|P7|NOT COMPLETED|Overall Study||6
2531607|NCT00651664|6204934|P6|NOT COMPLETED|Overall Study||3
2531608|NCT00651664|6204935|P5|NOT COMPLETED|Overall Study||6
2531609|NCT00651664|6204936|P4|NOT COMPLETED|Overall Study||14
2531610|NCT00651664|6204937|P3|NOT COMPLETED|Overall Study||3
2531611|NCT00651664|6204938|P2|NOT COMPLETED|Overall Study||3
2531612|NCT00651664|6204939|P1|NOT COMPLETED|Overall Study||3
2531613|NCT00651664|6204930|P10|COMPLETED|Overall Study||0
2531614|NCT00651664|6204931|P9|COMPLETED|Overall Study||0
2531615|NCT00651664|6204932|P8|COMPLETED|Overall Study||0
2531616|NCT00651664|6204933|P7|COMPLETED|Overall Study||0
2531617|NCT00651664|6204934|P6|COMPLETED|Overall Study||0
2531618|NCT00651664|6204935|P5|COMPLETED|Overall Study||0
2531619|NCT00651664|6204936|P4|COMPLETED|Overall Study||0
2531620|NCT00651664|6204937|P3|COMPLETED|Overall Study||0
2531621|NCT00651664|6204938|P2|COMPLETED|Overall Study||0
2531622|NCT00651664|6204939|P1|COMPLETED|Overall Study||0
2531623|NCT00651664|6204930|P10|STARTED|Overall Study||7
2531624|NCT00651664|6204931|P9|STARTED|Overall Study||7
2531625|NCT00651664|6204932|P8|STARTED|Overall Study||7
2531626|NCT00651664|6204933|P7|STARTED|Overall Study||6
2531627|NCT00651664|6204934|P6|STARTED|Overall Study||3
2531628|NCT00651664|6204935|P5|STARTED|Overall Study||6
2531629|NCT00651664|6204936|P4|STARTED|Overall Study||14
2531630|NCT00651664|6204937|P3|STARTED|Overall Study||3
2531631|NCT00651664|6204938|P2|STARTED|Overall Study||3
2531632|NCT00651664|6204939|P1|STARTED|Overall Study||3
2531633|NCT00651625|6205065|P2|NOT COMPLETED|Overall Study||0
2531634|NCT00651625|6205066|P1|NOT COMPLETED|Overall Study||0
2531635|NCT00651625|6205065|P2|COMPLETED|Overall Study||218
2531636|NCT00651625|6205066|P1|COMPLETED|Overall Study||219
2531637|NCT00651625|6205065|P2|STARTED|Overall Study||218
2531638|NCT00651625|6205066|P1|STARTED|Overall Study||219
2531639|NCT00651573|6205080|P2|NOT COMPLETED|Overall Study||3
2531640|NCT00651573|6205081|P1|NOT COMPLETED|Overall Study||2
2531641|NCT00651573|6205080|P2|COMPLETED|Overall Study||354
2531642|NCT00651573|6205081|P1|COMPLETED|Overall Study||363
2531643|NCT00651573|6205080|P2|STARTED|Overall Study||357
2531644|NCT00651573|6205081|P1|STARTED|Overall Study||365
2531645|NCT00651482|6205097|P1|NOT COMPLETED|Overall Study||0
2531646|NCT00651482|6205097|P1|COMPLETED|Overall Study||10
2531647|NCT00651482|6205097|P1|STARTED|Overall Study||10
2531648|NCT00651313|6205111|P2|NOT COMPLETED|Overall Study||6
2531649|NCT00651313|6205112|P1|NOT COMPLETED|Overall Study||6
2531650|NCT00651313|6205111|P2|COMPLETED|Overall Study||37
2531651|NCT00651313|6205112|P1|COMPLETED|Overall Study||35
2531652|NCT00651313|6205111|P2|STARTED|Overall Study||43
2531653|NCT00651313|6205112|P1|STARTED|Overall Study||41
2531654|NCT00651261|6205120|P2|NOT COMPLETED|Overall Study||306
2531655|NCT00651261|6205121|P1|NOT COMPLETED|Overall Study||291
2531656|NCT00651261|6205120|P2|COMPLETED|Overall Study||51
2531657|NCT00651261|6205121|P1|COMPLETED|Overall Study||69
2531658|NCT00651261|6205120|P2|STARTED|Overall Study||357
2531659|NCT00651261|6205121|P1|STARTED|Overall Study||360
2531660|NCT00651183|6205137|P2|NOT COMPLETED|Overall Study||10
2531661|NCT00651183|6205138|P1|NOT COMPLETED|Overall Study||20
2531662|NCT00651183|6205137|P2|COMPLETED|Overall Study|"other reasons. No explanation was required to be given by the physicians"|87
2531663|NCT00651183|6205138|P1|COMPLETED|Overall Study|Case Report Form (CRF) listed reasons for early termination, of which one was|169
2531664|NCT00651183|6205137|P2|STARTED|Overall Study||97
2531665|NCT00651183|6205138|P1|STARTED|Overall Study|"For one patient the information was not given, therefore, the patient was listed missing"|189
2531666|NCT00651157|6205150|P1|NOT COMPLETED|Overall Study||2
2531667|NCT00651157|6205150|P1|COMPLETED|Overall Study||21
2531668|NCT00651157|6205150|P1|STARTED|Overall Study||23
2531669|NCT00651118|6205160|P4|NOT COMPLETED|Overall Study||7
2531670|NCT00651118|6205161|P3|NOT COMPLETED|Overall Study||11
2531671|NCT00651118|6205162|P2|NOT COMPLETED|Overall Study||7
2531672|NCT00651118|6205163|P1|NOT COMPLETED|Overall Study||9
2531673|NCT00651118|6205160|P4|COMPLETED|Overall Study||203
2531674|NCT00651118|6205161|P3|COMPLETED|Overall Study||197
2531675|NCT00651118|6205162|P2|COMPLETED|Overall Study||200
2531676|NCT00651118|6205163|P1|COMPLETED|Overall Study||198
2531677|NCT00651118|6205160|P4|STARTED|Overall Study||210
2531678|NCT00651118|6205161|P3|STARTED|Overall Study||208
2531679|NCT00651118|6205162|P2|STARTED|Overall Study||207
2531680|NCT00651118|6205163|P1|STARTED|Overall Study||207
2531681|NCT00651040|6205183|P2|NOT COMPLETED|Overall Study||1
2531682|NCT00651040|6205184|P1|NOT COMPLETED|Overall Study||3
2531683|NCT00651040|6205183|P2|COMPLETED|Overall Study||14
2531684|NCT00651040|6205184|P1|COMPLETED|Overall Study||13
2531685|NCT00651040|6205183|P2|STARTED|Overall Study||15
2531686|NCT00651040|6205184|P1|STARTED|Overall Study||16
2531687|NCT00650936|6205190|P1|NOT COMPLETED|Overall Study||70
2531688|NCT00650936|6205190|P1|COMPLETED|Overall Study||930
2531689|NCT00650936|6205190|P1|STARTED|Overall Study||1000
2531690|NCT00650858|6205199|P3|NOT COMPLETED|Overall Study||0
2531691|NCT00650858|6205200|P2|NOT COMPLETED|Overall Study||0
2531692|NCT00650858|6205201|P1|NOT COMPLETED|Overall Study||0
2531693|NCT00650858|6205199|P3|COMPLETED|Overall Study||36
2531694|NCT00650858|6205200|P2|COMPLETED|Overall Study||8
2531695|NCT00650858|6205201|P1|COMPLETED|Overall Study||8
2531696|NCT00650858|6205199|P3|STARTED|Overall Study||36
2531697|NCT00650858|6205200|P2|STARTED|Overall Study||8
2531698|NCT00650858|6205201|P1|STARTED|Overall Study||8
2531699|NCT00650845|6205232|P2|NOT COMPLETED|Overall Study||13
2531700|NCT00650845|6205233|P1|NOT COMPLETED|Overall Study||5
2531701|NCT00650845|6205232|P2|COMPLETED|Overall Study||44
2531702|NCT00650845|6205233|P1|COMPLETED|Overall Study||70
2531703|NCT00650845|6205232|P2|STARTED|Overall Study||57
2531704|NCT00650845|6205233|P1|STARTED|Overall Study||75
2531705|NCT00650806|6205253|P4|NOT COMPLETED|Overall Study||26
2531706|NCT00650806|6205254|P3|NOT COMPLETED|Overall Study||29
2531707|NCT00650806|6205255|P2|NOT COMPLETED|Overall Study||21
2531708|NCT00650806|6205256|P1|NOT COMPLETED|Overall Study||18
2531709|NCT00650806|6205253|P4|COMPLETED|Overall Study||70
2531710|NCT00650806|6205254|P3|COMPLETED|Overall Study||64
2531711|NCT00650806|6205255|P2|COMPLETED|Overall Study||77
2531712|NCT00650806|6205256|P1|COMPLETED|Overall Study||71
2531713|NCT00650806|6205253|P4|STARTED|Overall Study||96
2531714|NCT00650806|6205254|P3|STARTED|Overall Study||93
2531715|NCT00650806|6205255|P2|STARTED|Overall Study||98
2531716|NCT00650806|6205256|P1|STARTED|Overall Study||89
2531717|NCT00650767|6205298|P4|NOT COMPLETED|Overall Study||11
2531718|NCT00650767|6205299|P3|NOT COMPLETED|Overall Study||14
2531719|NCT00650767|6205300|P2|NOT COMPLETED|Overall Study||9
2531720|NCT00650767|6205301|P1|NOT COMPLETED|Overall Study||5
2531721|NCT00650767|6205298|P4|COMPLETED|Overall Study||39
2531722|NCT00650767|6205299|P3|COMPLETED|Overall Study||36
2531723|NCT00650767|6205300|P2|COMPLETED|Overall Study||41
2531724|NCT00650767|6205301|P1|COMPLETED|Overall Study||46
2531725|NCT00650767|6205298|P4|STARTED|Overall Study||50
2531726|NCT00650767|6205299|P3|STARTED|Overall Study||50
2531727|NCT00650767|6205300|P2|STARTED|Overall Study||50
2531728|NCT00650767|6205301|P1|STARTED|Overall Study||51
2531729|NCT00650585|6205805|P2|NOT COMPLETED|Overall Study||1477
2531730|NCT00650585|6205806|P1|NOT COMPLETED|Overall Study||1797
2531731|NCT00650585|6205805|P2|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2513
2531732|NCT00650585|6205806|P1|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2551
2531733|NCT00650585|6205805|P2|STARTED|Overall Study||3990
2531734|NCT00650585|6205806|P1|STARTED|Overall Study||4348
2531735|NCT00650546|6205826|P1|NOT COMPLETED|Overall Study||0
2531736|NCT00650546|6205826|P1|COMPLETED|Overall Study||8
2531737|NCT00650546|6205826|P1|STARTED|Overall Study||8
2531738|NCT00650260|6205833|P2|NOT COMPLETED|Overall Study||0
2531739|NCT00650260|6205834|P1|NOT COMPLETED|Overall Study||0
2531740|NCT00650260|6205833|P2|COMPLETED|Overall Study||21
2531741|NCT00650260|6205834|P1|COMPLETED|Overall Study||21
2531742|NCT00650260|6205833|P2|STARTED|Overall Study||21
2531743|NCT00650260|6205834|P1|STARTED|Overall Study||21
2531744|NCT00650104|6205850|P1|NOT COMPLETED|Overall Study||41
2531745|NCT00650104|6205850|P1|COMPLETED|Overall Study||42
2531746|NCT00650104|6205850|P1|STARTED|Overall Study||83
2531747|NCT00650091|6205865|P3|NOT COMPLETED|Amended Study Design||0
2531748|NCT00650091|6205866|P2|NOT COMPLETED|Amended Study Design||20
2531749|NCT00650091|6205867|P1|NOT COMPLETED|Amended Study Design||23
2531750|NCT00650091|6205865|P3|COMPLETED|Amended Study Design||0
2531751|NCT00650091|6205866|P2|COMPLETED|Amended Study Design||111
2531752|NCT00650091|6205867|P1|COMPLETED|Amended Study Design||110
2531753|NCT00650091|6205865|P3|STARTED|Amended Study Design|Study Drug was discontinued for all subjects due to safety concerns.|0
2531754|NCT00650091|6205866|P2|STARTED|Amended Study Design||131
2531755|NCT00650091|6205867|P1|STARTED|Amended Study Design||133
2531756|NCT00650091|6205865|P3|NOT COMPLETED|Initial Study Design - Interim Analysis||0
2531757|NCT00650091|6205866|P2|NOT COMPLETED|Initial Study Design - Interim Analysis||0
2531758|NCT00650091|6205867|P1|NOT COMPLETED|Initial Study Design - Interim Analysis||0
2531759|NCT00650091|6205865|P3|COMPLETED|Initial Study Design - Interim Analysis||77
2531760|NCT00650091|6205866|P2|COMPLETED|Initial Study Design - Interim Analysis||78
2531761|NCT00650091|6205867|P1|COMPLETED|Initial Study Design - Interim Analysis||81
2531762|NCT00650091|6205865|P3|STARTED|Initial Study Design - Interim Analysis||77
2531763|NCT00650091|6205866|P2|STARTED|Initial Study Design - Interim Analysis||78
2531764|NCT00650091|6205867|P1|STARTED|Initial Study Design - Interim Analysis||81
2531765|NCT00650078|6205887|P2|NOT COMPLETED|Overall Study||13
2531766|NCT00650078|6205888|P1|NOT COMPLETED|Overall Study||14
2531767|NCT00650078|6205887|P2|COMPLETED|Overall Study||106
2531768|NCT00650078|6205888|P1|COMPLETED|Overall Study||217
2531769|NCT00650078|6205887|P2|STARTED|Overall Study||119
2531770|NCT00650078|6205888|P1|STARTED|Overall Study||231
2531771|NCT00649961|6205896|P1|NOT COMPLETED|Overall Study||0
2531772|NCT00649961|6205896|P1|COMPLETED|Overall Study||18
2531773|NCT00649961|6205896|P1|STARTED|Overall Study||18
2531774|NCT00649792|6205900|P1|NOT COMPLETED|Overall Study||68
2531775|NCT00649792|6205900|P1|COMPLETED|Overall Study||146
2531776|NCT00649792|6205900|P1|STARTED|Overall Study||214
2531777|NCT00649428|6205910|P2|NOT COMPLETED|Overall Study||15
2531778|NCT00649428|6205911|P1|NOT COMPLETED|Overall Study||20
2531779|NCT00649428|6205910|P2|COMPLETED|Overall Study||88
2531780|NCT00649428|6205911|P1|COMPLETED|Overall Study||80
2531781|NCT00649428|6205910|P2|STARTED|Overall Study||103
2531782|NCT00649428|6205911|P1|STARTED|Overall Study||100
2531783|NCT00649389|6205927|P4|NOT COMPLETED|Overall Study||111
2531784|NCT00649389|6205928|P3|NOT COMPLETED|Overall Study||88
2531785|NCT00649389|6205929|P2|NOT COMPLETED|Overall Study||106
2531786|NCT00649389|6205930|P1|NOT COMPLETED|Overall Study||71
2531787|NCT00649389|6205927|P4|COMPLETED|Overall Study||516
2531788|NCT00649389|6205928|P3|COMPLETED|Overall Study||512
2531789|NCT00649389|6205929|P2|COMPLETED|Overall Study||531
2531790|NCT00649389|6205930|P1|COMPLETED|Overall Study||557
2531791|NCT00649389|6205927|P4|STARTED|Overall Study||627
2531792|NCT00649389|6205928|P3|STARTED|Overall Study||600
2531793|NCT00649389|6205929|P2|STARTED|Overall Study||637
2531794|NCT00649389|6205930|P1|STARTED|Overall Study||628
2531795|NCT00649220|6205952|P1|NOT COMPLETED|Overall Study||3
2531796|NCT00649220|6205952|P1|COMPLETED|Overall Study||16
2531797|NCT00649220|6205952|P1|STARTED|Overall Study||19
2531798|NCT00648908|6205963|P1|NOT COMPLETED|Overall Study||115
2531799|NCT00648908|6205963|P1|COMPLETED|Overall Study||154
2531800|NCT00648908|6205963|P1|STARTED|Overall Study||269
2531801|NCT00648895|6205973|P2|NOT COMPLETED|Overall Study||1
2531802|NCT00648895|6205974|P1|NOT COMPLETED|Overall Study||0
2531803|NCT00648895|6205973|P2|COMPLETED|Overall Study||5
2531804|NCT00648895|6205974|P1|COMPLETED|Overall Study||6
2531805|NCT00648895|6205973|P2|STARTED|Overall Study||6
2531806|NCT00648895|6205974|P1|STARTED|Overall Study||6
2531807|NCT00648739|6205980|P7|NOT COMPLETED|Overall Study||1
2531808|NCT00648739|6205981|P6|NOT COMPLETED|Overall Study||5
2531809|NCT00648739|6205982|P5|NOT COMPLETED|Overall Study||2
2531810|NCT00648739|6205983|P4|NOT COMPLETED|Overall Study||2
2531811|NCT00648739|6205984|P3|NOT COMPLETED|Overall Study||3
2531812|NCT00648739|6205985|P2|NOT COMPLETED|Overall Study||2
2531813|NCT00648739|6205986|P1|NOT COMPLETED|Overall Study||2
2531814|NCT00648739|6205980|P7|COMPLETED|Overall Study||0
2531815|NCT00648739|6205981|P6|COMPLETED|Overall Study||2
2531816|NCT00648739|6205982|P5|COMPLETED|Overall Study||1
2531817|NCT00648739|6205983|P4|COMPLETED|Overall Study||1
2531818|NCT00648739|6205984|P3|COMPLETED|Overall Study||0
2531819|NCT00648739|6205985|P2|COMPLETED|Overall Study||3
2531820|NCT00648739|6205986|P1|COMPLETED|Overall Study||2
2531821|NCT00648739|6205980|P7|Received at Least 1 Dose of Study Drug|Overall Study||1
2531822|NCT00648739|6205981|P6|Received at Least 1 Dose of Study Drug|Overall Study||7
2531823|NCT00648739|6205982|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
2531824|NCT00648739|6205983|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
2531825|NCT00648739|6205984|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
2531826|NCT00648739|6205985|P2|Received at Least 1 Dose of Study Drug|Overall Study||5
2531827|NCT00648739|6205986|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
2531828|NCT00648739|6205980|P7|STARTED|Overall Study||1
2531829|NCT00648739|6205981|P6|STARTED|Overall Study||7
2531830|NCT00648739|6205982|P5|STARTED|Overall Study||3
2531831|NCT00648739|6205983|P4|STARTED|Overall Study||3
2531832|NCT00648739|6205984|P3|STARTED|Overall Study||3
2531833|NCT00648739|6205985|P2|STARTED|Overall Study||5
2531834|NCT00648739|6205986|P1|STARTED|Overall Study||4
2531835|NCT00648648|6206052|P28|NOT COMPLETED|Overall Study||12
2531836|NCT00648648|6206053|P27|NOT COMPLETED|Overall Study||26
2531837|NCT00648648|6206054|P26|NOT COMPLETED|Overall Study||4
2531838|NCT00648648|6206055|P25|NOT COMPLETED|Overall Study||4
2531839|NCT00648648|6206056|P24|NOT COMPLETED|Overall Study||4
2531840|NCT00648648|6206057|P23|NOT COMPLETED|Overall Study||14
2531841|NCT00648648|6206058|P22|NOT COMPLETED|Overall Study||10
2531842|NCT00648648|6206059|P21|NOT COMPLETED|Overall Study||6
2531843|NCT00648648|6206060|P20|NOT COMPLETED|Overall Study||7
2531844|NCT00648648|6206061|P19|NOT COMPLETED|Overall Study||5
2531845|NCT00648648|6206062|P18|NOT COMPLETED|Overall Study||6
2531846|NCT00648648|6206063|P17|NOT COMPLETED|Overall Study||14
2531847|NCT00648648|6206064|P16|NOT COMPLETED|Overall Study||11
2531848|NCT00648648|6206065|P15|NOT COMPLETED|Overall Study||4
2531849|NCT00648648|6206066|P14|NOT COMPLETED|Overall Study||5
2531850|NCT00648648|6206067|P13|NOT COMPLETED|Overall Study||6
2531851|NCT00648648|6206068|P12|NOT COMPLETED|Overall Study||13
2531852|NCT00648648|6206069|P11|NOT COMPLETED|Overall Study||6
2531853|NCT00648648|6206070|P10|NOT COMPLETED|Overall Study||10
2531854|NCT00648648|6206071|P9|NOT COMPLETED|Overall Study||3
2531855|NCT00648648|6206072|P8|NOT COMPLETED|Overall Study||1
2531856|NCT00648648|6206073|P7|NOT COMPLETED|Overall Study||10
2531857|NCT00648648|6206074|P6|NOT COMPLETED|Overall Study||1
2531858|NCT00648648|6206075|P5|NOT COMPLETED|Overall Study||9
2531859|NCT00648648|6206076|P4|NOT COMPLETED|Overall Study||4
2531860|NCT00648648|6206077|P3|NOT COMPLETED|Overall Study||0
2531861|NCT00648648|6206078|P2|NOT COMPLETED|Overall Study||0
2531862|NCT00648648|6206079|P1|NOT COMPLETED|Overall Study||0
2531863|NCT00648648|6206052|P28|COMPLETED|Overall Study||0
2531864|NCT00648648|6206053|P27|COMPLETED|Overall Study||0
2531865|NCT00648648|6206054|P26|COMPLETED|Overall Study||0
2531866|NCT00648648|6206055|P25|COMPLETED|Overall Study||0
2531867|NCT00648648|6206056|P24|COMPLETED|Overall Study||0
2531868|NCT00648648|6206057|P23|COMPLETED|Overall Study||0
2531869|NCT00648648|6206058|P22|COMPLETED|Overall Study||0
2531870|NCT00648648|6206059|P21|COMPLETED|Overall Study||0
2531871|NCT00648648|6206060|P20|COMPLETED|Overall Study||0
2531872|NCT00648648|6206061|P19|COMPLETED|Overall Study||0
2531873|NCT00648648|6206062|P18|COMPLETED|Overall Study||0
2531874|NCT00648648|6206063|P17|COMPLETED|Overall Study||2
2531875|NCT00648648|6206064|P16|COMPLETED|Overall Study||0
2531876|NCT00648648|6206065|P15|COMPLETED|Overall Study||0
2531877|NCT00648648|6206066|P14|COMPLETED|Overall Study||0
2531878|NCT00648648|6206067|P13|COMPLETED|Overall Study||0
2531879|NCT00648648|6206068|P12|COMPLETED|Overall Study||0
2531880|NCT00648648|6206069|P11|COMPLETED|Overall Study||0
2531881|NCT00648648|6206070|P10|COMPLETED|Overall Study||0
2531882|NCT00648648|6206071|P9|COMPLETED|Overall Study||0
2531883|NCT00648648|6206072|P8|COMPLETED|Overall Study||0
2531884|NCT00648648|6206073|P7|COMPLETED|Overall Study||0
2531885|NCT00648648|6206074|P6|COMPLETED|Overall Study||0
2531886|NCT00648648|6206075|P5|COMPLETED|Overall Study||0
2531887|NCT00648648|6206076|P4|COMPLETED|Overall Study||0
2531888|NCT00648648|6206077|P3|COMPLETED|Overall Study||3
2531889|NCT00648648|6206078|P2|COMPLETED|Overall Study||3
2531890|NCT00648648|6206079|P1|COMPLETED|Overall Study||3
2531891|NCT00648648|6206052|P28|Treated|Overall Study||12
2531892|NCT00648648|6206053|P27|Treated|Overall Study||26
2531893|NCT00648648|6206054|P26|Treated|Overall Study||4
2531894|NCT00648648|6206055|P25|Treated|Overall Study||4
2531895|NCT00648648|6206056|P24|Treated|Overall Study||4
2531896|NCT00648648|6206057|P23|Treated|Overall Study||14
2531897|NCT00648648|6206058|P22|Treated|Overall Study||10
2531898|NCT00648648|6206059|P21|Treated|Overall Study||6
2531899|NCT00648648|6206060|P20|Treated|Overall Study||7
2531900|NCT00648648|6206061|P19|Treated|Overall Study||4
2531901|NCT00648648|6206062|P18|Treated|Overall Study||6
2531902|NCT00648648|6206063|P17|Treated|Overall Study||16
2531903|NCT00648648|6206064|P16|Treated|Overall Study||11
2531904|NCT00648648|6206065|P15|Treated|Overall Study||4
2531905|NCT00648648|6206066|P14|Treated|Overall Study||5
2531906|NCT00648648|6206067|P13|Treated|Overall Study||6
2531907|NCT00648648|6206068|P12|Treated|Overall Study||13
2531908|NCT00648648|6206069|P11|Treated|Overall Study||6
2531909|NCT00648648|6206070|P10|Treated|Overall Study|Does not include one treated participant who was excluded from analysis.|9
2531910|NCT00648648|6206071|P9|Treated|Overall Study|Does not include one Part 1 participant who was treated in this arm.|3
2531911|NCT00648648|6206072|P8|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|1
2531912|NCT00648648|6206073|P7|Treated|Overall Study|Does not include one treated participant who was excluded from analysis.|9
2531913|NCT00648648|6206074|P6|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|1
2531914|NCT00648648|6206075|P5|Treated|Overall Study||8
2531915|NCT00648648|6206076|P4|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|4
2531916|NCT00648648|6206077|P3|Treated|Overall Study||3
2531917|NCT00648648|6206078|P2|Treated|Overall Study||3
2531918|NCT00648648|6206079|P1|Treated|Overall Study||3
2531919|NCT00648648|6206052|P28|STARTED|Overall Study||12
2531920|NCT00648648|6206053|P27|STARTED|Overall Study||26
2531921|NCT00648648|6206054|P26|STARTED|Overall Study||4
2531922|NCT00648648|6206055|P25|STARTED|Overall Study||4
2531923|NCT00648648|6206056|P24|STARTED|Overall Study||4
2531924|NCT00648648|6206057|P23|STARTED|Overall Study||14
2531925|NCT00648648|6206058|P22|STARTED|Overall Study||10
2531926|NCT00648648|6206059|P21|STARTED|Overall Study||6
2531927|NCT00648648|6206060|P20|STARTED|Overall Study||7
2531928|NCT00648648|6206061|P19|STARTED|Overall Study||5
2531929|NCT00648648|6206062|P18|STARTED|Overall Study||6
2531930|NCT00648648|6206063|P17|STARTED|Overall Study||16
2531931|NCT00648648|6206064|P16|STARTED|Overall Study||11
2531932|NCT00648648|6206065|P15|STARTED|Overall Study||4
2531933|NCT00648648|6206066|P14|STARTED|Overall Study||5
2531934|NCT00648648|6206067|P13|STARTED|Overall Study||6
2531935|NCT00648648|6206068|P12|STARTED|Overall Study||13
2531936|NCT00648648|6206069|P11|STARTED|Overall Study||6
2531937|NCT00648648|6206070|P10|STARTED|Overall Study||10
2531938|NCT00648648|6206071|P9|STARTED|Overall Study|Does not include one Part 1 participant who was randomized to this arm.|3
2531939|NCT00648648|6206072|P8|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|1
2531940|NCT00648648|6206073|P7|STARTED|Overall Study|Does not include one Part 1 participant who was randomized to this arm.|10
2531941|NCT00648648|6206074|P6|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|1
2531942|NCT00648648|6206075|P5|STARTED|Overall Study||9
2531943|NCT00648648|6206076|P4|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|4
2531944|NCT00648648|6206077|P3|STARTED|Overall Study||3
2531945|NCT00648648|6206078|P2|STARTED|Overall Study||3
2531946|NCT00648648|6206079|P1|STARTED|Overall Study||3
2531947|NCT00648375|6206307|P2|NOT COMPLETED|Overall Study||0
2531948|NCT00648375|6206308|P1|NOT COMPLETED|Overall Study||0
2531949|NCT00648375|6206307|P2|COMPLETED|Overall Study||2
2531950|NCT00648375|6206308|P1|COMPLETED|Overall Study||1
2531951|NCT00648375|6206307|P2|STARTED|Overall Study||2
2531952|NCT00648375|6206308|P1|STARTED|Overall Study||1
2531953|NCT00648167|6206320|P1|NOT COMPLETED|Overall Study||7
2531954|NCT00648167|6206320|P1|COMPLETED|Overall Study||48
2531955|NCT00648167|6206320|P1|Start Dose 6 g/Day|Overall Study||21
2531956|NCT00648167|6206320|P1|Start Dose 4.5 g/Day|Overall Study||34
2531957|NCT00648167|6206320|P1|STARTED|Overall Study||55
2531958|NCT00648115|6206327|P3|NOT COMPLETED|Overall Study||0
2531959|NCT00648115|6206328|P2|NOT COMPLETED|Overall Study||0
2531960|NCT00648115|6206329|P1|NOT COMPLETED|Overall Study||0
2531961|NCT00648115|6206327|P3|COMPLETED|Overall Study||27
2531962|NCT00648115|6206328|P2|COMPLETED|Overall Study||42
2531963|NCT00648115|6206329|P1|COMPLETED|Overall Study||42
2531964|NCT00648115|6206327|P3|STARTED|Overall Study||27
2531965|NCT00648115|6206328|P2|STARTED|Overall Study||42
2531966|NCT00648115|6206329|P1|STARTED|Overall Study||42
2531967|NCT00648037|6206340|P1|NOT COMPLETED|Overall Study||16
2531968|NCT00648037|6206340|P1|COMPLETED|Overall Study||10
2531969|NCT00648037|6206340|P1|STARTED|Overall Study||26
2531970|NCT00647998|6206346|P2|NOT COMPLETED|Overall Study||0
2531971|NCT00647998|6206347|P1|NOT COMPLETED|Overall Study||0
2531972|NCT00647998|6206346|P2|COMPLETED|Overall Study||9
2531973|NCT00647998|6206347|P1|COMPLETED|Overall Study||9
2531974|NCT00647998|6206346|P2|STARTED|Overall Study||9
2531975|NCT00647998|6206347|P1|STARTED|Overall Study||9
2531976|NCT00647699|6206359|P2|NOT COMPLETED|Overall Study||12
2531977|NCT00647699|6206360|P1|NOT COMPLETED|Overall Study||8
2531978|NCT00647699|6206359|P2|COMPLETED|Overall Study||62
2531979|NCT00647699|6206360|P1|COMPLETED|Overall Study||65
2531980|NCT00647699|6206359|P2|STARTED|Overall Study||74
2531981|NCT00647699|6206360|P1|STARTED|Overall Study||73
2531982|NCT00647556|6206368|P2|NOT COMPLETED|Overall Study||2
2531983|NCT00647556|6206369|P1|NOT COMPLETED|Overall Study||3
2531984|NCT00647556|6206368|P2|COMPLETED|Overall Study||13
2531985|NCT00647556|6206369|P1|COMPLETED|Overall Study||12
2531986|NCT00647556|6206368|P2|STARTED|Overall Study||15
2531987|NCT00647556|6206369|P1|STARTED|Overall Study||15
2531988|NCT00647426|6206383|P1|NOT COMPLETED|Overall Study||2
2531989|NCT00647426|6206383|P1|COMPLETED|Overall Study||5
2531990|NCT00647426|6206383|P1|STARTED|Overall Study||7
2531991|NCT00647400|6206392|P2|NOT COMPLETED|Overall Study||13
2531992|NCT00647400|6206393|P1|NOT COMPLETED|Overall Study||22
2531993|NCT00647400|6206392|P2|COMPLETED|Overall Study||45
2531994|NCT00647400|6206393|P1|COMPLETED|Overall Study||67
2531995|NCT00647400|6206392|P2|STARTED|Overall Study||58
2531996|NCT00647400|6206393|P1|STARTED|Overall Study||89
2531997|NCT00647348|6206405|P2|NOT COMPLETED|Overall Study||6
2531998|NCT00647348|6206406|P1|NOT COMPLETED|Overall Study||3
2531999|NCT00647348|6206405|P2|COMPLETED|Overall Study||64
2532000|NCT00647348|6206406|P1|COMPLETED|Overall Study||67
2532001|NCT00647348|6206405|P2|STARTED|Overall Study||70
2532002|NCT00647348|6206406|P1|STARTED|Overall Study||70
2532003|NCT00647270|6206431|P3|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||7
2532004|NCT00647270|6206432|P2|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||9
2532005|NCT00647270|6206433|P1|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||3
2532006|NCT00647270|6206431|P3|COMPLETED|Period 2, Placebo Switched to Adalimumab||175
2532007|NCT00647270|6206432|P2|COMPLETED|Period 2, Placebo Switched to Adalimumab||137
2532008|NCT00647270|6206433|P1|COMPLETED|Period 2, Placebo Switched to Adalimumab||45
2532009|NCT00647270|6206431|P3|STARTED|Period 2, Placebo Switched to Adalimumab||182
2532010|NCT00647270|6206432|P2|STARTED|Period 2, Placebo Switched to Adalimumab||146
2532011|NCT00647270|6206433|P1|STARTED|Period 2, Placebo Switched to Adalimumab|Placebo subjects in Period 1 received adalimumab 40 mg eow in Period 2|48
2532012|NCT00647270|6206431|P3|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||23
2532013|NCT00647270|6206432|P2|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||13
2532014|NCT00647270|6206433|P1|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||8
2532015|NCT00647270|6206431|P3|COMPLETED|Period 1, Placebo-control (12 Weeks)||182
2532016|NCT00647270|6206432|P2|COMPLETED|Period 1, Placebo-control (12 Weeks)||146
2532017|NCT00647270|6206433|P1|COMPLETED|Period 1, Placebo-control (12 Weeks)||48
2532018|NCT00647270|6206431|P3|STARTED|Period 1, Placebo-control (12 Weeks)||205
2532019|NCT00647270|6206432|P2|STARTED|Period 1, Placebo-control (12 Weeks)||159
2532020|NCT00647270|6206433|P1|STARTED|Period 1, Placebo-control (12 Weeks)|Placebo subjects in Period 1 received adalimumab 40 mg every other week in Period 2.|56
2532021|NCT00646958|6206459|P3|NOT COMPLETED|Overall Study||9
2532022|NCT00646958|6206460|P2|NOT COMPLETED|Overall Study||9
2532023|NCT00646958|6206461|P1|NOT COMPLETED|Overall Study||11
2532024|NCT00646958|6206459|P3|COMPLETED|Overall Study||40
2532025|NCT00646958|6206460|P2|COMPLETED|Overall Study||41
2532026|NCT00646958|6206461|P1|COMPLETED|Overall Study||40
2532027|NCT00646958|6206459|P3|STARTED|Overall Study|No. Participants Randomized|49
2532028|NCT00646958|6206460|P2|STARTED|Overall Study|No. Participants Randomized|50
2532029|NCT00646958|6206461|P1|STARTED|Overall Study|Number (No.) Participants Randomized|51
2532030|NCT00646906|6206476|P7|NOT COMPLETED|Crossover Period 2||1
2532031|NCT00646906|6206477|P6|NOT COMPLETED|Crossover Period 2||0
2532032|NCT00646906|6206478|P5|NOT COMPLETED|Crossover Period 2||0
2532033|NCT00646906|6206479|P4|NOT COMPLETED|Crossover Period 2||1
2532034|NCT00646906|6206480|P3|NOT COMPLETED|Crossover Period 2||2
2532035|NCT00646906|6206481|P2|NOT COMPLETED|Crossover Period 2||1
2532036|NCT00646906|6206482|P1|NOT COMPLETED|Crossover Period 2||0
2532037|NCT00646906|6206476|P7|COMPLETED|Crossover Period 2||4
2532038|NCT00646906|6206477|P6|COMPLETED|Crossover Period 2||4
2532039|NCT00646906|6206478|P5|COMPLETED|Crossover Period 2|Phase 1b had only one treatment period and no crossover.|0
2532040|NCT00646906|6206479|P4|COMPLETED|Crossover Period 2||8
2532041|NCT00646906|6206480|P3|COMPLETED|Crossover Period 2||8
2532042|NCT00646906|6206481|P2|COMPLETED|Crossover Period 2||8
2532043|NCT00646906|6206482|P1|COMPLETED|Crossover Period 2||8
2532044|NCT00646906|6206476|P7|STARTED|Crossover Period 2||5
2532045|NCT00646906|6206477|P6|STARTED|Crossover Period 2||4
2532046|NCT00646906|6206478|P5|STARTED|Crossover Period 2|Phase 1b had only one treatment period and no crossover.|0
2532047|NCT00646906|6206479|P4|STARTED|Crossover Period 2||9
2532048|NCT00646906|6206480|P3|STARTED|Crossover Period 2||10
2532049|NCT00646906|6206481|P2|STARTED|Crossover Period 2||9
2532050|NCT00646906|6206482|P1|STARTED|Crossover Period 2||8
2532051|NCT00646906|6206476|P7|NOT COMPLETED|Washout (>/= 14 Days)||0
2532052|NCT00646906|6206477|P6|NOT COMPLETED|Washout (>/= 14 Days)||0
2532053|NCT00646906|6206478|P5|NOT COMPLETED|Washout (>/= 14 Days)||0
2532054|NCT00646906|6206479|P4|NOT COMPLETED|Washout (>/= 14 Days)||0
2532055|NCT00646906|6206480|P3|NOT COMPLETED|Washout (>/= 14 Days)||0
2532056|NCT00646906|6206481|P2|NOT COMPLETED|Washout (>/= 14 Days)||0
2532057|NCT00646906|6206482|P1|NOT COMPLETED|Washout (>/= 14 Days)||0
2532058|NCT00646906|6206476|P7|COMPLETED|Washout (>/= 14 Days)||5
2532059|NCT00646906|6206477|P6|COMPLETED|Washout (>/= 14 Days)||4
2532060|NCT00646906|6206478|P5|COMPLETED|Washout (>/= 14 Days)|Phase 1b had only one treatment period and no crossover.|0
2532061|NCT00646906|6206479|P4|COMPLETED|Washout (>/= 14 Days)||9
2532062|NCT00646906|6206480|P3|COMPLETED|Washout (>/= 14 Days)||10
2532063|NCT00646906|6206481|P2|COMPLETED|Washout (>/= 14 Days)||9
2532064|NCT00646906|6206482|P1|COMPLETED|Washout (>/= 14 Days)||8
2532065|NCT00646906|6206476|P7|STARTED|Washout (>/= 14 Days)||5
2532066|NCT00646906|6206477|P6|STARTED|Washout (>/= 14 Days)||4
2532067|NCT00646906|6206478|P5|STARTED|Washout (>/= 14 Days)|Phase 1b had only one treatment period and no crossover.|0
2532068|NCT00646906|6206479|P4|STARTED|Washout (>/= 14 Days)||9
2532069|NCT00646906|6206480|P3|STARTED|Washout (>/= 14 Days)||10
2532070|NCT00646906|6206481|P2|STARTED|Washout (>/= 14 Days)||9
2532071|NCT00646906|6206482|P1|STARTED|Washout (>/= 14 Days)||8
2532072|NCT00646906|6206476|P7|NOT COMPLETED|Crossover Period 1||0
2532073|NCT00646906|6206477|P6|NOT COMPLETED|Crossover Period 1||1
2532074|NCT00646906|6206478|P5|NOT COMPLETED|Crossover Period 1||0
2532075|NCT00646906|6206479|P4|NOT COMPLETED|Crossover Period 1||0
2532076|NCT00646906|6206480|P3|NOT COMPLETED|Crossover Period 1||0
2532077|NCT00646906|6206481|P2|NOT COMPLETED|Crossover Period 1||0
2532078|NCT00646906|6206482|P1|NOT COMPLETED|Crossover Period 1||1
2532079|NCT00646906|6206476|P7|COMPLETED|Crossover Period 1||5
2532080|NCT00646906|6206477|P6|COMPLETED|Crossover Period 1||4
2532081|NCT00646906|6206478|P5|COMPLETED|Crossover Period 1|Phase 1b had only one treatment period and no crossover. Phase 1b ended here.|8
2532082|NCT00646906|6206479|P4|COMPLETED|Crossover Period 1||9
2532083|NCT00646906|6206480|P3|COMPLETED|Crossover Period 1||10
2532084|NCT00646906|6206481|P2|COMPLETED|Crossover Period 1||9
2532085|NCT00646906|6206482|P1|COMPLETED|Crossover Period 1||8
2532086|NCT00646906|6206476|P7|STARTED|Crossover Period 1||5
2532087|NCT00646906|6206477|P6|STARTED|Crossover Period 1||5
2532088|NCT00646906|6206478|P5|STARTED|Crossover Period 1||8
2532089|NCT00646906|6206479|P4|STARTED|Crossover Period 1||9
2532090|NCT00646906|6206480|P3|STARTED|Crossover Period 1||10
2532091|NCT00646906|6206481|P2|STARTED|Crossover Period 1||9
2532092|NCT00646906|6206482|P1|STARTED|Crossover Period 1||9
2532093|NCT00646776|6206501|P2|NOT COMPLETED|Overall Study||13
2532094|NCT00646776|6206502|P1|NOT COMPLETED|Overall Study||1
2532095|NCT00646776|6206501|P2|COMPLETED|Overall Study||5
2532096|NCT00646776|6206502|P1|COMPLETED|Overall Study||14
2532097|NCT00646776|6206501|P2|STARTED|Overall Study|Treated on Day 1|18
2532098|NCT00646776|6206502|P1|STARTED|Overall Study|Treated on Day 1|15
2532099|NCT00646763|6206551|P2|NOT COMPLETED|Overall Study||0
2532100|NCT00646763|6206552|P1|NOT COMPLETED|Overall Study||0
2532101|NCT00646763|6206551|P2|COMPLETED|Overall Study||17
2532102|NCT00646763|6206552|P1|COMPLETED|Overall Study||18
2532103|NCT00646763|6206551|P2|STARTED|Overall Study||17
2532104|NCT00646763|6206552|P1|STARTED|Overall Study||18
2532105|NCT00646646|6206566|P4|NOT COMPLETED|Overall Study||0
2532106|NCT00646646|6206567|P3|NOT COMPLETED|Overall Study||0
2532107|NCT00646646|6206568|P2|NOT COMPLETED|Overall Study||0
2532108|NCT00646646|6206569|P1|NOT COMPLETED|Overall Study||0
2532109|NCT00646646|6206566|P4|COMPLETED|Overall Study||20
2532110|NCT00646646|6206567|P3|COMPLETED|Overall Study||15
2532111|NCT00646646|6206568|P2|COMPLETED|Overall Study||15
2532112|NCT00646646|6206569|P1|COMPLETED|Overall Study||15
2532113|NCT00646646|6206566|P4|STARTED|Overall Study||20
2532114|NCT00646646|6206567|P3|STARTED|Overall Study||15
2532115|NCT00646646|6206568|P2|STARTED|Overall Study||15
2532116|NCT00646646|6206569|P1|STARTED|Overall Study||15
2532117|NCT00646581|6206581|P2|NOT COMPLETED|Overall Study||0
2532118|NCT00646581|6206582|P1|NOT COMPLETED|Overall Study||0
2532119|NCT00646581|6206581|P2|COMPLETED|Overall Study||15
2532120|NCT00646581|6206582|P1|COMPLETED|Overall Study||15
2532121|NCT00646581|6206581|P2|STARTED|Overall Study||15
2532122|NCT00646581|6206582|P1|STARTED|Overall Study||15
2532123|NCT00646399|6206600|P2|NOT COMPLETED|Overall Study||74
2532124|NCT00646399|6206601|P1|NOT COMPLETED|Overall Study||83
2532125|NCT00646399|6206600|P2|COMPLETED|Overall Study||713
2532126|NCT00646399|6206601|P1|COMPLETED|Overall Study||709
2532127|NCT00646399|6206600|P2|STARTED|Overall Study||787
2532128|NCT00646399|6206601|P1|STARTED|Overall Study||792
2532129|NCT00646282|6206609|P2|NOT COMPLETED|Overall Study||4
2532130|NCT00646282|6206610|P1|NOT COMPLETED|Overall Study||4
2532131|NCT00646282|6206609|P2|COMPLETED|Overall Study||0
2532132|NCT00646282|6206610|P1|COMPLETED|Overall Study||0
2532133|NCT00646282|6206609|P2|STARTED|Overall Study||4
2532134|NCT00646282|6206610|P1|STARTED|Overall Study||4
2532135|NCT00646113|6206616|P1|NOT COMPLETED|Overall Study||8
2532136|NCT00646113|6206616|P1|COMPLETED|Overall Study||61
2532137|NCT00646113|6206616|P1|STARTED|Overall Study|3 of the 72 enrolled participants were excluded before surgery.|69
2532138|NCT00646048|6206620|P1|NOT COMPLETED|Overall Study||16
2532139|NCT00646048|6206620|P1|COMPLETED|Overall Study||27
2532140|NCT00646048|6206620|P1|STARTED|Overall Study||43
2532141|NCT00645970|6206628|P2|NOT COMPLETED|Overall Study||186
2532142|NCT00645970|6206629|P1|NOT COMPLETED|Overall Study||109
2532143|NCT00645970|6206628|P2|COMPLETED|Overall Study||32
2532144|NCT00645970|6206629|P1|COMPLETED|Overall Study||32
2532145|NCT00645970|6206628|P2|1 Year|Overall Study||42
2532146|NCT00645970|6206629|P1|1 Year|Overall Study||37
2532147|NCT00645970|6206628|P2|6 Months|Overall Study||97
2532148|NCT00645970|6206629|P1|6 Months|Overall Study||58
2532149|NCT00645970|6206628|P2|STARTED|Overall Study||218
2532150|NCT00645970|6206629|P1|STARTED|Overall Study||141
2532151|NCT00645944|6206637|P2|NOT COMPLETED|Received Medication||3
2532152|NCT00645944|6206638|P1|NOT COMPLETED|Received Medication||6
2532153|NCT00645944|6206637|P2|COMPLETED|Received Medication||14
2532154|NCT00645944|6206638|P1|COMPLETED|Received Medication||13
2532155|NCT00645944|6206637|P2|STARTED|Received Medication||17
2532156|NCT00645944|6206638|P1|STARTED|Received Medication||19
2532157|NCT00645944|6206637|P2|NOT COMPLETED|Randomized||2
2532158|NCT00645944|6206638|P1|NOT COMPLETED|Randomized||1
2532159|NCT00645944|6206637|P2|COMPLETED|Randomized||17
2532160|NCT00645944|6206638|P1|COMPLETED|Randomized||19
2532161|NCT00645944|6206637|P2|STARTED|Randomized||19
2532162|NCT00645944|6206638|P1|STARTED|Randomized||20
2532163|NCT00645853|6206646|P2|NOT COMPLETED|Overall Study||57
2532164|NCT00645853|6206647|P1|NOT COMPLETED|Overall Study||92
2532165|NCT00645853|6206646|P2|COMPLETED|Overall Study||178
2532166|NCT00645853|6206647|P1|COMPLETED|Overall Study||196
2532167|NCT00645853|6206646|P2|AZ Study Closure in Hungary|Overall Study||40
2532168|NCT00645853|6206647|P1|AZ Study Closure in Hungary|Overall Study||60
2532258|NCT00645099|6206874|P1|NOT COMPLETED|Overall Study||71
2532169|NCT00645853|6206646|P2|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|178
2532170|NCT00645853|6206647|P1|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|196
2532171|NCT00645853|6206646|P2|No of Patients After Dose Switch|Overall Study|No changes for VKA patients|188
2532172|NCT00645853|6206647|P1|No of Patients After Dose Switch|Overall Study|All patients in the AZD0837 arm switched from their initial doses, to a general dose of 300 mg od|209
2532173|NCT00645853|6206646|P2|STARTED|Overall Study||235
2532174|NCT00645853|6206647|P1|STARTED|Overall Study||288
2532175|NCT00645840|6206665|P1|NOT COMPLETED|Overall Study||3
2532176|NCT00645840|6206665|P1|COMPLETED|Overall Study||12
2532177|NCT00645840|6206665|P1|STARTED|Overall Study||15
2532178|NCT00645827|6206672|P2|NOT COMPLETED|Overall Study||0
2532179|NCT00645827|6206673|P1|NOT COMPLETED|Overall Study||0
2532180|NCT00645827|6206672|P2|COMPLETED|Overall Study||17
2532181|NCT00645827|6206673|P1|COMPLETED|Overall Study||14
2532182|NCT00645827|6206672|P2|STARTED|Overall Study||17
2532183|NCT00645827|6206673|P1|STARTED|Overall Study||14
2532184|NCT00645788|6206683|P4|NOT COMPLETED|Overall Study||14
2532185|NCT00645788|6206684|P3|NOT COMPLETED|Overall Study||18
2532186|NCT00645788|6206685|P2|NOT COMPLETED|Overall Study||27
2532187|NCT00645788|6206686|P1|NOT COMPLETED|Overall Study||20
2532188|NCT00645788|6206683|P4|COMPLETED|Overall Study||21
2532189|NCT00645788|6206684|P3|COMPLETED|Overall Study||47
2532190|NCT00645788|6206685|P2|COMPLETED|Overall Study||67
2532191|NCT00645788|6206686|P1|COMPLETED|Overall Study||74
2532192|NCT00645788|6206683|P4|Participants Receive Treatment|Overall Study||35
2532193|NCT00645788|6206684|P3|Participants Receive Treatment|Overall Study||65
2532194|NCT00645788|6206685|P2|Participants Receive Treatment|Overall Study||93
2532195|NCT00645788|6206686|P1|Participants Receive Treatment|Overall Study||93
2532196|NCT00645788|6206683|P4|STARTED|Overall Study||35
2532197|NCT00645788|6206684|P3|STARTED|Overall Study||65
2532198|NCT00645788|6206685|P2|STARTED|Overall Study||94
2532199|NCT00645788|6206686|P1|STARTED|Overall Study||94
2532200|NCT00645762|6206736|P1|NOT COMPLETED|Overall Study||4
2532201|NCT00645762|6206736|P1|COMPLETED|Overall Study||67
2532202|NCT00645762|6206736|P1|STARTED|Overall Study||71
2532203|NCT00645710|6206745|P3|NOT COMPLETED|Overall Study||0
2532204|NCT00645710|6206746|P2|NOT COMPLETED|Overall Study||0
2532205|NCT00645710|6206747|P1|NOT COMPLETED|Overall Study||0
2532206|NCT00645710|6206745|P3|COMPLETED|Overall Study||10
2532207|NCT00645710|6206746|P2|COMPLETED|Overall Study||3
2532208|NCT00645710|6206747|P1|COMPLETED|Overall Study||3
2532209|NCT00645710|6206745|P3|STARTED|Overall Study||10
2532210|NCT00645710|6206746|P2|STARTED|Overall Study||3
2532211|NCT00645710|6206747|P1|STARTED|Overall Study||3
2532212|NCT00645671|6206764|P2|NOT COMPLETED|Overall Study||6
2532213|NCT00645671|6206765|P1|NOT COMPLETED|Overall Study||1
2532214|NCT00645671|6206764|P2|COMPLETED|Overall Study||193
2532215|NCT00645671|6206765|P1|COMPLETED|Overall Study||200
2532216|NCT00645671|6206764|P2|STARTED|Overall Study||199
2532217|NCT00645671|6206765|P1|STARTED|Overall Study||201
2532218|NCT00645593|6206779|P2|NOT COMPLETED|Overall Study||0
2532219|NCT00645593|6206780|P1|NOT COMPLETED|Overall Study||1
2532220|NCT00645593|6206779|P2|COMPLETED|Overall Study||60
2532221|NCT00645593|6206780|P1|COMPLETED|Overall Study||28
2532222|NCT00645593|6206779|P2|STARTED|Overall Study||60
2532223|NCT00645593|6206780|P1|STARTED|Overall Study||29
2532224|NCT00645567|6206792|P1|NOT COMPLETED|Overall Study||1
2532225|NCT00645567|6206792|P1|COMPLETED|Overall Study|One individual provided consent & was dropped due to an unrelated injury to his hand at his home.|4
2532226|NCT00645567|6206792|P1|STARTED|Overall Study||5
2532227|NCT00645528|6206800|P1|NOT COMPLETED|Overall Study||7
2532228|NCT00645528|6206800|P1|COMPLETED|Overall Study||32
2532229|NCT00645528|6206800|P1|STARTED|Overall Study||39
2532230|NCT00645450|6206811|P2|NOT COMPLETED|Overall Study||0
2532231|NCT00645450|6206812|P1|NOT COMPLETED|Overall Study||0
2532232|NCT00645450|6206811|P2|COMPLETED|Overall Study||4
2532233|NCT00645450|6206812|P1|COMPLETED|Overall Study||5
2532234|NCT00645450|6206811|P2|STARTED|Overall Study||4
2532235|NCT00645450|6206812|P1|STARTED|Overall Study||5
2532236|NCT00645411|6206822|P4|NOT COMPLETED|Overall Study||103
2532237|NCT00645411|6206823|P3|NOT COMPLETED|Overall Study||151
2532238|NCT00645411|6206824|P2|NOT COMPLETED|Overall Study||6
2532239|NCT00645411|6206825|P1|NOT COMPLETED|Overall Study||13
2532240|NCT00645411|6206822|P4|COMPLETED|Overall Study||919
2532241|NCT00645411|6206823|P3|COMPLETED|Overall Study||1457
2532242|NCT00645411|6206824|P2|COMPLETED|Overall Study||312
2532243|NCT00645411|6206825|P1|COMPLETED|Overall Study||643
2532244|NCT00645411|6206822|P4|STARTED|Overall Study||1022
2532245|NCT00645411|6206823|P3|STARTED|Overall Study||1608
2532246|NCT00645411|6206824|P2|STARTED|Overall Study||318
2532247|NCT00645411|6206825|P1|STARTED|Overall Study||656
2532248|NCT00645359|6206857|P1|NOT COMPLETED|Overall Study||0
2532249|NCT00645359|6206857|P1|COMPLETED|Overall Study||9
2532250|NCT00645359|6206857|P1|STARTED|Overall Study||9
2532251|NCT00645333|6206862|P1|NOT COMPLETED|Overall Study||0
2532252|NCT00645333|6206862|P1|COMPLETED|Overall Study||30
2532253|NCT00645333|6206862|P1|STARTED|Overall Study||30
2532254|NCT00645164|6206867|P1|NOT COMPLETED|Overall Study||7
2532255|NCT00645164|6206867|P1|COMPLETED|Overall Study||52
2532256|NCT00645164|6206867|P1|STARTED|Overall Study||59
2532257|NCT00645099|6206873|P2|NOT COMPLETED|Overall Study||42
2532259|NCT00645099|6206873|P2|COMPLETED|Overall Study||178
2532260|NCT00645099|6206874|P1|COMPLETED|Overall Study||168
2532261|NCT00645099|6206873|P2|STARTED|Overall Study||220
2532262|NCT00645099|6206874|P1|STARTED|Overall Study||239
2532263|NCT00645047|6206918|P2|NOT COMPLETED|Overall Study||39
2532264|NCT00645047|6206919|P1|NOT COMPLETED|Overall Study||43
2532265|NCT00645047|6206918|P2|COMPLETED|Overall Study||65
2532266|NCT00645047|6206919|P1|COMPLETED|Overall Study|6 month follow up|60
2532267|NCT00645047|6206918|P2|Post|Overall Study||80
2532268|NCT00645047|6206919|P1|Post|Overall Study||74
2532269|NCT00645047|6206918|P2|STARTED|Overall Study||104
2532270|NCT00645047|6206919|P1|STARTED|Overall Study||103
2532271|NCT00644995|6206943|P2|NOT COMPLETED|Overall Study||4
2532272|NCT00644995|6206944|P1|NOT COMPLETED|Overall Study||2
2532273|NCT00644995|6206943|P2|COMPLETED|Overall Study||23
2532274|NCT00644995|6206944|P1|COMPLETED|Overall Study|Completed 6 month assessment|23
2532275|NCT00644995|6206943|P2|Completed 4 Month Assessment|Overall Study||24
2532276|NCT00644995|6206944|P1|Completed 4 Month Assessment|Overall Study||23
2532277|NCT00644995|6206943|P2|STARTED|Overall Study||27
2532278|NCT00644995|6206944|P1|STARTED|Overall Study||25
2532279|NCT00644969|6206964|P2|NOT COMPLETED|Post Treatment Phase||3
2532280|NCT00644969|6206965|P1|NOT COMPLETED|Post Treatment Phase||10
2532281|NCT00644969|6206964|P2|COMPLETED|Post Treatment Phase||37
2532282|NCT00644969|6206965|P1|COMPLETED|Post Treatment Phase||61
2532283|NCT00644969|6206964|P2|STARTED|Post Treatment Phase||40
2532284|NCT00644969|6206965|P1|STARTED|Post Treatment Phase||71
2532285|NCT00644969|6206964|P2|NOT COMPLETED|Treatment Phase||3
2532286|NCT00644969|6206965|P1|NOT COMPLETED|Treatment Phase||14
2532287|NCT00644969|6206964|P2|COMPLETED|Treatment Phase||40
2532288|NCT00644969|6206965|P1|COMPLETED|Treatment Phase||71
2532289|NCT00644969|6206964|P2|STARTED|Treatment Phase||43
2532290|NCT00644969|6206965|P1|STARTED|Treatment Phase||85
2532291|NCT00644917|6207011|P1|NOT COMPLETED|Overall Study||2
2532292|NCT00644917|6207011|P1|COMPLETED|Overall Study||36
2532293|NCT00644917|6207011|P1|STARTED|Overall Study||38
2532294|NCT00644787|6207019|P3|NOT COMPLETED|Period 2: Double Blind Phase||7
2532295|NCT00644787|6207020|P2|NOT COMPLETED|Period 2: Double Blind Phase||9
2532296|NCT00644787|6207021|P1|NOT COMPLETED|Period 2: Double Blind Phase||0
2532297|NCT00644787|6207019|P3|COMPLETED|Period 2: Double Blind Phase||55
2532298|NCT00644787|6207020|P2|COMPLETED|Period 2: Double Blind Phase||49
2532299|NCT00644787|6207021|P1|COMPLETED|Period 2: Double Blind Phase||0
2532300|NCT00644787|6207019|P3|STARTED|Period 2: Double Blind Phase||62
2532301|NCT00644787|6207020|P2|STARTED|Period 2: Double Blind Phase||58
2532302|NCT00644787|6207021|P1|STARTED|Period 2: Double Blind Phase||0
2532303|NCT00644787|6207019|P3|NOT COMPLETED|Period 1: Titration Phase||0
2532304|NCT00644787|6207020|P2|NOT COMPLETED|Period 1: Titration Phase||0
2532305|NCT00644787|6207021|P1|NOT COMPLETED|Period 1: Titration Phase||27
2532306|NCT00644787|6207019|P3|COMPLETED|Period 1: Titration Phase||0
2532307|NCT00644787|6207020|P2|COMPLETED|Period 1: Titration Phase||0
2532308|NCT00644787|6207021|P1|COMPLETED|Period 1: Titration Phase||129
2532309|NCT00644787|6207019|P3|STARTED|Period 1: Titration Phase||0
2532310|NCT00644787|6207020|P2|STARTED|Period 1: Titration Phase||0
2532311|NCT00644787|6207021|P1|STARTED|Period 1: Titration Phase||156
2532312|NCT00644657|6207049|P1|NOT COMPLETED|Overall Study||0
2532313|NCT00644657|6207049|P1|COMPLETED|Overall Study||27
2532314|NCT00644657|6207049|P1|STARTED|Overall Study||27
2532315|NCT00644592|6207056|P2|NOT COMPLETED|Overall Study||0
2532316|NCT00644592|6207057|P1|NOT COMPLETED|Overall Study||0
2532317|NCT00644592|6207056|P2|COMPLETED|Overall Study||6
2532318|NCT00644592|6207057|P1|COMPLETED|Overall Study||5
2532319|NCT00644592|6207056|P2|STARTED|Overall Study||6
2532320|NCT00644592|6207057|P1|STARTED|Overall Study||5
2532321|NCT00644423|6207065|P2|NOT COMPLETED|Overall Study||1
2532322|NCT00644423|6207066|P1|NOT COMPLETED|Overall Study||1
2532323|NCT00644423|6207065|P2|COMPLETED|Overall Study||4
2532324|NCT00644423|6207066|P1|COMPLETED|Overall Study||5
2532325|NCT00644423|6207065|P2|STARTED|Overall Study||5
2532326|NCT00644423|6207066|P1|STARTED|Overall Study||6
2532327|NCT00644358|6207084|P1|NOT COMPLETED|Overall Study||362
2532328|NCT00644358|6207084|P1|COMPLETED|Overall Study||254
2532329|NCT00644358|6207084|P1|STARTED|Overall Study||616
2532330|NCT00644332|6207091|P1|NOT COMPLETED|Overall Study||21
2532331|NCT00644332|6207091|P1|COMPLETED|Overall Study||150
2532332|NCT00644332|6207091|P1|STARTED|Overall Study|172 patients were enrolled; one withdrew consent prior to starting treatment|171
2532333|NCT00644280|6207106|P2|NOT COMPLETED|Overall Study||0
2532334|NCT00644280|6207107|P1|NOT COMPLETED|Overall Study||0
2532335|NCT00644280|6207106|P2|COMPLETED|Overall Study||5
2532336|NCT00644280|6207107|P1|COMPLETED|Overall Study||6
2532337|NCT00644280|6207106|P2|STARTED|Overall Study||5
2532338|NCT00644280|6207107|P1|STARTED|Overall Study||6
2532339|NCT00644228|6207117|P2|NOT COMPLETED|Maintenance||135
2532340|NCT00644228|6207118|P1|NOT COMPLETED|Maintenance||143
2532341|NCT00644228|6207117|P2|COMPLETED|Maintenance||0
2532342|NCT00644228|6207118|P1|COMPLETED|Maintenance||0
2532343|NCT00644228|6207117|P2|STARTED|Maintenance|2 patients who completed induction did not continue on to maintenance due to other (2).|135
2532344|NCT00644228|6207118|P1|STARTED|Maintenance|3 patients who completed induction did not continue on to maintenance due to refusal (1), other (2).|143
2532345|NCT00644228|6207117|P2|NOT COMPLETED|Induction Therapy||105
2532346|NCT00644228|6207118|P1|NOT COMPLETED|Induction Therapy||83
2532347|NCT00644228|6207117|P2|COMPLETED|Induction Therapy||137
2532348|NCT00644228|6207118|P1|COMPLETED|Induction Therapy||146
2532349|NCT00644228|6207117|P2|STARTED|Induction Therapy||242
2532350|NCT00644228|6207118|P1|STARTED|Induction Therapy||229
2532351|NCT00644228|6207117|P2|NOT COMPLETED|Randomization & Eligibility||22
2532352|NCT00644228|6207118|P1|NOT COMPLETED|Randomization & Eligibility||32
2532353|NCT00644228|6207117|P2|COMPLETED|Randomization & Eligibility||242
2532354|NCT00644228|6207118|P1|COMPLETED|Randomization & Eligibility||229
2532355|NCT00644228|6207117|P2|Eligible and Analyzable|Randomization & Eligibility||242
2532356|NCT00644228|6207118|P1|Eligible and Analyzable|Randomization & Eligibility||229
2532357|NCT00644228|6207117|P2|STARTED|Randomization & Eligibility||264
2532358|NCT00644228|6207118|P1|STARTED|Randomization & Eligibility||261
2532359|NCT00644189|6207128|P4|NOT COMPLETED|Phase II||0
2532360|NCT00644189|6207129|P3|NOT COMPLETED|Phase II||0
2532361|NCT00644189|6207130|P2|NOT COMPLETED|Phase II||0
2532362|NCT00644189|6207131|P1|NOT COMPLETED|Phase II||0
2532363|NCT00644189|6207128|P4|COMPLETED|Phase II||50
2532364|NCT00644189|6207129|P3|COMPLETED|Phase II||0
2532365|NCT00644189|6207130|P2|COMPLETED|Phase II||0
2532366|NCT00644189|6207131|P1|COMPLETED|Phase II||0
2532367|NCT00644189|6207128|P4|Completed All 6 Cycles of Treatment|Phase II||19
2532368|NCT00644189|6207129|P3|Completed All 6 Cycles of Treatment|Phase II||0
2532369|NCT00644189|6207130|P2|Completed All 6 Cycles of Treatment|Phase II||0
2532370|NCT00644189|6207131|P1|Completed All 6 Cycles of Treatment|Phase II||0
2532371|NCT00644189|6207128|P4|STARTED|Phase II|Additional participants were added to the phase I sample at the phase II 3mg dose level|50
2532372|NCT00644189|6207129|P3|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
2532373|NCT00644189|6207130|P2|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
2532374|NCT00644189|6207131|P1|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
2532375|NCT00644189|6207128|P4|NOT COMPLETED|Phase I||0
2532376|NCT00644189|6207129|P3|NOT COMPLETED|Phase I||0
2532377|NCT00644189|6207130|P2|NOT COMPLETED|Phase I||0
2532378|NCT00644189|6207131|P1|NOT COMPLETED|Phase I||0
2532379|NCT00644189|6207128|P4|COMPLETED|Phase I||18
2532380|NCT00644189|6207129|P3|COMPLETED|Phase I||6
2532381|NCT00644189|6207130|P2|COMPLETED|Phase I||3
2532382|NCT00644189|6207131|P1|COMPLETED|Phase I||3
2532383|NCT00644189|6207128|P4|STARTED|Phase I||18
2532384|NCT00644189|6207129|P3|STARTED|Phase I||6
2532385|NCT00644189|6207130|P2|STARTED|Phase I||3
2532386|NCT00644189|6207131|P1|STARTED|Phase I||3
2532387|NCT00644059|6207147|P3|NOT COMPLETED|Overall Study||65
2532388|NCT00644059|6207148|P2|NOT COMPLETED|Overall Study||123
2532389|NCT00644059|6207149|P1|NOT COMPLETED|Overall Study||124
2532390|NCT00644059|6207147|P3|COMPLETED|Overall Study||969
2532391|NCT00644059|6207148|P2|COMPLETED|Overall Study||1726
2532392|NCT00644059|6207149|P1|COMPLETED|Overall Study||1895
2532393|NCT00644059|6207147|P3|STARTED|Overall Study||1034
2532394|NCT00644059|6207148|P2|STARTED|Overall Study||1849
2532395|NCT00644059|6207149|P1|STARTED|Overall Study||2019
2532396|NCT00643916|6207239|P6|NOT COMPLETED|Overall Study||1
2532397|NCT00643916|6207240|P5|NOT COMPLETED|Overall Study||2
2532398|NCT00643916|6207241|P4|NOT COMPLETED|Overall Study||2
2532399|NCT00643916|6207242|P3|NOT COMPLETED|Overall Study||6
2532400|NCT00643916|6207243|P2|NOT COMPLETED|Overall Study||6
2532401|NCT00643916|6207244|P1|NOT COMPLETED|Overall Study||4
2532402|NCT00643916|6207239|P6|COMPLETED|Overall Study||66
2532403|NCT00643916|6207240|P5|COMPLETED|Overall Study||57
2532404|NCT00643916|6207241|P4|COMPLETED|Overall Study||60
2532405|NCT00643916|6207242|P3|COMPLETED|Overall Study||62
2532406|NCT00643916|6207243|P2|COMPLETED|Overall Study||61
2532407|NCT00643916|6207244|P1|COMPLETED|Overall Study||51
2532408|NCT00643916|6207239|P6|STARTED|Overall Study||67
2532409|NCT00643916|6207240|P5|STARTED|Overall Study||59
2532410|NCT00643916|6207241|P4|STARTED|Overall Study||62
2532411|NCT00643916|6207242|P3|STARTED|Overall Study||68
2532412|NCT00643916|6207243|P2|STARTED|Overall Study||67
2532413|NCT00643916|6207244|P1|STARTED|Overall Study||55
2532414|NCT00643864|6207264|P1|NOT COMPLETED|Post-test Assessment||0
2532415|NCT00643864|6207264|P1|COMPLETED|Post-test Assessment||3
2532416|NCT00643864|6207264|P1|STARTED|Post-test Assessment||3
2532417|NCT00643864|6207264|P1|NOT COMPLETED|Pre-test Assessment||0
2532418|NCT00643864|6207264|P1|COMPLETED|Pre-test Assessment||3
2532419|NCT00643864|6207264|P1|STARTED|Pre-test Assessment||3
2532420|NCT00643851|6207273|P3|NOT COMPLETED|Overall Study||30
2532421|NCT00643851|6207274|P2|NOT COMPLETED|Overall Study||33
2532422|NCT00643851|6207275|P1|NOT COMPLETED|Overall Study||17
2532423|NCT00643851|6207273|P3|COMPLETED|Overall Study||171
2532424|NCT00643851|6207274|P2|COMPLETED|Overall Study||170
2532425|NCT00643851|6207275|P1|COMPLETED|Overall Study||177
2532426|NCT00643851|6207273|P3|STARTED|Overall Study||201
2532427|NCT00643851|6207274|P2|STARTED|Overall Study||203
2532428|NCT00643851|6207275|P1|STARTED|Overall Study||194
2532429|NCT00643760|6207303|P5|NOT COMPLETED|Overall Study||19
2532430|NCT00643760|6207304|P4|NOT COMPLETED|Overall Study||38
2532431|NCT00643760|6207305|P3|NOT COMPLETED|Overall Study||19
2532432|NCT00643760|6207306|P2|NOT COMPLETED|Overall Study||15
2532433|NCT00643760|6207307|P1|NOT COMPLETED|Overall Study||30
2532434|NCT00643760|6207303|P5|COMPLETED|Overall Study||47
2532435|NCT00643760|6207304|P4|COMPLETED|Overall Study||79
2532436|NCT00643760|6207305|P3|COMPLETED|Overall Study||37
2532437|NCT00643760|6207306|P2|COMPLETED|Overall Study||47
2532438|NCT00643760|6207307|P1|COMPLETED|Overall Study||90
2532439|NCT00643760|6207303|P5|ITT Population|Overall Study||66
2532440|NCT00643760|6207304|P4|ITT Population|Overall Study||116
2532441|NCT00643760|6207305|P3|ITT Population|Overall Study||56
2532442|NCT00643760|6207306|P2|ITT Population|Overall Study||62
2532443|NCT00643760|6207307|P1|ITT Population|Overall Study||120
2532444|NCT00643760|6207303|P5|Safety Population/Treated With Drug|Overall Study||66
2532445|NCT00643760|6207304|P4|Safety Population/Treated With Drug|Overall Study||116
2532446|NCT00643760|6207305|P3|Safety Population/Treated With Drug|Overall Study||56
2532447|NCT00643760|6207306|P2|Safety Population/Treated With Drug|Overall Study||62
2532448|NCT00643760|6207307|P1|Safety Population/Treated With Drug|Overall Study||120
2532449|NCT00643760|6207303|P5|STARTED|Overall Study||66
2532450|NCT00643760|6207304|P4|STARTED|Overall Study||117
2532451|NCT00643760|6207305|P3|STARTED|Overall Study||56
2532452|NCT00643760|6207306|P2|STARTED|Overall Study||62
2532453|NCT00643760|6207307|P1|STARTED|Overall Study||120
2532454|NCT00643682|6207411|P2|NOT COMPLETED|Overall Study||509
2532455|NCT00643682|6207412|P1|NOT COMPLETED|Overall Study||522
2532456|NCT00643682|6207411|P2|COMPLETED|Overall Study||492
2532457|NCT00643682|6207412|P1|COMPLETED|Overall Study||477
2532458|NCT00643682|6207411|P2|STARTED|Overall Study||1001
2532459|NCT00643682|6207412|P1|STARTED|Overall Study||999
2532460|NCT00643604|6207424|P1|NOT COMPLETED|Overall Study||1
2532461|NCT00643604|6207424|P1|COMPLETED|Overall Study||6
2532462|NCT00643604|6207424|P1|STARTED|Overall Study||7
2532463|NCT00643578|6207441|P2|NOT COMPLETED|Overall Study||0
2532464|NCT00643578|6207442|P1|NOT COMPLETED|Overall Study||2
2532465|NCT00643578|6207441|P2|COMPLETED|Overall Study||6
2532466|NCT00643578|6207442|P1|COMPLETED|Overall Study||4
2532467|NCT00643578|6207441|P2|STARTED|Overall Study||6
2532468|NCT00643578|6207442|P1|STARTED|Overall Study||6
2532469|NCT00643565|6207452|P2|NOT COMPLETED|Overall Study||67
2532470|NCT00643565|6207453|P1|NOT COMPLETED|Overall Study||73
2532471|NCT00643565|6207452|P2|COMPLETED|Overall Study||7
2532472|NCT00643565|6207453|P1|COMPLETED|Overall Study||7
2532473|NCT00643565|6207452|P2|STARTED|Overall Study||74
2532474|NCT00643565|6207453|P1|STARTED|Overall Study||80
2532475|NCT00643487|6207475|P1|NOT COMPLETED|Overall Study||3
2532476|NCT00643487|6207475|P1|COMPLETED|Overall Study||5
2532477|NCT00643487|6207475|P1|STARTED|Overall Study||8
2532478|NCT00643448|6207482|P3|NOT COMPLETED|Overall Study||6
2532479|NCT00643448|6207483|P2|NOT COMPLETED|Overall Study||5
2532480|NCT00643448|6207484|P1|NOT COMPLETED|Overall Study||4
2532481|NCT00643448|6207482|P3|COMPLETED|Overall Study||16
2532482|NCT00643448|6207483|P2|COMPLETED|Overall Study||17
2532483|NCT00643448|6207484|P1|COMPLETED|Overall Study||17
2532484|NCT00643448|6207482|P3|STARTED|Overall Study||22
2532485|NCT00643448|6207483|P2|STARTED|Overall Study||22
2532486|NCT00643448|6207484|P1|STARTED|Overall Study||21
2532487|NCT00643279|6207501|P2|NOT COMPLETED|Overall Study||13
2532488|NCT00643279|6207502|P1|NOT COMPLETED|Overall Study||16
2532489|NCT00643279|6207501|P2|COMPLETED|Overall Study||127
2532490|NCT00643279|6207502|P1|COMPLETED|Overall Study||118
2532491|NCT00643279|6207501|P2|STARTED|Overall Study||140
2532492|NCT00643279|6207502|P1|STARTED|Overall Study||134
2532493|NCT00643201|6207524|P2|NOT COMPLETED|Completed Study Follow Up||79
2532494|NCT00643201|6207525|P1|NOT COMPLETED|Completed Study Follow Up||70
2532495|NCT00643201|6207524|P2|COMPLETED|Completed Study Follow Up|Of 79 who did not complete follow up: 3 completed treatment, 76 discontinued treatment|2560
2532496|NCT00643201|6207525|P1|COMPLETED|Completed Study Follow Up|Of 70 who did not complete follow up: 7 completed treatment; 63 discontinued treatment|2547
2532497|NCT00643201|6207524|P2|STARTED|Completed Study Follow Up||2639
2532498|NCT00643201|6207525|P1|STARTED|Completed Study Follow Up||2617
2532499|NCT00643201|6207524|P2|NOT COMPLETED|Randomized, Completed 6 Months of Study||413
2532500|NCT00643201|6207525|P1|NOT COMPLETED|Randomized, Completed 6 Months of Study||377
2532501|NCT00643201|6207524|P2|COMPLETED|Randomized, Completed 6 Months of Study||2291
2532502|NCT00643201|6207525|P1|COMPLETED|Randomized, Completed 6 Months of Study||2314
2532503|NCT00643201|6207524|P2|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2704
2532504|NCT00643201|6207525|P1|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2691
2532505|NCT00643162|6207573|P2|NOT COMPLETED|Overall Study||1
2532506|NCT00643162|6207574|P1|NOT COMPLETED|Overall Study||1
2532507|NCT00643162|6207573|P2|COMPLETED|Overall Study||4
2532508|NCT00643162|6207574|P1|COMPLETED|Overall Study||6
2532509|NCT00643162|6207573|P2|STARTED|Overall Study||5
2532510|NCT00643162|6207574|P1|STARTED|Overall Study||7
2532511|NCT00643123|6207586|P2|NOT COMPLETED|Overall Study||1
2532512|NCT00643123|6207587|P1|NOT COMPLETED|Overall Study||5
2532513|NCT00643123|6207586|P2|COMPLETED|Overall Study||11
2532514|NCT00643123|6207587|P1|COMPLETED|Overall Study||10
2532515|NCT00643123|6207586|P2|STARTED|Overall Study||12
2532516|NCT00643123|6207587|P1|STARTED|Overall Study||15
2532517|NCT00643097|6207598|P3|NOT COMPLETED|Overall Study||0
2532518|NCT00643097|6207599|P2|NOT COMPLETED|Overall Study||0
2532519|NCT00643097|6207600|P1|NOT COMPLETED|Overall Study||0
2532520|NCT00643097|6207598|P3|COMPLETED|Overall Study||10
2532521|NCT00643097|6207599|P2|COMPLETED|Overall Study||12
2532522|NCT00643097|6207600|P1|COMPLETED|Overall Study||18
2532523|NCT00643097|6207598|P3|STARTED|Overall Study||10
2532524|NCT00643097|6207599|P2|STARTED|Overall Study||12
2532525|NCT00643097|6207600|P1|STARTED|Overall Study||18
2532526|NCT00643006|6207619|P2|NOT COMPLETED|Overall Study||4
2532527|NCT00643006|6207620|P1|NOT COMPLETED|Overall Study||5
2532528|NCT00643006|6207619|P2|COMPLETED|Overall Study||29
2532529|NCT00643006|6207620|P1|COMPLETED|Overall Study||29
2532530|NCT00643006|6207619|P2|STARTED|Overall Study||33
2532531|NCT00643006|6207620|P1|STARTED|Overall Study||34
2532532|NCT00642993|6207630|P2|NOT COMPLETED|Overall Study||16
2532533|NCT00642993|6207631|P1|NOT COMPLETED|Overall Study||106
2532534|NCT00642993|6207630|P2|COMPLETED|Overall Study||118
2532535|NCT00642993|6207631|P1|COMPLETED|Overall Study||161
2532536|NCT00642993|6207630|P2|STARTED|Overall Study||134
2532537|NCT00642993|6207631|P1|STARTED|Overall Study||267
2532538|NCT00642902|6207649|P4|NOT COMPLETED|Overall Study||40
2532539|NCT00642902|6207650|P3|NOT COMPLETED|Overall Study||43
2532540|NCT00642902|6207651|P2|NOT COMPLETED|Overall Study||42
2532541|NCT00642902|6207652|P1|NOT COMPLETED|Overall Study||40
2532542|NCT00642902|6207649|P4|COMPLETED|Overall Study||25
2532543|NCT00642902|6207650|P3|COMPLETED|Overall Study||21
2532544|NCT00642902|6207651|P2|COMPLETED|Overall Study||21
2532545|NCT00642902|6207652|P1|COMPLETED|Overall Study||23
2532546|NCT00642902|6207649|P4|Treated|Overall Study||65
2532547|NCT00642902|6207650|P3|Treated|Overall Study||63
2532548|NCT00642902|6207651|P2|Treated|Overall Study||63
2532549|NCT00642902|6207652|P1|Treated|Overall Study||63
2532550|NCT00642902|6207649|P4|STARTED|Overall Study||65
2532551|NCT00642902|6207650|P3|STARTED|Overall Study||64
2532552|NCT00642902|6207651|P2|STARTED|Overall Study||63
2532553|NCT00642902|6207652|P1|STARTED|Overall Study||63
2532554|NCT00642850|6207674|P1|NOT COMPLETED|Overall Study||33
2532555|NCT00642850|6207674|P1|COMPLETED|Overall Study||155
2532556|NCT00642850|6207674|P1|STARTED|Overall Study||188
2532557|NCT00642811|6207690|P6|NOT COMPLETED|Overall Study||1
2532558|NCT00642811|6207691|P5|NOT COMPLETED|Overall Study||1
2532559|NCT00642811|6207692|P4|NOT COMPLETED|Overall Study||1
2532560|NCT00642811|6207693|P3|NOT COMPLETED|Overall Study||0
2532561|NCT00642811|6207694|P2|NOT COMPLETED|Overall Study||4
2532562|NCT00642811|6207695|P1|NOT COMPLETED|Overall Study||3
2532563|NCT00642811|6207690|P6|COMPLETED|Overall Study||13
2532564|NCT00642811|6207691|P5|COMPLETED|Overall Study||13
2532565|NCT00642811|6207692|P4|COMPLETED|Overall Study||15
2532566|NCT00642811|6207693|P3|COMPLETED|Overall Study||13
2532567|NCT00642811|6207694|P2|COMPLETED|Overall Study||17
2532568|NCT00642811|6207695|P1|COMPLETED|Overall Study||17
2532569|NCT00642811|6207690|P6|STARTED|Overall Study||14
2532570|NCT00642811|6207691|P5|STARTED|Overall Study||14
2532571|NCT00642811|6207692|P4|STARTED|Overall Study||16
2532572|NCT00642811|6207693|P3|STARTED|Overall Study||13
2532573|NCT00642811|6207694|P2|STARTED|Overall Study||21
2532574|NCT00642811|6207695|P1|STARTED|Overall Study||20
2532575|NCT00642772|6207717|P1|NOT COMPLETED|Overall Study||10
2532576|NCT00642772|6207717|P1|COMPLETED|Overall Study||14
2532577|NCT00642772|6207717|P1|STARTED|Overall Study||24
2532578|NCT00642759|6207721|P1|NOT COMPLETED|Overall Study||1
2532579|NCT00642759|6207721|P1|COMPLETED|Overall Study||35
2532580|NCT00642759|6207721|P1|STARTED|Overall Study||36
2532581|NCT00642746|6207730|P2|NOT COMPLETED|Overall Study||0
2532582|NCT00642746|6207731|P1|NOT COMPLETED|Overall Study||1
2532583|NCT00642746|6207730|P2|COMPLETED|Overall Study||1
2532584|NCT00642746|6207731|P1|COMPLETED|Overall Study||9
2532585|NCT00642746|6207730|P2|STARTED|Overall Study||1
2532586|NCT00642746|6207731|P1|STARTED|Overall Study||10
2532587|NCT00642707|6207745|P4|NOT COMPLETED|Overall Study||2
2532588|NCT00642707|6207746|P3|NOT COMPLETED|Overall Study||0
2532589|NCT00642707|6207747|P2|NOT COMPLETED|Overall Study||0
2532590|NCT00642707|6207748|P1|NOT COMPLETED|Overall Study||1
2532591|NCT00642707|6207745|P4|COMPLETED|Overall Study||8
2532592|NCT00642707|6207746|P3|COMPLETED|Overall Study||12
2532593|NCT00642707|6207747|P2|COMPLETED|Overall Study||11
2532594|NCT00642707|6207748|P1|COMPLETED|Overall Study||10
2532595|NCT00642707|6207745|P4|STARTED|Overall Study||10
2532596|NCT00642707|6207746|P3|STARTED|Overall Study||12
2532597|NCT00642707|6207747|P2|STARTED|Overall Study||11
2532598|NCT00642707|6207748|P1|STARTED|Overall Study||11
2532599|NCT00642694|6207760|P2|NOT COMPLETED|Overall Study||4
2532600|NCT00642694|6207761|P1|NOT COMPLETED|Overall Study||6
2532601|NCT00642694|6207760|P2|COMPLETED|Overall Study||11
2532602|NCT00642694|6207761|P1|COMPLETED|Overall Study||8
2532603|NCT00642694|6207760|P2|STARTED|Overall Study||15
2532604|NCT00642694|6207761|P1|STARTED|Overall Study||14
2532605|NCT00642668|6207783|P1|NOT COMPLETED|Overall Study||14
2532606|NCT00642668|6207783|P1|COMPLETED|Overall Study||21
2532607|NCT00642668|6207783|P1|STARTED|Overall Study||35
2532608|NCT00642642|6207791|P1|NOT COMPLETED|Treatment & Follow Up||17
2532609|NCT00642642|6207791|P1|COMPLETED|Treatment & Follow Up||92
2532610|NCT00642642|6207791|P1|STARTED|Treatment & Follow Up||109
2532611|NCT00642642|6207791|P1|NOT COMPLETED|Biopsy & Product Manufacture||13
2532612|NCT00642642|6207791|P1|COMPLETED|Biopsy & Product Manufacture|Patients biopsied and for whom study product could be produced are considered completed|109
2532613|NCT00642642|6207791|P1|STARTED|Biopsy & Product Manufacture||122
2532614|NCT00642616|6207808|P4|NOT COMPLETED|Overall Study||7
2532615|NCT00642616|6207809|P3|NOT COMPLETED|Overall Study||9
2532616|NCT00642616|6207810|P2|NOT COMPLETED|Overall Study||7
2532617|NCT00642616|6207811|P1|NOT COMPLETED|Overall Study||9
2532618|NCT00642616|6207808|P4|COMPLETED|Overall Study||1
2532619|NCT00642616|6207809|P3|COMPLETED|Overall Study||0
2532620|NCT00642616|6207810|P2|COMPLETED|Overall Study||1
2532621|NCT00642616|6207811|P1|COMPLETED|Overall Study||0
2532622|NCT00642616|6207808|P4|STARTED|Overall Study||8
2532623|NCT00642616|6207809|P3|STARTED|Overall Study||9
2532624|NCT00642616|6207810|P2|STARTED|Overall Study||8
2532625|NCT00642616|6207811|P1|STARTED|Overall Study||9
2532626|NCT00642603|6207835|P2|NOT COMPLETED|Overall Study||18
2532627|NCT00642603|6207836|P1|NOT COMPLETED|Overall Study||21
2532628|NCT00642603|6207835|P2|COMPLETED|Overall Study||2
2532629|NCT00642603|6207836|P1|COMPLETED|Overall Study||0
2532630|NCT00642603|6207835|P2|Safety Population|Overall Study||20
2532631|NCT00642603|6207836|P1|Safety Population|Overall Study||19
2532632|NCT00642603|6207835|P2|STARTED|Overall Study||20
2532633|NCT00642603|6207836|P1|STARTED|Overall Study||21
2532634|NCT00642473|6207844|P2|NOT COMPLETED|Overall Study||11
2532635|NCT00642473|6207845|P1|NOT COMPLETED|Overall Study||4
2532636|NCT00642473|6207844|P2|COMPLETED|Overall Study||5
2532637|NCT00642473|6207845|P1|COMPLETED|Overall Study||14
2532638|NCT00642473|6207844|P2|STARTED|Overall Study||16
2532639|NCT00642473|6207845|P1|STARTED|Overall Study||18
2532640|NCT00642460|6207859|P6|NOT COMPLETED|Part III: Open-Label Up to Week 260||21
2532641|NCT00642460|6207860|P5|NOT COMPLETED|Part III: Open-Label Up to Week 260||25
2532642|NCT00642460|6207861|P4|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
2532643|NCT00642460|6207862|P3|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
2532644|NCT00642460|6207863|P2|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
2532645|NCT00642460|6207864|P1|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
2532646|NCT00642460|6207859|P6|COMPLETED|Part III: Open-Label Up to Week 260||38
2532647|NCT00642460|6207860|P5|COMPLETED|Part III: Open-Label Up to Week 260||28
2532648|NCT00642460|6207861|P4|COMPLETED|Part III: Open-Label Up to Week 260||0
2532649|NCT00642460|6207862|P3|COMPLETED|Part III: Open-Label Up to Week 260||0
2532650|NCT00642460|6207863|P2|COMPLETED|Part III: Open-Label Up to Week 260||0
2532651|NCT00642460|6207864|P1|COMPLETED|Part III: Open-Label Up to Week 260||0
2532652|NCT00642460|6207859|P6|STARTED|Part III: Open-Label Up to Week 260||59
2532653|NCT00642460|6207860|P5|STARTED|Part III: Open-Label Up to Week 260||53
2532654|NCT00642460|6207861|P4|STARTED|Part III: Open-Label Up to Week 260||0
2532655|NCT00642460|6207862|P3|STARTED|Part III: Open-Label Up to Week 260||0
2532656|NCT00642460|6207863|P2|STARTED|Part III: Open-Label Up to Week 260||0
2532657|NCT00642460|6207864|P1|STARTED|Part III: Open-Label Up to Week 260||0
2532658|NCT00642460|6207859|P6|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
2532659|NCT00642460|6207860|P5|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
2532660|NCT00642460|6207861|P4|NOT COMPLETED|Part II: Open-Label Up to Week 92||3
2532661|NCT00642460|6207862|P3|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
2532662|NCT00642460|6207863|P2|NOT COMPLETED|Part II: Open-Label Up to Week 92||8
2532663|NCT00642460|6207864|P1|NOT COMPLETED|Part II: Open-Label Up to Week 92||9
2532664|NCT00642460|6207859|P6|COMPLETED|Part II: Open-Label Up to Week 92||0
2532665|NCT00642460|6207860|P5|COMPLETED|Part II: Open-Label Up to Week 92||0
2532666|NCT00642460|6207861|P4|COMPLETED|Part II: Open-Label Up to Week 92||17
2532667|NCT00642460|6207862|P3|COMPLETED|Part II: Open-Label Up to Week 92||0
2532668|NCT00642460|6207863|P2|COMPLETED|Part II: Open-Label Up to Week 92||32
2532669|NCT00642460|6207864|P1|COMPLETED|Part II: Open-Label Up to Week 92||43
2532670|NCT00642460|6207859|P6|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
2532671|NCT00642460|6207860|P5|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
2532672|NCT00642460|6207861|P4|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||20
2532673|NCT00642460|6207862|P3|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
2532674|NCT00642460|6207863|P2|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||40
2532675|NCT00642460|6207864|P1|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||52
2532676|NCT00642460|6207859|P6|STARTED|Part II: Open-Label Up to Week 92||0
2532677|NCT00642460|6207860|P5|STARTED|Part II: Open-Label Up to Week 92||0
2532678|NCT00642460|6207861|P4|STARTED|Part II: Open-Label Up to Week 92|19 Participants switched from 12 mg/kg to 8 mg/kg and 1 Participant switched from 8mg/kg to 12 mg/kg|20
2532679|NCT00642460|6207862|P3|STARTED|Part II: Open-Label Up to Week 92|Placebo group received open-label Tocilizumab 8 mg/kg or 12 mg/kg based on body weight in Part II.|0
2532680|NCT00642460|6207863|P2|STARTED|Part II: Open-Label Up to Week 92||40
2532681|NCT00642460|6207864|P1|STARTED|Part II: Open-Label Up to Week 92|Includes Participants who received Open-Label in Part II or Open-Label escape therapy in Part I.|52
2532682|NCT00642460|6207859|P6|NOT COMPLETED|Part I: 12 Week Double-Blind||0
2532683|NCT00642460|6207860|P5|NOT COMPLETED|Part I: 12 Week Double-Blind||0
2532684|NCT00642460|6207861|P4|NOT COMPLETED|Part I: 12 Week Double-Blind||0
2532685|NCT00642460|6207862|P3|NOT COMPLETED|Part I: 12 Week Double-Blind||1
2532686|NCT00642460|6207863|P2|NOT COMPLETED|Part I: 12 Week Double-Blind||1
2532687|NCT00642460|6207864|P1|NOT COMPLETED|Part I: 12 Week Double-Blind||1
2532688|NCT00642460|6207859|P6|COMPLETED|Part I: 12 Week Double-Blind||0
2532689|NCT00642460|6207860|P5|COMPLETED|Part I: 12 Week Double-Blind||0
2532690|NCT00642460|6207861|P4|COMPLETED|Part I: 12 Week Double-Blind||0
2532691|NCT00642460|6207862|P3|COMPLETED|Part I: 12 Week Double-Blind||36
2532692|NCT00642460|6207863|P2|COMPLETED|Part I: 12 Week Double-Blind||37
2532693|NCT00642460|6207864|P1|COMPLETED|Part I: 12 Week Double-Blind||36
2532694|NCT00642460|6207859|P6|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
2532695|NCT00642460|6207860|P5|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
2532696|NCT00642460|6207861|P4|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
2532697|NCT00642460|6207862|P3|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
2532698|NCT00642460|6207863|P2|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||38
2532699|NCT00642460|6207864|P1|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
2532700|NCT00642460|6207859|P6|STARTED|Part I: 12 Week Double-Blind||0
2532701|NCT00642460|6207860|P5|STARTED|Part I: 12 Week Double-Blind||0
2532702|NCT00642460|6207861|P4|STARTED|Part I: 12 Week Double-Blind||0
2532703|NCT00642460|6207862|P3|STARTED|Part I: 12 Week Double-Blind||37
2532704|NCT00642460|6207863|P2|STARTED|Part I: 12 Week Double-Blind||38
2532705|NCT00642460|6207864|P1|STARTED|Part I: 12 Week Double-Blind||37
2532706|NCT00642382|6207930|P2|NOT COMPLETED|Overall Study||0
2532707|NCT00642382|6207931|P1|NOT COMPLETED|Overall Study||0
2532708|NCT00642382|6207930|P2|COMPLETED|Overall Study||0
2532709|NCT00642382|6207931|P1|COMPLETED|Overall Study||0
2532710|NCT00642382|6207930|P2|STARTED|Overall Study||0
2532711|NCT00642382|6207931|P1|STARTED|Overall Study||0
2532712|NCT00642369|6207939|P2|NOT COMPLETED|Overall Study||6
2532713|NCT00642369|6207940|P1|NOT COMPLETED|Overall Study||5
2532714|NCT00642369|6207939|P2|COMPLETED|Overall Study||24
2532715|NCT00642369|6207940|P1|COMPLETED|Overall Study||25
2532716|NCT00642369|6207939|P2|STARTED|Overall Study||30
2532717|NCT00642369|6207940|P1|STARTED|Overall Study||30
2532718|NCT00642356|6207950|P2|NOT COMPLETED|Overall Study||3
2532719|NCT00642356|6207951|P1|NOT COMPLETED|Overall Study||2
2532720|NCT00642356|6207950|P2|COMPLETED|Overall Study||4
2532721|NCT00642356|6207951|P1|COMPLETED|Overall Study||5
2532722|NCT00642356|6207950|P2|STARTED|Overall Study||7
2532723|NCT00642356|6207951|P1|STARTED|Overall Study||7
2532724|NCT00642304|6207959|P1|NOT COMPLETED|Overall Study||6
2532725|NCT00642304|6207959|P1|COMPLETED|Overall Study||14
2532726|NCT00642304|6207959|P1|STARTED|Overall Study||20
2532727|NCT00642278|6207975|P7|NOT COMPLETED|Overall Study||5
2532728|NCT00642278|6207976|P6|NOT COMPLETED|Overall Study||7
2532729|NCT00642278|6207977|P5|NOT COMPLETED|Overall Study||8
2532730|NCT00642278|6207978|P4|NOT COMPLETED|Overall Study||9
2532731|NCT00642278|6207979|P3|NOT COMPLETED|Overall Study||5
2532732|NCT00642278|6207980|P2|NOT COMPLETED|Overall Study||5
2532733|NCT00642278|6207981|P1|NOT COMPLETED|Overall Study||10
2532734|NCT00642278|6207975|P7|COMPLETED|Overall Study||60
2532735|NCT00642278|6207976|P6|COMPLETED|Overall Study||57
2532736|NCT00642278|6207977|P5|COMPLETED|Overall Study||56
2532737|NCT00642278|6207978|P4|COMPLETED|Overall Study||56
2532738|NCT00642278|6207979|P3|COMPLETED|Overall Study||59
2532739|NCT00642278|6207980|P2|COMPLETED|Overall Study||59
2532740|NCT00642278|6207981|P1|COMPLETED|Overall Study||55
2532741|NCT00642278|6207975|P7|STARTED|Overall Study||65
2532742|NCT00642278|6207976|P6|STARTED|Overall Study||64
2532743|NCT00642278|6207977|P5|STARTED|Overall Study||64
2532744|NCT00642278|6207978|P4|STARTED|Overall Study||65
2532745|NCT00642278|6207979|P3|STARTED|Overall Study||64
2532746|NCT00642278|6207980|P2|STARTED|Overall Study||64
2532747|NCT00642278|6207981|P1|STARTED|Overall Study||65
2532748|NCT00642174|6208034|P2|NOT COMPLETED|Period 2 - Crossover Drug||0
2532749|NCT00642174|6208035|P1|NOT COMPLETED|Period 2 - Crossover Drug||0
2532750|NCT00642174|6208034|P2|COMPLETED|Period 2 - Crossover Drug||16
2532751|NCT00642174|6208035|P1|COMPLETED|Period 2 - Crossover Drug||18
2532752|NCT00642174|6208034|P2|STARTED|Period 2 - Crossover Drug||16
2532753|NCT00642174|6208035|P1|STARTED|Period 2 - Crossover Drug||18
2532754|NCT00642174|6208034|P2|NOT COMPLETED|Period 1 - Initial Drug||1
2532755|NCT00642174|6208035|P1|NOT COMPLETED|Period 1 - Initial Drug||0
2532756|NCT00642174|6208034|P2|COMPLETED|Period 1 - Initial Drug||16
2532757|NCT00642174|6208035|P1|COMPLETED|Period 1 - Initial Drug||18
2532758|NCT00642174|6208034|P2|STARTED|Period 1 - Initial Drug||17
2532759|NCT00642174|6208035|P1|STARTED|Period 1 - Initial Drug||18
2532760|NCT00642018|6208051|P2|NOT COMPLETED|Overall Study||79
2532761|NCT00642018|6208052|P1|NOT COMPLETED|Overall Study||28
2532762|NCT00642018|6208051|P2|COMPLETED|Overall Study|Participants who completed 10 cycles of treatment.|23
2532763|NCT00642018|6208052|P1|COMPLETED|Overall Study|Participants who completed 10 cycles of treatment.|24
2532764|NCT00642018|6208051|P2|Received at Least One Dose of Study Drug|Overall Study||98
2532765|NCT00642018|6208052|P1|Received at Least One Dose of Study Drug|Overall Study||51
2532766|NCT00642018|6208051|P2|STARTED|Overall Study||102
2532767|NCT00642018|6208052|P1|STARTED|Overall Study||52
2532768|NCT00641862|6208082|P2|NOT COMPLETED|Overall Study||38
2532769|NCT00641862|6208083|P1|NOT COMPLETED|Overall Study||44
2532770|NCT00641862|6208082|P2|COMPLETED|Overall Study||145
2532771|NCT00641862|6208083|P1|COMPLETED|Overall Study||139
2532772|NCT00641862|6208082|P2|STARTED|Overall Study||183
2532773|NCT00641862|6208083|P1|STARTED|Overall Study||183
2532774|NCT00641797|6208101|P2|NOT COMPLETED|Overall Study||0
2532775|NCT00641797|6208102|P1|NOT COMPLETED|Overall Study||0
2532776|NCT00641797|6208101|P2|COMPLETED|Overall Study||15
2532777|NCT00641797|6208102|P1|COMPLETED|Overall Study||11
2532778|NCT00641797|6208101|P2|STARTED|Overall Study||15
2532779|NCT00641797|6208102|P1|STARTED|Overall Study||11
2532780|NCT00641745|6208110|P2|NOT COMPLETED|Overall Study||113
2532781|NCT00641745|6208111|P1|NOT COMPLETED|Overall Study||280
2532782|NCT00641745|6208110|P2|COMPLETED|Overall Study||89
2532783|NCT00641745|6208111|P1|COMPLETED|Overall Study||147
2532784|NCT00641745|6208110|P2|STARTED|Overall Study||202
2532785|NCT00641745|6208111|P1|STARTED|Overall Study||427
2532786|NCT00641719|6208119|P2|NOT COMPLETED|Overall Study||37
2532787|NCT00641719|6208120|P1|NOT COMPLETED|Overall Study||30
2532788|NCT00641719|6208119|P2|COMPLETED|Overall Study|1 participant discontinued during taper phase, not during treatment phase.|92
2532789|NCT00641719|6208120|P1|COMPLETED|Overall Study||99
2532790|NCT00641719|6208119|P2|STARTED|Overall Study||129
2532791|NCT00641719|6208120|P1|STARTED|Overall Study||129
2532792|NCT00641706|6208144|P2|NOT COMPLETED|Overall Study||3
2532793|NCT00641706|6208145|P1|NOT COMPLETED|Overall Study||9
2532794|NCT00641706|6208144|P2|COMPLETED|Overall Study||4
2532795|NCT00641706|6208145|P1|COMPLETED|Overall Study||28
2532796|NCT00641706|6208144|P2|STARTED|Overall Study||7
2532797|NCT00641706|6208145|P1|STARTED|Overall Study||37
2532798|NCT00641667|6208157|P1|NOT COMPLETED|Overall Study||6
2532799|NCT00641667|6208157|P1|COMPLETED|Overall Study||60
2532800|NCT00641667|6208157|P1|STARTED|Overall Study||66
2532801|NCT00641641|6208167|P1|NOT COMPLETED|Overall Study||0
2532802|NCT00641641|6208167|P1|COMPLETED|Overall Study||16
2532803|NCT00641641|6208167|P1|STARTED|Overall Study||16
2532804|NCT00641563|6208171|P2|NOT COMPLETED|Infusion 2||0
2532805|NCT00641563|6208172|P1|NOT COMPLETED|Infusion 2||0
2532806|NCT00641563|6208171|P2|COMPLETED|Infusion 2||5
2532807|NCT00641563|6208172|P1|COMPLETED|Infusion 2||5
2532808|NCT00641563|6208171|P2|STARTED|Infusion 2||5
2532809|NCT00641563|6208172|P1|STARTED|Infusion 2||5
2532810|NCT00641563|6208171|P2|NOT COMPLETED|Infusion 1||0
2532811|NCT00641563|6208172|P1|NOT COMPLETED|Infusion 1||0
2532812|NCT00641563|6208171|P2|COMPLETED|Infusion 1||5
2532813|NCT00641563|6208172|P1|COMPLETED|Infusion 1||5
2532814|NCT00641563|6208171|P2|STARTED|Infusion 1||5
2532815|NCT00641563|6208172|P1|STARTED|Infusion 1||5
2532816|NCT00641537|6208185|P8|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
2532817|NCT00641537|6208186|P7|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
2532818|NCT00641537|6208187|P6|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
2532819|NCT00641537|6208188|P5|NOT COMPLETED|24-Week Supplemental Follow-up Period||5
2532820|NCT00641537|6208189|P4|NOT COMPLETED|24-Week Supplemental Follow-up Period||4
2532821|NCT00641537|6208190|P3|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
2532822|NCT00641537|6208191|P2|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
2532823|NCT00641537|6208192|P1|NOT COMPLETED|24-Week Supplemental Follow-up Period||0
2532824|NCT00641537|6208185|P8|COMPLETED|24-Week Supplemental Follow-up Period||10
2532825|NCT00641537|6208186|P7|COMPLETED|24-Week Supplemental Follow-up Period||8
2532826|NCT00641537|6208187|P6|COMPLETED|24-Week Supplemental Follow-up Period||14
2532827|NCT00641537|6208188|P5|COMPLETED|24-Week Supplemental Follow-up Period||193
2532828|NCT00641537|6208189|P4|COMPLETED|24-Week Supplemental Follow-up Period||147
2532829|NCT00641537|6208190|P3|COMPLETED|24-Week Supplemental Follow-up Period||140
2532830|NCT00641537|6208191|P2|COMPLETED|24-Week Supplemental Follow-up Period||66
2532831|NCT00641537|6208192|P1|COMPLETED|24-Week Supplemental Follow-up Period||75
2532832|NCT00641537|6208185|P8|STARTED|24-Week Supplemental Follow-up Period||11
2532833|NCT00641537|6208186|P7|STARTED|24-Week Supplemental Follow-up Period||9
2532834|NCT00641537|6208187|P6|STARTED|24-Week Supplemental Follow-up Period||15
2532835|NCT00641537|6208188|P5|STARTED|24-Week Supplemental Follow-up Period||198
2532836|NCT00641537|6208189|P4|STARTED|24-Week Supplemental Follow-up Period||151
2532837|NCT00641537|6208190|P3|STARTED|24-Week Supplemental Follow-up Period||143
2532838|NCT00641537|6208191|P2|STARTED|24-Week Supplemental Follow-up Period||69
2532839|NCT00641537|6208192|P1|STARTED|24-Week Supplemental Follow-up Period||75
2532840|NCT00641537|6208185|P8|NOT COMPLETED|96-week Period||6
2532841|NCT00641537|6208186|P7|NOT COMPLETED|96-week Period||5
2532842|NCT00641537|6208187|P6|NOT COMPLETED|96-week Period||7
2532843|NCT00641537|6208188|P5|NOT COMPLETED|96-week Period||18
2532844|NCT00641537|6208189|P4|NOT COMPLETED|96-week Period||12
2532845|NCT00641537|6208190|P3|NOT COMPLETED|96-week Period||20
2532846|NCT00641537|6208191|P2|NOT COMPLETED|96-week Period||10
2532847|NCT00641537|6208192|P1|NOT COMPLETED|96-week Period||9
2532848|NCT00641537|6208185|P8|COMPLETED|96-week Period||16
2532849|NCT00641537|6208186|P7|COMPLETED|96-week Period||12
2532850|NCT00641537|6208187|P6|COMPLETED|96-week Period||15
2532851|NCT00641537|6208188|P5|COMPLETED|96-week Period||226
2532852|NCT00641537|6208189|P4|COMPLETED|96-week Period||174
2532853|NCT00641537|6208190|P3|COMPLETED|96-week Period||166
2532854|NCT00641537|6208191|P2|COMPLETED|96-week Period||82
2532855|NCT00641537|6208192|P1|COMPLETED|96-week Period||89
2532856|NCT00641537|6208185|P8|STARTED|96-week Period||22
2532857|NCT00641537|6208186|P7|STARTED|96-week Period||17
2532858|NCT00641537|6208187|P6|STARTED|96-week Period||22
2532859|NCT00641537|6208188|P5|STARTED|96-week Period||244
2532860|NCT00641537|6208189|P4|STARTED|96-week Period||186
2532861|NCT00641537|6208190|P3|STARTED|96-week Period||186
2532862|NCT00641537|6208191|P2|STARTED|96-week Period||92
2532863|NCT00641537|6208192|P1|STARTED|96-week Period||98
2532864|NCT00641147|6208247|P2|NOT COMPLETED|Completed 16 Months.||0
2532865|NCT00641147|6208248|P1|NOT COMPLETED|Completed 16 Months.||2
2532866|NCT00641147|6208247|P2|COMPLETED|Completed 16 Months.||19
2532867|NCT00641147|6208248|P1|COMPLETED|Completed 16 Months.||13
2532868|NCT00641147|6208247|P2|STARTED|Completed 16 Months.||19
2532869|NCT00641147|6208248|P1|STARTED|Completed 16 Months.||15
2532870|NCT00641147|6208247|P2|NOT COMPLETED|Completed 12 Months.||2
2532871|NCT00641147|6208248|P1|NOT COMPLETED|Completed 12 Months.||1
2532872|NCT00641147|6208247|P2|COMPLETED|Completed 12 Months.||19
2532873|NCT00641147|6208248|P1|COMPLETED|Completed 12 Months.||15
2532874|NCT00641147|6208247|P2|STARTED|Completed 12 Months.||21
2532875|NCT00641147|6208248|P1|STARTED|Completed 12 Months.||16
2532876|NCT00641147|6208247|P2|NOT COMPLETED|Completed 8 Months.||2
2532877|NCT00641147|6208248|P1|NOT COMPLETED|Completed 8 Months.||3
2532878|NCT00641147|6208247|P2|COMPLETED|Completed 8 Months.||21
2532879|NCT00641147|6208248|P1|COMPLETED|Completed 8 Months.||16
2532880|NCT00641147|6208247|P2|STARTED|Completed 8 Months.||23
2532881|NCT00641147|6208248|P1|STARTED|Completed 8 Months.||19
2532882|NCT00641147|6208247|P2|NOT COMPLETED|Completed 4 Months.||0
2532883|NCT00641147|6208248|P1|NOT COMPLETED|Completed 4 Months.||2
2532884|NCT00641147|6208247|P2|COMPLETED|Completed 4 Months.||23
2532885|NCT00641147|6208248|P1|COMPLETED|Completed 4 Months.||19
2532886|NCT00641147|6208247|P2|STARTED|Completed 4 Months.||23
2532887|NCT00641147|6208248|P1|STARTED|Completed 4 Months.||21
2532888|NCT00641056|6208292|P2|NOT COMPLETED|Overall Study||25
2532889|NCT00641056|6208293|P1|NOT COMPLETED|Overall Study||29
2532890|NCT00641056|6208292|P2|COMPLETED|Overall Study||209
2532891|NCT00641056|6208293|P1|COMPLETED|Overall Study||204
2532892|NCT00641056|6208292|P2|Intent to Treat (ITT)|Overall Study||223
2532893|NCT00641056|6208293|P1|Intent to Treat (ITT)|Overall Study||233
2532894|NCT00641056|6208292|P2|STARTED|Overall Study||234
2532895|NCT00641056|6208293|P1|STARTED|Overall Study||233
2532896|NCT00641043|6208321|P2|NOT COMPLETED|Overall Study||15
2532897|NCT00641043|6208322|P1|NOT COMPLETED|Overall Study||19
2532898|NCT00641043|6208321|P2|COMPLETED|Overall Study|number who completed treatment|244
2532899|NCT00641043|6208322|P1|COMPLETED|Overall Study|number who completed treatment|111
2532900|NCT00641043|6208321|P2|STARTED|Overall Study|number who started treatment|259
2532901|NCT00641043|6208322|P1|STARTED|Overall Study|number who started treatment|130
2532902|NCT00640978|6208352|P1|NOT COMPLETED|Overall Study||0
2532903|NCT00640978|6208352|P1|COMPLETED|Overall Study||15
2532904|NCT00640978|6208352|P1|STARTED|Overall Study||15
2532905|NCT00640926|6208359|P3|NOT COMPLETED|Overall Study||8
2532906|NCT00640926|6208360|P2|NOT COMPLETED|Overall Study||6
2532907|NCT00640926|6208361|P1|NOT COMPLETED|Overall Study||8
2532908|NCT00640926|6208359|P3|COMPLETED|Overall Study||45
2532909|NCT00640926|6208360|P2|COMPLETED|Overall Study||46
2532910|NCT00640926|6208361|P1|COMPLETED|Overall Study||45
2532911|NCT00640926|6208359|P3|STARTED|Overall Study||53
2532912|NCT00640926|6208360|P2|STARTED|Overall Study||52
2532913|NCT00640926|6208361|P1|STARTED|Overall Study||53
2532914|NCT00640835|6208374|P2|NOT COMPLETED|Overall Study||57
2532915|NCT00640835|6208375|P1|NOT COMPLETED|Overall Study||76
2532916|NCT00640835|6208374|P2|COMPLETED|Overall Study||131
2532917|NCT00640835|6208375|P1|COMPLETED|Overall Study||118
2532918|NCT00640835|6208374|P2|STARTED|Overall Study||188
2532919|NCT00640835|6208375|P1|STARTED|Overall Study||194
2532920|NCT00640822|6208386|P3|NOT COMPLETED|Overall Study||25
2532921|NCT00640822|6208387|P2|NOT COMPLETED|Overall Study||59
2532922|NCT00640822|6208388|P1|NOT COMPLETED|Overall Study||43
2532923|NCT00640822|6208386|P3|COMPLETED|Overall Study||77
2532924|NCT00640822|6208387|P2|COMPLETED|Overall Study||258
2532925|NCT00640822|6208388|P1|COMPLETED|Overall Study||279
2532926|NCT00640822|6208386|P3|STARTED|Overall Study||102
2532927|NCT00640822|6208387|P2|STARTED|Overall Study||317
2532928|NCT00640822|6208388|P1|STARTED|Overall Study||322
2532929|NCT00640653|6208401|P5|NOT COMPLETED|Overall Study||5
2532930|NCT00640653|6208402|P4|NOT COMPLETED|Overall Study||2
2532931|NCT00640653|6208403|P3|NOT COMPLETED|Overall Study||0
2532932|NCT00640653|6208404|P2|NOT COMPLETED|Overall Study||3
2532933|NCT00640653|6208405|P1|NOT COMPLETED|Overall Study||3
2532934|NCT00640653|6208401|P5|COMPLETED|Overall Study||129
2532935|NCT00640653|6208402|P4|COMPLETED|Overall Study||132
2532936|NCT00640653|6208403|P3|COMPLETED|Overall Study||129
2532937|NCT00640653|6208404|P2|COMPLETED|Overall Study||131
2532938|NCT00640653|6208405|P1|COMPLETED|Overall Study||128
2532939|NCT00640653|6208401|P5|Followed-up at 24 mo|Overall Study||112
2532940|NCT00640653|6208402|P4|Followed-up at 24 mo|Overall Study||112
2532941|NCT00640653|6208403|P3|Followed-up at 24 mo|Overall Study||105
2532942|NCT00640653|6208404|P2|Followed-up at 24 mo|Overall Study||116
2532943|NCT00640653|6208405|P1|Followed-up at 24 mo|Overall Study||114
2532944|NCT00640653|6208401|P5|Followed-up at 18 mo|Overall Study||117
2532945|NCT00640653|6208402|P4|Followed-up at 18 mo|Overall Study||117
2532946|NCT00640653|6208403|P3|Followed-up at 18 mo|Overall Study||113
2532947|NCT00640653|6208404|P2|Followed-up at 18 mo|Overall Study||112
2532948|NCT00640653|6208405|P1|Followed-up at 18 mo|Overall Study||118
2532949|NCT00640653|6208401|P5|Followed-up at 12 mo|Overall Study||116
2532950|NCT00640653|6208402|P4|Followed-up at 12 mo|Overall Study||122
2532951|NCT00640653|6208403|P3|Followed-up at 12 mo|Overall Study||115
2532952|NCT00640653|6208404|P2|Followed-up at 12 mo|Overall Study||121
2532953|NCT00640653|6208405|P1|Followed-up at 12 mo|Overall Study||124
2532954|NCT00640653|6208401|P5|Followed-up at 6 mo|Overall Study||125
2532955|NCT00640653|6208402|P4|Followed-up at 6 mo|Overall Study||130
2532956|NCT00640653|6208403|P3|Followed-up at 6 mo|Overall Study||124
2532957|NCT00640653|6208404|P2|Followed-up at 6 mo|Overall Study||130
2532958|NCT00640653|6208405|P1|Followed-up at 6 mo|Overall Study||127
2532959|NCT00640653|6208401|P5|Followed-up at 3 mo|Overall Study||126
2532960|NCT00640653|6208402|P4|Followed-up at 3 mo|Overall Study||129
2532961|NCT00640653|6208403|P3|Followed-up at 3 mo|Overall Study||125
2532962|NCT00640653|6208404|P2|Followed-up at 3 mo|Overall Study||127
2532963|NCT00640653|6208405|P1|Followed-up at 3 mo|Overall Study||126
2532964|NCT00640653|6208401|P5|STARTED|Overall Study||134
2532965|NCT00640653|6208402|P4|STARTED|Overall Study||134
2532966|NCT00640653|6208403|P3|STARTED|Overall Study||129
2532967|NCT00640653|6208404|P2|STARTED|Overall Study||134
2532968|NCT00640653|6208405|P1|STARTED|Overall Study||131
2532969|NCT00640614|6208439|P2|NOT COMPLETED|Overall Study||0
2532970|NCT00640614|6208440|P1|NOT COMPLETED|Overall Study||1
2532971|NCT00640614|6208439|P2|COMPLETED|Overall Study||110
2532972|NCT00640614|6208440|P1|COMPLETED|Overall Study||124
2532973|NCT00640614|6208439|P2|STARTED|Overall Study||110
2532974|NCT00640614|6208440|P1|STARTED|Overall Study||125
2532975|NCT00640601|6208482|P1|NOT COMPLETED|Overall Study||112
2532976|NCT00640601|6208482|P1|COMPLETED|Overall Study||183
2532977|NCT00640601|6208482|P1|STARTED|Overall Study|331 patients enrolled and 295 patients started investigational product (IP)|295
2532978|NCT00640562|6208498|P2|NOT COMPLETED|Overall Study||26
2532979|NCT00640562|6208499|P1|NOT COMPLETED|Overall Study||18
2532980|NCT00640562|6208498|P2|COMPLETED|Overall Study||81
2532981|NCT00640562|6208499|P1|COMPLETED|Overall Study||91
2532982|NCT00640562|6208498|P2|STARTED|Overall Study||107
2532983|NCT00640562|6208499|P1|STARTED|Overall Study||109
2532984|NCT00640510|6208527|P2|NOT COMPLETED|Overall Study||2
2532985|NCT00640510|6208528|P1|NOT COMPLETED|Overall Study||1
2532986|NCT00640510|6208527|P2|COMPLETED|Overall Study||15
2532987|NCT00640510|6208528|P1|COMPLETED|Overall Study||16
2532988|NCT00640510|6208527|P2|STARTED|Overall Study|One patient randomized to placebo discontinued prior to receiving study drug.|17
2532989|NCT00640510|6208528|P1|STARTED|Overall Study||17
2532990|NCT00640393|6208540|P3|NOT COMPLETED|Part 2||3
2532991|NCT00640393|6208541|P2|NOT COMPLETED|Part 2||10
2532992|NCT00640393|6208542|P1|NOT COMPLETED|Part 2||0
2532993|NCT00640393|6208540|P3|COMPLETED|Part 2|Per protocol analysis of 27 to 29 participants that were compliant depending on evaluation or visit|35
2532994|NCT00640393|6208541|P2|COMPLETED|Part 2|Per Protocol analysis is of 7 participants that were compliant to protocol|27
2532995|NCT00640393|6208542|P1|COMPLETED|Part 2||0
2532996|NCT00640393|6208540|P3|STARTED|Part 2||38
2532997|NCT00640393|6208541|P2|STARTED|Part 2||37
2532998|NCT00640393|6208542|P1|STARTED|Part 2||0
2532999|NCT00640393|6208540|P3|NOT COMPLETED|Randomization||0
2533000|NCT00640393|6208541|P2|NOT COMPLETED|Randomization||0
2533001|NCT00640393|6208542|P1|NOT COMPLETED|Randomization||19
2533002|NCT00640393|6208540|P3|COMPLETED|Randomization||0
2533003|NCT00640393|6208541|P2|COMPLETED|Randomization||0
2533004|NCT00640393|6208542|P1|COMPLETED|Randomization||75
2533005|NCT00640393|6208540|P3|STARTED|Randomization||0
2533006|NCT00640393|6208541|P2|STARTED|Randomization||0
2533007|NCT00640393|6208542|P1|STARTED|Randomization||94
2533008|NCT00640393|6208540|P3|NOT COMPLETED|Part 1||0
2533009|NCT00640393|6208541|P2|NOT COMPLETED|Part 1||0
2533010|NCT00640393|6208542|P1|NOT COMPLETED|Part 1||5
2533011|NCT00640393|6208540|P3|COMPLETED|Part 1||0
2533012|NCT00640393|6208541|P2|COMPLETED|Part 1||0
2533013|NCT00640393|6208542|P1|COMPLETED|Part 1||94
2533014|NCT00640393|6208540|P3|STARTED|Part 1||0
2533015|NCT00640393|6208541|P2|STARTED|Part 1||0
2533016|NCT00640393|6208542|P1|STARTED|Part 1||99
2533017|NCT00640341|6208607|P3|NOT COMPLETED|Overall Study||7
2533018|NCT00640341|6208608|P2|NOT COMPLETED|Overall Study||5
2533019|NCT00640341|6208609|P1|NOT COMPLETED|Overall Study||21
2533020|NCT00640341|6208607|P3|COMPLETED|Overall Study||163
2533021|NCT00640341|6208608|P2|COMPLETED|Overall Study||165
2533022|NCT00640341|6208609|P1|COMPLETED|Overall Study||149
2533023|NCT00640341|6208607|P3|Eligible Participants at Baseline|Overall Study||168
2533024|NCT00640341|6208608|P2|Eligible Participants at Baseline|Overall Study||167
2533025|NCT00640341|6208609|P1|Eligible Participants at Baseline|Overall Study||165
2533026|NCT00640341|6208607|P3|STARTED|Overall Study||170
2533027|NCT00640341|6208608|P2|STARTED|Overall Study||170
2533028|NCT00640341|6208609|P1|STARTED|Overall Study|All Starting participants were dispensed lenses|170
2533029|NCT00640328|6208629|P6|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
2533030|NCT00640328|6208630|P5|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
2533031|NCT00640328|6208631|P4|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
2533032|NCT00640328|6208632|P3|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
2533033|NCT00640328|6208633|P2|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
2533034|NCT00640328|6208634|P1|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
2533035|NCT00640328|6208629|P6|COMPLETED|IFUP (Week 48 to Individual Termination)||4
2533036|NCT00640328|6208630|P5|COMPLETED|IFUP (Week 48 to Individual Termination)||4
2533037|NCT00640328|6208631|P4|COMPLETED|IFUP (Week 48 to Individual Termination)||3
2533038|NCT00640328|6208632|P3|COMPLETED|IFUP (Week 48 to Individual Termination)||6
2533039|NCT00640328|6208633|P2|COMPLETED|IFUP (Week 48 to Individual Termination)||10
2533040|NCT00640328|6208634|P1|COMPLETED|IFUP (Week 48 to Individual Termination)||8
2533041|NCT00640328|6208629|P6|STARTED|IFUP (Week 48 to Individual Termination)||4
2533042|NCT00640328|6208630|P5|STARTED|IFUP (Week 48 to Individual Termination)||4
2533043|NCT00640328|6208631|P4|STARTED|IFUP (Week 48 to Individual Termination)||4
2533044|NCT00640328|6208632|P3|STARTED|IFUP (Week 48 to Individual Termination)||7
2533045|NCT00640328|6208633|P2|STARTED|IFUP (Week 48 to Individual Termination)||11
2533046|NCT00640328|6208634|P1|STARTED|IFUP (Week 48 to Individual Termination)||8
2533047|NCT00640328|6208629|P6|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
2533048|NCT00640328|6208630|P5|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||1
2533049|NCT00640328|6208631|P4|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
2533050|NCT00640328|6208632|P3|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
2533051|NCT00640328|6208633|P2|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
2533052|NCT00640328|6208634|P1|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
2533053|NCT00640328|6208629|P6|COMPLETED|Second Treatment Period (Weeks 24-48)||4
2533054|NCT00640328|6208630|P5|COMPLETED|Second Treatment Period (Weeks 24-48)||3
2533139|NCT00640016|6209192|P4|COMPLETED|Overall Study||1
2533055|NCT00640328|6208631|P4|COMPLETED|Second Treatment Period (Weeks 24-48)||4
2533056|NCT00640328|6208632|P3|COMPLETED|Second Treatment Period (Weeks 24-48)||7
2533057|NCT00640328|6208633|P2|COMPLETED|Second Treatment Period (Weeks 24-48)||10
2533058|NCT00640328|6208634|P1|COMPLETED|Second Treatment Period (Weeks 24-48)||8
2533059|NCT00640328|6208629|P6|STARTED|Second Treatment Period (Weeks 24-48)||4
2533060|NCT00640328|6208630|P5|STARTED|Second Treatment Period (Weeks 24-48)||4
2533061|NCT00640328|6208631|P4|STARTED|Second Treatment Period (Weeks 24-48)||4
2533062|NCT00640328|6208632|P3|STARTED|Second Treatment Period (Weeks 24-48)||7
2533063|NCT00640328|6208633|P2|STARTED|Second Treatment Period (Weeks 24-48)||10
2533064|NCT00640328|6208634|P1|STARTED|Second Treatment Period (Weeks 24-48)||8
2533065|NCT00640328|6208629|P6|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
2533066|NCT00640328|6208630|P5|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
2533067|NCT00640328|6208631|P4|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
2533068|NCT00640328|6208632|P3|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
2533069|NCT00640328|6208633|P2|NOT COMPLETED|First Treatment Period (Weeks 0-24)||1
2533070|NCT00640328|6208634|P1|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
2533071|NCT00640328|6208629|P6|COMPLETED|First Treatment Period (Weeks 0-24)||4
2533072|NCT00640328|6208630|P5|COMPLETED|First Treatment Period (Weeks 0-24)||4
2533073|NCT00640328|6208631|P4|COMPLETED|First Treatment Period (Weeks 0-24)||4
2533074|NCT00640328|6208632|P3|COMPLETED|First Treatment Period (Weeks 0-24)||7
2533075|NCT00640328|6208633|P2|COMPLETED|First Treatment Period (Weeks 0-24)||10
2533076|NCT00640328|6208634|P1|COMPLETED|First Treatment Period (Weeks 0-24)||8
2533077|NCT00640328|6208629|P6|STARTED|First Treatment Period (Weeks 0-24)||4
2533078|NCT00640328|6208630|P5|STARTED|First Treatment Period (Weeks 0-24)||4
2533079|NCT00640328|6208631|P4|STARTED|First Treatment Period (Weeks 0-24)||4
2533080|NCT00640328|6208632|P3|STARTED|First Treatment Period (Weeks 0-24)||7
2533081|NCT00640328|6208633|P2|STARTED|First Treatment Period (Weeks 0-24)||11
2533082|NCT00640328|6208634|P1|STARTED|First Treatment Period (Weeks 0-24)||8
2533083|NCT00640315|6208800|P2|NOT COMPLETED|Overall Study||1
2533084|NCT00640315|6208801|P1|NOT COMPLETED|Overall Study||0
2533085|NCT00640315|6208800|P2|COMPLETED|Overall Study||12
2533086|NCT00640315|6208801|P1|COMPLETED|Overall Study||10
2533087|NCT00640315|6208800|P2|Participants Received Treatment|Overall Study||13
2533088|NCT00640315|6208801|P1|Participants Received Treatment|Overall Study||10
2533089|NCT00640315|6208800|P2|STARTED|Overall Study||13
2533090|NCT00640315|6208801|P1|STARTED|Overall Study||10
2533091|NCT00640289|6208927|P1|NOT COMPLETED|Overall Study||13
2533092|NCT00640289|6208927|P1|COMPLETED|Overall Study||59
2533093|NCT00640289|6208927|P1|STARTED|Overall Study||72
2533094|NCT00640250|6208932|P1|NOT COMPLETED|Overall Study||0
2533095|NCT00640250|6208932|P1|COMPLETED|Overall Study||48
2533096|NCT00640250|6208932|P1|STARTED|Overall Study||48
2533097|NCT00640224|6209039|P4|NOT COMPLETED|Overall Study||0
2533098|NCT00640224|6209040|P3|NOT COMPLETED|Overall Study||0
2533099|NCT00640224|6209041|P2|NOT COMPLETED|Overall Study||3
2533100|NCT00640224|6209042|P1|NOT COMPLETED|Overall Study||6
2533101|NCT00640224|6209039|P4|COMPLETED|Overall Study||0
2533102|NCT00640224|6209040|P3|COMPLETED|Overall Study||0
2533103|NCT00640224|6209041|P2|COMPLETED|Overall Study||20
2533104|NCT00640224|6209042|P1|COMPLETED|Overall Study||17
2533105|NCT00640224|6209039|P4|STARTED|Overall Study||0
2533106|NCT00640224|6209040|P3|STARTED|Overall Study||0
2533107|NCT00640224|6209041|P2|STARTED|Overall Study||23
2533108|NCT00640224|6209042|P1|STARTED|Overall Study||23
2533109|NCT00640146|6209142|P2|NOT COMPLETED|Overall Study||6
2533110|NCT00640146|6209143|P1|NOT COMPLETED|Overall Study||4
2533111|NCT00640146|6209142|P2|COMPLETED|Overall Study||12
2533112|NCT00640146|6209143|P1|COMPLETED|Overall Study||15
2533113|NCT00640146|6209142|P2|Received at Least 1 Dose of Study Drug|Overall Study||15
2533114|NCT00640146|6209143|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
2533115|NCT00640146|6209142|P2|STARTED|Overall Study||18
2533116|NCT00640146|6209143|P1|STARTED|Overall Study||19
2533117|NCT00640133|6209155|P2|NOT COMPLETED|Open Label Phase (Month 4-12)||0
2533118|NCT00640133|6209156|P1|NOT COMPLETED|Open Label Phase (Month 4-12)||3
2533119|NCT00640133|6209155|P2|COMPLETED|Open Label Phase (Month 4-12)||0
2533120|NCT00640133|6209156|P1|COMPLETED|Open Label Phase (Month 4-12)||24
2533121|NCT00640133|6209155|P2|STARTED|Open Label Phase (Month 4-12)||0
2533122|NCT00640133|6209156|P1|STARTED|Open Label Phase (Month 4-12)||27
2533123|NCT00640133|6209155|P2|NOT COMPLETED|Randomization Phase (Baseline-Month 3)||0
2533124|NCT00640133|6209156|P1|NOT COMPLETED|Randomization Phase (Baseline-Month 3)||0
2533125|NCT00640133|6209155|P2|COMPLETED|Randomization Phase (Baseline-Month 3)||12
2533126|NCT00640133|6209156|P1|COMPLETED|Randomization Phase (Baseline-Month 3)||15
2533127|NCT00640133|6209155|P2|STARTED|Randomization Phase (Baseline-Month 3)||12
2533128|NCT00640133|6209156|P1|STARTED|Randomization Phase (Baseline-Month 3)||15
2533129|NCT00640042|6209176|P1|NOT COMPLETED|Treatment||926
2533130|NCT00640042|6209176|P1|COMPLETED|Treatment||561
2533131|NCT00640042|6209176|P1|STARTED|Treatment||1487
2533132|NCT00640042|6209176|P1|NOT COMPLETED|Enrollment||83
2533133|NCT00640042|6209176|P1|COMPLETED|Enrollment|Number of patients with evidence of study drug receipt|1487
2533134|NCT00640042|6209176|P1|STARTED|Enrollment|Number of patients with evidence of prescription card receipt|1570
2533135|NCT00640016|6209192|P4|NOT COMPLETED|Overall Study||3
2533136|NCT00640016|6209193|P3|NOT COMPLETED|Overall Study||3
2533137|NCT00640016|6209194|P2|NOT COMPLETED|Overall Study||2
2533138|NCT00640016|6209195|P1|NOT COMPLETED|Overall Study||2
2533140|NCT00640016|6209193|P3|COMPLETED|Overall Study||1
2533141|NCT00640016|6209194|P2|COMPLETED|Overall Study||1
2533142|NCT00640016|6209195|P1|COMPLETED|Overall Study||1
2533143|NCT00640016|6209192|P4|Treated|Overall Study||4
2533144|NCT00640016|6209193|P3|Treated|Overall Study||4
2533145|NCT00640016|6209194|P2|Treated|Overall Study||2
2533146|NCT00640016|6209195|P1|Treated|Overall Study||3
2533147|NCT00640016|6209192|P4|STARTED|Overall Study||4
2533148|NCT00640016|6209193|P3|STARTED|Overall Study||4
2533149|NCT00640016|6209194|P2|STARTED|Overall Study||3
2533150|NCT00640016|6209195|P1|STARTED|Overall Study||3
2533151|NCT00639860|6209239|P1|NOT COMPLETED|Overall Study||0
2533152|NCT00639860|6209239|P1|COMPLETED|Overall Study||10
2533153|NCT00639860|6209239|P1|STARTED|Overall Study||10
2533154|NCT00639769|6209247|P1|NOT COMPLETED|Overall Study||40
2533155|NCT00639769|6209247|P1|COMPLETED|Overall Study||0
2533156|NCT00639769|6209247|P1|STARTED|Overall Study||40
2533157|NCT00639717|6209252|P1|NOT COMPLETED|Overall Study||0
2533158|NCT00639717|6209252|P1|COMPLETED|Overall Study||48
2533159|NCT00639717|6209252|P1|STARTED|Overall Study||48
2533160|NCT00639678|6209264|P4|NOT COMPLETED|Overall Study||0
2533161|NCT00639678|6209265|P3|NOT COMPLETED|Overall Study||11
2533162|NCT00639678|6209266|P2|NOT COMPLETED|Overall Study||1
2533163|NCT00639678|6209267|P1|NOT COMPLETED|Overall Study||4
2533164|NCT00639678|6209264|P4|COMPLETED|Overall Study||23
2533165|NCT00639678|6209265|P3|COMPLETED|Overall Study||206
2533166|NCT00639678|6209266|P2|COMPLETED|Overall Study||5
2533167|NCT00639678|6209267|P1|COMPLETED|Overall Study||70
2533168|NCT00639678|6209264|P4|STARTED|Overall Study||23
2533169|NCT00639678|6209265|P3|STARTED|Overall Study||217
2533170|NCT00639678|6209266|P2|STARTED|Overall Study||6
2533171|NCT00639678|6209267|P1|STARTED|Overall Study||74
2533172|NCT00639626|6209327|P1|NOT COMPLETED|Overall Study||0
2533173|NCT00639626|6209327|P1|COMPLETED|Overall Study||0
2533174|NCT00639626|6209327|P1|STARTED|Overall Study||0
2533175|NCT00639509|6209332|P1|NOT COMPLETED|Overall Study||1
2533176|NCT00639509|6209332|P1|COMPLETED|Overall Study||23
2533177|NCT00639509|6209332|P1|STARTED|Overall Study||24
2533178|NCT00639457|6209340|P2|NOT COMPLETED|Overall Study||3
2533179|NCT00639457|6209341|P1|NOT COMPLETED|Overall Study||2
2533180|NCT00639457|6209340|P2|COMPLETED|Overall Study||19
2533181|NCT00639457|6209341|P1|COMPLETED|Overall Study||20
2533182|NCT00639457|6209340|P2|STARTED|Overall Study||22
2533183|NCT00639457|6209341|P1|STARTED|Overall Study||22
2533184|NCT00639418|6209379|P4|NOT COMPLETED|Overall Study||0
2533185|NCT00639418|6209380|P3|NOT COMPLETED|Overall Study||0
2533186|NCT00639418|6209381|P2|NOT COMPLETED|Overall Study||0
2533187|NCT00639418|6209382|P1|NOT COMPLETED|Overall Study||0
2533188|NCT00639418|6209379|P4|COMPLETED|Overall Study||46930
2533189|NCT00639418|6209380|P3|COMPLETED|Overall Study||36496
2533190|NCT00639418|6209381|P2|COMPLETED|Overall Study||35967
2533191|NCT00639418|6209382|P1|COMPLETED|Overall Study||28101
2533192|NCT00639418|6209379|P4|STARTED|Overall Study||46930
2533193|NCT00639418|6209380|P3|STARTED|Overall Study||36496
2533194|NCT00639418|6209381|P2|STARTED|Overall Study||35967
2533195|NCT00639418|6209382|P1|STARTED|Overall Study||28101
2533196|NCT00639379|6209400|P2|NOT COMPLETED|Period 2 - 2 Weeks||0
2533197|NCT00639379|6209401|P1|NOT COMPLETED|Period 2 - 2 Weeks||0
2533198|NCT00639379|6209400|P2|COMPLETED|Period 2 - 2 Weeks||45
2533199|NCT00639379|6209401|P1|COMPLETED|Period 2 - 2 Weeks||39
2533200|NCT00639379|6209400|P2|STARTED|Period 2 - 2 Weeks||45
2533201|NCT00639379|6209401|P1|STARTED|Period 2 - 2 Weeks||39
2533202|NCT00639379|6209400|P2|NOT COMPLETED|Period 1 - 2 Weeks||0
2533203|NCT00639379|6209401|P1|NOT COMPLETED|Period 1 - 2 Weeks||5
2533204|NCT00639379|6209400|P2|COMPLETED|Period 1 - 2 Weeks||45
2533205|NCT00639379|6209401|P1|COMPLETED|Period 1 - 2 Weeks||39
2533206|NCT00639379|6209400|P2|STARTED|Period 1 - 2 Weeks||45
2533207|NCT00639379|6209401|P1|STARTED|Period 1 - 2 Weeks||44
2533208|NCT00639223|6209417|P2|NOT COMPLETED|Overall Study||2
2533209|NCT00639223|6209418|P1|NOT COMPLETED|Overall Study||0
2533210|NCT00639223|6209417|P2|COMPLETED|Overall Study||19
2533211|NCT00639223|6209418|P1|COMPLETED|Overall Study||22
2533212|NCT00639223|6209417|P2|STARTED|Overall Study||21
2533213|NCT00639223|6209418|P1|STARTED|Overall Study||22
2533214|NCT00639158|6209428|P2|NOT COMPLETED|Overall Study||30
2533215|NCT00639158|6209429|P1|NOT COMPLETED|Overall Study||26
2533216|NCT00639158|6209428|P2|COMPLETED|Overall Study|30 subjects prematurely discontinued treatment|240
2533217|NCT00639158|6209429|P1|COMPLETED|Overall Study|26 subjects prematurely discontinued treatment.|246
2533218|NCT00639158|6209428|P2|STARTED|Overall Study|1 subject was randomized but not treated because of an abnormal ECG that precluded treatment.|270
2533219|NCT00639158|6209429|P1|STARTED|Overall Study|All randomized subjects were treated.|272
2533220|NCT00639093|6209451|P2|NOT COMPLETED|Overall Study||0
2533221|NCT00639093|6209452|P1|NOT COMPLETED|Overall Study||0
2533222|NCT00639093|6209451|P2|COMPLETED|Overall Study|46|46
2533223|NCT00639093|6209452|P1|COMPLETED|Overall Study|45|45
2533224|NCT00639093|6209451|P2|STARTED|Overall Study|46|46
2533225|NCT00639093|6209452|P1|STARTED|Overall Study|45|45
2533226|NCT00639002|6209458|P1|NOT COMPLETED|Overall Study||13
2533227|NCT00639002|6209458|P1|COMPLETED|Overall Study||0
2533228|NCT00639002|6209458|P1|Received Ruxolitinib + Dexamethasone|Overall Study||7
2533229|NCT00639002|6209458|P1|Received Ruxolitinib|Overall Study||13
2533230|NCT00639002|6209458|P1|STARTED|Overall Study||13
2533231|NCT00638989|6209467|P3|NOT COMPLETED|Overall Study||1
2533232|NCT00638989|6209468|P2|NOT COMPLETED|Overall Study||0
2533233|NCT00638989|6209469|P1|NOT COMPLETED|Overall Study||0
2533234|NCT00638989|6209467|P3|COMPLETED|Overall Study||9
2533235|NCT00638989|6209468|P2|COMPLETED|Overall Study||10
2533236|NCT00638989|6209469|P1|COMPLETED|Overall Study||10
2533237|NCT00638989|6209467|P3|STARTED|Overall Study||10
2533238|NCT00638989|6209468|P2|STARTED|Overall Study||10
2533239|NCT00638989|6209469|P1|STARTED|Overall Study||10
2533240|NCT00638963|6209509|P2|NOT COMPLETED|Overall Study||0
2533241|NCT00638963|6209510|P1|NOT COMPLETED|Overall Study||1
2533242|NCT00638963|6209509|P2|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|3
2533243|NCT00638963|6209510|P1|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|2
2533244|NCT00638963|6209509|P2|STARTED|Overall Study|Received randomized treatment assignment|3
2533245|NCT00638963|6209510|P1|STARTED|Overall Study|Received randomized treatment assignment|3
2533246|NCT00638937|6209529|P1|NOT COMPLETED|Overall Study||0
2533247|NCT00638937|6209529|P1|COMPLETED|Overall Study||37
2533248|NCT00638937|6209529|P1|STARTED|Overall Study||37
2533249|NCT00638924|6209540|P1|NOT COMPLETED|Overall Study||0
2533250|NCT00638924|6209540|P1|COMPLETED|Overall Study||40
2533251|NCT00638924|6209540|P1|2 Months|Overall Study||40
2533252|NCT00638924|6209540|P1|STARTED|Overall Study||40
2533253|NCT00638885|6209545|P1|NOT COMPLETED|Overall Study||0
2533254|NCT00638885|6209545|P1|COMPLETED|Overall Study||142
2533255|NCT00638885|6209545|P1|STARTED|Overall Study||142
2533256|NCT00638846|6209551|P2|NOT COMPLETED|Overall Study||6
2533257|NCT00638846|6209552|P1|NOT COMPLETED|Overall Study||4
2533258|NCT00638846|6209551|P2|COMPLETED|Overall Study||133
2533259|NCT00638846|6209552|P1|COMPLETED|Overall Study||133
2533260|NCT00638846|6209551|P2|STARTED|Overall Study||139
2533261|NCT00638846|6209552|P1|STARTED|Overall Study||137
2533262|NCT00638820|6209568|P1|NOT COMPLETED|Overall Study||0
2533263|NCT00638820|6209568|P1|COMPLETED|Overall Study||3
2533264|NCT00638820|6209568|P1|STARTED|Overall Study||3
2533265|NCT00638716|6209578|P3|NOT COMPLETED|Overall Study||12
2533266|NCT00638716|6209579|P2|NOT COMPLETED|Overall Study||15
2533267|NCT00638716|6209580|P1|NOT COMPLETED|Overall Study||7
2533268|NCT00638716|6209578|P3|COMPLETED|Overall Study||46
2533269|NCT00638716|6209579|P2|COMPLETED|Overall Study||37
2533270|NCT00638716|6209580|P1|COMPLETED|Overall Study||43
2533271|NCT00638716|6209578|P3|STARTED|Overall Study||58
2533272|NCT00638716|6209579|P2|STARTED|Overall Study||52
2533273|NCT00638716|6209580|P1|STARTED|Overall Study||50
2533274|NCT00638690|6209596|P2|NOT COMPLETED|Overall Study||342
2533275|NCT00638690|6209597|P1|NOT COMPLETED|Overall Study||681
2533276|NCT00638690|6209596|P2|COMPLETED|Overall Study||56
2533277|NCT00638690|6209597|P1|COMPLETED|Overall Study||116
2533278|NCT00638690|6209596|P2|STARTED|Overall Study||398
2533279|NCT00638690|6209597|P1|STARTED|Overall Study||797
2533280|NCT00638651|6209610|P1|NOT COMPLETED|Overall Study||0
2533281|NCT00638651|6209610|P1|COMPLETED|Overall Study||3
2533282|NCT00638651|6209610|P1|STARTED|Overall Study||3
2533283|NCT00638508|6209617|P2|NOT COMPLETED|Overall Study||2
2533284|NCT00638508|6209618|P1|NOT COMPLETED|Overall Study||5
2533285|NCT00638508|6209617|P2|COMPLETED|Overall Study||30
2533286|NCT00638508|6209618|P1|COMPLETED|Overall Study||30
2533287|NCT00638508|6209617|P2|STARTED|Overall Study||32
2533288|NCT00638508|6209618|P1|STARTED|Overall Study||35
2533289|NCT00638456|6209664|P2|NOT COMPLETED|Overall Study||2
2533290|NCT00638456|6209665|P1|NOT COMPLETED|Overall Study||6
2533291|NCT00638456|6209664|P2|COMPLETED|Overall Study||9
2533292|NCT00638456|6209665|P1|COMPLETED|Overall Study||15
2533293|NCT00638456|6209664|P2|STARTED|Overall Study||11
2533294|NCT00638456|6209665|P1|STARTED|Overall Study||21
2533295|NCT00638443|6209675|P2|NOT COMPLETED|Second Intervention||0
2533296|NCT00638443|6209676|P1|NOT COMPLETED|Second Intervention||0
2533297|NCT00638443|6209675|P2|COMPLETED|Second Intervention||14
2533298|NCT00638443|6209676|P1|COMPLETED|Second Intervention||12
2533299|NCT00638443|6209675|P2|STARTED|Second Intervention||14
2533300|NCT00638443|6209676|P1|STARTED|Second Intervention||12
2533301|NCT00638443|6209675|P2|NOT COMPLETED|Washout||0
2533302|NCT00638443|6209676|P1|NOT COMPLETED|Washout||0
2533303|NCT00638443|6209675|P2|COMPLETED|Washout||14
2533304|NCT00638443|6209676|P1|COMPLETED|Washout||12
2533305|NCT00638443|6209675|P2|STARTED|Washout||14
2533306|NCT00638443|6209676|P1|STARTED|Washout||12
2533307|NCT00638443|6209675|P2|NOT COMPLETED|First Intervention||1
2533308|NCT00638443|6209676|P1|NOT COMPLETED|First Intervention||2
2533309|NCT00638443|6209675|P2|COMPLETED|First Intervention||14
2533310|NCT00638443|6209676|P1|COMPLETED|First Intervention||12
2533311|NCT00638443|6209675|P2|STARTED|First Intervention||15
2533312|NCT00638443|6209676|P1|STARTED|First Intervention||14
2533313|NCT00638404|6209706|P2|NOT COMPLETED|Overall Study||0
2533314|NCT00638404|6209707|P1|NOT COMPLETED|Overall Study||8
2533315|NCT00638404|6209706|P2|COMPLETED|Overall Study||100
2533316|NCT00638404|6209707|P1|COMPLETED|Overall Study||192
2533317|NCT00638404|6209706|P2|STARTED|Overall Study||100
2533318|NCT00638404|6209707|P1|STARTED|Overall Study||200
2533319|NCT00638378|6209719|P1|NOT COMPLETED|Overall Study||22
2533320|NCT00638378|6209719|P1|COMPLETED|Overall Study||0
2533321|NCT00638378|6209719|P1|STARTED|Overall Study||22
2533322|NCT00638365|6209729|P3|NOT COMPLETED|Overall Study||0
2533323|NCT00638365|6209730|P2|NOT COMPLETED|Overall Study||0
2533324|NCT00638365|6209731|P1|NOT COMPLETED|Overall Study||0
2533325|NCT00638365|6209729|P3|COMPLETED|Overall Study||8
2533326|NCT00638365|6209730|P2|COMPLETED|Overall Study||10
2533327|NCT00638365|6209731|P1|COMPLETED|Overall Study||9
2533328|NCT00638365|6209729|P3|STARTED|Overall Study||8
2533329|NCT00638365|6209730|P2|STARTED|Overall Study||10
2533330|NCT00638365|6209731|P1|STARTED|Overall Study||9
2533331|NCT00638274|6209741|P2|NOT COMPLETED|Overall Study||5
2533332|NCT00638274|6209742|P1|NOT COMPLETED|Overall Study||6
2533333|NCT00638274|6209741|P2|COMPLETED|Overall Study||172
2533334|NCT00638274|6209742|P1|COMPLETED|Overall Study||173
2533335|NCT00638274|6209741|P2|STARTED|Overall Study||177
2533336|NCT00638274|6209742|P1|STARTED|Overall Study||179
2533337|NCT00638235|6209759|P9|NOT COMPLETED|Overall Study||18
2533338|NCT00638235|6209760|P8|NOT COMPLETED|Overall Study||1
2533339|NCT00638235|6209761|P7|NOT COMPLETED|Overall Study||0
2533340|NCT00638235|6209762|P6|NOT COMPLETED|Overall Study||26
2533341|NCT00638235|6209763|P5|NOT COMPLETED|Overall Study||13
2533342|NCT00638235|6209764|P4|NOT COMPLETED|Overall Study||10
2533343|NCT00638235|6209765|P3|NOT COMPLETED|Overall Study||18
2533344|NCT00638235|6209766|P2|NOT COMPLETED|Overall Study||3
2533345|NCT00638235|6209767|P1|NOT COMPLETED|Overall Study||31
2533346|NCT00638235|6209759|P9|COMPLETED|Overall Study||124
2533347|NCT00638235|6209760|P8|COMPLETED|Overall Study|Ph-VI ended after 12M b/c next generation of Elevate Anterior was already under trial in Phase VII|34
2533348|NCT00638235|6209761|P7|COMPLETED|Overall Study||23
2533349|NCT00638235|6209762|P6|COMPLETED|Overall Study||113
2533350|NCT00638235|6209763|P5|COMPLETED|Overall Study||42
2533351|NCT00638235|6209764|P4|COMPLETED|Overall Study||46
2533352|NCT00638235|6209765|P3|COMPLETED|Overall Study|Ph-II ended before all subjects had 24M b/c Perigee next generation was already under trial P-III/IV|63
2533353|NCT00638235|6209766|P2|COMPLETED|Overall Study||23
2533354|NCT00638235|6209767|P1|COMPLETED|Overall Study||110
2533355|NCT00638235|6209759|P9|STARTED|Overall Study||142
2533356|NCT00638235|6209760|P8|STARTED|Overall Study||35
2533357|NCT00638235|6209761|P7|STARTED|Overall Study||23
2533358|NCT00638235|6209762|P6|STARTED|Overall Study||139
2533359|NCT00638235|6209763|P5|STARTED|Overall Study||55
2533360|NCT00638235|6209764|P4|STARTED|Overall Study||56
2533361|NCT00638235|6209765|P3|STARTED|Overall Study||81
2533362|NCT00638235|6209766|P2|STARTED|Overall Study||26
2533363|NCT00638235|6209767|P1|STARTED|Overall Study||141
2533364|NCT00638222|6210168|P3|NOT COMPLETED|Overall Study||0
2533365|NCT00638222|6210169|P2|NOT COMPLETED|Overall Study||0
2533366|NCT00638222|6210170|P1|NOT COMPLETED|Overall Study||0
2533367|NCT00638222|6210168|P3|COMPLETED|Overall Study||6
2533368|NCT00638222|6210169|P2|COMPLETED|Overall Study||0
2533369|NCT00638222|6210170|P1|COMPLETED|Overall Study||0
2533370|NCT00638222|6210168|P3|STARTED|Overall Study||6
2533371|NCT00638222|6210169|P2|STARTED|Overall Study||0
2533372|NCT00638222|6210170|P1|STARTED|Overall Study||0
2533373|NCT00638183|6210177|P1|NOT COMPLETED|Overall Study||119
2533374|NCT00638183|6210177|P1|COMPLETED|Overall Study||266
2533375|NCT00638183|6210177|P1|STARTED|Overall Study||385
2533376|NCT00638157|6210186|P2|NOT COMPLETED|Overall Study||4
2533377|NCT00638157|6210187|P1|NOT COMPLETED|Overall Study||7
2533378|NCT00638157|6210186|P2|COMPLETED|Overall Study|4 subjects completed study drug in this arm|8
2533379|NCT00638157|6210187|P1|COMPLETED|Overall Study|4 subjects completed study drug in this arm|5
2533380|NCT00638157|6210186|P2|Treated|Overall Study||12
2533381|NCT00638157|6210187|P1|Treated|Overall Study||10
2533382|NCT00638157|6210186|P2|STARTED|Overall Study||12
2533383|NCT00638157|6210187|P1|STARTED|Overall Study||12
2533384|NCT00638027|6210197|P2|NOT COMPLETED|Overall Study||2
2533385|NCT00638027|6210198|P1|NOT COMPLETED|Overall Study||0
2533386|NCT00638027|6210197|P2|COMPLETED|Overall Study|all 10 included in analyses|8
2533387|NCT00638027|6210198|P1|COMPLETED|Overall Study||11
2533388|NCT00638027|6210197|P2|STARTED|Overall Study||10
2533389|NCT00638027|6210198|P1|STARTED|Overall Study||11
2533390|NCT00638014|6210210|P2|NOT COMPLETED|Overall Study||0
2533391|NCT00638014|6210211|P1|NOT COMPLETED|Overall Study||0
2533392|NCT00638014|6210210|P2|COMPLETED|Overall Study||28
2533393|NCT00638014|6210211|P1|COMPLETED|Overall Study||23
2533394|NCT00638014|6210210|P2|STARTED|Overall Study||28
2533395|NCT00638014|6210211|P1|STARTED|Overall Study||23
2533396|NCT00637923|6210221|P2|NOT COMPLETED|Overall Study||19
2533397|NCT00637923|6210222|P1|NOT COMPLETED|Overall Study||30
2533398|NCT00637923|6210221|P2|COMPLETED|Overall Study||18
2533399|NCT00637923|6210222|P1|COMPLETED|Overall Study||45
2533400|NCT00637923|6210221|P2|STARTED|Overall Study||37
2533401|NCT00637923|6210222|P1|STARTED|Overall Study||75
2533402|NCT00637806|6210245|P4|NOT COMPLETED|Extension Phase||1
2533403|NCT00637806|6210246|P3|NOT COMPLETED|Extension Phase||0
2533404|NCT00637806|6210247|P2|NOT COMPLETED|Extension Phase||0
2533405|NCT00637806|6210248|P1|NOT COMPLETED|Extension Phase||0
2533406|NCT00637806|6210245|P4|COMPLETED|Extension Phase||0
2533407|NCT00637806|6210246|P3|COMPLETED|Extension Phase||0
2533408|NCT00637806|6210247|P2|COMPLETED|Extension Phase||0
2533409|NCT00637806|6210248|P1|COMPLETED|Extension Phase||0
2533410|NCT00637806|6210245|P4|STARTED|Extension Phase||1
2533411|NCT00637806|6210246|P3|STARTED|Extension Phase||0
2533412|NCT00637806|6210247|P2|STARTED|Extension Phase||0
2533413|NCT00637806|6210248|P1|STARTED|Extension Phase||0
2533414|NCT00637806|6210245|P4|NOT COMPLETED|Double-blind Phase||0
2533415|NCT00637806|6210246|P3|NOT COMPLETED|Double-blind Phase||1
2533416|NCT00637806|6210247|P2|NOT COMPLETED|Double-blind Phase||0
2533417|NCT00637806|6210248|P1|NOT COMPLETED|Double-blind Phase||2
2533418|NCT00637806|6210245|P4|COMPLETED|Double-blind Phase||0
2533419|NCT00637806|6210246|P3|COMPLETED|Double-blind Phase||1
2533420|NCT00637806|6210247|P2|COMPLETED|Double-blind Phase||0
2533421|NCT00637806|6210248|P1|COMPLETED|Double-blind Phase||0
2533422|NCT00637806|6210245|P4|STARTED|Double-blind Phase||0
2533423|NCT00637806|6210246|P3|STARTED|Double-blind Phase||2
2533424|NCT00637806|6210247|P2|STARTED|Double-blind Phase||0
2533425|NCT00637806|6210248|P1|STARTED|Double-blind Phase||2
2533426|NCT00637780|6210266|P1|NOT COMPLETED|Overall Study||0
2533427|NCT00637780|6210266|P1|COMPLETED|Overall Study||2
2533428|NCT00637780|6210266|P1|STARTED|Overall Study||2
2533429|NCT00637728|6210283|P3|NOT COMPLETED|Extension Phase||0
2533430|NCT00637728|6210284|P2|NOT COMPLETED|Extension Phase||0
2533431|NCT00637728|6210285|P1|NOT COMPLETED|Extension Phase||0
2533432|NCT00637728|6210283|P3|COMPLETED|Extension Phase||0
2533433|NCT00637728|6210284|P2|COMPLETED|Extension Phase||0
2533434|NCT00637728|6210285|P1|COMPLETED|Extension Phase||0
2533435|NCT00637728|6210283|P3|STARTED|Extension Phase||0
2533436|NCT00637728|6210284|P2|STARTED|Extension Phase||0
2533437|NCT00637728|6210285|P1|STARTED|Extension Phase||0
2533438|NCT00637728|6210283|P3|NOT COMPLETED|Double-blind Phase||0
2533439|NCT00637728|6210284|P2|NOT COMPLETED|Double-blind Phase||1
2533440|NCT00637728|6210285|P1|NOT COMPLETED|Double-blind Phase||4
2533441|NCT00637728|6210283|P3|COMPLETED|Double-blind Phase||0
2533442|NCT00637728|6210284|P2|COMPLETED|Double-blind Phase||0
2533443|NCT00637728|6210285|P1|COMPLETED|Double-blind Phase||0
2533444|NCT00637728|6210283|P3|STARTED|Double-blind Phase||0
2533445|NCT00637728|6210284|P2|STARTED|Double-blind Phase||1
2533446|NCT00637728|6210285|P1|STARTED|Double-blind Phase||4
2533447|NCT00637572|6210300|P2|NOT COMPLETED|Overall Study||7
2533448|NCT00637572|6210301|P1|NOT COMPLETED|Overall Study||3
2533449|NCT00637572|6210300|P2|COMPLETED|Overall Study||24
2533450|NCT00637572|6210301|P1|COMPLETED|Overall Study||29
2533451|NCT00637572|6210300|P2|STARTED|Overall Study||31
2533452|NCT00637572|6210301|P1|STARTED|Overall Study||32
2533453|NCT00637494|6210329|P2|NOT COMPLETED|Overall Study||43
2533454|NCT00637494|6210330|P1|NOT COMPLETED|Overall Study||32
2533455|NCT00637494|6210329|P2|COMPLETED|Overall Study||108
2533456|NCT00637494|6210330|P1|COMPLETED|Overall Study||109
2533457|NCT00637494|6210329|P2|STARTED|Overall Study||151
2533458|NCT00637494|6210330|P1|STARTED|Overall Study||141
2533459|NCT00637416|6210340|P2|NOT COMPLETED|Overall Study||2
2533460|NCT00637416|6210341|P1|NOT COMPLETED|Overall Study||1
2533461|NCT00637416|6210340|P2|COMPLETED|Overall Study||3
2533462|NCT00637416|6210341|P1|COMPLETED|Overall Study||3
2533463|NCT00637416|6210340|P2|STARTED|Overall Study||5
2533464|NCT00637416|6210341|P1|STARTED|Overall Study||4
2533465|NCT00637377|6210351|P4|NOT COMPLETED|Overall Study||29
2533466|NCT00637377|6210352|P3|NOT COMPLETED|Overall Study||37
2533467|NCT00637377|6210353|P2|NOT COMPLETED|Overall Study||32
2533468|NCT00637377|6210354|P1|NOT COMPLETED|Overall Study||27
2533469|NCT00637377|6210351|P4|COMPLETED|Overall Study||284
2533470|NCT00637377|6210352|P3|COMPLETED|Overall Study||274
2533471|NCT00637377|6210353|P2|COMPLETED|Overall Study||281
2533472|NCT00637377|6210354|P1|COMPLETED|Overall Study||276
2533473|NCT00637377|6210351|P4|Participants Treated (FAS)|Overall Study||306
2533474|NCT00637377|6210352|P3|Participants Treated (FAS)|Overall Study||296
2533475|NCT00637377|6210353|P2|Participants Treated (FAS)|Overall Study||309
2533476|NCT00637377|6210354|P1|Participants Treated (FAS)|Overall Study||291
2533477|NCT00637377|6210351|P4|Participants Received Treatment|Overall Study|safety population|307
2533478|NCT00637377|6210352|P3|Participants Received Treatment|Overall Study|safety population|297
2533479|NCT00637377|6210353|P2|Participants Received Treatment|Overall Study|safety population|309
2533480|NCT00637377|6210354|P1|Participants Received Treatment|Overall Study|safety population|291
2533481|NCT00637377|6210351|P4|STARTED|Overall Study||313
2533482|NCT00637377|6210352|P3|STARTED|Overall Study||311
2533483|NCT00637377|6210353|P2|STARTED|Overall Study||313
2533484|NCT00637377|6210354|P1|STARTED|Overall Study||303
2533485|NCT00637312|6210382|P2|NOT COMPLETED|Overall Study||17
2533486|NCT00637312|6210383|P1|NOT COMPLETED|Overall Study||42
2533487|NCT00637312|6210382|P2|COMPLETED|Overall Study||19
2533488|NCT00637312|6210383|P1|COMPLETED|Overall Study||30
2533489|NCT00637312|6210382|P2|STARTED|Overall Study||36
2533490|NCT00637312|6210383|P1|STARTED|Overall Study||72
2533491|NCT00637299|6210391|P2|NOT COMPLETED|Overall Study||0
2533492|NCT00637299|6210392|P1|NOT COMPLETED|Overall Study||0
2533493|NCT00637299|6210391|P2|COMPLETED|Overall Study||10
2533494|NCT00637299|6210392|P1|COMPLETED|Overall Study||10
2533495|NCT00637299|6210391|P2|STARTED|Overall Study||10
2533496|NCT00637299|6210392|P1|STARTED|Overall Study||10
2533497|NCT00637273|6210403|P3|NOT COMPLETED|Overall Study||41
2533498|NCT00637273|6210404|P2|NOT COMPLETED|Overall Study||28
2533499|NCT00637273|6210405|P1|NOT COMPLETED|Overall Study||43
2533500|NCT00637273|6210403|P3|COMPLETED|Overall Study||131
2533501|NCT00637273|6210404|P2|COMPLETED|Overall Study||144
2533502|NCT00637273|6210405|P1|COMPLETED|Overall Study||127
2533503|NCT00637273|6210403|P3|Intent to Treat (ITT)|Overall Study||165
2533504|NCT00637273|6210404|P2|Intent to Treat (ITT)|Overall Study||166
2533505|NCT00637273|6210405|P1|Intent to Treat (ITT)|Overall Study||160
2533506|NCT00637273|6210403|P3|STARTED|Overall Study||172
2533507|NCT00637273|6210404|P2|STARTED|Overall Study||172
2533508|NCT00637273|6210405|P1|STARTED|Overall Study||170
2533509|NCT00637247|6210448|P2|NOT COMPLETED|Overall Study||0
2533510|NCT00637247|6210449|P1|NOT COMPLETED|Overall Study||0
2533511|NCT00637247|6210448|P2|COMPLETED|Overall Study||70
2533512|NCT00637247|6210449|P1|COMPLETED|Overall Study||72
2533513|NCT00637247|6210448|P2|STARTED|Overall Study||70
2533514|NCT00637247|6210449|P1|STARTED|Overall Study||72
2533515|NCT00637195|6210463|P2|NOT COMPLETED|Overall Study||1
2533516|NCT00637195|6210464|P1|NOT COMPLETED|Overall Study||3
2533517|NCT00637195|6210463|P2|COMPLETED|Overall Study||75
2533518|NCT00637195|6210464|P1|COMPLETED|Overall Study||73
2533519|NCT00637195|6210463|P2|STARTED|Overall Study||76
2533520|NCT00637195|6210464|P1|STARTED|Overall Study||76
2533521|NCT00637156|6210500|P2|NOT COMPLETED|Overall Study||24
2533522|NCT00637156|6210501|P1|NOT COMPLETED|Overall Study||10
2533523|NCT00637156|6210500|P2|COMPLETED|Overall Study||164
2533524|NCT00637156|6210501|P1|COMPLETED|Overall Study||199
2533525|NCT00637156|6210500|P2|STARTED|Overall Study||188
2533526|NCT00637156|6210501|P1|STARTED|Overall Study||209
2533527|NCT00637000|6210543|P2|NOT COMPLETED|Overall Study||3
2533528|NCT00637000|6210544|P1|NOT COMPLETED|Overall Study||4
2533529|NCT00637000|6210543|P2|COMPLETED|Overall Study||15
2533530|NCT00637000|6210544|P1|COMPLETED|Overall Study||16
2533531|NCT00637000|6210543|P2|Evaluable|Overall Study||16
2533532|NCT00637000|6210544|P1|Evaluable|Overall Study||18
2533533|NCT00637000|6210543|P2|STARTED|Overall Study|Randomized and treated|18
2533534|NCT00637000|6210544|P1|STARTED|Overall Study|Randomized and treated|20
2533535|NCT00636987|6210584|P1|NOT COMPLETED|Overall Study||189
2533536|NCT00636987|6210584|P1|COMPLETED|Overall Study||108
2533537|NCT00636987|6210584|P1|STARTED|Overall Study||297
2533538|NCT00636961|6210594|P2|NOT COMPLETED|Period 2||0
2533539|NCT00636961|6210595|P1|NOT COMPLETED|Period 2||1
2533540|NCT00636961|6210594|P2|COMPLETED|Period 2||12
2533541|NCT00636961|6210595|P1|COMPLETED|Period 2||12
2533542|NCT00636961|6210594|P2|STARTED|Period 2||12
2533543|NCT00636961|6210595|P1|STARTED|Period 2||13
2533544|NCT00636961|6210594|P2|NOT COMPLETED|Period 1||1
2533545|NCT00636961|6210595|P1|NOT COMPLETED|Period 1||1
2533546|NCT00636961|6210594|P2|COMPLETED|Period 1||12
2533547|NCT00636961|6210595|P1|COMPLETED|Period 1||13
2533548|NCT00636961|6210594|P2|STARTED|Period 1||13
2533549|NCT00636961|6210595|P1|STARTED|Period 1||14
2533550|NCT00636818|6210609|P1|NOT COMPLETED|Overall Study||11
2533551|NCT00636818|6210609|P1|COMPLETED|Overall Study||34
2533552|NCT00636818|6210609|P1|Received at Least One Dose of Study Drug|Overall Study|One patient was lost to follow up and did not receive any study drug.|44
2533553|NCT00636818|6210609|P1|STARTED|Overall Study||45
2533554|NCT00636805|6210624|P1|NOT COMPLETED|Overall Study||0
2533555|NCT00636805|6210624|P1|COMPLETED|Overall Study||63
2533556|NCT00636805|6210624|P1|STARTED|Overall Study||63
2533557|NCT00636792|6210634|P1|NOT COMPLETED|Overall Study||33
2533558|NCT00636792|6210634|P1|COMPLETED|Overall Study||40
2533559|NCT00636792|6210634|P1|STARTED|Overall Study||73
2533560|NCT00636701|6210641|P2|NOT COMPLETED|Overall Study||0
2533561|NCT00636701|6210642|P1|NOT COMPLETED|Overall Study||0
2533562|NCT00636701|6210641|P2|COMPLETED|Overall Study||2
2533563|NCT00636701|6210642|P1|COMPLETED|Overall Study||2
2533564|NCT00636701|6210641|P2|STARTED|Overall Study||2
2533565|NCT00636701|6210642|P1|STARTED|Overall Study||2
2533566|NCT00636675|6210650|P2|NOT COMPLETED|Overall Study||41
2533567|NCT00636675|6210651|P1|NOT COMPLETED|Overall Study||140
2533568|NCT00636675|6210650|P2|COMPLETED|Overall Study||734
2533569|NCT00636675|6210651|P1|COMPLETED|Overall Study||811
2533570|NCT00636675|6210650|P2|STARTED|Overall Study||775
2533571|NCT00636675|6210651|P1|STARTED|Overall Study||951
2533572|NCT00636649|6210663|P2|NOT COMPLETED|Overall Study||0
2533573|NCT00636649|6210664|P1|NOT COMPLETED|Overall Study||0
2533574|NCT00636649|6210663|P2|COMPLETED|Overall Study||20
2533575|NCT00636649|6210664|P1|COMPLETED|Overall Study||20
2533576|NCT00636649|6210663|P2|STARTED|Overall Study||20
2533577|NCT00636649|6210664|P1|STARTED|Overall Study||20
2533578|NCT00636636|6210694|P2|NOT COMPLETED|Overall Study||39
2533579|NCT00636636|6210695|P1|NOT COMPLETED|Overall Study||36
2533580|NCT00636636|6210694|P2|COMPLETED|Overall Study||192
2533581|NCT00636636|6210695|P1|COMPLETED|Overall Study||185
2533582|NCT00636636|6210694|P2|379|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
2533583|NCT00636636|6210695|P1|379|Overall Study||186
2533584|NCT00636636|6210694|P2|Safety & Efficacy of Gabapentin ER|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
2533585|NCT00636636|6210695|P1|Safety & Efficacy of Gabapentin ER|Overall Study||186
2533586|NCT00636636|6210694|P2|STARTED|Overall Study||231
2533587|NCT00636636|6210695|P1|STARTED|Overall Study||221
2533588|NCT00636610|6210711|P2|NOT COMPLETED|Overall Study||83
2533589|NCT00636610|6210712|P1|NOT COMPLETED|Overall Study||92
2533590|NCT00636610|6210711|P2|COMPLETED|Overall Study||18
2533591|NCT00636610|6210712|P1|COMPLETED|Overall Study||6
2533592|NCT00636610|6210711|P2|STARTED|Overall Study||101
2533593|NCT00636610|6210712|P1|STARTED|Overall Study||98
2533594|NCT00636506|6210722|P1|NOT COMPLETED|Overall Study||16
2533595|NCT00636506|6210722|P1|COMPLETED|Overall Study||60
2533596|NCT00636506|6210722|P1|STARTED|Overall Study||76
2533597|NCT00636441|6210769|P7|NOT COMPLETED|Overall Study||18
2533598|NCT00636441|6210770|P6|NOT COMPLETED|Overall Study||1
2533599|NCT00636441|6210771|P5|NOT COMPLETED|Overall Study||0
2533600|NCT00636441|6210772|P4|NOT COMPLETED|Overall Study||0
2533601|NCT00636441|6210773|P3|NOT COMPLETED|Overall Study||1
2533602|NCT00636441|6210774|P2|NOT COMPLETED|Overall Study||1
2533603|NCT00636441|6210775|P1|NOT COMPLETED|Overall Study||0
2533604|NCT00636441|6210769|P7|COMPLETED|Overall Study||0
2533605|NCT00636441|6210770|P6|COMPLETED|Overall Study||6
2533606|NCT00636441|6210771|P5|COMPLETED|Overall Study||6
2533607|NCT00636441|6210772|P4|COMPLETED|Overall Study||6
2533608|NCT00636441|6210773|P3|COMPLETED|Overall Study||5
2533609|NCT00636441|6210774|P2|COMPLETED|Overall Study||6
2533610|NCT00636441|6210775|P1|COMPLETED|Overall Study||6
2533611|NCT00636441|6210769|P7|Assigned Treatment|Overall Study|This is a late determined ineligibility.|1
2533612|NCT00636441|6210770|P6|Assigned Treatment|Overall Study||7
2533613|NCT00636441|6210771|P5|Assigned Treatment|Overall Study||6
2533614|NCT00636441|6210772|P4|Assigned Treatment|Overall Study||6
2533615|NCT00636441|6210773|P3|Assigned Treatment|Overall Study||6
2533616|NCT00636441|6210774|P2|Assigned Treatment|Overall Study||7
2533617|NCT00636441|6210775|P1|Assigned Treatment|Overall Study||6
2533618|NCT00636441|6210769|P7|STARTED|Overall Study||18
2533619|NCT00636441|6210770|P6|STARTED|Overall Study||7
2533620|NCT00636441|6210771|P5|STARTED|Overall Study||6
2533621|NCT00636441|6210772|P4|STARTED|Overall Study||6
2533622|NCT00636441|6210773|P3|STARTED|Overall Study||6
2533623|NCT00636441|6210774|P2|STARTED|Overall Study||7
2533624|NCT00636441|6210775|P1|STARTED|Overall Study||6
2533625|NCT00636389|6210804|P2|NOT COMPLETED|Period 2 - 1 Week||0
2533626|NCT00636389|6210805|P1|NOT COMPLETED|Period 2 - 1 Week||0
2533627|NCT00636389|6210804|P2|COMPLETED|Period 2 - 1 Week||5
2533628|NCT00636389|6210805|P1|COMPLETED|Period 2 - 1 Week||7
2533629|NCT00636389|6210804|P2|STARTED|Period 2 - 1 Week||5
2533630|NCT00636389|6210805|P1|STARTED|Period 2 - 1 Week||7
2533631|NCT00636389|6210804|P2|NOT COMPLETED|Period 1 - 1 Week||0
2533632|NCT00636389|6210805|P1|NOT COMPLETED|Period 1 - 1 Week||0
2533633|NCT00636389|6210804|P2|COMPLETED|Period 1 - 1 Week||5
2533634|NCT00636389|6210805|P1|COMPLETED|Period 1 - 1 Week||7
2533635|NCT00636389|6210804|P2|STARTED|Period 1 - 1 Week||5
2533636|NCT00636389|6210805|P1|STARTED|Period 1 - 1 Week||7
2533637|NCT00636363|6210818|P3|NOT COMPLETED|Overall Study||18
2533638|NCT00636363|6210819|P2|NOT COMPLETED|Overall Study||20
2533639|NCT00636363|6210820|P1|NOT COMPLETED|Overall Study||13
2533640|NCT00636363|6210818|P3|COMPLETED|Overall Study||163
2533641|NCT00636363|6210819|P2|COMPLETED|Overall Study||156
2533642|NCT00636363|6210820|P1|COMPLETED|Overall Study||165
2533643|NCT00636363|6210818|P3|STARTED|Overall Study||181
2533644|NCT00636363|6210819|P2|STARTED|Overall Study||176
2533645|NCT00636363|6210820|P1|STARTED|Overall Study||178
2533646|NCT00636220|6210834|P1|NOT COMPLETED|Overall Study||0
2533647|NCT00636220|6210834|P1|COMPLETED|Overall Study||101
2533648|NCT00636220|6210834|P1|STARTED|Overall Study||101
2533649|NCT00636207|6210841|P7|NOT COMPLETED|Overall Study||0
2533650|NCT00636207|6210842|P6|NOT COMPLETED|Overall Study||0
2533651|NCT00636207|6210843|P5|NOT COMPLETED|Overall Study||1
2533652|NCT00636207|6210844|P4|NOT COMPLETED|Overall Study||0
2533653|NCT00636207|6210845|P3|NOT COMPLETED|Overall Study||0
2533654|NCT00636207|6210846|P2|NOT COMPLETED|Overall Study||1
2533655|NCT00636207|6210847|P1|NOT COMPLETED|Overall Study||1
2533656|NCT00636207|6210841|P7|COMPLETED|Overall Study||3
2533657|NCT00636207|6210842|P6|COMPLETED|Overall Study||1
2533658|NCT00636207|6210843|P5|COMPLETED|Overall Study||8
2533659|NCT00636207|6210844|P4|COMPLETED|Overall Study||6
2533660|NCT00636207|6210845|P3|COMPLETED|Overall Study||18
2533661|NCT00636207|6210846|P2|COMPLETED|Overall Study||7
2533662|NCT00636207|6210847|P1|COMPLETED|Overall Study||0
2533663|NCT00636207|6210841|P7|STARTED|Overall Study||3
2533664|NCT00636207|6210842|P6|STARTED|Overall Study||1
2533665|NCT00636207|6210843|P5|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|9
2533666|NCT00636207|6210844|P4|STARTED|Overall Study||6
2533667|NCT00636207|6210845|P3|STARTED|Overall Study||18
2533668|NCT00636207|6210846|P2|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|8
2533669|NCT00636207|6210847|P1|STARTED|Overall Study|One participant discontinued after completing Period 2. Doses in Periods 1 and 2 were Montelukast.|1
2533670|NCT00636194|6210911|P2|NOT COMPLETED|Overall Study||0
2533671|NCT00636194|6210912|P1|NOT COMPLETED|Overall Study||3
2533672|NCT00636194|6210911|P2|COMPLETED|Overall Study||175
2533673|NCT00636194|6210912|P1|COMPLETED|Overall Study||172
2533674|NCT00636194|6210911|P2|STARTED|Overall Study||175
2533675|NCT00636194|6210912|P1|STARTED|Overall Study||175
2533676|NCT00636181|6210925|P3|NOT COMPLETED|Overall Study||10
2533677|NCT00636181|6210926|P2|NOT COMPLETED|Overall Study||6
2533678|NCT00636181|6210927|P1|NOT COMPLETED|Overall Study||8
2533679|NCT00636181|6210925|P3|COMPLETED|Overall Study||47
2533680|NCT00636181|6210926|P2|COMPLETED|Overall Study||47
2533681|NCT00636181|6210927|P1|COMPLETED|Overall Study||46
2533682|NCT00636181|6210925|P3|STARTED|Overall Study||57
2533683|NCT00636181|6210926|P2|STARTED|Overall Study||53
2533684|NCT00636181|6210927|P1|STARTED|Overall Study||54
2533685|NCT00636168|6210955|P2|NOT COMPLETED|Long Term Follow-Up||14
2533686|NCT00636168|6210956|P1|NOT COMPLETED|Long Term Follow-Up||11
2533687|NCT00636168|6210955|P2|COMPLETED|Long Term Follow-Up||129
2533688|NCT00636168|6210956|P1|COMPLETED|Long Term Follow-Up||130
2533689|NCT00636168|6210955|P2|STARTED|Long Term Follow-Up||143
2533690|NCT00636168|6210956|P1|STARTED|Long Term Follow-Up||141
2533691|NCT00636168|6210955|P2|NOT COMPLETED|Treated With Study Drug||331
2533692|NCT00636168|6210956|P1|NOT COMPLETED|Treated With Study Drug||408
2533693|NCT00636168|6210955|P2|COMPLETED|Treated With Study Drug||143
2533694|NCT00636168|6210956|P1|COMPLETED|Treated With Study Drug||63
2533695|NCT00636168|6210955|P2|STARTED|Treated With Study Drug||474
2533696|NCT00636168|6210956|P1|STARTED|Treated With Study Drug||471
2533697|NCT00636168|6210955|P2|NOT COMPLETED|Randomized to Study Drug||2
2533698|NCT00636168|6210956|P1|NOT COMPLETED|Randomized to Study Drug||4
2533699|NCT00636168|6210955|P2|COMPLETED|Randomized to Study Drug||474
2533700|NCT00636168|6210956|P1|COMPLETED|Randomized to Study Drug||471
2533701|NCT00636168|6210955|P2|STARTED|Randomized to Study Drug||476
2533702|NCT00636168|6210956|P1|STARTED|Randomized to Study Drug||475
2533703|NCT00636155|6210984|P1|NOT COMPLETED|Overall Study||18
2533704|NCT00636155|6210984|P1|COMPLETED|Overall Study|Completed maximum 6 cycles of treatment|2
2533705|NCT00636155|6210984|P1|STARTED|Overall Study||20
2533706|NCT00636077|6210990|P4|NOT COMPLETED|Week 4||0
2533707|NCT00636077|6210991|P3|NOT COMPLETED|Week 4||0
2533708|NCT00636077|6210992|P2|NOT COMPLETED|Week 4||0
2533709|NCT00636077|6210993|P1|NOT COMPLETED|Week 4||0
2533710|NCT00636077|6210990|P4|COMPLETED|Week 4||3
2533711|NCT00636077|6210991|P3|COMPLETED|Week 4||3
2533712|NCT00636077|6210992|P2|COMPLETED|Week 4||3
2533713|NCT00636077|6210993|P1|COMPLETED|Week 4||3
2533714|NCT00636077|6210990|P4|STARTED|Week 4||3
2533715|NCT00636077|6210991|P3|STARTED|Week 4||3
2533716|NCT00636077|6210992|P2|STARTED|Week 4||3
2533717|NCT00636077|6210993|P1|STARTED|Week 4||3
2533718|NCT00636077|6210990|P4|NOT COMPLETED|Week 3||0
2533719|NCT00636077|6210991|P3|NOT COMPLETED|Week 3||0
2533720|NCT00636077|6210992|P2|NOT COMPLETED|Week 3||0
2533721|NCT00636077|6210993|P1|NOT COMPLETED|Week 3||0
2533722|NCT00636077|6210990|P4|COMPLETED|Week 3||3
2533723|NCT00636077|6210991|P3|COMPLETED|Week 3||3
2533724|NCT00636077|6210992|P2|COMPLETED|Week 3||3
2533725|NCT00636077|6210993|P1|COMPLETED|Week 3||3
2533726|NCT00636077|6210990|P4|STARTED|Week 3||3
2533727|NCT00636077|6210991|P3|STARTED|Week 3||3
2533728|NCT00636077|6210992|P2|STARTED|Week 3||3
2533729|NCT00636077|6210993|P1|STARTED|Week 3||3
2533730|NCT00636077|6210990|P4|NOT COMPLETED|Week 2||0
2533731|NCT00636077|6210991|P3|NOT COMPLETED|Week 2||0
2533732|NCT00636077|6210992|P2|NOT COMPLETED|Week 2||0
2533733|NCT00636077|6210993|P1|NOT COMPLETED|Week 2||0
2533734|NCT00636077|6210990|P4|COMPLETED|Week 2||3
2533735|NCT00636077|6210991|P3|COMPLETED|Week 2||3
2533736|NCT00636077|6210992|P2|COMPLETED|Week 2||3
2533737|NCT00636077|6210993|P1|COMPLETED|Week 2||3
2533738|NCT00636077|6210990|P4|STARTED|Week 2||3
2533739|NCT00636077|6210991|P3|STARTED|Week 2||3
2533740|NCT00636077|6210992|P2|STARTED|Week 2||3
2533741|NCT00636077|6210993|P1|STARTED|Week 2||3
2533742|NCT00636077|6210990|P4|NOT COMPLETED|Week 1||0
2533743|NCT00636077|6210991|P3|NOT COMPLETED|Week 1||0
2533744|NCT00636077|6210992|P2|NOT COMPLETED|Week 1||0
2533745|NCT00636077|6210993|P1|NOT COMPLETED|Week 1||0
2533746|NCT00636077|6210990|P4|COMPLETED|Week 1||3
2533747|NCT00636077|6210991|P3|COMPLETED|Week 1||3
2533748|NCT00636077|6210992|P2|COMPLETED|Week 1||3
2533749|NCT00636077|6210993|P1|COMPLETED|Week 1||3
2533750|NCT00636077|6210990|P4|STARTED|Week 1||3
2533751|NCT00636077|6210991|P3|STARTED|Week 1||3
2533752|NCT00636077|6210992|P2|STARTED|Week 1||3
2533753|NCT00636077|6210993|P1|STARTED|Week 1||3
2533754|NCT00635999|6211026|P3|NOT COMPLETED|Overall Study||1
2533755|NCT00635999|6211027|P2|NOT COMPLETED|Overall Study||2
2533756|NCT00635999|6211028|P1|NOT COMPLETED|Overall Study||4
2533757|NCT00635999|6211026|P3|COMPLETED|Overall Study||23
2533758|NCT00635999|6211027|P2|COMPLETED|Overall Study||23
2533759|NCT00635999|6211028|P1|COMPLETED|Overall Study||23
2533760|NCT00635999|6211026|P3|STARTED|Overall Study||24
2533761|NCT00635999|6211027|P2|STARTED|Overall Study||25
2533762|NCT00635999|6211028|P1|STARTED|Overall Study||27
2533763|NCT00635882|6211045|P6|NOT COMPLETED|Overall Study||0
2533764|NCT00635882|6211046|P5|NOT COMPLETED|Overall Study||0
2533765|NCT00635882|6211047|P4|NOT COMPLETED|Overall Study||0
2533766|NCT00635882|6211048|P3|NOT COMPLETED|Overall Study||0
2533767|NCT00635882|6211049|P2|NOT COMPLETED|Overall Study||0
2533768|NCT00635882|6211050|P1|NOT COMPLETED|Overall Study||1
2533769|NCT00635882|6211045|P6|COMPLETED|Overall Study||13
2533770|NCT00635882|6211046|P5|COMPLETED|Overall Study||16
2533771|NCT00635882|6211047|P4|COMPLETED|Overall Study||15
2533772|NCT00635882|6211048|P3|COMPLETED|Overall Study||12
2533773|NCT00635882|6211049|P2|COMPLETED|Overall Study||17
2533774|NCT00635882|6211050|P1|COMPLETED|Overall Study||19
2533775|NCT00635882|6211045|P6|STARTED|Overall Study||13
2533776|NCT00635882|6211046|P5|STARTED|Overall Study||16
2533777|NCT00635882|6211047|P4|STARTED|Overall Study||15
2533778|NCT00635882|6211048|P3|STARTED|Overall Study||12
2533779|NCT00635882|6211049|P2|STARTED|Overall Study||17
2533780|NCT00635882|6211050|P1|STARTED|Overall Study||20
2533781|NCT00635830|6211114|P2|NOT COMPLETED|Overall Study||0
2533782|NCT00635830|6211115|P1|NOT COMPLETED|Overall Study||0
2533783|NCT00635830|6211114|P2|COMPLETED|Overall Study||20
2533784|NCT00635830|6211115|P1|COMPLETED|Overall Study||20
2533785|NCT00635830|6211114|P2|STARTED|Overall Study||20
2533786|NCT00635830|6211115|P1|STARTED|Overall Study||20
2533787|NCT00635817|6211125|P4|NOT COMPLETED|Overall Study||0
2533788|NCT00635817|6211126|P3|NOT COMPLETED|Overall Study||2
2533789|NCT00635817|6211127|P2|NOT COMPLETED|Overall Study||2
2533790|NCT00635817|6211128|P1|NOT COMPLETED|Overall Study||6
2533791|NCT00635817|6211125|P4|COMPLETED|Overall Study||21
2533792|NCT00635817|6211126|P3|COMPLETED|Overall Study||19
2533793|NCT00635817|6211127|P2|COMPLETED|Overall Study||19
2533794|NCT00635817|6211128|P1|COMPLETED|Overall Study||15
2533795|NCT00635817|6211125|P4|STARTED|Overall Study||21
2533796|NCT00635817|6211126|P3|STARTED|Overall Study||21
2533797|NCT00635817|6211127|P2|STARTED|Overall Study||21
2533798|NCT00635817|6211128|P1|STARTED|Overall Study||21
2533799|NCT00635804|6211180|P8|NOT COMPLETED|Overall Study||0
2533800|NCT00635804|6211181|P7|NOT COMPLETED|Overall Study||0
2533801|NCT00635804|6211182|P6|NOT COMPLETED|Overall Study||1
2533802|NCT00635804|6211183|P5|NOT COMPLETED|Overall Study||0
2533803|NCT00635804|6211184|P4|NOT COMPLETED|Overall Study||0
2533804|NCT00635804|6211185|P3|NOT COMPLETED|Overall Study||0
2533805|NCT00635804|6211186|P2|NOT COMPLETED|Overall Study||0
2533806|NCT00635804|6211187|P1|NOT COMPLETED|Overall Study||1
2533807|NCT00635804|6211180|P8|COMPLETED|Overall Study||14
2533808|NCT00635804|6211181|P7|COMPLETED|Overall Study||3
2533809|NCT00635804|6211182|P6|COMPLETED|Overall Study||11
2533810|NCT00635804|6211183|P5|COMPLETED|Overall Study||6
2533811|NCT00635804|6211184|P4|COMPLETED|Overall Study||6
2533812|NCT00635804|6211185|P3|COMPLETED|Overall Study||6
2533813|NCT00635804|6211186|P2|COMPLETED|Overall Study||6
2533814|NCT00635804|6211187|P1|COMPLETED|Overall Study||6
2533815|NCT00635804|6211180|P8|STARTED|Overall Study||14
2533816|NCT00635804|6211181|P7|STARTED|Overall Study||3
2533817|NCT00635804|6211182|P6|STARTED|Overall Study||12
2533818|NCT00635804|6211183|P5|STARTED|Overall Study||6
2533819|NCT00635804|6211184|P4|STARTED|Overall Study||6
2533820|NCT00635804|6211185|P3|STARTED|Overall Study||6
2533821|NCT00635804|6211186|P2|STARTED|Overall Study||6
2533822|NCT00635804|6211187|P1|STARTED|Overall Study||7
2533823|NCT00635778|6211291|P7|NOT COMPLETED|Overall Study||6
2533824|NCT00635778|6211292|P6|NOT COMPLETED|Overall Study||21
2533825|NCT00635778|6211293|P5|NOT COMPLETED|Overall Study||8
2533826|NCT00635778|6211294|P4|NOT COMPLETED|Overall Study||8
2533827|NCT00635778|6211295|P3|NOT COMPLETED|Overall Study||3
2533828|NCT00635778|6211296|P2|NOT COMPLETED|Overall Study||3
2533829|NCT00635778|6211297|P1|NOT COMPLETED|Overall Study||1
2533830|NCT00635778|6211291|P7|COMPLETED|Overall Study||0
2533831|NCT00635778|6211292|P6|COMPLETED|Overall Study||0
2533832|NCT00635778|6211293|P5|COMPLETED|Overall Study||0
2533833|NCT00635778|6211294|P4|COMPLETED|Overall Study||0
2533834|NCT00635778|6211295|P3|COMPLETED|Overall Study||0
2533835|NCT00635778|6211296|P2|COMPLETED|Overall Study||0
2533836|NCT00635778|6211297|P1|COMPLETED|Overall Study||0
2533837|NCT00635778|6211291|P7|STARTED|Overall Study||6
2533838|NCT00635778|6211292|P6|STARTED|Overall Study||21
2533839|NCT00635778|6211293|P5|STARTED|Overall Study||8
2533840|NCT00635778|6211294|P4|STARTED|Overall Study||8
2533841|NCT00635778|6211295|P3|STARTED|Overall Study||3
2533842|NCT00635778|6211296|P2|STARTED|Overall Study||3
2533843|NCT00635778|6211297|P1|STARTED|Overall Study||1
2533844|NCT00635739|6211350|P2|NOT COMPLETED|Overall Study||2
2533845|NCT00635739|6211351|P1|NOT COMPLETED|Overall Study||3
2533846|NCT00635739|6211350|P2|COMPLETED|Overall Study||36
2533847|NCT00635739|6211351|P1|COMPLETED|Overall Study||39
2533848|NCT00635739|6211350|P2|STARTED|Overall Study||38
2533849|NCT00635739|6211351|P1|STARTED|Overall Study||42
2533850|NCT00635700|6211361|P2|NOT COMPLETED|Overall Study||14
2533851|NCT00635700|6211362|P1|NOT COMPLETED|Overall Study||15
2533852|NCT00635700|6211361|P2|COMPLETED|Overall Study||13
2533853|NCT00635700|6211362|P1|COMPLETED|Overall Study||9
2533854|NCT00635700|6211361|P2|STARTED|Overall Study||27
2533855|NCT00635700|6211362|P1|STARTED|Overall Study||24
2533856|NCT00635661|6211368|P1|NOT COMPLETED|Overall Study||4
2533857|NCT00635661|6211368|P1|COMPLETED|Overall Study||30
2533858|NCT00635661|6211368|P1|STARTED|Overall Study||34
2533859|NCT00635648|6211372|P1|NOT COMPLETED|Overall Study||37
2533860|NCT00635648|6211372|P1|COMPLETED|Overall Study||26
2533861|NCT00635648|6211372|P1|STARTED|Overall Study||63
2533862|NCT00635609|6211381|P2|NOT COMPLETED|Overall Study||3
2533863|NCT00635609|6211382|P1|NOT COMPLETED|Overall Study||7
2533864|NCT00635609|6211381|P2|COMPLETED|Overall Study||42
2533865|NCT00635609|6211382|P1|COMPLETED|Overall Study||41
2533866|NCT00635609|6211381|P2|STARTED|Overall Study||45
2533867|NCT00635609|6211382|P1|STARTED|Overall Study||48
2533868|NCT00635570|6211394|P2|NOT COMPLETED|Overall Study||11
2533869|NCT00635570|6211395|P1|NOT COMPLETED|Overall Study||15
2533870|NCT00635570|6211394|P2|COMPLETED|Overall Study||126
2533871|NCT00635570|6211395|P1|COMPLETED|Overall Study||121
2533872|NCT00635570|6211394|P2|STARTED|Overall Study||137
2533873|NCT00635570|6211395|P1|STARTED|Overall Study||136
2533874|NCT00635492|6211409|P2|NOT COMPLETED|Overall Study||282
2533875|NCT00635492|6211410|P1|NOT COMPLETED|Overall Study||279
2533876|NCT00635492|6211409|P2|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|992
2533877|NCT00635492|6211410|P1|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|835
2533878|NCT00635492|6211409|P2|STARTED|Overall Study|This population consists of the analysis population.|1274
2533879|NCT00635492|6211410|P1|STARTED|Overall Study|This population consists of the analysis population.|1114
2533880|NCT00635479|6211456|P2|NOT COMPLETED|Overall Study||18
2533881|NCT00635479|6211457|P1|NOT COMPLETED|Overall Study||6
2533882|NCT00635479|6211456|P2|COMPLETED|Overall Study||42
2533883|NCT00635479|6211457|P1|COMPLETED|Overall Study||49
2533884|NCT00635479|6211456|P2|STARTED|Overall Study||60
2533885|NCT00635479|6211457|P1|STARTED|Overall Study||55
2533886|NCT00635453|6211465|P2|NOT COMPLETED|Overall Study||174
2533887|NCT00635453|6211466|P1|NOT COMPLETED|Overall Study||154
2533888|NCT00635453|6211465|P2|COMPLETED|Overall Study||181
2533889|NCT00635453|6211466|P1|COMPLETED|Overall Study||206
2533890|NCT00635453|6211465|P2|3 Years Assessment|Overall Study||204
2533891|NCT00635453|6211466|P1|3 Years Assessment|Overall Study||246
2533892|NCT00635453|6211465|P2|12 Months Assessment|Overall Study||260
2533893|NCT00635453|6211466|P1|12 Months Assessment|Overall Study||285
2533894|NCT00635453|6211465|P2|6 Months Assessment|Overall Study||311
2533895|NCT00635453|6211466|P1|6 Months Assessment|Overall Study||322
2533896|NCT00635453|6211465|P2|STARTED|Overall Study||355
2533897|NCT00635453|6211466|P1|STARTED|Overall Study||360
2533898|NCT00635427|6211483|P5|NOT COMPLETED|Overall Study||8
2533899|NCT00635427|6211484|P4|NOT COMPLETED|Overall Study||9
2533900|NCT00635427|6211485|P3|NOT COMPLETED|Overall Study||11
2533901|NCT00635427|6211486|P2|NOT COMPLETED|Overall Study||6
2533902|NCT00635427|6211487|P1|NOT COMPLETED|Overall Study||12
2533903|NCT00635427|6211483|P5|COMPLETED|Overall Study||30
2533904|NCT00635427|6211484|P4|COMPLETED|Overall Study||7
2533905|NCT00635427|6211485|P3|COMPLETED|Overall Study||5
2533906|NCT00635427|6211486|P2|COMPLETED|Overall Study||6
2533907|NCT00635427|6211487|P1|COMPLETED|Overall Study||1
2533908|NCT00635427|6211483|P5|STARTED|Overall Study||38
2533909|NCT00635427|6211484|P4|STARTED|Overall Study||16
2533910|NCT00635427|6211485|P3|STARTED|Overall Study||16
2533911|NCT00635427|6211486|P2|STARTED|Overall Study|11 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|12
2533912|NCT00635427|6211487|P1|STARTED|Overall Study|12 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|13
2533913|NCT00635362|6211509|P2|NOT COMPLETED|Overall Study||8
2533914|NCT00635362|6211510|P1|NOT COMPLETED|Overall Study||13
2533915|NCT00635362|6211509|P2|COMPLETED|Overall Study||12
2533916|NCT00635362|6211510|P1|COMPLETED|Overall Study||9
2533917|NCT00635362|6211509|P2|STARTED|Overall Study||20
2533918|NCT00635362|6211510|P1|STARTED|Overall Study||22
2533919|NCT00635349|6211526|P2|NOT COMPLETED|Overall Study||48
2533920|NCT00635349|6211527|P1|NOT COMPLETED|Overall Study||44
2533921|NCT00635349|6211526|P2|COMPLETED|Overall Study||19
2533922|NCT00635349|6211527|P1|COMPLETED|Overall Study||29
2533923|NCT00635349|6211526|P2|STARTED|Overall Study||67
2533924|NCT00635349|6211527|P1|STARTED|Overall Study||73
2533925|NCT00635232|6211550|P5|NOT COMPLETED|Overall Study||8
2533926|NCT00635232|6211551|P4|NOT COMPLETED|Overall Study||10
2533927|NCT00635232|6211552|P3|NOT COMPLETED|Overall Study||3
2533928|NCT00635232|6211553|P2|NOT COMPLETED|Overall Study||20
2533929|NCT00635232|6211554|P1|NOT COMPLETED|Overall Study||14
2533930|NCT00635232|6211550|P5|COMPLETED|Overall Study||20
2533931|NCT00635232|6211551|P4|COMPLETED|Overall Study||48
2533932|NCT00635232|6211552|P3|COMPLETED|Overall Study||55
2533933|NCT00635232|6211553|P2|COMPLETED|Overall Study||39
2533934|NCT00635232|6211554|P1|COMPLETED|Overall Study||44
2533935|NCT00635232|6211550|P5|STARTED|Overall Study||28
2533936|NCT00635232|6211551|P4|STARTED|Overall Study||58
2533937|NCT00635232|6211552|P3|STARTED|Overall Study||58
2533938|NCT00635232|6211553|P2|STARTED|Overall Study||59
2533939|NCT00635232|6211554|P1|STARTED|Overall Study||58
2533940|NCT00635219|6211581|P5|NOT COMPLETED|Overall Study||42
2533941|NCT00635219|6211582|P4|NOT COMPLETED|Overall Study||34
2533942|NCT00635219|6211583|P3|NOT COMPLETED|Overall Study||35
2533943|NCT00635219|6211584|P2|NOT COMPLETED|Overall Study||25
2533944|NCT00635219|6211585|P1|NOT COMPLETED|Overall Study||25
2533945|NCT00635219|6211581|P5|COMPLETED|Overall Study||113
2533946|NCT00635219|6211582|P4|COMPLETED|Overall Study||117
2533947|NCT00635219|6211583|P3|COMPLETED|Overall Study||122
2533948|NCT00635219|6211584|P2|COMPLETED|Overall Study||130
2533949|NCT00635219|6211585|P1|COMPLETED|Overall Study||123
2533950|NCT00635219|6211581|P5|STARTED|Overall Study||155
2533951|NCT00635219|6211582|P4|STARTED|Overall Study||151
2533952|NCT00635219|6211583|P3|STARTED|Overall Study||157
2533953|NCT00635219|6211584|P2|STARTED|Overall Study||155
2533954|NCT00635219|6211585|P1|STARTED|Overall Study||148
2533955|NCT00635167|6211642|P1|NOT COMPLETED|Overall Study||0
2533956|NCT00635167|6211642|P1|COMPLETED|Overall Study||1
2533957|NCT00635167|6211642|P1|STARTED|Overall Study||1
2533958|NCT00635154|6211648|P1|NOT COMPLETED|Overall Study||33
2533959|NCT00635154|6211648|P1|COMPLETED|Overall Study||21
2533960|NCT00635154|6211648|P1|STARTED|Overall Study||54
2533961|NCT00635128|6211660|P2|NOT COMPLETED|Overall Study||0
2533962|NCT00635128|6211661|P1|NOT COMPLETED|Overall Study||0
2533963|NCT00635128|6211660|P2|COMPLETED|Overall Study||64
2533964|NCT00635128|6211661|P1|COMPLETED|Overall Study||351
2533965|NCT00635128|6211660|P2|STARTED|Overall Study||64
2533966|NCT00635128|6211661|P1|STARTED|Overall Study||351
2533967|NCT00635102|6211691|P2|NOT COMPLETED|Overall Study||8
2533968|NCT00635102|6211692|P1|NOT COMPLETED|Overall Study||7
2533969|NCT00635102|6211691|P2|COMPLETED|Overall Study||22
2533970|NCT00635102|6211692|P1|COMPLETED|Overall Study||20
2533971|NCT00635102|6211691|P2|STARTED|Overall Study||30
2533972|NCT00635102|6211692|P1|STARTED|Overall Study||27
2533973|NCT00635089|6211786|P1|NOT COMPLETED|Overall Study||78
2533974|NCT00635089|6211786|P1|COMPLETED|Overall Study|Participants who had not withdrawn at the time of study termination.|112
2533975|NCT00635089|6211786|P1|Completed >/= 16 Weeks of Study|Overall Study||181
2533976|NCT00635089|6211786|P1|STARTED|Overall Study||190
2533977|NCT00635050|6211813|P1|NOT COMPLETED|Overall Study||1
2533978|NCT00635050|6211813|P1|COMPLETED|Overall Study|Followup through 10 years planned.|31
2534060|NCT00634842|6211976|P1|STARTED|Overall Study||122
2533979|NCT00635050|6211813|P1|STARTED|Overall Study|No patient received regimen B due to grade 3 toxicity in the third patient treated on regimen A.|32
2533980|NCT00635024|6211820|P1|NOT COMPLETED|Overall Study||1
2533981|NCT00635024|6211820|P1|COMPLETED|Overall Study||0
2533982|NCT00635024|6211820|P1|STARTED|Overall Study||1
2533983|NCT00634933|6211831|P5|NOT COMPLETED|Part B: Week 24 to Week 52||10
2533984|NCT00634933|6211832|P4|NOT COMPLETED|Part B: Week 24 to Week 52||6
2533985|NCT00634933|6211833|P3|NOT COMPLETED|Part B: Week 24 to Week 52||22
2533986|NCT00634933|6211834|P2|NOT COMPLETED|Part B: Week 24 to Week 52||14
2533987|NCT00634933|6211835|P1|NOT COMPLETED|Part B: Week 24 to Week 52||0
2533988|NCT00634933|6211831|P5|COMPLETED|Part B: Week 24 to Week 52||22
2533989|NCT00634933|6211832|P4|COMPLETED|Part B: Week 24 to Week 52||25
2533990|NCT00634933|6211833|P3|COMPLETED|Part B: Week 24 to Week 52||33
2533991|NCT00634933|6211834|P2|COMPLETED|Part B: Week 24 to Week 52||42
2533992|NCT00634933|6211835|P1|COMPLETED|Part B: Week 24 to Week 52||0
2533993|NCT00634933|6211831|P5|STARTED|Part B: Week 24 to Week 52||32
2533994|NCT00634933|6211832|P4|STARTED|Part B: Week 24 to Week 52||31
2533995|NCT00634933|6211833|P3|STARTED|Part B: Week 24 to Week 52||55
2533996|NCT00634933|6211834|P2|STARTED|Part B: Week 24 to Week 52||56
2533997|NCT00634933|6211835|P1|STARTED|Part B: Week 24 to Week 52||0
2533998|NCT00634933|6211831|P5|NOT COMPLETED|Between Part A and Part B||0
2533999|NCT00634933|6211832|P4|NOT COMPLETED|Between Part A and Part B||0
2534000|NCT00634933|6211833|P3|NOT COMPLETED|Between Part A and Part B||0
2534001|NCT00634933|6211834|P2|NOT COMPLETED|Between Part A and Part B||1
2534002|NCT00634933|6211835|P1|NOT COMPLETED|Between Part A and Part B||0
2534003|NCT00634933|6211831|P5|COMPLETED|Between Part A and Part B||32
2534004|NCT00634933|6211832|P4|COMPLETED|Between Part A and Part B||31
2534005|NCT00634933|6211833|P3|COMPLETED|Between Part A and Part B||55
2534006|NCT00634933|6211834|P2|COMPLETED|Between Part A and Part B||56
2534007|NCT00634933|6211835|P1|COMPLETED|Between Part A and Part B||0
2534008|NCT00634933|6211831|P5|STARTED|Between Part A and Part B||32
2534009|NCT00634933|6211832|P4|STARTED|Between Part A and Part B||31
2534010|NCT00634933|6211833|P3|STARTED|Between Part A and Part B||55
2534011|NCT00634933|6211834|P2|STARTED|Between Part A and Part B||57
2534012|NCT00634933|6211835|P1|STARTED|Between Part A and Part B||0
2534013|NCT00634933|6211831|P5|NOT COMPLETED|Part A: Baseline to Week 24||0
2534014|NCT00634933|6211832|P4|NOT COMPLETED|Part A: Baseline to Week 24||0
2534015|NCT00634933|6211833|P3|NOT COMPLETED|Part A: Baseline to Week 24||18
2534016|NCT00634933|6211834|P2|NOT COMPLETED|Part A: Baseline to Week 24||18
2534017|NCT00634933|6211835|P1|NOT COMPLETED|Part A: Baseline to Week 24||11
2534018|NCT00634933|6211831|P5|COMPLETED|Part A: Baseline to Week 24||0
2534019|NCT00634933|6211832|P4|COMPLETED|Part A: Baseline to Week 24||0
2534020|NCT00634933|6211833|P3|COMPLETED|Part A: Baseline to Week 24||55
2534021|NCT00634933|6211834|P2|COMPLETED|Part A: Baseline to Week 24||57
2534022|NCT00634933|6211835|P1|COMPLETED|Part A: Baseline to Week 24||63
2534023|NCT00634933|6211831|P5|STARTED|Part A: Baseline to Week 24||0
2534024|NCT00634933|6211832|P4|STARTED|Part A: Baseline to Week 24||0
2534025|NCT00634933|6211833|P3|STARTED|Part A: Baseline to Week 24||73
2534026|NCT00634933|6211834|P2|STARTED|Part A: Baseline to Week 24||75
2534027|NCT00634933|6211835|P1|STARTED|Part A: Baseline to Week 24||74
2534028|NCT00634920|6211904|P3|NOT COMPLETED|Period 2 - Post-Randomization||0
2534029|NCT00634920|6211905|P2|NOT COMPLETED|Period 2 - Post-Randomization||32
2534030|NCT00634920|6211906|P1|NOT COMPLETED|Period 2 - Post-Randomization||61
2534031|NCT00634920|6211904|P3|COMPLETED|Period 2 - Post-Randomization||0
2534032|NCT00634920|6211905|P2|COMPLETED|Period 2 - Post-Randomization||68
2534033|NCT00634920|6211906|P1|COMPLETED|Period 2 - Post-Randomization||43
2534034|NCT00634920|6211904|P3|Full Analysis Set (FAS)|Period 2 - Post-Randomization||0
2534035|NCT00634920|6211905|P2|Full Analysis Set (FAS)|Period 2 - Post-Randomization||90
2534036|NCT00634920|6211906|P1|Full Analysis Set (FAS)|Period 2 - Post-Randomization||92
2534037|NCT00634920|6211904|P3|STARTED|Period 2 - Post-Randomization|This group included patients who had renal TX but did not qualify for randomization at Visit 2.|0
2534038|NCT00634920|6211905|P2|STARTED|Period 2 - Post-Randomization||100
2534039|NCT00634920|6211906|P1|STARTED|Period 2 - Post-Randomization|2 patients randomized in this group did not receive at least one dose of study drug.|104
2534040|NCT00634920|6211904|P3|NOT COMPLETED|Period 1 - Pre-Randomization||137
2534041|NCT00634920|6211905|P2|NOT COMPLETED|Period 1 - Pre-Randomization||0
2534042|NCT00634920|6211906|P1|NOT COMPLETED|Period 1 - Pre-Randomization||0
2534043|NCT00634920|6211904|P3|COMPLETED|Period 1 - Pre-Randomization|Total number of patients who became randomized|204
2534044|NCT00634920|6211905|P2|COMPLETED|Period 1 - Pre-Randomization||0
2534045|NCT00634920|6211906|P1|COMPLETED|Period 1 - Pre-Randomization||0
2534046|NCT00634920|6211904|P3|STARTED|Period 1 - Pre-Randomization|Total number of Enrolled patients|341
2534047|NCT00634920|6211905|P2|STARTED|Period 1 - Pre-Randomization||0
2534048|NCT00634920|6211906|P1|STARTED|Period 1 - Pre-Randomization||0
2534049|NCT00634907|6211950|P2|NOT COMPLETED|Overall Study||17
2534050|NCT00634907|6211951|P1|NOT COMPLETED|Overall Study||17
2534051|NCT00634907|6211950|P2|COMPLETED|Overall Study||115
2534052|NCT00634907|6211951|P1|COMPLETED|Overall Study||114
2534053|NCT00634907|6211950|P2|STARTED|Overall Study||132
2534054|NCT00634907|6211951|P1|STARTED|Overall Study||131
2534055|NCT00634842|6211975|P2|NOT COMPLETED|Overall Study||18
2534056|NCT00634842|6211976|P1|NOT COMPLETED|Overall Study||15
2534057|NCT00634842|6211975|P2|COMPLETED|Overall Study||104
2534058|NCT00634842|6211976|P1|COMPLETED|Overall Study||107
2534059|NCT00634842|6211975|P2|STARTED|Overall Study||122
2534061|NCT00634751|6211992|P4|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
2534062|NCT00634751|6211993|P3|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
2534063|NCT00634751|6211994|P2|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
2534064|NCT00634751|6211995|P1|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
2534065|NCT00634751|6211992|P4|COMPLETED|Pancreatic and Bilial Tract Cancer||7
2534066|NCT00634751|6211993|P3|COMPLETED|Pancreatic and Bilial Tract Cancer||23
2534067|NCT00634751|6211994|P2|COMPLETED|Pancreatic and Bilial Tract Cancer||0
2534068|NCT00634751|6211995|P1|COMPLETED|Pancreatic and Bilial Tract Cancer||0
2534069|NCT00634751|6211992|P4|STARTED|Pancreatic and Bilial Tract Cancer||8
2534070|NCT00634751|6211993|P3|STARTED|Pancreatic and Bilial Tract Cancer||24
2534071|NCT00634751|6211994|P2|STARTED|Pancreatic and Bilial Tract Cancer||0
2534072|NCT00634751|6211995|P1|STARTED|Pancreatic and Bilial Tract Cancer||0
2534073|NCT00634751|6211992|P4|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
2534074|NCT00634751|6211993|P3|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
2534075|NCT00634751|6211994|P2|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||1
2534076|NCT00634751|6211995|P1|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
2534077|NCT00634751|6211992|P4|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
2534078|NCT00634751|6211993|P3|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
2534079|NCT00634751|6211994|P2|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||6
2534080|NCT00634751|6211995|P1|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
2534081|NCT00634751|6211992|P4|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
2534082|NCT00634751|6211993|P3|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
2534083|NCT00634751|6211994|P2|STARTED|Phase I: 400mg Sorafenib BID+2DOC||7
2534084|NCT00634751|6211995|P1|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
2534085|NCT00634751|6211992|P4|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
2534086|NCT00634751|6211993|P3|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
2534087|NCT00634751|6211994|P2|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
2534088|NCT00634751|6211995|P1|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||1
2534089|NCT00634751|6211992|P4|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
2534090|NCT00634751|6211993|P3|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
2534091|NCT00634751|6211994|P2|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
2534092|NCT00634751|6211995|P1|COMPLETED|Phase I: 200mg Sorafenib+2DOC||8
2534093|NCT00634751|6211992|P4|STARTED|Phase I: 200mg Sorafenib+2DOC||0
2534094|NCT00634751|6211993|P3|STARTED|Phase I: 200mg Sorafenib+2DOC||0
2534095|NCT00634751|6211994|P2|STARTED|Phase I: 200mg Sorafenib+2DOC||0
2534096|NCT00634751|6211995|P1|STARTED|Phase I: 200mg Sorafenib+2DOC||9
2534097|NCT00634647|6212013|P1|NOT COMPLETED|Overall Study||7
2534098|NCT00634647|6212013|P1|COMPLETED|Overall Study||17
2534099|NCT00634647|6212013|P1|STARTED|Overall Study||24
2534100|NCT00634621|6212019|P1|NOT COMPLETED|Overall Study||0
2534101|NCT00634621|6212019|P1|COMPLETED|Overall Study||283
2534102|NCT00634621|6212019|P1|STARTED|Overall Study||283
2534103|NCT00634582|6212027|P1|NOT COMPLETED|Overall Study||0
2534104|NCT00634582|6212027|P1|COMPLETED|Overall Study||2
2534105|NCT00634582|6212027|P1|STARTED|Overall Study||2
2534106|NCT00634569|6212033|P2|NOT COMPLETED|Overall Study||5
2534107|NCT00634569|6212034|P1|NOT COMPLETED|Overall Study||0
2534108|NCT00634569|6212033|P2|COMPLETED|Overall Study||5
2534109|NCT00634569|6212034|P1|COMPLETED|Overall Study||14
2534110|NCT00634569|6212033|P2|STARTED|Overall Study||10
2534111|NCT00634569|6212034|P1|STARTED|Overall Study||14
2534112|NCT00634543|6212048|P2|NOT COMPLETED|Overall Study||21
2534113|NCT00634543|6212049|P1|NOT COMPLETED|Overall Study||19
2534114|NCT00634543|6212048|P2|COMPLETED|Overall Study||63
2534115|NCT00634543|6212049|P1|COMPLETED|Overall Study||59
2534116|NCT00634543|6212048|P2|Treated|Overall Study||80
2534117|NCT00634543|6212049|P1|Treated|Overall Study||76
2534118|NCT00634543|6212048|P2|STARTED|Overall Study||84
2534119|NCT00634543|6212049|P1|STARTED|Overall Study||78
2534120|NCT00634504|6212067|P2|NOT COMPLETED|Overall Study||0
2534121|NCT00634504|6212068|P1|NOT COMPLETED|Overall Study||1
2534122|NCT00634504|6212067|P2|COMPLETED|Overall Study||9
2534123|NCT00634504|6212068|P1|COMPLETED|Overall Study||10
2534124|NCT00634504|6212067|P2|STARTED|Overall Study||9
2534125|NCT00634504|6212068|P1|STARTED|Overall Study||11
2534126|NCT00634322|6212077|P3|NOT COMPLETED|Overall Study||0
2534127|NCT00634322|6212078|P2|NOT COMPLETED|Overall Study||0
2534128|NCT00634322|6212079|P1|NOT COMPLETED|Overall Study||0
2534129|NCT00634322|6212077|P3|COMPLETED|Overall Study||5
2534130|NCT00634322|6212078|P2|COMPLETED|Overall Study||1
2534131|NCT00634322|6212079|P1|COMPLETED|Overall Study||1
2534132|NCT00634322|6212077|P3|STARTED|Overall Study||5
2534133|NCT00634322|6212078|P2|STARTED|Overall Study||1
2534134|NCT00634322|6212079|P1|STARTED|Overall Study||1
2534138|NCT00634270|6212097|P2|NOT COMPLETED|Overall Study||1
2534139|NCT00634270|6212098|P1|NOT COMPLETED|Overall Study||3
2534140|NCT00634270|6212097|P2|COMPLETED|Overall Study||12
2534141|NCT00634270|6212098|P1|COMPLETED|Overall Study||46
2534142|NCT00634270|6212097|P2|STARTED|Overall Study||13
2534143|NCT00634270|6212098|P1|STARTED|Overall Study|February 12, 2008|49
2534144|NCT00634244|6212127|P3|NOT COMPLETED|Overall Study||0
2534145|NCT00634244|6212128|P2|NOT COMPLETED|Overall Study||13
2534146|NCT00634244|6212129|P1|NOT COMPLETED|Overall Study||1
2534147|NCT00634244|6212127|P3|COMPLETED|Overall Study||20
2534148|NCT00634244|6212128|P2|COMPLETED|Overall Study||24
2534149|NCT00634244|6212129|P1|COMPLETED|Overall Study||34
2534150|NCT00634244|6212127|P3|Eligible and Treated|Overall Study||20
2534151|NCT00634244|6212128|P2|Eligible and Treated|Overall Study||36
2534152|NCT00634244|6212129|P1|Eligible and Treated|Overall Study||35
2534153|NCT00634244|6212127|P3|STARTED|Overall Study||20
2534154|NCT00634244|6212128|P2|STARTED|Overall Study||37
2534155|NCT00634244|6212129|P1|STARTED|Overall Study||35
2534156|NCT00634179|6212140|P1|NOT COMPLETED|Phase II: Maintenance||1
2534157|NCT00634179|6212140|P1|COMPLETED|Phase II: Maintenance||29
2534158|NCT00634179|6212140|P1|STARTED|Phase II: Maintenance||30
2534159|NCT00634179|6212140|P1|NOT COMPLETED|Phase I: Induction||0
2534160|NCT00634179|6212140|P1|COMPLETED|Phase I: Induction||19
2534161|NCT00634179|6212140|P1|STARTED|Phase I: Induction||19
2534162|NCT00634166|6212149|P2|NOT COMPLETED|Overall Study||60
2534163|NCT00634166|6212150|P1|NOT COMPLETED|Overall Study||60
2534164|NCT00634166|6212149|P2|COMPLETED|Overall Study||78
2534165|NCT00634166|6212150|P1|COMPLETED|Overall Study||22
2534166|NCT00634166|6212149|P2|STARTED|Overall Study||138
2534167|NCT00634166|6212150|P1|STARTED|Overall Study||82
2534168|NCT00634114|6212159|P3|NOT COMPLETED|Overall Study||39
2534169|NCT00634114|6212160|P2|NOT COMPLETED|Overall Study||35
2534170|NCT00634114|6212161|P1|NOT COMPLETED|Overall Study||28
2534171|NCT00634114|6212159|P3|COMPLETED|Overall Study|Completed|148
2534172|NCT00634114|6212160|P2|COMPLETED|Overall Study|Completed|154
2534173|NCT00634114|6212161|P1|COMPLETED|Overall Study|Completed|160
2534174|NCT00634114|6212159|P3|STARTED|Overall Study|Randomised|187
2534175|NCT00634114|6212160|P2|STARTED|Overall Study|Randomised|189
2534176|NCT00634114|6212161|P1|STARTED|Overall Study|Randomised|188
2534177|NCT00634088|6212179|P4|NOT COMPLETED|Time Period 4: Triplet Combination||0
2534178|NCT00634088|6212180|P3|NOT COMPLETED|Time Period 4: Triplet Combination||0
2534179|NCT00634088|6212181|P2|NOT COMPLETED|Time Period 4: Triplet Combination||0
2534180|NCT00634088|6212182|P1|NOT COMPLETED|Time Period 4: Triplet Combination||0
2534181|NCT00634088|6212179|P4|COMPLETED|Time Period 4: Triplet Combination||0
2534182|NCT00634088|6212180|P3|COMPLETED|Time Period 4: Triplet Combination||0
2534183|NCT00634088|6212181|P2|COMPLETED|Time Period 4: Triplet Combination||0
2534184|NCT00634088|6212182|P1|COMPLETED|Time Period 4: Triplet Combination||0
2534185|NCT00634088|6212179|P4|STARTED|Time Period 4: Triplet Combination||0
2534186|NCT00634088|6212180|P3|STARTED|Time Period 4: Triplet Combination||0
2534187|NCT00634088|6212181|P2|STARTED|Time Period 4: Triplet Combination||0
2534188|NCT00634088|6212182|P1|STARTED|Time Period 4: Triplet Combination||0
2534189|NCT00634088|6212179|P4|NOT COMPLETED|Time Period 3: Dose Level 3||0
2534190|NCT00634088|6212180|P3|NOT COMPLETED|Time Period 3: Dose Level 3||1
2534191|NCT00634088|6212181|P2|NOT COMPLETED|Time Period 3: Dose Level 3||0
2534192|NCT00634088|6212182|P1|NOT COMPLETED|Time Period 3: Dose Level 3||0
2534193|NCT00634088|6212179|P4|COMPLETED|Time Period 3: Dose Level 3||0
2534194|NCT00634088|6212180|P3|COMPLETED|Time Period 3: Dose Level 3||0
2534195|NCT00634088|6212181|P2|COMPLETED|Time Period 3: Dose Level 3||0
2534196|NCT00634088|6212182|P1|COMPLETED|Time Period 3: Dose Level 3||0
2534197|NCT00634088|6212179|P4|STARTED|Time Period 3: Dose Level 3||0
2534198|NCT00634088|6212180|P3|STARTED|Time Period 3: Dose Level 3||1
2534199|NCT00634088|6212181|P2|STARTED|Time Period 3: Dose Level 3||0
2534200|NCT00634088|6212182|P1|STARTED|Time Period 3: Dose Level 3||0
2534201|NCT00634088|6212179|P4|NOT COMPLETED|Time Period 2: Dose Level 2||0
2534202|NCT00634088|6212180|P3|NOT COMPLETED|Time Period 2: Dose Level 2||0
2534203|NCT00634088|6212181|P2|NOT COMPLETED|Time Period 2: Dose Level 2||3
2534204|NCT00634088|6212182|P1|NOT COMPLETED|Time Period 2: Dose Level 2||0
2534205|NCT00634088|6212179|P4|COMPLETED|Time Period 2: Dose Level 2||0
2534206|NCT00634088|6212180|P3|COMPLETED|Time Period 2: Dose Level 2||0
2534207|NCT00634088|6212181|P2|COMPLETED|Time Period 2: Dose Level 2||0
2534208|NCT00634088|6212182|P1|COMPLETED|Time Period 2: Dose Level 2||0
2534209|NCT00634088|6212179|P4|STARTED|Time Period 2: Dose Level 2||0
2534210|NCT00634088|6212180|P3|STARTED|Time Period 2: Dose Level 2||0
2534211|NCT00634088|6212181|P2|STARTED|Time Period 2: Dose Level 2||3
2534212|NCT00634088|6212182|P1|STARTED|Time Period 2: Dose Level 2||0
2534213|NCT00634088|6212179|P4|NOT COMPLETED|Time Period 1: Dose Level 1||0
2534214|NCT00634088|6212180|P3|NOT COMPLETED|Time Period 1: Dose Level 1||0
2534215|NCT00634088|6212181|P2|NOT COMPLETED|Time Period 1: Dose Level 1||0
2534216|NCT00634088|6212182|P1|NOT COMPLETED|Time Period 1: Dose Level 1||6
2534217|NCT00634088|6212179|P4|COMPLETED|Time Period 1: Dose Level 1||0
2534218|NCT00634088|6212180|P3|COMPLETED|Time Period 1: Dose Level 1||0
2534219|NCT00634088|6212181|P2|COMPLETED|Time Period 1: Dose Level 1||0
2534220|NCT00634088|6212182|P1|COMPLETED|Time Period 1: Dose Level 1||0
2534221|NCT00634088|6212179|P4|STARTED|Time Period 1: Dose Level 1||0
2534222|NCT00634088|6212180|P3|STARTED|Time Period 1: Dose Level 1||0
2534223|NCT00634088|6212181|P2|STARTED|Time Period 1: Dose Level 1||0
2534224|NCT00634088|6212182|P1|STARTED|Time Period 1: Dose Level 1||6
2534225|NCT00634049|6212233|P1|NOT COMPLETED|Overall Study||3
2534226|NCT00634049|6212233|P1|COMPLETED|Overall Study||146
2534227|NCT00634049|6212233|P1|STARTED|Overall Study||149
2534228|NCT00634036|6212312|P2|NOT COMPLETED|Overall Study||2
2534229|NCT00634036|6212313|P1|NOT COMPLETED|Overall Study||2
2534230|NCT00634036|6212312|P2|COMPLETED|Overall Study||9
2534231|NCT00634036|6212313|P1|COMPLETED|Overall Study||10
2534232|NCT00634036|6212312|P2|STARTED|Overall Study||11
2534233|NCT00634036|6212313|P1|STARTED|Overall Study||12
2534234|NCT00634010|6212327|P2|NOT COMPLETED|Overall Study||14
2534235|NCT00634010|6212328|P1|NOT COMPLETED|Overall Study||10
2534236|NCT00634010|6212327|P2|COMPLETED|Overall Study||4
2534237|NCT00634010|6212328|P1|COMPLETED|Overall Study||8
2534238|NCT00634010|6212327|P2|STARTED|Overall Study||18
2534239|NCT00634010|6212328|P1|STARTED|Overall Study||18
2534240|NCT00633984|6212336|P2|NOT COMPLETED|Overall Study||13
2534241|NCT00633984|6212337|P1|NOT COMPLETED|Overall Study||9
2534242|NCT00633984|6212336|P2|COMPLETED|Overall Study||69
2534243|NCT00633984|6212337|P1|COMPLETED|Overall Study||78
2534244|NCT00633984|6212336|P2|STARTED|Overall Study||82
2534245|NCT00633984|6212337|P1|STARTED|Overall Study||87
2534246|NCT00633945|6212345|P1|NOT COMPLETED|Overall Study||2
2534247|NCT00633945|6212345|P1|COMPLETED|Overall Study||3
2534248|NCT00633945|6212345|P1|STARTED|Overall Study||5
2534249|NCT00633932|6212361|P3|NOT COMPLETED|Overall Study||11
2534250|NCT00633932|6212362|P2|NOT COMPLETED|Overall Study||14
2534251|NCT00633932|6212363|P1|NOT COMPLETED|Overall Study||12
2534252|NCT00633932|6212361|P3|COMPLETED|Overall Study||180
2534253|NCT00633932|6212362|P2|COMPLETED|Overall Study||176
2534254|NCT00633932|6212363|P1|COMPLETED|Overall Study||179
2534255|NCT00633932|6212361|P3|STARTED|Overall Study|Randomised|191
2534256|NCT00633932|6212362|P2|STARTED|Overall Study|Randomised|190
2534257|NCT00633932|6212363|P1|STARTED|Overall Study|Randomised|191
2534258|NCT00633919|6212376|P2|NOT COMPLETED|Overall Study||22
2534259|NCT00633919|6212377|P1|NOT COMPLETED|Overall Study||27
2534260|NCT00633919|6212376|P2|COMPLETED|Overall Study||39
2534261|NCT00633919|6212377|P1|COMPLETED|Overall Study||36
2534262|NCT00633919|6212376|P2|STARTED|Overall Study||61
2534263|NCT00633919|6212377|P1|STARTED|Overall Study||63
2534264|NCT00633893|6212394|P3|NOT COMPLETED|Overall Study||188
2534265|NCT00633893|6212395|P2|NOT COMPLETED|Overall Study||129
2534266|NCT00633893|6212396|P1|NOT COMPLETED|Overall Study||114
2534267|NCT00633893|6212394|P3|COMPLETED|Overall Study||641
2534268|NCT00633893|6212395|P2|COMPLETED|Overall Study||684
2534269|NCT00633893|6212396|P1|COMPLETED|Overall Study||726
2534270|NCT00633893|6212394|P3|STARTED|Overall Study|3 participants were randomized to placebo but not treated.|829
2534271|NCT00633893|6212395|P2|STARTED|Overall Study|2 participants were randomized to 5 mg study drug but not treated.|813
2534272|NCT00633893|6212396|P1|STARTED|Overall Study||840
2534273|NCT00633880|6212470|P3|NOT COMPLETED|Randomized Double Blind||0
2534274|NCT00633880|6212471|P2|NOT COMPLETED|Randomized Double Blind||0
2534275|NCT00633880|6212472|P1|NOT COMPLETED|Randomized Double Blind||0
2534276|NCT00633880|6212470|P3|COMPLETED|Randomized Double Blind||51
2534277|NCT00633880|6212471|P2|COMPLETED|Randomized Double Blind||50
2534278|NCT00633880|6212472|P1|COMPLETED|Randomized Double Blind||0
2534279|NCT00633880|6212470|P3|STARTED|Randomized Double Blind||51
2534280|NCT00633880|6212471|P2|STARTED|Randomized Double Blind||50
2534281|NCT00633880|6212472|P1|STARTED|Randomized Double Blind||0
2534282|NCT00633880|6212470|P3|NOT COMPLETED|Open Label Titration||0
2534283|NCT00633880|6212471|P2|NOT COMPLETED|Open Label Titration||0
2534284|NCT00633880|6212472|P1|NOT COMPLETED|Open Label Titration||80
2534285|NCT00633880|6212470|P3|COMPLETED|Open Label Titration||0
2534286|NCT00633880|6212471|P2|COMPLETED|Open Label Titration||0
2534287|NCT00633880|6212472|P1|COMPLETED|Open Label Titration||101
2534288|NCT00633880|6212470|P3|STARTED|Open Label Titration||0
2534289|NCT00633880|6212471|P2|STARTED|Open Label Titration||0
2534290|NCT00633880|6212472|P1|STARTED|Open Label Titration||181
2534291|NCT00633867|6212501|P2|NOT COMPLETED|Overall Study||0
2534292|NCT00633867|6212502|P1|NOT COMPLETED|Overall Study||0
2534293|NCT00633867|6212501|P2|COMPLETED|Overall Study||60
2534294|NCT00633867|6212502|P1|COMPLETED|Overall Study||60
2534295|NCT00633867|6212501|P2|STARTED|Overall Study||60
2534296|NCT00633867|6212502|P1|STARTED|Overall Study||60
2534297|NCT00633750|6212508|P1|NOT COMPLETED|Overall Study||5
2534298|NCT00633750|6212508|P1|COMPLETED|Overall Study||42
2534299|NCT00633750|6212508|P1|STARTED|Overall Study||47
2534300|NCT00633594|6212517|P3|NOT COMPLETED|Overall Study||10
2534301|NCT00633594|6212518|P2|NOT COMPLETED|Overall Study||5
2534302|NCT00633594|6212519|P1|NOT COMPLETED|Overall Study||0
2534303|NCT00633594|6212517|P3|COMPLETED|Overall Study||16
2534304|NCT00633594|6212518|P2|COMPLETED|Overall Study||3
2534305|NCT00633594|6212519|P1|COMPLETED|Overall Study||5
2534306|NCT00633594|6212517|P3|STARTED|Overall Study||26
2534307|NCT00633594|6212518|P2|STARTED|Overall Study||8
2534308|NCT00633594|6212519|P1|STARTED|Overall Study||5
2534309|NCT00633477|6212548|P2|NOT COMPLETED|Overall Study||0
2534310|NCT00633477|6212549|P1|NOT COMPLETED|Overall Study||2
2534311|NCT00633477|6212548|P2|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|11
2534312|NCT00633477|6212549|P1|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|5
2534313|NCT00633477|6212548|P2|Completed Study Through Day 28|Overall Study||8
2534314|NCT00633477|6212549|P1|Completed Study Through Day 28|Overall Study||4
2534315|NCT00633477|6212548|P2|Prematurely Discontinued Study Drug|Overall Study||0
2534316|NCT00633477|6212549|P1|Prematurely Discontinued Study Drug|Overall Study||1
2534317|NCT00633477|6212548|P2|Randomized But Not Treated|Overall Study||0
2534318|NCT00633477|6212549|P1|Randomized But Not Treated|Overall Study||1
2534319|NCT00633477|6212548|P2|STARTED|Overall Study||11
2534320|NCT00633477|6212549|P1|STARTED|Overall Study|Seven subjects were randomized, however, one was not treated.|7
2534321|NCT00633464|6212565|P2|NOT COMPLETED|Overall Study||2
2534322|NCT00633464|6212566|P1|NOT COMPLETED|Overall Study||0
2534323|NCT00633464|6212565|P2|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-25,study drug toxicity-4,subject request-3|37
2534417|NCT00633009|6212774|P1|STARTED|Overall Study||12
2534324|NCT00633464|6212566|P1|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-27,study drug toxicity-7,max clinical benefit-3|40
2534325|NCT00633464|6212565|P2|Treated|Overall Study||37
2534326|NCT00633464|6212566|P1|Treated|Overall Study||40
2534327|NCT00633464|6212565|P2|STARTED|Overall Study||39
2534328|NCT00633464|6212566|P1|STARTED|Overall Study||40
2534329|NCT00633399|6212588|P2|NOT COMPLETED|Overall Study||15
2534330|NCT00633399|6212589|P1|NOT COMPLETED|Overall Study||22
2534331|NCT00633399|6212588|P2|COMPLETED|Overall Study||53
2534332|NCT00633399|6212589|P1|COMPLETED|Overall Study||49
2534333|NCT00633399|6212588|P2|STARTED|Overall Study||68
2534334|NCT00633399|6212589|P1|STARTED|Overall Study||71
2534335|NCT00633360|6212601|P2|NOT COMPLETED|Overall Study||3
2534336|NCT00633360|6212602|P1|NOT COMPLETED|Overall Study||4
2534337|NCT00633360|6212601|P2|COMPLETED|Overall Study||13
2534338|NCT00633360|6212602|P1|COMPLETED|Overall Study||12
2534339|NCT00633360|6212601|P2|STARTED|Overall Study||16
2534340|NCT00633360|6212602|P1|STARTED|Overall Study||16
2534341|NCT00633256|6212612|P2|NOT COMPLETED|Overall Study||3
2534342|NCT00633256|6212613|P1|NOT COMPLETED|Overall Study||4
2534343|NCT00633256|6212612|P2|COMPLETED|Overall Study||10
2534344|NCT00633256|6212613|P1|COMPLETED|Overall Study||8
2534345|NCT00633256|6212612|P2|STARTED|Overall Study||13
2534346|NCT00633256|6212613|P1|STARTED|Overall Study||12
2534347|NCT00633243|6212625|P2|NOT COMPLETED|Overall Study||7
2534348|NCT00633243|6212626|P1|NOT COMPLETED|Overall Study||1
2534349|NCT00633243|6212625|P2|COMPLETED|Overall Study||2
2534350|NCT00633243|6212626|P1|COMPLETED|Overall Study||11
2534351|NCT00633243|6212625|P2|STARTED|Overall Study||9
2534352|NCT00633243|6212626|P1|STARTED|Overall Study||12
2534353|NCT00633217|6212634|P2|NOT COMPLETED|Overall Study||23
2534354|NCT00633217|6212635|P1|NOT COMPLETED|Overall Study||15
2534355|NCT00633217|6212634|P2|COMPLETED|Overall Study||103
2534356|NCT00633217|6212635|P1|COMPLETED|Overall Study||106
2534357|NCT00633217|6212634|P2|STARTED|Overall Study||126
2534358|NCT00633217|6212635|P1|STARTED|Overall Study||121
2534359|NCT00633152|6212647|P2|NOT COMPLETED|Overall Study||6
2534360|NCT00633152|6212648|P1|NOT COMPLETED|Overall Study||14
2534361|NCT00633152|6212647|P2|COMPLETED|Overall Study||41
2534362|NCT00633152|6212648|P1|COMPLETED|Overall Study||89
2534363|NCT00633152|6212647|P2|Clinically Evaluable Population|Overall Study||39
2534364|NCT00633152|6212648|P1|Clinically Evaluable Population|Overall Study||86
2534365|NCT00633152|6212647|P2|MITT and Safety Population|Overall Study||45
2534366|NCT00633152|6212648|P1|MITT and Safety Population|Overall Study||98
2534367|NCT00633152|6212647|P2|STARTED|Overall Study||47
2534368|NCT00633152|6212648|P1|STARTED|Overall Study||103
2534369|NCT00633139|6212659|P3|NOT COMPLETED|Overall Study||1
2534370|NCT00633139|6212660|P2|NOT COMPLETED|Overall Study||1
2534371|NCT00633139|6212661|P1|NOT COMPLETED|Overall Study||0
2534372|NCT00633139|6212659|P3|COMPLETED|Overall Study||3
2534373|NCT00633139|6212660|P2|COMPLETED|Overall Study||4
2534374|NCT00633139|6212661|P1|COMPLETED|Overall Study||4
2534375|NCT00633139|6212659|P3|STARTED|Overall Study||4
2534376|NCT00633139|6212660|P2|STARTED|Overall Study||5
2534377|NCT00633139|6212661|P1|STARTED|Overall Study||4
2534378|NCT00633126|6212675|P1|NOT COMPLETED|Overall Study||1
2534379|NCT00633126|6212675|P1|COMPLETED|Overall Study||8
2534380|NCT00633126|6212675|P1|STARTED|Overall Study||9
2534381|NCT00633087|6212680|P1|NOT COMPLETED|Overall Study||0
2534382|NCT00633087|6212680|P1|COMPLETED|Overall Study||12
2534383|NCT00633087|6212680|P1|STARTED|Overall Study||12
2534384|NCT00633074|6212689|P2|NOT COMPLETED|Overall Study||0
2534385|NCT00633074|6212690|P1|NOT COMPLETED|Overall Study||1
2534386|NCT00633074|6212689|P2|COMPLETED|Overall Study||360
2534387|NCT00633074|6212690|P1|COMPLETED|Overall Study||359
2534388|NCT00633074|6212689|P2|STARTED|Overall Study||360
2534389|NCT00633074|6212690|P1|STARTED|Overall Study||360
2534390|NCT00633061|6212720|P2|NOT COMPLETED|Overall Study||0
2534391|NCT00633061|6212721|P1|NOT COMPLETED|Overall Study||86
2534392|NCT00633061|6212720|P2|COMPLETED|Overall Study||0
2534393|NCT00633061|6212721|P1|COMPLETED|Overall Study||50
2534394|NCT00633061|6212720|P2|Had Prior Thrombosis Identified|Overall Study||0
2534395|NCT00633061|6212721|P1|Had Prior Thrombosis Identified|Overall Study||25
2534396|NCT00633061|6212720|P2|Met Criteria for Imaging|Overall Study||0
2534397|NCT00633061|6212721|P1|Met Criteria for Imaging|Overall Study||25
2534398|NCT00633061|6212720|P2|STARTED|Overall Study||0
2534399|NCT00633061|6212721|P1|STARTED|Overall Study|Study was on hold for 2 months for continuing review|136
2534400|NCT00633022|6212732|P3|NOT COMPLETED|Overall Study||5
2534401|NCT00633022|6212733|P2|NOT COMPLETED|Overall Study||1
2534402|NCT00633022|6212734|P1|NOT COMPLETED|Overall Study||1
2534403|NCT00633022|6212732|P3|COMPLETED|Overall Study||27
2534404|NCT00633022|6212733|P2|COMPLETED|Overall Study||32
2534405|NCT00633022|6212734|P1|COMPLETED|Overall Study||33
2534406|NCT00633022|6212732|P3|STARTED|Overall Study||32
2534407|NCT00633022|6212733|P2|STARTED|Overall Study||33
2534408|NCT00633022|6212734|P1|STARTED|Overall Study||34
2534409|NCT00633009|6212772|P3|NOT COMPLETED|Overall Study||1
2534410|NCT00633009|6212773|P2|NOT COMPLETED|Overall Study||4
2534411|NCT00633009|6212774|P1|NOT COMPLETED|Overall Study||4
2534412|NCT00633009|6212772|P3|COMPLETED|Overall Study||10
2534413|NCT00633009|6212773|P2|COMPLETED|Overall Study||23
2534414|NCT00633009|6212774|P1|COMPLETED|Overall Study||8
2534415|NCT00633009|6212772|P3|STARTED|Overall Study||11
2534416|NCT00633009|6212773|P2|STARTED|Overall Study||27
2534418|NCT00632970|6212787|P2|NOT COMPLETED|Overall Study||0
2534419|NCT00632970|6212788|P1|NOT COMPLETED|Overall Study||0
2534420|NCT00632970|6212787|P2|COMPLETED|Overall Study||3
2534421|NCT00632970|6212788|P1|COMPLETED|Overall Study||3
2534422|NCT00632970|6212787|P2|STARTED|Overall Study||3
2534423|NCT00632970|6212788|P1|STARTED|Overall Study||3
2534424|NCT00632931|6212796|P3|NOT COMPLETED|Part 2||24
2534425|NCT00632931|6212797|P2|NOT COMPLETED|Part 2||0
2534426|NCT00632931|6212798|P1|NOT COMPLETED|Part 2||0
2534427|NCT00632931|6212796|P3|COMPLETED|Part 2||0
2534428|NCT00632931|6212797|P2|COMPLETED|Part 2||0
2534429|NCT00632931|6212798|P1|COMPLETED|Part 2||0
2534430|NCT00632931|6212796|P3|STARTED|Part 2||24
2534431|NCT00632931|6212797|P2|STARTED|Part 2||0
2534432|NCT00632931|6212798|P1|STARTED|Part 2||0
2534433|NCT00632931|6212796|P3|NOT COMPLETED|Post-Part 1 Washout||0
2534434|NCT00632931|6212797|P2|NOT COMPLETED|Post-Part 1 Washout||0
2534435|NCT00632931|6212798|P1|NOT COMPLETED|Post-Part 1 Washout||0
2534436|NCT00632931|6212796|P3|COMPLETED|Post-Part 1 Washout||0
2534437|NCT00632931|6212797|P2|COMPLETED|Post-Part 1 Washout||12
2534438|NCT00632931|6212798|P1|COMPLETED|Post-Part 1 Washout||12
2534439|NCT00632931|6212796|P3|STARTED|Post-Part 1 Washout||0
2534440|NCT00632931|6212797|P2|STARTED|Post-Part 1 Washout||12
2534441|NCT00632931|6212798|P1|STARTED|Post-Part 1 Washout|1 patient who did not complete Period 1 was subsequently enrolled into Post Part 1|12
2534442|NCT00632931|6212796|P3|NOT COMPLETED|Part 1, Period 2||0
2534443|NCT00632931|6212797|P2|NOT COMPLETED|Part 1, Period 2||0
2534444|NCT00632931|6212798|P1|NOT COMPLETED|Part 1, Period 2||0
2534445|NCT00632931|6212796|P3|COMPLETED|Part 1, Period 2||0
2534446|NCT00632931|6212797|P2|COMPLETED|Part 1, Period 2||12
2534447|NCT00632931|6212798|P1|COMPLETED|Part 1, Period 2||11
2534448|NCT00632931|6212796|P3|STARTED|Part 1, Period 2||0
2534449|NCT00632931|6212797|P2|STARTED|Part 1, Period 2||12
2534450|NCT00632931|6212798|P1|STARTED|Part 1, Period 2||11
2534451|NCT00632931|6212796|P3|NOT COMPLETED|Part 1, Washout||0
2534452|NCT00632931|6212797|P2|NOT COMPLETED|Part 1, Washout||0
2534453|NCT00632931|6212798|P1|NOT COMPLETED|Part 1, Washout||0
2534454|NCT00632931|6212796|P3|COMPLETED|Part 1, Washout||0
2534455|NCT00632931|6212797|P2|COMPLETED|Part 1, Washout||12
2534456|NCT00632931|6212798|P1|COMPLETED|Part 1, Washout||11
2534457|NCT00632931|6212796|P3|STARTED|Part 1, Washout||0
2534458|NCT00632931|6212797|P2|STARTED|Part 1, Washout||12
2534459|NCT00632931|6212798|P1|STARTED|Part 1, Washout||11
2534460|NCT00632931|6212796|P3|NOT COMPLETED|Part 1, Period 1||0
2534461|NCT00632931|6212797|P2|NOT COMPLETED|Part 1, Period 1||0
2534462|NCT00632931|6212798|P1|NOT COMPLETED|Part 1, Period 1||2
2534463|NCT00632931|6212796|P3|COMPLETED|Part 1, Period 1||0
2534464|NCT00632931|6212797|P2|COMPLETED|Part 1, Period 1||12
2534465|NCT00632931|6212798|P1|COMPLETED|Part 1, Period 1||11
2534466|NCT00632931|6212796|P3|STARTED|Part 1, Period 1||0
2534467|NCT00632931|6212797|P2|STARTED|Part 1, Period 1||12
2534468|NCT00632931|6212798|P1|STARTED|Part 1, Period 1||13
2534469|NCT00632814|6212820|P3|NOT COMPLETED|Overall Study||0
2534470|NCT00632814|6212821|P2|NOT COMPLETED|Overall Study||0
2534471|NCT00632814|6212822|P1|NOT COMPLETED|Overall Study||0
2534472|NCT00632814|6212820|P3|COMPLETED|Overall Study||8
2534473|NCT00632814|6212821|P2|COMPLETED|Overall Study||13
2534474|NCT00632814|6212822|P1|COMPLETED|Overall Study||11
2534475|NCT00632814|6212820|P3|STARTED|Overall Study||8
2534476|NCT00632814|6212821|P2|STARTED|Overall Study||13
2534477|NCT00632814|6212822|P1|STARTED|Overall Study||11
2534478|NCT00632749|6212868|P14|NOT COMPLETED|Overall Study||6
2534479|NCT00632749|6212869|P13|NOT COMPLETED|Overall Study||3
2534480|NCT00632749|6212870|P12|NOT COMPLETED|Overall Study||4
2534481|NCT00632749|6212871|P11|NOT COMPLETED|Overall Study||7
2534482|NCT00632749|6212872|P10|NOT COMPLETED|Overall Study||3
2534483|NCT00632749|6212873|P9|NOT COMPLETED|Overall Study||5
2534484|NCT00632749|6212874|P8|NOT COMPLETED|Overall Study||4
2534485|NCT00632749|6212875|P7|NOT COMPLETED|Overall Study||5
2534486|NCT00632749|6212876|P6|NOT COMPLETED|Overall Study||8
2534487|NCT00632749|6212877|P5|NOT COMPLETED|Overall Study||7
2534488|NCT00632749|6212878|P4|NOT COMPLETED|Overall Study||4
2534489|NCT00632749|6212879|P3|NOT COMPLETED|Overall Study||3
2534490|NCT00632749|6212880|P2|NOT COMPLETED|Overall Study||5
2534491|NCT00632749|6212881|P1|NOT COMPLETED|Overall Study||4
2534492|NCT00632749|6212868|P14|COMPLETED|Overall Study||0
2534493|NCT00632749|6212869|P13|COMPLETED|Overall Study||0
2534494|NCT00632749|6212870|P12|COMPLETED|Overall Study||0
2534495|NCT00632749|6212871|P11|COMPLETED|Overall Study||0
2534496|NCT00632749|6212872|P10|COMPLETED|Overall Study||0
2534497|NCT00632749|6212873|P9|COMPLETED|Overall Study||0
2534498|NCT00632749|6212874|P8|COMPLETED|Overall Study||0
2534499|NCT00632749|6212875|P7|COMPLETED|Overall Study||0
2534500|NCT00632749|6212876|P6|COMPLETED|Overall Study||0
2534501|NCT00632749|6212877|P5|COMPLETED|Overall Study||0
2534502|NCT00632749|6212878|P4|COMPLETED|Overall Study||0
2534503|NCT00632749|6212879|P3|COMPLETED|Overall Study||0
2534504|NCT00632749|6212880|P2|COMPLETED|Overall Study||0
2534505|NCT00632749|6212881|P1|COMPLETED|Overall Study||0
2534506|NCT00632749|6212868|P14|Not Treated|Overall Study||0
2534507|NCT00632749|6212869|P13|Not Treated|Overall Study||0
2534508|NCT00632749|6212870|P12|Not Treated|Overall Study||0
2534509|NCT00632749|6212871|P11|Not Treated|Overall Study||0
2534510|NCT00632749|6212872|P10|Not Treated|Overall Study||0
2534511|NCT00632749|6212873|P9|Not Treated|Overall Study||0
2534512|NCT00632749|6212874|P8|Not Treated|Overall Study||0
2534513|NCT00632749|6212875|P7|Not Treated|Overall Study||1
2534514|NCT00632749|6212876|P6|Not Treated|Overall Study||1
2534515|NCT00632749|6212877|P5|Not Treated|Overall Study||0
2534516|NCT00632749|6212878|P4|Not Treated|Overall Study||0
2534517|NCT00632749|6212879|P3|Not Treated|Overall Study||0
2534518|NCT00632749|6212880|P2|Not Treated|Overall Study||2
2534519|NCT00632749|6212881|P1|Not Treated|Overall Study||0
2534520|NCT00632749|6212868|P14|Treated|Overall Study||6
2534521|NCT00632749|6212869|P13|Treated|Overall Study||3
2534522|NCT00632749|6212870|P12|Treated|Overall Study||4
2534523|NCT00632749|6212871|P11|Treated|Overall Study||7
2534524|NCT00632749|6212872|P10|Treated|Overall Study||3
2534525|NCT00632749|6212873|P9|Treated|Overall Study||5
2534526|NCT00632749|6212874|P8|Treated|Overall Study||4
2534527|NCT00632749|6212875|P7|Treated|Overall Study||4
2534528|NCT00632749|6212876|P6|Treated|Overall Study||7
2534529|NCT00632749|6212877|P5|Treated|Overall Study||7
2534530|NCT00632749|6212878|P4|Treated|Overall Study||4
2534531|NCT00632749|6212879|P3|Treated|Overall Study||3
2534532|NCT00632749|6212880|P2|Treated|Overall Study||3
2534533|NCT00632749|6212881|P1|Treated|Overall Study||4
2534534|NCT00632749|6212868|P14|STARTED|Overall Study||6
2534535|NCT00632749|6212869|P13|STARTED|Overall Study||3
2534536|NCT00632749|6212870|P12|STARTED|Overall Study||4
2534537|NCT00632749|6212871|P11|STARTED|Overall Study||7
2534538|NCT00632749|6212872|P10|STARTED|Overall Study||3
2534539|NCT00632749|6212873|P9|STARTED|Overall Study||5
2534540|NCT00632749|6212874|P8|STARTED|Overall Study||4
2534541|NCT00632749|6212875|P7|STARTED|Overall Study||5
2534542|NCT00632749|6212876|P6|STARTED|Overall Study||8
2534543|NCT00632749|6212877|P5|STARTED|Overall Study||7
2534544|NCT00632749|6212878|P4|STARTED|Overall Study||4
2534545|NCT00632749|6212879|P3|STARTED|Overall Study||3
2534546|NCT00632749|6212880|P2|STARTED|Overall Study||5
2534547|NCT00632749|6212881|P1|STARTED|Overall Study||4
2534548|NCT00632736|6213175|P1|NOT COMPLETED|Overall Study||268
2534549|NCT00632736|6213175|P1|COMPLETED|Overall Study||151
2534550|NCT00632736|6213175|P1|STARTED|Overall Study||419
2534551|NCT00632632|6213182|P2|NOT COMPLETED|Overall Study||3
2534552|NCT00632632|6213183|P1|NOT COMPLETED|Overall Study||0
2534553|NCT00632632|6213182|P2|COMPLETED|Overall Study||9
2534554|NCT00632632|6213183|P1|COMPLETED|Overall Study||13
2534555|NCT00632632|6213182|P2|STARTED|Overall Study||12
2534556|NCT00632632|6213183|P1|STARTED|Overall Study||13
2534557|NCT00632619|6213195|P2|NOT COMPLETED|Overall Study||4
2534558|NCT00632619|6213196|P1|NOT COMPLETED|Overall Study||8
2534559|NCT00632619|6213195|P2|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10~nd cohort completed follow up 7/18/11"|31
2534560|NCT00632619|6213196|P1|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10~nd cohort completed follow up 7/18/11"|25
2534561|NCT00632619|6213195|P2|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|35
2534562|NCT00632619|6213196|P1|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|33
2534563|NCT00632541|6213210|P1|NOT COMPLETED|Overall Study||7
2534564|NCT00632541|6213210|P1|COMPLETED|Overall Study||11
2534565|NCT00632541|6213210|P1|STARTED|Overall Study|18 subjects were accrued to the study|18
2534566|NCT00632502|6213219|P2|NOT COMPLETED|Overall Study||1
2534567|NCT00632502|6213220|P1|NOT COMPLETED|Overall Study||3
2534568|NCT00632502|6213219|P2|COMPLETED|Overall Study||11
2534569|NCT00632502|6213220|P1|COMPLETED|Overall Study||22
2534570|NCT00632502|6213219|P2|Completed Treatment|Overall Study||9
2534571|NCT00632502|6213220|P1|Completed Treatment|Overall Study||19
2534572|NCT00632502|6213219|P2|Treated|Overall Study||12
2534573|NCT00632502|6213220|P1|Treated|Overall Study||22
2534574|NCT00632502|6213219|P2|STARTED|Overall Study||12
2534575|NCT00632502|6213220|P1|STARTED|Overall Study||25
2534576|NCT00632489|6213248|P3|NOT COMPLETED|Overall Study||0
2534577|NCT00632489|6213249|P2|NOT COMPLETED|Overall Study||5
2534578|NCT00632489|6213250|P1|NOT COMPLETED|Overall Study||15
2534579|NCT00632489|6213248|P3|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
2534580|NCT00632489|6213249|P2|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
2534581|NCT00632489|6213250|P1|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
2534582|NCT00632489|6213248|P3|STARTED|Overall Study||0
2534583|NCT00632489|6213249|P2|STARTED|Overall Study||5
2534584|NCT00632489|6213250|P1|STARTED|Overall Study||15
2534585|NCT00632463|6213264|P3|NOT COMPLETED|Overall Study||0
2534586|NCT00632463|6213265|P2|NOT COMPLETED|Overall Study||1
2534587|NCT00632463|6213266|P1|NOT COMPLETED|Overall Study||0
2534588|NCT00632463|6213264|P3|COMPLETED|Overall Study||7
2534589|NCT00632463|6213265|P2|COMPLETED|Overall Study||6
2534590|NCT00632463|6213266|P1|COMPLETED|Overall Study||7
2534591|NCT00632463|6213264|P3|STARTED|Overall Study||7
2534592|NCT00632463|6213265|P2|STARTED|Overall Study||7
2534593|NCT00632463|6213266|P1|STARTED|Overall Study||7
2534594|NCT00632424|6213283|P1|NOT COMPLETED|Overall Study||18
2534595|NCT00632424|6213283|P1|COMPLETED|Overall Study||0
2534596|NCT00632424|6213283|P1|STARTED|Overall Study||18
2534597|NCT00632411|6213307|P2|NOT COMPLETED|Overall Study||176
2534598|NCT00632411|6213308|P1|NOT COMPLETED|Overall Study||160
2534599|NCT00632411|6213307|P2|COMPLETED|Overall Study||473
2534600|NCT00632411|6213308|P1|COMPLETED|Overall Study||489
2534601|NCT00632411|6213307|P2|STARTED|Overall Study||649
2534602|NCT00632411|6213308|P1|STARTED|Overall Study||649
2534603|NCT00632359|6213314|P1|NOT COMPLETED|Overall Study||2
2534604|NCT00632359|6213314|P1|COMPLETED|Overall Study||31
2534605|NCT00632359|6213314|P1|STARTED|Overall Study||33
2534606|NCT00632281|6213320|P1|NOT COMPLETED|Overall Study||0
2534607|NCT00632281|6213320|P1|COMPLETED|Overall Study||38
2534608|NCT00632281|6213320|P1|STARTED|Overall Study||38
2534609|NCT00632229|6213327|P2|NOT COMPLETED|Overall Study||6
2534610|NCT00632229|6213328|P1|NOT COMPLETED|Overall Study||6
2534611|NCT00632229|6213327|P2|COMPLETED|Overall Study||11
2534612|NCT00632229|6213328|P1|COMPLETED|Overall Study||11
2534613|NCT00632229|6213327|P2|STARTED|Overall Study||17
2534614|NCT00632229|6213328|P1|STARTED|Overall Study||17
2534615|NCT00632203|6213338|P2|NOT COMPLETED|Overall Study||0
2534616|NCT00632203|6213339|P1|NOT COMPLETED|Overall Study||1
2534617|NCT00632203|6213338|P2|COMPLETED|Overall Study||27
2534618|NCT00632203|6213339|P1|COMPLETED|Overall Study||25
2534619|NCT00632203|6213338|P2|STARTED|Overall Study||27
2534620|NCT00632203|6213339|P1|STARTED|Overall Study||26
2534621|NCT00632125|6213357|P1|NOT COMPLETED|Overall Study||302
2534622|NCT00632125|6213357|P1|COMPLETED|Overall Study||1393
2534623|NCT00632125|6213357|P1|STARTED|Overall Study|1,698 patients were enrolled but 3 patients did not receive any study medication.|1695
2534624|NCT00632099|6213363|P2|NOT COMPLETED|Overall Study||3
2534625|NCT00632099|6213364|P1|NOT COMPLETED|Overall Study||3
2534626|NCT00632099|6213363|P2|COMPLETED|Overall Study||8
2534627|NCT00632099|6213364|P1|COMPLETED|Overall Study||7
2534628|NCT00632099|6213363|P2|STARTED|Overall Study||11
2534629|NCT00632099|6213364|P1|STARTED|Overall Study||10
2534630|NCT00632021|6213372|P2|NOT COMPLETED|Overall Study||7
2534631|NCT00632021|6213373|P1|NOT COMPLETED|Overall Study||4
2534632|NCT00632021|6213372|P2|COMPLETED|Overall Study||423
2534633|NCT00632021|6213373|P1|COMPLETED|Overall Study||428
2534634|NCT00632021|6213372|P2|STARTED|Overall Study||430
2534635|NCT00632021|6213373|P1|STARTED|Overall Study||432
2534636|NCT00631969|6213383|P2|NOT COMPLETED|Overall Study||21
2534637|NCT00631969|6213384|P1|NOT COMPLETED|Overall Study||15
2534638|NCT00631969|6213383|P2|COMPLETED|Overall Study||155
2534639|NCT00631969|6213384|P1|COMPLETED|Overall Study||171
2534640|NCT00631969|6213383|P2|Received Treatment|Overall Study|safety population|174
2534641|NCT00631969|6213384|P1|Received Treatment|Overall Study|safety population|184
2534642|NCT00631969|6213383|P2|STARTED|Overall Study||176
2534643|NCT00631969|6213384|P1|STARTED|Overall Study||186
2534644|NCT00631917|6213430|P2|NOT COMPLETED|Overall Study||108
2534645|NCT00631917|6213431|P1|NOT COMPLETED|Overall Study||88
2534646|NCT00631917|6213430|P2|COMPLETED|Overall Study||291
2534647|NCT00631917|6213431|P1|COMPLETED|Overall Study||287
2534648|NCT00631917|6213430|P2|STARTED|Overall Study||399
2534649|NCT00631917|6213431|P1|STARTED|Overall Study||375
2534650|NCT00631748|6213447|P2|NOT COMPLETED|Overall Study||22
2534651|NCT00631748|6213448|P1|NOT COMPLETED|Overall Study||18
2534652|NCT00631748|6213447|P2|COMPLETED|Overall Study|9 participants completed the double-blind portion of the study; 5 participants completed follow-up.|9
2534653|NCT00631748|6213448|P1|COMPLETED|Overall Study|11 participants completed the double-blind portion of the study; 8 participants completed follow-up.|11
2534654|NCT00631748|6213447|P2|STARTED|Overall Study||31
2534655|NCT00631748|6213448|P1|STARTED|Overall Study||29
2534656|NCT00631696|6213458|P2|NOT COMPLETED|Overall Study||40
2534657|NCT00631696|6213459|P1|NOT COMPLETED|Overall Study||37
2534658|NCT00631696|6213458|P2|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|70
2534659|NCT00631696|6213459|P1|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|75
2534660|NCT00631696|6213458|P2|Ongoing at Database Release 18Oct2011|Overall Study||0
2534661|NCT00631696|6213459|P1|Ongoing at Database Release 18Oct2011|Overall Study|Completed Tx at time of database release 18Oct2011; included in all analyses.|2
2534662|NCT00631696|6213458|P2|Received Study Treatment (Tx)|Overall Study||109
2534663|NCT00631696|6213459|P1|Received Study Treatment (Tx)|Overall Study||111
2534664|NCT00631696|6213458|P2|STARTED|Overall Study||110
2534665|NCT00631696|6213459|P1|STARTED|Overall Study||112
2534666|NCT00631670|6213485|P2|NOT COMPLETED|Overall Study||0
2534667|NCT00631670|6213486|P1|NOT COMPLETED|Overall Study||0
2534668|NCT00631670|6213485|P2|COMPLETED|Overall Study||0
2534669|NCT00631670|6213486|P1|COMPLETED|Overall Study||21
2534670|NCT00631670|6213485|P2|STARTED|Overall Study||0
2534671|NCT00631670|6213486|P1|STARTED|Overall Study||21
2534672|NCT00631657|6213502|P3|NOT COMPLETED|7-Day Discontinuation Period||1
2534673|NCT00631657|6213503|P2|NOT COMPLETED|7-Day Discontinuation Period||1
2534674|NCT00631657|6213504|P1|NOT COMPLETED|7-Day Discontinuation Period||2
2534675|NCT00631657|6213502|P3|COMPLETED|7-Day Discontinuation Period||65
2534676|NCT00631657|6213503|P2|COMPLETED|7-Day Discontinuation Period||136
2534677|NCT00631657|6213504|P1|COMPLETED|7-Day Discontinuation Period||65
2534678|NCT00631657|6213502|P3|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|65
2534679|NCT00631657|6213503|P2|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|136
2534680|NCT00631657|6213504|P1|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|66
2534681|NCT00631657|6213502|P3|STARTED|7-Day Discontinuation Period||66
2534682|NCT00631657|6213503|P2|STARTED|7-Day Discontinuation Period||137
2534683|NCT00631657|6213504|P1|STARTED|7-Day Discontinuation Period|One participant was radomized in the Discont. Period, without completing the Treatment Period.|67
2534684|NCT00631657|6213502|P3|NOT COMPLETED|6-Month Treatment Period||50
2534685|NCT00631657|6213503|P2|NOT COMPLETED|6-Month Treatment Period||0
2534686|NCT00631657|6213504|P1|NOT COMPLETED|6-Month Treatment Period||141
2534687|NCT00631657|6213502|P3|COMPLETED|6-Month Treatment Period||66
2534688|NCT00631657|6213503|P2|COMPLETED|6-Month Treatment Period||0
2534689|NCT00631657|6213504|P1|COMPLETED|6-Month Treatment Period||203
2534690|NCT00631657|6213502|P3|Treated|6-Month Treatment Period|One randomized participant was not treated during the 6-month Treatment Period.|115
2534691|NCT00631657|6213503|P2|Treated|6-Month Treatment Period||0
2534692|NCT00631657|6213504|P1|Treated|6-Month Treatment Period|Two randomized participants were not treated during the 6-month Treatment Period.|342
2534693|NCT00631657|6213502|P3|STARTED|6-Month Treatment Period||116
2534694|NCT00631657|6213503|P2|STARTED|6-Month Treatment Period||0
2534695|NCT00631657|6213504|P1|STARTED|6-Month Treatment Period||344
2534696|NCT00631566|6213534|P3|NOT COMPLETED|Overall Study||0
2534697|NCT00631566|6213535|P2|NOT COMPLETED|Overall Study||4
2534698|NCT00631566|6213536|P1|NOT COMPLETED|Overall Study||2
2534699|NCT00631566|6213534|P3|COMPLETED|Overall Study||501
2534700|NCT00631566|6213535|P2|COMPLETED|Overall Study||24
2534701|NCT00631566|6213536|P1|COMPLETED|Overall Study||19
2534702|NCT00631566|6213534|P3|STARTED|Overall Study||501
2534703|NCT00631566|6213535|P2|STARTED|Overall Study||28
2534704|NCT00631566|6213536|P1|STARTED|Overall Study||21
2534705|NCT00631540|6213553|P1|NOT COMPLETED|Overall Study||14
2534706|NCT00631540|6213553|P1|COMPLETED|Overall Study||86
2534707|NCT00631540|6213553|P1|STARTED|Overall Study||100
2534708|NCT00631488|6213565|P3|NOT COMPLETED|Overall Study||2
2534709|NCT00631488|6213566|P2|NOT COMPLETED|Overall Study||2
2534710|NCT00631488|6213567|P1|NOT COMPLETED|Overall Study||4
2534711|NCT00631488|6213565|P3|COMPLETED|Overall Study||47
2534712|NCT00631488|6213566|P2|COMPLETED|Overall Study||47
2534713|NCT00631488|6213567|P1|COMPLETED|Overall Study||44
2534714|NCT00631488|6213565|P3|Completed Post-Treatment Period|Overall Study||47
2534715|NCT00631488|6213566|P2|Completed Post-Treatment Period|Overall Study||47
2534716|NCT00631488|6213567|P1|Completed Post-Treatment Period|Overall Study||44
2534717|NCT00631488|6213565|P3|STARTED|Overall Study||49
2534718|NCT00631488|6213566|P2|STARTED|Overall Study||49
2534719|NCT00631488|6213567|P1|STARTED|Overall Study||48
2534720|NCT00631475|6213587|P1|NOT COMPLETED|Overall Study||45
2534721|NCT00631475|6213587|P1|COMPLETED|Overall Study||83
2534722|NCT00631475|6213587|P1|STARTED|Overall Study||128
2534723|NCT00631449|6213597|P2|NOT COMPLETED|Overall Study||0
2534724|NCT00631449|6213598|P1|NOT COMPLETED|Overall Study||0
2534725|NCT00631449|6213597|P2|COMPLETED|Overall Study||15
2534726|NCT00631449|6213598|P1|COMPLETED|Overall Study||15
2534727|NCT00631449|6213597|P2|STARTED|Overall Study||15
2534728|NCT00631449|6213598|P1|STARTED|Overall Study||15
2534729|NCT00631410|6213606|P2|NOT COMPLETED|Overall Study||6
2534730|NCT00631410|6213607|P1|NOT COMPLETED|Overall Study||6
2534731|NCT00631410|6213606|P2|COMPLETED|Overall Study||0
2534732|NCT00631410|6213607|P1|COMPLETED|Overall Study||0
2534733|NCT00631410|6213606|P2|STARTED|Overall Study||6
2534734|NCT00631410|6213607|P1|STARTED|Overall Study||6
2534735|NCT00631371|6213626|P2|NOT COMPLETED|Overall Study||391
2534736|NCT00631371|6213627|P1|NOT COMPLETED|Overall Study||400
2534737|NCT00631371|6213626|P2|COMPLETED|Overall Study||0
2534738|NCT00631371|6213627|P1|COMPLETED|Overall Study||0
2534739|NCT00631371|6213626|P2|Treated|Overall Study||391
2534740|NCT00631371|6213627|P1|Treated|Overall Study||393
2534741|NCT00631371|6213626|P2|STARTED|Overall Study||391
2534742|NCT00631371|6213627|P1|STARTED|Overall Study||400
2534743|NCT00631358|6213641|P2|NOT COMPLETED|Overall Study||2
2534744|NCT00631358|6213642|P1|NOT COMPLETED|Overall Study||6
2534745|NCT00631358|6213641|P2|COMPLETED|Overall Study||45
2534746|NCT00631358|6213642|P1|COMPLETED|Overall Study||44
2534747|NCT00631358|6213641|P2|STARTED|Overall Study||47
2534748|NCT00631358|6213642|P1|STARTED|Overall Study||50
2534749|NCT00631189|6213660|P4|NOT COMPLETED|Treatment Phase||7
2534750|NCT00631189|6213661|P3|NOT COMPLETED|Treatment Phase||11
2534751|NCT00631189|6213662|P2|NOT COMPLETED|Treatment Phase||7
2534752|NCT00631189|6213663|P1|NOT COMPLETED|Treatment Phase||0
2534753|NCT00631189|6213660|P4|COMPLETED|Treatment Phase||103
2534754|NCT00631189|6213661|P3|COMPLETED|Treatment Phase||92
2534755|NCT00631189|6213662|P2|COMPLETED|Treatment Phase||97
2534756|NCT00631189|6213663|P1|COMPLETED|Treatment Phase||0
2534757|NCT00631189|6213660|P4|STARTED|Treatment Phase||110
2534758|NCT00631189|6213661|P3|STARTED|Treatment Phase||103
2534759|NCT00631189|6213662|P2|STARTED|Treatment Phase||104
2534760|NCT00631189|6213663|P1|STARTED|Treatment Phase||0
2534761|NCT00631189|6213660|P4|NOT COMPLETED|Initial Phase||0
2534762|NCT00631189|6213661|P3|NOT COMPLETED|Initial Phase||0
2534763|NCT00631189|6213662|P2|NOT COMPLETED|Initial Phase||0
2534764|NCT00631189|6213663|P1|NOT COMPLETED|Initial Phase||351
2534765|NCT00631189|6213660|P4|COMPLETED|Initial Phase||0
2534766|NCT00631189|6213661|P3|COMPLETED|Initial Phase||0
2534767|NCT00631189|6213662|P2|COMPLETED|Initial Phase||0
2534768|NCT00631189|6213663|P1|COMPLETED|Initial Phase||317
2534769|NCT00631189|6213660|P4|STARTED|Initial Phase||0
2534770|NCT00631189|6213661|P3|STARTED|Initial Phase||0
2534771|NCT00631189|6213662|P2|STARTED|Initial Phase||0
2534772|NCT00631189|6213663|P1|STARTED|Initial Phase||668
2534773|NCT00631137|6213707|P2|NOT COMPLETED|Overall Study||0
2534774|NCT00631137|6213708|P1|NOT COMPLETED|Overall Study||1
2534775|NCT00631137|6213707|P2|COMPLETED|Overall Study||0
2534776|NCT00631137|6213708|P1|COMPLETED|Overall Study||0
2534777|NCT00631137|6213707|P2|STARTED|Overall Study||0
2534778|NCT00631137|6213708|P1|STARTED|Overall Study||1
2534779|NCT00631020|6213726|P1|NOT COMPLETED|Overall Study||8
2534780|NCT00631020|6213726|P1|COMPLETED|Overall Study||26
2534781|NCT00631020|6213726|P1|STARTED|Overall Study||34
2534782|NCT00631007|6213741|P6|NOT COMPLETED|Overall Study||15
2534783|NCT00631007|6213742|P5|NOT COMPLETED|Overall Study||12
2534784|NCT00631007|6213743|P4|NOT COMPLETED|Overall Study||9
2534785|NCT00631007|6213744|P3|NOT COMPLETED|Overall Study||10
2534786|NCT00631007|6213745|P2|NOT COMPLETED|Overall Study||11
2534787|NCT00631007|6213746|P1|NOT COMPLETED|Overall Study||11
2534788|NCT00631007|6213741|P6|COMPLETED|Overall Study||46
2534789|NCT00631007|6213742|P5|COMPLETED|Overall Study||48
2534790|NCT00631007|6213743|P4|COMPLETED|Overall Study||53
2534791|NCT00631007|6213744|P3|COMPLETED|Overall Study||53
2534792|NCT00631007|6213745|P2|COMPLETED|Overall Study||50
2534793|NCT00631007|6213746|P1|COMPLETED|Overall Study||49
2534794|NCT00631007|6213741|P6|STARTED|Overall Study||61
2534795|NCT00631007|6213742|P5|STARTED|Overall Study||60
2534796|NCT00631007|6213743|P4|STARTED|Overall Study||62
2534797|NCT00631007|6213744|P3|STARTED|Overall Study||63
2534798|NCT00631007|6213745|P2|STARTED|Overall Study||61
2534799|NCT00631007|6213746|P1|STARTED|Overall Study||60
2534800|NCT00630994|6213766|P1|NOT COMPLETED|Overall Study||4
2534801|NCT00630994|6213766|P1|COMPLETED|Overall Study||0
2534802|NCT00630994|6213766|P1|STARTED|Overall Study||4
2534803|NCT00630955|6213777|P3|NOT COMPLETED|Overall Study||12
2534804|NCT00630955|6213778|P2|NOT COMPLETED|Overall Study||6
2534805|NCT00630955|6213779|P1|NOT COMPLETED|Overall Study||3
2534806|NCT00630955|6213777|P3|COMPLETED|Overall Study||28
2534807|NCT00630955|6213778|P2|COMPLETED|Overall Study||31
2534808|NCT00630955|6213779|P1|COMPLETED|Overall Study||31
2534809|NCT00630955|6213777|P3|STARTED|Overall Study||40
2534810|NCT00630955|6213778|P2|STARTED|Overall Study||37
2534811|NCT00630955|6213779|P1|STARTED|Overall Study||34
2534812|NCT00630916|6213796|P1|NOT COMPLETED|Overall Study||210
2534813|NCT00630916|6213796|P1|COMPLETED|Overall Study|The number of patients that were active (i.e. not drop out) at the end of the study.|546
2534814|NCT00630916|6213796|P1|Study Cohort|Overall Study|Enrolled but did not receive device via physician decision, protocol violation, or lack of efficacy.|699
2534815|NCT00630916|6213796|P1|STARTED|Overall Study|Total patients enrolled (i.e. consented) to participate in the study.|756
2534816|NCT00630877|6213806|P3|NOT COMPLETED|Overall Study||10
2534817|NCT00630877|6213807|P2|NOT COMPLETED|Overall Study||15
2534818|NCT00630877|6213808|P1|NOT COMPLETED|Overall Study||19
2534819|NCT00630877|6213806|P3|COMPLETED|Overall Study||80
2534820|NCT00630877|6213807|P2|COMPLETED|Overall Study||75
2534821|NCT00630877|6213808|P1|COMPLETED|Overall Study||72
2534822|NCT00630877|6213806|P3|STARTED|Overall Study||90
2534823|NCT00630877|6213807|P2|STARTED|Overall Study||90
2534824|NCT00630877|6213808|P1|STARTED|Overall Study|For all arms, started means treated.|91
2534825|NCT00630864|6213826|P1|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||2
2534826|NCT00630864|6213826|P1|COMPLETED|Part 2 (After Week 6 up to Month 12)||18
2534827|NCT00630864|6213826|P1|STARTED|Part 2 (After Week 6 up to Month 12)||20
2534828|NCT00630864|6213826|P1|NOT COMPLETED|Part 1 (up to Week 6)||1
2534829|NCT00630864|6213826|P1|COMPLETED|Part 1 (up to Week 6)||20
2534830|NCT00630864|6213826|P1|STARTED|Part 1 (up to Week 6)||21
2534831|NCT00630838|6213865|P2|NOT COMPLETED|Overall Study||2
2534832|NCT00630838|6213866|P1|NOT COMPLETED|Overall Study||0
2534833|NCT00630838|6213865|P2|COMPLETED|Overall Study||28
2534834|NCT00630838|6213866|P1|COMPLETED|Overall Study||32
2534835|NCT00630838|6213865|P2|STARTED|Overall Study||30
2534836|NCT00630838|6213866|P1|STARTED|Overall Study||32
2534837|NCT00630825|6213878|P4|NOT COMPLETED|Overall Study||6
2534838|NCT00630825|6213879|P3|NOT COMPLETED|Overall Study||8
2534839|NCT00630825|6213880|P2|NOT COMPLETED|Overall Study||7
2534840|NCT00630825|6213881|P1|NOT COMPLETED|Overall Study||9
2534841|NCT00630825|6213878|P4|COMPLETED|Overall Study||60
2534842|NCT00630825|6213879|P3|COMPLETED|Overall Study||58
2534843|NCT00630825|6213880|P2|COMPLETED|Overall Study||58
2534844|NCT00630825|6213881|P1|COMPLETED|Overall Study||56
2534845|NCT00630825|6213878|P4|Received at Least One Dose of Study Drug|Overall Study||66
2534846|NCT00630825|6213879|P3|Received at Least One Dose of Study Drug|Overall Study||66
2534847|NCT00630825|6213880|P2|Received at Least One Dose of Study Drug|Overall Study||65
2534848|NCT00630825|6213881|P1|Received at Least One Dose of Study Drug|Overall Study||65
2534849|NCT00630825|6213878|P4|STARTED|Overall Study||66
2534850|NCT00630825|6213879|P3|STARTED|Overall Study||66
2534851|NCT00630825|6213880|P2|STARTED|Overall Study||65
2534852|NCT00630825|6213881|P1|STARTED|Overall Study||65
2534853|NCT00630786|6213953|P3|NOT COMPLETED|Overall Study||2
2534854|NCT00630786|6213954|P2|NOT COMPLETED|Overall Study||2
2534855|NCT00630786|6213955|P1|NOT COMPLETED|Overall Study||1
2534856|NCT00630786|6213953|P3|COMPLETED|Overall Study|Completed study defined as participant death|7
2534857|NCT00630786|6213954|P2|COMPLETED|Overall Study|Completed study defined as participant death|23
2534858|NCT00630786|6213955|P1|COMPLETED|Overall Study|Completed study defined as participant death|18
2534859|NCT00630786|6213953|P3|Received Study Medication|Overall Study||8
2534860|NCT00630786|6213954|P2|Received Study Medication|Overall Study||25
2534861|NCT00630786|6213955|P1|Received Study Medication|Overall Study||19
2534862|NCT00630786|6213953|P3|STARTED|Overall Study|All patients were enrolled in Part 2.|9
2534863|NCT00630786|6213954|P2|STARTED|Overall Study|Includes 3 patients enrolled in Part 1 and 22 patients enrolled in Part 2.|25
2534864|NCT00630786|6213955|P1|STARTED|Overall Study|Includes 2 patients enrolled in Part 1 and 17 patients enrolled in Part 2.|19
2534865|NCT00630747|6213974|P1|NOT COMPLETED|Overall Study||9
2534866|NCT00630747|6213974|P1|COMPLETED|Overall Study||85
2534867|NCT00630747|6213974|P1|Participants Treated in Phase I of Study|Overall Study||94
2534868|NCT00630747|6213974|P1|STARTED|Overall Study||94
2534869|NCT00630734|6213986|P3|NOT COMPLETED|Overall Study||1
2534870|NCT00630734|6213987|P2|NOT COMPLETED|Overall Study||1
2534871|NCT00630734|6213988|P1|NOT COMPLETED|Overall Study||2
2534872|NCT00630734|6213986|P3|COMPLETED|Overall Study||7
2534873|NCT00630734|6213987|P2|COMPLETED|Overall Study||12
2534874|NCT00630734|6213988|P1|COMPLETED|Overall Study||9
2534875|NCT00630734|6213986|P3|STARTED|Overall Study||8
2534876|NCT00630734|6213987|P2|STARTED|Overall Study||13
2534877|NCT00630734|6213988|P1|STARTED|Overall Study||11
2534878|NCT00630539|6214027|P4|NOT COMPLETED|Overall Study||3
2534879|NCT00630539|6214028|P3|NOT COMPLETED|Overall Study||1
2534880|NCT00630539|6214029|P2|NOT COMPLETED|Overall Study||4
2534881|NCT00630539|6214030|P1|NOT COMPLETED|Overall Study||1
2534882|NCT00630539|6214027|P4|COMPLETED|Overall Study||27
2534883|NCT00630539|6214028|P3|COMPLETED|Overall Study||28
2534884|NCT00630539|6214029|P2|COMPLETED|Overall Study||29
2534885|NCT00630539|6214030|P1|COMPLETED|Overall Study||33
2534886|NCT00630539|6214027|P4|STARTED|Overall Study||30
2534887|NCT00630539|6214028|P3|STARTED|Overall Study||29
2534888|NCT00630539|6214029|P2|STARTED|Overall Study||33
2534889|NCT00630539|6214030|P1|STARTED|Overall Study||34
2534890|NCT00630487|6214086|P2|NOT COMPLETED|Overall Study||0
2534891|NCT00630487|6214087|P1|NOT COMPLETED|Overall Study||0
2534892|NCT00630487|6214086|P2|COMPLETED|Overall Study||0
2534893|NCT00630487|6214087|P1|COMPLETED|Overall Study||0
2534894|NCT00630487|6214086|P2|STARTED|Overall Study||0
2534895|NCT00630487|6214087|P1|STARTED|Overall Study||0
2534896|NCT00630409|6214121|P1|NOT COMPLETED|Overall Study||1
2534897|NCT00630409|6214121|P1|COMPLETED|Overall Study||4
2534898|NCT00630409|6214121|P1|STARTED|Overall Study||5
2534899|NCT00630396|6214126|P1|NOT COMPLETED|Overall Study||7
2534900|NCT00630396|6214126|P1|COMPLETED|Overall Study||53
2534901|NCT00630396|6214126|P1|STARTED|Overall Study||60
2534902|NCT00630344|6214132|P1|NOT COMPLETED|Overall Study||36
2534903|NCT00630344|6214132|P1|COMPLETED|Overall Study||0
2534904|NCT00630344|6214132|P1|STARTED|Overall Study||36
2534905|NCT00630331|6214144|P3|NOT COMPLETED|Overall Study||188
2534906|NCT00630331|6214145|P2|NOT COMPLETED|Overall Study||166
2534907|NCT00630331|6214146|P1|NOT COMPLETED|Overall Study||206
2534908|NCT00630331|6214144|P3|COMPLETED|Overall Study||3712
2534909|NCT00630331|6214145|P2|COMPLETED|Overall Study||3510
2534910|NCT00630331|6214146|P1|COMPLETED|Overall Study||3622
2534911|NCT00630331|6214144|P3|STARTED|Overall Study||3900
2534912|NCT00630331|6214145|P2|STARTED|Overall Study||3676
2534913|NCT00630331|6214146|P1|STARTED|Overall Study||3828
2534914|NCT00630305|6214187|P1|NOT COMPLETED|Overall Study||2
2534915|NCT00630305|6214187|P1|COMPLETED|Overall Study||35
2534916|NCT00630305|6214187|P1|STARTED|Overall Study||37
2534917|NCT00630292|6214209|P1|NOT COMPLETED|Overall Study||1
2534918|NCT00630292|6214209|P1|COMPLETED|Overall Study||5
2534919|NCT00630292|6214209|P1|STARTED|Overall Study||6
2534920|NCT00630058|6214215|P2|NOT COMPLETED|Overall Study||4
2534921|NCT00630058|6214216|P1|NOT COMPLETED|Overall Study||4
2534922|NCT00630058|6214215|P2|COMPLETED|Overall Study||6
2534923|NCT00630058|6214216|P1|COMPLETED|Overall Study||6
2534924|NCT00630058|6214215|P2|STARTED|Overall Study||10
2534925|NCT00630058|6214216|P1|STARTED|Overall Study||10
2534926|NCT00629850|6214234|P2|NOT COMPLETED|Overall Study||0
2534927|NCT00629850|6214235|P1|NOT COMPLETED|Overall Study||0
2534928|NCT00629850|6214234|P2|COMPLETED|Overall Study||0
2534929|NCT00629850|6214235|P1|COMPLETED|Overall Study||1
2534930|NCT00629850|6214234|P2|STARTED|Overall Study||0
2534931|NCT00629850|6214235|P1|STARTED|Overall Study||1
2534932|NCT00629772|6214247|P2|NOT COMPLETED|Second Intervention Week 14 - Week 26||2
2534933|NCT00629772|6214248|P1|NOT COMPLETED|Second Intervention Week 14 - Week 26||1
2534934|NCT00629772|6214247|P2|COMPLETED|Second Intervention Week 14 - Week 26||10
2534935|NCT00629772|6214248|P1|COMPLETED|Second Intervention Week 14 - Week 26||11
2534936|NCT00629772|6214247|P2|STARTED|Second Intervention Week 14 - Week 26||12
2534937|NCT00629772|6214248|P1|STARTED|Second Intervention Week 14 - Week 26|Patient withdrew at Week 14 and therefore never received infliximab.|12
2534938|NCT00629772|6214247|P2|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
2534939|NCT00629772|6214248|P1|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
2534940|NCT00629772|6214247|P2|COMPLETED|First Intervention - Day 0 - Week 14||12
2534941|NCT00629772|6214248|P1|COMPLETED|First Intervention - Day 0 - Week 14||12
2534942|NCT00629772|6214247|P2|STARTED|First Intervention - Day 0 - Week 14||12
2534943|NCT00629772|6214248|P1|STARTED|First Intervention - Day 0 - Week 14||12
2534944|NCT00629707|6214268|P2|NOT COMPLETED|Overall Study||2
2534945|NCT00629707|6214269|P1|NOT COMPLETED|Overall Study||0
2534946|NCT00629707|6214268|P2|COMPLETED|Overall Study||8
2534947|NCT00629707|6214269|P1|COMPLETED|Overall Study||10
2534948|NCT00629707|6214268|P2|STARTED|Overall Study||10
2534949|NCT00629707|6214269|P1|STARTED|Overall Study||10
2534950|NCT00629525|6214275|P1|NOT COMPLETED|Overall Study||3
2534951|NCT00629525|6214275|P1|COMPLETED|Overall Study||32
2534952|NCT00629525|6214275|P1|STARTED|Overall Study||35
2534953|NCT00629499|6214283|P1|NOT COMPLETED|Overall Study||0
2534954|NCT00629499|6214283|P1|COMPLETED|Overall Study||63
2534955|NCT00629499|6214283|P1|STARTED|Overall Study||63
2534956|NCT00629265|6214289|P2|NOT COMPLETED|Overall Study||20
2534957|NCT00629265|6214290|P1|NOT COMPLETED|Overall Study||32
2534958|NCT00629265|6214289|P2|COMPLETED|Overall Study||34
2534959|NCT00629265|6214290|P1|COMPLETED|Overall Study||84
2534960|NCT00629265|6214289|P2|STARTED|Overall Study||54
2534961|NCT00629265|6214290|P1|STARTED|Overall Study||116
2534962|NCT00629239|6214300|P2|NOT COMPLETED|Overall Study||4
2534963|NCT00629239|6214301|P1|NOT COMPLETED|Overall Study||8
2534964|NCT00629239|6214300|P2|COMPLETED|Overall Study||28
2534965|NCT00629239|6214301|P1|COMPLETED|Overall Study||26
2534966|NCT00629239|6214300|P2|STARTED|Overall Study||32
2534967|NCT00629239|6214301|P1|STARTED|Overall Study||34
2534968|NCT00629122|6214335|P2|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0
2534969|NCT00629122|6214336|P1|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0
2534970|NCT00629122|6214335|P2|COMPLETED|Third Period: Day 6-8 (Oral)||3
2534971|NCT00629122|6214336|P1|COMPLETED|Third Period: Day 6-8 (Oral)||2
2534972|NCT00629122|6214335|P2|STARTED|Third Period: Day 6-8 (Oral)||3
2534973|NCT00629122|6214336|P1|STARTED|Third Period: Day 6-8 (Oral)||2
2534974|NCT00629122|6214335|P2|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0
2534975|NCT00629122|6214336|P1|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0
2534976|NCT00629122|6214335|P2|COMPLETED|Second Period: Day 3-5 (Washout)||3
2534977|NCT00629122|6214336|P1|COMPLETED|Second Period: Day 3-5 (Washout)||2
2534978|NCT00629122|6214335|P2|STARTED|Second Period: Day 3-5 (Washout)||3
2534979|NCT00629122|6214336|P1|STARTED|Second Period: Day 3-5 (Washout)||2
2534980|NCT00629122|6214335|P2|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0
2534981|NCT00629122|6214336|P1|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0
2534982|NCT00629122|6214335|P2|COMPLETED|First Period: Day 1- 3 (Sublingual)||3
2534983|NCT00629122|6214336|P1|COMPLETED|First Period: Day 1- 3 (Sublingual)||2
2534984|NCT00629122|6214335|P2|STARTED|First Period: Day 1- 3 (Sublingual)||3
2534985|NCT00629122|6214336|P1|STARTED|First Period: Day 1- 3 (Sublingual)||2
2534986|NCT00629083|6214354|P2|NOT COMPLETED|Overall Study||14
2534987|NCT00629083|6214355|P1|NOT COMPLETED|Overall Study||28
2534988|NCT00629083|6214354|P2|COMPLETED|Overall Study||103
2534989|NCT00629083|6214355|P1|COMPLETED|Overall Study||200
2534990|NCT00629083|6214354|P2|STARTED|Overall Study||117
2534991|NCT00629083|6214355|P1|STARTED|Overall Study||228
2534992|NCT00629018|6214375|P2|NOT COMPLETED|Overall Study||0
2534993|NCT00629018|6214376|P1|NOT COMPLETED|Overall Study||0
2534994|NCT00629018|6214375|P2|COMPLETED|Overall Study||55
2534995|NCT00629018|6214376|P1|COMPLETED|Overall Study||55
2534996|NCT00629018|6214375|P2|STARTED|Overall Study||55
2534997|NCT00629018|6214376|P1|STARTED|Overall Study||55
2534998|NCT00628927|6214386|P2|NOT COMPLETED|Overall Study||0
2534999|NCT00628927|6214387|P1|NOT COMPLETED|Overall Study||8
2535000|NCT00628927|6214386|P2|COMPLETED|Overall Study||30
2535001|NCT00628927|6214387|P1|COMPLETED|Overall Study||175
2535002|NCT00628927|6214386|P2|STARTED|Overall Study||30
2535003|NCT00628927|6214387|P1|STARTED|Overall Study||183
2535004|NCT00628901|6214400|P2|NOT COMPLETED|Overall Study||1
2535005|NCT00628901|6214401|P1|NOT COMPLETED|Overall Study||3
2535006|NCT00628901|6214400|P2|COMPLETED|Overall Study||29
2535007|NCT00628901|6214401|P1|COMPLETED|Overall Study||27
2535008|NCT00628901|6214400|P2|STARTED|Overall Study||30
2535009|NCT00628901|6214401|P1|STARTED|Overall Study||30
2535010|NCT00628862|6214432|P3|NOT COMPLETED|Overall Study||22
2535011|NCT00628862|6214433|P2|NOT COMPLETED|Overall Study||17
2535012|NCT00628862|6214434|P1|NOT COMPLETED|Overall Study||11
2535013|NCT00628862|6214432|P3|COMPLETED|Overall Study|randomised patients|186
2535014|NCT00628862|6214433|P2|COMPLETED|Overall Study|randomised patients|182
2535015|NCT00628862|6214434|P1|COMPLETED|Overall Study|randomised patients|195
2535016|NCT00628862|6214432|P3|STARTED|Overall Study|randomised patients|208
2535017|NCT00628862|6214433|P2|STARTED|Overall Study|randomised patients|199
2535018|NCT00628862|6214434|P1|STARTED|Overall Study|randomised patients|206
2535019|NCT00628758|6214480|P2|NOT COMPLETED|Overall Study||42
2535020|NCT00628758|6214481|P1|NOT COMPLETED|Overall Study||44
2535021|NCT00628758|6214480|P2|COMPLETED|Overall Study||179
2535022|NCT00628758|6214481|P1|COMPLETED|Overall Study||165
2535023|NCT00628758|6214480|P2|STARTED|Overall Study||221
2535024|NCT00628758|6214481|P1|STARTED|Overall Study||209
2535025|NCT00628628|6214495|P2|NOT COMPLETED|Overall Study||0
2535026|NCT00628628|6214496|P1|NOT COMPLETED|Overall Study||0
2535027|NCT00628628|6214495|P2|COMPLETED|Overall Study||40
2535028|NCT00628628|6214496|P1|COMPLETED|Overall Study||40
2535029|NCT00628628|6214495|P2|STARTED|Overall Study||40
2535030|NCT00628628|6214496|P1|STARTED|Overall Study||40
2535031|NCT00628589|6214505|P3|NOT COMPLETED|Overall Study||3
2535032|NCT00628589|6214506|P2|NOT COMPLETED|Overall Study||2
2535033|NCT00628589|6214507|P1|NOT COMPLETED|Overall Study||1
2535034|NCT00628589|6214505|P3|COMPLETED|Overall Study||110
2535035|NCT00628589|6214506|P2|COMPLETED|Overall Study||114
2535036|NCT00628589|6214507|P1|COMPLETED|Overall Study||114
2535037|NCT00628589|6214505|P3|STARTED|Overall Study||113
2535038|NCT00628589|6214506|P2|STARTED|Overall Study||116
2535039|NCT00628589|6214507|P1|STARTED|Overall Study||115
2535040|NCT00628498|6214521|P1|NOT COMPLETED|Overall Study||52
2535041|NCT00628498|6214521|P1|COMPLETED|Overall Study||1154
2535042|NCT00628498|6214521|P1|STARTED|Overall Study||1206
2535043|NCT00628446|6214525|P1|NOT COMPLETED|Overall Study||7
2535044|NCT00628446|6214525|P1|COMPLETED|Overall Study||38
2535045|NCT00628446|6214525|P1|STARTED|Overall Study||45
2535046|NCT00628407|6214530|P1|NOT COMPLETED|Overall Study||0
2535047|NCT00628407|6214530|P1|COMPLETED|Overall Study||13
2535048|NCT00628407|6214530|P1|STARTED|Overall Study||13
2535049|NCT00628355|6214536|P2|NOT COMPLETED|Overall Study||1
2535050|NCT00628355|6214537|P1|NOT COMPLETED|Overall Study||1
2535051|NCT00628355|6214536|P2|COMPLETED|Overall Study||14
2535052|NCT00628355|6214537|P1|COMPLETED|Overall Study||14
2535053|NCT00628355|6214536|P2|STARTED|Overall Study||15
2535054|NCT00628355|6214537|P1|STARTED|Overall Study||15
2535055|NCT00628251|6214548|P3|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||25
2535056|NCT00628251|6214549|P2|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||20
2535057|NCT00628251|6214550|P1|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||22
2535058|NCT00628251|6214548|P3|COMPLETED|Ongoing Initial Study Treatment at DCO|Patients ongoing initial study treatment (Liposomal doxorubicin)|7
2535059|NCT00628251|6214549|P2|COMPLETED|Ongoing Initial Study Treatment at DCO|Ongoing initial study treatment at primary data cut-off|12
2535060|NCT00628251|6214550|P1|COMPLETED|Ongoing Initial Study Treatment at DCO|Ongoing initial study treatment at primary data cut-off|10
2535061|NCT00628251|6214548|P3|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||9
2535062|NCT00628251|6214549|P2|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||0
2535063|NCT00628251|6214550|P1|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||0
2535064|NCT00628251|6214548|P3|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||5
2535065|NCT00628251|6214549|P2|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||0
2535066|NCT00628251|6214550|P1|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||0
2535067|NCT00628251|6214548|P3|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO|Crossover dosage was 400 mg bd Olaparib|14
2535068|NCT00628251|6214549|P2|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO||0
2535069|NCT00628251|6214550|P1|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO||0
2535070|NCT00628251|6214548|P3|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||25
2535071|NCT00628251|6214549|P2|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||20
2535072|NCT00628251|6214550|P1|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||22
2535073|NCT00628251|6214548|P3|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received Liposomal doxorubicin 50 mg/m2|32
2535074|NCT00628251|6214549|P2|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received treatment|32
2535075|NCT00628251|6214550|P1|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received treatment|32
2535076|NCT00628251|6214548|P3|NOT COMPLETED|Randomised Part||1
2535077|NCT00628251|6214549|P2|NOT COMPLETED|Randomised Part||0
2535078|NCT00628251|6214550|P1|NOT COMPLETED|Randomised Part||0
2535079|NCT00628251|6214548|P3|COMPLETED|Randomised Part|1 of 33 patients did not receive Liposomal Doxorubicin. Patient voluntarily discontinued|32
2535080|NCT00628251|6214549|P2|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
2535081|NCT00628251|6214550|P1|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
2535082|NCT00628251|6214548|P3|STARTED|Randomised Part|Patients randomised|33
2535083|NCT00628251|6214549|P2|STARTED|Randomised Part|Patients randomised|32
2535084|NCT00628251|6214550|P1|STARTED|Randomised Part|Patients randomised|32
2535085|NCT00628212|6214596|P4|NOT COMPLETED|Overall Study||5
2535086|NCT00628212|6214597|P3|NOT COMPLETED|Overall Study||3
2535087|NCT00628212|6214598|P2|NOT COMPLETED|Overall Study||1
2535088|NCT00628212|6214599|P1|NOT COMPLETED|Overall Study||3
2535089|NCT00628212|6214596|P4|COMPLETED|Overall Study||76
2535090|NCT00628212|6214597|P3|COMPLETED|Overall Study||76
2535091|NCT00628212|6214598|P2|COMPLETED|Overall Study||83
2535092|NCT00628212|6214599|P1|COMPLETED|Overall Study||77
2535093|NCT00628212|6214596|P4|STARTED|Overall Study||81
2535094|NCT00628212|6214597|P3|STARTED|Overall Study||79
2535095|NCT00628212|6214598|P2|STARTED|Overall Study||84
2535096|NCT00628212|6214599|P1|STARTED|Overall Study||80
2535097|NCT00628147|6214623|P2|NOT COMPLETED|Overall Study||1
2535098|NCT00628147|6214624|P1|NOT COMPLETED|Overall Study||7
2535099|NCT00628147|6214623|P2|COMPLETED|Overall Study||141
2535100|NCT00628147|6214624|P1|COMPLETED|Overall Study||135
2535101|NCT00628147|6214623|P2|STARTED|Overall Study||142
2535102|NCT00628147|6214624|P1|STARTED|Overall Study||142
2535103|NCT00628134|6214636|P2|NOT COMPLETED|Overall Study||0
2535104|NCT00628134|6214637|P1|NOT COMPLETED|Overall Study||0
2535105|NCT00628134|6214636|P2|COMPLETED|Overall Study||4
2535106|NCT00628134|6214637|P1|COMPLETED|Overall Study||4
2535107|NCT00628134|6214636|P2|STARTED|Overall Study||4
2535108|NCT00628134|6214637|P1|STARTED|Overall Study||4
2535109|NCT00628108|6214647|P2|NOT COMPLETED|Overall Study||3
2535110|NCT00628108|6214648|P1|NOT COMPLETED|Overall Study||1
2535111|NCT00628108|6214647|P2|COMPLETED|Overall Study||43
2535112|NCT00628108|6214648|P1|COMPLETED|Overall Study||22
2535113|NCT00628108|6214647|P2|Safety Population|Overall Study|Subjects in the Safety Population were analyzed as treated.|45
2535114|NCT00628108|6214648|P1|Safety Population|Overall Study||24
2535115|NCT00628108|6214647|P2|STARTED|Overall Study|One subject was randomized to levocetirizine but received placebo.|46
2535116|NCT00628108|6214648|P1|STARTED|Overall Study||23
2535117|NCT00628030|6214680|P2|NOT COMPLETED|Post to 6 Month Follow-up||30
2535118|NCT00628030|6214681|P1|NOT COMPLETED|Post to 6 Month Follow-up||32
2535119|NCT00628030|6214680|P2|COMPLETED|Post to 6 Month Follow-up||33
2535120|NCT00628030|6214681|P1|COMPLETED|Post to 6 Month Follow-up||27
2535121|NCT00628030|6214680|P2|STARTED|Post to 6 Month Follow-up||63
2535122|NCT00628030|6214681|P1|STARTED|Post to 6 Month Follow-up||59
2535123|NCT00628030|6214680|P2|NOT COMPLETED|Baseline to Post-Assessment||29
2535124|NCT00628030|6214681|P1|NOT COMPLETED|Baseline to Post-Assessment||33
2535125|NCT00628030|6214680|P2|COMPLETED|Baseline to Post-Assessment||63
2535126|NCT00628030|6214681|P1|COMPLETED|Baseline to Post-Assessment||59
2535127|NCT00628030|6214680|P2|STARTED|Baseline to Post-Assessment||92
2535128|NCT00628030|6214681|P1|STARTED|Baseline to Post-Assessment||92
2535129|NCT00627978|6214697|P2|NOT COMPLETED|Overall Study||0
2535130|NCT00627978|6214698|P1|NOT COMPLETED|Overall Study||0
2535131|NCT00627978|6214697|P2|COMPLETED|Overall Study||5
2535132|NCT00627978|6214698|P1|COMPLETED|Overall Study||10
2535133|NCT00627978|6214697|P2|STARTED|Overall Study||5
2535134|NCT00627978|6214698|P1|STARTED|Overall Study||10
2535135|NCT00627926|6214707|P3|NOT COMPLETED|Overall Study||95
2535136|NCT00627926|6214708|P2|NOT COMPLETED|Overall Study||104
2535137|NCT00627926|6214709|P1|NOT COMPLETED|Overall Study||159
2535138|NCT00627926|6214707|P3|COMPLETED|Overall Study||268
2535139|NCT00627926|6214708|P2|COMPLETED|Overall Study||260
2535140|NCT00627926|6214709|P1|COMPLETED|Overall Study||202
2535141|NCT00627926|6214707|P3|STARTED|Overall Study||363
2535142|NCT00627926|6214708|P2|STARTED|Overall Study||364
2535143|NCT00627926|6214709|P1|STARTED|Overall Study||361
2535144|NCT00627861|6214753|P1|NOT COMPLETED|Overall Study||0
2535145|NCT00627861|6214753|P1|COMPLETED|Overall Study||1
2535146|NCT00627861|6214753|P1|STARTED|Overall Study||1
2535147|NCT00627705|6214761|P2|NOT COMPLETED|Overall Study||6
2535148|NCT00627705|6214762|P1|NOT COMPLETED|Overall Study||2
2535149|NCT00627705|6214761|P2|COMPLETED|Overall Study||12
2535150|NCT00627705|6214762|P1|COMPLETED|Overall Study||13
2535151|NCT00627705|6214761|P2|STARTED|Overall Study||18
2535152|NCT00627705|6214762|P1|STARTED|Overall Study||15
2535153|NCT00627679|6214782|P4|NOT COMPLETED|Overall Study||0
2535154|NCT00627679|6214783|P3|NOT COMPLETED|Overall Study||0
2535155|NCT00627679|6214784|P2|NOT COMPLETED|Overall Study||0
2535156|NCT00627679|6214785|P1|NOT COMPLETED|Overall Study||0
2535157|NCT00627679|6214782|P4|COMPLETED|Overall Study||4
2535158|NCT00627679|6214783|P3|COMPLETED|Overall Study||4
2535159|NCT00627679|6214784|P2|COMPLETED|Overall Study||4
2535160|NCT00627679|6214785|P1|COMPLETED|Overall Study||4
2535161|NCT00627679|6214782|P4|STARTED|Overall Study||4
2535162|NCT00627679|6214783|P3|STARTED|Overall Study||4
2535163|NCT00627679|6214784|P2|STARTED|Overall Study||4
2535164|NCT00627679|6214785|P1|STARTED|Overall Study||4
2535165|NCT00627523|6214813|P2|NOT COMPLETED|Overall Study||2
2535166|NCT00627523|6214814|P1|NOT COMPLETED|Overall Study||2
2535167|NCT00627523|6214813|P2|COMPLETED|Overall Study||20
2535168|NCT00627523|6214814|P1|COMPLETED|Overall Study||19
2535169|NCT00627523|6214813|P2|STARTED|Overall Study||22
2535170|NCT00627523|6214814|P1|STARTED|Overall Study|22 assigned to Genotropin and 21 in Control; 1 did not take Genotropin, so considered as Control.|21
2535171|NCT00627497|6214842|P4|NOT COMPLETED|Overall Study||0
2535172|NCT00627497|6214843|P3|NOT COMPLETED|Overall Study||0
2535173|NCT00627497|6214844|P2|NOT COMPLETED|Overall Study||1
2535174|NCT00627497|6214845|P1|NOT COMPLETED|Overall Study||1
2535175|NCT00627497|6214842|P4|COMPLETED|Overall Study||2
2535176|NCT00627497|6214843|P3|COMPLETED|Overall Study||4
2535177|NCT00627497|6214844|P2|COMPLETED|Overall Study||11
2535178|NCT00627497|6214845|P1|COMPLETED|Overall Study||13
2535179|NCT00627497|6214842|P4|STARTED|Overall Study||2
2535180|NCT00627497|6214843|P3|STARTED|Overall Study||4
2535181|NCT00627497|6214844|P2|STARTED|Overall Study||12
2535182|NCT00627497|6214845|P1|STARTED|Overall Study||14
2535183|NCT00627458|6214906|P3|NOT COMPLETED|Overall Study||6
2535184|NCT00627458|6214907|P2|NOT COMPLETED|Overall Study||7
2535185|NCT00627458|6214908|P1|NOT COMPLETED|Overall Study||4
2535186|NCT00627458|6214906|P3|COMPLETED|Overall Study||133
2535187|NCT00627458|6214907|P2|COMPLETED|Overall Study||130
2535188|NCT00627458|6214908|P1|COMPLETED|Overall Study||123
2535189|NCT00627458|6214906|P3|STARTED|Overall Study||139
2535190|NCT00627458|6214907|P2|STARTED|Overall Study||137
2535191|NCT00627458|6214908|P1|STARTED|Overall Study||127
2535192|NCT00627445|6214983|P2|NOT COMPLETED|Overall Study||12
2535193|NCT00627445|6214984|P1|NOT COMPLETED|Overall Study||9
2535194|NCT00627445|6214983|P2|COMPLETED|Overall Study||210
2535195|NCT00627445|6214984|P1|COMPLETED|Overall Study||210
2535196|NCT00627445|6214983|P2|Exposed to Study Drug|Overall Study||222
2535197|NCT00627445|6214984|P1|Exposed to Study Drug|Overall Study||219
2535198|NCT00627445|6214983|P2|STARTED|Overall Study||222
2535199|NCT00627445|6214984|P1|STARTED|Overall Study||219
2535200|NCT00627406|6215008|P4|NOT COMPLETED|Overall Study||0
2535201|NCT00627406|6215009|P3|NOT COMPLETED|Overall Study||0
2535202|NCT00627406|6215010|P2|NOT COMPLETED|Overall Study||0
2535203|NCT00627406|6215011|P1|NOT COMPLETED|Overall Study||0
2535204|NCT00627406|6215008|P4|COMPLETED|Overall Study||141
2535205|NCT00627406|6215009|P3|COMPLETED|Overall Study||125
2535206|NCT00627406|6215010|P2|COMPLETED|Overall Study||58
2535207|NCT00627406|6215011|P1|COMPLETED|Overall Study||60
2535208|NCT00627406|6215008|P4|STARTED|Overall Study||141
2535209|NCT00627406|6215009|P3|STARTED|Overall Study||125
2535210|NCT00627406|6215010|P2|STARTED|Overall Study||58
2535211|NCT00627406|6215011|P1|STARTED|Overall Study||60
2535212|NCT00627393|6215027|P2|NOT COMPLETED|Per-Protocol Analysis||13
2535213|NCT00627393|6215028|P1|NOT COMPLETED|Per-Protocol Analysis||10
2535214|NCT00627393|6215027|P2|COMPLETED|Per-Protocol Analysis||35
2535215|NCT00627393|6215028|P1|COMPLETED|Per-Protocol Analysis||39
2535216|NCT00627393|6215027|P2|STARTED|Per-Protocol Analysis||48
2535217|NCT00627393|6215028|P1|STARTED|Per-Protocol Analysis||49
2535218|NCT00627393|6215027|P2|NOT COMPLETED|Intention-To-Treat Analysis||8
2535219|NCT00627393|6215028|P1|NOT COMPLETED|Intention-To-Treat Analysis||9
2535220|NCT00627393|6215027|P2|COMPLETED|Intention-To-Treat Analysis||48
2535221|NCT00627393|6215028|P1|COMPLETED|Intention-To-Treat Analysis||49
2535222|NCT00627393|6215027|P2|STARTED|Intention-To-Treat Analysis||56
2535223|NCT00627393|6215028|P1|STARTED|Intention-To-Treat Analysis||58
2535224|NCT00627367|6215049|P2|NOT COMPLETED|Overall Study||0
2535225|NCT00627367|6215050|P1|NOT COMPLETED|Overall Study||0
2535226|NCT00627367|6215049|P2|COMPLETED|Overall Study||112
2535227|NCT00627367|6215050|P1|COMPLETED|Overall Study||112
2535228|NCT00627367|6215049|P2|STARTED|Overall Study||112
2535229|NCT00627367|6215050|P1|STARTED|Overall Study||112
2535230|NCT00627094|6215064|P2|NOT COMPLETED|Overall Study||15
2535231|NCT00627094|6215065|P1|NOT COMPLETED|Overall Study||12
2535232|NCT00627094|6215064|P2|COMPLETED|Overall Study||45
2535233|NCT00627094|6215065|P1|COMPLETED|Overall Study||48
2535234|NCT00627094|6215064|P2|STARTED|Overall Study||60
2535235|NCT00627094|6215065|P1|STARTED|Overall Study||60
2535236|NCT00627042|6215077|P1|NOT COMPLETED|Overall Study||2
2535237|NCT00627042|6215077|P1|COMPLETED|Overall Study||40
2535238|NCT00627042|6215077|P1|Received at Least 1 Dose of Study Drug|Overall Study||42
2535239|NCT00627042|6215077|P1|STARTED|Overall Study||42
2535240|NCT00627016|6215089|P2|NOT COMPLETED|Overall Study||6
2535241|NCT00627016|6215090|P1|NOT COMPLETED|Overall Study||6
2535242|NCT00627016|6215089|P2|COMPLETED|Overall Study||146
2535243|NCT00627016|6215090|P1|COMPLETED|Overall Study||147
2535244|NCT00627016|6215089|P2|STARTED|Overall Study||152
2535245|NCT00627016|6215090|P1|STARTED|Overall Study||153
2535246|NCT00626925|6215102|P2|NOT COMPLETED|Overall Study||9
2535247|NCT00626925|6215103|P1|NOT COMPLETED|Overall Study||12
2535248|NCT00626925|6215102|P2|COMPLETED|Overall Study||62
2535249|NCT00626925|6215103|P1|COMPLETED|Overall Study||55
2535250|NCT00626925|6215102|P2|STARTED|Overall Study||71
2535251|NCT00626925|6215103|P1|STARTED|Overall Study||67
2535252|NCT00626912|6215137|P2|NOT COMPLETED|Overall Study||10
2535253|NCT00626912|6215138|P1|NOT COMPLETED|Overall Study||2
2535254|NCT00626912|6215137|P2|COMPLETED|Overall Study||215
2535255|NCT00626912|6215138|P1|COMPLETED|Overall Study||220
2535256|NCT00626912|6215137|P2|STARTED|Overall Study||225
2535257|NCT00626912|6215138|P1|STARTED|Overall Study||222
2535258|NCT00626821|6215150|P1|NOT COMPLETED|Overall Study||221
2535259|NCT00626821|6215150|P1|COMPLETED|Overall Study||2796
2535260|NCT00626821|6215150|P1|Quality of Life|Overall Study|Attended both visit 1 and visit 2|2672
2535261|NCT00626821|6215150|P1|STARTED|Overall Study||3017
2535262|NCT00626808|6215158|P4|NOT COMPLETED|Overall Study||0
2535263|NCT00626808|6215159|P3|NOT COMPLETED|Overall Study||0
2535264|NCT00626808|6215160|P2|NOT COMPLETED|Overall Study||0
2535265|NCT00626808|6215161|P1|NOT COMPLETED|Overall Study||0
2535266|NCT00626808|6215158|P4|COMPLETED|Overall Study||2906
2535267|NCT00626808|6215159|P3|COMPLETED|Overall Study||30011
2535268|NCT00626808|6215160|P2|COMPLETED|Overall Study||34316
2535269|NCT00626808|6215161|P1|COMPLETED|Overall Study||254464
2535270|NCT00626808|6215158|P4|STARTED|Overall Study||2906
2535271|NCT00626808|6215159|P3|STARTED|Overall Study||30011
2535272|NCT00626808|6215160|P2|STARTED|Overall Study||34316
2535273|NCT00626808|6215161|P1|STARTED|Overall Study||254464
2535274|NCT00626795|6215230|P3|NOT COMPLETED|Blinded Treatment||9
2535275|NCT00626795|6215231|P2|NOT COMPLETED|Blinded Treatment||5
2535276|NCT00626795|6215232|P1|NOT COMPLETED|Blinded Treatment||10
2535277|NCT00626795|6215230|P3|COMPLETED|Blinded Treatment||196
2535278|NCT00626795|6215231|P2|COMPLETED|Blinded Treatment||200
2535279|NCT00626795|6215232|P1|COMPLETED|Blinded Treatment||194
2535280|NCT00626795|6215230|P3|STARTED|Blinded Treatment||205
2535281|NCT00626795|6215231|P2|STARTED|Blinded Treatment||205
2535282|NCT00626795|6215232|P1|STARTED|Blinded Treatment||204
2535283|NCT00626795|6215230|P3|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||0
2535284|NCT00626795|6215231|P2|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||1
2535285|NCT00626795|6215232|P1|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||0
2535286|NCT00626795|6215230|P3|COMPLETED|Open-label TD1414 Cream TID Treatment||0
2535287|NCT00626795|6215231|P2|COMPLETED|Open-label TD1414 Cream TID Treatment||64
2535288|NCT00626795|6215232|P1|COMPLETED|Open-label TD1414 Cream TID Treatment||0
2535289|NCT00626795|6215230|P3|STARTED|Open-label TD1414 Cream TID Treatment||0
2535290|NCT00626795|6215231|P2|STARTED|Open-label TD1414 Cream TID Treatment||65
2535291|NCT00626795|6215232|P1|STARTED|Open-label TD1414 Cream TID Treatment||0
2535292|NCT00626782|6215261|P2|NOT COMPLETED|Overall Study||0
2535293|NCT00626782|6215262|P1|NOT COMPLETED|Overall Study||0
2535294|NCT00626782|6215261|P2|COMPLETED|Overall Study||12
2535295|NCT00626782|6215262|P1|COMPLETED|Overall Study||12
2535296|NCT00626782|6215261|P2|STARTED|Overall Study||12
2535297|NCT00626782|6215262|P1|STARTED|Overall Study||12
2535298|NCT00626743|6215272|P2|NOT COMPLETED|Treatment Period 2||0
2535299|NCT00626743|6215273|P1|NOT COMPLETED|Treatment Period 2||0
2535300|NCT00626743|6215272|P2|COMPLETED|Treatment Period 2||6
2535301|NCT00626743|6215273|P1|COMPLETED|Treatment Period 2||6
2535302|NCT00626743|6215272|P2|STARTED|Treatment Period 2||6
2535303|NCT00626743|6215273|P1|STARTED|Treatment Period 2||6
2535304|NCT00626743|6215272|P2|NOT COMPLETED|Wash-out Period of 6 Days||0
2535305|NCT00626743|6215273|P1|NOT COMPLETED|Wash-out Period of 6 Days||0
2535306|NCT00626743|6215272|P2|COMPLETED|Wash-out Period of 6 Days||6
2535307|NCT00626743|6215273|P1|COMPLETED|Wash-out Period of 6 Days||6
2535308|NCT00626743|6215272|P2|STARTED|Wash-out Period of 6 Days||6
2535309|NCT00626743|6215273|P1|STARTED|Wash-out Period of 6 Days||6
2535310|NCT00626743|6215272|P2|NOT COMPLETED|Treatment Period 1||1
2535311|NCT00626743|6215273|P1|NOT COMPLETED|Treatment Period 1||0
2535312|NCT00626743|6215272|P2|COMPLETED|Treatment Period 1||6
2535313|NCT00626743|6215273|P1|COMPLETED|Treatment Period 1||6
2535314|NCT00626743|6215272|P2|STARTED|Treatment Period 1||7
2535315|NCT00626743|6215273|P1|STARTED|Treatment Period 1||6
2535316|NCT00626639|6215283|P2|NOT COMPLETED|Overall Study||2
2535317|NCT00626639|6215284|P1|NOT COMPLETED|Overall Study||2
2535318|NCT00626639|6215283|P2|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|1
2535319|NCT00626639|6215284|P1|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|0
2535320|NCT00626639|6215283|P2|STARTED|Overall Study||3
2535321|NCT00626639|6215284|P1|STARTED|Overall Study||2
2535322|NCT00626626|6215304|P2|NOT COMPLETED|Overall Study||0
2535323|NCT00626626|6215305|P1|NOT COMPLETED|Overall Study||0
2535324|NCT00626626|6215304|P2|COMPLETED|Overall Study||3
2535325|NCT00626626|6215305|P1|COMPLETED|Overall Study||5
2535326|NCT00626626|6215304|P2|STARTED|Overall Study||3
2535327|NCT00626626|6215305|P1|STARTED|Overall Study||5
2535328|NCT00626574|6215317|P2|NOT COMPLETED|Overall Study||0
2535329|NCT00626574|6215318|P1|NOT COMPLETED|Overall Study||0
2535330|NCT00626574|6215317|P2|COMPLETED|Overall Study||1
2535331|NCT00626574|6215318|P1|COMPLETED|Overall Study||2
2535332|NCT00626574|6215317|P2|STARTED|Overall Study||1
2535333|NCT00626574|6215318|P1|STARTED|Overall Study||2
2535334|NCT00626561|6215330|P1|NOT COMPLETED|Overall Study||4
2535335|NCT00626561|6215330|P1|COMPLETED|Overall Study||0
2535336|NCT00626561|6215330|P1|STARTED|Overall Study||4
2535337|NCT00626548|6215336|P2|NOT COMPLETED|Overall Study||716
2535338|NCT00626548|6215337|P1|NOT COMPLETED|Overall Study||705
2535339|NCT00626548|6215336|P2|COMPLETED|Overall Study||0
2535340|NCT00626548|6215337|P1|COMPLETED|Overall Study||0
2535341|NCT00626548|6215336|P2|Patients Received Treatment|Overall Study||712
2535342|NCT00626548|6215337|P1|Patients Received Treatment|Overall Study||703
2535343|NCT00626548|6215336|P2|STARTED|Overall Study||716
2535344|NCT00626548|6215337|P1|STARTED|Overall Study||705
2535345|NCT00626522|6215351|P6|NOT COMPLETED|Overall Study||2
2535346|NCT00626522|6215352|P5|NOT COMPLETED|Overall Study||7
2535347|NCT00626522|6215353|P4|NOT COMPLETED|Overall Study||2
2535348|NCT00626522|6215354|P3|NOT COMPLETED|Overall Study||8
2535349|NCT00626522|6215355|P2|NOT COMPLETED|Overall Study||7
2535350|NCT00626522|6215356|P1|NOT COMPLETED|Overall Study||6
2535351|NCT00626522|6215351|P6|COMPLETED|Overall Study||57
2535352|NCT00626522|6215352|P5|COMPLETED|Overall Study||58
2535353|NCT00626522|6215353|P4|COMPLETED|Overall Study||74
2535354|NCT00626522|6215354|P3|COMPLETED|Overall Study||117
2535355|NCT00626522|6215355|P2|COMPLETED|Overall Study||113
2535356|NCT00626522|6215356|P1|COMPLETED|Overall Study||115
2535357|NCT00626522|6215351|P6|STARTED|Overall Study||59
2535358|NCT00626522|6215352|P5|STARTED|Overall Study||65
2535359|NCT00626522|6215353|P4|STARTED|Overall Study||76
2535360|NCT00626522|6215354|P3|STARTED|Overall Study||125
2535361|NCT00626522|6215355|P2|STARTED|Overall Study||120
2535362|NCT00626522|6215356|P1|STARTED|Overall Study||121
2535363|NCT00626444|6215394|P1|NOT COMPLETED|Overall Study||0
2535364|NCT00626444|6215394|P1|COMPLETED|Overall Study||2
2535365|NCT00626444|6215394|P1|STARTED|Overall Study||2
2535366|NCT00626431|6215401|P2|NOT COMPLETED|Overall Study||45
2535367|NCT00626431|6215402|P1|NOT COMPLETED|Overall Study||17
2535368|NCT00626431|6215401|P2|COMPLETED|Overall Study||114
2535369|NCT00626431|6215402|P1|COMPLETED|Overall Study||134
2535370|NCT00626431|6215401|P2|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|159
2535371|NCT00626431|6215402|P1|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|151
2535372|NCT00626405|6215419|P2|NOT COMPLETED|Overall Study||1
2535373|NCT00626405|6215420|P1|NOT COMPLETED|Overall Study||1
2535374|NCT00626405|6215419|P2|COMPLETED|Overall Study||51
2535375|NCT00626405|6215420|P1|COMPLETED|Overall Study||42
2535376|NCT00626405|6215419|P2|STARTED|Overall Study||52
2535377|NCT00626405|6215420|P1|STARTED|Overall Study||43
2535378|NCT00626392|6215436|P6|NOT COMPLETED|Coadministration Period||6
2535379|NCT00626392|6215437|P5|NOT COMPLETED|Coadministration Period||5
2535380|NCT00626392|6215438|P4|NOT COMPLETED|Coadministration Period||7
2535381|NCT00626392|6215439|P3|NOT COMPLETED|Coadministration Period||10
2535382|NCT00626392|6215440|P2|NOT COMPLETED|Coadministration Period||5
2535383|NCT00626392|6215441|P1|NOT COMPLETED|Coadministration Period||4
2535384|NCT00626392|6215436|P6|COMPLETED|Coadministration Period||38
2535385|NCT00626392|6215437|P5|COMPLETED|Coadministration Period||36
2535386|NCT00626392|6215438|P4|COMPLETED|Coadministration Period||36
2535387|NCT00626392|6215439|P3|COMPLETED|Coadministration Period||31
2535388|NCT00626392|6215440|P2|COMPLETED|Coadministration Period||38
2535389|NCT00626392|6215441|P1|COMPLETED|Coadministration Period||40
2535390|NCT00626392|6215436|P6|STARTED|Coadministration Period||44
2535391|NCT00626392|6215437|P5|STARTED|Coadministration Period||41
2535392|NCT00626392|6215438|P4|STARTED|Coadministration Period||43
2535393|NCT00626392|6215439|P3|STARTED|Coadministration Period||41
2535394|NCT00626392|6215440|P2|STARTED|Coadministration Period||43
2535395|NCT00626392|6215441|P1|STARTED|Coadministration Period||44
2535396|NCT00626392|6215436|P6|NOT COMPLETED|Run-in Period||1
2535397|NCT00626392|6215437|P5|NOT COMPLETED|Run-in Period||4
2535398|NCT00626392|6215438|P4|NOT COMPLETED|Run-in Period||1
2535399|NCT00626392|6215439|P3|NOT COMPLETED|Run-in Period||3
2535400|NCT00626392|6215440|P2|NOT COMPLETED|Run-in Period||1
2535401|NCT00626392|6215441|P1|NOT COMPLETED|Run-in Period||1
2535402|NCT00626392|6215436|P6|COMPLETED|Run-in Period||44
2535403|NCT00626392|6215437|P5|COMPLETED|Run-in Period||41
2535404|NCT00626392|6215438|P4|COMPLETED|Run-in Period||43
2535405|NCT00626392|6215439|P3|COMPLETED|Run-in Period||41
2535406|NCT00626392|6215440|P2|COMPLETED|Run-in Period||43
2535407|NCT00626392|6215441|P1|COMPLETED|Run-in Period||44
2535408|NCT00626392|6215436|P6|STARTED|Run-in Period||45
2535409|NCT00626392|6215437|P5|STARTED|Run-in Period||45
2535410|NCT00626392|6215438|P4|STARTED|Run-in Period||44
2535411|NCT00626392|6215439|P3|STARTED|Run-in Period||44
2535412|NCT00626392|6215440|P2|STARTED|Run-in Period||44
2535413|NCT00626392|6215441|P1|STARTED|Run-in Period||45
2535414|NCT00626366|6215455|P2|NOT COMPLETED|Overall Study||0
2535415|NCT00626366|6215456|P1|NOT COMPLETED|Overall Study||0
2535416|NCT00626366|6215455|P2|COMPLETED|Overall Study||9
2535417|NCT00626366|6215456|P1|COMPLETED|Overall Study||9
2535418|NCT00626366|6215455|P2|STARTED|Overall Study||9
2535419|NCT00626366|6215456|P1|STARTED|Overall Study||9
2535420|NCT00626340|6215462|P1|NOT COMPLETED|Overall Study||0
2535421|NCT00626340|6215462|P1|COMPLETED|Overall Study||18
2535422|NCT00626340|6215462|P1|STARTED|Overall Study||18
2535423|NCT00626327|6215469|P3|NOT COMPLETED|Overall Study||88
2535424|NCT00626327|6215470|P2|NOT COMPLETED|Overall Study||59
2535425|NCT00626327|6215471|P1|NOT COMPLETED|Overall Study||78
2535426|NCT00626327|6215469|P3|COMPLETED|Overall Study||422
2535427|NCT00626327|6215470|P2|COMPLETED|Overall Study||557
2535428|NCT00626327|6215471|P1|COMPLETED|Overall Study||426
2535429|NCT00626327|6215469|P3|STARTED|Overall Study||510
2535430|NCT00626327|6215470|P2|STARTED|Overall Study||616
2535431|NCT00626327|6215471|P1|STARTED|Overall Study||504
2535432|NCT00626275|6215497|P8|NOT COMPLETED|Part B||1
2535433|NCT00626275|6215498|P7|NOT COMPLETED|Part B||1
2535434|NCT00626275|6215499|P6|NOT COMPLETED|Part B||0
2535435|NCT00626275|6215500|P5|NOT COMPLETED|Part B||0
2535436|NCT00626275|6215501|P4|NOT COMPLETED|Part B||0
2535437|NCT00626275|6215502|P3|NOT COMPLETED|Part B||0
2535438|NCT00626275|6215503|P2|NOT COMPLETED|Part B||0
2535439|NCT00626275|6215504|P1|NOT COMPLETED|Part B||0
2535440|NCT00626275|6215497|P8|COMPLETED|Part B||23
2535441|NCT00626275|6215498|P7|COMPLETED|Part B||19
2535442|NCT00626275|6215499|P6|COMPLETED|Part B||0
2535443|NCT00626275|6215500|P5|COMPLETED|Part B||0
2535444|NCT00626275|6215501|P4|COMPLETED|Part B||0
2535445|NCT00626275|6215502|P3|COMPLETED|Part B||0
2535446|NCT00626275|6215503|P2|COMPLETED|Part B||0
2535447|NCT00626275|6215504|P1|COMPLETED|Part B||0
2535448|NCT00626275|6215497|P8|STARTED|Part B||24
2535449|NCT00626275|6215498|P7|STARTED|Part B||20
2535450|NCT00626275|6215499|P6|STARTED|Part B||0
2535451|NCT00626275|6215500|P5|STARTED|Part B||0
2535452|NCT00626275|6215501|P4|STARTED|Part B||0
2535453|NCT00626275|6215502|P3|STARTED|Part B||0
2535454|NCT00626275|6215503|P2|STARTED|Part B||0
2535455|NCT00626275|6215504|P1|STARTED|Part B||0
2535456|NCT00626275|6215497|P8|NOT COMPLETED|Re-randomization Period for Part B||0
2535457|NCT00626275|6215498|P7|NOT COMPLETED|Re-randomization Period for Part B||0
2535458|NCT00626275|6215499|P6|NOT COMPLETED|Re-randomization Period for Part B||0
2535459|NCT00626275|6215500|P5|NOT COMPLETED|Re-randomization Period for Part B||0
2535460|NCT00626275|6215501|P4|NOT COMPLETED|Re-randomization Period for Part B||0
2535461|NCT00626275|6215502|P3|NOT COMPLETED|Re-randomization Period for Part B||0
2535462|NCT00626275|6215503|P2|NOT COMPLETED|Re-randomization Period for Part B||0
2535463|NCT00626275|6215504|P1|NOT COMPLETED|Re-randomization Period for Part B||0
2535464|NCT00626275|6215497|P8|COMPLETED|Re-randomization Period for Part B||24
2535465|NCT00626275|6215498|P7|COMPLETED|Re-randomization Period for Part B||20
2535466|NCT00626275|6215499|P6|COMPLETED|Re-randomization Period for Part B||0
2535467|NCT00626275|6215500|P5|COMPLETED|Re-randomization Period for Part B||0
2535468|NCT00626275|6215501|P4|COMPLETED|Re-randomization Period for Part B||0
2535469|NCT00626275|6215502|P3|COMPLETED|Re-randomization Period for Part B||0
2535470|NCT00626275|6215503|P2|COMPLETED|Re-randomization Period for Part B||0
2535471|NCT00626275|6215504|P1|COMPLETED|Re-randomization Period for Part B||0
2535472|NCT00626275|6215497|P8|STARTED|Re-randomization Period for Part B||24
2535473|NCT00626275|6215498|P7|STARTED|Re-randomization Period for Part B||20
2535474|NCT00626275|6215499|P6|STARTED|Re-randomization Period for Part B||0
2535475|NCT00626275|6215500|P5|STARTED|Re-randomization Period for Part B||0
2535476|NCT00626275|6215501|P4|STARTED|Re-randomization Period for Part B||0
2535477|NCT00626275|6215502|P3|STARTED|Re-randomization Period for Part B||0
2535478|NCT00626275|6215503|P2|STARTED|Re-randomization Period for Part B||0
2535479|NCT00626275|6215504|P1|STARTED|Re-randomization Period for Part B||0
2535480|NCT00626275|6215497|P8|NOT COMPLETED|Part A - Treatment Period 3||0
2535481|NCT00626275|6215498|P7|NOT COMPLETED|Part A - Treatment Period 3||0
2535482|NCT00626275|6215499|P6|NOT COMPLETED|Part A - Treatment Period 3||0
2535483|NCT00626275|6215500|P5|NOT COMPLETED|Part A - Treatment Period 3||0
2535484|NCT00626275|6215501|P4|NOT COMPLETED|Part A - Treatment Period 3||0
2535485|NCT00626275|6215502|P3|NOT COMPLETED|Part A - Treatment Period 3||0
2535486|NCT00626275|6215503|P2|NOT COMPLETED|Part A - Treatment Period 3||0
2535487|NCT00626275|6215504|P1|NOT COMPLETED|Part A - Treatment Period 3||0
2535488|NCT00626275|6215497|P8|COMPLETED|Part A - Treatment Period 3||0
2535489|NCT00626275|6215498|P7|COMPLETED|Part A - Treatment Period 3||0
2535490|NCT00626275|6215499|P6|COMPLETED|Part A - Treatment Period 3||8
2535491|NCT00626275|6215500|P5|COMPLETED|Part A - Treatment Period 3||9
2535492|NCT00626275|6215501|P4|COMPLETED|Part A - Treatment Period 3||8
2535493|NCT00626275|6215502|P3|COMPLETED|Part A - Treatment Period 3||6
2535494|NCT00626275|6215503|P2|COMPLETED|Part A - Treatment Period 3||7
2535495|NCT00626275|6215504|P1|COMPLETED|Part A - Treatment Period 3||6
2535496|NCT00626275|6215497|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
2535497|NCT00626275|6215498|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
2535498|NCT00626275|6215499|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
2535499|NCT00626275|6215500|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||9
2535500|NCT00626275|6215501|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
2535501|NCT00626275|6215502|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
2535502|NCT00626275|6215503|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||7
2535503|NCT00626275|6215504|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
2535504|NCT00626275|6215497|P8|STARTED|Part A - Treatment Period 3||0
2535505|NCT00626275|6215498|P7|STARTED|Part A - Treatment Period 3||0
2535506|NCT00626275|6215499|P6|STARTED|Part A - Treatment Period 3||8
2535507|NCT00626275|6215500|P5|STARTED|Part A - Treatment Period 3||9
2535508|NCT00626275|6215501|P4|STARTED|Part A - Treatment Period 3||8
2535509|NCT00626275|6215502|P3|STARTED|Part A - Treatment Period 3||6
2535510|NCT00626275|6215503|P2|STARTED|Part A - Treatment Period 3||7
2535511|NCT00626275|6215504|P1|STARTED|Part A - Treatment Period 3||6
2535512|NCT00626275|6215497|P8|NOT COMPLETED|Part A - Washout Period 2||0
2535513|NCT00626275|6215498|P7|NOT COMPLETED|Part A - Washout Period 2||0
2535514|NCT00626275|6215499|P6|NOT COMPLETED|Part A - Washout Period 2||0
2535515|NCT00626275|6215500|P5|NOT COMPLETED|Part A - Washout Period 2||0
2535516|NCT00626275|6215501|P4|NOT COMPLETED|Part A - Washout Period 2||0
2535517|NCT00626275|6215502|P3|NOT COMPLETED|Part A - Washout Period 2||0
2535518|NCT00626275|6215503|P2|NOT COMPLETED|Part A - Washout Period 2||0
2535519|NCT00626275|6215504|P1|NOT COMPLETED|Part A - Washout Period 2||0
2535520|NCT00626275|6215497|P8|COMPLETED|Part A - Washout Period 2||0
2535521|NCT00626275|6215498|P7|COMPLETED|Part A - Washout Period 2||0
2535522|NCT00626275|6215499|P6|COMPLETED|Part A - Washout Period 2||8
2535523|NCT00626275|6215500|P5|COMPLETED|Part A - Washout Period 2||9
2535524|NCT00626275|6215501|P4|COMPLETED|Part A - Washout Period 2||8
2535525|NCT00626275|6215502|P3|COMPLETED|Part A - Washout Period 2||6
2535526|NCT00626275|6215503|P2|COMPLETED|Part A - Washout Period 2||7
2535527|NCT00626275|6215504|P1|COMPLETED|Part A - Washout Period 2||6
2535528|NCT00626275|6215497|P8|STARTED|Part A - Washout Period 2||0
2535529|NCT00626275|6215498|P7|STARTED|Part A - Washout Period 2||0
2535530|NCT00626275|6215499|P6|STARTED|Part A - Washout Period 2||8
2535531|NCT00626275|6215500|P5|STARTED|Part A - Washout Period 2||9
2535532|NCT00626275|6215501|P4|STARTED|Part A - Washout Period 2||8
2535533|NCT00626275|6215502|P3|STARTED|Part A - Washout Period 2||6
2535534|NCT00626275|6215503|P2|STARTED|Part A - Washout Period 2||7
2535535|NCT00626275|6215504|P1|STARTED|Part A - Washout Period 2||6
2535536|NCT00626275|6215497|P8|NOT COMPLETED|Part A - Treatment Period 2||0
2535537|NCT00626275|6215498|P7|NOT COMPLETED|Part A - Treatment Period 2||0
2535538|NCT00626275|6215499|P6|NOT COMPLETED|Part A - Treatment Period 2||0
2535539|NCT00626275|6215500|P5|NOT COMPLETED|Part A - Treatment Period 2||0
2535540|NCT00626275|6215501|P4|NOT COMPLETED|Part A - Treatment Period 2||0
2535541|NCT00626275|6215502|P3|NOT COMPLETED|Part A - Treatment Period 2||0
2535542|NCT00626275|6215503|P2|NOT COMPLETED|Part A - Treatment Period 2||0
2535543|NCT00626275|6215504|P1|NOT COMPLETED|Part A - Treatment Period 2||0
2535544|NCT00626275|6215497|P8|COMPLETED|Part A - Treatment Period 2||0
2535545|NCT00626275|6215498|P7|COMPLETED|Part A - Treatment Period 2||0
2535546|NCT00626275|6215499|P6|COMPLETED|Part A - Treatment Period 2||8
2535547|NCT00626275|6215500|P5|COMPLETED|Part A - Treatment Period 2||9
2535548|NCT00626275|6215501|P4|COMPLETED|Part A - Treatment Period 2||8
2535549|NCT00626275|6215502|P3|COMPLETED|Part A - Treatment Period 2||6
2535550|NCT00626275|6215503|P2|COMPLETED|Part A - Treatment Period 2||7
2535551|NCT00626275|6215504|P1|COMPLETED|Part A - Treatment Period 2||6
2535552|NCT00626275|6215497|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
2535553|NCT00626275|6215498|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
2535554|NCT00626275|6215499|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
2535555|NCT00626275|6215500|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||9
2535556|NCT00626275|6215501|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
2535557|NCT00626275|6215502|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
2535558|NCT00626275|6215503|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||7
2535559|NCT00626275|6215504|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
2535560|NCT00626275|6215497|P8|STARTED|Part A - Treatment Period 2||0
2535561|NCT00626275|6215498|P7|STARTED|Part A - Treatment Period 2||0
2535562|NCT00626275|6215499|P6|STARTED|Part A - Treatment Period 2||8
2535563|NCT00626275|6215500|P5|STARTED|Part A - Treatment Period 2||9
2535564|NCT00626275|6215501|P4|STARTED|Part A - Treatment Period 2||8
2535565|NCT00626275|6215502|P3|STARTED|Part A - Treatment Period 2||6
2535566|NCT00626275|6215503|P2|STARTED|Part A - Treatment Period 2||7
2535567|NCT00626275|6215504|P1|STARTED|Part A - Treatment Period 2||6
2535568|NCT00626275|6215497|P8|NOT COMPLETED|Part A - Washout Period 1||0
2535569|NCT00626275|6215498|P7|NOT COMPLETED|Part A - Washout Period 1||0
2535570|NCT00626275|6215499|P6|NOT COMPLETED|Part A - Washout Period 1||0
2535571|NCT00626275|6215500|P5|NOT COMPLETED|Part A - Washout Period 1||0
2535572|NCT00626275|6215501|P4|NOT COMPLETED|Part A - Washout Period 1||0
2535573|NCT00626275|6215502|P3|NOT COMPLETED|Part A - Washout Period 1||0
2535574|NCT00626275|6215503|P2|NOT COMPLETED|Part A - Washout Period 1||0
2535575|NCT00626275|6215504|P1|NOT COMPLETED|Part A - Washout Period 1||0
2535576|NCT00626275|6215497|P8|COMPLETED|Part A - Washout Period 1||0
2535577|NCT00626275|6215498|P7|COMPLETED|Part A - Washout Period 1||0
2535578|NCT00626275|6215499|P6|COMPLETED|Part A - Washout Period 1||8
2535579|NCT00626275|6215500|P5|COMPLETED|Part A - Washout Period 1||9
2535580|NCT00626275|6215501|P4|COMPLETED|Part A - Washout Period 1||8
2535581|NCT00626275|6215502|P3|COMPLETED|Part A - Washout Period 1||6
2535582|NCT00626275|6215503|P2|COMPLETED|Part A - Washout Period 1||7
2535583|NCT00626275|6215504|P1|COMPLETED|Part A - Washout Period 1||6
2535584|NCT00626275|6215497|P8|STARTED|Part A - Washout Period 1||0
2535585|NCT00626275|6215498|P7|STARTED|Part A - Washout Period 1||0
2535586|NCT00626275|6215499|P6|STARTED|Part A - Washout Period 1||8
2535587|NCT00626275|6215500|P5|STARTED|Part A - Washout Period 1||9
2535588|NCT00626275|6215501|P4|STARTED|Part A - Washout Period 1||8
2535589|NCT00626275|6215502|P3|STARTED|Part A - Washout Period 1||6
2535590|NCT00626275|6215503|P2|STARTED|Part A - Washout Period 1||7
2535591|NCT00626275|6215504|P1|STARTED|Part A - Washout Period 1||6
2535592|NCT00626275|6215497|P8|NOT COMPLETED|Part A - Treatment Period 1||0
2535593|NCT00626275|6215498|P7|NOT COMPLETED|Part A - Treatment Period 1||0
2535594|NCT00626275|6215499|P6|NOT COMPLETED|Part A - Treatment Period 1||0
2535595|NCT00626275|6215500|P5|NOT COMPLETED|Part A - Treatment Period 1||0
2535596|NCT00626275|6215501|P4|NOT COMPLETED|Part A - Treatment Period 1||0
2535597|NCT00626275|6215502|P3|NOT COMPLETED|Part A - Treatment Period 1||1
2535598|NCT00626275|6215503|P2|NOT COMPLETED|Part A - Treatment Period 1||0
2535599|NCT00626275|6215504|P1|NOT COMPLETED|Part A - Treatment Period 1||1
2535600|NCT00626275|6215497|P8|COMPLETED|Part A - Treatment Period 1||0
2535601|NCT00626275|6215498|P7|COMPLETED|Part A - Treatment Period 1||0
2535602|NCT00626275|6215499|P6|COMPLETED|Part A - Treatment Period 1||8
2535603|NCT00626275|6215500|P5|COMPLETED|Part A - Treatment Period 1||9
2535604|NCT00626275|6215501|P4|COMPLETED|Part A - Treatment Period 1||8
2535605|NCT00626275|6215502|P3|COMPLETED|Part A - Treatment Period 1||6
2535606|NCT00626275|6215503|P2|COMPLETED|Part A - Treatment Period 1||7
2535607|NCT00626275|6215504|P1|COMPLETED|Part A - Treatment Period 1||6
2535608|NCT00626275|6215497|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
2535609|NCT00626275|6215498|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
2535610|NCT00626275|6215499|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
2535611|NCT00626275|6215500|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||9
2535612|NCT00626275|6215501|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
2535613|NCT00626275|6215502|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
2535614|NCT00626275|6215503|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
2535615|NCT00626275|6215504|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
2535616|NCT00626275|6215497|P8|STARTED|Part A - Treatment Period 1||0
2535617|NCT00626275|6215498|P7|STARTED|Part A - Treatment Period 1||0
2535618|NCT00626275|6215499|P6|STARTED|Part A - Treatment Period 1||8
2535619|NCT00626275|6215500|P5|STARTED|Part A - Treatment Period 1||9
2535620|NCT00626275|6215501|P4|STARTED|Part A - Treatment Period 1||8
2535621|NCT00626275|6215502|P3|STARTED|Part A - Treatment Period 1||7
2535622|NCT00626275|6215503|P2|STARTED|Part A - Treatment Period 1||7
2535623|NCT00626275|6215504|P1|STARTED|Part A - Treatment Period 1||7
2535624|NCT00626210|6215544|P1|NOT COMPLETED|Overall Study||0
2535625|NCT00626210|6215544|P1|COMPLETED|Overall Study||2
2535626|NCT00626210|6215544|P1|STARTED|Overall Study||2
2535627|NCT00626093|6215548|P1|NOT COMPLETED|Overall Study||23
2535628|NCT00626093|6215548|P1|COMPLETED|Overall Study||54
2535629|NCT00626093|6215548|P1|STARTED|Overall Study||77
2535630|NCT00626028|6215555|P2|NOT COMPLETED|Overall Study||9
2535631|NCT00626028|6215556|P1|NOT COMPLETED|Overall Study||6
2535632|NCT00626028|6215555|P2|COMPLETED|Overall Study||59
2535633|NCT00626028|6215556|P1|COMPLETED|Overall Study||62
2535634|NCT00626028|6215555|P2|STARTED|Overall Study||68
2535635|NCT00626028|6215556|P1|STARTED|Overall Study||68
2535636|NCT00625989|6215570|P2|NOT COMPLETED|Overall Study||0
2535637|NCT00625989|6215571|P1|NOT COMPLETED|Overall Study||0
2535638|NCT00625989|6215570|P2|COMPLETED|Overall Study||6
2535639|NCT00625989|6215571|P1|COMPLETED|Overall Study||6
2535640|NCT00625989|6215570|P2|STARTED|Overall Study||6
2535641|NCT00625989|6215571|P1|STARTED|Overall Study||6
2535642|NCT00625872|6215580|P2|NOT COMPLETED|Overall Study||6
2535643|NCT00625872|6215581|P1|NOT COMPLETED|Overall Study||4
2535644|NCT00625872|6215580|P2|COMPLETED|Overall Study||5
2535645|NCT00625872|6215581|P1|COMPLETED|Overall Study||8
2535646|NCT00625872|6215580|P2|Treated|Overall Study||10
2535647|NCT00625872|6215581|P1|Treated|Overall Study||12
2535648|NCT00625872|6215580|P2|STARTED|Overall Study||11
2535649|NCT00625872|6215581|P1|STARTED|Overall Study||12
2535650|NCT00625820|6215691|P1|NOT COMPLETED|Overall Study||1
2535651|NCT00625820|6215691|P1|COMPLETED|Overall Study||16
2535652|NCT00625820|6215691|P1|STARTED|Overall Study||17
2535653|NCT00625807|6215699|P2|NOT COMPLETED|Overall Study||8
2535654|NCT00625807|6215700|P1|NOT COMPLETED|Overall Study||2
2535655|NCT00625807|6215699|P2|COMPLETED|Overall Study||20
2535656|NCT00625807|6215700|P1|COMPLETED|Overall Study||20
2535657|NCT00625807|6215699|P2|STARTED|Overall Study||28
2535658|NCT00625807|6215700|P1|STARTED|Overall Study||22
2535659|NCT00625742|6215716|P1|NOT COMPLETED|Overall Study||12
2535660|NCT00625742|6215716|P1|COMPLETED|Overall Study||3
2535661|NCT00625742|6215716|P1|STARTED|Overall Study||15
2535662|NCT00625729|6215721|P1|NOT COMPLETED|Overall Study||0
2535663|NCT00625729|6215721|P1|COMPLETED|Overall Study||6
2535664|NCT00625729|6215721|P1|STARTED|Overall Study||6
2535665|NCT00625586|6215730|P1|NOT COMPLETED|Overall Study||1
2535666|NCT00625586|6215730|P1|COMPLETED|Overall Study||1
2535667|NCT00625586|6215730|P1|STARTED|Overall Study||2
2535668|NCT00625443|6215743|P3|NOT COMPLETED|Overall Study||5
2535669|NCT00625443|6215744|P2|NOT COMPLETED|Overall Study||11
2535670|NCT00625443|6215745|P1|NOT COMPLETED|Overall Study||2
2535671|NCT00625443|6215743|P3|COMPLETED|Overall Study||10
2535672|NCT00625443|6215744|P2|COMPLETED|Overall Study||15
2535673|NCT00625443|6215745|P1|COMPLETED|Overall Study||10
2535674|NCT00625443|6215743|P3|STARTED|Overall Study||15
2535675|NCT00625443|6215744|P2|STARTED|Overall Study||26
2535676|NCT00625443|6215745|P1|STARTED|Overall Study||12
2535677|NCT00625404|6215775|P2|NOT COMPLETED|Overall Study||173
2535678|NCT00625404|6215776|P1|NOT COMPLETED|Overall Study||207
2535679|NCT00625404|6215775|P2|COMPLETED|Overall Study||885
2535680|NCT00625404|6215776|P1|COMPLETED|Overall Study||855
2535681|NCT00625404|6215775|P2|STARTED|Overall Study||1058
2535682|NCT00625404|6215776|P1|STARTED|Overall Study||1062
2535683|NCT00625391|6215808|P4|NOT COMPLETED|Overall Study||1
2535684|NCT00625391|6215809|P3|NOT COMPLETED|Overall Study||5
2535685|NCT00625391|6215810|P2|NOT COMPLETED|Overall Study||8
2535686|NCT00625391|6215811|P1|NOT COMPLETED|Overall Study||7
2535687|NCT00625391|6215808|P4|COMPLETED|Overall Study||37
2535688|NCT00625391|6215809|P3|COMPLETED|Overall Study||37
2535689|NCT00625391|6215810|P2|COMPLETED|Overall Study||39
2535690|NCT00625391|6215811|P1|COMPLETED|Overall Study||37
2535691|NCT00625391|6215808|P4|STARTED|Overall Study||38
2535692|NCT00625391|6215809|P3|STARTED|Overall Study||42
2535693|NCT00625391|6215810|P2|STARTED|Overall Study||47
2535694|NCT00625391|6215811|P1|STARTED|Overall Study||44
2535695|NCT00625365|6215825|P1|NOT COMPLETED|Overall Study||7
2535696|NCT00625365|6215825|P1|COMPLETED|Overall Study|Participants who were analyzed for safety|1053
2535697|NCT00625365|6215825|P1|STARTED|Overall Study||1060
2535698|NCT00625183|6215831|P1|NOT COMPLETED|Overall Study||1
2535699|NCT00625183|6215831|P1|COMPLETED|Overall Study||4
2535700|NCT00625183|6215831|P1|STARTED|Overall Study||5
2535701|NCT00625131|6215842|P3|NOT COMPLETED|Overall Study||5
2535702|NCT00625131|6215843|P2|NOT COMPLETED|Overall Study||2
2535703|NCT00625131|6215844|P1|NOT COMPLETED|Overall Study||4
2535704|NCT00625131|6215842|P3|COMPLETED|Overall Study||0
2535705|NCT00625131|6215843|P2|COMPLETED|Overall Study||42
2535706|NCT00625131|6215844|P1|COMPLETED|Overall Study||34
2535707|NCT00625131|6215842|P3|STARTED|Overall Study|These participants were not included in any analyses.|5
2535708|NCT00625131|6215843|P2|STARTED|Overall Study||44
2535709|NCT00625131|6215844|P1|STARTED|Overall Study||38
2535710|NCT00624923|6215856|P2|NOT COMPLETED|Overall Study||23
2535711|NCT00624923|6215857|P1|NOT COMPLETED|Overall Study||38
2535712|NCT00624923|6215856|P2|COMPLETED|Overall Study||101
2535713|NCT00624923|6215857|P1|COMPLETED|Overall Study||89
2535714|NCT00624923|6215856|P2|STARTED|Overall Study||124
2535715|NCT00624923|6215857|P1|STARTED|Overall Study||127
2535716|NCT00624832|6215873|P4|NOT COMPLETED|Overall Study||1
2535717|NCT00624832|6215874|P3|NOT COMPLETED|Overall Study||0
2535718|NCT00624832|6215875|P2|NOT COMPLETED|Overall Study||1
2535719|NCT00624832|6215876|P1|NOT COMPLETED|Overall Study||2
2535720|NCT00624832|6215873|P4|COMPLETED|Overall Study||15
2535721|NCT00624832|6215874|P3|COMPLETED|Overall Study||10
2535722|NCT00624832|6215875|P2|COMPLETED|Overall Study||15
2535723|NCT00624832|6215876|P1|COMPLETED|Overall Study||16
2535724|NCT00624832|6215873|P4|STARTED|Overall Study||16
2535725|NCT00624832|6215874|P3|STARTED|Overall Study||10
2535726|NCT00624832|6215875|P2|STARTED|Overall Study||16
2535727|NCT00624832|6215876|P1|STARTED|Overall Study||18
2535728|NCT00624806|6215890|P2|NOT COMPLETED|Overall Study||0
2535729|NCT00624806|6215891|P1|NOT COMPLETED|Overall Study||0
2535730|NCT00624806|6215890|P2|COMPLETED|Overall Study||8
2535731|NCT00624806|6215891|P1|COMPLETED|Overall Study||10
2535732|NCT00624806|6215890|P2|STARTED|Overall Study||8
2535733|NCT00624806|6215891|P1|STARTED|Overall Study||10
2535734|NCT00624780|6215907|P6|NOT COMPLETED|Follow-up (Week 26)||0
2535735|NCT00624780|6215908|P5|NOT COMPLETED|Follow-up (Week 26)||2
2535736|NCT00624780|6215909|P4|NOT COMPLETED|Follow-up (Week 26)||0
2535737|NCT00624780|6215910|P3|NOT COMPLETED|Follow-up (Week 26)||2
2535738|NCT00624780|6215911|P2|NOT COMPLETED|Follow-up (Week 26)||1
2535739|NCT00624780|6215912|P1|NOT COMPLETED|Follow-up (Week 26)||2
2535740|NCT00624780|6215907|P6|COMPLETED|Follow-up (Week 26)||29
2535741|NCT00624780|6215908|P5|COMPLETED|Follow-up (Week 26)||93
2535742|NCT00624780|6215909|P4|COMPLETED|Follow-up (Week 26)||26
2535743|NCT00624780|6215910|P3|COMPLETED|Follow-up (Week 26)||89
2535744|NCT00624780|6215911|P2|COMPLETED|Follow-up (Week 26)||27
2535745|NCT00624780|6215912|P1|COMPLETED|Follow-up (Week 26)||102
2535746|NCT00624780|6215907|P6|STARTED|Follow-up (Week 26)||29
2535747|NCT00624780|6215908|P5|STARTED|Follow-up (Week 26)||95
2535748|NCT00624780|6215909|P4|STARTED|Follow-up (Week 26)||26
2535749|NCT00624780|6215910|P3|STARTED|Follow-up (Week 26)||91
2535750|NCT00624780|6215911|P2|STARTED|Follow-up (Week 26)||28
2535751|NCT00624780|6215912|P1|STARTED|Follow-up (Week 26)||104
2535752|NCT00624780|6215907|P6|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
2535753|NCT00624780|6215908|P5|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
2535754|NCT00624780|6215909|P4|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
2535755|NCT00624780|6215910|P3|NOT COMPLETED|Treatment Discontinuation (Week 25)||3
2535756|NCT00624780|6215911|P2|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
2535757|NCT00624780|6215912|P1|NOT COMPLETED|Treatment Discontinuation (Week 25)||2
2535758|NCT00624780|6215907|P6|COMPLETED|Treatment Discontinuation (Week 25)||29
2535759|NCT00624780|6215908|P5|COMPLETED|Treatment Discontinuation (Week 25)||95
2535760|NCT00624780|6215909|P4|COMPLETED|Treatment Discontinuation (Week 25)||26
2535761|NCT00624780|6215910|P3|COMPLETED|Treatment Discontinuation (Week 25)||91
2535762|NCT00624780|6215911|P2|COMPLETED|Treatment Discontinuation (Week 25)||28
2535763|NCT00624780|6215912|P1|COMPLETED|Treatment Discontinuation (Week 25)||104
2535764|NCT00624780|6215907|P6|STARTED|Treatment Discontinuation (Week 25)||30
2535765|NCT00624780|6215908|P5|STARTED|Treatment Discontinuation (Week 25)||95
2535766|NCT00624780|6215909|P4|STARTED|Treatment Discontinuation (Week 25)||27
2535767|NCT00624780|6215910|P3|STARTED|Treatment Discontinuation (Week 25)||94
2535768|NCT00624780|6215911|P2|STARTED|Treatment Discontinuation (Week 25)||28
2535769|NCT00624780|6215912|P1|STARTED|Treatment Discontinuation (Week 25)||106
2535770|NCT00624780|6215907|P6|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||9
2535771|NCT00624780|6215908|P5|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||19
2535772|NCT00624780|6215909|P4|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
2535773|NCT00624780|6215910|P3|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||18
2535774|NCT00624780|6215911|P2|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
2535775|NCT00624780|6215912|P1|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||15
2535776|NCT00624780|6215907|P6|COMPLETED|Fixed Dosing (Week 13 to Week 24)||30
2535777|NCT00624780|6215908|P5|COMPLETED|Fixed Dosing (Week 13 to Week 24)||95
2535778|NCT00624780|6215909|P4|COMPLETED|Fixed Dosing (Week 13 to Week 24)||27
2535779|NCT00624780|6215910|P3|COMPLETED|Fixed Dosing (Week 13 to Week 24)||94
2535780|NCT00624780|6215911|P2|COMPLETED|Fixed Dosing (Week 13 to Week 24)||28
2535781|NCT00624780|6215912|P1|COMPLETED|Fixed Dosing (Week 13 to Week 24)||106
2535782|NCT00624780|6215907|P6|STARTED|Fixed Dosing (Week 13 to Week 24)||39
2535783|NCT00624780|6215908|P5|STARTED|Fixed Dosing (Week 13 to Week 24)||114
2535784|NCT00624780|6215909|P4|STARTED|Fixed Dosing (Week 13 to Week 24)||38
2535785|NCT00624780|6215910|P3|STARTED|Fixed Dosing (Week 13 to Week 24)||112
2535786|NCT00624780|6215911|P2|STARTED|Fixed Dosing (Week 13 to Week 24)||39
2535787|NCT00624780|6215912|P1|STARTED|Fixed Dosing (Week 13 to Week 24)||121
2535788|NCT00624780|6215907|P6|NOT COMPLETED|Treatment Optimization (Up to Week 12)||11
2535789|NCT00624780|6215908|P5|NOT COMPLETED|Treatment Optimization (Up to Week 12)||39
2535790|NCT00624780|6215909|P4|NOT COMPLETED|Treatment Optimization (Up to Week 12)||14
2535791|NCT00624780|6215910|P3|NOT COMPLETED|Treatment Optimization (Up to Week 12)||42
2535792|NCT00624780|6215911|P2|NOT COMPLETED|Treatment Optimization (Up to Week 12)||13
2535793|NCT00624780|6215912|P1|NOT COMPLETED|Treatment Optimization (Up to Week 12)||33
2535794|NCT00624780|6215907|P6|COMPLETED|Treatment Optimization (Up to Week 12)||39
2535795|NCT00624780|6215908|P5|COMPLETED|Treatment Optimization (Up to Week 12)||114
2535796|NCT00624780|6215909|P4|COMPLETED|Treatment Optimization (Up to Week 12)||38
2535797|NCT00624780|6215910|P3|COMPLETED|Treatment Optimization (Up to Week 12)||112
2535798|NCT00624780|6215911|P2|COMPLETED|Treatment Optimization (Up to Week 12)||39
2535799|NCT00624780|6215912|P1|COMPLETED|Treatment Optimization (Up to Week 12)||121
2535800|NCT00624780|6215907|P6|STARTED|Treatment Optimization (Up to Week 12)||50
2535801|NCT00624780|6215908|P5|STARTED|Treatment Optimization (Up to Week 12)||153
2535802|NCT00624780|6215909|P4|STARTED|Treatment Optimization (Up to Week 12)||52
2535803|NCT00624780|6215910|P3|STARTED|Treatment Optimization (Up to Week 12)||154
2535804|NCT00624780|6215911|P2|STARTED|Treatment Optimization (Up to Week 12)||52
2535805|NCT00624780|6215912|P1|STARTED|Treatment Optimization (Up to Week 12)||154
2535806|NCT00624650|6216096|P2|NOT COMPLETED|Overall Study||1
2535807|NCT00624650|6216097|P1|NOT COMPLETED|Overall Study||1
2535808|NCT00624650|6216096|P2|COMPLETED|Overall Study||15
2535809|NCT00624650|6216097|P1|COMPLETED|Overall Study||16
2535810|NCT00624650|6216096|P2|STARTED|Overall Study||16
2535811|NCT00624650|6216097|P1|STARTED|Overall Study||17
2535812|NCT00624585|6216103|P1|NOT COMPLETED|Overall Study||12
2535813|NCT00624585|6216103|P1|COMPLETED|Overall Study||6
2535814|NCT00624585|6216103|P1|STARTED|Overall Study||18
2535815|NCT00624559|6216114|P4|NOT COMPLETED|Overall Study||0
2535816|NCT00624559|6216115|P3|NOT COMPLETED|Overall Study||0
2535817|NCT00624559|6216116|P2|NOT COMPLETED|Overall Study||0
2535818|NCT00624559|6216117|P1|NOT COMPLETED|Overall Study||0
2535819|NCT00624559|6216114|P4|COMPLETED|Overall Study||3
2535820|NCT00624559|6216115|P3|COMPLETED|Overall Study||3
2535821|NCT00624559|6216116|P2|COMPLETED|Overall Study||3
2535822|NCT00624559|6216117|P1|COMPLETED|Overall Study||3
2535823|NCT00624559|6216114|P4|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
2535824|NCT00624559|6216115|P3|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
2535825|NCT00624559|6216116|P2|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
2535826|NCT00624559|6216117|P1|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
2535827|NCT00624520|6216133|P2|NOT COMPLETED|Overall Study||8
2535828|NCT00624520|6216134|P1|NOT COMPLETED|Overall Study||12
2535829|NCT00624520|6216133|P2|COMPLETED|Overall Study||39
2535830|NCT00624520|6216134|P1|COMPLETED|Overall Study||44
2535831|NCT00624520|6216133|P2|STARTED|Overall Study||47
2535832|NCT00624520|6216134|P1|STARTED|Overall Study||56
2535833|NCT00624468|6216161|P4|NOT COMPLETED|Safety Follow-up (SFU) Period||3
2535834|NCT00624468|6216162|P3|NOT COMPLETED|Safety Follow-up (SFU) Period||2
2535835|NCT00624468|6216163|P2|NOT COMPLETED|Safety Follow-up (SFU) Period||0
2535836|NCT00624468|6216164|P1|NOT COMPLETED|Safety Follow-up (SFU) Period||0
2535837|NCT00624468|6216161|P4|COMPLETED|Safety Follow-up (SFU) Period||11
2535838|NCT00624468|6216162|P3|COMPLETED|Safety Follow-up (SFU) Period||11
2535839|NCT00624468|6216163|P2|COMPLETED|Safety Follow-up (SFU) Period||0
2535840|NCT00624468|6216164|P1|COMPLETED|Safety Follow-up (SFU) Period||0
2535841|NCT00624468|6216161|P4|STARTED|Safety Follow-up (SFU) Period||14
2535842|NCT00624468|6216162|P3|STARTED|Safety Follow-up (SFU) Period||13
2535843|NCT00624468|6216163|P2|STARTED|Safety Follow-up (SFU) Period||0
2535844|NCT00624468|6216164|P1|STARTED|Safety Follow-up (SFU) Period||0
2535845|NCT00624468|6216161|P4|NOT COMPLETED|Double-blind Period||0
2535846|NCT00624468|6216162|P3|NOT COMPLETED|Double-blind Period||0
2535847|NCT00624468|6216163|P2|NOT COMPLETED|Double-blind Period||13
2535848|NCT00624468|6216164|P1|NOT COMPLETED|Double-blind Period||14
2535849|NCT00624468|6216161|P4|COMPLETED|Double-blind Period||0
2535850|NCT00624468|6216162|P3|COMPLETED|Double-blind Period||0
2535851|NCT00624468|6216163|P2|COMPLETED|Double-blind Period||4
2535852|NCT00624468|6216164|P1|COMPLETED|Double-blind Period||3
2535853|NCT00624468|6216161|P4|STARTED|Double-blind Period||0
2535854|NCT00624468|6216162|P3|STARTED|Double-blind Period||0
2535855|NCT00624468|6216163|P2|STARTED|Double-blind Period||17
2535856|NCT00624468|6216164|P1|STARTED|Double-blind Period||17
2535857|NCT00624442|6216195|P5|NOT COMPLETED|Overall Study||2
2535858|NCT00624442|6216196|P4|NOT COMPLETED|Overall Study||0
2535859|NCT00624442|6216197|P3|NOT COMPLETED|Overall Study||2
2535860|NCT00624442|6216198|P2|NOT COMPLETED|Overall Study||1
2535861|NCT00624442|6216199|P1|NOT COMPLETED|Overall Study||0
2535862|NCT00624442|6216195|P5|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
2535863|NCT00624442|6216196|P4|COMPLETED|Overall Study||8
2535864|NCT00624442|6216197|P3|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
2535865|NCT00624442|6216198|P2|COMPLETED|Overall Study|One patient was discontinued after inadvertant overdose.|8
2535866|NCT00624442|6216199|P1|COMPLETED|Overall Study||8
2535867|NCT00624442|6216195|P5|STARTED|Overall Study||10
2535868|NCT00624442|6216196|P4|STARTED|Overall Study||8
2535869|NCT00624442|6216197|P3|STARTED|Overall Study||10
2535870|NCT00624442|6216198|P2|STARTED|Overall Study||9
2535871|NCT00624442|6216199|P1|STARTED|Overall Study||8
2535872|NCT00624416|6216225|P1|NOT COMPLETED|Overall Study||0
2535873|NCT00624416|6216225|P1|COMPLETED|Overall Study||10
2535874|NCT00624416|6216225|P1|STARTED|Overall Study||10
2535875|NCT00624377|6216231|P1|NOT COMPLETED|Overall Study||644
2535876|NCT00624377|6216231|P1|COMPLETED|Overall Study||1387
2535877|NCT00624377|6216231|P1|STARTED|Overall Study||2031
2535878|NCT00624338|6216245|P3|NOT COMPLETED|Overall Study||46
2535879|NCT00624338|6216246|P2|NOT COMPLETED|Overall Study||83
2535880|NCT00624338|6216247|P1|NOT COMPLETED|Overall Study||47
2535881|NCT00624338|6216245|P3|COMPLETED|Overall Study||111
2535882|NCT00624338|6216246|P2|COMPLETED|Overall Study||62
2535883|NCT00624338|6216247|P1|COMPLETED|Overall Study||112
2535884|NCT00624338|6216245|P3|Treated|Overall Study||154
2535885|NCT00624338|6216246|P2|Treated|Overall Study||144
2535886|NCT00624338|6216247|P1|Treated|Overall Study||157
2535887|NCT00624338|6216245|P3|STARTED|Overall Study||157
2535888|NCT00624338|6216246|P2|STARTED|Overall Study||145
2535889|NCT00624338|6216247|P1|STARTED|Overall Study||159
2535890|NCT00624286|6216269|P2|NOT COMPLETED|Overall Study||27
2535891|NCT00624286|6216270|P1|NOT COMPLETED|Overall Study||25
2535892|NCT00624286|6216269|P2|COMPLETED|Overall Study||178
2535893|NCT00624286|6216270|P1|COMPLETED|Overall Study||186
2535894|NCT00624286|6216269|P2|STARTED|Overall Study||205
2535895|NCT00624286|6216270|P1|STARTED|Overall Study||211
2535896|NCT00624234|6216284|P6|NOT COMPLETED|Overall Study||0
2535897|NCT00624234|6216285|P5|NOT COMPLETED|Overall Study||0
2535898|NCT00624234|6216286|P4|NOT COMPLETED|Overall Study||0
2535899|NCT00624234|6216287|P3|NOT COMPLETED|Overall Study||0
2535900|NCT00624234|6216288|P2|NOT COMPLETED|Overall Study||0
2535901|NCT00624234|6216289|P1|NOT COMPLETED|Overall Study||0
2535902|NCT00624234|6216284|P6|COMPLETED|Overall Study||14
2535903|NCT00624234|6216285|P5|COMPLETED|Overall Study||18
2535904|NCT00624234|6216286|P4|COMPLETED|Overall Study||14
2535905|NCT00624234|6216287|P3|COMPLETED|Overall Study||26
2535906|NCT00624234|6216288|P2|COMPLETED|Overall Study||9
2535907|NCT00624234|6216289|P1|COMPLETED|Overall Study||8
2535908|NCT00624234|6216284|P6|STARTED|Overall Study||14
2535909|NCT00624234|6216285|P5|STARTED|Overall Study||18
2535910|NCT00624234|6216286|P4|STARTED|Overall Study||14
2535911|NCT00624234|6216287|P3|STARTED|Overall Study||26
2535912|NCT00624234|6216288|P2|STARTED|Overall Study||9
2535913|NCT00624234|6216289|P1|STARTED|Overall Study||8
2535914|NCT00624221|6216305|P2|NOT COMPLETED|Overall Study||0
2535915|NCT00624221|6216306|P1|NOT COMPLETED|Overall Study||0
2535916|NCT00624221|6216305|P2|COMPLETED|Overall Study||20
2535917|NCT00624221|6216306|P1|COMPLETED|Overall Study||20
2535918|NCT00624221|6216305|P2|STARTED|Overall Study||20
2535919|NCT00624221|6216306|P1|STARTED|Overall Study||20
2535920|NCT00624195|6216314|P2|NOT COMPLETED|Overall Study||7
2535921|NCT00624195|6216315|P1|NOT COMPLETED|Overall Study||3
2535922|NCT00624195|6216314|P2|COMPLETED|Overall Study||23
2535923|NCT00624195|6216315|P1|COMPLETED|Overall Study||26
2535924|NCT00624195|6216314|P2|STARTED|Overall Study||30
2535925|NCT00624195|6216315|P1|STARTED|Overall Study||29
2535926|NCT00624065|6216323|P2|NOT COMPLETED|Overall Study||24
2535927|NCT00624065|6216324|P1|NOT COMPLETED|Overall Study||19
2535928|NCT00624065|6216323|P2|COMPLETED|Overall Study||192
2535929|NCT00624065|6216324|P1|COMPLETED|Overall Study||197
2535930|NCT00624065|6216323|P2|STARTED|Overall Study||216
2535931|NCT00624065|6216324|P1|STARTED|Overall Study||216
2535932|NCT00624052|6216336|P4|NOT COMPLETED|Overall Study||4
2535933|NCT00624052|6216337|P3|NOT COMPLETED|Overall Study||3
2535934|NCT00624052|6216338|P2|NOT COMPLETED|Overall Study||14
2535935|NCT00624052|6216339|P1|NOT COMPLETED|Overall Study||15
2535936|NCT00624052|6216336|P4|COMPLETED|Overall Study||88
2535937|NCT00624052|6216337|P3|COMPLETED|Overall Study||88
2535938|NCT00624052|6216338|P2|COMPLETED|Overall Study||422
2535939|NCT00624052|6216339|P1|COMPLETED|Overall Study||204
2535940|NCT00624052|6216336|P4|STARTED|Overall Study||92
2535941|NCT00624052|6216337|P3|STARTED|Overall Study||91
2535942|NCT00624052|6216338|P2|STARTED|Overall Study||436
2535943|NCT00624052|6216339|P1|STARTED|Overall Study||219
2535944|NCT00624013|6216390|P2|NOT COMPLETED|Overall Study||6
2535945|NCT00624013|6216391|P1|NOT COMPLETED|Overall Study||8
2535946|NCT00624013|6216390|P2|COMPLETED|Overall Study||39
2535947|NCT00624013|6216391|P1|COMPLETED|Overall Study||36
2535948|NCT00624013|6216390|P2|STARTED|Overall Study||45
2535949|NCT00624013|6216391|P1|STARTED|Overall Study||44
2535950|NCT00623974|6216403|P4|NOT COMPLETED|Overall Study||0
2535951|NCT00623974|6216404|P3|NOT COMPLETED|Overall Study||0
2535952|NCT00623974|6216405|P2|NOT COMPLETED|Overall Study||0
2535953|NCT00623974|6216406|P1|NOT COMPLETED|Overall Study||0
2535954|NCT00623974|6216403|P4|COMPLETED|Overall Study||0
2535955|NCT00623974|6216404|P3|COMPLETED|Overall Study||0
2535956|NCT00623974|6216405|P2|COMPLETED|Overall Study||0
2535957|NCT00623974|6216406|P1|COMPLETED|Overall Study||0
2535958|NCT00623974|6216403|P4|STARTED|Overall Study||0
2535959|NCT00623974|6216404|P3|STARTED|Overall Study||0
2535960|NCT00623974|6216405|P2|STARTED|Overall Study||0
2535961|NCT00623974|6216406|P1|STARTED|Overall Study||0
2535962|NCT00623935|6216416|P1|NOT COMPLETED|Overall Study||2
2535963|NCT00623935|6216416|P1|COMPLETED|Overall Study||54
2535964|NCT00623935|6216416|P1|STARTED|Overall Study||56
2535965|NCT00623831|6216423|P2|NOT COMPLETED|Overall Study||1
2535966|NCT00623831|6216424|P1|NOT COMPLETED|Overall Study||1
2535967|NCT00623831|6216423|P2|COMPLETED|Overall Study||3
2535968|NCT00623831|6216424|P1|COMPLETED|Overall Study||12
2535969|NCT00623831|6216423|P2|STARTED|Overall Study||4
2535970|NCT00623831|6216424|P1|STARTED|Overall Study||13
2535971|NCT00623805|6216436|P2|NOT COMPLETED|Overall Study||22
2535972|NCT00623805|6216437|P1|NOT COMPLETED|Overall Study||20
2535973|NCT00623805|6216436|P2|COMPLETED|Overall Study||39
2535974|NCT00623805|6216437|P1|COMPLETED|Overall Study||42
2535975|NCT00623805|6216436|P2|STARTED|Overall Study||61
2535976|NCT00623805|6216437|P1|STARTED|Overall Study||62
2535977|NCT00623779|6216454|P3|NOT COMPLETED|Overall Study||1
2535978|NCT00623779|6216455|P2|NOT COMPLETED|Overall Study||3
2535979|NCT00623779|6216456|P1|NOT COMPLETED|Overall Study||3
2535980|NCT00623779|6216454|P3|COMPLETED|Overall Study||44
2535981|NCT00623779|6216455|P2|COMPLETED|Overall Study||39
2535982|NCT00623779|6216456|P1|COMPLETED|Overall Study||38
2535983|NCT00623779|6216454|P3|STARTED|Overall Study||45
2535984|NCT00623779|6216455|P2|STARTED|Overall Study||42
2535985|NCT00623779|6216456|P1|STARTED|Overall Study||41
2535986|NCT00623766|6216505|P2|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||2
2535987|NCT00623766|6216506|P1|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||10
2535988|NCT00623766|6216505|P2|COMPLETED|Maintenance Phase (Week 24 to Year 2)||0
2535989|NCT00623766|6216506|P1|COMPLETED|Maintenance Phase (Week 24 to Year 2)|Inadvertently not noted as discontinued (disease progression); data collection error at site closure|1
2535990|NCT00623766|6216505|P2|STARTED|Maintenance Phase (Week 24 to Year 2)||2
2535991|NCT00623766|6216506|P1|STARTED|Maintenance Phase (Week 24 to Year 2)||11
2535992|NCT00623766|6216505|P2|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||16
2535993|NCT00623766|6216506|P1|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||36
2535994|NCT00623766|6216505|P2|COMPLETED|Induction Phase (Day 1 to Week 24)|3 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|5
2535995|NCT00623766|6216506|P1|COMPLETED|Induction Phase (Day 1 to Week 24)|4 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|15
2535996|NCT00623766|6216505|P2|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|21
2535997|NCT00623766|6216506|P1|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|51
2535998|NCT00623727|6216530|P2|NOT COMPLETED|Open Label Extension Period||0
2535999|NCT00623727|6216531|P1|NOT COMPLETED|Open Label Extension Period||0
2536000|NCT00623727|6216530|P2|COMPLETED|Open Label Extension Period||0
2536001|NCT00623727|6216531|P1|COMPLETED|Open Label Extension Period||20
2536002|NCT00623727|6216530|P2|STARTED|Open Label Extension Period||0
2536003|NCT00623727|6216531|P1|STARTED|Open Label Extension Period|10 participants of each group entered open-label extension period after completion of DB study|20
2536004|NCT00623727|6216530|P2|NOT COMPLETED|Open Label Follow-up||8
2536005|NCT00623727|6216531|P1|NOT COMPLETED|Open Label Follow-up||0
2536006|NCT00623727|6216530|P2|COMPLETED|Open Label Follow-up||18
2536007|NCT00623727|6216531|P1|COMPLETED|Open Label Follow-up||0
2536008|NCT00623727|6216530|P2|STARTED|Open Label Follow-up|13 Participants from each group after DB period terminated entered open label follow up.|26
2536009|NCT00623727|6216531|P1|STARTED|Open Label Follow-up||0
2536010|NCT00623727|6216530|P2|NOT COMPLETED|Double Blind (DB)||32
2536011|NCT00623727|6216531|P1|NOT COMPLETED|Double Blind (DB)||36
2536012|NCT00623727|6216530|P2|COMPLETED|Double Blind (DB)||41
2536013|NCT00623727|6216531|P1|COMPLETED|Double Blind (DB)||34
2536014|NCT00623727|6216530|P2|Participants Received Treatment|Double Blind (DB)||72
2536015|NCT00623727|6216531|P1|Participants Received Treatment|Double Blind (DB)||67
2536016|NCT00623727|6216530|P2|STARTED|Double Blind (DB)|only 72 participants are applicable for baseline characteristic evaluation|73
2536017|NCT00623727|6216531|P1|STARTED|Double Blind (DB)|only 67 participants are applicable for baseline characteristic evaluation|70
2536018|NCT00623714|6216551|P2|NOT COMPLETED|Period 2||0
2536019|NCT00623714|6216552|P1|NOT COMPLETED|Period 2||0
2536020|NCT00623714|6216551|P2|COMPLETED|Period 2||7
2536021|NCT00623714|6216552|P1|COMPLETED|Period 2||6
2536022|NCT00623714|6216551|P2|STARTED|Period 2||7
2536023|NCT00623714|6216552|P1|STARTED|Period 2||6
2536024|NCT00623714|6216551|P2|NOT COMPLETED|Period 1||0
2536025|NCT00623714|6216552|P1|NOT COMPLETED|Period 1||0
2536026|NCT00623714|6216551|P2|COMPLETED|Period 1||7
2536027|NCT00623714|6216552|P1|COMPLETED|Period 1||6
2536028|NCT00623714|6216551|P2|STARTED|Period 1||7
2536029|NCT00623714|6216552|P1|STARTED|Period 1||6
2536030|NCT00623636|6216562|P2|NOT COMPLETED|Open Label||412
2536031|NCT00623636|6216563|P1|NOT COMPLETED|Open Label||0
2536032|NCT00623636|6216562|P2|COMPLETED|Open Label||263
2536033|NCT00623636|6216563|P1|COMPLETED|Open Label||0
2536034|NCT00623636|6216562|P2|STARTED|Open Label|Includes eligible Placebo and MAP0004 patients from the double-blind period.|675
2536035|NCT00623636|6216563|P1|STARTED|Open Label|Eligible double-blind placebo patients received MAP0004 in the open-label period.|0
2536036|NCT00623636|6216562|P2|NOT COMPLETED|Double Blind||28
2536037|NCT00623636|6216563|P1|NOT COMPLETED|Double Blind||33
2536038|NCT00623636|6216562|P2|COMPLETED|Double Blind||422
2536039|NCT00623636|6216563|P1|COMPLETED|Double Blind||419
2536040|NCT00623636|6216562|P2|STARTED|Double Blind||450
2536041|NCT00623636|6216563|P1|STARTED|Double Blind||452
2536042|NCT00623623|6216586|P2|NOT COMPLETED|Overall Study||1
2536043|NCT00623623|6216587|P1|NOT COMPLETED|Overall Study||1
2536044|NCT00623623|6216586|P2|COMPLETED|Overall Study||948
2536045|NCT00623623|6216587|P1|COMPLETED|Overall Study||949
2536046|NCT00623623|6216586|P2|STARTED|Overall Study||949
2536047|NCT00623623|6216587|P1|STARTED|Overall Study||950
2536048|NCT00623597|6216643|P2|NOT COMPLETED|Overall Study||0
2536049|NCT00623597|6216644|P1|NOT COMPLETED|Overall Study||1
2536050|NCT00623597|6216643|P2|COMPLETED|Overall Study||13
2536051|NCT00623597|6216644|P1|COMPLETED|Overall Study||4
2536052|NCT00623597|6216643|P2|STARTED|Overall Study||13
2536053|NCT00623597|6216644|P1|STARTED|Overall Study||5
2536054|NCT00623545|6216707|P1|NOT COMPLETED|Overall Study||10
2536055|NCT00623545|6216707|P1|COMPLETED|Overall Study||18
2536056|NCT00623545|6216707|P1|STARTED|Overall Study||28
2536057|NCT00623506|6216714|P2|NOT COMPLETED|Overall Study||4
2536058|NCT00623506|6216715|P1|NOT COMPLETED|Overall Study||4
2536059|NCT00623506|6216714|P2|COMPLETED|Overall Study||11
2536060|NCT00623506|6216715|P1|COMPLETED|Overall Study||11
2536061|NCT00623506|6216714|P2|Week 4|Overall Study||11
2536062|NCT00623506|6216715|P1|Week 4|Overall Study||11
2536063|NCT00623506|6216714|P2|STARTED|Overall Study||15
2536064|NCT00623506|6216715|P1|STARTED|Overall Study||15
2536065|NCT00623480|6216727|P2|NOT COMPLETED|Overall Study||7
2536066|NCT00623480|6216728|P1|NOT COMPLETED|Overall Study||7
2536067|NCT00623480|6216727|P2|COMPLETED|Overall Study||35
2536068|NCT00623480|6216728|P1|COMPLETED|Overall Study||35
2536069|NCT00623480|6216727|P2|STARTED|Overall Study||42
2536070|NCT00623480|6216728|P1|STARTED|Overall Study||42
2536071|NCT00623467|6216740|P1|NOT COMPLETED|Overall Study||7
2536072|NCT00623467|6216740|P1|COMPLETED|Overall Study||336
2536073|NCT00623467|6216740|P1|STARTED|Overall Study||343
2536074|NCT00623441|6216804|P1|NOT COMPLETED|Overall Study||0
2536075|NCT00623441|6216804|P1|COMPLETED|Overall Study|12 months follow-up compliance was 94.2%|8314
2536076|NCT00623441|6216804|P1|STARTED|Overall Study||8314
2536077|NCT00623428|6216810|P2|NOT COMPLETED|Follow-up Period||15
2536078|NCT00623428|6216811|P1|NOT COMPLETED|Follow-up Period||29
2536079|NCT00623428|6216810|P2|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 24 weeks of follow-up|78
2536080|NCT00623428|6216811|P1|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 48 weeks of follow-up|66
2536081|NCT00623428|6216810|P2|STARTED|Follow-up Period||93
2536082|NCT00623428|6216811|P1|STARTED|Follow-up Period||95
2536083|NCT00623428|6216810|P2|NOT COMPLETED|Treatment Period||27
2536084|NCT00623428|6216811|P1|NOT COMPLETED|Treatment Period||0
2536085|NCT00623428|6216810|P2|COMPLETED|Treatment Period|Patients who completed 48 weeks of treatment|66
2536086|NCT00623428|6216811|P1|COMPLETED|Treatment Period|Patients who completed 24 weeks of treatment|95
2536087|NCT00623428|6216810|P2|STARTED|Treatment Period||93
2536088|NCT00623428|6216811|P1|STARTED|Treatment Period||95
2536089|NCT00623233|6216829|P1|NOT COMPLETED|Overall Study||24
2536090|NCT00623233|6216829|P1|COMPLETED|Overall Study|Included those who discontinued due to PD or death and those who achieved complete response (CR).|28
2536091|NCT00623233|6216829|P1|STARTED|Overall Study||52
2536092|NCT00623194|6216836|P1|NOT COMPLETED|Overall Study||5
2536093|NCT00623194|6216836|P1|COMPLETED|Overall Study||141
2536094|NCT00623194|6216836|P1|STARTED|Overall Study||146
2536095|NCT00623181|6216858|P2|NOT COMPLETED|Overall Study||0
2536096|NCT00623181|6216859|P1|NOT COMPLETED|Overall Study||0
2536097|NCT00623181|6216858|P2|COMPLETED|Overall Study||54
2536098|NCT00623181|6216859|P1|COMPLETED|Overall Study||56
2536099|NCT00623181|6216858|P2|STARTED|Overall Study||54
2536100|NCT00623181|6216859|P1|STARTED|Overall Study||56
2536101|NCT00623103|6216873|P2|NOT COMPLETED|Overall Study||113
2536102|NCT00623103|6216874|P1|NOT COMPLETED|Overall Study||111
2536103|NCT00623103|6216873|P2|COMPLETED|Overall Study||175
2536104|NCT00623103|6216874|P1|COMPLETED|Overall Study||184
2536105|NCT00623103|6216873|P2|Safety Set: Received Study Drug|Overall Study||288
2536106|NCT00623103|6216874|P1|Safety Set: Received Study Drug|Overall Study|One randomized participant did not receive study drug and was not included in the Safety set.|294
2536107|NCT00623103|6216873|P2|STARTED|Overall Study||288
2536108|NCT00623103|6216874|P1|STARTED|Overall Study||295
2536109|NCT00623012|6216894|P1|NOT COMPLETED|Overall Study||0
2536110|NCT00623012|6216894|P1|COMPLETED|Overall Study||2
2536111|NCT00623012|6216894|P1|STARTED|Overall Study||2
2536112|NCT00622908|6216902|P2|NOT COMPLETED|Overall Study||10
2536113|NCT00622908|6216903|P1|NOT COMPLETED|Overall Study||3
2536114|NCT00622908|6216902|P2|COMPLETED|Overall Study||122
2536115|NCT00622908|6216903|P1|COMPLETED|Overall Study||134
2536116|NCT00622908|6216902|P2|STARTED|Overall Study|Intent to treat population|132
2536117|NCT00622908|6216903|P1|STARTED|Overall Study|Intent to treat population|137
2536118|NCT00622895|6216915|P1|NOT COMPLETED|Overall Study||0
2536119|NCT00622895|6216915|P1|COMPLETED|Overall Study||3
2536120|NCT00622895|6216915|P1|STARTED|Overall Study||3
2536121|NCT00622869|6216933|P3|NOT COMPLETED|Overall Study||39
2536122|NCT00622869|6216934|P2|NOT COMPLETED|Overall Study||57
2536123|NCT00622869|6216935|P1|NOT COMPLETED|Overall Study||43
2536124|NCT00622869|6216933|P3|COMPLETED|Overall Study||204
2536125|NCT00622869|6216934|P2|COMPLETED|Overall Study||174
2536126|NCT00622869|6216935|P1|COMPLETED|Overall Study||202
2536127|NCT00622869|6216933|P3|STARTED|Overall Study||243
2536128|NCT00622869|6216934|P2|STARTED|Overall Study||231
2536129|NCT00622869|6216935|P1|STARTED|Overall Study||245
2536130|NCT00622739|6216954|P2|NOT COMPLETED|Overall Study||6
2536131|NCT00622739|6216955|P1|NOT COMPLETED|Overall Study||2
2536132|NCT00622739|6216954|P2|COMPLETED|Overall Study||9
2536133|NCT00622739|6216955|P1|COMPLETED|Overall Study||11
2536134|NCT00622739|6216954|P2|STARTED|Overall Study||15
2536135|NCT00622739|6216955|P1|STARTED|Overall Study||13
2536136|NCT00622726|6216973|P2|NOT COMPLETED|August, 2010 to April, 2013||5
2536137|NCT00622726|6216974|P1|NOT COMPLETED|August, 2010 to April, 2013||1
2536138|NCT00622726|6216973|P2|COMPLETED|August, 2010 to April, 2013||68
2536139|NCT00622726|6216974|P1|COMPLETED|August, 2010 to April, 2013||69
2536140|NCT00622726|6216973|P2|STARTED|August, 2010 to April, 2013||73
2536141|NCT00622726|6216974|P1|STARTED|August, 2010 to April, 2013||70
2536142|NCT00622726|6216973|P2|NOT COMPLETED|March, 2008 to August, 2010||2
2536143|NCT00622726|6216974|P1|NOT COMPLETED|March, 2008 to August, 2010||5
2536144|NCT00622726|6216973|P2|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|73
2536145|NCT00622726|6216974|P1|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|70
2536146|NCT00622726|6216973|P2|STARTED|March, 2008 to August, 2010||75
2536147|NCT00622726|6216974|P1|STARTED|March, 2008 to August, 2010||75
2536148|NCT00622713|6216984|P1|NOT COMPLETED|Overall Study||59
2536149|NCT00622713|6216984|P1|COMPLETED|Overall Study||169
2536150|NCT00622713|6216984|P1|Intent to Treat (ITT) Population|Overall Study||218
2536151|NCT00622713|6216984|P1|Exposed to Study Drug|Overall Study||226
2536152|NCT00622713|6216984|P1|STARTED|Overall Study||228
2536153|NCT00622700|6216995|P7|NOT COMPLETED|Extension Treatment Period||30
2536154|NCT00622700|6216996|P6|NOT COMPLETED|Extension Treatment Period||17
2536155|NCT00622700|6216997|P5|NOT COMPLETED|Extension Treatment Period||39
2536156|NCT00622700|6216998|P4|NOT COMPLETED|Extension Treatment Period||21
2536157|NCT00622700|6216999|P3|NOT COMPLETED|Extension Treatment Period||0
2536158|NCT00622700|6217000|P2|NOT COMPLETED|Extension Treatment Period||0
2536159|NCT00622700|6217001|P1|NOT COMPLETED|Extension Treatment Period||0
2536160|NCT00622700|6216995|P7|COMPLETED|Extension Treatment Period||120
2536161|NCT00622700|6216996|P6|COMPLETED|Extension Treatment Period||50
2536162|NCT00622700|6216997|P5|COMPLETED|Extension Treatment Period||103
2536163|NCT00622700|6216998|P4|COMPLETED|Extension Treatment Period||43
2536164|NCT00622700|6216999|P3|COMPLETED|Extension Treatment Period||0
2536165|NCT00622700|6217000|P2|COMPLETED|Extension Treatment Period||0
2536166|NCT00622700|6217001|P1|COMPLETED|Extension Treatment Period||0
2536167|NCT00622700|6216995|P7|STARTED|Extension Treatment Period|13 participants completed core treatment period but did not enter in extension treatment period.|150
2536168|NCT00622700|6216996|P6|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|67
2536169|NCT00622700|6216997|P5|STARTED|Extension Treatment Period|8 participants completed core treatment period but did not enter in extension treatment period.|142
2536170|NCT00622700|6216998|P4|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|64
2536171|NCT00622700|6216999|P3|STARTED|Extension Treatment Period||0
2536172|NCT00622700|6217000|P2|STARTED|Extension Treatment Period||0
2536173|NCT00622700|6217001|P1|STARTED|Extension Treatment Period|Participants were re-randomized in a 1:1 ratio to either teriflunomide 7 mg or 14 mg treatment arm.|0
2536174|NCT00622700|6216995|P7|NOT COMPLETED|Core Treatment Period||0
2536175|NCT00622700|6216996|P6|NOT COMPLETED|Core Treatment Period||0
2536176|NCT00622700|6216997|P5|NOT COMPLETED|Core Treatment Period||0
2536177|NCT00622700|6216998|P4|NOT COMPLETED|Core Treatment Period||0
2536178|NCT00622700|6216999|P3|NOT COMPLETED|Core Treatment Period||53
2536179|NCT00622700|6217000|P2|NOT COMPLETED|Core Treatment Period||55
2536180|NCT00622700|6217001|P1|NOT COMPLETED|Core Treatment Period||56
2536181|NCT00622700|6216995|P7|COMPLETED|Core Treatment Period||0
2536182|NCT00622700|6216996|P6|COMPLETED|Core Treatment Period||0
2536183|NCT00622700|6216997|P5|COMPLETED|Core Treatment Period||0
2536184|NCT00622700|6216998|P4|COMPLETED|Core Treatment Period||0
2536185|NCT00622700|6216999|P3|COMPLETED|Core Treatment Period||163
2536186|NCT00622700|6217000|P2|COMPLETED|Core Treatment Period||150
2536187|NCT00622700|6217001|P1|COMPLETED|Core Treatment Period||141
2536188|NCT00622700|6216995|P7|Treated|Core Treatment Period||0
2536189|NCT00622700|6216996|P6|Treated|Core Treatment Period||0
2536190|NCT00622700|6216997|P5|Treated|Core Treatment Period||0
2536191|NCT00622700|6216998|P4|Treated|Core Treatment Period||0
2536192|NCT00622700|6216999|P3|Treated|Core Treatment Period||214
2536193|NCT00622700|6217000|P2|Treated|Core Treatment Period||203
2536194|NCT00622700|6217001|P1|Treated|Core Treatment Period||197
2536195|NCT00622700|6216995|P7|STARTED|Core Treatment Period||0
2536196|NCT00622700|6216996|P6|STARTED|Core Treatment Period||0
2536197|NCT00622700|6216997|P5|STARTED|Core Treatment Period||0
2536198|NCT00622700|6216998|P4|STARTED|Core Treatment Period||0
2536199|NCT00622700|6216999|P3|STARTED|Core Treatment Period||216
2536200|NCT00622700|6217000|P2|STARTED|Core Treatment Period||205
2536201|NCT00622700|6217001|P1|STARTED|Core Treatment Period||197
2536202|NCT00622635|6217060|P6|NOT COMPLETED|Treatment Period 3||0
2536203|NCT00622635|6217061|P5|NOT COMPLETED|Treatment Period 3||0
2536204|NCT00622635|6217062|P4|NOT COMPLETED|Treatment Period 3||3
2536205|NCT00622635|6217063|P3|NOT COMPLETED|Treatment Period 3||0
2536206|NCT00622635|6217064|P2|NOT COMPLETED|Treatment Period 3||0
2536207|NCT00622635|6217065|P1|NOT COMPLETED|Treatment Period 3||0
2536208|NCT00622635|6217060|P6|COMPLETED|Treatment Period 3||10
2536209|NCT00622635|6217061|P5|COMPLETED|Treatment Period 3||9
2536210|NCT00622635|6217062|P4|COMPLETED|Treatment Period 3||10
2536211|NCT00622635|6217063|P3|COMPLETED|Treatment Period 3||10
2536212|NCT00622635|6217064|P2|COMPLETED|Treatment Period 3||10
2536213|NCT00622635|6217065|P1|COMPLETED|Treatment Period 3||12
2536214|NCT00622635|6217060|P6|STARTED|Treatment Period 3||10
2536215|NCT00622635|6217061|P5|STARTED|Treatment Period 3||9
2536216|NCT00622635|6217062|P4|STARTED|Treatment Period 3||13
2536217|NCT00622635|6217063|P3|STARTED|Treatment Period 3||10
2536218|NCT00622635|6217064|P2|STARTED|Treatment Period 3||10
2536219|NCT00622635|6217065|P1|STARTED|Treatment Period 3||12
2536220|NCT00622635|6217060|P6|NOT COMPLETED|Treatment Period 2||0
2536221|NCT00622635|6217061|P5|NOT COMPLETED|Treatment Period 2||0
2536222|NCT00622635|6217062|P4|NOT COMPLETED|Treatment Period 2||0
2536223|NCT00622635|6217063|P3|NOT COMPLETED|Treatment Period 2||0
2536224|NCT00622635|6217064|P2|NOT COMPLETED|Treatment Period 2||0
2536225|NCT00622635|6217065|P1|NOT COMPLETED|Treatment Period 2||1
2536226|NCT00622635|6217060|P6|COMPLETED|Treatment Period 2||10
2536227|NCT00622635|6217061|P5|COMPLETED|Treatment Period 2||9
2536228|NCT00622635|6217062|P4|COMPLETED|Treatment Period 2||13
2536229|NCT00622635|6217063|P3|COMPLETED|Treatment Period 2||10
2536230|NCT00622635|6217064|P2|COMPLETED|Treatment Period 2||10
2536231|NCT00622635|6217065|P1|COMPLETED|Treatment Period 2||12
2536232|NCT00622635|6217060|P6|STARTED|Treatment Period 2||10
2536233|NCT00622635|6217061|P5|STARTED|Treatment Period 2||9
2536234|NCT00622635|6217062|P4|STARTED|Treatment Period 2||13
2536235|NCT00622635|6217063|P3|STARTED|Treatment Period 2||10
2536236|NCT00622635|6217064|P2|STARTED|Treatment Period 2||10
2536237|NCT00622635|6217065|P1|STARTED|Treatment Period 2||13
2536238|NCT00622635|6217060|P6|NOT COMPLETED|Treatment Period 1||0
2536239|NCT00622635|6217061|P5|NOT COMPLETED|Treatment Period 1||1
2536240|NCT00622635|6217062|P4|NOT COMPLETED|Treatment Period 1||0
2536241|NCT00622635|6217063|P3|NOT COMPLETED|Treatment Period 1||1
2536242|NCT00622635|6217064|P2|NOT COMPLETED|Treatment Period 1||1
2536243|NCT00622635|6217065|P1|NOT COMPLETED|Treatment Period 1||0
2536244|NCT00622635|6217060|P6|COMPLETED|Treatment Period 1||10
2536245|NCT00622635|6217061|P5|COMPLETED|Treatment Period 1||9
2536246|NCT00622635|6217062|P4|COMPLETED|Treatment Period 1||13
2536247|NCT00622635|6217063|P3|COMPLETED|Treatment Period 1||10
2536248|NCT00622635|6217064|P2|COMPLETED|Treatment Period 1||10
2536249|NCT00622635|6217065|P1|COMPLETED|Treatment Period 1||13
2536250|NCT00622635|6217060|P6|STARTED|Treatment Period 1||10
2536251|NCT00622635|6217061|P5|STARTED|Treatment Period 1||10
2536252|NCT00622635|6217062|P4|STARTED|Treatment Period 1||13
2536253|NCT00622635|6217063|P3|STARTED|Treatment Period 1||11
2536254|NCT00622635|6217064|P2|STARTED|Treatment Period 1||11
2536255|NCT00622635|6217065|P1|STARTED|Treatment Period 1||13
2536256|NCT00622544|6217130|P1|NOT COMPLETED|Overall Study||9
2536257|NCT00622544|6217130|P1|COMPLETED|Overall Study|35|35
2536258|NCT00622544|6217130|P1|STARTED|Overall Study||44
2536259|NCT00622518|6217137|P2|NOT COMPLETED|Overall Study||0
2536260|NCT00622518|6217138|P1|NOT COMPLETED|Overall Study||0
2536261|NCT00622518|6217137|P2|COMPLETED|Overall Study||60
2536262|NCT00622518|6217138|P1|COMPLETED|Overall Study||59
2536263|NCT00622518|6217137|P2|STARTED|Overall Study||60
2536264|NCT00622518|6217138|P1|STARTED|Overall Study||59
2536265|NCT00622440|6217148|P2|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||1
2536266|NCT00622440|6217149|P1|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||0
2536267|NCT00622440|6217148|P2|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||27
2536268|NCT00622440|6217149|P1|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||28
2536269|NCT00622440|6217148|P2|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
2536270|NCT00622440|6217149|P1|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
2536271|NCT00622440|6217148|P2|NOT COMPLETED|Week 12 - Week 48 (Treatment)||6
2536272|NCT00622440|6217149|P1|NOT COMPLETED|Week 12 - Week 48 (Treatment)||3
2536273|NCT00622440|6217148|P2|COMPLETED|Week 12 - Week 48 (Treatment)||28
2536274|NCT00622440|6217149|P1|COMPLETED|Week 12 - Week 48 (Treatment)||28
2536275|NCT00622440|6217148|P2|STARTED|Week 12 - Week 48 (Treatment)||34
2536276|NCT00622440|6217149|P1|STARTED|Week 12 - Week 48 (Treatment)||31
2536277|NCT00622440|6217148|P2|NOT COMPLETED|Baseline - Week 12 (Treatment)||1
2536278|NCT00622440|6217149|P1|NOT COMPLETED|Baseline - Week 12 (Treatment)||4
2536279|NCT00622440|6217148|P2|COMPLETED|Baseline - Week 12 (Treatment)||34
2536280|NCT00622440|6217149|P1|COMPLETED|Baseline - Week 12 (Treatment)||31
2536281|NCT00622440|6217148|P2|STARTED|Baseline - Week 12 (Treatment)||35
2536282|NCT00622440|6217149|P1|STARTED|Baseline - Week 12 (Treatment)||35
2536283|NCT00622427|6217163|P2|NOT COMPLETED|Overall Study||0
2536284|NCT00622427|6217164|P1|NOT COMPLETED|Overall Study||0
2536285|NCT00622427|6217163|P2|COMPLETED|Overall Study|each subject received 2 weeks of placebo, then 2 weeks of Ramelteon after a two week wash out period|16
2536286|NCT00622427|6217164|P1|COMPLETED|Overall Study|each subject received 2 weeks of Ramelteon, then 2 weeks of placebo after a two week wash out period|16
2536287|NCT00622427|6217163|P2|STARTED|Overall Study||16
2536288|NCT00622427|6217164|P1|STARTED|Overall Study||16
2536289|NCT00622401|6217175|P3|NOT COMPLETED|Overall Study||0
2536290|NCT00622401|6217176|P2|NOT COMPLETED|Overall Study||2
2536291|NCT00622401|6217177|P1|NOT COMPLETED|Overall Study||3
2536292|NCT00622401|6217175|P3|COMPLETED|Overall Study||0
2536293|NCT00622401|6217176|P2|COMPLETED|Overall Study||0
2536294|NCT00622401|6217177|P1|COMPLETED|Overall Study||3
2536295|NCT00622401|6217175|P3|STARTED|Overall Study|Never Opened|0
2536296|NCT00622401|6217176|P2|STARTED|Overall Study||2
2536297|NCT00622401|6217177|P1|STARTED|Overall Study||6
2536298|NCT00622388|6217184|P1|NOT COMPLETED|Overall Study||72
2536299|NCT00622388|6217184|P1|COMPLETED|Overall Study||9
2536300|NCT00622388|6217184|P1|STARTED|Overall Study||81
2536301|NCT00622336|6217202|P1|NOT COMPLETED|Extension Phase||21
2536302|NCT00622336|6217202|P1|COMPLETED|Extension Phase||0
2536303|NCT00622336|6217202|P1|STARTED|Extension Phase||21
2536304|NCT00622336|6217202|P1|NOT COMPLETED|Treatment Phase||309
2536305|NCT00622336|6217202|P1|COMPLETED|Treatment Phase|Completed = those who completed the treatment phase and were ongoing in the extension study|21
2536306|NCT00622336|6217202|P1|Safety Population|Treatment Phase||330
2536307|NCT00622336|6217202|P1|STARTED|Treatment Phase||330
2536308|NCT00622284|6217213|P2|NOT COMPLETED|Overall Study||171
2536309|NCT00622284|6217214|P1|NOT COMPLETED|Overall Study||189
2536310|NCT00622284|6217213|P2|COMPLETED|Overall Study|Number who completed treatment.|604
2536311|NCT00622284|6217214|P1|COMPLETED|Overall Study|Number who completed treatment.|587
2536312|NCT00622284|6217213|P2|STARTED|Overall Study|Number who started treatment.|775
2536313|NCT00622284|6217214|P1|STARTED|Overall Study|Number who started treatment. One patient in the Linagliptin group was randomized but not treated.|776
2536314|NCT00622180|6217276|P2|NOT COMPLETED|Overall Study||2
2536315|NCT00622180|6217277|P1|NOT COMPLETED|Overall Study||1
2536316|NCT00622180|6217276|P2|COMPLETED|Overall Study||5
2536317|NCT00622180|6217277|P1|COMPLETED|Overall Study||5
2536318|NCT00622180|6217276|P2|STARTED|Overall Study||7
2536319|NCT00622180|6217277|P1|STARTED|Overall Study||6
2536320|NCT00622167|6217283|P1|NOT COMPLETED|Overall Study||20
2536321|NCT00622167|6217283|P1|COMPLETED|Overall Study||4
2536322|NCT00622167|6217283|P1|STARTED|Overall Study||24
2536323|NCT00621985|6217287|P1|NOT COMPLETED|Dexamethasone Admission||1
2536324|NCT00621985|6217287|P1|COMPLETED|Dexamethasone Admission||4
2536325|NCT00621985|6217287|P1|STARTED|Dexamethasone Admission||5
2536326|NCT00621985|6217287|P1|NOT COMPLETED|Hydrocortisone Admission||0
2536327|NCT00621985|6217287|P1|COMPLETED|Hydrocortisone Admission||5
2536328|NCT00621985|6217287|P1|STARTED|Hydrocortisone Admission||5
2536329|NCT00621959|6217295|P2|NOT COMPLETED|Overall Study||9
2536330|NCT00621959|6217296|P1|NOT COMPLETED|Overall Study||7
2536331|NCT00621959|6217295|P2|COMPLETED|Overall Study||292
2536332|NCT00621959|6217296|P1|COMPLETED|Overall Study||288
2536333|NCT00621959|6217295|P2|STARTED|Overall Study||301
2536334|NCT00621959|6217296|P1|STARTED|Overall Study|In all 791 subjects have been screened and 596 have been randomized|295
2536335|NCT00621946|6217306|P2|NOT COMPLETED|Overall Study||1
2536336|NCT00621946|6217307|P1|NOT COMPLETED|Overall Study||0
2536337|NCT00621946|6217306|P2|COMPLETED|Overall Study||12
2536338|NCT00621946|6217307|P1|COMPLETED|Overall Study||13
2536339|NCT00621946|6217306|P2|STARTED|Overall Study||13
2536340|NCT00621946|6217307|P1|STARTED|Overall Study||13
2536341|NCT00621933|6217323|P1|NOT COMPLETED|Overall Study||0
2536342|NCT00621933|6217323|P1|COMPLETED|Overall Study||399
2536343|NCT00621933|6217323|P1|STARTED|Overall Study||399
2536344|NCT00621855|6217335|P5|NOT COMPLETED|Overall Study||55
2536345|NCT00621855|6217336|P4|NOT COMPLETED|Overall Study||67
2536346|NCT00621855|6217337|P3|NOT COMPLETED|Overall Study||81
2536347|NCT00621855|6217338|P2|NOT COMPLETED|Overall Study||61
2536348|NCT00621855|6217339|P1|NOT COMPLETED|Overall Study||76
2536349|NCT00621855|6217335|P5|COMPLETED|Overall Study|Completed means completed treatment|318
2536350|NCT00621855|6217336|P4|COMPLETED|Overall Study|Completed means completed treatment|284
2536351|NCT00621855|6217337|P3|COMPLETED|Overall Study|Completed means completed treatment|330
2536352|NCT00621855|6217338|P2|COMPLETED|Overall Study|Completed means completed treatment|310
2536353|NCT00621855|6217339|P1|COMPLETED|Overall Study|Completed means completed treatment|296
2536354|NCT00621855|6217335|P5|STARTED|Overall Study|Started means randomised to treatment|373
2536355|NCT00621855|6217336|P4|STARTED|Overall Study|Started means randomised to treatment|351
2536356|NCT00621855|6217337|P3|STARTED|Overall Study|Started means randomised to treatment|411
2536357|NCT00621855|6217338|P2|STARTED|Overall Study|Started means randomised to treatment|371
2536358|NCT00621855|6217339|P1|STARTED|Overall Study|Started means randomised to treatment|372
2536359|NCT00621842|6217381|P1|NOT COMPLETED|Overall Study||19
2536360|NCT00621842|6217381|P1|COMPLETED|Overall Study||38
2536361|NCT00621842|6217381|P1|STARTED|Overall Study||57
2536362|NCT00621777|6217398|P2|NOT COMPLETED|Randomized Phase||19
2536363|NCT00621777|6217399|P1|NOT COMPLETED|Randomized Phase||7
2536364|NCT00621777|6217398|P2|COMPLETED|Randomized Phase||28
2536365|NCT00621777|6217399|P1|COMPLETED|Randomized Phase||33
2536366|NCT00621777|6217398|P2|STARTED|Randomized Phase||47
2536367|NCT00621777|6217399|P1|STARTED|Randomized Phase|87 open phase participants were continuously abstinent for at least 14 days and were randomized|40
2536368|NCT00621777|6217398|P2|NOT COMPLETED|Open Phase||0
2536369|NCT00621777|6217399|P1|NOT COMPLETED|Open Phase||116
2536370|NCT00621777|6217398|P2|COMPLETED|Open Phase||0
2536371|NCT00621777|6217399|P1|COMPLETED|Open Phase||87
2536372|NCT00621777|6217398|P2|STARTED|Open Phase|During this open label phase, all study participants received varenicline|0
2536373|NCT00621777|6217399|P1|STARTED|Open Phase||203
2536374|NCT00621764|6217414|P4|NOT COMPLETED|Overall Study||1
2536375|NCT00621764|6217415|P3|NOT COMPLETED|Overall Study||0
2536376|NCT00621764|6217416|P2|NOT COMPLETED|Overall Study||0
2536377|NCT00621764|6217417|P1|NOT COMPLETED|Overall Study||0
2536378|NCT00621764|6217414|P4|COMPLETED|Overall Study||98
2536379|NCT00621764|6217415|P3|COMPLETED|Overall Study||101
2536380|NCT00621764|6217416|P2|COMPLETED|Overall Study||50
2536381|NCT00621764|6217417|P1|COMPLETED|Overall Study||50
2536382|NCT00621764|6217414|P4|STARTED|Overall Study||99
2536383|NCT00621764|6217415|P3|STARTED|Overall Study||101
2536384|NCT00621764|6217416|P2|STARTED|Overall Study||50
2536385|NCT00621764|6217417|P1|STARTED|Overall Study||50
2536386|NCT00621686|6217449|P2|NOT COMPLETED|Overall Study||0
2536387|NCT00621686|6217450|P1|NOT COMPLETED|Overall Study||0
2536388|NCT00621686|6217449|P2|COMPLETED|Overall Study||35
2536389|NCT00621686|6217450|P1|COMPLETED|Overall Study||19
2536390|NCT00621686|6217449|P2|STARTED|Overall Study||35
2536391|NCT00621686|6217450|P1|STARTED|Overall Study||19
2536392|NCT00621621|6217463|P2|NOT COMPLETED|Overall Study||0
2536393|NCT00621621|6217464|P1|NOT COMPLETED|Overall Study||30
2536394|NCT00621621|6217463|P2|COMPLETED|Overall Study||705
2536395|NCT00621621|6217464|P1|COMPLETED|Overall Study|Treated with the experimental catheter|75
2536396|NCT00621621|6217463|P2|STARTED|Overall Study||705
2536397|NCT00621621|6217464|P1|STARTED|Overall Study|Date of Post- Approval Study protocol approval|105
2536398|NCT00621582|6217472|P1|NOT COMPLETED|Overall Study||106
2536399|NCT00621582|6217472|P1|COMPLETED|Overall Study||4812
2536400|NCT00621582|6217472|P1|STARTED|Overall Study||4918
2536401|NCT00621543|6217479|P1|NOT COMPLETED|Overall Study||23
2536402|NCT00621543|6217479|P1|COMPLETED|Overall Study||97
2536403|NCT00621543|6217479|P1|STARTED|Overall Study||120
2536404|NCT00621530|6217486|P2|NOT COMPLETED|Overall Study||3
2536405|NCT00621530|6217487|P1|NOT COMPLETED|Overall Study||2
2536406|NCT00621530|6217486|P2|COMPLETED|Overall Study||29
2536407|NCT00621530|6217487|P1|COMPLETED|Overall Study||28
2536408|NCT00621530|6217486|P2|STARTED|Overall Study||32
2536409|NCT00621530|6217487|P1|STARTED|Overall Study||30
2536410|NCT00621517|6217503|P2|NOT COMPLETED|Overall Study||7
2536411|NCT00621517|6217504|P1|NOT COMPLETED|Overall Study||7
2536412|NCT00621517|6217503|P2|COMPLETED|Overall Study||24
2536413|NCT00621517|6217504|P1|COMPLETED|Overall Study||22
2536414|NCT00621517|6217503|P2|STARTED|Overall Study||31
2536415|NCT00621517|6217504|P1|STARTED|Overall Study||29
2536416|NCT00621504|6217516|P2|NOT COMPLETED|Overall Study||25
2536417|NCT00621504|6217517|P1|NOT COMPLETED|Overall Study||26
2536418|NCT00621504|6217516|P2|COMPLETED|Overall Study||282
2536419|NCT00621504|6217517|P1|COMPLETED|Overall Study||273
2536420|NCT00621504|6217516|P2|STARTED|Overall Study||307
2536421|NCT00621504|6217517|P1|STARTED|Overall Study||299
2536422|NCT00621348|6217526|P3|NOT COMPLETED|Overall Study||0
2536423|NCT00621348|6217527|P2|NOT COMPLETED|Overall Study||0
2536424|NCT00621348|6217528|P1|NOT COMPLETED|Overall Study||0
2536425|NCT00621348|6217526|P3|COMPLETED|Overall Study||56
2536426|NCT00621348|6217527|P2|COMPLETED|Overall Study||53
2536427|NCT00621348|6217528|P1|COMPLETED|Overall Study||58
2536428|NCT00621348|6217526|P3|STARTED|Overall Study||56
2536429|NCT00621348|6217527|P2|STARTED|Overall Study||53
2536430|NCT00621348|6217528|P1|STARTED|Overall Study||58
2536431|NCT00621322|6217551|P6|NOT COMPLETED|Overall Study||4
2536432|NCT00621322|6217552|P5|NOT COMPLETED|Overall Study||1
2536433|NCT00621322|6217553|P4|NOT COMPLETED|Overall Study||3
2536434|NCT00621322|6217554|P3|NOT COMPLETED|Overall Study||2
2536435|NCT00621322|6217555|P2|NOT COMPLETED|Overall Study||0
2536436|NCT00621322|6217556|P1|NOT COMPLETED|Overall Study||1
2536437|NCT00621322|6217551|P6|COMPLETED|Overall Study||36
2536438|NCT00621322|6217552|P5|COMPLETED|Overall Study||39
2536439|NCT00621322|6217553|P4|COMPLETED|Overall Study||37
2536440|NCT00621322|6217554|P3|COMPLETED|Overall Study||38
2536441|NCT00621322|6217555|P2|COMPLETED|Overall Study||10
2536442|NCT00621322|6217556|P1|COMPLETED|Overall Study||9
2536443|NCT00621322|6217551|P6|STARTED|Overall Study||40
2536444|NCT00621322|6217552|P5|STARTED|Overall Study||40
2536445|NCT00621322|6217553|P4|STARTED|Overall Study||40
2536446|NCT00621322|6217554|P3|STARTED|Overall Study||40
2536447|NCT00621322|6217555|P2|STARTED|Overall Study||10
2536448|NCT00621322|6217556|P1|STARTED|Overall Study||10
2536449|NCT00621309|6217636|P6|NOT COMPLETED|Overall Study||1
2536450|NCT00621309|6217637|P5|NOT COMPLETED|Overall Study||1
2536451|NCT00621309|6217638|P4|NOT COMPLETED|Overall Study||1
2536452|NCT00621309|6217639|P3|NOT COMPLETED|Overall Study||1
2536453|NCT00621309|6217640|P2|NOT COMPLETED|Overall Study||0
2536454|NCT00621309|6217641|P1|NOT COMPLETED|Overall Study||2
2536455|NCT00621309|6217636|P6|COMPLETED|Overall Study||3
2536456|NCT00621309|6217637|P5|COMPLETED|Overall Study||3
2536457|NCT00621309|6217638|P4|COMPLETED|Overall Study||5
2536458|NCT00621309|6217639|P3|COMPLETED|Overall Study||4
2536459|NCT00621309|6217640|P2|COMPLETED|Overall Study||4
2536460|NCT00621309|6217641|P1|COMPLETED|Overall Study||4
2536461|NCT00621309|6217636|P6|STARTED|Overall Study||4
2536462|NCT00621309|6217637|P5|STARTED|Overall Study||4
2536463|NCT00621309|6217638|P4|STARTED|Overall Study||6
2536464|NCT00621309|6217639|P3|STARTED|Overall Study||5
2536465|NCT00621309|6217640|P2|STARTED|Overall Study||4
2536466|NCT00621309|6217641|P1|STARTED|Overall Study||6
2536467|NCT00621296|6217647|P1|NOT COMPLETED|Overall Study||14
2536468|NCT00621296|6217647|P1|COMPLETED|Overall Study||1
2536469|NCT00621296|6217647|P1|STARTED|Overall Study||15
2536470|NCT00621257|6217656|P5|NOT COMPLETED|Overall Study||9
2536471|NCT00621257|6217657|P4|NOT COMPLETED|Overall Study||6
2536472|NCT00621257|6217658|P3|NOT COMPLETED|Overall Study||3
2536473|NCT00621257|6217659|P2|NOT COMPLETED|Overall Study||3
2536474|NCT00621257|6217660|P1|NOT COMPLETED|Overall Study||4
2536475|NCT00621257|6217656|P5|COMPLETED|Overall Study||22
2536476|NCT00621257|6217657|P4|COMPLETED|Overall Study||26
2536477|NCT00621257|6217658|P3|COMPLETED|Overall Study||20
2536478|NCT00621257|6217659|P2|COMPLETED|Overall Study||21
2536479|NCT00621257|6217660|P1|COMPLETED|Overall Study||20
2536480|NCT00621257|6217656|P5|STARTED|Overall Study||31
2536481|NCT00621257|6217657|P4|STARTED|Overall Study||32
2536482|NCT00621257|6217658|P3|STARTED|Overall Study||23
2536483|NCT00621257|6217659|P2|STARTED|Overall Study||24
2536484|NCT00621257|6217660|P1|STARTED|Overall Study||24
2536485|NCT00621244|6217676|P4|NOT COMPLETED|Overall Study||23
2536486|NCT00621244|6217677|P3|NOT COMPLETED|Overall Study||33
2536487|NCT00621244|6217678|P2|NOT COMPLETED|Overall Study||34
2536488|NCT00621244|6217679|P1|NOT COMPLETED|Overall Study||86
2536489|NCT00621244|6217676|P4|COMPLETED|Overall Study||0
2536490|NCT00621244|6217677|P3|COMPLETED|Overall Study||0
2536491|NCT00621244|6217678|P2|COMPLETED|Overall Study||0
2536492|NCT00621244|6217679|P1|COMPLETED|Overall Study||0
2536493|NCT00621244|6217676|P4|STARTED|Overall Study||23
2536494|NCT00621244|6217677|P3|STARTED|Overall Study||33
2536495|NCT00621244|6217678|P2|STARTED|Overall Study||34
2536496|NCT00621244|6217679|P1|STARTED|Overall Study||86
2536497|NCT00621192|6217783|P4|NOT COMPLETED|Overall Study||3
2536498|NCT00621192|6217784|P3|NOT COMPLETED|Overall Study||5
2536499|NCT00621192|6217785|P2|NOT COMPLETED|Overall Study||9
2536500|NCT00621192|6217786|P1|NOT COMPLETED|Overall Study||4
2536501|NCT00621192|6217783|P4|COMPLETED|Overall Study||24
2536502|NCT00621192|6217784|P3|COMPLETED|Overall Study||26
2536503|NCT00621192|6217785|P2|COMPLETED|Overall Study||94
2536504|NCT00621192|6217786|P1|COMPLETED|Overall Study||35
2536505|NCT00621192|6217783|P4|Efficacy Population|Overall Study||27
2536506|NCT00621192|6217784|P3|Efficacy Population|Overall Study||28
2536507|NCT00621192|6217785|P2|Efficacy Population|Overall Study||101
2536508|NCT00621192|6217786|P1|Efficacy Population|Overall Study||39
2536509|NCT00621192|6217783|P4|Safety Population|Overall Study||27
2536510|NCT00621192|6217784|P3|Safety Population|Overall Study||31
2536511|NCT00621192|6217785|P2|Safety Population|Overall Study||103
2536512|NCT00621192|6217786|P1|Safety Population|Overall Study||39
2536513|NCT00621192|6217783|P4|STARTED|Overall Study||27
2536514|NCT00621192|6217784|P3|STARTED|Overall Study||31
2536515|NCT00621192|6217785|P2|STARTED|Overall Study||103
2536516|NCT00621192|6217786|P1|STARTED|Overall Study||39
2536517|NCT00621153|6217810|P2|NOT COMPLETED|Overall Study||15
2536518|NCT00621153|6217811|P1|NOT COMPLETED|Overall Study||20
2536519|NCT00621153|6217810|P2|COMPLETED|Overall Study|completed|101
2536520|NCT00621153|6217811|P1|COMPLETED|Overall Study|completed|97
2536521|NCT00621153|6217810|P2|Discontinued|Overall Study||15
2536522|NCT00621153|6217811|P1|Discontinued|Overall Study||20
2536523|NCT00621153|6217810|P2|STARTED|Overall Study|randomised|116
2536524|NCT00621153|6217811|P1|STARTED|Overall Study|randomised|117
2536525|NCT00621140|6217819|P2|NOT COMPLETED|Overall Study||18
2536526|NCT00621140|6217820|P1|NOT COMPLETED|Overall Study||15
2536527|NCT00621140|6217819|P2|COMPLETED|Overall Study|number who completed treatment|318
2536528|NCT00621140|6217820|P1|COMPLETED|Overall Study|number who completed treatment|152
2536529|NCT00621140|6217819|P2|STARTED|Overall Study|number who started treatment|336
2536530|NCT00621140|6217820|P1|STARTED|Overall Study|number who started treatment|167
2536531|NCT00621049|6217854|P2|NOT COMPLETED|Maintenance Treatment||0
2536532|NCT00621049|6217855|P1|NOT COMPLETED|Maintenance Treatment||15
2536533|NCT00621049|6217854|P2|COMPLETED|Maintenance Treatment||0
2536534|NCT00621049|6217855|P1|COMPLETED|Maintenance Treatment||34
2536535|NCT00621049|6217854|P2|STARTED|Maintenance Treatment|Per protocol, only the Docetaxel/Carboplatin/Bevacizumab/Erlotinib arm enters maintenance therapy|0
2536536|NCT00621049|6217855|P1|STARTED|Maintenance Treatment|3 patients came off study between the end of adjuvant therapy and the start of maintenance|49
2536537|NCT00621049|6217854|P2|NOT COMPLETED|Adjuvant Treatment||10
2536538|NCT00621049|6217855|P1|NOT COMPLETED|Adjuvant Treatment||3
2536539|NCT00621049|6217854|P2|COMPLETED|Adjuvant Treatment||47
2536540|NCT00621049|6217855|P1|COMPLETED|Adjuvant Treatment||52
2536541|NCT00621049|6217854|P2|STARTED|Adjuvant Treatment||57
2536542|NCT00621049|6217855|P1|STARTED|Adjuvant Treatment||55
2536543|NCT00621023|6217867|P1|NOT COMPLETED|Overall Study||6
2536544|NCT00621023|6217867|P1|COMPLETED|Overall Study|Completed is defined as 5 years of follow up.|0
2536545|NCT00621023|6217867|P1|STARTED|Overall Study||6
2536546|NCT00620945|6217873|P1|NOT COMPLETED|Overall Study||0
2536547|NCT00620945|6217873|P1|COMPLETED|Overall Study||87
2536548|NCT00620945|6217873|P1|STARTED|Overall Study|Total number in the study|87
2536549|NCT00620854|6217884|P6|NOT COMPLETED|Period 3||0
2536550|NCT00620854|6217885|P5|NOT COMPLETED|Period 3||0
2536551|NCT00620854|6217886|P4|NOT COMPLETED|Period 3||0
2536552|NCT00620854|6217887|P3|NOT COMPLETED|Period 3||0
2536553|NCT00620854|6217888|P2|NOT COMPLETED|Period 3||0
2536554|NCT00620854|6217889|P1|NOT COMPLETED|Period 3||0
2536555|NCT00620854|6217884|P6|COMPLETED|Period 3||4
2536556|NCT00620854|6217885|P5|COMPLETED|Period 3||4
2536557|NCT00620854|6217886|P4|COMPLETED|Period 3||3
2536558|NCT00620854|6217887|P3|COMPLETED|Period 3||3
2536559|NCT00620854|6217888|P2|COMPLETED|Period 3||4
2536560|NCT00620854|6217889|P1|COMPLETED|Period 3||4
2536561|NCT00620854|6217884|P6|STARTED|Period 3||4
2536562|NCT00620854|6217885|P5|STARTED|Period 3||4
2536563|NCT00620854|6217886|P4|STARTED|Period 3||3
2536564|NCT00620854|6217887|P3|STARTED|Period 3||3
2536565|NCT00620854|6217888|P2|STARTED|Period 3||4
2536566|NCT00620854|6217889|P1|STARTED|Period 3||4
2536567|NCT00620854|6217884|P6|NOT COMPLETED|Washout 2||0
2536568|NCT00620854|6217885|P5|NOT COMPLETED|Washout 2||0
2536569|NCT00620854|6217886|P4|NOT COMPLETED|Washout 2||0
2536570|NCT00620854|6217887|P3|NOT COMPLETED|Washout 2||0
2536571|NCT00620854|6217888|P2|NOT COMPLETED|Washout 2||0
2536572|NCT00620854|6217889|P1|NOT COMPLETED|Washout 2||0
2536573|NCT00620854|6217884|P6|COMPLETED|Washout 2||4
2536574|NCT00620854|6217885|P5|COMPLETED|Washout 2||4
2536575|NCT00620854|6217886|P4|COMPLETED|Washout 2||3
2536576|NCT00620854|6217887|P3|COMPLETED|Washout 2||3
2536577|NCT00620854|6217888|P2|COMPLETED|Washout 2||4
2536578|NCT00620854|6217889|P1|COMPLETED|Washout 2||4
2536579|NCT00620854|6217884|P6|STARTED|Washout 2||4
2536580|NCT00620854|6217885|P5|STARTED|Washout 2||4
2536581|NCT00620854|6217886|P4|STARTED|Washout 2||3
2536582|NCT00620854|6217887|P3|STARTED|Washout 2||3
2536583|NCT00620854|6217888|P2|STARTED|Washout 2||4
2536584|NCT00620854|6217889|P1|STARTED|Washout 2||4
2536585|NCT00620854|6217884|P6|NOT COMPLETED|Period 2||0
2536586|NCT00620854|6217885|P5|NOT COMPLETED|Period 2||0
2536587|NCT00620854|6217886|P4|NOT COMPLETED|Period 2||0
2536588|NCT00620854|6217887|P3|NOT COMPLETED|Period 2||0
2536589|NCT00620854|6217888|P2|NOT COMPLETED|Period 2||0
2536590|NCT00620854|6217889|P1|NOT COMPLETED|Period 2||0
2536591|NCT00620854|6217884|P6|COMPLETED|Period 2||4
2536592|NCT00620854|6217885|P5|COMPLETED|Period 2||4
2536593|NCT00620854|6217886|P4|COMPLETED|Period 2||3
2536594|NCT00620854|6217887|P3|COMPLETED|Period 2||3
2536595|NCT00620854|6217888|P2|COMPLETED|Period 2||4
2536596|NCT00620854|6217889|P1|COMPLETED|Period 2||4
2536597|NCT00620854|6217884|P6|STARTED|Period 2||4
2536598|NCT00620854|6217885|P5|STARTED|Period 2||4
2536599|NCT00620854|6217886|P4|STARTED|Period 2||3
2536600|NCT00620854|6217887|P3|STARTED|Period 2||3
2536601|NCT00620854|6217888|P2|STARTED|Period 2||4
2536602|NCT00620854|6217889|P1|STARTED|Period 2||4
2536603|NCT00620854|6217884|P6|NOT COMPLETED|Washout 1||0
2536604|NCT00620854|6217885|P5|NOT COMPLETED|Washout 1||0
2536605|NCT00620854|6217886|P4|NOT COMPLETED|Washout 1||1
2536606|NCT00620854|6217887|P3|NOT COMPLETED|Washout 1||1
2536607|NCT00620854|6217888|P2|NOT COMPLETED|Washout 1||0
2536608|NCT00620854|6217889|P1|NOT COMPLETED|Washout 1||0
2536609|NCT00620854|6217884|P6|COMPLETED|Washout 1||4
2536610|NCT00620854|6217885|P5|COMPLETED|Washout 1||4
2536611|NCT00620854|6217886|P4|COMPLETED|Washout 1||3
2536612|NCT00620854|6217887|P3|COMPLETED|Washout 1||3
2536613|NCT00620854|6217888|P2|COMPLETED|Washout 1||4
2536614|NCT00620854|6217889|P1|COMPLETED|Washout 1||4
2536615|NCT00620854|6217884|P6|STARTED|Washout 1||4
2536616|NCT00620854|6217885|P5|STARTED|Washout 1||4
2536617|NCT00620854|6217886|P4|STARTED|Washout 1||4
2536618|NCT00620854|6217887|P3|STARTED|Washout 1||4
2536619|NCT00620854|6217888|P2|STARTED|Washout 1||4
2536620|NCT00620854|6217889|P1|STARTED|Washout 1||4
2536621|NCT00620854|6217884|P6|NOT COMPLETED|Period 1||0
2536622|NCT00620854|6217885|P5|NOT COMPLETED|Period 1||0
2536623|NCT00620854|6217886|P4|NOT COMPLETED|Period 1||0
2536624|NCT00620854|6217887|P3|NOT COMPLETED|Period 1||0
2536625|NCT00620854|6217888|P2|NOT COMPLETED|Period 1||0
2536626|NCT00620854|6217889|P1|NOT COMPLETED|Period 1||0
2536627|NCT00620854|6217884|P6|COMPLETED|Period 1||4
2536628|NCT00620854|6217885|P5|COMPLETED|Period 1||4
2536629|NCT00620854|6217886|P4|COMPLETED|Period 1||4
2536630|NCT00620854|6217887|P3|COMPLETED|Period 1||4
2536631|NCT00620854|6217888|P2|COMPLETED|Period 1||4
2536632|NCT00620854|6217889|P1|COMPLETED|Period 1||4
2536633|NCT00620854|6217884|P6|STARTED|Period 1||4
2536634|NCT00620854|6217885|P5|STARTED|Period 1||4
2536635|NCT00620854|6217886|P4|STARTED|Period 1||4
2536636|NCT00620854|6217887|P3|STARTED|Period 1||4
2536637|NCT00620854|6217888|P2|STARTED|Period 1||4
2536638|NCT00620854|6217889|P1|STARTED|Period 1||4
2536639|NCT00620828|6217902|P2|NOT COMPLETED|Overall Study||0
2536640|NCT00620828|6217903|P1|NOT COMPLETED|Overall Study||0
2536641|NCT00620828|6217902|P2|COMPLETED|Overall Study||35
2536642|NCT00620828|6217903|P1|COMPLETED|Overall Study||32
2536643|NCT00620828|6217902|P2|Number of Subjects Enrolled = 67|Overall Study||35
2536644|NCT00620828|6217903|P1|Number of Subjects Enrolled = 67|Overall Study||32
2536645|NCT00620828|6217902|P2|STARTED|Overall Study||35
2536646|NCT00620828|6217903|P1|STARTED|Overall Study||32
2536647|NCT00620815|6217920|P3|NOT COMPLETED|Overall Study||7
2536648|NCT00620815|6217921|P2|NOT COMPLETED|Overall Study||11
2536649|NCT00620815|6217922|P1|NOT COMPLETED|Overall Study||4
2536650|NCT00620815|6217920|P3|COMPLETED|Overall Study||192
2536651|NCT00620815|6217921|P2|COMPLETED|Overall Study||192
2536652|NCT00620815|6217922|P1|COMPLETED|Overall Study||195
2536653|NCT00620815|6217920|P3|STARTED|Overall Study||199
2536654|NCT00620815|6217921|P2|STARTED|Overall Study||203
2536655|NCT00620815|6217922|P1|STARTED|Overall Study||199
2536656|NCT00620776|6217962|P2|NOT COMPLETED|Overall Study||16
2536657|NCT00620776|6217963|P1|NOT COMPLETED|Overall Study||12
2536658|NCT00620776|6217962|P2|COMPLETED|Overall Study|24 out of 35 attended the week 24 (last) assessment.|24
2536659|NCT00620776|6217963|P1|COMPLETED|Overall Study|17 out of 26 attended the week 24 (last) assessment.|17
2536660|NCT00620776|6217962|P2|Received at Least One Session/Dose|Overall Study|35 out of 40 that consented to receive medication alone received at least one dose of medication.|35
2536661|NCT00620776|6217963|P1|Received at Least One Session/Dose|Overall Study|26 out of 29 that consented to the combined treatment option received at least one session of CBT.|26
2536662|NCT00620776|6217962|P2|STARTED|Overall Study|All 40 patients that were randomly assigned to not be offered CBT consented to this option.|40
2536663|NCT00620776|6217963|P1|STARTED|Overall Study|29 patients (of the 77 that were randomly assigned to add on CBT) consented to this option.|29
2536664|NCT00620763|6217991|P2|NOT COMPLETED|Period: Second Intervention||0
2536665|NCT00620763|6217992|P1|NOT COMPLETED|Period: Second Intervention||1
2536666|NCT00620763|6217991|P2|COMPLETED|Period: Second Intervention||7
2536667|NCT00620763|6217992|P1|COMPLETED|Period: Second Intervention||9
2536668|NCT00620763|6217991|P2|STARTED|Period: Second Intervention||7
2536669|NCT00620763|6217992|P1|STARTED|Period: Second Intervention||10
2536670|NCT00620763|6217991|P2|NOT COMPLETED|Period: Washout Period of 1 Week||0
2536671|NCT00620763|6217992|P1|NOT COMPLETED|Period: Washout Period of 1 Week||0
2536672|NCT00620763|6217991|P2|COMPLETED|Period: Washout Period of 1 Week||7
2536673|NCT00620763|6217992|P1|COMPLETED|Period: Washout Period of 1 Week||10
2536674|NCT00620763|6217991|P2|STARTED|Period: Washout Period of 1 Week||7
2536675|NCT00620763|6217992|P1|STARTED|Period: Washout Period of 1 Week||10
2536676|NCT00620763|6217991|P2|NOT COMPLETED|Period: First Intervention||5
2536677|NCT00620763|6217992|P1|NOT COMPLETED|Period: First Intervention||0
2536678|NCT00620763|6217991|P2|COMPLETED|Period: First Intervention||7
2536679|NCT00620763|6217992|P1|COMPLETED|Period: First Intervention||10
2536680|NCT00620763|6217991|P2|STARTED|Period: First Intervention||12
2536681|NCT00620763|6217992|P1|STARTED|Period: First Intervention||10
2536682|NCT00620750|6217998|P1|NOT COMPLETED|Overall Study||25
2536683|NCT00620750|6217998|P1|COMPLETED|Overall Study||40
2536684|NCT00620750|6217998|P1|STARTED|Overall Study||65
2536685|NCT00620711|6218002|P1|NOT COMPLETED|Overall Study||0
2536686|NCT00620711|6218002|P1|COMPLETED|Overall Study||4
2536687|NCT00620711|6218002|P1|STARTED|Overall Study||4
2536688|NCT00620698|6218007|P1|NOT COMPLETED|Overall Study||29
2536689|NCT00620698|6218007|P1|COMPLETED|Overall Study||60
2536690|NCT00620698|6218007|P1|STARTED|Overall Study||89
2536691|NCT00620659|6218013|P6|NOT COMPLETED|Treatment Period 3||0
2536692|NCT00620659|6218014|P5|NOT COMPLETED|Treatment Period 3||0
2536693|NCT00620659|6218015|P4|NOT COMPLETED|Treatment Period 3||1
2536694|NCT00620659|6218016|P3|NOT COMPLETED|Treatment Period 3||0
2536695|NCT00620659|6218017|P2|NOT COMPLETED|Treatment Period 3||2
2536696|NCT00620659|6218018|P1|NOT COMPLETED|Treatment Period 3||0
2536697|NCT00620659|6218013|P6|COMPLETED|Treatment Period 3||20
2536698|NCT00620659|6218014|P5|COMPLETED|Treatment Period 3||15
2536699|NCT00620659|6218015|P4|COMPLETED|Treatment Period 3||17
2536700|NCT00620659|6218016|P3|COMPLETED|Treatment Period 3||19
2536701|NCT00620659|6218017|P2|COMPLETED|Treatment Period 3||16
2536702|NCT00620659|6218018|P1|COMPLETED|Treatment Period 3||16
2536703|NCT00620659|6218013|P6|STARTED|Treatment Period 3||20
2536704|NCT00620659|6218014|P5|STARTED|Treatment Period 3||15
2536705|NCT00620659|6218015|P4|STARTED|Treatment Period 3||18
2536706|NCT00620659|6218016|P3|STARTED|Treatment Period 3||19
2536707|NCT00620659|6218017|P2|STARTED|Treatment Period 3||18
2536708|NCT00620659|6218018|P1|STARTED|Treatment Period 3||16
2536709|NCT00620659|6218013|P6|NOT COMPLETED|Placebo Washout Period 2||0
2536710|NCT00620659|6218014|P5|NOT COMPLETED|Placebo Washout Period 2||0
2536711|NCT00620659|6218015|P4|NOT COMPLETED|Placebo Washout Period 2||0
2536712|NCT00620659|6218016|P3|NOT COMPLETED|Placebo Washout Period 2||0
2536713|NCT00620659|6218017|P2|NOT COMPLETED|Placebo Washout Period 2||0
2536714|NCT00620659|6218018|P1|NOT COMPLETED|Placebo Washout Period 2||2
2536715|NCT00620659|6218013|P6|COMPLETED|Placebo Washout Period 2||20
2536716|NCT00620659|6218014|P5|COMPLETED|Placebo Washout Period 2||15
2536717|NCT00620659|6218015|P4|COMPLETED|Placebo Washout Period 2||18
2536718|NCT00620659|6218016|P3|COMPLETED|Placebo Washout Period 2||19
2536719|NCT00620659|6218017|P2|COMPLETED|Placebo Washout Period 2||18
2536720|NCT00620659|6218018|P1|COMPLETED|Placebo Washout Period 2||16
2536721|NCT00620659|6218013|P6|STARTED|Placebo Washout Period 2||20
2536722|NCT00620659|6218014|P5|STARTED|Placebo Washout Period 2||15
2536723|NCT00620659|6218015|P4|STARTED|Placebo Washout Period 2||18
2536724|NCT00620659|6218016|P3|STARTED|Placebo Washout Period 2||19
2536725|NCT00620659|6218017|P2|STARTED|Placebo Washout Period 2||18
2536726|NCT00620659|6218018|P1|STARTED|Placebo Washout Period 2||18
2536727|NCT00620659|6218013|P6|NOT COMPLETED|Treatment Period 2||0
2536728|NCT00620659|6218014|P5|NOT COMPLETED|Treatment Period 2||5
2536729|NCT00620659|6218015|P4|NOT COMPLETED|Treatment Period 2||0
2536730|NCT00620659|6218016|P3|NOT COMPLETED|Treatment Period 2||1
2536731|NCT00620659|6218017|P2|NOT COMPLETED|Treatment Period 2||3
2536732|NCT00620659|6218018|P1|NOT COMPLETED|Treatment Period 2||0
2536733|NCT00620659|6218013|P6|COMPLETED|Treatment Period 2||20
2536734|NCT00620659|6218014|P5|COMPLETED|Treatment Period 2||15
2536735|NCT00620659|6218015|P4|COMPLETED|Treatment Period 2||18
2536736|NCT00620659|6218016|P3|COMPLETED|Treatment Period 2||19
2536737|NCT00620659|6218017|P2|COMPLETED|Treatment Period 2||18
2536738|NCT00620659|6218018|P1|COMPLETED|Treatment Period 2||18
2536739|NCT00620659|6218013|P6|STARTED|Treatment Period 2||20
2536740|NCT00620659|6218014|P5|STARTED|Treatment Period 2||20
2536741|NCT00620659|6218015|P4|STARTED|Treatment Period 2||18
2536742|NCT00620659|6218016|P3|STARTED|Treatment Period 2||20
2536743|NCT00620659|6218017|P2|STARTED|Treatment Period 2||21
2536744|NCT00620659|6218018|P1|STARTED|Treatment Period 2||18
2536745|NCT00620659|6218013|P6|NOT COMPLETED|Placebo Washout Period 1||0
2536746|NCT00620659|6218014|P5|NOT COMPLETED|Placebo Washout Period 1||0
2536747|NCT00620659|6218015|P4|NOT COMPLETED|Placebo Washout Period 1||1
2536748|NCT00620659|6218016|P3|NOT COMPLETED|Placebo Washout Period 1||0
2536749|NCT00620659|6218017|P2|NOT COMPLETED|Placebo Washout Period 1||0
2536750|NCT00620659|6218018|P1|NOT COMPLETED|Placebo Washout Period 1||0
2536751|NCT00620659|6218013|P6|COMPLETED|Placebo Washout Period 1||20
2536752|NCT00620659|6218014|P5|COMPLETED|Placebo Washout Period 1||20
2536753|NCT00620659|6218015|P4|COMPLETED|Placebo Washout Period 1||18
2536754|NCT00620659|6218016|P3|COMPLETED|Placebo Washout Period 1||20
2536755|NCT00620659|6218017|P2|COMPLETED|Placebo Washout Period 1||21
2536756|NCT00620659|6218018|P1|COMPLETED|Placebo Washout Period 1||18
2536757|NCT00620659|6218013|P6|STARTED|Placebo Washout Period 1||20
2536758|NCT00620659|6218014|P5|STARTED|Placebo Washout Period 1||20
2536759|NCT00620659|6218015|P4|STARTED|Placebo Washout Period 1||19
2536760|NCT00620659|6218016|P3|STARTED|Placebo Washout Period 1||20
2536761|NCT00620659|6218017|P2|STARTED|Placebo Washout Period 1||21
2536762|NCT00620659|6218018|P1|STARTED|Placebo Washout Period 1||18
2536763|NCT00620659|6218013|P6|NOT COMPLETED|Treatment Period 1||0
2536764|NCT00620659|6218014|P5|NOT COMPLETED|Treatment Period 1||1
2536765|NCT00620659|6218015|P4|NOT COMPLETED|Treatment Period 1||3
2536766|NCT00620659|6218016|P3|NOT COMPLETED|Treatment Period 1||1
2536767|NCT00620659|6218017|P2|NOT COMPLETED|Treatment Period 1||0
2536768|NCT00620659|6218018|P1|NOT COMPLETED|Treatment Period 1||3
2536769|NCT00620659|6218013|P6|COMPLETED|Treatment Period 1||20
2536770|NCT00620659|6218014|P5|COMPLETED|Treatment Period 1||20
2536771|NCT00620659|6218015|P4|COMPLETED|Treatment Period 1|1 patient discontinued from MK0249, but continued in following periods, & completed the study|18
2536772|NCT00620659|6218016|P3|COMPLETED|Treatment Period 1||20
2536773|NCT00620659|6218017|P2|COMPLETED|Treatment Period 1||21
2536774|NCT00620659|6218018|P1|COMPLETED|Treatment Period 1||18
2536775|NCT00620659|6218013|P6|STARTED|Treatment Period 1||20
2536776|NCT00620659|6218014|P5|STARTED|Treatment Period 1||21
2536777|NCT00620659|6218015|P4|STARTED|Treatment Period 1||21
2536778|NCT00620659|6218016|P3|STARTED|Treatment Period 1||21
2536779|NCT00620659|6218017|P2|STARTED|Treatment Period 1||21
2536780|NCT00620659|6218018|P1|STARTED|Treatment Period 1||21
2536781|NCT00620555|6218036|P1|NOT COMPLETED|Overall Study||21
2536782|NCT00620555|6218036|P1|COMPLETED|Overall Study||44
2536783|NCT00620555|6218036|P1|STARTED|Overall Study||65
2536784|NCT00620542|6218045|P4|NOT COMPLETED|Part B (2 Year Core Study)||144
2536785|NCT00620542|6218046|P3|NOT COMPLETED|Part B (2 Year Core Study)||148
2536786|NCT00620542|6218047|P2|NOT COMPLETED|Part B (2 Year Core Study)||0
2536787|NCT00620542|6218048|P1|NOT COMPLETED|Part B (2 Year Core Study)||0
2536788|NCT00620542|6218045|P4|COMPLETED|Part B (2 Year Core Study)||547
2536789|NCT00620542|6218046|P3|COMPLETED|Part B (2 Year Core Study)||546
2536790|NCT00620542|6218047|P2|COMPLETED|Part B (2 Year Core Study)||0
2536791|NCT00620542|6218048|P1|COMPLETED|Part B (2 Year Core Study)||0
2536792|NCT00620542|6218045|P4|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|519
2536793|NCT00620542|6218046|P3|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|520
2536794|NCT00620542|6218047|P2|Intent-to-treat Population|Part B (2 Year Core Study)||0
2536795|NCT00620542|6218048|P1|Intent-to-treat Population|Part B (2 Year Core Study)||0
2536796|NCT00620542|6218045|P4|Received Treatment|Part B (2 Year Core Study)||689
2536797|NCT00620542|6218046|P3|Received Treatment|Part B (2 Year Core Study)||691
2536798|NCT00620542|6218047|P2|Received Treatment|Part B (2 Year Core Study)||0
2536799|NCT00620542|6218048|P1|Received Treatment|Part B (2 Year Core Study)||0
2536800|NCT00620542|6218045|P4|STARTED|Part B (2 Year Core Study)|Of 691 patients randomized, N=689 received treatment.|691
2536801|NCT00620542|6218046|P3|STARTED|Part B (2 Year Core Study)|Of 694 patients randomized, N=691 received treatment.|694
2536802|NCT00620542|6218047|P2|STARTED|Part B (2 Year Core Study)||0
2536803|NCT00620542|6218048|P1|STARTED|Part B (2 Year Core Study)||0
2536804|NCT00620542|6218045|P4|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
2536805|NCT00620542|6218046|P3|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
2536806|NCT00620542|6218047|P2|NOT COMPLETED|Part A (Run-in - 2 Weeks)||476
2536807|NCT00620542|6218048|P1|NOT COMPLETED|Part A (Run-in - 2 Weeks)||472
2536808|NCT00620542|6218045|P4|COMPLETED|Part A (Run-in - 2 Weeks)||0
2536809|NCT00620542|6218046|P3|COMPLETED|Part A (Run-in - 2 Weeks)||0
2536810|NCT00620542|6218047|P2|COMPLETED|Part A (Run-in - 2 Weeks)||690
2536811|NCT00620542|6218048|P1|COMPLETED|Part A (Run-in - 2 Weeks)||695
2536812|NCT00620542|6218045|P4|Received Treatment|Part A (Run-in - 2 Weeks)||0
2536813|NCT00620542|6218046|P3|Received Treatment|Part A (Run-in - 2 Weeks)||0
2536814|NCT00620542|6218047|P2|Received Treatment|Part A (Run-in - 2 Weeks)||795
2536815|NCT00620542|6218048|P1|Received Treatment|Part A (Run-in - 2 Weeks)||783
2536816|NCT00620542|6218045|P4|STARTED|Part A (Run-in - 2 Weeks)||0
2536817|NCT00620542|6218046|P3|STARTED|Part A (Run-in - 2 Weeks)||0
2536818|NCT00620542|6218047|P2|STARTED|Part A (Run-in - 2 Weeks)|Of 1166 randomized, N=795 received treatment.|1166
2536819|NCT00620542|6218048|P1|STARTED|Part A (Run-in - 2 Weeks)|Of 1167 randomized, N=783 received treatment.|1167
2536820|NCT00620503|6218086|P6|NOT COMPLETED|Follow-up (up to 14 Days)||0
2536821|NCT00620503|6218087|P5|NOT COMPLETED|Follow-up (up to 14 Days)||0
2536822|NCT00620503|6218088|P4|NOT COMPLETED|Follow-up (up to 14 Days)||0
2536823|NCT00620503|6218089|P3|NOT COMPLETED|Follow-up (up to 14 Days)||0
2536824|NCT00620503|6218090|P2|NOT COMPLETED|Follow-up (up to 14 Days)||0
2536825|NCT00620503|6218091|P1|NOT COMPLETED|Follow-up (up to 14 Days)||0
2536826|NCT00620503|6218086|P6|COMPLETED|Follow-up (up to 14 Days)||2
2536827|NCT00620503|6218087|P5|COMPLETED|Follow-up (up to 14 Days)||2
2536828|NCT00620503|6218088|P4|COMPLETED|Follow-up (up to 14 Days)||2
2536829|NCT00620503|6218089|P3|COMPLETED|Follow-up (up to 14 Days)||2
2536830|NCT00620503|6218090|P2|COMPLETED|Follow-up (up to 14 Days)||2
2536831|NCT00620503|6218091|P1|COMPLETED|Follow-up (up to 14 Days)||2
2536832|NCT00620503|6218086|P6|STARTED|Follow-up (up to 14 Days)||2
2536833|NCT00620503|6218087|P5|STARTED|Follow-up (up to 14 Days)||2
2536834|NCT00620503|6218088|P4|STARTED|Follow-up (up to 14 Days)||2
2536835|NCT00620503|6218089|P3|STARTED|Follow-up (up to 14 Days)||2
2536836|NCT00620503|6218090|P2|STARTED|Follow-up (up to 14 Days)||2
2536837|NCT00620503|6218091|P1|STARTED|Follow-up (up to 14 Days)||2
2536838|NCT00620503|6218086|P6|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
2536839|NCT00620503|6218087|P5|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
2536840|NCT00620503|6218088|P4|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
2536841|NCT00620503|6218089|P3|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
2536842|NCT00620503|6218090|P2|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
2536843|NCT00620503|6218091|P1|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
2536844|NCT00620503|6218086|P6|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
2536845|NCT00620503|6218087|P5|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
2536846|NCT00620503|6218088|P4|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
2536847|NCT00620503|6218089|P3|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
2536848|NCT00620503|6218090|P2|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
2536849|NCT00620503|6218091|P1|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
2536850|NCT00620503|6218086|P6|STARTED|Treatment Period 3 (TP3) (7 Days)||2
2536851|NCT00620503|6218087|P5|STARTED|Treatment Period 3 (TP3) (7 Days)||2
2536852|NCT00620503|6218088|P4|STARTED|Treatment Period 3 (TP3) (7 Days)||2
2536853|NCT00620503|6218089|P3|STARTED|Treatment Period 3 (TP3) (7 Days)||2
2536854|NCT00620503|6218090|P2|STARTED|Treatment Period 3 (TP3) (7 Days)||2
2536855|NCT00620503|6218091|P1|STARTED|Treatment Period 3 (TP3) (7 Days)||2
2536856|NCT00620503|6218086|P6|NOT COMPLETED|Washout (at Least 1 Day)||0
2536857|NCT00620503|6218087|P5|NOT COMPLETED|Washout (at Least 1 Day)||0
2536858|NCT00620503|6218088|P4|NOT COMPLETED|Washout (at Least 1 Day)||0
2536859|NCT00620503|6218089|P3|NOT COMPLETED|Washout (at Least 1 Day)||0
2536860|NCT00620503|6218090|P2|NOT COMPLETED|Washout (at Least 1 Day)||0
2536861|NCT00620503|6218091|P1|NOT COMPLETED|Washout (at Least 1 Day)||0
2536862|NCT00620503|6218086|P6|COMPLETED|Washout (at Least 1 Day)||2
2536863|NCT00620503|6218087|P5|COMPLETED|Washout (at Least 1 Day)||2
2536864|NCT00620503|6218088|P4|COMPLETED|Washout (at Least 1 Day)||2
2536865|NCT00620503|6218089|P3|COMPLETED|Washout (at Least 1 Day)||2
2536866|NCT00620503|6218090|P2|COMPLETED|Washout (at Least 1 Day)||2
2536867|NCT00620503|6218091|P1|COMPLETED|Washout (at Least 1 Day)||2
2536868|NCT00620503|6218086|P6|STARTED|Washout (at Least 1 Day)||2
2536869|NCT00620503|6218087|P5|STARTED|Washout (at Least 1 Day)||2
2536870|NCT00620503|6218088|P4|STARTED|Washout (at Least 1 Day)||2
2536871|NCT00620503|6218089|P3|STARTED|Washout (at Least 1 Day)||2
2536872|NCT00620503|6218090|P2|STARTED|Washout (at Least 1 Day)||2
2536873|NCT00620503|6218091|P1|STARTED|Washout (at Least 1 Day)||2
2536874|NCT00620503|6218086|P6|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
2536875|NCT00620503|6218087|P5|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
2536876|NCT00620503|6218088|P4|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
2536877|NCT00620503|6218089|P3|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
2536878|NCT00620503|6218090|P2|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
2536879|NCT00620503|6218091|P1|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
2536880|NCT00620503|6218086|P6|COMPLETED|Treatment Period 2 (TP2) (7days)||2
2536881|NCT00620503|6218087|P5|COMPLETED|Treatment Period 2 (TP2) (7days)||2
2536882|NCT00620503|6218088|P4|COMPLETED|Treatment Period 2 (TP2) (7days)||2
2536883|NCT00620503|6218089|P3|COMPLETED|Treatment Period 2 (TP2) (7days)||2
2536884|NCT00620503|6218090|P2|COMPLETED|Treatment Period 2 (TP2) (7days)||2
2536885|NCT00620503|6218091|P1|COMPLETED|Treatment Period 2 (TP2) (7days)||2
2536886|NCT00620503|6218086|P6|STARTED|Treatment Period 2 (TP2) (7days)||2
2536887|NCT00620503|6218087|P5|STARTED|Treatment Period 2 (TP2) (7days)||2
2536888|NCT00620503|6218088|P4|STARTED|Treatment Period 2 (TP2) (7days)||2
2536889|NCT00620503|6218089|P3|STARTED|Treatment Period 2 (TP2) (7days)||2
2536890|NCT00620503|6218090|P2|STARTED|Treatment Period 2 (TP2) (7days)||2
2536891|NCT00620503|6218091|P1|STARTED|Treatment Period 2 (TP2) (7days)||2
2536892|NCT00620503|6218086|P6|NOT COMPLETED|Washout (at Least 1 Day)||0
2536893|NCT00620503|6218087|P5|NOT COMPLETED|Washout (at Least 1 Day)||0
2536894|NCT00620503|6218088|P4|NOT COMPLETED|Washout (at Least 1 Day)||0
2536895|NCT00620503|6218089|P3|NOT COMPLETED|Washout (at Least 1 Day)||0
2536896|NCT00620503|6218090|P2|NOT COMPLETED|Washout (at Least 1 Day)||0
2536897|NCT00620503|6218091|P1|NOT COMPLETED|Washout (at Least 1 Day)||0
2536898|NCT00620503|6218086|P6|COMPLETED|Washout (at Least 1 Day)||2
2536899|NCT00620503|6218087|P5|COMPLETED|Washout (at Least 1 Day)||2
2536900|NCT00620503|6218088|P4|COMPLETED|Washout (at Least 1 Day)||2
2536901|NCT00620503|6218089|P3|COMPLETED|Washout (at Least 1 Day)||2
2536902|NCT00620503|6218090|P2|COMPLETED|Washout (at Least 1 Day)||2
2536903|NCT00620503|6218091|P1|COMPLETED|Washout (at Least 1 Day)||2
2536904|NCT00620503|6218086|P6|STARTED|Washout (at Least 1 Day)||2
2536905|NCT00620503|6218087|P5|STARTED|Washout (at Least 1 Day)||2
2536906|NCT00620503|6218088|P4|STARTED|Washout (at Least 1 Day)||2
2536907|NCT00620503|6218089|P3|STARTED|Washout (at Least 1 Day)||2
2536908|NCT00620503|6218090|P2|STARTED|Washout (at Least 1 Day)||2
2536909|NCT00620503|6218091|P1|STARTED|Washout (at Least 1 Day)||2
2536910|NCT00620503|6218086|P6|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
2536911|NCT00620503|6218087|P5|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
2536912|NCT00620503|6218088|P4|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
2536913|NCT00620503|6218089|P3|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
2536914|NCT00620503|6218090|P2|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
2536915|NCT00620503|6218091|P1|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
2536916|NCT00620503|6218086|P6|COMPLETED|Treatment Period 1 (TP1) (7days)||2
2536917|NCT00620503|6218087|P5|COMPLETED|Treatment Period 1 (TP1) (7days)||2
2536918|NCT00620503|6218088|P4|COMPLETED|Treatment Period 1 (TP1) (7days)||2
2536919|NCT00620503|6218089|P3|COMPLETED|Treatment Period 1 (TP1) (7days)||2
2536920|NCT00620503|6218090|P2|COMPLETED|Treatment Period 1 (TP1) (7days)||2
2536921|NCT00620503|6218091|P1|COMPLETED|Treatment Period 1 (TP1) (7days)||2
2536922|NCT00620503|6218086|P6|STARTED|Treatment Period 1 (TP1) (7days)||2
2536923|NCT00620503|6218087|P5|STARTED|Treatment Period 1 (TP1) (7days)||2
2536924|NCT00620503|6218088|P4|STARTED|Treatment Period 1 (TP1) (7days)||2
2536925|NCT00620503|6218089|P3|STARTED|Treatment Period 1 (TP1) (7days)||2
2536926|NCT00620503|6218090|P2|STARTED|Treatment Period 1 (TP1) (7days)||2
2536927|NCT00620503|6218091|P1|STARTED|Treatment Period 1 (TP1) (7days)||2
2536928|NCT00620503|6218086|P6|NOT COMPLETED|Screening (up to 21 Days)||0
2536929|NCT00620503|6218087|P5|NOT COMPLETED|Screening (up to 21 Days)||0
2536930|NCT00620503|6218088|P4|NOT COMPLETED|Screening (up to 21 Days)||0
2536931|NCT00620503|6218089|P3|NOT COMPLETED|Screening (up to 21 Days)||0
2536932|NCT00620503|6218090|P2|NOT COMPLETED|Screening (up to 21 Days)||0
2536933|NCT00620503|6218091|P1|NOT COMPLETED|Screening (up to 21 Days)||0
2536934|NCT00620503|6218086|P6|COMPLETED|Screening (up to 21 Days)||2
2536935|NCT00620503|6218087|P5|COMPLETED|Screening (up to 21 Days)||2
2536936|NCT00620503|6218088|P4|COMPLETED|Screening (up to 21 Days)||2
2536937|NCT00620503|6218089|P3|COMPLETED|Screening (up to 21 Days)||2
2536938|NCT00620503|6218090|P2|COMPLETED|Screening (up to 21 Days)||2
2536939|NCT00620503|6218091|P1|COMPLETED|Screening (up to 21 Days)||2
2536940|NCT00620503|6218086|P6|STARTED|Screening (up to 21 Days)||2
2536941|NCT00620503|6218087|P5|STARTED|Screening (up to 21 Days)||2
2536942|NCT00620503|6218088|P4|STARTED|Screening (up to 21 Days)||2
2536943|NCT00620503|6218089|P3|STARTED|Screening (up to 21 Days)||2
2536944|NCT00620503|6218090|P2|STARTED|Screening (up to 21 Days)||2
2536945|NCT00620503|6218091|P1|STARTED|Screening (up to 21 Days)||2
2536946|NCT00620464|6218113|P2|NOT COMPLETED|Overall Study||24
2536947|NCT00620464|6218114|P1|NOT COMPLETED|Overall Study||20
2536948|NCT00620464|6218113|P2|COMPLETED|Overall Study||32
2536949|NCT00620464|6218114|P1|COMPLETED|Overall Study||32
2536950|NCT00620464|6218113|P2|STARTED|Overall Study||56
2536951|NCT00620464|6218114|P1|STARTED|Overall Study||52
2536952|NCT00620425|6218122|P1|NOT COMPLETED|Overall Study||0
2536953|NCT00620425|6218122|P1|COMPLETED|Overall Study||18
2536954|NCT00620425|6218122|P1|STARTED|Overall Study||18
2536955|NCT00620373|6218133|P1|NOT COMPLETED|Overall Study||33
2536956|NCT00620373|6218133|P1|COMPLETED|Overall Study||936
2536957|NCT00620373|6218133|P1|STARTED|Overall Study||969
2536958|NCT00620321|6218151|P2|NOT COMPLETED|Overall Study||16
2536959|NCT00620321|6218152|P1|NOT COMPLETED|Overall Study||8
2536960|NCT00620321|6218151|P2|COMPLETED|Overall Study||0
2536961|NCT00620321|6218152|P1|COMPLETED|Overall Study||0
2536962|NCT00620321|6218151|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
2536963|NCT00620321|6218152|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
2536964|NCT00620321|6218151|P2|STARTED|Overall Study||16
2536965|NCT00620321|6218152|P1|STARTED|Overall Study||8
2536966|NCT00620282|6218171|P3|NOT COMPLETED|Overall Study||1
2536967|NCT00620282|6218172|P2|NOT COMPLETED|Overall Study||2
2536968|NCT00620282|6218173|P1|NOT COMPLETED|Overall Study||0
2536969|NCT00620282|6218171|P3|COMPLETED|Overall Study||16
2536970|NCT00620282|6218172|P2|COMPLETED|Overall Study||14
2536971|NCT00620282|6218173|P1|COMPLETED|Overall Study||16
2536972|NCT00620282|6218171|P3|STARTED|Overall Study||17
2536973|NCT00620282|6218172|P2|STARTED|Overall Study||16
2536974|NCT00620282|6218173|P1|STARTED|Overall Study||16
2536975|NCT00620126|6218222|P2|NOT COMPLETED|Overall Study||5
2536976|NCT00620126|6218223|P1|NOT COMPLETED|Overall Study||11
2536977|NCT00620126|6218222|P2|COMPLETED|Overall Study||17
2536978|NCT00620126|6218223|P1|COMPLETED|Overall Study||14
2536979|NCT00620126|6218222|P2|STARTED|Overall Study||22
2536980|NCT00620126|6218223|P1|STARTED|Overall Study||25
2536981|NCT00620113|6218237|P4|NOT COMPLETED|Overall Study||10
2536982|NCT00620113|6218238|P3|NOT COMPLETED|Overall Study||5
2536983|NCT00620113|6218239|P2|NOT COMPLETED|Overall Study||7
2536984|NCT00620113|6218240|P1|NOT COMPLETED|Overall Study||13
2536985|NCT00620113|6218237|P4|COMPLETED|Overall Study||59
2536986|NCT00620113|6218238|P3|COMPLETED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|66
2536987|NCT00620113|6218239|P2|COMPLETED|Overall Study||67
2536988|NCT00620113|6218240|P1|COMPLETED|Overall Study||60
2536989|NCT00620113|6218237|P4|Efficacy/Safety Population|Overall Study||69
2536990|NCT00620113|6218238|P3|Efficacy/Safety Population|Overall Study||70
2536991|NCT00620113|6218239|P2|Efficacy/Safety Population|Overall Study||74
2536992|NCT00620113|6218240|P1|Efficacy/Safety Population|Overall Study||73
2536993|NCT00620113|6218237|P4|STARTED|Overall Study||69
2536994|NCT00620113|6218238|P3|STARTED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|71
2536995|NCT00620113|6218239|P2|STARTED|Overall Study||74
2536996|NCT00620113|6218240|P1|STARTED|Overall Study||73
2536997|NCT00620074|6218290|P1|NOT COMPLETED|Overall Study||1
2536998|NCT00620074|6218290|P1|COMPLETED|Overall Study||5
2536999|NCT00620074|6218290|P1|STARTED|Overall Study||6
2537000|NCT00620061|6218298|P1|NOT COMPLETED|Overall Study||153
2537001|NCT00620061|6218298|P1|COMPLETED|Overall Study||286
2537002|NCT00620061|6218298|P1|STARTED|Overall Study||439
2537003|NCT00620035|6218313|P1|NOT COMPLETED|Overall Study||145
2537004|NCT00620035|6218313|P1|COMPLETED|Overall Study||156
2537005|NCT00620035|6218313|P1|STARTED|Overall Study||301
2537006|NCT00620022|6218323|P2|NOT COMPLETED|Treatment Period 2||2
2537007|NCT00620022|6218324|P1|NOT COMPLETED|Treatment Period 2||2
2537008|NCT00620022|6218323|P2|COMPLETED|Treatment Period 2||35
2537009|NCT00620022|6218324|P1|COMPLETED|Treatment Period 2||39
2537010|NCT00620022|6218323|P2|STARTED|Treatment Period 2||37
2537011|NCT00620022|6218324|P1|STARTED|Treatment Period 2||41
2537012|NCT00620022|6218323|P2|NOT COMPLETED|Treatment Period 1||6
2537013|NCT00620022|6218324|P1|NOT COMPLETED|Treatment Period 1||5
2537014|NCT00620022|6218323|P2|COMPLETED|Treatment Period 1||37
2537015|NCT00620022|6218324|P1|COMPLETED|Treatment Period 1||41
2537016|NCT00620022|6218323|P2|STARTED|Treatment Period 1|Of 44 randomized patients, 1 patient discontinued before receiving any study treatment.|43
2537017|NCT00620022|6218324|P1|STARTED|Treatment Period 1||46
2537018|NCT00619983|6218336|P4|NOT COMPLETED|Gabapentin Alone||0
2537019|NCT00619983|6218337|P3|NOT COMPLETED|Gabapentin Alone||0
2537020|NCT00619983|6218338|P2|NOT COMPLETED|Gabapentin Alone||0
2537021|NCT00619983|6218339|P1|NOT COMPLETED|Gabapentin Alone||0
2537022|NCT00619983|6218336|P4|COMPLETED|Gabapentin Alone||3
2537023|NCT00619983|6218337|P3|COMPLETED|Gabapentin Alone||4
2537024|NCT00619983|6218338|P2|COMPLETED|Gabapentin Alone||4
2537025|NCT00619983|6218339|P1|COMPLETED|Gabapentin Alone||3
2537026|NCT00619983|6218336|P4|STARTED|Gabapentin Alone||3
2537027|NCT00619983|6218337|P3|STARTED|Gabapentin Alone||4
2537028|NCT00619983|6218338|P2|STARTED|Gabapentin Alone||4
2537029|NCT00619983|6218339|P1|STARTED|Gabapentin Alone||3
2537030|NCT00619983|6218336|P4|NOT COMPLETED|Test Drug Plus Gabapentin||0
2537031|NCT00619983|6218337|P3|NOT COMPLETED|Test Drug Plus Gabapentin||0
2537032|NCT00619983|6218338|P2|NOT COMPLETED|Test Drug Plus Gabapentin||0
2537033|NCT00619983|6218339|P1|NOT COMPLETED|Test Drug Plus Gabapentin||0
2537034|NCT00619983|6218336|P4|COMPLETED|Test Drug Plus Gabapentin||3
2537035|NCT00619983|6218337|P3|COMPLETED|Test Drug Plus Gabapentin||4
2537036|NCT00619983|6218338|P2|COMPLETED|Test Drug Plus Gabapentin||4
2537037|NCT00619983|6218339|P1|COMPLETED|Test Drug Plus Gabapentin||3
2537038|NCT00619983|6218336|P4|STARTED|Test Drug Plus Gabapentin||3
2537039|NCT00619983|6218337|P3|STARTED|Test Drug Plus Gabapentin||4
2537040|NCT00619983|6218338|P2|STARTED|Test Drug Plus Gabapentin||4
2537041|NCT00619983|6218339|P1|STARTED|Test Drug Plus Gabapentin||3
2537042|NCT00619983|6218336|P4|NOT COMPLETED|Test Drug Alone||3
2537043|NCT00619983|6218337|P3|NOT COMPLETED|Test Drug Alone||2
2537044|NCT00619983|6218338|P2|NOT COMPLETED|Test Drug Alone||1
2537045|NCT00619983|6218339|P1|NOT COMPLETED|Test Drug Alone||2
2537046|NCT00619983|6218336|P4|COMPLETED|Test Drug Alone||3
2537047|NCT00619983|6218337|P3|COMPLETED|Test Drug Alone||4
2537048|NCT00619983|6218338|P2|COMPLETED|Test Drug Alone||4
2537049|NCT00619983|6218339|P1|COMPLETED|Test Drug Alone||3
2537050|NCT00619983|6218336|P4|STARTED|Test Drug Alone||6
2537051|NCT00619983|6218337|P3|STARTED|Test Drug Alone||6
2537052|NCT00619983|6218338|P2|STARTED|Test Drug Alone||5
2537053|NCT00619983|6218339|P1|STARTED|Test Drug Alone||5
2537054|NCT00619970|6218352|P3|NOT COMPLETED|Overall Study||2
2537055|NCT00619970|6218353|P2|NOT COMPLETED|Overall Study||3
2537056|NCT00619970|6218354|P1|NOT COMPLETED|Overall Study||0
2537057|NCT00619970|6218352|P3|COMPLETED|Overall Study||24
2537058|NCT00619970|6218353|P2|COMPLETED|Overall Study||46
2537059|NCT00619970|6218354|P1|COMPLETED|Overall Study||40
2537060|NCT00619970|6218352|P3|STARTED|Overall Study||26
2537061|NCT00619970|6218353|P2|STARTED|Overall Study||49
2537062|NCT00619970|6218354|P1|STARTED|Overall Study||40
2537063|NCT00619957|6218366|P2|NOT COMPLETED|Month 48 Open-Label||17
2537064|NCT00619957|6218367|P1|NOT COMPLETED|Month 48 Open-Label||12
2537065|NCT00619957|6218366|P2|COMPLETED|Month 48 Open-Label||134
2537066|NCT00619957|6218367|P1|COMPLETED|Month 48 Open-Label||55
2537067|NCT00619957|6218366|P2|STARTED|Month 48 Open-Label||151
2537068|NCT00619957|6218367|P1|STARTED|Month 48 Open-Label||67
2537069|NCT00619957|6218366|P2|NOT COMPLETED|Month 24 Double-Blind||17
2537070|NCT00619957|6218367|P1|NOT COMPLETED|Month 24 Double-Blind||18
2537071|NCT00619957|6218366|P2|COMPLETED|Month 24 Double-Blind||175
2537072|NCT00619957|6218367|P1|COMPLETED|Month 24 Double-Blind||75
2537073|NCT00619957|6218366|P2|Intent to Treat (ITT Population)|Month 24 Double-Blind|One subject did not take any study medication.|191
2537074|NCT00619957|6218367|P1|Intent to Treat (ITT Population)|Month 24 Double-Blind||93
2537075|NCT00619957|6218366|P2|STARTED|Month 24 Double-Blind||192
2537076|NCT00619957|6218367|P1|STARTED|Month 24 Double-Blind||93
2537077|NCT00619918|6218449|P2|NOT COMPLETED|Overall Study||22
2537078|NCT00619918|6218450|P1|NOT COMPLETED|Overall Study||20
2537079|NCT00619918|6218449|P2|COMPLETED|Overall Study||195
2537080|NCT00619918|6218450|P1|COMPLETED|Overall Study||210
2537081|NCT00619918|6218449|P2|STARTED|Overall Study||217
2537082|NCT00619918|6218450|P1|STARTED|Overall Study||230
2537083|NCT00619892|6218460|P2|NOT COMPLETED|Overall Study||2
2537084|NCT00619892|6218461|P1|NOT COMPLETED|Overall Study||3
2537085|NCT00619892|6218460|P2|COMPLETED|Overall Study||11
2537086|NCT00619892|6218461|P1|COMPLETED|Overall Study||10
2537087|NCT00619892|6218460|P2|STARTED|Overall Study||13
2537088|NCT00619892|6218461|P1|STARTED|Overall Study||13
2537089|NCT00619866|6218472|P5|NOT COMPLETED|Weeks 13 - 24||2
2537090|NCT00619866|6218473|P4|NOT COMPLETED|Weeks 13 - 24||4
2537091|NCT00619866|6218474|P3|NOT COMPLETED|Weeks 13 - 24||5
2537092|NCT00619866|6218475|P2|NOT COMPLETED|Weeks 13 - 24||7
2537093|NCT00619866|6218476|P1|NOT COMPLETED|Weeks 13 - 24||0
2537094|NCT00619866|6218472|P5|COMPLETED|Weeks 13 - 24||18
2537095|NCT00619866|6218473|P4|COMPLETED|Weeks 13 - 24||14
2537096|NCT00619866|6218474|P3|COMPLETED|Weeks 13 - 24||37
2537097|NCT00619866|6218475|P2|COMPLETED|Weeks 13 - 24||38
2537098|NCT00619866|6218476|P1|COMPLETED|Weeks 13 - 24||0
2537099|NCT00619866|6218472|P5|STARTED|Weeks 13 - 24||20
2537100|NCT00619866|6218473|P4|STARTED|Weeks 13 - 24||18
2537101|NCT00619866|6218474|P3|STARTED|Weeks 13 - 24||42
2537102|NCT00619866|6218475|P2|STARTED|Weeks 13 - 24||45
2537103|NCT00619866|6218476|P1|STARTED|Weeks 13 - 24||0
2537104|NCT00619866|6218472|P5|NOT COMPLETED|Weeks 1 - 12||0
2537105|NCT00619866|6218473|P4|NOT COMPLETED|Weeks 1 - 12||0
2537106|NCT00619866|6218474|P3|NOT COMPLETED|Weeks 1 - 12||10
2537107|NCT00619866|6218475|P2|NOT COMPLETED|Weeks 1 - 12||6
2537108|NCT00619866|6218476|P1|NOT COMPLETED|Weeks 1 - 12||14
2537109|NCT00619866|6218472|P5|COMPLETED|Weeks 1 - 12||0
2537110|NCT00619866|6218473|P4|COMPLETED|Weeks 1 - 12||0
2537111|NCT00619866|6218474|P3|COMPLETED|Weeks 1 - 12||42
2537112|NCT00619866|6218475|P2|COMPLETED|Weeks 1 - 12||45
2537113|NCT00619866|6218476|P1|COMPLETED|Weeks 1 - 12||38
2537114|NCT00619866|6218472|P5|STARTED|Weeks 1 - 12||0
2537115|NCT00619866|6218473|P4|STARTED|Weeks 1 - 12||0
2537116|NCT00619866|6218474|P3|STARTED|Weeks 1 - 12||52
2537117|NCT00619866|6218475|P2|STARTED|Weeks 1 - 12||51
2537118|NCT00619866|6218476|P1|STARTED|Weeks 1 - 12||52
2537119|NCT00619827|6218563|P2|NOT COMPLETED|Overall Study||4
2537120|NCT00619827|6218564|P1|NOT COMPLETED|Overall Study||3
2537121|NCT00619827|6218563|P2|COMPLETED|Overall Study||40
2537122|NCT00619827|6218564|P1|COMPLETED|Overall Study||42
2537123|NCT00619827|6218563|P2|STARTED|Overall Study||44
2537124|NCT00619827|6218564|P1|STARTED|Overall Study||45
2537125|NCT00619801|6218572|P2|NOT COMPLETED|Overall Study||3
2537126|NCT00619801|6218573|P1|NOT COMPLETED|Overall Study||1
2537127|NCT00619801|6218572|P2|COMPLETED|Overall Study||111
2537128|NCT00619801|6218573|P1|COMPLETED|Overall Study||58
2537129|NCT00619801|6218572|P2|Safety Population|Overall Study||114
2537130|NCT00619801|6218573|P1|Safety Population|Overall Study||59
2537131|NCT00619801|6218572|P2|STARTED|Overall Study||114
2537132|NCT00619801|6218573|P1|STARTED|Overall Study||59
2537133|NCT00619762|6218603|P1|NOT COMPLETED|Overall Study||3
2537134|NCT00619762|6218603|P1|COMPLETED|Overall Study|(25 breasts) last patient visit 11/09/2009|14
2537135|NCT00619762|6218603|P1|STARTED|Overall Study|(29 breasts) First patient implanted 10/23/2007|17
2537136|NCT00619723|6218610|P2|NOT COMPLETED|Overall Study||6
2537137|NCT00619723|6218611|P1|NOT COMPLETED|Overall Study||2
2537138|NCT00619723|6218610|P2|COMPLETED|Overall Study||61
2537139|NCT00619723|6218611|P1|COMPLETED|Overall Study||61
2537140|NCT00619723|6218610|P2|STARTED|Overall Study||67
2537141|NCT00619723|6218611|P1|STARTED|Overall Study||63
2537142|NCT00619684|6218621|P1|NOT COMPLETED|Overall Study||0
2537143|NCT00619684|6218621|P1|COMPLETED|Overall Study||18
2537144|NCT00619684|6218621|P1|STARTED|Overall Study||18
2537145|NCT00619645|6218630|P1|NOT COMPLETED|Overall Study||1
2537146|NCT00619645|6218630|P1|COMPLETED|Overall Study||7
2537147|NCT00619645|6218630|P1|STARTED|Overall Study||8
2537148|NCT00619619|6218644|P8|NOT COMPLETED|Overall Study||3
2537149|NCT00619619|6218645|P7|NOT COMPLETED|Overall Study||1
2537150|NCT00619619|6218646|P6|NOT COMPLETED|Overall Study||0
2537151|NCT00619619|6218647|P5|NOT COMPLETED|Overall Study||2
2537152|NCT00619619|6218648|P4|NOT COMPLETED|Overall Study||1
2537153|NCT00619619|6218649|P3|NOT COMPLETED|Overall Study||1
2537154|NCT00619619|6218650|P2|NOT COMPLETED|Overall Study||0
2537155|NCT00619619|6218651|P1|NOT COMPLETED|Overall Study||0
2537156|NCT00619619|6218644|P8|COMPLETED|Overall Study||5
2537157|NCT00619619|6218645|P7|COMPLETED|Overall Study||7
2537158|NCT00619619|6218646|P6|COMPLETED|Overall Study||7
2537159|NCT00619619|6218647|P5|COMPLETED|Overall Study||5
2537160|NCT00619619|6218648|P4|COMPLETED|Overall Study||6
2537161|NCT00619619|6218649|P3|COMPLETED|Overall Study||8
2537162|NCT00619619|6218650|P2|COMPLETED|Overall Study||7
2537163|NCT00619619|6218651|P1|COMPLETED|Overall Study|Completed=conclusion of Test Article (treatment) phase for all treatment groups in 3151A6-2000.|6
2537164|NCT00619619|6218644|P8|Entered the Extension Study|Overall Study||7
2537165|NCT00619619|6218645|P7|Entered the Extension Study|Overall Study||6
2537166|NCT00619619|6218646|P6|Entered the Extension Study|Overall Study||6
2537167|NCT00619619|6218647|P5|Entered the Extension Study|Overall Study||7
2537168|NCT00619619|6218648|P4|Entered the Extension Study|Overall Study||3
2537169|NCT00619619|6218649|P3|Entered the Extension Study|Overall Study||8
2537170|NCT00619619|6218650|P2|Entered the Extension Study|Overall Study||5
2537171|NCT00619619|6218651|P1|Entered the Extension Study|Overall Study|Extension study: 3151A6-2001 (NCT00669110)|6
2537172|NCT00619619|6218644|P8|STARTED|Overall Study||8
2537173|NCT00619619|6218645|P7|STARTED|Overall Study||8
2537174|NCT00619619|6218646|P6|STARTED|Overall Study||7
2537175|NCT00619619|6218647|P5|STARTED|Overall Study||7
2537176|NCT00619619|6218648|P4|STARTED|Overall Study||7
2537177|NCT00619619|6218649|P3|STARTED|Overall Study||9
2537178|NCT00619619|6218650|P2|STARTED|Overall Study||7
2537179|NCT00619619|6218651|P1|STARTED|Overall Study||6
2537180|NCT00619515|6218736|P1|NOT COMPLETED|Overall Study||73
2537181|NCT00619515|6218736|P1|COMPLETED|Overall Study||0
2537182|NCT00619515|6218736|P1|STARTED|Overall Study||73
2537183|NCT00619502|6218750|P2|NOT COMPLETED|Overall Study||10
2537184|NCT00619502|6218751|P1|NOT COMPLETED|Overall Study||8
2537185|NCT00619502|6218750|P2|COMPLETED|Overall Study||114
2537186|NCT00619502|6218751|P1|COMPLETED|Overall Study||122
2537187|NCT00619502|6218750|P2|STARTED|Overall Study||124
2537188|NCT00619502|6218751|P1|STARTED|Overall Study||130
2537189|NCT00619489|6218763|P2|NOT COMPLETED|Overall Study||34
2537190|NCT00619489|6218764|P1|NOT COMPLETED|Overall Study||23
2537191|NCT00619489|6218763|P2|COMPLETED|Overall Study||1
2537192|NCT00619489|6218764|P1|COMPLETED|Overall Study||14
2537193|NCT00619489|6218763|P2|STARTED|Overall Study||35
2537194|NCT00619489|6218764|P1|STARTED|Overall Study||37
2537195|NCT00619476|6218786|P4|NOT COMPLETED|Overall Study||34
2537196|NCT00619476|6218787|P3|NOT COMPLETED|Overall Study||24
2537197|NCT00619476|6218788|P2|NOT COMPLETED|Overall Study||22
2537198|NCT00619476|6218789|P1|NOT COMPLETED|Overall Study||31
2537199|NCT00619476|6218786|P4|COMPLETED|Overall Study||56
2537200|NCT00619476|6218787|P3|COMPLETED|Overall Study||60
2537201|NCT00619476|6218788|P2|COMPLETED|Overall Study||85
2537202|NCT00619476|6218789|P1|COMPLETED|Overall Study||64
2537203|NCT00619476|6218786|P4|Safety Population|Overall Study||87
2537204|NCT00619476|6218787|P3|Safety Population|Overall Study||82
2537205|NCT00619476|6218788|P2|Safety Population|Overall Study||107
2537206|NCT00619476|6218789|P1|Safety Population|Overall Study||95
2537207|NCT00619476|6218786|P4|Intent-to-Treat Population|Overall Study||87
2537208|NCT00619476|6218787|P3|Intent-to-Treat Population|Overall Study||82
2537209|NCT00619476|6218788|P2|Intent-to-Treat Population|Overall Study||107
2537210|NCT00619476|6218789|P1|Intent-to-Treat Population|Overall Study||95
2537211|NCT00619476|6218786|P4|STARTED|Overall Study||90
2537212|NCT00619476|6218787|P3|STARTED|Overall Study||84
2537213|NCT00619476|6218788|P2|STARTED|Overall Study||107
2537214|NCT00619476|6218789|P1|STARTED|Overall Study||95
2537215|NCT00619385|6218874|P3|NOT COMPLETED|Overall Study||4
2537216|NCT00619385|6218875|P2|NOT COMPLETED|Overall Study||2
2537217|NCT00619385|6218876|P1|NOT COMPLETED|Overall Study||1
2537218|NCT00619385|6218874|P3|COMPLETED|Overall Study||6
2537219|NCT00619385|6218875|P2|COMPLETED|Overall Study||6
2537220|NCT00619385|6218876|P1|COMPLETED|Overall Study||6
2537221|NCT00619385|6218874|P3|STARTED|Overall Study||10
2537222|NCT00619385|6218875|P2|STARTED|Overall Study||8
2537223|NCT00619385|6218876|P1|STARTED|Overall Study||7
2537224|NCT00619359|6218891|P2|NOT COMPLETED|Overall Study||81
2537225|NCT00619359|6218892|P1|NOT COMPLETED|Overall Study||67
2537226|NCT00619359|6218891|P2|COMPLETED|Overall Study||1094
2537227|NCT00619359|6218892|P1|COMPLETED|Overall Study||1080
2537228|NCT00619359|6218891|P2|STARTED|Overall Study||1175
2537229|NCT00619359|6218892|P1|STARTED|Overall Study||1147
2537230|NCT00619307|6218904|P2|NOT COMPLETED|Overall Study||4
2537231|NCT00619307|6218905|P1|NOT COMPLETED|Overall Study||4
2537232|NCT00619307|6218904|P2|COMPLETED|Overall Study||53
2537233|NCT00619307|6218905|P1|COMPLETED|Overall Study||56
2537234|NCT00619307|6218904|P2|STARTED|Overall Study||57
2537235|NCT00619307|6218905|P1|STARTED|Overall Study||60
2537236|NCT00619255|6218921|P2|NOT COMPLETED|Overall Study||0
2537237|NCT00619255|6218922|P1|NOT COMPLETED|Overall Study||2
2537238|NCT00619255|6218921|P2|COMPLETED|Overall Study||61
2537239|NCT00619255|6218922|P1|COMPLETED|Overall Study||57
2537240|NCT00619255|6218921|P2|STARTED|Overall Study||61
2537241|NCT00619255|6218922|P1|STARTED|Overall Study||59
2537242|NCT00619242|6218936|P1|NOT COMPLETED|Overall Study||0
2537243|NCT00619242|6218936|P1|COMPLETED|Overall Study||3
2537244|NCT00619242|6218936|P1|STARTED|Overall Study||3
2537245|NCT00619229|6218942|P2|NOT COMPLETED|Overall Study||2
2537246|NCT00619229|6218943|P1|NOT COMPLETED|Overall Study||4
2537247|NCT00619229|6218942|P2|COMPLETED|Overall Study||16
2537248|NCT00619229|6218943|P1|COMPLETED|Overall Study||14
2537249|NCT00619229|6218942|P2|Full Analysis Set (FAS)|Overall Study||17
2537250|NCT00619229|6218943|P1|Full Analysis Set (FAS)|Overall Study||16
2537251|NCT00619229|6218942|P2|STARTED|Overall Study||18
2537252|NCT00619229|6218943|P1|STARTED|Overall Study||18
2537253|NCT00619190|6218971|P2|NOT COMPLETED|Overall Study||0
2537254|NCT00619190|6218972|P1|NOT COMPLETED|Overall Study||1
2537255|NCT00619190|6218971|P2|COMPLETED|Overall Study||9
2537256|NCT00619190|6218972|P1|COMPLETED|Overall Study||20
2537257|NCT00619190|6218971|P2|STARTED|Overall Study||9
2537258|NCT00619190|6218972|P1|STARTED|Overall Study||21
2537259|NCT00619177|6218982|P1|NOT COMPLETED|Overall Study||508
2537260|NCT00619177|6218982|P1|COMPLETED|Overall Study|"Due to some missing termination information, the number of completed may be larger than 3061."|3061
2537261|NCT00619177|6218982|P1|STARTED|Overall Study|treated set = 3569 (treated with Movalis)|3569
2537262|NCT00619151|6218992|P2|NOT COMPLETED|Overall Study||0
2537263|NCT00619151|6218993|P1|NOT COMPLETED|Overall Study||1
2537264|NCT00619151|6218992|P2|COMPLETED|Overall Study||0
2537265|NCT00619151|6218993|P1|COMPLETED|Overall Study||1
2537266|NCT00619151|6218992|P2|STARTED|Overall Study||0
2537267|NCT00619151|6218993|P1|STARTED|Overall Study||2
2537268|NCT00619112|6219003|P2|NOT COMPLETED|Overall Study||2
2537269|NCT00619112|6219004|P1|NOT COMPLETED|Overall Study||1
2537270|NCT00619112|6219003|P2|COMPLETED|Overall Study|Data from patients who didn't complete study was still included in the final analysis.|18
2537271|NCT00619112|6219004|P1|COMPLETED|Overall Study|Data from patient who didn't complete study was still included in the final analysis.|39
2537272|NCT00619112|6219003|P2|STARTED|Overall Study||20
2537273|NCT00619112|6219004|P1|STARTED|Overall Study||40
2537274|NCT00619099|6219025|P2|NOT COMPLETED|Overall Study||19
2537275|NCT00619099|6219026|P1|NOT COMPLETED|Overall Study||33
2537276|NCT00619099|6219025|P2|COMPLETED|Overall Study||4
2537277|NCT00619099|6219026|P1|COMPLETED|Overall Study||11
2537278|NCT00619099|6219025|P2|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|22
2537279|NCT00619099|6219026|P1|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|43
2537280|NCT00619099|6219025|P2|STARTED|Overall Study|All randomized subjects|23
2537281|NCT00619099|6219026|P1|STARTED|Overall Study|All randomized subjects|44
2537282|NCT00619073|6219032|P2|NOT COMPLETED|Second Intervention - 60 Days||0
2537283|NCT00619073|6219033|P1|NOT COMPLETED|Second Intervention - 60 Days||0
2537284|NCT00619073|6219032|P2|COMPLETED|Second Intervention - 60 Days||8
2537285|NCT00619073|6219033|P1|COMPLETED|Second Intervention - 60 Days||8
2537286|NCT00619073|6219032|P2|STARTED|Second Intervention - 60 Days||8
2537287|NCT00619073|6219033|P1|STARTED|Second Intervention - 60 Days||8
2537288|NCT00619073|6219032|P2|NOT COMPLETED|Washout Period (30 Days)||0
2537289|NCT00619073|6219033|P1|NOT COMPLETED|Washout Period (30 Days)||0
2537290|NCT00619073|6219032|P2|COMPLETED|Washout Period (30 Days)||8
2537291|NCT00619073|6219033|P1|COMPLETED|Washout Period (30 Days)||8
2537292|NCT00619073|6219032|P2|STARTED|Washout Period (30 Days)||8
2537293|NCT00619073|6219033|P1|STARTED|Washout Period (30 Days)||8
2537294|NCT00619073|6219032|P2|NOT COMPLETED|First Intervention - 60 Days||0
2537295|NCT00619073|6219033|P1|NOT COMPLETED|First Intervention - 60 Days||0
2537296|NCT00619073|6219032|P2|COMPLETED|First Intervention - 60 Days||8
2537297|NCT00619073|6219033|P1|COMPLETED|First Intervention - 60 Days||8
2537298|NCT00619073|6219032|P2|STARTED|First Intervention - 60 Days||8
2537299|NCT00619073|6219033|P1|STARTED|First Intervention - 60 Days||8
2537300|NCT00619060|6219039|P2|NOT COMPLETED|Overall Study||0
2537301|NCT00619060|6219040|P1|NOT COMPLETED|Overall Study||0
2537302|NCT00619060|6219039|P2|COMPLETED|Overall Study||12
2537303|NCT00619060|6219040|P1|COMPLETED|Overall Study||10
2537304|NCT00619060|6219039|P2|STARTED|Overall Study||12
2537305|NCT00619060|6219040|P1|STARTED|Overall Study||10
2537306|NCT00618995|6219048|P4|NOT COMPLETED|Period 4||0
2537307|NCT00618995|6219049|P3|NOT COMPLETED|Period 4||0
2537308|NCT00618995|6219050|P2|NOT COMPLETED|Period 4||0
2537309|NCT00618995|6219051|P1|NOT COMPLETED|Period 4||1
2537310|NCT00618995|6219048|P4|COMPLETED|Period 4||6
2537311|NCT00618995|6219049|P3|COMPLETED|Period 4||4
2537312|NCT00618995|6219050|P2|COMPLETED|Period 4||6
2537313|NCT00618995|6219051|P1|COMPLETED|Period 4||5
2537314|NCT00618995|6219048|P4|STARTED|Period 4||6
2537315|NCT00618995|6219049|P3|STARTED|Period 4||4
2537316|NCT00618995|6219050|P2|STARTED|Period 4||6
2537317|NCT00618995|6219051|P1|STARTED|Period 4||6
2537318|NCT00618995|6219048|P4|NOT COMPLETED|Period 3||0
2537319|NCT00618995|6219049|P3|NOT COMPLETED|Period 3||0
2537320|NCT00618995|6219050|P2|NOT COMPLETED|Period 3||0
2537321|NCT00618995|6219051|P1|NOT COMPLETED|Period 3||0
2537322|NCT00618995|6219048|P4|COMPLETED|Period 3||6
2537323|NCT00618995|6219049|P3|COMPLETED|Period 3||4
2537324|NCT00618995|6219050|P2|COMPLETED|Period 3||6
2537325|NCT00618995|6219051|P1|COMPLETED|Period 3||6
2537326|NCT00618995|6219048|P4|STARTED|Period 3||6
2537327|NCT00618995|6219049|P3|STARTED|Period 3||4
2537328|NCT00618995|6219050|P2|STARTED|Period 3||6
2537329|NCT00618995|6219051|P1|STARTED|Period 3||6
2537330|NCT00618995|6219048|P4|NOT COMPLETED|Period 2||0
2537331|NCT00618995|6219049|P3|NOT COMPLETED|Period 2||1
2537332|NCT00618995|6219050|P2|NOT COMPLETED|Period 2||0
2537333|NCT00618995|6219051|P1|NOT COMPLETED|Period 2||0
2537334|NCT00618995|6219048|P4|COMPLETED|Period 2||6
2537335|NCT00618995|6219049|P3|COMPLETED|Period 2||4
2537336|NCT00618995|6219050|P2|COMPLETED|Period 2||6
2537337|NCT00618995|6219051|P1|COMPLETED|Period 2||6
2537338|NCT00618995|6219048|P4|STARTED|Period 2||6
2537339|NCT00618995|6219049|P3|STARTED|Period 2||5
2537340|NCT00618995|6219050|P2|STARTED|Period 2||6
2537341|NCT00618995|6219051|P1|STARTED|Period 2||6
2537342|NCT00618995|6219048|P4|NOT COMPLETED|Period 1||0
2537343|NCT00618995|6219049|P3|NOT COMPLETED|Period 1||2
2537344|NCT00618995|6219050|P2|NOT COMPLETED|Period 1||1
2537345|NCT00618995|6219051|P1|NOT COMPLETED|Period 1||0
2537346|NCT00618995|6219048|P4|COMPLETED|Period 1||6
2537347|NCT00618995|6219049|P3|COMPLETED|Period 1||5
2537348|NCT00618995|6219050|P2|COMPLETED|Period 1||6
2537349|NCT00618995|6219051|P1|COMPLETED|Period 1||6
2537350|NCT00618995|6219048|P4|STARTED|Period 1||6
2537351|NCT00618995|6219049|P3|STARTED|Period 1||7
2537352|NCT00618995|6219050|P2|STARTED|Period 1||7
2537353|NCT00618995|6219051|P1|STARTED|Period 1||6
2537354|NCT00618982|6219065|P1|NOT COMPLETED|Overall Study||50
2537355|NCT00618982|6219065|P1|COMPLETED|Overall Study||33
2537356|NCT00618982|6219065|P1|STARTED|Overall Study||83
2537357|NCT00618956|6219088|P2|NOT COMPLETED|Overall Study||50
2537358|NCT00618956|6219089|P1|NOT COMPLETED|Overall Study||25
2537359|NCT00618956|6219088|P2|COMPLETED|Overall Study||160
2537360|NCT00618956|6219089|P1|COMPLETED|Overall Study||86
2537361|NCT00618956|6219088|P2|STARTED|Overall Study||210
2537362|NCT00618956|6219089|P1|STARTED|Overall Study||111
2537363|NCT00618839|6219105|P1|NOT COMPLETED|Overall Study||0
2537364|NCT00618839|6219105|P1|COMPLETED|Overall Study||15
2537365|NCT00618839|6219105|P1|STARTED|Overall Study||15
2537366|NCT00618826|6219114|P1|NOT COMPLETED|Overall Study||1
2537367|NCT00618826|6219114|P1|COMPLETED|Overall Study||13
2537368|NCT00618826|6219114|P1|STARTED|Overall Study||14
2537369|NCT00618813|6219119|P1|NOT COMPLETED|Overall Study||4
2537370|NCT00618813|6219119|P1|COMPLETED|Overall Study||31
2537371|NCT00618813|6219119|P1|Completed Week 29 to Week 37 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|33
2537372|NCT00618813|6219119|P1|Completed Week 23 to Week 28 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
2537373|NCT00618813|6219119|P1|Completed Week 13 to Week 22 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
2537374|NCT00618813|6219119|P1|Completed Enrollment - Week 12 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|35
2537375|NCT00618813|6219119|P1|STARTED|Overall Study||35
2537376|NCT00618787|6219129|P2|NOT COMPLETED|Overall Study||2
2537377|NCT00618787|6219130|P1|NOT COMPLETED|Overall Study||3
2537378|NCT00618787|6219129|P2|COMPLETED|Overall Study||21
2537379|NCT00618787|6219130|P1|COMPLETED|Overall Study||19
2537380|NCT00618787|6219129|P2|STARTED|Overall Study||23
2537381|NCT00618787|6219130|P1|STARTED|Overall Study||22
2537382|NCT00618774|6219138|P2|NOT COMPLETED|Overall Study||3
2537383|NCT00618774|6219139|P1|NOT COMPLETED|Overall Study||6
2537384|NCT00618774|6219138|P2|COMPLETED|Overall Study||45
2537385|NCT00618774|6219139|P1|COMPLETED|Overall Study||205
2537386|NCT00618774|6219138|P2|STARTED|Overall Study||48
2537387|NCT00618774|6219139|P1|STARTED|Overall Study||211
2537388|NCT00618748|6219172|P3|NOT COMPLETED|Overall Study||14
2537389|NCT00618748|6219173|P2|NOT COMPLETED|Overall Study||5
2537390|NCT00618748|6219174|P1|NOT COMPLETED|Overall Study||11
2537391|NCT00618748|6219172|P3|COMPLETED|Overall Study||6
2537392|NCT00618748|6219173|P2|COMPLETED|Overall Study||20
2537393|NCT00618748|6219174|P1|COMPLETED|Overall Study||45
2537394|NCT00618748|6219172|P3|STARTED|Overall Study||20
2537395|NCT00618748|6219173|P2|STARTED|Overall Study||25
2537396|NCT00618748|6219174|P1|STARTED|Overall Study||56
2537397|NCT00618722|6219219|P4|NOT COMPLETED|Overall Study||4
2537398|NCT00618722|6219220|P3|NOT COMPLETED|Overall Study||3
2537399|NCT00618722|6219221|P2|NOT COMPLETED|Overall Study||2
2537400|NCT00618722|6219222|P1|NOT COMPLETED|Overall Study||3
2537401|NCT00618722|6219219|P4|COMPLETED|Overall Study||18
2537402|NCT00618722|6219220|P3|COMPLETED|Overall Study||19
2537403|NCT00618722|6219221|P2|COMPLETED|Overall Study||18
2537404|NCT00618722|6219222|P1|COMPLETED|Overall Study||18
2537405|NCT00618722|6219219|P4|Received Treatment|Overall Study||22
2537406|NCT00618722|6219220|P3|Received Treatment|Overall Study||22
2537407|NCT00618722|6219221|P2|Received Treatment|Overall Study||20
2537408|NCT00618722|6219222|P1|Received Treatment|Overall Study||20
2537409|NCT00618722|6219219|P4|STARTED|Overall Study||22
2537410|NCT00618722|6219220|P3|STARTED|Overall Study||22
2537411|NCT00618722|6219221|P2|STARTED|Overall Study||20
2537412|NCT00618722|6219222|P1|STARTED|Overall Study||21
2537413|NCT00618618|6219260|P4|NOT COMPLETED|Overall Study||1
2537414|NCT00618618|6219261|P3|NOT COMPLETED|Overall Study||3
2537415|NCT00618618|6219262|P2|NOT COMPLETED|Overall Study||3
2537416|NCT00618618|6219263|P1|NOT COMPLETED|Overall Study||4
2537417|NCT00618618|6219260|P4|COMPLETED|Overall Study||13
2537418|NCT00618618|6219261|P3|COMPLETED|Overall Study||18
2537419|NCT00618618|6219262|P2|COMPLETED|Overall Study||11
2537420|NCT00618618|6219263|P1|COMPLETED|Overall Study||20
2537421|NCT00618618|6219260|P4|Received Treatment|Overall Study||14
2537422|NCT00618618|6219261|P3|Received Treatment|Overall Study||20
2537423|NCT00618618|6219262|P2|Received Treatment|Overall Study||13
2537424|NCT00618618|6219263|P1|Received Treatment|Overall Study||24
2537425|NCT00618618|6219260|P4|STARTED|Overall Study||14
2537426|NCT00618618|6219261|P3|STARTED|Overall Study||21
2537427|NCT00618618|6219262|P2|STARTED|Overall Study||14
2537428|NCT00618618|6219263|P1|STARTED|Overall Study||24
2537429|NCT00618540|6219309|P1|NOT COMPLETED|Overall Study||0
2537430|NCT00618540|6219309|P1|COMPLETED|Overall Study||1
2537431|NCT00618540|6219309|P1|STARTED|Overall Study||1
2537432|NCT00618514|6219322|P3|NOT COMPLETED|Overall Study||4
2537433|NCT00618514|6219323|P2|NOT COMPLETED|Overall Study||12
2537434|NCT00618514|6219324|P1|NOT COMPLETED|Overall Study||11
2537435|NCT00618514|6219322|P3|COMPLETED|Overall Study||12
2537436|NCT00618514|6219323|P2|COMPLETED|Overall Study||26
2537437|NCT00618514|6219324|P1|COMPLETED|Overall Study||25
2537438|NCT00618514|6219322|P3|STARTED|Overall Study||16
2537439|NCT00618514|6219323|P2|STARTED|Overall Study||38
2537440|NCT00618514|6219324|P1|STARTED|Overall Study||36
2537441|NCT00618449|6219344|P2|NOT COMPLETED|Overall Study||110
2537442|NCT00618449|6219345|P1|NOT COMPLETED|Overall Study||98
2537443|NCT00618449|6219344|P2|COMPLETED|Overall Study||558
2537444|NCT00618449|6219345|P1|COMPLETED|Overall Study||581
2537445|NCT00618449|6219344|P2|1-year, Post-treatment|Overall Study||558
2537446|NCT00618449|6219345|P1|1-year, Post-treatment|Overall Study||581
2537447|NCT00618449|6219344|P2|1-month, Post-treatment|Overall Study||656
2537448|NCT00618449|6219345|P1|1-month, Post-treatment|Overall Study||666
2537449|NCT00618449|6219344|P2|STARTED|Overall Study||668
2537450|NCT00618449|6219345|P1|STARTED|Overall Study||679
2537451|NCT00618436|6219353|P2|NOT COMPLETED|Overall Study||0
2537452|NCT00618436|6219354|P1|NOT COMPLETED|Overall Study||0
2537453|NCT00618436|6219353|P2|COMPLETED|Overall Study||18
2537454|NCT00618436|6219354|P1|COMPLETED|Overall Study||34
2537455|NCT00618436|6219353|P2|STARTED|Overall Study||18
2537456|NCT00618436|6219354|P1|STARTED|Overall Study||34
2537457|NCT00618410|6219364|P2|NOT COMPLETED|Second Intervention||0
2537458|NCT00618410|6219365|P1|NOT COMPLETED|Second Intervention||0
2537459|NCT00618410|6219364|P2|COMPLETED|Second Intervention||5
2537460|NCT00618410|6219365|P1|COMPLETED|Second Intervention||7
2537461|NCT00618410|6219364|P2|STARTED|Second Intervention||5
2537462|NCT00618410|6219365|P1|STARTED|Second Intervention||7
2537463|NCT00618410|6219364|P2|NOT COMPLETED|Washout Period (2 Weeks)||1
2537464|NCT00618410|6219365|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
2537465|NCT00618410|6219364|P2|COMPLETED|Washout Period (2 Weeks)||5
2537466|NCT00618410|6219365|P1|COMPLETED|Washout Period (2 Weeks)||7
2537467|NCT00618410|6219364|P2|STARTED|Washout Period (2 Weeks)||6
2537468|NCT00618410|6219365|P1|STARTED|Washout Period (2 Weeks)||7
2537469|NCT00618410|6219364|P2|NOT COMPLETED|First Intervention||0
2537470|NCT00618410|6219365|P1|NOT COMPLETED|First Intervention||0
2537471|NCT00618410|6219364|P2|COMPLETED|First Intervention||6
2537472|NCT00618410|6219365|P1|COMPLETED|First Intervention||7
2537473|NCT00618410|6219364|P2|STARTED|First Intervention||6
2537474|NCT00618410|6219365|P1|STARTED|First Intervention||7
2537475|NCT00618371|6219381|P1|NOT COMPLETED|Overall Study||2
2537476|NCT00618371|6219381|P1|COMPLETED|Overall Study||10
2537477|NCT00618371|6219381|P1|STARTED|Overall Study||12
2537478|NCT00618332|6219388|P2|NOT COMPLETED|Overall Study||0
2537479|NCT00618332|6219389|P1|NOT COMPLETED|Overall Study||0
2537480|NCT00618332|6219388|P2|COMPLETED|Overall Study||20
2537481|NCT00618332|6219389|P1|COMPLETED|Overall Study||20
2537482|NCT00618332|6219388|P2|STARTED|Overall Study||20
2537483|NCT00618332|6219389|P1|STARTED|Overall Study||20
2537484|NCT00618072|6219414|P3|NOT COMPLETED|Overall Study||4
2537485|NCT00618072|6219415|P2|NOT COMPLETED|Overall Study||1
2537486|NCT00618072|6219416|P1|NOT COMPLETED|Overall Study||2
2537487|NCT00618072|6219414|P3|COMPLETED|Overall Study||11
2537488|NCT00618072|6219415|P2|COMPLETED|Overall Study||14
2537489|NCT00618072|6219416|P1|COMPLETED|Overall Study||14
2537490|NCT00618072|6219414|P3|STARTED|Overall Study||15
2537491|NCT00618072|6219415|P2|STARTED|Overall Study||15
2537492|NCT00618072|6219416|P1|STARTED|Overall Study||16
2537493|NCT00617981|6219450|P2|NOT COMPLETED|Overall Study||102
2537494|NCT00617981|6219451|P1|NOT COMPLETED|Overall Study||110
2537495|NCT00617981|6219450|P2|COMPLETED|Overall Study||245
2537496|NCT00617981|6219451|P1|COMPLETED|Overall Study||244
2537497|NCT00617981|6219450|P2|STARTED|Overall Study||347
2537498|NCT00617981|6219451|P1|STARTED|Overall Study||354
2537499|NCT00617942|6219459|P2|NOT COMPLETED|Overall Study||4
2537500|NCT00617942|6219460|P1|NOT COMPLETED|Overall Study||8
2537501|NCT00617942|6219459|P2|COMPLETED|Overall Study||19
2537502|NCT00617942|6219460|P1|COMPLETED|Overall Study||29
2537503|NCT00617942|6219459|P2|STARTED|Overall Study||23
2537504|NCT00617942|6219460|P1|STARTED|Overall Study||37
2537505|NCT00617929|6219472|P1|NOT COMPLETED|Overall Study||1
2537506|NCT00617929|6219472|P1|COMPLETED|Overall Study||11
2537507|NCT00617929|6219472|P1|STARTED|Overall Study||12
2537508|NCT00617903|6219484|P2|NOT COMPLETED|Overall Study||7
2537509|NCT00617903|6219485|P1|NOT COMPLETED|Overall Study||3
2537510|NCT00617903|6219484|P2|COMPLETED|Overall Study||35
2537511|NCT00617903|6219485|P1|COMPLETED|Overall Study||38
2537512|NCT00617903|6219484|P2|STARTED|Overall Study||42
2537513|NCT00617903|6219485|P1|STARTED|Overall Study||41
2537514|NCT00617890|6219531|P4|NOT COMPLETED|Overall Study||115
2537515|NCT00617890|6219532|P3|NOT COMPLETED|Overall Study||35
2537516|NCT00617890|6219533|P2|NOT COMPLETED|Overall Study||28
2537517|NCT00617890|6219534|P1|NOT COMPLETED|Overall Study||31
2537518|NCT00617890|6219531|P4|COMPLETED|Overall Study||1
2537519|NCT00617890|6219532|P3|COMPLETED|Overall Study||0
2537520|NCT00617890|6219533|P2|COMPLETED|Overall Study||5
2537521|NCT00617890|6219534|P1|COMPLETED|Overall Study||4
2537522|NCT00617890|6219531|P4|Received Treatment|Overall Study||115
2537523|NCT00617890|6219532|P3|Received Treatment|Overall Study||34
2537524|NCT00617890|6219533|P2|Received Treatment|Overall Study||33
2537525|NCT00617890|6219534|P1|Received Treatment|Overall Study||34
2537526|NCT00617890|6219531|P4|STARTED|Overall Study||116
2537527|NCT00617890|6219532|P3|STARTED|Overall Study||35
2537528|NCT00617890|6219533|P2|STARTED|Overall Study||33
2537529|NCT00617890|6219534|P1|STARTED|Overall Study||35
2537530|NCT00617851|6219570|P4|NOT COMPLETED|Overall Study||25
2537531|NCT00617851|6219571|P3|NOT COMPLETED|Overall Study||45
2537532|NCT00617851|6219572|P2|NOT COMPLETED|Overall Study||40
2537533|NCT00617851|6219573|P1|NOT COMPLETED|Overall Study||47
2537534|NCT00617851|6219570|P4|COMPLETED|Overall Study||192
2537535|NCT00617851|6219571|P3|COMPLETED|Overall Study||384
2537536|NCT00617851|6219572|P2|COMPLETED|Overall Study||391
2537537|NCT00617851|6219573|P1|COMPLETED|Overall Study||383
2537538|NCT00617851|6219570|P4|STARTED|Overall Study||217
2537539|NCT00617851|6219571|P3|STARTED|Overall Study||429
2537540|NCT00617851|6219572|P2|STARTED|Overall Study||431
2537541|NCT00617851|6219573|P1|STARTED|Overall Study||430
2537542|NCT00617773|6219611|P1|NOT COMPLETED|Overall Study||24
2537543|NCT00617773|6219611|P1|COMPLETED|Overall Study|Patients COMPLETED were evaluated as having no disease progression at the end of cycle 3.|7
2537544|NCT00617773|6219611|P1|STARTED|Overall Study||31
2537545|NCT00617734|6219628|P2|NOT COMPLETED|Overall Study||6
2537546|NCT00617734|6219629|P1|NOT COMPLETED|Overall Study||8
2537547|NCT00617734|6219628|P2|COMPLETED|Overall Study||42
2537548|NCT00617734|6219629|P1|COMPLETED|Overall Study||41
2537549|NCT00617734|6219628|P2|Received at Least 1 Dose of Study Drug|Overall Study||44
2537550|NCT00617734|6219629|P1|Received at Least 1 Dose of Study Drug|Overall Study||47
2537551|NCT00617734|6219628|P2|STARTED|Overall Study||48
2537552|NCT00617734|6219629|P1|STARTED|Overall Study||49
2537553|NCT00617708|6219650|P3|NOT COMPLETED|Overall Study||64
2537554|NCT00617708|6219651|P2|NOT COMPLETED|Overall Study||60
2537555|NCT00617708|6219652|P1|NOT COMPLETED|Overall Study||10
2537556|NCT00617708|6219650|P3|COMPLETED|Overall Study||0
2537557|NCT00617708|6219651|P2|COMPLETED|Overall Study||0
2537558|NCT00617708|6219652|P1|COMPLETED|Overall Study||0
2537559|NCT00617708|6219650|P3|Eligible and Began Protocol Therapy|Overall Study||59
2537560|NCT00617708|6219651|P2|Eligible and Began Protocol Therapy|Overall Study||57
2537561|NCT00617708|6219652|P1|Eligible and Began Protocol Therapy|Overall Study||9
2537562|NCT00617708|6219650|P3|STARTED|Overall Study||64
2537563|NCT00617708|6219651|P2|STARTED|Overall Study||60
2537564|NCT00617708|6219652|P1|STARTED|Overall Study||10
2537565|NCT00617669|6219669|P2|NOT COMPLETED|Overall Study||451
2537566|NCT00617669|6219670|P1|NOT COMPLETED|Overall Study||430
2537567|NCT00617669|6219669|P2|COMPLETED|Overall Study|Patients receiving placebo at data cut-off|77
2537568|NCT00617669|6219670|P1|COMPLETED|Overall Study|Patients receiving ZD4054 10 mg at data cut-off|94
2537569|NCT00617669|6219669|P2|Patients Who Received IP|Overall Study||525
2537570|NCT00617669|6219670|P1|Patients Who Received IP|Overall Study||522
2537571|NCT00617669|6219669|P2|STARTED|Overall Study||528
2537572|NCT00617669|6219670|P1|STARTED|Overall Study||524
2537573|NCT00617604|6219692|P2|NOT COMPLETED|Overall Study||20
2537574|NCT00617604|6219693|P1|NOT COMPLETED|Overall Study||18
2537575|NCT00617604|6219692|P2|COMPLETED|Overall Study|Completed Month 6 assessment|88
2537576|NCT00617604|6219693|P1|COMPLETED|Overall Study|Completed Month 6 assessment|92
2537577|NCT00617604|6219692|P2|Completed 12 Weeks of Treatment|Overall Study||83
2537578|NCT00617604|6219693|P1|Completed 12 Weeks of Treatment|Overall Study||89
2537579|NCT00617604|6219692|P2|Received Treatment|Overall Study||105
2537580|NCT00617604|6219693|P1|Received Treatment|Overall Study||107
2537581|NCT00617604|6219692|P2|STARTED|Overall Study||108
2537582|NCT00617604|6219693|P1|STARTED|Overall Study||110
2537583|NCT00617591|6219737|P1|NOT COMPLETED|Overall Study||10
2537584|NCT00617591|6219737|P1|COMPLETED|Overall Study||47
2537585|NCT00617591|6219737|P1|STARTED|Overall Study||57
2537586|NCT00617539|6219745|P1|NOT COMPLETED|Overall Study||0
2537587|NCT00617539|6219745|P1|COMPLETED|Overall Study||30
2537588|NCT00617539|6219745|P1|STARTED|Overall Study||30
2537589|NCT00617461|6219753|P2|NOT COMPLETED|6-Day Down-Titration Period||2
2537590|NCT00617461|6219754|P1|NOT COMPLETED|6-Day Down-Titration Period||2
2537591|NCT00617461|6219753|P2|COMPLETED|6-Day Down-Titration Period||35
2537592|NCT00617461|6219754|P1|COMPLETED|6-Day Down-Titration Period||39
2537593|NCT00617461|6219753|P2|STARTED|6-Day Down-Titration Period||37
2537594|NCT00617461|6219754|P1|STARTED|6-Day Down-Titration Period||41
2537595|NCT00617461|6219753|P2|NOT COMPLETED|Second Treatment Intervention Period||4
2537596|NCT00617461|6219754|P1|NOT COMPLETED|Second Treatment Intervention Period||0
2537597|NCT00617461|6219753|P2|COMPLETED|Second Treatment Intervention Period||37
2537598|NCT00617461|6219754|P1|COMPLETED|Second Treatment Intervention Period||41
2537599|NCT00617461|6219753|P2|STARTED|Second Treatment Intervention Period||41
2537600|NCT00617461|6219754|P1|STARTED|Second Treatment Intervention Period||41
2537601|NCT00617461|6219753|P2|NOT COMPLETED|4-Day Crossover Period||0
2537602|NCT00617461|6219754|P1|NOT COMPLETED|4-Day Crossover Period||1
2537603|NCT00617461|6219753|P2|COMPLETED|4-Day Crossover Period||40
2537604|NCT00617461|6219754|P1|COMPLETED|4-Day Crossover Period||41
2537605|NCT00617461|6219753|P2|STARTED|4-Day Crossover Period|One 3600:1200 participant skipped the Crossover period, going directly to second Treatment Period.|40
2537606|NCT00617461|6219754|P1|STARTED|4-Day Crossover Period||42
2537607|NCT00617461|6219753|P2|NOT COMPLETED|First Treatment Intervention Period||3
2537608|NCT00617461|6219754|P1|NOT COMPLETED|First Treatment Intervention Period||10
2537609|NCT00617461|6219753|P2|COMPLETED|First Treatment Intervention Period||41
2537610|NCT00617461|6219754|P1|COMPLETED|First Treatment Intervention Period||42
2537611|NCT00617461|6219753|P2|STARTED|First Treatment Intervention Period||44
2537612|NCT00617461|6219754|P1|STARTED|First Treatment Intervention Period|2 par. (1 withdrawal due to inv. discretion, 1 withdrawal by subject) did not take study drug.|52
2537613|NCT00617409|6219810|P3|NOT COMPLETED|Overall Study||27
2537614|NCT00617409|6219811|P2|NOT COMPLETED|Overall Study||18
2537615|NCT00617409|6219812|P1|NOT COMPLETED|Overall Study||16
2537616|NCT00617409|6219810|P3|COMPLETED|Overall Study||4
2537617|NCT00617409|6219811|P2|COMPLETED|Overall Study||2
2537618|NCT00617409|6219812|P1|COMPLETED|Overall Study||2
2537619|NCT00617409|6219810|P3|STARTED|Overall Study||31
2537620|NCT00617409|6219811|P2|STARTED|Overall Study||20
2537621|NCT00617409|6219812|P1|STARTED|Overall Study||18
2537622|NCT00617396|6219823|P1|NOT COMPLETED|Overall Study||0
2537623|NCT00617396|6219823|P1|COMPLETED|Overall Study||25
2537624|NCT00617396|6219823|P1|STARTED|Overall Study||25
2537625|NCT00617357|6219827|P1|NOT COMPLETED|Overall Study||16
2537626|NCT00617357|6219827|P1|COMPLETED|Overall Study|67 subjects completed study; 7 completed early, 60 completed 24 month visit|67
2537627|NCT00617357|6219827|P1|STARTED|Overall Study|83 subjects enrolled, 80 subjects received Strattice reinforcement of hernia repair|83
2537628|NCT00617344|6219840|P3|NOT COMPLETED|Overall Study||8
2537629|NCT00617344|6219841|P2|NOT COMPLETED|Overall Study||22
2537630|NCT00617344|6219842|P1|NOT COMPLETED|Overall Study||25
2537631|NCT00617344|6219840|P3|COMPLETED|Overall Study||45
2537632|NCT00617344|6219841|P2|COMPLETED|Overall Study||81
2537633|NCT00617344|6219842|P1|COMPLETED|Overall Study||79
2537634|NCT00617344|6219840|P3|Received Vaccination 3|Overall Study||45
2537635|NCT00617344|6219841|P2|Received Vaccination 3|Overall Study||81
2537636|NCT00617344|6219842|P1|Received Vaccination 3|Overall Study||79
2537637|NCT00617344|6219840|P3|Received Vaccination 2|Overall Study||46
2537638|NCT00617344|6219841|P2|Received Vaccination 2|Overall Study||85
2537639|NCT00617344|6219842|P1|Received Vaccination 2|Overall Study||86
2537640|NCT00617344|6219840|P3|Received Vaccination 1|Overall Study||53
2537641|NCT00617344|6219841|P2|Received Vaccination 1|Overall Study||103
2537642|NCT00617344|6219842|P1|Received Vaccination 1|Overall Study||104
2537643|NCT00617344|6219840|P3|STARTED|Overall Study||53
2537644|NCT00617344|6219841|P2|STARTED|Overall Study||103
2537645|NCT00617344|6219842|P1|STARTED|Overall Study||104
2537646|NCT00617305|6219870|P3|NOT COMPLETED|Overall Study||1
2537647|NCT00617305|6219871|P2|NOT COMPLETED|Overall Study||0
2537648|NCT00617305|6219872|P1|NOT COMPLETED|Overall Study||8
2537649|NCT00617305|6219870|P3|COMPLETED|Overall Study||0
2537650|NCT00617305|6219871|P2|COMPLETED|Overall Study||4
2537651|NCT00617305|6219872|P1|COMPLETED|Overall Study||25
2537652|NCT00617305|6219870|P3|Completed 24-week Primary Analysis|Overall Study||0
2537653|NCT00617305|6219871|P2|Completed 24-week Primary Analysis|Overall Study||4
2537654|NCT00617305|6219872|P1|Completed 24-week Primary Analysis|Overall Study||31
2537655|NCT00617305|6219870|P3|STARTED|Overall Study||1
2537656|NCT00617305|6219871|P2|STARTED|Overall Study||4
2537657|NCT00617305|6219872|P1|STARTED|Overall Study||33
2537658|NCT00617279|6219928|P2|NOT COMPLETED|Overall Study||17
2537659|NCT00617279|6219929|P1|NOT COMPLETED|Overall Study||14
2537660|NCT00617279|6219928|P2|COMPLETED|Overall Study||0
2537661|NCT00617279|6219929|P1|COMPLETED|Overall Study||0
2537662|NCT00617279|6219928|P2|STARTED|Overall Study||17
2537663|NCT00617279|6219929|P1|STARTED|Overall Study||14
2537664|NCT00617240|6219985|P2|NOT COMPLETED|Overall Study||0
2537665|NCT00617240|6219986|P1|NOT COMPLETED|Overall Study||1
2537666|NCT00617240|6219985|P2|COMPLETED|Overall Study||4
2537667|NCT00617240|6219986|P1|COMPLETED|Overall Study||4
2537668|NCT00617240|6219985|P2|STARTED|Overall Study||4
2537669|NCT00617240|6219986|P1|STARTED|Overall Study||5
2537670|NCT00617201|6220006|P2|NOT COMPLETED|Overall Study||13
2537671|NCT00617201|6220007|P1|NOT COMPLETED|Overall Study||9
2537672|NCT00617201|6220006|P2|COMPLETED|Overall Study||12
2537673|NCT00617201|6220007|P1|COMPLETED|Overall Study||16
2537674|NCT00617201|6220006|P2|STARTED|Overall Study||25
2537675|NCT00617201|6220007|P1|STARTED|Overall Study||25
2537676|NCT00617188|6220015|P1|NOT COMPLETED|Overall Study||0
2537677|NCT00617188|6220015|P1|COMPLETED|Overall Study||26
2537678|NCT00617188|6220015|P1|STARTED|Overall Study||26
2537679|NCT00617175|6220026|P2|NOT COMPLETED|Overall Study||0
2537680|NCT00617175|6220027|P1|NOT COMPLETED|Overall Study||0
2537681|NCT00617175|6220026|P2|COMPLETED|Overall Study||948
2537682|NCT00617175|6220027|P1|COMPLETED|Overall Study||954
2537683|NCT00617175|6220026|P2|STARTED|Overall Study||948
2537684|NCT00617175|6220027|P1|STARTED|Overall Study||954
2537685|NCT00617123|6220035|P2|NOT COMPLETED|Study Treatment Period||16
2537686|NCT00617123|6220036|P1|NOT COMPLETED|Study Treatment Period||17
2537687|NCT00617123|6220035|P2|COMPLETED|Study Treatment Period||79
2537688|NCT00617123|6220036|P1|COMPLETED|Study Treatment Period||81
2537689|NCT00617123|6220035|P2|Treated|Study Treatment Period||95
2537690|NCT00617123|6220036|P1|Treated|Study Treatment Period|1 participant was not treated|97
2537691|NCT00617123|6220035|P2|STARTED|Study Treatment Period||95
2537692|NCT00617123|6220036|P1|STARTED|Study Treatment Period||98
2537693|NCT00617123|6220035|P2|NOT COMPLETED|Referral Screening Period||26
2537694|NCT00617123|6220036|P1|NOT COMPLETED|Referral Screening Period||39
2537695|NCT00617123|6220035|P2|COMPLETED|Referral Screening Period||95
2537696|NCT00617123|6220036|P1|COMPLETED|Referral Screening Period||98
2537697|NCT00617123|6220035|P2|STARTED|Referral Screening Period||121
2537698|NCT00617123|6220036|P1|STARTED|Referral Screening Period||137
2537699|NCT00617097|6220052|P2|NOT COMPLETED|Overall Study||0
2537700|NCT00617097|6220053|P1|NOT COMPLETED|Overall Study||0
2537701|NCT00617097|6220052|P2|COMPLETED|Overall Study||25
2537702|NCT00617097|6220053|P1|COMPLETED|Overall Study||25
2537703|NCT00617097|6220052|P2|STARTED|Overall Study||25
2537704|NCT00617097|6220053|P1|STARTED|Overall Study||25
2537705|NCT00617084|6220067|P2|NOT COMPLETED|Overall Study||26
2537706|NCT00617084|6220068|P1|NOT COMPLETED|Overall Study||21
2537707|NCT00617084|6220067|P2|COMPLETED|Overall Study||1126
2537708|NCT00617084|6220068|P1|COMPLETED|Overall Study||1119
2537709|NCT00617084|6220067|P2|STARTED|Overall Study||1152
2537710|NCT00617084|6220068|P1|STARTED|Overall Study||1140
2537711|NCT00617058|6220079|P3|NOT COMPLETED|Overall Study||0
2537712|NCT00617058|6220080|P2|NOT COMPLETED|Overall Study||0
2537713|NCT00617058|6220081|P1|NOT COMPLETED|Overall Study||0
2537714|NCT00617058|6220079|P3|COMPLETED|Overall Study||0
2537715|NCT00617058|6220080|P2|COMPLETED|Overall Study||0
2537716|NCT00617058|6220081|P1|COMPLETED|Overall Study||1
2537717|NCT00617058|6220079|P3|STARTED|Overall Study||0
2537718|NCT00617058|6220080|P2|STARTED|Overall Study||0
2537719|NCT00617058|6220081|P1|STARTED|Overall Study||1
2537729|NCT00616941|6220148|P3|NOT COMPLETED|Overall Study||6
2537730|NCT00616941|6220149|P2|NOT COMPLETED|Overall Study||5
2537731|NCT00616941|6220150|P1|NOT COMPLETED|Overall Study||1
2537732|NCT00616941|6220148|P3|COMPLETED|Overall Study||5
2537733|NCT00616941|6220149|P2|COMPLETED|Overall Study||8
2537734|NCT00616941|6220150|P1|COMPLETED|Overall Study||3
2537735|NCT00616941|6220148|P3|STARTED|Overall Study||11
2537736|NCT00616941|6220149|P2|STARTED|Overall Study||13
2537737|NCT00616941|6220150|P1|STARTED|Overall Study||4
2537738|NCT00616928|6220177|P4|NOT COMPLETED|Overall Study||7
2537739|NCT00616928|6220178|P3|NOT COMPLETED|Overall Study||17
2537740|NCT00616928|6220179|P2|NOT COMPLETED|Overall Study||18
2537741|NCT00616928|6220180|P1|NOT COMPLETED|Overall Study||62
2537742|NCT00616928|6220177|P4|COMPLETED|Overall Study||364
2537743|NCT00616928|6220178|P3|COMPLETED|Overall Study||1101
2537744|NCT00616928|6220179|P2|COMPLETED|Overall Study||750
2537745|NCT00616928|6220180|P1|COMPLETED|Overall Study||2242
2537746|NCT00616928|6220177|P4|STARTED|Overall Study||371
2537747|NCT00616928|6220178|P3|STARTED|Overall Study||1118
2537748|NCT00616928|6220179|P2|STARTED|Overall Study||768
2537749|NCT00616928|6220180|P1|STARTED|Overall Study||2304
2537750|NCT00616902|6220244|P2|NOT COMPLETED|Overall Study||6
2537751|NCT00616902|6220245|P1|NOT COMPLETED|Overall Study||6
2537752|NCT00616902|6220244|P2|COMPLETED|Overall Study||0
2537753|NCT00616902|6220245|P1|COMPLETED|Overall Study||0
2537754|NCT00616902|6220244|P2|STARTED|Overall Study||6
2537755|NCT00616902|6220245|P1|STARTED|Overall Study||6
2537756|NCT00616772|6220271|P2|NOT COMPLETED|Overall Study||102
2537757|NCT00616772|6220272|P1|NOT COMPLETED|Overall Study||115
2537758|NCT00616772|6220271|P2|COMPLETED|Overall Study||240
2537759|NCT00616772|6220272|P1|COMPLETED|Overall Study||225
2537760|NCT00616772|6220271|P2|Treated|Overall Study||339
2537761|NCT00616772|6220272|P1|Treated|Overall Study||337
2537762|NCT00616772|6220271|P2|STARTED|Overall Study||342
2537763|NCT00616772|6220272|P1|STARTED|Overall Study||340
2537764|NCT00616759|6220288|P2|NOT COMPLETED|Overall Study||2
2537765|NCT00616759|6220289|P1|NOT COMPLETED|Overall Study||3
2537766|NCT00616759|6220288|P2|COMPLETED|Overall Study||8
2537767|NCT00616759|6220289|P1|COMPLETED|Overall Study||7
2537768|NCT00616759|6220288|P2|STARTED|Overall Study||10
2537769|NCT00616759|6220289|P1|STARTED|Overall Study||10
2537770|NCT00616655|6220298|P3|NOT COMPLETED|Overall Study||48
2537771|NCT00616655|6220299|P2|NOT COMPLETED|Overall Study||41
2537772|NCT00616655|6220300|P1|NOT COMPLETED|Overall Study||35
2537773|NCT00616655|6220298|P3|COMPLETED|Overall Study||103
2537774|NCT00616655|6220299|P2|COMPLETED|Overall Study||112
2537775|NCT00616655|6220300|P1|COMPLETED|Overall Study||117
2537776|NCT00616655|6220298|P3|STARTED|Overall Study||151
2537777|NCT00616655|6220299|P2|STARTED|Overall Study||153
2537778|NCT00616655|6220300|P1|STARTED|Overall Study||152
2537779|NCT00616642|6220340|P2|NOT COMPLETED|Overall Study||1
2537780|NCT00616642|6220341|P1|NOT COMPLETED|Overall Study||0
2537781|NCT00616642|6220340|P2|COMPLETED|Overall Study||0
2537782|NCT00616642|6220341|P1|COMPLETED|Overall Study||0
2537783|NCT00616642|6220340|P2|STARTED|Overall Study||1
2537784|NCT00616642|6220341|P1|STARTED|Overall Study||0
2537785|NCT00616629|6220352|P5|NOT COMPLETED|Overall Study||0
2537786|NCT00616629|6220353|P4|NOT COMPLETED|Overall Study||0
2537787|NCT00616629|6220354|P3|NOT COMPLETED|Overall Study||1
2537788|NCT00616629|6220355|P2|NOT COMPLETED|Overall Study||2
2537789|NCT00616629|6220356|P1|NOT COMPLETED|Overall Study||2
2537790|NCT00616629|6220352|P5|COMPLETED|Overall Study||12
2537791|NCT00616629|6220353|P4|COMPLETED|Overall Study||2
2537792|NCT00616629|6220354|P3|COMPLETED|Overall Study||13
2537793|NCT00616629|6220355|P2|COMPLETED|Overall Study||12
2537794|NCT00616629|6220356|P1|COMPLETED|Overall Study||11
2537795|NCT00616629|6220352|P5|STARTED|Overall Study||12
2537796|NCT00616629|6220353|P4|STARTED|Overall Study||2
2537797|NCT00616629|6220354|P3|STARTED|Overall Study|One patient never received study drug|14
2537798|NCT00616629|6220355|P2|STARTED|Overall Study|Two patients never received study drug|14
2537799|NCT00616629|6220356|P1|STARTED|Overall Study|Two patients never received study drug|13
2537800|NCT00616603|6220401|P3|NOT COMPLETED|Overall Study||2
2537801|NCT00616603|6220402|P2|NOT COMPLETED|Overall Study||0
2537802|NCT00616603|6220403|P1|NOT COMPLETED|Overall Study||2
2537803|NCT00616603|6220401|P3|COMPLETED|Overall Study||13
2537804|NCT00616603|6220402|P2|COMPLETED|Overall Study||14
2537805|NCT00616603|6220403|P1|COMPLETED|Overall Study||12
2537806|NCT00616603|6220401|P3|STARTED|Overall Study||15
2537807|NCT00616603|6220402|P2|STARTED|Overall Study||14
2537808|NCT00616603|6220403|P1|STARTED|Overall Study||14
2537809|NCT00616577|6220414|P3|NOT COMPLETED|Overall Study||0
2537810|NCT00616577|6220415|P2|NOT COMPLETED|Overall Study||0
2537811|NCT00616577|6220416|P1|NOT COMPLETED|Overall Study||0
2537812|NCT00616577|6220414|P3|COMPLETED|Overall Study||7
2537813|NCT00616577|6220415|P2|COMPLETED|Overall Study||9
2537814|NCT00616577|6220416|P1|COMPLETED|Overall Study||6
2537815|NCT00616577|6220414|P3|STARTED|Overall Study||7
2537816|NCT00616577|6220415|P2|STARTED|Overall Study||9
2537817|NCT00616577|6220416|P1|STARTED|Overall Study||6
2537818|NCT00616434|6220426|P2|NOT COMPLETED|Overall Study||8
2537819|NCT00616434|6220427|P1|NOT COMPLETED|Overall Study||6
2537820|NCT00616434|6220426|P2|COMPLETED|Overall Study||53
2537821|NCT00616434|6220427|P1|COMPLETED|Overall Study||56
2537822|NCT00616434|6220426|P2|STARTED|Overall Study||61
2537823|NCT00616434|6220427|P1|STARTED|Overall Study||62
2537824|NCT00616421|6220440|P3|NOT COMPLETED|Overall Study||41
2537825|NCT00616421|6220441|P2|NOT COMPLETED|Overall Study||38
2537826|NCT00616421|6220442|P1|NOT COMPLETED|Overall Study||26
2537827|NCT00616421|6220440|P3|COMPLETED|Overall Study||1229
2537828|NCT00616421|6220441|P2|COMPLETED|Overall Study||1240
2537829|NCT00616421|6220442|P1|COMPLETED|Overall Study||333
2537830|NCT00616421|6220440|P3|STARTED|Overall Study||1270
2537831|NCT00616421|6220441|P2|STARTED|Overall Study||1278
2537832|NCT00616421|6220442|P1|STARTED|Overall Study||359
2537833|NCT00616343|6220479|P1|NOT COMPLETED|Overall Study||0
2537834|NCT00616343|6220479|P1|COMPLETED|Overall Study||9
2537835|NCT00616343|6220479|P1|STARTED|Overall Study||9
2537836|NCT00616239|6220483|P1|NOT COMPLETED|Overall Study||2
2537837|NCT00616239|6220483|P1|COMPLETED|Overall Study||18
2537838|NCT00616239|6220483|P1|STARTED|Overall Study||20
2537839|NCT00616200|6220487|P1|NOT COMPLETED|Four Week Very Low Carbohydrate Diet||3
2537840|NCT00616200|6220487|P1|COMPLETED|Four Week Very Low Carbohydrate Diet||13
2537841|NCT00616200|6220487|P1|STARTED|Four Week Very Low Carbohydrate Diet||16
2537842|NCT00616200|6220487|P1|NOT COMPLETED|Two Week Standard Diet||1
2537843|NCT00616200|6220487|P1|COMPLETED|Two Week Standard Diet||16
2537844|NCT00616200|6220487|P1|STARTED|Two Week Standard Diet||17
2537845|NCT00616122|6220493|P4|NOT COMPLETED|Overall Study||11
2537846|NCT00616122|6220494|P3|NOT COMPLETED|Overall Study||0
2537847|NCT00616122|6220495|P2|NOT COMPLETED|Overall Study||0
2537848|NCT00616122|6220496|P1|NOT COMPLETED|Overall Study||0
2537849|NCT00616122|6220493|P4|COMPLETED|Overall Study||0
2537850|NCT00616122|6220494|P3|COMPLETED|Overall Study||10
2537851|NCT00616122|6220495|P2|COMPLETED|Overall Study||7
2537852|NCT00616122|6220496|P1|COMPLETED|Overall Study||4
2537853|NCT00616122|6220493|P4|STARTED|Overall Study||11
2537854|NCT00616122|6220494|P3|STARTED|Overall Study||10
2537855|NCT00616122|6220495|P2|STARTED|Overall Study||7
2537856|NCT00616122|6220496|P1|STARTED|Overall Study||4
2537857|NCT00616109|6220506|P1|NOT COMPLETED|Overall Study||0
2537858|NCT00616109|6220506|P1|COMPLETED|Overall Study||16
2537859|NCT00616109|6220506|P1|STARTED|Overall Study||16
2537860|NCT00616018|6220513|P1|NOT COMPLETED|Overall Study||3
2537861|NCT00616018|6220513|P1|COMPLETED|Overall Study||24
2537862|NCT00616018|6220513|P1|STARTED|Overall Study||27
2537863|NCT00615992|6220518|P1|NOT COMPLETED|Overall Study||67
2537864|NCT00615992|6220518|P1|COMPLETED|Overall Study||687
2537865|NCT00615992|6220518|P1|STARTED|Overall Study||754
2537866|NCT00615927|6220529|P2|NOT COMPLETED|Overall Study||0
2537867|NCT00615927|6220530|P1|NOT COMPLETED|Overall Study||0
2537868|NCT00615927|6220529|P2|COMPLETED|Overall Study||32
2537869|NCT00615927|6220530|P1|COMPLETED|Overall Study||32
2537870|NCT00615927|6220529|P2|STARTED|Overall Study||32
2537871|NCT00615927|6220530|P1|STARTED|Overall Study||32
2537872|NCT00615914|6220544|P1|NOT COMPLETED|Overall Study||637
2537873|NCT00615914|6220544|P1|COMPLETED|Overall Study||1008
2537874|NCT00615914|6220544|P1|STARTED|Overall Study|The number of patients enrolled|1645
2537875|NCT00615901|6220551|P1|NOT COMPLETED|Overall Study||9
2537876|NCT00615901|6220551|P1|COMPLETED|Overall Study||29
2537877|NCT00615901|6220551|P1|STARTED|Overall Study||38
2537878|NCT00615836|6220559|P5|NOT COMPLETED|Extension Study (FE992026 CS31)||0
2537879|NCT00615836|6220560|P4|NOT COMPLETED|Extension Study (FE992026 CS31)||84
2537880|NCT00615836|6220561|P3|NOT COMPLETED|Extension Study (FE992026 CS31)||73
2537881|NCT00615836|6220562|P2|NOT COMPLETED|Extension Study (FE992026 CS31)||86
2537882|NCT00615836|6220563|P1|NOT COMPLETED|Extension Study (FE992026 CS31)||141
2537883|NCT00615836|6220559|P5|COMPLETED|Extension Study (FE992026 CS31)||0
2537884|NCT00615836|6220560|P4|COMPLETED|Extension Study (FE992026 CS31)||53
2537885|NCT00615836|6220561|P3|COMPLETED|Extension Study (FE992026 CS31)||59
2537886|NCT00615836|6220562|P2|COMPLETED|Extension Study (FE992026 CS31)||58
2537887|NCT00615836|6220563|P1|COMPLETED|Extension Study (FE992026 CS31)||0
2537888|NCT00615836|6220559|P5|STARTED|Extension Study (FE992026 CS31)||0
2537889|NCT00615836|6220560|P4|STARTED|Extension Study (FE992026 CS31)||137
2537890|NCT00615836|6220561|P3|STARTED|Extension Study (FE992026 CS31)||132
2537891|NCT00615836|6220562|P2|STARTED|Extension Study (FE992026 CS31)||144
2537892|NCT00615836|6220563|P1|STARTED|Extension Study (FE992026 CS31)||141
2537893|NCT00615836|6220559|P5|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||15
2537894|NCT00615836|6220560|P4|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||25
2537895|NCT00615836|6220561|P3|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||20
2537896|NCT00615836|6220562|P2|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||10
2537897|NCT00615836|6220563|P1|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||19
2537898|NCT00615836|6220559|P5|COMPLETED|Part I of Core Study (FE992026 CS29)||145
2537899|NCT00615836|6220560|P4|COMPLETED|Part I of Core Study (FE992026 CS29)||135
2537900|NCT00615836|6220561|P3|COMPLETED|Part I of Core Study (FE992026 CS29)||138
2537901|NCT00615836|6220562|P2|COMPLETED|Part I of Core Study (FE992026 CS29)||148
2537902|NCT00615836|6220563|P1|COMPLETED|Part I of Core Study (FE992026 CS29)||144
2537903|NCT00615836|6220559|P5|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|156
2537904|NCT00615836|6220560|P4|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|146
2537905|NCT00615836|6220561|P3|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|148
2537906|NCT00615836|6220562|P2|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|152
2537907|NCT00615836|6220563|P1|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|155
2537908|NCT00615836|6220559|P5|STARTED|Part I of Core Study (FE992026 CS29)||160
2537909|NCT00615836|6220560|P4|STARTED|Part I of Core Study (FE992026 CS29)||160
2537910|NCT00615836|6220561|P3|STARTED|Part I of Core Study (FE992026 CS29)||158
2537911|NCT00615836|6220562|P2|STARTED|Part I of Core Study (FE992026 CS29)||158
2537912|NCT00615836|6220563|P1|STARTED|Part I of Core Study (FE992026 CS29)||163
2537913|NCT00615719|6220623|P1|NOT COMPLETED|Overall Study||5
2537914|NCT00615719|6220623|P1|COMPLETED|Overall Study||30
2537915|NCT00615719|6220623|P1|STARTED|Overall Study||35
2537916|NCT00615589|6220627|P1|NOT COMPLETED|Overall Study||0
2537917|NCT00615589|6220627|P1|COMPLETED|Overall Study||22
2537918|NCT00615589|6220627|P1|STARTED|Overall Study||22
2537919|NCT00615550|6220637|P2|NOT COMPLETED|Overall Study||1
2537920|NCT00615550|6220638|P1|NOT COMPLETED|Overall Study||6
2537921|NCT00615550|6220637|P2|COMPLETED|Overall Study||235
2537922|NCT00615550|6220638|P1|COMPLETED|Overall Study||223
2537923|NCT00615550|6220637|P2|STARTED|Overall Study||236
2537924|NCT00615550|6220638|P1|STARTED|Overall Study||229
2537925|NCT00615472|6220654|P2|NOT COMPLETED|Overall Study||0
2537926|NCT00615472|6220655|P1|NOT COMPLETED|Overall Study||0
2537927|NCT00615472|6220654|P2|COMPLETED|Overall Study||28
2537928|NCT00615472|6220655|P1|COMPLETED|Overall Study||30
2537929|NCT00615472|6220654|P2|STARTED|Overall Study||28
2537930|NCT00615472|6220655|P1|STARTED|Overall Study||30
2537931|NCT00615459|6220661|P4|NOT COMPLETED|Period III||0
2537932|NCT00615459|6220662|P3|NOT COMPLETED|Period III||1
2537933|NCT00615459|6220663|P2|NOT COMPLETED|Period III||3
2537934|NCT00615459|6220664|P1|NOT COMPLETED|Period III||0
2537935|NCT00615459|6220661|P4|COMPLETED|Period III||41
2537936|NCT00615459|6220662|P3|COMPLETED|Period III||39
2537937|NCT00615459|6220663|P2|COMPLETED|Period III||37
2537938|NCT00615459|6220664|P1|COMPLETED|Period III||36
2537939|NCT00615459|6220661|P4|STARTED|Period III||41
2537940|NCT00615459|6220662|P3|STARTED|Period III||40
2537941|NCT00615459|6220663|P2|STARTED|Period III||40
2537942|NCT00615459|6220664|P1|STARTED|Period III||36
2537943|NCT00615459|6220661|P4|NOT COMPLETED|Period II||1
2537944|NCT00615459|6220662|P3|NOT COMPLETED|Period II||0
2537945|NCT00615459|6220663|P2|NOT COMPLETED|Period II||0
2537946|NCT00615459|6220664|P1|NOT COMPLETED|Period II||1
2537947|NCT00615459|6220661|P4|COMPLETED|Period II||41
2537948|NCT00615459|6220662|P3|COMPLETED|Period II||40
2537949|NCT00615459|6220663|P2|COMPLETED|Period II||40
2537950|NCT00615459|6220664|P1|COMPLETED|Period II||36
2537951|NCT00615459|6220661|P4|STARTED|Period II||42
2537952|NCT00615459|6220662|P3|STARTED|Period II||40
2537953|NCT00615459|6220663|P2|STARTED|Period II||40
2537954|NCT00615459|6220664|P1|STARTED|Period II||37
2537955|NCT00615459|6220661|P4|NOT COMPLETED|Period I||1
2537956|NCT00615459|6220662|P3|NOT COMPLETED|Period I||2
2537957|NCT00615459|6220663|P2|NOT COMPLETED|Period I||1
2537958|NCT00615459|6220664|P1|NOT COMPLETED|Period I||4
2537959|NCT00615459|6220661|P4|COMPLETED|Period I||42
2537960|NCT00615459|6220662|P3|COMPLETED|Period I||40
2537961|NCT00615459|6220663|P2|COMPLETED|Period I||40
2537962|NCT00615459|6220664|P1|COMPLETED|Period I||37
2537963|NCT00615459|6220661|P4|STARTED|Period I||43
2537964|NCT00615459|6220662|P3|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|42
2537965|NCT00615459|6220663|P2|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|41
2537966|NCT00615459|6220664|P1|STARTED|Period I||41
2537967|NCT00615433|6220682|P4|NOT COMPLETED|Overall Study||45
2537968|NCT00615433|6220683|P3|NOT COMPLETED|Overall Study||39
2537969|NCT00615433|6220684|P2|NOT COMPLETED|Overall Study||53
2537970|NCT00615433|6220685|P1|NOT COMPLETED|Overall Study||43
2537971|NCT00615433|6220682|P4|COMPLETED|Overall Study||71
2537972|NCT00615433|6220683|P3|COMPLETED|Overall Study||84
2537973|NCT00615433|6220684|P2|COMPLETED|Overall Study||66
2537974|NCT00615433|6220685|P1|COMPLETED|Overall Study||77
2537975|NCT00615433|6220682|P4|STARTED|Overall Study||116
2537976|NCT00615433|6220683|P3|STARTED|Overall Study||123
2537977|NCT00615433|6220684|P2|STARTED|Overall Study||119
2537978|NCT00615433|6220685|P1|STARTED|Overall Study||120
2537979|NCT00615420|6220701|P2|NOT COMPLETED|Overall Study||27
2537980|NCT00615420|6220702|P1|NOT COMPLETED|Overall Study||31
2537981|NCT00615420|6220701|P2|COMPLETED|Overall Study||25
2537982|NCT00615420|6220702|P1|COMPLETED|Overall Study||23
2537983|NCT00615420|6220701|P2|STARTED|Overall Study||52
2537984|NCT00615420|6220702|P1|STARTED|Overall Study||54
2537985|NCT00615290|6220710|P1|NOT COMPLETED|Overall Study||8
2537986|NCT00615290|6220710|P1|COMPLETED|Overall Study||34
2537987|NCT00615290|6220710|P1|STARTED|Overall Study||42
2537988|NCT00615264|6220724|P2|NOT COMPLETED|Overall Study||52
2537989|NCT00615264|6220725|P1|NOT COMPLETED|Overall Study||50
2537990|NCT00615264|6220724|P2|COMPLETED|Overall Study||180
2537991|NCT00615264|6220725|P1|COMPLETED|Overall Study||175
2537992|NCT00615264|6220724|P2|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||213
2537993|NCT00615264|6220725|P1|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||209
2537994|NCT00615264|6220724|P2|Received at Least One Dose (ITT)|Overall Study||231
2537995|NCT00615264|6220725|P1|Received at Least One Dose (ITT)|Overall Study||225
2537996|NCT00615264|6220724|P2|STARTED|Overall Study||232
2537997|NCT00615264|6220725|P1|STARTED|Overall Study||225
2537998|NCT00615199|6220737|P4|NOT COMPLETED|Overall Study||2
2537999|NCT00615199|6220738|P3|NOT COMPLETED|Overall Study||1
2538000|NCT00615199|6220739|P2|NOT COMPLETED|Overall Study||2
2538001|NCT00615199|6220740|P1|NOT COMPLETED|Overall Study||8
2538002|NCT00615199|6220737|P4|COMPLETED|Overall Study||33
2538003|NCT00615199|6220738|P3|COMPLETED|Overall Study||33
2538004|NCT00615199|6220739|P2|COMPLETED|Overall Study||34
2538005|NCT00615199|6220740|P1|COMPLETED|Overall Study||26
2538006|NCT00615199|6220737|P4|STARTED|Overall Study||35
2538007|NCT00615199|6220738|P3|STARTED|Overall Study||34
2538008|NCT00615199|6220739|P2|STARTED|Overall Study||36
2538009|NCT00615199|6220740|P1|STARTED|Overall Study||34
2538010|NCT00615108|6220774|P1|NOT COMPLETED|Overall Study||507
2538011|NCT00615108|6220774|P1|COMPLETED|Overall Study||2641
2538012|NCT00615108|6220774|P1|STARTED|Overall Study||3148
2538013|NCT00615069|6220789|P1|NOT COMPLETED|Overall Study||16
2538014|NCT00615069|6220789|P1|COMPLETED|Overall Study||19
2538015|NCT00615069|6220789|P1|STARTED|Overall Study||35
2538016|NCT00615056|6220798|P4|NOT COMPLETED|Overall Study||35
2538017|NCT00615056|6220799|P3|NOT COMPLETED|Overall Study||36
2538018|NCT00615056|6220800|P2|NOT COMPLETED|Overall Study||51
2538019|NCT00615056|6220801|P1|NOT COMPLETED|Overall Study||49
2538020|NCT00615056|6220798|P4|COMPLETED|Overall Study||0
2538021|NCT00615056|6220799|P3|COMPLETED|Overall Study||0
2538022|NCT00615056|6220800|P2|COMPLETED|Overall Study||0
2538023|NCT00615056|6220801|P1|COMPLETED|Overall Study||0
2538024|NCT00615056|6220798|P4|Treated|Overall Study||35
2538025|NCT00615056|6220799|P3|Treated|Overall Study||36
2538026|NCT00615056|6220800|P2|Treated|Overall Study||51
2538027|NCT00615056|6220801|P1|Treated|Overall Study||46
2538028|NCT00615056|6220798|P4|STARTED|Overall Study||35
2538029|NCT00615056|6220799|P3|STARTED|Overall Study||36
2538030|NCT00615056|6220800|P2|STARTED|Overall Study||51
2538031|NCT00615056|6220801|P1|STARTED|Overall Study||49
2538032|NCT00615030|6220831|P12|NOT COMPLETED|Period III||0
2538033|NCT00615030|6220832|P11|NOT COMPLETED|Period III||0
2538034|NCT00615030|6220833|P10|NOT COMPLETED|Period III||0
2538035|NCT00615030|6220834|P9|NOT COMPLETED|Period III||0
2538036|NCT00615030|6220835|P8|NOT COMPLETED|Period III||0
2538037|NCT00615030|6220836|P7|NOT COMPLETED|Period III||0
2538038|NCT00615030|6220837|P6|NOT COMPLETED|Period III||0
2538039|NCT00615030|6220838|P5|NOT COMPLETED|Period III||0
2538040|NCT00615030|6220839|P4|NOT COMPLETED|Period III||1
2538041|NCT00615030|6220840|P3|NOT COMPLETED|Period III||0
2538042|NCT00615030|6220841|P2|NOT COMPLETED|Period III||0
2538043|NCT00615030|6220842|P1|NOT COMPLETED|Period III||1
2538044|NCT00615030|6220831|P12|COMPLETED|Period III||6
2538045|NCT00615030|6220832|P11|COMPLETED|Period III||7
2538046|NCT00615030|6220833|P10|COMPLETED|Period III||8
2538047|NCT00615030|6220834|P9|COMPLETED|Period III||7
2538048|NCT00615030|6220835|P8|COMPLETED|Period III||7
2538049|NCT00615030|6220836|P7|COMPLETED|Period III||6
2538050|NCT00615030|6220837|P6|COMPLETED|Period III||5
2538051|NCT00615030|6220838|P5|COMPLETED|Period III||8
2538052|NCT00615030|6220839|P4|COMPLETED|Period III||6
2538053|NCT00615030|6220840|P3|COMPLETED|Period III||8
2538054|NCT00615030|6220841|P2|COMPLETED|Period III||8
2538055|NCT00615030|6220842|P1|COMPLETED|Period III||7
2538056|NCT00615030|6220831|P12|STARTED|Period III||6
2538057|NCT00615030|6220832|P11|STARTED|Period III||7
2538058|NCT00615030|6220833|P10|STARTED|Period III||8
2538059|NCT00615030|6220834|P9|STARTED|Period III||7
2538060|NCT00615030|6220835|P8|STARTED|Period III||7
2538061|NCT00615030|6220836|P7|STARTED|Period III||6
2538062|NCT00615030|6220837|P6|STARTED|Period III||5
2538063|NCT00615030|6220838|P5|STARTED|Period III||8
2538064|NCT00615030|6220839|P4|STARTED|Period III||7
2538065|NCT00615030|6220840|P3|STARTED|Period III||8
2538066|NCT00615030|6220841|P2|STARTED|Period III||8
2538067|NCT00615030|6220842|P1|STARTED|Period III||8
2538068|NCT00615030|6220831|P12|NOT COMPLETED|Period II||0
2538069|NCT00615030|6220832|P11|NOT COMPLETED|Period II||0
2538070|NCT00615030|6220833|P10|NOT COMPLETED|Period II||0
2538071|NCT00615030|6220834|P9|NOT COMPLETED|Period II||1
2538072|NCT00615030|6220835|P8|NOT COMPLETED|Period II||0
2538073|NCT00615030|6220836|P7|NOT COMPLETED|Period II||1
2538074|NCT00615030|6220837|P6|NOT COMPLETED|Period II||0
2538075|NCT00615030|6220838|P5|NOT COMPLETED|Period II||0
2538076|NCT00615030|6220839|P4|NOT COMPLETED|Period II||1
2538077|NCT00615030|6220840|P3|NOT COMPLETED|Period II||1
2538078|NCT00615030|6220841|P2|NOT COMPLETED|Period II||0
2538079|NCT00615030|6220842|P1|NOT COMPLETED|Period II||0
2538080|NCT00615030|6220831|P12|COMPLETED|Period II||6
2538081|NCT00615030|6220832|P11|COMPLETED|Period II||7
2538082|NCT00615030|6220833|P10|COMPLETED|Period II||8
2538083|NCT00615030|6220834|P9|COMPLETED|Period II||7
2538084|NCT00615030|6220835|P8|COMPLETED|Period II||7
2538085|NCT00615030|6220836|P7|COMPLETED|Period II||6
2538086|NCT00615030|6220837|P6|COMPLETED|Period II||5
2538087|NCT00615030|6220838|P5|COMPLETED|Period II||8
2538088|NCT00615030|6220839|P4|COMPLETED|Period II||7
2538089|NCT00615030|6220840|P3|COMPLETED|Period II||8
2538090|NCT00615030|6220841|P2|COMPLETED|Period II||8
2538091|NCT00615030|6220842|P1|COMPLETED|Period II||8
2538092|NCT00615030|6220831|P12|STARTED|Period II||6
2538093|NCT00615030|6220832|P11|STARTED|Period II||7
2538094|NCT00615030|6220833|P10|STARTED|Period II||8
2538095|NCT00615030|6220834|P9|STARTED|Period II||8
2538096|NCT00615030|6220835|P8|STARTED|Period II||7
2538097|NCT00615030|6220836|P7|STARTED|Period II||7
2538098|NCT00615030|6220837|P6|STARTED|Period II||5
2538099|NCT00615030|6220838|P5|STARTED|Period II||8
2538100|NCT00615030|6220839|P4|STARTED|Period II||8
2538101|NCT00615030|6220840|P3|STARTED|Period II||9
2538102|NCT00615030|6220841|P2|STARTED|Period II||8
2538103|NCT00615030|6220842|P1|STARTED|Period II||8
2538104|NCT00615030|6220831|P12|NOT COMPLETED|Period I||1
2538105|NCT00615030|6220832|P11|NOT COMPLETED|Period I||1
2538106|NCT00615030|6220833|P10|NOT COMPLETED|Period I||0
2538107|NCT00615030|6220834|P9|NOT COMPLETED|Period I||1
2538108|NCT00615030|6220835|P8|NOT COMPLETED|Period I||0
2538109|NCT00615030|6220836|P7|NOT COMPLETED|Period I||0
2538110|NCT00615030|6220837|P6|NOT COMPLETED|Period I||1
2538111|NCT00615030|6220838|P5|NOT COMPLETED|Period I||1
2538112|NCT00615030|6220839|P4|NOT COMPLETED|Period I||0
2538113|NCT00615030|6220840|P3|NOT COMPLETED|Period I||0
2538114|NCT00615030|6220841|P2|NOT COMPLETED|Period I||0
2538115|NCT00615030|6220842|P1|NOT COMPLETED|Period I||1
2538116|NCT00615030|6220831|P12|COMPLETED|Period I||6
2538117|NCT00615030|6220832|P11|COMPLETED|Period I||7
2538118|NCT00615030|6220833|P10|COMPLETED|Period I||8
2538119|NCT00615030|6220834|P9|COMPLETED|Period I||8
2538120|NCT00615030|6220835|P8|COMPLETED|Period I||7
2538121|NCT00615030|6220836|P7|COMPLETED|Period I||7
2538122|NCT00615030|6220837|P6|COMPLETED|Period I||5
2538123|NCT00615030|6220838|P5|COMPLETED|Period I||8
2538124|NCT00615030|6220839|P4|COMPLETED|Period I||8
2538125|NCT00615030|6220840|P3|COMPLETED|Period I||9
2538126|NCT00615030|6220841|P2|COMPLETED|Period I||8
2538127|NCT00615030|6220842|P1|COMPLETED|Period I||8
2538128|NCT00615030|6220831|P12|STARTED|Period I||7
2538129|NCT00615030|6220832|P11|STARTED|Period I||8
2538130|NCT00615030|6220833|P10|STARTED|Period I||8
2538131|NCT00615030|6220834|P9|STARTED|Period I||9
2538132|NCT00615030|6220835|P8|STARTED|Period I||7
2538133|NCT00615030|6220836|P7|STARTED|Period I||7
2538134|NCT00615030|6220837|P6|STARTED|Period I|1 randomized patient in this sequence dropped out before exposure to study drug in Period I.|6
2538135|NCT00615030|6220838|P5|STARTED|Period I||9
2538136|NCT00615030|6220839|P4|STARTED|Period I||8
2538137|NCT00615030|6220840|P3|STARTED|Period I||9
2538138|NCT00615030|6220841|P2|STARTED|Period I||8
2538139|NCT00615030|6220842|P1|STARTED|Period I||9
2538140|NCT00615017|6220862|P6|NOT COMPLETED|Overall Study||3
2538141|NCT00615017|6220863|P5|NOT COMPLETED|Overall Study||1
2538142|NCT00615017|6220864|P4|NOT COMPLETED|Overall Study||1
2538143|NCT00615017|6220865|P3|NOT COMPLETED|Overall Study||5
2538144|NCT00615017|6220866|P2|NOT COMPLETED|Overall Study||1
2538145|NCT00615017|6220867|P1|NOT COMPLETED|Overall Study||0
2538146|NCT00615017|6220862|P6|COMPLETED|Overall Study|Patient completed the study drug|20
2538147|NCT00615017|6220863|P5|COMPLETED|Overall Study|Patient completed the study drug|7
2538148|NCT00615017|6220864|P4|COMPLETED|Overall Study|Patient completed the study drug|9
2538149|NCT00615017|6220865|P3|COMPLETED|Overall Study|Patient completed the study drug|7
2538150|NCT00615017|6220866|P2|COMPLETED|Overall Study|Patient completed the study drug|8
2538151|NCT00615017|6220867|P1|COMPLETED|Overall Study|Patient completed the study drug|8
2538152|NCT00615017|6220862|P6|STARTED|Overall Study|Patients received treatment|23
2538153|NCT00615017|6220863|P5|STARTED|Overall Study|Patients received treatment|8
2538154|NCT00615017|6220864|P4|STARTED|Overall Study|Patients received treatment|10
2538155|NCT00615017|6220865|P3|STARTED|Overall Study|Patients received treatment|12
2538156|NCT00615017|6220866|P2|STARTED|Overall Study|Patients received treatment|9
2538157|NCT00615017|6220867|P1|STARTED|Overall Study|Patients received treatment|8
2538158|NCT00614991|6221025|P6|NOT COMPLETED|Overall Study||0
2538159|NCT00614991|6221026|P5|NOT COMPLETED|Overall Study||1
2538160|NCT00614991|6221027|P4|NOT COMPLETED|Overall Study||0
2538161|NCT00614991|6221028|P3|NOT COMPLETED|Overall Study||0
2538162|NCT00614991|6221029|P2|NOT COMPLETED|Overall Study||3
2538163|NCT00614991|6221030|P1|NOT COMPLETED|Overall Study||3
2538164|NCT00614991|6221025|P6|COMPLETED|Overall Study||6
2538165|NCT00614991|6221026|P5|COMPLETED|Overall Study||6
2538166|NCT00614991|6221027|P4|COMPLETED|Overall Study||7
2538167|NCT00614991|6221028|P3|COMPLETED|Overall Study||7
2538168|NCT00614991|6221029|P2|COMPLETED|Overall Study||6
2538169|NCT00614991|6221030|P1|COMPLETED|Overall Study||5
2538170|NCT00614991|6221025|P6|STARTED|Overall Study||6
2538171|NCT00614991|6221026|P5|STARTED|Overall Study||7
2538172|NCT00614991|6221027|P4|STARTED|Overall Study||7
2538173|NCT00614991|6221028|P3|STARTED|Overall Study||7
2538174|NCT00614991|6221029|P2|STARTED|Overall Study||9
2538175|NCT00614991|6221030|P1|STARTED|Overall Study||8
2538176|NCT00614939|6221064|P2|NOT COMPLETED|Overall Study||43
2538177|NCT00614939|6221065|P1|NOT COMPLETED|Overall Study||35
2538178|NCT00614939|6221064|P2|COMPLETED|Overall Study|Completed 52 weeks of treatment|42
2538179|NCT00614939|6221065|P1|COMPLETED|Overall Study|Completed 52 weeks of treatment|50
2538180|NCT00614939|6221064|P2|STARTED|Overall Study|Randomized and treated|85
2538181|NCT00614939|6221065|P1|STARTED|Overall Study|Randomized and treated|85
2538182|NCT00614926|6221099|P2|NOT COMPLETED|Overall Study||0
2538183|NCT00614926|6221100|P1|NOT COMPLETED|Overall Study||4
2538184|NCT00614926|6221099|P2|COMPLETED|Overall Study||7
2538185|NCT00614926|6221100|P1|COMPLETED|Overall Study||21
2538186|NCT00614926|6221099|P2|STARTED|Overall Study||7
2538187|NCT00614926|6221100|P1|STARTED|Overall Study||25
2538188|NCT00614913|6221108|P1|NOT COMPLETED|Overall Study||0
2538189|NCT00614913|6221108|P1|COMPLETED|Overall Study||76
2538190|NCT00614913|6221108|P1|STARTED|Overall Study||76
2538191|NCT00614874|6221113|P1|NOT COMPLETED|Overall Study||2
2538192|NCT00614874|6221113|P1|COMPLETED|Overall Study||14
2538193|NCT00614874|6221113|P1|STARTED|Overall Study||16
2538194|NCT00614822|6221120|P1|NOT COMPLETED|Overall Study||3
2538195|NCT00614822|6221120|P1|COMPLETED|Overall Study||47
2538196|NCT00614822|6221120|P1|STARTED|Overall Study||50
2538197|NCT00614744|6221129|P2|NOT COMPLETED|Overall Study||6
2538198|NCT00614744|6221130|P1|NOT COMPLETED|Overall Study||5
2538199|NCT00614744|6221129|P2|COMPLETED|Overall Study||79
2538200|NCT00614744|6221130|P1|COMPLETED|Overall Study||78
2538201|NCT00614744|6221129|P2|STARTED|Overall Study||85
2538202|NCT00614744|6221130|P1|STARTED|Overall Study||83
2538203|NCT00614614|6221156|P5|NOT COMPLETED|Booster Vaccination Phase||13
2538204|NCT00614614|6221157|P4|NOT COMPLETED|Booster Vaccination Phase||19
2538205|NCT00614614|6221158|P3|NOT COMPLETED|Booster Vaccination Phase||27
2538206|NCT00614614|6221159|P2|NOT COMPLETED|Booster Vaccination Phase||6
2538207|NCT00614614|6221160|P1|NOT COMPLETED|Booster Vaccination Phase||0
2538208|NCT00614614|6221156|P5|COMPLETED|Booster Vaccination Phase||396
2538209|NCT00614614|6221157|P4|COMPLETED|Booster Vaccination Phase||210
2538210|NCT00614614|6221158|P3|COMPLETED|Booster Vaccination Phase||405
2538211|NCT00614614|6221159|P2|COMPLETED|Booster Vaccination Phase||227
2538212|NCT00614614|6221160|P1|COMPLETED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
2538213|NCT00614614|6221156|P5|STARTED|Booster Vaccination Phase||409
2538214|NCT00614614|6221157|P4|STARTED|Booster Vaccination Phase||229
2538215|NCT00614614|6221158|P3|STARTED|Booster Vaccination Phase||432
2538216|NCT00614614|6221159|P2|STARTED|Booster Vaccination Phase||233
2538217|NCT00614614|6221160|P1|STARTED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
2538218|NCT00614614|6221156|P5|NOT COMPLETED|Primary Vaccination Phase||0
2538219|NCT00614614|6221157|P4|NOT COMPLETED|Primary Vaccination Phase||0
2538220|NCT00614614|6221158|P3|NOT COMPLETED|Primary Vaccination Phase||0
2538221|NCT00614614|6221159|P2|NOT COMPLETED|Primary Vaccination Phase||17
2538222|NCT00614614|6221160|P1|NOT COMPLETED|Primary Vaccination Phase||90
2538223|NCT00614614|6221156|P5|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
2538224|NCT00614614|6221157|P4|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
2538225|NCT00614614|6221158|P3|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
2538226|NCT00614614|6221159|P2|COMPLETED|Primary Vaccination Phase||265
2538227|NCT00614614|6221160|P1|COMPLETED|Primary Vaccination Phase||1182
2538228|NCT00614614|6221156|P5|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
2538229|NCT00614614|6221157|P4|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
2538230|NCT00614614|6221158|P3|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
2538231|NCT00614614|6221159|P2|STARTED|Primary Vaccination Phase||282
2538232|NCT00614614|6221160|P1|STARTED|Primary Vaccination Phase||1272
2538233|NCT00614575|6221283|P1|NOT COMPLETED|Overall Study||228
2538234|NCT00614575|6221283|P1|COMPLETED|Overall Study||861
2538235|NCT00614575|6221283|P1|STARTED|Overall Study|The number of patients enrolled.|1089
2538236|NCT00614523|6221294|P2|NOT COMPLETED|Overall Study||131
2538237|NCT00614523|6221295|P1|NOT COMPLETED|Overall Study||63
2538238|NCT00614523|6221294|P2|COMPLETED|Overall Study||36
2538239|NCT00614523|6221295|P1|COMPLETED|Overall Study||20
2538240|NCT00614523|6221294|P2|STARTED|Overall Study||167
2538241|NCT00614523|6221295|P1|STARTED|Overall Study||83
2538242|NCT00614484|6221319|P1|NOT COMPLETED|Overall Study||0
2538243|NCT00614484|6221319|P1|COMPLETED|Overall Study||28
2538244|NCT00614484|6221319|P1|STARTED|Overall Study||28
2538245|NCT00614458|6221324|P1|NOT COMPLETED|Overall Study||0
2538246|NCT00614458|6221324|P1|COMPLETED|Overall Study||6
2538247|NCT00614458|6221324|P1|STARTED|Overall Study||6
2538248|NCT00614445|6221330|P2|NOT COMPLETED|Overall Study||49
2538249|NCT00614445|6221331|P1|NOT COMPLETED|Overall Study||28
2538250|NCT00614445|6221330|P2|COMPLETED|Overall Study||91
2538251|NCT00614445|6221331|P1|COMPLETED|Overall Study||112
2538252|NCT00614445|6221330|P2|STARTED|Overall Study||140
2538253|NCT00614445|6221331|P1|STARTED|Overall Study||140
2538254|NCT00614432|6221339|P2|NOT COMPLETED|Overall Study||0
2538255|NCT00614432|6221340|P1|NOT COMPLETED|Overall Study||0
2538256|NCT00614432|6221339|P2|COMPLETED|Overall Study||6
2538257|NCT00614432|6221340|P1|COMPLETED|Overall Study||4
2538258|NCT00614432|6221339|P2|STARTED|Overall Study||6
2538259|NCT00614432|6221340|P1|STARTED|Overall Study||4
2538260|NCT00614406|6221348|P2|NOT COMPLETED|Overall Study||0
2538261|NCT00614406|6221349|P1|NOT COMPLETED|Overall Study||0
2538262|NCT00614406|6221348|P2|COMPLETED|Overall Study||4
2538263|NCT00614406|6221349|P1|COMPLETED|Overall Study||7
2538264|NCT00614406|6221348|P2|STARTED|Overall Study||4
2538265|NCT00614406|6221349|P1|STARTED|Overall Study||7
2538266|NCT00614393|6221360|P5|NOT COMPLETED|Overall Study||180
2538267|NCT00614393|6221361|P4|NOT COMPLETED|Overall Study||180
2538268|NCT00614393|6221362|P3|NOT COMPLETED|Overall Study||10
2538269|NCT00614393|6221363|P2|NOT COMPLETED|Overall Study||8
2538270|NCT00614393|6221364|P1|NOT COMPLETED|Overall Study||180
2538271|NCT00614393|6221360|P5|COMPLETED|Overall Study||0
2538272|NCT00614393|6221361|P4|COMPLETED|Overall Study||0
2538273|NCT00614393|6221362|P3|COMPLETED|Overall Study||0
2538274|NCT00614393|6221363|P2|COMPLETED|Overall Study||0
2538275|NCT00614393|6221364|P1|COMPLETED|Overall Study||0
2538276|NCT00614393|6221360|P5|Treated|Overall Study||178
2538277|NCT00614393|6221361|P4|Treated|Overall Study||180
2538278|NCT00614393|6221362|P3|Treated|Overall Study||10
2538279|NCT00614393|6221363|P2|Treated|Overall Study||8
2538280|NCT00614393|6221364|P1|Treated|Overall Study||180
2538281|NCT00614393|6221360|P5|STARTED|Overall Study||180
2538282|NCT00614393|6221361|P4|STARTED|Overall Study||180
2538283|NCT00614393|6221362|P3|STARTED|Overall Study||10
2538284|NCT00614393|6221363|P2|STARTED|Overall Study||8
2538285|NCT00614393|6221364|P1|STARTED|Overall Study||180
2538286|NCT00614380|6221410|P4|NOT COMPLETED|Overall Study||2
2538287|NCT00614380|6221411|P3|NOT COMPLETED|Overall Study||1
2538288|NCT00614380|6221412|P2|NOT COMPLETED|Overall Study||8
2538289|NCT00614380|6221413|P1|NOT COMPLETED|Overall Study||35
2538290|NCT00614380|6221410|P4|COMPLETED|Overall Study||179
2538291|NCT00614380|6221411|P3|COMPLETED|Overall Study||24
2538292|NCT00614380|6221412|P2|COMPLETED|Overall Study||198
2538293|NCT00614380|6221413|P1|COMPLETED|Overall Study||529
2538294|NCT00614380|6221410|P4|STARTED|Overall Study||181
2538295|NCT00614380|6221411|P3|STARTED|Overall Study||25
2538296|NCT00614380|6221412|P2|STARTED|Overall Study||206
2538297|NCT00614380|6221413|P1|STARTED|Overall Study||564
2538298|NCT00614315|6221462|P1|NOT COMPLETED|Overall Study||0
2538299|NCT00614315|6221462|P1|COMPLETED|Overall Study||30
2538300|NCT00614315|6221462|P1|STARTED|Overall Study||30
2538301|NCT00614198|6221469|P2|NOT COMPLETED|Stage 2||12
2538302|NCT00614198|6221470|P1|NOT COMPLETED|Stage 2||8
2538303|NCT00614198|6221469|P2|COMPLETED|Stage 2||17
2538304|NCT00614198|6221470|P1|COMPLETED|Stage 2||18
2538305|NCT00614198|6221469|P2|STARTED|Stage 2|Reallocated to gluten- and casein-free dietary intervention|29
2538306|NCT00614198|6221470|P1|STARTED|Stage 2||26
2538307|NCT00614198|6221469|P2|NOT COMPLETED|Stage 1||5
2538308|NCT00614198|6221470|P1|NOT COMPLETED|Stage 1||12
2538309|NCT00614198|6221469|P2|COMPLETED|Stage 1||29
2538310|NCT00614198|6221470|P1|COMPLETED|Stage 1||26
2538311|NCT00614198|6221469|P2|STARTED|Stage 1||34
2538312|NCT00614198|6221470|P1|STARTED|Stage 1||38
2538313|NCT00614120|6221480|P4|NOT COMPLETED|Overall Study||16
2538314|NCT00614120|6221481|P3|NOT COMPLETED|Overall Study||59
2538315|NCT00614120|6221482|P2|NOT COMPLETED|Overall Study||46
2538316|NCT00614120|6221483|P1|NOT COMPLETED|Overall Study||29
2538317|NCT00614120|6221480|P4|COMPLETED|Overall Study||215
2538318|NCT00614120|6221481|P3|COMPLETED|Overall Study||175
2538319|NCT00614120|6221482|P2|COMPLETED|Overall Study||187
2538320|NCT00614120|6221483|P1|COMPLETED|Overall Study||202
2538321|NCT00614120|6221480|P4|Exposed to Study Drug|Overall Study||231
2538322|NCT00614120|6221481|P3|Exposed to Study Drug|Overall Study|Subject withdrew before exposure to study products, and thus not included in full analysis set.|233
2538323|NCT00614120|6221482|P2|Exposed to Study Drug|Overall Study||233
2538324|NCT00614120|6221483|P1|Exposed to Study Drug|Overall Study||231
2538325|NCT00614120|6221480|P4|STARTED|Overall Study|Randomised|231
2538326|NCT00614120|6221481|P3|STARTED|Overall Study|Randomised|234
2538327|NCT00614120|6221482|P2|STARTED|Overall Study|Randomised|233
2538328|NCT00614120|6221483|P1|STARTED|Overall Study|Randomised|231
2538329|NCT00614055|6221524|P3|NOT COMPLETED|Overall Study||5
2538330|NCT00614055|6221525|P2|NOT COMPLETED|Overall Study||6
2538331|NCT00614055|6221526|P1|NOT COMPLETED|Overall Study||4
2538332|NCT00614055|6221524|P3|COMPLETED|Overall Study||55
2538333|NCT00614055|6221525|P2|COMPLETED|Overall Study||53
2538334|NCT00614055|6221526|P1|COMPLETED|Overall Study||55
2538335|NCT00614055|6221524|P3|Exposed|Overall Study||60
2538336|NCT00614055|6221525|P2|Exposed|Overall Study||59
2538337|NCT00614055|6221526|P1|Exposed|Overall Study||59
2538338|NCT00614055|6221524|P3|STARTED|Overall Study||60
2538339|NCT00614055|6221525|P2|STARTED|Overall Study||59
2538340|NCT00614055|6221526|P1|STARTED|Overall Study||59
2538341|NCT00613951|6221573|P3|NOT COMPLETED|Overall Study||5
2538342|NCT00613951|6221574|P2|NOT COMPLETED|Overall Study||5
2538343|NCT00613951|6221575|P1|NOT COMPLETED|Overall Study||7
2538344|NCT00613951|6221573|P3|COMPLETED|Overall Study||57
2538345|NCT00613951|6221574|P2|COMPLETED|Overall Study||54
2538346|NCT00613951|6221575|P1|COMPLETED|Overall Study||54
2538347|NCT00613951|6221573|P3|Exposed|Overall Study||62
2538348|NCT00613951|6221574|P2|Exposed|Overall Study||59
2538349|NCT00613951|6221575|P1|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|60
2538350|NCT00613951|6221573|P3|STARTED|Overall Study||62
2538351|NCT00613951|6221574|P2|STARTED|Overall Study||59
2538352|NCT00613951|6221575|P1|STARTED|Overall Study||61
2538353|NCT00613938|6221620|P4|NOT COMPLETED|Overall Study||26
2538354|NCT00613938|6221621|P3|NOT COMPLETED|Overall Study||23
2538355|NCT00613938|6221622|P2|NOT COMPLETED|Overall Study||28
2538356|NCT00613938|6221623|P1|NOT COMPLETED|Overall Study||20
2538357|NCT00613938|6221620|P4|COMPLETED|Overall Study||253
2538358|NCT00613938|6221621|P3|COMPLETED|Overall Study||255
2538359|NCT00613938|6221622|P2|COMPLETED|Overall Study||247
2538360|NCT00613938|6221623|P1|COMPLETED|Overall Study||49
2538361|NCT00613938|6221620|P4|STARTED|Overall Study|one patient did not have a valid baseline score therefore excluded from above|279
2538362|NCT00613938|6221621|P3|STARTED|Overall Study||278
2538363|NCT00613938|6221622|P2|STARTED|Overall Study||275
2538364|NCT00613938|6221623|P1|STARTED|Overall Study||69
2538365|NCT00613925|6221655|P2|NOT COMPLETED|Overall Study||1
2538366|NCT00613925|6221656|P1|NOT COMPLETED|Overall Study||0
2538367|NCT00613925|6221655|P2|COMPLETED|Overall Study||32
2538368|NCT00613925|6221656|P1|COMPLETED|Overall Study||37
2538369|NCT00613925|6221655|P2|STARTED|Overall Study||33
2538370|NCT00613925|6221656|P1|STARTED|Overall Study||37
2538371|NCT00613834|6221666|P2|NOT COMPLETED|Overall Study||3
2538372|NCT00613834|6221667|P1|NOT COMPLETED|Overall Study||0
2538373|NCT00613834|6221666|P2|COMPLETED|Overall Study||26
2538374|NCT00613834|6221667|P1|COMPLETED|Overall Study||29
2538375|NCT00613834|6221666|P2|STARTED|Overall Study||29
2538376|NCT00613834|6221667|P1|STARTED|Overall Study||29
2538377|NCT00613821|6221679|P2|NOT COMPLETED|Overall Study||1
2538378|NCT00613821|6221680|P1|NOT COMPLETED|Overall Study||2
2538379|NCT00613821|6221679|P2|COMPLETED|Overall Study||39
2538380|NCT00613821|6221680|P1|COMPLETED|Overall Study||38
2538381|NCT00613821|6221679|P2|STARTED|Overall Study||40
2538382|NCT00613821|6221680|P1|STARTED|Overall Study||40
2538383|NCT00613730|6221686|P1|NOT COMPLETED|Overall Study||3
2538384|NCT00613730|6221686|P1|COMPLETED|Overall Study||0
2538385|NCT00613730|6221686|P1|STARTED|Overall Study||3
2538386|NCT00613626|6221695|P3|NOT COMPLETED|Overall Study||0
2538387|NCT00613626|6221696|P2|NOT COMPLETED|Overall Study||1
2538388|NCT00613626|6221697|P1|NOT COMPLETED|Overall Study||0
2538389|NCT00613626|6221695|P3|COMPLETED|Overall Study||7
2538390|NCT00613626|6221696|P2|COMPLETED|Overall Study||33
2538391|NCT00613626|6221697|P1|COMPLETED|Overall Study||33
2538392|NCT00613626|6221695|P3|1st Dose ZD6474|Overall Study||7
2538393|NCT00613626|6221696|P2|1st Dose ZD6474|Overall Study||34
2538394|NCT00613626|6221697|P1|1st Dose ZD6474|Overall Study||33
2538395|NCT00613626|6221695|P3|STARTED|Overall Study|These participants provided the toxicity data to determine if ZD6474+Etopiside+Cisplatin was safe.|7
2538396|NCT00613626|6221696|P2|STARTED|Overall Study||34
2538397|NCT00613626|6221697|P1|STARTED|Overall Study||33
2538398|NCT00613574|6221713|P1|NOT COMPLETED|Overall Study||6
2538399|NCT00613574|6221713|P1|COMPLETED|Overall Study||401
2538400|NCT00613574|6221713|P1|STARTED|Overall Study||407
2538401|NCT00613509|6221725|P2|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
2538402|NCT00613509|6221726|P1|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
2538403|NCT00613509|6221725|P2|COMPLETED|Cycle 2 (Group 2 = Crossover)||4
2538404|NCT00613509|6221726|P1|COMPLETED|Cycle 2 (Group 2 = Crossover)||11
2538405|NCT00613509|6221725|P2|STARTED|Cycle 2 (Group 2 = Crossover)||4
2538406|NCT00613509|6221726|P1|STARTED|Cycle 2 (Group 2 = Crossover)||11
2538407|NCT00613509|6221725|P2|NOT COMPLETED|Cycle 1||8
2538408|NCT00613509|6221726|P1|NOT COMPLETED|Cycle 1||5
2538409|NCT00613509|6221725|P2|COMPLETED|Cycle 1|Completion of Cycle 1. 12 participants were deemed evaluable|4
2538410|NCT00613509|6221726|P1|COMPLETED|Cycle 1|Completion of Cycle 1. 9 participants were deemed evaluable|6
2538411|NCT00613509|6221725|P2|STARTED|Cycle 1||12
2538412|NCT00613509|6221726|P1|STARTED|Cycle 1||11
2538413|NCT00613405|6221750|P2|NOT COMPLETED|Overall Study||0
2538414|NCT00613405|6221751|P1|NOT COMPLETED|Overall Study||0
2538415|NCT00613405|6221750|P2|COMPLETED|Overall Study||42
2538416|NCT00613405|6221751|P1|COMPLETED|Overall Study||45
2538417|NCT00613405|6221750|P2|STARTED|Overall Study||42
2538418|NCT00613405|6221751|P1|STARTED|Overall Study||45
2538419|NCT00613379|6221760|P3|NOT COMPLETED|Overall Study||0
2538420|NCT00613379|6221761|P2|NOT COMPLETED|Overall Study||0
2538421|NCT00613379|6221762|P1|NOT COMPLETED|Overall Study||0
2538422|NCT00613379|6221760|P3|COMPLETED|Overall Study||11
2538423|NCT00613379|6221761|P2|COMPLETED|Overall Study||10
2538424|NCT00613379|6221762|P1|COMPLETED|Overall Study||10
2538425|NCT00613379|6221760|P3|STARTED|Overall Study||11
2538426|NCT00613379|6221761|P2|STARTED|Overall Study||10
2538427|NCT00613379|6221762|P1|STARTED|Overall Study||10
2538428|NCT00613366|6221772|P2|NOT COMPLETED|Overall Study||2
2538429|NCT00613366|6221773|P1|NOT COMPLETED|Overall Study||3
2538430|NCT00613366|6221772|P2|COMPLETED|Overall Study||18
2538431|NCT00613366|6221773|P1|COMPLETED|Overall Study||17
2538432|NCT00613366|6221772|P2|STARTED|Overall Study||20
2538433|NCT00613366|6221773|P1|STARTED|Overall Study||20
2538434|NCT00613327|6221781|P1|NOT COMPLETED|Overall Study||101
2538435|NCT00613327|6221781|P1|COMPLETED|Overall Study||244
2538436|NCT00613327|6221781|P1|STARTED|Overall Study||345
2538437|NCT00613314|6221800|P1|NOT COMPLETED|Overall Study||155
2538438|NCT00613314|6221800|P1|COMPLETED|Overall Study||15113
2538439|NCT00613314|6221800|P1|STARTED|Overall Study||15268
2538440|NCT00613301|6221808|P1|NOT COMPLETED|Overall Study||228
2538441|NCT00613301|6221808|P1|COMPLETED|Overall Study||188
2538442|NCT00613301|6221808|P1|STARTED|Overall Study||416
2538443|NCT00613106|6221817|P2|NOT COMPLETED|Overall Study||9
2538444|NCT00613106|6221818|P1|NOT COMPLETED|Overall Study||20
2538445|NCT00613106|6221817|P2|COMPLETED|Overall Study||38
2538446|NCT00613106|6221818|P1|COMPLETED|Overall Study||112
2538447|NCT00613106|6221817|P2|STARTED|Overall Study||47
2538448|NCT00613106|6221818|P1|STARTED|Overall Study||132
2538449|NCT00613080|6221824|P1|NOT COMPLETED|Overall Study||11
2538450|NCT00613080|6221824|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|68
2538451|NCT00613080|6221824|P1|STARTED|Overall Study||79
2538452|NCT00613028|6221838|P2|NOT COMPLETED|Overall Study||1
2538453|NCT00613028|6221839|P1|NOT COMPLETED|Overall Study||0
2538454|NCT00613028|6221838|P2|COMPLETED|Overall Study||12
2538455|NCT00613028|6221839|P1|COMPLETED|Overall Study||10
2538456|NCT00613028|6221838|P2|STARTED|Overall Study||13
2538457|NCT00613028|6221839|P1|STARTED|Overall Study||10
2538458|NCT00613015|6221859|P6|NOT COMPLETED|Overall Study||3
2538459|NCT00613015|6221860|P5|NOT COMPLETED|Overall Study||2
2538460|NCT00613015|6221861|P4|NOT COMPLETED|Overall Study||3
2538461|NCT00613015|6221862|P3|NOT COMPLETED|Overall Study||3
2538462|NCT00613015|6221863|P2|NOT COMPLETED|Overall Study||1
2538463|NCT00613015|6221864|P1|NOT COMPLETED|Overall Study||0
2538464|NCT00613015|6221859|P6|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|16
2538465|NCT00613015|6221860|P5|COMPLETED|Overall Study|Two participants did not complete one-week follow-up visit.|13
2538466|NCT00613015|6221861|P4|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|21
2538467|NCT00613015|6221862|P3|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|23
2538468|NCT00613015|6221863|P2|COMPLETED|Overall Study|One participant did not complete the one-week follow-up visit.|11
2538469|NCT00613015|6221864|P1|COMPLETED|Overall Study||13
2538470|NCT00613015|6221859|P6|STARTED|Overall Study||19
2538471|NCT00613015|6221860|P5|STARTED|Overall Study||15
2538472|NCT00613015|6221861|P4|STARTED|Overall Study||24
2538473|NCT00613015|6221862|P3|STARTED|Overall Study||26
2538474|NCT00613015|6221863|P2|STARTED|Overall Study||12
2538475|NCT00613015|6221864|P1|STARTED|Overall Study||13
2538476|NCT00612924|6221886|P2|NOT COMPLETED|Overall Study||9
2538477|NCT00612924|6221887|P1|NOT COMPLETED|Overall Study||7
2538478|NCT00612924|6221886|P2|COMPLETED|Overall Study||85
2538479|NCT00612924|6221887|P1|COMPLETED|Overall Study||94
2538480|NCT00612924|6221886|P2|STARTED|Overall Study||94
2538481|NCT00612924|6221887|P1|STARTED|Overall Study||101
2538482|NCT00612807|6221900|P2|NOT COMPLETED|Overall Study||0
2538483|NCT00612807|6221901|P1|NOT COMPLETED|Overall Study||2
2538484|NCT00612807|6221900|P2|COMPLETED|Overall Study||28
2538485|NCT00612807|6221901|P1|COMPLETED|Overall Study||12
2538486|NCT00612807|6221900|P2|STARTED|Overall Study||28
2538487|NCT00612807|6221901|P1|STARTED|Overall Study||14
2538488|NCT00612768|6221909|P1|NOT COMPLETED|Overall Study||0
2538489|NCT00612768|6221909|P1|COMPLETED|Overall Study||50
2538490|NCT00612768|6221909|P1|STARTED|Overall Study||50
2538491|NCT00612690|6221936|P2|NOT COMPLETED|Overall Study||118
2538492|NCT00612690|6221937|P1|NOT COMPLETED|Overall Study||115
2538493|NCT00612690|6221936|P2|COMPLETED|Overall Study||89
2538494|NCT00612690|6221937|P1|COMPLETED|Overall Study||160
2538495|NCT00612690|6221936|P2|STARTED|Overall Study||207
2538496|NCT00612690|6221937|P1|STARTED|Overall Study||275
2538497|NCT00612677|6221945|P1|NOT COMPLETED|Overall Study||1
2538498|NCT00612677|6221945|P1|COMPLETED|Overall Study||0
2538499|NCT00612677|6221945|P1|STARTED|Overall Study||1
2538500|NCT00612573|6221955|P4|NOT COMPLETED|Overall Study||13
2538501|NCT00612573|6221956|P3|NOT COMPLETED|Overall Study||9
2538502|NCT00612573|6221957|P2|NOT COMPLETED|Overall Study||14
2538503|NCT00612573|6221958|P1|NOT COMPLETED|Overall Study||12
2538504|NCT00612573|6221955|P4|COMPLETED|Overall Study||54
2538505|NCT00612573|6221956|P3|COMPLETED|Overall Study||52
2538506|NCT00612573|6221957|P2|COMPLETED|Overall Study||51
2538507|NCT00612573|6221958|P1|COMPLETED|Overall Study||52
2538508|NCT00612573|6221955|P4|STARTED|Overall Study||67
2538509|NCT00612573|6221956|P3|STARTED|Overall Study||61
2538510|NCT00612573|6221957|P2|STARTED|Overall Study||65
2538511|NCT00612573|6221958|P1|STARTED|Overall Study||64
2538512|NCT00612560|6221984|P4|NOT COMPLETED|Overall Study||0
2538513|NCT00612560|6221985|P3|NOT COMPLETED|Overall Study||0
2538514|NCT00612560|6221986|P2|NOT COMPLETED|Overall Study||0
2538515|NCT00612560|6221987|P1|NOT COMPLETED|Overall Study||0
2538516|NCT00612560|6221984|P4|COMPLETED|Overall Study||6
2538517|NCT00612560|6221985|P3|COMPLETED|Overall Study||8
2538518|NCT00612560|6221986|P2|COMPLETED|Overall Study||7
2538519|NCT00612560|6221987|P1|COMPLETED|Overall Study||7
2538520|NCT00612560|6221984|P4|STARTED|Overall Study||6
2538521|NCT00612560|6221985|P3|STARTED|Overall Study||8
2538522|NCT00612560|6221986|P2|STARTED|Overall Study||7
2538523|NCT00612560|6221987|P1|STARTED|Overall Study||7
2538524|NCT00612534|6222013|P4|NOT COMPLETED|Overall Study||17
2538525|NCT00612534|6222014|P3|NOT COMPLETED|Overall Study||7
2538526|NCT00612534|6222015|P2|NOT COMPLETED|Overall Study||17
2538527|NCT00612534|6222016|P1|NOT COMPLETED|Overall Study||13
2538528|NCT00612534|6222013|P4|COMPLETED|Overall Study||7
2538529|NCT00612534|6222014|P3|COMPLETED|Overall Study||13
2538530|NCT00612534|6222015|P2|COMPLETED|Overall Study||9
2538531|NCT00612534|6222016|P1|COMPLETED|Overall Study||11
2538532|NCT00612534|6222013|P4|STARTED|Overall Study||24
2538533|NCT00612534|6222014|P3|STARTED|Overall Study||20
2538534|NCT00612534|6222015|P2|STARTED|Overall Study||26
2538535|NCT00612534|6222016|P1|STARTED|Overall Study||24
2538536|NCT00612508|6222028|P2|NOT COMPLETED|Overall Study||4
2538537|NCT00612508|6222029|P1|NOT COMPLETED|Overall Study||3
2538538|NCT00612508|6222028|P2|COMPLETED|Overall Study|6 nuvaring users returned for the 84 day biopsy|3
2538539|NCT00612508|6222029|P1|COMPLETED|Overall Study|5 desogen users returned for the 84 day biopsy|4
2538540|NCT00612508|6222028|P2|STARTED|Overall Study||7
2538541|NCT00612508|6222029|P1|STARTED|Overall Study||7
2538542|NCT00612456|6222040|P3|NOT COMPLETED|Overall Study||0
2538543|NCT00612456|6222041|P2|NOT COMPLETED|Overall Study||2
2538544|NCT00612456|6222042|P1|NOT COMPLETED|Overall Study||2
2538545|NCT00612456|6222040|P3|COMPLETED|Overall Study||16
2538546|NCT00612456|6222041|P2|COMPLETED|Overall Study||25
2538547|NCT00612456|6222042|P1|COMPLETED|Overall Study||25
2538548|NCT00612456|6222040|P3|STARTED|Overall Study||16
2538549|NCT00612456|6222041|P2|STARTED|Overall Study||27
2538550|NCT00612456|6222042|P1|STARTED|Overall Study||27
2538551|NCT00612430|6222088|P2|NOT COMPLETED|Overall Study||0
2538552|NCT00612430|6222089|P1|NOT COMPLETED|Overall Study||0
2538553|NCT00612430|6222088|P2|COMPLETED|Overall Study||27
2538554|NCT00612430|6222089|P1|COMPLETED|Overall Study||32
2538555|NCT00612430|6222088|P2|STARTED|Overall Study||27
2538556|NCT00612430|6222089|P1|STARTED|Overall Study||32
2538557|NCT00612352|6222105|P2|NOT COMPLETED|Overall Study||6
2538558|NCT00612352|6222106|P1|NOT COMPLETED|Overall Study||9
2538559|NCT00612352|6222105|P2|COMPLETED|Overall Study||109
2538560|NCT00612352|6222106|P1|COMPLETED|Overall Study||56
2538561|NCT00612352|6222105|P2|Placebo|Overall Study||4
2538562|NCT00612352|6222106|P1|Placebo|Overall Study||4
2538563|NCT00612352|6222105|P2|40%mg|Overall Study||0
2538564|NCT00612352|6222106|P1|40%mg|Overall Study||1
2538565|NCT00612352|6222105|P2|100%mg|Overall Study||1
2538566|NCT00612352|6222106|P1|100%mg|Overall Study||2
2538567|NCT00612352|6222105|P2|Placebo & 100%mg|Overall Study||0
2538568|NCT00612352|6222106|P1|Placebo & 100%mg|Overall Study||1
2538569|NCT00612352|6222105|P2|40%mg & 100%mg|Overall Study||1
2538570|NCT00612352|6222106|P1|40%mg & 100%mg|Overall Study||1
2538571|NCT00612352|6222105|P2|STARTED|Overall Study||115
2538572|NCT00612352|6222106|P1|STARTED|Overall Study||65
2538573|NCT00612339|6222220|P1|NOT COMPLETED|Overall Study||0
2538574|NCT00612339|6222220|P1|COMPLETED|Overall Study||41
2538575|NCT00612339|6222220|P1|STARTED|Overall Study||41
2538576|NCT00612313|6222226|P2|NOT COMPLETED|Overall Study||13
2538577|NCT00612313|6222227|P1|NOT COMPLETED|Overall Study||17
2538578|NCT00612313|6222226|P2|COMPLETED|Overall Study||62
2538579|NCT00612313|6222227|P1|COMPLETED|Overall Study||52
2538580|NCT00612313|6222226|P2|STARTED|Overall Study||75
2538581|NCT00612313|6222227|P1|STARTED|Overall Study||69
2538582|NCT00612235|6222247|P4|NOT COMPLETED|Overall Study||0
2538583|NCT00612235|6222248|P3|NOT COMPLETED|Overall Study||0
2538584|NCT00612235|6222249|P2|NOT COMPLETED|Overall Study||0
2538585|NCT00612235|6222250|P1|NOT COMPLETED|Overall Study||0
2538586|NCT00612235|6222247|P4|COMPLETED|Overall Study||20
2538587|NCT00612235|6222248|P3|COMPLETED|Overall Study||20
2538588|NCT00612235|6222249|P2|COMPLETED|Overall Study||20
2538589|NCT00612235|6222250|P1|COMPLETED|Overall Study||20
2538590|NCT00612235|6222247|P4|STARTED|Overall Study||20
2538591|NCT00612235|6222248|P3|STARTED|Overall Study||20
2538592|NCT00612235|6222249|P2|STARTED|Overall Study||20
2538593|NCT00612235|6222250|P1|STARTED|Overall Study||20
2538594|NCT00612222|6222261|P1|NOT COMPLETED|Overall Study||0
2538595|NCT00612222|6222261|P1|COMPLETED|Overall Study||4
2538596|NCT00612222|6222261|P1|STARTED|Overall Study||4
2538597|NCT00612105|6222269|P2|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||0
2538598|NCT00612105|6222270|P1|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||1
2538599|NCT00612105|6222269|P2|COMPLETED|Period Title 3: 3-Week Taper Phase||58
2538600|NCT00612105|6222270|P1|COMPLETED|Period Title 3: 3-Week Taper Phase||85
2538601|NCT00612105|6222269|P2|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|58
2538602|NCT00612105|6222270|P1|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|86
2538603|NCT00612105|6222269|P2|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||2
2538604|NCT00612105|6222270|P1|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||11
2538605|NCT00612105|6222269|P2|COMPLETED|Period Title 2: 4-Week Maintenance Phase||55
2538606|NCT00612105|6222270|P1|COMPLETED|Period Title 2: 4-Week Maintenance Phase||78
2538607|NCT00612105|6222269|P2|STARTED|Period Title 2: 4-Week Maintenance Phase||57
2538608|NCT00612105|6222270|P1|STARTED|Period Title 2: 4-Week Maintenance Phase||89
2538609|NCT00612105|6222269|P2|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||5
2538610|NCT00612105|6222270|P1|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||36
2538611|NCT00612105|6222269|P2|COMPLETED|Period Title 1: 6-Week Titration Phase||57
2538612|NCT00612105|6222270|P1|COMPLETED|Period Title 1: 6-Week Titration Phase||89
2538613|NCT00612105|6222269|P2|STARTED|Period Title 1: 6-Week Titration Phase||62
2538614|NCT00612105|6222270|P1|STARTED|Period Title 1: 6-Week Titration Phase||125
2538615|NCT00612066|6222320|P1|NOT COMPLETED|Overall Study||1
2538616|NCT00612066|6222320|P1|COMPLETED|Overall Study||1
2538617|NCT00612066|6222320|P1|STARTED|Overall Study||2
2538618|NCT00612040|6222327|P3|NOT COMPLETED|Overall Study||7
2538619|NCT00612040|6222328|P2|NOT COMPLETED|Overall Study||7
2538620|NCT00612040|6222329|P1|NOT COMPLETED|Overall Study||5
2538621|NCT00612040|6222327|P3|COMPLETED|Overall Study||52
2538622|NCT00612040|6222328|P2|COMPLETED|Overall Study||52
2538623|NCT00612040|6222329|P1|COMPLETED|Overall Study||55
2538624|NCT00612040|6222327|P3|Exposed|Overall Study||59
2538625|NCT00612040|6222328|P2|Exposed|Overall Study||59
2538626|NCT00612040|6222329|P1|Exposed|Overall Study||60
2538627|NCT00612040|6222327|P3|STARTED|Overall Study||59
2538628|NCT00612040|6222328|P2|STARTED|Overall Study||59
2538629|NCT00612040|6222329|P1|STARTED|Overall Study||60
2538630|NCT00611923|6222375|P2|NOT COMPLETED|Overall Study||2
2538631|NCT00611923|6222376|P1|NOT COMPLETED|Overall Study||2
2538632|NCT00611923|6222375|P2|COMPLETED|Overall Study||11
2538633|NCT00611923|6222376|P1|COMPLETED|Overall Study||10
2538634|NCT00611923|6222375|P2|STARTED|Overall Study||13
2538635|NCT00611923|6222376|P1|STARTED|Overall Study||12
2538636|NCT00611897|6222392|P2|NOT COMPLETED|Day 2: Crossover Treatment||0
2538637|NCT00611897|6222393|P1|NOT COMPLETED|Day 2: Crossover Treatment||0
2538638|NCT00611897|6222392|P2|COMPLETED|Day 2: Crossover Treatment||8
2538639|NCT00611897|6222393|P1|COMPLETED|Day 2: Crossover Treatment||8
2538640|NCT00611897|6222392|P2|STARTED|Day 2: Crossover Treatment||8
2538641|NCT00611897|6222393|P1|STARTED|Day 2: Crossover Treatment||8
2538642|NCT00611897|6222392|P2|NOT COMPLETED|Day 1: Initial Treatment||0
2538643|NCT00611897|6222393|P1|NOT COMPLETED|Day 1: Initial Treatment||0
2538644|NCT00611897|6222392|P2|COMPLETED|Day 1: Initial Treatment||8
2538645|NCT00611897|6222393|P1|COMPLETED|Day 1: Initial Treatment||8
2538646|NCT00611897|6222392|P2|STARTED|Day 1: Initial Treatment||8
2538647|NCT00611897|6222393|P1|STARTED|Day 1: Initial Treatment||8
2538648|NCT00611884|6222421|P4|NOT COMPLETED|Overall Study||6
2538649|NCT00611884|6222422|P3|NOT COMPLETED|Overall Study||4
2538650|NCT00611884|6222423|P2|NOT COMPLETED|Overall Study||9
2538651|NCT00611884|6222424|P1|NOT COMPLETED|Overall Study||9
2538652|NCT00611884|6222421|P4|COMPLETED|Overall Study||56
2538653|NCT00611884|6222422|P3|COMPLETED|Overall Study||58
2538654|NCT00611884|6222423|P2|COMPLETED|Overall Study||51
2538655|NCT00611884|6222424|P1|COMPLETED|Overall Study||52
2538656|NCT00611884|6222421|P4|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
2538657|NCT00611884|6222422|P3|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
2538658|NCT00611884|6222423|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|59
2538659|NCT00611884|6222424|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|58
2538660|NCT00611884|6222421|P4|STARTED|Overall Study||62
2538661|NCT00611884|6222422|P3|STARTED|Overall Study||62
2538662|NCT00611884|6222423|P2|STARTED|Overall Study||60
2538663|NCT00611884|6222424|P1|STARTED|Overall Study||61
2538664|NCT00611858|6222478|P1|NOT COMPLETED|Overall Study||4
2538665|NCT00611858|6222478|P1|COMPLETED|Overall Study||9
2538666|NCT00611858|6222478|P1|STARTED|Overall Study||13
2538667|NCT00611806|6222490|P2|NOT COMPLETED|Overall Study||3
2538668|NCT00611806|6222491|P1|NOT COMPLETED|Overall Study||16
2538669|NCT00611806|6222490|P2|COMPLETED|Overall Study||43
2538670|NCT00611806|6222491|P1|COMPLETED|Overall Study||78
2538671|NCT00611806|6222490|P2|STARTED|Overall Study||46
2538672|NCT00611806|6222491|P1|STARTED|Overall Study||94
2538673|NCT00611767|6222505|P2|NOT COMPLETED|Overall Study||2
2538674|NCT00611767|6222506|P1|NOT COMPLETED|Overall Study||9
2538675|NCT00611767|6222505|P2|COMPLETED|Overall Study||22
2538676|NCT00611767|6222506|P1|COMPLETED|Overall Study||40
2538677|NCT00611767|6222505|P2|Placebo Test Day|Overall Study||1
2538678|NCT00611767|6222506|P1|Placebo Test Day|Overall Study||6
2538679|NCT00611767|6222505|P2|Thiopental Test Day|Overall Study||1
2538680|NCT00611767|6222506|P1|Thiopental Test Day|Overall Study||3
2538681|NCT00611767|6222505|P2|STARTED|Overall Study||24
2538682|NCT00611767|6222506|P1|STARTED|Overall Study||49
2538683|NCT00611715|6222668|P2|NOT COMPLETED|Overall Study||6
2538684|NCT00611715|6222669|P1|NOT COMPLETED|Overall Study||41
2538685|NCT00611715|6222668|P2|COMPLETED|Overall Study||0
2538686|NCT00611715|6222669|P1|COMPLETED|Overall Study|"2 pts in Arm 1 remain on-tx. They are not accounted for in off-tx reasonor completed data fields"|1
2538687|NCT00611715|6222668|P2|STARTED|Overall Study||6
2538688|NCT00611715|6222669|P1|STARTED|Overall Study||42
2538689|NCT00611624|6222681|P1|NOT COMPLETED|Overall Study||0
2538690|NCT00611624|6222681|P1|COMPLETED|Overall Study||28
2538691|NCT00611624|6222681|P1|STARTED|Overall Study||28
2538692|NCT00611559|6222689|P3|NOT COMPLETED|Overall Study||1
2538693|NCT00611559|6222690|P2|NOT COMPLETED|Overall Study||1
2538694|NCT00611559|6222691|P1|NOT COMPLETED|Overall Study||1
2538695|NCT00611559|6222689|P3|COMPLETED|Overall Study||56
2538696|NCT00611559|6222690|P2|COMPLETED|Overall Study||114
2538697|NCT00611559|6222691|P1|COMPLETED|Overall Study||110
2538698|NCT00611559|6222689|P3|STARTED|Overall Study||57
2538699|NCT00611559|6222690|P2|STARTED|Overall Study||115
2538700|NCT00611559|6222691|P1|STARTED|Overall Study||111
2538701|NCT00611533|6222750|P2|NOT COMPLETED|Second Intervention (6 Weeks)||2
2538702|NCT00611533|6222751|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
2538703|NCT00611533|6222750|P2|COMPLETED|Second Intervention (6 Weeks)||4
2538704|NCT00611533|6222751|P1|COMPLETED|Second Intervention (6 Weeks)||8
2538705|NCT00611533|6222750|P2|STARTED|Second Intervention (6 Weeks)||6
2538706|NCT00611533|6222751|P1|STARTED|Second Intervention (6 Weeks)||8
2538707|NCT00611533|6222750|P2|NOT COMPLETED|First Intervention (6 Weeks)||2
2538708|NCT00611533|6222751|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
2538709|NCT00611533|6222750|P2|COMPLETED|First Intervention (6 Weeks)||6
2538710|NCT00611533|6222751|P1|COMPLETED|First Intervention (6 Weeks)||8
2538711|NCT00611533|6222750|P2|STARTED|First Intervention (6 Weeks)||8
2538712|NCT00611533|6222751|P1|STARTED|First Intervention (6 Weeks)||8
2538713|NCT00611468|6222770|P4|NOT COMPLETED|Overall Study||0
2538714|NCT00611468|6222771|P3|NOT COMPLETED|Overall Study||0
2538715|NCT00611468|6222772|P2|NOT COMPLETED|Overall Study||1
2538716|NCT00611468|6222773|P1|NOT COMPLETED|Overall Study||0
2538717|NCT00611468|6222770|P4|COMPLETED|Overall Study||13
2538718|NCT00611468|6222771|P3|COMPLETED|Overall Study||6
2538719|NCT00611468|6222772|P2|COMPLETED|Overall Study|One subject did not complete Cycle 1 of treatment and was replaced.|6
2538720|NCT00611468|6222773|P1|COMPLETED|Overall Study||3
2538721|NCT00611468|6222770|P4|STARTED|Overall Study||13
2538722|NCT00611468|6222771|P3|STARTED|Overall Study||6
2538723|NCT00611468|6222772|P2|STARTED|Overall Study||7
2538724|NCT00611468|6222773|P1|STARTED|Overall Study||3
2538725|NCT00611455|6222785|P3|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||211
2538726|NCT00611455|6222786|P2|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
2538727|NCT00611455|6222787|P1|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
2538728|NCT00611455|6222785|P3|COMPLETED|Follow-up Period (Approximately 2 Years)||49
2538729|NCT00611455|6222786|P2|COMPLETED|Follow-up Period (Approximately 2 Years)||0
2538730|NCT00611455|6222787|P1|COMPLETED|Follow-up Period (Approximately 2 Years)||0
2538731|NCT00611455|6222785|P3|STARTED|Follow-up Period (Approximately 2 Years)|These participants received at least one infusion of placebo or ofatumumab.|260
2538732|NCT00611455|6222786|P2|STARTED|Follow-up Period (Approximately 2 Years)||0
2538733|NCT00611455|6222787|P1|STARTED|Follow-up Period (Approximately 2 Years)||0
2538734|NCT00611455|6222785|P3|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
2538735|NCT00611455|6222786|P2|NOT COMPLETED|OL Treatment Period (120 Weeks)||179
2538736|NCT00611455|6222787|P1|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
2538737|NCT00611455|6222785|P3|COMPLETED|OL Treatment Period (120 Weeks)||0
2538738|NCT00611455|6222786|P2|COMPLETED|OL Treatment Period (120 Weeks)||52
2538739|NCT00611455|6222787|P1|COMPLETED|OL Treatment Period (120 Weeks)||0
2538740|NCT00611455|6222785|P3|STARTED|OL Treatment Period (120 Weeks)||0
2538741|NCT00611455|6222786|P2|STARTED|OL Treatment Period (120 Weeks)|118 participants received OFA during the DB Period; 113 received placebo during the DB Period.|231
2538742|NCT00611455|6222787|P1|STARTED|OL Treatment Period (120 Weeks)||0
2538743|NCT00611455|6222785|P3|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
2538744|NCT00611455|6222786|P2|NOT COMPLETED|DB Treatment Period (24 Weeks)||14
2538745|NCT00611455|6222787|P1|NOT COMPLETED|DB Treatment Period (24 Weeks)||13
2538746|NCT00611455|6222785|P3|COMPLETED|DB Treatment Period (24 Weeks)||0
2538747|NCT00611455|6222786|P2|COMPLETED|DB Treatment Period (24 Weeks)||117
2538748|NCT00611455|6222787|P1|COMPLETED|DB Treatment Period (24 Weeks)||121
2538749|NCT00611455|6222785|P3|STARTED|DB Treatment Period (24 Weeks)||0
2538750|NCT00611455|6222786|P2|STARTED|DB Treatment Period (24 Weeks)||131
2538751|NCT00611455|6222787|P1|STARTED|DB Treatment Period (24 Weeks)||134
2538752|NCT00611442|6222915|P2|NOT COMPLETED|Overall Study||2
2538753|NCT00611442|6222916|P1|NOT COMPLETED|Overall Study||1
2538754|NCT00611442|6222915|P2|COMPLETED|Overall Study||94
2538755|NCT00611442|6222916|P1|COMPLETED|Overall Study||94
2538756|NCT00611442|6222915|P2|STARTED|Overall Study||96
2538757|NCT00611442|6222916|P1|STARTED|Overall Study||95
2538758|NCT00611403|6222930|P2|NOT COMPLETED|Post Treatment Extension Phase||1
2538759|NCT00611403|6222931|P1|NOT COMPLETED|Post Treatment Extension Phase||4
2538760|NCT00611403|6222930|P2|COMPLETED|Post Treatment Extension Phase||24
2538761|NCT00611403|6222931|P1|COMPLETED|Post Treatment Extension Phase||22
2538762|NCT00611403|6222930|P2|STARTED|Post Treatment Extension Phase|25 of 69 pts who received ENDURA® in the Treatment Phase entered the Post Treatment Extension Phase|25
2538763|NCT00611403|6222931|P1|STARTED|Post Treatment Extension Phase|26 of 68 pts who received RESTASIS® in the Treatment Phase entered the Post Treatment Ext. Phase|26
2538764|NCT00611403|6222930|P2|NOT COMPLETED|Treatment Phase||11
2538765|NCT00611403|6222931|P1|NOT COMPLETED|Treatment Phase||6
2538766|NCT00611403|6222930|P2|COMPLETED|Treatment Phase||58
2538767|NCT00611403|6222931|P1|COMPLETED|Treatment Phase||62
2538768|NCT00611403|6222930|P2|STARTED|Treatment Phase||69
2538769|NCT00611403|6222931|P1|STARTED|Treatment Phase||68
2538770|NCT00611351|6222941|P1|NOT COMPLETED|Overall Study||2
2538771|NCT00611351|6222941|P1|COMPLETED|Overall Study||3
2538772|NCT00611351|6222941|P1|STARTED|Overall Study||5
2538773|NCT00611325|6222950|P2|NOT COMPLETED|Overall Study||0
2538774|NCT00611325|6222951|P1|NOT COMPLETED|Overall Study||0
2538775|NCT00611325|6222950|P2|COMPLETED|Overall Study||28
2538776|NCT00611325|6222951|P1|COMPLETED|Overall Study||28
2538777|NCT00611325|6222950|P2|STARTED|Overall Study||28
2538778|NCT00611325|6222951|P1|STARTED|Overall Study||28
2538779|NCT00611247|6222967|P2|NOT COMPLETED|Overall Study||21
2538780|NCT00611247|6222968|P1|NOT COMPLETED|Overall Study||2
2538781|NCT00611247|6222967|P2|COMPLETED|Overall Study||10
2538782|NCT00611247|6222968|P1|COMPLETED|Overall Study||3
2538783|NCT00611247|6222967|P2|STARTED|Overall Study||31
2538784|NCT00611247|6222968|P1|STARTED|Overall Study||5
2538785|NCT00611130|6222980|P2|NOT COMPLETED|Overall Study||47
2538786|NCT00611130|6222981|P1|NOT COMPLETED|Overall Study||49
2538787|NCT00611130|6222980|P2|COMPLETED|Overall Study||47
2538788|NCT00611130|6222981|P1|COMPLETED|Overall Study||43
2538789|NCT00611130|6222980|P2|Completed 12 Week Treatment Phase|Overall Study||64
2538790|NCT00611130|6222981|P1|Completed 12 Week Treatment Phase|Overall Study||61
2538791|NCT00611130|6222980|P2|STARTED|Overall Study||94
2538792|NCT00611130|6222981|P1|STARTED|Overall Study||92
2538793|NCT00611026|6222991|P3|NOT COMPLETED|Double-blind Treatment Period||98
2538794|NCT00611026|6222992|P2|NOT COMPLETED|Double-blind Treatment Period||88
2538795|NCT00611026|6222993|P1|NOT COMPLETED|Double-blind Treatment Period||47
2538796|NCT00611026|6222991|P3|COMPLETED|Double-blind Treatment Period||862
2538797|NCT00611026|6222992|P2|COMPLETED|Double-blind Treatment Period||885
2538798|NCT00611026|6222993|P1|COMPLETED|Double-blind Treatment Period||431
2538799|NCT00611026|6222991|P3|STARTED|Double-blind Treatment Period||960
2538800|NCT00611026|6222992|P2|STARTED|Double-blind Treatment Period||973
2538801|NCT00611026|6222993|P1|STARTED|Double-blind Treatment Period||478
2538802|NCT00611026|6222991|P3|NOT COMPLETED|Randomized to Double-blind Treatment||3
2538803|NCT00611026|6222992|P2|NOT COMPLETED|Randomized to Double-blind Treatment||1
2538804|NCT00611026|6222993|P1|NOT COMPLETED|Randomized to Double-blind Treatment||2
2538805|NCT00611026|6222991|P3|COMPLETED|Randomized to Double-blind Treatment||960
2538806|NCT00611026|6222992|P2|COMPLETED|Randomized to Double-blind Treatment||973
2538807|NCT00611026|6222993|P1|COMPLETED|Randomized to Double-blind Treatment||478
2538808|NCT00611026|6222991|P3|STARTED|Randomized to Double-blind Treatment||963
2538809|NCT00611026|6222992|P2|STARTED|Randomized to Double-blind Treatment||974
2538810|NCT00611026|6222993|P1|STARTED|Randomized to Double-blind Treatment||480
2538811|NCT00610987|6223059|P2|NOT COMPLETED|Overall Study||0
2538812|NCT00610987|6223060|P1|NOT COMPLETED|Overall Study||0
2538813|NCT00610987|6223059|P2|COMPLETED|Overall Study||71
2538814|NCT00610987|6223060|P1|COMPLETED|Overall Study||75
2538815|NCT00610987|6223059|P2|STARTED|Overall Study||71
2538816|NCT00610987|6223060|P1|STARTED|Overall Study||75
2538817|NCT00610883|6223066|P1|NOT COMPLETED|Overall Study||0
2538818|NCT00610883|6223066|P1|COMPLETED|Overall Study||17
2538819|NCT00610883|6223066|P1|STARTED|Overall Study||17
2538820|NCT00610857|6223070|P1|NOT COMPLETED|Overall Study||2
2538821|NCT00610857|6223070|P1|COMPLETED|Overall Study||35
2538822|NCT00610857|6223070|P1|STARTED|Overall Study||37
2538823|NCT00610740|6223077|P1|NOT COMPLETED|Overall Study||0
2538824|NCT00610740|6223077|P1|COMPLETED|Overall Study||18
2538825|NCT00610740|6223077|P1|STARTED|Overall Study||18
2538826|NCT00610727|6223089|P6|NOT COMPLETED|Overall Study||0
2538827|NCT00610727|6223090|P5|NOT COMPLETED|Overall Study||0
2538828|NCT00610727|6223091|P4|NOT COMPLETED|Overall Study||0
2538829|NCT00610727|6223092|P3|NOT COMPLETED|Overall Study||0
2538830|NCT00610727|6223093|P2|NOT COMPLETED|Overall Study||0
2538831|NCT00610727|6223094|P1|NOT COMPLETED|Overall Study||0
2538832|NCT00610727|6223089|P6|COMPLETED|Overall Study||8
2538833|NCT00610727|6223090|P5|COMPLETED|Overall Study||8
2538834|NCT00610727|6223091|P4|COMPLETED|Overall Study||8
2538835|NCT00610727|6223092|P3|COMPLETED|Overall Study||8
2538836|NCT00610727|6223093|P2|COMPLETED|Overall Study||8
2538837|NCT00610727|6223094|P1|COMPLETED|Overall Study||14
2538838|NCT00610727|6223089|P6|STARTED|Overall Study||8
2538839|NCT00610727|6223090|P5|STARTED|Overall Study||8
2538840|NCT00610727|6223091|P4|STARTED|Overall Study||8
2538841|NCT00610727|6223092|P3|STARTED|Overall Study||8
2538842|NCT00610727|6223093|P2|STARTED|Overall Study||8
2538843|NCT00610727|6223094|P1|STARTED|Overall Study||14
2538844|NCT00610714|6223114|P2|NOT COMPLETED|Overall Study||24
2538845|NCT00610714|6223115|P1|NOT COMPLETED|Overall Study||26
2538846|NCT00610714|6223114|P2|COMPLETED|Overall Study||82
2538847|NCT00610714|6223115|P1|COMPLETED|Overall Study||79
2538848|NCT00610714|6223114|P2|STARTED|Overall Study||106
2538849|NCT00610714|6223115|P1|STARTED|Overall Study||105
2538850|NCT00610701|6223127|P2|NOT COMPLETED|Overall Study||11
2538851|NCT00610701|6223128|P1|NOT COMPLETED|Overall Study||10
2538852|NCT00610701|6223127|P2|COMPLETED|Overall Study||9
2538853|NCT00610701|6223128|P1|COMPLETED|Overall Study||5
2538854|NCT00610701|6223127|P2|STARTED|Overall Study||20
2538855|NCT00610701|6223128|P1|STARTED|Overall Study||15
2538856|NCT00610688|6223137|P3|NOT COMPLETED|Overall Study||8
2538857|NCT00610688|6223138|P2|NOT COMPLETED|Overall Study||13
2538858|NCT00610688|6223139|P1|NOT COMPLETED|Overall Study||9
2538859|NCT00610688|6223137|P3|COMPLETED|Overall Study||55
2538860|NCT00610688|6223138|P2|COMPLETED|Overall Study||52
2538861|NCT00610688|6223139|P1|COMPLETED|Overall Study||55
2538862|NCT00610688|6223137|P3|STARTED|Overall Study||63
2538863|NCT00610688|6223138|P2|STARTED|Overall Study||65
2538864|NCT00610688|6223139|P1|STARTED|Overall Study||64
2538865|NCT00610675|6223153|P1|NOT COMPLETED|Overall Study||220
2538866|NCT00610675|6223153|P1|COMPLETED|Overall Study||126
2538867|NCT00610675|6223153|P1|Treated|Overall Study||342
2538868|NCT00610675|6223153|P1|STARTED|Overall Study||346
2538869|NCT00610649|6223175|P11|NOT COMPLETED|Overall Study||1
2538870|NCT00610649|6223176|P10|NOT COMPLETED|Overall Study||1
2538871|NCT00610649|6223177|P9|NOT COMPLETED|Overall Study||0
2538872|NCT00610649|6223178|P8|NOT COMPLETED|Overall Study||0
2538873|NCT00610649|6223179|P7|NOT COMPLETED|Overall Study||0
2538874|NCT00610649|6223180|P6|NOT COMPLETED|Overall Study||0
2538875|NCT00610649|6223181|P5|NOT COMPLETED|Overall Study||0
2538876|NCT00610649|6223182|P4|NOT COMPLETED|Overall Study||0
2538877|NCT00610649|6223183|P3|NOT COMPLETED|Overall Study||0
2538878|NCT00610649|6223184|P2|NOT COMPLETED|Overall Study||1
2538879|NCT00610649|6223185|P1|NOT COMPLETED|Overall Study||1
2538880|NCT00610649|6223175|P11|COMPLETED|Overall Study||9
2538881|NCT00610649|6223176|P10|COMPLETED|Overall Study||9
2538882|NCT00610649|6223177|P9|COMPLETED|Overall Study||10
2538883|NCT00610649|6223178|P8|COMPLETED|Overall Study||2
2538884|NCT00610649|6223179|P7|COMPLETED|Overall Study||4
2538885|NCT00610649|6223180|P6|COMPLETED|Overall Study||2
2538886|NCT00610649|6223181|P5|COMPLETED|Overall Study||4
2538887|NCT00610649|6223182|P4|COMPLETED|Overall Study||2
2538888|NCT00610649|6223183|P3|COMPLETED|Overall Study||4
2538889|NCT00610649|6223184|P2|COMPLETED|Overall Study||1
2538890|NCT00610649|6223185|P1|COMPLETED|Overall Study||3
2538891|NCT00610649|6223175|P11|STARTED|Overall Study||10
2538892|NCT00610649|6223176|P10|STARTED|Overall Study||10
2538893|NCT00610649|6223177|P9|STARTED|Overall Study||10
2538894|NCT00610649|6223178|P8|STARTED|Overall Study||2
2538895|NCT00610649|6223179|P7|STARTED|Overall Study||4
2538896|NCT00610649|6223180|P6|STARTED|Overall Study||2
2538897|NCT00610649|6223181|P5|STARTED|Overall Study||4
2538898|NCT00610649|6223182|P4|STARTED|Overall Study||2
2538899|NCT00610649|6223183|P3|STARTED|Overall Study||4
2538900|NCT00610649|6223184|P2|STARTED|Overall Study||2
2538901|NCT00610649|6223185|P1|STARTED|Overall Study||4
2538902|NCT00610558|6223242|P3|NOT COMPLETED|Overall Study||6
2538903|NCT00610558|6223243|P2|NOT COMPLETED|Overall Study||6
2538904|NCT00610558|6223244|P1|NOT COMPLETED|Overall Study||5
2538905|NCT00610558|6223242|P3|COMPLETED|Overall Study||14
2538906|NCT00610558|6223243|P2|COMPLETED|Overall Study||14
2538907|NCT00610558|6223244|P1|COMPLETED|Overall Study||15
2538908|NCT00610558|6223242|P3|STARTED|Overall Study||20
2538909|NCT00610558|6223243|P2|STARTED|Overall Study||20
2538910|NCT00610558|6223244|P1|STARTED|Overall Study||20
2538911|NCT00610532|6223252|P1|NOT COMPLETED|Intravenous Phenytoin Plus Probenecid||0
2538912|NCT00610532|6223252|P1|COMPLETED|Intravenous Phenytoin Plus Probenecid||7
2538913|NCT00610532|6223252|P1|STARTED|Intravenous Phenytoin Plus Probenecid|one participant dropped out between periods|7
2538914|NCT00610532|6223252|P1|NOT COMPLETED|Intravenous Phenytoin Alone||0
2538915|NCT00610532|6223252|P1|COMPLETED|Intravenous Phenytoin Alone||8
2538916|NCT00610532|6223252|P1|STARTED|Intravenous Phenytoin Alone||8
2538917|NCT00610441|6223262|P4|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
2538918|NCT00610441|6223263|P3|NOT COMPLETED|Treatment Period 2 - 3 Weeks||0
2538919|NCT00610441|6223264|P2|NOT COMPLETED|Treatment Period 2 - 3 Weeks||1
2538920|NCT00610441|6223265|P1|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
2538921|NCT00610441|6223262|P4|COMPLETED|Treatment Period 2 - 3 Weeks||14
2538922|NCT00610441|6223263|P3|COMPLETED|Treatment Period 2 - 3 Weeks||9
2538923|NCT00610441|6223264|P2|COMPLETED|Treatment Period 2 - 3 Weeks||12
2538924|NCT00610441|6223265|P1|COMPLETED|Treatment Period 2 - 3 Weeks||10
2538925|NCT00610441|6223262|P4|STARTED|Treatment Period 2 - 3 Weeks||16
2538926|NCT00610441|6223263|P3|STARTED|Treatment Period 2 - 3 Weeks||9
2538927|NCT00610441|6223264|P2|STARTED|Treatment Period 2 - 3 Weeks||13
2538928|NCT00610441|6223265|P1|STARTED|Treatment Period 2 - 3 Weeks||12
2538929|NCT00610441|6223262|P4|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
2538930|NCT00610441|6223263|P3|NOT COMPLETED|Placebo Washout Period - 2 Weeks||2
2538931|NCT00610441|6223264|P2|NOT COMPLETED|Placebo Washout Period - 2 Weeks||1
2538932|NCT00610441|6223265|P1|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
2538933|NCT00610441|6223262|P4|COMPLETED|Placebo Washout Period - 2 Weeks||16
2538934|NCT00610441|6223263|P3|COMPLETED|Placebo Washout Period - 2 Weeks||9
2538935|NCT00610441|6223264|P2|COMPLETED|Placebo Washout Period - 2 Weeks||13
2538936|NCT00610441|6223265|P1|COMPLETED|Placebo Washout Period - 2 Weeks||12
2538937|NCT00610441|6223262|P4|STARTED|Placebo Washout Period - 2 Weeks||16
2538938|NCT00610441|6223263|P3|STARTED|Placebo Washout Period - 2 Weeks||11
2538939|NCT00610441|6223264|P2|STARTED|Placebo Washout Period - 2 Weeks||14
2538940|NCT00610441|6223265|P1|STARTED|Placebo Washout Period - 2 Weeks||12
2538941|NCT00610441|6223262|P4|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
2538942|NCT00610441|6223263|P3|NOT COMPLETED|Treatment Period 1 - 3 Weeks||7
2538943|NCT00610441|6223264|P2|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
2538944|NCT00610441|6223265|P1|NOT COMPLETED|Treatment Period 1 - 3 Weeks||3
2538945|NCT00610441|6223262|P4|COMPLETED|Treatment Period 1 - 3 Weeks||16
2538946|NCT00610441|6223263|P3|COMPLETED|Treatment Period 1 - 3 Weeks||11
2538947|NCT00610441|6223264|P2|COMPLETED|Treatment Period 1 - 3 Weeks||14
2538948|NCT00610441|6223265|P1|COMPLETED|Treatment Period 1 - 3 Weeks||12
2538949|NCT00610441|6223262|P4|STARTED|Treatment Period 1 - 3 Weeks||18
2538950|NCT00610441|6223263|P3|STARTED|Treatment Period 1 - 3 Weeks||18
2538951|NCT00610441|6223264|P2|STARTED|Treatment Period 1 - 3 Weeks||16
2538952|NCT00610441|6223265|P1|STARTED|Treatment Period 1 - 3 Weeks||15
2538953|NCT00610428|6223359|P3|NOT COMPLETED|Overall Study||2
2538954|NCT00610428|6223360|P2|NOT COMPLETED|Overall Study||1
2538955|NCT00610428|6223361|P1|NOT COMPLETED|Overall Study||0
2538956|NCT00610428|6223359|P3|COMPLETED|Overall Study||25
2538957|NCT00610428|6223360|P2|COMPLETED|Overall Study||23
2538958|NCT00610428|6223361|P1|COMPLETED|Overall Study||24
2538959|NCT00610428|6223359|P3|STARTED|Overall Study||27
2538960|NCT00610428|6223360|P2|STARTED|Overall Study||24
2538961|NCT00610428|6223361|P1|STARTED|Overall Study||24
2538962|NCT00610363|6223374|P2|NOT COMPLETED|Overall Study||3
2538963|NCT00610363|6223375|P1|NOT COMPLETED|Overall Study||11
2538964|NCT00610363|6223374|P2|COMPLETED|Overall Study||38
2538965|NCT00610363|6223375|P1|COMPLETED|Overall Study||31
2538966|NCT00610363|6223374|P2|STARTED|Overall Study||41
2538967|NCT00610363|6223375|P1|STARTED|Overall Study||42
2538968|NCT00610311|6223393|P1|NOT COMPLETED|Overall Study||0
2538969|NCT00610311|6223393|P1|COMPLETED|Overall Study||3
2538970|NCT00610311|6223393|P1|STARTED|Overall Study||3
2538971|NCT00610207|6223400|P1|NOT COMPLETED|Overall Study||3
2538972|NCT00610207|6223400|P1|COMPLETED|Overall Study||18
2538973|NCT00610207|6223400|P1|STARTED|Overall Study||21
2538974|NCT00610168|6223407|P2|NOT COMPLETED|Overall Study||0
2538975|NCT00610168|6223408|P1|NOT COMPLETED|Overall Study||2
2538976|NCT00610168|6223407|P2|COMPLETED|Overall Study||7
2538977|NCT00610168|6223408|P1|COMPLETED|Overall Study||73
2538978|NCT00610168|6223407|P2|STARTED|Overall Study||7
2538979|NCT00610168|6223408|P1|STARTED|Overall Study||75
2538980|NCT00610155|6223427|P6|NOT COMPLETED|Period 3||0
2538981|NCT00610155|6223428|P5|NOT COMPLETED|Period 3||0
2538982|NCT00610155|6223429|P4|NOT COMPLETED|Period 3||0
2538983|NCT00610155|6223430|P3|NOT COMPLETED|Period 3||0
2538984|NCT00610155|6223431|P2|NOT COMPLETED|Period 3||0
2538985|NCT00610155|6223432|P1|NOT COMPLETED|Period 3||1
2538986|NCT00610155|6223427|P6|COMPLETED|Period 3||1
2538987|NCT00610155|6223428|P5|COMPLETED|Period 3||3
2538988|NCT00610155|6223429|P4|COMPLETED|Period 3||3
2538989|NCT00610155|6223430|P3|COMPLETED|Period 3||3
2538990|NCT00610155|6223431|P2|COMPLETED|Period 3||3
2538991|NCT00610155|6223432|P1|COMPLETED|Period 3||3
2538992|NCT00610155|6223427|P6|STARTED|Period 3||1
2538993|NCT00610155|6223428|P5|STARTED|Period 3||3
2538994|NCT00610155|6223429|P4|STARTED|Period 3||3
2538995|NCT00610155|6223430|P3|STARTED|Period 3||3
2538996|NCT00610155|6223431|P2|STARTED|Period 3||3
2538997|NCT00610155|6223432|P1|STARTED|Period 3||4
2538998|NCT00610155|6223427|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
2538999|NCT00610155|6223428|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
2539000|NCT00610155|6223429|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
2539001|NCT00610155|6223430|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
2539002|NCT00610155|6223431|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
2539003|NCT00610155|6223432|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
2539004|NCT00610155|6223427|P6|COMPLETED|Washout Period 2 (7 Days)||1
2539005|NCT00610155|6223428|P5|COMPLETED|Washout Period 2 (7 Days)||3
2539006|NCT00610155|6223429|P4|COMPLETED|Washout Period 2 (7 Days)||3
2539007|NCT00610155|6223430|P3|COMPLETED|Washout Period 2 (7 Days)||3
2539008|NCT00610155|6223431|P2|COMPLETED|Washout Period 2 (7 Days)||3
2539009|NCT00610155|6223432|P1|COMPLETED|Washout Period 2 (7 Days)||4
2539010|NCT00610155|6223427|P6|STARTED|Washout Period 2 (7 Days)||1
2539011|NCT00610155|6223428|P5|STARTED|Washout Period 2 (7 Days)||3
2539012|NCT00610155|6223429|P4|STARTED|Washout Period 2 (7 Days)||3
2539013|NCT00610155|6223430|P3|STARTED|Washout Period 2 (7 Days)||3
2539014|NCT00610155|6223431|P2|STARTED|Washout Period 2 (7 Days)||3
2539015|NCT00610155|6223432|P1|STARTED|Washout Period 2 (7 Days)||4
2539016|NCT00610155|6223427|P6|NOT COMPLETED|Period 2||0
2539017|NCT00610155|6223428|P5|NOT COMPLETED|Period 2||0
2539018|NCT00610155|6223429|P4|NOT COMPLETED|Period 2||0
2539019|NCT00610155|6223430|P3|NOT COMPLETED|Period 2||0
2539020|NCT00610155|6223431|P2|NOT COMPLETED|Period 2||0
2539021|NCT00610155|6223432|P1|NOT COMPLETED|Period 2||0
2539022|NCT00610155|6223427|P6|COMPLETED|Period 2||1
2539023|NCT00610155|6223428|P5|COMPLETED|Period 2||3
2539024|NCT00610155|6223429|P4|COMPLETED|Period 2||3
2539025|NCT00610155|6223430|P3|COMPLETED|Period 2||3
2539026|NCT00610155|6223431|P2|COMPLETED|Period 2||3
2539027|NCT00610155|6223432|P1|COMPLETED|Period 2||4
2539028|NCT00610155|6223427|P6|STARTED|Period 2||1
2539029|NCT00610155|6223428|P5|STARTED|Period 2||3
2539030|NCT00610155|6223429|P4|STARTED|Period 2||3
2539031|NCT00610155|6223430|P3|STARTED|Period 2||3
2539032|NCT00610155|6223431|P2|STARTED|Period 2||3
2539033|NCT00610155|6223432|P1|STARTED|Period 2||4
2539034|NCT00610155|6223427|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
2539035|NCT00610155|6223428|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
2539036|NCT00610155|6223429|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
2539037|NCT00610155|6223430|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
2539038|NCT00610155|6223431|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
2539039|NCT00610155|6223432|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
2539040|NCT00610155|6223427|P6|COMPLETED|Washout Period 1 (7 Days)||1
2539041|NCT00610155|6223428|P5|COMPLETED|Washout Period 1 (7 Days)||3
2539042|NCT00610155|6223429|P4|COMPLETED|Washout Period 1 (7 Days)||3
2539043|NCT00610155|6223430|P3|COMPLETED|Washout Period 1 (7 Days)||3
2539044|NCT00610155|6223431|P2|COMPLETED|Washout Period 1 (7 Days)||3
2539045|NCT00610155|6223432|P1|COMPLETED|Washout Period 1 (7 Days)||4
2539046|NCT00610155|6223427|P6|STARTED|Washout Period 1 (7 Days)||1
2539047|NCT00610155|6223428|P5|STARTED|Washout Period 1 (7 Days)||3
2539048|NCT00610155|6223429|P4|STARTED|Washout Period 1 (7 Days)||3
2539049|NCT00610155|6223430|P3|STARTED|Washout Period 1 (7 Days)||3
2539050|NCT00610155|6223431|P2|STARTED|Washout Period 1 (7 Days)||3
2539051|NCT00610155|6223432|P1|STARTED|Washout Period 1 (7 Days)||4
2539052|NCT00610155|6223427|P6|NOT COMPLETED|Period 1||0
2539053|NCT00610155|6223428|P5|NOT COMPLETED|Period 1||0
2539054|NCT00610155|6223429|P4|NOT COMPLETED|Period 1||0
2539055|NCT00610155|6223430|P3|NOT COMPLETED|Period 1||1
2539056|NCT00610155|6223431|P2|NOT COMPLETED|Period 1||0
2539057|NCT00610155|6223432|P1|NOT COMPLETED|Period 1||0
2539058|NCT00610155|6223427|P6|COMPLETED|Period 1||1
2539059|NCT00610155|6223428|P5|COMPLETED|Period 1||3
2539060|NCT00610155|6223429|P4|COMPLETED|Period 1||3
2539061|NCT00610155|6223430|P3|COMPLETED|Period 1||3
2539062|NCT00610155|6223431|P2|COMPLETED|Period 1||3
2539063|NCT00610155|6223432|P1|COMPLETED|Period 1||4
2539064|NCT00610155|6223427|P6|STARTED|Period 1||1
2539065|NCT00610155|6223428|P5|STARTED|Period 1||3
2539066|NCT00610155|6223429|P4|STARTED|Period 1||3
2539067|NCT00610155|6223430|P3|STARTED|Period 1||4
2539068|NCT00610155|6223431|P2|STARTED|Period 1||3
2539069|NCT00610155|6223432|P1|STARTED|Period 1||4
2539070|NCT00610129|6223479|P1|NOT COMPLETED|Overall Study||3
2539071|NCT00610129|6223479|P1|COMPLETED|Overall Study||25
2539072|NCT00610129|6223479|P1|STARTED|Overall Study||28
2539073|NCT00609986|6223485|P2|NOT COMPLETED|Overall Study||3
2539074|NCT00609986|6223486|P1|NOT COMPLETED|Overall Study||8
2539075|NCT00609986|6223485|P2|COMPLETED|Overall Study||49
2539076|NCT00609986|6223486|P1|COMPLETED|Overall Study||44
2539077|NCT00609986|6223485|P2|Received Transplant|Overall Study||49
2539078|NCT00609986|6223486|P1|Received Transplant|Overall Study||44
2539079|NCT00609986|6223485|P2|STARTED|Overall Study||52
2539080|NCT00609986|6223486|P1|STARTED|Overall Study||52
2539081|NCT00609973|6223500|P2|NOT COMPLETED|Overall Study||6
2539082|NCT00609973|6223501|P1|NOT COMPLETED|Overall Study||8
2539083|NCT00609973|6223500|P2|COMPLETED|Overall Study||10
2539084|NCT00609973|6223501|P1|COMPLETED|Overall Study||9
2539085|NCT00609973|6223500|P2|STARTED|Overall Study||16
2539086|NCT00609973|6223501|P1|STARTED|Overall Study||17
2539087|NCT00609947|6223509|P1|NOT COMPLETED|Overall Study||1
2539088|NCT00609947|6223509|P1|COMPLETED|Overall Study|One death due to automobile accident.|240
2539089|NCT00609947|6223509|P1|STARTED|Overall Study||241
2539090|NCT00609869|6223514|P1|NOT COMPLETED|Overall Study||11
2539091|NCT00609869|6223514|P1|COMPLETED|Overall Study||18
2539092|NCT00609869|6223514|P1|STARTED|Overall Study||29
2539093|NCT00609804|6223522|P2|NOT COMPLETED|Overall Study||28
2539094|NCT00609804|6223523|P1|NOT COMPLETED|Overall Study||25
2539095|NCT00609804|6223522|P2|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
2539096|NCT00609804|6223523|P1|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
2539097|NCT00609804|6223522|P2|STARTED|Overall Study||28
2539098|NCT00609804|6223523|P1|STARTED|Overall Study||25
2539099|NCT00609765|6223533|P1|NOT COMPLETED|Overall Study||1
2539100|NCT00609765|6223533|P1|COMPLETED|Overall Study||0
2539101|NCT00609765|6223533|P1|STARTED|Overall Study||1
2539102|NCT00609739|6223538|P1|NOT COMPLETED|Overall Study||0
2539103|NCT00609739|6223538|P1|COMPLETED|Overall Study||1
2539104|NCT00609739|6223538|P1|STARTED|Overall Study||1
2539105|NCT00609674|6223547|P2|NOT COMPLETED|Overall Study||7
2539106|NCT00609674|6223548|P1|NOT COMPLETED|Overall Study||7
2539107|NCT00609674|6223547|P2|COMPLETED|Overall Study||153
2539108|NCT00609674|6223548|P1|COMPLETED|Overall Study||148
2539109|NCT00609674|6223547|P2|STARTED|Overall Study||160
2539110|NCT00609674|6223548|P1|STARTED|Overall Study||155
2539111|NCT00609622|6223584|P2|NOT COMPLETED|Overall Study||95
2539112|NCT00609622|6223585|P1|NOT COMPLETED|Overall Study||96
2539113|NCT00609622|6223584|P2|COMPLETED|Overall Study||0
2539114|NCT00609622|6223585|P1|COMPLETED|Overall Study||0
2539115|NCT00609622|6223584|P2|STARTED|Overall Study||95
2539116|NCT00609622|6223585|P1|STARTED|Overall Study||96
2539117|NCT00609609|6223607|P2|NOT COMPLETED|Overall Study||2
2539118|NCT00609609|6223608|P1|NOT COMPLETED|Overall Study||6
2539119|NCT00609609|6223607|P2|COMPLETED|Overall Study||49
2539120|NCT00609609|6223608|P1|COMPLETED|Overall Study||24
2539121|NCT00609609|6223607|P2|STARTED|Overall Study||51
2539122|NCT00609609|6223608|P1|STARTED|Overall Study||30
2539123|NCT00609518|6223620|P2|NOT COMPLETED|Overall Study||40
2539124|NCT00609518|6223621|P1|NOT COMPLETED|Overall Study||43
2539125|NCT00609518|6223620|P2|COMPLETED|Overall Study||17
2539126|NCT00609518|6223621|P1|COMPLETED|Overall Study||11
2539127|NCT00609518|6223620|P2|Completed 6 Treatment Cycles|Overall Study||22
2539128|NCT00609518|6223621|P1|Completed 6 Treatment Cycles|Overall Study||19
2539129|NCT00609518|6223620|P2|STARTED|Overall Study||57
2539130|NCT00609518|6223621|P1|STARTED|Overall Study||54
2539131|NCT00609492|6223636|P3|NOT COMPLETED|Overall Study||7
2539132|NCT00609492|6223637|P2|NOT COMPLETED|Overall Study||3
2539133|NCT00609492|6223638|P1|NOT COMPLETED|Overall Study||1
2539134|NCT00609492|6223636|P3|COMPLETED|Overall Study||122
2539135|NCT00609492|6223637|P2|COMPLETED|Overall Study||69
2539136|NCT00609492|6223638|P1|COMPLETED|Overall Study||43
2539137|NCT00609492|6223636|P3|STARTED|Overall Study||129
2539138|NCT00609492|6223637|P2|STARTED|Overall Study||72
2539139|NCT00609492|6223638|P1|STARTED|Overall Study||44
2539140|NCT00609466|6223723|P3|NOT COMPLETED|Overall Study||4
2539141|NCT00609466|6223724|P2|NOT COMPLETED|Overall Study||6
2539142|NCT00609466|6223725|P1|NOT COMPLETED|Overall Study||2
2539143|NCT00609466|6223723|P3|COMPLETED|Overall Study||95
2539144|NCT00609466|6223724|P2|COMPLETED|Overall Study||90
2539145|NCT00609466|6223725|P1|COMPLETED|Overall Study||94
2539146|NCT00609466|6223723|P3|STARTED|Overall Study||99
2539147|NCT00609466|6223724|P2|STARTED|Overall Study||96
2539148|NCT00609466|6223725|P1|STARTED|Overall Study||96
2539149|NCT00609362|6223753|P2|NOT COMPLETED|Overall Study||1
2539150|NCT00609362|6223754|P1|NOT COMPLETED|Overall Study||3
2539151|NCT00609362|6223753|P2|COMPLETED|Overall Study||27
2539152|NCT00609362|6223754|P1|COMPLETED|Overall Study||26
2539153|NCT00609362|6223753|P2|STARTED|Overall Study||28
2539154|NCT00609362|6223754|P1|STARTED|Overall Study||29
2539155|NCT00609336|6223764|P1|NOT COMPLETED|Overall Study||13
2539156|NCT00609336|6223764|P1|COMPLETED|Overall Study||22
2539157|NCT00609336|6223764|P1|Surgery|Overall Study||22
2539158|NCT00609336|6223764|P1|STARTED|Overall Study||35
2539159|NCT00609271|6223778|P2|NOT COMPLETED|Overall Study||13
2539160|NCT00609271|6223779|P1|NOT COMPLETED|Overall Study||16
2539161|NCT00609271|6223778|P2|COMPLETED|Overall Study||60
2539162|NCT00609271|6223779|P1|COMPLETED|Overall Study||59
2539163|NCT00609271|6223778|P2|STARTED|Overall Study||73
2539164|NCT00609271|6223779|P1|STARTED|Overall Study||75
2539165|NCT00609245|6223815|P1|NOT COMPLETED|Overall Study||1
2539166|NCT00609245|6223815|P1|COMPLETED|Overall Study||12
2539167|NCT00609245|6223815|P1|STARTED|Overall Study||13
2539168|NCT00609167|6223823|P2|NOT COMPLETED|Overall Study||7
2539169|NCT00609167|6223824|P1|NOT COMPLETED|Overall Study||8
2539170|NCT00609167|6223823|P2|COMPLETED|Overall Study||23
2539171|NCT00609167|6223824|P1|COMPLETED|Overall Study||25
2539172|NCT00609167|6223823|P2|STARTED|Overall Study||30
2539173|NCT00609167|6223824|P1|STARTED|Overall Study||33
2539174|NCT00609128|6223846|P1|NOT COMPLETED|Overall Study||0
2539175|NCT00609128|6223846|P1|COMPLETED|Overall Study||21
2539176|NCT00609128|6223846|P1|STARTED|Overall Study||21
2539177|NCT00608985|6223855|P4|NOT COMPLETED|Overall Study||9
2539178|NCT00608985|6223856|P3|NOT COMPLETED|Overall Study||6
2539179|NCT00608985|6223857|P2|NOT COMPLETED|Overall Study||13
2539180|NCT00608985|6223858|P1|NOT COMPLETED|Overall Study||16
2539181|NCT00608985|6223855|P4|COMPLETED|Overall Study|Completed follow-up|159
2539182|NCT00608985|6223856|P3|COMPLETED|Overall Study|Completed follow-up|170
2539183|NCT00608985|6223857|P2|COMPLETED|Overall Study|Completed follow-up|173
2539184|NCT00608985|6223858|P1|COMPLETED|Overall Study|Completed follow-up|161
2539185|NCT00608985|6223855|P4|Completed Double-blind Treatment|Overall Study||161
2539186|NCT00608985|6223856|P3|Completed Double-blind Treatment|Overall Study||171
2539187|NCT00608985|6223857|P2|Completed Double-blind Treatment|Overall Study||174
2539188|NCT00608985|6223858|P1|Completed Double-blind Treatment|Overall Study||163
2539189|NCT00608985|6223855|P4|STARTED|Overall Study|Randomized and started double-blind treatment|168
2539190|NCT00608985|6223856|P3|STARTED|Overall Study|Randomized and started double-blind treatment|176
2539191|NCT00608985|6223857|P2|STARTED|Overall Study|Randomized and started double-blind treatment|186
2539192|NCT00608985|6223858|P1|STARTED|Overall Study|Randomized and started double-blind treatment|177
2539193|NCT00608959|6223890|P1|NOT COMPLETED|Part 2||0
2539194|NCT00608959|6223890|P1|COMPLETED|Part 2||25
2539195|NCT00608959|6223890|P1|STARTED|Part 2|20 Part 1 subjects also participated in Part 2.Five more subjects were enrolled for a total of 25.|25
2539196|NCT00608959|6223890|P1|NOT COMPLETED|Part 1||1
2539197|NCT00608959|6223890|P1|COMPLETED|Part 1||24
2539198|NCT00608959|6223890|P1|STARTED|Part 1|25 subjects each participated in Parts 1 and 2 .A total of 20 subjects participated in both parts.|25
2539199|NCT00608907|6223903|P3|NOT COMPLETED|Overall Study||1
2539200|NCT00608907|6223904|P2|NOT COMPLETED|Overall Study||0
2539201|NCT00608907|6223905|P1|NOT COMPLETED|Overall Study||12
2539202|NCT00608907|6223903|P3|COMPLETED|Overall Study||17
2539203|NCT00608907|6223904|P2|COMPLETED|Overall Study||13
2539204|NCT00608907|6223905|P1|COMPLETED|Overall Study||18
2539205|NCT00608907|6223903|P3|STARTED|Overall Study||18
2539206|NCT00608907|6223904|P2|STARTED|Overall Study||13
2539207|NCT00608907|6223905|P1|STARTED|Overall Study||30
2539208|NCT00608881|6223915|P2|NOT COMPLETED|Overall Study||66
2539209|NCT00608881|6223916|P1|NOT COMPLETED|Overall Study||79
2539210|NCT00608881|6223915|P2|COMPLETED|Overall Study||240
2539211|NCT00608881|6223916|P1|COMPLETED|Overall Study||224
2539212|NCT00608881|6223915|P2|STARTED|Overall Study||306
2539213|NCT00608881|6223916|P1|STARTED|Overall Study||303
2539214|NCT00608868|6223950|P1|NOT COMPLETED|Overall Study||15
2539215|NCT00608868|6223950|P1|COMPLETED|Overall Study||141
2539216|NCT00608868|6223950|P1|Per Protocol (PP) Population|Overall Study||121
2539217|NCT00608868|6223950|P1|Intention to Treat (ITT) Population|Overall Study|8 patients who had no target lesion and 8 who had no tumor assessment after baseline were excluded|138
2539218|NCT00608868|6223950|P1|Treatment Completed|Overall Study||141
2539219|NCT00608868|6223950|P1|Safety Population|Overall Study|2 patients who received no study treatment were excluded|154
2539220|NCT00608868|6223950|P1|Enrolled|Overall Study||156
2539221|NCT00608868|6223950|P1|STARTED|Overall Study||156
2539222|NCT00608842|6223961|P4|NOT COMPLETED|Overall Study||1
2539223|NCT00608842|6223962|P3|NOT COMPLETED|Overall Study||2
2539224|NCT00608842|6223963|P2|NOT COMPLETED|Overall Study||1
2539225|NCT00608842|6223964|P1|NOT COMPLETED|Overall Study||1
2539226|NCT00608842|6223961|P4|COMPLETED|Overall Study||16
2539227|NCT00608842|6223962|P3|COMPLETED|Overall Study||13
2539228|NCT00608842|6223963|P2|COMPLETED|Overall Study||14
2539229|NCT00608842|6223964|P1|COMPLETED|Overall Study||14
2539230|NCT00608842|6223961|P4|STARTED|Overall Study||17
2539231|NCT00608842|6223962|P3|STARTED|Overall Study||15
2539232|NCT00608842|6223963|P2|STARTED|Overall Study||15
2539233|NCT00608842|6223964|P1|STARTED|Overall Study||15
2539234|NCT00608829|6223998|P1|NOT COMPLETED|Overall Study||15
2539235|NCT00608829|6223998|P1|COMPLETED|Overall Study||8
2539236|NCT00608829|6223998|P1|STARTED|Overall Study||23
2539237|NCT00608777|6224002|P1|NOT COMPLETED|Overall Study||0
2539238|NCT00608777|6224002|P1|COMPLETED|Overall Study||6
2539239|NCT00608777|6224002|P1|STARTED|Overall Study||6
2539240|NCT00608634|6224009|P3|NOT COMPLETED|Overall Study||1
2539241|NCT00608634|6224010|P2|NOT COMPLETED|Overall Study||1
2539242|NCT00608634|6224011|P1|NOT COMPLETED|Overall Study||2
2539243|NCT00608634|6224009|P3|COMPLETED|Overall Study||27
2539244|NCT00608634|6224010|P2|COMPLETED|Overall Study||26
2539245|NCT00608634|6224011|P1|COMPLETED|Overall Study||26
2539246|NCT00608634|6224009|P3|STARTED|Overall Study||28
2539247|NCT00608634|6224010|P2|STARTED|Overall Study||27
2539248|NCT00608634|6224011|P1|STARTED|Overall Study||28
2539249|NCT00608582|6224024|P2|NOT COMPLETED|Overall Study||4
2539250|NCT00608582|6224025|P1|NOT COMPLETED|Overall Study||4
2539251|NCT00608582|6224024|P2|COMPLETED|Overall Study||7
2539252|NCT00608582|6224025|P1|COMPLETED|Overall Study||10
2539253|NCT00608582|6224024|P2|STARTED|Overall Study||11
2539254|NCT00608582|6224025|P1|STARTED|Overall Study||14
2539255|NCT00608569|6224035|P2|NOT COMPLETED|Overall Study||9
2539256|NCT00608569|6224036|P1|NOT COMPLETED|Overall Study||10
2539257|NCT00608569|6224035|P2|COMPLETED|Overall Study||119
2539258|NCT00608569|6224036|P1|COMPLETED|Overall Study||119
2539259|NCT00608569|6224035|P2|STARTED|Overall Study||128
2539260|NCT00608569|6224036|P1|STARTED|Overall Study||129
2539261|NCT00608543|6224056|P1|NOT COMPLETED|Overall Study||4
2539262|NCT00608543|6224056|P1|COMPLETED|Overall Study||13
2539263|NCT00608543|6224056|P1|STARTED|Overall Study||17
2539264|NCT00608530|6224069|P4|NOT COMPLETED|Study 2 Nurse-delivered Treatments||7
2539265|NCT00608530|6224070|P3|NOT COMPLETED|Study 2 Nurse-delivered Treatments||12
2539266|NCT00608530|6224071|P2|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0
2539267|NCT00608530|6224072|P1|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0
2539268|NCT00608530|6224069|P4|COMPLETED|Study 2 Nurse-delivered Treatments||27
2539269|NCT00608530|6224070|P3|COMPLETED|Study 2 Nurse-delivered Treatments||21
2539270|NCT00608530|6224071|P2|COMPLETED|Study 2 Nurse-delivered Treatments||0
2539271|NCT00608530|6224072|P1|COMPLETED|Study 2 Nurse-delivered Treatments||0
2539272|NCT00608530|6224069|P4|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||31
2539273|NCT00608530|6224070|P3|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||30
2539274|NCT00608530|6224071|P2|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0
2539275|NCT00608530|6224072|P1|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0
2539276|NCT00608530|6224069|P4|STARTED|Study 2 Nurse-delivered Treatments||34
2539277|NCT00608530|6224070|P3|STARTED|Study 2 Nurse-delivered Treatments||33
2539278|NCT00608530|6224071|P2|STARTED|Study 2 Nurse-delivered Treatments||0
2539279|NCT00608530|6224072|P1|STARTED|Study 2 Nurse-delivered Treatments||0
2539280|NCT00608530|6224069|P4|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0
2539281|NCT00608530|6224070|P3|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0
2539282|NCT00608530|6224071|P2|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||5
2539283|NCT00608530|6224072|P1|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||11
2539284|NCT00608530|6224069|P4|COMPLETED|Study 1 Psychologist-delivered Treatment||0
2539285|NCT00608530|6224070|P3|COMPLETED|Study 1 Psychologist-delivered Treatment||0
2539286|NCT00608530|6224071|P2|COMPLETED|Study 1 Psychologist-delivered Treatment||28
2539287|NCT00608530|6224072|P1|COMPLETED|Study 1 Psychologist-delivered Treatment||22
2539288|NCT00608530|6224069|P4|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0
2539289|NCT00608530|6224070|P3|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0
2539290|NCT00608530|6224071|P2|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||31
2539291|NCT00608530|6224072|P1|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||28
2539292|NCT00608530|6224069|P4|STARTED|Study 1 Psychologist-delivered Treatment||0
2539293|NCT00608530|6224070|P3|STARTED|Study 1 Psychologist-delivered Treatment||0
2539294|NCT00608530|6224071|P2|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33
2539295|NCT00608530|6224072|P1|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33
2539296|NCT00608517|6224093|P3|NOT COMPLETED|Overall Study||0
2539297|NCT00608517|6224094|P2|NOT COMPLETED|Overall Study||0
2539298|NCT00608517|6224095|P1|NOT COMPLETED|Overall Study||1
2539299|NCT00608517|6224093|P3|COMPLETED|Overall Study||1
2539300|NCT00608517|6224094|P2|COMPLETED|Overall Study||3
2539301|NCT00608517|6224095|P1|COMPLETED|Overall Study||1
2539302|NCT00608517|6224093|P3|STARTED|Overall Study||1
2539303|NCT00608517|6224094|P2|STARTED|Overall Study||3
2539304|NCT00608517|6224095|P1|STARTED|Overall Study||2
2539305|NCT00608491|6224123|P2|NOT COMPLETED|Overall Study||22
2539306|NCT00608491|6224124|P1|NOT COMPLETED|Overall Study||21
2539307|NCT00608491|6224123|P2|COMPLETED|Overall Study||72
2539308|NCT00608491|6224124|P1|COMPLETED|Overall Study||73
2539309|NCT00608491|6224123|P2|STARTED|Overall Study||94
2539310|NCT00608491|6224124|P1|STARTED|Overall Study||94
2539311|NCT00608465|6224268|P1|NOT COMPLETED|Overall Study||0
2539312|NCT00608465|6224268|P1|COMPLETED|Overall Study||4
2539313|NCT00608465|6224268|P1|STARTED|Overall Study||4
2539314|NCT00608426|6224275|P2|NOT COMPLETED|Overall Study||905
2539315|NCT00608426|6224276|P1|NOT COMPLETED|Overall Study||836
2539316|NCT00608426|6224275|P2|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1614
2539317|NCT00608426|6224276|P1|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1768
2539318|NCT00608426|6224275|P2|STARTED|Overall Study||2519
2539319|NCT00608426|6224276|P1|STARTED|Overall Study||2604
2539320|NCT00608322|6224288|P2|NOT COMPLETED|Overall Study||1
2539321|NCT00608322|6224289|P1|NOT COMPLETED|Overall Study||2
2539322|NCT00608322|6224288|P2|COMPLETED|Overall Study||22
2539323|NCT00608322|6224289|P1|COMPLETED|Overall Study||24
2539324|NCT00608322|6224288|P2|STARTED|Overall Study||23
2539325|NCT00608322|6224289|P1|STARTED|Overall Study||26
2539326|NCT00608244|6224295|P1|NOT COMPLETED|Overall Study||2
2539327|NCT00608244|6224295|P1|COMPLETED|Overall Study||57
2539328|NCT00608244|6224295|P1|STARTED|Overall Study||59
2539329|NCT00608205|6224306|P2|NOT COMPLETED|Overall Study||3
2539330|NCT00608205|6224307|P1|NOT COMPLETED|Overall Study||3
2539331|NCT00608205|6224306|P2|COMPLETED|Overall Study||31
2539332|NCT00608205|6224307|P1|COMPLETED|Overall Study||32
2539333|NCT00608205|6224306|P2|STARTED|Overall Study||34
2539334|NCT00608205|6224307|P1|STARTED|Overall Study||35
2539335|NCT00608140|6224397|P2|NOT COMPLETED|Overall Study||1
2539336|NCT00608140|6224398|P1|NOT COMPLETED|Overall Study||1
2539337|NCT00608140|6224397|P2|COMPLETED|Overall Study|Study ended early due to low enrollment|0
2539338|NCT00608140|6224398|P1|COMPLETED|Overall Study|Study ended early due to low enrollment|0
2539339|NCT00608140|6224397|P2|STARTED|Overall Study||1
2539340|NCT00608140|6224398|P1|STARTED|Overall Study||1
2539341|NCT00608023|6224424|P3|NOT COMPLETED|Overall Study||14
2539342|NCT00608023|6224425|P2|NOT COMPLETED|Overall Study||22
2539343|NCT00608023|6224426|P1|NOT COMPLETED|Overall Study||12
2539344|NCT00608023|6224424|P3|COMPLETED|Overall Study||72
2539345|NCT00608023|6224425|P2|COMPLETED|Overall Study||63
2539346|NCT00608023|6224426|P1|COMPLETED|Overall Study||80
2539347|NCT00608023|6224424|P3|STARTED|Overall Study||86
2539348|NCT00608023|6224425|P2|STARTED|Overall Study||85
2539349|NCT00608023|6224426|P1|STARTED|Overall Study||92
2539350|NCT00607997|6224450|P4|NOT COMPLETED|Overall Study||16
2539351|NCT00607997|6224451|P3|NOT COMPLETED|Overall Study||24
2539352|NCT00607997|6224452|P2|NOT COMPLETED|Overall Study||27
2539353|NCT00607997|6224453|P1|NOT COMPLETED|Overall Study||27
2539354|NCT00607997|6224450|P4|COMPLETED|Overall Study||4
2539355|NCT00607997|6224451|P3|COMPLETED|Overall Study||5
2539356|NCT00607997|6224452|P2|COMPLETED|Overall Study||8
2539357|NCT00607997|6224453|P1|COMPLETED|Overall Study||2
2539358|NCT00607997|6224450|P4|STARTED|Overall Study||20
2539359|NCT00607997|6224451|P3|STARTED|Overall Study||29
2539360|NCT00607997|6224452|P2|STARTED|Overall Study||35
2539361|NCT00607997|6224453|P1|STARTED|Overall Study||29
2539362|NCT00607919|6224511|P2|NOT COMPLETED|Open-Label Phase||12
2539363|NCT00607919|6224512|P1|NOT COMPLETED|Open-Label Phase||10
2539364|NCT00607919|6224511|P2|COMPLETED|Open-Label Phase||59
2539365|NCT00607919|6224512|P1|COMPLETED|Open-Label Phase||74
2539366|NCT00607919|6224511|P2|STARTED|Open-Label Phase||71
2539367|NCT00607919|6224512|P1|STARTED|Open-Label Phase||84
2539368|NCT00607919|6224511|P2|NOT COMPLETED|Acute Phase||16
2539369|NCT00607919|6224512|P1|NOT COMPLETED|Acute Phase||34
2539370|NCT00607919|6224511|P2|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|73
2539371|NCT00607919|6224512|P1|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|86
2539372|NCT00607919|6224511|P2|STARTED|Acute Phase||89
2539373|NCT00607919|6224512|P1|STARTED|Acute Phase||120
2539374|NCT00607893|6224570|P2|NOT COMPLETED|Overall Study||4
2539375|NCT00607893|6224571|P1|NOT COMPLETED|Overall Study||6
2539376|NCT00607893|6224570|P2|COMPLETED|Overall Study||72
2539377|NCT00607893|6224571|P1|COMPLETED|Overall Study||71
2539378|NCT00607893|6224570|P2|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|29
2539379|NCT00607893|6224571|P1|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|0
2539380|NCT00607893|6224570|P2|Completed 8 Week Visit|Overall Study||72
2539381|NCT00607893|6224571|P1|Completed 8 Week Visit|Overall Study||71
2539382|NCT00607893|6224570|P2|Completed Baseline Visit|Overall Study||75
2539383|NCT00607893|6224571|P1|Completed Baseline Visit|Overall Study||74
2539384|NCT00607893|6224570|P2|STARTED|Overall Study||76
2539385|NCT00607893|6224571|P1|STARTED|Overall Study||77
2539386|NCT00607880|6224599|P2|NOT COMPLETED|Overall Study||0
2539387|NCT00607880|6224600|P1|NOT COMPLETED|Overall Study||1
2539388|NCT00607880|6224599|P2|COMPLETED|Overall Study||50
2539389|NCT00607880|6224600|P1|COMPLETED|Overall Study||49
2539390|NCT00607880|6224599|P2|STARTED|Overall Study||50
2539391|NCT00607880|6224600|P1|STARTED|Overall Study||50
2539392|NCT00607867|6224614|P2|NOT COMPLETED|Overall Study||0
2539393|NCT00607867|6224615|P1|NOT COMPLETED|Overall Study||0
2539394|NCT00607867|6224614|P2|COMPLETED|Overall Study||7
2539395|NCT00607867|6224615|P1|COMPLETED|Overall Study||7
2539396|NCT00607867|6224614|P2|STARTED|Overall Study||7
2539397|NCT00607867|6224615|P1|STARTED|Overall Study||7
2539398|NCT00607815|6224633|P2|NOT COMPLETED|Overall Study||11
2539399|NCT00607815|6224634|P1|NOT COMPLETED|Overall Study||23
2539400|NCT00607815|6224633|P2|COMPLETED|Overall Study||25
2539401|NCT00607815|6224634|P1|COMPLETED|Overall Study||20
2539402|NCT00607815|6224633|P2|STARTED|Overall Study||36
2539403|NCT00607815|6224634|P1|STARTED|Overall Study||43
2539404|NCT00607789|6224650|P2|NOT COMPLETED|Overall Study||6
2539405|NCT00607789|6224651|P1|NOT COMPLETED|Overall Study||7
2539406|NCT00607789|6224650|P2|COMPLETED|Overall Study||14
2539407|NCT00607789|6224651|P1|COMPLETED|Overall Study||13
2539408|NCT00607789|6224650|P2|STARTED|Overall Study||20
2539409|NCT00607789|6224651|P1|STARTED|Overall Study|20 participants were randomized in each group|20
2539410|NCT00607724|6224666|P7|NOT COMPLETED|Stage 2: Expanded Cohort||11
2539411|NCT00607724|6224667|P6|NOT COMPLETED|Stage 2: Expanded Cohort||12
2539412|NCT00607724|6224668|P5|NOT COMPLETED|Stage 2: Expanded Cohort||9
2539413|NCT00607724|6224669|P4|NOT COMPLETED|Stage 2: Expanded Cohort||5
2539414|NCT00607724|6224670|P3|NOT COMPLETED|Stage 2: Expanded Cohort||0
2539415|NCT00607724|6224671|P2|NOT COMPLETED|Stage 2: Expanded Cohort||0
2539416|NCT00607724|6224672|P1|NOT COMPLETED|Stage 2: Expanded Cohort||0
2539417|NCT00607724|6224666|P7|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered ‘completers’.|5
2539418|NCT00607724|6224667|P6|COMPLETED|Stage 2: Expanded Cohort||0
2539419|NCT00607724|6224668|P5|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered ‘completers’.|5
2539420|NCT00607724|6224669|P4|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered ‘completers’.|1
2539421|NCT00607724|6224670|P3|COMPLETED|Stage 2: Expanded Cohort||0
2539422|NCT00607724|6224671|P2|COMPLETED|Stage 2: Expanded Cohort||0
2539423|NCT00607724|6224672|P1|COMPLETED|Stage 2: Expanded Cohort||0
2539424|NCT00607724|6224666|P7|STARTED|Stage 2: Expanded Cohort||16
2539425|NCT00607724|6224667|P6|STARTED|Stage 2: Expanded Cohort||12
2539426|NCT00607724|6224668|P5|STARTED|Stage 2: Expanded Cohort||14
2539427|NCT00607724|6224669|P4|STARTED|Stage 2: Expanded Cohort||6
2539428|NCT00607724|6224670|P3|STARTED|Stage 2: Expanded Cohort||0
2539429|NCT00607724|6224671|P2|STARTED|Stage 2: Expanded Cohort||0
2539430|NCT00607724|6224672|P1|STARTED|Stage 2: Expanded Cohort||0
2539431|NCT00607724|6224666|P7|NOT COMPLETED|Stage 1: Dose Escalation||0
2539432|NCT00607724|6224667|P6|NOT COMPLETED|Stage 1: Dose Escalation||0
2539433|NCT00607724|6224668|P5|NOT COMPLETED|Stage 1: Dose Escalation||0
2539434|NCT00607724|6224669|P4|NOT COMPLETED|Stage 1: Dose Escalation||0
2539435|NCT00607724|6224670|P3|NOT COMPLETED|Stage 1: Dose Escalation||4
2539436|NCT00607724|6224671|P2|NOT COMPLETED|Stage 1: Dose Escalation||8
2539437|NCT00607724|6224672|P1|NOT COMPLETED|Stage 1: Dose Escalation||7
2539438|NCT00607724|6224666|P7|COMPLETED|Stage 1: Dose Escalation||0
2539439|NCT00607724|6224667|P6|COMPLETED|Stage 1: Dose Escalation||0
2539440|NCT00607724|6224668|P5|COMPLETED|Stage 1: Dose Escalation||0
2539441|NCT00607724|6224669|P4|COMPLETED|Stage 1: Dose Escalation||0
2539442|NCT00607724|6224670|P3|COMPLETED|Stage 1: Dose Escalation||0
2539443|NCT00607724|6224671|P2|COMPLETED|Stage 1: Dose Escalation|Participants still on treatment at time of study closure were considered ‘completers’.|1
2539444|NCT00607724|6224672|P1|COMPLETED|Stage 1: Dose Escalation||0
2539445|NCT00607724|6224666|P7|STARTED|Stage 1: Dose Escalation||0
2539446|NCT00607724|6224667|P6|STARTED|Stage 1: Dose Escalation||0
2539447|NCT00607724|6224668|P5|STARTED|Stage 1: Dose Escalation||0
2539448|NCT00607724|6224669|P4|STARTED|Stage 1: Dose Escalation||0
2539449|NCT00607724|6224670|P3|STARTED|Stage 1: Dose Escalation||4
2539450|NCT00607724|6224671|P2|STARTED|Stage 1: Dose Escalation||9
2539451|NCT00607724|6224672|P1|STARTED|Stage 1: Dose Escalation||7
2539452|NCT00607672|6224751|P3|NOT COMPLETED|Overall Study||5
2539453|NCT00607672|6224752|P2|NOT COMPLETED|Overall Study||3
2539454|NCT00607672|6224753|P1|NOT COMPLETED|Overall Study||4
2539455|NCT00607672|6224751|P3|COMPLETED|Overall Study||22
2539456|NCT00607672|6224752|P2|COMPLETED|Overall Study||24
2539457|NCT00607672|6224753|P1|COMPLETED|Overall Study||28
2539458|NCT00607672|6224751|P3|STARTED|Overall Study||27
2539459|NCT00607672|6224752|P2|STARTED|Overall Study||27
2539460|NCT00607672|6224753|P1|STARTED|Overall Study||32
2539461|NCT00607620|6224799|P2|NOT COMPLETED|Overall Study||0
2539462|NCT00607620|6224800|P1|NOT COMPLETED|Overall Study||0
2539463|NCT00607620|6224799|P2|COMPLETED|Overall Study||469
2539464|NCT00607620|6224800|P1|COMPLETED|Overall Study||409
2539465|NCT00607620|6224799|P2|STARTED|Overall Study||469
2539466|NCT00607620|6224800|P1|STARTED|Overall Study||409
2539467|NCT00607594|6224814|P1|NOT COMPLETED|Overall Study||0
2539468|NCT00607594|6224814|P1|COMPLETED|Overall Study||21
2539469|NCT00607594|6224814|P1|STARTED|Overall Study||21
2539470|NCT00607477|6224828|P2|NOT COMPLETED|Overall Study||0
2539471|NCT00607477|6224829|P1|NOT COMPLETED|Overall Study||0
2539472|NCT00607477|6224828|P2|COMPLETED|Overall Study||2
2539473|NCT00607477|6224829|P1|COMPLETED|Overall Study||0
2539474|NCT00607477|6224828|P2|STARTED|Overall Study||2
2539475|NCT00607477|6224829|P1|STARTED|Overall Study||0
2539476|NCT00607386|6224835|P1|NOT COMPLETED|Overall Study||1
2539477|NCT00607386|6224835|P1|COMPLETED|Overall Study||27
2539478|NCT00607386|6224835|P1|STARTED|Overall Study||28
2539479|NCT00607373|6224850|P2|NOT COMPLETED|Follow-up Period||5
2539480|NCT00607373|6224851|P1|NOT COMPLETED|Follow-up Period||1
2539481|NCT00607373|6224850|P2|COMPLETED|Follow-up Period||6
2539482|NCT00607373|6224851|P1|COMPLETED|Follow-up Period||0
2539483|NCT00607373|6224850|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|11
2539484|NCT00607373|6224851|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|1
2539485|NCT00607373|6224850|P2|NOT COMPLETED|Treatment Period||6
2539486|NCT00607373|6224851|P1|NOT COMPLETED|Treatment Period||0
2539487|NCT00607373|6224850|P2|COMPLETED|Treatment Period|23 enrolled in open-label extension study NCT00694109|28
2539488|NCT00607373|6224851|P1|COMPLETED|Treatment Period|16 enrolled in open-label extension study NCT00694109|17
2539489|NCT00607373|6224850|P2|STARTED|Treatment Period||34
2539490|NCT00607373|6224851|P1|STARTED|Treatment Period||17
2539491|NCT00607321|6224895|P1|NOT COMPLETED|Overall Study||0
2539492|NCT00607321|6224895|P1|COMPLETED|Overall Study||60
2539493|NCT00607321|6224895|P1|STARTED|Overall Study||60
2539494|NCT00607269|6224905|P2|NOT COMPLETED|Overall Study||0
2539495|NCT00607269|6224906|P1|NOT COMPLETED|Overall Study||0
2539496|NCT00607269|6224905|P2|COMPLETED|Overall Study||64
2539497|NCT00607269|6224906|P1|COMPLETED|Overall Study||67
2539498|NCT00607269|6224905|P2|STARTED|Overall Study||64
2539499|NCT00607269|6224906|P1|STARTED|Overall Study||67
2539500|NCT00607243|6224920|P2|NOT COMPLETED|Telephone Safety Assessment Period||2
2539501|NCT00607243|6224921|P1|NOT COMPLETED|Telephone Safety Assessment Period||5
2539502|NCT00607243|6224920|P2|COMPLETED|Telephone Safety Assessment Period|40 Available for 3 months 39 Available for 6 months|39
2539503|NCT00607243|6224921|P1|COMPLETED|Telephone Safety Assessment Period|80 Available for 3 months 77 Available for 6 months|77
2539504|NCT00607243|6224920|P2|STARTED|Telephone Safety Assessment Period||41
2539505|NCT00607243|6224921|P1|STARTED|Telephone Safety Assessment Period||82
2539506|NCT00607243|6224920|P2|NOT COMPLETED|Initial Post-vaccination Period||0
2539507|NCT00607243|6224921|P1|NOT COMPLETED|Initial Post-vaccination Period||0
2539508|NCT00607243|6224920|P2|COMPLETED|Initial Post-vaccination Period||41
2539509|NCT00607243|6224921|P1|COMPLETED|Initial Post-vaccination Period||82
2539510|NCT00607243|6224920|P2|STARTED|Initial Post-vaccination Period||41
2539511|NCT00607243|6224921|P1|STARTED|Initial Post-vaccination Period||82
2539512|NCT00607126|6224929|P2|NOT COMPLETED|Overall Study||0
2539513|NCT00607126|6224930|P1|NOT COMPLETED|Overall Study||0
2539514|NCT00607126|6224929|P2|COMPLETED|Overall Study||19
2539515|NCT00607126|6224930|P1|COMPLETED|Overall Study||17
2539516|NCT00607126|6224929|P2|STARTED|Overall Study||19
2539517|NCT00607126|6224930|P1|STARTED|Overall Study||17
2539518|NCT00607113|6224944|P2|NOT COMPLETED|Overall Study||0
2539519|NCT00607113|6224945|P1|NOT COMPLETED|Overall Study||0
2539520|NCT00607113|6224944|P2|COMPLETED|Overall Study||20
2539521|NCT00607113|6224945|P1|COMPLETED|Overall Study||19
2539522|NCT00607113|6224944|P2|STARTED|Overall Study||20
2539523|NCT00607113|6224945|P1|STARTED|Overall Study||19
2539524|NCT00607087|6224953|P3|NOT COMPLETED|Period 3||0
2539525|NCT00607087|6224954|P2|NOT COMPLETED|Period 3||2
2539526|NCT00607087|6224955|P1|NOT COMPLETED|Period 3||2
2539527|NCT00607087|6224953|P3|COMPLETED|Period 3||84
2539528|NCT00607087|6224954|P2|COMPLETED|Period 3||84
2539529|NCT00607087|6224955|P1|COMPLETED|Period 3||84
2539530|NCT00607087|6224953|P3|STARTED|Period 3||84
2539531|NCT00607087|6224954|P2|STARTED|Period 3||86
2539532|NCT00607087|6224955|P1|STARTED|Period 3||86
2539533|NCT00607087|6224953|P3|NOT COMPLETED|Period 2||5
2539534|NCT00607087|6224954|P2|NOT COMPLETED|Period 2||3
2539535|NCT00607087|6224955|P1|NOT COMPLETED|Period 2||1
2539536|NCT00607087|6224953|P3|COMPLETED|Period 2||84
2539537|NCT00607087|6224954|P2|COMPLETED|Period 2||86
2539538|NCT00607087|6224955|P1|COMPLETED|Period 2||86
2539539|NCT00607087|6224953|P3|STARTED|Period 2||89
2539540|NCT00607087|6224954|P2|STARTED|Period 2||89
2539541|NCT00607087|6224955|P1|STARTED|Period 2||87
2539542|NCT00607087|6224953|P3|NOT COMPLETED|Period 1||5
2539543|NCT00607087|6224954|P2|NOT COMPLETED|Period 1||6
2539544|NCT00607087|6224955|P1|NOT COMPLETED|Period 1||12
2539545|NCT00607087|6224953|P3|COMPLETED|Period 1||89
2539546|NCT00607087|6224954|P2|COMPLETED|Period 1||89
2539547|NCT00607087|6224955|P1|COMPLETED|Period 1||87
2539548|NCT00607087|6224953|P3|STARTED|Period 1||94
2539549|NCT00607087|6224954|P2|STARTED|Period 1||95
2539550|NCT00607087|6224955|P1|STARTED|Period 1||99
2539551|NCT00607087|6224953|P3|NOT COMPLETED|Overall Study||10
2539552|NCT00607087|6224954|P2|NOT COMPLETED|Overall Study||11
2539553|NCT00607087|6224955|P1|NOT COMPLETED|Overall Study||15
2539554|NCT00607087|6224953|P3|COMPLETED|Overall Study||84
2539555|NCT00607087|6224954|P2|COMPLETED|Overall Study||84
2539556|NCT00607087|6224955|P1|COMPLETED|Overall Study||84
2539557|NCT00607087|6224953|P3|STARTED|Overall Study||94
2539558|NCT00607087|6224954|P2|STARTED|Overall Study||95
2539559|NCT00607087|6224955|P1|STARTED|Overall Study||99
2539560|NCT00607048|6225013|P6|NOT COMPLETED|Overall Study||5
2539561|NCT00607048|6225014|P5|NOT COMPLETED|Overall Study||6
2539562|NCT00607048|6225015|P4|NOT COMPLETED|Overall Study||3
2539563|NCT00607048|6225016|P3|NOT COMPLETED|Overall Study||4
2539564|NCT00607048|6225017|P2|NOT COMPLETED|Overall Study||4
2539565|NCT00607048|6225018|P1|NOT COMPLETED|Overall Study||3
2539566|NCT00607048|6225013|P6|COMPLETED|Overall Study||2
2539567|NCT00607048|6225014|P5|COMPLETED|Overall Study||0
2539568|NCT00607048|6225015|P4|COMPLETED|Overall Study||0
2539569|NCT00607048|6225016|P3|COMPLETED|Overall Study||3
2539570|NCT00607048|6225017|P2|COMPLETED|Overall Study||2
2539571|NCT00607048|6225018|P1|COMPLETED|Overall Study||0
2539572|NCT00607048|6225013|P6|STARTED|Overall Study||7
2539573|NCT00607048|6225014|P5|STARTED|Overall Study||6
2539574|NCT00607048|6225015|P4|STARTED|Overall Study||3
2539575|NCT00607048|6225016|P3|STARTED|Overall Study||7
2539576|NCT00607048|6225017|P2|STARTED|Overall Study||6
2539577|NCT00607048|6225018|P1|STARTED|Overall Study||3
2539578|NCT00607022|6225103|P3|NOT COMPLETED|Overall Study||0
2539579|NCT00607022|6225104|P2|NOT COMPLETED|Overall Study||0
2539580|NCT00607022|6225105|P1|NOT COMPLETED|Overall Study||1
2539581|NCT00607022|6225103|P3|COMPLETED|Overall Study||19
2539582|NCT00607022|6225104|P2|COMPLETED|Overall Study||15
2539583|NCT00607022|6225105|P1|COMPLETED|Overall Study||6
2539584|NCT00607022|6225103|P3|STARTED|Overall Study||19
2539585|NCT00607022|6225104|P2|STARTED|Overall Study||15
2539586|NCT00607022|6225105|P1|STARTED|Overall Study||7
2539587|NCT00606944|6225115|P2|NOT COMPLETED|Overall Study||0
2539588|NCT00606944|6225116|P1|NOT COMPLETED|Overall Study||0
2539589|NCT00606944|6225115|P2|COMPLETED|Overall Study||100
2539590|NCT00606944|6225116|P1|COMPLETED|Overall Study||98
2539591|NCT00606944|6225115|P2|STARTED|Overall Study||100
2539592|NCT00606944|6225116|P1|STARTED|Overall Study||98
2539593|NCT00606931|6225122|P1|NOT COMPLETED|Overall Study||3
2539594|NCT00606931|6225122|P1|COMPLETED|Overall Study||19
2539595|NCT00606931|6225122|P1|STARTED|Overall Study||22
2539596|NCT00606905|6225130|P2|NOT COMPLETED|Overall Study||15
2539597|NCT00606905|6225131|P1|NOT COMPLETED|Overall Study||15
2539598|NCT00606905|6225130|P2|COMPLETED|Overall Study||24
2539599|NCT00606905|6225131|P1|COMPLETED|Overall Study||23
2539600|NCT00606905|6225130|P2|Pregnancy|Overall Study||33
2539601|NCT00606905|6225131|P1|Pregnancy|Overall Study||29
2539602|NCT00606905|6225130|P2|STARTED|Overall Study||39
2539603|NCT00606905|6225131|P1|STARTED|Overall Study||38
2539604|NCT00606892|6225137|P2|NOT COMPLETED|Second Intervention||0
2539605|NCT00606892|6225138|P1|NOT COMPLETED|Second Intervention||0
2539606|NCT00606892|6225137|P2|COMPLETED|Second Intervention||4
2539607|NCT00606892|6225138|P1|COMPLETED|Second Intervention||8
2539608|NCT00606892|6225137|P2|STARTED|Second Intervention||4
2539609|NCT00606892|6225138|P1|STARTED|Second Intervention||8
2539610|NCT00606892|6225137|P2|NOT COMPLETED|Washout Period||0
2539611|NCT00606892|6225138|P1|NOT COMPLETED|Washout Period||0
2539612|NCT00606892|6225137|P2|COMPLETED|Washout Period||4
2539613|NCT00606892|6225138|P1|COMPLETED|Washout Period||8
2539614|NCT00606892|6225137|P2|STARTED|Washout Period||4
2539615|NCT00606892|6225138|P1|STARTED|Washout Period||8
2539616|NCT00606892|6225137|P2|NOT COMPLETED|First Intervention||4
2539617|NCT00606892|6225138|P1|NOT COMPLETED|First Intervention||1
2539618|NCT00606892|6225137|P2|COMPLETED|First Intervention||4
2539619|NCT00606892|6225138|P1|COMPLETED|First Intervention||8
2539620|NCT00606892|6225137|P2|STARTED|First Intervention||8
2539621|NCT00606892|6225138|P1|STARTED|First Intervention||9
2539622|NCT00606892|6225137|P2|NOT COMPLETED|Adaptation||0
2539623|NCT00606892|6225138|P1|NOT COMPLETED|Adaptation||0
2539624|NCT00606892|6225137|P2|COMPLETED|Adaptation||8
2539625|NCT00606892|6225138|P1|COMPLETED|Adaptation||9
2539626|NCT00606892|6225137|P2|STARTED|Adaptation||8
2539627|NCT00606892|6225138|P1|STARTED|Adaptation||9
2539628|NCT00606801|6225172|P2|NOT COMPLETED|Intervention||3
2539629|NCT00606801|6225173|P1|NOT COMPLETED|Intervention||3
2539630|NCT00606801|6225172|P2|COMPLETED|Intervention||14
2539631|NCT00606801|6225173|P1|COMPLETED|Intervention||14
2539632|NCT00606801|6225172|P2|STARTED|Intervention||17
2539633|NCT00606801|6225173|P1|STARTED|Intervention||17
2539634|NCT00606801|6225172|P2|NOT COMPLETED|Adaptation||0
2539635|NCT00606801|6225173|P1|NOT COMPLETED|Adaptation||0
2539636|NCT00606801|6225172|P2|COMPLETED|Adaptation||17
2539637|NCT00606801|6225173|P1|COMPLETED|Adaptation||17
2539638|NCT00606801|6225172|P2|STARTED|Adaptation||17
2539639|NCT00606801|6225173|P1|STARTED|Adaptation||17
2539640|NCT00606684|6225201|P7|NOT COMPLETED|Double-Blind Treatment Period||8
2539641|NCT00606684|6225202|P6|NOT COMPLETED|Double-Blind Treatment Period||9
2539642|NCT00606684|6225203|P5|NOT COMPLETED|Double-Blind Treatment Period||9
2539643|NCT00606684|6225204|P4|NOT COMPLETED|Double-Blind Treatment Period||10
2539644|NCT00606684|6225205|P3|NOT COMPLETED|Double-Blind Treatment Period||11
2539645|NCT00606684|6225206|P2|NOT COMPLETED|Double-Blind Treatment Period||16
2539646|NCT00606684|6225207|P1|NOT COMPLETED|Double-Blind Treatment Period||0
2539647|NCT00606684|6225201|P7|COMPLETED|Double-Blind Treatment Period||91
2539648|NCT00606684|6225202|P6|COMPLETED|Double-Blind Treatment Period||92
2539649|NCT00606684|6225203|P5|COMPLETED|Double-Blind Treatment Period||92
2539650|NCT00606684|6225204|P4|COMPLETED|Double-Blind Treatment Period||91
2539651|NCT00606684|6225205|P3|COMPLETED|Double-Blind Treatment Period||88
2539652|NCT00606684|6225206|P2|COMPLETED|Double-Blind Treatment Period||85
2539653|NCT00606684|6225207|P1|COMPLETED|Double-Blind Treatment Period||0
2539654|NCT00606684|6225201|P7|STARTED|Double-Blind Treatment Period||99
2539655|NCT00606684|6225202|P6|STARTED|Double-Blind Treatment Period||101
2539656|NCT00606684|6225203|P5|STARTED|Double-Blind Treatment Period||101
2539657|NCT00606684|6225204|P4|STARTED|Double-Blind Treatment Period||101
2539658|NCT00606684|6225205|P3|STARTED|Double-Blind Treatment Period||99
2539659|NCT00606684|6225206|P2|STARTED|Double-Blind Treatment Period||101
2539660|NCT00606684|6225207|P1|STARTED|Double-Blind Treatment Period||0
2539661|NCT00606684|6225201|P7|NOT COMPLETED|2-week Single-Blind Run-in Period||0
2539662|NCT00606684|6225202|P6|NOT COMPLETED|2-week Single-Blind Run-in Period||0
2539663|NCT00606684|6225203|P5|NOT COMPLETED|2-week Single-Blind Run-in Period||0
2539664|NCT00606684|6225204|P4|NOT COMPLETED|2-week Single-Blind Run-in Period||0
2539665|NCT00606684|6225205|P3|NOT COMPLETED|2-week Single-Blind Run-in Period||0
2539666|NCT00606684|6225206|P2|NOT COMPLETED|2-week Single-Blind Run-in Period||0
2539667|NCT00606684|6225207|P1|NOT COMPLETED|2-week Single-Blind Run-in Period||246
2539668|NCT00606684|6225201|P7|COMPLETED|2-week Single-Blind Run-in Period||0
2539669|NCT00606684|6225202|P6|COMPLETED|2-week Single-Blind Run-in Period||0
2539670|NCT00606684|6225203|P5|COMPLETED|2-week Single-Blind Run-in Period||0
2539671|NCT00606684|6225204|P4|COMPLETED|2-week Single-Blind Run-in Period||0
2539672|NCT00606684|6225205|P3|COMPLETED|2-week Single-Blind Run-in Period||0
2539673|NCT00606684|6225206|P2|COMPLETED|2-week Single-Blind Run-in Period||0
2539674|NCT00606684|6225207|P1|COMPLETED|2-week Single-Blind Run-in Period||605
2539675|NCT00606684|6225201|P7|STARTED|2-week Single-Blind Run-in Period||0
2539676|NCT00606684|6225202|P6|STARTED|2-week Single-Blind Run-in Period||0
2539677|NCT00606684|6225203|P5|STARTED|2-week Single-Blind Run-in Period||0
2539678|NCT00606684|6225204|P4|STARTED|2-week Single-Blind Run-in Period||0
2539679|NCT00606684|6225205|P3|STARTED|2-week Single-Blind Run-in Period||0
2539680|NCT00606684|6225206|P2|STARTED|2-week Single-Blind Run-in Period||0
2539681|NCT00606684|6225207|P1|STARTED|2-week Single-Blind Run-in Period||851
2539682|NCT00606632|6225239|P1|NOT COMPLETED|Overall Study||22
2539683|NCT00606632|6225239|P1|COMPLETED|Overall Study||204
2539684|NCT00606632|6225239|P1|STARTED|Overall Study||226
2539685|NCT00606593|6225252|P10|NOT COMPLETED|Overall Study||0
2539686|NCT00606593|6225253|P9|NOT COMPLETED|Overall Study||1
2539687|NCT00606593|6225254|P8|NOT COMPLETED|Overall Study||2
2539688|NCT00606593|6225255|P7|NOT COMPLETED|Overall Study||1
2539689|NCT00606593|6225256|P6|NOT COMPLETED|Overall Study||0
2539690|NCT00606593|6225257|P5|NOT COMPLETED|Overall Study||1
2539691|NCT00606593|6225258|P4|NOT COMPLETED|Overall Study||1
2539692|NCT00606593|6225259|P3|NOT COMPLETED|Overall Study||2
2539693|NCT00606593|6225260|P2|NOT COMPLETED|Overall Study||0
2539694|NCT00606593|6225261|P1|NOT COMPLETED|Overall Study||1
2539695|NCT00606593|6225252|P10|COMPLETED|Overall Study||11
2539696|NCT00606593|6225253|P9|COMPLETED|Overall Study||11
2539697|NCT00606593|6225254|P8|COMPLETED|Overall Study||9
2539698|NCT00606593|6225255|P7|COMPLETED|Overall Study||10
2539699|NCT00606593|6225256|P6|COMPLETED|Overall Study||11
2539700|NCT00606593|6225257|P5|COMPLETED|Overall Study||11
2539701|NCT00606593|6225258|P4|COMPLETED|Overall Study||10
2539702|NCT00606593|6225259|P3|COMPLETED|Overall Study||9
2539703|NCT00606593|6225260|P2|COMPLETED|Overall Study||11
2539704|NCT00606593|6225261|P1|COMPLETED|Overall Study||10
2539705|NCT00606593|6225252|P10|5th Double-blind Treatment|Overall Study||11
2539706|NCT00606593|6225253|P9|5th Double-blind Treatment|Overall Study||11
2539707|NCT00606593|6225254|P8|5th Double-blind Treatment|Overall Study||9
2539708|NCT00606593|6225255|P7|5th Double-blind Treatment|Overall Study||10
2539709|NCT00606593|6225256|P6|5th Double-blind Treatment|Overall Study||11
2539710|NCT00606593|6225257|P5|5th Double-blind Treatment|Overall Study||11
2539711|NCT00606593|6225258|P4|5th Double-blind Treatment|Overall Study||10
2539712|NCT00606593|6225259|P3|5th Double-blind Treatment|Overall Study||9
2539713|NCT00606593|6225260|P2|5th Double-blind Treatment|Overall Study||11
2539714|NCT00606593|6225261|P1|5th Double-blind Treatment|Overall Study||10
2539715|NCT00606593|6225252|P10|4th Double-blind Treatment|Overall Study||11
2539716|NCT00606593|6225253|P9|4th Double-blind Treatment|Overall Study||11
2539717|NCT00606593|6225254|P8|4th Double-blind Treatment|Overall Study||9
2539718|NCT00606593|6225255|P7|4th Double-blind Treatment|Overall Study||10
2539719|NCT00606593|6225256|P6|4th Double-blind Treatment|Overall Study||11
2539720|NCT00606593|6225257|P5|4th Double-blind Treatment|Overall Study||11
2539721|NCT00606593|6225258|P4|4th Double-blind Treatment|Overall Study||10
2539722|NCT00606593|6225259|P3|4th Double-blind Treatment|Overall Study||10
2539723|NCT00606593|6225260|P2|4th Double-blind Treatment|Overall Study||11
2539724|NCT00606593|6225261|P1|4th Double-blind Treatment|Overall Study||10
2539725|NCT00606593|6225252|P10|3rd Double-blind Treatment|Overall Study||11
2539726|NCT00606593|6225253|P9|3rd Double-blind Treatment|Overall Study||12
2539727|NCT00606593|6225254|P8|3rd Double-blind Treatment|Overall Study||9
2539728|NCT00606593|6225255|P7|3rd Double-blind Treatment|Overall Study||10
2539729|NCT00606593|6225256|P6|3rd Double-blind Treatment|Overall Study||11
2539730|NCT00606593|6225257|P5|3rd Double-blind Treatment|Overall Study||11
2539731|NCT00606593|6225258|P4|3rd Double-blind Treatment|Overall Study||10
2539732|NCT00606593|6225259|P3|3rd Double-blind Treatment|Overall Study||10
2539733|NCT00606593|6225260|P2|3rd Double-blind Treatment|Overall Study||11
2539734|NCT00606593|6225261|P1|3rd Double-blind Treatment|Overall Study||11
2539735|NCT00606593|6225252|P10|2nd Double-blind Treatment|Overall Study||11
2539736|NCT00606593|6225253|P9|2nd Double-blind Treatment|Overall Study||12
2539737|NCT00606593|6225254|P8|2nd Double-blind Treatment|Overall Study||9
2539738|NCT00606593|6225255|P7|2nd Double-blind Treatment|Overall Study||10
2539739|NCT00606593|6225256|P6|2nd Double-blind Treatment|Overall Study||11
2539740|NCT00606593|6225257|P5|2nd Double-blind Treatment|Overall Study||12
2539741|NCT00606593|6225258|P4|2nd Double-blind Treatment|Overall Study||10
2539742|NCT00606593|6225259|P3|2nd Double-blind Treatment|Overall Study||11
2539743|NCT00606593|6225260|P2|2nd Double-blind Treatment|Overall Study||11
2539744|NCT00606593|6225261|P1|2nd Double-blind Treatment|Overall Study||11
2539745|NCT00606593|6225252|P10|1st Double-blind Treatment|Overall Study||11
2539746|NCT00606593|6225253|P9|1st Double-blind Treatment|Overall Study||12
2539747|NCT00606593|6225254|P8|1st Double-blind Treatment|Overall Study||11
2539748|NCT00606593|6225255|P7|1st Double-blind Treatment|Overall Study||11
2539749|NCT00606593|6225256|P6|1st Double-blind Treatment|Overall Study||11
2539750|NCT00606593|6225257|P5|1st Double-blind Treatment|Overall Study||12
2539751|NCT00606593|6225258|P4|1st Double-blind Treatment|Overall Study||11
2539752|NCT00606593|6225259|P3|1st Double-blind Treatment|Overall Study||11
2539753|NCT00606593|6225260|P2|1st Double-blind Treatment|Overall Study||11
2539754|NCT00606593|6225261|P1|1st Double-blind Treatment|Overall Study||11
2539755|NCT00606593|6225252|P10|STARTED|Overall Study|Randomized participants|11
2539756|NCT00606593|6225253|P9|STARTED|Overall Study|Randomized participants|12
2539757|NCT00606593|6225254|P8|STARTED|Overall Study|Randomized participants. One participant actually received the treatment sequence 200/P/100/ 50/25|11
2539758|NCT00606593|6225255|P7|STARTED|Overall Study|Randomized participants|11
2539759|NCT00606593|6225256|P6|STARTED|Overall Study|Randomized participants|11
2539760|NCT00606593|6225257|P5|STARTED|Overall Study|Randomized participants|12
2539761|NCT00606593|6225258|P4|STARTED|Overall Study|Randomized participants|11
2539762|NCT00606593|6225259|P3|STARTED|Overall Study|Randomized participants|11
2539763|NCT00606593|6225260|P2|STARTED|Overall Study|Randomized participants|11
2539764|NCT00606593|6225261|P1|STARTED|Overall Study|Randomized participants|11
2539765|NCT00606580|6225282|P3|NOT COMPLETED|Overall Study||22
2539766|NCT00606580|6225283|P2|NOT COMPLETED|Overall Study||3
2539767|NCT00606580|6225284|P1|NOT COMPLETED|Overall Study||2
2539768|NCT00606580|6225282|P3|COMPLETED|Overall Study||103
2539769|NCT00606580|6225283|P2|COMPLETED|Overall Study||122
2539770|NCT00606580|6225284|P1|COMPLETED|Overall Study||123
2539771|NCT00606580|6225282|P3|STARTED|Overall Study||125
2539772|NCT00606580|6225283|P2|STARTED|Overall Study||125
2539773|NCT00606580|6225284|P1|STARTED|Overall Study||125
2539774|NCT00606554|6225327|P2|NOT COMPLETED|Overall Study||0
2539775|NCT00606554|6225328|P1|NOT COMPLETED|Overall Study||0
2539776|NCT00606554|6225327|P2|COMPLETED|Overall Study||18
2539777|NCT00606554|6225328|P1|COMPLETED|Overall Study||15
2539778|NCT00606554|6225327|P2|STARTED|Overall Study||18
2539779|NCT00606554|6225328|P1|STARTED|Overall Study||15
2539780|NCT00606502|6225350|P2|NOT COMPLETED|Treatment||3
2539781|NCT00606502|6225351|P1|NOT COMPLETED|Treatment||0
2539782|NCT00606502|6225350|P2|COMPLETED|Treatment||98
2539783|NCT00606502|6225351|P1|COMPLETED|Treatment||97
2539784|NCT00606502|6225350|P2|STARTED|Treatment||101
2539785|NCT00606502|6225351|P1|STARTED|Treatment||97
2539786|NCT00606502|6225350|P2|NOT COMPLETED|Randomization||0
2539787|NCT00606502|6225351|P1|NOT COMPLETED|Randomization||3
2539788|NCT00606502|6225350|P2|COMPLETED|Randomization||101
2539789|NCT00606502|6225351|P1|COMPLETED|Randomization||97
2539790|NCT00606502|6225350|P2|STARTED|Randomization||101
2539791|NCT00606502|6225351|P1|STARTED|Randomization||100
2539792|NCT00606489|6225365|P2|NOT COMPLETED|Overall Study||0
2539793|NCT00606489|6225366|P1|NOT COMPLETED|Overall Study||0
2539794|NCT00606489|6225365|P2|COMPLETED|Overall Study||40
2539795|NCT00606489|6225366|P1|COMPLETED|Overall Study||21
2539796|NCT00606489|6225365|P2|STARTED|Overall Study||40
2539797|NCT00606489|6225366|P1|STARTED|Overall Study||21
2539798|NCT00606320|6225372|P1|NOT COMPLETED|Overall Study||37
2539799|NCT00606320|6225372|P1|COMPLETED|Overall Study||22
2539800|NCT00606320|6225372|P1|STARTED|Overall Study||59
2539801|NCT00606307|6225377|P1|NOT COMPLETED|Overall Study||11
2539802|NCT00606307|6225377|P1|COMPLETED|Overall Study||18
2539803|NCT00606307|6225377|P1|STARTED|Overall Study||29
2539804|NCT00606281|6225385|P2|NOT COMPLETED|Overall Study||66
2539805|NCT00606281|6225386|P1|NOT COMPLETED|Overall Study||56
2539806|NCT00606281|6225385|P2|COMPLETED|Overall Study||64
2539807|NCT00606281|6225386|P1|COMPLETED|Overall Study||72
2539808|NCT00606281|6225385|P2|STARTED|Overall Study||130
2539809|NCT00606281|6225386|P1|STARTED|Overall Study||128
2539810|NCT00606229|6225394|P1|NOT COMPLETED|Overall Study||22
2539811|NCT00606229|6225394|P1|COMPLETED|Overall Study||19
2539812|NCT00606229|6225394|P1|STARTED|Overall Study||41
2539813|NCT00606177|6225401|P2|NOT COMPLETED|Overall Study||25
2539814|NCT00606177|6225402|P1|NOT COMPLETED|Overall Study||27
2539815|NCT00606177|6225401|P2|COMPLETED|Overall Study||19
2539816|NCT00606177|6225402|P1|COMPLETED|Overall Study||28
2539817|NCT00606177|6225401|P2|STARTED|Overall Study||44
2539818|NCT00606177|6225402|P1|STARTED|Overall Study||55
2539819|NCT00606138|6225412|P2|NOT COMPLETED|Overall Study||0
2539820|NCT00606138|6225413|P1|NOT COMPLETED|Overall Study||0
2539821|NCT00606138|6225412|P2|COMPLETED|Overall Study||2
2539822|NCT00606138|6225413|P1|COMPLETED|Overall Study||6
2539823|NCT00606138|6225412|P2|STARTED|Overall Study||2
2539824|NCT00606138|6225413|P1|STARTED|Overall Study||6
2539825|NCT00606086|6225429|P2|NOT COMPLETED|Overall Study||15
2539826|NCT00606086|6225430|P1|NOT COMPLETED|Overall Study||12
2539827|NCT00606086|6225429|P2|COMPLETED|Overall Study||53
2539828|NCT00606086|6225430|P1|COMPLETED|Overall Study||60
2539829|NCT00606086|6225429|P2|STARTED|Overall Study||68
2539830|NCT00606086|6225430|P1|STARTED|Overall Study||72
2539831|NCT00606034|6225436|P1|NOT COMPLETED|Overall Study||1
2539832|NCT00606034|6225436|P1|COMPLETED|Overall Study||20
2539833|NCT00606034|6225436|P1|STARTED|Overall Study||21
2539834|NCT00606021|6225444|P3|NOT COMPLETED|Maintenance Phase||17
2539835|NCT00606021|6225445|P2|NOT COMPLETED|Maintenance Phase||23
2539836|NCT00606021|6225446|P1|NOT COMPLETED|Maintenance Phase||0
2539837|NCT00606021|6225444|P3|COMPLETED|Maintenance Phase||10
2539838|NCT00606021|6225445|P2|COMPLETED|Maintenance Phase||5
2539839|NCT00606021|6225446|P1|COMPLETED|Maintenance Phase||0
2539840|NCT00606021|6225444|P3|STARTED|Maintenance Phase||27
2539841|NCT00606021|6225445|P2|STARTED|Maintenance Phase||28
2539842|NCT00606021|6225446|P1|STARTED|Maintenance Phase||0
2539843|NCT00606021|6225444|P3|NOT COMPLETED|Induction Phase||0
2539844|NCT00606021|6225445|P2|NOT COMPLETED|Induction Phase||0
2539845|NCT00606021|6225446|P1|NOT COMPLETED|Induction Phase||87
2539846|NCT00606021|6225444|P3|COMPLETED|Induction Phase||0
2539847|NCT00606021|6225445|P2|COMPLETED|Induction Phase||0
2539848|NCT00606021|6225446|P1|COMPLETED|Induction Phase||19
2539849|NCT00606021|6225444|P3|STARTED|Induction Phase||0
2539850|NCT00606021|6225445|P2|STARTED|Induction Phase||0
2539851|NCT00606021|6225446|P1|STARTED|Induction Phase||106
2539852|NCT00606008|6225464|P1|NOT COMPLETED|Overall Study||5
2539853|NCT00606008|6225464|P1|COMPLETED|Overall Study||25
2539854|NCT00606008|6225464|P1|STARTED|Overall Study||30
2539855|NCT00605917|6225478|P1|NOT COMPLETED|Overall Study||79
2539856|NCT00605917|6225478|P1|COMPLETED|Overall Study||908
2539857|NCT00605917|6225478|P1|STARTED|Overall Study||987
2539858|NCT00605904|6225519|P2|NOT COMPLETED|Infusion Sessions||3
2539859|NCT00605904|6225520|P1|NOT COMPLETED|Infusion Sessions||1
2539860|NCT00605904|6225519|P2|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|13
2539861|NCT00605904|6225520|P1|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|12
2539862|NCT00605904|6225519|P2|Yohimbine Infusion|Infusion Sessions|Milestones (infusions) were not received in the same order for each subjects so are not consecutive.|15
2539863|NCT00605904|6225520|P1|Yohimbine Infusion|Infusion Sessions||12
2539864|NCT00605904|6225519|P2|mCPP Infusion|Infusion Sessions||13
2539865|NCT00605904|6225520|P1|mCPP Infusion|Infusion Sessions||12
2539866|NCT00605904|6225519|P2|Saline Infusion|Infusion Sessions||14
2539867|NCT00605904|6225520|P1|Saline Infusion|Infusion Sessions||13
2539868|NCT00605904|6225519|P2|STARTED|Infusion Sessions||16
2539869|NCT00605904|6225520|P1|STARTED|Infusion Sessions||13
2539870|NCT00605904|6225519|P2|NOT COMPLETED|Baseline Data Collection and Dosing||5
2539871|NCT00605904|6225520|P1|NOT COMPLETED|Baseline Data Collection and Dosing||0
2539872|NCT00605904|6225519|P2|COMPLETED|Baseline Data Collection and Dosing||16
2539873|NCT00605904|6225520|P1|COMPLETED|Baseline Data Collection and Dosing||13
2539874|NCT00605904|6225519|P2|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|21
2539875|NCT00605904|6225520|P1|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|13
2539876|NCT00605865|6225530|P1|NOT COMPLETED|Overall Study||115
2539877|NCT00605865|6225530|P1|COMPLETED|Overall Study||2157
2539878|NCT00605865|6225530|P1|STARTED|Overall Study||2272
2539879|NCT00605839|6225572|P3|NOT COMPLETED|Overall Study||0
2539880|NCT00605839|6225573|P2|NOT COMPLETED|Overall Study||0
2539881|NCT00605839|6225574|P1|NOT COMPLETED|Overall Study||1
2539882|NCT00605839|6225572|P3|COMPLETED|Overall Study||28
2539883|NCT00605839|6225573|P2|COMPLETED|Overall Study||37
2539884|NCT00605839|6225574|P1|COMPLETED|Overall Study|One patient would not keep to the text messaging constraints and had to be removed.|39
2539885|NCT00605839|6225572|P3|STARTED|Overall Study||28
2539886|NCT00605839|6225573|P2|STARTED|Overall Study||37
2539887|NCT00605839|6225574|P1|STARTED|Overall Study||40
2539888|NCT00605813|6225582|P1|NOT COMPLETED|Overall Study||25
2539889|NCT00605813|6225582|P1|COMPLETED|Overall Study||517
2539890|NCT00605813|6225582|P1|STARTED|Overall Study||542
2539891|NCT00605722|6225595|P1|NOT COMPLETED|Overall Study||51
2539892|NCT00605722|6225595|P1|COMPLETED|Overall Study|Completed=Completed Treatment.|0
2539893|NCT00605722|6225595|P1|STARTED|Overall Study||51
2539894|NCT00605696|6225607|P2|NOT COMPLETED|Overall Study||0
2539895|NCT00605696|6225608|P1|NOT COMPLETED|Overall Study||0
2539896|NCT00605696|6225607|P2|COMPLETED|Overall Study||11
2539897|NCT00605696|6225608|P1|COMPLETED|Overall Study||7
2539898|NCT00605696|6225607|P2|STARTED|Overall Study||11
2539899|NCT00605696|6225608|P1|STARTED|Overall Study||7
2539900|NCT00605657|6225616|P1|NOT COMPLETED|Overall Study||2
2539901|NCT00605657|6225616|P1|COMPLETED|Overall Study||3
2539902|NCT00605657|6225616|P1|STARTED|Overall Study||5
2539903|NCT00605566|6225621|P1|NOT COMPLETED|Overall Study||3
2539904|NCT00605566|6225621|P1|COMPLETED|Overall Study||19
2539905|NCT00605566|6225621|P1|STARTED|Overall Study||22
2539906|NCT00605540|6225629|P1|NOT COMPLETED|Overall Study||38
2539907|NCT00605540|6225629|P1|COMPLETED|Overall Study||95
2539908|NCT00605540|6225629|P1|STARTED|Overall Study||133
2539909|NCT00605475|6225647|P10|NOT COMPLETED|Overall Study||2
2539910|NCT00605475|6225648|P9|NOT COMPLETED|Overall Study||2
2539911|NCT00605475|6225649|P8|NOT COMPLETED|Overall Study||0
2539912|NCT00605475|6225650|P7|NOT COMPLETED|Overall Study||1
2539913|NCT00605475|6225651|P6|NOT COMPLETED|Overall Study||2
2539914|NCT00605475|6225652|P5|NOT COMPLETED|Overall Study||1
2539915|NCT00605475|6225653|P4|NOT COMPLETED|Overall Study||0
2539916|NCT00605475|6225654|P3|NOT COMPLETED|Overall Study||0
2539917|NCT00605475|6225655|P2|NOT COMPLETED|Overall Study||0
2539918|NCT00605475|6225656|P1|NOT COMPLETED|Overall Study||0
2539919|NCT00605475|6225647|P10|COMPLETED|Overall Study||8
2539920|NCT00605475|6225648|P9|COMPLETED|Overall Study||18
2539921|NCT00605475|6225649|P8|COMPLETED|Overall Study||24
2539922|NCT00605475|6225650|P7|COMPLETED|Overall Study||22
2539923|NCT00605475|6225651|P6|COMPLETED|Overall Study||22
2539924|NCT00605475|6225652|P5|COMPLETED|Overall Study||24
2539925|NCT00605475|6225653|P4|COMPLETED|Overall Study||45
2539926|NCT00605475|6225654|P3|COMPLETED|Overall Study||45
2539927|NCT00605475|6225655|P2|COMPLETED|Overall Study||5
2539928|NCT00605475|6225656|P1|COMPLETED|Overall Study||10
2539929|NCT00605475|6225647|P10|STARTED|Overall Study||10
2539930|NCT00605475|6225648|P9|STARTED|Overall Study||20
2539931|NCT00605475|6225649|P8|STARTED|Overall Study||24
2539932|NCT00605475|6225650|P7|STARTED|Overall Study||23
2539933|NCT00605475|6225651|P6|STARTED|Overall Study||24
2539934|NCT00605475|6225652|P5|STARTED|Overall Study||25
2539935|NCT00605475|6225653|P4|STARTED|Overall Study||45
2539936|NCT00605475|6225654|P3|STARTED|Overall Study||45
2539937|NCT00605475|6225655|P2|STARTED|Overall Study||5
2539938|NCT00605475|6225656|P1|STARTED|Overall Study||10
2539939|NCT00605423|6225780|P2|NOT COMPLETED|Overall Study||0
2539940|NCT00605423|6225781|P1|NOT COMPLETED|Overall Study||0
2539941|NCT00605423|6225780|P2|COMPLETED|Overall Study||2
2539942|NCT00605423|6225781|P1|COMPLETED|Overall Study||4
2539943|NCT00605423|6225780|P2|STARTED|Overall Study||2
2539944|NCT00605423|6225781|P1|STARTED|Overall Study||4
2539945|NCT00605384|6225793|P2|NOT COMPLETED|Overall Study||1
2539946|NCT00605384|6225794|P1|NOT COMPLETED|Overall Study||1
2539947|NCT00605384|6225793|P2|COMPLETED|Overall Study|study terminated early|0
2539948|NCT00605384|6225794|P1|COMPLETED|Overall Study|study terminated early|0
2539949|NCT00605384|6225793|P2|STARTED|Overall Study||1
2539950|NCT00605384|6225794|P1|STARTED|Overall Study||1
2539951|NCT00605358|6225824|P2|NOT COMPLETED|Overall Study||0
2539952|NCT00605358|6225825|P1|NOT COMPLETED|Overall Study||0
2539953|NCT00605358|6225824|P2|COMPLETED|Overall Study||80
2539954|NCT00605358|6225825|P1|COMPLETED|Overall Study||81
2539955|NCT00605358|6225824|P2|STARTED|Overall Study||80
2539956|NCT00605358|6225825|P1|STARTED|Overall Study||81
2539957|NCT00605345|6225833|P2|NOT COMPLETED|Overall Study||3
2539958|NCT00605345|6225834|P1|NOT COMPLETED|Overall Study||1
2539959|NCT00605345|6225833|P2|COMPLETED|Overall Study||22
2539960|NCT00605345|6225834|P1|COMPLETED|Overall Study||45
2539961|NCT00605345|6225833|P2|STARTED|Overall Study||25
2539962|NCT00605345|6225834|P1|STARTED|Overall Study||46
2539963|NCT00605319|6225850|P1|NOT COMPLETED|Overall Study||6
2539964|NCT00605319|6225850|P1|COMPLETED|Overall Study||11
2539965|NCT00605319|6225850|P1|STARTED|Overall Study||17
2539966|NCT00605306|6225862|P2|NOT COMPLETED|Overall Study||1
2539967|NCT00605306|6225863|P1|NOT COMPLETED|Overall Study||0
2539968|NCT00605306|6225862|P2|COMPLETED|Overall Study||13
2539969|NCT00605306|6225863|P1|COMPLETED|Overall Study||14
2539970|NCT00605306|6225862|P2|STARTED|Overall Study||14
2539971|NCT00605306|6225863|P1|STARTED|Overall Study||14
2539972|NCT00605293|6225877|P2|NOT COMPLETED|Overall Study||5
2539973|NCT00605293|6225878|P1|NOT COMPLETED|Overall Study||17
2539974|NCT00605293|6225877|P2|COMPLETED|Overall Study||31
2539975|NCT00605293|6225878|P1|COMPLETED|Overall Study||48
2539976|NCT00605293|6225877|P2|STARTED|Overall Study||36
2539977|NCT00605293|6225878|P1|STARTED|Overall Study||65
2539978|NCT00605280|6225898|P4|NOT COMPLETED|Year 3 Extension||9
2539979|NCT00605280|6225899|P3|NOT COMPLETED|Year 3 Extension||0
2539980|NCT00605280|6225900|P2|NOT COMPLETED|Year 3 Extension||0
2539981|NCT00605280|6225901|P1|NOT COMPLETED|Year 3 Extension||8
2539982|NCT00605280|6225898|P4|COMPLETED|Year 3 Extension||45
2539983|NCT00605280|6225899|P3|COMPLETED|Year 3 Extension||0
2539984|NCT00605280|6225900|P2|COMPLETED|Year 3 Extension||0
2539985|NCT00605280|6225901|P1|COMPLETED|Year 3 Extension||38
2539986|NCT00605280|6225898|P4|Received 0.3 mg Treatment|Year 3 Extension||54
2539987|NCT00605280|6225899|P3|Received 0.3 mg Treatment|Year 3 Extension||0
2539988|NCT00605280|6225900|P2|Received 0.3 mg Treatment|Year 3 Extension||0
2539989|NCT00605280|6225901|P1|Received 0.3 mg Treatment|Year 3 Extension||46
2539990|NCT00605280|6225898|P4|STARTED|Year 3 Extension||54
2539991|NCT00605280|6225899|P3|STARTED|Year 3 Extension||0
2539992|NCT00605280|6225900|P2|STARTED|Year 3 Extension||0
2539993|NCT00605280|6225901|P1|STARTED|Year 3 Extension||46
2539994|NCT00605280|6225898|P4|NOT COMPLETED|Year 2||22
2539995|NCT00605280|6225899|P3|NOT COMPLETED|Year 2||6
2539996|NCT00605280|6225900|P2|NOT COMPLETED|Year 2||6
2539997|NCT00605280|6225901|P1|NOT COMPLETED|Year 2||24
2539998|NCT00605280|6225898|P4|COMPLETED|Year 2||102
2539999|NCT00605280|6225899|P3|COMPLETED|Year 2||0
2540000|NCT00605280|6225900|P2|COMPLETED|Year 2||5
2540001|NCT00605280|6225901|P1|COMPLETED|Year 2||102
2540002|NCT00605280|6225898|P4|Received 0.3 mg Treatment|Year 2||0
2540003|NCT00605280|6225899|P3|Received 0.3 mg Treatment|Year 2||2
2540004|NCT00605280|6225900|P2|Received 0.3 mg Treatment|Year 2||3
2540005|NCT00605280|6225901|P1|Received 0.3 mg Treatment|Year 2||126
2540006|NCT00605280|6225898|P4|STARTED|Year 2||124
2540007|NCT00605280|6225899|P3|STARTED|Year 2||6
2540008|NCT00605280|6225900|P2|STARTED|Year 2||11
2540009|NCT00605280|6225901|P1|STARTED|Year 2||126
2540010|NCT00605280|6225898|P4|NOT COMPLETED|Year 1||19
2540011|NCT00605280|6225899|P3|NOT COMPLETED|Year 1||1
2540012|NCT00605280|6225900|P2|NOT COMPLETED|Year 1||11
2540013|NCT00605280|6225901|P1|NOT COMPLETED|Year 1||19
2540014|NCT00605280|6225898|P4|COMPLETED|Year 1||124
2540015|NCT00605280|6225899|P3|COMPLETED|Year 1||6
2540016|NCT00605280|6225900|P2|COMPLETED|Year 1||11
2540017|NCT00605280|6225901|P1|COMPLETED|Year 1||126
2540018|NCT00605280|6225898|P4|Received 0.3 mg Treatment|Year 1||0
2540019|NCT00605280|6225899|P3|Received 0.3 mg Treatment|Year 1||3
2540020|NCT00605280|6225900|P2|Received 0.3 mg Treatment|Year 1||13
2540021|NCT00605280|6225901|P1|Received 0.3 mg Treatment|Year 1||144
2540022|NCT00605280|6225898|P4|STARTED|Year 1||143
2540023|NCT00605280|6225899|P3|STARTED|Year 1||7
2540024|NCT00605280|6225900|P2|STARTED|Year 1||22
2540025|NCT00605280|6225901|P1|STARTED|Year 1||145
2540026|NCT00605267|6225935|P2|NOT COMPLETED|Overall Study||9
2540027|NCT00605267|6225936|P1|NOT COMPLETED|Overall Study||3
2540028|NCT00605267|6225935|P2|COMPLETED|Overall Study|Breast surgery performed|90
2540029|NCT00605267|6225936|P1|COMPLETED|Overall Study|Breast surgery performed|95
2540030|NCT00605267|6225935|P2|STARTED|Overall Study||99
2540031|NCT00605267|6225936|P1|STARTED|Overall Study||98
2540032|NCT00605202|6225974|P2|NOT COMPLETED|Second Intervention||0
2540033|NCT00605202|6225975|P1|NOT COMPLETED|Second Intervention||0
2540034|NCT00605202|6225974|P2|COMPLETED|Second Intervention||5
2540035|NCT00605202|6225975|P1|COMPLETED|Second Intervention||5
2540036|NCT00605202|6225974|P2|STARTED|Second Intervention||5
2540037|NCT00605202|6225975|P1|STARTED|Second Intervention||5
2540038|NCT00605202|6225974|P2|NOT COMPLETED|Washout Period of 3 Weeks||0
2540039|NCT00605202|6225975|P1|NOT COMPLETED|Washout Period of 3 Weeks||0
2540040|NCT00605202|6225974|P2|COMPLETED|Washout Period of 3 Weeks||5
2540041|NCT00605202|6225975|P1|COMPLETED|Washout Period of 3 Weeks||5
2540042|NCT00605202|6225974|P2|STARTED|Washout Period of 3 Weeks||5
2540043|NCT00605202|6225975|P1|STARTED|Washout Period of 3 Weeks||5
2540044|NCT00605202|6225974|P2|NOT COMPLETED|First Intervention||0
2540045|NCT00605202|6225975|P1|NOT COMPLETED|First Intervention||0
2540046|NCT00605202|6225974|P2|COMPLETED|First Intervention||5
2540047|NCT00605202|6225975|P1|COMPLETED|First Intervention||5
2540048|NCT00605202|6225974|P2|STARTED|First Intervention||5
2540049|NCT00605202|6225975|P1|STARTED|First Intervention||5
2540050|NCT00605189|6225984|P3|NOT COMPLETED|Overall Study||0
2540051|NCT00605189|6225985|P2|NOT COMPLETED|Overall Study||2
2540052|NCT00605189|6225986|P1|NOT COMPLETED|Overall Study||3
2540053|NCT00605189|6225984|P3|COMPLETED|Overall Study||9
2540054|NCT00605189|6225985|P2|COMPLETED|Overall Study||19
2540055|NCT00605189|6225986|P1|COMPLETED|Overall Study||17
2540056|NCT00605189|6225984|P3|STARTED|Overall Study||9
2540057|NCT00605189|6225985|P2|STARTED|Overall Study||21
2540058|NCT00605189|6225986|P1|STARTED|Overall Study||20
2540059|NCT00605176|6225997|P3|NOT COMPLETED|Overall Study||9
2540060|NCT00605176|6225998|P2|NOT COMPLETED|Overall Study||6
2540061|NCT00605176|6225999|P1|NOT COMPLETED|Overall Study||11
2540062|NCT00605176|6225997|P3|COMPLETED|Overall Study||150
2540063|NCT00605176|6225998|P2|COMPLETED|Overall Study||154
2540064|NCT00605176|6225999|P1|COMPLETED|Overall Study||149
2540065|NCT00605176|6225997|P3|STARTED|Overall Study||159
2540066|NCT00605176|6225998|P2|STARTED|Overall Study||160
2540067|NCT00605176|6225999|P1|STARTED|Overall Study||160
2540068|NCT00605150|6226016|P1|NOT COMPLETED|Overall Study||1
2540069|NCT00605150|6226016|P1|COMPLETED|Overall Study||10
2540070|NCT00605150|6226016|P1|STARTED|Overall Study|11 started|11
2540071|NCT00605085|6226023|P2|NOT COMPLETED|Overall Study||25
2540072|NCT00605085|6226024|P1|NOT COMPLETED|Overall Study||50
2540073|NCT00605085|6226023|P2|COMPLETED|Overall Study||638
2540074|NCT00605085|6226024|P1|COMPLETED|Overall Study||1962
2540075|NCT00605085|6226023|P2|STARTED|Overall Study||663
2540076|NCT00605085|6226024|P1|STARTED|Overall Study||2012
2540077|NCT00605072|6226033|P3|NOT COMPLETED|Overall Study||4
2540078|NCT00605072|6226034|P2|NOT COMPLETED|Overall Study||11
2540079|NCT00605072|6226035|P1|NOT COMPLETED|Overall Study||7
2540080|NCT00605072|6226033|P3|COMPLETED|Overall Study||11
2540081|NCT00605072|6226034|P2|COMPLETED|Overall Study||9
2540082|NCT00605072|6226035|P1|COMPLETED|Overall Study||11
2540083|NCT00605072|6226033|P3|STARTED|Overall Study||15
2540084|NCT00605072|6226034|P2|STARTED|Overall Study||20
2540085|NCT00605072|6226035|P1|STARTED|Overall Study||18
2540086|NCT00605033|6226057|P2|NOT COMPLETED|Overall Study||8
2540087|NCT00605033|6226058|P1|NOT COMPLETED|Overall Study||7
2540088|NCT00605033|6226057|P2|COMPLETED|Overall Study||90
2540089|NCT00605033|6226058|P1|COMPLETED|Overall Study||136
2540090|NCT00605033|6226057|P2|STARTED|Overall Study|One participant was randomized but withdrew before taking any study medication (treated n=97).|98
2540091|NCT00605033|6226058|P1|STARTED|Overall Study||143
2540092|NCT00604968|6226064|P1|NOT COMPLETED|Overall Study||0
2540093|NCT00604968|6226064|P1|COMPLETED|Overall Study|Due to the nature of study, all subjects receiving drug were considered to have completed.|25
2540094|NCT00604968|6226064|P1|STARTED|Overall Study||25
2540095|NCT00604890|6226081|P4|NOT COMPLETED|Overall Study||4
2540096|NCT00604890|6226082|P3|NOT COMPLETED|Overall Study||1
2540097|NCT00604890|6226083|P2|NOT COMPLETED|Overall Study||0
2540098|NCT00604890|6226084|P1|NOT COMPLETED|Overall Study||3
2540099|NCT00604890|6226081|P4|COMPLETED|Overall Study||42
2540100|NCT00604890|6226082|P3|COMPLETED|Overall Study||47
2540101|NCT00604890|6226083|P2|COMPLETED|Overall Study||45
2540102|NCT00604890|6226084|P1|COMPLETED|Overall Study||44
2540103|NCT00604890|6226081|P4|STARTED|Overall Study||46
2540104|NCT00604890|6226082|P3|STARTED|Overall Study||48
2540105|NCT00604890|6226083|P2|STARTED|Overall Study||45
2540106|NCT00604890|6226084|P1|STARTED|Overall Study||47
2540107|NCT00604825|6226102|P4|NOT COMPLETED|Overall Study||11
2540108|NCT00604825|6226103|P3|NOT COMPLETED|Overall Study||16
2540109|NCT00604825|6226104|P2|NOT COMPLETED|Overall Study||15
2540110|NCT00604825|6226105|P1|NOT COMPLETED|Overall Study||9
2540111|NCT00604825|6226102|P4|COMPLETED|Overall Study||79
2540112|NCT00604825|6226103|P3|COMPLETED|Overall Study||73
2540113|NCT00604825|6226104|P2|COMPLETED|Overall Study||72
2540114|NCT00604825|6226105|P1|COMPLETED|Overall Study||81
2540115|NCT00604825|6226102|P4|STARTED|Overall Study||90
2540116|NCT00604825|6226103|P3|STARTED|Overall Study||89
2540117|NCT00604825|6226104|P2|STARTED|Overall Study||87
2540118|NCT00604825|6226105|P1|STARTED|Overall Study||90
2540119|NCT00604812|6226306|P6|NOT COMPLETED|Overall Study||0
2540120|NCT00604812|6226307|P5|NOT COMPLETED|Overall Study||0
2540121|NCT00604812|6226308|P4|NOT COMPLETED|Overall Study||0
2540122|NCT00604812|6226309|P3|NOT COMPLETED|Overall Study||0
2540123|NCT00604812|6226310|P2|NOT COMPLETED|Overall Study||0
2540124|NCT00604812|6226311|P1|NOT COMPLETED|Overall Study||0
2540125|NCT00604812|6226306|P6|COMPLETED|Overall Study||1
2540126|NCT00604812|6226307|P5|COMPLETED|Overall Study||5
2540127|NCT00604812|6226308|P4|COMPLETED|Overall Study||3
2540128|NCT00604812|6226309|P3|COMPLETED|Overall Study||10
2540129|NCT00604812|6226310|P2|COMPLETED|Overall Study||3
2540130|NCT00604812|6226311|P1|COMPLETED|Overall Study||9
2540131|NCT00604812|6226306|P6|STARTED|Overall Study||1
2540132|NCT00604812|6226307|P5|STARTED|Overall Study||5
2540133|NCT00604812|6226308|P4|STARTED|Overall Study||3
2540134|NCT00604812|6226309|P3|STARTED|Overall Study||10
2540135|NCT00604812|6226310|P2|STARTED|Overall Study||3
2540136|NCT00604812|6226311|P1|STARTED|Overall Study||9
2540137|NCT00604786|6226333|P2|NOT COMPLETED|Overall Study||0
2540138|NCT00604786|6226334|P1|NOT COMPLETED|Overall Study||2
2540139|NCT00604786|6226333|P2|COMPLETED|Overall Study||4
2540140|NCT00604786|6226334|P1|COMPLETED|Overall Study||12
2540141|NCT00604786|6226333|P2|STARTED|Overall Study||4
2540142|NCT00604786|6226334|P1|STARTED|Overall Study||14
2540143|NCT00604721|6226340|P1|NOT COMPLETED|Overall Study||2
2540144|NCT00604721|6226340|P1|COMPLETED|Overall Study|2 patients failed to complete a full cycle of therapy.|17
2540145|NCT00604721|6226340|P1|STARTED|Overall Study||19
2540146|NCT00604708|6226348|P2|NOT COMPLETED|Overall Study||40
2540147|NCT00604708|6226349|P1|NOT COMPLETED|Overall Study||31
2540148|NCT00604708|6226348|P2|COMPLETED|Overall Study||397
2540149|NCT00604708|6226349|P1|COMPLETED|Overall Study||399
2540150|NCT00604708|6226348|P2|STARTED|Overall Study||437
2540151|NCT00604708|6226349|P1|STARTED|Overall Study||430
2540152|NCT00604695|6226359|P2|NOT COMPLETED|Overall Study||4
2540153|NCT00604695|6226360|P1|NOT COMPLETED|Overall Study||0
2540154|NCT00604695|6226359|P2|COMPLETED|Overall Study||16
2540155|NCT00604695|6226360|P1|COMPLETED|Overall Study||20
2540156|NCT00604695|6226359|P2|STARTED|Overall Study||20
2540157|NCT00604695|6226360|P1|STARTED|Overall Study||20
2540158|NCT00604669|6226382|P1|NOT COMPLETED|Overall Study||7
2540159|NCT00604669|6226382|P1|COMPLETED|Overall Study||163
2540160|NCT00604669|6226382|P1|STARTED|Overall Study||170
2540161|NCT00604565|6226388|P2|NOT COMPLETED|Overall Study||3
2540162|NCT00604565|6226389|P1|NOT COMPLETED|Overall Study||0
2540163|NCT00604565|6226388|P2|COMPLETED|Overall Study||4
2540164|NCT00604565|6226389|P1|COMPLETED|Overall Study||4
2540165|NCT00604565|6226388|P2|STARTED|Overall Study||7
2540166|NCT00604565|6226389|P1|STARTED|Overall Study||4
2540167|NCT00604552|6226399|P2|NOT COMPLETED|Overall Study||0
2540168|NCT00604552|6226400|P1|NOT COMPLETED|Overall Study||0
2540169|NCT00604552|6226399|P2|COMPLETED|Overall Study||160
2540170|NCT00604552|6226400|P1|COMPLETED|Overall Study||189
2540171|NCT00604552|6226399|P2|STARTED|Overall Study||160
2540172|NCT00604552|6226400|P1|STARTED|Overall Study||189
2540173|NCT00604500|6226408|P1|NOT COMPLETED|Overall Study||11
2540174|NCT00604500|6226408|P1|COMPLETED|Overall Study|There were 233 participants who took at least 90% of the labeled actuations (Completer Population).|261
2540175|NCT00604500|6226408|P1|STARTED|Overall Study||272
2540176|NCT00604461|6226415|P1|NOT COMPLETED|Overall Study||1
2540177|NCT00604461|6226415|P1|COMPLETED|Overall Study|Death within 30 days of treatment occurred in 1 patient.|12
2540178|NCT00604461|6226415|P1|STARTED|Overall Study||13
2540179|NCT00604383|6226422|P2|NOT COMPLETED|Overall Study||84
2540180|NCT00604383|6226423|P1|NOT COMPLETED|Overall Study||87
2540181|NCT00604383|6226422|P2|COMPLETED|Overall Study||256
2540182|NCT00604383|6226423|P1|COMPLETED|Overall Study||258
2540183|NCT00604383|6226422|P2|Received Extended Treatment|Overall Study||141
2540184|NCT00604383|6226423|P1|Received Extended Treatment|Overall Study||136
2540185|NCT00604383|6226422|P2|Received at Least 1 Dose of Study Drug|Overall Study||340
2540186|NCT00604383|6226423|P1|Received at Least 1 Dose of Study Drug|Overall Study||345
2540187|NCT00604383|6226422|P2|STARTED|Overall Study||340
2540188|NCT00604383|6226423|P1|STARTED|Overall Study||345
2540189|NCT00604279|6226439|P2|NOT COMPLETED|Overall Study||38
2540190|NCT00604279|6226440|P1|NOT COMPLETED|Overall Study||64
2540191|NCT00604279|6226439|P2|COMPLETED|Overall Study||185
2540192|NCT00604279|6226440|P1|COMPLETED|Overall Study||165
2540193|NCT00604279|6226439|P2|STARTED|Overall Study||223
2540194|NCT00604279|6226440|P1|STARTED|Overall Study||229
2540195|NCT00604214|6226456|P2|NOT COMPLETED|Day 91 to Day 180||32
2540196|NCT00604214|6226457|P1|NOT COMPLETED|Day 91 to Day 180||26
2540197|NCT00604214|6226456|P2|COMPLETED|Day 91 to Day 180||521
2540198|NCT00604214|6226457|P1|COMPLETED|Day 91 to Day 180||529
2540199|NCT00604214|6226456|P2|STARTED|Day 91 to Day 180||553
2540200|NCT00604214|6226457|P1|STARTED|Day 91 to Day 180||555
2540201|NCT00604214|6226456|P2|NOT COMPLETED|Day 29 to Day 90||79
2540202|NCT00604214|6226457|P1|NOT COMPLETED|Day 29 to Day 90||68
2540203|NCT00604214|6226456|P2|COMPLETED|Day 29 to Day 90||553
2540204|NCT00604214|6226457|P1|COMPLETED|Day 29 to Day 90||555
2540205|NCT00604214|6226456|P2|STARTED|Day 29 to Day 90||632
2540206|NCT00604214|6226457|P1|STARTED|Day 29 to Day 90||623
2540207|NCT00604214|6226456|P2|NOT COMPLETED|Baseline to Day 28||213
2540208|NCT00604214|6226457|P1|NOT COMPLETED|Baseline to Day 28||228
2540209|NCT00604214|6226456|P2|COMPLETED|Baseline to Day 28||632
2540210|NCT00604214|6226457|P1|COMPLETED|Baseline to Day 28||623
2540211|NCT00604214|6226456|P2|Received Study Drug|Baseline to Day 28||833
2540212|NCT00604214|6226457|P1|Received Study Drug|Baseline to Day 28||833
2540213|NCT00604214|6226456|P2|STARTED|Baseline to Day 28||845
2540214|NCT00604214|6226457|P1|STARTED|Baseline to Day 28||851
2540215|NCT00604188|6226489|P2|NOT COMPLETED|Overall Study||25
2540216|NCT00604188|6226490|P1|NOT COMPLETED|Overall Study||27
2540217|NCT00604188|6226489|P2|COMPLETED|Overall Study||70
2540218|NCT00604188|6226490|P1|COMPLETED|Overall Study||66
2540219|NCT00604188|6226489|P2|STARTED|Overall Study|The ITT population for Subutex-to-Suboxone Induction is 94 participants|95
2540220|NCT00604188|6226490|P1|STARTED|Overall Study||93
2540221|NCT00604175|6226513|P3|NOT COMPLETED|Week 29 Through Week 72||4
2540222|NCT00604175|6226514|P2|NOT COMPLETED|Week 29 Through Week 72||7
2540223|NCT00604175|6226515|P1|NOT COMPLETED|Week 29 Through Week 72||12
2540224|NCT00604175|6226513|P3|COMPLETED|Week 29 Through Week 72||89
2540225|NCT00604175|6226514|P2|COMPLETED|Week 29 Through Week 72||85
2540226|NCT00604175|6226515|P1|COMPLETED|Week 29 Through Week 72||108
2540227|NCT00604175|6226513|P3|STARTED|Week 29 Through Week 72||93
2540228|NCT00604175|6226514|P2|STARTED|Week 29 Through Week 72||92
2540229|NCT00604175|6226515|P1|STARTED|Week 29 Through Week 72||120
2540230|NCT00604175|6226513|P3|NOT COMPLETED|Entry Through Week 28||1
2540231|NCT00604175|6226514|P2|NOT COMPLETED|Entry Through Week 28||3
2540232|NCT00604175|6226515|P1|NOT COMPLETED|Entry Through Week 28||10
2540233|NCT00604175|6226513|P3|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|93
2540234|NCT00604175|6226514|P2|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|92
2540235|NCT00604175|6226515|P1|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|120
2540236|NCT00604175|6226513|P3|STARTED|Entry Through Week 28||94
2540237|NCT00604175|6226514|P2|STARTED|Entry Through Week 28||95
2540238|NCT00604175|6226515|P1|STARTED|Entry Through Week 28||130
2540239|NCT00604162|6226568|P1|NOT COMPLETED|Overall Study||4
2540240|NCT00604162|6226568|P1|COMPLETED|Overall Study||328
2540241|NCT00604162|6226568|P1|STARTED|Overall Study||332
2540242|NCT00604045|6226581|P2|NOT COMPLETED|Overall Study||1
2540243|NCT00604045|6226582|P1|NOT COMPLETED|Overall Study||1
2540244|NCT00604045|6226581|P2|COMPLETED|Overall Study||9
2540245|NCT00604045|6226582|P1|COMPLETED|Overall Study||14
2540246|NCT00604045|6226581|P2|STARTED|Overall Study||10
2540247|NCT00604045|6226582|P1|STARTED|Overall Study||15
2540248|NCT00604019|6226590|P2|NOT COMPLETED|Overall Study||0
2540249|NCT00604019|6226591|P1|NOT COMPLETED|Overall Study||0
2540250|NCT00604019|6226590|P2|COMPLETED|Overall Study||118
2540251|NCT00604019|6226591|P1|COMPLETED|Overall Study||134
2540252|NCT00604019|6226590|P2|STARTED|Overall Study||118
2540253|NCT00604019|6226591|P1|STARTED|Overall Study||134
2540254|NCT00603993|6226597|P1|NOT COMPLETED|Overall Study||20
2540255|NCT00603993|6226597|P1|COMPLETED|Overall Study||68
2540256|NCT00603993|6226597|P1|STARTED|Overall Study||88
2540257|NCT00603980|6226610|P1|NOT COMPLETED|Main Study||1
2540258|NCT00603980|6226610|P1|COMPLETED|Main Study||14
2540259|NCT00603980|6226610|P1|STARTED|Main Study||15
2540260|NCT00603980|6226610|P1|NOT COMPLETED|Study Qualification||16
2540261|NCT00603980|6226610|P1|COMPLETED|Study Qualification||15
2540262|NCT00603980|6226610|P1|STARTED|Study Qualification||31
2540263|NCT00603915|6226726|P1|NOT COMPLETED|Overall Study||1
2540264|NCT00603915|6226726|P1|COMPLETED|Overall Study||19
2540265|NCT00603915|6226726|P1|STARTED|Overall Study||20
2540266|NCT00603902|6226734|P3|NOT COMPLETED|Overall Study||769
2540267|NCT00603902|6226735|P2|NOT COMPLETED|Overall Study||686
2540268|NCT00603902|6226736|P1|NOT COMPLETED|Overall Study||329
2540269|NCT00603902|6226734|P3|COMPLETED|Overall Study||834
2540270|NCT00603902|6226735|P2|COMPLETED|Overall Study||917
2540271|NCT00603902|6226736|P1|COMPLETED|Overall Study||473
2540272|NCT00603902|6226734|P3|STARTED|Overall Study||1603
2540273|NCT00603902|6226735|P2|STARTED|Overall Study||1603
2540274|NCT00603902|6226736|P1|STARTED|Overall Study||802
2540275|NCT00603889|6226747|P1|NOT COMPLETED|Overall Study||0
2540276|NCT00603889|6226747|P1|COMPLETED|Overall Study||12
2540277|NCT00603889|6226747|P1|STARTED|Overall Study||12
2540278|NCT00603837|6226756|P2|NOT COMPLETED|Overall Study||0
2540279|NCT00603837|6226757|P1|NOT COMPLETED|Overall Study||3
2540280|NCT00603837|6226756|P2|COMPLETED|Overall Study||19
2540281|NCT00603837|6226757|P1|COMPLETED|Overall Study||17
2540282|NCT00603837|6226756|P2|STARTED|Overall Study||19
2540283|NCT00603837|6226757|P1|STARTED|Overall Study||20
2540284|NCT00603798|6226766|P3|NOT COMPLETED|Overall Study||10
2540285|NCT00603798|6226767|P2|NOT COMPLETED|Overall Study||7
2540286|NCT00603798|6226768|P1|NOT COMPLETED|Overall Study||10
2540287|NCT00603798|6226766|P3|COMPLETED|Overall Study||154
2540288|NCT00603798|6226767|P2|COMPLETED|Overall Study||157
2540289|NCT00603798|6226768|P1|COMPLETED|Overall Study||152
2540290|NCT00603798|6226766|P3|STARTED|Overall Study||164
2540291|NCT00603798|6226767|P2|STARTED|Overall Study||164
2540292|NCT00603798|6226768|P1|STARTED|Overall Study||162
2540293|NCT00603746|6226791|P6|NOT COMPLETED|Overall Study||13
2540294|NCT00603746|6226792|P5|NOT COMPLETED|Overall Study||17
2540295|NCT00603746|6226793|P4|NOT COMPLETED|Overall Study||13
2540296|NCT00603746|6226794|P3|NOT COMPLETED|Overall Study||8
2540297|NCT00603746|6226795|P2|NOT COMPLETED|Overall Study||18
2540298|NCT00603746|6226796|P1|NOT COMPLETED|Overall Study||38
2540299|NCT00603746|6226791|P6|COMPLETED|Overall Study||97
2540300|NCT00603746|6226792|P5|COMPLETED|Overall Study||85
2540301|NCT00603746|6226793|P4|COMPLETED|Overall Study||94
2540302|NCT00603746|6226794|P3|COMPLETED|Overall Study||93
2540303|NCT00603746|6226795|P2|COMPLETED|Overall Study||81
2540304|NCT00603746|6226796|P1|COMPLETED|Overall Study||65
2540305|NCT00603746|6226791|P6|STARTED|Overall Study||110
2540306|NCT00603746|6226792|P5|STARTED|Overall Study||102
2540307|NCT00603746|6226793|P4|STARTED|Overall Study||107
2540308|NCT00603746|6226794|P3|STARTED|Overall Study||101
2540309|NCT00603746|6226795|P2|STARTED|Overall Study||99
2540310|NCT00603746|6226796|P1|STARTED|Overall Study||103
2540311|NCT00603733|6226944|P2|NOT COMPLETED|Maintenance Phase ITT||16
2540312|NCT00603733|6226945|P1|NOT COMPLETED|Maintenance Phase ITT||10
2540313|NCT00603733|6226944|P2|COMPLETED|Maintenance Phase ITT||66
2540314|NCT00603733|6226945|P1|COMPLETED|Maintenance Phase ITT||61
2540315|NCT00603733|6226944|P2|STARTED|Maintenance Phase ITT||82
2540397|NCT00603525|6227064|P1|STARTED|OL Treatment Period (120 Weeks)||0
2540316|NCT00603733|6226945|P1|STARTED|Maintenance Phase ITT|Note:82 subjects randomized at Active phase & 71 at Run-In phase progressed to the maintenance phase|71
2540317|NCT00603733|6226944|P2|NOT COMPLETED|Run-In Phase - 4 Weeks||13
2540318|NCT00603733|6226945|P1|NOT COMPLETED|Run-In Phase - 4 Weeks||14
2540319|NCT00603733|6226944|P2|COMPLETED|Run-In Phase - 4 Weeks||36
2540320|NCT00603733|6226945|P1|COMPLETED|Run-In Phase - 4 Weeks||35
2540321|NCT00603733|6226944|P2|STARTED|Run-In Phase - 4 Weeks||49
2540322|NCT00603733|6226945|P1|STARTED|Run-In Phase - 4 Weeks|Note: Of the 98 subjects randomized at Run-In, 71 progressed into the maintenance phase.|49
2540323|NCT00603733|6226944|P2|NOT COMPLETED|Active Phase ITT||17
2540324|NCT00603733|6226945|P1|NOT COMPLETED|Active Phase ITT||11
2540325|NCT00603733|6226944|P2|COMPLETED|Active Phase ITT||78
2540326|NCT00603733|6226945|P1|COMPLETED|Active Phase ITT||84
2540327|NCT00603733|6226944|P2|STARTED|Active Phase ITT||95
2540328|NCT00603733|6226945|P1|STARTED|Active Phase ITT|Note: a total of 190 new participants were enrolled and randomized in the Active Phase|95
2540329|NCT00603720|6226960|P5|NOT COMPLETED|Overall Study||0
2540330|NCT00603720|6226961|P4|NOT COMPLETED|Overall Study||0
2540331|NCT00603720|6226962|P3|NOT COMPLETED|Overall Study||0
2540332|NCT00603720|6226963|P2|NOT COMPLETED|Overall Study||0
2540333|NCT00603720|6226964|P1|NOT COMPLETED|Overall Study||0
2540334|NCT00603720|6226960|P5|COMPLETED|Overall Study||12
2540335|NCT00603720|6226961|P4|COMPLETED|Overall Study||10
2540336|NCT00603720|6226962|P3|COMPLETED|Overall Study||12
2540337|NCT00603720|6226963|P2|COMPLETED|Overall Study||10
2540338|NCT00603720|6226964|P1|COMPLETED|Overall Study||10
2540339|NCT00603720|6226960|P5|STARTED|Overall Study||12
2540340|NCT00603720|6226961|P4|STARTED|Overall Study||10
2540341|NCT00603720|6226962|P3|STARTED|Overall Study||12
2540342|NCT00603720|6226963|P2|STARTED|Overall Study||10
2540343|NCT00603720|6226964|P1|STARTED|Overall Study||10
2540344|NCT00603642|6226978|P2|NOT COMPLETED|Overall Study||0
2540345|NCT00603642|6226979|P1|NOT COMPLETED|Overall Study||0
2540346|NCT00603642|6226978|P2|COMPLETED|Overall Study||22
2540347|NCT00603642|6226979|P1|COMPLETED|Overall Study||12
2540348|NCT00603642|6226978|P2|STARTED|Overall Study||22
2540349|NCT00603642|6226979|P1|STARTED|Overall Study||12
2540350|NCT00603590|6226995|P2|NOT COMPLETED|Overall Study||51
2540351|NCT00603590|6226996|P1|NOT COMPLETED|Overall Study||76
2540352|NCT00603590|6226995|P2|COMPLETED|Overall Study||183
2540353|NCT00603590|6226996|P1|COMPLETED|Overall Study||165
2540354|NCT00603590|6226995|P2|Eight Months|Overall Study||194
2540355|NCT00603590|6226996|P1|Eight Months|Overall Study||178
2540356|NCT00603590|6226995|P2|Four Months|Overall Study||200
2540357|NCT00603590|6226996|P1|Four Months|Overall Study||187
2540358|NCT00603590|6226995|P2|One Month|Overall Study||212
2540359|NCT00603590|6226996|P1|One Month|Overall Study||204
2540360|NCT00603590|6226995|P2|STARTED|Overall Study||234
2540361|NCT00603590|6226996|P1|STARTED|Overall Study||241
2540362|NCT00603564|6227008|P2|NOT COMPLETED|Overall Study||0
2540363|NCT00603564|6227009|P1|NOT COMPLETED|Overall Study||0
2540364|NCT00603564|6227008|P2|COMPLETED|Overall Study|February 2008|27
2540365|NCT00603564|6227009|P1|COMPLETED|Overall Study|February 2008|20
2540366|NCT00603564|6227008|P2|STARTED|Overall Study|January 2006|27
2540367|NCT00603564|6227009|P1|STARTED|Overall Study|January 2006|20
2540368|NCT00603538|6227020|P3|NOT COMPLETED|Overall Study||2
2540369|NCT00603538|6227021|P2|NOT COMPLETED|Overall Study||4
2540370|NCT00603538|6227022|P1|NOT COMPLETED|Overall Study||3
2540371|NCT00603538|6227020|P3|COMPLETED|Overall Study||4
2540372|NCT00603538|6227021|P2|COMPLETED|Overall Study||3
2540373|NCT00603538|6227022|P1|COMPLETED|Overall Study||3
2540374|NCT00603538|6227020|P3|STARTED|Overall Study||6
2540375|NCT00603538|6227021|P2|STARTED|Overall Study|Including one participant who discontinued from the study prior to CP-751,871 administration.|7
2540376|NCT00603538|6227022|P1|STARTED|Overall Study||6
2540377|NCT00603525|6227062|P3|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||111
2540378|NCT00603525|6227063|P2|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
2540379|NCT00603525|6227064|P1|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
2540380|NCT00603525|6227062|P3|COMPLETED|Follow-up Period (Approximately 2 Years)||13
2540381|NCT00603525|6227063|P2|COMPLETED|Follow-up Period (Approximately 2 Years)||0
2540382|NCT00603525|6227064|P1|COMPLETED|Follow-up Period (Approximately 2 Years)||0
2540383|NCT00603525|6227062|P3|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)|As par. were not on active drug during the Follow-up Period, withdrawal reasons were not collected.|111
2540384|NCT00603525|6227063|P2|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
2540385|NCT00603525|6227064|P1|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
2540386|NCT00603525|6227062|P3|STARTED|Follow-up Period (Approximately 2 Years)|124 participants (par) completing/withdrawing from the DB or OL Periods attended >=1 follow-up visit|124
2540387|NCT00603525|6227063|P2|STARTED|Follow-up Period (Approximately 2 Years)||0
2540388|NCT00603525|6227064|P1|STARTED|Follow-up Period (Approximately 2 Years)||0
2540389|NCT00603525|6227062|P3|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
2540390|NCT00603525|6227063|P2|NOT COMPLETED|OL Treatment Period (120 Weeks)||112
2540391|NCT00603525|6227064|P1|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
2540392|NCT00603525|6227062|P3|COMPLETED|OL Treatment Period (120 Weeks)||0
2540393|NCT00603525|6227063|P2|COMPLETED|OL Treatment Period (120 Weeks)||13
2540394|NCT00603525|6227064|P1|COMPLETED|OL Treatment Period (120 Weeks)||0
2540395|NCT00603525|6227062|P3|STARTED|OL Treatment Period (120 Weeks)||0
2540396|NCT00603525|6227063|P2|STARTED|OL Treatment Period (120 Weeks)|61 participants received OFA during the DB Period; 64 received placebo during the DB Period.|125
2540398|NCT00603525|6227062|P3|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
2540399|NCT00603525|6227063|P2|NOT COMPLETED|DB Treatment Period (24 Weeks)||22
2540400|NCT00603525|6227064|P1|NOT COMPLETED|DB Treatment Period (24 Weeks)||17
2540401|NCT00603525|6227062|P3|COMPLETED|DB Treatment Period (24 Weeks)||0
2540402|NCT00603525|6227063|P2|COMPLETED|DB Treatment Period (24 Weeks)||63
2540403|NCT00603525|6227064|P1|COMPLETED|DB Treatment Period (24 Weeks)||67
2540404|NCT00603525|6227062|P3|STARTED|DB Treatment Period (24 Weeks)||0
2540405|NCT00603525|6227063|P2|STARTED|DB Treatment Period (24 Weeks)||85
2540406|NCT00603525|6227064|P1|STARTED|DB Treatment Period (24 Weeks)||84
2540407|NCT00603512|6227196|P5|NOT COMPLETED|Overall Study||5
2540408|NCT00603512|6227197|P4|NOT COMPLETED|Overall Study||7
2540409|NCT00603512|6227198|P3|NOT COMPLETED|Overall Study||5
2540410|NCT00603512|6227199|P2|NOT COMPLETED|Overall Study||5
2540411|NCT00603512|6227200|P1|NOT COMPLETED|Overall Study||2
2540412|NCT00603512|6227196|P5|COMPLETED|Overall Study||23
2540413|NCT00603512|6227197|P4|COMPLETED|Overall Study||21
2540414|NCT00603512|6227198|P3|COMPLETED|Overall Study||23
2540415|NCT00603512|6227199|P2|COMPLETED|Overall Study||23
2540416|NCT00603512|6227200|P1|COMPLETED|Overall Study||26
2540417|NCT00603512|6227196|P5|Treated|Overall Study||28
2540418|NCT00603512|6227197|P4|Treated|Overall Study||26
2540419|NCT00603512|6227198|P3|Treated|Overall Study||27
2540420|NCT00603512|6227199|P2|Treated|Overall Study||27
2540421|NCT00603512|6227200|P1|Treated|Overall Study||28
2540422|NCT00603512|6227196|P5|STARTED|Overall Study||28
2540423|NCT00603512|6227197|P4|STARTED|Overall Study||28
2540424|NCT00603512|6227198|P3|STARTED|Overall Study||28
2540425|NCT00603512|6227199|P2|STARTED|Overall Study||28
2540426|NCT00603512|6227200|P1|STARTED|Overall Study||28
2540427|NCT00603473|6227342|P1|NOT COMPLETED|Overall Study||9
2540428|NCT00603473|6227342|P1|COMPLETED|Overall Study||80
2540429|NCT00603473|6227342|P1|STARTED|Overall Study||89
2540430|NCT00603447|6227355|P7|NOT COMPLETED|Overall Study||24
2540431|NCT00603447|6227356|P6|NOT COMPLETED|Overall Study||2
2540432|NCT00603447|6227357|P5|NOT COMPLETED|Overall Study||5
2540433|NCT00603447|6227358|P4|NOT COMPLETED|Overall Study||2
2540434|NCT00603447|6227359|P3|NOT COMPLETED|Overall Study||2
2540435|NCT00603447|6227360|P2|NOT COMPLETED|Overall Study||3
2540436|NCT00603447|6227361|P1|NOT COMPLETED|Overall Study||0
2540437|NCT00603447|6227355|P7|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|20
2540438|NCT00603447|6227356|P6|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
2540439|NCT00603447|6227357|P5|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|1
2540440|NCT00603447|6227358|P4|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|4
2540441|NCT00603447|6227359|P3|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
2540442|NCT00603447|6227360|P2|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|3
2540443|NCT00603447|6227361|P1|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
2540444|NCT00603447|6227355|P7|STARTED|Overall Study||44
2540445|NCT00603447|6227356|P6|STARTED|Overall Study||8
2540446|NCT00603447|6227357|P5|STARTED|Overall Study||6
2540447|NCT00603447|6227358|P4|STARTED|Overall Study||6
2540448|NCT00603447|6227359|P3|STARTED|Overall Study||8
2540449|NCT00603447|6227360|P2|STARTED|Overall Study||6
2540450|NCT00603447|6227361|P1|STARTED|Overall Study||6
2540451|NCT00603408|6227383|P1|NOT COMPLETED|Overall Study||0
2540452|NCT00603408|6227383|P1|COMPLETED|Overall Study||5
2540453|NCT00603408|6227383|P1|STARTED|Overall Study||5
2540454|NCT00603382|6227400|P6|NOT COMPLETED|Overall Study||18
2540455|NCT00603382|6227401|P5|NOT COMPLETED|Overall Study||9
2540456|NCT00603382|6227402|P4|NOT COMPLETED|Overall Study||12
2540457|NCT00603382|6227403|P3|NOT COMPLETED|Overall Study||9
2540458|NCT00603382|6227404|P2|NOT COMPLETED|Overall Study||14
2540459|NCT00603382|6227405|P1|NOT COMPLETED|Overall Study||18
2540460|NCT00603382|6227400|P6|COMPLETED|Overall Study||84
2540461|NCT00603382|6227401|P5|COMPLETED|Overall Study||86
2540462|NCT00603382|6227402|P4|COMPLETED|Overall Study||98
2540463|NCT00603382|6227403|P3|COMPLETED|Overall Study||91
2540464|NCT00603382|6227404|P2|COMPLETED|Overall Study||83
2540465|NCT00603382|6227405|P1|COMPLETED|Overall Study||76
2540466|NCT00603382|6227400|P6|STARTED|Overall Study||102
2540467|NCT00603382|6227401|P5|STARTED|Overall Study||95
2540468|NCT00603382|6227402|P4|STARTED|Overall Study||110
2540469|NCT00603382|6227403|P3|STARTED|Overall Study||100
2540470|NCT00603382|6227404|P2|STARTED|Overall Study||97
2540471|NCT00603382|6227405|P1|STARTED|Overall Study||94
2540472|NCT00603304|6227553|P2|NOT COMPLETED|Overall Study||31
2540473|NCT00603304|6227554|P1|NOT COMPLETED|Overall Study||32
2540474|NCT00603304|6227553|P2|COMPLETED|Overall Study||155
2540475|NCT00603304|6227554|P1|COMPLETED|Overall Study||151
2540476|NCT00603304|6227553|P2|STARTED|Overall Study||186
2540477|NCT00603304|6227554|P1|STARTED|Overall Study||183
2540478|NCT00603291|6227591|P3|NOT COMPLETED|Overall Study||96
2540479|NCT00603291|6227592|P2|NOT COMPLETED|Overall Study||87
2540480|NCT00603291|6227593|P1|NOT COMPLETED|Overall Study||20
2540481|NCT00603291|6227591|P3|COMPLETED|Overall Study||157
2540482|NCT00603291|6227592|P2|COMPLETED|Overall Study||169
2540483|NCT00603291|6227593|P1|COMPLETED|Overall Study||75
2540484|NCT00603291|6227591|P3|STARTED|Overall Study||253
2540485|NCT00603291|6227592|P2|STARTED|Overall Study||256
2540486|NCT00603291|6227593|P1|STARTED|Overall Study||95
2540487|NCT00603278|6227610|P6|NOT COMPLETED|Overall Study||19
2540488|NCT00603278|6227611|P5|NOT COMPLETED|Overall Study||13
2540489|NCT00603278|6227612|P4|NOT COMPLETED|Overall Study||11
2540490|NCT00603278|6227613|P3|NOT COMPLETED|Overall Study||14
2540491|NCT00603278|6227614|P2|NOT COMPLETED|Overall Study||17
2540492|NCT00603278|6227615|P1|NOT COMPLETED|Overall Study||41
2540493|NCT00603278|6227610|P6|COMPLETED|Overall Study||81
2540494|NCT00603278|6227611|P5|COMPLETED|Overall Study||86
2540495|NCT00603278|6227612|P4|COMPLETED|Overall Study||92
2540496|NCT00603278|6227613|P3|COMPLETED|Overall Study||87
2540497|NCT00603278|6227614|P2|COMPLETED|Overall Study||88
2540498|NCT00603278|6227615|P1|COMPLETED|Overall Study||66
2540499|NCT00603278|6227610|P6|STARTED|Overall Study||100
2540500|NCT00603278|6227611|P5|STARTED|Overall Study||99
2540501|NCT00603278|6227612|P4|STARTED|Overall Study||103
2540502|NCT00603278|6227613|P3|STARTED|Overall Study||101
2540503|NCT00603278|6227614|P2|STARTED|Overall Study||105
2540504|NCT00603278|6227615|P1|STARTED|Overall Study||107
2540505|NCT00603265|6227764|P3|NOT COMPLETED|Overall Study||5
2540506|NCT00603265|6227765|P2|NOT COMPLETED|Overall Study||16
2540507|NCT00603265|6227766|P1|NOT COMPLETED|Overall Study||7
2540508|NCT00603265|6227764|P3|COMPLETED|Overall Study||67
2540509|NCT00603265|6227765|P2|COMPLETED|Overall Study||62
2540510|NCT00603265|6227766|P1|COMPLETED|Overall Study||69
2540511|NCT00603265|6227764|P3|Received at Least 1 Dose of Study Drug|Overall Study||72
2540512|NCT00603265|6227765|P2|Received at Least 1 Dose of Study Drug|Overall Study||78
2540513|NCT00603265|6227766|P1|Received at Least 1 Dose of Study Drug|Overall Study||75
2540514|NCT00603265|6227764|P3|STARTED|Overall Study||72
2540515|NCT00603265|6227765|P2|STARTED|Overall Study||78
2540516|NCT00603265|6227766|P1|STARTED|Overall Study|1 participant was randomized in error and did not receive study medication|76
2540517|NCT00603239|6227794|P2|NOT COMPLETED|Overall Study||4
2540518|NCT00603239|6227795|P1|NOT COMPLETED|Overall Study||15
2540519|NCT00603239|6227794|P2|COMPLETED|Overall Study||50
2540520|NCT00603239|6227795|P1|COMPLETED|Overall Study||96
2540521|NCT00603239|6227794|P2|STARTED|Overall Study||54
2540522|NCT00603239|6227795|P1|STARTED|Overall Study||111
2540523|NCT00603187|6227821|P1|NOT COMPLETED|Overall Study||0
2540524|NCT00603187|6227821|P1|COMPLETED|Overall Study||4
2540525|NCT00603187|6227821|P1|STARTED|Overall Study||4
2540526|NCT00603044|6227829|P2|NOT COMPLETED|Overall Study||0
2540527|NCT00603044|6227830|P1|NOT COMPLETED|Overall Study||0
2540528|NCT00603044|6227829|P2|COMPLETED|Overall Study||13
2540529|NCT00603044|6227830|P1|COMPLETED|Overall Study||11
2540530|NCT00603044|6227829|P2|STARTED|Overall Study||13
2540531|NCT00603044|6227830|P1|STARTED|Overall Study||11
2540532|NCT00603018|6227846|P1|NOT COMPLETED|Overall Study||0
2540533|NCT00603018|6227846|P1|COMPLETED|Overall Study||23
2540534|NCT00603018|6227846|P1|STARTED|Overall Study||23
2540535|NCT00602979|6227856|P5|NOT COMPLETED|Overall Study||3
2540536|NCT00602979|6227857|P4|NOT COMPLETED|Overall Study||3
2540537|NCT00602979|6227858|P3|NOT COMPLETED|Overall Study||3
2540538|NCT00602979|6227859|P2|NOT COMPLETED|Overall Study||3
2540539|NCT00602979|6227860|P1|NOT COMPLETED|Overall Study||3
2540540|NCT00602979|6227856|P5|COMPLETED|Overall Study||45
2540541|NCT00602979|6227857|P4|COMPLETED|Overall Study||45
2540542|NCT00602979|6227858|P3|COMPLETED|Overall Study||45
2540543|NCT00602979|6227859|P2|COMPLETED|Overall Study||45
2540544|NCT00602979|6227860|P1|COMPLETED|Overall Study||45
2540545|NCT00602979|6227856|P5|STARTED|Overall Study||48
2540546|NCT00602979|6227857|P4|STARTED|Overall Study||48
2540547|NCT00602979|6227858|P3|STARTED|Overall Study||48
2540548|NCT00602979|6227859|P2|STARTED|Overall Study||48
2540549|NCT00602979|6227860|P1|STARTED|Overall Study||48
2540550|NCT00602953|6227877|P5|NOT COMPLETED|Overall Study||0
2540551|NCT00602953|6227878|P4|NOT COMPLETED|Overall Study||0
2540552|NCT00602953|6227879|P3|NOT COMPLETED|Overall Study||0
2540553|NCT00602953|6227880|P2|NOT COMPLETED|Overall Study||0
2540554|NCT00602953|6227881|P1|NOT COMPLETED|Overall Study||0
2540555|NCT00602953|6227877|P5|COMPLETED|Overall Study||0
2540556|NCT00602953|6227878|P4|COMPLETED|Overall Study||13
2540557|NCT00602953|6227879|P3|COMPLETED|Overall Study||47
2540558|NCT00602953|6227880|P2|COMPLETED|Overall Study||26
2540559|NCT00602953|6227881|P1|COMPLETED|Overall Study||15
2540560|NCT00602953|6227877|P5|STARTED|Overall Study||0
2540561|NCT00602953|6227878|P4|STARTED|Overall Study||13
2540562|NCT00602953|6227879|P3|STARTED|Overall Study||47
2540563|NCT00602953|6227880|P2|STARTED|Overall Study||26
2540564|NCT00602953|6227881|P1|STARTED|Overall Study||15
2540565|NCT00602927|6227910|P2|NOT COMPLETED|Period 3: 13 Days||3
2540566|NCT00602927|6227911|P1|NOT COMPLETED|Period 3: 13 Days||2
2540567|NCT00602927|6227910|P2|COMPLETED|Period 3: 13 Days||9
2540568|NCT00602927|6227911|P1|COMPLETED|Period 3: 13 Days||13
2540569|NCT00602927|6227910|P2|STARTED|Period 3: 13 Days||12
2540570|NCT00602927|6227911|P1|STARTED|Period 3: 13 Days||15
2540571|NCT00602927|6227910|P2|NOT COMPLETED|Period 2: 14 Days||2
2540572|NCT00602927|6227911|P1|NOT COMPLETED|Period 2: 14 Days||0
2540573|NCT00602927|6227910|P2|COMPLETED|Period 2: 14 Days||12
2540574|NCT00602927|6227911|P1|COMPLETED|Period 2: 14 Days||15
2540575|NCT00602927|6227910|P2|STARTED|Period 2: 14 Days||14
2540576|NCT00602927|6227911|P1|STARTED|Period 2: 14 Days||15
2540577|NCT00602927|6227910|P2|NOT COMPLETED|Period 1: 13 Days||5
2540578|NCT00602927|6227911|P1|NOT COMPLETED|Period 1: 13 Days||4
2540579|NCT00602927|6227910|P2|COMPLETED|Period 1: 13 Days||14
2540580|NCT00602927|6227911|P1|COMPLETED|Period 1: 13 Days||15
2540581|NCT00602927|6227910|P2|STARTED|Period 1: 13 Days||19
2540582|NCT00602927|6227911|P1|STARTED|Period 1: 13 Days||19
2540583|NCT00602836|6227919|P1|NOT COMPLETED|Overall Study||5
2540584|NCT00602836|6227919|P1|COMPLETED|Overall Study||39
2540585|NCT00602836|6227919|P1|STARTED|Overall Study||44
2540586|NCT00602797|6227928|P1|NOT COMPLETED|Overall Study||1
2540587|NCT00602797|6227928|P1|COMPLETED|Overall Study||19
2540588|NCT00602797|6227928|P1|STARTED|Overall Study||20
2540589|NCT00602771|6227936|P2|NOT COMPLETED|Overall Study||0
2540590|NCT00602771|6227937|P1|NOT COMPLETED|Overall Study||1
2540591|NCT00602771|6227936|P2|COMPLETED|Overall Study||21
2540592|NCT00602771|6227937|P1|COMPLETED|Overall Study||62
2540593|NCT00602771|6227936|P2|STARTED|Overall Study||21
2540594|NCT00602771|6227937|P1|STARTED|Overall Study||63
2540595|NCT00602667|6227946|P3|NOT COMPLETED|Overall Study||63
2540596|NCT00602667|6227947|P2|NOT COMPLETED|Overall Study||81
2540597|NCT00602667|6227948|P1|NOT COMPLETED|Overall Study||19
2540598|NCT00602667|6227946|P3|COMPLETED|Overall Study||14
2540599|NCT00602667|6227947|P2|COMPLETED|Overall Study||75
2540600|NCT00602667|6227948|P1|COMPLETED|Overall Study||38
2540601|NCT00602667|6227946|P3|STARTED|Overall Study||77
2540602|NCT00602667|6227947|P2|STARTED|Overall Study||156
2540603|NCT00602667|6227948|P1|STARTED|Overall Study||57
2540604|NCT00602641|6228127|P2|NOT COMPLETED|Overall Study||152
2540605|NCT00602641|6228128|P1|NOT COMPLETED|Overall Study||154
2540606|NCT00602641|6228127|P2|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
2540607|NCT00602641|6228128|P1|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
2540608|NCT00602641|6228127|P2|Started Protocol Therapy|Overall Study||150
2540609|NCT00602641|6228128|P1|Started Protocol Therapy|Overall Study||148
2540610|NCT00602641|6228127|P2|STARTED|Overall Study||152
2540611|NCT00602641|6228128|P1|STARTED|Overall Study||154
2540612|NCT00602537|6228142|P2|NOT COMPLETED|Follow Up Study Comparison||3
2540613|NCT00602537|6228143|P1|NOT COMPLETED|Follow Up Study Comparison||11
2540614|NCT00602537|6228142|P2|COMPLETED|Follow Up Study Comparison||14
2540615|NCT00602537|6228143|P1|COMPLETED|Follow Up Study Comparison||31
2540616|NCT00602537|6228142|P2|STARTED|Follow Up Study Comparison||17
2540617|NCT00602537|6228143|P1|STARTED|Follow Up Study Comparison||42
2540618|NCT00602537|6228142|P2|NOT COMPLETED|12 Week Double Blind Comparison||47
2540619|NCT00602537|6228143|P1|NOT COMPLETED|12 Week Double Blind Comparison||23
2540620|NCT00602537|6228142|P2|COMPLETED|12 Week Double Blind Comparison||17
2540621|NCT00602537|6228143|P1|COMPLETED|12 Week Double Blind Comparison||42
2540622|NCT00602537|6228142|P2|Responded|12 Week Double Blind Comparison||22
2540623|NCT00602537|6228143|P1|Responded|12 Week Double Blind Comparison||44
2540624|NCT00602537|6228142|P2|STARTED|12 Week Double Blind Comparison||64
2540625|NCT00602537|6228143|P1|STARTED|12 Week Double Blind Comparison||65
2540626|NCT00602472|6228153|P2|NOT COMPLETED|Overall Study||58
2540627|NCT00602472|6228154|P1|NOT COMPLETED|Overall Study||21
2540628|NCT00602472|6228153|P2|COMPLETED|Overall Study|number who completed treatment|734
2540629|NCT00602472|6228154|P1|COMPLETED|Overall Study|number who completed treatment|242
2540630|NCT00602472|6228153|P2|STARTED|Overall Study|3 randomised patients never took medication.|792
2540631|NCT00602472|6228154|P1|STARTED|Overall Study|3 randomised patients never took medication.|263
2540632|NCT00602459|6228188|P4|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
2540633|NCT00602459|6228189|P3|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
2540634|NCT00602459|6228190|P2|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
2540635|NCT00602459|6228191|P1|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
2540636|NCT00602459|6228188|P4|COMPLETED|Re-assignment After Del(11q22.3) Testing||31
2540637|NCT00602459|6228189|P3|COMPLETED|Re-assignment After Del(11q22.3) Testing||137
2540638|NCT00602459|6228190|P2|COMPLETED|Re-assignment After Del(11q22.3) Testing||109
2540639|NCT00602459|6228191|P1|COMPLETED|Re-assignment After Del(11q22.3) Testing||123
2540640|NCT00602459|6228188|P4|STARTED|Re-assignment After Del(11q22.3) Testing||31
2540641|NCT00602459|6228189|P3|STARTED|Re-assignment After Del(11q22.3) Testing||137
2540642|NCT00602459|6228190|P2|STARTED|Re-assignment After Del(11q22.3) Testing||109
2540643|NCT00602459|6228191|P1|STARTED|Re-assignment After Del(11q22.3) Testing||123
2540644|NCT00602459|6228188|P4|NOT COMPLETED|Initial Registration/Randomization||0
2540645|NCT00602459|6228189|P3|NOT COMPLETED|Initial Registration/Randomization||3
2540646|NCT00602459|6228190|P2|NOT COMPLETED|Initial Registration/Randomization||10
2540647|NCT00602459|6228191|P1|NOT COMPLETED|Initial Registration/Randomization||5
2540648|NCT00602459|6228188|P4|COMPLETED|Initial Registration/Randomization||0
2540649|NCT00602459|6228189|P3|COMPLETED|Initial Registration/Randomization||137
2540650|NCT00602459|6228190|P2|COMPLETED|Initial Registration/Randomization||130
2540651|NCT00602459|6228191|P1|COMPLETED|Initial Registration/Randomization||133
2540652|NCT00602459|6228188|P4|STARTED|Initial Registration/Randomization||0
2540653|NCT00602459|6228189|P3|STARTED|Initial Registration/Randomization||140
2540654|NCT00602459|6228190|P2|STARTED|Initial Registration/Randomization||140
2540655|NCT00602459|6228191|P1|STARTED|Initial Registration/Randomization||138
2540656|NCT00602446|6228212|P1|NOT COMPLETED|Overall Study||0
2540657|NCT00602446|6228212|P1|COMPLETED|Overall Study||3
2540658|NCT00602446|6228212|P1|STARTED|Overall Study||3
2540659|NCT00602420|6228219|P2|NOT COMPLETED|Overall Study||24
2540660|NCT00602420|6228220|P1|NOT COMPLETED|Overall Study||25
2540661|NCT00602420|6228219|P2|COMPLETED|Overall Study||229
2540662|NCT00602420|6228220|P1|COMPLETED|Overall Study||232
2540663|NCT00602420|6228219|P2|STARTED|Overall Study||253
2540664|NCT00602420|6228220|P1|STARTED|Overall Study||257
2540665|NCT00602355|6228229|P3|NOT COMPLETED|Overall Study||10
2540666|NCT00602355|6228230|P2|NOT COMPLETED|Overall Study||18
2540667|NCT00602355|6228231|P1|NOT COMPLETED|Overall Study||9
2540668|NCT00602355|6228229|P3|COMPLETED|Overall Study||43
2540669|NCT00602355|6228230|P2|COMPLETED|Overall Study||38
2540670|NCT00602355|6228231|P1|COMPLETED|Overall Study||44
2540671|NCT00602355|6228229|P3|STARTED|Overall Study||53
2540672|NCT00602355|6228230|P2|STARTED|Overall Study||56
2540673|NCT00602355|6228231|P1|STARTED|Overall Study||53
2540674|NCT00602290|6228254|P3|NOT COMPLETED|Overall Study||1
2540675|NCT00602290|6228255|P2|NOT COMPLETED|Overall Study||2
2540676|NCT00602290|6228256|P1|NOT COMPLETED|Overall Study||2
2540677|NCT00602290|6228254|P3|COMPLETED|Overall Study||46
2540678|NCT00602290|6228255|P2|COMPLETED|Overall Study||46
2540679|NCT00602290|6228256|P1|COMPLETED|Overall Study||46
2540680|NCT00602290|6228254|P3|STARTED|Overall Study||47
2540681|NCT00602290|6228255|P2|STARTED|Overall Study||48
2540682|NCT00602290|6228256|P1|STARTED|Overall Study||48
2540683|NCT00602225|6228267|P1|NOT COMPLETED|Overall Study||0
2540684|NCT00602225|6228267|P1|COMPLETED|Overall Study||50
2540685|NCT00602225|6228267|P1|STARTED|Overall Study||50
2540689|NCT00601965|6228294|P4|NOT COMPLETED|Overall Study||1
2540690|NCT00601965|6228295|P3|NOT COMPLETED|Overall Study||0
2540691|NCT00601965|6228296|P2|NOT COMPLETED|Overall Study||2
2540692|NCT00601965|6228297|P1|NOT COMPLETED|Overall Study||0
2540693|NCT00601965|6228294|P4|COMPLETED|Overall Study||17
2540694|NCT00601965|6228295|P3|COMPLETED|Overall Study||19
2540695|NCT00601965|6228296|P2|COMPLETED|Overall Study||16
2540696|NCT00601965|6228297|P1|COMPLETED|Overall Study||18
2540697|NCT00601965|6228294|P4|STARTED|Overall Study||18
2540698|NCT00601965|6228295|P3|STARTED|Overall Study||19
2540699|NCT00601965|6228296|P2|STARTED|Overall Study||18
2540700|NCT00601965|6228297|P1|STARTED|Overall Study||18
2540701|NCT00601952|6228313|P2|NOT COMPLETED|Overall Study||0
2540702|NCT00601952|6228314|P1|NOT COMPLETED|Overall Study||2
2540703|NCT00601952|6228313|P2|COMPLETED|Overall Study||17
2540704|NCT00601952|6228314|P1|COMPLETED|Overall Study||12
2540705|NCT00601952|6228313|P2|STARTED|Overall Study||17
2540706|NCT00601952|6228314|P1|STARTED|Overall Study||14
2540707|NCT00601926|6228320|P1|NOT COMPLETED|Overall Study||0
2540708|NCT00601926|6228320|P1|COMPLETED|Overall Study||5
2540709|NCT00601926|6228320|P1|STARTED|Overall Study||5
2540716|NCT00601835|6228345|P2|NOT COMPLETED|Overall Study||14
2540717|NCT00601835|6228346|P1|NOT COMPLETED|Overall Study||60
2540718|NCT00601835|6228345|P2|COMPLETED|Overall Study||686
2540719|NCT00601835|6228346|P1|COMPLETED|Overall Study||2890
2540720|NCT00601835|6228345|P2|STARTED|Overall Study||700
2540721|NCT00601835|6228346|P1|STARTED|Overall Study||2950
2540722|NCT00601796|6228356|P1|NOT COMPLETED|Overall Study||0
2540723|NCT00601796|6228356|P1|COMPLETED|Overall Study||24
2540724|NCT00601796|6228356|P1|STARTED|Overall Study||24
2540725|NCT00601731|6228375|P4|NOT COMPLETED|Overall Study||1
2540726|NCT00601731|6228376|P3|NOT COMPLETED|Overall Study||15
2540727|NCT00601731|6228377|P2|NOT COMPLETED|Overall Study||0
2540728|NCT00601731|6228378|P1|NOT COMPLETED|Overall Study||23
2540729|NCT00601731|6228375|P4|COMPLETED|Overall Study||29
2540730|NCT00601731|6228376|P3|COMPLETED|Overall Study||151
2540731|NCT00601731|6228377|P2|COMPLETED|Overall Study||43
2540732|NCT00601731|6228378|P1|COMPLETED|Overall Study||120
2540733|NCT00601731|6228375|P4|STARTED|Overall Study||30
2540734|NCT00601731|6228376|P3|STARTED|Overall Study||166
2540735|NCT00601731|6228377|P2|STARTED|Overall Study||43
2540736|NCT00601731|6228378|P1|STARTED|Overall Study||143
2540737|NCT00601718|6228428|P1|NOT COMPLETED|Overall Study||0
2540738|NCT00601718|6228428|P1|COMPLETED|Overall Study||29
2540739|NCT00601718|6228428|P1|STARTED|Overall Study||29
2540740|NCT00601705|6228435|P1|NOT COMPLETED|Overall Study||1
2540741|NCT00601705|6228435|P1|COMPLETED|Overall Study||60
2540742|NCT00601705|6228435|P1|STARTED|Overall Study||61
2540743|NCT00601640|6228447|P3|NOT COMPLETED|Overall Study||10
2540744|NCT00601640|6228448|P2|NOT COMPLETED|Overall Study||5
2540745|NCT00601640|6228449|P1|NOT COMPLETED|Overall Study||5
2540746|NCT00601640|6228447|P3|COMPLETED|Overall Study||42
2540747|NCT00601640|6228448|P2|COMPLETED|Overall Study||47
2540748|NCT00601640|6228449|P1|COMPLETED|Overall Study||47
2540749|NCT00601640|6228447|P3|STARTED|Overall Study||52
2540750|NCT00601640|6228448|P2|STARTED|Overall Study||52
2540751|NCT00601640|6228449|P1|STARTED|Overall Study||52
2540752|NCT00601627|6228463|P1|NOT COMPLETED|Overall Study||0
2540753|NCT00601627|6228463|P1|COMPLETED|Overall Study||51
2540754|NCT00601627|6228463|P1|STARTED|Overall Study||51
2540755|NCT00601523|6228474|P2|NOT COMPLETED|Overall Study||26
2540756|NCT00601523|6228475|P1|NOT COMPLETED|Overall Study||77
2540757|NCT00601523|6228474|P2|COMPLETED|Overall Study||117
2540758|NCT00601523|6228475|P1|COMPLETED|Overall Study||291
2540759|NCT00601523|6228474|P2|STARTED|Overall Study||143
2540760|NCT00601523|6228475|P1|STARTED|Overall Study||368
2540761|NCT00601458|6228510|P3|NOT COMPLETED|Overall Study||2
2540762|NCT00601458|6228511|P2|NOT COMPLETED|Overall Study||5
2540763|NCT00601458|6228512|P1|NOT COMPLETED|Overall Study||4
2540764|NCT00601458|6228510|P3|COMPLETED|Overall Study||28
2540765|NCT00601458|6228511|P2|COMPLETED|Overall Study||29
2540766|NCT00601458|6228512|P1|COMPLETED|Overall Study||32
2540767|NCT00601458|6228510|P3|STARTED|Overall Study||30
2540768|NCT00601458|6228511|P2|STARTED|Overall Study||34
2540769|NCT00601458|6228512|P1|STARTED|Overall Study||36
2540770|NCT00601419|6228523|P1|NOT COMPLETED|Overall Study||4
2540771|NCT00601419|6228523|P1|COMPLETED|Overall Study||226
2540772|NCT00601419|6228523|P1|STARTED|Overall Study||230
2540773|NCT00601367|6228547|P1|NOT COMPLETED|Overall Study||187
2540774|NCT00601367|6228547|P1|COMPLETED|Overall Study||293
2540775|NCT00601367|6228547|P1|STARTED|Overall Study||480
2540776|NCT00601354|6228553|P2|NOT COMPLETED|Overall Study||5
2540777|NCT00601354|6228554|P1|NOT COMPLETED|Overall Study||4
2540778|NCT00601354|6228553|P2|COMPLETED|Overall Study||4
2540779|NCT00601354|6228554|P1|COMPLETED|Overall Study||4
2540780|NCT00601354|6228553|P2|STARTED|Overall Study||9
2540781|NCT00601354|6228554|P1|STARTED|Overall Study||8
2540782|NCT00601250|6228566|P2|NOT COMPLETED|Overall Study||39
2540783|NCT00601250|6228567|P1|NOT COMPLETED|Overall Study||14
2540784|NCT00601250|6228566|P2|COMPLETED|Overall Study|number who completed treatment|484
2540785|NCT00601250|6228567|P1|COMPLETED|Overall Study|number who completed treatment|163
2540786|NCT00601250|6228566|P2|STARTED|Overall Study|number who started treatment. One additional patient was randomised but not treated.|523
2540787|NCT00601250|6228567|P1|STARTED|Overall Study|number who started treatment|177
2540788|NCT00601172|6228603|P2|NOT COMPLETED|Overall Study||127
2540789|NCT00601172|6228604|P1|NOT COMPLETED|Overall Study||141
2540790|NCT00601172|6228603|P2|COMPLETED|Overall Study||228
2540791|NCT00601172|6228604|P1|COMPLETED|Overall Study||214
2540792|NCT00601172|6228603|P2|STARTED|Overall Study||355
2540793|NCT00601172|6228604|P1|STARTED|Overall Study||355
2540794|NCT00601146|6228653|P1|NOT COMPLETED|Overall Study||0
2540795|NCT00601146|6228653|P1|COMPLETED|Overall Study||39
2540796|NCT00601146|6228653|P1|STARTED|Overall Study||39
2540797|NCT00601107|6228661|P4|NOT COMPLETED|Overall Study||12
2540798|NCT00601107|6228662|P3|NOT COMPLETED|Overall Study||12
2540799|NCT00601107|6228663|P2|NOT COMPLETED|Overall Study||9
2540800|NCT00601107|6228664|P1|NOT COMPLETED|Overall Study||13
2540801|NCT00601107|6228661|P4|COMPLETED|Overall Study||13
2540802|NCT00601107|6228662|P3|COMPLETED|Overall Study||16
2540803|NCT00601107|6228663|P2|COMPLETED|Overall Study||22
2540804|NCT00601107|6228664|P1|COMPLETED|Overall Study||14
2540805|NCT00601107|6228661|P4|Treated|Overall Study||25
2540806|NCT00601107|6228662|P3|Treated|Overall Study||28
2540807|NCT00601107|6228663|P2|Treated|Overall Study||31
2540808|NCT00601107|6228664|P1|Treated|Overall Study||27
2540809|NCT00601107|6228661|P4|STARTED|Overall Study||25
2540810|NCT00601107|6228662|P3|STARTED|Overall Study||28
2540811|NCT00601107|6228663|P2|STARTED|Overall Study||31
2540812|NCT00601107|6228664|P1|STARTED|Overall Study|Randomized.|27
2540813|NCT00600938|6228684|P4|NOT COMPLETED|Extension Study||1
2540814|NCT00600938|6228685|P3|NOT COMPLETED|Extension Study||9
2540815|NCT00600938|6228686|P2|NOT COMPLETED|Extension Study||5
2540816|NCT00600938|6228687|P1|NOT COMPLETED|Extension Study||9
2540817|NCT00600938|6228684|P4|COMPLETED|Extension Study||0
2540818|NCT00600938|6228685|P3|COMPLETED|Extension Study||33
2540819|NCT00600938|6228686|P2|COMPLETED|Extension Study||24
2540820|NCT00600938|6228687|P1|COMPLETED|Extension Study||65
2540821|NCT00600938|6228684|P4|Extension Safety Set|Extension Study||1
2540822|NCT00600938|6228685|P3|Extension Safety Set|Extension Study||42
2540823|NCT00600938|6228686|P2|Extension Safety Set|Extension Study||29
2540824|NCT00600938|6228687|P1|Extension Safety Set|Extension Study|1 patient did not receive drug in the ext. phase but received drug in the core phase|73
2540825|NCT00600938|6228684|P4|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|1
2540826|NCT00600938|6228685|P3|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|42
2540827|NCT00600938|6228686|P2|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|29
2540828|NCT00600938|6228687|P1|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|74
2540829|NCT00600938|6228684|P4|NOT COMPLETED|Core Study||0
2540830|NCT00600938|6228685|P3|NOT COMPLETED|Core Study||0
2540831|NCT00600938|6228686|P2|NOT COMPLETED|Core Study||21
2540832|NCT00600938|6228687|P1|NOT COMPLETED|Core Study||16
2540833|NCT00600938|6228684|P4|COMPLETED|Core Study||0
2540834|NCT00600938|6228685|P3|COMPLETED|Core Study||0
2540835|NCT00600938|6228686|P2|COMPLETED|Core Study||78
2540836|NCT00600938|6228687|P1|COMPLETED|Core Study||82
2540837|NCT00600938|6228684|P4|Per Protocol Set (PPS)|Core Study||0
2540838|NCT00600938|6228685|P3|Per Protocol Set (PPS)|Core Study||0
2540839|NCT00600938|6228686|P2|Per Protocol Set (PPS)|Core Study||81
2540840|NCT00600938|6228687|P1|Per Protocol Set (PPS)|Core Study||91
2540841|NCT00600938|6228684|P4|Core Safety Set|Core Study||0
2540842|NCT00600938|6228685|P3|Core Safety Set|Core Study||0
2540843|NCT00600938|6228686|P2|Core Safety Set|Core Study||91
2540844|NCT00600938|6228687|P1|Core Safety Set|Core Study||96
2540845|NCT00600938|6228684|P4|STARTED|Core Study||0
2540846|NCT00600938|6228685|P3|STARTED|Core Study||0
2540847|NCT00600938|6228686|P2|STARTED|Core Study||99
2540848|NCT00600938|6228687|P1|STARTED|Core Study||98
2540849|NCT00600886|6228751|P2|NOT COMPLETED|Extension - After Crossover (CAS)||13
2540850|NCT00600886|6228752|P1|NOT COMPLETED|Extension - After Crossover (CAS)||62
2540851|NCT00600886|6228751|P2|COMPLETED|Extension - After Crossover (CAS)|Completed the study|25
2540852|NCT00600886|6228752|P1|COMPLETED|Extension - After Crossover (CAS)|Completed after month 26: transferred to a roll-over protocol or commercial supply of Pas.LAR|19
2540853|NCT00600886|6228751|P2|Discontinued After M26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|0
2540854|NCT00600886|6228752|P1|Discontinued After M26|Extension - After Crossover (CAS)||31
2540855|NCT00600886|6228751|P2|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||13
2540856|NCT00600886|6228752|P1|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||31
2540857|NCT00600886|6228751|P2|Completed After Month 26|Extension - After Crossover (CAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in study after M26|0
2540858|NCT00600886|6228752|P1|Completed After Month 26|Extension - After Crossover (CAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|19
2540859|NCT00600886|6228751|P2|Completed Study at Month 26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|25
2540860|NCT00600886|6228752|P1|Completed Study at Month 26|Extension - After Crossover (CAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
2540861|NCT00600886|6228751|P2|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Octreotide LAR|38
2540862|NCT00600886|6228752|P1|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Pasireotide LAR|81
2540863|NCT00600886|6228751|P2|NOT COMPLETED|Extension - Same Treatment (FAS)||11
2540864|NCT00600886|6228752|P1|NOT COMPLETED|Extension - Same Treatment (FAS)||46
2540865|NCT00600886|6228751|P2|COMPLETED|Extension - Same Treatment (FAS)|Completed = completed the study|35
2540866|NCT00600886|6228752|P1|COMPLETED|Extension - Same Treatment (FAS)|Completed= completed after M26, switched to commercial pasireotide LAR or entered roll-over protocol|28
2540867|NCT00600886|6228751|P2|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||10
2540868|NCT00600886|6228752|P1|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||23
2540869|NCT00600886|6228751|P2|Discontinued After Month 26|Extension - Same Treatment (FAS)|Received treatment and discontinued after M26: Recorded as protocol deviation|1
2540870|NCT00600886|6228752|P1|Discontinued After Month 26|Extension - Same Treatment (FAS)||23
2540871|NCT00600886|6228751|P2|Completed Study After Month 26|Extension - Same Treatment (FAS)|Received treatment and completed after M26: Recorded as protocol deviation|4
2540872|NCT00600886|6228752|P1|Completed Study After Month 26|Extension - Same Treatment (FAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|28
2540873|NCT00600886|6228751|P2|Completed Study at Month 26|Extension - Same Treatment (FAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in the study after M26|31
2540874|NCT00600886|6228752|P1|Completed Study at Month 26|Extension - Same Treatment (FAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
2540875|NCT00600886|6228751|P2|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Octreotide LAR|46
2540876|NCT00600886|6228752|P1|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Pasireotide LAR|74
2540877|NCT00600886|6228751|P2|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||26
2540878|NCT00600886|6228752|P1|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||35
2540879|NCT00600886|6228751|P2|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|156
2540880|NCT00600886|6228752|P1|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|141
2540881|NCT00600886|6228751|P2|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||46
2540882|NCT00600886|6228752|P1|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||74
2540883|NCT00600886|6228751|P2|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||81
2540884|NCT00600886|6228752|P1|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||38
2540885|NCT00600886|6228751|P2|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
2540886|NCT00600886|6228752|P1|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
2540887|NCT00600886|6228751|P2|STARTED|Core Phase - Full Analysis Set (FAS)||182
2540888|NCT00600886|6228752|P1|STARTED|Core Phase - Full Analysis Set (FAS)||176
2540889|NCT00600821|6228816|P2|NOT COMPLETED|Overall Study||60
2540890|NCT00600821|6228817|P1|NOT COMPLETED|Overall Study||58
2540891|NCT00600821|6228816|P2|COMPLETED|Overall Study||0
2540892|NCT00600821|6228817|P1|COMPLETED|Overall Study||0
2540893|NCT00600821|6228816|P2|Treated|Overall Study||59
2540894|NCT00600821|6228817|P1|Treated|Overall Study||58
2540895|NCT00600821|6228816|P2|STARTED|Overall Study||60
2540896|NCT00600821|6228817|P1|STARTED|Overall Study||58
2540897|NCT00600756|6228845|P2|NOT COMPLETED|Overall Study Analysis After 12 Months||176
2540898|NCT00600756|6228846|P1|NOT COMPLETED|Overall Study Analysis After 12 Months||183
2540899|NCT00600756|6228845|P2|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|227
2540900|NCT00600756|6228846|P1|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|212
2540901|NCT00600756|6228845|P2|ITT Analysis|Overall Study Analysis After 12 Months||392
2540902|NCT00600756|6228846|P1|ITT Analysis|Overall Study Analysis After 12 Months||379
2540903|NCT00600756|6228845|P2|Safety Analysis|Overall Study Analysis After 12 Months||402
2540904|NCT00600756|6228846|P1|Safety Analysis|Overall Study Analysis After 12 Months||391
2540905|NCT00600756|6228845|P2|Randomized Analysis|Overall Study Analysis After 12 Months||403
2540906|NCT00600756|6228846|P1|Randomized Analysis|Overall Study Analysis After 12 Months||395
2540907|NCT00600756|6228845|P2|STARTED|Overall Study Analysis After 12 Months||403
2540908|NCT00600756|6228846|P1|STARTED|Overall Study Analysis After 12 Months||395
2540909|NCT00600756|6228845|P2|NOT COMPLETED|Analysis After 6 Months||120
2540910|NCT00600756|6228846|P1|NOT COMPLETED|Analysis After 6 Months||131
2540911|NCT00600756|6228845|P2|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|283
2540912|NCT00600756|6228846|P1|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|264
2540913|NCT00600756|6228845|P2|STARTED|Analysis After 6 Months||403
2540914|NCT00600756|6228846|P1|STARTED|Analysis After 6 Months||395
2540915|NCT00600743|6228916|P4|NOT COMPLETED|Overall Study||0
2540916|NCT00600743|6228917|P3|NOT COMPLETED|Overall Study||0
2540917|NCT00600743|6228918|P2|NOT COMPLETED|Overall Study||0
2540918|NCT00600743|6228919|P1|NOT COMPLETED|Overall Study||0
2540919|NCT00600743|6228916|P4|COMPLETED|Overall Study||7
2540920|NCT00600743|6228917|P3|COMPLETED|Overall Study||8
2540921|NCT00600743|6228918|P2|COMPLETED|Overall Study||4
2540922|NCT00600743|6228919|P1|COMPLETED|Overall Study||4
2540923|NCT00600743|6228916|P4|STARTED|Overall Study||7
2540924|NCT00600743|6228917|P3|STARTED|Overall Study||8
2540925|NCT00600743|6228918|P2|STARTED|Overall Study||4
2540926|NCT00600743|6228919|P1|STARTED|Overall Study||4
2540927|NCT00600704|6228948|P2|NOT COMPLETED|Overall Study||0
2540928|NCT00600704|6228949|P1|NOT COMPLETED|Overall Study||0
2540929|NCT00600704|6228948|P2|COMPLETED|Overall Study||92
2540930|NCT00600704|6228949|P1|COMPLETED|Overall Study||100
2540931|NCT00600704|6228948|P2|STARTED|Overall Study||92
2540932|NCT00600704|6228949|P1|STARTED|Overall Study||100
2540933|NCT00600613|6228955|P1|NOT COMPLETED|Overall Study||1
2540934|NCT00600613|6228955|P1|COMPLETED|Overall Study||5
2540935|NCT00600613|6228955|P1|STARTED|Overall Study||6
2540936|NCT00600353|6228961|P2|NOT COMPLETED|Overall Study||1
2540937|NCT00600353|6228962|P1|NOT COMPLETED|Overall Study||1
2540938|NCT00600353|6228961|P2|COMPLETED|Overall Study||9
2540939|NCT00600353|6228962|P1|COMPLETED|Overall Study||9
2540940|NCT00600353|6228961|P2|STARTED|Overall Study||10
2540941|NCT00600353|6228962|P1|STARTED|Overall Study||10
2540942|NCT00600340|6228976|P2|NOT COMPLETED|Overall Study||0
2540943|NCT00600340|6228977|P1|NOT COMPLETED|Overall Study||0
2540944|NCT00600340|6228976|P2|COMPLETED|Overall Study||279
2540945|NCT00600340|6228977|P1|COMPLETED|Overall Study||285
2540946|NCT00600340|6228976|P2|STARTED|Overall Study||279
2540947|NCT00600340|6228977|P1|STARTED|Overall Study||285
2540948|NCT00600171|6229025|P6|NOT COMPLETED|Overall Study||5
2540949|NCT00600171|6229026|P5|NOT COMPLETED|Overall Study||8
2540950|NCT00600171|6229027|P4|NOT COMPLETED|Overall Study||12
2540951|NCT00600171|6229028|P3|NOT COMPLETED|Overall Study||10
2540952|NCT00600171|6229029|P2|NOT COMPLETED|Overall Study||17
2540953|NCT00600171|6229030|P1|NOT COMPLETED|Overall Study||16
2540954|NCT00600171|6229025|P6|COMPLETED|Overall Study||97
2540955|NCT00600171|6229026|P5|COMPLETED|Overall Study||93
2540956|NCT00600171|6229027|P4|COMPLETED|Overall Study||88
2540957|NCT00600171|6229028|P3|COMPLETED|Overall Study||91
2540958|NCT00600171|6229029|P2|COMPLETED|Overall Study||84
2540959|NCT00600171|6229030|P1|COMPLETED|Overall Study||86
2540960|NCT00600171|6229025|P6|STARTED|Overall Study||102
2540961|NCT00600171|6229026|P5|STARTED|Overall Study||101
2540962|NCT00600171|6229027|P4|STARTED|Overall Study||100
2540963|NCT00600171|6229028|P3|STARTED|Overall Study||101
2540964|NCT00600171|6229029|P2|STARTED|Overall Study||101
2540965|NCT00600171|6229030|P1|STARTED|Overall Study||102
2540966|NCT00600119|6229104|P6|NOT COMPLETED|Follow-up Period||1
2540967|NCT00600119|6229105|P5|NOT COMPLETED|Follow-up Period||0
2540968|NCT00600119|6229106|P4|NOT COMPLETED|Follow-up Period||0
2540969|NCT00600119|6229107|P3|NOT COMPLETED|Follow-up Period||0
2540970|NCT00600119|6229108|P2|NOT COMPLETED|Follow-up Period||0
2540971|NCT00600119|6229109|P1|NOT COMPLETED|Follow-up Period||1
2540972|NCT00600119|6229104|P6|COMPLETED|Follow-up Period||20
2540973|NCT00600119|6229105|P5|COMPLETED|Follow-up Period||31
2540974|NCT00600119|6229106|P4|COMPLETED|Follow-up Period||28
2540975|NCT00600119|6229107|P3|COMPLETED|Follow-up Period||27
2540976|NCT00600119|6229108|P2|COMPLETED|Follow-up Period||28
2540977|NCT00600119|6229109|P1|COMPLETED|Follow-up Period||26
2540978|NCT00600119|6229104|P6|STARTED|Follow-up Period||21
2540979|NCT00600119|6229105|P5|STARTED|Follow-up Period||31
2540980|NCT00600119|6229106|P4|STARTED|Follow-up Period||28
2540981|NCT00600119|6229107|P3|STARTED|Follow-up Period||27
2540982|NCT00600119|6229108|P2|STARTED|Follow-up Period||28
2540983|NCT00600119|6229109|P1|STARTED|Follow-up Period||27
2540984|NCT00600119|6229104|P6|NOT COMPLETED|Double-blind Treatment Period||14
2540985|NCT00600119|6229105|P5|NOT COMPLETED|Double-blind Treatment Period||6
2540986|NCT00600119|6229106|P4|NOT COMPLETED|Double-blind Treatment Period||2
2540987|NCT00600119|6229107|P3|NOT COMPLETED|Double-blind Treatment Period||0
2540988|NCT00600119|6229108|P2|NOT COMPLETED|Double-blind Treatment Period||5
2540989|NCT00600119|6229109|P1|NOT COMPLETED|Double-blind Treatment Period||5
2540990|NCT00600119|6229104|P6|COMPLETED|Double-blind Treatment Period||21
2540991|NCT00600119|6229105|P5|COMPLETED|Double-blind Treatment Period||31
2540992|NCT00600119|6229106|P4|COMPLETED|Double-blind Treatment Period||28
2540993|NCT00600119|6229107|P3|COMPLETED|Double-blind Treatment Period||27
2540994|NCT00600119|6229108|P2|COMPLETED|Double-blind Treatment Period||28
2540995|NCT00600119|6229109|P1|COMPLETED|Double-blind Treatment Period||27
2540996|NCT00600119|6229104|P6|STARTED|Double-blind Treatment Period||35
2540997|NCT00600119|6229105|P5|STARTED|Double-blind Treatment Period||37
2540998|NCT00600119|6229106|P4|STARTED|Double-blind Treatment Period||30
2540999|NCT00600119|6229107|P3|STARTED|Double-blind Treatment Period||27
2541000|NCT00600119|6229108|P2|STARTED|Double-blind Treatment Period||33
2541001|NCT00600119|6229109|P1|STARTED|Double-blind Treatment Period||32
2541002|NCT00600119|6229104|P6|NOT COMPLETED|Single-blind Placebo run-in Period||2
2541003|NCT00600119|6229105|P5|NOT COMPLETED|Single-blind Placebo run-in Period||2
2541004|NCT00600119|6229106|P4|NOT COMPLETED|Single-blind Placebo run-in Period||1
2541005|NCT00600119|6229107|P3|NOT COMPLETED|Single-blind Placebo run-in Period||2
2541006|NCT00600119|6229108|P2|NOT COMPLETED|Single-blind Placebo run-in Period||2
2541007|NCT00600119|6229109|P1|NOT COMPLETED|Single-blind Placebo run-in Period||4
2541008|NCT00600119|6229104|P6|COMPLETED|Single-blind Placebo run-in Period||35
2541009|NCT00600119|6229105|P5|COMPLETED|Single-blind Placebo run-in Period||37
2541010|NCT00600119|6229106|P4|COMPLETED|Single-blind Placebo run-in Period||30
2541011|NCT00600119|6229107|P3|COMPLETED|Single-blind Placebo run-in Period||27
2541012|NCT00600119|6229108|P2|COMPLETED|Single-blind Placebo run-in Period||33
2541013|NCT00600119|6229109|P1|COMPLETED|Single-blind Placebo run-in Period||32
2541014|NCT00600119|6229104|P6|STARTED|Single-blind Placebo run-in Period||37
2541015|NCT00600119|6229105|P5|STARTED|Single-blind Placebo run-in Period||39
2541016|NCT00600119|6229106|P4|STARTED|Single-blind Placebo run-in Period||31
2541017|NCT00600119|6229107|P3|STARTED|Single-blind Placebo run-in Period||29
2541018|NCT00600119|6229108|P2|STARTED|Single-blind Placebo run-in Period||35
2541019|NCT00600119|6229109|P1|STARTED|Single-blind Placebo run-in Period||36
2541020|NCT00600106|6229143|P2|NOT COMPLETED|Overall Study||1
2541021|NCT00600106|6229144|P1|NOT COMPLETED|Overall Study||1
2541022|NCT00600106|6229143|P2|COMPLETED|Overall Study||18
2541023|NCT00600106|6229144|P1|COMPLETED|Overall Study||17
2541024|NCT00600106|6229143|P2|STARTED|Overall Study||19
2541025|NCT00600106|6229144|P1|STARTED|Overall Study||18
2541026|NCT00600080|6229176|P2|NOT COMPLETED|Period 2: One-week to Two-weeks||0
2541027|NCT00600080|6229177|P1|NOT COMPLETED|Period 2: One-week to Two-weeks||0
2541028|NCT00600080|6229176|P2|COMPLETED|Period 2: One-week to Two-weeks||32
2541029|NCT00600080|6229177|P1|COMPLETED|Period 2: One-week to Two-weeks||28
2541030|NCT00600080|6229176|P2|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|32
2541031|NCT00600080|6229177|P1|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|28
2541032|NCT00600080|6229176|P2|NOT COMPLETED|Period 1: Baseline to One-week||0
2541033|NCT00600080|6229177|P1|NOT COMPLETED|Period 1: Baseline to One-week||0
2541034|NCT00600080|6229176|P2|COMPLETED|Period 1: Baseline to One-week||32
2541035|NCT00600080|6229177|P1|COMPLETED|Period 1: Baseline to One-week||28
2541036|NCT00600080|6229176|P2|STARTED|Period 1: Baseline to One-week||32
2541037|NCT00600080|6229177|P1|STARTED|Period 1: Baseline to One-week||28
2541038|NCT00600067|6229191|P2|NOT COMPLETED|Overall Study||7
2541039|NCT00600067|6229192|P1|NOT COMPLETED|Overall Study||3
2541040|NCT00600067|6229191|P2|COMPLETED|Overall Study||68
2541041|NCT00600067|6229192|P1|COMPLETED|Overall Study||52
2541042|NCT00600067|6229191|P2|STARTED|Overall Study||75
2541043|NCT00600067|6229192|P1|STARTED|Overall Study||55
2541044|NCT00600028|6229202|P2|NOT COMPLETED|Second Intervention (12 Weeks)||2
2541045|NCT00600028|6229203|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
2541046|NCT00600028|6229202|P2|COMPLETED|Second Intervention (12 Weeks)||8
2541047|NCT00600028|6229203|P1|COMPLETED|Second Intervention (12 Weeks)||12
2541048|NCT00600028|6229202|P2|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|10
2541049|NCT00600028|6229203|P1|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|12
2541050|NCT00600028|6229202|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
2541051|NCT00600028|6229203|P1|NOT COMPLETED|First Intervention (12 Weeks)||1
2541052|NCT00600028|6229202|P2|COMPLETED|First Intervention (12 Weeks)||10
2541053|NCT00600028|6229203|P1|COMPLETED|First Intervention (12 Weeks)||12
2541054|NCT00600028|6229202|P2|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|11
2541055|NCT00600028|6229203|P1|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|13
2541056|NCT00600015|6229217|P2|NOT COMPLETED|Overall Study||35
2541057|NCT00600015|6229218|P1|NOT COMPLETED|Overall Study||60
2541058|NCT00600015|6229217|P2|COMPLETED|Overall Study|Completed >=2 cycles|20
2541059|NCT00600015|6229218|P1|COMPLETED|Overall Study|Completed >=2 cycles|51
2541060|NCT00600015|6229217|P2|STARTED|Overall Study||55
2541061|NCT00600015|6229218|P1|STARTED|Overall Study||111
2541062|NCT00599924|6229233|P7|NOT COMPLETED|Overall Study||5
2541063|NCT00599924|6229234|P6|NOT COMPLETED|Overall Study||4
2541064|NCT00599924|6229235|P5|NOT COMPLETED|Overall Study||6
2541065|NCT00599924|6229236|P4|NOT COMPLETED|Overall Study||8
2541066|NCT00599924|6229237|P3|NOT COMPLETED|Overall Study||2
2541067|NCT00599924|6229238|P2|NOT COMPLETED|Overall Study||5
2541068|NCT00599924|6229239|P1|NOT COMPLETED|Overall Study||3
2541069|NCT00599924|6229233|P7|COMPLETED|Overall Study||3
2541070|NCT00599924|6229234|P6|COMPLETED|Overall Study||2
2541071|NCT00599924|6229235|P5|COMPLETED|Overall Study||3
2541072|NCT00599924|6229236|P4|COMPLETED|Overall Study||4
2541073|NCT00599924|6229237|P3|COMPLETED|Overall Study||3
2541074|NCT00599924|6229238|P2|COMPLETED|Overall Study||4
2541075|NCT00599924|6229239|P1|COMPLETED|Overall Study||1
2541076|NCT00599924|6229233|P7|STARTED|Overall Study||8
2541077|NCT00599924|6229234|P6|STARTED|Overall Study||6
2541078|NCT00599924|6229235|P5|STARTED|Overall Study||9
2541079|NCT00599924|6229236|P4|STARTED|Overall Study||12
2541080|NCT00599924|6229237|P3|STARTED|Overall Study||5
2541081|NCT00599924|6229238|P2|STARTED|Overall Study||9
2541082|NCT00599924|6229239|P1|STARTED|Overall Study||4
2541083|NCT00599872|6229326|P2|NOT COMPLETED|Overall Study||33
2541084|NCT00599872|6229327|P1|NOT COMPLETED|Overall Study||49
2541085|NCT00599872|6229326|P2|COMPLETED|Overall Study||181
2541086|NCT00599872|6229327|P1|COMPLETED|Overall Study||167
2541087|NCT00599872|6229326|P2|STARTED|Overall Study||214
2541088|NCT00599872|6229327|P1|STARTED|Overall Study||216
2541089|NCT00599755|6229343|P1|NOT COMPLETED|Overall Study||19
2541090|NCT00599755|6229343|P1|COMPLETED|Overall Study||49
2541091|NCT00599755|6229343|P1|STARTED|Overall Study||68
2541092|NCT00599521|6229354|P2|NOT COMPLETED|Overall Study||69
2541093|NCT00599521|6229355|P1|NOT COMPLETED|Overall Study||60
2541094|NCT00599521|6229354|P2|COMPLETED|Overall Study||462
2541095|NCT00599521|6229355|P1|COMPLETED|Overall Study||475
2541096|NCT00599521|6229354|P2|STARTED|Overall Study||531
2541097|NCT00599521|6229355|P1|STARTED|Overall Study||535
2541098|NCT00599339|6229369|P1|NOT COMPLETED|Overall Study||664
2541099|NCT00599339|6229369|P1|COMPLETED|Overall Study||1531
2541100|NCT00599339|6229369|P1|Safety Set|Overall Study||2179
2541101|NCT00599339|6229369|P1|STARTED|Overall Study||2195
2541102|NCT00599326|6229471|P1|NOT COMPLETED|Overall Study||2
2541103|NCT00599326|6229471|P1|COMPLETED|Overall Study||8
2541104|NCT00599326|6229471|P1|STARTED|Overall Study||10
2541105|NCT00599313|6229476|P1|NOT COMPLETED|Overall Study||36
2541106|NCT00599313|6229476|P1|COMPLETED|Overall Study||0
2541107|NCT00599313|6229476|P1|STARTED|Overall Study||36
2541108|NCT00599248|6229487|P4|NOT COMPLETED|Overall Study||0
2541109|NCT00599248|6229488|P3|NOT COMPLETED|Overall Study||0
2541110|NCT00599248|6229489|P2|NOT COMPLETED|Overall Study||0
2541111|NCT00599248|6229490|P1|NOT COMPLETED|Overall Study||0
2541112|NCT00599248|6229487|P4|COMPLETED|Overall Study||3
2541113|NCT00599248|6229488|P3|COMPLETED|Overall Study||3
2541114|NCT00599248|6229489|P2|COMPLETED|Overall Study||3
2541115|NCT00599248|6229490|P1|COMPLETED|Overall Study||3
2541116|NCT00599248|6229487|P4|STARTED|Overall Study||3
2541117|NCT00599248|6229488|P3|STARTED|Overall Study||3
2541118|NCT00599248|6229489|P2|STARTED|Overall Study||3
2541119|NCT00599248|6229490|P1|STARTED|Overall Study||3
2541120|NCT00599196|6229518|P1|NOT COMPLETED|Overall Study||381
2541121|NCT00599196|6229518|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
2541122|NCT00599196|6229518|P1|STARTED|Overall Study||381
2541123|NCT00599131|6229524|P1|NOT COMPLETED|Overall Study||0
2541124|NCT00599131|6229524|P1|COMPLETED|Overall Study||4
2541125|NCT00599131|6229524|P1|STARTED|Overall Study||4
2541126|NCT00599053|6229534|P2|NOT COMPLETED|Overall Study||0
2541127|NCT00599053|6229535|P1|NOT COMPLETED|Overall Study||0
2541128|NCT00599053|6229534|P2|COMPLETED|Overall Study||2
2541129|NCT00599053|6229535|P1|COMPLETED|Overall Study||5
2541130|NCT00599053|6229534|P2|STARTED|Overall Study||2
2541131|NCT00599053|6229535|P1|STARTED|Overall Study||5
2541132|NCT00599027|6229549|P2|NOT COMPLETED|Overall Study||3
2541133|NCT00599027|6229550|P1|NOT COMPLETED|Overall Study||1
2541134|NCT00599027|6229549|P2|COMPLETED|Overall Study||22
2541135|NCT00599027|6229550|P1|COMPLETED|Overall Study||25
2541136|NCT00599027|6229549|P2|STARTED|Overall Study||25
2541137|NCT00599027|6229550|P1|STARTED|Overall Study||26
2541138|NCT00599014|6229556|P1|NOT COMPLETED|Overall Study||0
2541139|NCT00599014|6229556|P1|COMPLETED|Overall Study||335
2541140|NCT00599014|6229556|P1|STARTED|Overall Study||335
2541141|NCT00598871|6229563|P2|NOT COMPLETED|Overall Study||1
2541142|NCT00598871|6229564|P1|NOT COMPLETED|Overall Study||0
2541143|NCT00598871|6229563|P2|COMPLETED|Overall Study||8
2541144|NCT00598871|6229564|P1|COMPLETED|Overall Study||3
2541145|NCT00598871|6229563|P2|STARTED|Overall Study||9
2541146|NCT00598871|6229564|P1|STARTED|Overall Study||3
2541147|NCT00598832|6229574|P2|NOT COMPLETED|Overall Study||82
2541148|NCT00598832|6229575|P1|NOT COMPLETED|Overall Study||62
2541149|NCT00598832|6229574|P2|COMPLETED|Overall Study||460
2541150|NCT00598832|6229575|P1|COMPLETED|Overall Study||471
2541151|NCT00598832|6229574|P2|STARTED|Overall Study||542
2541152|NCT00598832|6229575|P1|STARTED|Overall Study||533
2541153|NCT00598819|6229589|P1|NOT COMPLETED|Overall Study||0
2541154|NCT00598819|6229589|P1|COMPLETED|Overall Study||14
2541155|NCT00598819|6229589|P1|STARTED|Overall Study||14
2541156|NCT00598806|6229599|P2|NOT COMPLETED|Overall Study||64
2541157|NCT00598806|6229600|P1|NOT COMPLETED|Overall Study||73
2541158|NCT00598806|6229599|P2|COMPLETED|Overall Study||346
2541159|NCT00598806|6229600|P1|COMPLETED|Overall Study||329
2541160|NCT00598806|6229599|P2|STARTED|Overall Study||410
2541161|NCT00598806|6229600|P1|STARTED|Overall Study||402
2541162|NCT00598702|6229628|P8|NOT COMPLETED|Overall Study||0
2541163|NCT00598702|6229629|P7|NOT COMPLETED|Overall Study||1
2541164|NCT00598702|6229630|P6|NOT COMPLETED|Overall Study||12
2541165|NCT00598702|6229631|P5|NOT COMPLETED|Overall Study||3
2541166|NCT00598702|6229632|P4|NOT COMPLETED|Overall Study||8
2541167|NCT00598702|6229633|P3|NOT COMPLETED|Overall Study||2
2541168|NCT00598702|6229634|P2|NOT COMPLETED|Overall Study||2
2541169|NCT00598702|6229635|P1|NOT COMPLETED|Overall Study||0
2541170|NCT00598702|6229628|P8|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|4
2541171|NCT00598702|6229629|P7|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|0
2541172|NCT00598702|6229630|P6|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|30
2541173|NCT00598702|6229631|P5|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|6
2541174|NCT00598702|6229632|P4|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|25
2541175|NCT00598702|6229633|P3|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|5
2541176|NCT00598702|6229634|P2|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
2541177|NCT00598702|6229635|P1|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
2541178|NCT00598702|6229628|P8|STARTED|Overall Study||4
2541179|NCT00598702|6229629|P7|STARTED|Overall Study||1
2541180|NCT00598702|6229630|P6|STARTED|Overall Study||42
2541181|NCT00598702|6229631|P5|STARTED|Overall Study||9
2541182|NCT00598702|6229632|P4|STARTED|Overall Study||33
2541183|NCT00598702|6229633|P3|STARTED|Overall Study||7
2541184|NCT00598702|6229634|P2|STARTED|Overall Study||3
2541185|NCT00598702|6229635|P1|STARTED|Overall Study||1
2541186|NCT00598689|6229679|P2|NOT COMPLETED|Overall Study||0
2541187|NCT00598689|6229680|P1|NOT COMPLETED|Overall Study||0
2541188|NCT00598689|6229679|P2|COMPLETED|Overall Study||40
2541189|NCT00598689|6229680|P1|COMPLETED|Overall Study||40
2541190|NCT00598689|6229679|P2|STARTED|Overall Study||40
2541191|NCT00598689|6229680|P1|STARTED|Overall Study||40
2541192|NCT00598663|6229692|P2|NOT COMPLETED|Second Intervention (6 Months)||1
2541193|NCT00598663|6229693|P1|NOT COMPLETED|Second Intervention (6 Months)||4
2541194|NCT00598663|6229692|P2|COMPLETED|Second Intervention (6 Months)||69
2541195|NCT00598663|6229693|P1|COMPLETED|Second Intervention (6 Months)||69
2541196|NCT00598663|6229692|P2|STARTED|Second Intervention (6 Months)||70
2541197|NCT00598663|6229693|P1|STARTED|Second Intervention (6 Months)||73
2541198|NCT00598663|6229692|P2|NOT COMPLETED|Washout (4 Months)||1
2541199|NCT00598663|6229693|P1|NOT COMPLETED|Washout (4 Months)||0
2541200|NCT00598663|6229692|P2|COMPLETED|Washout (4 Months)||70
2541201|NCT00598663|6229693|P1|COMPLETED|Washout (4 Months)||73
2541202|NCT00598663|6229692|P2|STARTED|Washout (4 Months)||71
2541203|NCT00598663|6229693|P1|STARTED|Washout (4 Months)||73
2541204|NCT00598663|6229692|P2|NOT COMPLETED|First Intervention (6 Months)||6
2541205|NCT00598663|6229693|P1|NOT COMPLETED|First Intervention (6 Months)||3
2541206|NCT00598663|6229692|P2|COMPLETED|First Intervention (6 Months)||71
2541207|NCT00598663|6229693|P1|COMPLETED|First Intervention (6 Months)||73
2541208|NCT00598663|6229692|P2|STARTED|First Intervention (6 Months)||77
2541209|NCT00598663|6229693|P1|STARTED|First Intervention (6 Months)||76
2541210|NCT00598650|6229711|P1|NOT COMPLETED|Overall Study||27
2541211|NCT00598650|6229711|P1|COMPLETED|Overall Study|5 subjects withdrew for multiple reasons|81
2541212|NCT00598650|6229711|P1|STARTED|Overall Study||108
2541213|NCT00598585|6229720|P2|NOT COMPLETED|Overall Study||0
2541214|NCT00598585|6229721|P1|NOT COMPLETED|Overall Study||1
2541215|NCT00598585|6229720|P2|COMPLETED|Overall Study||6
2541216|NCT00598585|6229721|P1|COMPLETED|Overall Study||5
2541217|NCT00598585|6229720|P2|STARTED|Overall Study||6
2541218|NCT00598585|6229721|P1|STARTED|Overall Study||6
2541219|NCT00598559|6229730|P3|NOT COMPLETED|Overall Study||3
2541220|NCT00598559|6229731|P2|NOT COMPLETED|Overall Study||28
2541221|NCT00598559|6229732|P1|NOT COMPLETED|Overall Study||27
2541222|NCT00598559|6229730|P3|COMPLETED|Overall Study|Subjects completed 5 days of treatment|27
2541223|NCT00598559|6229731|P2|COMPLETED|Overall Study|Subjects completed 5 days of treatment|63
2541224|NCT00598559|6229732|P1|COMPLETED|Overall Study|Subjects completed 5 days of treatment|65
2541225|NCT00598559|6229730|P3|STARTED|Overall Study||30
2541226|NCT00598559|6229731|P2|STARTED|Overall Study||91
2541227|NCT00598559|6229732|P1|STARTED|Overall Study||92
2541228|NCT00598507|6229749|P1|NOT COMPLETED|Overall Study||0
2541229|NCT00598507|6229749|P1|COMPLETED|Overall Study||35
2541230|NCT00598507|6229749|P1|STARTED|Overall Study||35
2541231|NCT00598442|6229759|P3|NOT COMPLETED|Overall Study||24
2541232|NCT00598442|6229760|P2|NOT COMPLETED|Overall Study||39
2541233|NCT00598442|6229761|P1|NOT COMPLETED|Overall Study||43
2541234|NCT00598442|6229759|P3|COMPLETED|Overall Study||139
2541235|NCT00598442|6229760|P2|COMPLETED|Overall Study||124
2541236|NCT00598442|6229761|P1|COMPLETED|Overall Study||124
2541237|NCT00598442|6229759|P3|STARTED|Overall Study||163
2541238|NCT00598442|6229760|P2|STARTED|Overall Study||163
2541239|NCT00598442|6229761|P1|STARTED|Overall Study||167
2541240|NCT00598273|6229778|P3|NOT COMPLETED|Overall Study||39
2541241|NCT00598273|6229779|P2|NOT COMPLETED|Overall Study||38
2541242|NCT00598273|6229780|P1|NOT COMPLETED|Overall Study||41
2541243|NCT00598273|6229778|P3|COMPLETED|Overall Study||125
2541244|NCT00598273|6229779|P2|COMPLETED|Overall Study||127
2541245|NCT00598273|6229780|P1|COMPLETED|Overall Study||120
2541246|NCT00598273|6229778|P3|STARTED|Overall Study||164
2541247|NCT00598273|6229779|P2|STARTED|Overall Study||165
2541248|NCT00598273|6229780|P1|STARTED|Overall Study||161
2541249|NCT00598078|6229794|P2|NOT COMPLETED|Period 3 (Day 3)||0
2541250|NCT00598078|6229795|P1|NOT COMPLETED|Period 3 (Day 3)||0
2541251|NCT00598078|6229794|P2|COMPLETED|Period 3 (Day 3)||10
2541252|NCT00598078|6229795|P1|COMPLETED|Period 3 (Day 3)||9
2541253|NCT00598078|6229794|P2|STARTED|Period 3 (Day 3)||10
2541254|NCT00598078|6229795|P1|STARTED|Period 3 (Day 3)||9
2541255|NCT00598078|6229794|P2|NOT COMPLETED|Period 2 (Day 2)||0
2541256|NCT00598078|6229795|P1|NOT COMPLETED|Period 2 (Day 2)||1
2541257|NCT00598078|6229794|P2|COMPLETED|Period 2 (Day 2)||10
2541258|NCT00598078|6229795|P1|COMPLETED|Period 2 (Day 2)||9
2541259|NCT00598078|6229794|P2|STARTED|Period 2 (Day 2)||10
2541260|NCT00598078|6229795|P1|STARTED|Period 2 (Day 2)||10
2541261|NCT00598078|6229794|P2|NOT COMPLETED|Period 1 (Day 1)||0
2541262|NCT00598078|6229795|P1|NOT COMPLETED|Period 1 (Day 1)||0
2541263|NCT00598078|6229794|P2|COMPLETED|Period 1 (Day 1)||10
2541264|NCT00598078|6229795|P1|COMPLETED|Period 1 (Day 1)||10
2541265|NCT00598078|6229794|P2|STARTED|Period 1 (Day 1)||10
2541266|NCT00598078|6229795|P1|STARTED|Period 1 (Day 1)||10
2541267|NCT00597909|6229806|P3|NOT COMPLETED|Overall Study||0
2541268|NCT00597909|6229807|P2|NOT COMPLETED|Overall Study||0
2541269|NCT00597909|6229808|P1|NOT COMPLETED|Overall Study||0
2541270|NCT00597909|6229806|P3|COMPLETED|Overall Study||0
2541271|NCT00597909|6229807|P2|COMPLETED|Overall Study||0
2541272|NCT00597909|6229808|P1|COMPLETED|Overall Study||0
2541273|NCT00597909|6229806|P3|STARTED|Overall Study||0
2541274|NCT00597909|6229807|P2|STARTED|Overall Study||0
2541275|NCT00597909|6229808|P1|STARTED|Overall Study||0
2541276|NCT00597896|6229818|P2|NOT COMPLETED|Overall Study||2
2541277|NCT00597896|6229819|P1|NOT COMPLETED|Overall Study||3
2541278|NCT00597896|6229818|P2|COMPLETED|Overall Study||24
2541279|NCT00597896|6229819|P1|COMPLETED|Overall Study||21
2541280|NCT00597896|6229818|P2|STARTED|Overall Study||26
2541281|NCT00597896|6229819|P1|STARTED|Overall Study||24
2541282|NCT00597818|6229849|P4|NOT COMPLETED|Overall Study||10
2541283|NCT00597818|6229850|P3|NOT COMPLETED|Overall Study||19
2541284|NCT00597818|6229851|P2|NOT COMPLETED|Overall Study||16
2541285|NCT00597818|6229852|P1|NOT COMPLETED|Overall Study||18
2541286|NCT00597818|6229849|P4|COMPLETED|Overall Study||20
2541287|NCT00597818|6229850|P3|COMPLETED|Overall Study||12
2541288|NCT00597818|6229851|P2|COMPLETED|Overall Study||14
2541289|NCT00597818|6229852|P1|COMPLETED|Overall Study||12
2541290|NCT00597818|6229849|P4|STARTED|Overall Study||30
2541291|NCT00597818|6229850|P3|STARTED|Overall Study||31
2541292|NCT00597818|6229851|P2|STARTED|Overall Study||30
2541293|NCT00597818|6229852|P1|STARTED|Overall Study||30
2541294|NCT00597766|6229877|P3|NOT COMPLETED|Follow-up 3, Week 12||0
2541295|NCT00597766|6229878|P2|NOT COMPLETED|Follow-up 3, Week 12||0
2541296|NCT00597766|6229879|P1|NOT COMPLETED|Follow-up 3, Week 12||0
2541297|NCT00597766|6229877|P3|COMPLETED|Follow-up 3, Week 12||9
2541298|NCT00597766|6229878|P2|COMPLETED|Follow-up 3, Week 12||9
2541299|NCT00597766|6229879|P1|COMPLETED|Follow-up 3, Week 12||8
2541300|NCT00597766|6229877|P3|STARTED|Follow-up 3, Week 12||9
2541301|NCT00597766|6229878|P2|STARTED|Follow-up 3, Week 12||9
2541302|NCT00597766|6229879|P1|STARTED|Follow-up 3, Week 12||8
2541303|NCT00597766|6229877|P3|NOT COMPLETED|Follow-up 2, Week 8||1
2541304|NCT00597766|6229878|P2|NOT COMPLETED|Follow-up 2, Week 8||0
2541305|NCT00597766|6229879|P1|NOT COMPLETED|Follow-up 2, Week 8||0
2541306|NCT00597766|6229877|P3|COMPLETED|Follow-up 2, Week 8||9
2541307|NCT00597766|6229878|P2|COMPLETED|Follow-up 2, Week 8||9
2541308|NCT00597766|6229879|P1|COMPLETED|Follow-up 2, Week 8||8
2541309|NCT00597766|6229877|P3|STARTED|Follow-up 2, Week 8||10
2541310|NCT00597766|6229878|P2|STARTED|Follow-up 2, Week 8||9
2541311|NCT00597766|6229879|P1|STARTED|Follow-up 2, Week 8||8
2541312|NCT00597766|6229877|P3|NOT COMPLETED|Follow-up 1, Week 4||0
2541313|NCT00597766|6229878|P2|NOT COMPLETED|Follow-up 1, Week 4||0
2541314|NCT00597766|6229879|P1|NOT COMPLETED|Follow-up 1, Week 4||1
2541315|NCT00597766|6229877|P3|COMPLETED|Follow-up 1, Week 4||10
2541316|NCT00597766|6229878|P2|COMPLETED|Follow-up 1, Week 4||9
2541317|NCT00597766|6229879|P1|COMPLETED|Follow-up 1, Week 4||8
2541318|NCT00597766|6229877|P3|STARTED|Follow-up 1, Week 4||10
2541319|NCT00597766|6229878|P2|STARTED|Follow-up 1, Week 4||9
2541320|NCT00597766|6229879|P1|STARTED|Follow-up 1, Week 4||9
2541321|NCT00597766|6229877|P3|NOT COMPLETED|Enrolled||0
2541322|NCT00597766|6229878|P2|NOT COMPLETED|Enrolled||0
2541323|NCT00597766|6229879|P1|NOT COMPLETED|Enrolled||0
2541324|NCT00597766|6229877|P3|COMPLETED|Enrolled||10
2541325|NCT00597766|6229878|P2|COMPLETED|Enrolled||9
2541326|NCT00597766|6229879|P1|COMPLETED|Enrolled||9
2541327|NCT00597766|6229877|P3|STARTED|Enrolled||10
2541328|NCT00597766|6229878|P2|STARTED|Enrolled||9
2541329|NCT00597766|6229879|P1|STARTED|Enrolled||9
2541330|NCT00597753|6229898|P2|NOT COMPLETED|Overall Study||69
2541331|NCT00597753|6229899|P1|NOT COMPLETED|Overall Study||166
2541332|NCT00597753|6229898|P2|COMPLETED|Overall Study||202
2541333|NCT00597753|6229899|P1|COMPLETED|Overall Study||366
2541334|NCT00597753|6229898|P2|STARTED|Overall Study||271
2541335|NCT00597753|6229899|P1|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin alfa|532
2541336|NCT00597727|6229913|P5|NOT COMPLETED|Open-label Extended Maintenance Phase||2
2541337|NCT00597727|6229914|P4|NOT COMPLETED|Open-label Extended Maintenance Phase||3
2541338|NCT00597727|6229915|P3|NOT COMPLETED|Open-label Extended Maintenance Phase||6
2541339|NCT00597727|6229916|P2|NOT COMPLETED|Open-label Extended Maintenance Phase||0
2541340|NCT00597727|6229917|P1|NOT COMPLETED|Open-label Extended Maintenance Phase||0
2541341|NCT00597727|6229913|P5|COMPLETED|Open-label Extended Maintenance Phase||1
2541342|NCT00597727|6229914|P4|COMPLETED|Open-label Extended Maintenance Phase||14
2541343|NCT00597727|6229915|P3|COMPLETED|Open-label Extended Maintenance Phase||23
2541344|NCT00597727|6229916|P2|COMPLETED|Open-label Extended Maintenance Phase||0
2541345|NCT00597727|6229917|P1|COMPLETED|Open-label Extended Maintenance Phase||0
2541346|NCT00597727|6229913|P5|STARTED|Open-label Extended Maintenance Phase||3
2541347|NCT00597727|6229914|P4|STARTED|Open-label Extended Maintenance Phase||17
2541348|NCT00597727|6229915|P3|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding.|29
2541349|NCT00597727|6229916|P2|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
2541350|NCT00597727|6229917|P1|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
2541351|NCT00597727|6229913|P5|NOT COMPLETED|12 Month Blinded Phase||1
2541352|NCT00597727|6229914|P4|NOT COMPLETED|12 Month Blinded Phase||10
2541353|NCT00597727|6229915|P3|NOT COMPLETED|12 Month Blinded Phase||0
2541354|NCT00597727|6229916|P2|NOT COMPLETED|12 Month Blinded Phase||0
2541355|NCT00597727|6229917|P1|NOT COMPLETED|12 Month Blinded Phase||0
2541356|NCT00597727|6229913|P5|COMPLETED|12 Month Blinded Phase||3
2541357|NCT00597727|6229914|P4|COMPLETED|12 Month Blinded Phase||17
2541358|NCT00597727|6229915|P3|COMPLETED|12 Month Blinded Phase||0
2541359|NCT00597727|6229916|P2|COMPLETED|12 Month Blinded Phase||15
2541360|NCT00597727|6229917|P1|COMPLETED|12 Month Blinded Phase||14
2541361|NCT00597727|6229913|P5|STARTED|12 Month Blinded Phase||4
2541362|NCT00597727|6229914|P4|STARTED|12 Month Blinded Phase||27
2541363|NCT00597727|6229915|P3|STARTED|12 Month Blinded Phase||0
2541364|NCT00597727|6229916|P2|STARTED|12 Month Blinded Phase||15
2541365|NCT00597727|6229917|P1|STARTED|12 Month Blinded Phase||14
2541366|NCT00597714|6229933|P3|NOT COMPLETED|Overall Study||10
2541367|NCT00597714|6229934|P2|NOT COMPLETED|Overall Study||46
2541368|NCT00597714|6229935|P1|NOT COMPLETED|Overall Study||56
2541369|NCT00597714|6229933|P3|COMPLETED|Overall Study||84
2541370|NCT00597714|6229934|P2|COMPLETED|Overall Study||11
2541371|NCT00597714|6229935|P1|COMPLETED|Overall Study||24
2541372|NCT00597714|6229933|P3|STARTED|Overall Study||94
2541373|NCT00597714|6229934|P2|STARTED|Overall Study||57
2541374|NCT00597714|6229935|P1|STARTED|Overall Study||80
2541375|NCT00597701|6229947|P2|NOT COMPLETED|Overall Study||8
2541376|NCT00597701|6229948|P1|NOT COMPLETED|Overall Study||7
2541377|NCT00597701|6229947|P2|COMPLETED|Overall Study||13
2541378|NCT00597701|6229948|P1|COMPLETED|Overall Study||18
2541379|NCT00597701|6229947|P2|STARTED|Overall Study||21
2541380|NCT00597701|6229948|P1|STARTED|Overall Study||25
2541381|NCT00597675|6229956|P2|NOT COMPLETED|Open Label Phase||0
2541382|NCT00597675|6229957|P1|NOT COMPLETED|Open Label Phase||0
2541383|NCT00597675|6229956|P2|COMPLETED|Open Label Phase||5
2541384|NCT00597675|6229957|P1|COMPLETED|Open Label Phase||2
2541385|NCT00597675|6229956|P2|STARTED|Open Label Phase||5
2541386|NCT00597675|6229957|P1|STARTED|Open Label Phase|Patients previously on placebo were crossed over onto open label peanut OIT|2
2541387|NCT00597675|6229956|P2|NOT COMPLETED|Blinded Phase||1
2541388|NCT00597675|6229957|P1|NOT COMPLETED|Blinded Phase||2
2541389|NCT00597675|6229956|P2|COMPLETED|Blinded Phase||5
2541390|NCT00597675|6229957|P1|COMPLETED|Blinded Phase||2
2541391|NCT00597675|6229956|P2|STARTED|Blinded Phase||6
2541392|NCT00597675|6229957|P1|STARTED|Blinded Phase||4
2541393|NCT00597584|6229970|P2|NOT COMPLETED|Overall Study||63
2541394|NCT00597584|6229971|P1|NOT COMPLETED|Overall Study||128
2541395|NCT00597584|6229970|P2|COMPLETED|Overall Study||211
2541396|NCT00597584|6229971|P1|COMPLETED|Overall Study||421
2541397|NCT00597584|6229970|P2|STARTED|Overall Study||274
2541398|NCT00597584|6229971|P1|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin|549
2541399|NCT00597558|6229981|P1|NOT COMPLETED|Overall Study||4
2541400|NCT00597558|6229981|P1|COMPLETED|Overall Study||9
2541401|NCT00597558|6229981|P1|STARTED|Overall Study||13
2541402|NCT00597545|6229989|P2|NOT COMPLETED|Overall Study||0
2541403|NCT00597545|6229990|P1|NOT COMPLETED|Overall Study||0
2541404|NCT00597545|6229989|P2|COMPLETED|Overall Study||6
2541405|NCT00597545|6229990|P1|COMPLETED|Overall Study||4
2541406|NCT00597545|6229989|P2|STARTED|Overall Study||6
2541407|NCT00597545|6229990|P1|STARTED|Overall Study||4
2541408|NCT00597519|6229996|P1|NOT COMPLETED|Overall Study||1
2541409|NCT00597519|6229996|P1|COMPLETED|Overall Study||27
2541410|NCT00597519|6229996|P1|STARTED|Overall Study||28
2541411|NCT00597506|6230000|P1|NOT COMPLETED|Overall Study||1
2541412|NCT00597506|6230000|P1|COMPLETED|Overall Study||49
2541413|NCT00597506|6230000|P1|STARTED|Overall Study||50
2541414|NCT00597493|6230005|P1|NOT COMPLETED|Overall Study||0
2541415|NCT00597493|6230005|P1|COMPLETED|Overall Study||32
2541416|NCT00597493|6230005|P1|STARTED|Overall Study||32
2541417|NCT00597428|6230024|P2|NOT COMPLETED|Overall Study||71
2541418|NCT00597428|6230025|P1|NOT COMPLETED|Overall Study||61
2541419|NCT00597428|6230024|P2|COMPLETED|Overall Study||152
2541420|NCT00597428|6230025|P1|COMPLETED|Overall Study||153
2541421|NCT00597428|6230024|P2|STARTED|Overall Study||223
2541422|NCT00597428|6230025|P1|STARTED|Overall Study||214
2541423|NCT00597402|6230041|P1|NOT COMPLETED|Overall Study||0
2541424|NCT00597402|6230041|P1|COMPLETED|Overall Study||125
2541425|NCT00597402|6230041|P1|STARTED|Overall Study||125
2541426|NCT00597376|6230050|P2|NOT COMPLETED|Overall Study||4
2541427|NCT00597376|6230051|P1|NOT COMPLETED|Overall Study||8
2541428|NCT00597376|6230050|P2|COMPLETED|Overall Study|All participants started (53) were included in primary analyses.|49
2541429|NCT00597376|6230051|P1|COMPLETED|Overall Study|All participants started (51) were included in primary analyses.|43
2541430|NCT00597376|6230050|P2|STARTED|Overall Study||53
2541431|NCT00597376|6230051|P1|STARTED|Overall Study||51
2541432|NCT00597272|6230068|P7|NOT COMPLETED|Overall Study||0
2541433|NCT00597272|6230069|P6|NOT COMPLETED|Overall Study||0
2541434|NCT00597272|6230070|P5|NOT COMPLETED|Overall Study||0
2541435|NCT00597272|6230071|P4|NOT COMPLETED|Overall Study||0
2541436|NCT00597272|6230072|P3|NOT COMPLETED|Overall Study||0
2541437|NCT00597272|6230073|P2|NOT COMPLETED|Overall Study||0
2541438|NCT00597272|6230074|P1|NOT COMPLETED|Overall Study||0
2541439|NCT00597272|6230068|P7|COMPLETED|Overall Study||10
2541440|NCT00597272|6230069|P6|COMPLETED|Overall Study||10
2541441|NCT00597272|6230070|P5|COMPLETED|Overall Study||1
2541442|NCT00597272|6230071|P4|COMPLETED|Overall Study||1
2541443|NCT00597272|6230072|P3|COMPLETED|Overall Study||10
2541444|NCT00597272|6230073|P2|COMPLETED|Overall Study||1
2541445|NCT00597272|6230074|P1|COMPLETED|Overall Study||1
2541446|NCT00597272|6230068|P7|STARTED|Overall Study||10
2541447|NCT00597272|6230069|P6|STARTED|Overall Study||10
2541448|NCT00597272|6230070|P5|STARTED|Overall Study||1
2541449|NCT00597272|6230071|P4|STARTED|Overall Study||1
2541450|NCT00597272|6230072|P3|STARTED|Overall Study||10
2541451|NCT00597272|6230073|P2|STARTED|Overall Study||1
2541452|NCT00597272|6230074|P1|STARTED|Overall Study||1
2541453|NCT00597207|6230092|P2|NOT COMPLETED|Overall Study||7
2541454|NCT00597207|6230093|P1|NOT COMPLETED|Overall Study||5
2541455|NCT00597207|6230092|P2|COMPLETED|Overall Study||2125
2541456|NCT00597207|6230093|P1|COMPLETED|Overall Study||2094
2541457|NCT00597207|6230092|P2|STARTED|Overall Study||2132
2541458|NCT00597207|6230093|P1|STARTED|Overall Study||2099
2541459|NCT00597116|6230101|P2|NOT COMPLETED|Overall Study||11
2541460|NCT00597116|6230102|P1|NOT COMPLETED|Overall Study||14
2541461|NCT00597116|6230101|P2|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
2541462|NCT00597116|6230102|P1|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
2541463|NCT00597116|6230101|P2|STARTED|Overall Study||11
2541464|NCT00597116|6230102|P1|STARTED|Overall Study||14
2541465|NCT00597038|6230116|P2|NOT COMPLETED|Overall Study||4
2541466|NCT00597038|6230117|P1|NOT COMPLETED|Overall Study||2
2541467|NCT00597038|6230116|P2|COMPLETED|Overall Study|Two patients withdrew, one did not complete due to progressive disease, one patient died.|30
2541468|NCT00597038|6230117|P1|COMPLETED|Overall Study|One did not complete due to PI decision, one did not complete due to progressive disease.|14
2541469|NCT00597038|6230116|P2|STARTED|Overall Study||34
2541470|NCT00597038|6230117|P1|STARTED|Overall Study||16
2541471|NCT00597012|6230128|P2|NOT COMPLETED|Overall Study||8
2541472|NCT00597012|6230129|P1|NOT COMPLETED|Overall Study||13
2541473|NCT00597012|6230128|P2|COMPLETED|Overall Study||169
2541474|NCT00597012|6230129|P1|COMPLETED|Overall Study||161
2541475|NCT00597012|6230128|P2|STARTED|Overall Study||177
2541476|NCT00597012|6230129|P1|STARTED|Overall Study||174
2541477|NCT00596960|6230141|P2|NOT COMPLETED|Overall Study||9
2541478|NCT00596960|6230142|P1|NOT COMPLETED|Overall Study||11
2541479|NCT00596960|6230141|P2|COMPLETED|Overall Study||60
2541480|NCT00596960|6230142|P1|COMPLETED|Overall Study||59
2541481|NCT00596960|6230141|P2|STARTED|Overall Study|One subject did not have any alcohol use data and thus was excluded from the statistical analysis|69
2541482|NCT00596960|6230142|P1|STARTED|Overall Study||70
2541483|NCT00596947|6230154|P2|NOT COMPLETED|Overall Study||3
2541484|NCT00596947|6230155|P1|NOT COMPLETED|Overall Study||6
2541485|NCT00596947|6230154|P2|COMPLETED|Overall Study||6
2541486|NCT00596947|6230155|P1|COMPLETED|Overall Study||3
2541487|NCT00596947|6230154|P2|STARTED|Overall Study||9
2541488|NCT00596947|6230155|P1|STARTED|Overall Study||9
2541489|NCT00596934|6230195|P1|NOT COMPLETED|Overall Study||2
2541490|NCT00596934|6230195|P1|COMPLETED|Overall Study||7
2541491|NCT00596934|6230195|P1|STARTED|Overall Study||9
2541492|NCT00596830|6230208|P2|NOT COMPLETED|Overall Study||339
2541493|NCT00596830|6230209|P1|NOT COMPLETED|Overall Study||342
2541494|NCT00596830|6230208|P2|COMPLETED|Overall Study||0
2541495|NCT00596830|6230209|P1|COMPLETED|Overall Study||0
2541496|NCT00596830|6230208|P2|Treated|Overall Study||332
2541497|NCT00596830|6230209|P1|Treated|Overall Study|1 participant in this group only received chemo and did not complete due to death.|339
2541498|NCT00596830|6230208|P2|STARTED|Overall Study||339
2541499|NCT00596830|6230209|P1|STARTED|Overall Study|1 participant in this group only received paclitaxel and carboplatin (chemo).|342
2541500|NCT00596817|6230235|P2|NOT COMPLETED|Double-blind Period||79
2541501|NCT00596817|6230236|P1|NOT COMPLETED|Double-blind Period||88
2541502|NCT00596817|6230235|P2|COMPLETED|Double-blind Period||125
2541503|NCT00596817|6230236|P1|COMPLETED|Double-blind Period||104
2541504|NCT00596817|6230235|P2|STARTED|Double-blind Period|206 patients were randomised. 2 did not receive study medication. 204 is FAS.|204
2541505|NCT00596817|6230236|P1|STARTED|Double-blind Period|194 patients were randomised. 2 did not receive study medication. 192 is full-analysis set (FAS).|192
2541506|NCT00596817|6230235|P2|NOT COMPLETED|Open-label Period to Double-blind Period||92
2541507|NCT00596817|6230236|P1|NOT COMPLETED|Open-label Period to Double-blind Period||0
2541508|NCT00596817|6230235|P2|COMPLETED|Open-label Period to Double-blind Period||400
2541509|NCT00596817|6230236|P1|COMPLETED|Open-label Period to Double-blind Period||0
2541510|NCT00596817|6230235|P2|STARTED|Open-label Period to Double-blind Period||492
2541511|NCT00596817|6230236|P1|STARTED|Open-label Period to Double-blind Period||0
2541512|NCT00596817|6230235|P2|NOT COMPLETED|Open-label Period||147
2541513|NCT00596817|6230236|P1|NOT COMPLETED|Open-label Period||0
2541514|NCT00596817|6230235|P2|COMPLETED|Open-label Period||492
2541515|NCT00596817|6230236|P1|COMPLETED|Open-label Period||0
2541516|NCT00596817|6230235|P2|STARTED|Open-label Period||639
2541517|NCT00596817|6230236|P1|STARTED|Open-label Period||0
2541518|NCT00596752|6230261|P2|NOT COMPLETED|Overall Study||143
2541519|NCT00596752|6230262|P1|NOT COMPLETED|Overall Study||126
2541520|NCT00596752|6230261|P2|COMPLETED|Overall Study||282
2541521|NCT00596752|6230262|P1|COMPLETED|Overall Study||289
2541522|NCT00596752|6230261|P2|Randomized and Treated|Overall Study||424
2541523|NCT00596752|6230262|P1|Randomized and Treated|Overall Study||415
2541524|NCT00596752|6230261|P2|STARTED|Overall Study||425
2541525|NCT00596752|6230262|P1|STARTED|Overall Study||415
2541526|NCT00596687|6230292|P2|NOT COMPLETED|Overall Study||9
2541527|NCT00596687|6230293|P1|NOT COMPLETED|Overall Study||14
2541528|NCT00596687|6230292|P2|COMPLETED|Overall Study||107
2541529|NCT00596687|6230293|P1|COMPLETED|Overall Study||104
2541530|NCT00596687|6230292|P2|STARTED|Overall Study||116
2541531|NCT00596687|6230293|P1|STARTED|Overall Study||118
2541532|NCT00596635|6230304|P3|NOT COMPLETED|Overall Study||8
2541533|NCT00596635|6230305|P2|NOT COMPLETED|Overall Study||13
2541534|NCT00596635|6230306|P1|NOT COMPLETED|Overall Study||7
2541535|NCT00596635|6230304|P3|COMPLETED|Overall Study||11
2541536|NCT00596635|6230305|P2|COMPLETED|Overall Study||7
2541537|NCT00596635|6230306|P1|COMPLETED|Overall Study||10
2541538|NCT00596635|6230304|P3|STARTED|Overall Study||19
2541539|NCT00596635|6230305|P2|STARTED|Overall Study||20
2541540|NCT00596635|6230306|P1|STARTED|Overall Study||17
2541541|NCT00596622|6230323|P1|NOT COMPLETED|Overall Study||13
2541542|NCT00596622|6230323|P1|COMPLETED|Overall Study||33
2541543|NCT00596622|6230323|P1|STARTED|Overall Study||46
2541544|NCT00596466|6230332|P1|NOT COMPLETED|Overall Study||17
2541545|NCT00596466|6230332|P1|COMPLETED|Overall Study||58
2541546|NCT00596466|6230332|P1|Enrolled, Treated|Overall Study||73
2541547|NCT00596466|6230332|P1|STARTED|Overall Study||75
2541548|NCT00596453|6230340|P2|NOT COMPLETED|Overall Study||3
2541549|NCT00596453|6230341|P1|NOT COMPLETED|Overall Study||1
2541550|NCT00596453|6230340|P2|COMPLETED|Overall Study||12
2541551|NCT00596453|6230341|P1|COMPLETED|Overall Study||12
2541552|NCT00596453|6230340|P2|STARTED|Overall Study||15
2541553|NCT00596453|6230341|P1|STARTED|Overall Study||13
2541554|NCT00596440|6230349|P2|NOT COMPLETED|Overall Study||80
2541555|NCT00596440|6230350|P1|NOT COMPLETED|Overall Study||65
2541556|NCT00596440|6230349|P2|COMPLETED|Overall Study||41
2541557|NCT00596440|6230350|P1|COMPLETED|Overall Study||48
2541558|NCT00596440|6230349|P2|Showed to First Treatment Session|Overall Study||52
2541559|NCT00596440|6230350|P1|Showed to First Treatment Session|Overall Study||61
2541560|NCT00596440|6230349|P2|Showed to Eligibility Visit|Overall Study||72
2541561|NCT00596440|6230350|P1|Showed to Eligibility Visit|Overall Study||85
2541562|NCT00596440|6230349|P2|STARTED|Overall Study||121
2541563|NCT00596440|6230350|P1|STARTED|Overall Study||113
2541564|NCT00596427|6230362|P2|NOT COMPLETED|Overall Study||2
2541565|NCT00596427|6230363|P1|NOT COMPLETED|Overall Study||4
2541566|NCT00596427|6230362|P2|COMPLETED|Overall Study||28
2541567|NCT00596427|6230363|P1|COMPLETED|Overall Study||26
2541568|NCT00596427|6230362|P2|STARTED|Overall Study||30
2541569|NCT00596427|6230363|P1|STARTED|Overall Study||30
2541570|NCT00596362|6230391|P1|NOT COMPLETED|Overall Study||1
2541571|NCT00596362|6230391|P1|COMPLETED|Overall Study||0
2541572|NCT00596362|6230391|P1|STARTED|Overall Study||1
2541573|NCT00596271|6230398|P3|NOT COMPLETED|Overall Study||1
2541574|NCT00596271|6230399|P2|NOT COMPLETED|Overall Study||6
2541575|NCT00596271|6230400|P1|NOT COMPLETED|Overall Study||5
2541576|NCT00596271|6230398|P3|COMPLETED|Overall Study||61
2541577|NCT00596271|6230399|P2|COMPLETED|Overall Study||59
2541578|NCT00596271|6230400|P1|COMPLETED|Overall Study||60
2541579|NCT00596271|6230398|P3|STARTED|Overall Study||62
2541580|NCT00596271|6230399|P2|STARTED|Overall Study||65
2541581|NCT00596271|6230400|P1|STARTED|Overall Study||65
2541582|NCT00596167|6230409|P1|NOT COMPLETED|Overall Study||0
2541583|NCT00596167|6230409|P1|COMPLETED|Overall Study||6
2541584|NCT00596167|6230409|P1|STARTED|Overall Study|All recruited subjects completed the study.|6
2541585|NCT00596102|6230416|P3|NOT COMPLETED|Up to Month 60||637
2541586|NCT00596102|6230417|P2|NOT COMPLETED|Up to Month 60||338
2541587|NCT00596102|6230418|P1|NOT COMPLETED|Up to Month 60||2181
2541588|NCT00596102|6230416|P3|COMPLETED|Up to Month 60||0
2541589|NCT00596102|6230417|P2|COMPLETED|Up to Month 60||0
2541590|NCT00596102|6230418|P1|COMPLETED|Up to Month 60|"long-term safety follow-up beyond Month 6 for a sub-set of subjects in IC51 group only"|102
2541591|NCT00596102|6230416|P3|STARTED|Up to Month 60||637
2541592|NCT00596102|6230417|P2|STARTED|Up to Month 60||338
2541593|NCT00596102|6230418|P1|STARTED|Up to Month 60||2283
2541594|NCT00596102|6230416|P3|NOT COMPLETED|Up to Month 6||0
2541595|NCT00596102|6230417|P2|NOT COMPLETED|Up to Month 6||0
2541596|NCT00596102|6230418|P1|NOT COMPLETED|Up to Month 6||0
2541597|NCT00596102|6230416|P3|COMPLETED|Up to Month 6||637
2541598|NCT00596102|6230417|P2|COMPLETED|Up to Month 6||338
2541599|NCT00596102|6230418|P1|COMPLETED|Up to Month 6||2283
2541600|NCT00596102|6230416|P3|STARTED|Up to Month 6||637
2541601|NCT00596102|6230417|P2|STARTED|Up to Month 6||338
2541602|NCT00596102|6230418|P1|STARTED|Up to Month 6||2283
2541603|NCT00596011|6230427|P2|NOT COMPLETED|Overall Study||10
2541604|NCT00596011|6230428|P1|NOT COMPLETED|Overall Study||13
2541605|NCT00596011|6230427|P2|COMPLETED|Overall Study||38
2541606|NCT00596011|6230428|P1|COMPLETED|Overall Study||36
2541607|NCT00596011|6230427|P2|STARTED|Overall Study||48
2541608|NCT00596011|6230428|P1|STARTED|Overall Study||49
2541609|NCT00595959|6230444|P1|NOT COMPLETED|Overall Study||2
2541610|NCT00595959|6230444|P1|COMPLETED|Overall Study||63
2541611|NCT00595959|6230444|P1|STARTED|Overall Study||65
2541612|NCT00595946|6230461|P2|NOT COMPLETED|Overall Study||69
2541613|NCT00595946|6230462|P1|NOT COMPLETED|Overall Study||64
2541614|NCT00595946|6230461|P2|COMPLETED|Overall Study||152
2541615|NCT00595946|6230462|P1|COMPLETED|Overall Study||154
2541616|NCT00595946|6230461|P2|STARTED|Overall Study||221
2541617|NCT00595946|6230462|P1|STARTED|Overall Study||218
2541618|NCT00595920|6230478|P1|NOT COMPLETED|Overall Study||116
2541619|NCT00595920|6230478|P1|COMPLETED|Overall Study||0
2541620|NCT00595920|6230478|P1|Patients Dosed|Overall Study|116 patients enrolled; however, only 38 received at least 1 dose.|38
2541621|NCT00595920|6230478|P1|STARTED|Overall Study||116
2541622|NCT00595881|6230482|P1|NOT COMPLETED|Overall Study||0
2541623|NCT00595881|6230482|P1|COMPLETED|Overall Study||420
2541624|NCT00595881|6230482|P1|STARTED|Overall Study||420
2541625|NCT00595868|6230489|P2|NOT COMPLETED|Overall Study||50
2541626|NCT00595868|6230490|P1|NOT COMPLETED|Overall Study||45
2541627|NCT00595868|6230489|P2|COMPLETED|Overall Study||61
2541628|NCT00595868|6230490|P1|COMPLETED|Overall Study||62
2541629|NCT00595868|6230489|P2|STARTED|Overall Study||111
2541630|NCT00595868|6230490|P1|STARTED|Overall Study||107
2541631|NCT00595790|6230501|P3|NOT COMPLETED|Overall Study||3
2541632|NCT00595790|6230502|P2|NOT COMPLETED|Overall Study||1
2541633|NCT00595790|6230503|P1|NOT COMPLETED|Overall Study||2
2541634|NCT00595790|6230501|P3|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|122
2541635|NCT00595790|6230502|P2|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
2541636|NCT00595790|6230503|P1|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
2541637|NCT00595790|6230501|P3|STARTED|Overall Study|125 subjects randomized to this group, 124 subjects received 1x6 mcg.(Safety Population: N=124)|125
2541638|NCT00595790|6230502|P2|STARTED|Overall Study|124 subjects randomized to this group, 125 subjects received 1x12 mcg.(Safety Population: N=125)|124
2541639|NCT00595790|6230503|P1|STARTED|Overall Study||125
2541640|NCT00595764|6230513|P2|NOT COMPLETED|Overall Study||43
2541641|NCT00595764|6230514|P1|NOT COMPLETED|Overall Study||39
2541642|NCT00595764|6230513|P2|COMPLETED|Overall Study||27
2541643|NCT00595764|6230514|P1|COMPLETED|Overall Study||32
2541644|NCT00595764|6230513|P2|STARTED|Overall Study||70
2541645|NCT00595764|6230514|P1|STARTED|Overall Study||71
2541646|NCT00595621|6230530|P2|NOT COMPLETED|Randomization and Study||1
2541647|NCT00595621|6230531|P1|NOT COMPLETED|Randomization and Study||2
2541648|NCT00595621|6230530|P2|COMPLETED|Randomization and Study||8
2541649|NCT00595621|6230531|P1|COMPLETED|Randomization and Study||8
2541650|NCT00595621|6230530|P2|STARTED|Randomization and Study||9
2541651|NCT00595621|6230531|P1|STARTED|Randomization and Study||10
2541652|NCT00595621|6230530|P2|NOT COMPLETED|Open Label Run in||0
2541653|NCT00595621|6230531|P1|NOT COMPLETED|Open Label Run in||3
2541654|NCT00595621|6230530|P2|COMPLETED|Open Label Run in||0
2541655|NCT00595621|6230531|P1|COMPLETED|Open Label Run in||19
2541656|NCT00595621|6230530|P2|STARTED|Open Label Run in||0
2541657|NCT00595621|6230531|P1|STARTED|Open Label Run in||22
2541658|NCT00595582|6230548|P1|NOT COMPLETED|Overall Study||10
2541659|NCT00595582|6230548|P1|COMPLETED|Overall Study||0
2541660|NCT00595582|6230548|P1|STARTED|Overall Study||10
2541661|NCT00595556|6230554|P2|NOT COMPLETED|Overall Study||1
2541662|NCT00595556|6230555|P1|NOT COMPLETED|Overall Study||3
2541663|NCT00595556|6230554|P2|COMPLETED|Overall Study||19
2541664|NCT00595556|6230555|P1|COMPLETED|Overall Study||17
2541665|NCT00595556|6230554|P2|STARTED|Overall Study||20
2541666|NCT00595556|6230555|P1|STARTED|Overall Study||20
2541667|NCT00595530|6230569|P1|NOT COMPLETED|Overall Study||0
2541668|NCT00595530|6230569|P1|COMPLETED|Overall Study||3
2541669|NCT00595530|6230569|P1|STARTED|Overall Study||3
2541670|NCT00595517|6230574|P1|NOT COMPLETED|Overall Study||19
2541671|NCT00595517|6230574|P1|COMPLETED|Overall Study||111
2541672|NCT00595517|6230574|P1|STARTED|Overall Study||130
2541673|NCT00595504|6230583|P2|NOT COMPLETED|Overall Study||3
2541674|NCT00595504|6230584|P1|NOT COMPLETED|Overall Study||2
2541675|NCT00595504|6230583|P2|COMPLETED|Overall Study||6
2541676|NCT00595504|6230584|P1|COMPLETED|Overall Study||14
2541677|NCT00595504|6230583|P2|STARTED|Overall Study||9
2541678|NCT00595504|6230584|P1|STARTED|Overall Study||16
2541679|NCT00595478|6230596|P2|NOT COMPLETED|36-week Follow-up Period||8
2541680|NCT00595478|6230597|P1|NOT COMPLETED|36-week Follow-up Period||9
2541681|NCT00595478|6230596|P2|COMPLETED|36-week Follow-up Period||30
2541682|NCT00595478|6230597|P1|COMPLETED|36-week Follow-up Period||28
2541683|NCT00595478|6230596|P2|STARTED|36-week Follow-up Period||38
2541684|NCT00595478|6230597|P1|STARTED|36-week Follow-up Period||37
2541685|NCT00595478|6230596|P2|NOT COMPLETED|Treatment||0
2541686|NCT00595478|6230597|P1|NOT COMPLETED|Treatment||0
2541687|NCT00595478|6230596|P2|COMPLETED|Treatment||38
2541688|NCT00595478|6230597|P1|COMPLETED|Treatment||37
2541689|NCT00595478|6230596|P2|STARTED|Treatment||38
2541690|NCT00595478|6230597|P1|STARTED|Treatment||37
2541691|NCT00595465|6230608|P3|NOT COMPLETED|Overall Study||7
2541692|NCT00595465|6230609|P2|NOT COMPLETED|Overall Study||4
2541693|NCT00595465|6230610|P1|NOT COMPLETED|Overall Study||6
2541694|NCT00595465|6230608|P3|COMPLETED|Overall Study||121
2541695|NCT00595465|6230609|P2|COMPLETED|Overall Study||125
2541696|NCT00595465|6230610|P1|COMPLETED|Overall Study||124
2541697|NCT00595465|6230608|P3|STARTED|Overall Study||128
2541698|NCT00595465|6230609|P2|STARTED|Overall Study||129
2541699|NCT00595465|6230610|P1|STARTED|Overall Study||130
2541700|NCT00595413|6230622|P4|NOT COMPLETED|Overall Study||4
2541701|NCT00595413|6230623|P3|NOT COMPLETED|Overall Study||8
2541702|NCT00595413|6230624|P2|NOT COMPLETED|Overall Study||5
2541703|NCT00595413|6230625|P1|NOT COMPLETED|Overall Study||7
2541704|NCT00595413|6230622|P4|COMPLETED|Overall Study||75
2541705|NCT00595413|6230623|P3|COMPLETED|Overall Study||70
2541706|NCT00595413|6230624|P2|COMPLETED|Overall Study||73
2541707|NCT00595413|6230625|P1|COMPLETED|Overall Study||69
2541708|NCT00595413|6230622|P4|STARTED|Overall Study||79
2541709|NCT00595413|6230623|P3|STARTED|Overall Study||78
2541710|NCT00595413|6230624|P2|STARTED|Overall Study||78
2541711|NCT00595413|6230625|P1|STARTED|Overall Study||76
2541712|NCT00595361|6230653|P2|NOT COMPLETED|Overall Study||0
2541713|NCT00595361|6230654|P1|NOT COMPLETED|Overall Study||0
2541714|NCT00595361|6230653|P2|COMPLETED|Overall Study||18
2541715|NCT00595361|6230654|P1|COMPLETED|Overall Study||12
2541716|NCT00595361|6230653|P2|STARTED|Overall Study||18
2541717|NCT00595361|6230654|P1|STARTED|Overall Study||12
2541718|NCT00595335|6230666|P2|NOT COMPLETED|Six Months to Twelve Months||1
2541719|NCT00595335|6230667|P1|NOT COMPLETED|Six Months to Twelve Months||1
2541720|NCT00595335|6230666|P2|COMPLETED|Six Months to Twelve Months||9
2541721|NCT00595335|6230667|P1|COMPLETED|Six Months to Twelve Months||10
2541722|NCT00595335|6230666|P2|STARTED|Six Months to Twelve Months||10
2541723|NCT00595335|6230667|P1|STARTED|Six Months to Twelve Months||11
2541724|NCT00595335|6230666|P2|NOT COMPLETED|Baseline to Six Months||2
2541725|NCT00595335|6230667|P1|NOT COMPLETED|Baseline to Six Months||2
2541726|NCT00595335|6230666|P2|COMPLETED|Baseline to Six Months||10
2541727|NCT00595335|6230667|P1|COMPLETED|Baseline to Six Months||11
2541728|NCT00595335|6230666|P2|STARTED|Baseline to Six Months||12
2541729|NCT00595335|6230667|P1|STARTED|Baseline to Six Months||13
2541730|NCT00595309|6230687|P1|NOT COMPLETED|Overall Study||4
2541731|NCT00595309|6230687|P1|COMPLETED|Overall Study||194
2541732|NCT00595309|6230687|P1|STARTED|Overall Study||198
2541733|NCT00595270|6230694|P3|NOT COMPLETED|Overall Study||8
2541734|NCT00595270|6230695|P2|NOT COMPLETED|Overall Study||10
2541735|NCT00595270|6230696|P1|NOT COMPLETED|Overall Study||6
2541736|NCT00595270|6230694|P3|COMPLETED|Overall Study||108
2541737|NCT00595270|6230695|P2|COMPLETED|Overall Study||107
2541738|NCT00595270|6230696|P1|COMPLETED|Overall Study||110
2541739|NCT00595270|6230694|P3|STARTED|Overall Study||116
2541740|NCT00595270|6230695|P2|STARTED|Overall Study||117
2541741|NCT00595270|6230696|P1|STARTED|Overall Study||116
2541742|NCT00595231|6230706|P2|NOT COMPLETED|Overall Study||5
2541743|NCT00595231|6230707|P1|NOT COMPLETED|Overall Study||5
2541744|NCT00595231|6230706|P2|COMPLETED|Overall Study||114
2541745|NCT00595231|6230707|P1|COMPLETED|Overall Study||115
2541746|NCT00595231|6230706|P2|STARTED|Overall Study||119
2541747|NCT00595231|6230707|P1|STARTED|Overall Study||120
2541748|NCT00595153|6230726|P3|NOT COMPLETED|Overall Study||25
2541749|NCT00595153|6230727|P2|NOT COMPLETED|Overall Study||16
2541750|NCT00595153|6230728|P1|NOT COMPLETED|Overall Study||4
2541751|NCT00595153|6230726|P3|COMPLETED|Overall Study||36
2541752|NCT00595153|6230727|P2|COMPLETED|Overall Study||26
2541753|NCT00595153|6230728|P1|COMPLETED|Overall Study||20
2541754|NCT00595153|6230726|P3|STARTED|Overall Study||61
2541755|NCT00595153|6230727|P2|STARTED|Overall Study||42
2541756|NCT00595153|6230728|P1|STARTED|Overall Study||24
2541757|NCT00595127|6230736|P1|NOT COMPLETED|Overall Study||10
2541758|NCT00595127|6230736|P1|COMPLETED|Overall Study||11
2541759|NCT00595127|6230736|P1|STARTED|Overall Study||21
2541760|NCT00595114|6230742|P2|NOT COMPLETED|Overall Study||0
2541761|NCT00595114|6230743|P1|NOT COMPLETED|Overall Study||0
2541762|NCT00595114|6230742|P2|COMPLETED|Overall Study||19
2541763|NCT00595114|6230743|P1|COMPLETED|Overall Study||24
2541764|NCT00595114|6230742|P2|STARTED|Overall Study||19
2541765|NCT00595114|6230743|P1|STARTED|Overall Study||24
2541766|NCT00595088|6230749|P1|NOT COMPLETED|Overall Study||40
2541767|NCT00595088|6230749|P1|COMPLETED|Overall Study|5 patients ongoing, 7 completed the study (week 46)and 35 withdrew prematurely|7
2541768|NCT00595088|6230749|P1|STARTED|Overall Study||47
2541769|NCT00595075|6230757|P2|NOT COMPLETED|Overall Study||0
2541770|NCT00595075|6230758|P1|NOT COMPLETED|Overall Study||1
2541771|NCT00595075|6230757|P2|COMPLETED|Overall Study||5
2541772|NCT00595075|6230758|P1|COMPLETED|Overall Study||5
2541773|NCT00595075|6230757|P2|STARTED|Overall Study||5
2541774|NCT00595075|6230758|P1|STARTED|Overall Study||6
2541775|NCT00594958|6230779|P3|NOT COMPLETED|Overall Study||10
2541776|NCT00594958|6230780|P2|NOT COMPLETED|Overall Study||3
2541777|NCT00594958|6230781|P1|NOT COMPLETED|Overall Study||14
2541778|NCT00594958|6230779|P3|COMPLETED|Overall Study||202
2541779|NCT00594958|6230780|P2|COMPLETED|Overall Study||210
2541780|NCT00594958|6230781|P1|COMPLETED|Overall Study||200
2541781|NCT00594958|6230779|P3|Randomized and at Least 1 Vaccination|Overall Study||211
2541782|NCT00594958|6230780|P2|Randomized and at Least 1 Vaccination|Overall Study||213
2541783|NCT00594958|6230781|P1|Randomized and at Least 1 Vaccination|Overall Study||212
2541784|NCT00594958|6230779|P3|STARTED|Overall Study||212
2541785|NCT00594958|6230780|P2|STARTED|Overall Study||213
2541786|NCT00594958|6230781|P1|STARTED|Overall Study||214
2541787|NCT00594945|6230792|P3|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
2541788|NCT00594945|6230793|P2|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
2541789|NCT00594945|6230794|P1|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
2541790|NCT00594945|6230792|P3|COMPLETED|Cohort 2 / Treatment Period 2||2
2541791|NCT00594945|6230793|P2|COMPLETED|Cohort 2 / Treatment Period 2||3
2541792|NCT00594945|6230794|P1|COMPLETED|Cohort 2 / Treatment Period 2||0
2541793|NCT00594945|6230792|P3|STARTED|Cohort 2 / Treatment Period 2||2
2541794|NCT00594945|6230793|P2|STARTED|Cohort 2 / Treatment Period 2||3
2541795|NCT00594945|6230794|P1|STARTED|Cohort 2 / Treatment Period 2||0
2541796|NCT00594945|6230792|P3|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
2541797|NCT00594945|6230793|P2|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
2541798|NCT00594945|6230794|P1|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
2541799|NCT00594945|6230792|P3|COMPLETED|Cohort 1 / Treatment Period 1||2
2541800|NCT00594945|6230793|P2|COMPLETED|Cohort 1 / Treatment Period 1||0
2541801|NCT00594945|6230794|P1|COMPLETED|Cohort 1 / Treatment Period 1||4
2541802|NCT00594945|6230792|P3|STARTED|Cohort 1 / Treatment Period 1||2
2541803|NCT00594945|6230793|P2|STARTED|Cohort 1 / Treatment Period 1||0
2541804|NCT00594945|6230794|P1|STARTED|Cohort 1 / Treatment Period 1||4
2541805|NCT00594906|6230802|P2|NOT COMPLETED|Overall Study||2
2541806|NCT00594906|6230803|P1|NOT COMPLETED|Overall Study||1
2541807|NCT00594906|6230802|P2|COMPLETED|Overall Study||1
2541808|NCT00594906|6230803|P1|COMPLETED|Overall Study||6
2541809|NCT00594906|6230802|P2|STARTED|Overall Study||3
2541810|NCT00594906|6230803|P1|STARTED|Overall Study||7
2541811|NCT00594880|6230811|P2|NOT COMPLETED|Overall Study||1
2541812|NCT00594880|6230812|P1|NOT COMPLETED|Overall Study||2
2541813|NCT00594880|6230811|P2|COMPLETED|Overall Study||10
2541814|NCT00594880|6230812|P1|COMPLETED|Overall Study||10
2541815|NCT00594880|6230811|P2|STARTED|Overall Study||11
2541816|NCT00594880|6230812|P1|STARTED|Overall Study||12
2541817|NCT00594854|6230824|P2|NOT COMPLETED|Overall Study||10
2541818|NCT00594854|6230825|P1|NOT COMPLETED|Overall Study||7
2541819|NCT00594854|6230824|P2|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|1
2541820|NCT00594854|6230825|P1|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|2
2541821|NCT00594854|6230824|P2|STARTED|Overall Study||11
2541822|NCT00594854|6230825|P1|STARTED|Overall Study||9
2541823|NCT00594815|6230835|P1|NOT COMPLETED|Overall Study||9
2541824|NCT00594815|6230835|P1|COMPLETED|Overall Study||43
2541825|NCT00594815|6230835|P1|STARTED|Overall Study||52
2541826|NCT00594685|6230840|P1|NOT COMPLETED|Overall Study||0
2541827|NCT00594685|6230840|P1|COMPLETED|Overall Study||10
2541828|NCT00594685|6230840|P1|STARTED|Overall Study||10
2541829|NCT00594659|6230860|P3|NOT COMPLETED|Overall Study||7
2541830|NCT00594659|6230861|P2|NOT COMPLETED|Overall Study||9
2541831|NCT00594659|6230862|P1|NOT COMPLETED|Overall Study||13
2541832|NCT00594659|6230860|P3|COMPLETED|Overall Study||9
2541833|NCT00594659|6230861|P2|COMPLETED|Overall Study||21
2541834|NCT00594659|6230862|P1|COMPLETED|Overall Study||16
2541835|NCT00594659|6230860|P3|STARTED|Overall Study||16
2541836|NCT00594659|6230861|P2|STARTED|Overall Study||30
2541837|NCT00594659|6230862|P1|STARTED|Overall Study||29
2541838|NCT00594646|6230873|P1|NOT COMPLETED|Overall Study||16
2541839|NCT00594646|6230873|P1|COMPLETED|Overall Study||84
2541840|NCT00594646|6230873|P1|STARTED|Overall Study||100
2541841|NCT00594568|6230881|P3|NOT COMPLETED|Safety Follow Up (SFU)-Optional||42
2541842|NCT00594568|6230882|P2|NOT COMPLETED|Safety Follow Up (SFU)-Optional||55
2541843|NCT00594568|6230883|P1|NOT COMPLETED|Safety Follow Up (SFU)-Optional||61
2541844|NCT00594568|6230881|P3|COMPLETED|Safety Follow Up (SFU)-Optional||172
2541845|NCT00594568|6230882|P2|COMPLETED|Safety Follow Up (SFU)-Optional||168
2541846|NCT00594568|6230883|P1|COMPLETED|Safety Follow Up (SFU)-Optional||229
2541847|NCT00594568|6230881|P3|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional, pts entered from initial treatment and delayed start or did not enter SFU.|214
2541848|NCT00594568|6230882|P2|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|223
2541849|NCT00594568|6230883|P1|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|290
2541850|NCT00594568|6230881|P3|NOT COMPLETED|Delayed Start||66
2541851|NCT00594568|6230882|P2|NOT COMPLETED|Delayed Start||77
2541852|NCT00594568|6230883|P1|NOT COMPLETED|Delayed Start||98
2541853|NCT00594568|6230881|P3|COMPLETED|Delayed Start||55
2541854|NCT00594568|6230882|P2|COMPLETED|Delayed Start||76
2541855|NCT00594568|6230883|P1|COMPLETED|Delayed Start||91
2541856|NCT00594568|6230881|P3|STARTED|Delayed Start||121
2541857|NCT00594568|6230882|P2|STARTED|Delayed Start||153
2541858|NCT00594568|6230883|P1|STARTED|Delayed Start||189
2541859|NCT00594568|6230881|P3|NOT COMPLETED|Initial Treatment||408
2541860|NCT00594568|6230882|P2|NOT COMPLETED|Initial Treatment||354
2541861|NCT00594568|6230883|P1|NOT COMPLETED|Initial Treatment||312
2541862|NCT00594568|6230881|P3|COMPLETED|Initial Treatment||121
2541863|NCT00594568|6230882|P2|COMPLETED|Initial Treatment||153
2541864|NCT00594568|6230883|P1|COMPLETED|Initial Treatment||189
2541865|NCT00594568|6230881|P3|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|527
2541866|NCT00594568|6230882|P2|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|506
2541867|NCT00594568|6230883|P1|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants (pts) who had at least 1 dose of study drug.|501
2541868|NCT00594568|6230881|P3|STARTED|Initial Treatment||529
2541869|NCT00594568|6230882|P2|STARTED|Initial Treatment||507
2541870|NCT00594568|6230883|P1|STARTED|Initial Treatment||501
2541871|NCT00594516|6230971|P3|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||8
2541872|NCT00594516|6230972|P2|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||7
2541873|NCT00594516|6230973|P1|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
2541874|NCT00594516|6230971|P3|COMPLETED|DB: Tapentadol IR to ER & ER to IR||35
2541875|NCT00594516|6230972|P2|COMPLETED|DB: Tapentadol IR to ER & ER to IR||37
2541876|NCT00594516|6230973|P1|COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
2541877|NCT00594516|6230971|P3|STARTED|DB: Tapentadol IR to ER & ER to IR||43
2541878|NCT00594516|6230972|P2|STARTED|DB: Tapentadol IR to ER & ER to IR||44
2541879|NCT00594516|6230973|P1|STARTED|DB: Tapentadol IR to ER & ER to IR||0
2541880|NCT00594516|6230971|P3|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
2541881|NCT00594516|6230972|P2|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
2541882|NCT00594516|6230973|P1|NOT COMPLETED|Open Label (OL): Tapentadol IR||29
2541883|NCT00594516|6230971|P3|COMPLETED|Open Label (OL): Tapentadol IR||0
2541884|NCT00594516|6230972|P2|COMPLETED|Open Label (OL): Tapentadol IR||0
2541885|NCT00594516|6230973|P1|COMPLETED|Open Label (OL): Tapentadol IR||87
2541886|NCT00594516|6230971|P3|STARTED|Open Label (OL): Tapentadol IR||0
2541887|NCT00594516|6230972|P2|STARTED|Open Label (OL): Tapentadol IR||0
2541888|NCT00594516|6230973|P1|STARTED|Open Label (OL): Tapentadol IR|one patient was enrolled but lost to follow up at the start of open label therefore was not included|116
2541889|NCT00594464|6230981|P1|NOT COMPLETED|Overall Study||3
2541890|NCT00594464|6230981|P1|COMPLETED|Overall Study||11
2541891|NCT00594464|6230981|P1|STARTED|Overall Study||14
2541892|NCT00594425|6230996|P3|NOT COMPLETED|Overall Study||10
2541893|NCT00594425|6230997|P2|NOT COMPLETED|Overall Study||14
2541894|NCT00594425|6230998|P1|NOT COMPLETED|Overall Study||7
2541895|NCT00594425|6230996|P3|COMPLETED|Overall Study||42
2541896|NCT00594425|6230997|P2|COMPLETED|Overall Study||34
2541897|NCT00594425|6230998|P1|COMPLETED|Overall Study||43
2541898|NCT00594425|6230996|P3|STARTED|Overall Study||52
2541899|NCT00594425|6230997|P2|STARTED|Overall Study||48
2541900|NCT00594425|6230998|P1|STARTED|Overall Study||50
2541901|NCT00594399|6231110|P3|NOT COMPLETED|Rerandomization Arm 1 Only||0
2541902|NCT00594399|6231111|P2|NOT COMPLETED|Rerandomization Arm 1 Only||4
2541903|NCT00594399|6231112|P1|NOT COMPLETED|Rerandomization Arm 1 Only||2
2541904|NCT00594399|6231110|P3|COMPLETED|Rerandomization Arm 1 Only||82
2541905|NCT00594399|6231111|P2|COMPLETED|Rerandomization Arm 1 Only||114
2541906|NCT00594399|6231112|P1|COMPLETED|Rerandomization Arm 1 Only||79
2541907|NCT00594399|6231110|P3|Rerandomization|Rerandomization Arm 1 Only||82
2541908|NCT00594399|6231111|P2|Rerandomization|Rerandomization Arm 1 Only||114
2541909|NCT00594399|6231112|P1|Rerandomization|Rerandomization Arm 1 Only|Rerandomized to continue to receive telephone calls every 2 weeks or at a reduced dose of 1/ month|81
2541910|NCT00594399|6231110|P3|STARTED|Rerandomization Arm 1 Only|This sample reflects newly randomized study Arm|82
2541911|NCT00594399|6231111|P2|STARTED|Rerandomization Arm 1 Only||118
2541912|NCT00594399|6231112|P1|STARTED|Rerandomization Arm 1 Only|Total sample in Arm 1 was rerandomized and allocated to remain in Arm 1 or assigned to Arm 3|81
2541913|NCT00594399|6231110|P3|NOT COMPLETED|Initial 3 Month Counseling||0
2541914|NCT00594399|6231111|P2|NOT COMPLETED|Initial 3 Month Counseling||4
2541915|NCT00594399|6231112|P1|NOT COMPLETED|Initial 3 Month Counseling||17
2541916|NCT00594399|6231110|P3|COMPLETED|Initial 3 Month Counseling||0
2541917|NCT00594399|6231111|P2|COMPLETED|Initial 3 Month Counseling||118
2541918|NCT00594399|6231112|P1|COMPLETED|Initial 3 Month Counseling||163
2541919|NCT00594399|6231110|P3|STARTED|Initial 3 Month Counseling||0
2541920|NCT00594399|6231111|P2|STARTED|Initial 3 Month Counseling||122
2541921|NCT00594399|6231112|P1|STARTED|Initial 3 Month Counseling||180
2541922|NCT00594386|6231134|P1|NOT COMPLETED|Overall Study||258
2541923|NCT00594386|6231134|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
2541924|NCT00594386|6231134|P1|STARTED|Overall Study||258
2541925|NCT00594308|6231140|P1|NOT COMPLETED|Overall Study||0
2541926|NCT00594308|6231140|P1|COMPLETED|Overall Study||10
2541927|NCT00594308|6231140|P1|STARTED|Overall Study||10
2541928|NCT00594256|6231148|P1|NOT COMPLETED|Overall Study||0
2541929|NCT00594256|6231148|P1|COMPLETED|Overall Study||8
2541930|NCT00594256|6231148|P1|STARTED|Overall Study||8
2541931|NCT00594230|6231158|P2|NOT COMPLETED|Overall Study||9
2541932|NCT00594230|6231159|P1|NOT COMPLETED|Overall Study||15
2541933|NCT00594230|6231158|P2|COMPLETED|Overall Study||1
2541934|NCT00594230|6231159|P1|COMPLETED|Overall Study||1
2541935|NCT00594230|6231158|P2|STARTED|Overall Study||10
2541936|NCT00594230|6231159|P1|STARTED|Overall Study||16
2541937|NCT00594204|6231167|P2|NOT COMPLETED|Overall Study||45
2541938|NCT00594204|6231168|P1|NOT COMPLETED|Overall Study||58
2541939|NCT00594204|6231167|P2|COMPLETED|Overall Study||154
2541940|NCT00594204|6231168|P1|COMPLETED|Overall Study||336
2541941|NCT00594204|6231167|P2|Received Treatment|Overall Study||198
2541942|NCT00594204|6231168|P1|Received Treatment|Overall Study||390
2541943|NCT00594204|6231167|P2|STARTED|Overall Study||199
2541944|NCT00594204|6231168|P1|STARTED|Overall Study||394
2541945|NCT00594178|6231178|P1|NOT COMPLETED|Overall Study||5
2541946|NCT00594178|6231178|P1|COMPLETED|Overall Study||12
2541947|NCT00594178|6231178|P1|STARTED|Overall Study||17
2541948|NCT00594165|6231183|P1|NOT COMPLETED|Overall Study||217
2541949|NCT00594165|6231183|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
2541950|NCT00594165|6231183|P1|STARTED|Overall Study||217
2541951|NCT00594100|6231189|P1|NOT COMPLETED|Follow-up Through 30 Days Post Procedure||12
2541952|NCT00594100|6231189|P1|COMPLETED|Follow-up Through 30 Days Post Procedure||224
2541953|NCT00594100|6231189|P1|STARTED|Follow-up Through 30 Days Post Procedure||236
2541954|NCT00594100|6231189|P1|NOT COMPLETED|Procedure||9
2541955|NCT00594100|6231189|P1|COMPLETED|Procedure||236
2541956|NCT00594100|6231189|P1|STARTED|Procedure||245
2541957|NCT00594061|6231198|P1|NOT COMPLETED|Overall Study||0
2541958|NCT00594061|6231198|P1|COMPLETED|Overall Study||9
2541959|NCT00594061|6231198|P1|STARTED|Overall Study||9
2541960|NCT00594035|6231205|P2|NOT COMPLETED|Overall Study||3
2541961|NCT00594035|6231206|P1|NOT COMPLETED|Overall Study||2
2541962|NCT00594035|6231205|P2|COMPLETED|Overall Study|53 control group subjects were evaluable at the 90-day visit|53
2541963|NCT00594035|6231206|P1|COMPLETED|Overall Study|100 Spinal Sealant subjects were evaluable at the 90-day visit|100
2541964|NCT00594035|6231205|P2|STARTED|Overall Study|56 subjects were randomized to the control group (standard of care)|56
2541965|NCT00594035|6231206|P1|STARTED|Overall Study|102 subjects were randomized to Spinal Sealant|102
2541966|NCT00594022|6231214|P2|NOT COMPLETED|Overall Study||0
2541967|NCT00594022|6231215|P1|NOT COMPLETED|Overall Study||0
2541968|NCT00594022|6231214|P2|COMPLETED|Overall Study||173
2541969|NCT00594022|6231215|P1|COMPLETED|Overall Study||176
2541970|NCT00594022|6231214|P2|STARTED|Overall Study||173
2541971|NCT00594022|6231215|P1|STARTED|Overall Study||176
2541972|NCT00594009|6231229|P1|NOT COMPLETED|Overall Study||0
2541973|NCT00594009|6231229|P1|COMPLETED|Overall Study||1
2541974|NCT00594009|6231229|P1|STARTED|Overall Study||1
2541975|NCT00593957|6231236|P3|NOT COMPLETED|Overall Study||2
2541976|NCT00593957|6231237|P2|NOT COMPLETED|Overall Study||1
2541977|NCT00593957|6231238|P1|NOT COMPLETED|Overall Study||0
2541978|NCT00593957|6231236|P3|COMPLETED|Overall Study||10
2541979|NCT00593957|6231237|P2|COMPLETED|Overall Study||12
2541980|NCT00593957|6231238|P1|COMPLETED|Overall Study||13
2541981|NCT00593957|6231236|P3|STARTED|Overall Study||12
2541982|NCT00593957|6231237|P2|STARTED|Overall Study||13
2541983|NCT00593957|6231238|P1|STARTED|Overall Study||13
2541984|NCT00593918|6231262|P2|NOT COMPLETED|Overall Study||24
2541985|NCT00593918|6231263|P1|NOT COMPLETED|Overall Study||5
2541986|NCT00593918|6231262|P2|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|50
2541987|NCT00593918|6231263|P1|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|12
2541988|NCT00593918|6231262|P2|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/AG and AA genotypes|74
2541989|NCT00593918|6231263|P1|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/GG Genotype|17
2541990|NCT00593866|6231271|P1|NOT COMPLETED|Overall Study||0
2541991|NCT00593866|6231271|P1|COMPLETED|Overall Study||50
2541992|NCT00593866|6231271|P1|STARTED|Overall Study||50
2541993|NCT00593840|6231276|P1|NOT COMPLETED|Overall Study||1
2541994|NCT00593840|6231276|P1|COMPLETED|Overall Study||72
2541995|NCT00593840|6231276|P1|STARTED|Overall Study||73
2541996|NCT00593827|6231288|P2|NOT COMPLETED|Overall Study||2
2541997|NCT00593827|6231289|P1|NOT COMPLETED|Overall Study||0
2541998|NCT00593827|6231288|P2|COMPLETED|Overall Study|Completed=off-study (Major reasons: AEs=30; disease progression=55; not treated=2).|89
2541999|NCT00593827|6231289|P1|COMPLETED|Overall Study|Completed=off-study (Major reasons: Adverse events (AE)=15; disease progression=76; not treated=3).|85
2542000|NCT00593827|6231288|P2|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|89
2542001|NCT00593827|6231289|P1|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|79
2542002|NCT00593827|6231288|P2|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|89
2542003|NCT00593827|6231289|P1|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|82
2542004|NCT00593827|6231288|P2|STARTED|Overall Study|ITT Population: Participants who were randomized (eligible and ineligible).|91
2542005|NCT00593827|6231289|P1|STARTED|Overall Study|Intent-to-Treat (ITT) Population: Participants who were randomized (eligible and ineligible).|85
2542006|NCT00593814|6231313|P2|NOT COMPLETED|Overall Study||0
2542007|NCT00593814|6231314|P1|NOT COMPLETED|Overall Study||24
2542008|NCT00593814|6231313|P2|COMPLETED|Overall Study||120
2542009|NCT00593814|6231314|P1|COMPLETED|Overall Study||115
2542010|NCT00593814|6231313|P2|STARTED|Overall Study||120
2542011|NCT00593814|6231314|P1|STARTED|Overall Study||139
2542012|NCT00593736|6231326|P4|NOT COMPLETED|Treatment Period and Placebo Run-out||4
2542013|NCT00593736|6231327|P3|NOT COMPLETED|Treatment Period and Placebo Run-out||5
2542014|NCT00593736|6231328|P2|NOT COMPLETED|Treatment Period and Placebo Run-out||2
2542015|NCT00593736|6231329|P1|NOT COMPLETED|Treatment Period and Placebo Run-out||3
2542016|NCT00593736|6231326|P4|COMPLETED|Treatment Period and Placebo Run-out||28
2542017|NCT00593736|6231327|P3|COMPLETED|Treatment Period and Placebo Run-out||30
2542018|NCT00593736|6231328|P2|COMPLETED|Treatment Period and Placebo Run-out||31
2542019|NCT00593736|6231329|P1|COMPLETED|Treatment Period and Placebo Run-out||29
2542020|NCT00593736|6231326|P4|STARTED|Treatment Period and Placebo Run-out||32
2542021|NCT00593736|6231327|P3|STARTED|Treatment Period and Placebo Run-out||35
2542022|NCT00593736|6231328|P2|STARTED|Treatment Period and Placebo Run-out||33
2542023|NCT00593736|6231329|P1|STARTED|Treatment Period and Placebo Run-out||32
2542024|NCT00593736|6231326|P4|NOT COMPLETED|Screening Period and Placebo Run-in||417
2542025|NCT00593736|6231327|P3|NOT COMPLETED|Screening Period and Placebo Run-in||0
2542026|NCT00593736|6231328|P2|NOT COMPLETED|Screening Period and Placebo Run-in||0
2542027|NCT00593736|6231329|P1|NOT COMPLETED|Screening Period and Placebo Run-in||0
2542028|NCT00593736|6231326|P4|COMPLETED|Screening Period and Placebo Run-in||132
2542029|NCT00593736|6231327|P3|COMPLETED|Screening Period and Placebo Run-in||0
2542030|NCT00593736|6231328|P2|COMPLETED|Screening Period and Placebo Run-in||0
2542031|NCT00593736|6231329|P1|COMPLETED|Screening Period and Placebo Run-in||0
2542032|NCT00593736|6231326|P4|STARTED|Screening Period and Placebo Run-in||549
2542033|NCT00593736|6231327|P3|STARTED|Screening Period and Placebo Run-in||0
2542034|NCT00593736|6231328|P2|STARTED|Screening Period and Placebo Run-in||0
2542035|NCT00593736|6231329|P1|STARTED|Screening Period and Placebo Run-in||0
2542036|NCT00593684|6231577|P2|NOT COMPLETED|Overall Study||1
2542037|NCT00593684|6231578|P1|NOT COMPLETED|Overall Study||2
2542038|NCT00593684|6231577|P2|COMPLETED|Overall Study||24
2542039|NCT00593684|6231578|P1|COMPLETED|Overall Study||23
2542040|NCT00593684|6231577|P2|STARTED|Overall Study||25
2542041|NCT00593684|6231578|P1|STARTED|Overall Study||25
2542042|NCT00593645|6231590|P1|NOT COMPLETED|Overall Study||0
2542043|NCT00593645|6231590|P1|COMPLETED|Overall Study||7
2542044|NCT00593645|6231590|P1|STARTED|Overall Study||7
2542045|NCT00593606|6231604|P1|NOT COMPLETED|Overall Study||27
2542046|NCT00593606|6231604|P1|COMPLETED|Overall Study||97
2542047|NCT00593606|6231604|P1|Treatment Period Completed|Overall Study||99
2542048|NCT00593606|6231604|P1|Full Analysis Set|Overall Study||114
2542049|NCT00593606|6231604|P1|Start of Treatment - Safety Set|Overall Study||116
2542050|NCT00593606|6231604|P1|STARTED|Overall Study||124
2542051|NCT00593554|6231702|P2|NOT COMPLETED|Overall Study||5
2542052|NCT00593554|6231703|P1|NOT COMPLETED|Overall Study||3
2542053|NCT00593554|6231702|P2|COMPLETED|Overall Study||0
2542054|NCT00593554|6231703|P1|COMPLETED|Overall Study||0
2542055|NCT00593554|6231702|P2|STARTED|Overall Study||5
2542056|NCT00593554|6231703|P1|STARTED|Overall Study||3
2542057|NCT00593450|6231725|P4|NOT COMPLETED|Overall Study||29
2542058|NCT00593450|6231726|P3|NOT COMPLETED|Overall Study||13
2542059|NCT00593450|6231727|P2|NOT COMPLETED|Overall Study||21
2542060|NCT00593450|6231728|P1|NOT COMPLETED|Overall Study||17
2542061|NCT00593450|6231725|P4|COMPLETED|Overall Study||271
2542062|NCT00593450|6231726|P3|COMPLETED|Overall Study||285
2542063|NCT00593450|6231727|P2|COMPLETED|Overall Study||265
2542064|NCT00593450|6231728|P1|COMPLETED|Overall Study||284
2542065|NCT00593450|6231725|P4|STARTED|Overall Study||300
2542066|NCT00593450|6231726|P3|STARTED|Overall Study||298
2542067|NCT00593450|6231727|P2|STARTED|Overall Study||286
2542068|NCT00593450|6231728|P1|STARTED|Overall Study||301
2542069|NCT00593385|6231798|P1|NOT COMPLETED|Overall Study||40
2542070|NCT00593385|6231798|P1|COMPLETED|Overall Study|125 of 165 enrolled patients completed the study.|125
2542071|NCT00593385|6231798|P1|Intention to Treat (ITT) Population|Overall Study|Excludes 13 subjects who did not meet inclusion/exclusion criteria.|152
2542072|NCT00593385|6231798|P1|STARTED|Overall Study||165
2542073|NCT00593372|6231835|P2|NOT COMPLETED|Overall Study||0
2542074|NCT00593372|6231836|P1|NOT COMPLETED|Overall Study||0
2542075|NCT00593372|6231835|P2|COMPLETED|Overall Study|Three evaluated and completed protocol.|3
2542076|NCT00593372|6231836|P1|COMPLETED|Overall Study|Eight completed behavioral treatment.|8
2542077|NCT00593372|6231835|P2|STARTED|Overall Study|Three evaluated but only maintained medical treatment.|3
2542078|NCT00593372|6231836|P1|STARTED|Overall Study|Eight enrolled in behavioral treatment.|8
2542079|NCT00593346|6231842|P1|NOT COMPLETED|Overall Study||0
2542080|NCT00593346|6231842|P1|COMPLETED|Overall Study||151
2542081|NCT00593346|6231842|P1|STARTED|Overall Study||151
2542082|NCT00593333|6231859|P2|NOT COMPLETED|Overall Study||11
2542083|NCT00593333|6231860|P1|NOT COMPLETED|Overall Study||10
2542084|NCT00593333|6231859|P2|COMPLETED|Overall Study||45
2542085|NCT00593333|6231860|P1|COMPLETED|Overall Study||44
2542086|NCT00593333|6231859|P2|STARTED|Overall Study||56
2542087|NCT00593333|6231860|P1|STARTED|Overall Study||54
2542088|NCT00593320|6231868|P2|NOT COMPLETED|Overall Study||0
2542089|NCT00593320|6231869|P1|NOT COMPLETED|Overall Study||0
2542090|NCT00593320|6231868|P2|COMPLETED|Overall Study||1
2542091|NCT00593320|6231869|P1|COMPLETED|Overall Study||1
2542092|NCT00593320|6231868|P2|STARTED|Overall Study||1
2542093|NCT00593320|6231869|P1|STARTED|Overall Study||1
2542094|NCT00593112|6231883|P2|NOT COMPLETED|Overall Study||0
2542095|NCT00593112|6231884|P1|NOT COMPLETED|Overall Study||10
2542096|NCT00593112|6231883|P2|COMPLETED|Overall Study||12
2542097|NCT00593112|6231884|P1|COMPLETED|Overall Study||17
2542098|NCT00593112|6231883|P2|STARTED|Overall Study||12
2542099|NCT00593112|6231884|P1|STARTED|Overall Study||27
2542100|NCT00592943|6231896|P2|NOT COMPLETED|Overall Study||0
2542101|NCT00592943|6231897|P1|NOT COMPLETED|Overall Study||0
2542102|NCT00592943|6231896|P2|COMPLETED|Overall Study||6
2542103|NCT00592943|6231897|P1|COMPLETED|Overall Study||6
2542104|NCT00592943|6231896|P2|STARTED|Overall Study||6
2542105|NCT00592943|6231897|P1|STARTED|Overall Study||6
2542106|NCT00592904|6231911|P4|NOT COMPLETED|Overall Study||11
2542107|NCT00592904|6231912|P3|NOT COMPLETED|Overall Study||17
2542108|NCT00592904|6231913|P2|NOT COMPLETED|Overall Study||55
2542109|NCT00592904|6231914|P1|NOT COMPLETED|Overall Study||25
2542110|NCT00592904|6231911|P4|COMPLETED|Overall Study||19
2542111|NCT00592904|6231912|P3|COMPLETED|Overall Study||10
2542112|NCT00592904|6231913|P2|COMPLETED|Overall Study||93
2542113|NCT00592904|6231914|P1|COMPLETED|Overall Study||32
2542114|NCT00592904|6231911|P4|STARTED|Overall Study||30
2542115|NCT00592904|6231912|P3|STARTED|Overall Study||27
2542116|NCT00592904|6231913|P2|STARTED|Overall Study||148
2542117|NCT00592904|6231914|P1|STARTED|Overall Study||57
2542118|NCT00592852|6231940|P1|NOT COMPLETED|Overall Study||6
2542119|NCT00592852|6231940|P1|COMPLETED|Overall Study||7
2542120|NCT00592852|6231940|P1|STARTED|Overall Study||13
2542121|NCT00592839|6231948|P3|NOT COMPLETED|Overall Study||6
2542122|NCT00592839|6231949|P2|NOT COMPLETED|Overall Study||4
2542123|NCT00592839|6231950|P1|NOT COMPLETED|Overall Study||2
2542124|NCT00592839|6231948|P3|COMPLETED|Overall Study||46
2542125|NCT00592839|6231949|P2|COMPLETED|Overall Study||48
2542126|NCT00592839|6231950|P1|COMPLETED|Overall Study||51
2542127|NCT00592839|6231948|P3|STARTED|Overall Study||52
2542128|NCT00592839|6231949|P2|STARTED|Overall Study||52
2542129|NCT00592839|6231950|P1|STARTED|Overall Study||53
2542130|NCT00592774|6231978|P5|NOT COMPLETED|Overall Study||14
2542131|NCT00592774|6231979|P4|NOT COMPLETED|Overall Study||14
2542132|NCT00592774|6231980|P3|NOT COMPLETED|Overall Study||4
2542133|NCT00592774|6231981|P2|NOT COMPLETED|Overall Study||32
2542134|NCT00592774|6231982|P1|NOT COMPLETED|Overall Study||11
2542135|NCT00592774|6231978|P5|COMPLETED|Overall Study||9
2542136|NCT00592774|6231979|P4|COMPLETED|Overall Study||8
2542137|NCT00592774|6231980|P3|COMPLETED|Overall Study||18
2542138|NCT00592774|6231981|P2|COMPLETED|Overall Study||21
2542139|NCT00592774|6231982|P1|COMPLETED|Overall Study||15
2542140|NCT00592774|6231978|P5|STARTED|Overall Study||23
2542141|NCT00592774|6231979|P4|STARTED|Overall Study||22
2542142|NCT00592774|6231980|P3|STARTED|Overall Study||22
2542143|NCT00592774|6231981|P2|STARTED|Overall Study||53
2542144|NCT00592774|6231982|P1|STARTED|Overall Study||26
2542145|NCT00592761|6232039|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
2542146|NCT00592761|6232040|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
2542147|NCT00592761|6232039|P2|COMPLETED|Second Intervention (2 Weeks)||9
2542148|NCT00592761|6232040|P1|COMPLETED|Second Intervention (2 Weeks)||9
2542149|NCT00592761|6232039|P2|STARTED|Second Intervention (2 Weeks)||9
2542150|NCT00592761|6232040|P1|STARTED|Second Intervention (2 Weeks)||9
2542151|NCT00592761|6232039|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
2542152|NCT00592761|6232040|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
2542153|NCT00592761|6232039|P2|COMPLETED|First Intervention (2 Weeks)||9
2542154|NCT00592761|6232040|P1|COMPLETED|First Intervention (2 Weeks)||9
2542155|NCT00592761|6232039|P2|STARTED|First Intervention (2 Weeks)||9
2542156|NCT00592761|6232040|P1|STARTED|First Intervention (2 Weeks)||9
2542157|NCT00592683|6232054|P2|NOT COMPLETED|Overall Study||4
2542158|NCT00592683|6232055|P1|NOT COMPLETED|Overall Study||4
2542159|NCT00592683|6232054|P2|COMPLETED|Overall Study||6
2542160|NCT00592683|6232055|P1|COMPLETED|Overall Study||6
2542161|NCT00592683|6232054|P2|STARTED|Overall Study||10
2542162|NCT00592683|6232055|P1|STARTED|Overall Study||10
2542163|NCT00592631|6232065|P2|NOT COMPLETED|Overall Study||2
2542164|NCT00592631|6232066|P1|NOT COMPLETED|Overall Study||0
2542165|NCT00592631|6232065|P2|COMPLETED|Overall Study||9
2542166|NCT00592631|6232066|P1|COMPLETED|Overall Study||16
2542167|NCT00592631|6232065|P2|STARTED|Overall Study||11
2542168|NCT00592631|6232066|P1|STARTED|Overall Study||16
2542169|NCT00592488|6232074|P2|NOT COMPLETED|Overall Study||0
2542170|NCT00592488|6232075|P1|NOT COMPLETED|Overall Study||0
2542171|NCT00592488|6232074|P2|COMPLETED|Overall Study||7
2542172|NCT00592488|6232075|P1|COMPLETED|Overall Study||6
2542173|NCT00592488|6232074|P2|STARTED|Overall Study||7
2542174|NCT00592488|6232075|P1|STARTED|Overall Study||6
2542175|NCT00592475|6232088|P3|NOT COMPLETED|Overall Study||0
2542176|NCT00592475|6232089|P2|NOT COMPLETED|Overall Study||0
2542177|NCT00592475|6232090|P1|NOT COMPLETED|Overall Study||0
2542178|NCT00592475|6232088|P3|COMPLETED|Overall Study||5
2542179|NCT00592475|6232089|P2|COMPLETED|Overall Study||9
2542180|NCT00592475|6232090|P1|COMPLETED|Overall Study||6
2542181|NCT00592475|6232088|P3|STARTED|Overall Study||5
2542182|NCT00592475|6232089|P2|STARTED|Overall Study||9
2542183|NCT00592475|6232090|P1|STARTED|Overall Study||6
2542184|NCT00592384|6232115|P2|NOT COMPLETED|Overall Study||6
2542185|NCT00592384|6232116|P1|NOT COMPLETED|Overall Study||5
2542186|NCT00592384|6232115|P2|COMPLETED|Overall Study||63
2542187|NCT00592384|6232116|P1|COMPLETED|Overall Study||59
2542188|NCT00592384|6232115|P2|STARTED|Overall Study||69
2542189|NCT00592384|6232116|P1|STARTED|Overall Study||64
2542190|NCT00592358|6232124|P1|NOT COMPLETED|Overall Study||6
2542191|NCT00592358|6232124|P1|COMPLETED|Overall Study||11
2542192|NCT00592358|6232124|P1|STARTED|Overall Study||17
2542193|NCT00592319|6232131|P2|NOT COMPLETED|Overall Study||3
2542194|NCT00592319|6232132|P1|NOT COMPLETED|Overall Study||0
2542195|NCT00592319|6232131|P2|COMPLETED|Overall Study||5
2542196|NCT00592319|6232132|P1|COMPLETED|Overall Study||2
2542197|NCT00592319|6232131|P2|STARTED|Overall Study||8
2542198|NCT00592319|6232132|P1|STARTED|Overall Study||2
2542199|NCT00592176|6232140|P1|NOT COMPLETED|Overall Study||0
2542200|NCT00592176|6232140|P1|COMPLETED|Overall Study||5
2542201|NCT00592176|6232140|P1|STARTED|Overall Study||5
2542202|NCT00592124|6232151|P6|NOT COMPLETED|Overall Study||3
2542203|NCT00592124|6232152|P5|NOT COMPLETED|Overall Study||3
2542204|NCT00592124|6232153|P4|NOT COMPLETED|Overall Study||3
2542205|NCT00592124|6232154|P3|NOT COMPLETED|Overall Study||6
2542206|NCT00592124|6232155|P2|NOT COMPLETED|Overall Study||5
2542207|NCT00592124|6232156|P1|NOT COMPLETED|Overall Study||4
2542208|NCT00592124|6232151|P6|COMPLETED|Overall Study||24
2542209|NCT00592124|6232152|P5|COMPLETED|Overall Study||24
2542210|NCT00592124|6232153|P4|COMPLETED|Overall Study||24
2542211|NCT00592124|6232154|P3|COMPLETED|Overall Study||24
2542212|NCT00592124|6232155|P2|COMPLETED|Overall Study||24
2542213|NCT00592124|6232156|P1|COMPLETED|Overall Study||24
2542214|NCT00592124|6232151|P6|STARTED|Overall Study||27
2542215|NCT00592124|6232152|P5|STARTED|Overall Study||27
2542216|NCT00592124|6232153|P4|STARTED|Overall Study||27
2542217|NCT00592124|6232154|P3|STARTED|Overall Study||30
2542218|NCT00592124|6232155|P2|STARTED|Overall Study||29
2542219|NCT00592124|6232156|P1|STARTED|Overall Study||28
2542220|NCT00592072|6232207|P2|NOT COMPLETED|Second Sequence||0
2542221|NCT00592072|6232208|P1|NOT COMPLETED|Second Sequence||0
2542222|NCT00592072|6232207|P2|COMPLETED|Second Sequence||5
2542223|NCT00592072|6232208|P1|COMPLETED|Second Sequence||5
2542224|NCT00592072|6232207|P2|STARTED|Second Sequence||5
2542225|NCT00592072|6232208|P1|STARTED|Second Sequence||5
2542226|NCT00592072|6232207|P2|NOT COMPLETED|Wash Out Period||1
2542227|NCT00592072|6232208|P1|NOT COMPLETED|Wash Out Period||1
2542228|NCT00592072|6232207|P2|COMPLETED|Wash Out Period||5
2542229|NCT00592072|6232208|P1|COMPLETED|Wash Out Period||5
2542230|NCT00592072|6232207|P2|STARTED|Wash Out Period||6
2542231|NCT00592072|6232208|P1|STARTED|Wash Out Period||6
2542232|NCT00592072|6232207|P2|NOT COMPLETED|First Sequence||0
2542233|NCT00592072|6232208|P1|NOT COMPLETED|First Sequence||0
2542234|NCT00592072|6232207|P2|COMPLETED|First Sequence||6
2542235|NCT00592072|6232208|P1|COMPLETED|First Sequence||6
2542236|NCT00592072|6232207|P2|STARTED|First Sequence||6
2542237|NCT00592072|6232208|P1|STARTED|First Sequence||6
2542238|NCT00592007|6232230|P1|NOT COMPLETED|Overall Study||2
2542239|NCT00592007|6232230|P1|COMPLETED|Overall Study||5
2542240|NCT00592007|6232230|P1|STARTED|Overall Study||7
2542241|NCT00591942|6232235|P2|NOT COMPLETED|Overall Study||0
2542242|NCT00591942|6232236|P1|NOT COMPLETED|Overall Study||0
2542243|NCT00591942|6232235|P2|COMPLETED|Overall Study||36
2542244|NCT00591942|6232236|P1|COMPLETED|Overall Study||36
2542245|NCT00591942|6232235|P2|STARTED|Overall Study||36
2542246|NCT00591942|6232236|P1|STARTED|Overall Study||36
2542247|NCT00591864|6232242|P1|NOT COMPLETED|Overall Study||5
2542248|NCT00591864|6232242|P1|COMPLETED|Overall Study||84
2542249|NCT00591864|6232242|P1|STARTED|Overall Study||89
2542250|NCT00591851|6232248|P1|NOT COMPLETED|Overall Study||6
2542251|NCT00591851|6232248|P1|COMPLETED|Overall Study||64
2542252|NCT00591851|6232248|P1|STARTED|Overall Study||70
2542253|NCT00591838|6232257|P5|NOT COMPLETED|Overall Study||0
2542254|NCT00591838|6232258|P4|NOT COMPLETED|Overall Study||1
2542255|NCT00591838|6232259|P3|NOT COMPLETED|Overall Study||0
2542256|NCT00591838|6232260|P2|NOT COMPLETED|Overall Study||0
2542257|NCT00591838|6232261|P1|NOT COMPLETED|Overall Study||0
2542258|NCT00591838|6232257|P5|COMPLETED|Overall Study||51
2542259|NCT00591838|6232258|P4|COMPLETED|Overall Study||5
2542260|NCT00591838|6232259|P3|COMPLETED|Overall Study||6
2542261|NCT00591838|6232260|P2|COMPLETED|Overall Study||6
2542262|NCT00591838|6232261|P1|COMPLETED|Overall Study||5
2542263|NCT00591838|6232257|P5|STARTED|Overall Study||51
2542264|NCT00591838|6232258|P4|STARTED|Overall Study||6
2542265|NCT00591838|6232259|P3|STARTED|Overall Study||6
2542266|NCT00591838|6232260|P2|STARTED|Overall Study||6
2542267|NCT00591838|6232261|P1|STARTED|Overall Study||5
2542268|NCT00591825|6232286|P4|NOT COMPLETED|Overall Study||0
2542269|NCT00591825|6232287|P3|NOT COMPLETED|Overall Study||0
2542270|NCT00591825|6232288|P2|NOT COMPLETED|Overall Study||0
2542271|NCT00591825|6232289|P1|NOT COMPLETED|Overall Study||0
2542272|NCT00591825|6232286|P4|COMPLETED|Overall Study||14
2542273|NCT00591825|6232287|P3|COMPLETED|Overall Study||13
2542274|NCT00591825|6232288|P2|COMPLETED|Overall Study||13
2542275|NCT00591825|6232289|P1|COMPLETED|Overall Study||14
2542276|NCT00591825|6232286|P4|STARTED|Overall Study||14
2542277|NCT00591825|6232287|P3|STARTED|Overall Study||13
2542278|NCT00591825|6232288|P2|STARTED|Overall Study||13
2542279|NCT00591825|6232289|P1|STARTED|Overall Study||14
2542280|NCT00591786|6232325|P10|NOT COMPLETED|Overall Study||0
2542281|NCT00591786|6232326|P9|NOT COMPLETED|Overall Study||0
2542282|NCT00591786|6232327|P8|NOT COMPLETED|Overall Study||0
2542283|NCT00591786|6232328|P7|NOT COMPLETED|Overall Study||0
2542284|NCT00591786|6232329|P6|NOT COMPLETED|Overall Study||0
2542285|NCT00591786|6232330|P5|NOT COMPLETED|Overall Study||0
2542286|NCT00591786|6232331|P4|NOT COMPLETED|Overall Study||0
2542287|NCT00591786|6232332|P3|NOT COMPLETED|Overall Study||1
2542288|NCT00591786|6232333|P2|NOT COMPLETED|Overall Study||0
2542289|NCT00591786|6232334|P1|NOT COMPLETED|Overall Study||0
2542290|NCT00591786|6232325|P10|COMPLETED|Overall Study||10
2542291|NCT00591786|6232326|P9|COMPLETED|Overall Study||10
2542292|NCT00591786|6232327|P8|COMPLETED|Overall Study||10
2542293|NCT00591786|6232328|P7|COMPLETED|Overall Study||10
2542294|NCT00591786|6232329|P6|COMPLETED|Overall Study||10
2542295|NCT00591786|6232330|P5|COMPLETED|Overall Study||10
2542296|NCT00591786|6232331|P4|COMPLETED|Overall Study||11
2542297|NCT00591786|6232332|P3|COMPLETED|Overall Study||10
2542298|NCT00591786|6232333|P2|COMPLETED|Overall Study||9
2542299|NCT00591786|6232334|P1|COMPLETED|Overall Study||9
2542300|NCT00591786|6232325|P10|Treated Participants|Overall Study||10
2542301|NCT00591786|6232326|P9|Treated Participants|Overall Study||10
2542302|NCT00591786|6232327|P8|Treated Participants|Overall Study||10
2542303|NCT00591786|6232328|P7|Treated Participants|Overall Study||10
2542304|NCT00591786|6232329|P6|Treated Participants|Overall Study||10
2542305|NCT00591786|6232330|P5|Treated Participants|Overall Study||10
2542306|NCT00591786|6232331|P4|Treated Participants|Overall Study||11
2542307|NCT00591786|6232332|P3|Treated Participants|Overall Study||10
2542308|NCT00591786|6232333|P2|Treated Participants|Overall Study||9
2542309|NCT00591786|6232334|P1|Treated Participants|Overall Study||9
2542310|NCT00591786|6232325|P10|STARTED|Overall Study||10
2542311|NCT00591786|6232326|P9|STARTED|Overall Study||10
2542312|NCT00591786|6232327|P8|STARTED|Overall Study||10
2542313|NCT00591786|6232328|P7|STARTED|Overall Study||10
2542314|NCT00591786|6232329|P6|STARTED|Overall Study||10
2542315|NCT00591786|6232330|P5|STARTED|Overall Study||10
2542316|NCT00591786|6232331|P4|STARTED|Overall Study||11
2542317|NCT00591786|6232332|P3|STARTED|Overall Study||11
2542318|NCT00591786|6232333|P2|STARTED|Overall Study||9
2542319|NCT00591786|6232334|P1|STARTED|Overall Study||9
2542320|NCT00591773|6232379|P3|NOT COMPLETED|Overall Study||16
2542321|NCT00591773|6232380|P2|NOT COMPLETED|Overall Study||24
2542322|NCT00591773|6232381|P1|NOT COMPLETED|Overall Study||16
2542323|NCT00591773|6232379|P3|COMPLETED|Overall Study||168
2542324|NCT00591773|6232380|P2|COMPLETED|Overall Study||158
2542325|NCT00591773|6232381|P1|COMPLETED|Overall Study||169
2542326|NCT00591773|6232379|P3|STARTED|Overall Study||184
2542327|NCT00591773|6232380|P2|STARTED|Overall Study||182
2542328|NCT00591773|6232381|P1|STARTED|Overall Study||185
2542329|NCT00591760|6232433|P2|NOT COMPLETED|Overall Study||0
2542330|NCT00591760|6232434|P1|NOT COMPLETED|Overall Study||0
2542331|NCT00591760|6232433|P2|COMPLETED|Overall Study||28
2542332|NCT00591760|6232434|P1|COMPLETED|Overall Study||28
2542333|NCT00591760|6232433|P2|STARTED|Overall Study||28
2542334|NCT00591760|6232434|P1|STARTED|Overall Study||28
2542335|NCT00591734|6232440|P1|NOT COMPLETED|Overall Study||53
2542336|NCT00591734|6232440|P1|COMPLETED|Overall Study||4
2542337|NCT00591734|6232440|P1|STARTED|Overall Study||57
2542338|NCT00591721|6232446|P2|NOT COMPLETED|Overall Study||22
2542339|NCT00591721|6232447|P1|NOT COMPLETED|Overall Study||21
2542340|NCT00591721|6232446|P2|COMPLETED|Overall Study||70
2542341|NCT00591721|6232447|P1|COMPLETED|Overall Study||68
2542342|NCT00591721|6232446|P2|STARTED|Overall Study||92
2542343|NCT00591721|6232447|P1|STARTED|Overall Study||89
2542344|NCT00591591|6232455|P2|NOT COMPLETED|Overall Study||39
2542345|NCT00591591|6232456|P1|NOT COMPLETED|Overall Study||11
2542346|NCT00591591|6232455|P2|COMPLETED|Overall Study||94
2542347|NCT00591591|6232456|P1|COMPLETED|Overall Study||165
2542348|NCT00591591|6232455|P2|STARTED|Overall Study||133
2542349|NCT00591591|6232456|P1|STARTED|Overall Study||176
2542350|NCT00591578|6232473|P3|NOT COMPLETED|Open-Label Extension Phase||0
2542351|NCT00591578|6232474|P2|NOT COMPLETED|Open-Label Extension Phase||10
2542352|NCT00591578|6232475|P1|NOT COMPLETED|Open-Label Extension Phase||6
2542353|NCT00591578|6232473|P3|COMPLETED|Open-Label Extension Phase||0
2542354|NCT00591578|6232474|P2|COMPLETED|Open-Label Extension Phase||105
2542355|NCT00591578|6232475|P1|COMPLETED|Open-Label Extension Phase||49
2542356|NCT00591578|6232473|P3|STARTED|Open-Label Extension Phase||0
2542357|NCT00591578|6232474|P2|STARTED|Open-Label Extension Phase||115
2542358|NCT00591578|6232475|P1|STARTED|Open-Label Extension Phase||55
2542359|NCT00591578|6232473|P3|NOT COMPLETED|Double-Blind Treatment Phase||84
2542360|NCT00591578|6232474|P2|NOT COMPLETED|Double-Blind Treatment Phase||80
2542361|NCT00591578|6232475|P1|NOT COMPLETED|Double-Blind Treatment Phase||78
2542362|NCT00591578|6232473|P3|COMPLETED|Double-Blind Treatment Phase||244
2542363|NCT00591578|6232474|P2|COMPLETED|Double-Blind Treatment Phase||249
2542364|NCT00591578|6232475|P1|COMPLETED|Double-Blind Treatment Phase||249
2542365|NCT00591578|6232473|P3|STARTED|Double-Blind Treatment Phase|Two participants randomized but not treated.|328
2542366|NCT00591578|6232474|P2|STARTED|Double-Blind Treatment Phase||329
2542367|NCT00591578|6232475|P1|STARTED|Double-Blind Treatment Phase||327
2542368|NCT00591565|6232526|P1|NOT COMPLETED|Overall Study||5
2542369|NCT00591565|6232526|P1|COMPLETED|Overall Study||8
2542370|NCT00591565|6232526|P1|STARTED|Overall Study||13
2542371|NCT00591409|6232540|P10|NOT COMPLETED|Overall Study||1
2542372|NCT00591409|6232541|P9|NOT COMPLETED|Overall Study||0
2542373|NCT00591409|6232542|P8|NOT COMPLETED|Overall Study||0
2542374|NCT00591409|6232543|P7|NOT COMPLETED|Overall Study||0
2542375|NCT00591409|6232544|P6|NOT COMPLETED|Overall Study||0
2542376|NCT00591409|6232545|P5|NOT COMPLETED|Overall Study||1
2542377|NCT00591409|6232546|P4|NOT COMPLETED|Overall Study||0
2542378|NCT00591409|6232547|P3|NOT COMPLETED|Overall Study||0
2542379|NCT00591409|6232548|P2|NOT COMPLETED|Overall Study||0
2542380|NCT00591409|6232549|P1|NOT COMPLETED|Overall Study||0
2542381|NCT00591409|6232540|P10|COMPLETED|Overall Study||10
2542382|NCT00591409|6232541|P9|COMPLETED|Overall Study||9
2542383|NCT00591409|6232542|P8|COMPLETED|Overall Study||10
2542384|NCT00591409|6232543|P7|COMPLETED|Overall Study||10
2542385|NCT00591409|6232544|P6|COMPLETED|Overall Study||10
2542386|NCT00591409|6232545|P5|COMPLETED|Overall Study||9
2542387|NCT00591409|6232546|P4|COMPLETED|Overall Study||10
2542388|NCT00591409|6232547|P3|COMPLETED|Overall Study||10
2542389|NCT00591409|6232548|P2|COMPLETED|Overall Study||10
2542390|NCT00591409|6232549|P1|COMPLETED|Overall Study||10
2542391|NCT00591409|6232540|P10|Treated|Overall Study||10
2542392|NCT00591409|6232541|P9|Treated|Overall Study||9
2542393|NCT00591409|6232542|P8|Treated|Overall Study||10
2542394|NCT00591409|6232543|P7|Treated|Overall Study||10
2542395|NCT00591409|6232544|P6|Treated|Overall Study||10
2542396|NCT00591409|6232545|P5|Treated|Overall Study||9
2542397|NCT00591409|6232546|P4|Treated|Overall Study||10
2542398|NCT00591409|6232547|P3|Treated|Overall Study||10
2542399|NCT00591409|6232548|P2|Treated|Overall Study||10
2542400|NCT00591409|6232549|P1|Treated|Overall Study||10
2542401|NCT00591409|6232540|P10|STARTED|Overall Study||11
2542402|NCT00591409|6232541|P9|STARTED|Overall Study||9
2542403|NCT00591409|6232542|P8|STARTED|Overall Study||10
2542404|NCT00591409|6232543|P7|STARTED|Overall Study||10
2542405|NCT00591409|6232544|P6|STARTED|Overall Study||10
2542406|NCT00591409|6232545|P5|STARTED|Overall Study||10
2542407|NCT00591409|6232546|P4|STARTED|Overall Study||10
2542408|NCT00591409|6232547|P3|STARTED|Overall Study||10
2542409|NCT00591409|6232548|P2|STARTED|Overall Study||10
2542410|NCT00591409|6232549|P1|STARTED|Overall Study||10
2542411|NCT00591370|6232591|P1|NOT COMPLETED|Overall Study||2
2542412|NCT00591370|6232591|P1|COMPLETED|Overall Study||49
2542413|NCT00591370|6232591|P1|STARTED|Overall Study||51
2542414|NCT00591344|6232599|P2|NOT COMPLETED|Overall Study||8
2542415|NCT00591344|6232600|P1|NOT COMPLETED|Overall Study||5
2542416|NCT00591344|6232599|P2|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|18
2542417|NCT00591344|6232600|P1|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|20
2542418|NCT00591344|6232599|P2|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
2542419|NCT00591344|6232600|P1|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
2542420|NCT00591344|6232599|P2|STARTED|Overall Study|26 randomized, 2 withdrew before the 6 month test and were replaced, 24 completed 6 month test|26
2542421|NCT00591344|6232600|P1|STARTED|Overall Study|25 randomized, 1 withdrew before the 6 month test and was replaced; 24 completed the 6 month test|25
2542422|NCT00591305|6232612|P2|NOT COMPLETED|Overall Study||0
2542423|NCT00591305|6232613|P1|NOT COMPLETED|Overall Study||0
2542424|NCT00591305|6232612|P2|COMPLETED|Overall Study||0
2542425|NCT00591305|6232613|P1|COMPLETED|Overall Study||1
2542426|NCT00591305|6232612|P2|1st Follow-up in 2 Wks After Surgery|Overall Study||0
2542427|NCT00591305|6232613|P1|1st Follow-up in 2 Wks After Surgery|Overall Study||1
2542428|NCT00591305|6232612|P2|STARTED|Overall Study||0
2542429|NCT00591305|6232613|P1|STARTED|Overall Study||1
2542430|NCT00591266|6232626|P3|NOT COMPLETED|Overall Study||14
2542431|NCT00591266|6232627|P2|NOT COMPLETED|Overall Study||11
2542432|NCT00591266|6232628|P1|NOT COMPLETED|Overall Study||9
2542433|NCT00591266|6232626|P3|COMPLETED|Overall Study||175
2542434|NCT00591266|6232627|P2|COMPLETED|Overall Study||177
2542435|NCT00591266|6232628|P1|COMPLETED|Overall Study||180
2542436|NCT00591266|6232626|P3|STARTED|Overall Study|Randomized only|189
2542437|NCT00591266|6232627|P2|STARTED|Overall Study|Randomized only|188
2542438|NCT00591266|6232628|P1|STARTED|Overall Study|Randomized only|189
2542439|NCT00591253|6232681|P3|NOT COMPLETED|Overall Study||15
2542440|NCT00591253|6232682|P2|NOT COMPLETED|Overall Study||21
2542441|NCT00591253|6232683|P1|NOT COMPLETED|Overall Study||14
2542442|NCT00591253|6232681|P3|COMPLETED|Overall Study||123
2542443|NCT00591253|6232682|P2|COMPLETED|Overall Study||116
2542444|NCT00591253|6232683|P1|COMPLETED|Overall Study||126
2542445|NCT00591253|6232681|P3|STARTED|Overall Study|Randomized or Treated|138
2542446|NCT00591253|6232682|P2|STARTED|Overall Study|Randomized or Treated|137
2542447|NCT00591253|6232683|P1|STARTED|Overall Study|Randomized or Treated|140
2542448|NCT00591240|6232735|P2|NOT COMPLETED|Overall Study||0
2542449|NCT00591240|6232736|P1|NOT COMPLETED|Overall Study||0
2542450|NCT00591240|6232735|P2|COMPLETED|Overall Study||222
2542451|NCT00591240|6232736|P1|COMPLETED|Overall Study||116
2542452|NCT00591240|6232735|P2|STARTED|Overall Study||222
2542453|NCT00591240|6232736|P1|STARTED|Overall Study||116
2542454|NCT00591227|6232744|P2|NOT COMPLETED|Overall Study||0
2542455|NCT00591227|6232745|P1|NOT COMPLETED|Overall Study||0
2542456|NCT00591227|6232744|P2|COMPLETED|Overall Study||87
2542457|NCT00591227|6232745|P1|COMPLETED|Overall Study||89
2542458|NCT00591227|6232744|P2|STARTED|Overall Study||87
2542459|NCT00591227|6232745|P1|STARTED|Overall Study||89
2542460|NCT00591214|6232751|P1|NOT COMPLETED|Overall Study||8
2542461|NCT00591214|6232751|P1|COMPLETED|Overall Study||2
2542462|NCT00591214|6232751|P1|STARTED|Overall Study||10
2542463|NCT00591149|6232760|P1|NOT COMPLETED|Overall Study||5
2542464|NCT00591149|6232760|P1|COMPLETED|Overall Study||11
2542465|NCT00591149|6232760|P1|STARTED|Overall Study||16
2542466|NCT00591019|6232764|P2|NOT COMPLETED|Intevention 2 (14 Days)||0
2542467|NCT00591019|6232765|P1|NOT COMPLETED|Intevention 2 (14 Days)||0
2542468|NCT00591019|6232764|P2|COMPLETED|Intevention 2 (14 Days)||3
2542469|NCT00591019|6232765|P1|COMPLETED|Intevention 2 (14 Days)||2
2542470|NCT00591019|6232764|P2|STARTED|Intevention 2 (14 Days)||3
2542471|NCT00591019|6232765|P1|STARTED|Intevention 2 (14 Days)||2
2542472|NCT00591019|6232764|P2|NOT COMPLETED|Intervention 1 (14 Days)||0
2542473|NCT00591019|6232765|P1|NOT COMPLETED|Intervention 1 (14 Days)||0
2542474|NCT00591019|6232764|P2|COMPLETED|Intervention 1 (14 Days)||3
2542475|NCT00591019|6232765|P1|COMPLETED|Intervention 1 (14 Days)||2
2542476|NCT00591019|6232764|P2|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|3
2542477|NCT00591019|6232765|P1|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|2
2542478|NCT00591019|6232764|P2|NOT COMPLETED|Baseline (1 Day)||0
2542479|NCT00591019|6232765|P1|NOT COMPLETED|Baseline (1 Day)||0
2542480|NCT00591019|6232764|P2|COMPLETED|Baseline (1 Day)||4
2542481|NCT00591019|6232765|P1|COMPLETED|Baseline (1 Day)||3
2542482|NCT00591019|6232764|P2|STARTED|Baseline (1 Day)||4
2542483|NCT00591019|6232765|P1|STARTED|Baseline (1 Day)||3
2542484|NCT00591006|6232776|P24|NOT COMPLETED|Overall Study||1
2542485|NCT00591006|6232777|P23|NOT COMPLETED|Overall Study||1
2542486|NCT00591006|6232778|P22|NOT COMPLETED|Overall Study||0
2542487|NCT00591006|6232779|P21|NOT COMPLETED|Overall Study||0
2542488|NCT00591006|6232780|P20|NOT COMPLETED|Overall Study||0
2542489|NCT00591006|6232781|P19|NOT COMPLETED|Overall Study||0
2542490|NCT00591006|6232782|P18|NOT COMPLETED|Overall Study||0
2542491|NCT00591006|6232783|P17|NOT COMPLETED|Overall Study||0
2542492|NCT00591006|6232784|P16|NOT COMPLETED|Overall Study||1
2542493|NCT00591006|6232785|P15|NOT COMPLETED|Overall Study||0
2542494|NCT00591006|6232786|P14|NOT COMPLETED|Overall Study||0
2542495|NCT00591006|6232787|P13|NOT COMPLETED|Overall Study||0
2542496|NCT00591006|6232788|P12|NOT COMPLETED|Overall Study||0
2542497|NCT00591006|6232789|P11|NOT COMPLETED|Overall Study||0
2542498|NCT00591006|6232790|P10|NOT COMPLETED|Overall Study||0
2542499|NCT00591006|6232791|P9|NOT COMPLETED|Overall Study||0
2542500|NCT00591006|6232792|P8|NOT COMPLETED|Overall Study||0
2542501|NCT00591006|6232793|P7|NOT COMPLETED|Overall Study||0
2542502|NCT00591006|6232794|P6|NOT COMPLETED|Overall Study||0
2542503|NCT00591006|6232795|P5|NOT COMPLETED|Overall Study||0
2542504|NCT00591006|6232796|P4|NOT COMPLETED|Overall Study||0
2542505|NCT00591006|6232797|P3|NOT COMPLETED|Overall Study||0
2542506|NCT00591006|6232798|P2|NOT COMPLETED|Overall Study||0
2542507|NCT00591006|6232799|P1|NOT COMPLETED|Overall Study||0
2542508|NCT00591006|6232776|P24|COMPLETED|Overall Study||0
2542509|NCT00591006|6232777|P23|COMPLETED|Overall Study||0
2542510|NCT00591006|6232778|P22|COMPLETED|Overall Study||1
2542511|NCT00591006|6232779|P21|COMPLETED|Overall Study||0
2542512|NCT00591006|6232780|P20|COMPLETED|Overall Study||1
2542513|NCT00591006|6232781|P19|COMPLETED|Overall Study||0
2542514|NCT00591006|6232782|P18|COMPLETED|Overall Study||1
2542515|NCT00591006|6232783|P17|COMPLETED|Overall Study||0
2542516|NCT00591006|6232784|P16|COMPLETED|Overall Study||0
2542517|NCT00591006|6232785|P15|COMPLETED|Overall Study||0
2542518|NCT00591006|6232786|P14|COMPLETED|Overall Study||2
2542519|NCT00591006|6232787|P13|COMPLETED|Overall Study||1
2542520|NCT00591006|6232788|P12|COMPLETED|Overall Study||1
2542521|NCT00591006|6232789|P11|COMPLETED|Overall Study||0
2542522|NCT00591006|6232790|P10|COMPLETED|Overall Study||1
2542523|NCT00591006|6232791|P9|COMPLETED|Overall Study||1
2542524|NCT00591006|6232792|P8|COMPLETED|Overall Study||0
2542525|NCT00591006|6232793|P7|COMPLETED|Overall Study||1
2542526|NCT00591006|6232794|P6|COMPLETED|Overall Study||0
2542527|NCT00591006|6232795|P5|COMPLETED|Overall Study||1
2542528|NCT00591006|6232796|P4|COMPLETED|Overall Study||1
2542529|NCT00591006|6232797|P3|COMPLETED|Overall Study||1
2542530|NCT00591006|6232798|P2|COMPLETED|Overall Study||0
2542531|NCT00591006|6232799|P1|COMPLETED|Overall Study||1
2542532|NCT00591006|6232776|P24|Treatment #4|Overall Study||0
2542533|NCT00591006|6232777|P23|Treatment #4|Overall Study||0
2542534|NCT00591006|6232778|P22|Treatment #4|Overall Study||1
2542535|NCT00591006|6232779|P21|Treatment #4|Overall Study||0
2542536|NCT00591006|6232780|P20|Treatment #4|Overall Study||1
2542537|NCT00591006|6232781|P19|Treatment #4|Overall Study||0
2542538|NCT00591006|6232782|P18|Treatment #4|Overall Study||1
2542539|NCT00591006|6232783|P17|Treatment #4|Overall Study||0
2542540|NCT00591006|6232784|P16|Treatment #4|Overall Study||0
2542541|NCT00591006|6232785|P15|Treatment #4|Overall Study||0
2542542|NCT00591006|6232786|P14|Treatment #4|Overall Study||2
2542543|NCT00591006|6232787|P13|Treatment #4|Overall Study||1
2542544|NCT00591006|6232788|P12|Treatment #4|Overall Study||1
2542545|NCT00591006|6232789|P11|Treatment #4|Overall Study||0
2542546|NCT00591006|6232790|P10|Treatment #4|Overall Study||1
2542547|NCT00591006|6232791|P9|Treatment #4|Overall Study||1
2542548|NCT00591006|6232792|P8|Treatment #4|Overall Study||0
2542549|NCT00591006|6232793|P7|Treatment #4|Overall Study||1
2542550|NCT00591006|6232794|P6|Treatment #4|Overall Study||0
2542551|NCT00591006|6232795|P5|Treatment #4|Overall Study||1
2542552|NCT00591006|6232796|P4|Treatment #4|Overall Study||1
2542553|NCT00591006|6232797|P3|Treatment #4|Overall Study||1
2542554|NCT00591006|6232798|P2|Treatment #4|Overall Study||0
2542555|NCT00591006|6232799|P1|Treatment #4|Overall Study||1
2542556|NCT00591006|6232776|P24|Treatment #3|Overall Study||1
2542557|NCT00591006|6232777|P23|Treatment #3|Overall Study||1
2542558|NCT00591006|6232778|P22|Treatment #3|Overall Study||1
2542559|NCT00591006|6232779|P21|Treatment #3|Overall Study||0
2542560|NCT00591006|6232780|P20|Treatment #3|Overall Study||1
2542561|NCT00591006|6232781|P19|Treatment #3|Overall Study||0
2542562|NCT00591006|6232782|P18|Treatment #3|Overall Study||1
2542563|NCT00591006|6232783|P17|Treatment #3|Overall Study||0
2542564|NCT00591006|6232784|P16|Treatment #3|Overall Study||0
2542565|NCT00591006|6232785|P15|Treatment #3|Overall Study||0
2542566|NCT00591006|6232786|P14|Treatment #3|Overall Study||2
2542567|NCT00591006|6232787|P13|Treatment #3|Overall Study||1
2542568|NCT00591006|6232788|P12|Treatment #3|Overall Study||1
2542569|NCT00591006|6232789|P11|Treatment #3|Overall Study||0
2542570|NCT00591006|6232790|P10|Treatment #3|Overall Study||1
2542571|NCT00591006|6232791|P9|Treatment #3|Overall Study||1
2542572|NCT00591006|6232792|P8|Treatment #3|Overall Study||0
2542573|NCT00591006|6232793|P7|Treatment #3|Overall Study||1
2542574|NCT00591006|6232794|P6|Treatment #3|Overall Study||0
2542575|NCT00591006|6232795|P5|Treatment #3|Overall Study||1
2542576|NCT00591006|6232796|P4|Treatment #3|Overall Study||1
2542577|NCT00591006|6232797|P3|Treatment #3|Overall Study||1
2542578|NCT00591006|6232798|P2|Treatment #3|Overall Study||0
2542579|NCT00591006|6232799|P1|Treatment #3|Overall Study||1
2542580|NCT00591006|6232776|P24|Treatment #2|Overall Study||1
2542581|NCT00591006|6232777|P23|Treatment #2|Overall Study||1
2542582|NCT00591006|6232778|P22|Treatment #2|Overall Study||1
2542583|NCT00591006|6232779|P21|Treatment #2|Overall Study||0
2542584|NCT00591006|6232780|P20|Treatment #2|Overall Study||1
2542585|NCT00591006|6232781|P19|Treatment #2|Overall Study||0
2542586|NCT00591006|6232782|P18|Treatment #2|Overall Study||1
2542587|NCT00591006|6232783|P17|Treatment #2|Overall Study||0
2542588|NCT00591006|6232784|P16|Treatment #2|Overall Study||0
2542589|NCT00591006|6232785|P15|Treatment #2|Overall Study||0
2542590|NCT00591006|6232786|P14|Treatment #2|Overall Study||2
2542591|NCT00591006|6232787|P13|Treatment #2|Overall Study||1
2542592|NCT00591006|6232788|P12|Treatment #2|Overall Study||1
2542593|NCT00591006|6232789|P11|Treatment #2|Overall Study||0
2542594|NCT00591006|6232790|P10|Treatment #2|Overall Study||1
2542595|NCT00591006|6232791|P9|Treatment #2|Overall Study||1
2542596|NCT00591006|6232792|P8|Treatment #2|Overall Study||0
2542597|NCT00591006|6232793|P7|Treatment #2|Overall Study||1
2542598|NCT00591006|6232794|P6|Treatment #2|Overall Study||0
2542599|NCT00591006|6232795|P5|Treatment #2|Overall Study||1
2542600|NCT00591006|6232796|P4|Treatment #2|Overall Study||1
2542601|NCT00591006|6232797|P3|Treatment #2|Overall Study||1
2542602|NCT00591006|6232798|P2|Treatment #2|Overall Study||0
2542603|NCT00591006|6232799|P1|Treatment #2|Overall Study||1
2542604|NCT00591006|6232776|P24|STARTED|Overall Study||1
2542605|NCT00591006|6232777|P23|STARTED|Overall Study||1
2542606|NCT00591006|6232778|P22|STARTED|Overall Study||1
2542607|NCT00591006|6232779|P21|STARTED|Overall Study||0
2542608|NCT00591006|6232780|P20|STARTED|Overall Study||1
2542609|NCT00591006|6232781|P19|STARTED|Overall Study||0
2542610|NCT00591006|6232782|P18|STARTED|Overall Study||1
2542611|NCT00591006|6232783|P17|STARTED|Overall Study||0
2542612|NCT00591006|6232784|P16|STARTED|Overall Study||1
2542613|NCT00591006|6232785|P15|STARTED|Overall Study||0
2542614|NCT00591006|6232786|P14|STARTED|Overall Study||2
2542615|NCT00591006|6232787|P13|STARTED|Overall Study||1
2542616|NCT00591006|6232788|P12|STARTED|Overall Study||1
2542617|NCT00591006|6232789|P11|STARTED|Overall Study||0
2542618|NCT00591006|6232790|P10|STARTED|Overall Study||1
2542619|NCT00591006|6232791|P9|STARTED|Overall Study||1
2542620|NCT00591006|6232792|P8|STARTED|Overall Study||0
2542621|NCT00591006|6232793|P7|STARTED|Overall Study||1
2542622|NCT00591006|6232794|P6|STARTED|Overall Study||0
2542623|NCT00591006|6232795|P5|STARTED|Overall Study||1
2542624|NCT00591006|6232796|P4|STARTED|Overall Study||1
2542625|NCT00591006|6232797|P3|STARTED|Overall Study||1
2542626|NCT00591006|6232798|P2|STARTED|Overall Study||0
2542627|NCT00591006|6232799|P1|STARTED|Overall Study||1
2542628|NCT00590980|6232817|P1|NOT COMPLETED|Overall Study||10
2542629|NCT00590980|6232817|P1|COMPLETED|Overall Study||72
2542630|NCT00590980|6232817|P1|STARTED|Overall Study||82
2542631|NCT00590967|6232823|P2|NOT COMPLETED|Overall Study||5
2542632|NCT00590967|6232824|P1|NOT COMPLETED|Overall Study||3
2542633|NCT00590967|6232823|P2|COMPLETED|Overall Study||20
2542634|NCT00590967|6232824|P1|COMPLETED|Overall Study||41
2542635|NCT00590967|6232823|P2|STARTED|Overall Study||25
2542636|NCT00590967|6232824|P1|STARTED|Overall Study||44
2542637|NCT00590902|6232836|P1|NOT COMPLETED|Overall Study||1
2542638|NCT00590902|6232836|P1|COMPLETED|Overall Study||80
2542639|NCT00590902|6232836|P1|STARTED|Overall Study||81
2542640|NCT00590889|6232842|P2|NOT COMPLETED|Overall Study||299
2542641|NCT00590889|6232843|P1|NOT COMPLETED|Overall Study||286
2542642|NCT00590889|6232842|P2|COMPLETED|Overall Study||104
2542643|NCT00590889|6232843|P1|COMPLETED|Overall Study||118
2542644|NCT00590889|6232842|P2|STARTED|Overall Study||403
2542645|NCT00590889|6232843|P1|STARTED|Overall Study||404
2542646|NCT00590863|6232852|P3|NOT COMPLETED|Overall Study||78
2542647|NCT00590863|6232853|P2|NOT COMPLETED|Overall Study||82
2542648|NCT00590863|6232854|P1|NOT COMPLETED|Overall Study||84
2542649|NCT00590863|6232852|P3|COMPLETED|Overall Study||146
2542650|NCT00590863|6232853|P2|COMPLETED|Overall Study||138
2542651|NCT00590863|6232854|P1|COMPLETED|Overall Study||137
2542652|NCT00590863|6232852|P3|STARTED|Overall Study||224
2542653|NCT00590863|6232853|P2|STARTED|Overall Study||220
2542654|NCT00590863|6232854|P1|STARTED|Overall Study||221
2542655|NCT00590824|6232869|P4|NOT COMPLETED|Overall Study||1
2542656|NCT00590824|6232870|P3|NOT COMPLETED|Overall Study||1
2542657|NCT00590824|6232871|P2|NOT COMPLETED|Overall Study||2
2542658|NCT00590824|6232872|P1|NOT COMPLETED|Overall Study||0
2542659|NCT00590824|6232869|P4|COMPLETED|Overall Study||0
2542660|NCT00590824|6232870|P3|COMPLETED|Overall Study||1
2542661|NCT00590824|6232871|P2|COMPLETED|Overall Study||7
2542662|NCT00590824|6232872|P1|COMPLETED|Overall Study||11
2542663|NCT00590824|6232869|P4|STARTED|Overall Study||1
2542664|NCT00590824|6232870|P3|STARTED|Overall Study||2
2542665|NCT00590824|6232871|P2|STARTED|Overall Study||9
2542666|NCT00590824|6232872|P1|STARTED|Overall Study||11
2542667|NCT00590772|6232892|P1|NOT COMPLETED|Overall Study||0
2542668|NCT00590772|6232892|P1|COMPLETED|Overall Study||31
2542669|NCT00590772|6232892|P1|STARTED|Overall Study||31
2542670|NCT00590759|6232898|P1|NOT COMPLETED|Overall Study||80
2542671|NCT00590759|6232898|P1|COMPLETED|Overall Study||70
2542672|NCT00590759|6232898|P1|STARTED|Overall Study||150
2542673|NCT00590720|6232905|P2|NOT COMPLETED|Overall Study||1
2542674|NCT00590720|6232906|P1|NOT COMPLETED|Overall Study||1
2542675|NCT00590720|6232905|P2|COMPLETED|Overall Study||6
2542676|NCT00590720|6232906|P1|COMPLETED|Overall Study||3
2542677|NCT00590720|6232905|P2|STARTED|Overall Study||7
2542678|NCT00590720|6232906|P1|STARTED|Overall Study||4
2542679|NCT00590707|6232950|P2|NOT COMPLETED|Overall Study||0
2542680|NCT00590707|6232951|P1|NOT COMPLETED|Overall Study||0
2542681|NCT00590707|6232950|P2|COMPLETED|Overall Study||100
2542682|NCT00590707|6232951|P1|COMPLETED|Overall Study||100
2542683|NCT00590707|6232950|P2|STARTED|Overall Study||100
2542684|NCT00590707|6232951|P1|STARTED|Overall Study||100
2542685|NCT00590590|6232968|P3|NOT COMPLETED|Overall Study||6
2542686|NCT00590590|6232969|P2|NOT COMPLETED|Overall Study||6
2542687|NCT00590590|6232970|P1|NOT COMPLETED|Overall Study||7
2542688|NCT00590590|6232968|P3|COMPLETED|Overall Study||21
2542689|NCT00590590|6232969|P2|COMPLETED|Overall Study||33
2542690|NCT00590590|6232970|P1|COMPLETED|Overall Study||32
2542691|NCT00590590|6232968|P3|STARTED|Overall Study||27
2542692|NCT00590590|6232969|P2|STARTED|Overall Study||39
2542693|NCT00590590|6232970|P1|STARTED|Overall Study||39
2542694|NCT00590577|6232997|P4|NOT COMPLETED|Overall Study||93
2542695|NCT00590577|6232998|P3|NOT COMPLETED|Overall Study||73
2542696|NCT00590577|6232999|P2|NOT COMPLETED|Overall Study||76
2542697|NCT00590577|6233000|P1|NOT COMPLETED|Overall Study||77
2542698|NCT00590577|6232997|P4|COMPLETED|Overall Study||71
2542699|NCT00590577|6232998|P3|COMPLETED|Overall Study||90
2542700|NCT00590577|6232999|P2|COMPLETED|Overall Study||89
2542701|NCT00590577|6233000|P1|COMPLETED|Overall Study||83
2542702|NCT00590577|6232997|P4|STARTED|Overall Study||164
2542703|NCT00590577|6232998|P3|STARTED|Overall Study||163
2542704|NCT00590577|6232999|P2|STARTED|Overall Study||165
2542705|NCT00590577|6233000|P1|STARTED|Overall Study||160
2542706|NCT00590564|6233018|P1|NOT COMPLETED|Overall Study||18
2542707|NCT00590564|6233018|P1|COMPLETED|Overall Study||24
2542708|NCT00590564|6233018|P1|STARTED|Overall Study||42
2542709|NCT00590538|6233022|P1|NOT COMPLETED|Overall Study||2
2542710|NCT00590538|6233022|P1|COMPLETED|Overall Study||7
2542711|NCT00590538|6233022|P1|STARTED|Overall Study|STUDY NOT UNBLINDED AT TIME OF TERMINATION; THEREFORE NUMBER ASSIGNED TO EACH GROUP IS NOT KNOWN.|9
2542712|NCT00590460|6233030|P1|NOT COMPLETED|Overall Study||0
2542713|NCT00590460|6233030|P1|COMPLETED|Overall Study||5
2542714|NCT00590460|6233030|P1|STARTED|Overall Study||5
2542715|NCT00590395|6233043|P1|NOT COMPLETED|Overall Study||0
2542716|NCT00590395|6233043|P1|COMPLETED|Overall Study||19
2542717|NCT00590395|6233043|P1|STARTED|Overall Study||19
2542718|NCT00590369|6233049|P2|NOT COMPLETED|Overall Study||0
2542719|NCT00590369|6233050|P1|NOT COMPLETED|Overall Study||0
2542720|NCT00590369|6233049|P2|COMPLETED|Overall Study||5
2542721|NCT00590369|6233050|P1|COMPLETED|Overall Study|Study stopped early due to difficulty recruiting subjects|6
2542722|NCT00590369|6233049|P2|STARTED|Overall Study||5
2542723|NCT00590369|6233050|P1|STARTED|Overall Study||6
2542724|NCT00590317|6233068|P2|NOT COMPLETED|Overall Study||5
2542725|NCT00590317|6233069|P1|NOT COMPLETED|Overall Study||1
2542726|NCT00590317|6233068|P2|COMPLETED|Overall Study||27
2542727|NCT00590317|6233069|P1|COMPLETED|Overall Study||31
2542728|NCT00590317|6233068|P2|STARTED|Overall Study||32
2542729|NCT00590317|6233069|P1|STARTED|Overall Study||32
2542730|NCT00590226|6233081|P2|NOT COMPLETED|Overall Study||0
2542731|NCT00590226|6233082|P1|NOT COMPLETED|Overall Study||0
2542732|NCT00590226|6233081|P2|COMPLETED|Overall Study||63
2542733|NCT00590226|6233082|P1|COMPLETED|Overall Study||67
2542734|NCT00590226|6233081|P2|STARTED|Overall Study||63
2542735|NCT00590226|6233082|P1|STARTED|Overall Study||67
2542736|NCT00590161|6233092|P2|NOT COMPLETED|Overall Study||3
2542737|NCT00590161|6233093|P1|NOT COMPLETED|Overall Study||3
2542738|NCT00590161|6233092|P2|COMPLETED|Overall Study||26
2542739|NCT00590161|6233093|P1|COMPLETED|Overall Study||23
2542740|NCT00590161|6233092|P2|STARTED|Overall Study||29
2542741|NCT00590161|6233093|P1|STARTED|Overall Study||26
2542742|NCT00590135|6233099|P1|NOT COMPLETED|Overall Study||59
2542743|NCT00590135|6233099|P1|COMPLETED|Overall Study||0
2542744|NCT00590135|6233099|P1|STARTED|Overall Study||59
2542745|NCT00590044|6233109|P2|NOT COMPLETED|Overall Study||2
2542746|NCT00590044|6233110|P1|NOT COMPLETED|Overall Study||4
2542747|NCT00590044|6233109|P2|COMPLETED|Overall Study||34
2542748|NCT00590044|6233110|P1|COMPLETED|Overall Study||34
2542749|NCT00590044|6233109|P2|STARTED|Overall Study||36
2542750|NCT00590044|6233110|P1|STARTED|Overall Study||38
2542751|NCT00590031|6233122|P1|NOT COMPLETED|Overall Study||6
2542752|NCT00590031|6233122|P1|COMPLETED|Overall Study||55
2542753|NCT00590031|6233122|P1|STARTED|Overall Study||61
2542754|NCT00590018|6233129|P2|NOT COMPLETED|Overall Study||0
2542755|NCT00590018|6233130|P1|NOT COMPLETED|Overall Study||0
2542756|NCT00590018|6233129|P2|COMPLETED|Overall Study||9
2542757|NCT00590018|6233130|P1|COMPLETED|Overall Study||9
2542758|NCT00590018|6233129|P2|STARTED|Overall Study||9
2542759|NCT00590018|6233130|P1|STARTED|Overall Study||9
2542760|NCT00590005|6233138|P2|NOT COMPLETED|Overall Study||0
2542761|NCT00590005|6233139|P1|NOT COMPLETED|Overall Study||0
2542762|NCT00590005|6233138|P2|COMPLETED|Overall Study||119
2542763|NCT00590005|6233139|P1|COMPLETED|Overall Study||106
2542764|NCT00590005|6233138|P2|STARTED|Overall Study||119
2542765|NCT00590005|6233139|P1|STARTED|Overall Study||106
2542766|NCT00589979|6233149|P3|NOT COMPLETED|Double-Blind Treatment Period 3||1
2542767|NCT00589979|6233150|P2|NOT COMPLETED|Double-Blind Treatment Period 3||1
2542768|NCT00589979|6233151|P1|NOT COMPLETED|Double-Blind Treatment Period 3||0
2542769|NCT00589979|6233149|P3|COMPLETED|Double-Blind Treatment Period 3||38
2542770|NCT00589979|6233150|P2|COMPLETED|Double-Blind Treatment Period 3||46
2542771|NCT00589979|6233151|P1|COMPLETED|Double-Blind Treatment Period 3||0
2542772|NCT00589979|6233149|P3|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|39
2542773|NCT00589979|6233150|P2|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|47
2542774|NCT00589979|6233151|P1|STARTED|Double-Blind Treatment Period 3||0
2542775|NCT00589979|6233149|P3|NOT COMPLETED|Double-Blind Treatment Period 2||2
2542776|NCT00589979|6233150|P2|NOT COMPLETED|Double-Blind Treatment Period 2||1
2542777|NCT00589979|6233151|P1|NOT COMPLETED|Double-Blind Treatment Period 2||0
2542778|NCT00589979|6233149|P3|COMPLETED|Double-Blind Treatment Period 2||39
2542779|NCT00589979|6233150|P2|COMPLETED|Double-Blind Treatment Period 2||47
2542780|NCT00589979|6233151|P1|COMPLETED|Double-Blind Treatment Period 2||0
2542781|NCT00589979|6233149|P3|STARTED|Double-Blind Treatment Period 2|N=20 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|41
2542782|NCT00589979|6233150|P2|STARTED|Double-Blind Treatment Period 2|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|48
2542783|NCT00589979|6233151|P1|STARTED|Double-Blind Treatment Period 2||0
2542784|NCT00589979|6233149|P3|NOT COMPLETED|Double-Blind Treatment Period 1||2
2542785|NCT00589979|6233150|P2|NOT COMPLETED|Double-Blind Treatment Period 1||2
2542786|NCT00589979|6233151|P1|NOT COMPLETED|Double-Blind Treatment Period 1||0
2542787|NCT00589979|6233149|P3|COMPLETED|Double-Blind Treatment Period 1||41
2542788|NCT00589979|6233150|P2|COMPLETED|Double-Blind Treatment Period 1||48
2542789|NCT00589979|6233151|P1|COMPLETED|Double-Blind Treatment Period 1||0
2542790|NCT00589979|6233149|P3|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|43
2542791|NCT00589979|6233150|P2|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|50
2542792|NCT00589979|6233151|P1|STARTED|Double-Blind Treatment Period 1|Participants completing the Run-in Period were then randomized to two different treatment sequences.|0
2542793|NCT00589979|6233149|P3|NOT COMPLETED|Run-In Period||0
2542794|NCT00589979|6233150|P2|NOT COMPLETED|Run-In Period||0
2542795|NCT00589979|6233151|P1|NOT COMPLETED|Run-In Period||76
2542796|NCT00589979|6233149|P3|COMPLETED|Run-In Period||0
2542797|NCT00589979|6233150|P2|COMPLETED|Run-In Period||0
2542798|NCT00589979|6233151|P1|COMPLETED|Run-In Period||93
2542799|NCT00589979|6233149|P3|STARTED|Run-In Period||0
2542800|NCT00589979|6233150|P2|STARTED|Run-In Period||0
2542801|NCT00589979|6233151|P1|STARTED|Run-In Period||169
2542802|NCT00589914|6233190|P2|NOT COMPLETED|Overall Study||137
2542803|NCT00589914|6233191|P1|NOT COMPLETED|Overall Study||150
2542804|NCT00589914|6233190|P2|COMPLETED|Overall Study||471
2542805|NCT00589914|6233191|P1|COMPLETED|Overall Study||456
2542806|NCT00589914|6233190|P2|STARTED|Overall Study||608
2542807|NCT00589914|6233191|P1|STARTED|Overall Study||606
2542808|NCT00589888|6233201|P5|NOT COMPLETED|64-gram Oral Fat Load||0
2542809|NCT00589888|6233202|P4|NOT COMPLETED|64-gram Oral Fat Load||0
2542810|NCT00589888|6233203|P3|NOT COMPLETED|64-gram Oral Fat Load||0
2542811|NCT00589888|6233204|P2|NOT COMPLETED|64-gram Oral Fat Load||0
2542812|NCT00589888|6233205|P1|NOT COMPLETED|64-gram Oral Fat Load||0
2542813|NCT00589888|6233201|P5|COMPLETED|64-gram Oral Fat Load||13
2542814|NCT00589888|6233202|P4|COMPLETED|64-gram Oral Fat Load||0
2542815|NCT00589888|6233203|P3|COMPLETED|64-gram Oral Fat Load||0
2542816|NCT00589888|6233204|P2|COMPLETED|64-gram Oral Fat Load||0
2542817|NCT00589888|6233205|P1|COMPLETED|64-gram Oral Fat Load||0
2542818|NCT00589888|6233201|P5|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
2542819|NCT00589888|6233202|P4|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
2542820|NCT00589888|6233203|P3|STARTED|64-gram Oral Fat Load||0
2542821|NCT00589888|6233204|P2|STARTED|64-gram Oral Fat Load||0
2542822|NCT00589888|6233205|P1|STARTED|64-gram Oral Fat Load||0
2542823|NCT00589888|6233201|P5|NOT COMPLETED|32-gram Oral Fat Load||0
2542824|NCT00589888|6233202|P4|NOT COMPLETED|32-gram Oral Fat Load||0
2542825|NCT00589888|6233203|P3|NOT COMPLETED|32-gram Oral Fat Load||0
2542826|NCT00589888|6233204|P2|NOT COMPLETED|32-gram Oral Fat Load||0
2542827|NCT00589888|6233205|P1|NOT COMPLETED|32-gram Oral Fat Load||0
2542828|NCT00589888|6233201|P5|COMPLETED|32-gram Oral Fat Load||0
2542829|NCT00589888|6233202|P4|COMPLETED|32-gram Oral Fat Load||13
2542830|NCT00589888|6233203|P3|COMPLETED|32-gram Oral Fat Load||0
2542831|NCT00589888|6233204|P2|COMPLETED|32-gram Oral Fat Load||0
2542832|NCT00589888|6233205|P1|COMPLETED|32-gram Oral Fat Load||0
2542833|NCT00589888|6233201|P5|STARTED|32-gram Oral Fat Load||0
2542834|NCT00589888|6233202|P4|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
2542835|NCT00589888|6233203|P3|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
2542836|NCT00589888|6233204|P2|STARTED|32-gram Oral Fat Load||0
2542837|NCT00589888|6233205|P1|STARTED|32-gram Oral Fat Load||0
2542838|NCT00589888|6233201|P5|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
2542839|NCT00589888|6233202|P4|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
2542840|NCT00589888|6233203|P3|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
2542841|NCT00589888|6233204|P2|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
2542842|NCT00589888|6233205|P1|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
2542843|NCT00589888|6233201|P5|COMPLETED|Intralipid 20% @ 40cc/Hour||0
2542844|NCT00589888|6233202|P4|COMPLETED|Intralipid 20% @ 40cc/Hour||0
2542845|NCT00589888|6233203|P3|COMPLETED|Intralipid 20% @ 40cc/Hour||13
2542846|NCT00589888|6233204|P2|COMPLETED|Intralipid 20% @ 40cc/Hour||0
2542847|NCT00589888|6233205|P1|COMPLETED|Intralipid 20% @ 40cc/Hour||0
2542848|NCT00589888|6233201|P5|STARTED|Intralipid 20% @ 40cc/Hour||0
2542849|NCT00589888|6233202|P4|STARTED|Intralipid 20% @ 40cc/Hour||0
2542850|NCT00589888|6233203|P3|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
2542851|NCT00589888|6233204|P2|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|0
2542852|NCT00589888|6233205|P1|STARTED|Intralipid 20% @ 40cc/Hour||0
2542853|NCT00589888|6233201|P5|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
2542854|NCT00589888|6233202|P4|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
2542855|NCT00589888|6233203|P3|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
2542856|NCT00589888|6233204|P2|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
2542857|NCT00589888|6233205|P1|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
2542858|NCT00589888|6233201|P5|COMPLETED|Intralipid 20% @ 20cc/hr||0
2542859|NCT00589888|6233202|P4|COMPLETED|Intralipid 20% @ 20cc/hr||0
2542860|NCT00589888|6233203|P3|COMPLETED|Intralipid 20% @ 20cc/hr||0
2542861|NCT00589888|6233204|P2|COMPLETED|Intralipid 20% @ 20cc/hr||13
2542862|NCT00589888|6233205|P1|COMPLETED|Intralipid 20% @ 20cc/hr||0
2542863|NCT00589888|6233201|P5|STARTED|Intralipid 20% @ 20cc/hr||0
2542864|NCT00589888|6233202|P4|STARTED|Intralipid 20% @ 20cc/hr||0
2542865|NCT00589888|6233203|P3|STARTED|Intralipid 20% @ 20cc/hr||0
2542866|NCT00589888|6233204|P2|STARTED|Intralipid 20% @ 20cc/hr||13
2542867|NCT00589888|6233205|P1|STARTED|Intralipid 20% @ 20cc/hr|the same 13 patients did each of the 5 arms at 5 different visits|0
2542868|NCT00589888|6233201|P5|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
2542869|NCT00589888|6233202|P4|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
2542870|NCT00589888|6233203|P3|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
2542871|NCT00589888|6233204|P2|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
2542872|NCT00589888|6233205|P1|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
2542873|NCT00589888|6233201|P5|COMPLETED|Normal Saline @ 40cc/Hour||0
2542874|NCT00589888|6233202|P4|COMPLETED|Normal Saline @ 40cc/Hour||0
2542875|NCT00589888|6233203|P3|COMPLETED|Normal Saline @ 40cc/Hour||0
2542876|NCT00589888|6233204|P2|COMPLETED|Normal Saline @ 40cc/Hour||0
2542877|NCT00589888|6233205|P1|COMPLETED|Normal Saline @ 40cc/Hour||13
2542878|NCT00589888|6233201|P5|STARTED|Normal Saline @ 40cc/Hour||0
2542879|NCT00589888|6233202|P4|STARTED|Normal Saline @ 40cc/Hour||0
2542880|NCT00589888|6233203|P3|STARTED|Normal Saline @ 40cc/Hour||0
2542881|NCT00589888|6233204|P2|STARTED|Normal Saline @ 40cc/Hour||0
2542882|NCT00589888|6233205|P1|STARTED|Normal Saline @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
2542883|NCT00589849|6233237|P1|NOT COMPLETED|Overall Study||0
2542884|NCT00589849|6233237|P1|COMPLETED|Overall Study||32
2542885|NCT00589849|6233237|P1|STARTED|Overall Study||32
2542886|NCT00589836|6233241|P1|NOT COMPLETED|Overall Study||0
2542887|NCT00589836|6233241|P1|COMPLETED|Overall Study||20
2542888|NCT00589836|6233241|P1|STARTED|Overall Study||20
2542889|NCT00589797|6233247|P2|NOT COMPLETED|Overall Study||23
2542890|NCT00589797|6233248|P1|NOT COMPLETED|Overall Study||73
2542891|NCT00589797|6233247|P2|COMPLETED|Overall Study||89
2542892|NCT00589797|6233248|P1|COMPLETED|Overall Study||191
2542893|NCT00589797|6233247|P2|24 Months|Overall Study||89
2542894|NCT00589797|6233248|P1|24 Months|Overall Study||191
2542895|NCT00589797|6233247|P2|Baseline|Overall Study||106
2542896|NCT00589797|6233248|P1|Baseline|Overall Study||218
2542897|NCT00589797|6233247|P2|STARTED|Overall Study||112
2542898|NCT00589797|6233248|P1|STARTED|Overall Study||264
2542899|NCT00589784|6233272|P2|NOT COMPLETED|Overall Study||10
2542900|NCT00589784|6233273|P1|NOT COMPLETED|Overall Study||1
2542901|NCT00589784|6233272|P2|COMPLETED|Overall Study||4
2542902|NCT00589784|6233273|P1|COMPLETED|Overall Study||35
2542903|NCT00589784|6233272|P2|STARTED|Overall Study||14
2542904|NCT00589784|6233273|P1|STARTED|Overall Study||36
2542905|NCT00589693|6233280|P2|NOT COMPLETED|Overall Study||29
2542906|NCT00589693|6233281|P1|NOT COMPLETED|Overall Study||44
2542907|NCT00589693|6233280|P2|COMPLETED|Overall Study||83
2542908|NCT00589693|6233281|P1|COMPLETED|Overall Study||71
2542909|NCT00589693|6233280|P2|STARTED|Overall Study||112
2542910|NCT00589693|6233281|P1|STARTED|Overall Study||115
2542911|NCT00589667|6233295|P1|NOT COMPLETED|Overall Study||3
2542912|NCT00589667|6233295|P1|COMPLETED|Overall Study||23
2542913|NCT00589667|6233295|P1|STARTED|Overall Study||26
2542914|NCT00589628|6233302|P2|NOT COMPLETED|Overall Study||1
2542915|NCT00589628|6233303|P1|NOT COMPLETED|Overall Study||0
2542916|NCT00589628|6233302|P2|COMPLETED|Overall Study||5
2542917|NCT00589628|6233303|P1|COMPLETED|Overall Study||7
2542918|NCT00589628|6233302|P2|STARTED|Overall Study||6
2542919|NCT00589628|6233303|P1|STARTED|Overall Study||7
2542920|NCT00589602|6233309|P1|NOT COMPLETED|Overall Study||1
2542921|NCT00589602|6233309|P1|COMPLETED|Overall Study||12
2542922|NCT00589602|6233309|P1|STARTED|Overall Study||13
2542923|NCT00589563|6233317|P1|NOT COMPLETED|Overall Study||0
2542924|NCT00589563|6233317|P1|COMPLETED|Overall Study||32
2542925|NCT00589563|6233317|P1|STARTED|Overall Study||32
2542926|NCT00589550|6233334|P1|NOT COMPLETED|Overall Study||1
2542927|NCT00589550|6233334|P1|COMPLETED|Overall Study||0
2542928|NCT00589550|6233334|P1|Withdrew From Study|Overall Study||1
2542929|NCT00589550|6233334|P1|STARTED|Overall Study||1
2542930|NCT00589472|6233344|P1|NOT COMPLETED|Overall Study||1
2542931|NCT00589472|6233344|P1|COMPLETED|Overall Study||18
2542932|NCT00589472|6233344|P1|STARTED|Overall Study||19
2542933|NCT00589329|6233356|P2|NOT COMPLETED|Overall Study||0
2542934|NCT00589329|6233357|P1|NOT COMPLETED|Overall Study||0
2542935|NCT00589329|6233356|P2|COMPLETED|Overall Study||10
2542936|NCT00589329|6233357|P1|COMPLETED|Overall Study||10
2542937|NCT00589329|6233356|P2|STARTED|Overall Study||10
2542938|NCT00589329|6233357|P1|STARTED|Overall Study||10
2542939|NCT00589303|6233367|P2|NOT COMPLETED|Overall Study||1
2542940|NCT00589303|6233368|P1|NOT COMPLETED|Overall Study||2
2542941|NCT00589303|6233367|P2|COMPLETED|Overall Study||12
2542942|NCT00589303|6233368|P1|COMPLETED|Overall Study||12
2542943|NCT00589303|6233367|P2|STARTED|Overall Study||13
2542944|NCT00589303|6233368|P1|STARTED|Overall Study||14
2542945|NCT00589290|6233374|P1|NOT COMPLETED|Overall Study||1
2542946|NCT00589290|6233374|P1|COMPLETED|Overall Study||40
2542947|NCT00589290|6233374|P1|STARTED|Overall Study||41
2542948|NCT00589277|6233384|P2|NOT COMPLETED|Overall Study||286
2542949|NCT00589277|6233385|P1|NOT COMPLETED|Overall Study||460
2542950|NCT00589277|6233384|P2|COMPLETED|Overall Study||524
2542951|NCT00589277|6233385|P1|COMPLETED|Overall Study||762
2542952|NCT00589277|6233384|P2|Completed 3 Month Follow Up|Overall Study||524
2542953|NCT00589277|6233385|P1|Completed 3 Month Follow Up|Overall Study||762
2542954|NCT00589277|6233384|P2|Completed 2 Week Follow Up|Overall Study||424
2542955|NCT00589277|6233385|P1|Completed 2 Week Follow Up|Overall Study||603
2542956|NCT00589277|6233384|P2|STARTED|Overall Study||810
2542957|NCT00589277|6233385|P1|STARTED|Overall Study||1222
2542958|NCT00589121|6233397|P2|NOT COMPLETED|Overall Study||7
2542959|NCT00589121|6233398|P1|NOT COMPLETED|Overall Study||2
2542960|NCT00589121|6233397|P2|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|79
2542961|NCT00589121|6233398|P1|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|10
2542962|NCT00589121|6233397|P2|STARTED|Overall Study||86
2542963|NCT00589121|6233398|P1|STARTED|Overall Study||12
2542964|NCT00589108|6233420|P3|NOT COMPLETED|Overall Study||5
2542965|NCT00589108|6233421|P2|NOT COMPLETED|Overall Study||4
2542966|NCT00589108|6233422|P1|NOT COMPLETED|Overall Study||4
2542967|NCT00589108|6233420|P3|COMPLETED|Overall Study||75
2542968|NCT00589108|6233421|P2|COMPLETED|Overall Study||76
2542969|NCT00589108|6233422|P1|COMPLETED|Overall Study||76
2542970|NCT00589108|6233420|P3|STARTED|Overall Study||80
2542971|NCT00589108|6233421|P2|STARTED|Overall Study||80
2542972|NCT00589108|6233422|P1|STARTED|Overall Study||80
2542973|NCT00588965|6233442|P1|NOT COMPLETED|Overall Study||0
2542974|NCT00588965|6233442|P1|COMPLETED|Overall Study||35
2542975|NCT00588965|6233442|P1|STARTED|Overall Study||35
2542976|NCT00588952|6233452|P2|NOT COMPLETED|Overall Study||7
2542977|NCT00588952|6233453|P1|NOT COMPLETED|Overall Study||3
2542978|NCT00588952|6233452|P2|COMPLETED|Overall Study||63
2542979|NCT00588952|6233453|P1|COMPLETED|Overall Study||26
2542980|NCT00588952|6233452|P2|STARTED|Overall Study||70
2542981|NCT00588952|6233453|P1|STARTED|Overall Study||29
2542982|NCT00588900|6233473|P1|NOT COMPLETED|Overall Study||0
2542983|NCT00588900|6233473|P1|COMPLETED|Overall Study||5
2542984|NCT00588900|6233473|P1|STARTED|Overall Study||5
2542985|NCT00588861|6233481|P2|NOT COMPLETED|10 Years||114
2542986|NCT00588861|6233482|P1|NOT COMPLETED|10 Years||107
2542987|NCT00588861|6233481|P2|COMPLETED|10 Years||0
2542988|NCT00588861|6233482|P1|COMPLETED|10 Years||0
2542989|NCT00588861|6233481|P2|STARTED|10 Years|114 cases were due at 10 Years, however no patients returned for follow-up.|114
2542990|NCT00588861|6233482|P1|STARTED|10 Years|107 cases were due at 10 Years, however no patients returned for follow-up.|107
2542991|NCT00588861|6233481|P2|NOT COMPLETED|8 Years||114
2542992|NCT00588861|6233482|P1|NOT COMPLETED|8 Years||105
2542993|NCT00588861|6233481|P2|COMPLETED|8 Years||0
2542994|NCT00588861|6233482|P1|COMPLETED|8 Years||2
2542995|NCT00588861|6233481|P2|STARTED|8 Years|114 cases were due at 8 Years, however no patients returned for follow-up.|114
2542996|NCT00588861|6233482|P1|STARTED|8 Years|107 cases were due at 8 Years, however only 2 returned for follow-up.|107
2542997|NCT00588861|6233481|P2|NOT COMPLETED|6 Years||109
2542998|NCT00588861|6233482|P1|NOT COMPLETED|6 Years||104
2542999|NCT00588861|6233481|P2|COMPLETED|6 Years||5
2543000|NCT00588861|6233482|P1|COMPLETED|6 Years||3
2543001|NCT00588861|6233481|P2|STARTED|6 Years|114 cases were due at 6 Years, however only 5 returned for follow-up.|114
2543002|NCT00588861|6233482|P1|STARTED|6 Years|107 cases were due at 6 Years, however only 3 returned for follow-up.|107
2543003|NCT00588861|6233481|P2|NOT COMPLETED|4 Years||103
2543004|NCT00588861|6233482|P1|NOT COMPLETED|4 Years||91
2543005|NCT00588861|6233481|P2|COMPLETED|4 Years||11
2543006|NCT00588861|6233482|P1|COMPLETED|4 Years||16
2543007|NCT00588861|6233481|P2|STARTED|4 Years|114 cases were due at 4 Years, however only 11 returned for follow-up.|114
2543008|NCT00588861|6233482|P1|STARTED|4 Years|107 cases were due at 4 Years, however only 16 returned for follow-up.|107
2543009|NCT00588861|6233481|P2|NOT COMPLETED|2 Years||87
2543010|NCT00588861|6233482|P1|NOT COMPLETED|2 Years||92
2543011|NCT00588861|6233481|P2|COMPLETED|2 Years||27
2543012|NCT00588861|6233482|P1|COMPLETED|2 Years||15
2543013|NCT00588861|6233481|P2|STARTED|2 Years|114 cases were due at 2 Years, however only 27 returned for follow-up.|114
2543014|NCT00588861|6233482|P1|STARTED|2 Years|107 cases were due at 2 Years, however only 15 returned for follow-up.|107
2543015|NCT00588861|6233481|P2|NOT COMPLETED|1 Year||82
2543016|NCT00588861|6233482|P1|NOT COMPLETED|1 Year||89
2543017|NCT00588861|6233481|P2|COMPLETED|1 Year||32
2543018|NCT00588861|6233482|P1|COMPLETED|1 Year||18
2543019|NCT00588861|6233481|P2|STARTED|1 Year|114 cases were due at 1 Year, however only 32 returned for follow-up.|114
2543020|NCT00588861|6233482|P1|STARTED|1 Year|107 cases were due at 1 Year, however only 18 returned for follow-up.|107
2543021|NCT00588861|6233481|P2|NOT COMPLETED|6 Months||73
2543022|NCT00588861|6233482|P1|NOT COMPLETED|6 Months||98
2543023|NCT00588861|6233481|P2|COMPLETED|6 Months||41
2543024|NCT00588861|6233482|P1|COMPLETED|6 Months||9
2543025|NCT00588861|6233481|P2|STARTED|6 Months|114 cases were due at 6 Months, however only 41 returned for follow-up.|114
2543026|NCT00588861|6233482|P1|STARTED|6 Months|107 cases were due at 6 Months, however only 9 returned for follow-up.|107
2543027|NCT00588861|6233481|P2|NOT COMPLETED|Pre-Operative||86
2543028|NCT00588861|6233482|P1|NOT COMPLETED|Pre-Operative||95
2543029|NCT00588861|6233481|P2|COMPLETED|Pre-Operative||114
2543030|NCT00588861|6233482|P1|COMPLETED|Pre-Operative||107
2543031|NCT00588861|6233481|P2|STARTED|Pre-Operative|200 patients were enrolled, however only 114 contributed preop data.|200
2543032|NCT00588861|6233482|P1|STARTED|Pre-Operative|202 Patients were enrolled, however only 107 contributed preop data.|202
2543033|NCT00588848|6233492|P2|NOT COMPLETED|Overall Study||3
2543034|NCT00588848|6233493|P1|NOT COMPLETED|Overall Study||0
2543035|NCT00588848|6233492|P2|COMPLETED|Overall Study||5
2543036|NCT00588848|6233493|P1|COMPLETED|Overall Study||3
2543037|NCT00588848|6233492|P2|STARTED|Overall Study||8
2543038|NCT00588848|6233493|P1|STARTED|Overall Study||3
2543039|NCT00588822|6233503|P1|NOT COMPLETED|Overall Study||8
2543040|NCT00588822|6233503|P1|COMPLETED|Overall Study||13
2543041|NCT00588822|6233503|P1|STARTED|Overall Study||21
2543042|NCT00588809|6233512|P1|NOT COMPLETED|Overall Study||0
2543043|NCT00588809|6233512|P1|COMPLETED|Overall Study||47
2543044|NCT00588809|6233512|P1|STARTED|Overall Study||47
2543055|NCT00588731|6233536|P2|NOT COMPLETED|Overall Study||2
2543056|NCT00588731|6233537|P1|NOT COMPLETED|Overall Study||3
2543057|NCT00588731|6233536|P2|COMPLETED|Overall Study||18
2543058|NCT00588731|6233537|P1|COMPLETED|Overall Study||18
2543059|NCT00588731|6233536|P2|STARTED|Overall Study||20
2543060|NCT00588731|6233537|P1|STARTED|Overall Study||21
2543061|NCT00588692|6233547|P2|NOT COMPLETED|Overall Study||3
2543062|NCT00588692|6233548|P1|NOT COMPLETED|Overall Study||7
2543063|NCT00588692|6233547|P2|COMPLETED|Overall Study||27
2543064|NCT00588692|6233548|P1|COMPLETED|Overall Study||23
2543065|NCT00588692|6233547|P2|STARTED|Overall Study||30
2543066|NCT00588692|6233548|P1|STARTED|Overall Study||30
2543067|NCT00588666|6233584|P1|NOT COMPLETED|Overall Study||4
2543068|NCT00588666|6233584|P1|COMPLETED|Overall Study||47
2543069|NCT00588666|6233584|P1|STARTED|Overall Study||51
2543070|NCT00588640|6233589|P1|NOT COMPLETED|Overall Study||2
2543071|NCT00588640|6233589|P1|COMPLETED|Overall Study||8
2543072|NCT00588640|6233589|P1|STARTED|Overall Study||10
2543073|NCT00588536|6233593|P1|NOT COMPLETED|Overall Study||0
2543074|NCT00588536|6233593|P1|COMPLETED|Overall Study||5
2543075|NCT00588536|6233593|P1|STARTED|Overall Study||5
2543076|NCT00588471|6233599|P2|NOT COMPLETED|Overall Study||0
2543077|NCT00588471|6233600|P1|NOT COMPLETED|Overall Study||0
2543078|NCT00588471|6233599|P2|COMPLETED|Overall Study||29
2543079|NCT00588471|6233600|P1|COMPLETED|Overall Study||28
2543080|NCT00588471|6233599|P2|STARTED|Overall Study||29
2543081|NCT00588471|6233600|P1|STARTED|Overall Study||28
2543082|NCT00588445|6233608|P1|NOT COMPLETED|Overall Study||15
2543083|NCT00588445|6233608|P1|COMPLETED|Overall Study||50
2543084|NCT00588445|6233608|P1|STARTED|Overall Study||65
2543085|NCT00588406|6233616|P2|NOT COMPLETED|Overall Study||0
2543086|NCT00588406|6233617|P1|NOT COMPLETED|Overall Study||0
2543087|NCT00588406|6233616|P2|COMPLETED|Overall Study||49
2543088|NCT00588406|6233617|P1|COMPLETED|Overall Study||46
2543089|NCT00588406|6233616|P2|STARTED|Overall Study||49
2543090|NCT00588406|6233617|P1|STARTED|Overall Study||46
2543091|NCT00588380|6233625|P1|NOT COMPLETED|Overall Study||0
2543092|NCT00588380|6233625|P1|COMPLETED|Overall Study||88
2543093|NCT00588380|6233625|P1|STARTED|Overall Study||88
2543094|NCT00588354|6233632|P2|NOT COMPLETED|Baseline to 4 Weeks||1
2543095|NCT00588354|6233633|P1|NOT COMPLETED|Baseline to 4 Weeks||0
2543096|NCT00588354|6233632|P2|COMPLETED|Baseline to 4 Weeks||14
2543097|NCT00588354|6233633|P1|COMPLETED|Baseline to 4 Weeks||9
2543098|NCT00588354|6233632|P2|STARTED|Baseline to 4 Weeks||15
2543099|NCT00588354|6233633|P1|STARTED|Baseline to 4 Weeks||9
2543100|NCT00588354|6233632|P2|NOT COMPLETED|Baseline to 2 Weeks||0
2543101|NCT00588354|6233633|P1|NOT COMPLETED|Baseline to 2 Weeks||2
2543102|NCT00588354|6233632|P2|COMPLETED|Baseline to 2 Weeks||15
2543103|NCT00588354|6233633|P1|COMPLETED|Baseline to 2 Weeks||9
2543104|NCT00588354|6233632|P2|STARTED|Baseline to 2 Weeks||15
2543105|NCT00588354|6233633|P1|STARTED|Baseline to 2 Weeks||11
2543106|NCT00588341|6233653|P1|NOT COMPLETED|Overall Study||5
2543107|NCT00588341|6233653|P1|COMPLETED|Overall Study||19
2543108|NCT00588341|6233653|P1|STARTED|Overall Study||24
2543109|NCT00588237|6233657|P1|NOT COMPLETED|Overall Study||4
2543110|NCT00588237|6233657|P1|COMPLETED|Overall Study||38
2543111|NCT00588237|6233657|P1|STARTED|Overall Study||42
2543112|NCT00588159|6233663|P2|NOT COMPLETED|Overall Study||11
2543113|NCT00588159|6233664|P1|NOT COMPLETED|Overall Study||15
2543114|NCT00588159|6233663|P2|COMPLETED|Overall Study||63
2543115|NCT00588159|6233664|P1|COMPLETED|Overall Study||57
2543116|NCT00588159|6233663|P2|STARTED|Overall Study||74
2543117|NCT00588159|6233664|P1|STARTED|Overall Study||72
2543118|NCT00588146|6233680|P2|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
2543119|NCT00588146|6233681|P1|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
2543120|NCT00588146|6233680|P2|COMPLETED|Second Intervention (6 Months to 1 Year)||2
2543121|NCT00588146|6233681|P1|COMPLETED|Second Intervention (6 Months to 1 Year)||1
2543122|NCT00588146|6233680|P2|STARTED|Second Intervention (6 Months to 1 Year)||2
2543123|NCT00588146|6233681|P1|STARTED|Second Intervention (6 Months to 1 Year)||1
2543124|NCT00588146|6233680|P2|NOT COMPLETED|First Intervention (Baseline to 6 mo)||3
2543125|NCT00588146|6233681|P1|NOT COMPLETED|First Intervention (Baseline to 6 mo)||4
2543126|NCT00588146|6233680|P2|COMPLETED|First Intervention (Baseline to 6 mo)||2
2543127|NCT00588146|6233681|P1|COMPLETED|First Intervention (Baseline to 6 mo)||1
2543128|NCT00588146|6233680|P2|STARTED|First Intervention (Baseline to 6 mo)||5
2543129|NCT00588146|6233681|P1|STARTED|First Intervention (Baseline to 6 mo)||5
2543130|NCT00588094|6233687|P1|NOT COMPLETED|Overall Study||5
2543131|NCT00588094|6233687|P1|COMPLETED|Overall Study||15
2543132|NCT00588094|6233687|P1|STARTED|Overall Study||20
2543133|NCT00587990|6233694|P3|NOT COMPLETED|Overall Study||1
2543134|NCT00587990|6233695|P2|NOT COMPLETED|Overall Study||0
2543135|NCT00587990|6233696|P1|NOT COMPLETED|Overall Study||0
2543136|NCT00587990|6233694|P3|COMPLETED|Overall Study||2
2543137|NCT00587990|6233695|P2|COMPLETED|Overall Study||4
2543138|NCT00587990|6233696|P1|COMPLETED|Overall Study||2
2543139|NCT00587990|6233694|P3|STARTED|Overall Study||3
2543140|NCT00587990|6233695|P2|STARTED|Overall Study||4
2543141|NCT00587990|6233696|P1|STARTED|Overall Study||2
2543142|NCT00587964|6233739|P1|NOT COMPLETED|Overall Study||12
2543143|NCT00587964|6233739|P1|COMPLETED|Overall Study||39
2543144|NCT00587964|6233739|P1|STARTED|Overall Study||51
2543145|NCT00587860|6233745|P2|NOT COMPLETED|Overall Study||5
2543146|NCT00587860|6233746|P1|NOT COMPLETED|Overall Study||5
2543147|NCT00587860|6233745|P2|COMPLETED|Overall Study||30
2543148|NCT00587860|6233746|P1|COMPLETED|Overall Study||30
2543149|NCT00587860|6233745|P2|STARTED|Overall Study||35
2543150|NCT00587860|6233746|P1|STARTED|Overall Study||35
2543151|NCT00587847|6233766|P1|NOT COMPLETED|Overall Study||7
2543152|NCT00587847|6233766|P1|COMPLETED|Overall Study||5
2543153|NCT00587847|6233766|P1|STARTED|Overall Study||12
2543154|NCT00587834|6233771|P1|NOT COMPLETED|Overall Study||0
2543155|NCT00587834|6233771|P1|COMPLETED|Overall Study||96
2543156|NCT00587834|6233771|P1|STARTED|Overall Study||96
2543157|NCT00587795|6233789|P2|NOT COMPLETED|Overall Study||0
2543158|NCT00587795|6233790|P1|NOT COMPLETED|Overall Study||1
2543159|NCT00587795|6233789|P2|COMPLETED|Overall Study||0
2543160|NCT00587795|6233790|P1|COMPLETED|Overall Study||0
2543161|NCT00587795|6233789|P2|STARTED|Overall Study||0
2543162|NCT00587795|6233790|P1|STARTED|Overall Study||1
2543163|NCT00587769|6233796|P1|NOT COMPLETED|Overall Study||0
2543164|NCT00587769|6233796|P1|COMPLETED|Overall Study||38
2543165|NCT00587769|6233796|P1|STARTED|Overall Study||38
2543166|NCT00587678|6233804|P3|NOT COMPLETED|Overall Study||8
2543167|NCT00587678|6233805|P2|NOT COMPLETED|Overall Study||4
2543168|NCT00587678|6233806|P1|NOT COMPLETED|Overall Study||6
2543169|NCT00587678|6233804|P3|COMPLETED|Overall Study||33
2543170|NCT00587678|6233805|P2|COMPLETED|Overall Study||18
2543171|NCT00587678|6233806|P1|COMPLETED|Overall Study||16
2543172|NCT00587678|6233804|P3|STARTED|Overall Study||41
2543173|NCT00587678|6233805|P2|STARTED|Overall Study||22
2543174|NCT00587678|6233806|P1|STARTED|Overall Study||22
2543175|NCT00587639|6233844|P1|NOT COMPLETED|Overall Study||1
2543176|NCT00587639|6233844|P1|COMPLETED|Overall Study||7
2543177|NCT00587639|6233844|P1|STARTED|Overall Study||8
2543178|NCT00587587|6233851|P2|NOT COMPLETED|Overall Study||1
2543179|NCT00587587|6233852|P1|NOT COMPLETED|Overall Study||6
2543180|NCT00587587|6233851|P2|COMPLETED|Overall Study||12
2543181|NCT00587587|6233852|P1|COMPLETED|Overall Study||11
2543182|NCT00587587|6233851|P2|STARTED|Overall Study||13
2543183|NCT00587587|6233852|P1|STARTED|Overall Study||17
2543184|NCT00587483|6233875|P3|NOT COMPLETED|Overall Study||0
2543185|NCT00587483|6233876|P2|NOT COMPLETED|Overall Study||0
2543186|NCT00587483|6233877|P1|NOT COMPLETED|Overall Study||0
2543187|NCT00587483|6233875|P3|COMPLETED|Overall Study||112
2543188|NCT00587483|6233876|P2|COMPLETED|Overall Study||115
2543189|NCT00587483|6233877|P1|COMPLETED|Overall Study||115
2543190|NCT00587483|6233875|P3|STARTED|Overall Study||112
2543191|NCT00587483|6233876|P2|STARTED|Overall Study||115
2543192|NCT00587483|6233877|P1|STARTED|Overall Study||115
2543193|NCT00587457|6233906|P3|NOT COMPLETED|Overall Study||5
2543194|NCT00587457|6233907|P2|NOT COMPLETED|Overall Study||3
2543195|NCT00587457|6233908|P1|NOT COMPLETED|Overall Study||3
2543196|NCT00587457|6233906|P3|COMPLETED|Overall Study||0
2543197|NCT00587457|6233907|P2|COMPLETED|Overall Study||0
2543198|NCT00587457|6233908|P1|COMPLETED|Overall Study||0
2543199|NCT00587457|6233906|P3|STARTED|Overall Study||5
2543200|NCT00587457|6233907|P2|STARTED|Overall Study||3
2543201|NCT00587457|6233908|P1|STARTED|Overall Study||3
2543202|NCT00587431|6233945|P2|NOT COMPLETED|Overall Study||1
2543203|NCT00587431|6233946|P1|NOT COMPLETED|Overall Study||1
2543204|NCT00587431|6233945|P2|COMPLETED|Overall Study||38
2543205|NCT00587431|6233946|P1|COMPLETED|Overall Study||62
2543206|NCT00587431|6233945|P2|STARTED|Overall Study||39
2543207|NCT00587431|6233946|P1|STARTED|Overall Study||63
2543208|NCT00587288|6233957|P2|NOT COMPLETED|Overall Study||9
2543209|NCT00587288|6233958|P1|NOT COMPLETED|Overall Study||3
2543210|NCT00587288|6233957|P2|COMPLETED|Overall Study||44
2543211|NCT00587288|6233958|P1|COMPLETED|Overall Study||50
2543212|NCT00587288|6233957|P2|STARTED|Overall Study||53
2543213|NCT00587288|6233958|P1|STARTED|Overall Study||53
2543214|NCT00587223|6233976|P1|NOT COMPLETED|Overall Study||1
2543215|NCT00587223|6233976|P1|COMPLETED|Overall Study|Subject withdrawn from study at Day 7.|0
2543311|NCT00586664|6234371|P1|NOT COMPLETED|Overall Study||5
2543216|NCT00587223|6233976|P1|STARTED|Overall Study|Study design was within-subject control. Only 1 subject was enrolled in the study.|1
2543217|NCT00587171|6233993|P2|NOT COMPLETED|Overall Study||1
2543218|NCT00587171|6233994|P1|NOT COMPLETED|Overall Study||1
2543219|NCT00587171|6233993|P2|COMPLETED|Overall Study||9
2543220|NCT00587171|6233994|P1|COMPLETED|Overall Study||8
2543221|NCT00587171|6233993|P2|STARTED|Overall Study||10
2543222|NCT00587171|6233994|P1|STARTED|Overall Study||9
2543223|NCT00587158|6234024|P2|NOT COMPLETED|Overall Study||8
2543224|NCT00587158|6234025|P1|NOT COMPLETED|Overall Study||5
2543225|NCT00587158|6234024|P2|COMPLETED|Overall Study||43
2543226|NCT00587158|6234025|P1|COMPLETED|Overall Study||44
2543227|NCT00587158|6234024|P2|Continued in Study|Overall Study||46
2543228|NCT00587158|6234025|P1|Continued in Study|Overall Study||45
2543229|NCT00587158|6234024|P2|STARTED|Overall Study||51
2543230|NCT00587158|6234025|P1|STARTED|Overall Study||49
2543231|NCT00587132|6234059|P4|NOT COMPLETED|Overall Study||0
2543232|NCT00587132|6234060|P3|NOT COMPLETED|Overall Study||0
2543233|NCT00587132|6234061|P2|NOT COMPLETED|Overall Study||0
2543234|NCT00587132|6234062|P1|NOT COMPLETED|Overall Study||0
2543235|NCT00587132|6234059|P4|COMPLETED|Overall Study||0
2543236|NCT00587132|6234060|P3|COMPLETED|Overall Study||0
2543237|NCT00587132|6234061|P2|COMPLETED|Overall Study||0
2543238|NCT00587132|6234062|P1|COMPLETED|Overall Study||4
2543239|NCT00587132|6234059|P4|STARTED|Overall Study||0
2543240|NCT00587132|6234060|P3|STARTED|Overall Study||0
2543241|NCT00587132|6234061|P2|STARTED|Overall Study||0
2543242|NCT00587132|6234062|P1|STARTED|Overall Study||4
2543243|NCT00587067|6234072|P1|NOT COMPLETED|Overall Study||0
2543244|NCT00587067|6234072|P1|COMPLETED|Overall Study||34
2543245|NCT00587067|6234072|P1|STARTED|Overall Study||34
2543246|NCT00587054|6234078|P1|NOT COMPLETED|Overall Study||9
2543247|NCT00587054|6234078|P1|COMPLETED|Overall Study||120
2543248|NCT00587054|6234078|P1|STARTED|Overall Study||129
2543249|NCT00587041|6234085|P3|NOT COMPLETED|Overall Study||0
2543250|NCT00587041|6234086|P2|NOT COMPLETED|Overall Study||0
2543251|NCT00587041|6234087|P1|NOT COMPLETED|Overall Study||0
2543252|NCT00587041|6234085|P3|COMPLETED|Overall Study||14
2543253|NCT00587041|6234086|P2|COMPLETED|Overall Study||14
2543254|NCT00587041|6234087|P1|COMPLETED|Overall Study||12
2543255|NCT00587041|6234085|P3|STARTED|Overall Study||14
2543256|NCT00587041|6234086|P2|STARTED|Overall Study||14
2543257|NCT00587041|6234087|P1|STARTED|Overall Study||12
2543258|NCT00586924|6234104|P6|NOT COMPLETED|Overall Study||33
2543259|NCT00586924|6234105|P5|NOT COMPLETED|Overall Study||4
2543260|NCT00586924|6234106|P4|NOT COMPLETED|Overall Study||3
2543261|NCT00586924|6234107|P3|NOT COMPLETED|Overall Study||3
2543262|NCT00586924|6234108|P2|NOT COMPLETED|Overall Study||3
2543263|NCT00586924|6234109|P1|NOT COMPLETED|Overall Study||3
2543264|NCT00586924|6234104|P6|COMPLETED|Overall Study||0
2543265|NCT00586924|6234105|P5|COMPLETED|Overall Study||0
2543266|NCT00586924|6234106|P4|COMPLETED|Overall Study||0
2543267|NCT00586924|6234107|P3|COMPLETED|Overall Study||0
2543268|NCT00586924|6234108|P2|COMPLETED|Overall Study||0
2543269|NCT00586924|6234109|P1|COMPLETED|Overall Study||0
2543270|NCT00586924|6234104|P6|STARTED|Overall Study||33
2543271|NCT00586924|6234105|P5|STARTED|Overall Study||4
2543272|NCT00586924|6234106|P4|STARTED|Overall Study||3
2543273|NCT00586924|6234107|P3|STARTED|Overall Study||3
2543274|NCT00586924|6234108|P2|STARTED|Overall Study||3
2543275|NCT00586924|6234109|P1|STARTED|Overall Study||3
2543276|NCT00586898|6234309|P1|NOT COMPLETED|Overall Study||7
2543277|NCT00586898|6234309|P1|COMPLETED|Overall Study||29
2543278|NCT00586898|6234309|P1|STARTED|Overall Study||36
2543279|NCT00586846|6234313|P1|NOT COMPLETED|Overall Study||6
2543280|NCT00586846|6234313|P1|COMPLETED|Overall Study||34
2543281|NCT00586846|6234313|P1|STARTED|Overall Study||40
2543282|NCT00586820|6234319|P2|NOT COMPLETED|Overall Study||0
2543283|NCT00586820|6234320|P1|NOT COMPLETED|Overall Study||1
2543284|NCT00586820|6234319|P2|COMPLETED|Overall Study||11
2543285|NCT00586820|6234320|P1|COMPLETED|Overall Study||11
2543286|NCT00586820|6234319|P2|STARTED|Overall Study||11
2543287|NCT00586820|6234320|P1|STARTED|Overall Study||12
2543288|NCT00586729|6234330|P2|NOT COMPLETED|Overall Study||1
2543289|NCT00586729|6234331|P1|NOT COMPLETED|Overall Study||3
2543290|NCT00586729|6234330|P2|COMPLETED|Overall Study||8
2543291|NCT00586729|6234331|P1|COMPLETED|Overall Study||11
2543292|NCT00586729|6234330|P2|STARTED|Overall Study||9
2543293|NCT00586729|6234331|P1|STARTED|Overall Study||14
2543294|NCT00586716|6234343|P2|NOT COMPLETED|Overall Study||0
2543295|NCT00586716|6234344|P1|NOT COMPLETED|Overall Study||0
2543296|NCT00586716|6234343|P2|COMPLETED|Overall Study||8
2543297|NCT00586716|6234344|P1|COMPLETED|Overall Study||14
2543298|NCT00586716|6234343|P2|STARTED|Overall Study||8
2543299|NCT00586716|6234344|P1|STARTED|Overall Study||14
2543300|NCT00586703|6234351|P1|NOT COMPLETED|Overall Study||12
2543301|NCT00586703|6234351|P1|COMPLETED|Overall Study||4
2543302|NCT00586703|6234351|P1|STARTED|Overall Study||16
2543303|NCT00586690|6234358|P2|NOT COMPLETED|Overall Study||0
2543304|NCT00586690|6234359|P1|NOT COMPLETED|Overall Study||16
2543305|NCT00586690|6234358|P2|COMPLETED|Overall Study||22
2543306|NCT00586690|6234359|P1|COMPLETED|Overall Study||5
2543307|NCT00586690|6234358|P2|STARTED|Overall Study||22
2543308|NCT00586690|6234359|P1|STARTED|Overall Study|Four consented subjects were screen failures.|21
2543309|NCT00586664|6234369|P3|NOT COMPLETED|Overall Study||1
2543310|NCT00586664|6234370|P2|NOT COMPLETED|Overall Study||7
2543312|NCT00586664|6234369|P3|COMPLETED|Overall Study||43
2543313|NCT00586664|6234370|P2|COMPLETED|Overall Study||36
2543314|NCT00586664|6234371|P1|COMPLETED|Overall Study||38
2543315|NCT00586664|6234369|P3|STARTED|Overall Study||44
2543316|NCT00586664|6234370|P2|STARTED|Overall Study||43
2543317|NCT00586664|6234371|P1|STARTED|Overall Study||43
2543318|NCT00586625|6234417|P2|NOT COMPLETED|Overall Study||17
2543319|NCT00586625|6234418|P1|NOT COMPLETED|Overall Study||43
2543320|NCT00586625|6234417|P2|COMPLETED|Overall Study||269
2543321|NCT00586625|6234418|P1|COMPLETED|Overall Study||532
2543322|NCT00586625|6234417|P2|STARTED|Overall Study||286
2543323|NCT00586625|6234418|P1|STARTED|Overall Study||575
2543324|NCT00586612|6234426|P2|NOT COMPLETED|Booster Phase||1
2543325|NCT00586612|6234427|P1|NOT COMPLETED|Booster Phase||3
2543326|NCT00586612|6234426|P2|COMPLETED|Booster Phase||143
2543327|NCT00586612|6234427|P1|COMPLETED|Booster Phase||151
2543328|NCT00586612|6234426|P2|STARTED|Booster Phase||144
2543329|NCT00586612|6234427|P1|STARTED|Booster Phase||154
2543330|NCT00586612|6234426|P2|NOT COMPLETED|Primary Phase||3
2543331|NCT00586612|6234427|P1|NOT COMPLETED|Primary Phase||1
2543332|NCT00586612|6234426|P2|COMPLETED|Primary Phase||147
2543333|NCT00586612|6234427|P1|COMPLETED|Primary Phase||162
2543334|NCT00586612|6234426|P2|STARTED|Primary Phase||150
2543335|NCT00586612|6234427|P1|STARTED|Primary Phase||163
2543336|NCT00586573|6234493|P1|NOT COMPLETED|Overall Study||6
2543337|NCT00586573|6234493|P1|COMPLETED|Overall Study||28
2543338|NCT00586573|6234493|P1|STARTED|Overall Study||34
2543339|NCT00586521|6234497|P1|NOT COMPLETED|Prophylactic Treatment (Months 8-13)||0
2543340|NCT00586521|6234497|P1|COMPLETED|Prophylactic Treatment (Months 8-13)||19
2543341|NCT00586521|6234497|P1|STARTED|Prophylactic Treatment (Months 8-13)||19
2543342|NCT00586521|6234497|P1|NOT COMPLETED|On Demand Treatment (Months 1-6)||1
2543343|NCT00586521|6234497|P1|COMPLETED|On Demand Treatment (Months 1-6)||19
2543344|NCT00586521|6234497|P1|STARTED|On Demand Treatment (Months 1-6)||20
2543345|NCT00586495|6234504|P1|NOT COMPLETED|Follow-up||92
2543346|NCT00586495|6234504|P1|COMPLETED|Follow-up||0
2543347|NCT00586495|6234504|P1|STARTED|Follow-up||92
2543348|NCT00586495|6234504|P1|NOT COMPLETED|Treatment Period||95
2543349|NCT00586495|6234504|P1|COMPLETED|Treatment Period||0
2543350|NCT00586495|6234504|P1|STARTED|Treatment Period||95
2543351|NCT00586482|6234516|P2|NOT COMPLETED|Overall Study||0
2543352|NCT00586482|6234517|P1|NOT COMPLETED|Overall Study||0
2543353|NCT00586482|6234516|P2|COMPLETED|Overall Study||24
2543354|NCT00586482|6234517|P1|COMPLETED|Overall Study||22
2543355|NCT00586482|6234516|P2|STARTED|Overall Study||24
2543356|NCT00586482|6234517|P1|STARTED|Overall Study||22
2543357|NCT00586469|6234533|P2|NOT COMPLETED|Overall Study||1
2543358|NCT00586469|6234534|P1|NOT COMPLETED|Overall Study||0
2543359|NCT00586469|6234533|P2|COMPLETED|Overall Study||499
2543360|NCT00586469|6234534|P1|COMPLETED|Overall Study||500
2543361|NCT00586469|6234533|P2|STARTED|Overall Study||500
2543362|NCT00586469|6234534|P1|STARTED|Overall Study||500
2543363|NCT00586339|6234561|P3|NOT COMPLETED|Overall Study||6
2543364|NCT00586339|6234562|P2|NOT COMPLETED|Overall Study||7
2543365|NCT00586339|6234563|P1|NOT COMPLETED|Overall Study||7
2543366|NCT00586339|6234561|P3|COMPLETED|Overall Study||24
2543367|NCT00586339|6234562|P2|COMPLETED|Overall Study||52
2543368|NCT00586339|6234563|P1|COMPLETED|Overall Study||54
2543369|NCT00586339|6234561|P3|STARTED|Overall Study||30
2543370|NCT00586339|6234562|P2|STARTED|Overall Study||59
2543371|NCT00586339|6234563|P1|STARTED|Overall Study||61
2543372|NCT00586326|6234664|P1|NOT COMPLETED|Treated Through 5-yr Follow Up-Treated||26
2543373|NCT00586326|6234664|P1|COMPLETED|Treated Through 5-yr Follow Up-Treated||74
2543374|NCT00586326|6234664|P1|STARTED|Treated Through 5-yr Follow Up-Treated||100
2543375|NCT00586326|6234664|P1|NOT COMPLETED|Device Placed toTreatment-ITT||18
2543376|NCT00586326|6234664|P1|COMPLETED|Device Placed toTreatment-ITT||100
2543377|NCT00586326|6234664|P1|STARTED|Device Placed toTreatment-ITT||118
2543378|NCT00586326|6234664|P1|NOT COMPLETED|Enrollment to Device Placement-Enrolled||15
2543379|NCT00586326|6234664|P1|COMPLETED|Enrollment to Device Placement-Enrolled||118
2543380|NCT00586326|6234664|P1|STARTED|Enrollment to Device Placement-Enrolled||133
2543381|NCT00586313|6234675|P1|NOT COMPLETED|Overall Study||2
2543382|NCT00586313|6234675|P1|COMPLETED|Overall Study||19
2543383|NCT00586313|6234675|P1|STARTED|Overall Study||21
2543384|NCT00586261|6234682|P2|NOT COMPLETED|Overall Study||0
2543385|NCT00586261|6234683|P1|NOT COMPLETED|Overall Study||0
2543386|NCT00586261|6234682|P2|COMPLETED|Overall Study||19
2543387|NCT00586261|6234683|P1|COMPLETED|Overall Study||17
2543388|NCT00586261|6234682|P2|STARTED|Overall Study||19
2543389|NCT00586261|6234683|P1|STARTED|Overall Study||17
2543390|NCT00586196|6234691|P2|NOT COMPLETED|Overall Study||0
2543391|NCT00586196|6234692|P1|NOT COMPLETED|Overall Study||0
2543392|NCT00586196|6234691|P2|COMPLETED|Overall Study||9
2543393|NCT00586196|6234692|P1|COMPLETED|Overall Study||7
2543394|NCT00586196|6234691|P2|STARTED|Overall Study||9
2543395|NCT00586196|6234692|P1|STARTED|Overall Study||7
2543396|NCT00586170|6234702|P2|NOT COMPLETED|Overall Study||0
2543397|NCT00586170|6234703|P1|NOT COMPLETED|Overall Study||0
2543398|NCT00586170|6234702|P2|COMPLETED|Overall Study||3
2543399|NCT00586170|6234703|P1|COMPLETED|Overall Study||5
2543400|NCT00586170|6234702|P2|STARTED|Overall Study|Initially enrollment was listed as 9. 1 placebo patient withdrew prior to surgery, so enrollment=8.|3
2543401|NCT00586170|6234703|P1|STARTED|Overall Study||5
2543402|NCT00586157|6234711|P2|NOT COMPLETED|Second Intervention||1
2543403|NCT00586157|6234712|P1|NOT COMPLETED|Second Intervention||2
2543404|NCT00586157|6234711|P2|COMPLETED|Second Intervention||14
2543405|NCT00586157|6234712|P1|COMPLETED|Second Intervention||12
2543406|NCT00586157|6234711|P2|STARTED|Second Intervention||15
2543407|NCT00586157|6234712|P1|STARTED|Second Intervention||14
2543408|NCT00586157|6234711|P2|NOT COMPLETED|First Intervention||0
2543409|NCT00586157|6234712|P1|NOT COMPLETED|First Intervention||1
2543410|NCT00586157|6234711|P2|COMPLETED|First Intervention||15
2543411|NCT00586157|6234712|P1|COMPLETED|First Intervention||14
2543412|NCT00586157|6234711|P2|STARTED|First Intervention||15
2543413|NCT00586157|6234712|P1|STARTED|First Intervention||15
2543414|NCT00586105|6234722|P1|NOT COMPLETED|Overall Study||39
2543415|NCT00586105|6234722|P1|COMPLETED|Overall Study||0
2543416|NCT00586105|6234722|P1|STARTED|Overall Study||39
2543417|NCT00586066|6234737|P2|NOT COMPLETED|Overall Study||10
2543418|NCT00586066|6234738|P1|NOT COMPLETED|Overall Study||18
2543419|NCT00586066|6234737|P2|COMPLETED|Overall Study||14
2543420|NCT00586066|6234738|P1|COMPLETED|Overall Study||30
2543421|NCT00586066|6234737|P2|STARTED|Overall Study||24
2543422|NCT00586066|6234738|P1|STARTED|Overall Study||48
2543423|NCT00586001|6234750|P2|NOT COMPLETED|Overall Study||1
2543424|NCT00586001|6234751|P1|NOT COMPLETED|Overall Study||4
2543425|NCT00586001|6234750|P2|COMPLETED|Overall Study||10
2543426|NCT00586001|6234751|P1|COMPLETED|Overall Study||22
2543427|NCT00586001|6234750|P2|STARTED|Overall Study||11
2543428|NCT00586001|6234751|P1|STARTED|Overall Study||26
2543429|NCT00585975|6234795|P2|NOT COMPLETED|Overall Study||13
2543430|NCT00585975|6234796|P1|NOT COMPLETED|Overall Study||15
2543431|NCT00585975|6234795|P2|COMPLETED|Overall Study||278
2543432|NCT00585975|6234796|P1|COMPLETED|Overall Study||262
2543433|NCT00585975|6234795|P2|STARTED|Overall Study||291
2543434|NCT00585975|6234796|P1|STARTED|Overall Study||277
2543435|NCT00585923|6234806|P2|NOT COMPLETED|Overall Study||33
2543436|NCT00585923|6234807|P1|NOT COMPLETED|Overall Study||31
2543437|NCT00585923|6234806|P2|COMPLETED|Overall Study||26
2543438|NCT00585923|6234807|P1|COMPLETED|Overall Study||25
2543439|NCT00585923|6234806|P2|STARTED|Overall Study||59
2543440|NCT00585923|6234807|P1|STARTED|Overall Study||56
2543441|NCT00585910|6234821|P1|NOT COMPLETED|ATMX + Osmotic-Release Methylphenidate||9
2543442|NCT00585910|6234821|P1|COMPLETED|ATMX + Osmotic-Release Methylphenidate||41
2543443|NCT00585910|6234821|P1|STARTED|ATMX + Osmotic-Release Methylphenidate|Number of participants to add OROS MPH to their ATMX regimen|50
2543444|NCT00585910|6234821|P1|NOT COMPLETED|Atomoxetine (ATMX) Alone||17
2543445|NCT00585910|6234821|P1|COMPLETED|Atomoxetine (ATMX) Alone|Number of subjects who completed Phase I. 15 completed only Phase I. 40 proceeded onto Phase II.|55
2543446|NCT00585910|6234821|P1|STARTED|Atomoxetine (ATMX) Alone|This is the number of subjects who were exposed to ATMX in Phase I of the study.|72
2543447|NCT00585715|6234829|P2|NOT COMPLETED|Overall Study||0
2543448|NCT00585715|6234830|P1|NOT COMPLETED|Overall Study||3
2543449|NCT00585715|6234829|P2|COMPLETED|Overall Study||11
2543450|NCT00585715|6234830|P1|COMPLETED|Overall Study||8
2543451|NCT00585715|6234829|P2|STARTED|Overall Study||11
2543452|NCT00585715|6234830|P1|STARTED|Overall Study||11
2543453|NCT00585689|6234838|P1|NOT COMPLETED|Overall Study||7
2543454|NCT00585689|6234838|P1|COMPLETED|Overall Study||22
2543455|NCT00585689|6234838|P1|STARTED|Overall Study||29
2543456|NCT00585650|6234844|P2|NOT COMPLETED|Overall Study||0
2543457|NCT00585650|6234845|P1|NOT COMPLETED|Overall Study||0
2543458|NCT00585650|6234844|P2|COMPLETED|Overall Study||12
2543459|NCT00585650|6234845|P1|COMPLETED|Overall Study||8
2543460|NCT00585650|6234844|P2|STARTED|Overall Study||12
2543461|NCT00585650|6234845|P1|STARTED|Overall Study||8
2543462|NCT00585637|6234855|P4|NOT COMPLETED|6-month Time Point||6
2543463|NCT00585637|6234856|P3|NOT COMPLETED|6-month Time Point||11
2543464|NCT00585637|6234857|P2|NOT COMPLETED|6-month Time Point||13
2543465|NCT00585637|6234858|P1|NOT COMPLETED|6-month Time Point||6
2543466|NCT00585637|6234855|P4|COMPLETED|6-month Time Point||77
2543467|NCT00585637|6234856|P3|COMPLETED|6-month Time Point||72
2543468|NCT00585637|6234857|P2|COMPLETED|6-month Time Point||68
2543469|NCT00585637|6234858|P1|COMPLETED|6-month Time Point||75
2543470|NCT00585637|6234855|P4|STARTED|6-month Time Point||83
2543471|NCT00585637|6234856|P3|STARTED|6-month Time Point||83
2543472|NCT00585637|6234857|P2|STARTED|6-month Time Point||81
2543473|NCT00585637|6234858|P1|STARTED|6-month Time Point||81
2543474|NCT00585637|6234855|P4|NOT COMPLETED|3-month Time Point||5
2543475|NCT00585637|6234856|P3|NOT COMPLETED|3-month Time Point||7
2543476|NCT00585637|6234857|P2|NOT COMPLETED|3-month Time Point||14
2543477|NCT00585637|6234858|P1|NOT COMPLETED|3-month Time Point||10
2543478|NCT00585637|6234855|P4|COMPLETED|3-month Time Point||78
2543479|NCT00585637|6234856|P3|COMPLETED|3-month Time Point||76
2543480|NCT00585637|6234857|P2|COMPLETED|3-month Time Point||67
2543481|NCT00585637|6234858|P1|COMPLETED|3-month Time Point||71
2543482|NCT00585637|6234855|P4|STARTED|3-month Time Point||83
2543483|NCT00585637|6234856|P3|STARTED|3-month Time Point||83
2543484|NCT00585637|6234857|P2|STARTED|3-month Time Point||81
2543485|NCT00585637|6234858|P1|STARTED|3-month Time Point||81
2543486|NCT00585637|6234855|P4|NOT COMPLETED|Baseline||0
2543487|NCT00585637|6234856|P3|NOT COMPLETED|Baseline||0
2543488|NCT00585637|6234857|P2|NOT COMPLETED|Baseline||0
2543489|NCT00585637|6234858|P1|NOT COMPLETED|Baseline||0
2543490|NCT00585637|6234855|P4|COMPLETED|Baseline||83
2543491|NCT00585637|6234856|P3|COMPLETED|Baseline||83
2543492|NCT00585637|6234857|P2|COMPLETED|Baseline||81
2543493|NCT00585637|6234858|P1|COMPLETED|Baseline||81
2543494|NCT00585637|6234855|P4|STARTED|Baseline||83
2543495|NCT00585637|6234856|P3|STARTED|Baseline||83
2543496|NCT00585637|6234857|P2|STARTED|Baseline||81
2543497|NCT00585637|6234858|P1|STARTED|Baseline||81
2543498|NCT00585611|6234886|P2|NOT COMPLETED|Overall Study||0
2543499|NCT00585611|6234887|P1|NOT COMPLETED|Overall Study||0
2543500|NCT00585611|6234886|P2|COMPLETED|Overall Study||0
2543501|NCT00585611|6234887|P1|COMPLETED|Overall Study||0
2543502|NCT00585611|6234886|P2|STARTED|Overall Study||0
2543503|NCT00585611|6234887|P1|STARTED|Overall Study||0
2543504|NCT00585585|6234897|P1|NOT COMPLETED|Overall Study||1
2543505|NCT00585585|6234897|P1|COMPLETED|Overall Study||0
2543506|NCT00585585|6234897|P1|Patients Receiving Drug|Overall Study||1
2543507|NCT00585585|6234897|P1|STARTED|Overall Study||1
2543508|NCT00585546|6234901|P1|NOT COMPLETED|Clenbuterol Treatment - up to 12 Months||4
2543509|NCT00585546|6234901|P1|COMPLETED|Clenbuterol Treatment - up to 12 Months||9
2543510|NCT00585546|6234901|P1|STARTED|Clenbuterol Treatment - up to 12 Months||13
2543511|NCT00585546|6234901|P1|NOT COMPLETED|LVAD Implantation Required for 4 Months||5
2543512|NCT00585546|6234901|P1|COMPLETED|LVAD Implantation Required for 4 Months||13
2543513|NCT00585546|6234901|P1|STARTED|LVAD Implantation Required for 4 Months||18
2543514|NCT00585533|6234915|P1|NOT COMPLETED|Overall Study||9
2543515|NCT00585533|6234915|P1|COMPLETED|Overall Study||31
2543516|NCT00585533|6234915|P1|STARTED|Overall Study||40
2543517|NCT00585494|6234920|P1|NOT COMPLETED|Overall Study||56
2543518|NCT00585494|6234920|P1|COMPLETED|Overall Study||244
2543519|NCT00585494|6234920|P1|STARTED|Overall Study||300
2543520|NCT00585468|6234924|P2|NOT COMPLETED|Second Intervention||0
2543521|NCT00585468|6234925|P1|NOT COMPLETED|Second Intervention||0
2543522|NCT00585468|6234924|P2|COMPLETED|Second Intervention||10
2543523|NCT00585468|6234925|P1|COMPLETED|Second Intervention||9
2543524|NCT00585468|6234924|P2|STARTED|Second Intervention||10
2543525|NCT00585468|6234925|P1|STARTED|Second Intervention||9
2543526|NCT00585468|6234924|P2|NOT COMPLETED|First Intervention||1
2543527|NCT00585468|6234925|P1|NOT COMPLETED|First Intervention||1
2543528|NCT00585468|6234924|P2|COMPLETED|First Intervention||10
2543529|NCT00585468|6234925|P1|COMPLETED|First Intervention||9
2543530|NCT00585468|6234924|P2|STARTED|First Intervention||11
2543531|NCT00585468|6234925|P1|STARTED|First Intervention||10
2543532|NCT00585377|6234945|P1|NOT COMPLETED|Overall Study||0
2543533|NCT00585377|6234945|P1|COMPLETED|Overall Study||50
2543534|NCT00585377|6234945|P1|STARTED|Overall Study||50
2543535|NCT00585351|6234957|P8|NOT COMPLETED|Enrollment Period (Intervention)||1
2543536|NCT00585351|6234958|P7|NOT COMPLETED|Enrollment Period (Intervention)||2
2543537|NCT00585351|6234959|P6|NOT COMPLETED|Enrollment Period (Intervention)||2
2543538|NCT00585351|6234960|P5|NOT COMPLETED|Enrollment Period (Intervention)||2
2543539|NCT00585351|6234961|P4|NOT COMPLETED|Enrollment Period (Intervention)||0
2543540|NCT00585351|6234962|P3|NOT COMPLETED|Enrollment Period (Intervention)||0
2543541|NCT00585351|6234963|P2|NOT COMPLETED|Enrollment Period (Intervention)||0
2543542|NCT00585351|6234964|P1|NOT COMPLETED|Enrollment Period (Intervention)||0
2543543|NCT00585351|6234957|P8|COMPLETED|Enrollment Period (Intervention)||2
2543544|NCT00585351|6234958|P7|COMPLETED|Enrollment Period (Intervention)||5
2543545|NCT00585351|6234959|P6|COMPLETED|Enrollment Period (Intervention)||5
2543546|NCT00585351|6234960|P5|COMPLETED|Enrollment Period (Intervention)||3
2543547|NCT00585351|6234961|P4|COMPLETED|Enrollment Period (Intervention)||15
2543548|NCT00585351|6234962|P3|COMPLETED|Enrollment Period (Intervention)||15
2543549|NCT00585351|6234963|P2|COMPLETED|Enrollment Period (Intervention)||0
2543550|NCT00585351|6234964|P1|COMPLETED|Enrollment Period (Intervention)||0
2543551|NCT00585351|6234957|P8|STARTED|Enrollment Period (Intervention)||3
2543552|NCT00585351|6234958|P7|STARTED|Enrollment Period (Intervention)||7
2543553|NCT00585351|6234959|P6|STARTED|Enrollment Period (Intervention)||7
2543554|NCT00585351|6234960|P5|STARTED|Enrollment Period (Intervention)||5
2543555|NCT00585351|6234961|P4|STARTED|Enrollment Period (Intervention)||15
2543556|NCT00585351|6234962|P3|STARTED|Enrollment Period (Intervention)||15
2543557|NCT00585351|6234963|P2|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in No Advanced Notification group for this period."|0
2543558|NCT00585351|6234964|P1|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in Advanced Notification group for this period."|0
2543559|NCT00585351|6234957|P8|NOT COMPLETED|Notification Period (Informed Consent)||0
2543560|NCT00585351|6234958|P7|NOT COMPLETED|Notification Period (Informed Consent)||0
2543561|NCT00585351|6234959|P6|NOT COMPLETED|Notification Period (Informed Consent)||0
2543562|NCT00585351|6234960|P5|NOT COMPLETED|Notification Period (Informed Consent)||0
2543563|NCT00585351|6234961|P4|NOT COMPLETED|Notification Period (Informed Consent)||0
2543564|NCT00585351|6234962|P3|NOT COMPLETED|Notification Period (Informed Consent)||0
2543565|NCT00585351|6234963|P2|NOT COMPLETED|Notification Period (Informed Consent)||25
2543566|NCT00585351|6234964|P1|NOT COMPLETED|Notification Period (Informed Consent)||23
2543567|NCT00585351|6234957|P8|COMPLETED|Notification Period (Informed Consent)||0
2543568|NCT00585351|6234958|P7|COMPLETED|Notification Period (Informed Consent)||0
2543569|NCT00585351|6234959|P6|COMPLETED|Notification Period (Informed Consent)||0
2543570|NCT00585351|6234960|P5|COMPLETED|Notification Period (Informed Consent)||0
2543571|NCT00585351|6234961|P4|COMPLETED|Notification Period (Informed Consent)||0
2543572|NCT00585351|6234962|P3|COMPLETED|Notification Period (Informed Consent)||0
2543573|NCT00585351|6234963|P2|COMPLETED|Notification Period (Informed Consent)||25
2543574|NCT00585351|6234964|P1|COMPLETED|Notification Period (Informed Consent)||27
2543575|NCT00585351|6234957|P8|STARTED|Notification Period (Informed Consent)||0
2543576|NCT00585351|6234958|P7|STARTED|Notification Period (Informed Consent)||0
2543577|NCT00585351|6234959|P6|STARTED|Notification Period (Informed Consent)||0
2543578|NCT00585351|6234960|P5|STARTED|Notification Period (Informed Consent)||0
2543579|NCT00585351|6234961|P4|STARTED|Notification Period (Informed Consent)||0
2543580|NCT00585351|6234962|P3|STARTED|Notification Period (Informed Consent)||0
2543581|NCT00585351|6234963|P2|STARTED|Notification Period (Informed Consent)||50
2543582|NCT00585351|6234964|P1|STARTED|Notification Period (Informed Consent)||50
2543583|NCT00585325|6234980|P2|NOT COMPLETED|Overall Study||1
2543584|NCT00585325|6234981|P1|NOT COMPLETED|Overall Study||1
2543585|NCT00585325|6234980|P2|COMPLETED|Overall Study||12
2543586|NCT00585325|6234981|P1|COMPLETED|Overall Study||9
2543587|NCT00585325|6234980|P2|STARTED|Overall Study||13
2543588|NCT00585325|6234981|P1|STARTED|Overall Study||10
2543589|NCT00585312|6234989|P2|NOT COMPLETED|Overall Study||44
2543590|NCT00585312|6234990|P1|NOT COMPLETED|Overall Study||51
2543591|NCT00585312|6234989|P2|COMPLETED|Overall Study||7
2543592|NCT00585312|6234990|P1|COMPLETED|Overall Study||4
2543593|NCT00585312|6234989|P2|Treated|Overall Study||48
2543594|NCT00585312|6234990|P1|Treated|Overall Study||53
2543595|NCT00585312|6234989|P2|STARTED|Overall Study|STARTED=Randomized|51
2543596|NCT00585312|6234990|P1|STARTED|Overall Study|STARTED=Randomized|55
2543597|NCT00585286|6235002|P1|NOT COMPLETED|Overall Study||1
2543598|NCT00585286|6235002|P1|COMPLETED|Overall Study||14
2543599|NCT00585286|6235002|P1|STARTED|Overall Study||15
2543600|NCT00585247|6235011|P2|NOT COMPLETED|Overall Study||0
2543601|NCT00585247|6235012|P1|NOT COMPLETED|Overall Study||0
2543602|NCT00585247|6235011|P2|COMPLETED|Overall Study||13
2543603|NCT00585247|6235012|P1|COMPLETED|Overall Study||14
2543604|NCT00585247|6235011|P2|STARTED|Overall Study||13
2543605|NCT00585247|6235012|P1|STARTED|Overall Study||14
2543606|NCT00585221|6235018|P1|NOT COMPLETED|Overall Study||8
2543607|NCT00585221|6235018|P1|COMPLETED|Overall Study||0
2543608|NCT00585221|6235018|P1|STARTED|Overall Study||8
2543609|NCT00585182|6235023|P1|NOT COMPLETED|Overall Study||0
2543610|NCT00585182|6235023|P1|COMPLETED|Overall Study||28
2543611|NCT00585182|6235023|P1|STARTED|Overall Study||28
2543612|NCT00585169|6235028|P1|NOT COMPLETED|Overall Study||1
2543613|NCT00585169|6235028|P1|COMPLETED|Overall Study||28
2543614|NCT00585169|6235028|P1|STARTED|Overall Study||29
2543615|NCT00585104|6235034|P1|NOT COMPLETED|Overall Study||4
2543616|NCT00585104|6235034|P1|COMPLETED|Overall Study||6
2543617|NCT00585104|6235034|P1|STARTED|Overall Study||10
2543618|NCT00585078|6235038|P1|NOT COMPLETED|Overall Study||40
2543619|NCT00585078|6235038|P1|COMPLETED|Overall Study||0
2543620|NCT00585078|6235038|P1|Response Evaluable|Overall Study||24
2543621|NCT00585078|6235038|P1|Toxicity Evaluable|Overall Study||36
2543622|NCT00585078|6235038|P1|Treated|Overall Study||37
2543623|NCT00585078|6235038|P1|STARTED|Overall Study||40
2543624|NCT00585052|6235045|P1|NOT COMPLETED|Overall Study||1
2543625|NCT00585052|6235045|P1|COMPLETED|Overall Study||10
2543626|NCT00585052|6235045|P1|STARTED|Overall Study||11
2543627|NCT00585039|6235052|P2|NOT COMPLETED|Overall Study||0
2543628|NCT00585039|6235053|P1|NOT COMPLETED|Overall Study||2
2543629|NCT00585039|6235052|P2|COMPLETED|Overall Study||44
2543630|NCT00585039|6235053|P1|COMPLETED|Overall Study||55
2543631|NCT00585039|6235052|P2|STARTED|Overall Study||44
2543632|NCT00585039|6235053|P1|STARTED|Overall Study||57
2543633|NCT00585013|6235063|P2|NOT COMPLETED|Overall Study||0
2543634|NCT00585013|6235064|P1|NOT COMPLETED|Overall Study||0
2543635|NCT00585013|6235063|P2|COMPLETED|Overall Study||8
2543636|NCT00585013|6235064|P1|COMPLETED|Overall Study||8
2543637|NCT00585013|6235063|P2|STARTED|Overall Study||8
2543638|NCT00585013|6235064|P1|STARTED|Overall Study||8
2543639|NCT00584987|6235082|P4|NOT COMPLETED|Overall Study||1
2543640|NCT00584987|6235083|P3|NOT COMPLETED|Overall Study||1
2543641|NCT00584987|6235084|P2|NOT COMPLETED|Overall Study||1
2543642|NCT00584987|6235085|P1|NOT COMPLETED|Overall Study||1
2543643|NCT00584987|6235082|P4|COMPLETED|Overall Study||15
2543644|NCT00584987|6235083|P3|COMPLETED|Overall Study||16
2543645|NCT00584987|6235084|P2|COMPLETED|Overall Study||15
2543646|NCT00584987|6235085|P1|COMPLETED|Overall Study||14
2543647|NCT00584987|6235082|P4|STARTED|Overall Study||16
2543648|NCT00584987|6235083|P3|STARTED|Overall Study||17
2543649|NCT00584987|6235084|P2|STARTED|Overall Study||16
2543650|NCT00584987|6235085|P1|STARTED|Overall Study||15
2543651|NCT00584948|6235117|P2|NOT COMPLETED|Overall Study||11
2543652|NCT00584948|6235118|P1|NOT COMPLETED|Overall Study||13
2543653|NCT00584948|6235117|P2|COMPLETED|Overall Study||36
2543654|NCT00584948|6235118|P1|COMPLETED|Overall Study||34
2543655|NCT00584948|6235117|P2|STARTED|Overall Study||47
2543656|NCT00584948|6235118|P1|STARTED|Overall Study||47
2543657|NCT00584935|6235126|P1|NOT COMPLETED|Overall Study||0
2543658|NCT00584935|6235126|P1|COMPLETED|Overall Study||3
2543659|NCT00584935|6235126|P1|STARTED|Overall Study||3
2543660|NCT00584922|6235133|P1|NOT COMPLETED|Overall Study||0
2543661|NCT00584922|6235133|P1|COMPLETED|Overall Study||175
2543662|NCT00584922|6235133|P1|STARTED|Overall Study||175
2543663|NCT00584909|6235137|P1|NOT COMPLETED|Overall Study||4
2543664|NCT00584909|6235137|P1|COMPLETED|Overall Study||9
2543665|NCT00584909|6235137|P1|STARTED|Overall Study||13
2543666|NCT00584857|6235142|P1|NOT COMPLETED|Overall Study||0
2543667|NCT00584857|6235142|P1|COMPLETED|Overall Study||30
2543668|NCT00584857|6235142|P1|STARTED|Overall Study||30
2543669|NCT00584844|6235147|P1|NOT COMPLETED|Overall Study||79
2543670|NCT00584844|6235147|P1|COMPLETED|Overall Study||405
2543671|NCT00584844|6235147|P1|STARTED|Overall Study||484
2543672|NCT00584831|6235157|P19|NOT COMPLETED|Intervention 4||0
2543673|NCT00584831|6235158|P18|NOT COMPLETED|Intervention 4||0
2543674|NCT00584831|6235159|P17|NOT COMPLETED|Intervention 4||0
2543675|NCT00584831|6235160|P16|NOT COMPLETED|Intervention 4||0
2543676|NCT00584831|6235161|P15|NOT COMPLETED|Intervention 4||0
2543677|NCT00584831|6235162|P14|NOT COMPLETED|Intervention 4||0
2543678|NCT00584831|6235163|P13|NOT COMPLETED|Intervention 4||0
2543679|NCT00584831|6235164|P12|NOT COMPLETED|Intervention 4||0
2543680|NCT00584831|6235165|P11|NOT COMPLETED|Intervention 4||0
2543681|NCT00584831|6235166|P10|NOT COMPLETED|Intervention 4||0
2543682|NCT00584831|6235167|P9|NOT COMPLETED|Intervention 4||0
2543683|NCT00584831|6235168|P8|NOT COMPLETED|Intervention 4||0
2543684|NCT00584831|6235169|P7|NOT COMPLETED|Intervention 4||0
2543685|NCT00584831|6235170|P6|NOT COMPLETED|Intervention 4||0
2543686|NCT00584831|6235171|P5|NOT COMPLETED|Intervention 4||0
2543687|NCT00584831|6235172|P4|NOT COMPLETED|Intervention 4||0
2543688|NCT00584831|6235173|P3|NOT COMPLETED|Intervention 4||0
2543689|NCT00584831|6235174|P2|NOT COMPLETED|Intervention 4||0
2543690|NCT00584831|6235175|P1|NOT COMPLETED|Intervention 4||0
2543691|NCT00584831|6235157|P19|COMPLETED|Intervention 4||1
2543692|NCT00584831|6235158|P18|COMPLETED|Intervention 4||1
2543693|NCT00584831|6235159|P17|COMPLETED|Intervention 4||4
2543694|NCT00584831|6235160|P16|COMPLETED|Intervention 4||1
2543695|NCT00584831|6235161|P15|COMPLETED|Intervention 4||2
2543696|NCT00584831|6235162|P14|COMPLETED|Intervention 4||1
2543697|NCT00584831|6235163|P13|COMPLETED|Intervention 4||2
2543698|NCT00584831|6235164|P12|COMPLETED|Intervention 4||1
2543699|NCT00584831|6235165|P11|COMPLETED|Intervention 4||2
2543700|NCT00584831|6235166|P10|COMPLETED|Intervention 4||2
2543701|NCT00584831|6235167|P9|COMPLETED|Intervention 4||3
2543702|NCT00584831|6235168|P8|COMPLETED|Intervention 4||2
2543703|NCT00584831|6235169|P7|COMPLETED|Intervention 4||6
2543704|NCT00584831|6235170|P6|COMPLETED|Intervention 4||1
2543705|NCT00584831|6235171|P5|COMPLETED|Intervention 4||2
2543706|NCT00584831|6235172|P4|COMPLETED|Intervention 4||1
2543707|NCT00584831|6235173|P3|COMPLETED|Intervention 4||2
2543708|NCT00584831|6235174|P2|COMPLETED|Intervention 4||3
2543709|NCT00584831|6235175|P1|COMPLETED|Intervention 4||1
2543710|NCT00584831|6235157|P19|STARTED|Intervention 4||1
2543711|NCT00584831|6235158|P18|STARTED|Intervention 4||1
2543712|NCT00584831|6235159|P17|STARTED|Intervention 4||4
2543713|NCT00584831|6235160|P16|STARTED|Intervention 4||1
2543714|NCT00584831|6235161|P15|STARTED|Intervention 4||2
2543715|NCT00584831|6235162|P14|STARTED|Intervention 4||1
2543716|NCT00584831|6235163|P13|STARTED|Intervention 4||2
2543717|NCT00584831|6235164|P12|STARTED|Intervention 4||1
2543718|NCT00584831|6235165|P11|STARTED|Intervention 4||2
2543719|NCT00584831|6235166|P10|STARTED|Intervention 4||2
2543720|NCT00584831|6235167|P9|STARTED|Intervention 4||3
2543721|NCT00584831|6235168|P8|STARTED|Intervention 4||2
2543722|NCT00584831|6235169|P7|STARTED|Intervention 4||6
2543723|NCT00584831|6235170|P6|STARTED|Intervention 4||1
2543724|NCT00584831|6235171|P5|STARTED|Intervention 4||2
2543725|NCT00584831|6235172|P4|STARTED|Intervention 4||1
2543726|NCT00584831|6235173|P3|STARTED|Intervention 4||2
2543727|NCT00584831|6235174|P2|STARTED|Intervention 4||3
2543728|NCT00584831|6235175|P1|STARTED|Intervention 4||1
2543729|NCT00584831|6235157|P19|NOT COMPLETED|Intervention 3||0
2543730|NCT00584831|6235158|P18|NOT COMPLETED|Intervention 3||0
2543731|NCT00584831|6235159|P17|NOT COMPLETED|Intervention 3||0
2543732|NCT00584831|6235160|P16|NOT COMPLETED|Intervention 3||0
2543733|NCT00584831|6235161|P15|NOT COMPLETED|Intervention 3||0
2543734|NCT00584831|6235162|P14|NOT COMPLETED|Intervention 3||0
2543735|NCT00584831|6235163|P13|NOT COMPLETED|Intervention 3||0
2543736|NCT00584831|6235164|P12|NOT COMPLETED|Intervention 3||0
2543737|NCT00584831|6235165|P11|NOT COMPLETED|Intervention 3||0
2543738|NCT00584831|6235166|P10|NOT COMPLETED|Intervention 3||0
2543739|NCT00584831|6235167|P9|NOT COMPLETED|Intervention 3||0
2543740|NCT00584831|6235168|P8|NOT COMPLETED|Intervention 3||0
2543741|NCT00584831|6235169|P7|NOT COMPLETED|Intervention 3||0
2543742|NCT00584831|6235170|P6|NOT COMPLETED|Intervention 3||0
2543743|NCT00584831|6235171|P5|NOT COMPLETED|Intervention 3||0
2543744|NCT00584831|6235172|P4|NOT COMPLETED|Intervention 3||0
2543745|NCT00584831|6235173|P3|NOT COMPLETED|Intervention 3||0
2543746|NCT00584831|6235174|P2|NOT COMPLETED|Intervention 3||0
2543747|NCT00584831|6235175|P1|NOT COMPLETED|Intervention 3||0
2543748|NCT00584831|6235157|P19|COMPLETED|Intervention 3||1
2543749|NCT00584831|6235158|P18|COMPLETED|Intervention 3||1
2543750|NCT00584831|6235159|P17|COMPLETED|Intervention 3||4
2543751|NCT00584831|6235160|P16|COMPLETED|Intervention 3||1
2543752|NCT00584831|6235161|P15|COMPLETED|Intervention 3||3
2543753|NCT00584831|6235162|P14|COMPLETED|Intervention 3||1
2543754|NCT00584831|6235163|P13|COMPLETED|Intervention 3||2
2543755|NCT00584831|6235164|P12|COMPLETED|Intervention 3||1
2543756|NCT00584831|6235165|P11|COMPLETED|Intervention 3||2
2543757|NCT00584831|6235166|P10|COMPLETED|Intervention 3||2
2543758|NCT00584831|6235167|P9|COMPLETED|Intervention 3||4
2543759|NCT00584831|6235168|P8|COMPLETED|Intervention 3||2
2543760|NCT00584831|6235169|P7|COMPLETED|Intervention 3||6
2543761|NCT00584831|6235170|P6|COMPLETED|Intervention 3||1
2543762|NCT00584831|6235171|P5|COMPLETED|Intervention 3||2
2543763|NCT00584831|6235172|P4|COMPLETED|Intervention 3||1
2543764|NCT00584831|6235173|P3|COMPLETED|Intervention 3||2
2543765|NCT00584831|6235174|P2|COMPLETED|Intervention 3||3
2543766|NCT00584831|6235175|P1|COMPLETED|Intervention 3||1
2543767|NCT00584831|6235157|P19|STARTED|Intervention 3||1
2543768|NCT00584831|6235158|P18|STARTED|Intervention 3||1
2543769|NCT00584831|6235159|P17|STARTED|Intervention 3||4
2543770|NCT00584831|6235160|P16|STARTED|Intervention 3||1
2543771|NCT00584831|6235161|P15|STARTED|Intervention 3||3
2543772|NCT00584831|6235162|P14|STARTED|Intervention 3||1
2543773|NCT00584831|6235163|P13|STARTED|Intervention 3||2
2543774|NCT00584831|6235164|P12|STARTED|Intervention 3||1
2543775|NCT00584831|6235165|P11|STARTED|Intervention 3||2
2543776|NCT00584831|6235166|P10|STARTED|Intervention 3||2
2543777|NCT00584831|6235167|P9|STARTED|Intervention 3||4
2543778|NCT00584831|6235168|P8|STARTED|Intervention 3||2
2543779|NCT00584831|6235169|P7|STARTED|Intervention 3||6
2543780|NCT00584831|6235170|P6|STARTED|Intervention 3||1
2543781|NCT00584831|6235171|P5|STARTED|Intervention 3||2
2543782|NCT00584831|6235172|P4|STARTED|Intervention 3||1
2543783|NCT00584831|6235173|P3|STARTED|Intervention 3||2
2543784|NCT00584831|6235174|P2|STARTED|Intervention 3||3
2543785|NCT00584831|6235175|P1|STARTED|Intervention 3||1
2543786|NCT00584831|6235157|P19|NOT COMPLETED|Intervention 2||0
2543787|NCT00584831|6235158|P18|NOT COMPLETED|Intervention 2||0
2543788|NCT00584831|6235159|P17|NOT COMPLETED|Intervention 2||0
2543789|NCT00584831|6235160|P16|NOT COMPLETED|Intervention 2||0
2543790|NCT00584831|6235161|P15|NOT COMPLETED|Intervention 2||0
2543791|NCT00584831|6235162|P14|NOT COMPLETED|Intervention 2||0
2543792|NCT00584831|6235163|P13|NOT COMPLETED|Intervention 2||0
2543793|NCT00584831|6235164|P12|NOT COMPLETED|Intervention 2||0
2543794|NCT00584831|6235165|P11|NOT COMPLETED|Intervention 2||0
2543795|NCT00584831|6235166|P10|NOT COMPLETED|Intervention 2||0
2543796|NCT00584831|6235167|P9|NOT COMPLETED|Intervention 2||0
2543797|NCT00584831|6235168|P8|NOT COMPLETED|Intervention 2||0
2543798|NCT00584831|6235169|P7|NOT COMPLETED|Intervention 2||0
2543799|NCT00584831|6235170|P6|NOT COMPLETED|Intervention 2||0
2543800|NCT00584831|6235171|P5|NOT COMPLETED|Intervention 2||0
2543801|NCT00584831|6235172|P4|NOT COMPLETED|Intervention 2||0
2543802|NCT00584831|6235173|P3|NOT COMPLETED|Intervention 2||0
2543803|NCT00584831|6235174|P2|NOT COMPLETED|Intervention 2||0
2543804|NCT00584831|6235175|P1|NOT COMPLETED|Intervention 2||0
2543805|NCT00584831|6235157|P19|COMPLETED|Intervention 2||1
2543806|NCT00584831|6235158|P18|COMPLETED|Intervention 2||1
2543807|NCT00584831|6235159|P17|COMPLETED|Intervention 2||4
2543808|NCT00584831|6235160|P16|COMPLETED|Intervention 2||1
2543809|NCT00584831|6235161|P15|COMPLETED|Intervention 2||3
2543810|NCT00584831|6235162|P14|COMPLETED|Intervention 2||1
2543811|NCT00584831|6235163|P13|COMPLETED|Intervention 2||2
2543812|NCT00584831|6235164|P12|COMPLETED|Intervention 2||1
2543813|NCT00584831|6235165|P11|COMPLETED|Intervention 2||2
2543814|NCT00584831|6235166|P10|COMPLETED|Intervention 2||2
2543815|NCT00584831|6235167|P9|COMPLETED|Intervention 2||4
2543816|NCT00584831|6235168|P8|COMPLETED|Intervention 2||2
2543817|NCT00584831|6235169|P7|COMPLETED|Intervention 2||6
2543818|NCT00584831|6235170|P6|COMPLETED|Intervention 2||1
2543819|NCT00584831|6235171|P5|COMPLETED|Intervention 2||2
2543820|NCT00584831|6235172|P4|COMPLETED|Intervention 2||1
2543821|NCT00584831|6235173|P3|COMPLETED|Intervention 2||2
2543822|NCT00584831|6235174|P2|COMPLETED|Intervention 2||3
2543823|NCT00584831|6235175|P1|COMPLETED|Intervention 2||1
2543824|NCT00584831|6235157|P19|STARTED|Intervention 2||1
2543825|NCT00584831|6235158|P18|STARTED|Intervention 2||1
2543826|NCT00584831|6235159|P17|STARTED|Intervention 2||4
2543827|NCT00584831|6235160|P16|STARTED|Intervention 2||1
2543828|NCT00584831|6235161|P15|STARTED|Intervention 2||3
2543829|NCT00584831|6235162|P14|STARTED|Intervention 2||1
2543830|NCT00584831|6235163|P13|STARTED|Intervention 2||2
2543831|NCT00584831|6235164|P12|STARTED|Intervention 2||1
2543832|NCT00584831|6235165|P11|STARTED|Intervention 2||2
2543833|NCT00584831|6235166|P10|STARTED|Intervention 2||2
2543834|NCT00584831|6235167|P9|STARTED|Intervention 2||4
2543835|NCT00584831|6235168|P8|STARTED|Intervention 2||2
2543836|NCT00584831|6235169|P7|STARTED|Intervention 2||6
2543837|NCT00584831|6235170|P6|STARTED|Intervention 2||1
2543838|NCT00584831|6235171|P5|STARTED|Intervention 2||2
2543839|NCT00584831|6235172|P4|STARTED|Intervention 2||1
2543840|NCT00584831|6235173|P3|STARTED|Intervention 2||2
2543841|NCT00584831|6235174|P2|STARTED|Intervention 2||3
2543842|NCT00584831|6235175|P1|STARTED|Intervention 2||1
2543843|NCT00584831|6235157|P19|NOT COMPLETED|Intervention 1||0
2543844|NCT00584831|6235158|P18|NOT COMPLETED|Intervention 1||0
2543845|NCT00584831|6235159|P17|NOT COMPLETED|Intervention 1||0
2543846|NCT00584831|6235160|P16|NOT COMPLETED|Intervention 1||0
2543847|NCT00584831|6235161|P15|NOT COMPLETED|Intervention 1||0
2543848|NCT00584831|6235162|P14|NOT COMPLETED|Intervention 1||0
2543849|NCT00584831|6235163|P13|NOT COMPLETED|Intervention 1||0
2543850|NCT00584831|6235164|P12|NOT COMPLETED|Intervention 1||0
2543851|NCT00584831|6235165|P11|NOT COMPLETED|Intervention 1||0
2543852|NCT00584831|6235166|P10|NOT COMPLETED|Intervention 1||0
2543853|NCT00584831|6235167|P9|NOT COMPLETED|Intervention 1||0
2543854|NCT00584831|6235168|P8|NOT COMPLETED|Intervention 1||0
2543855|NCT00584831|6235169|P7|NOT COMPLETED|Intervention 1||0
2543856|NCT00584831|6235170|P6|NOT COMPLETED|Intervention 1||0
2543857|NCT00584831|6235171|P5|NOT COMPLETED|Intervention 1||0
2543858|NCT00584831|6235172|P4|NOT COMPLETED|Intervention 1||0
2543859|NCT00584831|6235173|P3|NOT COMPLETED|Intervention 1||0
2543860|NCT00584831|6235174|P2|NOT COMPLETED|Intervention 1||0
2543861|NCT00584831|6235175|P1|NOT COMPLETED|Intervention 1||0
2543862|NCT00584831|6235157|P19|COMPLETED|Intervention 1||1
2543863|NCT00584831|6235158|P18|COMPLETED|Intervention 1||1
2543864|NCT00584831|6235159|P17|COMPLETED|Intervention 1||4
2543865|NCT00584831|6235160|P16|COMPLETED|Intervention 1||1
2543866|NCT00584831|6235161|P15|COMPLETED|Intervention 1||3
2543867|NCT00584831|6235162|P14|COMPLETED|Intervention 1||1
2543868|NCT00584831|6235163|P13|COMPLETED|Intervention 1||2
2543869|NCT00584831|6235164|P12|COMPLETED|Intervention 1||1
2543870|NCT00584831|6235165|P11|COMPLETED|Intervention 1||2
2543871|NCT00584831|6235166|P10|COMPLETED|Intervention 1||2
2543872|NCT00584831|6235167|P9|COMPLETED|Intervention 1||4
2543873|NCT00584831|6235168|P8|COMPLETED|Intervention 1||2
2543874|NCT00584831|6235169|P7|COMPLETED|Intervention 1||6
2543875|NCT00584831|6235170|P6|COMPLETED|Intervention 1||1
2543876|NCT00584831|6235171|P5|COMPLETED|Intervention 1||2
2543877|NCT00584831|6235172|P4|COMPLETED|Intervention 1||1
2543878|NCT00584831|6235173|P3|COMPLETED|Intervention 1||2
2543879|NCT00584831|6235174|P2|COMPLETED|Intervention 1||3
2543880|NCT00584831|6235175|P1|COMPLETED|Intervention 1||1
2543881|NCT00584831|6235157|P19|STARTED|Intervention 1||1
2543882|NCT00584831|6235158|P18|STARTED|Intervention 1||1
2543883|NCT00584831|6235159|P17|STARTED|Intervention 1||4
2543884|NCT00584831|6235160|P16|STARTED|Intervention 1||1
2543885|NCT00584831|6235161|P15|STARTED|Intervention 1||3
2543886|NCT00584831|6235162|P14|STARTED|Intervention 1||1
2543887|NCT00584831|6235163|P13|STARTED|Intervention 1||2
2543888|NCT00584831|6235164|P12|STARTED|Intervention 1||1
2543889|NCT00584831|6235165|P11|STARTED|Intervention 1||2
2543890|NCT00584831|6235166|P10|STARTED|Intervention 1||2
2543891|NCT00584831|6235167|P9|STARTED|Intervention 1||4
2543892|NCT00584831|6235168|P8|STARTED|Intervention 1||2
2543893|NCT00584831|6235169|P7|STARTED|Intervention 1||6
2543894|NCT00584831|6235170|P6|STARTED|Intervention 1||1
2543895|NCT00584831|6235171|P5|STARTED|Intervention 1||2
2543896|NCT00584831|6235172|P4|STARTED|Intervention 1||1
2543897|NCT00584831|6235173|P3|STARTED|Intervention 1||2
2543898|NCT00584831|6235174|P2|STARTED|Intervention 1||3
2543899|NCT00584831|6235175|P1|STARTED|Intervention 1||1
2543900|NCT00584805|6235197|P1|NOT COMPLETED|Overall Study||99
2543901|NCT00584805|6235197|P1|COMPLETED|Overall Study||39
2543902|NCT00584805|6235197|P1|STARTED|Overall Study||138
2543903|NCT00584740|6235210|P2|NOT COMPLETED|Overall Study||6
2543904|NCT00584740|6235211|P1|NOT COMPLETED|Overall Study||12
2543905|NCT00584740|6235210|P2|COMPLETED|Overall Study||14
2543906|NCT00584740|6235211|P1|COMPLETED|Overall Study||27
2543907|NCT00584740|6235210|P2|STARTED|Overall Study||20
2543908|NCT00584740|6235211|P1|STARTED|Overall Study||39
2543909|NCT00584727|6235229|P6|NOT COMPLETED|Third Intervention||2
2543910|NCT00584727|6235230|P5|NOT COMPLETED|Third Intervention||4
2543911|NCT00584727|6235231|P4|NOT COMPLETED|Third Intervention||0
2543912|NCT00584727|6235232|P3|NOT COMPLETED|Third Intervention||1
2543913|NCT00584727|6235233|P2|NOT COMPLETED|Third Intervention||0
2543914|NCT00584727|6235234|P1|NOT COMPLETED|Third Intervention||0
2543915|NCT00584727|6235229|P6|COMPLETED|Third Intervention||14
2543916|NCT00584727|6235230|P5|COMPLETED|Third Intervention||12
2543917|NCT00584727|6235231|P4|COMPLETED|Third Intervention||14
2543918|NCT00584727|6235232|P3|COMPLETED|Third Intervention||14
2543919|NCT00584727|6235233|P2|COMPLETED|Third Intervention||17
2543920|NCT00584727|6235234|P1|COMPLETED|Third Intervention||17
2543921|NCT00584727|6235229|P6|STARTED|Third Intervention||16
2543922|NCT00584727|6235230|P5|STARTED|Third Intervention||16
2543923|NCT00584727|6235231|P4|STARTED|Third Intervention||14
2543924|NCT00584727|6235232|P3|STARTED|Third Intervention||15
2543925|NCT00584727|6235233|P2|STARTED|Third Intervention||17
2543926|NCT00584727|6235234|P1|STARTED|Third Intervention||17
2543927|NCT00584727|6235229|P6|NOT COMPLETED|Second Intervention||0
2543928|NCT00584727|6235230|P5|NOT COMPLETED|Second Intervention||0
2543929|NCT00584727|6235231|P4|NOT COMPLETED|Second Intervention||0
2543930|NCT00584727|6235232|P3|NOT COMPLETED|Second Intervention||0
2543931|NCT00584727|6235233|P2|NOT COMPLETED|Second Intervention||0
2543932|NCT00584727|6235234|P1|NOT COMPLETED|Second Intervention||0
2543933|NCT00584727|6235229|P6|COMPLETED|Second Intervention||16
2543934|NCT00584727|6235230|P5|COMPLETED|Second Intervention||16
2543935|NCT00584727|6235231|P4|COMPLETED|Second Intervention||14
2543936|NCT00584727|6235232|P3|COMPLETED|Second Intervention||15
2543937|NCT00584727|6235233|P2|COMPLETED|Second Intervention||17
2543938|NCT00584727|6235234|P1|COMPLETED|Second Intervention||17
2543939|NCT00584727|6235229|P6|STARTED|Second Intervention||16
2543940|NCT00584727|6235230|P5|STARTED|Second Intervention||16
2543941|NCT00584727|6235231|P4|STARTED|Second Intervention||14
2543942|NCT00584727|6235232|P3|STARTED|Second Intervention||15
2543943|NCT00584727|6235233|P2|STARTED|Second Intervention||17
2543944|NCT00584727|6235234|P1|STARTED|Second Intervention||17
2543945|NCT00584727|6235229|P6|NOT COMPLETED|First Intervention||0
2543946|NCT00584727|6235230|P5|NOT COMPLETED|First Intervention||0
2543947|NCT00584727|6235231|P4|NOT COMPLETED|First Intervention||0
2543948|NCT00584727|6235232|P3|NOT COMPLETED|First Intervention||1
2543949|NCT00584727|6235233|P2|NOT COMPLETED|First Intervention||0
2543950|NCT00584727|6235234|P1|NOT COMPLETED|First Intervention||0
2543951|NCT00584727|6235229|P6|COMPLETED|First Intervention||16
2543952|NCT00584727|6235230|P5|COMPLETED|First Intervention||16
2543953|NCT00584727|6235231|P4|COMPLETED|First Intervention||14
2543954|NCT00584727|6235232|P3|COMPLETED|First Intervention||15
2543955|NCT00584727|6235233|P2|COMPLETED|First Intervention||17
2543956|NCT00584727|6235234|P1|COMPLETED|First Intervention||17
2543957|NCT00584727|6235229|P6|STARTED|First Intervention||16
2543958|NCT00584727|6235230|P5|STARTED|First Intervention||16
2543959|NCT00584727|6235231|P4|STARTED|First Intervention||14
2543960|NCT00584727|6235232|P3|STARTED|First Intervention||16
2543961|NCT00584727|6235233|P2|STARTED|First Intervention||17
2543962|NCT00584727|6235234|P1|STARTED|First Intervention||17
2543963|NCT00584701|6235258|P1|NOT COMPLETED|Follow-up||12
2543964|NCT00584701|6235258|P1|COMPLETED|Follow-up||34
2543965|NCT00584701|6235258|P1|STARTED|Follow-up||46
2543966|NCT00584701|6235258|P1|NOT COMPLETED|Active Risperidone||3
2543967|NCT00584701|6235258|P1|COMPLETED|Active Risperidone||46
2543968|NCT00584701|6235258|P1|STARTED|Active Risperidone||49
2543969|NCT00584558|6235263|P1|NOT COMPLETED|Overall Study||0
2543970|NCT00584558|6235263|P1|COMPLETED|Overall Study||2420
2543971|NCT00584558|6235263|P1|STARTED|Overall Study||2420
2543972|NCT00584480|6235268|P1|NOT COMPLETED|Second 8 Weeks (40 Treatments)||0
2543973|NCT00584480|6235268|P1|COMPLETED|Second 8 Weeks (40 Treatments)||10
2543974|NCT00584480|6235268|P1|STARTED|Second 8 Weeks (40 Treatments)||10
2543975|NCT00584480|6235268|P1|NOT COMPLETED|4-Week Break From Treatment||0
2543976|NCT00584480|6235268|P1|COMPLETED|4-Week Break From Treatment||10
2543977|NCT00584480|6235268|P1|STARTED|4-Week Break From Treatment||10
2543978|NCT00584480|6235268|P1|NOT COMPLETED|First 8 Weeks (40 Treatments)||0
2543979|NCT00584480|6235268|P1|COMPLETED|First 8 Weeks (40 Treatments)||10
2543980|NCT00584480|6235268|P1|STARTED|First 8 Weeks (40 Treatments)||10
2543981|NCT00584454|6235272|P1|NOT COMPLETED|Overall Study||4
2543982|NCT00584454|6235272|P1|COMPLETED|Overall Study||6
2543983|NCT00584454|6235272|P1|STARTED|Overall Study||10
2543984|NCT00584415|6235276|P1|NOT COMPLETED|Overall Study||7
2543985|NCT00584415|6235276|P1|COMPLETED|Overall Study||112
2543986|NCT00584415|6235276|P1|STARTED|Overall Study|A total of 119 enrolled and 112 underwent the ablation procedure;|119
2543987|NCT00584402|6235281|P1|NOT COMPLETED|Overall Study||0
2543988|NCT00584402|6235281|P1|COMPLETED|Overall Study||8
2543989|NCT00584402|6235281|P1|STARTED|Overall Study||8
2543990|NCT00584285|6235286|P1|NOT COMPLETED|Overall Study||0
2543991|NCT00584285|6235286|P1|COMPLETED|Overall Study||18
2543992|NCT00584285|6235286|P1|STARTED|Overall Study||18
2543993|NCT00584220|6235290|P2|NOT COMPLETED|Second Period||0
2543994|NCT00584220|6235291|P1|NOT COMPLETED|Second Period||0
2543995|NCT00584220|6235290|P2|COMPLETED|Second Period||39
2543996|NCT00584220|6235291|P1|COMPLETED|Second Period||48
2543997|NCT00584220|6235290|P2|STARTED|Second Period||39
2543998|NCT00584220|6235291|P1|STARTED|Second Period||48
2543999|NCT00584220|6235290|P2|NOT COMPLETED|First Period||0
2544000|NCT00584220|6235291|P1|NOT COMPLETED|First Period||0
2544001|NCT00584220|6235290|P2|COMPLETED|First Period||39
2544002|NCT00584220|6235291|P1|COMPLETED|First Period||48
2544003|NCT00584220|6235290|P2|STARTED|First Period||39
2544004|NCT00584220|6235291|P1|STARTED|First Period||48
2544005|NCT00584194|6235299|P1|NOT COMPLETED|Overall Study||135
2544006|NCT00584194|6235299|P1|COMPLETED|Overall Study||143
2544007|NCT00584194|6235299|P1|STARTED|Overall Study||278
2544008|NCT00584077|6235307|P1|NOT COMPLETED|Overall Study||0
2544009|NCT00584077|6235307|P1|COMPLETED|Overall Study||15
2544010|NCT00584077|6235307|P1|STARTED|Overall Study||15
2544011|NCT00584012|6235312|P1|NOT COMPLETED|Overall Study||1
2544012|NCT00584012|6235312|P1|COMPLETED|Overall Study||8
2544013|NCT00584012|6235312|P1|STARTED|Overall Study||9
2544014|NCT00583947|6235318|P2|NOT COMPLETED|Open Label Period||0
2544015|NCT00583947|6235319|P1|NOT COMPLETED|Open Label Period||0
2544016|NCT00583947|6235318|P2|COMPLETED|Open Label Period||24
2544017|NCT00583947|6235319|P1|COMPLETED|Open Label Period||22
2544018|NCT00583947|6235318|P2|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|24
2544019|NCT00583947|6235319|P1|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|22
2544020|NCT00583947|6235318|P2|NOT COMPLETED|Washout||0
2544021|NCT00583947|6235319|P1|NOT COMPLETED|Washout||0
2544022|NCT00583947|6235318|P2|COMPLETED|Washout||24
2544023|NCT00583947|6235319|P1|COMPLETED|Washout||22
2544024|NCT00583947|6235318|P2|STARTED|Washout||24
2544025|NCT00583947|6235319|P1|STARTED|Washout||22
2544026|NCT00583947|6235318|P2|NOT COMPLETED|Cross-over Period||2
2544027|NCT00583947|6235319|P1|NOT COMPLETED|Cross-over Period||5
2544028|NCT00583947|6235318|P2|COMPLETED|Cross-over Period||24
2544029|NCT00583947|6235319|P1|COMPLETED|Cross-over Period||22
2544030|NCT00583947|6235318|P2|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|26
2544031|NCT00583947|6235319|P1|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|27
2544032|NCT00583908|6235369|P12|NOT COMPLETED|Period 4 - Fourth Intervention||0
2544033|NCT00583908|6235370|P11|NOT COMPLETED|Period 4 - Fourth Intervention||0
2544034|NCT00583908|6235371|P10|NOT COMPLETED|Period 4 - Fourth Intervention||0
2544035|NCT00583908|6235372|P9|NOT COMPLETED|Period 4 - Fourth Intervention||0
2544036|NCT00583908|6235373|P8|NOT COMPLETED|Period 4 - Fourth Intervention||0
2544037|NCT00583908|6235374|P7|NOT COMPLETED|Period 4 - Fourth Intervention||0
2544038|NCT00583908|6235375|P6|NOT COMPLETED|Period 4 - Fourth Intervention||0
2544039|NCT00583908|6235376|P5|NOT COMPLETED|Period 4 - Fourth Intervention||0
2544040|NCT00583908|6235377|P4|NOT COMPLETED|Period 4 - Fourth Intervention||0
2544041|NCT00583908|6235378|P3|NOT COMPLETED|Period 4 - Fourth Intervention||0
2544042|NCT00583908|6235379|P2|NOT COMPLETED|Period 4 - Fourth Intervention||0
2544043|NCT00583908|6235380|P1|NOT COMPLETED|Period 4 - Fourth Intervention||0
2544044|NCT00583908|6235369|P12|COMPLETED|Period 4 - Fourth Intervention||1
2544045|NCT00583908|6235370|P11|COMPLETED|Period 4 - Fourth Intervention||1
2544046|NCT00583908|6235371|P10|COMPLETED|Period 4 - Fourth Intervention||1
2544047|NCT00583908|6235372|P9|COMPLETED|Period 4 - Fourth Intervention||1
2544048|NCT00583908|6235373|P8|COMPLETED|Period 4 - Fourth Intervention||1
2544049|NCT00583908|6235374|P7|COMPLETED|Period 4 - Fourth Intervention||1
2544050|NCT00583908|6235375|P6|COMPLETED|Period 4 - Fourth Intervention||1
2544051|NCT00583908|6235376|P5|COMPLETED|Period 4 - Fourth Intervention||2
2544052|NCT00583908|6235377|P4|COMPLETED|Period 4 - Fourth Intervention||1
2544053|NCT00583908|6235378|P3|COMPLETED|Period 4 - Fourth Intervention||1
2544054|NCT00583908|6235379|P2|COMPLETED|Period 4 - Fourth Intervention||2
2544055|NCT00583908|6235380|P1|COMPLETED|Period 4 - Fourth Intervention||1
2544056|NCT00583908|6235369|P12|STARTED|Period 4 - Fourth Intervention||1
2544057|NCT00583908|6235370|P11|STARTED|Period 4 - Fourth Intervention||1
2544058|NCT00583908|6235371|P10|STARTED|Period 4 - Fourth Intervention||1
2544059|NCT00583908|6235372|P9|STARTED|Period 4 - Fourth Intervention||1
2544060|NCT00583908|6235373|P8|STARTED|Period 4 - Fourth Intervention||1
2544061|NCT00583908|6235374|P7|STARTED|Period 4 - Fourth Intervention||1
2544062|NCT00583908|6235375|P6|STARTED|Period 4 - Fourth Intervention||1
2544063|NCT00583908|6235376|P5|STARTED|Period 4 - Fourth Intervention||2
2544064|NCT00583908|6235377|P4|STARTED|Period 4 - Fourth Intervention||1
2544065|NCT00583908|6235378|P3|STARTED|Period 4 - Fourth Intervention||1
2544066|NCT00583908|6235379|P2|STARTED|Period 4 - Fourth Intervention||2
2544067|NCT00583908|6235380|P1|STARTED|Period 4 - Fourth Intervention||1
2544068|NCT00583908|6235369|P12|NOT COMPLETED|Period 3 - Third Intervention||0
2544069|NCT00583908|6235370|P11|NOT COMPLETED|Period 3 - Third Intervention||0
2544070|NCT00583908|6235371|P10|NOT COMPLETED|Period 3 - Third Intervention||0
2544071|NCT00583908|6235372|P9|NOT COMPLETED|Period 3 - Third Intervention||0
2544072|NCT00583908|6235373|P8|NOT COMPLETED|Period 3 - Third Intervention||0
2544073|NCT00583908|6235374|P7|NOT COMPLETED|Period 3 - Third Intervention||0
2544074|NCT00583908|6235375|P6|NOT COMPLETED|Period 3 - Third Intervention||0
2544075|NCT00583908|6235376|P5|NOT COMPLETED|Period 3 - Third Intervention||0
2544076|NCT00583908|6235377|P4|NOT COMPLETED|Period 3 - Third Intervention||0
2544077|NCT00583908|6235378|P3|NOT COMPLETED|Period 3 - Third Intervention||0
2544078|NCT00583908|6235379|P2|NOT COMPLETED|Period 3 - Third Intervention||0
2544079|NCT00583908|6235380|P1|NOT COMPLETED|Period 3 - Third Intervention||0
2544080|NCT00583908|6235369|P12|COMPLETED|Period 3 - Third Intervention||1
2544081|NCT00583908|6235370|P11|COMPLETED|Period 3 - Third Intervention||1
2544082|NCT00583908|6235371|P10|COMPLETED|Period 3 - Third Intervention||1
2544083|NCT00583908|6235372|P9|COMPLETED|Period 3 - Third Intervention||1
2544084|NCT00583908|6235373|P8|COMPLETED|Period 3 - Third Intervention||1
2544085|NCT00583908|6235374|P7|COMPLETED|Period 3 - Third Intervention||1
2544086|NCT00583908|6235375|P6|COMPLETED|Period 3 - Third Intervention||1
2544087|NCT00583908|6235376|P5|COMPLETED|Period 3 - Third Intervention||2
2544088|NCT00583908|6235377|P4|COMPLETED|Period 3 - Third Intervention||1
2544089|NCT00583908|6235378|P3|COMPLETED|Period 3 - Third Intervention||1
2544090|NCT00583908|6235379|P2|COMPLETED|Period 3 - Third Intervention||2
2544091|NCT00583908|6235380|P1|COMPLETED|Period 3 - Third Intervention||1
2544092|NCT00583908|6235369|P12|STARTED|Period 3 - Third Intervention||1
2544093|NCT00583908|6235370|P11|STARTED|Period 3 - Third Intervention||1
2544094|NCT00583908|6235371|P10|STARTED|Period 3 - Third Intervention||1
2544095|NCT00583908|6235372|P9|STARTED|Period 3 - Third Intervention||1
2544096|NCT00583908|6235373|P8|STARTED|Period 3 - Third Intervention||1
2544097|NCT00583908|6235374|P7|STARTED|Period 3 - Third Intervention||1
2544098|NCT00583908|6235375|P6|STARTED|Period 3 - Third Intervention||1
2544099|NCT00583908|6235376|P5|STARTED|Period 3 - Third Intervention||2
2544100|NCT00583908|6235377|P4|STARTED|Period 3 - Third Intervention||1
2544101|NCT00583908|6235378|P3|STARTED|Period 3 - Third Intervention||1
2544102|NCT00583908|6235379|P2|STARTED|Period 3 - Third Intervention||2
2544103|NCT00583908|6235380|P1|STARTED|Period 3 - Third Intervention||1
2544104|NCT00583908|6235369|P12|NOT COMPLETED|Period 2 - Second Intervention||0
2544105|NCT00583908|6235370|P11|NOT COMPLETED|Period 2 - Second Intervention||0
2544106|NCT00583908|6235371|P10|NOT COMPLETED|Period 2 - Second Intervention||0
2544107|NCT00583908|6235372|P9|NOT COMPLETED|Period 2 - Second Intervention||0
2544108|NCT00583908|6235373|P8|NOT COMPLETED|Period 2 - Second Intervention||0
2544109|NCT00583908|6235374|P7|NOT COMPLETED|Period 2 - Second Intervention||0
2544110|NCT00583908|6235375|P6|NOT COMPLETED|Period 2 - Second Intervention||0
2544111|NCT00583908|6235376|P5|NOT COMPLETED|Period 2 - Second Intervention||0
2544112|NCT00583908|6235377|P4|NOT COMPLETED|Period 2 - Second Intervention||0
2544113|NCT00583908|6235378|P3|NOT COMPLETED|Period 2 - Second Intervention||0
2544114|NCT00583908|6235379|P2|NOT COMPLETED|Period 2 - Second Intervention||0
2544115|NCT00583908|6235380|P1|NOT COMPLETED|Period 2 - Second Intervention||0
2544116|NCT00583908|6235369|P12|COMPLETED|Period 2 - Second Intervention||1
2544117|NCT00583908|6235370|P11|COMPLETED|Period 2 - Second Intervention||1
2544118|NCT00583908|6235371|P10|COMPLETED|Period 2 - Second Intervention||1
2544119|NCT00583908|6235372|P9|COMPLETED|Period 2 - Second Intervention||1
2544120|NCT00583908|6235373|P8|COMPLETED|Period 2 - Second Intervention||1
2544121|NCT00583908|6235374|P7|COMPLETED|Period 2 - Second Intervention||1
2544122|NCT00583908|6235375|P6|COMPLETED|Period 2 - Second Intervention||1
2544123|NCT00583908|6235376|P5|COMPLETED|Period 2 - Second Intervention||2
2544124|NCT00583908|6235377|P4|COMPLETED|Period 2 - Second Intervention||1
2544125|NCT00583908|6235378|P3|COMPLETED|Period 2 - Second Intervention||1
2544126|NCT00583908|6235379|P2|COMPLETED|Period 2 - Second Intervention||2
2544127|NCT00583908|6235380|P1|COMPLETED|Period 2 - Second Intervention||1
2544128|NCT00583908|6235369|P12|STARTED|Period 2 - Second Intervention||1
2544129|NCT00583908|6235370|P11|STARTED|Period 2 - Second Intervention||1
2544130|NCT00583908|6235371|P10|STARTED|Period 2 - Second Intervention||1
2544131|NCT00583908|6235372|P9|STARTED|Period 2 - Second Intervention||1
2544132|NCT00583908|6235373|P8|STARTED|Period 2 - Second Intervention||1
2544133|NCT00583908|6235374|P7|STARTED|Period 2 - Second Intervention||1
2544134|NCT00583908|6235375|P6|STARTED|Period 2 - Second Intervention||1
2544135|NCT00583908|6235376|P5|STARTED|Period 2 - Second Intervention||2
2544136|NCT00583908|6235377|P4|STARTED|Period 2 - Second Intervention||1
2544137|NCT00583908|6235378|P3|STARTED|Period 2 - Second Intervention||1
2544138|NCT00583908|6235379|P2|STARTED|Period 2 - Second Intervention||2
2544139|NCT00583908|6235380|P1|STARTED|Period 2 - Second Intervention||1
2544140|NCT00583908|6235369|P12|NOT COMPLETED|Period 1 - First Intervention||0
2544141|NCT00583908|6235370|P11|NOT COMPLETED|Period 1 - First Intervention||0
2544142|NCT00583908|6235371|P10|NOT COMPLETED|Period 1 - First Intervention||0
2544143|NCT00583908|6235372|P9|NOT COMPLETED|Period 1 - First Intervention||0
2544144|NCT00583908|6235373|P8|NOT COMPLETED|Period 1 - First Intervention||0
2544145|NCT00583908|6235374|P7|NOT COMPLETED|Period 1 - First Intervention||0
2544146|NCT00583908|6235375|P6|NOT COMPLETED|Period 1 - First Intervention||0
2544147|NCT00583908|6235376|P5|NOT COMPLETED|Period 1 - First Intervention||0
2544148|NCT00583908|6235377|P4|NOT COMPLETED|Period 1 - First Intervention||0
2544149|NCT00583908|6235378|P3|NOT COMPLETED|Period 1 - First Intervention||0
2544150|NCT00583908|6235379|P2|NOT COMPLETED|Period 1 - First Intervention||0
2544151|NCT00583908|6235380|P1|NOT COMPLETED|Period 1 - First Intervention||0
2544152|NCT00583908|6235369|P12|COMPLETED|Period 1 - First Intervention||1
2544153|NCT00583908|6235370|P11|COMPLETED|Period 1 - First Intervention||1
2544154|NCT00583908|6235371|P10|COMPLETED|Period 1 - First Intervention||1
2544155|NCT00583908|6235372|P9|COMPLETED|Period 1 - First Intervention||1
2544156|NCT00583908|6235373|P8|COMPLETED|Period 1 - First Intervention||1
2544157|NCT00583908|6235374|P7|COMPLETED|Period 1 - First Intervention||1
2544158|NCT00583908|6235375|P6|COMPLETED|Period 1 - First Intervention||1
2544159|NCT00583908|6235376|P5|COMPLETED|Period 1 - First Intervention||2
2544160|NCT00583908|6235377|P4|COMPLETED|Period 1 - First Intervention||1
2544161|NCT00583908|6235378|P3|COMPLETED|Period 1 - First Intervention||1
2544162|NCT00583908|6235379|P2|COMPLETED|Period 1 - First Intervention||2
2544163|NCT00583908|6235380|P1|COMPLETED|Period 1 - First Intervention||1
2544164|NCT00583908|6235369|P12|STARTED|Period 1 - First Intervention||1
2544165|NCT00583908|6235370|P11|STARTED|Period 1 - First Intervention||1
2544166|NCT00583908|6235371|P10|STARTED|Period 1 - First Intervention||1
2544167|NCT00583908|6235372|P9|STARTED|Period 1 - First Intervention||1
2544168|NCT00583908|6235373|P8|STARTED|Period 1 - First Intervention||1
2544169|NCT00583908|6235374|P7|STARTED|Period 1 - First Intervention||1
2544170|NCT00583908|6235375|P6|STARTED|Period 1 - First Intervention||1
2544171|NCT00583908|6235376|P5|STARTED|Period 1 - First Intervention||2
2544172|NCT00583908|6235377|P4|STARTED|Period 1 - First Intervention||1
2544173|NCT00583908|6235378|P3|STARTED|Period 1 - First Intervention||1
2544174|NCT00583908|6235379|P2|STARTED|Period 1 - First Intervention||2
2544175|NCT00583908|6235380|P1|STARTED|Period 1 - First Intervention||1
2544176|NCT00583804|6235434|P1|NOT COMPLETED|Overall Study||0
2544177|NCT00583804|6235434|P1|COMPLETED|Overall Study|Subjects were considered enrolled when they underwent implantation of the device. All completed.|10
2544178|NCT00583804|6235434|P1|STARTED|Overall Study||10
2544179|NCT00583791|6235440|P1|NOT COMPLETED|Overall Study||73
2544180|NCT00583791|6235440|P1|COMPLETED|Overall Study||18
2544181|NCT00583791|6235440|P1|STARTED|Overall Study||91
2544182|NCT00583713|6235447|P3|NOT COMPLETED|Overall Study||0
2544183|NCT00583713|6235448|P2|NOT COMPLETED|Overall Study||0
2544184|NCT00583713|6235449|P1|NOT COMPLETED|Overall Study||0
2544185|NCT00583713|6235447|P3|COMPLETED|Overall Study||6
2544186|NCT00583713|6235448|P2|COMPLETED|Overall Study||6
2544187|NCT00583713|6235449|P1|COMPLETED|Overall Study||6
2544188|NCT00583713|6235447|P3|STARTED|Overall Study||6
2544189|NCT00583713|6235448|P2|STARTED|Overall Study||6
2544190|NCT00583713|6235449|P1|STARTED|Overall Study||6
2544191|NCT00583700|6235474|P2|NOT COMPLETED|Overall Study||4
2544192|NCT00583700|6235475|P1|NOT COMPLETED|Overall Study||3
2544193|NCT00583700|6235474|P2|COMPLETED|Overall Study||23
2544194|NCT00583700|6235475|P1|COMPLETED|Overall Study||24
2544195|NCT00583700|6235474|P2|STARTED|Overall Study||27
2544196|NCT00583700|6235475|P1|STARTED|Overall Study||27
2544197|NCT00583661|6235483|P1|NOT COMPLETED|Overall Study||0
2544198|NCT00583661|6235483|P1|COMPLETED|Overall Study||48
2544199|NCT00583661|6235483|P1|STARTED|Overall Study||48
2544200|NCT00583622|6235490|P1|NOT COMPLETED|Overall Study||0
2544201|NCT00583622|6235490|P1|COMPLETED|Overall Study||12
2544202|NCT00583622|6235490|P1|STARTED|Overall Study||12
2544203|NCT00583596|6235495|P1|NOT COMPLETED|Overall Study||284
2544204|NCT00583596|6235495|P1|COMPLETED|Overall Study||152
2544205|NCT00583596|6235495|P1|STARTED|Overall Study|Subjects in Phase 2 clinical trial who received the AMPLATZER Duct Occluder.|436
2544206|NCT00583557|6235500|P1|NOT COMPLETED|Overall Study||70
2544207|NCT00583557|6235500|P1|COMPLETED|Overall Study|Completer defined as subjects whose reason for discontinuation was sponsor discontinuation of study|85
2544208|NCT00583557|6235500|P1|Received at Least 1 Dose Belimumab|Overall Study||153
2544209|NCT00583557|6235500|P1|STARTED|Overall Study||155
2544210|NCT00583492|6235506|P2|NOT COMPLETED|Overall Study||0
2544211|NCT00583492|6235507|P1|NOT COMPLETED|Overall Study||0
2544212|NCT00583492|6235506|P2|COMPLETED|Overall Study||23
2544213|NCT00583492|6235507|P1|COMPLETED|Overall Study||21
2544214|NCT00583492|6235506|P2|STARTED|Overall Study||23
2544215|NCT00583492|6235507|P1|STARTED|Overall Study||21
2544216|NCT00583466|6235523|P1|NOT COMPLETED|Overall Study||0
2544217|NCT00583466|6235523|P1|COMPLETED|Overall Study||18
2544218|NCT00583466|6235523|P1|STARTED|Overall Study||18
2544219|NCT00583453|6235531|P2|NOT COMPLETED|Overall Study||2
2544220|NCT00583453|6235532|P1|NOT COMPLETED|Overall Study||0
2544221|NCT00583453|6235531|P2|COMPLETED|Overall Study||6
2544222|NCT00583453|6235532|P1|COMPLETED|Overall Study||9
2544223|NCT00583453|6235531|P2|STARTED|Overall Study||8
2544224|NCT00583453|6235532|P1|STARTED|Overall Study||9
2544225|NCT00583414|6235546|P1|NOT COMPLETED|Overall Study||0
2544226|NCT00583414|6235546|P1|COMPLETED|Overall Study||401
2544227|NCT00583414|6235546|P1|STARTED|Overall Study||401
2544228|NCT00583375|6235552|P2|NOT COMPLETED|Overall Study||0
2544229|NCT00583375|6235553|P1|NOT COMPLETED|Overall Study||0
2544230|NCT00583375|6235552|P2|COMPLETED|Overall Study||272
2544231|NCT00583375|6235553|P1|COMPLETED|Overall Study||142
2544232|NCT00583375|6235552|P2|STARTED|Overall Study||272
2544233|NCT00583375|6235553|P1|STARTED|Overall Study||142
2544234|NCT00583362|6235569|P1|NOT COMPLETED|Overall Study||202
2544235|NCT00583362|6235569|P1|COMPLETED|Overall Study||96
2544236|NCT00583362|6235569|P1|STARTED|Overall Study||298
2544237|NCT00583219|6235593|P1|NOT COMPLETED|Phase 2||1
2544238|NCT00583219|6235593|P1|COMPLETED|Phase 2||21
2544239|NCT00583219|6235593|P1|STARTED|Phase 2|6 subjects from P1 continued in P2; plus 16 new subjects. All subjects in P2 got 300 units Botox.|22
2544240|NCT00583219|6235593|P1|NOT COMPLETED|Phase 1||0
2544241|NCT00583219|6235593|P1|COMPLETED|Phase 1||9
2544242|NCT00583219|6235593|P1|STARTED|Phase 1|First 3 subjects in Phase 1 received 200 units Botox. The remaining subjects got 300 units Botox.|9
2544243|NCT00583115|6235610|P1|NOT COMPLETED|Overall Study||1
2544244|NCT00583115|6235610|P1|COMPLETED|Overall Study||0
2544245|NCT00583115|6235610|P1|STARTED|Overall Study||1
2544246|NCT00583102|6235615|P1|NOT COMPLETED|Overall Study||3
2544247|NCT00583102|6235615|P1|COMPLETED|Overall Study||20
2544248|NCT00583102|6235615|P1|STARTED|Overall Study||23
2544249|NCT00582998|6235621|P2|NOT COMPLETED|Overall Study||0
2544250|NCT00582998|6235622|P1|NOT COMPLETED|Overall Study||0
2544251|NCT00582998|6235621|P2|COMPLETED|Overall Study||130
2544252|NCT00582998|6235622|P1|COMPLETED|Overall Study||119
2544253|NCT00582998|6235621|P2|STARTED|Overall Study||130
2544254|NCT00582998|6235622|P1|STARTED|Overall Study||119
2544255|NCT00582972|6235628|P1|NOT COMPLETED|Overall Study||2
2544256|NCT00582972|6235628|P1|COMPLETED|Overall Study||21
2544257|NCT00582972|6235628|P1|STARTED|Overall Study||23
2544258|NCT00582946|6235633|P1|NOT COMPLETED|Overall Study||0
2544259|NCT00582946|6235633|P1|COMPLETED|Overall Study||16
2544260|NCT00582946|6235633|P1|STARTED|Overall Study||16
2544261|NCT00582933|6235637|P1|NOT COMPLETED|Overall Study||3
2544262|NCT00582933|6235637|P1|COMPLETED|Overall Study||92
2544263|NCT00582933|6235637|P1|STARTED|Overall Study||95
2544264|NCT00582907|6235641|P4|NOT COMPLETED|4th Course||0
2544265|NCT00582907|6235642|P3|NOT COMPLETED|4th Course||0
2544266|NCT00582907|6235643|P2|NOT COMPLETED|4th Course||0
2544267|NCT00582907|6235644|P1|NOT COMPLETED|4th Course||0
2544268|NCT00582907|6235641|P4|COMPLETED|4th Course||3
2544269|NCT00582907|6235642|P3|COMPLETED|4th Course||3
2544270|NCT00582907|6235643|P2|COMPLETED|4th Course||3
2544271|NCT00582907|6235644|P1|COMPLETED|4th Course||2
2544272|NCT00582907|6235641|P4|STARTED|4th Course||3
2544273|NCT00582907|6235642|P3|STARTED|4th Course||3
2544274|NCT00582907|6235643|P2|STARTED|4th Course||3
2544275|NCT00582907|6235644|P1|STARTED|4th Course||2
2544276|NCT00582907|6235641|P4|NOT COMPLETED|3rd Course||0
2544277|NCT00582907|6235642|P3|NOT COMPLETED|3rd Course||0
2544278|NCT00582907|6235643|P2|NOT COMPLETED|3rd Course||0
2544279|NCT00582907|6235644|P1|NOT COMPLETED|3rd Course||0
2544280|NCT00582907|6235641|P4|COMPLETED|3rd Course||3
2544281|NCT00582907|6235642|P3|COMPLETED|3rd Course||3
2544282|NCT00582907|6235643|P2|COMPLETED|3rd Course||3
2544283|NCT00582907|6235644|P1|COMPLETED|3rd Course||2
2544284|NCT00582907|6235641|P4|STARTED|3rd Course||3
2544285|NCT00582907|6235642|P3|STARTED|3rd Course||3
2544286|NCT00582907|6235643|P2|STARTED|3rd Course||3
2544287|NCT00582907|6235644|P1|STARTED|3rd Course||2
2544288|NCT00582907|6235641|P4|NOT COMPLETED|2nd Course||0
2544289|NCT00582907|6235642|P3|NOT COMPLETED|2nd Course||0
2544290|NCT00582907|6235643|P2|NOT COMPLETED|2nd Course||0
2544291|NCT00582907|6235644|P1|NOT COMPLETED|2nd Course||1
2544292|NCT00582907|6235641|P4|COMPLETED|2nd Course||3
2544293|NCT00582907|6235642|P3|COMPLETED|2nd Course||3
2544294|NCT00582907|6235643|P2|COMPLETED|2nd Course||3
2544295|NCT00582907|6235644|P1|COMPLETED|2nd Course||2
2544296|NCT00582907|6235641|P4|STARTED|2nd Course||3
2544297|NCT00582907|6235642|P3|STARTED|2nd Course||3
2544298|NCT00582907|6235643|P2|STARTED|2nd Course||3
2544299|NCT00582907|6235644|P1|STARTED|2nd Course||3
2544300|NCT00582907|6235641|P4|NOT COMPLETED|1st Course||1
2544301|NCT00582907|6235642|P3|NOT COMPLETED|1st Course||0
2544302|NCT00582907|6235643|P2|NOT COMPLETED|1st Course||0
2544303|NCT00582907|6235644|P1|NOT COMPLETED|1st Course||1
2544304|NCT00582907|6235641|P4|COMPLETED|1st Course|Patient lost to follow-up towards end of 1st course|3
2544305|NCT00582907|6235642|P3|COMPLETED|1st Course||3
2544306|NCT00582907|6235643|P2|COMPLETED|1st Course||3
2544307|NCT00582907|6235644|P1|COMPLETED|1st Course|1 left after 1st course (transportation issues)|3
2544308|NCT00582907|6235641|P4|STARTED|1st Course||4
2544309|NCT00582907|6235642|P3|STARTED|1st Course||3
2544310|NCT00582907|6235643|P2|STARTED|1st Course||3
2544311|NCT00582907|6235644|P1|STARTED|1st Course||4
2544312|NCT00582894|6235676|P1|NOT COMPLETED|Overall Study||0
2544313|NCT00582894|6235676|P1|COMPLETED|Overall Study||17
2544314|NCT00582894|6235676|P1|Day 100 Post Transplant|Overall Study||17
2544315|NCT00582894|6235676|P1|STARTED|Overall Study||17
2544316|NCT00582816|6235683|P1|NOT COMPLETED|Overall Study||3
2544317|NCT00582816|6235683|P1|COMPLETED|Overall Study|"Completed here means patients stably engrafted with donor cells."|6
2544318|NCT00582816|6235683|P1|STARTED|Overall Study||9
2544319|NCT00582790|6235693|P1|NOT COMPLETED|Overall Study||1
2544320|NCT00582790|6235693|P1|COMPLETED|Overall Study||11
2544321|NCT00582790|6235693|P1|STARTED|Overall Study|only 11 of the 12 patients received study treatment.|12
2544322|NCT00582738|6235702|P2|NOT COMPLETED|Overall Study||18
2544323|NCT00582738|6235703|P1|NOT COMPLETED|Overall Study||9
2544324|NCT00582738|6235702|P2|COMPLETED|Overall Study||4
2544325|NCT00582738|6235703|P1|COMPLETED|Overall Study||12
2544326|NCT00582738|6235702|P2|STARTED|Overall Study||22
2544327|NCT00582738|6235703|P1|STARTED|Overall Study||21
2544328|NCT00582712|6235727|P1|NOT COMPLETED|Overall Study||4
2544329|NCT00582712|6235727|P1|COMPLETED|Overall Study||1
2544330|NCT00582712|6235727|P1|STARTED|Overall Study||5
2544331|NCT00582660|6235733|P2|NOT COMPLETED|Overall Study||0
2544332|NCT00582660|6235734|P1|NOT COMPLETED|Overall Study||0
2544333|NCT00582660|6235733|P2|COMPLETED|Overall Study||20
2544334|NCT00582660|6235734|P1|COMPLETED|Overall Study||20
2544335|NCT00582660|6235733|P2|STARTED|Overall Study||20
2544336|NCT00582660|6235734|P1|STARTED|Overall Study||20
2544337|NCT00582608|6235742|P1|NOT COMPLETED|Overall Study||12
2544338|NCT00582608|6235742|P1|COMPLETED|Overall Study||0
2544339|NCT00582608|6235742|P1|STARTED|Overall Study||12
2544340|NCT00582556|6235749|P3|NOT COMPLETED|Overall Study||2
2544341|NCT00582556|6235750|P2|NOT COMPLETED|Overall Study||1
2544342|NCT00582556|6235751|P1|NOT COMPLETED|Overall Study||0
2544343|NCT00582556|6235749|P3|COMPLETED|Overall Study||12
2544344|NCT00582556|6235750|P2|COMPLETED|Overall Study||14
2544345|NCT00582556|6235751|P1|COMPLETED|Overall Study||14
2544346|NCT00582556|6235749|P3|STARTED|Overall Study||14
2544347|NCT00582556|6235750|P2|STARTED|Overall Study||15
2544348|NCT00582556|6235751|P1|STARTED|Overall Study||14
2544349|NCT00582517|6235770|P2|NOT COMPLETED|Overall Study||0
2544350|NCT00582517|6235771|P1|NOT COMPLETED|Overall Study||0
2544351|NCT00582517|6235770|P2|COMPLETED|Overall Study||55
2544352|NCT00582517|6235771|P1|COMPLETED|Overall Study||45
2544353|NCT00582517|6235770|P2|STARTED|Overall Study||55
2544354|NCT00582517|6235771|P1|STARTED|Overall Study||45
2544355|NCT00582491|6235779|P2|NOT COMPLETED|Overall Study||0
2544356|NCT00582491|6235780|P1|NOT COMPLETED|Overall Study||1
2544357|NCT00582491|6235779|P2|COMPLETED|Overall Study||10
2544358|NCT00582491|6235780|P1|COMPLETED|Overall Study||10
2544359|NCT00582491|6235779|P2|STARTED|Overall Study||10
2544360|NCT00582491|6235780|P1|STARTED|Overall Study||11
2544361|NCT00582426|6235804|P2|NOT COMPLETED|Overall Study||13
2544362|NCT00582426|6235805|P1|NOT COMPLETED|Overall Study||20
2544363|NCT00582426|6235804|P2|COMPLETED|Overall Study||58
2544364|NCT00582426|6235805|P1|COMPLETED|Overall Study||48
2544365|NCT00582426|6235804|P2|STARTED|Overall Study||71
2544366|NCT00582426|6235805|P1|STARTED|Overall Study|"Patient in both arms belongs to started indicates safety and intent to treat (ITT) populations."|68
2544367|NCT00582400|6235831|P1|NOT COMPLETED|Overall Study||3
2544368|NCT00582400|6235831|P1|COMPLETED|Overall Study||6
2544369|NCT00582400|6235831|P1|STARTED|Overall Study||9
2544370|NCT00582361|6235840|P2|NOT COMPLETED|Overall Study||0
2544371|NCT00582361|6235841|P1|NOT COMPLETED|Overall Study||0
2544372|NCT00582361|6235840|P2|COMPLETED|Overall Study||38
2544373|NCT00582361|6235841|P1|COMPLETED|Overall Study||25
2544374|NCT00582361|6235840|P2|STARTED|Overall Study||38
2544375|NCT00582361|6235841|P1|STARTED|Overall Study||25
2544376|NCT00582309|6235852|P3|NOT COMPLETED|Overall Study||2
2544377|NCT00582309|6235853|P2|NOT COMPLETED|Overall Study||0
2544378|NCT00582309|6235854|P1|NOT COMPLETED|Overall Study||0
2544379|NCT00582309|6235852|P3|COMPLETED|Overall Study|2 did not have enough data collected to be used|44
2544380|NCT00582309|6235853|P2|COMPLETED|Overall Study||49
2544381|NCT00582309|6235854|P1|COMPLETED|Overall Study||56
2544382|NCT00582309|6235852|P3|STARTED|Overall Study||46
2544383|NCT00582309|6235853|P2|STARTED|Overall Study||49
2544384|NCT00582309|6235854|P1|STARTED|Overall Study||56
2544385|NCT00582205|6235862|P1|NOT COMPLETED|Overall Study||10
2544386|NCT00582205|6235862|P1|COMPLETED|Overall Study||11
2544387|NCT00582205|6235862|P1|STARTED|Overall Study||21
2544388|NCT00582166|6235867|P1|NOT COMPLETED|Overall Study||2
2544389|NCT00582166|6235867|P1|COMPLETED|Overall Study||16
2544390|NCT00582166|6235867|P1|STARTED|Overall Study||18
2544391|NCT00582114|6235877|P2|NOT COMPLETED|Overall Study||54
2544392|NCT00582114|6235878|P1|NOT COMPLETED|Overall Study||42
2544393|NCT00582114|6235877|P2|COMPLETED|Overall Study||46
2544394|NCT00582114|6235878|P1|COMPLETED|Overall Study||58
2544395|NCT00582114|6235877|P2|STARTED|Overall Study||100
2544396|NCT00582114|6235878|P1|STARTED|Overall Study||100
2544397|NCT00582075|6235886|P1|NOT COMPLETED|Overall Study||0
2544398|NCT00582075|6235886|P1|COMPLETED|Overall Study||25
2544399|NCT00582075|6235886|P1|STARTED|Overall Study||25
2544400|NCT00582036|6235893|P2|NOT COMPLETED|Overall Study||1
2544401|NCT00582036|6235894|P1|NOT COMPLETED|Overall Study||0
2544402|NCT00582036|6235893|P2|COMPLETED|Overall Study|One patient withdrew consent|5
2544403|NCT00582036|6235894|P1|COMPLETED|Overall Study||5
2544404|NCT00582036|6235893|P2|STARTED|Overall Study||6
2544405|NCT00582036|6235894|P1|STARTED|Overall Study||5
2544406|NCT00582010|6235902|P2|NOT COMPLETED|Overall Study||1
2544407|NCT00582010|6235903|P1|NOT COMPLETED|Overall Study||0
2544408|NCT00582010|6235902|P2|COMPLETED|Overall Study||39
2544409|NCT00582010|6235903|P1|COMPLETED|Overall Study||40
2544410|NCT00582010|6235902|P2|STARTED|Overall Study||40
2544411|NCT00582010|6235903|P1|STARTED|Overall Study||40
2544412|NCT00581971|6235925|P1|NOT COMPLETED|Overall Study||0
2544413|NCT00581971|6235925|P1|COMPLETED|Overall Study||30
2544414|NCT00581971|6235925|P1|STARTED|Overall Study||30
2544415|NCT00581945|6235932|P2|NOT COMPLETED|Overall Study||10
2544416|NCT00581945|6235933|P1|NOT COMPLETED|Overall Study||9
2544417|NCT00581945|6235932|P2|COMPLETED|Overall Study||63
2544418|NCT00581945|6235933|P1|COMPLETED|Overall Study||65
2544419|NCT00581945|6235932|P2|STARTED|Overall Study||73
2544420|NCT00581945|6235933|P1|STARTED|Overall Study||74
2544421|NCT00581919|6235949|P1|NOT COMPLETED|Overall Study||24
2544422|NCT00581919|6235949|P1|COMPLETED|Overall Study||8
2544423|NCT00581919|6235949|P1|STARTED|Overall Study||32
2544424|NCT00581867|6235955|P2|NOT COMPLETED|Second Intervention||0
2544425|NCT00581867|6235956|P1|NOT COMPLETED|Second Intervention||0
2544426|NCT00581867|6235955|P2|COMPLETED|Second Intervention||14
2544427|NCT00581867|6235956|P1|COMPLETED|Second Intervention||15
2544428|NCT00581867|6235955|P2|STARTED|Second Intervention|1 individual completed period 1 (Intranasal Insulin) but did not complete period 2 (Placebo).|14
2544429|NCT00581867|6235956|P1|STARTED|Second Intervention|n=1 completed period 1 (placebo) but not period 2 (insulin). This individuals died between periods.|15
2544430|NCT00581867|6235955|P2|NOT COMPLETED|First Intervention||0
2544431|NCT00581867|6235956|P1|NOT COMPLETED|First Intervention||0
2544432|NCT00581867|6235955|P2|COMPLETED|First Intervention||15
2544433|NCT00581867|6235956|P1|COMPLETED|First Intervention||16
2544434|NCT00581867|6235955|P2|STARTED|First Intervention||15
2544435|NCT00581867|6235956|P1|STARTED|First Intervention||16
2544436|NCT00581854|6235964|P1|NOT COMPLETED|Overall Study||0
2544437|NCT00581854|6235964|P1|COMPLETED|Overall Study||22
2544438|NCT00581854|6235964|P1|STARTED|Overall Study||22
2544439|NCT00581828|6235968|P1|NOT COMPLETED|Overall Study||1
2544440|NCT00581828|6235968|P1|COMPLETED|Overall Study||18
2544441|NCT00581828|6235968|P1|STARTED|Overall Study||19
2544442|NCT00581776|6235972|P1|NOT COMPLETED|Overall Study||3
2544443|NCT00581776|6235972|P1|COMPLETED|Overall Study|3 subjects did not complete the planned induction chemotherapy.|27
2544444|NCT00581776|6235972|P1|STARTED|Overall Study||30
2544445|NCT00581581|6235981|P2|NOT COMPLETED|Overall Study||0
2544446|NCT00581581|6235982|P1|NOT COMPLETED|Overall Study||0
2544447|NCT00581581|6235981|P2|COMPLETED|Overall Study||30
2544448|NCT00581581|6235982|P1|COMPLETED|Overall Study||32
2544449|NCT00581581|6235981|P2|STARTED|Overall Study||30
2544450|NCT00581581|6235982|P1|STARTED|Overall Study||32
2544451|NCT00581555|6235990|P2|NOT COMPLETED|Overall Study||20
2544452|NCT00581555|6235991|P1|NOT COMPLETED|Overall Study||43
2544453|NCT00581555|6235990|P2|COMPLETED|Overall Study||38
2544454|NCT00581555|6235991|P1|COMPLETED|Overall Study||19
2544455|NCT00581555|6235990|P2|STARTED|Overall Study||58
2544456|NCT00581555|6235991|P1|STARTED|Overall Study||62
2544457|NCT00581542|6236015|P2|NOT COMPLETED|Overall Study||23
2544458|NCT00581542|6236016|P1|NOT COMPLETED|Overall Study||11
2544459|NCT00581542|6236015|P2|COMPLETED|Overall Study||39
2544460|NCT00581542|6236016|P1|COMPLETED|Overall Study||51
2544461|NCT00581542|6236015|P2|STARTED|Overall Study||62
2544462|NCT00581542|6236016|P1|STARTED|Overall Study||62
2544463|NCT00581529|6236024|P1|NOT COMPLETED|Overall Study||0
2544464|NCT00581529|6236024|P1|COMPLETED|Overall Study||34
2544465|NCT00581529|6236024|P1|STARTED|Overall Study||34
2544466|NCT00581399|6236033|P2|NOT COMPLETED|Overall Study||0
2544467|NCT00581399|6236034|P1|NOT COMPLETED|Overall Study||0
2544468|NCT00581399|6236033|P2|COMPLETED|Overall Study||48
2544469|NCT00581399|6236034|P1|COMPLETED|Overall Study||46
2544470|NCT00581399|6236033|P2|STARTED|Overall Study||48
2544471|NCT00581399|6236034|P1|STARTED|Overall Study||46
2544472|NCT00581386|6236045|P3|NOT COMPLETED|Overall Study||0
2544473|NCT00581386|6236046|P2|NOT COMPLETED|Overall Study||0
2544474|NCT00581386|6236047|P1|NOT COMPLETED|Overall Study||0
2544475|NCT00581386|6236045|P3|COMPLETED|Overall Study|04/15/2009|72
2544476|NCT00581386|6236046|P2|COMPLETED|Overall Study|04/15/2009|73
2544477|NCT00581386|6236047|P1|COMPLETED|Overall Study|04/15/2009|73
2544478|NCT00581386|6236045|P3|STARTED|Overall Study|05/30/2007|72
2544479|NCT00581386|6236046|P2|STARTED|Overall Study|05/30/2007|73
2544480|NCT00581386|6236047|P1|STARTED|Overall Study|05/30/2007|73
2544481|NCT00581360|6236070|P1|NOT COMPLETED|Overall Study||1
2544482|NCT00581360|6236070|P1|COMPLETED|Overall Study||9
2544483|NCT00581360|6236070|P1|STARTED|Overall Study||10
2544484|NCT00581347|6236080|P2|NOT COMPLETED|Overall Study||0
2544485|NCT00581347|6236081|P1|NOT COMPLETED|Overall Study||0
2544486|NCT00581347|6236080|P2|COMPLETED|Overall Study||3707
2544487|NCT00581347|6236081|P1|COMPLETED|Overall Study||3839
2544488|NCT00581347|6236080|P2|STARTED|Overall Study||3707
2544489|NCT00581347|6236081|P1|STARTED|Overall Study||3839
2544490|NCT00581308|6236089|P1|NOT COMPLETED|60 Months||3
2544491|NCT00581308|6236089|P1|COMPLETED|60 Months||158
2544492|NCT00581308|6236089|P1|STARTED|60 Months||161
2544493|NCT00581308|6236089|P1|NOT COMPLETED|48 Months||9
2544494|NCT00581308|6236089|P1|COMPLETED|48 Months||161
2544495|NCT00581308|6236089|P1|STARTED|48 Months||170
2544496|NCT00581308|6236089|P1|NOT COMPLETED|36 Months||6
2544497|NCT00581308|6236089|P1|COMPLETED|36 Months||170
2544498|NCT00581308|6236089|P1|STARTED|36 Months||176
2544499|NCT00581308|6236089|P1|NOT COMPLETED|24 Months||6
2544500|NCT00581308|6236089|P1|COMPLETED|24 Months||176
2544501|NCT00581308|6236089|P1|STARTED|24 Months||182
2544502|NCT00581308|6236089|P1|NOT COMPLETED|Month 12||20
2544503|NCT00581308|6236089|P1|COMPLETED|Month 12||182
2544504|NCT00581308|6236089|P1|STARTED|Month 12||202
2544505|NCT00581308|6236089|P1|NOT COMPLETED|Month 6||3
2544506|NCT00581308|6236089|P1|COMPLETED|Month 6||202
2544507|NCT00581308|6236089|P1|STARTED|Month 6||205
2544508|NCT00581308|6236089|P1|NOT COMPLETED|Month 1||8
2544509|NCT00581308|6236089|P1|COMPLETED|Month 1||205
2544510|NCT00581308|6236089|P1|STARTED|Month 1||213
2544511|NCT00581308|6236089|P1|NOT COMPLETED|Pre Discharge||2
2544512|NCT00581308|6236089|P1|COMPLETED|Pre Discharge||213
2544513|NCT00581308|6236089|P1|STARTED|Pre Discharge||215
2544514|NCT00581256|6236098|P2|NOT COMPLETED|Overall Study||0
2544515|NCT00581256|6236099|P1|NOT COMPLETED|Overall Study||0
2544516|NCT00581256|6236098|P2|COMPLETED|Overall Study||26
2544517|NCT00581256|6236099|P1|COMPLETED|Overall Study||28
2544518|NCT00581256|6236098|P2|STARTED|Overall Study||26
2544519|NCT00581256|6236099|P1|STARTED|Overall Study||28
2544520|NCT00581230|6236111|P1|NOT COMPLETED|Overall Study||0
2544521|NCT00581230|6236111|P1|COMPLETED|Overall Study||51
2544522|NCT00581230|6236111|P1|Laryngoscopy With RAMP|Overall Study||51
2544523|NCT00581230|6236111|P1|Laryngoscopy Without RAMP|Overall Study||51
2544524|NCT00581230|6236111|P1|STARTED|Overall Study||51
2544525|NCT00581113|6236120|P2|NOT COMPLETED|Overall Study||1
2544526|NCT00581113|6236121|P1|NOT COMPLETED|Overall Study||0
2544527|NCT00581113|6236120|P2|COMPLETED|Overall Study||3
2544528|NCT00581113|6236121|P1|COMPLETED|Overall Study||4
2544529|NCT00581113|6236120|P2|STARTED|Overall Study||4
2544530|NCT00581113|6236121|P1|STARTED|Overall Study||4
2544531|NCT00581100|6236131|P2|NOT COMPLETED|Overall Study||5
2544532|NCT00581100|6236132|P1|NOT COMPLETED|Overall Study||7
2544533|NCT00581100|6236131|P2|COMPLETED|Overall Study||29
2544534|NCT00581100|6236132|P1|COMPLETED|Overall Study||31
2544535|NCT00581100|6236131|P2|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|33
2544536|NCT00581100|6236132|P1|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|36
2544537|NCT00581100|6236131|P2|STARTED|Overall Study||34
2544538|NCT00581100|6236132|P1|STARTED|Overall Study||38
2544539|NCT00581061|6236168|P1|NOT COMPLETED|Overall Study||0
2544540|NCT00581061|6236168|P1|COMPLETED|Overall Study||13
2544541|NCT00581061|6236168|P1|STARTED|Overall Study||13
2544542|NCT00581048|6236174|P1|NOT COMPLETED|Overall Study||0
2544543|NCT00581048|6236174|P1|COMPLETED|Overall Study||33
2544544|NCT00581048|6236174|P1|STARTED|Overall Study||33
2544545|NCT00580983|6236185|P1|NOT COMPLETED|Overall Study||7
2544546|NCT00580983|6236185|P1|COMPLETED|Overall Study||73
2544547|NCT00580983|6236185|P1|STARTED|Overall Study||80
2544548|NCT00580970|6236192|P1|NOT COMPLETED|Treatment (Lovastatin)||19
2544549|NCT00580970|6236192|P1|COMPLETED|Treatment (Lovastatin)||53
2544550|NCT00580970|6236192|P1|6 Months of Treatment|Treatment (Lovastatin)|Subjects evaluable for analysis|53
2544551|NCT00580970|6236192|P1|STARTED|Treatment (Lovastatin)||72
2544552|NCT00580970|6236192|P1|NOT COMPLETED|Pre-treatment||1
2544553|NCT00580970|6236192|P1|COMPLETED|Pre-treatment||72
2544554|NCT00580970|6236192|P1|STARTED|Pre-treatment||73
2544555|NCT00580957|6236198|P2|NOT COMPLETED|Overall Study||7
2544556|NCT00580957|6236199|P1|NOT COMPLETED|Overall Study||7
2544557|NCT00580957|6236198|P2|COMPLETED|Overall Study||21
2544558|NCT00580957|6236199|P1|COMPLETED|Overall Study||21
2544559|NCT00580957|6236198|P2|STARTED|Overall Study||28
2544560|NCT00580957|6236199|P1|STARTED|Overall Study||28
2544561|NCT00580866|6236207|P2|NOT COMPLETED|Overall Study||2
2544562|NCT00580866|6236208|P1|NOT COMPLETED|Overall Study||2
2544563|NCT00580866|6236207|P2|COMPLETED|Overall Study||5
2544564|NCT00580866|6236208|P1|COMPLETED|Overall Study||8
2544565|NCT00580866|6236207|P2|STARTED|Overall Study||7
2544566|NCT00580866|6236208|P1|STARTED|Overall Study||10
2544567|NCT00580853|6236219|P3|NOT COMPLETED|Overall Study||0
2544568|NCT00580853|6236220|P2|NOT COMPLETED|Overall Study||0
2544569|NCT00580853|6236221|P1|NOT COMPLETED|Overall Study||0
2544570|NCT00580853|6236219|P3|COMPLETED|Overall Study||21
2544571|NCT00580853|6236220|P2|COMPLETED|Overall Study||21
2544572|NCT00580853|6236221|P1|COMPLETED|Overall Study||20
2544573|NCT00580853|6236219|P3|STARTED|Overall Study||21
2544574|NCT00580853|6236220|P2|STARTED|Overall Study||21
2544575|NCT00580853|6236221|P1|STARTED|Overall Study||20
2544576|NCT00580840|6236232|P4|NOT COMPLETED|Double-Blind||15
2544577|NCT00580840|6236233|P3|NOT COMPLETED|Double-Blind||9
2544578|NCT00580840|6236234|P2|NOT COMPLETED|Double-Blind||7
2544579|NCT00580840|6236235|P1|NOT COMPLETED|Double-Blind||0
2544580|NCT00580840|6236232|P4|COMPLETED|Double-Blind||54
2544581|NCT00580840|6236233|P3|COMPLETED|Double-Blind||61
2544582|NCT00580840|6236234|P2|COMPLETED|Double-Blind||63
2544583|NCT00580840|6236235|P1|COMPLETED|Double-Blind||0
2544584|NCT00580840|6236232|P4|STARTED|Double-Blind||69
2544585|NCT00580840|6236233|P3|STARTED|Double-Blind||70
2544586|NCT00580840|6236234|P2|STARTED|Double-Blind||70
2544587|NCT00580840|6236235|P1|STARTED|Double-Blind||0
2544588|NCT00580840|6236232|P4|NOT COMPLETED|Run-in||0
2544589|NCT00580840|6236233|P3|NOT COMPLETED|Run-in||0
2544590|NCT00580840|6236234|P2|NOT COMPLETED|Run-in||0
2544591|NCT00580840|6236235|P1|NOT COMPLETED|Run-in||124
2544592|NCT00580840|6236232|P4|COMPLETED|Run-in||0
2544593|NCT00580840|6236233|P3|COMPLETED|Run-in||0
2544594|NCT00580840|6236234|P2|COMPLETED|Run-in||0
2544595|NCT00580840|6236235|P1|COMPLETED|Run-in|Of the 209 randomized participants, 208 are in the Full Analysis Set (FAS).|209
2544596|NCT00580840|6236232|P4|STARTED|Run-in||0
2544597|NCT00580840|6236233|P3|STARTED|Run-in||0
2544598|NCT00580840|6236234|P2|STARTED|Run-in||0
2544599|NCT00580840|6236235|P1|STARTED|Run-in|620 subjects were screened for the study with 333 being enrolled.|333
2544600|NCT00580801|6236343|P3|NOT COMPLETED|Overall Study||3
2544601|NCT00580801|6236344|P2|NOT COMPLETED|Overall Study||1
2544602|NCT00580801|6236345|P1|NOT COMPLETED|Overall Study||6
2544603|NCT00580801|6236343|P3|COMPLETED|Overall Study||5
2544604|NCT00580801|6236344|P2|COMPLETED|Overall Study||7
2544605|NCT00580801|6236345|P1|COMPLETED|Overall Study||2
2544606|NCT00580801|6236343|P3|STARTED|Overall Study||8
2544607|NCT00580801|6236344|P2|STARTED|Overall Study||8
2544608|NCT00580801|6236345|P1|STARTED|Overall Study||8
2544609|NCT00580788|6236384|P4|NOT COMPLETED|Overall Study||1
2544610|NCT00580788|6236385|P3|NOT COMPLETED|Overall Study||0
2544611|NCT00580788|6236386|P2|NOT COMPLETED|Overall Study||0
2544612|NCT00580788|6236387|P1|NOT COMPLETED|Overall Study||0
2544613|NCT00580788|6236384|P4|COMPLETED|Overall Study|One subject was stopped early for hypertension. One subject completed but was not analyzed.|1
2544614|NCT00580788|6236385|P3|COMPLETED|Overall Study||3
2544615|NCT00580788|6236386|P2|COMPLETED|Overall Study||6
2544616|NCT00580788|6236387|P1|COMPLETED|Overall Study||3
2544617|NCT00580788|6236384|P4|STARTED|Overall Study||2
2544618|NCT00580788|6236385|P3|STARTED|Overall Study||3
2544619|NCT00580788|6236386|P2|STARTED|Overall Study||6
2544620|NCT00580788|6236387|P1|STARTED|Overall Study||3
2544621|NCT00580723|6236445|P1|NOT COMPLETED|Overall Study||8
2544622|NCT00580723|6236445|P1|COMPLETED|Overall Study||16
2544623|NCT00580723|6236445|P1|STARTED|Overall Study||24
2544624|NCT00580671|6236454|P3|NOT COMPLETED|Overall Study||17
2544625|NCT00580671|6236455|P2|NOT COMPLETED|Overall Study||16
2544626|NCT00580671|6236456|P1|NOT COMPLETED|Overall Study||16
2544627|NCT00580671|6236454|P3|COMPLETED|Overall Study||34
2544628|NCT00580671|6236455|P2|COMPLETED|Overall Study||35
2544629|NCT00580671|6236456|P1|COMPLETED|Overall Study||35
2544630|NCT00580671|6236454|P3|STARTED|Overall Study||51
2544631|NCT00580671|6236455|P2|STARTED|Overall Study||51
2544632|NCT00580671|6236456|P1|STARTED|Overall Study||51
2544633|NCT00580645|6236473|P3|NOT COMPLETED|Overall Study||0
2544634|NCT00580645|6236474|P2|NOT COMPLETED|Overall Study||0
2544635|NCT00580645|6236475|P1|NOT COMPLETED|Overall Study||0
2544636|NCT00580645|6236473|P3|COMPLETED|Overall Study||20
2544637|NCT00580645|6236474|P2|COMPLETED|Overall Study||20
2544638|NCT00580645|6236475|P1|COMPLETED|Overall Study||20
2544639|NCT00580645|6236473|P3|STARTED|Overall Study||20
2544640|NCT00580645|6236474|P2|STARTED|Overall Study||20
2544641|NCT00580645|6236475|P1|STARTED|Overall Study||20
2544642|NCT00580606|6236488|P2|NOT COMPLETED|Open Label (OL)||12
2544643|NCT00580606|6236489|P1|NOT COMPLETED|Open Label (OL)||9
2544644|NCT00580606|6236488|P2|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|5
2544645|NCT00580606|6236489|P1|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|9
2544646|NCT00580606|6236488|P2|Had Week 172 Oral Food Challenge|Open Label (OL)||2
2544647|NCT00580606|6236489|P1|Had Week 172 Oral Food Challenge|Open Label (OL)||2
2544648|NCT00580606|6236488|P2|Had Week 164 Oral Food Challenge|Open Label (OL)||5
2544649|NCT00580606|6236489|P1|Had Week 164 Oral Food Challenge|Open Label (OL)||9
2544650|NCT00580606|6236488|P2|Had Week 116 Oral Food Challenge|Open Label (OL)||6
2544651|NCT00580606|6236489|P1|Had Week 116 Oral Food Challenge|Open Label (OL)||13
2544652|NCT00580606|6236488|P2|Had Week 68 Oral Food Challenge|Open Label (OL)||12
2544653|NCT00580606|6236489|P1|Had Week 68 Oral Food Challenge|Open Label (OL)||15
2544654|NCT00580606|6236488|P2|Had Week 44 Oral Food Challenge|Open Label (OL)|After 44 weeks of OL high dose SLIT; 1 additional participant declined Week 44 OFC in OL period.|12
2544655|NCT00580606|6236489|P1|Had Week 44 Oral Food Challenge|Open Label (OL)|The Week 44 OFC for Low Dose Peanut SLIT was done at the end of the DB Period, not the OL period.|0
2544656|NCT00580606|6236488|P2|STARTED|Open Label (OL)|1 participant discontinued dosing before OL period; 2 passed Week 44 OFC & ineligible to crossover.|17
2544657|NCT00580606|6236489|P1|STARTED|Open Label (OL)|2 participants discontinued dosing before Open Label (OL) period.|18
2544658|NCT00580606|6236488|P2|NOT COMPLETED|Double Blind (DB)||0
2544659|NCT00580606|6236489|P1|NOT COMPLETED|Double Blind (DB)||0
2544660|NCT00580606|6236488|P2|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
2544661|NCT00580606|6236489|P1|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
2544662|NCT00580606|6236488|P2|Had Week 44 Oral Food Challenge|Double Blind (DB)||19
2544663|NCT00580606|6236489|P1|Had Week 44 Oral Food Challenge|Double Blind (DB)||18
2544664|NCT00580606|6236488|P2|STARTED|Double Blind (DB)||20
2544665|NCT00580606|6236489|P1|STARTED|Double Blind (DB)||20
2544666|NCT00580502|6236507|P1|NOT COMPLETED|Overall Study||0
2544667|NCT00580502|6236507|P1|COMPLETED|Overall Study||50
2544668|NCT00580502|6236507|P1|STARTED|Overall Study||50
2544669|NCT00580398|6236516|P2|NOT COMPLETED|Overall Study||0
2544670|NCT00580398|6236517|P1|NOT COMPLETED|Overall Study||0
2544671|NCT00580398|6236516|P2|COMPLETED|Overall Study||32
2544672|NCT00580398|6236517|P1|COMPLETED|Overall Study||17
2544673|NCT00580398|6236516|P2|STARTED|Overall Study||32
2544674|NCT00580398|6236517|P1|STARTED|Overall Study||17
2544675|NCT00580372|6236525|P1|NOT COMPLETED|Overall Study||0
2544676|NCT00580372|6236525|P1|COMPLETED|Overall Study||231
2544677|NCT00580372|6236525|P1|STARTED|Overall Study||231
2544678|NCT00580333|6236529|P1|NOT COMPLETED|Overall Study||0
2544679|NCT00580333|6236529|P1|COMPLETED|Overall Study||51
2544680|NCT00580333|6236529|P1|STARTED|Overall Study||51
2544681|NCT00580294|6236536|P1|NOT COMPLETED|Overall Study||0
2544682|NCT00580294|6236536|P1|COMPLETED|Overall Study||12
2544683|NCT00580294|6236536|P1|STARTED|Overall Study||12
2544684|NCT00580229|6236540|P1|NOT COMPLETED|Overall Study||0
2544685|NCT00580229|6236540|P1|COMPLETED|Overall Study||50
2544686|NCT00580229|6236540|P1|STARTED|Overall Study||50
2544687|NCT00580151|6236548|P2|NOT COMPLETED|Overall Study||0
2544688|NCT00580151|6236549|P1|NOT COMPLETED|Overall Study||0
2544689|NCT00580151|6236548|P2|COMPLETED|Overall Study||0
2544690|NCT00580151|6236549|P1|COMPLETED|Overall Study||9
2544691|NCT00580151|6236548|P2|STARTED|Overall Study||0
2544692|NCT00580151|6236549|P1|STARTED|Overall Study||9
2544693|NCT00580138|6236557|P1|NOT COMPLETED|Overall Study||0
2544694|NCT00580138|6236557|P1|COMPLETED|Overall Study||30
2544695|NCT00580138|6236557|P1|STARTED|Overall Study||30
2544696|NCT00580073|6236561|P1|NOT COMPLETED|Overall Study||0
2544697|NCT00580073|6236561|P1|COMPLETED|Overall Study||6
2544698|NCT00580073|6236561|P1|STARTED|Overall Study||6
2544699|NCT00580047|6236570|P3|NOT COMPLETED|Overall Study||2
2544700|NCT00580047|6236571|P2|NOT COMPLETED|Overall Study||2
2544701|NCT00580047|6236572|P1|NOT COMPLETED|Overall Study||3
2544702|NCT00580047|6236570|P3|COMPLETED|Overall Study||10
2544703|NCT00580047|6236571|P2|COMPLETED|Overall Study||21
2544704|NCT00580047|6236572|P1|COMPLETED|Overall Study||21
2544705|NCT00580047|6236570|P3|STARTED|Overall Study||12
2544706|NCT00580047|6236571|P2|STARTED|Overall Study||23
2544707|NCT00580047|6236572|P1|STARTED|Overall Study||24
2544708|NCT00580034|6236583|P2|NOT COMPLETED|Overall Study||0
2544709|NCT00580034|6236584|P1|NOT COMPLETED|Overall Study||10
2544710|NCT00580034|6236583|P2|COMPLETED|Overall Study||88
2544711|NCT00580034|6236584|P1|COMPLETED|Overall Study||78
2544712|NCT00580034|6236583|P2|STARTED|Overall Study||88
2544713|NCT00580034|6236584|P1|STARTED|Overall Study||88
2544714|NCT00579982|6236590|P1|NOT COMPLETED|Overall Study||8
2544715|NCT00579982|6236590|P1|COMPLETED|Overall Study||89
2544716|NCT00579982|6236590|P1|STARTED|Overall Study||97
2544717|NCT00579878|6236612|P3|NOT COMPLETED|Overall Study||10
2544718|NCT00579878|6236613|P2|NOT COMPLETED|Overall Study||3
2544719|NCT00579878|6236614|P1|NOT COMPLETED|Overall Study||7
2544720|NCT00579878|6236612|P3|COMPLETED|Overall Study||14
2544721|NCT00579878|6236613|P2|COMPLETED|Overall Study||20
2544722|NCT00579878|6236614|P1|COMPLETED|Overall Study||15
2544723|NCT00579878|6236612|P3|STARTED|Overall Study||24
2544724|NCT00579878|6236613|P2|STARTED|Overall Study||23
2544725|NCT00579878|6236614|P1|STARTED|Overall Study||22
2544726|NCT00579826|6236624|P2|NOT COMPLETED|Overall Study||3
2544727|NCT00579826|6236625|P1|NOT COMPLETED|Overall Study||5
2544728|NCT00579826|6236624|P2|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|23
2544729|NCT00579826|6236625|P1|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|24
2544730|NCT00579826|6236624|P2|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|25
2544731|NCT00579826|6236625|P1|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|28
2544732|NCT00579826|6236624|P2|STARTED|Overall Study||26
2544733|NCT00579826|6236625|P1|STARTED|Overall Study||29
2544734|NCT00579813|6236637|P2|NOT COMPLETED|Overall Study||0
2544735|NCT00579813|6236638|P1|NOT COMPLETED|Overall Study||0
2544736|NCT00579813|6236637|P2|COMPLETED|Overall Study||10
2544737|NCT00579813|6236638|P1|COMPLETED|Overall Study||60
2544738|NCT00579813|6236637|P2|STARTED|Overall Study||10
2544739|NCT00579813|6236638|P1|STARTED|Overall Study||60
2544740|NCT00579670|6236659|P5|NOT COMPLETED|Overall Study||0
2544741|NCT00579670|6236660|P4|NOT COMPLETED|Overall Study||22
2544742|NCT00579670|6236661|P3|NOT COMPLETED|Overall Study||4
2544743|NCT00579670|6236662|P2|NOT COMPLETED|Overall Study||1
2544744|NCT00579670|6236663|P1|NOT COMPLETED|Overall Study||2
2544745|NCT00579670|6236659|P5|COMPLETED|Overall Study||5
2544746|NCT00579670|6236660|P4|COMPLETED|Overall Study||263
2544747|NCT00579670|6236661|P3|COMPLETED|Overall Study||84
2544748|NCT00579670|6236662|P2|COMPLETED|Overall Study||56
2544749|NCT00579670|6236663|P1|COMPLETED|Overall Study||13
2544920|NCT00578669|6237269|P2|STARTED|Overall Study||99
2544750|NCT00579670|6236659|P5|Population: Within SmPC (Completed)|Overall Study||0
2544751|NCT00579670|6236660|P4|Population: Within SmPC (Completed)|Overall Study|DC: AE N=2; Lack of efficacy N=5; LTFU N=3; Other unspecified N=2|147
2544752|NCT00579670|6236661|P3|Population: Within SmPC (Completed)|Overall Study|DC: AE N=1; Lack of efficacy N=1; Other unspecified N=1; Withdrawal by subject N=1|79
2544753|NCT00579670|6236662|P2|Population: Within SmPC (Completed)|Overall Study|DC: Lost to follow-up (LTFU) N=1|55
2544754|NCT00579670|6236663|P1|Population: Within SmPC (Completed)|Overall Study|Not Completed (DC): Subject died N=1; Adverse Event (AE) N=1|13
2544755|NCT00579670|6236659|P5|Population: Within SmPC (Started)|Overall Study|"Ziprasidone Unknown reporting group is not applicable to the Within SmPC population"|0
2544756|NCT00579670|6236660|P4|Population: Within SmPC (Started)|Overall Study||159
2544757|NCT00579670|6236661|P3|Population: Within SmPC (Started)|Overall Study||83
2544758|NCT00579670|6236662|P2|Population: Within SmPC (Started)|Overall Study||56
2544759|NCT00579670|6236663|P1|Population: Within SmPC (Started)|Overall Study|"Within summary of product characteristics (SmPC): FAS subjects who received all doses Within SmPC"|15
2544760|NCT00579670|6236659|P5|STARTED|Overall Study||5
2544761|NCT00579670|6236660|P4|STARTED|Overall Study||285
2544762|NCT00579670|6236661|P3|STARTED|Overall Study||88
2544763|NCT00579670|6236662|P2|STARTED|Overall Study||57
2544764|NCT00579670|6236663|P1|STARTED|Overall Study|Full Analysis Set (FAS): at least 1 dose study medication and at least 1 efficacy measurement|15
2544768|NCT00579501|6236887|P1|NOT COMPLETED|Overall Study||29
2544769|NCT00579501|6236887|P1|COMPLETED|Overall Study||0
2544770|NCT00579501|6236887|P1|STARTED|Overall Study||29
2544771|NCT00579436|6236894|P2|NOT COMPLETED|Overall Study||0
2544772|NCT00579436|6236895|P1|NOT COMPLETED|Overall Study||0
2544773|NCT00579436|6236894|P2|COMPLETED|Overall Study||14
2544774|NCT00579436|6236895|P1|COMPLETED|Overall Study||19
2544775|NCT00579436|6236894|P2|STARTED|Overall Study||14
2544776|NCT00579436|6236895|P1|STARTED|Overall Study||19
2544777|NCT00579345|6236915|P8|NOT COMPLETED|Overall Study||2
2544778|NCT00579345|6236916|P7|NOT COMPLETED|Overall Study||0
2544779|NCT00579345|6236917|P6|NOT COMPLETED|Overall Study||0
2544780|NCT00579345|6236918|P5|NOT COMPLETED|Overall Study||0
2544781|NCT00579345|6236919|P4|NOT COMPLETED|Overall Study||1
2544782|NCT00579345|6236920|P3|NOT COMPLETED|Overall Study||2
2544783|NCT00579345|6236921|P2|NOT COMPLETED|Overall Study||1
2544784|NCT00579345|6236922|P1|NOT COMPLETED|Overall Study||5
2544785|NCT00579345|6236915|P8|COMPLETED|Overall Study||42
2544786|NCT00579345|6236916|P7|COMPLETED|Overall Study||57
2544787|NCT00579345|6236917|P6|COMPLETED|Overall Study||78
2544788|NCT00579345|6236918|P5|COMPLETED|Overall Study||90
2544789|NCT00579345|6236919|P4|COMPLETED|Overall Study||143
2544790|NCT00579345|6236920|P3|COMPLETED|Overall Study||389
2544791|NCT00579345|6236921|P2|COMPLETED|Overall Study||168
2544792|NCT00579345|6236922|P1|COMPLETED|Overall Study||544
2544793|NCT00579345|6236915|P8|STARTED|Overall Study||44
2544794|NCT00579345|6236916|P7|STARTED|Overall Study||57
2544795|NCT00579345|6236917|P6|STARTED|Overall Study||78
2544796|NCT00579345|6236918|P5|STARTED|Overall Study||90
2544797|NCT00579345|6236919|P4|STARTED|Overall Study||144
2544798|NCT00579345|6236920|P3|STARTED|Overall Study||391
2544799|NCT00579345|6236921|P2|STARTED|Overall Study||169
2544800|NCT00579345|6236922|P1|STARTED|Overall Study||549
2544801|NCT00579254|6236954|P1|NOT COMPLETED|Overall Study||112
2544802|NCT00579254|6236954|P1|COMPLETED|Overall Study||0
2544803|NCT00579254|6236954|P1|STARTED|Overall Study||112
2544804|NCT00579137|6236958|P1|NOT COMPLETED|Overall Study||0
2544805|NCT00579137|6236958|P1|COMPLETED|Overall Study||3
2544806|NCT00579137|6236958|P1|STARTED|Overall Study||3
2544807|NCT00579111|6236967|P2|NOT COMPLETED|Overall Study||1
2544808|NCT00579111|6236968|P1|NOT COMPLETED|Overall Study||2
2544809|NCT00579111|6236967|P2|COMPLETED|Overall Study||0
2544810|NCT00579111|6236968|P1|COMPLETED|Overall Study||1
2544811|NCT00579111|6236967|P2|STARTED|Overall Study||1
2544812|NCT00579111|6236968|P1|STARTED|Overall Study||3
2544813|NCT00579098|6236978|P2|NOT COMPLETED|Overall Study||8
2544814|NCT00579098|6236979|P1|NOT COMPLETED|Overall Study||9
2544815|NCT00579098|6236978|P2|COMPLETED|Overall Study||55
2544816|NCT00579098|6236979|P1|COMPLETED|Overall Study||53
2544817|NCT00579098|6236978|P2|STARTED|Overall Study||63
2544818|NCT00579098|6236979|P1|STARTED|Overall Study||62
2544819|NCT00579059|6236995|P2|NOT COMPLETED|Overall Study||10
2544820|NCT00579059|6236996|P1|NOT COMPLETED|Overall Study||21
2544821|NCT00579059|6236995|P2|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
2544822|NCT00579059|6236996|P1|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
2544823|NCT00579059|6236995|P2|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
2544824|NCT00579059|6236996|P1|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
2544825|NCT00579059|6236995|P2|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
2544826|NCT00579059|6236996|P1|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
2544827|NCT00579059|6236995|P2|1 Year|Overall Study|7 patients didn't return for follow-up.|3
2544828|NCT00579059|6236996|P1|1 Year|Overall Study|13 patients didn't return for follow-up.|8
2544829|NCT00579059|6236995|P2|6 Months|Overall Study|6 patients didn't return for follow-up.|4
2544830|NCT00579059|6236996|P1|6 Months|Overall Study|10 Patients didn't return for follow-up.|11
2544831|NCT00579059|6236995|P2|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|9
2544832|NCT00579059|6236996|P1|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|20
2544833|NCT00579059|6236995|P2|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|10
2544834|NCT00579059|6236996|P1|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|21
2544835|NCT00578968|6237007|P3|NOT COMPLETED|Intervention||0
2544836|NCT00578968|6237008|P2|NOT COMPLETED|Intervention||0
2544837|NCT00578968|6237009|P1|NOT COMPLETED|Intervention||0
2544838|NCT00578968|6237007|P3|COMPLETED|Intervention||0
2544839|NCT00578968|6237008|P2|COMPLETED|Intervention||12
2544840|NCT00578968|6237009|P1|COMPLETED|Intervention||12
2544841|NCT00578968|6237007|P3|STARTED|Intervention||0
2544842|NCT00578968|6237008|P2|STARTED|Intervention||12
2544843|NCT00578968|6237009|P1|STARTED|Intervention||12
2544844|NCT00578968|6237007|P3|NOT COMPLETED|Baseline (Prior to Intervention)||0
2544845|NCT00578968|6237008|P2|NOT COMPLETED|Baseline (Prior to Intervention)||0
2544846|NCT00578968|6237009|P1|NOT COMPLETED|Baseline (Prior to Intervention)||0
2544847|NCT00578968|6237007|P3|COMPLETED|Baseline (Prior to Intervention)||12
2544848|NCT00578968|6237008|P2|COMPLETED|Baseline (Prior to Intervention)||12
2544849|NCT00578968|6237009|P1|COMPLETED|Baseline (Prior to Intervention)||12
2544850|NCT00578968|6237007|P3|STARTED|Baseline (Prior to Intervention)||12
2544851|NCT00578968|6237008|P2|STARTED|Baseline (Prior to Intervention)||12
2544852|NCT00578968|6237009|P1|STARTED|Baseline (Prior to Intervention)||12
2544853|NCT00578942|6237070|P1|NOT COMPLETED|Overall Study||1
2544854|NCT00578942|6237070|P1|COMPLETED|Overall Study||47
2544855|NCT00578942|6237070|P1|STARTED|Overall Study||48
2544856|NCT00578929|6237080|P4|NOT COMPLETED|Randomized Period||14
2544857|NCT00578929|6237081|P3|NOT COMPLETED|Randomized Period||8
2544858|NCT00578929|6237082|P2|NOT COMPLETED|Randomized Period||14
2544859|NCT00578929|6237083|P1|NOT COMPLETED|Randomized Period||17
2544860|NCT00578929|6237080|P4|COMPLETED|Randomized Period||283
2544861|NCT00578929|6237081|P3|COMPLETED|Randomized Period||288
2544862|NCT00578929|6237082|P2|COMPLETED|Randomized Period||283
2544863|NCT00578929|6237083|P1|COMPLETED|Randomized Period||281
2544864|NCT00578929|6237080|P4|STARTED|Randomized Period||297
2544865|NCT00578929|6237081|P3|STARTED|Randomized Period||296
2544866|NCT00578929|6237082|P2|STARTED|Randomized Period||297
2544867|NCT00578929|6237083|P1|STARTED|Randomized Period||298
2544868|NCT00578929|6237080|P4|NOT COMPLETED|Vehicle Run-In Period||0
2544869|NCT00578929|6237081|P3|NOT COMPLETED|Vehicle Run-In Period||0
2544870|NCT00578929|6237082|P2|NOT COMPLETED|Vehicle Run-In Period||0
2544871|NCT00578929|6237083|P1|NOT COMPLETED|Vehicle Run-In Period||0
2544872|NCT00578929|6237080|P4|COMPLETED|Vehicle Run-In Period||0
2544873|NCT00578929|6237081|P3|COMPLETED|Vehicle Run-In Period||0
2544874|NCT00578929|6237082|P2|COMPLETED|Vehicle Run-In Period||2388
2544875|NCT00578929|6237083|P1|COMPLETED|Vehicle Run-In Period||0
2544876|NCT00578929|6237080|P4|STARTED|Vehicle Run-In Period||0
2544877|NCT00578929|6237081|P3|STARTED|Vehicle Run-In Period||0
2544878|NCT00578929|6237082|P2|STARTED|Vehicle Run-In Period||2388
2544879|NCT00578929|6237083|P1|STARTED|Vehicle Run-In Period||0
2544880|NCT00578903|6237098|P1|NOT COMPLETED|Overall Study||0
2544881|NCT00578903|6237098|P1|COMPLETED|Overall Study||22
2544882|NCT00578903|6237098|P1|STARTED|Overall Study||22
2544883|NCT00578877|6237109|P2|NOT COMPLETED|Overall Study||128
2544884|NCT00578877|6237110|P1|NOT COMPLETED|Overall Study||81
2544885|NCT00578877|6237109|P2|COMPLETED|Overall Study||172
2544886|NCT00578877|6237110|P1|COMPLETED|Overall Study||69
2544887|NCT00578877|6237109|P2|STARTED|Overall Study||300
2544888|NCT00578877|6237110|P1|STARTED|Overall Study||150
2544889|NCT00578864|6237118|P2|NOT COMPLETED|Overall Study||0
2544890|NCT00578864|6237119|P1|NOT COMPLETED|Overall Study||1
2544891|NCT00578864|6237118|P2|COMPLETED|Overall Study||6
2544892|NCT00578864|6237119|P1|COMPLETED|Overall Study|died of complications of surgery after 2 cycles|6
2544893|NCT00578864|6237118|P2|STARTED|Overall Study||6
2544894|NCT00578864|6237119|P1|STARTED|Overall Study||7
2544895|NCT00578812|6237135|P2|NOT COMPLETED|Overall Study||7
2544896|NCT00578812|6237136|P1|NOT COMPLETED|Overall Study||6
2544897|NCT00578812|6237135|P2|COMPLETED|Overall Study||185
2544898|NCT00578812|6237136|P1|COMPLETED|Overall Study|Modified Intent-to-Treat (treated patients; analyzed as randomized).|218
2544899|NCT00578812|6237135|P2|STARTED|Overall Study||192
2544900|NCT00578812|6237136|P1|STARTED|Overall Study|Does not include investigational training patients (78 STARTED, 76 COMPLETED, 2 Not Treated).|224
2544901|NCT00578786|6237175|P3|NOT COMPLETED|Overall Study||30
2544902|NCT00578786|6237176|P2|NOT COMPLETED|Overall Study||66
2544903|NCT00578786|6237177|P1|NOT COMPLETED|Overall Study||39
2544904|NCT00578786|6237175|P3|COMPLETED|Overall Study||67
2544905|NCT00578786|6237176|P2|COMPLETED|Overall Study||124
2544906|NCT00578786|6237177|P1|COMPLETED|Overall Study||57
2544907|NCT00578786|6237175|P3|STARTED|Overall Study||97
2544908|NCT00578786|6237176|P2|STARTED|Overall Study||190
2544909|NCT00578786|6237177|P1|STARTED|Overall Study||96
2544910|NCT00578734|6237258|P2|NOT COMPLETED|Overall Study||0
2544911|NCT00578734|6237259|P1|NOT COMPLETED|Overall Study||0
2544912|NCT00578734|6237258|P2|COMPLETED|Overall Study||81
2544913|NCT00578734|6237259|P1|COMPLETED|Overall Study||84
2544914|NCT00578734|6237258|P2|STARTED|Overall Study||81
2544915|NCT00578734|6237259|P1|STARTED|Overall Study||84
2544916|NCT00578669|6237269|P2|NOT COMPLETED|Overall Study||0
2544917|NCT00578669|6237270|P1|NOT COMPLETED|Overall Study||0
2544918|NCT00578669|6237269|P2|COMPLETED|Overall Study||99
2544919|NCT00578669|6237270|P1|COMPLETED|Overall Study||107
2544921|NCT00578669|6237270|P1|STARTED|Overall Study||107
2544922|NCT00578643|6237278|P1|NOT COMPLETED|Overall Study||2
2544923|NCT00578643|6237278|P1|COMPLETED|Overall Study||13
2544924|NCT00578643|6237278|P1|STARTED|Overall Study||15
2544925|NCT00578617|6237287|P2|NOT COMPLETED|Overall Study||0
2544926|NCT00578617|6237288|P1|NOT COMPLETED|Overall Study||0
2544927|NCT00578617|6237287|P2|COMPLETED|Overall Study||29
2544928|NCT00578617|6237288|P1|COMPLETED|Overall Study||31
2544929|NCT00578617|6237287|P2|STARTED|Overall Study||29
2544930|NCT00578617|6237288|P1|STARTED|Overall Study||31
2544931|NCT00578565|6237294|P1|NOT COMPLETED|Overall Study||3
2544932|NCT00578565|6237294|P1|COMPLETED|Overall Study||7
2544933|NCT00578565|6237294|P1|STARTED|Overall Study||10
2544934|NCT00578552|6237306|P3|NOT COMPLETED|Overall Study||15
2544935|NCT00578552|6237307|P2|NOT COMPLETED|Overall Study||14
2544936|NCT00578552|6237308|P1|NOT COMPLETED|Overall Study||15
2544937|NCT00578552|6237306|P3|COMPLETED|Overall Study||11
2544938|NCT00578552|6237307|P2|COMPLETED|Overall Study||13
2544939|NCT00578552|6237308|P1|COMPLETED|Overall Study||12
2544940|NCT00578552|6237306|P3|STARTED|Overall Study||26
2544941|NCT00578552|6237307|P2|STARTED|Overall Study||27
2544942|NCT00578552|6237308|P1|STARTED|Overall Study||27
2544943|NCT00578539|6237316|P1|NOT COMPLETED|Overall Study||0
2544944|NCT00578539|6237316|P1|COMPLETED|Overall Study||24
2544945|NCT00578539|6237316|P1|STARTED|Overall Study||24
2544946|NCT00578461|6237320|P1|NOT COMPLETED|Overall Study||0
2544947|NCT00578461|6237320|P1|COMPLETED|Overall Study||26
2544948|NCT00578461|6237320|P1|STARTED|Overall Study||26
2544949|NCT00578448|6237324|P1|NOT COMPLETED|1 Year Long Term Extension (LTE)||1
2544950|NCT00578448|6237324|P1|COMPLETED|1 Year Long Term Extension (LTE)||8
2544951|NCT00578448|6237324|P1|STARTED|1 Year Long Term Extension (LTE)||9
2544952|NCT00578448|6237324|P1|NOT COMPLETED|Day 1 up to 3 Years of Planned Study||3
2544953|NCT00578448|6237324|P1|COMPLETED|Day 1 up to 3 Years of Planned Study||9
2544954|NCT00578448|6237324|P1|STARTED|Day 1 up to 3 Years of Planned Study||12
2544955|NCT00578383|6237342|P4|NOT COMPLETED|Overall Study||6
2544956|NCT00578383|6237343|P3|NOT COMPLETED|Overall Study||6
2544957|NCT00578383|6237344|P2|NOT COMPLETED|Overall Study||16
2544958|NCT00578383|6237345|P1|NOT COMPLETED|Overall Study||16
2544959|NCT00578383|6237342|P4|COMPLETED|Overall Study||9
2544960|NCT00578383|6237343|P3|COMPLETED|Overall Study||13
2544961|NCT00578383|6237344|P2|COMPLETED|Overall Study||20
2544962|NCT00578383|6237345|P1|COMPLETED|Overall Study||21
2544963|NCT00578383|6237342|P4|STARTED|Overall Study||15
2544964|NCT00578383|6237343|P3|STARTED|Overall Study||19
2544965|NCT00578383|6237344|P2|STARTED|Overall Study||36
2544966|NCT00578383|6237345|P1|STARTED|Overall Study||37
2544967|NCT00578331|6237377|P2|NOT COMPLETED|Overall Study||125
2544968|NCT00578331|6237378|P1|NOT COMPLETED|Overall Study||116
2544969|NCT00578331|6237377|P2|COMPLETED|Overall Study||320
2544970|NCT00578331|6237378|P1|COMPLETED|Overall Study||329
2544971|NCT00578331|6237377|P2|STARTED|Overall Study||445
2544972|NCT00578331|6237378|P1|STARTED|Overall Study||445
2544973|NCT00578318|6237388|P2|NOT COMPLETED|Overall Study||0
2544974|NCT00578318|6237389|P1|NOT COMPLETED|Overall Study||3
2544975|NCT00578318|6237388|P2|COMPLETED|Overall Study||8
2544976|NCT00578318|6237389|P1|COMPLETED|Overall Study||5
2544977|NCT00578318|6237388|P2|STARTED|Overall Study||8
2544978|NCT00578318|6237389|P1|STARTED|Overall Study||8
2544979|NCT00578305|6237398|P3|NOT COMPLETED|Safety Follow-up Phase||46
2544980|NCT00578305|6237399|P2|NOT COMPLETED|Safety Follow-up Phase||45
2544981|NCT00578305|6237400|P1|NOT COMPLETED|Safety Follow-up Phase||46
2544982|NCT00578305|6237398|P3|COMPLETED|Safety Follow-up Phase||8
2544983|NCT00578305|6237399|P2|COMPLETED|Safety Follow-up Phase||9
2544984|NCT00578305|6237400|P1|COMPLETED|Safety Follow-up Phase||11
2544985|NCT00578305|6237398|P3|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
2544986|NCT00578305|6237399|P2|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
2544987|NCT00578305|6237400|P1|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|57
2544988|NCT00578305|6237398|P3|NOT COMPLETED|Extension Phase||3
2544989|NCT00578305|6237399|P2|NOT COMPLETED|Extension Phase||1
2544990|NCT00578305|6237400|P1|NOT COMPLETED|Extension Phase||4
2544991|NCT00578305|6237398|P3|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|40
2544992|NCT00578305|6237399|P2|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
2544993|NCT00578305|6237400|P1|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
2544994|NCT00578305|6237398|P3|STARTED|Extension Phase||43
2544995|NCT00578305|6237399|P2|STARTED|Extension Phase||50
2544996|NCT00578305|6237400|P1|STARTED|Extension Phase||53
2544997|NCT00578305|6237398|P3|NOT COMPLETED|Double-blind Treatment Phase||14
2544998|NCT00578305|6237399|P2|NOT COMPLETED|Double-blind Treatment Phase||4
2544999|NCT00578305|6237400|P1|NOT COMPLETED|Double-blind Treatment Phase||3
2545000|NCT00578305|6237398|P3|COMPLETED|Double-blind Treatment Phase||49
2545001|NCT00578305|6237399|P2|COMPLETED|Double-blind Treatment Phase||56
2545002|NCT00578305|6237400|P1|COMPLETED|Double-blind Treatment Phase||59
2545003|NCT00578305|6237398|P3|Treated|Double-blind Treatment Phase||63
2545004|NCT00578305|6237399|P2|Treated|Double-blind Treatment Phase||60
2545005|NCT00578305|6237400|P1|Treated|Double-blind Treatment Phase||62
2545006|NCT00578305|6237398|P3|STARTED|Double-blind Treatment Phase||63
2545007|NCT00578305|6237399|P2|STARTED|Double-blind Treatment Phase||60
2545008|NCT00578305|6237400|P1|STARTED|Double-blind Treatment Phase||62
2545009|NCT00578279|6237461|P2|NOT COMPLETED|Overall Study||0
2545010|NCT00578279|6237462|P1|NOT COMPLETED|Overall Study||0
2545011|NCT00578279|6237461|P2|COMPLETED|Overall Study||10
2545012|NCT00578279|6237462|P1|COMPLETED|Overall Study||10
2545013|NCT00578279|6237461|P2|STARTED|Overall Study||10
2545014|NCT00578279|6237462|P1|STARTED|Overall Study||10
2545015|NCT00578227|6237471|P3|NOT COMPLETED|Overall Study||4
2545016|NCT00578227|6237472|P2|NOT COMPLETED|Overall Study||2
2545017|NCT00578227|6237473|P1|NOT COMPLETED|Overall Study||5
2545018|NCT00578227|6237471|P3|COMPLETED|Overall Study||267
2545019|NCT00578227|6237472|P2|COMPLETED|Overall Study||268
2545020|NCT00578227|6237473|P1|COMPLETED|Overall Study||267
2545021|NCT00578227|6237471|P3|STARTED|Overall Study||271
2545022|NCT00578227|6237472|P2|STARTED|Overall Study||270
2545023|NCT00578227|6237473|P1|STARTED|Overall Study||272
2545024|NCT00578214|6237546|P3|NOT COMPLETED|Overall Study||0
2545025|NCT00578214|6237547|P2|NOT COMPLETED|Overall Study||0
2545026|NCT00578214|6237548|P1|NOT COMPLETED|Overall Study||0
2545027|NCT00578214|6237546|P3|COMPLETED|Overall Study||31
2545028|NCT00578214|6237547|P2|COMPLETED|Overall Study||22
2545029|NCT00578214|6237548|P1|COMPLETED|Overall Study||22
2545030|NCT00578214|6237546|P3|STARTED|Overall Study||31
2545031|NCT00578214|6237547|P2|STARTED|Overall Study||22
2545032|NCT00578214|6237548|P1|STARTED|Overall Study||22
2545033|NCT00578175|6237598|P3|NOT COMPLETED|Overall Study||24
2545034|NCT00578175|6237599|P2|NOT COMPLETED|Overall Study||43
2545035|NCT00578175|6237600|P1|NOT COMPLETED|Overall Study||70
2545036|NCT00578175|6237598|P3|COMPLETED|Overall Study||365
2545037|NCT00578175|6237599|P2|COMPLETED|Overall Study||646
2545038|NCT00578175|6237600|P1|COMPLETED|Overall Study||635
2545039|NCT00578175|6237598|P3|STARTED|Overall Study||389
2545040|NCT00578175|6237599|P2|STARTED|Overall Study||689
2545041|NCT00578175|6237600|P1|STARTED|Overall Study||705
2545042|NCT00578136|6237679|P2|NOT COMPLETED|Overall Study||1
2545043|NCT00578136|6237680|P1|NOT COMPLETED|Overall Study||1
2545044|NCT00578136|6237679|P2|COMPLETED|Overall Study||26
2545045|NCT00578136|6237680|P1|COMPLETED|Overall Study||26
2545046|NCT00578136|6237679|P2|STARTED|Overall Study||27
2545047|NCT00578136|6237680|P1|STARTED|Overall Study||27
2545048|NCT00578071|6237688|P1|NOT COMPLETED|Overall Study||0
2545049|NCT00578071|6237688|P1|COMPLETED|Overall Study||29
2545050|NCT00578071|6237688|P1|STARTED|Overall Study||29
2545051|NCT00577889|6237698|P3|NOT COMPLETED|Overall Study||0
2545052|NCT00577889|6237699|P2|NOT COMPLETED|Overall Study||0
2545053|NCT00577889|6237700|P1|NOT COMPLETED|Overall Study||1
2545054|NCT00577889|6237698|P3|COMPLETED|Overall Study||6
2545055|NCT00577889|6237699|P2|COMPLETED|Overall Study||6
2545056|NCT00577889|6237700|P1|COMPLETED|Overall Study||8
2545057|NCT00577889|6237698|P3|STARTED|Overall Study||6
2545058|NCT00577889|6237699|P2|STARTED|Overall Study||6
2545059|NCT00577889|6237700|P1|STARTED|Overall Study||9
2545060|NCT00577863|6237719|P2|NOT COMPLETED|Overall Study||14
2545061|NCT00577863|6237720|P1|NOT COMPLETED|Overall Study||10
2545062|NCT00577863|6237719|P2|COMPLETED|Overall Study||94
2545063|NCT00577863|6237720|P1|COMPLETED|Overall Study||82
2545064|NCT00577863|6237719|P2|Received at Least One Injection|Overall Study||107
2545065|NCT00577863|6237720|P1|Received at Least One Injection|Overall Study||92
2545066|NCT00577863|6237719|P2|STARTED|Overall Study||108
2545067|NCT00577863|6237720|P1|STARTED|Overall Study||92
2545068|NCT00577824|6237762|P3|NOT COMPLETED|Overall Study||2
2545069|NCT00577824|6237763|P2|NOT COMPLETED|Overall Study||20
2545070|NCT00577824|6237764|P1|NOT COMPLETED|Overall Study||7
2545071|NCT00577824|6237762|P3|COMPLETED|Overall Study||34
2545072|NCT00577824|6237763|P2|COMPLETED|Overall Study||53
2545073|NCT00577824|6237764|P1|COMPLETED|Overall Study||65
2545074|NCT00577824|6237762|P3|Full Analysis Set|Overall Study||35
2545075|NCT00577824|6237763|P2|Full Analysis Set|Overall Study||72
2545076|NCT00577824|6237764|P1|Full Analysis Set|Overall Study|Full Analysis Set=subject received at least one dose of study medication (active or placebo)|72
2545077|NCT00577824|6237762|P3|STARTED|Overall Study||36
2545078|NCT00577824|6237763|P2|STARTED|Overall Study||73
2545079|NCT00577824|6237764|P1|STARTED|Overall Study|Started=Randomized|72
2545080|NCT00577772|6237822|P2|NOT COMPLETED|Overall Study||1
2545081|NCT00577772|6237823|P1|NOT COMPLETED|Overall Study||0
2545082|NCT00577772|6237822|P2|COMPLETED|Overall Study||6
2545083|NCT00577772|6237823|P1|COMPLETED|Overall Study||10
2545084|NCT00577772|6237822|P2|STARTED|Overall Study||7
2545085|NCT00577772|6237823|P1|STARTED|Overall Study||10
2545086|NCT00577720|6237833|P4|NOT COMPLETED|Overall Study||7
2545087|NCT00577720|6237834|P3|NOT COMPLETED|Overall Study||1
2545088|NCT00577720|6237835|P2|NOT COMPLETED|Overall Study||1
2545089|NCT00577720|6237836|P1|NOT COMPLETED|Overall Study||4
2545090|NCT00577720|6237833|P4|COMPLETED|Overall Study||65
2545091|NCT00577720|6237834|P3|COMPLETED|Overall Study||35
2545092|NCT00577720|6237835|P2|COMPLETED|Overall Study||35
2545093|NCT00577720|6237836|P1|COMPLETED|Overall Study||33
2545094|NCT00577720|6237833|P4|ITT (Intent to Treat) Population|Overall Study||65
2545095|NCT00577720|6237834|P3|ITT (Intent to Treat) Population|Overall Study||35
2545096|NCT00577720|6237835|P2|ITT (Intent to Treat) Population|Overall Study||35
2545097|NCT00577720|6237836|P1|ITT (Intent to Treat) Population|Overall Study||34
2545098|NCT00577720|6237833|P4|STARTED|Overall Study||72
2545099|NCT00577720|6237834|P3|STARTED|Overall Study||36
2545100|NCT00577720|6237835|P2|STARTED|Overall Study||36
2545101|NCT00577720|6237836|P1|STARTED|Overall Study||37
2545102|NCT00577707|6237854|P1|NOT COMPLETED|Overall Study||3
2545103|NCT00577707|6237854|P1|COMPLETED|Overall Study||6
2545104|NCT00577707|6237854|P1|STARTED|Overall Study||9
2545105|NCT00577655|6237862|P2|NOT COMPLETED|Overall Study||4
2545106|NCT00577655|6237863|P1|NOT COMPLETED|Overall Study||1
2545107|NCT00577655|6237862|P2|COMPLETED|Overall Study||47
2545108|NCT00577655|6237863|P1|COMPLETED|Overall Study||51
2545109|NCT00577655|6237862|P2|STARTED|Overall Study|This number represents the number of participants randomized.|51
2545110|NCT00577655|6237863|P1|STARTED|Overall Study|This number represents the number of participants randomized.|52
2545111|NCT00577642|6237901|P1|NOT COMPLETED|Overall Study||1
2545112|NCT00577642|6237901|P1|COMPLETED|Overall Study||28
2545113|NCT00577642|6237901|P1|STARTED|Overall Study||29
2545114|NCT00577629|6237905|P1|NOT COMPLETED|Long Term Follow-Up||25
2545115|NCT00577629|6237905|P1|COMPLETED|Long Term Follow-Up||13
2545116|NCT00577629|6237905|P1|STARTED|Long Term Follow-Up||38
2545117|NCT00577629|6237905|P1|NOT COMPLETED|Treatment Period||1
2545118|NCT00577629|6237905|P1|COMPLETED|Treatment Period||38
2545119|NCT00577629|6237905|P1|STARTED|Treatment Period||39
2545120|NCT00577590|6237916|P3|NOT COMPLETED|Overall Study||0
2545121|NCT00577590|6237917|P2|NOT COMPLETED|Overall Study||0
2545122|NCT00577590|6237918|P1|NOT COMPLETED|Overall Study||0
2545123|NCT00577590|6237916|P3|COMPLETED|Overall Study||23
2545124|NCT00577590|6237917|P2|COMPLETED|Overall Study||27
2545125|NCT00577590|6237918|P1|COMPLETED|Overall Study||28
2545126|NCT00577590|6237916|P3|STARTED|Overall Study||23
2545127|NCT00577590|6237917|P2|STARTED|Overall Study||27
2545128|NCT00577590|6237918|P1|STARTED|Overall Study||28
2545129|NCT00577512|6237926|P1|NOT COMPLETED|Overall Study||4
2545130|NCT00577512|6237926|P1|COMPLETED|Overall Study||0
2545131|NCT00577512|6237926|P1|STARTED|Overall Study||4
2545132|NCT00577473|6237932|P2|NOT COMPLETED|Overall Study||24
2545133|NCT00577473|6237933|P1|NOT COMPLETED|Overall Study||21
2545134|NCT00577473|6237932|P2|COMPLETED|Overall Study||123
2545135|NCT00577473|6237933|P1|COMPLETED|Overall Study||133
2545136|NCT00577473|6237932|P2|ITT Population|Overall Study||136
2545137|NCT00577473|6237933|P1|ITT Population|Overall Study||150
2545138|NCT00577473|6237932|P2|STARTED|Overall Study||147
2545139|NCT00577473|6237933|P1|STARTED|Overall Study||154
2545140|NCT00577460|6237964|P3|NOT COMPLETED|Overall Study||27
2545141|NCT00577460|6237965|P2|NOT COMPLETED|Overall Study||19
2545142|NCT00577460|6237966|P1|NOT COMPLETED|Overall Study||16
2545143|NCT00577460|6237964|P3|COMPLETED|Overall Study||112
2545144|NCT00577460|6237965|P2|COMPLETED|Overall Study||104
2545145|NCT00577460|6237966|P1|COMPLETED|Overall Study||113
2545146|NCT00577460|6237964|P3|STARTED|Overall Study||139
2545147|NCT00577460|6237965|P2|STARTED|Overall Study||123
2545148|NCT00577460|6237966|P1|STARTED|Overall Study||129
2545149|NCT00577408|6238075|P2|NOT COMPLETED|Overall Study||23
2545150|NCT00577408|6238076|P1|NOT COMPLETED|Overall Study||12
2545151|NCT00577408|6238075|P2|COMPLETED|Overall Study||9
2545152|NCT00577408|6238076|P1|COMPLETED|Overall Study||16
2545153|NCT00577408|6238075|P2|STARTED|Overall Study||32
2545154|NCT00577408|6238076|P1|STARTED|Overall Study||28
2545155|NCT00577395|6238084|P2|NOT COMPLETED|Overall Study||6
2545156|NCT00577395|6238085|P1|NOT COMPLETED|Overall Study||7
2545157|NCT00577395|6238084|P2|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
2545158|NCT00577395|6238085|P1|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
2545159|NCT00577395|6238084|P2|STARTED|Overall Study|67 were planned for Treatment 1, but due to enrollment difficulties this was not met.|6
2545160|NCT00577395|6238085|P1|STARTED|Overall Study|67 planned for Treatment 2, but due to enrollment difficulties this was not met.|7
2545161|NCT00577382|6238095|P2|NOT COMPLETED|Overall Study||31
2545162|NCT00577382|6238096|P1|NOT COMPLETED|Overall Study||21
2545163|NCT00577382|6238095|P2|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
2545164|NCT00577382|6238096|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
2545165|NCT00577382|6238095|P2|STARTED|Overall Study||31
2545166|NCT00577382|6238096|P1|STARTED|Overall Study||21
2545167|NCT00577356|6238108|P1|NOT COMPLETED|Overall Study||0
2545168|NCT00577356|6238108|P1|COMPLETED|Overall Study||6
2545169|NCT00577356|6238108|P1|STARTED|Overall Study||6
2545170|NCT00577135|6238116|P4|NOT COMPLETED|Overall Study||0
2545171|NCT00577135|6238117|P3|NOT COMPLETED|Overall Study||0
2545172|NCT00577135|6238118|P2|NOT COMPLETED|Overall Study||0
2545173|NCT00577135|6238119|P1|NOT COMPLETED|Overall Study||0
2545174|NCT00577135|6238116|P4|COMPLETED|Overall Study||75
2545175|NCT00577135|6238117|P3|COMPLETED|Overall Study||77
2545176|NCT00577135|6238118|P2|COMPLETED|Overall Study||82
2545177|NCT00577135|6238119|P1|COMPLETED|Overall Study||74
2545178|NCT00577135|6238116|P4|STARTED|Overall Study||75
2545179|NCT00577135|6238117|P3|STARTED|Overall Study||77
2545180|NCT00577135|6238118|P2|STARTED|Overall Study||82
2545181|NCT00577135|6238119|P1|STARTED|Overall Study||74
2545182|NCT00577122|6238239|P2|NOT COMPLETED|Overall Study||16
2545183|NCT00577122|6238240|P1|NOT COMPLETED|Overall Study||14
2545184|NCT00577122|6238239|P2|COMPLETED|Overall Study||0
2545185|NCT00577122|6238240|P1|COMPLETED|Overall Study||0
2545186|NCT00577122|6238239|P2|STARTED|Overall Study||16
2545187|NCT00577122|6238240|P1|STARTED|Overall Study||14
2545188|NCT00577096|6238254|P2|NOT COMPLETED|Long Term Participation||0
2545189|NCT00577096|6238255|P1|NOT COMPLETED|Long Term Participation||0
2545190|NCT00577096|6238254|P2|COMPLETED|Long Term Participation|Sub-set of patients (n=69) who completed short term (n=120) continued in long term participation.|35
2545191|NCT00577096|6238255|P1|COMPLETED|Long Term Participation||34
2545192|NCT00577096|6238254|P2|STARTED|Long Term Participation|Only 35 patients who met long-term eligibility (response to EPO) were enrolled.|35
2545193|NCT00577096|6238255|P1|STARTED|Long Term Participation|Only the first 34 patients who met long-term eligibility (response to EPO) were enrolled.|34
2545194|NCT00577096|6238254|P2|NOT COMPLETED|Short Term Participation||8
2545195|NCT00577096|6238255|P1|NOT COMPLETED|Short Term Participation||7
2545196|NCT00577096|6238254|P2|COMPLETED|Short Term Participation||58
2545197|NCT00577096|6238255|P1|COMPLETED|Short Term Participation||62
2545198|NCT00577096|6238254|P2|STARTED|Short Term Participation||66
2545199|NCT00577096|6238255|P1|STARTED|Short Term Participation||69
2545200|NCT00577083|6238281|P2|NOT COMPLETED|Second Intervention (14days)||0
2545201|NCT00577083|6238282|P1|NOT COMPLETED|Second Intervention (14days)||0
2545202|NCT00577083|6238281|P2|COMPLETED|Second Intervention (14days)||52
2545203|NCT00577083|6238282|P1|COMPLETED|Second Intervention (14days)||48
2545204|NCT00577083|6238281|P2|STARTED|Second Intervention (14days)||52
2545205|NCT00577083|6238282|P1|STARTED|Second Intervention (14days)||48
2545206|NCT00577083|6238281|P2|NOT COMPLETED|Washout (14 Days)||0
2545207|NCT00577083|6238282|P1|NOT COMPLETED|Washout (14 Days)||0
2545208|NCT00577083|6238281|P2|COMPLETED|Washout (14 Days)||52
2545209|NCT00577083|6238282|P1|COMPLETED|Washout (14 Days)||48
2545210|NCT00577083|6238281|P2|STARTED|Washout (14 Days)||52
2545211|NCT00577083|6238282|P1|STARTED|Washout (14 Days)||48
2545212|NCT00577083|6238281|P2|NOT COMPLETED|First Intervention (14 Days)||0
2545213|NCT00577083|6238282|P1|NOT COMPLETED|First Intervention (14 Days)||0
2545214|NCT00577083|6238281|P2|COMPLETED|First Intervention (14 Days)||52
2545215|NCT00577083|6238282|P1|COMPLETED|First Intervention (14 Days)||48
2545216|NCT00577083|6238281|P2|STARTED|First Intervention (14 Days)||52
2545217|NCT00577083|6238282|P1|STARTED|First Intervention (14 Days)||48
2545218|NCT00577031|6238294|P1|NOT COMPLETED|Overall Study||205
2545219|NCT00577031|6238294|P1|COMPLETED|Overall Study||0
2545220|NCT00577031|6238294|P1|STARTED|Overall Study||205
2545221|NCT00577005|6238315|P2|NOT COMPLETED|Overall Study||3
2545222|NCT00577005|6238316|P1|NOT COMPLETED|Overall Study||5
2545223|NCT00577005|6238315|P2|COMPLETED|Overall Study||9
2545224|NCT00577005|6238316|P1|COMPLETED|Overall Study||11
2545225|NCT00577005|6238315|P2|STARTED|Overall Study||12
2545226|NCT00577005|6238316|P1|STARTED|Overall Study||16
2545227|NCT00576927|6238330|P1|NOT COMPLETED|Randomization 1:1 Placebo or Active Drug||0
2545228|NCT00576927|6238330|P1|COMPLETED|Randomization 1:1 Placebo or Active Drug||22
2545229|NCT00576927|6238330|P1|STARTED|Randomization 1:1 Placebo or Active Drug||22
2545230|NCT00576927|6238330|P1|NOT COMPLETED|Sleep Hygiene With Study Drug||0
2545231|NCT00576927|6238330|P1|COMPLETED|Sleep Hygiene With Study Drug||22
2545232|NCT00576927|6238330|P1|STARTED|Sleep Hygiene With Study Drug||22
2545233|NCT00576927|6238330|P1|NOT COMPLETED|Sleep Hygiene With the Placebo||1
2545234|NCT00576927|6238330|P1|COMPLETED|Sleep Hygiene With the Placebo||22
2545235|NCT00576927|6238330|P1|STARTED|Sleep Hygiene With the Placebo||23
2545236|NCT00576927|6238330|P1|NOT COMPLETED|Sleep Hygiene Behavioral Intervention||7
2545237|NCT00576927|6238330|P1|COMPLETED|Sleep Hygiene Behavioral Intervention||23
2545238|NCT00576927|6238330|P1|STARTED|Sleep Hygiene Behavioral Intervention||30
2545239|NCT00576927|6238330|P1|NOT COMPLETED|Baseline||13
2545240|NCT00576927|6238330|P1|COMPLETED|Baseline||30
2545241|NCT00576927|6238330|P1|STARTED|Baseline||43
2545242|NCT00576927|6238330|P1|NOT COMPLETED|Clinical Assessment||36
2545243|NCT00576927|6238330|P1|COMPLETED|Clinical Assessment||43
2545244|NCT00576927|6238330|P1|STARTED|Clinical Assessment||79
2545245|NCT00576901|6238342|P1|NOT COMPLETED|Overall Study||3
2545246|NCT00576901|6238342|P1|COMPLETED|Overall Study||20
2545247|NCT00576901|6238342|P1|STARTED|Overall Study||23
2545254|NCT00576823|6238366|P3|NOT COMPLETED|40-week Safety Extension Phase||0
2545255|NCT00576823|6238367|P2|NOT COMPLETED|40-week Safety Extension Phase||0
2545256|NCT00576823|6238368|P1|NOT COMPLETED|40-week Safety Extension Phase||1
2545257|NCT00576823|6238366|P3|COMPLETED|40-week Safety Extension Phase||6
2545258|NCT00576823|6238367|P2|COMPLETED|40-week Safety Extension Phase||6
2545259|NCT00576823|6238368|P1|COMPLETED|40-week Safety Extension Phase||10
2545260|NCT00576823|6238366|P3|STARTED|40-week Safety Extension Phase|One patient refused to continue in the extension phase.|6
2545261|NCT00576823|6238367|P2|STARTED|40-week Safety Extension Phase||6
2545262|NCT00576823|6238368|P1|STARTED|40-week Safety Extension Phase||11
2545263|NCT00576823|6238366|P3|NOT COMPLETED|12-week Efficacy Phase||0
2545264|NCT00576823|6238367|P2|NOT COMPLETED|12-week Efficacy Phase||0
2545265|NCT00576823|6238368|P1|NOT COMPLETED|12-week Efficacy Phase||1
2545266|NCT00576823|6238366|P3|COMPLETED|12-week Efficacy Phase||7
2545267|NCT00576823|6238367|P2|COMPLETED|12-week Efficacy Phase||6
2545268|NCT00576823|6238368|P1|COMPLETED|12-week Efficacy Phase||11
2545269|NCT00576823|6238366|P3|STARTED|12-week Efficacy Phase||7
2545270|NCT00576823|6238367|P2|STARTED|12-week Efficacy Phase||6
2545271|NCT00576823|6238368|P1|STARTED|12-week Efficacy Phase||12
2545272|NCT00576758|6238384|P2|NOT COMPLETED|Follow-up Period||17
2545273|NCT00576758|6238385|P1|NOT COMPLETED|Follow-up Period||27
2545274|NCT00576758|6238384|P2|COMPLETED|Follow-up Period||34
2545275|NCT00576758|6238385|P1|COMPLETED|Follow-up Period||28
2545276|NCT00576758|6238384|P2|STARTED|Follow-up Period|Includes 21 pts who entered follow-up after induction and didn't enter the extended treatment phase.|51
2545277|NCT00576758|6238385|P1|STARTED|Follow-up Period|Includes 23 pts who entered follow-up after induction and didn't enter the extended treatment phase.|55
2545278|NCT00576758|6238384|P2|NOT COMPLETED|Extension Treatment Period||43
2545279|NCT00576758|6238385|P1|NOT COMPLETED|Extension Treatment Period||42
2545280|NCT00576758|6238384|P2|COMPLETED|Extension Treatment Period||30
2545281|NCT00576758|6238385|P1|COMPLETED|Extension Treatment Period|+ 2 patients (pts) who withdrew prior to receiving study drug.|30
2545282|NCT00576758|6238384|P2|STARTED|Extension Treatment Period|8 patients did not enter extended treatment phase/follow-up phase + 2 patients entered follow-up.|73
2545283|NCT00576758|6238385|P1|STARTED|Extension Treatment Period|6 patients did not enter extended treatment phase/follow-up + 1 patient entered follow-up.|72
2545284|NCT00576758|6238384|P2|NOT COMPLETED|Induction Treatment Period||5
2545285|NCT00576758|6238385|P1|NOT COMPLETED|Induction Treatment Period||8
2545286|NCT00576758|6238384|P2|COMPLETED|Induction Treatment Period||83
2545287|NCT00576758|6238385|P1|COMPLETED|Induction Treatment Period||79
2545288|NCT00576758|6238384|P2|Received Treatment|Induction Treatment Period||87
2545289|NCT00576758|6238385|P1|Received Treatment|Induction Treatment Period||86
2545290|NCT00576758|6238384|P2|STARTED|Induction Treatment Period||88
2545291|NCT00576758|6238385|P1|STARTED|Induction Treatment Period||87
2545292|NCT00576732|6238431|P6|NOT COMPLETED|OPEN LABEL||8
2545293|NCT00576732|6238432|P5|NOT COMPLETED|OPEN LABEL||4
2545294|NCT00576732|6238433|P4|NOT COMPLETED|OPEN LABEL||11
2545295|NCT00576732|6238434|P3|NOT COMPLETED|OPEN LABEL||0
2545296|NCT00576732|6238435|P2|NOT COMPLETED|OPEN LABEL||0
2545297|NCT00576732|6238436|P1|NOT COMPLETED|OPEN LABEL||0
2545298|NCT00576732|6238431|P6|COMPLETED|OPEN LABEL||17
2545299|NCT00576732|6238432|P5|COMPLETED|OPEN LABEL||20
2545300|NCT00576732|6238433|P4|COMPLETED|OPEN LABEL||19
2545301|NCT00576732|6238434|P3|COMPLETED|OPEN LABEL||0
2545302|NCT00576732|6238435|P2|COMPLETED|OPEN LABEL||0
2545303|NCT00576732|6238436|P1|COMPLETED|OPEN LABEL||0
2545304|NCT00576732|6238431|P6|STARTED|OPEN LABEL|All 25 double-blind RIS high dose completers and 0 RIS high dose non-completers entered open-label.|25
2545305|NCT00576732|6238432|P5|STARTED|OPEN LABEL|24 of 25 double-blind RIS low dose completers and 0 RIS low dose non-completers entered open-label.|24
2545306|NCT00576732|6238433|P4|STARTED|OPEN LABEL|26 of 27 double-blind placebo completers and 4 of 8 placebo non-completers entered open-label.|30
2545307|NCT00576732|6238434|P3|STARTED|OPEN LABEL||0
2545308|NCT00576732|6238435|P2|STARTED|OPEN LABEL||0
2545309|NCT00576732|6238436|P1|STARTED|OPEN LABEL||0
2545310|NCT00576732|6238431|P6|NOT COMPLETED|DOUBLE BLIND||0
2545311|NCT00576732|6238432|P5|NOT COMPLETED|DOUBLE BLIND||0
2545312|NCT00576732|6238433|P4|NOT COMPLETED|DOUBLE BLIND||0
2545313|NCT00576732|6238434|P3|NOT COMPLETED|DOUBLE BLIND||6
2545314|NCT00576732|6238435|P2|NOT COMPLETED|DOUBLE BLIND||5
2545315|NCT00576732|6238436|P1|NOT COMPLETED|DOUBLE BLIND||8
2545316|NCT00576732|6238431|P6|COMPLETED|DOUBLE BLIND||0
2545317|NCT00576732|6238432|P5|COMPLETED|DOUBLE BLIND||0
2545318|NCT00576732|6238433|P4|COMPLETED|DOUBLE BLIND||0
2545319|NCT00576732|6238434|P3|COMPLETED|DOUBLE BLIND||25
2545320|NCT00576732|6238435|P2|COMPLETED|DOUBLE BLIND||25
2545321|NCT00576732|6238436|P1|COMPLETED|DOUBLE BLIND||27
2545322|NCT00576732|6238431|P6|STARTED|DOUBLE BLIND||0
2545323|NCT00576732|6238432|P5|STARTED|DOUBLE BLIND||0
2545324|NCT00576732|6238433|P4|STARTED|DOUBLE BLIND||0
2545325|NCT00576732|6238434|P3|STARTED|DOUBLE BLIND||31
2545326|NCT00576732|6238435|P2|STARTED|DOUBLE BLIND||30
2545327|NCT00576732|6238436|P1|STARTED|DOUBLE BLIND||35
2545328|NCT00576693|6238468|P2|NOT COMPLETED|Overall Study||24
2545329|NCT00576693|6238469|P1|NOT COMPLETED|Overall Study||10
2545330|NCT00576693|6238468|P2|COMPLETED|Overall Study||203
2545331|NCT00576693|6238469|P1|COMPLETED|Overall Study||214
2545332|NCT00576693|6238468|P2|STARTED|Overall Study||227
2545333|NCT00576693|6238469|P1|STARTED|Overall Study||224
2545334|NCT00576628|6238475|P1|NOT COMPLETED|Overall Study||43
2545335|NCT00576628|6238475|P1|COMPLETED|Overall Study||82
2545336|NCT00576628|6238475|P1|STARTED|Overall Study||125
2545337|NCT00576576|6238495|P1|NOT COMPLETED|Overall Study||7
2545338|NCT00576576|6238495|P1|COMPLETED|Overall Study||20
2545339|NCT00576576|6238495|P1|STARTED|Overall Study||27
2545340|NCT00576524|6238503|P2|NOT COMPLETED|Overall Study||0
2545341|NCT00576524|6238504|P1|NOT COMPLETED|Overall Study||0
2545342|NCT00576524|6238503|P2|COMPLETED|Overall Study||0
2545343|NCT00576524|6238504|P1|COMPLETED|Overall Study||2
2545344|NCT00576524|6238503|P2|STARTED|Overall Study||0
2545345|NCT00576524|6238504|P1|STARTED|Overall Study||2
2545346|NCT00576472|6238529|P15|NOT COMPLETED|MPH Home Maintenance Phase||23
2545347|NCT00576472|6238530|P14|NOT COMPLETED|MPH Home Maintenance Phase||27
2545348|NCT00576472|6238531|P13|NOT COMPLETED|MPH Home Maintenance Phase||0
2545349|NCT00576472|6238532|P12|NOT COMPLETED|MPH Home Maintenance Phase||0
2545350|NCT00576472|6238533|P11|NOT COMPLETED|MPH Home Maintenance Phase||0
2545351|NCT00576472|6238534|P10|NOT COMPLETED|MPH Home Maintenance Phase||0
2545352|NCT00576472|6238535|P9|NOT COMPLETED|MPH Home Maintenance Phase||0
2545353|NCT00576472|6238536|P8|NOT COMPLETED|MPH Home Maintenance Phase||0
2545354|NCT00576472|6238537|P7|NOT COMPLETED|MPH Home Maintenance Phase||0
2545355|NCT00576472|6238538|P6|NOT COMPLETED|MPH Home Maintenance Phase||0
2545356|NCT00576472|6238539|P5|NOT COMPLETED|MPH Home Maintenance Phase||0
2545357|NCT00576472|6238540|P4|NOT COMPLETED|MPH Home Maintenance Phase||0
2545358|NCT00576472|6238541|P3|NOT COMPLETED|MPH Home Maintenance Phase||0
2545359|NCT00576472|6238542|P2|NOT COMPLETED|MPH Home Maintenance Phase||0
2545360|NCT00576472|6238543|P1|NOT COMPLETED|MPH Home Maintenance Phase||0
2545361|NCT00576472|6238529|P15|COMPLETED|MPH Home Maintenance Phase||68
2545362|NCT00576472|6238530|P14|COMPLETED|MPH Home Maintenance Phase||0
2545363|NCT00576472|6238531|P13|COMPLETED|MPH Home Maintenance Phase||0
2545364|NCT00576472|6238532|P12|COMPLETED|MPH Home Maintenance Phase||0
2545365|NCT00576472|6238533|P11|COMPLETED|MPH Home Maintenance Phase||0
2545366|NCT00576472|6238534|P10|COMPLETED|MPH Home Maintenance Phase||0
2545367|NCT00576472|6238535|P9|COMPLETED|MPH Home Maintenance Phase||0
2545368|NCT00576472|6238536|P8|COMPLETED|MPH Home Maintenance Phase||0
2545369|NCT00576472|6238537|P7|COMPLETED|MPH Home Maintenance Phase||0
2545370|NCT00576472|6238538|P6|COMPLETED|MPH Home Maintenance Phase||0
2545371|NCT00576472|6238539|P5|COMPLETED|MPH Home Maintenance Phase||0
2545372|NCT00576472|6238540|P4|COMPLETED|MPH Home Maintenance Phase||0
2545373|NCT00576472|6238541|P3|COMPLETED|MPH Home Maintenance Phase||0
2545374|NCT00576472|6238542|P2|COMPLETED|MPH Home Maintenance Phase||0
2545375|NCT00576472|6238543|P1|COMPLETED|MPH Home Maintenance Phase||0
2545376|NCT00576472|6238529|P15|STARTED|MPH Home Maintenance Phase||91
2545377|NCT00576472|6238530|P14|STARTED|MPH Home Maintenance Phase||27
2545378|NCT00576472|6238531|P13|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
2545379|NCT00576472|6238532|P12|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
2545380|NCT00576472|6238533|P11|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
2545381|NCT00576472|6238534|P10|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
2545382|NCT00576472|6238535|P9|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
2545383|NCT00576472|6238536|P8|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
2545384|NCT00576472|6238537|P7|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
2545385|NCT00576472|6238538|P6|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
2545386|NCT00576472|6238539|P5|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
2545387|NCT00576472|6238540|P4|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
2545388|NCT00576472|6238541|P3|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
2545389|NCT00576472|6238542|P2|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
2545390|NCT00576472|6238543|P1|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
2545391|NCT00576472|6238529|P15|NOT COMPLETED|MPH Cross Over Phase||0
2545392|NCT00576472|6238530|P14|NOT COMPLETED|MPH Cross Over Phase||0
2545393|NCT00576472|6238531|P13|NOT COMPLETED|MPH Cross Over Phase||0
2545394|NCT00576472|6238532|P12|NOT COMPLETED|MPH Cross Over Phase||1
2545395|NCT00576472|6238533|P11|NOT COMPLETED|MPH Cross Over Phase||1
2545396|NCT00576472|6238534|P10|NOT COMPLETED|MPH Cross Over Phase||0
2545397|NCT00576472|6238535|P9|NOT COMPLETED|MPH Cross Over Phase||2
2545398|NCT00576472|6238536|P8|NOT COMPLETED|MPH Cross Over Phase||0
2545399|NCT00576472|6238537|P7|NOT COMPLETED|MPH Cross Over Phase||12
2545400|NCT00576472|6238538|P6|NOT COMPLETED|MPH Cross Over Phase||0
2545401|NCT00576472|6238539|P5|NOT COMPLETED|MPH Cross Over Phase||0
2545402|NCT00576472|6238540|P4|NOT COMPLETED|MPH Cross Over Phase||0
2545403|NCT00576472|6238541|P3|NOT COMPLETED|MPH Cross Over Phase||0
2545404|NCT00576472|6238542|P2|NOT COMPLETED|MPH Cross Over Phase||0
2545405|NCT00576472|6238543|P1|NOT COMPLETED|MPH Cross Over Phase||0
2545406|NCT00576472|6238529|P15|COMPLETED|MPH Cross Over Phase||0
2545407|NCT00576472|6238530|P14|COMPLETED|MPH Cross Over Phase||0
2545408|NCT00576472|6238531|P13|COMPLETED|MPH Cross Over Phase||21
2545409|NCT00576472|6238532|P12|COMPLETED|MPH Cross Over Phase||17
2545410|NCT00576472|6238533|P11|COMPLETED|MPH Cross Over Phase||22
2545411|NCT00576472|6238534|P10|COMPLETED|MPH Cross Over Phase||22
2545412|NCT00576472|6238535|P9|COMPLETED|MPH Cross Over Phase||16
2545413|NCT00576472|6238536|P8|COMPLETED|MPH Cross Over Phase||20
2545414|NCT00576472|6238537|P7|COMPLETED|MPH Cross Over Phase||0
2545415|NCT00576472|6238538|P6|COMPLETED|MPH Cross Over Phase||0
2545416|NCT00576472|6238539|P5|COMPLETED|MPH Cross Over Phase||0
2545417|NCT00576472|6238540|P4|COMPLETED|MPH Cross Over Phase||0
2545418|NCT00576472|6238541|P3|COMPLETED|MPH Cross Over Phase||0
2545419|NCT00576472|6238542|P2|COMPLETED|MPH Cross Over Phase||0
2545420|NCT00576472|6238543|P1|COMPLETED|MPH Cross Over Phase||0
2545421|NCT00576472|6238529|P15|STARTED|MPH Cross Over Phase||0
2545422|NCT00576472|6238530|P14|STARTED|MPH Cross Over Phase||0
2545423|NCT00576472|6238531|P13|STARTED|MPH Cross Over Phase||21
2545424|NCT00576472|6238532|P12|STARTED|MPH Cross Over Phase||18
2545425|NCT00576472|6238533|P11|STARTED|MPH Cross Over Phase||23
2545426|NCT00576472|6238534|P10|STARTED|MPH Cross Over Phase||22
2545427|NCT00576472|6238535|P9|STARTED|MPH Cross Over Phase||18
2545428|NCT00576472|6238536|P8|STARTED|MPH Cross Over Phase||20
2545429|NCT00576472|6238537|P7|STARTED|MPH Cross Over Phase||12
2545430|NCT00576472|6238538|P6|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
2545431|NCT00576472|6238539|P5|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
2545432|NCT00576472|6238540|P4|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
2545433|NCT00576472|6238541|P3|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
2545434|NCT00576472|6238542|P2|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
2545435|NCT00576472|6238543|P1|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
2545436|NCT00576472|6238529|P15|NOT COMPLETED|MPH In-Lab Phase||0
2545437|NCT00576472|6238530|P14|NOT COMPLETED|MPH In-Lab Phase||0
2545438|NCT00576472|6238531|P13|NOT COMPLETED|MPH In-Lab Phase||0
2545439|NCT00576472|6238532|P12|NOT COMPLETED|MPH In-Lab Phase||0
2545440|NCT00576472|6238533|P11|NOT COMPLETED|MPH In-Lab Phase||0
2545441|NCT00576472|6238534|P10|NOT COMPLETED|MPH In-Lab Phase||0
2545442|NCT00576472|6238535|P9|NOT COMPLETED|MPH In-Lab Phase||0
2545443|NCT00576472|6238536|P8|NOT COMPLETED|MPH In-Lab Phase||0
2545444|NCT00576472|6238537|P7|NOT COMPLETED|MPH In-Lab Phase||0
2545445|NCT00576472|6238538|P6|NOT COMPLETED|MPH In-Lab Phase||0
2545446|NCT00576472|6238539|P5|NOT COMPLETED|MPH In-Lab Phase||0
2545447|NCT00576472|6238540|P4|NOT COMPLETED|MPH In-Lab Phase||335
2545448|NCT00576472|6238541|P3|NOT COMPLETED|MPH In-Lab Phase||0
2545449|NCT00576472|6238542|P2|NOT COMPLETED|MPH In-Lab Phase||0
2545450|NCT00576472|6238543|P1|NOT COMPLETED|MPH In-Lab Phase||0
2545451|NCT00576472|6238529|P15|COMPLETED|MPH In-Lab Phase||0
2545452|NCT00576472|6238530|P14|COMPLETED|MPH In-Lab Phase||0
2545453|NCT00576472|6238531|P13|COMPLETED|MPH In-Lab Phase||0
2545454|NCT00576472|6238532|P12|COMPLETED|MPH In-Lab Phase||0
2545455|NCT00576472|6238533|P11|COMPLETED|MPH In-Lab Phase||0
2545456|NCT00576472|6238534|P10|COMPLETED|MPH In-Lab Phase||0
2545457|NCT00576472|6238535|P9|COMPLETED|MPH In-Lab Phase||0
2545458|NCT00576472|6238536|P8|COMPLETED|MPH In-Lab Phase||0
2545459|NCT00576472|6238537|P7|COMPLETED|MPH In-Lab Phase||0
2545460|NCT00576472|6238538|P6|COMPLETED|MPH In-Lab Phase||67
2545461|NCT00576472|6238539|P5|COMPLETED|MPH In-Lab Phase||67
2545462|NCT00576472|6238540|P4|COMPLETED|MPH In-Lab Phase||0
2545463|NCT00576472|6238541|P3|COMPLETED|MPH In-Lab Phase||0
2545464|NCT00576472|6238542|P2|COMPLETED|MPH In-Lab Phase||0
2545465|NCT00576472|6238543|P1|COMPLETED|MPH In-Lab Phase||0
2545466|NCT00576472|6238529|P15|STARTED|MPH In-Lab Phase||0
2545467|NCT00576472|6238530|P14|STARTED|MPH In-Lab Phase||0
2545468|NCT00576472|6238531|P13|STARTED|MPH In-Lab Phase||0
2545469|NCT00576472|6238532|P12|STARTED|MPH In-Lab Phase||0
2545470|NCT00576472|6238533|P11|STARTED|MPH In-Lab Phase||0
2545471|NCT00576472|6238534|P10|STARTED|MPH In-Lab Phase||0
2545472|NCT00576472|6238535|P9|STARTED|MPH In-Lab Phase||0
2545473|NCT00576472|6238536|P8|STARTED|MPH In-Lab Phase||0
2545474|NCT00576472|6238537|P7|STARTED|MPH In-Lab Phase||0
2545475|NCT00576472|6238538|P6|STARTED|MPH In-Lab Phase||67
2545476|NCT00576472|6238539|P5|STARTED|MPH In-Lab Phase||67
2545477|NCT00576472|6238540|P4|STARTED|MPH In-Lab Phase||335
2545478|NCT00576472|6238541|P3|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
2545479|NCT00576472|6238542|P2|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
2545480|NCT00576472|6238543|P1|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
2545481|NCT00576472|6238529|P15|NOT COMPLETED|Initial Screening||0
2545482|NCT00576472|6238530|P14|NOT COMPLETED|Initial Screening||0
2545483|NCT00576472|6238531|P13|NOT COMPLETED|Initial Screening||0
2545484|NCT00576472|6238532|P12|NOT COMPLETED|Initial Screening||0
2545485|NCT00576472|6238533|P11|NOT COMPLETED|Initial Screening||0
2545486|NCT00576472|6238534|P10|NOT COMPLETED|Initial Screening||0
2545487|NCT00576472|6238535|P9|NOT COMPLETED|Initial Screening||0
2545488|NCT00576472|6238536|P8|NOT COMPLETED|Initial Screening||0
2545489|NCT00576472|6238537|P7|NOT COMPLETED|Initial Screening||0
2545490|NCT00576472|6238538|P6|NOT COMPLETED|Initial Screening||0
2545491|NCT00576472|6238539|P5|NOT COMPLETED|Initial Screening||0
2545492|NCT00576472|6238540|P4|NOT COMPLETED|Initial Screening||0
2545493|NCT00576472|6238541|P3|NOT COMPLETED|Initial Screening||0
2545494|NCT00576472|6238542|P2|NOT COMPLETED|Initial Screening||0
2545495|NCT00576472|6238543|P1|NOT COMPLETED|Initial Screening||0
2545496|NCT00576472|6238529|P15|COMPLETED|Initial Screening||0
2545497|NCT00576472|6238530|P14|COMPLETED|Initial Screening||0
2545498|NCT00576472|6238531|P13|COMPLETED|Initial Screening||0
2545499|NCT00576472|6238532|P12|COMPLETED|Initial Screening||0
2545500|NCT00576472|6238533|P11|COMPLETED|Initial Screening||0
2545501|NCT00576472|6238534|P10|COMPLETED|Initial Screening||0
2545502|NCT00576472|6238535|P9|COMPLETED|Initial Screening||0
2545503|NCT00576472|6238536|P8|COMPLETED|Initial Screening||0
2545504|NCT00576472|6238537|P7|COMPLETED|Initial Screening||0
2545505|NCT00576472|6238538|P6|COMPLETED|Initial Screening||0
2545506|NCT00576472|6238539|P5|COMPLETED|Initial Screening||0
2545507|NCT00576472|6238540|P4|COMPLETED|Initial Screening||0
2545508|NCT00576472|6238541|P3|COMPLETED|Initial Screening||199
2545509|NCT00576472|6238542|P2|COMPLETED|Initial Screening||40
2545510|NCT00576472|6238543|P1|COMPLETED|Initial Screening||230
2545511|NCT00576472|6238529|P15|STARTED|Initial Screening||0
2545512|NCT00576472|6238530|P14|STARTED|Initial Screening||0
2545513|NCT00576472|6238531|P13|STARTED|Initial Screening||0
2545514|NCT00576472|6238532|P12|STARTED|Initial Screening||0
2545515|NCT00576472|6238533|P11|STARTED|Initial Screening||0
2545516|NCT00576472|6238534|P10|STARTED|Initial Screening||0
2545517|NCT00576472|6238535|P9|STARTED|Initial Screening||0
2545518|NCT00576472|6238536|P8|STARTED|Initial Screening||0
2545519|NCT00576472|6238537|P7|STARTED|Initial Screening||0
2545520|NCT00576472|6238538|P6|STARTED|Initial Screening||0
2545521|NCT00576472|6238539|P5|STARTED|Initial Screening||0
2545522|NCT00576472|6238540|P4|STARTED|Initial Screening||0
2545523|NCT00576472|6238541|P3|STARTED|Initial Screening||199
2545524|NCT00576472|6238542|P2|STARTED|Initial Screening||40
2545525|NCT00576472|6238543|P1|STARTED|Initial Screening||230
2545526|NCT00576420|6238636|P3|NOT COMPLETED|Overall Study||1
2545527|NCT00576420|6238637|P2|NOT COMPLETED|Overall Study||0
2545528|NCT00576420|6238638|P1|NOT COMPLETED|Overall Study||0
2545529|NCT00576420|6238636|P3|COMPLETED|Overall Study||22
2545530|NCT00576420|6238637|P2|COMPLETED|Overall Study||24
2545531|NCT00576420|6238638|P1|COMPLETED|Overall Study||26
2545532|NCT00576420|6238636|P3|STARTED|Overall Study||23
2545533|NCT00576420|6238637|P2|STARTED|Overall Study||24
2545534|NCT00576420|6238638|P1|STARTED|Overall Study||26
2545538|NCT00576381|6238815|P1|NOT COMPLETED|Overall Study||7
2545539|NCT00576381|6238815|P1|COMPLETED|Overall Study||23
2545540|NCT00576381|6238815|P1|STARTED|Overall Study||30
2545541|NCT00576316|6238819|P1|NOT COMPLETED|Overall Study||20
2545542|NCT00576316|6238819|P1|COMPLETED|Overall Study|Number of patients who completed study|181
2545543|NCT00576316|6238819|P1|STARTED|Overall Study|Number of patients recruited|201
2545544|NCT00576303|6238824|P1|NOT COMPLETED|Long Term Safety Period||16
2545545|NCT00576303|6238824|P1|COMPLETED|Long Term Safety Period||162
2545546|NCT00576303|6238824|P1|STARTED|Long Term Safety Period||178
2545547|NCT00576303|6238824|P1|NOT COMPLETED|Efficacy Evaluation Period||5
2545548|NCT00576303|6238824|P1|COMPLETED|Efficacy Evaluation Period||178
2545549|NCT00576303|6238824|P1|STARTED|Efficacy Evaluation Period||183
2545550|NCT00576303|6238824|P1|NOT COMPLETED|Dose Titration Period||17
2545551|NCT00576303|6238824|P1|COMPLETED|Dose Titration Period||183
2545552|NCT00576303|6238824|P1|STARTED|Dose Titration Period||200
2545553|NCT00576251|6238835|P2|NOT COMPLETED|Overall Study||1
2545554|NCT00576251|6238836|P1|NOT COMPLETED|Overall Study||1
2545555|NCT00576251|6238835|P2|COMPLETED|Overall Study||111
2545556|NCT00576251|6238836|P1|COMPLETED|Overall Study||108
2545557|NCT00576251|6238835|P2|STARTED|Overall Study||112
2545558|NCT00576251|6238836|P1|STARTED|Overall Study||109
2545559|NCT00576199|6238842|P1|NOT COMPLETED|Overall Study||30
2545560|NCT00576199|6238842|P1|COMPLETED|Overall Study||0
2545561|NCT00576199|6238842|P1|STARTED|Overall Study||30
2545562|NCT00576147|6238851|P1|NOT COMPLETED|Overall Study||0
2545563|NCT00576147|6238851|P1|COMPLETED|Overall Study||431
2545564|NCT00576147|6238851|P1|STARTED|Overall Study||431
2545565|NCT00576056|6238855|P1|NOT COMPLETED|Overall Study||14
2545566|NCT00576056|6238855|P1|COMPLETED|Overall Study||5
2545567|NCT00576056|6238855|P1|STARTED|Overall Study||19
2545568|NCT00575965|6238860|P1|NOT COMPLETED|Overall Study||0
2545569|NCT00575965|6238860|P1|COMPLETED|Overall Study||18
2545570|NCT00575965|6238860|P1|STARTED|Overall Study||18
2545571|NCT00575887|6238865|P1|NOT COMPLETED|Overall Study||0
2545572|NCT00575887|6238865|P1|COMPLETED|Overall Study||25
2545573|NCT00575887|6238865|P1|STARTED|Overall Study||25
2545574|NCT00575666|6238871|P2|NOT COMPLETED|Overall Study||3
2545575|NCT00575666|6238872|P1|NOT COMPLETED|Overall Study||4
2545576|NCT00575666|6238871|P2|COMPLETED|Overall Study||21
2545577|NCT00575666|6238872|P1|COMPLETED|Overall Study||17
2545578|NCT00575666|6238871|P2|STARTED|Overall Study||24
2545579|NCT00575666|6238872|P1|STARTED|Overall Study||21
2545580|NCT00575588|6238912|P2|NOT COMPLETED|Overall Study||283
2545581|NCT00575588|6238913|P1|NOT COMPLETED|Overall Study||263
2545582|NCT00575588|6238912|P2|COMPLETED|Overall Study|Completed 104 weeks of treatment|147
2545583|NCT00575588|6238913|P1|COMPLETED|Overall Study|Completed 104 weeks of treatment|165
2545584|NCT00575588|6238912|P2|STARTED|Overall Study|Randomized and treated|430
2545585|NCT00575588|6238913|P1|STARTED|Overall Study|Randomized and treated|428
2545586|NCT00575510|6238936|P3|NOT COMPLETED|Overall Study||17
2545587|NCT00575510|6238937|P2|NOT COMPLETED|Overall Study||13
2545588|NCT00575510|6238938|P1|NOT COMPLETED|Overall Study||12
2545589|NCT00575510|6238936|P3|COMPLETED|Overall Study||96
2545590|NCT00575510|6238937|P2|COMPLETED|Overall Study||101
2545591|NCT00575510|6238938|P1|COMPLETED|Overall Study||102
2545592|NCT00575510|6238936|P3|STARTED|Overall Study||113
2545593|NCT00575510|6238937|P2|STARTED|Overall Study||114
2545594|NCT00575510|6238938|P1|STARTED|Overall Study||114
2545595|NCT00575380|6238951|P2|NOT COMPLETED|Overall Study||3
2545596|NCT00575380|6238952|P1|NOT COMPLETED|Overall Study||1
2545597|NCT00575380|6238951|P2|COMPLETED|Overall Study||55
2545598|NCT00575380|6238952|P1|COMPLETED|Overall Study||57
2545599|NCT00575380|6238951|P2|STARTED|Overall Study||58
2545600|NCT00575380|6238952|P1|STARTED|Overall Study||58
2545601|NCT00575367|6238962|P2|NOT COMPLETED|Overall Study||0
2545602|NCT00575367|6238963|P1|NOT COMPLETED|Overall Study||0
2545603|NCT00575367|6238962|P2|COMPLETED|Overall Study||18
2545604|NCT00575367|6238963|P1|COMPLETED|Overall Study||19
2545605|NCT00575367|6238962|P2|STARTED|Overall Study||18
2545606|NCT00575367|6238963|P1|STARTED|Overall Study||19
2545607|NCT00575185|6238971|P2|NOT COMPLETED|Overall Study||0
2545608|NCT00575185|6238972|P1|NOT COMPLETED|Overall Study||0
2545609|NCT00575185|6238971|P2|COMPLETED|Overall Study||11
2545610|NCT00575185|6238972|P1|COMPLETED|Overall Study||12
2545611|NCT00575185|6238971|P2|STARTED|Overall Study||11
2545612|NCT00575185|6238972|P1|STARTED|Overall Study||12
2545613|NCT00575159|6238980|P1|NOT COMPLETED|Overall Study||0
2545614|NCT00575159|6238980|P1|COMPLETED|Overall Study||10
2545615|NCT00575159|6238980|P1|STARTED|Overall Study||10
2545616|NCT00575146|6239088|P1|NOT COMPLETED|Overall Study||3
2545617|NCT00575146|6239088|P1|COMPLETED|Overall Study||17
2545618|NCT00575146|6239088|P1|STARTED|Overall Study||20
2545619|NCT00575094|6239094|P1|NOT COMPLETED|Overall Study||3
2545620|NCT00575094|6239094|P1|COMPLETED|Overall Study||6
2545621|NCT00575094|6239094|P1|STARTED|Overall Study||9
2545622|NCT00575042|6239098|P1|NOT COMPLETED|Overall Study||3
2545623|NCT00575042|6239098|P1|COMPLETED|Overall Study|2 with side effects and 1 lost to follow-up|17
2545624|NCT00575042|6239098|P1|STARTED|Overall Study||20
2545625|NCT00575029|6239103|P1|NOT COMPLETED|Overall Study||0
2545626|NCT00575029|6239103|P1|COMPLETED|Overall Study||7
2545627|NCT00575029|6239103|P1|STARTED|Overall Study||7
2545628|NCT00575016|6239112|P4|NOT COMPLETED|Treatment Cycle 2||0
2545629|NCT00575016|6239113|P3|NOT COMPLETED|Treatment Cycle 2||0
2545630|NCT00575016|6239114|P2|NOT COMPLETED|Treatment Cycle 2||0
2545631|NCT00575016|6239115|P1|NOT COMPLETED|Treatment Cycle 2||1
2545632|NCT00575016|6239112|P4|COMPLETED|Treatment Cycle 2||0
2545633|NCT00575016|6239113|P3|COMPLETED|Treatment Cycle 2||0
2545634|NCT00575016|6239114|P2|COMPLETED|Treatment Cycle 2||0
2545635|NCT00575016|6239115|P1|COMPLETED|Treatment Cycle 2||30
2545636|NCT00575016|6239112|P4|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
2545637|NCT00575016|6239113|P3|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
2545638|NCT00575016|6239114|P2|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
2545639|NCT00575016|6239115|P1|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|31
2545640|NCT00575016|6239112|P4|NOT COMPLETED|Treatment Cycle 1||5
2545641|NCT00575016|6239113|P3|NOT COMPLETED|Treatment Cycle 1||4
2545642|NCT00575016|6239114|P2|NOT COMPLETED|Treatment Cycle 1||5
2545643|NCT00575016|6239115|P1|NOT COMPLETED|Treatment Cycle 1||9
2545644|NCT00575016|6239112|P4|COMPLETED|Treatment Cycle 1|9 pts from Placebo group entered Cycle 2|12
2545645|NCT00575016|6239113|P3|COMPLETED|Treatment Cycle 1|8 pts from 50U group entered Cycle 2|15
2545646|NCT00575016|6239114|P2|COMPLETED|Treatment Cycle 1|11 pts from 100U group entered Cycle 2|16
2545647|NCT00575016|6239115|P1|COMPLETED|Treatment Cycle 1|3 pts from 200U group entered Cycle 2|8
2545648|NCT00575016|6239112|P4|STARTED|Treatment Cycle 1|1 pt randomized to Placebo never received treatment|17
2545649|NCT00575016|6239113|P3|STARTED|Treatment Cycle 1||19
2545650|NCT00575016|6239114|P2|STARTED|Treatment Cycle 1||21
2545651|NCT00575016|6239115|P1|STARTED|Treatment Cycle 1||17
2545652|NCT00574990|6239136|P3|NOT COMPLETED|Overall Study||0
2545653|NCT00574990|6239137|P2|NOT COMPLETED|Overall Study||0
2545654|NCT00574990|6239138|P1|NOT COMPLETED|Overall Study||0
2545655|NCT00574990|6239136|P3|COMPLETED|Overall Study||8
2545656|NCT00574990|6239137|P2|COMPLETED|Overall Study||19
2545657|NCT00574990|6239138|P1|COMPLETED|Overall Study||12
2545658|NCT00574990|6239136|P3|STARTED|Overall Study||8
2545659|NCT00574990|6239137|P2|STARTED|Overall Study||19
2545660|NCT00574990|6239138|P1|STARTED|Overall Study||12
2545661|NCT00574951|6239149|P1|NOT COMPLETED|Overall Study||1
2545662|NCT00574951|6239149|P1|COMPLETED|Overall Study||22
2545663|NCT00574951|6239149|P1|STARTED|Overall Study||23
2545664|NCT00574912|6239157|P1|NOT COMPLETED|Overall Study||8
2545665|NCT00574912|6239157|P1|COMPLETED|Overall Study||12
2545666|NCT00574912|6239157|P1|Completed 2.0|Overall Study||12
2545667|NCT00574912|6239157|P1|Completed 1.5|Overall Study||12
2545668|NCT00574912|6239157|P1|Completed 1.0|Overall Study||12
2545669|NCT00574912|6239157|P1|Completed 0.5|Overall Study||12
2545670|NCT00574912|6239157|P1|Completed Placebo|Overall Study|12 original participants started the trial.|12
2545671|NCT00574912|6239157|P1|STARTED|Overall Study||20
2545672|NCT00574873|6239171|P2|NOT COMPLETED|Overall Study||251
2545673|NCT00574873|6239172|P1|NOT COMPLETED|Overall Study||238
2545674|NCT00574873|6239171|P2|COMPLETED|Overall Study||1
2545675|NCT00574873|6239172|P1|COMPLETED|Overall Study||12
2545676|NCT00574873|6239171|P2|Treated|Overall Study||251
2545677|NCT00574873|6239172|P1|Treated|Overall Study||248
2545678|NCT00574873|6239171|P2|STARTED|Overall Study||252
2545679|NCT00574873|6239172|P1|STARTED|Overall Study||250
2545680|NCT00574847|6239190|P2|NOT COMPLETED|Overall Study||7
2545681|NCT00574847|6239191|P1|NOT COMPLETED|Overall Study||8
2545682|NCT00574847|6239190|P2|COMPLETED|Overall Study||56
2545683|NCT00574847|6239191|P1|COMPLETED|Overall Study||56
2545684|NCT00574847|6239190|P2|STARTED|Overall Study||63
2545685|NCT00574847|6239191|P1|STARTED|Overall Study||64
2545686|NCT00574834|6239226|P3|NOT COMPLETED|Overall Study||0
2545687|NCT00574834|6239227|P2|NOT COMPLETED|Overall Study||0
2545688|NCT00574834|6239228|P1|NOT COMPLETED|Overall Study||0
2545689|NCT00574834|6239226|P3|COMPLETED|Overall Study||4
2545690|NCT00574834|6239227|P2|COMPLETED|Overall Study||4
2545691|NCT00574834|6239228|P1|COMPLETED|Overall Study||9
2545692|NCT00574834|6239226|P3|STARTED|Overall Study||4
2545693|NCT00574834|6239227|P2|STARTED|Overall Study||4
2545694|NCT00574834|6239228|P1|STARTED|Overall Study||9
2545695|NCT00574795|6239236|P1|NOT COMPLETED|Toddler Dose||1
2545696|NCT00574795|6239236|P1|COMPLETED|Toddler Dose||184
2545697|NCT00574795|6239236|P1|STARTED|Toddler Dose||185
2545698|NCT00574795|6239236|P1|NOT COMPLETED|After Infant Series||3
2545699|NCT00574795|6239236|P1|COMPLETED|After Infant Series||185
2545700|NCT00574795|6239236|P1|STARTED|After Infant Series||188
2545701|NCT00574795|6239236|P1|NOT COMPLETED|Infant Series||5
2545702|NCT00574795|6239236|P1|COMPLETED|Infant Series||188
2545703|NCT00574795|6239236|P1|Vaccinated Dose 3|Infant Series||190
2545704|NCT00574795|6239236|P1|Vaccinated Dose 2|Infant Series||190
2545705|NCT00574795|6239236|P1|Vaccinated Dose 1|Infant Series||193
2545706|NCT00574795|6239236|P1|STARTED|Infant Series||193
2545707|NCT00574704|6239257|P4|NOT COMPLETED|Overall Study||0
2545708|NCT00574704|6239258|P3|NOT COMPLETED|Overall Study||1
2545709|NCT00574704|6239259|P2|NOT COMPLETED|Overall Study||0
2545710|NCT00574704|6239260|P1|NOT COMPLETED|Overall Study||0
2545711|NCT00574704|6239257|P4|COMPLETED|Overall Study||10
2545712|NCT00574704|6239258|P3|COMPLETED|Overall Study||9
2545713|NCT00574704|6239259|P2|COMPLETED|Overall Study||10
2545714|NCT00574704|6239260|P1|COMPLETED|Overall Study||10
2545715|NCT00574704|6239257|P4|STARTED|Overall Study||10
2545716|NCT00574704|6239258|P3|STARTED|Overall Study||10
2545717|NCT00574704|6239259|P2|STARTED|Overall Study||10
2545718|NCT00574704|6239260|P1|STARTED|Overall Study||10
2545719|NCT00574548|6239272|P2|NOT COMPLETED|Overall Study||16
2545720|NCT00574548|6239273|P1|NOT COMPLETED|Overall Study||61
2545721|NCT00574548|6239272|P2|COMPLETED|Overall Study||222
2545722|NCT00574548|6239273|P1|COMPLETED|Overall Study||421
2545723|NCT00574548|6239272|P2|Completed Vax 2 (6 Month Contact)|Overall Study||222
2545724|NCT00574548|6239273|P1|Completed Vax 2 (6 Month Contact)|Overall Study||421
2545725|NCT00574548|6239272|P2|Received Vax 2|Overall Study||223
2545726|NCT00574548|6239273|P1|Received Vax 2|Overall Study||427
2545727|NCT00574548|6239272|P2|Withdrawn Before Vax 2|Overall Study||11
2545728|NCT00574548|6239273|P1|Withdrawn Before Vax 2|Overall Study||41
2545729|NCT00574548|6239272|P2|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||3
2545730|NCT00574548|6239273|P1|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||7
2545731|NCT00574548|6239272|P2|Completed Vax 1 (6 Month Contact)|Overall Study||234
2545732|NCT00574548|6239273|P1|Completed Vax 1 (6 Month Contact)|Overall Study||468
2545733|NCT00574548|6239272|P2|Received Vaccination 1 (Vax 1)|Overall Study||237
2545734|NCT00574548|6239273|P1|Received Vaccination 1 (Vax 1)|Overall Study||478
2545735|NCT00574548|6239272|P2|STARTED|Overall Study||238
2545736|NCT00574548|6239273|P1|STARTED|Overall Study||482
2545737|NCT00574405|6239319|P2|NOT COMPLETED|Overall Study||2
2545738|NCT00574405|6239320|P1|NOT COMPLETED|Overall Study||3
2545739|NCT00574405|6239319|P2|COMPLETED|Overall Study||10
2545740|NCT00574405|6239320|P1|COMPLETED|Overall Study||9
2545741|NCT00574405|6239319|P2|STARTED|Overall Study||12
2545742|NCT00574405|6239320|P1|STARTED|Overall Study||12
2545743|NCT00574340|6239326|P2|NOT COMPLETED|Study 2 (2 Days)||0
2545744|NCT00574340|6239327|P1|NOT COMPLETED|Study 2 (2 Days)||0
2545745|NCT00574340|6239326|P2|COMPLETED|Study 2 (2 Days)||6
2545746|NCT00574340|6239327|P1|COMPLETED|Study 2 (2 Days)||6
2545747|NCT00574340|6239326|P2|STARTED|Study 2 (2 Days)||6
2545748|NCT00574340|6239327|P1|STARTED|Study 2 (2 Days)||6
2545749|NCT00574340|6239326|P2|NOT COMPLETED|Study 1 (2 Days)||0
2545750|NCT00574340|6239327|P1|NOT COMPLETED|Study 1 (2 Days)||0
2545751|NCT00574340|6239326|P2|COMPLETED|Study 1 (2 Days)||10
2545752|NCT00574340|6239327|P1|COMPLETED|Study 1 (2 Days)||10
2545753|NCT00574340|6239326|P2|STARTED|Study 1 (2 Days)||10
2545754|NCT00574340|6239327|P1|STARTED|Study 1 (2 Days)||10
2545755|NCT00574288|6239340|P7|NOT COMPLETED|Overall Study||28
2545756|NCT00574288|6239341|P6|NOT COMPLETED|Overall Study||26
2545757|NCT00574288|6239342|P5|NOT COMPLETED|Overall Study||2
2545758|NCT00574288|6239343|P4|NOT COMPLETED|Overall Study||2
2545759|NCT00574288|6239344|P3|NOT COMPLETED|Overall Study||3
2545760|NCT00574288|6239345|P2|NOT COMPLETED|Overall Study||3
2545761|NCT00574288|6239346|P1|NOT COMPLETED|Overall Study||20
2545762|NCT00574288|6239340|P7|COMPLETED|Overall Study||14
2545763|NCT00574288|6239341|P6|COMPLETED|Overall Study||4
2545764|NCT00574288|6239342|P5|COMPLETED|Overall Study||1
2545765|NCT00574288|6239343|P4|COMPLETED|Overall Study||1
2545766|NCT00574288|6239344|P3|COMPLETED|Overall Study||0
2545767|NCT00574288|6239345|P2|COMPLETED|Overall Study||0
2545768|NCT00574288|6239346|P1|COMPLETED|Overall Study||0
2545769|NCT00574288|6239340|P7|STARTED|Overall Study||42
2545770|NCT00574288|6239341|P6|STARTED|Overall Study||30
2545771|NCT00574288|6239342|P5|STARTED|Overall Study||3
2545772|NCT00574288|6239343|P4|STARTED|Overall Study||3
2545773|NCT00574288|6239344|P3|STARTED|Overall Study||3
2545774|NCT00574288|6239345|P2|STARTED|Overall Study||3
2545775|NCT00574288|6239346|P1|STARTED|Overall Study||20
2545776|NCT00574275|6239384|P2|NOT COMPLETED|Overall Study||271
2545777|NCT00574275|6239385|P1|NOT COMPLETED|Overall Study||275
2545778|NCT00574275|6239384|P2|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
2545779|NCT00574275|6239385|P1|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
2545780|NCT00574275|6239384|P2|SAFETY POPULATION|Overall Study|Includes 2 participants from the Placebo and Gemcitabine arm who received 1 dose of Aflibercept|270
2545781|NCT00574275|6239385|P1|SAFETY POPULATION|Overall Study|Excludes 2 participants who received 1 dose of Aflibercept|271
2545782|NCT00574275|6239384|P2|TREATED|Overall Study||268
2545783|NCT00574275|6239385|P1|TREATED|Overall Study||273
2545784|NCT00574275|6239384|P2|STARTED|Overall Study||271
2545785|NCT00574275|6239385|P1|STARTED|Overall Study||275
2545786|NCT00574249|6239403|P2|NOT COMPLETED|Overall Study||28
2545787|NCT00574249|6239404|P1|NOT COMPLETED|Overall Study||26
2545788|NCT00574249|6239403|P2|COMPLETED|Overall Study||338
2545789|NCT00574249|6239404|P1|COMPLETED|Overall Study||338
2545790|NCT00574249|6239403|P2|STARTED|Overall Study||366
2545791|NCT00574249|6239404|P1|STARTED|Overall Study||364
2545792|NCT00574236|6239444|P1|NOT COMPLETED|Overall Study||0
2545793|NCT00574236|6239444|P1|COMPLETED|Overall Study||4
2545794|NCT00574236|6239444|P1|STARTED|Overall Study||4
2545795|NCT00574171|6239449|P1|NOT COMPLETED|Overall Study||0
2545796|NCT00574171|6239449|P1|COMPLETED|Overall Study||29
2545797|NCT00574171|6239449|P1|STARTED|Overall Study||29
2545798|NCT00574145|6239455|P2|NOT COMPLETED|Overall Study||1
2545799|NCT00574145|6239456|P1|NOT COMPLETED|Overall Study||2
2545800|NCT00574145|6239455|P2|COMPLETED|Overall Study||21
2545801|NCT00574145|6239456|P1|COMPLETED|Overall Study||20
2545802|NCT00574145|6239455|P2|STARTED|Overall Study||22
2545803|NCT00574145|6239456|P1|STARTED|Overall Study||22
2545804|NCT00574119|6239466|P1|NOT COMPLETED|Overall Study||4
2545805|NCT00574119|6239466|P1|COMPLETED|Overall Study||12
2545806|NCT00574119|6239466|P1|STARTED|Overall Study||16
2545807|NCT00574080|6239480|P2|NOT COMPLETED|Overall Study||10
2545808|NCT00574080|6239481|P1|NOT COMPLETED|Overall Study||10
2545809|NCT00574080|6239480|P2|COMPLETED|Overall Study||0
2545810|NCT00574080|6239481|P1|COMPLETED|Overall Study||0
2545811|NCT00574080|6239480|P2|STARTED|Overall Study||10
2545812|NCT00574080|6239481|P1|STARTED|Overall Study||10
2545813|NCT00574067|6239491|P4|NOT COMPLETED|Overall Study||0
2545814|NCT00574067|6239492|P3|NOT COMPLETED|Overall Study||0
2545815|NCT00574067|6239493|P2|NOT COMPLETED|Overall Study||1
2545816|NCT00574067|6239494|P1|NOT COMPLETED|Overall Study||1
2545817|NCT00574067|6239491|P4|COMPLETED|Overall Study||53
2545818|NCT00574067|6239492|P3|COMPLETED|Overall Study||54
2545819|NCT00574067|6239493|P2|COMPLETED|Overall Study||52
2545820|NCT00574067|6239494|P1|COMPLETED|Overall Study||52
2545821|NCT00574067|6239491|P4|STARTED|Overall Study||53
2545822|NCT00574067|6239492|P3|STARTED|Overall Study||54
2545823|NCT00574067|6239493|P2|STARTED|Overall Study||53
2545824|NCT00574067|6239494|P1|STARTED|Overall Study||53
2545825|NCT00573989|6239528|P4|NOT COMPLETED|Erlotinib 125mg- Phase II||0
2545826|NCT00573989|6239529|P3|NOT COMPLETED|Erlotinib 125mg- Phase II||0
2545827|NCT00573989|6239530|P2|NOT COMPLETED|Erlotinib 125mg- Phase II||0
2545828|NCT00573989|6239531|P1|NOT COMPLETED|Erlotinib 125mg- Phase II||0
2545829|NCT00573989|6239528|P4|COMPLETED|Erlotinib 125mg- Phase II||12
2545830|NCT00573989|6239529|P3|COMPLETED|Erlotinib 125mg- Phase II||0
2545831|NCT00573989|6239530|P2|COMPLETED|Erlotinib 125mg- Phase II||0
2545832|NCT00573989|6239531|P1|COMPLETED|Erlotinib 125mg- Phase II||0
2545833|NCT00573989|6239528|P4|STARTED|Erlotinib 125mg- Phase II||12
2545834|NCT00573989|6239529|P3|STARTED|Erlotinib 125mg- Phase II||0
2545835|NCT00573989|6239530|P2|STARTED|Erlotinib 125mg- Phase II||0
2545836|NCT00573989|6239531|P1|STARTED|Erlotinib 125mg- Phase II||0
2545837|NCT00573989|6239528|P4|NOT COMPLETED|Erlotinib Phase I||0
2545838|NCT00573989|6239529|P3|NOT COMPLETED|Erlotinib Phase I||0
2545839|NCT00573989|6239530|P2|NOT COMPLETED|Erlotinib Phase I||0
2545840|NCT00573989|6239531|P1|NOT COMPLETED|Erlotinib Phase I||0
2545841|NCT00573989|6239528|P4|COMPLETED|Erlotinib Phase I||0
2545842|NCT00573989|6239529|P3|COMPLETED|Erlotinib Phase I||5
2545843|NCT00573989|6239530|P2|COMPLETED|Erlotinib Phase I||6
2545844|NCT00573989|6239531|P1|COMPLETED|Erlotinib Phase I||4
2545845|NCT00573989|6239528|P4|STARTED|Erlotinib Phase I||0
2545846|NCT00573989|6239529|P3|STARTED|Erlotinib Phase I||5
2545847|NCT00573989|6239530|P2|STARTED|Erlotinib Phase I||6
2545848|NCT00573989|6239531|P1|STARTED|Erlotinib Phase I||4
2545849|NCT00573937|6239550|P2|NOT COMPLETED|Overall Study||1
2545850|NCT00573937|6239551|P1|NOT COMPLETED|Overall Study||0
2545851|NCT00573937|6239550|P2|COMPLETED|Overall Study||0
2545852|NCT00573937|6239551|P1|COMPLETED|Overall Study||0
2545853|NCT00573937|6239550|P2|STARTED|Overall Study||1
2545854|NCT00573937|6239551|P1|STARTED|Overall Study||0
2545855|NCT00573872|6239559|P1|NOT COMPLETED|Overall Study||11
2545856|NCT00573872|6239559|P1|COMPLETED|Overall Study|# of patients that completed treatment|32
2545857|NCT00573872|6239559|P1|STARTED|Overall Study|# of patients that signed consent|43
2545858|NCT00573859|6239565|P1|NOT COMPLETED|Smoking Versus Abstinence||12
2545859|NCT00573859|6239565|P1|COMPLETED|Smoking Versus Abstinence||15
2545860|NCT00573859|6239565|P1|STARTED|Smoking Versus Abstinence||27
2545861|NCT00573859|6239565|P1|NOT COMPLETED|Medication Versus Placebo||12
2545862|NCT00573859|6239565|P1|COMPLETED|Medication Versus Placebo||15
2545863|NCT00573859|6239565|P1|STARTED|Medication Versus Placebo||27
2545864|NCT00573833|6239571|P1|NOT COMPLETED|Overall Study||2
2545865|NCT00573833|6239571|P1|COMPLETED|Overall Study||21
2545866|NCT00573833|6239571|P1|STARTED|Overall Study||23
2545867|NCT00573794|6239578|P1|NOT COMPLETED|Overall Study||330
2545868|NCT00573794|6239578|P1|COMPLETED|Overall Study||255
2545869|NCT00573794|6239578|P1|STARTED|Overall Study||585
2545870|NCT00573768|6239609|P3|NOT COMPLETED|Overall Study||4
2545871|NCT00573768|6239610|P2|NOT COMPLETED|Overall Study||2
2545872|NCT00573768|6239611|P1|NOT COMPLETED|Overall Study||2
2545873|NCT00573768|6239609|P3|COMPLETED|Overall Study||87
2545874|NCT00573768|6239610|P2|COMPLETED|Overall Study||89
2545875|NCT00573768|6239611|P1|COMPLETED|Overall Study||87
2545876|NCT00573768|6239609|P3|STARTED|Overall Study||91
2545877|NCT00573768|6239610|P2|STARTED|Overall Study||91
2545878|NCT00573768|6239611|P1|STARTED|Overall Study||89
2545879|NCT00573755|6239621|P2|NOT COMPLETED|Overall Study||0
2545880|NCT00573755|6239622|P1|NOT COMPLETED|Overall Study||1
2545881|NCT00573755|6239621|P2|COMPLETED|Overall Study||2
2545882|NCT00573755|6239622|P1|COMPLETED|Overall Study||1
2545883|NCT00573755|6239621|P2|STARTED|Overall Study||2
2545884|NCT00573755|6239622|P1|STARTED|Overall Study||2
2545885|NCT00573534|6239638|P1|NOT COMPLETED|Overall Study||3
2545886|NCT00573534|6239638|P1|COMPLETED|Overall Study||5
2545887|NCT00573534|6239638|P1|STARTED|Overall Study||8
2545888|NCT00573508|6239645|P2|NOT COMPLETED|Overall Study||41
2545889|NCT00573508|6239646|P1|NOT COMPLETED|Overall Study||64
2545890|NCT00573508|6239645|P2|COMPLETED|Overall Study||345
2545891|NCT00573508|6239646|P1|COMPLETED|Overall Study||318
2545892|NCT00573508|6239645|P2|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|377
2545893|NCT00573508|6239646|P1|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|374
2545894|NCT00573508|6239645|P2|STARTED|Overall Study||386
2545895|NCT00573508|6239646|P1|STARTED|Overall Study||382
2545896|NCT00573469|6239679|P3|NOT COMPLETED|Overall Study||4
2545897|NCT00573469|6239680|P2|NOT COMPLETED|Overall Study||4
2545898|NCT00573469|6239681|P1|NOT COMPLETED|Overall Study||6
2545899|NCT00573469|6239679|P3|COMPLETED|Overall Study||22
2545900|NCT00573469|6239680|P2|COMPLETED|Overall Study||21
2545901|NCT00573469|6239681|P1|COMPLETED|Overall Study||20
2545902|NCT00573469|6239679|P3|STARTED|Overall Study||26
2545903|NCT00573469|6239680|P2|STARTED|Overall Study||25
2545904|NCT00573469|6239681|P1|STARTED|Overall Study||26
2545905|NCT00573443|6239704|P3|NOT COMPLETED|Open-Label Extension Phase||0
2545906|NCT00573443|6239705|P2|NOT COMPLETED|Open-Label Extension Phase||0
2545907|NCT00573443|6239706|P1|NOT COMPLETED|Open-Label Extension Phase||18
2545908|NCT00573443|6239704|P3|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
2545909|NCT00573443|6239705|P2|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
2545910|NCT00573443|6239706|P1|COMPLETED|Open-Label Extension Phase||235
2545911|NCT00573443|6239704|P3|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
2545912|NCT00573443|6239705|P2|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
2545913|NCT00573443|6239706|P1|Subjects With PBA Secondary to MS|Open-Label Extension Phase||107
2545914|NCT00573443|6239704|P3|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
2545915|NCT00573443|6239705|P2|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
2545916|NCT00573443|6239706|P1|Subjects With PBA Secondary to ALS|Open-Label Extension Phase||146
2545917|NCT00573443|6239704|P3|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
2545918|NCT00573443|6239705|P2|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
2545919|NCT00573443|6239706|P1|STARTED|Open-Label Extension Phase|Subjects who completed any of the arms in the DB phase had the option to enroll in this OLE phase|253
2545920|NCT00573443|6239704|P3|NOT COMPLETED|Double-Blind Phase||15
2545921|NCT00573443|6239705|P2|NOT COMPLETED|Double-Blind Phase||19
2545922|NCT00573443|6239706|P1|NOT COMPLETED|Double-Blind Phase||9
2545923|NCT00573443|6239704|P3|COMPLETED|Double-Blind Phase||94
2545924|NCT00573443|6239705|P2|COMPLETED|Double-Blind Phase||88
2545925|NCT00573443|6239706|P1|COMPLETED|Double-Blind Phase||101
2545926|NCT00573443|6239704|P3|Subjects With PBA Secondary to MS|Double-Blind Phase||45
2545927|NCT00573443|6239705|P2|Subjects With PBA Secondary to MS|Double-Blind Phase||39
2545928|NCT00573443|6239706|P1|Subjects With PBA Secondary to MS|Double-Blind Phase||45
2545929|NCT00573443|6239704|P3|Subjects With PBA Secondary to ALS|Double-Blind Phase||64
2545930|NCT00573443|6239705|P2|Subjects With PBA Secondary to ALS|Double-Blind Phase||68
2545931|NCT00573443|6239706|P1|Subjects With PBA Secondary to ALS|Double-Blind Phase||65
2545932|NCT00573443|6239704|P3|STARTED|Double-Blind Phase||109
2545933|NCT00573443|6239705|P2|STARTED|Double-Blind Phase||107
2545934|NCT00573443|6239706|P1|STARTED|Double-Blind Phase||110
2545935|NCT00573430|6239736|P3|NOT COMPLETED|Overall Study||10
2545936|NCT00573430|6239737|P2|NOT COMPLETED|Overall Study||5
2545937|NCT00573430|6239738|P1|NOT COMPLETED|Overall Study||1
2545938|NCT00573430|6239736|P3|COMPLETED|Overall Study||33
2545939|NCT00573430|6239737|P2|COMPLETED|Overall Study||40
2545940|NCT00573430|6239738|P1|COMPLETED|Overall Study||39
2545941|NCT00573430|6239736|P3|STARTED|Overall Study|randomized|43
2545942|NCT00573430|6239737|P2|STARTED|Overall Study|randomized|45
2545943|NCT00573430|6239738|P1|STARTED|Overall Study|randomized|40
2545944|NCT00573391|6239760|P2|NOT COMPLETED|Overall Study||2
2545945|NCT00573391|6239761|P1|NOT COMPLETED|Overall Study||3
2545946|NCT00573391|6239760|P2|COMPLETED|Overall Study||0
2545947|NCT00573391|6239761|P1|COMPLETED|Overall Study||0
2545948|NCT00573391|6239760|P2|STARTED|Overall Study||2
2545949|NCT00573391|6239761|P1|STARTED|Overall Study||3
2545950|NCT00573313|6239771|P4|NOT COMPLETED|Overall Study||0
2545951|NCT00573313|6239772|P3|NOT COMPLETED|Overall Study||6
2545952|NCT00573313|6239773|P2|NOT COMPLETED|Overall Study||0
2545953|NCT00573313|6239774|P1|NOT COMPLETED|Overall Study||5
2545954|NCT00573313|6239771|P4|COMPLETED|Overall Study||26
2545955|NCT00573313|6239772|P3|COMPLETED|Overall Study||13
2545956|NCT00573313|6239773|P2|COMPLETED|Overall Study||28
2545957|NCT00573313|6239774|P1|COMPLETED|Overall Study||13
2545958|NCT00573313|6239771|P4|STARTED|Overall Study||26
2545959|NCT00573313|6239772|P3|STARTED|Overall Study|Nineteen recruited to start.|19
2545960|NCT00573313|6239773|P2|STARTED|Overall Study||28
2545961|NCT00573313|6239774|P1|STARTED|Overall Study|Eighteen participants recruited to start.|18
2545962|NCT00573287|6239784|P2|NOT COMPLETED|Overall Study||3
2545963|NCT00573287|6239785|P1|NOT COMPLETED|Overall Study||4
2545964|NCT00573287|6239784|P2|COMPLETED|Overall Study||4
2545965|NCT00573287|6239785|P1|COMPLETED|Overall Study||3
2545966|NCT00573287|6239784|P2|STARTED|Overall Study||7
2545967|NCT00573287|6239785|P1|STARTED|Overall Study||7
2545968|NCT00573261|6239795|P2|NOT COMPLETED|Overall Study||5
2545969|NCT00573261|6239796|P1|NOT COMPLETED|Overall Study||6
2545970|NCT00573261|6239795|P2|COMPLETED|Overall Study||15
2545971|NCT00573261|6239796|P1|COMPLETED|Overall Study||14
2545972|NCT00573261|6239795|P2|STARTED|Overall Study||20
2545973|NCT00573261|6239796|P1|STARTED|Overall Study||20
2545974|NCT00573248|6239824|P2|NOT COMPLETED|Overall Study||11
2545975|NCT00573248|6239825|P1|NOT COMPLETED|Overall Study||15
2545976|NCT00573248|6239824|P2|COMPLETED|Overall Study||27
2545977|NCT00573248|6239825|P1|COMPLETED|Overall Study||25
2545978|NCT00573248|6239824|P2|Nicotine Patches and Placebo Patches|Overall Study||27
2545979|NCT00573248|6239825|P1|Nicotine Patches and Placebo Patches|Overall Study||25
2545980|NCT00573248|6239824|P2|STARTED|Overall Study||38
2545981|NCT00573248|6239825|P1|STARTED|Overall Study||40
2545982|NCT00573183|6239839|P2|NOT COMPLETED|Overall Study||63
2545983|NCT00573183|6239840|P1|NOT COMPLETED|Overall Study||72
2545984|NCT00573183|6239839|P2|COMPLETED|Overall Study||174
2545985|NCT00573183|6239840|P1|COMPLETED|Overall Study||162
2545986|NCT00573183|6239839|P2|STARTED|Overall Study||237
2545987|NCT00573183|6239840|P1|STARTED|Overall Study||234
2545988|NCT00573170|6239848|P6|NOT COMPLETED|Third Treatment Period||2
2545989|NCT00573170|6239849|P5|NOT COMPLETED|Third Treatment Period||0
2545990|NCT00573170|6239850|P4|NOT COMPLETED|Third Treatment Period||0
2545991|NCT00573170|6239851|P3|NOT COMPLETED|Third Treatment Period||0
2545992|NCT00573170|6239852|P2|NOT COMPLETED|Third Treatment Period||0
2545993|NCT00573170|6239853|P1|NOT COMPLETED|Third Treatment Period||1
2545994|NCT00573170|6239848|P6|COMPLETED|Third Treatment Period||51
2545995|NCT00573170|6239849|P5|COMPLETED|Third Treatment Period||51
2545996|NCT00573170|6239850|P4|COMPLETED|Third Treatment Period||56
2545997|NCT00573170|6239851|P3|COMPLETED|Third Treatment Period||55
2545998|NCT00573170|6239852|P2|COMPLETED|Third Treatment Period||54
2545999|NCT00573170|6239853|P1|COMPLETED|Third Treatment Period||50
2546000|NCT00573170|6239848|P6|STARTED|Third Treatment Period||53
2546001|NCT00573170|6239849|P5|STARTED|Third Treatment Period||51
2546002|NCT00573170|6239850|P4|STARTED|Third Treatment Period||56
2546003|NCT00573170|6239851|P3|STARTED|Third Treatment Period||55
2546004|NCT00573170|6239852|P2|STARTED|Third Treatment Period||54
2546005|NCT00573170|6239853|P1|STARTED|Third Treatment Period||51
2546006|NCT00573170|6239848|P6|NOT COMPLETED|Second Washout Period||2
2546007|NCT00573170|6239849|P5|NOT COMPLETED|Second Washout Period||8
2546008|NCT00573170|6239850|P4|NOT COMPLETED|Second Washout Period||5
2546009|NCT00573170|6239851|P3|NOT COMPLETED|Second Washout Period||4
2546010|NCT00573170|6239852|P2|NOT COMPLETED|Second Washout Period||4
2546011|NCT00573170|6239853|P1|NOT COMPLETED|Second Washout Period||5
2546012|NCT00573170|6239848|P6|COMPLETED|Second Washout Period||53
2546013|NCT00573170|6239849|P5|COMPLETED|Second Washout Period||51
2546014|NCT00573170|6239850|P4|COMPLETED|Second Washout Period||56
2546015|NCT00573170|6239851|P3|COMPLETED|Second Washout Period||55
2546016|NCT00573170|6239852|P2|COMPLETED|Second Washout Period||54
2546017|NCT00573170|6239853|P1|COMPLETED|Second Washout Period||51
2546018|NCT00573170|6239848|P6|STARTED|Second Washout Period||55
2546019|NCT00573170|6239849|P5|STARTED|Second Washout Period||59
2546020|NCT00573170|6239850|P4|STARTED|Second Washout Period||61
2546021|NCT00573170|6239851|P3|STARTED|Second Washout Period||59
2546022|NCT00573170|6239852|P2|STARTED|Second Washout Period||58
2546023|NCT00573170|6239853|P1|STARTED|Second Washout Period||56
2546024|NCT00573170|6239848|P6|NOT COMPLETED|Second Treatment Period||0
2546025|NCT00573170|6239849|P5|NOT COMPLETED|Second Treatment Period||0
2546026|NCT00573170|6239850|P4|NOT COMPLETED|Second Treatment Period||0
2546027|NCT00573170|6239851|P3|NOT COMPLETED|Second Treatment Period||0
2546028|NCT00573170|6239852|P2|NOT COMPLETED|Second Treatment Period||0
2546029|NCT00573170|6239853|P1|NOT COMPLETED|Second Treatment Period||0
2546030|NCT00573170|6239848|P6|COMPLETED|Second Treatment Period||55
2546031|NCT00573170|6239849|P5|COMPLETED|Second Treatment Period||59
2546032|NCT00573170|6239850|P4|COMPLETED|Second Treatment Period||61
2546033|NCT00573170|6239851|P3|COMPLETED|Second Treatment Period||59
2546034|NCT00573170|6239852|P2|COMPLETED|Second Treatment Period||58
2546035|NCT00573170|6239853|P1|COMPLETED|Second Treatment Period||56
2546036|NCT00573170|6239848|P6|STARTED|Second Treatment Period||55
2546037|NCT00573170|6239849|P5|STARTED|Second Treatment Period||59
2546038|NCT00573170|6239850|P4|STARTED|Second Treatment Period||61
2546039|NCT00573170|6239851|P3|STARTED|Second Treatment Period||59
2546040|NCT00573170|6239852|P2|STARTED|Second Treatment Period||58
2546041|NCT00573170|6239853|P1|STARTED|Second Treatment Period||56
2546042|NCT00573170|6239848|P6|NOT COMPLETED|First Washout Period||7
2546043|NCT00573170|6239849|P5|NOT COMPLETED|First Washout Period||3
2546044|NCT00573170|6239850|P4|NOT COMPLETED|First Washout Period||5
2546045|NCT00573170|6239851|P3|NOT COMPLETED|First Washout Period||1
2546046|NCT00573170|6239852|P2|NOT COMPLETED|First Washout Period||2
2546047|NCT00573170|6239853|P1|NOT COMPLETED|First Washout Period||8
2546048|NCT00573170|6239848|P6|COMPLETED|First Washout Period||55
2546049|NCT00573170|6239849|P5|COMPLETED|First Washout Period|Source data list 4 noncompleters; per number starting next period, there were only 3 noncompleters.|59
2546050|NCT00573170|6239850|P4|COMPLETED|First Washout Period||61
2546051|NCT00573170|6239851|P3|COMPLETED|First Washout Period||59
2546052|NCT00573170|6239852|P2|COMPLETED|First Washout Period||58
2546053|NCT00573170|6239853|P1|COMPLETED|First Washout Period||56
2546054|NCT00573170|6239848|P6|STARTED|First Washout Period||62
2546055|NCT00573170|6239849|P5|STARTED|First Washout Period||62
2546056|NCT00573170|6239850|P4|STARTED|First Washout Period||66
2546057|NCT00573170|6239851|P3|STARTED|First Washout Period||60
2546058|NCT00573170|6239852|P2|STARTED|First Washout Period||60
2546059|NCT00573170|6239853|P1|STARTED|First Washout Period||64
2546060|NCT00573170|6239848|P6|NOT COMPLETED|First Treatment Period||0
2546061|NCT00573170|6239849|P5|NOT COMPLETED|First Treatment Period||1
2546062|NCT00573170|6239850|P4|NOT COMPLETED|First Treatment Period||0
2546063|NCT00573170|6239851|P3|NOT COMPLETED|First Treatment Period||0
2546064|NCT00573170|6239852|P2|NOT COMPLETED|First Treatment Period||0
2546065|NCT00573170|6239853|P1|NOT COMPLETED|First Treatment Period||0
2546066|NCT00573170|6239848|P6|COMPLETED|First Treatment Period||62
2546067|NCT00573170|6239849|P5|COMPLETED|First Treatment Period||62
2546068|NCT00573170|6239850|P4|COMPLETED|First Treatment Period||66
2546069|NCT00573170|6239851|P3|COMPLETED|First Treatment Period||60
2546070|NCT00573170|6239852|P2|COMPLETED|First Treatment Period||60
2546071|NCT00573170|6239853|P1|COMPLETED|First Treatment Period||64
2546072|NCT00573170|6239848|P6|STARTED|First Treatment Period||62
2546073|NCT00573170|6239849|P5|STARTED|First Treatment Period||63
2546074|NCT00573170|6239850|P4|STARTED|First Treatment Period||66
2546075|NCT00573170|6239851|P3|STARTED|First Treatment Period||60
2546076|NCT00573170|6239852|P2|STARTED|First Treatment Period||60
2546077|NCT00573170|6239853|P1|STARTED|First Treatment Period||64
2546078|NCT00573157|6239929|P2|NOT COMPLETED|Overall Study||2
2546079|NCT00573157|6239930|P1|NOT COMPLETED|Overall Study||4
2546080|NCT00573157|6239929|P2|COMPLETED|Overall Study||0
2546081|NCT00573157|6239930|P1|COMPLETED|Overall Study||0
2546082|NCT00573157|6239929|P2|STARTED|Overall Study||2
2546083|NCT00573157|6239930|P1|STARTED|Overall Study||4
2546084|NCT00573144|6239942|P2|NOT COMPLETED|Overall Study||3
2546085|NCT00573144|6239943|P1|NOT COMPLETED|Overall Study||2
2546086|NCT00573144|6239942|P2|COMPLETED|Overall Study||25
2546087|NCT00573144|6239943|P1|COMPLETED|Overall Study||28
2546088|NCT00573144|6239942|P2|STARTED|Overall Study||28
2546089|NCT00573144|6239943|P1|STARTED|Overall Study||30
2546090|NCT00573131|6239955|P2|NOT COMPLETED|Overall Study||8
2546091|NCT00573131|6239956|P1|NOT COMPLETED|Overall Study||10
2546092|NCT00573131|6239955|P2|COMPLETED|Overall Study||57
2546093|NCT00573131|6239956|P1|COMPLETED|Overall Study||62
2546094|NCT00573131|6239955|P2|STARTED|Overall Study||65
2546095|NCT00573131|6239956|P1|STARTED|Overall Study||72
2546096|NCT00573066|6239962|P1|NOT COMPLETED|Overall Study||20
2546097|NCT00573066|6239962|P1|COMPLETED|Overall Study||36
2546098|NCT00573066|6239962|P1|STARTED|Overall Study||56
2546099|NCT00572936|6239966|P6|NOT COMPLETED|Third Intervention||0
2546100|NCT00572936|6239967|P5|NOT COMPLETED|Third Intervention||0
2546101|NCT00572936|6239968|P4|NOT COMPLETED|Third Intervention||0
2546102|NCT00572936|6239969|P3|NOT COMPLETED|Third Intervention||0
2546103|NCT00572936|6239970|P2|NOT COMPLETED|Third Intervention||0
2546104|NCT00572936|6239971|P1|NOT COMPLETED|Third Intervention||0
2546105|NCT00572936|6239966|P6|COMPLETED|Third Intervention||5
2546106|NCT00572936|6239967|P5|COMPLETED|Third Intervention||3
2546107|NCT00572936|6239968|P4|COMPLETED|Third Intervention||5
2546108|NCT00572936|6239969|P3|COMPLETED|Third Intervention||4
2546109|NCT00572936|6239970|P2|COMPLETED|Third Intervention||3
2546110|NCT00572936|6239971|P1|COMPLETED|Third Intervention||4
2546111|NCT00572936|6239966|P6|STARTED|Third Intervention||5
2546112|NCT00572936|6239967|P5|STARTED|Third Intervention|1 participant dropped out between second intervention and third intervention due to increased IOP|3
2546113|NCT00572936|6239968|P4|STARTED|Third Intervention||5
2546114|NCT00572936|6239969|P3|STARTED|Third Intervention||4
2546115|NCT00572936|6239970|P2|STARTED|Third Intervention||3
2546116|NCT00572936|6239971|P1|STARTED|Third Intervention||4
2546117|NCT00572936|6239966|P6|NOT COMPLETED|Second Intervention||0
2546118|NCT00572936|6239967|P5|NOT COMPLETED|Second Intervention||0
2546119|NCT00572936|6239968|P4|NOT COMPLETED|Second Intervention||0
2546120|NCT00572936|6239969|P3|NOT COMPLETED|Second Intervention||0
2546121|NCT00572936|6239970|P2|NOT COMPLETED|Second Intervention||0
2546122|NCT00572936|6239971|P1|NOT COMPLETED|Second Intervention||0
2546123|NCT00572936|6239966|P6|COMPLETED|Second Intervention||5
2546124|NCT00572936|6239967|P5|COMPLETED|Second Intervention||4
2546125|NCT00572936|6239968|P4|COMPLETED|Second Intervention||5
2546126|NCT00572936|6239969|P3|COMPLETED|Second Intervention||4
2546127|NCT00572936|6239970|P2|COMPLETED|Second Intervention||3
2546128|NCT00572936|6239971|P1|COMPLETED|Second Intervention||4
2546129|NCT00572936|6239966|P6|STARTED|Second Intervention||5
2546130|NCT00572936|6239967|P5|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4
2546131|NCT00572936|6239968|P4|STARTED|Second Intervention||5
2546132|NCT00572936|6239969|P3|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4
2546133|NCT00572936|6239970|P2|STARTED|Second Intervention|1 participant dropped out between the first and second intervention due to car accident|3
2546134|NCT00572936|6239971|P1|STARTED|Second Intervention||4
2546135|NCT00572936|6239966|P6|NOT COMPLETED|First Intervention||0
2546136|NCT00572936|6239967|P5|NOT COMPLETED|First Intervention||0
2546137|NCT00572936|6239968|P4|NOT COMPLETED|First Intervention||0
2546138|NCT00572936|6239969|P3|NOT COMPLETED|First Intervention||0
2546139|NCT00572936|6239970|P2|NOT COMPLETED|First Intervention||0
2546140|NCT00572936|6239971|P1|NOT COMPLETED|First Intervention||0
2546141|NCT00572936|6239966|P6|COMPLETED|First Intervention||5
2546142|NCT00572936|6239967|P5|COMPLETED|First Intervention||5
2546143|NCT00572936|6239968|P4|COMPLETED|First Intervention||5
2546144|NCT00572936|6239969|P3|COMPLETED|First Intervention||5
2546145|NCT00572936|6239970|P2|COMPLETED|First Intervention||4
2546146|NCT00572936|6239971|P1|COMPLETED|First Intervention||4
2546147|NCT00572936|6239966|P6|STARTED|First Intervention||5
2546148|NCT00572936|6239967|P5|STARTED|First Intervention||5
2546149|NCT00572936|6239968|P4|STARTED|First Intervention||5
2546150|NCT00572936|6239969|P3|STARTED|First Intervention||5
2546151|NCT00572936|6239970|P2|STARTED|First Intervention||4
2546152|NCT00572936|6239971|P1|STARTED|First Intervention||4
2546153|NCT00572910|6240006|P11|NOT COMPLETED|Overall Study||3
2546154|NCT00572910|6240007|P10|NOT COMPLETED|Overall Study||6
2546155|NCT00572910|6240008|P9|NOT COMPLETED|Overall Study||3
2546156|NCT00572910|6240009|P8|NOT COMPLETED|Overall Study||4
2546157|NCT00572910|6240010|P7|NOT COMPLETED|Overall Study||4
2546158|NCT00572910|6240011|P6|NOT COMPLETED|Overall Study||3
2546159|NCT00572910|6240012|P5|NOT COMPLETED|Overall Study||2
2546160|NCT00572910|6240013|P4|NOT COMPLETED|Overall Study||4
2546161|NCT00572910|6240014|P3|NOT COMPLETED|Overall Study||2
2546162|NCT00572910|6240015|P2|NOT COMPLETED|Overall Study||3
2546163|NCT00572910|6240016|P1|NOT COMPLETED|Overall Study||4
2546164|NCT00572910|6240006|P11|COMPLETED|Overall Study||15
2546165|NCT00572910|6240007|P10|COMPLETED|Overall Study||13
2546166|NCT00572910|6240008|P9|COMPLETED|Overall Study||16
2546167|NCT00572910|6240009|P8|COMPLETED|Overall Study||15
2546168|NCT00572910|6240010|P7|COMPLETED|Overall Study||15
2546169|NCT00572910|6240011|P6|COMPLETED|Overall Study||16
2546170|NCT00572910|6240012|P5|COMPLETED|Overall Study||17
2546171|NCT00572910|6240013|P4|COMPLETED|Overall Study||14
2546172|NCT00572910|6240014|P3|COMPLETED|Overall Study||17
2546173|NCT00572910|6240015|P2|COMPLETED|Overall Study||15
2546174|NCT00572910|6240016|P1|COMPLETED|Overall Study||15
2546175|NCT00572910|6240006|P11|STARTED|Overall Study||18
2546176|NCT00572910|6240007|P10|STARTED|Overall Study||19
2546177|NCT00572910|6240008|P9|STARTED|Overall Study||19
2546178|NCT00572910|6240009|P8|STARTED|Overall Study||19
2546179|NCT00572910|6240010|P7|STARTED|Overall Study||19
2546180|NCT00572910|6240011|P6|STARTED|Overall Study||19
2546181|NCT00572910|6240012|P5|STARTED|Overall Study||19
2546182|NCT00572910|6240013|P4|STARTED|Overall Study||18
2546183|NCT00572910|6240014|P3|STARTED|Overall Study||19
2546184|NCT00572910|6240015|P2|STARTED|Overall Study||18
2546185|NCT00572910|6240016|P1|STARTED|Overall Study||19
2546186|NCT00572897|6240064|P2|NOT COMPLETED|Overall Study||0
2546187|NCT00572897|6240065|P1|NOT COMPLETED|Overall Study||0
2546188|NCT00572897|6240064|P2|COMPLETED|Overall Study||34
2546189|NCT00572897|6240065|P1|COMPLETED|Overall Study||32
2546190|NCT00572897|6240064|P2|STARTED|Overall Study||34
2546191|NCT00572897|6240065|P1|STARTED|Overall Study||32
2546192|NCT00572832|6240083|P2|NOT COMPLETED|Overall Study||12
2546193|NCT00572832|6240084|P1|NOT COMPLETED|Overall Study||0
2546194|NCT00572832|6240083|P2|COMPLETED|Overall Study||88
2546195|NCT00572832|6240084|P1|COMPLETED|Overall Study||100
2546196|NCT00572832|6240083|P2|STARTED|Overall Study||100
2546197|NCT00572832|6240084|P1|STARTED|Overall Study||100
2546198|NCT00572728|6240090|P1|NOT COMPLETED|Overall Study||39
2546199|NCT00572728|6240090|P1|COMPLETED|Overall Study|51 patients eligible for primary objective analysis|51
2546200|NCT00572728|6240090|P1|RCB Evaluation|Overall Study|Secondary: histopathology was available in 35 patients for RCB evaluation|35
2546201|NCT00572728|6240090|P1|LN Evaluation After NAC|Overall Study|Secondary:38 patients were available for histopathological LN evaluation after NAC|38
2546202|NCT00572728|6240090|P1|Completed FLT3 Scan|Overall Study|Secondary analysis milestone: 43 pts had FLT-3 performed.|43
2546203|NCT00572728|6240090|P1|Pathology Complete|Overall Study||51
2546204|NCT00572728|6240090|P1|Second Chemotherapy Initiated After FLT2|Overall Study||52
2546205|NCT00572728|6240090|P1|Second Chemotherapy Initiated|Overall Study||59
2546206|NCT00572728|6240090|P1|Completed FLT2 Scan|Overall Study||60
2546207|NCT00572728|6240090|P1|First Therapy Initiated|Overall Study||65
2546208|NCT00572728|6240090|P1|Completed FLT1 Scan|Overall Study||67
2546209|NCT00572728|6240090|P1|On Study|Overall Study||71
2546210|NCT00572728|6240090|P1|Did Not Withdraw|Overall Study||72
2546211|NCT00572728|6240090|P1|Enrolled Under Amendment 5 or Later|Overall Study||82
2546212|NCT00572728|6240090|P1|Eligible|Overall Study||87
2546213|NCT00572728|6240090|P1|STARTED|Overall Study|Registered|90
2546214|NCT00572624|6240104|P2|NOT COMPLETED|Overall Study||4
2546215|NCT00572624|6240105|P1|NOT COMPLETED|Overall Study||17
2546216|NCT00572624|6240104|P2|COMPLETED|Overall Study||10
2546217|NCT00572624|6240105|P1|COMPLETED|Overall Study||20
2546218|NCT00572624|6240104|P2|STARTED|Overall Study||14
2546219|NCT00572624|6240105|P1|STARTED|Overall Study||37
2546220|NCT00572572|6240133|P2|NOT COMPLETED|Overall Study||6
2546221|NCT00572572|6240134|P1|NOT COMPLETED|Overall Study||3
2546222|NCT00572572|6240133|P2|COMPLETED|Overall Study||28
2546223|NCT00572572|6240134|P1|COMPLETED|Overall Study||32
2546224|NCT00572572|6240133|P2|STARTED|Overall Study||34
2546225|NCT00572572|6240134|P1|STARTED|Overall Study||35
2546226|NCT00572533|6240152|P2|NOT COMPLETED|Overall Study||3
2546227|NCT00572533|6240153|P1|NOT COMPLETED|Overall Study||7
2546228|NCT00572533|6240152|P2|COMPLETED|Overall Study||28
2546229|NCT00572533|6240153|P1|COMPLETED|Overall Study||24
2546230|NCT00572533|6240152|P2|STARTED|Overall Study||31
2546231|NCT00572533|6240153|P1|STARTED|Overall Study||31
2546232|NCT00572468|6240175|P2|NOT COMPLETED|Overall Study||4
2546233|NCT00572468|6240176|P1|NOT COMPLETED|Overall Study||2
2546234|NCT00572468|6240175|P2|COMPLETED|Overall Study||16
2546235|NCT00572468|6240176|P1|COMPLETED|Overall Study||20
2546236|NCT00572468|6240175|P2|STARTED|Overall Study||20
2546237|NCT00572468|6240176|P1|STARTED|Overall Study||22
2546238|NCT00572260|6240184|P1|NOT COMPLETED|Overall Study||0
2546239|NCT00572260|6240184|P1|COMPLETED|Overall Study||11
2546240|NCT00572260|6240184|P1|STARTED|Overall Study||11
2546241|NCT00572234|6240190|P2|NOT COMPLETED|Overall Study||5
2546242|NCT00572234|6240191|P1|NOT COMPLETED|Overall Study||1
2546243|NCT00572234|6240190|P2|COMPLETED|Overall Study||16
2546244|NCT00572234|6240191|P1|COMPLETED|Overall Study||18
2546245|NCT00572234|6240190|P2|STARTED|Overall Study||21
2546246|NCT00572234|6240191|P1|STARTED|Overall Study||19
2546247|NCT00572195|6240197|P1|NOT COMPLETED|Overall Study||68
2546248|NCT00572195|6240197|P1|COMPLETED|Overall Study||162
2546249|NCT00572195|6240197|P1|STARTED|Overall Study||230
2546250|NCT00572156|6240209|P4|NOT COMPLETED|Overall Study||25
2546251|NCT00572156|6240210|P3|NOT COMPLETED|Overall Study||27
2546252|NCT00572156|6240211|P2|NOT COMPLETED|Overall Study||26
2546253|NCT00572156|6240212|P1|NOT COMPLETED|Overall Study||26
2546254|NCT00572156|6240209|P4|COMPLETED|Overall Study||1
2546255|NCT00572156|6240210|P3|COMPLETED|Overall Study||0
2546256|NCT00572156|6240211|P2|COMPLETED|Overall Study||1
2546257|NCT00572156|6240212|P1|COMPLETED|Overall Study||0
2546258|NCT00572156|6240209|P4|STARTED|Overall Study||26
2546259|NCT00572156|6240210|P3|STARTED|Overall Study||27
2546260|NCT00572156|6240211|P2|STARTED|Overall Study||27
2546261|NCT00572156|6240212|P1|STARTED|Overall Study||26
2546262|NCT00572117|6240272|P2|NOT COMPLETED|Overall Study||2
2546263|NCT00572117|6240273|P1|NOT COMPLETED|Overall Study||2
2546264|NCT00572117|6240272|P2|COMPLETED|Overall Study||5
2546265|NCT00572117|6240273|P1|COMPLETED|Overall Study||3
2546266|NCT00572117|6240272|P2|STARTED|Overall Study||7
2546267|NCT00572117|6240273|P1|STARTED|Overall Study||5
2546268|NCT00572039|6240283|P2|NOT COMPLETED|Overall Study||10
2546269|NCT00572039|6240284|P1|NOT COMPLETED|Overall Study||16
2546270|NCT00572039|6240283|P2|COMPLETED|Overall Study||110
2546271|NCT00572039|6240284|P1|COMPLETED|Overall Study||105
2546272|NCT00572039|6240283|P2|STARTED|Overall Study||120
2546273|NCT00572039|6240284|P1|STARTED|Overall Study||121
2546274|NCT00571987|6240296|P1|NOT COMPLETED|Overall Study||7
2546275|NCT00571987|6240296|P1|COMPLETED|Overall Study||100
2546276|NCT00571987|6240296|P1|STARTED|Overall Study||107
2546277|NCT00571974|6240303|P2|NOT COMPLETED|Phase II||4
2546278|NCT00571974|6240304|P1|NOT COMPLETED|Phase II||0
2546279|NCT00571974|6240303|P2|COMPLETED|Phase II||17
2546280|NCT00571974|6240304|P1|COMPLETED|Phase II||0
2546281|NCT00571974|6240303|P2|STARTED|Phase II|3 participants are from phase I|21
2546282|NCT00571974|6240304|P1|STARTED|Phase II||0
2546283|NCT00571974|6240303|P2|NOT COMPLETED|Phase I||0
2546284|NCT00571974|6240304|P1|NOT COMPLETED|Phase I||0
2546285|NCT00571974|6240303|P2|COMPLETED|Phase I||0
2546286|NCT00571974|6240304|P1|COMPLETED|Phase I||9
2546287|NCT00571974|6240303|P2|STARTED|Phase I||0
2546288|NCT00571974|6240304|P1|STARTED|Phase I||9
2546289|NCT00571961|6240310|P1|NOT COMPLETED|Overall Study||0
2546290|NCT00571961|6240310|P1|COMPLETED|Overall Study||12
2546291|NCT00571961|6240310|P1|STARTED|Overall Study||12
2546292|NCT00571948|6240316|P2|NOT COMPLETED|Overall Study||14
2546293|NCT00571948|6240317|P1|NOT COMPLETED|Overall Study||11
2546294|NCT00571948|6240316|P2|COMPLETED|Overall Study|Excluded n = 3) Reasons: diet record < 75 % of days (n = 2); blood analysis failed (n= 1)|52
2546295|NCT00571948|6240317|P1|COMPLETED|Overall Study|Excluded from analysis (n = 2) Reason: diet record for less than 75 % of days (n = 2)|55
2546296|NCT00571948|6240316|P2|STARTED|Overall Study||66
2546297|NCT00571948|6240317|P1|STARTED|Overall Study||66
2546298|NCT00571922|6240325|P2|NOT COMPLETED|Overall Study||36
2546299|NCT00571922|6240326|P1|NOT COMPLETED|Overall Study||36
2546300|NCT00571922|6240325|P2|COMPLETED|Overall Study||0
2546301|NCT00571922|6240326|P1|COMPLETED|Overall Study||0
2546302|NCT00571922|6240325|P2|STARTED|Overall Study||36
2546303|NCT00571922|6240326|P1|STARTED|Overall Study||36
2546304|NCT00571701|6240336|P2|NOT COMPLETED|Second Intervention 12 Months||1
2546305|NCT00571701|6240337|P1|NOT COMPLETED|Second Intervention 12 Months||3
2546306|NCT00571701|6240336|P2|COMPLETED|Second Intervention 12 Months||20
2546307|NCT00571701|6240337|P1|COMPLETED|Second Intervention 12 Months||13
2546308|NCT00571701|6240336|P2|STARTED|Second Intervention 12 Months||21
2546309|NCT00571701|6240337|P1|STARTED|Second Intervention 12 Months||16
2546310|NCT00571701|6240336|P2|NOT COMPLETED|First Intervention 12 Months||1
2546311|NCT00571701|6240337|P1|NOT COMPLETED|First Intervention 12 Months||3
2546312|NCT00571701|6240336|P2|COMPLETED|First Intervention 12 Months||21
2546313|NCT00571701|6240337|P1|COMPLETED|First Intervention 12 Months||16
2546314|NCT00571701|6240336|P2|STARTED|First Intervention 12 Months||22
2546315|NCT00571701|6240337|P1|STARTED|First Intervention 12 Months||19
2546316|NCT00571688|6240363|P2|NOT COMPLETED|Overall Study||6
2546317|NCT00571688|6240364|P1|NOT COMPLETED|Overall Study||5
2546318|NCT00571688|6240363|P2|COMPLETED|Overall Study||19
2546319|NCT00571688|6240364|P1|COMPLETED|Overall Study||20
2546320|NCT00571688|6240363|P2|STARTED|Overall Study||25
2546321|NCT00571688|6240364|P1|STARTED|Overall Study||25
2546322|NCT00571662|6240370|P1|NOT COMPLETED|Overall Study||8
2546323|NCT00571662|6240370|P1|COMPLETED|Overall Study||68
2546324|NCT00571662|6240370|P1|STARTED|Overall Study||76
2546325|NCT00571649|6240381|P2|NOT COMPLETED|Follow-up Period||528
2546326|NCT00571649|6240382|P1|NOT COMPLETED|Follow-up Period||545
2546327|NCT00571649|6240381|P2|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3107
2546328|NCT00571649|6240382|P1|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3038
2546329|NCT00571649|6240381|P2|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3635
2546330|NCT00571649|6240382|P1|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3583
2546331|NCT00571649|6240381|P2|NOT COMPLETED|Treatment Period||1004
2546332|NCT00571649|6240382|P1|NOT COMPLETED|Treatment Period||1092
2546333|NCT00571649|6240381|P2|COMPLETED|Treatment Period||3047
2546334|NCT00571649|6240382|P1|COMPLETED|Treatment Period||2958
2546335|NCT00571649|6240381|P2|Day 35|Treatment Period||3115
2546336|NCT00571649|6240382|P1|Day 35|Treatment Period||3033
2546337|NCT00571649|6240381|P2|Day 10|Treatment Period||3499
2546338|NCT00571649|6240382|P1|Day 10|Treatment Period||3454
2546339|NCT00571649|6240381|P2|Participants Received Treatment|Treatment Period||4001
2546340|NCT00571649|6240382|P1|Participants Received Treatment|Treatment Period||3997
2546341|NCT00571649|6240381|P2|STARTED|Treatment Period||4051
2546342|NCT00571649|6240382|P1|STARTED|Treatment Period||4050
2546343|NCT00571493|6240414|P7|NOT COMPLETED|Overall Study||0
2546344|NCT00571493|6240415|P6|NOT COMPLETED|Overall Study||0
2546345|NCT00571493|6240416|P5|NOT COMPLETED|Overall Study||0
2546346|NCT00571493|6240417|P4|NOT COMPLETED|Overall Study||0
2546347|NCT00571493|6240418|P3|NOT COMPLETED|Overall Study||0
2546348|NCT00571493|6240419|P2|NOT COMPLETED|Overall Study||0
2546349|NCT00571493|6240420|P1|NOT COMPLETED|Overall Study||0
2546350|NCT00571493|6240414|P7|COMPLETED|Overall Study||6
2546351|NCT00571493|6240415|P6|COMPLETED|Overall Study||12
2546352|NCT00571493|6240416|P5|COMPLETED|Overall Study||11
2546353|NCT00571493|6240417|P4|COMPLETED|Overall Study||3
2546354|NCT00571493|6240418|P3|COMPLETED|Overall Study||3
2546355|NCT00571493|6240419|P2|COMPLETED|Overall Study||4
2546356|NCT00571493|6240420|P1|COMPLETED|Overall Study||3
2546357|NCT00571493|6240414|P7|STARTED|Overall Study||6
2546358|NCT00571493|6240415|P6|STARTED|Overall Study||12
2546359|NCT00571493|6240416|P5|STARTED|Overall Study||11
2546360|NCT00571493|6240417|P4|STARTED|Overall Study||3
2546361|NCT00571493|6240418|P3|STARTED|Overall Study||3
2546362|NCT00571493|6240419|P2|STARTED|Overall Study||4
2546363|NCT00571493|6240420|P1|STARTED|Overall Study||3
2546364|NCT00571428|6240430|P2|NOT COMPLETED|Overall Study||0
2546365|NCT00571428|6240431|P1|NOT COMPLETED|Overall Study||0
2546366|NCT00571428|6240430|P2|COMPLETED|Overall Study||18
2546367|NCT00571428|6240431|P1|COMPLETED|Overall Study||15
2546368|NCT00571428|6240430|P2|STARTED|Overall Study||18
2546369|NCT00571428|6240431|P1|STARTED|Overall Study||15
2546370|NCT00571324|6240463|P2|NOT COMPLETED|Intervention 2 (7 Hours)||0
2546371|NCT00571324|6240464|P1|NOT COMPLETED|Intervention 2 (7 Hours)||0
2546372|NCT00571324|6240463|P2|COMPLETED|Intervention 2 (7 Hours)||4
2546373|NCT00571324|6240464|P1|COMPLETED|Intervention 2 (7 Hours)||5
2546374|NCT00571324|6240463|P2|STARTED|Intervention 2 (7 Hours)||4
2546375|NCT00571324|6240464|P1|STARTED|Intervention 2 (7 Hours)||5
2546376|NCT00571324|6240463|P2|NOT COMPLETED|Intervention 1 (7 Hours)||0
2546377|NCT00571324|6240464|P1|NOT COMPLETED|Intervention 1 (7 Hours)||0
2546378|NCT00571324|6240463|P2|COMPLETED|Intervention 1 (7 Hours)||4
2546379|NCT00571324|6240464|P1|COMPLETED|Intervention 1 (7 Hours)||5
2546380|NCT00571324|6240463|P2|STARTED|Intervention 1 (7 Hours)||4
2546381|NCT00571324|6240464|P1|STARTED|Intervention 1 (7 Hours)||5
2546382|NCT00571194|6240476|P1|NOT COMPLETED|Overall Study||0
2546383|NCT00571194|6240476|P1|COMPLETED|Overall Study||7
2546384|NCT00571194|6240476|P1|STARTED|Overall Study||7
2546385|NCT00571103|6240480|P1|NOT COMPLETED|Overall Study||2
2546386|NCT00571103|6240480|P1|COMPLETED|Overall Study|Of the 28 participants, 1 subject withdrew and 1 was lost to follow-up after their baseline visit.|26
2546387|NCT00571103|6240480|P1|STARTED|Overall Study||28
2546388|NCT00571064|6240485|P1|NOT COMPLETED|Overall Study||21
2546389|NCT00571064|6240485|P1|COMPLETED|Overall Study||76
2546390|NCT00571064|6240485|P1|STARTED|Overall Study||97
2546391|NCT00571038|6240500|P2|NOT COMPLETED|Overall Study||14
2546392|NCT00571038|6240501|P1|NOT COMPLETED|Overall Study||11
2546393|NCT00571038|6240500|P2|COMPLETED|Overall Study|5 died 2 moved 3 asked to be withdrawn 4 unable to reach|171
2546394|NCT00571038|6240501|P1|COMPLETED|Overall Study|"7 died 2 moved~1 asked to be withdrawn~1 unable to reach"|208
2546395|NCT00571038|6240500|P2|18 Month Survey Only|Overall Study||163
2546396|NCT00571038|6240501|P1|18 Month Survey Only|Overall Study||199
2546397|NCT00571038|6240500|P2|6 Month Follow up|Overall Study||176
2546398|NCT00571038|6240501|P1|6 Month Follow up|Overall Study||208
2546399|NCT00571038|6240500|P2|STARTED|Overall Study||185
2546400|NCT00571038|6240501|P1|STARTED|Overall Study||219
2546401|NCT00570960|6240549|P2|NOT COMPLETED|Overall Study||0
2546402|NCT00570960|6240550|P1|NOT COMPLETED|Overall Study||0
2546403|NCT00570960|6240549|P2|COMPLETED|Overall Study||4
2546404|NCT00570960|6240550|P1|COMPLETED|Overall Study||4
2546405|NCT00570960|6240549|P2|STARTED|Overall Study||4
2546406|NCT00570960|6240550|P1|STARTED|Overall Study||4
2546407|NCT00570921|6240556|P1|NOT COMPLETED|Overall Study||2
2546408|NCT00570921|6240556|P1|COMPLETED|Overall Study||31
2546409|NCT00570921|6240556|P1|STARTED|Overall Study||33
2546410|NCT00570908|6240562|P1|NOT COMPLETED|Overall Study||7
2546411|NCT00570908|6240562|P1|COMPLETED|Overall Study|5 patients progressed during the study treatment|5
2546412|NCT00570908|6240562|P1|STARTED|Overall Study||12
2546413|NCT00570778|6240566|P4|NOT COMPLETED|Overall Study||4
2546414|NCT00570778|6240567|P3|NOT COMPLETED|Overall Study||7
2546415|NCT00570778|6240568|P2|NOT COMPLETED|Overall Study||4
2546416|NCT00570778|6240569|P1|NOT COMPLETED|Overall Study||4
2546417|NCT00570778|6240566|P4|COMPLETED|Overall Study||34
2546418|NCT00570778|6240567|P3|COMPLETED|Overall Study||30
2546419|NCT00570778|6240568|P2|COMPLETED|Overall Study||34
2546420|NCT00570778|6240569|P1|COMPLETED|Overall Study||37
2546421|NCT00570778|6240566|P4|Modified Intent-to-treat Population|Overall Study||37
2546422|NCT00570778|6240567|P3|Modified Intent-to-treat Population|Overall Study||35
2546423|NCT00570778|6240568|P2|Modified Intent-to-treat Population|Overall Study||37
2546424|NCT00570778|6240569|P1|Modified Intent-to-treat Population|Overall Study||40
2546425|NCT00570778|6240566|P4|Safety Population: Received Study Drug|Overall Study||38
2546426|NCT00570778|6240567|P3|Safety Population: Received Study Drug|Overall Study||36
2546427|NCT00570778|6240568|P2|Safety Population: Received Study Drug|Overall Study||38
2546428|NCT00570778|6240569|P1|Safety Population: Received Study Drug|Overall Study|Safety Population included all participants who received at least 1 dose of any study drug.|41
2546429|NCT00570778|6240566|P4|STARTED|Overall Study||38
2546430|NCT00570778|6240567|P3|STARTED|Overall Study||37
2546431|NCT00570778|6240568|P2|STARTED|Overall Study||38
2546432|NCT00570778|6240569|P1|STARTED|Overall Study||41
2546433|NCT00570765|6240590|P3|NOT COMPLETED|Overall Study||0
2546434|NCT00570765|6240591|P2|NOT COMPLETED|Overall Study||7
2546435|NCT00570765|6240592|P1|NOT COMPLETED|Overall Study||4
2546436|NCT00570765|6240590|P3|COMPLETED|Overall Study||23
2546437|NCT00570765|6240591|P2|COMPLETED|Overall Study||9
2546438|NCT00570765|6240592|P1|COMPLETED|Overall Study||16
2546439|NCT00570765|6240590|P3|STARTED|Overall Study||23
2546440|NCT00570765|6240591|P2|STARTED|Overall Study||16
2546441|NCT00570765|6240592|P1|STARTED|Overall Study||20
2546442|NCT00570739|6240610|P4|NOT COMPLETED|Overall Study||12
2546443|NCT00570739|6240611|P3|NOT COMPLETED|Overall Study||16
2546444|NCT00570739|6240612|P2|NOT COMPLETED|Overall Study||21
2546445|NCT00570739|6240613|P1|NOT COMPLETED|Overall Study||21
2546446|NCT00570739|6240610|P4|COMPLETED|Overall Study||96
2546447|NCT00570739|6240611|P3|COMPLETED|Overall Study||92
2546448|NCT00570739|6240612|P2|COMPLETED|Overall Study||124
2546449|NCT00570739|6240613|P1|COMPLETED|Overall Study||120
2546450|NCT00570739|6240610|P4|STARTED|Overall Study||108
2546451|NCT00570739|6240611|P3|STARTED|Overall Study||108
2546452|NCT00570739|6240612|P2|STARTED|Overall Study||145
2546453|NCT00570739|6240613|P1|STARTED|Overall Study||141
2546454|NCT00570713|6240765|P2|NOT COMPLETED|Overall Study||77
2546455|NCT00570713|6240766|P1|NOT COMPLETED|Overall Study||78
2546456|NCT00570713|6240765|P2|COMPLETED|Overall Study||0
2546457|NCT00570713|6240766|P1|COMPLETED|Overall Study||0
2546458|NCT00570713|6240765|P2|STARTED|Overall Study||77
2546459|NCT00570713|6240766|P1|STARTED|Overall Study||78
2546460|NCT00570700|6240776|P1|NOT COMPLETED|Overall Study||11
2546461|NCT00570700|6240776|P1|COMPLETED|Overall Study||27
2546462|NCT00570700|6240776|P1|STARTED|Overall Study||38
2546463|NCT00570687|6240784|P10|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
2546464|NCT00570687|6240785|P9|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
2546465|NCT00570687|6240786|P8|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
2546466|NCT00570687|6240787|P7|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
2546467|NCT00570687|6240788|P6|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
2546468|NCT00570687|6240789|P5|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
2546469|NCT00570687|6240790|P4|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
2546470|NCT00570687|6240791|P3|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
2546471|NCT00570687|6240792|P2|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
2546472|NCT00570687|6240793|P1|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
2546473|NCT00570687|6240784|P10|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
2546474|NCT00570687|6240785|P9|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
2546475|NCT00570687|6240786|P8|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
2546476|NCT00570687|6240787|P7|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
2546477|NCT00570687|6240788|P6|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
2546478|NCT00570687|6240789|P5|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
2546479|NCT00570687|6240790|P4|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
2546480|NCT00570687|6240791|P3|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
2546481|NCT00570687|6240792|P2|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
2546482|NCT00570687|6240793|P1|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
2546483|NCT00570687|6240784|P10|STARTED|Clamp 2 (1 Day) - Amendment 1||0
2546484|NCT00570687|6240785|P9|STARTED|Clamp 2 (1 Day) - Amendment 1||0
2546485|NCT00570687|6240786|P8|STARTED|Clamp 2 (1 Day) - Amendment 1||0
2546486|NCT00570687|6240787|P7|STARTED|Clamp 2 (1 Day) - Amendment 1||0
2546487|NCT00570687|6240788|P6|STARTED|Clamp 2 (1 Day) - Amendment 1||0
2546488|NCT00570687|6240789|P5|STARTED|Clamp 2 (1 Day) - Amendment 1||0
2546489|NCT00570687|6240790|P4|STARTED|Clamp 2 (1 Day) - Amendment 1||4
2546490|NCT00570687|6240791|P3|STARTED|Clamp 2 (1 Day) - Amendment 1||2
2546491|NCT00570687|6240792|P2|STARTED|Clamp 2 (1 Day) - Amendment 1||2
2546492|NCT00570687|6240793|P1|STARTED|Clamp 2 (1 Day) - Amendment 1||4
2546493|NCT00570687|6240784|P10|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
2546494|NCT00570687|6240785|P9|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
2546495|NCT00570687|6240786|P8|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
2546496|NCT00570687|6240787|P7|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
2546497|NCT00570687|6240788|P6|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
2546498|NCT00570687|6240789|P5|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
2546499|NCT00570687|6240790|P4|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
2546500|NCT00570687|6240791|P3|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
2546501|NCT00570687|6240792|P2|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
2546502|NCT00570687|6240793|P1|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
2546503|NCT00570687|6240784|P10|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
2546504|NCT00570687|6240785|P9|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
2546505|NCT00570687|6240786|P8|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
2546506|NCT00570687|6240787|P7|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
2546507|NCT00570687|6240788|P6|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
2546508|NCT00570687|6240789|P5|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
2546509|NCT00570687|6240790|P4|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
2546510|NCT00570687|6240791|P3|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
2546511|NCT00570687|6240792|P2|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
2546512|NCT00570687|6240793|P1|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
2546513|NCT00570687|6240784|P10|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
2546514|NCT00570687|6240785|P9|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
2546515|NCT00570687|6240786|P8|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
2546516|NCT00570687|6240787|P7|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
2546517|NCT00570687|6240788|P6|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
2546518|NCT00570687|6240789|P5|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
2546519|NCT00570687|6240790|P4|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
2546520|NCT00570687|6240791|P3|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
2546521|NCT00570687|6240792|P2|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
2546522|NCT00570687|6240793|P1|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
2546523|NCT00570687|6240784|P10|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
2546524|NCT00570687|6240785|P9|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
2546525|NCT00570687|6240786|P8|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
2546526|NCT00570687|6240787|P7|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
2546527|NCT00570687|6240788|P6|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
2546528|NCT00570687|6240789|P5|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
2546529|NCT00570687|6240790|P4|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
2546530|NCT00570687|6240791|P3|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
2546531|NCT00570687|6240792|P2|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
2546532|NCT00570687|6240793|P1|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
2546533|NCT00570687|6240784|P10|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
2546534|NCT00570687|6240785|P9|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
2546535|NCT00570687|6240786|P8|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
2546536|NCT00570687|6240787|P7|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
2546537|NCT00570687|6240788|P6|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
2546538|NCT00570687|6240789|P5|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
2546539|NCT00570687|6240790|P4|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
2546540|NCT00570687|6240791|P3|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
2546541|NCT00570687|6240792|P2|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
2546542|NCT00570687|6240793|P1|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
2546543|NCT00570687|6240784|P10|STARTED|Clamp 1 (1 Day) - Amendment 1||0
2546544|NCT00570687|6240785|P9|STARTED|Clamp 1 (1 Day) - Amendment 1||0
2546545|NCT00570687|6240786|P8|STARTED|Clamp 1 (1 Day) - Amendment 1||0
2546546|NCT00570687|6240787|P7|STARTED|Clamp 1 (1 Day) - Amendment 1||0
2546547|NCT00570687|6240788|P6|STARTED|Clamp 1 (1 Day) - Amendment 1||0
2546548|NCT00570687|6240789|P5|STARTED|Clamp 1 (1 Day) - Amendment 1||0
2546549|NCT00570687|6240790|P4|STARTED|Clamp 1 (1 Day) - Amendment 1||4
2546550|NCT00570687|6240791|P3|STARTED|Clamp 1 (1 Day) - Amendment 1||2
2546551|NCT00570687|6240792|P2|STARTED|Clamp 1 (1 Day) - Amendment 1||2
2546552|NCT00570687|6240793|P1|STARTED|Clamp 1 (1 Day) - Amendment 1||4
2546553|NCT00570687|6240784|P10|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
2546554|NCT00570687|6240785|P9|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
2546555|NCT00570687|6240786|P8|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
2546556|NCT00570687|6240787|P7|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
2546557|NCT00570687|6240788|P6|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
2546558|NCT00570687|6240789|P5|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
2546559|NCT00570687|6240790|P4|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
2546560|NCT00570687|6240791|P3|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
2546561|NCT00570687|6240792|P2|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
2546562|NCT00570687|6240793|P1|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
2546563|NCT00570687|6240784|P10|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
2546564|NCT00570687|6240785|P9|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
2546565|NCT00570687|6240786|P8|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
2546566|NCT00570687|6240787|P7|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
2546567|NCT00570687|6240788|P6|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
2546568|NCT00570687|6240789|P5|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
2546569|NCT00570687|6240790|P4|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
2546570|NCT00570687|6240791|P3|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
2546571|NCT00570687|6240792|P2|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
2546572|NCT00570687|6240793|P1|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
2546573|NCT00570687|6240784|P10|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
2546574|NCT00570687|6240785|P9|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
2546575|NCT00570687|6240786|P8|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
2546576|NCT00570687|6240787|P7|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
2546577|NCT00570687|6240788|P6|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
2546578|NCT00570687|6240789|P5|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
2546579|NCT00570687|6240790|P4|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
2546580|NCT00570687|6240791|P3|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
2546581|NCT00570687|6240792|P2|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
2546582|NCT00570687|6240793|P1|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
2546583|NCT00570687|6240784|P10|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
2546584|NCT00570687|6240785|P9|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
2546585|NCT00570687|6240786|P8|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
2546586|NCT00570687|6240787|P7|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
2546587|NCT00570687|6240788|P6|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
2546588|NCT00570687|6240789|P5|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
2546589|NCT00570687|6240790|P4|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
2546590|NCT00570687|6240791|P3|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
2546591|NCT00570687|6240792|P2|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
2546592|NCT00570687|6240793|P1|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
2546593|NCT00570687|6240784|P10|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
2546594|NCT00570687|6240785|P9|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
2546595|NCT00570687|6240786|P8|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
2546596|NCT00570687|6240787|P7|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
2546597|NCT00570687|6240788|P6|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
2546598|NCT00570687|6240789|P5|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
2546599|NCT00570687|6240790|P4|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
2546600|NCT00570687|6240791|P3|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
2546601|NCT00570687|6240792|P2|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
2546602|NCT00570687|6240793|P1|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
2546603|NCT00570687|6240784|P10|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
2546604|NCT00570687|6240785|P9|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
2546605|NCT00570687|6240786|P8|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
2546606|NCT00570687|6240787|P7|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
2546607|NCT00570687|6240788|P6|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
2546608|NCT00570687|6240789|P5|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
2546609|NCT00570687|6240790|P4|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
2546610|NCT00570687|6240791|P3|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
2546611|NCT00570687|6240792|P2|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
2546612|NCT00570687|6240793|P1|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
2546613|NCT00570687|6240784|P10|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
2546614|NCT00570687|6240785|P9|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
2546615|NCT00570687|6240786|P8|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
2546616|NCT00570687|6240787|P7|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
2546617|NCT00570687|6240788|P6|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
2546618|NCT00570687|6240789|P5|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
2546619|NCT00570687|6240790|P4|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
2546620|NCT00570687|6240791|P3|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
2546621|NCT00570687|6240792|P2|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
2546622|NCT00570687|6240793|P1|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
2546623|NCT00570687|6240784|P10|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
2546624|NCT00570687|6240785|P9|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
2546625|NCT00570687|6240786|P8|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
2546626|NCT00570687|6240787|P7|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
2546627|NCT00570687|6240788|P6|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
2546628|NCT00570687|6240789|P5|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
2546629|NCT00570687|6240790|P4|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
2546630|NCT00570687|6240791|P3|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
2546631|NCT00570687|6240792|P2|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
2546632|NCT00570687|6240793|P1|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
2546633|NCT00570687|6240784|P10|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
2546634|NCT00570687|6240785|P9|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
2546635|NCT00570687|6240786|P8|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
2546636|NCT00570687|6240787|P7|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
2546637|NCT00570687|6240788|P6|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
2546638|NCT00570687|6240789|P5|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
2546639|NCT00570687|6240790|P4|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
2546640|NCT00570687|6240791|P3|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
2546641|NCT00570687|6240792|P2|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
2546642|NCT00570687|6240793|P1|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
2546643|NCT00570687|6240784|P10|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
2546644|NCT00570687|6240785|P9|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
2546645|NCT00570687|6240786|P8|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
2546646|NCT00570687|6240787|P7|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
2546647|NCT00570687|6240788|P6|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
2546648|NCT00570687|6240789|P5|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
2546649|NCT00570687|6240790|P4|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
2546650|NCT00570687|6240791|P3|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
2546651|NCT00570687|6240792|P2|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
2546652|NCT00570687|6240793|P1|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
2546653|NCT00570687|6240784|P10|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
2546654|NCT00570687|6240785|P9|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
2546655|NCT00570687|6240786|P8|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
2546656|NCT00570687|6240787|P7|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
2546657|NCT00570687|6240788|P6|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
2546658|NCT00570687|6240789|P5|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
2546659|NCT00570687|6240790|P4|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
2546660|NCT00570687|6240791|P3|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
2546661|NCT00570687|6240792|P2|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
2546662|NCT00570687|6240793|P1|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
2546663|NCT00570687|6240784|P10|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
2546664|NCT00570687|6240785|P9|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
2546665|NCT00570687|6240786|P8|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
2546666|NCT00570687|6240787|P7|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
2546667|NCT00570687|6240788|P6|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
2546668|NCT00570687|6240789|P5|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
2546669|NCT00570687|6240790|P4|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
2546670|NCT00570687|6240791|P3|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
2546671|NCT00570687|6240792|P2|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
2546672|NCT00570687|6240793|P1|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
2546673|NCT00570687|6240784|P10|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2546674|NCT00570687|6240785|P9|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2546675|NCT00570687|6240786|P8|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2546676|NCT00570687|6240787|P7|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||1
2546677|NCT00570687|6240788|P6|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2546678|NCT00570687|6240789|P5|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2546679|NCT00570687|6240790|P4|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2546680|NCT00570687|6240791|P3|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2546681|NCT00570687|6240792|P2|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2546682|NCT00570687|6240793|P1|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2546683|NCT00570687|6240784|P10|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2546684|NCT00570687|6240785|P9|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2546685|NCT00570687|6240786|P8|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2546686|NCT00570687|6240787|P7|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2546687|NCT00570687|6240788|P6|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2546688|NCT00570687|6240789|P5|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2546689|NCT00570687|6240790|P4|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2546690|NCT00570687|6240791|P3|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2546691|NCT00570687|6240792|P2|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2546692|NCT00570687|6240793|P1|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
2546693|NCT00570687|6240784|P10|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
2546694|NCT00570687|6240785|P9|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
2546695|NCT00570687|6240786|P8|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
2546696|NCT00570687|6240787|P7|STARTED|Washout 5 (7-21 Days) - Orig Protocol||1
2546697|NCT00570687|6240788|P6|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
2546698|NCT00570687|6240789|P5|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
2546699|NCT00570687|6240790|P4|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
2546700|NCT00570687|6240791|P3|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
2546701|NCT00570687|6240792|P2|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
2546702|NCT00570687|6240793|P1|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
2546703|NCT00570687|6240784|P10|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2546704|NCT00570687|6240785|P9|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2546705|NCT00570687|6240786|P8|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2546706|NCT00570687|6240787|P7|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2546707|NCT00570687|6240788|P6|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2546708|NCT00570687|6240789|P5|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2546709|NCT00570687|6240790|P4|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2546710|NCT00570687|6240791|P3|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2546711|NCT00570687|6240792|P2|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2546712|NCT00570687|6240793|P1|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2546713|NCT00570687|6240784|P10|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2546714|NCT00570687|6240785|P9|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2546715|NCT00570687|6240786|P8|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2546716|NCT00570687|6240787|P7|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||1
2546717|NCT00570687|6240788|P6|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2546718|NCT00570687|6240789|P5|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2546719|NCT00570687|6240790|P4|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2546720|NCT00570687|6240791|P3|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2546721|NCT00570687|6240792|P2|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2546722|NCT00570687|6240793|P1|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
2546723|NCT00570687|6240784|P10|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
2546724|NCT00570687|6240785|P9|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
2546725|NCT00570687|6240786|P8|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
2546726|NCT00570687|6240787|P7|STARTED|Clamp 2 (1 Day) - Orig Protocol||1
2546727|NCT00570687|6240788|P6|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
2546728|NCT00570687|6240789|P5|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
2546729|NCT00570687|6240790|P4|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
2546730|NCT00570687|6240791|P3|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
2546731|NCT00570687|6240792|P2|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
2546732|NCT00570687|6240793|P1|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
2546733|NCT00570687|6240784|P10|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2546734|NCT00570687|6240785|P9|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
2546735|NCT00570687|6240786|P8|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2546736|NCT00570687|6240787|P7|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2546737|NCT00570687|6240788|P6|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2546738|NCT00570687|6240789|P5|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2546739|NCT00570687|6240790|P4|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2546740|NCT00570687|6240791|P3|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2546741|NCT00570687|6240792|P2|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2546742|NCT00570687|6240793|P1|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2546743|NCT00570687|6240784|P10|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2546744|NCT00570687|6240785|P9|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2546745|NCT00570687|6240786|P8|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2546746|NCT00570687|6240787|P7|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
2546747|NCT00570687|6240788|P6|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2546748|NCT00570687|6240789|P5|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2546749|NCT00570687|6240790|P4|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2546750|NCT00570687|6240791|P3|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2546751|NCT00570687|6240792|P2|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2546752|NCT00570687|6240793|P1|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
2546753|NCT00570687|6240784|P10|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
2546754|NCT00570687|6240785|P9|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
2546755|NCT00570687|6240786|P8|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
2546756|NCT00570687|6240787|P7|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
2546757|NCT00570687|6240788|P6|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
2546758|NCT00570687|6240789|P5|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
2546759|NCT00570687|6240790|P4|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
2546760|NCT00570687|6240791|P3|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
2546761|NCT00570687|6240792|P2|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
2546762|NCT00570687|6240793|P1|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
2546763|NCT00570687|6240784|P10|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2546764|NCT00570687|6240785|P9|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2546765|NCT00570687|6240786|P8|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2546766|NCT00570687|6240787|P7|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2546767|NCT00570687|6240788|P6|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2546768|NCT00570687|6240789|P5|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2546769|NCT00570687|6240790|P4|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2546770|NCT00570687|6240791|P3|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2546771|NCT00570687|6240792|P2|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2546772|NCT00570687|6240793|P1|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2546773|NCT00570687|6240784|P10|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2546774|NCT00570687|6240785|P9|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
2546775|NCT00570687|6240786|P8|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2546776|NCT00570687|6240787|P7|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
2546777|NCT00570687|6240788|P6|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2546778|NCT00570687|6240789|P5|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2546779|NCT00570687|6240790|P4|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2546780|NCT00570687|6240791|P3|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2546781|NCT00570687|6240792|P2|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2546782|NCT00570687|6240793|P1|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
2546783|NCT00570687|6240784|P10|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
2546784|NCT00570687|6240785|P9|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
2546785|NCT00570687|6240786|P8|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
2546786|NCT00570687|6240787|P7|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
2546787|NCT00570687|6240788|P6|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
2546788|NCT00570687|6240789|P5|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
2546789|NCT00570687|6240790|P4|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
2546790|NCT00570687|6240791|P3|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
2546791|NCT00570687|6240792|P2|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
2546792|NCT00570687|6240793|P1|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
2546793|NCT00570687|6240784|P10|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
2546794|NCT00570687|6240785|P9|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
2546795|NCT00570687|6240786|P8|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
2546796|NCT00570687|6240787|P7|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
2546797|NCT00570687|6240788|P6|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
2546798|NCT00570687|6240789|P5|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
2546799|NCT00570687|6240790|P4|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
2546800|NCT00570687|6240791|P3|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
2546801|NCT00570687|6240792|P2|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
2546802|NCT00570687|6240793|P1|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
2546803|NCT00570687|6240784|P10|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
2546804|NCT00570687|6240785|P9|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
2546805|NCT00570687|6240786|P8|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
2546806|NCT00570687|6240787|P7|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
2546807|NCT00570687|6240788|P6|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
2546808|NCT00570687|6240789|P5|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
2546809|NCT00570687|6240790|P4|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
2546810|NCT00570687|6240791|P3|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
2546811|NCT00570687|6240792|P2|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
2546812|NCT00570687|6240793|P1|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
2546813|NCT00570687|6240784|P10|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
2546814|NCT00570687|6240785|P9|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
2546815|NCT00570687|6240786|P8|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
2546816|NCT00570687|6240787|P7|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
2546817|NCT00570687|6240788|P6|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
2546818|NCT00570687|6240789|P5|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
2546819|NCT00570687|6240790|P4|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
2546820|NCT00570687|6240791|P3|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
2546821|NCT00570687|6240792|P2|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
2546822|NCT00570687|6240793|P1|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
2546823|NCT00570687|6240784|P10|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
2546824|NCT00570687|6240785|P9|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
2546825|NCT00570687|6240786|P8|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
2546826|NCT00570687|6240787|P7|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
2546827|NCT00570687|6240788|P6|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
2546828|NCT00570687|6240789|P5|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
2546829|NCT00570687|6240790|P4|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
2546830|NCT00570687|6240791|P3|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
2546831|NCT00570687|6240792|P2|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
2546832|NCT00570687|6240793|P1|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
2546833|NCT00570687|6240784|P10|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
2546834|NCT00570687|6240785|P9|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
2546835|NCT00570687|6240786|P8|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
2546836|NCT00570687|6240787|P7|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
2546837|NCT00570687|6240788|P6|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
2546838|NCT00570687|6240789|P5|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
2546839|NCT00570687|6240790|P4|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
2546840|NCT00570687|6240791|P3|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
2546841|NCT00570687|6240792|P2|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
2546842|NCT00570687|6240793|P1|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
2546843|NCT00570687|6240784|P10|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
2546844|NCT00570687|6240785|P9|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
2546845|NCT00570687|6240786|P8|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
2546846|NCT00570687|6240787|P7|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
2546847|NCT00570687|6240788|P6|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
2546848|NCT00570687|6240789|P5|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
2546849|NCT00570687|6240790|P4|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
2546850|NCT00570687|6240791|P3|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
2546851|NCT00570687|6240792|P2|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
2546852|NCT00570687|6240793|P1|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
2546853|NCT00570687|6240784|P10|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
2546854|NCT00570687|6240785|P9|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
2546855|NCT00570687|6240786|P8|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
2546856|NCT00570687|6240787|P7|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
2546857|NCT00570687|6240788|P6|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
2546858|NCT00570687|6240789|P5|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
2546859|NCT00570687|6240790|P4|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
2546860|NCT00570687|6240791|P3|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
2546861|NCT00570687|6240792|P2|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
2546862|NCT00570687|6240793|P1|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
2546863|NCT00570687|6240784|P10|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
2546864|NCT00570687|6240785|P9|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
2546865|NCT00570687|6240786|P8|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
2546866|NCT00570687|6240787|P7|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
2546867|NCT00570687|6240788|P6|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
2546868|NCT00570687|6240789|P5|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
2546869|NCT00570687|6240790|P4|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
2546870|NCT00570687|6240791|P3|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
2546871|NCT00570687|6240792|P2|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
2546872|NCT00570687|6240793|P1|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
2546873|NCT00570687|6240784|P10|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
2546874|NCT00570687|6240785|P9|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
2546875|NCT00570687|6240786|P8|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
2546876|NCT00570687|6240787|P7|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
2546877|NCT00570687|6240788|P6|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
2546878|NCT00570687|6240789|P5|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
2546879|NCT00570687|6240790|P4|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
2546880|NCT00570687|6240791|P3|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
2546881|NCT00570687|6240792|P2|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
2546882|NCT00570687|6240793|P1|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
2546883|NCT00570687|6240784|P10|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
2546884|NCT00570687|6240785|P9|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
2546885|NCT00570687|6240786|P8|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
2546886|NCT00570687|6240787|P7|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
2546887|NCT00570687|6240788|P6|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
2546888|NCT00570687|6240789|P5|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
2546889|NCT00570687|6240790|P4|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
2546890|NCT00570687|6240791|P3|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
2546891|NCT00570687|6240792|P2|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
2546892|NCT00570687|6240793|P1|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
2546893|NCT00570687|6240784|P10|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
2546894|NCT00570687|6240785|P9|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
2546895|NCT00570687|6240786|P8|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
2546896|NCT00570687|6240787|P7|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
2546897|NCT00570687|6240788|P6|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
2546898|NCT00570687|6240789|P5|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
2546899|NCT00570687|6240790|P4|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
2546900|NCT00570687|6240791|P3|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
2546901|NCT00570687|6240792|P2|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
2546902|NCT00570687|6240793|P1|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
2546903|NCT00570687|6240784|P10|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
2546904|NCT00570687|6240785|P9|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
2546905|NCT00570687|6240786|P8|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
2546906|NCT00570687|6240787|P7|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
2546907|NCT00570687|6240788|P6|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
2546908|NCT00570687|6240789|P5|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
2546909|NCT00570687|6240790|P4|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
2546910|NCT00570687|6240791|P3|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
2546911|NCT00570687|6240792|P2|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
2546912|NCT00570687|6240793|P1|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
2546913|NCT00570687|6240784|P10|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
2546914|NCT00570687|6240785|P9|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
2546915|NCT00570687|6240786|P8|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
2546916|NCT00570687|6240787|P7|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
2546917|NCT00570687|6240788|P6|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
2546918|NCT00570687|6240789|P5|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
2546919|NCT00570687|6240790|P4|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
2546920|NCT00570687|6240791|P3|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
2546921|NCT00570687|6240792|P2|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
2546922|NCT00570687|6240793|P1|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
2546923|NCT00570687|6240784|P10|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
2546924|NCT00570687|6240785|P9|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
2546925|NCT00570687|6240786|P8|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
2546926|NCT00570687|6240787|P7|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
2546927|NCT00570687|6240788|P6|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
2546928|NCT00570687|6240789|P5|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
2546929|NCT00570687|6240790|P4|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
2546930|NCT00570687|6240791|P3|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
2546931|NCT00570687|6240792|P2|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
2546932|NCT00570687|6240793|P1|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
2546933|NCT00570687|6240784|P10|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
2546934|NCT00570687|6240785|P9|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
2546935|NCT00570687|6240786|P8|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
2546936|NCT00570687|6240787|P7|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
2546937|NCT00570687|6240788|P6|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
2546938|NCT00570687|6240789|P5|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
2546939|NCT00570687|6240790|P4|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
2546940|NCT00570687|6240791|P3|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
2546941|NCT00570687|6240792|P2|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
2546942|NCT00570687|6240793|P1|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
2546943|NCT00570687|6240784|P10|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2546944|NCT00570687|6240785|P9|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2546945|NCT00570687|6240786|P8|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2546946|NCT00570687|6240787|P7|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2546947|NCT00570687|6240788|P6|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2546948|NCT00570687|6240789|P5|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2546949|NCT00570687|6240790|P4|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2546950|NCT00570687|6240791|P3|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2546951|NCT00570687|6240792|P2|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2546952|NCT00570687|6240793|P1|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2546953|NCT00570687|6240784|P10|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
2546954|NCT00570687|6240785|P9|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
2546955|NCT00570687|6240786|P8|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
2546956|NCT00570687|6240787|P7|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
2546957|NCT00570687|6240788|P6|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
2546958|NCT00570687|6240789|P5|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
2546959|NCT00570687|6240790|P4|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2546960|NCT00570687|6240791|P3|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2546961|NCT00570687|6240792|P2|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2546962|NCT00570687|6240793|P1|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2546963|NCT00570687|6240784|P10|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
2546964|NCT00570687|6240785|P9|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
2546965|NCT00570687|6240786|P8|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
2546966|NCT00570687|6240787|P7|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
2546967|NCT00570687|6240788|P6|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
2546968|NCT00570687|6240789|P5|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
2546969|NCT00570687|6240790|P4|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2546970|NCT00570687|6240791|P3|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2546971|NCT00570687|6240792|P2|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2546972|NCT00570687|6240793|P1|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
2546973|NCT00570674|6240819|P7|NOT COMPLETED|Overall Study||0
2546974|NCT00570674|6240820|P6|NOT COMPLETED|Overall Study||0
2546975|NCT00570674|6240821|P5|NOT COMPLETED|Overall Study||0
2546976|NCT00570674|6240822|P4|NOT COMPLETED|Overall Study||0
2546977|NCT00570674|6240823|P3|NOT COMPLETED|Overall Study||1
2546978|NCT00570674|6240824|P2|NOT COMPLETED|Overall Study||0
2546979|NCT00570674|6240825|P1|NOT COMPLETED|Overall Study||0
2546980|NCT00570674|6240819|P7|COMPLETED|Overall Study||0
2546981|NCT00570674|6240820|P6|COMPLETED|Overall Study||10
2546982|NCT00570674|6240821|P5|COMPLETED|Overall Study||3
2546983|NCT00570674|6240822|P4|COMPLETED|Overall Study||3
2546984|NCT00570674|6240823|P3|COMPLETED|Overall Study||3
2546985|NCT00570674|6240824|P2|COMPLETED|Overall Study||3
2546986|NCT00570674|6240825|P1|COMPLETED|Overall Study||6
2546987|NCT00570674|6240819|P7|PEG Evaluable|Overall Study||0
2546988|NCT00570674|6240820|P6|PEG Evaluable|Overall Study||10
2546989|NCT00570674|6240821|P5|PEG Evaluable|Overall Study||2
2546990|NCT00570674|6240822|P4|PEG Evaluable|Overall Study||3
2546991|NCT00570674|6240823|P3|PEG Evaluable|Overall Study||3
2546992|NCT00570674|6240824|P2|PEG Evaluable|Overall Study||3
2546993|NCT00570674|6240825|P1|PEG Evaluable|Overall Study||6
2546994|NCT00570674|6240819|P7|Treated|Overall Study||0
2546995|NCT00570674|6240820|P6|Treated|Overall Study||10
2546996|NCT00570674|6240821|P5|Treated|Overall Study||3
2546997|NCT00570674|6240822|P4|Treated|Overall Study||3
2546998|NCT00570674|6240823|P3|Treated|Overall Study||3
2546999|NCT00570674|6240824|P2|Treated|Overall Study||3
2547000|NCT00570674|6240825|P1|Treated|Overall Study||6
2547001|NCT00570674|6240819|P7|STARTED|Overall Study|The study did not continue beyond phase I.|0
2547002|NCT00570674|6240820|P6|STARTED|Overall Study||10
2547003|NCT00570674|6240821|P5|STARTED|Overall Study||3
2547004|NCT00570674|6240822|P4|STARTED|Overall Study||3
2547005|NCT00570674|6240823|P3|STARTED|Overall Study||4
2547006|NCT00570674|6240824|P2|STARTED|Overall Study||3
2547007|NCT00570674|6240825|P1|STARTED|Overall Study||6
2547008|NCT00570531|6240842|P1|NOT COMPLETED|Overall Study||0
2547009|NCT00570531|6240842|P1|COMPLETED|Overall Study||6
2547010|NCT00570531|6240842|P1|STARTED|Overall Study||6
2547011|NCT00570505|6240848|P1|NOT COMPLETED|Overall Study||41
2547012|NCT00570505|6240848|P1|COMPLETED|Overall Study|The number of subjects completing the 60-month study|108
2547013|NCT00570505|6240848|P1|STARTED|Overall Study||149
2547014|NCT00570492|6240861|P3|NOT COMPLETED|52-week Double-blind Treatment Period||51
2547015|NCT00570492|6240862|P2|NOT COMPLETED|52-week Double-blind Treatment Period||50
2547016|NCT00570492|6240863|P1|NOT COMPLETED|52-week Double-blind Treatment Period||0
2547017|NCT00570492|6240861|P3|COMPLETED|52-week Double-blind Treatment Period||186
2547018|NCT00570492|6240862|P2|COMPLETED|52-week Double-blind Treatment Period||187
2547019|NCT00570492|6240863|P1|COMPLETED|52-week Double-blind Treatment Period||0
2547020|NCT00570492|6240861|P3|STARTED|52-week Double-blind Treatment Period||237
2547021|NCT00570492|6240862|P2|STARTED|52-week Double-blind Treatment Period||237
2547022|NCT00570492|6240863|P1|STARTED|52-week Double-blind Treatment Period||0
2547023|NCT00570492|6240861|P3|NOT COMPLETED|16-week Single-blind Baseline Period||0
2547024|NCT00570492|6240862|P2|NOT COMPLETED|16-week Single-blind Baseline Period||0
2547025|NCT00570492|6240863|P1|NOT COMPLETED|16-week Single-blind Baseline Period||436
2547026|NCT00570492|6240861|P3|COMPLETED|16-week Single-blind Baseline Period||0
2547027|NCT00570492|6240862|P2|COMPLETED|16-week Single-blind Baseline Period||0
2547028|NCT00570492|6240863|P1|COMPLETED|16-week Single-blind Baseline Period||474
2547029|NCT00570492|6240861|P3|STARTED|16-week Single-blind Baseline Period||0
2547030|NCT00570492|6240862|P2|STARTED|16-week Single-blind Baseline Period||0
2547031|NCT00570492|6240863|P1|STARTED|16-week Single-blind Baseline Period||910
2547032|NCT00570401|6240901|P1|NOT COMPLETED|Overall Study||2
2547033|NCT00570401|6240901|P1|COMPLETED|Overall Study||19
2547034|NCT00570401|6240901|P1|STARTED|Overall Study||21
2547035|NCT00570362|6240907|P2|NOT COMPLETED|Overall Study||0
2547036|NCT00570362|6240908|P1|NOT COMPLETED|Overall Study||0
2547037|NCT00570362|6240907|P2|COMPLETED|Overall Study||30
2547038|NCT00570362|6240908|P1|COMPLETED|Overall Study||19
2547039|NCT00570362|6240907|P2|STARTED|Overall Study||30
2547040|NCT00570362|6240908|P1|STARTED|Overall Study||19
2547041|NCT00570349|6240917|P3|NOT COMPLETED|Overall Study||0
2547042|NCT00570349|6240918|P2|NOT COMPLETED|Overall Study||0
2547043|NCT00570349|6240919|P1|NOT COMPLETED|Overall Study||0
2547044|NCT00570349|6240917|P3|COMPLETED|Overall Study||6
2547045|NCT00570349|6240918|P2|COMPLETED|Overall Study||6
2547046|NCT00570349|6240919|P1|COMPLETED|Overall Study||6
2547047|NCT00570349|6240917|P3|STARTED|Overall Study||6
2547048|NCT00570349|6240918|P2|STARTED|Overall Study||6
2547049|NCT00570349|6240919|P1|STARTED|Overall Study||6
2547050|NCT00570323|6240935|P2|NOT COMPLETED|Complete Study After Start||1
2547051|NCT00570323|6240936|P1|NOT COMPLETED|Complete Study After Start||3
2547052|NCT00570323|6240935|P2|COMPLETED|Complete Study After Start||34
2547053|NCT00570323|6240936|P1|COMPLETED|Complete Study After Start||31
2547054|NCT00570323|6240935|P2|STARTED|Complete Study After Start||35
2547055|NCT00570323|6240936|P1|STARTED|Complete Study After Start||34
2547056|NCT00570323|6240935|P2|NOT COMPLETED|Started Treatment After Randomization||1
2547057|NCT00570323|6240936|P1|NOT COMPLETED|Started Treatment After Randomization||2
2547058|NCT00570323|6240935|P2|COMPLETED|Started Treatment After Randomization||35
2547059|NCT00570323|6240936|P1|COMPLETED|Started Treatment After Randomization||34
2547060|NCT00570323|6240935|P2|STARTED|Started Treatment After Randomization||36
2547061|NCT00570323|6240936|P1|STARTED|Started Treatment After Randomization||36
2547062|NCT00570310|6240948|P2|NOT COMPLETED|Overall Study||6
2547063|NCT00570310|6240949|P1|NOT COMPLETED|Overall Study||2
2547064|NCT00570310|6240948|P2|COMPLETED|Overall Study||45
2547065|NCT00570310|6240949|P1|COMPLETED|Overall Study||51
2547066|NCT00570310|6240948|P2|STARTED|Overall Study||51
2547067|NCT00570310|6240949|P1|STARTED|Overall Study||53
2547068|NCT00570258|6240959|P2|NOT COMPLETED|Overall Study||15
2547069|NCT00570258|6240960|P1|NOT COMPLETED|Overall Study||12
2547070|NCT00570258|6240959|P2|COMPLETED|Overall Study|Early termination due to a change in drug FDA approval.|0
2547071|NCT00570258|6240960|P1|COMPLETED|Overall Study|Early termination due to a change in drug FDA approval.|0
2547072|NCT00570258|6240959|P2|STARTED|Overall Study||15
2547073|NCT00570258|6240960|P1|STARTED|Overall Study||12
2547074|NCT00570232|6240968|P1|NOT COMPLETED|Overall Study||23
2547075|NCT00570232|6240968|P1|COMPLETED|Overall Study||8
2547076|NCT00570232|6240968|P1|STARTED|Overall Study||31
2547077|NCT00570141|6240974|P1|NOT COMPLETED|Overall Study||3
2547078|NCT00570141|6240974|P1|COMPLETED|Overall Study||10
2547079|NCT00570141|6240974|P1|STARTED|Overall Study||13
2547080|NCT00570089|6240979|P2|NOT COMPLETED|Perod 2||0
2547081|NCT00570089|6240980|P1|NOT COMPLETED|Perod 2||0
2547082|NCT00570089|6240979|P2|COMPLETED|Perod 2||10
2547083|NCT00570089|6240980|P1|COMPLETED|Perod 2||10
2547084|NCT00570089|6240979|P2|STARTED|Perod 2||10
2547085|NCT00570089|6240980|P1|STARTED|Perod 2||10
2547086|NCT00570089|6240979|P2|NOT COMPLETED|Period 1||0
2547087|NCT00570089|6240980|P1|NOT COMPLETED|Period 1||0
2547088|NCT00570089|6240979|P2|COMPLETED|Period 1||10
2547089|NCT00570089|6240980|P1|COMPLETED|Period 1||10
2547090|NCT00570089|6240979|P2|STARTED|Period 1||10
2547091|NCT00570089|6240980|P1|STARTED|Period 1||10
2547092|NCT00570063|6240990|P2|NOT COMPLETED|Overall Study||8
2547093|NCT00570063|6240991|P1|NOT COMPLETED|Overall Study||15
2547094|NCT00570063|6240990|P2|COMPLETED|Overall Study||3
2547095|NCT00570063|6240991|P1|COMPLETED|Overall Study||9
2547096|NCT00570063|6240990|P2|STARTED|Overall Study||11
2547097|NCT00570063|6240991|P1|STARTED|Overall Study||24
2547098|NCT00570037|6241057|P2|NOT COMPLETED|Overall Study||69
2547099|NCT00570037|6241058|P1|NOT COMPLETED|Overall Study||44
2547100|NCT00570037|6241057|P2|COMPLETED|Overall Study||237
2547101|NCT00570037|6241058|P1|COMPLETED|Overall Study||194
2547102|NCT00570037|6241057|P2|STARTED|Overall Study||306
2547103|NCT00570037|6241058|P1|STARTED|Overall Study||238
2547104|NCT00569946|6241068|P1|NOT COMPLETED|Overall Study||59
2547105|NCT00569946|6241068|P1|COMPLETED|Overall Study||5
2547106|NCT00569946|6241068|P1|STARTED|Overall Study||64
2547107|NCT00569868|6241084|P1|NOT COMPLETED|Overall Study||0
2547108|NCT00569868|6241084|P1|COMPLETED|Overall Study||11
2547109|NCT00569868|6241084|P1|STARTED|Overall Study||11
2547110|NCT00569855|6241088|P1|NOT COMPLETED|Overall Study||0
2547111|NCT00569855|6241088|P1|COMPLETED|Overall Study|785 subjects treated with study drug|785
2547112|NCT00569855|6241088|P1|STARTED|Overall Study|832 subjects enrolled; however, study records only available for analysis from 2004 =446 subjects|785
2547113|NCT00569803|6241100|P8|NOT COMPLETED|Overall Study||1
2547114|NCT00569803|6241101|P7|NOT COMPLETED|Overall Study||0
2547115|NCT00569803|6241102|P6|NOT COMPLETED|Overall Study||0
2547116|NCT00569803|6241103|P5|NOT COMPLETED|Overall Study||0
2547117|NCT00569803|6241104|P4|NOT COMPLETED|Overall Study||1
2547118|NCT00569803|6241105|P3|NOT COMPLETED|Overall Study||0
2547119|NCT00569803|6241106|P2|NOT COMPLETED|Overall Study||0
2547120|NCT00569803|6241107|P1|NOT COMPLETED|Overall Study||1
2547121|NCT00569803|6241100|P8|COMPLETED|Overall Study||5
2547122|NCT00569803|6241101|P7|COMPLETED|Overall Study||10
2547123|NCT00569803|6241102|P6|COMPLETED|Overall Study||5
2547124|NCT00569803|6241103|P5|COMPLETED|Overall Study||5
2547125|NCT00569803|6241104|P4|COMPLETED|Overall Study||5
2547126|NCT00569803|6241105|P3|COMPLETED|Overall Study||5
2547127|NCT00569803|6241106|P2|COMPLETED|Overall Study||5
2547128|NCT00569803|6241107|P1|COMPLETED|Overall Study||4
2547129|NCT00569803|6241100|P8|STARTED|Overall Study||6
2547130|NCT00569803|6241101|P7|STARTED|Overall Study||10
2547131|NCT00569803|6241102|P6|STARTED|Overall Study||5
2547132|NCT00569803|6241103|P5|STARTED|Overall Study||5
2547133|NCT00569803|6241104|P4|STARTED|Overall Study||6
2547134|NCT00569803|6241105|P3|STARTED|Overall Study||5
2547135|NCT00569803|6241106|P2|STARTED|Overall Study||5
2547136|NCT00569803|6241107|P1|STARTED|Overall Study||5
2547137|NCT00569777|6241234|P2|NOT COMPLETED|Overall Study||3
2547138|NCT00569777|6241235|P1|NOT COMPLETED|Overall Study||10
2547139|NCT00569777|6241234|P2|COMPLETED|Overall Study||101
2547140|NCT00569777|6241235|P1|COMPLETED|Overall Study||196
2547141|NCT00569777|6241234|P2|STARTED|Overall Study||104
2547142|NCT00569777|6241235|P1|STARTED|Overall Study||206
2547143|NCT00569673|6241277|P1|NOT COMPLETED|Overall Study||0
2547144|NCT00569673|6241277|P1|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|71
2547145|NCT00569673|6241277|P1|STARTED|Overall Study|Total number participants enrolled on study|71
2547146|NCT00569660|6241282|P1|NOT COMPLETED|Overall Study||0
2547147|NCT00569660|6241282|P1|COMPLETED|Overall Study||34
2547148|NCT00569660|6241282|P1|STARTED|Overall Study||34
2547149|NCT00569582|6241286|P1|NOT COMPLETED|Overall Study||16
2547150|NCT00569582|6241286|P1|COMPLETED|Overall Study||34
2547151|NCT00569582|6241286|P1|STARTED|Overall Study||50
2547152|NCT00569530|6241293|P2|NOT COMPLETED|Overall Study||0
2547153|NCT00569530|6241294|P1|NOT COMPLETED|Overall Study||0
2547154|NCT00569530|6241293|P2|COMPLETED|Overall Study||42
2547155|NCT00569530|6241294|P1|COMPLETED|Overall Study||43
2547156|NCT00569530|6241293|P2|STARTED|Overall Study||42
2547157|NCT00569530|6241294|P1|STARTED|Overall Study||43
2547158|NCT00569374|6241302|P1|NOT COMPLETED|Overall Study||4
2547159|NCT00569374|6241302|P1|COMPLETED|Overall Study||4
2547160|NCT00569374|6241302|P1|STARTED|Overall Study||8
2547161|NCT00569309|6241312|P1|NOT COMPLETED|Overall Study||0
2547162|NCT00569309|6241312|P1|COMPLETED|Overall Study||30
2547163|NCT00569309|6241312|P1|STARTED|Overall Study||30
2547164|NCT00569270|6241321|P2|NOT COMPLETED|Period: Second Intervention||0
2547165|NCT00569270|6241322|P1|NOT COMPLETED|Period: Second Intervention||0
2547166|NCT00569270|6241321|P2|COMPLETED|Period: Second Intervention||14
2547167|NCT00569270|6241322|P1|COMPLETED|Period: Second Intervention||15
2547168|NCT00569270|6241321|P2|29 Days|Period: Second Intervention||14
2547169|NCT00569270|6241322|P1|29 Days|Period: Second Intervention||15
2547170|NCT00569270|6241321|P2|STARTED|Period: Second Intervention||14
2547171|NCT00569270|6241322|P1|STARTED|Period: Second Intervention||15
2547172|NCT00569270|6241321|P2|NOT COMPLETED|Period: First Intervention||1
2547173|NCT00569270|6241322|P1|NOT COMPLETED|Period: First Intervention||0
2547174|NCT00569270|6241321|P2|COMPLETED|Period: First Intervention||14
2547175|NCT00569270|6241322|P1|COMPLETED|Period: First Intervention||15
2547176|NCT00569270|6241321|P2|STARTED|Period: First Intervention||15
2547177|NCT00569270|6241322|P1|STARTED|Period: First Intervention|randomized cross over study|15
2547178|NCT00569231|6241357|P1|NOT COMPLETED|Overall Study||7
2547179|NCT00569231|6241357|P1|COMPLETED|Overall Study||11
2547180|NCT00569231|6241357|P1|STARTED|Overall Study||18
2547181|NCT00569192|6241367|P3|NOT COMPLETED|Overall Study||25
2547182|NCT00569192|6241368|P2|NOT COMPLETED|Overall Study||20
2547183|NCT00569192|6241369|P1|NOT COMPLETED|Overall Study||23
2547184|NCT00569192|6241367|P3|COMPLETED|Overall Study||99
2547185|NCT00569192|6241368|P2|COMPLETED|Overall Study||105
2547186|NCT00569192|6241369|P1|COMPLETED|Overall Study||88
2547187|NCT00569192|6241367|P3|STARTED|Overall Study||124
2547188|NCT00569192|6241368|P2|STARTED|Overall Study||125
2547189|NCT00569192|6241369|P1|STARTED|Overall Study||111
2547190|NCT00569166|6241395|P3|NOT COMPLETED|Overall Study||4
2547191|NCT00569166|6241396|P2|NOT COMPLETED|Overall Study||6
2547192|NCT00569166|6241397|P1|NOT COMPLETED|Overall Study||9
2547193|NCT00569166|6241395|P3|COMPLETED|Overall Study||27
2547194|NCT00569166|6241396|P2|COMPLETED|Overall Study||25
2547195|NCT00569166|6241397|P1|COMPLETED|Overall Study||21
2547196|NCT00569166|6241395|P3|STARTED|Overall Study||31
2547197|NCT00569166|6241396|P2|STARTED|Overall Study||31
2547198|NCT00569166|6241397|P1|STARTED|Overall Study||30
2547199|NCT00569127|6241431|P2|NOT COMPLETED|Overall Study||213
2547200|NCT00569127|6241432|P1|NOT COMPLETED|Overall Study||214
2547201|NCT00569127|6241431|P2|COMPLETED|Overall Study||0
2547202|NCT00569127|6241432|P1|COMPLETED|Overall Study||0
2547203|NCT00569127|6241431|P2|Eligible|Overall Study||202
2547204|NCT00569127|6241432|P1|Eligible|Overall Study||200
2547205|NCT00569127|6241431|P2|STARTED|Overall Study||213
2547206|NCT00569127|6241432|P1|STARTED|Overall Study||214
2547207|NCT00569010|6241452|P4|NOT COMPLETED|Overall Study||0
2547208|NCT00569010|6241453|P3|NOT COMPLETED|Overall Study||0
2547209|NCT00569010|6241454|P2|NOT COMPLETED|Overall Study||0
2547210|NCT00569010|6241455|P1|NOT COMPLETED|Overall Study||0
2547211|NCT00569010|6241452|P4|COMPLETED|Overall Study||11
2547212|NCT00569010|6241453|P3|COMPLETED|Overall Study||11
2547213|NCT00569010|6241454|P2|COMPLETED|Overall Study||6
2547214|NCT00569010|6241455|P1|COMPLETED|Overall Study||6
2547215|NCT00569010|6241452|P4|STARTED|Overall Study||11
2547216|NCT00569010|6241453|P3|STARTED|Overall Study||11
2547217|NCT00569010|6241454|P2|STARTED|Overall Study||6
2547218|NCT00569010|6241455|P1|STARTED|Overall Study||6
2547219|NCT00568958|6241467|P2|NOT COMPLETED|Follow-Up||7
2547220|NCT00568958|6241468|P1|NOT COMPLETED|Follow-Up||9
2547221|NCT00568958|6241467|P2|COMPLETED|Follow-Up||60
2547222|NCT00568958|6241468|P1|COMPLETED|Follow-Up||52
2547223|NCT00568958|6241467|P2|STARTED|Follow-Up||67
2547224|NCT00568958|6241468|P1|STARTED|Follow-Up||61
2547225|NCT00568958|6241467|P2|NOT COMPLETED|Allocation||3
2547226|NCT00568958|6241468|P1|NOT COMPLETED|Allocation||9
2547227|NCT00568958|6241467|P2|COMPLETED|Allocation||67
2547228|NCT00568958|6241468|P1|COMPLETED|Allocation||61
2547229|NCT00568958|6241467|P2|STARTED|Allocation||70
2547230|NCT00568958|6241468|P1|STARTED|Allocation||70
2547231|NCT00568854|6241488|P2|NOT COMPLETED|Overall Study||0
2547232|NCT00568854|6241489|P1|NOT COMPLETED|Overall Study||0
2547233|NCT00568854|6241488|P2|COMPLETED|Overall Study||4
2547234|NCT00568854|6241489|P1|COMPLETED|Overall Study||6
2547235|NCT00568854|6241488|P2|STARTED|Overall Study||4
2547236|NCT00568854|6241489|P1|STARTED|Overall Study||6
2547237|NCT00568802|6241497|P1|NOT COMPLETED|Overall Study||3
2547238|NCT00568802|6241497|P1|COMPLETED|Overall Study||24
2547239|NCT00568802|6241497|P1|STARTED|Overall Study||27
2547240|NCT00568776|6241515|P4|NOT COMPLETED|Overall Study||72
2547241|NCT00568776|6241516|P3|NOT COMPLETED|Overall Study||74
2547242|NCT00568776|6241517|P2|NOT COMPLETED|Overall Study||36
2547243|NCT00568776|6241518|P1|NOT COMPLETED|Overall Study||30
2547244|NCT00568776|6241515|P4|COMPLETED|Overall Study||19
2547245|NCT00568776|6241516|P3|COMPLETED|Overall Study||15
2547246|NCT00568776|6241517|P2|COMPLETED|Overall Study||52
2547247|NCT00568776|6241518|P1|COMPLETED|Overall Study||53
2547248|NCT00568776|6241515|P4|STARTED|Overall Study|42 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|91
2547249|NCT00568776|6241516|P3|STARTED|Overall Study|41 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|89
2547250|NCT00568776|6241517|P2|STARTED|Overall Study|One randomized patient withdrew consent and did not receive ELND005 250 mg BID|88
2547251|NCT00568776|6241518|P1|STARTED|Overall Study|One randomized patient withdrew consent and did not receive placebo|83
2547252|NCT00568698|6241552|P1|NOT COMPLETED|Overall Study||11
2547253|NCT00568698|6241552|P1|COMPLETED|Overall Study||18
2547254|NCT00568698|6241552|P1|STARTED|Overall Study||29
2547255|NCT00568685|6241567|P3|NOT COMPLETED|Overall Study||5
2547256|NCT00568685|6241568|P2|NOT COMPLETED|Overall Study||5
2547257|NCT00568685|6241569|P1|NOT COMPLETED|Overall Study||10
2547258|NCT00568685|6241567|P3|COMPLETED|Overall Study||46
2547259|NCT00568685|6241568|P2|COMPLETED|Overall Study||46
2547260|NCT00568685|6241569|P1|COMPLETED|Overall Study||41
2547261|NCT00568685|6241567|P3|STARTED|Overall Study||51
2547262|NCT00568685|6241568|P2|STARTED|Overall Study||51
2547263|NCT00568685|6241569|P1|STARTED|Overall Study||51
2547264|NCT00568633|6241603|P2|NOT COMPLETED|Overall Study||0
2547265|NCT00568633|6241604|P1|NOT COMPLETED|Overall Study||0
2547266|NCT00568633|6241603|P2|COMPLETED|Overall Study||33
2547267|NCT00568633|6241604|P1|COMPLETED|Overall Study||25
2547268|NCT00568633|6241603|P2|STARTED|Overall Study||33
2547269|NCT00568633|6241604|P1|STARTED|Overall Study||25
2547270|NCT00568555|6241626|P2|NOT COMPLETED|Overall Study||1
2547271|NCT00568555|6241627|P1|NOT COMPLETED|Overall Study||1
2547272|NCT00568555|6241626|P2|COMPLETED|Overall Study||14
2547273|NCT00568555|6241627|P1|COMPLETED|Overall Study||15
2547274|NCT00568555|6241626|P2|STARTED|Overall Study||15
2547275|NCT00568555|6241627|P1|STARTED|Overall Study||16
2547276|NCT00568451|6241645|P4|NOT COMPLETED|Overall Study||7
2547277|NCT00568451|6241646|P3|NOT COMPLETED|Overall Study||2
2547278|NCT00568451|6241647|P2|NOT COMPLETED|Overall Study||0
2547279|NCT00568451|6241648|P1|NOT COMPLETED|Overall Study||0
2547280|NCT00568451|6241645|P4|COMPLETED|Overall Study||2
2547281|NCT00568451|6241646|P3|COMPLETED|Overall Study||0
2547282|NCT00568451|6241647|P2|COMPLETED|Overall Study||0
2547283|NCT00568451|6241648|P1|COMPLETED|Overall Study||0
2547284|NCT00568451|6241645|P4|STARTED|Overall Study||9
2547285|NCT00568451|6241646|P3|STARTED|Overall Study||2
2547286|NCT00568451|6241647|P2|STARTED|Overall Study||0
2547287|NCT00568451|6241648|P1|STARTED|Overall Study||0
2547288|NCT00568399|6241664|P1|NOT COMPLETED|Overall Study||15
2547289|NCT00568399|6241664|P1|COMPLETED|Overall Study|Of 48 subject enrolled, 37 initiated sodium thiosulfate treatment. 22 completed the entire protocol|22
2547290|NCT00568399|6241664|P1|STARTED|Overall Study||37
2547291|NCT00568386|6241670|P2|NOT COMPLETED|Overall Study||0
2547292|NCT00568386|6241671|P1|NOT COMPLETED|Overall Study||0
2547293|NCT00568386|6241670|P2|COMPLETED|Overall Study||20
2547294|NCT00568386|6241671|P1|COMPLETED|Overall Study||20
2547295|NCT00568386|6241670|P2|STARTED|Overall Study||20
2547296|NCT00568386|6241671|P1|STARTED|Overall Study||20
2547297|NCT00568334|6241679|P2|NOT COMPLETED|Overall Study||1
2547298|NCT00568334|6241680|P1|NOT COMPLETED|Overall Study||1
2547299|NCT00568334|6241679|P2|COMPLETED|Overall Study||121
2547300|NCT00568334|6241680|P1|COMPLETED|Overall Study||121
2547301|NCT00568334|6241679|P2|STARTED|Overall Study||122
2547302|NCT00568334|6241680|P1|STARTED|Overall Study||122
2547303|NCT00568178|6241706|P6|NOT COMPLETED|Open Label Extension||80
2547304|NCT00568178|6241707|P5|NOT COMPLETED|Open Label Extension||79
2547305|NCT00568178|6241708|P4|NOT COMPLETED|Open Label Extension||0
2547306|NCT00568178|6241709|P3|NOT COMPLETED|Open Label Extension||0
2547307|NCT00568178|6241710|P2|NOT COMPLETED|Open Label Extension||0
2547308|NCT00568178|6241711|P1|NOT COMPLETED|Open Label Extension||0
2547309|NCT00568178|6241706|P6|COMPLETED|Open Label Extension||54
2547310|NCT00568178|6241707|P5|COMPLETED|Open Label Extension||55
2547311|NCT00568178|6241708|P4|COMPLETED|Open Label Extension||0
2547312|NCT00568178|6241709|P3|COMPLETED|Open Label Extension||0
2547313|NCT00568178|6241710|P2|COMPLETED|Open Label Extension||0
2547314|NCT00568178|6241711|P1|COMPLETED|Open Label Extension||0
2547315|NCT00568178|6241706|P6|STARTED|Open Label Extension||134
2547316|NCT00568178|6241707|P5|STARTED|Open Label Extension||134
2547317|NCT00568178|6241708|P4|STARTED|Open Label Extension||0
2547318|NCT00568178|6241709|P3|STARTED|Open Label Extension||0
2547319|NCT00568178|6241710|P2|STARTED|Open Label Extension||0
2547320|NCT00568178|6241711|P1|STARTED|Open Label Extension||0
2547321|NCT00568178|6241706|P6|NOT COMPLETED|Double Blind Base Study||0
2547322|NCT00568178|6241707|P5|NOT COMPLETED|Double Blind Base Study||0
2547323|NCT00568178|6241708|P4|NOT COMPLETED|Double Blind Base Study||5
2547324|NCT00568178|6241709|P3|NOT COMPLETED|Double Blind Base Study||1
2547325|NCT00568178|6241710|P2|NOT COMPLETED|Double Blind Base Study||6
2547326|NCT00568178|6241711|P1|NOT COMPLETED|Double Blind Base Study||6
2547327|NCT00568178|6241706|P6|COMPLETED|Double Blind Base Study||0
2547328|NCT00568178|6241707|P5|COMPLETED|Double Blind Base Study||0
2547329|NCT00568178|6241708|P4|COMPLETED|Double Blind Base Study||25
2547330|NCT00568178|6241709|P3|COMPLETED|Double Blind Base Study||29
2547331|NCT00568178|6241710|P2|COMPLETED|Double Blind Base Study||118
2547332|NCT00568178|6241711|P1|COMPLETED|Double Blind Base Study||116
2547333|NCT00568178|6241706|P6|STARTED|Double Blind Base Study||0
2547334|NCT00568178|6241707|P5|STARTED|Double Blind Base Study||0
2547335|NCT00568178|6241708|P4|STARTED|Double Blind Base Study||30
2547336|NCT00568178|6241709|P3|STARTED|Double Blind Base Study||30
2547337|NCT00568178|6241710|P2|STARTED|Double Blind Base Study||124
2547338|NCT00568178|6241711|P1|STARTED|Double Blind Base Study||122
2547339|NCT00568087|6241729|P2|NOT COMPLETED|Overall Study||7
2547340|NCT00568087|6241730|P1|NOT COMPLETED|Overall Study||7
2547341|NCT00568087|6241729|P2|COMPLETED|Overall Study||17
2547342|NCT00568087|6241730|P1|COMPLETED|Overall Study||15
2547343|NCT00568087|6241729|P2|Received Intervention|Overall Study||23
2547344|NCT00568087|6241730|P1|Received Intervention|Overall Study||21
2547345|NCT00568087|6241729|P2|STARTED|Overall Study||24
2547346|NCT00568087|6241730|P1|STARTED|Overall Study||22
2547347|NCT00568061|6241742|P2|NOT COMPLETED|Overall Study||2
2547348|NCT00568061|6241743|P1|NOT COMPLETED|Overall Study||5
2547349|NCT00568061|6241742|P2|COMPLETED|Overall Study||14
2547350|NCT00568061|6241743|P1|COMPLETED|Overall Study||8
2547351|NCT00568061|6241742|P2|STARTED|Overall Study||16
2547352|NCT00568061|6241743|P1|STARTED|Overall Study||13
2547353|NCT00568022|6241771|P3|NOT COMPLETED|Overall Study||0
2547354|NCT00568022|6241772|P2|NOT COMPLETED|Overall Study||0
2547355|NCT00568022|6241773|P1|NOT COMPLETED|Overall Study||0
2547356|NCT00568022|6241771|P3|COMPLETED|Overall Study||3
2547357|NCT00568022|6241772|P2|COMPLETED|Overall Study||3
2547358|NCT00568022|6241773|P1|COMPLETED|Overall Study||3
2547359|NCT00568022|6241771|P3|STARTED|Overall Study||3
2547360|NCT00568022|6241772|P2|STARTED|Overall Study||3
2547361|NCT00568022|6241773|P1|STARTED|Overall Study||3
2547362|NCT00567996|6241806|P3|NOT COMPLETED|Overall Study||70
2547363|NCT00567996|6241807|P2|NOT COMPLETED|Overall Study||50
2547364|NCT00567996|6241808|P1|NOT COMPLETED|Overall Study||44
2547365|NCT00567996|6241806|P3|COMPLETED|Overall Study||265
2547366|NCT00567996|6241807|P2|COMPLETED|Overall Study||284
2547367|NCT00567996|6241808|P1|COMPLETED|Overall Study||289
2547368|NCT00567996|6241806|P3|Intent-to-treat: Received Study Drug|Overall Study||335
2547369|NCT00567996|6241807|P2|Intent-to-treat: Received Study Drug|Overall Study||333
2547370|NCT00567996|6241808|P1|Intent-to-treat: Received Study Drug|Overall Study||330
2547371|NCT00567996|6241806|P3|STARTED|Overall Study||335
2547372|NCT00567996|6241807|P2|STARTED|Overall Study||334
2547373|NCT00567996|6241808|P1|STARTED|Overall Study|Randomized participants|333
2547374|NCT00567892|6241824|P4|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||1
2547375|NCT00567892|6241825|P3|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
2547376|NCT00567892|6241826|P2|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
2547377|NCT00567892|6241827|P1|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
2547378|NCT00567892|6241824|P4|COMPLETED|Second Treatment (2 or 4 Weeks)||5
2547379|NCT00567892|6241825|P3|COMPLETED|Second Treatment (2 or 4 Weeks)||9
2547380|NCT00567892|6241826|P2|COMPLETED|Second Treatment (2 or 4 Weeks)||7
2547381|NCT00567892|6241827|P1|COMPLETED|Second Treatment (2 or 4 Weeks)||7
2547382|NCT00567892|6241824|P4|STARTED|Second Treatment (2 or 4 Weeks)||6
2547383|NCT00567892|6241825|P3|STARTED|Second Treatment (2 or 4 Weeks)||9
2547384|NCT00567892|6241826|P2|STARTED|Second Treatment (2 or 4 Weeks)||7
2547385|NCT00567892|6241827|P1|STARTED|Second Treatment (2 or 4 Weeks)||7
2547386|NCT00567892|6241824|P4|NOT COMPLETED|Washout (2 Weeks)||0
2547387|NCT00567892|6241825|P3|NOT COMPLETED|Washout (2 Weeks)||0
2547388|NCT00567892|6241826|P2|NOT COMPLETED|Washout (2 Weeks)||0
2547389|NCT00567892|6241827|P1|NOT COMPLETED|Washout (2 Weeks)||0
2547390|NCT00567892|6241824|P4|COMPLETED|Washout (2 Weeks)||6
2547391|NCT00567892|6241825|P3|COMPLETED|Washout (2 Weeks)||9
2547392|NCT00567892|6241826|P2|COMPLETED|Washout (2 Weeks)||7
2547393|NCT00567892|6241827|P1|COMPLETED|Washout (2 Weeks)||7
2547394|NCT00567892|6241824|P4|STARTED|Washout (2 Weeks)||6
2547395|NCT00567892|6241825|P3|STARTED|Washout (2 Weeks)||9
2547396|NCT00567892|6241826|P2|STARTED|Washout (2 Weeks)||7
2547397|NCT00567892|6241827|P1|STARTED|Washout (2 Weeks)||7
2547398|NCT00567892|6241824|P4|NOT COMPLETED|First Treatment (2 or 4 Weeks)||4
2547399|NCT00567892|6241825|P3|NOT COMPLETED|First Treatment (2 or 4 Weeks)||1
2547400|NCT00567892|6241826|P2|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
2547401|NCT00567892|6241827|P1|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
2547402|NCT00567892|6241824|P4|COMPLETED|First Treatment (2 or 4 Weeks)||6
2547403|NCT00567892|6241825|P3|COMPLETED|First Treatment (2 or 4 Weeks)||9
2547404|NCT00567892|6241826|P2|COMPLETED|First Treatment (2 or 4 Weeks)||7
2547405|NCT00567892|6241827|P1|COMPLETED|First Treatment (2 or 4 Weeks)||7
2547406|NCT00567892|6241824|P4|STARTED|First Treatment (2 or 4 Weeks)||10
2547407|NCT00567892|6241825|P3|STARTED|First Treatment (2 or 4 Weeks)||10
2547408|NCT00567892|6241826|P2|STARTED|First Treatment (2 or 4 Weeks)||7
2547409|NCT00567892|6241827|P1|STARTED|First Treatment (2 or 4 Weeks)||7
2547410|NCT00567879|6241845|P6|NOT COMPLETED|Overall Study||3
2547411|NCT00567879|6241846|P5|NOT COMPLETED|Overall Study||12
2547412|NCT00567879|6241847|P4|NOT COMPLETED|Overall Study||6
2547413|NCT00567879|6241848|P3|NOT COMPLETED|Overall Study||21
2547414|NCT00567879|6241849|P2|NOT COMPLETED|Overall Study||7
2547415|NCT00567879|6241850|P1|NOT COMPLETED|Overall Study||7
2547416|NCT00567879|6241845|P6|COMPLETED|Overall Study||0
2547417|NCT00567879|6241846|P5|COMPLETED|Overall Study||0
2547418|NCT00567879|6241847|P4|COMPLETED|Overall Study||0
2547419|NCT00567879|6241848|P3|COMPLETED|Overall Study||0
2547420|NCT00567879|6241849|P2|COMPLETED|Overall Study||0
2547421|NCT00567879|6241850|P1|COMPLETED|Overall Study||0
2547422|NCT00567879|6241845|P6|Maximum Tolerated Dose Determining Set|Overall Study||3
2547423|NCT00567879|6241846|P5|Maximum Tolerated Dose Determining Set|Overall Study||12
2547424|NCT00567879|6241847|P4|Maximum Tolerated Dose Determining Set|Overall Study||6
2547425|NCT00567879|6241848|P3|Maximum Tolerated Dose Determining Set|Overall Study|6 participants belonged to the dose expansion group at 20mg/m2 i.v.|18
2547426|NCT00567879|6241849|P2|Maximum Tolerated Dose Determining Set|Overall Study||7
2547427|NCT00567879|6241850|P1|Maximum Tolerated Dose Determining Set|Overall Study||5
2547428|NCT00567879|6241845|P6|STARTED|Overall Study||3
2547429|NCT00567879|6241846|P5|STARTED|Overall Study||12
2547430|NCT00567879|6241847|P4|STARTED|Overall Study||6
2547431|NCT00567879|6241848|P3|STARTED|Overall Study|7 participants belonged to the dose expansion group at 20mg/m2 i.v.|21
2547432|NCT00567879|6241849|P2|STARTED|Overall Study||7
2547433|NCT00567879|6241850|P1|STARTED|Overall Study||7
2547434|NCT00567840|6241876|P5|NOT COMPLETED|Overall Study||0
2547435|NCT00567840|6241877|P4|NOT COMPLETED|Overall Study||1
2547436|NCT00567840|6241878|P3|NOT COMPLETED|Overall Study||1
2547437|NCT00567840|6241879|P2|NOT COMPLETED|Overall Study||0
2547438|NCT00567840|6241880|P1|NOT COMPLETED|Overall Study||2
2547439|NCT00567840|6241876|P5|COMPLETED|Overall Study||8
2547440|NCT00567840|6241877|P4|COMPLETED|Overall Study||14
2547441|NCT00567840|6241878|P3|COMPLETED|Overall Study||15
2547442|NCT00567840|6241879|P2|COMPLETED|Overall Study||15
2547443|NCT00567840|6241880|P1|COMPLETED|Overall Study||13
2547444|NCT00567840|6241876|P5|STARTED|Overall Study||8
2547445|NCT00567840|6241877|P4|STARTED|Overall Study||15
2547446|NCT00567840|6241878|P3|STARTED|Overall Study||16
2547447|NCT00567840|6241879|P2|STARTED|Overall Study||15
2547448|NCT00567840|6241880|P1|STARTED|Overall Study||15
2547449|NCT00567593|6241917|P1|NOT COMPLETED|Overall Study||2
2547450|NCT00567593|6241917|P1|COMPLETED|Overall Study||10
2547451|NCT00567593|6241917|P1|STARTED|Overall Study||12
2547452|NCT00567567|6241924|P3|NOT COMPLETED|Overall Study||278
2547453|NCT00567567|6241925|P2|NOT COMPLETED|Overall Study||134
2547454|NCT00567567|6241926|P1|NOT COMPLETED|Overall Study||152
2547455|NCT00567567|6241924|P3|COMPLETED|Overall Study||1
2547456|NCT00567567|6241925|P2|COMPLETED|Overall Study||42
2547457|NCT00567567|6241926|P1|COMPLETED|Overall Study||58
2547458|NCT00567567|6241924|P3|STARTED|Overall Study||279
2547459|NCT00567567|6241925|P2|STARTED|Overall Study||176
2547460|NCT00567567|6241926|P1|STARTED|Overall Study||210
2547461|NCT00567541|6241974|P2|NOT COMPLETED|Overall Study||1
2547462|NCT00567541|6241975|P1|NOT COMPLETED|Overall Study||0
2547463|NCT00567541|6241974|P2|COMPLETED|Overall Study||8
2547464|NCT00567541|6241975|P1|COMPLETED|Overall Study||7
2547465|NCT00567541|6241974|P2|STARTED|Overall Study||9
2547466|NCT00567541|6241975|P1|STARTED|Overall Study||7
2547467|NCT00567502|6241985|P4|NOT COMPLETED|Overall Study||87
2547468|NCT00567502|6241986|P3|NOT COMPLETED|Overall Study||908
2547469|NCT00567502|6241987|P2|NOT COMPLETED|Overall Study||33
2547470|NCT00567502|6241988|P1|NOT COMPLETED|Overall Study||241
2547471|NCT00567502|6241985|P4|COMPLETED|Overall Study||23
2547472|NCT00567502|6241986|P3|COMPLETED|Overall Study||1758
2547473|NCT00567502|6241987|P2|COMPLETED|Overall Study||108
2547474|NCT00567502|6241988|P1|COMPLETED|Overall Study||563
2547475|NCT00567502|6241985|P4|Initiated Treatment|Overall Study||38
2547476|NCT00567502|6241986|P3|Initiated Treatment|Overall Study||2666
2547477|NCT00567502|6241987|P2|Initiated Treatment|Overall Study||141
2547478|NCT00567502|6241988|P1|Initiated Treatment|Overall Study||804
2547479|NCT00567502|6241985|P4|STARTED|Overall Study||110
2547480|NCT00567502|6241986|P3|STARTED|Overall Study||2666
2547481|NCT00567502|6241987|P2|STARTED|Overall Study||141
2547482|NCT00567502|6241988|P1|STARTED|Overall Study||804
2547483|NCT00567489|6242025|P2|NOT COMPLETED|Overall Study||23
2547484|NCT00567489|6242026|P1|NOT COMPLETED|Overall Study||7
2547485|NCT00567489|6242025|P2|COMPLETED|Overall Study||101
2547486|NCT00567489|6242026|P1|COMPLETED|Overall Study||120
2547487|NCT00567489|6242025|P2|STARTED|Overall Study||124
2547488|NCT00567489|6242026|P1|STARTED|Overall Study||127
2547489|NCT00567476|6242076|P2|NOT COMPLETED|Overall Study||4
2547490|NCT00567476|6242077|P1|NOT COMPLETED|Overall Study||8
2547491|NCT00567476|6242076|P2|COMPLETED|Overall Study||34
2547492|NCT00567476|6242077|P1|COMPLETED|Overall Study||70
2547493|NCT00567476|6242076|P2|STARTED|Overall Study||38
2547494|NCT00567476|6242077|P1|STARTED|Overall Study||78
2547495|NCT00567398|6242103|P2|NOT COMPLETED|Overall Study||23
2547496|NCT00567398|6242104|P1|NOT COMPLETED|Overall Study||7
2547497|NCT00567398|6242103|P2|COMPLETED|Overall Study||101
2547498|NCT00567398|6242104|P1|COMPLETED|Overall Study||120
2547499|NCT00567398|6242103|P2|STARTED|Overall Study||124
2547500|NCT00567398|6242104|P1|STARTED|Overall Study||127
2547501|NCT00567359|6242152|P1|NOT COMPLETED|Overall Study||1
2547502|NCT00567359|6242152|P1|COMPLETED|Overall Study||99
2547503|NCT00567359|6242152|P1|STARTED|Overall Study||100
2547504|NCT00567320|6242161|P2|NOT COMPLETED|Overall Study||0
2547505|NCT00567320|6242162|P1|NOT COMPLETED|Overall Study||0
2547506|NCT00567320|6242161|P2|COMPLETED|Overall Study||18
2547507|NCT00567320|6242162|P1|COMPLETED|Overall Study||13
2547508|NCT00567320|6242161|P2|STARTED|Overall Study||18
2547509|NCT00567320|6242162|P1|STARTED|Overall Study||13
2547510|NCT00567307|6242170|P2|NOT COMPLETED|Overall Study||1
2547511|NCT00567307|6242171|P1|NOT COMPLETED|Overall Study||12
2547512|NCT00567307|6242170|P2|COMPLETED|Overall Study||104
2547513|NCT00567307|6242171|P1|COMPLETED|Overall Study||99
2547514|NCT00567307|6242170|P2|STARTED|Overall Study||105
2547515|NCT00567307|6242171|P1|STARTED|Overall Study||111
2547516|NCT00567268|6242177|P1|NOT COMPLETED|Overall Study||50
2547517|NCT00567268|6242177|P1|COMPLETED|Overall Study||1144
2547518|NCT00567268|6242177|P1|STARTED|Overall Study||1194
2547519|NCT00567255|6242228|P2|NOT COMPLETED|Overall Study||228
2547520|NCT00567255|6242229|P1|NOT COMPLETED|Overall Study||463
2547521|NCT00567255|6242228|P2|COMPLETED|Overall Study||267
2547522|NCT00567255|6242229|P1|COMPLETED|Overall Study||538
2547523|NCT00567255|6242228|P2|STARTED|Overall Study||495
2547524|NCT00567255|6242229|P1|STARTED|Overall Study||1001
2547525|NCT00567242|6242275|P2|NOT COMPLETED|Overall Study||0
2547526|NCT00567242|6242276|P1|NOT COMPLETED|Overall Study||0
2547527|NCT00567242|6242275|P2|COMPLETED|Overall Study||7
2547528|NCT00567242|6242276|P1|COMPLETED|Overall Study||7
2547529|NCT00567242|6242275|P2|STARTED|Overall Study||7
2547530|NCT00567242|6242276|P1|STARTED|Overall Study||7
2547531|NCT00567229|6242286|P1|NOT COMPLETED|Overall Study||0
2547532|NCT00567229|6242286|P1|COMPLETED|Overall Study||3
2547533|NCT00567229|6242286|P1|STARTED|Overall Study||3
2547534|NCT00567190|6242292|P2|NOT COMPLETED|Overall Study||333
2547535|NCT00567190|6242293|P1|NOT COMPLETED|Overall Study||283
2547536|NCT00567190|6242292|P2|COMPLETED|Overall Study||73
2547537|NCT00567190|6242293|P1|COMPLETED|Overall Study||119
2547538|NCT00567190|6242292|P2|Crossover From Placebo to Pertuzumab|Overall Study|From July 2012, 50 participants randomized to Placebo arm crossed over to open-label pertuzumab.|50
2547539|NCT00567190|6242293|P1|Crossover From Placebo to Pertuzumab|Overall Study||0
2547540|NCT00567190|6242292|P2|Received at Least One Dose of Placebo|Overall Study||395
2547541|NCT00567190|6242293|P1|Received at Least One Dose of Placebo|Overall Study|1 participant randomized to the Pertuzumab arm actually received placebo at every treatment cycle.|1
2547542|NCT00567190|6242292|P2|Received at Least One Dose of Pertuzumab|Overall Study|9 participants randomized to the Placebo arm actually received at least one dose of pertuzumab.|9
2547543|NCT00567190|6242293|P1|Received at Least One Dose of Pertuzumab|Overall Study||399
2547544|NCT00567190|6242292|P2|Did Not Receive Any Study Treatment|Overall Study||2
2547545|NCT00567190|6242293|P1|Did Not Receive Any Study Treatment|Overall Study||2
2547546|NCT00567190|6242292|P2|STARTED|Overall Study||406
2547547|NCT00567190|6242293|P1|STARTED|Overall Study||402
2547548|NCT00567164|6242344|P3|NOT COMPLETED|Overall Study||72
2547549|NCT00567164|6242345|P2|NOT COMPLETED|Overall Study||73
2547550|NCT00567164|6242346|P1|NOT COMPLETED|Overall Study||546
2547551|NCT00567164|6242344|P3|COMPLETED|Overall Study||160
2547552|NCT00567164|6242345|P2|COMPLETED|Overall Study||161
2547553|NCT00567164|6242346|P1|COMPLETED|Overall Study||875
2547554|NCT00567164|6242344|P3|Subjects Received Treatment|Overall Study|Full Analysis Set|226
2547555|NCT00567164|6242345|P2|Subjects Received Treatment|Overall Study|Full Analysis Set|232
2547556|NCT00567164|6242346|P1|Subjects Received Treatment|Overall Study|Full Analysis Set|1406
2547557|NCT00567164|6242344|P3|STARTED|Overall Study||232
2547558|NCT00567164|6242345|P2|STARTED|Overall Study||234
2547559|NCT00567164|6242346|P1|STARTED|Overall Study||1421
2547560|NCT00567112|6242418|P3|NOT COMPLETED|Treatment Period 4 (3 Days)||0
2547561|NCT00567112|6242419|P2|NOT COMPLETED|Treatment Period 4 (3 Days)||0
2547562|NCT00567112|6242420|P1|NOT COMPLETED|Treatment Period 4 (3 Days)||0
2547563|NCT00567112|6242418|P3|COMPLETED|Treatment Period 4 (3 Days)||3
2547564|NCT00567112|6242419|P2|COMPLETED|Treatment Period 4 (3 Days)||7
2547565|NCT00567112|6242420|P1|COMPLETED|Treatment Period 4 (3 Days)||4
2547566|NCT00567112|6242418|P3|STARTED|Treatment Period 4 (3 Days)||3
2547567|NCT00567112|6242419|P2|STARTED|Treatment Period 4 (3 Days)||7
2547568|NCT00567112|6242420|P1|STARTED|Treatment Period 4 (3 Days)||4
2547569|NCT00567112|6242418|P3|NOT COMPLETED|Washout Period 3 (3 Days)||0
2547570|NCT00567112|6242419|P2|NOT COMPLETED|Washout Period 3 (3 Days)||0
2547571|NCT00567112|6242420|P1|NOT COMPLETED|Washout Period 3 (3 Days)||3
2547572|NCT00567112|6242418|P3|COMPLETED|Washout Period 3 (3 Days)||3
2547573|NCT00567112|6242419|P2|COMPLETED|Washout Period 3 (3 Days)||7
2547574|NCT00567112|6242420|P1|COMPLETED|Washout Period 3 (3 Days)||4
2547575|NCT00567112|6242418|P3|STARTED|Washout Period 3 (3 Days)||3
2547576|NCT00567112|6242419|P2|STARTED|Washout Period 3 (3 Days)||7
2547577|NCT00567112|6242420|P1|STARTED|Washout Period 3 (3 Days)||7
2547578|NCT00567112|6242418|P3|NOT COMPLETED|Treatment Period 3 (3 Days)||0
2547579|NCT00567112|6242419|P2|NOT COMPLETED|Treatment Period 3 (3 Days)||0
2547580|NCT00567112|6242420|P1|NOT COMPLETED|Treatment Period 3 (3 Days)||0
2547581|NCT00567112|6242418|P3|COMPLETED|Treatment Period 3 (3 Days)||3
2547582|NCT00567112|6242419|P2|COMPLETED|Treatment Period 3 (3 Days)||7
2547583|NCT00567112|6242420|P1|COMPLETED|Treatment Period 3 (3 Days)||7
2547584|NCT00567112|6242418|P3|STARTED|Treatment Period 3 (3 Days)||3
2547585|NCT00567112|6242419|P2|STARTED|Treatment Period 3 (3 Days)||7
2547586|NCT00567112|6242420|P1|STARTED|Treatment Period 3 (3 Days)||7
2547587|NCT00567112|6242418|P3|NOT COMPLETED|Washout Period 2 (3 Days)||0
2547588|NCT00567112|6242419|P2|NOT COMPLETED|Washout Period 2 (3 Days)||0
2547589|NCT00567112|6242420|P1|NOT COMPLETED|Washout Period 2 (3 Days)||0
2547590|NCT00567112|6242418|P3|COMPLETED|Washout Period 2 (3 Days)||3
2547591|NCT00567112|6242419|P2|COMPLETED|Washout Period 2 (3 Days)||7
2547592|NCT00567112|6242420|P1|COMPLETED|Washout Period 2 (3 Days)||7
2547593|NCT00567112|6242418|P3|STARTED|Washout Period 2 (3 Days)||3
2547594|NCT00567112|6242419|P2|STARTED|Washout Period 2 (3 Days)||7
2547595|NCT00567112|6242420|P1|STARTED|Washout Period 2 (3 Days)||7
2547596|NCT00567112|6242418|P3|NOT COMPLETED|Treatment Period 2 (3 Days)||0
2547597|NCT00567112|6242419|P2|NOT COMPLETED|Treatment Period 2 (3 Days)||1
2547598|NCT00567112|6242420|P1|NOT COMPLETED|Treatment Period 2 (3 Days)||0
2547599|NCT00567112|6242418|P3|COMPLETED|Treatment Period 2 (3 Days)||3
2547600|NCT00567112|6242419|P2|COMPLETED|Treatment Period 2 (3 Days)||7
2547601|NCT00567112|6242420|P1|COMPLETED|Treatment Period 2 (3 Days)||7
2547602|NCT00567112|6242418|P3|STARTED|Treatment Period 2 (3 Days)|3 new participants added to Treatment Group ABCD & received treatment sequence BCD for Periods 2-4|3
2547603|NCT00567112|6242419|P2|STARTED|Treatment Period 2 (3 Days)||8
2547604|NCT00567112|6242420|P1|STARTED|Treatment Period 2 (3 Days)||7
2547605|NCT00567112|6242418|P3|NOT COMPLETED|Washout Period 1 (3 Days)||0
2547606|NCT00567112|6242419|P2|NOT COMPLETED|Washout Period 1 (3 Days)||0
2547607|NCT00567112|6242420|P1|NOT COMPLETED|Washout Period 1 (3 Days)||0
2547608|NCT00567112|6242418|P3|COMPLETED|Washout Period 1 (3 Days)||0
2547609|NCT00567112|6242419|P2|COMPLETED|Washout Period 1 (3 Days)||8
2547610|NCT00567112|6242420|P1|COMPLETED|Washout Period 1 (3 Days)||7
2547611|NCT00567112|6242418|P3|STARTED|Washout Period 1 (3 Days)||0
2547612|NCT00567112|6242419|P2|STARTED|Washout Period 1 (3 Days)||8
2547613|NCT00567112|6242420|P1|STARTED|Washout Period 1 (3 Days)||7
2547614|NCT00567112|6242418|P3|NOT COMPLETED|Treatment Period 1 (3 Days)||0
2547615|NCT00567112|6242419|P2|NOT COMPLETED|Treatment Period 1 (3 Days)||0
2547616|NCT00567112|6242420|P1|NOT COMPLETED|Treatment Period 1 (3 Days)||0
2547617|NCT00567112|6242418|P3|COMPLETED|Treatment Period 1 (3 Days)||0
2547618|NCT00567112|6242419|P2|COMPLETED|Treatment Period 1 (3 Days)||8
2547619|NCT00567112|6242420|P1|COMPLETED|Treatment Period 1 (3 Days)||7
2547620|NCT00567112|6242418|P3|STARTED|Treatment Period 1 (3 Days)||0
2547621|NCT00567112|6242419|P2|STARTED|Treatment Period 1 (3 Days)||8
2547622|NCT00567112|6242420|P1|STARTED|Treatment Period 1 (3 Days)||7
2547623|NCT00567008|6242444|P2|NOT COMPLETED|Overall Study||1
2547624|NCT00567008|6242445|P1|NOT COMPLETED|Overall Study||1
2547625|NCT00567008|6242444|P2|COMPLETED|Overall Study||18
2547626|NCT00567008|6242445|P1|COMPLETED|Overall Study||17
2547627|NCT00567008|6242444|P2|STARTED|Overall Study||19
2547628|NCT00567008|6242445|P1|STARTED|Overall Study||18
2547629|NCT00566995|6242451|P1|NOT COMPLETED|Overall Study||7
2547630|NCT00566995|6242451|P1|COMPLETED|Overall Study||30
2547631|NCT00566995|6242451|P1|STARTED|Overall Study||37
2547632|NCT00566982|6242466|P2|NOT COMPLETED|Overall Study||69
2547633|NCT00566982|6242467|P1|NOT COMPLETED|Overall Study||8
2547634|NCT00566982|6242466|P2|COMPLETED|Overall Study||294
2547635|NCT00566982|6242467|P1|COMPLETED|Overall Study||55
2547636|NCT00566982|6242466|P2|STARTED|Overall Study||363
2547637|NCT00566982|6242467|P1|STARTED|Overall Study||63
2547638|NCT00566969|6242492|P3|NOT COMPLETED|Overall Study||12
2547639|NCT00566969|6242493|P2|NOT COMPLETED|Overall Study||9
2547640|NCT00566969|6242494|P1|NOT COMPLETED|Overall Study||15
2547641|NCT00566969|6242492|P3|COMPLETED|Overall Study||23
2547642|NCT00566969|6242493|P2|COMPLETED|Overall Study||28
2547643|NCT00566969|6242494|P1|COMPLETED|Overall Study||19
2547644|NCT00566969|6242492|P3|STARTED|Overall Study||35
2547645|NCT00566969|6242493|P2|STARTED|Overall Study||37
2547646|NCT00566969|6242494|P1|STARTED|Overall Study||34
2547647|NCT00566943|6242504|P2|NOT COMPLETED|Overall Study||0
2547648|NCT00566943|6242505|P1|NOT COMPLETED|Overall Study||0
2547649|NCT00566943|6242504|P2|COMPLETED|Overall Study||49
2547650|NCT00566943|6242505|P1|COMPLETED|Overall Study||52
2547651|NCT00566943|6242504|P2|STARTED|Overall Study||49
2547652|NCT00566943|6242505|P1|STARTED|Overall Study||52
2547653|NCT00566930|6242520|P3|NOT COMPLETED|Overall Study||1
2547654|NCT00566930|6242521|P2|NOT COMPLETED|Overall Study||4
2547655|NCT00566930|6242522|P1|NOT COMPLETED|Overall Study||2
2547656|NCT00566930|6242520|P3|COMPLETED|Overall Study||32
2547657|NCT00566930|6242521|P2|COMPLETED|Overall Study||32
2547658|NCT00566930|6242522|P1|COMPLETED|Overall Study||27
2547659|NCT00566930|6242520|P3|STARTED|Overall Study||33
2547660|NCT00566930|6242521|P2|STARTED|Overall Study||36
2547661|NCT00566930|6242522|P1|STARTED|Overall Study||29
2547662|NCT00566852|6242532|P2|NOT COMPLETED|Overall Study||198
2547663|NCT00566852|6242533|P1|NOT COMPLETED|Overall Study||207
2547664|NCT00566852|6242532|P2|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|78
2547665|NCT00566852|6242533|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|71
2547666|NCT00566852|6242532|P2|STARTED|Overall Study||276
2547667|NCT00566852|6242533|P1|STARTED|Overall Study||278
2547668|NCT00566813|6242551|P2|NOT COMPLETED|Overall Study||0
2547669|NCT00566813|6242552|P1|NOT COMPLETED|Overall Study||0
2547670|NCT00566813|6242551|P2|COMPLETED|Overall Study||6
2547671|NCT00566813|6242552|P1|COMPLETED|Overall Study||4
2547672|NCT00566813|6242551|P2|STARTED|Overall Study||6
2547673|NCT00566813|6242552|P1|STARTED|Overall Study||4
2547674|NCT00566735|6242564|P2|NOT COMPLETED|Overall Study||7
2547675|NCT00566735|6242565|P1|NOT COMPLETED|Overall Study||2
2547676|NCT00566735|6242564|P2|COMPLETED|Overall Study|7 participants withdrew before baselines. Therefore, 12 participants will be included in baselines.|12
2547677|NCT00566735|6242565|P1|COMPLETED|Overall Study|2 participants withdrew before baselines. Therefore, 18 participants will be included in baselines.|18
2547678|NCT00566735|6242564|P2|Withdrew Before Baseline Measures|Overall Study||7
2547679|NCT00566735|6242565|P1|Withdrew Before Baseline Measures|Overall Study||2
2547680|NCT00566735|6242564|P2|STARTED|Overall Study||19
2547681|NCT00566735|6242565|P1|STARTED|Overall Study||20
2547682|NCT00566722|6242578|P3|NOT COMPLETED|Overall Study||9
2547683|NCT00566722|6242579|P2|NOT COMPLETED|Overall Study||5
2547684|NCT00566722|6242580|P1|NOT COMPLETED|Overall Study||2
2547685|NCT00566722|6242578|P3|COMPLETED|Overall Study||73
2547686|NCT00566722|6242579|P2|COMPLETED|Overall Study||24
2547687|NCT00566722|6242580|P1|COMPLETED|Overall Study||39
2547688|NCT00566722|6242578|P3|STARTED|Overall Study||82
2547689|NCT00566722|6242579|P2|STARTED|Overall Study||29
2547690|NCT00566722|6242580|P1|STARTED|Overall Study||41
2547691|NCT00566709|6242626|P2|NOT COMPLETED|Overall Study||0
2547692|NCT00566709|6242627|P1|NOT COMPLETED|Overall Study||5
2547693|NCT00566709|6242626|P2|COMPLETED|Overall Study||51
2547694|NCT00566709|6242627|P1|COMPLETED|Overall Study||46
2547695|NCT00566709|6242626|P2|STARTED|Overall Study||51
2547696|NCT00566709|6242627|P1|STARTED|Overall Study||51
2547697|NCT00566696|6242643|P1|NOT COMPLETED|Overall Study||42
2547698|NCT00566696|6242643|P1|COMPLETED|Overall Study||31
2547699|NCT00566696|6242643|P1|STARTED|Overall Study||73
2547700|NCT00566631|6242653|P1|NOT COMPLETED|Part 2: Extension Phase||82
2547701|NCT00566631|6242653|P1|COMPLETED|Part 2: Extension Phase||57
2547702|NCT00566631|6242653|P1|STARTED|Part 2: Extension Phase||139
2547703|NCT00566631|6242653|P1|NOT COMPLETED|Between Treatment and Extension Phase||95
2547704|NCT00566631|6242653|P1|COMPLETED|Between Treatment and Extension Phase||139
2547705|NCT00566631|6242653|P1|STARTED|Between Treatment and Extension Phase||234
2547706|NCT00566631|6242653|P1|NOT COMPLETED|Part 1: Core Treatment Phase||60
2547707|NCT00566631|6242653|P1|COMPLETED|Part 1: Core Treatment Phase||234
2547708|NCT00566631|6242653|P1|STARTED|Part 1: Core Treatment Phase||294
2547709|NCT00566579|6242670|P2|NOT COMPLETED|Overall Study||0
2547710|NCT00566579|6242671|P1|NOT COMPLETED|Overall Study||0
2547711|NCT00566579|6242670|P2|COMPLETED|Overall Study||31
2547712|NCT00566579|6242671|P1|COMPLETED|Overall Study||29
2547713|NCT00566579|6242670|P2|STARTED|Overall Study||31
2547714|NCT00566579|6242671|P1|STARTED|Overall Study||29
2547715|NCT00566527|6242680|P3|NOT COMPLETED|Overall Study||78
2547716|NCT00566527|6242681|P2|NOT COMPLETED|Overall Study||66
2547717|NCT00566527|6242682|P1|NOT COMPLETED|Overall Study||17
2547718|NCT00566527|6242680|P3|COMPLETED|Overall Study||461
2547719|NCT00566527|6242681|P2|COMPLETED|Overall Study||474
2547720|NCT00566527|6242682|P1|COMPLETED|Overall Study||524
2547721|NCT00566527|6242680|P3|Received ProQuad® Dose 2|Overall Study||462
2547722|NCT00566527|6242681|P2|Received ProQuad® Dose 2|Overall Study||478
2547723|NCT00566527|6242682|P1|Received ProQuad® Dose 2|Overall Study||525
2547724|NCT00566527|6242680|P3|Received ProQuad® Dose 1|Overall Study||470
2547725|NCT00566527|6242681|P2|Received ProQuad® Dose 1|Overall Study||484
2547726|NCT00566527|6242682|P1|Received ProQuad® Dose 1|Overall Study||529
2547727|NCT00566527|6242680|P3|STARTED|Overall Study|Number randomized.|539
2547728|NCT00566527|6242681|P2|STARTED|Overall Study|Number randomized.|540
2547729|NCT00566527|6242682|P1|STARTED|Overall Study|Number randomized.|541
2547730|NCT00566501|6242723|P2|NOT COMPLETED|Overall Study||126
2547731|NCT00566501|6242724|P1|NOT COMPLETED|Overall Study||156
2547732|NCT00566501|6242723|P2|COMPLETED|Overall Study||210
2547733|NCT00566501|6242724|P1|COMPLETED|Overall Study||423
2547734|NCT00566501|6242723|P2|Not Determined|Overall Study||0
2547735|NCT00566501|6242724|P1|Not Determined|Overall Study||1
2547736|NCT00566501|6242723|P2|Other ( Not Specified)|Overall Study||21
2547737|NCT00566501|6242724|P1|Other ( Not Specified)|Overall Study||24
2547738|NCT00566501|6242723|P2|Medication Non-compliance|Overall Study||0
2547739|NCT00566501|6242724|P1|Medication Non-compliance|Overall Study||5
2547740|NCT00566501|6242723|P2|Protocol Violation|Overall Study||2
2547741|NCT00566501|6242724|P1|Protocol Violation|Overall Study||2
2547742|NCT00566501|6242723|P2|Request of Investigator or Sponsor|Overall Study||7
2547743|NCT00566501|6242724|P1|Request of Investigator or Sponsor|Overall Study||6
2547744|NCT00566501|6242723|P2|Withdraw of Consent by Subject|Overall Study||30
2547745|NCT00566501|6242724|P1|Withdraw of Consent by Subject|Overall Study||33
2547746|NCT00566501|6242723|P2|Lack of Efficacy|Overall Study||3
2547747|NCT00566501|6242724|P1|Lack of Efficacy|Overall Study||8
2547748|NCT00566501|6242723|P2|Adverse Event|Overall Study||59
2547749|NCT00566501|6242724|P1|Adverse Event|Overall Study||68
2547750|NCT00566501|6242723|P2|Discontinued|Overall Study||122
2547751|NCT00566501|6242724|P1|Discontinued|Overall Study||146
2547752|NCT00566501|6242723|P2|Safety Population|Overall Study||332
2547753|NCT00566501|6242724|P1|Safety Population|Overall Study||570
2547754|NCT00566501|6242723|P2|STARTED|Overall Study||336
2547755|NCT00566501|6242724|P1|STARTED|Overall Study||579
2547756|NCT00566462|6242732|P2|NOT COMPLETED|Overall Study||0
2547757|NCT00566462|6242733|P1|NOT COMPLETED|Overall Study||0
2547758|NCT00566462|6242732|P2|COMPLETED|Overall Study||0
2547759|NCT00566462|6242733|P1|COMPLETED|Overall Study||1
2547760|NCT00566462|6242732|P2|STARTED|Overall Study||0
2547761|NCT00566462|6242733|P1|STARTED|Overall Study||1
2547762|NCT00566254|6242743|P2|NOT COMPLETED|Overall Study||14
2547763|NCT00566254|6242744|P1|NOT COMPLETED|Overall Study||10
2547764|NCT00566254|6242743|P2|COMPLETED|Overall Study||93
2547765|NCT00566254|6242744|P1|COMPLETED|Overall Study||90
2547766|NCT00566254|6242743|P2|STARTED|Overall Study||107
2547767|NCT00566254|6242744|P1|STARTED|Overall Study||100
2547768|NCT00566228|6242758|P2|NOT COMPLETED|Overall Study||5
2547769|NCT00566228|6242759|P1|NOT COMPLETED|Overall Study||6
2547770|NCT00566228|6242758|P2|COMPLETED|Overall Study||55
2547771|NCT00566228|6242759|P1|COMPLETED|Overall Study||56
2547772|NCT00566228|6242758|P2|STARTED|Overall Study||60
2547773|NCT00566228|6242759|P1|STARTED|Overall Study||62
2547774|NCT00566150|6242777|P2|NOT COMPLETED|Overall Study||5
2547775|NCT00566150|6242778|P1|NOT COMPLETED|Overall Study||9
2547776|NCT00566150|6242777|P2|COMPLETED|Overall Study||11
2547777|NCT00566150|6242778|P1|COMPLETED|Overall Study||10
2547778|NCT00566150|6242777|P2|STARTED|Overall Study||16
2547779|NCT00566150|6242778|P1|STARTED|Overall Study||19
2547780|NCT00566111|6242792|P2|NOT COMPLETED|Overall Study||2
2547781|NCT00566111|6242793|P1|NOT COMPLETED|Overall Study||0
2547782|NCT00566111|6242792|P2|COMPLETED|Overall Study||1
2547783|NCT00566111|6242793|P1|COMPLETED|Overall Study||2
2547784|NCT00566111|6242792|P2|STARTED|Overall Study||3
2547785|NCT00566111|6242793|P1|STARTED|Overall Study||2
2547786|NCT00566098|6242807|P1|NOT COMPLETED|Administration of ASCT+MILs||18
2547787|NCT00566098|6242807|P1|COMPLETED|Administration of ASCT+MILs||4
2547788|NCT00566098|6242807|P1|STARTED|Administration of ASCT+MILs||22
2547789|NCT00566098|6242807|P1|NOT COMPLETED|Generation of MILs Product||1
2547790|NCT00566098|6242807|P1|COMPLETED|Generation of MILs Product||22
2547791|NCT00566098|6242807|P1|STARTED|Generation of MILs Product||23
2547792|NCT00566098|6242807|P1|NOT COMPLETED|Collection of MILs||2
2547793|NCT00566098|6242807|P1|COMPLETED|Collection of MILs||23
2547794|NCT00566098|6242807|P1|STARTED|Collection of MILs||25
2547795|NCT00566020|6242817|P2|NOT COMPLETED|46-week Long-term Administration Phase||17
2547796|NCT00566020|6242818|P1|NOT COMPLETED|46-week Long-term Administration Phase||0
2547797|NCT00566020|6242817|P2|COMPLETED|46-week Long-term Administration Phase||68
2547798|NCT00566020|6242818|P1|COMPLETED|46-week Long-term Administration Phase||0
2547799|NCT00566020|6242817|P2|STARTED|46-week Long-term Administration Phase||85
2547800|NCT00566020|6242818|P1|STARTED|46-week Long-term Administration Phase||0
2547801|NCT00566020|6242817|P2|NOT COMPLETED|6-week Dosage Adjustment Phase||0
2547802|NCT00566020|6242818|P1|NOT COMPLETED|6-week Dosage Adjustment Phase||7
2547803|NCT00566020|6242817|P2|COMPLETED|6-week Dosage Adjustment Phase||0
2547804|NCT00566020|6242818|P1|COMPLETED|6-week Dosage Adjustment Phase||85
2547805|NCT00566020|6242817|P2|STARTED|6-week Dosage Adjustment Phase||0
2547806|NCT00566020|6242818|P1|STARTED|6-week Dosage Adjustment Phase||92
2547807|NCT00565916|6242845|P2|NOT COMPLETED|Overall Study||0
2547808|NCT00565916|6242846|P1|NOT COMPLETED|Overall Study||0
2547809|NCT00565916|6242845|P2|COMPLETED|Overall Study||11
2547810|NCT00565916|6242846|P1|COMPLETED|Overall Study||11
2547811|NCT00565916|6242845|P2|STARTED|Overall Study||11
2547812|NCT00565916|6242846|P1|STARTED|Overall Study||11
2547813|NCT00565864|6242855|P3|NOT COMPLETED|Overall Study||11
2547814|NCT00565864|6242856|P2|NOT COMPLETED|Overall Study||12
2547815|NCT00565864|6242857|P1|NOT COMPLETED|Overall Study||12
2547816|NCT00565864|6242855|P3|COMPLETED|Overall Study||45
2547817|NCT00565864|6242856|P2|COMPLETED|Overall Study||47
2547818|NCT00565864|6242857|P1|COMPLETED|Overall Study||46
2547819|NCT00565864|6242855|P3|STARTED|Overall Study||56
2547820|NCT00565864|6242856|P2|STARTED|Overall Study||59
2547821|NCT00565864|6242857|P1|STARTED|Overall Study||58
2547822|NCT00565812|6242907|P3|NOT COMPLETED|Overall Study||130
2547823|NCT00565812|6242908|P2|NOT COMPLETED|Overall Study||135
2547824|NCT00565812|6242909|P1|NOT COMPLETED|Overall Study||144
2547825|NCT00565812|6242907|P3|COMPLETED|Overall Study||356
2547826|NCT00565812|6242908|P2|COMPLETED|Overall Study||351
2547827|NCT00565812|6242909|P1|COMPLETED|Overall Study||341
2547828|NCT00565812|6242907|P3|STARTED|Overall Study||486
2547829|NCT00565812|6242908|P2|STARTED|Overall Study||486
2547830|NCT00565812|6242909|P1|STARTED|Overall Study||485
2547831|NCT00565773|6243046|P1|NOT COMPLETED|Overall Study||2
2547832|NCT00565773|6243046|P1|COMPLETED|Overall Study||38
2547833|NCT00565773|6243046|P1|STARTED|Overall Study||40
2547834|NCT00565747|6243058|P2|NOT COMPLETED|Overall Study||73
2547835|NCT00565747|6243059|P1|NOT COMPLETED|Overall Study||67
2547836|NCT00565747|6243058|P2|COMPLETED|Overall Study|Completed with an embryo transfer|605
2547837|NCT00565747|6243059|P1|COMPLETED|Overall Study|Completed with an embryo transfer|587
2547838|NCT00565747|6243058|P2|STARTED|Overall Study||678
2547839|NCT00565747|6243059|P1|STARTED|Overall Study||654
2547840|NCT00565721|6243069|P1|NOT COMPLETED|Overall Study||17
2547841|NCT00565721|6243069|P1|COMPLETED|Overall Study||16
2547842|NCT00565721|6243069|P1|STARTED|Overall Study||33
2547843|NCT00565669|6243090|P2|NOT COMPLETED|Overall Study||0
2547844|NCT00565669|6243091|P1|NOT COMPLETED|Overall Study||0
2547845|NCT00565669|6243090|P2|COMPLETED|Overall Study||9
2547846|NCT00565669|6243091|P1|COMPLETED|Overall Study||11
2547847|NCT00565669|6243090|P2|STARTED|Overall Study||9
2547848|NCT00565669|6243091|P1|STARTED|Overall Study||11
2547849|NCT00565643|6243099|P2|NOT COMPLETED|Overall Study||0
2547850|NCT00565643|6243100|P1|NOT COMPLETED|Overall Study||0
2547851|NCT00565643|6243099|P2|COMPLETED|Overall Study||373
2547852|NCT00565643|6243100|P1|COMPLETED|Overall Study||380
2547853|NCT00565643|6243099|P2|Primary Outcome (Subsequent Cesarean)|Overall Study||92
2547854|NCT00565643|6243100|P1|Primary Outcome (Subsequent Cesarean)|Overall Study||80
2547855|NCT00565643|6243099|P2|Safety Data|Overall Study||373
2547856|NCT00565643|6243100|P1|Safety Data|Overall Study||380
2547857|NCT00565643|6243099|P2|STARTED|Overall Study||373
2547858|NCT00565643|6243100|P1|STARTED|Overall Study||380
2547859|NCT00565617|6243118|P1|NOT COMPLETED|Overall Study||1
2547860|NCT00565617|6243118|P1|COMPLETED|Overall Study||5
2547861|NCT00565617|6243118|P1|STARTED|Overall Study||6
2547862|NCT00565604|6243122|P1|NOT COMPLETED|Overall Study||4
2547863|NCT00565604|6243122|P1|COMPLETED|Overall Study||39
2547864|NCT00565604|6243122|P1|6 Month|Overall Study||39
2547865|NCT00565604|6243122|P1|6 Week|Overall Study||39
2547866|NCT00565604|6243122|P1|2 Week|Overall Study||41
2547867|NCT00565604|6243122|P1|7 Day|Overall Study||41
2547868|NCT00565604|6243122|P1|STARTED|Overall Study||43
2547869|NCT00565461|6243133|P4|NOT COMPLETED|Overall Study||3
2547870|NCT00565461|6243134|P3|NOT COMPLETED|Overall Study||1
2547871|NCT00565461|6243135|P2|NOT COMPLETED|Overall Study||1
2547872|NCT00565461|6243136|P1|NOT COMPLETED|Overall Study||0
2547873|NCT00565461|6243133|P4|COMPLETED|Overall Study||37
2547874|NCT00565461|6243134|P3|COMPLETED|Overall Study||39
2547875|NCT00565461|6243135|P2|COMPLETED|Overall Study||39
2547876|NCT00565461|6243136|P1|COMPLETED|Overall Study||40
2547877|NCT00565461|6243133|P4|STARTED|Overall Study||40
2547878|NCT00565461|6243134|P3|STARTED|Overall Study||40
2547879|NCT00565461|6243135|P2|STARTED|Overall Study||40
2547880|NCT00565461|6243136|P1|STARTED|Overall Study||40
2547881|NCT00565448|6243150|P2|NOT COMPLETED|Overall Study||2
2547882|NCT00565448|6243151|P1|NOT COMPLETED|Overall Study||3
2547883|NCT00565448|6243150|P2|COMPLETED|Overall Study|Completed induction period as per protocol.|23
2547884|NCT00565448|6243151|P1|COMPLETED|Overall Study|Completed induction period as per protocol.|47
2547885|NCT00565448|6243150|P2|STARTED|Overall Study|ITT population: all randomized participants. All were treated.|25
2547886|NCT00565448|6243151|P1|STARTED|Overall Study|Intent to treat (ITT) population: all randomized participants. All were treated.|50
2547887|NCT00565409|6243162|P4|NOT COMPLETED|Period 2 Double-Blind||59
2547888|NCT00565409|6243163|P3|NOT COMPLETED|Period 2 Double-Blind||27
2547889|NCT00565409|6243164|P2|NOT COMPLETED|Period 2 Double-Blind||21
2547890|NCT00565409|6243165|P1|NOT COMPLETED|Period 2 Double-Blind||0
2547891|NCT00565409|6243162|P4|COMPLETED|Period 2 Double-Blind||141
2547892|NCT00565409|6243163|P3|COMPLETED|Period 2 Double-Blind||175
2547893|NCT00565409|6243164|P2|COMPLETED|Period 2 Double-Blind||181
2547894|NCT00565409|6243165|P1|COMPLETED|Period 2 Double-Blind||0
2547895|NCT00565409|6243162|P4|STARTED|Period 2 Double-Blind||200
2547896|NCT00565409|6243163|P3|STARTED|Period 2 Double-Blind||202
2547897|NCT00565409|6243164|P2|STARTED|Period 2 Double-Blind||202
2547898|NCT00565409|6243165|P1|STARTED|Period 2 Double-Blind||0
2547899|NCT00565409|6243162|P4|NOT COMPLETED|After Period 1, Prior to Period 2||0
2547900|NCT00565409|6243163|P3|NOT COMPLETED|After Period 1, Prior to Period 2||0
2547901|NCT00565409|6243164|P2|NOT COMPLETED|After Period 1, Prior to Period 2||0
2547902|NCT00565409|6243165|P1|NOT COMPLETED|After Period 1, Prior to Period 2||152
2547903|NCT00565409|6243162|P4|COMPLETED|After Period 1, Prior to Period 2||0
2547904|NCT00565409|6243163|P3|COMPLETED|After Period 1, Prior to Period 2||0
2547905|NCT00565409|6243164|P2|COMPLETED|After Period 1, Prior to Period 2||0
2547906|NCT00565409|6243165|P1|COMPLETED|After Period 1, Prior to Period 2||604
2547907|NCT00565409|6243162|P4|STARTED|After Period 1, Prior to Period 2||0
2547908|NCT00565409|6243163|P3|STARTED|After Period 1, Prior to Period 2||0
2547909|NCT00565409|6243164|P2|STARTED|After Period 1, Prior to Period 2||0
2547910|NCT00565409|6243165|P1|STARTED|After Period 1, Prior to Period 2||756
2547911|NCT00565409|6243162|P4|NOT COMPLETED|Period 1 Open Label||0
2547912|NCT00565409|6243163|P3|NOT COMPLETED|Period 1 Open Label||0
2547913|NCT00565409|6243164|P2|NOT COMPLETED|Period 1 Open Label||0
2547914|NCT00565409|6243165|P1|NOT COMPLETED|Period 1 Open Label||78
2547915|NCT00565409|6243162|P4|COMPLETED|Period 1 Open Label||0
2547916|NCT00565409|6243163|P3|COMPLETED|Period 1 Open Label||0
2547917|NCT00565409|6243164|P2|COMPLETED|Period 1 Open Label||0
2547918|NCT00565409|6243165|P1|COMPLETED|Period 1 Open Label||756
2547919|NCT00565409|6243162|P4|STARTED|Period 1 Open Label||0
2547920|NCT00565409|6243163|P3|STARTED|Period 1 Open Label||0
2547921|NCT00565409|6243164|P2|STARTED|Period 1 Open Label||0
2547922|NCT00565409|6243165|P1|STARTED|Period 1 Open Label||834
2547923|NCT00565370|6243267|P1|NOT COMPLETED|Overall Study||0
2547924|NCT00565370|6243267|P1|COMPLETED|Overall Study||21
2547925|NCT00565370|6243267|P1|STARTED|Overall Study||21
2547926|NCT00565266|6243275|P1|NOT COMPLETED|Overall Study||36
2547927|NCT00565266|6243275|P1|COMPLETED|Overall Study||174
2547928|NCT00565266|6243275|P1|STARTED|Overall Study||210
2547929|NCT00565136|6243301|P1|NOT COMPLETED|Overall Study||3
2547930|NCT00565136|6243301|P1|COMPLETED|Overall Study||26
2547931|NCT00565136|6243301|P1|STARTED|Overall Study||29
2547932|NCT00565110|6243321|P2|NOT COMPLETED|Overall Study||131
2547933|NCT00565110|6243322|P1|NOT COMPLETED|Overall Study||131
2547934|NCT00565110|6243321|P2|COMPLETED|Overall Study||111
2547935|NCT00565110|6243322|P1|COMPLETED|Overall Study||99
2547936|NCT00565110|6243321|P2|12-Month|Overall Study||144
2547937|NCT00565110|6243322|P1|12-Month|Overall Study||114
2547938|NCT00565110|6243321|P2|STARTED|Overall Study||242
2547939|NCT00565110|6243322|P1|STARTED|Overall Study||230
2547940|NCT00565084|6243330|P3|NOT COMPLETED|Third Treatment Period||0
2547941|NCT00565084|6243331|P2|NOT COMPLETED|Third Treatment Period||0
2547942|NCT00565084|6243332|P1|NOT COMPLETED|Third Treatment Period||0
2547943|NCT00565084|6243330|P3|COMPLETED|Third Treatment Period||11
2547944|NCT00565084|6243331|P2|COMPLETED|Third Treatment Period||11
2547945|NCT00565084|6243332|P1|COMPLETED|Third Treatment Period||11
2547946|NCT00565084|6243330|P3|STARTED|Third Treatment Period||11
2547947|NCT00565084|6243331|P2|STARTED|Third Treatment Period||11
2547948|NCT00565084|6243332|P1|STARTED|Third Treatment Period||11
2547949|NCT00565084|6243330|P3|NOT COMPLETED|Second Treatment Period||0
2547950|NCT00565084|6243331|P2|NOT COMPLETED|Second Treatment Period||0
2547951|NCT00565084|6243332|P1|NOT COMPLETED|Second Treatment Period||0
2547952|NCT00565084|6243330|P3|COMPLETED|Second Treatment Period||11
2547953|NCT00565084|6243331|P2|COMPLETED|Second Treatment Period||11
2547954|NCT00565084|6243332|P1|COMPLETED|Second Treatment Period||11
2547955|NCT00565084|6243330|P3|STARTED|Second Treatment Period||11
2547956|NCT00565084|6243331|P2|STARTED|Second Treatment Period||11
2547957|NCT00565084|6243332|P1|STARTED|Second Treatment Period||11
2547958|NCT00565084|6243330|P3|NOT COMPLETED|First Treatment Period||0
2547959|NCT00565084|6243331|P2|NOT COMPLETED|First Treatment Period||0
2547960|NCT00565084|6243332|P1|NOT COMPLETED|First Treatment Period||0
2547961|NCT00565084|6243330|P3|COMPLETED|First Treatment Period||11
2547962|NCT00565084|6243331|P2|COMPLETED|First Treatment Period||11
2547963|NCT00565084|6243332|P1|COMPLETED|First Treatment Period||11
2547964|NCT00565084|6243330|P3|STARTED|First Treatment Period||11
2547965|NCT00565084|6243331|P2|STARTED|First Treatment Period||11
2547966|NCT00565084|6243332|P1|STARTED|First Treatment Period||11
2547967|NCT00565058|6243342|P2|NOT COMPLETED|Overall Study||0
2547968|NCT00565058|6243343|P1|NOT COMPLETED|Overall Study||1
2547969|NCT00565058|6243342|P2|COMPLETED|Overall Study||15
2547970|NCT00565058|6243343|P1|COMPLETED|Overall Study||9
2547971|NCT00565058|6243342|P2|STARTED|Overall Study||15
2547972|NCT00565058|6243343|P1|STARTED|Overall Study||10
2547973|NCT00565045|6243353|P2|NOT COMPLETED|Overall Study||3
2547974|NCT00565045|6243354|P1|NOT COMPLETED|Overall Study||1
2547975|NCT00565045|6243353|P2|COMPLETED|Overall Study||8
2547976|NCT00565045|6243354|P1|COMPLETED|Overall Study||9
2547977|NCT00565045|6243353|P2|STARTED|Overall Study||11
2547978|NCT00565045|6243354|P1|STARTED|Overall Study||10
2547979|NCT00564954|6243370|P2|NOT COMPLETED|Period 2- 1 Week||0
2547980|NCT00564954|6243371|P1|NOT COMPLETED|Period 2- 1 Week||0
2547981|NCT00564954|6243370|P2|COMPLETED|Period 2- 1 Week||42
2547982|NCT00564954|6243371|P1|COMPLETED|Period 2- 1 Week||44
2547983|NCT00564954|6243370|P2|STARTED|Period 2- 1 Week||42
2547984|NCT00564954|6243371|P1|STARTED|Period 2- 1 Week||44
2547985|NCT00564954|6243370|P2|NOT COMPLETED|Period 1- 1 Week||0
2547986|NCT00564954|6243371|P1|NOT COMPLETED|Period 1- 1 Week||0
2547987|NCT00564954|6243370|P2|COMPLETED|Period 1- 1 Week||42
2547988|NCT00564954|6243371|P1|COMPLETED|Period 1- 1 Week||44
2547989|NCT00564954|6243370|P2|STARTED|Period 1- 1 Week||42
2547990|NCT00564954|6243371|P1|STARTED|Period 1- 1 Week||44
2547991|NCT00564902|6243390|P3|NOT COMPLETED|Overall Study||4
2547992|NCT00564902|6243391|P2|NOT COMPLETED|Overall Study||4
2547993|NCT00564902|6243392|P1|NOT COMPLETED|Overall Study||1
2547994|NCT00564902|6243390|P3|COMPLETED|Overall Study||21
2547995|NCT00564902|6243391|P2|COMPLETED|Overall Study||21
2547996|NCT00564902|6243392|P1|COMPLETED|Overall Study||9
2547997|NCT00564902|6243390|P3|12 Months|Overall Study||21
2547998|NCT00564902|6243391|P2|12 Months|Overall Study||21
2547999|NCT00564902|6243392|P1|12 Months|Overall Study||9
2548000|NCT00564902|6243390|P3|8 Months|Overall Study||21
2548001|NCT00564902|6243391|P2|8 Months|Overall Study||22
2548002|NCT00564902|6243392|P1|8 Months|Overall Study||9
2548003|NCT00564902|6243390|P3|4 Months|Overall Study||23
2548004|NCT00564902|6243391|P2|4 Months|Overall Study||24
2548005|NCT00564902|6243392|P1|4 Months|Overall Study||9
2548006|NCT00564902|6243390|P3|STARTED|Overall Study||25
2548007|NCT00564902|6243391|P2|STARTED|Overall Study||25
2548008|NCT00564902|6243392|P1|STARTED|Overall Study||10
2548009|NCT00564889|6243424|P1|NOT COMPLETED|Overall Study||29
2548010|NCT00564889|6243424|P1|COMPLETED|Overall Study||6
2548011|NCT00564889|6243424|P1|STARTED|Overall Study||35
2548012|NCT00564876|6243432|P1|NOT COMPLETED|Overall Study||0
2548013|NCT00564876|6243432|P1|COMPLETED|Overall Study||2
2548014|NCT00564876|6243432|P1|STARTED|Overall Study||2
2548015|NCT00564850|6243439|P1|NOT COMPLETED|Overall Study||2
2548016|NCT00564850|6243439|P1|COMPLETED|Overall Study||35
2548017|NCT00564850|6243439|P1|STARTED|Overall Study||37
2548018|NCT00564733|6243457|P1|NOT COMPLETED|Overall Study||9
2548019|NCT00564733|6243457|P1|COMPLETED|Overall Study||46
2548020|NCT00564733|6243457|P1|STARTED|Overall Study||55
2548021|NCT00564681|6243465|P4|NOT COMPLETED|Overall Study||2
2548022|NCT00564681|6243466|P3|NOT COMPLETED|Overall Study||3
2548023|NCT00564681|6243467|P2|NOT COMPLETED|Overall Study||3
2548024|NCT00564681|6243468|P1|NOT COMPLETED|Overall Study||11
2548025|NCT00564681|6243465|P4|COMPLETED|Overall Study||19
2548026|NCT00564681|6243466|P3|COMPLETED|Overall Study||40
2548027|NCT00564681|6243467|P2|COMPLETED|Overall Study||58
2548028|NCT00564681|6243468|P1|COMPLETED|Overall Study||106
2548029|NCT00564681|6243465|P4|STARTED|Overall Study||21
2548030|NCT00564681|6243466|P3|STARTED|Overall Study||43
2548031|NCT00564681|6243467|P2|STARTED|Overall Study||61
2548032|NCT00564681|6243468|P1|STARTED|Overall Study||117
2548033|NCT00564629|6243491|P2|NOT COMPLETED|Overall Study||9
2548034|NCT00564629|6243492|P1|NOT COMPLETED|Overall Study||15
2548035|NCT00564629|6243491|P2|COMPLETED|Overall Study||45
2548036|NCT00564629|6243492|P1|COMPLETED|Overall Study||36
2548037|NCT00564629|6243491|P2|STARTED|Overall Study||54
2548038|NCT00564629|6243492|P1|STARTED|Overall Study||51
2548039|NCT00564486|6243517|P4|NOT COMPLETED|Overall Study||7
2548040|NCT00564486|6243518|P3|NOT COMPLETED|Overall Study||3
2548041|NCT00564486|6243519|P2|NOT COMPLETED|Overall Study||1
2548042|NCT00564486|6243520|P1|NOT COMPLETED|Overall Study||7
2548043|NCT00564486|6243517|P4|COMPLETED|Overall Study||60
2548044|NCT00564486|6243518|P3|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|39
2548045|NCT00564486|6243519|P2|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|91
2548046|NCT00564486|6243520|P1|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|36
2548047|NCT00564486|6243517|P4|STARTED|Overall Study||67
2548048|NCT00564486|6243518|P3|STARTED|Overall Study|One subject randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|42
2548049|NCT00564486|6243519|P2|STARTED|Overall Study|One subject was randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|92
2548050|NCT00564486|6243520|P1|STARTED|Overall Study||43
2548051|NCT00564447|6243544|P8|NOT COMPLETED|Overall Study||0
2548052|NCT00564447|6243545|P7|NOT COMPLETED|Overall Study||0
2548053|NCT00564447|6243546|P6|NOT COMPLETED|Overall Study||0
2548054|NCT00564447|6243547|P5|NOT COMPLETED|Overall Study||0
2548055|NCT00564447|6243548|P4|NOT COMPLETED|Overall Study||0
2548056|NCT00564447|6243549|P3|NOT COMPLETED|Overall Study||0
2548057|NCT00564447|6243550|P2|NOT COMPLETED|Overall Study||0
2548058|NCT00564447|6243551|P1|NOT COMPLETED|Overall Study||0
2548059|NCT00564447|6243544|P8|COMPLETED|Overall Study||6
2548060|NCT00564447|6243545|P7|COMPLETED|Overall Study||6
2548061|NCT00564447|6243546|P6|COMPLETED|Overall Study||6
2548062|NCT00564447|6243547|P5|COMPLETED|Overall Study||6
2548063|NCT00564447|6243548|P4|COMPLETED|Overall Study||6
2548064|NCT00564447|6243549|P3|COMPLETED|Overall Study||6
2548065|NCT00564447|6243550|P2|COMPLETED|Overall Study||6
2548066|NCT00564447|6243551|P1|COMPLETED|Overall Study||6
2548067|NCT00564447|6243544|P8|STARTED|Overall Study||6
2548068|NCT00564447|6243545|P7|STARTED|Overall Study||6
2548069|NCT00564447|6243546|P6|STARTED|Overall Study||6
2548070|NCT00564447|6243547|P5|STARTED|Overall Study||6
2548071|NCT00564447|6243548|P4|STARTED|Overall Study||6
2548072|NCT00564447|6243549|P3|STARTED|Overall Study||6
2548073|NCT00564447|6243550|P2|STARTED|Overall Study||6
2548074|NCT00564447|6243551|P1|STARTED|Overall Study||6
2548075|NCT00564395|6243569|P2|NOT COMPLETED|Second Intervention (10 Days)||0
2548076|NCT00564395|6243570|P1|NOT COMPLETED|Second Intervention (10 Days)||0
2548077|NCT00564395|6243569|P2|COMPLETED|Second Intervention (10 Days)||7
2548078|NCT00564395|6243570|P1|COMPLETED|Second Intervention (10 Days)||7
2548079|NCT00564395|6243569|P2|STARTED|Second Intervention (10 Days)||7
2548080|NCT00564395|6243570|P1|STARTED|Second Intervention (10 Days)||7
2548081|NCT00564395|6243569|P2|NOT COMPLETED|First Intervention (10 Days)||2
2548082|NCT00564395|6243570|P1|NOT COMPLETED|First Intervention (10 Days)||2
2548083|NCT00564395|6243569|P2|COMPLETED|First Intervention (10 Days)||7
2548084|NCT00564395|6243570|P1|COMPLETED|First Intervention (10 Days)||7
2548085|NCT00564395|6243569|P2|Received Intervention|First Intervention (10 Days)||7
2548086|NCT00564395|6243570|P1|Received Intervention|First Intervention (10 Days)||7
2548087|NCT00564395|6243569|P2|STARTED|First Intervention (10 Days)||9
2548088|NCT00564395|6243570|P1|STARTED|First Intervention (10 Days)||9
2548089|NCT00564278|6243578|P2|NOT COMPLETED|Overall Study||42
2548090|NCT00564278|6243579|P1|NOT COMPLETED|Overall Study||47
2548091|NCT00564278|6243578|P2|COMPLETED|Overall Study||56
2548092|NCT00564278|6243579|P1|COMPLETED|Overall Study||50
2548093|NCT00564278|6243578|P2|STARTED|Overall Study||98
2548094|NCT00564278|6243579|P1|STARTED|Overall Study||97
2548095|NCT00564265|6243595|P1|NOT COMPLETED|Overall Study||0
2548096|NCT00564265|6243595|P1|COMPLETED|Overall Study||24
2548097|NCT00564265|6243595|P1|STARTED|Overall Study||24
2548098|NCT00564070|6243601|P2|NOT COMPLETED|Overall Study||7
2548099|NCT00564070|6243602|P1|NOT COMPLETED|Overall Study||12
2548100|NCT00564070|6243601|P2|COMPLETED|Overall Study||38
2548101|NCT00564070|6243602|P1|COMPLETED|Overall Study||30
2548102|NCT00564070|6243601|P2|STARTED|Overall Study||45
2548103|NCT00564070|6243602|P1|STARTED|Overall Study||42
2548104|NCT00564018|6243629|P3|NOT COMPLETED|Overall Study||1
2548105|NCT00564018|6243630|P2|NOT COMPLETED|Overall Study||3
2548106|NCT00564018|6243631|P1|NOT COMPLETED|Overall Study||2
2548107|NCT00564018|6243629|P3|COMPLETED|Overall Study||11
2548108|NCT00564018|6243630|P2|COMPLETED|Overall Study||7
2548109|NCT00564018|6243631|P1|COMPLETED|Overall Study||9
2548110|NCT00564018|6243629|P3|STARTED|Overall Study||12
2548111|NCT00564018|6243630|P2|STARTED|Overall Study||10
2548112|NCT00564018|6243631|P1|STARTED|Overall Study||11
2548113|NCT00563797|6243644|P2|NOT COMPLETED|Overall Study||2
2548114|NCT00563797|6243645|P1|NOT COMPLETED|Overall Study||7
2548115|NCT00563797|6243644|P2|COMPLETED|Overall Study||8
2548116|NCT00563797|6243645|P1|COMPLETED|Overall Study||4
2548117|NCT00563797|6243644|P2|Follow-Up|Overall Study||10
2548118|NCT00563797|6243645|P1|Follow-Up|Overall Study||11
2548119|NCT00563797|6243644|P2|Received Allocated Intervention|Overall Study||10
2548120|NCT00563797|6243645|P1|Received Allocated Intervention|Overall Study||11
2548121|NCT00563797|6243644|P2|STARTED|Overall Study||10
2548122|NCT00563797|6243645|P1|STARTED|Overall Study||11
2548123|NCT00563784|6243657|P1|NOT COMPLETED|Overall Study||22
2548124|NCT00563784|6243657|P1|COMPLETED|Overall Study||46
2548125|NCT00563784|6243657|P1|STARTED|Overall Study||68
2548126|NCT00563706|6243671|P9|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
2548127|NCT00563706|6243672|P8|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
2548128|NCT00563706|6243673|P7|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
2548129|NCT00563706|6243674|P6|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
2548130|NCT00563706|6243675|P5|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
2548131|NCT00563706|6243676|P4|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
2548132|NCT00563706|6243677|P3|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
2548133|NCT00563706|6243678|P2|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
2548134|NCT00563706|6243679|P1|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
2548135|NCT00563706|6243671|P9|COMPLETED|Taper Phase (Day 29 up to Day 35)||32
2548136|NCT00563706|6243672|P8|COMPLETED|Taper Phase (Day 29 up to Day 35)||16
2548137|NCT00563706|6243673|P7|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
2548138|NCT00563706|6243674|P6|COMPLETED|Taper Phase (Day 29 up to Day 35)||14
2548139|NCT00563706|6243675|P5|COMPLETED|Taper Phase (Day 29 up to Day 35)||11
2548140|NCT00563706|6243676|P4|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
2548141|NCT00563706|6243677|P3|COMPLETED|Taper Phase (Day 29 up to Day 35)||3
2548142|NCT00563706|6243678|P2|COMPLETED|Taper Phase (Day 29 up to Day 35)||13
2548143|NCT00563706|6243679|P1|COMPLETED|Taper Phase (Day 29 up to Day 35)||20
2548144|NCT00563706|6243671|P9|STARTED|Taper Phase (Day 29 up to Day 35)||32
2548145|NCT00563706|6243672|P8|STARTED|Taper Phase (Day 29 up to Day 35)||16
2548146|NCT00563706|6243673|P7|STARTED|Taper Phase (Day 29 up to Day 35)||9
2548147|NCT00563706|6243674|P6|STARTED|Taper Phase (Day 29 up to Day 35)||14
2548148|NCT00563706|6243675|P5|STARTED|Taper Phase (Day 29 up to Day 35)||11
2548149|NCT00563706|6243676|P4|STARTED|Taper Phase (Day 29 up to Day 35)||9
2548150|NCT00563706|6243677|P3|STARTED|Taper Phase (Day 29 up to Day 35)||3
2548151|NCT00563706|6243678|P2|STARTED|Taper Phase (Day 29 up to Day 35)||13
2548152|NCT00563706|6243679|P1|STARTED|Taper Phase (Day 29 up to Day 35)||20
2548153|NCT00563706|6243671|P9|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
2548154|NCT00563706|6243672|P8|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
2548155|NCT00563706|6243673|P7|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
2548156|NCT00563706|6243674|P6|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
2548157|NCT00563706|6243675|P5|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
2548158|NCT00563706|6243676|P4|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||10
2548159|NCT00563706|6243677|P3|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
2548160|NCT00563706|6243678|P2|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
2548161|NCT00563706|6243679|P1|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||17
2548162|NCT00563706|6243671|P9|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||32
2548163|NCT00563706|6243672|P8|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||16
2548164|NCT00563706|6243673|P7|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
2548165|NCT00563706|6243674|P6|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
2548166|NCT00563706|6243675|P5|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
2548167|NCT00563706|6243676|P4|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
2548168|NCT00563706|6243677|P3|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
2548169|NCT00563706|6243678|P2|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||13
2548170|NCT00563706|6243679|P1|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||20
2548171|NCT00563706|6243671|P9|STARTED|DB Treatment Period (Day 1 up to Day 28)||43
2548172|NCT00563706|6243672|P8|STARTED|DB Treatment Period (Day 1 up to Day 28)||30
2548173|NCT00563706|6243673|P7|STARTED|DB Treatment Period (Day 1 up to Day 28)||12
2548174|NCT00563706|6243674|P6|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
2548175|NCT00563706|6243675|P5|STARTED|DB Treatment Period (Day 1 up to Day 28)||16
2548176|NCT00563706|6243676|P4|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
2548177|NCT00563706|6243677|P3|STARTED|DB Treatment Period (Day 1 up to Day 28)||8
2548178|NCT00563706|6243678|P2|STARTED|DB Treatment Period (Day 1 up to Day 28)||18
2548179|NCT00563706|6243679|P1|STARTED|DB Treatment Period (Day 1 up to Day 28)||37
2548180|NCT00563576|6243782|P2|NOT COMPLETED|Overall Study||14
2548181|NCT00563576|6243783|P1|NOT COMPLETED|Overall Study||14
2548182|NCT00563576|6243782|P2|COMPLETED|Overall Study||22
2548183|NCT00563576|6243783|P1|COMPLETED|Overall Study||21
2548184|NCT00563576|6243782|P2|STARTED|Overall Study||36
2548185|NCT00563576|6243783|P1|STARTED|Overall Study||35
2548186|NCT00563381|6243797|P2|NOT COMPLETED|Overall Study||648
2548187|NCT00563381|6243798|P1|NOT COMPLETED|Overall Study||585
2548188|NCT00563381|6243797|P2|COMPLETED|Overall Study|Completed treatment|3021
2548189|NCT00563381|6243798|P1|COMPLETED|Overall Study|Completed treatment|3122
2548190|NCT00563381|6243797|P2|STARTED|Overall Study|Started treatment|3669
2548191|NCT00563381|6243798|P1|STARTED|Overall Study|Started treatment|3707
2548192|NCT00563368|6243871|P7|NOT COMPLETED|Overall Study||33
2548193|NCT00563368|6243872|P6|NOT COMPLETED|Overall Study||30
2548194|NCT00563368|6243873|P5|NOT COMPLETED|Overall Study||28
2548195|NCT00563368|6243874|P4|NOT COMPLETED|Overall Study||29
2548196|NCT00563368|6243875|P3|NOT COMPLETED|Overall Study||30
2548197|NCT00563368|6243876|P2|NOT COMPLETED|Overall Study||30
2548198|NCT00563368|6243877|P1|NOT COMPLETED|Overall Study||35
2548199|NCT00563368|6243871|P7|COMPLETED|Overall Study||75
2548200|NCT00563368|6243872|P6|COMPLETED|Overall Study||77
2548201|NCT00563368|6243873|P5|COMPLETED|Overall Study||80
2548202|NCT00563368|6243874|P4|COMPLETED|Overall Study||78
2548203|NCT00563368|6243875|P3|COMPLETED|Overall Study||78
2548204|NCT00563368|6243876|P2|COMPLETED|Overall Study||79
2548205|NCT00563368|6243877|P1|COMPLETED|Overall Study||74
2548206|NCT00563368|6243871|P7|STARTED|Overall Study||108
2548207|NCT00563368|6243872|P6|STARTED|Overall Study||107
2548208|NCT00563368|6243873|P5|STARTED|Overall Study||108
2548209|NCT00563368|6243874|P4|STARTED|Overall Study||107
2548210|NCT00563368|6243875|P3|STARTED|Overall Study||108
2548211|NCT00563368|6243876|P2|STARTED|Overall Study||109
2548212|NCT00563368|6243877|P1|STARTED|Overall Study||109
2548213|NCT00563316|6243900|P1|NOT COMPLETED|Overall Study||12
2548214|NCT00563316|6243900|P1|COMPLETED|Overall Study||16
2548215|NCT00563316|6243900|P1|Received Investigational Product|Overall Study||27
2548216|NCT00563316|6243900|P1|STARTED|Overall Study||28
2548217|NCT00563290|6243913|P2|NOT COMPLETED|Overall Study||0
2548218|NCT00563290|6243914|P1|NOT COMPLETED|Overall Study||0
2548219|NCT00563290|6243913|P2|COMPLETED|Overall Study||4
2548220|NCT00563290|6243914|P1|COMPLETED|Overall Study||3
2548221|NCT00563290|6243913|P2|STARTED|Overall Study||4
2548222|NCT00563290|6243914|P1|STARTED|Overall Study||3
2548223|NCT00563186|6243925|P2|NOT COMPLETED|Overall Study||75
2548224|NCT00563186|6243926|P1|NOT COMPLETED|Overall Study||98
2548225|NCT00563186|6243925|P2|COMPLETED|Overall Study||604
2548226|NCT00563186|6243926|P1|COMPLETED|Overall Study||910
2548227|NCT00563186|6243925|P2|STARTED|Overall Study|Patients allocated to the Traditional Hospital Ward|679
2548228|NCT00563186|6243926|P1|STARTED|Overall Study|Patients allocated to the Novel Hospital Ward|1008
2548229|NCT00562965|6243937|P2|NOT COMPLETED|Overall Study||6
2548230|NCT00562965|6243938|P1|NOT COMPLETED|Overall Study||3
2548231|NCT00562965|6243937|P2|COMPLETED|Overall Study||8
2548232|NCT00562965|6243938|P1|COMPLETED|Overall Study||12
2548233|NCT00562965|6243937|P2|Treated|Overall Study||13
2548234|NCT00562965|6243938|P1|Treated|Overall Study||15
2548235|NCT00562965|6243937|P2|STARTED|Overall Study||14
2548236|NCT00562965|6243938|P1|STARTED|Overall Study||15
2548237|NCT00562861|6243959|P2|NOT COMPLETED|Overall Study||11
2548238|NCT00562861|6243960|P1|NOT COMPLETED|Overall Study||20
2548239|NCT00562861|6243959|P2|COMPLETED|Overall Study||48
2548240|NCT00562861|6243960|P1|COMPLETED|Overall Study||40
2548241|NCT00562861|6243959|P2|STARTED|Overall Study||59
2548242|NCT00562861|6243960|P1|STARTED|Overall Study||60
2548243|NCT00562718|6243966|P1|NOT COMPLETED|Overall Study||11
2548244|NCT00562718|6243966|P1|COMPLETED|Overall Study||39
2548245|NCT00562718|6243966|P1|STARTED|Overall Study||50
2548246|NCT00562627|6243975|P3|NOT COMPLETED|Overall Study||1
2548247|NCT00562627|6243976|P2|NOT COMPLETED|Overall Study||1
2548248|NCT00562627|6243977|P1|NOT COMPLETED|Overall Study||1
2548249|NCT00562627|6243975|P3|COMPLETED|Overall Study||33
2548250|NCT00562627|6243976|P2|COMPLETED|Overall Study||33
2548251|NCT00562627|6243977|P1|COMPLETED|Overall Study||33
2548252|NCT00562627|6243975|P3|STARTED|Overall Study||34
2548253|NCT00562627|6243976|P2|STARTED|Overall Study||34
2548254|NCT00562627|6243977|P1|STARTED|Overall Study||34
2548255|NCT00562588|6243993|P2|NOT COMPLETED|Overall Study||99
2548256|NCT00562588|6243994|P1|NOT COMPLETED|Overall Study||92
2548257|NCT00562588|6243993|P2|COMPLETED|Overall Study||184
2548258|NCT00562588|6243994|P1|COMPLETED|Overall Study||168
2548259|NCT00562588|6243993|P2|STARTED|Overall Study||283
2548260|NCT00562588|6243994|P1|STARTED|Overall Study||260
2548261|NCT00562484|6244024|P2|NOT COMPLETED|Overall Study||104
2548262|NCT00562484|6244025|P1|NOT COMPLETED|Overall Study||206
2548263|NCT00562484|6244024|P2|COMPLETED|Overall Study||4907
2548264|NCT00562484|6244025|P1|COMPLETED|Overall Study||9827
2548265|NCT00562484|6244024|P2|STARTED|Overall Study||5011
2548266|NCT00562484|6244025|P1|STARTED|Overall Study||10033
2548267|NCT00562354|6244057|P2|NOT COMPLETED|Overall Study||2
2548268|NCT00562354|6244058|P1|NOT COMPLETED|Overall Study||0
2548269|NCT00562354|6244057|P2|COMPLETED|Overall Study||135
2548270|NCT00562354|6244058|P1|COMPLETED|Overall Study||134
2548271|NCT00562354|6244057|P2|Evaluable Immunogenicity Population|Overall Study||134
2548272|NCT00562354|6244058|P1|Evaluable Immunogenicity Population|Overall Study||134
2548273|NCT00562354|6244057|P2|Received Study Treatment|Overall Study||136
2548274|NCT00562354|6244058|P1|Received Study Treatment|Overall Study||134
2548275|NCT00562354|6244057|P2|STARTED|Overall Study||137
2548276|NCT00562354|6244058|P1|STARTED|Overall Study||134
2548277|NCT00562328|6244099|P1|NOT COMPLETED|Overall Study||0
2548278|NCT00562328|6244099|P1|COMPLETED|Overall Study||33
2548279|NCT00562328|6244099|P1|STARTED|Overall Study||33
2548280|NCT00562315|6244107|P1|NOT COMPLETED|Overall Study||0
2548281|NCT00562315|6244107|P1|COMPLETED|Overall Study||93
2548282|NCT00562315|6244107|P1|STARTED|Overall Study||93
2548283|NCT00562302|6244124|P2|NOT COMPLETED|Overall Study||32
2548284|NCT00562302|6244125|P1|NOT COMPLETED|Overall Study||20
2548285|NCT00562302|6244124|P2|COMPLETED|Overall Study||137
2548286|NCT00562302|6244125|P1|COMPLETED|Overall Study||150
2548287|NCT00562302|6244124|P2|STARTED|Overall Study||169
2548288|NCT00562302|6244125|P1|STARTED|Overall Study||170
2548289|NCT00562159|6244147|P2|NOT COMPLETED|Overall Study||33
2548290|NCT00562159|6244148|P1|NOT COMPLETED|Overall Study||38
2548291|NCT00562159|6244147|P2|COMPLETED|Overall Study||192
2548292|NCT00562159|6244148|P1|COMPLETED|Overall Study||175
2548293|NCT00562159|6244147|P2|STARTED|Overall Study||225
2548294|NCT00562159|6244148|P1|STARTED|Overall Study||213
2548295|NCT00562120|6244160|P4|NOT COMPLETED|Fourth Intervention Period||0
2548296|NCT00562120|6244161|P3|NOT COMPLETED|Fourth Intervention Period||0
2548297|NCT00562120|6244162|P2|NOT COMPLETED|Fourth Intervention Period||0
2548298|NCT00562120|6244163|P1|NOT COMPLETED|Fourth Intervention Period||0
2548299|NCT00562120|6244160|P4|COMPLETED|Fourth Intervention Period||5
2548300|NCT00562120|6244161|P3|COMPLETED|Fourth Intervention Period||5
2548301|NCT00562120|6244162|P2|COMPLETED|Fourth Intervention Period||5
2548302|NCT00562120|6244163|P1|COMPLETED|Fourth Intervention Period||4
2548303|NCT00562120|6244160|P4|STARTED|Fourth Intervention Period||5
2548304|NCT00562120|6244161|P3|STARTED|Fourth Intervention Period||5
2548305|NCT00562120|6244162|P2|STARTED|Fourth Intervention Period||5
2548306|NCT00562120|6244163|P1|STARTED|Fourth Intervention Period||4
2548307|NCT00562120|6244160|P4|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
2548308|NCT00562120|6244161|P3|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
2548309|NCT00562120|6244162|P2|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
2548310|NCT00562120|6244163|P1|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
2548311|NCT00562120|6244160|P4|COMPLETED|Washout Period 3 (At Least 14 Days)||5
2548312|NCT00562120|6244161|P3|COMPLETED|Washout Period 3 (At Least 14 Days)||5
2548313|NCT00562120|6244162|P2|COMPLETED|Washout Period 3 (At Least 14 Days)||5
2548314|NCT00562120|6244163|P1|COMPLETED|Washout Period 3 (At Least 14 Days)||4
2548315|NCT00562120|6244160|P4|STARTED|Washout Period 3 (At Least 14 Days)||5
2548316|NCT00562120|6244161|P3|STARTED|Washout Period 3 (At Least 14 Days)||5
2548317|NCT00562120|6244162|P2|STARTED|Washout Period 3 (At Least 14 Days)||5
2548318|NCT00562120|6244163|P1|STARTED|Washout Period 3 (At Least 14 Days)||4
2548319|NCT00562120|6244160|P4|NOT COMPLETED|Third Intervention Period||0
2548320|NCT00562120|6244161|P3|NOT COMPLETED|Third Intervention Period||0
2548321|NCT00562120|6244162|P2|NOT COMPLETED|Third Intervention Period||0
2548322|NCT00562120|6244163|P1|NOT COMPLETED|Third Intervention Period||0
2548323|NCT00562120|6244160|P4|COMPLETED|Third Intervention Period||5
2548324|NCT00562120|6244161|P3|COMPLETED|Third Intervention Period||5
2548325|NCT00562120|6244162|P2|COMPLETED|Third Intervention Period||5
2548326|NCT00562120|6244163|P1|COMPLETED|Third Intervention Period||4
2548327|NCT00562120|6244160|P4|STARTED|Third Intervention Period||5
2548328|NCT00562120|6244161|P3|STARTED|Third Intervention Period||5
2548329|NCT00562120|6244162|P2|STARTED|Third Intervention Period||5
2548330|NCT00562120|6244163|P1|STARTED|Third Intervention Period||4
2548331|NCT00562120|6244160|P4|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
2548332|NCT00562120|6244161|P3|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
2548333|NCT00562120|6244162|P2|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
2548334|NCT00562120|6244163|P1|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
2548335|NCT00562120|6244160|P4|COMPLETED|Washout Period 2 (At Least 14 Days)||5
2548336|NCT00562120|6244161|P3|COMPLETED|Washout Period 2 (At Least 14 Days)||5
2548337|NCT00562120|6244162|P2|COMPLETED|Washout Period 2 (At Least 14 Days)||5
2548338|NCT00562120|6244163|P1|COMPLETED|Washout Period 2 (At Least 14 Days)||4
2548339|NCT00562120|6244160|P4|STARTED|Washout Period 2 (At Least 14 Days)||5
2548340|NCT00562120|6244161|P3|STARTED|Washout Period 2 (At Least 14 Days)||5
2548341|NCT00562120|6244162|P2|STARTED|Washout Period 2 (At Least 14 Days)||5
2548342|NCT00562120|6244163|P1|STARTED|Washout Period 2 (At Least 14 Days)||4
2548343|NCT00562120|6244160|P4|NOT COMPLETED|Second Intervention Period||0
2548344|NCT00562120|6244161|P3|NOT COMPLETED|Second Intervention Period||0
2548345|NCT00562120|6244162|P2|NOT COMPLETED|Second Intervention Period||0
2548346|NCT00562120|6244163|P1|NOT COMPLETED|Second Intervention Period||0
2548347|NCT00562120|6244160|P4|COMPLETED|Second Intervention Period||5
2548348|NCT00562120|6244161|P3|COMPLETED|Second Intervention Period||5
2548349|NCT00562120|6244162|P2|COMPLETED|Second Intervention Period||5
2548350|NCT00562120|6244163|P1|COMPLETED|Second Intervention Period||4
2548351|NCT00562120|6244160|P4|STARTED|Second Intervention Period||5
2548352|NCT00562120|6244161|P3|STARTED|Second Intervention Period||5
2548353|NCT00562120|6244162|P2|STARTED|Second Intervention Period||5
2548354|NCT00562120|6244163|P1|STARTED|Second Intervention Period||4
2548355|NCT00562120|6244160|P4|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
2548356|NCT00562120|6244161|P3|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
2548357|NCT00562120|6244162|P2|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
2548358|NCT00562120|6244163|P1|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
2548359|NCT00562120|6244160|P4|COMPLETED|Washout Period 1 (At Least 14 Days)||5
2548360|NCT00562120|6244161|P3|COMPLETED|Washout Period 1 (At Least 14 Days)||5
2548361|NCT00562120|6244162|P2|COMPLETED|Washout Period 1 (At Least 14 Days)||5
2548362|NCT00562120|6244163|P1|COMPLETED|Washout Period 1 (At Least 14 Days)||4
2548363|NCT00562120|6244160|P4|STARTED|Washout Period 1 (At Least 14 Days)||5
2548364|NCT00562120|6244161|P3|STARTED|Washout Period 1 (At Least 14 Days)||5
2548365|NCT00562120|6244162|P2|STARTED|Washout Period 1 (At Least 14 Days)||5
2548366|NCT00562120|6244163|P1|STARTED|Washout Period 1 (At Least 14 Days)||4
2548367|NCT00562120|6244160|P4|NOT COMPLETED|First Intervention Period||0
2548368|NCT00562120|6244161|P3|NOT COMPLETED|First Intervention Period||0
2548369|NCT00562120|6244162|P2|NOT COMPLETED|First Intervention Period||0
2548370|NCT00562120|6244163|P1|NOT COMPLETED|First Intervention Period||2
2548371|NCT00562120|6244160|P4|COMPLETED|First Intervention Period||5
2548372|NCT00562120|6244161|P3|COMPLETED|First Intervention Period||5
2548373|NCT00562120|6244162|P2|COMPLETED|First Intervention Period||5
2548374|NCT00562120|6244163|P1|COMPLETED|First Intervention Period||4
2548375|NCT00562120|6244160|P4|Treated|First Intervention Period||5
2548376|NCT00562120|6244161|P3|Treated|First Intervention Period||5
2548377|NCT00562120|6244162|P2|Treated|First Intervention Period||5
2548378|NCT00562120|6244163|P1|Treated|First Intervention Period||5
2548379|NCT00562120|6244160|P4|STARTED|First Intervention Period||5
2548380|NCT00562120|6244161|P3|STARTED|First Intervention Period||5
2548381|NCT00562120|6244162|P2|STARTED|First Intervention Period||5
2548382|NCT00562120|6244163|P1|STARTED|First Intervention Period||6
2548383|NCT00562094|6244195|P1|NOT COMPLETED|Overall Study||62
2548384|NCT00562094|6244195|P1|COMPLETED|Overall Study||8554
2548385|NCT00562094|6244195|P1|STARTED|Overall Study||8616
2548386|NCT00561977|6244210|P3|NOT COMPLETED|Overall Study||2
2548387|NCT00561977|6244211|P2|NOT COMPLETED|Overall Study||3
2548388|NCT00561977|6244212|P1|NOT COMPLETED|Overall Study||0
2548389|NCT00561977|6244210|P3|COMPLETED|Overall Study||10
2548390|NCT00561977|6244211|P2|COMPLETED|Overall Study||9
2548391|NCT00561977|6244212|P1|COMPLETED|Overall Study||12
2548392|NCT00561977|6244210|P3|STARTED|Overall Study||12
2548393|NCT00561977|6244211|P2|STARTED|Overall Study||12
2548394|NCT00561977|6244212|P1|STARTED|Overall Study||12
2548395|NCT00561951|6244238|P3|NOT COMPLETED|Overall Study||32
2548396|NCT00561951|6244239|P2|NOT COMPLETED|Overall Study||34
2548397|NCT00561951|6244240|P1|NOT COMPLETED|Overall Study||33
2548398|NCT00561951|6244238|P3|COMPLETED|Overall Study||281
2548399|NCT00561951|6244239|P2|COMPLETED|Overall Study||286
2548400|NCT00561951|6244240|P1|COMPLETED|Overall Study||285
2548401|NCT00561951|6244238|P3|STARTED|Overall Study||313
2548402|NCT00561951|6244239|P2|STARTED|Overall Study||320
2548403|NCT00561951|6244240|P1|STARTED|Overall Study||318
2548404|NCT00561925|6244296|P5|NOT COMPLETED|Open-Label Extension Period||50
2548405|NCT00561925|6244297|P4|NOT COMPLETED|Open-Label Extension Period||43
2548406|NCT00561925|6244298|P3|NOT COMPLETED|Open-Label Extension Period||0
2548407|NCT00561925|6244299|P2|NOT COMPLETED|Open-Label Extension Period||0
2548408|NCT00561925|6244300|P1|NOT COMPLETED|Open-Label Extension Period||0
2548409|NCT00561925|6244296|P5|COMPLETED|Open-Label Extension Period||328
2548410|NCT00561925|6244297|P4|COMPLETED|Open-Label Extension Period||315
2548411|NCT00561925|6244298|P3|COMPLETED|Open-Label Extension Period||0
2548412|NCT00561925|6244299|P2|COMPLETED|Open-Label Extension Period||1
2548413|NCT00561925|6244300|P1|COMPLETED|Open-Label Extension Period||0
2548414|NCT00561925|6244296|P5|STARTED|Open-Label Extension Period||378
2548415|NCT00561925|6244297|P4|STARTED|Open-Label Extension Period||358
2548416|NCT00561925|6244298|P3|STARTED|Open-Label Extension Period||0
2548417|NCT00561925|6244299|P2|STARTED|Open-Label Extension Period||1
2548418|NCT00561925|6244300|P1|STARTED|Open-Label Extension Period||0
2548419|NCT00561925|6244296|P5|NOT COMPLETED|144-week Double-blind, Double-dummy||0
2548420|NCT00561925|6244297|P4|NOT COMPLETED|144-week Double-blind, Double-dummy||0
2548421|NCT00561925|6244298|P3|NOT COMPLETED|144-week Double-blind, Double-dummy||127
2548422|NCT00561925|6244299|P2|NOT COMPLETED|144-week Double-blind, Double-dummy||150
2548423|NCT00561925|6244300|P1|NOT COMPLETED|144-week Double-blind, Double-dummy||0
2548424|NCT00561925|6244296|P5|COMPLETED|144-week Double-blind, Double-dummy||0
2548425|NCT00561925|6244297|P4|COMPLETED|144-week Double-blind, Double-dummy||0
2548426|NCT00561925|6244298|P3|COMPLETED|144-week Double-blind, Double-dummy||378
2548427|NCT00561925|6244299|P2|COMPLETED|144-week Double-blind, Double-dummy||358
2548428|NCT00561925|6244300|P1|COMPLETED|144-week Double-blind, Double-dummy||0
2548429|NCT00561925|6244296|P5|STARTED|144-week Double-blind, Double-dummy||0
2548430|NCT00561925|6244297|P4|STARTED|144-week Double-blind, Double-dummy||0
2548431|NCT00561925|6244298|P3|STARTED|144-week Double-blind, Double-dummy||505
2548432|NCT00561925|6244299|P2|STARTED|144-week Double-blind, Double-dummy||508
2548433|NCT00561925|6244300|P1|STARTED|144-week Double-blind, Double-dummy||0
2548434|NCT00561925|6244296|P5|NOT COMPLETED|14 Day Lead-In Period||0
2548435|NCT00561925|6244297|P4|NOT COMPLETED|14 Day Lead-In Period||0
2548436|NCT00561925|6244298|P3|NOT COMPLETED|14 Day Lead-In Period||0
2548437|NCT00561925|6244299|P2|NOT COMPLETED|14 Day Lead-In Period||0
2548438|NCT00561925|6244300|P1|NOT COMPLETED|14 Day Lead-In Period||55
2548439|NCT00561925|6244296|P5|COMPLETED|14 Day Lead-In Period||0
2548440|NCT00561925|6244297|P4|COMPLETED|14 Day Lead-In Period||0
2548441|NCT00561925|6244298|P3|COMPLETED|14 Day Lead-In Period||0
2548442|NCT00561925|6244299|P2|COMPLETED|14 Day Lead-In Period||0
2548443|NCT00561925|6244300|P1|COMPLETED|14 Day Lead-In Period||1013
2548444|NCT00561925|6244296|P5|STARTED|14 Day Lead-In Period||0
2548445|NCT00561925|6244297|P4|STARTED|14 Day Lead-In Period||0
2548446|NCT00561925|6244298|P3|STARTED|14 Day Lead-In Period||0
2548447|NCT00561925|6244299|P2|STARTED|14 Day Lead-In Period||0
2548448|NCT00561925|6244300|P1|STARTED|14 Day Lead-In Period||1068
2548449|NCT00561912|6244349|P1|NOT COMPLETED|Overall Study||1
2548450|NCT00561912|6244349|P1|COMPLETED|Overall Study||1
2548451|NCT00561912|6244349|P1|STARTED|Overall Study||2
2548452|NCT00561834|6244353|P1|NOT COMPLETED|Overall Study||0
2548453|NCT00561834|6244353|P1|COMPLETED|Overall Study||2
2548454|NCT00561834|6244353|P1|STARTED|Overall Study||2
2548455|NCT00561821|6244361|P4|NOT COMPLETED|Overall Study||3
2548456|NCT00561821|6244362|P3|NOT COMPLETED|Overall Study||2
2548457|NCT00561821|6244363|P2|NOT COMPLETED|Overall Study||6
2548458|NCT00561821|6244364|P1|NOT COMPLETED|Overall Study||5
2548459|NCT00561821|6244361|P4|COMPLETED|Overall Study||133
2548460|NCT00561821|6244362|P3|COMPLETED|Overall Study||132
2548461|NCT00561821|6244363|P2|COMPLETED|Overall Study||130
2548462|NCT00561821|6244364|P1|COMPLETED|Overall Study||127
2548463|NCT00561821|6244361|P4|Treated|Overall Study||136
2548464|NCT00561821|6244362|P3|Treated|Overall Study||133
2548465|NCT00561821|6244363|P2|Treated|Overall Study||136
2548466|NCT00561821|6244364|P1|Treated|Overall Study||132
2548467|NCT00561821|6244361|P4|STARTED|Overall Study||136
2548468|NCT00561821|6244362|P3|STARTED|Overall Study||134
2548469|NCT00561821|6244363|P2|STARTED|Overall Study||136
2548470|NCT00561821|6244364|P1|STARTED|Overall Study||132
2548471|NCT00561795|6244440|P4|NOT COMPLETED|Overall Study||0
2548472|NCT00561795|6244441|P3|NOT COMPLETED|Overall Study||0
2548473|NCT00561795|6244442|P2|NOT COMPLETED|Overall Study||6
2548474|NCT00561795|6244443|P1|NOT COMPLETED|Overall Study||4
2548475|NCT00561795|6244440|P4|COMPLETED|Overall Study||0
2548476|NCT00561795|6244441|P3|COMPLETED|Overall Study||0
2548477|NCT00561795|6244442|P2|COMPLETED|Overall Study||0
2548478|NCT00561795|6244443|P1|COMPLETED|Overall Study||2
2548479|NCT00561795|6244440|P4|STARTED|Overall Study||0
2548480|NCT00561795|6244441|P3|STARTED|Overall Study||0
2548481|NCT00561795|6244442|P2|STARTED|Overall Study||6
2548482|NCT00561795|6244443|P1|STARTED|Overall Study||6
2548483|NCT00561730|6244463|P1|NOT COMPLETED|Overall Study||9
2548484|NCT00561730|6244463|P1|COMPLETED|Overall Study||1986
2548485|NCT00561730|6244463|P1|STARTED|Overall Study||1995
2548486|NCT00561678|6244479|P2|NOT COMPLETED|Overall Study||6
2548487|NCT00561678|6244480|P1|NOT COMPLETED|Overall Study||8
2548488|NCT00561678|6244479|P2|COMPLETED|Overall Study||201
2548489|NCT00561678|6244480|P1|COMPLETED|Overall Study||189
2548490|NCT00561678|6244479|P2|STARTED|Overall Study||207
2548491|NCT00561678|6244480|P1|STARTED|Overall Study||197
2548492|NCT00561652|6244498|P2|NOT COMPLETED|Overall Study||1
2548493|NCT00561652|6244499|P1|NOT COMPLETED|Overall Study||0
2548494|NCT00561652|6244498|P2|COMPLETED|Overall Study||19
2548495|NCT00561652|6244499|P1|COMPLETED|Overall Study||10
2548496|NCT00561652|6244498|P2|STARTED|Overall Study||20
2548497|NCT00561652|6244499|P1|STARTED|Overall Study||10
2548498|NCT00561600|6244519|P2|NOT COMPLETED|Overall Study||16
2548499|NCT00561600|6244520|P1|NOT COMPLETED|Overall Study||18
2548500|NCT00561600|6244519|P2|COMPLETED|Overall Study||119
2548501|NCT00561600|6244520|P1|COMPLETED|Overall Study||112
2548502|NCT00561600|6244519|P2|STARTED|Overall Study||135
2548503|NCT00561600|6244520|P1|STARTED|Overall Study||130
2548504|NCT00561574|6244582|P2|NOT COMPLETED|Overall Study||58
2548505|NCT00561574|6244583|P1|NOT COMPLETED|Overall Study||48
2548506|NCT00561574|6244582|P2|COMPLETED|Overall Study||73
2548507|NCT00561574|6244583|P1|COMPLETED|Overall Study||80
2548508|NCT00561574|6244582|P2|STARTED|Overall Study||131
2548509|NCT00561574|6244583|P1|STARTED|Overall Study||128
2548510|NCT00561470|6244609|P2|NOT COMPLETED|Overall Study||612
2548511|NCT00561470|6244610|P1|NOT COMPLETED|Overall Study||614
2548512|NCT00561470|6244609|P2|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
2548513|NCT00561470|6244610|P1|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
2548514|NCT00561470|6244609|P2|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|14
2548515|NCT00561470|6244610|P1|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|11
2548516|NCT00561470|6244609|P2|SAFETY POPULATION|Overall Study|Treated participants including 4 from Placebo/FOLFIRI who received at least 1 dose of Aflibercept|611
2548517|NCT00561470|6244610|P1|SAFETY POPULATION|Overall Study|Treated participants excluding 4 who received at least 1 dose of Aflibercept|605
2548518|NCT00561470|6244609|P2|TREATED|Overall Study||607
2548519|NCT00561470|6244610|P1|TREATED|Overall Study||609
2548520|NCT00561470|6244609|P2|STARTED|Overall Study||612
2548521|NCT00561470|6244610|P1|STARTED|Overall Study||614
2548522|NCT00561457|6244624|P1|NOT COMPLETED|Overall Study||24
2548523|NCT00561457|6244624|P1|COMPLETED|Overall Study||110
2548524|NCT00561457|6244624|P1|STARTED|Overall Study||134
2548525|NCT00561431|6244630|P2|NOT COMPLETED|Overall Study||0
2548526|NCT00561431|6244631|P1|NOT COMPLETED|Overall Study||0
2548527|NCT00561431|6244630|P2|COMPLETED|Overall Study||100
2548528|NCT00561431|6244631|P1|COMPLETED|Overall Study||100
2548529|NCT00561431|6244630|P2|STARTED|Overall Study||100
2548530|NCT00561431|6244631|P1|STARTED|Overall Study||100
2548531|NCT00561418|6244639|P1|NOT COMPLETED|Overall Study||0
2548532|NCT00561418|6244639|P1|COMPLETED|Overall Study||23
2548533|NCT00561418|6244639|P1|STARTED|Overall Study||23
2548534|NCT00561392|6244646|P1|NOT COMPLETED|Overall Study||53
2548535|NCT00561392|6244646|P1|COMPLETED|Overall Study||155
2548536|NCT00561392|6244646|P1|STARTED|Overall Study||208
2548537|NCT00561353|6244668|P10|NOT COMPLETED|Overall Study||2
2548538|NCT00561353|6244669|P9|NOT COMPLETED|Overall Study||7
2548539|NCT00561353|6244670|P8|NOT COMPLETED|Overall Study||4
2548540|NCT00561353|6244671|P7|NOT COMPLETED|Overall Study||6
2548541|NCT00561353|6244672|P6|NOT COMPLETED|Overall Study||6
2548542|NCT00561353|6244673|P5|NOT COMPLETED|Overall Study||1
2548543|NCT00561353|6244674|P4|NOT COMPLETED|Overall Study||6
2548544|NCT00561353|6244675|P3|NOT COMPLETED|Overall Study||3
2548545|NCT00561353|6244676|P2|NOT COMPLETED|Overall Study||3
2548546|NCT00561353|6244677|P1|NOT COMPLETED|Overall Study||5
2548547|NCT00561353|6244668|P10|COMPLETED|Overall Study||3
2548548|NCT00561353|6244669|P9|COMPLETED|Overall Study||2
2548549|NCT00561353|6244670|P8|COMPLETED|Overall Study||6
2548550|NCT00561353|6244671|P7|COMPLETED|Overall Study||3
2548551|NCT00561353|6244672|P6|COMPLETED|Overall Study||3
2548552|NCT00561353|6244673|P5|COMPLETED|Overall Study||5
2548553|NCT00561353|6244674|P4|COMPLETED|Overall Study||12
2548554|NCT00561353|6244675|P3|COMPLETED|Overall Study||10
2548555|NCT00561353|6244676|P2|COMPLETED|Overall Study||16
2548556|NCT00561353|6244677|P1|COMPLETED|Overall Study||13
2548557|NCT00561353|6244668|P10|STARTED|Overall Study||5
2548558|NCT00561353|6244669|P9|STARTED|Overall Study||9
2548559|NCT00561353|6244670|P8|STARTED|Overall Study||10
2548560|NCT00561353|6244671|P7|STARTED|Overall Study||9
2548561|NCT00561353|6244672|P6|STARTED|Overall Study||9
2548562|NCT00561353|6244673|P5|STARTED|Overall Study||6
2548563|NCT00561353|6244674|P4|STARTED|Overall Study||18
2548564|NCT00561353|6244675|P3|STARTED|Overall Study||13
2548565|NCT00561353|6244676|P2|STARTED|Overall Study||19
2548566|NCT00561353|6244677|P1|STARTED|Overall Study||18
2548567|NCT00561340|6244832|P2|NOT COMPLETED|Overall Study||0
2548568|NCT00561340|6244833|P1|NOT COMPLETED|Overall Study||6
2548569|NCT00561340|6244832|P2|COMPLETED|Overall Study||16
2548570|NCT00561340|6244833|P1|COMPLETED|Overall Study||7
2548571|NCT00561340|6244832|P2|STARTED|Overall Study||16
2548572|NCT00561340|6244833|P1|STARTED|Overall Study||13
2548573|NCT00561145|6244843|P2|NOT COMPLETED|Overall Study||0
2548574|NCT00561145|6244844|P1|NOT COMPLETED|Overall Study||0
2548575|NCT00561145|6244843|P2|COMPLETED|Overall Study||17
2548576|NCT00561145|6244844|P1|COMPLETED|Overall Study||15
2548577|NCT00561145|6244843|P2|STARTED|Overall Study||17
2548578|NCT00561145|6244844|P1|STARTED|Overall Study||15
2548579|NCT00561080|6244853|P3|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
2548580|NCT00561080|6244854|P2|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
2548581|NCT00561080|6244855|P1|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
2548582|NCT00561080|6244853|P3|COMPLETED|36 Month Post Last Dose Follow-up||0
2548583|NCT00561080|6244854|P2|COMPLETED|36 Month Post Last Dose Follow-up||0
2548584|NCT00561080|6244855|P1|COMPLETED|36 Month Post Last Dose Follow-up||0
2548585|NCT00561080|6244853|P3|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
2548586|NCT00561080|6244854|P2|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
2548587|NCT00561080|6244855|P1|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
2548588|NCT00561080|6244853|P3|NOT COMPLETED|24-month Post Last Dose Follow-up||0
2548589|NCT00561080|6244854|P2|NOT COMPLETED|24-month Post Last Dose Follow-up||0
2548590|NCT00561080|6244855|P1|NOT COMPLETED|24-month Post Last Dose Follow-up||0
2548591|NCT00561080|6244853|P3|COMPLETED|24-month Post Last Dose Follow-up||0
2548592|NCT00561080|6244854|P2|COMPLETED|24-month Post Last Dose Follow-up||0
2548593|NCT00561080|6244855|P1|COMPLETED|24-month Post Last Dose Follow-up||0
2548594|NCT00561080|6244853|P3|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
2548595|NCT00561080|6244854|P2|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
2548596|NCT00561080|6244855|P1|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
2548597|NCT00561080|6244853|P3|NOT COMPLETED|12-month Post Last Dose Follow-up||10
2548598|NCT00561080|6244854|P2|NOT COMPLETED|12-month Post Last Dose Follow-up||9
2548599|NCT00561080|6244855|P1|NOT COMPLETED|12-month Post Last Dose Follow-up||7
2548600|NCT00561080|6244853|P3|COMPLETED|12-month Post Last Dose Follow-up||215
2548601|NCT00561080|6244854|P2|COMPLETED|12-month Post Last Dose Follow-up||220
2548602|NCT00561080|6244855|P1|COMPLETED|12-month Post Last Dose Follow-up||243
2548603|NCT00561080|6244853|P3|STARTED|12-month Post Last Dose Follow-up||225
2548604|NCT00561080|6244854|P2|STARTED|12-month Post Last Dose Follow-up||229
2548605|NCT00561080|6244855|P1|STARTED|12-month Post Last Dose Follow-up||250
2548606|NCT00561080|6244853|P3|NOT COMPLETED|Vaccination Period (up to Month 4)||26
2548607|NCT00561080|6244854|P2|NOT COMPLETED|Vaccination Period (up to Month 4)||26
2548608|NCT00561080|6244855|P1|NOT COMPLETED|Vaccination Period (up to Month 4)||3
2548609|NCT00561080|6244853|P3|COMPLETED|Vaccination Period (up to Month 4)||225
2548610|NCT00561080|6244854|P2|COMPLETED|Vaccination Period (up to Month 4)||229
2548611|NCT00561080|6244855|P1|COMPLETED|Vaccination Period (up to Month 4)||250
2548612|NCT00561080|6244853|P3|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||250
2548613|NCT00561080|6244854|P2|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||254
2548614|NCT00561080|6244855|P1|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||253
2548615|NCT00561080|6244853|P3|STARTED|Vaccination Period (up to Month 4)||251
2548616|NCT00561080|6244854|P2|STARTED|Vaccination Period (up to Month 4)||255
2548617|NCT00561080|6244855|P1|STARTED|Vaccination Period (up to Month 4)||253
2548618|NCT00561015|6244932|P6|NOT COMPLETED|Overall Study||3
2548619|NCT00561015|6244933|P5|NOT COMPLETED|Overall Study||1
2548620|NCT00561015|6244934|P4|NOT COMPLETED|Overall Study||1
2548621|NCT00561015|6244935|P3|NOT COMPLETED|Overall Study||0
2548622|NCT00561015|6244936|P2|NOT COMPLETED|Overall Study||0
2548623|NCT00561015|6244937|P1|NOT COMPLETED|Overall Study||4
2548624|NCT00561015|6244932|P6|COMPLETED|Overall Study||6
2548625|NCT00561015|6244933|P5|COMPLETED|Overall Study||8
2548626|NCT00561015|6244934|P4|COMPLETED|Overall Study||7
2548627|NCT00561015|6244935|P3|COMPLETED|Overall Study||9
2548628|NCT00561015|6244936|P2|COMPLETED|Overall Study||5
2548629|NCT00561015|6244937|P1|COMPLETED|Overall Study||5
2548630|NCT00561015|6244932|P6|STARTED|Overall Study||9
2548631|NCT00561015|6244933|P5|STARTED|Overall Study||9
2548632|NCT00561015|6244934|P4|STARTED|Overall Study||8
2548633|NCT00561015|6244935|P3|STARTED|Overall Study||9
2548634|NCT00561015|6244936|P2|STARTED|Overall Study||5
2548635|NCT00561015|6244937|P1|STARTED|Overall Study||9
2548636|NCT00561002|6245013|P2|NOT COMPLETED|Overall Study||0
2548637|NCT00561002|6245014|P1|NOT COMPLETED|Overall Study||0
2548638|NCT00561002|6245013|P2|COMPLETED|Overall Study||9
2548639|NCT00561002|6245014|P1|COMPLETED|Overall Study||23
2548640|NCT00561002|6245013|P2|STARTED|Overall Study||9
2548641|NCT00561002|6245014|P1|STARTED|Overall Study||23
2548642|NCT00560950|6245028|P2|NOT COMPLETED|Overall Study||0
2548643|NCT00560950|6245029|P1|NOT COMPLETED|Overall Study||1
2548644|NCT00560950|6245028|P2|COMPLETED|Overall Study||71
2548645|NCT00560950|6245029|P1|COMPLETED|Overall Study||71
2548646|NCT00560950|6245028|P2|STARTED|Overall Study||71
2548647|NCT00560950|6245029|P1|STARTED|Overall Study||72
2548648|NCT00560937|6245067|P2|NOT COMPLETED|Overall Study||2
2548649|NCT00560937|6245068|P1|NOT COMPLETED|Overall Study||1
2548650|NCT00560937|6245067|P2|COMPLETED|Overall Study||9
2548651|NCT00560937|6245068|P1|COMPLETED|Overall Study|One participant was withdrawn after 6 weeks and data were carried forward|9
2548652|NCT00560937|6245067|P2|STARTED|Overall Study||11
2548653|NCT00560937|6245068|P1|STARTED|Overall Study||10
2548654|NCT00560885|6245084|P1|NOT COMPLETED|Overall Study||8
2548655|NCT00560885|6245084|P1|COMPLETED|Overall Study||47
2548656|NCT00560885|6245084|P1|2 Year Follow-up|Overall Study||47
2548657|NCT00560885|6245084|P1|12 Month Follow-up|Overall Study|48 pts available for 12 month follow-up, 46 pts assessed|48
2548658|NCT00560885|6245084|P1|6 Month Follow-up|Overall Study|50 pts available for 6 month follow-up, 50 pts assessed|50
2548659|NCT00560885|6245084|P1|3 Month Follow-up|Overall Study|51 pts available for 3 month follow-up, 48 pts assessed.|51
2548660|NCT00560885|6245084|P1|30 Day Follow-up|Overall Study|53 pts available for 30 day follow-up, 52 pts assessed|53
2548661|NCT00560885|6245084|P1|STARTED|Overall Study||55
2548662|NCT00560859|6245093|P2|NOT COMPLETED|Overall Study||24
2548663|NCT00560859|6245094|P1|NOT COMPLETED|Overall Study||32
2548664|NCT00560859|6245093|P2|COMPLETED|Overall Study||203
2548665|NCT00560859|6245094|P1|COMPLETED|Overall Study||194
2548666|NCT00560859|6245093|P2|STARTED|Overall Study||227
2548667|NCT00560859|6245094|P1|STARTED|Overall Study||226
2548668|NCT00560833|6245109|P5|NOT COMPLETED|Overall Study||42
2548669|NCT00560833|6245110|P4|NOT COMPLETED|Overall Study||31
2548670|NCT00560833|6245111|P3|NOT COMPLETED|Overall Study||39
2548671|NCT00560833|6245112|P2|NOT COMPLETED|Overall Study||26
2548672|NCT00560833|6245113|P1|NOT COMPLETED|Overall Study||44
2548673|NCT00560833|6245109|P5|COMPLETED|Overall Study||114
2548674|NCT00560833|6245110|P4|COMPLETED|Overall Study||124
2548675|NCT00560833|6245111|P3|COMPLETED|Overall Study||121
2548676|NCT00560833|6245112|P2|COMPLETED|Overall Study||129
2548677|NCT00560833|6245113|P1|COMPLETED|Overall Study||273
2548678|NCT00560833|6245109|P5|Treated|Overall Study|One participant was randomized but not treated|155
2548679|NCT00560833|6245110|P4|Treated|Overall Study||155
2548680|NCT00560833|6245111|P3|Treated|Overall Study||160
2548681|NCT00560833|6245112|P2|Treated|Overall Study|One participant was randomized but not treated|154
2548682|NCT00560833|6245113|P1|Treated|Overall Study|One participant was not randomized but was treated with placebo|317
2548683|NCT00560833|6245109|P5|STARTED|Overall Study||156
2548684|NCT00560833|6245110|P4|STARTED|Overall Study||155
2548685|NCT00560833|6245111|P3|STARTED|Overall Study||160
2548686|NCT00560833|6245112|P2|STARTED|Overall Study||155
2548687|NCT00560833|6245113|P1|STARTED|Overall Study||317
2548688|NCT00560794|6245145|P1|NOT COMPLETED|Overall Study||11
2548689|NCT00560794|6245145|P1|COMPLETED|Overall Study||10
2548690|NCT00560794|6245145|P1|Completed 1 Treatment Cycle|Overall Study||20
2548691|NCT00560794|6245145|P1|STARTED|Overall Study||21
2548692|NCT00560755|6245162|P1|NOT COMPLETED|Overall Study||60
2548693|NCT00560755|6245162|P1|COMPLETED|Overall Study||3328
2548694|NCT00560755|6245162|P1|ProQuad® Dose 1 and Dose 2|Overall Study||3346
2548695|NCT00560755|6245162|P1|STARTED|Overall Study|Vaccinated (at least one ProQuad® dose)|3388
2548696|NCT00560703|6245183|P2|NOT COMPLETED|Overall Study||6
2548697|NCT00560703|6245184|P1|NOT COMPLETED|Overall Study||0
2548698|NCT00560703|6245183|P2|COMPLETED|Overall Study||18
2548699|NCT00560703|6245184|P1|COMPLETED|Overall Study||46
2548700|NCT00560703|6245183|P2|STARTED|Overall Study||24
2548701|NCT00560703|6245184|P1|STARTED|Overall Study||46
2548702|NCT00560612|6245194|P2|NOT COMPLETED|Overall Study||0
2548703|NCT00560612|6245195|P1|NOT COMPLETED|Overall Study||0
2548704|NCT00560612|6245194|P2|COMPLETED|Overall Study||7
2548705|NCT00560612|6245195|P1|COMPLETED|Overall Study||5
2548706|NCT00560612|6245194|P2|STARTED|Overall Study||7
2548707|NCT00560612|6245195|P1|STARTED|Overall Study||5
2548708|NCT00560573|6245207|P6|NOT COMPLETED|Overall Study||13
2548709|NCT00560573|6245208|P5|NOT COMPLETED|Overall Study||7
2548710|NCT00560573|6245209|P4|NOT COMPLETED|Overall Study||10
2548711|NCT00560573|6245210|P3|NOT COMPLETED|Overall Study||6
2548712|NCT00560573|6245211|P2|NOT COMPLETED|Overall Study||3
2548713|NCT00560573|6245212|P1|NOT COMPLETED|Overall Study||6
2548714|NCT00560573|6245207|P6|COMPLETED|Overall Study||0
2548715|NCT00560573|6245208|P5|COMPLETED|Overall Study||1
2548716|NCT00560573|6245209|P4|COMPLETED|Overall Study||0
2548717|NCT00560573|6245210|P3|COMPLETED|Overall Study||0
2548718|NCT00560573|6245211|P2|COMPLETED|Overall Study||0
2548719|NCT00560573|6245212|P1|COMPLETED|Overall Study||0
2548720|NCT00560573|6245207|P6|Treated|Overall Study||13
2548721|NCT00560573|6245208|P5|Treated|Overall Study||7
2548722|NCT00560573|6245209|P4|Treated|Overall Study||10
2548723|NCT00560573|6245210|P3|Treated|Overall Study||6
2548724|NCT00560573|6245211|P2|Treated|Overall Study||3
2548725|NCT00560573|6245212|P1|Treated|Overall Study||6
2548726|NCT00560573|6245207|P6|STARTED|Overall Study||13
2548727|NCT00560573|6245208|P5|STARTED|Overall Study||8
2548728|NCT00560573|6245209|P4|STARTED|Overall Study||10
2548729|NCT00560573|6245210|P3|STARTED|Overall Study||6
2548730|NCT00560573|6245211|P2|STARTED|Overall Study||3
2548731|NCT00560573|6245212|P1|STARTED|Overall Study||6
2548732|NCT00560560|6245266|P2|NOT COMPLETED|Overall Study||83
2548733|NCT00560560|6245267|P1|NOT COMPLETED|Overall Study||85
2548734|NCT00560560|6245266|P2|COMPLETED|Overall Study||0
2548735|NCT00560560|6245267|P1|COMPLETED|Overall Study||0
2548736|NCT00560560|6245266|P2|STARTED|Overall Study||83
2548737|NCT00560560|6245267|P1|STARTED|Overall Study||85
2548738|NCT00560508|6245289|P2|NOT COMPLETED|52-week Open-label Period Pramipexole ER||11
2548739|NCT00560508|6245290|P1|NOT COMPLETED|52-week Open-label Period Pramipexole ER||8
2548740|NCT00560508|6245289|P2|COMPLETED|52-week Open-label Period Pramipexole ER||42
2548741|NCT00560508|6245290|P1|COMPLETED|52-week Open-label Period Pramipexole ER||43
2548742|NCT00560508|6245289|P2|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|53
2548743|NCT00560508|6245290|P1|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|51
2548744|NCT00560508|6245289|P2|NOT COMPLETED|12 Week Double-blind Period||3
2548745|NCT00560508|6245290|P1|NOT COMPLETED|12 Week Double-blind Period||5
2548746|NCT00560508|6245289|P2|COMPLETED|12 Week Double-blind Period||53
2548747|NCT00560508|6245290|P1|COMPLETED|12 Week Double-blind Period||51
2548748|NCT00560508|6245289|P2|STARTED|12 Week Double-blind Period||56
2548749|NCT00560508|6245290|P1|STARTED|12 Week Double-blind Period||56
2548750|NCT00560417|6245349|P2|NOT COMPLETED|Overall Study||17
2548751|NCT00560417|6245350|P1|NOT COMPLETED|Overall Study||17
2548752|NCT00560417|6245349|P2|COMPLETED|Overall Study||151
2548753|NCT00560417|6245350|P1|COMPLETED|Overall Study||154
2548754|NCT00560417|6245349|P2|Intention to Treat (ITT) Population|Overall Study||167
2548755|NCT00560417|6245350|P1|Intention to Treat (ITT) Population|Overall Study||170
2548756|NCT00560417|6245349|P2|STARTED|Overall Study||168
2548757|NCT00560417|6245350|P1|STARTED|Overall Study||171
2548758|NCT00560404|6245378|P2|NOT COMPLETED|Overall Study||21
2548759|NCT00560404|6245379|P1|NOT COMPLETED|Overall Study||36
2548760|NCT00560404|6245378|P2|COMPLETED|Overall Study||100
2548761|NCT00560404|6245379|P1|COMPLETED|Overall Study||76
2548762|NCT00560404|6245378|P2|STARTED|Overall Study||121
2548763|NCT00560404|6245379|P1|STARTED|Overall Study||112
2548764|NCT00560391|6245426|P5|NOT COMPLETED|Overall Study||2
2548765|NCT00560391|6245427|P4|NOT COMPLETED|Overall Study||1
2548766|NCT00560391|6245428|P3|NOT COMPLETED|Overall Study||0
2548767|NCT00560391|6245429|P2|NOT COMPLETED|Overall Study||0
2548768|NCT00560391|6245430|P1|NOT COMPLETED|Overall Study||0
2548769|NCT00560391|6245426|P5|COMPLETED|Overall Study|Completed=offtreatment;Disease progression-6;Study drug toxicity-7; Unrelated AE-1,Subject request-1|15
2548770|NCT00560391|6245427|P4|COMPLETED|Overall Study|Completed=off treatment; Disease progression-2; Unrelated AE 1 and Subject request 2|5
2548771|NCT00560391|6245428|P3|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Maximum clinical benefit-1; Unrelated AE-1|3
2548772|NCT00560391|6245429|P2|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Death-1; Unrelated AE-1|3
2548773|NCT00560391|6245430|P1|COMPLETED|Overall Study|Completed=off treatment;Disease progression-1;Death-1;Max. clinical benefit-2;Study drug toxicity-2|6
2548774|NCT00560391|6245426|P5|STARTED|Overall Study|Participants who received treatment|17
2548775|NCT00560391|6245427|P4|STARTED|Overall Study|Participants who received treatment|6
2548776|NCT00560391|6245428|P3|STARTED|Overall Study|Participants who received treatment|3
2548777|NCT00560391|6245429|P2|STARTED|Overall Study|Participants who received treatment|3
2548778|NCT00560391|6245430|P1|STARTED|Overall Study|Participants who received treatment|6
2548779|NCT00560352|6245486|P3|NOT COMPLETED|Overall Study||4
2548780|NCT00560352|6245487|P2|NOT COMPLETED|Overall Study||3
2548781|NCT00560352|6245488|P1|NOT COMPLETED|Overall Study||7
2548782|NCT00560352|6245486|P3|COMPLETED|Overall Study||0
2548783|NCT00560352|6245487|P2|COMPLETED|Overall Study||0
2548784|NCT00560352|6245488|P1|COMPLETED|Overall Study||0
2548785|NCT00560352|6245486|P3|STARTED|Overall Study||4
2548786|NCT00560352|6245487|P2|STARTED|Overall Study||3
2548787|NCT00560352|6245488|P1|STARTED|Overall Study||7
2548788|NCT00560313|6245505|P1|NOT COMPLETED|Overall Study||6
2548789|NCT00560313|6245505|P1|COMPLETED|Overall Study||48
2548790|NCT00560313|6245505|P1|STARTED|Overall Study||54
2548791|NCT00560235|6245532|P3|NOT COMPLETED|Phase 2||97
2548792|NCT00560235|6245533|P2|NOT COMPLETED|Phase 2||0
2548793|NCT00560235|6245534|P1|NOT COMPLETED|Phase 2||0
2548794|NCT00560235|6245532|P3|COMPLETED|Phase 2||10
2548795|NCT00560235|6245533|P2|COMPLETED|Phase 2||0
2548796|NCT00560235|6245534|P1|COMPLETED|Phase 2||0
2548797|NCT00560235|6245532|P3|STARTED|Phase 2||107
2548798|NCT00560235|6245533|P2|STARTED|Phase 2||0
2548799|NCT00560235|6245534|P1|STARTED|Phase 2||0
2548800|NCT00560235|6245532|P3|NOT COMPLETED|Phase 1B||0
2548801|NCT00560235|6245533|P2|NOT COMPLETED|Phase 1B||19
2548802|NCT00560235|6245534|P1|NOT COMPLETED|Phase 1B||0
2548803|NCT00560235|6245532|P3|COMPLETED|Phase 1B||0
2548804|NCT00560235|6245533|P2|COMPLETED|Phase 1B||2
2548805|NCT00560235|6245534|P1|COMPLETED|Phase 1B||0
2548806|NCT00560235|6245532|P3|STARTED|Phase 1B||0
2548807|NCT00560235|6245533|P2|STARTED|Phase 1B||21
2548808|NCT00560235|6245534|P1|STARTED|Phase 1B||0
2548809|NCT00560235|6245532|P3|NOT COMPLETED|Phase 1||0
2548810|NCT00560235|6245533|P2|NOT COMPLETED|Phase 1||0
2548811|NCT00560235|6245534|P1|NOT COMPLETED|Phase 1||8
2548812|NCT00560235|6245532|P3|COMPLETED|Phase 1||0
2548813|NCT00560235|6245533|P2|COMPLETED|Phase 1||0
2548814|NCT00560235|6245534|P1|COMPLETED|Phase 1||2
2548815|NCT00560235|6245532|P3|STARTED|Phase 1||0
2548816|NCT00560235|6245533|P2|STARTED|Phase 1||0
2548817|NCT00560235|6245534|P1|STARTED|Phase 1||10
2548818|NCT00560105|6245565|P2|NOT COMPLETED|Overall Study||2
2548819|NCT00560105|6245566|P1|NOT COMPLETED|Overall Study||1
2548820|NCT00560105|6245565|P2|COMPLETED|Overall Study||18
2548821|NCT00560105|6245566|P1|COMPLETED|Overall Study||19
2548822|NCT00560105|6245565|P2|STARTED|Overall Study||20
2548823|NCT00560105|6245566|P1|STARTED|Overall Study||20
2548824|NCT00560066|6245580|P2|NOT COMPLETED|Overall Study||22
2548825|NCT00560066|6245581|P1|NOT COMPLETED|Overall Study||6
2548826|NCT00560066|6245580|P2|COMPLETED|Overall Study||980
2548827|NCT00560066|6245581|P1|COMPLETED|Overall Study||390
2548828|NCT00560066|6245580|P2|STARTED|Overall Study||1002
2548829|NCT00560066|6245581|P1|STARTED|Overall Study||396
2548830|NCT00559988|6245613|P2|NOT COMPLETED|Overall Study||352
2548831|NCT00559988|6245614|P1|NOT COMPLETED|Overall Study||351
2548832|NCT00559988|6245613|P2|COMPLETED|Overall Study||1009
2548833|NCT00559988|6245614|P1|COMPLETED|Overall Study||1006
2548834|NCT00559988|6245613|P2|STARTED|Overall Study||1361
2548835|NCT00559988|6245614|P1|STARTED|Overall Study||1357
2548836|NCT00559962|6245644|P8|NOT COMPLETED|Overall Study||4
2548837|NCT00559962|6245645|P7|NOT COMPLETED|Overall Study||5
2548838|NCT00559962|6245646|P6|NOT COMPLETED|Overall Study||5
2548839|NCT00559962|6245647|P5|NOT COMPLETED|Overall Study||14
2548840|NCT00559962|6245648|P4|NOT COMPLETED|Overall Study||5
2548841|NCT00559962|6245649|P3|NOT COMPLETED|Overall Study||10
2548842|NCT00559962|6245650|P2|NOT COMPLETED|Overall Study||9
2548843|NCT00559962|6245651|P1|NOT COMPLETED|Overall Study||2
2548844|NCT00559962|6245644|P8|COMPLETED|Overall Study||25
2548845|NCT00559962|6245645|P7|COMPLETED|Overall Study||28
2548846|NCT00559962|6245646|P6|COMPLETED|Overall Study||23
2548847|NCT00559962|6245647|P5|COMPLETED|Overall Study||21
2548848|NCT00559962|6245648|P4|COMPLETED|Overall Study||29
2548849|NCT00559962|6245649|P3|COMPLETED|Overall Study||24
2548850|NCT00559962|6245650|P2|COMPLETED|Overall Study||25
2548851|NCT00559962|6245651|P1|COMPLETED|Overall Study||31
2548852|NCT00559962|6245644|P8|STARTED|Overall Study||29
2548853|NCT00559962|6245645|P7|STARTED|Overall Study||33
2548854|NCT00559962|6245646|P6|STARTED|Overall Study||28
2548855|NCT00559962|6245647|P5|STARTED|Overall Study||35
2548856|NCT00559962|6245648|P4|STARTED|Overall Study||34
2548857|NCT00559962|6245649|P3|STARTED|Overall Study||34
2548858|NCT00559962|6245650|P2|STARTED|Overall Study||34
2548859|NCT00559962|6245651|P1|STARTED|Overall Study||33
2548860|NCT00559949|6245671|P1|NOT COMPLETED|Overall Study||7
2548861|NCT00559949|6245671|P1|COMPLETED|Overall Study||32
2548862|NCT00559949|6245671|P1|STARTED|Overall Study||39
2548863|NCT00559936|6245678|P1|NOT COMPLETED|Overall Study||4
2548864|NCT00559936|6245678|P1|COMPLETED|Overall Study||20
2548865|NCT00559936|6245678|P1|STARTED|Overall Study||24
2548866|NCT00559897|6245683|P1|NOT COMPLETED|Overall Study||0
2548867|NCT00559897|6245683|P1|COMPLETED|Overall Study||6
2548868|NCT00559897|6245683|P1|STARTED|Overall Study||6
2548869|NCT00559845|6245687|P1|NOT COMPLETED|Overall Study||7
2548870|NCT00559845|6245687|P1|COMPLETED|Overall Study||49
2548871|NCT00559845|6245687|P1|STARTED|Overall Study||56
2548872|NCT00559754|6245696|P1|NOT COMPLETED|Overall Study||11
2548873|NCT00559754|6245696|P1|COMPLETED|Overall Study||61
2548874|NCT00559754|6245696|P1|STARTED|Overall Study||72
2548875|NCT00559637|6245720|P1|NOT COMPLETED|Overall Study||54
2548876|NCT00559637|6245720|P1|COMPLETED|Overall Study||130
2548877|NCT00559637|6245720|P1|STARTED|Overall Study||184
2548878|NCT00559585|6245733|P2|NOT COMPLETED|Open Label LT Period Main + Sub-Study||0
2548879|NCT00559585|6245734|P1|NOT COMPLETED|Open Label LT Period Main + Sub-Study||428
2548880|NCT00559585|6245733|P2|COMPLETED|Open Label LT Period Main + Sub-Study||0
2548881|NCT00559585|6245734|P1|COMPLETED|Open Label LT Period Main + Sub-Study||945
2548882|NCT00559585|6245733|P2|STARTED|Open Label LT Period Main + Sub-Study|IV administration was discontinued and abatacept was only administered SC during LT Period.|0
2548883|NCT00559585|6245734|P1|STARTED|Open Label LT Period Main + Sub-Study|1373 includes 15 participants from ST Period Sub-Study who rolled over into LT Period (6 SC + 9 IV).|1373
2548884|NCT00559585|6245733|P2|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
2548885|NCT00559585|6245734|P1|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
2548886|NCT00559585|6245733|P2|COMPLETED|Anti-TNF Sub-Study in ST Period||9
2548887|NCT00559585|6245734|P1|COMPLETED|Anti-TNF Sub-Study in ST Period||7
2548888|NCT00559585|6245733|P2|STARTED|Anti-TNF Sub-Study in ST Period|9 completed Sub-Study ST Period and 9 chose to over into the LT Period.|10
2548889|NCT00559585|6245734|P1|STARTED|Anti-TNF Sub-Study in ST Period|7 completed Sub-Study ST period and 6 chose to roll over into LT Period.|8
2548890|NCT00559585|6245733|P2|NOT COMPLETED|Double Blind ST Period Main Study||45
2548891|NCT00559585|6245734|P1|NOT COMPLETED|Double Blind ST Period Main Study||43
2548892|NCT00559585|6245733|P2|COMPLETED|Double Blind ST Period Main Study||676
2548893|NCT00559585|6245734|P1|COMPLETED|Double Blind ST Period Main Study||693
2548894|NCT00559585|6245733|P2|STARTED|Double Blind ST Period Main Study|Randomized and treated|721
2548895|NCT00559585|6245734|P1|STARTED|Double Blind ST Period Main Study|Randomized and treated|736
2548896|NCT00559507|6245794|P1|NOT COMPLETED|Overall Study||3
2548897|NCT00559507|6245794|P1|COMPLETED|Overall Study||9
2548898|NCT00559507|6245794|P1|STARTED|Overall Study||12
2548899|NCT00559468|6245802|P2|NOT COMPLETED|Overall Study||1
2548900|NCT00559468|6245803|P1|NOT COMPLETED|Overall Study||0
2548901|NCT00559468|6245802|P2|COMPLETED|Overall Study||25
2548902|NCT00559468|6245803|P1|COMPLETED|Overall Study||26
2548903|NCT00559468|6245802|P2|Treated|Overall Study||25
2548904|NCT00559468|6245803|P1|Treated|Overall Study||26
2548905|NCT00559468|6245802|P2|STARTED|Overall Study||26
2548906|NCT00559468|6245803|P1|STARTED|Overall Study||26
2548907|NCT00559377|6245813|P1|NOT COMPLETED|Overall Study||9
2548908|NCT00559377|6245813|P1|COMPLETED|Overall Study||7
2548909|NCT00559377|6245813|P1|STARTED|Overall Study||16
2548910|NCT00559364|6245823|P2|NOT COMPLETED|Overall Study||0
2548911|NCT00559364|6245824|P1|NOT COMPLETED|Overall Study||1
2548912|NCT00559364|6245823|P2|COMPLETED|Overall Study||20
2548913|NCT00559364|6245824|P1|COMPLETED|Overall Study||29
2548914|NCT00559364|6245823|P2|STARTED|Overall Study||20
2548915|NCT00559364|6245824|P1|STARTED|Overall Study||30
2548916|NCT00559273|6245836|P2|NOT COMPLETED|Evaluation Period (8 Weeks)||5
2548917|NCT00559273|6245837|P1|NOT COMPLETED|Evaluation Period (8 Weeks)||3
2548918|NCT00559273|6245836|P2|COMPLETED|Evaluation Period (8 Weeks)||137
2548919|NCT00559273|6245837|P1|COMPLETED|Evaluation Period (8 Weeks)||141
2548920|NCT00559273|6245836|P2|STARTED|Evaluation Period (8 Weeks)||142
2548921|NCT00559273|6245837|P1|STARTED|Evaluation Period (8 Weeks)||144
2548922|NCT00559273|6245836|P2|NOT COMPLETED|Correction Period (20 Weeks)||12
2548923|NCT00559273|6245837|P1|NOT COMPLETED|Correction Period (20 Weeks)||9
2548924|NCT00559273|6245836|P2|COMPLETED|Correction Period (20 Weeks)||142
2548925|NCT00559273|6245837|P1|COMPLETED|Correction Period (20 Weeks)||144
2548926|NCT00559273|6245836|P2|Treated|Correction Period (20 Weeks)||154
2548927|NCT00559273|6245837|P1|Treated|Correction Period (20 Weeks)||151
2548928|NCT00559273|6245836|P2|STARTED|Correction Period (20 Weeks)||154
2548929|NCT00559273|6245837|P1|STARTED|Correction Period (20 Weeks)||153
2548930|NCT00559104|6245859|P2|NOT COMPLETED|Overall Study||0
2548931|NCT00559104|6245860|P1|NOT COMPLETED|Overall Study||9
2548932|NCT00559104|6245859|P2|COMPLETED|Overall Study||5
2548933|NCT00559104|6245860|P1|COMPLETED|Overall Study|Progression was the reason for off-treatment for 9 of 9 patients who went off of treatment.|46
2548934|NCT00559104|6245859|P2|STARTED|Overall Study||5
2548935|NCT00559104|6245860|P1|STARTED|Overall Study||55
2548936|NCT00559013|6245870|P1|NOT COMPLETED|Overall Study||0
2548937|NCT00559013|6245870|P1|COMPLETED|Overall Study||38
2548938|NCT00559013|6245870|P1|STARTED|Overall Study||38
2548939|NCT00558896|6245881|P7|NOT COMPLETED|Overall Study||24
2548940|NCT00558896|6245882|P6|NOT COMPLETED|Overall Study||52
2548941|NCT00558896|6245883|P5|NOT COMPLETED|Overall Study||23
2548942|NCT00558896|6245884|P4|NOT COMPLETED|Overall Study||12
2548943|NCT00558896|6245885|P3|NOT COMPLETED|Overall Study||5
2548944|NCT00558896|6245886|P2|NOT COMPLETED|Overall Study||7
2548945|NCT00558896|6245887|P1|NOT COMPLETED|Overall Study||21
2548946|NCT00558896|6245881|P7|COMPLETED|Overall Study||9
2548947|NCT00558896|6245882|P6|COMPLETED|Overall Study||68
2548948|NCT00558896|6245883|P5|COMPLETED|Overall Study||37
2548949|NCT00558896|6245884|P4|COMPLETED|Overall Study||23
2548950|NCT00558896|6245885|P3|COMPLETED|Overall Study||30
2548951|NCT00558896|6245886|P2|COMPLETED|Overall Study||27
2548952|NCT00558896|6245887|P1|COMPLETED|Overall Study||39
2548953|NCT00558896|6245881|P7|STARTED|Overall Study||33
2548954|NCT00558896|6245882|P6|STARTED|Overall Study||120
2548955|NCT00558896|6245883|P5|STARTED|Overall Study||60
2548956|NCT00558896|6245884|P4|STARTED|Overall Study||35
2548957|NCT00558896|6245885|P3|STARTED|Overall Study||35
2548958|NCT00558896|6245886|P2|STARTED|Overall Study||34
2548959|NCT00558896|6245887|P1|STARTED|Overall Study||60
2548960|NCT00558870|6245919|P2|NOT COMPLETED|Overall Study||0
2548961|NCT00558870|6245920|P1|NOT COMPLETED|Overall Study||0
2548962|NCT00558870|6245919|P2|COMPLETED|Overall Study||2
2548963|NCT00558870|6245920|P1|COMPLETED|Overall Study||2
2548964|NCT00558870|6245919|P2|STARTED|Overall Study||2
2548965|NCT00558870|6245920|P1|STARTED|Overall Study||2
2548966|NCT00558844|6245933|P5|NOT COMPLETED|Overall Study||1
2548967|NCT00558844|6245934|P4|NOT COMPLETED|Overall Study||0
2548968|NCT00558844|6245935|P3|NOT COMPLETED|Overall Study||1
2548969|NCT00558844|6245936|P2|NOT COMPLETED|Overall Study||0
2548970|NCT00558844|6245937|P1|NOT COMPLETED|Overall Study||3
2548971|NCT00558844|6245933|P5|COMPLETED|Overall Study||6
2548972|NCT00558844|6245934|P4|COMPLETED|Overall Study||5
2548973|NCT00558844|6245935|P3|COMPLETED|Overall Study||6
2548974|NCT00558844|6245936|P2|COMPLETED|Overall Study||7
2548975|NCT00558844|6245937|P1|COMPLETED|Overall Study||12
2548976|NCT00558844|6245933|P5|STARTED|Overall Study||7
2548977|NCT00558844|6245934|P4|STARTED|Overall Study||5
2548978|NCT00558844|6245935|P3|STARTED|Overall Study||7
2548979|NCT00558844|6245936|P2|STARTED|Overall Study||7
2548980|NCT00558844|6245937|P1|STARTED|Overall Study||15
2548981|NCT00558831|6245989|P1|NOT COMPLETED|Overall Study||1
2548982|NCT00558831|6245989|P1|COMPLETED|Overall Study||10
2548983|NCT00558831|6245989|P1|STARTED|Overall Study||11
2548984|NCT00558792|6245998|P3|NOT COMPLETED|Overall Study||0
2548985|NCT00558792|6245999|P2|NOT COMPLETED|Overall Study||0
2548986|NCT00558792|6246000|P1|NOT COMPLETED|Overall Study||0
2548987|NCT00558792|6245998|P3|COMPLETED|Overall Study||60
2548988|NCT00558792|6245999|P2|COMPLETED|Overall Study||63
2548989|NCT00558792|6246000|P1|COMPLETED|Overall Study||68
2548990|NCT00558792|6245998|P3|STARTED|Overall Study||60
2548991|NCT00558792|6245999|P2|STARTED|Overall Study||63
2548992|NCT00558792|6246000|P1|STARTED|Overall Study||68
2548993|NCT00558753|6246046|P2|NOT COMPLETED|Overall Study||7
2548994|NCT00558753|6246047|P1|NOT COMPLETED|Overall Study||5
2548995|NCT00558753|6246046|P2|COMPLETED|Overall Study||113
2548996|NCT00558753|6246047|P1|COMPLETED|Overall Study||115
2548997|NCT00558753|6246046|P2|STARTED|Overall Study||120
2548998|NCT00558753|6246047|P1|STARTED|Overall Study||120
2548999|NCT00558701|6246059|P2|NOT COMPLETED|Overall Study||4
2549000|NCT00558701|6246060|P1|NOT COMPLETED|Overall Study||1
2549001|NCT00558701|6246059|P2|COMPLETED|Overall Study||11
2549002|NCT00558701|6246060|P1|COMPLETED|Overall Study||14
2549003|NCT00558701|6246059|P2|STARTED|Overall Study||15
2549004|NCT00558701|6246060|P1|STARTED|Overall Study||15
2549005|NCT00558636|6246068|P2|NOT COMPLETED|Follow-up||7
2549006|NCT00558636|6246069|P1|NOT COMPLETED|Follow-up||12
2549007|NCT00558636|6246068|P2|COMPLETED|Follow-up|Study was prematurely terminated|0
2549008|NCT00558636|6246069|P1|COMPLETED|Follow-up|Study was prematurely terminated|0
2549009|NCT00558636|6246068|P2|STARTED|Follow-up|7 subjects entered Follow-up phase before they completed the treatment phase|7
2549010|NCT00558636|6246069|P1|STARTED|Follow-up|12 subjects entered Follow-up phase before they completed the treatment phase|12
2549011|NCT00558636|6246068|P2|NOT COMPLETED|Treatment||44
2549012|NCT00558636|6246069|P1|NOT COMPLETED|Treatment||47
2549013|NCT00558636|6246068|P2|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
2549014|NCT00558636|6246069|P1|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
2549015|NCT00558636|6246068|P2|Start of Maintenance Monotherapy|Treatment|Placebo taken as the single agent in the Maintenance Phase|2
2549016|NCT00558636|6246069|P1|Start of Maintenance Monotherapy|Treatment|Sorafenib taken as the single agent in the Maintenance Phase|2
2549017|NCT00558636|6246068|P2|STARTED|Treatment||44
2549018|NCT00558636|6246069|P1|STARTED|Treatment|up to 6 cycles of combination therapy|47
2549019|NCT00558571|6246091|P4|NOT COMPLETED|Overall Study||0
2549020|NCT00558571|6246092|P3|NOT COMPLETED|Overall Study||0
2549021|NCT00558571|6246093|P2|NOT COMPLETED|Overall Study||0
2549022|NCT00558571|6246094|P1|NOT COMPLETED|Overall Study||0
2549023|NCT00558571|6246091|P4|COMPLETED|Overall Study||30
2549024|NCT00558571|6246092|P3|COMPLETED|Overall Study||16
2549025|NCT00558571|6246093|P2|COMPLETED|Overall Study||16
2549026|NCT00558571|6246094|P1|COMPLETED|Overall Study||16
2549027|NCT00558571|6246091|P4|STARTED|Overall Study||30
2549028|NCT00558571|6246092|P3|STARTED|Overall Study||16
2549029|NCT00558571|6246093|P2|STARTED|Overall Study||16
2549030|NCT00558571|6246094|P1|STARTED|Overall Study||16
2549031|NCT00558558|6246169|P1|NOT COMPLETED|Overall Study||6
2549032|NCT00558558|6246169|P1|COMPLETED|Overall Study||0
2549033|NCT00558558|6246169|P1|STARTED|Overall Study||6
2549034|NCT00558519|6246173|P1|NOT COMPLETED|Overall Study||23
2549035|NCT00558519|6246173|P1|COMPLETED|Overall Study||295
2549036|NCT00558519|6246173|P1|STARTED|Overall Study||318
2549037|NCT00558467|6246183|P2|NOT COMPLETED|Overall Study||4
2549038|NCT00558467|6246184|P1|NOT COMPLETED|Overall Study||1
2549039|NCT00558467|6246183|P2|COMPLETED|Overall Study||39
2549040|NCT00558467|6246184|P1|COMPLETED|Overall Study||19
2549041|NCT00558467|6246183|P2|STARTED|Overall Study||43
2549042|NCT00558467|6246184|P1|STARTED|Overall Study||20
2549043|NCT00558428|6246244|P4|NOT COMPLETED|Overall Study||11
2549044|NCT00558428|6246245|P3|NOT COMPLETED|Overall Study||4
2549045|NCT00558428|6246246|P2|NOT COMPLETED|Overall Study||24
2549046|NCT00558428|6246247|P1|NOT COMPLETED|Overall Study||12
2549047|NCT00558428|6246244|P4|COMPLETED|Overall Study||266
2549048|NCT00558428|6246245|P3|COMPLETED|Overall Study||273
2549049|NCT00558428|6246246|P2|COMPLETED|Overall Study||252
2549050|NCT00558428|6246247|P1|COMPLETED|Overall Study||255
2549051|NCT00558428|6246244|P4|STARTED|Overall Study||277
2549052|NCT00558428|6246245|P3|STARTED|Overall Study||277
2549053|NCT00558428|6246246|P2|STARTED|Overall Study||276
2549054|NCT00558428|6246247|P1|STARTED|Overall Study||267
2549055|NCT00558363|6246287|P2|NOT COMPLETED|Overall Study||36
2549056|NCT00558363|6246288|P1|NOT COMPLETED|Overall Study||71
2549057|NCT00558363|6246287|P2|COMPLETED|Overall Study||111
2549058|NCT00558363|6246288|P1|COMPLETED|Overall Study||76
2549059|NCT00558363|6246287|P2|STARTED|Overall Study||147
2549060|NCT00558363|6246288|P1|STARTED|Overall Study||147
2549061|NCT00558285|6246343|P5|NOT COMPLETED|Overall Study||4
2549062|NCT00558285|6246344|P4|NOT COMPLETED|Overall Study||4
2549063|NCT00558285|6246345|P3|NOT COMPLETED|Overall Study||5
2549064|NCT00558285|6246346|P2|NOT COMPLETED|Overall Study||3
2549065|NCT00558285|6246347|P1|NOT COMPLETED|Overall Study||6
2549066|NCT00558285|6246343|P5|COMPLETED|Overall Study||49
2549067|NCT00558285|6246344|P4|COMPLETED|Overall Study||48
2549068|NCT00558285|6246345|P3|COMPLETED|Overall Study||46
2549069|NCT00558285|6246346|P2|COMPLETED|Overall Study||48
2549070|NCT00558285|6246347|P1|COMPLETED|Overall Study||44
2549071|NCT00558285|6246343|P5|Safety: Received Study Drug|Overall Study||53
2549072|NCT00558285|6246344|P4|Safety: Received Study Drug|Overall Study||51
2549073|NCT00558285|6246345|P3|Safety: Received Study Drug|Overall Study||51
2549074|NCT00558285|6246346|P2|Safety: Received Study Drug|Overall Study||51
2549075|NCT00558285|6246347|P1|Safety: Received Study Drug|Overall Study||49
2549076|NCT00558285|6246343|P5|STARTED|Overall Study||53
2549077|NCT00558285|6246344|P4|STARTED|Overall Study||52
2549078|NCT00558285|6246345|P3|STARTED|Overall Study||51
2549079|NCT00558285|6246346|P2|STARTED|Overall Study||51
2549080|NCT00558285|6246347|P1|STARTED|Overall Study||50
2549081|NCT00558272|6246391|P2|NOT COMPLETED|Overall Study||2
2549082|NCT00558272|6246392|P1|NOT COMPLETED|Overall Study||13
2549083|NCT00558272|6246391|P2|COMPLETED|Overall Study|4-week treatment period|68
2549084|NCT00558272|6246392|P1|COMPLETED|Overall Study|4-week treatment period|56
2549085|NCT00558272|6246391|P2|30 Days Follow-up|Overall Study|30 days after last dose|67
2549086|NCT00558272|6246392|P1|30 Days Follow-up|Overall Study|30 days after last dose|41
2549087|NCT00558272|6246391|P2|STARTED|Overall Study|Randomised|70
2549088|NCT00558272|6246392|P1|STARTED|Overall Study|Randomised|69
2549089|NCT00558259|6246432|P2|NOT COMPLETED|Overall Study||99
2549090|NCT00558259|6246433|P1|NOT COMPLETED|Overall Study||71
2549091|NCT00558259|6246432|P2|COMPLETED|Overall Study|Completed treatment.|563
2549092|NCT00558259|6246433|P1|COMPLETED|Overall Study|Completed treatment.|610
2549093|NCT00558259|6246432|P2|STARTED|Overall Study|Number who started treatment. There were 6 patients randomised to placebo and not treated.|662
2549094|NCT00558259|6246433|P1|STARTED|Overall Study|Number who started treatment. There were 4 patients randomised to Dabigatran and not treated.|681
2549095|NCT00558246|6246453|P1|NOT COMPLETED|Overall Study||0
2549096|NCT00558246|6246453|P1|COMPLETED|Overall Study||79
2549097|NCT00558246|6246453|P1|STARTED|Overall Study||79
2549098|NCT00558103|6246473|P6|NOT COMPLETED|Monotherapy Extension Phase||9
2549099|NCT00558103|6246474|P5|NOT COMPLETED|Monotherapy Extension Phase||0
2549100|NCT00558103|6246475|P4|NOT COMPLETED|Monotherapy Extension Phase||0
2549101|NCT00558103|6246476|P3|NOT COMPLETED|Monotherapy Extension Phase||0
2549102|NCT00558103|6246477|P2|NOT COMPLETED|Monotherapy Extension Phase||0
2549103|NCT00558103|6246478|P1|NOT COMPLETED|Monotherapy Extension Phase||0
2549104|NCT00558103|6246473|P6|COMPLETED|Monotherapy Extension Phase||0
2549105|NCT00558103|6246474|P5|COMPLETED|Monotherapy Extension Phase||0
2549106|NCT00558103|6246475|P4|COMPLETED|Monotherapy Extension Phase||0
2549107|NCT00558103|6246476|P3|COMPLETED|Monotherapy Extension Phase||0
2549108|NCT00558103|6246477|P2|COMPLETED|Monotherapy Extension Phase||0
2549109|NCT00558103|6246478|P1|COMPLETED|Monotherapy Extension Phase||0
2549110|NCT00558103|6246473|P6|STARTED|Monotherapy Extension Phase|9/11 participants completing pazopanib monotherapy elected to receive lapatinib monotherapy.|9
2549111|NCT00558103|6246474|P5|STARTED|Monotherapy Extension Phase||0
2549112|NCT00558103|6246475|P4|STARTED|Monotherapy Extension Phase||0
2549113|NCT00558103|6246476|P3|STARTED|Monotherapy Extension Phase||0
2549114|NCT00558103|6246477|P2|STARTED|Monotherapy Extension Phase||0
2549115|NCT00558103|6246478|P1|STARTED|Monotherapy Extension Phase||0
2549116|NCT00558103|6246473|P6|NOT COMPLETED|Randomized Treatment Phase||0
2549117|NCT00558103|6246474|P5|NOT COMPLETED|Randomized Treatment Phase||5
2549118|NCT00558103|6246475|P4|NOT COMPLETED|Randomized Treatment Phase||2
2549119|NCT00558103|6246476|P3|NOT COMPLETED|Randomized Treatment Phase||3
2549120|NCT00558103|6246477|P2|NOT COMPLETED|Randomized Treatment Phase||4
2549121|NCT00558103|6246478|P1|NOT COMPLETED|Randomized Treatment Phase||5
2549122|NCT00558103|6246473|P6|COMPLETED|Randomized Treatment Phase||0
2549123|NCT00558103|6246474|P5|COMPLETED|Randomized Treatment Phase||33
2549124|NCT00558103|6246475|P4|COMPLETED|Randomized Treatment Phase||11
2549125|NCT00558103|6246476|P3|COMPLETED|Randomized Treatment Phase||33
2549126|NCT00558103|6246477|P2|COMPLETED|Randomized Treatment Phase||34
2549127|NCT00558103|6246478|P1|COMPLETED|Randomized Treatment Phase||33
2549128|NCT00558103|6246473|P6|STARTED|Randomized Treatment Phase||0
2549129|NCT00558103|6246474|P5|STARTED|Randomized Treatment Phase||38
2549130|NCT00558103|6246475|P4|STARTED|Randomized Treatment Phase||13
2549131|NCT00558103|6246476|P3|STARTED|Randomized Treatment Phase||36
2549132|NCT00558103|6246477|P2|STARTED|Randomized Treatment Phase||38
2549133|NCT00558103|6246478|P1|STARTED|Randomized Treatment Phase||38
2549134|NCT00558064|6246508|P2|NOT COMPLETED|Overall Study||5
2549135|NCT00558064|6246509|P1|NOT COMPLETED|Overall Study||5
2549136|NCT00558064|6246508|P2|COMPLETED|Overall Study||257
2549137|NCT00558064|6246509|P1|COMPLETED|Overall Study||264
2549138|NCT00558064|6246508|P2|STARTED|Overall Study||262
2549139|NCT00558064|6246509|P1|STARTED|Overall Study||269
2549140|NCT00558025|6246531|P2|NOT COMPLETED|Overall Study||3
2549141|NCT00558025|6246532|P1|NOT COMPLETED|Overall Study||4
2549142|NCT00558025|6246531|P2|COMPLETED|Overall Study||49
2549143|NCT00558025|6246532|P1|COMPLETED|Overall Study||100
2549144|NCT00558025|6246531|P2|STARTED|Overall Study||52
2549145|NCT00558025|6246532|P1|STARTED|Overall Study||104
2549146|NCT00558012|6246556|P2|NOT COMPLETED|Overall Study||18
2549147|NCT00558012|6246557|P1|NOT COMPLETED|Overall Study||25
2549148|NCT00558012|6246556|P2|COMPLETED|Overall Study||74
2549149|NCT00558012|6246557|P1|COMPLETED|Overall Study||64
2549150|NCT00558012|6246556|P2|STARTED|Overall Study||92
2549151|NCT00558012|6246557|P1|STARTED|Overall Study||89
2549152|NCT00557947|6246563|P1|NOT COMPLETED|Overall Study||0
2549153|NCT00557947|6246563|P1|COMPLETED|Overall Study||83
2549154|NCT00557947|6246563|P1|STARTED|Overall Study||83
2549155|NCT00557856|6246579|P9|NOT COMPLETED|Part 2: Exploratory Phase||24
2549156|NCT00557856|6246580|P8|NOT COMPLETED|Part 2: Exploratory Phase||0
2549157|NCT00557856|6246581|P7|NOT COMPLETED|Part 2: Exploratory Phase||0
2549158|NCT00557856|6246582|P6|NOT COMPLETED|Part 2: Exploratory Phase||0
2549159|NCT00557856|6246583|P5|NOT COMPLETED|Part 2: Exploratory Phase||0
2549160|NCT00557856|6246584|P4|NOT COMPLETED|Part 2: Exploratory Phase||0
2549161|NCT00557856|6246585|P3|NOT COMPLETED|Part 2: Exploratory Phase||0
2549162|NCT00557856|6246586|P2|NOT COMPLETED|Part 2: Exploratory Phase||0
2549163|NCT00557856|6246587|P1|NOT COMPLETED|Part 2: Exploratory Phase||0
2549164|NCT00557856|6246579|P9|COMPLETED|Part 2: Exploratory Phase||0
2549165|NCT00557856|6246580|P8|COMPLETED|Part 2: Exploratory Phase||0
2549166|NCT00557856|6246581|P7|COMPLETED|Part 2: Exploratory Phase||0
2549167|NCT00557856|6246582|P6|COMPLETED|Part 2: Exploratory Phase||0
2549168|NCT00557856|6246583|P5|COMPLETED|Part 2: Exploratory Phase||0
2549169|NCT00557856|6246584|P4|COMPLETED|Part 2: Exploratory Phase||0
2549170|NCT00557856|6246585|P3|COMPLETED|Part 2: Exploratory Phase||0
2549171|NCT00557856|6246586|P2|COMPLETED|Part 2: Exploratory Phase||0
2549172|NCT00557856|6246587|P1|COMPLETED|Part 2: Exploratory Phase||0
2549173|NCT00557856|6246579|P9|STARTED|Part 2: Exploratory Phase||24
2549174|NCT00557856|6246580|P8|STARTED|Part 2: Exploratory Phase||0
2549175|NCT00557856|6246581|P7|STARTED|Part 2: Exploratory Phase||0
2549176|NCT00557856|6246582|P6|STARTED|Part 2: Exploratory Phase||0
2549177|NCT00557856|6246583|P5|STARTED|Part 2: Exploratory Phase||0
2549178|NCT00557856|6246584|P4|STARTED|Part 2: Exploratory Phase||0
2549179|NCT00557856|6246585|P3|STARTED|Part 2: Exploratory Phase||0
2549180|NCT00557856|6246586|P2|STARTED|Part 2: Exploratory Phase||0
2549181|NCT00557856|6246587|P1|STARTED|Part 2: Exploratory Phase||0
2549182|NCT00557856|6246579|P9|NOT COMPLETED|Part 1: Dose Escalation Phase||0
2549183|NCT00557856|6246580|P8|NOT COMPLETED|Part 1: Dose Escalation Phase||6
2549184|NCT00557856|6246581|P7|NOT COMPLETED|Part 1: Dose Escalation Phase||7
2549185|NCT00557856|6246582|P6|NOT COMPLETED|Part 1: Dose Escalation Phase||8
2549186|NCT00557856|6246583|P5|NOT COMPLETED|Part 1: Dose Escalation Phase||4
2549187|NCT00557856|6246584|P4|NOT COMPLETED|Part 1: Dose Escalation Phase||3
2549188|NCT00557856|6246585|P3|NOT COMPLETED|Part 1: Dose Escalation Phase||6
2549189|NCT00557856|6246586|P2|NOT COMPLETED|Part 1: Dose Escalation Phase||5
2549190|NCT00557856|6246587|P1|NOT COMPLETED|Part 1: Dose Escalation Phase||7
2549191|NCT00557856|6246579|P9|COMPLETED|Part 1: Dose Escalation Phase||0
2549192|NCT00557856|6246580|P8|COMPLETED|Part 1: Dose Escalation Phase||0
2549193|NCT00557856|6246581|P7|COMPLETED|Part 1: Dose Escalation Phase||0
2549194|NCT00557856|6246582|P6|COMPLETED|Part 1: Dose Escalation Phase||0
2549195|NCT00557856|6246583|P5|COMPLETED|Part 1: Dose Escalation Phase||0
2549196|NCT00557856|6246584|P4|COMPLETED|Part 1: Dose Escalation Phase||0
2549197|NCT00557856|6246585|P3|COMPLETED|Part 1: Dose Escalation Phase||0
2549198|NCT00557856|6246586|P2|COMPLETED|Part 1: Dose Escalation Phase||0
2549199|NCT00557856|6246587|P1|COMPLETED|Part 1: Dose Escalation Phase||0
2549200|NCT00557856|6246579|P9|Treated|Part 1: Dose Escalation Phase||0
2549201|NCT00557856|6246580|P8|Treated|Part 1: Dose Escalation Phase||6
2549202|NCT00557856|6246581|P7|Treated|Part 1: Dose Escalation Phase||7
2549203|NCT00557856|6246582|P6|Treated|Part 1: Dose Escalation Phase||8
2549204|NCT00557856|6246583|P5|Treated|Part 1: Dose Escalation Phase||4
2549205|NCT00557856|6246584|P4|Treated|Part 1: Dose Escalation Phase||3
2549206|NCT00557856|6246585|P3|Treated|Part 1: Dose Escalation Phase||6
2549207|NCT00557856|6246586|P2|Treated|Part 1: Dose Escalation Phase||5
2549208|NCT00557856|6246587|P1|Treated|Part 1: Dose Escalation Phase||5
2549209|NCT00557856|6246579|P9|STARTED|Part 1: Dose Escalation Phase||0
2549210|NCT00557856|6246580|P8|STARTED|Part 1: Dose Escalation Phase||6
2549211|NCT00557856|6246581|P7|STARTED|Part 1: Dose Escalation Phase||7
2549212|NCT00557856|6246582|P6|STARTED|Part 1: Dose Escalation Phase||8
2549213|NCT00557856|6246583|P5|STARTED|Part 1: Dose Escalation Phase||4
2549214|NCT00557856|6246584|P4|STARTED|Part 1: Dose Escalation Phase||3
2549215|NCT00557856|6246585|P3|STARTED|Part 1: Dose Escalation Phase||6
2549216|NCT00557856|6246586|P2|STARTED|Part 1: Dose Escalation Phase||5
2549217|NCT00557856|6246587|P1|STARTED|Part 1: Dose Escalation Phase||7
2549218|NCT00557830|6246786|P3|NOT COMPLETED|Treatment Phase||0
2549219|NCT00557830|6246787|P2|NOT COMPLETED|Treatment Phase||0
2549220|NCT00557830|6246788|P1|NOT COMPLETED|Treatment Phase||0
2549221|NCT00557830|6246786|P3|COMPLETED|Treatment Phase||2
2549222|NCT00557830|6246787|P2|COMPLETED|Treatment Phase||4
2549223|NCT00557830|6246788|P1|COMPLETED|Treatment Phase||0
2549224|NCT00557830|6246786|P3|STARTED|Treatment Phase||2
2549225|NCT00557830|6246787|P2|STARTED|Treatment Phase||4
2549226|NCT00557830|6246788|P1|STARTED|Treatment Phase||0
2549227|NCT00557830|6246786|P3|NOT COMPLETED|Screening Treatment Phase||0
2549228|NCT00557830|6246787|P2|NOT COMPLETED|Screening Treatment Phase||0
2549229|NCT00557830|6246788|P1|NOT COMPLETED|Screening Treatment Phase||6
2549230|NCT00557830|6246786|P3|COMPLETED|Screening Treatment Phase||0
2549231|NCT00557830|6246787|P2|COMPLETED|Screening Treatment Phase||0
2549232|NCT00557830|6246788|P1|COMPLETED|Screening Treatment Phase||6
2549233|NCT00557830|6246786|P3|STARTED|Screening Treatment Phase||0
2549234|NCT00557830|6246787|P2|STARTED|Screening Treatment Phase||0
2549235|NCT00557830|6246788|P1|STARTED|Screening Treatment Phase||12
2549236|NCT00557622|6246810|P2|NOT COMPLETED|12-Week Treatment Phase||1
2549237|NCT00557622|6246811|P1|NOT COMPLETED|12-Week Treatment Phase||0
2549238|NCT00557622|6246810|P2|COMPLETED|12-Week Treatment Phase||1
2549239|NCT00557622|6246811|P1|COMPLETED|12-Week Treatment Phase||1
2549240|NCT00557622|6246810|P2|STARTED|12-Week Treatment Phase||2
2549241|NCT00557622|6246811|P1|STARTED|12-Week Treatment Phase||1
2549242|NCT00557622|6246810|P2|NOT COMPLETED|4-Week Run-in Phase||0
2549243|NCT00557622|6246811|P1|NOT COMPLETED|4-Week Run-in Phase||2
2549244|NCT00557622|6246810|P2|COMPLETED|4-Week Run-in Phase||0
2549245|NCT00557622|6246811|P1|COMPLETED|4-Week Run-in Phase||3
2549246|NCT00557622|6246810|P2|STARTED|4-Week Run-in Phase||0
2549247|NCT00557622|6246811|P1|STARTED|4-Week Run-in Phase||5
2549248|NCT00557505|6246840|P9|NOT COMPLETED|Overall Study||17
2549249|NCT00557505|6246841|P8|NOT COMPLETED|Overall Study||5
2549250|NCT00557505|6246842|P7|NOT COMPLETED|Overall Study||3
2549251|NCT00557505|6246843|P6|NOT COMPLETED|Overall Study||3
2549252|NCT00557505|6246844|P5|NOT COMPLETED|Overall Study||2
2549253|NCT00557505|6246845|P4|NOT COMPLETED|Overall Study||3
2549254|NCT00557505|6246846|P3|NOT COMPLETED|Overall Study||4
2549255|NCT00557505|6246847|P2|NOT COMPLETED|Overall Study||3
2549256|NCT00557505|6246848|P1|NOT COMPLETED|Overall Study||3
2549257|NCT00557505|6246840|P9|COMPLETED|Overall Study||0
2549258|NCT00557505|6246841|P8|COMPLETED|Overall Study||0
2549259|NCT00557505|6246842|P7|COMPLETED|Overall Study||0
2549260|NCT00557505|6246843|P6|COMPLETED|Overall Study||0
2549261|NCT00557505|6246844|P5|COMPLETED|Overall Study||0
2549262|NCT00557505|6246845|P4|COMPLETED|Overall Study||0
2549263|NCT00557505|6246846|P3|COMPLETED|Overall Study||0
2549264|NCT00557505|6246847|P2|COMPLETED|Overall Study||0
2549265|NCT00557505|6246848|P1|COMPLETED|Overall Study||0
2549266|NCT00557505|6246840|P9|STARTED|Overall Study||17
2549267|NCT00557505|6246841|P8|STARTED|Overall Study||5
2549268|NCT00557505|6246842|P7|STARTED|Overall Study||3
2549269|NCT00557505|6246843|P6|STARTED|Overall Study||3
2549270|NCT00557505|6246844|P5|STARTED|Overall Study||2
2549271|NCT00557505|6246845|P4|STARTED|Overall Study||3
2549272|NCT00557505|6246846|P3|STARTED|Overall Study||4
2549273|NCT00557505|6246847|P2|STARTED|Overall Study||3
2549274|NCT00557505|6246848|P1|STARTED|Overall Study||3
2549275|NCT00557492|6247012|P1|NOT COMPLETED|Overall Study||1
2549276|NCT00557492|6247012|P1|COMPLETED|Overall Study|Evaluable for outcomes|58
2549277|NCT00557492|6247012|P1|STARTED|Overall Study||59
2549278|NCT00557466|6247030|P6|NOT COMPLETED|Overall Study||6
2549279|NCT00557466|6247031|P5|NOT COMPLETED|Overall Study||3
2549280|NCT00557466|6247032|P4|NOT COMPLETED|Overall Study||4
2549281|NCT00557466|6247033|P3|NOT COMPLETED|Overall Study||6
2549282|NCT00557466|6247034|P2|NOT COMPLETED|Overall Study||5
2549283|NCT00557466|6247035|P1|NOT COMPLETED|Overall Study||4
2549284|NCT00557466|6247030|P6|COMPLETED|Overall Study||85
2549285|NCT00557466|6247031|P5|COMPLETED|Overall Study||87
2549286|NCT00557466|6247032|P4|COMPLETED|Overall Study||92
2549287|NCT00557466|6247033|P3|COMPLETED|Overall Study||95
2549288|NCT00557466|6247034|P2|COMPLETED|Overall Study||87
2549289|NCT00557466|6247035|P1|COMPLETED|Overall Study||94
2549290|NCT00557466|6247030|P6|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|89
2549291|NCT00557466|6247031|P5|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|87
2549292|NCT00557466|6247032|P4|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|93
2549293|NCT00557466|6247033|P3|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
2549294|NCT00557466|6247034|P2|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|91
2549295|NCT00557466|6247035|P1|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
2549296|NCT00557466|6247030|P6|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|91
2549297|NCT00557466|6247031|P5|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|90
2549298|NCT00557466|6247032|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|96
2549299|NCT00557466|6247033|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|101
2549300|NCT00557466|6247034|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|92
2549301|NCT00557466|6247035|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|98
2549302|NCT00557466|6247030|P6|STARTED|Overall Study||91
2549303|NCT00557466|6247031|P5|STARTED|Overall Study||90
2549304|NCT00557466|6247032|P4|STARTED|Overall Study||96
2549305|NCT00557466|6247033|P3|STARTED|Overall Study||101
2549306|NCT00557466|6247034|P2|STARTED|Overall Study||92
2549307|NCT00557466|6247035|P1|STARTED|Overall Study||98
2549308|NCT00557440|6247088|P3|NOT COMPLETED|Treatment Period 3||0
2549309|NCT00557440|6247089|P2|NOT COMPLETED|Treatment Period 3||0
2549310|NCT00557440|6247090|P1|NOT COMPLETED|Treatment Period 3||0
2549311|NCT00557440|6247088|P3|COMPLETED|Treatment Period 3||12
2549312|NCT00557440|6247089|P2|COMPLETED|Treatment Period 3||12
2549313|NCT00557440|6247090|P1|COMPLETED|Treatment Period 3||12
2549314|NCT00557440|6247088|P3|STARTED|Treatment Period 3||12
2549315|NCT00557440|6247089|P2|STARTED|Treatment Period 3||12
2549316|NCT00557440|6247090|P1|STARTED|Treatment Period 3||12
2549317|NCT00557440|6247088|P3|NOT COMPLETED|Treatment Period 2||0
2549318|NCT00557440|6247089|P2|NOT COMPLETED|Treatment Period 2||0
2549319|NCT00557440|6247090|P1|NOT COMPLETED|Treatment Period 2||0
2549320|NCT00557440|6247088|P3|COMPLETED|Treatment Period 2||12
2549321|NCT00557440|6247089|P2|COMPLETED|Treatment Period 2||12
2549322|NCT00557440|6247090|P1|COMPLETED|Treatment Period 2||12
2549323|NCT00557440|6247088|P3|STARTED|Treatment Period 2||12
2549324|NCT00557440|6247089|P2|STARTED|Treatment Period 2||12
2549325|NCT00557440|6247090|P1|STARTED|Treatment Period 2||12
2549326|NCT00557440|6247088|P3|NOT COMPLETED|Treatment Period 1||1
2549327|NCT00557440|6247089|P2|NOT COMPLETED|Treatment Period 1||0
2549328|NCT00557440|6247090|P1|NOT COMPLETED|Treatment Period 1||0
2549329|NCT00557440|6247088|P3|COMPLETED|Treatment Period 1||12
2549330|NCT00557440|6247089|P2|COMPLETED|Treatment Period 1||12
2549331|NCT00557440|6247090|P1|COMPLETED|Treatment Period 1||12
2549332|NCT00557440|6247088|P3|STARTED|Treatment Period 1||13
2549333|NCT00557440|6247089|P2|STARTED|Treatment Period 1||12
2549334|NCT00557440|6247090|P1|STARTED|Treatment Period 1||12
2549335|NCT00557362|6247114|P4|NOT COMPLETED|Overall Study||3
2549336|NCT00557362|6247115|P3|NOT COMPLETED|Overall Study||4
2549337|NCT00557362|6247116|P2|NOT COMPLETED|Overall Study||2
2549338|NCT00557362|6247117|P1|NOT COMPLETED|Overall Study||2
2549339|NCT00557362|6247114|P4|COMPLETED|Overall Study||27
2549340|NCT00557362|6247115|P3|COMPLETED|Overall Study||26
2549341|NCT00557362|6247116|P2|COMPLETED|Overall Study||28
2549342|NCT00557362|6247117|P1|COMPLETED|Overall Study||28
2549343|NCT00557362|6247114|P4|STARTED|Overall Study||30
2549344|NCT00557362|6247115|P3|STARTED|Overall Study||30
2549345|NCT00557362|6247116|P2|STARTED|Overall Study||30
2549346|NCT00557362|6247117|P1|STARTED|Overall Study||30
2549347|NCT00557349|6247135|P2|NOT COMPLETED|Overall Study||5
2549348|NCT00557349|6247136|P1|NOT COMPLETED|Overall Study||5
2549349|NCT00557349|6247135|P2|COMPLETED|Overall Study||13
2549350|NCT00557349|6247136|P1|COMPLETED|Overall Study||17
2549351|NCT00557349|6247135|P2|STARTED|Overall Study||18
2549352|NCT00557349|6247136|P1|STARTED|Overall Study|omeprazole/bicarb|22
2549353|NCT00557323|6247144|P1|NOT COMPLETED|Overall Study||7
2549354|NCT00557323|6247144|P1|COMPLETED|Overall Study||27
2549355|NCT00557323|6247144|P1|STARTED|Overall Study||34
2549356|NCT00557310|6247149|P1|NOT COMPLETED|Extension Phase (18 - 24 Months)||5
2549357|NCT00557310|6247149|P1|COMPLETED|Extension Phase (18 - 24 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|25
2549358|NCT00557310|6247149|P1|STARTED|Extension Phase (18 - 24 Months)||30
2549359|NCT00557310|6247149|P1|NOT COMPLETED|Main Study (0 - 18 Months)||5
2549360|NCT00557310|6247149|P1|COMPLETED|Main Study (0 - 18 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|30
2549361|NCT00557310|6247149|P1|STARTED|Main Study (0 - 18 Months)||35
2549362|NCT00557284|6247171|P2|NOT COMPLETED|Overall Study||0
2549363|NCT00557284|6247172|P1|NOT COMPLETED|Overall Study||0
2549364|NCT00557284|6247171|P2|COMPLETED|Overall Study||11
2549365|NCT00557284|6247172|P1|COMPLETED|Overall Study||9
2549366|NCT00557284|6247171|P2|STARTED|Overall Study||11
2549367|NCT00557284|6247172|P1|STARTED|Overall Study||9
2549368|NCT00557245|6247195|P3|NOT COMPLETED|Overall Study||12
2549369|NCT00557245|6247196|P2|NOT COMPLETED|Overall Study||12
2549370|NCT00557245|6247197|P1|NOT COMPLETED|Overall Study||12
2549371|NCT00557245|6247195|P3|COMPLETED|Overall Study||1574
2549372|NCT00557245|6247196|P2|COMPLETED|Overall Study||1571
2549373|NCT00557245|6247197|P1|COMPLETED|Overall Study||1577
2549374|NCT00557245|6247195|P3|STARTED|Overall Study||1586
2549375|NCT00557245|6247196|P2|STARTED|Overall Study||1583
2549376|NCT00557245|6247197|P1|STARTED|Overall Study||1589
2549377|NCT00557193|6247235|P6|NOT COMPLETED|Post Induction Therapy by Tx Assignment||37
2549378|NCT00557193|6247236|P5|NOT COMPLETED|Post Induction Therapy by Tx Assignment||7
2549379|NCT00557193|6247237|P4|NOT COMPLETED|Post Induction Therapy by Tx Assignment||7
2549380|NCT00557193|6247238|P3|NOT COMPLETED|Post Induction Therapy by Tx Assignment||32
2549381|NCT00557193|6247239|P2|NOT COMPLETED|Post Induction Therapy by Tx Assignment||10
2549382|NCT00557193|6247240|P1|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
2549383|NCT00557193|6247235|P6|COMPLETED|Post Induction Therapy by Tx Assignment||19
2549384|NCT00557193|6247236|P5|COMPLETED|Post Induction Therapy by Tx Assignment||4
2549385|NCT00557193|6247237|P4|COMPLETED|Post Induction Therapy by Tx Assignment||4
2549386|NCT00557193|6247238|P3|COMPLETED|Post Induction Therapy by Tx Assignment||22
2549387|NCT00557193|6247239|P2|COMPLETED|Post Induction Therapy by Tx Assignment||50
2549388|NCT00557193|6247240|P1|COMPLETED|Post Induction Therapy by Tx Assignment||0
2549389|NCT00557193|6247235|P6|STARTED|Post Induction Therapy by Tx Assignment||56
2549390|NCT00557193|6247236|P5|STARTED|Post Induction Therapy by Tx Assignment||11
2549391|NCT00557193|6247237|P4|STARTED|Post Induction Therapy by Tx Assignment||11
2549392|NCT00557193|6247238|P3|STARTED|Post Induction Therapy by Tx Assignment||54
2549393|NCT00557193|6247239|P2|STARTED|Post Induction Therapy by Tx Assignment||60
2549394|NCT00557193|6247240|P1|STARTED|Post Induction Therapy by Tx Assignment||0
2549395|NCT00557193|6247235|P6|NOT COMPLETED|Induction||0
2549396|NCT00557193|6247236|P5|NOT COMPLETED|Induction||0
2549397|NCT00557193|6247237|P4|NOT COMPLETED|Induction||0
2549398|NCT00557193|6247238|P3|NOT COMPLETED|Induction||0
2549399|NCT00557193|6247239|P2|NOT COMPLETED|Induction||0
2549400|NCT00557193|6247240|P1|NOT COMPLETED|Induction||26
2549401|NCT00557193|6247235|P6|COMPLETED|Induction||0
2549402|NCT00557193|6247236|P5|COMPLETED|Induction||0
2549403|NCT00557193|6247237|P4|COMPLETED|Induction||0
2549404|NCT00557193|6247238|P3|COMPLETED|Induction||0
2549405|NCT00557193|6247239|P2|COMPLETED|Induction||0
2549406|NCT00557193|6247240|P1|COMPLETED|Induction||192
2549407|NCT00557193|6247235|P6|STARTED|Induction||0
2549408|NCT00557193|6247236|P5|STARTED|Induction||0
2549409|NCT00557193|6247237|P4|STARTED|Induction||0
2549410|NCT00557193|6247238|P3|STARTED|Induction||0
2549411|NCT00557193|6247239|P2|STARTED|Induction||0
2549412|NCT00557193|6247240|P1|STARTED|Induction||218
2549413|NCT00557076|6247280|P2|NOT COMPLETED|Overall Study||1
2549414|NCT00557076|6247281|P1|NOT COMPLETED|Overall Study||0
2549415|NCT00557076|6247280|P2|COMPLETED|Overall Study|One participant was withdrawn due to unblinding|7
2549416|NCT00557076|6247281|P1|COMPLETED|Overall Study||8
2549417|NCT00557076|6247280|P2|STARTED|Overall Study||8
2549418|NCT00557076|6247281|P1|STARTED|Overall Study||8
2549419|NCT00556998|6247289|P1|NOT COMPLETED|Voriconazole Oral||2
2549420|NCT00556998|6247289|P1|COMPLETED|Voriconazole Oral||20
2549421|NCT00556998|6247289|P1|STARTED|Voriconazole Oral|One participant received voriconazole 150 mg every 12 hours during oral phase.|22
2549422|NCT00556998|6247289|P1|NOT COMPLETED|Voriconazole Intravenous (IV)||5
2549423|NCT00556998|6247289|P1|COMPLETED|Voriconazole Intravenous (IV)|One participant received 2 days of oral; then received IV again before discontinuing from study.|21
2549424|NCT00556998|6247289|P1|Treated|Voriconazole Intravenous (IV)||26
2549425|NCT00556998|6247289|P1|STARTED|Voriconazole Intravenous (IV)||26
2549426|NCT00556972|6247309|P1|NOT COMPLETED|Overall Study||0
2549427|NCT00556972|6247309|P1|COMPLETED|Overall Study||4
2549428|NCT00556972|6247309|P1|STARTED|Overall Study||4
2549429|NCT00556946|6247316|P1|NOT COMPLETED|Overall Study||1
2549430|NCT00556946|6247316|P1|COMPLETED|Overall Study||16
2549431|NCT00556946|6247316|P1|STARTED|Overall Study||17
2549432|NCT00556933|6247324|P4|NOT COMPLETED|CNI Withdrawal vs. Minimization||2
2549433|NCT00556933|6247325|P3|NOT COMPLETED|CNI Withdrawal vs. Minimization||3
2549434|NCT00556933|6247326|P2|NOT COMPLETED|CNI Withdrawal vs. Minimization||4
2549435|NCT00556933|6247327|P1|NOT COMPLETED|CNI Withdrawal vs. Minimization||1
2549436|NCT00556933|6247324|P4|COMPLETED|CNI Withdrawal vs. Minimization||41
2549437|NCT00556933|6247325|P3|COMPLETED|CNI Withdrawal vs. Minimization||36
2549438|NCT00556933|6247326|P2|COMPLETED|CNI Withdrawal vs. Minimization||33
2549439|NCT00556933|6247327|P1|COMPLETED|CNI Withdrawal vs. Minimization||42
2549440|NCT00556933|6247324|P4|STARTED|CNI Withdrawal vs. Minimization||43
2549441|NCT00556933|6247325|P3|STARTED|CNI Withdrawal vs. Minimization||39
2549442|NCT00556933|6247326|P2|STARTED|CNI Withdrawal vs. Minimization||37
2549443|NCT00556933|6247327|P1|STARTED|CNI Withdrawal vs. Minimization||43
2549444|NCT00556933|6247324|P4|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
2549445|NCT00556933|6247325|P3|NOT COMPLETED|Single vs. Divided-dose rATG Induction||6
2549446|NCT00556933|6247326|P2|NOT COMPLETED|Single vs. Divided-dose rATG Induction||8
2549447|NCT00556933|6247327|P1|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
2549448|NCT00556933|6247324|P4|COMPLETED|Single vs. Divided-dose rATG Induction||43
2549449|NCT00556933|6247325|P3|COMPLETED|Single vs. Divided-dose rATG Induction||39
2549450|NCT00556933|6247326|P2|COMPLETED|Single vs. Divided-dose rATG Induction||37
2549451|NCT00556933|6247327|P1|COMPLETED|Single vs. Divided-dose rATG Induction||43
2549452|NCT00556933|6247324|P4|STARTED|Single vs. Divided-dose rATG Induction||45
2549453|NCT00556933|6247325|P3|STARTED|Single vs. Divided-dose rATG Induction||45
2549454|NCT00556933|6247326|P2|STARTED|Single vs. Divided-dose rATG Induction||45
2549455|NCT00556933|6247327|P1|STARTED|Single vs. Divided-dose rATG Induction||45
2549456|NCT00556894|6247384|P3|NOT COMPLETED|Overall Study||19
2549457|NCT00556894|6247385|P2|NOT COMPLETED|Overall Study||19
2549458|NCT00556894|6247386|P1|NOT COMPLETED|Overall Study||16
2549459|NCT00556894|6247384|P3|COMPLETED|Overall Study||65
2549460|NCT00556894|6247385|P2|COMPLETED|Overall Study||68
2549461|NCT00556894|6247386|P1|COMPLETED|Overall Study||66
2549462|NCT00556894|6247384|P3|STARTED|Overall Study||84
2549463|NCT00556894|6247385|P2|STARTED|Overall Study||87
2549464|NCT00556894|6247386|P1|STARTED|Overall Study||82
2549465|NCT00556712|6247396|P2|NOT COMPLETED|Overall Study||438
2549466|NCT00556712|6247397|P1|NOT COMPLETED|Overall Study||451
2549467|NCT00556712|6247396|P2|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
2549468|NCT00556712|6247397|P1|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
2549469|NCT00556712|6247396|P2|STARTED|Overall Study||438
2549470|NCT00556712|6247397|P1|STARTED|Overall Study||451
2549471|NCT00556673|6247475|P2|NOT COMPLETED|Overall Study||2
2549472|NCT00556673|6247476|P1|NOT COMPLETED|Overall Study||3
2549473|NCT00556673|6247475|P2|COMPLETED|Overall Study||13
2549474|NCT00556673|6247476|P1|COMPLETED|Overall Study||13
2549475|NCT00556673|6247475|P2|Pharmacodynamic (PD) Population|Overall Study|3 patients inadvertently unblinded were not included in PD analysis population.|12
2549476|NCT00556673|6247476|P1|Pharmacodynamic (PD) Population|Overall Study|4 patients inadvertently unblinded were not included in PD analysis population.|12
2549477|NCT00556673|6247475|P2|STARTED|Overall Study||15
2549478|NCT00556673|6247476|P1|STARTED|Overall Study||16
2549479|NCT00556543|6247512|P1|NOT COMPLETED|Overall Study||0
2549480|NCT00556543|6247512|P1|COMPLETED|Overall Study|Subjects completed 180 days of study enrollment|10
2549481|NCT00556543|6247512|P1|STARTED|Overall Study||10
2549482|NCT00556504|6247530|P2|NOT COMPLETED|Overall Study||9
2549483|NCT00556504|6247531|P1|NOT COMPLETED|Overall Study||8
2549484|NCT00556504|6247530|P2|COMPLETED|Overall Study||33
2549485|NCT00556504|6247531|P1|COMPLETED|Overall Study||34
2549486|NCT00556504|6247530|P2|Safety Population|Overall Study||42
2549487|NCT00556504|6247531|P1|Safety Population|Overall Study||41
2549488|NCT00556504|6247530|P2|Intend-to Treat Population|Overall Study||42
2549489|NCT00556504|6247531|P1|Intend-to Treat Population|Overall Study||42
2549490|NCT00556504|6247530|P2|STARTED|Overall Study||42
2549491|NCT00556504|6247531|P1|STARTED|Overall Study||42
2549492|NCT00556491|6247551|P2|NOT COMPLETED|Overall Study||1
2549493|NCT00556491|6247552|P1|NOT COMPLETED|Overall Study||1
2549494|NCT00556491|6247551|P2|COMPLETED|Overall Study||19
2549495|NCT00556491|6247552|P1|COMPLETED|Overall Study||19
2549496|NCT00556491|6247551|P2|STARTED|Overall Study||20
2549497|NCT00556491|6247552|P1|STARTED|Overall Study|January 2008|20
2549498|NCT00556478|6247570|P2|NOT COMPLETED|Open-Label Phase||10
2549499|NCT00556478|6247571|P1|NOT COMPLETED|Open-Label Phase||14
2549500|NCT00556478|6247570|P2|COMPLETED|Open-Label Phase||67
2549501|NCT00556478|6247571|P1|COMPLETED|Open-Label Phase||132
2549502|NCT00556478|6247570|P2|Treated in Open-label|Open-Label Phase||71
2549503|NCT00556478|6247571|P1|Treated in Open-label|Open-Label Phase||142
2549504|NCT00556478|6247570|P2|STARTED|Open-Label Phase||77
2549505|NCT00556478|6247571|P1|STARTED|Open-Label Phase||146
2549506|NCT00556478|6247570|P2|NOT COMPLETED|Double-blind Phase||8
2549507|NCT00556478|6247571|P1|NOT COMPLETED|Double-blind Phase||21
2549508|NCT00556478|6247570|P2|COMPLETED|Double-blind Phase||77
2549509|NCT00556478|6247571|P1|COMPLETED|Double-blind Phase||150
2549510|NCT00556478|6247570|P2|ITT|Double-blind Phase||82
2549511|NCT00556478|6247571|P1|ITT|Double-blind Phase||167
2549512|NCT00556478|6247570|P2|STARTED|Double-blind Phase||85
2549513|NCT00556478|6247571|P1|STARTED|Double-blind Phase||171
2549514|NCT00556452|6247599|P3|NOT COMPLETED|Overall Study||0
2549515|NCT00556452|6247600|P2|NOT COMPLETED|Overall Study||0
2549516|NCT00556452|6247601|P1|NOT COMPLETED|Overall Study||0
2549517|NCT00556452|6247599|P3|COMPLETED|Overall Study||19
2549518|NCT00556452|6247600|P2|COMPLETED|Overall Study||21
2549519|NCT00556452|6247601|P1|COMPLETED|Overall Study||6
2549520|NCT00556452|6247599|P3|STARTED|Overall Study||19
2549521|NCT00556452|6247600|P2|STARTED|Overall Study||21
2549522|NCT00556452|6247601|P1|STARTED|Overall Study||6
2549523|NCT00556439|6247612|P4|NOT COMPLETED|After Week 12 (Randomized Study Period)||1
2549524|NCT00556439|6247613|P3|NOT COMPLETED|After Week 12 (Randomized Study Period)||0
2549525|NCT00556439|6247614|P2|NOT COMPLETED|After Week 12 (Randomized Study Period)||4
2549526|NCT00556439|6247615|P1|NOT COMPLETED|After Week 12 (Randomized Study Period)||3
2549527|NCT00556439|6247612|P4|COMPLETED|After Week 12 (Randomized Study Period)||14
2549528|NCT00556439|6247613|P3|COMPLETED|After Week 12 (Randomized Study Period)||11
2549529|NCT00556439|6247614|P2|COMPLETED|After Week 12 (Randomized Study Period)||17
2549530|NCT00556439|6247615|P1|COMPLETED|After Week 12 (Randomized Study Period)||17
2549531|NCT00556439|6247612|P4|STARTED|After Week 12 (Randomized Study Period)||15
2549532|NCT00556439|6247613|P3|STARTED|After Week 12 (Randomized Study Period)||11
2549533|NCT00556439|6247614|P2|STARTED|After Week 12 (Randomized Study Period)||21
2549534|NCT00556439|6247615|P1|STARTED|After Week 12 (Randomized Study Period)||20
2549535|NCT00556439|6247612|P4|NOT COMPLETED|Study Entry to Week 12||0
2549536|NCT00556439|6247613|P3|NOT COMPLETED|Study Entry to Week 12||8
2549537|NCT00556439|6247614|P2|NOT COMPLETED|Study Entry to Week 12||0
2549538|NCT00556439|6247615|P1|NOT COMPLETED|Study Entry to Week 12||8
2549539|NCT00556439|6247612|P4|COMPLETED|Study Entry to Week 12||0
2549540|NCT00556439|6247613|P3|COMPLETED|Study Entry to Week 12||26
2549541|NCT00556439|6247614|P2|COMPLETED|Study Entry to Week 12||0
2549542|NCT00556439|6247615|P1|COMPLETED|Study Entry to Week 12||41
2549543|NCT00556439|6247612|P4|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0
2549544|NCT00556439|6247613|P3|STARTED|Study Entry to Week 12|39 signed informed consent with 5 not being eligible. The remaining 34 received study drug.|34
2549545|NCT00556439|6247614|P2|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0
2549546|NCT00556439|6247615|P1|STARTED|Study Entry to Week 12|58 signed informed consent with 9 not being eligible. The remaining 49 received study drug.|49
2549547|NCT00556426|6247625|P1|NOT COMPLETED|Overall Study||9
2549548|NCT00556426|6247625|P1|COMPLETED|Overall Study||91
2549549|NCT00556426|6247625|P1|STARTED|Overall Study||100
2549550|NCT00556400|6247635|P2|NOT COMPLETED|Overall Study||0
2549551|NCT00556400|6247636|P1|NOT COMPLETED|Overall Study||0
2549552|NCT00556400|6247635|P2|COMPLETED|Overall Study||0
2549553|NCT00556400|6247636|P1|COMPLETED|Overall Study||1
2549554|NCT00556400|6247635|P2|STARTED|Overall Study||0
2549555|NCT00556400|6247636|P1|STARTED|Overall Study||1
2549556|NCT00556374|6247647|P2|NOT COMPLETED|Overall Study||220
2549557|NCT00556374|6247648|P1|NOT COMPLETED|Overall Study||247
2549558|NCT00556374|6247647|P2|COMPLETED|Overall Study|Indicates participants continuing study|1491
2549559|NCT00556374|6247648|P1|COMPLETED|Overall Study|Indicates participants continuing study|1462
2549560|NCT00556374|6247647|P2|Received Study Drug|Overall Study||1700
2549561|NCT00556374|6247648|P1|Received Study Drug|Overall Study||1699
2549562|NCT00556374|6247647|P2|STARTED|Overall Study||1711
2549563|NCT00556374|6247648|P1|STARTED|Overall Study||1709
2549564|NCT00556322|6247668|P2|NOT COMPLETED|Overall Study||203
2549565|NCT00556322|6247669|P1|NOT COMPLETED|Overall Study||221
2549566|NCT00556322|6247668|P2|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
2549567|NCT00556322|6247669|P1|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
2549568|NCT00556322|6247668|P2|STARTED|Overall Study||203
2549569|NCT00556322|6247669|P1|STARTED|Overall Study||221
2549570|NCT00556166|6247717|P1|NOT COMPLETED|Overall Study||1
2549571|NCT00556166|6247717|P1|COMPLETED|Overall Study||3
2549572|NCT00556166|6247717|P1|STARTED|Overall Study||4
2549573|NCT00556140|6247722|P1|NOT COMPLETED|Overall Study||3
2549574|NCT00556140|6247722|P1|COMPLETED|Overall Study||13
2549575|NCT00556140|6247722|P1|STARTED|Overall Study||16
2549576|NCT00556075|6247730|P3|NOT COMPLETED|Overall Study||8
2549577|NCT00556075|6247731|P2|NOT COMPLETED|Overall Study||9
2549578|NCT00556075|6247732|P1|NOT COMPLETED|Overall Study||13
2549579|NCT00556075|6247730|P3|COMPLETED|Overall Study||15
2549580|NCT00556075|6247731|P2|COMPLETED|Overall Study||13
2549581|NCT00556075|6247732|P1|COMPLETED|Overall Study||9
2549582|NCT00556075|6247730|P3|STARTED|Overall Study||23
2549583|NCT00556075|6247731|P2|STARTED|Overall Study||22
2549584|NCT00556075|6247732|P1|STARTED|Overall Study||22
2549585|NCT00556049|6247755|P1|NOT COMPLETED|Overall Study||0
2549586|NCT00556049|6247755|P1|COMPLETED|Overall Study||72
2549587|NCT00556049|6247755|P1|STARTED|Overall Study||72
2549588|NCT00555997|6247762|P4|NOT COMPLETED|Phase 2 SPCD||3
2549589|NCT00555997|6247763|P3|NOT COMPLETED|Phase 2 SPCD||7
2549590|NCT00555997|6247764|P2|NOT COMPLETED|Phase 2 SPCD||0
2549591|NCT00555997|6247765|P1|NOT COMPLETED|Phase 2 SPCD||0
2549592|NCT00555997|6247762|P4|COMPLETED|Phase 2 SPCD||22
2549593|NCT00555997|6247763|P3|COMPLETED|Phase 2 SPCD||31
2549594|NCT00555997|6247764|P2|COMPLETED|Phase 2 SPCD||0
2549595|NCT00555997|6247765|P1|COMPLETED|Phase 2 SPCD||0
2549596|NCT00555997|6247762|P4|STARTED|Phase 2 SPCD||25
2549597|NCT00555997|6247763|P3|STARTED|Phase 2 SPCD||38
2549598|NCT00555997|6247764|P2|STARTED|Phase 2 SPCD||0
2549599|NCT00555997|6247765|P1|STARTED|Phase 2 SPCD||0
2549600|NCT00555997|6247762|P4|NOT COMPLETED|Phase 1 SPCD||0
2549601|NCT00555997|6247763|P3|NOT COMPLETED|Phase 1 SPCD||0
2549602|NCT00555997|6247764|P2|NOT COMPLETED|Phase 1 SPCD||15
2549603|NCT00555997|6247765|P1|NOT COMPLETED|Phase 1 SPCD||12
2549604|NCT00555997|6247762|P4|COMPLETED|Phase 1 SPCD||0
2549605|NCT00555997|6247763|P3|COMPLETED|Phase 1 SPCD||0
2549606|NCT00555997|6247764|P2|COMPLETED|Phase 1 SPCD||76
2549607|NCT00555997|6247765|P1|COMPLETED|Phase 1 SPCD||17
2549608|NCT00555997|6247762|P4|STARTED|Phase 1 SPCD||0
2549609|NCT00555997|6247763|P3|STARTED|Phase 1 SPCD||0
2549610|NCT00555997|6247764|P2|STARTED|Phase 1 SPCD||91
2549611|NCT00555997|6247765|P1|STARTED|Phase 1 SPCD||29
2549612|NCT00555971|6247783|P2|NOT COMPLETED|Overall Study||1
2549613|NCT00555971|6247784|P1|NOT COMPLETED|Overall Study||1
2549614|NCT00555971|6247783|P2|COMPLETED|Overall Study||7
2549615|NCT00555971|6247784|P1|COMPLETED|Overall Study||4
2549616|NCT00555971|6247783|P2|STARTED|Overall Study||8
2549617|NCT00555971|6247784|P1|STARTED|Overall Study||5
2549618|NCT00555906|6247795|P5|NOT COMPLETED|Phase 2||32
2549619|NCT00555906|6247796|P4|NOT COMPLETED|Phase 2||0
2549620|NCT00555906|6247797|P3|NOT COMPLETED|Phase 2||0
2549621|NCT00555906|6247798|P2|NOT COMPLETED|Phase 2||0
2549622|NCT00555906|6247799|P1|NOT COMPLETED|Phase 2||0
2549623|NCT00555906|6247795|P5|COMPLETED|Phase 2||0
2549624|NCT00555906|6247796|P4|COMPLETED|Phase 2||0
2549625|NCT00555906|6247797|P3|COMPLETED|Phase 2||0
2549626|NCT00555906|6247798|P2|COMPLETED|Phase 2||0
2549627|NCT00555906|6247799|P1|COMPLETED|Phase 2||0
2549628|NCT00555906|6247795|P5|Treated|Phase 2||30
2549629|NCT00555906|6247796|P4|Treated|Phase 2||0
2549630|NCT00555906|6247797|P3|Treated|Phase 2||0
2549631|NCT00555906|6247798|P2|Treated|Phase 2||0
2549632|NCT00555906|6247799|P1|Treated|Phase 2||0
2549633|NCT00555906|6247795|P5|STARTED|Phase 2||32
2549634|NCT00555906|6247796|P4|STARTED|Phase 2||0
2549635|NCT00555906|6247797|P3|STARTED|Phase 2||0
2549636|NCT00555906|6247798|P2|STARTED|Phase 2||0
2549637|NCT00555906|6247799|P1|STARTED|Phase 2||0
2549638|NCT00555906|6247795|P5|NOT COMPLETED|Phase 1||0
2549639|NCT00555906|6247796|P4|NOT COMPLETED|Phase 1||5
2549640|NCT00555906|6247797|P3|NOT COMPLETED|Phase 1||7
2549641|NCT00555906|6247798|P2|NOT COMPLETED|Phase 1||6
2549642|NCT00555906|6247799|P1|NOT COMPLETED|Phase 1||3
2549643|NCT00555906|6247795|P5|COMPLETED|Phase 1||0
2549644|NCT00555906|6247796|P4|COMPLETED|Phase 1||0
2549645|NCT00555906|6247797|P3|COMPLETED|Phase 1||0
2549646|NCT00555906|6247798|P2|COMPLETED|Phase 1||0
2549647|NCT00555906|6247799|P1|COMPLETED|Phase 1||0
2549648|NCT00555906|6247795|P5|STARTED|Phase 1||0
2549649|NCT00555906|6247796|P4|STARTED|Phase 1||5
2549650|NCT00555906|6247797|P3|STARTED|Phase 1||7
2549651|NCT00555906|6247798|P2|STARTED|Phase 1||6
2549652|NCT00555906|6247799|P1|STARTED|Phase 1||3
2549653|NCT00555893|6247831|P2|NOT COMPLETED|Overall Study||0
2549654|NCT00555893|6247832|P1|NOT COMPLETED|Overall Study||0
2549655|NCT00555893|6247831|P2|COMPLETED|Overall Study||63
2549656|NCT00555893|6247832|P1|COMPLETED|Overall Study||130
2549657|NCT00555893|6247831|P2|Final Analysis|Overall Study|n=12 excluded from number started because >119 hrs|51
2549658|NCT00555893|6247832|P1|Final Analysis|Overall Study|n=16 excluded from number started because >119 hrs|114
2549659|NCT00555893|6247831|P2|STARTED|Overall Study||63
2549660|NCT00555893|6247832|P1|STARTED|Overall Study||130
2549661|NCT00555880|6247848|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
2549662|NCT00555880|6247849|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
2549663|NCT00555880|6247848|P2|COMPLETED|Treatment Period 2 (1 Day)||11
2549664|NCT00555880|6247849|P1|COMPLETED|Treatment Period 2 (1 Day)||13
2549665|NCT00555880|6247848|P2|STARTED|Treatment Period 2 (1 Day)||11
2549666|NCT00555880|6247849|P1|STARTED|Treatment Period 2 (1 Day)||13
2549667|NCT00555880|6247848|P2|NOT COMPLETED|Washout (1 Day)||0
2549668|NCT00555880|6247849|P1|NOT COMPLETED|Washout (1 Day)||0
2549669|NCT00555880|6247848|P2|COMPLETED|Washout (1 Day)||11
2549670|NCT00555880|6247849|P1|COMPLETED|Washout (1 Day)||13
2549671|NCT00555880|6247848|P2|STARTED|Washout (1 Day)||11
2549672|NCT00555880|6247849|P1|STARTED|Washout (1 Day)||13
2549673|NCT00555880|6247848|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
2549674|NCT00555880|6247849|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
2549675|NCT00555880|6247848|P2|COMPLETED|Treatment Period 1 (1 Day)||11
2549676|NCT00555880|6247849|P1|COMPLETED|Treatment Period 1 (1 Day)||13
2549677|NCT00555880|6247848|P2|STARTED|Treatment Period 1 (1 Day)||11
2549678|NCT00555880|6247849|P1|STARTED|Treatment Period 1 (1 Day)||13
2549679|NCT00555750|6247888|P2|NOT COMPLETED|Overall Study||0
2549680|NCT00555750|6247889|P1|NOT COMPLETED|Overall Study||0
2549681|NCT00555750|6247888|P2|COMPLETED|Overall Study||10
2549682|NCT00555750|6247889|P1|COMPLETED|Overall Study||10
2549683|NCT00555750|6247888|P2|STARTED|Overall Study||10
2549684|NCT00555750|6247889|P1|STARTED|Overall Study||10
2549685|NCT00555672|6247921|P2|NOT COMPLETED|Overall Study||10
2549686|NCT00555672|6247922|P1|NOT COMPLETED|Overall Study||24
2549687|NCT00555672|6247921|P2|COMPLETED|Overall Study||0
2549688|NCT00555672|6247922|P1|COMPLETED|Overall Study||0
2549689|NCT00555672|6247921|P2|STARTED|Overall Study||10
2549690|NCT00555672|6247922|P1|STARTED|Overall Study||24
2549691|NCT00555620|6247947|P6|NOT COMPLETED|Overall Study||22
2549692|NCT00555620|6247948|P5|NOT COMPLETED|Overall Study||3
2549693|NCT00555620|6247949|P4|NOT COMPLETED|Overall Study||23
2549694|NCT00555620|6247950|P3|NOT COMPLETED|Overall Study||15
2549695|NCT00555620|6247951|P2|NOT COMPLETED|Overall Study||7
2549696|NCT00555620|6247952|P1|NOT COMPLETED|Overall Study||6
2549697|NCT00555620|6247947|P6|COMPLETED|Overall Study||0
2549698|NCT00555620|6247948|P5|COMPLETED|Overall Study||0
2549699|NCT00555620|6247949|P4|COMPLETED|Overall Study||0
2549700|NCT00555620|6247950|P3|COMPLETED|Overall Study||0
2549701|NCT00555620|6247951|P2|COMPLETED|Overall Study||0
2549702|NCT00555620|6247952|P1|COMPLETED|Overall Study||0
2549703|NCT00555620|6247947|P6|STARTED|Overall Study||22
2549704|NCT00555620|6247948|P5|STARTED|Overall Study||3
2549705|NCT00555620|6247949|P4|STARTED|Overall Study||23
2549706|NCT00555620|6247950|P3|STARTED|Overall Study||15
2549707|NCT00555620|6247951|P2|STARTED|Overall Study||7
2549708|NCT00555620|6247952|P1|STARTED|Overall Study||6
2549709|NCT00555581|6248064|P1|NOT COMPLETED|Overall Study||6
2549710|NCT00555581|6248064|P1|COMPLETED|Overall Study||24
2549711|NCT00555581|6248064|P1|STARTED|Overall Study||30
2549712|NCT00555568|6248076|P3|NOT COMPLETED|Overall Study||16
2549713|NCT00555568|6248077|P2|NOT COMPLETED|Overall Study||16
2549714|NCT00555568|6248078|P1|NOT COMPLETED|Overall Study||26
2549715|NCT00555568|6248076|P3|COMPLETED|Overall Study||84
2549716|NCT00555568|6248077|P2|COMPLETED|Overall Study||82
2549717|NCT00555568|6248078|P1|COMPLETED|Overall Study||74
2549718|NCT00555568|6248076|P3|STARTED|Overall Study||100
2549719|NCT00555568|6248077|P2|STARTED|Overall Study||98
2549720|NCT00555568|6248078|P1|STARTED|Overall Study||100
2549721|NCT00555477|6248100|P2|NOT COMPLETED|Overall Study||13
2549722|NCT00555477|6248101|P1|NOT COMPLETED|Overall Study||2
2549723|NCT00555477|6248100|P2|COMPLETED|Overall Study||32
2549724|NCT00555477|6248101|P1|COMPLETED|Overall Study||12
2549725|NCT00555477|6248100|P2|STARTED|Overall Study||45
2549726|NCT00555477|6248101|P1|STARTED|Overall Study||14
2549727|NCT00555464|6248108|P2|NOT COMPLETED|Overall Study||3
2549728|NCT00555464|6248109|P1|NOT COMPLETED|Overall Study||0
2549729|NCT00555464|6248108|P2|COMPLETED|Overall Study||1
2549730|NCT00555464|6248109|P1|COMPLETED|Overall Study||4
2549731|NCT00555464|6248108|P2|STARTED|Overall Study||4
2549732|NCT00555464|6248109|P1|STARTED|Overall Study||4
2549733|NCT00555438|6248117|P1|NOT COMPLETED|Between 10 Days and 30 Days Postoperativ||5
2549734|NCT00555438|6248117|P1|COMPLETED|Between 10 Days and 30 Days Postoperativ||433
2549735|NCT00555438|6248117|P1|STARTED|Between 10 Days and 30 Days Postoperativ||438
2549736|NCT00555438|6248117|P1|NOT COMPLETED|10 Days Post-operative||4
2549737|NCT00555438|6248117|P1|COMPLETED|10 Days Post-operative|438 patients attended the day 10 visit (four patients died during hospitalization)|438
2549738|NCT00555438|6248117|P1|STARTED|10 Days Post-operative||442
2549739|NCT00555425|6248127|P2|NOT COMPLETED|Overall Study||19
2549740|NCT00555425|6248128|P1|NOT COMPLETED|Overall Study||51
2549741|NCT00555425|6248127|P2|COMPLETED|Overall Study||37
2549742|NCT00555425|6248128|P1|COMPLETED|Overall Study||6
2549743|NCT00555425|6248127|P2|STARTED|Overall Study||56
2549744|NCT00555425|6248128|P1|STARTED|Overall Study||57
2549745|NCT00555360|6248148|P2|NOT COMPLETED|Overall Study||36
2549746|NCT00555360|6248149|P1|NOT COMPLETED|Overall Study||27
2549747|NCT00555360|6248148|P2|COMPLETED|Overall Study||153
2549748|NCT00555360|6248149|P1|COMPLETED|Overall Study||156
2549749|NCT00555360|6248148|P2|STARTED|Overall Study||189
2549750|NCT00555360|6248149|P1|STARTED|Overall Study||183
2549751|NCT00555321|6248164|P5|NOT COMPLETED|Long-term Extension Phase||26
2549752|NCT00555321|6248165|P4|NOT COMPLETED|Long-term Extension Phase||38
2549753|NCT00555321|6248166|P3|NOT COMPLETED|Long-term Extension Phase||24
2549754|NCT00555321|6248167|P2|NOT COMPLETED|Long-term Extension Phase||27
2549755|NCT00555321|6248168|P1|NOT COMPLETED|Long-term Extension Phase||30
2549756|NCT00555321|6248164|P5|COMPLETED|Long-term Extension Phase||0
2549757|NCT00555321|6248165|P4|COMPLETED|Long-term Extension Phase||0
2549758|NCT00555321|6248166|P3|COMPLETED|Long-term Extension Phase||0
2549759|NCT00555321|6248167|P2|COMPLETED|Long-term Extension Phase||0
2549760|NCT00555321|6248168|P1|COMPLETED|Long-term Extension Phase||0
2549761|NCT00555321|6248164|P5|STARTED|Long-term Extension Phase|6 participants did not enter LTE|26
2549762|NCT00555321|6248165|P4|STARTED|Long-term Extension Phase|8 participants did not enter LTE|38
2549763|NCT00555321|6248166|P3|STARTED|Long-term Extension Phase|2 participants did not enter LTE|24
2549764|NCT00555321|6248167|P2|STARTED|Long-term Extension Phase|2 participants did not enter LTE|27
2549765|NCT00555321|6248168|P1|STARTED|Long-term Extension Phase|1 participant did not enter LTE|30
2549766|NCT00555321|6248164|P5|NOT COMPLETED|Treatment Phase up to 12-months||22
2549767|NCT00555321|6248165|P4|NOT COMPLETED|Treatment Phase up to 12-months||7
2549768|NCT00555321|6248166|P3|NOT COMPLETED|Treatment Phase up to 12-months||24
2549769|NCT00555321|6248167|P2|NOT COMPLETED|Treatment Phase up to 12-months||22
2549770|NCT00555321|6248168|P1|NOT COMPLETED|Treatment Phase up to 12-months||21
2549771|NCT00555321|6248164|P5|COMPLETED|Treatment Phase up to 12-months||32
2549772|NCT00555321|6248165|P4|COMPLETED|Treatment Phase up to 12-months||46
2549773|NCT00555321|6248166|P3|COMPLETED|Treatment Phase up to 12-months||26
2549774|NCT00555321|6248167|P2|COMPLETED|Treatment Phase up to 12-months||29
2549775|NCT00555321|6248168|P1|COMPLETED|Treatment Phase up to 12-months||31
2549776|NCT00555321|6248164|P5|Received Transplant and Treated|Treatment Phase up to 12-months||50
2549777|NCT00555321|6248165|P4|Received Transplant and Treated|Treatment Phase up to 12-months||53
2549778|NCT00555321|6248166|P3|Received Transplant and Treated|Treatment Phase up to 12-months||49
2549779|NCT00555321|6248167|P2|Received Transplant and Treated|Treatment Phase up to 12-months||48
2549780|NCT00555321|6248168|P1|Received Transplant and Treated|Treatment Phase up to 12-months||50
2549781|NCT00555321|6248164|P5|STARTED|Treatment Phase up to 12-months||54
2549782|NCT00555321|6248165|P4|STARTED|Treatment Phase up to 12-months||53
2549783|NCT00555321|6248166|P3|STARTED|Treatment Phase up to 12-months||50
2549784|NCT00555321|6248167|P2|STARTED|Treatment Phase up to 12-months||51
2549785|NCT00555321|6248168|P1|STARTED|Treatment Phase up to 12-months||52
2549786|NCT00555217|6248472|P2|NOT COMPLETED|Overall Study||68
2549787|NCT00555217|6248473|P1|NOT COMPLETED|Overall Study||75
2549788|NCT00555217|6248472|P2|COMPLETED|Overall Study||656
2549789|NCT00555217|6248473|P1|COMPLETED|Overall Study||649
2549790|NCT00555217|6248472|P2|STARTED|Overall Study||724
2549791|NCT00555217|6248473|P1|STARTED|Overall Study||724
2549792|NCT00555152|6248485|P4|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
2549793|NCT00555152|6248486|P3|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
2549794|NCT00555152|6248487|P2|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
2549795|NCT00555152|6248488|P1|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
2549796|NCT00555152|6248485|P4|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||9
2549797|NCT00555152|6248486|P3|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
2549798|NCT00555152|6248487|P2|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||10
2549799|NCT00555152|6248488|P1|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
2549800|NCT00555152|6248485|P4|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||9
2549801|NCT00555152|6248486|P3|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||0
2549802|NCT00555152|6248487|P2|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||10
2549803|NCT00555152|6248488|P1|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14|Participants in initial and second study registration periods reported separately.|0
2549804|NCT00555152|6248485|P4|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
2549805|NCT00555152|6248486|P3|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
2549806|NCT00555152|6248487|P2|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
2549807|NCT00555152|6248488|P1|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
2549808|NCT00555152|6248485|P4|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||1
2549809|NCT00555152|6248486|P3|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
2549810|NCT00555152|6248487|P2|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
2549811|NCT00555152|6248488|P1|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||2
2549812|NCT00555152|6248485|P4|STARTED|Period Open at BCM: 1/17/08-3/8/10||1
2549813|NCT00555152|6248486|P3|STARTED|Period Open at BCM: 1/17/08-3/8/10||0
2549814|NCT00555152|6248487|P2|STARTED|Period Open at BCM: 1/17/08-3/8/10|Participants in initial and second study registration periods reported separately.|0
2549815|NCT00555152|6248488|P1|STARTED|Period Open at BCM: 1/17/08-3/8/10||2
2549816|NCT00555061|6248510|P1|NOT COMPLETED|Overall Study||9
2549817|NCT00555061|6248510|P1|COMPLETED|Overall Study||78
2549818|NCT00555061|6248510|P1|STARTED|Overall Study|One participant did not receive study medication and was not included in the analysis population.|87
2549819|NCT00555048|6248517|P1|NOT COMPLETED|Overall Study||0
2549820|NCT00555048|6248517|P1|COMPLETED|Overall Study||1
2549821|NCT00555048|6248517|P1|STARTED|Overall Study||1
2549822|NCT00555009|6248529|P2|NOT COMPLETED|Overall Study||6
2549823|NCT00555009|6248530|P1|NOT COMPLETED|Overall Study||2
2549824|NCT00555009|6248529|P2|COMPLETED|Overall Study||0
2549825|NCT00555009|6248530|P1|COMPLETED|Overall Study||2
2549826|NCT00555009|6248529|P2|STARTED|Overall Study||6
2549827|NCT00555009|6248530|P1|STARTED|Overall Study||4
2549828|NCT00554996|6248552|P1|NOT COMPLETED|Overall Study||0
2549829|NCT00554996|6248552|P1|COMPLETED|Overall Study||10
2549830|NCT00554996|6248552|P1|STARTED|Overall Study||10
2549831|NCT00554970|6248560|P4|NOT COMPLETED|Period 2||0
2549832|NCT00554970|6248561|P3|NOT COMPLETED|Period 2||1
2549833|NCT00554970|6248562|P2|NOT COMPLETED|Period 2||0
2549834|NCT00554970|6248563|P1|NOT COMPLETED|Period 2||0
2549835|NCT00554970|6248560|P4|COMPLETED|Period 2||8
2549836|NCT00554970|6248561|P3|COMPLETED|Period 2||7
2549837|NCT00554970|6248562|P2|COMPLETED|Period 2||8
2549838|NCT00554970|6248563|P1|COMPLETED|Period 2||7
2549839|NCT00554970|6248560|P4|STARTED|Period 2||8
2549840|NCT00554970|6248561|P3|STARTED|Period 2||8
2549841|NCT00554970|6248562|P2|STARTED|Period 2||8
2549842|NCT00554970|6248563|P1|STARTED|Period 2||7
2549843|NCT00554970|6248560|P4|NOT COMPLETED|Period 1||0
2549844|NCT00554970|6248561|P3|NOT COMPLETED|Period 1||0
2549845|NCT00554970|6248562|P2|NOT COMPLETED|Period 1||0
2549846|NCT00554970|6248563|P1|NOT COMPLETED|Period 1||1
2549847|NCT00554970|6248560|P4|COMPLETED|Period 1||8
2549848|NCT00554970|6248561|P3|COMPLETED|Period 1||8
2549849|NCT00554970|6248562|P2|COMPLETED|Period 1||8
2549850|NCT00554970|6248563|P1|COMPLETED|Period 1||7
2549851|NCT00554970|6248560|P4|STARTED|Period 1||8
2549852|NCT00554970|6248561|P3|STARTED|Period 1||8
2549853|NCT00554970|6248562|P2|STARTED|Period 1||8
2549854|NCT00554970|6248563|P1|STARTED|Period 1||8
2549855|NCT00554853|6248595|P2|NOT COMPLETED|Crossover Arm (3 Months)||2
2549856|NCT00554853|6248596|P1|NOT COMPLETED|Crossover Arm (3 Months)||3
2549857|NCT00554853|6248595|P2|COMPLETED|Crossover Arm (3 Months)||55
2549858|NCT00554853|6248596|P1|COMPLETED|Crossover Arm (3 Months)||53
2549859|NCT00554853|6248595|P2|STARTED|Crossover Arm (3 Months)||57
2549860|NCT00554853|6248596|P1|STARTED|Crossover Arm (3 Months)||56
2549861|NCT00554853|6248595|P2|NOT COMPLETED|Washout Period (2 Weeks)||7
2549862|NCT00554853|6248596|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
2549863|NCT00554853|6248595|P2|COMPLETED|Washout Period (2 Weeks)||57
2549864|NCT00554853|6248596|P1|COMPLETED|Washout Period (2 Weeks)||56
2549865|NCT00554853|6248595|P2|STARTED|Washout Period (2 Weeks)||64
2549866|NCT00554853|6248596|P1|STARTED|Washout Period (2 Weeks)||56
2549867|NCT00554853|6248595|P2|NOT COMPLETED|First Arm of Study||7
2549868|NCT00554853|6248596|P1|NOT COMPLETED|First Arm of Study||16
2549869|NCT00554853|6248595|P2|COMPLETED|First Arm of Study||64
2549870|NCT00554853|6248596|P1|COMPLETED|First Arm of Study||56
2549871|NCT00554853|6248595|P2|STARTED|First Arm of Study||71
2549872|NCT00554853|6248596|P1|STARTED|First Arm of Study||72
2549873|NCT00554840|6248610|P2|NOT COMPLETED|Overall Study||1
2549874|NCT00554840|6248611|P1|NOT COMPLETED|Overall Study||0
2549875|NCT00554840|6248610|P2|COMPLETED|Overall Study||4
2549876|NCT00554840|6248611|P1|COMPLETED|Overall Study||4
2549877|NCT00554840|6248610|P2|STARTED|Overall Study||5
2549878|NCT00554840|6248611|P1|STARTED|Overall Study||4
2549879|NCT00554801|6248629|P2|NOT COMPLETED|Overall Study||0
2549880|NCT00554801|6248630|P1|NOT COMPLETED|Overall Study||19
2549881|NCT00554801|6248629|P2|COMPLETED|Overall Study||29
2549882|NCT00554801|6248630|P1|COMPLETED|Overall Study||36
2549883|NCT00554801|6248629|P2|STARTED|Overall Study||29
2549884|NCT00554801|6248630|P1|STARTED|Overall Study||55
2549885|NCT00554788|6248641|P3|NOT COMPLETED|Overall Study||14
2549886|NCT00554788|6248642|P2|NOT COMPLETED|Overall Study||6
2549887|NCT00554788|6248643|P1|NOT COMPLETED|Overall Study||7
2549888|NCT00554788|6248641|P3|COMPLETED|Overall Study||7
2549889|NCT00554788|6248642|P2|COMPLETED|Overall Study||12
2549890|NCT00554788|6248643|P1|COMPLETED|Overall Study||14
2549891|NCT00554788|6248641|P3|STARTED|Overall Study||21
2549892|NCT00554788|6248642|P2|STARTED|Overall Study||18
2549893|NCT00554788|6248643|P1|STARTED|Overall Study||21
2549894|NCT00554749|6248655|P1|NOT COMPLETED|Overall Study||0
2549895|NCT00554749|6248655|P1|COMPLETED|Overall Study||7
2549896|NCT00554749|6248655|P1|STARTED|Overall Study||7
2549897|NCT00554671|6248662|P2|NOT COMPLETED|Overall Study||16
2549898|NCT00554671|6248663|P1|NOT COMPLETED|Overall Study||20
2549899|NCT00554671|6248662|P2|COMPLETED|Overall Study||117
2549900|NCT00554671|6248663|P1|COMPLETED|Overall Study||97
2549901|NCT00554671|6248662|P2|STARTED|Overall Study||133
2549902|NCT00554671|6248663|P1|STARTED|Overall Study||117
2549903|NCT00554619|6248675|P1|NOT COMPLETED|Overall Study||3
2549904|NCT00554619|6248675|P1|COMPLETED|Overall Study||18
2549905|NCT00554619|6248675|P1|STARTED|Overall Study||21
2549906|NCT00554515|6248687|P1|NOT COMPLETED|Overall Study||118
2549907|NCT00554515|6248687|P1|COMPLETED|Overall Study||5
2549908|NCT00554515|6248687|P1|Treated|Overall Study||120
2549909|NCT00554515|6248687|P1|STARTED|Overall Study||123
2549910|NCT00554463|6248716|P1|NOT COMPLETED|Overall Study||0
2549911|NCT00554463|6248716|P1|COMPLETED|Overall Study||5
2549912|NCT00554463|6248716|P1|STARTED|Overall Study||5
2549913|NCT00554372|6248728|P2|NOT COMPLETED|Overall Study||0
2549914|NCT00554372|6248729|P1|NOT COMPLETED|Overall Study||0
2549915|NCT00554372|6248728|P2|COMPLETED|Overall Study||16
2549916|NCT00554372|6248729|P1|COMPLETED|Overall Study||14
2549917|NCT00554372|6248728|P2|STARTED|Overall Study||16
2549918|NCT00554372|6248729|P1|STARTED|Overall Study||14
2549919|NCT00554294|6248743|P2|NOT COMPLETED|Overall Study||80
2549920|NCT00554294|6248744|P1|NOT COMPLETED|Overall Study||160
2549921|NCT00554294|6248743|P2|COMPLETED|Overall Study||1641
2549922|NCT00554294|6248744|P1|COMPLETED|Overall Study||1309
2549923|NCT00554294|6248743|P2|STARTED|Overall Study||1721
2549924|NCT00554294|6248744|P1|STARTED|Overall Study||1469
2549925|NCT00554229|6248750|P2|NOT COMPLETED|Overall Study||225
2549926|NCT00554229|6248751|P1|NOT COMPLETED|Overall Study||226
2549927|NCT00554229|6248750|P2|COMPLETED|Overall Study||70
2549928|NCT00554229|6248751|P1|COMPLETED|Overall Study||73
2549929|NCT00554229|6248750|P2|Patients Who Received Treatment|Overall Study||295
2549930|NCT00554229|6248751|P1|Patients Who Received Treatment|Overall Study||298
2549931|NCT00554229|6248750|P2|STARTED|Overall Study||295
2549932|NCT00554229|6248751|P1|STARTED|Overall Study||299
2549933|NCT00554216|6248776|P3|NOT COMPLETED|Overall Study||172
2549934|NCT00554216|6248777|P2|NOT COMPLETED|Overall Study||94
2549935|NCT00554216|6248778|P1|NOT COMPLETED|Overall Study||242
2549936|NCT00554216|6248776|P3|COMPLETED|Overall Study||340
2549937|NCT00554216|6248777|P2|COMPLETED|Overall Study||147
2549938|NCT00554216|6248778|P1|COMPLETED|Overall Study||272
2549939|NCT00554216|6248776|P3|STARTED|Overall Study||512
2549940|NCT00554216|6248777|P2|STARTED|Overall Study||241
2549941|NCT00554216|6248778|P1|STARTED|Overall Study||514
2549942|NCT00554190|6248789|P1|NOT COMPLETED|Overall Study||10
2549943|NCT00554190|6248789|P1|COMPLETED|Overall Study|10 subjects did not complete the Termination Study Forms|19
2549944|NCT00554190|6248789|P1|STARTED|Overall Study|29 subjects treated.|29
2549945|NCT00554099|6248798|P3|NOT COMPLETED|Non-Treatment Phase (9 Months)||3
2549946|NCT00554099|6248799|P2|NOT COMPLETED|Non-Treatment Phase (9 Months)||5
2549947|NCT00554099|6248800|P1|NOT COMPLETED|Non-Treatment Phase (9 Months)||7
2549948|NCT00554099|6248798|P3|COMPLETED|Non-Treatment Phase (9 Months)||24
2549949|NCT00554099|6248799|P2|COMPLETED|Non-Treatment Phase (9 Months)||27
2549950|NCT00554099|6248800|P1|COMPLETED|Non-Treatment Phase (9 Months)||22
2549951|NCT00554099|6248798|P3|STARTED|Non-Treatment Phase (9 Months)||27
2549952|NCT00554099|6248799|P2|STARTED|Non-Treatment Phase (9 Months)||32
2549953|NCT00554099|6248800|P1|STARTED|Non-Treatment Phase (9 Months)||29
2549954|NCT00554099|6248798|P3|NOT COMPLETED|Treatment Period (12 Weeks)||9
2549955|NCT00554099|6248799|P2|NOT COMPLETED|Treatment Period (12 Weeks)||8
2549956|NCT00554099|6248800|P1|NOT COMPLETED|Treatment Period (12 Weeks)||12
2549957|NCT00554099|6248798|P3|COMPLETED|Treatment Period (12 Weeks)||27
2549958|NCT00554099|6248799|P2|COMPLETED|Treatment Period (12 Weeks)||32
2549959|NCT00554099|6248800|P1|COMPLETED|Treatment Period (12 Weeks)||29
2549960|NCT00554099|6248798|P3|STARTED|Treatment Period (12 Weeks)||36
2549961|NCT00554099|6248799|P2|STARTED|Treatment Period (12 Weeks)||40
2549962|NCT00554099|6248800|P1|STARTED|Treatment Period (12 Weeks)||41
2549963|NCT00553969|6248833|P4|NOT COMPLETED|Overall Study||1
2549964|NCT00553969|6248834|P3|NOT COMPLETED|Overall Study||1
2549965|NCT00553969|6248835|P2|NOT COMPLETED|Overall Study||0
2549966|NCT00553969|6248836|P1|NOT COMPLETED|Overall Study||8
2549967|NCT00553969|6248833|P4|COMPLETED|Overall Study||23
2549968|NCT00553969|6248834|P3|COMPLETED|Overall Study||21
2549969|NCT00553969|6248835|P2|COMPLETED|Overall Study||24
2549970|NCT00553969|6248836|P1|COMPLETED|Overall Study||23
2549971|NCT00553969|6248833|P4|STARTED|Overall Study||24
2549972|NCT00553969|6248834|P3|STARTED|Overall Study||22
2549973|NCT00553969|6248835|P2|STARTED|Overall Study||24
2549974|NCT00553969|6248836|P1|STARTED|Overall Study||31
2549975|NCT00553839|6248846|P1|NOT COMPLETED|Overall Study||0
2549976|NCT00553839|6248846|P1|COMPLETED|Overall Study||21
2549977|NCT00553839|6248846|P1|STARTED|Overall Study||21
2549978|NCT00553787|6248855|P3|NOT COMPLETED|Overall Study||262
2549979|NCT00553787|6248856|P2|NOT COMPLETED|Overall Study||124
2549980|NCT00553787|6248857|P1|NOT COMPLETED|Overall Study||378
2549981|NCT00553787|6248855|P3|COMPLETED|Overall Study||733
2549982|NCT00553787|6248856|P2|COMPLETED|Overall Study||374
2549983|NCT00553787|6248857|P1|COMPLETED|Overall Study||616
2549984|NCT00553787|6248855|P3|STARTED|Overall Study||995
2549985|NCT00553787|6248856|P2|STARTED|Overall Study||498
2549986|NCT00553787|6248857|P1|STARTED|Overall Study||994
2549987|NCT00553735|6248868|P1|NOT COMPLETED|Overall Study||7
2549988|NCT00553735|6248868|P1|COMPLETED|Overall Study||1
2549989|NCT00553735|6248868|P1|STARTED|Overall Study||8
2549990|NCT00553696|6248889|P4|NOT COMPLETED|Overall Study||1
2549991|NCT00553696|6248890|P3|NOT COMPLETED|Overall Study||6
2549992|NCT00553696|6248891|P2|NOT COMPLETED|Overall Study||16
2549993|NCT00553696|6248892|P1|NOT COMPLETED|Overall Study||4
2549994|NCT00553696|6248889|P4|COMPLETED|Overall Study||0
2549995|NCT00553696|6248890|P3|COMPLETED|Overall Study||0
2549996|NCT00553696|6248891|P2|COMPLETED|Overall Study||0
2549997|NCT00553696|6248892|P1|COMPLETED|Overall Study||0
2549998|NCT00553696|6248889|P4|STARTED|Overall Study||1
2549999|NCT00553696|6248890|P3|STARTED|Overall Study||6
2550000|NCT00553696|6248891|P2|STARTED|Overall Study||16
2550001|NCT00553696|6248892|P1|STARTED|Overall Study||4
2550002|NCT00553644|6248930|P1|NOT COMPLETED|Overall Study||28
2550003|NCT00553644|6248930|P1|COMPLETED|Overall Study||25
2550004|NCT00553644|6248930|P1|STARTED|Overall Study||53
2550005|NCT00553631|6248939|P2|NOT COMPLETED|Overall Study||1
2550006|NCT00553631|6248940|P1|NOT COMPLETED|Overall Study||1
2550007|NCT00553631|6248939|P2|COMPLETED|Overall Study||16
2550008|NCT00553631|6248940|P1|COMPLETED|Overall Study||16
2550009|NCT00553631|6248939|P2|STARTED|Overall Study|Intent-to-treat (ITT) population|17
2550010|NCT00553631|6248940|P1|STARTED|Overall Study|Intent-to-treat (ITT) population|17
2550011|NCT00553605|6248962|P2|NOT COMPLETED|Overall Study||3
2550012|NCT00553605|6248963|P1|NOT COMPLETED|Overall Study||4
2550013|NCT00553605|6248962|P2|COMPLETED|Overall Study||161
2550014|NCT00553605|6248963|P1|COMPLETED|Overall Study||172
2550015|NCT00553605|6248962|P2|Treated|Overall Study||164
2550016|NCT00553605|6248963|P1|Treated|Overall Study||174
2550017|NCT00553605|6248962|P2|STARTED|Overall Study||164
2550018|NCT00553605|6248963|P1|STARTED|Overall Study||176
2550019|NCT00553540|6248989|P2|NOT COMPLETED|Overall Study||5
2550020|NCT00553540|6248990|P1|NOT COMPLETED|Overall Study||2
2550021|NCT00553540|6248989|P2|COMPLETED|Overall Study||20
2550022|NCT00553540|6248990|P1|COMPLETED|Overall Study||23
2550023|NCT00553540|6248989|P2|STARTED|Overall Study||25
2550024|NCT00553540|6248990|P1|STARTED|Overall Study||25
2550025|NCT00553514|6249001|P5|NOT COMPLETED|Overall Study||7
2550026|NCT00553514|6249002|P4|NOT COMPLETED|Overall Study||7
2550027|NCT00553514|6249003|P3|NOT COMPLETED|Overall Study||6
2550028|NCT00553514|6249004|P2|NOT COMPLETED|Overall Study||8
2550029|NCT00553514|6249005|P1|NOT COMPLETED|Overall Study||8
2550030|NCT00553514|6249001|P5|COMPLETED|Overall Study||8
2550031|NCT00553514|6249002|P4|COMPLETED|Overall Study||6
2550032|NCT00553514|6249003|P3|COMPLETED|Overall Study||9
2550033|NCT00553514|6249004|P2|COMPLETED|Overall Study||6
2550034|NCT00553514|6249005|P1|COMPLETED|Overall Study||6
2550035|NCT00553514|6249001|P5|STARTED|Overall Study||15
2550036|NCT00553514|6249002|P4|STARTED|Overall Study||13
2550037|NCT00553514|6249003|P3|STARTED|Overall Study||15
2550038|NCT00553514|6249004|P2|STARTED|Overall Study||14
2550039|NCT00553514|6249005|P1|STARTED|Overall Study||14
2550040|NCT00553501|6249042|P1|NOT COMPLETED|Overall Study||4
2550041|NCT00553501|6249042|P1|COMPLETED|Overall Study||55
2550042|NCT00553501|6249042|P1|STARTED|Overall Study||59
2550043|NCT00553475|6249051|P3|NOT COMPLETED|Overall Study||13
2550044|NCT00553475|6249052|P2|NOT COMPLETED|Overall Study||20
2550045|NCT00553475|6249053|P1|NOT COMPLETED|Overall Study||16
2550046|NCT00553475|6249051|P3|COMPLETED|Overall Study||32
2550047|NCT00553475|6249052|P2|COMPLETED|Overall Study||114
2550048|NCT00553475|6249053|P1|COMPLETED|Overall Study||119
2550049|NCT00553475|6249051|P3|STARTED|Overall Study||45
2550050|NCT00553475|6249052|P2|STARTED|Overall Study||134
2550051|NCT00553475|6249053|P1|STARTED|Overall Study||135
2550052|NCT00553462|6249175|P1|NOT COMPLETED|Overall Study||14
2550053|NCT00553462|6249175|P1|COMPLETED|Overall Study||61
2550054|NCT00553462|6249175|P1|STARTED|Overall Study||75
2550055|NCT00553436|6249181|P1|NOT COMPLETED|Overall Study||1
2550056|NCT00553436|6249181|P1|COMPLETED|Overall Study|09 April 2009|6
2550057|NCT00553436|6249181|P1|STARTED|Overall Study|20 August 2007|7
2550058|NCT00553410|6249189|P2|NOT COMPLETED|Overall Study||18
2550059|NCT00553410|6249190|P1|NOT COMPLETED|Overall Study||15
2550060|NCT00553410|6249189|P2|COMPLETED|Overall Study||2425
2550061|NCT00553410|6249190|P1|COMPLETED|Overall Study||2426
2550062|NCT00553410|6249189|P2|STARTED|Overall Study||2443
2550063|NCT00553410|6249190|P1|STARTED|Overall Study||2441
2550064|NCT00553358|6249205|P3|NOT COMPLETED|Overall Study||60
2550065|NCT00553358|6249206|P2|NOT COMPLETED|Overall Study||12
2550066|NCT00553358|6249207|P1|NOT COMPLETED|Overall Study||53
2550067|NCT00553358|6249205|P3|COMPLETED|Overall Study||92
2550068|NCT00553358|6249206|P2|COMPLETED|Overall Study||137
2550069|NCT00553358|6249207|P1|COMPLETED|Overall Study||101
2550070|NCT00553358|6249205|P3|STARTED|Overall Study||152
2550071|NCT00553358|6249206|P2|STARTED|Overall Study||149
2550072|NCT00553358|6249207|P1|STARTED|Overall Study||154
2550073|NCT00553332|6249233|P1|NOT COMPLETED|Overall Study||1
2550074|NCT00553332|6249233|P1|COMPLETED|Overall Study|evaluable for response|28
2550075|NCT00553332|6249233|P1|STARTED|Overall Study||29
2550076|NCT00553319|6249245|P3|NOT COMPLETED|Overall Study||9
2550077|NCT00553319|6249246|P2|NOT COMPLETED|Overall Study||10
2550078|NCT00553319|6249247|P1|NOT COMPLETED|Overall Study||14
2550079|NCT00553319|6249245|P3|COMPLETED|Overall Study||34
2550080|NCT00553319|6249246|P2|COMPLETED|Overall Study||30
2550081|NCT00553319|6249247|P1|COMPLETED|Overall Study||29
2550082|NCT00553319|6249245|P3|STARTED|Overall Study||43
2550083|NCT00553319|6249246|P2|STARTED|Overall Study||40
2550084|NCT00553319|6249247|P1|STARTED|Overall Study||43
2550085|NCT00553280|6249258|P1|NOT COMPLETED|Overall Study||26
2550086|NCT00553280|6249258|P1|COMPLETED|Overall Study||97
2550087|NCT00553280|6249258|P1|STARTED|Overall Study||123
2550088|NCT00553267|6249270|P3|NOT COMPLETED|Overall Study||10
2550089|NCT00553267|6249271|P2|NOT COMPLETED|Overall Study||18
2550090|NCT00553267|6249272|P1|NOT COMPLETED|Overall Study||14
2550091|NCT00553267|6249270|P3|COMPLETED|Overall Study||307
2550092|NCT00553267|6249271|P2|COMPLETED|Overall Study||297
2550093|NCT00553267|6249272|P1|COMPLETED|Overall Study||301
2550094|NCT00553267|6249270|P3|STARTED|Overall Study||317
2550095|NCT00553267|6249271|P2|STARTED|Overall Study||315
2550096|NCT00553267|6249272|P1|STARTED|Overall Study||315
2550097|NCT00553202|6249307|P1|NOT COMPLETED|Overall Study||68
2550098|NCT00553202|6249307|P1|COMPLETED|Overall Study||90
2550099|NCT00553202|6249307|P1|STARTED|Overall Study||158
2550100|NCT00553163|6249317|P2|NOT COMPLETED|Overall Study||0
2550101|NCT00553163|6249318|P1|NOT COMPLETED|Overall Study||0
2550102|NCT00553163|6249317|P2|COMPLETED|Overall Study||10
2550103|NCT00553163|6249318|P1|COMPLETED|Overall Study||16
2550104|NCT00553163|6249317|P2|STARTED|Overall Study||10
2550105|NCT00553163|6249318|P1|STARTED|Overall Study||16
2550106|NCT00553150|6249334|P4|NOT COMPLETED|Overall Study||4
2550107|NCT00553150|6249335|P3|NOT COMPLETED|Overall Study||0
2550108|NCT00553150|6249336|P2|NOT COMPLETED|Overall Study||0
2550109|NCT00553150|6249337|P1|NOT COMPLETED|Overall Study||0
2550110|NCT00553150|6249334|P4|COMPLETED|Overall Study||100
2550111|NCT00553150|6249335|P3|COMPLETED|Overall Study||6
2550112|NCT00553150|6249336|P2|COMPLETED|Overall Study||6
2550113|NCT00553150|6249337|P1|COMPLETED|Overall Study||6
2550114|NCT00553150|6249334|P4|STARTED|Overall Study||104
2550115|NCT00553150|6249335|P3|STARTED|Overall Study||6
2550116|NCT00553150|6249336|P2|STARTED|Overall Study||6
2550117|NCT00553150|6249337|P1|STARTED|Overall Study||6
2550121|NCT00552929|6249373|P10|NOT COMPLETED|Overall Study||0
2550122|NCT00552929|6249374|P9|NOT COMPLETED|Overall Study||1
2550123|NCT00552929|6249375|P8|NOT COMPLETED|Overall Study||0
2550124|NCT00552929|6249376|P7|NOT COMPLETED|Overall Study||0
2550125|NCT00552929|6249377|P6|NOT COMPLETED|Overall Study||1
2550126|NCT00552929|6249378|P5|NOT COMPLETED|Overall Study||0
2550127|NCT00552929|6249379|P4|NOT COMPLETED|Overall Study||0
2550128|NCT00552929|6249380|P3|NOT COMPLETED|Overall Study||0
2550129|NCT00552929|6249381|P2|NOT COMPLETED|Overall Study||0
2550130|NCT00552929|6249382|P1|NOT COMPLETED|Overall Study||0
2550131|NCT00552929|6249373|P10|COMPLETED|Overall Study||11
2550132|NCT00552929|6249374|P9|COMPLETED|Overall Study||9
2550133|NCT00552929|6249375|P8|COMPLETED|Overall Study||11
2550134|NCT00552929|6249376|P7|COMPLETED|Overall Study||10
2550135|NCT00552929|6249377|P6|COMPLETED|Overall Study||9
2550136|NCT00552929|6249378|P5|COMPLETED|Overall Study||10
2550137|NCT00552929|6249379|P4|COMPLETED|Overall Study||11
2550138|NCT00552929|6249380|P3|COMPLETED|Overall Study||10
2550139|NCT00552929|6249381|P2|COMPLETED|Overall Study||10
2550140|NCT00552929|6249382|P1|COMPLETED|Overall Study||9
2550141|NCT00552929|6249373|P10|Participants as Treated|Overall Study||11
2550142|NCT00552929|6249374|P9|Participants as Treated|Overall Study||10
2550143|NCT00552929|6249375|P8|Participants as Treated|Overall Study||11
2550144|NCT00552929|6249376|P7|Participants as Treated|Overall Study||10
2550145|NCT00552929|6249377|P6|Participants as Treated|Overall Study||9
2550146|NCT00552929|6249378|P5|Participants as Treated|Overall Study||10
2550147|NCT00552929|6249379|P4|Participants as Treated|Overall Study|One participant randomized to sugammadex 0.5 mg/kg received sugammadex 3.7 mg/kg (4.0 mg\kg group)|11
2550148|NCT00552929|6249380|P3|Participants as Treated|Overall Study||10
2550149|NCT00552929|6249381|P2|Participants as Treated|Overall Study||10
2550150|NCT00552929|6249382|P1|Participants as Treated|Overall Study|One participant randomized to sugammadex 0.5 mg/kg received sugammadex 3.7 mg/kg (4.0 mg\kg group)|9
2550151|NCT00552929|6249373|P10|STARTED|Overall Study||11
2550152|NCT00552929|6249374|P9|STARTED|Overall Study||10
2550153|NCT00552929|6249375|P8|STARTED|Overall Study||11
2550154|NCT00552929|6249376|P7|STARTED|Overall Study||10
2550155|NCT00552929|6249377|P6|STARTED|Overall Study||10
2550156|NCT00552929|6249378|P5|STARTED|Overall Study||10
2550157|NCT00552929|6249379|P4|STARTED|Overall Study||11
2550158|NCT00552929|6249380|P3|STARTED|Overall Study||10
2550159|NCT00552929|6249381|P2|STARTED|Overall Study||10
2550160|NCT00552929|6249382|P1|STARTED|Overall Study||9
2550161|NCT00552812|6249434|P1|NOT COMPLETED|Overall Study||20
2550162|NCT00552812|6249434|P1|COMPLETED|Overall Study|Some still remain inside the 2 year follow up window. 2 year follow up data is not yet complete.|85
2550163|NCT00552812|6249434|P1|STARTED|Overall Study|168 consents, 57 failed cath criteria, 5 met criteria but received covered stent, 1 withdrew consent|105
2550164|NCT00552786|6249442|P2|NOT COMPLETED|Second Intervention||0
2550165|NCT00552786|6249443|P1|NOT COMPLETED|Second Intervention||0
2550166|NCT00552786|6249442|P2|COMPLETED|Second Intervention||28
2550167|NCT00552786|6249443|P1|COMPLETED|Second Intervention||25
2550168|NCT00552786|6249442|P2|STARTED|Second Intervention||28
2550169|NCT00552786|6249443|P1|STARTED|Second Intervention||25
2550170|NCT00552786|6249442|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
2550171|NCT00552786|6249443|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
2550172|NCT00552786|6249442|P2|COMPLETED|Washout Period of 2 Weeks||28
2550173|NCT00552786|6249443|P1|COMPLETED|Washout Period of 2 Weeks||25
2550174|NCT00552786|6249442|P2|STARTED|Washout Period of 2 Weeks||28
2550175|NCT00552786|6249443|P1|STARTED|Washout Period of 2 Weeks||25
2550176|NCT00552786|6249442|P2|NOT COMPLETED|First Intervention||0
2550177|NCT00552786|6249443|P1|NOT COMPLETED|First Intervention||0
2550178|NCT00552786|6249442|P2|COMPLETED|First Intervention||28
2550179|NCT00552786|6249443|P1|COMPLETED|First Intervention||25
2550180|NCT00552786|6249442|P2|Medication and Hearing Evaluation|First Intervention||28
2550181|NCT00552786|6249443|P1|Medication and Hearing Evaluation|First Intervention||25
2550182|NCT00552786|6249442|P2|STARTED|First Intervention||28
2550183|NCT00552786|6249443|P1|STARTED|First Intervention||25
2550184|NCT00552760|6249453|P2|NOT COMPLETED|Overall Study||33
2550185|NCT00552760|6249454|P1|NOT COMPLETED|Overall Study||26
2550186|NCT00552760|6249453|P2|COMPLETED|Overall Study||8
2550187|NCT00552760|6249454|P1|COMPLETED|Overall Study||16
2550188|NCT00552760|6249453|P2|STARTED|Overall Study||41
2550189|NCT00552760|6249454|P1|STARTED|Overall Study||42
2550190|NCT00552695|6249470|P2|NOT COMPLETED|Overall Study||0
2550191|NCT00552695|6249471|P1|NOT COMPLETED|Overall Study||0
2550192|NCT00552695|6249470|P2|COMPLETED|Overall Study|September 2007|23
2550193|NCT00552695|6249471|P1|COMPLETED|Overall Study|September 2007|22
2550194|NCT00552695|6249470|P2|STARTED|Overall Study|August 2007|23
2550195|NCT00552695|6249471|P1|STARTED|Overall Study|August 2007|22
2550196|NCT00552669|6249481|P2|NOT COMPLETED|Overall Study||7
2550197|NCT00552669|6249482|P1|NOT COMPLETED|Overall Study||3
2550198|NCT00552669|6249481|P2|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|93
2550199|NCT00552669|6249482|P1|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|97
2550200|NCT00552669|6249481|P2|STARTED|Overall Study|patients|100
2550201|NCT00552669|6249482|P1|STARTED|Overall Study|patients|100
2550202|NCT00552617|6249502|P10|NOT COMPLETED|Overall Study||1
2550203|NCT00552617|6249503|P9|NOT COMPLETED|Overall Study||2
2550204|NCT00552617|6249504|P8|NOT COMPLETED|Overall Study||0
2550205|NCT00552617|6249505|P7|NOT COMPLETED|Overall Study||0
2550206|NCT00552617|6249506|P6|NOT COMPLETED|Overall Study||2
2550207|NCT00552617|6249507|P5|NOT COMPLETED|Overall Study||0
2550208|NCT00552617|6249508|P4|NOT COMPLETED|Overall Study||1
2550209|NCT00552617|6249509|P3|NOT COMPLETED|Overall Study||1
2550210|NCT00552617|6249510|P2|NOT COMPLETED|Overall Study||0
2550211|NCT00552617|6249511|P1|NOT COMPLETED|Overall Study||0
2550212|NCT00552617|6249502|P10|COMPLETED|Overall Study||9
2550213|NCT00552617|6249503|P9|COMPLETED|Overall Study||8
2550214|NCT00552617|6249504|P8|COMPLETED|Overall Study||10
2550215|NCT00552617|6249505|P7|COMPLETED|Overall Study||10
2550216|NCT00552617|6249506|P6|COMPLETED|Overall Study||8
2550217|NCT00552617|6249507|P5|COMPLETED|Overall Study||10
2550218|NCT00552617|6249508|P4|COMPLETED|Overall Study||9
2550219|NCT00552617|6249509|P3|COMPLETED|Overall Study||9
2550220|NCT00552617|6249510|P2|COMPLETED|Overall Study||10
2550221|NCT00552617|6249511|P1|COMPLETED|Overall Study||10
2550222|NCT00552617|6249502|P10|Treated|Overall Study||9
2550223|NCT00552617|6249503|P9|Treated|Overall Study||10
2550224|NCT00552617|6249504|P8|Treated|Overall Study||10
2550225|NCT00552617|6249505|P7|Treated|Overall Study||10
2550226|NCT00552617|6249506|P6|Treated|Overall Study||10
2550227|NCT00552617|6249507|P5|Treated|Overall Study||10
2550228|NCT00552617|6249508|P4|Treated|Overall Study||10
2550229|NCT00552617|6249509|P3|Treated|Overall Study||9
2550230|NCT00552617|6249510|P2|Treated|Overall Study||10
2550231|NCT00552617|6249511|P1|Treated|Overall Study||10
2550232|NCT00552617|6249502|P10|STARTED|Overall Study||10
2550233|NCT00552617|6249503|P9|STARTED|Overall Study||10
2550234|NCT00552617|6249504|P8|STARTED|Overall Study||10
2550235|NCT00552617|6249505|P7|STARTED|Overall Study||10
2550236|NCT00552617|6249506|P6|STARTED|Overall Study||10
2550237|NCT00552617|6249507|P5|STARTED|Overall Study||10
2550238|NCT00552617|6249508|P4|STARTED|Overall Study||10
2550239|NCT00552617|6249509|P3|STARTED|Overall Study||10
2550240|NCT00552617|6249510|P2|STARTED|Overall Study||10
2550241|NCT00552617|6249511|P1|STARTED|Overall Study||10
2550242|NCT00552578|6249555|P2|NOT COMPLETED|Overall Study||1
2550243|NCT00552578|6249556|P1|NOT COMPLETED|Overall Study||1
2550244|NCT00552578|6249555|P2|COMPLETED|Overall Study||5
2550245|NCT00552578|6249556|P1|COMPLETED|Overall Study||5
2550246|NCT00552578|6249555|P2|STARTED|Overall Study||6
2550247|NCT00552578|6249556|P1|STARTED|Overall Study||6
2550248|NCT00552513|6249568|P2|NOT COMPLETED|Overall Study||1
2550249|NCT00552513|6249569|P1|NOT COMPLETED|Overall Study||5
2550250|NCT00552513|6249568|P2|COMPLETED|Overall Study||1437
2550251|NCT00552513|6249569|P1|COMPLETED|Overall Study||1588
2550252|NCT00552513|6249568|P2|STARTED|Overall Study||1438
2550253|NCT00552513|6249569|P1|STARTED|Overall Study||1593
2550254|NCT00552448|6249581|P2|NOT COMPLETED|Overall Study||0
2550255|NCT00552448|6249582|P1|NOT COMPLETED|Overall Study||1
2550256|NCT00552448|6249581|P2|COMPLETED|Overall Study||16
2550257|NCT00552448|6249582|P1|COMPLETED|Overall Study||19
2550258|NCT00552448|6249581|P2|STARTED|Overall Study||16
2550259|NCT00552448|6249582|P1|STARTED|Overall Study||20
2550260|NCT00552422|6249594|P1|NOT COMPLETED|Overall Study||0
2550261|NCT00552422|6249594|P1|COMPLETED|Overall Study||6
2550262|NCT00552422|6249594|P1|STARTED|Overall Study||6
2550263|NCT00552409|6249600|P2|NOT COMPLETED|Overall Study||2
2550264|NCT00552409|6249601|P1|NOT COMPLETED|Overall Study||1
2550265|NCT00552409|6249600|P2|COMPLETED|Overall Study||9
2550266|NCT00552409|6249601|P1|COMPLETED|Overall Study||10
2550267|NCT00552409|6249600|P2|STARTED|Overall Study||11
2550268|NCT00552409|6249601|P1|STARTED|Overall Study||11
2550269|NCT00552396|6249614|P7|NOT COMPLETED|Overall Study||9
2550270|NCT00552396|6249615|P6|NOT COMPLETED|Overall Study||3
2550271|NCT00552396|6249616|P5|NOT COMPLETED|Overall Study||3
2550272|NCT00552396|6249617|P4|NOT COMPLETED|Overall Study||6
2550273|NCT00552396|6249618|P3|NOT COMPLETED|Overall Study||3
2550274|NCT00552396|6249619|P2|NOT COMPLETED|Overall Study||3
2550275|NCT00552396|6249620|P1|NOT COMPLETED|Overall Study||3
2550276|NCT00552396|6249614|P7|COMPLETED|Overall Study||1
2550277|NCT00552396|6249615|P6|COMPLETED|Overall Study||0
2550278|NCT00552396|6249616|P5|COMPLETED|Overall Study||0
2550279|NCT00552396|6249617|P4|COMPLETED|Overall Study||0
2550280|NCT00552396|6249618|P3|COMPLETED|Overall Study||0
2550281|NCT00552396|6249619|P2|COMPLETED|Overall Study||0
2550282|NCT00552396|6249620|P1|COMPLETED|Overall Study||1
2550283|NCT00552396|6249614|P7|STARTED|Overall Study||10
2550284|NCT00552396|6249615|P6|STARTED|Overall Study||3
2550285|NCT00552396|6249616|P5|STARTED|Overall Study||3
2550286|NCT00552396|6249617|P4|STARTED|Overall Study||6
2550287|NCT00552396|6249618|P3|STARTED|Overall Study||3
2550288|NCT00552396|6249619|P2|STARTED|Overall Study||3
2550289|NCT00552396|6249620|P1|STARTED|Overall Study||4
2550290|NCT00552344|6249657|P1|NOT COMPLETED|Overall Study||315
2550291|NCT00552344|6249657|P1|COMPLETED|Overall Study||87
2550292|NCT00552344|6249657|P1|STARTED|Overall Study||402
2550293|NCT00552305|6249666|P1|NOT COMPLETED|Overall Study||250
2550294|NCT00552305|6249666|P1|COMPLETED|Overall Study||120
2550295|NCT00552305|6249666|P1|STARTED|Overall Study||370
2550296|NCT00552279|6249676|P2|NOT COMPLETED|Overall Study||3
2550297|NCT00552279|6249677|P1|NOT COMPLETED|Overall Study||14
2550298|NCT00552279|6249676|P2|COMPLETED|Overall Study||398
2550299|NCT00552279|6249677|P1|COMPLETED|Overall Study||389
2550300|NCT00552279|6249676|P2|STARTED|Overall Study||401
2550301|NCT00552279|6249677|P1|STARTED|Overall Study||403
2550302|NCT00552240|6249703|P2|NOT COMPLETED|Overall Study||18
2550303|NCT00552240|6249704|P1|NOT COMPLETED|Overall Study||24
2550304|NCT00552240|6249703|P2|COMPLETED|Overall Study||59
2550305|NCT00552240|6249704|P1|COMPLETED|Overall Study||51
2550306|NCT00552240|6249703|P2|STARTED|Overall Study|Number in Full Analysis Set (FAS)|77
2550307|NCT00552240|6249704|P1|STARTED|Overall Study|Number in Full Analysis Set (FAS)|75
2550308|NCT00552188|6249806|P2|NOT COMPLETED|Overall Study||5
2550309|NCT00552188|6249807|P1|NOT COMPLETED|Overall Study||2
2550310|NCT00552188|6249806|P2|COMPLETED|Overall Study||21
2550311|NCT00552188|6249807|P1|COMPLETED|Overall Study||24
2550312|NCT00552188|6249806|P2|STARTED|Overall Study||26
2550313|NCT00552188|6249807|P1|STARTED|Overall Study||26
2550314|NCT00552175|6249818|P3|NOT COMPLETED|Overall Study||14
2550315|NCT00552175|6249819|P2|NOT COMPLETED|Overall Study||13
2550316|NCT00552175|6249820|P1|NOT COMPLETED|Overall Study||17
2550317|NCT00552175|6249818|P3|COMPLETED|Overall Study||72
2550318|NCT00552175|6249819|P2|COMPLETED|Overall Study||73
2550319|NCT00552175|6249820|P1|COMPLETED|Overall Study||150
2550320|NCT00552175|6249818|P3|Full Analysis Set Population|Overall Study||86
2550321|NCT00552175|6249819|P2|Full Analysis Set Population|Overall Study||85
2550322|NCT00552175|6249820|P1|Full Analysis Set Population|Overall Study||167
2550323|NCT00552175|6249818|P3|STARTED|Overall Study||86
2550324|NCT00552175|6249819|P2|STARTED|Overall Study||86
2550325|NCT00552175|6249820|P1|STARTED|Overall Study||167
2550326|NCT00552110|6249860|P5|NOT COMPLETED|Overall Study||9
2550327|NCT00552110|6249861|P4|NOT COMPLETED|Overall Study||8
2550328|NCT00552110|6249862|P3|NOT COMPLETED|Overall Study||2
2550329|NCT00552110|6249863|P2|NOT COMPLETED|Overall Study||5
2550330|NCT00552110|6249864|P1|NOT COMPLETED|Overall Study||4
2550331|NCT00552110|6249860|P5|COMPLETED|Overall Study||133
2550332|NCT00552110|6249861|P4|COMPLETED|Overall Study||133
2550333|NCT00552110|6249862|P3|COMPLETED|Overall Study||137
2550334|NCT00552110|6249863|P2|COMPLETED|Overall Study||134
2550335|NCT00552110|6249864|P1|COMPLETED|Overall Study||142
2550336|NCT00552110|6249860|P5|STARTED|Overall Study||142
2550337|NCT00552110|6249861|P4|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|141
2550338|NCT00552110|6249862|P3|STARTED|Overall Study||139
2550339|NCT00552110|6249863|P2|STARTED|Overall Study||139
2550340|NCT00552110|6249864|P1|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|146
2550341|NCT00552084|6249883|P2|NOT COMPLETED|Overall Study||9
2550342|NCT00552084|6249884|P1|NOT COMPLETED|Overall Study||8
2550343|NCT00552084|6249883|P2|COMPLETED|Overall Study||55
2550344|NCT00552084|6249884|P1|COMPLETED|Overall Study||118
2550345|NCT00552084|6249883|P2|STARTED|Overall Study||64
2550346|NCT00552084|6249884|P1|STARTED|Overall Study||126
2550347|NCT00552071|6249892|P2|NOT COMPLETED|Overall Study||2
2550348|NCT00552071|6249893|P1|NOT COMPLETED|Overall Study||4
2550349|NCT00552071|6249892|P2|COMPLETED|Overall Study||9
2550350|NCT00552071|6249893|P1|COMPLETED|Overall Study||6
2550351|NCT00552071|6249892|P2|STARTED|Overall Study||11
2550352|NCT00552071|6249893|P1|STARTED|Overall Study||10
2550353|NCT00552058|6249903|P2|NOT COMPLETED|Overall Study||24
2550354|NCT00552058|6249904|P1|NOT COMPLETED|Overall Study||16
2550355|NCT00552058|6249903|P2|COMPLETED|Overall Study||192
2550356|NCT00552058|6249904|P1|COMPLETED|Overall Study||207
2550357|NCT00552058|6249903|P2|STARTED|Overall Study||216
2550358|NCT00552058|6249904|P1|STARTED|Overall Study||223
2550359|NCT00552032|6249944|P2|NOT COMPLETED|Overall Study||19
2550360|NCT00552032|6249945|P1|NOT COMPLETED|Overall Study||17
2550361|NCT00552032|6249944|P2|COMPLETED|Overall Study||47
2550362|NCT00552032|6249945|P1|COMPLETED|Overall Study||49
2550363|NCT00552032|6249944|P2|STARTED|Overall Study||66
2550364|NCT00552032|6249945|P1|STARTED|Overall Study||66
2550365|NCT00551759|6249989|P1|NOT COMPLETED|Overall Study||13
2550366|NCT00551759|6249989|P1|COMPLETED|Overall Study||9
2550367|NCT00551759|6249989|P1|Received Adjuvant Therapy|Overall Study||12
2550368|NCT00551759|6249989|P1|Underwent Surgery|Overall Study||17
2550369|NCT00551759|6249989|P1|Eligible and Began Treatment|Overall Study||21
2550370|NCT00551759|6249989|P1|STARTED|Overall Study||22
2550371|NCT00551746|6249995|P2|NOT COMPLETED|Overall Study||8
2550372|NCT00551746|6249996|P1|NOT COMPLETED|Overall Study||11
2550373|NCT00551746|6249995|P2|COMPLETED|Overall Study||26
2550374|NCT00551746|6249996|P1|COMPLETED|Overall Study||25
2550375|NCT00551746|6249995|P2|STARTED|Overall Study||34
2550376|NCT00551746|6249996|P1|STARTED|Overall Study||36
2550377|NCT00551707|6250007|P5|NOT COMPLETED|Overall Study||1
2550378|NCT00551707|6250008|P4|NOT COMPLETED|Overall Study||4
2550379|NCT00551707|6250009|P3|NOT COMPLETED|Overall Study||3
2550380|NCT00551707|6250010|P2|NOT COMPLETED|Overall Study||6
2550381|NCT00551707|6250011|P1|NOT COMPLETED|Overall Study||0
2550382|NCT00551707|6250007|P5|COMPLETED|Overall Study||3
2550383|NCT00551707|6250008|P4|COMPLETED|Overall Study||4
2550384|NCT00551707|6250009|P3|COMPLETED|Overall Study||10
2550385|NCT00551707|6250010|P2|COMPLETED|Overall Study||16
2550386|NCT00551707|6250011|P1|COMPLETED|Overall Study||4
2550387|NCT00551707|6250007|P5|STARTED|Overall Study||4
2550388|NCT00551707|6250008|P4|STARTED|Overall Study||8
2550389|NCT00551707|6250009|P3|STARTED|Overall Study||13
2550390|NCT00551707|6250010|P2|STARTED|Overall Study||22
2550391|NCT00551707|6250011|P1|STARTED|Overall Study||4
2550392|NCT00551642|6250030|P2|NOT COMPLETED|Overall Study||63
2550393|NCT00551642|6250031|P1|NOT COMPLETED|Overall Study||61
2550394|NCT00551642|6250030|P2|COMPLETED|Overall Study||338
2550395|NCT00551642|6250031|P1|COMPLETED|Overall Study||338
2550396|NCT00551642|6250030|P2|STARTED|Overall Study||401
2550397|NCT00551642|6250031|P1|STARTED|Overall Study||399
2550398|NCT00551525|6250037|P1|NOT COMPLETED|Overall Study||5
2550399|NCT00551525|6250037|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study|62
2550400|NCT00551525|6250037|P1|STARTED|Overall Study||67
2550401|NCT00551460|6250046|P1|NOT COMPLETED|Overall Study||18
2550402|NCT00551460|6250046|P1|COMPLETED|Overall Study||60
2550403|NCT00551460|6250046|P1|STARTED|Overall Study||78
2550404|NCT00551421|6250052|P1|NOT COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||1
2550405|NCT00551421|6250052|P1|COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||13
2550406|NCT00551421|6250052|P1|STARTED|Amended Protocol (Cetuximab-refr. mCRC)||14
2550407|NCT00551421|6250052|P1|NOT COMPLETED|Original Protocol, Dose Level 1||0
2550408|NCT00551421|6250052|P1|COMPLETED|Original Protocol, Dose Level 1|1 subject developed Grade 3 diarrhea, all 3 subjects experienced significant skin toxicity.|3
2550409|NCT00551421|6250052|P1|STARTED|Original Protocol, Dose Level 1||3
2550410|NCT00551369|6250059|P1|NOT COMPLETED|Overall Study||7
2550411|NCT00551369|6250059|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|26
2550412|NCT00551369|6250059|P1|STARTED|Overall Study||33
2550413|NCT00551291|6250068|P1|NOT COMPLETED|Overall Study||1
2550414|NCT00551291|6250068|P1|COMPLETED|Overall Study||9
2550415|NCT00551291|6250068|P1|STARTED|Overall Study||10
2550416|NCT00551213|6250076|P2|NOT COMPLETED|Overall Study||17
2550417|NCT00551213|6250077|P1|NOT COMPLETED|Overall Study||50
2550418|NCT00551213|6250076|P2|COMPLETED|Overall Study||0
2550419|NCT00551213|6250077|P1|COMPLETED|Overall Study||0
2550420|NCT00551213|6250076|P2|Treated|Overall Study||15
2550421|NCT00551213|6250077|P1|Treated|Overall Study||49
2550422|NCT00551213|6250076|P2|STARTED|Overall Study||17
2550423|NCT00551213|6250077|P1|STARTED|Overall Study||50
2550424|NCT00551200|6250093|P1|NOT COMPLETED|Overall Study||4
2550425|NCT00551200|6250093|P1|COMPLETED|Overall Study||10
2550426|NCT00551200|6250093|P1|STARTED|Overall Study||14
2550427|NCT00551174|6250108|P2|NOT COMPLETED|Overall Study||6
2550428|NCT00551174|6250109|P1|NOT COMPLETED|Overall Study||19
2550429|NCT00551174|6250108|P2|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|394
2550430|NCT00551174|6250109|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|362
2550431|NCT00551174|6250108|P2|STARTED|Overall Study||400
2550432|NCT00551174|6250109|P1|STARTED|Overall Study||381
2550433|NCT00551161|6250121|P1|NOT COMPLETED|Overall Study||1
2550434|NCT00551161|6250121|P1|COMPLETED|Overall Study||11
2550435|NCT00551161|6250121|P1|STARTED|Overall Study||12
2550436|NCT00551135|6250129|P4|NOT COMPLETED|Overall Study||5
2550437|NCT00551135|6250130|P3|NOT COMPLETED|Overall Study||5
2550438|NCT00551135|6250131|P2|NOT COMPLETED|Overall Study||2
2550439|NCT00551135|6250132|P1|NOT COMPLETED|Overall Study||5
2550440|NCT00551135|6250129|P4|COMPLETED|Overall Study||103
2550441|NCT00551135|6250130|P3|COMPLETED|Overall Study||98
2550442|NCT00551135|6250131|P2|COMPLETED|Overall Study||104
2550443|NCT00551135|6250132|P1|COMPLETED|Overall Study||103
2550444|NCT00551135|6250129|P4|STARTED|Overall Study||108
2550445|NCT00551135|6250130|P3|STARTED|Overall Study||103
2550446|NCT00551135|6250131|P2|STARTED|Overall Study||106
2550447|NCT00551135|6250132|P1|STARTED|Overall Study||108
2550448|NCT00551070|6250246|P1|NOT COMPLETED|Overall Study||0
2550449|NCT00551070|6250246|P1|COMPLETED|Overall Study||52
2550450|NCT00551070|6250246|P1|STARTED|Overall Study||52
2550451|NCT00551031|6250261|P5|NOT COMPLETED|Overall Study||1
2550452|NCT00551031|6250262|P4|NOT COMPLETED|Overall Study||3
2550453|NCT00551031|6250263|P3|NOT COMPLETED|Overall Study||2
2550454|NCT00551031|6250264|P2|NOT COMPLETED|Overall Study||11
2550455|NCT00551031|6250265|P1|NOT COMPLETED|Overall Study||2
2550456|NCT00551031|6250261|P5|COMPLETED|Overall Study||185
2550457|NCT00551031|6250262|P4|COMPLETED|Overall Study||317
2550458|NCT00551031|6250263|P3|COMPLETED|Overall Study||317
2550459|NCT00551031|6250264|P2|COMPLETED|Overall Study||625
2550460|NCT00551031|6250265|P1|COMPLETED|Overall Study||635
2550461|NCT00551031|6250261|P5|STARTED|Overall Study||186
2550462|NCT00551031|6250262|P4|STARTED|Overall Study||320
2550463|NCT00551031|6250263|P3|STARTED|Overall Study||319
2550464|NCT00551031|6250264|P2|STARTED|Overall Study||636
2550465|NCT00551031|6250265|P1|STARTED|Overall Study||637
2550466|NCT00550953|6250294|P2|NOT COMPLETED|Overall Study||6
2550467|NCT00550953|6250295|P1|NOT COMPLETED|Overall Study||6
2550468|NCT00550953|6250294|P2|COMPLETED|Overall Study||152
2550469|NCT00550953|6250295|P1|COMPLETED|Overall Study||150
2550470|NCT00550953|6250294|P2|STARTED|Overall Study||158
2550471|NCT00550953|6250295|P1|STARTED|Overall Study||156
2550472|NCT00550862|6250319|P4|NOT COMPLETED|Overall Study||1
2550473|NCT00550862|6250320|P3|NOT COMPLETED|Overall Study||16
2550474|NCT00550862|6250321|P2|NOT COMPLETED|Overall Study||6
2550475|NCT00550862|6250322|P1|NOT COMPLETED|Overall Study||6
2550476|NCT00550862|6250319|P4|COMPLETED|Overall Study||37
2550477|NCT00550862|6250320|P3|COMPLETED|Overall Study||25
2550478|NCT00550862|6250321|P2|COMPLETED|Overall Study||42
2550479|NCT00550862|6250322|P1|COMPLETED|Overall Study||32
2550480|NCT00550862|6250319|P4|STARTED|Overall Study||38
2550481|NCT00550862|6250320|P3|STARTED|Overall Study||41
2550482|NCT00550862|6250321|P2|STARTED|Overall Study||48
2550483|NCT00550862|6250322|P1|STARTED|Overall Study||38
2550484|NCT00550836|6250342|P2|NOT COMPLETED|Overall Study||9
2550485|NCT00550836|6250343|P1|NOT COMPLETED|Overall Study||3
2550486|NCT00550836|6250342|P2|COMPLETED|Overall Study||46
2550487|NCT00550836|6250343|P1|COMPLETED|Overall Study||46
2550488|NCT00550836|6250342|P2|STARTED|Overall Study||55
2550489|NCT00550836|6250343|P1|STARTED|Overall Study||49
2550490|NCT00550771|6250359|P2|NOT COMPLETED|Overall Study||10
2550491|NCT00550771|6250360|P1|NOT COMPLETED|Overall Study||17
2550492|NCT00550771|6250359|P2|COMPLETED|Overall Study||50
2550493|NCT00550771|6250360|P1|COMPLETED|Overall Study||104
2550494|NCT00550771|6250359|P2|STARTED|Overall Study||60
2550495|NCT00550771|6250360|P1|STARTED|Overall Study||121
2550496|NCT00550745|6250374|P2|NOT COMPLETED|Overall Study||60
2550497|NCT00550745|6250375|P1|NOT COMPLETED|Overall Study||87
2550498|NCT00550745|6250374|P2|COMPLETED|Overall Study||5939
2550499|NCT00550745|6250375|P1|COMPLETED|Overall Study||5913
2550500|NCT00550745|6250374|P2|STARTED|Overall Study||5999
2550501|NCT00550745|6250375|P1|STARTED|Overall Study||6000
2550502|NCT00550732|6250383|P1|NOT COMPLETED|Overall Study||11
2550503|NCT00550732|6250383|P1|COMPLETED|Overall Study||29
2550504|NCT00550732|6250383|P1|STARTED|Overall Study||40
2550505|NCT00550680|6250394|P1|NOT COMPLETED|Overall Study||56
2550506|NCT00550680|6250394|P1|COMPLETED|Overall Study||152
2550507|NCT00550680|6250394|P1|STARTED|Overall Study||208
2550508|NCT00550654|6250403|P1|NOT COMPLETED|Overall Study||0
2550509|NCT00550654|6250403|P1|COMPLETED|Overall Study||1
2550510|NCT00550654|6250403|P1|STARTED|Overall Study||1
2550511|NCT00550615|6250415|P4|NOT COMPLETED|Overall Study||10
2550512|NCT00550615|6250416|P3|NOT COMPLETED|Overall Study||4
2550513|NCT00550615|6250417|P2|NOT COMPLETED|Overall Study||0
2550514|NCT00550615|6250418|P1|NOT COMPLETED|Overall Study||0
2550515|NCT00550615|6250415|P4|COMPLETED|Overall Study||12
2550516|NCT00550615|6250416|P3|COMPLETED|Overall Study||6
2550517|NCT00550615|6250417|P2|COMPLETED|Overall Study||3
2550518|NCT00550615|6250418|P1|COMPLETED|Overall Study||3
2550519|NCT00550615|6250415|P4|STARTED|Overall Study||22
2550520|NCT00550615|6250416|P3|STARTED|Overall Study||10
2550521|NCT00550615|6250417|P2|STARTED|Overall Study||3
2550522|NCT00550615|6250418|P1|STARTED|Overall Study||3
2550523|NCT00550589|6250424|P1|NOT COMPLETED|Overall Study||0
2550524|NCT00550589|6250424|P1|COMPLETED|Overall Study||33
2550525|NCT00550589|6250424|P1|STARTED|Overall Study||33
2550526|NCT00550550|6250437|P2|NOT COMPLETED|Overall Study||29
2550527|NCT00550550|6250438|P1|NOT COMPLETED|Overall Study||34
2550528|NCT00550550|6250437|P2|COMPLETED|Overall Study||140
2550529|NCT00550550|6250438|P1|COMPLETED|Overall Study||142
2550530|NCT00550550|6250437|P2|Number Treated|Overall Study||169
2550531|NCT00550550|6250438|P1|Number Treated|Overall Study||175
2550532|NCT00550550|6250437|P2|STARTED|Overall Study||169
2550533|NCT00550550|6250438|P1|STARTED|Overall Study||176
2550534|NCT00550537|6250450|P1|NOT COMPLETED|Overall Study||104
2550535|NCT00550537|6250450|P1|COMPLETED|Overall Study||12
2550536|NCT00550537|6250450|P1|STARTED|Overall Study||116
2550537|NCT00550459|6250467|P2|NOT COMPLETED|Overall Study||3
2550538|NCT00550459|6250468|P1|NOT COMPLETED|Overall Study||1
2550539|NCT00550459|6250467|P2|COMPLETED|Overall Study||26
2550540|NCT00550459|6250468|P1|COMPLETED|Overall Study||27
2550541|NCT00550459|6250467|P2|STARTED|Overall Study||29
2550542|NCT00550459|6250468|P1|STARTED|Overall Study||28
2550543|NCT00550446|6250537|P11|NOT COMPLETED|Post Week 12||1
2550544|NCT00550446|6250538|P10|NOT COMPLETED|Post Week 12||7
2550545|NCT00550446|6250539|P9|NOT COMPLETED|Post Week 12||2
2550546|NCT00550446|6250540|P8|NOT COMPLETED|Post Week 12||1
2550547|NCT00550446|6250541|P7|NOT COMPLETED|Post Week 12||2
2550548|NCT00550446|6250542|P6|NOT COMPLETED|Post Week 12||1
2550549|NCT00550446|6250543|P5|NOT COMPLETED|Post Week 12||2
2550550|NCT00550446|6250544|P4|NOT COMPLETED|Post Week 12||3
2550551|NCT00550446|6250545|P3|NOT COMPLETED|Post Week 12||3
2550552|NCT00550446|6250546|P2|NOT COMPLETED|Post Week 12||2
2550553|NCT00550446|6250547|P1|NOT COMPLETED|Post Week 12||3
2550554|NCT00550446|6250537|P11|COMPLETED|Post Week 12||24
2550555|NCT00550446|6250538|P10|COMPLETED|Post Week 12||37
2550556|NCT00550446|6250539|P9|COMPLETED|Post Week 12||15
2550557|NCT00550446|6250540|P8|COMPLETED|Post Week 12||16
2550558|NCT00550446|6250541|P7|COMPLETED|Post Week 12||19
2550559|NCT00550446|6250542|P6|COMPLETED|Post Week 12||0
2550560|NCT00550446|6250543|P5|COMPLETED|Post Week 12||52
2550561|NCT00550446|6250544|P4|COMPLETED|Post Week 12||55
2550562|NCT00550446|6250545|P3|COMPLETED|Post Week 12||43
2550563|NCT00550446|6250546|P2|COMPLETED|Post Week 12||28
2550564|NCT00550446|6250547|P1|COMPLETED|Post Week 12||24
2550565|NCT00550446|6250537|P11|STARTED|Post Week 12||25
2550566|NCT00550446|6250538|P10|STARTED|Post Week 12||44
2550567|NCT00550446|6250539|P9|STARTED|Post Week 12||17
2550568|NCT00550446|6250540|P8|STARTED|Post Week 12||17
2550569|NCT00550446|6250541|P7|STARTED|Post Week 12||21
2550570|NCT00550446|6250542|P6|STARTED|Post Week 12||1
2550571|NCT00550446|6250543|P5|STARTED|Post Week 12||54
2550572|NCT00550446|6250544|P4|STARTED|Post Week 12||58
2550573|NCT00550446|6250545|P3|STARTED|Post Week 12||46
2550574|NCT00550446|6250546|P2|STARTED|Post Week 12||30
2550575|NCT00550446|6250547|P1|STARTED|Post Week 12||27
2550576|NCT00550446|6250537|P11|NOT COMPLETED|Up To Week 12||0
2550577|NCT00550446|6250538|P10|NOT COMPLETED|Up To Week 12||0
2550578|NCT00550446|6250539|P9|NOT COMPLETED|Up To Week 12||0
2550579|NCT00550446|6250540|P8|NOT COMPLETED|Up To Week 12||0
2550580|NCT00550446|6250541|P7|NOT COMPLETED|Up To Week 12||13
2550581|NCT00550446|6250542|P6|NOT COMPLETED|Up To Week 12||8
2550582|NCT00550446|6250543|P5|NOT COMPLETED|Up To Week 12||3
2550583|NCT00550446|6250544|P4|NOT COMPLETED|Up To Week 12||3
2550584|NCT00550446|6250545|P3|NOT COMPLETED|Up To Week 12||4
2550585|NCT00550446|6250546|P2|NOT COMPLETED|Up To Week 12||5
2550586|NCT00550446|6250547|P1|NOT COMPLETED|Up To Week 12||10
2550587|NCT00550446|6250537|P11|COMPLETED|Up To Week 12||0
2550588|NCT00550446|6250538|P10|COMPLETED|Up To Week 12||0
2550589|NCT00550446|6250539|P9|COMPLETED|Up To Week 12||0
2550590|NCT00550446|6250540|P8|COMPLETED|Up To Week 12||0
2550591|NCT00550446|6250541|P7|COMPLETED|Up To Week 12||46
2550592|NCT00550446|6250542|P6|COMPLETED|Up To Week 12||45
2550593|NCT00550446|6250543|P5|COMPLETED|Up To Week 12||54
2550594|NCT00550446|6250544|P4|COMPLETED|Up To Week 12||58
2550595|NCT00550446|6250545|P3|COMPLETED|Up To Week 12||46
2550596|NCT00550446|6250546|P2|COMPLETED|Up To Week 12||47
2550597|NCT00550446|6250547|P1|COMPLETED|Up To Week 12||44
2550598|NCT00550446|6250537|P11|Treated|Up To Week 12||0
2550599|NCT00550446|6250538|P10|Treated|Up To Week 12||0
2550600|NCT00550446|6250539|P9|Treated|Up To Week 12||0
2550601|NCT00550446|6250540|P8|Treated|Up To Week 12||0
2550602|NCT00550446|6250541|P7|Treated|Up To Week 12||59
2550603|NCT00550446|6250542|P6|Treated|Up To Week 12||53
2550604|NCT00550446|6250543|P5|Treated|Up To Week 12||57
2550605|NCT00550446|6250544|P4|Treated|Up To Week 12||61
2550606|NCT00550446|6250545|P3|Treated|Up To Week 12||49
2550607|NCT00550446|6250546|P2|Treated|Up To Week 12||51
2550608|NCT00550446|6250547|P1|Treated|Up To Week 12||54
2550609|NCT00550446|6250537|P11|STARTED|Up To Week 12||0
2550610|NCT00550446|6250538|P10|STARTED|Up To Week 12||0
2550611|NCT00550446|6250539|P9|STARTED|Up To Week 12||0
2550612|NCT00550446|6250540|P8|STARTED|Up To Week 12||0
2550613|NCT00550446|6250541|P7|STARTED|Up To Week 12||59
2550614|NCT00550446|6250542|P6|STARTED|Up To Week 12||53
2550615|NCT00550446|6250543|P5|STARTED|Up To Week 12||57
2550616|NCT00550446|6250544|P4|STARTED|Up To Week 12||61
2550617|NCT00550446|6250545|P3|STARTED|Up To Week 12||50
2550618|NCT00550446|6250546|P2|STARTED|Up To Week 12||52
2550619|NCT00550446|6250547|P1|STARTED|Up To Week 12||54
2550620|NCT00550420|6250979|P1|NOT COMPLETED|Overall Study||305
2550621|NCT00550420|6250979|P1|COMPLETED|Overall Study||26
2550622|NCT00550420|6250979|P1|STARTED|Overall Study||331
2550623|NCT00550407|6251002|P3|NOT COMPLETED|26-Week Randomized Phase||24
2550624|NCT00550407|6251003|P2|NOT COMPLETED|26-Week Randomized Phase||43
2550625|NCT00550407|6251004|P1|NOT COMPLETED|26-Week Randomized Phase||0
2550626|NCT00550407|6251002|P3|COMPLETED|26-Week Randomized Phase||21
2550627|NCT00550407|6251003|P2|COMPLETED|26-Week Randomized Phase||15
2550628|NCT00550407|6251004|P1|COMPLETED|26-Week Randomized Phase||0
2550629|NCT00550407|6251002|P3|STARTED|26-Week Randomized Phase||45
2550630|NCT00550407|6251003|P2|STARTED|26-Week Randomized Phase||58
2550631|NCT00550407|6251004|P1|STARTED|26-Week Randomized Phase||0
2550632|NCT00550407|6251002|P3|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
2550633|NCT00550407|6251003|P2|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
2550634|NCT00550407|6251004|P1|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||112
2550635|NCT00550407|6251002|P3|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
2550636|NCT00550407|6251003|P2|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
2550637|NCT00550407|6251004|P1|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||103
2550638|NCT00550407|6251002|P3|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
2550639|NCT00550407|6251003|P2|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
2550640|NCT00550407|6251004|P1|STARTED|8-16 Week Preliminary (Open-Label) Phase||215
2550641|NCT00550394|6251039|P2|NOT COMPLETED|Overall Study||13
2550642|NCT00550394|6251040|P1|NOT COMPLETED|Overall Study||12
2550643|NCT00550394|6251039|P2|COMPLETED|Overall Study||5
2550644|NCT00550394|6251040|P1|COMPLETED|Overall Study||9
2550645|NCT00550394|6251039|P2|STARTED|Overall Study||18
2550646|NCT00550394|6251040|P1|STARTED|Overall Study||21
2550647|NCT00550368|6251054|P2|NOT COMPLETED|Overall Study||0
2550648|NCT00550368|6251055|P1|NOT COMPLETED|Overall Study||0
2550649|NCT00550368|6251054|P2|COMPLETED|Overall Study||19
2550650|NCT00550368|6251055|P1|COMPLETED|Overall Study||26
2550651|NCT00550368|6251054|P2|STARTED|Overall Study||19
2550652|NCT00550368|6251055|P1|STARTED|Overall Study||26
2550653|NCT00550290|6251065|P2|NOT COMPLETED|Overall Study||0
2550654|NCT00550290|6251066|P1|NOT COMPLETED|Overall Study||0
2550655|NCT00550290|6251065|P2|COMPLETED|Overall Study||8
2550656|NCT00550290|6251066|P1|COMPLETED|Overall Study||10
2550657|NCT00550290|6251065|P2|STARTED|Overall Study||8
2550658|NCT00550290|6251066|P1|STARTED|Overall Study||10
2550659|NCT00550277|6251072|P1|NOT COMPLETED|Overall Study||9
2550660|NCT00550277|6251072|P1|COMPLETED|Overall Study||11
2550661|NCT00550277|6251072|P1|STARTED|Overall Study||20
2550662|NCT00550238|6251076|P1|NOT COMPLETED|Overall Study||459
2550663|NCT00550238|6251076|P1|COMPLETED|Overall Study||0
2550664|NCT00550238|6251076|P1|STARTED|Overall Study||459
2550665|NCT00550173|6251083|P3|NOT COMPLETED|Overall Study||73
2550666|NCT00550173|6251084|P2|NOT COMPLETED|Overall Study||63
2550667|NCT00550173|6251085|P1|NOT COMPLETED|Overall Study||72
2550668|NCT00550173|6251083|P3|COMPLETED|Overall Study||11
2550669|NCT00550173|6251084|P2|COMPLETED|Overall Study||19
2550670|NCT00550173|6251085|P1|COMPLETED|Overall Study||9
2550671|NCT00550173|6251083|P3|Not Discontinued at 18 Months|Overall Study||11
2550672|NCT00550173|6251084|P2|Not Discontinued at 18 Months|Overall Study||19
2550673|NCT00550173|6251085|P1|Not Discontinued at 18 Months|Overall Study||9
2550674|NCT00550173|6251083|P3|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|80
2550675|NCT00550173|6251084|P2|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|82
2550676|NCT00550173|6251085|P1|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|78
2550677|NCT00550173|6251083|P3|STARTED|Overall Study||84
2550678|NCT00550173|6251084|P2|STARTED|Overall Study||82
2550679|NCT00550173|6251085|P1|STARTED|Overall Study||81
2550680|NCT00550147|6251114|P1|NOT COMPLETED|Quetiapine Addition Treatment Period||6
2550681|NCT00550147|6251114|P1|COMPLETED|Quetiapine Addition Treatment Period||18
2550682|NCT00550147|6251114|P1|STARTED|Quetiapine Addition Treatment Period||24
2550683|NCT00550147|6251114|P1|NOT COMPLETED|OROS Methylphenidate Monotherapy||6
2550684|NCT00550147|6251114|P1|COMPLETED|OROS Methylphenidate Monotherapy||24
2550685|NCT00550147|6251114|P1|STARTED|OROS Methylphenidate Monotherapy||30
2550686|NCT00550043|6251137|P5|NOT COMPLETED|Overall Study||1
2550687|NCT00550043|6251138|P4|NOT COMPLETED|Overall Study||2
2550688|NCT00550043|6251139|P3|NOT COMPLETED|Overall Study||1
2550689|NCT00550043|6251140|P2|NOT COMPLETED|Overall Study||3
2550690|NCT00550043|6251141|P1|NOT COMPLETED|Overall Study||0
2550691|NCT00550043|6251137|P5|COMPLETED|Overall Study||9
2550692|NCT00550043|6251138|P4|COMPLETED|Overall Study||8
2550693|NCT00550043|6251139|P3|COMPLETED|Overall Study||8
2550694|NCT00550043|6251140|P2|COMPLETED|Overall Study||9
2550695|NCT00550043|6251141|P1|COMPLETED|Overall Study||9
2550696|NCT00550043|6251137|P5|STARTED|Overall Study||10
2550697|NCT00550043|6251138|P4|STARTED|Overall Study||10
2550698|NCT00550043|6251139|P3|STARTED|Overall Study||9
2550699|NCT00550043|6251140|P2|STARTED|Overall Study||12
2550700|NCT00550043|6251141|P1|STARTED|Overall Study||9
2550701|NCT00549939|6251196|P3|NOT COMPLETED|40-week Open Label Treatment Period||5
2550702|NCT00549939|6251197|P2|NOT COMPLETED|40-week Open Label Treatment Period||5
2550703|NCT00549939|6251198|P1|NOT COMPLETED|40-week Open Label Treatment Period||0
2550704|NCT00549939|6251196|P3|COMPLETED|40-week Open Label Treatment Period||78
2550705|NCT00549939|6251197|P2|COMPLETED|40-week Open Label Treatment Period||75
2550706|NCT00549939|6251198|P1|COMPLETED|40-week Open Label Treatment Period||0
2550707|NCT00549939|6251196|P3|STARTED|40-week Open Label Treatment Period|55 patients continued Alfuzosin 0.2 mg/kg/day and 28 patients started Alfuzosin 0.2 mg/kg/day.|83
2550708|NCT00549939|6251197|P2|STARTED|40-week Open Label Treatment Period|54 patients continued Alfuzosin 0.1 mg/kg/day and 26 patients started Alfuzosin 0.1 mg/kg/day.|80
2550709|NCT00549939|6251198|P1|STARTED|40-week Open Label Treatment Period|54 patients continued and switched to Alfuzosin: 26 to 0.1 mg/kg/day and 28 to 0.2 mg/kg/day.|0
2550710|NCT00549939|6251196|P3|NOT COMPLETED|12-week Double Blind Treatment Period||2
2550711|NCT00549939|6251197|P2|NOT COMPLETED|12-week Double Blind Treatment Period||2
2550712|NCT00549939|6251198|P1|NOT COMPLETED|12-week Double Blind Treatment Period||1
2550713|NCT00549939|6251196|P3|COMPLETED|12-week Double Blind Treatment Period||56
2550714|NCT00549939|6251197|P2|COMPLETED|12-week Double Blind Treatment Period||55
2550715|NCT00549939|6251198|P1|COMPLETED|12-week Double Blind Treatment Period||56
2550716|NCT00549939|6251196|P3|STARTED|12-week Double Blind Treatment Period||58
2550717|NCT00549939|6251197|P2|STARTED|12-week Double Blind Treatment Period||57
2550718|NCT00549939|6251198|P1|STARTED|12-week Double Blind Treatment Period|29 (Alfuzosin 0.1 mg/kg/day matching placebo) + 28 (Alfuzosin 0.2 mg/kg/day matching placebo)|57
2550719|NCT00549900|6251225|P1|NOT COMPLETED|Overall Study||1
2550720|NCT00549900|6251225|P1|COMPLETED|Overall Study||29
2550721|NCT00549900|6251225|P1|STARTED|Overall Study||30
2550722|NCT00549822|6251234|P1|NOT COMPLETED|Overall Study||0
2550723|NCT00549822|6251234|P1|COMPLETED|Overall Study||3
2550724|NCT00549822|6251234|P1|STARTED|Overall Study||3
2550725|NCT00549783|6251242|P2|NOT COMPLETED|Overall Study||13
2550726|NCT00549783|6251243|P1|NOT COMPLETED|Overall Study||8
2550727|NCT00549783|6251242|P2|COMPLETED|Overall Study||122
2550728|NCT00549783|6251243|P1|COMPLETED|Overall Study||131
2550729|NCT00549783|6251242|P2|STARTED|Overall Study||135
2550730|NCT00549783|6251243|P1|STARTED|Overall Study||139
2550731|NCT00549770|6251281|P8|NOT COMPLETED|Overall Study||25
2550732|NCT00549770|6251282|P7|NOT COMPLETED|Overall Study||14
2550733|NCT00549770|6251283|P6|NOT COMPLETED|Overall Study||13
2550734|NCT00549770|6251284|P5|NOT COMPLETED|Overall Study||17
2550735|NCT00549770|6251285|P4|NOT COMPLETED|Overall Study||16
2550736|NCT00549770|6251286|P3|NOT COMPLETED|Overall Study||10
2550737|NCT00549770|6251287|P2|NOT COMPLETED|Overall Study||11
2550738|NCT00549770|6251288|P1|NOT COMPLETED|Overall Study||7
2550739|NCT00549770|6251281|P8|COMPLETED|Overall Study||148
2550740|NCT00549770|6251282|P7|COMPLETED|Overall Study||151
2550741|NCT00549770|6251283|P6|COMPLETED|Overall Study||151
2550742|NCT00549770|6251284|P5|COMPLETED|Overall Study||149
2550743|NCT00549770|6251285|P4|COMPLETED|Overall Study||147
2550744|NCT00549770|6251286|P3|COMPLETED|Overall Study||162
2550745|NCT00549770|6251287|P2|COMPLETED|Overall Study||158
2550746|NCT00549770|6251288|P1|COMPLETED|Overall Study||149
2550747|NCT00549770|6251281|P8|Ambulatory Blood Pressure Monitoring|Overall Study||57
2550748|NCT00549770|6251282|P7|Ambulatory Blood Pressure Monitoring|Overall Study||50
2550749|NCT00549770|6251283|P6|Ambulatory Blood Pressure Monitoring|Overall Study||54
2550750|NCT00549770|6251284|P5|Ambulatory Blood Pressure Monitoring|Overall Study||49
2550751|NCT00549770|6251285|P4|Ambulatory Blood Pressure Monitoring|Overall Study||55
2550752|NCT00549770|6251286|P3|Ambulatory Blood Pressure Monitoring|Overall Study||53
2550753|NCT00549770|6251287|P2|Ambulatory Blood Pressure Monitoring|Overall Study||61
2550754|NCT00549770|6251288|P1|Ambulatory Blood Pressure Monitoring|Overall Study||48
2550755|NCT00549770|6251281|P8|Intent-to-treat Population|Overall Study||172
2550756|NCT00549770|6251282|P7|Intent-to-treat Population|Overall Study||164
2550757|NCT00549770|6251283|P6|Intent-to-treat Population|Overall Study||163
2550758|NCT00549770|6251284|P5|Intent-to-treat Population|Overall Study||163
2550759|NCT00549770|6251285|P4|Intent-to-treat Population|Overall Study||163
2550760|NCT00549770|6251286|P3|Intent-to-treat Population|Overall Study||170
2550761|NCT00549770|6251287|P2|Intent-to-treat Population|Overall Study||168
2550762|NCT00549770|6251288|P1|Intent-to-treat Population|Overall Study||154
2550763|NCT00549770|6251281|P8|STARTED|Overall Study||173
2550764|NCT00549770|6251282|P7|STARTED|Overall Study||165
2550765|NCT00549770|6251283|P6|STARTED|Overall Study||164
2550766|NCT00549770|6251284|P5|STARTED|Overall Study||166
2550767|NCT00549770|6251285|P4|STARTED|Overall Study||163
2550768|NCT00549770|6251286|P3|STARTED|Overall Study||172
2550769|NCT00549770|6251287|P2|STARTED|Overall Study||169
2550770|NCT00549770|6251288|P1|STARTED|Overall Study||156
2550771|NCT00549757|6251372|P2|NOT COMPLETED|Extension Period (in Average 9 Months)||635
2550772|NCT00549757|6251373|P1|NOT COMPLETED|Extension Period (in Average 9 Months)||625
2550773|NCT00549757|6251372|P2|COMPLETED|Extension Period (in Average 9 Months)||3182
2550774|NCT00549757|6251373|P1|COMPLETED|Extension Period (in Average 9 Months)||3148
2550775|NCT00549757|6251372|P2|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3817
2550776|NCT00549757|6251373|P1|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3773
2550777|NCT00549757|6251372|P2|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4310
2550778|NCT00549757|6251373|P1|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4296
2550779|NCT00549757|6251372|P2|COMPLETED|Active Treatment Phase: Max. 50 Months||0
2550780|NCT00549757|6251373|P1|COMPLETED|Active Treatment Phase: Max. 50 Months||0
2550781|NCT00549757|6251372|P2|Safety Set|Active Treatment Phase: Max. 50 Months||4285
2550782|NCT00549757|6251373|P1|Safety Set|Active Treatment Phase: Max. 50 Months||4272
2550783|NCT00549757|6251372|P2|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4287
2550784|NCT00549757|6251373|P1|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4274
2550785|NCT00549757|6251372|P2|STARTED|Active Treatment Phase: Max. 50 Months||4310
2550786|NCT00549757|6251373|P1|STARTED|Active Treatment Phase: Max. 50 Months|"Started indicates randomized patients."|4296
2550787|NCT00549718|6251435|P4|NOT COMPLETED|Overall Study||55
2550788|NCT00549718|6251436|P3|NOT COMPLETED|Overall Study||39
2550789|NCT00549718|6251437|P2|NOT COMPLETED|Overall Study||37
2550790|NCT00549718|6251438|P1|NOT COMPLETED|Overall Study||41
2550791|NCT00549718|6251435|P4|COMPLETED|Overall Study||73
2550792|NCT00549718|6251436|P3|COMPLETED|Overall Study||85
2550793|NCT00549718|6251437|P2|COMPLETED|Overall Study||86
2550794|NCT00549718|6251438|P1|COMPLETED|Overall Study||84
2550795|NCT00549718|6251435|P4|STARTED|Overall Study||128
2550796|NCT00549718|6251436|P3|STARTED|Overall Study||124
2550797|NCT00549718|6251437|P2|STARTED|Overall Study||123
2550798|NCT00549718|6251438|P1|STARTED|Overall Study||125
2550799|NCT00549640|6251454|P2|NOT COMPLETED|Overall Study||16
2550800|NCT00549640|6251455|P1|NOT COMPLETED|Overall Study||18
2550801|NCT00549640|6251454|P2|COMPLETED|Overall Study||24
2550802|NCT00549640|6251455|P1|COMPLETED|Overall Study|For the primary endpoint, subjects who discontinued participation were assumed to be smoking.|22
2550803|NCT00549640|6251454|P2|STARTED|Overall Study||40
2550804|NCT00549640|6251455|P1|STARTED|Overall Study||40
2550805|NCT00549601|6251468|P3|NOT COMPLETED|Received Study Drug||4
2550806|NCT00549601|6251469|P2|NOT COMPLETED|Received Study Drug||11
2550807|NCT00549601|6251470|P1|NOT COMPLETED|Received Study Drug||7
2550808|NCT00549601|6251468|P3|COMPLETED|Received Study Drug||45
2550809|NCT00549601|6251469|P2|COMPLETED|Received Study Drug||36
2550810|NCT00549601|6251470|P1|COMPLETED|Received Study Drug||36
2550811|NCT00549601|6251468|P3|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|49
2550812|NCT00549601|6251469|P2|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|47
2550813|NCT00549601|6251470|P1|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|43
2550814|NCT00549601|6251468|P3|NOT COMPLETED|Randomized||2
2550815|NCT00549601|6251469|P2|NOT COMPLETED|Randomized||1
2550816|NCT00549601|6251470|P1|NOT COMPLETED|Randomized||0
2550817|NCT00549601|6251468|P3|COMPLETED|Randomized||49
2550818|NCT00549601|6251469|P2|COMPLETED|Randomized||47
2550819|NCT00549601|6251470|P1|COMPLETED|Randomized||43
2550820|NCT00549601|6251468|P3|STARTED|Randomized||51
2550821|NCT00549601|6251469|P2|STARTED|Randomized||48
2550822|NCT00549601|6251470|P1|STARTED|Randomized||43
2550823|NCT00549562|6251492|P1|NOT COMPLETED|Overall Study||2
2550824|NCT00549562|6251492|P1|COMPLETED|Overall Study||23
2550825|NCT00549562|6251492|P1|STARTED|Overall Study||25
2550826|NCT00549549|6251504|P4|NOT COMPLETED|Overall Study||25
2550827|NCT00549549|6251505|P3|NOT COMPLETED|Overall Study||17
2550828|NCT00549549|6251506|P2|NOT COMPLETED|Overall Study||22
2550829|NCT00549549|6251507|P1|NOT COMPLETED|Overall Study||24
2550830|NCT00549549|6251504|P4|COMPLETED|Overall Study||78
2550831|NCT00549549|6251505|P3|COMPLETED|Overall Study||82
2550832|NCT00549549|6251506|P2|COMPLETED|Overall Study||77
2550833|NCT00549549|6251507|P1|COMPLETED|Overall Study||77
2550834|NCT00549549|6251504|P4|Treated|Overall Study||102
2550835|NCT00549549|6251505|P3|Treated|Overall Study||98
2550836|NCT00549549|6251506|P2|Treated|Overall Study||99
2550837|NCT00549549|6251507|P1|Treated|Overall Study||101
2550838|NCT00549549|6251504|P4|STARTED|Overall Study||103
2550839|NCT00549549|6251505|P3|STARTED|Overall Study||99
2550840|NCT00549549|6251506|P2|STARTED|Overall Study||99
2550841|NCT00549549|6251507|P1|STARTED|Overall Study||101
2550842|NCT00549445|6251575|P2|NOT COMPLETED|Overall Study||17
2550843|NCT00549445|6251576|P1|NOT COMPLETED|Overall Study||15
2550844|NCT00549445|6251575|P2|COMPLETED|Overall Study||13
2550845|NCT00549445|6251576|P1|COMPLETED|Overall Study||8
2550846|NCT00549445|6251575|P2|STARTED|Overall Study||30
2550847|NCT00549445|6251576|P1|STARTED|Overall Study||23
2550848|NCT00549393|6251584|P2|NOT COMPLETED|Period 3 (6 Months)||0
2550849|NCT00549393|6251585|P1|NOT COMPLETED|Period 3 (6 Months)||0
2550850|NCT00549393|6251584|P2|COMPLETED|Period 3 (6 Months)||1326
2550851|NCT00549393|6251585|P1|COMPLETED|Period 3 (6 Months)||1103
2550852|NCT00549393|6251584|P2|Per Protocol|Period 3 (6 Months)||1326
2550853|NCT00549393|6251585|P1|Per Protocol|Period 3 (6 Months)||667
2550854|NCT00549393|6251584|P2|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1326
2550855|NCT00549393|6251585|P1|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1103
2550856|NCT00549393|6251584|P2|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
2550857|NCT00549393|6251585|P1|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
2550858|NCT00549393|6251584|P2|COMPLETED|Period 2 Washout (2 Weeks)||0
2550859|NCT00549393|6251585|P1|COMPLETED|Period 2 Washout (2 Weeks)||0
2550860|NCT00549393|6251584|P2|STARTED|Period 2 Washout (2 Weeks)||0
2550861|NCT00549393|6251585|P1|STARTED|Period 2 Washout (2 Weeks)||0
2550862|NCT00549393|6251584|P2|NOT COMPLETED|Period 1 (6 Months)||0
2550863|NCT00549393|6251585|P1|NOT COMPLETED|Period 1 (6 Months)||0
2550864|NCT00549393|6251584|P2|COMPLETED|Period 1 (6 Months)||1199
2550865|NCT00549393|6251585|P1|COMPLETED|Period 1 (6 Months)||1319
2550866|NCT00549393|6251584|P2|Per Protocol|Period 1 (6 Months)||1199
2550867|NCT00549393|6251585|P1|Per Protocol|Period 1 (6 Months)||880
2550868|NCT00549393|6251584|P2|STARTED|Period 1 (6 Months)|ITT|1199
2550869|NCT00549393|6251585|P1|STARTED|Period 1 (6 Months)|intention to treat (ITT)|1319
2550870|NCT00549328|6251595|P1|NOT COMPLETED|Overall Study||14
2550871|NCT00549328|6251595|P1|COMPLETED|Overall Study||0
2550872|NCT00549328|6251595|P1|STARTED|Overall Study||14
2550873|NCT00549302|6251606|P3|NOT COMPLETED|Open-Label||69
2550874|NCT00549302|6251607|P2|NOT COMPLETED|Open-Label||0
2550875|NCT00549302|6251608|P1|NOT COMPLETED|Open-Label||0
2550876|NCT00549302|6251606|P3|COMPLETED|Open-Label|Another death occurred during the 30-day follow-up period after study drug discontinuation|217
2550877|NCT00549302|6251607|P2|COMPLETED|Open-Label||0
2550878|NCT00549302|6251608|P1|COMPLETED|Open-Label||0
2550879|NCT00549302|6251606|P3|STARTED|Open-Label|7 participants who completed the Double-Blind Period did not enter the Open-Label Period.|286
2550880|NCT00549302|6251607|P2|STARTED|Open-Label||0
2550881|NCT00549302|6251608|P1|STARTED|Open-Label||0
2550882|NCT00549302|6251606|P3|NOT COMPLETED|Double-Blind||0
2550883|NCT00549302|6251607|P2|NOT COMPLETED|Double-Blind||53
2550884|NCT00549302|6251608|P1|NOT COMPLETED|Double-Blind||11
2550885|NCT00549302|6251606|P3|COMPLETED|Double-Blind||0
2550886|NCT00549302|6251607|P2|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|241
2550887|NCT00549302|6251608|P1|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|52
2550888|NCT00549302|6251606|P3|Received at Least One Dose of Study Drug|Double-Blind||0
2550889|NCT00549302|6251607|P2|Received at Least One Dose of Study Drug|Double-Blind||294
2550890|NCT00549302|6251608|P1|Received at Least One Dose of Study Drug|Double-Blind||63
2550891|NCT00549302|6251606|P3|STARTED|Double-Blind||0
2550892|NCT00549302|6251607|P2|STARTED|Double-Blind||294
2550893|NCT00549302|6251608|P1|STARTED|Double-Blind||63
2550894|NCT00549198|6251620|P2|NOT COMPLETED|Overall Study||63
2550895|NCT00549198|6251621|P1|NOT COMPLETED|Overall Study||80
2550896|NCT00549198|6251620|P2|COMPLETED|Overall Study||134
2550897|NCT00549198|6251621|P1|COMPLETED|Overall Study||115
2550898|NCT00549198|6251620|P2|STARTED|Overall Study|Four participants were randomized but were not exposed to study drug (TDF/FTC).|197
2550899|NCT00549198|6251621|P1|STARTED|Overall Study|Three participants were randomized but were not exposed to study drug (ABC/3TC).|195
2550900|NCT00549172|6251743|P2|NOT COMPLETED|Overall Study||0
2550901|NCT00549172|6251744|P1|NOT COMPLETED|Overall Study||0
2550902|NCT00549172|6251743|P2|COMPLETED|Overall Study||76
2550903|NCT00549172|6251744|P1|COMPLETED|Overall Study||70
2550904|NCT00549172|6251743|P2|STARTED|Overall Study||76
2550905|NCT00549172|6251744|P1|STARTED|Overall Study||70
2550906|NCT00549055|6251758|P1|NOT COMPLETED|Overall Study||35
2550907|NCT00549055|6251758|P1|COMPLETED|Overall Study||3
2550908|NCT00549055|6251758|P1|STARTED|Overall Study||38
2550909|NCT00548886|6251768|P1|NOT COMPLETED|Overall Study||0
2550910|NCT00548886|6251768|P1|COMPLETED|Overall Study||7
2550911|NCT00548886|6251768|P1|STARTED|Overall Study||7
2550912|NCT00548860|6251775|P2|NOT COMPLETED|Overall Study||175
2550913|NCT00548860|6251776|P1|NOT COMPLETED|Overall Study||136
2550914|NCT00548860|6251775|P2|COMPLETED|Overall Study||847
2550915|NCT00548860|6251776|P1|COMPLETED|Overall Study||860
2550916|NCT00548860|6251775|P2|STARTED|Overall Study||1022
2550917|NCT00548860|6251776|P1|STARTED|Overall Study||996
2550918|NCT00548847|6251782|P1|NOT COMPLETED|Overall Study||7
2550919|NCT00548847|6251782|P1|COMPLETED|Overall Study||8
2550920|NCT00548847|6251782|P1|STARTED|Overall Study||15
2550921|NCT00548808|6251789|P2|NOT COMPLETED|Overall Study||26
2550922|NCT00548808|6251790|P1|NOT COMPLETED|Overall Study||42
2550923|NCT00548808|6251789|P2|COMPLETED|Overall Study||186
2550924|NCT00548808|6251790|P1|COMPLETED|Overall Study||172
2550925|NCT00548808|6251789|P2|Per-Protocol Set|Overall Study||184
2550926|NCT00548808|6251790|P1|Per-Protocol Set|Overall Study||177
2550927|NCT00548808|6251789|P2|Full Analysis Set|Overall Study||212
2550928|NCT00548808|6251790|P1|Full Analysis Set|Overall Study||211
2550929|NCT00548808|6251789|P2|STARTED|Overall Study||212
2550930|NCT00548808|6251790|P1|STARTED|Overall Study||214
2550931|NCT00548717|6251814|P2|NOT COMPLETED|Overall Study||2
2550932|NCT00548717|6251815|P1|NOT COMPLETED|Overall Study||9
2550933|NCT00548717|6251814|P2|COMPLETED|Overall Study||0
2550934|NCT00548717|6251815|P1|COMPLETED|Overall Study||4
2550935|NCT00548717|6251814|P2|STARTED|Overall Study||2
2550936|NCT00548717|6251815|P1|STARTED|Overall Study||13
2550937|NCT00548691|6251834|P2|NOT COMPLETED|Overall Study||9
2550938|NCT00548691|6251835|P1|NOT COMPLETED|Overall Study||7
2550939|NCT00548691|6251834|P2|COMPLETED|Overall Study||250
2550940|NCT00548691|6251835|P1|COMPLETED|Overall Study||251
2550941|NCT00548691|6251834|P2|STARTED|Overall Study||259
2550942|NCT00548691|6251835|P1|STARTED|Overall Study||258
2550943|NCT00548652|6251844|P3|NOT COMPLETED|Overall Study||11
2550944|NCT00548652|6251845|P2|NOT COMPLETED|Overall Study||9
2550945|NCT00548652|6251846|P1|NOT COMPLETED|Overall Study||2
2550946|NCT00548652|6251844|P3|COMPLETED|Overall Study||34
2550947|NCT00548652|6251845|P2|COMPLETED|Overall Study||29
2550948|NCT00548652|6251846|P1|COMPLETED|Overall Study||16
2550949|NCT00548652|6251844|P3|STARTED|Overall Study||45
2550950|NCT00548652|6251845|P2|STARTED|Overall Study||38
2550951|NCT00548652|6251846|P1|STARTED|Overall Study||18
2550952|NCT00548548|6251859|P2|NOT COMPLETED|Overall Study||366
2550953|NCT00548548|6251860|P1|NOT COMPLETED|Overall Study||362
2550954|NCT00548548|6251859|P2|COMPLETED|Overall Study||21
2550955|NCT00548548|6251860|P1|COMPLETED|Overall Study|Completed treatment discontinuation form was not completed; patient was counted alive on treatment.|25
2550956|NCT00548548|6251859|P2|Safety Population|Overall Study||381
2550957|NCT00548548|6251860|P1|Safety Population|Overall Study|Four patients randomized to placebo received single doses of bevacizumab in error.|386
2550958|NCT00548548|6251859|P2|Treated|Overall Study||384
2550959|NCT00548548|6251860|P1|Treated|Overall Study||383
2550960|NCT00548548|6251859|P2|STARTED|Overall Study||387
2550961|NCT00548548|6251860|P1|STARTED|Overall Study||387
2550962|NCT00548470|6251880|P1|NOT COMPLETED|Overall Study||2
2550963|NCT00548470|6251880|P1|COMPLETED|Overall Study||12
2550964|NCT00548470|6251880|P1|STARTED|Overall Study||14
2550965|NCT00548431|6251888|P1|NOT COMPLETED|Overall Study||0
2550966|NCT00548431|6251888|P1|COMPLETED|Overall Study||38
2550967|NCT00548431|6251888|P1|STARTED|Overall Study||38
2550968|NCT00548418|6251892|P1|NOT COMPLETED|Overall Study||0
2550969|NCT00548418|6251892|P1|COMPLETED|Overall Study||27
2550970|NCT00548418|6251892|P1|STARTED|Overall Study||27
2550971|NCT00548405|6251903|P3|NOT COMPLETED|Overall Study||9
2550972|NCT00548405|6251904|P2|NOT COMPLETED|Overall Study||20
2550973|NCT00548405|6251905|P1|NOT COMPLETED|Overall Study||56
2550974|NCT00548405|6251903|P3|COMPLETED|Overall Study||164
2550975|NCT00548405|6251904|P2|COMPLETED|Overall Study||416
2550976|NCT00548405|6251905|P1|COMPLETED|Overall Study||175
2550977|NCT00548405|6251903|P3|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|170
2550978|NCT00548405|6251904|P2|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|426
2550979|NCT00548405|6251905|P1|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|202
2550980|NCT00548405|6251903|P3|STARTED|Overall Study|Randomized.|173
2550981|NCT00548405|6251904|P2|STARTED|Overall Study|Randomized.|436
2550982|NCT00548405|6251905|P1|STARTED|Overall Study|Randomized.|231
2550983|NCT00548340|6251926|P3|NOT COMPLETED|Overall Study||9
2550984|NCT00548340|6251927|P2|NOT COMPLETED|Overall Study||11
2550985|NCT00548340|6251928|P1|NOT COMPLETED|Overall Study||8
2550986|NCT00548340|6251926|P3|COMPLETED|Overall Study||95
2550987|NCT00548340|6251927|P2|COMPLETED|Overall Study||98
2550988|NCT00548340|6251928|P1|COMPLETED|Overall Study||101
2550989|NCT00548340|6251926|P3|STARTED|Overall Study||104
2550990|NCT00548340|6251927|P2|STARTED|Overall Study||109
2550991|NCT00548340|6251928|P1|STARTED|Overall Study||109
2550992|NCT00548327|6251947|P2|NOT COMPLETED|Overall Study||1
2550993|NCT00548327|6251948|P1|NOT COMPLETED|Overall Study||0
2550994|NCT00548327|6251947|P2|COMPLETED|Overall Study|Patient randomized to receive placebo first. While on placebo, Adverse Event lead to discontinuation|4
2550995|NCT00548327|6251948|P1|COMPLETED|Overall Study||6
2550996|NCT00548327|6251947|P2|STARTED|Overall Study||5
2550997|NCT00548327|6251948|P1|STARTED|Overall Study||6
2550998|NCT00548262|6251966|P1|NOT COMPLETED|Overall Study||32
2550999|NCT00548262|6251966|P1|COMPLETED|Overall Study|1 N had D/C recorded as died and as lack of efficacy; reported as lack of efficacy in reason for D/C|22
2551000|NCT00548262|6251966|P1|STARTED|Overall Study|1 participant (N) had death recorded twice; reported as 1 death in reason for discontinuation (D/C)|54
2551001|NCT00548249|6251996|P5|NOT COMPLETED|Overall Study||21
2551002|NCT00548249|6251997|P4|NOT COMPLETED|Overall Study||13
2551003|NCT00548249|6251998|P3|NOT COMPLETED|Overall Study||20
2551004|NCT00548249|6251999|P2|NOT COMPLETED|Overall Study||13
2551005|NCT00548249|6252000|P1|NOT COMPLETED|Overall Study||16
2551006|NCT00548249|6251996|P5|COMPLETED|Overall Study||7
2551007|NCT00548249|6251997|P4|COMPLETED|Overall Study||9
2551008|NCT00548249|6251998|P3|COMPLETED|Overall Study||9
2551009|NCT00548249|6251999|P2|COMPLETED|Overall Study||13
2551010|NCT00548249|6252000|P1|COMPLETED|Overall Study||10
2551011|NCT00548249|6251996|P5|STARTED|Overall Study||28
2551012|NCT00548249|6251997|P4|STARTED|Overall Study||22
2551013|NCT00548249|6251998|P3|STARTED|Overall Study||29
2551014|NCT00548249|6251999|P2|STARTED|Overall Study||26
2551015|NCT00548249|6252000|P1|STARTED|Overall Study||26
2551016|NCT00548197|6252039|P2|NOT COMPLETED|Overall Study||0
2551017|NCT00548197|6252040|P1|NOT COMPLETED|Overall Study||0
2551018|NCT00548197|6252039|P2|COMPLETED|Overall Study||22
2551019|NCT00548197|6252040|P1|COMPLETED|Overall Study||18
2551020|NCT00548197|6252039|P2|STARTED|Overall Study||22
2551021|NCT00548197|6252040|P1|STARTED|Overall Study||18
2551022|NCT00548184|6252048|P1|NOT COMPLETED|Overall Study||5
2551023|NCT00548184|6252048|P1|COMPLETED|Overall Study|65 patients were on treatment. 5 did not complete due to adverse events or other reasons.|60
2551024|NCT00548184|6252048|P1|STARTED|Overall Study||65
2551025|NCT00548171|6252054|P2|NOT COMPLETED|Overall Study||0
2551026|NCT00548171|6252055|P1|NOT COMPLETED|Overall Study||0
2551027|NCT00548171|6252054|P2|COMPLETED|Overall Study||39
2551028|NCT00548171|6252055|P1|COMPLETED|Overall Study||164
2551029|NCT00548171|6252054|P2|STARTED|Overall Study||39
2551030|NCT00548171|6252055|P1|STARTED|Overall Study||164
2551031|NCT00548145|6252096|P2|NOT COMPLETED|Overall Study||4
2551032|NCT00548145|6252097|P1|NOT COMPLETED|Overall Study||1
2551033|NCT00548145|6252096|P2|COMPLETED|Overall Study||16
2551034|NCT00548145|6252097|P1|COMPLETED|Overall Study||17
2551035|NCT00548145|6252096|P2|STARTED|Overall Study||20
2551036|NCT00548145|6252097|P1|STARTED|Overall Study||18
2551037|NCT00548132|6252105|P2|NOT COMPLETED|Overall Study||0
2551038|NCT00548132|6252106|P1|NOT COMPLETED|Overall Study||0
2551039|NCT00548132|6252105|P2|COMPLETED|Overall Study||554
2551040|NCT00548132|6252106|P1|COMPLETED|Overall Study||534
2551041|NCT00548132|6252105|P2|Consented to Study|Overall Study||554
2551042|NCT00548132|6252106|P1|Consented to Study|Overall Study||534
2551043|NCT00548132|6252105|P2|STARTED|Overall Study||554
2551044|NCT00548132|6252106|P1|STARTED|Overall Study||534
2551045|NCT00548093|6252116|P2|NOT COMPLETED|Overall Study||16
2551046|NCT00548093|6252117|P1|NOT COMPLETED|Overall Study||50
2551047|NCT00548093|6252116|P2|COMPLETED|Overall Study||0
2551048|NCT00548093|6252117|P1|COMPLETED|Overall Study||0
2551049|NCT00548093|6252116|P2|STARTED|Overall Study||16
2551050|NCT00548093|6252117|P1|STARTED|Overall Study||50
2551051|NCT00548041|6252147|P1|NOT COMPLETED|Overall Study||0
2551052|NCT00548041|6252147|P1|COMPLETED|Overall Study||100
2551053|NCT00548041|6252147|P1|STARTED|Overall Study||100
2551054|NCT00547911|6252155|P6|NOT COMPLETED|Overall Study||0
2551055|NCT00547911|6252156|P5|NOT COMPLETED|Overall Study||0
2551056|NCT00547911|6252157|P4|NOT COMPLETED|Overall Study||1
2551057|NCT00547911|6252158|P3|NOT COMPLETED|Overall Study||0
2551058|NCT00547911|6252159|P2|NOT COMPLETED|Overall Study||0
2551059|NCT00547911|6252160|P1|NOT COMPLETED|Overall Study||0
2551060|NCT00547911|6252155|P6|COMPLETED|Overall Study||3
2551061|NCT00547911|6252156|P5|COMPLETED|Overall Study||3
2551062|NCT00547911|6252157|P4|COMPLETED|Overall Study||1
2551063|NCT00547911|6252158|P3|COMPLETED|Overall Study||2
2551064|NCT00547911|6252159|P2|COMPLETED|Overall Study||2
2551065|NCT00547911|6252160|P1|COMPLETED|Overall Study||2
2551066|NCT00547911|6252155|P6|STARTED|Overall Study||3
2551067|NCT00547911|6252156|P5|STARTED|Overall Study||3
2551068|NCT00547911|6252157|P4|STARTED|Overall Study||2
2551069|NCT00547911|6252158|P3|STARTED|Overall Study||2
2551070|NCT00547911|6252159|P2|STARTED|Overall Study||2
2551071|NCT00547911|6252160|P1|STARTED|Overall Study||2
2551072|NCT00547703|6252191|P2|NOT COMPLETED|Overall Study||0
2551073|NCT00547703|6252192|P1|NOT COMPLETED|Overall Study||1
2551074|NCT00547703|6252191|P2|COMPLETED|Overall Study||1
2551075|NCT00547703|6252192|P1|COMPLETED|Overall Study||3
2551076|NCT00547703|6252191|P2|STARTED|Overall Study||1
2551077|NCT00547703|6252192|P1|STARTED|Overall Study||4
2551078|NCT00547638|6252200|P2|NOT COMPLETED|Overall Study||14
2551079|NCT00547638|6252201|P1|NOT COMPLETED|Overall Study||24
2551080|NCT00547638|6252200|P2|COMPLETED|Overall Study||59
2551081|NCT00547638|6252201|P1|COMPLETED|Overall Study||119
2551082|NCT00547638|6252200|P2|STARTED|Overall Study||73
2551083|NCT00547638|6252201|P1|STARTED|Overall Study||143
2551084|NCT00547534|6252217|P1|NOT COMPLETED|Overall Study||11
2551085|NCT00547534|6252217|P1|COMPLETED|Overall Study|25 patients received at least 4 cycles. 29 patients were evaluable for response.|19
2551086|NCT00547534|6252217|P1|STARTED|Overall Study|31 patients enrolled; one patient was determined to be ineligible, and did not receive any therapy.|30
2551087|NCT00547521|6252225|P2|NOT COMPLETED|Long Term Extension (LTE) Study||31
2551088|NCT00547521|6252226|P1|NOT COMPLETED|Long Term Extension (LTE) Study||0
2551089|NCT00547521|6252225|P2|COMPLETED|Long Term Extension (LTE) Study||59
2551090|NCT00547521|6252226|P1|COMPLETED|Long Term Extension (LTE) Study||0
2551091|NCT00547521|6252225|P2|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|90
2551092|NCT00547521|6252226|P1|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|0
2551093|NCT00547521|6252225|P2|NOT COMPLETED|Short Term Study (4 Months)||4
2551094|NCT00547521|6252226|P1|NOT COMPLETED|Short Term Study (4 Months)||1
2551095|NCT00547521|6252225|P2|COMPLETED|Short Term Study (4 Months)||45
2551096|NCT00547521|6252226|P1|COMPLETED|Short Term Study (4 Months)||50
2551097|NCT00547521|6252225|P2|STARTED|Short Term Study (4 Months)|Number of participants treated.|49
2551098|NCT00547521|6252226|P1|STARTED|Short Term Study (4 Months)|Number of participants treated.|51
2551099|NCT00547456|6252296|P1|NOT COMPLETED|Overall Study||0
2551100|NCT00547456|6252296|P1|COMPLETED|Overall Study||20
2551101|NCT00547456|6252296|P1|STARTED|Overall Study||20
2551102|NCT00547378|6252303|P3|NOT COMPLETED|All Implanted Cohort||70
2551103|NCT00547378|6252304|P2|NOT COMPLETED|All Implanted Cohort||18
2551104|NCT00547378|6252305|P1|NOT COMPLETED|All Implanted Cohort||15
2551105|NCT00547378|6252303|P3|COMPLETED|All Implanted Cohort||111
2551106|NCT00547378|6252304|P2|COMPLETED|All Implanted Cohort||22
2551107|NCT00547378|6252305|P1|COMPLETED|All Implanted Cohort||36
2551108|NCT00547378|6252303|P3|Month 60|All Implanted Cohort||114
2551109|NCT00547378|6252304|P2|Month 60|All Implanted Cohort||23
2551110|NCT00547378|6252305|P1|Month 60|All Implanted Cohort||36
2551111|NCT00547378|6252303|P3|Month 48|All Implanted Cohort||136
2551112|NCT00547378|6252304|P2|Month 48|All Implanted Cohort||27
2551113|NCT00547378|6252305|P1|Month 48|All Implanted Cohort||38
2551114|NCT00547378|6252303|P3|Month 36|All Implanted Cohort||146
2551115|NCT00547378|6252304|P2|Month 36|All Implanted Cohort||29
2551116|NCT00547378|6252305|P1|Month 36|All Implanted Cohort||42
2551117|NCT00547378|6252303|P3|Month 24|All Implanted Cohort||161
2551118|NCT00547378|6252304|P2|Month 24|All Implanted Cohort||30
2551119|NCT00547378|6252305|P1|Month 24|All Implanted Cohort||42
2551120|NCT00547378|6252303|P3|Month 12|All Implanted Cohort||175
2551121|NCT00547378|6252304|P2|Month 12|All Implanted Cohort||32
2551122|NCT00547378|6252305|P1|Month 12|All Implanted Cohort||48
2551123|NCT00547378|6252303|P3|Month 6|All Implanted Cohort||178
2551124|NCT00547378|6252304|P2|Month 6|All Implanted Cohort||36
2551125|NCT00547378|6252305|P1|Month 6|All Implanted Cohort||50
2551126|NCT00547378|6252303|P3|Month 3|All Implanted Cohort||178
2551127|NCT00547378|6252304|P2|Month 3|All Implanted Cohort||39
2551128|NCT00547378|6252305|P1|Month 3|All Implanted Cohort||51
2551129|NCT00547378|6252303|P3|STARTED|All Implanted Cohort|This included subjects who received full system implant from non-randomized subjects.|181
2551130|NCT00547378|6252304|P2|STARTED|All Implanted Cohort|This included SMT subjects who received full system implant after completing randomization period.|40
2551131|NCT00547378|6252305|P1|STARTED|All Implanted Cohort|This included subjects who received full system implant after randomized to IST.|51
2551132|NCT00547378|6252303|P3|NOT COMPLETED|Randomized Cohort||0
2551133|NCT00547378|6252304|P2|NOT COMPLETED|Randomized Cohort||6
2551134|NCT00547378|6252305|P1|NOT COMPLETED|Randomized Cohort||11
2551135|NCT00547378|6252303|P3|COMPLETED|Randomized Cohort||0
2551136|NCT00547378|6252304|P2|COMPLETED|Randomized Cohort||71
2551137|NCT00547378|6252305|P1|COMPLETED|Randomized Cohort||59
2551138|NCT00547378|6252303|P3|Month 6|Randomized Cohort||0
2551139|NCT00547378|6252304|P2|Month 6|Randomized Cohort|This included SMT subjects who reached SMT Month 6 visit.|71
2551140|NCT00547378|6252305|P1|Month 6|Randomized Cohort|This includes IST subjects reached Month 6 visit, regardless of implant or not.|59
2551141|NCT00547378|6252303|P3|Month 3|Randomized Cohort||0
2551142|NCT00547378|6252304|P2|Month 3|Randomized Cohort|This included SMT subjects who reached SMT Month 3 visit.|72
2551143|NCT00547378|6252305|P1|Month 3|Randomized Cohort|This includes IST subjects reached Month 3 visit, regardless of implant or not.|62
2551144|NCT00547378|6252303|P3|STARTED|Randomized Cohort||0
2551145|NCT00547378|6252304|P2|STARTED|Randomized Cohort||77
2551146|NCT00547378|6252305|P1|STARTED|Randomized Cohort||70
2551147|NCT00547365|6252315|P1|NOT COMPLETED|Overall Study||8
2551148|NCT00547365|6252315|P1|COMPLETED|Overall Study||2
2551149|NCT00547365|6252315|P1|STARTED|Overall Study||10
2551150|NCT00547300|6252322|P2|NOT COMPLETED|Overall Study||26
2551151|NCT00547300|6252323|P1|NOT COMPLETED|Overall Study||25
2551152|NCT00547300|6252322|P2|COMPLETED|Overall Study|No patients completed because the study was administratively terminated.|0
2551153|NCT00547300|6252323|P1|COMPLETED|Overall Study|No patients completed because the study was administratively terminated.|0
2551154|NCT00547300|6252322|P2|STARTED|Overall Study|Two (2) patients were randomized in error, but no study medication taken.|26
2551155|NCT00547300|6252323|P1|STARTED|Overall Study||25
2551156|NCT00547248|6252337|P4|NOT COMPLETED|Overall Study||2
2551157|NCT00547248|6252338|P3|NOT COMPLETED|Overall Study||10
2551158|NCT00547248|6252339|P2|NOT COMPLETED|Overall Study||0
2551159|NCT00547248|6252340|P1|NOT COMPLETED|Overall Study||0
2551160|NCT00547248|6252337|P4|COMPLETED|Overall Study||96
2551161|NCT00547248|6252338|P3|COMPLETED|Overall Study||275
2551162|NCT00547248|6252339|P2|COMPLETED|Overall Study||93
2551163|NCT00547248|6252340|P1|COMPLETED|Overall Study||280
2551164|NCT00547248|6252337|P4|STARTED|Overall Study||98
2551165|NCT00547248|6252338|P3|STARTED|Overall Study||285
2551166|NCT00547248|6252339|P2|STARTED|Overall Study||93
2551167|NCT00547248|6252340|P1|STARTED|Overall Study||280
2551168|NCT00547157|6252458|P2|NOT COMPLETED|Overall Study||23
2551169|NCT00547157|6252459|P1|NOT COMPLETED|Overall Study||49
2551170|NCT00547157|6252458|P2|COMPLETED|Overall Study||39
2551171|NCT00547157|6252459|P1|COMPLETED|Overall Study||41
2551172|NCT00547157|6252458|P2|STARTED|Overall Study||62
2551173|NCT00547157|6252459|P1|STARTED|Overall Study||90
2551174|NCT00547118|6252477|P2|NOT COMPLETED|Overall Study||9
2551175|NCT00547118|6252478|P1|NOT COMPLETED|Overall Study||8
2551176|NCT00547118|6252477|P2|COMPLETED|Overall Study||0
2551177|NCT00547118|6252478|P1|COMPLETED|Overall Study||0
2551178|NCT00547118|6252477|P2|STARTED|Overall Study||9
2551179|NCT00547118|6252478|P1|STARTED|Overall Study||8
2551180|NCT00547105|6252510|P1|NOT COMPLETED|Overall Study||0
2551181|NCT00547105|6252510|P1|COMPLETED|Overall Study||24
2551182|NCT00547105|6252510|P1|STARTED|Overall Study||24
2551183|NCT00546910|6252522|P2|NOT COMPLETED|Overall Study||11
2551184|NCT00546910|6252523|P1|NOT COMPLETED|Overall Study||9
2551185|NCT00546910|6252522|P2|COMPLETED|Overall Study||51
2551186|NCT00546910|6252523|P1|COMPLETED|Overall Study||54
2551187|NCT00546910|6252522|P2|STARTED|Overall Study||62
2551188|NCT00546910|6252523|P1|STARTED|Overall Study||63
2551189|NCT00546897|6252543|P2|NOT COMPLETED|Overall Study||0
2551190|NCT00546897|6252544|P1|NOT COMPLETED|Overall Study||0
2551191|NCT00546897|6252543|P2|COMPLETED|Overall Study||33
2551192|NCT00546897|6252544|P1|COMPLETED|Overall Study||15
2551193|NCT00546897|6252543|P2|STARTED|Overall Study||33
2551194|NCT00546897|6252544|P1|STARTED|Overall Study||15
2551195|NCT00546884|6252582|P2|NOT COMPLETED|Overall Study||0
2551196|NCT00546884|6252583|P1|NOT COMPLETED|Overall Study||0
2551197|NCT00546884|6252582|P2|COMPLETED|Overall Study||117
2551198|NCT00546884|6252583|P1|COMPLETED|Overall Study||145
2551199|NCT00546884|6252582|P2|STARTED|Overall Study||117
2551200|NCT00546884|6252583|P1|STARTED|Overall Study||145
2551201|NCT00546871|6252589|P2|NOT COMPLETED|Study Extension Period||1
2551202|NCT00546871|6252590|P1|NOT COMPLETED|Study Extension Period||1
2551203|NCT00546871|6252589|P2|COMPLETED|Study Extension Period||25
2551204|NCT00546871|6252590|P1|COMPLETED|Study Extension Period||9
2551205|NCT00546871|6252589|P2|STARTED|Study Extension Period|6 withdrawn after Part 3b|26
2551206|NCT00546871|6252590|P1|STARTED|Study Extension Period|2 withdrawn after Part 3b|10
2551207|NCT00546871|6252589|P2|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
2551208|NCT00546871|6252590|P1|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
2551209|NCT00546871|6252589|P2|COMPLETED|Part 3b - SC IGIV 12 Weeks||32
2551210|NCT00546871|6252590|P1|COMPLETED|Part 3b - SC IGIV 12 Weeks||12
2551211|NCT00546871|6252589|P2|STARTED|Part 3b - SC IGIV 12 Weeks||32
2551212|NCT00546871|6252590|P1|STARTED|Part 3b - SC IGIV 12 Weeks||12
2551213|NCT00546871|6252589|P2|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
2551214|NCT00546871|6252590|P1|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
2551215|NCT00546871|6252589|P2|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
2551216|NCT00546871|6252590|P1|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
2551217|NCT00546871|6252589|P2|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
2551218|NCT00546871|6252590|P1|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
2551219|NCT00546871|6252589|P2|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||3
2551220|NCT00546871|6252590|P1|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||1
2551221|NCT00546871|6252589|P2|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||32
2551222|NCT00546871|6252590|P1|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||12
2551223|NCT00546871|6252589|P2|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||35
2551224|NCT00546871|6252590|P1|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||13
2551225|NCT00546871|6252589|P2|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||0
2551226|NCT00546871|6252590|P1|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||1
2551227|NCT00546871|6252589|P2|COMPLETED|Part 1 - IV Infusions of IGIV, PK||35
2551228|NCT00546871|6252590|P1|COMPLETED|Part 1 - IV Infusions of IGIV, PK||13
2551229|NCT00546871|6252589|P2|STARTED|Part 1 - IV Infusions of IGIV, PK||35
2551230|NCT00546871|6252590|P1|STARTED|Part 1 - IV Infusions of IGIV, PK||14
2551231|NCT00546819|6252695|P2|NOT COMPLETED|Overall Study||6
2551232|NCT00546819|6252696|P1|NOT COMPLETED|Overall Study||8
2551233|NCT00546819|6252695|P2|COMPLETED|Overall Study||96
2551234|NCT00546819|6252696|P1|COMPLETED|Overall Study||199
2551235|NCT00546819|6252695|P2|VACCINATED|Overall Study||100
2551236|NCT00546819|6252696|P1|VACCINATED|Overall Study||206
2551237|NCT00546819|6252695|P2|STARTED|Overall Study||102
2551238|NCT00546819|6252696|P1|STARTED|Overall Study||207
2551239|NCT00546754|6252708|P2|NOT COMPLETED|Overall Study||49
2551240|NCT00546754|6252709|P1|NOT COMPLETED|Overall Study||50
2551241|NCT00546754|6252708|P2|COMPLETED|Overall Study||334
2551242|NCT00546754|6252709|P1|COMPLETED|Overall Study||375
2551243|NCT00546754|6252708|P2|Week 12|Overall Study||334
2551244|NCT00546754|6252709|P1|Week 12|Overall Study||375
2551245|NCT00546754|6252708|P2|Week 6|Overall Study||347
2551246|NCT00546754|6252709|P1|Week 6|Overall Study||396
2551247|NCT00546754|6252708|P2|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|373
2551248|NCT00546754|6252709|P1|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|416
2551249|NCT00546754|6252708|P2|STARTED|Overall Study|Number of patients enrolled and randomized|383
2551250|NCT00546754|6252709|P1|STARTED|Overall Study|Number of patients enrolled and randomized|425
2551251|NCT00546728|6252741|P2|NOT COMPLETED|Overall Study||0
2551252|NCT00546728|6252742|P1|NOT COMPLETED|Overall Study||0
2551253|NCT00546728|6252741|P2|COMPLETED|Overall Study||25
2551254|NCT00546728|6252742|P1|COMPLETED|Overall Study||25
2551255|NCT00546728|6252741|P2|STARTED|Overall Study||25
2551256|NCT00546728|6252742|P1|STARTED|Overall Study||25
2551257|NCT00546715|6252752|P4|NOT COMPLETED|Overall Study||0
2551258|NCT00546715|6252753|P3|NOT COMPLETED|Overall Study||0
2551259|NCT00546715|6252754|P2|NOT COMPLETED|Overall Study||1
2551260|NCT00546715|6252755|P1|NOT COMPLETED|Overall Study||0
2551261|NCT00546715|6252752|P4|COMPLETED|Overall Study||2
2551262|NCT00546715|6252753|P3|COMPLETED|Overall Study||5
2551263|NCT00546715|6252754|P2|COMPLETED|Overall Study||4
2551264|NCT00546715|6252755|P1|COMPLETED|Overall Study||6
2551265|NCT00546715|6252752|P4|STARTED|Overall Study||2
2551266|NCT00546715|6252753|P3|STARTED|Overall Study||5
2551267|NCT00546715|6252754|P2|STARTED|Overall Study||5
2551268|NCT00546715|6252755|P1|STARTED|Overall Study||6
2551269|NCT00546637|6252810|P2|NOT COMPLETED|Overall Study||49
2551270|NCT00546637|6252811|P1|NOT COMPLETED|Overall Study||73
2551271|NCT00546637|6252810|P2|COMPLETED|Overall Study||424
2551272|NCT00546637|6252811|P1|COMPLETED|Overall Study||401
2551273|NCT00546637|6252810|P2|Received Treatment|Overall Study||472
2551274|NCT00546637|6252811|P1|Received Treatment|Overall Study||471
2551275|NCT00546637|6252810|P2|STARTED|Overall Study||473
2551276|NCT00546637|6252811|P1|STARTED|Overall Study||474
2551277|NCT00546572|6252885|P2|NOT COMPLETED|Vax 2 / Year 1||2
2551278|NCT00546572|6252886|P1|NOT COMPLETED|Vax 2 / Year 1||4
2551279|NCT00546572|6252885|P2|COMPLETED|Vax 2 / Year 1||402
2551280|NCT00546572|6252886|P1|COMPLETED|Vax 2 / Year 1||387
2551281|NCT00546572|6252885|P2|Received Vax 2|Vax 2 / Year 1||404
2551282|NCT00546572|6252886|P1|Received Vax 2|Vax 2 / Year 1||391
2551283|NCT00546572|6252885|P2|STARTED|Vax 2 / Year 1||404
2551284|NCT00546572|6252886|P1|STARTED|Vax 2 / Year 1||391
2551285|NCT00546572|6252885|P2|NOT COMPLETED|Vax 1 / Year 0||70
2551286|NCT00546572|6252886|P1|NOT COMPLETED|Vax 1 / Year 0||73
2551287|NCT00546572|6252885|P2|COMPLETED|Vax 1 / Year 0||404
2551288|NCT00546572|6252886|P1|COMPLETED|Vax 1 / Year 0||391
2551289|NCT00546572|6252885|P2|Received Vax 1|Vax 1 / Year 0||473
2551290|NCT00546572|6252886|P1|Received Vax 1|Vax 1 / Year 0||463
2551291|NCT00546572|6252885|P2|STARTED|Vax 1 / Year 0||474
2551292|NCT00546572|6252886|P1|STARTED|Vax 1 / Year 0||464
2551293|NCT00546481|6252930|P3|NOT COMPLETED|Maintenance Phase (CERA)||4
2551294|NCT00546481|6252931|P2|NOT COMPLETED|Maintenance Phase (CERA)||0
2551295|NCT00546481|6252932|P1|NOT COMPLETED|Maintenance Phase (CERA)||0
2551296|NCT00546481|6252930|P3|COMPLETED|Maintenance Phase (CERA)||50
2551297|NCT00546481|6252931|P2|COMPLETED|Maintenance Phase (CERA)||0
2551298|NCT00546481|6252932|P1|COMPLETED|Maintenance Phase (CERA)||0
2551299|NCT00546481|6252930|P3|STARTED|Maintenance Phase (CERA)||54
2551300|NCT00546481|6252931|P2|STARTED|Maintenance Phase (CERA)||0
2551301|NCT00546481|6252932|P1|STARTED|Maintenance Phase (CERA)||0
2551302|NCT00546481|6252930|P3|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
2551303|NCT00546481|6252931|P2|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||5
2551304|NCT00546481|6252932|P1|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||6
2551305|NCT00546481|6252930|P3|COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
2551306|NCT00546481|6252931|P2|COMPLETED|Correction Phase (CERA or Epoetin Beta)||36
2551307|NCT00546481|6252932|P1|COMPLETED|Correction Phase (CERA or Epoetin Beta)||33
2551308|NCT00546481|6252930|P3|STARTED|Correction Phase (CERA or Epoetin Beta)||0
2551309|NCT00546481|6252931|P2|STARTED|Correction Phase (CERA or Epoetin Beta)||41
2551310|NCT00546481|6252932|P1|STARTED|Correction Phase (CERA or Epoetin Beta)||39
2551311|NCT00546429|6252955|P1|NOT COMPLETED|Overall Study||30
2551312|NCT00546429|6252955|P1|COMPLETED|Overall Study||32
2551313|NCT00546429|6252955|P1|STARTED|Overall Study|2 subjects did not have a preoperative Merle D'Aubigne score.|62
2551314|NCT00546390|6252961|P2|NOT COMPLETED|Overall Study||0
2551315|NCT00546390|6252962|P1|NOT COMPLETED|Overall Study||0
2551316|NCT00546390|6252961|P2|COMPLETED|Overall Study||28
2551317|NCT00546390|6252962|P1|COMPLETED|Overall Study||27
2551318|NCT00546390|6252961|P2|STARTED|Overall Study||28
2551319|NCT00546390|6252962|P1|STARTED|Overall Study||27
2551320|NCT00546377|6252970|P1|NOT COMPLETED|Overall Study||7
2551321|NCT00546377|6252970|P1|COMPLETED|Overall Study||43
2551322|NCT00546377|6252970|P1|STARTED|Overall Study||50
2551323|NCT00546364|6252978|P3|NOT COMPLETED|Overall Study||17
2551324|NCT00546364|6252979|P2|NOT COMPLETED|Overall Study||18
2551325|NCT00546364|6252980|P1|NOT COMPLETED|Overall Study||17
2551326|NCT00546364|6252978|P3|COMPLETED|Overall Study|Still on treatment|3
2551327|NCT00546364|6252979|P2|COMPLETED|Overall Study|Still on treatment|4
2551328|NCT00546364|6252980|P1|COMPLETED|Overall Study|Still on treatment|3
2551329|NCT00546364|6252978|P3|Never Treated|Overall Study||0
2551330|NCT00546364|6252979|P2|Never Treated|Overall Study||0
2551331|NCT00546364|6252980|P1|Never Treated|Overall Study||0
2551332|NCT00546364|6252978|P3|STARTED|Overall Study||20
2551333|NCT00546364|6252979|P2|STARTED|Overall Study||22
2551334|NCT00546364|6252980|P1|STARTED|Overall Study||20
2551335|NCT00546351|6253015|P1|NOT COMPLETED|Overall Study||236
2551336|NCT00546351|6253015|P1|COMPLETED|Overall Study||385
2551337|NCT00546351|6253015|P1|STARTED|Overall Study||621
2551338|NCT00546273|6253048|P5|NOT COMPLETED|IV||0
2551339|NCT00546273|6253049|P4|NOT COMPLETED|IV||0
2551340|NCT00546273|6253050|P3|NOT COMPLETED|IV||0
2551341|NCT00546273|6253051|P2|NOT COMPLETED|IV||0
2551342|NCT00546273|6253052|P1|NOT COMPLETED|IV||0
2551343|NCT00546273|6253048|P5|COMPLETED|IV||2
2551344|NCT00546273|6253049|P4|COMPLETED|IV||4
2551345|NCT00546273|6253050|P3|COMPLETED|IV||0
2551346|NCT00546273|6253051|P2|COMPLETED|IV||0
2551347|NCT00546273|6253052|P1|COMPLETED|IV||0
2551348|NCT00546273|6253048|P5|STARTED|IV||2
2551349|NCT00546273|6253049|P4|STARTED|IV||4
2551350|NCT00546273|6253050|P3|STARTED|IV||0
2551351|NCT00546273|6253051|P2|STARTED|IV||0
2551352|NCT00546273|6253052|P1|STARTED|IV||0
2551353|NCT00546273|6253048|P5|NOT COMPLETED|III||0
2551354|NCT00546273|6253049|P4|NOT COMPLETED|III||0
2551355|NCT00546273|6253050|P3|NOT COMPLETED|III||0
2551356|NCT00546273|6253051|P2|NOT COMPLETED|III||0
2551357|NCT00546273|6253052|P1|NOT COMPLETED|III||0
2551358|NCT00546273|6253048|P5|COMPLETED|III||2
2551359|NCT00546273|6253049|P4|COMPLETED|III||0
2551360|NCT00546273|6253050|P3|COMPLETED|III||4
2551361|NCT00546273|6253051|P2|COMPLETED|III||0
2551362|NCT00546273|6253052|P1|COMPLETED|III||0
2551363|NCT00546273|6253048|P5|STARTED|III||2
2551364|NCT00546273|6253049|P4|STARTED|III||0
2551365|NCT00546273|6253050|P3|STARTED|III||4
2551366|NCT00546273|6253051|P2|STARTED|III||0
2551367|NCT00546273|6253052|P1|STARTED|III||0
2551368|NCT00546273|6253048|P5|NOT COMPLETED|II||0
2551369|NCT00546273|6253049|P4|NOT COMPLETED|II||0
2551370|NCT00546273|6253050|P3|NOT COMPLETED|II||0
2551371|NCT00546273|6253051|P2|NOT COMPLETED|II||0
2551372|NCT00546273|6253052|P1|NOT COMPLETED|II||0
2551373|NCT00546273|6253048|P5|COMPLETED|II||2
2551374|NCT00546273|6253049|P4|COMPLETED|II||0
2551375|NCT00546273|6253050|P3|COMPLETED|II||0
2551376|NCT00546273|6253051|P2|COMPLETED|II||4
2551377|NCT00546273|6253052|P1|COMPLETED|II||0
2551378|NCT00546273|6253048|P5|STARTED|II||2
2551379|NCT00546273|6253049|P4|STARTED|II||0
2551380|NCT00546273|6253050|P3|STARTED|II||0
2551381|NCT00546273|6253051|P2|STARTED|II||4
2551382|NCT00546273|6253052|P1|STARTED|II||0
2551383|NCT00546273|6253048|P5|NOT COMPLETED|I||0
2551384|NCT00546273|6253049|P4|NOT COMPLETED|I||0
2551385|NCT00546273|6253050|P3|NOT COMPLETED|I||0
2551386|NCT00546273|6253051|P2|NOT COMPLETED|I||0
2551387|NCT00546273|6253052|P1|NOT COMPLETED|I||0
2551388|NCT00546273|6253048|P5|COMPLETED|I||2
2551389|NCT00546273|6253049|P4|COMPLETED|I||0
2551390|NCT00546273|6253050|P3|COMPLETED|I||0
2551391|NCT00546273|6253051|P2|COMPLETED|I||0
2551392|NCT00546273|6253052|P1|COMPLETED|I||4
2551393|NCT00546273|6253048|P5|STARTED|I||2
2551394|NCT00546273|6253049|P4|STARTED|I||0
2551395|NCT00546273|6253050|P3|STARTED|I||0
2551396|NCT00546273|6253051|P2|STARTED|I||0
2551397|NCT00546273|6253052|P1|STARTED|I||4
2551398|NCT00546260|6253061|P2|NOT COMPLETED|Overall Study||2
2551399|NCT00546260|6253062|P1|NOT COMPLETED|Overall Study||8
2551400|NCT00546260|6253061|P2|COMPLETED|Overall Study||32
2551401|NCT00546260|6253062|P1|COMPLETED|Overall Study||28
2551402|NCT00546260|6253061|P2|STARTED|Overall Study||34
2551403|NCT00546260|6253062|P1|STARTED|Overall Study||36
2551404|NCT00546156|6253074|P2|NOT COMPLETED|Overall Study||1
2551405|NCT00546156|6253075|P1|NOT COMPLETED|Overall Study||14
2551406|NCT00546156|6253074|P2|COMPLETED|Overall Study||19
2551407|NCT00546156|6253075|P1|COMPLETED|Overall Study||70
2551408|NCT00546156|6253074|P2|STARTED|Overall Study||20
2551409|NCT00546156|6253075|P1|STARTED|Overall Study||84
2551410|NCT00546117|6253084|P2|NOT COMPLETED|Overall Study||0
2551411|NCT00546117|6253085|P1|NOT COMPLETED|Overall Study||4
2551412|NCT00546117|6253084|P2|COMPLETED|Overall Study||7
2551413|NCT00546117|6253085|P1|COMPLETED|Overall Study||5
2551414|NCT00546117|6253084|P2|STARTED|Overall Study||7
2551415|NCT00546117|6253085|P1|STARTED|Overall Study||9
2551416|NCT00546104|6253099|P1|NOT COMPLETED|Overall Study||0
2551417|NCT00546104|6253099|P1|COMPLETED|Overall Study||31
2551418|NCT00546104|6253099|P1|STARTED|Overall Study||31
2551419|NCT00546078|6253110|P2|NOT COMPLETED|Overall Study||7
2551420|NCT00546078|6253111|P1|NOT COMPLETED|Overall Study||4
2551421|NCT00546078|6253110|P2|COMPLETED|Overall Study||43
2551422|NCT00546078|6253111|P1|COMPLETED|Overall Study||61
2551423|NCT00546078|6253110|P2|Month 18|Overall Study||45
2551424|NCT00546078|6253111|P1|Month 18|Overall Study||61
2551425|NCT00546078|6253110|P2|STARTED|Overall Study||50
2551426|NCT00546078|6253111|P1|STARTED|Overall Study||65
2551427|NCT00546052|6253149|P1|NOT COMPLETED|Overall Study||227
2551428|NCT00546052|6253149|P1|COMPLETED|Overall Study||1511
2551429|NCT00546052|6253149|P1|Week 52|Overall Study||1511
2551430|NCT00546052|6253149|P1|Week 32|Overall Study||1583
2551431|NCT00546052|6253149|P1|Week 12|Overall Study||1650
2551432|NCT00546052|6253149|P1|Week 8|Overall Study||1680
2551433|NCT00546052|6253149|P1|Week 4|Overall Study||1714
2551434|NCT00546052|6253149|P1|STARTED|Overall Study||1738
2551435|NCT00546000|6253167|P1|NOT COMPLETED|Overall Study||4
2551436|NCT00546000|6253167|P1|COMPLETED|Overall Study||52
2551437|NCT00546000|6253167|P1|STARTED|Overall Study||56
2551438|NCT00545974|6253174|P2|NOT COMPLETED|Overall Study||3
2551439|NCT00545974|6253175|P1|NOT COMPLETED|Overall Study||2
2551440|NCT00545974|6253174|P2|COMPLETED|Overall Study|subjects completed 26 weeks treatment in placebo cohort|39
2551441|NCT00545974|6253175|P1|COMPLETED|Overall Study|subjects completed 26 weeks treatment in memantine cohort|37
2551442|NCT00545974|6253174|P2|STARTED|Overall Study|subjects randomized to placebo cohort|42
2551443|NCT00545974|6253175|P1|STARTED|Overall Study|subjects randomized to memantine cohort|39
2551444|NCT00545948|6253186|P3|NOT COMPLETED|Overall Study||7
2551445|NCT00545948|6253187|P2|NOT COMPLETED|Overall Study||1
2551446|NCT00545948|6253188|P1|NOT COMPLETED|Overall Study||1
2551447|NCT00545948|6253186|P3|COMPLETED|Overall Study||0
2551448|NCT00545948|6253187|P2|COMPLETED|Overall Study|Patients who received pemetrexed + cisplatin protocol therapy.|14
2551449|NCT00545948|6253188|P1|COMPLETED|Overall Study|Patients who received vinorelbine + cisplatin protocol therapy.|8
2551450|NCT00545948|6253186|P3|Assigned Treatment|Overall Study||0
2551451|NCT00545948|6253187|P2|Assigned Treatment|Overall Study||15
2551452|NCT00545948|6253188|P1|Assigned Treatment|Overall Study||9
2551453|NCT00545948|6253186|P3|STARTED|Overall Study|Registered patients who were not assigned to receive protocol therapy.|7
2551454|NCT00545948|6253187|P2|STARTED|Overall Study|Registered patients assigned to receive pemetrexed + cisplatin protocol therapy.|15
2551455|NCT00545948|6253188|P1|STARTED|Overall Study|Registered patients assigned to receive vinorelbine + cisplatin protocol therapy.|9
2551456|NCT00545844|6253198|P1|NOT COMPLETED|Overall Study||12
2551457|NCT00545844|6253198|P1|COMPLETED|Overall Study||301
2551458|NCT00545844|6253198|P1|STARTED|Overall Study||313
2551459|NCT00545792|6253212|P1|NOT COMPLETED|Overall Study||1
2551460|NCT00545792|6253212|P1|COMPLETED|Overall Study||20
2551461|NCT00545792|6253212|P1|STARTED|Overall Study||21
2551462|NCT00545779|6253217|P1|NOT COMPLETED|Overall Study||44
2551463|NCT00545779|6253217|P1|COMPLETED|Overall Study||633
2551464|NCT00545779|6253217|P1|STARTED|Overall Study||677
2551465|NCT00545766|6253230|P1|NOT COMPLETED|Overall Study||5
2551466|NCT00545766|6253230|P1|COMPLETED|Overall Study||36
2551467|NCT00545766|6253230|P1|STARTED|Overall Study||41
2551468|NCT00545753|6253237|P3|NOT COMPLETED|Overall Study||26
2551469|NCT00545753|6253238|P2|NOT COMPLETED|Overall Study||5
2551470|NCT00545753|6253239|P1|NOT COMPLETED|Overall Study||16
2551471|NCT00545753|6253237|P3|COMPLETED|Overall Study||230
2551472|NCT00545753|6253238|P2|COMPLETED|Overall Study||54
2551473|NCT00545753|6253239|P1|COMPLETED|Overall Study||227
2551474|NCT00545753|6253237|P3|STARTED|Overall Study||256
2551475|NCT00545753|6253238|P2|STARTED|Overall Study||59
2551476|NCT00545753|6253239|P1|STARTED|Overall Study||243
2551477|NCT00545740|6253252|P4|NOT COMPLETED|Overall Study||71
2551478|NCT00545740|6253253|P3|NOT COMPLETED|Overall Study||96
2551479|NCT00545740|6253254|P2|NOT COMPLETED|Overall Study||83
2551480|NCT00545740|6253255|P1|NOT COMPLETED|Overall Study||75
2551481|NCT00545740|6253252|P4|COMPLETED|Overall Study||78
2551482|NCT00545740|6253253|P3|COMPLETED|Overall Study||55
2551483|NCT00545740|6253254|P2|COMPLETED|Overall Study||62
2551484|NCT00545740|6253255|P1|COMPLETED|Overall Study||70
2551485|NCT00545740|6253252|P4|STARTED|Overall Study||149
2551486|NCT00545740|6253253|P3|STARTED|Overall Study||151
2551487|NCT00545740|6253254|P2|STARTED|Overall Study||145
2551488|NCT00545740|6253255|P1|STARTED|Overall Study||145
2551489|NCT00545714|6253289|P1|NOT COMPLETED|Maintenance Phase (36 Months)||32
2551490|NCT00545714|6253289|P1|COMPLETED|Maintenance Phase (36 Months)||42
2551491|NCT00545714|6253289|P1|STARTED|Maintenance Phase (36 Months)||74
2551492|NCT00545714|6253289|P1|NOT COMPLETED|Induction Phase (6 Months)||12
2551493|NCT00545714|6253289|P1|COMPLETED|Induction Phase (6 Months)||74
2551494|NCT00545714|6253289|P1|Intent-to-Treat (ITT) Population|Induction Phase (6 Months)||84
2551495|NCT00545714|6253289|P1|Safety Population|Induction Phase (6 Months)||86
2551496|NCT00545714|6253289|P1|STARTED|Induction Phase (6 Months)||86
2551497|NCT00545688|6253310|P4|NOT COMPLETED|Follow-Up Period||27
2551498|NCT00545688|6253311|P3|NOT COMPLETED|Follow-Up Period||20
2551499|NCT00545688|6253312|P2|NOT COMPLETED|Follow-Up Period||19
2551500|NCT00545688|6253313|P1|NOT COMPLETED|Follow-Up Period||21
2551501|NCT00545688|6253310|P4|COMPLETED|Follow-Up Period||60
2551502|NCT00545688|6253311|P3|COMPLETED|Follow-Up Period||78
2551503|NCT00545688|6253312|P2|COMPLETED|Follow-Up Period||83
2551504|NCT00545688|6253313|P1|COMPLETED|Follow-Up Period||77
2551505|NCT00545688|6253310|P4|STARTED|Follow-Up Period||87
2551506|NCT00545688|6253311|P3|STARTED|Follow-Up Period||98
2551507|NCT00545688|6253312|P2|STARTED|Follow-Up Period||102
2551508|NCT00545688|6253313|P1|STARTED|Follow-Up Period||98
2551509|NCT00545688|6253310|P4|NOT COMPLETED|Adjuvant Treatment Period||14
2551510|NCT00545688|6253311|P3|NOT COMPLETED|Adjuvant Treatment Period||4
2551511|NCT00545688|6253312|P2|NOT COMPLETED|Adjuvant Treatment Period||8
2551512|NCT00545688|6253313|P1|NOT COMPLETED|Adjuvant Treatment Period||5
2551513|NCT00545688|6253310|P4|COMPLETED|Adjuvant Treatment Period||74
2551514|NCT00545688|6253311|P3|COMPLETED|Adjuvant Treatment Period||90
2551515|NCT00545688|6253312|P2|COMPLETED|Adjuvant Treatment Period||94
2551516|NCT00545688|6253313|P1|COMPLETED|Adjuvant Treatment Period||98
2551517|NCT00545688|6253310|P4|STARTED|Adjuvant Treatment Period||88
2551518|NCT00545688|6253311|P3|STARTED|Adjuvant Treatment Period||94
2551519|NCT00545688|6253312|P2|STARTED|Adjuvant Treatment Period||102
2551520|NCT00545688|6253313|P1|STARTED|Adjuvant Treatment Period||103
2551521|NCT00545688|6253310|P4|NOT COMPLETED|Neo-Adjuvant Treatment Period||6
2551522|NCT00545688|6253311|P3|NOT COMPLETED|Neo-Adjuvant Treatment Period||14
2551523|NCT00545688|6253312|P2|NOT COMPLETED|Neo-Adjuvant Treatment Period||5
2551524|NCT00545688|6253313|P1|NOT COMPLETED|Neo-Adjuvant Treatment Period||4
2551525|NCT00545688|6253310|P4|COMPLETED|Neo-Adjuvant Treatment Period||88
2551526|NCT00545688|6253311|P3|COMPLETED|Neo-Adjuvant Treatment Period||94
2551527|NCT00545688|6253312|P2|COMPLETED|Neo-Adjuvant Treatment Period||102
2551528|NCT00545688|6253313|P1|COMPLETED|Neo-Adjuvant Treatment Period||103
2551529|NCT00545688|6253310|P4|STARTED|Neo-Adjuvant Treatment Period||94
2551530|NCT00545688|6253311|P3|STARTED|Neo-Adjuvant Treatment Period||108
2551531|NCT00545688|6253312|P2|STARTED|Neo-Adjuvant Treatment Period||107
2551532|NCT00545688|6253313|P1|STARTED|Neo-Adjuvant Treatment Period||107
2551533|NCT00545662|6253385|P2|NOT COMPLETED|Overall Study||79
2551534|NCT00545662|6253386|P1|NOT COMPLETED|Overall Study||85
2551535|NCT00545662|6253385|P2|COMPLETED|Overall Study||528
2551536|NCT00545662|6253386|P1|COMPLETED|Overall Study||521
2551537|NCT00545662|6253385|P2|STARTED|Overall Study||607
2551538|NCT00545662|6253386|P1|STARTED|Overall Study||606
2551539|NCT00545623|6253396|P4|NOT COMPLETED|Overall Study||11
2551540|NCT00545623|6253397|P3|NOT COMPLETED|Overall Study||13
2551541|NCT00545623|6253398|P2|NOT COMPLETED|Overall Study||10
2551542|NCT00545623|6253399|P1|NOT COMPLETED|Overall Study||7
2551543|NCT00545623|6253396|P4|COMPLETED|Overall Study||23
2551544|NCT00545623|6253397|P3|COMPLETED|Overall Study||20
2551545|NCT00545623|6253398|P2|COMPLETED|Overall Study||21
2551546|NCT00545623|6253399|P1|COMPLETED|Overall Study||25
2551547|NCT00545623|6253396|P4|STARTED|Overall Study||34
2551548|NCT00545623|6253397|P3|STARTED|Overall Study||33
2551549|NCT00545623|6253398|P2|STARTED|Overall Study||31
2551550|NCT00545623|6253399|P1|STARTED|Overall Study||32
2551551|NCT00545584|6253412|P3|NOT COMPLETED|Overall Study||56
2551552|NCT00545584|6253413|P2|NOT COMPLETED|Overall Study||80
2551553|NCT00545584|6253414|P1|NOT COMPLETED|Overall Study||79
2551554|NCT00545584|6253412|P3|COMPLETED|Overall Study||250
2551555|NCT00545584|6253413|P2|COMPLETED|Overall Study||334
2551556|NCT00545584|6253414|P1|COMPLETED|Overall Study||333
2551557|NCT00545584|6253412|P3|STARTED|Overall Study|306 subjects were randomized but only 305 were treated.|306
2551558|NCT00545584|6253413|P2|STARTED|Overall Study||414
2551559|NCT00545584|6253414|P1|STARTED|Overall Study||412
2551560|NCT00545571|6253425|P1|NOT COMPLETED|Overall Study||67
2551561|NCT00545571|6253425|P1|COMPLETED|Overall Study||53
2551562|NCT00545571|6253425|P1|STARTED|Overall Study||120
2551563|NCT00545532|6253440|P2|NOT COMPLETED|Overall Study||10
2551564|NCT00545532|6253441|P1|NOT COMPLETED|Overall Study||6
2551565|NCT00545532|6253440|P2|COMPLETED|Overall Study||100
2551566|NCT00545532|6253441|P1|COMPLETED|Overall Study||99
2551567|NCT00545532|6253440|P2|STARTED|Overall Study||110
2551568|NCT00545532|6253441|P1|STARTED|Overall Study||105
2551569|NCT00545506|6253523|P2|NOT COMPLETED|Overall Study||0
2551570|NCT00545506|6253524|P1|NOT COMPLETED|Overall Study||0
2551571|NCT00545506|6253523|P2|COMPLETED|Overall Study||3
2551572|NCT00545506|6253524|P1|COMPLETED|Overall Study||3
2551573|NCT00545506|6253523|P2|STARTED|Overall Study||3
2551574|NCT00545506|6253524|P1|STARTED|Overall Study||3
2551575|NCT00545441|6253532|P2|NOT COMPLETED|Overall Study||16
2551576|NCT00545441|6253533|P1|NOT COMPLETED|Overall Study||18
2551577|NCT00545441|6253532|P2|COMPLETED|Overall Study||26
2551578|NCT00545441|6253533|P1|COMPLETED|Overall Study||26
2551579|NCT00545441|6253532|P2|STARTED|Overall Study||42
2551580|NCT00545441|6253533|P1|STARTED|Overall Study||44
2551581|NCT00545402|6253541|P2|NOT COMPLETED|Overall Study||29
2551582|NCT00545402|6253542|P1|NOT COMPLETED|Overall Study||34
2551583|NCT00545402|6253541|P2|COMPLETED|Overall Study||61
2551584|NCT00545402|6253542|P1|COMPLETED|Overall Study||56
2551585|NCT00545402|6253541|P2|STARTED|Overall Study||90
2551586|NCT00545402|6253542|P1|STARTED|Overall Study||90
2551587|NCT00545363|6253560|P2|NOT COMPLETED|Overall Study||15
2551588|NCT00545363|6253561|P1|NOT COMPLETED|Overall Study||19
2551589|NCT00545363|6253560|P2|COMPLETED|Overall Study||343
2551590|NCT00545363|6253561|P1|COMPLETED|Overall Study||339
2551591|NCT00545363|6253560|P2|Treated|Overall Study||357
2551592|NCT00545363|6253561|P1|Treated|Overall Study||354
2551593|NCT00545363|6253560|P2|STARTED|Overall Study||358
2551594|NCT00545363|6253561|P1|STARTED|Overall Study||358
2551595|NCT00545298|6253576|P3|NOT COMPLETED|Overall Study||1
2551596|NCT00545298|6253577|P2|NOT COMPLETED|Overall Study||0
2551597|NCT00545298|6253578|P1|NOT COMPLETED|Overall Study||2
2551598|NCT00545298|6253576|P3|COMPLETED|Overall Study||0
2551599|NCT00545298|6253577|P2|COMPLETED|Overall Study||1
2551600|NCT00545298|6253578|P1|COMPLETED|Overall Study||0
2551601|NCT00545298|6253576|P3|STARTED|Overall Study||1
2551602|NCT00545298|6253577|P2|STARTED|Overall Study||1
2551603|NCT00545298|6253578|P1|STARTED|Overall Study||2
2551604|NCT00545272|6253595|P6|NOT COMPLETED|Overall Study||3
2551605|NCT00545272|6253596|P5|NOT COMPLETED|Overall Study||2
2551606|NCT00545272|6253597|P4|NOT COMPLETED|Overall Study||1
2551607|NCT00545272|6253598|P3|NOT COMPLETED|Overall Study||1
2551608|NCT00545272|6253599|P2|NOT COMPLETED|Overall Study||1
2551609|NCT00545272|6253600|P1|NOT COMPLETED|Overall Study||0
2551610|NCT00545272|6253595|P6|COMPLETED|Overall Study||59
2551611|NCT00545272|6253596|P5|COMPLETED|Overall Study||62
2551612|NCT00545272|6253597|P4|COMPLETED|Overall Study||71
2551613|NCT00545272|6253598|P3|COMPLETED|Overall Study||64
2551614|NCT00545272|6253599|P2|COMPLETED|Overall Study||67
2551615|NCT00545272|6253600|P1|COMPLETED|Overall Study||61
2551616|NCT00545272|6253595|P6|STARTED|Overall Study||62
2551617|NCT00545272|6253596|P5|STARTED|Overall Study||64
2551618|NCT00545272|6253597|P4|STARTED|Overall Study||72
2551619|NCT00545272|6253598|P3|STARTED|Overall Study||65
2551620|NCT00545272|6253599|P2|STARTED|Overall Study||68
2551621|NCT00545272|6253600|P1|STARTED|Overall Study||61
2551622|NCT00545233|6253652|P2|NOT COMPLETED|Overall Study||35
2551623|NCT00545233|6253653|P1|NOT COMPLETED|Overall Study||46
2551624|NCT00545233|6253652|P2|COMPLETED|Overall Study||41
2551625|NCT00545233|6253653|P1|COMPLETED|Overall Study||33
2551626|NCT00545233|6253652|P2|Intent-to-Treat (ITT)|Overall Study||73
2551627|NCT00545233|6253653|P1|Intent-to-Treat (ITT)|Overall Study||77
2551628|NCT00545233|6253652|P2|Safety Set|Overall Study||75
2551629|NCT00545233|6253653|P1|Safety Set|Overall Study||77
2551630|NCT00545233|6253652|P2|STARTED|Overall Study||76
2551631|NCT00545233|6253653|P1|STARTED|Overall Study||79
2551632|NCT00545181|6253702|P2|NOT COMPLETED|Overall Study||0
2551633|NCT00545181|6253703|P1|NOT COMPLETED|Overall Study||0
2551634|NCT00545181|6253702|P2|COMPLETED|Overall Study||25
2551635|NCT00545181|6253703|P1|COMPLETED|Overall Study||29
2551636|NCT00545181|6253702|P2|STARTED|Overall Study||25
2551637|NCT00545181|6253703|P1|STARTED|Overall Study||29
2551638|NCT00545168|6253712|P3|NOT COMPLETED|Overall Study||21
2551639|NCT00545168|6253713|P2|NOT COMPLETED|Overall Study||5
2551640|NCT00545168|6253714|P1|NOT COMPLETED|Overall Study||16
2551641|NCT00545168|6253712|P3|COMPLETED|Overall Study||193
2551642|NCT00545168|6253713|P2|COMPLETED|Overall Study||58
2551643|NCT00545168|6253714|P1|COMPLETED|Overall Study||187
2551644|NCT00545168|6253712|P3|STARTED|Overall Study||214
2551645|NCT00545168|6253713|P2|STARTED|Overall Study||63
2551646|NCT00545168|6253714|P1|STARTED|Overall Study||203
2551647|NCT00545155|6253723|P1|NOT COMPLETED|Overall Study||0
2551648|NCT00545155|6253723|P1|COMPLETED|Overall Study||187
2551649|NCT00545155|6253723|P1|STARTED|Overall Study||187
2551650|NCT00545103|6253740|P4|NOT COMPLETED|Overall Study||70
2551651|NCT00545103|6253741|P3|NOT COMPLETED|Overall Study||76
2551652|NCT00545103|6253742|P2|NOT COMPLETED|Overall Study||78
2551653|NCT00545103|6253743|P1|NOT COMPLETED|Overall Study||75
2551654|NCT00545103|6253740|P4|COMPLETED|Overall Study||76
2551655|NCT00545103|6253741|P3|COMPLETED|Overall Study||74
2551656|NCT00545103|6253742|P2|COMPLETED|Overall Study||70
2551657|NCT00545103|6253743|P1|COMPLETED|Overall Study||73
2551658|NCT00545103|6253740|P4|STARTED|Overall Study||146
2551659|NCT00545103|6253741|P3|STARTED|Overall Study||150
2551660|NCT00545103|6253742|P2|STARTED|Overall Study||148
2551661|NCT00545103|6253743|P1|STARTED|Overall Study||148
2551662|NCT00545077|6253779|P2|NOT COMPLETED|Overall Study||155
2551663|NCT00545077|6253780|P1|NOT COMPLETED|Overall Study||148
2551664|NCT00545077|6253779|P2|COMPLETED|Overall Study||36
2551665|NCT00545077|6253780|P1|COMPLETED|Overall Study||41
2551666|NCT00545077|6253779|P2|STARTED|Overall Study||191
2551667|NCT00545077|6253780|P1|STARTED|Overall Study||189
2551668|NCT00545064|6253796|P1|NOT COMPLETED|Overall Study||8
2551669|NCT00545064|6253796|P1|COMPLETED|Overall Study||170
2551670|NCT00545064|6253796|P1|Visit 3 (Week 8)|Overall Study|8 patients didn’t complete the 8-week period. 6 were retrieved and considered as Visit 3 (Week 8)|176
2551671|NCT00545064|6253796|P1|Visit 2 (Week 4)|Overall Study||169
2551672|NCT00545064|6253796|P1|Visit 1 (Baseline)|Overall Study||178
2551673|NCT00545064|6253796|P1|STARTED|Overall Study||178
2551674|NCT00545051|6253807|P2|NOT COMPLETED|Overall Study||7
2551675|NCT00545051|6253808|P1|NOT COMPLETED|Overall Study||9
2551676|NCT00545051|6253807|P2|COMPLETED|Overall Study||65
2551677|NCT00545051|6253808|P1|COMPLETED|Overall Study||59
2551678|NCT00545051|6253807|P2|STARTED|Overall Study||72
2551679|NCT00545051|6253808|P1|STARTED|Overall Study||68
2551680|NCT00545025|6253824|P2|NOT COMPLETED|Overall Study||0
2551681|NCT00545025|6253825|P1|NOT COMPLETED|Overall Study||0
2551682|NCT00545025|6253824|P2|COMPLETED|Overall Study||83
2551683|NCT00545025|6253825|P1|COMPLETED|Overall Study||160
2551684|NCT00545025|6253824|P2|STARTED|Overall Study||83
2551685|NCT00545025|6253825|P1|STARTED|Overall Study||160
2551686|NCT00544908|6253845|P1|NOT COMPLETED|Overall Study||0
2551687|NCT00544908|6253845|P1|COMPLETED|Overall Study||7
2551688|NCT00544908|6253845|P1|STARTED|Overall Study||7
2551689|NCT00544882|6253852|P3|NOT COMPLETED|Cycle 3: Follow-up||0
2551690|NCT00544882|6253853|P2|NOT COMPLETED|Cycle 3: Follow-up||2
2551691|NCT00544882|6253854|P1|NOT COMPLETED|Cycle 3: Follow-up||0
2551692|NCT00544882|6253852|P3|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|28
2551693|NCT00544882|6253853|P2|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|26
2551694|NCT00544882|6253854|P1|COMPLETED|Cycle 3: Follow-up||0
2551695|NCT00544882|6253852|P3|STARTED|Cycle 3: Follow-up||28
2551696|NCT00544882|6253853|P2|STARTED|Cycle 3: Follow-up||28
2551697|NCT00544882|6253854|P1|STARTED|Cycle 3: Follow-up||0
2551698|NCT00544882|6253852|P3|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
2551699|NCT00544882|6253853|P2|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
2551700|NCT00544882|6253854|P1|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||0
2551701|NCT00544882|6253852|P3|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
2551702|NCT00544882|6253853|P2|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
2551703|NCT00544882|6253854|P1|COMPLETED|Cycle 2: Randomized Treatment Cycle||0
2551704|NCT00544882|6253852|P3|Treated|Cycle 2: Randomized Treatment Cycle|One participant was dropped from the study due to noncompliance prior to treatment.|28
2551705|NCT00544882|6253853|P2|Treated|Cycle 2: Randomized Treatment Cycle|One participant withdrew prior to treatment|28
2551706|NCT00544882|6253854|P1|Treated|Cycle 2: Randomized Treatment Cycle||0
2551707|NCT00544882|6253852|P3|STARTED|Cycle 2: Randomized Treatment Cycle||29
2551708|NCT00544882|6253853|P2|STARTED|Cycle 2: Randomized Treatment Cycle||29
2551709|NCT00544882|6253854|P1|STARTED|Cycle 2: Randomized Treatment Cycle||0
2551710|NCT00544882|6253852|P3|NOT COMPLETED|Cycle 1: Run-in Cycle||0
2551711|NCT00544882|6253853|P2|NOT COMPLETED|Cycle 1: Run-in Cycle||0
2551712|NCT00544882|6253854|P1|NOT COMPLETED|Cycle 1: Run-in Cycle||3
2551713|NCT00544882|6253852|P3|COMPLETED|Cycle 1: Run-in Cycle||0
2551714|NCT00544882|6253853|P2|COMPLETED|Cycle 1: Run-in Cycle||0
2551715|NCT00544882|6253854|P1|COMPLETED|Cycle 1: Run-in Cycle||58
2551716|NCT00544882|6253852|P3|STARTED|Cycle 1: Run-in Cycle||0
2551717|NCT00544882|6253853|P2|STARTED|Cycle 1: Run-in Cycle||0
2551718|NCT00544882|6253854|P1|STARTED|Cycle 1: Run-in Cycle||61
2551719|NCT00544869|6253879|P3|NOT COMPLETED|Overall Study||0
2551720|NCT00544869|6253880|P2|NOT COMPLETED|Overall Study||2
2551721|NCT00544869|6253881|P1|NOT COMPLETED|Overall Study||12
2551722|NCT00544869|6253879|P3|COMPLETED|Overall Study||2
2551723|NCT00544869|6253880|P2|COMPLETED|Overall Study||12
2551724|NCT00544869|6253881|P1|COMPLETED|Overall Study||24
2551725|NCT00544869|6253879|P3|STARTED|Overall Study||2
2551726|NCT00544869|6253880|P2|STARTED|Overall Study||14
2551727|NCT00544869|6253881|P1|STARTED|Overall Study||36
2551728|NCT00544817|6253889|P1|NOT COMPLETED|Follow-up Systemic Therapy||19
2551729|NCT00544817|6253889|P1|COMPLETED|Follow-up Systemic Therapy||9
2551730|NCT00544817|6253889|P1|STARTED|Follow-up Systemic Therapy||28
2551731|NCT00544817|6253889|P1|NOT COMPLETED|No Treatment Interval||12
2551732|NCT00544817|6253889|P1|COMPLETED|No Treatment Interval||28
2551733|NCT00544817|6253889|P1|STARTED|No Treatment Interval||40
2551734|NCT00544817|6253889|P1|NOT COMPLETED|Combined Modality||7
2551735|NCT00544817|6253889|P1|COMPLETED|Combined Modality||40
2551736|NCT00544817|6253889|P1|STARTED|Combined Modality||47
2551737|NCT00544778|6253895|P1|NOT COMPLETED|Overall Study||0
2551738|NCT00544778|6253895|P1|COMPLETED|Overall Study||7
2551739|NCT00544778|6253895|P1|STARTED|Overall Study||7
2551740|NCT00544713|6253901|P2|NOT COMPLETED|Overall Study||5
2551741|NCT00544713|6253902|P1|NOT COMPLETED|Overall Study||3
2551742|NCT00544713|6253901|P2|COMPLETED|Overall Study||109
2551743|NCT00544713|6253902|P1|COMPLETED|Overall Study||111
2551744|NCT00544713|6253901|P2|STARTED|Overall Study||114
2551745|NCT00544713|6253902|P1|STARTED|Overall Study||114
2551746|NCT00544674|6253932|P1|NOT COMPLETED|Overall Study||1
2551747|NCT00544674|6253932|P1|COMPLETED|Overall Study||4
2551748|NCT00544674|6253932|P1|STARTED|Overall Study|1 subject registered and expired prior to dosing|5
2551749|NCT00544648|6253938|P2|NOT COMPLETED|Overall Study||1
2551750|NCT00544648|6253939|P1|NOT COMPLETED|Overall Study||3
2551751|NCT00544648|6253938|P2|COMPLETED|Overall Study||1
2551752|NCT00544648|6253939|P1|COMPLETED|Overall Study||8
2551753|NCT00544648|6253938|P2|STARTED|Overall Study||2
2551754|NCT00544648|6253939|P1|STARTED|Overall Study||11
2551755|NCT00544557|6253953|P1|NOT COMPLETED|Overall Study||434
2551756|NCT00544557|6253953|P1|COMPLETED|Overall Study||1251
2551757|NCT00544557|6253953|P1|STARTED|Overall Study||1685
2551758|NCT00544544|6253984|P1|NOT COMPLETED|Overall Study||3
2551759|NCT00544544|6253984|P1|COMPLETED|Overall Study||11
2551760|NCT00544544|6253984|P1|STARTED|Overall Study||14
2551761|NCT00544440|6253991|P1|NOT COMPLETED|Overall Study||57
2551762|NCT00544440|6253991|P1|COMPLETED|Overall Study||0
2551763|NCT00544440|6253991|P1|STARTED|Overall Study||57
2551764|NCT00544167|6253998|P1|NOT COMPLETED|Overall Study||29
2551765|NCT00544167|6253998|P1|COMPLETED|Overall Study||16
2551766|NCT00544167|6253998|P1|STARTED|Overall Study||45
2551767|NCT00544076|6254005|P3|NOT COMPLETED|Overall Study||11
2551768|NCT00544076|6254006|P2|NOT COMPLETED|Overall Study||16
2551769|NCT00544076|6254007|P1|NOT COMPLETED|Overall Study||17
2551770|NCT00544076|6254005|P3|COMPLETED|Overall Study||20
2551771|NCT00544076|6254006|P2|COMPLETED|Overall Study||19
2551772|NCT00544076|6254007|P1|COMPLETED|Overall Study||17
2551773|NCT00544076|6254005|P3|STARTED|Overall Study||31
2551774|NCT00544076|6254006|P2|STARTED|Overall Study||35
2551775|NCT00544076|6254007|P1|STARTED|Overall Study||34
2551776|NCT00543985|6254024|P1|NOT COMPLETED|Overall Study||4
2551777|NCT00543985|6254024|P1|COMPLETED|Overall Study||32
2551778|NCT00543985|6254024|P1|STARTED|Overall Study||36
2551779|NCT00543855|6254035|P4|NOT COMPLETED|Overall Study||4
2551780|NCT00543855|6254036|P3|NOT COMPLETED|Overall Study||6
2551781|NCT00543855|6254037|P2|NOT COMPLETED|Overall Study||2
2551782|NCT00543855|6254038|P1|NOT COMPLETED|Overall Study||4
2551783|NCT00543855|6254035|P4|COMPLETED|Overall Study||30
2551784|NCT00543855|6254036|P3|COMPLETED|Overall Study||31
2551785|NCT00543855|6254037|P2|COMPLETED|Overall Study||31
2551786|NCT00543855|6254038|P1|COMPLETED|Overall Study||31
2551787|NCT00543855|6254035|P4|STARTED|Overall Study||34
2551788|NCT00543855|6254036|P3|STARTED|Overall Study||37
2551789|NCT00543855|6254037|P2|STARTED|Overall Study||33
2551790|NCT00543855|6254038|P1|STARTED|Overall Study||35
2551791|NCT00543803|6254060|P1|NOT COMPLETED|Overall Study||142
2551792|NCT00543803|6254060|P1|COMPLETED|Overall Study||192
2551793|NCT00543803|6254060|P1|STARTED|Overall Study||334
2551794|NCT00543764|6254079|P2|NOT COMPLETED|Overall Study||0
2551795|NCT00543764|6254080|P1|NOT COMPLETED|Overall Study||0
2551796|NCT00543764|6254079|P2|COMPLETED|Overall Study||50
2551797|NCT00543764|6254080|P1|COMPLETED|Overall Study||100
2551798|NCT00543764|6254079|P2|STARTED|Overall Study||50
2551799|NCT00543764|6254080|P1|STARTED|Overall Study||100
2551800|NCT00543725|6254088|P2|NOT COMPLETED|Overall Study||74
2551801|NCT00543725|6254089|P1|NOT COMPLETED|Overall Study||68
2551802|NCT00543725|6254088|P2|COMPLETED|Overall Study||264
2551803|NCT00543725|6254089|P1|COMPLETED|Overall Study||272
2551804|NCT00543725|6254088|P2|STARTED|Overall Study||338
2551805|NCT00543725|6254089|P1|STARTED|Overall Study||340
2551806|NCT00543569|6254115|P4|NOT COMPLETED|Overall Study||9
2551807|NCT00543569|6254116|P3|NOT COMPLETED|Overall Study||20
2551808|NCT00543569|6254117|P2|NOT COMPLETED|Overall Study||8
2551809|NCT00543569|6254118|P1|NOT COMPLETED|Overall Study||12
2551810|NCT00543569|6254115|P4|COMPLETED|Overall Study||72
2551811|NCT00543569|6254116|P3|COMPLETED|Overall Study||60
2551812|NCT00543569|6254117|P2|COMPLETED|Overall Study||72
2551813|NCT00543569|6254118|P1|COMPLETED|Overall Study||70
2551814|NCT00543569|6254115|P4|Received Treatment|Overall Study||78
2551815|NCT00543569|6254116|P3|Received Treatment|Overall Study||75
2551816|NCT00543569|6254117|P2|Received Treatment|Overall Study||77
2551817|NCT00543569|6254118|P1|Received Treatment|Overall Study||79
2551818|NCT00543569|6254115|P4|STARTED|Overall Study||81
2551819|NCT00543569|6254116|P3|STARTED|Overall Study||80
2551820|NCT00543569|6254117|P2|STARTED|Overall Study||80
2551821|NCT00543569|6254118|P1|STARTED|Overall Study||82
2551822|NCT00543543|6254224|P4|NOT COMPLETED|Extension Study||226
2551823|NCT00543543|6254225|P3|NOT COMPLETED|Extension Study||0
2551824|NCT00543543|6254226|P2|NOT COMPLETED|Extension Study||0
2551825|NCT00543543|6254227|P1|NOT COMPLETED|Extension Study||0
2551826|NCT00543543|6254224|P4|COMPLETED|Extension Study||2824
2551827|NCT00543543|6254225|P3|COMPLETED|Extension Study||0
2551828|NCT00543543|6254226|P2|COMPLETED|Extension Study||150
2551829|NCT00543543|6254227|P1|COMPLETED|Extension Study||0
2551830|NCT00543543|6254224|P4|STARTED|Extension Study|Cohort 2|3050
2551831|NCT00543543|6254225|P3|STARTED|Extension Study|This group did not participate in the Extension Study|0
2551832|NCT00543543|6254226|P2|STARTED|Extension Study|Cohort 1|150
2551833|NCT00543543|6254227|P1|STARTED|Extension Study|This group did not participate in the Extension Study|0
2551834|NCT00543543|6254224|P4|NOT COMPLETED|Base Study||1222
2551835|NCT00543543|6254225|P3|NOT COMPLETED|Base Study||14
2551836|NCT00543543|6254226|P2|NOT COMPLETED|Base Study||1252
2551837|NCT00543543|6254227|P1|NOT COMPLETED|Base Study||20
2551838|NCT00543543|6254224|P4|COMPLETED|Base Study|Follow-up was up to 54 months|5887
2551839|NCT00543543|6254225|P3|COMPLETED|Base Study|Follow-up was up to 7 months|296
2551840|NCT00543543|6254226|P2|COMPLETED|Base Study|Follow-up was up to 54 months|5854
2551841|NCT00543543|6254227|P1|COMPLETED|Base Study|Follow-up was up to 7 months|295
2551842|NCT00543543|6254224|P4|Completed 3 Vaccinations|Base Study||6934
2551843|NCT00543543|6254225|P3|Completed 3 Vaccinations|Base Study||297
2551844|NCT00543543|6254226|P2|Completed 3 Vaccinations|Base Study||6928
2551845|NCT00543543|6254227|P1|Completed 3 Vaccinations|Base Study||300
2551846|NCT00543543|6254224|P4|STARTED|Base Study||7109
2551847|NCT00543543|6254225|P3|STARTED|Base Study||310
2551848|NCT00543543|6254226|P2|STARTED|Base Study||7106
2551849|NCT00543543|6254227|P1|STARTED|Base Study||315
2551850|NCT00543439|6254271|P3|NOT COMPLETED|Period 2||2
2551851|NCT00543439|6254272|P2|NOT COMPLETED|Period 2||1
2551852|NCT00543439|6254273|P1|NOT COMPLETED|Period 2||1
2551853|NCT00543439|6254271|P3|COMPLETED|Period 2||23
2551854|NCT00543439|6254272|P2|COMPLETED|Period 2||25
2551855|NCT00543439|6254273|P1|COMPLETED|Period 2||8
2551856|NCT00543439|6254271|P3|STARTED|Period 2||25
2551857|NCT00543439|6254272|P2|STARTED|Period 2||26
2551858|NCT00543439|6254273|P1|STARTED|Period 2||9
2551859|NCT00543439|6254271|P3|NOT COMPLETED|Period 1||2
2551860|NCT00543439|6254272|P2|NOT COMPLETED|Period 1||3
2551861|NCT00543439|6254273|P1|NOT COMPLETED|Period 1||1
2551862|NCT00543439|6254271|P3|COMPLETED|Period 1||25
2551863|NCT00543439|6254272|P2|COMPLETED|Period 1||26
2551864|NCT00543439|6254273|P1|COMPLETED|Period 1||9
2551865|NCT00543439|6254271|P3|Treated|Period 1||27
2551866|NCT00543439|6254272|P2|Treated|Period 1||29
2551867|NCT00543439|6254273|P1|Treated|Period 1||9
2551868|NCT00543439|6254271|P3|STARTED|Period 1||27
2551869|NCT00543439|6254272|P2|STARTED|Period 1||29
2551870|NCT00543439|6254273|P1|STARTED|Period 1||10
2551871|NCT00543400|6254320|P4|NOT COMPLETED|Overall Study||5
2551872|NCT00543400|6254321|P3|NOT COMPLETED|Overall Study||4
2551873|NCT00543400|6254322|P2|NOT COMPLETED|Overall Study||1
2551874|NCT00543400|6254323|P1|NOT COMPLETED|Overall Study||5
2551875|NCT00543400|6254320|P4|COMPLETED|Overall Study||151
2551876|NCT00543400|6254321|P3|COMPLETED|Overall Study||148
2551877|NCT00543400|6254322|P2|COMPLETED|Overall Study||43
2551878|NCT00543400|6254323|P1|COMPLETED|Overall Study||146
2551879|NCT00543400|6254320|P4|STARTED|Overall Study||156
2551880|NCT00543400|6254321|P3|STARTED|Overall Study||152
2551881|NCT00543400|6254322|P2|STARTED|Overall Study||44
2551882|NCT00543400|6254323|P1|STARTED|Overall Study||151
2551883|NCT00543387|6254342|P11|NOT COMPLETED|Crossover Participants||3
2551884|NCT00543387|6254343|P10|NOT COMPLETED|Crossover Participants||1
2551885|NCT00543387|6254344|P9|NOT COMPLETED|Crossover Participants||0
2551886|NCT00543387|6254345|P8|NOT COMPLETED|Crossover Participants||0
2551887|NCT00543387|6254346|P7|NOT COMPLETED|Crossover Participants||0
2551888|NCT00543387|6254347|P6|NOT COMPLETED|Crossover Participants||0
2551889|NCT00543387|6254348|P5|NOT COMPLETED|Crossover Participants||0
2551890|NCT00543387|6254349|P4|NOT COMPLETED|Crossover Participants||0
2551891|NCT00543387|6254350|P3|NOT COMPLETED|Crossover Participants||0
2551892|NCT00543387|6254351|P2|NOT COMPLETED|Crossover Participants||0
2551893|NCT00543387|6254352|P1|NOT COMPLETED|Crossover Participants||0
2551894|NCT00543387|6254342|P11|COMPLETED|Crossover Participants||0
2551895|NCT00543387|6254343|P10|COMPLETED|Crossover Participants||0
2551896|NCT00543387|6254344|P9|COMPLETED|Crossover Participants||0
2551897|NCT00543387|6254345|P8|COMPLETED|Crossover Participants||0
2551898|NCT00543387|6254346|P7|COMPLETED|Crossover Participants||0
2551899|NCT00543387|6254347|P6|COMPLETED|Crossover Participants||0
2551900|NCT00543387|6254348|P5|COMPLETED|Crossover Participants||0
2551901|NCT00543387|6254349|P4|COMPLETED|Crossover Participants||0
2551902|NCT00543387|6254350|P3|COMPLETED|Crossover Participants||0
2551903|NCT00543387|6254351|P2|COMPLETED|Crossover Participants||0
2551904|NCT00543387|6254352|P1|COMPLETED|Crossover Participants||0
2551905|NCT00543387|6254342|P11|STARTED|Crossover Participants|3 participants originally treated with 1500 (2) and 1800 mg (1) MK-5108 in Panel 1 Period 1|3
2551906|NCT00543387|6254343|P10|STARTED|Crossover Participants|Participant originally treated in MK-5108 400 mg BID (Panel 1) in Period 1|1
2551907|NCT00543387|6254344|P9|STARTED|Crossover Participants||0
2551908|NCT00543387|6254345|P8|STARTED|Crossover Participants||0
2551909|NCT00543387|6254346|P7|STARTED|Crossover Participants||0
2551910|NCT00543387|6254347|P6|STARTED|Crossover Participants||0
2551911|NCT00543387|6254348|P5|STARTED|Crossover Participants||0
2551912|NCT00543387|6254349|P4|STARTED|Crossover Participants||0
2551913|NCT00543387|6254350|P3|STARTED|Crossover Participants||0
2551914|NCT00543387|6254351|P2|STARTED|Crossover Participants||0
2551915|NCT00543387|6254352|P1|STARTED|Crossover Participants||0
2551916|NCT00543387|6254342|P11|NOT COMPLETED|Panel 1 + Panel 2||0
2551917|NCT00543387|6254343|P10|NOT COMPLETED|Panel 1 + Panel 2||0
2551918|NCT00543387|6254344|P9|NOT COMPLETED|Panel 1 + Panel 2||5
2551919|NCT00543387|6254345|P8|NOT COMPLETED|Panel 1 + Panel 2||6
2551920|NCT00543387|6254346|P7|NOT COMPLETED|Panel 1 + Panel 2||6
2551921|NCT00543387|6254347|P6|NOT COMPLETED|Panel 1 + Panel 2||3
2551922|NCT00543387|6254348|P5|NOT COMPLETED|Panel 1 + Panel 2||3
2551923|NCT00543387|6254349|P4|NOT COMPLETED|Panel 1 + Panel 2||3
2551924|NCT00543387|6254350|P3|NOT COMPLETED|Panel 1 + Panel 2||3
2551925|NCT00543387|6254351|P2|NOT COMPLETED|Panel 1 + Panel 2||3
2551926|NCT00543387|6254352|P1|NOT COMPLETED|Panel 1 + Panel 2||3
2551927|NCT00543387|6254342|P11|COMPLETED|Panel 1 + Panel 2||0
2551928|NCT00543387|6254343|P10|COMPLETED|Panel 1 + Panel 2||0
2551929|NCT00543387|6254344|P9|COMPLETED|Panel 1 + Panel 2||0
2551930|NCT00543387|6254345|P8|COMPLETED|Panel 1 + Panel 2||0
2551931|NCT00543387|6254346|P7|COMPLETED|Panel 1 + Panel 2||0
2551932|NCT00543387|6254347|P6|COMPLETED|Panel 1 + Panel 2||0
2551933|NCT00543387|6254348|P5|COMPLETED|Panel 1 + Panel 2||0
2551934|NCT00543387|6254349|P4|COMPLETED|Panel 1 + Panel 2||0
2551935|NCT00543387|6254350|P3|COMPLETED|Panel 1 + Panel 2||0
2551936|NCT00543387|6254351|P2|COMPLETED|Panel 1 + Panel 2||0
2551937|NCT00543387|6254352|P1|COMPLETED|Panel 1 + Panel 2||0
2551938|NCT00543387|6254342|P11|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
2551939|NCT00543387|6254343|P10|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
2551940|NCT00543387|6254344|P9|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
2551941|NCT00543387|6254345|P8|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
2551942|NCT00543387|6254346|P7|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
2551943|NCT00543387|6254347|P6|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||1
2551944|NCT00543387|6254348|P5|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||2
2551945|NCT00543387|6254349|P4|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
2551946|NCT00543387|6254350|P3|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
2551947|NCT00543387|6254351|P2|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||1
2551948|NCT00543387|6254352|P1|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
2551949|NCT00543387|6254342|P11|STARTED|Panel 1 + Panel 2||0
2551950|NCT00543387|6254343|P10|STARTED|Panel 1 + Panel 2||0
2551951|NCT00543387|6254344|P9|STARTED|Panel 1 + Panel 2||5
2551952|NCT00543387|6254345|P8|STARTED|Panel 1 + Panel 2||6
2551953|NCT00543387|6254346|P7|STARTED|Panel 1 + Panel 2||6
2551954|NCT00543387|6254347|P6|STARTED|Panel 1 + Panel 2||3
2551955|NCT00543387|6254348|P5|STARTED|Panel 1 + Panel 2||3
2551956|NCT00543387|6254349|P4|STARTED|Panel 1 + Panel 2||3
2551957|NCT00543387|6254350|P3|STARTED|Panel 1 + Panel 2||3
2551958|NCT00543387|6254351|P2|STARTED|Panel 1 + Panel 2||3
2551959|NCT00543387|6254352|P1|STARTED|Panel 1 + Panel 2||3
2551960|NCT00543309|6254390|P3|NOT COMPLETED|Overall Study||0
2551961|NCT00543309|6254391|P2|NOT COMPLETED|Overall Study||1
2551962|NCT00543309|6254392|P1|NOT COMPLETED|Overall Study||0
2551963|NCT00543309|6254390|P3|COMPLETED|Overall Study||35
2551964|NCT00543309|6254391|P2|COMPLETED|Overall Study||35
2551965|NCT00543309|6254392|P1|COMPLETED|Overall Study||35
2551966|NCT00543309|6254390|P3|STARTED|Overall Study||35
2551967|NCT00543309|6254391|P2|STARTED|Overall Study||36
2551968|NCT00543309|6254392|P1|STARTED|Overall Study||35
2551969|NCT00543296|6254442|P1|NOT COMPLETED|Overall Study||7
2551970|NCT00543296|6254442|P1|COMPLETED|Overall Study||14
2551971|NCT00543296|6254442|P1|STARTED|Overall Study||21
2551972|NCT00543140|6254449|P1|NOT COMPLETED|Overall Study||72
2551973|NCT00543140|6254449|P1|COMPLETED|Overall Study||231
2551974|NCT00543140|6254449|P1|STARTED|Overall Study||303
2551975|NCT00543127|6254459|P2|NOT COMPLETED|Overall Study||87
2551976|NCT00543127|6254460|P1|NOT COMPLETED|Overall Study||130
2551977|NCT00543127|6254459|P2|COMPLETED|Overall Study||350
2551978|NCT00543127|6254460|P1|COMPLETED|Overall Study||303
2551979|NCT00543127|6254459|P2|STARTED|Overall Study||437
2551980|NCT00543127|6254460|P1|STARTED|Overall Study||433
2551981|NCT00543101|6254474|P2|NOT COMPLETED|Overall Study||0
2551982|NCT00543101|6254475|P1|NOT COMPLETED|Overall Study||0
2551983|NCT00543101|6254474|P2|COMPLETED|Overall Study||12
2551984|NCT00543101|6254475|P1|COMPLETED|Overall Study||12
2551985|NCT00543101|6254474|P2|STARTED|Overall Study||12
2551986|NCT00543101|6254475|P1|STARTED|Overall Study||12
2551987|NCT00543062|6254487|P4|NOT COMPLETED|Overall Study||1
2551988|NCT00543062|6254488|P3|NOT COMPLETED|Overall Study||3
2551989|NCT00543062|6254489|P2|NOT COMPLETED|Overall Study||1
2551990|NCT00543062|6254490|P1|NOT COMPLETED|Overall Study||2
2551991|NCT00543062|6254487|P4|COMPLETED|Overall Study||11
2551992|NCT00543062|6254488|P3|COMPLETED|Overall Study||9
2551993|NCT00543062|6254489|P2|COMPLETED|Overall Study||11
2551994|NCT00543062|6254490|P1|COMPLETED|Overall Study||10
2551995|NCT00543062|6254487|P4|STARTED|Overall Study||12
2551996|NCT00543062|6254488|P3|STARTED|Overall Study||12
2551997|NCT00543062|6254489|P2|STARTED|Overall Study||12
2551998|NCT00543062|6254490|P1|STARTED|Overall Study||12
2551999|NCT00542997|6254512|P1|NOT COMPLETED|Efficacy Period||3
2552000|NCT00542997|6254512|P1|COMPLETED|Efficacy Period||43
2552001|NCT00542997|6254512|P1|STARTED|Efficacy Period||46
2552002|NCT00542997|6254512|P1|NOT COMPLETED|Wash in / Wash Out Period||5
2552003|NCT00542997|6254512|P1|COMPLETED|Wash in / Wash Out Period||46
2552004|NCT00542997|6254512|P1|STARTED|Wash in / Wash Out Period||51
2552005|NCT00542971|6254527|P1|NOT COMPLETED|Overall Study||0
2552006|NCT00542971|6254527|P1|COMPLETED|Overall Study||75
2552007|NCT00542971|6254527|P1|STARTED|Overall Study||75
2552008|NCT00542880|6254534|P2|NOT COMPLETED|Period 3||2
2552009|NCT00542880|6254535|P1|NOT COMPLETED|Period 3||0
2552010|NCT00542880|6254534|P2|COMPLETED|Period 3||201
2552011|NCT00542880|6254535|P1|COMPLETED|Period 3||204
2552012|NCT00542880|6254534|P2|STARTED|Period 3||203
2552013|NCT00542880|6254535|P1|STARTED|Period 3||204
2552014|NCT00542880|6254534|P2|NOT COMPLETED|Period 2||10
2552015|NCT00542880|6254535|P1|NOT COMPLETED|Period 2||7
2552016|NCT00542880|6254534|P2|COMPLETED|Period 2||203
2552017|NCT00542880|6254535|P1|COMPLETED|Period 2||204
2552018|NCT00542880|6254534|P2|STARTED|Period 2||213
2552019|NCT00542880|6254535|P1|STARTED|Period 2||211
2552020|NCT00542880|6254534|P2|NOT COMPLETED|Period 1||12
2552021|NCT00542880|6254535|P1|NOT COMPLETED|Period 1||6
2552022|NCT00542880|6254534|P2|COMPLETED|Period 1||213
2552023|NCT00542880|6254535|P1|COMPLETED|Period 1||211
2552024|NCT00542880|6254534|P2|STARTED|Period 1||225
2552025|NCT00542880|6254535|P1|STARTED|Period 1|This was a cross-over study|217
2552026|NCT00542828|6254571|P1|NOT COMPLETED|Overall Study||13
2552027|NCT00542828|6254571|P1|COMPLETED|Overall Study|Number of participants who completed the 12-month study period.|3
2552028|NCT00542828|6254571|P1|STARTED|Overall Study|Number of participants enrolled in the study; of the 16 enrolled, 14 received study treatment.|16
2552029|NCT00542815|6254589|P3|NOT COMPLETED|Overall Study||32
2552030|NCT00542815|6254590|P2|NOT COMPLETED|Overall Study||32
2552031|NCT00542815|6254591|P1|NOT COMPLETED|Overall Study||106
2552032|NCT00542815|6254589|P3|COMPLETED|Overall Study||92
2552033|NCT00542815|6254590|P2|COMPLETED|Overall Study||44
2552034|NCT00542815|6254591|P1|COMPLETED|Overall Study||326
2552035|NCT00542815|6254589|P3|STARTED|Overall Study||124
2552036|NCT00542815|6254590|P2|STARTED|Overall Study||76
2552037|NCT00542815|6254591|P1|STARTED|Overall Study||432
2552038|NCT00542789|6254604|P2|NOT COMPLETED|Overall Study||78
2552039|NCT00542789|6254605|P1|NOT COMPLETED|Overall Study||41
2552040|NCT00542789|6254604|P2|COMPLETED|Overall Study||90
2552041|NCT00542789|6254605|P1|COMPLETED|Overall Study||134
2552042|NCT00542789|6254604|P2|STARTED|Overall Study|Randomised|168
2552043|NCT00542789|6254605|P1|STARTED|Overall Study|Randomised|175
2552044|NCT00542750|6254615|P1|NOT COMPLETED|Overall Study||0
2552045|NCT00542750|6254615|P1|COMPLETED|Overall Study||24
2552046|NCT00542750|6254615|P1|STARTED|Overall Study||24
2552047|NCT00542620|6254621|P2|NOT COMPLETED|Overall Study||0
2552048|NCT00542620|6254622|P1|NOT COMPLETED|Overall Study||0
2552049|NCT00542620|6254621|P2|COMPLETED|Overall Study||12
2552050|NCT00542620|6254622|P1|COMPLETED|Overall Study||13
2552051|NCT00542620|6254621|P2|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|13
2552052|NCT00542620|6254622|P1|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|12
2552053|NCT00542620|6254621|P2|STARTED|Overall Study||12
2552054|NCT00542620|6254622|P1|STARTED|Overall Study||13
2552055|NCT00542542|6254688|P2|NOT COMPLETED|Overall Study||0
2552056|NCT00542542|6254689|P1|NOT COMPLETED|Overall Study||0
2552057|NCT00542542|6254688|P2|COMPLETED|Overall Study||44
2552058|NCT00542542|6254689|P1|COMPLETED|Overall Study||44
2552059|NCT00542542|6254688|P2|STARTED|Overall Study||44
2552060|NCT00542542|6254689|P1|STARTED|Overall Study||44
2552061|NCT00542490|6254695|P1|NOT COMPLETED|Overall Study||2
2552062|NCT00542490|6254695|P1|COMPLETED|Overall Study||21
2552063|NCT00542490|6254695|P1|STARTED|Overall Study||23
2552064|NCT00542425|6254705|P5|NOT COMPLETED|Extended 24 Weeks of Treatment||1
2552065|NCT00542425|6254706|P4|NOT COMPLETED|Extended 24 Weeks of Treatment||1
2552066|NCT00542425|6254707|P3|NOT COMPLETED|Extended 24 Weeks of Treatment||2
2552067|NCT00542425|6254708|P2|NOT COMPLETED|Extended 24 Weeks of Treatment||2
2552068|NCT00542425|6254709|P1|NOT COMPLETED|Extended 24 Weeks of Treatment||1
2552069|NCT00542425|6254705|P5|COMPLETED|Extended 24 Weeks of Treatment||13
2552070|NCT00542425|6254706|P4|COMPLETED|Extended 24 Weeks of Treatment||6
2552071|NCT00542425|6254707|P3|COMPLETED|Extended 24 Weeks of Treatment||8
2552072|NCT00542425|6254708|P2|COMPLETED|Extended 24 Weeks of Treatment||11
2552073|NCT00542425|6254709|P1|COMPLETED|Extended 24 Weeks of Treatment||10
2552074|NCT00542425|6254705|P5|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|14
2552075|NCT00542425|6254706|P4|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|7
2552076|NCT00542425|6254707|P3|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|10
2552077|NCT00542425|6254708|P2|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|13
2552078|NCT00542425|6254709|P1|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|11
2552079|NCT00542425|6254705|P5|NOT COMPLETED|Initial 24 Weeks||6
2552080|NCT00542425|6254706|P4|NOT COMPLETED|Initial 24 Weeks||11
2552081|NCT00542425|6254707|P3|NOT COMPLETED|Initial 24 Weeks||7
2552082|NCT00542425|6254708|P2|NOT COMPLETED|Initial 24 Weeks||10
2552083|NCT00542425|6254709|P1|NOT COMPLETED|Initial 24 Weeks||4
2552084|NCT00542425|6254705|P5|COMPLETED|Initial 24 Weeks||39
2552085|NCT00542425|6254706|P4|COMPLETED|Initial 24 Weeks||34
2552086|NCT00542425|6254707|P3|COMPLETED|Initial 24 Weeks||36
2552087|NCT00542425|6254708|P2|COMPLETED|Initial 24 Weeks||33
2552088|NCT00542425|6254709|P1|COMPLETED|Initial 24 Weeks||42
2552089|NCT00542425|6254705|P5|STARTED|Initial 24 Weeks||45
2552090|NCT00542425|6254706|P4|STARTED|Initial 24 Weeks||45
2552091|NCT00542425|6254707|P3|STARTED|Initial 24 Weeks||43
2552092|NCT00542425|6254708|P2|STARTED|Initial 24 Weeks||43
2552093|NCT00542425|6254709|P1|STARTED|Initial 24 Weeks||46
2552094|NCT00542386|6254747|P6|NOT COMPLETED|Overall Study||50
2552095|NCT00542386|6254748|P5|NOT COMPLETED|Overall Study||40
2552096|NCT00542386|6254749|P4|NOT COMPLETED|Overall Study||38
2552097|NCT00542386|6254750|P3|NOT COMPLETED|Overall Study||33
2552098|NCT00542386|6254751|P2|NOT COMPLETED|Overall Study||28
2552099|NCT00542386|6254752|P1|NOT COMPLETED|Overall Study||43
2552100|NCT00542386|6254747|P6|COMPLETED|Overall Study||82
2552101|NCT00542386|6254748|P5|COMPLETED|Overall Study||62
2552102|NCT00542386|6254749|P4|COMPLETED|Overall Study||65
2552103|NCT00542386|6254750|P3|COMPLETED|Overall Study||66
2552104|NCT00542386|6254751|P2|COMPLETED|Overall Study||74
2552105|NCT00542386|6254752|P1|COMPLETED|Overall Study||61
2552106|NCT00542386|6254747|P6|STARTED|Overall Study||132
2552107|NCT00542386|6254748|P5|STARTED|Overall Study||102
2552108|NCT00542386|6254749|P4|STARTED|Overall Study||103
2552109|NCT00542386|6254750|P3|STARTED|Overall Study||99
2552110|NCT00542386|6254751|P2|STARTED|Overall Study||102
2552111|NCT00542386|6254752|P1|STARTED|Overall Study||104
2552112|NCT00542321|6254774|P2|NOT COMPLETED|Overall Study||1
2552113|NCT00542321|6254775|P1|NOT COMPLETED|Overall Study||0
2552114|NCT00542321|6254774|P2|COMPLETED|Overall Study||7
2552115|NCT00542321|6254775|P1|COMPLETED|Overall Study||8
2552116|NCT00542321|6254774|P2|STARTED|Overall Study||8
2552117|NCT00542321|6254775|P1|STARTED|Overall Study||8
2552118|NCT00542308|6254789|P1|NOT COMPLETED|Overall Study||0
2552119|NCT00542308|6254789|P1|COMPLETED|Overall Study||90
2552120|NCT00542308|6254789|P1|STARTED|Overall Study||90
2552121|NCT00542269|6254797|P3|NOT COMPLETED|Overall Study||6
2552122|NCT00542269|6254798|P2|NOT COMPLETED|Overall Study||6
2552123|NCT00542269|6254799|P1|NOT COMPLETED|Overall Study||13
2552124|NCT00542269|6254797|P3|COMPLETED|Overall Study||51
2552125|NCT00542269|6254798|P2|COMPLETED|Overall Study||54
2552126|NCT00542269|6254799|P1|COMPLETED|Overall Study||48
2552127|NCT00542269|6254797|P3|STARTED|Overall Study||57
2552128|NCT00542269|6254798|P2|STARTED|Overall Study||60
2552129|NCT00542269|6254799|P1|STARTED|Overall Study||61
2552130|NCT00542191|6254828|P1|NOT COMPLETED|Overall Study||3
2552131|NCT00542191|6254828|P1|COMPLETED|Overall Study||18
2552132|NCT00542191|6254828|P1|STARTED|Overall Study||21
2552133|NCT00542178|6254838|P8|NOT COMPLETED|Overall Study||85
2552134|NCT00542178|6254839|P7|NOT COMPLETED|Overall Study||87
2552135|NCT00542178|6254840|P6|NOT COMPLETED|Overall Study||89
2552136|NCT00542178|6254841|P5|NOT COMPLETED|Overall Study||64
2552137|NCT00542178|6254842|P4|NOT COMPLETED|Overall Study||62
2552138|NCT00542178|6254843|P3|NOT COMPLETED|Overall Study||74
2552139|NCT00542178|6254844|P2|NOT COMPLETED|Overall Study||80
2552140|NCT00542178|6254845|P1|NOT COMPLETED|Overall Study||75
2552141|NCT00542178|6254838|P8|COMPLETED|Overall Study||381
2552142|NCT00542178|6254839|P7|COMPLETED|Overall Study||406
2552143|NCT00542178|6254840|P6|COMPLETED|Overall Study||406
2552144|NCT00542178|6254841|P5|COMPLETED|Overall Study||400
2552145|NCT00542178|6254842|P4|COMPLETED|Overall Study||308
2552146|NCT00542178|6254843|P3|COMPLETED|Overall Study||308
2552147|NCT00542178|6254844|P2|COMPLETED|Overall Study||332
2552148|NCT00542178|6254845|P1|COMPLETED|Overall Study||315
2552149|NCT00542178|6254838|P8|STARTED|Overall Study||466
2552150|NCT00542178|6254839|P7|STARTED|Overall Study||493
2552151|NCT00542178|6254840|P6|STARTED|Overall Study||495
2552152|NCT00542178|6254841|P5|STARTED|Overall Study||464
2552153|NCT00542178|6254842|P4|STARTED|Overall Study||370
2552154|NCT00542178|6254843|P3|STARTED|Overall Study||382
2552155|NCT00542178|6254844|P2|STARTED|Overall Study||412
2552156|NCT00542178|6254845|P1|STARTED|Overall Study||390
2552157|NCT00541970|6254881|P4|NOT COMPLETED|Month 60||72
2552158|NCT00541970|6254882|P3|NOT COMPLETED|Month 60||82
2552159|NCT00541970|6254883|P2|NOT COMPLETED|Month 60||77
2552160|NCT00541970|6254884|P1|NOT COMPLETED|Month 60||78
2552161|NCT00541970|6254881|P4|COMPLETED|Month 60||167
2552162|NCT00541970|6254882|P3|COMPLETED|Month 60||158
2552163|NCT00541970|6254883|P2|COMPLETED|Month 60||164
2552164|NCT00541970|6254884|P1|COMPLETED|Month 60||162
2552165|NCT00541970|6254881|P4|STARTED|Month 60||239
2552166|NCT00541970|6254882|P3|STARTED|Month 60||240
2552167|NCT00541970|6254883|P2|STARTED|Month 60||241
2552168|NCT00541970|6254884|P1|STARTED|Month 60||240
2552169|NCT00541970|6254881|P4|NOT COMPLETED|Month 48||75
2552170|NCT00541970|6254882|P3|NOT COMPLETED|Month 48||73
2552171|NCT00541970|6254883|P2|NOT COMPLETED|Month 48||73
2552172|NCT00541970|6254884|P1|NOT COMPLETED|Month 48||71
2552173|NCT00541970|6254881|P4|COMPLETED|Month 48||164
2552174|NCT00541970|6254882|P3|COMPLETED|Month 48||167
2552175|NCT00541970|6254883|P2|COMPLETED|Month 48||168
2552176|NCT00541970|6254884|P1|COMPLETED|Month 48||169
2552177|NCT00541970|6254881|P4|STARTED|Month 48||239
2552178|NCT00541970|6254882|P3|STARTED|Month 48||240
2552179|NCT00541970|6254883|P2|STARTED|Month 48||241
2552180|NCT00541970|6254884|P1|STARTED|Month 48||240
2552181|NCT00541970|6254881|P4|NOT COMPLETED|Month 36||60
2552182|NCT00541970|6254882|P3|NOT COMPLETED|Month 36||66
2552183|NCT00541970|6254883|P2|NOT COMPLETED|Month 36||66
2552184|NCT00541970|6254884|P1|NOT COMPLETED|Month 36||61
2552185|NCT00541970|6254881|P4|COMPLETED|Month 36||179
2552186|NCT00541970|6254882|P3|COMPLETED|Month 36||174
2552187|NCT00541970|6254883|P2|COMPLETED|Month 36||175
2552188|NCT00541970|6254884|P1|COMPLETED|Month 36||179
2552189|NCT00541970|6254881|P4|STARTED|Month 36||239
2552190|NCT00541970|6254882|P3|STARTED|Month 36||240
2552191|NCT00541970|6254883|P2|STARTED|Month 36||241
2552192|NCT00541970|6254884|P1|STARTED|Month 36||240
2552193|NCT00541970|6254881|P4|NOT COMPLETED|Month 24||22
2552194|NCT00541970|6254882|P3|NOT COMPLETED|Month 24||32
2552195|NCT00541970|6254883|P2|NOT COMPLETED|Month 24||32
2552196|NCT00541970|6254884|P1|NOT COMPLETED|Month 24||29
2552197|NCT00541970|6254881|P4|COMPLETED|Month 24||217
2552198|NCT00541970|6254882|P3|COMPLETED|Month 24||208
2552199|NCT00541970|6254883|P2|COMPLETED|Month 24||209
2552200|NCT00541970|6254884|P1|COMPLETED|Month 24||211
2552201|NCT00541970|6254881|P4|STARTED|Month 24||239
2552202|NCT00541970|6254882|P3|STARTED|Month 24||240
2552203|NCT00541970|6254883|P2|STARTED|Month 24||241
2552204|NCT00541970|6254884|P1|STARTED|Month 24||240
2552205|NCT00541970|6254881|P4|NOT COMPLETED|Month 18||17
2552206|NCT00541970|6254882|P3|NOT COMPLETED|Month 18||25
2552207|NCT00541970|6254883|P2|NOT COMPLETED|Month 18||24
2552208|NCT00541970|6254884|P1|NOT COMPLETED|Month 18||14
2552209|NCT00541970|6254881|P4|COMPLETED|Month 18||222
2552210|NCT00541970|6254882|P3|COMPLETED|Month 18||215
2552211|NCT00541970|6254883|P2|COMPLETED|Month 18||217
2552212|NCT00541970|6254884|P1|COMPLETED|Month 18||226
2552213|NCT00541970|6254881|P4|STARTED|Month 18||239
2552214|NCT00541970|6254882|P3|STARTED|Month 18||240
2552215|NCT00541970|6254883|P2|STARTED|Month 18||241
2552216|NCT00541970|6254884|P1|STARTED|Month 18||240
2552217|NCT00541970|6254881|P4|NOT COMPLETED|Month 12||16
2552218|NCT00541970|6254882|P3|NOT COMPLETED|Month 12||21
2552219|NCT00541970|6254883|P2|NOT COMPLETED|Month 12||22
2552220|NCT00541970|6254884|P1|NOT COMPLETED|Month 12||12
2552221|NCT00541970|6254881|P4|COMPLETED|Month 12||223
2552222|NCT00541970|6254882|P3|COMPLETED|Month 12||219
2552223|NCT00541970|6254883|P2|COMPLETED|Month 12||219
2552224|NCT00541970|6254884|P1|COMPLETED|Month 12||228
2552225|NCT00541970|6254881|P4|STARTED|Month 12||239
2552226|NCT00541970|6254882|P3|STARTED|Month 12||240
2552227|NCT00541970|6254883|P2|STARTED|Month 12||241
2552228|NCT00541970|6254884|P1|STARTED|Month 12||240
2552229|NCT00541970|6254881|P4|NOT COMPLETED|Month 7||5
2552230|NCT00541970|6254882|P3|NOT COMPLETED|Month 7||11
2552231|NCT00541970|6254883|P2|NOT COMPLETED|Month 7||13
2552232|NCT00541970|6254884|P1|NOT COMPLETED|Month 7||9
2552233|NCT00541970|6254881|P4|COMPLETED|Month 7||234
2552234|NCT00541970|6254882|P3|COMPLETED|Month 7||229
2552235|NCT00541970|6254883|P2|COMPLETED|Month 7||228
2552236|NCT00541970|6254884|P1|COMPLETED|Month 7||231
2552237|NCT00541970|6254881|P4|STARTED|Month 7||239
2552238|NCT00541970|6254882|P3|STARTED|Month 7||240
2552239|NCT00541970|6254883|P2|STARTED|Month 7||241
2552240|NCT00541970|6254884|P1|STARTED|Month 7||240
2552241|NCT00541931|6255035|P2|NOT COMPLETED|Overall Study||4
2552242|NCT00541931|6255036|P1|NOT COMPLETED|Overall Study||5
2552243|NCT00541931|6255035|P2|COMPLETED|Overall Study||11
2552244|NCT00541931|6255036|P1|COMPLETED|Overall Study||17
2552245|NCT00541931|6255035|P2|STARTED|Overall Study||15
2552246|NCT00541931|6255036|P1|STARTED|Overall Study||22
2552247|NCT00541866|6255049|P5|NOT COMPLETED|Overall Study||15
2552248|NCT00541866|6255050|P4|NOT COMPLETED|Overall Study||16
2552249|NCT00541866|6255051|P3|NOT COMPLETED|Overall Study||15
2552250|NCT00541866|6255052|P2|NOT COMPLETED|Overall Study||18
2552251|NCT00541866|6255053|P1|NOT COMPLETED|Overall Study||34
2552252|NCT00541866|6255049|P5|COMPLETED|Overall Study||3
2552253|NCT00541866|6255050|P4|COMPLETED|Overall Study||0
2552254|NCT00541866|6255051|P3|COMPLETED|Overall Study||2
2552255|NCT00541866|6255052|P2|COMPLETED|Overall Study||0
2552256|NCT00541866|6255053|P1|COMPLETED|Overall Study||7
2552257|NCT00541866|6255049|P5|STARTED|Overall Study||18
2552258|NCT00541866|6255050|P4|STARTED|Overall Study||16
2552259|NCT00541866|6255051|P3|STARTED|Overall Study||17
2552260|NCT00541866|6255052|P2|STARTED|Overall Study||18
2552261|NCT00541866|6255053|P1|STARTED|Overall Study|41 started, but only 39 treated|41
2552262|NCT00541775|6255094|P3|NOT COMPLETED|Overall Study||8
2552263|NCT00541775|6255095|P2|NOT COMPLETED|Overall Study||2
2552264|NCT00541775|6255096|P1|NOT COMPLETED|Overall Study||9
2552265|NCT00541775|6255094|P3|COMPLETED|Overall Study||84
2552266|NCT00541775|6255095|P2|COMPLETED|Overall Study||85
2552267|NCT00541775|6255096|P1|COMPLETED|Overall Study||85
2552268|NCT00541775|6255094|P3|STARTED|Overall Study||92
2552269|NCT00541775|6255095|P2|STARTED|Overall Study||87
2552270|NCT00541775|6255096|P1|STARTED|Overall Study||94
2552271|NCT00541671|6255112|P2|NOT COMPLETED|Overall Study||0
2552272|NCT00541671|6255113|P1|NOT COMPLETED|Overall Study||0
2552273|NCT00541671|6255112|P2|COMPLETED|Overall Study||12
2552274|NCT00541671|6255113|P1|COMPLETED|Overall Study||13
2552275|NCT00541671|6255112|P2|STARTED|Overall Study||12
2552276|NCT00541671|6255113|P1|STARTED|Overall Study||13
2552277|NCT00541658|6255122|P3|NOT COMPLETED|Overall Study||68
2552278|NCT00541658|6255123|P2|NOT COMPLETED|Overall Study||73
2552279|NCT00541658|6255124|P1|NOT COMPLETED|Overall Study||60
2552280|NCT00541658|6255122|P3|COMPLETED|Overall Study||240
2552281|NCT00541658|6255123|P2|COMPLETED|Overall Study||234
2552282|NCT00541658|6255124|P1|COMPLETED|Overall Study||248
2552283|NCT00541658|6255122|P3|ITT Population|Overall Study||308
2552284|NCT00541658|6255123|P2|ITT Population|Overall Study||307
2552285|NCT00541658|6255124|P1|ITT Population|Overall Study||307
2552286|NCT00541658|6255122|P3|STARTED|Overall Study||308
2552287|NCT00541658|6255123|P2|STARTED|Overall Study||307
2552288|NCT00541658|6255124|P1|STARTED|Overall Study||308
2552289|NCT00541593|6255281|P1|NOT COMPLETED|Overall Study||0
2552290|NCT00541593|6255281|P1|COMPLETED|Overall Study||5
2552291|NCT00541593|6255281|P1|STARTED|Overall Study||5
2552292|NCT00541450|6255287|P2|NOT COMPLETED|Phase B||31
2552293|NCT00541450|6255288|P1|NOT COMPLETED|Phase B||37
2552294|NCT00541450|6255287|P2|COMPLETED|Phase B||200
2552295|NCT00541450|6255288|P1|COMPLETED|Phase B||187
2552296|NCT00541450|6255287|P2|STARTED|Phase B||231
2552297|NCT00541450|6255288|P1|STARTED|Phase B||224
2552298|NCT00541450|6255287|P2|NOT COMPLETED|Phase A||17
2552299|NCT00541450|6255288|P1|NOT COMPLETED|Phase A||20
2552300|NCT00541450|6255287|P2|COMPLETED|Phase A||231
2552301|NCT00541450|6255288|P1|COMPLETED|Phase A||224
2552302|NCT00541450|6255287|P2|STARTED|Phase A||248
2552303|NCT00541450|6255288|P1|STARTED|Phase A||244
2552304|NCT00541346|6255306|P1|NOT COMPLETED|Follow-up||1
2552305|NCT00541346|6255306|P1|COMPLETED|Follow-up||15
2552306|NCT00541346|6255306|P1|STARTED|Follow-up||16
2552307|NCT00541346|6255306|P1|NOT COMPLETED|Baseline||0
2552308|NCT00541346|6255306|P1|COMPLETED|Baseline||16
2552309|NCT00541346|6255306|P1|STARTED|Baseline||16
2552310|NCT00541307|6255320|P1|NOT COMPLETED|Overall Study||24
2552311|NCT00541307|6255320|P1|COMPLETED|Overall Study||95
2552312|NCT00541307|6255320|P1|STARTED|Overall Study||119
2552313|NCT00541242|6255330|P2|NOT COMPLETED|Treatment Period 2||7
2552314|NCT00541242|6255331|P1|NOT COMPLETED|Treatment Period 2||9
2552315|NCT00541242|6255330|P2|COMPLETED|Treatment Period 2||266
2552316|NCT00541242|6255331|P1|COMPLETED|Treatment Period 2||261
2552317|NCT00541242|6255330|P2|STARTED|Treatment Period 2||273
2552318|NCT00541242|6255331|P1|STARTED|Treatment Period 2||270
2552319|NCT00541242|6255330|P2|NOT COMPLETED|Treatment Period 1||0
2552320|NCT00541242|6255331|P1|NOT COMPLETED|Treatment Period 1||0
2552321|NCT00541242|6255330|P2|COMPLETED|Treatment Period 1|43 of the 586 patients did not enter Treatment Period 2 (Randomized at Week 6)|586
2552322|NCT00541242|6255331|P1|COMPLETED|Treatment Period 1||0
2552323|NCT00541242|6255330|P2|STARTED|Treatment Period 1|586 patients were enrolled and received open-label latanoprost for 6 weeks|586
2552324|NCT00541242|6255331|P1|STARTED|Treatment Period 1||0
2552325|NCT00541229|6255345|P6|NOT COMPLETED|Treatment Period III (Week 11)||1
2552326|NCT00541229|6255346|P5|NOT COMPLETED|Treatment Period III (Week 11)||1
2552327|NCT00541229|6255347|P4|NOT COMPLETED|Treatment Period III (Week 11)||0
2552328|NCT00541229|6255348|P3|NOT COMPLETED|Treatment Period III (Week 11)||1
2552329|NCT00541229|6255349|P2|NOT COMPLETED|Treatment Period III (Week 11)||0
2552330|NCT00541229|6255350|P1|NOT COMPLETED|Treatment Period III (Week 11)||0
2552331|NCT00541229|6255345|P6|COMPLETED|Treatment Period III (Week 11)||4
2552332|NCT00541229|6255346|P5|COMPLETED|Treatment Period III (Week 11)||6
2552333|NCT00541229|6255347|P4|COMPLETED|Treatment Period III (Week 11)||8
2552334|NCT00541229|6255348|P3|COMPLETED|Treatment Period III (Week 11)||9
2552335|NCT00541229|6255349|P2|COMPLETED|Treatment Period III (Week 11)||8
2552336|NCT00541229|6255350|P1|COMPLETED|Treatment Period III (Week 11)||7
2552337|NCT00541229|6255345|P6|STARTED|Treatment Period III (Week 11)||5
2552338|NCT00541229|6255346|P5|STARTED|Treatment Period III (Week 11)||7
2552339|NCT00541229|6255347|P4|STARTED|Treatment Period III (Week 11)||8
2552340|NCT00541229|6255348|P3|STARTED|Treatment Period III (Week 11)||10
2552341|NCT00541229|6255349|P2|STARTED|Treatment Period III (Week 11)||8
2552342|NCT00541229|6255350|P1|STARTED|Treatment Period III (Week 11)||7
2552343|NCT00541229|6255345|P6|NOT COMPLETED|Washout Period II (Week 7-10)||3
2552344|NCT00541229|6255346|P5|NOT COMPLETED|Washout Period II (Week 7-10)||4
2552345|NCT00541229|6255347|P4|NOT COMPLETED|Washout Period II (Week 7-10)||4
2552346|NCT00541229|6255348|P3|NOT COMPLETED|Washout Period II (Week 7-10)||2
2552347|NCT00541229|6255349|P2|NOT COMPLETED|Washout Period II (Week 7-10)||4
2552348|NCT00541229|6255350|P1|NOT COMPLETED|Washout Period II (Week 7-10)||4
2552349|NCT00541229|6255345|P6|COMPLETED|Washout Period II (Week 7-10)||5
2552350|NCT00541229|6255346|P5|COMPLETED|Washout Period II (Week 7-10)||7
2552351|NCT00541229|6255347|P4|COMPLETED|Washout Period II (Week 7-10)||8
2552352|NCT00541229|6255348|P3|COMPLETED|Washout Period II (Week 7-10)||10
2552353|NCT00541229|6255349|P2|COMPLETED|Washout Period II (Week 7-10)||8
2552354|NCT00541229|6255350|P1|COMPLETED|Washout Period II (Week 7-10)||7
2552355|NCT00541229|6255345|P6|STARTED|Washout Period II (Week 7-10)||8
2552356|NCT00541229|6255346|P5|STARTED|Washout Period II (Week 7-10)||11
2552357|NCT00541229|6255347|P4|STARTED|Washout Period II (Week 7-10)||12
2552358|NCT00541229|6255348|P3|STARTED|Washout Period II (Week 7-10)||12
2552359|NCT00541229|6255349|P2|STARTED|Washout Period II (Week 7-10)||12
2552360|NCT00541229|6255350|P1|STARTED|Washout Period II (Week 7-10)||11
2552361|NCT00541229|6255345|P6|NOT COMPLETED|Treatment Period II (Week 6)||3
2552362|NCT00541229|6255346|P5|NOT COMPLETED|Treatment Period II (Week 6)||2
2552363|NCT00541229|6255347|P4|NOT COMPLETED|Treatment Period II (Week 6)||1
2552364|NCT00541229|6255348|P3|NOT COMPLETED|Treatment Period II (Week 6)||1
2552365|NCT00541229|6255349|P2|NOT COMPLETED|Treatment Period II (Week 6)||1
2552366|NCT00541229|6255350|P1|NOT COMPLETED|Treatment Period II (Week 6)||2
2552367|NCT00541229|6255345|P6|COMPLETED|Treatment Period II (Week 6)||8
2552368|NCT00541229|6255346|P5|COMPLETED|Treatment Period II (Week 6)||11
2552369|NCT00541229|6255347|P4|COMPLETED|Treatment Period II (Week 6)||12
2552370|NCT00541229|6255348|P3|COMPLETED|Treatment Period II (Week 6)||12
2552371|NCT00541229|6255349|P2|COMPLETED|Treatment Period II (Week 6)||12
2552372|NCT00541229|6255350|P1|COMPLETED|Treatment Period II (Week 6)||11
2552373|NCT00541229|6255345|P6|STARTED|Treatment Period II (Week 6)||11
2552374|NCT00541229|6255346|P5|STARTED|Treatment Period II (Week 6)||13
2552375|NCT00541229|6255347|P4|STARTED|Treatment Period II (Week 6)||13
2552376|NCT00541229|6255348|P3|STARTED|Treatment Period II (Week 6)||13
2552377|NCT00541229|6255349|P2|STARTED|Treatment Period II (Week 6)||13
2552378|NCT00541229|6255350|P1|STARTED|Treatment Period II (Week 6)||13
2552379|NCT00541229|6255345|P6|NOT COMPLETED|Washout Period I (Week 2-5)||5
2552380|NCT00541229|6255346|P5|NOT COMPLETED|Washout Period I (Week 2-5)||1
2552381|NCT00541229|6255347|P4|NOT COMPLETED|Washout Period I (Week 2-5)||4
2552382|NCT00541229|6255348|P3|NOT COMPLETED|Washout Period I (Week 2-5)||4
2552383|NCT00541229|6255349|P2|NOT COMPLETED|Washout Period I (Week 2-5)||2
2552384|NCT00541229|6255350|P1|NOT COMPLETED|Washout Period I (Week 2-5)||4
2552385|NCT00541229|6255345|P6|COMPLETED|Washout Period I (Week 2-5)||11
2552386|NCT00541229|6255346|P5|COMPLETED|Washout Period I (Week 2-5)||13
2552387|NCT00541229|6255347|P4|COMPLETED|Washout Period I (Week 2-5)||13
2552388|NCT00541229|6255348|P3|COMPLETED|Washout Period I (Week 2-5)||13
2552389|NCT00541229|6255349|P2|COMPLETED|Washout Period I (Week 2-5)||13
2552390|NCT00541229|6255350|P1|COMPLETED|Washout Period I (Week 2-5)||13
2552391|NCT00541229|6255345|P6|STARTED|Washout Period I (Week 2-5)||16
2552392|NCT00541229|6255346|P5|STARTED|Washout Period I (Week 2-5)||14
2552393|NCT00541229|6255347|P4|STARTED|Washout Period I (Week 2-5)||17
2552394|NCT00541229|6255348|P3|STARTED|Washout Period I (Week 2-5)||17
2552395|NCT00541229|6255349|P2|STARTED|Washout Period I (Week 2-5)||15
2552396|NCT00541229|6255350|P1|STARTED|Washout Period I (Week 2-5)||17
2552397|NCT00541229|6255345|P6|NOT COMPLETED|Treatment Period I (Week 1)||2
2552398|NCT00541229|6255346|P5|NOT COMPLETED|Treatment Period I (Week 1)||0
2552399|NCT00541229|6255347|P4|NOT COMPLETED|Treatment Period I (Week 1)||1
2552400|NCT00541229|6255348|P3|NOT COMPLETED|Treatment Period I (Week 1)||3
2552401|NCT00541229|6255349|P2|NOT COMPLETED|Treatment Period I (Week 1)||1
2552402|NCT00541229|6255350|P1|NOT COMPLETED|Treatment Period I (Week 1)||0
2552403|NCT00541229|6255345|P6|COMPLETED|Treatment Period I (Week 1)||16
2552404|NCT00541229|6255346|P5|COMPLETED|Treatment Period I (Week 1)||14
2552405|NCT00541229|6255347|P4|COMPLETED|Treatment Period I (Week 1)||17
2552406|NCT00541229|6255348|P3|COMPLETED|Treatment Period I (Week 1)||17
2552407|NCT00541229|6255349|P2|COMPLETED|Treatment Period I (Week 1)||15
2552408|NCT00541229|6255350|P1|COMPLETED|Treatment Period I (Week 1)||17
2552409|NCT00541229|6255345|P6|STARTED|Treatment Period I (Week 1)||18
2552410|NCT00541229|6255346|P5|STARTED|Treatment Period I (Week 1)||14
2552411|NCT00541229|6255347|P4|STARTED|Treatment Period I (Week 1)||18
2552412|NCT00541229|6255348|P3|STARTED|Treatment Period I (Week 1)||20
2552413|NCT00541229|6255349|P2|STARTED|Treatment Period I (Week 1)||16
2552414|NCT00541229|6255350|P1|STARTED|Treatment Period I (Week 1)||17
2552415|NCT00541190|6255360|P2|NOT COMPLETED|Overall Study||0
2552416|NCT00541190|6255361|P1|NOT COMPLETED|Overall Study||0
2552417|NCT00541190|6255360|P2|COMPLETED|Overall Study||11
2552418|NCT00541190|6255361|P1|COMPLETED|Overall Study||10
2552419|NCT00541190|6255360|P2|STARTED|Overall Study||11
2552420|NCT00541190|6255361|P1|STARTED|Overall Study||10
2552421|NCT00541099|6255369|P1|NOT COMPLETED|Overall Study||3
2552422|NCT00541099|6255369|P1|COMPLETED|Overall Study||8
2552423|NCT00541099|6255369|P1|STARTED|Overall Study||11
2552424|NCT00541034|6255377|P1|NOT COMPLETED|Overall Study||3
2552425|NCT00541034|6255377|P1|COMPLETED|Overall Study||46
2552426|NCT00541034|6255377|P1|STARTED|Overall Study||49
2552427|NCT00540982|6255381|P1|NOT COMPLETED|Overall Study||0
2552428|NCT00540982|6255381|P1|COMPLETED|Overall Study||47
2552429|NCT00540982|6255381|P1|Severe Liver Dysfunction|Overall Study||12
2552430|NCT00540982|6255381|P1|Moderate Liver Dysfunction|Overall Study||18
2552431|NCT00540982|6255381|P1|Mild Liver Dysfunction|Overall Study||6
2552432|NCT00540982|6255381|P1|Normal Liver Function|Overall Study||11
2552433|NCT00540982|6255381|P1|STARTED|Overall Study||47
2552434|NCT00540969|6255405|P2|NOT COMPLETED|Overall Study||0
2552435|NCT00540969|6255406|P1|NOT COMPLETED|Overall Study||0
2552436|NCT00540969|6255405|P2|COMPLETED|Overall Study||1
2552437|NCT00540969|6255406|P1|COMPLETED|Overall Study||2
2552438|NCT00540969|6255405|P2|STARTED|Overall Study||1
2552439|NCT00540969|6255406|P1|STARTED|Overall Study||2
2552440|NCT00540722|6255416|P1|NOT COMPLETED|Overall Study||0
2552441|NCT00540722|6255416|P1|COMPLETED|Overall Study||56
2552442|NCT00540722|6255416|P1|STARTED|Overall Study||56
2552443|NCT00540644|6255426|P2|NOT COMPLETED|Overall Study||9
2552444|NCT00540644|6255427|P1|NOT COMPLETED|Overall Study||9
2552445|NCT00540644|6255426|P2|COMPLETED|Overall Study||13
2552446|NCT00540644|6255427|P1|COMPLETED|Overall Study||39
2552447|NCT00540644|6255426|P2|STARTED|Overall Study||22
2552448|NCT00540644|6255427|P1|STARTED|Overall Study||48
2552449|NCT00540592|6255447|P10|NOT COMPLETED|Overall Study||2
2552450|NCT00540592|6255448|P9|NOT COMPLETED|Overall Study||1
2552451|NCT00540592|6255449|P8|NOT COMPLETED|Overall Study||1
2552452|NCT00540592|6255450|P7|NOT COMPLETED|Overall Study||0
2552453|NCT00540592|6255451|P6|NOT COMPLETED|Overall Study||0
2552454|NCT00540592|6255452|P5|NOT COMPLETED|Overall Study||1
2552455|NCT00540592|6255453|P4|NOT COMPLETED|Overall Study||1
2552456|NCT00540592|6255454|P3|NOT COMPLETED|Overall Study||1
2552457|NCT00540592|6255455|P2|NOT COMPLETED|Overall Study||1
2552458|NCT00540592|6255456|P1|NOT COMPLETED|Overall Study||2
2552459|NCT00540592|6255447|P10|COMPLETED|Overall Study||201
2552460|NCT00540592|6255448|P9|COMPLETED|Overall Study||199
2552461|NCT00540592|6255449|P8|COMPLETED|Overall Study||198
2552462|NCT00540592|6255450|P7|COMPLETED|Overall Study||198
2552463|NCT00540592|6255451|P6|COMPLETED|Overall Study||198
2552464|NCT00540592|6255452|P5|COMPLETED|Overall Study||198
2552465|NCT00540592|6255453|P4|COMPLETED|Overall Study||201
2552466|NCT00540592|6255454|P3|COMPLETED|Overall Study||201
2552467|NCT00540592|6255455|P2|COMPLETED|Overall Study||201
2552468|NCT00540592|6255456|P1|COMPLETED|Overall Study||202
2552469|NCT00540592|6255447|P10|Completed at Day 180|Overall Study||189
2552470|NCT00540592|6255448|P9|Completed at Day 180|Overall Study||198
2552471|NCT00540592|6255449|P8|Completed at Day 180|Overall Study||193
2552472|NCT00540592|6255450|P7|Completed at Day 180|Overall Study||196
2552473|NCT00540592|6255451|P6|Completed at Day 180|Overall Study||198
2552474|NCT00540592|6255452|P5|Completed at Day 180|Overall Study||195
2552475|NCT00540592|6255453|P4|Completed at Day 180|Overall Study||197
2552476|NCT00540592|6255454|P3|Completed at Day 180|Overall Study||197
2552477|NCT00540592|6255455|P2|Completed at Day 180|Overall Study||201
2552478|NCT00540592|6255456|P1|Completed at Day 180|Overall Study||200
2552479|NCT00540592|6255447|P10|STARTED|Overall Study||203
2552480|NCT00540592|6255448|P9|STARTED|Overall Study||200
2552481|NCT00540592|6255449|P8|STARTED|Overall Study||199
2552482|NCT00540592|6255450|P7|STARTED|Overall Study||198
2552483|NCT00540592|6255451|P6|STARTED|Overall Study||198
2552484|NCT00540592|6255452|P5|STARTED|Overall Study||199
2552485|NCT00540592|6255453|P4|STARTED|Overall Study||202
2552486|NCT00540592|6255454|P3|STARTED|Overall Study||202
2552487|NCT00540592|6255455|P2|STARTED|Overall Study||202
2552488|NCT00540592|6255456|P1|STARTED|Overall Study||204
2552489|NCT00540579|6255688|P1|NOT COMPLETED|Overall Study||0
2552490|NCT00540579|6255688|P1|COMPLETED|Overall Study||23
2552491|NCT00540579|6255688|P1|STARTED|Overall Study||23
2552492|NCT00540514|6255695|P2|NOT COMPLETED|Overall Study||266
2552493|NCT00540514|6255696|P1|NOT COMPLETED|Overall Study||246
2552494|NCT00540514|6255695|P2|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|265
2552495|NCT00540514|6255696|P1|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|275
2552496|NCT00540514|6255695|P2|Biomarker Population|Overall Study||36
2552497|NCT00540514|6255696|P1|Biomarker Population|Overall Study||35
2552498|NCT00540514|6255695|P2|Treated|Overall Study||524
2552499|NCT00540514|6255696|P1|Treated|Overall Study||514
2552500|NCT00540514|6255695|P2|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|531
2552501|NCT00540514|6255696|P1|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|521
2552502|NCT00540449|6255728|P2|NOT COMPLETED|Overall Study||78
2552503|NCT00540449|6255729|P1|NOT COMPLETED|Overall Study||84
2552504|NCT00540449|6255728|P2|COMPLETED|Overall Study||266
2552505|NCT00540449|6255729|P1|COMPLETED|Overall Study||262
2552506|NCT00540449|6255728|P2|STARTED|Overall Study||344
2552507|NCT00540449|6255729|P1|STARTED|Overall Study||346
2552508|NCT00540436|6255751|P1|NOT COMPLETED|Second 12-Week Treatment Period||1
2552509|NCT00540436|6255751|P1|COMPLETED|Second 12-Week Treatment Period||21
2552510|NCT00540436|6255751|P1|STARTED|Second 12-Week Treatment Period||22
2552511|NCT00540436|6255751|P1|NOT COMPLETED|First 12-Week Treatment Period||3
2552512|NCT00540436|6255751|P1|COMPLETED|First 12-Week Treatment Period||22
2552513|NCT00540436|6255751|P1|STARTED|First 12-Week Treatment Period||25
2552514|NCT00540423|6255766|P3|NOT COMPLETED|Open-Label Treatment Period||2
2552515|NCT00540423|6255767|P2|NOT COMPLETED|Open-Label Treatment Period||0
2552516|NCT00540423|6255768|P1|NOT COMPLETED|Open-Label Treatment Period||0
2552517|NCT00540423|6255766|P3|COMPLETED|Open-Label Treatment Period||20
2552518|NCT00540423|6255767|P2|COMPLETED|Open-Label Treatment Period||0
2552519|NCT00540423|6255768|P1|COMPLETED|Open-Label Treatment Period||0
2552520|NCT00540423|6255766|P3|STARTED|Open-Label Treatment Period||22
2552521|NCT00540423|6255767|P2|STARTED|Open-Label Treatment Period||0
2552522|NCT00540423|6255768|P1|STARTED|Open-Label Treatment Period||0
2552523|NCT00540423|6255766|P3|NOT COMPLETED|Double-Blind Treatment Period||0
2552524|NCT00540423|6255767|P2|NOT COMPLETED|Double-Blind Treatment Period||1
2552525|NCT00540423|6255768|P1|NOT COMPLETED|Double-Blind Treatment Period||0
2552526|NCT00540423|6255766|P3|COMPLETED|Double-Blind Treatment Period||0
2552527|NCT00540423|6255767|P2|COMPLETED|Double-Blind Treatment Period||14
2552528|NCT00540423|6255768|P1|COMPLETED|Double-Blind Treatment Period||8
2552529|NCT00540423|6255766|P3|STARTED|Double-Blind Treatment Period||0
2552530|NCT00540423|6255767|P2|STARTED|Double-Blind Treatment Period||15
2552531|NCT00540423|6255768|P1|STARTED|Double-Blind Treatment Period||8
2552532|NCT00540293|6255818|P1|NOT COMPLETED|Overall Study||35
2552533|NCT00540293|6255818|P1|COMPLETED|Overall Study||390
2552534|NCT00540293|6255818|P1|STARTED|Overall Study||425
2552535|NCT00540228|6255866|P5|NOT COMPLETED|Overall Study||0
2552536|NCT00540228|6255867|P4|NOT COMPLETED|Overall Study||0
2552537|NCT00540228|6255868|P3|NOT COMPLETED|Overall Study||0
2552538|NCT00540228|6255869|P2|NOT COMPLETED|Overall Study||1
2552539|NCT00540228|6255870|P1|NOT COMPLETED|Overall Study||3
2552540|NCT00540228|6255866|P5|COMPLETED|Overall Study||202
2552541|NCT00540228|6255867|P4|COMPLETED|Overall Study||202
2552542|NCT00540228|6255868|P3|COMPLETED|Overall Study||204
2552543|NCT00540228|6255869|P2|COMPLETED|Overall Study||197
2552544|NCT00540228|6255870|P1|COMPLETED|Overall Study||197
2552545|NCT00540228|6255866|P5|STARTED|Overall Study||202
2552546|NCT00540228|6255867|P4|STARTED|Overall Study||202
2552547|NCT00540228|6255868|P3|STARTED|Overall Study||204
2552548|NCT00540228|6255869|P2|STARTED|Overall Study||198
2552549|NCT00540228|6255870|P1|STARTED|Overall Study||200
2552550|NCT00540124|6255940|P3|NOT COMPLETED|Overall Study||1
2552551|NCT00540124|6255941|P2|NOT COMPLETED|Overall Study||3
2552552|NCT00540124|6255942|P1|NOT COMPLETED|Overall Study||4
2552553|NCT00540124|6255940|P3|COMPLETED|Overall Study||48
2552554|NCT00540124|6255941|P2|COMPLETED|Overall Study||48
2552555|NCT00540124|6255942|P1|COMPLETED|Overall Study||47
2552556|NCT00540124|6255940|P3|STARTED|Overall Study||49
2552557|NCT00540124|6255941|P2|STARTED|Overall Study||51
2552558|NCT00540124|6255942|P1|STARTED|Overall Study||51
2552559|NCT00540046|6255988|P2|NOT COMPLETED|Overall Study||23
2552560|NCT00540046|6255989|P1|NOT COMPLETED|Overall Study||33
2552561|NCT00540046|6255988|P2|COMPLETED|Overall Study||88
2552562|NCT00540046|6255989|P1|COMPLETED|Overall Study||71
2552563|NCT00540046|6255988|P2|STARTED|Overall Study||111
2552564|NCT00540046|6255989|P1|STARTED|Overall Study||104
2552565|NCT00540007|6255999|P2|NOT COMPLETED|Overall Study||0
2552566|NCT00540007|6256000|P1|NOT COMPLETED|Overall Study||0
2552567|NCT00540007|6255999|P2|COMPLETED|Overall Study||42
2552568|NCT00540007|6256000|P1|COMPLETED|Overall Study||38
2552569|NCT00540007|6255999|P2|STARTED|Overall Study||42
2552570|NCT00540007|6256000|P1|STARTED|Overall Study||38
2552571|NCT00539994|6256025|P3|NOT COMPLETED|Overall Study||2
2552572|NCT00539994|6256026|P2|NOT COMPLETED|Overall Study||1
2552573|NCT00539994|6256027|P1|NOT COMPLETED|Overall Study||3
2552574|NCT00539994|6256025|P3|COMPLETED|Overall Study||13
2552575|NCT00539994|6256026|P2|COMPLETED|Overall Study||18
2552576|NCT00539994|6256027|P1|COMPLETED|Overall Study||20
2552577|NCT00539994|6256025|P3|STARTED|Overall Study||15
2552578|NCT00539994|6256026|P2|STARTED|Overall Study||19
2552579|NCT00539994|6256027|P1|STARTED|Overall Study||23
2552580|NCT00539942|6256066|P2|NOT COMPLETED|Overall Study||0
2552581|NCT00539942|6256067|P1|NOT COMPLETED|Overall Study||0
2552582|NCT00539942|6256066|P2|COMPLETED|Overall Study||3
2552583|NCT00539942|6256067|P1|COMPLETED|Overall Study||4
2552584|NCT00539942|6256066|P2|STARTED|Overall Study||3
2552585|NCT00539942|6256067|P1|STARTED|Overall Study||4
2552586|NCT00539864|6256077|P2|NOT COMPLETED|Overall Study||2
2552587|NCT00539864|6256078|P1|NOT COMPLETED|Overall Study||1
2552588|NCT00539864|6256077|P2|COMPLETED|Overall Study||300
2552589|NCT00539864|6256078|P1|COMPLETED|Overall Study||299
2552590|NCT00539864|6256077|P2|STARTED|Overall Study||302
2552591|NCT00539864|6256078|P1|STARTED|Overall Study||300
2552592|NCT00539734|6256090|P1|NOT COMPLETED|Overall Study||1
2552593|NCT00539734|6256090|P1|COMPLETED|Overall Study||25
2552594|NCT00539734|6256090|P1|STARTED|Overall Study||26
2552595|NCT00539695|6256095|P1|NOT COMPLETED|Overall Study||13
2552596|NCT00539695|6256095|P1|COMPLETED|Overall Study||12
2552597|NCT00539695|6256095|P1|Evaluable Patients|Overall Study|Patients who received IL-2.|22
2552598|NCT00539695|6256095|P1|STARTED|Overall Study||25
2552602|NCT00539617|6256107|P1|NOT COMPLETED|Treatment Period||0
2552603|NCT00539617|6256107|P1|COMPLETED|Treatment Period||3
2552604|NCT00539617|6256107|P1|STARTED|Treatment Period||3
2552605|NCT00539617|6256107|P1|NOT COMPLETED|Run-In Period||1
2552606|NCT00539617|6256107|P1|COMPLETED|Run-In Period||3
2552607|NCT00539617|6256107|P1|STARTED|Run-In Period||4
2552608|NCT00539617|6256107|P1|NOT COMPLETED|Pre-screening Period||3
2552609|NCT00539617|6256107|P1|COMPLETED|Pre-screening Period||4
2552610|NCT00539617|6256107|P1|STARTED|Pre-screening Period||7
2552611|NCT00539591|6256115|P3|NOT COMPLETED|Overall Study||3
2552612|NCT00539591|6256116|P2|NOT COMPLETED|Overall Study||2
2552613|NCT00539591|6256117|P1|NOT COMPLETED|Overall Study||5
2552614|NCT00539591|6256115|P3|COMPLETED|Overall Study||1
2552615|NCT00539591|6256116|P2|COMPLETED|Overall Study||0
2552616|NCT00539591|6256117|P1|COMPLETED|Overall Study||18
2552617|NCT00539591|6256115|P3|STARTED|Overall Study||4
2552618|NCT00539591|6256116|P2|STARTED|Overall Study||2
2552619|NCT00539591|6256117|P1|STARTED|Overall Study||23
2552620|NCT00539539|6256227|P2|NOT COMPLETED|Overall Study||0
2552621|NCT00539539|6256228|P1|NOT COMPLETED|Overall Study||0
2552622|NCT00539539|6256227|P2|COMPLETED|Overall Study||771
2552623|NCT00539539|6256228|P1|COMPLETED|Overall Study||815
2552624|NCT00539539|6256227|P2|STARTED|Overall Study||771
2552625|NCT00539539|6256228|P1|STARTED|Overall Study||815
2552626|NCT00539526|6256251|P3|NOT COMPLETED|Overall Study||2
2552627|NCT00539526|6256252|P2|NOT COMPLETED|Overall Study||2
2552628|NCT00539526|6256253|P1|NOT COMPLETED|Overall Study||3
2552629|NCT00539526|6256251|P3|COMPLETED|Overall Study||36
2552630|NCT00539526|6256252|P2|COMPLETED|Overall Study||31
2552631|NCT00539526|6256253|P1|COMPLETED|Overall Study||32
2552632|NCT00539526|6256251|P3|STARTED|Overall Study||38
2552633|NCT00539526|6256252|P2|STARTED|Overall Study||33
2552634|NCT00539526|6256253|P1|STARTED|Overall Study||35
2552635|NCT00539513|6256269|P2|NOT COMPLETED|Overall Study||2
2552636|NCT00539513|6256270|P1|NOT COMPLETED|Overall Study||2
2552637|NCT00539513|6256269|P2|COMPLETED|Overall Study||3
2552638|NCT00539513|6256270|P1|COMPLETED|Overall Study||3
2552639|NCT00539513|6256269|P2|Received Allocated Intervention|Overall Study||4
2552640|NCT00539513|6256270|P1|Received Allocated Intervention|Overall Study||3
2552641|NCT00539513|6256269|P2|STARTED|Overall Study||5
2552642|NCT00539513|6256270|P1|STARTED|Overall Study||5
2552643|NCT00539500|6256282|P1|NOT COMPLETED|Overall Study||3
2552644|NCT00539500|6256282|P1|COMPLETED|Overall Study||0
2552645|NCT00539500|6256282|P1|STARTED|Overall Study||3
2552646|NCT00539305|6256290|P2|NOT COMPLETED|Overall Study||2
2552647|NCT00539305|6256291|P1|NOT COMPLETED|Overall Study||1
2552648|NCT00539305|6256290|P2|COMPLETED|Overall Study||10
2552649|NCT00539305|6256291|P1|COMPLETED|Overall Study||9
2552650|NCT00539305|6256290|P2|STARTED|Overall Study||12
2552651|NCT00539305|6256291|P1|STARTED|Overall Study||10
2552652|NCT00539279|6256305|P2|NOT COMPLETED|6-Month Follow-Up Assessment||7
2552653|NCT00539279|6256306|P1|NOT COMPLETED|6-Month Follow-Up Assessment||1
2552654|NCT00539279|6256305|P2|COMPLETED|6-Month Follow-Up Assessment||22
2552655|NCT00539279|6256306|P1|COMPLETED|6-Month Follow-Up Assessment||17
2552656|NCT00539279|6256305|P2|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to RT)|29
2552657|NCT00539279|6256306|P1|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to PE)|18
2552658|NCT00539279|6256305|P2|NOT COMPLETED|Post-Treatment Assessment||9
2552659|NCT00539279|6256306|P1|NOT COMPLETED|Post-Treatment Assessment||12
2552660|NCT00539279|6256305|P2|COMPLETED|Post-Treatment Assessment||29
2552661|NCT00539279|6256306|P1|COMPLETED|Post-Treatment Assessment||18
2552662|NCT00539279|6256305|P2|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to RT)|38
2552663|NCT00539279|6256306|P1|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to PE)|30
2552664|NCT00539279|6256305|P2|NOT COMPLETED|Treatment||8
2552665|NCT00539279|6256306|P1|NOT COMPLETED|Treatment||11
2552666|NCT00539279|6256305|P2|COMPLETED|Treatment||38
2552667|NCT00539279|6256306|P1|COMPLETED|Treatment||30
2552668|NCT00539279|6256305|P2|STARTED|Treatment||46
2552669|NCT00539279|6256306|P1|STARTED|Treatment||41
2552670|NCT00539253|6256324|P1|NOT COMPLETED|Overall Study||26
2552671|NCT00539253|6256324|P1|COMPLETED|Overall Study||19
2552672|NCT00539253|6256324|P1|STARTED|Overall Study||45
2552673|NCT00539240|6256332|P3|NOT COMPLETED|Overall Study||15
2552674|NCT00539240|6256333|P2|NOT COMPLETED|Overall Study||7
2552675|NCT00539240|6256334|P1|NOT COMPLETED|Overall Study||6
2552676|NCT00539240|6256332|P3|COMPLETED|Overall Study||39
2552677|NCT00539240|6256333|P2|COMPLETED|Overall Study||48
2552678|NCT00539240|6256334|P1|COMPLETED|Overall Study||53
2552679|NCT00539240|6256332|P3|STARTED|Overall Study||54
2552680|NCT00539240|6256333|P2|STARTED|Overall Study||55
2552681|NCT00539240|6256334|P1|STARTED|Overall Study||59
2552682|NCT00539188|6256353|P2|NOT COMPLETED|Overall Study||1
2552683|NCT00539188|6256354|P1|NOT COMPLETED|Overall Study||3
2552684|NCT00539188|6256353|P2|COMPLETED|Overall Study||1
2552685|NCT00539188|6256354|P1|COMPLETED|Overall Study||1
2552686|NCT00539188|6256353|P2|Received Allocated Intervention|Overall Study||2
2552687|NCT00539188|6256354|P1|Received Allocated Intervention|Overall Study||3
2552688|NCT00539188|6256353|P2|STARTED|Overall Study||2
2552689|NCT00539188|6256354|P1|STARTED|Overall Study||4
2552690|NCT00539110|6256368|P2|NOT COMPLETED|Overall Study||0
2552691|NCT00539110|6256369|P1|NOT COMPLETED|Overall Study||0
2552692|NCT00539110|6256368|P2|COMPLETED|Overall Study||5
2552693|NCT00539110|6256369|P1|COMPLETED|Overall Study||5
2552694|NCT00539110|6256368|P2|STARTED|Overall Study||5
2552695|NCT00539110|6256369|P1|STARTED|Overall Study||5
2552696|NCT00539032|6256377|P2|NOT COMPLETED|Overall Study||1
2552697|NCT00539032|6256378|P1|NOT COMPLETED|Overall Study||2
2552698|NCT00539032|6256377|P2|COMPLETED|Overall Study||84
2552699|NCT00539032|6256378|P1|COMPLETED|Overall Study||151
2552700|NCT00539032|6256377|P2|STARTED|Overall Study||85
2552701|NCT00539032|6256378|P1|STARTED|Overall Study||153
2552702|NCT00539006|6256392|P4|NOT COMPLETED|Post-Study||0
2552703|NCT00539006|6256393|P3|NOT COMPLETED|Post-Study||0
2552704|NCT00539006|6256394|P2|NOT COMPLETED|Post-Study||0
2552705|NCT00539006|6256395|P1|NOT COMPLETED|Post-Study||0
2552706|NCT00539006|6256392|P4|COMPLETED|Post-Study||81
2552707|NCT00539006|6256393|P3|COMPLETED|Post-Study||77
2552708|NCT00539006|6256394|P2|COMPLETED|Post-Study||83
2552709|NCT00539006|6256395|P1|COMPLETED|Post-Study||75
2552710|NCT00539006|6256392|P4|STARTED|Post-Study||81
2552711|NCT00539006|6256393|P3|STARTED|Post-Study||77
2552712|NCT00539006|6256394|P2|STARTED|Post-Study||83
2552713|NCT00539006|6256395|P1|STARTED|Post-Study||75
2552714|NCT00539006|6256392|P4|NOT COMPLETED|Treatment Period 2||0
2552715|NCT00539006|6256393|P3|NOT COMPLETED|Treatment Period 2||0
2552716|NCT00539006|6256394|P2|NOT COMPLETED|Treatment Period 2||1
2552717|NCT00539006|6256395|P1|NOT COMPLETED|Treatment Period 2||1
2552718|NCT00539006|6256392|P4|COMPLETED|Treatment Period 2||81
2552719|NCT00539006|6256393|P3|COMPLETED|Treatment Period 2||77
2552720|NCT00539006|6256394|P2|COMPLETED|Treatment Period 2||83
2552721|NCT00539006|6256395|P1|COMPLETED|Treatment Period 2||75
2552722|NCT00539006|6256392|P4|STARTED|Treatment Period 2||81
2552723|NCT00539006|6256393|P3|STARTED|Treatment Period 2||77
2552724|NCT00539006|6256394|P2|STARTED|Treatment Period 2||84
2552725|NCT00539006|6256395|P1|STARTED|Treatment Period 2||76
2552726|NCT00539006|6256392|P4|NOT COMPLETED|Washout||9
2552727|NCT00539006|6256393|P3|NOT COMPLETED|Washout||16
2552728|NCT00539006|6256394|P2|NOT COMPLETED|Washout||10
2552729|NCT00539006|6256395|P1|NOT COMPLETED|Washout||20
2552730|NCT00539006|6256392|P4|COMPLETED|Washout||81
2552731|NCT00539006|6256393|P3|COMPLETED|Washout||77
2552732|NCT00539006|6256394|P2|COMPLETED|Washout||84
2552733|NCT00539006|6256395|P1|COMPLETED|Washout||76
2552734|NCT00539006|6256392|P4|STARTED|Washout||90
2552735|NCT00539006|6256393|P3|STARTED|Washout||93
2552736|NCT00539006|6256394|P2|STARTED|Washout||94
2552737|NCT00539006|6256395|P1|STARTED|Washout||96
2552738|NCT00539006|6256392|P4|NOT COMPLETED|Treatment Period 1||1
2552739|NCT00539006|6256393|P3|NOT COMPLETED|Treatment Period 1||2
2552740|NCT00539006|6256394|P2|NOT COMPLETED|Treatment Period 1||0
2552741|NCT00539006|6256395|P1|NOT COMPLETED|Treatment Period 1||0
2552742|NCT00539006|6256392|P4|COMPLETED|Treatment Period 1||90
2552743|NCT00539006|6256393|P3|COMPLETED|Treatment Period 1||93
2552744|NCT00539006|6256394|P2|COMPLETED|Treatment Period 1||94
2552745|NCT00539006|6256395|P1|COMPLETED|Treatment Period 1||96
2552746|NCT00539006|6256392|P4|STARTED|Treatment Period 1||91
2552747|NCT00539006|6256393|P3|STARTED|Treatment Period 1||95
2552748|NCT00539006|6256394|P2|STARTED|Treatment Period 1||94
2552749|NCT00539006|6256395|P1|STARTED|Treatment Period 1||96
2552750|NCT00539006|6256392|P4|NOT COMPLETED|Pre-treatment||0
2552751|NCT00539006|6256393|P3|NOT COMPLETED|Pre-treatment||0
2552752|NCT00539006|6256394|P2|NOT COMPLETED|Pre-treatment||1
2552753|NCT00539006|6256395|P1|NOT COMPLETED|Pre-treatment||0
2552754|NCT00539006|6256392|P4|COMPLETED|Pre-treatment||91
2552755|NCT00539006|6256393|P3|COMPLETED|Pre-treatment||95
2552756|NCT00539006|6256394|P2|COMPLETED|Pre-treatment||94
2552757|NCT00539006|6256395|P1|COMPLETED|Pre-treatment||96
2552758|NCT00539006|6256392|P4|STARTED|Pre-treatment||91
2552759|NCT00539006|6256393|P3|STARTED|Pre-treatment||95
2552760|NCT00539006|6256394|P2|STARTED|Pre-treatment||95
2552761|NCT00539006|6256395|P1|STARTED|Pre-treatment||96
2552762|NCT00538980|6256425|P1|NOT COMPLETED|Overall Study||10
2552763|NCT00538980|6256425|P1|COMPLETED|Overall Study||0
2552764|NCT00538980|6256425|P1|STARTED|Overall Study||10
2552765|NCT00538915|6256433|P1|NOT COMPLETED|Overall Study||11
2552766|NCT00538915|6256433|P1|COMPLETED|Overall Study||52
2552767|NCT00538915|6256433|P1|STARTED|Overall Study||63
2552768|NCT00538902|6256440|P3|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
2552769|NCT00538902|6256441|P2|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
2552770|NCT00538902|6256442|P1|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||36
2552771|NCT00538902|6256440|P3|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||52
2552772|NCT00538902|6256441|P2|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||55
2552773|NCT00538902|6256442|P1|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||23
2552774|NCT00538902|6256440|P3|STARTED|OL Wk 24 to End (Primary D/C Reasons)||116
2552775|NCT00538902|6256441|P2|STARTED|OL Wk 24 to End (Primary D/C Reasons)||119
2552776|NCT00538902|6256442|P1|STARTED|OL Wk 24 to End (Primary D/C Reasons)||59
2552777|NCT00538902|6256440|P3|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||5
2552778|NCT00538902|6256441|P2|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||2
2552779|NCT00538902|6256442|P1|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||1
2552780|NCT00538902|6256440|P3|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||116
2552781|NCT00538902|6256441|P2|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||119
2552782|NCT00538902|6256442|P1|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||59
2552783|NCT00538902|6256440|P3|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
2552784|NCT00538902|6256441|P2|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
2552785|NCT00538902|6256442|P1|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||60
2552786|NCT00538863|6256477|P1|NOT COMPLETED|Open-label Maintenance||106
2552787|NCT00538863|6256477|P1|COMPLETED|Open-label Maintenance||163
2552788|NCT00538863|6256477|P1|STARTED|Open-label Maintenance|Five participants who completed the titration period did not start the maintenance period.|269
2552789|NCT00538863|6256477|P1|NOT COMPLETED|Open-label Titration||45
2552790|NCT00538863|6256477|P1|COMPLETED|Open-label Titration||184
2552791|NCT00538863|6256477|P1|STARTED|Open-label Titration||229
2552792|NCT00538850|6256483|P3|NOT COMPLETED|Placebo - Double-blind||3
2552793|NCT00538850|6256484|P2|NOT COMPLETED|Placebo - Double-blind||0
2552794|NCT00538850|6256485|P1|NOT COMPLETED|Placebo - Double-blind||0
2552795|NCT00538850|6256483|P3|COMPLETED|Placebo - Double-blind||95
2552796|NCT00538850|6256484|P2|COMPLETED|Placebo - Double-blind||0
2552797|NCT00538850|6256485|P1|COMPLETED|Placebo - Double-blind||0
2552798|NCT00538850|6256483|P3|STARTED|Placebo - Double-blind||98
2552799|NCT00538850|6256484|P2|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
2552800|NCT00538850|6256485|P1|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
2552801|NCT00538850|6256483|P3|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
2552802|NCT00538850|6256484|P2|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||3
2552803|NCT00538850|6256485|P1|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
2552804|NCT00538850|6256483|P3|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
2552805|NCT00538850|6256484|P2|COMPLETED|Fentanyl Sublingual Spray - Double-blind||95
2552806|NCT00538850|6256485|P1|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
2552807|NCT00538850|6256483|P3|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
2552808|NCT00538850|6256484|P2|STARTED|Fentanyl Sublingual Spray - Double-blind||98
2552809|NCT00538850|6256485|P1|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
2552810|NCT00538850|6256483|P3|NOT COMPLETED|Titration Period||0
2552811|NCT00538850|6256484|P2|NOT COMPLETED|Titration Period||0
2552812|NCT00538850|6256485|P1|NOT COMPLETED|Titration Period||32
2552813|NCT00538850|6256483|P3|COMPLETED|Titration Period||0
2552814|NCT00538850|6256484|P2|COMPLETED|Titration Period||0
2552815|NCT00538850|6256485|P1|COMPLETED|Titration Period||98
2552816|NCT00538850|6256483|P3|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
2552817|NCT00538850|6256484|P2|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
2552818|NCT00538850|6256485|P1|STARTED|Titration Period||130
2552819|NCT00538824|6256497|P1|NOT COMPLETED|Overall Study||0
2552820|NCT00538824|6256497|P1|COMPLETED|Overall Study||5
2552821|NCT00538824|6256497|P1|Progression of Disease|Overall Study||2
2552822|NCT00538824|6256497|P1|STARTED|Overall Study||5
2552823|NCT00538785|6256503|P2|NOT COMPLETED|Overall Study||17
2552824|NCT00538785|6256504|P1|NOT COMPLETED|Overall Study||19
2552825|NCT00538785|6256503|P2|COMPLETED|Overall Study||595
2552826|NCT00538785|6256504|P1|COMPLETED|Overall Study||604
2552827|NCT00538785|6256503|P2|STARTED|Overall Study||612
2552828|NCT00538785|6256504|P1|STARTED|Overall Study|A subject was randomized without appropriate consent in France and is not included in the results.|623
2552829|NCT00538759|6256527|P2|NOT COMPLETED|Overall Study||0
2552830|NCT00538759|6256528|P1|NOT COMPLETED|Overall Study||0
2552831|NCT00538759|6256527|P2|COMPLETED|Overall Study||8
2552832|NCT00538759|6256528|P1|COMPLETED|Overall Study||13
2552833|NCT00538759|6256527|P2|STARTED|Overall Study||8
2552834|NCT00538759|6256528|P1|STARTED|Overall Study||13
2552835|NCT00538733|6256546|P1|NOT COMPLETED|Overall Study||12
2552836|NCT00538733|6256546|P1|COMPLETED|Overall Study||14
2552837|NCT00538733|6256546|P1|Removed to Pursue Alternative Theray|Overall Study||2
2552838|NCT00538733|6256546|P1|Removed to Pursue a Stem Cell Transplant|Overall Study||11
2552839|NCT00538733|6256546|P1|Removed Due to Progression of Disease|Overall Study||1
2552840|NCT00538733|6256546|P1|STARTED|Overall Study||26
2552841|NCT00538642|6256555|P2|NOT COMPLETED|Overall Study||5
2552842|NCT00538642|6256556|P1|NOT COMPLETED|Overall Study||1
2552843|NCT00538642|6256555|P2|COMPLETED|Overall Study||9
2552844|NCT00538642|6256556|P1|COMPLETED|Overall Study||9
2552845|NCT00538642|6256555|P2|STARTED|Overall Study||14
2552846|NCT00538642|6256556|P1|STARTED|Overall Study||10
2552847|NCT00538629|6256596|P1|NOT COMPLETED|Overall Study||22
2552848|NCT00538629|6256596|P1|COMPLETED|Overall Study||449
2552849|NCT00538629|6256596|P1|STARTED|Overall Study||471
2552850|NCT00538616|6256643|P2|NOT COMPLETED|Overall Study||0
2552851|NCT00538616|6256644|P1|NOT COMPLETED|Overall Study||0
2552852|NCT00538616|6256643|P2|COMPLETED|Overall Study||3
2552853|NCT00538616|6256644|P1|COMPLETED|Overall Study||5
2552854|NCT00538616|6256643|P2|STARTED|Overall Study||3
2552855|NCT00538616|6256644|P1|STARTED|Overall Study||5
2552856|NCT00538590|6256652|P2|NOT COMPLETED|Overall Study||0
2552857|NCT00538590|6256653|P1|NOT COMPLETED|Overall Study||1
2552858|NCT00538590|6256652|P2|COMPLETED|Overall Study||10
2552859|NCT00538590|6256653|P1|COMPLETED|Overall Study|Deceased 8 months after surgery due to known cardiovascular co-morbidity.|9
2552860|NCT00538590|6256652|P2|STARTED|Overall Study||10
2552861|NCT00538590|6256653|P1|STARTED|Overall Study||10
2552862|NCT00538512|6256670|P3|NOT COMPLETED|Overall Study||13
2552863|NCT00538512|6256671|P2|NOT COMPLETED|Overall Study||30
2552864|NCT00538512|6256672|P1|NOT COMPLETED|Overall Study||27
2552865|NCT00538512|6256670|P3|COMPLETED|Overall Study||312
2552866|NCT00538512|6256671|P2|COMPLETED|Overall Study||783
2552867|NCT00538512|6256672|P1|COMPLETED|Overall Study||787
2552868|NCT00538512|6256670|P3|STARTED|Overall Study||325
2552869|NCT00538512|6256671|P2|STARTED|Overall Study||813
2552870|NCT00538512|6256672|P1|STARTED|Overall Study||814
2552871|NCT00538473|6256691|P2|NOT COMPLETED|Overall Study||0
2552872|NCT00538473|6256692|P1|NOT COMPLETED|Overall Study||1
2552873|NCT00538473|6256691|P2|COMPLETED|Overall Study||35
2552874|NCT00538473|6256692|P1|COMPLETED|Overall Study||32
2552875|NCT00538473|6256691|P2|STARTED|Overall Study||35
2552876|NCT00538473|6256692|P1|STARTED|Overall Study||33
2552877|NCT00538434|6256728|P4|NOT COMPLETED|Overall Study||6
2552878|NCT00538434|6256729|P3|NOT COMPLETED|Overall Study||7
2552879|NCT00538434|6256730|P2|NOT COMPLETED|Overall Study||11
2552880|NCT00538434|6256731|P1|NOT COMPLETED|Overall Study||9
2552881|NCT00538434|6256728|P4|COMPLETED|Overall Study|Completed all scheduled study visits|51
2552882|NCT00538434|6256729|P3|COMPLETED|Overall Study|Completed all scheduled study visits|50
2552883|NCT00538434|6256730|P2|COMPLETED|Overall Study|Completed all scheduled study visits|46
2552884|NCT00538434|6256731|P1|COMPLETED|Overall Study|Completed all scheduled study visits|47
2552885|NCT00538434|6256728|P4|Intent-to-treat (ITT) Population|Overall Study||57
2552886|NCT00538434|6256729|P3|Intent-to-treat (ITT) Population|Overall Study||57
2552887|NCT00538434|6256730|P2|Intent-to-treat (ITT) Population|Overall Study||57
2552888|NCT00538434|6256731|P1|Intent-to-treat (ITT) Population|Overall Study|1 participant was randomized but not treated|55
2552889|NCT00538434|6256728|P4|STARTED|Overall Study||57
2552890|NCT00538434|6256729|P3|STARTED|Overall Study||57
2552891|NCT00538434|6256730|P2|STARTED|Overall Study||57
2552892|NCT00538434|6256731|P1|STARTED|Overall Study||56
2552893|NCT00538304|6256755|P2|NOT COMPLETED|Overall Study||5
2552894|NCT00538304|6256756|P1|NOT COMPLETED|Overall Study||7
2552895|NCT00538304|6256755|P2|COMPLETED|Overall Study||66
2552896|NCT00538304|6256756|P1|COMPLETED|Overall Study||144
2552897|NCT00538304|6256755|P2|STARTED|Overall Study||71
2552898|NCT00538304|6256756|P1|STARTED|Overall Study||151
2552899|NCT00538291|6256772|P1|NOT COMPLETED|Overall Study||3
2552900|NCT00538291|6256772|P1|COMPLETED|Overall Study||10
2552901|NCT00538291|6256772|P1|STARTED|Overall Study||13
2552902|NCT00538213|6256779|P3|NOT COMPLETED|Overall Study||0
2552903|NCT00538213|6256780|P2|NOT COMPLETED|Overall Study||0
2552904|NCT00538213|6256781|P1|NOT COMPLETED|Overall Study||0
2552905|NCT00538213|6256779|P3|COMPLETED|Overall Study||38
2552906|NCT00538213|6256780|P2|COMPLETED|Overall Study||40
2552907|NCT00538213|6256781|P1|COMPLETED|Overall Study||55
2552908|NCT00538213|6256779|P3|STARTED|Overall Study||38
2552909|NCT00538213|6256780|P2|STARTED|Overall Study||40
2552910|NCT00538213|6256781|P1|STARTED|Overall Study||55
2552911|NCT00537979|6256830|P2|NOT COMPLETED|Overall Study||20
2552912|NCT00537979|6256831|P1|NOT COMPLETED|Overall Study||6
2552913|NCT00537979|6256830|P2|COMPLETED|Overall Study||89
2552914|NCT00537979|6256831|P1|COMPLETED|Overall Study||32
2552915|NCT00537979|6256830|P2|STARTED|Overall Study||109
2552916|NCT00537979|6256831|P1|STARTED|Overall Study||38
2552917|NCT00537940|6256847|P2|NOT COMPLETED|Overall Study||179
2552918|NCT00537940|6256848|P1|NOT COMPLETED|Overall Study||183
2552919|NCT00537940|6256847|P2|COMPLETED|Overall Study||62
2552920|NCT00537940|6256848|P1|COMPLETED|Overall Study|2 participants had both treatment related and non-treatment related AE leading to discontinuation.|58
2552921|NCT00537940|6256847|P2|Entered Opt Blinded Continuation Phase|Overall Study||139
2552922|NCT00537940|6256848|P1|Entered Opt Blinded Continuation Phase|Overall Study||140
2552923|NCT00537940|6256847|P2|Completed Maintenance Phase|Overall Study||172
2552924|NCT00537940|6256848|P1|Completed Maintenance Phase|Overall Study||187
2552925|NCT00537940|6256847|P2|Completed Titration Phase|Overall Study||210
2552926|NCT00537940|6256848|P1|Completed Titration Phase|Overall Study||213
2552927|NCT00537940|6256847|P2|STARTED|Overall Study||241
2552928|NCT00537940|6256848|P1|STARTED|Overall Study||241
2552929|NCT00537823|6256872|P2|NOT COMPLETED|Overall Study||0
2552930|NCT00537823|6256873|P1|NOT COMPLETED|Overall Study||2
2552931|NCT00537823|6256872|P2|COMPLETED|Overall Study||2
2552932|NCT00537823|6256873|P1|COMPLETED|Overall Study||5
2552933|NCT00537823|6256872|P2|STARTED|Overall Study||2
2552934|NCT00537823|6256873|P1|STARTED|Overall Study||7
2552935|NCT00537810|6256899|P4|NOT COMPLETED|Overall Study||4
2552936|NCT00537810|6256900|P3|NOT COMPLETED|Overall Study||4
2552937|NCT00537810|6256901|P2|NOT COMPLETED|Overall Study||13
2552938|NCT00537810|6256902|P1|NOT COMPLETED|Overall Study||6
2552939|NCT00537810|6256899|P4|COMPLETED|Overall Study||22
2552940|NCT00537810|6256900|P3|COMPLETED|Overall Study||21
2552941|NCT00537810|6256901|P2|COMPLETED|Overall Study||14
2552942|NCT00537810|6256902|P1|COMPLETED|Overall Study||20
2552943|NCT00537810|6256899|P4|STARTED|Overall Study||26
2552944|NCT00537810|6256900|P3|STARTED|Overall Study||25
2552945|NCT00537810|6256901|P2|STARTED|Overall Study||27
2552946|NCT00537810|6256902|P1|STARTED|Overall Study||26
2552947|NCT00537771|6256918|P2|NOT COMPLETED|Overall Study||61
2552948|NCT00537771|6256919|P1|NOT COMPLETED|Overall Study||29
2552949|NCT00537771|6256918|P2|COMPLETED|Overall Study||114
2552950|NCT00537771|6256919|P1|COMPLETED|Overall Study||149
2552951|NCT00537771|6256918|P2|STARTED|Overall Study||175
2552952|NCT00537771|6256919|P1|STARTED|Overall Study||178
2552953|NCT00537745|6256929|P1|NOT COMPLETED|Overall Study||5
2552954|NCT00537745|6256929|P1|COMPLETED|Overall Study||9
2552955|NCT00537745|6256929|P1|Began Intervention|Overall Study||11
2552956|NCT00537745|6256929|P1|STARTED|Overall Study|There were three screen fails and two early terminations.|14
2552957|NCT00537680|6256937|P3|NOT COMPLETED|Overall Study||0
2552958|NCT00537680|6256938|P2|NOT COMPLETED|Overall Study||2
2552959|NCT00537680|6256939|P1|NOT COMPLETED|Overall Study||0
2552960|NCT00537680|6256937|P3|COMPLETED|Overall Study||24
2552961|NCT00537680|6256938|P2|COMPLETED|Overall Study||22
2552962|NCT00537680|6256939|P1|COMPLETED|Overall Study||22
2552963|NCT00537680|6256937|P3|STARTED|Overall Study||24
2552964|NCT00537680|6256938|P2|STARTED|Overall Study||24
2552965|NCT00537680|6256939|P1|STARTED|Overall Study||22
2552966|NCT00537511|6256947|P1|NOT COMPLETED|Maintenance Phase (Monotherapy)||8
2552967|NCT00537511|6256947|P1|COMPLETED|Maintenance Phase (Monotherapy)||0
2552968|NCT00537511|6256947|P1|STARTED|Maintenance Phase (Monotherapy)||8
2552969|NCT00537511|6256947|P1|NOT COMPLETED|Recovery Period (Monotherapy)||8
2552970|NCT00537511|6256947|P1|COMPLETED|Recovery Period (Monotherapy)||3
2552971|NCT00537511|6256947|P1|STARTED|Recovery Period (Monotherapy)||11
2552972|NCT00537511|6256947|P1|NOT COMPLETED|Extension Period (Combination)||6
2552973|NCT00537511|6256947|P1|COMPLETED|Extension Period (Combination)||11
2552974|NCT00537511|6256947|P1|STARTED|Extension Period (Combination)||17
2552975|NCT00537511|6256947|P1|NOT COMPLETED|Treatment Period (Combination)||5
2552976|NCT00537511|6256947|P1|COMPLETED|Treatment Period (Combination)||17
2552977|NCT00537511|6256947|P1|Safety Population|Treatment Period (Combination)|Safety = All participants who took ≥1 dose of study treatment.|22
2552978|NCT00537511|6256947|P1|Intent-to-Treat (ITT) Populaton|Treatment Period (Combination)|ITT = all participants enrolled in the study.|22
2552979|NCT00537511|6256947|P1|STARTED|Treatment Period (Combination)||22
2552980|NCT00537485|6256974|P2|NOT COMPLETED|Overall Study||10
2552981|NCT00537485|6256975|P1|NOT COMPLETED|Overall Study||15
2552982|NCT00537485|6256974|P2|COMPLETED|Overall Study||80
2552983|NCT00537485|6256975|P1|COMPLETED|Overall Study||75
2552984|NCT00537485|6256974|P2|STARTED|Overall Study||90
2552985|NCT00537485|6256975|P1|STARTED|Overall Study||90
2552986|NCT00537407|6257004|P5|NOT COMPLETED|Part 2 Weeks 5-48 or 72||7
2552987|NCT00537407|6257005|P4|NOT COMPLETED|Part 2 Weeks 5-48 or 72||6
2552988|NCT00537407|6257006|P3|NOT COMPLETED|Part 2 Weeks 5-48 or 72||9
2552989|NCT00537407|6257007|P2|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
2552990|NCT00537407|6257008|P1|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
2552991|NCT00537407|6257004|P5|COMPLETED|Part 2 Weeks 5-48 or 72||3
2552992|NCT00537407|6257005|P4|COMPLETED|Part 2 Weeks 5-48 or 72||4
2552993|NCT00537407|6257006|P3|COMPLETED|Part 2 Weeks 5-48 or 72||2
2552994|NCT00537407|6257007|P2|COMPLETED|Part 2 Weeks 5-48 or 72||1
2552995|NCT00537407|6257008|P1|COMPLETED|Part 2 Weeks 5-48 or 72||2
2552996|NCT00537407|6257004|P5|STARTED|Part 2 Weeks 5-48 or 72||10
2552997|NCT00537407|6257005|P4|STARTED|Part 2 Weeks 5-48 or 72||10
2552998|NCT00537407|6257006|P3|STARTED|Part 2 Weeks 5-48 or 72||11
2552999|NCT00537407|6257007|P2|STARTED|Part 2 Weeks 5-48 or 72||9
2553000|NCT00537407|6257008|P1|STARTED|Part 2 Weeks 5-48 or 72||10
2553001|NCT00537407|6257004|P5|NOT COMPLETED|Part 1 Weeks 1-4||0
2553002|NCT00537407|6257005|P4|NOT COMPLETED|Part 1 Weeks 1-4||0
2553003|NCT00537407|6257006|P3|NOT COMPLETED|Part 1 Weeks 1-4||0
2553004|NCT00537407|6257007|P2|NOT COMPLETED|Part 1 Weeks 1-4||0
2553005|NCT00537407|6257008|P1|NOT COMPLETED|Part 1 Weeks 1-4||0
2553006|NCT00537407|6257004|P5|COMPLETED|Part 1 Weeks 1-4||10
2553007|NCT00537407|6257005|P4|COMPLETED|Part 1 Weeks 1-4||10
2553008|NCT00537407|6257006|P3|COMPLETED|Part 1 Weeks 1-4||11
2553009|NCT00537407|6257007|P2|COMPLETED|Part 1 Weeks 1-4||9
2553010|NCT00537407|6257008|P1|COMPLETED|Part 1 Weeks 1-4||10
2553011|NCT00537407|6257004|P5|STARTED|Part 1 Weeks 1-4||10
2553012|NCT00537407|6257005|P4|STARTED|Part 1 Weeks 1-4||10
2553013|NCT00537407|6257006|P3|STARTED|Part 1 Weeks 1-4||11
2553014|NCT00537407|6257007|P2|STARTED|Part 1 Weeks 1-4||9
2553015|NCT00537407|6257008|P1|STARTED|Part 1 Weeks 1-4||10
2553016|NCT00537394|6257048|P3|NOT COMPLETED|2nd Year of Follow-up||6
2553017|NCT00537394|6257049|P2|NOT COMPLETED|2nd Year of Follow-up||9
2553018|NCT00537394|6257050|P1|NOT COMPLETED|2nd Year of Follow-up||11
2553019|NCT00537394|6257048|P3|COMPLETED|2nd Year of Follow-up||44
2553020|NCT00537394|6257049|P2|COMPLETED|2nd Year of Follow-up||159
2553021|NCT00537394|6257050|P1|COMPLETED|2nd Year of Follow-up||158
2553022|NCT00537394|6257048|P3|STARTED|2nd Year of Follow-up||50
2553023|NCT00537394|6257049|P2|STARTED|2nd Year of Follow-up||168
2553024|NCT00537394|6257050|P1|STARTED|2nd Year of Follow-up||169
2553025|NCT00537394|6257048|P3|NOT COMPLETED|First Year of Follow-up||3
2553026|NCT00537394|6257049|P2|NOT COMPLETED|First Year of Follow-up||11
2553027|NCT00537394|6257050|P1|NOT COMPLETED|First Year of Follow-up||12
2553028|NCT00537394|6257048|P3|COMPLETED|First Year of Follow-up||50
2553029|NCT00537394|6257049|P2|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|168
2553030|NCT00537394|6257050|P1|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|169
2553031|NCT00537394|6257048|P3|STARTED|First Year of Follow-up||53
2553032|NCT00537394|6257049|P2|STARTED|First Year of Follow-up||179
2553033|NCT00537394|6257050|P1|STARTED|First Year of Follow-up||181
2553034|NCT00537381|6257086|P2|NOT COMPLETED|Overall Study||62
2553035|NCT00537381|6257087|P1|NOT COMPLETED|Overall Study||56
2553036|NCT00537381|6257086|P2|COMPLETED|Overall Study||4
2553037|NCT00537381|6257087|P1|COMPLETED|Overall Study||9
2553038|NCT00537381|6257086|P2|STARTED|Overall Study||66
2553039|NCT00537381|6257087|P1|STARTED|Overall Study|11 Participants after disease progression switched to intetumumab alone (2) or D+P+ Intetumumab (9).|65
2553040|NCT00537329|6257107|P1|NOT COMPLETED|Overall Study||26
2553041|NCT00537329|6257107|P1|COMPLETED|Overall Study||17
2553042|NCT00537329|6257107|P1|STARTED|Overall Study||43
2553043|NCT00537316|6257127|P7|NOT COMPLETED|Part 2||2
2553044|NCT00537316|6257128|P6|NOT COMPLETED|Part 2||4
2553045|NCT00537316|6257129|P5|NOT COMPLETED|Part 2||1
2553046|NCT00537316|6257130|P4|NOT COMPLETED|Part 2||3
2553047|NCT00537316|6257131|P3|NOT COMPLETED|Part 2||32
2553048|NCT00537316|6257132|P2|NOT COMPLETED|Part 2||9
2553049|NCT00537316|6257133|P1|NOT COMPLETED|Part 2||26
2553050|NCT00537316|6257127|P7|COMPLETED|Part 2||0
2553051|NCT00537316|6257128|P6|COMPLETED|Part 2||0
2553052|NCT00537316|6257129|P5|COMPLETED|Part 2||1
2553053|NCT00537316|6257130|P4|COMPLETED|Part 2||2
2553054|NCT00537316|6257131|P3|COMPLETED|Part 2||16
2553055|NCT00537316|6257132|P2|COMPLETED|Part 2||1
2553056|NCT00537316|6257133|P1|COMPLETED|Part 2||11
2553057|NCT00537316|6257127|P7|STARTED|Part 2||2
2553058|NCT00537316|6257128|P6|STARTED|Part 2||4
2553059|NCT00537316|6257129|P5|STARTED|Part 2||2
2553060|NCT00537316|6257130|P4|STARTED|Part 2||5
2553061|NCT00537316|6257131|P3|STARTED|Part 2||48
2553062|NCT00537316|6257132|P2|STARTED|Part 2||10
2553063|NCT00537316|6257133|P1|STARTED|Part 2||37
2553064|NCT00537316|6257127|P7|NOT COMPLETED|Part 1||0
2553065|NCT00537316|6257128|P6|NOT COMPLETED|Part 1||0
2553066|NCT00537316|6257129|P5|NOT COMPLETED|Part 1||0
2553067|NCT00537316|6257130|P4|NOT COMPLETED|Part 1||0
2553068|NCT00537316|6257131|P3|NOT COMPLETED|Part 1||17
2553069|NCT00537316|6257132|P2|NOT COMPLETED|Part 1||27
2553070|NCT00537316|6257133|P1|NOT COMPLETED|Part 1||14
2553071|NCT00537316|6257127|P7|COMPLETED|Part 1||0
2553072|NCT00537316|6257128|P6|COMPLETED|Part 1||0
2553073|NCT00537316|6257129|P5|COMPLETED|Part 1||0
2553074|NCT00537316|6257130|P4|COMPLETED|Part 1||0
2553075|NCT00537316|6257131|P3|COMPLETED|Part 1||63
2553076|NCT00537316|6257132|P2|COMPLETED|Part 1||53
2553077|NCT00537316|6257133|P1|COMPLETED|Part 1||65
2553078|NCT00537316|6257127|P7|STARTED|Part 1||0
2553079|NCT00537316|6257128|P6|STARTED|Part 1||0
2553080|NCT00537316|6257129|P5|STARTED|Part 1||0
2553081|NCT00537316|6257130|P4|STARTED|Part 1||0
2553082|NCT00537316|6257131|P3|STARTED|Part 1||80
2553083|NCT00537316|6257132|P2|STARTED|Part 1||80
2553084|NCT00537316|6257133|P1|STARTED|Part 1||79
2553085|NCT00537303|6257160|P2|NOT COMPLETED|Overall Study||25
2553086|NCT00537303|6257161|P1|NOT COMPLETED|Overall Study||26
2553087|NCT00537303|6257160|P2|COMPLETED|Overall Study||125
2553088|NCT00537303|6257161|P1|COMPLETED|Overall Study||120
2553089|NCT00537303|6257160|P2|STARTED|Overall Study||150
2553090|NCT00537303|6257161|P1|STARTED|Overall Study||146
2553091|NCT00537290|6257177|P1|NOT COMPLETED|Overall Study||0
2553092|NCT00537290|6257177|P1|COMPLETED|Overall Study||19
2553093|NCT00537290|6257177|P1|STARTED|Overall Study||19
2553094|NCT00537277|6257182|P1|NOT COMPLETED|Overall Study||49
2553095|NCT00537277|6257182|P1|COMPLETED|Overall Study||112
2553096|NCT00537277|6257182|P1|Exposed to Trial Drug|Overall Study|One subject not exposed to trial drug, and thus not included in full analysis set (FAS)|160
2553097|NCT00537277|6257182|P1|STARTED|Overall Study||161
2553098|NCT00537238|6257193|P2|NOT COMPLETED|Overall Study||173
2553099|NCT00537238|6257194|P1|NOT COMPLETED|Overall Study||174
2553100|NCT00537238|6257193|P2|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|82
2553101|NCT00537238|6257194|P1|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|80
2553191|NCT00536484|6257427|P2|NOT COMPLETED|Overall Study||56
2553192|NCT00536484|6257428|P1|NOT COMPLETED|Overall Study||60
2553102|NCT00537238|6257193|P2|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|195
2553103|NCT00537238|6257194|P1|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|185
2553104|NCT00537238|6257193|P2|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|210
2553105|NCT00537238|6257194|P1|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|208
2553106|NCT00537238|6257193|P2|Completed Titration Phase|Overall Study||236
2553107|NCT00537238|6257194|P1|Completed Titration Phase|Overall Study||226
2553108|NCT00537238|6257193|P2|STARTED|Overall Study||255
2553109|NCT00537238|6257194|P1|STARTED|Overall Study||254
2553110|NCT00537199|6257214|P1|NOT COMPLETED|Overall Study||1
2553111|NCT00537199|6257214|P1|COMPLETED|Overall Study||0
2553112|NCT00537199|6257214|P1|STARTED|Overall Study||1
2553113|NCT00537095|6257220|P2|NOT COMPLETED|Overall Study||57
2553114|NCT00537095|6257221|P1|NOT COMPLETED|Overall Study||51
2553115|NCT00537095|6257220|P2|COMPLETED|Overall Study||16
2553116|NCT00537095|6257221|P1|COMPLETED|Overall Study||21
2553117|NCT00537095|6257220|P2|STARTED|Overall Study||73
2553118|NCT00537095|6257221|P1|STARTED|Overall Study||72
2553119|NCT00537082|6257236|P3|NOT COMPLETED|Overall Study||6
2553120|NCT00537082|6257237|P2|NOT COMPLETED|Overall Study||9
2553121|NCT00537082|6257238|P1|NOT COMPLETED|Overall Study||9
2553122|NCT00537082|6257236|P3|COMPLETED|Overall Study||51
2553123|NCT00537082|6257237|P2|COMPLETED|Overall Study||48
2553124|NCT00537082|6257238|P1|COMPLETED|Overall Study||48
2553125|NCT00537082|6257236|P3|STARTED|Overall Study||57
2553126|NCT00537082|6257237|P2|STARTED|Overall Study||57
2553127|NCT00537082|6257238|P1|STARTED|Overall Study||57
2553128|NCT00537056|6257255|P1|NOT COMPLETED|12-month Follow-up||0
2553129|NCT00537056|6257255|P1|COMPLETED|12-month Follow-up||17
2553130|NCT00537056|6257255|P1|STARTED|12-month Follow-up||17
2553131|NCT00537056|6257255|P1|NOT COMPLETED|Interim PET/CT||5
2553132|NCT00537056|6257255|P1|COMPLETED|Interim PET/CT||12
2553133|NCT00537056|6257255|P1|STARTED|Interim PET/CT||17
2553134|NCT00537056|6257255|P1|NOT COMPLETED|Baseline PET/CT||0
2553135|NCT00537056|6257255|P1|COMPLETED|Baseline PET/CT||17
2553136|NCT00537056|6257255|P1|STARTED|Baseline PET/CT||17
2553137|NCT00537030|6257267|P1|NOT COMPLETED|Overall Study||16
2553138|NCT00537030|6257267|P1|COMPLETED|Overall Study||43
2553139|NCT00537030|6257267|P1|STARTED|Overall Study||59
2553140|NCT00537017|6257274|P1|NOT COMPLETED|Follow-up Phase||9
2553141|NCT00537017|6257274|P1|COMPLETED|Follow-up Phase||126
2553142|NCT00537017|6257274|P1|STARTED|Follow-up Phase|All TP participants were eligible for FUP entry. 5 participants completing TP did not enter FUP.|135
2553143|NCT00537017|6257274|P1|NOT COMPLETED|Treatment Phase||34
2553144|NCT00537017|6257274|P1|COMPLETED|Treatment Phase||106
2553145|NCT00537017|6257274|P1|STARTED|Treatment Phase||140
2553146|NCT00536991|6257285|P1|NOT COMPLETED|Overall Study||13
2553147|NCT00536991|6257285|P1|COMPLETED|Overall Study||38
2553148|NCT00536991|6257285|P1|STARTED|Overall Study||51
2553149|NCT00536978|6257292|P1|NOT COMPLETED|Overall Study||22
2553150|NCT00536978|6257292|P1|COMPLETED|Overall Study||0
2553151|NCT00536978|6257292|P1|STARTED|Overall Study||22
2553152|NCT00536913|6257298|P2|NOT COMPLETED|Overall Study||0
2553153|NCT00536913|6257299|P1|NOT COMPLETED|Overall Study||0
2553154|NCT00536913|6257298|P2|COMPLETED|Overall Study||52
2553155|NCT00536913|6257299|P1|COMPLETED|Overall Study||55
2553156|NCT00536913|6257298|P2|STARTED|Overall Study||52
2553157|NCT00536913|6257299|P1|STARTED|Overall Study||55
2553158|NCT00536874|6257321|P1|NOT COMPLETED|Overall Study||4
2553159|NCT00536874|6257321|P1|COMPLETED|Overall Study||35
2553160|NCT00536874|6257321|P1|STARTED|Overall Study||39
2553161|NCT00536809|6257331|P1|NOT COMPLETED|Phase II||2
2553162|NCT00536809|6257331|P1|COMPLETED|Phase II||0
2553163|NCT00536809|6257331|P1|STARTED|Phase II||2
2553164|NCT00536809|6257331|P1|NOT COMPLETED|Phase I (Dose-finding Phase)||0
2553165|NCT00536809|6257331|P1|COMPLETED|Phase I (Dose-finding Phase)||10
2553166|NCT00536809|6257331|P1|STARTED|Phase I (Dose-finding Phase)||10
2553167|NCT00536744|6257354|P2|NOT COMPLETED|Overall Study||28
2553168|NCT00536744|6257355|P1|NOT COMPLETED|Overall Study||29
2553169|NCT00536744|6257354|P2|COMPLETED|Overall Study||71
2553170|NCT00536744|6257355|P1|COMPLETED|Overall Study||78
2553171|NCT00536744|6257354|P2|STARTED|Overall Study||99
2553172|NCT00536744|6257355|P1|STARTED|Overall Study||107
2553173|NCT00536731|6257364|P3|NOT COMPLETED|Overall Study||5
2553174|NCT00536731|6257365|P2|NOT COMPLETED|Overall Study||5
2553175|NCT00536731|6257366|P1|NOT COMPLETED|Overall Study||4
2553176|NCT00536731|6257364|P3|COMPLETED|Overall Study||238
2553177|NCT00536731|6257365|P2|COMPLETED|Overall Study||241
2553178|NCT00536731|6257366|P1|COMPLETED|Overall Study||249
2553179|NCT00536731|6257364|P3|STARTED|Overall Study||243
2553180|NCT00536731|6257365|P2|STARTED|Overall Study||246
2553181|NCT00536731|6257366|P1|STARTED|Overall Study||253
2553182|NCT00536575|6257410|P1|NOT COMPLETED|Overall Study||2
2553183|NCT00536575|6257410|P1|COMPLETED|Overall Study||11
2553184|NCT00536575|6257410|P1|STARTED|Overall Study||13
2553185|NCT00536510|6257416|P2|NOT COMPLETED|Overall Study||29
2553186|NCT00536510|6257417|P1|NOT COMPLETED|Overall Study||82
2553187|NCT00536510|6257416|P2|COMPLETED|Overall Study||295
2553188|NCT00536510|6257417|P1|COMPLETED|Overall Study||240
2553189|NCT00536510|6257416|P2|STARTED|Overall Study||324
2553190|NCT00536510|6257417|P1|STARTED|Overall Study||322
2553193|NCT00536484|6257427|P2|COMPLETED|Overall Study|134 completed on 4mg dose and 248 on 8mg dose|382
2553194|NCT00536484|6257428|P1|COMPLETED|Overall Study|88 completed on matched 4mg dose and 297 on matched 8mg dose|385
2553195|NCT00536484|6257427|P2|STARTED|Overall Study|448 participants randomised; 10 not treated|438
2553196|NCT00536484|6257428|P1|STARTED|Overall Study|448 participants randomised; 3 not treated|445
2553197|NCT00536471|6257462|P4|NOT COMPLETED|Overall Study||74
2553198|NCT00536471|6257463|P3|NOT COMPLETED|Overall Study||139
2553199|NCT00536471|6257464|P2|NOT COMPLETED|Overall Study||84
2553200|NCT00536471|6257465|P1|NOT COMPLETED|Overall Study||156
2553201|NCT00536471|6257462|P4|COMPLETED|Overall Study||57
2553202|NCT00536471|6257463|P3|COMPLETED|Overall Study||122
2553203|NCT00536471|6257464|P2|COMPLETED|Overall Study||43
2553204|NCT00536471|6257465|P1|COMPLETED|Overall Study||101
2553205|NCT00536471|6257462|P4|STARTED|Overall Study||131
2553206|NCT00536471|6257463|P3|STARTED|Overall Study||261
2553207|NCT00536471|6257464|P2|STARTED|Overall Study||127
2553208|NCT00536471|6257465|P1|STARTED|Overall Study||257
2553209|NCT00536380|6257710|P3|NOT COMPLETED|Overall Study||10
2553210|NCT00536380|6257711|P2|NOT COMPLETED|Overall Study||9
2553211|NCT00536380|6257712|P1|NOT COMPLETED|Overall Study||12
2553212|NCT00536380|6257710|P3|COMPLETED|Overall Study||94
2553213|NCT00536380|6257711|P2|COMPLETED|Overall Study||95
2553214|NCT00536380|6257712|P1|COMPLETED|Overall Study||94
2553215|NCT00536380|6257710|P3|STARTED|Overall Study||104
2553216|NCT00536380|6257711|P2|STARTED|Overall Study||104
2553217|NCT00536380|6257712|P1|STARTED|Overall Study||106
2553218|NCT00536341|6257722|P2|NOT COMPLETED|Overall Study||11
2553219|NCT00536341|6257723|P1|NOT COMPLETED|Overall Study||5
2553220|NCT00536341|6257722|P2|COMPLETED|Overall Study||43
2553221|NCT00536341|6257723|P1|COMPLETED|Overall Study||5
2553222|NCT00536341|6257722|P2|STARTED|Overall Study||54
2553223|NCT00536341|6257723|P1|STARTED|Overall Study||10
2553224|NCT00536263|6257736|P3|NOT COMPLETED|Overall Study||21
2553225|NCT00536263|6257737|P2|NOT COMPLETED|Overall Study||14
2553226|NCT00536263|6257738|P1|NOT COMPLETED|Overall Study||11
2553227|NCT00536263|6257736|P3|COMPLETED|Overall Study||204
2553228|NCT00536263|6257737|P2|COMPLETED|Overall Study||207
2553229|NCT00536263|6257738|P1|COMPLETED|Overall Study||214
2553230|NCT00536263|6257736|P3|STARTED|Overall Study|One (1) participant withdrawn from study for non-compliance.|225
2553231|NCT00536263|6257737|P2|STARTED|Overall Study||221
2553232|NCT00536263|6257738|P1|STARTED|Overall Study||225
2553233|NCT00536198|6257778|P2|NOT COMPLETED|Overall Study||39
2553234|NCT00536198|6257779|P1|NOT COMPLETED|Overall Study||37
2553235|NCT00536198|6257778|P2|COMPLETED|Overall Study||88
2553236|NCT00536198|6257779|P1|COMPLETED|Overall Study||88
2553237|NCT00536198|6257778|P2|Cycle 6|Overall Study||88
2553238|NCT00536198|6257779|P1|Cycle 6|Overall Study||88
2553239|NCT00536198|6257778|P2|Cycle 5|Overall Study||85
2553240|NCT00536198|6257779|P1|Cycle 5|Overall Study||88
2553241|NCT00536198|6257778|P2|Cycle 4|Overall Study||98
2553242|NCT00536198|6257779|P1|Cycle 4|Overall Study||95
2553243|NCT00536198|6257778|P2|Cycle 3|Overall Study||101
2553244|NCT00536198|6257779|P1|Cycle 3|Overall Study||100
2553245|NCT00536198|6257778|P2|Cycle 2|Overall Study||112
2553246|NCT00536198|6257779|P1|Cycle 2|Overall Study||104
2553247|NCT00536198|6257778|P2|Cycle 1|Overall Study||123
2553248|NCT00536198|6257779|P1|Cycle 1|Overall Study||110
2553249|NCT00536198|6257778|P2|STARTED|Overall Study||127
2553250|NCT00536198|6257779|P1|STARTED|Overall Study||125
2553251|NCT00536172|6257809|P2|NOT COMPLETED|Overall Study||9
2553252|NCT00536172|6257810|P1|NOT COMPLETED|Overall Study||14
2553253|NCT00536172|6257809|P2|COMPLETED|Overall Study||65
2553254|NCT00536172|6257810|P1|COMPLETED|Overall Study||60
2553255|NCT00536172|6257809|P2|STARTED|Overall Study||74
2553256|NCT00536172|6257810|P1|STARTED|Overall Study||74
2553257|NCT00536120|6257818|P2|NOT COMPLETED|Overall Study||3
2553258|NCT00536120|6257819|P1|NOT COMPLETED|Overall Study||6
2553259|NCT00536120|6257818|P2|COMPLETED|Overall Study||27
2553260|NCT00536120|6257819|P1|COMPLETED|Overall Study||24
2553261|NCT00536120|6257818|P2|STARTED|Overall Study||30
2553262|NCT00536120|6257819|P1|STARTED|Overall Study||30
2553263|NCT00536107|6257833|P2|NOT COMPLETED|Overall Study||6
2553264|NCT00536107|6257834|P1|NOT COMPLETED|Overall Study||8
2553265|NCT00536107|6257833|P2|COMPLETED|Overall Study||0
2553266|NCT00536107|6257834|P1|COMPLETED|Overall Study||0
2553267|NCT00536107|6257833|P2|STARTED|Overall Study||6
2553268|NCT00536107|6257834|P1|STARTED|Overall Study||8
2553269|NCT00535938|6257844|P2|NOT COMPLETED|Overall Study||462
2553270|NCT00535938|6257845|P1|NOT COMPLETED|Overall Study||391
2553271|NCT00535938|6257844|P2|COMPLETED|Overall Study||404
2553272|NCT00535938|6257845|P1|COMPLETED|Overall Study||115
2553273|NCT00535938|6257844|P2|STARTED|Overall Study||866
2553274|NCT00535938|6257845|P1|STARTED|Overall Study||506
2553275|NCT00535873|6257881|P1|NOT COMPLETED|Overall Study||0
2553276|NCT00535873|6257881|P1|COMPLETED|Overall Study||60
2553277|NCT00535873|6257881|P1|STARTED|Overall Study||60
2553278|NCT00535847|6257888|P3|NOT COMPLETED|Overall Study||2
2553279|NCT00535847|6257889|P2|NOT COMPLETED|Overall Study||14
2553280|NCT00535847|6257890|P1|NOT COMPLETED|Overall Study||22
2553281|NCT00535847|6257888|P3|COMPLETED|Overall Study||0
2553282|NCT00535847|6257889|P2|COMPLETED|Overall Study||20
2553283|NCT00535847|6257890|P1|COMPLETED|Overall Study||59
2553284|NCT00535847|6257888|P3|STARTED|Overall Study||2
2553285|NCT00535847|6257889|P2|STARTED|Overall Study||34
2553286|NCT00535847|6257890|P1|STARTED|Overall Study||81
2553287|NCT00535821|6257916|P2|NOT COMPLETED|Overall Study||0
2553288|NCT00535821|6257917|P1|NOT COMPLETED|Overall Study||0
2553289|NCT00535821|6257916|P2|COMPLETED|Overall Study||3
2553290|NCT00535821|6257917|P1|COMPLETED|Overall Study||2
2553291|NCT00535821|6257916|P2|STARTED|Overall Study||3
2553292|NCT00535821|6257917|P1|STARTED|Overall Study||2
2553293|NCT00535782|6257925|P3|NOT COMPLETED|Part 2: 80-Week Open-label Period||26
2553294|NCT00535782|6257926|P2|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
2553295|NCT00535782|6257927|P1|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
2553296|NCT00535782|6257925|P3|COMPLETED|Part 2: 80-Week Open-label Period||98
2553297|NCT00535782|6257926|P2|COMPLETED|Part 2: 80-Week Open-label Period||0
2553298|NCT00535782|6257927|P1|COMPLETED|Part 2: 80-Week Open-label Period||0
2553299|NCT00535782|6257925|P3|STARTED|Part 2: 80-Week Open-label Period||124
2553300|NCT00535782|6257926|P2|STARTED|Part 2: 80-Week Open-label Period||0
2553301|NCT00535782|6257927|P1|STARTED|Part 2: 80-Week Open-label Period||0
2553302|NCT00535782|6257925|P3|NOT COMPLETED|Part 1: 24-Week Double-blind Period||0
2553303|NCT00535782|6257926|P2|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
2553304|NCT00535782|6257927|P1|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
2553305|NCT00535782|6257925|P3|COMPLETED|Part 1: 24-Week Double-blind Period||0
2553306|NCT00535782|6257926|P2|COMPLETED|Part 1: 24-Week Double-blind Period||59
2553307|NCT00535782|6257927|P1|COMPLETED|Part 1: 24-Week Double-blind Period||65
2553308|NCT00535782|6257925|P3|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
2553309|NCT00535782|6257926|P2|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||62
2553310|NCT00535782|6257927|P1|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
2553311|NCT00535782|6257925|P3|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||0
2553312|NCT00535782|6257926|P2|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period|1 misrandomized patient received the TCZ in error, and 1 patient received TCZ as rescue therapy.|2
2553313|NCT00535782|6257927|P1|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||69
2553314|NCT00535782|6257925|P3|STARTED|Part 1: 24-Week Double-blind Period||0
2553315|NCT00535782|6257926|P2|STARTED|Part 1: 24-Week Double-blind Period||63
2553316|NCT00535782|6257927|P1|STARTED|Part 1: 24-Week Double-blind Period||69
2553317|NCT00535769|6257944|P2|NOT COMPLETED|Overall Study||0
2553318|NCT00535769|6257945|P1|NOT COMPLETED|Overall Study||0
2553319|NCT00535769|6257944|P2|COMPLETED|Overall Study||35
2553320|NCT00535769|6257945|P1|COMPLETED|Overall Study||35
2553321|NCT00535769|6257944|P2|STARTED|Overall Study||35
2553322|NCT00535769|6257945|P1|STARTED|Overall Study||35
2553323|NCT00535743|6257978|P24|NOT COMPLETED|Overall Study||0
2553324|NCT00535743|6257979|P23|NOT COMPLETED|Overall Study||0
2553325|NCT00535743|6257980|P22|NOT COMPLETED|Overall Study||1
2553326|NCT00535743|6257981|P21|NOT COMPLETED|Overall Study||0
2553327|NCT00535743|6257982|P20|NOT COMPLETED|Overall Study||0
2553328|NCT00535743|6257983|P19|NOT COMPLETED|Overall Study||0
2553329|NCT00535743|6257984|P18|NOT COMPLETED|Overall Study||0
2553330|NCT00535743|6257985|P17|NOT COMPLETED|Overall Study||0
2553331|NCT00535743|6257986|P16|NOT COMPLETED|Overall Study||0
2553332|NCT00535743|6257987|P15|NOT COMPLETED|Overall Study||0
2553333|NCT00535743|6257988|P14|NOT COMPLETED|Overall Study||0
2553334|NCT00535743|6257989|P13|NOT COMPLETED|Overall Study||0
2553335|NCT00535743|6257990|P12|NOT COMPLETED|Overall Study||0
2553336|NCT00535743|6257991|P11|NOT COMPLETED|Overall Study||0
2553337|NCT00535743|6257992|P10|NOT COMPLETED|Overall Study||1
2553338|NCT00535743|6257993|P9|NOT COMPLETED|Overall Study||1
2553339|NCT00535743|6257994|P8|NOT COMPLETED|Overall Study||0
2553340|NCT00535743|6257995|P7|NOT COMPLETED|Overall Study||0
2553341|NCT00535743|6257996|P6|NOT COMPLETED|Overall Study||0
2553342|NCT00535743|6257997|P5|NOT COMPLETED|Overall Study||0
2553343|NCT00535743|6257998|P4|NOT COMPLETED|Overall Study||0
2553344|NCT00535743|6257999|P3|NOT COMPLETED|Overall Study||0
2553345|NCT00535743|6258000|P2|NOT COMPLETED|Overall Study||0
2553346|NCT00535743|6258001|P1|NOT COMPLETED|Overall Study||0
2553347|NCT00535743|6257978|P24|COMPLETED|Overall Study||5
2553348|NCT00535743|6257979|P23|COMPLETED|Overall Study||6
2553349|NCT00535743|6257980|P22|COMPLETED|Overall Study||4
2553350|NCT00535743|6257981|P21|COMPLETED|Overall Study||5
2553351|NCT00535743|6257982|P20|COMPLETED|Overall Study||5
2553352|NCT00535743|6257983|P19|COMPLETED|Overall Study||3
2553353|NCT00535743|6257984|P18|COMPLETED|Overall Study||11
2553354|NCT00535743|6257985|P17|COMPLETED|Overall Study||10
2553355|NCT00535743|6257986|P16|COMPLETED|Overall Study||13
2553356|NCT00535743|6257987|P15|COMPLETED|Overall Study||9
2553357|NCT00535743|6257988|P14|COMPLETED|Overall Study||10
2553358|NCT00535743|6257989|P13|COMPLETED|Overall Study||5
2553359|NCT00535743|6257990|P12|COMPLETED|Overall Study||5
2553360|NCT00535743|6257991|P11|COMPLETED|Overall Study||5
2553361|NCT00535743|6257992|P10|COMPLETED|Overall Study||4
2553362|NCT00535743|6257993|P9|COMPLETED|Overall Study||4
2553363|NCT00535743|6257994|P8|COMPLETED|Overall Study||5
2553364|NCT00535743|6257995|P7|COMPLETED|Overall Study||3
2553365|NCT00535743|6257996|P6|COMPLETED|Overall Study||10
2553366|NCT00535743|6257997|P5|COMPLETED|Overall Study||11
2553367|NCT00535743|6257998|P4|COMPLETED|Overall Study||11
2553368|NCT00535743|6257999|P3|COMPLETED|Overall Study||11
2553369|NCT00535743|6258000|P2|COMPLETED|Overall Study||11
2553370|NCT00535743|6258001|P1|COMPLETED|Overall Study||5
2553371|NCT00535743|6257978|P24|Treated|Overall Study||5
2553372|NCT00535743|6257979|P23|Treated|Overall Study|N=1 (randomized to Arm Q) rec’d 12 mg/kg Sugammadex, 29 min after 1.2 mg/kg Esmeron®|6
2553373|NCT00535743|6257980|P22|Treated|Overall Study||5
2553374|NCT00535743|6257981|P21|Treated|Overall Study||5
2553375|NCT00535743|6257982|P20|Treated|Overall Study||5
2553376|NCT00535743|6257983|P19|Treated|Overall Study||3
2553377|NCT00535743|6257984|P18|Treated|Overall Study||11
2553378|NCT00535743|6257985|P17|Treated|Overall Study||10
2553379|NCT00535743|6257986|P16|Treated|Overall Study|N=2 (randomized to Arm O) rec’d 8 mg/kg Sugammadex, 3 min after 1.2 mg/kg Esmeron®|13
2553380|NCT00535743|6257987|P15|Treated|Overall Study||9
2553381|NCT00535743|6257988|P14|Treated|Overall Study||10
2553382|NCT00535743|6257989|P13|Treated|Overall Study||5
2553383|NCT00535743|6257990|P12|Treated|Overall Study||5
2553384|NCT00535743|6257991|P11|Treated|Overall Study||5
2553385|NCT00535743|6257992|P10|Treated|Overall Study||5
2553386|NCT00535743|6257993|P9|Treated|Overall Study||4
2553387|NCT00535743|6257994|P8|Treated|Overall Study||5
2553388|NCT00535743|6257995|P7|Treated|Overall Study||3
2553389|NCT00535743|6257996|P6|Treated|Overall Study||10
2553390|NCT00535743|6257997|P5|Treated|Overall Study||11
2553391|NCT00535743|6257998|P4|Treated|Overall Study||11
2553392|NCT00535743|6257999|P3|Treated|Overall Study||11
2553393|NCT00535743|6258000|P2|Treated|Overall Study||11
2553394|NCT00535743|6258001|P1|Treated|Overall Study||5
2553395|NCT00535743|6257978|P24|STARTED|Overall Study||5
2553396|NCT00535743|6257979|P23|STARTED|Overall Study|N=5 randomized to Arm W. An additional N=1 (randomized to Arm Q) is counted as Started in Arm W|6
2553397|NCT00535743|6257980|P22|STARTED|Overall Study||5
2553398|NCT00535743|6257981|P21|STARTED|Overall Study||5
2553399|NCT00535743|6257982|P20|STARTED|Overall Study||5
2553400|NCT00535743|6257983|P19|STARTED|Overall Study||3
2553401|NCT00535743|6257984|P18|STARTED|Overall Study||11
2553402|NCT00535743|6257985|P17|STARTED|Overall Study||10
2553403|NCT00535743|6257986|P16|STARTED|Overall Study|N=11 randomized to Arm P. An additional N=2 (randomized to Arm O) are counted as Started in Arm P|13
2553404|NCT00535743|6257987|P15|STARTED|Overall Study||9
2553405|NCT00535743|6257988|P14|STARTED|Overall Study||10
2553406|NCT00535743|6257989|P13|STARTED|Overall Study||5
2553407|NCT00535743|6257990|P12|STARTED|Overall Study||5
2553408|NCT00535743|6257991|P11|STARTED|Overall Study||5
2553409|NCT00535743|6257992|P10|STARTED|Overall Study||5
2553410|NCT00535743|6257993|P9|STARTED|Overall Study||5
2553411|NCT00535743|6257994|P8|STARTED|Overall Study||5
2553412|NCT00535743|6257995|P7|STARTED|Overall Study||3
2553413|NCT00535743|6257996|P6|STARTED|Overall Study||10
2553414|NCT00535743|6257997|P5|STARTED|Overall Study||11
2553415|NCT00535743|6257998|P4|STARTED|Overall Study||11
2553416|NCT00535743|6257999|P3|STARTED|Overall Study||11
2553417|NCT00535743|6258000|P2|STARTED|Overall Study||11
2553418|NCT00535743|6258001|P1|STARTED|Overall Study||5
2553419|NCT00535730|6258125|P2|NOT COMPLETED|Overall Study||7
2553420|NCT00535730|6258126|P1|NOT COMPLETED|Overall Study||2
2553421|NCT00535730|6258125|P2|COMPLETED|Overall Study||230
2553422|NCT00535730|6258126|P1|COMPLETED|Overall Study||234
2553423|NCT00535730|6258125|P2|STARTED|Overall Study|Two subjects were allocated but not vaccinated making the number of subjects vaccinated 235|237
2553424|NCT00535730|6258126|P1|STARTED|Overall Study||236
2553425|NCT00535652|6258143|P1|NOT COMPLETED|Overall Study||3
2553426|NCT00535652|6258143|P1|COMPLETED|Overall Study||20
2553427|NCT00535652|6258143|P1|STARTED|Overall Study||23
2553428|NCT00535626|6258147|P1|NOT COMPLETED|Overall Study||105
2553429|NCT00535626|6258147|P1|COMPLETED|Overall Study||85
2553430|NCT00535626|6258147|P1|STARTED|Overall Study||190
2553431|NCT00535613|6258159|P2|NOT COMPLETED|Overall Study||0
2553432|NCT00535613|6258160|P1|NOT COMPLETED|Overall Study||0
2553433|NCT00535613|6258159|P2|COMPLETED|Overall Study||50
2553434|NCT00535613|6258160|P1|COMPLETED|Overall Study||49
2553435|NCT00535613|6258159|P2|STARTED|Overall Study||50
2553436|NCT00535613|6258160|P1|STARTED|Overall Study||49
2553437|NCT00535587|6258174|P4|NOT COMPLETED|Overall Study||13
2553438|NCT00535587|6258175|P3|NOT COMPLETED|Overall Study||8
2553439|NCT00535587|6258176|P2|NOT COMPLETED|Overall Study||11
2553440|NCT00535587|6258177|P1|NOT COMPLETED|Overall Study||10
2553441|NCT00535587|6258174|P4|COMPLETED|Overall Study||41
2553442|NCT00535587|6258175|P3|COMPLETED|Overall Study||39
2553443|NCT00535587|6258176|P2|COMPLETED|Overall Study||42
2553444|NCT00535587|6258177|P1|COMPLETED|Overall Study||43
2553445|NCT00535587|6258174|P4|STARTED|Overall Study||54
2553446|NCT00535587|6258175|P3|STARTED|Overall Study||47
2553447|NCT00535587|6258176|P2|STARTED|Overall Study||53
2553448|NCT00535587|6258177|P1|STARTED|Overall Study||53
2553449|NCT00535496|6258187|P4|NOT COMPLETED|Overall Study||0
2553450|NCT00535496|6258188|P3|NOT COMPLETED|Overall Study||0
2553451|NCT00535496|6258189|P2|NOT COMPLETED|Overall Study||2
2553452|NCT00535496|6258190|P1|NOT COMPLETED|Overall Study||0
2553453|NCT00535496|6258187|P4|COMPLETED|Overall Study||31
2553454|NCT00535496|6258188|P3|COMPLETED|Overall Study||30
2553455|NCT00535496|6258189|P2|COMPLETED|Overall Study||13
2553456|NCT00535496|6258190|P1|COMPLETED|Overall Study||15
2553457|NCT00535496|6258187|P4|All-Subjects-Treated (AST) Group|Overall Study||31
2553458|NCT00535496|6258188|P3|All-Subjects-Treated (AST) Group|Overall Study||30
2553459|NCT00535496|6258189|P2|All-Subjects-Treated (AST) Group|Overall Study||14
2553460|NCT00535496|6258190|P1|All-Subjects-Treated (AST) Group|Overall Study||15
2553461|NCT00535496|6258187|P4|STARTED|Overall Study||31
2553462|NCT00535496|6258188|P3|STARTED|Overall Study||30
2553463|NCT00535496|6258189|P2|STARTED|Overall Study||15
2553464|NCT00535496|6258190|P1|STARTED|Overall Study||15
2553465|NCT00535405|6258210|P5|NOT COMPLETED|Overall Study||16
2553466|NCT00535405|6258211|P4|NOT COMPLETED|Overall Study||22
2553467|NCT00535405|6258212|P3|NOT COMPLETED|Overall Study||18
2553468|NCT00535405|6258213|P2|NOT COMPLETED|Overall Study||26
2553469|NCT00535405|6258214|P1|NOT COMPLETED|Overall Study||17
2553470|NCT00535405|6258210|P5|COMPLETED|Overall Study||241
2553471|NCT00535405|6258211|P4|COMPLETED|Overall Study||235
2553472|NCT00535405|6258212|P3|COMPLETED|Overall Study||241
2553473|NCT00535405|6258213|P2|COMPLETED|Overall Study||233
2553474|NCT00535405|6258214|P1|COMPLETED|Overall Study||240
2553475|NCT00535405|6258210|P5|STARTED|Overall Study||257
2553476|NCT00535405|6258211|P4|STARTED|Overall Study||257
2553477|NCT00535405|6258212|P3|STARTED|Overall Study||259
2553478|NCT00535405|6258213|P2|STARTED|Overall Study||259
2553479|NCT00535405|6258214|P1|STARTED|Overall Study||257
2553480|NCT00535392|6258251|P1|NOT COMPLETED|Overall Study||0
2553481|NCT00535392|6258251|P1|COMPLETED|Overall Study||33
2553482|NCT00535392|6258251|P1|STARTED|Overall Study||33
2553483|NCT00535301|6258259|P2|NOT COMPLETED|Overall Study||5
2553484|NCT00535301|6258260|P1|NOT COMPLETED|Overall Study||5
2553485|NCT00535301|6258259|P2|COMPLETED|Overall Study||33
2553486|NCT00535301|6258260|P1|COMPLETED|Overall Study||33
2553487|NCT00535301|6258259|P2|STARTED|Overall Study||38
2553488|NCT00535301|6258260|P1|STARTED|Overall Study||38
2553489|NCT00535288|6258275|P5|NOT COMPLETED|Overall Study||42
2553490|NCT00535288|6258276|P4|NOT COMPLETED|Overall Study||29
2553491|NCT00535288|6258277|P3|NOT COMPLETED|Overall Study||33
2553492|NCT00535288|6258278|P2|NOT COMPLETED|Overall Study||32
2553493|NCT00535288|6258279|P1|NOT COMPLETED|Overall Study||54
2553494|NCT00535288|6258275|P5|COMPLETED|Overall Study||116
2553495|NCT00535288|6258276|P4|COMPLETED|Overall Study||122
2553496|NCT00535288|6258277|P3|COMPLETED|Overall Study||127
2553497|NCT00535288|6258278|P2|COMPLETED|Overall Study||130
2553498|NCT00535288|6258279|P1|COMPLETED|Overall Study||260
2553499|NCT00535288|6258275|P5|STARTED|Overall Study|One participant randomized to receive placebo received esmirtazapine 18 mg.|158
2553500|NCT00535288|6258276|P4|STARTED|Overall Study||151
2553501|NCT00535288|6258277|P3|STARTED|Overall Study||160
2553502|NCT00535288|6258278|P2|STARTED|Overall Study||162
2553503|NCT00535288|6258279|P1|STARTED|Overall Study|2 participants randomized to receive placebo did not receive placebo|314
2553504|NCT00535262|6258356|P1|NOT COMPLETED|Overall Study||3
2553505|NCT00535262|6258356|P1|COMPLETED|Overall Study|Pharmaceutical company withdrew supply of EmSam prematurely before protocol was complete.|0
2553506|NCT00535262|6258356|P1|STARTED|Overall Study|3 patients were enrolled in the study. Data was collected for only two weeks before funding expired.|3
2553507|NCT00535236|6258370|P10|NOT COMPLETED|Overall Study||4
2553508|NCT00535236|6258371|P9|NOT COMPLETED|Overall Study||13
2553509|NCT00535236|6258372|P8|NOT COMPLETED|Overall Study||1
2553510|NCT00535236|6258373|P7|NOT COMPLETED|Overall Study||11
2553511|NCT00535236|6258374|P6|NOT COMPLETED|Overall Study||1
2553512|NCT00535236|6258375|P5|NOT COMPLETED|Overall Study||12
2553513|NCT00535236|6258376|P4|NOT COMPLETED|Overall Study||4
2553514|NCT00535236|6258377|P3|NOT COMPLETED|Overall Study||12
2553515|NCT00535236|6258378|P2|NOT COMPLETED|Overall Study||2
2553516|NCT00535236|6258379|P1|NOT COMPLETED|Overall Study||7
2553517|NCT00535236|6258370|P10|COMPLETED|Overall Study||16
2553518|NCT00535236|6258371|P9|COMPLETED|Overall Study||47
2553519|NCT00535236|6258372|P8|COMPLETED|Overall Study||18
2553520|NCT00535236|6258373|P7|COMPLETED|Overall Study||51
2553521|NCT00535236|6258374|P6|COMPLETED|Overall Study||19
2553522|NCT00535236|6258375|P5|COMPLETED|Overall Study||47
2553523|NCT00535236|6258376|P4|COMPLETED|Overall Study||6
2553524|NCT00535236|6258377|P3|COMPLETED|Overall Study||29
2553525|NCT00535236|6258378|P2|COMPLETED|Overall Study||8
2553526|NCT00535236|6258379|P1|COMPLETED|Overall Study||33
2553527|NCT00535236|6258370|P10|Vaccination 4|Overall Study||17
2553528|NCT00535236|6258371|P9|Vaccination 4|Overall Study||50
2553529|NCT00535236|6258372|P8|Vaccination 4|Overall Study||18
2553530|NCT00535236|6258373|P7|Vaccination 4|Overall Study||51
2553531|NCT00535236|6258374|P6|Vaccination 4|Overall Study||19
2553532|NCT00535236|6258375|P5|Vaccination 4|Overall Study||47
2553533|NCT00535236|6258376|P4|Vaccination 4|Overall Study||6
2553534|NCT00535236|6258377|P3|Vaccination 4|Overall Study||32
2553535|NCT00535236|6258378|P2|Vaccination 4|Overall Study||10
2553536|NCT00535236|6258379|P1|Vaccination 4|Overall Study||34
2553537|NCT00535236|6258370|P10|Vaccination 3|Overall Study||18
2553538|NCT00535236|6258371|P9|Vaccination 3|Overall Study||53
2553539|NCT00535236|6258372|P8|Vaccination 3|Overall Study||18
2553540|NCT00535236|6258373|P7|Vaccination 3|Overall Study||51
2553541|NCT00535236|6258374|P6|Vaccination 3|Overall Study||19
2553542|NCT00535236|6258375|P5|Vaccination 3|Overall Study||48
2553543|NCT00535236|6258376|P4|Vaccination 3|Overall Study||8
2553544|NCT00535236|6258377|P3|Vaccination 3|Overall Study||35
2553545|NCT00535236|6258378|P2|Vaccination 3|Overall Study||10
2553546|NCT00535236|6258379|P1|Vaccination 3|Overall Study||34
2553547|NCT00535236|6258370|P10|Vaccination 2|Overall Study||19
2553548|NCT00535236|6258371|P9|Vaccination 2|Overall Study||57
2553549|NCT00535236|6258372|P8|Vaccination 2|Overall Study||19
2553550|NCT00535236|6258373|P7|Vaccination 2|Overall Study||58
2553551|NCT00535236|6258374|P6|Vaccination 2|Overall Study||19
2553552|NCT00535236|6258375|P5|Vaccination 2|Overall Study||52
2553553|NCT00535236|6258376|P4|Vaccination 2|Overall Study||8
2553554|NCT00535236|6258377|P3|Vaccination 2|Overall Study||37
2553555|NCT00535236|6258378|P2|Vaccination 2|Overall Study||10
2553556|NCT00535236|6258379|P1|Vaccination 2|Overall Study||35
2553557|NCT00535236|6258370|P10|Vaccination 1|Overall Study||20
2553558|NCT00535236|6258371|P9|Vaccination 1|Overall Study||60
2553559|NCT00535236|6258372|P8|Vaccination 1|Overall Study||19
2553560|NCT00535236|6258373|P7|Vaccination 1|Overall Study||61
2553561|NCT00535236|6258374|P6|Vaccination 1|Overall Study||19
2553562|NCT00535236|6258375|P5|Vaccination 1|Overall Study||58
2553563|NCT00535236|6258376|P4|Vaccination 1|Overall Study||10
2553564|NCT00535236|6258377|P3|Vaccination 1|Overall Study||40
2553565|NCT00535236|6258378|P2|Vaccination 1|Overall Study||10
2553566|NCT00535236|6258379|P1|Vaccination 1|Overall Study||40
2553567|NCT00535236|6258370|P10|STARTED|Overall Study||20
2553568|NCT00535236|6258371|P9|STARTED|Overall Study||60
2553569|NCT00535236|6258372|P8|STARTED|Overall Study||19
2553570|NCT00535236|6258373|P7|STARTED|Overall Study||62
2553571|NCT00535236|6258374|P6|STARTED|Overall Study||20
2553572|NCT00535236|6258375|P5|STARTED|Overall Study||59
2553573|NCT00535236|6258376|P4|STARTED|Overall Study||10
2553574|NCT00535236|6258377|P3|STARTED|Overall Study||41
2553575|NCT00535236|6258378|P2|STARTED|Overall Study||10
2553576|NCT00535236|6258379|P1|STARTED|Overall Study||40
2553577|NCT00535223|6258439|P2|NOT COMPLETED|Overall Study||1
2553578|NCT00535223|6258440|P1|NOT COMPLETED|Overall Study||4
2553579|NCT00535223|6258439|P2|COMPLETED|Overall Study||39
2553580|NCT00535223|6258440|P1|COMPLETED|Overall Study||37
2553581|NCT00535223|6258439|P2|STARTED|Overall Study|Patients were randomized in cohorts of ten.|40
2553582|NCT00535223|6258440|P1|STARTED|Overall Study|Patients were randomized in cohorts of ten.|41
2553583|NCT00535145|6258448|P1|NOT COMPLETED|Phase II||15
2553584|NCT00535145|6258448|P1|COMPLETED|Phase II||69
2553585|NCT00535145|6258448|P1|STARTED|Phase II|Of the 85 participants who completed Phase 1, 84 met the criteria to enroll into Phase 2|84
2553586|NCT00535145|6258448|P1|NOT COMPLETED|Phase I||29
2553587|NCT00535145|6258448|P1|COMPLETED|Phase I||85
2553588|NCT00535145|6258448|P1|STARTED|Phase I||114
2553589|NCT00535132|6258460|P2|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
2553590|NCT00535132|6258461|P1|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
2553591|NCT00535132|6258460|P2|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|96
2553592|NCT00535132|6258461|P1|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|95
2553593|NCT00535132|6258460|P2|STARTED|Intent-to-Treat (ITT) Analysis Set||99
2553594|NCT00535132|6258461|P1|STARTED|Intent-to-Treat (ITT) Analysis Set||98
2553595|NCT00535132|6258460|P2|NOT COMPLETED|Safety Analysis Set||2
2553596|NCT00535132|6258461|P1|NOT COMPLETED|Safety Analysis Set||2
2553597|NCT00535132|6258460|P2|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|99
2553598|NCT00535132|6258461|P1|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|98
2553599|NCT00535132|6258460|P2|STARTED|Safety Analysis Set||101
2553600|NCT00535132|6258461|P1|STARTED|Safety Analysis Set||100
2553601|NCT00535132|6258460|P2|NOT COMPLETED|Randomized Population||0
2553602|NCT00535132|6258461|P1|NOT COMPLETED|Randomized Population||0
2553603|NCT00535132|6258460|P2|COMPLETED|Randomized Population||101
2553604|NCT00535132|6258461|P1|COMPLETED|Randomized Population||100
2553605|NCT00535132|6258460|P2|STARTED|Randomized Population|Number of Subjects Randomized|101
2553606|NCT00535132|6258461|P1|STARTED|Randomized Population|Number of Subjects Randomized|100
2553607|NCT00535002|6258519|P8|NOT COMPLETED|Overall Study||0
2553608|NCT00535002|6258520|P7|NOT COMPLETED|Overall Study||0
2553609|NCT00535002|6258521|P6|NOT COMPLETED|Overall Study||0
2553610|NCT00535002|6258522|P5|NOT COMPLETED|Overall Study||0
2553611|NCT00535002|6258523|P4|NOT COMPLETED|Overall Study||0
2553612|NCT00535002|6258524|P3|NOT COMPLETED|Overall Study||0
2553613|NCT00535002|6258525|P2|NOT COMPLETED|Overall Study||0
2553614|NCT00535002|6258526|P1|NOT COMPLETED|Overall Study||0
2553615|NCT00535002|6258519|P8|COMPLETED|Overall Study||16
2553616|NCT00535002|6258520|P7|COMPLETED|Overall Study||12
2553617|NCT00535002|6258521|P6|COMPLETED|Overall Study||17
2553618|NCT00535002|6258522|P5|COMPLETED|Overall Study||9
2553619|NCT00535002|6258523|P4|COMPLETED|Overall Study||14
2553620|NCT00535002|6258524|P3|COMPLETED|Overall Study||13
2553621|NCT00535002|6258525|P2|COMPLETED|Overall Study||12
2553622|NCT00535002|6258526|P1|COMPLETED|Overall Study||19
2553623|NCT00535002|6258519|P8|STARTED|Overall Study||16
2553624|NCT00535002|6258520|P7|STARTED|Overall Study||12
2553625|NCT00535002|6258521|P6|STARTED|Overall Study||17
2553626|NCT00535002|6258522|P5|STARTED|Overall Study||9
2553627|NCT00535002|6258523|P4|STARTED|Overall Study||14
2553628|NCT00535002|6258524|P3|STARTED|Overall Study||13
2553629|NCT00535002|6258525|P2|STARTED|Overall Study||12
2553630|NCT00535002|6258526|P1|STARTED|Overall Study||19
2553631|NCT00534976|6258542|P2|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||0
2553632|NCT00534976|6258543|P1|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||2
2553633|NCT00534976|6258542|P2|COMPLETED|Period 3: Crossover Placebo/ Montelukast||32
2553634|NCT00534976|6258543|P1|COMPLETED|Period 3: Crossover Placebo/ Montelukast||31
2553635|NCT00534976|6258542|P2|STARTED|Period 3: Crossover Placebo/ Montelukast||32
2553636|NCT00534976|6258543|P1|STARTED|Period 3: Crossover Placebo/ Montelukast||33
2553637|NCT00534976|6258542|P2|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||1
2553638|NCT00534976|6258543|P1|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||0
2553639|NCT00534976|6258542|P2|COMPLETED|Period 2: Treatment Montelukast/ Placebo||32
2553640|NCT00534976|6258543|P1|COMPLETED|Period 2: Treatment Montelukast/ Placebo||33
2553641|NCT00534976|6258542|P2|STARTED|Period 2: Treatment Montelukast/ Placebo||33
2553642|NCT00534976|6258543|P1|STARTED|Period 2: Treatment Montelukast/ Placebo||33
2553643|NCT00534976|6258542|P2|NOT COMPLETED|Period 1: Placebo Run-in||0
2553644|NCT00534976|6258543|P1|NOT COMPLETED|Period 1: Placebo Run-in||0
2553645|NCT00534976|6258542|P2|COMPLETED|Period 1: Placebo Run-in||33
2553646|NCT00534976|6258543|P1|COMPLETED|Period 1: Placebo Run-in||33
2553647|NCT00534976|6258542|P2|STARTED|Period 1: Placebo Run-in||33
2553648|NCT00534976|6258543|P1|STARTED|Period 1: Placebo Run-in||33
2553649|NCT00534937|6258565|P2|NOT COMPLETED|Overall Study||12
2553650|NCT00534937|6258566|P1|NOT COMPLETED|Overall Study||8
2553651|NCT00534937|6258565|P2|COMPLETED|Overall Study||35
2553652|NCT00534937|6258566|P1|COMPLETED|Overall Study||34
2553653|NCT00534937|6258565|P2|STARTED|Overall Study||47
2553654|NCT00534937|6258566|P1|STARTED|Overall Study||42
2553655|NCT00534833|6258580|P2|NOT COMPLETED|Overall Study||0
2553656|NCT00534833|6258581|P1|NOT COMPLETED|Overall Study||0
2553657|NCT00534833|6258580|P2|COMPLETED|Overall Study||180
2553658|NCT00534833|6258581|P1|COMPLETED|Overall Study||182
2553659|NCT00534833|6258580|P2|STARTED|Overall Study||180
2553660|NCT00534833|6258581|P1|STARTED|Overall Study||182
2553661|NCT00534794|6258593|P2|NOT COMPLETED|Overall Study||0
2553662|NCT00534794|6258594|P1|NOT COMPLETED|Overall Study||0
2553663|NCT00534794|6258593|P2|COMPLETED|Overall Study||39
2553664|NCT00534794|6258594|P1|COMPLETED|Overall Study||40
2553665|NCT00534794|6258593|P2|STARTED|Overall Study||39
2553666|NCT00534794|6258594|P1|STARTED|Overall Study||40
2553673|NCT00534638|6258623|P2|NOT COMPLETED|Overall Study||11791
2553674|NCT00534638|6258624|P1|NOT COMPLETED|Overall Study||6491
2553675|NCT00534638|6258623|P2|COMPLETED|Overall Study||5547
2553676|NCT00534638|6258624|P1|COMPLETED|Overall Study||8346
2553677|NCT00534638|6258623|P2|STARTED|Overall Study||17338
2553678|NCT00534638|6258624|P1|STARTED|Overall Study||14837
2553679|NCT00534599|6258662|P2|NOT COMPLETED|Overall Study||32
2553680|NCT00534599|6258663|P1|NOT COMPLETED|Overall Study||57
2553681|NCT00534599|6258662|P2|COMPLETED|Overall Study||168
2553682|NCT00534599|6258663|P1|COMPLETED|Overall Study||152
2553683|NCT00534599|6258662|P2|STARTED|Overall Study|Randomized|200
2553684|NCT00534599|6258663|P1|STARTED|Overall Study|Randomized|209
2553685|NCT00534495|6258699|P3|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||11
2553686|NCT00534495|6258700|P2|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
2553687|NCT00534495|6258701|P1|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
2553688|NCT00534495|6258699|P3|COMPLETED|Long Term Ext. Phase Week 24-month 21||29
2553689|NCT00534495|6258700|P2|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
2553690|NCT00534495|6258701|P1|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
2553691|NCT00534495|6258699|P3|STARTED|Long Term Ext. Phase Week 24-month 21||40
2553692|NCT00534495|6258700|P2|STARTED|Long Term Ext. Phase Week 24-month 21||0
2553693|NCT00534495|6258701|P1|STARTED|Long Term Ext. Phase Week 24-month 21||0
2553694|NCT00534495|6258699|P3|NOT COMPLETED|All Active Treatment Phase Week 4-24||0
2553695|NCT00534495|6258700|P2|NOT COMPLETED|All Active Treatment Phase Week 4-24||9
2553696|NCT00534495|6258701|P1|NOT COMPLETED|All Active Treatment Phase Week 4-24||4
2553697|NCT00534495|6258699|P3|COMPLETED|All Active Treatment Phase Week 4-24||0
2553698|NCT00534495|6258700|P2|COMPLETED|All Active Treatment Phase Week 4-24||25
2553699|NCT00534495|6258701|P1|COMPLETED|All Active Treatment Phase Week 4-24||32
2553700|NCT00534495|6258699|P3|STARTED|All Active Treatment Phase Week 4-24||0
2553701|NCT00534495|6258700|P2|STARTED|All Active Treatment Phase Week 4-24||34
2553702|NCT00534495|6258701|P1|STARTED|All Active Treatment Phase Week 4-24||36
2553703|NCT00534495|6258699|P3|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
2553704|NCT00534495|6258700|P2|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||1
2553705|NCT00534495|6258701|P1|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
2553706|NCT00534495|6258699|P3|COMPLETED|Double Blind Placebo Phase Week 0-4||0
2553707|NCT00534495|6258700|P2|COMPLETED|Double Blind Placebo Phase Week 0-4||34
2553708|NCT00534495|6258701|P1|COMPLETED|Double Blind Placebo Phase Week 0-4||36
2553709|NCT00534495|6258699|P3|STARTED|Double Blind Placebo Phase Week 0-4||0
2553710|NCT00534495|6258700|P2|STARTED|Double Blind Placebo Phase Week 0-4||35
2553711|NCT00534495|6258701|P1|STARTED|Double Blind Placebo Phase Week 0-4||36
2553712|NCT00534417|6258724|P1|NOT COMPLETED|Overall Study||0
2553713|NCT00534417|6258724|P1|COMPLETED|Overall Study||41
2553714|NCT00534417|6258724|P1|STARTED|Overall Study||41
2553715|NCT00534404|6258739|P3|NOT COMPLETED|Overall Study||242
2553716|NCT00534404|6258740|P2|NOT COMPLETED|Overall Study||143
2553717|NCT00534404|6258741|P1|NOT COMPLETED|Overall Study||180
2553718|NCT00534404|6258739|P3|COMPLETED|Overall Study||586
2553719|NCT00534404|6258740|P2|COMPLETED|Overall Study||687
2553720|NCT00534404|6258741|P1|COMPLETED|Overall Study||647
2553721|NCT00534404|6258739|P3|3-month Follow up Completed|Overall Study||593
2553722|NCT00534404|6258740|P2|3-month Follow up Completed|Overall Study||731
2553723|NCT00534404|6258741|P1|3-month Follow up Completed|Overall Study||682
2553724|NCT00534404|6258739|P3|1-month Follow up Completed|Overall Study||626
2553725|NCT00534404|6258740|P2|1-month Follow up Completed|Overall Study||781
2553726|NCT00534404|6258741|P1|1-month Follow up Completed|Overall Study||742
2553727|NCT00534404|6258739|P3|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
2553728|NCT00534404|6258740|P2|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
2553729|NCT00534404|6258741|P1|Completed at Least 1 Counseling Call|Overall Study||813
2553730|NCT00534404|6258739|P3|Completed Second NRT Order|Overall Study|NRT not available for this arm.|0
2553731|NCT00534404|6258740|P2|Completed Second NRT Order|Overall Study||789
2553732|NCT00534404|6258741|P1|Completed Second NRT Order|Overall Study||640
2553733|NCT00534404|6258739|P3|Completed First NRT Order|Overall Study|NRT was not available for this arm|0
2553734|NCT00534404|6258740|P2|Completed First NRT Order|Overall Study|Participants could order NRT without completing a web session|821
2553735|NCT00534404|6258741|P1|Completed First NRT Order|Overall Study||765
2553736|NCT00534404|6258739|P3|Completed at Least 1 Online Session|Overall Study||658
2553737|NCT00534404|6258740|P2|Completed at Least 1 Online Session|Overall Study||813
2553738|NCT00534404|6258741|P1|Completed at Least 1 Online Session|Overall Study||781
2553739|NCT00534404|6258739|P3|STARTED|Overall Study||828
2553740|NCT00534404|6258740|P2|STARTED|Overall Study||830
2553741|NCT00534404|6258741|P1|STARTED|Overall Study||827
2553742|NCT00534365|6258757|P2|NOT COMPLETED|Overall Study||7
2553743|NCT00534365|6258758|P1|NOT COMPLETED|Overall Study||0
2553744|NCT00534365|6258757|P2|COMPLETED|Overall Study||129
2553745|NCT00534365|6258758|P1|COMPLETED|Overall Study||127
2553746|NCT00534365|6258757|P2|Included in Intent to Treat Analysis|Overall Study||136
2553747|NCT00534365|6258758|P1|Included in Intent to Treat Analysis|Overall Study||127
2553748|NCT00534365|6258757|P2|Follow up at 12 Months or More|Overall Study||128
2553749|NCT00534365|6258758|P1|Follow up at 12 Months or More|Overall Study||119
2553750|NCT00534365|6258757|P2|Any Follow up|Overall Study||135
2553751|NCT00534365|6258758|P1|Any Follow up|Overall Study||126
2553752|NCT00534365|6258757|P2|Received Procedure|Overall Study|7 patients excluded due to receipt of sling other than mini-sling|129
2553753|NCT00534365|6258758|P1|Received Procedure|Overall Study||127
2553754|NCT00534365|6258757|P2|STARTED|Overall Study||136
2553755|NCT00534365|6258758|P1|STARTED|Overall Study||127
2553756|NCT00534352|6258772|P1|NOT COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||4
2553757|NCT00534352|6258772|P1|COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||14
2553758|NCT00534352|6258772|P1|STARTED|Optional Extension: DRV/Rtv + TDF/FTC||18
2553759|NCT00534352|6258772|P1|NOT COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||1
2553760|NCT00534352|6258772|P1|COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||20
2553761|NCT00534352|6258772|P1|STARTED|Treatment C: DRV/Rtv + TDF/FTC||21
2553762|NCT00534352|6258772|P1|NOT COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||0
2553763|NCT00534352|6258772|P1|COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
2553764|NCT00534352|6258772|P1|STARTED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
2553765|NCT00534352|6258772|P1|NOT COMPLETED|Treatment A: TMC125 + TDF/FTC||2
2553766|NCT00534352|6258772|P1|COMPLETED|Treatment A: TMC125 + TDF/FTC||21
2553767|NCT00534352|6258772|P1|STARTED|Treatment A: TMC125 + TDF/FTC||23
2553768|NCT00534313|6258816|P4|NOT COMPLETED|Long-term Period||33
2553769|NCT00534313|6258817|P3|NOT COMPLETED|Long-term Period||43
2553770|NCT00534313|6258818|P2|NOT COMPLETED|Long-term Period||34
2553771|NCT00534313|6258819|P1|NOT COMPLETED|Long-term Period||37
2553772|NCT00534313|6258816|P4|COMPLETED|Long-term Period||0
2553773|NCT00534313|6258817|P3|COMPLETED|Long-term Period||0
2553774|NCT00534313|6258818|P2|COMPLETED|Long-term Period||0
2553775|NCT00534313|6258819|P1|COMPLETED|Long-term Period||0
2553776|NCT00534313|6258816|P4|STARTED|Long-term Period||33
2553777|NCT00534313|6258817|P3|STARTED|Long-term Period||43
2553778|NCT00534313|6258818|P2|STARTED|Long-term Period||34
2553779|NCT00534313|6258819|P1|STARTED|Long-term Period||37
2553780|NCT00534313|6258816|P4|NOT COMPLETED|Short-term Period||9
2553781|NCT00534313|6258817|P3|NOT COMPLETED|Short-term Period||2
2553782|NCT00534313|6258818|P2|NOT COMPLETED|Short-term Period||6
2553783|NCT00534313|6258819|P1|NOT COMPLETED|Short-term Period||6
2553784|NCT00534313|6258816|P4|COMPLETED|Short-term Period|Completed the short-term study|33
2553785|NCT00534313|6258817|P3|COMPLETED|Short-term Period|Completed the short-term study|43
2553786|NCT00534313|6258818|P2|COMPLETED|Short-term Period|Completed the short-term study|34
2553787|NCT00534313|6258819|P1|COMPLETED|Short-term Period|Completed the short-term study|37
2553788|NCT00534313|6258816|P4|STARTED|Short-term Period||42
2553789|NCT00534313|6258817|P3|STARTED|Short-term Period||45
2553790|NCT00534313|6258818|P2|STARTED|Short-term Period||40
2553791|NCT00534313|6258819|P1|STARTED|Short-term Period||43
2553792|NCT00534248|6258914|P2|NOT COMPLETED|Overall Study||673
2553793|NCT00534248|6258915|P1|NOT COMPLETED|Overall Study||661
2553794|NCT00534248|6258914|P2|COMPLETED|Overall Study||10555
2553795|NCT00534248|6258915|P1|COMPLETED|Overall Study||10550
2553796|NCT00534248|6258914|P2|VACCINATED|Overall Study||11210
2553797|NCT00534248|6258915|P1|VACCINATED|Overall Study||11186
2553798|NCT00534248|6258914|P2|STARTED|Overall Study||11228
2553799|NCT00534248|6258915|P1|STARTED|Overall Study||11211
2553800|NCT00534235|6258927|P2|NOT COMPLETED|Overall Study||23
2553801|NCT00534235|6258928|P1|NOT COMPLETED|Overall Study||16
2553802|NCT00534235|6258927|P2|COMPLETED|Overall Study||192
2553803|NCT00534235|6258928|P1|COMPLETED|Overall Study||91
2553804|NCT00534235|6258927|P2|STARTED|Overall Study||215
2553805|NCT00534235|6258928|P1|STARTED|Overall Study||107
2553806|NCT00534209|6259052|P1|NOT COMPLETED|Overall Study||0
2553807|NCT00534209|6259052|P1|COMPLETED|Overall Study||1
2553808|NCT00534209|6259052|P1|STARTED|Overall Study||1
2553809|NCT00534105|6259072|P2|NOT COMPLETED|Overall Study||39
2553810|NCT00534105|6259073|P1|NOT COMPLETED|Overall Study||23
2553811|NCT00534105|6259072|P2|COMPLETED|Overall Study||20
2553812|NCT00534105|6259073|P1|COMPLETED|Overall Study||24
2553813|NCT00534105|6259072|P2|STARTED|Overall Study||59
2553814|NCT00534105|6259073|P1|STARTED|Overall Study||47
2553815|NCT00534092|6259087|P2|NOT COMPLETED|Overall Study||0
2553816|NCT00534092|6259088|P1|NOT COMPLETED|Overall Study||2
2553817|NCT00534092|6259087|P2|COMPLETED|Overall Study||14
2553818|NCT00534092|6259088|P1|COMPLETED|Overall Study||53
2553819|NCT00534092|6259087|P2|STARTED|Overall Study||14
2553820|NCT00534092|6259088|P1|STARTED|Overall Study||55
2553821|NCT00534001|6259113|P2|NOT COMPLETED|Overall Study||4
2553822|NCT00534001|6259114|P1|NOT COMPLETED|Overall Study||5
2553823|NCT00534001|6259113|P2|COMPLETED|Overall Study||43
2553824|NCT00534001|6259114|P1|COMPLETED|Overall Study||43
2553825|NCT00534001|6259113|P2|STARTED|Overall Study||47
2553826|NCT00534001|6259114|P1|STARTED|Overall Study||48
2553827|NCT00533949|6259126|P4|NOT COMPLETED|Overall Study||10
2553828|NCT00533949|6259127|P3|NOT COMPLETED|Overall Study||10
2553829|NCT00533949|6259128|P2|NOT COMPLETED|Overall Study||14
2553830|NCT00533949|6259129|P1|NOT COMPLETED|Overall Study||15
2553831|NCT00533949|6259126|P4|COMPLETED|Overall Study||100
2553832|NCT00533949|6259127|P3|COMPLETED|Overall Study||137
2553833|NCT00533949|6259128|P2|COMPLETED|Overall Study||107
2553834|NCT00533949|6259129|P1|COMPLETED|Overall Study||151
2553835|NCT00533949|6259126|P4|STARTED|Overall Study||110
2553836|NCT00533949|6259127|P3|STARTED|Overall Study||147
2553837|NCT00533949|6259128|P2|STARTED|Overall Study||121
2553838|NCT00533949|6259129|P1|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|166
2553839|NCT00533897|6259170|P8|NOT COMPLETED|Long Term Extension (LTE)||25
2553840|NCT00533897|6259171|P7|NOT COMPLETED|Long Term Extension (LTE)||13
2553841|NCT00533897|6259172|P6|NOT COMPLETED|Long Term Extension (LTE)||0
2553842|NCT00533897|6259173|P5|NOT COMPLETED|Long Term Extension (LTE)||0
2553843|NCT00533897|6259174|P4|NOT COMPLETED|Long Term Extension (LTE)||0
2553844|NCT00533897|6259175|P3|NOT COMPLETED|Long Term Extension (LTE)||0
2553845|NCT00533897|6259176|P2|NOT COMPLETED|Long Term Extension (LTE)||0
2553846|NCT00533897|6259177|P1|NOT COMPLETED|Long Term Extension (LTE)||0
2553847|NCT00533897|6259170|P8|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|88
2553848|NCT00533897|6259171|P7|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|24
2553849|NCT00533897|6259172|P6|COMPLETED|Long Term Extension (LTE)||0
2553850|NCT00533897|6259173|P5|COMPLETED|Long Term Extension (LTE)||0
2553851|NCT00533897|6259174|P4|COMPLETED|Long Term Extension (LTE)||0
2553852|NCT00533897|6259175|P3|COMPLETED|Long Term Extension (LTE)||0
2553853|NCT00533897|6259176|P2|COMPLETED|Long Term Extension (LTE)||0
2553854|NCT00533897|6259177|P1|COMPLETED|Long Term Extension (LTE)||0
2553855|NCT00533897|6259170|P8|STARTED|Long Term Extension (LTE)|117 completed RI but 4 did not enter LTE: 1 lack of efficacy and 3 had their site closed.|113
2553856|NCT00533897|6259171|P7|STARTED|Long Term Extension (LTE)|37 non-responders in Lead-In entered the LTE directly and didn't participate in DBW or RI Periods.|37
2553857|NCT00533897|6259172|P6|STARTED|Long Term Extension (LTE)||0
2553858|NCT00533897|6259173|P5|STARTED|Long Term Extension (LTE)||0
2553859|NCT00533897|6259174|P4|STARTED|Long Term Extension (LTE)||0
2553860|NCT00533897|6259175|P3|STARTED|Long Term Extension (LTE)||0
2553861|NCT00533897|6259176|P2|STARTED|Long Term Extension (LTE)||0
2553862|NCT00533897|6259177|P1|STARTED|Long Term Extension (LTE)||0
2553863|NCT00533897|6259170|P8|NOT COMPLETED|Re-introduction (RI) Period 3||0
2553864|NCT00533897|6259171|P7|NOT COMPLETED|Re-introduction (RI) Period 3||0
2553865|NCT00533897|6259172|P6|NOT COMPLETED|Re-introduction (RI) Period 3||2
2553866|NCT00533897|6259173|P5|NOT COMPLETED|Re-introduction (RI) Period 3||0
2553867|NCT00533897|6259174|P4|NOT COMPLETED|Re-introduction (RI) Period 3||0
2553868|NCT00533897|6259175|P3|NOT COMPLETED|Re-introduction (RI) Period 3||0
2553869|NCT00533897|6259176|P2|NOT COMPLETED|Re-introduction (RI) Period 3||0
2553870|NCT00533897|6259177|P1|NOT COMPLETED|Re-introduction (RI) Period 3||0
2553871|NCT00533897|6259170|P8|COMPLETED|Re-introduction (RI) Period 3||0
2553872|NCT00533897|6259171|P7|COMPLETED|Re-introduction (RI) Period 3||0
2553873|NCT00533897|6259172|P6|COMPLETED|Re-introduction (RI) Period 3||42
2553874|NCT00533897|6259173|P5|COMPLETED|Re-introduction (RI) Period 3||35
2553875|NCT00533897|6259174|P4|COMPLETED|Re-introduction (RI) Period 3||40
2553876|NCT00533897|6259175|P3|COMPLETED|Re-introduction (RI) Period 3||0
2553877|NCT00533897|6259176|P2|COMPLETED|Re-introduction (RI) Period 3||0
2553878|NCT00533897|6259177|P1|COMPLETED|Re-introduction (RI) Period 3||0
2553879|NCT00533897|6259170|P8|STARTED|Re-introduction (RI) Period 3||0
2553880|NCT00533897|6259171|P7|STARTED|Re-introduction (RI) Period 3||0
2553881|NCT00533897|6259172|P6|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|44
2553882|NCT00533897|6259173|P5|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|35
2553883|NCT00533897|6259174|P4|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|40
2553884|NCT00533897|6259175|P3|STARTED|Re-introduction (RI) Period 3||0
2553885|NCT00533897|6259176|P2|STARTED|Re-introduction (RI) Period 3||0
2553886|NCT00533897|6259177|P1|STARTED|Re-introduction (RI) Period 3||0
2553887|NCT00533897|6259170|P8|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
2553888|NCT00533897|6259171|P7|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
2553889|NCT00533897|6259172|P6|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
2553890|NCT00533897|6259173|P5|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
2553891|NCT00533897|6259174|P4|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
2553892|NCT00533897|6259175|P3|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||3
2553893|NCT00533897|6259176|P2|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||1
2553894|NCT00533897|6259177|P1|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
2553895|NCT00533897|6259170|P8|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
2553896|NCT00533897|6259171|P7|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
2553897|NCT00533897|6259172|P6|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
2553898|NCT00533897|6259173|P5|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
2553899|NCT00533897|6259174|P4|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
2553900|NCT00533897|6259175|P3|COMPLETED|Double-blind Withdrawal (DBW) Period 2|Two participants discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|77
2553901|NCT00533897|6259176|P2|COMPLETED|Double-blind Withdrawal (DBW) Period 2|One participant discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|39
2553902|NCT00533897|6259177|P1|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
2553903|NCT00533897|6259170|P8|STARTED|Double-blind Withdrawal (DBW) Period 2||0
2553904|NCT00533897|6259171|P7|STARTED|Double-blind Withdrawal (DBW) Period 2||0
2553905|NCT00533897|6259172|P6|STARTED|Double-blind Withdrawal (DBW) Period 2||0
2553906|NCT00533897|6259173|P5|STARTED|Double-blind Withdrawal (DBW) Period 2||0
2553907|NCT00533897|6259174|P4|STARTED|Double-blind Withdrawal (DBW) Period 2||0
2553908|NCT00533897|6259175|P3|STARTED|Double-blind Withdrawal (DBW) Period 2||80
2553909|NCT00533897|6259176|P2|STARTED|Double-blind Withdrawal (DBW) Period 2||40
2553910|NCT00533897|6259177|P1|STARTED|Double-blind Withdrawal (DBW) Period 2||0
2553911|NCT00533897|6259170|P8|NOT COMPLETED|Lead-in (LI) Period 1||0
2553912|NCT00533897|6259171|P7|NOT COMPLETED|Lead-in (LI) Period 1||0
2553913|NCT00533897|6259172|P6|NOT COMPLETED|Lead-in (LI) Period 1||0
2553914|NCT00533897|6259173|P5|NOT COMPLETED|Lead-in (LI) Period 1||0
2553915|NCT00533897|6259174|P4|NOT COMPLETED|Lead-in (LI) Period 1||0
2553916|NCT00533897|6259175|P3|NOT COMPLETED|Lead-in (LI) Period 1||0
2553917|NCT00533897|6259176|P2|NOT COMPLETED|Lead-in (LI) Period 1||0
2553918|NCT00533897|6259177|P1|NOT COMPLETED|Lead-in (LI) Period 1||10
2553919|NCT00533897|6259170|P8|COMPLETED|Lead-in (LI) Period 1||0
2553920|NCT00533897|6259171|P7|COMPLETED|Lead-in (LI) Period 1||0
2553921|NCT00533897|6259172|P6|COMPLETED|Lead-in (LI) Period 1||0
2553922|NCT00533897|6259173|P5|COMPLETED|Lead-in (LI) Period 1||0
2553923|NCT00533897|6259174|P4|COMPLETED|Lead-in (LI) Period 1||0
2553924|NCT00533897|6259175|P3|COMPLETED|Lead-in (LI) Period 1||0
2553925|NCT00533897|6259176|P2|COMPLETED|Lead-in (LI) Period 1||0
2553926|NCT00533897|6259177|P1|COMPLETED|Lead-in (LI) Period 1|37 participants entered the LTE directly and did not enter the DBW Period nor receive DBW treatment.|157
2553927|NCT00533897|6259170|P8|STARTED|Lead-in (LI) Period 1||0
2553928|NCT00533897|6259171|P7|STARTED|Lead-in (LI) Period 1||0
2553929|NCT00533897|6259172|P6|STARTED|Lead-in (LI) Period 1||0
2553930|NCT00533897|6259173|P5|STARTED|Lead-in (LI) Period 1||0
2553931|NCT00533897|6259174|P4|STARTED|Lead-in (LI) Period 1||0
2553932|NCT00533897|6259175|P3|STARTED|Lead-in (LI) Period 1||0
2553933|NCT00533897|6259176|P2|STARTED|Lead-in (LI) Period 1||0
2553934|NCT00533897|6259177|P1|STARTED|Lead-in (LI) Period 1||167
2553935|NCT00533845|6259317|P2|NOT COMPLETED|Overall Study||0
2553936|NCT00533845|6259318|P1|NOT COMPLETED|Overall Study||1
2553937|NCT00533845|6259317|P2|COMPLETED|Overall Study||15
2553938|NCT00533845|6259318|P1|COMPLETED|Overall Study||14
2553939|NCT00533845|6259317|P2|STARTED|Overall Study||15
2553940|NCT00533845|6259318|P1|STARTED|Overall Study||15
2553941|NCT00533702|6259326|P2|NOT COMPLETED|Overall Study||2
2553942|NCT00533702|6259327|P1|NOT COMPLETED|Overall Study||5
2553943|NCT00533702|6259326|P2|COMPLETED|Overall Study||50
2553944|NCT00533702|6259327|P1|COMPLETED|Overall Study||49
2553945|NCT00533702|6259326|P2|Received Any Quantity of Study Drug|Overall Study||50
2553946|NCT00533702|6259327|P1|Received Any Quantity of Study Drug|Overall Study||52
2553947|NCT00533702|6259326|P2|STARTED|Overall Study||52
2553948|NCT00533702|6259327|P1|STARTED|Overall Study||54
2553949|NCT00533546|6259351|P1|NOT COMPLETED|Overall Study||0
2553950|NCT00533546|6259351|P1|COMPLETED|Overall Study||12
2553951|NCT00533546|6259351|P1|STARTED|Overall Study||12
2553952|NCT00533507|6259358|P1|NOT COMPLETED|Overall Study||1
2553953|NCT00533507|6259358|P1|COMPLETED|Overall Study||229
2553954|NCT00533507|6259358|P1|STARTED|Overall Study||230
2553955|NCT00533442|6259379|P2|NOT COMPLETED|Follow-up||10
2553956|NCT00533442|6259380|P1|NOT COMPLETED|Follow-up||9
2553957|NCT00533442|6259379|P2|COMPLETED|Follow-up||74
2553958|NCT00533442|6259380|P1|COMPLETED|Follow-up||77
2553959|NCT00533442|6259379|P2|STARTED|Follow-up|Ongoing Follow-up at 17-124 months (N=74); Lost to Follow-up (N=10, at 5-67 months).|84
2553960|NCT00533442|6259380|P1|STARTED|Follow-up|Ongoing Follow-up at 13-123 months (N=77); Lost to Follow-up (N=9, at 5-100 months).|86
2553961|NCT00533442|6259379|P2|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
2553962|NCT00533442|6259380|P1|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
2553963|NCT00533442|6259379|P2|COMPLETED|Allocation and Intent to Treat Analysis||84
2553964|NCT00533442|6259380|P1|COMPLETED|Allocation and Intent to Treat Analysis||86
2553965|NCT00533442|6259379|P2|STARTED|Allocation and Intent to Treat Analysis||84
2553966|NCT00533442|6259380|P1|STARTED|Allocation and Intent to Treat Analysis||86
2553967|NCT00533351|6259392|P2|NOT COMPLETED|Period 3||0
2553968|NCT00533351|6259393|P1|NOT COMPLETED|Period 3||0
2553969|NCT00533351|6259392|P2|COMPLETED|Period 3||0
2553970|NCT00533351|6259393|P1|COMPLETED|Period 3||3
2553971|NCT00533351|6259392|P2|STARTED|Period 3|No patients continued to Period 3|0
2553972|NCT00533351|6259393|P1|STARTED|Period 3|Three out of the five patients who completed Period 2 continued to Period 3|3
2553973|NCT00533351|6259392|P2|NOT COMPLETED|Period 2||0
2553974|NCT00533351|6259393|P1|NOT COMPLETED|Period 2||0
2553975|NCT00533351|6259392|P2|COMPLETED|Period 2||1
2553976|NCT00533351|6259393|P1|COMPLETED|Period 2||5
2553977|NCT00533351|6259392|P2|STARTED|Period 2||1
2553978|NCT00533351|6259393|P1|STARTED|Period 2||5
2553979|NCT00533351|6259392|P2|NOT COMPLETED|Period 1||1
2553980|NCT00533351|6259393|P1|NOT COMPLETED|Period 1||2
2553981|NCT00533351|6259392|P2|COMPLETED|Period 1||1
2553982|NCT00533351|6259393|P1|COMPLETED|Period 1||5
2553983|NCT00533351|6259392|P2|STARTED|Period 1||2
2553984|NCT00533351|6259393|P1|STARTED|Period 1||7
2553985|NCT00533273|6259403|P2|NOT COMPLETED|Open-label||0
2553986|NCT00533273|6259404|P1|NOT COMPLETED|Open-label||6
2553987|NCT00533273|6259403|P2|COMPLETED|Open-label||0
2553988|NCT00533273|6259404|P1|COMPLETED|Open-label||58
2553989|NCT00533273|6259403|P2|STARTED|Open-label|no placebo - this phase was open label|0
2553990|NCT00533273|6259404|P1|STARTED|Open-label|open-label was extension of double-blind; 64 of 66 patients continued into open-label|64
2553991|NCT00533273|6259403|P2|NOT COMPLETED|Double-blind||2
2553992|NCT00533273|6259404|P1|NOT COMPLETED|Double-blind||0
2553993|NCT00533273|6259403|P2|COMPLETED|Double-blind||19
2553994|NCT00533273|6259404|P1|COMPLETED|Double-blind||45
2553995|NCT00533273|6259403|P2|STARTED|Double-blind||21
2553996|NCT00533273|6259404|P1|STARTED|Double-blind||45
2553997|NCT00533117|6259439|P4|NOT COMPLETED|Overall Study||5
2553998|NCT00533117|6259440|P3|NOT COMPLETED|Overall Study||6
2553999|NCT00533117|6259441|P2|NOT COMPLETED|Overall Study||5
2554000|NCT00533117|6259442|P1|NOT COMPLETED|Overall Study||4
2554001|NCT00533117|6259439|P4|COMPLETED|Overall Study||13
2554002|NCT00533117|6259440|P3|COMPLETED|Overall Study||14
2554003|NCT00533117|6259441|P2|COMPLETED|Overall Study||14
2554004|NCT00533117|6259442|P1|COMPLETED|Overall Study||14
2554005|NCT00533117|6259439|P4|STARTED|Overall Study||18
2554006|NCT00533117|6259440|P3|STARTED|Overall Study||20
2554007|NCT00533117|6259441|P2|STARTED|Overall Study||19
2554008|NCT00533117|6259442|P1|STARTED|Overall Study||18
2554009|NCT00532948|6259455|P3|NOT COMPLETED|Overall Study||4
2554010|NCT00532948|6259456|P2|NOT COMPLETED|Overall Study||5
2554011|NCT00532948|6259457|P1|NOT COMPLETED|Overall Study||4
2554012|NCT00532948|6259455|P3|COMPLETED|Overall Study||2
2554013|NCT00532948|6259456|P2|COMPLETED|Overall Study||9
2554014|NCT00532948|6259457|P1|COMPLETED|Overall Study||0
2554015|NCT00532948|6259455|P3|STARTED|Overall Study||6
2554016|NCT00532948|6259456|P2|STARTED|Overall Study||14
2554017|NCT00532948|6259457|P1|STARTED|Overall Study||4
2554018|NCT00532935|6259489|P2|NOT COMPLETED|Overall Study||52
2554019|NCT00532935|6259490|P1|NOT COMPLETED|Overall Study||51
2554020|NCT00532935|6259489|P2|COMPLETED|Overall Study||204
2554021|NCT00532935|6259490|P1|COMPLETED|Overall Study||210
2554022|NCT00532935|6259489|P2|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|256
2554023|NCT00532935|6259490|P1|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|261
2554024|NCT00532883|6259508|P4|NOT COMPLETED|Overall Study||5
2554025|NCT00532883|6259509|P3|NOT COMPLETED|Overall Study||4
2554026|NCT00532883|6259510|P2|NOT COMPLETED|Overall Study||7
2554027|NCT00532883|6259511|P1|NOT COMPLETED|Overall Study||6
2554028|NCT00532883|6259508|P4|COMPLETED|Overall Study|Study terminated early.|6
2554029|NCT00532883|6259509|P3|COMPLETED|Overall Study|Study terminated early.|6
2554030|NCT00532883|6259510|P2|COMPLETED|Overall Study|Study terminated early.|5
2554031|NCT00532883|6259511|P1|COMPLETED|Overall Study|Study terminated early.|5
2554032|NCT00532883|6259508|P4|STARTED|Overall Study||11
2554033|NCT00532883|6259509|P3|STARTED|Overall Study||10
2554034|NCT00532883|6259510|P2|STARTED|Overall Study||12
2554035|NCT00532883|6259511|P1|STARTED|Overall Study||11
2554036|NCT00532779|6259524|P3|NOT COMPLETED|Overall Study||291
2554037|NCT00532779|6259525|P2|NOT COMPLETED|Overall Study||287
2554038|NCT00532779|6259526|P1|NOT COMPLETED|Overall Study||294
2554039|NCT00532779|6259524|P3|COMPLETED|Overall Study||290
2554040|NCT00532779|6259525|P2|COMPLETED|Overall Study||296
2554041|NCT00532779|6259526|P1|COMPLETED|Overall Study||284
2554042|NCT00532779|6259524|P3|STARTED|Overall Study||581
2554043|NCT00532779|6259525|P2|STARTED|Overall Study||583
2554044|NCT00532779|6259526|P1|STARTED|Overall Study||578
2554045|NCT00532493|6259587|P2|NOT COMPLETED|Overall Study||29
2554046|NCT00532493|6259588|P1|NOT COMPLETED|Overall Study||30
2554047|NCT00532493|6259587|P2|COMPLETED|Overall Study||123
2554048|NCT00532493|6259588|P1|COMPLETED|Overall Study||122
2554049|NCT00532493|6259587|P2|STARTED|Overall Study||152
2554050|NCT00532493|6259588|P1|STARTED|Overall Study||152
2554051|NCT00532480|6259618|P1|NOT COMPLETED|Overall Study||3
2554052|NCT00532480|6259618|P1|COMPLETED|Overall Study||7
2554053|NCT00532480|6259618|P1|STARTED|Overall Study||10
2554054|NCT00532441|6259622|P2|NOT COMPLETED|Overall Study||0
2554055|NCT00532441|6259623|P1|NOT COMPLETED|Overall Study||1
2554056|NCT00532441|6259622|P2|COMPLETED|Overall Study||11
2554057|NCT00532441|6259623|P1|COMPLETED|Overall Study||13
2554058|NCT00532441|6259622|P2|STARTED|Overall Study||11
2554059|NCT00532441|6259623|P1|STARTED|Overall Study||14
2554060|NCT00532298|6259638|P6|NOT COMPLETED|Overall Study||2
2554061|NCT00532298|6259639|P5|NOT COMPLETED|Overall Study||1
2554062|NCT00532298|6259640|P4|NOT COMPLETED|Overall Study||0
2554063|NCT00532298|6259641|P3|NOT COMPLETED|Overall Study||1
2554064|NCT00532298|6259642|P2|NOT COMPLETED|Overall Study||1
2554065|NCT00532298|6259643|P1|NOT COMPLETED|Overall Study||2
2554066|NCT00532298|6259638|P6|COMPLETED|Overall Study||261
2554067|NCT00532298|6259639|P5|COMPLETED|Overall Study||267
2554068|NCT00532298|6259640|P4|COMPLETED|Overall Study||264
2554069|NCT00532298|6259641|P3|COMPLETED|Overall Study||263
2554070|NCT00532298|6259642|P2|COMPLETED|Overall Study||265
2554071|NCT00532298|6259643|P1|COMPLETED|Overall Study||267
2554072|NCT00532298|6259638|P6|STARTED|Overall Study||263
2554073|NCT00532298|6259639|P5|STARTED|Overall Study||268
2554074|NCT00532298|6259640|P4|STARTED|Overall Study||264
2554075|NCT00532298|6259641|P3|STARTED|Overall Study||264
2554076|NCT00532298|6259642|P2|STARTED|Overall Study||266
2554077|NCT00532298|6259643|P1|STARTED|Overall Study||269
2554078|NCT00532259|6259723|P1|NOT COMPLETED|Overall Study||32
2554079|NCT00532259|6259723|P1|COMPLETED|Overall Study||40
2554080|NCT00532259|6259723|P1|STARTED|Overall Study||72
2554081|NCT00532155|6259730|P2|NOT COMPLETED|Overall Study||456
2554082|NCT00532155|6259731|P1|NOT COMPLETED|Overall Study||457
2554083|NCT00532155|6259730|P2|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
2554084|NCT00532155|6259731|P1|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
2554085|NCT00532155|6259730|P2|SAFETY POPULATION|Overall Study||450
2554086|NCT00532155|6259731|P1|SAFETY POPULATION|Overall Study||455
2554087|NCT00532155|6259730|P2|STARTED|Overall Study||456
2554088|NCT00532155|6259731|P1|STARTED|Overall Study||457
2554089|NCT00532129|6259745|P1|NOT COMPLETED|Follow-up Period||65
2554090|NCT00532129|6259745|P1|COMPLETED|Follow-up Period||33
2554091|NCT00532129|6259745|P1|STARTED|Follow-up Period||98
2554092|NCT00532129|6259745|P1|NOT COMPLETED|Treatment Period||49
2554093|NCT00532129|6259745|P1|COMPLETED|Treatment Period||51
2554094|NCT00532129|6259745|P1|STARTED|Treatment Period||100
2554095|NCT00531960|6259765|P2|NOT COMPLETED|Overall Study||63
2554096|NCT00531960|6259766|P1|NOT COMPLETED|Overall Study||61
2554097|NCT00531960|6259765|P2|COMPLETED|Overall Study||0
2554098|NCT00531960|6259766|P1|COMPLETED|Overall Study||0
2554099|NCT00531960|6259765|P2|STARTED|Overall Study||63
2554100|NCT00531960|6259766|P1|STARTED|Overall Study||61
2554101|NCT00531947|6259784|P2|NOT COMPLETED|Overall Study||51
2554102|NCT00531947|6259785|P1|NOT COMPLETED|Overall Study||42
2554103|NCT00531947|6259784|P2|COMPLETED|Overall Study||101
2554104|NCT00531947|6259785|P1|COMPLETED|Overall Study||114
2554105|NCT00531947|6259784|P2|STARTED|Overall Study|all randomized subjects who received at least one dose of EMSAM study medication|152
2554106|NCT00531947|6259785|P1|STARTED|Overall Study|all randomized subjects who received at least one dose of placebo study medication|156
2554107|NCT00531934|6259829|P2|NOT COMPLETED|Overall Study||63
2554108|NCT00531934|6259830|P1|NOT COMPLETED|Overall Study||66
2554109|NCT00531934|6259829|P2|COMPLETED|Overall Study||11
2554110|NCT00531934|6259830|P1|COMPLETED|Overall Study||7
2554111|NCT00531934|6259829|P2|STARTED|Overall Study||74
2554112|NCT00531934|6259830|P1|STARTED|Overall Study||73
2554113|NCT00531882|6259901|P3|NOT COMPLETED|Overall Study||0
2554114|NCT00531882|6259902|P2|NOT COMPLETED|Overall Study||0
2554115|NCT00531882|6259903|P1|NOT COMPLETED|Overall Study||0
2554116|NCT00531882|6259901|P3|COMPLETED|Overall Study||5
2554117|NCT00531882|6259902|P2|COMPLETED|Overall Study||10
2554118|NCT00531882|6259903|P1|COMPLETED|Overall Study||10
2554119|NCT00531882|6259901|P3|STARTED|Overall Study||5
2554120|NCT00531882|6259902|P2|STARTED|Overall Study||10
2554121|NCT00531882|6259903|P1|STARTED|Overall Study||10
2554122|NCT00531843|6259913|P2|NOT COMPLETED|Overall Study||0
2554123|NCT00531843|6259914|P1|NOT COMPLETED|Overall Study||0
2554124|NCT00531843|6259913|P2|COMPLETED|Overall Study||6
2554125|NCT00531843|6259914|P1|COMPLETED|Overall Study||81
2554126|NCT00531843|6259913|P2|STARTED|Overall Study||6
2554127|NCT00531843|6259914|P1|STARTED|Overall Study||81
2554128|NCT00531817|6259926|P2|NOT COMPLETED|Entered Extended Treatment Period||57
2554129|NCT00531817|6259927|P1|NOT COMPLETED|Entered Extended Treatment Period||137
2554130|NCT00531817|6259926|P2|COMPLETED|Entered Extended Treatment Period||113
2554131|NCT00531817|6259927|P1|COMPLETED|Entered Extended Treatment Period||206
2554132|NCT00531817|6259926|P2|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator’s discretion.|170
2554133|NCT00531817|6259927|P1|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator’s discretion.|343
2554134|NCT00531817|6259926|P2|NOT COMPLETED|Randomized||34
2554135|NCT00531817|6259927|P1|NOT COMPLETED|Randomized||59
2554136|NCT00531817|6259926|P2|COMPLETED|Randomized||173
2554137|NCT00531817|6259927|P1|COMPLETED|Randomized||353
2554138|NCT00531817|6259926|P2|Received Study Drug in Core Study|Randomized|2 patients did not receive any study medication. Intent-to-treat population = 205.|205
2554139|NCT00531817|6259927|P1|Received Study Drug in Core Study|Randomized|3 patients did not receive any study medication. Intent-to-treat population = 409.|409
2554140|NCT00531817|6259926|P2|STARTED|Randomized||207
2554141|NCT00531817|6259927|P1|STARTED|Randomized||412
2554142|NCT00531752|6259958|P4|NOT COMPLETED|Second Double-blind Intervention Period||2
2554143|NCT00531752|6259959|P3|NOT COMPLETED|Second Double-blind Intervention Period||0
2554144|NCT00531752|6259960|P2|NOT COMPLETED|Second Double-blind Intervention Period||2
2554145|NCT00531752|6259961|P1|NOT COMPLETED|Second Double-blind Intervention Period||2
2554146|NCT00531752|6259958|P4|COMPLETED|Second Double-blind Intervention Period||11
2554147|NCT00531752|6259959|P3|COMPLETED|Second Double-blind Intervention Period||9
2554148|NCT00531752|6259960|P2|COMPLETED|Second Double-blind Intervention Period||11
2554149|NCT00531752|6259961|P1|COMPLETED|Second Double-blind Intervention Period||9
2554150|NCT00531752|6259958|P4|STARTED|Second Double-blind Intervention Period||13
2554151|NCT00531752|6259959|P3|STARTED|Second Double-blind Intervention Period||9
2554152|NCT00531752|6259960|P2|STARTED|Second Double-blind Intervention Period||13
2554153|NCT00531752|6259961|P1|STARTED|Second Double-blind Intervention Period||11
2554154|NCT00531752|6259958|P4|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
2554155|NCT00531752|6259959|P3|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
2554156|NCT00531752|6259960|P2|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
2554157|NCT00531752|6259961|P1|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
2554158|NCT00531752|6259958|P4|COMPLETED|Wash-out Period (at Least 7 Days)||13
2554159|NCT00531752|6259959|P3|COMPLETED|Wash-out Period (at Least 7 Days)||9
2554160|NCT00531752|6259960|P2|COMPLETED|Wash-out Period (at Least 7 Days)||13
2554161|NCT00531752|6259961|P1|COMPLETED|Wash-out Period (at Least 7 Days)||11
2554162|NCT00531752|6259958|P4|STARTED|Wash-out Period (at Least 7 Days)||13
2554163|NCT00531752|6259959|P3|STARTED|Wash-out Period (at Least 7 Days)||9
2554164|NCT00531752|6259960|P2|STARTED|Wash-out Period (at Least 7 Days)||13
2554165|NCT00531752|6259961|P1|STARTED|Wash-out Period (at Least 7 Days)||11
2554166|NCT00531752|6259958|P4|NOT COMPLETED|First Double-blind Intervention Period||3
2554167|NCT00531752|6259959|P3|NOT COMPLETED|First Double-blind Intervention Period||7
2554168|NCT00531752|6259960|P2|NOT COMPLETED|First Double-blind Intervention Period||4
2554169|NCT00531752|6259961|P1|NOT COMPLETED|First Double-blind Intervention Period||6
2554170|NCT00531752|6259958|P4|COMPLETED|First Double-blind Intervention Period||13
2554171|NCT00531752|6259959|P3|COMPLETED|First Double-blind Intervention Period||9
2554172|NCT00531752|6259960|P2|COMPLETED|First Double-blind Intervention Period||13
2554173|NCT00531752|6259961|P1|COMPLETED|First Double-blind Intervention Period||11
2554174|NCT00531752|6259958|P4|Treated|First Double-blind Intervention Period||16
2554175|NCT00531752|6259959|P3|Treated|First Double-blind Intervention Period||16
2554176|NCT00531752|6259960|P2|Treated|First Double-blind Intervention Period||17
2554177|NCT00531752|6259961|P1|Treated|First Double-blind Intervention Period||16
2554178|NCT00531752|6259958|P4|STARTED|First Double-blind Intervention Period||16
2554179|NCT00531752|6259959|P3|STARTED|First Double-blind Intervention Period||16
2554180|NCT00531752|6259960|P2|STARTED|First Double-blind Intervention Period||17
2554181|NCT00531752|6259961|P1|STARTED|First Double-blind Intervention Period||17
2554182|NCT00531661|6260040|P2|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||57
2554183|NCT00531661|6260041|P1|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||58
2554184|NCT00531661|6260040|P2|COMPLETED|Study Duration: 15 Months Avg. Follow-up||197
2554185|NCT00531661|6260041|P1|COMPLETED|Study Duration: 15 Months Avg. Follow-up||186
2554186|NCT00531661|6260040|P2|STARTED|Study Duration: 15 Months Avg. Follow-up||254
2554187|NCT00531661|6260041|P1|STARTED|Study Duration: 15 Months Avg. Follow-up||244
2554188|NCT00531661|6260040|P2|NOT COMPLETED|6 Months||26
2554189|NCT00531661|6260041|P1|NOT COMPLETED|6 Months||26
2554190|NCT00531661|6260040|P2|COMPLETED|6 Months||254
2554191|NCT00531661|6260041|P1|COMPLETED|6 Months||244
2554192|NCT00531661|6260040|P2|STARTED|6 Months||280
2554193|NCT00531661|6260041|P1|STARTED|6 Months||270
2554194|NCT00531518|6260063|P2|NOT COMPLETED|Overall Study||71
2554195|NCT00531518|6260064|P1|NOT COMPLETED|Overall Study||32
2554196|NCT00531518|6260063|P2|COMPLETED|Overall Study||134
2554197|NCT00531518|6260064|P1|COMPLETED|Overall Study||55
2554198|NCT00531518|6260063|P2|STARTED|Overall Study||205
2554199|NCT00531518|6260064|P1|STARTED|Overall Study||87
2554200|NCT00531479|6260072|P2|NOT COMPLETED|Overall Study||83
2554201|NCT00531479|6260073|P1|NOT COMPLETED|Overall Study||76
2554202|NCT00531479|6260072|P2|COMPLETED|Overall Study||146
2554203|NCT00531479|6260073|P1|COMPLETED|Overall Study||154
2554204|NCT00531479|6260072|P2|Treated|Overall Study||226
2554205|NCT00531479|6260073|P1|Treated|Overall Study||228
2554206|NCT00531479|6260072|P2|STARTED|Overall Study||229
2554207|NCT00531479|6260073|P1|STARTED|Overall Study||230
2554208|NCT00531453|6260093|P2|NOT COMPLETED|Overall Study||0
2554209|NCT00531453|6260094|P1|NOT COMPLETED|Overall Study||0
2554210|NCT00531453|6260093|P2|COMPLETED|Overall Study|10 April 2009|49
2554211|NCT00531453|6260094|P1|COMPLETED|Overall Study|10 April 2009|49
2554212|NCT00531453|6260093|P2|STARTED|Overall Study|02 October 2007|49
2554213|NCT00531453|6260094|P1|STARTED|Overall Study|02 October 2007|49
2554214|NCT00531427|6260104|P2|NOT COMPLETED|Overall Study||94
2554215|NCT00531427|6260105|P1|NOT COMPLETED|Overall Study||73
2554216|NCT00531427|6260104|P2|COMPLETED|Overall Study||191
2554217|NCT00531427|6260105|P1|COMPLETED|Overall Study||209
2554218|NCT00531427|6260104|P2|STARTED|Overall Study||285
2554219|NCT00531427|6260105|P1|STARTED|Overall Study||282
2554220|NCT00531284|6260133|P17|NOT COMPLETED|Overall Study||8
2554221|NCT00531284|6260134|P16|NOT COMPLETED|Overall Study||12
2554222|NCT00531284|6260135|P15|NOT COMPLETED|Overall Study||4
2554223|NCT00531284|6260136|P14|NOT COMPLETED|Overall Study||3
2554224|NCT00531284|6260137|P13|NOT COMPLETED|Overall Study||2
2554225|NCT00531284|6260138|P12|NOT COMPLETED|Overall Study||24
2554226|NCT00531284|6260139|P11|NOT COMPLETED|Overall Study||3
2554227|NCT00531284|6260140|P10|NOT COMPLETED|Overall Study||4
2554228|NCT00531284|6260141|P9|NOT COMPLETED|Overall Study||11
2554229|NCT00531284|6260142|P8|NOT COMPLETED|Overall Study||10
2554230|NCT00531284|6260143|P7|NOT COMPLETED|Overall Study||6
2554231|NCT00531284|6260144|P6|NOT COMPLETED|Overall Study||7
2554232|NCT00531284|6260145|P5|NOT COMPLETED|Overall Study||6
2554233|NCT00531284|6260146|P4|NOT COMPLETED|Overall Study||63
2554234|NCT00531284|6260147|P3|NOT COMPLETED|Overall Study||6
2554235|NCT00531284|6260148|P2|NOT COMPLETED|Overall Study||4
2554236|NCT00531284|6260149|P1|NOT COMPLETED|Overall Study||3
2554237|NCT00531284|6260133|P17|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
2554238|NCT00531284|6260134|P16|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|2
2554239|NCT00531284|6260135|P15|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|3
2554240|NCT00531284|6260136|P14|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
2554241|NCT00531284|6260137|P13|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
2554242|NCT00531284|6260138|P12|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
2554243|NCT00531284|6260139|P11|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
2554244|NCT00531284|6260140|P10|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
2554245|NCT00531284|6260141|P9|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
2554246|NCT00531284|6260142|P8|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
2554247|NCT00531284|6260143|P7|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
2554248|NCT00531284|6260144|P6|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
2554249|NCT00531284|6260145|P5|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
2554250|NCT00531284|6260146|P4|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|2
2554251|NCT00531284|6260147|P3|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|1
2554252|NCT00531284|6260148|P2|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
2554253|NCT00531284|6260149|P1|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
2554254|NCT00531284|6260133|P17|STARTED|Overall Study||8
2554255|NCT00531284|6260134|P16|STARTED|Overall Study||14
2554256|NCT00531284|6260135|P15|STARTED|Overall Study||7
2554257|NCT00531284|6260136|P14|STARTED|Overall Study||3
2554258|NCT00531284|6260137|P13|STARTED|Overall Study||2
2554259|NCT00531284|6260138|P12|STARTED|Overall Study||24
2554260|NCT00531284|6260139|P11|STARTED|Overall Study||3
2554261|NCT00531284|6260140|P10|STARTED|Overall Study||4
2554262|NCT00531284|6260141|P9|STARTED|Overall Study||11
2554263|NCT00531284|6260142|P8|STARTED|Overall Study||10
2554264|NCT00531284|6260143|P7|STARTED|Overall Study||6
2554265|NCT00531284|6260144|P6|STARTED|Overall Study||7
2554266|NCT00531284|6260145|P5|STARTED|Overall Study||6
2554267|NCT00531284|6260146|P4|STARTED|Overall Study||65
2554268|NCT00531284|6260147|P3|STARTED|Overall Study||7
2554269|NCT00531284|6260148|P2|STARTED|Overall Study||4
2554270|NCT00531284|6260149|P1|STARTED|Overall Study||3
2554271|NCT00531206|6260299|P1|NOT COMPLETED|Overall Study||20
2554272|NCT00531206|6260299|P1|COMPLETED|Overall Study||45
2554273|NCT00531206|6260299|P1|STARTED|Overall Study||65
2554274|NCT00531050|6260329|P6|NOT COMPLETED|Part 2: Period 3||1
2554275|NCT00531050|6260330|P5|NOT COMPLETED|Part 2: Period 3||0
2554276|NCT00531050|6260331|P4|NOT COMPLETED|Part 2: Period 3||0
2554277|NCT00531050|6260332|P3|NOT COMPLETED|Part 2: Period 3||0
2554278|NCT00531050|6260333|P2|NOT COMPLETED|Part 2: Period 3||0
2554279|NCT00531050|6260334|P1|NOT COMPLETED|Part 2: Period 3||1
2554280|NCT00531050|6260329|P6|COMPLETED|Part 2: Period 3||3
2554281|NCT00531050|6260330|P5|COMPLETED|Part 2: Period 3||4
2554282|NCT00531050|6260331|P4|COMPLETED|Part 2: Period 3||4
2554283|NCT00531050|6260332|P3|COMPLETED|Part 2: Period 3||4
2554284|NCT00531050|6260333|P2|COMPLETED|Part 2: Period 3||4
2554285|NCT00531050|6260334|P1|COMPLETED|Part 2: Period 3||2
2554286|NCT00531050|6260329|P6|STARTED|Part 2: Period 3||4
2554287|NCT00531050|6260330|P5|STARTED|Part 2: Period 3||4
2554288|NCT00531050|6260331|P4|STARTED|Part 2: Period 3||4
2554289|NCT00531050|6260332|P3|STARTED|Part 2: Period 3||4
2554290|NCT00531050|6260333|P2|STARTED|Part 2: Period 3||4
2554291|NCT00531050|6260334|P1|STARTED|Part 2: Period 3||3
2554292|NCT00531050|6260329|P6|NOT COMPLETED|Part 2: Period 2||0
2554293|NCT00531050|6260330|P5|NOT COMPLETED|Part 2: Period 2||0
2554294|NCT00531050|6260331|P4|NOT COMPLETED|Part 2: Period 2||0
2554295|NCT00531050|6260332|P3|NOT COMPLETED|Part 2: Period 2||0
2554296|NCT00531050|6260333|P2|NOT COMPLETED|Part 2: Period 2||0
2554297|NCT00531050|6260334|P1|NOT COMPLETED|Part 2: Period 2||0
2554298|NCT00531050|6260329|P6|COMPLETED|Part 2: Period 2||4
2554299|NCT00531050|6260330|P5|COMPLETED|Part 2: Period 2||4
2554300|NCT00531050|6260331|P4|COMPLETED|Part 2: Period 2||4
2554301|NCT00531050|6260332|P3|COMPLETED|Part 2: Period 2||4
2554302|NCT00531050|6260333|P2|COMPLETED|Part 2: Period 2||4
2554303|NCT00531050|6260334|P1|COMPLETED|Part 2: Period 2||3
2554304|NCT00531050|6260329|P6|STARTED|Part 2: Period 2||4
2554305|NCT00531050|6260330|P5|STARTED|Part 2: Period 2||4
2554306|NCT00531050|6260331|P4|STARTED|Part 2: Period 2||4
2554307|NCT00531050|6260332|P3|STARTED|Part 2: Period 2||4
2554308|NCT00531050|6260333|P2|STARTED|Part 2: Period 2||4
2554309|NCT00531050|6260334|P1|STARTED|Part 2: Period 2||3
2554310|NCT00531050|6260329|P6|NOT COMPLETED|Part 2: Period 1||1
2554311|NCT00531050|6260330|P5|NOT COMPLETED|Part 2: Period 1||0
2554312|NCT00531050|6260331|P4|NOT COMPLETED|Part 2: Period 1||0
2554313|NCT00531050|6260332|P3|NOT COMPLETED|Part 2: Period 1||0
2554314|NCT00531050|6260333|P2|NOT COMPLETED|Part 2: Period 1||0
2554315|NCT00531050|6260334|P1|NOT COMPLETED|Part 2: Period 1||0
2554316|NCT00531050|6260329|P6|COMPLETED|Part 2: Period 1||4
2554317|NCT00531050|6260330|P5|COMPLETED|Part 2: Period 1||4
2554318|NCT00531050|6260331|P4|COMPLETED|Part 2: Period 1||4
2554319|NCT00531050|6260332|P3|COMPLETED|Part 2: Period 1||4
2554320|NCT00531050|6260333|P2|COMPLETED|Part 2: Period 1||4
2554321|NCT00531050|6260334|P1|COMPLETED|Part 2: Period 1||3
2554322|NCT00531050|6260329|P6|STARTED|Part 2: Period 1||5
2554323|NCT00531050|6260330|P5|STARTED|Part 2: Period 1||4
2554324|NCT00531050|6260331|P4|STARTED|Part 2: Period 1||4
2554325|NCT00531050|6260332|P3|STARTED|Part 2: Period 1||4
2554326|NCT00531050|6260333|P2|STARTED|Part 2: Period 1||4
2554327|NCT00531050|6260334|P1|STARTED|Part 2: Period 1||3
2554328|NCT00531050|6260329|P6|NOT COMPLETED|Part 1: Period 3||0
2554329|NCT00531050|6260330|P5|NOT COMPLETED|Part 1: Period 3||0
2554330|NCT00531050|6260331|P4|NOT COMPLETED|Part 1: Period 3||0
2554331|NCT00531050|6260332|P3|NOT COMPLETED|Part 1: Period 3||0
2554332|NCT00531050|6260333|P2|NOT COMPLETED|Part 1: Period 3||0
2554333|NCT00531050|6260334|P1|NOT COMPLETED|Part 1: Period 3||1
2554334|NCT00531050|6260329|P6|COMPLETED|Part 1: Period 3||5
2554335|NCT00531050|6260330|P5|COMPLETED|Part 1: Period 3||4
2554336|NCT00531050|6260331|P4|COMPLETED|Part 1: Period 3||4
2554337|NCT00531050|6260332|P3|COMPLETED|Part 1: Period 3||4
2554338|NCT00531050|6260333|P2|COMPLETED|Part 1: Period 3||4
2554339|NCT00531050|6260334|P1|COMPLETED|Part 1: Period 3||3
2554340|NCT00531050|6260329|P6|STARTED|Part 1: Period 3||5
2554341|NCT00531050|6260330|P5|STARTED|Part 1: Period 3||4
2554342|NCT00531050|6260331|P4|STARTED|Part 1: Period 3||4
2554343|NCT00531050|6260332|P3|STARTED|Part 1: Period 3||4
2554344|NCT00531050|6260333|P2|STARTED|Part 1: Period 3||4
2554345|NCT00531050|6260334|P1|STARTED|Part 1: Period 3||4
2554346|NCT00531050|6260329|P6|NOT COMPLETED|Part 1: Period 2||0
2554347|NCT00531050|6260330|P5|NOT COMPLETED|Part 1: Period 2||0
2554348|NCT00531050|6260331|P4|NOT COMPLETED|Part 1: Period 2||0
2554349|NCT00531050|6260332|P3|NOT COMPLETED|Part 1: Period 2||0
2554350|NCT00531050|6260333|P2|NOT COMPLETED|Part 1: Period 2||0
2554351|NCT00531050|6260334|P1|NOT COMPLETED|Part 1: Period 2||0
2554352|NCT00531050|6260329|P6|COMPLETED|Part 1: Period 2||5
2554353|NCT00531050|6260330|P5|COMPLETED|Part 1: Period 2||4
2554354|NCT00531050|6260331|P4|COMPLETED|Part 1: Period 2||4
2554355|NCT00531050|6260332|P3|COMPLETED|Part 1: Period 2||4
2554356|NCT00531050|6260333|P2|COMPLETED|Part 1: Period 2||4
2554357|NCT00531050|6260334|P1|COMPLETED|Part 1: Period 2||4
2554358|NCT00531050|6260329|P6|STARTED|Part 1: Period 2||5
2554359|NCT00531050|6260330|P5|STARTED|Part 1: Period 2||4
2554360|NCT00531050|6260331|P4|STARTED|Part 1: Period 2||4
2554361|NCT00531050|6260332|P3|STARTED|Part 1: Period 2||4
2554362|NCT00531050|6260333|P2|STARTED|Part 1: Period 2||4
2554363|NCT00531050|6260334|P1|STARTED|Part 1: Period 2||4
2554364|NCT00531050|6260329|P6|NOT COMPLETED|Part 1: Period 1||0
2554365|NCT00531050|6260330|P5|NOT COMPLETED|Part 1: Period 1||0
2554366|NCT00531050|6260331|P4|NOT COMPLETED|Part 1: Period 1||1
2554367|NCT00531050|6260332|P3|NOT COMPLETED|Part 1: Period 1||0
2554368|NCT00531050|6260333|P2|NOT COMPLETED|Part 1: Period 1||1
2554369|NCT00531050|6260334|P1|NOT COMPLETED|Part 1: Period 1||0
2554370|NCT00531050|6260329|P6|COMPLETED|Part 1: Period 1||5
2554371|NCT00531050|6260330|P5|COMPLETED|Part 1: Period 1||4
2554372|NCT00531050|6260331|P4|COMPLETED|Part 1: Period 1||4
2554373|NCT00531050|6260332|P3|COMPLETED|Part 1: Period 1||4
2554374|NCT00531050|6260333|P2|COMPLETED|Part 1: Period 1||4
2554375|NCT00531050|6260334|P1|COMPLETED|Part 1: Period 1||4
2554376|NCT00531050|6260329|P6|STARTED|Part 1: Period 1||5
2554377|NCT00531050|6260330|P5|STARTED|Part 1: Period 1||4
2554378|NCT00531050|6260331|P4|STARTED|Part 1: Period 1||5
2554379|NCT00531050|6260332|P3|STARTED|Part 1: Period 1||4
2554380|NCT00531050|6260333|P2|STARTED|Part 1: Period 1||5
2554381|NCT00531050|6260334|P1|STARTED|Part 1: Period 1||4
2554382|NCT00531011|6260363|P2|NOT COMPLETED|Overall Study||7
2554383|NCT00531011|6260364|P1|NOT COMPLETED|Overall Study||4
2554384|NCT00531011|6260363|P2|COMPLETED|Overall Study||90
2554385|NCT00531011|6260364|P1|COMPLETED|Overall Study||99
2554386|NCT00531011|6260363|P2|STARTED|Overall Study||97
2554387|NCT00531011|6260364|P1|STARTED|Overall Study||103
2554388|NCT00530946|6260410|P4|NOT COMPLETED|Overall Study||2
2554389|NCT00530946|6260411|P3|NOT COMPLETED|Overall Study||1
2554390|NCT00530946|6260412|P2|NOT COMPLETED|Overall Study||2
2554391|NCT00530946|6260413|P1|NOT COMPLETED|Overall Study||2
2554392|NCT00530946|6260410|P4|COMPLETED|Overall Study||38
2554393|NCT00530946|6260411|P3|COMPLETED|Overall Study||40
2554394|NCT00530946|6260412|P2|COMPLETED|Overall Study||39
2554395|NCT00530946|6260413|P1|COMPLETED|Overall Study||41
2554396|NCT00530946|6260410|P4|STARTED|Overall Study||40
2554397|NCT00530946|6260411|P3|STARTED|Overall Study||41
2554398|NCT00530946|6260412|P2|STARTED|Overall Study||41
2554399|NCT00530946|6260413|P1|STARTED|Overall Study||43
2554400|NCT00530920|6260466|P3|NOT COMPLETED|Overall Study||4
2554401|NCT00530920|6260467|P2|NOT COMPLETED|Overall Study||2
2554402|NCT00530920|6260468|P1|NOT COMPLETED|Overall Study||0
2554403|NCT00530920|6260466|P3|COMPLETED|Overall Study||24
2554404|NCT00530920|6260467|P2|COMPLETED|Overall Study||25
2554405|NCT00530920|6260468|P1|COMPLETED|Overall Study||30
2554406|NCT00530920|6260466|P3|STARTED|Overall Study||28
2554407|NCT00530920|6260467|P2|STARTED|Overall Study||27
2554408|NCT00530920|6260468|P1|STARTED|Overall Study||30
2554409|NCT00530894|6260528|P4|NOT COMPLETED|Overall Study||94
2554410|NCT00530894|6260529|P3|NOT COMPLETED|Overall Study||55
2554411|NCT00530894|6260530|P2|NOT COMPLETED|Overall Study||115
2554412|NCT00530894|6260531|P1|NOT COMPLETED|Overall Study||88
2554413|NCT00530894|6260528|P4|COMPLETED|Overall Study||85
2554414|NCT00530894|6260529|P3|COMPLETED|Overall Study||124
2554415|NCT00530894|6260530|P2|COMPLETED|Overall Study||236
2554416|NCT00530894|6260531|P1|COMPLETED|Overall Study||260
2554417|NCT00530894|6260528|P4|STARTED|Overall Study||179
2554418|NCT00530894|6260529|P3|STARTED|Overall Study||179
2554419|NCT00530894|6260530|P2|STARTED|Overall Study||351
2554420|NCT00530894|6260531|P1|STARTED|Overall Study||348
2554421|NCT00530855|6260559|P1|NOT COMPLETED|Overall Study||112
2554422|NCT00530855|6260559|P1|COMPLETED|Overall Study||210
2554423|NCT00530855|6260559|P1|STARTED|Overall Study||322
2554424|NCT00530842|6260568|P2|NOT COMPLETED|Period 2||9
2554425|NCT00530842|6260569|P1|NOT COMPLETED|Period 2||8
2554426|NCT00530842|6260568|P2|COMPLETED|Period 2||151
2554427|NCT00530842|6260569|P1|COMPLETED|Period 2||149
2554428|NCT00530842|6260568|P2|STARTED|Period 2||160
2554429|NCT00530842|6260569|P1|STARTED|Period 2||157
2554430|NCT00530842|6260568|P2|NOT COMPLETED|Period 1||11
2554431|NCT00530842|6260569|P1|NOT COMPLETED|Period 1||14
2554432|NCT00530842|6260568|P2|COMPLETED|Period 1||161
2554433|NCT00530842|6260569|P1|COMPLETED|Period 1||158
2554434|NCT00530842|6260568|P2|STARTED|Period 1||172
2554435|NCT00530842|6260569|P1|STARTED|Period 1||172
2554436|NCT00530842|6260568|P2|NOT COMPLETED|Overall Study||21
2554437|NCT00530842|6260569|P1|NOT COMPLETED|Overall Study||23
2554438|NCT00530842|6260568|P2|COMPLETED|Overall Study||151
2554439|NCT00530842|6260569|P1|COMPLETED|Overall Study||149
2554440|NCT00530842|6260568|P2|STARTED|Overall Study||172
2554441|NCT00530842|6260569|P1|STARTED|Overall Study||172
2554442|NCT00530816|6260696|P3|NOT COMPLETED|Overall Study||41
2554443|NCT00530816|6260697|P2|NOT COMPLETED|Overall Study||42
2554444|NCT00530816|6260698|P1|NOT COMPLETED|Overall Study||26
2554445|NCT00530816|6260696|P3|COMPLETED|Overall Study||29
2554446|NCT00530816|6260697|P2|COMPLETED|Overall Study||17
2554447|NCT00530816|6260698|P1|COMPLETED|Overall Study||9
2554448|NCT00530816|6260696|P3|STARTED|Overall Study||70
2554449|NCT00530816|6260697|P2|STARTED|Overall Study||59
2554450|NCT00530816|6260698|P1|STARTED|Overall Study||35
2554451|NCT00530803|6260726|P2|NOT COMPLETED|Overall Study||0
2554452|NCT00530803|6260727|P1|NOT COMPLETED|Overall Study||0
2554453|NCT00530803|6260726|P2|COMPLETED|Overall Study||50
2554454|NCT00530803|6260727|P1|COMPLETED|Overall Study||50
2554455|NCT00530803|6260726|P2|STARTED|Overall Study||50
2554456|NCT00530803|6260727|P1|STARTED|Overall Study||50
2554457|NCT00530790|6260741|P1|NOT COMPLETED|Overall Study||5
2554458|NCT00530790|6260741|P1|COMPLETED|Overall Study||30
2554459|NCT00530790|6260741|P1|STARTED|Overall Study||35
2554460|NCT00530777|6260763|P2|NOT COMPLETED|Overall Study||5
2554461|NCT00530777|6260764|P1|NOT COMPLETED|Overall Study||7
2554462|NCT00530777|6260763|P2|COMPLETED|Overall Study||69
2554463|NCT00530777|6260764|P1|COMPLETED|Overall Study||67
2554464|NCT00530777|6260763|P2|STARTED|Overall Study||74
2554465|NCT00530777|6260764|P1|STARTED|Overall Study||74
2554466|NCT00530764|6260776|P4|NOT COMPLETED|Overall Study||25
2554467|NCT00530764|6260777|P3|NOT COMPLETED|Overall Study||20
2554468|NCT00530764|6260778|P2|NOT COMPLETED|Overall Study||21
2554469|NCT00530764|6260779|P1|NOT COMPLETED|Overall Study||31
2554470|NCT00530764|6260776|P4|COMPLETED|Overall Study||66
2554471|NCT00530764|6260777|P3|COMPLETED|Overall Study||71
2554472|NCT00530764|6260778|P2|COMPLETED|Overall Study||67
2554473|NCT00530764|6260779|P1|COMPLETED|Overall Study||59
2554474|NCT00530764|6260776|P4|STARTED|Overall Study||91
2554475|NCT00530764|6260777|P3|STARTED|Overall Study||91
2554476|NCT00530764|6260778|P2|STARTED|Overall Study||88
2554477|NCT00530764|6260779|P1|STARTED|Overall Study||90
2554478|NCT00530712|6260821|P1|NOT COMPLETED|12 Month Follow-up Visit||24
2554479|NCT00530712|6260821|P1|COMPLETED|12 Month Follow-up Visit|Subjects that Completed 12-Month Follow-up Visit|263
2554480|NCT00530712|6260821|P1|STARTED|12 Month Follow-up Visit|Subjects Expected for 12 Month Visit|287
2554481|NCT00530712|6260821|P1|NOT COMPLETED|6 Month Follow-up Visit||12
2554482|NCT00530712|6260821|P1|COMPLETED|6 Month Follow-up Visit|Subjects that Completed 6-Month Follow-up Visit|275
2554483|NCT00530712|6260821|P1|STARTED|6 Month Follow-up Visit|Subjects Expected for 6-Month Visit|287
2554484|NCT00530712|6260821|P1|NOT COMPLETED|30 Day Follow-up Visit||7
2554485|NCT00530712|6260821|P1|COMPLETED|30 Day Follow-up Visit|Subjects that Completed 30-Day Follow-up Visit|280
2554486|NCT00530712|6260821|P1|STARTED|30 Day Follow-up Visit|Subjects Expected for 30-Day Visit|287
2554487|NCT00530712|6260821|P1|NOT COMPLETED|Enrollment||0
2554488|NCT00530712|6260821|P1|COMPLETED|Enrollment|Subjects Available at Discharge|287
2554489|NCT00530712|6260821|P1|STARTED|Enrollment|Total Enrolled Subjects|287
2554490|NCT00530634|6260838|P1|NOT COMPLETED|Overall Study||0
2554491|NCT00530634|6260838|P1|COMPLETED|Overall Study||3
2554492|NCT00530634|6260838|P1|STARTED|Overall Study||3
2554493|NCT00530504|6260842|P1|NOT COMPLETED|Overall Study||152
2554494|NCT00530504|6260842|P1|COMPLETED|Overall Study||1348
2554495|NCT00530504|6260842|P1|STARTED|Overall Study||1500
2554496|NCT00530439|6260848|P2|NOT COMPLETED|Overall Study||26
2554497|NCT00530439|6260849|P1|NOT COMPLETED|Overall Study||30
2554498|NCT00530439|6260848|P2|COMPLETED|Overall Study||154
2554499|NCT00530439|6260849|P1|COMPLETED|Overall Study||150
2554500|NCT00530439|6260848|P2|STARTED|Overall Study||180
2554501|NCT00530439|6260849|P1|STARTED|Overall Study||180
2554502|NCT00530348|6260857|P2|NOT COMPLETED|Overall Study||19
2554503|NCT00530348|6260858|P1|NOT COMPLETED|Overall Study||22
2554504|NCT00530348|6260857|P2|COMPLETED|Overall Study||367
2554505|NCT00530348|6260858|P1|COMPLETED|Overall Study||173
2554506|NCT00530348|6260857|P2|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|376
2554507|NCT00530348|6260858|P1|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|187
2554508|NCT00530348|6260857|P2|STARTED|Overall Study|Randomized.|386
2554509|NCT00530348|6260858|P1|STARTED|Overall Study|Randomized.|195
2554510|NCT00530335|6260874|P1|NOT COMPLETED|Overall Study||6
2554511|NCT00530335|6260874|P1|COMPLETED|Overall Study||39
2554512|NCT00530335|6260874|P1|STARTED|Overall Study||45
2554513|NCT00530270|6260891|P2|NOT COMPLETED|Overall Study||0
2554514|NCT00530270|6260892|P1|NOT COMPLETED|Overall Study||1
2554515|NCT00530270|6260891|P2|COMPLETED|Overall Study||6
2554516|NCT00530270|6260892|P1|COMPLETED|Overall Study||5
2554517|NCT00530270|6260891|P2|STARTED|Overall Study||6
2554518|NCT00530270|6260892|P1|STARTED|Overall Study||6
2554519|NCT00530257|6260906|P1|NOT COMPLETED|Overall Study||1
2554520|NCT00530257|6260906|P1|COMPLETED|Overall Study||30
2554521|NCT00530257|6260906|P1|STARTED|Overall Study||31
2554522|NCT00530218|6260934|P1|NOT COMPLETED|Overall Study||25
2554523|NCT00530218|6260934|P1|COMPLETED|Overall Study|CMV Reactivation Was Detected|36
2554524|NCT00530218|6260934|P1|STARTED|Overall Study||61
2554525|NCT00530088|6260941|P1|NOT COMPLETED|Overall Study||10
2554526|NCT00530088|6260941|P1|COMPLETED|Overall Study||20
2554527|NCT00530088|6260941|P1|STARTED|Overall Study||30
2554528|NCT00530075|6260946|P1|NOT COMPLETED|Overall Study||7
2554529|NCT00530075|6260946|P1|COMPLETED|Overall Study||38
2554530|NCT00530075|6260946|P1|STARTED|Overall Study||45
2554531|NCT00530023|6260959|P2|NOT COMPLETED|Overall Study||1
2554532|NCT00530023|6260960|P1|NOT COMPLETED|Overall Study||0
2554533|NCT00530023|6260959|P2|COMPLETED|Overall Study||14
2554534|NCT00530023|6260960|P1|COMPLETED|Overall Study||14
2554535|NCT00530023|6260959|P2|STARTED|Overall Study||15
2554536|NCT00530023|6260960|P1|STARTED|Overall Study||14
2554537|NCT00529958|6260977|P3|NOT COMPLETED|5-Year Follow-up||1
2554538|NCT00529958|6260978|P2|NOT COMPLETED|5-Year Follow-up||3
2554539|NCT00529958|6260979|P1|NOT COMPLETED|5-Year Follow-up||3
2554540|NCT00529958|6260977|P3|COMPLETED|5-Year Follow-up||107
2554541|NCT00529958|6260978|P2|COMPLETED|5-Year Follow-up||105
2554542|NCT00529958|6260979|P1|COMPLETED|5-Year Follow-up||103
2554543|NCT00529958|6260977|P3|STARTED|5-Year Follow-up|108 DB patients available for 5-year follow-up includes n=1 cross-over with a single-bundle HT graft|108
2554544|NCT00529958|6260978|P2|STARTED|5-Year Follow-up|108 HT patients available for 5-year follow-up excludes n=1 cross-over patient from the DB group|108
2554545|NCT00529958|6260979|P1|STARTED|5-Year Follow-up||106
2554546|NCT00529958|6260977|P3|NOT COMPLETED|2-Year Follow-up||2
2554547|NCT00529958|6260978|P2|NOT COMPLETED|2-Year Follow-up||2
2554548|NCT00529958|6260979|P1|NOT COMPLETED|2-Year Follow-up||4
2554549|NCT00529958|6260977|P3|COMPLETED|2-Year Follow-up|108 DB patients analyzed include 1 cross-over with HT graft (analyzed on intention-to-treat basis).|108
2554550|NCT00529958|6260978|P2|COMPLETED|2-Year Follow-up|108 HT patients analyzed excludes n=1 cross-over patient (analyzed on intention-to-treat basis).|108
2554551|NCT00529958|6260979|P1|COMPLETED|2-Year Follow-up||106
2554552|NCT00529958|6260977|P3|STARTED|2-Year Follow-up|110 randomized to DB, but there was (n=1) cross-over to the HT group|110
2554553|NCT00529958|6260978|P2|STARTED|2-Year Follow-up|110 randomized to HT, but there was (n=1) cross-over from the DB group|110
2554554|NCT00529958|6260979|P1|STARTED|2-Year Follow-up||110
2554555|NCT00529802|6261020|P1|NOT COMPLETED|Evaluable for Secondary Endpoint||2
2554556|NCT00529802|6261020|P1|COMPLETED|Evaluable for Secondary Endpoint||48
2554557|NCT00529802|6261020|P1|STARTED|Evaluable for Secondary Endpoint||50
2554558|NCT00529802|6261020|P1|NOT COMPLETED|Evaluable for Primary Endpoint||10
2554559|NCT00529802|6261020|P1|COMPLETED|Evaluable for Primary Endpoint|Evaluable for primary endpoint|50
2554560|NCT00529802|6261020|P1|STARTED|Evaluable for Primary Endpoint|60 patients started trial|60
2554561|NCT00529789|6261026|P1|NOT COMPLETED|Study Period IV||6
2554562|NCT00529789|6261026|P1|COMPLETED|Study Period IV|Includes 1 patient who withdrew at last visit; didn't enter Taper; however received 30 weeks of drug|42
2554563|NCT00529789|6261026|P1|STARTED|Study Period IV||48
2554564|NCT00529789|6261026|P1|NOT COMPLETED|Study Period II/III||24
2554565|NCT00529789|6261026|P1|COMPLETED|Study Period II/III||48
2554566|NCT00529789|6261026|P1|STARTED|Study Period II/III||72
2554567|NCT00529763|6261051|P3|NOT COMPLETED|Overall Study||7
2554568|NCT00529763|6261052|P2|NOT COMPLETED|Overall Study||33
2554569|NCT00529763|6261053|P1|NOT COMPLETED|Overall Study||10
2554570|NCT00529763|6261051|P3|COMPLETED|Overall Study|52 participants still on treatment; not completed = off treatment (n=7)|52
2554571|NCT00529763|6261052|P2|COMPLETED|Overall Study|4 participants still on treatment; not completed = off treatment (n=33)|4
2554572|NCT00529763|6261053|P1|COMPLETED|Overall Study|15 participants still on treatment; not completed = off treatment (n=10)|15
2554573|NCT00529763|6261051|P3|STARTED|Overall Study||59
2554574|NCT00529763|6261052|P2|STARTED|Overall Study|38 participants were enrolled; 37 were treated in this cohort|37
2554575|NCT00529763|6261053|P1|STARTED|Overall Study||25
2554576|NCT00529659|6261091|P2|NOT COMPLETED|Overall Study||23
2554577|NCT00529659|6261092|P1|NOT COMPLETED|Overall Study||11
2554578|NCT00529659|6261091|P2|COMPLETED|Overall Study||66
2554579|NCT00529659|6261092|P1|COMPLETED|Overall Study||70
2554580|NCT00529659|6261091|P2|STARTED|Overall Study||89
2554581|NCT00529659|6261092|P1|STARTED|Overall Study||81
2554582|NCT00529633|6261110|P2|NOT COMPLETED|Overall Study||1
2554583|NCT00529633|6261111|P1|NOT COMPLETED|Overall Study||1
2554584|NCT00529633|6261110|P2|COMPLETED|Overall Study||1
2554585|NCT00529633|6261111|P1|COMPLETED|Overall Study||1
2554586|NCT00529633|6261110|P2|STARTED|Overall Study||2
2554587|NCT00529633|6261111|P1|STARTED|Overall Study||2
2554588|NCT00529568|6261123|P3|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||102
2554589|NCT00529568|6261124|P2|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||48
2554590|NCT00529568|6261125|P1|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||0
2554591|NCT00529568|6261123|P3|COMPLETED|Double-bilnd Antiviral Treatment Phase||404
2554592|NCT00529568|6261124|P2|COMPLETED|Double-bilnd Antiviral Treatment Phase||205
2554593|NCT00529568|6261125|P1|COMPLETED|Double-bilnd Antiviral Treatment Phase||0
2554594|NCT00529568|6261123|P3|STARTED|Double-bilnd Antiviral Treatment Phase||506
2554595|NCT00529568|6261124|P2|STARTED|Double-bilnd Antiviral Treatment Phase||253
2554596|NCT00529568|6261125|P1|STARTED|Double-bilnd Antiviral Treatment Phase||0
2554597|NCT00529568|6261123|P3|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
2554598|NCT00529568|6261124|P2|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
2554599|NCT00529568|6261125|P1|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||46
2554600|NCT00529568|6261123|P3|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
2554601|NCT00529568|6261124|P2|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
2554602|NCT00529568|6261125|P1|COMPLETED|Open-label Pre-Antiviral Treatment Phase||759
2554603|NCT00529568|6261123|P3|STARTED|Open-label Pre-Antiviral Treatment Phase||0
2554604|NCT00529568|6261124|P2|STARTED|Open-label Pre-Antiviral Treatment Phase||0
2554605|NCT00529568|6261125|P1|STARTED|Open-label Pre-Antiviral Treatment Phase||805
2554606|NCT00529555|6261176|P3|NOT COMPLETED|Overall Study||26
2554607|NCT00529555|6261177|P2|NOT COMPLETED|Overall Study||30
2554608|NCT00529555|6261178|P1|NOT COMPLETED|Overall Study||29
2554609|NCT00529555|6261176|P3|COMPLETED|Overall Study||174
2554610|NCT00529555|6261177|P2|COMPLETED|Overall Study||172
2554611|NCT00529555|6261178|P1|COMPLETED|Overall Study||171
2554612|NCT00529555|6261176|P3|STARTED|Overall Study||200
2554613|NCT00529555|6261177|P2|STARTED|Overall Study||202
2554614|NCT00529555|6261178|P1|STARTED|Overall Study||200
2554615|NCT00529542|6261188|P2|NOT COMPLETED|Overall Study||1
2554616|NCT00529542|6261189|P1|NOT COMPLETED|Overall Study||1
2554617|NCT00529542|6261188|P2|COMPLETED|Overall Study||10
2554618|NCT00529542|6261189|P1|COMPLETED|Overall Study||8
2554619|NCT00529542|6261188|P2|STARTED|Overall Study||11
2554620|NCT00529542|6261189|P1|STARTED|Overall Study||9
2554621|NCT00529529|6261232|P3|NOT COMPLETED|Overall Study||31
2554622|NCT00529529|6261233|P2|NOT COMPLETED|Overall Study||43
2554623|NCT00529529|6261234|P1|NOT COMPLETED|Overall Study||43
2554624|NCT00529529|6261232|P3|COMPLETED|Overall Study||238
2554625|NCT00529529|6261233|P2|COMPLETED|Overall Study||225
2554626|NCT00529529|6261234|P1|COMPLETED|Overall Study||225
2554627|NCT00529529|6261232|P3|STARTED|Overall Study||269
2554628|NCT00529529|6261233|P2|STARTED|Overall Study||268
2554629|NCT00529529|6261234|P1|STARTED|Overall Study||268
2554630|NCT00529516|6261293|P3|NOT COMPLETED|Overall Study||1
2554631|NCT00529516|6261294|P2|NOT COMPLETED|Overall Study||2
2554632|NCT00529516|6261295|P1|NOT COMPLETED|Overall Study||3
2554633|NCT00529516|6261293|P3|COMPLETED|Overall Study||288
2554634|NCT00529516|6261294|P2|COMPLETED|Overall Study||486
2554635|NCT00529516|6261295|P1|COMPLETED|Overall Study||472
2554636|NCT00529516|6261293|P3|STARTED|Overall Study||289
2554637|NCT00529516|6261294|P2|STARTED|Overall Study||488
2554638|NCT00529516|6261295|P1|STARTED|Overall Study||475
2554639|NCT00529464|6261366|P3|NOT COMPLETED|Overall Study||0
2554640|NCT00529464|6261367|P2|NOT COMPLETED|Overall Study||0
2554641|NCT00529464|6261368|P1|NOT COMPLETED|Overall Study||0
2554642|NCT00529464|6261366|P3|COMPLETED|Overall Study||0
2554643|NCT00529464|6261367|P2|COMPLETED|Overall Study||0
2554644|NCT00529464|6261368|P1|COMPLETED|Overall Study||0
2554645|NCT00529464|6261366|P3|STARTED|Overall Study||0
2554646|NCT00529464|6261367|P2|STARTED|Overall Study||0
2554647|NCT00529464|6261368|P1|STARTED|Overall Study||0
2554648|NCT00529451|6261380|P4|NOT COMPLETED|Overall Study||31
2554649|NCT00529451|6261381|P3|NOT COMPLETED|Overall Study||40
2554650|NCT00529451|6261382|P2|NOT COMPLETED|Overall Study||48
2554651|NCT00529451|6261383|P1|NOT COMPLETED|Overall Study||37
2554652|NCT00529451|6261380|P4|COMPLETED|Overall Study||299
2554653|NCT00529451|6261381|P3|COMPLETED|Overall Study||292
2554654|NCT00529451|6261382|P2|COMPLETED|Overall Study||275
2554655|NCT00529451|6261383|P1|COMPLETED|Overall Study||294
2554656|NCT00529451|6261380|P4|STARTED|Overall Study||330
2554657|NCT00529451|6261381|P3|STARTED|Overall Study||332
2554658|NCT00529451|6261382|P2|STARTED|Overall Study||323
2554659|NCT00529451|6261383|P1|STARTED|Overall Study||331
2554660|NCT00529399|6261410|P3|NOT COMPLETED|Overall Study||2
2554661|NCT00529399|6261411|P2|NOT COMPLETED|Overall Study||1
2554662|NCT00529399|6261412|P1|NOT COMPLETED|Overall Study||2
2554663|NCT00529399|6261410|P3|COMPLETED|Overall Study||46
2554664|NCT00529399|6261411|P2|COMPLETED|Overall Study||48
2554665|NCT00529399|6261412|P1|COMPLETED|Overall Study||46
2554666|NCT00529399|6261410|P3|STARTED|Overall Study||48
2554667|NCT00529399|6261411|P2|STARTED|Overall Study||49
2554668|NCT00529399|6261412|P1|STARTED|Overall Study||48
2554669|NCT00529386|6261420|P1|NOT COMPLETED|Overall Study||1
2554670|NCT00529386|6261420|P1|COMPLETED|Overall Study|Study discontinued after 7 patients enrolled and analyzed|6
2554671|NCT00529386|6261420|P1|STARTED|Overall Study|Study has been discontinued|7
2554672|NCT00529373|6261426|P2|NOT COMPLETED|Second Extension Study||197
2554673|NCT00529373|6261427|P1|NOT COMPLETED|Second Extension Study||300
2554674|NCT00529373|6261426|P2|COMPLETED|Second Extension Study||2112
2554675|NCT00529373|6261427|P1|COMPLETED|Second Extension Study||2844
2554676|NCT00529373|6261426|P2|STARTED|Second Extension Study||2309
2554677|NCT00529373|6261427|P1|STARTED|Second Extension Study||3144
2554678|NCT00529373|6261426|P2|NOT COMPLETED|First Extension Study||1651
2554679|NCT00529373|6261427|P1|NOT COMPLETED|First Extension Study||1153
2554680|NCT00529373|6261426|P2|COMPLETED|First Extension Study||2309
2554681|NCT00529373|6261427|P1|COMPLETED|First Extension Study||3144
2554682|NCT00529373|6261426|P2|STARTED|First Extension Study||3960
2554683|NCT00529373|6261427|P1|STARTED|First Extension Study||4297
2554684|NCT00529373|6261426|P2|NOT COMPLETED|Base Study||4068
2554685|NCT00529373|6261427|P1|NOT COMPLETED|Base Study||3746
2554686|NCT00529373|6261426|P2|COMPLETED|Base Study||3960
2554687|NCT00529373|6261427|P1|COMPLETED|Base Study||4297
2554688|NCT00529373|6261426|P2|STARTED|Base Study||8028
2554689|NCT00529373|6261427|P1|STARTED|Base Study||8043
2554690|NCT00529308|6261621|P2|NOT COMPLETED|Overall Study||1
2554691|NCT00529308|6261622|P1|NOT COMPLETED|Overall Study||1
2554692|NCT00529308|6261621|P2|COMPLETED|Overall Study||10
2554693|NCT00529308|6261622|P1|COMPLETED|Overall Study||8
2554694|NCT00529308|6261621|P2|STARTED|Overall Study||11
2554695|NCT00529308|6261622|P1|STARTED|Overall Study||9
2554696|NCT00529282|6261638|P2|NOT COMPLETED|Overall Study||0
2554697|NCT00529282|6261639|P1|NOT COMPLETED|Overall Study||0
2554698|NCT00529282|6261638|P2|COMPLETED|Overall Study||2
2554699|NCT00529282|6261639|P1|COMPLETED|Overall Study||0
2554700|NCT00529282|6261638|P2|STARTED|Overall Study||2
2554701|NCT00529282|6261639|P1|STARTED|Overall Study||0
2554702|NCT00529243|6261651|P1|NOT COMPLETED|Overall Study||3
2554703|NCT00529243|6261651|P1|COMPLETED|Overall Study||49
2554704|NCT00529243|6261651|P1|STARTED|Overall Study||52
2554705|NCT00529217|6261656|P1|NOT COMPLETED|Overall Study||4
2554706|NCT00529217|6261656|P1|COMPLETED|Overall Study||8
2554707|NCT00529217|6261656|P1|STARTED|Overall Study||12
2554708|NCT00529204|6261661|P1|NOT COMPLETED|Overall Study||0
2554709|NCT00529204|6261661|P1|COMPLETED|Overall Study||1
2554710|NCT00529204|6261661|P1|STARTED|Overall Study||1
2554711|NCT00529191|6261669|P2|NOT COMPLETED|Overall Study||0
2554712|NCT00529191|6261670|P1|NOT COMPLETED|Overall Study||3
2554713|NCT00529191|6261669|P2|COMPLETED|Overall Study||13
2554714|NCT00529191|6261670|P1|COMPLETED|Overall Study||24
2554715|NCT00529191|6261669|P2|STARTED|Overall Study||13
2554716|NCT00529191|6261670|P1|STARTED|Overall Study||27
2554717|NCT00529152|6261692|P1|NOT COMPLETED|Overall Study||5
2554718|NCT00529152|6261692|P1|COMPLETED|Overall Study||95
2554719|NCT00529152|6261692|P1|STARTED|Overall Study||100
2554720|NCT00529126|6261700|P4|NOT COMPLETED|Overall Study||0
2554721|NCT00529126|6261701|P3|NOT COMPLETED|Overall Study||0
2554722|NCT00529126|6261702|P2|NOT COMPLETED|Overall Study||0
2554723|NCT00529126|6261703|P1|NOT COMPLETED|Overall Study||0
2554724|NCT00529126|6261700|P4|COMPLETED|Overall Study||26
2554725|NCT00529126|6261701|P3|COMPLETED|Overall Study||24
2554726|NCT00529126|6261702|P2|COMPLETED|Overall Study||25
2554727|NCT00529126|6261703|P1|COMPLETED|Overall Study||25
2554728|NCT00529126|6261700|P4|STARTED|Overall Study||26
2554729|NCT00529126|6261701|P3|STARTED|Overall Study||24
2554730|NCT00529126|6261702|P2|STARTED|Overall Study||25
2554731|NCT00529126|6261703|P1|STARTED|Overall Study||25
2554732|NCT00529100|6261716|P2|NOT COMPLETED|Overall Study||9
2554733|NCT00529100|6261717|P1|NOT COMPLETED|Overall Study||0
2554734|NCT00529100|6261716|P2|COMPLETED|Overall Study||24
2554735|NCT00529100|6261717|P1|COMPLETED|Overall Study||16
2554736|NCT00529100|6261716|P2|Received at Least 1 Dose of Study Drug|Overall Study||33
2554737|NCT00529100|6261717|P1|Received at Least 1 Dose of Study Drug|Overall Study||16
2554738|NCT00529100|6261716|P2|STARTED|Overall Study||33
2554739|NCT00529100|6261717|P1|STARTED|Overall Study||16
2554740|NCT00529087|6261734|P3|NOT COMPLETED|Overall Study||16
2554741|NCT00529087|6261735|P2|NOT COMPLETED|Overall Study||28
2554742|NCT00529087|6261736|P1|NOT COMPLETED|Overall Study||28
2554743|NCT00529087|6261734|P3|COMPLETED|Overall Study||146
2554744|NCT00529087|6261735|P2|COMPLETED|Overall Study||120
2554745|NCT00529087|6261736|P1|COMPLETED|Overall Study||122
2554746|NCT00529087|6261734|P3|STARTED|Overall Study||162
2554747|NCT00529087|6261735|P2|STARTED|Overall Study||148
2554748|NCT00529087|6261736|P1|STARTED|Overall Study||150
2554749|NCT00529035|6261800|P1|NOT COMPLETED|Overall Study||1
2554750|NCT00529035|6261800|P1|COMPLETED|Overall Study|28 evaluable, 1 patient withdrew participation and was not evaluable|28
2554751|NCT00529035|6261800|P1|STARTED|Overall Study|29 enrolled|29
2554752|NCT00528970|6261814|P3|NOT COMPLETED|Overall Study||20
2554753|NCT00528970|6261815|P2|NOT COMPLETED|Overall Study||15
2554754|NCT00528970|6261816|P1|NOT COMPLETED|Overall Study||14
2554755|NCT00528970|6261814|P3|COMPLETED|Overall Study||105
2554756|NCT00528970|6261815|P2|COMPLETED|Overall Study||110
2554757|NCT00528970|6261816|P1|COMPLETED|Overall Study||110
2554758|NCT00528970|6261814|P3|Received at Least 1 Dose of Study Drug|Overall Study||124
2554759|NCT00528970|6261815|P2|Received at Least 1 Dose of Study Drug|Overall Study||125
2554760|NCT00528970|6261816|P1|Received at Least 1 Dose of Study Drug|Overall Study||124
2554761|NCT00528970|6261814|P3|STARTED|Overall Study||125
2554762|NCT00528970|6261815|P2|STARTED|Overall Study||125
2554763|NCT00528970|6261816|P1|STARTED|Overall Study||124
2554764|NCT00528957|6261835|P2|NOT COMPLETED|Long-Term Extension (Week 336 and On)||17
2554765|NCT00528957|6261836|P1|NOT COMPLETED|Long-Term Extension (Week 336 and On)||10
2554766|NCT00528957|6261835|P2|COMPLETED|Long-Term Extension (Week 336 and On)||8
2554767|NCT00528957|6261836|P1|COMPLETED|Long-Term Extension (Week 336 and On)||9
2554768|NCT00528957|6261835|P2|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|25
2554769|NCT00528957|6261836|P1|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|19
2554770|NCT00528957|6261835|P2|NOT COMPLETED|Third Extension (Week 240 to Week 336)||10
2554771|NCT00528957|6261836|P1|NOT COMPLETED|Third Extension (Week 240 to Week 336)||6
2554772|NCT00528957|6261835|P2|COMPLETED|Third Extension (Week 240 to Week 336)||27
2554773|NCT00528957|6261836|P1|COMPLETED|Third Extension (Week 240 to Week 336)||21
2554774|NCT00528957|6261835|P2|STARTED|Third Extension (Week 240 to Week 336)||37
2554775|NCT00528957|6261836|P1|STARTED|Third Extension (Week 240 to Week 336)||27
2554776|NCT00528957|6261835|P2|NOT COMPLETED|Second Extension (Week 144 to Week 240)||3
2554777|NCT00528957|6261836|P1|NOT COMPLETED|Second Extension (Week 144 to Week 240)||7
2554778|NCT00528957|6261835|P2|COMPLETED|Second Extension (Week 144 to Week 240)||37
2554779|NCT00528957|6261836|P1|COMPLETED|Second Extension (Week 144 to Week 240)||27
2554780|NCT00528957|6261835|P2|STARTED|Second Extension (Week 144 to Week 240)||40
2554781|NCT00528957|6261836|P1|STARTED|Second Extension (Week 144 to Week 240)|One participant completed the first extension and did not enroll in the second extension.|34
2554782|NCT00528957|6261835|P2|NOT COMPLETED|First Extension (Week 48 to Week 144)||1
2554783|NCT00528957|6261836|P1|NOT COMPLETED|First Extension (Week 48 to Week 144)||3
2554784|NCT00528957|6261835|P2|COMPLETED|First Extension (Week 48 to Week 144)||40
2554785|NCT00528957|6261836|P1|COMPLETED|First Extension (Week 48 to Week 144)||35
2554786|NCT00528957|6261835|P2|STARTED|First Extension (Week 48 to Week 144)|Seven participants completed the 48-week randomized phase and did not enroll in the first extension.|41
2554787|NCT00528957|6261836|P1|STARTED|First Extension (Week 48 to Week 144)|Six participants completed the 48-week randomized phase and did not enroll in the first extension.|38
2554788|NCT00528957|6261835|P2|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||1
2554789|NCT00528957|6261836|P1|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||4
2554790|NCT00528957|6261835|P2|COMPLETED|Randomized Phase (Baseline to Week 48)||48
2554791|NCT00528957|6261836|P1|COMPLETED|Randomized Phase (Baseline to Week 48)||44
2554792|NCT00528957|6261835|P2|STARTED|Randomized Phase (Baseline to Week 48)||49
2554793|NCT00528957|6261836|P1|STARTED|Randomized Phase (Baseline to Week 48)||48
2554794|NCT00528931|6261977|P1|NOT COMPLETED|Overall Study||1
2554795|NCT00528931|6261977|P1|COMPLETED|Overall Study||15
2554796|NCT00528931|6261977|P1|STARTED|Overall Study||16
2554797|NCT00528879|6261989|P4|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||24
2554798|NCT00528879|6261990|P3|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||33
2554799|NCT00528879|6261991|P2|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||38
2554800|NCT00528879|6261992|P1|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||42
2554801|NCT00528879|6261989|P4|COMPLETED|Long-term Period (Weeks 24 to 102)||95
2554802|NCT00528879|6261990|P3|COMPLETED|Long-term Period (Weeks 24 to 102)||89
2554803|NCT00528879|6261991|P2|COMPLETED|Long-term Period (Weeks 24 to 102)||82
2554804|NCT00528879|6261992|P1|COMPLETED|Long-term Period (Weeks 24 to 102)||73
2554805|NCT00528879|6261989|P4|STARTED|Long-term Period (Weeks 24 to 102)||119
2554806|NCT00528879|6261990|P3|STARTED|Long-term Period (Weeks 24 to 102)||122
2554807|NCT00528879|6261991|P2|STARTED|Long-term Period (Weeks 24 to 102)||120
2554808|NCT00528879|6261992|P1|STARTED|Long-term Period (Weeks 24 to 102)||115
2554809|NCT00528879|6261989|P4|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||16
2554810|NCT00528879|6261990|P3|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||15
2554811|NCT00528879|6261991|P2|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||17
2554812|NCT00528879|6261992|P1|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||22
2554813|NCT00528879|6261989|P4|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|119
2554814|NCT00528879|6261990|P3|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|122
2554815|NCT00528879|6261991|P2|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|120
2554816|NCT00528879|6261992|P1|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|115
2554817|NCT00528879|6261989|P4|Completed the Period|Short-term Period (Day 1 to Week 24)||121
2554818|NCT00528879|6261990|P3|Completed the Period|Short-term Period (Day 1 to Week 24)||122
2554819|NCT00528879|6261991|P2|Completed the Period|Short-term Period (Day 1 to Week 24)||121
2554820|NCT00528879|6261992|P1|Completed the Period|Short-term Period (Day 1 to Week 24)||119
2554821|NCT00528879|6261989|P4|STARTED|Short-term Period (Day 1 to Week 24)||135
2554822|NCT00528879|6261990|P3|STARTED|Short-term Period (Day 1 to Week 24)||137
2554823|NCT00528879|6261991|P2|STARTED|Short-term Period (Day 1 to Week 24)||137
2554824|NCT00528879|6261992|P1|STARTED|Short-term Period (Day 1 to Week 24)||137
2554825|NCT00528866|6262058|P1|NOT COMPLETED|Overall Study||6
2554826|NCT00528866|6262058|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|74
2554827|NCT00528866|6262058|P1|STARTED|Overall Study||80
2554828|NCT00528840|6262071|P1|NOT COMPLETED|Overall Study||33
2554829|NCT00528840|6262071|P1|COMPLETED|Overall Study||168
2554830|NCT00528840|6262071|P1|STARTED|Overall Study||201
2554831|NCT00528801|6262085|P2|NOT COMPLETED|Overall Study||11
2554832|NCT00528801|6262086|P1|NOT COMPLETED|Overall Study||27
2554833|NCT00528801|6262085|P2|COMPLETED|Overall Study||41
2554834|NCT00528801|6262086|P1|COMPLETED|Overall Study||133
2554835|NCT00528801|6262085|P2|STARTED|Overall Study||52
2554836|NCT00528801|6262086|P1|STARTED|Overall Study||160
2554837|NCT00528788|6262096|P1|NOT COMPLETED|Overall Study||4
2554838|NCT00528788|6262096|P1|COMPLETED|Overall Study||20
2554839|NCT00528788|6262096|P1|STARTED|Overall Study||24
2554840|NCT00528775|6262100|P1|NOT COMPLETED|Overall Study||1
2554841|NCT00528775|6262100|P1|COMPLETED|Overall Study||5
2554842|NCT00528775|6262100|P1|STARTED|Overall Study||6
2554843|NCT00528645|6262108|P1|NOT COMPLETED|Overall Study||3
2554844|NCT00528645|6262108|P1|COMPLETED|Overall Study||20
2554845|NCT00528645|6262108|P1|STARTED|Overall Study||23
2554846|NCT00528606|6262117|P2|NOT COMPLETED|Overall Study||4
2554847|NCT00528606|6262118|P1|NOT COMPLETED|Overall Study||13
2554848|NCT00528606|6262117|P2|COMPLETED|Overall Study||100
2554849|NCT00528606|6262118|P1|COMPLETED|Overall Study||191
2554850|NCT00528606|6262117|P2|STARTED|Overall Study||104
2554851|NCT00528606|6262118|P1|STARTED|Overall Study||204
2554852|NCT00528580|6262142|P2|NOT COMPLETED|Overall Study||0
2554853|NCT00528580|6262143|P1|NOT COMPLETED|Overall Study||0
2554854|NCT00528580|6262142|P2|COMPLETED|Overall Study||34
2554855|NCT00528580|6262143|P1|COMPLETED|Overall Study||34
2554856|NCT00528580|6262142|P2|STARTED|Overall Study||34
2554857|NCT00528580|6262143|P1|STARTED|Overall Study||34
2554858|NCT00528567|6262151|P2|NOT COMPLETED|Overall Study||308
2554859|NCT00528567|6262152|P1|NOT COMPLETED|Overall Study||431
2554860|NCT00528567|6262151|P2|COMPLETED|Overall Study||982
2554861|NCT00528567|6262152|P1|COMPLETED|Overall Study||870
2554862|NCT00528567|6262151|P2|Safety Population|Overall Study||1271
2554863|NCT00528567|6262152|P1|Safety Population|Overall Study||1288
2554864|NCT00528567|6262151|P2|Intention to Treat|Overall Study||1290
2554865|NCT00528567|6262152|P1|Intention to Treat|Overall Study||1301
2554866|NCT00528567|6262151|P2|STARTED|Overall Study||1290
2554867|NCT00528567|6262152|P1|STARTED|Overall Study||1301
2554868|NCT00528541|6262192|P2|NOT COMPLETED|Overall Study||1
2554869|NCT00528541|6262193|P1|NOT COMPLETED|Overall Study||2
2554870|NCT00528541|6262192|P2|COMPLETED|Overall Study||69
2554871|NCT00528541|6262193|P1|COMPLETED|Overall Study||73
2554872|NCT00528541|6262192|P2|STARTED|Overall Study||70
2554873|NCT00528541|6262193|P1|STARTED|Overall Study||75
2554874|NCT00528528|6262219|P4|NOT COMPLETED|Overall Study||3
2554875|NCT00528528|6262220|P3|NOT COMPLETED|Overall Study||3
2554876|NCT00528528|6262221|P2|NOT COMPLETED|Overall Study||3
2554877|NCT00528528|6262222|P1|NOT COMPLETED|Overall Study||3
2554878|NCT00528528|6262219|P4|COMPLETED|Overall Study||36
2554879|NCT00528528|6262220|P3|COMPLETED|Overall Study||37
2554880|NCT00528528|6262221|P2|COMPLETED|Overall Study||39
2554881|NCT00528528|6262222|P1|COMPLETED|Overall Study||37
2554882|NCT00528528|6262219|P4|Ongoing at Time of Cut-off|Overall Study||0
2554883|NCT00528528|6262220|P3|Ongoing at Time of Cut-off|Overall Study||1
2554884|NCT00528528|6262221|P2|Ongoing at Time of Cut-off|Overall Study||0
2554885|NCT00528528|6262222|P1|Ongoing at Time of Cut-off|Overall Study||0
2554886|NCT00528528|6262219|P4|STARTED|Overall Study||39
2554887|NCT00528528|6262220|P3|STARTED|Overall Study||40
2554888|NCT00528528|6262221|P2|STARTED|Overall Study||42
2554889|NCT00528528|6262222|P1|STARTED|Overall Study||40
2554890|NCT00528450|6262256|P1|NOT COMPLETED|Overall Study||0
2554891|NCT00528450|6262256|P1|COMPLETED|Overall Study||1
2554892|NCT00528450|6262256|P1|STARTED|Overall Study||1
2554893|NCT00528424|6262260|P1|NOT COMPLETED|Overall Study||29
2554894|NCT00528424|6262260|P1|COMPLETED|Overall Study||257
2554895|NCT00528424|6262260|P1|STARTED|Overall Study||286
2554896|NCT00528411|6262275|P3|NOT COMPLETED|Overall Study||1
2554897|NCT00528411|6262276|P2|NOT COMPLETED|Overall Study||3
2554898|NCT00528411|6262277|P1|NOT COMPLETED|Overall Study||5
2554899|NCT00528411|6262275|P3|COMPLETED|Overall Study||11
2554900|NCT00528411|6262276|P2|COMPLETED|Overall Study||51
2554901|NCT00528411|6262277|P1|COMPLETED|Overall Study||52
2554902|NCT00528411|6262275|P3|STARTED|Overall Study||12
2554903|NCT00528411|6262276|P2|STARTED|Overall Study||54
2554904|NCT00528411|6262277|P1|STARTED|Overall Study||57
2554905|NCT00528398|6262400|P1|NOT COMPLETED|Overall Study||0
2554906|NCT00528398|6262400|P1|COMPLETED|Overall Study||111
2554907|NCT00528398|6262400|P1|STARTED|Overall Study||111
2554908|NCT00528372|6262414|P9|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
2554909|NCT00528372|6262415|P8|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
2554910|NCT00528372|6262416|P7|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||17
2554911|NCT00528372|6262417|P6|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||15
2554912|NCT00528372|6262418|P5|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||21
2554913|NCT00528372|6262419|P4|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||14
2554914|NCT00528372|6262420|P3|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||8
2554915|NCT00528372|6262421|P2|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||19
2554916|NCT00528372|6262422|P1|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||20
2554917|NCT00528372|6262414|P9|COMPLETED|Long-term (LT) Period (Weeks 24-102)||27
2554918|NCT00528372|6262415|P8|COMPLETED|Long-term (LT) Period (Weeks 24-102)||22
2554919|NCT00528372|6262416|P7|COMPLETED|Long-term (LT) Period (Weeks 24-102)||48
2554920|NCT00528372|6262417|P6|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
2554921|NCT00528372|6262418|P5|COMPLETED|Long-term (LT) Period (Weeks 24-102)||37
2554922|NCT00528372|6262419|P4|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
2554923|NCT00528372|6262420|P3|COMPLETED|Long-term (LT) Period (Weeks 24-102)||43
2554924|NCT00528372|6262421|P2|COMPLETED|Long-term (LT) Period (Weeks 24-102)||40
2554925|NCT00528372|6262422|P1|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
2555007|NCT00527943|6262638|P1|NOT COMPLETED|Overall Study||160
2554926|NCT00528372|6262414|P9|STARTED|Long-term (LT) Period (Weeks 24-102)|1 patient completed ST phase but withdrew for sponsor administrative reason before start of LT phase|33
2554927|NCT00528372|6262415|P8|STARTED|Long-term (LT) Period (Weeks 24-102)||28
2554928|NCT00528372|6262416|P7|STARTED|Long-term (LT) Period (Weeks 24-102)||65
2554929|NCT00528372|6262417|P6|STARTED|Long-term (LT) Period (Weeks 24-102)||57
2554930|NCT00528372|6262418|P5|STARTED|Long-term (LT) Period (Weeks 24-102)||58
2554931|NCT00528372|6262419|P4|STARTED|Long-term (LT) Period (Weeks 24-102)||56
2554932|NCT00528372|6262420|P3|STARTED|Long-term (LT) Period (Weeks 24-102)||51
2554933|NCT00528372|6262421|P2|STARTED|Long-term (LT) Period (Weeks 24-102)||59
2554934|NCT00528372|6262422|P1|STARTED|Long-term (LT) Period (Weeks 24-102)||62
2554935|NCT00528372|6262414|P9|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
2554936|NCT00528372|6262415|P8|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||6
2554937|NCT00528372|6262416|P7|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
2554938|NCT00528372|6262417|P6|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
2554939|NCT00528372|6262418|P5|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||9
2554940|NCT00528372|6262419|P4|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||13
2554941|NCT00528372|6262420|P3|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
2554942|NCT00528372|6262421|P2|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
2554943|NCT00528372|6262422|P1|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
2554944|NCT00528372|6262414|P9|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||34
2554945|NCT00528372|6262415|P8|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||28
2554946|NCT00528372|6262416|P7|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||65
2554947|NCT00528372|6262417|P6|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
2554948|NCT00528372|6262418|P5|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||58
2554949|NCT00528372|6262419|P4|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
2554950|NCT00528372|6262420|P3|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||52
2554951|NCT00528372|6262421|P2|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||60
2554952|NCT00528372|6262422|P1|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||63
2554953|NCT00528372|6262414|P9|STARTED|Short-term (ST) Period (Day 1-Week 24)||39
2554954|NCT00528372|6262415|P8|STARTED|Short-term (ST) Period (Day 1-Week 24)||34
2554955|NCT00528372|6262416|P7|STARTED|Short-term (ST) Period (Day 1-Week 24)||76
2554956|NCT00528372|6262417|P6|STARTED|Short-term (ST) Period (Day 1-Week 24)||68
2554957|NCT00528372|6262418|P5|STARTED|Short-term (ST) Period (Day 1-Week 24)||67
2554958|NCT00528372|6262419|P4|STARTED|Short-term (ST) Period (Day 1-Week 24)||70
2554959|NCT00528372|6262420|P3|STARTED|Short-term (ST) Period (Day 1-Week 24)||64
2554960|NCT00528372|6262421|P2|STARTED|Short-term (ST) Period (Day 1-Week 24)||65
2554961|NCT00528372|6262422|P1|STARTED|Short-term (ST) Period (Day 1-Week 24)||75
2554962|NCT00528268|6262536|P2|NOT COMPLETED|Overall Study||1
2554963|NCT00528268|6262537|P1|NOT COMPLETED|Overall Study||1
2554964|NCT00528268|6262536|P2|COMPLETED|Overall Study||7
2554965|NCT00528268|6262537|P1|COMPLETED|Overall Study||5
2554966|NCT00528268|6262536|P2|STARTED|Overall Study||8
2554967|NCT00528268|6262537|P1|STARTED|Overall Study||6
2554968|NCT00528190|6262545|P2|NOT COMPLETED|Overall Study||1
2554969|NCT00528190|6262546|P1|NOT COMPLETED|Overall Study||0
2554970|NCT00528190|6262545|P2|COMPLETED|Overall Study||16
2554971|NCT00528190|6262546|P1|COMPLETED|Overall Study||18
2554972|NCT00528190|6262545|P2|STARTED|Overall Study||17
2554973|NCT00528190|6262546|P1|STARTED|Overall Study||18
2554974|NCT00528112|6262554|P2|NOT COMPLETED|Extension Phase||157
2554975|NCT00528112|6262555|P1|NOT COMPLETED|Extension Phase||0
2554976|NCT00528112|6262554|P2|COMPLETED|Extension Phase||550
2554977|NCT00528112|6262555|P1|COMPLETED|Extension Phase||0
2554978|NCT00528112|6262554|P2|STARTED|Extension Phase||707
2554979|NCT00528112|6262555|P1|STARTED|Extension Phase|Only subjects in the LCS16 groups could participate in the extension phase|0
2554980|NCT00528112|6262554|P2|NOT COMPLETED|Treatment up to 3 Years||583
2554981|NCT00528112|6262555|P1|NOT COMPLETED|Treatment up to 3 Years||613
2554982|NCT00528112|6262554|P2|COMPLETED|Treatment up to 3 Years||870
2554983|NCT00528112|6262555|P1|COMPLETED|Treatment up to 3 Years||819
2554984|NCT00528112|6262554|P2|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1452
2554985|NCT00528112|6262555|P1|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1432
2554986|NCT00528112|6262554|P2|STARTED|Treatment up to 3 Years||1453
2554987|NCT00528112|6262555|P1|STARTED|Treatment up to 3 Years||1432
2554988|NCT00528021|6262613|P4|NOT COMPLETED|Overall Study||9
2554989|NCT00528021|6262614|P3|NOT COMPLETED|Overall Study||7
2554990|NCT00528021|6262615|P2|NOT COMPLETED|Overall Study||13
2554991|NCT00528021|6262616|P1|NOT COMPLETED|Overall Study||17
2554992|NCT00528021|6262613|P4|COMPLETED|Overall Study||47
2554993|NCT00528021|6262614|P3|COMPLETED|Overall Study||49
2554994|NCT00528021|6262615|P2|COMPLETED|Overall Study||46
2554995|NCT00528021|6262616|P1|COMPLETED|Overall Study||42
2554996|NCT00528021|6262613|P4|STARTED|Overall Study||56
2554997|NCT00528021|6262614|P3|STARTED|Overall Study||56
2554998|NCT00528021|6262615|P2|STARTED|Overall Study||59
2554999|NCT00528021|6262616|P1|STARTED|Overall Study||59
2555000|NCT00527982|6262628|P2|NOT COMPLETED|Overall Study||0
2555001|NCT00527982|6262629|P1|NOT COMPLETED|Overall Study||1
2555002|NCT00527982|6262628|P2|COMPLETED|Overall Study||0
2555003|NCT00527982|6262629|P1|COMPLETED|Overall Study||0
2555004|NCT00527982|6262628|P2|STARTED|Overall Study||0
2555005|NCT00527982|6262629|P1|STARTED|Overall Study||1
2555006|NCT00527943|6262637|P2|NOT COMPLETED|Overall Study||146
2555008|NCT00527943|6262637|P2|COMPLETED|Overall Study||6327
2555009|NCT00527943|6262638|P1|COMPLETED|Overall Study||6311
2555010|NCT00527943|6262637|P2|Received Treatment|Overall Study||6446
2555011|NCT00527943|6262638|P1|Received Treatment|Overall Study||6441
2555012|NCT00527943|6262637|P2|STARTED|Overall Study||6473
2555013|NCT00527943|6262638|P1|STARTED|Overall Study||6471
2555014|NCT00527904|6262670|P1|NOT COMPLETED|Overall Study||96
2555015|NCT00527904|6262670|P1|COMPLETED|Overall Study||143
2555016|NCT00527904|6262670|P1|STARTED|Overall Study||239
2555017|NCT00527878|6262674|P2|NOT COMPLETED|Intervention 2||0
2555018|NCT00527878|6262675|P1|NOT COMPLETED|Intervention 2||0
2555019|NCT00527878|6262674|P2|COMPLETED|Intervention 2||4
2555020|NCT00527878|6262675|P1|COMPLETED|Intervention 2||5
2555021|NCT00527878|6262674|P2|STARTED|Intervention 2||4
2555022|NCT00527878|6262675|P1|STARTED|Intervention 2||5
2555023|NCT00527878|6262674|P2|NOT COMPLETED|Intervention 1||3
2555024|NCT00527878|6262675|P1|NOT COMPLETED|Intervention 1||2
2555025|NCT00527878|6262674|P2|COMPLETED|Intervention 1||4
2555026|NCT00527878|6262675|P1|COMPLETED|Intervention 1||5
2555027|NCT00527878|6262674|P2|STARTED|Intervention 1||7
2555028|NCT00527878|6262675|P1|STARTED|Intervention 1||7
2555029|NCT00527826|6262689|P2|NOT COMPLETED|Overall Study||26
2555030|NCT00527826|6262690|P1|NOT COMPLETED|Overall Study||21
2555031|NCT00527826|6262689|P2|COMPLETED|Overall Study||80
2555032|NCT00527826|6262690|P1|COMPLETED|Overall Study||87
2555033|NCT00527826|6262689|P2|STARTED|Overall Study||106
2555034|NCT00527826|6262690|P1|STARTED|Overall Study|All Patients Population was used for Participant Flow section.|108
2555035|NCT00527787|6262739|P2|NOT COMPLETED|Overall Study||63
2555036|NCT00527787|6262740|P1|NOT COMPLETED|Overall Study||38
2555037|NCT00527787|6262739|P2|COMPLETED|Overall Study||153
2555038|NCT00527787|6262740|P1|COMPLETED|Overall Study||180
2555039|NCT00527787|6262739|P2|STARTED|Overall Study|Safety and Intent-to-treat population (>=1 dose drug + no baseline ulcer) N=216|216
2555040|NCT00527787|6262740|P1|STARTED|Overall Study||218
2555041|NCT00527748|6262762|P1|NOT COMPLETED|Overall Study||3
2555042|NCT00527748|6262762|P1|COMPLETED|Overall Study||23
2555043|NCT00527748|6262762|P1|STARTED|Overall Study||26
2555044|NCT00527735|6262769|P3|NOT COMPLETED|Overall Study||107
2555045|NCT00527735|6262770|P2|NOT COMPLETED|Overall Study||107
2555046|NCT00527735|6262771|P1|NOT COMPLETED|Overall Study||108
2555047|NCT00527735|6262769|P3|COMPLETED|Overall Study|Still on treatment|2
2555048|NCT00527735|6262770|P2|COMPLETED|Overall Study|Still on treatment|2
2555049|NCT00527735|6262771|P1|COMPLETED|Overall Study|Still on treatment|5
2555050|NCT00527735|6262769|P3|STARTED|Overall Study|Treated|109
2555051|NCT00527735|6262770|P2|STARTED|Overall Study|Treated|109
2555052|NCT00527735|6262771|P1|STARTED|Overall Study|Treated|113
2555053|NCT00527722|6262845|P2|NOT COMPLETED|Overall Study||0
2555054|NCT00527722|6262846|P1|NOT COMPLETED|Overall Study||0
2555055|NCT00527722|6262845|P2|COMPLETED|Overall Study||25
2555056|NCT00527722|6262846|P1|COMPLETED|Overall Study||22
2555057|NCT00527722|6262845|P2|STARTED|Overall Study||25
2555058|NCT00527722|6262846|P1|STARTED|Overall Study||22
2555059|NCT00527644|6262852|P1|NOT COMPLETED|Overall Study||0
2555060|NCT00527644|6262852|P1|COMPLETED|Overall Study||14
2555061|NCT00527644|6262852|P1|STARTED|Overall Study||14
2555062|NCT00527618|6262857|P2|NOT COMPLETED|Week 15-18 (Second Intervention)||3
2555063|NCT00527618|6262858|P1|NOT COMPLETED|Week 15-18 (Second Intervention)||0
2555064|NCT00527618|6262857|P2|COMPLETED|Week 15-18 (Second Intervention)|Acyclovir|13
2555065|NCT00527618|6262858|P1|COMPLETED|Week 15-18 (Second Intervention)|Valacyclovir|12
2555066|NCT00527618|6262857|P2|STARTED|Week 15-18 (Second Intervention)|Acyclovir|16
2555067|NCT00527618|6262858|P1|STARTED|Week 15-18 (Second Intervention)|Valacyclovir|12
2555068|NCT00527618|6262857|P2|NOT COMPLETED|Week 13-14 (Washout)||0
2555069|NCT00527618|6262858|P1|NOT COMPLETED|Week 13-14 (Washout)||1
2555070|NCT00527618|6262857|P2|COMPLETED|Week 13-14 (Washout)||16
2555071|NCT00527618|6262858|P1|COMPLETED|Week 13-14 (Washout)||12
2555072|NCT00527618|6262857|P2|STARTED|Week 13-14 (Washout)||16
2555073|NCT00527618|6262858|P1|STARTED|Week 13-14 (Washout)||13
2555074|NCT00527618|6262857|P2|NOT COMPLETED|Week 1-12 (First Intervention)||2
2555075|NCT00527618|6262858|P1|NOT COMPLETED|Week 1-12 (First Intervention)||3
2555076|NCT00527618|6262857|P2|COMPLETED|Week 1-12 (First Intervention)|Valacyclovir|16
2555077|NCT00527618|6262858|P1|COMPLETED|Week 1-12 (First Intervention)|Acyclovir|13
2555078|NCT00527618|6262857|P2|STARTED|Week 1-12 (First Intervention)|Valacyclovir; one participant was removed from the study due to urticaria after 2.5 weeks|18
2555079|NCT00527618|6262858|P1|STARTED|Week 1-12 (First Intervention)|Acyclovir|16
2555080|NCT00527605|6262873|P2|NOT COMPLETED|Overall Study||11
2555081|NCT00527605|6262874|P1|NOT COMPLETED|Overall Study||13
2555082|NCT00527605|6262873|P2|COMPLETED|Overall Study||116
2555083|NCT00527605|6262874|P1|COMPLETED|Overall Study||113
2555084|NCT00527605|6262873|P2|STARTED|Overall Study||127
2555085|NCT00527605|6262874|P1|STARTED|Overall Study||126
2555086|NCT00527592|6262910|P1|NOT COMPLETED|Overall Study||0
2555087|NCT00527592|6262910|P1|COMPLETED|Overall Study||54
2555088|NCT00527592|6262910|P1|STARTED|Overall Study||54
2555089|NCT00527566|6262916|P1|NOT COMPLETED|Overall Study||0
2555090|NCT00527566|6262916|P1|COMPLETED|Overall Study||10
2555091|NCT00527566|6262916|P1|STARTED|Overall Study||10
2555092|NCT00527514|6262925|P1|NOT COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||2
2555093|NCT00527514|6262925|P1|COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||132
2555094|NCT00527514|6262925|P1|STARTED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|158 -24 who met blood pressure goal = 134|134
2555095|NCT00527514|6262925|P1|NOT COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||3
2555096|NCT00527514|6262925|P1|COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||158
2555097|NCT00527514|6262925|P1|STARTED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|178 -19 who met blood pressure goal + 2 who were mis-titrated = 161|161
2555098|NCT00527514|6262925|P1|NOT COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||2
2555099|NCT00527514|6262925|P1|COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||178
2555100|NCT00527514|6262925|P1|STARTED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|184 -2 who were mis-titrated -2 who met blood pressure goal = 180|180
2555101|NCT00527514|6262925|P1|NOT COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg||1
2555102|NCT00527514|6262925|P1|COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg|1 participant dropped out. 2 participants were subsequently mis-titrated to the third regimen.|184
2555103|NCT00527514|6262925|P1|STARTED|Weeks 1-3: Amlodipine (Aml) 5mg||185
2555104|NCT00527488|6262941|P4|NOT COMPLETED|Overall Study||0
2555105|NCT00527488|6262942|P3|NOT COMPLETED|Overall Study||1
2555106|NCT00527488|6262943|P2|NOT COMPLETED|Overall Study||1
2555107|NCT00527488|6262944|P1|NOT COMPLETED|Overall Study||0
2555108|NCT00527488|6262941|P4|COMPLETED|Overall Study||13
2555109|NCT00527488|6262942|P3|COMPLETED|Overall Study||12
2555110|NCT00527488|6262943|P2|COMPLETED|Overall Study||12
2555111|NCT00527488|6262944|P1|COMPLETED|Overall Study||13
2555112|NCT00527488|6262941|P4|STARTED|Overall Study||13
2555113|NCT00527488|6262942|P3|STARTED|Overall Study||13
2555114|NCT00527488|6262943|P2|STARTED|Overall Study||13
2555115|NCT00527488|6262944|P1|STARTED|Overall Study||13
2555116|NCT00527475|6263020|P2|NOT COMPLETED|Overall Study||1
2555117|NCT00527475|6263021|P1|NOT COMPLETED|Overall Study||3
2555118|NCT00527475|6263020|P2|COMPLETED|Overall Study||29
2555119|NCT00527475|6263021|P1|COMPLETED|Overall Study||27
2555120|NCT00527475|6263020|P2|STARTED|Overall Study||30
2555121|NCT00527475|6263021|P1|STARTED|Overall Study||30
2555122|NCT00527423|6263027|P1|NOT COMPLETED|Overall Study||37
2555123|NCT00527423|6263027|P1|COMPLETED|Overall Study||120
2555124|NCT00527423|6263027|P1|STARTED|Overall Study||157
2555125|NCT00527397|6263033|P1|NOT COMPLETED|Overall Study||24
2555126|NCT00527397|6263033|P1|COMPLETED|Overall Study||0
2555127|NCT00527397|6263033|P1|STARTED|Overall Study||24
2555128|NCT00527332|6263059|P2|NOT COMPLETED|Overall Study||9
2555129|NCT00527332|6263060|P1|NOT COMPLETED|Overall Study||9
2555130|NCT00527332|6263059|P2|COMPLETED|Overall Study||80
2555131|NCT00527332|6263060|P1|COMPLETED|Overall Study||82
2555132|NCT00527332|6263059|P2|STARTED|Overall Study||89
2555133|NCT00527332|6263060|P1|STARTED|Overall Study||91
2555134|NCT00527319|6263069|P3|NOT COMPLETED|Overall Study||6
2555135|NCT00527319|6263070|P2|NOT COMPLETED|Overall Study||4
2555136|NCT00527319|6263071|P1|NOT COMPLETED|Overall Study||6
2555137|NCT00527319|6263069|P3|COMPLETED|Overall Study||7
2555138|NCT00527319|6263070|P2|COMPLETED|Overall Study||8
2555139|NCT00527319|6263071|P1|COMPLETED|Overall Study||6
2555140|NCT00527319|6263069|P3|STARTED|Overall Study||13
2555141|NCT00527319|6263070|P2|STARTED|Overall Study||12
2555142|NCT00527319|6263071|P1|STARTED|Overall Study||12
2555143|NCT00527124|6263084|P2|NOT COMPLETED|Overall Study||0
2555144|NCT00527124|6263085|P1|NOT COMPLETED|Overall Study||0
2555145|NCT00527124|6263084|P2|COMPLETED|Overall Study||28
2555146|NCT00527124|6263085|P1|COMPLETED|Overall Study||29
2555147|NCT00527124|6263084|P2|STARTED|Overall Study||28
2555148|NCT00527124|6263085|P1|STARTED|Overall Study||29
2555149|NCT00527111|6263101|P2|NOT COMPLETED|Overall Study||22
2555150|NCT00527111|6263102|P1|NOT COMPLETED|Overall Study||20
2555151|NCT00527111|6263101|P2|COMPLETED|Overall Study||47
2555152|NCT00527111|6263102|P1|COMPLETED|Overall Study||50
2555153|NCT00527111|6263101|P2|STARTED|Overall Study||69
2555154|NCT00527111|6263102|P1|STARTED|Overall Study||70
2555155|NCT00527098|6263118|P2|NOT COMPLETED|Overall Study||0
2555156|NCT00527098|6263119|P1|NOT COMPLETED|Overall Study||0
2555157|NCT00527098|6263118|P2|COMPLETED|Overall Study||83
2555158|NCT00527098|6263119|P1|COMPLETED|Overall Study||36
2555159|NCT00527098|6263118|P2|STARTED|Overall Study||83
2555160|NCT00527098|6263119|P1|STARTED|Overall Study||36
2555161|NCT00527072|6263124|P1|NOT COMPLETED|Overall Study||36
2555162|NCT00527072|6263124|P1|COMPLETED|Overall Study||179
2555163|NCT00527072|6263124|P1|STARTED|Overall Study||215
2555164|NCT00526994|6263133|P3|NOT COMPLETED|Overall Study||107
2555165|NCT00526994|6263134|P2|NOT COMPLETED|Overall Study||121
2555166|NCT00526994|6263135|P1|NOT COMPLETED|Overall Study||108
2555167|NCT00526994|6263133|P3|COMPLETED|Overall Study||791
2555168|NCT00526994|6263134|P2|COMPLETED|Overall Study||772
2555169|NCT00526994|6263135|P1|COMPLETED|Overall Study||801
2555170|NCT00526994|6263133|P3|STARTED|Overall Study||898
2555171|NCT00526994|6263134|P2|STARTED|Overall Study||893
2555172|NCT00526994|6263135|P1|STARTED|Overall Study||909
2555173|NCT00526890|6263152|P1|NOT COMPLETED|Overall Study||2
2555174|NCT00526890|6263152|P1|COMPLETED|Overall Study||14
2555175|NCT00526890|6263152|P1|STARTED|Overall Study||16
2555176|NCT00526799|6263164|P2|NOT COMPLETED|Overall Study||1
2555177|NCT00526799|6263165|P1|NOT COMPLETED|Overall Study||1
2555178|NCT00526799|6263164|P2|COMPLETED|Overall Study||13
2555179|NCT00526799|6263165|P1|COMPLETED|Overall Study||15
2555180|NCT00526799|6263164|P2|STARTED|Overall Study||14
2555181|NCT00526799|6263165|P1|STARTED|Overall Study||16
2555182|NCT00526669|6263173|P2|NOT COMPLETED|Combined Treatment Phase||8
2555183|NCT00526669|6263174|P1|NOT COMPLETED|Combined Treatment Phase||0
2555184|NCT00526669|6263173|P2|COMPLETED|Combined Treatment Phase||59
2555185|NCT00526669|6263174|P1|COMPLETED|Combined Treatment Phase||0
2555186|NCT00526669|6263173|P2|STARTED|Combined Treatment Phase||67
2555187|NCT00526669|6263174|P1|STARTED|Combined Treatment Phase||0
2555188|NCT00526669|6263173|P2|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
2555189|NCT00526669|6263174|P1|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
2555190|NCT00526669|6263173|P2|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
2555191|NCT00526669|6263174|P1|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||67
2555192|NCT00526669|6263173|P2|STARTED|7-Day Run-in Monotherapy Treatment Phase||0
2555193|NCT00526669|6263174|P1|STARTED|7-Day Run-in Monotherapy Treatment Phase||67
2555194|NCT00526656|6263203|P1|NOT COMPLETED|Overall Study||2
2555195|NCT00526656|6263203|P1|COMPLETED|Overall Study||7
2555196|NCT00526656|6263203|P1|STARTED|Overall Study||9
2555197|NCT00526630|6263209|P2|NOT COMPLETED|Second Intervention Period - 12 Weeks||1
2555198|NCT00526630|6263210|P1|NOT COMPLETED|Second Intervention Period - 12 Weeks||2
2555199|NCT00526630|6263209|P2|COMPLETED|Second Intervention Period - 12 Weeks||7
2555200|NCT00526630|6263210|P1|COMPLETED|Second Intervention Period - 12 Weeks||10
2555201|NCT00526630|6263209|P2|STARTED|Second Intervention Period - 12 Weeks||8
2555202|NCT00526630|6263210|P1|STARTED|Second Intervention Period - 12 Weeks||12
2555203|NCT00526630|6263209|P2|NOT COMPLETED|First Intervention Period - 12 Weeks||3
2555204|NCT00526630|6263210|P1|NOT COMPLETED|First Intervention Period - 12 Weeks||0
2555205|NCT00526630|6263209|P2|COMPLETED|First Intervention Period - 12 Weeks||8
2555206|NCT00526630|6263210|P1|COMPLETED|First Intervention Period - 12 Weeks||12
2555207|NCT00526630|6263209|P2|STARTED|First Intervention Period - 12 Weeks||11
2555208|NCT00526630|6263210|P1|STARTED|First Intervention Period - 12 Weeks||12
2555209|NCT00526591|6263240|P2|NOT COMPLETED|Overall Study||0
2555210|NCT00526591|6263241|P1|NOT COMPLETED|Overall Study||0
2555211|NCT00526591|6263240|P2|COMPLETED|Overall Study||9
2555212|NCT00526591|6263241|P1|COMPLETED|Overall Study||8
2555213|NCT00526591|6263240|P2|STARTED|Overall Study||9
2555214|NCT00526591|6263241|P1|STARTED|Overall Study||8
2555215|NCT00526474|6263253|P2|NOT COMPLETED|Overall Study||272
2555216|NCT00526474|6263254|P1|NOT COMPLETED|Overall Study||292
2555217|NCT00526474|6263253|P2|COMPLETED|Overall Study||12953
2555218|NCT00526474|6263254|P1|COMPLETED|Overall Study||12932
2555219|NCT00526474|6263253|P2|Received Study Drug|Overall Study||13186
2555220|NCT00526474|6263254|P1|Received Study Drug|Overall Study||13166
2555221|NCT00526474|6263253|P2|STARTED|Overall Study||13225
2555222|NCT00526474|6263254|P1|STARTED|Overall Study||13224
2555223|NCT00526331|6263322|P1|NOT COMPLETED|Overall Study||55
2555224|NCT00526331|6263322|P1|COMPLETED|Overall Study||0
2555225|NCT00526331|6263322|P1|STARTED|Overall Study||55
2555226|NCT00526292|6263326|P1|NOT COMPLETED|Overall Study||0
2555227|NCT00526292|6263326|P1|COMPLETED|Overall Study||6
2555228|NCT00526292|6263326|P1|STARTED|Overall Study||6
2555229|NCT00526227|6263330|P1|NOT COMPLETED|Overall Study||2
2555230|NCT00526227|6263330|P1|COMPLETED|Overall Study||79
2555231|NCT00526227|6263330|P1|STARTED|Overall Study||81
2555232|NCT00526188|6263335|P1|NOT COMPLETED|Overall Study||0
2555233|NCT00526188|6263335|P1|COMPLETED|Overall Study||234
2555234|NCT00526188|6263335|P1|STARTED|Overall Study||234
2555235|NCT00526162|6263341|P1|NOT COMPLETED|Overall Study||3
2555236|NCT00526162|6263341|P1|COMPLETED|Overall Study||80
2555237|NCT00526162|6263341|P1|STARTED|Overall Study||83
2555238|NCT00526123|6263351|P2|NOT COMPLETED|Overall Study||246
2555239|NCT00526123|6263352|P1|NOT COMPLETED|Overall Study||264
2555240|NCT00526123|6263351|P2|COMPLETED|Overall Study||50
2555241|NCT00526123|6263352|P1|COMPLETED|Overall Study||39
2555242|NCT00526123|6263351|P2|STARTED|Overall Study|Intent-to-Treat population|296
2555243|NCT00526123|6263352|P1|STARTED|Overall Study|Intent-to-Treat population|303
2555244|NCT00526110|6263374|P2|NOT COMPLETED|Overall Study||41
2555245|NCT00526110|6263375|P1|NOT COMPLETED|Overall Study||2
2555246|NCT00526110|6263374|P2|COMPLETED|Overall Study||4
2555247|NCT00526110|6263375|P1|COMPLETED|Overall Study||51
2555248|NCT00526110|6263374|P2|STARTED|Overall Study||45
2555249|NCT00526110|6263375|P1|STARTED|Overall Study||53
2555250|NCT00526097|6263384|P2|NOT COMPLETED|Overall Study||56
2555251|NCT00526097|6263385|P1|NOT COMPLETED|Overall Study||15
2555252|NCT00526097|6263384|P2|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|191
2555253|NCT00526097|6263385|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|106
2555254|NCT00526097|6263384|P2|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|247
2555255|NCT00526097|6263385|P1|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|121
2555256|NCT00526071|6263561|P1|NOT COMPLETED|Overall Study||6
2555257|NCT00526071|6263561|P1|COMPLETED|Overall Study||17
2555258|NCT00526071|6263561|P1|Non-amenable Population; Women|Overall Study||4
2555259|NCT00526071|6263561|P1|Non-amenable Population; Men|Overall Study||3
2555260|NCT00526071|6263561|P1|Amenable Population; Women|Overall Study||5
2555261|NCT00526071|6263561|P1|Amenable Population; Men|Overall Study||11
2555262|NCT00526071|6263561|P1|Pharmacodynamic (PD) Population|Overall Study||23
2555263|NCT00526071|6263561|P1|Safety Population|Overall Study||23
2555264|NCT00526071|6263561|P1|STARTED|Overall Study||23
2555265|NCT00526058|6263572|P2|NOT COMPLETED|Period: Second Intervention||0
2555266|NCT00526058|6263573|P1|NOT COMPLETED|Period: Second Intervention||0
2555267|NCT00526058|6263572|P2|COMPLETED|Period: Second Intervention||9
2555268|NCT00526058|6263573|P1|COMPLETED|Period: Second Intervention||9
2555269|NCT00526058|6263572|P2|STARTED|Period: Second Intervention||9
2555270|NCT00526058|6263573|P1|STARTED|Period: Second Intervention||9
2555271|NCT00526058|6263572|P2|NOT COMPLETED|Period: First Intervention||0
2555272|NCT00526058|6263573|P1|NOT COMPLETED|Period: First Intervention||0
2555273|NCT00526058|6263572|P2|COMPLETED|Period: First Intervention||9
2555274|NCT00526058|6263573|P1|COMPLETED|Period: First Intervention||9
2555275|NCT00526058|6263572|P2|STARTED|Period: First Intervention||9
2555276|NCT00526058|6263573|P1|STARTED|Period: First Intervention||9
2555277|NCT00525915|6263587|P2|NOT COMPLETED|Overall Study||9
2555278|NCT00525915|6263588|P1|NOT COMPLETED|Overall Study||8
2555279|NCT00525915|6263587|P2|COMPLETED|Overall Study||54
2555280|NCT00525915|6263588|P1|COMPLETED|Overall Study|Participants who underwent surgery.|55
2555281|NCT00525915|6263587|P2|STARTED|Overall Study||63
2555282|NCT00525915|6263588|P1|STARTED|Overall Study||63
2555283|NCT00525902|6263594|P1|NOT COMPLETED|Overall Study||1
2555284|NCT00525902|6263594|P1|COMPLETED|Overall Study||30
2555285|NCT00525902|6263594|P1|50 Weeks|Overall Study||12
2555286|NCT00525902|6263594|P1|10 Weeks|Overall Study||30
2555287|NCT00525902|6263594|P1|STARTED|Overall Study||31
2555288|NCT00525876|6263601|P2|NOT COMPLETED|Overall Study||0
2555289|NCT00525876|6263602|P1|NOT COMPLETED|Overall Study||0
2555290|NCT00525876|6263601|P2|COMPLETED|Overall Study||20
2555291|NCT00525876|6263602|P1|COMPLETED|Overall Study||16
2555292|NCT00525876|6263601|P2|STARTED|Overall Study||20
2555293|NCT00525876|6263602|P1|STARTED|Overall Study||16
2555294|NCT00525837|6263608|P1|NOT COMPLETED|Overall Study||4
2555295|NCT00525837|6263608|P1|COMPLETED|Overall Study||14
2555296|NCT00525837|6263608|P1|STARTED|Overall Study||18
2555297|NCT00525824|6263618|P4|NOT COMPLETED|Overall Study||15
2555298|NCT00525824|6263619|P3|NOT COMPLETED|Overall Study||19
2555299|NCT00525824|6263620|P2|NOT COMPLETED|Overall Study||28
2555300|NCT00525824|6263621|P1|NOT COMPLETED|Overall Study||19
2555301|NCT00525824|6263618|P4|COMPLETED|Overall Study||188
2555302|NCT00525824|6263619|P3|COMPLETED|Overall Study||183
2555303|NCT00525824|6263620|P2|COMPLETED|Overall Study||186
2555304|NCT00525824|6263621|P1|COMPLETED|Overall Study||195
2555305|NCT00525824|6263618|P4|STARTED|Overall Study|Randomized population|203
2555306|NCT00525824|6263619|P3|STARTED|Overall Study|Randomized population|202
2555307|NCT00525824|6263620|P2|STARTED|Overall Study|Randomized population|214
2555308|NCT00525824|6263621|P1|STARTED|Overall Study|Randomized population|214
2555309|NCT00525798|6263685|P2|NOT COMPLETED|Overall Study||599
2555310|NCT00525798|6263686|P1|NOT COMPLETED|Overall Study||756
2555311|NCT00525798|6263685|P2|COMPLETED|Overall Study||1732
2555312|NCT00525798|6263686|P1|COMPLETED|Overall Study||1578
2555313|NCT00525798|6263685|P2|STARTED|Overall Study||2331
2555314|NCT00525798|6263686|P1|STARTED|Overall Study||2334
2555315|NCT00525785|6263694|P1|NOT COMPLETED|Overall Study||3
2555316|NCT00525785|6263694|P1|COMPLETED|Overall Study||55
2555317|NCT00525785|6263694|P1|STARTED|Overall Study||58
2555318|NCT00525733|6263700|P2|NOT COMPLETED|Overall Study||3
2555319|NCT00525733|6263701|P1|NOT COMPLETED|Overall Study||3
2555320|NCT00525733|6263700|P2|COMPLETED|Overall Study||23
2555321|NCT00525733|6263701|P1|COMPLETED|Overall Study||11
2555322|NCT00525733|6263700|P2|STARTED|Overall Study||26
2555323|NCT00525733|6263701|P1|STARTED|Overall Study||14
2555324|NCT00525629|6263707|P2|NOT COMPLETED|Second Intervention||15
2555325|NCT00525629|6263708|P1|NOT COMPLETED|Second Intervention||15
2555326|NCT00525629|6263707|P2|COMPLETED|Second Intervention||0
2555327|NCT00525629|6263708|P1|COMPLETED|Second Intervention||0
2555328|NCT00525629|6263707|P2|STARTED|Second Intervention||15
2555329|NCT00525629|6263708|P1|STARTED|Second Intervention||15
2555330|NCT00525629|6263707|P2|NOT COMPLETED|Washout||0
2555331|NCT00525629|6263708|P1|NOT COMPLETED|Washout||0
2555332|NCT00525629|6263707|P2|COMPLETED|Washout||15
2555333|NCT00525629|6263708|P1|COMPLETED|Washout||15
2555334|NCT00525629|6263707|P2|STARTED|Washout||15
2555335|NCT00525629|6263708|P1|STARTED|Washout||15
2555336|NCT00525629|6263707|P2|NOT COMPLETED|First Intervention||5
2555337|NCT00525629|6263708|P1|NOT COMPLETED|First Intervention||5
2555338|NCT00525629|6263707|P2|COMPLETED|First Intervention||15
2555339|NCT00525629|6263708|P1|COMPLETED|First Intervention||15
2555340|NCT00525629|6263707|P2|STARTED|First Intervention||20
2555341|NCT00525629|6263708|P1|STARTED|First Intervention||20
2555342|NCT00525603|6263714|P1|NOT COMPLETED|Overall Study||0
2555343|NCT00525603|6263714|P1|COMPLETED|Overall Study||60
2555344|NCT00525603|6263714|P1|STARTED|Overall Study||60
2555345|NCT00525525|6263720|P2|NOT COMPLETED|Overall Study||0
2555346|NCT00525525|6263721|P1|NOT COMPLETED|Overall Study||0
2555347|NCT00525525|6263720|P2|COMPLETED|Overall Study||15
2555348|NCT00525525|6263721|P1|COMPLETED|Overall Study||59
2555349|NCT00525525|6263720|P2|STARTED|Overall Study||15
2555350|NCT00525525|6263721|P1|STARTED|Overall Study||59
2555351|NCT00525512|6263730|P4|NOT COMPLETED|Open-Label Phase||5
2555352|NCT00525512|6263731|P3|NOT COMPLETED|Open-Label Phase||6
2555353|NCT00525512|6263732|P2|NOT COMPLETED|Open-Label Phase||0
2555354|NCT00525512|6263733|P1|NOT COMPLETED|Open-Label Phase||0
2555355|NCT00525512|6263730|P4|COMPLETED|Open-Label Phase||189
2555356|NCT00525512|6263731|P3|COMPLETED|Open-Label Phase||158
2555357|NCT00525512|6263732|P2|COMPLETED|Open-Label Phase||0
2555358|NCT00525512|6263733|P1|COMPLETED|Open-Label Phase||0
2555359|NCT00525512|6263730|P4|STARTED|Open-Label Phase||194
2555360|NCT00525512|6263731|P3|STARTED|Open-Label Phase||164
2555361|NCT00525512|6263732|P2|STARTED|Open-Label Phase||0
2555362|NCT00525512|6263733|P1|STARTED|Open-Label Phase||0
2555363|NCT00525512|6263730|P4|NOT COMPLETED|Double-Blind Phase||0
2555364|NCT00525512|6263731|P3|NOT COMPLETED|Double-Blind Phase||0
2555365|NCT00525512|6263732|P2|NOT COMPLETED|Double-Blind Phase||66
2555366|NCT00525512|6263733|P1|NOT COMPLETED|Double-Blind Phase||96
2555367|NCT00525512|6263730|P4|COMPLETED|Double-Blind Phase||0
2555368|NCT00525512|6263731|P3|COMPLETED|Double-Blind Phase||0
2555369|NCT00525512|6263732|P2|COMPLETED|Double-Blind Phase||194
2555370|NCT00525512|6263733|P1|COMPLETED|Double-Blind Phase||163
2555371|NCT00525512|6263730|P4|STARTED|Double-Blind Phase||0
2555372|NCT00525512|6263731|P3|STARTED|Double-Blind Phase||0
2555373|NCT00525512|6263732|P2|STARTED|Double-Blind Phase||260
2555374|NCT00525512|6263733|P1|STARTED|Double-Blind Phase||259
2555375|NCT00525499|6263875|P4|NOT COMPLETED|Overall Study||7
2555376|NCT00525499|6263876|P3|NOT COMPLETED|Overall Study||7
2555377|NCT00525499|6263877|P2|NOT COMPLETED|Overall Study||7
2555378|NCT00525499|6263878|P1|NOT COMPLETED|Overall Study||7
2555379|NCT00525499|6263875|P4|COMPLETED|Overall Study||39
2555380|NCT00525499|6263876|P3|COMPLETED|Overall Study||40
2555381|NCT00525499|6263877|P2|COMPLETED|Overall Study||39
2555382|NCT00525499|6263878|P1|COMPLETED|Overall Study||40
2555383|NCT00525499|6263875|P4|STARTED|Overall Study||46
2555384|NCT00525499|6263876|P3|STARTED|Overall Study||47
2555385|NCT00525499|6263877|P2|STARTED|Overall Study||46
2555386|NCT00525499|6263878|P1|STARTED|Overall Study||47
2555387|NCT00525421|6263894|P2|NOT COMPLETED|Overall Study||0
2555388|NCT00525421|6263895|P1|NOT COMPLETED|Overall Study||0
2555389|NCT00525421|6263894|P2|COMPLETED|Overall Study||10
2555390|NCT00525421|6263895|P1|COMPLETED|Overall Study||10
2555391|NCT00525421|6263894|P2|STARTED|Overall Study||10
2555392|NCT00525421|6263895|P1|STARTED|Overall Study|Enrollment started october 2007|10
2555393|NCT00525265|6263905|P2|NOT COMPLETED|Overall Study||0
2555394|NCT00525265|6263906|P1|NOT COMPLETED|Overall Study||1
2555395|NCT00525265|6263905|P2|COMPLETED|Overall Study||10
2555396|NCT00525265|6263906|P1|COMPLETED|Overall Study||9
2555397|NCT00525265|6263905|P2|STARTED|Overall Study||10
2555398|NCT00525265|6263906|P1|STARTED|Overall Study||10
2555399|NCT00525174|6263914|P2|NOT COMPLETED|Overall Study||8
2555400|NCT00525174|6263915|P1|NOT COMPLETED|Overall Study||9
2555401|NCT00525174|6263914|P2|COMPLETED|Overall Study||81
2555402|NCT00525174|6263915|P1|COMPLETED|Overall Study||88
2555403|NCT00525174|6263914|P2|STARTED|Overall Study||89
2555404|NCT00525174|6263915|P1|STARTED|Overall Study||97
2555405|NCT00525161|6263963|P1|NOT COMPLETED|Overall Study||1
2555406|NCT00525161|6263963|P1|COMPLETED|Overall Study||10
2555407|NCT00525161|6263963|P1|STARTED|Overall Study||11
2555408|NCT00525148|6263973|P4|NOT COMPLETED|Overall Study||61
2555409|NCT00525148|6263974|P3|NOT COMPLETED|Overall Study||7
2555410|NCT00525148|6263975|P2|NOT COMPLETED|Overall Study||38
2555411|NCT00525148|6263976|P1|NOT COMPLETED|Overall Study||23
2555412|NCT00525148|6263973|P4|COMPLETED|Overall Study||0
2555413|NCT00525148|6263974|P3|COMPLETED|Overall Study||0
2555414|NCT00525148|6263975|P2|COMPLETED|Overall Study||0
2555415|NCT00525148|6263976|P1|COMPLETED|Overall Study||0
2555416|NCT00525148|6263973|P4|STARTED|Overall Study|entered and treated|61
2555417|NCT00525148|6263974|P3|STARTED|Overall Study|entered and treated|7
2555418|NCT00525148|6263975|P2|STARTED|Overall Study|entered and treated|38
2555419|NCT00525148|6263976|P1|STARTED|Overall Study|entered and treated|23
2555420|NCT00525135|6263994|P1|NOT COMPLETED|Overall Study||0
2555421|NCT00525135|6263994|P1|COMPLETED|Overall Study||5
2555422|NCT00525135|6263994|P1|STARTED|Overall Study||5
2555423|NCT00525044|6264004|P2|NOT COMPLETED|Overall Study||1
2555424|NCT00525044|6264005|P1|NOT COMPLETED|Overall Study||0
2555425|NCT00525044|6264004|P2|COMPLETED|Overall Study||124
2555426|NCT00525044|6264005|P1|COMPLETED|Overall Study||124
2555427|NCT00525044|6264004|P2|STARTED|Overall Study||125
2555428|NCT00525044|6264005|P1|STARTED|Overall Study||124
2555429|NCT00525031|6264021|P2|NOT COMPLETED|Overall Study||1
2555430|NCT00525031|6264022|P1|NOT COMPLETED|Overall Study||1
2555431|NCT00525031|6264021|P2|COMPLETED|Overall Study||24
2555432|NCT00525031|6264022|P1|COMPLETED|Overall Study||26
2555433|NCT00525031|6264021|P2|STARTED|Overall Study||25
2555434|NCT00525031|6264022|P1|STARTED|Overall Study||27
2555435|NCT00524940|6264029|P1|NOT COMPLETED|Overall Study||0
2555436|NCT00524940|6264029|P1|COMPLETED|Overall Study||124
2555437|NCT00524940|6264029|P1|STARTED|Overall Study||124
2555438|NCT00524771|6264036|P2|NOT COMPLETED|Overall Study||585
2555439|NCT00524771|6264037|P1|NOT COMPLETED|Overall Study||220
2555440|NCT00524771|6264036|P2|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16431
2555441|NCT00524771|6264037|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16864
2555442|NCT00524771|6264036|P2|STARTED|Overall Study||17016
2555443|NCT00524771|6264037|P1|STARTED|Overall Study||17084
2555444|NCT00524745|6264051|P4|NOT COMPLETED|Overall Study||22
2555445|NCT00524745|6264052|P3|NOT COMPLETED|Overall Study||29
2555446|NCT00524745|6264053|P2|NOT COMPLETED|Overall Study||13
2555447|NCT00524745|6264054|P1|NOT COMPLETED|Overall Study||34
2555448|NCT00524745|6264051|P4|COMPLETED|Overall Study||205
2555449|NCT00524745|6264052|P3|COMPLETED|Overall Study||212
2555450|NCT00524745|6264053|P2|COMPLETED|Overall Study||193
2555451|NCT00524745|6264054|P1|COMPLETED|Overall Study||195
2555452|NCT00524745|6264051|P4|STARTED|Overall Study||227
2555453|NCT00524745|6264052|P3|STARTED|Overall Study||241
2555454|NCT00524745|6264053|P2|STARTED|Overall Study||206
2555455|NCT00524745|6264054|P1|STARTED|Overall Study||229
2555456|NCT00524680|6264080|P4|NOT COMPLETED|Overall Study||6
2555457|NCT00524680|6264081|P3|NOT COMPLETED|Overall Study||3
2555458|NCT00524680|6264082|P2|NOT COMPLETED|Overall Study||1
2555459|NCT00524680|6264083|P1|NOT COMPLETED|Overall Study||3
2555460|NCT00524680|6264080|P4|COMPLETED|Overall Study||34
2555461|NCT00524680|6264081|P3|COMPLETED|Overall Study||33
2555462|NCT00524680|6264082|P2|COMPLETED|Overall Study||34
2555463|NCT00524680|6264083|P1|COMPLETED|Overall Study||34
2555464|NCT00524680|6264080|P4|STARTED|Overall Study||40
2555465|NCT00524680|6264081|P3|STARTED|Overall Study||36
2555466|NCT00524680|6264082|P2|STARTED|Overall Study||35
2555467|NCT00524680|6264083|P1|STARTED|Overall Study||37
2555468|NCT00524589|6264105|P1|NOT COMPLETED|Overall Study||18
2555469|NCT00524589|6264105|P1|COMPLETED|Overall Study||0
2555470|NCT00524589|6264105|P1|STARTED|Overall Study||18
2555471|NCT00524576|6264112|P2|NOT COMPLETED|Overall Study||0
2555472|NCT00524576|6264113|P1|NOT COMPLETED|Overall Study||0
2555473|NCT00524576|6264112|P2|COMPLETED|Overall Study||47
2555474|NCT00524576|6264113|P1|COMPLETED|Overall Study||97
2555475|NCT00524576|6264112|P2|STARTED|Overall Study||47
2555476|NCT00524576|6264113|P1|STARTED|Overall Study||97
2555477|NCT00524537|6264131|P1|NOT COMPLETED|Overall Study||2574
2555478|NCT00524537|6264131|P1|COMPLETED|Overall Study|Still enrolled in study at the end of study|2451
2555479|NCT00524537|6264131|P1|Discontinued After Re-enrollment|Overall Study|Discontinued from study after re-enrollment|102
2555480|NCT00524537|6264131|P1|Re-enrolled|Overall Study|Discontinued from study and later re-enrolled in study|339
2555481|NCT00524537|6264131|P1|Discontinued|Overall Study|Discontinued from study|2811
2555482|NCT00524537|6264131|P1|STARTED|Overall Study|All Treated Population: All participants who received at least 1 injection of Humira in the registry|5025
2555483|NCT00524511|6264147|P2|NOT COMPLETED|Overall Study||7
2555484|NCT00524511|6264148|P1|NOT COMPLETED|Overall Study||4
2555485|NCT00524511|6264147|P2|COMPLETED|Overall Study||61
2555486|NCT00524511|6264148|P1|COMPLETED|Overall Study||64
2555487|NCT00524511|6264147|P2|STARTED|Overall Study||68
2555488|NCT00524511|6264148|P1|STARTED|Overall Study||68
2555489|NCT00524485|6264156|P1|NOT COMPLETED|Overall Study||5
2555490|NCT00524485|6264156|P1|COMPLETED|Overall Study||7
2555491|NCT00524485|6264156|P1|STARTED|Overall Study||12
2555492|NCT00524472|6264168|P2|NOT COMPLETED|Overall Study||0
2555493|NCT00524472|6264169|P1|NOT COMPLETED|Overall Study||0
2555494|NCT00524472|6264168|P2|COMPLETED|Overall Study||730
2555495|NCT00524472|6264169|P1|COMPLETED|Overall Study||709
2555496|NCT00524472|6264168|P2|STARTED|Overall Study||730
2555497|NCT00524472|6264169|P1|STARTED|Overall Study||709
2555498|NCT00524459|6264185|P1|NOT COMPLETED|Overall Study||2
2555499|NCT00524459|6264185|P1|COMPLETED|Overall Study||4
2555500|NCT00524459|6264185|P1|STARTED|Overall Study||6
2555501|NCT00524420|6264195|P2|NOT COMPLETED|Overall Study||0
2555502|NCT00524420|6264196|P1|NOT COMPLETED|Overall Study||1
2555503|NCT00524420|6264195|P2|COMPLETED|Overall Study||11
2555504|NCT00524420|6264196|P1|COMPLETED|Overall Study|1 dropped out after treatment 10 because of poor response and was included in the efficacy analyses.|7
2555505|NCT00524420|6264195|P2|STARTED|Overall Study||11
2555506|NCT00524420|6264196|P1|STARTED|Overall Study|One was incorrectly randomized;she did not have a BIRS of >7. Was excluded from efficacy analysis.|8
2555507|NCT00524394|6264208|P1|NOT COMPLETED|Overall Study||1
2555508|NCT00524394|6264208|P1|COMPLETED|Overall Study||1
2555509|NCT00524394|6264208|P1|STARTED|Overall Study||2
2555510|NCT00524368|6264214|P2|NOT COMPLETED|Overall Study||48
2555511|NCT00524368|6264215|P1|NOT COMPLETED|Overall Study||41
2555512|NCT00524368|6264214|P2|COMPLETED|Overall Study||248
2555513|NCT00524368|6264215|P1|COMPLETED|Overall Study||253
2555514|NCT00524368|6264214|P2|STARTED|Overall Study||296
2555515|NCT00524368|6264215|P1|STARTED|Overall Study||294
2555516|NCT00524342|6264243|P1|NOT COMPLETED|Overall Study||0
2555517|NCT00524342|6264243|P1|COMPLETED|Overall Study||7
2555518|NCT00524342|6264243|P1|STARTED|Overall Study||7
2555519|NCT00524316|6264249|P1|NOT COMPLETED|Overall Study||16
2555520|NCT00524316|6264249|P1|COMPLETED|Overall Study||0
2555521|NCT00524316|6264249|P1|STARTED|Overall Study||16
2555522|NCT00524303|6264261|P3|NOT COMPLETED|Overall Study||18
2555523|NCT00524303|6264262|P2|NOT COMPLETED|Overall Study||10
2555524|NCT00524303|6264263|P1|NOT COMPLETED|Overall Study||12
2555525|NCT00524303|6264261|P3|COMPLETED|Overall Study||15
2555526|NCT00524303|6264262|P2|COMPLETED|Overall Study||24
2555527|NCT00524303|6264263|P1|COMPLETED|Overall Study||21
2555528|NCT00524303|6264261|P3|STARTED|Overall Study||33
2555529|NCT00524303|6264262|P2|STARTED|Overall Study||34
2555530|NCT00524303|6264263|P1|STARTED|Overall Study||33
2555531|NCT00524264|6264293|P2|NOT COMPLETED|Overall Study||27
2555532|NCT00524264|6264294|P1|NOT COMPLETED|Overall Study||20
2555533|NCT00524264|6264293|P2|COMPLETED|Overall Study||57
2555534|NCT00524264|6264294|P1|COMPLETED|Overall Study||144
2555535|NCT00524264|6264293|P2|STARTED|Overall Study||84
2555536|NCT00524264|6264294|P1|STARTED|Overall Study||164
2555537|NCT00524225|6264306|P1|NOT COMPLETED|Overall Study||0
2555538|NCT00524225|6264306|P1|COMPLETED|Overall Study||3
2555539|NCT00524225|6264306|P1|STARTED|Overall Study||3
2555540|NCT00524173|6264315|P2|NOT COMPLETED|Overall Study||2
2555541|NCT00524173|6264316|P1|NOT COMPLETED|Overall Study||5
2555542|NCT00524173|6264315|P2|COMPLETED|Overall Study||13
2555543|NCT00524173|6264316|P1|COMPLETED|Overall Study||12
2555544|NCT00524173|6264315|P2|STARTED|Overall Study||15
2555545|NCT00524173|6264316|P1|STARTED|Overall Study||17
2555546|NCT00524134|6264328|P1|NOT COMPLETED|Overall Study||2
2555547|NCT00524134|6264328|P1|COMPLETED|Overall Study||4
2555548|NCT00524134|6264328|P1|STARTED|Overall Study||6
2555549|NCT00524121|6264335|P1|NOT COMPLETED|Overall Study||19
2555550|NCT00524121|6264335|P1|COMPLETED|Overall Study||3
2555551|NCT00524121|6264335|P1|STARTED|Overall Study||22
2555552|NCT00524043|6264355|P3|NOT COMPLETED|Overall Study||31
2555553|NCT00524043|6264356|P2|NOT COMPLETED|Overall Study||28
2555554|NCT00524043|6264357|P1|NOT COMPLETED|Overall Study||30
2555555|NCT00524043|6264355|P3|COMPLETED|Overall Study||35
2555556|NCT00524043|6264356|P2|COMPLETED|Overall Study||42
2555557|NCT00524043|6264357|P1|COMPLETED|Overall Study||34
2555558|NCT00524043|6264355|P3|STARTED|Overall Study||66
2555559|NCT00524043|6264356|P2|STARTED|Overall Study||70
2555560|NCT00524043|6264357|P1|STARTED|Overall Study|One patient was randomly assigned to treatment but did not receive placebo.|64
2555561|NCT00524030|6264379|P2|NOT COMPLETED|Overall Study||59
2555562|NCT00524030|6264380|P1|NOT COMPLETED|Overall Study||17
2555563|NCT00524030|6264379|P2|COMPLETED|Overall Study||70
2555564|NCT00524030|6264380|P1|COMPLETED|Overall Study||15
2555565|NCT00524030|6264379|P2|Completed Taper/Titration Phase|Overall Study||70
2555566|NCT00524030|6264380|P1|Completed Taper/Titration Phase|Overall Study||15
2555567|NCT00524030|6264379|P2|Completed Double-Blind Treatment Phase|Overall Study||70
2555568|NCT00524030|6264380|P1|Completed Double-Blind Treatment Phase|Overall Study||15
2555569|NCT00524030|6264379|P2|STARTED|Overall Study||129
2555570|NCT00524030|6264380|P1|STARTED|Overall Study||32
2555571|NCT00523991|6264400|P2|NOT COMPLETED|Overall Study||27
2555572|NCT00523991|6264401|P1|NOT COMPLETED|Overall Study||21
2555573|NCT00523991|6264400|P2|COMPLETED|Overall Study||211
2555574|NCT00523991|6264401|P1|COMPLETED|Overall Study||198
2555575|NCT00523991|6264400|P2|STARTED|Overall Study||238
2555576|NCT00523991|6264401|P1|STARTED|Overall Study||219
2555577|NCT00523978|6264681|P2|NOT COMPLETED|Overall Study||8
2555578|NCT00523978|6264682|P1|NOT COMPLETED|Overall Study||9
2555579|NCT00523978|6264681|P2|COMPLETED|Overall Study||79
2555580|NCT00523978|6264682|P1|COMPLETED|Overall Study||162
2555581|NCT00523978|6264681|P2|STARTED|Overall Study||87
2555582|NCT00523978|6264682|P1|STARTED|Overall Study||171
2555583|NCT00523939|6264696|P2|NOT COMPLETED|Overall Study||0
2555584|NCT00523939|6264697|P1|NOT COMPLETED|Overall Study||0
2555585|NCT00523939|6264696|P2|COMPLETED|Overall Study||2
2555586|NCT00523939|6264697|P1|COMPLETED|Overall Study||2
2555587|NCT00523939|6264696|P2|STARTED|Overall Study||2
2555588|NCT00523939|6264697|P1|STARTED|Overall Study||2
2555589|NCT00523848|6264704|P1|NOT COMPLETED|Overall Study||24
2555590|NCT00523848|6264704|P1|COMPLETED|Overall Study||22
2555591|NCT00523848|6264704|P1|Treated With Study Therapy|Overall Study||44
2555592|NCT00523848|6264704|P1|STARTED|Overall Study||46
2555593|NCT00523809|6264710|P1|NOT COMPLETED|Overall Study||0
2555594|NCT00523809|6264710|P1|COMPLETED|Overall Study||5
2555595|NCT00523809|6264710|P1|STARTED|Overall Study||5
2555596|NCT00523744|6264714|P1|NOT COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||0
2555597|NCT00523744|6264714|P1|COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||91
2555598|NCT00523744|6264714|P1|STARTED|Phase 3 - Amlodipine+Valsartan+HCTZ|Only patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg at the end of Phase 2.|91
2555599|NCT00523744|6264714|P1|NOT COMPLETED|Phase 2 - Amlodipine+Valsartan||3
2555600|NCT00523744|6264714|P1|COMPLETED|Phase 2 - Amlodipine+Valsartan||173
2555601|NCT00523744|6264714|P1|STARTED|Phase 2 - Amlodipine+Valsartan|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|176
2555602|NCT00523744|6264714|P1|NOT COMPLETED|Phase 1 - Amlodipine+Olmesartan||6
2555603|NCT00523744|6264714|P1|COMPLETED|Phase 1 - Amlodipine+Olmesartan||251
2555604|NCT00523744|6264714|P1|STARTED|Phase 1 - Amlodipine+Olmesartan||257
2555605|NCT00523718|6264733|P2|NOT COMPLETED|Overall Study||0
2555606|NCT00523718|6264734|P1|NOT COMPLETED|Overall Study||3
2555607|NCT00523718|6264733|P2|COMPLETED|Overall Study||18
2555608|NCT00523718|6264734|P1|COMPLETED|Overall Study||17
2555609|NCT00523718|6264733|P2|STARTED|Overall Study||18
2555610|NCT00523718|6264734|P1|STARTED|Overall Study||20
2555611|NCT00523705|6264748|P2|NOT COMPLETED|Overall Study||1
2555612|NCT00523705|6264749|P1|NOT COMPLETED|Overall Study||0
2555613|NCT00523705|6264748|P2|COMPLETED|Overall Study|1 withdrew due to no time|3
2555614|NCT00523705|6264749|P1|COMPLETED|Overall Study||7
2555615|NCT00523705|6264748|P2|STARTED|Overall Study||4
2555616|NCT00523705|6264749|P1|STARTED|Overall Study||7
2555617|NCT00523640|6264761|P1|NOT COMPLETED|Overall Study||1
2555618|NCT00523640|6264761|P1|COMPLETED|Overall Study|1 patient died before starting treatment|29
2555619|NCT00523640|6264761|P1|STARTED|Overall Study||30
2555620|NCT00523614|6264769|P2|NOT COMPLETED|Overall Study||0
2555621|NCT00523614|6264770|P1|NOT COMPLETED|Overall Study||0
2555622|NCT00523614|6264769|P2|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
2555623|NCT00523614|6264770|P1|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
2555624|NCT00523614|6264769|P2|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
2555625|NCT00523614|6264770|P1|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
2555626|NCT00523549|6264778|P2|NOT COMPLETED|Overall Study||16
2555627|NCT00523549|6264779|P1|NOT COMPLETED|Overall Study||19
2555628|NCT00523549|6264778|P2|COMPLETED|Overall Study||99
2555629|NCT00523549|6264779|P1|COMPLETED|Overall Study||95
2555630|NCT00523549|6264778|P2|STARTED|Overall Study||115
2555631|NCT00523549|6264779|P1|STARTED|Overall Study||114
2555632|NCT00523419|6264797|P1|NOT COMPLETED|Overall Study||32
2555633|NCT00523419|6264797|P1|COMPLETED|Overall Study||0
2555634|NCT00523419|6264797|P1|STARTED|Overall Study||32
2555635|NCT00523367|6264807|P1|NOT COMPLETED|Overall Study||23
2555636|NCT00523367|6264807|P1|COMPLETED|Overall Study||2
2555637|NCT00523367|6264807|P1|STARTED|Overall Study||25
2555638|NCT00523341|6264813|P2|NOT COMPLETED|Overall Study||1000
2555639|NCT00523341|6264814|P1|NOT COMPLETED|Overall Study||924
2555640|NCT00523341|6264813|P2|COMPLETED|Overall Study||1343
2555641|NCT00523341|6264814|P1|COMPLETED|Overall Study||1283
2555642|NCT00523341|6264813|P2|Received Treatment|Overall Study||2343
2555643|NCT00523341|6264814|P1|Received Treatment|Overall Study||2206
2555644|NCT00523341|6264813|P2|STARTED|Overall Study||2343
2555645|NCT00523341|6264814|P1|STARTED|Overall Study||2207
2555646|NCT00523302|6264916|P2|NOT COMPLETED|Overall Study||0
2555647|NCT00523302|6264917|P1|NOT COMPLETED|Overall Study||0
2555648|NCT00523302|6264916|P2|COMPLETED|Overall Study||10
2555649|NCT00523302|6264917|P1|COMPLETED|Overall Study||10
2555650|NCT00523302|6264916|P2|STARTED|Overall Study||10
2555651|NCT00523302|6264917|P1|STARTED|Overall Study||10
2555652|NCT00523237|6264927|P1|NOT COMPLETED|Overall Study||0
2555653|NCT00523237|6264927|P1|COMPLETED|Overall Study||14
2555654|NCT00523237|6264927|P1|STARTED|Overall Study||14
2555655|NCT00522951|6264931|P2|NOT COMPLETED|Period 2||1
2555656|NCT00522951|6264932|P1|NOT COMPLETED|Period 2||2
2555657|NCT00522951|6264931|P2|COMPLETED|Period 2||75
2555658|NCT00522951|6264932|P1|COMPLETED|Period 2||84
2555659|NCT00522951|6264931|P2|Subjects Received Treatment|Period 2||75
2555660|NCT00522951|6264932|P1|Subjects Received Treatment|Period 2||84
2555661|NCT00522951|6264931|P2|STARTED|Period 2||76
2555662|NCT00522951|6264932|P1|STARTED|Period 2||86
2555663|NCT00522951|6264931|P2|NOT COMPLETED|Washout Period||2
2555664|NCT00522951|6264932|P1|NOT COMPLETED|Washout Period||0
2555665|NCT00522951|6264931|P2|COMPLETED|Washout Period||76
2555666|NCT00522951|6264932|P1|COMPLETED|Washout Period||86
2555667|NCT00522951|6264931|P2|STARTED|Washout Period||78
2555668|NCT00522951|6264932|P1|STARTED|Washout Period||86
2555669|NCT00522951|6264931|P2|NOT COMPLETED|Period 1||1
2555670|NCT00522951|6264932|P1|NOT COMPLETED|Period 1||0
2555671|NCT00522951|6264931|P2|COMPLETED|Period 1||78
2555672|NCT00522951|6264932|P1|COMPLETED|Period 1||86
2555673|NCT00522951|6264931|P2|Received Treatment|Period 1||78
2555674|NCT00522951|6264932|P1|Received Treatment|Period 1||86
2555675|NCT00522951|6264931|P2|STARTED|Period 1||79
2555676|NCT00522951|6264932|P1|STARTED|Period 1||86
2555677|NCT00522925|6264975|P3|NOT COMPLETED|Overall Study||2
2555678|NCT00522925|6264976|P2|NOT COMPLETED|Overall Study||1
2555679|NCT00522925|6264977|P1|NOT COMPLETED|Overall Study||8
2555680|NCT00522925|6264975|P3|COMPLETED|Overall Study||36
2555681|NCT00522925|6264976|P2|COMPLETED|Overall Study||38
2555682|NCT00522925|6264977|P1|COMPLETED|Overall Study||28
2555683|NCT00522925|6264975|P3|STARTED|Overall Study||38
2555684|NCT00522925|6264976|P2|STARTED|Overall Study||39
2555685|NCT00522925|6264977|P1|STARTED|Overall Study||36
2555686|NCT00522873|6264987|P2|NOT COMPLETED|Overall Study||44
2555687|NCT00522873|6264988|P1|NOT COMPLETED|Overall Study||96
2555688|NCT00522873|6264987|P2|COMPLETED|Overall Study|128 women completed study medication. 129 women completed the study.|128
2555689|NCT00522873|6264988|P1|COMPLETED|Overall Study|394 women completed study medication. 398 women completed the study.|394
2555690|NCT00522873|6264987|P2|Received Treatment|Overall Study||172
2555691|NCT00522873|6264988|P1|Received Treatment|Overall Study||489
2555692|NCT00522873|6264987|P2|STARTED|Overall Study||172
2555693|NCT00522873|6264988|P1|STARTED|Overall Study||490
2555697|NCT00522626|6265001|P1|NOT COMPLETED|Overall Study||7
2555698|NCT00522626|6265001|P1|COMPLETED|Overall Study||12
2555699|NCT00522626|6265001|P1|STARTED|Overall Study||19
2555700|NCT00522548|6265007|P2|NOT COMPLETED|Overall Study||4
2555701|NCT00522548|6265008|P1|NOT COMPLETED|Overall Study||2
2555702|NCT00522548|6265007|P2|COMPLETED|Overall Study||15
2555703|NCT00522548|6265008|P1|COMPLETED|Overall Study||16
2555704|NCT00522548|6265007|P2|Completed 2/2 PK Visits|Overall Study||5
2555705|NCT00522548|6265008|P1|Completed 2/2 PK Visits|Overall Study||7
2555706|NCT00522548|6265007|P2|Completed 1/2 PK Visits|Overall Study||1
2555707|NCT00522548|6265008|P1|Completed 1/2 PK Visits|Overall Study||1
2555708|NCT00522548|6265007|P2|Completed 0/2 PK Visits|Overall Study||4
2555709|NCT00522548|6265008|P1|Completed 0/2 PK Visits|Overall Study||3
2555710|NCT00522548|6265007|P2|Consented to Pharmacokinetic Study|Overall Study||10
2555711|NCT00522548|6265008|P1|Consented to Pharmacokinetic Study|Overall Study||11
2555712|NCT00522548|6265007|P2|STARTED|Overall Study||19
2555713|NCT00522548|6265008|P1|STARTED|Overall Study||18
2555714|NCT00522457|6265036|P1|NOT COMPLETED|Overall Study||18
2555715|NCT00522457|6265036|P1|COMPLETED|Overall Study||1
2555716|NCT00522457|6265036|P1|STARTED|Overall Study||19
2555717|NCT00522431|6265042|P1|NOT COMPLETED|Overall Study||11
2555718|NCT00522431|6265042|P1|COMPLETED|Overall Study||138
2555719|NCT00522431|6265042|P1|STARTED|Overall Study||149
2555720|NCT00522418|6265049|P2|NOT COMPLETED|Overall Study||58
2555721|NCT00522418|6265050|P1|NOT COMPLETED|Overall Study||57
2555722|NCT00522418|6265049|P2|COMPLETED|Overall Study|Completed 2-year follow-up|5
2555723|NCT00522418|6265050|P1|COMPLETED|Overall Study|Completed 2-year follow-up|2
2555724|NCT00522418|6265049|P2|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|29
2555725|NCT00522418|6265050|P1|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|31
2555726|NCT00522418|6265049|P2|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|35
2555727|NCT00522418|6265050|P1|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|33
2555728|NCT00522418|6265049|P2|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|45
2555729|NCT00522418|6265050|P1|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|38
2555730|NCT00522418|6265049|P2|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
2555731|NCT00522418|6265050|P1|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
2555732|NCT00522418|6265049|P2|Efficacy Set|Overall Study|10 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
2555733|NCT00522418|6265050|P1|Efficacy Set|Overall Study|6 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
2555734|NCT00522418|6265049|P2|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site’s local ethics committee.|58
2555735|NCT00522418|6265050|P1|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site’s local ethics committee.|54
2555736|NCT00522418|6265049|P2|STARTED|Overall Study||63
2555737|NCT00522418|6265050|P1|STARTED|Overall Study||59
2555738|NCT00522392|6265098|P2|NOT COMPLETED|Overall Study||13
2555739|NCT00522392|6265099|P1|NOT COMPLETED|Overall Study||8
2555740|NCT00522392|6265098|P2|COMPLETED|Overall Study||12
2555741|NCT00522392|6265099|P1|COMPLETED|Overall Study||15
2555742|NCT00522392|6265098|P2|Pts w/ QOL Assessments Complete|Overall Study||8
2555743|NCT00522392|6265099|P1|Pts w/ QOL Assessments Complete|Overall Study||12
2555744|NCT00522392|6265098|P2|Pts w/ Measurable Disease at Baseline|Overall Study||16
2555745|NCT00522392|6265099|P1|Pts w/ Measurable Disease at Baseline|Overall Study||16
2555746|NCT00522392|6265098|P2|STARTED|Overall Study||25
2555747|NCT00522392|6265099|P1|STARTED|Overall Study||23
2555748|NCT00522379|6265116|P5|NOT COMPLETED|Overall Study||27
2555749|NCT00522379|6265117|P4|NOT COMPLETED|Overall Study||14
2555750|NCT00522379|6265118|P3|NOT COMPLETED|Overall Study||22
2555751|NCT00522379|6265119|P2|NOT COMPLETED|Overall Study||23
2555752|NCT00522379|6265120|P1|NOT COMPLETED|Overall Study||22
2555753|NCT00522379|6265116|P5|COMPLETED|Overall Study||81
2555754|NCT00522379|6265117|P4|COMPLETED|Overall Study||80
2555755|NCT00522379|6265118|P3|COMPLETED|Overall Study||82
2555756|NCT00522379|6265119|P2|COMPLETED|Overall Study||84
2555757|NCT00522379|6265120|P1|COMPLETED|Overall Study||79
2555758|NCT00522379|6265116|P5|STARTED|Overall Study||108
2555759|NCT00522379|6265117|P4|STARTED|Overall Study||94
2555760|NCT00522379|6265118|P3|STARTED|Overall Study||104
2555761|NCT00522379|6265119|P2|STARTED|Overall Study||107
2555762|NCT00522379|6265120|P1|STARTED|Overall Study||101
2555763|NCT00522301|6265222|P1|NOT COMPLETED|Overall Study||6
2555764|NCT00522301|6265222|P1|COMPLETED|Overall Study||0
2555765|NCT00522301|6265222|P1|STARTED|Overall Study||6
2555766|NCT00522275|6265226|P1|NOT COMPLETED|Overall Study||170
2555767|NCT00522275|6265226|P1|COMPLETED|Overall Study||138
2555768|NCT00522275|6265226|P1|STARTED|Overall Study||308
2555769|NCT00522171|6265236|P2|NOT COMPLETED|Overall Study||0
2555770|NCT00522171|6265237|P1|NOT COMPLETED|Overall Study||0
2555771|NCT00522171|6265236|P2|COMPLETED|Overall Study||15
2555772|NCT00522171|6265237|P1|COMPLETED|Overall Study||15
2555773|NCT00522171|6265236|P2|STARTED|Overall Study||15
2555774|NCT00522171|6265237|P1|STARTED|Overall Study||15
2555775|NCT00522041|6265247|P2|NOT COMPLETED|Overall Study||12
2555776|NCT00522041|6265248|P1|NOT COMPLETED|Overall Study||17
2555777|NCT00522041|6265247|P2|COMPLETED|Overall Study||113
2555778|NCT00522041|6265248|P1|COMPLETED|Overall Study||106
2555779|NCT00522041|6265247|P2|Received Treatment|Overall Study||124
2555780|NCT00522041|6265248|P1|Received Treatment|Overall Study||123
2555781|NCT00522041|6265247|P2|STARTED|Overall Study||125
2555782|NCT00522041|6265248|P1|STARTED|Overall Study||123
2555783|NCT00521989|6265263|P5|NOT COMPLETED|Overall Study||23
2555784|NCT00521989|6265264|P4|NOT COMPLETED|Overall Study||12
2555785|NCT00521989|6265265|P3|NOT COMPLETED|Overall Study||16
2555786|NCT00521989|6265266|P2|NOT COMPLETED|Overall Study||17
2555787|NCT00521989|6265267|P1|NOT COMPLETED|Overall Study||20
2555788|NCT00521989|6265263|P5|COMPLETED|Overall Study||35
2555789|NCT00521989|6265264|P4|COMPLETED|Overall Study||42
2555790|NCT00521989|6265265|P3|COMPLETED|Overall Study||41
2555791|NCT00521989|6265266|P2|COMPLETED|Overall Study||37
2555792|NCT00521989|6265267|P1|COMPLETED|Overall Study||36
2555793|NCT00521989|6265263|P5|STARTED|Overall Study||58
2555794|NCT00521989|6265264|P4|STARTED|Overall Study||54
2555795|NCT00521989|6265265|P3|STARTED|Overall Study||57
2555796|NCT00521989|6265266|P2|STARTED|Overall Study||54
2555797|NCT00521989|6265267|P1|STARTED|Overall Study||56
2555798|NCT00521976|6265279|P1|NOT COMPLETED|Overall Study||0
2555799|NCT00521976|6265279|P1|COMPLETED|Overall Study||871
2555800|NCT00521976|6265279|P1|STARTED|Overall Study||871
2555801|NCT00521924|6265286|P2|NOT COMPLETED|Overall Study||4
2555802|NCT00521924|6265287|P1|NOT COMPLETED|Overall Study||4
2555803|NCT00521924|6265286|P2|COMPLETED|Overall Study|At Early Termination, 3 patients completed Week 6 and 1 completed Week 22.|0
2555804|NCT00521924|6265287|P1|COMPLETED|Overall Study|At Early Termination, 1 patient completed Week 2 and 2 patients completed Week 6.|0
2555805|NCT00521924|6265286|P2|STARTED|Overall Study|Subjects randomized|4
2555806|NCT00521924|6265287|P1|STARTED|Overall Study|Subjects randomized|4
2555807|NCT00521885|6265295|P2|NOT COMPLETED|Overall Study||0
2555808|NCT00521885|6265296|P1|NOT COMPLETED|Overall Study||0
2555809|NCT00521885|6265295|P2|COMPLETED|Overall Study||0
2555810|NCT00521885|6265296|P1|COMPLETED|Overall Study||0
2555811|NCT00521885|6265295|P2|STARTED|Overall Study||0
2555812|NCT00521885|6265296|P1|STARTED|Overall Study||0
2555813|NCT00521599|6265307|P3|NOT COMPLETED|Overall Study||36
2555814|NCT00521599|6265308|P2|NOT COMPLETED|Overall Study||29
2555815|NCT00521599|6265309|P1|NOT COMPLETED|Overall Study||25
2555816|NCT00521599|6265307|P3|COMPLETED|Overall Study||100
2555817|NCT00521599|6265308|P2|COMPLETED|Overall Study||239
2555818|NCT00521599|6265309|P1|COMPLETED|Overall Study||243
2555819|NCT00521599|6265307|P3|STARTED|Overall Study||136
2555820|NCT00521599|6265308|P2|STARTED|Overall Study||268
2555821|NCT00521599|6265309|P1|STARTED|Overall Study||268
2555822|NCT00521586|6265320|P2|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||12
2555823|NCT00521586|6265321|P1|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||3
2555824|NCT00521586|6265320|P2|COMPLETED|Revaccination With 13vPnC (Year 5)||351
2555825|NCT00521586|6265321|P1|COMPLETED|Revaccination With 13vPnC (Year 5)||361
2555826|NCT00521586|6265320|P2|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||351
2555827|NCT00521586|6265321|P1|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||361
2555828|NCT00521586|6265320|P2|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||359
2555829|NCT00521586|6265321|P1|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||363
2555830|NCT00521586|6265320|P2|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||363
2555831|NCT00521586|6265321|P1|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||364
2555832|NCT00521586|6265320|P2|STARTED|Revaccination With 13vPnC (Year 5)||363
2555833|NCT00521586|6265321|P1|STARTED|Revaccination With 13vPnC (Year 5)||364
2555834|NCT00521586|6265320|P2|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||170
2555835|NCT00521586|6265321|P1|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||169
2555836|NCT00521586|6265320|P2|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||363
2555837|NCT00521586|6265321|P1|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||364
2555838|NCT00521586|6265320|P2|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
2555839|NCT00521586|6265321|P1|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
2555840|NCT00521586|6265320|P2|NOT COMPLETED|Initial Vaccination (Year 0)||29
2555841|NCT00521586|6265321|P1|NOT COMPLETED|Initial Vaccination (Year 0)||21
2555842|NCT00521586|6265320|P2|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
2555843|NCT00521586|6265321|P1|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
2555844|NCT00521586|6265320|P2|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|529
2555845|NCT00521586|6265321|P1|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|531
2555846|NCT00521586|6265320|P2|Vaccinated Dose 2|Initial Vaccination (Year 0)||543
2555847|NCT00521586|6265321|P1|Vaccinated Dose 2|Initial Vaccination (Year 0)||538
2555848|NCT00521586|6265320|P2|Vaccinated Dose 1|Initial Vaccination (Year 0)||560
2555849|NCT00521586|6265321|P1|Vaccinated Dose 1|Initial Vaccination (Year 0)||551
2555850|NCT00521586|6265320|P2|STARTED|Initial Vaccination (Year 0)||562
2555851|NCT00521586|6265321|P1|STARTED|Initial Vaccination (Year 0)||554
2555852|NCT00521456|6265381|P2|NOT COMPLETED|Overall Study||28
2555853|NCT00521456|6265382|P1|NOT COMPLETED|Overall Study||13
2555854|NCT00521456|6265381|P2|COMPLETED|Overall Study||59
2555855|NCT00521456|6265382|P1|COMPLETED|Overall Study||163
2555856|NCT00521456|6265381|P2|STARTED|Overall Study||87
2555857|NCT00521456|6265382|P1|STARTED|Overall Study||176
2555858|NCT00521365|6265394|P1|NOT COMPLETED|Overall Study||20
2555859|NCT00521365|6265394|P1|COMPLETED|Overall Study|68 participants completed the study and 68 completed without protocol deviations|68
2555860|NCT00521365|6265394|P1|Safety Analysis Set|Overall Study|All participants who received study treatment|88
2555861|NCT00521365|6265394|P1|Per Protocol (PP) Population|Overall Study|All participants without protocol deviations|68
2555862|NCT00521365|6265394|P1|Modified Intention to Treat (mITT)|Overall Study|Participants who have an YMRS assessment at inclusion, and at least one assessment after inclusion|88
2555863|NCT00521365|6265394|P1|STARTED|Overall Study|98 participants were screened and obtain 88 patients who receive study treatment|88
2555864|NCT00521352|6265413|P2|NOT COMPLETED|Overall Study||3
2555865|NCT00521352|6265414|P1|NOT COMPLETED|Overall Study||1
2555866|NCT00521352|6265413|P2|COMPLETED|Overall Study||10
2555867|NCT00521352|6265414|P1|COMPLETED|Overall Study||11
2555868|NCT00521352|6265413|P2|STARTED|Overall Study||13
2555869|NCT00521352|6265414|P1|STARTED|Overall Study||12
2555870|NCT00521339|6265424|P3|NOT COMPLETED|Observational Follow Up Phase||0
2555871|NCT00521339|6265425|P2|NOT COMPLETED|Observational Follow Up Phase||0
2555872|NCT00521339|6265426|P1|NOT COMPLETED|Observational Follow Up Phase||0
2555873|NCT00521339|6265424|P3|COMPLETED|Observational Follow Up Phase||4
2555874|NCT00521339|6265425|P2|COMPLETED|Observational Follow Up Phase||4
2555875|NCT00521339|6265426|P1|COMPLETED|Observational Follow Up Phase||14
2555876|NCT00521339|6265424|P3|STARTED|Observational Follow Up Phase||4
2555877|NCT00521339|6265425|P2|STARTED|Observational Follow Up Phase||4
2555878|NCT00521339|6265426|P1|STARTED|Observational Follow Up Phase||14
2555879|NCT00521339|6265424|P3|NOT COMPLETED|Treatment Extension Phase||3
2555880|NCT00521339|6265425|P2|NOT COMPLETED|Treatment Extension Phase||0
2555881|NCT00521339|6265426|P1|NOT COMPLETED|Treatment Extension Phase||0
2555882|NCT00521339|6265424|P3|COMPLETED|Treatment Extension Phase||4
2555883|NCT00521339|6265425|P2|COMPLETED|Treatment Extension Phase||4
2555884|NCT00521339|6265426|P1|COMPLETED|Treatment Extension Phase||0
2555885|NCT00521339|6265424|P3|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|7
2555886|NCT00521339|6265425|P2|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|4
2555887|NCT00521339|6265426|P1|STARTED|Treatment Extension Phase||0
2555888|NCT00521339|6265424|P3|NOT COMPLETED|Treatment Phase||0
2555889|NCT00521339|6265425|P2|NOT COMPLETED|Treatment Phase||0
2555890|NCT00521339|6265426|P1|NOT COMPLETED|Treatment Phase||12
2555891|NCT00521339|6265424|P3|COMPLETED|Treatment Phase||0
2555892|NCT00521339|6265425|P2|COMPLETED|Treatment Phase||0
2555893|NCT00521339|6265426|P1|COMPLETED|Treatment Phase||19
2555894|NCT00521339|6265424|P3|Received Apremilast|Treatment Phase||0
2555895|NCT00521339|6265425|P2|Received Apremilast|Treatment Phase||0
2555896|NCT00521339|6265426|P1|Received Apremilast|Treatment Phase|1 participant withdrew consent prior to first visit and was excluded from safety population|30
2555897|NCT00521339|6265424|P3|STARTED|Treatment Phase||0
2555898|NCT00521339|6265425|P2|STARTED|Treatment Phase||0
2555899|NCT00521339|6265426|P1|STARTED|Treatment Phase||31
2555900|NCT00521144|6265494|P5|NOT COMPLETED|Overall Study||7
2555901|NCT00521144|6265495|P4|NOT COMPLETED|Overall Study||1
2555902|NCT00521144|6265496|P3|NOT COMPLETED|Overall Study||2
2555903|NCT00521144|6265497|P2|NOT COMPLETED|Overall Study||3
2555904|NCT00521144|6265498|P1|NOT COMPLETED|Overall Study||4
2555905|NCT00521144|6265494|P5|COMPLETED|Overall Study||0
2555906|NCT00521144|6265495|P4|COMPLETED|Overall Study||0
2555907|NCT00521144|6265496|P3|COMPLETED|Overall Study||1
2555908|NCT00521144|6265497|P2|COMPLETED|Overall Study||2
2555909|NCT00521144|6265498|P1|COMPLETED|Overall Study||2
2555910|NCT00521144|6265494|P5|STARTED|Overall Study||7
2555911|NCT00521144|6265495|P4|STARTED|Overall Study||1
2555912|NCT00521144|6265496|P3|STARTED|Overall Study||3
2555913|NCT00521144|6265497|P2|STARTED|Overall Study||5
2555914|NCT00521144|6265498|P1|STARTED|Overall Study||6
2555915|NCT00521079|6265512|P2|NOT COMPLETED|Overall Study||5
2555916|NCT00521079|6265513|P1|NOT COMPLETED|Overall Study||14
2555917|NCT00521079|6265512|P2|COMPLETED|Overall Study||97
2555918|NCT00521079|6265513|P1|COMPLETED|Overall Study||178
2555919|NCT00521079|6265512|P2|Surgical Roll-In|Overall Study||5
2555920|NCT00521079|6265513|P1|Surgical Roll-In|Overall Study||9
2555921|NCT00521079|6265512|P2|STARTED|Overall Study||102
2555922|NCT00521079|6265513|P1|STARTED|Overall Study||192
2555923|NCT00521053|6265523|P1|NOT COMPLETED|Observation Phase||68
2555924|NCT00521053|6265523|P1|COMPLETED|Observation Phase||12
2555925|NCT00521053|6265523|P1|STARTED|Observation Phase||80
2555926|NCT00521053|6265523|P1|NOT COMPLETED|Treatment Phase||0
2555927|NCT00521053|6265523|P1|COMPLETED|Treatment Phase||80
2555928|NCT00521053|6265523|P1|Received 4 Cycles of PV-10|Treatment Phase||3
2555929|NCT00521053|6265523|P1|Received 3 Cycles of PV-10|Treatment Phase||16
2555930|NCT00521053|6265523|P1|Received 2 Cycles of PV-10|Treatment Phase||26
2555931|NCT00521053|6265523|P1|Received 1 Cycle of PV-10|Treatment Phase||35
2555932|NCT00521053|6265523|P1|STARTED|Treatment Phase||80
2555933|NCT00521014|6265533|P1|NOT COMPLETED|Overall Study||1
2555934|NCT00521014|6265533|P1|COMPLETED|Overall Study||13
2555935|NCT00521014|6265533|P1|STARTED|Overall Study||14
2555936|NCT00521001|6265537|P1|NOT COMPLETED|Overall Study||1
2555937|NCT00521001|6265537|P1|COMPLETED|Overall Study||48
2555938|NCT00521001|6265537|P1|STARTED|Overall Study||49
2555939|NCT00520975|6265546|P2|NOT COMPLETED|Overall Study||48
2555940|NCT00520975|6265547|P1|NOT COMPLETED|Overall Study||48
2555941|NCT00520975|6265546|P2|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
2555942|NCT00520975|6265547|P1|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
2555943|NCT00520975|6265546|P2|Treated and Reported Adverse Events Data|Overall Study||45
2555944|NCT00520975|6265547|P1|Treated and Reported Adverse Events Data|Overall Study||47
2555945|NCT00520975|6265546|P2|STARTED|Overall Study||48
2555946|NCT00520975|6265547|P1|STARTED|Overall Study||48
2555947|NCT00520936|6265579|P8|NOT COMPLETED|Overall Study||1
2555948|NCT00520936|6265580|P7|NOT COMPLETED|Overall Study||4
2555949|NCT00520936|6265581|P6|NOT COMPLETED|Overall Study||0
2555950|NCT00520936|6265582|P5|NOT COMPLETED|Overall Study||1
2555951|NCT00520936|6265583|P4|NOT COMPLETED|Overall Study||0
2555952|NCT00520936|6265584|P3|NOT COMPLETED|Overall Study||2
2555953|NCT00520936|6265585|P2|NOT COMPLETED|Overall Study||4
2555954|NCT00520936|6265586|P1|NOT COMPLETED|Overall Study||0
2555955|NCT00520936|6265579|P8|COMPLETED|Overall Study||9
2555956|NCT00520936|6265580|P7|COMPLETED|Overall Study||7
2555957|NCT00520936|6265581|P6|COMPLETED|Overall Study||10
2555958|NCT00520936|6265582|P5|COMPLETED|Overall Study||5
2555959|NCT00520936|6265583|P4|COMPLETED|Overall Study||5
2555960|NCT00520936|6265584|P3|COMPLETED|Overall Study||7
2555961|NCT00520936|6265585|P2|COMPLETED|Overall Study||7
2555962|NCT00520936|6265586|P1|COMPLETED|Overall Study|Study completion defined as treated until disease progression. Completed=progressive disease.|10
2555963|NCT00520936|6265579|P8|STARTED|Overall Study||10
2555964|NCT00520936|6265580|P7|STARTED|Overall Study||11
2555965|NCT00520936|6265581|P6|STARTED|Overall Study||10
2555966|NCT00520936|6265582|P5|STARTED|Overall Study||6
2555967|NCT00520936|6265583|P4|STARTED|Overall Study||5
2555968|NCT00520936|6265584|P3|STARTED|Overall Study||9
2555969|NCT00520936|6265585|P2|STARTED|Overall Study||11
2555970|NCT00520936|6265586|P1|STARTED|Overall Study|75 participants entered the study and 72 were enrolled and received study drug.|10
2555971|NCT00520910|6265615|P2|NOT COMPLETED|Overall Study||0
2555972|NCT00520910|6265616|P1|NOT COMPLETED|Overall Study||0
2555973|NCT00520910|6265615|P2|COMPLETED|Overall Study||5
2555974|NCT00520910|6265616|P1|COMPLETED|Overall Study||5
2555975|NCT00520910|6265615|P2|STARTED|Overall Study||5
2555976|NCT00520910|6265616|P1|STARTED|Overall Study||5
2555977|NCT00520884|6265626|P4|NOT COMPLETED|Overall Study||0
2555978|NCT00520884|6265627|P3|NOT COMPLETED|Overall Study||0
2555979|NCT00520884|6265628|P2|NOT COMPLETED|Overall Study||0
2555980|NCT00520884|6265629|P1|NOT COMPLETED|Overall Study||0
2555981|NCT00520884|6265626|P4|COMPLETED|Overall Study||3
2555982|NCT00520884|6265627|P3|COMPLETED|Overall Study||2
2555983|NCT00520884|6265628|P2|COMPLETED|Overall Study||2
2555984|NCT00520884|6265629|P1|COMPLETED|Overall Study||3
2555985|NCT00520884|6265626|P4|STARTED|Overall Study||3
2555986|NCT00520884|6265627|P3|STARTED|Overall Study||2
2555987|NCT00520884|6265628|P2|STARTED|Overall Study||2
2555988|NCT00520884|6265629|P1|STARTED|Overall Study||3
2555989|NCT00520845|6265641|P1|NOT COMPLETED|Overall Study||22
2555990|NCT00520845|6265641|P1|COMPLETED|Overall Study||1
2555991|NCT00520845|6265641|P1|STARTED|Overall Study||23
2555992|NCT00520767|6265649|P1|NOT COMPLETED|Overall Study||2
2555993|NCT00520767|6265649|P1|COMPLETED|Overall Study||33
2555994|NCT00520767|6265649|P1|STARTED|Overall Study||35
2555995|NCT00520741|6265655|P2|NOT COMPLETED|Overall Study||125
2555996|NCT00520741|6265656|P1|NOT COMPLETED|Overall Study||37
2555997|NCT00520741|6265655|P2|COMPLETED|Overall Study||194
2555998|NCT00520741|6265656|P1|COMPLETED|Overall Study||69
2555999|NCT00520741|6265655|P2|STARTED|Overall Study|One subject was randomized at 2 sites and excluded from the Safety Set.|319
2556000|NCT00520741|6265656|P1|STARTED|Overall Study||106
2556001|NCT00520676|6265674|P2|NOT COMPLETED|Overall Study||103
2556002|NCT00520676|6265675|P1|NOT COMPLETED|Overall Study||101
2556003|NCT00520676|6265674|P2|COMPLETED|Overall Study||29
2556004|NCT00520676|6265675|P1|COMPLETED|Overall Study||27
2556005|NCT00520676|6265674|P2|Qualified Intent-to-treat (Q-ITT)|Overall Study||105
2556006|NCT00520676|6265675|P1|Qualified Intent-to-treat (Q-ITT)|Overall Study||106
2556007|NCT00520676|6265674|P2|Received at Least 1 Dose of Study Drug|Overall Study||127
2556008|NCT00520676|6265675|P1|Received at Least 1 Dose of Study Drug|Overall Study||118
2556009|NCT00520676|6265674|P2|STARTED|Overall Study||132
2556010|NCT00520676|6265675|P1|STARTED|Overall Study||128
2556011|NCT00520572|6265701|P6|NOT COMPLETED|Overall Study||2
2556012|NCT00520572|6265702|P5|NOT COMPLETED|Overall Study||12
2556013|NCT00520572|6265703|P4|NOT COMPLETED|Overall Study||14
2556014|NCT00520572|6265704|P3|NOT COMPLETED|Overall Study||15
2556015|NCT00520572|6265705|P2|NOT COMPLETED|Overall Study||14
2556016|NCT00520572|6265706|P1|NOT COMPLETED|Overall Study||12
2556017|NCT00520572|6265701|P6|COMPLETED|Overall Study|Participants completed the study.|62
2556018|NCT00520572|6265702|P5|COMPLETED|Overall Study|Participants completed the study.|53
2556019|NCT00520572|6265703|P4|COMPLETED|Overall Study|Participants completed the study.|50
2556020|NCT00520572|6265704|P3|COMPLETED|Overall Study|Participants completed the study.|49
2556021|NCT00520572|6265705|P2|COMPLETED|Overall Study|Participants completed the study.|50
2556022|NCT00520572|6265706|P1|COMPLETED|Overall Study|Participants completed the study.|52
2556023|NCT00520572|6265701|P6|STARTED|Overall Study|Participants randomised.|64
2556024|NCT00520572|6265702|P5|STARTED|Overall Study|Participants randomised.|65
2556025|NCT00520572|6265703|P4|STARTED|Overall Study|Participants randomised.|64
2556026|NCT00520572|6265704|P3|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
2556027|NCT00520572|6265705|P2|STARTED|Overall Study|Participants randomised.|64
2556028|NCT00520572|6265706|P1|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
2556029|NCT00520546|6265744|P1|NOT COMPLETED|Overall Study||6
2556030|NCT00520546|6265744|P1|COMPLETED|Overall Study||38
2556031|NCT00520546|6265744|P1|STARTED|Overall Study||44
2556032|NCT00520494|6265759|P1|NOT COMPLETED|Overall Study||1
2556033|NCT00520494|6265759|P1|COMPLETED|Overall Study||17
2556034|NCT00520494|6265759|P1|STARTED|Overall Study||18
2556035|NCT00520481|6265784|P2|NOT COMPLETED|Overall Study||1
2556036|NCT00520481|6265785|P1|NOT COMPLETED|Overall Study||7
2556037|NCT00520481|6265784|P2|COMPLETED|Overall Study||9
2556038|NCT00520481|6265785|P1|COMPLETED|Overall Study||24
2556039|NCT00520481|6265784|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
2556040|NCT00520481|6265785|P1|Received at Least 1 Dose of Study Drug|Overall Study||31
2556041|NCT00520481|6265784|P2|STARTED|Overall Study||10
2556042|NCT00520481|6265785|P1|STARTED|Overall Study||31
2556043|NCT00520468|6265805|P1|NOT COMPLETED|Overall Study||0
2556044|NCT00520468|6265805|P1|COMPLETED|Overall Study||14
2556045|NCT00520468|6265805|P1|STARTED|Overall Study||14
2556046|NCT00520403|6265809|P1|NOT COMPLETED|Bevacizumab Monotherapy||2
2556047|NCT00520403|6265809|P1|COMPLETED|Bevacizumab Monotherapy||0
2556048|NCT00520403|6265809|P1|STARTED|Bevacizumab Monotherapy|2 of 7 participants completing Bevacizumab+IFN/vinblastine cycles initiated bevacizumab monotherapy|2
2556049|NCT00520403|6265809|P1|NOT COMPLETED|Bevacizumab + IFN/Vinblastine||18
2556050|NCT00520403|6265809|P1|COMPLETED|Bevacizumab + IFN/Vinblastine||7
2556051|NCT00520403|6265809|P1|STARTED|Bevacizumab + IFN/Vinblastine||25
2556052|NCT00520351|6265818|P2|NOT COMPLETED|Second Intervention||0
2556053|NCT00520351|6265819|P1|NOT COMPLETED|Second Intervention||0
2556054|NCT00520351|6265818|P2|COMPLETED|Second Intervention||14
2556055|NCT00520351|6265819|P1|COMPLETED|Second Intervention||14
2556056|NCT00520351|6265818|P2|STARTED|Second Intervention||14
2556057|NCT00520351|6265819|P1|STARTED|Second Intervention||14
2556058|NCT00520351|6265818|P2|NOT COMPLETED|First Intervention||1
2556059|NCT00520351|6265819|P1|NOT COMPLETED|First Intervention||1
2556060|NCT00520351|6265818|P2|COMPLETED|First Intervention|End date is Feb.25, 2008|14
2556061|NCT00520351|6265819|P1|COMPLETED|First Intervention|End date is Feb.25, 2008|14
2556062|NCT00520351|6265818|P2|STARTED|First Intervention|Start date is Sep.06, 2007|15
2556063|NCT00520351|6265819|P1|STARTED|First Intervention|Start date is Sep.06, 2007|15
2556064|NCT00520299|6265834|P3|NOT COMPLETED|Overall Study||6
2556065|NCT00520299|6265835|P2|NOT COMPLETED|Overall Study||3
2556066|NCT00520299|6265836|P1|NOT COMPLETED|Overall Study||0
2556067|NCT00520299|6265834|P3|COMPLETED|Overall Study||13
2556068|NCT00520299|6265835|P2|COMPLETED|Overall Study||3
2556069|NCT00520299|6265836|P1|COMPLETED|Overall Study|Defined as completion of 1 treatment cycle|6
2556070|NCT00520299|6265834|P3|STARTED|Overall Study||19
2556071|NCT00520299|6265835|P2|STARTED|Overall Study||6
2556072|NCT00520299|6265836|P1|STARTED|Overall Study||6
2556073|NCT00520286|6265867|P2|NOT COMPLETED|Overall Study||32
2556074|NCT00520286|6265868|P1|NOT COMPLETED|Overall Study||66
2556075|NCT00520286|6265867|P2|COMPLETED|Overall Study||36
2556076|NCT00520286|6265868|P1|COMPLETED|Overall Study||76
2556077|NCT00520286|6265867|P2|STARTED|Overall Study||68
2556078|NCT00520286|6265868|P1|STARTED|Overall Study||142
2556079|NCT00520234|6265878|P2|NOT COMPLETED|Overall Study||2
2556080|NCT00520234|6265879|P1|NOT COMPLETED|Overall Study||1
2556081|NCT00520234|6265878|P2|COMPLETED|Overall Study||102
2556082|NCT00520234|6265879|P1|COMPLETED|Overall Study||117
2556083|NCT00520234|6265878|P2|STARTED|Overall Study||104
2556084|NCT00520234|6265879|P1|STARTED|Overall Study||118
2556085|NCT00520130|6265891|P2|NOT COMPLETED|Overall Study||1
2556086|NCT00520130|6265892|P1|NOT COMPLETED|Overall Study||5
2556087|NCT00520130|6265891|P2|COMPLETED|Overall Study||44
2556088|NCT00520130|6265892|P1|COMPLETED|Overall Study||39
2556089|NCT00520130|6265891|P2|STARTED|Overall Study||45
2556090|NCT00520130|6265892|P1|STARTED|Overall Study||44
2556091|NCT00520039|6265934|P2|NOT COMPLETED|Overall Study||5
2556092|NCT00520039|6265935|P1|NOT COMPLETED|Overall Study||7
2556093|NCT00520039|6265934|P2|COMPLETED|Overall Study||19
2556094|NCT00520039|6265935|P1|COMPLETED|Overall Study||21
2556095|NCT00520039|6265934|P2|STARTED|Overall Study||24
2556096|NCT00520039|6265935|P1|STARTED|Overall Study||28
2556097|NCT00520013|6265948|P3|NOT COMPLETED|Overall Study||11
2556098|NCT00520013|6265949|P2|NOT COMPLETED|Overall Study||15
2556099|NCT00520013|6265950|P1|NOT COMPLETED|Overall Study||12
2556100|NCT00520013|6265948|P3|COMPLETED|Overall Study||0
2556101|NCT00520013|6265949|P2|COMPLETED|Overall Study||10
2556102|NCT00520013|6265950|P1|COMPLETED|Overall Study||11
2556103|NCT00520013|6265948|P3|Treated|Overall Study||11
2556104|NCT00520013|6265949|P2|Treated|Overall Study||25
2556105|NCT00520013|6265950|P1|Treated|Overall Study||23
2556106|NCT00520013|6265948|P3|STARTED|Overall Study|Excludes a pt who went off-study (on reg day) due to consent that may not have been informed (ESL).|11
2556107|NCT00520013|6265949|P2|STARTED|Overall Study||25
2556108|NCT00520013|6265950|P1|STARTED|Overall Study||23
2556109|NCT00519896|6265960|P1|NOT COMPLETED|Overall Study||2
2556110|NCT00519896|6265960|P1|COMPLETED|Overall Study||33
2556111|NCT00519896|6265960|P1|STARTED|Overall Study||35
2556112|NCT00519831|6265966|P1|NOT COMPLETED|Overall Study||3
2556113|NCT00519831|6265966|P1|COMPLETED|Overall Study||13
2556114|NCT00519831|6265966|P1|STARTED|Overall Study||16
2556115|NCT00519818|6265973|P1|NOT COMPLETED|Overall Study||0
2556116|NCT00519818|6265973|P1|COMPLETED|Overall Study||14
2556117|NCT00519818|6265973|P1|STARTED|Overall Study||14
2556118|NCT00519779|6265983|P2|NOT COMPLETED|Overall Study||1
2556119|NCT00519779|6265984|P1|NOT COMPLETED|Overall Study||0
2556120|NCT00519779|6265983|P2|COMPLETED|Overall Study||33
2556121|NCT00519779|6265984|P1|COMPLETED|Overall Study||34
2556122|NCT00519779|6265983|P2|STARTED|Overall Study||34
2556123|NCT00519779|6265984|P1|STARTED|Overall Study||34
2556124|NCT00519649|6266000|P1|NOT COMPLETED|Overall Study||1
2556125|NCT00519649|6266000|P1|COMPLETED|Overall Study||299
2556126|NCT00519649|6266000|P1|STARTED|Overall Study||300
2556127|NCT00519636|6266013|P4|NOT COMPLETED|Post Study Period||1
2556128|NCT00519636|6266014|P3|NOT COMPLETED|Post Study Period||0
2556129|NCT00519636|6266015|P2|NOT COMPLETED|Post Study Period||0
2556130|NCT00519636|6266016|P1|NOT COMPLETED|Post Study Period||0
2556131|NCT00519636|6266013|P4|COMPLETED|Post Study Period||85
2556132|NCT00519636|6266014|P3|COMPLETED|Post Study Period||74
2556133|NCT00519636|6266015|P2|COMPLETED|Post Study Period||71
2556134|NCT00519636|6266016|P1|COMPLETED|Post Study Period||69
2556135|NCT00519636|6266013|P4|STARTED|Post Study Period||86
2556136|NCT00519636|6266014|P3|STARTED|Post Study Period||74
2556137|NCT00519636|6266015|P2|STARTED|Post Study Period||71
2556138|NCT00519636|6266016|P1|STARTED|Post Study Period||69
2556139|NCT00519636|6266013|P4|NOT COMPLETED|Treatment Period 2||2
2556140|NCT00519636|6266014|P3|NOT COMPLETED|Treatment Period 2||1
2556141|NCT00519636|6266015|P2|NOT COMPLETED|Treatment Period 2||1
2556142|NCT00519636|6266016|P1|NOT COMPLETED|Treatment Period 2||0
2556143|NCT00519636|6266013|P4|COMPLETED|Treatment Period 2||86
2556144|NCT00519636|6266014|P3|COMPLETED|Treatment Period 2||74
2556145|NCT00519636|6266015|P2|COMPLETED|Treatment Period 2||71
2556146|NCT00519636|6266016|P1|COMPLETED|Treatment Period 2||69
2556147|NCT00519636|6266013|P4|STARTED|Treatment Period 2||88
2556148|NCT00519636|6266014|P3|STARTED|Treatment Period 2||75
2556149|NCT00519636|6266015|P2|STARTED|Treatment Period 2||72
2556150|NCT00519636|6266016|P1|STARTED|Treatment Period 2||69
2556151|NCT00519636|6266013|P4|NOT COMPLETED|Washout Period||5
2556152|NCT00519636|6266014|P3|NOT COMPLETED|Washout Period||14
2556153|NCT00519636|6266015|P2|NOT COMPLETED|Washout Period||14
2556154|NCT00519636|6266016|P1|NOT COMPLETED|Washout Period||20
2556155|NCT00519636|6266013|P4|COMPLETED|Washout Period||88
2556156|NCT00519636|6266014|P3|COMPLETED|Washout Period||75
2556157|NCT00519636|6266015|P2|COMPLETED|Washout Period||72
2556158|NCT00519636|6266016|P1|COMPLETED|Washout Period||69
2556159|NCT00519636|6266013|P4|STARTED|Washout Period||93
2556160|NCT00519636|6266014|P3|STARTED|Washout Period||89
2556161|NCT00519636|6266015|P2|STARTED|Washout Period||86
2556162|NCT00519636|6266016|P1|STARTED|Washout Period||89
2556163|NCT00519636|6266013|P4|NOT COMPLETED|Treatment Period 1||0
2556164|NCT00519636|6266014|P3|NOT COMPLETED|Treatment Period 1||1
2556165|NCT00519636|6266015|P2|NOT COMPLETED|Treatment Period 1||0
2556166|NCT00519636|6266016|P1|NOT COMPLETED|Treatment Period 1||2
2556167|NCT00519636|6266013|P4|COMPLETED|Treatment Period 1||93
2556168|NCT00519636|6266014|P3|COMPLETED|Treatment Period 1||89
2556169|NCT00519636|6266015|P2|COMPLETED|Treatment Period 1||86
2556170|NCT00519636|6266016|P1|COMPLETED|Treatment Period 1||89
2556171|NCT00519636|6266013|P4|STARTED|Treatment Period 1||93
2556172|NCT00519636|6266014|P3|STARTED|Treatment Period 1||90
2556173|NCT00519636|6266015|P2|STARTED|Treatment Period 1||86
2556174|NCT00519636|6266016|P1|STARTED|Treatment Period 1||91
2556175|NCT00519623|6266046|P1|NOT COMPLETED|Overall Study||1
2556176|NCT00519623|6266046|P1|COMPLETED|Overall Study||8
2556177|NCT00519623|6266046|P1|STARTED|Overall Study||9
2556178|NCT00519584|6266055|P4|NOT COMPLETED|Overall Study||0
2556179|NCT00519584|6266056|P3|NOT COMPLETED|Overall Study||0
2556180|NCT00519584|6266057|P2|NOT COMPLETED|Overall Study||0
2556181|NCT00519584|6266058|P1|NOT COMPLETED|Overall Study||0
2556182|NCT00519584|6266055|P4|COMPLETED|Overall Study||56
2556183|NCT00519584|6266056|P3|COMPLETED|Overall Study||54
2556184|NCT00519584|6266057|P2|COMPLETED|Overall Study||54
2556185|NCT00519584|6266058|P1|COMPLETED|Overall Study||54
2556186|NCT00519584|6266055|P4|STARTED|Overall Study||56
2556187|NCT00519584|6266056|P3|STARTED|Overall Study||54
2556188|NCT00519584|6266057|P2|STARTED|Overall Study||54
2556189|NCT00519584|6266058|P1|STARTED|Overall Study||54
2556190|NCT00519532|6266080|P1|NOT COMPLETED|Overall Study||18
2556191|NCT00519532|6266080|P1|COMPLETED|Overall Study||66
2556192|NCT00519532|6266080|P1|STARTED|Overall Study||84
2556193|NCT00519428|6266090|P3|NOT COMPLETED|Overall Study||25
2556194|NCT00519428|6266091|P2|NOT COMPLETED|Overall Study||15
2556195|NCT00519428|6266092|P1|NOT COMPLETED|Overall Study||21
2556196|NCT00519428|6266090|P3|COMPLETED|Overall Study||58
2556197|NCT00519428|6266091|P2|COMPLETED|Overall Study||69
2556198|NCT00519428|6266092|P1|COMPLETED|Overall Study||57
2556199|NCT00519428|6266090|P3|STARTED|Overall Study||83
2556200|NCT00519428|6266091|P2|STARTED|Overall Study||84
2556201|NCT00519428|6266092|P1|STARTED|Overall Study||78
2556202|NCT00519376|6266112|P16|NOT COMPLETED|Treatment Period 4||0
2556203|NCT00519376|6266113|P15|NOT COMPLETED|Treatment Period 4||0
2556204|NCT00519376|6266114|P14|NOT COMPLETED|Treatment Period 4||0
2556205|NCT00519376|6266115|P13|NOT COMPLETED|Treatment Period 4||0
2556206|NCT00519376|6266116|P12|NOT COMPLETED|Treatment Period 4||0
2556207|NCT00519376|6266117|P11|NOT COMPLETED|Treatment Period 4||0
2556208|NCT00519376|6266118|P10|NOT COMPLETED|Treatment Period 4||0
2556209|NCT00519376|6266119|P9|NOT COMPLETED|Treatment Period 4||0
2556210|NCT00519376|6266120|P8|NOT COMPLETED|Treatment Period 4||0
2556211|NCT00519376|6266121|P7|NOT COMPLETED|Treatment Period 4||0
2556212|NCT00519376|6266122|P6|NOT COMPLETED|Treatment Period 4||0
2556213|NCT00519376|6266123|P5|NOT COMPLETED|Treatment Period 4||0
2556214|NCT00519376|6266124|P4|NOT COMPLETED|Treatment Period 4||0
2556215|NCT00519376|6266125|P3|NOT COMPLETED|Treatment Period 4||1
2556216|NCT00519376|6266126|P2|NOT COMPLETED|Treatment Period 4||0
2556217|NCT00519376|6266127|P1|NOT COMPLETED|Treatment Period 4||0
2556218|NCT00519376|6266112|P16|COMPLETED|Treatment Period 4||1
2556219|NCT00519376|6266113|P15|COMPLETED|Treatment Period 4||1
2556220|NCT00519376|6266114|P14|COMPLETED|Treatment Period 4||1
2556221|NCT00519376|6266115|P13|COMPLETED|Treatment Period 4||0
2556222|NCT00519376|6266116|P12|COMPLETED|Treatment Period 4||1
2556223|NCT00519376|6266117|P11|COMPLETED|Treatment Period 4||1
2556224|NCT00519376|6266118|P10|COMPLETED|Treatment Period 4||1
2556225|NCT00519376|6266119|P9|COMPLETED|Treatment Period 4||1
2556226|NCT00519376|6266120|P8|COMPLETED|Treatment Period 4||1
2556227|NCT00519376|6266121|P7|COMPLETED|Treatment Period 4||1
2556228|NCT00519376|6266122|P6|COMPLETED|Treatment Period 4||1
2556229|NCT00519376|6266123|P5|COMPLETED|Treatment Period 4||1
2556230|NCT00519376|6266124|P4|COMPLETED|Treatment Period 4||2
2556231|NCT00519376|6266125|P3|COMPLETED|Treatment Period 4||1
2556232|NCT00519376|6266126|P2|COMPLETED|Treatment Period 4||2
2556233|NCT00519376|6266127|P1|COMPLETED|Treatment Period 4||2
2556234|NCT00519376|6266112|P16|STARTED|Treatment Period 4||1
2556235|NCT00519376|6266113|P15|STARTED|Treatment Period 4||1
2556236|NCT00519376|6266114|P14|STARTED|Treatment Period 4||1
2556237|NCT00519376|6266115|P13|STARTED|Treatment Period 4||0
2556238|NCT00519376|6266116|P12|STARTED|Treatment Period 4||1
2556239|NCT00519376|6266117|P11|STARTED|Treatment Period 4||1
2556240|NCT00519376|6266118|P10|STARTED|Treatment Period 4||1
2556241|NCT00519376|6266119|P9|STARTED|Treatment Period 4||1
2556242|NCT00519376|6266120|P8|STARTED|Treatment Period 4||1
2556243|NCT00519376|6266121|P7|STARTED|Treatment Period 4||1
2556244|NCT00519376|6266122|P6|STARTED|Treatment Period 4||1
2556245|NCT00519376|6266123|P5|STARTED|Treatment Period 4||1
2556246|NCT00519376|6266124|P4|STARTED|Treatment Period 4||2
2556247|NCT00519376|6266125|P3|STARTED|Treatment Period 4||2
2556248|NCT00519376|6266126|P2|STARTED|Treatment Period 4||2
2556249|NCT00519376|6266127|P1|STARTED|Treatment Period 4||2
2556250|NCT00519376|6266112|P16|NOT COMPLETED|Washout Period 3||0
2556251|NCT00519376|6266113|P15|NOT COMPLETED|Washout Period 3||0
2556252|NCT00519376|6266114|P14|NOT COMPLETED|Washout Period 3||0
2556253|NCT00519376|6266115|P13|NOT COMPLETED|Washout Period 3||0
2556254|NCT00519376|6266116|P12|NOT COMPLETED|Washout Period 3||0
2556255|NCT00519376|6266117|P11|NOT COMPLETED|Washout Period 3||0
2556256|NCT00519376|6266118|P10|NOT COMPLETED|Washout Period 3||0
2556257|NCT00519376|6266119|P9|NOT COMPLETED|Washout Period 3||0
2556258|NCT00519376|6266120|P8|NOT COMPLETED|Washout Period 3||0
2556259|NCT00519376|6266121|P7|NOT COMPLETED|Washout Period 3||0
2556260|NCT00519376|6266122|P6|NOT COMPLETED|Washout Period 3||0
2556261|NCT00519376|6266123|P5|NOT COMPLETED|Washout Period 3||0
2556262|NCT00519376|6266124|P4|NOT COMPLETED|Washout Period 3||0
2556263|NCT00519376|6266125|P3|NOT COMPLETED|Washout Period 3||0
2556264|NCT00519376|6266126|P2|NOT COMPLETED|Washout Period 3||0
2556265|NCT00519376|6266127|P1|NOT COMPLETED|Washout Period 3||0
2556266|NCT00519376|6266112|P16|COMPLETED|Washout Period 3||1
2556267|NCT00519376|6266113|P15|COMPLETED|Washout Period 3||1
2556268|NCT00519376|6266114|P14|COMPLETED|Washout Period 3||1
2556269|NCT00519376|6266115|P13|COMPLETED|Washout Period 3||0
2556270|NCT00519376|6266116|P12|COMPLETED|Washout Period 3||1
2556271|NCT00519376|6266117|P11|COMPLETED|Washout Period 3||1
2556272|NCT00519376|6266118|P10|COMPLETED|Washout Period 3||1
2556273|NCT00519376|6266119|P9|COMPLETED|Washout Period 3||1
2556274|NCT00519376|6266120|P8|COMPLETED|Washout Period 3||1
2556275|NCT00519376|6266121|P7|COMPLETED|Washout Period 3||1
2556276|NCT00519376|6266122|P6|COMPLETED|Washout Period 3||1
2556277|NCT00519376|6266123|P5|COMPLETED|Washout Period 3||1
2556278|NCT00519376|6266124|P4|COMPLETED|Washout Period 3||2
2556279|NCT00519376|6266125|P3|COMPLETED|Washout Period 3||2
2556280|NCT00519376|6266126|P2|COMPLETED|Washout Period 3||2
2556281|NCT00519376|6266127|P1|COMPLETED|Washout Period 3||2
2556282|NCT00519376|6266112|P16|STARTED|Washout Period 3||1
2556283|NCT00519376|6266113|P15|STARTED|Washout Period 3||1
2556284|NCT00519376|6266114|P14|STARTED|Washout Period 3||1
2556285|NCT00519376|6266115|P13|STARTED|Washout Period 3||0
2556286|NCT00519376|6266116|P12|STARTED|Washout Period 3||1
2556287|NCT00519376|6266117|P11|STARTED|Washout Period 3||1
2556288|NCT00519376|6266118|P10|STARTED|Washout Period 3||1
2556289|NCT00519376|6266119|P9|STARTED|Washout Period 3||1
2556290|NCT00519376|6266120|P8|STARTED|Washout Period 3||1
2556291|NCT00519376|6266121|P7|STARTED|Washout Period 3||1
2556292|NCT00519376|6266122|P6|STARTED|Washout Period 3||1
2556293|NCT00519376|6266123|P5|STARTED|Washout Period 3||1
2556294|NCT00519376|6266124|P4|STARTED|Washout Period 3||2
2556295|NCT00519376|6266125|P3|STARTED|Washout Period 3||2
2556296|NCT00519376|6266126|P2|STARTED|Washout Period 3||2
2556297|NCT00519376|6266127|P1|STARTED|Washout Period 3||2
2556298|NCT00519376|6266112|P16|NOT COMPLETED|Treatment Period 3||0
2556299|NCT00519376|6266113|P15|NOT COMPLETED|Treatment Period 3||0
2556300|NCT00519376|6266114|P14|NOT COMPLETED|Treatment Period 3||0
2556301|NCT00519376|6266115|P13|NOT COMPLETED|Treatment Period 3||0
2556302|NCT00519376|6266116|P12|NOT COMPLETED|Treatment Period 3||0
2556303|NCT00519376|6266117|P11|NOT COMPLETED|Treatment Period 3||0
2556304|NCT00519376|6266118|P10|NOT COMPLETED|Treatment Period 3||0
2556305|NCT00519376|6266119|P9|NOT COMPLETED|Treatment Period 3||0
2556306|NCT00519376|6266120|P8|NOT COMPLETED|Treatment Period 3||0
2556307|NCT00519376|6266121|P7|NOT COMPLETED|Treatment Period 3||0
2556308|NCT00519376|6266122|P6|NOT COMPLETED|Treatment Period 3||0
2556309|NCT00519376|6266123|P5|NOT COMPLETED|Treatment Period 3||0
2556310|NCT00519376|6266124|P4|NOT COMPLETED|Treatment Period 3||0
2556311|NCT00519376|6266125|P3|NOT COMPLETED|Treatment Period 3||0
2556312|NCT00519376|6266126|P2|NOT COMPLETED|Treatment Period 3||0
2556313|NCT00519376|6266127|P1|NOT COMPLETED|Treatment Period 3||0
2556314|NCT00519376|6266112|P16|COMPLETED|Treatment Period 3||1
2556315|NCT00519376|6266113|P15|COMPLETED|Treatment Period 3||1
2556316|NCT00519376|6266114|P14|COMPLETED|Treatment Period 3||1
2556317|NCT00519376|6266115|P13|COMPLETED|Treatment Period 3||0
2556318|NCT00519376|6266116|P12|COMPLETED|Treatment Period 3||1
2556319|NCT00519376|6266117|P11|COMPLETED|Treatment Period 3||1
2556320|NCT00519376|6266118|P10|COMPLETED|Treatment Period 3||1
2556321|NCT00519376|6266119|P9|COMPLETED|Treatment Period 3||1
2556322|NCT00519376|6266120|P8|COMPLETED|Treatment Period 3||1
2556323|NCT00519376|6266121|P7|COMPLETED|Treatment Period 3||1
2556324|NCT00519376|6266122|P6|COMPLETED|Treatment Period 3||1
2556325|NCT00519376|6266123|P5|COMPLETED|Treatment Period 3||1
2556326|NCT00519376|6266124|P4|COMPLETED|Treatment Period 3||2
2556327|NCT00519376|6266125|P3|COMPLETED|Treatment Period 3||2
2556328|NCT00519376|6266126|P2|COMPLETED|Treatment Period 3||2
2556329|NCT00519376|6266127|P1|COMPLETED|Treatment Period 3||2
2556330|NCT00519376|6266112|P16|STARTED|Treatment Period 3||1
2556331|NCT00519376|6266113|P15|STARTED|Treatment Period 3||1
2556332|NCT00519376|6266114|P14|STARTED|Treatment Period 3||1
2556333|NCT00519376|6266115|P13|STARTED|Treatment Period 3||0
2556334|NCT00519376|6266116|P12|STARTED|Treatment Period 3||1
2556335|NCT00519376|6266117|P11|STARTED|Treatment Period 3||1
2556336|NCT00519376|6266118|P10|STARTED|Treatment Period 3||1
2556337|NCT00519376|6266119|P9|STARTED|Treatment Period 3||1
2556338|NCT00519376|6266120|P8|STARTED|Treatment Period 3||1
2556339|NCT00519376|6266121|P7|STARTED|Treatment Period 3||1
2556340|NCT00519376|6266122|P6|STARTED|Treatment Period 3||1
2556341|NCT00519376|6266123|P5|STARTED|Treatment Period 3||1
2556342|NCT00519376|6266124|P4|STARTED|Treatment Period 3||2
2556343|NCT00519376|6266125|P3|STARTED|Treatment Period 3||2
2556344|NCT00519376|6266126|P2|STARTED|Treatment Period 3||2
2556345|NCT00519376|6266127|P1|STARTED|Treatment Period 3||2
2556346|NCT00519376|6266112|P16|NOT COMPLETED|Washout Period 2||0
2556347|NCT00519376|6266113|P15|NOT COMPLETED|Washout Period 2||0
2556348|NCT00519376|6266114|P14|NOT COMPLETED|Washout Period 2||0
2556349|NCT00519376|6266115|P13|NOT COMPLETED|Washout Period 2||0
2556350|NCT00519376|6266116|P12|NOT COMPLETED|Washout Period 2||0
2556351|NCT00519376|6266117|P11|NOT COMPLETED|Washout Period 2||0
2556352|NCT00519376|6266118|P10|NOT COMPLETED|Washout Period 2||0
2556353|NCT00519376|6266119|P9|NOT COMPLETED|Washout Period 2||0
2556354|NCT00519376|6266120|P8|NOT COMPLETED|Washout Period 2||0
2556355|NCT00519376|6266121|P7|NOT COMPLETED|Washout Period 2||0
2556356|NCT00519376|6266122|P6|NOT COMPLETED|Washout Period 2||0
2556357|NCT00519376|6266123|P5|NOT COMPLETED|Washout Period 2||0
2556358|NCT00519376|6266124|P4|NOT COMPLETED|Washout Period 2||0
2556359|NCT00519376|6266125|P3|NOT COMPLETED|Washout Period 2||0
2556360|NCT00519376|6266126|P2|NOT COMPLETED|Washout Period 2||0
2556361|NCT00519376|6266127|P1|NOT COMPLETED|Washout Period 2||0
2556362|NCT00519376|6266112|P16|COMPLETED|Washout Period 2||1
2556363|NCT00519376|6266113|P15|COMPLETED|Washout Period 2||1
2556364|NCT00519376|6266114|P14|COMPLETED|Washout Period 2||1
2556365|NCT00519376|6266115|P13|COMPLETED|Washout Period 2||0
2556366|NCT00519376|6266116|P12|COMPLETED|Washout Period 2||1
2556367|NCT00519376|6266117|P11|COMPLETED|Washout Period 2||1
2556368|NCT00519376|6266118|P10|COMPLETED|Washout Period 2||1
2556369|NCT00519376|6266119|P9|COMPLETED|Washout Period 2||1
2556370|NCT00519376|6266120|P8|COMPLETED|Washout Period 2||1
2556371|NCT00519376|6266121|P7|COMPLETED|Washout Period 2||1
2556372|NCT00519376|6266122|P6|COMPLETED|Washout Period 2||1
2556373|NCT00519376|6266123|P5|COMPLETED|Washout Period 2||1
2556374|NCT00519376|6266124|P4|COMPLETED|Washout Period 2||2
2556375|NCT00519376|6266125|P3|COMPLETED|Washout Period 2||2
2556376|NCT00519376|6266126|P2|COMPLETED|Washout Period 2||2
2556377|NCT00519376|6266127|P1|COMPLETED|Washout Period 2||2
2556378|NCT00519376|6266112|P16|STARTED|Washout Period 2||1
2556379|NCT00519376|6266113|P15|STARTED|Washout Period 2||1
2556380|NCT00519376|6266114|P14|STARTED|Washout Period 2||1
2556381|NCT00519376|6266115|P13|STARTED|Washout Period 2||0
2556382|NCT00519376|6266116|P12|STARTED|Washout Period 2||1
2556383|NCT00519376|6266117|P11|STARTED|Washout Period 2||1
2556384|NCT00519376|6266118|P10|STARTED|Washout Period 2||1
2556385|NCT00519376|6266119|P9|STARTED|Washout Period 2||1
2556386|NCT00519376|6266120|P8|STARTED|Washout Period 2||1
2556387|NCT00519376|6266121|P7|STARTED|Washout Period 2||1
2556388|NCT00519376|6266122|P6|STARTED|Washout Period 2||1
2556389|NCT00519376|6266123|P5|STARTED|Washout Period 2||1
2556390|NCT00519376|6266124|P4|STARTED|Washout Period 2||2
2556391|NCT00519376|6266125|P3|STARTED|Washout Period 2||2
2556392|NCT00519376|6266126|P2|STARTED|Washout Period 2||2
2556393|NCT00519376|6266127|P1|STARTED|Washout Period 2||2
2556394|NCT00519376|6266112|P16|NOT COMPLETED|Treatment Period 2||0
2556395|NCT00519376|6266113|P15|NOT COMPLETED|Treatment Period 2||0
2556396|NCT00519376|6266114|P14|NOT COMPLETED|Treatment Period 2||0
2556397|NCT00519376|6266115|P13|NOT COMPLETED|Treatment Period 2||1
2556398|NCT00519376|6266116|P12|NOT COMPLETED|Treatment Period 2||0
2556399|NCT00519376|6266117|P11|NOT COMPLETED|Treatment Period 2||0
2556400|NCT00519376|6266118|P10|NOT COMPLETED|Treatment Period 2||0
2556401|NCT00519376|6266119|P9|NOT COMPLETED|Treatment Period 2||0
2556402|NCT00519376|6266120|P8|NOT COMPLETED|Treatment Period 2||0
2556403|NCT00519376|6266121|P7|NOT COMPLETED|Treatment Period 2||0
2556404|NCT00519376|6266122|P6|NOT COMPLETED|Treatment Period 2||0
2556405|NCT00519376|6266123|P5|NOT COMPLETED|Treatment Period 2||0
2556406|NCT00519376|6266124|P4|NOT COMPLETED|Treatment Period 2||0
2556407|NCT00519376|6266125|P3|NOT COMPLETED|Treatment Period 2||0
2556408|NCT00519376|6266126|P2|NOT COMPLETED|Treatment Period 2||0
2556409|NCT00519376|6266127|P1|NOT COMPLETED|Treatment Period 2||0
2556410|NCT00519376|6266112|P16|COMPLETED|Treatment Period 2||1
2556411|NCT00519376|6266113|P15|COMPLETED|Treatment Period 2||1
2556412|NCT00519376|6266114|P14|COMPLETED|Treatment Period 2||1
2556413|NCT00519376|6266115|P13|COMPLETED|Treatment Period 2||0
2556414|NCT00519376|6266116|P12|COMPLETED|Treatment Period 2||1
2556415|NCT00519376|6266117|P11|COMPLETED|Treatment Period 2||1
2556416|NCT00519376|6266118|P10|COMPLETED|Treatment Period 2||1
2556417|NCT00519376|6266119|P9|COMPLETED|Treatment Period 2||1
2556418|NCT00519376|6266120|P8|COMPLETED|Treatment Period 2||1
2556419|NCT00519376|6266121|P7|COMPLETED|Treatment Period 2||1
2556420|NCT00519376|6266122|P6|COMPLETED|Treatment Period 2||1
2556421|NCT00519376|6266123|P5|COMPLETED|Treatment Period 2||1
2556422|NCT00519376|6266124|P4|COMPLETED|Treatment Period 2||2
2556423|NCT00519376|6266125|P3|COMPLETED|Treatment Period 2||2
2556424|NCT00519376|6266126|P2|COMPLETED|Treatment Period 2||2
2556425|NCT00519376|6266127|P1|COMPLETED|Treatment Period 2||2
2556426|NCT00519376|6266112|P16|STARTED|Treatment Period 2||1
2556427|NCT00519376|6266113|P15|STARTED|Treatment Period 2||1
2556428|NCT00519376|6266114|P14|STARTED|Treatment Period 2||1
2556429|NCT00519376|6266115|P13|STARTED|Treatment Period 2||1
2556430|NCT00519376|6266116|P12|STARTED|Treatment Period 2||1
2556431|NCT00519376|6266117|P11|STARTED|Treatment Period 2||1
2556432|NCT00519376|6266118|P10|STARTED|Treatment Period 2||1
2556433|NCT00519376|6266119|P9|STARTED|Treatment Period 2||1
2556434|NCT00519376|6266120|P8|STARTED|Treatment Period 2||1
2556435|NCT00519376|6266121|P7|STARTED|Treatment Period 2||1
2556436|NCT00519376|6266122|P6|STARTED|Treatment Period 2||1
2556437|NCT00519376|6266123|P5|STARTED|Treatment Period 2||1
2556438|NCT00519376|6266124|P4|STARTED|Treatment Period 2||2
2556439|NCT00519376|6266125|P3|STARTED|Treatment Period 2||2
2556440|NCT00519376|6266126|P2|STARTED|Treatment Period 2||2
2556441|NCT00519376|6266127|P1|STARTED|Treatment Period 2||2
2556442|NCT00519376|6266112|P16|NOT COMPLETED|Washout Period 1||0
2556443|NCT00519376|6266113|P15|NOT COMPLETED|Washout Period 1||0
2556444|NCT00519376|6266114|P14|NOT COMPLETED|Washout Period 1||0
2556445|NCT00519376|6266115|P13|NOT COMPLETED|Washout Period 1||0
2556446|NCT00519376|6266116|P12|NOT COMPLETED|Washout Period 1||0
2556447|NCT00519376|6266117|P11|NOT COMPLETED|Washout Period 1||0
2556448|NCT00519376|6266118|P10|NOT COMPLETED|Washout Period 1||0
2556449|NCT00519376|6266119|P9|NOT COMPLETED|Washout Period 1||0
2556450|NCT00519376|6266120|P8|NOT COMPLETED|Washout Period 1||0
2556451|NCT00519376|6266121|P7|NOT COMPLETED|Washout Period 1||0
2556452|NCT00519376|6266122|P6|NOT COMPLETED|Washout Period 1||0
2556453|NCT00519376|6266123|P5|NOT COMPLETED|Washout Period 1||0
2556454|NCT00519376|6266124|P4|NOT COMPLETED|Washout Period 1||0
2556455|NCT00519376|6266125|P3|NOT COMPLETED|Washout Period 1||0
2556456|NCT00519376|6266126|P2|NOT COMPLETED|Washout Period 1||0
2556457|NCT00519376|6266127|P1|NOT COMPLETED|Washout Period 1||0
2556458|NCT00519376|6266112|P16|COMPLETED|Washout Period 1||1
2556459|NCT00519376|6266113|P15|COMPLETED|Washout Period 1||1
2556460|NCT00519376|6266114|P14|COMPLETED|Washout Period 1||1
2556461|NCT00519376|6266115|P13|COMPLETED|Washout Period 1||1
2556462|NCT00519376|6266116|P12|COMPLETED|Washout Period 1||1
2556463|NCT00519376|6266117|P11|COMPLETED|Washout Period 1||1
2556464|NCT00519376|6266118|P10|COMPLETED|Washout Period 1||1
2556465|NCT00519376|6266119|P9|COMPLETED|Washout Period 1||1
2556466|NCT00519376|6266120|P8|COMPLETED|Washout Period 1||1
2556467|NCT00519376|6266121|P7|COMPLETED|Washout Period 1||1
2556468|NCT00519376|6266122|P6|COMPLETED|Washout Period 1||1
2556469|NCT00519376|6266123|P5|COMPLETED|Washout Period 1||1
2556470|NCT00519376|6266124|P4|COMPLETED|Washout Period 1||2
2556471|NCT00519376|6266125|P3|COMPLETED|Washout Period 1||2
2556472|NCT00519376|6266126|P2|COMPLETED|Washout Period 1||2
2556473|NCT00519376|6266127|P1|COMPLETED|Washout Period 1||2
2556474|NCT00519376|6266112|P16|STARTED|Washout Period 1||1
2556475|NCT00519376|6266113|P15|STARTED|Washout Period 1||1
2556476|NCT00519376|6266114|P14|STARTED|Washout Period 1||1
2556477|NCT00519376|6266115|P13|STARTED|Washout Period 1||1
2556478|NCT00519376|6266116|P12|STARTED|Washout Period 1||1
2556479|NCT00519376|6266117|P11|STARTED|Washout Period 1||1
2556480|NCT00519376|6266118|P10|STARTED|Washout Period 1||1
2556481|NCT00519376|6266119|P9|STARTED|Washout Period 1||1
2556482|NCT00519376|6266120|P8|STARTED|Washout Period 1||1
2556483|NCT00519376|6266121|P7|STARTED|Washout Period 1||1
2556484|NCT00519376|6266122|P6|STARTED|Washout Period 1||1
2556485|NCT00519376|6266123|P5|STARTED|Washout Period 1||1
2556486|NCT00519376|6266124|P4|STARTED|Washout Period 1||2
2556487|NCT00519376|6266125|P3|STARTED|Washout Period 1||2
2556488|NCT00519376|6266126|P2|STARTED|Washout Period 1||2
2556489|NCT00519376|6266127|P1|STARTED|Washout Period 1||2
2556490|NCT00519376|6266112|P16|NOT COMPLETED|Treatment Period 1||0
2556491|NCT00519376|6266113|P15|NOT COMPLETED|Treatment Period 1||0
2556492|NCT00519376|6266114|P14|NOT COMPLETED|Treatment Period 1||0
2556493|NCT00519376|6266115|P13|NOT COMPLETED|Treatment Period 1||0
2556494|NCT00519376|6266116|P12|NOT COMPLETED|Treatment Period 1||0
2556495|NCT00519376|6266117|P11|NOT COMPLETED|Treatment Period 1||0
2556496|NCT00519376|6266118|P10|NOT COMPLETED|Treatment Period 1||0
2556497|NCT00519376|6266119|P9|NOT COMPLETED|Treatment Period 1||0
2556498|NCT00519376|6266120|P8|NOT COMPLETED|Treatment Period 1||0
2556499|NCT00519376|6266121|P7|NOT COMPLETED|Treatment Period 1||0
2556500|NCT00519376|6266122|P6|NOT COMPLETED|Treatment Period 1||0
2556501|NCT00519376|6266123|P5|NOT COMPLETED|Treatment Period 1||0
2556502|NCT00519376|6266124|P4|NOT COMPLETED|Treatment Period 1||0
2556503|NCT00519376|6266125|P3|NOT COMPLETED|Treatment Period 1||0
2556504|NCT00519376|6266126|P2|NOT COMPLETED|Treatment Period 1||0
2556505|NCT00519376|6266127|P1|NOT COMPLETED|Treatment Period 1||0
2556506|NCT00519376|6266112|P16|COMPLETED|Treatment Period 1||1
2556507|NCT00519376|6266113|P15|COMPLETED|Treatment Period 1||1
2556508|NCT00519376|6266114|P14|COMPLETED|Treatment Period 1||1
2556509|NCT00519376|6266115|P13|COMPLETED|Treatment Period 1||1
2556510|NCT00519376|6266116|P12|COMPLETED|Treatment Period 1||1
2556511|NCT00519376|6266117|P11|COMPLETED|Treatment Period 1||1
2556512|NCT00519376|6266118|P10|COMPLETED|Treatment Period 1||1
2556513|NCT00519376|6266119|P9|COMPLETED|Treatment Period 1||1
2556514|NCT00519376|6266120|P8|COMPLETED|Treatment Period 1||1
2556515|NCT00519376|6266121|P7|COMPLETED|Treatment Period 1||1
2556516|NCT00519376|6266122|P6|COMPLETED|Treatment Period 1||1
2556517|NCT00519376|6266123|P5|COMPLETED|Treatment Period 1||1
2556518|NCT00519376|6266124|P4|COMPLETED|Treatment Period 1||2
2556519|NCT00519376|6266125|P3|COMPLETED|Treatment Period 1||2
2556520|NCT00519376|6266126|P2|COMPLETED|Treatment Period 1||2
2556521|NCT00519376|6266127|P1|COMPLETED|Treatment Period 1||2
2556522|NCT00519376|6266112|P16|STARTED|Treatment Period 1||1
2556523|NCT00519376|6266113|P15|STARTED|Treatment Period 1||1
2556524|NCT00519376|6266114|P14|STARTED|Treatment Period 1||1
2556525|NCT00519376|6266115|P13|STARTED|Treatment Period 1||1
2556526|NCT00519376|6266116|P12|STARTED|Treatment Period 1||1
2556527|NCT00519376|6266117|P11|STARTED|Treatment Period 1||1
2556528|NCT00519376|6266118|P10|STARTED|Treatment Period 1||1
2556529|NCT00519376|6266119|P9|STARTED|Treatment Period 1||1
2556530|NCT00519376|6266120|P8|STARTED|Treatment Period 1||1
2556531|NCT00519376|6266121|P7|STARTED|Treatment Period 1||1
2556532|NCT00519376|6266122|P6|STARTED|Treatment Period 1||1
2556533|NCT00519376|6266123|P5|STARTED|Treatment Period 1||1
2556534|NCT00519376|6266124|P4|STARTED|Treatment Period 1||2
2556535|NCT00519376|6266125|P3|STARTED|Treatment Period 1||2
2556536|NCT00519376|6266126|P2|STARTED|Treatment Period 1||2
2556537|NCT00519376|6266127|P1|STARTED|Treatment Period 1||2
2556538|NCT00519285|6266251|P2|NOT COMPLETED|Overall Study||612
2556539|NCT00519285|6266252|P1|NOT COMPLETED|Overall Study||612
2556540|NCT00519285|6266251|P2|COMPLETED|Overall Study||0
2556541|NCT00519285|6266252|P1|COMPLETED|Overall Study|Participants were treated until progressive disease, unacceptable toxicity, or refusal of treatment|0
2556542|NCT00519285|6266251|P2|Still Treated at Cut-off Date|Overall Study||2
2556543|NCT00519285|6266252|P1|Still Treated at Cut-off Date|Overall Study|The cut-off date for analysis was defined as 07 February 2012, date at which 873 deaths has occurred|1
2556544|NCT00519285|6266251|P2|TREATED|Overall Study|Received at least part of one dose of aflibercept|605
2556545|NCT00519285|6266252|P1|TREATED|Overall Study|Received at least part of one dose of placebo|604
2556546|NCT00519285|6266251|P2|STARTED|Overall Study|Randomized|612
2556547|NCT00519285|6266252|P1|STARTED|Overall Study|Randomized|612
2556548|NCT00519194|6266278|P1|NOT COMPLETED|Overall Study||21
2556549|NCT00519194|6266278|P1|COMPLETED|Overall Study||91
2556550|NCT00519194|6266278|P1|STARTED|Overall Study||112
2556551|NCT00519090|6266284|P2|NOT COMPLETED|Overall Study||0
2556552|NCT00519090|6266285|P1|NOT COMPLETED|Overall Study||0
2556553|NCT00519090|6266284|P2|COMPLETED|Overall Study||4
2556554|NCT00519090|6266285|P1|COMPLETED|Overall Study||2
2556555|NCT00519090|6266284|P2|STARTED|Overall Study||4
2556556|NCT00519090|6266285|P1|STARTED|Overall Study||2
2556557|NCT00519077|6266293|P1|NOT COMPLETED|Overall Study||8
2556558|NCT00519077|6266293|P1|COMPLETED|Overall Study||36
2556559|NCT00519077|6266293|P1|STARTED|Overall Study||44
2556560|NCT00518986|6266300|P2|NOT COMPLETED|Overall Study||26
2556561|NCT00518986|6266301|P1|NOT COMPLETED|Overall Study||26
2556562|NCT00518986|6266300|P2|COMPLETED|Overall Study||98
2556563|NCT00518986|6266301|P1|COMPLETED|Overall Study||99
2556564|NCT00518986|6266300|P2|STARTED|Overall Study||124
2556565|NCT00518986|6266301|P1|STARTED|Overall Study|One subject discontinued before treatment, only 124 subjects in each treatment group were dosed.|125
2556566|NCT00518973|6266427|P2|NOT COMPLETED|Overall Study||2
2556567|NCT00518973|6266428|P1|NOT COMPLETED|Overall Study||3
2556568|NCT00518973|6266427|P2|COMPLETED|Overall Study||4
2556569|NCT00518973|6266428|P1|COMPLETED|Overall Study||6
2556570|NCT00518973|6266427|P2|STARTED|Overall Study||6
2556571|NCT00518973|6266428|P1|STARTED|Overall Study||9
2556572|NCT00518882|6266444|P2|NOT COMPLETED|Open-Label Extension, Week 26-78||49
2556573|NCT00518882|6266445|P1|NOT COMPLETED|Open-Label Extension, Week 26-78||41
2556574|NCT00518882|6266444|P2|COMPLETED|Open-Label Extension, Week 26-78||138
2556575|NCT00518882|6266445|P1|COMPLETED|Open-Label Extension, Week 26-78||161
2556576|NCT00518882|6266444|P2|STARTED|Open-Label Extension, Week 26-78||187
2556577|NCT00518882|6266445|P1|STARTED|Open-Label Extension, Week 26-78||202
2556578|NCT00518882|6266444|P2|NOT COMPLETED|Double-Blind, Week 0-26||45
2556579|NCT00518882|6266445|P1|NOT COMPLETED|Double-Blind, Week 0-26||33
2556580|NCT00518882|6266444|P2|COMPLETED|Double-Blind, Week 0-26||187
2556581|NCT00518882|6266445|P1|COMPLETED|Double-Blind, Week 0-26||202
2556582|NCT00518882|6266444|P2|Randomised|Double-Blind, Week 0-26||231
2556583|NCT00518882|6266445|P1|Randomised|Double-Blind, Week 0-26||233
2556584|NCT00518882|6266444|P2|STARTED|Double-Blind, Week 0-26|1 subject exposed to study drug before randomisation. Subject only included in safety analysis set|232
2556585|NCT00518882|6266445|P1|STARTED|Double-Blind, Week 0-26|2 subjects exposed to study drug before randomisation. Subjects only included in safety analysis set|235
2556586|NCT00518713|6266563|P4|NOT COMPLETED|Overall Study||18
2556587|NCT00518713|6266564|P3|NOT COMPLETED|Overall Study||18
2556588|NCT00518713|6266565|P2|NOT COMPLETED|Overall Study||17
2556589|NCT00518713|6266566|P1|NOT COMPLETED|Overall Study||8
2556590|NCT00518713|6266563|P4|COMPLETED|Overall Study||41
2556591|NCT00518713|6266564|P3|COMPLETED|Overall Study||41
2556592|NCT00518713|6266565|P2|COMPLETED|Overall Study||45
2556593|NCT00518713|6266566|P1|COMPLETED|Overall Study||50
2556594|NCT00518713|6266563|P4|Modified Intent-to-Treat Population|Overall Study||57
2556595|NCT00518713|6266564|P3|Modified Intent-to-Treat Population|Overall Study||49
2556596|NCT00518713|6266565|P2|Modified Intent-to-Treat Population|Overall Study||58
2556597|NCT00518713|6266566|P1|Modified Intent-to-Treat Population|Overall Study||53
2556598|NCT00518713|6266563|P4|STARTED|Overall Study||59
2556599|NCT00518713|6266564|P3|STARTED|Overall Study||59
2556600|NCT00518713|6266565|P2|STARTED|Overall Study||62
2556601|NCT00518713|6266566|P1|STARTED|Overall Study||58
2556602|NCT00518687|6266626|P2|NOT COMPLETED|Overall Study||1420
2556603|NCT00518687|6266627|P1|NOT COMPLETED|Overall Study||1437
2556604|NCT00518687|6266626|P2|COMPLETED|Overall Study||2585
2556605|NCT00518687|6266627|P1|COMPLETED|Overall Study||2568
2556606|NCT00518687|6266626|P2|Vaccinated|Overall Study||3982
2556607|NCT00518687|6266627|P1|Vaccinated|Overall Study||3981
2556608|NCT00518687|6266626|P2|STARTED|Overall Study|An additional 11 participants were not analyzed because of questionable clinical practices at 1 site|4005
2556609|NCT00518687|6266627|P1|STARTED|Overall Study|An additional 10 participants were not analyzed because of questionable clinical practices at 1 site|4005
2556610|NCT00518622|6266647|P8|NOT COMPLETED|Overall Study||0
2556611|NCT00518622|6266648|P7|NOT COMPLETED|Overall Study||0
2556612|NCT00518622|6266649|P6|NOT COMPLETED|Overall Study||0
2556613|NCT00518622|6266650|P5|NOT COMPLETED|Overall Study||0
2556614|NCT00518622|6266651|P4|NOT COMPLETED|Overall Study||0
2556615|NCT00518622|6266652|P3|NOT COMPLETED|Overall Study||1
2556616|NCT00518622|6266653|P2|NOT COMPLETED|Overall Study||1
2556617|NCT00518622|6266654|P1|NOT COMPLETED|Overall Study||0
2556618|NCT00518622|6266647|P8|COMPLETED|Overall Study||5
2556619|NCT00518622|6266648|P7|COMPLETED|Overall Study||4
2556620|NCT00518622|6266649|P6|COMPLETED|Overall Study||5
2556621|NCT00518622|6266650|P5|COMPLETED|Overall Study||6
2556622|NCT00518622|6266651|P4|COMPLETED|Overall Study||5
2556623|NCT00518622|6266652|P3|COMPLETED|Overall Study||5
2556624|NCT00518622|6266653|P2|COMPLETED|Overall Study||5
2556625|NCT00518622|6266654|P1|COMPLETED|Overall Study||3
2556626|NCT00518622|6266647|P8|Discontinued Therapy|Overall Study||0
2556627|NCT00518622|6266648|P7|Discontinued Therapy|Overall Study||0
2556628|NCT00518622|6266649|P6|Discontinued Therapy|Overall Study||0
2556629|NCT00518622|6266650|P5|Discontinued Therapy|Overall Study||0
2556630|NCT00518622|6266651|P4|Discontinued Therapy|Overall Study||0
2556631|NCT00518622|6266652|P3|Discontinued Therapy|Overall Study||0
2556632|NCT00518622|6266653|P2|Discontinued Therapy|Overall Study||1
2556633|NCT00518622|6266654|P1|Discontinued Therapy|Overall Study|Discontinued therapy defined if participant has not taken 8 days of medication per the protocol.|0
2556634|NCT00518622|6266647|P8|Completed Therapy|Overall Study||5
2556635|NCT00518622|6266648|P7|Completed Therapy|Overall Study||4
2556636|NCT00518622|6266649|P6|Completed Therapy|Overall Study||5
2556637|NCT00518622|6266650|P5|Completed Therapy|Overall Study||6
2556638|NCT00518622|6266651|P4|Completed Therapy|Overall Study||5
2556639|NCT00518622|6266652|P3|Completed Therapy|Overall Study||6
2556640|NCT00518622|6266653|P2|Completed Therapy|Overall Study||5
2556641|NCT00518622|6266654|P1|Completed Therapy|Overall Study|Completed therapy defined if participant has taken 8 days of study medication per the protocol.|3
2556642|NCT00518622|6266647|P8|STARTED|Overall Study||5
2556643|NCT00518622|6266648|P7|STARTED|Overall Study||4
2556644|NCT00518622|6266649|P6|STARTED|Overall Study||5
2556645|NCT00518622|6266650|P5|STARTED|Overall Study||6
2556646|NCT00518622|6266651|P4|STARTED|Overall Study||5
2556647|NCT00518622|6266652|P3|STARTED|Overall Study||6
2556648|NCT00518622|6266653|P2|STARTED|Overall Study||6
2556649|NCT00518622|6266654|P1|STARTED|Overall Study||3
2556650|NCT00518531|6266682|P2|NOT COMPLETED|Treatment Period 2||20
2556651|NCT00518531|6266683|P1|NOT COMPLETED|Treatment Period 2||3
2556652|NCT00518531|6266682|P2|COMPLETED|Treatment Period 2||95
2556653|NCT00518531|6266683|P1|COMPLETED|Treatment Period 2||103
2556654|NCT00518531|6266682|P2|Received Treatment|Treatment Period 2||110
2556655|NCT00518531|6266683|P1|Received Treatment|Treatment Period 2||106
2556656|NCT00518531|6266682|P2|STARTED|Treatment Period 2|Participants can start Treatment Period 2 without completing Treatment Period 1.|115
2556657|NCT00518531|6266683|P1|STARTED|Treatment Period 2||106
2556658|NCT00518531|6266682|P2|NOT COMPLETED|Treatment Period 1||12
2556659|NCT00518531|6266683|P1|NOT COMPLETED|Treatment Period 1||18
2556660|NCT00518531|6266682|P2|COMPLETED|Treatment Period 1|Participants who completed Treatment Period 1 may choose not to start Treatment Period 2|114
2556661|NCT00518531|6266683|P1|COMPLETED|Treatment Period 1||106
2556662|NCT00518531|6266682|P2|Received Treatment|Treatment Period 1||124
2556663|NCT00518531|6266683|P1|Received Treatment|Treatment Period 1||119
2556664|NCT00518531|6266682|P2|STARTED|Treatment Period 1||126
2556665|NCT00518531|6266683|P1|STARTED|Treatment Period 1||124
2556666|NCT00518349|6266719|P2|NOT COMPLETED|Overall Study||0
2556667|NCT00518349|6266720|P1|NOT COMPLETED|Overall Study||0
2556668|NCT00518349|6266719|P2|COMPLETED|Overall Study||60
2556669|NCT00518349|6266720|P1|COMPLETED|Overall Study||60
2556670|NCT00518349|6266719|P2|STARTED|Overall Study||60
2556671|NCT00518349|6266720|P1|STARTED|Overall Study||60
2556672|NCT00518336|6266728|P2|NOT COMPLETED|Year 9||1
2556673|NCT00518336|6266729|P1|NOT COMPLETED|Year 9||5
2556674|NCT00518336|6266728|P2|COMPLETED|Year 9||212
2556675|NCT00518336|6266729|P1|COMPLETED|Year 9||219
2556676|NCT00518336|6266728|P2|STARTED|Year 9||213
2556677|NCT00518336|6266729|P1|STARTED|Year 9|1 subject did not particpate at the previous timepoint, came back and was added in the Total cohort|224
2556678|NCT00518336|6266728|P2|NOT COMPLETED|Year 8||2
2556679|NCT00518336|6266729|P1|NOT COMPLETED|Year 8||1
2556680|NCT00518336|6266728|P2|COMPLETED|Year 8||211
2556681|NCT00518336|6266729|P1|COMPLETED|Year 8||222
2556682|NCT00518336|6266728|P2|STARTED|Year 8|2 subjects withdrawn at Year 7 came back and were therefore no longer considered as withdrawn.|213
2556683|NCT00518336|6266729|P1|STARTED|Year 8|1 subject withdrawn at Year 7 came back and was therefore no longer considered as withdrawn.|223
2556684|NCT00518336|6266728|P2|NOT COMPLETED|Year 7||3
2556685|NCT00518336|6266729|P1|NOT COMPLETED|Year 7||2
2556686|NCT00518336|6266728|P2|COMPLETED|Year 7||208
2556687|NCT00518336|6266729|P1|COMPLETED|Year 7||220
2556688|NCT00518336|6266728|P2|STARTED|Year 7||211
2556689|NCT00518336|6266729|P1|STARTED|Year 7||222
2556690|NCT00518323|6266895|P4|NOT COMPLETED|Overall Study||25
2556691|NCT00518323|6266896|P3|NOT COMPLETED|Overall Study||11
2556692|NCT00518323|6266897|P2|NOT COMPLETED|Overall Study||8
2556693|NCT00518323|6266898|P1|NOT COMPLETED|Overall Study||19
2556694|NCT00518323|6266895|P4|COMPLETED|Overall Study||26
2556695|NCT00518323|6266896|P3|COMPLETED|Overall Study||37
2556696|NCT00518323|6266897|P2|COMPLETED|Overall Study||40
2556697|NCT00518323|6266898|P1|COMPLETED|Overall Study||35
2556698|NCT00518323|6266895|P4|STARTED|Overall Study||51
2556699|NCT00518323|6266896|P3|STARTED|Overall Study||48
2556700|NCT00518323|6266897|P2|STARTED|Overall Study||48
2556701|NCT00518323|6266898|P1|STARTED|Overall Study||54
2556702|NCT00518284|6266928|P4|NOT COMPLETED|Overall Study||2
2556703|NCT00518284|6266929|P3|NOT COMPLETED|Overall Study||1
2556704|NCT00518284|6266930|P2|NOT COMPLETED|Overall Study||3
2556705|NCT00518284|6266931|P1|NOT COMPLETED|Overall Study||0
2556706|NCT00518284|6266928|P4|COMPLETED|Overall Study||0
2556707|NCT00518284|6266929|P3|COMPLETED|Overall Study||0
2556708|NCT00518284|6266930|P2|COMPLETED|Overall Study||0
2556709|NCT00518284|6266931|P1|COMPLETED|Overall Study||0
2556710|NCT00518284|6266928|P4|STARTED|Overall Study||2
2556711|NCT00518284|6266929|P3|STARTED|Overall Study||1
2556712|NCT00518284|6266930|P2|STARTED|Overall Study||3
2556713|NCT00518284|6266931|P1|STARTED|Overall Study||0
2556714|NCT00518206|6266987|P2|NOT COMPLETED|Overall Study||6
2556715|NCT00518206|6266988|P1|NOT COMPLETED|Overall Study||11
2556716|NCT00518206|6266987|P2|COMPLETED|Overall Study||13
2556717|NCT00518206|6266988|P1|COMPLETED|Overall Study||16
2556718|NCT00518206|6266987|P2|STARTED|Overall Study||19
2556719|NCT00518206|6266988|P1|STARTED|Overall Study||27
2556720|NCT00518180|6267005|P3|NOT COMPLETED|Overall Study||82
2556721|NCT00518180|6267006|P2|NOT COMPLETED|Overall Study||69
2556722|NCT00518180|6267007|P1|NOT COMPLETED|Overall Study||65
2556723|NCT00518180|6267005|P3|COMPLETED|Overall Study||457
2556724|NCT00518180|6267006|P2|COMPLETED|Overall Study||472
2556725|NCT00518180|6267007|P1|COMPLETED|Overall Study||475
2556726|NCT00518180|6267005|P3|STARTED|Overall Study||539
2556727|NCT00518180|6267006|P2|STARTED|Overall Study||541
2556728|NCT00518180|6267007|P1|STARTED|Overall Study||540
2556729|NCT00518154|6267049|P1|NOT COMPLETED|Overall Study||0
2556730|NCT00518154|6267049|P1|COMPLETED|Overall Study||7
2556731|NCT00518154|6267049|P1|STARTED|Overall Study||7
2556732|NCT00518115|6267063|P10|NOT COMPLETED|Overall Study||15
2556733|NCT00518115|6267064|P9|NOT COMPLETED|Overall Study||5
2556734|NCT00518115|6267065|P8|NOT COMPLETED|Overall Study||15
2556735|NCT00518115|6267066|P7|NOT COMPLETED|Overall Study||8
2556736|NCT00518115|6267067|P6|NOT COMPLETED|Overall Study||15
2556737|NCT00518115|6267068|P5|NOT COMPLETED|Overall Study||10
2556738|NCT00518115|6267069|P4|NOT COMPLETED|Overall Study||11
2556739|NCT00518115|6267070|P3|NOT COMPLETED|Overall Study||17
2556740|NCT00518115|6267071|P2|NOT COMPLETED|Overall Study||6
2556741|NCT00518115|6267072|P1|NOT COMPLETED|Overall Study||12
2556742|NCT00518115|6267063|P10|COMPLETED|Overall Study||20
2556743|NCT00518115|6267064|P9|COMPLETED|Overall Study||30
2556744|NCT00518115|6267065|P8|COMPLETED|Overall Study||20
2556745|NCT00518115|6267066|P7|COMPLETED|Overall Study||25
2556746|NCT00518115|6267067|P6|COMPLETED|Overall Study||19
2556747|NCT00518115|6267068|P5|COMPLETED|Overall Study||21
2556748|NCT00518115|6267069|P4|COMPLETED|Overall Study||24
2556749|NCT00518115|6267070|P3|COMPLETED|Overall Study||19
2556750|NCT00518115|6267071|P2|COMPLETED|Overall Study||29
2556751|NCT00518115|6267072|P1|COMPLETED|Overall Study||40
2556752|NCT00518115|6267063|P10|Safety Population|Overall Study|These participants received at least one dose of study drug.|34
2556753|NCT00518115|6267064|P9|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
2556754|NCT00518115|6267065|P8|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
2556755|NCT00518115|6267066|P7|Safety Population|Overall Study|These participants received at least one dose of study drug.|32
2556756|NCT00518115|6267067|P6|Safety Population|Overall Study|These participants received at least one dose of study drug.|33
2556757|NCT00518115|6267068|P5|Safety Population|Overall Study|These participants received at least one dose of study drug.|31
2556758|NCT00518115|6267069|P4|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
2556759|NCT00518115|6267070|P3|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
2556760|NCT00518115|6267071|P2|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
2556761|NCT00518115|6267072|P1|Safety Population|Overall Study|These participants received at least one dose of study drug.|51
2556762|NCT00518115|6267063|P10|STARTED|Overall Study||35
2556763|NCT00518115|6267064|P9|STARTED|Overall Study||35
2556764|NCT00518115|6267065|P8|STARTED|Overall Study||35
2556765|NCT00518115|6267066|P7|STARTED|Overall Study||33
2556766|NCT00518115|6267067|P6|STARTED|Overall Study||34
2556767|NCT00518115|6267068|P5|STARTED|Overall Study||31
2556768|NCT00518115|6267069|P4|STARTED|Overall Study||35
2556769|NCT00518115|6267070|P3|STARTED|Overall Study||36
2556770|NCT00518115|6267071|P2|STARTED|Overall Study||35
2556771|NCT00518115|6267072|P1|STARTED|Overall Study||52
2556772|NCT00518089|6267230|P2|NOT COMPLETED|Overall Study||31
2556773|NCT00518089|6267231|P1|NOT COMPLETED|Overall Study||28
2556774|NCT00518089|6267230|P2|COMPLETED|Overall Study||398
2556775|NCT00518089|6267231|P1|COMPLETED|Overall Study||402
2556776|NCT00518089|6267230|P2|STARTED|Overall Study||429
2556777|NCT00518089|6267231|P1|STARTED|Overall Study||430
2556778|NCT00518011|6267247|P2|NOT COMPLETED|Overall Study||8
2556779|NCT00518011|6267248|P1|NOT COMPLETED|Overall Study||9
2556780|NCT00518011|6267247|P2|COMPLETED|Overall Study||0
2556781|NCT00518011|6267248|P1|COMPLETED|Overall Study||0
2556782|NCT00518011|6267247|P2|STARTED|Overall Study||8
2556783|NCT00518011|6267248|P1|STARTED|Overall Study||9
2556784|NCT00517933|6267270|P2|NOT COMPLETED|Period 2||13
2556785|NCT00517933|6267271|P1|NOT COMPLETED|Period 2||6
2556786|NCT00517933|6267270|P2|COMPLETED|Period 2||70
2556787|NCT00517933|6267271|P1|COMPLETED|Period 2||73
2556788|NCT00517933|6267270|P2|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|83
2556789|NCT00517933|6267271|P1|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|79
2556790|NCT00517933|6267270|P2|NOT COMPLETED|Period 1||6
2556791|NCT00517933|6267271|P1|NOT COMPLETED|Period 1||8
2556792|NCT00517933|6267270|P2|COMPLETED|Period 1||85
2556793|NCT00517933|6267271|P1|COMPLETED|Period 1||81
2556794|NCT00517933|6267270|P2|STARTED|Period 1|Patients decreased due to death, adverse event and other (see below)|91
2556795|NCT00517933|6267271|P1|STARTED|Period 1|Patients decreased due to death, adverse event, lost to follow up and other (see below)|89
2556796|NCT00517881|6267335|P1|NOT COMPLETED|Overall Study||5
2556797|NCT00517881|6267335|P1|COMPLETED|Overall Study||24
2556798|NCT00517881|6267335|P1|STARTED|Overall Study||29
2556799|NCT00517829|6267347|P2|NOT COMPLETED|Overall Study||75
2556800|NCT00517829|6267348|P1|NOT COMPLETED|Overall Study||75
2556801|NCT00517829|6267347|P2|COMPLETED|Overall Study||0
2556802|NCT00517829|6267348|P1|COMPLETED|Overall Study||0
2556803|NCT00517829|6267347|P2|STARTED|Overall Study||75
2556804|NCT00517829|6267348|P1|STARTED|Overall Study||75
2556805|NCT00517751|6267362|P1|NOT COMPLETED|Overall Study||129
2556806|NCT00517751|6267362|P1|COMPLETED|Overall Study||33
2556807|NCT00517751|6267362|P1|STARTED|Overall Study||162
2556808|NCT00517699|6267385|P1|NOT COMPLETED|Overall Study||5
2556809|NCT00517699|6267385|P1|COMPLETED|Overall Study||0
2556810|NCT00517699|6267385|P1|STARTED|Overall Study||5
2556811|NCT00517634|6267393|P6|NOT COMPLETED|Third Treatment Period||0
2556812|NCT00517634|6267394|P5|NOT COMPLETED|Third Treatment Period||0
2556813|NCT00517634|6267395|P4|NOT COMPLETED|Third Treatment Period||0
2556814|NCT00517634|6267396|P3|NOT COMPLETED|Third Treatment Period||0
2556815|NCT00517634|6267397|P2|NOT COMPLETED|Third Treatment Period||0
2556816|NCT00517634|6267398|P1|NOT COMPLETED|Third Treatment Period||0
2556817|NCT00517634|6267393|P6|COMPLETED|Third Treatment Period||4
2556818|NCT00517634|6267394|P5|COMPLETED|Third Treatment Period||3
2556819|NCT00517634|6267395|P4|COMPLETED|Third Treatment Period||3
2556820|NCT00517634|6267396|P3|COMPLETED|Third Treatment Period||4
2556821|NCT00517634|6267397|P2|COMPLETED|Third Treatment Period||4
2556822|NCT00517634|6267398|P1|COMPLETED|Third Treatment Period||4
2556823|NCT00517634|6267393|P6|STARTED|Third Treatment Period||4
2556824|NCT00517634|6267394|P5|STARTED|Third Treatment Period||3
2556825|NCT00517634|6267395|P4|STARTED|Third Treatment Period||3
2556826|NCT00517634|6267396|P3|STARTED|Third Treatment Period||4
2556827|NCT00517634|6267397|P2|STARTED|Third Treatment Period||4
2556828|NCT00517634|6267398|P1|STARTED|Third Treatment Period||4
2556829|NCT00517634|6267393|P6|NOT COMPLETED|Second Treatment Period||0
2556830|NCT00517634|6267394|P5|NOT COMPLETED|Second Treatment Period||1
2556831|NCT00517634|6267395|P4|NOT COMPLETED|Second Treatment Period||0
2556832|NCT00517634|6267396|P3|NOT COMPLETED|Second Treatment Period||0
2556833|NCT00517634|6267397|P2|NOT COMPLETED|Second Treatment Period||0
2556834|NCT00517634|6267398|P1|NOT COMPLETED|Second Treatment Period||0
2556835|NCT00517634|6267393|P6|COMPLETED|Second Treatment Period||4
2556836|NCT00517634|6267394|P5|COMPLETED|Second Treatment Period||3
2556837|NCT00517634|6267395|P4|COMPLETED|Second Treatment Period||3
2556838|NCT00517634|6267396|P3|COMPLETED|Second Treatment Period||4
2556839|NCT00517634|6267397|P2|COMPLETED|Second Treatment Period||4
2556840|NCT00517634|6267398|P1|COMPLETED|Second Treatment Period||4
2556841|NCT00517634|6267393|P6|STARTED|Second Treatment Period||4
2556842|NCT00517634|6267394|P5|STARTED|Second Treatment Period||4
2556843|NCT00517634|6267395|P4|STARTED|Second Treatment Period||3
2556844|NCT00517634|6267396|P3|STARTED|Second Treatment Period||4
2556845|NCT00517634|6267397|P2|STARTED|Second Treatment Period||4
2556846|NCT00517634|6267398|P1|STARTED|Second Treatment Period||4
2556847|NCT00517634|6267393|P6|NOT COMPLETED|First Treatment Period||0
2556848|NCT00517634|6267394|P5|NOT COMPLETED|First Treatment Period||0
2556849|NCT00517634|6267395|P4|NOT COMPLETED|First Treatment Period||0
2556850|NCT00517634|6267396|P3|NOT COMPLETED|First Treatment Period||0
2556851|NCT00517634|6267397|P2|NOT COMPLETED|First Treatment Period||0
2556852|NCT00517634|6267398|P1|NOT COMPLETED|First Treatment Period||0
2556853|NCT00517634|6267393|P6|COMPLETED|First Treatment Period||4
2556854|NCT00517634|6267394|P5|COMPLETED|First Treatment Period||4
2556855|NCT00517634|6267395|P4|COMPLETED|First Treatment Period||3
2556856|NCT00517634|6267396|P3|COMPLETED|First Treatment Period||4
2556857|NCT00517634|6267397|P2|COMPLETED|First Treatment Period||4
2556858|NCT00517634|6267398|P1|COMPLETED|First Treatment Period||4
2556859|NCT00517634|6267393|P6|STARTED|First Treatment Period||4
2556860|NCT00517634|6267394|P5|STARTED|First Treatment Period||4
2556861|NCT00517634|6267395|P4|STARTED|First Treatment Period||3
2556862|NCT00517634|6267396|P3|STARTED|First Treatment Period||4
2556863|NCT00517634|6267397|P2|STARTED|First Treatment Period||4
2556864|NCT00517634|6267398|P1|STARTED|First Treatment Period||4
2556865|NCT00517595|6267409|P1|NOT COMPLETED|Overall Study||0
2556866|NCT00517595|6267409|P1|COMPLETED|Overall Study||48
2556867|NCT00517595|6267409|P1|STARTED|Overall Study||48
2556868|NCT00517556|6267420|P2|NOT COMPLETED|Overall Study||5
2556869|NCT00517556|6267421|P1|NOT COMPLETED|Overall Study||4
2556870|NCT00517556|6267420|P2|COMPLETED|Overall Study||14
2556871|NCT00517556|6267421|P1|COMPLETED|Overall Study||15
2556872|NCT00517556|6267420|P2|STARTED|Overall Study||19
2556873|NCT00517556|6267421|P1|STARTED|Overall Study||19
2556874|NCT00517530|6267434|P7|NOT COMPLETED|Overall Study||19
2556875|NCT00517530|6267435|P6|NOT COMPLETED|Overall Study||19
2556876|NCT00517530|6267436|P5|NOT COMPLETED|Overall Study||20
2556877|NCT00517530|6267437|P4|NOT COMPLETED|Overall Study||21
2556878|NCT00517530|6267438|P3|NOT COMPLETED|Overall Study||18
2556879|NCT00517530|6267439|P2|NOT COMPLETED|Overall Study||13
2556880|NCT00517530|6267440|P1|NOT COMPLETED|Overall Study||19
2556881|NCT00517530|6267434|P7|COMPLETED|Overall Study||1
2556882|NCT00517530|6267435|P6|COMPLETED|Overall Study||0
2556883|NCT00517530|6267436|P5|COMPLETED|Overall Study||1
2556884|NCT00517530|6267437|P4|COMPLETED|Overall Study||1
2556885|NCT00517530|6267438|P3|COMPLETED|Overall Study||0
2556886|NCT00517530|6267439|P2|COMPLETED|Overall Study||0
2556887|NCT00517530|6267440|P1|COMPLETED|Overall Study||2
2556888|NCT00517530|6267434|P7|Retreated Population|Overall Study||0
2556889|NCT00517530|6267435|P6|Retreated Population|Overall Study||2
2556890|NCT00517530|6267436|P5|Retreated Population|Overall Study||2
2556891|NCT00517530|6267437|P4|Retreated Population|Overall Study||4
2556892|NCT00517530|6267438|P3|Retreated Population|Overall Study||1
2556893|NCT00517530|6267439|P2|Retreated Population|Overall Study||2
2556894|NCT00517530|6267440|P1|Retreated Population|Overall Study||2
2556895|NCT00517530|6267434|P7|Completed Follow-up|Overall Study||1
2556896|NCT00517530|6267435|P6|Completed Follow-up|Overall Study||0
2556897|NCT00517530|6267436|P5|Completed Follow-up|Overall Study||0
2556898|NCT00517530|6267437|P4|Completed Follow-up|Overall Study||1
2556899|NCT00517530|6267438|P3|Completed Follow-up|Overall Study||0
2556900|NCT00517530|6267439|P2|Completed Follow-up|Overall Study||0
2556901|NCT00517530|6267440|P1|Completed Follow-up|Overall Study||2
2556902|NCT00517530|6267434|P7|Started Follow-up|Overall Study||19
2556903|NCT00517530|6267435|P6|Started Follow-up|Overall Study||16
2556904|NCT00517530|6267436|P5|Started Follow-up|Overall Study||17
2556905|NCT00517530|6267437|P4|Started Follow-up|Overall Study||21
2556906|NCT00517530|6267438|P3|Started Follow-up|Overall Study||17
2556907|NCT00517530|6267439|P2|Started Follow-up|Overall Study||13
2556908|NCT00517530|6267440|P1|Started Follow-up|Overall Study||20
2556909|NCT00517530|6267434|P7|Completed Treatment|Overall Study||13
2556910|NCT00517530|6267435|P6|Completed Treatment|Overall Study||9
2556911|NCT00517530|6267436|P5|Completed Treatment|Overall Study||9
2556912|NCT00517530|6267437|P4|Completed Treatment|Overall Study||18
2556913|NCT00517530|6267438|P3|Completed Treatment|Overall Study||13
2556914|NCT00517530|6267439|P2|Completed Treatment|Overall Study||13
2556915|NCT00517530|6267440|P1|Completed Treatment|Overall Study||11
2556916|NCT00517530|6267434|P7|STARTED|Overall Study||20
2556917|NCT00517530|6267435|P6|STARTED|Overall Study||19
2556918|NCT00517530|6267436|P5|STARTED|Overall Study||21
2556919|NCT00517530|6267437|P4|STARTED|Overall Study||22
2556920|NCT00517530|6267438|P3|STARTED|Overall Study||18
2556921|NCT00517530|6267439|P2|STARTED|Overall Study||13
2556922|NCT00517530|6267440|P1|STARTED|Overall Study||21
2556923|NCT00517413|6267500|P1|NOT COMPLETED|Overall Study||61
2556924|NCT00517413|6267500|P1|COMPLETED|Overall Study||102
2556925|NCT00517413|6267500|P1|STARTED|Overall Study||163
2556926|NCT00517361|6267521|P1|NOT COMPLETED|Overall Study||11
2556927|NCT00517361|6267521|P1|COMPLETED|Overall Study|This study has been terminated due to poor accrual.|0
2556928|NCT00517361|6267521|P1|STARTED|Overall Study||11
2556929|NCT00517296|6267530|P2|NOT COMPLETED|Overall Study||0
2556930|NCT00517296|6267531|P1|NOT COMPLETED|Overall Study||1
2556931|NCT00517296|6267530|P2|COMPLETED|Overall Study||11
2556932|NCT00517296|6267531|P1|COMPLETED|Overall Study||9
2556933|NCT00517296|6267530|P2|STARTED|Overall Study||11
2556934|NCT00517296|6267531|P1|STARTED|Overall Study||10
2556935|NCT00517192|6267543|P2|NOT COMPLETED|Overall Study||20
2556936|NCT00517192|6267544|P1|NOT COMPLETED|Overall Study||19
2556937|NCT00517192|6267543|P2|COMPLETED|Overall Study||0
2556938|NCT00517192|6267544|P1|COMPLETED|Overall Study||0
2556939|NCT00517192|6267543|P2|STARTED|Overall Study||20
2556940|NCT00517192|6267544|P1|STARTED|Overall Study||19
2556941|NCT00517075|6267596|P4|NOT COMPLETED|Overall Study||0
2556942|NCT00517075|6267597|P3|NOT COMPLETED|Overall Study||0
2556943|NCT00517075|6267598|P2|NOT COMPLETED|Overall Study||0
2556944|NCT00517075|6267599|P1|NOT COMPLETED|Overall Study||0
2556945|NCT00517075|6267596|P4|COMPLETED|Overall Study||0
2556946|NCT00517075|6267597|P3|COMPLETED|Overall Study||0
2556947|NCT00517075|6267598|P2|COMPLETED|Overall Study||0
2556948|NCT00517075|6267599|P1|COMPLETED|Overall Study||0
2556949|NCT00517075|6267596|P4|STARTED|Overall Study||0
2556950|NCT00517075|6267597|P3|STARTED|Overall Study||0
2556951|NCT00517075|6267598|P2|STARTED|Overall Study||0
2556952|NCT00517075|6267599|P1|STARTED|Overall Study||0
2556953|NCT00517010|6267637|P1|NOT COMPLETED|Overall Study||1
2556954|NCT00517010|6267637|P1|COMPLETED|Overall Study||5
2556955|NCT00517010|6267637|P1|STARTED|Overall Study||6
2556956|NCT00516919|6267642|P2|NOT COMPLETED|Overall Study||7
2556957|NCT00516919|6267643|P1|NOT COMPLETED|Overall Study||10
2556958|NCT00516919|6267642|P2|COMPLETED|Overall Study||32
2556959|NCT00516919|6267643|P1|COMPLETED|Overall Study||30
2556960|NCT00516919|6267642|P2|STARTED|Overall Study||39
2556961|NCT00516919|6267643|P1|STARTED|Overall Study||40
2556962|NCT00516906|6267651|P2|NOT COMPLETED|Overall Study||2
2556963|NCT00516906|6267652|P1|NOT COMPLETED|Overall Study||6
2556964|NCT00516906|6267651|P2|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
2556965|NCT00516906|6267652|P1|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
2556966|NCT00516906|6267651|P2|STARTED|Overall Study|33 patients were randomized but one patient was discharged prior to treatment.|32
2556967|NCT00516906|6267652|P1|STARTED|Overall Study||36
2556968|NCT00516893|6267662|P1|NOT COMPLETED|Overall Study||21
2556969|NCT00516893|6267662|P1|COMPLETED|Overall Study||92
2556970|NCT00516893|6267662|P1|Received Study Treatment|Overall Study||112
2556971|NCT00516893|6267662|P1|STARTED|Overall Study||113
2556972|NCT00516737|6267671|P2|NOT COMPLETED|Overall Study||8
2556973|NCT00516737|6267672|P1|NOT COMPLETED|Overall Study||11
2556974|NCT00516737|6267671|P2|COMPLETED|Overall Study||96
2556975|NCT00516737|6267672|P1|COMPLETED|Overall Study||92
2556976|NCT00516737|6267671|P2|STARTED|Overall Study||104
2556977|NCT00516737|6267672|P1|STARTED|Overall Study||103
2556978|NCT00516503|6267692|P2|NOT COMPLETED|Overall Study||0
2556979|NCT00516503|6267693|P1|NOT COMPLETED|Overall Study||0
2556980|NCT00516503|6267692|P2|COMPLETED|Overall Study||102
2556981|NCT00516503|6267693|P1|COMPLETED|Overall Study||101
2556982|NCT00516503|6267692|P2|STARTED|Overall Study||102
2556983|NCT00516503|6267693|P1|STARTED|Overall Study||101
2556984|NCT00516386|6267711|P1|NOT COMPLETED|Overall Study||6
2556985|NCT00516386|6267711|P1|COMPLETED|Overall Study||10
2556986|NCT00516386|6267711|P1|STARTED|Overall Study||16
2556987|NCT00516321|6267718|P3|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||54
2556988|NCT00516321|6267719|P2|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||35
2556989|NCT00516321|6267720|P1|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||0
2556990|NCT00516321|6267718|P3|COMPLETED|Double-blind (DB) Antiviral Treatment||396
2556991|NCT00516321|6267719|P2|COMPLETED|Double-blind (DB) Antiviral Treatment||197
2556992|NCT00516321|6267720|P1|COMPLETED|Double-blind (DB) Antiviral Treatment||0
2556993|NCT00516321|6267718|P3|STARTED|Double-blind (DB) Antiviral Treatment||450
2556994|NCT00516321|6267719|P2|STARTED|Double-blind (DB) Antiviral Treatment||232
2556995|NCT00516321|6267720|P1|STARTED|Double-blind (DB) Antiviral Treatment||0
2556996|NCT00516321|6267718|P3|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
2556997|NCT00516321|6267719|P2|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
2556998|NCT00516321|6267720|P1|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||33
2556999|NCT00516321|6267718|P3|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
2557000|NCT00516321|6267719|P2|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
2557001|NCT00516321|6267720|P1|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||682
2557002|NCT00516321|6267718|P3|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
2557003|NCT00516321|6267719|P2|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
2557004|NCT00516321|6267720|P1|STARTED|Open-label (OL) Pre-Antiviral Treatment||715
2557005|NCT00516295|6267771|P3|NOT COMPLETED|Overall Study||0
2557006|NCT00516295|6267772|P2|NOT COMPLETED|Overall Study||0
2557007|NCT00516295|6267773|P1|NOT COMPLETED|Overall Study||3
2557008|NCT00516295|6267771|P3|COMPLETED|Overall Study||0
2557009|NCT00516295|6267772|P2|COMPLETED|Overall Study||0
2557010|NCT00516295|6267773|P1|COMPLETED|Overall Study||4
2557011|NCT00516295|6267771|P3|STARTED|Overall Study||0
2557012|NCT00516295|6267772|P2|STARTED|Overall Study||0
2557013|NCT00516295|6267773|P1|STARTED|Overall Study||7
2557014|NCT00516269|6267786|P2|NOT COMPLETED|Overall Study||3
2557015|NCT00516269|6267787|P1|NOT COMPLETED|Overall Study||2
2557016|NCT00516269|6267786|P2|COMPLETED|Overall Study|2 patients did not complete the study and 1 randomized to placebo twice.|16
2557017|NCT00516269|6267787|P1|COMPLETED|Overall Study|2 patients had an early termination|17
2557018|NCT00516269|6267786|P2|STARTED|Overall Study||19
2557019|NCT00516269|6267787|P1|STARTED|Overall Study||19
2557020|NCT00516217|6267793|P1|NOT COMPLETED|Overall Study||0
2557021|NCT00516217|6267793|P1|COMPLETED|Overall Study||29
2557022|NCT00516217|6267793|P1|STARTED|Overall Study||29
2557023|NCT00516165|6267799|P1|NOT COMPLETED|Overall Study||0
2557024|NCT00516165|6267799|P1|COMPLETED|Overall Study||28
2557025|NCT00516165|6267799|P1|STARTED|Overall Study||28
2557026|NCT00516139|6267808|P1|NOT COMPLETED|Overall Study||38
2557027|NCT00516139|6267808|P1|COMPLETED|Overall Study|Study completers completed Escalation, AM, and either AO or both Conversion and Monotherapy Phases.|84
2557028|NCT00516139|6267808|P1|STARTED|Overall Study||122
2557029|NCT00516074|6267839|P2|NOT COMPLETED|Overall Study||3
2557030|NCT00516074|6267840|P1|NOT COMPLETED|Overall Study||6
2557031|NCT00516074|6267839|P2|COMPLETED|Overall Study||23
2557032|NCT00516074|6267840|P1|COMPLETED|Overall Study||22
2557033|NCT00516074|6267839|P2|STARTED|Overall Study||26
2557034|NCT00516074|6267840|P1|STARTED|Overall Study||28
2557035|NCT00516048|6267858|P3|NOT COMPLETED|Overall Study||1
2557036|NCT00516048|6267859|P2|NOT COMPLETED|Overall Study||2
2557037|NCT00516048|6267860|P1|NOT COMPLETED|Overall Study||0
2557038|NCT00516048|6267858|P3|COMPLETED|Overall Study||0
2557039|NCT00516048|6267859|P2|COMPLETED|Overall Study||40
2557040|NCT00516048|6267860|P1|COMPLETED|Overall Study||15
2557041|NCT00516048|6267858|P3|STARTED|Overall Study||1
2557042|NCT00516048|6267859|P2|STARTED|Overall Study||42
2557043|NCT00516048|6267860|P1|STARTED|Overall Study||15
2557044|NCT00515879|6267876|P2|NOT COMPLETED|Overall Study||20
2557045|NCT00515879|6267877|P1|NOT COMPLETED|Overall Study||25
2557046|NCT00515879|6267876|P2|COMPLETED|Overall Study||62
2557047|NCT00515879|6267877|P1|COMPLETED|Overall Study||62
2557048|NCT00515879|6267876|P2|STARTED|Overall Study||82
2557049|NCT00515879|6267877|P1|STARTED|Overall Study||87
2557050|NCT00515827|6267895|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
2557051|NCT00515827|6267896|P1|NOT COMPLETED|Second Intervention (12 Weeks)||1
2557052|NCT00515827|6267895|P2|COMPLETED|Second Intervention (12 Weeks)||25
2557053|NCT00515827|6267896|P1|COMPLETED|Second Intervention (12 Weeks)||25
2557054|NCT00515827|6267895|P2|STARTED|Second Intervention (12 Weeks)||25
2557055|NCT00515827|6267896|P1|STARTED|Second Intervention (12 Weeks)||26
2557056|NCT00515827|6267895|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
2557057|NCT00515827|6267896|P1|NOT COMPLETED|First Intervention (12 Weeks)||1
2557058|NCT00515827|6267895|P2|COMPLETED|First Intervention (12 Weeks)||25
2557059|NCT00515827|6267896|P1|COMPLETED|First Intervention (12 Weeks)||26
2557060|NCT00515827|6267895|P2|STARTED|First Intervention (12 Weeks)||26
2557061|NCT00515827|6267896|P1|STARTED|First Intervention (12 Weeks)||27
2557062|NCT00515723|6267922|P4|NOT COMPLETED|Overall Study||6
2557063|NCT00515723|6267923|P3|NOT COMPLETED|Overall Study||1
2557064|NCT00515723|6267924|P2|NOT COMPLETED|Overall Study||1
2557065|NCT00515723|6267925|P1|NOT COMPLETED|Overall Study||5
2557066|NCT00515723|6267922|P4|COMPLETED|Overall Study||21
2557067|NCT00515723|6267923|P3|COMPLETED|Overall Study||21
2557068|NCT00515723|6267924|P2|COMPLETED|Overall Study||21
2557069|NCT00515723|6267925|P1|COMPLETED|Overall Study||20
2557070|NCT00515723|6267922|P4|STARTED|Overall Study||27
2557071|NCT00515723|6267923|P3|STARTED|Overall Study||22
2557072|NCT00515723|6267924|P2|STARTED|Overall Study||22
2557073|NCT00515723|6267925|P1|STARTED|Overall Study||25
2557074|NCT00515697|6267941|P1|NOT COMPLETED|Overall Study||0
2557075|NCT00515697|6267941|P1|COMPLETED|Overall Study||39
2557076|NCT00515697|6267941|P1|Received at Least 1 Dose of Study Drug|Overall Study||39
2557077|NCT00515697|6267941|P1|STARTED|Overall Study||39
2557078|NCT00515671|6267954|P2|NOT COMPLETED|Overall Study||17
2557079|NCT00515671|6267955|P1|NOT COMPLETED|Overall Study||17
2557080|NCT00515671|6267954|P2|COMPLETED|Overall Study||41
2557081|NCT00515671|6267955|P1|COMPLETED|Overall Study||43
2557082|NCT00515671|6267954|P2|STARTED|Overall Study||58
2557083|NCT00515671|6267955|P1|STARTED|Overall Study||60
2557084|NCT00515619|6267963|P1|NOT COMPLETED|Overall Study||216
2557085|NCT00515619|6267963|P1|COMPLETED|Overall Study||160
2557086|NCT00515619|6267963|P1|Safety Set|Overall Study||376
2557087|NCT00515619|6267963|P1|STARTED|Overall Study||376
2557088|NCT00515541|6267975|P4|NOT COMPLETED|Overall Study||5
2557089|NCT00515541|6267976|P3|NOT COMPLETED|Overall Study||0
2557090|NCT00515541|6267977|P2|NOT COMPLETED|Overall Study||5
2557091|NCT00515541|6267978|P1|NOT COMPLETED|Overall Study||0
2557092|NCT00515541|6267975|P4|COMPLETED|Overall Study||6
2557093|NCT00515541|6267976|P3|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
2557094|NCT00515541|6267977|P2|COMPLETED|Overall Study||7
2557095|NCT00515541|6267978|P1|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
2557096|NCT00515541|6267975|P4|24 Weeks (8 gm Lovaza)|Overall Study|Three subjects withdrew after 18 weeks (1 GI problem, 1 undefined medical problem, 1 no show)|6
2557097|NCT00515541|6267976|P3|24 Weeks (8 gm Lovaza)|Overall Study||10
2557098|NCT00515541|6267977|P2|24 Weeks (8 gm Lovaza)|Overall Study|Two subjects withdrew at 20 and 21 weeks due to nausea. Subjects were closed out early.|7
2557099|NCT00515541|6267978|P1|24 Weeks (8 gm Lovaza)|Overall Study||10
2557100|NCT00515541|6267975|P4|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 14 weeks with GI problems.|9
2557101|NCT00515541|6267976|P3|18 Weeks (4 gm Lovaza)|Overall Study||10
2557102|NCT00515541|6267977|P2|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 12 weeks due to acquired bleeding disorder present before enrolling.|9
2557103|NCT00515541|6267978|P1|18 Weeks (4 gm Lovaza)|Overall Study||10
2557104|NCT00515541|6267975|P4|12 Weeks (2 gm Lovaza)|Overall Study||10
2557105|NCT00515541|6267976|P3|12 Weeks (2 gm Lovaza)|Overall Study||10
2557106|NCT00515541|6267977|P2|12 Weeks (2 gm Lovaza)|Overall Study||10
2557107|NCT00515541|6267978|P1|12 Weeks (2 gm Lovaza)|Overall Study||10
2557108|NCT00515541|6267975|P4|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled due to no show for appt. after baseline.|10
2557109|NCT00515541|6267976|P3|6 Weeks (1 gm Lovaza)|Overall Study||10
2557110|NCT00515541|6267977|P2|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled after baseline. One subject pulled due to no show for appt.after baseline|10
2557111|NCT00515541|6267978|P1|6 Weeks (1 gm Lovaza)|Overall Study||10
2557112|NCT00515541|6267975|P4|STARTED|Overall Study||11
2557113|NCT00515541|6267976|P3|STARTED|Overall Study||10
2557114|NCT00515541|6267977|P2|STARTED|Overall Study||12
2557115|NCT00515541|6267978|P1|STARTED|Overall Study||10
2557116|NCT00515502|6268000|P12|NOT COMPLETED|Treatment Period 4||0
2557117|NCT00515502|6268001|P11|NOT COMPLETED|Treatment Period 4||0
2557118|NCT00515502|6268002|P10|NOT COMPLETED|Treatment Period 4||0
2557119|NCT00515502|6268003|P9|NOT COMPLETED|Treatment Period 4||0
2557120|NCT00515502|6268004|P8|NOT COMPLETED|Treatment Period 4||0
2557121|NCT00515502|6268005|P7|NOT COMPLETED|Treatment Period 4||0
2557122|NCT00515502|6268006|P6|NOT COMPLETED|Treatment Period 4||0
2557123|NCT00515502|6268007|P5|NOT COMPLETED|Treatment Period 4||0
2557124|NCT00515502|6268008|P4|NOT COMPLETED|Treatment Period 4||0
2557125|NCT00515502|6268009|P3|NOT COMPLETED|Treatment Period 4||0
2557126|NCT00515502|6268010|P2|NOT COMPLETED|Treatment Period 4||0
2557127|NCT00515502|6268011|P1|NOT COMPLETED|Treatment Period 4||0
2557128|NCT00515502|6268000|P12|COMPLETED|Treatment Period 4||0
2557129|NCT00515502|6268001|P11|COMPLETED|Treatment Period 4||1
2557130|NCT00515502|6268002|P10|COMPLETED|Treatment Period 4||2
2557131|NCT00515502|6268003|P9|COMPLETED|Treatment Period 4||0
2557132|NCT00515502|6268004|P8|COMPLETED|Treatment Period 4||1
2557133|NCT00515502|6268005|P7|COMPLETED|Treatment Period 4||1
2557134|NCT00515502|6268006|P6|COMPLETED|Treatment Period 4||1
2557135|NCT00515502|6268007|P5|COMPLETED|Treatment Period 4||3
2557136|NCT00515502|6268008|P4|COMPLETED|Treatment Period 4||3
2557137|NCT00515502|6268009|P3|COMPLETED|Treatment Period 4||4
2557138|NCT00515502|6268010|P2|COMPLETED|Treatment Period 4||3
2557139|NCT00515502|6268011|P1|COMPLETED|Treatment Period 4||1
2557140|NCT00515502|6268000|P12|STARTED|Treatment Period 4||0
2557141|NCT00515502|6268001|P11|STARTED|Treatment Period 4||1
2557142|NCT00515502|6268002|P10|STARTED|Treatment Period 4||2
2557143|NCT00515502|6268003|P9|STARTED|Treatment Period 4||0
2557144|NCT00515502|6268004|P8|STARTED|Treatment Period 4||1
2557145|NCT00515502|6268005|P7|STARTED|Treatment Period 4||1
2557146|NCT00515502|6268006|P6|STARTED|Treatment Period 4||1
2557147|NCT00515502|6268007|P5|STARTED|Treatment Period 4||3
2557148|NCT00515502|6268008|P4|STARTED|Treatment Period 4||3
2557149|NCT00515502|6268009|P3|STARTED|Treatment Period 4||4
2557150|NCT00515502|6268010|P2|STARTED|Treatment Period 4||3
2557151|NCT00515502|6268011|P1|STARTED|Treatment Period 4||1
2557152|NCT00515502|6268000|P12|NOT COMPLETED|Washout Period 3||0
2557153|NCT00515502|6268001|P11|NOT COMPLETED|Washout Period 3||0
2557154|NCT00515502|6268002|P10|NOT COMPLETED|Washout Period 3||0
2557155|NCT00515502|6268003|P9|NOT COMPLETED|Washout Period 3||0
2557156|NCT00515502|6268004|P8|NOT COMPLETED|Washout Period 3||0
2557157|NCT00515502|6268005|P7|NOT COMPLETED|Washout Period 3||0
2557158|NCT00515502|6268006|P6|NOT COMPLETED|Washout Period 3||0
2557159|NCT00515502|6268007|P5|NOT COMPLETED|Washout Period 3||0
2557160|NCT00515502|6268008|P4|NOT COMPLETED|Washout Period 3||0
2557161|NCT00515502|6268009|P3|NOT COMPLETED|Washout Period 3||0
2557162|NCT00515502|6268010|P2|NOT COMPLETED|Washout Period 3||0
2557163|NCT00515502|6268011|P1|NOT COMPLETED|Washout Period 3||0
2557164|NCT00515502|6268000|P12|COMPLETED|Washout Period 3||0
2557165|NCT00515502|6268001|P11|COMPLETED|Washout Period 3||1
2557166|NCT00515502|6268002|P10|COMPLETED|Washout Period 3||2
2557167|NCT00515502|6268003|P9|COMPLETED|Washout Period 3||0
2557168|NCT00515502|6268004|P8|COMPLETED|Washout Period 3||1
2557169|NCT00515502|6268005|P7|COMPLETED|Washout Period 3||1
2557170|NCT00515502|6268006|P6|COMPLETED|Washout Period 3||1
2557171|NCT00515502|6268007|P5|COMPLETED|Washout Period 3||3
2557172|NCT00515502|6268008|P4|COMPLETED|Washout Period 3||3
2557173|NCT00515502|6268009|P3|COMPLETED|Washout Period 3||4
2557174|NCT00515502|6268010|P2|COMPLETED|Washout Period 3||3
2557175|NCT00515502|6268011|P1|COMPLETED|Washout Period 3||1
2557176|NCT00515502|6268000|P12|STARTED|Washout Period 3||0
2557177|NCT00515502|6268001|P11|STARTED|Washout Period 3||1
2557178|NCT00515502|6268002|P10|STARTED|Washout Period 3||2
2557179|NCT00515502|6268003|P9|STARTED|Washout Period 3||0
2557180|NCT00515502|6268004|P8|STARTED|Washout Period 3||1
2557181|NCT00515502|6268005|P7|STARTED|Washout Period 3||1
2557182|NCT00515502|6268006|P6|STARTED|Washout Period 3||1
2557183|NCT00515502|6268007|P5|STARTED|Washout Period 3||3
2557184|NCT00515502|6268008|P4|STARTED|Washout Period 3||3
2557185|NCT00515502|6268009|P3|STARTED|Washout Period 3||4
2557186|NCT00515502|6268010|P2|STARTED|Washout Period 3||3
2557187|NCT00515502|6268011|P1|STARTED|Washout Period 3||1
2557188|NCT00515502|6268000|P12|NOT COMPLETED|Treatment Period 3||0
2557189|NCT00515502|6268001|P11|NOT COMPLETED|Treatment Period 3||0
2557190|NCT00515502|6268002|P10|NOT COMPLETED|Treatment Period 3||0
2557191|NCT00515502|6268003|P9|NOT COMPLETED|Treatment Period 3||0
2557192|NCT00515502|6268004|P8|NOT COMPLETED|Treatment Period 3||0
2557193|NCT00515502|6268005|P7|NOT COMPLETED|Treatment Period 3||0
2557194|NCT00515502|6268006|P6|NOT COMPLETED|Treatment Period 3||0
2557195|NCT00515502|6268007|P5|NOT COMPLETED|Treatment Period 3||0
2557196|NCT00515502|6268008|P4|NOT COMPLETED|Treatment Period 3||0
2557197|NCT00515502|6268009|P3|NOT COMPLETED|Treatment Period 3||0
2557198|NCT00515502|6268010|P2|NOT COMPLETED|Treatment Period 3||0
2557199|NCT00515502|6268011|P1|NOT COMPLETED|Treatment Period 3||0
2557200|NCT00515502|6268000|P12|COMPLETED|Treatment Period 3||0
2557201|NCT00515502|6268001|P11|COMPLETED|Treatment Period 3||1
2557202|NCT00515502|6268002|P10|COMPLETED|Treatment Period 3||2
2557203|NCT00515502|6268003|P9|COMPLETED|Treatment Period 3||0
2557204|NCT00515502|6268004|P8|COMPLETED|Treatment Period 3||1
2557205|NCT00515502|6268005|P7|COMPLETED|Treatment Period 3||1
2557206|NCT00515502|6268006|P6|COMPLETED|Treatment Period 3||1
2557207|NCT00515502|6268007|P5|COMPLETED|Treatment Period 3||3
2557208|NCT00515502|6268008|P4|COMPLETED|Treatment Period 3||3
2557209|NCT00515502|6268009|P3|COMPLETED|Treatment Period 3||4
2557210|NCT00515502|6268010|P2|COMPLETED|Treatment Period 3||3
2557211|NCT00515502|6268011|P1|COMPLETED|Treatment Period 3||1
2557212|NCT00515502|6268000|P12|STARTED|Treatment Period 3||0
2557213|NCT00515502|6268001|P11|STARTED|Treatment Period 3||1
2557214|NCT00515502|6268002|P10|STARTED|Treatment Period 3||2
2557215|NCT00515502|6268003|P9|STARTED|Treatment Period 3||0
2557216|NCT00515502|6268004|P8|STARTED|Treatment Period 3||1
2557217|NCT00515502|6268005|P7|STARTED|Treatment Period 3||1
2557218|NCT00515502|6268006|P6|STARTED|Treatment Period 3||1
2557219|NCT00515502|6268007|P5|STARTED|Treatment Period 3||3
2557220|NCT00515502|6268008|P4|STARTED|Treatment Period 3||3
2557221|NCT00515502|6268009|P3|STARTED|Treatment Period 3||4
2557222|NCT00515502|6268010|P2|STARTED|Treatment Period 3||3
2557223|NCT00515502|6268011|P1|STARTED|Treatment Period 3||1
2557224|NCT00515502|6268000|P12|NOT COMPLETED|Washout Period 2||0
2557225|NCT00515502|6268001|P11|NOT COMPLETED|Washout Period 2||0
2557226|NCT00515502|6268002|P10|NOT COMPLETED|Washout Period 2||0
2557227|NCT00515502|6268003|P9|NOT COMPLETED|Washout Period 2||0
2557228|NCT00515502|6268004|P8|NOT COMPLETED|Washout Period 2||0
2557229|NCT00515502|6268005|P7|NOT COMPLETED|Washout Period 2||0
2557230|NCT00515502|6268006|P6|NOT COMPLETED|Washout Period 2||0
2557231|NCT00515502|6268007|P5|NOT COMPLETED|Washout Period 2||0
2557232|NCT00515502|6268008|P4|NOT COMPLETED|Washout Period 2||0
2557233|NCT00515502|6268009|P3|NOT COMPLETED|Washout Period 2||0
2557234|NCT00515502|6268010|P2|NOT COMPLETED|Washout Period 2||0
2557235|NCT00515502|6268011|P1|NOT COMPLETED|Washout Period 2||0
2557236|NCT00515502|6268000|P12|COMPLETED|Washout Period 2||0
2557237|NCT00515502|6268001|P11|COMPLETED|Washout Period 2||1
2557238|NCT00515502|6268002|P10|COMPLETED|Washout Period 2||2
2557239|NCT00515502|6268003|P9|COMPLETED|Washout Period 2||0
2557240|NCT00515502|6268004|P8|COMPLETED|Washout Period 2||1
2557241|NCT00515502|6268005|P7|COMPLETED|Washout Period 2||1
2557242|NCT00515502|6268006|P6|COMPLETED|Washout Period 2||1
2557243|NCT00515502|6268007|P5|COMPLETED|Washout Period 2||3
2557244|NCT00515502|6268008|P4|COMPLETED|Washout Period 2||3
2557245|NCT00515502|6268009|P3|COMPLETED|Washout Period 2||4
2557246|NCT00515502|6268010|P2|COMPLETED|Washout Period 2||3
2557247|NCT00515502|6268011|P1|COMPLETED|Washout Period 2||1
2557248|NCT00515502|6268000|P12|STARTED|Washout Period 2||0
2557249|NCT00515502|6268001|P11|STARTED|Washout Period 2||1
2557250|NCT00515502|6268002|P10|STARTED|Washout Period 2||2
2557251|NCT00515502|6268003|P9|STARTED|Washout Period 2||0
2557252|NCT00515502|6268004|P8|STARTED|Washout Period 2||1
2557253|NCT00515502|6268005|P7|STARTED|Washout Period 2||1
2557254|NCT00515502|6268006|P6|STARTED|Washout Period 2||1
2557255|NCT00515502|6268007|P5|STARTED|Washout Period 2||3
2557256|NCT00515502|6268008|P4|STARTED|Washout Period 2||3
2557257|NCT00515502|6268009|P3|STARTED|Washout Period 2||4
2557258|NCT00515502|6268010|P2|STARTED|Washout Period 2||3
2557259|NCT00515502|6268011|P1|STARTED|Washout Period 2||1
2557260|NCT00515502|6268000|P12|NOT COMPLETED|Treatment Period 2||0
2557261|NCT00515502|6268001|P11|NOT COMPLETED|Treatment Period 2||0
2557262|NCT00515502|6268002|P10|NOT COMPLETED|Treatment Period 2||0
2557263|NCT00515502|6268003|P9|NOT COMPLETED|Treatment Period 2||0
2557264|NCT00515502|6268004|P8|NOT COMPLETED|Treatment Period 2||0
2557265|NCT00515502|6268005|P7|NOT COMPLETED|Treatment Period 2||0
2557266|NCT00515502|6268006|P6|NOT COMPLETED|Treatment Period 2||0
2557267|NCT00515502|6268007|P5|NOT COMPLETED|Treatment Period 2||0
2557268|NCT00515502|6268008|P4|NOT COMPLETED|Treatment Period 2||0
2557269|NCT00515502|6268009|P3|NOT COMPLETED|Treatment Period 2||0
2557270|NCT00515502|6268010|P2|NOT COMPLETED|Treatment Period 2||1
2557271|NCT00515502|6268011|P1|NOT COMPLETED|Treatment Period 2||0
2557272|NCT00515502|6268000|P12|COMPLETED|Treatment Period 2||0
2557273|NCT00515502|6268001|P11|COMPLETED|Treatment Period 2||1
2557274|NCT00515502|6268002|P10|COMPLETED|Treatment Period 2||2
2557275|NCT00515502|6268003|P9|COMPLETED|Treatment Period 2||0
2557276|NCT00515502|6268004|P8|COMPLETED|Treatment Period 2||1
2557277|NCT00515502|6268005|P7|COMPLETED|Treatment Period 2||1
2557278|NCT00515502|6268006|P6|COMPLETED|Treatment Period 2||1
2557279|NCT00515502|6268007|P5|COMPLETED|Treatment Period 2||3
2557280|NCT00515502|6268008|P4|COMPLETED|Treatment Period 2||3
2557281|NCT00515502|6268009|P3|COMPLETED|Treatment Period 2||4
2557282|NCT00515502|6268010|P2|COMPLETED|Treatment Period 2||3
2557283|NCT00515502|6268011|P1|COMPLETED|Treatment Period 2||1
2557284|NCT00515502|6268000|P12|STARTED|Treatment Period 2||0
2557285|NCT00515502|6268001|P11|STARTED|Treatment Period 2||1
2557286|NCT00515502|6268002|P10|STARTED|Treatment Period 2||2
2557287|NCT00515502|6268003|P9|STARTED|Treatment Period 2||0
2557288|NCT00515502|6268004|P8|STARTED|Treatment Period 2||1
2557289|NCT00515502|6268005|P7|STARTED|Treatment Period 2||1
2557290|NCT00515502|6268006|P6|STARTED|Treatment Period 2||1
2557291|NCT00515502|6268007|P5|STARTED|Treatment Period 2||3
2557292|NCT00515502|6268008|P4|STARTED|Treatment Period 2||3
2557293|NCT00515502|6268009|P3|STARTED|Treatment Period 2||4
2557294|NCT00515502|6268010|P2|STARTED|Treatment Period 2||4
2557295|NCT00515502|6268011|P1|STARTED|Treatment Period 2||1
2557296|NCT00515502|6268000|P12|NOT COMPLETED|Washout Period 1||0
2557297|NCT00515502|6268001|P11|NOT COMPLETED|Washout Period 1||0
2557298|NCT00515502|6268002|P10|NOT COMPLETED|Washout Period 1||0
2557299|NCT00515502|6268003|P9|NOT COMPLETED|Washout Period 1||0
2557300|NCT00515502|6268004|P8|NOT COMPLETED|Washout Period 1||0
2557301|NCT00515502|6268005|P7|NOT COMPLETED|Washout Period 1||0
2557302|NCT00515502|6268006|P6|NOT COMPLETED|Washout Period 1||0
2557303|NCT00515502|6268007|P5|NOT COMPLETED|Washout Period 1||0
2557304|NCT00515502|6268008|P4|NOT COMPLETED|Washout Period 1||0
2557305|NCT00515502|6268009|P3|NOT COMPLETED|Washout Period 1||0
2557306|NCT00515502|6268010|P2|NOT COMPLETED|Washout Period 1||0
2557307|NCT00515502|6268011|P1|NOT COMPLETED|Washout Period 1||0
2557308|NCT00515502|6268000|P12|COMPLETED|Washout Period 1||0
2557309|NCT00515502|6268001|P11|COMPLETED|Washout Period 1||1
2557310|NCT00515502|6268002|P10|COMPLETED|Washout Period 1||2
2557311|NCT00515502|6268003|P9|COMPLETED|Washout Period 1||0
2557312|NCT00515502|6268004|P8|COMPLETED|Washout Period 1||1
2557313|NCT00515502|6268005|P7|COMPLETED|Washout Period 1||1
2557314|NCT00515502|6268006|P6|COMPLETED|Washout Period 1||1
2557315|NCT00515502|6268007|P5|COMPLETED|Washout Period 1||3
2557316|NCT00515502|6268008|P4|COMPLETED|Washout Period 1||3
2557317|NCT00515502|6268009|P3|COMPLETED|Washout Period 1||4
2557318|NCT00515502|6268010|P2|COMPLETED|Washout Period 1||4
2557319|NCT00515502|6268011|P1|COMPLETED|Washout Period 1||1
2557320|NCT00515502|6268000|P12|STARTED|Washout Period 1||0
2557321|NCT00515502|6268001|P11|STARTED|Washout Period 1||1
2557322|NCT00515502|6268002|P10|STARTED|Washout Period 1||2
2557323|NCT00515502|6268003|P9|STARTED|Washout Period 1||0
2557324|NCT00515502|6268004|P8|STARTED|Washout Period 1||1
2557325|NCT00515502|6268005|P7|STARTED|Washout Period 1||1
2557326|NCT00515502|6268006|P6|STARTED|Washout Period 1||1
2557327|NCT00515502|6268007|P5|STARTED|Washout Period 1||3
2557328|NCT00515502|6268008|P4|STARTED|Washout Period 1||3
2557329|NCT00515502|6268009|P3|STARTED|Washout Period 1||4
2557330|NCT00515502|6268010|P2|STARTED|Washout Period 1||4
2557331|NCT00515502|6268011|P1|STARTED|Washout Period 1||1
2557332|NCT00515502|6268000|P12|NOT COMPLETED|Treatment Period 1||1
2557333|NCT00515502|6268001|P11|NOT COMPLETED|Treatment Period 1||0
2557334|NCT00515502|6268002|P10|NOT COMPLETED|Treatment Period 1||0
2557335|NCT00515502|6268003|P9|NOT COMPLETED|Treatment Period 1||1
2557336|NCT00515502|6268004|P8|NOT COMPLETED|Treatment Period 1||0
2557337|NCT00515502|6268005|P7|NOT COMPLETED|Treatment Period 1||1
2557338|NCT00515502|6268006|P6|NOT COMPLETED|Treatment Period 1||0
2557339|NCT00515502|6268007|P5|NOT COMPLETED|Treatment Period 1||0
2557340|NCT00515502|6268008|P4|NOT COMPLETED|Treatment Period 1||0
2557341|NCT00515502|6268009|P3|NOT COMPLETED|Treatment Period 1||0
2557342|NCT00515502|6268010|P2|NOT COMPLETED|Treatment Period 1||0
2557343|NCT00515502|6268011|P1|NOT COMPLETED|Treatment Period 1||0
2557344|NCT00515502|6268000|P12|COMPLETED|Treatment Period 1||0
2557345|NCT00515502|6268001|P11|COMPLETED|Treatment Period 1||1
2557346|NCT00515502|6268002|P10|COMPLETED|Treatment Period 1||2
2557347|NCT00515502|6268003|P9|COMPLETED|Treatment Period 1||0
2557348|NCT00515502|6268004|P8|COMPLETED|Treatment Period 1||1
2557349|NCT00515502|6268005|P7|COMPLETED|Treatment Period 1||1
2557350|NCT00515502|6268006|P6|COMPLETED|Treatment Period 1||1
2557351|NCT00515502|6268007|P5|COMPLETED|Treatment Period 1||3
2557352|NCT00515502|6268008|P4|COMPLETED|Treatment Period 1||3
2557353|NCT00515502|6268009|P3|COMPLETED|Treatment Period 1||4
2557354|NCT00515502|6268010|P2|COMPLETED|Treatment Period 1||4
2557355|NCT00515502|6268011|P1|COMPLETED|Treatment Period 1||1
2557356|NCT00515502|6268000|P12|STARTED|Treatment Period 1||1
2557357|NCT00515502|6268001|P11|STARTED|Treatment Period 1||1
2557358|NCT00515502|6268002|P10|STARTED|Treatment Period 1||2
2557359|NCT00515502|6268003|P9|STARTED|Treatment Period 1||1
2557360|NCT00515502|6268004|P8|STARTED|Treatment Period 1||1
2557361|NCT00515502|6268005|P7|STARTED|Treatment Period 1||2
2557362|NCT00515502|6268006|P6|STARTED|Treatment Period 1||1
2557363|NCT00515502|6268007|P5|STARTED|Treatment Period 1||3
2557364|NCT00515502|6268008|P4|STARTED|Treatment Period 1||3
2557365|NCT00515502|6268009|P3|STARTED|Treatment Period 1||4
2557366|NCT00515502|6268010|P2|STARTED|Treatment Period 1||4
2557367|NCT00515502|6268011|P1|STARTED|Treatment Period 1||1
2557368|NCT00515463|6268171|P2|NOT COMPLETED|Overall Study||14
2557369|NCT00515463|6268172|P1|NOT COMPLETED|Overall Study||14
2557370|NCT00515463|6268171|P2|COMPLETED|Overall Study||142
2557371|NCT00515463|6268172|P1|COMPLETED|Overall Study||141
2557372|NCT00515463|6268171|P2|Received Study Medication|Overall Study||156
2557373|NCT00515463|6268172|P1|Received Study Medication|Overall Study||154
2557374|NCT00515463|6268171|P2|STARTED|Overall Study||156
2557375|NCT00515463|6268172|P1|STARTED|Overall Study||155
2557376|NCT00515437|6268326|P4|NOT COMPLETED|Overall Study||1
2557377|NCT00515437|6268327|P3|NOT COMPLETED|Overall Study||0
2557378|NCT00515437|6268328|P2|NOT COMPLETED|Overall Study||0
2557379|NCT00515437|6268329|P1|NOT COMPLETED|Overall Study||0
2557380|NCT00515437|6268326|P4|COMPLETED|Overall Study||14
2557381|NCT00515437|6268327|P3|COMPLETED|Overall Study||13
2557382|NCT00515437|6268328|P2|COMPLETED|Overall Study||12
2557383|NCT00515437|6268329|P1|COMPLETED|Overall Study||14
2557384|NCT00515437|6268326|P4|STARTED|Overall Study||15
2557385|NCT00515437|6268327|P3|STARTED|Overall Study||13
2557386|NCT00515437|6268328|P2|STARTED|Overall Study||12
2557387|NCT00515437|6268329|P1|STARTED|Overall Study||14
2557388|NCT00515411|6268354|P3|NOT COMPLETED|Overall Study||0
2557389|NCT00515411|6268355|P2|NOT COMPLETED|Overall Study||0
2557390|NCT00515411|6268356|P1|NOT COMPLETED|Overall Study||0
2557391|NCT00515411|6268354|P3|COMPLETED|Overall Study||26
2557392|NCT00515411|6268355|P2|COMPLETED|Overall Study||31
2557393|NCT00515411|6268356|P1|COMPLETED|Overall Study||54
2557394|NCT00515411|6268354|P3|STARTED|Overall Study||26
2557395|NCT00515411|6268355|P2|STARTED|Overall Study||31
2557396|NCT00515411|6268356|P1|STARTED|Overall Study||54
2557397|NCT00515294|6268371|P4|NOT COMPLETED|Overall Study||4
2557398|NCT00515294|6268372|P3|NOT COMPLETED|Overall Study||11
2557399|NCT00515294|6268373|P2|NOT COMPLETED|Overall Study||3
2557400|NCT00515294|6268374|P1|NOT COMPLETED|Overall Study||9
2557401|NCT00515294|6268371|P4|COMPLETED|Overall Study||35
2557402|NCT00515294|6268372|P3|COMPLETED|Overall Study||27
2557403|NCT00515294|6268373|P2|COMPLETED|Overall Study||36
2557404|NCT00515294|6268374|P1|COMPLETED|Overall Study||29
2557405|NCT00515294|6268371|P4|STARTED|Overall Study||39
2557406|NCT00515294|6268372|P3|STARTED|Overall Study||38
2557407|NCT00515294|6268373|P2|STARTED|Overall Study||39
2557408|NCT00515294|6268374|P1|STARTED|Overall Study||38
2557409|NCT00515216|6268388|P1|NOT COMPLETED|Overall Study||1
2557410|NCT00515216|6268388|P1|COMPLETED|Overall Study||25
2557411|NCT00515216|6268388|P1|STARTED|Overall Study||26
2557412|NCT00515203|6268412|P2|NOT COMPLETED|Overall Study||0
2557413|NCT00515203|6268413|P1|NOT COMPLETED|Overall Study||0
2557414|NCT00515203|6268412|P2|COMPLETED|Overall Study||5
2557415|NCT00515203|6268413|P1|COMPLETED|Overall Study||17
2557416|NCT00515203|6268412|P2|STARTED|Overall Study||5
2557417|NCT00515203|6268413|P1|STARTED|Overall Study||17
2557418|NCT00515177|6268431|P2|NOT COMPLETED|Overall Study||1
2557419|NCT00515177|6268432|P1|NOT COMPLETED|Overall Study||2
2557420|NCT00515177|6268431|P2|COMPLETED|Overall Study||9
2557421|NCT00515177|6268432|P1|COMPLETED|Overall Study||18
2557422|NCT00515177|6268431|P2|STARTED|Overall Study||10
2557423|NCT00515177|6268432|P1|STARTED|Overall Study||20
2557424|NCT00515112|6268450|P2|NOT COMPLETED|Overall Study||3
2557425|NCT00515112|6268451|P1|NOT COMPLETED|Overall Study||3
2557426|NCT00515112|6268450|P2|COMPLETED|Overall Study||0
2557427|NCT00515112|6268451|P1|COMPLETED|Overall Study||0
2557428|NCT00515112|6268450|P2|STARTED|Overall Study||3
2557429|NCT00515112|6268451|P1|STARTED|Overall Study||3
2557430|NCT00515099|6268461|P2|NOT COMPLETED|Overall Study||4
2557431|NCT00515099|6268462|P1|NOT COMPLETED|Overall Study||3
2557432|NCT00515099|6268461|P2|COMPLETED|Overall Study||16
2557433|NCT00515099|6268462|P1|COMPLETED|Overall Study||35
2557434|NCT00515099|6268461|P2|STARTED|Overall Study||20
2557435|NCT00515099|6268462|P1|STARTED|Overall Study||38
2557436|NCT00515086|6268484|P4|NOT COMPLETED|Overall Study||6
2557437|NCT00515086|6268485|P3|NOT COMPLETED|Overall Study||5
2557438|NCT00515086|6268486|P2|NOT COMPLETED|Overall Study||6
2557439|NCT00515086|6268487|P1|NOT COMPLETED|Overall Study||24
2557440|NCT00515086|6268484|P4|COMPLETED|Overall Study||0
2557441|NCT00515086|6268485|P3|COMPLETED|Overall Study||0
2557442|NCT00515086|6268486|P2|COMPLETED|Overall Study||0
2557443|NCT00515086|6268487|P1|COMPLETED|Overall Study||0
2557444|NCT00515086|6268484|P4|STARTED|Overall Study||6
2557445|NCT00515086|6268485|P3|STARTED|Overall Study||5
2557446|NCT00515086|6268486|P2|STARTED|Overall Study||6
2557447|NCT00515086|6268487|P1|STARTED|Overall Study||24
2557448|NCT00515073|6268514|P1|NOT COMPLETED|Overall Study||2
2557449|NCT00515073|6268514|P1|COMPLETED|Overall Study||28
2557450|NCT00515073|6268514|P1|STARTED|Overall Study||30
2557451|NCT00515034|6268522|P4|NOT COMPLETED|Overall Study||5
2557452|NCT00515034|6268523|P3|NOT COMPLETED|Overall Study||8
2557453|NCT00515034|6268524|P2|NOT COMPLETED|Overall Study||2
2557454|NCT00515034|6268525|P1|NOT COMPLETED|Overall Study||8
2557455|NCT00515034|6268522|P4|COMPLETED|Overall Study||15
2557456|NCT00515034|6268523|P3|COMPLETED|Overall Study||54
2557457|NCT00515034|6268524|P2|COMPLETED|Overall Study||13
2557458|NCT00515034|6268525|P1|COMPLETED|Overall Study||41
2557459|NCT00515034|6268522|P4|TREATED|Overall Study||19
2557460|NCT00515034|6268523|P3|TREATED|Overall Study||61
2557461|NCT00515034|6268524|P2|TREATED|Overall Study||15
2557462|NCT00515034|6268525|P1|TREATED|Overall Study||48
2557463|NCT00515034|6268522|P4|STARTED|Overall Study||20
2557464|NCT00515034|6268523|P3|STARTED|Overall Study||62
2557465|NCT00515034|6268524|P2|STARTED|Overall Study||15
2557466|NCT00515034|6268525|P1|STARTED|Overall Study||49
2557467|NCT00515021|6268545|P2|NOT COMPLETED|Overall Study||0
2557468|NCT00515021|6268546|P1|NOT COMPLETED|Overall Study||0
2557469|NCT00515021|6268545|P2|COMPLETED|Overall Study||11
2557470|NCT00515021|6268546|P1|COMPLETED|Overall Study||9
2557471|NCT00515021|6268545|P2|STARTED|Overall Study||11
2557472|NCT00515021|6268546|P1|STARTED|Overall Study||9
2557473|NCT00515008|6268556|P2|NOT COMPLETED|Overall Study||4
2557474|NCT00515008|6268557|P1|NOT COMPLETED|Overall Study||3
2557475|NCT00515008|6268556|P2|COMPLETED|Overall Study||29
2557476|NCT00515008|6268557|P1|COMPLETED|Overall Study||30
2557477|NCT00515008|6268556|P2|Completed 12 Week Evaluation|Overall Study||29
2557478|NCT00515008|6268557|P1|Completed 12 Week Evaluation|Overall Study||32
2557479|NCT00515008|6268556|P2|STARTED|Overall Study||33
2557480|NCT00515008|6268557|P1|STARTED|Overall Study||33
2557481|NCT00514943|6268581|P2|NOT COMPLETED|Stage 2||36
2557482|NCT00514943|6268582|P1|NOT COMPLETED|Stage 2||32
2557483|NCT00514943|6268581|P2|COMPLETED|Stage 2||0
2557484|NCT00514943|6268582|P1|COMPLETED|Stage 2||0
2557485|NCT00514943|6268581|P2|STARTED|Stage 2||36
2557486|NCT00514943|6268582|P1|STARTED|Stage 2||32
2557487|NCT00514943|6268581|P2|NOT COMPLETED|Stage 1||26
2557488|NCT00514943|6268582|P1|NOT COMPLETED|Stage 1||30
2557489|NCT00514943|6268581|P2|COMPLETED|Stage 1||36
2557490|NCT00514943|6268582|P1|COMPLETED|Stage 1||32
2557491|NCT00514943|6268581|P2|STARTED|Stage 1|2 randomized patients were not treated|62
2557492|NCT00514943|6268582|P1|STARTED|Stage 1|1 randomized patient was not treated|62
2557493|NCT00514917|6268640|P2|NOT COMPLETED|Overall Study||115
2557494|NCT00514917|6268641|P1|NOT COMPLETED|Overall Study||126
2557495|NCT00514917|6268640|P2|COMPLETED|Overall Study||91
2557496|NCT00514917|6268641|P1|COMPLETED|Overall Study||81
2557497|NCT00514917|6268640|P2|Testosterone-Specific Evaluable|Overall Study||124
2557498|NCT00514917|6268641|P1|Testosterone-Specific Evaluable|Overall Study||122
2557499|NCT00514917|6268640|P2|Completed Study Treatment|Overall Study||182
2557500|NCT00514917|6268641|P1|Completed Study Treatment|Overall Study||170
2557501|NCT00514917|6268640|P2|Treated|Overall Study||204
2557502|NCT00514917|6268641|P1|Treated|Overall Study||196
2557503|NCT00514917|6268640|P2|STARTED|Overall Study||206
2557504|NCT00514917|6268641|P1|STARTED|Overall Study||207
2557505|NCT00514904|6268669|P2|NOT COMPLETED|Overall Study||5
2557506|NCT00514904|6268670|P1|NOT COMPLETED|Overall Study||24
2557507|NCT00514904|6268669|P2|COMPLETED|Overall Study||371
2557508|NCT00514904|6268670|P1|COMPLETED|Overall Study||1101
2557509|NCT00514904|6268669|P2|STARTED|Overall Study||376
2557510|NCT00514904|6268670|P1|STARTED|Overall Study||1125
2557511|NCT00514852|6268706|P2|NOT COMPLETED|Overall Study||5
2557512|NCT00514852|6268707|P1|NOT COMPLETED|Overall Study||5
2557513|NCT00514852|6268706|P2|COMPLETED|Overall Study||154
2557514|NCT00514852|6268707|P1|COMPLETED|Overall Study||152
2557515|NCT00514852|6268706|P2|STARTED|Overall Study||159
2557516|NCT00514852|6268707|P1|STARTED|Overall Study||157
2557517|NCT00514813|6268735|P4|NOT COMPLETED|Overall Study||4
2557518|NCT00514813|6268736|P3|NOT COMPLETED|Overall Study||47
2557519|NCT00514813|6268737|P2|NOT COMPLETED|Overall Study||86
2557520|NCT00514813|6268738|P1|NOT COMPLETED|Overall Study||15
2557521|NCT00514813|6268735|P4|COMPLETED|Overall Study||0
2557522|NCT00514813|6268736|P3|COMPLETED|Overall Study||0
2557523|NCT00514813|6268737|P2|COMPLETED|Overall Study||0
2557524|NCT00514813|6268738|P1|COMPLETED|Overall Study||0
2557525|NCT00514813|6268735|P4|STARTED|Overall Study||4
2557526|NCT00514813|6268736|P3|STARTED|Overall Study||47
2557527|NCT00514813|6268737|P2|STARTED|Overall Study||86
2557528|NCT00514813|6268738|P1|STARTED|Overall Study||15
2557529|NCT00514735|6268758|P2|NOT COMPLETED|Overall Study||6
2557530|NCT00514735|6268759|P1|NOT COMPLETED|Overall Study||14
2557531|NCT00514735|6268758|P2|COMPLETED|Overall Study||66
2557532|NCT00514735|6268759|P1|COMPLETED|Overall Study||124
2557533|NCT00514735|6268758|P2|STARTED|Overall Study||72
2557534|NCT00514735|6268759|P1|STARTED|Overall Study||138
2557535|NCT00514709|6268779|P2|NOT COMPLETED|Overall Study||0
2557536|NCT00514709|6268780|P1|NOT COMPLETED|Overall Study||0
2557537|NCT00514709|6268779|P2|COMPLETED|Overall Study||613
2557538|NCT00514709|6268780|P1|COMPLETED|Overall Study||1230
2557539|NCT00514709|6268779|P2|STARTED|Overall Study||613
2557540|NCT00514709|6268780|P1|STARTED|Overall Study||1230
2557541|NCT00514683|6268795|P5|NOT COMPLETED|Overall Study||33
2557542|NCT00514683|6268796|P4|NOT COMPLETED|Overall Study||14
2557543|NCT00514683|6268797|P3|NOT COMPLETED|Overall Study||18
2557544|NCT00514683|6268798|P2|NOT COMPLETED|Overall Study||25
2557545|NCT00514683|6268799|P1|NOT COMPLETED|Overall Study||26
2557546|NCT00514683|6268795|P5|COMPLETED|Overall Study||53
2557547|NCT00514683|6268796|P4|COMPLETED|Overall Study||72
2557548|NCT00514683|6268797|P3|COMPLETED|Overall Study||68
2557549|NCT00514683|6268798|P2|COMPLETED|Overall Study||62
2557550|NCT00514683|6268799|P1|COMPLETED|Overall Study||61
2557551|NCT00514683|6268795|P5|STARTED|Overall Study|Randomised|86
2557552|NCT00514683|6268796|P4|STARTED|Overall Study|Randomised|86
2557553|NCT00514683|6268797|P3|STARTED|Overall Study|Randomised|86
2557554|NCT00514683|6268798|P2|STARTED|Overall Study|Randomised|87
2557555|NCT00514683|6268799|P1|STARTED|Overall Study|Randomised|87
2557556|NCT00514592|6268990|P1|NOT COMPLETED|Overall Study||0
2557557|NCT00514592|6268990|P1|COMPLETED|Overall Study||230
2557558|NCT00514592|6268990|P1|STARTED|Overall Study||230
2557559|NCT00514514|6268998|P3|NOT COMPLETED|Extension - 4 Years||21
2557560|NCT00514514|6268999|P2|NOT COMPLETED|Extension - 4 Years||22
2557561|NCT00514514|6269000|P1|NOT COMPLETED|Extension - 4 Years||37
2557562|NCT00514514|6268998|P3|COMPLETED|Extension - 4 Years||113
2557563|NCT00514514|6268999|P2|COMPLETED|Extension - 4 Years||117
2557564|NCT00514514|6269000|P1|COMPLETED|Extension - 4 Years||108
2557565|NCT00514514|6268998|P3|Non-randomized (Followed)|Extension - 4 Years||0
2557566|NCT00514514|6268999|P2|Non-randomized (Followed)|Extension - 4 Years||0
2557567|NCT00514514|6269000|P1|Non-randomized (Followed)|Extension - 4 Years|Patients were not randomized but continued on standard regimen and entered follow up.|95
2557568|NCT00514514|6268998|P3|STARTED|Extension - 4 Years||134
2557569|NCT00514514|6268999|P2|STARTED|Extension - 4 Years||139
2557570|NCT00514514|6269000|P1|STARTED|Extension - 4 Years||145
2557571|NCT00514514|6268998|P3|NOT COMPLETED|Randomized - 9 Month||38
2557572|NCT00514514|6268999|P2|NOT COMPLETED|Randomized - 9 Month||61
2557573|NCT00514514|6269000|P1|NOT COMPLETED|Randomized - 9 Month||39
2557574|NCT00514514|6268998|P3|COMPLETED|Randomized - 9 Month||124
2557575|NCT00514514|6268999|P2|COMPLETED|Randomized - 9 Month||110
2557576|NCT00514514|6269000|P1|COMPLETED|Randomized - 9 Month||127
2557577|NCT00514514|6268998|P3|Randomized - Received Treatment|Randomized - 9 Month||161
2557578|NCT00514514|6268999|P2|Randomized - Received Treatment|Randomized - 9 Month||171
2557579|NCT00514514|6269000|P1|Randomized - Received Treatment|Randomized - 9 Month||165
2557580|NCT00514514|6268998|P3|STARTED|Randomized - 9 Month||162
2557581|NCT00514514|6268999|P2|STARTED|Randomized - 9 Month||171
2557582|NCT00514514|6269000|P1|STARTED|Randomized - 9 Month||166
2557583|NCT00514514|6268998|P3|NOT COMPLETED|Pre-phase||0
2557584|NCT00514514|6268999|P2|NOT COMPLETED|Pre-phase||0
2557585|NCT00514514|6269000|P1|NOT COMPLETED|Pre-phase||303
2557586|NCT00514514|6268998|P3|COMPLETED|Pre-phase||0
2557587|NCT00514514|6268999|P2|COMPLETED|Pre-phase||0
2557588|NCT00514514|6269000|P1|COMPLETED|Pre-phase||499
2557589|NCT00514514|6268998|P3|STARTED|Pre-phase||0
2557590|NCT00514514|6268999|P2|STARTED|Pre-phase||0
2557591|NCT00514514|6269000|P1|STARTED|Pre-phase|All enrolled patients received standard regimen for 3 months|802
2557592|NCT00514501|6269044|P1|NOT COMPLETED|Overall Study||3
2557593|NCT00514501|6269044|P1|COMPLETED|Overall Study||507
2557594|NCT00514501|6269044|P1|STARTED|Overall Study||510
2557595|NCT00514449|6269052|P2|NOT COMPLETED|Overall Study||4
2557596|NCT00514449|6269053|P1|NOT COMPLETED|Overall Study||3
2557597|NCT00514449|6269052|P2|COMPLETED|Overall Study||8
2557598|NCT00514449|6269053|P1|COMPLETED|Overall Study||9
2557599|NCT00514449|6269052|P2|STARTED|Overall Study||12
2557600|NCT00514449|6269053|P1|STARTED|Overall Study||12
2557601|NCT00514215|6269063|P1|NOT COMPLETED|Overall Study||0
2557602|NCT00514215|6269063|P1|COMPLETED|Overall Study||8
2557603|NCT00514215|6269063|P1|STARTED|Overall Study||8
2557604|NCT00514137|6269070|P1|NOT COMPLETED|Overall Study||0
2557605|NCT00514137|6269070|P1|COMPLETED|Overall Study||13
2557606|NCT00514137|6269070|P1|STARTED|Overall Study||13
2557607|NCT00514020|6269077|P1|NOT COMPLETED|Overall Study||28
2557608|NCT00514020|6269077|P1|COMPLETED|Overall Study||5
2557609|NCT00514020|6269077|P1|STARTED|Overall Study|two patients withdrew before treatment; one withdrew after treatment|33
2557610|NCT00513799|6269085|P4|NOT COMPLETED|Four-Month Follow-Up||3
2557611|NCT00513799|6269086|P3|NOT COMPLETED|Four-Month Follow-Up||7
2557612|NCT00513799|6269087|P2|NOT COMPLETED|Four-Month Follow-Up||5
2557613|NCT00513799|6269088|P1|NOT COMPLETED|Four-Month Follow-Up||0
2557614|NCT00513799|6269085|P4|COMPLETED|Four-Month Follow-Up||51
2557615|NCT00513799|6269086|P3|COMPLETED|Four-Month Follow-Up||57
2557616|NCT00513799|6269087|P2|COMPLETED|Four-Month Follow-Up||57
2557617|NCT00513799|6269088|P1|COMPLETED|Four-Month Follow-Up||64
2557618|NCT00513799|6269085|P4|STARTED|Four-Month Follow-Up||54
2557619|NCT00513799|6269086|P3|STARTED|Four-Month Follow-Up||64
2557620|NCT00513799|6269087|P2|STARTED|Four-Month Follow-Up||62
2557621|NCT00513799|6269088|P1|STARTED|Four-Month Follow-Up||64
2557622|NCT00513799|6269085|P4|NOT COMPLETED|One-Month Follow-Up||21
2557623|NCT00513799|6269086|P3|NOT COMPLETED|One-Month Follow-Up||11
2557624|NCT00513799|6269087|P2|NOT COMPLETED|One-Month Follow-Up||13
2557625|NCT00513799|6269088|P1|NOT COMPLETED|One-Month Follow-Up||11
2557626|NCT00513799|6269085|P4|COMPLETED|One-Month Follow-Up||54
2557627|NCT00513799|6269086|P3|COMPLETED|One-Month Follow-Up||64
2557628|NCT00513799|6269087|P2|COMPLETED|One-Month Follow-Up||62
2557629|NCT00513799|6269088|P1|COMPLETED|One-Month Follow-Up||64
2557630|NCT00513799|6269085|P4|STARTED|One-Month Follow-Up||75
2557631|NCT00513799|6269086|P3|STARTED|One-Month Follow-Up||75
2557632|NCT00513799|6269087|P2|STARTED|One-Month Follow-Up||75
2557633|NCT00513799|6269088|P1|STARTED|One-Month Follow-Up||75
2557634|NCT00513708|6269109|P3|NOT COMPLETED|Overall Study||4
2557635|NCT00513708|6269110|P2|NOT COMPLETED|Overall Study||4
2557636|NCT00513708|6269111|P1|NOT COMPLETED|Overall Study||4
2557637|NCT00513708|6269109|P3|COMPLETED|Overall Study||46
2557638|NCT00513708|6269110|P2|COMPLETED|Overall Study||46
2557639|NCT00513708|6269111|P1|COMPLETED|Overall Study||46
2557640|NCT00513708|6269109|P3|STARTED|Overall Study||50
2557641|NCT00513708|6269110|P2|STARTED|Overall Study||50
2557642|NCT00513708|6269111|P1|STARTED|Overall Study||50
2557643|NCT00513695|6269125|P1|NOT COMPLETED|Overall Study||5
2557644|NCT00513695|6269125|P1|COMPLETED|Overall Study||63
2557645|NCT00513695|6269125|P1|STARTED|Overall Study||68
2557646|NCT00513682|6269134|P1|NOT COMPLETED|Treatment Phase||0
2557647|NCT00513682|6269134|P1|COMPLETED|Treatment Phase||7
2557648|NCT00513682|6269134|P1|STARTED|Treatment Phase||7
2557649|NCT00513682|6269134|P1|NOT COMPLETED|Washout Phase||2
2557650|NCT00513682|6269134|P1|COMPLETED|Washout Phase||7
2557651|NCT00513682|6269134|P1|STARTED|Washout Phase||9
2557652|NCT00513682|6269134|P1|NOT COMPLETED|Screening Phase||0
2557653|NCT00513682|6269134|P1|COMPLETED|Screening Phase||9
2557654|NCT00513682|6269134|P1|STARTED|Screening Phase||9
2557655|NCT00513617|6269146|P3|NOT COMPLETED|Overall Study||8
2557656|NCT00513617|6269147|P2|NOT COMPLETED|Overall Study||10
2557657|NCT00513617|6269148|P1|NOT COMPLETED|Overall Study||11
2557658|NCT00513617|6269146|P3|COMPLETED|Overall Study||30
2557659|NCT00513617|6269147|P2|COMPLETED|Overall Study||25
2557660|NCT00513617|6269148|P1|COMPLETED|Overall Study||25
2557661|NCT00513617|6269146|P3|STARTED|Overall Study||38
2557662|NCT00513617|6269147|P2|STARTED|Overall Study||35
2557663|NCT00513617|6269148|P1|STARTED|Overall Study||36
2557664|NCT00513604|6269164|P5|NOT COMPLETED|Overall Study||0
2557665|NCT00513604|6269165|P4|NOT COMPLETED|Overall Study||0
2557666|NCT00513604|6269166|P3|NOT COMPLETED|Overall Study||3
2557667|NCT00513604|6269167|P2|NOT COMPLETED|Overall Study||3
2557668|NCT00513604|6269168|P1|NOT COMPLETED|Overall Study||2
2557669|NCT00513604|6269164|P5|COMPLETED|Overall Study||35
2557670|NCT00513604|6269165|P4|COMPLETED|Overall Study||34
2557671|NCT00513604|6269166|P3|COMPLETED|Overall Study||21
2557672|NCT00513604|6269167|P2|COMPLETED|Overall Study||36
2557673|NCT00513604|6269168|P1|COMPLETED|Overall Study||24
2557674|NCT00513604|6269164|P5|STARTED|Overall Study|Cohort 5 = CD4+ depleted TIL-it is the SAME as cohort 2|35
2557675|NCT00513604|6269165|P4|STARTED|Overall Study|Cohort 4 = unselected TIL - it is the SAME as cohort 1|34
2557676|NCT00513604|6269166|P3|STARTED|Overall Study|Cohort 3 = CD4+ depleted (selected) TIL + 600Gy radiation|24
2557677|NCT00513604|6269167|P2|STARTED|Overall Study|Cohort 2 = CD4+ depleted (selected) TIL|39
2557678|NCT00513604|6269168|P1|STARTED|Overall Study|Cohort 1 = unselected TIL|26
2557679|NCT00513526|6269185|P1|NOT COMPLETED|Overall Study||17
2557680|NCT00513526|6269185|P1|COMPLETED|Overall Study||92
2557681|NCT00513526|6269185|P1|STARTED|Overall Study||109
2557682|NCT00513500|6269202|P2|NOT COMPLETED|Overall Study||54
2557683|NCT00513500|6269203|P1|NOT COMPLETED|Overall Study||41
2557684|NCT00513500|6269202|P2|COMPLETED|Overall Study||2054
2557685|NCT00513500|6269203|P1|COMPLETED|Overall Study||976
2557686|NCT00513500|6269202|P2|STARTED|Overall Study||2108
2557687|NCT00513500|6269203|P1|STARTED|Overall Study||1017
2557688|NCT00513474|6269215|P2|NOT COMPLETED|Overall Study||9
2557689|NCT00513474|6269216|P1|NOT COMPLETED|Overall Study||7
2557690|NCT00513474|6269215|P2|COMPLETED|Overall Study||12
2557691|NCT00513474|6269216|P1|COMPLETED|Overall Study||18
2557692|NCT00513474|6269215|P2|Received Rasburicase Per Protocol|Overall Study||0
2557693|NCT00513474|6269216|P1|Received Rasburicase Per Protocol|Overall Study||24
2557694|NCT00513474|6269215|P2|STARTED|Overall Study||21
2557695|NCT00513474|6269216|P1|STARTED|Overall Study||25
2557696|NCT00513461|6269230|P2|NOT COMPLETED|Overall Study||10
2557697|NCT00513461|6269231|P1|NOT COMPLETED|Overall Study||13
2557698|NCT00513461|6269230|P2|COMPLETED|Overall Study||43
2557699|NCT00513461|6269231|P1|COMPLETED|Overall Study||44
2557700|NCT00513461|6269230|P2|STARTED|Overall Study||53
2557701|NCT00513461|6269231|P1|STARTED|Overall Study||57
2557702|NCT00513435|6269265|P1|NOT COMPLETED|Overall Study||0
2557703|NCT00513435|6269265|P1|COMPLETED|Overall Study||9
2557704|NCT00513435|6269265|P1|STARTED|Overall Study||9
2557705|NCT00513409|6269272|P2|NOT COMPLETED|Overall Study||6
2557706|NCT00513409|6269273|P1|NOT COMPLETED|Overall Study||2
2557707|NCT00513409|6269272|P2|COMPLETED|Overall Study||73
2557708|NCT00513409|6269273|P1|COMPLETED|Overall Study||82
2557709|NCT00513409|6269272|P2|STARTED|Overall Study||79
2557710|NCT00513409|6269273|P1|STARTED|Overall Study||84
2557711|NCT00513370|6269299|P1|NOT COMPLETED|Overall Study||24
2557712|NCT00513370|6269299|P1|COMPLETED|Overall Study||179
2557713|NCT00513370|6269299|P1|STARTED|Overall Study||203
2557714|NCT00513357|6269329|P2|NOT COMPLETED|Overall Study||10
2557715|NCT00513357|6269330|P1|NOT COMPLETED|Overall Study||15
2557716|NCT00513357|6269329|P2|COMPLETED|Overall Study||25
2557717|NCT00513357|6269330|P1|COMPLETED|Overall Study||23
2557718|NCT00513357|6269329|P2|STARTED|Overall Study||35
2557719|NCT00513357|6269330|P1|STARTED|Overall Study||38
2557720|NCT00513344|6269336|P1|NOT COMPLETED|3rd Intervention 1 Day||0
2557721|NCT00513344|6269336|P1|COMPLETED|3rd Intervention 1 Day||5
2557722|NCT00513344|6269336|P1|STARTED|3rd Intervention 1 Day||5
2557723|NCT00513344|6269336|P1|NOT COMPLETED|Washout Period 3 Days||0
2557724|NCT00513344|6269336|P1|COMPLETED|Washout Period 3 Days||5
2557725|NCT00513344|6269336|P1|STARTED|Washout Period 3 Days||5
2557726|NCT00513344|6269336|P1|NOT COMPLETED|2nd Intervention 1 Day||0
2557727|NCT00513344|6269336|P1|COMPLETED|2nd Intervention 1 Day||5
2557728|NCT00513344|6269336|P1|STARTED|2nd Intervention 1 Day||5
2557729|NCT00513344|6269336|P1|NOT COMPLETED|Washout Period 3 Days||0
2557730|NCT00513344|6269336|P1|COMPLETED|Washout Period 3 Days||5
2557731|NCT00513344|6269336|P1|STARTED|Washout Period 3 Days||5
2557732|NCT00513344|6269336|P1|NOT COMPLETED|1st Intervention 1 Day||0
2557733|NCT00513344|6269336|P1|COMPLETED|1st Intervention 1 Day||5
2557734|NCT00513344|6269336|P1|STARTED|1st Intervention 1 Day||5
2557735|NCT00513344|6269336|P1|NOT COMPLETED|Diet Restriction (3 Days)||0
2557736|NCT00513344|6269336|P1|COMPLETED|Diet Restriction (3 Days)||5
2557737|NCT00513344|6269336|P1|STARTED|Diet Restriction (3 Days)||5
2557738|NCT00513305|6269349|P2|NOT COMPLETED|Overall Study||27
2557739|NCT00513305|6269350|P1|NOT COMPLETED|Overall Study||28
2557740|NCT00513305|6269349|P2|COMPLETED|Overall Study||7
2557741|NCT00513305|6269350|P1|COMPLETED|Overall Study||5
2557742|NCT00513305|6269349|P2|STARTED|Overall Study|One subject withdrew prior to receiving study medication|34
2557743|NCT00513305|6269350|P1|STARTED|Overall Study||33
2557744|NCT00513292|6269368|P2|NOT COMPLETED|Overall Study||0
2557745|NCT00513292|6269369|P1|NOT COMPLETED|Overall Study||0
2557746|NCT00513292|6269368|P2|COMPLETED|Overall Study||142
2557747|NCT00513292|6269369|P1|COMPLETED|Overall Study||138
2557748|NCT00513292|6269368|P2|STARTED|Overall Study||142
2557749|NCT00513292|6269369|P1|STARTED|Overall Study||138
2557750|NCT00513240|6269393|P2|NOT COMPLETED|Overall Study||7
2557751|NCT00513240|6269394|P1|NOT COMPLETED|Overall Study||13
2557752|NCT00513240|6269393|P2|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|20
2557753|NCT00513240|6269394|P1|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|22
2557754|NCT00513240|6269393|P2|Clinical Data Collection &Pre/Postop MRI|Overall Study||27
2557755|NCT00513240|6269394|P1|Clinical Data Collection &Pre/Postop MRI|Overall Study|3 not having intended surgery are subtracted from original 35 subjects, leaving 32|32
2557756|NCT00513240|6269393|P2|STARTED|Overall Study|25 had 3 doses; 1 had 1 dose due to rash; 1 had 2 doses and 1 dose of EPO due to pharmacy error|27
2557757|NCT00513240|6269394|P1|STARTED|Overall Study|3 did not have intended surgery; 28 had all 3 doses; 4 had 1 dose but no more due to delayed surgery|35
2557758|NCT00513071|6269407|P1|NOT COMPLETED|Overall Study||5
2557759|NCT00513071|6269407|P1|COMPLETED|Overall Study||23
2557760|NCT00513071|6269407|P1|STARTED|Overall Study||28
2557761|NCT00513019|6269419|P2|NOT COMPLETED|Overall Study||5
2557762|NCT00513019|6269420|P1|NOT COMPLETED|Overall Study||5
2557763|NCT00513019|6269419|P2|COMPLETED|Overall Study||13
2557764|NCT00513019|6269420|P1|COMPLETED|Overall Study||12
2557765|NCT00513019|6269419|P2|STARTED|Overall Study||18
2557766|NCT00513019|6269420|P1|STARTED|Overall Study||17
2557767|NCT00512902|6269426|P1|NOT COMPLETED|Overall Study||8
2557768|NCT00512902|6269426|P1|COMPLETED|Overall Study||12
2557769|NCT00512902|6269426|P1|STARTED|Overall Study||20
2557770|NCT00512876|6269434|P1|NOT COMPLETED|Overall Study||4
2557771|NCT00512876|6269434|P1|COMPLETED|Overall Study||20
2557772|NCT00512876|6269434|P1|STARTED|Overall Study||24
2557773|NCT00512798|6269441|P2|NOT COMPLETED|Overall Study||27
2557774|NCT00512798|6269442|P1|NOT COMPLETED|Overall Study||19
2557775|NCT00512798|6269441|P2|COMPLETED|Overall Study||1
2557776|NCT00512798|6269442|P1|COMPLETED|Overall Study||0
2557777|NCT00512798|6269441|P2|STARTED|Overall Study||28
2557778|NCT00512798|6269442|P1|STARTED|Overall Study||19
2557779|NCT00512707|6269453|P2|NOT COMPLETED|Overall Study||12
2557780|NCT00512707|6269454|P1|NOT COMPLETED|Overall Study||10
2557781|NCT00512707|6269453|P2|COMPLETED|Overall Study||58
2557782|NCT00512707|6269454|P1|COMPLETED|Overall Study||60
2557783|NCT00512707|6269453|P2|STARTED|Overall Study||70
2557784|NCT00512707|6269454|P1|STARTED|Overall Study||70
2557785|NCT00512278|6269486|P2|NOT COMPLETED|Overall Study||17
2557786|NCT00512278|6269487|P1|NOT COMPLETED|Overall Study||28
2557787|NCT00512278|6269486|P2|COMPLETED|Overall Study||56
2557788|NCT00512278|6269487|P1|COMPLETED|Overall Study||45
2557789|NCT00512278|6269486|P2|STARTED|Overall Study||73
2557790|NCT00512278|6269487|P1|STARTED|Overall Study||73
2557791|NCT00512252|6269504|P3|NOT COMPLETED|Overall Study||3
2557792|NCT00512252|6269505|P2|NOT COMPLETED|Overall Study||0
2557793|NCT00512252|6269506|P1|NOT COMPLETED|Overall Study||0
2557794|NCT00512252|6269504|P3|COMPLETED|Overall Study||43
2557795|NCT00512252|6269505|P2|COMPLETED|Overall Study||3
2557796|NCT00512252|6269506|P1|COMPLETED|Overall Study||3
2557797|NCT00512252|6269504|P3|STARTED|Overall Study||46
2557798|NCT00512252|6269505|P2|STARTED|Overall Study||3
2557799|NCT00512252|6269506|P1|STARTED|Overall Study||3
2557800|NCT00512148|6269534|P1|NOT COMPLETED|Long Term Follow Up Period||6
2557801|NCT00512148|6269534|P1|COMPLETED|Long Term Follow Up Period|6 patients are being followed in long term follow up|0
2557802|NCT00512148|6269534|P1|STARTED|Long Term Follow Up Period||6
2557803|NCT00512148|6269534|P1|NOT COMPLETED|Primay Study Period||1
2557804|NCT00512148|6269534|P1|COMPLETED|Primay Study Period||6
2557805|NCT00512148|6269534|P1|STARTED|Primay Study Period||7
2557806|NCT00512096|6269540|P1|NOT COMPLETED|Overall Study||7
2557807|NCT00512096|6269540|P1|COMPLETED|Overall Study||23
2557808|NCT00512096|6269540|P1|STARTED|Overall Study||30
2557809|NCT00511992|6269544|P1|NOT COMPLETED|Overall Study||7
2557810|NCT00511992|6269544|P1|COMPLETED|Overall Study||13
2557811|NCT00511992|6269544|P1|STARTED|Overall Study||20
2557812|NCT00511914|6269551|P2|NOT COMPLETED|Overall Study||0
2557813|NCT00511914|6269552|P1|NOT COMPLETED|Overall Study||0
2557814|NCT00511914|6269551|P2|COMPLETED|Overall Study||67
2557815|NCT00511914|6269552|P1|COMPLETED|Overall Study||68
2557816|NCT00511914|6269551|P2|STARTED|Overall Study||67
2557817|NCT00511914|6269552|P1|STARTED|Overall Study||68
2557818|NCT00511901|6269568|P2|NOT COMPLETED|Overall Study||3
2557819|NCT00511901|6269569|P1|NOT COMPLETED|Overall Study||1
2557820|NCT00511901|6269568|P2|COMPLETED|Overall Study||8
2557821|NCT00511901|6269569|P1|COMPLETED|Overall Study||10
2557822|NCT00511901|6269568|P2|STARTED|Overall Study||11
2557823|NCT00511901|6269569|P1|STARTED|Overall Study||11
2557824|NCT00511875|6269591|P2|NOT COMPLETED|Overall Study||0
2557825|NCT00511875|6269592|P1|NOT COMPLETED|Overall Study||5
2557826|NCT00511875|6269591|P2|COMPLETED|Overall Study||15
2557827|NCT00511875|6269592|P1|COMPLETED|Overall Study||10
2557828|NCT00511875|6269591|P2|STARTED|Overall Study||15
2557829|NCT00511875|6269592|P1|STARTED|Overall Study||15
2557830|NCT00511862|6269617|P3|NOT COMPLETED|Overall Study||0
2557831|NCT00511862|6269618|P2|NOT COMPLETED|Overall Study||0
2557832|NCT00511862|6269619|P1|NOT COMPLETED|Overall Study||0
2557833|NCT00511862|6269617|P3|COMPLETED|Overall Study||47
2557834|NCT00511862|6269618|P2|COMPLETED|Overall Study||43
2557835|NCT00511862|6269619|P1|COMPLETED|Overall Study||61
2557836|NCT00511862|6269617|P3|STARTED|Overall Study||47
2557837|NCT00511862|6269618|P2|STARTED|Overall Study||43
2557838|NCT00511862|6269619|P1|STARTED|Overall Study||61
2557839|NCT00511836|6269632|P2|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||0
2557840|NCT00511836|6269633|P1|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||16
2557841|NCT00511836|6269632|P2|COMPLETED|Optional Open-label VIVITROL (2 Months)||0
2557842|NCT00511836|6269633|P1|COMPLETED|Optional Open-label VIVITROL (2 Months)||6
2557843|NCT00511836|6269632|P2|STARTED|Optional Open-label VIVITROL (2 Months)|Not all subjects from the double-blind phase entered the optional open-label extension.|0
2557844|NCT00511836|6269633|P1|STARTED|Optional Open-label VIVITROL (2 Months)|Subjects who received placebo during Month 1 switched to VIVITROL for the optional extension phase.|22
2557845|NCT00511836|6269632|P2|NOT COMPLETED|Double-blind Period||0
2557846|NCT00511836|6269633|P1|NOT COMPLETED|Double-blind Period||1
2557847|NCT00511836|6269632|P2|COMPLETED|Double-blind Period||15
2557848|NCT00511836|6269633|P1|COMPLETED|Double-blind Period||15
2557849|NCT00511836|6269632|P2|STARTED|Double-blind Period||15
2557850|NCT00511836|6269633|P1|STARTED|Double-blind Period||16
2557851|NCT00511810|6269650|P2|NOT COMPLETED|Overall Study||5
2557852|NCT00511810|6269651|P1|NOT COMPLETED|Overall Study||1
2557853|NCT00511810|6269650|P2|COMPLETED|Overall Study|2 terminated for worsening symptoms;1 refused a scan;2 lost to follow up (could not be contacted)|7
2557854|NCT00511810|6269651|P1|COMPLETED|Overall Study||7
2557855|NCT00511810|6269650|P2|STARTED|Overall Study||12
2557856|NCT00511810|6269651|P1|STARTED|Overall Study||8
2557857|NCT00511797|6269661|P4|NOT COMPLETED|Overall Study||15
2557858|NCT00511797|6269662|P3|NOT COMPLETED|Overall Study||11
2557859|NCT00511797|6269663|P2|NOT COMPLETED|Overall Study||8
2557860|NCT00511797|6269664|P1|NOT COMPLETED|Overall Study||7
2557861|NCT00511797|6269661|P4|COMPLETED|Overall Study||47
2557862|NCT00511797|6269662|P3|COMPLETED|Overall Study||51
2557863|NCT00511797|6269663|P2|COMPLETED|Overall Study||55
2557864|NCT00511797|6269664|P1|COMPLETED|Overall Study||55
2557865|NCT00511797|6269661|P4|Subjects Received Treatment|Overall Study|FAS|58
2557866|NCT00511797|6269662|P3|Subjects Received Treatment|Overall Study|FAS|61
2557867|NCT00511797|6269663|P2|Subjects Received Treatment|Overall Study|FAS|62
2557868|NCT00511797|6269664|P1|Subjects Received Treatment|Overall Study|FAS|61
2557869|NCT00511797|6269661|P4|Subjects Dispensed Drugs|Overall Study||59
2557870|NCT00511797|6269662|P3|Subjects Dispensed Drugs|Overall Study||61
2557871|NCT00511797|6269663|P2|Subjects Dispensed Drugs|Overall Study||63
2557872|NCT00511797|6269664|P1|Subjects Dispensed Drugs|Overall Study||61
2557873|NCT00511797|6269661|P4|STARTED|Overall Study||62
2557874|NCT00511797|6269662|P3|STARTED|Overall Study||62
2557875|NCT00511797|6269663|P2|STARTED|Overall Study||63
2557876|NCT00511797|6269664|P1|STARTED|Overall Study||62
2557877|NCT00511706|6269768|P2|NOT COMPLETED|Overall Study||5
2557878|NCT00511706|6269769|P1|NOT COMPLETED|Overall Study||8
2557879|NCT00511706|6269768|P2|COMPLETED|Overall Study||115
2557880|NCT00511706|6269769|P1|COMPLETED|Overall Study||115
2557881|NCT00511706|6269768|P2|STARTED|Overall Study||120
2557882|NCT00511706|6269769|P1|STARTED|Overall Study||123
2557883|NCT00511667|6269783|P2|NOT COMPLETED|Overall Study||3
2557884|NCT00511667|6269784|P1|NOT COMPLETED|Overall Study||12
2557885|NCT00511667|6269783|P2|COMPLETED|Overall Study||15
2557886|NCT00511667|6269784|P1|COMPLETED|Overall Study||40
2557887|NCT00511667|6269783|P2|STARTED|Overall Study||18
2557888|NCT00511667|6269784|P1|STARTED|Overall Study||52
2557889|NCT00511472|6269819|P2|NOT COMPLETED|Overall Study||6
2557890|NCT00511472|6269820|P1|NOT COMPLETED|Overall Study||3
2557891|NCT00511472|6269819|P2|COMPLETED|Overall Study||17
2557892|NCT00511472|6269820|P1|COMPLETED|Overall Study||44
2557893|NCT00511472|6269819|P2|STARTED|Overall Study||23
2557894|NCT00511472|6269820|P1|STARTED|Overall Study||47
2557895|NCT00511433|6269839|P2|NOT COMPLETED|Overall Study||1
2557896|NCT00511433|6269840|P1|NOT COMPLETED|Overall Study||6
2557897|NCT00511433|6269839|P2|COMPLETED|Overall Study||15
2557898|NCT00511433|6269840|P1|COMPLETED|Overall Study||26
2557899|NCT00511433|6269839|P2|STARTED|Overall Study||16
2557900|NCT00511433|6269840|P1|STARTED|Overall Study||32
2557901|NCT00511355|6269880|P2|NOT COMPLETED|Overall Study||9
2557902|NCT00511355|6269881|P1|NOT COMPLETED|Overall Study||7
2557903|NCT00511355|6269880|P2|COMPLETED|Overall Study||52
2557904|NCT00511355|6269881|P1|COMPLETED|Overall Study||53
2557905|NCT00511355|6269880|P2|STARTED|Overall Study||61
2557906|NCT00511355|6269881|P1|STARTED|Overall Study||60
2557907|NCT00511342|6269981|P2|NOT COMPLETED|Overall Study||22
2557908|NCT00511342|6269982|P1|NOT COMPLETED|Overall Study||13
2557909|NCT00511342|6269981|P2|COMPLETED|Overall Study||32
2557910|NCT00511342|6269982|P1|COMPLETED|Overall Study||43
2557911|NCT00511342|6269981|P2|STARTED|Overall Study||54
2557912|NCT00511342|6269982|P1|STARTED|Overall Study||56
2557913|NCT00511329|6270006|P1|NOT COMPLETED|Overall Study||0
2557914|NCT00511329|6270006|P1|COMPLETED|Overall Study||0
2557915|NCT00511329|6270006|P1|STARTED|Overall Study||0
2557916|NCT00511238|6270013|P2|NOT COMPLETED|Overall Study||226
2557917|NCT00511238|6270014|P1|NOT COMPLETED|Overall Study||42
2557918|NCT00511238|6270013|P2|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|40
2557919|NCT00511238|6270014|P1|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|4
2557920|NCT00511238|6270013|P2|STARTED|Overall Study||266
2557921|NCT00511238|6270014|P1|STARTED|Overall Study||46
2557922|NCT00511199|6270033|P2|NOT COMPLETED|Overall Study||125
2557923|NCT00511199|6270034|P1|NOT COMPLETED|Overall Study||449
2557924|NCT00511199|6270033|P2|COMPLETED|Overall Study||410
2557925|NCT00511199|6270034|P1|COMPLETED|Overall Study||1142
2557926|NCT00511199|6270033|P2|STARTED|Overall Study||535
2557927|NCT00511199|6270034|P1|STARTED|Overall Study||1591
2557928|NCT00511173|6270058|P1|NOT COMPLETED|Overall Study||0
2557929|NCT00511173|6270058|P1|COMPLETED|Overall Study||102
2557930|NCT00511173|6270058|P1|STARTED|Overall Study||102
2557931|NCT00511147|6270063|P1|NOT COMPLETED|Overall Study||7
2557932|NCT00511147|6270063|P1|COMPLETED|Overall Study||57
2557933|NCT00511147|6270063|P1|STARTED|Overall Study||64
2557934|NCT00511134|6270072|P2|NOT COMPLETED|Overall Study||2
2557935|NCT00511134|6270073|P1|NOT COMPLETED|Overall Study||0
2557936|NCT00511134|6270072|P2|COMPLETED|Overall Study||1
2557937|NCT00511134|6270073|P1|COMPLETED|Overall Study||1
2557938|NCT00511134|6270072|P2|STARTED|Overall Study||3
2557939|NCT00511134|6270073|P1|STARTED|Overall Study||1
2557940|NCT00511108|6270085|P4|NOT COMPLETED|Overall Study||5
2557941|NCT00511108|6270086|P3|NOT COMPLETED|Overall Study||5
2557942|NCT00511108|6270087|P2|NOT COMPLETED|Overall Study||2
2557943|NCT00511108|6270088|P1|NOT COMPLETED|Overall Study||6
2557944|NCT00511108|6270085|P4|COMPLETED|Overall Study||48
2557945|NCT00511108|6270086|P3|COMPLETED|Overall Study||47
2557946|NCT00511108|6270087|P2|COMPLETED|Overall Study||52
2557947|NCT00511108|6270088|P1|COMPLETED|Overall Study||46
2557948|NCT00511108|6270085|P4|STARTED|Overall Study||53
2557949|NCT00511108|6270086|P3|STARTED|Overall Study||52
2557950|NCT00511108|6270087|P2|STARTED|Overall Study||54
2557951|NCT00511108|6270088|P1|STARTED|Overall Study||52
2557952|NCT00511095|6270106|P1|NOT COMPLETED|Overall Study||11
2557953|NCT00511095|6270106|P1|COMPLETED|Overall Study||196
2557954|NCT00511095|6270106|P1|STARTED|Overall Study||207
2557955|NCT00511004|6270119|P3|NOT COMPLETED|Overall Study||4
2557956|NCT00511004|6270120|P2|NOT COMPLETED|Overall Study||0
2557957|NCT00511004|6270121|P1|NOT COMPLETED|Overall Study||0
2557958|NCT00511004|6270119|P3|COMPLETED|Overall Study||10
2557959|NCT00511004|6270120|P2|COMPLETED|Overall Study||13
2557960|NCT00511004|6270121|P1|COMPLETED|Overall Study||13
2557961|NCT00511004|6270119|P3|STARTED|Overall Study||14
2557962|NCT00511004|6270120|P2|STARTED|Overall Study||13
2557963|NCT00511004|6270121|P1|STARTED|Overall Study||13
2557964|NCT00510952|6270140|P2|NOT COMPLETED|Overall Study||16
2557965|NCT00510952|6270141|P1|NOT COMPLETED|Overall Study||26
2557966|NCT00510952|6270140|P2|COMPLETED|Overall Study||220
2557967|NCT00510952|6270141|P1|COMPLETED|Overall Study||209
2557968|NCT00510952|6270140|P2|Full Analysis Set (Intent to Treat)|Overall Study||229
2557969|NCT00510952|6270141|P1|Full Analysis Set (Intent to Treat)|Overall Study||229
2557970|NCT00510952|6270140|P2|STARTED|Overall Study||236
2557971|NCT00510952|6270141|P1|STARTED|Overall Study||235
2557972|NCT00510887|6270167|P1|NOT COMPLETED|Overall Study||1
2557973|NCT00510887|6270167|P1|COMPLETED|Overall Study||11
2557974|NCT00510887|6270167|P1|STARTED|Overall Study||12
2557975|NCT00510874|6270183|P7|NOT COMPLETED|Overall Study||1
2557976|NCT00510874|6270184|P6|NOT COMPLETED|Overall Study||0
2557977|NCT00510874|6270185|P5|NOT COMPLETED|Overall Study||7
2557978|NCT00510874|6270186|P4|NOT COMPLETED|Overall Study||3
2557979|NCT00510874|6270187|P3|NOT COMPLETED|Overall Study||1
2557980|NCT00510874|6270188|P2|NOT COMPLETED|Overall Study||4
2557981|NCT00510874|6270189|P1|NOT COMPLETED|Overall Study||3
2557982|NCT00510874|6270183|P7|COMPLETED|Overall Study|Upto Day 182|49
2557983|NCT00510874|6270184|P6|COMPLETED|Overall Study|Upto Day 182|50
2557984|NCT00510874|6270185|P5|COMPLETED|Overall Study|Upto Day 182|141
2557985|NCT00510874|6270186|P4|COMPLETED|Overall Study|Upto Day 182|148
2557986|NCT00510874|6270187|P3|COMPLETED|Overall Study|Upto Day 182|150
2557987|NCT00510874|6270188|P2|COMPLETED|Overall Study|Upto Day 182|148
2557988|NCT00510874|6270189|P1|COMPLETED|Overall Study|Upto Day 182|75
2557989|NCT00510874|6270183|P7|STARTED|Overall Study||50
2557990|NCT00510874|6270184|P6|STARTED|Overall Study||50
2557991|NCT00510874|6270185|P5|STARTED|Overall Study||148
2557992|NCT00510874|6270186|P4|STARTED|Overall Study||151
2557993|NCT00510874|6270187|P3|STARTED|Overall Study||151
2557994|NCT00510874|6270188|P2|STARTED|Overall Study||152
2557995|NCT00510874|6270189|P1|STARTED|Overall Study||78
2557996|NCT00510835|6270292|P3|NOT COMPLETED|Overall Study||2
2557997|NCT00510835|6270293|P2|NOT COMPLETED|Overall Study||2
2557998|NCT00510835|6270294|P1|NOT COMPLETED|Overall Study||6
2557999|NCT00510835|6270292|P3|COMPLETED|Overall Study||456
2558000|NCT00510835|6270293|P2|COMPLETED|Overall Study||446
2558001|NCT00510835|6270294|P1|COMPLETED|Overall Study||439
2558002|NCT00510835|6270292|P3|STARTED|Overall Study||458
2558003|NCT00510835|6270293|P2|STARTED|Overall Study||448
2558004|NCT00510835|6270294|P1|STARTED|Overall Study||445
2558005|NCT00510809|6270305|P3|NOT COMPLETED|Overall Study||0
2558006|NCT00510809|6270306|P2|NOT COMPLETED|Overall Study||0
2558007|NCT00510809|6270307|P1|NOT COMPLETED|Overall Study||0
2558008|NCT00510809|6270305|P3|COMPLETED|Overall Study||18
2558009|NCT00510809|6270306|P2|COMPLETED|Overall Study||18
2558010|NCT00510809|6270307|P1|COMPLETED|Overall Study||18
2558011|NCT00510809|6270305|P3|STARTED|Overall Study||18
2558012|NCT00510809|6270306|P2|STARTED|Overall Study||18
2558013|NCT00510809|6270307|P1|STARTED|Overall Study||18
2558014|NCT00510783|6270320|P2|NOT COMPLETED|Overall Study||29
2558015|NCT00510783|6270321|P1|NOT COMPLETED|Overall Study||31
2558016|NCT00510783|6270320|P2|COMPLETED|Overall Study||47
2558017|NCT00510783|6270321|P1|COMPLETED|Overall Study||51
2558018|NCT00510783|6270320|P2|STARTED|Overall Study||76
2558019|NCT00510783|6270321|P1|STARTED|Overall Study||82
2558020|NCT00510744|6270327|P1|NOT COMPLETED|Overall Study||0
2558021|NCT00510744|6270327|P1|COMPLETED|Overall Study||5
2558022|NCT00510744|6270327|P1|STARTED|Overall Study||5
2558023|NCT00510718|6270338|P2|NOT COMPLETED|Multiple Dose Period: 12 Weeks||32
2558024|NCT00510718|6270339|P1|NOT COMPLETED|Multiple Dose Period: 12 Weeks||15
2558025|NCT00510718|6270338|P2|COMPLETED|Multiple Dose Period: 12 Weeks||43
2558026|NCT00510718|6270339|P1|COMPLETED|Multiple Dose Period: 12 Weeks||50
2558027|NCT00510718|6270338|P2|600 mg/Day|Multiple Dose Period: 12 Weeks||3
2558028|NCT00510718|6270339|P1|600 mg/Day|Multiple Dose Period: 12 Weeks||0
2558029|NCT00510718|6270338|P2|480 mg/Day|Multiple Dose Period: 12 Weeks||22
2558030|NCT00510718|6270339|P1|480 mg/Day|Multiple Dose Period: 12 Weeks||0
2558031|NCT00510718|6270338|P2|360 mg/Day|Multiple Dose Period: 12 Weeks||13
2558032|NCT00510718|6270339|P1|360 mg/Day|Multiple Dose Period: 12 Weeks||15
2558033|NCT00510718|6270338|P2|240 mg/Day|Multiple Dose Period: 12 Weeks||12
2558034|NCT00510718|6270339|P1|240 mg/Day|Multiple Dose Period: 12 Weeks||17
2558035|NCT00510718|6270338|P2|150/160 mg/Day|Multiple Dose Period: 12 Weeks||13
2558036|NCT00510718|6270339|P1|150/160 mg/Day|Multiple Dose Period: 12 Weeks||15
2558037|NCT00510718|6270338|P2|60 mg/Day|Multiple Dose Period: 12 Weeks||12
2558038|NCT00510718|6270339|P1|60 mg/Day|Multiple Dose Period: 12 Weeks||15
2558039|NCT00510718|6270338|P2|30 mg/Day|Multiple Dose Period: 12 Weeks||0
2558040|NCT00510718|6270339|P1|30 mg/Day|Multiple Dose Period: 12 Weeks||3
2558041|NCT00510718|6270338|P2|STARTED|Multiple Dose Period: 12 Weeks|Participants who completed single dose period + new participants enrolled in multiple dose period.|75
2558042|NCT00510718|6270339|P1|STARTED|Multiple Dose Period: 12 Weeks|Participants who completed single dose period + new participants enrolled in multiple dose period.|65
2558043|NCT00510718|6270338|P2|NOT COMPLETED|Single Dose Period: 1 Week||0
2558044|NCT00510718|6270339|P1|NOT COMPLETED|Single Dose Period: 1 Week||0
2558045|NCT00510718|6270338|P2|COMPLETED|Single Dose Period: 1 Week||12
2558046|NCT00510718|6270339|P1|COMPLETED|Single Dose Period: 1 Week||15
2558047|NCT00510718|6270338|P2|600 mg/Day|Single Dose Period: 1 Week||3
2558048|NCT00510718|6270339|P1|600 mg/Day|Single Dose Period: 1 Week||0
2558049|NCT00510718|6270338|P2|480 mg/Day|Single Dose Period: 1 Week||6
2558050|NCT00510718|6270339|P1|480 mg/Day|Single Dose Period: 1 Week||0
2558051|NCT00510718|6270338|P2|360 mg/Day|Single Dose Period: 1 Week||2
2558052|NCT00510718|6270339|P1|360 mg/Day|Single Dose Period: 1 Week||4
2558053|NCT00510718|6270338|P2|240 mg/Day|Single Dose Period: 1 Week||0
2558054|NCT00510718|6270339|P1|240 mg/Day|Single Dose Period: 1 Week||3
2558055|NCT00510718|6270338|P2|150/160 mg/Day|Single Dose Period: 1 Week||1
2558056|NCT00510718|6270339|P1|150/160 mg/Day|Single Dose Period: 1 Week||2
2558057|NCT00510718|6270338|P2|60 mg/Day|Single Dose Period: 1 Week||0
2558058|NCT00510718|6270339|P1|60 mg/Day|Single Dose Period: 1 Week||3
2558059|NCT00510718|6270338|P2|30 mg/Day|Single Dose Period: 1 Week||0
2558060|NCT00510718|6270339|P1|30 mg/Day|Single Dose Period: 1 Week||3
2558061|NCT00510718|6270338|P2|STARTED|Single Dose Period: 1 Week||12
2558062|NCT00510718|6270339|P1|STARTED|Single Dose Period: 1 Week||15
2558063|NCT00510692|6270465|P2|NOT COMPLETED|Overall Study||3
2558064|NCT00510692|6270466|P1|NOT COMPLETED|Overall Study||2
2558065|NCT00510692|6270465|P2|COMPLETED|Overall Study||26
2558066|NCT00510692|6270466|P1|COMPLETED|Overall Study||27
2558067|NCT00510692|6270465|P2|STARTED|Overall Study||29
2558068|NCT00510692|6270466|P1|STARTED|Overall Study||29
2558069|NCT00510653|6270480|P1|NOT COMPLETED|Overall Study||11
2558070|NCT00510653|6270480|P1|COMPLETED|Overall Study||13
2558071|NCT00510653|6270480|P1|STARTED|Overall Study||24
2558072|NCT00510510|6270487|P3|NOT COMPLETED|Overall Study||17
2558073|NCT00510510|6270488|P2|NOT COMPLETED|Overall Study||9
2558074|NCT00510510|6270489|P1|NOT COMPLETED|Overall Study||5
2558075|NCT00510510|6270487|P3|COMPLETED|Overall Study||74
2558076|NCT00510510|6270488|P2|COMPLETED|Overall Study||89
2558077|NCT00510510|6270489|P1|COMPLETED|Overall Study||87
2558078|NCT00510510|6270487|P3|STARTED|Overall Study||91
2558079|NCT00510510|6270488|P2|STARTED|Overall Study||98
2558080|NCT00510510|6270489|P1|STARTED|Overall Study||92
2558081|NCT00510497|6270500|P1|NOT COMPLETED|Overall Study||3
2558082|NCT00510497|6270500|P1|COMPLETED|Overall Study||8
2558083|NCT00510497|6270500|P1|STARTED|Overall Study||11
2558084|NCT00510484|6270507|P2|NOT COMPLETED|Period 2||0
2558085|NCT00510484|6270508|P1|NOT COMPLETED|Period 2||0
2558086|NCT00510484|6270507|P2|COMPLETED|Period 2||15
2558087|NCT00510484|6270508|P1|COMPLETED|Period 2||16
2558088|NCT00510484|6270507|P2|STARTED|Period 2||15
2558089|NCT00510484|6270508|P1|STARTED|Period 2||16
2558090|NCT00510484|6270507|P2|NOT COMPLETED|Wash-out Period||1
2558091|NCT00510484|6270508|P1|NOT COMPLETED|Wash-out Period||0
2558092|NCT00510484|6270507|P2|COMPLETED|Wash-out Period||15
2558093|NCT00510484|6270508|P1|COMPLETED|Wash-out Period||16
2558094|NCT00510484|6270507|P2|STARTED|Wash-out Period||16
2558095|NCT00510484|6270508|P1|STARTED|Wash-out Period||16
2558096|NCT00510484|6270507|P2|NOT COMPLETED|Period 1||0
2558097|NCT00510484|6270508|P1|NOT COMPLETED|Period 1||0
2558098|NCT00510484|6270507|P2|COMPLETED|Period 1||16
2558099|NCT00510484|6270508|P1|COMPLETED|Period 1||16
2558100|NCT00510484|6270507|P2|STARTED|Period 1||16
2558101|NCT00510484|6270508|P1|STARTED|Period 1||16
2558102|NCT00510458|6270528|P1|NOT COMPLETED|Overall Study||47
2558103|NCT00510458|6270528|P1|COMPLETED|Overall Study||27
2558104|NCT00510458|6270528|P1|STARTED|Overall Study||74
2558105|NCT00510289|6270541|P1|NOT COMPLETED|Overall Study||12
2558106|NCT00510289|6270541|P1|COMPLETED|Overall Study|Completed at least one cycle of study drug and had disease assessments|7
2558107|NCT00510289|6270541|P1|Started Study Drug|Overall Study|3 patients progressed prior to starting study drug|16
2558108|NCT00510289|6270541|P1|STARTED|Overall Study|All patients who consented|19
2558109|NCT00510276|6270551|P2|NOT COMPLETED|Extension Open-Label Phase||48
2558110|NCT00510276|6270552|P1|NOT COMPLETED|Extension Open-Label Phase||33
2558111|NCT00510276|6270551|P2|COMPLETED|Extension Open-Label Phase||81
2558112|NCT00510276|6270552|P1|COMPLETED|Extension Open-Label Phase||78
2558113|NCT00510276|6270551|P2|STARTED|Extension Open-Label Phase|1 patient who completed acute phase did not participate in the optional atometine extension phase|129
2558114|NCT00510276|6270552|P1|STARTED|Extension Open-Label Phase|4 patients who completed acute phase did not participate in the optional atomoxetine extension phase|111
2558115|NCT00510276|6270551|P2|NOT COMPLETED|Acute Double-Blind Phase||95
2558116|NCT00510276|6270552|P1|NOT COMPLETED|Acute Double-Blind Phase||105
2558117|NCT00510276|6270551|P2|COMPLETED|Acute Double-Blind Phase||130
2558118|NCT00510276|6270552|P1|COMPLETED|Acute Double-Blind Phase||115
2558119|NCT00510276|6270551|P2|STARTED|Acute Double-Blind Phase||225
2558120|NCT00510276|6270552|P1|STARTED|Acute Double-Blind Phase||220
2558121|NCT00510224|6270637|P1|NOT COMPLETED|Overall Study||3
2558122|NCT00510224|6270637|P1|COMPLETED|Overall Study||10
2558123|NCT00510224|6270637|P1|STARTED|Overall Study||13
2558124|NCT00510198|6270646|P2|NOT COMPLETED|Overall Study||4
2558125|NCT00510198|6270647|P1|NOT COMPLETED|Overall Study||5
2558126|NCT00510198|6270646|P2|COMPLETED|Overall Study||54
2558127|NCT00510198|6270647|P1|COMPLETED|Overall Study||54
2558128|NCT00510198|6270646|P2|STARTED|Overall Study||58
2558129|NCT00510198|6270647|P1|STARTED|Overall Study||59
2558130|NCT00510146|6270661|P2|NOT COMPLETED|Open-Label Treatment||26
2558131|NCT00510146|6270662|P1|NOT COMPLETED|Open-Label Treatment||71
2558132|NCT00510146|6270661|P2|COMPLETED|Open-Label Treatment||96
2558133|NCT00510146|6270662|P1|COMPLETED|Open-Label Treatment||196
2558134|NCT00510146|6270661|P2|STARTED|Open-Label Treatment||122
2558135|NCT00510146|6270662|P1|STARTED|Open-Label Treatment||267
2558136|NCT00510146|6270661|P2|NOT COMPLETED|Double-Blind Treatment||49
2558137|NCT00510146|6270662|P1|NOT COMPLETED|Double-Blind Treatment||76
2558138|NCT00510146|6270661|P2|COMPLETED|Double-Blind Treatment||122
2558139|NCT00510146|6270662|P1|COMPLETED|Double-Blind Treatment||267
2558140|NCT00510146|6270661|P2|STARTED|Double-Blind Treatment||171
2558141|NCT00510146|6270662|P1|STARTED|Double-Blind Treatment||343
2558142|NCT00510068|6270751|P2|NOT COMPLETED|Open-label Period||0
2558143|NCT00510068|6270752|P1|NOT COMPLETED|Open-label Period||225
2558144|NCT00510068|6270751|P2|COMPLETED|Open-label Period||0
2558145|NCT00510068|6270752|P1|COMPLETED|Open-label Period||0
2558146|NCT00510068|6270751|P2|STARTED|Open-label Period||0
2558147|NCT00510068|6270752|P1|STARTED|Open-label Period|172 patients switched over from placebo & 53 who were initially randomized to Everolimus arm.|225
2558148|NCT00510068|6270751|P2|NOT COMPLETED|Double-blind Period||203
2558149|NCT00510068|6270752|P1|NOT COMPLETED|Double-blind Period||207
2558150|NCT00510068|6270751|P2|COMPLETED|Double-blind Period||0
2558151|NCT00510068|6270752|P1|COMPLETED|Double-blind Period||0
2558152|NCT00510068|6270751|P2|Safety Population|Double-blind Period||203
2558153|NCT00510068|6270752|P1|Safety Population|Double-blind Period||204
2558154|NCT00510068|6270751|P2|STARTED|Double-blind Period||203
2558155|NCT00510068|6270752|P1|STARTED|Double-blind Period||207
2558156|NCT00509925|6270793|P2|NOT COMPLETED|Overall Study||1
2558157|NCT00509925|6270794|P1|NOT COMPLETED|Overall Study||0
2558158|NCT00509925|6270793|P2|COMPLETED|Overall Study||10
2558159|NCT00509925|6270794|P1|COMPLETED|Overall Study||12
2558160|NCT00509925|6270793|P2|STARTED|Overall Study||11
2558161|NCT00509925|6270794|P1|STARTED|Overall Study||12
2558162|NCT00509899|6270842|P8|NOT COMPLETED|Overall Study||1
2558163|NCT00509899|6270843|P7|NOT COMPLETED|Overall Study||1
2558164|NCT00509899|6270844|P6|NOT COMPLETED|Overall Study||10
2558165|NCT00509899|6270845|P5|NOT COMPLETED|Overall Study||5
2558166|NCT00509899|6270846|P4|NOT COMPLETED|Overall Study||4
2558167|NCT00509899|6270847|P3|NOT COMPLETED|Overall Study||20
2558168|NCT00509899|6270848|P2|NOT COMPLETED|Overall Study||9
2558169|NCT00509899|6270849|P1|NOT COMPLETED|Overall Study||16
2558170|NCT00509899|6270842|P8|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|2
2558171|NCT00509899|6270843|P7|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|5
2558172|NCT00509899|6270844|P6|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|12
2558173|NCT00509899|6270845|P5|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
2558174|NCT00509899|6270846|P4|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
2558175|NCT00509899|6270847|P3|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|27
2558176|NCT00509899|6270848|P2|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|26
2558177|NCT00509899|6270849|P1|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|14
2558178|NCT00509899|6270842|P8|STARTED|Overall Study||3
2558179|NCT00509899|6270843|P7|STARTED|Overall Study||6
2558180|NCT00509899|6270844|P6|STARTED|Overall Study||22
2558181|NCT00509899|6270845|P5|STARTED|Overall Study||6
2558182|NCT00509899|6270846|P4|STARTED|Overall Study||5
2558183|NCT00509899|6270847|P3|STARTED|Overall Study||47
2558184|NCT00509899|6270848|P2|STARTED|Overall Study||35
2558185|NCT00509899|6270849|P1|STARTED|Overall Study||30
2558186|NCT00509873|6270889|P2|NOT COMPLETED|Overall Study||15
2558187|NCT00509873|6270890|P1|NOT COMPLETED|Overall Study||11
2558188|NCT00509873|6270889|P2|COMPLETED|Overall Study||276
2558189|NCT00509873|6270890|P1|COMPLETED|Overall Study||276
2558190|NCT00509873|6270889|P2|STARTED|Overall Study||291
2558191|NCT00509873|6270890|P1|STARTED|Overall Study||287
2558192|NCT00509821|6270906|P2|NOT COMPLETED|Study Period 4 (Follow Up)||0
2558193|NCT00509821|6270907|P1|NOT COMPLETED|Study Period 4 (Follow Up)||0
2558194|NCT00509821|6270906|P2|COMPLETED|Study Period 4 (Follow Up)||50
2558195|NCT00509821|6270907|P1|COMPLETED|Study Period 4 (Follow Up)||2
2558196|NCT00509821|6270906|P2|STARTED|Study Period 4 (Follow Up)|1 Participant completed Radiation Phase, did not enter Maintenance Phase but entered Follow Up.|50
2558197|NCT00509821|6270907|P1|STARTED|Study Period 4 (Follow Up)|1 Participant completed Maintenance Phase but did not enter Follow-Up.|2
2558198|NCT00509821|6270906|P2|NOT COMPLETED|Study Period 3 (Maintenance)||49
2558199|NCT00509821|6270907|P1|NOT COMPLETED|Study Period 3 (Maintenance)||0
2558200|NCT00509821|6270906|P2|COMPLETED|Study Period 3 (Maintenance)||0
2558201|NCT00509821|6270907|P1|COMPLETED|Study Period 3 (Maintenance)||3
2558202|NCT00509821|6270906|P2|STARTED|Study Period 3 (Maintenance)|4 participants completed Radiation Phase but did not enter Maintenance Phase.|49
2558203|NCT00509821|6270907|P1|STARTED|Study Period 3 (Maintenance)||3
2558204|NCT00509821|6270906|P2|NOT COMPLETED|Study Period 2 (Radiation)||53
2558205|NCT00509821|6270907|P1|NOT COMPLETED|Study Period 2 (Radiation)||0
2558206|NCT00509821|6270906|P2|COMPLETED|Study Period 2 (Radiation)||0
2558207|NCT00509821|6270907|P1|COMPLETED|Study Period 2 (Radiation)||3
2558208|NCT00509821|6270906|P2|STARTED|Study Period 2 (Radiation)|Participants moved to Radiation Phase.|53
2558209|NCT00509821|6270907|P1|STARTED|Study Period 2 (Radiation)|Participants moved to Radiation Phase.|3
2558210|NCT00509821|6270906|P2|NOT COMPLETED|Study Period 1 (Induction)||4
2558211|NCT00509821|6270907|P1|NOT COMPLETED|Study Period 1 (Induction)||0
2558212|NCT00509821|6270906|P2|COMPLETED|Study Period 1 (Induction)||53
2558213|NCT00509821|6270907|P1|COMPLETED|Study Period 1 (Induction)||3
2558214|NCT00509821|6270906|P2|Received at Least 1 Dose of Study Drug|Study Period 1 (Induction)||57
2558215|NCT00509821|6270907|P1|Received at Least 1 Dose of Study Drug|Study Period 1 (Induction)||3
2558216|NCT00509821|6270906|P2|STARTED|Study Period 1 (Induction)||57
2558217|NCT00509821|6270907|P1|STARTED|Study Period 1 (Induction)||3
2558218|NCT00509795|6270925|P4|NOT COMPLETED|Overall Study||27
2558219|NCT00509795|6270926|P3|NOT COMPLETED|Overall Study||27
2558220|NCT00509795|6270927|P2|NOT COMPLETED|Overall Study||11
2558221|NCT00509795|6270928|P1|NOT COMPLETED|Overall Study||22
2558222|NCT00509795|6270925|P4|COMPLETED|Overall Study||276
2558223|NCT00509795|6270926|P3|COMPLETED|Overall Study||277
2558224|NCT00509795|6270927|P2|COMPLETED|Overall Study||293
2558225|NCT00509795|6270928|P1|COMPLETED|Overall Study||284
2558226|NCT00509795|6270925|P4|Per Protocol Set (PPS) Population|Overall Study||265
2558227|NCT00509795|6270926|P3|Per Protocol Set (PPS) Population|Overall Study||270
2558228|NCT00509795|6270927|P2|Per Protocol Set (PPS) Population|Overall Study||285
2558229|NCT00509795|6270928|P1|Per Protocol Set (PPS) Population|Overall Study||269
2558230|NCT00509795|6270925|P4|Full Analysis Set (FAS) Population|Overall Study||301
2558231|NCT00509795|6270926|P3|Full Analysis Set (FAS) Population|Overall Study||301
2558232|NCT00509795|6270927|P2|Full Analysis Set (FAS) Population|Overall Study||304
2558233|NCT00509795|6270928|P1|Full Analysis Set (FAS) Population|Overall Study||304
2558234|NCT00509795|6270925|P4|Patients Received Treatment (SAF)|Overall Study||303
2558235|NCT00509795|6270926|P3|Patients Received Treatment (SAF)|Overall Study||304
2558236|NCT00509795|6270927|P2|Patients Received Treatment (SAF)|Overall Study||304
2558237|NCT00509795|6270928|P1|Patients Received Treatment (SAF)|Overall Study||304
2558238|NCT00509795|6270925|P4|STARTED|Overall Study||303
2558239|NCT00509795|6270926|P3|STARTED|Overall Study||304
2558240|NCT00509795|6270927|P2|STARTED|Overall Study||304
2558241|NCT00509795|6270928|P1|STARTED|Overall Study||306
2558242|NCT00509769|6270959|P1|NOT COMPLETED|Overall Study||91
2558243|NCT00509769|6270959|P1|COMPLETED|Overall Study||21
2558244|NCT00509769|6270959|P1|STARTED|Overall Study||112
2558245|NCT00509665|6270968|P1|NOT COMPLETED|Overall Study||0
2558246|NCT00509665|6270968|P1|COMPLETED|Overall Study||18
2558247|NCT00509665|6270968|P1|STARTED|Overall Study||18
2558248|NCT00509600|6270978|P1|NOT COMPLETED|Overall Study||1
2558249|NCT00509600|6270978|P1|COMPLETED|Overall Study||0
2558250|NCT00509600|6270978|P1|STARTED|Overall Study||1
2558251|NCT00509587|6270982|P1|NOT COMPLETED|Overall Study||0
2558252|NCT00509587|6270982|P1|COMPLETED|Overall Study||21
2558253|NCT00509587|6270982|P1|STARTED|Overall Study||21
2558254|NCT00509496|6270993|P2|NOT COMPLETED|Overall Study||0
2558255|NCT00509496|6270994|P1|NOT COMPLETED|Overall Study||0
2558256|NCT00509496|6270993|P2|COMPLETED|Overall Study||2
2558257|NCT00509496|6270994|P1|COMPLETED|Overall Study||19
2558258|NCT00509496|6270993|P2|STARTED|Overall Study||2
2558259|NCT00509496|6270994|P1|STARTED|Overall Study||19
2558260|NCT00509392|6271004|P3|NOT COMPLETED|Overall Study||0
2558261|NCT00509392|6271005|P2|NOT COMPLETED|Overall Study||0
2558262|NCT00509392|6271006|P1|NOT COMPLETED|Overall Study||0
2558263|NCT00509392|6271004|P3|COMPLETED|Overall Study||4
2558264|NCT00509392|6271005|P2|COMPLETED|Overall Study||33
2558265|NCT00509392|6271006|P1|COMPLETED|Overall Study||32
2558266|NCT00509392|6271004|P3|STARTED|Overall Study||4
2558267|NCT00509392|6271005|P2|STARTED|Overall Study||33
2558268|NCT00509392|6271006|P1|STARTED|Overall Study||32
2558269|NCT00509366|6271057|P5|NOT COMPLETED|Overall Study||0
2558270|NCT00509366|6271058|P4|NOT COMPLETED|Overall Study||0
2558271|NCT00509366|6271059|P3|NOT COMPLETED|Overall Study||1
2558272|NCT00509366|6271060|P2|NOT COMPLETED|Overall Study||1
2558273|NCT00509366|6271061|P1|NOT COMPLETED|Overall Study||1
2558274|NCT00509366|6271057|P5|COMPLETED|Overall Study|Patients who were neither assigned nor treated with protocol-based therapy.|51
2558275|NCT00509366|6271058|P4|COMPLETED|Overall Study|Patients assigned to treatment and treated with docetaxel/gemcitabine treatment combination.|2
2558276|NCT00509366|6271059|P3|COMPLETED|Overall Study|Patients assigned to treatment and treated with pemetrexed/gemcitabine treatment combination.|21
2558277|NCT00509366|6271060|P2|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/pemetrexed treatment combination.|7
2558278|NCT00509366|6271061|P1|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/gemcitabine treatment combination.|17
2558279|NCT00509366|6271057|P5|Assigned Treatment|Overall Study||0
2558280|NCT00509366|6271058|P4|Assigned Treatment|Overall Study|Patients who were assigned to docetaxel/gemcitabine treatment arm.|2
2558281|NCT00509366|6271059|P3|Assigned Treatment|Overall Study|Patients who were assigned to pemetrexed/gemcitabine treatment arm.|22
2558282|NCT00509366|6271060|P2|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/pemetrexed treatment arm.|8
2558283|NCT00509366|6271061|P1|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/gemcitabine treatment arm.|18
2558284|NCT00509366|6271057|P5|STARTED|Overall Study|Registered patients who were neither assigned nor treated with protocol-based therapy.|51
2558285|NCT00509366|6271058|P4|STARTED|Overall Study|Registered patients who were assigned docetaxel/gemcitabine treatment.|2
2558286|NCT00509366|6271059|P3|STARTED|Overall Study|Registered patients who were assigned pemetrexed/gemcitabine treatment.|22
2558287|NCT00509366|6271060|P2|STARTED|Overall Study|Registered patients who were assigned cisplatin/pemetrexed treatment.|8
2558288|NCT00509366|6271061|P1|STARTED|Overall Study|Registered patients who were assigned cisplatin/gemcitabine treatment.|18
2558289|NCT00509288|6271074|P2|NOT COMPLETED|Overall Study||0
2558290|NCT00509288|6271075|P1|NOT COMPLETED|Overall Study||0
2558291|NCT00509288|6271074|P2|COMPLETED|Overall Study||3
2558292|NCT00509288|6271075|P1|COMPLETED|Overall Study||21
2558293|NCT00509288|6271074|P2|STARTED|Overall Study||3
2558294|NCT00509288|6271075|P1|STARTED|Overall Study||21
2558295|NCT00509262|6271085|P2|NOT COMPLETED|Overall Study||42
2558296|NCT00509262|6271086|P1|NOT COMPLETED|Overall Study||47
2558297|NCT00509262|6271085|P2|COMPLETED|Overall Study||170
2558298|NCT00509262|6271086|P1|COMPLETED|Overall Study||164
2558299|NCT00509262|6271085|P2|STARTED|Overall Study||212
2558300|NCT00509262|6271086|P1|STARTED|Overall Study||211
2558301|NCT00509249|6271098|P1|NOT COMPLETED|Overall Study||0
2558302|NCT00509249|6271098|P1|COMPLETED|Overall Study||18
2558303|NCT00509249|6271098|P1|STARTED|Overall Study||18
2558304|NCT00509236|6271104|P2|NOT COMPLETED|Overall Study||20
2558305|NCT00509236|6271105|P1|NOT COMPLETED|Overall Study||17
2558306|NCT00509236|6271104|P2|COMPLETED|Overall Study||45
2558307|NCT00509236|6271105|P1|COMPLETED|Overall Study||47
2558308|NCT00509236|6271104|P2|STARTED|Overall Study||65
2558309|NCT00509236|6271105|P1|STARTED|Overall Study||64
2558310|NCT00509223|6271120|P2|NOT COMPLETED|Overall Study||72
2558311|NCT00509223|6271121|P1|NOT COMPLETED|Overall Study||88
2558312|NCT00509223|6271120|P2|COMPLETED|Overall Study||137
2558313|NCT00509223|6271121|P1|COMPLETED|Overall Study||119
2558314|NCT00509223|6271120|P2|STARTED|Overall Study||209
2558315|NCT00509223|6271121|P1|STARTED|Overall Study||207
2558316|NCT00509197|6271129|P2|NOT COMPLETED|Overall Study||0
2558317|NCT00509197|6271130|P1|NOT COMPLETED|Overall Study||0
2558318|NCT00509197|6271129|P2|COMPLETED|Overall Study||6
2558319|NCT00509197|6271130|P1|COMPLETED|Overall Study||6
2558320|NCT00509197|6271129|P2|STARTED|Overall Study||6
2558321|NCT00509197|6271130|P1|STARTED|Overall Study||6
2558322|NCT00509106|6271144|P2|NOT COMPLETED|Overall Study||29
2558323|NCT00509106|6271145|P1|NOT COMPLETED|Overall Study||31
2558324|NCT00509106|6271144|P2|COMPLETED|Overall Study||278
2558325|NCT00509106|6271145|P1|COMPLETED|Overall Study||284
2558326|NCT00509106|6271144|P2|STARTED|Overall Study||307
2558327|NCT00509106|6271145|P1|STARTED|Overall Study||315
2558328|NCT00509067|6271153|P2|NOT COMPLETED|Overall Study||5
2558329|NCT00509067|6271154|P1|NOT COMPLETED|Overall Study||4
2558330|NCT00509067|6271153|P2|COMPLETED|Overall Study||19
2558331|NCT00509067|6271154|P1|COMPLETED|Overall Study||15
2558332|NCT00509067|6271153|P2|STARTED|Overall Study||24
2558333|NCT00509067|6271154|P1|STARTED|Overall Study||19
2558334|NCT00509041|6271164|P1|NOT COMPLETED|Overall Study||0
2558335|NCT00509041|6271164|P1|COMPLETED|Overall Study||43
2558336|NCT00509041|6271164|P1|STARTED|Overall Study||43
2558337|NCT00509028|6271173|P2|NOT COMPLETED|Overall Study||7
2558338|NCT00509028|6271174|P1|NOT COMPLETED|Overall Study||12
2558339|NCT00509028|6271173|P2|COMPLETED|Overall Study||113
2558340|NCT00509028|6271174|P1|COMPLETED|Overall Study||109
2558341|NCT00509028|6271173|P2|STARTED|Overall Study||120
2558342|NCT00509028|6271174|P1|STARTED|Overall Study||121
2558343|NCT00509002|6271206|P1|NOT COMPLETED|Overall Study||0
2558344|NCT00509002|6271206|P1|COMPLETED|Overall Study||37
2558345|NCT00509002|6271206|P1|STARTED|Overall Study||37
2558346|NCT00508924|6271214|P4|NOT COMPLETED|Overall Study||1
2558347|NCT00508924|6271215|P3|NOT COMPLETED|Overall Study||1
2558348|NCT00508924|6271216|P2|NOT COMPLETED|Overall Study||0
2558349|NCT00508924|6271217|P1|NOT COMPLETED|Overall Study||0
2558350|NCT00508924|6271214|P4|COMPLETED|Overall Study||33
2558351|NCT00508924|6271215|P3|COMPLETED|Overall Study||31
2558352|NCT00508924|6271216|P2|COMPLETED|Overall Study||38
2558353|NCT00508924|6271217|P1|COMPLETED|Overall Study||36
2558354|NCT00508924|6271214|P4|STARTED|Overall Study||34
2558355|NCT00508924|6271215|P3|STARTED|Overall Study||32
2558356|NCT00508924|6271216|P2|STARTED|Overall Study||38
2558357|NCT00508924|6271217|P1|STARTED|Overall Study||36
2558358|NCT00508872|6271231|P1|NOT COMPLETED|Overall Study||2
2558359|NCT00508872|6271231|P1|COMPLETED|Overall Study||0
2558360|NCT00508872|6271231|P1|STARTED|Overall Study||2
2558361|NCT00508820|6271237|P2|NOT COMPLETED|Overall Study||64
2558362|NCT00508820|6271238|P1|NOT COMPLETED|Overall Study||55
2558363|NCT00508820|6271237|P2|COMPLETED|Overall Study||175
2558364|NCT00508820|6271238|P1|COMPLETED|Overall Study||113
2558365|NCT00508820|6271237|P2|STARTED|Overall Study||239
2558366|NCT00508820|6271238|P1|STARTED|Overall Study||168
2558367|NCT00508755|6271248|P1|NOT COMPLETED|Overall Study||1
2558368|NCT00508755|6271248|P1|COMPLETED|Overall Study||5
2558369|NCT00508755|6271248|P1|STARTED|Overall Study||6
2558370|NCT00508742|6271256|P2|NOT COMPLETED|Period 3: Toddler Dose||15
2558371|NCT00508742|6271257|P1|NOT COMPLETED|Period 3: Toddler Dose||25
2558372|NCT00508742|6271256|P2|COMPLETED|Period 3: Toddler Dose||863
2558373|NCT00508742|6271257|P1|COMPLETED|Period 3: Toddler Dose||858
2558374|NCT00508742|6271256|P2|STARTED|Period 3: Toddler Dose||878
2558375|NCT00508742|6271257|P1|STARTED|Period 3: Toddler Dose||883
2558376|NCT00508742|6271256|P2|NOT COMPLETED|Period 2: After Infant Series||11
2558377|NCT00508742|6271257|P1|NOT COMPLETED|Period 2: After Infant Series||7
2558378|NCT00508742|6271256|P2|COMPLETED|Period 2: After Infant Series||878
2558379|NCT00508742|6271257|P1|COMPLETED|Period 2: After Infant Series||883
2558380|NCT00508742|6271256|P2|STARTED|Period 2: After Infant Series||889
2558381|NCT00508742|6271257|P1|STARTED|Period 2: After Infant Series||890
2558382|NCT00508742|6271256|P2|NOT COMPLETED|Period 1: Infant Series||45
2558383|NCT00508742|6271257|P1|NOT COMPLETED|Period 1: Infant Series||42
2558384|NCT00508742|6271256|P2|COMPLETED|Period 1: Infant Series||889
2558385|NCT00508742|6271257|P1|COMPLETED|Period 1: Infant Series||890
2558386|NCT00508742|6271256|P2|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||892
2558387|NCT00508742|6271257|P1|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||898
2558388|NCT00508742|6271256|P2|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||902
2558389|NCT00508742|6271257|P1|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||904
2558390|NCT00508742|6271256|P2|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||933
2558391|NCT00508742|6271257|P1|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||930
2558392|NCT00508742|6271256|P2|STARTED|Period 1: Infant Series||934
2558393|NCT00508742|6271257|P1|STARTED|Period 1: Infant Series||932
2558394|NCT00508716|6271273|P2|NOT COMPLETED|Overall Study||0
2558395|NCT00508716|6271274|P1|NOT COMPLETED|Overall Study||0
2558396|NCT00508716|6271273|P2|COMPLETED|Overall Study||63
2558397|NCT00508716|6271274|P1|COMPLETED|Overall Study||61
2558398|NCT00508716|6271273|P2|STARTED|Overall Study||63
2558399|NCT00508716|6271274|P1|STARTED|Overall Study||61
2558400|NCT00508651|6271282|P2|NOT COMPLETED|Overall Study||2
2558401|NCT00508651|6271283|P1|NOT COMPLETED|Overall Study||4
2558402|NCT00508651|6271282|P2|COMPLETED|Overall Study||8
2558403|NCT00508651|6271283|P1|COMPLETED|Overall Study||16
2558404|NCT00508651|6271282|P2|STARTED|Overall Study||10
2558405|NCT00508651|6271283|P1|STARTED|Overall Study||20
2558406|NCT00508521|6271357|P1|NOT COMPLETED|Overall Study||0
2558407|NCT00508521|6271357|P1|COMPLETED|Overall Study||4
2558408|NCT00508521|6271357|P1|STARTED|Overall Study||4
2558409|NCT00508482|6271364|P3|NOT COMPLETED|at the 12th Week of Follow-up||0
2558410|NCT00508482|6271365|P2|NOT COMPLETED|at the 12th Week of Follow-up||0
2558411|NCT00508482|6271366|P1|NOT COMPLETED|at the 12th Week of Follow-up||0
2558412|NCT00508482|6271364|P3|COMPLETED|at the 12th Week of Follow-up||98
2558413|NCT00508482|6271365|P2|COMPLETED|at the 12th Week of Follow-up||96
2558414|NCT00508482|6271366|P1|COMPLETED|at the 12th Week of Follow-up||196
2558415|NCT00508482|6271364|P3|STARTED|at the 12th Week of Follow-up||98
2558416|NCT00508482|6271365|P2|STARTED|at the 12th Week of Follow-up||96
2558417|NCT00508482|6271366|P1|STARTED|at the 12th Week of Follow-up||196
2558418|NCT00508482|6271364|P3|NOT COMPLETED|at the 4th Week of Follow-up||1
2558419|NCT00508482|6271365|P2|NOT COMPLETED|at the 4th Week of Follow-up||6
2558420|NCT00508482|6271366|P1|NOT COMPLETED|at the 4th Week of Follow-up||20
2558421|NCT00508482|6271364|P3|COMPLETED|at the 4th Week of Follow-up||98
2558422|NCT00508482|6271365|P2|COMPLETED|at the 4th Week of Follow-up||96
2558423|NCT00508482|6271366|P1|COMPLETED|at the 4th Week of Follow-up||196
2558424|NCT00508482|6271364|P3|STARTED|at the 4th Week of Follow-up||99
2558425|NCT00508482|6271365|P2|STARTED|at the 4th Week of Follow-up||102
2558426|NCT00508482|6271366|P1|STARTED|at the 4th Week of Follow-up||216
2558427|NCT00508482|6271364|P3|NOT COMPLETED|Over 4 Weeks of Treatment||20
2558428|NCT00508482|6271365|P2|NOT COMPLETED|Over 4 Weeks of Treatment||17
2558429|NCT00508482|6271366|P1|NOT COMPLETED|Over 4 Weeks of Treatment||21
2558430|NCT00508482|6271364|P3|COMPLETED|Over 4 Weeks of Treatment||99
2558431|NCT00508482|6271365|P2|COMPLETED|Over 4 Weeks of Treatment||102
2558432|NCT00508482|6271366|P1|COMPLETED|Over 4 Weeks of Treatment||216
2558433|NCT00508482|6271364|P3|STARTED|Over 4 Weeks of Treatment||119
2558434|NCT00508482|6271365|P2|STARTED|Over 4 Weeks of Treatment||119
2558435|NCT00508482|6271366|P1|STARTED|Over 4 Weeks of Treatment||237
2558436|NCT00508469|6271403|P2|NOT COMPLETED|Overall Study||10
2558437|NCT00508469|6271404|P1|NOT COMPLETED|Overall Study||17
2558438|NCT00508469|6271403|P2|COMPLETED|Overall Study||40
2558439|NCT00508469|6271404|P1|COMPLETED|Overall Study||35
2558440|NCT00508469|6271403|P2|STARTED|Overall Study||50
2558441|NCT00508469|6271404|P1|STARTED|Overall Study||52
2558442|NCT00508404|6271410|P1|NOT COMPLETED|Overall Study||42
2558443|NCT00508404|6271410|P1|COMPLETED|Overall Study|Completion of safety follow-up visit conducted 8 weeks after last dose|112
2558444|NCT00508404|6271410|P1|STARTED|Overall Study||154
2558445|NCT00508391|6271437|P2|NOT COMPLETED|Second Treatment||0
2558446|NCT00508391|6271438|P1|NOT COMPLETED|Second Treatment||2
2558447|NCT00508391|6271437|P2|COMPLETED|Second Treatment||59
2558448|NCT00508391|6271438|P1|COMPLETED|Second Treatment||52
2558449|NCT00508391|6271437|P2|STARTED|Second Treatment||59
2558450|NCT00508391|6271438|P1|STARTED|Second Treatment||54
2558451|NCT00508391|6271437|P2|NOT COMPLETED|First Treatment||3
2558452|NCT00508391|6271438|P1|NOT COMPLETED|First Treatment||6
2558453|NCT00508391|6271437|P2|COMPLETED|First Treatment||59
2558454|NCT00508391|6271438|P1|COMPLETED|First Treatment||54
2558455|NCT00508391|6271437|P2|STARTED|First Treatment||62
2558456|NCT00508391|6271438|P1|STARTED|First Treatment||60
2558457|NCT00508300|6271451|P2|NOT COMPLETED|Overall Study||4
2558458|NCT00508300|6271452|P1|NOT COMPLETED|Overall Study||2
2558459|NCT00508300|6271451|P2|COMPLETED|Overall Study||57
2558460|NCT00508300|6271452|P1|COMPLETED|Overall Study||65
2558461|NCT00508300|6271451|P2|STARTED|Overall Study||61
2558462|NCT00508300|6271452|P1|STARTED|Overall Study||67
2558463|NCT00508274|6271458|P1|NOT COMPLETED|Overall Study||2
2558464|NCT00508274|6271458|P1|COMPLETED|Overall Study||50
2558465|NCT00508274|6271458|P1|STARTED|Overall Study||52
2558466|NCT00508261|6271471|P4|NOT COMPLETED|Overall Study||1
2558467|NCT00508261|6271472|P3|NOT COMPLETED|Overall Study||6
2558468|NCT00508261|6271473|P2|NOT COMPLETED|Overall Study||8
2558469|NCT00508261|6271474|P1|NOT COMPLETED|Overall Study||3
2558470|NCT00508261|6271471|P4|COMPLETED|Overall Study||126
2558471|NCT00508261|6271472|P3|COMPLETED|Overall Study||218
2558472|NCT00508261|6271473|P2|COMPLETED|Overall Study||212
2558473|NCT00508261|6271474|P1|COMPLETED|Overall Study||219
2558474|NCT00508261|6271471|P4|STARTED|Overall Study||127
2558475|NCT00508261|6271472|P3|STARTED|Overall Study||224
2558476|NCT00508261|6271473|P2|STARTED|Overall Study||220
2558477|NCT00508261|6271474|P1|STARTED|Overall Study||222
2558478|NCT00508196|6271584|P2|NOT COMPLETED|Overall Study||0
2558479|NCT00508196|6271585|P1|NOT COMPLETED|Overall Study||0
2558480|NCT00508196|6271584|P2|COMPLETED|Overall Study||11
2558481|NCT00508196|6271585|P1|COMPLETED|Overall Study||11
2558482|NCT00508196|6271584|P2|STARTED|Overall Study||11
2558483|NCT00508196|6271585|P1|STARTED|Overall Study||11
2558484|NCT00508183|6271597|P2|NOT COMPLETED|Overall Study||8
2558485|NCT00508183|6271598|P1|NOT COMPLETED|Overall Study||9
2558486|NCT00508183|6271597|P2|COMPLETED|Overall Study||34
2558487|NCT00508183|6271598|P1|COMPLETED|Overall Study||39
2558488|NCT00508183|6271597|P2|STARTED|Overall Study||42
2558489|NCT00508183|6271598|P1|STARTED|Overall Study||48
2558490|NCT00508157|6271614|P2|NOT COMPLETED|Overall Study||3
2558491|NCT00508157|6271615|P1|NOT COMPLETED|Overall Study||2
2558492|NCT00508157|6271614|P2|COMPLETED|Overall Study||23
2558493|NCT00508157|6271615|P1|COMPLETED|Overall Study||24
2558494|NCT00508157|6271614|P2|Safety Sample|Overall Study|1 participant was withdrawn from study prior to receiving study drug & excluded from safety sample.|25
2558495|NCT00508157|6271615|P1|Safety Sample|Overall Study||26
2558496|NCT00508157|6271614|P2|Randomized Sample|Overall Study||26
2558497|NCT00508157|6271615|P1|Randomized Sample|Overall Study||26
2558498|NCT00508157|6271614|P2|STARTED|Overall Study||26
2558499|NCT00508157|6271615|P1|STARTED|Overall Study||26
2558500|NCT00508144|6271637|P1|NOT COMPLETED|Overall Study||11
2558501|NCT00508144|6271637|P1|COMPLETED|Overall Study||53
2558502|NCT00508144|6271637|P1|STARTED|Overall Study||64
2558503|NCT00508118|6271643|P2|NOT COMPLETED|Overall Study||0
2558504|NCT00508118|6271644|P1|NOT COMPLETED|Overall Study||0
2558505|NCT00508118|6271643|P2|COMPLETED|Overall Study||4
2558506|NCT00508118|6271644|P1|COMPLETED|Overall Study||3
2558507|NCT00508118|6271643|P2|STARTED|Overall Study|Documentation is not available for the 7th subject and treatment arm.|4
2558508|NCT00508118|6271644|P1|STARTED|Overall Study||3
2558509|NCT00508027|6271663|P1|NOT COMPLETED|Dose Level 3||0
2558510|NCT00508027|6271663|P1|COMPLETED|Dose Level 3||2
2558511|NCT00508027|6271663|P1|STARTED|Dose Level 3|enrollment discontinued due to FDA recommendations regarding high dose (80mg/day) simvastatin|2
2558512|NCT00508027|6271663|P1|NOT COMPLETED|Dose Level 2||4
2558513|NCT00508027|6271663|P1|COMPLETED|Dose Level 2||16
2558514|NCT00508027|6271663|P1|STARTED|Dose Level 2|The participants starting each dose period is a new cohort of subjects. 20 new subjects in dose 2|20
2558515|NCT00508027|6271663|P1|NOT COMPLETED|Dose Level 1||8
2558516|NCT00508027|6271663|P1|COMPLETED|Dose Level 1||12
2558517|NCT00508027|6271663|P1|STARTED|Dose Level 1|The participants starting each dose period is a new cohort of subjects. 20 subjects started dose 1|20
2558518|NCT00508001|6271704|P3|NOT COMPLETED|Overall Study||7
2558519|NCT00508001|6271705|P2|NOT COMPLETED|Overall Study||12
2558520|NCT00508001|6271706|P1|NOT COMPLETED|Overall Study||19
2558521|NCT00508001|6271704|P3|COMPLETED|Overall Study||16
2558522|NCT00508001|6271705|P2|COMPLETED|Overall Study||13
2558523|NCT00508001|6271706|P1|COMPLETED|Overall Study||0
2558524|NCT00508001|6271704|P3|Secondary Treatment Phase|Overall Study||16
2558525|NCT00508001|6271705|P2|Secondary Treatment Phase|Overall Study||13
2558526|NCT00508001|6271706|P1|Secondary Treatment Phase|Overall Study||0
2558527|NCT00508001|6271704|P3|STARTED|Overall Study||23
2558528|NCT00508001|6271705|P2|STARTED|Overall Study||25
2558529|NCT00508001|6271706|P1|STARTED|Overall Study||19
2558530|NCT00507819|6271723|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
2558531|NCT00507819|6271724|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
2558532|NCT00507819|6271723|P2|COMPLETED|Second Intervention (6 Weeks)||14
2558533|NCT00507819|6271724|P1|COMPLETED|Second Intervention (6 Weeks)||13
2558534|NCT00507819|6271723|P2|STARTED|Second Intervention (6 Weeks)||14
2558535|NCT00507819|6271724|P1|STARTED|Second Intervention (6 Weeks)||13
2558536|NCT00507819|6271723|P2|NOT COMPLETED|Washout (6 Weeks)||0
2558537|NCT00507819|6271724|P1|NOT COMPLETED|Washout (6 Weeks)||1
2558538|NCT00507819|6271723|P2|COMPLETED|Washout (6 Weeks)||14
2558539|NCT00507819|6271724|P1|COMPLETED|Washout (6 Weeks)||13
2558540|NCT00507819|6271723|P2|STARTED|Washout (6 Weeks)||14
2558541|NCT00507819|6271724|P1|STARTED|Washout (6 Weeks)||14
2558542|NCT00507819|6271723|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
2558543|NCT00507819|6271724|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
2558544|NCT00507819|6271723|P2|COMPLETED|First Intervention (6 Weeks)||14
2558545|NCT00507819|6271724|P1|COMPLETED|First Intervention (6 Weeks)||14
2558546|NCT00507819|6271723|P2|STARTED|First Intervention (6 Weeks)||14
2558547|NCT00507819|6271724|P1|STARTED|First Intervention (6 Weeks)||14
2558548|NCT00507767|6271736|P1|NOT COMPLETED|Overall Study||0
2558549|NCT00507767|6271736|P1|COMPLETED|Overall Study||15
2558550|NCT00507767|6271736|P1|STARTED|Overall Study||15
2558551|NCT00507689|6271743|P2|NOT COMPLETED|Randomized Period||2
2558552|NCT00507689|6271744|P1|NOT COMPLETED|Randomized Period||1
2558553|NCT00507689|6271743|P2|COMPLETED|Randomized Period||16
2558554|NCT00507689|6271744|P1|COMPLETED|Randomized Period||18
2558555|NCT00507689|6271743|P2|STARTED|Randomized Period|18 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF.|18
2558556|NCT00507689|6271744|P1|STARTED|Randomized Period|19 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF+HBIg.|19
2558557|NCT00507689|6271743|P2|NOT COMPLETED|Pre-Randomization Period||0
2558558|NCT00507689|6271744|P1|NOT COMPLETED|Pre-Randomization Period||3
2558559|NCT00507689|6271743|P2|COMPLETED|Pre-Randomization Period||0
2558560|NCT00507689|6271744|P1|COMPLETED|Pre-Randomization Period||37
2558561|NCT00507689|6271743|P2|STARTED|Pre-Randomization Period||0
2558562|NCT00507689|6271744|P1|STARTED|Pre-Randomization Period||40
2558563|NCT00507559|6271761|P1|NOT COMPLETED|Overall Study||71
2558564|NCT00507559|6271761|P1|COMPLETED|Overall Study||84
2558565|NCT00507559|6271761|P1|STARTED|Overall Study||155
2558566|NCT00507546|6271776|P2|NOT COMPLETED|Overall Study||1
2558567|NCT00507546|6271777|P1|NOT COMPLETED|Overall Study||2
2558568|NCT00507546|6271776|P2|COMPLETED|Overall Study||3
2558569|NCT00507546|6271777|P1|COMPLETED|Overall Study||2
2558570|NCT00507546|6271776|P2|STARTED|Overall Study||4
2558571|NCT00507546|6271777|P1|STARTED|Overall Study||4
2558572|NCT00507507|6271787|P2|NOT COMPLETED|24-week Treatment-free Follow-up Period||17
2558573|NCT00507507|6271788|P1|NOT COMPLETED|24-week Treatment-free Follow-up Period||10
2558574|NCT00507507|6271787|P2|COMPLETED|24-week Treatment-free Follow-up Period||12
2558575|NCT00507507|6271788|P1|COMPLETED|24-week Treatment-free Follow-up Period||16
2558576|NCT00507507|6271787|P2|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|29
2558577|NCT00507507|6271788|P1|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|26
2558578|NCT00507507|6271787|P2|NOT COMPLETED|Treatment Period||53
2558579|NCT00507507|6271788|P1|NOT COMPLETED|Treatment Period||52
2558580|NCT00507507|6271787|P2|COMPLETED|Treatment Period||9
2558581|NCT00507507|6271788|P1|COMPLETED|Treatment Period||12
2558582|NCT00507507|6271787|P2|Completed 192 Weeks of Treatment|Treatment Period||52
2558583|NCT00507507|6271788|P1|Completed 192 Weeks of Treatment|Treatment Period||52
2558584|NCT00507507|6271787|P2|STARTED|Treatment Period||62
2558585|NCT00507507|6271788|P1|STARTED|Treatment Period||64
2558586|NCT00507455|6271823|P3|NOT COMPLETED|Overall Study||12
2558587|NCT00507455|6271824|P2|NOT COMPLETED|Overall Study||6
2558588|NCT00507455|6271825|P1|NOT COMPLETED|Overall Study||12
2558589|NCT00507455|6271823|P3|COMPLETED|Overall Study||62
2558590|NCT00507455|6271824|P2|COMPLETED|Overall Study||68
2558591|NCT00507455|6271825|P1|COMPLETED|Overall Study||62
2558592|NCT00507455|6271823|P3|STARTED|Overall Study||74
2558593|NCT00507455|6271824|P2|STARTED|Overall Study||74
2558594|NCT00507455|6271825|P1|STARTED|Overall Study||74
2558595|NCT00507442|6271888|P4|NOT COMPLETED|Overall Study||5
2558596|NCT00507442|6271889|P3|NOT COMPLETED|Overall Study||15
2558597|NCT00507442|6271890|P2|NOT COMPLETED|Overall Study||27
2558598|NCT00507442|6271891|P1|NOT COMPLETED|Overall Study||16
2558599|NCT00507442|6271888|P4|COMPLETED|Overall Study||12
2558600|NCT00507442|6271889|P3|COMPLETED|Overall Study||18
2558601|NCT00507442|6271890|P2|COMPLETED|Overall Study||39
2558602|NCT00507442|6271891|P1|COMPLETED|Overall Study||26
2558603|NCT00507442|6271888|P4|STARTED|Overall Study||17
2558604|NCT00507442|6271889|P3|STARTED|Overall Study||33
2558605|NCT00507442|6271890|P2|STARTED|Overall Study||66
2558606|NCT00507442|6271891|P1|STARTED|Overall Study||42
2558607|NCT00507429|6271943|P2|NOT COMPLETED|Maintenance Phase||0
2558608|NCT00507429|6271944|P1|NOT COMPLETED|Maintenance Phase||14
2558609|NCT00507429|6271943|P2|COMPLETED|Maintenance Phase||0
2558610|NCT00507429|6271944|P1|COMPLETED|Maintenance Phase|14 subjects were withdrawn due to progressive disease, 2 subjects continued beyond data cut-off|2
2558611|NCT00507429|6271943|P2|STARTED|Maintenance Phase|Control arm subjects followed for survival only; not enrolled in Maintenance period|0
2558612|NCT00507429|6271944|P1|STARTED|Maintenance Phase|2 subjects did not enter maintenance: 1/18 progressive disease; 1/18 lost to follow-up.|16
2558613|NCT00507429|6271943|P2|NOT COMPLETED|Treatment Phase||18
2558614|NCT00507429|6271944|P1|NOT COMPLETED|Treatment Phase||37
2558615|NCT00507429|6271943|P2|COMPLETED|Treatment Phase||7
2558616|NCT00507429|6271944|P1|COMPLETED|Treatment Phase||18
2558617|NCT00507429|6271943|P2|STARTED|Treatment Phase|Randomized|25
2558618|NCT00507429|6271944|P1|STARTED|Treatment Phase|Randomized|55
2558619|NCT00507416|6271955|P3|NOT COMPLETED|Overall Study||114
2558620|NCT00507416|6271956|P2|NOT COMPLETED|Overall Study||125
2558621|NCT00507416|6271957|P1|NOT COMPLETED|Overall Study||118
2558622|NCT00507416|6271955|P3|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|53
2558623|NCT00507416|6271956|P2|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|42
2558624|NCT00507416|6271957|P1|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|50
2558625|NCT00507416|6271955|P3|Completed 8 Treatment Cycles|Overall Study||69
2558626|NCT00507416|6271956|P2|Completed 8 Treatment Cycles|Overall Study||60
2558627|NCT00507416|6271957|P1|Completed 8 Treatment Cycles|Overall Study||82
2558628|NCT00507416|6271955|P3|Treated (Safety Population)|Overall Study||163
2558629|NCT00507416|6271956|P2|Treated (Safety Population)|Overall Study||158
2558630|NCT00507416|6271957|P1|Treated (Safety Population)|Overall Study||165
2558631|NCT00507416|6271955|P3|STARTED|Overall Study||167
2558632|NCT00507416|6271956|P2|STARTED|Overall Study||167
2558633|NCT00507416|6271957|P1|STARTED|Overall Study||168
2558634|NCT00507208|6271988|P2|NOT COMPLETED|Overall Study||0
2558635|NCT00507208|6271989|P1|NOT COMPLETED|Overall Study||0
2558636|NCT00507208|6271988|P2|COMPLETED|Overall Study||26
2558637|NCT00507208|6271989|P1|COMPLETED|Overall Study||27
2558638|NCT00507208|6271988|P2|Received Dynasplint in Crossover|Overall Study||3
2558639|NCT00507208|6271989|P1|Received Dynasplint in Crossover|Overall Study||0
2558640|NCT00507208|6271988|P2|STARTED|Overall Study||26
2558641|NCT00507208|6271989|P1|STARTED|Overall Study||27
2558642|NCT00507130|6271999|P4|NOT COMPLETED|Overall Study||1
2558643|NCT00507130|6272000|P3|NOT COMPLETED|Overall Study||1
2558644|NCT00507130|6272001|P2|NOT COMPLETED|Overall Study||0
2558645|NCT00507130|6272002|P1|NOT COMPLETED|Overall Study||1
2558646|NCT00507130|6271999|P4|COMPLETED|Overall Study||8
2558647|NCT00507130|6272000|P3|COMPLETED|Overall Study||8
2558648|NCT00507130|6272001|P2|COMPLETED|Overall Study||9
2558649|NCT00507130|6272002|P1|COMPLETED|Overall Study||8
2558650|NCT00507130|6271999|P4|STARTED|Overall Study||9
2558651|NCT00507130|6272000|P3|STARTED|Overall Study||9
2558652|NCT00507130|6272001|P2|STARTED|Overall Study||9
2558653|NCT00507130|6272002|P1|STARTED|Overall Study||9
2558654|NCT00506948|6272044|P1|NOT COMPLETED|Overall Study||10
2558655|NCT00506948|6272044|P1|COMPLETED|Overall Study||0
2558656|NCT00506948|6272044|P1|STARTED|Overall Study||10
2558657|NCT00506922|6272053|P5|NOT COMPLETED|Overall Study||1
2558658|NCT00506922|6272054|P4|NOT COMPLETED|Overall Study||2
2558659|NCT00506922|6272055|P3|NOT COMPLETED|Overall Study||0
2558660|NCT00506922|6272056|P2|NOT COMPLETED|Overall Study||0
2558661|NCT00506922|6272057|P1|NOT COMPLETED|Overall Study||0
2558662|NCT00506922|6272053|P5|COMPLETED|Overall Study||10
2558663|NCT00506922|6272054|P4|COMPLETED|Overall Study||61
2558664|NCT00506922|6272055|P3|COMPLETED|Overall Study||29
2558665|NCT00506922|6272056|P2|COMPLETED|Overall Study||10
2558666|NCT00506922|6272057|P1|COMPLETED|Overall Study||37
2558667|NCT00506922|6272053|P5|STARTED|Overall Study||11
2558668|NCT00506922|6272054|P4|STARTED|Overall Study||63
2558669|NCT00506922|6272055|P3|STARTED|Overall Study||29
2558670|NCT00506922|6272056|P2|STARTED|Overall Study||10
2558671|NCT00506922|6272057|P1|STARTED|Overall Study||37
2558672|NCT00506909|6272065|P1|NOT COMPLETED|Overall Study||0
2558673|NCT00506909|6272065|P1|COMPLETED|Overall Study||0
2558674|NCT00506909|6272065|P1|STARTED|Overall Study||0
2558675|NCT00506883|6272084|P3|NOT COMPLETED|Overall Study||4
2558676|NCT00506883|6272085|P2|NOT COMPLETED|Overall Study||3
2558677|NCT00506883|6272086|P1|NOT COMPLETED|Overall Study||7
2558678|NCT00506883|6272084|P3|COMPLETED|Overall Study||55
2558679|NCT00506883|6272085|P2|COMPLETED|Overall Study||71
2558680|NCT00506883|6272086|P1|COMPLETED|Overall Study||45
2558681|NCT00506883|6272084|P3|STARTED|Overall Study||59
2558682|NCT00506883|6272085|P2|STARTED|Overall Study||74
2558683|NCT00506883|6272086|P1|STARTED|Overall Study||52
2558684|NCT00506857|6272094|P1|NOT COMPLETED|Overall Study||0
2558685|NCT00506857|6272094|P1|COMPLETED|Overall Study||80
2558686|NCT00506857|6272094|P1|STARTED|Overall Study||80
2558687|NCT00506831|6272099|P1|NOT COMPLETED|Overall Study||2
2558688|NCT00506831|6272099|P1|COMPLETED|Overall Study||7
2558689|NCT00506831|6272099|P1|STARTED|Overall Study||9
2558690|NCT00506753|6272112|P2|NOT COMPLETED|Overall Study||15
2558691|NCT00506753|6272113|P1|NOT COMPLETED|Overall Study||21
2558692|NCT00506753|6272112|P2|COMPLETED|Overall Study||84
2558693|NCT00506753|6272113|P1|COMPLETED|Overall Study||79
2558694|NCT00506753|6272112|P2|STARTED|Overall Study||99
2558695|NCT00506753|6272113|P1|STARTED|Overall Study||100
2558696|NCT00506714|6272125|P2|NOT COMPLETED|Overall Study||0
2558697|NCT00506714|6272126|P1|NOT COMPLETED|Overall Study||0
2558698|NCT00506714|6272125|P2|COMPLETED|Overall Study||13
2558699|NCT00506714|6272126|P1|COMPLETED|Overall Study||13
2558700|NCT00506714|6272125|P2|STARTED|Overall Study||13
2558701|NCT00506714|6272126|P1|STARTED|Overall Study||13
2558702|NCT00506675|6272136|P2|NOT COMPLETED|Overall Study||0
2558703|NCT00506675|6272137|P1|NOT COMPLETED|Overall Study||0
2558704|NCT00506675|6272136|P2|COMPLETED|Overall Study||28
2558705|NCT00506675|6272137|P1|COMPLETED|Overall Study||27
2558706|NCT00506675|6272136|P2|STARTED|Overall Study||28
2558707|NCT00506675|6272137|P1|STARTED|Overall Study||27
2558708|NCT00506662|6272151|P2|NOT COMPLETED|Overall Study||28
2558709|NCT00506662|6272152|P1|NOT COMPLETED|Overall Study||17
2558710|NCT00506662|6272151|P2|COMPLETED|Overall Study||20
2558711|NCT00506662|6272152|P1|COMPLETED|Overall Study||21
2558712|NCT00506662|6272151|P2|STARTED|Overall Study||48
2558713|NCT00506662|6272152|P1|STARTED|Overall Study||38
2558714|NCT00506597|6272182|P1|NOT COMPLETED|Overall Study||0
2558715|NCT00506597|6272182|P1|COMPLETED|Overall Study||33
2558716|NCT00506597|6272182|P1|STARTED|Overall Study||33
2558717|NCT00506493|6272186|P1|NOT COMPLETED|Overall Study||11
2558718|NCT00506493|6272186|P1|COMPLETED|Overall Study||64
2558719|NCT00506493|6272186|P1|STARTED|Overall Study||75
2558720|NCT00506454|6272195|P2|NOT COMPLETED|Overall Study||1
2558721|NCT00506454|6272196|P1|NOT COMPLETED|Overall Study||1
2558722|NCT00506454|6272195|P2|COMPLETED|Overall Study||10
2558723|NCT00506454|6272196|P1|COMPLETED|Overall Study||10
2558724|NCT00506454|6272195|P2|STARTED|Overall Study||11
2558725|NCT00506454|6272196|P1|STARTED|Overall Study||11
2558726|NCT00506441|6272202|P2|NOT COMPLETED|Period 2; Double-blind Period||5
2558727|NCT00506441|6272203|P1|NOT COMPLETED|Period 2; Double-blind Period||3
2558728|NCT00506441|6272202|P2|COMPLETED|Period 2; Double-blind Period||79
2558729|NCT00506441|6272203|P1|COMPLETED|Period 2; Double-blind Period||82
2558730|NCT00506441|6272202|P2|STARTED|Period 2; Double-blind Period||84
2558731|NCT00506441|6272203|P1|STARTED|Period 2; Double-blind Period||85
2558732|NCT00506441|6272202|P2|NOT COMPLETED|Period 1; Open-label Period||0
2558733|NCT00506441|6272203|P1|NOT COMPLETED|Period 1; Open-label Period||76
2558734|NCT00506441|6272202|P2|COMPLETED|Period 1; Open-label Period||0
2558735|NCT00506441|6272203|P1|COMPLETED|Period 1; Open-label Period||169
2558736|NCT00506441|6272202|P2|STARTED|Period 1; Open-label Period||0
2558737|NCT00506441|6272203|P1|STARTED|Period 1; Open-label Period||245
2558738|NCT00506415|6272211|P4|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||62
2558739|NCT00506415|6272212|P3|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
2558740|NCT00506415|6272213|P2|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
2558741|NCT00506415|6272214|P1|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
2558742|NCT00506415|6272211|P4|COMPLETED|Extended Open Label (Maximum 48 Weeks)||395
2558743|NCT00506415|6272212|P3|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
2558744|NCT00506415|6272213|P2|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
2558745|NCT00506415|6272214|P1|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
2558746|NCT00506415|6272211|P4|STARTED|Extended Open Label (Maximum 48 Weeks)|Two participants did not receive study drug, hence excluded from this arm.|457
2558747|NCT00506415|6272212|P3|STARTED|Extended Open Label (Maximum 48 Weeks)||0
2558748|NCT00506415|6272213|P2|STARTED|Extended Open Label (Maximum 48 Weeks)||0
2558749|NCT00506415|6272214|P1|STARTED|Extended Open Label (Maximum 48 Weeks)||0
2558750|NCT00506415|6272211|P4|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
2558751|NCT00506415|6272212|P3|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||73
2558752|NCT00506415|6272213|P2|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||83
2558753|NCT00506415|6272214|P1|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
2558754|NCT00506415|6272211|P4|COMPLETED|Double Blind (Maximum 48 Weeks )||0
2558755|NCT00506415|6272212|P3|COMPLETED|Double Blind (Maximum 48 Weeks )||207
2558756|NCT00506415|6272213|P2|COMPLETED|Double Blind (Maximum 48 Weeks )||203
2558757|NCT00506415|6272214|P1|COMPLETED|Double Blind (Maximum 48 Weeks )||0
2558758|NCT00506415|6272211|P4|STARTED|Double Blind (Maximum 48 Weeks )||0
2558759|NCT00506415|6272212|P3|STARTED|Double Blind (Maximum 48 Weeks )||280
2558760|NCT00506415|6272213|P2|STARTED|Double Blind (Maximum 48 Weeks )|1 patient was randomized in error and did not receive study drug, hence excluded from this arm.|286
2558761|NCT00506415|6272214|P1|STARTED|Double Blind (Maximum 48 Weeks )||0
2558762|NCT00506415|6272211|P4|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
2558763|NCT00506415|6272212|P3|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
2558764|NCT00506415|6272213|P2|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
2558765|NCT00506415|6272214|P1|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||499
2558766|NCT00506415|6272211|P4|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
2558767|NCT00506415|6272212|P3|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
2558768|NCT00506415|6272213|P2|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
2558769|NCT00506415|6272214|P1|COMPLETED|Initial Open Label (Maximum 48 Weeks)||1085
2558770|NCT00506415|6272211|P4|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
2558771|NCT00506415|6272212|P3|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
2558772|NCT00506415|6272213|P2|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
2558773|NCT00506415|6272214|P1|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||1582
2558774|NCT00506415|6272211|P4|STARTED|Initial Open Label (Maximum 48 Weeks)||0
2558775|NCT00506415|6272212|P3|STARTED|Initial Open Label (Maximum 48 Weeks)||0
2558776|NCT00506415|6272213|P2|STARTED|Initial Open Label (Maximum 48 Weeks)||0
2558777|NCT00506415|6272214|P1|STARTED|Initial Open Label (Maximum 48 Weeks)|Enrolled patients.|1584
2558778|NCT00506389|6272239|P3|NOT COMPLETED|Follow-up Period||0
2558779|NCT00506389|6272240|P2|NOT COMPLETED|Follow-up Period||0
2558780|NCT00506389|6272241|P1|NOT COMPLETED|Follow-up Period||0
2558781|NCT00506389|6272239|P3|COMPLETED|Follow-up Period||136
2558782|NCT00506389|6272240|P2|COMPLETED|Follow-up Period||138
2558783|NCT00506389|6272241|P1|COMPLETED|Follow-up Period||139
2558784|NCT00506389|6272239|P3|STARTED|Follow-up Period|11 participants who discontinued treatment entered the Follow-up Period.|136
2558785|NCT00506389|6272240|P2|STARTED|Follow-up Period|14 participants who discontinued treatment entered the Follow-up Period.|138
2558786|NCT00506389|6272241|P1|STARTED|Follow-up Period|22 participants who discontinued treatment entered the Follow-up Period.|139
2558787|NCT00506389|6272239|P3|NOT COMPLETED|In-treatment Period||12
2558788|NCT00506389|6272240|P2|NOT COMPLETED|In-treatment Period||15
2558789|NCT00506389|6272241|P1|NOT COMPLETED|In-treatment Period||26
2558790|NCT00506389|6272239|P3|COMPLETED|In-treatment Period||125
2558791|NCT00506389|6272240|P2|COMPLETED|In-treatment Period||124
2558792|NCT00506389|6272241|P1|COMPLETED|In-treatment Period||117
2558793|NCT00506389|6272239|P3|All Participants Treated|In-treatment Period||136
2558794|NCT00506389|6272240|P2|All Participants Treated|In-treatment Period||138
2558795|NCT00506389|6272241|P1|All Participants Treated|In-treatment Period||139
2558796|NCT00506389|6272239|P3|STARTED|In-treatment Period||137
2558797|NCT00506389|6272240|P2|STARTED|In-treatment Period||139
2558798|NCT00506389|6272241|P1|STARTED|In-treatment Period||143
2558799|NCT00506350|6272267|P9|NOT COMPLETED|Overall Study||5
2558800|NCT00506350|6272268|P8|NOT COMPLETED|Overall Study||5
2558801|NCT00506350|6272269|P7|NOT COMPLETED|Overall Study||2
2558802|NCT00506350|6272270|P6|NOT COMPLETED|Overall Study||2
2558803|NCT00506350|6272271|P5|NOT COMPLETED|Overall Study||10
2558804|NCT00506350|6272272|P4|NOT COMPLETED|Overall Study||2
2558805|NCT00506350|6272273|P3|NOT COMPLETED|Overall Study||6
2558806|NCT00506350|6272274|P2|NOT COMPLETED|Overall Study||3
2558807|NCT00506350|6272275|P1|NOT COMPLETED|Overall Study||3
2558808|NCT00506350|6272267|P9|COMPLETED|Overall Study||30
2558809|NCT00506350|6272268|P8|COMPLETED|Overall Study||36
2558810|NCT00506350|6272269|P7|COMPLETED|Overall Study||33
2558811|NCT00506350|6272270|P6|COMPLETED|Overall Study||38
2558812|NCT00506350|6272271|P5|COMPLETED|Overall Study||40
2558813|NCT00506350|6272272|P4|COMPLETED|Overall Study||34
2558814|NCT00506350|6272273|P3|COMPLETED|Overall Study||31
2558815|NCT00506350|6272274|P2|COMPLETED|Overall Study||37
2558816|NCT00506350|6272275|P1|COMPLETED|Overall Study||33
2558817|NCT00506350|6272267|P9|STARTED|Overall Study||35
2558818|NCT00506350|6272268|P8|STARTED|Overall Study||41
2558819|NCT00506350|6272269|P7|STARTED|Overall Study||35
2558820|NCT00506350|6272270|P6|STARTED|Overall Study||40
2558821|NCT00506350|6272271|P5|STARTED|Overall Study||50
2558822|NCT00506350|6272272|P4|STARTED|Overall Study||36
2558823|NCT00506350|6272273|P3|STARTED|Overall Study||37
2558824|NCT00506350|6272274|P2|STARTED|Overall Study||40
2558825|NCT00506350|6272275|P1|STARTED|Overall Study||36
2558826|NCT00506285|6272422|P2|NOT COMPLETED|6-month Open Label Phase||12
2558827|NCT00506285|6272423|P1|NOT COMPLETED|6-month Open Label Phase||10
2558828|NCT00506285|6272422|P2|COMPLETED|6-month Open Label Phase||19
2558829|NCT00506285|6272423|P1|COMPLETED|6-month Open Label Phase||10
2558830|NCT00506285|6272422|P2|STARTED|6-month Open Label Phase||31
2558831|NCT00506285|6272423|P1|STARTED|6-month Open Label Phase||20
2558832|NCT00506285|6272422|P2|NOT COMPLETED|Double Blind Cross-Over Phase||5
2558833|NCT00506285|6272423|P1|NOT COMPLETED|Double Blind Cross-Over Phase||9
2558834|NCT00506285|6272422|P2|COMPLETED|Double Blind Cross-Over Phase||31
2558835|NCT00506285|6272423|P1|COMPLETED|Double Blind Cross-Over Phase||20
2558836|NCT00506285|6272422|P2|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||31
2558837|NCT00506285|6272423|P1|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||29
2558838|NCT00506285|6272422|P2|STARTED|Double Blind Cross-Over Phase||36
2558839|NCT00506285|6272423|P1|STARTED|Double Blind Cross-Over Phase||29
2558840|NCT00506285|6272422|P2|NOT COMPLETED|3 Week Screening Phase||10
2558841|NCT00506285|6272423|P1|NOT COMPLETED|3 Week Screening Phase||17
2558842|NCT00506285|6272422|P2|COMPLETED|3 Week Screening Phase||36
2558843|NCT00506285|6272423|P1|COMPLETED|3 Week Screening Phase||29
2558844|NCT00506285|6272422|P2|STARTED|3 Week Screening Phase||46
2558845|NCT00506285|6272423|P1|STARTED|3 Week Screening Phase||46
2558846|NCT00506155|6272431|P1|NOT COMPLETED|Overall Study||0
2558847|NCT00506155|6272431|P1|COMPLETED|Overall Study||60
2558848|NCT00506155|6272431|P1|STARTED|Overall Study||60
2558849|NCT00506142|6272438|P2|NOT COMPLETED|Overall Study||19
2558850|NCT00506142|6272439|P1|NOT COMPLETED|Overall Study||35
2558851|NCT00506142|6272438|P2|COMPLETED|Overall Study||0
2558852|NCT00506142|6272439|P1|COMPLETED|Overall Study||0
2558853|NCT00506142|6272438|P2|STARTED|Overall Study||19
2558854|NCT00506142|6272439|P1|STARTED|Overall Study||35
2558855|NCT00506077|6272447|P2|NOT COMPLETED|Treatment Period 2||1
2558856|NCT00506077|6272448|P1|NOT COMPLETED|Treatment Period 2||1
2558857|NCT00506077|6272447|P2|COMPLETED|Treatment Period 2||23
2558858|NCT00506077|6272448|P1|COMPLETED|Treatment Period 2||23
2558859|NCT00506077|6272447|P2|STARTED|Treatment Period 2||24
2558860|NCT00506077|6272448|P1|STARTED|Treatment Period 2||24
2558861|NCT00506077|6272447|P2|NOT COMPLETED|Washout||0
2558862|NCT00506077|6272448|P1|NOT COMPLETED|Washout||0
2558863|NCT00506077|6272447|P2|COMPLETED|Washout||24
2558864|NCT00506077|6272448|P1|COMPLETED|Washout||24
2558865|NCT00506077|6272447|P2|STARTED|Washout||24
2558866|NCT00506077|6272448|P1|STARTED|Washout||24
2558867|NCT00506077|6272447|P2|NOT COMPLETED|Treatment Period 1||3
2558868|NCT00506077|6272448|P1|NOT COMPLETED|Treatment Period 1||4
2558869|NCT00506077|6272447|P2|COMPLETED|Treatment Period 1||24
2558870|NCT00506077|6272448|P1|COMPLETED|Treatment Period 1||24
2558871|NCT00506077|6272447|P2|STARTED|Treatment Period 1||27
2558872|NCT00506077|6272448|P1|STARTED|Treatment Period 1||28
2558873|NCT00506064|6272470|P2|NOT COMPLETED|Overall Study||0
2558874|NCT00506064|6272471|P1|NOT COMPLETED|Overall Study||0
2558875|NCT00506064|6272470|P2|COMPLETED|Overall Study||0
2558876|NCT00506064|6272471|P1|COMPLETED|Overall Study||1
2558877|NCT00506064|6272470|P2|STARTED|Overall Study||0
2558878|NCT00506064|6272471|P1|STARTED|Overall Study||1
2558879|NCT00506025|6272480|P3|NOT COMPLETED|Overall Study||0
2558880|NCT00506025|6272481|P2|NOT COMPLETED|Overall Study||0
2558881|NCT00506025|6272482|P1|NOT COMPLETED|Overall Study||0
2558882|NCT00506025|6272480|P3|COMPLETED|Overall Study||8
2558883|NCT00506025|6272481|P2|COMPLETED|Overall Study||9
2558884|NCT00506025|6272482|P1|COMPLETED|Overall Study||10
2558885|NCT00506025|6272480|P3|STARTED|Overall Study||8
2558886|NCT00506025|6272481|P2|STARTED|Overall Study||9
2558887|NCT00506025|6272482|P1|STARTED|Overall Study||10
2558888|NCT00505934|6272490|P1|NOT COMPLETED|Overall Study||3
2558889|NCT00505934|6272490|P1|COMPLETED|Overall Study||16
2558890|NCT00505934|6272490|P1|STARTED|Overall Study|Of the 23 subjects screened, 19 were enrolled into the study and received levetiracetam IV (LEV IV).|19
2558891|NCT00505921|6272496|P1|NOT COMPLETED|Overall Study||9
2558892|NCT00505921|6272496|P1|COMPLETED|Overall Study||18
2558893|NCT00505921|6272496|P1|STARTED|Overall Study||27
2558894|NCT00505895|6272502|P2|NOT COMPLETED|Overall Study||0
2558895|NCT00505895|6272503|P1|NOT COMPLETED|Overall Study||0
2558896|NCT00505895|6272502|P2|COMPLETED|Overall Study||23
2558897|NCT00505895|6272503|P1|COMPLETED|Overall Study||27
2558898|NCT00505895|6272502|P2|STARTED|Overall Study||23
2558899|NCT00505895|6272503|P1|STARTED|Overall Study||27
2558900|NCT00505778|6272513|P2|NOT COMPLETED|Overall Study||135
2558901|NCT00505778|6272514|P1|NOT COMPLETED|Overall Study||134
2558902|NCT00505778|6272513|P2|COMPLETED|Overall Study||378
2558903|NCT00505778|6272514|P1|COMPLETED|Overall Study||380
2558904|NCT00505778|6272513|P2|Intent to Treat (ITT) Population|Overall Study||511
2558905|NCT00505778|6272514|P1|Intent to Treat (ITT) Population|Overall Study||512
2558906|NCT00505778|6272513|P2|STARTED|Overall Study||513
2558907|NCT00505778|6272514|P1|STARTED|Overall Study||514
2558908|NCT00505765|6272533|P3|NOT COMPLETED|Overall Study||3
2558909|NCT00505765|6272534|P2|NOT COMPLETED|Overall Study||3
2558910|NCT00505765|6272535|P1|NOT COMPLETED|Overall Study||2
2558911|NCT00505765|6272533|P3|COMPLETED|Overall Study||19
2558912|NCT00505765|6272534|P2|COMPLETED|Overall Study||17
2558913|NCT00505765|6272535|P1|COMPLETED|Overall Study||19
2558914|NCT00505765|6272533|P3|Mid-Point Assessment|Overall Study||21
2558915|NCT00505765|6272534|P2|Mid-Point Assessment|Overall Study||19
2558916|NCT00505765|6272535|P1|Mid-Point Assessment|Overall Study||20
2558917|NCT00505765|6272533|P3|STARTED|Overall Study||22
2558918|NCT00505765|6272534|P2|STARTED|Overall Study||20
2558919|NCT00505765|6272535|P1|STARTED|Overall Study||21
2558920|NCT00505752|6272562|P4|NOT COMPLETED|Overall Study||6
2558921|NCT00505752|6272563|P3|NOT COMPLETED|Overall Study||8
2558922|NCT00505752|6272564|P2|NOT COMPLETED|Overall Study||9
2558923|NCT00505752|6272565|P1|NOT COMPLETED|Overall Study||6
2558924|NCT00505752|6272562|P4|COMPLETED|Overall Study||126
2558925|NCT00505752|6272563|P3|COMPLETED|Overall Study||120
2558926|NCT00505752|6272564|P2|COMPLETED|Overall Study||119
2558927|NCT00505752|6272565|P1|COMPLETED|Overall Study||126
2558928|NCT00505752|6272562|P4|STARTED|Overall Study||132
2558929|NCT00505752|6272563|P3|STARTED|Overall Study||128
2558930|NCT00505752|6272564|P2|STARTED|Overall Study||128
2558931|NCT00505752|6272565|P1|STARTED|Overall Study||132
2558932|NCT00505687|6272579|P1|NOT COMPLETED|Overall Study||95
2558933|NCT00505687|6272579|P1|COMPLETED|Overall Study||91
2558934|NCT00505687|6272579|P1|STARTED|Overall Study||186
2558935|NCT00505661|6272585|P1|NOT COMPLETED|Overall Study||4
2558936|NCT00505661|6272585|P1|COMPLETED|Overall Study||12
2558937|NCT00505661|6272585|P1|STARTED|Overall Study||16
2558938|NCT00505635|6272589|P1|NOT COMPLETED|Overall Study||0
2558939|NCT00505635|6272589|P1|COMPLETED|Overall Study||5
2558940|NCT00505635|6272589|P1|STARTED|Overall Study||5
2558941|NCT00505622|6272596|P3|NOT COMPLETED|Overall Study||96
2558942|NCT00505622|6272597|P2|NOT COMPLETED|Overall Study||108
2558943|NCT00505622|6272598|P1|NOT COMPLETED|Overall Study||121
2558944|NCT00505622|6272596|P3|COMPLETED|Overall Study||0
2558945|NCT00505622|6272597|P2|COMPLETED|Overall Study||0
2558946|NCT00505622|6272598|P1|COMPLETED|Overall Study||0
2558947|NCT00505622|6272596|P3|STARTED|Overall Study||96
2558948|NCT00505622|6272597|P2|STARTED|Overall Study||108
2558949|NCT00505622|6272598|P1|STARTED|Overall Study||121
2558950|NCT00505518|6272615|P1|NOT COMPLETED|Overall Study||0
2558951|NCT00505518|6272615|P1|COMPLETED|Overall Study||9
2558952|NCT00505518|6272615|P1|STARTED|Overall Study||9
2558953|NCT00505414|6272623|P5|NOT COMPLETED|Maintenance Phase||0
2558954|NCT00505414|6272624|P4|NOT COMPLETED|Maintenance Phase||0
2558955|NCT00505414|6272625|P3|NOT COMPLETED|Maintenance Phase||8
2558956|NCT00505414|6272626|P2|NOT COMPLETED|Maintenance Phase||5
2558957|NCT00505414|6272627|P1|NOT COMPLETED|Maintenance Phase||6
2558958|NCT00505414|6272623|P5|COMPLETED|Maintenance Phase||0
2558959|NCT00505414|6272624|P4|COMPLETED|Maintenance Phase||0
2558960|NCT00505414|6272625|P3|COMPLETED|Maintenance Phase||6
2558961|NCT00505414|6272626|P2|COMPLETED|Maintenance Phase||10
2558962|NCT00505414|6272627|P1|COMPLETED|Maintenance Phase||12
2558963|NCT00505414|6272623|P5|Did Not Qualify for Maintenance Phase|Maintenance Phase||1
2558964|NCT00505414|6272624|P4|Did Not Qualify for Maintenance Phase|Maintenance Phase||3
2558965|NCT00505414|6272625|P3|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
2558966|NCT00505414|6272626|P2|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
2558967|NCT00505414|6272627|P1|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
2558968|NCT00505414|6272623|P5|STARTED|Maintenance Phase|18 of 19 participants completing the morphine titration phase were continued on morphine.|0
2558969|NCT00505414|6272624|P4|STARTED|Maintenance Phase|29 of 32 participants were treated in the maintenance phase either with placebo or tapentadol|0
2558970|NCT00505414|6272625|P3|STARTED|Maintenance Phase|14 of 32 tapentadol titration participants were treated with placebo in the maintenance phase.|14
2558971|NCT00505414|6272626|P2|STARTED|Maintenance Phase|15 of 32 tapentadol titration participants continued with tapentadol in the maintenance phase|15
2558972|NCT00505414|6272627|P1|STARTED|Maintenance Phase|18 of the 19 morphine participants continued with morphine in the maintenance phase.|18
2558973|NCT00505414|6272623|P5|NOT COMPLETED|Titration Phase||12
2558974|NCT00505414|6272624|P4|NOT COMPLETED|Titration Phase||30
2558975|NCT00505414|6272625|P3|NOT COMPLETED|Titration Phase||0
2558976|NCT00505414|6272626|P2|NOT COMPLETED|Titration Phase||0
2558977|NCT00505414|6272627|P1|NOT COMPLETED|Titration Phase||0
2558978|NCT00505414|6272623|P5|COMPLETED|Titration Phase||19
2558979|NCT00505414|6272624|P4|COMPLETED|Titration Phase||32
2558980|NCT00505414|6272625|P3|COMPLETED|Titration Phase||0
2558981|NCT00505414|6272626|P2|COMPLETED|Titration Phase||0
2558982|NCT00505414|6272627|P1|COMPLETED|Titration Phase||0
2558983|NCT00505414|6272623|P5|STARTED|Titration Phase||31
2558984|NCT00505414|6272624|P4|STARTED|Titration Phase||62
2558985|NCT00505414|6272625|P3|STARTED|Titration Phase||0
2558986|NCT00505414|6272626|P2|STARTED|Titration Phase||0
2558987|NCT00505414|6272627|P1|STARTED|Titration Phase||0
2558988|NCT00505375|6272644|P2|NOT COMPLETED|Overall Study||5
2558989|NCT00505375|6272645|P1|NOT COMPLETED|Overall Study||4
2558990|NCT00505375|6272644|P2|COMPLETED|Overall Study||30
2558991|NCT00505375|6272645|P1|COMPLETED|Overall Study||73
2558992|NCT00505375|6272644|P2|STARTED|Overall Study||35
2558993|NCT00505375|6272645|P1|STARTED|Overall Study||77
2558994|NCT00505362|6272653|P2|NOT COMPLETED|Overall Study||0
2558995|NCT00505362|6272654|P1|NOT COMPLETED|Overall Study||0
2558996|NCT00505362|6272653|P2|COMPLETED|Overall Study||28
2558997|NCT00505362|6272654|P1|COMPLETED|Overall Study||35
2558998|NCT00505362|6272653|P2|STARTED|Overall Study||28
2558999|NCT00505362|6272654|P1|STARTED|Overall Study||35
2559000|NCT00505284|6272667|P5|NOT COMPLETED|Overall Study||33
2559001|NCT00505284|6272668|P4|NOT COMPLETED|Overall Study||19
2559002|NCT00505284|6272669|P3|NOT COMPLETED|Overall Study||12
2559003|NCT00505284|6272670|P2|NOT COMPLETED|Overall Study||16
2559004|NCT00505284|6272671|P1|NOT COMPLETED|Overall Study||10
2559005|NCT00505284|6272667|P5|COMPLETED|Overall Study||37
2559006|NCT00505284|6272668|P4|COMPLETED|Overall Study||49
2559007|NCT00505284|6272669|P3|COMPLETED|Overall Study||57
2559008|NCT00505284|6272670|P2|COMPLETED|Overall Study||56
2559009|NCT00505284|6272671|P1|COMPLETED|Overall Study||63
2559010|NCT00505284|6272667|P5|STARTED|Overall Study||70
2559011|NCT00505284|6272668|P4|STARTED|Overall Study||68
2559012|NCT00505284|6272669|P3|STARTED|Overall Study||69
2559013|NCT00505284|6272670|P2|STARTED|Overall Study||72
2559014|NCT00505284|6272671|P1|STARTED|Overall Study||73
2559015|NCT00505076|6272741|P3|NOT COMPLETED|Overall Study||5
2559016|NCT00505076|6272742|P2|NOT COMPLETED|Overall Study||2
2559017|NCT00505076|6272743|P1|NOT COMPLETED|Overall Study||3
2559018|NCT00505076|6272741|P3|COMPLETED|Overall Study||17
2559019|NCT00505076|6272742|P2|COMPLETED|Overall Study||17
2559020|NCT00505076|6272743|P1|COMPLETED|Overall Study||19
2559021|NCT00505076|6272741|P3|STARTED|Overall Study||22
2559022|NCT00505076|6272742|P2|STARTED|Overall Study||19
2559023|NCT00505076|6272743|P1|STARTED|Overall Study||22
2559024|NCT00504985|6272757|P1|NOT COMPLETED|Overall Study||0
2559025|NCT00504985|6272757|P1|COMPLETED|Overall Study||14
2559026|NCT00504985|6272757|P1|STARTED|Overall Study||14
2559027|NCT00504894|6272763|P2|NOT COMPLETED|Overall Study||0
2559028|NCT00504894|6272764|P1|NOT COMPLETED|Overall Study||0
2559029|NCT00504894|6272763|P2|COMPLETED|Overall Study||18
2559030|NCT00504894|6272764|P1|COMPLETED|Overall Study||17
2559031|NCT00504894|6272763|P2|STARTED|Overall Study||18
2559032|NCT00504894|6272764|P1|STARTED|Overall Study||17
2559033|NCT00504881|6272772|P2|NOT COMPLETED|Overall Study||36
2559034|NCT00504881|6272773|P1|NOT COMPLETED|Overall Study||10
2559035|NCT00504881|6272772|P2|COMPLETED|Overall Study||323
2559036|NCT00504881|6272773|P1|COMPLETED|Overall Study||111
2559037|NCT00504881|6272772|P2|STARTED|Overall Study||359
2559038|NCT00504881|6272773|P1|STARTED|Overall Study||121
2559048|NCT00504777|6272837|P1|NOT COMPLETED|Overall Study||1
2559049|NCT00504777|6272837|P1|COMPLETED|Overall Study||35
2559050|NCT00504777|6272837|P1|STARTED|Overall Study||36
2559051|NCT00504751|6272844|P1|NOT COMPLETED|Overall Study||0
2559052|NCT00504751|6272844|P1|COMPLETED|Overall Study||15
2559053|NCT00504751|6272844|P1|STARTED|Overall Study||15
2559054|NCT00504725|6272850|P2|NOT COMPLETED|Overall Study||0
2559055|NCT00504725|6272851|P1|NOT COMPLETED|Overall Study||1
2559056|NCT00504725|6272850|P2|COMPLETED|Overall Study||20
2559057|NCT00504725|6272851|P1|COMPLETED|Overall Study|Prior to unblinding, one subject was discontinued due to elevated CRP levels at baseline.|20
2559058|NCT00504725|6272850|P2|STARTED|Overall Study||20
2559059|NCT00504725|6272851|P1|STARTED|Overall Study||21
2559060|NCT00504660|6272863|P2|NOT COMPLETED|Overall Study||0
2559061|NCT00504660|6272864|P1|NOT COMPLETED|Overall Study||0
2559062|NCT00504660|6272863|P2|COMPLETED|Overall Study||43
2559063|NCT00504660|6272864|P1|COMPLETED|Overall Study||31
2559064|NCT00504660|6272863|P2|STARTED|Overall Study||43
2559065|NCT00504660|6272864|P1|STARTED|Overall Study||31
2559066|NCT00504595|6272874|P4|NOT COMPLETED|Overall Study||0
2559067|NCT00504595|6272875|P3|NOT COMPLETED|Overall Study||2
2559068|NCT00504595|6272876|P2|NOT COMPLETED|Overall Study||0
2559069|NCT00504595|6272877|P1|NOT COMPLETED|Overall Study||1
2559070|NCT00504595|6272874|P4|COMPLETED|Overall Study||10
2559071|NCT00504595|6272875|P3|COMPLETED|Overall Study||8
2559072|NCT00504595|6272876|P2|COMPLETED|Overall Study||10
2559073|NCT00504595|6272877|P1|COMPLETED|Overall Study||49
2559074|NCT00504595|6272874|P4|STARTED|Overall Study||10
2559075|NCT00504595|6272875|P3|STARTED|Overall Study||10
2559076|NCT00504595|6272876|P2|STARTED|Overall Study||10
2559077|NCT00504595|6272877|P1|STARTED|Overall Study||50
2559078|NCT00504556|6272894|P5|NOT COMPLETED|Overall Study||25
2559079|NCT00504556|6272895|P4|NOT COMPLETED|Overall Study||128
2559080|NCT00504556|6272896|P3|NOT COMPLETED|Overall Study||31
2559081|NCT00504556|6272897|P2|NOT COMPLETED|Overall Study||38
2559082|NCT00504556|6272898|P1|NOT COMPLETED|Overall Study||35
2559083|NCT00504556|6272894|P5|COMPLETED|Overall Study||226
2559084|NCT00504556|6272895|P4|COMPLETED|Overall Study||52
2559085|NCT00504556|6272896|P3|COMPLETED|Overall Study||204
2559086|NCT00504556|6272897|P2|COMPLETED|Overall Study||207
2559087|NCT00504556|6272898|P1|COMPLETED|Overall Study||200
2559088|NCT00504556|6272894|P5|Pharmacodynamic Analysis Set|Overall Study||244
2559089|NCT00504556|6272895|P4|Pharmacodynamic Analysis Set|Overall Study||170
2559090|NCT00504556|6272896|P3|Pharmacodynamic Analysis Set|Overall Study||228
2559091|NCT00504556|6272897|P2|Pharmacodynamic Analysis Set|Overall Study||236
2559092|NCT00504556|6272898|P1|Pharmacodynamic Analysis Set|Overall Study||230
2559093|NCT00504556|6272894|P5|Per Protocol Analysis Set|Overall Study||250
2559094|NCT00504556|6272895|P4|Per Protocol Analysis Set|Overall Study||180
2559095|NCT00504556|6272896|P3|Per Protocol Analysis Set|Overall Study||234
2559096|NCT00504556|6272897|P2|Per Protocol Analysis Set|Overall Study||243
2559097|NCT00504556|6272898|P1|Per Protocol Analysis Set|Overall Study||235
2559098|NCT00504556|6272894|P5|Safety Analysis Set|Overall Study||250
2559099|NCT00504556|6272895|P4|Safety Analysis Set|Overall Study||180
2559100|NCT00504556|6272896|P3|Safety Analysis Set|Overall Study||234
2559101|NCT00504556|6272897|P2|Safety Analysis Set|Overall Study||244
2559102|NCT00504556|6272898|P1|Safety Analysis Set|Overall Study||235
2559103|NCT00504556|6272894|P5|STARTED|Overall Study||251
2559104|NCT00504556|6272895|P4|STARTED|Overall Study||180
2559105|NCT00504556|6272896|P3|STARTED|Overall Study||235
2559106|NCT00504556|6272897|P2|STARTED|Overall Study||245
2559107|NCT00504556|6272898|P1|STARTED|Overall Study||235
2559108|NCT00504504|6272958|P1|NOT COMPLETED|Overall Study||0
2559109|NCT00504504|6272958|P1|COMPLETED|Overall Study||82
2559110|NCT00504504|6272958|P1|STARTED|Overall Study||82
2559111|NCT00504426|6272966|P4|NOT COMPLETED|Overall Study||0
2559112|NCT00504426|6272967|P3|NOT COMPLETED|Overall Study||4
2559113|NCT00504426|6272968|P2|NOT COMPLETED|Overall Study||1
2559114|NCT00504426|6272969|P1|NOT COMPLETED|Overall Study||3
2559115|NCT00504426|6272966|P4|COMPLETED|Overall Study||24
2559116|NCT00504426|6272967|P3|COMPLETED|Overall Study||18
2559117|NCT00504426|6272968|P2|COMPLETED|Overall Study||22
2559118|NCT00504426|6272969|P1|COMPLETED|Overall Study||29
2559119|NCT00504426|6272966|P4|STARTED|Overall Study||24
2559120|NCT00504426|6272967|P3|STARTED|Overall Study||22
2559121|NCT00504426|6272968|P2|STARTED|Overall Study||23
2559122|NCT00504426|6272969|P1|STARTED|Overall Study||32
2559123|NCT00504309|6272989|P6|NOT COMPLETED|Overall Study||0
2559124|NCT00504309|6272990|P5|NOT COMPLETED|Overall Study||1
2559125|NCT00504309|6272991|P4|NOT COMPLETED|Overall Study||0
2559126|NCT00504309|6272992|P3|NOT COMPLETED|Overall Study||1
2559127|NCT00504309|6272993|P2|NOT COMPLETED|Overall Study||0
2559128|NCT00504309|6272994|P1|NOT COMPLETED|Overall Study||0
2559129|NCT00504309|6272989|P6|COMPLETED|Overall Study||3
2559130|NCT00504309|6272990|P5|COMPLETED|Overall Study|Participant died during washout after 2nd period|7
2559131|NCT00504309|6272991|P4|COMPLETED|Overall Study||3
2559132|NCT00504309|6272992|P3|COMPLETED|Overall Study|Participant dropped out during second period|1
2559133|NCT00504309|6272993|P2|COMPLETED|Overall Study||5
2559134|NCT00504309|6272994|P1|COMPLETED|Overall Study||7
2559135|NCT00504309|6272989|P6|STARTED|Overall Study||3
2559136|NCT00504309|6272990|P5|STARTED|Overall Study||8
2559137|NCT00504309|6272991|P4|STARTED|Overall Study||3
2559138|NCT00504309|6272992|P3|STARTED|Overall Study||2
2559139|NCT00504309|6272993|P2|STARTED|Overall Study||5
2559140|NCT00504309|6272994|P1|STARTED|Overall Study||7
2559141|NCT00504257|6273032|P1|NOT COMPLETED|Overall Study||4
2559142|NCT00504257|6273032|P1|COMPLETED|Overall Study||41
2559143|NCT00504257|6273032|P1|STARTED|Overall Study||45
2559144|NCT00504231|6273044|P4|NOT COMPLETED|Overall Study||0
2559145|NCT00504231|6273045|P3|NOT COMPLETED|Overall Study||1
2559146|NCT00504231|6273046|P2|NOT COMPLETED|Overall Study||0
2559147|NCT00504231|6273047|P1|NOT COMPLETED|Overall Study||0
2559148|NCT00504231|6273044|P4|COMPLETED|Overall Study||65
2559149|NCT00504231|6273045|P3|COMPLETED|Overall Study||63
2559150|NCT00504231|6273046|P2|COMPLETED|Overall Study||64
2559151|NCT00504231|6273047|P1|COMPLETED|Overall Study||65
2559152|NCT00504231|6273044|P4|STARTED|Overall Study||65
2559153|NCT00504231|6273045|P3|STARTED|Overall Study||64
2559154|NCT00504231|6273046|P2|STARTED|Overall Study||64
2559155|NCT00504231|6273047|P1|STARTED|Overall Study||65
2559156|NCT00504166|6273067|P2|NOT COMPLETED|Overall Study||14
2559157|NCT00504166|6273068|P1|NOT COMPLETED|Overall Study||6
2559158|NCT00504166|6273067|P2|COMPLETED|Overall Study||13
2559159|NCT00504166|6273068|P1|COMPLETED|Overall Study||20
2559160|NCT00504166|6273067|P2|STARTED|Overall Study||27
2559161|NCT00504166|6273068|P1|STARTED|Overall Study||26
2559162|NCT00504153|6273074|P1|NOT COMPLETED|Overall Study||6
2559163|NCT00504153|6273074|P1|COMPLETED|Overall Study||13
2559164|NCT00504153|6273074|P1|STARTED|Overall Study||19
2559165|NCT00504075|6273082|P1|NOT COMPLETED|Overall Study||8
2559166|NCT00504075|6273082|P1|COMPLETED|Overall Study||27
2559167|NCT00504075|6273082|P1|STARTED|Overall Study||35
2559168|NCT00504023|6273088|P1|NOT COMPLETED|Overall Study||0
2559169|NCT00504023|6273088|P1|COMPLETED|Overall Study||8
2559170|NCT00504023|6273088|P1|STARTED|Overall Study||8
2559171|NCT00503997|6273092|P1|NOT COMPLETED|Overall Study||8
2559172|NCT00503997|6273092|P1|COMPLETED|Overall Study||34
2559173|NCT00503997|6273092|P1|STARTED|Overall Study||42
2559174|NCT00503984|6273098|P6|NOT COMPLETED|Overall Study||0
2559175|NCT00503984|6273099|P5|NOT COMPLETED|Overall Study||1
2559176|NCT00503984|6273100|P4|NOT COMPLETED|Overall Study||0
2559177|NCT00503984|6273101|P3|NOT COMPLETED|Overall Study||0
2559178|NCT00503984|6273102|P2|NOT COMPLETED|Overall Study||2
2559179|NCT00503984|6273103|P1|NOT COMPLETED|Overall Study||0
2559180|NCT00503984|6273098|P6|COMPLETED|Overall Study||1
2559181|NCT00503984|6273099|P5|COMPLETED|Overall Study||5
2559182|NCT00503984|6273100|P4|COMPLETED|Overall Study||6
2559183|NCT00503984|6273101|P3|COMPLETED|Overall Study||3
2559184|NCT00503984|6273102|P2|COMPLETED|Overall Study||1
2559185|NCT00503984|6273103|P1|COMPLETED|Overall Study||3
2559186|NCT00503984|6273098|P6|STARTED|Overall Study||1
2559187|NCT00503984|6273099|P5|STARTED|Overall Study||6
2559188|NCT00503984|6273100|P4|STARTED|Overall Study||6
2559189|NCT00503984|6273101|P3|STARTED|Overall Study||3
2559190|NCT00503984|6273102|P2|STARTED|Overall Study||3
2559191|NCT00503984|6273103|P1|STARTED|Overall Study||3
2559192|NCT00503906|6273129|P1|NOT COMPLETED|Overall Study||1
2559193|NCT00503906|6273129|P1|COMPLETED|Overall Study||29
2559194|NCT00503906|6273129|P1|STARTED|Overall Study||30
2559195|NCT00503880|6273138|P5|NOT COMPLETED|Overall Study||0
2559196|NCT00503880|6273139|P4|NOT COMPLETED|Overall Study||0
2559197|NCT00503880|6273140|P3|NOT COMPLETED|Overall Study||0
2559198|NCT00503880|6273141|P2|NOT COMPLETED|Overall Study||0
2559199|NCT00503880|6273142|P1|NOT COMPLETED|Overall Study||2
2559200|NCT00503880|6273138|P5|COMPLETED|Overall Study||0
2559201|NCT00503880|6273139|P4|COMPLETED|Overall Study||0
2559202|NCT00503880|6273140|P3|COMPLETED|Overall Study||0
2559203|NCT00503880|6273141|P2|COMPLETED|Overall Study||0
2559204|NCT00503880|6273142|P1|COMPLETED|Overall Study||0
2559205|NCT00503880|6273138|P5|STARTED|Overall Study||0
2559206|NCT00503880|6273139|P4|STARTED|Overall Study||0
2559207|NCT00503880|6273140|P3|STARTED|Overall Study||0
2559208|NCT00503880|6273141|P2|STARTED|Overall Study||0
2559209|NCT00503880|6273142|P1|STARTED|Overall Study||2
2559210|NCT00503841|6273151|P1|NOT COMPLETED|Overall Study||44
2559211|NCT00503841|6273151|P1|COMPLETED|Overall Study||0
2559212|NCT00503841|6273151|P1|STARTED|Overall Study||44
2559213|NCT00503776|6273162|P4|NOT COMPLETED|Overall Study||2
2559214|NCT00503776|6273163|P3|NOT COMPLETED|Overall Study||2
2559215|NCT00503776|6273164|P2|NOT COMPLETED|Overall Study||0
2559216|NCT00503776|6273165|P1|NOT COMPLETED|Overall Study||1
2559217|NCT00503776|6273162|P4|COMPLETED|Overall Study||8
2559218|NCT00503776|6273163|P3|COMPLETED|Overall Study||10
2559219|NCT00503776|6273164|P2|COMPLETED|Overall Study||12
2559220|NCT00503776|6273165|P1|COMPLETED|Overall Study||7
2559221|NCT00503776|6273162|P4|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|10
2559222|NCT00503776|6273163|P3|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|12
2559223|NCT00503776|6273164|P2|STARTED|Overall Study||12
2559224|NCT00503776|6273165|P1|STARTED|Overall Study||8
2559225|NCT00503750|6273191|P1|NOT COMPLETED|Overall Study||0
2559226|NCT00503750|6273191|P1|COMPLETED|Overall Study||27
2559227|NCT00503750|6273191|P1|STARTED|Overall Study||27
2559228|NCT00503698|6273198|P2|NOT COMPLETED|Overall Study||355
2559229|NCT00503698|6273199|P1|NOT COMPLETED|Overall Study||357
2559230|NCT00503698|6273198|P2|COMPLETED|Overall Study|Trial prematurely terminated|0
2559231|NCT00503698|6273199|P1|COMPLETED|Overall Study|Trial prematurely terminated|0
2559232|NCT00503698|6273198|P2|Exposed to Trial Drug|Overall Study|6 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|349
2559233|NCT00503698|6273199|P1|Exposed to Trial Drug|Overall Study|11 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|346
2559234|NCT00503698|6273198|P2|STARTED|Overall Study|Randomised|355
2559235|NCT00503698|6273199|P1|STARTED|Overall Study|Randomised|357
2559236|NCT00503685|6273216|P3|NOT COMPLETED|Overall Study||2
2559237|NCT00503685|6273217|P2|NOT COMPLETED|Overall Study||3
2559238|NCT00503685|6273218|P1|NOT COMPLETED|Overall Study||0
2559239|NCT00503685|6273216|P3|COMPLETED|Overall Study||18
2559240|NCT00503685|6273217|P2|COMPLETED|Overall Study||19
2559241|NCT00503685|6273218|P1|COMPLETED|Overall Study||23
2559242|NCT00503685|6273216|P3|Received at Least 1 Dose of Study Drug|Overall Study||20
2559243|NCT00503685|6273217|P2|Received at Least 1 Dose of Study Drug|Overall Study||21
2559244|NCT00503685|6273218|P1|Received at Least 1 Dose of Study Drug|Overall Study||23
2559245|NCT00503685|6273216|P3|STARTED|Overall Study||20
2559246|NCT00503685|6273217|P2|STARTED|Overall Study||22
2559247|NCT00503685|6273218|P1|STARTED|Overall Study||23
2559248|NCT00503425|6273260|P1|NOT COMPLETED|Overall Study||54
2559249|NCT00503425|6273260|P1|COMPLETED|Overall Study||161
2559250|NCT00503425|6273260|P1|STARTED|Overall Study||215
2559251|NCT00503399|6273270|P2|NOT COMPLETED|Overall Study||8
2559252|NCT00503399|6273271|P1|NOT COMPLETED|Overall Study||7
2559253|NCT00503399|6273270|P2|COMPLETED|Overall Study||39
2559254|NCT00503399|6273271|P1|COMPLETED|Overall Study||38
2559255|NCT00503399|6273270|P2|STARTED|Overall Study||47
2559256|NCT00503399|6273271|P1|STARTED|Overall Study||45
2559257|NCT00503308|6273295|P2|NOT COMPLETED|Overall Study||1
2559258|NCT00503308|6273296|P1|NOT COMPLETED|Overall Study||2
2559259|NCT00503308|6273295|P2|COMPLETED|Overall Study||134
2559260|NCT00503308|6273296|P1|COMPLETED|Overall Study||144
2559261|NCT00503308|6273295|P2|STARTED|Overall Study||135
2559262|NCT00503308|6273296|P1|STARTED|Overall Study||146
2559263|NCT00503139|6273302|P1|NOT COMPLETED|Overall Study||8
2559264|NCT00503139|6273302|P1|COMPLETED|Overall Study||676
2559265|NCT00503139|6273302|P1|STARTED|Overall Study||684
2559266|NCT00503113|6273316|P3|NOT COMPLETED|Overall Study||28
2559267|NCT00503113|6273317|P2|NOT COMPLETED|Overall Study||28
2559268|NCT00503113|6273318|P1|NOT COMPLETED|Overall Study||33
2559269|NCT00503113|6273316|P3|COMPLETED|Overall Study||241
2559270|NCT00503113|6273317|P2|COMPLETED|Overall Study||236
2559271|NCT00503113|6273318|P1|COMPLETED|Overall Study||235
2559272|NCT00503113|6273316|P3|Safety Population|Overall Study||267
2559273|NCT00503113|6273317|P2|Safety Population|Overall Study||263
2559274|NCT00503113|6273318|P1|Safety Population|Overall Study||263
2559275|NCT00503113|6273316|P3|Per Protocol Population (PP)|Overall Study||241
2559276|NCT00503113|6273317|P2|Per Protocol Population (PP)|Overall Study||243
2559277|NCT00503113|6273318|P1|Per Protocol Population (PP)|Overall Study||246
2559278|NCT00503113|6273316|P3|Intent to Treat Population (ITT)|Overall Study||268
2559279|NCT00503113|6273317|P2|Intent to Treat Population (ITT)|Overall Study||261
2559280|NCT00503113|6273318|P1|Intent to Treat Population (ITT)|Overall Study||262
2559281|NCT00503113|6273316|P3|STARTED|Overall Study||269
2559282|NCT00503113|6273317|P2|STARTED|Overall Study||264
2559283|NCT00503113|6273318|P1|STARTED|Overall Study||268
2559284|NCT00503009|6273350|P3|NOT COMPLETED|Overall Study||3
2559285|NCT00503009|6273351|P2|NOT COMPLETED|Overall Study||2
2559286|NCT00503009|6273352|P1|NOT COMPLETED|Overall Study||1
2559287|NCT00503009|6273350|P3|COMPLETED|Overall Study||3
2559288|NCT00503009|6273351|P2|COMPLETED|Overall Study||3
2559289|NCT00503009|6273352|P1|COMPLETED|Overall Study||4
2559290|NCT00503009|6273350|P3|STARTED|Overall Study||6
2559291|NCT00503009|6273351|P2|STARTED|Overall Study||5
2559292|NCT00503009|6273352|P1|STARTED|Overall Study||5
2559293|NCT00502996|6273369|P1|NOT COMPLETED|Overall Study||44
2559294|NCT00502996|6273369|P1|COMPLETED|Overall Study||188
2559295|NCT00502996|6273369|P1|STARTED|Overall Study||232
2559296|NCT00502944|6273395|P2|NOT COMPLETED|Overall Study||1766
2559297|NCT00502944|6273396|P1|NOT COMPLETED|Overall Study||1064
2559298|NCT00502944|6273395|P2|COMPLETED|Overall Study||643
2559299|NCT00502944|6273396|P1|COMPLETED|Overall Study||1382
2559300|NCT00502944|6273395|P2|STARTED|Overall Study||2409
2559301|NCT00502944|6273396|P1|STARTED|Overall Study||2446
2559302|NCT00502905|6273408|P1|NOT COMPLETED|Overall Study||0
2559303|NCT00502905|6273408|P1|COMPLETED|Overall Study||196
2559304|NCT00502905|6273408|P1|STARTED|Overall Study||196
2559305|NCT00502853|6273412|P1|NOT COMPLETED|Overall Study||0
2559306|NCT00502853|6273412|P1|COMPLETED|Overall Study||10
2559307|NCT00502853|6273412|P1|STARTED|Overall Study||10
2559308|NCT00502840|6273437|P1|NOT COMPLETED|Overall Study||100
2559309|NCT00502840|6273437|P1|COMPLETED|Overall Study||93
2559310|NCT00502840|6273437|P1|STARTED|Overall Study||193
2559311|NCT00502801|6273465|P1|NOT COMPLETED|End of Therapy to Test of Cure||8
2559312|NCT00502801|6273465|P1|COMPLETED|End of Therapy to Test of Cure||121
2559313|NCT00502801|6273465|P1|STARTED|End of Therapy to Test of Cure||129
2559314|NCT00502801|6273465|P1|NOT COMPLETED|Treatment Period||54
2559315|NCT00502801|6273465|P1|COMPLETED|Treatment Period||129
2559316|NCT00502801|6273465|P1|STARTED|Treatment Period||183
2559317|NCT00502775|6273473|P3|NOT COMPLETED|Overall Study||13
2559318|NCT00502775|6273474|P2|NOT COMPLETED|Overall Study||15
2559319|NCT00502775|6273475|P1|NOT COMPLETED|Overall Study||10
2559320|NCT00502775|6273473|P3|COMPLETED|Overall Study||214
2559321|NCT00502775|6273474|P2|COMPLETED|Overall Study||209
2559322|NCT00502775|6273475|P1|COMPLETED|Overall Study||219
2559323|NCT00502775|6273473|P3|STARTED|Overall Study||227
2559324|NCT00502775|6273474|P2|STARTED|Overall Study||224
2559325|NCT00502775|6273475|P1|STARTED|Overall Study||229
2559326|NCT00502697|6273518|P2|NOT COMPLETED|Overall Study||12
2559327|NCT00502697|6273519|P1|NOT COMPLETED|Overall Study||13
2559328|NCT00502697|6273518|P2|COMPLETED|Overall Study||102
2559329|NCT00502697|6273519|P1|COMPLETED|Overall Study||109
2559330|NCT00502697|6273518|P2|STARTED|Overall Study||114
2559331|NCT00502697|6273519|P1|STARTED|Overall Study||122
2559332|NCT00502671|6273527|P1|NOT COMPLETED|Overall Study||77
2559333|NCT00502671|6273527|P1|COMPLETED|Overall Study||151
2559334|NCT00502671|6273527|P1|STARTED|Overall Study||228
2559335|NCT00502593|6273544|P12|NOT COMPLETED|Overall Study||0
2559336|NCT00502593|6273545|P11|NOT COMPLETED|Overall Study||2
2559337|NCT00502593|6273546|P10|NOT COMPLETED|Overall Study||0
2559338|NCT00502593|6273547|P9|NOT COMPLETED|Overall Study||6
2559339|NCT00502593|6273548|P8|NOT COMPLETED|Overall Study||0
2559340|NCT00502593|6273549|P7|NOT COMPLETED|Overall Study||5
2559341|NCT00502593|6273550|P6|NOT COMPLETED|Overall Study||0
2559342|NCT00502593|6273551|P5|NOT COMPLETED|Overall Study||4
2559343|NCT00502593|6273552|P4|NOT COMPLETED|Overall Study||4
2559344|NCT00502593|6273553|P3|NOT COMPLETED|Overall Study||10
2559345|NCT00502593|6273554|P2|NOT COMPLETED|Overall Study||2
2559346|NCT00502593|6273555|P1|NOT COMPLETED|Overall Study||3
2559347|NCT00502593|6273544|P12|COMPLETED|Overall Study||18
2559348|NCT00502593|6273545|P11|COMPLETED|Overall Study||47
2559349|NCT00502593|6273546|P10|COMPLETED|Overall Study||17
2559350|NCT00502593|6273547|P9|COMPLETED|Overall Study||43
2559351|NCT00502593|6273548|P8|COMPLETED|Overall Study||17
2559352|NCT00502593|6273549|P7|COMPLETED|Overall Study||44
2559353|NCT00502593|6273550|P6|COMPLETED|Overall Study||17
2559354|NCT00502593|6273551|P5|COMPLETED|Overall Study||47
2559355|NCT00502593|6273552|P4|COMPLETED|Overall Study||14
2559356|NCT00502593|6273553|P3|COMPLETED|Overall Study||41
2559357|NCT00502593|6273554|P2|COMPLETED|Overall Study||16
2559358|NCT00502593|6273555|P1|COMPLETED|Overall Study||48
2559359|NCT00502593|6273544|P12|STARTED|Overall Study||18
2559360|NCT00502593|6273545|P11|STARTED|Overall Study||49
2559361|NCT00502593|6273546|P10|STARTED|Overall Study||17
2559362|NCT00502593|6273547|P9|STARTED|Overall Study||49
2559363|NCT00502593|6273548|P8|STARTED|Overall Study||17
2559364|NCT00502593|6273549|P7|STARTED|Overall Study||49
2559365|NCT00502593|6273550|P6|STARTED|Overall Study||17
2559366|NCT00502593|6273551|P5|STARTED|Overall Study||51
2559367|NCT00502593|6273552|P4|STARTED|Overall Study||18
2559368|NCT00502593|6273553|P3|STARTED|Overall Study||51
2559369|NCT00502593|6273554|P2|STARTED|Overall Study||18
2559370|NCT00502593|6273555|P1|STARTED|Overall Study||51
2559371|NCT00502320|6274071|P2|NOT COMPLETED|Overall Study||7
2559372|NCT00502320|6274072|P1|NOT COMPLETED|Overall Study||6
2559373|NCT00502320|6274071|P2|COMPLETED|Overall Study||18
2559374|NCT00502320|6274072|P1|COMPLETED|Overall Study||19
2559375|NCT00502320|6274071|P2|Screening Visit|Overall Study|Participant signed informed consent but was a screen failure because she was nursing at the time.|24
2559376|NCT00502320|6274072|P1|Screening Visit|Overall Study||25
2559377|NCT00502320|6274071|P2|STARTED|Overall Study||25
2559378|NCT00502320|6274072|P1|STARTED|Overall Study||25
2559379|NCT00502242|6274084|P2|NOT COMPLETED|Overall Study||56
2559380|NCT00502242|6274085|P1|NOT COMPLETED|Overall Study||51
2559381|NCT00502242|6274084|P2|COMPLETED|Overall Study||84
2559382|NCT00502242|6274085|P1|COMPLETED|Overall Study||104
2559383|NCT00502242|6274084|P2|STARTED|Overall Study||140
2559384|NCT00502242|6274085|P1|STARTED|Overall Study||155
2559385|NCT00502216|6274138|P2|NOT COMPLETED|Overall Study||0
2559386|NCT00502216|6274139|P1|NOT COMPLETED|Overall Study||0
2559387|NCT00502216|6274138|P2|COMPLETED|Overall Study||19
2559388|NCT00502216|6274139|P1|COMPLETED|Overall Study||21
2559389|NCT00502216|6274138|P2|STARTED|Overall Study||19
2559390|NCT00502216|6274139|P1|STARTED|Overall Study||21
2559391|NCT00502203|6274149|P1|NOT COMPLETED|Overall Study||1
2559392|NCT00502203|6274149|P1|COMPLETED|Overall Study||22
2559393|NCT00502203|6274149|P1|STARTED|Overall Study||23
2559394|NCT00501995|6274153|P1|NOT COMPLETED|Overall Study||1
2559395|NCT00501995|6274153|P1|COMPLETED|Overall Study||5
2559396|NCT00501995|6274153|P1|STARTED|Overall Study||6
2559397|NCT00501969|6274158|P1|NOT COMPLETED|Overall Study||206
2559398|NCT00501969|6274158|P1|COMPLETED|Overall Study||189
2559399|NCT00501969|6274158|P1|STARTED|Overall Study||395
2559400|NCT00501943|6274166|P2|NOT COMPLETED|Overall Study||3
2559401|NCT00501943|6274167|P1|NOT COMPLETED|Overall Study||2
2559402|NCT00501943|6274166|P2|COMPLETED|Overall Study||18
2559403|NCT00501943|6274167|P1|COMPLETED|Overall Study||20
2559404|NCT00501943|6274166|P2|STARTED|Overall Study||21
2559405|NCT00501943|6274167|P1|STARTED|Overall Study||22
2559406|NCT00501891|6274183|P1|NOT COMPLETED|Overall Study||0
2559407|NCT00501891|6274183|P1|COMPLETED|Overall Study||32
2559408|NCT00501891|6274183|P1|STARTED|Overall Study||32
2559409|NCT00501852|6274190|P1|NOT COMPLETED|Overall Study||5
2559410|NCT00501852|6274190|P1|COMPLETED|Overall Study||78
2559411|NCT00501852|6274190|P1|Tiotropium|Overall Study||55
2559412|NCT00501852|6274190|P1|Placebo|Overall Study||55
2559413|NCT00501852|6274190|P1|NVA237 100µg|Overall Study||54
2559414|NCT00501852|6274190|P1|NVA237 50µg|Overall Study||53
2559415|NCT00501852|6274190|P1|NVA237 25µg|Overall Study||51
2559416|NCT00501852|6274190|P1|NVA237 12.5µg|Overall Study||55
2559417|NCT00501852|6274190|P1|STARTED|Overall Study||83
2559418|NCT00501644|6274210|P1|NOT COMPLETED|Overall Study||5
2559419|NCT00501644|6274210|P1|COMPLETED|Overall Study||54
2559420|NCT00501644|6274210|P1|STARTED|Overall Study||59
2559421|NCT00501631|6274216|P2|NOT COMPLETED|Part B (Open-label Period)||51
2559422|NCT00501631|6274217|P1|NOT COMPLETED|Part B (Open-label Period)||53
2559423|NCT00501631|6274216|P2|COMPLETED|Part B (Open-label Period)||48
2559424|NCT00501631|6274217|P1|COMPLETED|Part B (Open-label Period)||37
2559425|NCT00501631|6274216|P2|STARTED|Part B (Open-label Period)||99
2559426|NCT00501631|6274217|P1|STARTED|Part B (Open-label Period)||90
2559427|NCT00501631|6274216|P2|NOT COMPLETED|Part A (Double-blind Period)||49
2559428|NCT00501631|6274217|P1|NOT COMPLETED|Part A (Double-blind Period)||62
2559429|NCT00501631|6274216|P2|COMPLETED|Part A (Double-blind Period)||99
2559430|NCT00501631|6274217|P1|COMPLETED|Part A (Double-blind Period)||90
2559431|NCT00501631|6274216|P2|STARTED|Part A (Double-blind Period)||148
2559432|NCT00501631|6274217|P1|STARTED|Part A (Double-blind Period)||152
2559433|NCT00501592|6274226|P3|NOT COMPLETED|Overall Study||3
2559434|NCT00501592|6274227|P2|NOT COMPLETED|Overall Study||5
2559435|NCT00501592|6274228|P1|NOT COMPLETED|Overall Study||0
2559436|NCT00501592|6274226|P3|COMPLETED|Overall Study||20
2559437|NCT00501592|6274227|P2|COMPLETED|Overall Study||16
2559438|NCT00501592|6274228|P1|COMPLETED|Overall Study||20
2559439|NCT00501592|6274226|P3|STARTED|Overall Study||23
2559440|NCT00501592|6274227|P2|STARTED|Overall Study||21
2559441|NCT00501592|6274228|P1|STARTED|Overall Study||20
2559442|NCT00501540|6274239|P1|NOT COMPLETED|Overall Study||5
2559443|NCT00501540|6274239|P1|COMPLETED|Overall Study||10
2559444|NCT00501540|6274239|P1|STARTED|Overall Study||15
2559445|NCT00501345|6274245|P1|NOT COMPLETED|Overall Study||0
2559446|NCT00501345|6274245|P1|COMPLETED|Overall Study||5
2559447|NCT00501345|6274245|P1|STARTED|Overall Study||5
2559448|NCT00501293|6274251|P2|NOT COMPLETED|Maintenance Period||28
2559449|NCT00501293|6274252|P1|NOT COMPLETED|Maintenance Period||46
2559450|NCT00501293|6274251|P2|COMPLETED|Maintenance Period||25
2559451|NCT00501293|6274252|P1|COMPLETED|Maintenance Period||63
2559452|NCT00501293|6274251|P2|STARTED|Maintenance Period||53
2559453|NCT00501293|6274252|P1|STARTED|Maintenance Period||109
2559454|NCT00501293|6274251|P2|NOT COMPLETED|Optimization Period||0
2559455|NCT00501293|6274252|P1|NOT COMPLETED|Optimization Period||1
2559456|NCT00501293|6274251|P2|COMPLETED|Optimization Period||53
2559457|NCT00501293|6274252|P1|COMPLETED|Optimization Period||109
2559458|NCT00501293|6274251|P2|STARTED|Optimization Period||53
2559459|NCT00501293|6274252|P1|STARTED|Optimization Period||110
2559460|NCT00501228|6274279|P1|NOT COMPLETED|Overall Study||1
2559461|NCT00501228|6274279|P1|COMPLETED|Overall Study||1
2559462|NCT00501228|6274279|P1|STARTED|Overall Study||2
2559463|NCT00501085|6274283|P1|NOT COMPLETED|Overall Study||432
2559464|NCT00501085|6274283|P1|COMPLETED|Overall Study|Number of participants completing 5 year follow-up visit.|83
2559465|NCT00501085|6274283|P1|STARTED|Overall Study|Number of participants who were treated with the LAP-BAND System.|515
2559466|NCT00501059|6274293|P2|NOT COMPLETED|Overall Study||1892
2559467|NCT00501059|6274294|P1|NOT COMPLETED|Overall Study||1868
2559468|NCT00501059|6274293|P2|COMPLETED|Overall Study||4384
2559469|NCT00501059|6274294|P1|COMPLETED|Overall Study||4402
2559470|NCT00501059|6274293|P2|STARTED|Overall Study||6276
2559471|NCT00501059|6274294|P1|STARTED|Overall Study||6270
2559472|NCT00501046|6274318|P2|NOT COMPLETED|Overall Study||294
2559473|NCT00501046|6274319|P1|NOT COMPLETED|Overall Study||270
2559474|NCT00501046|6274318|P2|COMPLETED|Overall Study||213
2559475|NCT00501046|6274319|P1|COMPLETED|Overall Study||238
2559476|NCT00501046|6274318|P2|STARTED|Overall Study||507
2559477|NCT00501046|6274319|P1|STARTED|Overall Study||508
2559478|NCT00501007|6274325|P2|NOT COMPLETED|Overall Study||25
2559479|NCT00501007|6274326|P1|NOT COMPLETED|Overall Study||29
2559480|NCT00501007|6274325|P2|COMPLETED|Overall Study||78
2559481|NCT00501007|6274326|P1|COMPLETED|Overall Study||71
2559482|NCT00501007|6274325|P2|STARTED|Overall Study||103
2559483|NCT00501007|6274326|P1|STARTED|Overall Study||100
2559484|NCT00500903|6274335|P3|NOT COMPLETED|Overall Study||20
2559485|NCT00500903|6274336|P2|NOT COMPLETED|Overall Study||2
2559486|NCT00500903|6274337|P1|NOT COMPLETED|Overall Study||65
2559487|NCT00500903|6274335|P3|COMPLETED|Overall Study||0
2559488|NCT00500903|6274336|P2|COMPLETED|Overall Study||0
2559489|NCT00500903|6274337|P1|COMPLETED|Overall Study||0
2559490|NCT00500903|6274335|P3|STARTED|Overall Study||20
2559491|NCT00500903|6274336|P2|STARTED|Overall Study||2
2559492|NCT00500903|6274337|P1|STARTED|Overall Study||65
2559493|NCT00500760|6274518|P2|NOT COMPLETED|Overall Study||24
2559494|NCT00500760|6274519|P1|NOT COMPLETED|Overall Study||43
2559495|NCT00500760|6274518|P2|COMPLETED|Overall Study||40
2559496|NCT00500760|6274519|P1|COMPLETED|Overall Study||46
2559497|NCT00500760|6274518|P2|Received Treatment|Overall Study||63
2559498|NCT00500760|6274519|P1|Received Treatment|Overall Study||87
2559499|NCT00500760|6274518|P2|STARTED|Overall Study||64
2559500|NCT00500760|6274519|P1|STARTED|Overall Study||89
2559501|NCT00500682|6274539|P2|NOT COMPLETED|Overall Study||287
2559502|NCT00500682|6274540|P1|NOT COMPLETED|Overall Study||306
2559503|NCT00500682|6274539|P2|COMPLETED|Overall Study||223
2559504|NCT00500682|6274540|P1|COMPLETED|Overall Study||204
2559505|NCT00500682|6274539|P2|STARTED|Overall Study||510
2559506|NCT00500682|6274540|P1|STARTED|Overall Study||510
2559507|NCT00500656|6274550|P4|NOT COMPLETED|Open Label Extension (OLE) Phase||2
2559508|NCT00500656|6274551|P3|NOT COMPLETED|Open Label Extension (OLE) Phase||1
2559509|NCT00500656|6274552|P2|NOT COMPLETED|Open Label Extension (OLE) Phase||12
2559510|NCT00500656|6274553|P1|NOT COMPLETED|Open Label Extension (OLE) Phase||7
2559511|NCT00500656|6274550|P4|COMPLETED|Open Label Extension (OLE) Phase||6
2559512|NCT00500656|6274551|P3|COMPLETED|Open Label Extension (OLE) Phase||1
2559513|NCT00500656|6274552|P2|COMPLETED|Open Label Extension (OLE) Phase||9
2559514|NCT00500656|6274553|P1|COMPLETED|Open Label Extension (OLE) Phase||16
2559515|NCT00500656|6274550|P4|STARTED|Open Label Extension (OLE) Phase|Subjects did not experience an angioedema attack during the controlled phase|8
2559516|NCT00500656|6274551|P3|STARTED|Open Label Extension (OLE) Phase||2
2559517|NCT00500656|6274552|P2|STARTED|Open Label Extension (OLE) Phase|7 Subjects did not experience an angioedema attack after their first attack in the controlled phase|21
2559518|NCT00500656|6274553|P1|STARTED|Open Label Extension (OLE) Phase|3 Subjects did not experience an angioedema attack after their first attack in the controlled phase|23
2559519|NCT00500656|6274550|P4|NOT COMPLETED|Controlled Phase||8
2559520|NCT00500656|6274551|P3|NOT COMPLETED|Controlled Phase||1
2559521|NCT00500656|6274552|P2|NOT COMPLETED|Controlled Phase||10
2559522|NCT00500656|6274553|P1|NOT COMPLETED|Controlled Phase||10
2559523|NCT00500656|6274550|P4|COMPLETED|Controlled Phase||0
2559524|NCT00500656|6274551|P3|COMPLETED|Controlled Phase||2
2559525|NCT00500656|6274552|P2|COMPLETED|Controlled Phase||28
2559526|NCT00500656|6274553|P1|COMPLETED|Controlled Phase||26
2559527|NCT00500656|6274550|P4|STARTED|Controlled Phase||8
2559528|NCT00500656|6274551|P3|STARTED|Controlled Phase||3
2559529|NCT00500656|6274552|P2|STARTED|Controlled Phase||38
2559530|NCT00500656|6274553|P1|STARTED|Controlled Phase||36
2559531|NCT00500578|6274567|P2|NOT COMPLETED|Overall Study||0
2559532|NCT00500578|6274568|P1|NOT COMPLETED|Overall Study||0
2559533|NCT00500578|6274567|P2|COMPLETED|Overall Study|All completed|32
2559534|NCT00500578|6274568|P1|COMPLETED|Overall Study|All completed|18
2559535|NCT00500578|6274567|P2|STARTED|Overall Study||32
2559536|NCT00500578|6274568|P1|STARTED|Overall Study||18
2559537|NCT00500539|6274574|P1|NOT COMPLETED|Follow-up Period (16 Weeks)||12
2559538|NCT00500539|6274574|P1|COMPLETED|Follow-up Period (16 Weeks)||136
2559539|NCT00500539|6274574|P1|STARTED|Follow-up Period (16 Weeks)|Participants could discontinue study drug and still enter the follow-up period.|148
2559540|NCT00500539|6274574|P1|NOT COMPLETED|Treatment Period (24 Weeks)||15
2559541|NCT00500539|6274574|P1|COMPLETED|Treatment Period (24 Weeks)||140
2559542|NCT00500539|6274574|P1|STARTED|Treatment Period (24 Weeks)||155
2559543|NCT00500448|6274583|P2|NOT COMPLETED|Overall Study||0
2559544|NCT00500448|6274584|P1|NOT COMPLETED|Overall Study||0
2559545|NCT00500448|6274583|P2|COMPLETED|Overall Study||16
2559546|NCT00500448|6274584|P1|COMPLETED|Overall Study||14
2559547|NCT00500448|6274583|P2|STARTED|Overall Study||16
2559548|NCT00500448|6274584|P1|STARTED|Overall Study||14
2559549|NCT00500370|6274600|P2|NOT COMPLETED|Overall Study||34
2559550|NCT00500370|6274601|P1|NOT COMPLETED|Overall Study||33
2559551|NCT00500370|6274600|P2|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|49
2559552|NCT00500370|6274601|P1|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|47
2559553|NCT00500370|6274600|P2|Treatment Complete (Week 24)|Overall Study||54
2559554|NCT00500370|6274601|P1|Treatment Complete (Week 24)|Overall Study||48
2559555|NCT00500370|6274600|P2|Treatment Start-Baseline (Week 0)|Overall Study||79
2559556|NCT00500370|6274601|P1|Treatment Start-Baseline (Week 0)|Overall Study||73
2559557|NCT00500370|6274600|P2|STARTED|Overall Study||83
2559558|NCT00500370|6274601|P1|STARTED|Overall Study||80
2559559|NCT00500357|6274637|P1|NOT COMPLETED|Overall Study||1
2559560|NCT00500357|6274637|P1|COMPLETED|Overall Study||104
2559561|NCT00500357|6274637|P1|Evaluable Immunogenicity Population|Overall Study|Administered Vax 1 and Vax 2 in study 6115A1-500; Vax 3 and at least 1 assay result in 6115A1-3009.|98
2559562|NCT00500357|6274637|P1|Received 13vPnC (Vax 3)|Overall Study||105
2559563|NCT00500357|6274637|P1|STARTED|Overall Study||105
2559564|NCT00500331|6274663|P7|NOT COMPLETED|Overall Study||2
2559565|NCT00500331|6274664|P6|NOT COMPLETED|Overall Study||5
2559566|NCT00500331|6274665|P5|NOT COMPLETED|Overall Study||4
2559567|NCT00500331|6274666|P4|NOT COMPLETED|Overall Study||10
2559568|NCT00500331|6274667|P3|NOT COMPLETED|Overall Study||5
2559569|NCT00500331|6274668|P2|NOT COMPLETED|Overall Study||5
2559570|NCT00500331|6274669|P1|NOT COMPLETED|Overall Study||15
2559571|NCT00500331|6274663|P7|COMPLETED|Overall Study||46
2559572|NCT00500331|6274664|P6|COMPLETED|Overall Study||42
2559573|NCT00500331|6274665|P5|COMPLETED|Overall Study||44
2559574|NCT00500331|6274666|P4|COMPLETED|Overall Study||38
2559575|NCT00500331|6274667|P3|COMPLETED|Overall Study||43
2559576|NCT00500331|6274668|P2|COMPLETED|Overall Study||42
2559577|NCT00500331|6274669|P1|COMPLETED|Overall Study||33
2559578|NCT00500331|6274663|P7|STARTED|Overall Study||48
2559579|NCT00500331|6274664|P6|STARTED|Overall Study||47
2559580|NCT00500331|6274665|P5|STARTED|Overall Study||48
2559581|NCT00500331|6274666|P4|STARTED|Overall Study||48
2559582|NCT00500331|6274667|P3|STARTED|Overall Study||48
2559583|NCT00500331|6274668|P2|STARTED|Overall Study||47
2559584|NCT00500331|6274669|P1|STARTED|Overall Study||48
2559585|NCT00500318|6274806|P2|NOT COMPLETED|Overall Study||17
2559586|NCT00500318|6274807|P1|NOT COMPLETED|Overall Study||5
2559587|NCT00500318|6274806|P2|COMPLETED|Overall Study||78
2559588|NCT00500318|6274807|P1|COMPLETED|Overall Study||81
2559589|NCT00500318|6274806|P2|STARTED|Overall Study||95
2559590|NCT00500318|6274807|P1|STARTED|Overall Study||86
2559591|NCT00500292|6274824|P3|NOT COMPLETED|Overall Study||27
2559592|NCT00500292|6274825|P2|NOT COMPLETED|Overall Study||31
2559593|NCT00500292|6274826|P1|NOT COMPLETED|Overall Study||25
2559594|NCT00500292|6274824|P3|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|10
2559595|NCT00500292|6274825|P2|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|4
2559596|NCT00500292|6274826|P1|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|7
2559597|NCT00500292|6274824|P3|STARTED|Overall Study|randomised patients|37
2559598|NCT00500292|6274825|P2|STARTED|Overall Study|randomised patients|35
2559599|NCT00500292|6274826|P1|STARTED|Overall Study|randomised patients|32
2559600|NCT00500240|6274836|P2|NOT COMPLETED|Overall Study||0
2559601|NCT00500240|6274837|P1|NOT COMPLETED|Overall Study||0
2559602|NCT00500240|6274836|P2|COMPLETED|Overall Study||26
2559603|NCT00500240|6274837|P1|COMPLETED|Overall Study||25
2559604|NCT00500240|6274836|P2|STARTED|Overall Study||26
2559605|NCT00500240|6274837|P1|STARTED|Overall Study||25
2559606|NCT00500149|6274847|P2|NOT COMPLETED|Second Intervention (Cross-over Phase)||0
2559607|NCT00500149|6274848|P1|NOT COMPLETED|Second Intervention (Cross-over Phase)||2
2559608|NCT00500149|6274847|P2|COMPLETED|Second Intervention (Cross-over Phase)||57
2559609|NCT00500149|6274848|P1|COMPLETED|Second Intervention (Cross-over Phase)||54
2559610|NCT00500149|6274847|P2|STARTED|Second Intervention (Cross-over Phase)||57
2559611|NCT00500149|6274848|P1|STARTED|Second Intervention (Cross-over Phase)||56
2559612|NCT00500149|6274847|P2|NOT COMPLETED|First Intervention (Cross-over Phase)||2
2559613|NCT00500149|6274848|P1|NOT COMPLETED|First Intervention (Cross-over Phase)||2
2559614|NCT00500149|6274847|P2|COMPLETED|First Intervention (Cross-over Phase)||57
2559615|NCT00500149|6274848|P1|COMPLETED|First Intervention (Cross-over Phase)||56
2559616|NCT00500149|6274847|P2|STARTED|First Intervention (Cross-over Phase)||59
2559617|NCT00500149|6274848|P1|STARTED|First Intervention (Cross-over Phase)||58
2559618|NCT00500149|6274847|P2|NOT COMPLETED|Enrolled (Dose-optimization Phase)||0
2559619|NCT00500149|6274848|P1|NOT COMPLETED|Enrolled (Dose-optimization Phase)||12
2559620|NCT00500149|6274847|P2|COMPLETED|Enrolled (Dose-optimization Phase)||0
2559621|NCT00500149|6274848|P1|COMPLETED|Enrolled (Dose-optimization Phase)||117
2559622|NCT00500149|6274847|P2|STARTED|Enrolled (Dose-optimization Phase)||0
2559623|NCT00500149|6274848|P1|STARTED|Enrolled (Dose-optimization Phase)||129
2559624|NCT00500110|6274856|P1|NOT COMPLETED|Overall Study||3
2559625|NCT00500110|6274856|P1|COMPLETED|Overall Study||36
2559626|NCT00500110|6274856|P1|STARTED|Overall Study||39
2559627|NCT00500071|6274860|P1|NOT COMPLETED|30-day Safety Follow-up||17
2559628|NCT00500071|6274860|P1|COMPLETED|30-day Safety Follow-up||278
2559629|NCT00500071|6274860|P1|STARTED|30-day Safety Follow-up||295
2559630|NCT00500071|6274860|P1|NOT COMPLETED|Dose-optimization and Maintenance Phase||22
2559631|NCT00500071|6274860|P1|COMPLETED|Dose-optimization and Maintenance Phase||295
2559632|NCT00500071|6274860|P1|STARTED|Dose-optimization and Maintenance Phase|Safety population (i.e., received at least one dose of study medication)|317
2559633|NCT00500071|6274860|P1|NOT COMPLETED|Screening and Washout Phase||1
2559634|NCT00500071|6274860|P1|COMPLETED|Screening and Washout Phase||317
2559635|NCT00500071|6274860|P1|STARTED|Screening and Washout Phase||318
2559636|NCT00500045|6274869|P1|NOT COMPLETED|Overall Study||0
2559637|NCT00500045|6274869|P1|COMPLETED|Overall Study||0
2559638|NCT00500045|6274869|P1|STARTED|Overall Study||0
2559639|NCT00499915|6274876|P2|NOT COMPLETED|Overall Study||6
2559640|NCT00499915|6274877|P1|NOT COMPLETED|Overall Study||15
2559641|NCT00499915|6274876|P2|COMPLETED|Overall Study||76
2559642|NCT00499915|6274877|P1|COMPLETED|Overall Study||68
2559643|NCT00499915|6274876|P2|STARTED|Overall Study||82
2559644|NCT00499915|6274877|P1|STARTED|Overall Study||83
2559645|NCT00499889|6274883|P1|NOT COMPLETED|Overall Study||1
2559646|NCT00499889|6274883|P1|COMPLETED|Overall Study||41
2559647|NCT00499889|6274883|P1|STARTED|Overall Study||42
2559648|NCT00499863|6274891|P2|NOT COMPLETED|Overall Study||43
2559649|NCT00499863|6274892|P1|NOT COMPLETED|Overall Study||50
2559650|NCT00499863|6274891|P2|COMPLETED|Overall Study||29
2559651|NCT00499863|6274892|P1|COMPLETED|Overall Study||95
2559652|NCT00499863|6274891|P2|STARTED|Overall Study||72
2559653|NCT00499863|6274892|P1|STARTED|Overall Study||145
2559654|NCT00500266|6274920|P1|NOT COMPLETED|Overall Study||13
2559655|NCT00500266|6274920|P1|COMPLETED|Overall Study||1040
2559656|NCT00500266|6274920|P1|Treated|Overall Study||1049
2559657|NCT00500266|6274920|P1|STARTED|Overall Study||1053
2559658|NCT00499746|6274927|P1|NOT COMPLETED|Phase 3 (9-14 One Day Sessions)||0
2559659|NCT00499746|6274927|P1|COMPLETED|Phase 3 (9-14 One Day Sessions)||8
2559660|NCT00499746|6274927|P1|STARTED|Phase 3 (9-14 One Day Sessions)||8
2559661|NCT00499746|6274927|P1|NOT COMPLETED|Phase 2 (6-9 One Day Sessions)||0
2559662|NCT00499746|6274927|P1|COMPLETED|Phase 2 (6-9 One Day Sessions)||8
2559663|NCT00499746|6274927|P1|STARTED|Phase 2 (6-9 One Day Sessions)||8
2559664|NCT00499746|6274927|P1|NOT COMPLETED|Phase 1(6-9 One Day Sessions)||12
2559665|NCT00499746|6274927|P1|COMPLETED|Phase 1(6-9 One Day Sessions)||8
2559666|NCT00499746|6274927|P1|STARTED|Phase 1(6-9 One Day Sessions)||20
2559667|NCT00499694|6274996|P1|NOT COMPLETED|Overall Study||1
2559668|NCT00499694|6274996|P1|COMPLETED|Overall Study||30
2559669|NCT00499694|6274996|P1|STARTED|Overall Study||31
2559670|NCT00499681|6275005|P2|NOT COMPLETED|Overall Study||2
2559671|NCT00499681|6275006|P1|NOT COMPLETED|Overall Study||0
2559672|NCT00499681|6275005|P2|COMPLETED|Overall Study||0
2559673|NCT00499681|6275006|P1|COMPLETED|Overall Study||4
2559674|NCT00499681|6275005|P2|STARTED|Overall Study||2
2559675|NCT00499681|6275006|P1|STARTED|Overall Study||4
2559676|NCT00499655|6275014|P2|NOT COMPLETED|Overall Study||0
2559677|NCT00499655|6275015|P1|NOT COMPLETED|Overall Study||0
2559678|NCT00499655|6275014|P2|COMPLETED|Overall Study||54
2559679|NCT00499655|6275015|P1|COMPLETED|Overall Study||53
2559680|NCT00499655|6275014|P2|STARTED|Overall Study||54
2559681|NCT00499655|6275015|P1|STARTED|Overall Study||53
2559682|NCT00499616|6275033|P4|NOT COMPLETED|Overall Study||57
2559683|NCT00499616|6275034|P3|NOT COMPLETED|Overall Study||36
2559684|NCT00499616|6275035|P2|NOT COMPLETED|Overall Study||28
2559685|NCT00499616|6275036|P1|NOT COMPLETED|Overall Study||15
2559686|NCT00499616|6275033|P4|COMPLETED|Overall Study||0
2559687|NCT00499616|6275034|P3|COMPLETED|Overall Study||53
2559688|NCT00499616|6275035|P2|COMPLETED|Overall Study||114
2559689|NCT00499616|6275036|P1|COMPLETED|Overall Study||161
2559690|NCT00499616|6275033|P4|STARTED|Overall Study||57
2559691|NCT00499616|6275034|P3|STARTED|Overall Study||89
2559692|NCT00499616|6275035|P2|STARTED|Overall Study||142
2559693|NCT00499616|6275036|P1|STARTED|Overall Study||176
2559694|NCT00499603|6275081|P2|NOT COMPLETED|Overall Study||1
2559695|NCT00499603|6275082|P1|NOT COMPLETED|Overall Study||0
2559696|NCT00499603|6275081|P2|COMPLETED|Overall Study||22
2559697|NCT00499603|6275082|P1|COMPLETED|Overall Study||27
2559698|NCT00499603|6275081|P2|STARTED|Overall Study||23
2559699|NCT00499603|6275082|P1|STARTED|Overall Study||27
2559700|NCT00499590|6275095|P3|NOT COMPLETED|Overall Study||113
2559701|NCT00499590|6275096|P2|NOT COMPLETED|Overall Study||112
2559702|NCT00499590|6275097|P1|NOT COMPLETED|Overall Study||113
2559703|NCT00499590|6275095|P3|COMPLETED|Overall Study||0
2559704|NCT00499590|6275096|P2|COMPLETED|Overall Study||0
2559705|NCT00499590|6275097|P1|COMPLETED|Overall Study||0
2559706|NCT00499590|6275095|P3|STARTED|Overall Study||113
2559707|NCT00499590|6275096|P2|STARTED|Overall Study||112
2559708|NCT00499590|6275097|P1|STARTED|Overall Study||113
2559709|NCT00499486|6275108|P1|NOT COMPLETED|Overall Study||16
2559710|NCT00499486|6275108|P1|COMPLETED|Overall Study||31
2559711|NCT00499486|6275108|P1|STARTED|Overall Study||47
2559712|NCT00499473|6275116|P2|NOT COMPLETED|Overall Study||0
2559713|NCT00499473|6275117|P1|NOT COMPLETED|Overall Study||6
2559714|NCT00499473|6275116|P2|COMPLETED|Overall Study||4
2559715|NCT00499473|6275117|P1|COMPLETED|Overall Study|Patients evaluable|21
2559716|NCT00499473|6275116|P2|STARTED|Overall Study||4
2559717|NCT00499473|6275117|P1|STARTED|Overall Study||27
2559718|NCT00499460|6275135|P2|NOT COMPLETED|Intervention 2 (30 Days)||1
2559719|NCT00499460|6275136|P1|NOT COMPLETED|Intervention 2 (30 Days)||0
2559720|NCT00499460|6275135|P2|COMPLETED|Intervention 2 (30 Days)||6
2559721|NCT00499460|6275136|P1|COMPLETED|Intervention 2 (30 Days)||6
2559722|NCT00499460|6275135|P2|STARTED|Intervention 2 (30 Days)||7
2559723|NCT00499460|6275136|P1|STARTED|Intervention 2 (30 Days)||6
2559724|NCT00499460|6275135|P2|NOT COMPLETED|Intervention 1 (30 Days)||0
2559725|NCT00499460|6275136|P1|NOT COMPLETED|Intervention 1 (30 Days)||2
2559726|NCT00499460|6275135|P2|COMPLETED|Intervention 1 (30 Days)||7
2559727|NCT00499460|6275136|P1|COMPLETED|Intervention 1 (30 Days)||6
2559728|NCT00499460|6275135|P2|STARTED|Intervention 1 (30 Days)||7
2559729|NCT00499460|6275136|P1|STARTED|Intervention 1 (30 Days)||8
2559730|NCT00499447|6275152|P1|NOT COMPLETED|Overall Study||0
2559731|NCT00499447|6275152|P1|COMPLETED|Overall Study||13
2559732|NCT00499447|6275152|P1|STARTED|Overall Study||13
2559733|NCT00499408|6275156|P1|NOT COMPLETED|Overall Study||0
2559734|NCT00499408|6275156|P1|COMPLETED|Overall Study|Three patients did not have adequate testing to be evaluable for a response.|26
2559735|NCT00499408|6275156|P1|STARTED|Overall Study||26
2559736|NCT00499369|6275169|P5|NOT COMPLETED|Overall Study||12
2559737|NCT00499369|6275170|P4|NOT COMPLETED|Overall Study||9
2559738|NCT00499369|6275171|P3|NOT COMPLETED|Overall Study||17
2559739|NCT00499369|6275172|P2|NOT COMPLETED|Overall Study||18
2559740|NCT00499369|6275173|P1|NOT COMPLETED|Overall Study||16
2559741|NCT00499369|6275169|P5|COMPLETED|Overall Study||0
2559742|NCT00499369|6275170|P4|COMPLETED|Overall Study||0
2559743|NCT00499369|6275171|P3|COMPLETED|Overall Study||0
2559744|NCT00499369|6275172|P2|COMPLETED|Overall Study||0
2559745|NCT00499369|6275173|P1|COMPLETED|Overall Study||0
2559746|NCT00499369|6275169|P5|Eligible|Overall Study||12
2559747|NCT00499369|6275170|P4|Eligible|Overall Study||8
2559748|NCT00499369|6275171|P3|Eligible|Overall Study||16
2559749|NCT00499369|6275172|P2|Eligible|Overall Study||16
2559750|NCT00499369|6275173|P1|Eligible|Overall Study||14
2559751|NCT00499369|6275169|P5|STARTED|Overall Study||12
2559752|NCT00499369|6275170|P4|STARTED|Overall Study||9
2559753|NCT00499369|6275171|P3|STARTED|Overall Study||17
2559754|NCT00499369|6275172|P2|STARTED|Overall Study||18
2559755|NCT00499369|6275173|P1|STARTED|Overall Study||16
2559756|NCT00499343|6275202|P2|NOT COMPLETED|Overall Study||0
2559757|NCT00499343|6275203|P1|NOT COMPLETED|Overall Study||0
2559758|NCT00499343|6275202|P2|COMPLETED|Overall Study||43
2559759|NCT00499343|6275203|P1|COMPLETED|Overall Study||41
2559760|NCT00499343|6275202|P2|STARTED|Overall Study||43
2559761|NCT00499343|6275203|P1|STARTED|Overall Study||41
2559762|NCT00499252|6275209|P1|NOT COMPLETED|Overall Study||12
2559763|NCT00499252|6275209|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|39
2559764|NCT00499252|6275209|P1|STARTED|Overall Study||51
2559765|NCT00499122|6275219|P1|NOT COMPLETED|Overall Study||2
2559766|NCT00499122|6275219|P1|COMPLETED|Overall Study||39
2559767|NCT00499122|6275219|P1|STARTED|Overall Study||41
2559768|NCT00499109|6275227|P2|NOT COMPLETED|Overall Study||7
2559769|NCT00499109|6275228|P1|NOT COMPLETED|Overall Study||18
2559770|NCT00499109|6275227|P2|COMPLETED|Overall Study||85
2559771|NCT00499109|6275228|P1|COMPLETED|Overall Study||165
2559772|NCT00499109|6275227|P2|STARTED|Overall Study||92
2559773|NCT00499109|6275228|P1|STARTED|Overall Study||183
2559774|NCT00499096|6275243|P2|NOT COMPLETED|Overall Study||20
2559775|NCT00499096|6275244|P1|NOT COMPLETED|Overall Study||23
2559776|NCT00499096|6275243|P2|COMPLETED|Overall Study||40
2559777|NCT00499096|6275244|P1|COMPLETED|Overall Study||35
2559778|NCT00499096|6275243|P2|STARTED|Overall Study||60
2559779|NCT00499096|6275244|P1|STARTED|Overall Study||58
2559780|NCT00499083|6275262|P1|NOT COMPLETED|Overall Study||3
2559781|NCT00499083|6275262|P1|COMPLETED|Overall Study||14
2559782|NCT00499083|6275262|P1|Participants at Moffitt Cancer Center|Overall Study||14
2559783|NCT00499083|6275262|P1|Participants at UNMC|Overall Study||3
2559784|NCT00499083|6275262|P1|STARTED|Overall Study||17
2559785|NCT00499031|6275269|P1|NOT COMPLETED|Overall Study||3
2559786|NCT00499031|6275269|P1|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|35
2559787|NCT00499031|6275269|P1|STARTED|Overall Study|Total number participants enrolled on study|38
2559788|NCT00498940|6275276|P2|NOT COMPLETED|Overall Study||0
2559789|NCT00498940|6275277|P1|NOT COMPLETED|Overall Study||0
2559790|NCT00498940|6275276|P2|COMPLETED|Overall Study||31
2559791|NCT00498940|6275277|P1|COMPLETED|Overall Study||30
2559792|NCT00498940|6275276|P2|STARTED|Overall Study||31
2559793|NCT00498940|6275277|P1|STARTED|Overall Study||30
2559794|NCT00498927|6275285|P1|NOT COMPLETED|Overall Study||0
2559795|NCT00498927|6275285|P1|COMPLETED|Overall Study||47
2559796|NCT00498927|6275285|P1|STARTED|Overall Study||47
2559797|NCT00498797|6275292|P2|NOT COMPLETED|Overall Study||29
2559798|NCT00498797|6275293|P1|NOT COMPLETED|Overall Study||38
2559799|NCT00498797|6275292|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
2559800|NCT00498797|6275293|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
2559801|NCT00498797|6275292|P2|STARTED|Overall Study|randomised patients|43
2559802|NCT00498797|6275293|P1|STARTED|Overall Study|randomised patients|43
2559803|NCT00498706|6275303|P2|NOT COMPLETED|Overall Study||0
2559804|NCT00498706|6275304|P1|NOT COMPLETED|Overall Study||0
2559805|NCT00498706|6275303|P2|COMPLETED|Overall Study||162
2559806|NCT00498706|6275304|P1|COMPLETED|Overall Study||163
2559807|NCT00498706|6275303|P2|Post Treatment Week 18|Overall Study||162
2559808|NCT00498706|6275304|P1|Post Treatment Week 18|Overall Study||163
2559809|NCT00498706|6275303|P2|STARTED|Overall Study||162
2559810|NCT00498706|6275304|P1|STARTED|Overall Study||163
2559811|NCT00498628|6275318|P2|NOT COMPLETED|Overall Study||21
2559812|NCT00498628|6275319|P1|NOT COMPLETED|Overall Study||15
2559813|NCT00498628|6275318|P2|COMPLETED|Overall Study||92
2559814|NCT00498628|6275319|P1|COMPLETED|Overall Study||90
2559815|NCT00498628|6275318|P2|STARTED|Overall Study||113
2559816|NCT00498628|6275319|P1|STARTED|Overall Study||105
2559817|NCT00498615|6275351|P6|NOT COMPLETED|Placebo||0
2559818|NCT00498615|6275352|P5|NOT COMPLETED|Placebo||0
2559819|NCT00498615|6275353|P4|NOT COMPLETED|Placebo||0
2559820|NCT00498615|6275354|P3|NOT COMPLETED|Placebo||0
2559821|NCT00498615|6275355|P2|NOT COMPLETED|Placebo||0
2559822|NCT00498615|6275356|P1|NOT COMPLETED|Placebo||0
2559823|NCT00498615|6275351|P6|COMPLETED|Placebo||3
2559824|NCT00498615|6275352|P5|COMPLETED|Placebo||3
2559825|NCT00498615|6275353|P4|COMPLETED|Placebo||2
2559826|NCT00498615|6275354|P3|COMPLETED|Placebo||3
2559827|NCT00498615|6275355|P2|COMPLETED|Placebo||4
2559828|NCT00498615|6275356|P1|COMPLETED|Placebo||2
2559829|NCT00498615|6275351|P6|STARTED|Placebo||3
2559830|NCT00498615|6275352|P5|STARTED|Placebo||3
2559831|NCT00498615|6275353|P4|STARTED|Placebo||2
2559832|NCT00498615|6275354|P3|STARTED|Placebo||3
2559833|NCT00498615|6275355|P2|STARTED|Placebo||4
2559834|NCT00498615|6275356|P1|STARTED|Placebo||2
2559835|NCT00498615|6275351|P6|NOT COMPLETED|Fasudil 40mg||0
2559836|NCT00498615|6275352|P5|NOT COMPLETED|Fasudil 40mg||0
2559837|NCT00498615|6275353|P4|NOT COMPLETED|Fasudil 40mg||0
2559838|NCT00498615|6275354|P3|NOT COMPLETED|Fasudil 40mg||0
2559839|NCT00498615|6275355|P2|NOT COMPLETED|Fasudil 40mg||0
2559840|NCT00498615|6275356|P1|NOT COMPLETED|Fasudil 40mg||0
2559841|NCT00498615|6275351|P6|COMPLETED|Fasudil 40mg||3
2559842|NCT00498615|6275352|P5|COMPLETED|Fasudil 40mg||3
2559843|NCT00498615|6275353|P4|COMPLETED|Fasudil 40mg||2
2559844|NCT00498615|6275354|P3|COMPLETED|Fasudil 40mg||3
2559845|NCT00498615|6275355|P2|COMPLETED|Fasudil 40mg||4
2559846|NCT00498615|6275356|P1|COMPLETED|Fasudil 40mg||2
2559847|NCT00498615|6275351|P6|STARTED|Fasudil 40mg||3
2559848|NCT00498615|6275352|P5|STARTED|Fasudil 40mg||3
2559849|NCT00498615|6275353|P4|STARTED|Fasudil 40mg||2
2559850|NCT00498615|6275354|P3|STARTED|Fasudil 40mg||3
2559851|NCT00498615|6275355|P2|STARTED|Fasudil 40mg||4
2559852|NCT00498615|6275356|P1|STARTED|Fasudil 40mg||2
2559853|NCT00498615|6275351|P6|NOT COMPLETED|Fasudil 80mg||0
2559854|NCT00498615|6275352|P5|NOT COMPLETED|Fasudil 80mg||0
2559855|NCT00498615|6275353|P4|NOT COMPLETED|Fasudil 80mg||0
2559856|NCT00498615|6275354|P3|NOT COMPLETED|Fasudil 80mg||0
2559857|NCT00498615|6275355|P2|NOT COMPLETED|Fasudil 80mg||0
2559858|NCT00498615|6275356|P1|NOT COMPLETED|Fasudil 80mg||0
2559859|NCT00498615|6275351|P6|COMPLETED|Fasudil 80mg||3
2559860|NCT00498615|6275352|P5|COMPLETED|Fasudil 80mg||3
2559861|NCT00498615|6275353|P4|COMPLETED|Fasudil 80mg||2
2559862|NCT00498615|6275354|P3|COMPLETED|Fasudil 80mg||3
2559863|NCT00498615|6275355|P2|COMPLETED|Fasudil 80mg||4
2559864|NCT00498615|6275356|P1|COMPLETED|Fasudil 80mg||2
2559865|NCT00498615|6275351|P6|STARTED|Fasudil 80mg||3
2559866|NCT00498615|6275352|P5|STARTED|Fasudil 80mg||3
2559867|NCT00498615|6275353|P4|STARTED|Fasudil 80mg||2
2559868|NCT00498615|6275354|P3|STARTED|Fasudil 80mg||3
2559869|NCT00498615|6275355|P2|STARTED|Fasudil 80mg||4
2559870|NCT00498615|6275356|P1|STARTED|Fasudil 80mg||2
2559871|NCT00498602|6275377|P7|NOT COMPLETED|Overall Study||2
2559872|NCT00498602|6275378|P6|NOT COMPLETED|Overall Study||13
2559873|NCT00498602|6275379|P5|NOT COMPLETED|Overall Study||4
2559874|NCT00498602|6275380|P4|NOT COMPLETED|Overall Study||5
2559875|NCT00498602|6275381|P3|NOT COMPLETED|Overall Study||8
2559876|NCT00498602|6275382|P2|NOT COMPLETED|Overall Study||10
2559877|NCT00498602|6275383|P1|NOT COMPLETED|Overall Study||10
2559878|NCT00498602|6275377|P7|COMPLETED|Overall Study||15
2559879|NCT00498602|6275378|P6|COMPLETED|Overall Study||31
2559880|NCT00498602|6275379|P5|COMPLETED|Overall Study||8
2559881|NCT00498602|6275380|P4|COMPLETED|Overall Study||30
2559882|NCT00498602|6275381|P3|COMPLETED|Overall Study||32
2559883|NCT00498602|6275382|P2|COMPLETED|Overall Study||51
2559884|NCT00498602|6275383|P1|COMPLETED|Overall Study||26
2559885|NCT00498602|6275377|P7|Treated|Overall Study||17
2559886|NCT00498602|6275378|P6|Treated|Overall Study||44
2559887|NCT00498602|6275379|P5|Treated|Overall Study||12
2559888|NCT00498602|6275380|P4|Treated|Overall Study||35
2559889|NCT00498602|6275381|P3|Treated|Overall Study||40
2559890|NCT00498602|6275382|P2|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
2559891|NCT00498602|6275383|P1|Treated|Overall Study||36
2559892|NCT00498602|6275377|P7|STARTED|Overall Study||17
2559893|NCT00498602|6275378|P6|STARTED|Overall Study||44
2559894|NCT00498602|6275379|P5|STARTED|Overall Study||12
2559895|NCT00498602|6275380|P4|STARTED|Overall Study||35
2559896|NCT00498602|6275381|P3|STARTED|Overall Study||40
2559897|NCT00498602|6275382|P2|STARTED|Overall Study||61
2559898|NCT00498602|6275383|P1|STARTED|Overall Study||36
2559899|NCT00498550|6275422|P2|NOT COMPLETED|Overall Study||1
2559900|NCT00498550|6275423|P1|NOT COMPLETED|Overall Study||0
2559901|NCT00498550|6275422|P2|COMPLETED|Overall Study||15
2559902|NCT00498550|6275423|P1|COMPLETED|Overall Study|13 of 15 received clozapine all 12 visits, two discontinued clozapine early but remained in study.|15
2559903|NCT00498550|6275422|P2|STARTED|Overall Study||16
2559904|NCT00498550|6275423|P1|STARTED|Overall Study||15
2559905|NCT00498485|6275431|P2|NOT COMPLETED|Overall Study||5
2559906|NCT00498485|6275432|P1|NOT COMPLETED|Overall Study||1
2559907|NCT00498485|6275431|P2|COMPLETED|Overall Study||5
2559908|NCT00498485|6275432|P1|COMPLETED|Overall Study||6
2559909|NCT00498485|6275431|P2|STARTED|Overall Study||10
2559910|NCT00498485|6275432|P1|STARTED|Overall Study||7
2559911|NCT00498433|6275443|P3|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
2559912|NCT00498433|6275444|P2|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
2559913|NCT00498433|6275445|P1|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
2559914|NCT00498433|6275443|P3|COMPLETED|Part 2: Double Blind (12 Weeks)||8
2559915|NCT00498433|6275444|P2|COMPLETED|Part 2: Double Blind (12 Weeks)||8
2559916|NCT00498433|6275445|P1|COMPLETED|Part 2: Double Blind (12 Weeks)||0
2559917|NCT00498433|6275443|P3|STARTED|Part 2: Double Blind (12 Weeks)||8
2559918|NCT00498433|6275444|P2|STARTED|Part 2: Double Blind (12 Weeks)||8
2559919|NCT00498433|6275445|P1|STARTED|Part 2: Double Blind (12 Weeks)||0
2559920|NCT00498433|6275443|P3|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
2559921|NCT00498433|6275444|P2|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
2559922|NCT00498433|6275445|P1|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||20
2559923|NCT00498433|6275443|P3|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
2559924|NCT00498433|6275444|P2|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
2559925|NCT00498433|6275445|P1|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||16
2559926|NCT00498433|6275443|P3|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
2559927|NCT00498433|6275444|P2|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
2559928|NCT00498433|6275445|P1|STARTED|Part 2: Placebo Run-in (2 Weeks)||36
2559929|NCT00498433|6275443|P3|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
2559930|NCT00498433|6275444|P2|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
2559931|NCT00498433|6275445|P1|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
2559932|NCT00498433|6275443|P3|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
2559933|NCT00498433|6275444|P2|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
2559934|NCT00498433|6275445|P1|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
2559935|NCT00498433|6275443|P3|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
2559936|NCT00498433|6275444|P2|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
2559937|NCT00498433|6275445|P1|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
2559938|NCT00498433|6275443|P3|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
2559939|NCT00498433|6275444|P2|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
2559940|NCT00498433|6275445|P1|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
2559941|NCT00498433|6275443|P3|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
2559942|NCT00498433|6275444|P2|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||10
2559943|NCT00498433|6275445|P1|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
2559944|NCT00498433|6275443|P3|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
2559945|NCT00498433|6275444|P2|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||10
2559946|NCT00498433|6275445|P1|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
2559947|NCT00498433|6275443|P3|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
2559948|NCT00498433|6275444|P2|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
2559949|NCT00498433|6275445|P1|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
2559950|NCT00498433|6275443|P3|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
2559951|NCT00498433|6275444|P2|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
2559952|NCT00498433|6275445|P1|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
2559953|NCT00498433|6275443|P3|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
2559954|NCT00498433|6275444|P2|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
2559955|NCT00498433|6275445|P1|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
2559956|NCT00498368|6275490|P2|NOT COMPLETED|Overall Study||2
2559957|NCT00498368|6275491|P1|NOT COMPLETED|Overall Study||3
2559958|NCT00498368|6275490|P2|COMPLETED|Overall Study||15
2559959|NCT00498368|6275491|P1|COMPLETED|Overall Study||14
2559960|NCT00498368|6275490|P2|STARTED|Overall Study||17
2559961|NCT00498368|6275491|P1|STARTED|Overall Study||17
2559962|NCT00498355|6275503|P1|NOT COMPLETED|Overall Study||1
2559963|NCT00498355|6275503|P1|COMPLETED|Overall Study||6
2559964|NCT00498355|6275503|P1|STARTED|Overall Study||7
2559965|NCT00498186|6275511|P1|NOT COMPLETED|Overall Study||173
2559966|NCT00498186|6275511|P1|COMPLETED|Overall Study||122
2559967|NCT00498186|6275511|P1|STARTED|Overall Study||295
2559968|NCT00498173|6275518|P3|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
2559969|NCT00498173|6275519|P2|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
2559970|NCT00498173|6275520|P1|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
2559971|NCT00498173|6275518|P3|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
2559972|NCT00498173|6275519|P2|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
2559973|NCT00498173|6275520|P1|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
2559974|NCT00498173|6275518|P3|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
2559975|NCT00498173|6275519|P2|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
2559976|NCT00498173|6275520|P1|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
2559977|NCT00498173|6275518|P3|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
2559978|NCT00498173|6275519|P2|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||1
2559979|NCT00498173|6275520|P1|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||2
2559980|NCT00498173|6275518|P3|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
2559981|NCT00498173|6275519|P2|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||30
2559982|NCT00498173|6275520|P1|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||27
2559983|NCT00498173|6275518|P3|STARTED|Phase 1-Blinded Randomization (8 Weeks)||0
2559984|NCT00498173|6275519|P2|STARTED|Phase 1-Blinded Randomization (8 Weeks)||31
2559985|NCT00498173|6275520|P1|STARTED|Phase 1-Blinded Randomization (8 Weeks)||29
2559986|NCT00497874|6275550|P2|NOT COMPLETED|Overall Study||116
2559987|NCT00497874|6275551|P1|NOT COMPLETED|Overall Study||147
2559988|NCT00497874|6275550|P2|COMPLETED|Overall Study||343
2559989|NCT00497874|6275551|P1|COMPLETED|Overall Study||296
2559990|NCT00497874|6275550|P2|STARTED|Overall Study||459
2559991|NCT00497874|6275551|P1|STARTED|Overall Study||443
2559992|NCT00497796|6275569|P2|NOT COMPLETED|Overall Study||59
2559993|NCT00497796|6275570|P1|NOT COMPLETED|Overall Study||85
2559994|NCT00497796|6275569|P2|COMPLETED|Overall Study||101
2559995|NCT00497796|6275570|P1|COMPLETED|Overall Study||62
2559996|NCT00497796|6275569|P2|STARTED|Overall Study||160
2559997|NCT00497796|6275570|P1|STARTED|Overall Study||147
2559998|NCT00497770|6275602|P4|NOT COMPLETED|Overall Study||0
2559999|NCT00497770|6275603|P3|NOT COMPLETED|Overall Study||0
2560000|NCT00497770|6275604|P2|NOT COMPLETED|Overall Study||0
2560001|NCT00497770|6275605|P1|NOT COMPLETED|Overall Study||0
2560002|NCT00497770|6275602|P4|COMPLETED|Overall Study||28
2560003|NCT00497770|6275603|P3|COMPLETED|Overall Study||37
2560004|NCT00497770|6275604|P2|COMPLETED|Overall Study||65
2560005|NCT00497770|6275605|P1|COMPLETED|Overall Study||304
2560006|NCT00497770|6275602|P4|STARTED|Overall Study||28
2560007|NCT00497770|6275603|P3|STARTED|Overall Study||37
2560008|NCT00497770|6275604|P2|STARTED|Overall Study||65
2560009|NCT00497770|6275605|P1|STARTED|Overall Study||304
2560010|NCT00497198|6275657|P2|NOT COMPLETED|Overall Study||5
2560011|NCT00497198|6275658|P1|NOT COMPLETED|Overall Study||5
2560012|NCT00497198|6275657|P2|COMPLETED|Overall Study||86
2560013|NCT00497198|6275658|P1|COMPLETED|Overall Study||87
2560014|NCT00497198|6275657|P2|STARTED|Overall Study||91
2560015|NCT00497198|6275658|P1|STARTED|Overall Study||92
2560016|NCT00497146|6275674|P2|NOT COMPLETED|Long-term Follow-up Period||6
2560017|NCT00497146|6275675|P1|NOT COMPLETED|Long-term Follow-up Period||15
2560018|NCT00497146|6275674|P2|COMPLETED|Long-term Follow-up Period||66
2560019|NCT00497146|6275675|P1|COMPLETED|Long-term Follow-up Period||50
2560020|NCT00497146|6275674|P2|STARTED|Long-term Follow-up Period||72
2560021|NCT00497146|6275675|P1|STARTED|Long-term Follow-up Period||65
2560022|NCT00497146|6275674|P2|NOT COMPLETED|Treatment Period||21
2560023|NCT00497146|6275675|P1|NOT COMPLETED|Treatment Period||27
2560024|NCT00497146|6275674|P2|COMPLETED|Treatment Period||91
2560025|NCT00497146|6275675|P1|COMPLETED|Treatment Period||88
2560026|NCT00497146|6275674|P2|STARTED|Treatment Period||112
2560027|NCT00497146|6275675|P1|STARTED|Treatment Period||115
2560028|NCT00497081|6275717|P2|NOT COMPLETED|Overall Study||2
2560029|NCT00497081|6275718|P1|NOT COMPLETED|Overall Study||2
2560030|NCT00497081|6275717|P2|COMPLETED|Overall Study||28
2560031|NCT00497081|6275718|P1|COMPLETED|Overall Study||28
2560032|NCT00497081|6275717|P2|STARTED|Overall Study||30
2560033|NCT00497081|6275718|P1|STARTED|Overall Study||30
2560034|NCT00497055|6275730|P2|NOT COMPLETED|Overall Study||5
2560035|NCT00497055|6275731|P1|NOT COMPLETED|Overall Study||10
2560036|NCT00497055|6275730|P2|COMPLETED|Overall Study||40
2560037|NCT00497055|6275731|P1|COMPLETED|Overall Study||35
2560038|NCT00497055|6275730|P2|STARTED|Overall Study||45
2560039|NCT00497055|6275731|P1|STARTED|Overall Study||45
2560040|NCT00496964|6275743|P2|NOT COMPLETED|Overall Study||1
2560041|NCT00496964|6275744|P1|NOT COMPLETED|Overall Study||0
2560042|NCT00496964|6275743|P2|COMPLETED|Overall Study||3
2560043|NCT00496964|6275744|P1|COMPLETED|Overall Study||1
2560044|NCT00496964|6275743|P2|STARTED|Overall Study||4
2560045|NCT00496964|6275744|P1|STARTED|Overall Study||1
2560046|NCT00496873|6275762|P1|NOT COMPLETED|Overall Study||7
2560047|NCT00496873|6275762|P1|COMPLETED|Overall Study||78
2560048|NCT00496873|6275762|P1|STARTED|Overall Study||85
2560049|NCT00496860|6275771|P3|NOT COMPLETED|Overall Study||0
2560050|NCT00496860|6275772|P2|NOT COMPLETED|Overall Study||1
2560051|NCT00496860|6275773|P1|NOT COMPLETED|Overall Study||1
2560052|NCT00496860|6275771|P3|COMPLETED|Overall Study||6
2560053|NCT00496860|6275772|P2|COMPLETED|Overall Study||15
2560054|NCT00496860|6275773|P1|COMPLETED|Overall Study||3
2560055|NCT00496860|6275771|P3|STARTED|Overall Study||6
2560056|NCT00496860|6275772|P2|STARTED|Overall Study||16
2560057|NCT00496860|6275773|P1|STARTED|Overall Study||4
2560058|NCT00496834|6275795|P2|NOT COMPLETED|Overall Study||13
2560059|NCT00496834|6275796|P1|NOT COMPLETED|Overall Study||18
2560060|NCT00496834|6275795|P2|COMPLETED|Overall Study||87
2560061|NCT00496834|6275796|P1|COMPLETED|Overall Study||83
2560062|NCT00496834|6275795|P2|STARTED|Overall Study||100
2560063|NCT00496834|6275796|P1|STARTED|Overall Study||101
2560064|NCT00496808|6275808|P1|NOT COMPLETED|Overall Study||0
2560065|NCT00496808|6275808|P1|COMPLETED|Overall Study||69
2560066|NCT00496808|6275808|P1|STARTED|Overall Study||69
2560067|NCT00496782|6275815|P2|NOT COMPLETED|Overall Study||2
2560068|NCT00496782|6275816|P1|NOT COMPLETED|Overall Study||1
2560069|NCT00496782|6275815|P2|COMPLETED|Overall Study||5
2560070|NCT00496782|6275816|P1|COMPLETED|Overall Study||8
2560071|NCT00496782|6275815|P2|STARTED|Overall Study||7
2560072|NCT00496782|6275816|P1|STARTED|Overall Study||9
2560073|NCT00496769|6275850|P3|NOT COMPLETED|Open Label||1011
2560074|NCT00496769|6275851|P2|NOT COMPLETED|Open Label||0
2560075|NCT00496769|6275852|P1|NOT COMPLETED|Open Label||0
2560076|NCT00496769|6275850|P3|COMPLETED|Open Label||2264
2560077|NCT00496769|6275851|P2|COMPLETED|Open Label||0
2560078|NCT00496769|6275852|P1|COMPLETED|Open Label||0
2560079|NCT00496769|6275850|P3|STARTED|Open Label||3275
2560080|NCT00496769|6275851|P2|STARTED|Open Label||0
2560081|NCT00496769|6275852|P1|STARTED|Open Label||0
2560082|NCT00496769|6275850|P3|NOT COMPLETED|Double Blind||0
2560083|NCT00496769|6275851|P2|NOT COMPLETED|Double Blind||649
2560084|NCT00496769|6275852|P1|NOT COMPLETED|Double Blind||558
2560085|NCT00496769|6275850|P3|COMPLETED|Double Blind||0
2560086|NCT00496769|6275851|P2|COMPLETED|Double Blind||2142
2560087|NCT00496769|6275852|P1|COMPLETED|Double Blind||2249
2560088|NCT00496769|6275850|P3|Received Treatment|Double Blind||0
2560089|NCT00496769|6275851|P2|Received Treatment|Double Blind||2708
2560090|NCT00496769|6275852|P1|Received Treatment|Double Blind||2798
2560091|NCT00496769|6275850|P3|STARTED|Double Blind||0
2560092|NCT00496769|6275851|P2|STARTED|Double Blind|Randomized|2791
2560093|NCT00496769|6275852|P1|STARTED|Double Blind|Randomized|2807
2560094|NCT00496756|6275875|P1|NOT COMPLETED|Overall Study||3
2560095|NCT00496756|6275875|P1|COMPLETED|Overall Study||11
2560096|NCT00496756|6275875|P1|STARTED|Overall Study||14
2560097|NCT00496730|6275882|P2|NOT COMPLETED|Overall Study||5
2560098|NCT00496730|6275883|P1|NOT COMPLETED|Overall Study||6
2560099|NCT00496730|6275882|P2|COMPLETED|Overall Study||121
2560100|NCT00496730|6275883|P1|COMPLETED|Overall Study||124
2560101|NCT00496730|6275882|P2|STARTED|Overall Study||126
2560102|NCT00496730|6275883|P1|STARTED|Overall Study||130
2560103|NCT00496626|6275895|P2|NOT COMPLETED|Overall Study||6
2560104|NCT00496626|6275896|P1|NOT COMPLETED|Overall Study||6
2560105|NCT00496626|6275895|P2|COMPLETED|Overall Study||292
2560106|NCT00496626|6275896|P1|COMPLETED|Overall Study||296
2560107|NCT00496626|6275895|P2|STARTED|Overall Study||298
2560108|NCT00496626|6275896|P1|STARTED|Overall Study||302
2560109|NCT00496587|6275908|P1|NOT COMPLETED|Overall Study||31
2560110|NCT00496587|6275908|P1|COMPLETED|Overall Study||3
2560111|NCT00496587|6275908|P1|STARTED|Overall Study||34
2560112|NCT00496483|6275914|P1|NOT COMPLETED|Overall Study||12
2560113|NCT00496483|6275914|P1|COMPLETED|Overall Study||48
2560114|NCT00496483|6275914|P1|Dosed|Overall Study||51
2560115|NCT00496483|6275914|P1|STARTED|Overall Study||60
2560116|NCT00496470|6275931|P2|NOT COMPLETED|Overall Study||29
2560117|NCT00496470|6275932|P1|NOT COMPLETED|Overall Study||26
2560118|NCT00496470|6275931|P2|COMPLETED|Overall Study||302
2560119|NCT00496470|6275932|P1|COMPLETED|Overall Study||303
2560120|NCT00496470|6275931|P2|Received Study Medication|Overall Study||330
2560121|NCT00496470|6275932|P1|Received Study Medication|Overall Study||329
2560122|NCT00496470|6275931|P2|STARTED|Overall Study||331
2560123|NCT00496470|6275932|P1|STARTED|Overall Study||329
2560124|NCT00496379|6276010|P1|NOT COMPLETED|Overall Study||0
2560125|NCT00496379|6276010|P1|COMPLETED|Overall Study||15
2560126|NCT00496379|6276010|P1|STARTED|Overall Study||15
2560127|NCT00496366|6276018|P1|NOT COMPLETED|Overall Study||1
2560128|NCT00496366|6276018|P1|COMPLETED|Overall Study||10
2560129|NCT00496366|6276018|P1|STARTED|Overall Study||11
2560130|NCT00496340|6276023|P1|NOT COMPLETED|Overall Study||0
2560131|NCT00496340|6276023|P1|COMPLETED|Overall Study||42
2560132|NCT00496340|6276023|P1|STARTED|Overall Study||42
2560133|NCT00496262|6276036|P1|NOT COMPLETED|Overall Study||0
2560134|NCT00496262|6276036|P1|COMPLETED|Overall Study||15
2560135|NCT00496262|6276036|P1|STARTED|Overall Study||15
2560136|NCT00496197|6276049|P1|NOT COMPLETED|Overall Study||122
2560137|NCT00496197|6276049|P1|COMPLETED|Overall Study||160
2560138|NCT00496197|6276049|P1|STARTED|Overall Study||282
2560139|NCT00496080|6276076|P1|NOT COMPLETED|Overall Study||27
2560140|NCT00496080|6276076|P1|COMPLETED|Overall Study||60
2560141|NCT00496080|6276076|P1|STARTED|Overall Study||87
2560142|NCT00496054|6276086|P1|NOT COMPLETED|Overall Study||8
2560143|NCT00496054|6276086|P1|COMPLETED|Overall Study||102
2560144|NCT00496054|6276086|P1|STARTED|Overall Study||110
2560145|NCT00496015|6276118|P5|NOT COMPLETED|Overall Study||0
2560146|NCT00496015|6276119|P4|NOT COMPLETED|Overall Study||1
2560147|NCT00496015|6276120|P3|NOT COMPLETED|Overall Study||0
2560148|NCT00496015|6276121|P2|NOT COMPLETED|Overall Study||0
2560149|NCT00496015|6276122|P1|NOT COMPLETED|Overall Study||1
2560150|NCT00496015|6276118|P5|COMPLETED|Overall Study||336
2560151|NCT00496015|6276119|P4|COMPLETED|Overall Study||36
2560152|NCT00496015|6276120|P3|COMPLETED|Overall Study||172
2560153|NCT00496015|6276121|P2|COMPLETED|Overall Study||27
2560154|NCT00496015|6276122|P1|COMPLETED|Overall Study||177
2560155|NCT00496015|6276118|P5|STARTED|Overall Study||336
2560156|NCT00496015|6276119|P4|STARTED|Overall Study||37
2560157|NCT00496015|6276120|P3|STARTED|Overall Study||172
2560158|NCT00496015|6276121|P2|STARTED|Overall Study||27
2560159|NCT00496015|6276122|P1|STARTED|Overall Study||178
2560160|NCT00495820|6276246|P2|NOT COMPLETED|Overall Study||1
2560161|NCT00495820|6276247|P1|NOT COMPLETED|Overall Study||1
2560162|NCT00495820|6276246|P2|COMPLETED|Overall Study||29
2560163|NCT00495820|6276247|P1|COMPLETED|Overall Study||29
2560164|NCT00495820|6276246|P2|STARTED|Overall Study||30
2560165|NCT00495820|6276247|P1|STARTED|Overall Study||30
2560166|NCT00495794|6276259|P2|NOT COMPLETED|Overall Study||0
2560167|NCT00495794|6276260|P1|NOT COMPLETED|Overall Study||522
2560168|NCT00495794|6276259|P2|COMPLETED|Overall Study||2303
2560169|NCT00495794|6276260|P1|COMPLETED|Overall Study||1797
2560170|NCT00495794|6276259|P2|STARTED|Overall Study||2303
2560171|NCT00495794|6276260|P1|STARTED|Overall Study||2319
2560172|NCT00495755|6276270|P1|NOT COMPLETED|Overall Study||3
2560173|NCT00495755|6276270|P1|COMPLETED|Overall Study||10
2560174|NCT00495755|6276270|P1|STARTED|Overall Study||13
2560175|NCT00495716|6276277|P2|NOT COMPLETED|Overall Study||13
2560176|NCT00495716|6276278|P1|NOT COMPLETED|Overall Study||15
2560177|NCT00495716|6276277|P2|COMPLETED|Overall Study||24
2560178|NCT00495716|6276278|P1|COMPLETED|Overall Study||20
2560179|NCT00495716|6276277|P2|STARTED|Overall Study||37
2560180|NCT00495716|6276278|P1|STARTED|Overall Study||35
2560181|NCT00495677|6276291|P7|NOT COMPLETED|Stage 2 (25 Days)||0
2560182|NCT00495677|6276292|P6|NOT COMPLETED|Stage 2 (25 Days)||0
2560183|NCT00495677|6276293|P5|NOT COMPLETED|Stage 2 (25 Days)||0
2560184|NCT00495677|6276294|P4|NOT COMPLETED|Stage 2 (25 Days)||0
2560185|NCT00495677|6276295|P3|NOT COMPLETED|Stage 2 (25 Days)||0
2560186|NCT00495677|6276296|P2|NOT COMPLETED|Stage 2 (25 Days)||0
2560187|NCT00495677|6276297|P1|NOT COMPLETED|Stage 2 (25 Days)||0
2560188|NCT00495677|6276291|P7|COMPLETED|Stage 2 (25 Days)||7
2560189|NCT00495677|6276292|P6|COMPLETED|Stage 2 (25 Days)||8
2560190|NCT00495677|6276293|P5|COMPLETED|Stage 2 (25 Days)||8
2560191|NCT00495677|6276294|P4|COMPLETED|Stage 2 (25 Days)||0
2560192|NCT00495677|6276295|P3|COMPLETED|Stage 2 (25 Days)||0
2560193|NCT00495677|6276296|P2|COMPLETED|Stage 2 (25 Days)||0
2560194|NCT00495677|6276297|P1|COMPLETED|Stage 2 (25 Days)||0
2560195|NCT00495677|6276291|P7|STARTED|Stage 2 (25 Days)||7
2560196|NCT00495677|6276292|P6|STARTED|Stage 2 (25 Days)||8
2560197|NCT00495677|6276293|P5|STARTED|Stage 2 (25 Days)||8
2560198|NCT00495677|6276294|P4|STARTED|Stage 2 (25 Days)||0
2560199|NCT00495677|6276295|P3|STARTED|Stage 2 (25 Days)||0
2560200|NCT00495677|6276296|P2|STARTED|Stage 2 (25 Days)||0
2560201|NCT00495677|6276297|P1|STARTED|Stage 2 (25 Days)||0
2560202|NCT00495677|6276291|P7|NOT COMPLETED|Stage 1 (25 Days)||0
2560203|NCT00495677|6276292|P6|NOT COMPLETED|Stage 1 (25 Days)||0
2560204|NCT00495677|6276293|P5|NOT COMPLETED|Stage 1 (25 Days)||0
2560205|NCT00495677|6276294|P4|NOT COMPLETED|Stage 1 (25 Days)||0
2560206|NCT00495677|6276295|P3|NOT COMPLETED|Stage 1 (25 Days)||1
2560207|NCT00495677|6276296|P2|NOT COMPLETED|Stage 1 (25 Days)||0
2560208|NCT00495677|6276297|P1|NOT COMPLETED|Stage 1 (25 Days)||0
2560209|NCT00495677|6276291|P7|COMPLETED|Stage 1 (25 Days)||0
2560210|NCT00495677|6276292|P6|COMPLETED|Stage 1 (25 Days)||0
2560211|NCT00495677|6276293|P5|COMPLETED|Stage 1 (25 Days)||0
2560212|NCT00495677|6276294|P4|COMPLETED|Stage 1 (25 Days)||6
2560213|NCT00495677|6276295|P3|COMPLETED|Stage 1 (25 Days)||5
2560214|NCT00495677|6276296|P2|COMPLETED|Stage 1 (25 Days)||6
2560215|NCT00495677|6276297|P1|COMPLETED|Stage 1 (25 Days)||2
2560216|NCT00495677|6276291|P7|STARTED|Stage 1 (25 Days)||0
2560217|NCT00495677|6276292|P6|STARTED|Stage 1 (25 Days)||0
2560218|NCT00495677|6276293|P5|STARTED|Stage 1 (25 Days)||0
2560219|NCT00495677|6276294|P4|STARTED|Stage 1 (25 Days)||6
2560220|NCT00495677|6276295|P3|STARTED|Stage 1 (25 Days)||6
2560221|NCT00495677|6276296|P2|STARTED|Stage 1 (25 Days)||6
2560222|NCT00495677|6276297|P1|STARTED|Stage 1 (25 Days)||2
2560223|NCT00495625|6276352|P1|NOT COMPLETED|Overall Study||10
2560224|NCT00495625|6276352|P1|COMPLETED|Overall Study||23
2560225|NCT00495625|6276352|P1|STARTED|Overall Study||33
2560226|NCT00495612|6276363|P2|NOT COMPLETED|Overall Study||0
2560227|NCT00495612|6276364|P1|NOT COMPLETED|Overall Study||4
2560228|NCT00495612|6276363|P2|COMPLETED|Overall Study||33
2560229|NCT00495612|6276364|P1|COMPLETED|Overall Study||32
2560230|NCT00495612|6276363|P2|STARTED|Overall Study||33
2560231|NCT00495612|6276364|P1|STARTED|Overall Study||36
2560232|NCT00495586|6276382|P2|NOT COMPLETED|Overall Study||4
2560233|NCT00495586|6276383|P1|NOT COMPLETED|Overall Study||4
2560234|NCT00495586|6276382|P2|COMPLETED|Overall Study||158
2560235|NCT00495586|6276383|P1|COMPLETED|Overall Study||152
2560236|NCT00495586|6276382|P2|STARTED|Overall Study||162
2560237|NCT00495586|6276383|P1|STARTED|Overall Study||156
2560238|NCT00495521|6276393|P2|NOT COMPLETED|Overall Study||1
2560239|NCT00495521|6276394|P1|NOT COMPLETED|Overall Study||0
2560240|NCT00495521|6276393|P2|COMPLETED|Overall Study||0
2560241|NCT00495521|6276394|P1|COMPLETED|Overall Study||1
2560242|NCT00495521|6276393|P2|STARTED|Overall Study||1
2560243|NCT00495521|6276394|P1|STARTED|Overall Study||1
2560244|NCT00495495|6276424|P1|NOT COMPLETED|Overall Study||99
2560245|NCT00495495|6276424|P1|COMPLETED|Overall Study||295
2560246|NCT00495495|6276424|P1|STARTED|Overall Study||394
2560247|NCT00495469|6276444|P7|NOT COMPLETED|Overall Study||5
2560248|NCT00495469|6276445|P6|NOT COMPLETED|Overall Study||5
2560249|NCT00495469|6276446|P5|NOT COMPLETED|Overall Study||5
2560250|NCT00495469|6276447|P4|NOT COMPLETED|Overall Study||4
2560251|NCT00495469|6276448|P3|NOT COMPLETED|Overall Study||7
2560252|NCT00495469|6276449|P2|NOT COMPLETED|Overall Study||7
2560253|NCT00495469|6276450|P1|NOT COMPLETED|Overall Study||6
2560254|NCT00495469|6276444|P7|COMPLETED|Overall Study||30
2560255|NCT00495469|6276445|P6|COMPLETED|Overall Study||31
2560256|NCT00495469|6276446|P5|COMPLETED|Overall Study||31
2560257|NCT00495469|6276447|P4|COMPLETED|Overall Study||32
2560258|NCT00495469|6276448|P3|COMPLETED|Overall Study||27
2560259|NCT00495469|6276449|P2|COMPLETED|Overall Study||30
2560260|NCT00495469|6276450|P1|COMPLETED|Overall Study||30
2560261|NCT00495469|6276444|P7|STARTED|Overall Study||35
2560262|NCT00495469|6276445|P6|STARTED|Overall Study||36
2560263|NCT00495469|6276446|P5|STARTED|Overall Study||36
2560264|NCT00495469|6276447|P4|STARTED|Overall Study||36
2560265|NCT00495469|6276448|P3|STARTED|Overall Study||34
2560266|NCT00495469|6276449|P2|STARTED|Overall Study||37
2560267|NCT00495469|6276450|P1|STARTED|Overall Study||36
2560268|NCT00495391|6276594|P2|NOT COMPLETED|Overall Study||21
2560269|NCT00495391|6276595|P1|NOT COMPLETED|Overall Study||36
2560270|NCT00495391|6276594|P2|COMPLETED|Overall Study||1
2560271|NCT00495391|6276595|P1|COMPLETED|Overall Study||6
2560272|NCT00495391|6276594|P2|From Baseline to End of Follow up|Overall Study||1
2560273|NCT00495391|6276595|P1|From Baseline to End of Follow up|Overall Study||6
2560274|NCT00495391|6276594|P2|From Baseline to End of Treatment|Overall Study||1
2560275|NCT00495391|6276595|P1|From Baseline to End of Treatment|Overall Study||6
2560276|NCT00495391|6276594|P2|From Baseline to Week 16|Overall Study||11
2560277|NCT00495391|6276595|P1|From Baseline to Week 16|Overall Study||24
2560278|NCT00495391|6276594|P2|From Baseline to Week 8|Overall Study||20
2560279|NCT00495391|6276595|P1|From Baseline to Week 8|Overall Study||31
2560280|NCT00495391|6276594|P2|STARTED|Overall Study||22
2560281|NCT00495391|6276595|P1|STARTED|Overall Study||42
2560282|NCT00495222|6276615|P1|NOT COMPLETED|Overall Study||0
2560283|NCT00495222|6276615|P1|COMPLETED|Overall Study||9
2560284|NCT00495222|6276615|P1|STARTED|Overall Study||9
2560285|NCT00495170|6276618|P1|NOT COMPLETED|Overall Study||20
2560286|NCT00495170|6276618|P1|COMPLETED|Overall Study||64
2560287|NCT00495170|6276618|P1|STARTED|Overall Study||84
2560288|NCT00495157|6276625|P3|NOT COMPLETED|Overall Study||13
2560289|NCT00495157|6276626|P2|NOT COMPLETED|Overall Study||23
2560290|NCT00495157|6276627|P1|NOT COMPLETED|Overall Study||16
2560291|NCT00495157|6276625|P3|COMPLETED|Overall Study||101
2560292|NCT00495157|6276626|P2|COMPLETED|Overall Study||92
2560293|NCT00495157|6276627|P1|COMPLETED|Overall Study||97
2560294|NCT00495157|6276625|P3|STARTED|Overall Study||114
2560295|NCT00495157|6276626|P2|STARTED|Overall Study||115
2560296|NCT00495157|6276627|P1|STARTED|Overall Study||113
2560297|NCT00495131|6276637|P2|NOT COMPLETED|Overall Study||6
2560298|NCT00495131|6276638|P1|NOT COMPLETED|Overall Study||7
2560299|NCT00495131|6276637|P2|COMPLETED|Overall Study||148
2560300|NCT00495131|6276638|P1|COMPLETED|Overall Study||147
2560301|NCT00495131|6276637|P2|STARTED|Overall Study||154
2560302|NCT00495131|6276638|P1|STARTED|Overall Study||154
2560303|NCT00495079|6276648|P1|NOT COMPLETED|Overall Study||0
2560304|NCT00495079|6276648|P1|COMPLETED|Overall Study||65
2560305|NCT00495079|6276648|P1|STARTED|Overall Study||65
2560306|NCT00495040|6276655|P1|NOT COMPLETED|Overall Study||3
2560307|NCT00495040|6276655|P1|COMPLETED|Overall Study||35
2560308|NCT00495040|6276655|P1|STARTED|Overall Study||38
2560309|NCT00494975|6276661|P2|NOT COMPLETED|Overall Study||1
2560310|NCT00494975|6276662|P1|NOT COMPLETED|Overall Study||2
2560311|NCT00494975|6276661|P2|COMPLETED|Overall Study||10
2560312|NCT00494975|6276662|P1|COMPLETED|Overall Study||8
2560313|NCT00494975|6276661|P2|STARTED|Overall Study||11
2560314|NCT00494975|6276662|P1|STARTED|Overall Study||10
2560315|NCT00494871|6276670|P2|NOT COMPLETED|Follow-up (FU) Period||23
2560316|NCT00494871|6276671|P1|NOT COMPLETED|Follow-up (FU) Period||29
2560317|NCT00494871|6276670|P2|COMPLETED|Follow-up (FU) Period||616
2560318|NCT00494871|6276671|P1|COMPLETED|Follow-up (FU) Period||610
2560319|NCT00494871|6276670|P2|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|630
2560320|NCT00494871|6276671|P1|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|628
2560321|NCT00494871|6276670|P2|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
2560322|NCT00494871|6276671|P1|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
2560323|NCT00494871|6276670|P2|NOT COMPLETED|Double-blind (DB) Treatment Period||172
2560324|NCT00494871|6276671|P1|NOT COMPLETED|Double-blind (DB) Treatment Period||160
2560325|NCT00494871|6276670|P2|COMPLETED|Double-blind (DB) Treatment Period||468
2560326|NCT00494871|6276671|P1|COMPLETED|Double-blind (DB) Treatment Period||480
2560327|NCT00494871|6276670|P2|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
2560328|NCT00494871|6276671|P1|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
2560329|NCT00494871|6276670|P2|STARTED|Double-blind (DB) Treatment Period||640
2560330|NCT00494871|6276671|P1|STARTED|Double-blind (DB) Treatment Period||640
2560331|NCT00494806|6276703|P2|NOT COMPLETED|Overall Study||0
2560332|NCT00494806|6276704|P1|NOT COMPLETED|Overall Study||0
2560333|NCT00494806|6276703|P2|COMPLETED|Overall Study||32
2560334|NCT00494806|6276704|P1|COMPLETED|Overall Study||34
2560335|NCT00494806|6276703|P2|STARTED|Overall Study||32
2560336|NCT00494806|6276704|P1|STARTED|Overall Study||34
2560337|NCT00494780|6276712|P2|NOT COMPLETED|Overall Study||13
2560338|NCT00494780|6276713|P1|NOT COMPLETED|Overall Study||11
2560339|NCT00494780|6276712|P2|COMPLETED|Overall Study||17
2560340|NCT00494780|6276713|P1|COMPLETED|Overall Study||18
2560341|NCT00494780|6276712|P2|STARTED|Overall Study||30
2560342|NCT00494780|6276713|P1|STARTED|Overall Study||29
2560343|NCT00494676|6276751|P2|NOT COMPLETED|Second Intervention||1
2560344|NCT00494676|6276752|P1|NOT COMPLETED|Second Intervention||1
2560345|NCT00494676|6276751|P2|COMPLETED|Second Intervention||28
2560346|NCT00494676|6276752|P1|COMPLETED|Second Intervention||33
2560347|NCT00494676|6276751|P2|STARTED|Second Intervention||29
2560348|NCT00494676|6276752|P1|STARTED|Second Intervention||34
2560349|NCT00494676|6276751|P2|NOT COMPLETED|First Intervention||3
2560350|NCT00494676|6276752|P1|NOT COMPLETED|First Intervention||1
2560351|NCT00494676|6276751|P2|COMPLETED|First Intervention||29
2560352|NCT00494676|6276752|P1|COMPLETED|First Intervention||34
2560353|NCT00494676|6276751|P2|STARTED|First Intervention||32
2560354|NCT00494676|6276752|P1|STARTED|First Intervention||35
2560355|NCT00494676|6276751|P2|NOT COMPLETED|Allocation||4
2560356|NCT00494676|6276752|P1|NOT COMPLETED|Allocation||2
2560357|NCT00494676|6276751|P2|COMPLETED|Allocation||32
2560358|NCT00494676|6276752|P1|COMPLETED|Allocation||35
2560359|NCT00494676|6276751|P2|STARTED|Allocation||36
2560360|NCT00494676|6276752|P1|STARTED|Allocation||37
2560361|NCT00494585|6276759|P1|NOT COMPLETED|Overall Study||0
2560362|NCT00494585|6276759|P1|COMPLETED|Overall Study||22
2560363|NCT00494585|6276759|P1|STARTED|Overall Study||22
2560364|NCT00494507|6276767|P4|NOT COMPLETED|Open-Label Phase||5
2560365|NCT00494507|6276768|P3|NOT COMPLETED|Open-Label Phase||5
2560366|NCT00494507|6276769|P2|NOT COMPLETED|Open-Label Phase||1
2560367|NCT00494507|6276770|P1|NOT COMPLETED|Open-Label Phase||0
2560368|NCT00494507|6276767|P4|COMPLETED|Open-Label Phase||14
2560369|NCT00494507|6276768|P3|COMPLETED|Open-Label Phase||17
2560370|NCT00494507|6276769|P2|COMPLETED|Open-Label Phase||7
2560371|NCT00494507|6276770|P1|COMPLETED|Open-Label Phase||9
2560372|NCT00494507|6276767|P4|STARTED|Open-Label Phase||19
2560373|NCT00494507|6276768|P3|STARTED|Open-Label Phase||22
2560374|NCT00494507|6276769|P2|STARTED|Open-Label Phase|1 subject randomized to Acetazolamide in this phase is not included-drug arm was removed from trial.|8
2560375|NCT00494507|6276770|P1|STARTED|Open-Label Phase||9
2560376|NCT00494507|6276767|P4|NOT COMPLETED|Double-Blind Phase||1
2560377|NCT00494507|6276768|P3|NOT COMPLETED|Double-Blind Phase||2
2560378|NCT00494507|6276769|P2|NOT COMPLETED|Double-Blind Phase||0
2560379|NCT00494507|6276770|P1|NOT COMPLETED|Double-Blind Phase||3
2560380|NCT00494507|6276767|P4|COMPLETED|Double-Blind Phase||19
2560381|NCT00494507|6276768|P3|COMPLETED|Double-Blind Phase||22
2560382|NCT00494507|6276769|P2|COMPLETED|Double-Blind Phase||9
2560383|NCT00494507|6276770|P1|COMPLETED|Double-Blind Phase||9
2560384|NCT00494507|6276767|P4|Reached Endpoint of Acute Worsening|Double-Blind Phase||5
2560385|NCT00494507|6276768|P3|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
2560386|NCT00494507|6276769|P2|Reached Endpoint of Acute Worsening|Double-Blind Phase||2
2560387|NCT00494507|6276770|P1|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
2560388|NCT00494507|6276767|P4|STARTED|Double-Blind Phase||20
2560389|NCT00494507|6276768|P3|STARTED|Double-Blind Phase||24
2560390|NCT00494507|6276769|P2|STARTED|Double-Blind Phase||9
2560391|NCT00494507|6276770|P1|STARTED|Double-Blind Phase||12
2560392|NCT00494494|6276820|P2|NOT COMPLETED|Overall Study||0
2560393|NCT00494494|6276821|P1|NOT COMPLETED|Overall Study||0
2560394|NCT00494494|6276820|P2|COMPLETED|Overall Study||39
2560395|NCT00494494|6276821|P1|COMPLETED|Overall Study||40
2560396|NCT00494494|6276820|P2|STARTED|Overall Study||39
2560397|NCT00494494|6276821|P1|STARTED|Overall Study||40
2560398|NCT00494481|6276837|P2|NOT COMPLETED|Overall Study||24
2560399|NCT00494481|6276838|P1|NOT COMPLETED|Overall Study||29
2560400|NCT00494481|6276837|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
2560401|NCT00494481|6276838|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|6
2560402|NCT00494481|6276837|P2|STARTED|Overall Study|randomised patients|29
2560403|NCT00494481|6276838|P1|STARTED|Overall Study|randomised patients|35
2560404|NCT00494442|6276846|P2|NOT COMPLETED|Overall Study||16
2560405|NCT00494442|6276847|P1|NOT COMPLETED|Overall Study||17
2560406|NCT00494442|6276846|P2|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|17
2560407|NCT00494442|6276847|P1|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|7
2560408|NCT00494442|6276846|P2|STARTED|Overall Study|Patients received treatment|33
2560409|NCT00494442|6276847|P1|STARTED|Overall Study|Patients received treatment|24
2560410|NCT00494299|6276863|P2|NOT COMPLETED|Overall Study||229
2560411|NCT00494299|6276864|P1|NOT COMPLETED|Overall Study||229
2560412|NCT00494299|6276863|P2|COMPLETED|Overall Study||0
2560413|NCT00494299|6276864|P1|COMPLETED|Overall Study||0
2560414|NCT00494299|6276863|P2|Received Treatment|Overall Study||227
2560415|NCT00494299|6276864|P1|Received Treatment|Overall Study||229
2560416|NCT00494299|6276863|P2|STARTED|Overall Study||229
2560417|NCT00494299|6276864|P1|STARTED|Overall Study||229
2560418|NCT00494234|6276876|P2|NOT COMPLETED|Overall Study||10
2560419|NCT00494234|6276877|P1|NOT COMPLETED|Overall Study||15
2560420|NCT00494234|6276876|P2|COMPLETED|Overall Study||17
2560421|NCT00494234|6276877|P1|COMPLETED|Overall Study||12
2560422|NCT00494234|6276876|P2|STARTED|Overall Study||27
2560423|NCT00494234|6276877|P1|STARTED|Overall Study||27
2560424|NCT00494221|6276896|P3|NOT COMPLETED|Overall Study||14
2560425|NCT00494221|6276897|P2|NOT COMPLETED|Overall Study||11
2560426|NCT00494221|6276898|P1|NOT COMPLETED|Overall Study||16
2560427|NCT00494221|6276896|P3|COMPLETED|Overall Study||44
2560428|NCT00494221|6276897|P2|COMPLETED|Overall Study||45
2560429|NCT00494221|6276898|P1|COMPLETED|Overall Study||42
2560430|NCT00494221|6276896|P3|STARTED|Overall Study||58
2560431|NCT00494221|6276897|P2|STARTED|Overall Study||56
2560432|NCT00494221|6276898|P1|STARTED|Overall Study||58
2560433|NCT00494143|6276918|P6|NOT COMPLETED|Overall Study||0
2560434|NCT00494143|6276919|P5|NOT COMPLETED|Overall Study||0
2560435|NCT00494143|6276920|P4|NOT COMPLETED|Overall Study||0
2560436|NCT00494143|6276921|P3|NOT COMPLETED|Overall Study||0
2560437|NCT00494143|6276922|P2|NOT COMPLETED|Overall Study||0
2560438|NCT00494143|6276923|P1|NOT COMPLETED|Overall Study||0
2560439|NCT00494143|6276918|P6|COMPLETED|Overall Study||0
2560440|NCT00494143|6276919|P5|COMPLETED|Overall Study||1
2560441|NCT00494143|6276920|P4|COMPLETED|Overall Study||0
2560442|NCT00494143|6276921|P3|COMPLETED|Overall Study||3
2560443|NCT00494143|6276922|P2|COMPLETED|Overall Study||2
2560444|NCT00494143|6276923|P1|COMPLETED|Overall Study||1
2560445|NCT00494143|6276918|P6|STARTED|Overall Study||0
2560446|NCT00494143|6276919|P5|STARTED|Overall Study||1
2560447|NCT00494143|6276920|P4|STARTED|Overall Study||0
2560448|NCT00494143|6276921|P3|STARTED|Overall Study||3
2560449|NCT00494143|6276922|P2|STARTED|Overall Study||2
2560450|NCT00494143|6276923|P1|STARTED|Overall Study||1
2560451|NCT00494091|6276939|P2|NOT COMPLETED|Overall Study||76
2560452|NCT00494091|6276940|P1|NOT COMPLETED|Overall Study||6
2560453|NCT00494091|6276939|P2|COMPLETED|Overall Study||0
2560454|NCT00494091|6276940|P1|COMPLETED|Overall Study||0
2560455|NCT00494091|6276939|P2|STARTED|Overall Study||76
2560456|NCT00494091|6276940|P1|STARTED|Overall Study||6
2560457|NCT00494026|6276962|P1|NOT COMPLETED|Overall Study||4
2560458|NCT00494026|6276962|P1|COMPLETED|Overall Study|2 patients did receive the full study treatment prior to the study being terminated.|0
2560459|NCT00494026|6276962|P1|STARTED|Overall Study||4
2560460|NCT00494013|6276972|P2|NOT COMPLETED|Overall Study||36
2560461|NCT00494013|6276973|P1|NOT COMPLETED|Overall Study||30
2560462|NCT00494013|6276972|P2|COMPLETED|Overall Study||183
2560463|NCT00494013|6276973|P1|COMPLETED|Overall Study||193
2560464|NCT00494013|6276972|P2|Full Analysis Set (Intent to Treat)|Overall Study||210
2560465|NCT00494013|6276973|P1|Full Analysis Set (Intent to Treat)|Overall Study||219
2560466|NCT00494013|6276972|P2|STARTED|Overall Study||219
2560467|NCT00494013|6276973|P1|STARTED|Overall Study||223
2560468|NCT00493974|6277003|P2|NOT COMPLETED|Overall Study||14
2560469|NCT00493974|6277004|P1|NOT COMPLETED|Overall Study||13
2560470|NCT00493974|6277003|P2|COMPLETED|Overall Study||45
2560471|NCT00493974|6277004|P1|COMPLETED|Overall Study||47
2560472|NCT00493974|6277003|P2|STARTED|Overall Study||59
2560473|NCT00493974|6277004|P1|STARTED|Overall Study||60
2560474|NCT00493805|6277022|P2|NOT COMPLETED|Overall Study||0
2560475|NCT00493805|6277023|P1|NOT COMPLETED|Overall Study||0
2560476|NCT00493805|6277022|P2|COMPLETED|Overall Study||42
2560477|NCT00493805|6277023|P1|COMPLETED|Overall Study||17
2560478|NCT00493805|6277022|P2|STARTED|Overall Study||42
2560479|NCT00493805|6277023|P1|STARTED|Overall Study||17
2560480|NCT00493779|6277031|P1|NOT COMPLETED|Overall Study||1
2560481|NCT00493779|6277031|P1|COMPLETED|Overall Study|Completed follow-up phase|97
2560482|NCT00493779|6277031|P1|STARTED|Overall Study|Number of subjects who had discontinued clopidogrel treatment and entered follow-up phase|98
2560483|NCT00493649|6277038|P1|NOT COMPLETED|Overall Study||82
2560484|NCT00493649|6277038|P1|COMPLETED|Overall Study||411
2560485|NCT00493649|6277038|P1|STARTED|Overall Study||493
2560486|NCT00493636|6277051|P2|NOT COMPLETED|Overall Study||2
2560487|NCT00493636|6277052|P1|NOT COMPLETED|Overall Study||2
2560488|NCT00493636|6277051|P2|COMPLETED|Overall Study||77
2560489|NCT00493636|6277052|P1|COMPLETED|Overall Study||79
2560490|NCT00493636|6277051|P2|STARTED|Overall Study||79
2560491|NCT00493636|6277052|P1|STARTED|Overall Study||81
2560492|NCT00493454|6277066|P1|NOT COMPLETED|Overall Study||1
2560493|NCT00493454|6277066|P1|COMPLETED|Overall Study||5
2560494|NCT00493454|6277066|P1|STARTED|Overall Study||6
2560495|NCT00493311|6277072|P2|NOT COMPLETED|Overall Study||2
2560496|NCT00493311|6277073|P1|NOT COMPLETED|Overall Study||2
2560497|NCT00493311|6277072|P2|COMPLETED|Overall Study||29
2560498|NCT00493311|6277073|P1|COMPLETED|Overall Study||27
2560499|NCT00493311|6277072|P2|STARTED|Overall Study||31
2560500|NCT00493311|6277073|P1|STARTED|Overall Study||29
2560501|NCT00493285|6277093|P6|NOT COMPLETED|Overall Study||0
2560502|NCT00493285|6277094|P5|NOT COMPLETED|Overall Study||1
2560503|NCT00493285|6277095|P4|NOT COMPLETED|Overall Study||0
2560504|NCT00493285|6277096|P3|NOT COMPLETED|Overall Study||0
2560505|NCT00493285|6277097|P2|NOT COMPLETED|Overall Study||0
2560506|NCT00493285|6277098|P1|NOT COMPLETED|Overall Study||0
2560507|NCT00493285|6277093|P6|COMPLETED|Overall Study||5
2560508|NCT00493285|6277094|P5|COMPLETED|Overall Study||9
2560509|NCT00493285|6277095|P4|COMPLETED|Overall Study||6
2560510|NCT00493285|6277096|P3|COMPLETED|Overall Study||9
2560511|NCT00493285|6277097|P2|COMPLETED|Overall Study||6
2560512|NCT00493285|6277098|P1|COMPLETED|Overall Study||13
2560513|NCT00493285|6277093|P6|STARTED|Overall Study||5
2560514|NCT00493285|6277094|P5|STARTED|Overall Study||10
2560515|NCT00493285|6277095|P4|STARTED|Overall Study||6
2560516|NCT00493285|6277096|P3|STARTED|Overall Study||9
2560517|NCT00493285|6277097|P2|STARTED|Overall Study||6
2560518|NCT00493285|6277098|P1|STARTED|Overall Study||13
2560519|NCT00493246|6277330|P8|NOT COMPLETED|Overall Study||0
2560520|NCT00493246|6277331|P7|NOT COMPLETED|Overall Study||1
2560521|NCT00493246|6277332|P6|NOT COMPLETED|Overall Study||1
2560522|NCT00493246|6277333|P5|NOT COMPLETED|Overall Study||1
2560523|NCT00493246|6277334|P4|NOT COMPLETED|Overall Study||0
2560524|NCT00493246|6277335|P3|NOT COMPLETED|Overall Study||0
2560525|NCT00493246|6277336|P2|NOT COMPLETED|Overall Study||0
2560526|NCT00493246|6277337|P1|NOT COMPLETED|Overall Study||0
2560527|NCT00493246|6277330|P8|COMPLETED|Overall Study|Completed study 30 days after the last dose|10
2560528|NCT00493246|6277331|P7|COMPLETED|Overall Study|Completed study 30 days after the last dose|11
2560529|NCT00493246|6277332|P6|COMPLETED|Overall Study|Completed study 30 days after the last dose|15
2560530|NCT00493246|6277333|P5|COMPLETED|Overall Study|Completed study 30 days after the last dose|8
2560531|NCT00493246|6277334|P4|COMPLETED|Overall Study|Completed study 30 days after the last dose|13
2560532|NCT00493246|6277335|P3|COMPLETED|Overall Study|Completed study 30 days after the last dose|12
2560533|NCT00493246|6277336|P2|COMPLETED|Overall Study|Completed study 30 days after the last dose|1
2560534|NCT00493246|6277337|P1|COMPLETED|Overall Study|Completed study 30 days after the last dose|2
2560535|NCT00493246|6277330|P8|STARTED|Overall Study|All subjects who were randomized.|10
2560536|NCT00493246|6277331|P7|STARTED|Overall Study|All subjects who were randomized.|12
2560537|NCT00493246|6277332|P6|STARTED|Overall Study|All subjects who were randomized.|16
2560538|NCT00493246|6277333|P5|STARTED|Overall Study|All subjects who were randomized.Excludes 1 subject who was randomized in error.|9
2560539|NCT00493246|6277334|P4|STARTED|Overall Study||13
2560540|NCT00493246|6277335|P3|STARTED|Overall Study||12
2560541|NCT00493246|6277336|P2|STARTED|Overall Study||1
2560542|NCT00493246|6277337|P1|STARTED|Overall Study||2
2560543|NCT00493220|6277401|P6|NOT COMPLETED|Final 7-Day Safety Follow-up||0
2560544|NCT00493220|6277402|P5|NOT COMPLETED|Final 7-Day Safety Follow-up||0
2560545|NCT00493220|6277403|P4|NOT COMPLETED|Final 7-Day Safety Follow-up||0
2560546|NCT00493220|6277404|P3|NOT COMPLETED|Final 7-Day Safety Follow-up||0
2560547|NCT00493220|6277405|P2|NOT COMPLETED|Final 7-Day Safety Follow-up||0
2560548|NCT00493220|6277406|P1|NOT COMPLETED|Final 7-Day Safety Follow-up||0
2560549|NCT00493220|6277401|P6|COMPLETED|Final 7-Day Safety Follow-up||5
2560550|NCT00493220|6277402|P5|COMPLETED|Final 7-Day Safety Follow-up||5
2560551|NCT00493220|6277403|P4|COMPLETED|Final 7-Day Safety Follow-up||5
2560552|NCT00493220|6277404|P3|COMPLETED|Final 7-Day Safety Follow-up||5
2560553|NCT00493220|6277405|P2|COMPLETED|Final 7-Day Safety Follow-up||5
2560554|NCT00493220|6277406|P1|COMPLETED|Final 7-Day Safety Follow-up||4
2560555|NCT00493220|6277401|P6|STARTED|Final 7-Day Safety Follow-up||5
2560556|NCT00493220|6277402|P5|STARTED|Final 7-Day Safety Follow-up||5
2560557|NCT00493220|6277403|P4|STARTED|Final 7-Day Safety Follow-up||5
2560558|NCT00493220|6277404|P3|STARTED|Final 7-Day Safety Follow-up||5
2560559|NCT00493220|6277405|P2|STARTED|Final 7-Day Safety Follow-up||5
2560560|NCT00493220|6277406|P1|STARTED|Final 7-Day Safety Follow-up||4
2560561|NCT00493220|6277401|P6|NOT COMPLETED|Third Intervention||0
2560562|NCT00493220|6277402|P5|NOT COMPLETED|Third Intervention||0
2560563|NCT00493220|6277403|P4|NOT COMPLETED|Third Intervention||0
2560564|NCT00493220|6277404|P3|NOT COMPLETED|Third Intervention||0
2560565|NCT00493220|6277405|P2|NOT COMPLETED|Third Intervention||0
2560566|NCT00493220|6277406|P1|NOT COMPLETED|Third Intervention||1
2560567|NCT00493220|6277401|P6|COMPLETED|Third Intervention||5
2560568|NCT00493220|6277402|P5|COMPLETED|Third Intervention||5
2560569|NCT00493220|6277403|P4|COMPLETED|Third Intervention||5
2560570|NCT00493220|6277404|P3|COMPLETED|Third Intervention||5
2560571|NCT00493220|6277405|P2|COMPLETED|Third Intervention||5
2560572|NCT00493220|6277406|P1|COMPLETED|Third Intervention||4
2560573|NCT00493220|6277401|P6|STARTED|Third Intervention||5
2560574|NCT00493220|6277402|P5|STARTED|Third Intervention||5
2560575|NCT00493220|6277403|P4|STARTED|Third Intervention||5
2560576|NCT00493220|6277404|P3|STARTED|Third Intervention||5
2560577|NCT00493220|6277405|P2|STARTED|Third Intervention||5
2560578|NCT00493220|6277406|P1|STARTED|Third Intervention||5
2560579|NCT00493220|6277401|P6|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
2560580|NCT00493220|6277402|P5|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
2560581|NCT00493220|6277403|P4|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
2560582|NCT00493220|6277404|P3|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
2560583|NCT00493220|6277405|P2|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
2560584|NCT00493220|6277406|P1|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
2560585|NCT00493220|6277401|P6|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
2560586|NCT00493220|6277402|P5|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
2560587|NCT00493220|6277403|P4|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
2560588|NCT00493220|6277404|P3|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
2560589|NCT00493220|6277405|P2|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
2560590|NCT00493220|6277406|P1|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
2560591|NCT00493220|6277401|P6|STARTED|Second 7-Day Washout & Safety Follow-up||5
2560592|NCT00493220|6277402|P5|STARTED|Second 7-Day Washout & Safety Follow-up||5
2560593|NCT00493220|6277403|P4|STARTED|Second 7-Day Washout & Safety Follow-up||5
2560594|NCT00493220|6277404|P3|STARTED|Second 7-Day Washout & Safety Follow-up||5
2560595|NCT00493220|6277405|P2|STARTED|Second 7-Day Washout & Safety Follow-up||5
2560596|NCT00493220|6277406|P1|STARTED|Second 7-Day Washout & Safety Follow-up||5
2560597|NCT00493220|6277401|P6|NOT COMPLETED|Second Intervention||0
2560598|NCT00493220|6277402|P5|NOT COMPLETED|Second Intervention||0
2560599|NCT00493220|6277403|P4|NOT COMPLETED|Second Intervention||0
2560600|NCT00493220|6277404|P3|NOT COMPLETED|Second Intervention||0
2560601|NCT00493220|6277405|P2|NOT COMPLETED|Second Intervention||0
2560602|NCT00493220|6277406|P1|NOT COMPLETED|Second Intervention||0
2560603|NCT00493220|6277401|P6|COMPLETED|Second Intervention||5
2560604|NCT00493220|6277402|P5|COMPLETED|Second Intervention||5
2560605|NCT00493220|6277403|P4|COMPLETED|Second Intervention||5
2560606|NCT00493220|6277404|P3|COMPLETED|Second Intervention||5
2560607|NCT00493220|6277405|P2|COMPLETED|Second Intervention||5
2560608|NCT00493220|6277406|P1|COMPLETED|Second Intervention||5
2560609|NCT00493220|6277401|P6|STARTED|Second Intervention||5
2560610|NCT00493220|6277402|P5|STARTED|Second Intervention||5
2560611|NCT00493220|6277403|P4|STARTED|Second Intervention||5
2560612|NCT00493220|6277404|P3|STARTED|Second Intervention||5
2560613|NCT00493220|6277405|P2|STARTED|Second Intervention||5
2560614|NCT00493220|6277406|P1|STARTED|Second Intervention||5
2560615|NCT00493220|6277401|P6|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
2560616|NCT00493220|6277402|P5|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
2560617|NCT00493220|6277403|P4|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
2560618|NCT00493220|6277404|P3|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
2560619|NCT00493220|6277405|P2|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
2560620|NCT00493220|6277406|P1|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
2560621|NCT00493220|6277401|P6|COMPLETED|First 7-Day Washout & Safety Follow-up||5
2560622|NCT00493220|6277402|P5|COMPLETED|First 7-Day Washout & Safety Follow-up||5
2560623|NCT00493220|6277403|P4|COMPLETED|First 7-Day Washout & Safety Follow-up||5
2560624|NCT00493220|6277404|P3|COMPLETED|First 7-Day Washout & Safety Follow-up||5
2560625|NCT00493220|6277405|P2|COMPLETED|First 7-Day Washout & Safety Follow-up||5
2560626|NCT00493220|6277406|P1|COMPLETED|First 7-Day Washout & Safety Follow-up||5
2560627|NCT00493220|6277401|P6|STARTED|First 7-Day Washout & Safety Follow-up||5
2560628|NCT00493220|6277402|P5|STARTED|First 7-Day Washout & Safety Follow-up||5
2560629|NCT00493220|6277403|P4|STARTED|First 7-Day Washout & Safety Follow-up||5
2560630|NCT00493220|6277404|P3|STARTED|First 7-Day Washout & Safety Follow-up||5
2560631|NCT00493220|6277405|P2|STARTED|First 7-Day Washout & Safety Follow-up||5
2560632|NCT00493220|6277406|P1|STARTED|First 7-Day Washout & Safety Follow-up||5
2560633|NCT00493220|6277401|P6|NOT COMPLETED|First Intervention||0
2560634|NCT00493220|6277402|P5|NOT COMPLETED|First Intervention||0
2560635|NCT00493220|6277403|P4|NOT COMPLETED|First Intervention||0
2560636|NCT00493220|6277404|P3|NOT COMPLETED|First Intervention||0
2560637|NCT00493220|6277405|P2|NOT COMPLETED|First Intervention||0
2560638|NCT00493220|6277406|P1|NOT COMPLETED|First Intervention||0
2560639|NCT00493220|6277401|P6|COMPLETED|First Intervention||5
2560640|NCT00493220|6277402|P5|COMPLETED|First Intervention||5
2560641|NCT00493220|6277403|P4|COMPLETED|First Intervention||5
2560642|NCT00493220|6277404|P3|COMPLETED|First Intervention||5
2560643|NCT00493220|6277405|P2|COMPLETED|First Intervention||5
2560644|NCT00493220|6277406|P1|COMPLETED|First Intervention||5
2560645|NCT00493220|6277401|P6|STARTED|First Intervention||5
2560646|NCT00493220|6277402|P5|STARTED|First Intervention||5
2560647|NCT00493220|6277403|P4|STARTED|First Intervention||5
2560648|NCT00493220|6277404|P3|STARTED|First Intervention||5
2560649|NCT00493220|6277405|P2|STARTED|First Intervention||5
2560650|NCT00493220|6277406|P1|STARTED|First Intervention||5
2560651|NCT00493181|6277423|P1|NOT COMPLETED|Overall Study||0
2560652|NCT00493181|6277423|P1|COMPLETED|Overall Study||8
2560653|NCT00493181|6277423|P1|STARTED|Overall Study||8
2560654|NCT00493064|6277427|P1|NOT COMPLETED|Overall Study||11
2560655|NCT00493064|6277427|P1|COMPLETED|Overall Study||52
2560656|NCT00493064|6277427|P1|STARTED|Overall Study||63
2560657|NCT00493038|6277434|P2|NOT COMPLETED|Follow-up||0
2560658|NCT00493038|6277435|P1|NOT COMPLETED|Follow-up||1
2560659|NCT00493038|6277434|P2|COMPLETED|Follow-up||126
2560660|NCT00493038|6277435|P1|COMPLETED|Follow-up||122
2560661|NCT00493038|6277434|P2|STARTED|Follow-up||126
2560662|NCT00493038|6277435|P1|STARTED|Follow-up||123
2560663|NCT00493038|6277434|P2|NOT COMPLETED|Treatment||20
2560664|NCT00493038|6277435|P1|NOT COMPLETED|Treatment||24
2560665|NCT00493038|6277434|P2|COMPLETED|Treatment||126
2560666|NCT00493038|6277435|P1|COMPLETED|Treatment||123
2560667|NCT00493038|6277434|P2|Test-of-Cure Visit|Treatment||126
2560668|NCT00493038|6277435|P1|Test-of-Cure Visit|Treatment||123
2560669|NCT00493038|6277434|P2|Treated With Study Medication|Treatment||142
2560670|NCT00493038|6277435|P1|Treated With Study Medication|Treatment||145
2560671|NCT00493038|6277434|P2|Randomization|Treatment||146
2560672|NCT00493038|6277435|P1|Randomization|Treatment||147
2560673|NCT00493038|6277434|P2|STARTED|Treatment||146
2560674|NCT00493038|6277435|P1|STARTED|Treatment||147
2560675|NCT00493025|6277449|P1|NOT COMPLETED|Overall Study||19
2560676|NCT00493025|6277449|P1|COMPLETED|Overall Study|Trial stopped due to early stopping rule|0
2560677|NCT00493025|6277449|P1|STARTED|Overall Study||19
2560678|NCT00493012|6277460|P2|NOT COMPLETED|Overall Study||17
2560679|NCT00493012|6277461|P1|NOT COMPLETED|Overall Study||18
2560680|NCT00493012|6277460|P2|COMPLETED|Overall Study||83
2560681|NCT00493012|6277461|P1|COMPLETED|Overall Study||82
2560682|NCT00493012|6277460|P2|STARTED|Overall Study||100
2560683|NCT00493012|6277461|P1|STARTED|Overall Study||100
2560684|NCT00492973|6277489|P2|NOT COMPLETED|Overall Study||1
2560685|NCT00492973|6277490|P1|NOT COMPLETED|Overall Study||0
2560686|NCT00492973|6277489|P2|COMPLETED|Overall Study|One patient died of complications related to deep joint sepsis in the early postoperative period.|38
2560687|NCT00492973|6277490|P1|COMPLETED|Overall Study||37
2560688|NCT00492973|6277489|P2|STARTED|Overall Study||39
2560689|NCT00492973|6277490|P1|STARTED|Overall Study||37
2560690|NCT00492921|6277504|P3|NOT COMPLETED|Overall Study||1
2560691|NCT00492921|6277505|P2|NOT COMPLETED|Overall Study||0
2560692|NCT00492921|6277506|P1|NOT COMPLETED|Overall Study||1
2560693|NCT00492921|6277504|P3|COMPLETED|Overall Study||2
2560694|NCT00492921|6277505|P2|COMPLETED|Overall Study||4
2560695|NCT00492921|6277506|P1|COMPLETED|Overall Study||4
2560696|NCT00492921|6277504|P3|STARTED|Overall Study||3
2560697|NCT00492921|6277505|P2|STARTED|Overall Study||4
2560698|NCT00492921|6277506|P1|STARTED|Overall Study||5
2560699|NCT00492856|6277517|P4|NOT COMPLETED|Post-consolidation||1
2560700|NCT00492856|6277518|P3|NOT COMPLETED|Post-consolidation||27
2560701|NCT00492856|6277519|P2|NOT COMPLETED|Post-consolidation||12
2560702|NCT00492856|6277520|P1|NOT COMPLETED|Post-consolidation||0
2560703|NCT00492856|6277517|P4|COMPLETED|Post-consolidation||0
2560704|NCT00492856|6277518|P3|COMPLETED|Post-consolidation||0
2560705|NCT00492856|6277519|P2|COMPLETED|Post-consolidation||29
2560706|NCT00492856|6277520|P1|COMPLETED|Post-consolidation||0
2560707|NCT00492856|6277517|P4|STARTED|Post-consolidation||1
2560708|NCT00492856|6277518|P3|STARTED|Post-consolidation||27
2560709|NCT00492856|6277519|P2|STARTED|Post-consolidation||41
2560710|NCT00492856|6277520|P1|STARTED|Post-consolidation|Patients who achieve CRm, are randomized to the treatment arm, and are eligible.|0
2560711|NCT00492856|6277517|P4|NOT COMPLETED|Consolidation||0
2560712|NCT00492856|6277518|P3|NOT COMPLETED|Consolidation||0
2560713|NCT00492856|6277519|P2|NOT COMPLETED|Consolidation||0
2560714|NCT00492856|6277520|P1|NOT COMPLETED|Consolidation||9
2560715|NCT00492856|6277517|P4|COMPLETED|Consolidation||0
2560716|NCT00492856|6277518|P3|COMPLETED|Consolidation||0
2560717|NCT00492856|6277519|P2|COMPLETED|Consolidation||0
2560718|NCT00492856|6277520|P1|COMPLETED|Consolidation||83
2560719|NCT00492856|6277517|P4|STARTED|Consolidation||0
2560720|NCT00492856|6277518|P3|STARTED|Consolidation||0
2560721|NCT00492856|6277519|P2|STARTED|Consolidation||0
2560722|NCT00492856|6277520|P1|STARTED|Consolidation|Patients in CR (CRm), CRi, or PR after induction, register for consolidation and are eligible.|92
2560723|NCT00492856|6277517|P4|NOT COMPLETED|Induction||0
2560724|NCT00492856|6277518|P3|NOT COMPLETED|Induction||0
2560725|NCT00492856|6277519|P2|NOT COMPLETED|Induction||0
2560726|NCT00492856|6277520|P1|NOT COMPLETED|Induction||6
2560727|NCT00492856|6277517|P4|COMPLETED|Induction||0
2560728|NCT00492856|6277518|P3|COMPLETED|Induction||0
2560729|NCT00492856|6277519|P2|COMPLETED|Induction||0
2560730|NCT00492856|6277520|P1|COMPLETED|Induction||99
2560731|NCT00492856|6277517|P4|STARTED|Induction||0
2560732|NCT00492856|6277518|P3|STARTED|Induction||0
2560733|NCT00492856|6277519|P2|STARTED|Induction||0
2560734|NCT00492856|6277520|P1|STARTED|Induction||105
2560735|NCT00492752|6277534|P4|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||6
2560736|NCT00492752|6277535|P3|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||47
2560737|NCT00492752|6277536|P2|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||16
2560738|NCT00492752|6277537|P1|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||86
2560739|NCT00492752|6277534|P4|COMPLETED|Follow-up and/or Open Label Sorafenib||0
2560740|NCT00492752|6277535|P3|COMPLETED|Follow-up and/or Open Label Sorafenib|20 participants were followed up until the end of this trial|20
2560741|NCT00492752|6277536|P2|COMPLETED|Follow-up and/or Open Label Sorafenib||0
2560742|NCT00492752|6277537|P1|COMPLETED|Follow-up and/or Open Label Sorafenib|1 participant completed all assessments, 33 were followed up until the end of this trial|34
2560743|NCT00492752|6277534|P4|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||6
2560744|NCT00492752|6277535|P3|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
2560745|NCT00492752|6277536|P2|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||16
2560746|NCT00492752|6277537|P1|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
2560747|NCT00492752|6277534|P4|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
2560748|NCT00492752|6277535|P3|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||67
2560749|NCT00492752|6277536|P2|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
2560750|NCT00492752|6277537|P1|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||120
2560751|NCT00492752|6277534|P4|STARTED|Follow-up and/or Open Label Sorafenib||6
2560752|NCT00492752|6277535|P3|STARTED|Follow-up and/or Open Label Sorafenib||67
2560753|NCT00492752|6277536|P2|STARTED|Follow-up and/or Open Label Sorafenib||16
2560754|NCT00492752|6277537|P1|STARTED|Follow-up and/or Open Label Sorafenib||120
2560755|NCT00492752|6277534|P4|NOT COMPLETED|Double Blind Treatment||0
2560756|NCT00492752|6277535|P3|NOT COMPLETED|Double Blind Treatment||3
2560757|NCT00492752|6277536|P2|NOT COMPLETED|Double Blind Treatment||0
2560758|NCT00492752|6277537|P1|NOT COMPLETED|Double Blind Treatment||14
2560759|NCT00492752|6277534|P4|COMPLETED|Double Blind Treatment||6
2560760|NCT00492752|6277535|P3|COMPLETED|Double Blind Treatment||67
2560761|NCT00492752|6277536|P2|COMPLETED|Double Blind Treatment||16
2560762|NCT00492752|6277537|P1|COMPLETED|Double Blind Treatment||120
2560763|NCT00492752|6277534|P4|Received Treatment|Double Blind Treatment|Safety Population|6
2560764|NCT00492752|6277535|P3|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to protocol violation.|69
2560765|NCT00492752|6277536|P2|Received Treatment|Double Blind Treatment|Safety Population|16
2560766|NCT00492752|6277537|P1|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to an Adverse Event.|133
2560767|NCT00492752|6277534|P4|STARTED|Double Blind Treatment||6
2560768|NCT00492752|6277535|P3|STARTED|Double Blind Treatment||70
2560769|NCT00492752|6277536|P2|STARTED|Double Blind Treatment||16
2560770|NCT00492752|6277537|P1|STARTED|Double Blind Treatment||134
2560771|NCT00492726|6277572|P2|NOT COMPLETED|Overall Study||36
2560772|NCT00492726|6277573|P1|NOT COMPLETED|Overall Study||50
2560773|NCT00492726|6277572|P2|COMPLETED|Overall Study||358
2560774|NCT00492726|6277573|P1|COMPLETED|Overall Study||360
2560775|NCT00492726|6277572|P2|End of Study|Overall Study||358
2560776|NCT00492726|6277573|P1|End of Study|Overall Study||360
2560777|NCT00492726|6277572|P2|End of Treatment (EOT, Day 5 to 14)|Overall Study||377
2560778|NCT00492726|6277573|P1|End of Treatment (EOT, Day 5 to 14)|Overall Study||387
2560779|NCT00492726|6277572|P2|STARTED|Overall Study||394
2560780|NCT00492726|6277573|P1|STARTED|Overall Study||410
2560781|NCT00492648|6277599|P2|NOT COMPLETED|Month 42 (109674 Study)||0
2560782|NCT00492648|6277600|P1|NOT COMPLETED|Month 42 (109674 Study)||0
2560783|NCT00492648|6277599|P2|COMPLETED|Month 42 (109674 Study)||20
2560784|NCT00492648|6277600|P1|COMPLETED|Month 42 (109674 Study)||3
2560785|NCT00492648|6277599|P2|STARTED|Month 42 (109674 Study)||20
2560786|NCT00492648|6277600|P1|STARTED|Month 42 (109674 Study)||3
2560787|NCT00492648|6277599|P2|NOT COMPLETED|Month 30 (109671 Study)||1
2560788|NCT00492648|6277600|P1|NOT COMPLETED|Month 30 (109671 Study)||0
2560789|NCT00492648|6277599|P2|COMPLETED|Month 30 (109671 Study)||29
2560790|NCT00492648|6277600|P1|COMPLETED|Month 30 (109671 Study)||4
2560791|NCT00492648|6277599|P2|STARTED|Month 30 (109671 Study)||30
2560792|NCT00492648|6277600|P1|STARTED|Month 30 (109671 Study)||4
2560793|NCT00492622|6277626|P1|NOT COMPLETED|Overall Study||0
2560794|NCT00492622|6277626|P1|COMPLETED|Overall Study||12
2560795|NCT00492622|6277626|P1|STARTED|Overall Study|all subjects received the immediate release formulation|12
2560796|NCT00492583|6277638|P2|NOT COMPLETED|Overall Study||0
2560797|NCT00492583|6277639|P1|NOT COMPLETED|Overall Study||0
2560798|NCT00492583|6277638|P2|COMPLETED|Overall Study||87
2560799|NCT00492583|6277639|P1|COMPLETED|Overall Study||95
2560800|NCT00492583|6277638|P2|STARTED|Overall Study||87
2560801|NCT00492583|6277639|P1|STARTED|Overall Study||95
2560802|NCT00492557|6277647|P2|NOT COMPLETED|Overall Study||23
2560803|NCT00492557|6277648|P1|NOT COMPLETED|Overall Study||24
2560804|NCT00492557|6277647|P2|COMPLETED|Overall Study||557
2560805|NCT00492557|6277648|P1|COMPLETED|Overall Study||556
2560806|NCT00492557|6277647|P2|Vaccinated Dose 2|Overall Study||558
2560807|NCT00492557|6277648|P1|Vaccinated Dose 2|Overall Study||560
2560808|NCT00492557|6277647|P2|Vaccinated Dose 1|Overall Study||575
2560809|NCT00492557|6277648|P1|Vaccinated Dose 1|Overall Study||577
2560810|NCT00492557|6277647|P2|STARTED|Overall Study||580
2560811|NCT00492557|6277648|P1|STARTED|Overall Study||580
2560812|NCT00492544|6277664|P1|NOT COMPLETED|Overall Study||0
2560813|NCT00492544|6277664|P1|COMPLETED|Overall Study||100
2560814|NCT00492544|6277664|P1|STARTED|Overall Study||100
2560815|NCT00492531|6277678|P2|NOT COMPLETED|Overall Study||23
2560816|NCT00492531|6277679|P1|NOT COMPLETED|Overall Study||22
2560817|NCT00492531|6277678|P2|COMPLETED|Overall Study|Of 14 subjects who completed study, 13 were enrolled in Open label.|14
2560818|NCT00492531|6277679|P1|COMPLETED|Overall Study|Of 15 subjects who completed study, 13 were enrolled in Open label.|15
2560819|NCT00492531|6277678|P2|STARTED|Overall Study||37
2560820|NCT00492531|6277679|P1|STARTED|Overall Study||37
2560821|NCT00492401|6277691|P1|NOT COMPLETED|Overall Study||0
2560822|NCT00492401|6277691|P1|COMPLETED|Overall Study||55
2560823|NCT00492401|6277691|P1|STARTED|Overall Study||55
2560824|NCT00492349|6277702|P2|NOT COMPLETED|Overall Study||7
2560825|NCT00492349|6277703|P1|NOT COMPLETED|Overall Study||3
2560826|NCT00492349|6277702|P2|COMPLETED|Overall Study||27
2560827|NCT00492349|6277703|P1|COMPLETED|Overall Study||32
2560828|NCT00492349|6277702|P2|Week 8|Overall Study||27
2560829|NCT00492349|6277703|P1|Week 8|Overall Study||32
2560830|NCT00492349|6277702|P2|Week 2|Overall Study||33
2560831|NCT00492349|6277703|P1|Week 2|Overall Study||32
2560832|NCT00492349|6277702|P2|STARTED|Overall Study||34
2560833|NCT00492349|6277703|P1|STARTED|Overall Study||35
2560834|NCT00492336|6277725|P2|NOT COMPLETED|Overall Study||6
2560835|NCT00492336|6277726|P1|NOT COMPLETED|Overall Study||2
2560836|NCT00492336|6277725|P2|COMPLETED|Overall Study||23
2560837|NCT00492336|6277726|P1|COMPLETED|Overall Study||26
2560838|NCT00492336|6277725|P2|STARTED|Overall Study||29
2560839|NCT00492336|6277726|P1|STARTED|Overall Study||28
2560840|NCT00492297|6277752|P1|NOT COMPLETED|Survival Only Follow-up||59
2560841|NCT00492297|6277752|P1|COMPLETED|Survival Only Follow-up||0
2560842|NCT00492297|6277752|P1|STARTED|Survival Only Follow-up||59
2560843|NCT00492297|6277752|P1|NOT COMPLETED|Active Follow-up 30(+4) Days Duration||19
2560844|NCT00492297|6277752|P1|COMPLETED|Active Follow-up 30(+4) Days Duration||59
2560845|NCT00492297|6277752|P1|STARTED|Active Follow-up 30(+4) Days Duration|AFU is 30(+4) days duration for subjects withdrawn from sorafenib due to PD.|78
2560846|NCT00492297|6277752|P1|NOT COMPLETED|Treatment||5
2560847|NCT00492297|6277752|P1|COMPLETED|Treatment||78
2560848|NCT00492297|6277752|P1|Second Stage of Simon Optimal Design|Treatment|Recruitment continued into the second stage. 51 of 83 subjects were treated in the second stage.|51
2560849|NCT00492297|6277752|P1|First Stage of Simon Optimal Design|Treatment|32 subjects of 83 subjects enrolled were treated in first stage.|32
2560850|NCT00492297|6277752|P1|STARTED|Treatment||83
2560851|NCT00492284|6277770|P4|NOT COMPLETED|Overall Study||10
2560852|NCT00492284|6277771|P3|NOT COMPLETED|Overall Study||6
2560853|NCT00492284|6277772|P2|NOT COMPLETED|Overall Study||4
2560854|NCT00492284|6277773|P1|NOT COMPLETED|Overall Study||1
2560855|NCT00492284|6277770|P4|COMPLETED|Overall Study||31
2560856|NCT00492284|6277771|P3|COMPLETED|Overall Study||37
2560857|NCT00492284|6277772|P2|COMPLETED|Overall Study||35
2560858|NCT00492284|6277773|P1|COMPLETED|Overall Study||38
2560859|NCT00492284|6277770|P4|STARTED|Overall Study||41
2560860|NCT00492284|6277771|P3|STARTED|Overall Study||43
2560861|NCT00492284|6277772|P2|STARTED|Overall Study||39
2560862|NCT00492284|6277773|P1|STARTED|Overall Study||39
2560863|NCT00492232|6277817|P2|NOT COMPLETED|Open-Label Treatment||0
2560864|NCT00492232|6277818|P1|NOT COMPLETED|Open-Label Treatment||1
2560865|NCT00492232|6277817|P2|COMPLETED|Open-Label Treatment||0
2560866|NCT00492232|6277818|P1|COMPLETED|Open-Label Treatment||88
2560867|NCT00492232|6277817|P2|STARTED|Open-Label Treatment|All subjects received ramelteon in the OLTP.|0
2560868|NCT00492232|6277818|P1|STARTED|Open-Label Treatment|In the previous DBTP, 45 and 44 subjects were randomized to ramelteon and placebo, respectively.|89
2560869|NCT00492232|6277817|P2|NOT COMPLETED|Double-Blind Treatment||25
2560870|NCT00492232|6277818|P1|NOT COMPLETED|Double-Blind Treatment||18
2560871|NCT00492232|6277817|P2|COMPLETED|Double-Blind Treatment||45
2560872|NCT00492232|6277818|P1|COMPLETED|Double-Blind Treatment||47
2560873|NCT00492232|6277817|P2|STARTED|Double-Blind Treatment||70
2560874|NCT00492232|6277818|P1|STARTED|Double-Blind Treatment||65
2560875|NCT00492232|6277817|P2|NOT COMPLETED|Placebo Run-in||70
2560876|NCT00492232|6277818|P1|NOT COMPLETED|Placebo Run-in||0
2560877|NCT00492232|6277817|P2|COMPLETED|Placebo Run-in|These subjects successfully completed the placebo run-in period and were randomized to the DBTP.|135
2560878|NCT00492232|6277818|P1|COMPLETED|Placebo Run-in||0
2560879|NCT00492232|6277817|P2|STARTED|Placebo Run-in|All subjects received placebo in the placebo run-in period.|205
2560880|NCT00492232|6277818|P1|STARTED|Placebo Run-in||0
2560881|NCT00492206|6277850|P1|NOT COMPLETED|Overall Study||0
2560882|NCT00492206|6277850|P1|COMPLETED|Overall Study||40
2560883|NCT00492206|6277850|P1|STARTED|Overall Study||40
2560884|NCT00492115|6277859|P2|NOT COMPLETED|Overall Study||4
2560885|NCT00492115|6277860|P1|NOT COMPLETED|Overall Study||3
2560886|NCT00492115|6277859|P2|COMPLETED|Overall Study|4 dropped due to not being able to tolerate CPAP|15
2560887|NCT00492115|6277860|P1|COMPLETED|Overall Study|3 dropped due to anxiety or not being able to tolerate CPAP|16
2560888|NCT00492115|6277859|P2|STARTED|Overall Study||19
2560889|NCT00492115|6277860|P1|STARTED|Overall Study||19
2560890|NCT00492089|6277870|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
2560891|NCT00492089|6277871|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
2560892|NCT00492089|6277870|P2|COMPLETED|Second Intervention (6 Weeks)||6
2560893|NCT00492089|6277871|P1|COMPLETED|Second Intervention (6 Weeks)||5
2560894|NCT00492089|6277870|P2|STARTED|Second Intervention (6 Weeks)||6
2560895|NCT00492089|6277871|P1|STARTED|Second Intervention (6 Weeks)||5
2560896|NCT00492089|6277870|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
2560897|NCT00492089|6277871|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
2560898|NCT00492089|6277870|P2|COMPLETED|First Intervention (6 Weeks)||6
2560899|NCT00492089|6277871|P1|COMPLETED|First Intervention (6 Weeks)||5
2560900|NCT00492089|6277870|P2|STARTED|First Intervention (6 Weeks)||6
2560901|NCT00492089|6277871|P1|STARTED|First Intervention (6 Weeks)||5
2560902|NCT00492063|6277881|P4|NOT COMPLETED|Overall Study||10
2560903|NCT00492063|6277882|P3|NOT COMPLETED|Overall Study||11
2560904|NCT00492063|6277883|P2|NOT COMPLETED|Overall Study||14
2560905|NCT00492063|6277884|P1|NOT COMPLETED|Overall Study||10
2560906|NCT00492063|6277881|P4|COMPLETED|Overall Study||666
2560907|NCT00492063|6277882|P3|COMPLETED|Overall Study||667
2560908|NCT00492063|6277883|P2|COMPLETED|Overall Study||634
2560909|NCT00492063|6277884|P1|COMPLETED|Overall Study||642
2560910|NCT00492063|6277881|P4|STARTED|Overall Study||676
2560911|NCT00492063|6277882|P3|STARTED|Overall Study||678
2560912|NCT00492063|6277883|P2|STARTED|Overall Study||648
2560913|NCT00492063|6277884|P1|STARTED|Overall Study||652
2560914|NCT00492024|6277908|P2|NOT COMPLETED|Follow up||2
2560915|NCT00492024|6277909|P1|NOT COMPLETED|Follow up||1
2560916|NCT00492024|6277908|P2|COMPLETED|Follow up||99
2560917|NCT00492024|6277909|P1|COMPLETED|Follow up||221
2560918|NCT00492024|6277908|P2|STARTED|Follow up||101
2560919|NCT00492024|6277909|P1|STARTED|Follow up||222
2560920|NCT00492024|6277908|P2|NOT COMPLETED|Treatment||22
2560921|NCT00492024|6277909|P1|NOT COMPLETED|Treatment||29
2560922|NCT00492024|6277908|P2|COMPLETED|Treatment||101
2560923|NCT00492024|6277909|P1|COMPLETED|Treatment||222
2560924|NCT00492024|6277908|P2|STARTED|Treatment||123
2560925|NCT00492024|6277909|P1|STARTED|Treatment||251
2560926|NCT00491894|6277925|P1|NOT COMPLETED|Overall Study||34
2560927|NCT00491894|6277925|P1|COMPLETED|Overall Study||103
2560928|NCT00491894|6277925|P1|STARTED|Overall Study||137
2560929|NCT00491829|6277936|P3|NOT COMPLETED|Overall Study||75
2560930|NCT00491829|6277937|P2|NOT COMPLETED|Overall Study||114
2560931|NCT00491829|6277938|P1|NOT COMPLETED|Overall Study||95
2560932|NCT00491829|6277936|P3|COMPLETED|Overall Study||243
2560933|NCT00491829|6277937|P2|COMPLETED|Overall Study||202
2560934|NCT00491829|6277938|P1|COMPLETED|Overall Study||216
2560935|NCT00491829|6277936|P3|STARTED|Overall Study||318
2560936|NCT00491829|6277937|P2|STARTED|Overall Study||316
2560937|NCT00491829|6277938|P1|STARTED|Overall Study||311
2560938|NCT00491764|6277952|P6|NOT COMPLETED|Overall Study||9
2560939|NCT00491764|6277953|P5|NOT COMPLETED|Overall Study||3
2560940|NCT00491764|6277954|P4|NOT COMPLETED|Overall Study||8
2560941|NCT00491764|6277955|P3|NOT COMPLETED|Overall Study||8
2560942|NCT00491764|6277956|P2|NOT COMPLETED|Overall Study||7
2560943|NCT00491764|6277957|P1|NOT COMPLETED|Overall Study||5
2560944|NCT00491764|6277952|P6|COMPLETED|Overall Study||27
2560945|NCT00491764|6277953|P5|COMPLETED|Overall Study||33
2560946|NCT00491764|6277954|P4|COMPLETED|Overall Study||28
2560947|NCT00491764|6277955|P3|COMPLETED|Overall Study||28
2560948|NCT00491764|6277956|P2|COMPLETED|Overall Study||30
2560949|NCT00491764|6277957|P1|COMPLETED|Overall Study||32
2560950|NCT00491764|6277952|P6|STARTED|Overall Study||36
2560951|NCT00491764|6277953|P5|STARTED|Overall Study||36
2560952|NCT00491764|6277954|P4|STARTED|Overall Study||36
2560953|NCT00491764|6277955|P3|STARTED|Overall Study||36
2560954|NCT00491764|6277956|P2|STARTED|Overall Study||37
2560955|NCT00491764|6277957|P1|STARTED|Overall Study||37
2560956|NCT00491751|6277986|P3|NOT COMPLETED|Overall Study||0
2560957|NCT00491751|6277987|P2|NOT COMPLETED|Overall Study||0
2560958|NCT00491751|6277988|P1|NOT COMPLETED|Overall Study||0
2560959|NCT00491751|6277986|P3|COMPLETED|Overall Study||42
2560960|NCT00491751|6277987|P2|COMPLETED|Overall Study||44
2560961|NCT00491751|6277988|P1|COMPLETED|Overall Study||22
2560962|NCT00491751|6277986|P3|STARTED|Overall Study||42
2560963|NCT00491751|6277987|P2|STARTED|Overall Study||44
2560964|NCT00491751|6277988|P1|STARTED|Overall Study||22
2560965|NCT00491738|6278000|P2|NOT COMPLETED|Overall Study||0
2560966|NCT00491738|6278001|P1|NOT COMPLETED|Overall Study||0
2560967|NCT00491738|6278000|P2|COMPLETED|Overall Study||9
2560968|NCT00491738|6278001|P1|COMPLETED|Overall Study||7
2560969|NCT00491738|6278000|P2|STARTED|Overall Study||9
2560970|NCT00491738|6278001|P1|STARTED|Overall Study||7
2560971|NCT00491608|6278005|P1|NOT COMPLETED|Overall Study||3
2560972|NCT00491608|6278005|P1|COMPLETED|Overall Study||206
2560973|NCT00491608|6278005|P1|STARTED|Overall Study|Participants who received treatment|209
2560974|NCT00491556|6278016|P2|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||5
2560975|NCT00491556|6278017|P1|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||24
2560976|NCT00491556|6278016|P2|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||22
2560977|NCT00491556|6278017|P1|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||25
2560978|NCT00491556|6278016|P2|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||27
2560979|NCT00491556|6278017|P1|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||49
2560980|NCT00491556|6278016|P2|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||0
2560981|NCT00491556|6278017|P1|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||26
2560982|NCT00491556|6278016|P2|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||27
2560983|NCT00491556|6278017|P1|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||49
2560984|NCT00491556|6278016|P2|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||27
2560985|NCT00491556|6278017|P1|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||53
2560986|NCT00491556|6278016|P2|STARTED|Entry-Week (WK) 48: EXP/Standard Care||27
2560987|NCT00491556|6278017|P1|STARTED|Entry-Week (WK) 48: EXP/Standard Care||75
2560988|NCT00491530|6278076|P3|NOT COMPLETED|Overall Study||5
2560989|NCT00491530|6278077|P2|NOT COMPLETED|Overall Study||6
2560990|NCT00491530|6278078|P1|NOT COMPLETED|Overall Study||12
2560991|NCT00491530|6278076|P3|COMPLETED|Overall Study||81
2560992|NCT00491530|6278077|P2|COMPLETED|Overall Study||44
2560993|NCT00491530|6278078|P1|COMPLETED|Overall Study||162
2560994|NCT00491530|6278076|P3|STARTED|Overall Study||86
2560995|NCT00491530|6278077|P2|STARTED|Overall Study||50
2560996|NCT00491530|6278078|P1|STARTED|Overall Study||174
2560997|NCT00491504|6278108|P4|NOT COMPLETED|Overall Study||4
2560998|NCT00491504|6278109|P3|NOT COMPLETED|Overall Study||4
2560999|NCT00491504|6278110|P2|NOT COMPLETED|Overall Study||1
2561000|NCT00491504|6278111|P1|NOT COMPLETED|Overall Study||0
2561001|NCT00491504|6278108|P4|COMPLETED|Overall Study||73
2561002|NCT00491504|6278109|P3|COMPLETED|Overall Study||74
2561003|NCT00491504|6278110|P2|COMPLETED|Overall Study||77
2561004|NCT00491504|6278111|P1|COMPLETED|Overall Study||77
2561005|NCT00491504|6278108|P4|STARTED|Overall Study|All subjects who received placebo on Day 1 through Day 7|77
2561006|NCT00491504|6278109|P3|STARTED|Overall Study|All subjects who received MFNS on Day 1 through Day 7|78
2561007|NCT00491504|6278110|P2|STARTED|Overall Study|All subjects who received placebo only on Day 1|78
2561008|NCT00491504|6278111|P1|STARTED|Overall Study|All subjects who received MFNS only on Day 1|77
2561009|NCT00491400|6278121|P2|NOT COMPLETED|Overall Study||4
2561010|NCT00491400|6278122|P1|NOT COMPLETED|Overall Study||5
2561011|NCT00491400|6278121|P2|COMPLETED|Overall Study||9
2561012|NCT00491400|6278122|P1|COMPLETED|Overall Study||10
2561013|NCT00491400|6278121|P2|Finished Second Treatment|Overall Study|None withdrew during fenofibrate treatment (second treatment)|9
2561014|NCT00491400|6278122|P1|Finished Second Treatment|Overall Study|2 withdrew during atorvastatin treatment (second treatment)|10
2561015|NCT00491400|6278121|P2|Started Second Treatment|Overall Study|None withdrew during the washout period|9
2561016|NCT00491400|6278122|P1|Started Second Treatment|Overall Study|2 withdrew during washout period|12
2561017|NCT00491400|6278121|P2|Completed First Treatment|Overall Study|4 withdrew during atorvastatin treatment (first treatment)|9
2561018|NCT00491400|6278122|P1|Completed First Treatment|Overall Study|None withdrew during fenofibrate treatment (first treatment)|14
2561019|NCT00491400|6278121|P2|Started First Treatment|Overall Study|None withdrew prior to starting atorvastatin|13
2561020|NCT00491400|6278122|P1|Started First Treatment|Overall Study|1 withdrew prior to starting fenofibrate|14
2561021|NCT00491400|6278121|P2|STARTED|Overall Study||13
2561022|NCT00491400|6278122|P1|STARTED|Overall Study||15
2561023|NCT00491387|6278130|P1|NOT COMPLETED|Overall Study||20
2561024|NCT00491387|6278130|P1|COMPLETED|Overall Study||4
2561025|NCT00491387|6278130|P1|Study Enrollment|Overall Study||24
2561026|NCT00491387|6278130|P1|STARTED|Overall Study||24
2561027|NCT00491374|6278136|P2|NOT COMPLETED|Overall Study||0
2561028|NCT00491374|6278137|P1|NOT COMPLETED|Overall Study||0
2561029|NCT00491374|6278136|P2|COMPLETED|Overall Study||0
2561030|NCT00491374|6278137|P1|COMPLETED|Overall Study||0
2561031|NCT00491374|6278136|P2|STARTED|Overall Study||0
2561032|NCT00491374|6278137|P1|STARTED|Overall Study||0
2561033|NCT00491322|6278145|P2|NOT COMPLETED|Overall Study||1
2561034|NCT00491322|6278146|P1|NOT COMPLETED|Overall Study||1
2561035|NCT00491322|6278145|P2|COMPLETED|Overall Study||50
2561036|NCT00491322|6278146|P1|COMPLETED|Overall Study||40
2561037|NCT00491322|6278145|P2|STARTED|Overall Study||51
2561038|NCT00491322|6278146|P1|STARTED|Overall Study||41
2561039|NCT00491244|6278154|P2|NOT COMPLETED|Overall Study||20
2561040|NCT00491244|6278155|P1|NOT COMPLETED|Overall Study||27
2561041|NCT00491244|6278154|P2|COMPLETED|Overall Study||168
2561042|NCT00491244|6278155|P1|COMPLETED|Overall Study||162
2561043|NCT00491244|6278154|P2|STARTED|Overall Study||188
2561044|NCT00491244|6278155|P1|STARTED|Overall Study||189
2561045|NCT00491179|6278165|P2|NOT COMPLETED|Overall Study||2
2561046|NCT00491179|6278166|P1|NOT COMPLETED|Overall Study||7
2561047|NCT00491179|6278165|P2|COMPLETED|Overall Study||8
2561048|NCT00491179|6278166|P1|COMPLETED|Overall Study||18
2561049|NCT00491179|6278165|P2|STARTED|Overall Study||10
2561050|NCT00491179|6278166|P1|STARTED|Overall Study||25
2561051|NCT00491075|6278174|P1|NOT COMPLETED|Overall Study||2
2561052|NCT00491075|6278174|P1|COMPLETED|Overall Study||14
2561053|NCT00491075|6278174|P1|STARTED|Overall Study||16
2561054|NCT00490971|6278180|P5|NOT COMPLETED|Maintenance||39
2561055|NCT00490971|6278181|P4|NOT COMPLETED|Maintenance||53
2561056|NCT00490971|6278182|P3|NOT COMPLETED|Maintenance||51
2561057|NCT00490971|6278183|P2|NOT COMPLETED|Maintenance||0
2561058|NCT00490971|6278184|P1|NOT COMPLETED|Maintenance||0
2561059|NCT00490971|6278180|P5|COMPLETED|Maintenance||44
2561060|NCT00490971|6278181|P4|COMPLETED|Maintenance||96
2561061|NCT00490971|6278182|P3|COMPLETED|Maintenance||96
2561062|NCT00490971|6278183|P2|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
2561063|NCT00490971|6278184|P1|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
2561064|NCT00490971|6278180|P5|STARTED|Maintenance||83
2561065|NCT00490971|6278181|P4|STARTED|Maintenance|152 participants were assigned to pali/pali, out of which 149 took the study medication.|149
2561066|NCT00490971|6278182|P3|STARTED|Maintenance|148 participants were assigned to pali/placebo, out of which 147 took the study medication.|147
2561067|NCT00490971|6278183|P2|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
2561068|NCT00490971|6278184|P1|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
2561069|NCT00490971|6278180|P5|NOT COMPLETED|Acute/Continuation||0
2561070|NCT00490971|6278181|P4|NOT COMPLETED|Acute/Continuation||0
2561071|NCT00490971|6278182|P3|NOT COMPLETED|Acute/Continuation||0
2561072|NCT00490971|6278183|P2|NOT COMPLETED|Acute/Continuation||62
2561073|NCT00490971|6278184|P1|NOT COMPLETED|Acute/Continuation||306
2561074|NCT00490971|6278180|P5|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
2561075|NCT00490971|6278181|P4|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
2561076|NCT00490971|6278182|P3|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
2561077|NCT00490971|6278183|P2|COMPLETED|Acute/Continuation||86
2561078|NCT00490971|6278184|P1|COMPLETED|Acute/Continuation||308
2561079|NCT00490971|6278180|P5|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
2561080|NCT00490971|6278181|P4|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
2561081|NCT00490971|6278182|P3|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
2561082|NCT00490971|6278183|P2|STARTED|Acute/Continuation|149 participants were assigned to paliperidone, out of which 148 took the study medication.|148
2561083|NCT00490971|6278184|P1|STARTED|Acute/Continuation|617 participants were assigned to paliperidone, out of which 614 took the study medication.|614
2561084|NCT00490945|6278231|P5|NOT COMPLETED|Overall Study||0
2561085|NCT00490945|6278232|P4|NOT COMPLETED|Overall Study||0
2561086|NCT00490945|6278233|P3|NOT COMPLETED|Overall Study||0
2561087|NCT00490945|6278234|P2|NOT COMPLETED|Overall Study||1
2561088|NCT00490945|6278235|P1|NOT COMPLETED|Overall Study||0
2561089|NCT00490945|6278231|P5|COMPLETED|Overall Study||7
2561090|NCT00490945|6278232|P4|COMPLETED|Overall Study||7
2561091|NCT00490945|6278233|P3|COMPLETED|Overall Study||8
2561092|NCT00490945|6278234|P2|COMPLETED|Overall Study||8
2561093|NCT00490945|6278235|P1|COMPLETED|Overall Study||8
2561094|NCT00490945|6278231|P5|STARTED|Overall Study||7
2561095|NCT00490945|6278232|P4|STARTED|Overall Study||7
2561096|NCT00490945|6278233|P3|STARTED|Overall Study||8
2561097|NCT00490945|6278234|P2|STARTED|Overall Study||9
2561098|NCT00490945|6278235|P1|STARTED|Overall Study||8
2561099|NCT00490919|6278271|P3|NOT COMPLETED|Double-blind Phase||84
2561100|NCT00490919|6278272|P2|NOT COMPLETED|Double-blind Phase||86
2561101|NCT00490919|6278273|P1|NOT COMPLETED|Double-blind Phase||0
2561102|NCT00490919|6278271|P3|COMPLETED|Double-blind Phase||199
2561103|NCT00490919|6278272|P2|COMPLETED|Double-blind Phase||170
2561104|NCT00490919|6278273|P1|COMPLETED|Double-blind Phase||0
2561105|NCT00490919|6278271|P3|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|283
2561106|NCT00490919|6278272|P2|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|256
2561107|NCT00490919|6278273|P1|STARTED|Double-blind Phase||0
2561108|NCT00490919|6278271|P3|NOT COMPLETED|Open-label Run-in Period||0
2561109|NCT00490919|6278272|P2|NOT COMPLETED|Open-label Run-in Period||0
2561110|NCT00490919|6278273|P1|NOT COMPLETED|Open-label Run-in Period||483
2561111|NCT00490919|6278271|P3|COMPLETED|Open-label Run-in Period||0
2561112|NCT00490919|6278272|P2|COMPLETED|Open-label Run-in Period||0
2561113|NCT00490919|6278273|P1|COMPLETED|Open-label Run-in Period|Completed run-in and randomized; however 2 had no safety data after randomization visit (N = 539)|541
2561114|NCT00490919|6278271|P3|STARTED|Open-label Run-in Period||0
2561115|NCT00490919|6278272|P2|STARTED|Open-label Run-in Period||0
2561116|NCT00490919|6278273|P1|STARTED|Open-label Run-in Period||1024
2561117|NCT00490841|6278284|P1|NOT COMPLETED|Overall Study||13
2561118|NCT00490841|6278284|P1|COMPLETED|Overall Study||189
2561119|NCT00490841|6278284|P1|STARTED|Overall Study||202
2561120|NCT00490815|6278306|P2|NOT COMPLETED|Overall Study||9
2561121|NCT00490815|6278307|P1|NOT COMPLETED|Overall Study||8
2561122|NCT00490815|6278306|P2|COMPLETED|Overall Study||8
2561123|NCT00490815|6278307|P1|COMPLETED|Overall Study||12
2561124|NCT00490815|6278306|P2|STARTED|Overall Study||17
2561125|NCT00490815|6278307|P1|STARTED|Overall Study||20
2561126|NCT00490802|6278317|P2|NOT COMPLETED|Overall Study||2
2561127|NCT00490802|6278318|P1|NOT COMPLETED|Overall Study||1
2561128|NCT00490802|6278317|P2|COMPLETED|Overall Study||7
2561129|NCT00490802|6278318|P1|COMPLETED|Overall Study||9
2561130|NCT00490802|6278317|P2|STARTED|Overall Study||9
2561131|NCT00490802|6278318|P1|STARTED|Overall Study||10
2561132|NCT00490724|6278335|P3|NOT COMPLETED|Period II||3
2561133|NCT00490724|6278336|P2|NOT COMPLETED|Period II||1
2561134|NCT00490724|6278337|P1|NOT COMPLETED|Period II||3
2561135|NCT00490724|6278335|P3|COMPLETED|Period II||16
2561136|NCT00490724|6278336|P2|COMPLETED|Period II||19
2561137|NCT00490724|6278337|P1|COMPLETED|Period II||18
2561138|NCT00490724|6278335|P3|STARTED|Period II||19
2561139|NCT00490724|6278336|P2|STARTED|Period II||20
2561140|NCT00490724|6278337|P1|STARTED|Period II||21
2561141|NCT00490724|6278335|P3|NOT COMPLETED|Period I||1
2561142|NCT00490724|6278336|P2|NOT COMPLETED|Period I||0
2561143|NCT00490724|6278337|P1|NOT COMPLETED|Period I||0
2561144|NCT00490724|6278335|P3|COMPLETED|Period I||19
2561145|NCT00490724|6278336|P2|COMPLETED|Period I||20
2561146|NCT00490724|6278337|P1|COMPLETED|Period I||21
2561147|NCT00490724|6278335|P3|STARTED|Period I||20
2561148|NCT00490724|6278336|P2|STARTED|Period I||20
2561149|NCT00490724|6278337|P1|STARTED|Period I||21
2561150|NCT00490698|6278402|P1|NOT COMPLETED|Overall Study||10
2561151|NCT00490698|6278402|P1|COMPLETED|Overall Study||1
2561152|NCT00490698|6278402|P1|STARTED|Overall Study||11
2561153|NCT00490646|6278408|P2|NOT COMPLETED|Overall Study||2
2561154|NCT00490646|6278409|P1|NOT COMPLETED|Overall Study||2
2561155|NCT00490646|6278408|P2|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=13; study drug toxicity=1)|23
2561156|NCT00490646|6278409|P1|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=14; study drug toxicity=4)|23
2561157|NCT00490646|6278408|P2|Treated|Overall Study||24
2561158|NCT00490646|6278409|P1|Treated|Overall Study||24
2561159|NCT00490646|6278408|P2|STARTED|Overall Study||25
2561160|NCT00490646|6278409|P1|STARTED|Overall Study||25
2561161|NCT00490568|6278429|P1|NOT COMPLETED|Overall Study||1364
2561162|NCT00490568|6278429|P1|COMPLETED|Overall Study||97
2561163|NCT00490568|6278429|P1|STARTED|Overall Study||1461
2561164|NCT00490555|6278453|P4|NOT COMPLETED|Overall Study||0
2561165|NCT00490555|6278454|P3|NOT COMPLETED|Overall Study||2
2561166|NCT00490555|6278455|P2|NOT COMPLETED|Overall Study||0
2561167|NCT00490555|6278456|P1|NOT COMPLETED|Overall Study||0
2561168|NCT00490555|6278453|P4|COMPLETED|Overall Study||7
2561169|NCT00490555|6278454|P3|COMPLETED|Overall Study||7
2561170|NCT00490555|6278455|P2|COMPLETED|Overall Study||8
2561171|NCT00490555|6278456|P1|COMPLETED|Overall Study||8
2561172|NCT00490555|6278453|P4|STARTED|Overall Study||7
2561173|NCT00490555|6278454|P3|STARTED|Overall Study||9
2561174|NCT00490555|6278455|P2|STARTED|Overall Study||8
2561175|NCT00490555|6278456|P1|STARTED|Overall Study||8
2561176|NCT00490542|6278484|P2|NOT COMPLETED|Overall Study||4
2561177|NCT00490542|6278485|P1|NOT COMPLETED|Overall Study||7
2561178|NCT00490542|6278484|P2|COMPLETED|Overall Study||31
2561179|NCT00490542|6278485|P1|COMPLETED|Overall Study||31
2561180|NCT00490542|6278484|P2|STARTED|Overall Study||35
2561181|NCT00490542|6278485|P1|STARTED|Overall Study||38
2561182|NCT00490529|6278491|P1|NOT COMPLETED|Treatment With CpG-MCL Vaccine||1
2561183|NCT00490529|6278491|P1|COMPLETED|Treatment With CpG-MCL Vaccine||47
2561184|NCT00490529|6278491|P1|STARTED|Treatment With CpG-MCL Vaccine||48
2561185|NCT00490529|6278491|P1|NOT COMPLETED|Completed Pre-CpG-MCL Vaccine Procedures||11
2561186|NCT00490529|6278491|P1|COMPLETED|Completed Pre-CpG-MCL Vaccine Procedures||48
2561187|NCT00490529|6278491|P1|STARTED|Completed Pre-CpG-MCL Vaccine Procedures||59
2561188|NCT00490490|6278499|P1|NOT COMPLETED|Completed Assessment for TTP||3
2561189|NCT00490490|6278499|P1|COMPLETED|Completed Assessment for TTP||5
2561190|NCT00490490|6278499|P1|STARTED|Completed Assessment for TTP||8
2561191|NCT00490490|6278499|P1|NOT COMPLETED|Completed Assessment for CR||0
2561192|NCT00490490|6278499|P1|COMPLETED|Completed Assessment for CR||8
2561193|NCT00490490|6278499|P1|STARTED|Completed Assessment for CR||8
2561194|NCT00490477|6278507|P2|NOT COMPLETED|Overall Study||0
2561195|NCT00490477|6278508|P1|NOT COMPLETED|Overall Study||0
2561196|NCT00490477|6278507|P2|COMPLETED|Overall Study||8
2561197|NCT00490477|6278508|P1|COMPLETED|Overall Study||8
2561198|NCT00490477|6278507|P2|STARTED|Overall Study||8
2561199|NCT00490477|6278508|P1|STARTED|Overall Study||8
2561200|NCT00490451|6278516|P2|NOT COMPLETED|Overall Study||38
2561201|NCT00490451|6278517|P1|NOT COMPLETED|Overall Study||63
2561202|NCT00490451|6278516|P2|COMPLETED|Overall Study||0
2561203|NCT00490451|6278517|P1|COMPLETED|Overall Study||0
2561204|NCT00490451|6278516|P2|STARTED|Overall Study||38
2561205|NCT00490451|6278517|P1|STARTED|Overall Study||63
2561206|NCT00490269|6278539|P2|NOT COMPLETED|Placebo Then Dronabinol||0
2561207|NCT00490269|6278540|P1|NOT COMPLETED|Placebo Then Dronabinol||0
2561208|NCT00490269|6278539|P2|COMPLETED|Placebo Then Dronabinol||6
2561209|NCT00490269|6278540|P1|COMPLETED|Placebo Then Dronabinol||6
2561210|NCT00490269|6278539|P2|STARTED|Placebo Then Dronabinol||6
2561211|NCT00490269|6278540|P1|STARTED|Placebo Then Dronabinol||6
2561212|NCT00490269|6278539|P2|NOT COMPLETED|Dronabinol Then Placebo||0
2561213|NCT00490269|6278540|P1|NOT COMPLETED|Dronabinol Then Placebo||0
2561214|NCT00490269|6278539|P2|COMPLETED|Dronabinol Then Placebo||6
2561215|NCT00490269|6278540|P1|COMPLETED|Dronabinol Then Placebo||6
2561216|NCT00490269|6278539|P2|STARTED|Dronabinol Then Placebo||6
2561217|NCT00490269|6278540|P1|STARTED|Dronabinol Then Placebo||6
2561218|NCT00490256|6278548|P2|NOT COMPLETED|Overall Study||0
2561219|NCT00490256|6278549|P1|NOT COMPLETED|Overall Study||0
2561220|NCT00490256|6278548|P2|COMPLETED|Overall Study||7
2561221|NCT00490256|6278549|P1|COMPLETED|Overall Study||7
2561222|NCT00490256|6278548|P2|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
2561223|NCT00490256|6278549|P1|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
2561224|NCT00490256|6278548|P2|STARTED|Overall Study||7
2561225|NCT00490256|6278549|P1|STARTED|Overall Study||7
2561226|NCT00490139|6278559|P4|NOT COMPLETED|Overall Study||307
2561227|NCT00490139|6278560|P3|NOT COMPLETED|Overall Study||434
2561228|NCT00490139|6278561|P2|NOT COMPLETED|Overall Study||275
2561229|NCT00490139|6278562|P1|NOT COMPLETED|Overall Study||308
2561230|NCT00490139|6278559|P4|COMPLETED|Overall Study||1790
2561231|NCT00490139|6278560|P3|COMPLETED|Overall Study||1666
2561232|NCT00490139|6278561|P2|COMPLETED|Overall Study||1816
2561233|NCT00490139|6278562|P1|COMPLETED|Overall Study||1785
2561234|NCT00490139|6278559|P4|STARTED|Overall Study||2097
2561235|NCT00490139|6278560|P3|STARTED|Overall Study||2100
2561236|NCT00490139|6278561|P2|STARTED|Overall Study||2091
2561237|NCT00490139|6278562|P1|STARTED|Overall Study||2093
2561238|NCT00490100|6278592|P1|NOT COMPLETED|Overall Study||3
2561239|NCT00490100|6278592|P1|COMPLETED|Overall Study||3
2561240|NCT00490100|6278592|P1|STARTED|Overall Study||6
2561241|NCT00490061|6278597|P1|NOT COMPLETED|Overall Study||1
2561242|NCT00490061|6278597|P1|COMPLETED|Overall Study||16
2561243|NCT00490061|6278597|P1|STARTED|Overall Study||17
2561244|NCT00490035|6278606|P4|NOT COMPLETED|Overall Study||6
2561245|NCT00490035|6278607|P3|NOT COMPLETED|Overall Study||12
2561246|NCT00490035|6278608|P2|NOT COMPLETED|Overall Study||6
2561247|NCT00490035|6278609|P1|NOT COMPLETED|Overall Study||8
2561248|NCT00490035|6278606|P4|COMPLETED|Overall Study||94
2561249|NCT00490035|6278607|P3|COMPLETED|Overall Study||88
2561250|NCT00490035|6278608|P2|COMPLETED|Overall Study||93
2561251|NCT00490035|6278609|P1|COMPLETED|Overall Study||92
2561252|NCT00490035|6278606|P4|STARTED|Overall Study||100
2561253|NCT00490035|6278607|P3|STARTED|Overall Study||100
2561254|NCT00490035|6278608|P2|STARTED|Overall Study||99
2561255|NCT00490035|6278609|P1|STARTED|Overall Study||100
2561256|NCT00490022|6278709|P2|NOT COMPLETED|Overall Study||3
2561257|NCT00490022|6278710|P1|NOT COMPLETED|Overall Study||1
2561258|NCT00490022|6278709|P2|COMPLETED|Overall Study||12
2561259|NCT00490022|6278710|P1|COMPLETED|Overall Study||15
2561260|NCT00490022|6278709|P2|STARTED|Overall Study||15
2561261|NCT00490022|6278710|P1|STARTED|Overall Study||16
2561262|NCT00490009|6278718|P1|NOT COMPLETED|Overall Study||0
2561263|NCT00490009|6278718|P1|COMPLETED|Overall Study||9
2561264|NCT00490009|6278718|P1|STARTED|Overall Study||9
2561265|NCT00489970|6278727|P3|NOT COMPLETED|Persistence Year 9||5
2561266|NCT00489970|6278728|P2|NOT COMPLETED|Persistence Year 9||2
2561267|NCT00489970|6278729|P1|NOT COMPLETED|Persistence Year 9||3
2561268|NCT00489970|6278727|P3|COMPLETED|Persistence Year 9||357
2561269|NCT00489970|6278728|P2|COMPLETED|Persistence Year 9||136
2561270|NCT00489970|6278729|P1|COMPLETED|Persistence Year 9||306
2561271|NCT00489970|6278727|P3|STARTED|Persistence Year 9|Number of subjects who received the first dose at Year 9.|362
2561272|NCT00489970|6278728|P2|STARTED|Persistence Year 9|Number of subjects who returned at Year 9.|138
2561273|NCT00489970|6278729|P1|STARTED|Persistence Year 9|Number of subjects who returned at Year 9.|309
2561274|NCT00489970|6278727|P3|NOT COMPLETED|Persistence Year 5||0
2561275|NCT00489970|6278728|P2|NOT COMPLETED|Persistence Year 5||0
2561276|NCT00489970|6278729|P1|NOT COMPLETED|Persistence Year 5||0
2561277|NCT00489970|6278727|P3|COMPLETED|Persistence Year 5||0
2561278|NCT00489970|6278728|P2|COMPLETED|Persistence Year 5||401
2561279|NCT00489970|6278729|P1|COMPLETED|Persistence Year 5||856
2561280|NCT00489970|6278727|P3|STARTED|Persistence Year 5||0
2561281|NCT00489970|6278728|P2|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|401
2561282|NCT00489970|6278729|P1|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|856
2561283|NCT00489970|6278727|P3|NOT COMPLETED|Persistence Year 3||0
2561284|NCT00489970|6278728|P2|NOT COMPLETED|Persistence Year 3||0
2561285|NCT00489970|6278729|P1|NOT COMPLETED|Persistence Year 3||0
2561286|NCT00489970|6278727|P3|COMPLETED|Persistence Year 3||0
2561287|NCT00489970|6278728|P2|COMPLETED|Persistence Year 3||486
2561288|NCT00489970|6278729|P1|COMPLETED|Persistence Year 3||1019
2561289|NCT00489970|6278727|P3|STARTED|Persistence Year 3||0
2561290|NCT00489970|6278728|P2|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|486
2561291|NCT00489970|6278729|P1|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|1019
2561292|NCT00489970|6278727|P3|NOT COMPLETED|Persistence Year 1||0
2561293|NCT00489970|6278728|P2|NOT COMPLETED|Persistence Year 1||0
2561294|NCT00489970|6278729|P1|NOT COMPLETED|Persistence Year 1||0
2561295|NCT00489970|6278727|P3|COMPLETED|Persistence Year 1||0
2561296|NCT00489970|6278728|P2|COMPLETED|Persistence Year 1||523
2561297|NCT00489970|6278729|P1|COMPLETED|Persistence Year 1||1069
2561298|NCT00489970|6278727|P3|STARTED|Persistence Year 1||0
2561299|NCT00489970|6278728|P2|STARTED|Persistence Year 1||523
2561300|NCT00489970|6278729|P1|STARTED|Persistence Year 1||1069
2561301|NCT00489918|6278833|P5|NOT COMPLETED|Overall Study||1
2561302|NCT00489918|6278834|P4|NOT COMPLETED|Overall Study||1
2561303|NCT00489918|6278835|P3|NOT COMPLETED|Overall Study||4
2561304|NCT00489918|6278836|P2|NOT COMPLETED|Overall Study||2
2561305|NCT00489918|6278837|P1|NOT COMPLETED|Overall Study||2
2561306|NCT00489918|6278833|P5|COMPLETED|Overall Study||32
2561307|NCT00489918|6278834|P4|COMPLETED|Overall Study||32
2561308|NCT00489918|6278835|P3|COMPLETED|Overall Study||28
2561309|NCT00489918|6278836|P2|COMPLETED|Overall Study||32
2561310|NCT00489918|6278837|P1|COMPLETED|Overall Study||31
2561311|NCT00489918|6278833|P5|STARTED|Overall Study||33
2561312|NCT00489918|6278834|P4|STARTED|Overall Study||33
2561313|NCT00489918|6278835|P3|STARTED|Overall Study||32
2561314|NCT00489918|6278836|P2|STARTED|Overall Study||34
2561315|NCT00489918|6278837|P1|STARTED|Overall Study||33
2561316|NCT00489866|6278871|P2|NOT COMPLETED|Overall Study||0
2561317|NCT00489866|6278872|P1|NOT COMPLETED|Overall Study||2
2561318|NCT00489866|6278871|P2|COMPLETED|Overall Study||7
2561319|NCT00489866|6278872|P1|COMPLETED|Overall Study||5
2561320|NCT00489866|6278871|P2|STARTED|Overall Study||7
2561321|NCT00489866|6278872|P1|STARTED|Overall Study||7
2561322|NCT00489853|6278886|P3|NOT COMPLETED|Follow-up Period||0
2561323|NCT00489853|6278887|P2|NOT COMPLETED|Follow-up Period||0
2561324|NCT00489853|6278888|P1|NOT COMPLETED|Follow-up Period||0
2561325|NCT00489853|6278886|P3|COMPLETED|Follow-up Period||33
2561326|NCT00489853|6278887|P2|COMPLETED|Follow-up Period||29
2561327|NCT00489853|6278888|P1|COMPLETED|Follow-up Period||29
2561328|NCT00489853|6278886|P3|STARTED|Follow-up Period||33
2561329|NCT00489853|6278887|P2|STARTED|Follow-up Period||29
2561330|NCT00489853|6278888|P1|STARTED|Follow-up Period||29
2561331|NCT00489853|6278886|P3|NOT COMPLETED|Treatment Period 3||0
2561332|NCT00489853|6278887|P2|NOT COMPLETED|Treatment Period 3||1
2561333|NCT00489853|6278888|P1|NOT COMPLETED|Treatment Period 3||0
2561334|NCT00489853|6278886|P3|COMPLETED|Treatment Period 3||33
2561335|NCT00489853|6278887|P2|COMPLETED|Treatment Period 3||29
2561336|NCT00489853|6278888|P1|COMPLETED|Treatment Period 3||29
2561337|NCT00489853|6278886|P3|STARTED|Treatment Period 3||33
2561338|NCT00489853|6278887|P2|STARTED|Treatment Period 3||30
2561339|NCT00489853|6278888|P1|STARTED|Treatment Period 3||29
2561340|NCT00489853|6278886|P3|NOT COMPLETED|Wash-out Period 2||2
2561341|NCT00489853|6278887|P2|NOT COMPLETED|Wash-out Period 2||3
2561342|NCT00489853|6278888|P1|NOT COMPLETED|Wash-out Period 2||4
2561343|NCT00489853|6278886|P3|COMPLETED|Wash-out Period 2||31
2561344|NCT00489853|6278887|P2|COMPLETED|Wash-out Period 2||32
2561345|NCT00489853|6278888|P1|COMPLETED|Wash-out Period 2||29
2561346|NCT00489853|6278886|P3|STARTED|Wash-out Period 2||33
2561347|NCT00489853|6278887|P2|STARTED|Wash-out Period 2||35
2561348|NCT00489853|6278888|P1|STARTED|Wash-out Period 2||33
2561349|NCT00489853|6278886|P3|NOT COMPLETED|Treatment Period 2||0
2561350|NCT00489853|6278887|P2|NOT COMPLETED|Treatment Period 2||0
2561351|NCT00489853|6278888|P1|NOT COMPLETED|Treatment Period 2||0
2561352|NCT00489853|6278886|P3|COMPLETED|Treatment Period 2||33
2561353|NCT00489853|6278887|P2|COMPLETED|Treatment Period 2||35
2561354|NCT00489853|6278888|P1|COMPLETED|Treatment Period 2||33
2561355|NCT00489853|6278886|P3|STARTED|Treatment Period 2||33
2561356|NCT00489853|6278887|P2|STARTED|Treatment Period 2||35
2561357|NCT00489853|6278888|P1|STARTED|Treatment Period 2||33
2561358|NCT00489853|6278886|P3|NOT COMPLETED|Wash-out Period 1||6
2561359|NCT00489853|6278887|P2|NOT COMPLETED|Wash-out Period 1||3
2561360|NCT00489853|6278888|P1|NOT COMPLETED|Wash-out Period 1||1
2561361|NCT00489853|6278886|P3|COMPLETED|Wash-out Period 1||32
2561362|NCT00489853|6278887|P2|COMPLETED|Wash-out Period 1||34
2561363|NCT00489853|6278888|P1|COMPLETED|Wash-out Period 1||35
2561364|NCT00489853|6278886|P3|STARTED|Wash-out Period 1||38
2561365|NCT00489853|6278887|P2|STARTED|Wash-out Period 1||37
2561366|NCT00489853|6278888|P1|STARTED|Wash-out Period 1||36
2561367|NCT00489853|6278886|P3|NOT COMPLETED|Treatment Period 1||0
2561368|NCT00489853|6278887|P2|NOT COMPLETED|Treatment Period 1||0
2561369|NCT00489853|6278888|P1|NOT COMPLETED|Treatment Period 1||0
2561370|NCT00489853|6278886|P3|COMPLETED|Treatment Period 1||38
2561371|NCT00489853|6278887|P2|COMPLETED|Treatment Period 1||37
2561372|NCT00489853|6278888|P1|COMPLETED|Treatment Period 1||36
2561373|NCT00489853|6278886|P3|STARTED|Treatment Period 1||38
2561374|NCT00489853|6278887|P2|STARTED|Treatment Period 1||37
2561375|NCT00489853|6278888|P1|STARTED|Treatment Period 1||36
2561376|NCT00489827|6278985|P2|NOT COMPLETED|Overall Study||2
2561377|NCT00489827|6278986|P1|NOT COMPLETED|Overall Study||2
2561378|NCT00489827|6278985|P2|COMPLETED|Overall Study||433
2561379|NCT00489827|6278986|P1|COMPLETED|Overall Study||428
2561380|NCT00489827|6278985|P2|STARTED|Overall Study||435
2561381|NCT00489827|6278986|P1|STARTED|Overall Study||430
2561382|NCT00489736|6279010|P2|NOT COMPLETED|Overall Study||69
2561383|NCT00489736|6279011|P1|NOT COMPLETED|Overall Study||96
2561384|NCT00489736|6279010|P2|COMPLETED|Overall Study|completed study drug period|186
2561385|NCT00489736|6279011|P1|COMPLETED|Overall Study|completed study drug period|153
2561386|NCT00489736|6279010|P2|STARTED|Overall Study|Randomized and treated patients|255
2561387|NCT00489736|6279011|P1|STARTED|Overall Study|Randomized and treated patients|249
2561388|NCT00489554|6279021|P1|NOT COMPLETED|Overall Study||4
2561389|NCT00489554|6279021|P1|COMPLETED|Overall Study||226
2561390|NCT00489554|6279021|P1|STARTED|Overall Study||230
2561391|NCT00489541|6279041|P2|NOT COMPLETED|9-Month Angiographic Follow-up||17
2561392|NCT00489541|6279042|P1|NOT COMPLETED|9-Month Angiographic Follow-up||27
2561393|NCT00489541|6279041|P2|COMPLETED|9-Month Angiographic Follow-up||108
2561394|NCT00489541|6279042|P1|COMPLETED|9-Month Angiographic Follow-up||197
2561395|NCT00489541|6279041|P2|STARTED|9-Month Angiographic Follow-up||125
2561396|NCT00489541|6279042|P1|STARTED|9-Month Angiographic Follow-up||224
2561397|NCT00489541|6279041|P2|NOT COMPLETED|12-Month Clinical Follow-up||5
2561398|NCT00489541|6279042|P1|NOT COMPLETED|12-Month Clinical Follow-up||9
2561399|NCT00489541|6279041|P2|COMPLETED|12-Month Clinical Follow-up||120
2561400|NCT00489541|6279042|P1|COMPLETED|12-Month Clinical Follow-up||215
2561401|NCT00489541|6279041|P2|STARTED|12-Month Clinical Follow-up||125
2561402|NCT00489541|6279042|P1|STARTED|12-Month Clinical Follow-up||224
2561403|NCT00489489|6279053|P3|NOT COMPLETED|Overall Study||3
2561404|NCT00489489|6279054|P2|NOT COMPLETED|Overall Study||5
2561405|NCT00489489|6279055|P1|NOT COMPLETED|Overall Study||3
2561406|NCT00489489|6279053|P3|COMPLETED|Overall Study|completed treatment period|37
2561407|NCT00489489|6279054|P2|COMPLETED|Overall Study|completed treatment period|32
2561408|NCT00489489|6279055|P1|COMPLETED|Overall Study|completed treatment period|38
2561409|NCT00489489|6279053|P3|Treated|Overall Study|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|39
2561410|NCT00489489|6279054|P2|Treated|Overall Study||36
2561411|NCT00489489|6279055|P1|Treated|Overall Study||41
2561412|NCT00489489|6279053|P3|STARTED|Overall Study|randomized|40
2561413|NCT00489489|6279054|P2|STARTED|Overall Study|randomized|37
2561414|NCT00489489|6279055|P1|STARTED|Overall Study|randomized|41
2561415|NCT00489476|6279087|P4|NOT COMPLETED|Overall Study||0
2561416|NCT00489476|6279088|P3|NOT COMPLETED|Overall Study||0
2561417|NCT00489476|6279089|P2|NOT COMPLETED|Overall Study||1
2561418|NCT00489476|6279090|P1|NOT COMPLETED|Overall Study||0
2561419|NCT00489476|6279087|P4|COMPLETED|Overall Study||43
2561420|NCT00489476|6279088|P3|COMPLETED|Overall Study||43
2561421|NCT00489476|6279089|P2|COMPLETED|Overall Study||42
2561422|NCT00489476|6279090|P1|COMPLETED|Overall Study||39
2561423|NCT00489476|6279087|P4|STARTED|Overall Study||43
2561424|NCT00489476|6279088|P3|STARTED|Overall Study||43
2561425|NCT00489476|6279089|P2|STARTED|Overall Study||43
2561426|NCT00489476|6279090|P1|STARTED|Overall Study||39
2561427|NCT00489424|6279111|P3|NOT COMPLETED|Overall Study||5
2561428|NCT00489424|6279112|P2|NOT COMPLETED|Overall Study||5
2561429|NCT00489424|6279113|P1|NOT COMPLETED|Overall Study||4
2561430|NCT00489424|6279111|P3|COMPLETED|Overall Study||257
2561431|NCT00489424|6279112|P2|COMPLETED|Overall Study||259
2561432|NCT00489424|6279113|P1|COMPLETED|Overall Study||263
2561433|NCT00489424|6279111|P3|STARTED|Overall Study||262
2561434|NCT00489424|6279112|P2|STARTED|Overall Study||264
2561435|NCT00489424|6279113|P1|STARTED|Overall Study||267
2561436|NCT00489411|6279144|P2|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||19
2561437|NCT00489411|6279145|P1|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||18
2561438|NCT00489411|6279144|P2|COMPLETED|Crossover Treatment Period (Weeks 8-12)||74
2561439|NCT00489411|6279145|P1|COMPLETED|Crossover Treatment Period (Weeks 8-12)||67
2561440|NCT00489411|6279144|P2|STARTED|Crossover Treatment Period (Weeks 8-12)||93
2561441|NCT00489411|6279145|P1|STARTED|Crossover Treatment Period (Weeks 8-12)||85
2561442|NCT00489411|6279144|P2|NOT COMPLETED|Washout Period (Weeks 6-7)||1
2561443|NCT00489411|6279145|P1|NOT COMPLETED|Washout Period (Weeks 6-7)||2
2561444|NCT00489411|6279144|P2|COMPLETED|Washout Period (Weeks 6-7)||93
2561445|NCT00489411|6279145|P1|COMPLETED|Washout Period (Weeks 6-7)||85
2561446|NCT00489411|6279144|P2|STARTED|Washout Period (Weeks 6-7)||94
2561447|NCT00489411|6279145|P1|STARTED|Washout Period (Weeks 6-7)||87
2561448|NCT00489411|6279144|P2|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||22
2561449|NCT00489411|6279145|P1|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||28
2561450|NCT00489411|6279144|P2|COMPLETED|Initial Treatment Period (Weeks 1-5)||94
2561451|NCT00489411|6279145|P1|COMPLETED|Initial Treatment Period (Weeks 1-5)||87
2561452|NCT00489411|6279144|P2|STARTED|Initial Treatment Period (Weeks 1-5)||116
2561453|NCT00489411|6279145|P1|STARTED|Initial Treatment Period (Weeks 1-5)||115
2561454|NCT00489359|6279159|P2|NOT COMPLETED|Overall Study||29
2561455|NCT00489359|6279160|P1|NOT COMPLETED|Overall Study||7
2561456|NCT00489359|6279159|P2|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|37
2561457|NCT00489359|6279160|P1|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|13
2561458|NCT00489359|6279159|P2|STARTED|Overall Study||66
2561459|NCT00489359|6279160|P1|STARTED|Overall Study||20
2561460|NCT00489281|6279185|P2|NOT COMPLETED|Overall Study||0
2561461|NCT00489281|6279186|P1|NOT COMPLETED|Overall Study||0
2561462|NCT00489281|6279185|P2|COMPLETED|Overall Study||13
2561463|NCT00489281|6279186|P1|COMPLETED|Overall Study||29
2561464|NCT00489281|6279185|P2|STARTED|Overall Study||13
2561465|NCT00489281|6279186|P1|STARTED|Overall Study||29
2561466|NCT00489268|6279203|P5|NOT COMPLETED|Overall Study||20
2561467|NCT00489268|6279204|P4|NOT COMPLETED|Overall Study||0
2561468|NCT00489268|6279205|P3|NOT COMPLETED|Overall Study||1
2561469|NCT00489268|6279206|P2|NOT COMPLETED|Overall Study||0
2561470|NCT00489268|6279207|P1|NOT COMPLETED|Overall Study||0
2561471|NCT00489268|6279203|P5|COMPLETED|Overall Study||50
2561472|NCT00489268|6279204|P4|COMPLETED|Overall Study||11
2561473|NCT00489268|6279205|P3|COMPLETED|Overall Study||9
2561474|NCT00489268|6279206|P2|COMPLETED|Overall Study||10
2561475|NCT00489268|6279207|P1|COMPLETED|Overall Study||1
2561476|NCT00489268|6279203|P5|STARTED|Overall Study||70
2561477|NCT00489268|6279204|P4|STARTED|Overall Study||11
2561478|NCT00489268|6279205|P3|STARTED|Overall Study||10
2561479|NCT00489268|6279206|P2|STARTED|Overall Study||10
2561480|NCT00489268|6279207|P1|STARTED|Overall Study||1
2561481|NCT00489255|6279236|P2|NOT COMPLETED|Period 3: Days 57 to 84||4
2561482|NCT00489255|6279237|P1|NOT COMPLETED|Period 3: Days 57 to 84||4
2561483|NCT00489255|6279236|P2|COMPLETED|Period 3: Days 57 to 84|Re-randomized participants is 27.Sample sizes differed due to withdrawal&re-randomization design.|78
2561484|NCT00489255|6279237|P1|COMPLETED|Period 3: Days 57 to 84||24
2561485|NCT00489255|6279236|P2|STARTED|Period 3: Days 57 to 84|Re-randomized participants is 30.Sample sizes differed due to withdrawal&re-randomization design.|82
2561486|NCT00489255|6279237|P1|STARTED|Period 3: Days 57 to 84||28
2561487|NCT00489255|6279236|P2|NOT COMPLETED|Period 2: Days 29 to 56||4
2561488|NCT00489255|6279237|P1|NOT COMPLETED|Period 2: Days 29 to 56||3
2561489|NCT00489255|6279236|P2|COMPLETED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|55
2561490|NCT00489255|6279237|P1|COMPLETED|Period 2: Days 29 to 56||61
2561491|NCT00489255|6279236|P2|Completed But Discontinued Study|Period 2: Days 29 to 56|Re-randomized participants is 2.Sample sizes differed due to withdrawal&re-randomization design.|3
2561492|NCT00489255|6279237|P1|Completed But Discontinued Study|Period 2: Days 29 to 56||3
2561493|NCT00489255|6279236|P2|Completed and Follow Period 3|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|52
2561494|NCT00489255|6279237|P1|Completed and Follow Period 3|Period 2: Days 29 to 56||58
2561495|NCT00489255|6279236|P2|STARTED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|59
2561496|NCT00489255|6279237|P1|STARTED|Period 2: Days 29 to 56||64
2561497|NCT00489255|6279236|P2|NOT COMPLETED|Period 1: Days 1 to 28||12
2561498|NCT00489255|6279237|P1|NOT COMPLETED|Period 1: Days 1 to 28||29
2561499|NCT00489255|6279236|P2|COMPLETED|Period 1: Days 1 to 28||34
2561500|NCT00489255|6279237|P1|COMPLETED|Period 1: Days 1 to 28||107
2561501|NCT00489255|6279236|P2|Completed But Discontinued Study|Period 1: Days 1 to 28||5
2561502|NCT00489255|6279237|P1|Completed But Discontinued Study|Period 1: Days 1 to 28||13
2561503|NCT00489255|6279236|P2|Completed and Follow Period 2|Period 1: Days 1 to 28||29
2561504|NCT00489255|6279237|P1|Completed and Follow Period 2|Period 1: Days 1 to 28||94
2561505|NCT00489255|6279236|P2|STARTED|Period 1: Days 1 to 28||46
2561506|NCT00489255|6279237|P1|STARTED|Period 1: Days 1 to 28||136
2561507|NCT00489255|6279236|P2|NOT COMPLETED|Screening and Initial Randomization||3
2561508|NCT00489255|6279237|P1|NOT COMPLETED|Screening and Initial Randomization||9
2561509|NCT00489255|6279236|P2|COMPLETED|Screening and Initial Randomization||46
2561510|NCT00489255|6279237|P1|COMPLETED|Screening and Initial Randomization||136
2561511|NCT00489255|6279236|P2|STARTED|Screening and Initial Randomization|Total randomized subjects to receive placebo|49
2561512|NCT00489255|6279237|P1|STARTED|Screening and Initial Randomization|Total randomized subjects to receive Tigan|145
2561513|NCT00489216|6279285|P1|NOT COMPLETED|Overall Study||1
2561514|NCT00489216|6279285|P1|COMPLETED|Overall Study||1
2561515|NCT00489216|6279285|P1|STARTED|Overall Study||2
2561516|NCT00489086|6279294|P1|NOT COMPLETED|Overall Study||23
2561517|NCT00489086|6279294|P1|COMPLETED|Overall Study|23 subjects completed 18 months|13
2561518|NCT00489086|6279294|P1|STARTED|Overall Study||36
2561519|NCT00488982|6279298|P3|NOT COMPLETED|Response to Course 3||3
2561520|NCT00488982|6279299|P2|NOT COMPLETED|Response to Course 3||1
2561521|NCT00488982|6279300|P1|NOT COMPLETED|Response to Course 3||0
2561522|NCT00488982|6279298|P3|COMPLETED|Response to Course 3||0
2561523|NCT00488982|6279299|P2|COMPLETED|Response to Course 3||1
2561524|NCT00488982|6279300|P1|COMPLETED|Response to Course 3||0
2561525|NCT00488982|6279298|P3|STARTED|Response to Course 3||3
2561526|NCT00488982|6279299|P2|STARTED|Response to Course 3||2
2561527|NCT00488982|6279300|P1|STARTED|Response to Course 3||0
2561528|NCT00488982|6279298|P3|NOT COMPLETED|Course 3||5
2561529|NCT00488982|6279299|P2|NOT COMPLETED|Course 3||2
2561530|NCT00488982|6279300|P1|NOT COMPLETED|Course 3||0
2561531|NCT00488982|6279298|P3|COMPLETED|Course 3||3
2561532|NCT00488982|6279299|P2|COMPLETED|Course 3||2
2561533|NCT00488982|6279300|P1|COMPLETED|Course 3||0
2561534|NCT00488982|6279298|P3|STARTED|Course 3||8
2561535|NCT00488982|6279299|P2|STARTED|Course 3||4
2561536|NCT00488982|6279300|P1|STARTED|Course 3||0
2561537|NCT00488982|6279298|P3|NOT COMPLETED|Course 2||5
2561538|NCT00488982|6279299|P2|NOT COMPLETED|Course 2||9
2561539|NCT00488982|6279300|P1|NOT COMPLETED|Course 2||0
2561540|NCT00488982|6279298|P3|COMPLETED|Course 2||8
2561541|NCT00488982|6279299|P2|COMPLETED|Course 2||4
2561542|NCT00488982|6279300|P1|COMPLETED|Course 2||0
2561543|NCT00488982|6279298|P3|STARTED|Course 2||13
2561544|NCT00488982|6279299|P2|STARTED|Course 2||13
2561545|NCT00488982|6279300|P1|STARTED|Course 2||0
2561546|NCT00488982|6279298|P3|NOT COMPLETED|Course 1||14
2561547|NCT00488982|6279299|P2|NOT COMPLETED|Course 1||12
2561548|NCT00488982|6279300|P1|NOT COMPLETED|Course 1||0
2561549|NCT00488982|6279298|P3|COMPLETED|Course 1||13
2561550|NCT00488982|6279299|P2|COMPLETED|Course 1||13
2561551|NCT00488982|6279300|P1|COMPLETED|Course 1||0
2561552|NCT00488982|6279298|P3|STARTED|Course 1||27
2561553|NCT00488982|6279299|P2|STARTED|Course 1||25
2561554|NCT00488982|6279300|P1|STARTED|Course 1||0
2561555|NCT00488982|6279298|P3|NOT COMPLETED|Induction Chemotherapy||0
2561556|NCT00488982|6279299|P2|NOT COMPLETED|Induction Chemotherapy||0
2561557|NCT00488982|6279300|P1|NOT COMPLETED|Induction Chemotherapy||73
2561558|NCT00488982|6279298|P3|COMPLETED|Induction Chemotherapy||0
2561559|NCT00488982|6279299|P2|COMPLETED|Induction Chemotherapy||0
2561560|NCT00488982|6279300|P1|COMPLETED|Induction Chemotherapy||52
2561561|NCT00488982|6279298|P3|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||0
2561562|NCT00488982|6279299|P2|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||0
2561563|NCT00488982|6279300|P1|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||52
2561564|NCT00488982|6279298|P3|6 Cycles Completed|Induction Chemotherapy||0
2561565|NCT00488982|6279299|P2|6 Cycles Completed|Induction Chemotherapy||0
2561566|NCT00488982|6279300|P1|6 Cycles Completed|Induction Chemotherapy||94
2561567|NCT00488982|6279298|P3|STARTED|Induction Chemotherapy||0
2561568|NCT00488982|6279299|P2|STARTED|Induction Chemotherapy||0
2561569|NCT00488982|6279300|P1|STARTED|Induction Chemotherapy||125
2561570|NCT00488865|6279314|P1|NOT COMPLETED|Overall Study||0
2561571|NCT00488865|6279314|P1|COMPLETED|Overall Study||100
2561572|NCT00488865|6279314|P1|STARTED|Overall Study||100
2561573|NCT00488826|6279323|P3|NOT COMPLETED|Overall Study||26
2561574|NCT00488826|6279324|P2|NOT COMPLETED|Overall Study||52
2561575|NCT00488826|6279325|P1|NOT COMPLETED|Overall Study||56
2561576|NCT00488826|6279323|P3|COMPLETED|Overall Study||178
2561577|NCT00488826|6279324|P2|COMPLETED|Overall Study||244
2561578|NCT00488826|6279325|P1|COMPLETED|Overall Study||244
2561579|NCT00488826|6279323|P3|STARTED|Overall Study||204
2561580|NCT00488826|6279324|P2|STARTED|Overall Study||296
2561581|NCT00488826|6279325|P1|STARTED|Overall Study||300
2561582|NCT00488774|6279340|P4|NOT COMPLETED|Overall Study||3
2561583|NCT00488774|6279341|P3|NOT COMPLETED|Overall Study||5
2561584|NCT00488774|6279342|P2|NOT COMPLETED|Overall Study||5
2561585|NCT00488774|6279343|P1|NOT COMPLETED|Overall Study||8
2561586|NCT00488774|6279340|P4|COMPLETED|Overall Study||74
2561587|NCT00488774|6279341|P3|COMPLETED|Overall Study||70
2561588|NCT00488774|6279342|P2|COMPLETED|Overall Study||57
2561589|NCT00488774|6279343|P1|COMPLETED|Overall Study||69
2561590|NCT00488774|6279340|P4|STARTED|Overall Study||77
2561591|NCT00488774|6279341|P3|STARTED|Overall Study||75
2561592|NCT00488774|6279342|P2|STARTED|Overall Study||62
2561593|NCT00488774|6279343|P1|STARTED|Overall Study||77
2561594|NCT00488683|6279360|P3|NOT COMPLETED|Overall Study||2
2561595|NCT00488683|6279361|P2|NOT COMPLETED|Overall Study||6
2561596|NCT00488683|6279362|P1|NOT COMPLETED|Overall Study||12
2561597|NCT00488683|6279360|P3|COMPLETED|Overall Study||52
2561598|NCT00488683|6279361|P2|COMPLETED|Overall Study||48
2561599|NCT00488683|6279362|P1|COMPLETED|Overall Study||96
2561600|NCT00488683|6279360|P3|STARTED|Overall Study||54
2561601|NCT00488683|6279361|P2|STARTED|Overall Study||54
2561602|NCT00488683|6279362|P1|STARTED|Overall Study||108
2561603|NCT00488644|6279421|P1|NOT COMPLETED|Overall Study||2
2561604|NCT00488644|6279421|P1|COMPLETED|Overall Study||10
2561605|NCT00488644|6279421|P1|STARTED|Overall Study||12
2561606|NCT00488631|6279431|P10|NOT COMPLETED|Open Label Study Extension (Week 54-228)||3
2561607|NCT00488631|6279432|P9|NOT COMPLETED|Open Label Study Extension (Week 54-228)||182
2561608|NCT00488631|6279433|P8|NOT COMPLETED|Open Label Study Extension (Week 54-228)||27
2561609|NCT00488631|6279434|P7|NOT COMPLETED|Open Label Study Extension (Week 54-228)||80
2561610|NCT00488631|6279435|P6|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
2561611|NCT00488631|6279436|P5|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
2561612|NCT00488631|6279437|P4|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
2561613|NCT00488631|6279438|P3|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
2561614|NCT00488631|6279439|P2|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
2561615|NCT00488631|6279440|P1|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
2561616|NCT00488631|6279431|P10|COMPLETED|Open Label Study Extension (Week 54-228)||4
2561617|NCT00488631|6279432|P9|COMPLETED|Open Label Study Extension (Week 54-228)||288
2561618|NCT00488631|6279433|P8|COMPLETED|Open Label Study Extension (Week 54-228)||66
2561619|NCT00488631|6279434|P7|COMPLETED|Open Label Study Extension (Week 54-228)||16
2561620|NCT00488631|6279435|P6|COMPLETED|Open Label Study Extension (Week 54-228)||0
2561621|NCT00488631|6279436|P5|COMPLETED|Open Label Study Extension (Week 54-228)||0
2561622|NCT00488631|6279437|P4|COMPLETED|Open Label Study Extension (Week 54-228)||0
2561623|NCT00488631|6279438|P3|COMPLETED|Open Label Study Extension (Week 54-228)||0
2561624|NCT00488631|6279439|P2|COMPLETED|Open Label Study Extension (Week 54-228)||0
2561625|NCT00488631|6279440|P1|COMPLETED|Open Label Study Extension (Week 54-228)||0
2561626|NCT00488631|6279431|P10|STARTED|Open Label Study Extension (Week 54-228)||7
2561627|NCT00488631|6279432|P9|STARTED|Open Label Study Extension (Week 54-228)||470
2561628|NCT00488631|6279433|P8|STARTED|Open Label Study Extension (Week 54-228)||93
2561629|NCT00488631|6279434|P7|STARTED|Open Label Study Extension (Week 54-228)||96
2561630|NCT00488631|6279435|P6|STARTED|Open Label Study Extension (Week 54-228)||0
2561631|NCT00488631|6279436|P5|STARTED|Open Label Study Extension (Week 54-228)||0
2561632|NCT00488631|6279437|P4|STARTED|Open Label Study Extension (Week 54-228)||0
2561633|NCT00488631|6279438|P3|STARTED|Open Label Study Extension (Week 54-228)||0
2561634|NCT00488631|6279439|P2|STARTED|Open Label Study Extension (Week 54-228)||0
2561635|NCT00488631|6279440|P1|STARTED|Open Label Study Extension (Week 54-228)||0
2561636|NCT00488631|6279431|P10|NOT COMPLETED|Double Blind Period (Week 0-54)||0
2561637|NCT00488631|6279432|P9|NOT COMPLETED|Double Blind Period (Week 0-54)||0
2561638|NCT00488631|6279433|P8|NOT COMPLETED|Double Blind Period (Week 0-54)||0
2561639|NCT00488631|6279434|P7|NOT COMPLETED|Double Blind Period (Week 0-54)||0
2561640|NCT00488631|6279435|P6|NOT COMPLETED|Double Blind Period (Week 0-54)||216
2561641|NCT00488631|6279436|P5|NOT COMPLETED|Double Blind Period (Week 0-54)||103
2561642|NCT00488631|6279437|P4|NOT COMPLETED|Double Blind Period (Week 0-54)||41
2561643|NCT00488631|6279438|P3|NOT COMPLETED|Double Blind Period (Week 0-54)||45
2561644|NCT00488631|6279439|P2|NOT COMPLETED|Double Blind Period (Week 0-54)||43
2561645|NCT00488631|6279440|P1|NOT COMPLETED|Double Blind Period (Week 0-54)||43
2561646|NCT00488631|6279431|P10|COMPLETED|Double Blind Period (Week 0-54)||0
2561647|NCT00488631|6279432|P9|COMPLETED|Double Blind Period (Week 0-54)||0
2561648|NCT00488631|6279433|P8|COMPLETED|Double Blind Period (Week 0-54)||0
2561649|NCT00488631|6279434|P7|COMPLETED|Double Blind Period (Week 0-54)||0
2561650|NCT00488631|6279435|P6|COMPLETED|Double Blind Period (Week 0-54)||189
2561651|NCT00488631|6279436|P5|COMPLETED|Double Blind Period (Week 0-54)||127
2561652|NCT00488631|6279437|P4|COMPLETED|Double Blind Period (Week 0-54)||88
2561653|NCT00488631|6279438|P3|COMPLETED|Double Blind Period (Week 0-54)||109
2561654|NCT00488631|6279439|P2|COMPLETED|Double Blind Period (Week 0-54)||111
2561655|NCT00488631|6279440|P1|COMPLETED|Double Blind Period (Week 0-54)||113
2561656|NCT00488631|6279431|P10|STARTED|Double Blind Period (Week 0-54)||0
2561657|NCT00488631|6279432|P9|STARTED|Double Blind Period (Week 0-54)||0
2561658|NCT00488631|6279433|P8|STARTED|Double Blind Period (Week 0-54)||0
2561659|NCT00488631|6279434|P7|STARTED|Double Blind Period (Week 0-54)||0
2561660|NCT00488631|6279435|P6|STARTED|Double Blind Period (Week 0-54)||405
2561661|NCT00488631|6279436|P5|STARTED|Double Blind Period (Week 0-54)||230
2561662|NCT00488631|6279437|P4|STARTED|Double Blind Period (Week 0-54)||129
2561663|NCT00488631|6279438|P3|STARTED|Double Blind Period (Week 0-54)||154
2561664|NCT00488631|6279439|P2|STARTED|Double Blind Period (Week 0-54)||154
2561665|NCT00488631|6279440|P1|STARTED|Double Blind Period (Week 0-54)||156
2561666|NCT00488618|6279477|P2|NOT COMPLETED|Overall Study||43
2561667|NCT00488618|6279478|P1|NOT COMPLETED|Overall Study||47
2561668|NCT00488618|6279477|P2|COMPLETED|Overall Study||75
2561669|NCT00488618|6279478|P1|COMPLETED|Overall Study||73
2561670|NCT00488618|6279477|P2|Safety Population: Received Study Drug|Overall Study||118
2561671|NCT00488618|6279478|P1|Safety Population: Received Study Drug|Overall Study||118
2561672|NCT00488618|6279477|P2|STARTED|Overall Study||118
2561673|NCT00488618|6279478|P1|STARTED|Overall Study||120
2561674|NCT00488592|6279486|P1|NOT COMPLETED|Overall Study||3
2561675|NCT00488592|6279486|P1|COMPLETED|Overall Study|7 completed the initial series of 6 vaccinations|7
2561676|NCT00488592|6279486|P1|STARTED|Overall Study|10 subjects were accrued|10
2561677|NCT00488514|6279490|P1|NOT COMPLETED|Overall Study||293
2561678|NCT00488514|6279490|P1|COMPLETED|Overall Study||363
2561679|NCT00488514|6279490|P1|STARTED|Overall Study||656
2561680|NCT00488488|6279563|P1|NOT COMPLETED|Overall Study||268
2561681|NCT00488488|6279563|P1|COMPLETED|Overall Study|Excludes 4 participants with missing information.|760
2561682|NCT00488488|6279563|P1|Analyzed|Overall Study|3 participants were not analyzed due to retrospective documentation.|1025
2561683|NCT00488488|6279563|P1|STARTED|Overall Study||1028
2561684|NCT00488475|6279578|P1|NOT COMPLETED|Overall Study||1754
2561685|NCT00488475|6279578|P1|COMPLETED|Overall Study||3191
2561686|NCT00488475|6279578|P1|STARTED|Overall Study||4945
2561687|NCT00488345|6279607|P3|NOT COMPLETED|Overall Study||3
2561688|NCT00488345|6279608|P2|NOT COMPLETED|Overall Study||4
2561689|NCT00488345|6279609|P1|NOT COMPLETED|Overall Study||0
2561690|NCT00488345|6279607|P3|COMPLETED|Overall Study||17
2561691|NCT00488345|6279608|P2|COMPLETED|Overall Study||17
2561692|NCT00488345|6279609|P1|COMPLETED|Overall Study||17
2561693|NCT00488345|6279607|P3|STARTED|Overall Study||20
2561694|NCT00488345|6279608|P2|STARTED|Overall Study||21
2561695|NCT00488345|6279609|P1|STARTED|Overall Study||17
2561696|NCT00488319|6279635|P3|NOT COMPLETED|Overall Study||122
2561697|NCT00488319|6279636|P2|NOT COMPLETED|Overall Study||43
2561698|NCT00488319|6279637|P1|NOT COMPLETED|Overall Study||15
2561699|NCT00488319|6279635|P3|COMPLETED|Overall Study||121
2561700|NCT00488319|6279636|P2|COMPLETED|Overall Study||75
2561701|NCT00488319|6279637|P1|COMPLETED|Overall Study||24
2561702|NCT00488319|6279635|P3|STARTED|Overall Study||243
2561703|NCT00488319|6279636|P2|STARTED|Overall Study||118
2561704|NCT00488319|6279637|P1|STARTED|Overall Study||39
2561705|NCT00488293|6279724|P2|NOT COMPLETED|Overall Study||30
2561706|NCT00488293|6279725|P1|NOT COMPLETED|Overall Study||36
2561707|NCT00488293|6279724|P2|COMPLETED|Overall Study||166
2561708|NCT00488293|6279725|P1|COMPLETED|Overall Study||160
2561709|NCT00488293|6279724|P2|STARTED|Overall Study||196
2561710|NCT00488293|6279725|P1|STARTED|Overall Study||196
2561711|NCT00488059|6279749|P3|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||4
2561712|NCT00488059|6279750|P2|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
2561713|NCT00488059|6279751|P1|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
2561714|NCT00488059|6279749|P3|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||1
2561715|NCT00488059|6279750|P2|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
2561716|NCT00488059|6279751|P1|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
2561717|NCT00488059|6279749|P3|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||5
2561718|NCT00488059|6279750|P2|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
2561719|NCT00488059|6279751|P1|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
2561720|NCT00488059|6279749|P3|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
2561721|NCT00488059|6279750|P2|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||2
2561722|NCT00488059|6279751|P1|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
2561723|NCT00488059|6279749|P3|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
2561724|NCT00488059|6279750|P2|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||7
2561725|NCT00488059|6279751|P1|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
2561726|NCT00488059|6279749|P3|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
2561727|NCT00488059|6279750|P2|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||9
2561728|NCT00488059|6279751|P1|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
2561729|NCT00488059|6279749|P3|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
2561730|NCT00488059|6279750|P2|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
2561731|NCT00488059|6279751|P1|NOT COMPLETED|Phase I: ENF 90mg SC BID||15
2561732|NCT00488059|6279749|P3|COMPLETED|Phase I: ENF 90mg SC BID||0
2561733|NCT00488059|6279750|P2|COMPLETED|Phase I: ENF 90mg SC BID||0
2561734|NCT00488059|6279751|P1|COMPLETED|Phase I: ENF 90mg SC BID||14
2561735|NCT00488059|6279749|P3|STARTED|Phase I: ENF 90mg SC BID||0
2561736|NCT00488059|6279750|P2|STARTED|Phase I: ENF 90mg SC BID||0
2561737|NCT00488059|6279751|P1|STARTED|Phase I: ENF 90mg SC BID||29
2561738|NCT00488033|6279770|P2|NOT COMPLETED|Overall Study||0
2561739|NCT00488033|6279771|P1|NOT COMPLETED|Overall Study||1
2561740|NCT00488033|6279770|P2|COMPLETED|Overall Study||452
2561741|NCT00488033|6279771|P1|COMPLETED|Overall Study||447
2561742|NCT00488033|6279770|P2|STARTED|Overall Study||452
2561743|NCT00488033|6279771|P1|STARTED|Overall Study||448
2561744|NCT00487981|6279787|P1|NOT COMPLETED|Overall Study||1
2561745|NCT00487981|6279787|P1|COMPLETED|Overall Study||0
2561746|NCT00487981|6279787|P1|STARTED|Overall Study||1
2561747|NCT00487942|6279795|P4|NOT COMPLETED|Overall Study||2
2561748|NCT00487942|6279796|P3|NOT COMPLETED|Overall Study||3
2561749|NCT00487942|6279797|P2|NOT COMPLETED|Overall Study||3
2561750|NCT00487942|6279798|P1|NOT COMPLETED|Overall Study||3
2561751|NCT00487942|6279795|P4|COMPLETED|Overall Study||13
2561752|NCT00487942|6279796|P3|COMPLETED|Overall Study||12
2561753|NCT00487942|6279797|P2|COMPLETED|Overall Study||12
2561754|NCT00487942|6279798|P1|COMPLETED|Overall Study||12
2561755|NCT00487942|6279795|P4|STARTED|Overall Study|One subject randomized to placebo discontinued prior to receiving any study drug, leaving 14.|15
2561756|NCT00487942|6279796|P3|STARTED|Overall Study||15
2561757|NCT00487942|6279797|P2|STARTED|Overall Study||15
2561758|NCT00487942|6279798|P1|STARTED|Overall Study||15
2561759|NCT00487825|6280182|P2|NOT COMPLETED|Overall Study||5
2561760|NCT00487825|6280183|P1|NOT COMPLETED|Overall Study||6
2561761|NCT00487825|6280182|P2|COMPLETED|Overall Study||21
2561762|NCT00487825|6280183|P1|COMPLETED|Overall Study||46
2561763|NCT00487825|6280182|P2|STARTED|Overall Study||26
2561764|NCT00487825|6280183|P1|STARTED|Overall Study|"Started indicates Intent-to-treat population (ITT)"|52
2561765|NCT00487747|6280195|P1|NOT COMPLETED|Overall Study||11
2561766|NCT00487747|6280195|P1|COMPLETED|Overall Study||7
2561767|NCT00487747|6280195|P1|STARTED|Overall Study||18
2561768|NCT00487721|6280206|P2|NOT COMPLETED|Overall Study||0
2561769|NCT00487721|6280207|P1|NOT COMPLETED|Overall Study||0
2561770|NCT00487721|6280206|P2|COMPLETED|Overall Study||6
2561771|NCT00487721|6280207|P1|COMPLETED|Overall Study||6
2561772|NCT00487721|6280206|P2|STARTED|Overall Study||6
2561773|NCT00487721|6280207|P1|STARTED|Overall Study||6
2561774|NCT00487695|6280212|P2|NOT COMPLETED|Second Procedure||3
2561775|NCT00487695|6280213|P1|NOT COMPLETED|Second Procedure||1
2561776|NCT00487695|6280212|P2|COMPLETED|Second Procedure||20
2561777|NCT00487695|6280213|P1|COMPLETED|Second Procedure||19
2561778|NCT00487695|6280212|P2|STARTED|Second Procedure||23
2561779|NCT00487695|6280213|P1|STARTED|Second Procedure||20
2561780|NCT00487695|6280212|P2|NOT COMPLETED|First Procedure||0
2561781|NCT00487695|6280213|P1|NOT COMPLETED|First Procedure||3
2561782|NCT00487695|6280212|P2|COMPLETED|First Procedure||23
2561783|NCT00487695|6280213|P1|COMPLETED|First Procedure||20
2561784|NCT00487695|6280212|P2|STARTED|First Procedure||23
2561785|NCT00487695|6280213|P1|STARTED|First Procedure||23
2561786|NCT00487669|6280229|P1|NOT COMPLETED|Overall Study||0
2561787|NCT00487669|6280229|P1|COMPLETED|Overall Study||12
2561788|NCT00487669|6280229|P1|STARTED|Overall Study||12
2561789|NCT00487578|6280241|P2|NOT COMPLETED|Overall Study||4
2561790|NCT00487578|6280242|P1|NOT COMPLETED|Overall Study||1
2561791|NCT00487578|6280241|P2|COMPLETED|Overall Study||5
2561792|NCT00487578|6280242|P1|COMPLETED|Overall Study||2
2561793|NCT00487578|6280241|P2|STARTED|Overall Study||9
2561794|NCT00487578|6280242|P1|STARTED|Overall Study||3
2561795|NCT00487565|6280258|P1|NOT COMPLETED|Overall Study||28
2561796|NCT00487565|6280258|P1|COMPLETED|Overall Study||182
2561797|NCT00487565|6280258|P1|STARTED|Overall Study||210
2561798|NCT00487552|6280262|P1|NOT COMPLETED|Overall Study||6
2561799|NCT00487552|6280262|P1|COMPLETED|Overall Study||12
2561800|NCT00487552|6280262|P1|STARTED|Overall Study||18
2561801|NCT00487539|6280271|P4|NOT COMPLETED|Overall Study||4
2561802|NCT00487539|6280272|P3|NOT COMPLETED|Overall Study||3
2561803|NCT00487539|6280273|P2|NOT COMPLETED|Overall Study||3
2561804|NCT00487539|6280274|P1|NOT COMPLETED|Overall Study||7
2561805|NCT00487539|6280271|P4|COMPLETED|Overall Study||327
2561806|NCT00487539|6280272|P3|COMPLETED|Overall Study||328
2561807|NCT00487539|6280273|P2|COMPLETED|Overall Study||69
2561808|NCT00487539|6280274|P1|COMPLETED|Overall Study||324
2561809|NCT00487539|6280271|P4|STARTED|Overall Study||331
2561810|NCT00487539|6280272|P3|STARTED|Overall Study||331
2561811|NCT00487539|6280273|P2|STARTED|Overall Study||72
2561812|NCT00487539|6280274|P1|STARTED|Overall Study||331
2561813|NCT00487461|6280295|P3|NOT COMPLETED|Overall Study||4
2561814|NCT00487461|6280296|P2|NOT COMPLETED|Overall Study||2
2561815|NCT00487461|6280297|P1|NOT COMPLETED|Overall Study||0
2561816|NCT00487461|6280295|P3|COMPLETED|Overall Study||7
2561817|NCT00487461|6280296|P2|COMPLETED|Overall Study||10
2561818|NCT00487461|6280297|P1|COMPLETED|Overall Study||2
2561819|NCT00487461|6280295|P3|STARTED|Overall Study||11
2561820|NCT00487461|6280296|P2|STARTED|Overall Study||12
2561821|NCT00487461|6280297|P1|STARTED|Overall Study||2
2561822|NCT00487435|6280308|P1|NOT COMPLETED|Overall Study||485
2561823|NCT00487435|6280308|P1|COMPLETED|Overall Study||669
2561824|NCT00487435|6280308|P1|STARTED|Overall Study|Patients who received at least one dose of Tapentadol (CG5503) Extended Release (ER)|1154
2561825|NCT00487396|6280313|P1|NOT COMPLETED|Overall Study||3
2561826|NCT00487396|6280313|P1|COMPLETED|Overall Study||95
2561827|NCT00487396|6280313|P1|STARTED|Overall Study||98
2561828|NCT00487279|6280321|P2|NOT COMPLETED|Overall Study||2
2561829|NCT00487279|6280322|P1|NOT COMPLETED|Overall Study||1
2561830|NCT00487279|6280321|P2|COMPLETED|Overall Study||35
2561831|NCT00487279|6280322|P1|COMPLETED|Overall Study||43
2561832|NCT00487279|6280321|P2|STARTED|Overall Study||37
2561833|NCT00487279|6280322|P1|STARTED|Overall Study||44
2561834|NCT00487240|6280332|P2|NOT COMPLETED|Overall Study||26
2561835|NCT00487240|6280333|P1|NOT COMPLETED|Overall Study||31
2561836|NCT00487240|6280332|P2|COMPLETED|Overall Study||166
2561837|NCT00487240|6280333|P1|COMPLETED|Overall Study||164
2561838|NCT00487240|6280332|P2|Full Analysis Set (ITT Population)|Overall Study||189
2561839|NCT00487240|6280333|P1|Full Analysis Set (ITT Population)|Overall Study||192
2561840|NCT00487240|6280332|P2|STARTED|Overall Study||192
2561841|NCT00487240|6280333|P1|STARTED|Overall Study||195
2561842|NCT00487188|6280361|P3|NOT COMPLETED|Maintenance Phase||1
2561843|NCT00487188|6280362|P2|NOT COMPLETED|Maintenance Phase||0
2561844|NCT00487188|6280363|P1|NOT COMPLETED|Maintenance Phase||3
2561845|NCT00487188|6280361|P3|COMPLETED|Maintenance Phase||8
2561846|NCT00487188|6280362|P2|COMPLETED|Maintenance Phase||8
2561847|NCT00487188|6280363|P1|COMPLETED|Maintenance Phase||7
2561848|NCT00487188|6280361|P3|STARTED|Maintenance Phase||9
2561849|NCT00487188|6280362|P2|STARTED|Maintenance Phase||8
2561850|NCT00487188|6280363|P1|STARTED|Maintenance Phase||10
2561851|NCT00487188|6280361|P3|NOT COMPLETED|Induction Phase||0
2561852|NCT00487188|6280362|P2|NOT COMPLETED|Induction Phase||7
2561853|NCT00487188|6280363|P1|NOT COMPLETED|Induction Phase||9
2561854|NCT00487188|6280361|P3|COMPLETED|Induction Phase||0
2561855|NCT00487188|6280362|P2|COMPLETED|Induction Phase||9
2561856|NCT00487188|6280363|P1|COMPLETED|Induction Phase||22
2561857|NCT00487188|6280361|P3|Safety Population|Induction Phase||0
2561858|NCT00487188|6280362|P2|Safety Population|Induction Phase|2 patients randomized to ENF + HARRT only received treatment with HAART|18
2561859|NCT00487188|6280363|P1|Safety Population|Induction Phase||29
2561860|NCT00487188|6280361|P3|STARTED|Induction Phase|Participants were only randomized to this treatment arm in the Maintenance Phase|0
2561861|NCT00487188|6280362|P2|STARTED|Induction Phase||16
2561862|NCT00487188|6280363|P1|STARTED|Induction Phase||31
2561863|NCT00487162|6280402|P2|NOT COMPLETED|Overall Study||5
2561864|NCT00487162|6280403|P1|NOT COMPLETED|Overall Study||2
2561865|NCT00487162|6280402|P2|COMPLETED|Overall Study||21
2561866|NCT00487162|6280403|P1|COMPLETED|Overall Study||28
2561867|NCT00487162|6280402|P2|STARTED|Overall Study||26
2561868|NCT00487162|6280403|P1|STARTED|Overall Study||30
2561869|NCT00487084|6280414|P3|NOT COMPLETED|Overall Study||5
2561870|NCT00487084|6280415|P2|NOT COMPLETED|Overall Study||3
2561871|NCT00487084|6280416|P1|NOT COMPLETED|Overall Study||4
2561872|NCT00487084|6280414|P3|COMPLETED|Overall Study||28
2561873|NCT00487084|6280415|P2|COMPLETED|Overall Study||30
2561874|NCT00487084|6280416|P1|COMPLETED|Overall Study||29
2561875|NCT00487084|6280414|P3|STARTED|Overall Study||33
2561876|NCT00487084|6280415|P2|STARTED|Overall Study||33
2561877|NCT00487084|6280416|P1|STARTED|Overall Study||33
2561878|NCT00486954|6280437|P5|NOT COMPLETED|Randomized Part||14
2561879|NCT00486954|6280438|P4|NOT COMPLETED|Randomized Part||20
2561880|NCT00486954|6280439|P3|NOT COMPLETED|Randomized Part||0
2561881|NCT00486954|6280440|P2|NOT COMPLETED|Randomized Part||0
2561882|NCT00486954|6280441|P1|NOT COMPLETED|Randomized Part||0
2561883|NCT00486954|6280437|P5|COMPLETED|Randomized Part||115
2561884|NCT00486954|6280438|P4|COMPLETED|Randomized Part||112
2561885|NCT00486954|6280439|P3|COMPLETED|Randomized Part||0
2561886|NCT00486954|6280440|P2|COMPLETED|Randomized Part||0
2561887|NCT00486954|6280441|P1|COMPLETED|Randomized Part||0
2561888|NCT00486954|6280437|P5|STARTED|Randomized Part||129
2561889|NCT00486954|6280438|P4|STARTED|Randomized Part||132
2561890|NCT00486954|6280439|P3|STARTED|Randomized Part||0
2561891|NCT00486954|6280440|P2|STARTED|Randomized Part||0
2561892|NCT00486954|6280441|P1|STARTED|Randomized Part||0
2561893|NCT00486954|6280437|P5|NOT COMPLETED|Pilot Part||0
2561894|NCT00486954|6280438|P4|NOT COMPLETED|Pilot Part||0
2561895|NCT00486954|6280439|P3|NOT COMPLETED|Pilot Part||6
2561896|NCT00486954|6280440|P2|NOT COMPLETED|Pilot Part||0
2561897|NCT00486954|6280441|P1|NOT COMPLETED|Pilot Part||6
2561898|NCT00486954|6280437|P5|COMPLETED|Pilot Part||0
2561899|NCT00486954|6280438|P4|COMPLETED|Pilot Part||0
2561900|NCT00486954|6280439|P3|COMPLETED|Pilot Part||0
2561901|NCT00486954|6280440|P2|COMPLETED|Pilot Part||0
2561902|NCT00486954|6280441|P1|COMPLETED|Pilot Part||0
2561903|NCT00486954|6280437|P5|STARTED|Pilot Part||0
2561904|NCT00486954|6280438|P4|STARTED|Pilot Part||0
2561905|NCT00486954|6280439|P3|STARTED|Pilot Part||6
2561906|NCT00486954|6280440|P2|STARTED|Pilot Part||0
2561907|NCT00486954|6280441|P1|STARTED|Pilot Part||6
2561908|NCT00486902|6280539|P2|NOT COMPLETED|Overall Study||5
2561909|NCT00486902|6280540|P1|NOT COMPLETED|Overall Study||9
2561910|NCT00486902|6280539|P2|COMPLETED|Overall Study||89
2561911|NCT00486902|6280540|P1|COMPLETED|Overall Study||85
2561912|NCT00486902|6280539|P2|STARTED|Overall Study||94
2561913|NCT00486902|6280540|P1|STARTED|Overall Study||94
2561914|NCT00486863|6280562|P2|NOT COMPLETED|Overall Study||3
2561915|NCT00486863|6280563|P1|NOT COMPLETED|Overall Study||1
2561916|NCT00486863|6280562|P2|COMPLETED|Overall Study||183
2561917|NCT00486863|6280563|P1|COMPLETED|Overall Study||183
2561918|NCT00486863|6280562|P2|STARTED|Overall Study||186
2561919|NCT00486863|6280563|P1|STARTED|Overall Study||184
2561920|NCT00486837|6280607|P2|NOT COMPLETED|Overall Study||7
2561921|NCT00486837|6280608|P1|NOT COMPLETED|Overall Study||9
2561922|NCT00486837|6280607|P2|COMPLETED|Overall Study||28
2561923|NCT00486837|6280608|P1|COMPLETED|Overall Study||28
2561924|NCT00486837|6280607|P2|STARTED|Overall Study||35
2561925|NCT00486837|6280608|P1|STARTED|Overall Study||37
2561926|NCT00486824|6280626|P2|NOT COMPLETED|Overall Study||2
2561927|NCT00486824|6280627|P1|NOT COMPLETED|Overall Study||2
2561928|NCT00486824|6280626|P2|COMPLETED|Overall Study||3
2561929|NCT00486824|6280627|P1|COMPLETED|Overall Study||3
2561930|NCT00486824|6280626|P2|STARTED|Overall Study||5
2561931|NCT00486824|6280627|P1|STARTED|Overall Study||5
2561932|NCT00486811|6280648|P3|NOT COMPLETED|Overall Study||214
2561933|NCT00486811|6280649|P2|NOT COMPLETED|Overall Study||141
2561934|NCT00486811|6280650|P1|NOT COMPLETED|Overall Study||122
2561935|NCT00486811|6280648|P3|COMPLETED|Overall Study||119
2561936|NCT00486811|6280649|P2|COMPLETED|Overall Study||179
2561937|NCT00486811|6280650|P1|COMPLETED|Overall Study||215
2561938|NCT00486811|6280648|P3|STARTED|Overall Study|Two participants were not eligible to be dosed.|333
2561939|NCT00486811|6280649|P2|STARTED|Overall Study|One participant was not eligible to be dosed.|320
2561940|NCT00486811|6280650|P1|STARTED|Overall Study||337
2561941|NCT00486759|6280693|P2|NOT COMPLETED|Safety Follow-up||118
2561942|NCT00486759|6280694|P1|NOT COMPLETED|Safety Follow-up||139
2561943|NCT00486759|6280693|P2|COMPLETED|Safety Follow-up||142
2561944|NCT00486759|6280694|P1|COMPLETED|Safety Follow-up||64
2561945|NCT00486759|6280693|P2|STARTED|Safety Follow-up||260
2561946|NCT00486759|6280694|P1|STARTED|Safety Follow-up||203
2561947|NCT00486759|6280693|P2|NOT COMPLETED|Treatment||137
2561948|NCT00486759|6280694|P1|NOT COMPLETED|Treatment||187
2561949|NCT00486759|6280693|P2|COMPLETED|Treatment||260
2561950|NCT00486759|6280694|P1|COMPLETED|Treatment||203
2561951|NCT00486759|6280693|P2|STARTED|Treatment||397
2561952|NCT00486759|6280694|P1|STARTED|Treatment||390
2561953|NCT00486720|6280706|P2|NOT COMPLETED|Overall Study||12
2561954|NCT00486720|6280707|P1|NOT COMPLETED|Overall Study||10
2561955|NCT00486720|6280706|P2|COMPLETED|Overall Study||0
2561956|NCT00486720|6280707|P1|COMPLETED|Overall Study||0
2561957|NCT00486720|6280706|P2|STARTED|Overall Study||12
2561958|NCT00486720|6280707|P1|STARTED|Overall Study|1 randomized patient was discontinued before receiving treatment due to a protocol violation|10
2561959|NCT00486642|6280717|P2|NOT COMPLETED|Overall Study||0
2561960|NCT00486642|6280718|P1|NOT COMPLETED|Overall Study||0
2561961|NCT00486642|6280717|P2|COMPLETED|Overall Study||13
2561962|NCT00486642|6280718|P1|COMPLETED|Overall Study||10
2561963|NCT00486642|6280717|P2|STARTED|Overall Study||13
2561964|NCT00486642|6280718|P1|STARTED|Overall Study||10
2561965|NCT00486603|6280742|P5|NOT COMPLETED|Overall Study||0
2561966|NCT00486603|6280743|P4|NOT COMPLETED|Overall Study||0
2561967|NCT00486603|6280744|P3|NOT COMPLETED|Overall Study||0
2561968|NCT00486603|6280745|P2|NOT COMPLETED|Overall Study||1
2561969|NCT00486603|6280746|P1|NOT COMPLETED|Overall Study||1
2561970|NCT00486603|6280742|P5|COMPLETED|Overall Study||76
2561971|NCT00486603|6280743|P4|COMPLETED|Overall Study||3
2561972|NCT00486603|6280744|P3|COMPLETED|Overall Study||3
2561973|NCT00486603|6280745|P2|COMPLETED|Overall Study||6
2561974|NCT00486603|6280746|P1|COMPLETED|Overall Study||2
2561975|NCT00486603|6280742|P5|STARTED|Overall Study||76
2561976|NCT00486603|6280743|P4|STARTED|Overall Study||3
2561977|NCT00486603|6280744|P3|STARTED|Overall Study||3
2561978|NCT00486603|6280745|P2|STARTED|Overall Study||7
2561979|NCT00486603|6280746|P1|STARTED|Overall Study||3
2561980|NCT00486525|6280770|P2|NOT COMPLETED|Overall Study||13
2561981|NCT00486525|6280771|P1|NOT COMPLETED|Overall Study||6
2561982|NCT00486525|6280770|P2|COMPLETED|Overall Study||87
2561983|NCT00486525|6280771|P1|COMPLETED|Overall Study||94
2561984|NCT00486525|6280770|P2|STARTED|Overall Study||100
2561985|NCT00486525|6280771|P1|STARTED|Overall Study||100
2561986|NCT00486447|6280787|P1|NOT COMPLETED|Overall Study||0
2561987|NCT00486447|6280787|P1|COMPLETED|Overall Study||249
2561988|NCT00486447|6280787|P1|STARTED|Overall Study||249
2561989|NCT00486434|6280794|P2|NOT COMPLETED|Overall Study||134
2561990|NCT00486434|6280795|P1|NOT COMPLETED|Overall Study||194
2561991|NCT00486434|6280794|P2|COMPLETED|Overall Study||454
2561992|NCT00486434|6280795|P1|COMPLETED|Overall Study||394
2561993|NCT00486434|6280794|P2|STARTED|Overall Study||588
2561994|NCT00486434|6280795|P1|STARTED|Overall Study||588
2561995|NCT00486330|6280814|P1|NOT COMPLETED|Overall Study||2
2561996|NCT00486330|6280814|P1|COMPLETED|Overall Study|Of the 12 subjects treated, two developed adverse events leading to study drug discontinuation.|10
2561997|NCT00486330|6280814|P1|STARTED|Overall Study|Twelve subjects met inclusion/exclusion criteria|12
2561998|NCT00486291|6280820|P2|NOT COMPLETED|Overall Study||29
2561999|NCT00486291|6280821|P1|NOT COMPLETED|Overall Study||16
2562000|NCT00486291|6280820|P2|COMPLETED|Overall Study||76
2562001|NCT00486291|6280821|P1|COMPLETED|Overall Study||89
2562002|NCT00486291|6280820|P2|STARTED|Overall Study|1 subject discontinued prior to first dose|105
2562003|NCT00486291|6280821|P1|STARTED|Overall Study|3 subjects discontinued prior to first dose|105
2562004|NCT00486278|6280829|P1|NOT COMPLETED|Overall Study||9
2562005|NCT00486278|6280829|P1|COMPLETED|Overall Study||42
2562006|NCT00486278|6280829|P1|STARTED|Overall Study|96 bleeds by 51 subjects, 77 were treated with vatreptacog alfa and 19 with rFVIIa|51
2562007|NCT00486265|6280963|P1|NOT COMPLETED|Overall Study||9
2562008|NCT00486265|6280963|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met|0
2562009|NCT00486265|6280963|P1|STARTED|Overall Study|Partipants dosed on day 1.|9
2562010|NCT00486252|6280967|P1|NOT COMPLETED|Overall Study||58
2562011|NCT00486252|6280967|P1|COMPLETED|Overall Study||938
2562012|NCT00486252|6280967|P1|STARTED|Overall Study||996
2562013|NCT00486226|6280982|P1|NOT COMPLETED|Overall Study||13
2562014|NCT00486226|6280982|P1|COMPLETED|Overall Study||92
2562015|NCT00486226|6280982|P1|STARTED|Overall Study||105
2562016|NCT00486044|6280992|P2|NOT COMPLETED|Overall Study||3
2562017|NCT00486044|6280993|P1|NOT COMPLETED|Overall Study||2
2562018|NCT00486044|6280992|P2|COMPLETED|Overall Study|21 completed MRI sub-study|46
2562019|NCT00486044|6280993|P1|COMPLETED|Overall Study|27 completed MRI sub-study|49
2562020|NCT00486044|6280992|P2|STARTED|Overall Study|23 in MRI sub-study|49
2562021|NCT00486044|6280993|P1|STARTED|Overall Study|50 received assigned intervention (1 withdrew during baseline) 27 in MRI sub-study|51
2562022|NCT00486031|6281005|P1|NOT COMPLETED|Overall Study||3
2562023|NCT00486031|6281005|P1|COMPLETED|Overall Study||440
2562024|NCT00486031|6281005|P1|STARTED|Overall Study||443
2562025|NCT00486018|6281013|P3|NOT COMPLETED|Overall Study||6
2562026|NCT00486018|6281014|P2|NOT COMPLETED|Overall Study||6
2562027|NCT00486018|6281015|P1|NOT COMPLETED|Overall Study||9
2562028|NCT00486018|6281013|P3|COMPLETED|Overall Study||125
2562029|NCT00486018|6281014|P2|COMPLETED|Overall Study||128
2562030|NCT00486018|6281015|P1|COMPLETED|Overall Study||123
2562031|NCT00486018|6281013|P3|Received Drug (Safety Population)|Overall Study||130
2562032|NCT00486018|6281014|P2|Received Drug (Safety Population)|Overall Study||134
2562033|NCT00486018|6281015|P1|Received Drug (Safety Population)|Overall Study||131
2562034|NCT00486018|6281013|P3|STARTED|Overall Study||131
2562035|NCT00486018|6281014|P2|STARTED|Overall Study||134
2562036|NCT00486018|6281015|P1|STARTED|Overall Study||132
2562037|NCT00485953|6281043|P2|NOT COMPLETED|Overall Study||7
2562038|NCT00485953|6281044|P1|NOT COMPLETED|Overall Study||7
2562039|NCT00485953|6281043|P2|COMPLETED|Overall Study||47
2562040|NCT00485953|6281044|P1|COMPLETED|Overall Study||48
2562041|NCT00485953|6281043|P2|STARTED|Overall Study||54
2562042|NCT00485953|6281044|P1|STARTED|Overall Study||55
2562043|NCT00485836|6281057|P3|NOT COMPLETED|Overall Study||11
2562044|NCT00485836|6281058|P2|NOT COMPLETED|Overall Study||3
2562045|NCT00485836|6281059|P1|NOT COMPLETED|Overall Study||15
2562046|NCT00485836|6281057|P3|COMPLETED|Overall Study||119
2562047|NCT00485836|6281058|P2|COMPLETED|Overall Study||129
2562048|NCT00485836|6281059|P1|COMPLETED|Overall Study||115
2562049|NCT00485836|6281057|P3|Received Study Drug (Safety Population)|Overall Study||129
2562050|NCT00485836|6281058|P2|Received Study Drug (Safety Population)|Overall Study||132
2562051|NCT00485836|6281059|P1|Received Study Drug (Safety Population)|Overall Study||129
2562052|NCT00485836|6281057|P3|STARTED|Overall Study||130
2562053|NCT00485836|6281058|P2|STARTED|Overall Study||132
2562054|NCT00485836|6281059|P1|STARTED|Overall Study||130
2562055|NCT00485758|6281087|P2|NOT COMPLETED|Overall Study||65
2562056|NCT00485758|6281088|P1|NOT COMPLETED|Overall Study||156
2562057|NCT00485758|6281087|P2|COMPLETED|Overall Study||277
2562058|NCT00485758|6281088|P1|COMPLETED|Overall Study||298
2562059|NCT00485758|6281087|P2|STARTED|Overall Study||342
2562060|NCT00485758|6281088|P1|STARTED|Overall Study||454
2562061|NCT00485732|6281100|P2|NOT COMPLETED|Overall Study||9
2562062|NCT00485732|6281101|P1|NOT COMPLETED|Overall Study||8
2562063|NCT00485732|6281100|P2|COMPLETED|Overall Study||67
2562064|NCT00485732|6281101|P1|COMPLETED|Overall Study||141
2562065|NCT00485732|6281100|P2|STARTED|Overall Study||76
2562066|NCT00485732|6281101|P1|STARTED|Overall Study||149
2562067|NCT00485693|6281123|P2|NOT COMPLETED|Overall Study||0
2562068|NCT00485693|6281124|P1|NOT COMPLETED|Overall Study||0
2562069|NCT00485693|6281123|P2|COMPLETED|Overall Study||104
2562070|NCT00485693|6281124|P1|COMPLETED|Overall Study||34
2562071|NCT00485693|6281123|P2|STARTED|Overall Study||104
2562072|NCT00485693|6281124|P1|STARTED|Overall Study||34
2562073|NCT00485485|6281133|P1|NOT COMPLETED|Overall Study||0
2562074|NCT00485485|6281133|P1|COMPLETED|Overall Study||7
2562075|NCT00485485|6281133|P1|STARTED|Overall Study||7
2562076|NCT00485472|6281139|P2|NOT COMPLETED|Overall Study||12
2562077|NCT00485472|6281140|P1|NOT COMPLETED|Overall Study||16
2562078|NCT00485472|6281139|P2|COMPLETED|Overall Study||64
2562079|NCT00485472|6281140|P1|COMPLETED|Overall Study||57
2562080|NCT00485472|6281139|P2|Entered Maintenance Phase|Overall Study||67
2562081|NCT00485472|6281140|P1|Entered Maintenance Phase|Overall Study||65
2562082|NCT00485472|6281139|P2|STARTED|Overall Study||76
2562083|NCT00485472|6281140|P1|STARTED|Overall Study||73
2562084|NCT00485433|6281166|P4|NOT COMPLETED|Overall Study||0
2562085|NCT00485433|6281167|P3|NOT COMPLETED|Overall Study||0
2562086|NCT00485433|6281168|P2|NOT COMPLETED|Overall Study||0
2562087|NCT00485433|6281169|P1|NOT COMPLETED|Overall Study||0
2562088|NCT00485433|6281166|P4|COMPLETED|Overall Study||25
2562089|NCT00485433|6281167|P3|COMPLETED|Overall Study||24
2562090|NCT00485433|6281168|P2|COMPLETED|Overall Study||25
2562091|NCT00485433|6281169|P1|COMPLETED|Overall Study||24
2562092|NCT00485433|6281166|P4|STARTED|Overall Study||25
2562093|NCT00485433|6281167|P3|STARTED|Overall Study||24
2562094|NCT00485433|6281168|P2|STARTED|Overall Study||25
2562095|NCT00485433|6281169|P1|STARTED|Overall Study||24
2562096|NCT00485303|6281177|P1|NOT COMPLETED|Overall Study||56
2562097|NCT00485303|6281177|P1|COMPLETED|Overall Study||2
2562098|NCT00485303|6281177|P1|STARTED|Overall Study||58
2562099|NCT00485264|6281195|P6|NOT COMPLETED|Overall Study||7
2562100|NCT00485264|6281196|P5|NOT COMPLETED|Overall Study||6
2562101|NCT00485264|6281197|P4|NOT COMPLETED|Overall Study||4
2562102|NCT00485264|6281198|P3|NOT COMPLETED|Overall Study||6
2562103|NCT00485264|6281199|P2|NOT COMPLETED|Overall Study||7
2562104|NCT00485264|6281200|P1|NOT COMPLETED|Overall Study||36
2562105|NCT00485264|6281195|P6|COMPLETED|Overall Study||5
2562106|NCT00485264|6281196|P5|COMPLETED|Overall Study||9
2562107|NCT00485264|6281197|P4|COMPLETED|Overall Study||17
2562108|NCT00485264|6281198|P3|COMPLETED|Overall Study||12
2562109|NCT00485264|6281199|P2|COMPLETED|Overall Study||9
2562110|NCT00485264|6281200|P1|COMPLETED|Overall Study||35
2562111|NCT00485264|6281195|P6|Completed Week 24|Overall Study||11
2562112|NCT00485264|6281196|P5|Completed Week 24|Overall Study||14
2562113|NCT00485264|6281197|P4|Completed Week 24|Overall Study||21
2562114|NCT00485264|6281198|P3|Completed Week 24|Overall Study||18
2562115|NCT00485264|6281199|P2|Completed Week 24|Overall Study||16
2562116|NCT00485264|6281200|P1|Completed Week 24|Overall Study||67
2562117|NCT00485264|6281195|P6|STARTED|Overall Study||12
2562118|NCT00485264|6281196|P5|STARTED|Overall Study||15
2562119|NCT00485264|6281197|P4|STARTED|Overall Study||21
2562120|NCT00485264|6281198|P3|STARTED|Overall Study||18
2562121|NCT00485264|6281199|P2|STARTED|Overall Study||16
2562122|NCT00485264|6281200|P1|STARTED|Overall Study||71
2562123|NCT00485173|6281288|P2|NOT COMPLETED|Overall Study||64
2562124|NCT00485173|6281289|P1|NOT COMPLETED|Overall Study||36
2562125|NCT00485173|6281288|P2|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|422
2562126|NCT00485173|6281289|P1|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|188
2562127|NCT00485173|6281288|P2|STARTED|Overall Study||486
2562128|NCT00485173|6281289|P1|STARTED|Overall Study||224
2562129|NCT00485134|6281337|P8|NOT COMPLETED|Overall Study||1
2562130|NCT00485134|6281338|P7|NOT COMPLETED|Overall Study||3
2562131|NCT00485134|6281339|P6|NOT COMPLETED|Overall Study||4
2562132|NCT00485134|6281340|P5|NOT COMPLETED|Overall Study||3
2562133|NCT00485134|6281341|P4|NOT COMPLETED|Overall Study||1
2562134|NCT00485134|6281342|P3|NOT COMPLETED|Overall Study||3
2562135|NCT00485134|6281343|P2|NOT COMPLETED|Overall Study||2
2562136|NCT00485134|6281344|P1|NOT COMPLETED|Overall Study||1
2562137|NCT00485134|6281337|P8|COMPLETED|Overall Study||20
2562138|NCT00485134|6281338|P7|COMPLETED|Overall Study||28
2562139|NCT00485134|6281339|P6|COMPLETED|Overall Study||3
2562140|NCT00485134|6281340|P5|COMPLETED|Overall Study||7
2562141|NCT00485134|6281341|P4|COMPLETED|Overall Study||7
2562142|NCT00485134|6281342|P3|COMPLETED|Overall Study||9
2562143|NCT00485134|6281343|P2|COMPLETED|Overall Study||10
2562144|NCT00485134|6281344|P1|COMPLETED|Overall Study||11
2562145|NCT00485134|6281337|P8|STARTED|Overall Study||21
2562146|NCT00485134|6281338|P7|STARTED|Overall Study||31
2562147|NCT00485134|6281339|P6|STARTED|Overall Study||7
2562148|NCT00485134|6281340|P5|STARTED|Overall Study||10
2562149|NCT00485134|6281341|P4|STARTED|Overall Study||8
2562150|NCT00485134|6281342|P3|STARTED|Overall Study||12
2562151|NCT00485134|6281343|P2|STARTED|Overall Study||12
2562152|NCT00485134|6281344|P1|STARTED|Overall Study||12
2562153|NCT00485069|6281366|P2|NOT COMPLETED|Overall Study||12
2562154|NCT00485069|6281367|P1|NOT COMPLETED|Overall Study||18
2562155|NCT00485069|6281366|P2|COMPLETED|Overall Study||46
2562156|NCT00485069|6281367|P1|COMPLETED|Overall Study||47
2562157|NCT00485069|6281366|P2|STARTED|Overall Study||58
2562158|NCT00485069|6281367|P1|STARTED|Overall Study||65
2562159|NCT00484939|6281412|P2|NOT COMPLETED|Overall Study||140
2562160|NCT00484939|6281413|P1|NOT COMPLETED|Overall Study||140
2562161|NCT00484939|6281412|P2|COMPLETED|Overall Study||0
2562162|NCT00484939|6281413|P1|COMPLETED|Overall Study||0
2562163|NCT00484939|6281412|P2|STARTED|Overall Study||140
2562164|NCT00484939|6281413|P1|STARTED|Overall Study||140
2562165|NCT00484874|6281433|P1|NOT COMPLETED|Overall Study||0
2562166|NCT00484874|6281433|P1|COMPLETED|Overall Study||12
2562167|NCT00484874|6281433|P1|STARTED|Overall Study||12
2562168|NCT00484679|6281440|P1|NOT COMPLETED|Overall Study||3
2562169|NCT00484679|6281440|P1|COMPLETED|Overall Study||15
2562170|NCT00484679|6281440|P1|STARTED|Overall Study||18
2562171|NCT00484419|6281447|P3|NOT COMPLETED|Overall Study||11
2562172|NCT00484419|6281448|P2|NOT COMPLETED|Overall Study||5
2562173|NCT00484419|6281449|P1|NOT COMPLETED|Overall Study||12
2562174|NCT00484419|6281447|P3|COMPLETED|Overall Study||45
2562175|NCT00484419|6281448|P2|COMPLETED|Overall Study||51
2562176|NCT00484419|6281449|P1|COMPLETED|Overall Study||45
2562177|NCT00484419|6281447|P3|STARTED|Overall Study||56
2562178|NCT00484419|6281448|P2|STARTED|Overall Study||56
2562179|NCT00484419|6281449|P1|STARTED|Overall Study||57
2562180|NCT00484393|6281507|P2|NOT COMPLETED|Overall Study||0
2562181|NCT00484393|6281508|P1|NOT COMPLETED|Overall Study||0
2562182|NCT00484393|6281507|P2|COMPLETED|Overall Study||3
2562183|NCT00484393|6281508|P1|COMPLETED|Overall Study||4
2562184|NCT00484393|6281507|P2|STARTED|Overall Study||3
2562185|NCT00484393|6281508|P1|STARTED|Overall Study||4
2562186|NCT00484354|6281516|P2|NOT COMPLETED|Overall Study||2
2562187|NCT00484354|6281517|P1|NOT COMPLETED|Overall Study||1
2562188|NCT00484354|6281516|P2|COMPLETED|Overall Study||57
2562189|NCT00484354|6281517|P1|COMPLETED|Overall Study||63
2562190|NCT00484354|6281516|P2|STARTED|Overall Study||59
2562191|NCT00484354|6281517|P1|STARTED|Overall Study||64
2562192|NCT00484315|6281533|P2|NOT COMPLETED|9-Month Angiographic Follow-up||13
2562193|NCT00484315|6281534|P1|NOT COMPLETED|9-Month Angiographic Follow-up||28
2562194|NCT00484315|6281533|P2|COMPLETED|9-Month Angiographic Follow-up||61
2562195|NCT00484315|6281534|P1|COMPLETED|9-Month Angiographic Follow-up||228
2562196|NCT00484315|6281533|P2|STARTED|9-Month Angiographic Follow-up||74
2562197|NCT00484315|6281534|P1|STARTED|9-Month Angiographic Follow-up||256
2562198|NCT00484315|6281533|P2|NOT COMPLETED|12-Month Clinical Follow-up||9
2562199|NCT00484315|6281534|P1|NOT COMPLETED|12-Month Clinical Follow-up||28
2562200|NCT00484315|6281533|P2|COMPLETED|12-Month Clinical Follow-up||311
2562201|NCT00484315|6281534|P1|COMPLETED|12-Month Clinical Follow-up||914
2562202|NCT00484315|6281533|P2|STARTED|12-Month Clinical Follow-up||320
2562203|NCT00484315|6281534|P1|STARTED|12-Month Clinical Follow-up||942
2562204|NCT00484289|6281545|P3|NOT COMPLETED|Post Marketing Phase||0
2562205|NCT00484289|6281546|P2|NOT COMPLETED|Post Marketing Phase||1
2562206|NCT00484289|6281547|P1|NOT COMPLETED|Post Marketing Phase||0
2562207|NCT00484289|6281545|P3|COMPLETED|Post Marketing Phase||10
2562208|NCT00484289|6281546|P2|COMPLETED|Post Marketing Phase||141
2562209|NCT00484289|6281547|P1|COMPLETED|Post Marketing Phase||10
2562210|NCT00484289|6281545|P3|STARTED|Post Marketing Phase||10
2562211|NCT00484289|6281546|P2|STARTED|Post Marketing Phase||142
2562212|NCT00484289|6281547|P1|STARTED|Post Marketing Phase||10
2562213|NCT00484289|6281545|P3|NOT COMPLETED|Long Term Phase||16
2562214|NCT00484289|6281546|P2|NOT COMPLETED|Long Term Phase||36
2562215|NCT00484289|6281547|P1|NOT COMPLETED|Long Term Phase||3
2562216|NCT00484289|6281545|P3|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
2562217|NCT00484289|6281546|P2|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|142
2562218|NCT00484289|6281547|P1|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
2562219|NCT00484289|6281545|P3|STARTED|Long Term Phase||26
2562220|NCT00484289|6281546|P2|STARTED|Long Term Phase||178
2562221|NCT00484289|6281547|P1|STARTED|Long Term Phase||13
2562222|NCT00484185|6281619|P1|NOT COMPLETED|Overall Study||71
2562223|NCT00484185|6281619|P1|COMPLETED|Overall Study||112
2562224|NCT00484185|6281619|P1|Treated|Overall Study||178
2562225|NCT00484185|6281619|P1|STARTED|Overall Study||183
2562226|NCT00484159|6281641|P3|NOT COMPLETED|Overall Study||0
2562227|NCT00484159|6281642|P2|NOT COMPLETED|Overall Study||1
2562228|NCT00484159|6281643|P1|NOT COMPLETED|Overall Study||1
2562229|NCT00484159|6281641|P3|COMPLETED|Overall Study||51
2562230|NCT00484159|6281642|P2|COMPLETED|Overall Study||49
2562231|NCT00484159|6281643|P1|COMPLETED|Overall Study||49
2562232|NCT00484159|6281641|P3|STARTED|Overall Study||51
2562233|NCT00484159|6281642|P2|STARTED|Overall Study||50
2562234|NCT00484159|6281643|P1|STARTED|Overall Study||50
2562235|NCT00484094|6281654|P1|NOT COMPLETED|Overall Study||42
2562236|NCT00484094|6281654|P1|COMPLETED|Overall Study||167
2562237|NCT00484094|6281654|P1|STARTED|Overall Study||209
2562238|NCT00483938|6281670|P7|NOT COMPLETED|Overall Study||40
2562239|NCT00483938|6281671|P6|NOT COMPLETED|Overall Study||8
2562240|NCT00483938|6281672|P5|NOT COMPLETED|Overall Study||2
2562241|NCT00483938|6281673|P4|NOT COMPLETED|Overall Study||6
2562242|NCT00483938|6281674|P3|NOT COMPLETED|Overall Study||0
2562243|NCT00483938|6281675|P2|NOT COMPLETED|Overall Study||19
2562244|NCT00483938|6281676|P1|NOT COMPLETED|Overall Study||5
2562245|NCT00483938|6281670|P7|COMPLETED|Overall Study||0
2562246|NCT00483938|6281671|P6|COMPLETED|Overall Study||18
2562247|NCT00483938|6281672|P5|COMPLETED|Overall Study||23
2562248|NCT00483938|6281673|P4|COMPLETED|Overall Study||25
2562249|NCT00483938|6281674|P3|COMPLETED|Overall Study||30
2562250|NCT00483938|6281675|P2|COMPLETED|Overall Study||24
2562251|NCT00483938|6281676|P1|COMPLETED|Overall Study||36
2562252|NCT00483938|6281670|P7|STARTED|Overall Study||40
2562253|NCT00483938|6281671|P6|STARTED|Overall Study||26
2562254|NCT00483938|6281672|P5|STARTED|Overall Study||25
2562255|NCT00483938|6281673|P4|STARTED|Overall Study||31
2562256|NCT00483938|6281674|P3|STARTED|Overall Study||30
2562257|NCT00483938|6281675|P2|STARTED|Overall Study||43
2562258|NCT00483938|6281676|P1|STARTED|Overall Study||41
2562259|NCT00483756|6281700|P3|NOT COMPLETED|Overall Study||52
2562260|NCT00483756|6281701|P2|NOT COMPLETED|Overall Study||50
2562261|NCT00483756|6281702|P1|NOT COMPLETED|Overall Study||33
2562262|NCT00483756|6281700|P3|COMPLETED|Overall Study||59
2562263|NCT00483756|6281701|P2|COMPLETED|Overall Study||60
2562264|NCT00483756|6281702|P1|COMPLETED|Overall Study||77
2562265|NCT00483756|6281700|P3|Treated|Overall Study||107
2562266|NCT00483756|6281701|P2|Treated|Overall Study||106
2562267|NCT00483756|6281702|P1|Treated|Overall Study||109
2562268|NCT00483756|6281700|P3|STARTED|Overall Study||111
2562269|NCT00483756|6281701|P2|STARTED|Overall Study||110
2562270|NCT00483756|6281702|P1|STARTED|Overall Study||110
2562271|NCT00483717|6281766|P2|NOT COMPLETED|Overall Study||21
2562272|NCT00483717|6281767|P1|NOT COMPLETED|Overall Study||24
2562273|NCT00483717|6281766|P2|COMPLETED|Overall Study||65
2562274|NCT00483717|6281767|P1|COMPLETED|Overall Study||63
2562275|NCT00483717|6281766|P2|STARTED|Overall Study||86
2562276|NCT00483717|6281767|P1|STARTED|Overall Study||87
2562277|NCT00483704|6281790|P3|NOT COMPLETED|Treatment||156
2562278|NCT00483704|6281791|P2|NOT COMPLETED|Treatment||129
2562279|NCT00483704|6281792|P1|NOT COMPLETED|Treatment||129
2562280|NCT00483704|6281790|P3|COMPLETED|Treatment||399
2562281|NCT00483704|6281791|P2|COMPLETED|Treatment||420
2562282|NCT00483704|6281792|P1|COMPLETED|Treatment||444
2562283|NCT00483704|6281790|P3|STARTED|Treatment||555
2562284|NCT00483704|6281791|P2|STARTED|Treatment||549
2562285|NCT00483704|6281792|P1|STARTED|Treatment||573
2562286|NCT00483704|6281790|P3|NOT COMPLETED|Randomization||91
2562287|NCT00483704|6281791|P2|NOT COMPLETED|Randomization||96
2562288|NCT00483704|6281792|P1|NOT COMPLETED|Randomization||71
2562289|NCT00483704|6281790|P3|COMPLETED|Randomization||555
2562290|NCT00483704|6281791|P2|COMPLETED|Randomization||549
2562291|NCT00483704|6281792|P1|COMPLETED|Randomization||573
2562292|NCT00483704|6281790|P3|STARTED|Randomization||646
2562293|NCT00483704|6281791|P2|STARTED|Randomization||645
2562294|NCT00483704|6281792|P1|STARTED|Randomization||644
2562295|NCT00483652|6281838|P2|NOT COMPLETED|Post-study Follow-up||0
2562296|NCT00483652|6281839|P1|NOT COMPLETED|Post-study Follow-up||0
2562297|NCT00483652|6281838|P2|COMPLETED|Post-study Follow-up||114
2562298|NCT00483652|6281839|P1|COMPLETED|Post-study Follow-up||113
2562299|NCT00483652|6281838|P2|STARTED|Post-study Follow-up||114
2562300|NCT00483652|6281839|P1|STARTED|Post-study Follow-up||113
2562301|NCT00483652|6281838|P2|NOT COMPLETED|Double-blind Treatment Period||5
2562302|NCT00483652|6281839|P1|NOT COMPLETED|Double-blind Treatment Period||7
2562303|NCT00483652|6281838|P2|COMPLETED|Double-blind Treatment Period||114
2562304|NCT00483652|6281839|P1|COMPLETED|Double-blind Treatment Period||113
2562305|NCT00483652|6281838|P2|STARTED|Double-blind Treatment Period||119
2562306|NCT00483652|6281839|P1|STARTED|Double-blind Treatment Period||120
2562307|NCT00483574|6281849|P2|NOT COMPLETED|Overall Study||13
2562308|NCT00483574|6281850|P1|NOT COMPLETED|Overall Study||102
2562309|NCT00483574|6281849|P2|COMPLETED|Overall Study||308
2562310|NCT00483574|6281850|P1|COMPLETED|Overall Study||951
2562311|NCT00483574|6281849|P2|STARTED|Overall Study||321
2562312|NCT00483574|6281850|P1|STARTED|Overall Study||1053
2562313|NCT00483561|6281858|P1|NOT COMPLETED|Overall Study||11
2562314|NCT00483561|6281858|P1|COMPLETED|Overall Study||15
2562315|NCT00483561|6281858|P1|STARTED|Overall Study||26
2562316|NCT00483548|6281865|P2|NOT COMPLETED|Overall Study||46
2562317|NCT00483548|6281866|P1|NOT COMPLETED|Overall Study||60
2562318|NCT00483548|6281865|P2|COMPLETED|Overall Study||104
2562319|NCT00483548|6281866|P1|COMPLETED|Overall Study||88
2562320|NCT00483548|6281865|P2|Received Study Treatment|Overall Study|3 subjects randomized but not treated.|147
2562321|NCT00483548|6281866|P1|Received Study Treatment|Overall Study|1 subject randomized but lost to follow up; no treatment data.|147
2562322|NCT00483548|6281865|P2|STARTED|Overall Study||150
2562323|NCT00483548|6281866|P1|STARTED|Overall Study||148
2562324|NCT00483509|6281904|P1|NOT COMPLETED|Overall Study||0
2562325|NCT00483509|6281904|P1|COMPLETED|Overall Study||28
2562326|NCT00483509|6281904|P1|STARTED|Overall Study||28
2562327|NCT00483496|6281912|P1|NOT COMPLETED|Overall Study||1
2562328|NCT00483496|6281912|P1|COMPLETED|Overall Study||15
2562329|NCT00483496|6281912|P1|STARTED|Overall Study||16
2562330|NCT00483405|6281924|P1|NOT COMPLETED|Overall Study||28
2562331|NCT00483405|6281924|P1|COMPLETED|Overall Study||0
2562332|NCT00483405|6281924|P1|STARTED|Overall Study||28
2562333|NCT00483379|6281933|P2|NOT COMPLETED|Extension Period||0
2562334|NCT00483379|6281934|P1|NOT COMPLETED|Extension Period||0
2562335|NCT00483379|6281933|P2|COMPLETED|Extension Period||2
2562336|NCT00483379|6281934|P1|COMPLETED|Extension Period||1
2562337|NCT00483379|6281933|P2|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|2
2562338|NCT00483379|6281934|P1|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|1
2562339|NCT00483379|6281933|P2|NOT COMPLETED|Treatment Period||0
2562340|NCT00483379|6281934|P1|NOT COMPLETED|Treatment Period||2
2562341|NCT00483379|6281933|P2|COMPLETED|Treatment Period||7
2562342|NCT00483379|6281934|P1|COMPLETED|Treatment Period||4
2562343|NCT00483379|6281933|P2|STARTED|Treatment Period||7
2562344|NCT00483379|6281934|P1|STARTED|Treatment Period||6
2562345|NCT00483327|6281970|P1|NOT COMPLETED|Overall Study||10
2562346|NCT00483327|6281970|P1|COMPLETED|Overall Study||20
2562347|NCT00483327|6281970|P1|STARTED|Overall Study||30
2562348|NCT00483262|6281981|P2|NOT COMPLETED|Overall Study||0
2562349|NCT00483262|6281982|P1|NOT COMPLETED|Overall Study||0
2562350|NCT00483262|6281981|P2|COMPLETED|Overall Study||43
2562351|NCT00483262|6281982|P1|COMPLETED|Overall Study||20
2562352|NCT00483262|6281981|P2|STARTED|Overall Study||43
2562353|NCT00483262|6281982|P1|STARTED|Overall Study||20
2562354|NCT00483223|6281992|P1|NOT COMPLETED|Overall Study||0
2562355|NCT00483223|6281992|P1|COMPLETED|Overall Study||86
2562356|NCT00483223|6281992|P1|STARTED|Overall Study||86
2562357|NCT00483184|6282002|P3|NOT COMPLETED|Overall Study||3
2562358|NCT00483184|6282003|P2|NOT COMPLETED|Overall Study||4
2562359|NCT00483184|6282004|P1|NOT COMPLETED|Overall Study||5
2562360|NCT00483184|6282002|P3|COMPLETED|Overall Study||23
2562361|NCT00483184|6282003|P2|COMPLETED|Overall Study||27
2562362|NCT00483184|6282004|P1|COMPLETED|Overall Study||22
2562363|NCT00483184|6282002|P3|STARTED|Overall Study||26
2562364|NCT00483184|6282003|P2|STARTED|Overall Study||31
2562365|NCT00483184|6282004|P1|STARTED|Overall Study||27
2562366|NCT00483119|6282014|P2|NOT COMPLETED|Overall Study||1
2562367|NCT00483119|6282015|P1|NOT COMPLETED|Overall Study||1
2562368|NCT00483119|6282014|P2|COMPLETED|Overall Study||3
2562369|NCT00483119|6282015|P1|COMPLETED|Overall Study||4
2562370|NCT00483119|6282014|P2|STARTED|Overall Study||4
2562371|NCT00483119|6282015|P1|STARTED|Overall Study||5
2562372|NCT00483041|6282029|P2|NOT COMPLETED|Overall Study||1
2562373|NCT00483041|6282030|P1|NOT COMPLETED|Overall Study||0
2562374|NCT00483041|6282029|P2|COMPLETED|Overall Study||5
2562375|NCT00483041|6282030|P1|COMPLETED|Overall Study||5
2562376|NCT00483041|6282029|P2|STARTED|Overall Study||6
2562377|NCT00483041|6282030|P1|STARTED|Overall Study||5
2562378|NCT00483002|6282060|P1|NOT COMPLETED|Overall Study||2554
2562379|NCT00483002|6282060|P1|COMPLETED|Overall Study||1165
2562380|NCT00483002|6282060|P1|STARTED|Overall Study||3719
2562381|NCT00482911|6282068|P2|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
2562382|NCT00482911|6282069|P1|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
2562462|NCT00482391|6282226|P1|NOT COMPLETED|Overall Study||3
2562383|NCT00482911|6282068|P2|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun|5 stopped at Dose D-QOD, 2 stopped at Dose D-QD (1 after first increasing to Dose E-QD)|7
2562384|NCT00482911|6282069|P1|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
2562385|NCT00482911|6282068|P2|STARTED|Dosing Schedule 2: Len, Cyc, & Sun|All received Dose D-QD in cycle 1|7
2562386|NCT00482911|6282069|P1|STARTED|Dosing Schedule 2: Len, Cyc, & Sun||0
2562387|NCT00482911|6282068|P2|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
2562388|NCT00482911|6282069|P1|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
2562389|NCT00482911|6282068|P2|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QOD|2
2562390|NCT00482911|6282069|P1|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QD, 1 stopped at Dose C-QOD|3
2562391|NCT00482911|6282068|P2|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 1|2
2562392|NCT00482911|6282069|P1|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 2|3
2562393|NCT00482911|6282068|P2|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
2562394|NCT00482911|6282069|P1|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
2562395|NCT00482911|6282068|P2|COMPLETED|Dosing Schedule 1: Len & Cyc||0
2562396|NCT00482911|6282069|P1|COMPLETED|Dosing Schedule 1: Len & Cyc||3
2562397|NCT00482911|6282068|P2|STARTED|Dosing Schedule 1: Len & Cyc||0
2562398|NCT00482911|6282069|P1|STARTED|Dosing Schedule 1: Len & Cyc|All received Dose A-QD in cycle 1|3
2562399|NCT00482729|6282085|P2|NOT COMPLETED|Overall Study||218
2562400|NCT00482729|6282086|P1|NOT COMPLETED|Overall Study||217
2562401|NCT00482729|6282085|P2|COMPLETED|Overall Study||406
2562402|NCT00482729|6282086|P1|COMPLETED|Overall Study||409
2562403|NCT00482729|6282085|P2|Completed Phase B|Overall Study||406
2562404|NCT00482729|6282086|P1|Completed Phase B|Overall Study||409
2562405|NCT00482729|6282085|P2|Completed Phase A|Overall Study||482
2562406|NCT00482729|6282086|P1|Completed Phase A|Overall Study||484
2562407|NCT00482729|6282085|P2|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 3 patients were excluded from all analysis|624
2562408|NCT00482729|6282086|P1|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 1 patient was excluded from all analysis|626
2562409|NCT00482703|6282102|P2|NOT COMPLETED|Overall Study||0
2562410|NCT00482703|6282103|P1|NOT COMPLETED|Overall Study||1
2562411|NCT00482703|6282102|P2|COMPLETED|Overall Study||12
2562412|NCT00482703|6282103|P1|COMPLETED|Overall Study||10
2562413|NCT00482703|6282102|P2|STARTED|Overall Study|number enrolled, randomized and treated|12
2562414|NCT00482703|6282103|P1|STARTED|Overall Study|number enrolled, randomized and treated|11
2562415|NCT00482677|6282150|P2|NOT COMPLETED|Overall Study||0
2562416|NCT00482677|6282151|P1|NOT COMPLETED|Overall Study||0
2562417|NCT00482677|6282150|P2|COMPLETED|Overall Study||281
2562418|NCT00482677|6282151|P1|COMPLETED|Overall Study||281
2562419|NCT00482677|6282150|P2|STARTED|Overall Study||281
2562420|NCT00482677|6282151|P1|STARTED|Overall Study||281
2562421|NCT00482625|6282161|P1|NOT COMPLETED|Overall Study||0
2562422|NCT00482625|6282161|P1|COMPLETED|Overall Study||6
2562423|NCT00482625|6282161|P1|STARTED|Overall Study||6
2562424|NCT00482612|6282174|P4|NOT COMPLETED|Follow-up Period||8
2562425|NCT00482612|6282175|P3|NOT COMPLETED|Follow-up Period||22
2562426|NCT00482612|6282176|P2|NOT COMPLETED|Follow-up Period||18
2562427|NCT00482612|6282177|P1|NOT COMPLETED|Follow-up Period||14
2562428|NCT00482612|6282174|P4|COMPLETED|Follow-up Period||127
2562429|NCT00482612|6282175|P3|COMPLETED|Follow-up Period||106
2562430|NCT00482612|6282176|P2|COMPLETED|Follow-up Period||107
2562431|NCT00482612|6282177|P1|COMPLETED|Follow-up Period||123
2562432|NCT00482612|6282174|P4|STARTED|Follow-up Period||135
2562433|NCT00482612|6282175|P3|STARTED|Follow-up Period||128
2562434|NCT00482612|6282176|P2|STARTED|Follow-up Period||125
2562435|NCT00482612|6282177|P1|STARTED|Follow-up Period||137
2562436|NCT00482612|6282174|P4|NOT COMPLETED|In-treatment Period||0
2562437|NCT00482612|6282175|P3|NOT COMPLETED|In-treatment Period||1
2562438|NCT00482612|6282176|P2|NOT COMPLETED|In-treatment Period||0
2562439|NCT00482612|6282177|P1|NOT COMPLETED|In-treatment Period||0
2562440|NCT00482612|6282174|P4|COMPLETED|In-treatment Period||135
2562441|NCT00482612|6282175|P3|COMPLETED|In-treatment Period||128
2562442|NCT00482612|6282176|P2|COMPLETED|In-treatment Period||125
2562443|NCT00482612|6282177|P1|COMPLETED|In-treatment Period||137
2562444|NCT00482612|6282174|P4|Treated|In-treatment Period||135
2562445|NCT00482612|6282175|P3|Treated|In-treatment Period||128
2562446|NCT00482612|6282176|P2|Treated|In-treatment Period||125
2562447|NCT00482612|6282177|P1|Treated|In-treatment Period||137
2562448|NCT00482612|6282174|P4|STARTED|In-treatment Period||135
2562449|NCT00482612|6282175|P3|STARTED|In-treatment Period||129
2562450|NCT00482612|6282176|P2|STARTED|In-treatment Period||125
2562451|NCT00482612|6282177|P1|STARTED|In-treatment Period||137
2562452|NCT00482547|6282205|P2|NOT COMPLETED|Overall Study||161
2562453|NCT00482547|6282206|P1|NOT COMPLETED|Overall Study||173
2562454|NCT00482547|6282205|P2|COMPLETED|Overall Study||428
2562455|NCT00482547|6282206|P1|COMPLETED|Overall Study||426
2562456|NCT00482547|6282205|P2|48 Hour Evaluation|Overall Study|428 went on to be included in the Silicone-coated 48 hour efficacy evaluable population.|428
2562457|NCT00482547|6282206|P1|48 Hour Evaluation|Overall Study|426 went on to be included in the Silver-coated 48 hour efficacy evaluable population.|426
2562458|NCT00482547|6282205|P2|Successful Catheterization|Overall Study|Out of the 589 SiCS catheter subjects 568 (96.4%) had a successful catheterization.|568
2562459|NCT00482547|6282206|P1|Successful Catheterization|Overall Study|Out of the 599 AgCS subjects 565 (94.3%) had a successful catheterization.|565
2562460|NCT00482547|6282205|P2|STARTED|Overall Study|589 subjects were enrolled in the silicone-coated catheter group.|589
2562461|NCT00482547|6282206|P1|STARTED|Overall Study|599 subjects were enrolled in the silver-coated catheter group.|599
2562463|NCT00482391|6282226|P1|COMPLETED|Overall Study||92
2562464|NCT00482391|6282226|P1|STARTED|Overall Study||95
2562465|NCT00482274|6282231|P1|NOT COMPLETED|Overall Study||1
2562466|NCT00482274|6282231|P1|COMPLETED|Overall Study||2
2562467|NCT00482274|6282231|P1|STARTED|Overall Study||3
2562468|NCT00482170|6282241|P2|NOT COMPLETED|Overall Study||20
2562469|NCT00482170|6282242|P1|NOT COMPLETED|Overall Study||15
2562470|NCT00482170|6282241|P2|COMPLETED|Overall Study||194
2562471|NCT00482170|6282242|P1|COMPLETED|Overall Study||192
2562472|NCT00482170|6282241|P2|Treated|Overall Study||211
2562473|NCT00482170|6282242|P1|Treated|Overall Study||207
2562474|NCT00482170|6282241|P2|STARTED|Overall Study||214
2562475|NCT00482170|6282242|P1|STARTED|Overall Study||207
2562476|NCT00482053|6282360|P1|NOT COMPLETED|Allogeneic Peripheral Stem Cells||0
2562477|NCT00482053|6282360|P1|COMPLETED|Allogeneic Peripheral Stem Cells||2
2562478|NCT00482053|6282360|P1|STARTED|Allogeneic Peripheral Stem Cells||2
2562479|NCT00482053|6282360|P1|NOT COMPLETED|Inter-treatment Period||1
2562480|NCT00482053|6282360|P1|COMPLETED|Inter-treatment Period||2
2562481|NCT00482053|6282360|P1|STARTED|Inter-treatment Period||3
2562482|NCT00482053|6282360|P1|NOT COMPLETED|Autologous Peripheral Stem Cells||0
2562483|NCT00482053|6282360|P1|COMPLETED|Autologous Peripheral Stem Cells||3
2562484|NCT00482053|6282360|P1|STARTED|Autologous Peripheral Stem Cells||3
2562485|NCT00482014|6282374|P4|NOT COMPLETED|Overall Study||23
2562486|NCT00482014|6282375|P3|NOT COMPLETED|Overall Study||11
2562487|NCT00482014|6282376|P2|NOT COMPLETED|Overall Study||6
2562488|NCT00482014|6282377|P1|NOT COMPLETED|Overall Study||7
2562489|NCT00482014|6282374|P4|COMPLETED|Overall Study||29
2562490|NCT00482014|6282375|P3|COMPLETED|Overall Study||35
2562491|NCT00482014|6282376|P2|COMPLETED|Overall Study||7
2562492|NCT00482014|6282377|P1|COMPLETED|Overall Study||2
2562493|NCT00482014|6282374|P4|STARTED|Overall Study||52
2562494|NCT00482014|6282375|P3|STARTED|Overall Study||46
2562495|NCT00482014|6282376|P2|STARTED|Overall Study||13
2562496|NCT00482014|6282377|P1|STARTED|Overall Study||9
2562497|NCT00482001|6282401|P2|NOT COMPLETED|Overall Study||1
2562498|NCT00482001|6282402|P1|NOT COMPLETED|Overall Study||1
2562499|NCT00482001|6282401|P2|COMPLETED|Overall Study||10
2562500|NCT00482001|6282402|P1|COMPLETED|Overall Study||10
2562501|NCT00482001|6282401|P2|STARTED|Overall Study||11
2562502|NCT00482001|6282402|P1|STARTED|Overall Study||11
2562503|NCT00481988|6282422|P2|NOT COMPLETED|Overall Study||1
2562504|NCT00481988|6282423|P1|NOT COMPLETED|Overall Study||1
2562505|NCT00481988|6282422|P2|COMPLETED|Overall Study||8
2562506|NCT00481988|6282423|P1|COMPLETED|Overall Study||11
2562507|NCT00481988|6282422|P2|Crossover|Overall Study|patient dropped out of study after 5 sessions to illness unrelated to study|8
2562508|NCT00481988|6282423|P1|Crossover|Overall Study|patient dropped out of study after 5 sessions to pursue other treatment options|11
2562509|NCT00481988|6282422|P2|STARTED|Overall Study|one patient was dropped from the study before randomization|9
2562510|NCT00481988|6282423|P1|STARTED|Overall Study||12
2562511|NCT00481871|6282436|P5|NOT COMPLETED|Overall Study||0
2562512|NCT00481871|6282437|P4|NOT COMPLETED|Overall Study||0
2562513|NCT00481871|6282438|P3|NOT COMPLETED|Overall Study||1
2562514|NCT00481871|6282439|P2|NOT COMPLETED|Overall Study||0
2562515|NCT00481871|6282440|P1|NOT COMPLETED|Overall Study||0
2562516|NCT00481871|6282436|P5|COMPLETED|Overall Study||34
2562517|NCT00481871|6282437|P4|COMPLETED|Overall Study||38
2562518|NCT00481871|6282438|P3|COMPLETED|Overall Study||17
2562519|NCT00481871|6282439|P2|COMPLETED|Overall Study||10
2562520|NCT00481871|6282440|P1|COMPLETED|Overall Study||7
2562521|NCT00481871|6282436|P5|STARTED|Overall Study||34
2562522|NCT00481871|6282437|P4|STARTED|Overall Study||38
2562523|NCT00481871|6282438|P3|STARTED|Overall Study||18
2562524|NCT00481871|6282439|P2|STARTED|Overall Study||10
2562525|NCT00481871|6282440|P1|STARTED|Overall Study||7
2562526|NCT00481845|6282456|P2|NOT COMPLETED|Overall Study||0
2562527|NCT00481845|6282457|P1|NOT COMPLETED|Overall Study||0
2562528|NCT00481845|6282456|P2|COMPLETED|Overall Study||0
2562529|NCT00481845|6282457|P1|COMPLETED|Overall Study||1
2562530|NCT00481845|6282456|P2|STARTED|Overall Study||0
2562531|NCT00481845|6282457|P1|STARTED|Overall Study||1
2562532|NCT00481832|6282465|P1|NOT COMPLETED|Allogenic Hematopoietic Cell Transplant||0
2562533|NCT00481832|6282465|P1|COMPLETED|Allogenic Hematopoietic Cell Transplant||13
2562534|NCT00481832|6282465|P1|STARTED|Allogenic Hematopoietic Cell Transplant||13
2562535|NCT00481832|6282465|P1|NOT COMPLETED|Inter-transplant Period||27
2562536|NCT00481832|6282465|P1|COMPLETED|Inter-transplant Period||13
2562537|NCT00481832|6282465|P1|STARTED|Inter-transplant Period||40
2562538|NCT00481832|6282465|P1|NOT COMPLETED|Autologous Hematopoietic Cell Transplant||0
2562539|NCT00481832|6282465|P1|COMPLETED|Autologous Hematopoietic Cell Transplant||40
2562540|NCT00481832|6282465|P1|STARTED|Autologous Hematopoietic Cell Transplant||40
2562541|NCT00481832|6282465|P1|NOT COMPLETED|Enrollment||10
2562542|NCT00481832|6282465|P1|COMPLETED|Enrollment||40
2562543|NCT00481832|6282465|P1|STARTED|Enrollment||50
2562544|NCT00481767|6282480|P2|NOT COMPLETED|Overall Study||21
2562545|NCT00481767|6282481|P1|NOT COMPLETED|Overall Study||32
2562546|NCT00481767|6282480|P2|COMPLETED|Overall Study||205
2562547|NCT00481767|6282481|P1|COMPLETED|Overall Study||418
2562548|NCT00481767|6282480|P2|STARTED|Overall Study||226
2562549|NCT00481767|6282481|P1|STARTED|Overall Study||450
2562550|NCT00481676|6282515|P2|NOT COMPLETED|Overall Study||5
2562551|NCT00481676|6282516|P1|NOT COMPLETED|Overall Study||2
2562552|NCT00481676|6282515|P2|COMPLETED|Overall Study||17
2562553|NCT00481676|6282516|P1|COMPLETED|Overall Study||25
2562554|NCT00481676|6282515|P2|STARTED|Overall Study||22
2562555|NCT00481676|6282516|P1|STARTED|Overall Study||27
2562556|NCT00481507|6282540|P2|NOT COMPLETED|Overall Study||0
2562557|NCT00481507|6282541|P1|NOT COMPLETED|Overall Study||0
2562558|NCT00481507|6282540|P2|COMPLETED|Overall Study||61
2562559|NCT00481507|6282541|P1|COMPLETED|Overall Study||64
2562560|NCT00481507|6282540|P2|STARTED|Overall Study||61
2562561|NCT00481507|6282541|P1|STARTED|Overall Study||64
2562562|NCT00481351|6282551|P2|NOT COMPLETED|Overall Study||0
2562563|NCT00481351|6282552|P1|NOT COMPLETED|Overall Study||0
2562564|NCT00481351|6282551|P2|COMPLETED|Overall Study||12
2562565|NCT00481351|6282552|P1|COMPLETED|Overall Study||13
2562566|NCT00481351|6282551|P2|STARTED|Overall Study||12
2562567|NCT00481351|6282552|P1|STARTED|Overall Study||13
2562568|NCT00481247|6282568|P2|NOT COMPLETED|Overall Study||260
2562569|NCT00481247|6282569|P1|NOT COMPLETED|Overall Study||259
2562570|NCT00481247|6282568|P2|COMPLETED|Overall Study||0
2562571|NCT00481247|6282569|P1|COMPLETED|Overall Study||0
2562572|NCT00481247|6282568|P2|Received Treatment|Overall Study||258
2562573|NCT00481247|6282569|P1|Received Treatment|Overall Study||258
2562574|NCT00481247|6282568|P2|STARTED|Overall Study|Randomized|260
2562575|NCT00481247|6282569|P1|STARTED|Overall Study|Randomized|259
2562576|NCT00481195|6282593|P2|NOT COMPLETED|Overall Study||39
2562577|NCT00481195|6282594|P1|NOT COMPLETED|Overall Study||39
2562578|NCT00481195|6282593|P2|COMPLETED|Overall Study||90
2562579|NCT00481195|6282594|P1|COMPLETED|Overall Study||89
2562580|NCT00481195|6282593|P2|STARTED|Overall Study|Four of these subjects were randomized but never received study medication.|129
2562581|NCT00481195|6282594|P1|STARTED|Overall Study|Two of these subjects were randomized but never received study medication.|128
2562582|NCT00481078|6282680|P2|NOT COMPLETED|Overall Study||20
2562583|NCT00481078|6282681|P1|NOT COMPLETED|Overall Study||42
2562584|NCT00481078|6282680|P2|COMPLETED|Overall Study||12
2562585|NCT00481078|6282681|P1|COMPLETED|Overall Study||20
2562586|NCT00481078|6282680|P2|STARTED|Overall Study||32
2562587|NCT00481078|6282681|P1|STARTED|Overall Study||62
2562588|NCT00481065|6282699|P8|NOT COMPLETED|Overall Study||19
2562589|NCT00481065|6282700|P7|NOT COMPLETED|Overall Study||16
2562590|NCT00481065|6282701|P6|NOT COMPLETED|Overall Study||24
2562591|NCT00481065|6282702|P5|NOT COMPLETED|Overall Study||23
2562592|NCT00481065|6282703|P4|NOT COMPLETED|Overall Study||15
2562593|NCT00481065|6282704|P3|NOT COMPLETED|Overall Study||19
2562594|NCT00481065|6282705|P2|NOT COMPLETED|Overall Study||17
2562595|NCT00481065|6282706|P1|NOT COMPLETED|Overall Study||22
2562596|NCT00481065|6282699|P8|COMPLETED|Overall Study||30
2562597|NCT00481065|6282700|P7|COMPLETED|Overall Study||34
2562598|NCT00481065|6282701|P6|COMPLETED|Overall Study||27
2562599|NCT00481065|6282702|P5|COMPLETED|Overall Study||28
2562600|NCT00481065|6282703|P4|COMPLETED|Overall Study||37
2562601|NCT00481065|6282704|P3|COMPLETED|Overall Study||32
2562602|NCT00481065|6282705|P2|COMPLETED|Overall Study||33
2562603|NCT00481065|6282706|P1|COMPLETED|Overall Study||29
2562604|NCT00481065|6282699|P8|STARTED|Overall Study||49
2562605|NCT00481065|6282700|P7|STARTED|Overall Study||50
2562606|NCT00481065|6282701|P6|STARTED|Overall Study||51
2562607|NCT00481065|6282702|P5|STARTED|Overall Study||51
2562608|NCT00481065|6282703|P4|STARTED|Overall Study||52
2562609|NCT00481065|6282704|P3|STARTED|Overall Study||51
2562610|NCT00481065|6282705|P2|STARTED|Overall Study||50
2562611|NCT00481065|6282706|P1|STARTED|Overall Study||51
2562612|NCT00480987|6282792|P1|NOT COMPLETED|Overall Study||0
2562613|NCT00480987|6282792|P1|COMPLETED|Overall Study||27
2562614|NCT00480987|6282792|P1|STARTED|Overall Study||27
2562615|NCT00480857|6282796|P1|NOT COMPLETED|Overall Study||2
2562616|NCT00480857|6282796|P1|COMPLETED|Overall Study||17
2562617|NCT00480857|6282796|P1|STARTED|Overall Study||19
2562618|NCT00480779|6282806|P2|NOT COMPLETED|Overall Study||3
2562619|NCT00480779|6282807|P1|NOT COMPLETED|Overall Study||2
2562620|NCT00480779|6282806|P2|COMPLETED|Overall Study||19
2562621|NCT00480779|6282807|P1|COMPLETED|Overall Study||24
2562622|NCT00480779|6282806|P2|STARTED|Overall Study||22
2562623|NCT00480779|6282807|P1|STARTED|Overall Study||26
2562624|NCT00480740|6282834|P3|NOT COMPLETED|Overall Study||0
2562625|NCT00480740|6282835|P2|NOT COMPLETED|Overall Study||0
2562626|NCT00480740|6282836|P1|NOT COMPLETED|Overall Study||0
2562627|NCT00480740|6282834|P3|COMPLETED|Overall Study||6
2562628|NCT00480740|6282835|P2|COMPLETED|Overall Study||9
2562629|NCT00480740|6282836|P1|COMPLETED|Overall Study||26
2562630|NCT00480740|6282834|P3|STARTED|Overall Study||6
2562631|NCT00480740|6282835|P2|STARTED|Overall Study||9
2562632|NCT00480740|6282836|P1|STARTED|Overall Study||26
2562633|NCT00480636|6282844|P1|NOT COMPLETED|Overall Study||19
2562634|NCT00480636|6282844|P1|COMPLETED|Overall Study||83
2562635|NCT00480636|6282844|P1|STARTED|Overall Study||102
2562636|NCT00480532|6282856|P4|NOT COMPLETED|Overall Study||1
2562637|NCT00480532|6282857|P3|NOT COMPLETED|Overall Study||4
2562638|NCT00480532|6282858|P2|NOT COMPLETED|Overall Study||4
2562639|NCT00480532|6282859|P1|NOT COMPLETED|Overall Study||2
2562640|NCT00480532|6282856|P4|COMPLETED|Overall Study||31
2562641|NCT00480532|6282857|P3|COMPLETED|Overall Study||29
2562642|NCT00480532|6282858|P2|COMPLETED|Overall Study||29
2562643|NCT00480532|6282859|P1|COMPLETED|Overall Study||31
2562644|NCT00480532|6282856|P4|STARTED|Overall Study||32
2562645|NCT00480532|6282857|P3|STARTED|Overall Study||33
2562646|NCT00480532|6282858|P2|STARTED|Overall Study||33
2562647|NCT00480532|6282859|P1|STARTED|Overall Study||33
2562648|NCT00480493|6282879|P2|NOT COMPLETED|Overall Study||7
2562649|NCT00480493|6282880|P1|NOT COMPLETED|Overall Study||2
2562650|NCT00480493|6282879|P2|COMPLETED|Overall Study||21
2562651|NCT00480493|6282880|P1|COMPLETED|Overall Study||30
2562652|NCT00480493|6282879|P2|Randomized|Overall Study||28
2562653|NCT00480493|6282880|P1|Randomized|Overall Study||32
2562654|NCT00480493|6282879|P2|STARTED|Overall Study||28
2562655|NCT00480493|6282880|P1|STARTED|Overall Study||32
2562656|NCT00480441|6282892|P3|NOT COMPLETED|Randomization||2
2562657|NCT00480441|6282893|P2|NOT COMPLETED|Randomization||7
2562658|NCT00480441|6282894|P1|NOT COMPLETED|Randomization||0
2562659|NCT00480441|6282892|P3|COMPLETED|Randomization||9
2562660|NCT00480441|6282893|P2|COMPLETED|Randomization||6
2562661|NCT00480441|6282894|P1|COMPLETED|Randomization||0
2562662|NCT00480441|6282892|P3|STARTED|Randomization||11
2562663|NCT00480441|6282893|P2|STARTED|Randomization||13
2562664|NCT00480441|6282894|P1|STARTED|Randomization||0
2562665|NCT00480441|6282892|P3|NOT COMPLETED|Baseline Functional MRI||0
2562666|NCT00480441|6282893|P2|NOT COMPLETED|Baseline Functional MRI||0
2562667|NCT00480441|6282894|P1|NOT COMPLETED|Baseline Functional MRI||12
2562668|NCT00480441|6282892|P3|COMPLETED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
2562669|NCT00480441|6282893|P2|COMPLETED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
2562670|NCT00480441|6282894|P1|COMPLETED|Baseline Functional MRI||12
2562671|NCT00480441|6282892|P3|STARTED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
2562672|NCT00480441|6282893|P2|STARTED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
2562673|NCT00480441|6282894|P1|STARTED|Baseline Functional MRI|All non-randomized participants who also met specific eligibility for baseline functional MRI|24
2562674|NCT00480441|6282892|P3|NOT COMPLETED|Screening||0
2562675|NCT00480441|6282893|P2|NOT COMPLETED|Screening||0
2562676|NCT00480441|6282894|P1|NOT COMPLETED|Screening||37
2562677|NCT00480441|6282892|P3|COMPLETED|Screening|"Participants did not enter this arm until period 3 randomization"|0
2562678|NCT00480441|6282893|P2|COMPLETED|Screening|"Participants did not enter this arm until period 3 randomization"|0
2562679|NCT00480441|6282894|P1|COMPLETED|Screening||24
2562680|NCT00480441|6282892|P3|STARTED|Screening|"Participants did not enter this arm until period 3 randomization"|0
2562681|NCT00480441|6282893|P2|STARTED|Screening|"Participants did not enter this arm until period 3 randomization"|0
2562682|NCT00480441|6282894|P1|STARTED|Screening||61
2562683|NCT00480324|6282903|P2|NOT COMPLETED|Overall Study||16
2562684|NCT00480324|6282904|P1|NOT COMPLETED|Overall Study||32
2562685|NCT00480324|6282903|P2|COMPLETED|Overall Study||241
2562686|NCT00480324|6282904|P1|COMPLETED|Overall Study||476
2562687|NCT00480324|6282903|P2|STARTED|Overall Study||257
2562688|NCT00480324|6282904|P1|STARTED|Overall Study||508
2562689|NCT00480077|6282932|P2|NOT COMPLETED|Overall Study||26
2562690|NCT00480077|6282933|P1|NOT COMPLETED|Overall Study||31
2562691|NCT00480077|6282932|P2|COMPLETED|Overall Study||141
2562692|NCT00480077|6282933|P1|COMPLETED|Overall Study||137
2562693|NCT00480077|6282932|P2|STARTED|Overall Study||167
2562694|NCT00480077|6282933|P1|STARTED|Overall Study||168
2562695|NCT00480025|6282941|P2|NOT COMPLETED|Overall Study||369
2562696|NCT00480025|6282942|P1|NOT COMPLETED|Overall Study||752
2562697|NCT00480025|6282941|P2|COMPLETED|Overall Study||388
2562698|NCT00480025|6282942|P1|COMPLETED|Overall Study||763
2562699|NCT00480025|6282941|P2|STARTED|Overall Study||757
2562700|NCT00480025|6282942|P1|STARTED|Overall Study||1515
2562701|NCT00479882|6283014|P4|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||18
2562702|NCT00479882|6283015|P3|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||20
2562703|NCT00479882|6283016|P2|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||21
2562704|NCT00479882|6283017|P1|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||25
2562705|NCT00479882|6283014|P4|COMPLETED|Crossover: Period III (Weeks 13-20)||447
2562706|NCT00479882|6283015|P3|COMPLETED|Crossover: Period III (Weeks 13-20)||420
2562707|NCT00479882|6283016|P2|COMPLETED|Crossover: Period III (Weeks 13-20)||419
2562708|NCT00479882|6283017|P1|COMPLETED|Crossover: Period III (Weeks 13-20)||447
2562709|NCT00479882|6283014|P4|STARTED|Crossover: Period III (Weeks 13-20)||465
2562710|NCT00479882|6283015|P3|STARTED|Crossover: Period III (Weeks 13-20)||440
2562711|NCT00479882|6283016|P2|STARTED|Crossover: Period III (Weeks 13-20)||440
2562712|NCT00479882|6283017|P1|STARTED|Crossover: Period III (Weeks 13-20)||472
2562713|NCT00479882|6283014|P4|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||140
2562714|NCT00479882|6283015|P3|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||157
2562715|NCT00479882|6283016|P2|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||162
2562716|NCT00479882|6283017|P1|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||138
2562717|NCT00479882|6283014|P4|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||465
2562718|NCT00479882|6283015|P3|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
2562719|NCT00479882|6283016|P2|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
2562720|NCT00479882|6283017|P1|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||472
2562721|NCT00479882|6283014|P4|STARTED|Precrossover: Periods I/II (Weeks 1-12)||605
2562722|NCT00479882|6283015|P3|STARTED|Precrossover: Periods I/II (Weeks 1-12)||597
2562723|NCT00479882|6283016|P2|STARTED|Precrossover: Periods I/II (Weeks 1-12)||602
2562724|NCT00479882|6283017|P1|STARTED|Precrossover: Periods I/II (Weeks 1-12)||610
2562725|NCT00479856|6283147|P1|NOT COMPLETED|Overall Study||3
2562726|NCT00479856|6283147|P1|COMPLETED|Overall Study||6
2562727|NCT00479856|6283147|P1|STARTED|Overall Study||9
2562728|NCT00479765|6283156|P1|NOT COMPLETED|Overall Study||4
2562729|NCT00479765|6283156|P1|COMPLETED|Overall Study||0
2562730|NCT00479765|6283156|P1|STARTED|Overall Study||4
2562731|NCT00479713|6283162|P2|NOT COMPLETED|Overall Study||9
2562732|NCT00479713|6283163|P1|NOT COMPLETED|Overall Study||13
2562733|NCT00479713|6283162|P2|COMPLETED|Overall Study||295
2562734|NCT00479713|6283163|P1|COMPLETED|Overall Study||301
2562735|NCT00479713|6283162|P2|STARTED|Overall Study||304
2562736|NCT00479713|6283163|P1|STARTED|Overall Study||314
2562737|NCT00479674|6283187|P1|NOT COMPLETED|Overall Study||41
2562738|NCT00479674|6283187|P1|COMPLETED|Overall Study||0
2562739|NCT00479674|6283187|P1|STARTED|Overall Study||41
2562740|NCT00479557|6283202|P7|NOT COMPLETED|Overall Study||2
2562741|NCT00479557|6283203|P6|NOT COMPLETED|Overall Study||13
2562742|NCT00479557|6283204|P5|NOT COMPLETED|Overall Study||4
2562743|NCT00479557|6283205|P4|NOT COMPLETED|Overall Study||5
2562744|NCT00479557|6283206|P3|NOT COMPLETED|Overall Study||8
2562745|NCT00479557|6283207|P2|NOT COMPLETED|Overall Study||10
2562746|NCT00479557|6283208|P1|NOT COMPLETED|Overall Study||10
2562747|NCT00479557|6283202|P7|COMPLETED|Overall Study||15
2562748|NCT00479557|6283203|P6|COMPLETED|Overall Study||31
2562749|NCT00479557|6283204|P5|COMPLETED|Overall Study||8
2562750|NCT00479557|6283205|P4|COMPLETED|Overall Study||30
2562751|NCT00479557|6283206|P3|COMPLETED|Overall Study||32
2562752|NCT00479557|6283207|P2|COMPLETED|Overall Study||51
2562753|NCT00479557|6283208|P1|COMPLETED|Overall Study||26
2562754|NCT00479557|6283202|P7|Treated|Overall Study||17
2562755|NCT00479557|6283203|P6|Treated|Overall Study||44
2562756|NCT00479557|6283204|P5|Treated|Overall Study||12
2562757|NCT00479557|6283205|P4|Treated|Overall Study||35
2562758|NCT00479557|6283206|P3|Treated|Overall Study||40
2562759|NCT00479557|6283207|P2|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
2562760|NCT00479557|6283208|P1|Treated|Overall Study||36
2562761|NCT00479557|6283202|P7|STARTED|Overall Study||17
2562762|NCT00479557|6283203|P6|STARTED|Overall Study||44
2562763|NCT00479557|6283204|P5|STARTED|Overall Study||12
2562764|NCT00479557|6283205|P4|STARTED|Overall Study||35
2562765|NCT00479557|6283206|P3|STARTED|Overall Study||40
2562766|NCT00479557|6283207|P2|STARTED|Overall Study||61
2562767|NCT00479557|6283208|P1|STARTED|Overall Study||36
2562768|NCT00479466|6283251|P6|NOT COMPLETED|Overall Study||4
2562769|NCT00479466|6283252|P5|NOT COMPLETED|Overall Study||8
2562770|NCT00479466|6283253|P4|NOT COMPLETED|Overall Study||3
2562771|NCT00479466|6283254|P3|NOT COMPLETED|Overall Study||3
2562772|NCT00479466|6283255|P2|NOT COMPLETED|Overall Study||8
2562773|NCT00479466|6283256|P1|NOT COMPLETED|Overall Study||13
2562774|NCT00479466|6283251|P6|COMPLETED|Overall Study||53
2562775|NCT00479466|6283252|P5|COMPLETED|Overall Study||48
2562776|NCT00479466|6283253|P4|COMPLETED|Overall Study||55
2562777|NCT00479466|6283254|P3|COMPLETED|Overall Study||54
2562778|NCT00479466|6283255|P2|COMPLETED|Overall Study||49
2562779|NCT00479466|6283256|P1|COMPLETED|Overall Study||44
2562780|NCT00479466|6283251|P6|STARTED|Overall Study||57
2562781|NCT00479466|6283252|P5|STARTED|Overall Study||56
2562782|NCT00479466|6283253|P4|STARTED|Overall Study||58
2562783|NCT00479466|6283254|P3|STARTED|Overall Study||57
2562784|NCT00479466|6283255|P2|STARTED|Overall Study||57
2562785|NCT00479466|6283256|P1|STARTED|Overall Study||57
2562786|NCT00479401|6283285|P3|NOT COMPLETED|Overall Study||12
2562787|NCT00479401|6283286|P2|NOT COMPLETED|Overall Study||37
2562788|NCT00479401|6283287|P1|NOT COMPLETED|Overall Study||49
2562789|NCT00479401|6283285|P3|COMPLETED|Overall Study||91
2562790|NCT00479401|6283286|P2|COMPLETED|Overall Study||176
2562791|NCT00479401|6283287|P1|COMPLETED|Overall Study||174
2562792|NCT00479401|6283285|P3|STARTED|Overall Study||103
2562793|NCT00479401|6283286|P2|STARTED|Overall Study||213
2562794|NCT00479401|6283287|P1|STARTED|Overall Study||223
2562795|NCT00479388|6283342|P2|NOT COMPLETED|Overall Study||73
2562796|NCT00479388|6283343|P1|NOT COMPLETED|Overall Study||132
2562797|NCT00479388|6283342|P2|COMPLETED|Overall Study||537
2562798|NCT00479388|6283343|P1|COMPLETED|Overall Study||474
2562799|NCT00479388|6283342|P2|STARTED|Overall Study||610
2562800|NCT00479388|6283343|P1|STARTED|Overall Study||606
2562801|NCT00479336|6283357|P4|NOT COMPLETED|Overall Study||5
2562802|NCT00479336|6283358|P3|NOT COMPLETED|Overall Study||1
2562803|NCT00479336|6283359|P2|NOT COMPLETED|Overall Study||6
2562804|NCT00479336|6283360|P1|NOT COMPLETED|Overall Study||4
2562805|NCT00479336|6283357|P4|COMPLETED|Overall Study||21
2562806|NCT00479336|6283358|P3|COMPLETED|Overall Study||24
2562807|NCT00479336|6283359|P2|COMPLETED|Overall Study||20
2562808|NCT00479336|6283360|P1|COMPLETED|Overall Study||23
2562809|NCT00479336|6283357|P4|STARTED|Overall Study||26
2562810|NCT00479336|6283358|P3|STARTED|Overall Study||25
2562811|NCT00479336|6283359|P2|STARTED|Overall Study||26
2562812|NCT00479336|6283360|P1|STARTED|Overall Study||27
2562813|NCT00479258|6283376|P2|NOT COMPLETED|Overall Study||0
2562814|NCT00479258|6283377|P1|NOT COMPLETED|Overall Study||0
2562815|NCT00479258|6283376|P2|COMPLETED|Overall Study||0
2562816|NCT00479258|6283377|P1|COMPLETED|Overall Study||0
2562817|NCT00479258|6283376|P2|STARTED|Overall Study||0
2562818|NCT00479258|6283377|P1|STARTED|Overall Study||0
2562819|NCT00479232|6283383|P6|NOT COMPLETED|Overall Study||30
2562820|NCT00479232|6283384|P5|NOT COMPLETED|Overall Study||4
2562821|NCT00479232|6283385|P4|NOT COMPLETED|Overall Study||3
2562822|NCT00479232|6283386|P3|NOT COMPLETED|Overall Study||28
2562823|NCT00479232|6283387|P2|NOT COMPLETED|Overall Study||3
2562824|NCT00479232|6283388|P1|NOT COMPLETED|Overall Study||3
2562825|NCT00479232|6283383|P6|COMPLETED|Overall Study||0
2562826|NCT00479232|6283384|P5|COMPLETED|Overall Study||0
2562827|NCT00479232|6283385|P4|COMPLETED|Overall Study||0
2562828|NCT00479232|6283386|P3|COMPLETED|Overall Study||0
2562829|NCT00479232|6283387|P2|COMPLETED|Overall Study||0
2562830|NCT00479232|6283388|P1|COMPLETED|Overall Study||0
2562831|NCT00479232|6283383|P6|STARTED|Overall Study||30
2562832|NCT00479232|6283384|P5|STARTED|Overall Study||4
2562833|NCT00479232|6283385|P4|STARTED|Overall Study||3
2562834|NCT00479232|6283386|P3|STARTED|Overall Study||28
2562835|NCT00479232|6283387|P2|STARTED|Overall Study||3
2562836|NCT00479232|6283388|P1|STARTED|Overall Study||3
2562837|NCT00479154|6283408|P2|NOT COMPLETED|Overall Study||0
2562838|NCT00479154|6283409|P1|NOT COMPLETED|Overall Study||0
2562839|NCT00479154|6283408|P2|COMPLETED|Overall Study||3
2562840|NCT00479154|6283409|P1|COMPLETED|Overall Study||3
2562841|NCT00479154|6283408|P2|STARTED|Overall Study||3
2562842|NCT00479154|6283409|P1|STARTED|Overall Study||3
2562843|NCT00479089|6283417|P2|NOT COMPLETED|Overall Study||0
2562844|NCT00479089|6283418|P1|NOT COMPLETED|Overall Study||0
2562845|NCT00479089|6283417|P2|COMPLETED|Overall Study||25
2562846|NCT00479089|6283418|P1|COMPLETED|Overall Study||25
2562847|NCT00479089|6283417|P2|STARTED|Overall Study||25
2562848|NCT00479089|6283418|P1|STARTED|Overall Study||25
2562849|NCT00479037|6283430|P2|NOT COMPLETED|Overall Study||6
2562850|NCT00479037|6283431|P1|NOT COMPLETED|Overall Study||3
2562851|NCT00479037|6283430|P2|COMPLETED|Overall Study||34
2562852|NCT00479037|6283431|P1|COMPLETED|Overall Study||38
2562853|NCT00479037|6283430|P2|STARTED|Overall Study||40
2562854|NCT00479037|6283431|P1|STARTED|Overall Study||41
2562855|NCT00478933|6283441|P1|NOT COMPLETED|Overall Study||78
2562856|NCT00478933|6283441|P1|COMPLETED|Overall Study||1145
2562857|NCT00478933|6283441|P1|STARTED|Overall Study||1223
2562858|NCT00478881|6283467|P2|NOT COMPLETED|Overall Study||22
2562859|NCT00478881|6283468|P1|NOT COMPLETED|Overall Study||39
2562860|NCT00478881|6283467|P2|COMPLETED|Overall Study||176
2562861|NCT00478881|6283468|P1|COMPLETED|Overall Study||160
2562862|NCT00478881|6283467|P2|Received Medication|Overall Study||198
2562863|NCT00478881|6283468|P1|Received Medication|Overall Study||198
2562864|NCT00478881|6283467|P2|STARTED|Overall Study||198
2562865|NCT00478881|6283468|P1|STARTED|Overall Study||199
2562866|NCT00478777|6283492|P1|NOT COMPLETED|Overall Study||77
2562867|NCT00478777|6283492|P1|COMPLETED|Overall Study|10 participants had >= 6 months and 63 participants < 6 months treatment prior to study termination.|73
2562868|NCT00478777|6283492|P1|Safety and Full Analysis Set (FAS)|Overall Study|6 enrolled participants did not receive lenalidomide.|144
2562869|NCT00478777|6283492|P1|STARTED|Overall Study||150
2562870|NCT00478673|6283499|P1|NOT COMPLETED|12-Months Post-Procedure||64
2562871|NCT00478673|6283499|P1|COMPLETED|12-Months Post-Procedure||231
2562872|NCT00478673|6283499|P1|STARTED|12-Months Post-Procedure|3 participants who did not complete Period 1 due to death (2) and withdrawal (1) are not included.|295
2562873|NCT00478673|6283499|P1|NOT COMPLETED|30-Days Post-Procedure||10
2562874|NCT00478673|6283499|P1|COMPLETED|30-Days Post-Procedure|"7 participants who did not complete this Period due to Missed Visit still continued on to Period 2"|288
2562875|NCT00478673|6283499|P1|STARTED|30-Days Post-Procedure||298
2562876|NCT00478647|6283504|P1|NOT COMPLETED|Overall Study||2
2562877|NCT00478647|6283504|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT)=participants who have received at least 1 full or partial dose of study drug.|38
2562878|NCT00478647|6283504|P1|STARTED|Overall Study||40
2562879|NCT00478608|6283512|P1|NOT COMPLETED|Overall Study||20
2562880|NCT00478608|6283512|P1|COMPLETED|Overall Study||59
2562881|NCT00478608|6283512|P1|STARTED|Overall Study||79
2562882|NCT00478569|6283520|P1|NOT COMPLETED|Overall Study||409
2562883|NCT00478569|6283520|P1|COMPLETED|Overall Study||761
2562884|NCT00478569|6283520|P1|STARTED|Overall Study||1170
2562885|NCT00478556|6283536|P2|NOT COMPLETED|Overall Study||0
2562886|NCT00478556|6283537|P1|NOT COMPLETED|Overall Study||0
2562887|NCT00478556|6283536|P2|COMPLETED|Overall Study||149
2562888|NCT00478556|6283537|P1|COMPLETED|Overall Study||151
2562889|NCT00478556|6283536|P2|STARTED|Overall Study||149
2562890|NCT00478556|6283537|P1|STARTED|Overall Study||151
2562894|NCT00478335|6283555|P2|NOT COMPLETED|Period 2 (4 Days)||0
2562895|NCT00478335|6283556|P1|NOT COMPLETED|Period 2 (4 Days)||0
2562896|NCT00478335|6283555|P2|COMPLETED|Period 2 (4 Days)||2
2562897|NCT00478335|6283556|P1|COMPLETED|Period 2 (4 Days)||2
2562898|NCT00478335|6283555|P2|STARTED|Period 2 (4 Days)||2
2562899|NCT00478335|6283556|P1|STARTED|Period 2 (4 Days)||2
2562900|NCT00478335|6283555|P2|NOT COMPLETED|Period 1 (4 Days)||0
2562901|NCT00478335|6283556|P1|NOT COMPLETED|Period 1 (4 Days)||0
2562902|NCT00478335|6283555|P2|COMPLETED|Period 1 (4 Days)||2
2562903|NCT00478335|6283556|P1|COMPLETED|Period 1 (4 Days)||2
2562904|NCT00478335|6283555|P2|STARTED|Period 1 (4 Days)||2
2562905|NCT00478335|6283556|P1|STARTED|Period 1 (4 Days)||2
2562906|NCT00478257|6283564|P2|NOT COMPLETED|Overall Study||3
2562907|NCT00478257|6283565|P1|NOT COMPLETED|Overall Study||8
2562908|NCT00478257|6283564|P2|COMPLETED|Overall Study||13
2562909|NCT00478257|6283565|P1|COMPLETED|Overall Study||15
2562910|NCT00478257|6283564|P2|STARTED|Overall Study||16
2562911|NCT00478257|6283565|P1|STARTED|Overall Study||23
2562912|NCT00478244|6283571|P1|NOT COMPLETED|Overall Study||1
2562913|NCT00478244|6283571|P1|COMPLETED|Overall Study||6
2562914|NCT00478244|6283571|P1|STARTED|Overall Study||7
2562915|NCT00478231|6283584|P1|NOT COMPLETED|Overall Study||84
2562916|NCT00478231|6283584|P1|COMPLETED|Overall Study||125
2562917|NCT00478231|6283584|P1|Treated|Overall Study||206
2562918|NCT00478231|6283584|P1|STARTED|Overall Study||209
2562919|NCT00478218|6283605|P2|NOT COMPLETED|Overall Study||0
2562920|NCT00478218|6283606|P1|NOT COMPLETED|Overall Study||0
2562921|NCT00478218|6283605|P2|COMPLETED|Overall Study||19
2562922|NCT00478218|6283606|P1|COMPLETED|Overall Study||34
2562923|NCT00478218|6283605|P2|STARTED|Overall Study||19
2562924|NCT00478218|6283606|P1|STARTED|Overall Study||34
2562925|NCT00478205|6283620|P2|NOT COMPLETED|Overall Study||87
2562926|NCT00478205|6283621|P1|NOT COMPLETED|Overall Study||296
2562927|NCT00478205|6283620|P2|COMPLETED|Overall Study||399
2562928|NCT00478205|6283621|P1|COMPLETED|Overall Study||685
2562929|NCT00478205|6283620|P2|STARTED|Overall Study||486
2562930|NCT00478205|6283621|P1|STARTED|Overall Study||981
2562931|NCT00478192|6283636|P3|NOT COMPLETED|Overall Study||2
2562932|NCT00478192|6283637|P2|NOT COMPLETED|Overall Study||5
2562933|NCT00478192|6283638|P1|NOT COMPLETED|Overall Study||4
2562934|NCT00478192|6283636|P3|COMPLETED|Overall Study||8
2562935|NCT00478192|6283637|P2|COMPLETED|Overall Study||15
2562936|NCT00478192|6283638|P1|COMPLETED|Overall Study||16
2562937|NCT00478192|6283636|P3|End of Treatment|Overall Study||8
2562938|NCT00478192|6283637|P2|End of Treatment|Overall Study||16
2562939|NCT00478192|6283638|P1|End of Treatment|Overall Study||18
2562940|NCT00478192|6283636|P3|Full Analysis Set / Safety Analysis Set|Overall Study||9
2562941|NCT00478192|6283637|P2|Full Analysis Set / Safety Analysis Set|Overall Study||20
2562942|NCT00478192|6283638|P1|Full Analysis Set / Safety Analysis Set|Overall Study||20
2562943|NCT00478192|6283636|P3|STARTED|Overall Study||10
2562944|NCT00478192|6283637|P2|STARTED|Overall Study||20
2562945|NCT00478192|6283638|P1|STARTED|Overall Study||20
2562946|NCT00478140|6283665|P1|NOT COMPLETED|Overall Study||1
2562947|NCT00478140|6283665|P1|COMPLETED|Overall Study||3
2562948|NCT00478140|6283665|P1|STARTED|Overall Study||4
2562949|NCT00478062|6283672|P1|NOT COMPLETED|Overall Study||0
2562950|NCT00478062|6283672|P1|COMPLETED|Overall Study||1
2562951|NCT00478062|6283672|P1|STARTED|Overall Study||1
2562952|NCT00478036|6283682|P3|NOT COMPLETED|Overall Study||0
2562953|NCT00478036|6283683|P2|NOT COMPLETED|Overall Study||0
2562954|NCT00478036|6283684|P1|NOT COMPLETED|Overall Study||0
2562955|NCT00478036|6283682|P3|COMPLETED|Overall Study||14
2562956|NCT00478036|6283683|P2|COMPLETED|Overall Study||7
2562957|NCT00478036|6283684|P1|COMPLETED|Overall Study||10
2562958|NCT00478036|6283682|P3|STARTED|Overall Study||14
2562959|NCT00478036|6283683|P2|STARTED|Overall Study||7
2562960|NCT00478036|6283684|P1|STARTED|Overall Study||10
2562961|NCT00478023|6283697|P5|NOT COMPLETED|Overall Study||55
2562962|NCT00478023|6283698|P4|NOT COMPLETED|Overall Study||30
2562963|NCT00478023|6283699|P3|NOT COMPLETED|Overall Study||20
2562964|NCT00478023|6283700|P2|NOT COMPLETED|Overall Study||24
2562965|NCT00478023|6283701|P1|NOT COMPLETED|Overall Study||35
2562966|NCT00478023|6283697|P5|COMPLETED|Overall Study||114
2562967|NCT00478023|6283698|P4|COMPLETED|Overall Study||146
2562968|NCT00478023|6283699|P3|COMPLETED|Overall Study||151
2562969|NCT00478023|6283700|P2|COMPLETED|Overall Study||144
2562970|NCT00478023|6283701|P1|COMPLETED|Overall Study||135
2562971|NCT00478023|6283697|P5|STARTED|Overall Study||169
2562972|NCT00478023|6283698|P4|STARTED|Overall Study||176
2562973|NCT00478023|6283699|P3|STARTED|Overall Study||171
2562974|NCT00478023|6283700|P2|STARTED|Overall Study||168
2562975|NCT00478023|6283701|P1|STARTED|Overall Study||170
2562976|NCT00477971|6283720|P2|NOT COMPLETED|Overall Study||6
2562977|NCT00477971|6283721|P1|NOT COMPLETED|Overall Study||17
2562978|NCT00477971|6283720|P2|COMPLETED|Overall Study||49
2562979|NCT00477971|6283721|P1|COMPLETED|Overall Study||17
2562980|NCT00477971|6283720|P2|STARTED|Overall Study||55
2562981|NCT00477971|6283721|P1|STARTED|Overall Study||34
2562982|NCT00477750|6283733|P1|NOT COMPLETED|Overall Study||11
2562983|NCT00477750|6283733|P1|COMPLETED|Overall Study||15
2562984|NCT00477750|6283733|P1|STARTED|Overall Study||26
2562985|NCT00477685|6283741|P1|NOT COMPLETED|Overall Study||0
2562986|NCT00477685|6283741|P1|COMPLETED|Overall Study||10
2562987|NCT00477685|6283741|P1|STARTED|Overall Study||10
2562988|NCT00477672|6283749|P3|NOT COMPLETED|Overall Study||16
2562989|NCT00477672|6283750|P2|NOT COMPLETED|Overall Study||16
2562990|NCT00477672|6283751|P1|NOT COMPLETED|Overall Study||7
2562991|NCT00477672|6283749|P3|COMPLETED|Overall Study||83
2562992|NCT00477672|6283750|P2|COMPLETED|Overall Study||85
2562993|NCT00477672|6283751|P1|COMPLETED|Overall Study||91
2562994|NCT00477672|6283749|P3|STARTED|Overall Study||99
2562995|NCT00477672|6283750|P2|STARTED|Overall Study||101
2562996|NCT00477672|6283751|P1|STARTED|Overall Study||98
2562997|NCT00477633|6283762|P1|NOT COMPLETED|Overall Study||709
2562998|NCT00477633|6283762|P1|COMPLETED|Overall Study||991
2562999|NCT00477633|6283762|P1|STARTED|Overall Study||1700
2563000|NCT00477607|6283770|P2|NOT COMPLETED|Overall Study||7
2563001|NCT00477607|6283771|P1|NOT COMPLETED|Overall Study||7
2563002|NCT00477607|6283770|P2|COMPLETED|Overall Study||13
2563003|NCT00477607|6283771|P1|COMPLETED|Overall Study||12
2563004|NCT00477607|6283770|P2|STARTED|Overall Study||20
2563005|NCT00477607|6283771|P1|STARTED|Overall Study||19
2563006|NCT00477594|6283783|P2|NOT COMPLETED|Follow-up Period||1
2563007|NCT00477594|6283784|P1|NOT COMPLETED|Follow-up Period||3
2563008|NCT00477594|6283783|P2|COMPLETED|Follow-up Period||4
2563009|NCT00477594|6283784|P1|COMPLETED|Follow-up Period||13
2563010|NCT00477594|6283783|P2|STARTED|Follow-up Period||5
2563011|NCT00477594|6283784|P1|STARTED|Follow-up Period||16
2563012|NCT00477594|6283783|P2|NOT COMPLETED|Year 3||0
2563013|NCT00477594|6283784|P1|NOT COMPLETED|Year 3||2
2563014|NCT00477594|6283783|P2|COMPLETED|Year 3||0
2563015|NCT00477594|6283784|P1|COMPLETED|Year 3||2
2563016|NCT00477594|6283783|P2|STARTED|Year 3||0
2563017|NCT00477594|6283784|P1|STARTED|Year 3||4
2563018|NCT00477594|6283783|P2|NOT COMPLETED|Year 1 and Year 2||4
2563019|NCT00477594|6283784|P1|NOT COMPLETED|Year 1 and Year 2||9
2563020|NCT00477594|6283783|P2|COMPLETED|Year 1 and Year 2||1
2563021|NCT00477594|6283784|P1|COMPLETED|Year 1 and Year 2||7
2563022|NCT00477594|6283783|P2|STARTED|Year 1 and Year 2||5
2563023|NCT00477594|6283784|P1|STARTED|Year 1 and Year 2||16
2563024|NCT00477490|6283845|P9|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||8
2563025|NCT00477490|6283846|P8|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
2563026|NCT00477490|6283847|P7|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
2563027|NCT00477490|6283848|P6|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||6
2563028|NCT00477490|6283849|P5|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||20
2563029|NCT00477490|6283850|P4|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||12
2563030|NCT00477490|6283851|P3|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||15
2563031|NCT00477490|6283852|P2|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||28
2563032|NCT00477490|6283853|P1|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||0
2563033|NCT00477490|6283845|P9|COMPLETED|Part II: Extension Week 5 up to Day 169||26
2563034|NCT00477490|6283846|P8|COMPLETED|Part II: Extension Week 5 up to Day 169||29
2563035|NCT00477490|6283847|P7|COMPLETED|Part II: Extension Week 5 up to Day 169||32
2563036|NCT00477490|6283848|P6|COMPLETED|Part II: Extension Week 5 up to Day 169||25
2563037|NCT00477490|6283849|P5|COMPLETED|Part II: Extension Week 5 up to Day 169||107
2563038|NCT00477490|6283850|P4|COMPLETED|Part II: Extension Week 5 up to Day 169||120
2563039|NCT00477490|6283851|P3|COMPLETED|Part II: Extension Week 5 up to Day 169||120
2563040|NCT00477490|6283852|P2|COMPLETED|Part II: Extension Week 5 up to Day 169||107
2563041|NCT00477490|6283853|P1|COMPLETED|Part II: Extension Week 5 up to Day 169||0
2563042|NCT00477490|6283845|P9|STARTED|Part II: Extension Week 5 up to Day 169||34
2563043|NCT00477490|6283846|P8|STARTED|Part II: Extension Week 5 up to Day 169||34
2563044|NCT00477490|6283847|P7|STARTED|Part II: Extension Week 5 up to Day 169||37
2563045|NCT00477490|6283848|P6|STARTED|Part II: Extension Week 5 up to Day 169||31
2563046|NCT00477490|6283849|P5|STARTED|Part II: Extension Week 5 up to Day 169||127
2563047|NCT00477490|6283850|P4|STARTED|Part II: Extension Week 5 up to Day 169||132
2563048|NCT00477490|6283851|P3|STARTED|Part II: Extension Week 5 up to Day 169||135
2563049|NCT00477490|6283852|P2|STARTED|Part II: Extension Week 5 up to Day 169||135
2563050|NCT00477490|6283853|P1|STARTED|Part II: Extension Week 5 up to Day 169||0
2563051|NCT00477490|6283845|P9|NOT COMPLETED|Part I: 4 Week Efficacy||0
2563052|NCT00477490|6283846|P8|NOT COMPLETED|Part I: 4 Week Efficacy||0
2563053|NCT00477490|6283847|P7|NOT COMPLETED|Part I: 4 Week Efficacy||0
2563054|NCT00477490|6283848|P6|NOT COMPLETED|Part I: 4 Week Efficacy||0
2563055|NCT00477490|6283849|P5|NOT COMPLETED|Part I: 4 Week Efficacy||25
2563056|NCT00477490|6283850|P4|NOT COMPLETED|Part I: 4 Week Efficacy||20
2563057|NCT00477490|6283851|P3|NOT COMPLETED|Part I: 4 Week Efficacy||10
2563058|NCT00477490|6283852|P2|NOT COMPLETED|Part I: 4 Week Efficacy||19
2563059|NCT00477490|6283853|P1|NOT COMPLETED|Part I: 4 Week Efficacy||15
2563060|NCT00477490|6283845|P9|COMPLETED|Part I: 4 Week Efficacy||0
2563061|NCT00477490|6283846|P8|COMPLETED|Part I: 4 Week Efficacy||0
2563062|NCT00477490|6283847|P7|COMPLETED|Part I: 4 Week Efficacy||0
2563063|NCT00477490|6283848|P6|COMPLETED|Part I: 4 Week Efficacy||0
2563064|NCT00477490|6283849|P5|COMPLETED|Part I: 4 Week Efficacy||135
2563065|NCT00477490|6283850|P4|COMPLETED|Part I: 4 Week Efficacy||138
2563066|NCT00477490|6283851|P3|COMPLETED|Part I: 4 Week Efficacy||148
2563067|NCT00477490|6283852|P2|COMPLETED|Part I: 4 Week Efficacy||144
2563068|NCT00477490|6283853|P1|COMPLETED|Part I: 4 Week Efficacy||145
2563069|NCT00477490|6283845|P9|ITT Population|Part I: 4 Week Efficacy||0
2563070|NCT00477490|6283846|P8|ITT Population|Part I: 4 Week Efficacy||0
2563071|NCT00477490|6283847|P7|ITT Population|Part I: 4 Week Efficacy||0
2563072|NCT00477490|6283848|P6|ITT Population|Part I: 4 Week Efficacy||0
2563073|NCT00477490|6283849|P5|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|146
2563074|NCT00477490|6283850|P4|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|148
2563075|NCT00477490|6283851|P3|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|152
2563076|NCT00477490|6283852|P2|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|155
2563077|NCT00477490|6283853|P1|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|156
2563078|NCT00477490|6283845|P9|STARTED|Part I: 4 Week Efficacy||0
2563079|NCT00477490|6283846|P8|STARTED|Part I: 4 Week Efficacy||0
2563080|NCT00477490|6283847|P7|STARTED|Part I: 4 Week Efficacy||0
2563081|NCT00477490|6283848|P6|STARTED|Part I: 4 Week Efficacy||0
2563082|NCT00477490|6283849|P5|STARTED|Part I: 4 Week Efficacy||160
2563083|NCT00477490|6283850|P4|STARTED|Part I: 4 Week Efficacy||158
2563084|NCT00477490|6283851|P3|STARTED|Part I: 4 Week Efficacy||158
2563085|NCT00477490|6283852|P2|STARTED|Part I: 4 Week Efficacy||163
2563086|NCT00477490|6283853|P1|STARTED|Part I: 4 Week Efficacy||160
2563087|NCT00477464|6283937|P1|NOT COMPLETED|Overall Study||51
2563088|NCT00477464|6283937|P1|COMPLETED|Overall Study||0
2563089|NCT00477464|6283937|P1|STARTED|Overall Study||51
2563090|NCT00477451|6283964|P4|NOT COMPLETED|Overall Study||0
2563091|NCT00477451|6283965|P3|NOT COMPLETED|Overall Study||0
2563092|NCT00477451|6283966|P2|NOT COMPLETED|Overall Study||0
2563093|NCT00477451|6283967|P1|NOT COMPLETED|Overall Study||0
2563094|NCT00477451|6283964|P4|COMPLETED|Overall Study||2
2563095|NCT00477451|6283965|P3|COMPLETED|Overall Study||7
2563096|NCT00477451|6283966|P2|COMPLETED|Overall Study||20
2563097|NCT00477451|6283967|P1|COMPLETED|Overall Study||20
2563098|NCT00477451|6283964|P4|STARTED|Overall Study||2
2563099|NCT00477451|6283965|P3|STARTED|Overall Study||7
2563100|NCT00477451|6283966|P2|STARTED|Overall Study||20
2563101|NCT00477451|6283967|P1|STARTED|Overall Study||20
2563102|NCT00477386|6283981|P2|NOT COMPLETED|Overall Study||17
2563103|NCT00477386|6283982|P1|NOT COMPLETED|Overall Study||11
2563104|NCT00477386|6283981|P2|COMPLETED|Overall Study||0
2563105|NCT00477386|6283982|P1|COMPLETED|Overall Study||0
2563106|NCT00477386|6283981|P2|STARTED|Overall Study||17
2563107|NCT00477386|6283982|P1|STARTED|Overall Study||11
2563108|NCT00477334|6283992|P2|NOT COMPLETED|Overall Study||76
2563109|NCT00477334|6283993|P1|NOT COMPLETED|Overall Study||170
2563110|NCT00477334|6283992|P2|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|75
2563111|NCT00477334|6283993|P1|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|142
2563112|NCT00477334|6283992|P2|Modified Intent to Treat Population|Overall Study||78
2563113|NCT00477334|6283993|P1|Modified Intent to Treat Population|Overall Study||152
2563114|NCT00477334|6283992|P2|Participants Completing First Recurrence|Overall Study||92
2563115|NCT00477334|6283993|P1|Participants Completing First Recurrence|Overall Study||187
2563116|NCT00477334|6283992|P2|Intent to Treat Population|Overall Study||98
2563117|NCT00477334|6283993|P1|Intent to Treat Population|Overall Study||201
2563118|NCT00477334|6283992|P2|Randomized and Took Study Drug|Overall Study||98
2563119|NCT00477334|6283993|P1|Randomized and Took Study Drug|Overall Study||206
2563120|NCT00477334|6283992|P2|STARTED|Overall Study||151
2563121|NCT00477334|6283993|P1|STARTED|Overall Study||312
2563122|NCT00477295|6284019|P2|NOT COMPLETED|Overall Study||109
2563123|NCT00477295|6284020|P1|NOT COMPLETED|Overall Study||121
2563124|NCT00477295|6284019|P2|COMPLETED|Overall Study||192
2563125|NCT00477295|6284020|P1|COMPLETED|Overall Study||161
2563126|NCT00477295|6284019|P2|STARTED|Overall Study||301
2563127|NCT00477295|6284020|P1|STARTED|Overall Study||282
2563128|NCT00477269|6284048|P3|NOT COMPLETED|Open Label Extension||13
2563129|NCT00477269|6284049|P2|NOT COMPLETED|Open Label Extension||0
2563130|NCT00477269|6284050|P1|NOT COMPLETED|Open Label Extension||0
2563131|NCT00477269|6284048|P3|COMPLETED|Open Label Extension||9
2563132|NCT00477269|6284049|P2|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
2563133|NCT00477269|6284050|P1|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
2563134|NCT00477269|6284048|P3|STARTED|Open Label Extension||22
2563135|NCT00477269|6284049|P2|STARTED|Open Label Extension|Arm in the Core study not extension|0
2563136|NCT00477269|6284050|P1|STARTED|Open Label Extension|Arm in the Core study not extension|0
2563137|NCT00477269|6284048|P3|NOT COMPLETED|Core Study||0
2563138|NCT00477269|6284049|P2|NOT COMPLETED|Core Study||8
2563139|NCT00477269|6284050|P1|NOT COMPLETED|Core Study||9
2563140|NCT00477269|6284048|P3|COMPLETED|Core Study||0
2563141|NCT00477269|6284049|P2|COMPLETED|Core Study||23
2563142|NCT00477269|6284050|P1|COMPLETED|Core Study||19
2563143|NCT00477269|6284048|P3|STARTED|Core Study||0
2563144|NCT00477269|6284049|P2|STARTED|Core Study||31
2563145|NCT00477269|6284050|P1|STARTED|Core Study||28
2563146|NCT00477230|6284104|P2|NOT COMPLETED|Overall Study||31
2563147|NCT00477230|6284105|P1|NOT COMPLETED|Overall Study||20
2563148|NCT00477230|6284104|P2|COMPLETED|Overall Study||1
2563149|NCT00477230|6284105|P1|COMPLETED|Overall Study||12
2563150|NCT00477230|6284104|P2|STARTED|Overall Study||32
2563151|NCT00477230|6284105|P1|STARTED|Overall Study||32
2563152|NCT00477204|6284113|P2|NOT COMPLETED|Overall Study||0
2563153|NCT00477204|6284114|P1|NOT COMPLETED|Overall Study||0
2563154|NCT00477204|6284113|P2|COMPLETED|Overall Study||5
2563155|NCT00477204|6284114|P1|COMPLETED|Overall Study||4
2563156|NCT00477204|6284113|P2|STARTED|Overall Study||5
2563157|NCT00477204|6284114|P1|STARTED|Overall Study||4
2563158|NCT00477191|6284120|P1|NOT COMPLETED|Overall Study||5
2563159|NCT00477191|6284120|P1|COMPLETED|Overall Study||13
2563160|NCT00477191|6284120|P1|STARTED|Overall Study||18
2563161|NCT00477165|6284129|P2|NOT COMPLETED|Overall Study||2
2563162|NCT00477165|6284130|P1|NOT COMPLETED|Overall Study||7
2563163|NCT00477165|6284129|P2|COMPLETED|Overall Study||25
2563164|NCT00477165|6284130|P1|COMPLETED|Overall Study||20
2563165|NCT00477165|6284129|P2|STARTED|Overall Study||27
2563166|NCT00477165|6284130|P1|STARTED|Overall Study||27
2563167|NCT00477152|6284142|P1|NOT COMPLETED|Overall Study||3
2563168|NCT00477152|6284142|P1|COMPLETED|Overall Study|Two patients treated, but assessments incomplete. All available data included in analyses for these.|49
2563169|NCT00477152|6284142|P1|STARTED|Overall Study|One patient withdrawn prior to treatment, so not included in analyses.|52
2563170|NCT00477087|6284149|P1|NOT COMPLETED|Overall Study||0
2563171|NCT00477087|6284149|P1|COMPLETED|Overall Study||10
2563172|NCT00477087|6284149|P1|STARTED|Overall Study||10
2563173|NCT00476996|6284158|P4|NOT COMPLETED|OLE Phase (From Week 48)||664
2563174|NCT00476996|6284159|P3|NOT COMPLETED|OLE Phase (From Week 48)||0
2563175|NCT00476996|6284160|P2|NOT COMPLETED|OLE Phase (From Week 48)||0
2563176|NCT00476996|6284161|P1|NOT COMPLETED|OLE Phase (From Week 48)||0
2563177|NCT00476996|6284158|P4|COMPLETED|OLE Phase (From Week 48)||0
2563178|NCT00476996|6284159|P3|COMPLETED|OLE Phase (From Week 48)||0
2563179|NCT00476996|6284160|P2|COMPLETED|OLE Phase (From Week 48)||0
2563180|NCT00476996|6284161|P1|COMPLETED|OLE Phase (From Week 48)||0
2563181|NCT00476996|6284158|P4|STARTED|OLE Phase (From Week 48)||664
2563182|NCT00476996|6284159|P3|STARTED|OLE Phase (From Week 48)||0
2563183|NCT00476996|6284160|P2|STARTED|OLE Phase (From Week 48)||0
2563184|NCT00476996|6284161|P1|STARTED|OLE Phase (From Week 48)||0
2563185|NCT00476996|6284158|P4|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||0
2563186|NCT00476996|6284159|P3|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||45
2563187|NCT00476996|6284160|P2|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||55
2563188|NCT00476996|6284161|P1|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||72
2563189|NCT00476996|6284158|P4|COMPLETED|Blinded Treatment Phase (up to Week 48)||0
2563190|NCT00476996|6284159|P3|COMPLETED|Blinded Treatment Phase (up to Week 48)||237
2563191|NCT00476996|6284160|P2|COMPLETED|Blinded Treatment Phase (up to Week 48)||222
2563192|NCT00476996|6284161|P1|COMPLETED|Blinded Treatment Phase (up to Week 48)||205
2563193|NCT00476996|6284158|P4|STARTED|Blinded Treatment Phase (up to Week 48)||0
2563194|NCT00476996|6284159|P3|STARTED|Blinded Treatment Phase (up to Week 48)||282
2563195|NCT00476996|6284160|P2|STARTED|Blinded Treatment Phase (up to Week 48)||277
2563196|NCT00476996|6284161|P1|STARTED|Blinded Treatment Phase (up to Week 48)||277
2563197|NCT00476957|6284193|P2|NOT COMPLETED|Overall Study||193
2563198|NCT00476957|6284194|P1|NOT COMPLETED|Overall Study||176
2563199|NCT00476957|6284193|P2|COMPLETED|Overall Study||4159
2563200|NCT00476957|6284194|P1|COMPLETED|Overall Study||4181
2563201|NCT00476957|6284193|P2|STARTED|Overall Study||4352
2563202|NCT00476957|6284194|P1|STARTED|Overall Study||4357
2563203|NCT00476827|6284208|P6|NOT COMPLETED|Overall Study||0
2563204|NCT00476827|6284209|P5|NOT COMPLETED|Overall Study||0
2563205|NCT00476827|6284210|P4|NOT COMPLETED|Overall Study||0
2563206|NCT00476827|6284211|P3|NOT COMPLETED|Overall Study||0
2563207|NCT00476827|6284212|P2|NOT COMPLETED|Overall Study||0
2563208|NCT00476827|6284213|P1|NOT COMPLETED|Overall Study||0
2563209|NCT00476827|6284208|P6|COMPLETED|Overall Study||2
2563210|NCT00476827|6284209|P5|COMPLETED|Overall Study||2
2563211|NCT00476827|6284210|P4|COMPLETED|Overall Study||0
2563212|NCT00476827|6284211|P3|COMPLETED|Overall Study||1
2563213|NCT00476827|6284212|P2|COMPLETED|Overall Study||0
2563214|NCT00476827|6284213|P1|COMPLETED|Overall Study||3
2563215|NCT00476827|6284208|P6|STARTED|Overall Study||2
2563216|NCT00476827|6284209|P5|STARTED|Overall Study||2
2563217|NCT00476827|6284210|P4|STARTED|Overall Study||0
2563218|NCT00476827|6284211|P3|STARTED|Overall Study||1
2563219|NCT00476827|6284212|P2|STARTED|Overall Study||0
2563220|NCT00476827|6284213|P1|STARTED|Overall Study||3
2563221|NCT00476788|6284243|P1|NOT COMPLETED|Overall Study||3
2563222|NCT00476788|6284243|P1|COMPLETED|Overall Study||11
2563223|NCT00476788|6284243|P1|STARTED|Overall Study||14
2563224|NCT00476645|6284248|P1|NOT COMPLETED|Overall Study||0
2563225|NCT00476645|6284248|P1|COMPLETED|Overall Study||10
2563226|NCT00476645|6284248|P1|STARTED|Overall Study||10
2563227|NCT00476593|6284258|P4|NOT COMPLETED|Overall Study||22
2563228|NCT00476593|6284259|P3|NOT COMPLETED|Overall Study||8
2563229|NCT00476593|6284260|P2|NOT COMPLETED|Overall Study||2
2563230|NCT00476593|6284261|P1|NOT COMPLETED|Overall Study||10
2563231|NCT00476593|6284258|P4|COMPLETED|Overall Study||107
2563232|NCT00476593|6284259|P3|COMPLETED|Overall Study||30
2563233|NCT00476593|6284260|P2|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 17 cases|17
2563234|NCT00476593|6284261|P1|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 22 cases|22
2563235|NCT00476593|6284258|P4|STARTED|Overall Study||129
2563236|NCT00476593|6284259|P3|STARTED|Overall Study||38
2563237|NCT00476593|6284260|P2|STARTED|Overall Study||19
2563238|NCT00476593|6284261|P1|STARTED|Overall Study||32
2563239|NCT00476476|6284273|P2|NOT COMPLETED|Overall Study||24
2563240|NCT00476476|6284274|P1|NOT COMPLETED|Overall Study||2
2563241|NCT00476476|6284273|P2|COMPLETED|Overall Study|Treatment was not of fixed duration and thus pts are not considered to have 'Completed' treatment.|0
2563242|NCT00476476|6284274|P1|COMPLETED|Overall Study||15
2563243|NCT00476476|6284273|P2|Response Evaluable|Overall Study|One woman was unevaluable due to an allergic reaction that developed after the 2nd dose.|23
2563244|NCT00476476|6284274|P1|Response Evaluable|Overall Study||17
2563245|NCT00476476|6284273|P2|STARTED|Overall Study||24
2563246|NCT00476476|6284274|P1|STARTED|Overall Study||17
2563247|NCT00476242|6284281|P2|NOT COMPLETED|Overall Study||16
2563248|NCT00476242|6284282|P1|NOT COMPLETED|Overall Study||8
2563249|NCT00476242|6284281|P2|COMPLETED|Overall Study||12
2563250|NCT00476242|6284282|P1|COMPLETED|Overall Study||19
2563251|NCT00476242|6284281|P2|STARTED|Overall Study||28
2563252|NCT00476242|6284282|P1|STARTED|Overall Study||27
2563253|NCT00476229|6284292|P1|NOT COMPLETED|Overall Study||1
2563254|NCT00476229|6284292|P1|COMPLETED|Overall Study||19
2563255|NCT00476229|6284292|P1|STARTED|Overall Study||20
2563256|NCT00476151|6284298|P2|NOT COMPLETED|Overall Study||7
2563257|NCT00476151|6284299|P1|NOT COMPLETED|Overall Study||3
2563258|NCT00476151|6284298|P2|COMPLETED|Overall Study||107
2563259|NCT00476151|6284299|P1|COMPLETED|Overall Study||109
2563260|NCT00476151|6284298|P2|STARTED|Overall Study||114
2563261|NCT00476151|6284299|P1|STARTED|Overall Study||112
2563262|NCT00476086|6284305|P1|NOT COMPLETED|Overall Study||5
2563263|NCT00476086|6284305|P1|COMPLETED|Overall Study||15
2563264|NCT00476086|6284305|P1|Received Radiation|Overall Study||15
2563265|NCT00476086|6284305|P1|Received Chemotherapy|Overall Study||19
2563266|NCT00476086|6284305|P1|STARTED|Overall Study||20
2563267|NCT00476047|6284311|P1|NOT COMPLETED|Overall Study||1
2563268|NCT00476047|6284311|P1|COMPLETED|Overall Study||15
2563269|NCT00476047|6284311|P1|Completed Treatment|Overall Study||16
2563270|NCT00476047|6284311|P1|STARTED|Overall Study||16
2563271|NCT00476021|6284320|P2|NOT COMPLETED|Overall Study||0
2563272|NCT00476021|6284321|P1|NOT COMPLETED|Overall Study||0
2563273|NCT00476021|6284320|P2|COMPLETED|Overall Study||51
2563274|NCT00476021|6284321|P1|COMPLETED|Overall Study||51
2563275|NCT00476021|6284320|P2|STARTED|Overall Study||51
2563276|NCT00476021|6284321|P1|STARTED|Overall Study||51
2563277|NCT00476008|6284337|P2|NOT COMPLETED|Overall Study||8
2563278|NCT00476008|6284338|P1|NOT COMPLETED|Overall Study||9
2563279|NCT00476008|6284337|P2|COMPLETED|Overall Study||13
2563280|NCT00476008|6284338|P1|COMPLETED|Overall Study||13
2563281|NCT00476008|6284337|P2|6 Month Testing|Overall Study||14
2563282|NCT00476008|6284338|P1|6 Month Testing|Overall Study||15
2563283|NCT00476008|6284337|P2|STARTED|Overall Study||21
2563284|NCT00476008|6284338|P1|STARTED|Overall Study||22
2563285|NCT00475982|6284364|P2|NOT COMPLETED|Overall Study||3
2563286|NCT00475982|6284365|P1|NOT COMPLETED|Overall Study||7
2563287|NCT00475982|6284364|P2|COMPLETED|Overall Study||18
2563288|NCT00475982|6284365|P1|COMPLETED|Overall Study||16
2563289|NCT00475982|6284364|P2|STARTED|Overall Study||21
2563290|NCT00475982|6284365|P1|STARTED|Overall Study||23
2563291|NCT00475904|6284386|P3|NOT COMPLETED|Overall Study||4
2563292|NCT00475904|6284387|P2|NOT COMPLETED|Overall Study||13
2563293|NCT00475904|6284388|P1|NOT COMPLETED|Overall Study||15
2563294|NCT00475904|6284386|P3|COMPLETED|Overall Study||72
2563295|NCT00475904|6284387|P2|COMPLETED|Overall Study||131
2563296|NCT00475904|6284388|P1|COMPLETED|Overall Study||125
2563297|NCT00475904|6284386|P3|STARTED|Overall Study||76
2563298|NCT00475904|6284387|P2|STARTED|Overall Study||144
2563299|NCT00475904|6284388|P1|STARTED|Overall Study||140
2563300|NCT00475878|6284401|P2|NOT COMPLETED|Overall Study||0
2563301|NCT00475878|6284402|P1|NOT COMPLETED|Overall Study||0
2563302|NCT00475878|6284401|P2|COMPLETED|Overall Study||72
2563303|NCT00475878|6284402|P1|COMPLETED|Overall Study||75
2563304|NCT00475878|6284401|P2|STARTED|Overall Study||72
2563305|NCT00475878|6284402|P1|STARTED|Overall Study||75
2563306|NCT00475865|6284413|P3|NOT COMPLETED|Overall Study||6
2563307|NCT00475865|6284414|P2|NOT COMPLETED|Overall Study||5
2563308|NCT00475865|6284415|P1|NOT COMPLETED|Overall Study||2
2563309|NCT00475865|6284413|P3|COMPLETED|Overall Study|completed treatment period|34
2563310|NCT00475865|6284414|P2|COMPLETED|Overall Study|completed treatment period|37
2563311|NCT00475865|6284415|P1|COMPLETED|Overall Study||39
2563312|NCT00475865|6284413|P3|Treated|Overall Study||40
2563313|NCT00475865|6284414|P2|Treated|Overall Study||42
2563314|NCT00475865|6284415|P1|Treated|Overall Study|completed treatment period|41
2563315|NCT00475865|6284413|P3|STARTED|Overall Study|randomized|40
2563316|NCT00475865|6284414|P2|STARTED|Overall Study|randomized|42
2563317|NCT00475865|6284415|P1|STARTED|Overall Study|randomized|41
2563318|NCT00475852|6284445|P2|NOT COMPLETED|Overall Study||548
2563319|NCT00475852|6284446|P1|NOT COMPLETED|Overall Study||517
2563320|NCT00475852|6284445|P2|COMPLETED|Overall Study||3029
2563321|NCT00475852|6284446|P1|COMPLETED|Overall Study||3047
2563322|NCT00475852|6284445|P2|STARTED|Overall Study||3577
2563323|NCT00475852|6284446|P1|STARTED|Overall Study||3564
2563324|NCT00475787|6284476|P2|NOT COMPLETED|Overall Study||7
2563325|NCT00475787|6284477|P1|NOT COMPLETED|Overall Study||8
2563326|NCT00475787|6284476|P2|COMPLETED|Overall Study||60
2563327|NCT00475787|6284477|P1|COMPLETED|Overall Study||61
2563328|NCT00475787|6284476|P2|STARTED|Overall Study||67
2563329|NCT00475787|6284477|P1|STARTED|Overall Study||69
2563330|NCT00475735|6284497|P6|NOT COMPLETED|Treatment Period 2||1
2563331|NCT00475735|6284498|P5|NOT COMPLETED|Treatment Period 2||1
2563332|NCT00475735|6284499|P4|NOT COMPLETED|Treatment Period 2||2
2563333|NCT00475735|6284500|P3|NOT COMPLETED|Treatment Period 2||0
2563334|NCT00475735|6284501|P2|NOT COMPLETED|Treatment Period 2||1
2563335|NCT00475735|6284502|P1|NOT COMPLETED|Treatment Period 2||0
2563336|NCT00475735|6284497|P6|COMPLETED|Treatment Period 2||13
2563337|NCT00475735|6284498|P5|COMPLETED|Treatment Period 2||15
2563338|NCT00475735|6284499|P4|COMPLETED|Treatment Period 2||4
2563339|NCT00475735|6284500|P3|COMPLETED|Treatment Period 2||7
2563340|NCT00475735|6284501|P2|COMPLETED|Treatment Period 2||9
2563341|NCT00475735|6284502|P1|COMPLETED|Treatment Period 2||10
2563342|NCT00475735|6284497|P6|STARTED|Treatment Period 2||14
2563343|NCT00475735|6284498|P5|STARTED|Treatment Period 2||16
2563344|NCT00475735|6284499|P4|STARTED|Treatment Period 2||6
2563345|NCT00475735|6284500|P3|STARTED|Treatment Period 2||7
2563346|NCT00475735|6284501|P2|STARTED|Treatment Period 2||10
2563347|NCT00475735|6284502|P1|STARTED|Treatment Period 2||10
2563348|NCT00475735|6284497|P6|NOT COMPLETED|Treatment Washout||0
2563349|NCT00475735|6284498|P5|NOT COMPLETED|Treatment Washout||0
2563350|NCT00475735|6284499|P4|NOT COMPLETED|Treatment Washout||0
2563351|NCT00475735|6284500|P3|NOT COMPLETED|Treatment Washout||0
2563352|NCT00475735|6284501|P2|NOT COMPLETED|Treatment Washout||2
2563353|NCT00475735|6284502|P1|NOT COMPLETED|Treatment Washout||0
2563354|NCT00475735|6284497|P6|COMPLETED|Treatment Washout||14
2563355|NCT00475735|6284498|P5|COMPLETED|Treatment Washout||16
2563356|NCT00475735|6284499|P4|COMPLETED|Treatment Washout||6
2563357|NCT00475735|6284500|P3|COMPLETED|Treatment Washout||7
2563358|NCT00475735|6284501|P2|COMPLETED|Treatment Washout||10
2563359|NCT00475735|6284502|P1|COMPLETED|Treatment Washout||10
2563360|NCT00475735|6284497|P6|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|14
2563361|NCT00475735|6284498|P5|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|16
2563362|NCT00475735|6284499|P4|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|6
2563363|NCT00475735|6284500|P3|STARTED|Treatment Washout||7
2563364|NCT00475735|6284501|P2|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|12
2563365|NCT00475735|6284502|P1|STARTED|Treatment Washout||10
2563366|NCT00475735|6284497|P6|NOT COMPLETED|Treatment Period 1||3
2563367|NCT00475735|6284498|P5|NOT COMPLETED|Treatment Period 1||2
2563368|NCT00475735|6284499|P4|NOT COMPLETED|Treatment Period 1||2
2563369|NCT00475735|6284500|P3|NOT COMPLETED|Treatment Period 1||0
2563370|NCT00475735|6284501|P2|NOT COMPLETED|Treatment Period 1||2
2563371|NCT00475735|6284502|P1|NOT COMPLETED|Treatment Period 1||4
2563372|NCT00475735|6284497|P6|COMPLETED|Treatment Period 1||12
2563373|NCT00475735|6284498|P5|COMPLETED|Treatment Period 1||14
2563374|NCT00475735|6284499|P4|COMPLETED|Treatment Period 1||5
2563375|NCT00475735|6284500|P3|COMPLETED|Treatment Period 1||7
2563376|NCT00475735|6284501|P2|COMPLETED|Treatment Period 1||11
2563377|NCT00475735|6284502|P1|COMPLETED|Treatment Period 1||10
2563378|NCT00475735|6284497|P6|STARTED|Treatment Period 1||15
2563379|NCT00475735|6284498|P5|STARTED|Treatment Period 1||16
2563380|NCT00475735|6284499|P4|STARTED|Treatment Period 1||7
2563381|NCT00475735|6284500|P3|STARTED|Treatment Period 1||7
2563382|NCT00475735|6284501|P2|STARTED|Treatment Period 1||13
2563383|NCT00475735|6284502|P1|STARTED|Treatment Period 1||14
2563384|NCT00475722|6284515|P2|NOT COMPLETED|Overall Study||12
2563385|NCT00475722|6284516|P1|NOT COMPLETED|Overall Study||15
2563386|NCT00475722|6284515|P2|COMPLETED|Overall Study||47
2563387|NCT00475722|6284516|P1|COMPLETED|Overall Study||46
2563388|NCT00475722|6284515|P2|STARTED|Overall Study||59
2563389|NCT00475722|6284516|P1|STARTED|Overall Study||61
2563390|NCT00475709|6284522|P1|NOT COMPLETED|Overall Study||76
2563391|NCT00475709|6284522|P1|COMPLETED|Overall Study||946
2563392|NCT00475709|6284522|P1|Eligible of Analysis|Overall Study|Excludes eight ineligible subjects|1014
2563393|NCT00475709|6284522|P1|STARTED|Overall Study||1022
2563394|NCT00475670|6284530|P2|NOT COMPLETED|Overall Study||41
2563395|NCT00475670|6284531|P1|NOT COMPLETED|Overall Study||3
2563396|NCT00475670|6284530|P2|COMPLETED|Overall Study||0
2563397|NCT00475670|6284531|P1|COMPLETED|Overall Study|This cohort was closed prematurely (with only 3 participants) because of enrollment difficulties.|0
2563398|NCT00475670|6284530|P2|STARTED|Overall Study||41
2563399|NCT00475670|6284531|P1|STARTED|Overall Study||3
2563400|NCT00475657|6284555|P1|NOT COMPLETED|Overall Study||4
2563401|NCT00475657|6284555|P1|COMPLETED|Overall Study||1
2563402|NCT00475657|6284555|P1|STARTED|Overall Study||5
2563403|NCT00475644|6284563|P1|NOT COMPLETED|Overall Study||13
2563404|NCT00475644|6284563|P1|COMPLETED|Overall Study||53
2563405|NCT00475644|6284563|P1|Received at Least One Dose of Study Drug|Overall Study||66
2563406|NCT00475644|6284563|P1|STARTED|Overall Study||66
2563407|NCT00475501|6284575|P4|NOT COMPLETED|Overall Study||4
2563408|NCT00475501|6284576|P3|NOT COMPLETED|Overall Study||4
2563409|NCT00475501|6284577|P2|NOT COMPLETED|Overall Study||5
2563410|NCT00475501|6284578|P1|NOT COMPLETED|Overall Study||7
2563411|NCT00475501|6284575|P4|COMPLETED|Overall Study||12
2563412|NCT00475501|6284576|P3|COMPLETED|Overall Study||13
2563413|NCT00475501|6284577|P2|COMPLETED|Overall Study||8
2563414|NCT00475501|6284578|P1|COMPLETED|Overall Study||7
2563415|NCT00475501|6284575|P4|STARTED|Overall Study||16
2563416|NCT00475501|6284576|P3|STARTED|Overall Study||17
2563417|NCT00475501|6284577|P2|STARTED|Overall Study||13
2563418|NCT00475501|6284578|P1|STARTED|Overall Study||14
2563419|NCT00475423|6284628|P1|NOT COMPLETED|Overall Study||32
2563420|NCT00475423|6284628|P1|COMPLETED|Overall Study||90
2563421|NCT00475423|6284628|P1|STARTED|Overall Study||122
2563422|NCT00475332|6284649|P1|NOT COMPLETED|Overall Study||0
2563423|NCT00475332|6284649|P1|COMPLETED|Overall Study||2
2563424|NCT00475332|6284649|P1|STARTED|Overall Study||2
2563425|NCT00475319|6284657|P3|NOT COMPLETED|Overall Study||4
2563426|NCT00475319|6284658|P2|NOT COMPLETED|Overall Study||1
2563427|NCT00475319|6284659|P1|NOT COMPLETED|Overall Study||2
2563428|NCT00475319|6284657|P3|COMPLETED|Overall Study||99
2563429|NCT00475319|6284658|P2|COMPLETED|Overall Study||101
2563430|NCT00475319|6284659|P1|COMPLETED|Overall Study||101
2563431|NCT00475319|6284657|P3|STARTED|Overall Study||103
2563432|NCT00475319|6284658|P2|STARTED|Overall Study||102
2563433|NCT00475319|6284659|P1|STARTED|Overall Study||103
2563434|NCT00475306|6284674|P4|NOT COMPLETED|Overall Study||1
2563435|NCT00475306|6284675|P3|NOT COMPLETED|Overall Study||0
2563436|NCT00475306|6284676|P2|NOT COMPLETED|Overall Study||1
2563437|NCT00475306|6284677|P1|NOT COMPLETED|Overall Study||1
2563438|NCT00475306|6284674|P4|COMPLETED|Overall Study|1 patient's intravenous line infiltrated.|71
2563439|NCT00475306|6284675|P3|COMPLETED|Overall Study||72
2563440|NCT00475306|6284676|P2|COMPLETED|Overall Study|For 1 patient, data collection was incomplete and results could not be analyzed|71
2563441|NCT00475306|6284677|P1|COMPLETED|Overall Study|1 patient had resolution of nausea prior and did not receive the investigational medication|72
2563442|NCT00475306|6284674|P4|STARTED|Overall Study||72
2563443|NCT00475306|6284675|P3|STARTED|Overall Study||72
2563444|NCT00475306|6284676|P2|STARTED|Overall Study||72
2563445|NCT00475306|6284677|P1|STARTED|Overall Study||73
2563446|NCT00475241|6284693|P2|NOT COMPLETED|Overall Study||3
2563447|NCT00475241|6284694|P1|NOT COMPLETED|Overall Study||7
2563448|NCT00475241|6284693|P2|COMPLETED|Overall Study||15
2563449|NCT00475241|6284694|P1|COMPLETED|Overall Study||11
2563450|NCT00475241|6284693|P2|STARTED|Overall Study||18
2563451|NCT00475241|6284694|P1|STARTED|Overall Study||18
2563452|NCT00475228|6284708|P2|NOT COMPLETED|Overall Study||17
2563453|NCT00475228|6284709|P1|NOT COMPLETED|Overall Study||17
2563454|NCT00475228|6284708|P2|COMPLETED|Overall Study||27
2563455|NCT00475228|6284709|P1|COMPLETED|Overall Study||27
2563456|NCT00475228|6284708|P2|STARTED|Overall Study||44
2563457|NCT00475228|6284709|P1|STARTED|Overall Study||44
2563458|NCT00475215|6284721|P2|NOT COMPLETED|Overall Study||4
2563459|NCT00475215|6284722|P1|NOT COMPLETED|Overall Study||5
2563460|NCT00475215|6284721|P2|COMPLETED|Overall Study||38
2563461|NCT00475215|6284722|P1|COMPLETED|Overall Study||39
2563462|NCT00475215|6284721|P2|Treated|Overall Study||38
2563463|NCT00475215|6284722|P1|Treated|Overall Study||39
2563464|NCT00475215|6284721|P2|STARTED|Overall Study||42
2563465|NCT00475215|6284722|P1|STARTED|Overall Study||44
2563466|NCT00475176|6284748|P1|NOT COMPLETED|Overall Study||4
2563467|NCT00475176|6284748|P1|COMPLETED|Overall Study||20
2563468|NCT00475176|6284748|P1|STARTED|Overall Study||24
2563469|NCT00475150|6284755|P2|NOT COMPLETED|Overall Study||0
2563470|NCT00475150|6284756|P1|NOT COMPLETED|Overall Study||0
2563471|NCT00475150|6284755|P2|COMPLETED|Overall Study||16
2563472|NCT00475150|6284756|P1|COMPLETED|Overall Study||23
2563473|NCT00475150|6284755|P2|STARTED|Overall Study||16
2563474|NCT00475150|6284756|P1|STARTED|Overall Study||23
2563475|NCT00475085|6284773|P4|NOT COMPLETED|Overall Study||20
2563476|NCT00475085|6284774|P3|NOT COMPLETED|Overall Study||19
2563477|NCT00475085|6284775|P2|NOT COMPLETED|Overall Study||20
2563478|NCT00475085|6284776|P1|NOT COMPLETED|Overall Study||18
2563479|NCT00475085|6284773|P4|COMPLETED|Overall Study||234
2563480|NCT00475085|6284774|P3|COMPLETED|Overall Study||241
2563481|NCT00475085|6284775|P2|COMPLETED|Overall Study||234
2563482|NCT00475085|6284776|P1|COMPLETED|Overall Study||235
2563483|NCT00475085|6284773|P4|STARTED|Overall Study||254
2563484|NCT00475085|6284774|P3|STARTED|Overall Study||260
2563485|NCT00475085|6284775|P2|STARTED|Overall Study||254
2563486|NCT00475085|6284776|P1|STARTED|Overall Study||253
2563487|NCT00475033|6284788|P2|NOT COMPLETED|Toddler Dose||0
2563488|NCT00475033|6284789|P1|NOT COMPLETED|Toddler Dose||4
2563489|NCT00475033|6284788|P2|COMPLETED|Toddler Dose||282
2563490|NCT00475033|6284789|P1|COMPLETED|Toddler Dose||283
2563491|NCT00475033|6284788|P2|STARTED|Toddler Dose|Vaccinated Toddler Dose|282
2563492|NCT00475033|6284789|P1|STARTED|Toddler Dose|Vaccinated Toddler Dose|287
2563493|NCT00475033|6284788|P2|NOT COMPLETED|After the Infant Series||8
2563494|NCT00475033|6284789|P1|NOT COMPLETED|After the Infant Series||6
2563495|NCT00475033|6284788|P2|COMPLETED|After the Infant Series||282
2563496|NCT00475033|6284789|P1|COMPLETED|After the Infant Series||287
2563497|NCT00475033|6284788|P2|Withdrawn After Infant Series|After the Infant Series||8
2563498|NCT00475033|6284789|P1|Withdrawn After Infant Series|After the Infant Series||6
2563499|NCT00475033|6284788|P2|STARTED|After the Infant Series||290
2563500|NCT00475033|6284789|P1|STARTED|After the Infant Series||293
2563501|NCT00475033|6284788|P2|NOT COMPLETED|Infant Series||13
2563502|NCT00475033|6284789|P1|NOT COMPLETED|Infant Series||7
2563503|NCT00475033|6284788|P2|COMPLETED|Infant Series||290
2563504|NCT00475033|6284789|P1|COMPLETED|Infant Series||293
2563505|NCT00475033|6284788|P2|Vaccinated Dose 3|Infant Series||294
2563506|NCT00475033|6284789|P1|Vaccinated Dose 3|Infant Series||293
2563507|NCT00475033|6284788|P2|Vaccinated Dose 2|Infant Series||296
2563508|NCT00475033|6284789|P1|Vaccinated Dose 2|Infant Series||297
2563509|NCT00475033|6284788|P2|Vaccinated Dose 1|Infant Series||303
2563510|NCT00475033|6284789|P1|Vaccinated Dose 1|Infant Series||300
2563511|NCT00475033|6284788|P2|STARTED|Infant Series||303
2563512|NCT00475033|6284789|P1|STARTED|Infant Series||300
2563513|NCT00475020|6284837|P1|NOT COMPLETED|Overall Study||5
2563514|NCT00475020|6284837|P1|COMPLETED|Overall Study||58
2563515|NCT00475020|6284837|P1|STARTED|Overall Study||63
2563516|NCT00474994|6284842|P1|NOT COMPLETED|Overall Study||5
2563517|NCT00474994|6284842|P1|COMPLETED|Overall Study||48
2563518|NCT00474994|6284842|P1|STARTED|Overall Study||53
2563519|NCT00474968|6284848|P2|NOT COMPLETED|Overall Study||16
2563520|NCT00474968|6284849|P1|NOT COMPLETED|Overall Study||18
2563521|NCT00474968|6284848|P2|COMPLETED|Overall Study||355
2563522|NCT00474968|6284849|P1|COMPLETED|Overall Study||348
2563523|NCT00474968|6284848|P2|STARTED|Overall Study||371
2563524|NCT00474968|6284849|P1|STARTED|Overall Study||366
2563525|NCT00474955|6284859|P1|NOT COMPLETED|Overall Study||8
2563526|NCT00474955|6284859|P1|COMPLETED|Overall Study||19
2563527|NCT00474955|6284859|P1|STARTED|Overall Study||27
2563528|NCT00474929|6284875|P5|NOT COMPLETED|Overall Study||0
2563529|NCT00474929|6284876|P4|NOT COMPLETED|Overall Study||2
2563530|NCT00474929|6284877|P3|NOT COMPLETED|Overall Study||2
2563531|NCT00474929|6284878|P2|NOT COMPLETED|Overall Study||1
2563532|NCT00474929|6284879|P1|NOT COMPLETED|Overall Study||0
2563533|NCT00474929|6284875|P5|COMPLETED|Overall Study||77
2563534|NCT00474929|6284876|P4|COMPLETED|Overall Study||5
2563535|NCT00474929|6284877|P3|COMPLETED|Overall Study||5
2563536|NCT00474929|6284878|P2|COMPLETED|Overall Study||5
2563537|NCT00474929|6284879|P1|COMPLETED|Overall Study||6
2563538|NCT00474929|6284875|P5|STARTED|Overall Study||77
2563539|NCT00474929|6284876|P4|STARTED|Overall Study||7
2563540|NCT00474929|6284877|P3|STARTED|Overall Study||7
2563541|NCT00474929|6284878|P2|STARTED|Overall Study||6
2563542|NCT00474929|6284879|P1|STARTED|Overall Study||6
2563543|NCT00474903|6284896|P3|NOT COMPLETED|Overall Study||2
2563544|NCT00474903|6284897|P2|NOT COMPLETED|Overall Study||5
2563545|NCT00474903|6284898|P1|NOT COMPLETED|Overall Study||1
2563546|NCT00474903|6284896|P3|COMPLETED|Overall Study||43
2563547|NCT00474903|6284897|P2|COMPLETED|Overall Study||42
2563548|NCT00474903|6284898|P1|COMPLETED|Overall Study||29
2563549|NCT00474903|6284896|P3|STARTED|Overall Study||45
2563550|NCT00474903|6284897|P2|STARTED|Overall Study||47
2563551|NCT00474903|6284898|P1|STARTED|Overall Study||30
2563552|NCT00474851|6284911|P2|NOT COMPLETED|Overall Study||11
2563553|NCT00474851|6284912|P1|NOT COMPLETED|Overall Study||8
2563554|NCT00474851|6284911|P2|COMPLETED|Overall Study||16
2563555|NCT00474851|6284912|P1|COMPLETED|Overall Study||18
2563556|NCT00474851|6284911|P2|Completed Baseline|Overall Study||26
2563557|NCT00474851|6284912|P1|Completed Baseline|Overall Study||25
2563558|NCT00474851|6284911|P2|STARTED|Overall Study||27
2563559|NCT00474851|6284912|P1|STARTED|Overall Study||26
2563560|NCT00474812|6284920|P1|NOT COMPLETED|Overall Study||7
2563561|NCT00474812|6284920|P1|COMPLETED|Overall Study||44
2563562|NCT00474812|6284920|P1|STARTED|Overall Study||51
2563563|NCT00474786|6284930|P2|NOT COMPLETED|Overall Study||253
2563564|NCT00474786|6284931|P1|NOT COMPLETED|Overall Study||259
2563565|NCT00474786|6284930|P2|COMPLETED|Overall Study||0
2563566|NCT00474786|6284931|P1|COMPLETED|Overall Study||0
2563567|NCT00474786|6284930|P2|STARTED|Overall Study||253
2563568|NCT00474786|6284931|P1|STARTED|Overall Study||259
2563569|NCT00474760|6284956|P7|NOT COMPLETED|Overall Study||10
2563570|NCT00474760|6284957|P6|NOT COMPLETED|Overall Study||29
2563571|NCT00474760|6284958|P5|NOT COMPLETED|Overall Study||12
2563572|NCT00474760|6284959|P4|NOT COMPLETED|Overall Study||3
2563573|NCT00474760|6284960|P3|NOT COMPLETED|Overall Study||3
2563574|NCT00474760|6284961|P2|NOT COMPLETED|Overall Study||3
2563575|NCT00474760|6284962|P1|NOT COMPLETED|Overall Study||3
2563576|NCT00474760|6284956|P7|COMPLETED|Overall Study||1
2563577|NCT00474760|6284957|P6|COMPLETED|Overall Study||0
2563578|NCT00474760|6284958|P5|COMPLETED|Overall Study||1
2563579|NCT00474760|6284959|P4|COMPLETED|Overall Study||0
2563580|NCT00474760|6284960|P3|COMPLETED|Overall Study||0
2563581|NCT00474760|6284961|P2|COMPLETED|Overall Study||0
2563582|NCT00474760|6284962|P1|COMPLETED|Overall Study||0
2563583|NCT00474760|6284956|P7|STARTED|Overall Study||11
2563584|NCT00474760|6284957|P6|STARTED|Overall Study||29
2563585|NCT00474760|6284958|P5|STARTED|Overall Study||13
2563586|NCT00474760|6284959|P4|STARTED|Overall Study||3
2563587|NCT00474760|6284960|P3|STARTED|Overall Study||3
2563588|NCT00474760|6284961|P2|STARTED|Overall Study||3
2563589|NCT00474760|6284962|P1|STARTED|Overall Study||3
2563590|NCT00474708|6285069|P2|NOT COMPLETED|Overall Study||25
2563591|NCT00474708|6285070|P1|NOT COMPLETED|Overall Study||57
2563592|NCT00474708|6285069|P2|COMPLETED|Overall Study||342
2563593|NCT00474708|6285070|P1|COMPLETED|Overall Study||734
2563594|NCT00474708|6285069|P2|STARTED|Overall Study||367
2563595|NCT00474708|6285070|P1|STARTED|Overall Study||791
2563596|NCT00474630|6285080|P2|NOT COMPLETED|Overall Study||70
2563597|NCT00474630|6285081|P1|NOT COMPLETED|Overall Study||160
2563598|NCT00474630|6285080|P2|COMPLETED|Overall Study||100
2563599|NCT00474630|6285081|P1|COMPLETED|Overall Study||175
2563600|NCT00474630|6285080|P2|STARTED|Overall Study||170
2563601|NCT00474630|6285081|P1|STARTED|Overall Study||335
2563602|NCT00474617|6285138|P3|NOT COMPLETED|Overall Study||2
2563603|NCT00474617|6285139|P2|NOT COMPLETED|Overall Study||3
2563604|NCT00474617|6285140|P1|NOT COMPLETED|Overall Study||8
2563605|NCT00474617|6285138|P3|COMPLETED|Overall Study||40
2563606|NCT00474617|6285139|P2|COMPLETED|Overall Study||61
2563607|NCT00474617|6285140|P1|COMPLETED|Overall Study||48
2563608|NCT00474617|6285138|P3|Treated|Overall Study||40
2563609|NCT00474617|6285139|P2|Treated|Overall Study||62
2563610|NCT00474617|6285140|P1|Treated|Overall Study||48
2563611|NCT00474617|6285138|P3|STARTED|Overall Study||42
2563612|NCT00474617|6285139|P2|STARTED|Overall Study||64
2563613|NCT00474617|6285140|P1|STARTED|Overall Study||56
2563614|NCT00474539|6285174|P2|NOT COMPLETED|Toddler Dose||0
2563615|NCT00474539|6285175|P1|NOT COMPLETED|Toddler Dose||1
2563616|NCT00474539|6285174|P2|COMPLETED|Toddler Dose||220
2563617|NCT00474539|6285175|P1|COMPLETED|Toddler Dose||208
2563618|NCT00474539|6285174|P2|STARTED|Toddler Dose||220
2563619|NCT00474539|6285175|P1|STARTED|Toddler Dose||209
2563620|NCT00474539|6285174|P2|NOT COMPLETED|After Infant Series||0
2563621|NCT00474539|6285175|P1|NOT COMPLETED|After Infant Series||4
2563622|NCT00474539|6285174|P2|COMPLETED|After Infant Series||220
2563623|NCT00474539|6285175|P1|COMPLETED|After Infant Series||209
2563624|NCT00474539|6285174|P2|STARTED|After Infant Series||220
2563625|NCT00474539|6285175|P1|STARTED|After Infant Series||213
2563626|NCT00474539|6285174|P2|NOT COMPLETED|Infant Series||6
2563627|NCT00474539|6285175|P1|NOT COMPLETED|Infant Series||10
2563628|NCT00474539|6285174|P2|COMPLETED|Infant Series||220
2563629|NCT00474539|6285175|P1|COMPLETED|Infant Series||213
2563630|NCT00474539|6285174|P2|Vaccinated Dose 3|Infant Series||221
2563631|NCT00474539|6285175|P1|Vaccinated Dose 3|Infant Series||214
2563632|NCT00474539|6285174|P2|Vaccinated Dose 2|Infant Series||222
2563633|NCT00474539|6285175|P1|Vaccinated Dose 2|Infant Series||217
2563634|NCT00474539|6285174|P2|Vaccinated Dose 1|Infant Series||226
2563635|NCT00474539|6285175|P1|Vaccinated Dose 1|Infant Series||218
2563636|NCT00474539|6285174|P2|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|226
2563637|NCT00474539|6285175|P1|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|223
2563638|NCT00474526|6285240|P17|NOT COMPLETED|Overall Study||9
2563639|NCT00474526|6285241|P16|NOT COMPLETED|Overall Study||18
2563640|NCT00474526|6285242|P15|NOT COMPLETED|Overall Study||77
2563641|NCT00474526|6285243|P14|NOT COMPLETED|Overall Study||156
2563642|NCT00474526|6285244|P13|NOT COMPLETED|Overall Study||15
2563643|NCT00474526|6285245|P12|NOT COMPLETED|Overall Study||11
2563644|NCT00474526|6285246|P11|NOT COMPLETED|Overall Study||10
2563645|NCT00474526|6285247|P10|NOT COMPLETED|Overall Study||27
2563646|NCT00474526|6285248|P9|NOT COMPLETED|Overall Study||6
2563647|NCT00474526|6285249|P8|NOT COMPLETED|Overall Study||6
2563648|NCT00474526|6285250|P7|NOT COMPLETED|Overall Study||25
2563649|NCT00474526|6285251|P6|NOT COMPLETED|Overall Study||16
2563650|NCT00474526|6285252|P5|NOT COMPLETED|Overall Study||68
2563651|NCT00474526|6285253|P4|NOT COMPLETED|Overall Study||119
2563652|NCT00474526|6285254|P3|NOT COMPLETED|Overall Study||49
2563653|NCT00474526|6285255|P2|NOT COMPLETED|Overall Study||46
2563654|NCT00474526|6285256|P1|NOT COMPLETED|Overall Study||33
2563655|NCT00474526|6285240|P17|COMPLETED|Overall Study||174
2563656|NCT00474526|6285241|P16|COMPLETED|Overall Study||152
2563657|NCT00474526|6285242|P15|COMPLETED|Overall Study||281
2563658|NCT00474526|6285243|P14|COMPLETED|Overall Study||1270
2563659|NCT00474526|6285244|P13|COMPLETED|Overall Study||135
2563660|NCT00474526|6285245|P12|COMPLETED|Overall Study||139
2563661|NCT00474526|6285246|P11|COMPLETED|Overall Study||141
2563662|NCT00474526|6285247|P10|COMPLETED|Overall Study||121
2563663|NCT00474526|6285248|P9|COMPLETED|Overall Study||144
2563664|NCT00474526|6285249|P8|COMPLETED|Overall Study||145
2563665|NCT00474526|6285250|P7|COMPLETED|Overall Study||178
2563666|NCT00474526|6285251|P6|COMPLETED|Overall Study||54
2563667|NCT00474526|6285252|P5|COMPLETED|Overall Study||8
2563668|NCT00474526|6285253|P4|COMPLETED|Overall Study||561
2563669|NCT00474526|6285254|P3|COMPLETED|Overall Study||110
2563670|NCT00474526|6285255|P2|COMPLETED|Overall Study||120
2563671|NCT00474526|6285256|P1|COMPLETED|Overall Study||121
2563672|NCT00474526|6285240|P17|STARTED|Overall Study||183
2563673|NCT00474526|6285241|P16|STARTED|Overall Study||170
2563674|NCT00474526|6285242|P15|STARTED|Overall Study||358
2563675|NCT00474526|6285243|P14|STARTED|Overall Study||1426
2563676|NCT00474526|6285244|P13|STARTED|Overall Study||150
2563677|NCT00474526|6285245|P12|STARTED|Overall Study||150
2563678|NCT00474526|6285246|P11|STARTED|Overall Study||151
2563679|NCT00474526|6285247|P10|STARTED|Overall Study||148
2563680|NCT00474526|6285248|P9|STARTED|Overall Study||150
2563681|NCT00474526|6285249|P8|STARTED|Overall Study||151
2563682|NCT00474526|6285250|P7|STARTED|Overall Study||203
2563683|NCT00474526|6285251|P6|STARTED|Overall Study||70
2563684|NCT00474526|6285252|P5|STARTED|Overall Study||76
2563685|NCT00474526|6285253|P4|STARTED|Overall Study||680
2563686|NCT00474526|6285254|P3|STARTED|Overall Study||159
2563687|NCT00474526|6285255|P2|STARTED|Overall Study||166
2563688|NCT00474526|6285256|P1|STARTED|Overall Study||154
2563689|NCT00474487|6285421|P4|NOT COMPLETED|Overall Study||0
2563690|NCT00474487|6285422|P3|NOT COMPLETED|Overall Study||14
2563691|NCT00474487|6285423|P2|NOT COMPLETED|Overall Study||2
2563692|NCT00474487|6285424|P1|NOT COMPLETED|Overall Study||30
2563693|NCT00474487|6285421|P4|COMPLETED|Overall Study||109
2563694|NCT00474487|6285422|P3|COMPLETED|Overall Study||885
2563695|NCT00474487|6285423|P2|COMPLETED|Overall Study||215
2563696|NCT00474487|6285424|P1|COMPLETED|Overall Study||1576
2563697|NCT00474487|6285421|P4|STARTED|Overall Study||109
2563698|NCT00474487|6285422|P3|STARTED|Overall Study||899
2563699|NCT00474487|6285423|P2|STARTED|Overall Study||217
2563700|NCT00474487|6285424|P1|STARTED|Overall Study||1606
2563701|NCT00474383|6285444|P2|NOT COMPLETED|Extension||5
2563702|NCT00474383|6285445|P1|NOT COMPLETED|Extension||0
2563703|NCT00474383|6285444|P2|COMPLETED|Extension||0
2563704|NCT00474383|6285445|P1|COMPLETED|Extension||0
2563705|NCT00474383|6285444|P2|STARTED|Extension||5
2563706|NCT00474383|6285445|P1|STARTED|Extension||0
2563707|NCT00474383|6285444|P2|NOT COMPLETED|Between Main Study and Extension||0
2563708|NCT00474383|6285445|P1|NOT COMPLETED|Between Main Study and Extension||6
2563709|NCT00474383|6285444|P2|COMPLETED|Between Main Study and Extension||0
2563710|NCT00474383|6285445|P1|COMPLETED|Between Main Study and Extension||5
2563711|NCT00474383|6285444|P2|STARTED|Between Main Study and Extension||0
2563712|NCT00474383|6285445|P1|STARTED|Between Main Study and Extension||11
2563713|NCT00474383|6285444|P2|NOT COMPLETED|Main Study||0
2563714|NCT00474383|6285445|P1|NOT COMPLETED|Main Study||36
2563715|NCT00474383|6285444|P2|COMPLETED|Main Study||0
2563716|NCT00474383|6285445|P1|COMPLETED|Main Study||11
2563717|NCT00474383|6285444|P2|STARTED|Main Study||0
2563718|NCT00474383|6285445|P1|STARTED|Main Study||47
2563719|NCT00474266|6285460|P4|NOT COMPLETED|Overall Study||7
2563720|NCT00474266|6285461|P3|NOT COMPLETED|Overall Study||4
2563721|NCT00474266|6285462|P2|NOT COMPLETED|Overall Study||20
2563722|NCT00474266|6285463|P1|NOT COMPLETED|Overall Study||7
2563723|NCT00474266|6285460|P4|COMPLETED|Overall Study||118
2563724|NCT00474266|6285461|P3|COMPLETED|Overall Study||122
2563725|NCT00474266|6285462|P2|COMPLETED|Overall Study||354
2563726|NCT00474266|6285463|P1|COMPLETED|Overall Study||368
2563727|NCT00474266|6285460|P4|STARTED|Overall Study||125
2563728|NCT00474266|6285461|P3|STARTED|Overall Study||126
2563729|NCT00474266|6285462|P2|STARTED|Overall Study||374
2563730|NCT00474266|6285463|P1|STARTED|Overall Study||375
2563731|NCT00474253|6285567|P2|NOT COMPLETED|Overall Study||4
2563732|NCT00474253|6285568|P1|NOT COMPLETED|Overall Study||3
2563733|NCT00474253|6285567|P2|COMPLETED|Overall Study|Based on actual treatment received.|53
2563734|NCT00474253|6285568|P1|COMPLETED|Overall Study|Based on actual treatment received.|55
2563735|NCT00474253|6285567|P2|Treated|Overall Study|Based on actual treatment received.|54
2563736|NCT00474253|6285568|P1|Treated|Overall Study|Based on actual treatment received.|56
2563737|NCT00474253|6285567|P2|STARTED|Overall Study|Includes 1 participant randomized to rocuronium + sugammadex group who received succinylcholine.|57
2563738|NCT00474253|6285568|P1|STARTED|Overall Study|Includes 2 participants randomized to succinylcholine group who received rocuronium + sugammadex.|58
2563739|NCT00474240|6285592|P6|NOT COMPLETED|Overall Study||18
2563740|NCT00474240|6285593|P5|NOT COMPLETED|Overall Study||8
2563741|NCT00474240|6285594|P4|NOT COMPLETED|Overall Study||16
2563742|NCT00474240|6285595|P3|NOT COMPLETED|Overall Study||9
2563743|NCT00474240|6285596|P2|NOT COMPLETED|Overall Study||1
2563744|NCT00474240|6285597|P1|NOT COMPLETED|Overall Study||1
2563745|NCT00474240|6285592|P6|COMPLETED|Overall Study||8
2563746|NCT00474240|6285593|P5|COMPLETED|Overall Study||18
2563747|NCT00474240|6285594|P4|COMPLETED|Overall Study||10
2563748|NCT00474240|6285595|P3|COMPLETED|Overall Study||17
2563749|NCT00474240|6285596|P2|COMPLETED|Overall Study||25
2563750|NCT00474240|6285597|P1|COMPLETED|Overall Study||26
2563751|NCT00474240|6285592|P6|STARTED|Overall Study||26
2563752|NCT00474240|6285593|P5|STARTED|Overall Study||26
2563753|NCT00474240|6285594|P4|STARTED|Overall Study||26
2563754|NCT00474240|6285595|P3|STARTED|Overall Study||26
2563755|NCT00474240|6285596|P2|STARTED|Overall Study||26
2563756|NCT00474240|6285597|P1|STARTED|Overall Study||27
2563757|NCT00474201|6285617|P1|NOT COMPLETED|Overall Study||0
2563758|NCT00474201|6285617|P1|COMPLETED|Overall Study||15
2563759|NCT00474201|6285617|P1|STARTED|Overall Study||15
2563760|NCT00474188|6285622|P1|NOT COMPLETED|Overall Study||6
2563761|NCT00474188|6285622|P1|COMPLETED|Overall Study|Disease progression=15, adverse event=4, death=1|20
2563762|NCT00474188|6285622|P1|STARTED|Overall Study||26
2563763|NCT00474175|6285632|P3|NOT COMPLETED|Overall Study||4
2563764|NCT00474175|6285633|P2|NOT COMPLETED|Overall Study||7
2563765|NCT00474175|6285634|P1|NOT COMPLETED|Overall Study||1
2563766|NCT00474175|6285632|P3|COMPLETED|Overall Study||225
2563767|NCT00474175|6285633|P2|COMPLETED|Overall Study||226
2563768|NCT00474175|6285634|P1|COMPLETED|Overall Study||114
2563769|NCT00474175|6285632|P3|Treated|Overall Study||228
2563770|NCT00474175|6285633|P2|Treated|Overall Study||233
2563771|NCT00474175|6285634|P1|Treated|Overall Study||115
2563772|NCT00474175|6285632|P3|STARTED|Overall Study||229
2563773|NCT00474175|6285633|P2|STARTED|Overall Study||233
2563774|NCT00474175|6285634|P1|STARTED|Overall Study||115
2563775|NCT00474123|6285671|P2|NOT COMPLETED|Overall Study||0
2563776|NCT00474123|6285672|P1|NOT COMPLETED|Overall Study||0
2563777|NCT00474123|6285671|P2|COMPLETED|Overall Study||40
2563778|NCT00474123|6285672|P1|COMPLETED|Overall Study||38
2563779|NCT00474123|6285671|P2|STARTED|Overall Study||40
2563780|NCT00474123|6285672|P1|STARTED|Overall Study||38
2563781|NCT00474058|6285698|P2|NOT COMPLETED|Overall Study||17
2563782|NCT00474058|6285699|P1|NOT COMPLETED|Overall Study||24
2563783|NCT00474058|6285698|P2|COMPLETED|Overall Study||80
2563784|NCT00474058|6285699|P1|COMPLETED|Overall Study||166
2563785|NCT00474058|6285698|P2|STARTED|Overall Study||97
2563786|NCT00474058|6285699|P1|STARTED|Overall Study||190
2563787|NCT00474045|6285713|P2|NOT COMPLETED|Overall Study||101
2563788|NCT00474045|6285714|P1|NOT COMPLETED|Overall Study||106
2563789|NCT00474045|6285713|P2|COMPLETED|Overall Study||136
2563790|NCT00474045|6285714|P1|COMPLETED|Overall Study||127
2563791|NCT00474045|6285713|P2|Pregnancies (for Exposed-pregnant)|Overall Study|2 subjects had spontaneous abortion and became pregnant again|160
2563792|NCT00474045|6285714|P1|Pregnancies (for Exposed-pregnant)|Overall Study||152
2563793|NCT00474045|6285713|P2|Exposed-Pregnant Subjects|Overall Study|3 withdrawn before treatment initiation|158
2563794|NCT00474045|6285714|P1|Exposed-Pregnant Subjects|Overall Study||152
2563795|NCT00474045|6285713|P2|Exposed-All Subjects|Overall Study|5 withdrawn before treatment initiation|232
2563796|NCT00474045|6285714|P1|Exposed-All Subjects|Overall Study||233
2563797|NCT00474045|6285713|P2|STARTED|Overall Study||237
2563798|NCT00474045|6285714|P1|STARTED|Overall Study||233
2563799|NCT00473889|6285814|P2|NOT COMPLETED|Overall Study||64
2563800|NCT00473889|6285815|P1|NOT COMPLETED|Overall Study||83
2563801|NCT00473889|6285814|P2|COMPLETED|Overall Study||63
2563802|NCT00473889|6285815|P1|COMPLETED|Overall Study||43
2563803|NCT00473889|6285814|P2|STARTED|Overall Study||127
2563804|NCT00473889|6285815|P1|STARTED|Overall Study||126
2563805|NCT00473876|6285827|P2|NOT COMPLETED|Overall Study||1
2563806|NCT00473876|6285828|P1|NOT COMPLETED|Overall Study||3
2563807|NCT00473876|6285827|P2|COMPLETED|Overall Study||22
2563808|NCT00473876|6285828|P1|COMPLETED|Overall Study||36
2563809|NCT00473876|6285827|P2|STARTED|Overall Study||23
2563810|NCT00473876|6285828|P1|STARTED|Overall Study||39
2563811|NCT00473837|6285838|P2|NOT COMPLETED|Overall Study||3
2563812|NCT00473837|6285839|P1|NOT COMPLETED|Overall Study||1
2563813|NCT00473837|6285838|P2|COMPLETED|Overall Study||43
2563814|NCT00473837|6285839|P1|COMPLETED|Overall Study||49
2563815|NCT00473837|6285838|P2|STARTED|Overall Study||46
2563816|NCT00473837|6285839|P1|STARTED|Overall Study||50
2563817|NCT00473824|6285847|P2|NOT COMPLETED|Overall Study||0
2563818|NCT00473824|6285848|P1|NOT COMPLETED|Overall Study||5
2563819|NCT00473824|6285847|P2|COMPLETED|Overall Study|Study Completion/Early Termination Date|2
2563820|NCT00473824|6285848|P1|COMPLETED|Overall Study|Study Completion/Early Termination Date|0
2563821|NCT00473824|6285847|P2|STARTED|Overall Study||2
2563822|NCT00473824|6285848|P1|STARTED|Overall Study||5
2563823|NCT00473746|6285859|P5|NOT COMPLETED|Period 2 (Phase 2)||27
2563824|NCT00473746|6285860|P4|NOT COMPLETED|Period 2 (Phase 2)||0
2563825|NCT00473746|6285861|P3|NOT COMPLETED|Period 2 (Phase 2)||0
2563826|NCT00473746|6285862|P2|NOT COMPLETED|Period 2 (Phase 2)||0
2563827|NCT00473746|6285863|P1|NOT COMPLETED|Period 2 (Phase 2)||0
2563828|NCT00473746|6285859|P5|COMPLETED|Period 2 (Phase 2)||6
2563829|NCT00473746|6285860|P4|COMPLETED|Period 2 (Phase 2)||0
2563830|NCT00473746|6285861|P3|COMPLETED|Period 2 (Phase 2)||0
2563831|NCT00473746|6285862|P2|COMPLETED|Period 2 (Phase 2)||0
2563832|NCT00473746|6285863|P1|COMPLETED|Period 2 (Phase 2)||0
2563833|NCT00473746|6285859|P5|STARTED|Period 2 (Phase 2)||33
2563834|NCT00473746|6285860|P4|STARTED|Period 2 (Phase 2)||0
2563835|NCT00473746|6285861|P3|STARTED|Period 2 (Phase 2)||0
2563836|NCT00473746|6285862|P2|STARTED|Period 2 (Phase 2)||0
2563837|NCT00473746|6285863|P1|STARTED|Period 2 (Phase 2)||0
2563838|NCT00473746|6285859|P5|NOT COMPLETED|Period 1 (Phase 1)||0
2563839|NCT00473746|6285860|P4|NOT COMPLETED|Period 1 (Phase 1)||10
2563840|NCT00473746|6285861|P3|NOT COMPLETED|Period 1 (Phase 1)||6
2563841|NCT00473746|6285862|P2|NOT COMPLETED|Period 1 (Phase 1)||9
2563842|NCT00473746|6285863|P1|NOT COMPLETED|Period 1 (Phase 1)||6
2563843|NCT00473746|6285859|P5|COMPLETED|Period 1 (Phase 1)||0
2563844|NCT00473746|6285860|P4|COMPLETED|Period 1 (Phase 1)|Treatment ongoing|2
2563845|NCT00473746|6285861|P3|COMPLETED|Period 1 (Phase 1)||0
2563846|NCT00473746|6285862|P2|COMPLETED|Period 1 (Phase 1)||0
2563847|NCT00473746|6285863|P1|COMPLETED|Period 1 (Phase 1)||0
2563848|NCT00473746|6285859|P5|STARTED|Period 1 (Phase 1)||0
2563849|NCT00473746|6285860|P4|STARTED|Period 1 (Phase 1)||12
2563850|NCT00473746|6285861|P3|STARTED|Period 1 (Phase 1)||6
2563851|NCT00473746|6285862|P2|STARTED|Period 1 (Phase 1)||9
2563852|NCT00473746|6285863|P1|STARTED|Period 1 (Phase 1)||6
2563853|NCT00473694|6285912|P4|NOT COMPLETED|Overall Study||7
2563854|NCT00473694|6285913|P3|NOT COMPLETED|Overall Study||5
2563855|NCT00473694|6285914|P2|NOT COMPLETED|Overall Study||4
2563856|NCT00473694|6285915|P1|NOT COMPLETED|Overall Study||11
2563857|NCT00473694|6285912|P4|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|35
2563858|NCT00473694|6285913|P3|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|46
2563859|NCT00473694|6285914|P2|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|37
2563860|NCT00473694|6285915|P1|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|37
2563861|NCT00473694|6285912|P4|Treated|Overall Study|Number of participants treated was based on actual treatment received.|36
2563862|NCT00473694|6285913|P3|Treated|Overall Study|Number of participants treated was based on actual treatment received.|46
2563863|NCT00473694|6285914|P2|Treated|Overall Study|Number of participants treated was based on actual treatment received.|38
2563864|NCT00473694|6285915|P1|Treated|Overall Study|Number of participants treated was based on actual treatment received.|37
2563865|NCT00473694|6285912|P4|STARTED|Overall Study||42
2563866|NCT00473694|6285913|P3|STARTED|Overall Study||51
2563867|NCT00473694|6285914|P2|STARTED|Overall Study|Includes 1 participant randomized to vecuronium+sugammadex but treated with rocuronium+neostigmine|41
2563868|NCT00473694|6285915|P1|STARTED|Overall Study||48
2563869|NCT00473668|6285956|P3|NOT COMPLETED|Overall Study||10
2563870|NCT00473668|6285957|P2|NOT COMPLETED|Overall Study||11
2563871|NCT00473668|6285958|P1|NOT COMPLETED|Overall Study||5
2563872|NCT00473668|6285956|P3|COMPLETED|Overall Study||89
2563873|NCT00473668|6285957|P2|COMPLETED|Overall Study||89
2563874|NCT00473668|6285958|P1|COMPLETED|Overall Study||95
2563875|NCT00473668|6285956|P3|STARTED|Overall Study||99
2563876|NCT00473668|6285957|P2|STARTED|Overall Study||100
2563877|NCT00473668|6285958|P1|STARTED|Overall Study||100
2563878|NCT00473655|6286011|P3|NOT COMPLETED|Overall Study||8
2563879|NCT00473655|6286012|P2|NOT COMPLETED|Overall Study||5
2563880|NCT00473655|6286013|P1|NOT COMPLETED|Overall Study||9
2563881|NCT00473655|6286011|P3|COMPLETED|Overall Study|8 participants were lost of follow up|103
2563882|NCT00473655|6286012|P2|COMPLETED|Overall Study|5 participants were lost of follow up|107
2563883|NCT00473655|6286013|P1|COMPLETED|Overall Study|9 participants were lost of follow up|102
2563884|NCT00473655|6286011|P3|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
2563885|NCT00473655|6286012|P2|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|112
2563886|NCT00473655|6286013|P1|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
2563887|NCT00473642|6286048|P3|NOT COMPLETED|Overall Study||2
2563888|NCT00473642|6286049|P2|NOT COMPLETED|Overall Study||1
2563889|NCT00473642|6286050|P1|NOT COMPLETED|Overall Study||2
2563890|NCT00473642|6286048|P3|COMPLETED|Overall Study||8
2563891|NCT00473642|6286049|P2|COMPLETED|Overall Study||10
2563892|NCT00473642|6286050|P1|COMPLETED|Overall Study||8
2563893|NCT00473642|6286048|P3|STARTED|Overall Study||10
2563894|NCT00473642|6286049|P2|STARTED|Overall Study||11
2563895|NCT00473642|6286050|P1|STARTED|Overall Study||10
2563896|NCT00473590|6286060|P2|NOT COMPLETED|Overall Study||38
2563897|NCT00473590|6286061|P1|NOT COMPLETED|Overall Study||45
2563898|NCT00473590|6286060|P2|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|11
2564062|NCT00472303|6286481|P3|COMPLETED|Maintenance Phase||95
2563899|NCT00473590|6286061|P1|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|8
2563900|NCT00473590|6286060|P2|Safety Population|Overall Study||50
2563901|NCT00473590|6286061|P1|Safety Population|Overall Study|2 patients received at least 1 bevacizumab dose & were analyzed as bevacizumab-treated patients|50
2563902|NCT00473590|6286060|P2|Treated|Overall Study||48
2563903|NCT00473590|6286061|P1|Treated|Overall Study||52
2563904|NCT00473590|6286060|P2|STARTED|Overall Study||49
2563905|NCT00473590|6286061|P1|STARTED|Overall Study||53
2563906|NCT00473564|6286077|P1|NOT COMPLETED|Overall Study||23
2563907|NCT00473564|6286077|P1|COMPLETED|Overall Study||147
2563908|NCT00473564|6286077|P1|STARTED|Overall Study||170
2563909|NCT00473512|6286087|P5|NOT COMPLETED|Period 2 (Phase 2)||2
2563910|NCT00473512|6286088|P4|NOT COMPLETED|Period 2 (Phase 2)||23
2563911|NCT00473512|6286089|P3|NOT COMPLETED|Period 2 (Phase 2)||2
2563912|NCT00473512|6286090|P2|NOT COMPLETED|Period 2 (Phase 2)||2
2563913|NCT00473512|6286091|P1|NOT COMPLETED|Period 2 (Phase 2)||1
2563914|NCT00473512|6286087|P5|COMPLETED|Period 2 (Phase 2)||0
2563915|NCT00473512|6286088|P4|COMPLETED|Period 2 (Phase 2)||0
2563916|NCT00473512|6286089|P3|COMPLETED|Period 2 (Phase 2)||0
2563917|NCT00473512|6286090|P2|COMPLETED|Period 2 (Phase 2)||0
2563918|NCT00473512|6286091|P1|COMPLETED|Period 2 (Phase 2)||0
2563919|NCT00473512|6286087|P5|STARTED|Period 2 (Phase 2)||2
2563920|NCT00473512|6286088|P4|STARTED|Period 2 (Phase 2)|2 participants did not continue to Phase 2 of the study.|23
2563921|NCT00473512|6286089|P3|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|2
2563922|NCT00473512|6286090|P2|STARTED|Period 2 (Phase 2)||2
2563923|NCT00473512|6286091|P1|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|1
2563924|NCT00473512|6286087|P5|NOT COMPLETED|Period 1 (Phase 1)||1
2563925|NCT00473512|6286088|P4|NOT COMPLETED|Period 1 (Phase 1)||17
2563926|NCT00473512|6286089|P3|NOT COMPLETED|Period 1 (Phase 1)||0
2563927|NCT00473512|6286090|P2|NOT COMPLETED|Period 1 (Phase 1)||1
2563928|NCT00473512|6286091|P1|NOT COMPLETED|Period 1 (Phase 1)||1
2563929|NCT00473512|6286087|P5|COMPLETED|Period 1 (Phase 1)||2
2563930|NCT00473512|6286088|P4|COMPLETED|Period 1 (Phase 1)||25
2563931|NCT00473512|6286089|P3|COMPLETED|Period 1 (Phase 1)||3
2563932|NCT00473512|6286090|P2|COMPLETED|Period 1 (Phase 1)||2
2563933|NCT00473512|6286091|P1|COMPLETED|Period 1 (Phase 1)||2
2563934|NCT00473512|6286087|P5|STARTED|Period 1 (Phase 1)||3
2563935|NCT00473512|6286088|P4|STARTED|Period 1 (Phase 1)||42
2563936|NCT00473512|6286089|P3|STARTED|Period 1 (Phase 1)||3
2563937|NCT00473512|6286090|P2|STARTED|Period 1 (Phase 1)||3
2563938|NCT00473512|6286091|P1|STARTED|Period 1 (Phase 1)||3
2563939|NCT00473434|6286149|P1|NOT COMPLETED|Overall Study||32
2563940|NCT00473434|6286149|P1|COMPLETED|Overall Study||32
2563941|NCT00473434|6286149|P1|STARTED|Overall Study||64
2563942|NCT00473382|6286214|P3|NOT COMPLETED|Open-label Extension Through Month 60||82
2563943|NCT00473382|6286215|P2|NOT COMPLETED|Open-label Extension Through Month 60||82
2563944|NCT00473382|6286216|P1|NOT COMPLETED|Open-label Extension Through Month 60||86
2563945|NCT00473382|6286214|P3|COMPLETED|Open-label Extension Through Month 60||2
2563946|NCT00473382|6286215|P2|COMPLETED|Open-label Extension Through Month 60||1
2563947|NCT00473382|6286216|P1|COMPLETED|Open-label Extension Through Month 60||2
2563948|NCT00473382|6286214|P3|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|84
2563949|NCT00473382|6286215|P2|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|83
2563950|NCT00473382|6286216|P1|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|88
2563951|NCT00473382|6286214|P3|NOT COMPLETED|Open-label Extension Through Month 48||47
2563952|NCT00473382|6286215|P2|NOT COMPLETED|Open-label Extension Through Month 48||41
2563953|NCT00473382|6286216|P1|NOT COMPLETED|Open-label Extension Through Month 48||50
2563954|NCT00473382|6286214|P3|COMPLETED|Open-label Extension Through Month 48||37
2563955|NCT00473382|6286215|P2|COMPLETED|Open-label Extension Through Month 48||42
2563956|NCT00473382|6286216|P1|COMPLETED|Open-label Extension Through Month 48||38
2563957|NCT00473382|6286214|P3|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|84
2563958|NCT00473382|6286215|P2|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|83
2563959|NCT00473382|6286216|P1|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|88
2563960|NCT00473382|6286214|P3|NOT COMPLETED|Core Study||29
2563961|NCT00473382|6286215|P2|NOT COMPLETED|Core Study||27
2563962|NCT00473382|6286216|P1|NOT COMPLETED|Core Study||28
2563963|NCT00473382|6286214|P3|COMPLETED|Core Study||98
2563964|NCT00473382|6286215|P2|COMPLETED|Core Study||98
2563965|NCT00473382|6286216|P1|COMPLETED|Core Study||102
2563966|NCT00473382|6286214|P3|STARTED|Core Study||127
2563967|NCT00473382|6286215|P2|STARTED|Core Study||125
2563968|NCT00473382|6286216|P1|STARTED|Core Study||130
2563969|NCT00473330|6286274|P3|NOT COMPLETED|Open-label Extension Through Month 60||77
2563970|NCT00473330|6286275|P2|NOT COMPLETED|Open-label Extension Through Month 60||78
2563971|NCT00473330|6286276|P1|NOT COMPLETED|Open-label Extension Through Month 60||88
2563972|NCT00473330|6286274|P3|COMPLETED|Open-label Extension Through Month 60||0
2563973|NCT00473330|6286275|P2|COMPLETED|Open-label Extension Through Month 60||1
2563974|NCT00473330|6286276|P1|COMPLETED|Open-label Extension Through Month 60||1
2563975|NCT00473330|6286274|P3|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|77
2563976|NCT00473330|6286275|P2|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|79
2563977|NCT00473330|6286276|P1|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|89
2563978|NCT00473330|6286274|P3|NOT COMPLETED|Open-label Extension Through Month 48||27
2563979|NCT00473330|6286275|P2|NOT COMPLETED|Open-label Extension Through Month 48||20
2563980|NCT00473330|6286276|P1|NOT COMPLETED|Open-label Extension Through Month 48||26
2563981|NCT00473330|6286274|P3|COMPLETED|Open-label Extension Through Month 48||50
2563982|NCT00473330|6286275|P2|COMPLETED|Open-label Extension Through Month 48||59
2563983|NCT00473330|6286276|P1|COMPLETED|Open-label Extension Through Month 48||63
2563984|NCT00473330|6286274|P3|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|77
2563985|NCT00473330|6286275|P2|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|79
2563986|NCT00473330|6286276|P1|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|89
2563987|NCT00473330|6286274|P3|NOT COMPLETED|Core Study||41
2563988|NCT00473330|6286275|P2|NOT COMPLETED|Core Study||25
2563989|NCT00473330|6286276|P1|NOT COMPLETED|Core Study||27
2563990|NCT00473330|6286274|P3|COMPLETED|Core Study||86
2563991|NCT00473330|6286275|P2|COMPLETED|Core Study||100
2563992|NCT00473330|6286276|P1|COMPLETED|Core Study||98
2563993|NCT00473330|6286274|P3|STARTED|Core Study||127
2563994|NCT00473330|6286275|P2|STARTED|Core Study||125
2563995|NCT00473330|6286276|P1|STARTED|Core Study||125
2563996|NCT00473265|6286331|P1|NOT COMPLETED|Overall Study||20
2563997|NCT00473265|6286331|P1|COMPLETED|Overall Study||48
2563998|NCT00473265|6286331|P1|STARTED|Overall Study||68
2563999|NCT00473083|6286343|P3|NOT COMPLETED|Overall Study||0
2564000|NCT00473083|6286344|P2|NOT COMPLETED|Overall Study||0
2564001|NCT00473083|6286345|P1|NOT COMPLETED|Overall Study||1
2564002|NCT00473083|6286343|P3|COMPLETED|Overall Study||50
2564003|NCT00473083|6286344|P2|COMPLETED|Overall Study||50
2564004|NCT00473083|6286345|P1|COMPLETED|Overall Study|One patient (2%) from treatment arm 1 discontinued the study drug as a result of a TEAE (dizziness)|49
2564005|NCT00473083|6286343|P3|STARTED|Overall Study||50
2564006|NCT00473083|6286344|P2|STARTED|Overall Study||50
2564007|NCT00473083|6286345|P1|STARTED|Overall Study||50
2564008|NCT00472849|6286373|P2|NOT COMPLETED|Overall Study||0
2564009|NCT00472849|6286374|P1|NOT COMPLETED|Overall Study||0
2564010|NCT00472849|6286373|P2|COMPLETED|Overall Study||78
2564011|NCT00472849|6286374|P1|COMPLETED|Overall Study||12
2564012|NCT00472849|6286373|P2|STARTED|Overall Study||78
2564013|NCT00472849|6286374|P1|STARTED|Overall Study||12
2564014|NCT00472797|6286382|P2|NOT COMPLETED|Overall Study||1
2564015|NCT00472797|6286383|P1|NOT COMPLETED|Overall Study||4
2564016|NCT00472797|6286382|P2|COMPLETED|Overall Study||112
2564017|NCT00472797|6286383|P1|COMPLETED|Overall Study||115
2564018|NCT00472797|6286382|P2|STARTED|Overall Study||113
2564019|NCT00472797|6286383|P1|STARTED|Overall Study||119
2564020|NCT00472732|6286409|P2|NOT COMPLETED|Overall Study||0
2564021|NCT00472732|6286410|P1|NOT COMPLETED|Overall Study||0
2564022|NCT00472732|6286409|P2|COMPLETED|Overall Study||22
2564023|NCT00472732|6286410|P1|COMPLETED|Overall Study||24
2564024|NCT00472732|6286409|P2|STARTED|Overall Study||22
2564025|NCT00472732|6286410|P1|STARTED|Overall Study||24
2564026|NCT00472641|6286420|P1|NOT COMPLETED|Overall Study||7
2564027|NCT00472641|6286420|P1|COMPLETED|Overall Study||18
2564028|NCT00472641|6286420|P1|STARTED|Overall Study||25
2564029|NCT00472576|6286427|P2|NOT COMPLETED|Second Intervention||0
2564030|NCT00472576|6286428|P1|NOT COMPLETED|Second Intervention||0
2564031|NCT00472576|6286427|P2|COMPLETED|Second Intervention||3
2564032|NCT00472576|6286428|P1|COMPLETED|Second Intervention||2
2564033|NCT00472576|6286427|P2|STARTED|Second Intervention||3
2564034|NCT00472576|6286428|P1|STARTED|Second Intervention||2
2564035|NCT00472576|6286427|P2|NOT COMPLETED|First Intervention||0
2564036|NCT00472576|6286428|P1|NOT COMPLETED|First Intervention||0
2564037|NCT00472576|6286427|P2|COMPLETED|First Intervention||3
2564038|NCT00472576|6286428|P1|COMPLETED|First Intervention||2
2564039|NCT00472576|6286427|P2|STARTED|First Intervention||3
2564040|NCT00472576|6286428|P1|STARTED|First Intervention||2
2564041|NCT00472446|6286440|P4|NOT COMPLETED|Overall Study||6
2564042|NCT00472446|6286441|P3|NOT COMPLETED|Overall Study||7
2564043|NCT00472446|6286442|P2|NOT COMPLETED|Overall Study||6
2564044|NCT00472446|6286443|P1|NOT COMPLETED|Overall Study||5
2564045|NCT00472446|6286440|P4|COMPLETED|Overall Study||39
2564046|NCT00472446|6286441|P3|COMPLETED|Overall Study||38
2564047|NCT00472446|6286442|P2|COMPLETED|Overall Study||41
2564048|NCT00472446|6286443|P1|COMPLETED|Overall Study||41
2564049|NCT00472446|6286440|P4|STARTED|Overall Study||45
2564050|NCT00472446|6286441|P3|STARTED|Overall Study||45
2564051|NCT00472446|6286442|P2|STARTED|Overall Study||47
2564052|NCT00472446|6286443|P1|STARTED|Overall Study||46
2564053|NCT00472420|6286473|P1|NOT COMPLETED|Follow-up Period||17
2564054|NCT00472420|6286473|P1|COMPLETED|Follow-up Period||15
2564055|NCT00472420|6286473|P1|STARTED|Follow-up Period||32
2564056|NCT00472420|6286473|P1|NOT COMPLETED|Induction Treatment Period||16
2564057|NCT00472420|6286473|P1|COMPLETED|Induction Treatment Period||32
2564058|NCT00472420|6286473|P1|STARTED|Induction Treatment Period||48
2564059|NCT00472303|6286481|P3|NOT COMPLETED|Maintenance Phase||17
2564060|NCT00472303|6286482|P2|NOT COMPLETED|Maintenance Phase||16
2564061|NCT00472303|6286483|P1|NOT COMPLETED|Maintenance Phase||17
2564063|NCT00472303|6286482|P2|COMPLETED|Maintenance Phase||93
2564064|NCT00472303|6286483|P1|COMPLETED|Maintenance Phase||89
2564065|NCT00472303|6286481|P3|STARTED|Maintenance Phase|112 of 218 participants in the tapentadol titration arm were re-randomized and treated.|112
2564066|NCT00472303|6286482|P2|STARTED|Maintenance Phase||109
2564067|NCT00472303|6286483|P1|STARTED|Maintenance Phase|106 of 218 participants in the tapentadol titration arm were re-randomized and treated.|106
2564068|NCT00472303|6286481|P3|NOT COMPLETED|Discontinuations After Titration Phase||0
2564069|NCT00472303|6286482|P2|NOT COMPLETED|Discontinuations After Titration Phase||20
2564070|NCT00472303|6286483|P1|NOT COMPLETED|Discontinuations After Titration Phase||61
2564071|NCT00472303|6286481|P3|COMPLETED|Discontinuations After Titration Phase||0
2564072|NCT00472303|6286482|P2|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|109
2564073|NCT00472303|6286483|P1|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|218
2564074|NCT00472303|6286481|P3|STARTED|Discontinuations After Titration Phase||0
2564075|NCT00472303|6286482|P2|STARTED|Discontinuations After Titration Phase||129
2564076|NCT00472303|6286483|P1|STARTED|Discontinuations After Titration Phase||279
2564077|NCT00472303|6286481|P3|NOT COMPLETED|Titration Phase||0
2564078|NCT00472303|6286482|P2|NOT COMPLETED|Titration Phase||29
2564079|NCT00472303|6286483|P1|NOT COMPLETED|Titration Phase||59
2564080|NCT00472303|6286481|P3|COMPLETED|Titration Phase||0
2564081|NCT00472303|6286482|P2|COMPLETED|Titration Phase||129
2564082|NCT00472303|6286483|P1|COMPLETED|Titration Phase||279
2564083|NCT00472303|6286481|P3|STARTED|Titration Phase|All participants in the titration phase were in the tapentadol arm during the titration phase.|0
2564084|NCT00472303|6286482|P2|STARTED|Titration Phase||158
2564085|NCT00472303|6286483|P1|STARTED|Titration Phase||338
2564086|NCT00472290|6286546|P1|NOT COMPLETED|Overall Study||72
2564087|NCT00472290|6286546|P1|COMPLETED|Overall Study||0
2564088|NCT00472290|6286546|P1|STARTED|Overall Study||72
2564089|NCT00472199|6286558|P2|NOT COMPLETED|Overall Study||60
2564090|NCT00472199|6286559|P1|NOT COMPLETED|Overall Study||35
2564091|NCT00472199|6286558|P2|COMPLETED|Overall Study||103
2564092|NCT00472199|6286559|P1|COMPLETED|Overall Study||131
2564093|NCT00472199|6286558|P2|STARTED|Overall Study||163
2564094|NCT00472199|6286559|P1|STARTED|Overall Study||166
2564095|NCT00472082|6286625|P1|NOT COMPLETED|Overall Study||5
2564096|NCT00472082|6286625|P1|COMPLETED|Overall Study||0
2564097|NCT00472082|6286625|P1|STARTED|Overall Study||5
2564098|NCT00472056|6286634|P4|NOT COMPLETED|Overall Study||0
2564099|NCT00472056|6286635|P3|NOT COMPLETED|Overall Study||0
2564100|NCT00472056|6286636|P2|NOT COMPLETED|Overall Study||0
2564101|NCT00472056|6286637|P1|NOT COMPLETED|Overall Study||0
2564102|NCT00472056|6286634|P4|COMPLETED|Overall Study||17
2564103|NCT00472056|6286635|P3|COMPLETED|Overall Study||32
2564104|NCT00472056|6286636|P2|COMPLETED|Overall Study||19
2564105|NCT00472056|6286637|P1|COMPLETED|Overall Study||25
2564106|NCT00472056|6286634|P4|STARTED|Overall Study||17
2564107|NCT00472056|6286635|P3|STARTED|Overall Study||32
2564108|NCT00472056|6286636|P2|STARTED|Overall Study||19
2564109|NCT00472056|6286637|P1|STARTED|Overall Study||25
2564110|NCT00472030|6286647|P2|NOT COMPLETED|Overall Study||0
2564111|NCT00472030|6286648|P1|NOT COMPLETED|Overall Study||1
2564112|NCT00472030|6286647|P2|COMPLETED|Overall Study||0
2564113|NCT00472030|6286648|P1|COMPLETED|Overall Study||1
2564114|NCT00472030|6286647|P2|STARTED|Overall Study||0
2564115|NCT00472030|6286648|P1|STARTED|Overall Study||2
2564116|NCT00471822|6286664|P1|NOT COMPLETED|Overall Study||2
2564117|NCT00471822|6286664|P1|COMPLETED|Overall Study||9705
2564118|NCT00471822|6286664|P1|Treated|Overall Study||9705
2564119|NCT00471822|6286664|P1|STARTED|Overall Study||9707
2564120|NCT00471718|6286672|P1|NOT COMPLETED|Overall Study||27
2564121|NCT00471718|6286672|P1|COMPLETED|Overall Study||0
2564122|NCT00471718|6286672|P1|STARTED|Overall Study||27
2564123|NCT00471705|6286684|P3|NOT COMPLETED|Overall Study||15
2564124|NCT00471705|6286685|P2|NOT COMPLETED|Overall Study||22
2564125|NCT00471705|6286686|P1|NOT COMPLETED|Overall Study||24
2564126|NCT00471705|6286684|P3|COMPLETED|Overall Study||134
2564127|NCT00471705|6286685|P2|COMPLETED|Overall Study||121
2564128|NCT00471705|6286686|P1|COMPLETED|Overall Study||121
2564129|NCT00471705|6286684|P3|STARTED|Overall Study||149
2564130|NCT00471705|6286685|P2|STARTED|Overall Study||143
2564131|NCT00471705|6286686|P1|STARTED|Overall Study||145
2564132|NCT00471536|6286700|P1|NOT COMPLETED|Overall Study||1
2564133|NCT00471536|6286700|P1|COMPLETED|Overall Study||18
2564134|NCT00471536|6286700|P1|STARTED|Overall Study||19
2564135|NCT00471497|6286712|P3|NOT COMPLETED|Overall Study||40
2564136|NCT00471497|6286713|P2|NOT COMPLETED|Overall Study||35
2564137|NCT00471497|6286714|P1|NOT COMPLETED|Overall Study||46
2564138|NCT00471497|6286712|P3|COMPLETED|Overall Study|Completed means patient is on treatment in core phase of the study (ongoing) by data cut-off.|241
2564139|NCT00471497|6286713|P2|COMPLETED|Overall Study|Completed means patient is on treatment in core phase of the study (ongoing) by data cut-off.|247
2564140|NCT00471497|6286714|P1|COMPLETED|Overall Study|Completed means patient is on treatment in core phase of the study (ongoing) by data cut-off.|237
2564141|NCT00471497|6286712|P3|SAFETY ANALYSIS SET|Overall Study|Safety set contained patients who received at least one dose of study medication.|277
2564142|NCT00471497|6286713|P2|SAFETY ANALYSIS SET|Overall Study|Safety set contained patients who received at least one dose of study medication.|279
2564143|NCT00471497|6286714|P1|SAFETY ANALYSIS SET|Overall Study|Safety set contained patients who received at least one dose of study medication.|280
2564144|NCT00471497|6286712|P3|STARTED|Overall Study||281
2564145|NCT00471497|6286713|P2|STARTED|Overall Study||282
2564146|NCT00471497|6286714|P1|STARTED|Overall Study||283
2564147|NCT00471445|6286724|P2|NOT COMPLETED|Overall Study||2
2564148|NCT00471445|6286725|P1|NOT COMPLETED|Overall Study||2
2564149|NCT00471445|6286724|P2|COMPLETED|Overall Study||231
2564150|NCT00471445|6286725|P1|COMPLETED|Overall Study||227
2564151|NCT00471445|6286724|P2|STARTED|Overall Study||233
2564152|NCT00471445|6286725|P1|STARTED|Overall Study||229
2564153|NCT00471380|6286731|P2|NOT COMPLETED|Third Intervention||2
2564154|NCT00471380|6286732|P1|NOT COMPLETED|Third Intervention||1
2564155|NCT00471380|6286731|P2|COMPLETED|Third Intervention||14
2564156|NCT00471380|6286732|P1|COMPLETED|Third Intervention||17
2564157|NCT00471380|6286731|P2|STARTED|Third Intervention||16
2564158|NCT00471380|6286732|P1|STARTED|Third Intervention||18
2564159|NCT00471380|6286731|P2|NOT COMPLETED|Second Intervention||4
2564160|NCT00471380|6286732|P1|NOT COMPLETED|Second Intervention||0
2564161|NCT00471380|6286731|P2|COMPLETED|Second Intervention||16
2564162|NCT00471380|6286732|P1|COMPLETED|Second Intervention||18
2564163|NCT00471380|6286731|P2|STARTED|Second Intervention||20
2564164|NCT00471380|6286732|P1|STARTED|Second Intervention||18
2564165|NCT00471380|6286731|P2|NOT COMPLETED|First Intervention||4
2564166|NCT00471380|6286732|P1|NOT COMPLETED|First Intervention||4
2564167|NCT00471380|6286731|P2|COMPLETED|First Intervention||20
2564168|NCT00471380|6286732|P1|COMPLETED|First Intervention||18
2564169|NCT00471380|6286731|P2|STARTED|First Intervention||24
2564170|NCT00471380|6286732|P1|STARTED|First Intervention||22
2564171|NCT00471354|6286738|P1|NOT COMPLETED|Overall Study||52
2564172|NCT00471354|6286738|P1|COMPLETED|Overall Study||176
2564173|NCT00471354|6286738|P1|STARTED|Overall Study||228
2564174|NCT00471328|6286750|P2|NOT COMPLETED|Extension Phase||67
2564175|NCT00471328|6286751|P1|NOT COMPLETED|Extension Phase||41
2564176|NCT00471328|6286750|P2|COMPLETED|Extension Phase||0
2564177|NCT00471328|6286751|P1|COMPLETED|Extension Phase||0
2564178|NCT00471328|6286750|P2|Started:CrossOver During Extension|Extension Phase||10
2564179|NCT00471328|6286751|P1|Started:CrossOver During Extension|Extension Phase||0
2564180|NCT00471328|6286750|P2|Started:CrossOver After PrimaryAnalysis|Extension Phase||4
2564181|NCT00471328|6286751|P1|Started:CrossOver After PrimaryAnalysis|Extension Phase||0
2564182|NCT00471328|6286750|P2|Started:CrossOver Before PrimaryAnalysis|Extension Phase||53
2564183|NCT00471328|6286751|P1|Started:CrossOver Before PrimaryAnalysis|Extension Phase||0
2564184|NCT00471328|6286750|P2|STARTED|Extension Phase||67
2564185|NCT00471328|6286751|P1|STARTED|Extension Phase|Out of 58 ongoing patients, 17 patients had progression or died before they could enter extension|41
2564186|NCT00471328|6286750|P2|NOT COMPLETED|Core Phase||67
2564187|NCT00471328|6286751|P1|NOT COMPLETED|Core Phase||107
2564188|NCT00471328|6286750|P2|COMPLETED|Core Phase|Ongoing on treatment during completion of core|16
2564189|NCT00471328|6286751|P1|COMPLETED|Core Phase|Ongoing on treatment during completion of core.|58
2564190|NCT00471328|6286750|P2|Crossover to Nilotinib:Started Extension|Core Phase||53
2564191|NCT00471328|6286751|P1|Crossover to Nilotinib:Started Extension|Core Phase||0
2564192|NCT00471328|6286750|P2|STARTED|Core Phase||83
2564193|NCT00471328|6286751|P1|STARTED|Core Phase||165
2564194|NCT00471315|6286770|P1|NOT COMPLETED|Overall Study||8
2564195|NCT00471315|6286770|P1|COMPLETED|Overall Study||10
2564196|NCT00471315|6286770|P1|STARTED|Overall Study||18
2564197|NCT00471276|6286775|P1|NOT COMPLETED|Overall Study||83
2564198|NCT00471276|6286775|P1|COMPLETED|Overall Study||0
2564199|NCT00471276|6286775|P1|STARTED|Overall Study||83
2564200|NCT00471237|6286805|P7|NOT COMPLETED|Overall Study||3
2564201|NCT00471237|6286806|P6|NOT COMPLETED|Overall Study||39
2564202|NCT00471237|6286807|P5|NOT COMPLETED|Overall Study||41
2564203|NCT00471237|6286808|P4|NOT COMPLETED|Overall Study||45
2564204|NCT00471237|6286809|P3|NOT COMPLETED|Overall Study||34
2564205|NCT00471237|6286810|P2|NOT COMPLETED|Overall Study||42
2564206|NCT00471237|6286811|P1|NOT COMPLETED|Overall Study||41
2564207|NCT00471237|6286805|P7|COMPLETED|Overall Study||38
2564208|NCT00471237|6286806|P6|COMPLETED|Overall Study||50
2564209|NCT00471237|6286807|P5|COMPLETED|Overall Study||46
2564210|NCT00471237|6286808|P4|COMPLETED|Overall Study||43
2564211|NCT00471237|6286809|P3|COMPLETED|Overall Study||48
2564212|NCT00471237|6286810|P2|COMPLETED|Overall Study||45
2564213|NCT00471237|6286811|P1|COMPLETED|Overall Study||49
2564214|NCT00471237|6286805|P7|STARTED|Overall Study||41
2564215|NCT00471237|6286806|P6|STARTED|Overall Study||89
2564216|NCT00471237|6286807|P5|STARTED|Overall Study||87
2564217|NCT00471237|6286808|P4|STARTED|Overall Study||88
2564218|NCT00471237|6286809|P3|STARTED|Overall Study||82
2564219|NCT00471237|6286810|P2|STARTED|Overall Study||87
2564220|NCT00471237|6286811|P1|STARTED|Overall Study||90
2564221|NCT00471146|6286961|P2|NOT COMPLETED|Overall Study||174
2564222|NCT00471146|6286962|P1|NOT COMPLETED|Overall Study||172
2564223|NCT00471146|6286961|P2|COMPLETED|Overall Study||142
2564224|NCT00471146|6286962|P1|COMPLETED|Overall Study||142
2564225|NCT00471146|6286961|P2|Treated|Overall Study||308
2564226|NCT00471146|6286962|P1|Treated|Overall Study||305
2564227|NCT00471146|6286961|P2|STARTED|Overall Study||316
2564228|NCT00471146|6286962|P1|STARTED|Overall Study||314
2564229|NCT00471107|6286987|P3|NOT COMPLETED|Overall Study||3
2564230|NCT00471107|6286988|P2|NOT COMPLETED|Overall Study||1
2564231|NCT00471107|6286989|P1|NOT COMPLETED|Overall Study||3
2564232|NCT00471107|6286987|P3|COMPLETED|Overall Study||12
2564233|NCT00471107|6286988|P2|COMPLETED|Overall Study||14
2564234|NCT00471107|6286989|P1|COMPLETED|Overall Study||12
2564235|NCT00471107|6286987|P3|STARTED|Overall Study||15
2564236|NCT00471107|6286988|P2|STARTED|Overall Study||15
2564237|NCT00471107|6286989|P1|STARTED|Overall Study||15
2564238|NCT00471081|6286999|P2|NOT COMPLETED|Extended Safety Follow-Up||13
2564239|NCT00471081|6287000|P1|NOT COMPLETED|Extended Safety Follow-Up||2
2564240|NCT00471081|6286999|P2|COMPLETED|Extended Safety Follow-Up||176
2564241|NCT00471081|6287000|P1|COMPLETED|Extended Safety Follow-Up||158
2564242|NCT00471081|6286999|P2|STARTED|Extended Safety Follow-Up||189
2564243|NCT00471081|6287000|P1|STARTED|Extended Safety Follow-Up||160
2564244|NCT00471081|6286999|P2|NOT COMPLETED|Active Phase||13
2564245|NCT00471081|6287000|P1|NOT COMPLETED|Active Phase||2
2564246|NCT00471081|6286999|P2|COMPLETED|Active Phase||176
2564247|NCT00471081|6287000|P1|COMPLETED|Active Phase||158
2564248|NCT00471081|6286999|P2|STARTED|Active Phase||189
2564249|NCT00471081|6287000|P1|STARTED|Active Phase||160
2564250|NCT00471068|6287039|P2|NOT COMPLETED|Overall Study||1
2564251|NCT00471068|6287040|P1|NOT COMPLETED|Overall Study||1
2564252|NCT00471068|6287039|P2|COMPLETED|Overall Study||24
2564253|NCT00471068|6287040|P1|COMPLETED|Overall Study||20
2564254|NCT00471068|6287039|P2|STARTED|Overall Study||25
2564255|NCT00471068|6287040|P1|STARTED|Overall Study||21
2564256|NCT00470847|6287046|P1|NOT COMPLETED|Overall Study||1
2564257|NCT00470847|6287046|P1|COMPLETED|Overall Study||34
2564258|NCT00470847|6287046|P1|STARTED|Overall Study||35
2564259|NCT00470834|6287059|P2|NOT COMPLETED|Extension Period (24 Months)||23
2564260|NCT00470834|6287060|P1|NOT COMPLETED|Extension Period (24 Months)||15
2564261|NCT00470834|6287059|P2|COMPLETED|Extension Period (24 Months)||7
2564262|NCT00470834|6287060|P1|COMPLETED|Extension Period (24 Months)||11
2564263|NCT00470834|6287059|P2|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|30
2564264|NCT00470834|6287060|P1|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|26
2564265|NCT00470834|6287059|P2|NOT COMPLETED|Treatment Period (18 Months)||31
2564266|NCT00470834|6287060|P1|NOT COMPLETED|Treatment Period (18 Months)||38
2564267|NCT00470834|6287059|P2|COMPLETED|Treatment Period (18 Months)||31
2564268|NCT00470834|6287060|P1|COMPLETED|Treatment Period (18 Months)||27
2564269|NCT00470834|6287059|P2|STARTED|Treatment Period (18 Months)||62
2564270|NCT00470834|6287060|P1|STARTED|Treatment Period (18 Months)||65
2564271|NCT00470626|6287074|P1|NOT COMPLETED|Overall Study||17
2564272|NCT00470626|6287074|P1|COMPLETED|Overall Study||112
2564273|NCT00470626|6287074|P1|STARTED|Overall Study||129
2564274|NCT00470600|6287082|P2|NOT COMPLETED|Overall Study||0
2564275|NCT00470600|6287083|P1|NOT COMPLETED|Overall Study||0
2564276|NCT00470600|6287082|P2|COMPLETED|Overall Study|One subject was randomized to incorrect stratification categories (weight).|99
2564277|NCT00470600|6287083|P1|COMPLETED|Overall Study|Two subjects were randomized to incorrect stratification categories (weight).|86
2564278|NCT00470600|6287082|P2|STARTED|Overall Study||99
2564279|NCT00470600|6287083|P1|STARTED|Overall Study||86
2564280|NCT00470548|6287095|P4|NOT COMPLETED|Overall Study||0
2564281|NCT00470548|6287096|P3|NOT COMPLETED|Overall Study||0
2564282|NCT00470548|6287097|P2|NOT COMPLETED|Overall Study||0
2564283|NCT00470548|6287098|P1|NOT COMPLETED|Overall Study||0
2564284|NCT00470548|6287095|P4|COMPLETED|Overall Study||37
2564285|NCT00470548|6287096|P3|COMPLETED|Overall Study||6
2564286|NCT00470548|6287097|P2|COMPLETED|Overall Study||3
2564287|NCT00470548|6287098|P1|COMPLETED|Overall Study||3
2564288|NCT00470548|6287095|P4|STARTED|Overall Study||37
2564289|NCT00470548|6287096|P3|STARTED|Overall Study||6
2564290|NCT00470548|6287097|P2|STARTED|Overall Study||3
2564291|NCT00470548|6287098|P1|STARTED|Overall Study||3
2564292|NCT00470535|6287116|P1|NOT COMPLETED|Overall Study||18
2564293|NCT00470535|6287116|P1|COMPLETED|Overall Study||0
2564294|NCT00470535|6287116|P1|STARTED|Overall Study||18
2564295|NCT00470470|6287125|P1|NOT COMPLETED|Overall Study||5
2564296|NCT00470470|6287125|P1|COMPLETED|Overall Study||25
2564297|NCT00470470|6287125|P1|STARTED|Overall Study||30
2564298|NCT00470418|6287132|P2|NOT COMPLETED|Overall Study||0
2564299|NCT00470418|6287133|P1|NOT COMPLETED|Overall Study||1
2564300|NCT00470418|6287132|P2|COMPLETED|Overall Study||3
2564301|NCT00470418|6287133|P1|COMPLETED|Overall Study||6
2564302|NCT00470418|6287132|P2|STARTED|Overall Study||3
2564303|NCT00470418|6287133|P1|STARTED|Overall Study||7
2564304|NCT00470392|6287143|P2|NOT COMPLETED|Overall Study||0
2564305|NCT00470392|6287144|P1|NOT COMPLETED|Overall Study||0
2564306|NCT00470392|6287143|P2|COMPLETED|Overall Study||2
2564307|NCT00470392|6287144|P1|COMPLETED|Overall Study||7
2564308|NCT00470392|6287143|P2|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|2
2564309|NCT00470392|6287144|P1|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|7
2564310|NCT00470366|6287154|P1|NOT COMPLETED|Overall Study||4
2564311|NCT00470366|6287154|P1|COMPLETED|Overall Study||56
2564312|NCT00470366|6287154|P1|STARTED|Overall Study||60
2564313|NCT00470301|6287161|P1|NOT COMPLETED|Overall Study||5
2564314|NCT00470301|6287161|P1|COMPLETED|Overall Study||55
2564315|NCT00470301|6287161|P1|STARTED|Overall Study||60
2564316|NCT00470275|6287165|P1|NOT COMPLETED|Overall Study||10
2564317|NCT00470275|6287165|P1|COMPLETED|Overall Study||0
2564318|NCT00470275|6287165|P1|STARTED|Overall Study||10
2564319|NCT00470262|6287171|P2|NOT COMPLETED|Overall Study||0
2564320|NCT00470262|6287172|P1|NOT COMPLETED|Overall Study||2
2564321|NCT00470262|6287171|P2|COMPLETED|Overall Study||12
2564322|NCT00470262|6287172|P1|COMPLETED|Overall Study||13
2564323|NCT00470262|6287171|P2|STARTED|Overall Study||12
2564324|NCT00470262|6287172|P1|STARTED|Overall Study||15
2564325|NCT00470184|6287180|P1|NOT COMPLETED|Overall Study||22
2564326|NCT00470184|6287180|P1|COMPLETED|Overall Study||19
2564327|NCT00470184|6287180|P1|Treated With Study Therapy|Overall Study||36
2564328|NCT00470184|6287180|P1|STARTED|Overall Study||41
2564329|NCT00470158|6287192|P5|NOT COMPLETED|Overall Study||6
2564330|NCT00470158|6287193|P4|NOT COMPLETED|Overall Study||5
2564331|NCT00470158|6287194|P3|NOT COMPLETED|Overall Study||8
2564332|NCT00470158|6287195|P2|NOT COMPLETED|Overall Study||8
2564333|NCT00470158|6287196|P1|NOT COMPLETED|Overall Study||8
2564334|NCT00470158|6287192|P5|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|195
2564335|NCT00470158|6287193|P4|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
2564336|NCT00470158|6287194|P3|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
2564337|NCT00470158|6287195|P2|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|191
2564338|NCT00470158|6287196|P1|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
2564339|NCT00470158|6287192|P5|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
2564340|NCT00470158|6287193|P4|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|198
2564341|NCT00470158|6287194|P3|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
2564342|NCT00470158|6287195|P2|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|199
2564343|NCT00470158|6287196|P1|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
2564344|NCT00470106|6287212|P4|NOT COMPLETED|Overall Study||2
2564345|NCT00470106|6287213|P3|NOT COMPLETED|Overall Study||7
2564346|NCT00470106|6287214|P2|NOT COMPLETED|Overall Study||5
2564347|NCT00470106|6287215|P1|NOT COMPLETED|Overall Study||3
2564348|NCT00470106|6287212|P4|COMPLETED|Overall Study||19
2564349|NCT00470106|6287213|P3|COMPLETED|Overall Study||14
2564350|NCT00470106|6287214|P2|COMPLETED|Overall Study||19
2564351|NCT00470106|6287215|P1|COMPLETED|Overall Study||16
2564352|NCT00470106|6287212|P4|STARTED|Overall Study||21
2564353|NCT00470106|6287213|P3|STARTED|Overall Study||21
2564354|NCT00470106|6287214|P2|STARTED|Overall Study||24
2564355|NCT00470106|6287215|P1|STARTED|Overall Study||19
2564356|NCT00470093|6287229|P1|NOT COMPLETED|Overall Study||2
2564357|NCT00470093|6287229|P1|COMPLETED|Overall Study||0
2564358|NCT00470093|6287229|P1|STARTED|Overall Study||2
2564359|NCT00470067|6287236|P1|NOT COMPLETED|Overall Study||7
2564360|NCT00470067|6287236|P1|COMPLETED|Overall Study||2
2564361|NCT00470067|6287236|P1|STARTED|Overall Study||9
2564362|NCT00470054|6287240|P1|NOT COMPLETED|Overall Study||1
2564363|NCT00470054|6287240|P1|COMPLETED|Overall Study||43
2564364|NCT00470054|6287240|P1|STARTED|Overall Study||44
2564365|NCT00469911|6287250|P2|NOT COMPLETED|Overall Study||0
2564366|NCT00469911|6287251|P1|NOT COMPLETED|Overall Study||0
2564367|NCT00469911|6287250|P2|COMPLETED|Overall Study||10
2564368|NCT00469911|6287251|P1|COMPLETED|Overall Study||8
2564369|NCT00469911|6287250|P2|STARTED|Overall Study||10
2564370|NCT00469911|6287251|P1|STARTED|Overall Study||8
2564371|NCT00469898|6287256|P1|NOT COMPLETED|Overall Study||25
2564372|NCT00469898|6287256|P1|COMPLETED|Overall Study||25
2564373|NCT00469898|6287256|P1|STARTED|Overall Study||50
2564374|NCT00469859|6287265|P2|NOT COMPLETED|Overall Study||2
2564375|NCT00469859|6287266|P1|NOT COMPLETED|Overall Study||0
2564376|NCT00469859|6287265|P2|COMPLETED|Overall Study||6
2564377|NCT00469859|6287266|P1|COMPLETED|Overall Study||6
2564378|NCT00469859|6287265|P2|STARTED|Overall Study||8
2564379|NCT00469859|6287266|P1|STARTED|Overall Study||6
2564380|NCT00469833|6287274|P1|NOT COMPLETED|Overall Study||2
2564381|NCT00469833|6287274|P1|COMPLETED|Overall Study||15
2564382|NCT00469833|6287274|P1|STARTED|Overall Study|17 subjects met inclusion criteria and consented for the study|17
2564383|NCT00469612|6287286|P2|NOT COMPLETED|Overall Study||0
2564384|NCT00469612|6287287|P1|NOT COMPLETED|Overall Study||2
2564385|NCT00469612|6287286|P2|COMPLETED|Overall Study||0
2564386|NCT00469612|6287287|P1|COMPLETED|Overall Study|Subjects enrolled, but no data collected. Study terminated before data collection.|0
2564387|NCT00469612|6287286|P2|STARTED|Overall Study||0
2564388|NCT00469612|6287287|P1|STARTED|Overall Study||2
2564389|NCT00469508|6287299|P2|NOT COMPLETED|Overall Study||24
2564390|NCT00469508|6287300|P1|NOT COMPLETED|Overall Study||20
2564391|NCT00469508|6287299|P2|COMPLETED|Overall Study||13
2564392|NCT00469508|6287300|P1|COMPLETED|Overall Study||14
2564393|NCT00469508|6287299|P2|STARTED|Overall Study||37
2564394|NCT00469508|6287300|P1|STARTED|Overall Study||34
2564395|NCT00469456|6287314|P2|NOT COMPLETED|Overall Study||4
2564396|NCT00469456|6287315|P1|NOT COMPLETED|Overall Study||9
2564397|NCT00469456|6287314|P2|COMPLETED|Overall Study||131
2564398|NCT00469456|6287315|P1|COMPLETED|Overall Study||120
2564399|NCT00469456|6287314|P2|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug.|135
2564400|NCT00469456|6287315|P1|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|129
2564401|NCT00469391|6287325|P2|NOT COMPLETED|Overall Study||5
2564402|NCT00469391|6287326|P1|NOT COMPLETED|Overall Study||14
2564403|NCT00469391|6287325|P2|COMPLETED|Overall Study||24
2564404|NCT00469391|6287326|P1|COMPLETED|Overall Study||13
2564405|NCT00469391|6287325|P2|Patient Preference|Overall Study||1
2564406|NCT00469391|6287326|P1|Patient Preference|Overall Study||0
2564407|NCT00469391|6287325|P2|Lost to Follow up|Overall Study||1
2564408|NCT00469391|6287326|P1|Lost to Follow up|Overall Study||0
2564409|NCT00469391|6287325|P2|Adverse Event|Overall Study||0
2564410|NCT00469391|6287326|P1|Adverse Event|Overall Study||8
2564411|NCT00469391|6287325|P2|Unsuccessful Implant Procedure|Overall Study||0
2564412|NCT00469391|6287326|P1|Unsuccessful Implant Procedure|Overall Study||4
2564413|NCT00469391|6287325|P2|Discontinued Prior to Procedure|Overall Study||3
2564414|NCT00469391|6287326|P1|Discontinued Prior to Procedure|Overall Study||2
2564415|NCT00469391|6287325|P2|STARTED|Overall Study||29
2564416|NCT00469391|6287326|P1|STARTED|Overall Study||27
2564417|NCT00469274|6287334|P2|NOT COMPLETED|Overall Study||0
2564418|NCT00469274|6287335|P1|NOT COMPLETED|Overall Study||0
2564419|NCT00469274|6287334|P2|COMPLETED|Overall Study||42
2564420|NCT00469274|6287335|P1|COMPLETED|Overall Study||44
2564421|NCT00469274|6287334|P2|STARTED|Overall Study||42
2564422|NCT00469274|6287335|P1|STARTED|Overall Study||44
2564423|NCT00469209|6287344|P3|NOT COMPLETED|Overall Study||1
2564424|NCT00469209|6287345|P2|NOT COMPLETED|Overall Study||0
2564425|NCT00469209|6287346|P1|NOT COMPLETED|Overall Study||1
2564426|NCT00469209|6287344|P3|COMPLETED|Overall Study||19
2564427|NCT00469209|6287345|P2|COMPLETED|Overall Study||20
2564428|NCT00469209|6287346|P1|COMPLETED|Overall Study||19
2564429|NCT00469209|6287344|P3|STARTED|Overall Study||20
2564430|NCT00469209|6287345|P2|STARTED|Overall Study||20
2564431|NCT00469209|6287346|P1|STARTED|Overall Study||20
2564432|NCT00469092|6287356|P2|NOT COMPLETED|Overall Study||21
2564433|NCT00469092|6287357|P1|NOT COMPLETED|Overall Study||26
2564434|NCT00469092|6287356|P2|COMPLETED|Overall Study||220
2564435|NCT00469092|6287357|P1|COMPLETED|Overall Study||213
2564436|NCT00469092|6287356|P2|Exposed to Study Drug|Overall Study||238
2564437|NCT00469092|6287357|P1|Exposed to Study Drug|Overall Study||231
2564438|NCT00469092|6287356|P2|STARTED|Overall Study||241
2564439|NCT00469092|6287357|P1|STARTED|Overall Study||239
2564440|NCT00469079|6287376|P3|NOT COMPLETED|Overall Study||19
2564441|NCT00469079|6287377|P2|NOT COMPLETED|Overall Study||22
2564442|NCT00469079|6287378|P1|NOT COMPLETED|Overall Study||9
2564443|NCT00469079|6287376|P3|COMPLETED|Overall Study||32
2564444|NCT00469079|6287377|P2|COMPLETED|Overall Study||30
2564445|NCT00469079|6287378|P1|COMPLETED|Overall Study||18
2564446|NCT00469079|6287376|P3|STARTED|Overall Study||51
2564447|NCT00469079|6287377|P2|STARTED|Overall Study||52
2564448|NCT00469079|6287378|P1|STARTED|Overall Study||27
2564449|NCT00468910|6287397|P2|NOT COMPLETED|Overall Study||3
2564450|NCT00468910|6287398|P1|NOT COMPLETED|Overall Study||4
2564451|NCT00468910|6287397|P2|COMPLETED|Overall Study||36
2564452|NCT00468910|6287398|P1|COMPLETED|Overall Study||36
2564453|NCT00468910|6287397|P2|Follow-up|Overall Study||36
2564454|NCT00468910|6287398|P1|Follow-up|Overall Study||36
2564455|NCT00468910|6287397|P2|Post-Treatment Biopsy|Overall Study||36
2564456|NCT00468910|6287398|P1|Post-Treatment Biopsy|Overall Study||36
2564457|NCT00468910|6287397|P2|Treatment|Overall Study||36
2564458|NCT00468910|6287398|P1|Treatment|Overall Study||36
2564459|NCT00468910|6287397|P2|Randomization|Overall Study||39
2564460|NCT00468910|6287398|P1|Randomization|Overall Study||40
2564461|NCT00468910|6287397|P2|STARTED|Overall Study||39
2564462|NCT00468910|6287398|P1|STARTED|Overall Study||40
2564463|NCT00468858|6287417|P3|NOT COMPLETED|Overall Study||14
2564464|NCT00468858|6287418|P2|NOT COMPLETED|Overall Study||10
2564465|NCT00468858|6287419|P1|NOT COMPLETED|Overall Study||9
2564466|NCT00468858|6287417|P3|COMPLETED|Overall Study||199
2564467|NCT00468858|6287418|P2|COMPLETED|Overall Study||202
2564468|NCT00468858|6287419|P1|COMPLETED|Overall Study||202
2564469|NCT00468858|6287417|P3|STARTED|Overall Study||213
2564470|NCT00468858|6287418|P2|STARTED|Overall Study||212
2564471|NCT00468858|6287419|P1|STARTED|Overall Study||211
2564472|NCT00468845|6287540|P3|NOT COMPLETED|Overall Study||30
2564473|NCT00468845|6287541|P2|NOT COMPLETED|Overall Study||34
2564474|NCT00468845|6287542|P1|NOT COMPLETED|Overall Study||21
2564475|NCT00468845|6287540|P3|COMPLETED|Overall Study||139
2564476|NCT00468845|6287541|P2|COMPLETED|Overall Study||136
2564477|NCT00468845|6287542|P1|COMPLETED|Overall Study||141
2564478|NCT00468845|6287540|P3|Received Treatment|Overall Study||167
2564479|NCT00468845|6287541|P2|Received Treatment|Overall Study||166
2564480|NCT00468845|6287542|P1|Received Treatment|Overall Study||161
2564481|NCT00468845|6287540|P3|STARTED|Overall Study||169
2564482|NCT00468845|6287541|P2|STARTED|Overall Study||170
2564483|NCT00468845|6287542|P1|STARTED|Overall Study||162
2564484|NCT00468819|6287679|P3|NOT COMPLETED|Overall Study||2
2564485|NCT00468819|6287680|P2|NOT COMPLETED|Overall Study||0
2564486|NCT00468819|6287681|P1|NOT COMPLETED|Overall Study||6
2564487|NCT00468819|6287679|P3|COMPLETED|Overall Study||46
2564488|NCT00468819|6287680|P2|COMPLETED|Overall Study||44
2564489|NCT00468819|6287681|P1|COMPLETED|Overall Study||42
2564490|NCT00468819|6287679|P3|Treatment Received/ Safety Follow-up|Overall Study|FAS|48
2564491|NCT00468819|6287680|P2|Treatment Received/ Safety Follow-up|Overall Study|FAS|44
2564492|NCT00468819|6287681|P1|Treatment Received/ Safety Follow-up|Overall Study|FAS (Full Analysis Set)|46
2564493|NCT00468819|6287679|P3|STARTED|Overall Study|Enrolled participants|48
2564494|NCT00468819|6287680|P2|STARTED|Overall Study|Enrolled participants|44
2564495|NCT00468819|6287681|P1|STARTED|Overall Study|Enrolled participants|48
2564496|NCT00468728|6287761|P2|NOT COMPLETED|Follow-up||31
2564497|NCT00468728|6287762|P1|NOT COMPLETED|Follow-up||34
2564498|NCT00468728|6287761|P2|COMPLETED|Follow-up||222
2564499|NCT00468728|6287762|P1|COMPLETED|Follow-up||222
2564500|NCT00468728|6287761|P2|STARTED|Follow-up||253
2564501|NCT00468728|6287762|P1|STARTED|Follow-up||256
2564502|NCT00468728|6287761|P2|NOT COMPLETED|Treatment||11
2564503|NCT00468728|6287762|P1|NOT COMPLETED|Treatment||4
2564504|NCT00468728|6287761|P2|COMPLETED|Treatment||253
2564505|NCT00468728|6287762|P1|COMPLETED|Treatment||256
2564506|NCT00468728|6287761|P2|STARTED|Treatment||264
2564507|NCT00468728|6287762|P1|STARTED|Treatment||260
2564508|NCT00468728|6287761|P2|NOT COMPLETED|Enrollment||7
2564509|NCT00468728|6287762|P1|NOT COMPLETED|Enrollment||4
2564510|NCT00468728|6287761|P2|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|264
2564511|NCT00468728|6287762|P1|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|260
2564512|NCT00468728|6287761|P2|STARTED|Enrollment||271
2564513|NCT00468728|6287762|P1|STARTED|Enrollment||264
2564514|NCT00468676|6287774|P2|NOT COMPLETED|Overall Study||12
2564515|NCT00468676|6287775|P1|NOT COMPLETED|Overall Study||16
2564516|NCT00468676|6287774|P2|COMPLETED|Overall Study||94
2564517|NCT00468676|6287775|P1|COMPLETED|Overall Study||92
2564518|NCT00468676|6287774|P2|STARTED|Overall Study||106
2564519|NCT00468676|6287775|P1|STARTED|Overall Study||108
2564520|NCT00468650|6287792|P1|NOT COMPLETED|Overall Study||7
2564521|NCT00468650|6287792|P1|COMPLETED|Overall Study||110
2564522|NCT00468650|6287792|P1|STARTED|Overall Study||117
2564523|NCT00468585|6287840|P4|NOT COMPLETED|Overall Study||1
2564524|NCT00468585|6287841|P3|NOT COMPLETED|Overall Study||5
2564525|NCT00468585|6287842|P2|NOT COMPLETED|Overall Study||0
2564526|NCT00468585|6287843|P1|NOT COMPLETED|Overall Study||1
2564527|NCT00468585|6287840|P4|COMPLETED|Overall Study||5
2564528|NCT00468585|6287841|P3|COMPLETED|Overall Study||45
2564529|NCT00468585|6287842|P2|COMPLETED|Overall Study||3
2564530|NCT00468585|6287843|P1|COMPLETED|Overall Study||3
2564531|NCT00468585|6287840|P4|STARTED|Overall Study||6
2564532|NCT00468585|6287841|P3|STARTED|Overall Study||50
2564533|NCT00468585|6287842|P2|STARTED|Overall Study||3
2564534|NCT00468585|6287843|P1|STARTED|Overall Study||4
2564535|NCT00468559|6287855|P3|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||17
2564536|NCT00468559|6287856|P2|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||10
2564537|NCT00468559|6287857|P1|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||0
2564538|NCT00468559|6287855|P3|COMPLETED|Double-blind, Treatment-withdrawal Phase||24
2564539|NCT00468559|6287856|P2|COMPLETED|Double-blind, Treatment-withdrawal Phase||29
2564540|NCT00468559|6287857|P1|COMPLETED|Double-blind, Treatment-withdrawal Phase||0
2564541|NCT00468559|6287855|P3|STARTED|Double-blind, Treatment-withdrawal Phase||41
2564542|NCT00468559|6287856|P2|STARTED|Double-blind, Treatment-withdrawal Phase||39
2564543|NCT00468559|6287857|P1|STARTED|Double-blind, Treatment-withdrawal Phase||0
2564544|NCT00468559|6287855|P3|NOT COMPLETED|Open-label Treatment Phase||0
2564545|NCT00468559|6287856|P2|NOT COMPLETED|Open-label Treatment Phase||0
2564546|NCT00468559|6287857|P1|NOT COMPLETED|Open-label Treatment Phase||18
2564547|NCT00468559|6287855|P3|COMPLETED|Open-label Treatment Phase||0
2564548|NCT00468559|6287856|P2|COMPLETED|Open-label Treatment Phase||0
2564549|NCT00468559|6287857|P1|COMPLETED|Open-label Treatment Phase|18 patients discontinued (were not randomized into the double-blind treatment withdrawal phase)|80
2564550|NCT00468559|6287855|P3|STARTED|Open-label Treatment Phase||0
2564551|NCT00468559|6287856|P2|STARTED|Open-label Treatment Phase||0
2564552|NCT00468559|6287857|P1|STARTED|Open-label Treatment Phase|All participants received open-label esomeprazole during this phase of the study|98
2564553|NCT00468546|6287885|P2|NOT COMPLETED|Week 24 to Week 104 Analysis||225
2564554|NCT00468546|6287886|P1|NOT COMPLETED|Week 24 to Week 104 Analysis||105
2564555|NCT00468546|6287885|P2|COMPLETED|Week 24 to Week 104 Analysis||83
2564556|NCT00468546|6287886|P1|COMPLETED|Week 24 to Week 104 Analysis||103
2564557|NCT00468546|6287885|P2|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed W24 analysis were entered in W24 to W104 analysis.|308
2564558|NCT00468546|6287886|P1|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed Week (W) 24 analysis were entered in W24 to W104 analysis.|208
2564559|NCT00468546|6287885|P2|NOT COMPLETED|Week 24 Analysis||55
2564560|NCT00468546|6287886|P1|NOT COMPLETED|Week 24 Analysis||97
2564561|NCT00468546|6287885|P2|COMPLETED|Week 24 Analysis||253
2564562|NCT00468546|6287886|P1|COMPLETED|Week 24 Analysis||111
2564563|NCT00468546|6287885|P2|STARTED|Week 24 Analysis||308
2564564|NCT00468546|6287886|P1|STARTED|Week 24 Analysis||208
2564565|NCT00468481|6287916|P2|NOT COMPLETED|Overall Study||24
2564566|NCT00468481|6287917|P1|NOT COMPLETED|Overall Study||88
2564567|NCT00468481|6287916|P2|COMPLETED|Overall Study||70
2564568|NCT00468481|6287917|P1|COMPLETED|Overall Study||203
2564569|NCT00468481|6287916|P2|Subjects Treated|Overall Study||94
2564570|NCT00468481|6287917|P1|Subjects Treated|Overall Study||285
2564571|NCT00468481|6287916|P2|STARTED|Overall Study||94
2564572|NCT00468481|6287917|P1|STARTED|Overall Study|6 of these randomized subjects did not take any study medication|291
2564573|NCT00468312|6288017|P2|NOT COMPLETED|Overall Study||5
2564574|NCT00468312|6288018|P1|NOT COMPLETED|Overall Study||4
2564575|NCT00468312|6288017|P2|COMPLETED|Overall Study||204
2564576|NCT00468312|6288018|P1|COMPLETED|Overall Study||216
2564577|NCT00468312|6288017|P2|STARTED|Overall Study||209
2564578|NCT00468312|6288018|P1|STARTED|Overall Study||220
2564579|NCT00468299|6288034|P2|NOT COMPLETED|Overall Study||1
2564580|NCT00468299|6288035|P1|NOT COMPLETED|Overall Study||0
2564581|NCT00468299|6288034|P2|COMPLETED|Overall Study||7
2564582|NCT00468299|6288035|P1|COMPLETED|Overall Study||9
2564583|NCT00468299|6288034|P2|STARTED|Overall Study||8
2564584|NCT00468299|6288035|P1|STARTED|Overall Study||9
2564585|NCT00468286|6288045|P2|NOT COMPLETED|Overall Study||12
2564586|NCT00468286|6288046|P1|NOT COMPLETED|Overall Study||7
2564587|NCT00468286|6288045|P2|COMPLETED|Overall Study||54
2564588|NCT00468286|6288046|P1|COMPLETED|Overall Study||60
2564589|NCT00468286|6288045|P2|STARTED|Overall Study||66
2564590|NCT00468286|6288046|P1|STARTED|Overall Study|Started=Intention to treat (ITT) population.|67
2564591|NCT00468208|6288068|P1|NOT COMPLETED|Overall Study||0
2564592|NCT00468208|6288068|P1|COMPLETED|Overall Study|All patients reached common closing or early termination|20
2564593|NCT00468208|6288068|P1|STARTED|Overall Study||20
2564594|NCT00468169|6288078|P2|NOT COMPLETED|Overall Study||0
2564595|NCT00468169|6288079|P1|NOT COMPLETED|Overall Study||1
2564596|NCT00468169|6288078|P2|COMPLETED|Overall Study||53
2564597|NCT00468169|6288079|P1|COMPLETED|Overall Study||56
2564598|NCT00468169|6288078|P2|STARTED|Overall Study||53
2564599|NCT00468169|6288079|P1|STARTED|Overall Study||57
2564600|NCT00468143|6288095|P2|NOT COMPLETED|Second Intervention (3 Weeks)||3
2564601|NCT00468143|6288096|P1|NOT COMPLETED|Second Intervention (3 Weeks)||3
2564602|NCT00468143|6288095|P2|COMPLETED|Second Intervention (3 Weeks)||24
2564603|NCT00468143|6288096|P1|COMPLETED|Second Intervention (3 Weeks)||25
2564604|NCT00468143|6288095|P2|STARTED|Second Intervention (3 Weeks)||27
2564605|NCT00468143|6288096|P1|STARTED|Second Intervention (3 Weeks)||28
2564606|NCT00468143|6288095|P2|NOT COMPLETED|First Intervention (3 Weeks)||4
2564607|NCT00468143|6288096|P1|NOT COMPLETED|First Intervention (3 Weeks)||3
2564608|NCT00468143|6288095|P2|COMPLETED|First Intervention (3 Weeks)||27
2564609|NCT00468143|6288096|P1|COMPLETED|First Intervention (3 Weeks)||28
2564610|NCT00468143|6288095|P2|STARTED|First Intervention (3 Weeks)||31
2564611|NCT00468143|6288096|P1|STARTED|First Intervention (3 Weeks)||31
2564612|NCT00468104|6288110|P2|NOT COMPLETED|Second Intervention||4
2564613|NCT00468104|6288111|P1|NOT COMPLETED|Second Intervention||5
2564614|NCT00468104|6288110|P2|COMPLETED|Second Intervention||37
2564615|NCT00468104|6288111|P1|COMPLETED|Second Intervention||3
2564616|NCT00468104|6288110|P2|STARTED|Second Intervention|4 patients responded to Placebo and did not go to the second intervention|41
2564617|NCT00468104|6288111|P1|STARTED|Second Intervention|37 responded to Alteplase and did not go to the second intervention|8
2564618|NCT00468104|6288110|P2|NOT COMPLETED|First Intervention||1
2564619|NCT00468104|6288111|P1|NOT COMPLETED|First Intervention||9
2564620|NCT00468104|6288110|P2|COMPLETED|First Intervention||45
2564621|NCT00468104|6288111|P1|COMPLETED|First Intervention||45
2564622|NCT00468104|6288110|P2|STARTED|First Intervention||46
2564623|NCT00468104|6288111|P1|STARTED|First Intervention||54
2564624|NCT00468052|6288128|P2|NOT COMPLETED|Overall Study||8
2564625|NCT00468052|6288129|P1|NOT COMPLETED|Overall Study||7
2564626|NCT00468052|6288128|P2|COMPLETED|Overall Study||61
2564627|NCT00468052|6288129|P1|COMPLETED|Overall Study||61
2564628|NCT00468052|6288128|P2|Target Enrollment|Overall Study||70
2564629|NCT00468052|6288129|P1|Target Enrollment|Overall Study||70
2564630|NCT00468052|6288128|P2|STARTED|Overall Study|One had an intraoperative complication and was withdrawn. 7 eliminated for a break in protocol.|69
2564631|NCT00468052|6288129|P1|STARTED|Overall Study|1 subject withdrew consent.Surgery was cancelled for 2. 4 subjects eliminated for break in protocol|68
2564632|NCT00467961|6288147|P1|NOT COMPLETED|Overall Study||7
2564633|NCT00467961|6288147|P1|COMPLETED|Overall Study||24
2564634|NCT00467961|6288147|P1|STARTED|Overall Study||31
2564635|NCT00467896|6288151|P1|NOT COMPLETED|Overall Study||51
2564636|NCT00467896|6288151|P1|COMPLETED|Overall Study||11
2564637|NCT00467896|6288151|P1|STARTED|Overall Study||62
2564638|NCT00467870|6288177|P6|NOT COMPLETED|Overall Study||2
2564639|NCT00467870|6288178|P5|NOT COMPLETED|Overall Study||37
2564640|NCT00467870|6288179|P4|NOT COMPLETED|Overall Study||33
2564641|NCT00467870|6288180|P3|NOT COMPLETED|Overall Study||4
2564642|NCT00467870|6288181|P2|NOT COMPLETED|Overall Study||43
2564643|NCT00467870|6288182|P1|NOT COMPLETED|Overall Study||45
2564644|NCT00467870|6288177|P6|COMPLETED|Overall Study||21
2564645|NCT00467870|6288178|P5|COMPLETED|Overall Study||93
2564646|NCT00467870|6288179|P4|COMPLETED|Overall Study||79
2564647|NCT00467870|6288180|P3|COMPLETED|Overall Study||18
2564648|NCT00467870|6288181|P2|COMPLETED|Overall Study||74
2564649|NCT00467870|6288182|P1|COMPLETED|Overall Study||75
2564650|NCT00467870|6288177|P6|STARTED|Overall Study||23
2564651|NCT00467870|6288178|P5|STARTED|Overall Study||130
2564652|NCT00467870|6288179|P4|STARTED|Overall Study||112
2564653|NCT00467870|6288180|P3|STARTED|Overall Study||22
2564654|NCT00467870|6288181|P2|STARTED|Overall Study||117
2564655|NCT00467870|6288182|P1|STARTED|Overall Study||120
2564656|NCT00467857|6288225|P2|NOT COMPLETED|Overall Study||8
2564657|NCT00467857|6288226|P1|NOT COMPLETED|Overall Study||3
2564658|NCT00467857|6288225|P2|COMPLETED|Overall Study||139
2564659|NCT00467857|6288226|P1|COMPLETED|Overall Study||143
2564660|NCT00467857|6288225|P2|STARTED|Overall Study||147
2564661|NCT00467857|6288226|P1|STARTED|Overall Study||146
2564662|NCT00467844|6288261|P3|NOT COMPLETED|Overall Study||14
2564663|NCT00467844|6288262|P2|NOT COMPLETED|Overall Study||20
2564664|NCT00467844|6288263|P1|NOT COMPLETED|Overall Study||19
2564665|NCT00467844|6288261|P3|COMPLETED|Overall Study||38
2564666|NCT00467844|6288262|P2|COMPLETED|Overall Study||34
2564667|NCT00467844|6288263|P1|COMPLETED|Overall Study||34
2564668|NCT00467844|6288261|P3|STARTED|Overall Study||52
2564669|NCT00467844|6288262|P2|STARTED|Overall Study||54
2564670|NCT00467844|6288263|P1|STARTED|Overall Study||53
2564671|NCT00467831|6288274|P1|NOT COMPLETED|Overall Study||3
2564672|NCT00467831|6288274|P1|COMPLETED|Overall Study||0
2564673|NCT00467831|6288274|P1|STARTED|Overall Study||3
2564674|NCT00467779|6288293|P15|NOT COMPLETED|Stage 3||17
2564675|NCT00467779|6288294|P14|NOT COMPLETED|Stage 3||0
2564676|NCT00467779|6288295|P13|NOT COMPLETED|Stage 3||0
2564677|NCT00467779|6288296|P12|NOT COMPLETED|Stage 3||0
2564678|NCT00467779|6288297|P11|NOT COMPLETED|Stage 3||0
2564679|NCT00467779|6288298|P10|NOT COMPLETED|Stage 3||0
2564680|NCT00467779|6288299|P9|NOT COMPLETED|Stage 3||0
2564681|NCT00467779|6288300|P8|NOT COMPLETED|Stage 3||0
2564682|NCT00467779|6288301|P7|NOT COMPLETED|Stage 3||0
2564683|NCT00467779|6288302|P6|NOT COMPLETED|Stage 3||0
2564684|NCT00467779|6288303|P5|NOT COMPLETED|Stage 3||0
2564685|NCT00467779|6288304|P4|NOT COMPLETED|Stage 3||0
2564686|NCT00467779|6288305|P3|NOT COMPLETED|Stage 3||0
2564687|NCT00467779|6288306|P2|NOT COMPLETED|Stage 3||0
2564688|NCT00467779|6288307|P1|NOT COMPLETED|Stage 3||0
2564689|NCT00467779|6288293|P15|COMPLETED|Stage 3||3
2564690|NCT00467779|6288294|P14|COMPLETED|Stage 3||0
2564691|NCT00467779|6288295|P13|COMPLETED|Stage 3||0
2564692|NCT00467779|6288296|P12|COMPLETED|Stage 3||0
2564693|NCT00467779|6288297|P11|COMPLETED|Stage 3||0
2564694|NCT00467779|6288298|P10|COMPLETED|Stage 3||0
2564695|NCT00467779|6288299|P9|COMPLETED|Stage 3||0
2564696|NCT00467779|6288300|P8|COMPLETED|Stage 3||0
2564697|NCT00467779|6288301|P7|COMPLETED|Stage 3||0
2564698|NCT00467779|6288302|P6|COMPLETED|Stage 3||0
2564699|NCT00467779|6288303|P5|COMPLETED|Stage 3||0
2564700|NCT00467779|6288304|P4|COMPLETED|Stage 3||0
2564701|NCT00467779|6288305|P3|COMPLETED|Stage 3||0
2564702|NCT00467779|6288306|P2|COMPLETED|Stage 3||0
2564703|NCT00467779|6288307|P1|COMPLETED|Stage 3||0
2564704|NCT00467779|6288293|P15|STARTED|Stage 3||20
2564705|NCT00467779|6288294|P14|STARTED|Stage 3||0
2564706|NCT00467779|6288295|P13|STARTED|Stage 3||0
2564707|NCT00467779|6288296|P12|STARTED|Stage 3||0
2564708|NCT00467779|6288297|P11|STARTED|Stage 3||0
2564709|NCT00467779|6288298|P10|STARTED|Stage 3||0
2564710|NCT00467779|6288299|P9|STARTED|Stage 3||0
2564711|NCT00467779|6288300|P8|STARTED|Stage 3||0
2564712|NCT00467779|6288301|P7|STARTED|Stage 3||0
2564713|NCT00467779|6288302|P6|STARTED|Stage 3||0
2564714|NCT00467779|6288303|P5|STARTED|Stage 3||0
2564715|NCT00467779|6288304|P4|STARTED|Stage 3||0
2564716|NCT00467779|6288305|P3|STARTED|Stage 3||0
2564717|NCT00467779|6288306|P2|STARTED|Stage 3||0
2564718|NCT00467779|6288307|P1|STARTED|Stage 3||0
2564719|NCT00467779|6288293|P15|NOT COMPLETED|Stage 2A||0
2564720|NCT00467779|6288294|P14|NOT COMPLETED|Stage 2A||21
2564721|NCT00467779|6288295|P13|NOT COMPLETED|Stage 2A||0
2564722|NCT00467779|6288296|P12|NOT COMPLETED|Stage 2A||0
2564723|NCT00467779|6288297|P11|NOT COMPLETED|Stage 2A||0
2564724|NCT00467779|6288298|P10|NOT COMPLETED|Stage 2A||0
2564725|NCT00467779|6288299|P9|NOT COMPLETED|Stage 2A||0
2564726|NCT00467779|6288300|P8|NOT COMPLETED|Stage 2A||0
2564727|NCT00467779|6288301|P7|NOT COMPLETED|Stage 2A||0
2564728|NCT00467779|6288302|P6|NOT COMPLETED|Stage 2A||0
2564729|NCT00467779|6288303|P5|NOT COMPLETED|Stage 2A||0
2564730|NCT00467779|6288304|P4|NOT COMPLETED|Stage 2A||0
2564731|NCT00467779|6288305|P3|NOT COMPLETED|Stage 2A||0
2564732|NCT00467779|6288306|P2|NOT COMPLETED|Stage 2A||0
2564733|NCT00467779|6288307|P1|NOT COMPLETED|Stage 2A||0
2564734|NCT00467779|6288293|P15|COMPLETED|Stage 2A||0
2564735|NCT00467779|6288294|P14|COMPLETED|Stage 2A||1
2564736|NCT00467779|6288295|P13|COMPLETED|Stage 2A||0
2564737|NCT00467779|6288296|P12|COMPLETED|Stage 2A||0
2564738|NCT00467779|6288297|P11|COMPLETED|Stage 2A||0
2564739|NCT00467779|6288298|P10|COMPLETED|Stage 2A||0
2564740|NCT00467779|6288299|P9|COMPLETED|Stage 2A||0
2564741|NCT00467779|6288300|P8|COMPLETED|Stage 2A||0
2564742|NCT00467779|6288301|P7|COMPLETED|Stage 2A||0
2564743|NCT00467779|6288302|P6|COMPLETED|Stage 2A||0
2564744|NCT00467779|6288303|P5|COMPLETED|Stage 2A||0
2564745|NCT00467779|6288304|P4|COMPLETED|Stage 2A||0
2564746|NCT00467779|6288305|P3|COMPLETED|Stage 2A||0
2564747|NCT00467779|6288306|P2|COMPLETED|Stage 2A||0
2564748|NCT00467779|6288307|P1|COMPLETED|Stage 2A||0
2564749|NCT00467779|6288293|P15|STARTED|Stage 2A||0
2564750|NCT00467779|6288294|P14|STARTED|Stage 2A||22
2564751|NCT00467779|6288295|P13|STARTED|Stage 2A||0
2564752|NCT00467779|6288296|P12|STARTED|Stage 2A||0
2564753|NCT00467779|6288297|P11|STARTED|Stage 2A||0
2564754|NCT00467779|6288298|P10|STARTED|Stage 2A||0
2564755|NCT00467779|6288299|P9|STARTED|Stage 2A||0
2564756|NCT00467779|6288300|P8|STARTED|Stage 2A||0
2564757|NCT00467779|6288301|P7|STARTED|Stage 2A||0
2564758|NCT00467779|6288302|P6|STARTED|Stage 2A||0
2564759|NCT00467779|6288303|P5|STARTED|Stage 2A||0
2564760|NCT00467779|6288304|P4|STARTED|Stage 2A||0
2564761|NCT00467779|6288305|P3|STARTED|Stage 2A||0
2564762|NCT00467779|6288306|P2|STARTED|Stage 2A||0
2564763|NCT00467779|6288307|P1|STARTED|Stage 2A||0
2564764|NCT00467779|6288293|P15|NOT COMPLETED|Stage 2||0
2564765|NCT00467779|6288294|P14|NOT COMPLETED|Stage 2||0
2564766|NCT00467779|6288295|P13|NOT COMPLETED|Stage 2||0
2564767|NCT00467779|6288296|P12|NOT COMPLETED|Stage 2||0
2564768|NCT00467779|6288297|P11|NOT COMPLETED|Stage 2||0
2564769|NCT00467779|6288298|P10|NOT COMPLETED|Stage 2||0
2564770|NCT00467779|6288299|P9|NOT COMPLETED|Stage 2||21
2564771|NCT00467779|6288300|P8|NOT COMPLETED|Stage 2||0
2564772|NCT00467779|6288301|P7|NOT COMPLETED|Stage 2||0
2564773|NCT00467779|6288302|P6|NOT COMPLETED|Stage 2||0
2564774|NCT00467779|6288303|P5|NOT COMPLETED|Stage 2||0
2564775|NCT00467779|6288304|P4|NOT COMPLETED|Stage 2||0
2564776|NCT00467779|6288305|P3|NOT COMPLETED|Stage 2||0
2564777|NCT00467779|6288306|P2|NOT COMPLETED|Stage 2||0
2564778|NCT00467779|6288307|P1|NOT COMPLETED|Stage 2||0
2564779|NCT00467779|6288293|P15|COMPLETED|Stage 2||0
2564780|NCT00467779|6288294|P14|COMPLETED|Stage 2||0
2564781|NCT00467779|6288295|P13|COMPLETED|Stage 2||0
2564782|NCT00467779|6288296|P12|COMPLETED|Stage 2||0
2564783|NCT00467779|6288297|P11|COMPLETED|Stage 2||0
2564784|NCT00467779|6288298|P10|COMPLETED|Stage 2||0
2564785|NCT00467779|6288299|P9|COMPLETED|Stage 2||0
2564786|NCT00467779|6288300|P8|COMPLETED|Stage 2||0
2564787|NCT00467779|6288301|P7|COMPLETED|Stage 2||0
2564788|NCT00467779|6288302|P6|COMPLETED|Stage 2||0
2564789|NCT00467779|6288303|P5|COMPLETED|Stage 2||0
2564790|NCT00467779|6288304|P4|COMPLETED|Stage 2||0
2564791|NCT00467779|6288305|P3|COMPLETED|Stage 2||0
2564792|NCT00467779|6288306|P2|COMPLETED|Stage 2||0
2564793|NCT00467779|6288307|P1|COMPLETED|Stage 2||0
2564794|NCT00467779|6288293|P15|STARTED|Stage 2||0
2564795|NCT00467779|6288294|P14|STARTED|Stage 2||0
2564796|NCT00467779|6288295|P13|STARTED|Stage 2||0
2564797|NCT00467779|6288296|P12|STARTED|Stage 2||0
2564798|NCT00467779|6288297|P11|STARTED|Stage 2||0
2564799|NCT00467779|6288298|P10|STARTED|Stage 2||0
2564800|NCT00467779|6288299|P9|STARTED|Stage 2||21
2564801|NCT00467779|6288300|P8|STARTED|Stage 2||0
2564802|NCT00467779|6288301|P7|STARTED|Stage 2||0
2564803|NCT00467779|6288302|P6|STARTED|Stage 2||0
2564804|NCT00467779|6288303|P5|STARTED|Stage 2||0
2564805|NCT00467779|6288304|P4|STARTED|Stage 2||0
2564806|NCT00467779|6288305|P3|STARTED|Stage 2||0
2564807|NCT00467779|6288306|P2|STARTED|Stage 2||0
2564808|NCT00467779|6288307|P1|STARTED|Stage 2||0
2564809|NCT00467779|6288293|P15|NOT COMPLETED|Stage 1A||0
2564810|NCT00467779|6288294|P14|NOT COMPLETED|Stage 1A||0
2564811|NCT00467779|6288295|P13|NOT COMPLETED|Stage 1A||6
2564812|NCT00467779|6288296|P12|NOT COMPLETED|Stage 1A||8
2564813|NCT00467779|6288297|P11|NOT COMPLETED|Stage 1A||3
2564814|NCT00467779|6288298|P10|NOT COMPLETED|Stage 1A||3
2564815|NCT00467779|6288299|P9|NOT COMPLETED|Stage 1A||0
2564816|NCT00467779|6288300|P8|NOT COMPLETED|Stage 1A||0
2564817|NCT00467779|6288301|P7|NOT COMPLETED|Stage 1A||0
2564818|NCT00467779|6288302|P6|NOT COMPLETED|Stage 1A||0
2564819|NCT00467779|6288303|P5|NOT COMPLETED|Stage 1A||0
2564820|NCT00467779|6288304|P4|NOT COMPLETED|Stage 1A||0
2564821|NCT00467779|6288305|P3|NOT COMPLETED|Stage 1A||0
2564822|NCT00467779|6288306|P2|NOT COMPLETED|Stage 1A||0
2564823|NCT00467779|6288307|P1|NOT COMPLETED|Stage 1A||0
2564824|NCT00467779|6288293|P15|COMPLETED|Stage 1A||0
2564825|NCT00467779|6288294|P14|COMPLETED|Stage 1A||0
2564826|NCT00467779|6288295|P13|COMPLETED|Stage 1A||0
2564827|NCT00467779|6288296|P12|COMPLETED|Stage 1A||0
2564828|NCT00467779|6288297|P11|COMPLETED|Stage 1A||0
2564829|NCT00467779|6288298|P10|COMPLETED|Stage 1A||0
2564830|NCT00467779|6288299|P9|COMPLETED|Stage 1A||0
2564831|NCT00467779|6288300|P8|COMPLETED|Stage 1A||0
2564832|NCT00467779|6288301|P7|COMPLETED|Stage 1A||0
2564833|NCT00467779|6288302|P6|COMPLETED|Stage 1A||0
2564834|NCT00467779|6288303|P5|COMPLETED|Stage 1A||0
2564835|NCT00467779|6288304|P4|COMPLETED|Stage 1A||0
2564836|NCT00467779|6288305|P3|COMPLETED|Stage 1A||0
2564837|NCT00467779|6288306|P2|COMPLETED|Stage 1A||0
2564838|NCT00467779|6288307|P1|COMPLETED|Stage 1A||0
2564839|NCT00467779|6288293|P15|STARTED|Stage 1A||0
2564840|NCT00467779|6288294|P14|STARTED|Stage 1A||0
2564841|NCT00467779|6288295|P13|STARTED|Stage 1A||6
2564842|NCT00467779|6288296|P12|STARTED|Stage 1A||8
2564843|NCT00467779|6288297|P11|STARTED|Stage 1A||3
2564844|NCT00467779|6288298|P10|STARTED|Stage 1A||3
2564845|NCT00467779|6288299|P9|STARTED|Stage 1A||0
2564846|NCT00467779|6288300|P8|STARTED|Stage 1A||0
2564847|NCT00467779|6288301|P7|STARTED|Stage 1A||0
2564848|NCT00467779|6288302|P6|STARTED|Stage 1A||0
2564849|NCT00467779|6288303|P5|STARTED|Stage 1A||0
2564850|NCT00467779|6288304|P4|STARTED|Stage 1A||0
2564851|NCT00467779|6288305|P3|STARTED|Stage 1A||0
2564852|NCT00467779|6288306|P2|STARTED|Stage 1A||0
2564853|NCT00467779|6288307|P1|STARTED|Stage 1A||0
2564854|NCT00467779|6288293|P15|NOT COMPLETED|Stage 1||0
2564855|NCT00467779|6288294|P14|NOT COMPLETED|Stage 1||0
2564856|NCT00467779|6288295|P13|NOT COMPLETED|Stage 1||0
2564857|NCT00467779|6288296|P12|NOT COMPLETED|Stage 1||0
2564858|NCT00467779|6288297|P11|NOT COMPLETED|Stage 1||0
2564859|NCT00467779|6288298|P10|NOT COMPLETED|Stage 1||0
2564860|NCT00467779|6288299|P9|NOT COMPLETED|Stage 1||0
2564861|NCT00467779|6288300|P8|NOT COMPLETED|Stage 1||7
2564862|NCT00467779|6288301|P7|NOT COMPLETED|Stage 1||7
2564863|NCT00467779|6288302|P6|NOT COMPLETED|Stage 1||5
2564864|NCT00467779|6288303|P5|NOT COMPLETED|Stage 1||3
2564865|NCT00467779|6288304|P4|NOT COMPLETED|Stage 1||3
2564866|NCT00467779|6288305|P3|NOT COMPLETED|Stage 1||3
2564867|NCT00467779|6288306|P2|NOT COMPLETED|Stage 1||3
2564868|NCT00467779|6288307|P1|NOT COMPLETED|Stage 1||4
2564869|NCT00467779|6288293|P15|COMPLETED|Stage 1||0
2564870|NCT00467779|6288294|P14|COMPLETED|Stage 1||0
2564871|NCT00467779|6288295|P13|COMPLETED|Stage 1||0
2564872|NCT00467779|6288296|P12|COMPLETED|Stage 1||0
2564873|NCT00467779|6288297|P11|COMPLETED|Stage 1||0
2564874|NCT00467779|6288298|P10|COMPLETED|Stage 1||0
2564875|NCT00467779|6288299|P9|COMPLETED|Stage 1||0
2564876|NCT00467779|6288300|P8|COMPLETED|Stage 1||0
2564877|NCT00467779|6288301|P7|COMPLETED|Stage 1||0
2564878|NCT00467779|6288302|P6|COMPLETED|Stage 1||1
2564879|NCT00467779|6288303|P5|COMPLETED|Stage 1||0
2564880|NCT00467779|6288304|P4|COMPLETED|Stage 1||0
2564881|NCT00467779|6288305|P3|COMPLETED|Stage 1||0
2564882|NCT00467779|6288306|P2|COMPLETED|Stage 1||0
2564883|NCT00467779|6288307|P1|COMPLETED|Stage 1||0
2564884|NCT00467779|6288293|P15|STARTED|Stage 1||0
2564885|NCT00467779|6288294|P14|STARTED|Stage 1||0
2564886|NCT00467779|6288295|P13|STARTED|Stage 1||0
2564887|NCT00467779|6288296|P12|STARTED|Stage 1||0
2564888|NCT00467779|6288297|P11|STARTED|Stage 1||0
2564889|NCT00467779|6288298|P10|STARTED|Stage 1||0
2564890|NCT00467779|6288299|P9|STARTED|Stage 1||0
2564891|NCT00467779|6288300|P8|STARTED|Stage 1||7
2564892|NCT00467779|6288301|P7|STARTED|Stage 1||7
2564893|NCT00467779|6288302|P6|STARTED|Stage 1||6
2564894|NCT00467779|6288303|P5|STARTED|Stage 1||3
2564895|NCT00467779|6288304|P4|STARTED|Stage 1||3
2564896|NCT00467779|6288305|P3|STARTED|Stage 1||3
2564897|NCT00467779|6288306|P2|STARTED|Stage 1||3
2564898|NCT00467779|6288307|P1|STARTED|Stage 1||4
2564899|NCT00467753|6288481|P2|NOT COMPLETED|Overall Study||2
2564900|NCT00467753|6288482|P1|NOT COMPLETED|Overall Study||3
2564901|NCT00467753|6288481|P2|COMPLETED|Overall Study||0
2564902|NCT00467753|6288482|P1|COMPLETED|Overall Study||0
2564903|NCT00467753|6288481|P2|STARTED|Overall Study||2
2564904|NCT00467753|6288482|P1|STARTED|Overall Study||3
2564905|NCT00467740|6288493|P5|NOT COMPLETED|Overall Study||0
2564906|NCT00467740|6288494|P4|NOT COMPLETED|Overall Study||1
2564907|NCT00467740|6288495|P3|NOT COMPLETED|Overall Study||2
2564908|NCT00467740|6288496|P2|NOT COMPLETED|Overall Study||3
2564909|NCT00467740|6288497|P1|NOT COMPLETED|Overall Study||1
2564910|NCT00467740|6288493|P5|COMPLETED|Overall Study||61
2564911|NCT00467740|6288494|P4|COMPLETED|Overall Study||59
2564912|NCT00467740|6288495|P3|COMPLETED|Overall Study||58
2564913|NCT00467740|6288496|P2|COMPLETED|Overall Study||58
2564914|NCT00467740|6288497|P1|COMPLETED|Overall Study||53
2564915|NCT00467740|6288493|P5|STARTED|Overall Study||61
2564916|NCT00467740|6288494|P4|STARTED|Overall Study||60
2564917|NCT00467740|6288495|P3|STARTED|Overall Study||60
2564918|NCT00467740|6288496|P2|STARTED|Overall Study||61
2564919|NCT00467740|6288497|P1|STARTED|Overall Study||54
2564920|NCT00467649|6288686|P6|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||1
2564921|NCT00467649|6288687|P5|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
2564922|NCT00467649|6288688|P4|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||2
2564923|NCT00467649|6288689|P3|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
2564924|NCT00467649|6288690|P2|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
2564925|NCT00467649|6288691|P1|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
2564926|NCT00467649|6288686|P6|COMPLETED|Phase 2 (Intent-to-Treat Population)||35
2564927|NCT00467649|6288687|P5|COMPLETED|Phase 2 (Intent-to-Treat Population)||14
2564928|NCT00467649|6288688|P4|COMPLETED|Phase 2 (Intent-to-Treat Population)||29
2564929|NCT00467649|6288689|P3|COMPLETED|Phase 2 (Intent-to-Treat Population)||17
2564930|NCT00467649|6288690|P2|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
2564931|NCT00467649|6288691|P1|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
2564932|NCT00467649|6288686|P6|STARTED|Phase 2 (Intent-to-Treat Population)||36
2564933|NCT00467649|6288687|P5|STARTED|Phase 2 (Intent-to-Treat Population)||14
2564934|NCT00467649|6288688|P4|STARTED|Phase 2 (Intent-to-Treat Population)||31
2564935|NCT00467649|6288689|P3|STARTED|Phase 2 (Intent-to-Treat Population)||17
2564936|NCT00467649|6288690|P2|STARTED|Phase 2 (Intent-to-Treat Population)||0
2564937|NCT00467649|6288691|P1|STARTED|Phase 2 (Intent-to-Treat Population)||0
2564938|NCT00467649|6288686|P6|NOT COMPLETED|Phase 1 (Randomized Population)||0
2564939|NCT00467649|6288687|P5|NOT COMPLETED|Phase 1 (Randomized Population)||0
2564940|NCT00467649|6288688|P4|NOT COMPLETED|Phase 1 (Randomized Population)||0
2564941|NCT00467649|6288689|P3|NOT COMPLETED|Phase 1 (Randomized Population)||0
2564942|NCT00467649|6288690|P2|NOT COMPLETED|Phase 1 (Randomized Population)||6
2564943|NCT00467649|6288691|P1|NOT COMPLETED|Phase 1 (Randomized Population)||9
2564944|NCT00467649|6288686|P6|COMPLETED|Phase 1 (Randomized Population)||0
2564945|NCT00467649|6288687|P5|COMPLETED|Phase 1 (Randomized Population)||0
2564946|NCT00467649|6288688|P4|COMPLETED|Phase 1 (Randomized Population)||0
2564947|NCT00467649|6288689|P3|COMPLETED|Phase 1 (Randomized Population)||0
2564948|NCT00467649|6288690|P2|COMPLETED|Phase 1 (Randomized Population)||50
2564949|NCT00467649|6288691|P1|COMPLETED|Phase 1 (Randomized Population)||48
2564950|NCT00467649|6288686|P6|Intent to Treat|Phase 1 (Randomized Population)||0
2564951|NCT00467649|6288687|P5|Intent to Treat|Phase 1 (Randomized Population)||0
2564952|NCT00467649|6288688|P4|Intent to Treat|Phase 1 (Randomized Population)||0
2564953|NCT00467649|6288689|P3|Intent to Treat|Phase 1 (Randomized Population)||0
2564954|NCT00467649|6288690|P2|Intent to Treat|Phase 1 (Randomized Population)||56
2564955|NCT00467649|6288691|P1|Intent to Treat|Phase 1 (Randomized Population)||56
2564956|NCT00467649|6288686|P6|STARTED|Phase 1 (Randomized Population)||0
2564957|NCT00467649|6288687|P5|STARTED|Phase 1 (Randomized Population)||0
2564958|NCT00467649|6288688|P4|STARTED|Phase 1 (Randomized Population)||0
2564959|NCT00467649|6288689|P3|STARTED|Phase 1 (Randomized Population)||0
2564960|NCT00467649|6288690|P2|STARTED|Phase 1 (Randomized Population)||56
2564961|NCT00467649|6288691|P1|STARTED|Phase 1 (Randomized Population)|One patient randomized to the SYMLIN group withdrew consent prior to receiving the first dose|57
2564962|NCT00467610|6288731|P1|NOT COMPLETED|Overall Study||1
2564963|NCT00467610|6288731|P1|COMPLETED|Overall Study||5
2564964|NCT00467610|6288731|P1|STARTED|Overall Study||6
2564965|NCT00467597|6288742|P2|NOT COMPLETED|Overall Study||0
2564966|NCT00467597|6288743|P1|NOT COMPLETED|Overall Study||2
2564967|NCT00467597|6288742|P2|COMPLETED|Overall Study||6
2564968|NCT00467597|6288743|P1|COMPLETED|Overall Study||24
2564969|NCT00467597|6288742|P2|STARTED|Overall Study||6
2564970|NCT00467597|6288743|P1|STARTED|Overall Study||26
2564971|NCT00467584|6288756|P3|NOT COMPLETED|Overall Study||1
2564972|NCT00467584|6288757|P2|NOT COMPLETED|Overall Study||5
2564973|NCT00467584|6288758|P1|NOT COMPLETED|Overall Study||4
2564974|NCT00467584|6288756|P3|COMPLETED|Overall Study||20
2564975|NCT00467584|6288757|P2|COMPLETED|Overall Study||15
2564976|NCT00467584|6288758|P1|COMPLETED|Overall Study||17
2564977|NCT00467584|6288756|P3|STARTED|Overall Study||21
2564978|NCT00467584|6288757|P2|STARTED|Overall Study||20
2564979|NCT00467584|6288758|P1|STARTED|Overall Study||21
2564980|NCT00467558|6288768|P2|NOT COMPLETED|Overall Study||0
2564981|NCT00467558|6288769|P1|NOT COMPLETED|Overall Study||2
2564982|NCT00467558|6288768|P2|COMPLETED|Overall Study||3
2564983|NCT00467558|6288769|P1|COMPLETED|Overall Study||2
2564984|NCT00467558|6288768|P2|STARTED|Overall Study||3
2564985|NCT00467558|6288769|P1|STARTED|Overall Study||4
2564986|NCT00467519|6288779|P2|NOT COMPLETED|Overall Study||23
2564987|NCT00467519|6288780|P1|NOT COMPLETED|Overall Study||14
2564988|NCT00467519|6288779|P2|COMPLETED|Overall Study||488
2564989|NCT00467519|6288780|P1|COMPLETED|Overall Study||517
2564990|NCT00467519|6288779|P2|STARTED|Overall Study||511
2564991|NCT00467519|6288780|P1|STARTED|Overall Study||531
2564992|NCT00467389|6288796|P2|NOT COMPLETED|Overall Study||0
2564993|NCT00467389|6288797|P1|NOT COMPLETED|Overall Study||0
2564994|NCT00467389|6288796|P2|COMPLETED|Overall Study||6
2564995|NCT00467389|6288797|P1|COMPLETED|Overall Study||6
2564996|NCT00467389|6288796|P2|STARTED|Overall Study||6
2564997|NCT00467389|6288797|P1|STARTED|Overall Study||6
2564998|NCT00467363|6288809|P2|NOT COMPLETED|Overall Study||70
2564999|NCT00467363|6288810|P1|NOT COMPLETED|Overall Study||80
2565000|NCT00467363|6288809|P2|COMPLETED|Overall Study||543
2565001|NCT00467363|6288810|P1|COMPLETED|Overall Study||535
2565002|NCT00467363|6288809|P2|STARTED|Overall Study||613
2565003|NCT00467363|6288810|P1|STARTED|Overall Study||615
2565004|NCT00467298|6288846|P2|NOT COMPLETED|Overall Study||6
2565005|NCT00467298|6288847|P1|NOT COMPLETED|Overall Study||4
2565006|NCT00467298|6288846|P2|COMPLETED|Overall Study||38
2565007|NCT00467298|6288847|P1|COMPLETED|Overall Study||42
2565008|NCT00467298|6288846|P2|STARTED|Overall Study||44
2565009|NCT00467298|6288847|P1|STARTED|Overall Study||46
2565010|NCT00467285|6288857|P2|NOT COMPLETED|Overall Study||4
2565011|NCT00467285|6288858|P1|NOT COMPLETED|Overall Study||4
2565012|NCT00467285|6288857|P2|COMPLETED|Overall Study||60
2565013|NCT00467285|6288858|P1|COMPLETED|Overall Study||28
2565014|NCT00467285|6288857|P2|STARTED|Overall Study||64
2565015|NCT00467285|6288858|P1|STARTED|Overall Study||32
2565016|NCT00467259|6288878|P2|NOT COMPLETED|Overall Study||242
2565017|NCT00467259|6288879|P1|NOT COMPLETED|Overall Study||75
2565018|NCT00467259|6288878|P2|COMPLETED|Overall Study||778
2565019|NCT00467259|6288879|P1|COMPLETED|Overall Study||176
2565020|NCT00467259|6288878|P2|ITT Population|Overall Study|One subject did not take any study medication and was excluded from ITT population.|1019
2565021|NCT00467259|6288879|P1|ITT Population|Overall Study||251
2565022|NCT00467259|6288878|P2|STARTED|Overall Study||1020
2565023|NCT00467259|6288879|P1|STARTED|Overall Study||251
2565024|NCT00467077|6288889|P1|NOT COMPLETED|Overall Study||0
2565025|NCT00467077|6288889|P1|COMPLETED|Overall Study||21
2565026|NCT00467077|6288889|P1|STARTED|Overall Study||21
2565027|NCT00467051|6288896|P1|NOT COMPLETED|Overall Study||2
2565028|NCT00467051|6288896|P1|COMPLETED|Overall Study||18
2565029|NCT00467051|6288896|P1|STARTED|Overall Study||20
2565030|NCT00467038|6288903|P2|NOT COMPLETED|Overall Study||0
2565031|NCT00467038|6288904|P1|NOT COMPLETED|Overall Study||0
2565032|NCT00467038|6288903|P2|COMPLETED|Overall Study||11
2565033|NCT00467038|6288904|P1|COMPLETED|Overall Study||11
2565034|NCT00467038|6288903|P2|STARTED|Overall Study||11
2565035|NCT00467038|6288904|P1|STARTED|Overall Study||11
2565036|NCT00466960|6288912|P1|NOT COMPLETED|Overall Study||0
2565037|NCT00466960|6288912|P1|COMPLETED|Overall Study||21
2565038|NCT00466960|6288912|P1|STARTED|Overall Study||21
2565039|NCT00466947|6288923|P2|NOT COMPLETED|Study End Analysis Period||2534
2565040|NCT00466947|6288924|P1|NOT COMPLETED|Study End Analysis Period||2496
2565041|NCT00466947|6288923|P2|COMPLETED|Study End Analysis Period||9265
2565042|NCT00466947|6288924|P1|COMPLETED|Study End Analysis Period||9302
2565043|NCT00466947|6288923|P2|STARTED|Study End Analysis Period||11799
2565044|NCT00466947|6288924|P1|STARTED|Study End Analysis Period||11798
2565045|NCT00466947|6288923|P2|NOT COMPLETED|Primary Outcome Analysis Period||11863
2565046|NCT00466947|6288924|P1|NOT COMPLETED|Primary Outcome Analysis Period||11875
2565047|NCT00466947|6288923|P2|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
2565048|NCT00466947|6288924|P1|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
2565049|NCT00466947|6288923|P2|Ongoing|Primary Outcome Analysis Period||11863
2565050|NCT00466947|6288924|P1|Ongoing|Primary Outcome Analysis Period||11875
2565051|NCT00466947|6288923|P2|STARTED|Primary Outcome Analysis Period||11863
2565052|NCT00466947|6288924|P1|STARTED|Primary Outcome Analysis Period||11875
2565053|NCT00466817|6289048|P2|NOT COMPLETED|Overall Study||4
2565054|NCT00466817|6289049|P1|NOT COMPLETED|Overall Study||5
2565055|NCT00466817|6289048|P2|COMPLETED|Overall Study||43
2565056|NCT00466817|6289049|P1|COMPLETED|Overall Study||44
2565057|NCT00466817|6289048|P2|STARTED|Overall Study||47
2565058|NCT00466817|6289049|P1|STARTED|Overall Study||49
2565059|NCT00466752|6289104|P2|NOT COMPLETED|Overall Study||0
2565060|NCT00466752|6289105|P1|NOT COMPLETED|Overall Study||0
2565061|NCT00466752|6289104|P2|COMPLETED|Overall Study||0
2565062|NCT00466752|6289105|P1|COMPLETED|Overall Study||5
2565063|NCT00466752|6289104|P2|STARTED|Overall Study||0
2565064|NCT00466752|6289105|P1|STARTED|Overall Study||5
2565065|NCT00466726|6289115|P1|NOT COMPLETED|Overall Study||14
2565066|NCT00466726|6289115|P1|COMPLETED|Overall Study||43
2565067|NCT00466726|6289115|P1|STARTED|Overall Study||57
2565068|NCT00466687|6289121|P1|NOT COMPLETED|Overall Study||34
2565069|NCT00466687|6289121|P1|COMPLETED|Overall Study||0
2565070|NCT00466687|6289121|P1|STARTED|Overall Study||34
2565071|NCT00466661|6289130|P2|NOT COMPLETED|Overall Study||6
2565072|NCT00466661|6289131|P1|NOT COMPLETED|Overall Study||4
2565073|NCT00466661|6289130|P2|COMPLETED|Overall Study||11
2565074|NCT00466661|6289131|P1|COMPLETED|Overall Study||12
2565075|NCT00466661|6289130|P2|At Least 1 Postrandomization Visit|Overall Study||16
2565076|NCT00466661|6289131|P1|At Least 1 Postrandomization Visit|Overall Study||14
2565077|NCT00466661|6289130|P2|STARTED|Overall Study||17
2565078|NCT00466661|6289131|P1|STARTED|Overall Study||16
2565079|NCT00466505|6289153|P1|NOT COMPLETED|Overall Study||17
2565080|NCT00466505|6289153|P1|COMPLETED|Overall Study||0
2565081|NCT00466505|6289153|P1|STARTED|Overall Study||17
2565082|NCT00466323|6289167|P2|NOT COMPLETED|Overall Study||23
2565083|NCT00466323|6289168|P1|NOT COMPLETED|Overall Study||28
2565084|NCT00466323|6289167|P2|COMPLETED|Overall Study||92
2565085|NCT00466323|6289168|P1|COMPLETED|Overall Study||89
2565086|NCT00466323|6289167|P2|STARTED|Overall Study||115
2565087|NCT00466323|6289168|P1|STARTED|Overall Study||117
2565088|NCT00466310|6289183|P3|NOT COMPLETED|Overall Study||0
2565089|NCT00466310|6289184|P2|NOT COMPLETED|Overall Study||0
2565090|NCT00466310|6289185|P1|NOT COMPLETED|Overall Study||0
2565091|NCT00466310|6289183|P3|COMPLETED|Overall Study||31
2565092|NCT00466310|6289184|P2|COMPLETED|Overall Study||20
2565093|NCT00466310|6289185|P1|COMPLETED|Overall Study||20
2565094|NCT00466310|6289183|P3|STARTED|Overall Study||31
2565095|NCT00466310|6289184|P2|STARTED|Overall Study||20
2565096|NCT00466310|6289185|P1|STARTED|Overall Study||20
2565097|NCT00466206|6289193|P1|NOT COMPLETED|Overall Study||0
2565098|NCT00466206|6289193|P1|COMPLETED|Overall Study|One of 10 patients withdrawn from study but completed treatment under Compassionate Use Designation|10
2565099|NCT00466206|6289193|P1|STARTED|Overall Study||10
2565100|NCT00466193|6289203|P2|NOT COMPLETED|Overall Study||8
2565101|NCT00466193|6289204|P1|NOT COMPLETED|Overall Study||12
2565102|NCT00466193|6289203|P2|COMPLETED|Overall Study|One patient did not report at least one Latency Sleep Onset following middle-of-the-night awakening.|137
2565103|NCT00466193|6289204|P1|COMPLETED|Overall Study||138
2565104|NCT00466193|6289203|P2|STARTED|Overall Study||145
2565105|NCT00466193|6289204|P1|STARTED|Overall Study||150
2565106|NCT00466167|6289231|P3|NOT COMPLETED|Overall Study||21
2565107|NCT00466167|6289232|P2|NOT COMPLETED|Overall Study||12
2565108|NCT00466167|6289233|P1|NOT COMPLETED|Overall Study||20
2565109|NCT00466167|6289231|P3|COMPLETED|Overall Study||157
2565110|NCT00466167|6289232|P2|COMPLETED|Overall Study||163
2565111|NCT00466167|6289233|P1|COMPLETED|Overall Study||145
2565112|NCT00466167|6289231|P3|STARTED|Overall Study||178
2565113|NCT00466167|6289232|P2|STARTED|Overall Study||175
2565114|NCT00466167|6289233|P1|STARTED|Overall Study||165
2565115|NCT00465998|6289289|P1|NOT COMPLETED|Overall Study||0
2565116|NCT00465998|6289289|P1|COMPLETED|Overall Study||275
2565117|NCT00465998|6289289|P1|STARTED|Overall Study||275
2565118|NCT00465985|6289294|P2|NOT COMPLETED|Part III - Open-label Treatment Period||0
2565119|NCT00465985|6289295|P1|NOT COMPLETED|Part III - Open-label Treatment Period||2
2565120|NCT00465985|6289294|P2|COMPLETED|Part III - Open-label Treatment Period||0
2565121|NCT00465985|6289295|P1|COMPLETED|Part III - Open-label Treatment Period||29
2565122|NCT00465985|6289294|P2|STARTED|Part III - Open-label Treatment Period||0
2565123|NCT00465985|6289295|P1|STARTED|Part III - Open-label Treatment Period|All patients received treatment with ACZ885 in Part III of the study.|31
2565124|NCT00465985|6289294|P2|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||12
2565125|NCT00465985|6289295|P1|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||0
2565126|NCT00465985|6289294|P2|COMPLETED|Part II - 1:1 ACZ885:Placebo||4
2565127|NCT00465985|6289295|P1|COMPLETED|Part II - 1:1 ACZ885:Placebo||15
2565128|NCT00465985|6289294|P2|STARTED|Part II - 1:1 ACZ885:Placebo||16
2565129|NCT00465985|6289295|P1|STARTED|Part II - 1:1 ACZ885:Placebo|Patients with complete response to treatment entered Part II and were randomized to ACZ885 ,placebo.|15
2565130|NCT00465985|6289294|P2|NOT COMPLETED|Part I - Open-label Treatment Period||0
2565131|NCT00465985|6289295|P1|NOT COMPLETED|Part I - Open-label Treatment Period||4
2565132|NCT00465985|6289294|P2|COMPLETED|Part I - Open-label Treatment Period||0
2565133|NCT00465985|6289295|P1|COMPLETED|Part I - Open-label Treatment Period|Only patients with a complete response completed Part I and entered Part II of the study.|31
2565134|NCT00465985|6289294|P2|STARTED|Part I - Open-label Treatment Period||0
2565135|NCT00465985|6289295|P1|STARTED|Part I - Open-label Treatment Period|All patients received treatment with ACZ885 in Part I of the study.|35
2565136|NCT00465972|6289318|P2|NOT COMPLETED|Overall Study||1
2565137|NCT00465972|6289319|P1|NOT COMPLETED|Overall Study||2
2565138|NCT00465972|6289318|P2|COMPLETED|Overall Study||23
2565139|NCT00465972|6289319|P1|COMPLETED|Overall Study||18
2565140|NCT00465972|6289318|P2|STARTED|Overall Study||24
2565141|NCT00465972|6289319|P1|STARTED|Overall Study||20
2565142|NCT00465894|6289329|P2|NOT COMPLETED|Treatment From 24 Weeks to 52 Weeks||0
2565143|NCT00465894|6289330|P1|NOT COMPLETED|Treatment From 24 Weeks to 52 Weeks||0
2565144|NCT00465894|6289329|P2|COMPLETED|Treatment From 24 Weeks to 52 Weeks||14
2565145|NCT00465894|6289330|P1|COMPLETED|Treatment From 24 Weeks to 52 Weeks||11
2565146|NCT00465894|6289329|P2|STARTED|Treatment From 24 Weeks to 52 Weeks||14
2565147|NCT00465894|6289330|P1|STARTED|Treatment From 24 Weeks to 52 Weeks|We included data only from participants that had complete data sets.|11
2565148|NCT00465894|6289329|P2|NOT COMPLETED|Treatment From 12 Weeks To 24 Weeks||0
2565149|NCT00465894|6289330|P1|NOT COMPLETED|Treatment From 12 Weeks To 24 Weeks||0
2565150|NCT00465894|6289329|P2|COMPLETED|Treatment From 12 Weeks To 24 Weeks||14
2565151|NCT00465894|6289330|P1|COMPLETED|Treatment From 12 Weeks To 24 Weeks||14
2565152|NCT00465894|6289329|P2|STARTED|Treatment From 12 Weeks To 24 Weeks|We included data only from participants that had complete data sets.|14
2565153|NCT00465894|6289330|P1|STARTED|Treatment From 12 Weeks To 24 Weeks|We included data only from participants that had complete data sets.|14
2565154|NCT00465894|6289329|P2|NOT COMPLETED|Treatment For 12 Weeks||3
2565155|NCT00465894|6289330|P1|NOT COMPLETED|Treatment For 12 Weeks||5
2565156|NCT00465894|6289329|P2|COMPLETED|Treatment For 12 Weeks||25
2565157|NCT00465894|6289330|P1|COMPLETED|Treatment For 12 Weeks||25
2565158|NCT00465894|6289329|P2|STARTED|Treatment For 12 Weeks||28
2565159|NCT00465894|6289330|P1|STARTED|Treatment For 12 Weeks||30
2565160|NCT00465816|6289363|P3|NOT COMPLETED|Overall Study||2
2565161|NCT00465816|6289364|P2|NOT COMPLETED|Overall Study||0
2565162|NCT00465816|6289365|P1|NOT COMPLETED|Overall Study||0
2565163|NCT00465816|6289363|P3|COMPLETED|Overall Study||120
2565164|NCT00465816|6289364|P2|COMPLETED|Overall Study||122
2565165|NCT00465816|6289365|P1|COMPLETED|Overall Study||367
2565166|NCT00465816|6289363|P3|STARTED|Overall Study||122
2565167|NCT00465816|6289364|P2|STARTED|Overall Study||122
2565168|NCT00465816|6289365|P1|STARTED|Overall Study||367
2565169|NCT00465738|6289428|P2|NOT COMPLETED|Overall Study||6
2565170|NCT00465738|6289429|P1|NOT COMPLETED|Overall Study||6
2565171|NCT00465738|6289428|P2|COMPLETED|Overall Study||89
2565172|NCT00465738|6289429|P1|COMPLETED|Overall Study||91
2565173|NCT00465738|6289428|P2|STARTED|Overall Study||95
2565174|NCT00465738|6289429|P1|STARTED|Overall Study||97
2565175|NCT00465647|6289523|P4|NOT COMPLETED|Overall Study||13
2565176|NCT00465647|6289524|P3|NOT COMPLETED|Overall Study||11
2565177|NCT00465647|6289525|P2|NOT COMPLETED|Overall Study||8
2565178|NCT00465647|6289526|P1|NOT COMPLETED|Overall Study||13
2565179|NCT00465647|6289523|P4|COMPLETED|Overall Study||12
2565180|NCT00465647|6289524|P3|COMPLETED|Overall Study||18
2565181|NCT00465647|6289525|P2|COMPLETED|Overall Study||15
2565182|NCT00465647|6289526|P1|COMPLETED|Overall Study||26
2565183|NCT00465647|6289523|P4|STARTED|Overall Study||25
2565184|NCT00465647|6289524|P3|STARTED|Overall Study||29
2565185|NCT00465647|6289525|P2|STARTED|Overall Study||23
2565186|NCT00465647|6289526|P1|STARTED|Overall Study||39
2565187|NCT00465595|6289551|P2|NOT COMPLETED|Overall Study||5
2565188|NCT00465595|6289552|P1|NOT COMPLETED|Overall Study||5
2565189|NCT00465595|6289551|P2|COMPLETED|Overall Study||24
2565190|NCT00465595|6289552|P1|COMPLETED|Overall Study||22
2565191|NCT00465595|6289551|P2|STARTED|Overall Study||29
2565192|NCT00465595|6289552|P1|STARTED|Overall Study||27
2565193|NCT00465569|6289574|P2|NOT COMPLETED|Overall Study||0
2565194|NCT00465569|6289575|P1|NOT COMPLETED|Overall Study||1
2565195|NCT00465569|6289574|P2|COMPLETED|Overall Study||7
2565196|NCT00465569|6289575|P1|COMPLETED|Overall Study||12
2565197|NCT00465569|6289574|P2|STARTED|Overall Study||7
2565198|NCT00465569|6289575|P1|STARTED|Overall Study||13
2565199|NCT00465530|6289587|P2|NOT COMPLETED|Overall Study||4
2565200|NCT00465530|6289588|P1|NOT COMPLETED|Overall Study||2
2565201|NCT00465530|6289587|P2|COMPLETED|Overall Study||15
2565202|NCT00465530|6289588|P1|COMPLETED|Overall Study||19
2565203|NCT00465530|6289587|P2|STARTED|Overall Study||19
2565204|NCT00465530|6289588|P1|STARTED|Overall Study||21
2565205|NCT00465361|6289598|P1|NOT COMPLETED|Post-Intervention Assessment||0
2565206|NCT00465361|6289598|P1|COMPLETED|Post-Intervention Assessment||3
2565207|NCT00465361|6289598|P1|STARTED|Post-Intervention Assessment||3
2565208|NCT00465361|6289598|P1|NOT COMPLETED|Baseline Assessment||4
2565209|NCT00465361|6289598|P1|COMPLETED|Baseline Assessment||3
2565210|NCT00465361|6289598|P1|STARTED|Baseline Assessment||7
2565211|NCT00465270|6289604|P2|NOT COMPLETED|Overall Study||160
2565212|NCT00465270|6289605|P1|NOT COMPLETED|Overall Study||104
2565213|NCT00465270|6289604|P2|COMPLETED|Overall Study||321
2565214|NCT00465270|6289605|P1|COMPLETED|Overall Study||395
2565215|NCT00465270|6289604|P2|STARTED|Overall Study||481
2565216|NCT00465270|6289605|P1|STARTED|Overall Study||499
2565217|NCT00465179|6289614|P1|NOT COMPLETED|Overall Study||53
2565218|NCT00465179|6289614|P1|COMPLETED|Overall Study||4
2565219|NCT00465179|6289614|P1|STARTED|Overall Study||57
2565220|NCT00465101|6289620|P1|NOT COMPLETED|Overall Study||59
2565221|NCT00465101|6289620|P1|COMPLETED|Overall Study||91
2565222|NCT00465101|6289620|P1|STARTED|Overall Study||150
2565223|NCT00465088|6289655|P2|NOT COMPLETED|Overall Study||9
2565224|NCT00465088|6289656|P1|NOT COMPLETED|Overall Study||32
2565225|NCT00465088|6289655|P2|COMPLETED|Overall Study||70
2565226|NCT00465088|6289656|P1|COMPLETED|Overall Study||82
2565227|NCT00465088|6289655|P2|STARTED|Overall Study||79
2565228|NCT00465088|6289656|P1|STARTED|Overall Study|For both arms, started means treated.|114
2565229|NCT00464945|6289690|P2|NOT COMPLETED|Toddler Dose||1
2565230|NCT00464945|6289691|P1|NOT COMPLETED|Toddler Dose||0
2565231|NCT00464945|6289690|P2|COMPLETED|Toddler Dose||130
2565232|NCT00464945|6289691|P1|COMPLETED|Toddler Dose||131
2565233|NCT00464945|6289690|P2|STARTED|Toddler Dose||131
2565234|NCT00464945|6289691|P1|STARTED|Toddler Dose||131
2565235|NCT00464945|6289690|P2|NOT COMPLETED|After Infant Series||2
2565236|NCT00464945|6289691|P1|NOT COMPLETED|After Infant Series||0
2565237|NCT00464945|6289690|P2|COMPLETED|After Infant Series||131
2565238|NCT00464945|6289691|P1|COMPLETED|After Infant Series||131
2565239|NCT00464945|6289690|P2|STARTED|After Infant Series||133
2565240|NCT00464945|6289691|P1|STARTED|After Infant Series||131
2565241|NCT00464945|6289690|P2|NOT COMPLETED|Infant Series||1
2565242|NCT00464945|6289691|P1|NOT COMPLETED|Infant Series||4
2565243|NCT00464945|6289690|P2|COMPLETED|Infant Series||133
2565244|NCT00464945|6289691|P1|COMPLETED|Infant Series||131
2565245|NCT00464945|6289690|P2|Vaccinated Dose 3|Infant Series||133
2565246|NCT00464945|6289691|P1|Vaccinated Dose 3|Infant Series||132
2565247|NCT00464945|6289690|P2|Vaccinated Dose 2|Infant Series||133
2565248|NCT00464945|6289691|P1|Vaccinated Dose 2|Infant Series||132
2565249|NCT00464945|6289690|P2|Vaccinated Dose 1|Infant Series||134
2565250|NCT00464945|6289691|P1|Vaccinated Dose 1|Infant Series||134
2565251|NCT00464945|6289690|P2|STARTED|Infant Series||134
2565252|NCT00464945|6289691|P1|STARTED|Infant Series||135
2565253|NCT00464815|6289721|P2|NOT COMPLETED|Overall Study||3
2565254|NCT00464815|6289722|P1|NOT COMPLETED|Overall Study||6
2565255|NCT00464815|6289721|P2|COMPLETED|Overall Study||254
2565256|NCT00464815|6289722|P1|COMPLETED|Overall Study||762
2565257|NCT00464815|6289721|P2|STARTED|Overall Study||257
2565258|NCT00464815|6289722|P1|STARTED|Overall Study||768
2565259|NCT00464737|6289755|P3|NOT COMPLETED|Overall Study||55
2565260|NCT00464737|6289756|P2|NOT COMPLETED|Overall Study||32
2565261|NCT00464737|6289757|P1|NOT COMPLETED|Overall Study||32
2565262|NCT00464737|6289755|P3|COMPLETED|Overall Study||19
2565263|NCT00464737|6289756|P2|COMPLETED|Overall Study||42
2565264|NCT00464737|6289757|P1|COMPLETED|Overall Study||50
2565265|NCT00464737|6289755|P3|STARTED|Overall Study||74
2565266|NCT00464737|6289756|P2|STARTED|Overall Study||74
2565267|NCT00464737|6289757|P1|STARTED|Overall Study||82
2565268|NCT00464711|6289804|P1|NOT COMPLETED|Overall Study||15
2565269|NCT00464711|6289804|P1|COMPLETED|Overall Study||25
2565270|NCT00464711|6289804|P1|STARTED|Overall Study||40
2565271|NCT00464698|6289808|P1|NOT COMPLETED|Period 3: 120mg||2
2565272|NCT00464698|6289808|P1|COMPLETED|Period 3: 120mg||12
2565273|NCT00464698|6289808|P1|STARTED|Period 3: 120mg||14
2565274|NCT00464698|6289808|P1|NOT COMPLETED|Period 2: 60 mg||0
2565275|NCT00464698|6289808|P1|COMPLETED|Period 2: 60 mg||17
2565276|NCT00464698|6289808|P1|STARTED|Period 2: 60 mg||17
2565277|NCT00464698|6289808|P1|NOT COMPLETED|Period 1: 30 mg||3
2565278|NCT00464698|6289808|P1|COMPLETED|Period 1: 30 mg||17
2565279|NCT00464698|6289808|P1|STARTED|Period 1: 30 mg||20
2565280|NCT00464685|6289820|P2|NOT COMPLETED|Overall Study||33
2565281|NCT00464685|6289821|P1|NOT COMPLETED|Overall Study||23
2565282|NCT00464685|6289820|P2|COMPLETED|Overall Study||94
2565283|NCT00464685|6289821|P1|COMPLETED|Overall Study||103
2565284|NCT00464685|6289820|P2|STARTED|Overall Study||127
2565285|NCT00464685|6289821|P1|STARTED|Overall Study||126
2565286|NCT00464672|6289837|P6|NOT COMPLETED|Overall Study||4
2565287|NCT00464672|6289838|P5|NOT COMPLETED|Overall Study||10
2565288|NCT00464672|6289839|P4|NOT COMPLETED|Overall Study||1
2565289|NCT00464672|6289840|P3|NOT COMPLETED|Overall Study||0
2565290|NCT00464672|6289841|P2|NOT COMPLETED|Overall Study||10
2565291|NCT00464672|6289842|P1|NOT COMPLETED|Overall Study||25
2565292|NCT00464672|6289837|P6|COMPLETED|Overall Study||195
2565293|NCT00464672|6289838|P5|COMPLETED|Overall Study||392
2565294|NCT00464672|6289839|P4|COMPLETED|Overall Study||199
2565295|NCT00464672|6289840|P3|COMPLETED|Overall Study||400
2565296|NCT00464672|6289841|P2|COMPLETED|Overall Study||222
2565297|NCT00464672|6289842|P1|COMPLETED|Overall Study||435
2565298|NCT00464672|6289837|P6|STARTED|Overall Study||199
2565299|NCT00464672|6289838|P5|STARTED|Overall Study||402
2565300|NCT00464672|6289839|P4|STARTED|Overall Study||200
2565301|NCT00464672|6289840|P3|STARTED|Overall Study||400
2565302|NCT00464672|6289841|P2|STARTED|Overall Study||232
2565303|NCT00464672|6289842|P1|STARTED|Overall Study||460
2565304|NCT00464646|6289914|P2|NOT COMPLETED|Overall Study||0
2565305|NCT00464646|6289915|P1|NOT COMPLETED|Overall Study||0
2565306|NCT00464646|6289914|P2|COMPLETED|Overall Study||29
2565307|NCT00464646|6289915|P1|COMPLETED|Overall Study||76
2565308|NCT00464646|6289914|P2|STARTED|Overall Study||29
2565309|NCT00464646|6289915|P1|STARTED|Overall Study||76
2565310|NCT00464620|6289921|P3|NOT COMPLETED|Overall Study||7
2565311|NCT00464620|6289922|P2|NOT COMPLETED|Overall Study||2
2565312|NCT00464620|6289923|P1|NOT COMPLETED|Overall Study||2
2565313|NCT00464620|6289921|P3|COMPLETED|Overall Study||109
2565314|NCT00464620|6289922|P2|COMPLETED|Overall Study||198
2565315|NCT00464620|6289923|P1|COMPLETED|Overall Study|48 patients were evaluable.|48
2565316|NCT00464620|6289921|P3|STARTED|Overall Study||116
2565317|NCT00464620|6289922|P2|STARTED|Overall Study||200
2565318|NCT00464620|6289923|P1|STARTED|Overall Study||50
2565319|NCT00464568|6289950|P1|NOT COMPLETED|Overall Study||2
2565320|NCT00464568|6289950|P1|COMPLETED|Overall Study||30
2565321|NCT00464568|6289950|P1|STARTED|Overall Study||32
2565322|NCT00464542|6290023|P1|NOT COMPLETED|Post-treatment||0
2565323|NCT00464542|6290023|P1|COMPLETED|Post-treatment||10
2565324|NCT00464542|6290023|P1|STARTED|Post-treatment||10
2565325|NCT00464542|6290023|P1|NOT COMPLETED|Pre-treatment||2
2565326|NCT00464542|6290023|P1|COMPLETED|Pre-treatment||10
2565327|NCT00464542|6290023|P1|STARTED|Pre-treatment||12
2565328|NCT00464490|6290030|P2|NOT COMPLETED|Overall Study||11
2565329|NCT00464490|6290031|P1|NOT COMPLETED|Overall Study||11
2565330|NCT00464490|6290030|P2|COMPLETED|Overall Study||10
2565331|NCT00464490|6290031|P1|COMPLETED|Overall Study||10
2565332|NCT00464490|6290030|P2|STARTED|Overall Study||21
2565333|NCT00464490|6290031|P1|STARTED|Overall Study||21
2565334|NCT00464464|6290039|P2|NOT COMPLETED|Overall Study||3
2565335|NCT00464464|6290040|P1|NOT COMPLETED|Overall Study||5
2565336|NCT00464464|6290039|P2|COMPLETED|Overall Study||36
2565337|NCT00464464|6290040|P1|COMPLETED|Overall Study||36
2565338|NCT00464464|6290039|P2|STARTED|Overall Study||39
2565339|NCT00464464|6290040|P1|STARTED|Overall Study||41
2565340|NCT00464438|6290054|P2|NOT COMPLETED|Overall Study||6
2565341|NCT00464438|6290055|P1|NOT COMPLETED|Overall Study||2
2565342|NCT00464438|6290054|P2|COMPLETED|Overall Study||80
2565343|NCT00464438|6290055|P1|COMPLETED|Overall Study||83
2565344|NCT00464438|6290054|P2|STARTED|Overall Study||86
2565345|NCT00464438|6290055|P1|STARTED|Overall Study||85
2565346|NCT00464334|6290078|P11|NOT COMPLETED|Overall Study||4
2565347|NCT00464334|6290079|P10|NOT COMPLETED|Overall Study||1
2565348|NCT00464334|6290080|P9|NOT COMPLETED|Overall Study||6
2565349|NCT00464334|6290081|P8|NOT COMPLETED|Overall Study||1
2565350|NCT00464334|6290082|P7|NOT COMPLETED|Overall Study||3
2565351|NCT00464334|6290083|P6|NOT COMPLETED|Overall Study||4
2565352|NCT00464334|6290084|P5|NOT COMPLETED|Overall Study||4
2565353|NCT00464334|6290085|P4|NOT COMPLETED|Overall Study||4
2565354|NCT00464334|6290086|P3|NOT COMPLETED|Overall Study||5
2565355|NCT00464334|6290087|P2|NOT COMPLETED|Overall Study||8
2565356|NCT00464334|6290088|P1|NOT COMPLETED|Overall Study||1
2565357|NCT00464334|6290078|P11|COMPLETED|Overall Study||4
2565358|NCT00464334|6290079|P10|COMPLETED|Overall Study||4
2565359|NCT00464334|6290080|P9|COMPLETED|Overall Study||2
2565360|NCT00464334|6290081|P8|COMPLETED|Overall Study||7
2565361|NCT00464334|6290082|P7|COMPLETED|Overall Study||6
2565362|NCT00464334|6290083|P6|COMPLETED|Overall Study||3
2565363|NCT00464334|6290084|P5|COMPLETED|Overall Study||3
2565364|NCT00464334|6290085|P4|COMPLETED|Overall Study||4
2565365|NCT00464334|6290086|P3|COMPLETED|Overall Study||3
2565366|NCT00464334|6290087|P2|COMPLETED|Overall Study||5
2565367|NCT00464334|6290088|P1|COMPLETED|Overall Study||4
2565368|NCT00464334|6290078|P11|STARTED|Overall Study||8
2565369|NCT00464334|6290079|P10|STARTED|Overall Study||5
2565370|NCT00464334|6290080|P9|STARTED|Overall Study||8
2565371|NCT00464334|6290081|P8|STARTED|Overall Study||8
2565372|NCT00464334|6290082|P7|STARTED|Overall Study||9
2565373|NCT00464334|6290083|P6|STARTED|Overall Study||7
2565374|NCT00464334|6290084|P5|STARTED|Overall Study||7
2565375|NCT00464334|6290085|P4|STARTED|Overall Study||8
2565376|NCT00464334|6290086|P3|STARTED|Overall Study||8
2565377|NCT00464334|6290087|P2|STARTED|Overall Study||13
2565378|NCT00464334|6290088|P1|STARTED|Overall Study||5
2565379|NCT00464308|6290148|P3|NOT COMPLETED|Overall Study||59
2565380|NCT00464308|6290149|P2|NOT COMPLETED|Overall Study||63
2565381|NCT00464308|6290150|P1|NOT COMPLETED|Overall Study||69
2565382|NCT00464308|6290148|P3|COMPLETED|Overall Study||400
2565383|NCT00464308|6290149|P2|COMPLETED|Overall Study||406
2565384|NCT00464308|6290150|P1|COMPLETED|Overall Study||395
2565385|NCT00464308|6290148|P3|STARTED|Overall Study||459
2565386|NCT00464308|6290149|P2|STARTED|Overall Study||469
2565387|NCT00464308|6290150|P1|STARTED|Overall Study||464
2565388|NCT00464269|6290180|P4|NOT COMPLETED|Overall Study||9
2565389|NCT00464269|6290181|P3|NOT COMPLETED|Overall Study||7
2565390|NCT00464269|6290182|P2|NOT COMPLETED|Overall Study||17
2565391|NCT00464269|6290183|P1|NOT COMPLETED|Overall Study||6
2565392|NCT00464269|6290180|P4|COMPLETED|Overall Study||93
2565393|NCT00464269|6290181|P3|COMPLETED|Overall Study||93
2565394|NCT00464269|6290182|P2|COMPLETED|Overall Study||82
2565395|NCT00464269|6290183|P1|COMPLETED|Overall Study||93
2565396|NCT00464269|6290180|P4|STARTED|Overall Study||102
2565397|NCT00464269|6290181|P3|STARTED|Overall Study||100
2565398|NCT00464269|6290182|P2|STARTED|Overall Study||99
2565399|NCT00464269|6290183|P1|STARTED|Overall Study||99
2565400|NCT00464204|6290283|P2|NOT COMPLETED|Overall Study||32
2565401|NCT00464204|6290284|P1|NOT COMPLETED|Overall Study||49
2565402|NCT00464204|6290283|P2|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|64
2565403|NCT00464204|6290284|P1|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|51
2565404|NCT00464204|6290283|P2|Withdrawal Due to Discharge From ICU|Overall Study||11
2565405|NCT00464204|6290284|P1|Withdrawal Due to Discharge From ICU|Overall Study||18
2565406|NCT00464204|6290283|P2|Day 90 Follow-up Performed|Overall Study||74
2565407|NCT00464204|6290284|P1|Day 90 Follow-up Performed|Overall Study||69
2565408|NCT00464204|6290283|P2|Day 30 Follow-up Performed|Overall Study||83
2565409|NCT00464204|6290284|P1|Day 30 Follow-up Performed|Overall Study||89
2565410|NCT00464204|6290283|P2|Completed Treatment|Overall Study||83
2565411|NCT00464204|6290284|P1|Completed Treatment|Overall Study||81
2565412|NCT00464204|6290283|P2|STARTED|Overall Study||96
2565413|NCT00464204|6290284|P1|STARTED|Overall Study||100
2565414|NCT00464087|6290321|P3|NOT COMPLETED|Overall Study||29
2565415|NCT00464087|6290322|P2|NOT COMPLETED|Overall Study||0
2565416|NCT00464087|6290323|P1|NOT COMPLETED|Overall Study||0
2565417|NCT00464087|6290321|P3|COMPLETED|Overall Study||0
2565418|NCT00464087|6290322|P2|COMPLETED|Overall Study||51
2565419|NCT00464087|6290323|P1|COMPLETED|Overall Study||49
2565420|NCT00464087|6290321|P3|STARTED|Overall Study||29
2565421|NCT00464087|6290322|P2|STARTED|Overall Study||51
2565422|NCT00464087|6290323|P1|STARTED|Overall Study||49
2565423|NCT00463866|6290341|P2|NOT COMPLETED|Overall Study||340
2565424|NCT00463866|6290342|P1|NOT COMPLETED|Overall Study||309
2565425|NCT00463866|6290341|P2|COMPLETED|Overall Study||3705
2565426|NCT00463866|6290342|P1|COMPLETED|Overall Study||3699
2565427|NCT00463866|6290341|P2|STARTED|Overall Study|4221 participants randomised. Out of these, 176 had no efficacy data after randomisation.|4045
2565428|NCT00463866|6290342|P1|STARTED|Overall Study|4203 participants randomised. Out of these, 195 had no efficacy data after randomisation.|4008
2565429|NCT00463840|6290362|P1|NOT COMPLETED|Overall Study||12
2565430|NCT00463840|6290362|P1|COMPLETED|Overall Study||12
2565431|NCT00463840|6290362|P1|STARTED|Overall Study||24
2565432|NCT00463801|6290367|P1|NOT COMPLETED|Overall Study||13
2565433|NCT00463801|6290367|P1|COMPLETED|Overall Study||39
2565434|NCT00463801|6290367|P1|STARTED|Overall Study||52
2565435|NCT00463788|6290373|P2|NOT COMPLETED|Overall Study||54
2565436|NCT00463788|6290374|P1|NOT COMPLETED|Overall Study||109
2565437|NCT00463788|6290373|P2|COMPLETED|Overall Study||4
2565438|NCT00463788|6290374|P1|COMPLETED|Overall Study||6
2565439|NCT00463788|6290373|P2|Treated|Overall Study||57
2565440|NCT00463788|6290374|P1|Treated|Overall Study||114
2565441|NCT00463788|6290373|P2|STARTED|Overall Study||58
2565442|NCT00463788|6290374|P1|STARTED|Overall Study||115
2565443|NCT00463684|6290389|P1|NOT COMPLETED|Overall Study||4
2565444|NCT00463684|6290389|P1|COMPLETED|Overall Study||274
2565445|NCT00463684|6290389|P1|STARTED|Overall Study||278
2565446|NCT00463606|6290407|P3|NOT COMPLETED|Overall Study||20
2565447|NCT00463606|6290408|P2|NOT COMPLETED|Overall Study||34
2565448|NCT00463606|6290409|P1|NOT COMPLETED|Overall Study||41
2565449|NCT00463606|6290407|P3|COMPLETED|Overall Study||231
2565450|NCT00463606|6290408|P2|COMPLETED|Overall Study||220
2565451|NCT00463606|6290409|P1|COMPLETED|Overall Study||212
2565452|NCT00463606|6290407|P3|STARTED|Overall Study||251
2565453|NCT00463606|6290408|P2|STARTED|Overall Study||254
2565454|NCT00463606|6290409|P1|STARTED|Overall Study||253
2565455|NCT00463580|6290434|P2|NOT COMPLETED|Overall Study||2
2565456|NCT00463580|6290435|P1|NOT COMPLETED|Overall Study||3
2565457|NCT00463580|6290434|P2|COMPLETED|Overall Study||28
2565458|NCT00463580|6290435|P1|COMPLETED|Overall Study||27
2565459|NCT00463580|6290434|P2|STARTED|Overall Study||30
2565460|NCT00463580|6290435|P1|STARTED|Overall Study||30
2565461|NCT00463567|6290468|P7|NOT COMPLETED|Overall Study||11
2565462|NCT00463567|6290469|P6|NOT COMPLETED|Overall Study||21
2565463|NCT00463567|6290470|P5|NOT COMPLETED|Overall Study||23
2565464|NCT00463567|6290471|P4|NOT COMPLETED|Overall Study||131
2565465|NCT00463567|6290472|P3|NOT COMPLETED|Overall Study||89
2565466|NCT00463567|6290473|P2|NOT COMPLETED|Overall Study||77
2565467|NCT00463567|6290474|P1|NOT COMPLETED|Overall Study||95
2565468|NCT00463567|6290468|P7|COMPLETED|Overall Study||112
2565469|NCT00463567|6290469|P6|COMPLETED|Overall Study||102
2565470|NCT00463567|6290470|P5|COMPLETED|Overall Study||107
2565471|NCT00463567|6290471|P4|COMPLETED|Overall Study||294
2565472|NCT00463567|6290472|P3|COMPLETED|Overall Study||331
2565473|NCT00463567|6290473|P2|COMPLETED|Overall Study||341
2565474|NCT00463567|6290474|P1|COMPLETED|Overall Study||325
2565475|NCT00463567|6290468|P7|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
2565476|NCT00463567|6290469|P6|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
2565477|NCT00463567|6290470|P5|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|127
2565478|NCT00463567|6290471|P4|Safety Population: Received Study Drug|Overall Study||418
2565479|NCT00463567|6290472|P3|Safety Population: Received Study Drug|Overall Study||415
2565480|NCT00463567|6290473|P2|Safety Population: Received Study Drug|Overall Study||416
2565481|NCT00463567|6290474|P1|Safety Population: Received Study Drug|Overall Study||416
2565482|NCT00463567|6290468|P7|STARTED|Overall Study||123
2565483|NCT00463567|6290469|P6|STARTED|Overall Study||123
2565484|NCT00463567|6290470|P5|STARTED|Overall Study||130
2565485|NCT00463567|6290471|P4|STARTED|Overall Study||425
2565486|NCT00463567|6290472|P3|STARTED|Overall Study||420
2565487|NCT00463567|6290473|P2|STARTED|Overall Study||418
2565488|NCT00463567|6290474|P1|STARTED|Overall Study|Randomized Participants|420
2565489|NCT00463437|6290509|P4|NOT COMPLETED|Overall Study||7
2565490|NCT00463437|6290510|P3|NOT COMPLETED|Overall Study||6
2565491|NCT00463437|6290511|P2|NOT COMPLETED|Overall Study||11
2565492|NCT00463437|6290512|P1|NOT COMPLETED|Overall Study||4
2565493|NCT00463437|6290509|P4|COMPLETED|Overall Study||350
2565494|NCT00463437|6290510|P3|COMPLETED|Overall Study||352
2565495|NCT00463437|6290511|P2|COMPLETED|Overall Study||352
2565496|NCT00463437|6290512|P1|COMPLETED|Overall Study||355
2565497|NCT00463437|6290509|P4|STARTED|Overall Study||357
2565498|NCT00463437|6290510|P3|STARTED|Overall Study||358
2565499|NCT00463437|6290511|P2|STARTED|Overall Study||363
2565500|NCT00463437|6290512|P1|STARTED|Overall Study||359
2565501|NCT00463385|6290578|P4|NOT COMPLETED|Overall Study||22
2565502|NCT00463385|6290579|P3|NOT COMPLETED|Overall Study||22
2565503|NCT00463385|6290580|P2|NOT COMPLETED|Overall Study||22
2565504|NCT00463385|6290581|P1|NOT COMPLETED|Overall Study||22
2565505|NCT00463385|6290578|P4|COMPLETED|Overall Study||0
2565506|NCT00463385|6290579|P3|COMPLETED|Overall Study||0
2565507|NCT00463385|6290580|P2|COMPLETED|Overall Study||0
2565508|NCT00463385|6290581|P1|COMPLETED|Overall Study||0
2565509|NCT00463385|6290578|P4|Treated|Overall Study||22
2565510|NCT00463385|6290579|P3|Treated|Overall Study||19
2565511|NCT00463385|6290580|P2|Treated|Overall Study||22
2565512|NCT00463385|6290581|P1|Treated|Overall Study||22
2565513|NCT00463385|6290578|P4|STARTED|Overall Study||22
2565514|NCT00463385|6290579|P3|STARTED|Overall Study||22
2565515|NCT00463385|6290580|P2|STARTED|Overall Study||22
2565516|NCT00463385|6290581|P1|STARTED|Overall Study||22
2565517|NCT00463346|6290633|P2|NOT COMPLETED|Overall Study||3
2565518|NCT00463346|6290634|P1|NOT COMPLETED|Overall Study||3
2565519|NCT00463346|6290633|P2|COMPLETED|Overall Study||8
2565520|NCT00463346|6290634|P1|COMPLETED|Overall Study||9
2565521|NCT00463346|6290633|P2|STARTED|Overall Study||11
2565522|NCT00463346|6290634|P1|STARTED|Overall Study||12
2565523|NCT00463229|6290644|P2|NOT COMPLETED|Overall Study||10
2565524|NCT00463229|6290645|P1|NOT COMPLETED|Overall Study||9
2565525|NCT00463229|6290644|P2|COMPLETED|Overall Study||39
2565526|NCT00463229|6290645|P1|COMPLETED|Overall Study||43
2565527|NCT00463229|6290644|P2|STARTED|Overall Study||49
2565528|NCT00463229|6290645|P1|STARTED|Overall Study||52
2565529|NCT00463060|6290665|P1|NOT COMPLETED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg||1
2565530|NCT00463060|6290665|P1|COMPLETED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg||25
2565531|NCT00463060|6290665|P1|STARTED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Not all patients participated in both Phase 1 and Phase II|26
2565532|NCT00463060|6290665|P1|NOT COMPLETED|Phase 1-Radiation 50Gy +Sunitinib 50mg||5
2565533|NCT00463060|6290665|P1|COMPLETED|Phase 1-Radiation 50Gy +Sunitinib 50mg||0
2565534|NCT00463060|6290665|P1|STARTED|Phase 1-Radiation 50Gy +Sunitinib 50mg||5
2565535|NCT00463060|6290665|P1|NOT COMPLETED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||0
2565536|NCT00463060|6290665|P1|COMPLETED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||10
2565537|NCT00463060|6290665|P1|STARTED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||10
2565538|NCT00463060|6290665|P1|NOT COMPLETED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||0
2565539|NCT00463060|6290665|P1|COMPLETED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||3
2565540|NCT00463060|6290665|P1|STARTED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||3
2565541|NCT00463060|6290665|P1|NOT COMPLETED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||0
2565542|NCT00463060|6290665|P1|COMPLETED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||3
2565543|NCT00463060|6290665|P1|STARTED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||3
2565544|NCT00463047|6290679|P2|NOT COMPLETED|Double-Blind Treatment Period 2||2
2565545|NCT00463047|6290680|P1|NOT COMPLETED|Double-Blind Treatment Period 2||1
2565546|NCT00463047|6290679|P2|COMPLETED|Double-Blind Treatment Period 2||88
2565547|NCT00463047|6290680|P1|COMPLETED|Double-Blind Treatment Period 2||92
2565548|NCT00463047|6290679|P2|STARTED|Double-Blind Treatment Period 2||90
2565549|NCT00463047|6290680|P1|STARTED|Double-Blind Treatment Period 2||93
2565550|NCT00463047|6290679|P2|NOT COMPLETED|Double-Blind Treatment Period 1||4
2565551|NCT00463047|6290680|P1|NOT COMPLETED|Double-Blind Treatment Period 1||3
2565552|NCT00463047|6290679|P2|COMPLETED|Double-Blind Treatment Period 1||90
2565553|NCT00463047|6290680|P1|COMPLETED|Double-Blind Treatment Period 1||93
2565554|NCT00463047|6290679|P2|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|94
2565555|NCT00463047|6290680|P1|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|96
2565556|NCT00463047|6290679|P2|NOT COMPLETED|Titration Period 2||23
2565557|NCT00463047|6290680|P1|NOT COMPLETED|Titration Period 2||30
2565558|NCT00463047|6290679|P2|COMPLETED|Titration Period 2||98
2565559|NCT00463047|6290680|P1|COMPLETED|Titration Period 2||93
2565560|NCT00463047|6290679|P2|STARTED|Titration Period 2||121
2565561|NCT00463047|6290680|P1|STARTED|Titration Period 2||123
2565562|NCT00463047|6290679|P2|NOT COMPLETED|Titration Period 1||39
2565563|NCT00463047|6290680|P1|NOT COMPLETED|Titration Period 1||37
2565564|NCT00463047|6290679|P2|COMPLETED|Titration Period 1||121
2565565|NCT00463047|6290680|P1|COMPLETED|Titration Period 1||123
2565566|NCT00463047|6290679|P2|STARTED|Titration Period 1||160
2565567|NCT00463047|6290680|P1|STARTED|Titration Period 1|323 subjects entered study period but 3 discontinued before being randomized to treatment|160
2565568|NCT00462982|6290765|P1|NOT COMPLETED|Overall Study||3
2565569|NCT00462982|6290765|P1|COMPLETED|Overall Study||5
2565570|NCT00462982|6290765|P1|STARTED|Overall Study||8
2565571|NCT00462943|6290772|P3|NOT COMPLETED|Overall Study||23
2565572|NCT00462943|6290773|P2|NOT COMPLETED|Overall Study||30
2565573|NCT00462943|6290774|P1|NOT COMPLETED|Overall Study||45
2565574|NCT00462943|6290772|P3|COMPLETED|Overall Study||0
2565575|NCT00462943|6290773|P2|COMPLETED|Overall Study||1
2565576|NCT00462943|6290774|P1|COMPLETED|Overall Study||1
2565577|NCT00462943|6290772|P3|STARTED|Overall Study||23
2565578|NCT00462943|6290773|P2|STARTED|Overall Study||31
2565579|NCT00462943|6290774|P1|STARTED|Overall Study||46
2565580|NCT00462917|6290845|P4|NOT COMPLETED|Overall Study||11
2565581|NCT00462917|6290846|P3|NOT COMPLETED|Overall Study||12
2565582|NCT00462917|6290847|P2|NOT COMPLETED|Overall Study||10
2565583|NCT00462917|6290848|P1|NOT COMPLETED|Overall Study||10
2565584|NCT00462917|6290845|P4|COMPLETED|Overall Study||66
2565585|NCT00462917|6290846|P3|COMPLETED|Overall Study||54
2565586|NCT00462917|6290847|P2|COMPLETED|Overall Study||65
2565587|NCT00462917|6290848|P1|COMPLETED|Overall Study||62
2565588|NCT00462917|6290845|P4|Completed 6 Month Follow-up|Overall Study||66
2565589|NCT00462917|6290846|P3|Completed 6 Month Follow-up|Overall Study||55
2565590|NCT00462917|6290847|P2|Completed 6 Month Follow-up|Overall Study||68
2565591|NCT00462917|6290848|P1|Completed 6 Month Follow-up|Overall Study||63
2565592|NCT00462917|6290845|P4|Completed 6 Week Follow-up|Overall Study||68
2565593|NCT00462917|6290846|P3|Completed 6 Week Follow-up|Overall Study||55
2565594|NCT00462917|6290847|P2|Completed 6 Week Follow-up|Overall Study||70
2565595|NCT00462917|6290848|P1|Completed 6 Week Follow-up|Overall Study||63
2565596|NCT00462917|6290845|P4|Received Risk Information|Overall Study||68
2565597|NCT00462917|6290846|P3|Received Risk Information|Overall Study||55
2565598|NCT00462917|6290847|P2|Received Risk Information|Overall Study||70
2565599|NCT00462917|6290848|P1|Received Risk Information|Overall Study||64
2565600|NCT00462917|6290845|P4|Met With Genetic Counselor|Overall Study||71
2565601|NCT00462917|6290846|P3|Met With Genetic Counselor|Overall Study||56
2565602|NCT00462917|6290847|P2|Met With Genetic Counselor|Overall Study||71
2565603|NCT00462917|6290848|P1|Met With Genetic Counselor|Overall Study||66
2565604|NCT00462917|6290845|P4|STARTED|Overall Study||77
2565605|NCT00462917|6290846|P3|STARTED|Overall Study||66
2565606|NCT00462917|6290847|P2|STARTED|Overall Study||75
2565607|NCT00462917|6290848|P1|STARTED|Overall Study||72
2565608|NCT00462904|6290866|P1|NOT COMPLETED|Overall Study||1
2565609|NCT00462904|6290866|P1|COMPLETED|Overall Study||3
2565610|NCT00462904|6290866|P1|STARTED|Overall Study||4
2565611|NCT00462865|6290871|P1|NOT COMPLETED|Overall Study||1
2565612|NCT00462865|6290871|P1|COMPLETED|Overall Study||17
2565613|NCT00462865|6290871|P1|STARTED|Overall Study|18 pts enrolled,1 pt experienced a SAE infection normal ANC (gr 3) and did not begin study,see SAE|18
2565614|NCT00462839|6290878|P2|NOT COMPLETED|Viewed Second||0
2565615|NCT00462839|6290879|P1|NOT COMPLETED|Viewed Second||0
2565616|NCT00462839|6290878|P2|COMPLETED|Viewed Second||53
2565617|NCT00462839|6290879|P1|COMPLETED|Viewed Second||53
2565618|NCT00462839|6290878|P2|STARTED|Viewed Second||53
2565619|NCT00462839|6290879|P1|STARTED|Viewed Second||53
2565620|NCT00462839|6290878|P2|NOT COMPLETED|Viewed First||0
2565621|NCT00462839|6290879|P1|NOT COMPLETED|Viewed First||0
2565622|NCT00462839|6290878|P2|COMPLETED|Viewed First||53
2565623|NCT00462839|6290879|P1|COMPLETED|Viewed First||53
2565624|NCT00462839|6290878|P2|STARTED|Viewed First||53
2565625|NCT00462839|6290879|P1|STARTED|Viewed First||53
2565626|NCT00462826|6290891|P1|NOT COMPLETED|Overall Study||5
2565627|NCT00462826|6290891|P1|COMPLETED|Overall Study||44
2565628|NCT00462826|6290891|P1|STARTED|Overall Study||49
2565629|NCT00462748|6290907|P3|NOT COMPLETED|Overall Study||11
2565630|NCT00462748|6290908|P2|NOT COMPLETED|Overall Study||11
2565631|NCT00462748|6290909|P1|NOT COMPLETED|Overall Study||12
2565632|NCT00462748|6290907|P3|COMPLETED|Overall Study||251
2565633|NCT00462748|6290908|P2|COMPLETED|Overall Study||252
2565634|NCT00462748|6290909|P1|COMPLETED|Overall Study||249
2565635|NCT00462748|6290907|P3|STARTED|Overall Study||262
2565636|NCT00462748|6290908|P2|STARTED|Overall Study||263
2565637|NCT00462748|6290909|P1|STARTED|Overall Study||261
2565638|NCT00462735|6290917|P1|NOT COMPLETED|Overall Study||0
2565639|NCT00462735|6290917|P1|COMPLETED|Overall Study||33
2565640|NCT00462735|6290917|P1|STARTED|Overall Study||33
2565641|NCT00462722|6290928|P3|NOT COMPLETED|Overall Study||12
2565642|NCT00462722|6290929|P2|NOT COMPLETED|Overall Study||4
2565643|NCT00462722|6290930|P1|NOT COMPLETED|Overall Study||13
2565644|NCT00462722|6290928|P3|COMPLETED|Overall Study||42
2565645|NCT00462722|6290929|P2|COMPLETED|Overall Study||51
2565646|NCT00462722|6290930|P1|COMPLETED|Overall Study||37
2565647|NCT00462722|6290928|P3|STARTED|Overall Study||54
2565648|NCT00462722|6290929|P2|STARTED|Overall Study||55
2565649|NCT00462722|6290930|P1|STARTED|Overall Study||50
2565650|NCT00462709|6290962|P1|NOT COMPLETED|Overall Study||67
2565651|NCT00462709|6290962|P1|COMPLETED|Overall Study||79
2565652|NCT00462709|6290962|P1|STARTED|Overall Study||146
2565653|NCT00462670|6290971|P2|NOT COMPLETED|Overall Study||7
2565654|NCT00462670|6290972|P1|NOT COMPLETED|Overall Study||5
2565655|NCT00462670|6290971|P2|COMPLETED|Overall Study||46
2565656|NCT00462670|6290972|P1|COMPLETED|Overall Study||52
2565657|NCT00462670|6290971|P2|STARTED|Overall Study||53
2565658|NCT00462670|6290972|P1|STARTED|Overall Study||57
2565659|NCT00462644|6290982|P2|NOT COMPLETED|Overall Study||0
2565660|NCT00462644|6290983|P1|NOT COMPLETED|Overall Study||0
2565661|NCT00462644|6290982|P2|COMPLETED|Overall Study||12
2565662|NCT00462644|6290983|P1|COMPLETED|Overall Study||18
2565663|NCT00462644|6290982|P2|STARTED|Overall Study||12
2565664|NCT00462644|6290983|P1|STARTED|Overall Study||18
2565665|NCT00462605|6291001|P1|NOT COMPLETED|Overall Study||14
2565666|NCT00462605|6291001|P1|COMPLETED|Overall Study||10
2565667|NCT00462605|6291001|P1|STARTED|Overall Study||24
2565668|NCT00462501|6291009|P1|NOT COMPLETED|Overall Study||5
2565669|NCT00462501|6291009|P1|COMPLETED|Overall Study||30
2565670|NCT00462501|6291009|P1|STARTED|Overall Study||35
2565671|NCT00462462|6291015|P2|NOT COMPLETED|Overall Study||1
2565672|NCT00462462|6291016|P1|NOT COMPLETED|Overall Study||0
2565673|NCT00462462|6291015|P2|COMPLETED|Overall Study||13
2565674|NCT00462462|6291016|P1|COMPLETED|Overall Study||17
2565675|NCT00462462|6291015|P2|STARTED|Overall Study||14
2565676|NCT00462462|6291016|P1|STARTED|Overall Study||17
2565677|NCT00462449|6291026|P2|NOT COMPLETED|Overall Study||0
2565678|NCT00462449|6291027|P1|NOT COMPLETED|Overall Study||0
2565679|NCT00462449|6291026|P2|COMPLETED|Overall Study||10
2565680|NCT00462449|6291027|P1|COMPLETED|Overall Study||13
2565681|NCT00462449|6291026|P2|STARTED|Overall Study||10
2565682|NCT00462449|6291027|P1|STARTED|Overall Study||13
2565683|NCT00462423|6291037|P1|NOT COMPLETED|Overall Study||0
2565684|NCT00462423|6291037|P1|COMPLETED|Overall Study||50
2565685|NCT00462423|6291037|P1|STARTED|Overall Study||50
2565686|NCT00462384|6291044|P1|NOT COMPLETED|Overall Study||9
2565687|NCT00462384|6291044|P1|COMPLETED|Overall Study||30
2565688|NCT00462384|6291044|P1|STARTED|Overall Study||39
2565689|NCT00462345|6291052|P1|NOT COMPLETED|Overall Study||3
2565690|NCT00462345|6291052|P1|COMPLETED|Overall Study||37
2565691|NCT00462345|6291052|P1|Completed First Course|Overall Study||38
2565692|NCT00462345|6291052|P1|STARTED|Overall Study||40
2565693|NCT00462332|6291076|P2|NOT COMPLETED|Overall Study||0
2565694|NCT00462332|6291077|P1|NOT COMPLETED|Overall Study||0
2565695|NCT00462332|6291076|P2|COMPLETED|Overall Study||41
2565696|NCT00462332|6291077|P1|COMPLETED|Overall Study||45
2565697|NCT00462332|6291076|P2|STARTED|Overall Study||41
2565698|NCT00462332|6291077|P1|STARTED|Overall Study||45
2565699|NCT00462306|6291087|P2|NOT COMPLETED|Overall Study||13
2565700|NCT00462306|6291088|P1|NOT COMPLETED|Overall Study||0
2565701|NCT00462306|6291087|P2|COMPLETED|Overall Study||490
2565702|NCT00462306|6291088|P1|COMPLETED|Overall Study||4074
2565703|NCT00462306|6291087|P2|STARTED|Overall Study||503
2565704|NCT00462306|6291088|P1|STARTED|Overall Study||4074
2565705|NCT00462280|6291100|P4|NOT COMPLETED|Overall Study||3
2565706|NCT00462280|6291101|P3|NOT COMPLETED|Overall Study||0
2565707|NCT00462280|6291102|P2|NOT COMPLETED|Overall Study||7
2565708|NCT00462280|6291103|P1|NOT COMPLETED|Overall Study||10
2565709|NCT00462280|6291100|P4|COMPLETED|Overall Study||4
2565710|NCT00462280|6291101|P3|COMPLETED|Overall Study||7
2565711|NCT00462280|6291102|P2|COMPLETED|Overall Study||25
2565712|NCT00462280|6291103|P1|COMPLETED|Overall Study||24
2565713|NCT00462280|6291100|P4|STARTED|Overall Study||7
2565714|NCT00462280|6291101|P3|STARTED|Overall Study||7
2565715|NCT00462280|6291102|P2|STARTED|Overall Study||32
2565716|NCT00462280|6291103|P1|STARTED|Overall Study||34
2565717|NCT00462228|6291163|P1|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
2565718|NCT00462228|6291163|P1|COMPLETED|No Treatment (Washout) 4 Weeks||11
2565719|NCT00462228|6291163|P1|STARTED|No Treatment (Washout) 4 Weeks||11
2565720|NCT00462228|6291163|P1|NOT COMPLETED|Placebo or Memantine 12 Weeks||0
2565721|NCT00462228|6291163|P1|COMPLETED|Placebo or Memantine 12 Weeks||11
2565722|NCT00462228|6291163|P1|STARTED|Placebo or Memantine 12 Weeks||11
2565723|NCT00462228|6291163|P1|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
2565724|NCT00462228|6291163|P1|COMPLETED|No Treatment (Washout) 4 Weeks||11
2565725|NCT00462228|6291163|P1|STARTED|No Treatment (Washout) 4 Weeks||11
2565726|NCT00462228|6291163|P1|NOT COMPLETED|Memantine or Placebo 12 Weeks||0
2565727|NCT00462228|6291163|P1|COMPLETED|Memantine or Placebo 12 Weeks||11
2565728|NCT00462228|6291163|P1|STARTED|Memantine or Placebo 12 Weeks||11
2565729|NCT00462124|6291184|P1|NOT COMPLETED|Overall Study||1
2565730|NCT00462124|6291184|P1|COMPLETED|Overall Study|One implant was misplaced and was disacitivated by puncture.|6
2565731|NCT00462124|6291184|P1|STARTED|Overall Study||7
2565732|NCT00462072|6291192|P3|NOT COMPLETED|Week 10||0
2565733|NCT00462072|6291193|P2|NOT COMPLETED|Week 10||0
2565734|NCT00462072|6291194|P1|NOT COMPLETED|Week 10||0
2565735|NCT00462072|6291192|P3|COMPLETED|Week 10||9
2565736|NCT00462072|6291193|P2|COMPLETED|Week 10||12
2565737|NCT00462072|6291194|P1|COMPLETED|Week 10||10
2565738|NCT00462072|6291192|P3|STARTED|Week 10||9
2565739|NCT00462072|6291193|P2|STARTED|Week 10||12
2565740|NCT00462072|6291194|P1|STARTED|Week 10||10
2565741|NCT00462072|6291192|P3|NOT COMPLETED|Baseline (Week 0)||0
2565742|NCT00462072|6291193|P2|NOT COMPLETED|Baseline (Week 0)||0
2565743|NCT00462072|6291194|P1|NOT COMPLETED|Baseline (Week 0)||0
2565744|NCT00462072|6291192|P3|COMPLETED|Baseline (Week 0)||9
2565745|NCT00462072|6291193|P2|COMPLETED|Baseline (Week 0)||12
2565746|NCT00462072|6291194|P1|COMPLETED|Baseline (Week 0)||10
2565747|NCT00462072|6291192|P3|STARTED|Baseline (Week 0)||9
2565748|NCT00462072|6291193|P2|STARTED|Baseline (Week 0)||12
2565749|NCT00462072|6291194|P1|STARTED|Baseline (Week 0)||10
2565750|NCT00462020|6291210|P2|NOT COMPLETED|Overall Study||0
2565751|NCT00462020|6291211|P1|NOT COMPLETED|Overall Study||0
2565752|NCT00462020|6291210|P2|COMPLETED|Overall Study||50
2565753|NCT00462020|6291211|P1|COMPLETED|Overall Study||52
2565754|NCT00462020|6291210|P2|STARTED|Overall Study||50
2565755|NCT00462020|6291211|P1|STARTED|Overall Study||52
2565756|NCT00461981|6291219|P2|NOT COMPLETED|Overall Study||9
2565757|NCT00461981|6291220|P1|NOT COMPLETED|Overall Study||11
2565758|NCT00461981|6291219|P2|COMPLETED|Overall Study||42
2565759|NCT00461981|6291220|P1|COMPLETED|Overall Study||39
2565760|NCT00461981|6291219|P2|STARTED|Overall Study||51
2565761|NCT00461981|6291220|P1|STARTED|Overall Study||50
2565762|NCT00461851|6291330|P1|NOT COMPLETED|Overall Study||0
2565763|NCT00461851|6291330|P1|COMPLETED|Overall Study||17
2565764|NCT00461851|6291330|P1|STARTED|Overall Study||17
2565765|NCT00461812|6291336|P1|NOT COMPLETED|Overall Study||10
2565766|NCT00461812|6291336|P1|COMPLETED|Overall Study||0
2565767|NCT00461812|6291336|P1|STARTED|Overall Study||10
2565768|NCT00461786|6291341|P1|NOT COMPLETED|Overall Study||3
2565769|NCT00461786|6291341|P1|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|48
2565770|NCT00461786|6291341|P1|STARTED|Overall Study||51
2565771|NCT00461734|6291351|P2|NOT COMPLETED|Overall Study||60
2565772|NCT00461734|6291352|P1|NOT COMPLETED|Overall Study||58
2565773|NCT00461734|6291351|P2|COMPLETED|Overall Study||60
2565774|NCT00461734|6291352|P1|COMPLETED|Overall Study||62
2565775|NCT00461734|6291351|P2|STARTED|Overall Study||120
2565776|NCT00461734|6291352|P1|STARTED|Overall Study||120
2565777|NCT00461708|6291386|P2|NOT COMPLETED|Overall Study||38
2565778|NCT00461708|6291387|P1|NOT COMPLETED|Overall Study||115
2565779|NCT00461708|6291386|P2|COMPLETED|Overall Study||0
2565780|NCT00461708|6291387|P1|COMPLETED|Overall Study||0
2565781|NCT00461708|6291386|P2|STARTED|Overall Study||38
2565782|NCT00461708|6291387|P1|STARTED|Overall Study||115
2565783|NCT00461682|6291413|P1|NOT COMPLETED|Overall Study||1
2565784|NCT00461682|6291413|P1|COMPLETED|Overall Study||0
2565785|NCT00461682|6291413|P1|STARTED|Overall Study||1
2565786|NCT00461630|6291441|P2|NOT COMPLETED|Overall Study||827
2565787|NCT00461630|6291442|P1|NOT COMPLETED|Overall Study||906
2565788|NCT00461630|6291441|P2|COMPLETED|Overall Study||12008
2565789|NCT00461630|6291442|P1|COMPLETED|Overall Study||11932
2565790|NCT00461630|6291441|P2|STARTED|Overall Study||12835
2565791|NCT00461630|6291442|P1|STARTED|Overall Study||12838
2565792|NCT00461591|6291458|P2|NOT COMPLETED|Overall Study||85
2565793|NCT00461591|6291459|P1|NOT COMPLETED|Overall Study||89
2565794|NCT00461591|6291458|P2|COMPLETED|Overall Study||311
2565795|NCT00461591|6291459|P1|COMPLETED|Overall Study||317
2565796|NCT00461591|6291458|P2|STARTED|Overall Study||396
2565797|NCT00461591|6291459|P1|STARTED|Overall Study||406
2565798|NCT00461552|6291481|P2|NOT COMPLETED|Overall Study||2
2565799|NCT00461552|6291482|P1|NOT COMPLETED|Overall Study||0
2565800|NCT00461552|6291481|P2|COMPLETED|Overall Study||5
2565801|NCT00461552|6291482|P1|COMPLETED|Overall Study||7
2565802|NCT00461552|6291481|P2|STARTED|Overall Study||7
2565803|NCT00461552|6291482|P1|STARTED|Overall Study||7
2565804|NCT00461513|6291492|P2|NOT COMPLETED|Overall Study||25
2565805|NCT00461513|6291493|P1|NOT COMPLETED|Overall Study||22
2565806|NCT00461513|6291492|P2|COMPLETED|Overall Study||172
2565807|NCT00461513|6291493|P1|COMPLETED|Overall Study||165
2565808|NCT00461513|6291492|P2|STARTED|Overall Study|2 patients dropped at time of randomization|197
2565809|NCT00461513|6291493|P1|STARTED|Overall Study|6 patients dropped at time of randomization|187
2565810|NCT00461500|6291505|P2|NOT COMPLETED|Overall Study||6
2565811|NCT00461500|6291506|P1|NOT COMPLETED|Overall Study||7
2565812|NCT00461500|6291505|P2|COMPLETED|Overall Study||38
2565813|NCT00461500|6291506|P1|COMPLETED|Overall Study||30
2565814|NCT00461500|6291505|P2|STARTED|Overall Study||44
2565815|NCT00461500|6291506|P1|STARTED|Overall Study||37
2565816|NCT00461331|6291536|P2|NOT COMPLETED|Intervention 2||0
2565817|NCT00461331|6291537|P1|NOT COMPLETED|Intervention 2||0
2565818|NCT00461331|6291536|P2|COMPLETED|Intervention 2||10
2565819|NCT00461331|6291537|P1|COMPLETED|Intervention 2||10
2565820|NCT00461331|6291536|P2|STARTED|Intervention 2||10
2565821|NCT00461331|6291537|P1|STARTED|Intervention 2||10
2565822|NCT00461331|6291536|P2|NOT COMPLETED|Washout||0
2565823|NCT00461331|6291537|P1|NOT COMPLETED|Washout||0
2565824|NCT00461331|6291536|P2|COMPLETED|Washout||10
2565825|NCT00461331|6291537|P1|COMPLETED|Washout||10
2565826|NCT00461331|6291536|P2|STARTED|Washout||10
2565827|NCT00461331|6291537|P1|STARTED|Washout||10
2565828|NCT00461331|6291536|P2|NOT COMPLETED|Intervention 1||0
2565829|NCT00461331|6291537|P1|NOT COMPLETED|Intervention 1||0
2565830|NCT00461331|6291536|P2|COMPLETED|Intervention 1||10
2565831|NCT00461331|6291537|P1|COMPLETED|Intervention 1||10
2565832|NCT00461331|6291536|P2|STARTED|Intervention 1||10
2565833|NCT00461331|6291537|P1|STARTED|Intervention 1||10
2565834|NCT00461305|6291549|P2|NOT COMPLETED|Continued Treatment||0
2565835|NCT00461305|6291550|P1|NOT COMPLETED|Continued Treatment||95
2565836|NCT00461305|6291549|P2|COMPLETED|Continued Treatment||0
2565837|NCT00461305|6291550|P1|COMPLETED|Continued Treatment||254
2565838|NCT00461305|6291549|P2|STARTED|Continued Treatment|no participants were treated with the DRSP 3 mg/EE 30 μg combination beyond 6 cycles|0
2565839|NCT00461305|6291550|P1|STARTED|Continued Treatment|FAS, participants from previous treatment who were available to continue treatment|349
2565840|NCT00461305|6291549|P2|NOT COMPLETED|Treatment||9
2565841|NCT00461305|6291550|P1|NOT COMPLETED|Treatment||101
2565842|NCT00461305|6291549|P2|COMPLETED|Treatment||56
2565843|NCT00461305|6291550|P1|COMPLETED|Treatment||254
2565844|NCT00461305|6291549|P2|Subjects Received Treatment|Treatment|FAS, safety population|65
2565845|NCT00461305|6291550|P1|Subjects Received Treatment|Treatment|FAS, safety population|349
2565846|NCT00461305|6291549|P2|Subjects Dispensed Drugs|Treatment||65
2565847|NCT00461305|6291550|P1|Subjects Dispensed Drugs|Treatment||350
2565848|NCT00461305|6291549|P2|STARTED|Treatment|Enrolled|65
2565849|NCT00461305|6291550|P1|STARTED|Treatment|Enrolled|355
2565850|NCT00461292|6291613|P3|NOT COMPLETED|Treatment Cycle 2||0
2565851|NCT00461292|6291614|P2|NOT COMPLETED|Treatment Cycle 2||2
2565852|NCT00461292|6291615|P1|NOT COMPLETED|Treatment Cycle 2||5
2565853|NCT00461292|6291613|P3|COMPLETED|Treatment Cycle 2||0
2565854|NCT00461292|6291614|P2|COMPLETED|Treatment Cycle 2||72
2565855|NCT00461292|6291615|P1|COMPLETED|Treatment Cycle 2||58
2565856|NCT00461292|6291613|P3|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200 U in Cycle 2|0
2565857|NCT00461292|6291614|P2|STARTED|Treatment Cycle 2|42 from the 200U group + 32 from the Placebo group entered Cycle 2|74
2565858|NCT00461292|6291615|P1|STARTED|Treatment Cycle 2|32 from the 300U group + 31 from the Placebo group entered Cycle 2|63
2565859|NCT00461292|6291613|P3|NOT COMPLETED|Treatment Cycle 1||11
2565860|NCT00461292|6291614|P2|NOT COMPLETED|Treatment Cycle 1||12
2565861|NCT00461292|6291615|P1|NOT COMPLETED|Treatment Cycle 1||15
2565862|NCT00461292|6291613|P3|COMPLETED|Treatment Cycle 1||81
2565863|NCT00461292|6291614|P2|COMPLETED|Treatment Cycle 1||80
2565864|NCT00461292|6291615|P1|COMPLETED|Treatment Cycle 1||76
2565865|NCT00461292|6291613|P3|STARTED|Treatment Cycle 1||92
2565866|NCT00461292|6291614|P2|STARTED|Treatment Cycle 1||92
2565867|NCT00461292|6291615|P1|STARTED|Treatment Cycle 1||91
2565868|NCT00461253|6291634|P2|NOT COMPLETED|Overall Study||19798
2565869|NCT00461253|6291635|P1|NOT COMPLETED|Overall Study||4980
2565870|NCT00461253|6291634|P2|COMPLETED|Overall Study|Analyzed controls|20452
2565871|NCT00461253|6291635|P1|COMPLETED|Overall Study|Analyzed cases|5113
2565872|NCT00461253|6291634|P2|STARTED|Overall Study|Identified controls|40250
2565873|NCT00461253|6291635|P1|STARTED|Overall Study|Identified cases|10093
2565874|NCT00461175|6291643|P2|NOT COMPLETED|Overall Study||365
2565875|NCT00461175|6291644|P1|NOT COMPLETED|Overall Study||522
2565876|NCT00461175|6291643|P2|COMPLETED|Overall Study||18370
2565877|NCT00461175|6291644|P1|COMPLETED|Overall Study||43078
2565878|NCT00461175|6291643|P2|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|18735
2565879|NCT00461175|6291644|P1|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|43600
2565880|NCT00461123|6291654|P2|NOT COMPLETED|Overall Study||6
2565881|NCT00461123|6291655|P1|NOT COMPLETED|Overall Study||6
2565882|NCT00461123|6291654|P2|COMPLETED|Overall Study||19
2565883|NCT00461123|6291655|P1|COMPLETED|Overall Study||19
2565884|NCT00461123|6291654|P2|STARTED|Overall Study||25
2565885|NCT00461123|6291655|P1|STARTED|Overall Study||25
2565886|NCT00461097|6291671|P2|NOT COMPLETED|Overall Study||0
2565887|NCT00461097|6291672|P1|NOT COMPLETED|Overall Study||0
2565888|NCT00461097|6291671|P2|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure.|15
2565889|NCT00461097|6291672|P1|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure and outcome measure #6.|40
2565890|NCT00461097|6291671|P2|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||0
2565891|NCT00461097|6291672|P1|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||7
2565892|NCT00461097|6291671|P2|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||0
2565893|NCT00461097|6291672|P1|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||16
2565894|NCT00461097|6291671|P2|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||1
2565895|NCT00461097|6291672|P1|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||34
2565896|NCT00461097|6291671|P2|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||13
2565897|NCT00461097|6291672|P1|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||35
2565898|NCT00461097|6291671|P2|STARTED|Overall Study||15
2565899|NCT00461097|6291672|P1|STARTED|Overall Study||40
2565900|NCT00461045|6291688|P1|NOT COMPLETED|Overall Study||0
2565901|NCT00461045|6291688|P1|COMPLETED|Overall Study||15
2565902|NCT00461045|6291688|P1|STARTED|Overall Study||15
2565903|NCT00461032|6291700|P2|NOT COMPLETED|Overall Study||44
2565904|NCT00461032|6291701|P1|NOT COMPLETED|Overall Study||37
2565905|NCT00461032|6291700|P2|COMPLETED|Overall Study||536
2565906|NCT00461032|6291701|P1|COMPLETED|Overall Study||545
2565907|NCT00461032|6291700|P2|STARTED|Overall Study||580
2565908|NCT00461032|6291701|P1|STARTED|Overall Study||582
2565909|NCT00460993|6291715|P2|NOT COMPLETED|Phase 2 (6 Days)||0
2565910|NCT00460993|6291716|P1|NOT COMPLETED|Phase 2 (6 Days)||0
2565911|NCT00460993|6291715|P2|COMPLETED|Phase 2 (6 Days)||17
2565912|NCT00460993|6291716|P1|COMPLETED|Phase 2 (6 Days)||14
2565913|NCT00460993|6291715|P2|STARTED|Phase 2 (6 Days)||17
2565914|NCT00460993|6291716|P1|STARTED|Phase 2 (6 Days)||14
2565915|NCT00460993|6291715|P2|NOT COMPLETED|Phase 1 (6 Days)||0
2565916|NCT00460993|6291716|P1|NOT COMPLETED|Phase 1 (6 Days)||0
2565917|NCT00460993|6291715|P2|COMPLETED|Phase 1 (6 Days)||17
2565918|NCT00460993|6291716|P1|COMPLETED|Phase 1 (6 Days)||14
2565919|NCT00460993|6291715|P2|STARTED|Phase 1 (6 Days)||17
2565920|NCT00460993|6291716|P1|STARTED|Phase 1 (6 Days)||14
2565921|NCT00460811|6291727|P5|NOT COMPLETED|Overall Study||20
2565922|NCT00460811|6291728|P4|NOT COMPLETED|Overall Study||18
2565923|NCT00460811|6291729|P3|NOT COMPLETED|Overall Study||14
2565924|NCT00460811|6291730|P2|NOT COMPLETED|Overall Study||15
2565925|NCT00460811|6291731|P1|NOT COMPLETED|Overall Study||16
2565926|NCT00460811|6291727|P5|COMPLETED|Overall Study||65
2565927|NCT00460811|6291728|P4|COMPLETED|Overall Study||71
2565928|NCT00460811|6291729|P3|COMPLETED|Overall Study||71
2565929|NCT00460811|6291730|P2|COMPLETED|Overall Study||67
2565930|NCT00460811|6291731|P1|COMPLETED|Overall Study||63
2565931|NCT00460811|6291727|P5|STARTED|Overall Study||85
2565932|NCT00460811|6291728|P4|STARTED|Overall Study||89
2565933|NCT00460811|6291729|P3|STARTED|Overall Study||85
2565934|NCT00460811|6291730|P2|STARTED|Overall Study||82
2565935|NCT00460811|6291731|P1|STARTED|Overall Study||79
2565936|NCT00460798|6291773|P1|NOT COMPLETED|Overall Study||340
2565937|NCT00460798|6291773|P1|COMPLETED|Overall Study||108
2565938|NCT00460798|6291773|P1|Treated|Overall Study|Subjects with complete dosing information were recorded as 'Treated'|421
2565939|NCT00460798|6291773|P1|STARTED|Overall Study||448
2565940|NCT00460746|6291781|P1|NOT COMPLETED|Overall Study||2
2565941|NCT00460746|6291781|P1|COMPLETED|Overall Study||8
2565942|NCT00460746|6291781|P1|STARTED|Overall Study||10
2565943|NCT00460655|6291796|P4|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
2565944|NCT00460655|6291797|P3|NOT COMPLETED|Open-Label Phase (36 Weeks)||7
2565945|NCT00460655|6291798|P2|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
2565946|NCT00460655|6291799|P1|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
2565947|NCT00460655|6291796|P4|COMPLETED|Open-Label Phase (36 Weeks)||52
2565948|NCT00460655|6291797|P3|COMPLETED|Open-Label Phase (36 Weeks)||45
2565949|NCT00460655|6291798|P2|COMPLETED|Open-Label Phase (36 Weeks)||0
2565950|NCT00460655|6291799|P1|COMPLETED|Open-Label Phase (36 Weeks)||0
2565951|NCT00460655|6291796|P4|STARTED|Open-Label Phase (36 Weeks)||61
2565952|NCT00460655|6291797|P3|STARTED|Open-Label Phase (36 Weeks)||52
2565953|NCT00460655|6291798|P2|STARTED|Open-Label Phase (36 Weeks)||0
2565954|NCT00460655|6291799|P1|STARTED|Open-Label Phase (36 Weeks)||0
2565955|NCT00460655|6291796|P4|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
2565956|NCT00460655|6291797|P3|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
2565957|NCT00460655|6291798|P2|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
2565958|NCT00460655|6291799|P1|NOT COMPLETED|Double-Blind Phase (12 Weeks)||6
2565959|NCT00460655|6291796|P4|COMPLETED|Double-Blind Phase (12 Weeks)||0
2565960|NCT00460655|6291797|P3|COMPLETED|Double-Blind Phase (12 Weeks)||0
2565961|NCT00460655|6291798|P2|COMPLETED|Double-Blind Phase (12 Weeks)||61
2565962|NCT00460655|6291799|P1|COMPLETED|Double-Blind Phase (12 Weeks)||52
2565963|NCT00460655|6291796|P4|STARTED|Double-Blind Phase (12 Weeks)||0
2565964|NCT00460655|6291797|P3|STARTED|Double-Blind Phase (12 Weeks)||0
2565965|NCT00460655|6291798|P2|STARTED|Double-Blind Phase (12 Weeks)||62
2565966|NCT00460655|6291799|P1|STARTED|Double-Blind Phase (12 Weeks)||58
2565967|NCT00460603|6291843|P12|NOT COMPLETED|Phase 2||41
2565968|NCT00460603|6291844|P11|NOT COMPLETED|Phase 2||43
2565969|NCT00460603|6291845|P10|NOT COMPLETED|Phase 2||42
2565970|NCT00460603|6291846|P9|NOT COMPLETED|Phase 2||0
2565971|NCT00460603|6291847|P8|NOT COMPLETED|Phase 2||0
2565972|NCT00460603|6291848|P7|NOT COMPLETED|Phase 2||0
2565973|NCT00460603|6291849|P6|NOT COMPLETED|Phase 2||0
2565974|NCT00460603|6291850|P5|NOT COMPLETED|Phase 2||0
2565975|NCT00460603|6291851|P4|NOT COMPLETED|Phase 2||0
2565976|NCT00460603|6291852|P3|NOT COMPLETED|Phase 2||0
2565977|NCT00460603|6291853|P2|NOT COMPLETED|Phase 2||0
2565978|NCT00460603|6291854|P1|NOT COMPLETED|Phase 2||0
2565979|NCT00460603|6291843|P12|COMPLETED|Phase 2||0
2565980|NCT00460603|6291844|P11|COMPLETED|Phase 2||0
2565981|NCT00460603|6291845|P10|COMPLETED|Phase 2||0
2565982|NCT00460603|6291846|P9|COMPLETED|Phase 2||0
2565983|NCT00460603|6291847|P8|COMPLETED|Phase 2||0
2565984|NCT00460603|6291848|P7|COMPLETED|Phase 2||0
2565985|NCT00460603|6291849|P6|COMPLETED|Phase 2||0
2565986|NCT00460603|6291850|P5|COMPLETED|Phase 2||0
2565987|NCT00460603|6291851|P4|COMPLETED|Phase 2||0
2565988|NCT00460603|6291852|P3|COMPLETED|Phase 2||0
2565989|NCT00460603|6291853|P2|COMPLETED|Phase 2||0
2565990|NCT00460603|6291854|P1|COMPLETED|Phase 2||0
2565991|NCT00460603|6291843|P12|Treated|Phase 2||41
2565992|NCT00460603|6291844|P11|Treated|Phase 2||43
2565993|NCT00460603|6291845|P10|Treated|Phase 2||39
2565994|NCT00460603|6291846|P9|Treated|Phase 2||0
2565995|NCT00460603|6291847|P8|Treated|Phase 2||0
2565996|NCT00460603|6291848|P7|Treated|Phase 2||0
2565997|NCT00460603|6291849|P6|Treated|Phase 2||0
2565998|NCT00460603|6291850|P5|Treated|Phase 2||0
2565999|NCT00460603|6291851|P4|Treated|Phase 2||0
2566000|NCT00460603|6291852|P3|Treated|Phase 2||0
2566001|NCT00460603|6291853|P2|Treated|Phase 2||0
2566002|NCT00460603|6291854|P1|Treated|Phase 2||0
2566003|NCT00460603|6291843|P12|STARTED|Phase 2||41
2566004|NCT00460603|6291844|P11|STARTED|Phase 2||43
2566005|NCT00460603|6291845|P10|STARTED|Phase 2||42
2566006|NCT00460603|6291846|P9|STARTED|Phase 2||0
2566007|NCT00460603|6291847|P8|STARTED|Phase 2||0
2566008|NCT00460603|6291848|P7|STARTED|Phase 2||0
2566009|NCT00460603|6291849|P6|STARTED|Phase 2||0
2566010|NCT00460603|6291850|P5|STARTED|Phase 2||0
2566011|NCT00460603|6291851|P4|STARTED|Phase 2||0
2566012|NCT00460603|6291852|P3|STARTED|Phase 2||0
2566013|NCT00460603|6291853|P2|STARTED|Phase 2||0
2566014|NCT00460603|6291854|P1|STARTED|Phase 2||0
2566015|NCT00460603|6291843|P12|NOT COMPLETED|Phase 1||0
2566016|NCT00460603|6291844|P11|NOT COMPLETED|Phase 1||0
2566017|NCT00460603|6291845|P10|NOT COMPLETED|Phase 1||0
2566018|NCT00460603|6291846|P9|NOT COMPLETED|Phase 1||18
2566019|NCT00460603|6291847|P8|NOT COMPLETED|Phase 1||3
2566020|NCT00460603|6291848|P7|NOT COMPLETED|Phase 1||6
2566021|NCT00460603|6291849|P6|NOT COMPLETED|Phase 1||4
2566022|NCT00460603|6291850|P5|NOT COMPLETED|Phase 1||6
2566023|NCT00460603|6291851|P4|NOT COMPLETED|Phase 1||8
2566024|NCT00460603|6291852|P3|NOT COMPLETED|Phase 1||4
2566025|NCT00460603|6291853|P2|NOT COMPLETED|Phase 1||6
2566026|NCT00460603|6291854|P1|NOT COMPLETED|Phase 1||6
2566027|NCT00460603|6291843|P12|COMPLETED|Phase 1||0
2566028|NCT00460603|6291844|P11|COMPLETED|Phase 1||0
2566029|NCT00460603|6291845|P10|COMPLETED|Phase 1||0
2566030|NCT00460603|6291846|P9|COMPLETED|Phase 1||0
2566031|NCT00460603|6291847|P8|COMPLETED|Phase 1||0
2566032|NCT00460603|6291848|P7|COMPLETED|Phase 1||0
2566033|NCT00460603|6291849|P6|COMPLETED|Phase 1||0
2566034|NCT00460603|6291850|P5|COMPLETED|Phase 1||0
2566035|NCT00460603|6291851|P4|COMPLETED|Phase 1||0
2566036|NCT00460603|6291852|P3|COMPLETED|Phase 1||0
2566037|NCT00460603|6291853|P2|COMPLETED|Phase 1||0
2566038|NCT00460603|6291854|P1|COMPLETED|Phase 1||0
2566039|NCT00460603|6291843|P12|STARTED|Phase 1||0
2566040|NCT00460603|6291844|P11|STARTED|Phase 1||0
2566041|NCT00460603|6291845|P10|STARTED|Phase 1||0
2566042|NCT00460603|6291846|P9|STARTED|Phase 1||18
2566043|NCT00460603|6291847|P8|STARTED|Phase 1||3
2566044|NCT00460603|6291848|P7|STARTED|Phase 1||6
2566045|NCT00460603|6291849|P6|STARTED|Phase 1||4
2566046|NCT00460603|6291850|P5|STARTED|Phase 1||6
2566047|NCT00460603|6291851|P4|STARTED|Phase 1||8
2566048|NCT00460603|6291852|P3|STARTED|Phase 1||4
2566049|NCT00460603|6291853|P2|STARTED|Phase 1||6
2566050|NCT00460603|6291854|P1|STARTED|Phase 1||6
2566051|NCT00460577|6291948|P2|NOT COMPLETED|Overall Study||6
2566052|NCT00460577|6291949|P1|NOT COMPLETED|Overall Study||2
2566053|NCT00460577|6291948|P2|COMPLETED|Overall Study||24
2566054|NCT00460577|6291949|P1|COMPLETED|Overall Study||28
2566055|NCT00460577|6291948|P2|STARTED|Overall Study||30
2566056|NCT00460577|6291949|P1|STARTED|Overall Study|148 patients were screened; however, 22 did not consent and 66 did not meet inclusion/exclusion.|30
2566057|NCT00460564|6291967|P8|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
2566058|NCT00460564|6291968|P7|NOT COMPLETED|Open-Label Phase (36 Weeks)||2
2566059|NCT00460564|6291969|P6|NOT COMPLETED|Open-Label Phase (36 Weeks)||6
2566060|NCT00460564|6291970|P5|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
2566061|NCT00460564|6291971|P4|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
2566062|NCT00460564|6291972|P3|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
2566063|NCT00460564|6291973|P2|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
2566064|NCT00460564|6291974|P1|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
2566065|NCT00460564|6291967|P8|COMPLETED|Open-Label Phase (36 Weeks)||11
2566066|NCT00460564|6291968|P7|COMPLETED|Open-Label Phase (36 Weeks)||19
2566067|NCT00460564|6291969|P6|COMPLETED|Open-Label Phase (36 Weeks)||19
2566068|NCT00460564|6291970|P5|COMPLETED|Open-Label Phase (36 Weeks)||38
2566069|NCT00460564|6291971|P4|COMPLETED|Open-Label Phase (36 Weeks)||0
2566070|NCT00460564|6291972|P3|COMPLETED|Open-Label Phase (36 Weeks)||0
2566071|NCT00460564|6291973|P2|COMPLETED|Open-Label Phase (36 Weeks)||0
2566072|NCT00460564|6291974|P1|COMPLETED|Open-Label Phase (36 Weeks)||0
2566073|NCT00460564|6291967|P8|STARTED|Open-Label Phase (36 Weeks)||11
2566074|NCT00460564|6291968|P7|STARTED|Open-Label Phase (36 Weeks)||21
2566075|NCT00460564|6291969|P6|STARTED|Open-Label Phase (36 Weeks)||25
2566076|NCT00460564|6291970|P5|STARTED|Open-Label Phase (36 Weeks)||47
2566077|NCT00460564|6291971|P4|STARTED|Open-Label Phase (36 Weeks)||0
2566078|NCT00460564|6291972|P3|STARTED|Open-Label Phase (36 Weeks)||0
2566079|NCT00460564|6291973|P2|STARTED|Open-Label Phase (36 Weeks)||0
2566080|NCT00460564|6291974|P1|STARTED|Open-Label Phase (36 Weeks)||0
2566081|NCT00460564|6291967|P8|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
2566082|NCT00460564|6291968|P7|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
2566083|NCT00460564|6291969|P6|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
2566084|NCT00460564|6291970|P5|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
2566085|NCT00460564|6291971|P4|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
2566086|NCT00460564|6291972|P3|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
2566087|NCT00460564|6291973|P2|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
2566088|NCT00460564|6291974|P1|NOT COMPLETED|Double-Blind Phase (12 Weeks)||4
2566089|NCT00460564|6291967|P8|COMPLETED|Double-Blind Phase (12 Weeks)||0
2566090|NCT00460564|6291968|P7|COMPLETED|Double-Blind Phase (12 Weeks)||0
2566091|NCT00460564|6291969|P6|COMPLETED|Double-Blind Phase (12 Weeks)||0
2566092|NCT00460564|6291970|P5|COMPLETED|Double-Blind Phase (12 Weeks)||0
2566093|NCT00460564|6291971|P4|COMPLETED|Double-Blind Phase (12 Weeks)||11
2566094|NCT00460564|6291972|P3|COMPLETED|Double-Blind Phase (12 Weeks)||21
2566095|NCT00460564|6291973|P2|COMPLETED|Double-Blind Phase (12 Weeks)||25
2566096|NCT00460564|6291974|P1|COMPLETED|Double-Blind Phase (12 Weeks)||47
2566097|NCT00460564|6291967|P8|STARTED|Double-Blind Phase (12 Weeks)||0
2566098|NCT00460564|6291968|P7|STARTED|Double-Blind Phase (12 Weeks)||0
2566099|NCT00460564|6291969|P6|STARTED|Double-Blind Phase (12 Weeks)||0
2566100|NCT00460564|6291970|P5|STARTED|Double-Blind Phase (12 Weeks)||0
2566101|NCT00460564|6291971|P4|STARTED|Double-Blind Phase (12 Weeks)||11
2566102|NCT00460564|6291972|P3|STARTED|Double-Blind Phase (12 Weeks)||21
2566103|NCT00460564|6291973|P2|STARTED|Double-Blind Phase (12 Weeks)||26
2566104|NCT00460564|6291974|P1|STARTED|Double-Blind Phase (12 Weeks)||51
2566105|NCT00460551|6292068|P1|NOT COMPLETED|Overall Study||0
2566106|NCT00460551|6292068|P1|COMPLETED|Overall Study|The trial was terminated after Period 1A. Only safety was measured.|13
2566107|NCT00460551|6292068|P1|STARTED|Overall Study||13
2566108|NCT00460525|6292075|P2|NOT COMPLETED|Overall Study||5
2566109|NCT00460525|6292076|P1|NOT COMPLETED|Overall Study||11
2566110|NCT00460525|6292075|P2|COMPLETED|Overall Study||194
2566111|NCT00460525|6292076|P1|COMPLETED|Overall Study||190
2566112|NCT00460525|6292075|P2|STARTED|Overall Study||199
2566113|NCT00460525|6292076|P1|STARTED|Overall Study||201
2566114|NCT00460434|6292118|P2|NOT COMPLETED|Overall Study||7
2566115|NCT00460434|6292119|P1|NOT COMPLETED|Overall Study||3
2566116|NCT00460434|6292118|P2|COMPLETED|Overall Study||165
2566117|NCT00460434|6292119|P1|COMPLETED|Overall Study||162
2566118|NCT00460434|6292118|P2|12 Months|Overall Study||165
2566119|NCT00460434|6292119|P1|12 Months|Overall Study||162
2566120|NCT00460434|6292118|P2|3 Months|Overall Study||171
2566121|NCT00460434|6292119|P1|3 Months|Overall Study||163
2566122|NCT00460434|6292118|P2|STARTED|Overall Study||172
2566123|NCT00460434|6292119|P1|STARTED|Overall Study||165
2566124|NCT00460421|6292148|P3|NOT COMPLETED|Overall Study||0
2566125|NCT00460421|6292149|P2|NOT COMPLETED|Overall Study||0
2566126|NCT00460421|6292150|P1|NOT COMPLETED|Overall Study||0
2566127|NCT00460421|6292148|P3|COMPLETED|Overall Study||9
2566128|NCT00460421|6292149|P2|COMPLETED|Overall Study||9
2566129|NCT00460421|6292150|P1|COMPLETED|Overall Study||9
2566130|NCT00460421|6292148|P3|STARTED|Overall Study||9
2566131|NCT00460421|6292149|P2|STARTED|Overall Study||9
2566132|NCT00460421|6292150|P1|STARTED|Overall Study||9
2566133|NCT00460408|6292198|P4|NOT COMPLETED|Overall Study||0
2566134|NCT00460408|6292199|P3|NOT COMPLETED|Overall Study||6
2566135|NCT00460408|6292200|P2|NOT COMPLETED|Overall Study||3
2566136|NCT00460408|6292201|P1|NOT COMPLETED|Overall Study||67
2566137|NCT00460408|6292198|P4|COMPLETED|Overall Study||7
2566138|NCT00460408|6292199|P3|COMPLETED|Overall Study||69
2566139|NCT00460408|6292200|P2|COMPLETED|Overall Study||13
2566140|NCT00460408|6292201|P1|COMPLETED|Overall Study||336
2566141|NCT00460408|6292198|P4|STARTED|Overall Study||7
2566142|NCT00460408|6292199|P3|STARTED|Overall Study||75
2566143|NCT00460408|6292200|P2|STARTED|Overall Study||16
2566144|NCT00460408|6292201|P1|STARTED|Overall Study||403
2566145|NCT00460265|6292238|P2|NOT COMPLETED|Overall Study||89
2566146|NCT00460265|6292239|P1|NOT COMPLETED|Overall Study||85
2566147|NCT00460265|6292238|P2|COMPLETED|Overall Study|Completed study=death|241
2566148|NCT00460265|6292239|P1|COMPLETED|Overall Study|Completed study=death|243
2566149|NCT00460265|6292238|P2|Received Study Medication|Overall Study||325
2566150|NCT00460265|6292239|P1|Received Study Medication|Overall Study||325
2566151|NCT00460265|6292238|P2|Randomized While Alive|Overall Study||330
2566152|NCT00460265|6292239|P1|Randomized While Alive|Overall Study|1 subject was randomized by error after death|327
2566153|NCT00460265|6292238|P2|STARTED|Overall Study||330
2566154|NCT00460265|6292239|P1|STARTED|Overall Study||328
2566155|NCT00460239|6292255|P9|NOT COMPLETED|Overall Study||0
2566156|NCT00460239|6292256|P8|NOT COMPLETED|Overall Study||0
2566157|NCT00460239|6292257|P7|NOT COMPLETED|Overall Study||0
2566158|NCT00460239|6292258|P6|NOT COMPLETED|Overall Study||3
2566159|NCT00460239|6292259|P5|NOT COMPLETED|Overall Study||0
2566160|NCT00460239|6292260|P4|NOT COMPLETED|Overall Study||0
2566161|NCT00460239|6292261|P3|NOT COMPLETED|Overall Study||0
2566162|NCT00460239|6292262|P2|NOT COMPLETED|Overall Study||1
2566163|NCT00460239|6292263|P1|NOT COMPLETED|Overall Study||0
2566164|NCT00460239|6292255|P9|COMPLETED|Overall Study||1
2566165|NCT00460239|6292256|P8|COMPLETED|Overall Study||1
2566166|NCT00460239|6292257|P7|COMPLETED|Overall Study||1
2566167|NCT00460239|6292258|P6|COMPLETED|Overall Study||1
2566168|NCT00460239|6292259|P5|COMPLETED|Overall Study||1
2566169|NCT00460239|6292260|P4|COMPLETED|Overall Study||0
2566170|NCT00460239|6292261|P3|COMPLETED|Overall Study||1
2566171|NCT00460239|6292262|P2|COMPLETED|Overall Study||2
2566172|NCT00460239|6292263|P1|COMPLETED|Overall Study||0
2566173|NCT00460239|6292255|P9|STARTED|Overall Study||1
2566174|NCT00460239|6292256|P8|STARTED|Overall Study||1
2566175|NCT00460239|6292257|P7|STARTED|Overall Study||1
2566176|NCT00460239|6292258|P6|STARTED|Overall Study||4
2566177|NCT00460239|6292259|P5|STARTED|Overall Study||1
2566178|NCT00460239|6292260|P4|STARTED|Overall Study||0
2566179|NCT00460239|6292261|P3|STARTED|Overall Study||1
2566180|NCT00460239|6292262|P2|STARTED|Overall Study||3
2566181|NCT00460239|6292263|P1|STARTED|Overall Study||0
2566182|NCT00460109|6292332|P1|NOT COMPLETED|Overall Study||1
2566183|NCT00460109|6292332|P1|COMPLETED|Overall Study||23
2566184|NCT00460109|6292332|P1|STARTED|Overall Study||24
2566185|NCT00460031|6292340|P1|NOT COMPLETED|Overall Study||11
2566186|NCT00460031|6292340|P1|COMPLETED|Overall Study||23
2566187|NCT00460031|6292340|P1|STARTED|Overall Study||34
2566188|NCT00459979|6292348|P1|NOT COMPLETED|Overall Study||2
2566189|NCT00459979|6292348|P1|COMPLETED|Overall Study||28
2566190|NCT00459979|6292348|P1|STARTED|Overall Study||30
2566191|NCT00459953|6292360|P2|NOT COMPLETED|Overall Study||1
2566192|NCT00459953|6292361|P1|NOT COMPLETED|Overall Study||1
2566193|NCT00459953|6292360|P2|COMPLETED|Overall Study||70
2566194|NCT00459953|6292361|P1|COMPLETED|Overall Study||71
2566195|NCT00459953|6292360|P2|STARTED|Overall Study||71
2566196|NCT00459953|6292361|P1|STARTED|Overall Study||72
2566197|NCT00459875|6292367|P1|NOT COMPLETED|Overall Study||3
2566198|NCT00459875|6292367|P1|COMPLETED|Overall Study||21
2566199|NCT00459875|6292367|P1|STARTED|Overall Study||24
2566200|NCT00459862|6292371|P1|NOT COMPLETED|Overall Study||0
2566201|NCT00459862|6292371|P1|COMPLETED|Overall Study||34
2566202|NCT00459862|6292371|P1|STARTED|Overall Study||34
2566203|NCT00459810|6292380|P1|NOT COMPLETED|Overall Study||0
2566204|NCT00459810|6292380|P1|COMPLETED|Overall Study||21
2566205|NCT00459810|6292380|P1|STARTED|Overall Study||21
2566206|NCT00459732|6292390|P2|NOT COMPLETED|Overall Study||3
2566207|NCT00459732|6292391|P1|NOT COMPLETED|Overall Study||4
2566208|NCT00459732|6292390|P2|COMPLETED|Overall Study|3 on placebo dropped: 1 pregnant after 12 mo, 1 lost to followup, one died after 12 month timepoint|14
2566209|NCT00459732|6292391|P1|COMPLETED|Overall Study|4 on zn dropped: 1 pregnant and 1 nausea after baseline, 1 lost to followup, 1 exited after 12 month|19
2566210|NCT00459732|6292390|P2|STARTED|Overall Study||17
2566211|NCT00459732|6292391|P1|STARTED|Overall Study||23
2566212|NCT00459706|6292403|P2|NOT COMPLETED|Overall Study||21
2566213|NCT00459706|6292404|P1|NOT COMPLETED|Overall Study||26
2566214|NCT00459706|6292403|P2|COMPLETED|Overall Study||294
2566215|NCT00459706|6292404|P1|COMPLETED|Overall Study||299
2566216|NCT00459706|6292403|P2|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|2 participants withdrew consent before the first injection|313
2566217|NCT00459706|6292404|P1|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|1 participant had no evaluation after the first injection|324
2566218|NCT00459706|6292403|P2|STARTED|Overall Study||315
2566219|NCT00459706|6292404|P1|STARTED|Overall Study||325
2566220|NCT00459667|6292547|P3|NOT COMPLETED|Overall Study||20
2566221|NCT00459667|6292548|P2|NOT COMPLETED|Overall Study||47
2566222|NCT00459667|6292549|P1|NOT COMPLETED|Overall Study||38
2566223|NCT00459667|6292547|P3|COMPLETED|Overall Study||161
2566224|NCT00459667|6292548|P2|COMPLETED|Overall Study||600
2566225|NCT00459667|6292549|P1|COMPLETED|Overall Study||554
2566226|NCT00459667|6292547|P3|Started Treatment|Overall Study||180
2566227|NCT00459667|6292548|P2|Started Treatment|Overall Study||644
2566228|NCT00459667|6292549|P1|Started Treatment|Overall Study||586
2566229|NCT00459667|6292547|P3|Study Medication Dispensed|Overall Study||180
2566230|NCT00459667|6292548|P2|Study Medication Dispensed|Overall Study||645
2566231|NCT00459667|6292549|P1|Study Medication Dispensed|Overall Study||586
2566232|NCT00459667|6292547|P3|STARTED|Overall Study||181
2566233|NCT00459667|6292548|P2|STARTED|Overall Study||647
2566234|NCT00459667|6292549|P1|STARTED|Overall Study||592
2566235|NCT00459537|6292571|P2|NOT COMPLETED|Overall Study||76
2566236|NCT00459537|6292572|P1|NOT COMPLETED|Overall Study||66
2566237|NCT00459537|6292571|P2|COMPLETED|Overall Study||446
2566238|NCT00459537|6292572|P1|COMPLETED|Overall Study||441
2566239|NCT00459537|6292571|P2|Safety Population|Overall Study||512
2566240|NCT00459537|6292572|P1|Safety Population|Overall Study|Participants who had at least one dose of study drug and one post-baseline safety assessment.|493
2566241|NCT00459537|6292571|P2|STARTED|Overall Study||522
2566242|NCT00459537|6292572|P1|STARTED|Overall Study||507
2566243|NCT00459381|6292586|P1|NOT COMPLETED|Overall Study||0
2566244|NCT00459381|6292586|P1|COMPLETED|Overall Study||35
2566245|NCT00459381|6292586|P1|STARTED|Overall Study||35
2566246|NCT00459368|6292598|P2|NOT COMPLETED|Overall Study||329
2566247|NCT00459368|6292599|P1|NOT COMPLETED|Overall Study||295
2566248|NCT00459368|6292598|P2|COMPLETED|Overall Study||1034
2566249|NCT00459368|6292599|P1|COMPLETED|Overall Study||1040
2566250|NCT00459368|6292598|P2|STARTED|Overall Study||1363
2566251|NCT00459368|6292599|P1|STARTED|Overall Study||1335
2566252|NCT00459355|6292607|P2|NOT COMPLETED|Overall Study||18
2566253|NCT00459355|6292608|P1|NOT COMPLETED|Overall Study||20
2566254|NCT00459355|6292607|P2|COMPLETED|Overall Study|Includes 48 dyads, caregiver + care-recipient|96
2566255|NCT00459355|6292608|P1|COMPLETED|Overall Study|Includes 60 dyads, caregiver + care-recipient|120
2566256|NCT00459355|6292607|P2|STARTED|Overall Study|Includes 57 dyads, caregiver + care-recipient|114
2566257|NCT00459355|6292608|P1|STARTED|Overall Study|Includes 70 dyads, caregiver/care-recipient|140
2566258|NCT00459342|6292620|P1|NOT COMPLETED|Overall Study||1
2566259|NCT00459342|6292620|P1|COMPLETED|Overall Study||34
2566260|NCT00459342|6292620|P1|STARTED|Overall Study||35
2566261|NCT00459316|6292633|P3|NOT COMPLETED|Step 3||1
2566262|NCT00459316|6292634|P2|NOT COMPLETED|Step 3||0
2566263|NCT00459316|6292635|P1|NOT COMPLETED|Step 3||3
2566264|NCT00459316|6292633|P3|COMPLETED|Step 3||39
2566265|NCT00459316|6292634|P2|COMPLETED|Step 3||0
2566266|NCT00459316|6292635|P1|COMPLETED|Step 3||149
2566267|NCT00459316|6292633|P3|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|40
2566268|NCT00459316|6292634|P2|STARTED|Step 3|Group 2 participants were not eligible for Step 3|0
2566269|NCT00459316|6292635|P1|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|152
2566270|NCT00459316|6292633|P3|NOT COMPLETED|Steps 1 & 2||2
2566271|NCT00459316|6292634|P2|NOT COMPLETED|Steps 1 & 2||7
2566272|NCT00459316|6292635|P1|NOT COMPLETED|Steps 1 & 2||21
2566273|NCT00459316|6292633|P3|COMPLETED|Steps 1 & 2||57
2566274|NCT00459316|6292634|P2|COMPLETED|Steps 1 & 2||32
2566275|NCT00459316|6292635|P1|COMPLETED|Steps 1 & 2||259
2566276|NCT00459316|6292633|P3|STARTED|Steps 1 & 2||59
2566277|NCT00459316|6292634|P2|STARTED|Steps 1 & 2||39
2566278|NCT00459316|6292635|P1|STARTED|Steps 1 & 2||280
2566279|NCT00459303|6292689|P1|NOT COMPLETED|Overall Study||0
2566280|NCT00459303|6292689|P1|COMPLETED|Overall Study||20
2566281|NCT00459303|6292689|P1|STARTED|Overall Study||20
2566282|NCT00459290|6292700|P1|NOT COMPLETED|Overall Study||5
2566283|NCT00459290|6292700|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|19
2566284|NCT00459290|6292700|P1|STARTED|Overall Study||24
2566285|NCT00459186|6292715|P1|NOT COMPLETED|Combination RAD001 + Docetaxel||0
2566286|NCT00459186|6292715|P1|COMPLETED|Combination RAD001 + Docetaxel||15
2566287|NCT00459186|6292715|P1|STARTED|Combination RAD001 + Docetaxel||15
2566288|NCT00459186|6292715|P1|NOT COMPLETED|PET Imaging and Assessment||3
2566289|NCT00459186|6292715|P1|COMPLETED|PET Imaging and Assessment||15
2566290|NCT00459186|6292715|P1|STARTED|PET Imaging and Assessment||18
2566291|NCT00459186|6292715|P1|NOT COMPLETED|Single Agent RAD001||1
2566292|NCT00459186|6292715|P1|COMPLETED|Single Agent RAD001||18
2566293|NCT00459186|6292715|P1|STARTED|Single Agent RAD001||19
2566294|NCT00459134|6292722|P2|NOT COMPLETED|Overall Study||25
2566295|NCT00459134|6292723|P1|NOT COMPLETED|Overall Study||23
2566296|NCT00459134|6292722|P2|COMPLETED|Overall Study||67
2566297|NCT00459134|6292723|P1|COMPLETED|Overall Study||71
2566298|NCT00459134|6292722|P2|STARTED|Overall Study||92
2566299|NCT00459134|6292723|P1|STARTED|Overall Study||94
2566300|NCT00459121|6292731|P1|NOT COMPLETED|Overall Study||0
2566301|NCT00459121|6292731|P1|COMPLETED|Overall Study||2
2566302|NCT00459121|6292731|P1|STARTED|Overall Study||2
2566303|NCT00459108|6292739|P1|NOT COMPLETED|Overall Study||11
2566304|NCT00459108|6292739|P1|COMPLETED|Overall Study||14
2566305|NCT00459108|6292739|P1|STARTED|Overall Study||25
2566306|NCT00459056|6292749|P2|NOT COMPLETED|Second Intervention (Final Three Months)||0
2566307|NCT00459056|6292750|P1|NOT COMPLETED|Second Intervention (Final Three Months)||0
2566308|NCT00459056|6292749|P2|COMPLETED|Second Intervention (Final Three Months)||14
2566309|NCT00459056|6292750|P1|COMPLETED|Second Intervention (Final Three Months)||9
2566310|NCT00459056|6292749|P2|STARTED|Second Intervention (Final Three Months)||14
2566311|NCT00459056|6292750|P1|STARTED|Second Intervention (Final Three Months)||9
2566312|NCT00459056|6292749|P2|NOT COMPLETED|Washout (1 Month)||0
2566313|NCT00459056|6292750|P1|NOT COMPLETED|Washout (1 Month)||0
2566314|NCT00459056|6292749|P2|COMPLETED|Washout (1 Month)||14
2566315|NCT00459056|6292750|P1|COMPLETED|Washout (1 Month)||9
2566316|NCT00459056|6292749|P2|STARTED|Washout (1 Month)||14
2566317|NCT00459056|6292750|P1|STARTED|Washout (1 Month)||9
2566318|NCT00459056|6292749|P2|NOT COMPLETED|First Intervention (First Three Months)||1
2566319|NCT00459056|6292750|P1|NOT COMPLETED|First Intervention (First Three Months)||1
2566320|NCT00459056|6292749|P2|COMPLETED|First Intervention (First Three Months)||14
2566321|NCT00459056|6292750|P1|COMPLETED|First Intervention (First Three Months)||9
2566322|NCT00459056|6292749|P2|STARTED|First Intervention (First Three Months)||15
2566323|NCT00459056|6292750|P1|STARTED|First Intervention (First Three Months)||10
2566324|NCT00459043|6292758|P2|NOT COMPLETED|Overall Study||0
2566325|NCT00459043|6292759|P1|NOT COMPLETED|Overall Study||1
2566326|NCT00459043|6292758|P2|COMPLETED|Overall Study||15
2566327|NCT00459043|6292759|P1|COMPLETED|Overall Study||14
2566328|NCT00459043|6292758|P2|STARTED|Overall Study||15
2566329|NCT00459043|6292759|P1|STARTED|Overall Study||15
2566330|NCT00458952|6292771|P2|NOT COMPLETED|Overall Study||5
2566331|NCT00458952|6292772|P1|NOT COMPLETED|Overall Study||2
2566332|NCT00458952|6292771|P2|COMPLETED|Overall Study||9
2566333|NCT00458952|6292772|P1|COMPLETED|Overall Study||5
2566334|NCT00458952|6292771|P2|STARTED|Overall Study||14
2566335|NCT00458952|6292772|P1|STARTED|Overall Study||7
2566336|NCT00458848|6292776|P1|NOT COMPLETED|Overall Study||0
2566337|NCT00458848|6292776|P1|COMPLETED|Overall Study||51
2566338|NCT00458848|6292776|P1|STARTED|Overall Study||51
2566339|NCT00458822|6292782|P1|NOT COMPLETED|Overall Study||0
2566340|NCT00458822|6292782|P1|COMPLETED|Overall Study||40
2566341|NCT00458822|6292782|P1|STARTED|Overall Study||40
2566342|NCT00458705|6292786|P1|NOT COMPLETED|Overall Study||5
2566343|NCT00458705|6292786|P1|COMPLETED|Overall Study||40
2566344|NCT00458705|6292786|P1|STARTED|Overall Study||45
2566345|NCT00458536|6292790|P1|NOT COMPLETED|Overall Study||19
2566346|NCT00458536|6292790|P1|COMPLETED|Overall Study||19
2566347|NCT00458536|6292790|P1|STARTED|Overall Study||38
2566348|NCT00458406|6292796|P2|NOT COMPLETED|Month 3||0
2566349|NCT00458406|6292797|P1|NOT COMPLETED|Month 3||0
2566350|NCT00458406|6292796|P2|COMPLETED|Month 3||13
2566351|NCT00458406|6292797|P1|COMPLETED|Month 3||43
2566352|NCT00458406|6292796|P2|STARTED|Month 3||13
2566353|NCT00458406|6292797|P1|STARTED|Month 3||43
2566354|NCT00458406|6292796|P2|NOT COMPLETED|Month 1||0
2566355|NCT00458406|6292797|P1|NOT COMPLETED|Month 1||0
2566356|NCT00458406|6292796|P2|COMPLETED|Month 1||13
2566357|NCT00458406|6292797|P1|COMPLETED|Month 1||43
2566358|NCT00458406|6292796|P2|STARTED|Month 1||13
2566359|NCT00458406|6292797|P1|STARTED|Month 1||43
2566360|NCT00458393|6292821|P2|NOT COMPLETED|Overall Study||295
2566361|NCT00458393|6292822|P1|NOT COMPLETED|Overall Study||309
2566362|NCT00458393|6292821|P2|COMPLETED|Overall Study||953
2566363|NCT00458393|6292822|P1|COMPLETED|Overall Study||942
2566364|NCT00458393|6292821|P2|STARTED|Overall Study||1248
2566365|NCT00458393|6292822|P1|STARTED|Overall Study||1251
2566366|NCT00458302|6292870|P2|NOT COMPLETED|Overall Study||24
2566367|NCT00458302|6292871|P1|NOT COMPLETED|Overall Study||20
2566368|NCT00458302|6292870|P2|COMPLETED|Overall Study||103
2566369|NCT00458302|6292871|P1|COMPLETED|Overall Study||109
2566370|NCT00458302|6292870|P2|STARTED|Overall Study||127
2566371|NCT00458302|6292871|P1|STARTED|Overall Study||129
2566372|NCT00458237|6292905|P3|NOT COMPLETED|Overall Study||0
2566373|NCT00458237|6292906|P2|NOT COMPLETED|Overall Study||0
2566374|NCT00458237|6292907|P1|NOT COMPLETED|Overall Study||0
2566375|NCT00458237|6292905|P3|COMPLETED|Overall Study||5
2566376|NCT00458237|6292906|P2|COMPLETED|Overall Study||3
2566377|NCT00458237|6292907|P1|COMPLETED|Overall Study||3
2566378|NCT00458237|6292905|P3|STARTED|Overall Study||5
2566379|NCT00458237|6292906|P2|STARTED|Overall Study||3
2566380|NCT00458237|6292907|P1|STARTED|Overall Study||3
2566381|NCT00458211|6292916|P1|NOT COMPLETED|Overall Study||16
2566382|NCT00458211|6292916|P1|COMPLETED|Overall Study|12 early termination 2 protocol violation 2 ( from Rochester) withdrawn from further analysis|24
2566383|NCT00458211|6292916|P1|STARTED|Overall Study||40
2566384|NCT00457977|6292929|P2|NOT COMPLETED|Overall Study||25
2566385|NCT00457977|6292930|P1|NOT COMPLETED|Overall Study||28
2566386|NCT00457977|6292929|P2|COMPLETED|Overall Study||66
2566387|NCT00457977|6292930|P1|COMPLETED|Overall Study||62
2566388|NCT00457977|6292929|P2|2-Year|Overall Study||66
2566389|NCT00457977|6292930|P1|2-Year|Overall Study||62
2566390|NCT00457977|6292929|P2|1-Year|Overall Study||76
2566391|NCT00457977|6292930|P1|1-Year|Overall Study||69
2566392|NCT00457977|6292929|P2|1-Month|Overall Study||87
2566393|NCT00457977|6292930|P1|1-Month|Overall Study||88
2566394|NCT00457977|6292929|P2|STARTED|Overall Study||91
2566395|NCT00457977|6292930|P1|STARTED|Overall Study||90
2566396|NCT00457951|6292941|P3|NOT COMPLETED|Overall Study||12
2566397|NCT00457951|6292942|P2|NOT COMPLETED|Overall Study||16
2566398|NCT00457951|6292943|P1|NOT COMPLETED|Overall Study||0
2566399|NCT00457951|6292941|P3|COMPLETED|Overall Study||60
2566400|NCT00457951|6292942|P2|COMPLETED|Overall Study||50
2566401|NCT00457951|6292943|P1|COMPLETED|Overall Study||13
2566402|NCT00457951|6292941|P3|STARTED|Overall Study||72
2566403|NCT00457951|6292942|P2|STARTED|Overall Study||66
2566404|NCT00457951|6292943|P1|STARTED|Overall Study||13
2566405|NCT00457821|6292958|P8|NOT COMPLETED|Part 2||1
2566406|NCT00457821|6292959|P7|NOT COMPLETED|Part 2||0
2566407|NCT00457821|6292960|P6|NOT COMPLETED|Part 2||0
2566408|NCT00457821|6292961|P5|NOT COMPLETED|Part 2||0
2566409|NCT00457821|6292962|P4|NOT COMPLETED|Part 2||0
2566410|NCT00457821|6292963|P3|NOT COMPLETED|Part 2||0
2566411|NCT00457821|6292964|P2|NOT COMPLETED|Part 2||0
2566412|NCT00457821|6292965|P1|NOT COMPLETED|Part 2||0
2566413|NCT00457821|6292958|P8|COMPLETED|Part 2||4
2566414|NCT00457821|6292959|P7|COMPLETED|Part 2||7
2566415|NCT00457821|6292960|P6|COMPLETED|Part 2||8
2566416|NCT00457821|6292961|P5|COMPLETED|Part 2||0
2566417|NCT00457821|6292962|P4|COMPLETED|Part 2||0
2566418|NCT00457821|6292963|P3|COMPLETED|Part 2||0
2566419|NCT00457821|6292964|P2|COMPLETED|Part 2||0
2566420|NCT00457821|6292965|P1|COMPLETED|Part 2||0
2566421|NCT00457821|6292958|P8|Completed Study Drug Treatment|Part 2||4
2566422|NCT00457821|6292959|P7|Completed Study Drug Treatment|Part 2|1 subject missed a 250-mg dose of ivacaftor on Day 28 of Part 2.|7
2566423|NCT00457821|6292960|P6|Completed Study Drug Treatment|Part 2||8
2566424|NCT00457821|6292961|P5|Completed Study Drug Treatment|Part 2||0
2566425|NCT00457821|6292962|P4|Completed Study Drug Treatment|Part 2||0
2566426|NCT00457821|6292963|P3|Completed Study Drug Treatment|Part 2||0
2566427|NCT00457821|6292964|P2|Completed Study Drug Treatment|Part 2||0
2566428|NCT00457821|6292965|P1|Completed Study Drug Treatment|Part 2||0
2566429|NCT00457821|6292958|P8|STARTED|Part 2|All subjects who received at least 1 dose of study drug (placebo).|5
2566430|NCT00457821|6292959|P7|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|7
2566431|NCT00457821|6292960|P6|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|8
2566432|NCT00457821|6292961|P5|STARTED|Part 2|Arm in Part 1 only|0
2566433|NCT00457821|6292962|P4|STARTED|Part 2|Arm in Part 1 only|0
2566434|NCT00457821|6292963|P3|STARTED|Part 2|Arm in Part 1 only|0
2566435|NCT00457821|6292964|P2|STARTED|Part 2|Arm in Part 1 only|0
2566436|NCT00457821|6292965|P1|STARTED|Part 2|Arm in Part 1 only|0
2566437|NCT00457821|6292958|P8|NOT COMPLETED|Part 1||0
2566438|NCT00457821|6292959|P7|NOT COMPLETED|Part 1||0
2566439|NCT00457821|6292960|P6|NOT COMPLETED|Part 1||0
2566440|NCT00457821|6292961|P5|NOT COMPLETED|Part 1||0
2566441|NCT00457821|6292962|P4|NOT COMPLETED|Part 1||0
2566442|NCT00457821|6292963|P3|NOT COMPLETED|Part 1||1
2566443|NCT00457821|6292964|P2|NOT COMPLETED|Part 1||0
2566444|NCT00457821|6292965|P1|NOT COMPLETED|Part 1||0
2566445|NCT00457821|6292958|P8|COMPLETED|Part 1||0
2566446|NCT00457821|6292959|P7|COMPLETED|Part 1||0
2566447|NCT00457821|6292960|P6|COMPLETED|Part 1||0
2566448|NCT00457821|6292961|P5|COMPLETED|Part 1||4
2566449|NCT00457821|6292962|P4|COMPLETED|Part 1||4
2566450|NCT00457821|6292963|P3|COMPLETED|Part 1||4
2566451|NCT00457821|6292964|P2|COMPLETED|Part 1||4
2566452|NCT00457821|6292965|P1|COMPLETED|Part 1||4
2566453|NCT00457821|6292958|P8|STARTED|Part 1|Arm in Part 2 only|0
2566454|NCT00457821|6292959|P7|STARTED|Part 1|Arm in Part 2 only|0
2566455|NCT00457821|6292960|P6|STARTED|Part 1|Arm in Part 2 only|0
2566456|NCT00457821|6292961|P5|STARTED|Part 1|Number of subjects randomized|4
2566457|NCT00457821|6292962|P4|STARTED|Part 1|Number of subjects randomized|4
2566458|NCT00457821|6292963|P3|STARTED|Part 1|Number of subjects randomized|5
2566459|NCT00457821|6292964|P2|STARTED|Part 1|Number of subjects randomized|4
2566460|NCT00457821|6292965|P1|STARTED|Part 1|Number of subjects randomized|4
2566461|NCT00457795|6292994|P1|NOT COMPLETED|Overall Study||0
2566462|NCT00457795|6292994|P1|COMPLETED|Overall Study||15
2566463|NCT00457795|6292994|P1|STARTED|Overall Study||15
2566464|NCT00457743|6293004|P3|NOT COMPLETED|Overall Study||3
2566465|NCT00457743|6293005|P2|NOT COMPLETED|Overall Study||27
2566466|NCT00457743|6293006|P1|NOT COMPLETED|Overall Study||3
2566467|NCT00457743|6293004|P3|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis(Intent-to treat population).|0
2566468|NCT00457743|6293005|P2|COMPLETED|Overall Study|However, all 30 subjects enrolled were included in analysis(Intent-to treat population).|3
2566469|NCT00457743|6293006|P1|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis (Intent-to treat population).|0
2566470|NCT00457743|6293004|P3|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
2566471|NCT00457743|6293005|P2|Enrolled in Phase 2|Overall Study|Six subjects who completed Phase 1 entered Phase 2, and 24 subjects were newly enrolled.|30
2566472|NCT00457743|6293006|P1|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
2566473|NCT00457743|6293004|P3|Completed Phase 1|Overall Study||3
2566474|NCT00457743|6293005|P2|Completed Phase 1|Overall Study||6
2566475|NCT00457743|6293006|P1|Completed Phase 1|Overall Study||3
2566476|NCT00457743|6293004|P3|Enrolled in Phase 1|Overall Study||3
2566477|NCT00457743|6293005|P2|Enrolled in Phase 1|Overall Study||6
2566478|NCT00457743|6293006|P1|Enrolled in Phase 1|Overall Study||3
2566479|NCT00457743|6293004|P3|STARTED|Overall Study|Overall study|3
2566480|NCT00457743|6293005|P2|STARTED|Overall Study|Overall study|30
2566481|NCT00457743|6293006|P1|STARTED|Overall Study|Overall study|3
2566482|NCT00457730|6293050|P2|NOT COMPLETED|Overall Study||1
2566483|NCT00457730|6293051|P1|NOT COMPLETED|Overall Study||4
2566484|NCT00457730|6293050|P2|COMPLETED|Overall Study||19
2566485|NCT00457730|6293051|P1|COMPLETED|Overall Study||14
2566486|NCT00457730|6293050|P2|STARTED|Overall Study||20
2566487|NCT00457730|6293051|P1|STARTED|Overall Study||18
2566488|NCT00457691|6293063|P2|NOT COMPLETED|Overall Study||382
2566489|NCT00457691|6293064|P1|NOT COMPLETED|Overall Study||386
2566490|NCT00457691|6293063|P2|COMPLETED|Overall Study||0
2566491|NCT00457691|6293064|P1|COMPLETED|Overall Study||0
2566492|NCT00457691|6293063|P2|STARTED|Overall Study||382
2566493|NCT00457691|6293064|P1|STARTED|Overall Study||386
2566494|NCT00457665|6293086|P2|NOT COMPLETED|24 Months||8
2566495|NCT00457665|6293087|P1|NOT COMPLETED|24 Months||5
2566496|NCT00457665|6293086|P2|COMPLETED|24 Months||11
2566497|NCT00457665|6293087|P1|COMPLETED|24 Months||15
2566498|NCT00457665|6293086|P2|STARTED|24 Months||19
2566499|NCT00457665|6293087|P1|STARTED|24 Months||20
2566500|NCT00457665|6293086|P2|NOT COMPLETED|12 Months||9
2566501|NCT00457665|6293087|P1|NOT COMPLETED|12 Months||8
2566502|NCT00457665|6293086|P2|COMPLETED|12 Months||19
2566503|NCT00457665|6293087|P1|COMPLETED|12 Months||20
2566504|NCT00457665|6293086|P2|STARTED|12 Months||28
2566505|NCT00457665|6293087|P1|STARTED|12 Months||28
2566506|NCT00457639|6293093|P2|NOT COMPLETED|Intervention 2 (6 Months)||1
2566507|NCT00457639|6293094|P1|NOT COMPLETED|Intervention 2 (6 Months)||0
2566508|NCT00457639|6293093|P2|COMPLETED|Intervention 2 (6 Months)||6
2566509|NCT00457639|6293094|P1|COMPLETED|Intervention 2 (6 Months)||6
2566510|NCT00457639|6293093|P2|STARTED|Intervention 2 (6 Months)||7
2566511|NCT00457639|6293094|P1|STARTED|Intervention 2 (6 Months)||6
2566512|NCT00457639|6293093|P2|NOT COMPLETED|Intervention 1 (6 Months)||2
2566513|NCT00457639|6293094|P1|NOT COMPLETED|Intervention 1 (6 Months)||3
2566514|NCT00457639|6293093|P2|COMPLETED|Intervention 1 (6 Months)|Number of patients completing Placebo Phase|7
2566515|NCT00457639|6293094|P1|COMPLETED|Intervention 1 (6 Months)|Number of Patients completing Cholic Acid Phase|6
2566516|NCT00457639|6293093|P2|STARTED|Intervention 1 (6 Months)|6 months on Placebo and crossover to cholic acid for 6 months|9
2566517|NCT00457639|6293094|P1|STARTED|Intervention 1 (6 Months)|6 months on Cholic Acid and crossover to Placebo for 6 months|9
2566518|NCT00457418|6293102|P1|NOT COMPLETED|Post PK Maintenance||28
2566519|NCT00457418|6293102|P1|COMPLETED|Post PK Maintenance||3
2566520|NCT00457418|6293102|P1|STARTED|Post PK Maintenance|4 participants didn't complete the PK sampling phase but continued to post PK maintenance treatment.|31
2566521|NCT00457418|6293102|P1|NOT COMPLETED|Pharmacokinetic (PK) Sampling Phase||5
2566522|NCT00457418|6293102|P1|COMPLETED|Pharmacokinetic (PK) Sampling Phase||27
2566523|NCT00457418|6293102|P1|STARTED|Pharmacokinetic (PK) Sampling Phase||32
2566524|NCT00457392|6293114|P2|NOT COMPLETED|Overall Study||480
2566525|NCT00457392|6293115|P1|NOT COMPLETED|Overall Study||480
2566526|NCT00457392|6293114|P2|COMPLETED|Overall Study||0
2566527|NCT00457392|6293115|P1|COMPLETED|Overall Study||0
2566528|NCT00457392|6293114|P2|Treated|Overall Study||477
2566529|NCT00457392|6293115|P1|Treated|Overall Study||473
2566530|NCT00457392|6293114|P2|STARTED|Overall Study||480
2566531|NCT00457392|6293115|P1|STARTED|Overall Study||480
2566532|NCT00457366|6293133|P2|NOT COMPLETED|Overall Study||0
2566533|NCT00457366|6293134|P1|NOT COMPLETED|Overall Study||0
2566534|NCT00457366|6293133|P2|COMPLETED|Overall Study||32
2566535|NCT00457366|6293134|P1|COMPLETED|Overall Study||40
2566536|NCT00457366|6293133|P2|STARTED|Overall Study||32
2566537|NCT00457366|6293134|P1|STARTED|Overall Study||40
2566538|NCT00457301|6293142|P2|NOT COMPLETED|Overall Study||24
2566539|NCT00457301|6293143|P1|NOT COMPLETED|Overall Study||23
2566540|NCT00457301|6293142|P2|COMPLETED|Overall Study||84
2566541|NCT00457301|6293143|P1|COMPLETED|Overall Study||82
2566542|NCT00457301|6293142|P2|STARTED|Overall Study||108
2566543|NCT00457301|6293143|P1|STARTED|Overall Study||105
2566544|NCT00457249|6293157|P2|NOT COMPLETED|Overall Study||2
2566545|NCT00457249|6293158|P1|NOT COMPLETED|Overall Study||12
2566546|NCT00457249|6293157|P2|COMPLETED|Overall Study||389
2566547|NCT00457249|6293158|P1|COMPLETED|Overall Study||1158
2566548|NCT00457249|6293157|P2|STARTED|Overall Study||391
2566549|NCT00457249|6293158|P1|STARTED|Overall Study||1170
2566550|NCT00457197|6293172|P2|NOT COMPLETED|Overall Study||1
2566551|NCT00457197|6293173|P1|NOT COMPLETED|Overall Study||1
2566552|NCT00457197|6293172|P2|COMPLETED|Overall Study||44
2566553|NCT00457197|6293173|P1|COMPLETED|Overall Study||44
2566554|NCT00457197|6293172|P2|STARTED|Overall Study||45
2566555|NCT00457197|6293173|P1|STARTED|Overall Study||45
2566556|NCT00457015|6293197|P2|NOT COMPLETED|Overall Study||1
2566557|NCT00457015|6293198|P1|NOT COMPLETED|Overall Study||0
2566558|NCT00457015|6293197|P2|COMPLETED|Overall Study||47
2566559|NCT00457015|6293198|P1|COMPLETED|Overall Study||48
2566560|NCT00457015|6293197|P2|STARTED|Overall Study||48
2566561|NCT00457015|6293198|P1|STARTED|Overall Study||48
2566562|NCT00457002|6293214|P2|NOT COMPLETED|Overall Study||757
2566563|NCT00457002|6293215|P1|NOT COMPLETED|Overall Study||813
2566564|NCT00457002|6293214|P2|COMPLETED|Overall Study||2516
2566565|NCT00457002|6293215|P1|COMPLETED|Overall Study||2442
2566566|NCT00457002|6293214|P2|STARTED|Overall Study||3273
2566567|NCT00457002|6293215|P1|STARTED|Overall Study||3255
2566568|NCT00456989|6293283|P1|NOT COMPLETED|Overall Study||0
2566569|NCT00456989|6293283|P1|COMPLETED|Overall Study||39
2566570|NCT00456989|6293283|P1|STARTED|Overall Study||39
2566571|NCT00456885|6293288|P2|NOT COMPLETED|Second Treatment Period, 16 Weeks||0
2566572|NCT00456885|6293289|P1|NOT COMPLETED|Second Treatment Period, 16 Weeks||1
2566573|NCT00456885|6293288|P2|COMPLETED|Second Treatment Period, 16 Weeks||17
2566574|NCT00456885|6293289|P1|COMPLETED|Second Treatment Period, 16 Weeks||23
2566575|NCT00456885|6293288|P2|STARTED|Second Treatment Period, 16 Weeks||17
2566576|NCT00456885|6293289|P1|STARTED|Second Treatment Period, 16 Weeks||24
2566577|NCT00456885|6293288|P2|NOT COMPLETED|Washout, 3 Weeks||0
2566578|NCT00456885|6293289|P1|NOT COMPLETED|Washout, 3 Weeks||0
2566579|NCT00456885|6293288|P2|COMPLETED|Washout, 3 Weeks||17
2566580|NCT00456885|6293289|P1|COMPLETED|Washout, 3 Weeks||24
2566581|NCT00456885|6293288|P2|STARTED|Washout, 3 Weeks||17
2566582|NCT00456885|6293289|P1|STARTED|Washout, 3 Weeks||24
2566583|NCT00456885|6293288|P2|NOT COMPLETED|First Treatment Period, 16 Weeks||0
2566584|NCT00456885|6293289|P1|NOT COMPLETED|First Treatment Period, 16 Weeks||0
2566585|NCT00456885|6293288|P2|COMPLETED|First Treatment Period, 16 Weeks||17
2566586|NCT00456885|6293289|P1|COMPLETED|First Treatment Period, 16 Weeks||24
2566587|NCT00456885|6293288|P2|STARTED|First Treatment Period, 16 Weeks||17
2566588|NCT00456885|6293289|P1|STARTED|First Treatment Period, 16 Weeks||24
2566589|NCT00456846|6293320|P2|NOT COMPLETED|Overall Study||28
2566590|NCT00456846|6293321|P1|NOT COMPLETED|Overall Study||16
2566591|NCT00456846|6293320|P2|COMPLETED|Overall Study|Treatment considered completed upon disease progression|48
2566592|NCT00456846|6293321|P1|COMPLETED|Overall Study|Treatment considered completed upon disease progression|31
2566593|NCT00456846|6293320|P2|STARTED|Overall Study||76
2566594|NCT00456846|6293321|P1|STARTED|Overall Study||47
2566595|NCT00456807|6293343|P2|NOT COMPLETED|Overall Study||0
2566596|NCT00456807|6293344|P1|NOT COMPLETED|Overall Study||1
2566597|NCT00456807|6293343|P2|COMPLETED|Overall Study||47
2566598|NCT00456807|6293344|P1|COMPLETED|Overall Study||52
2566599|NCT00456807|6293343|P2|STARTED|Overall Study||47
2566600|NCT00456807|6293344|P1|STARTED|Overall Study||53
2566601|NCT00456755|6293362|P2|NOT COMPLETED|Overall Study||1
2566602|NCT00456755|6293363|P1|NOT COMPLETED|Overall Study||2
2566603|NCT00456755|6293362|P2|COMPLETED|Overall Study||62
2566604|NCT00456755|6293363|P1|COMPLETED|Overall Study||61
2566605|NCT00456755|6293362|P2|STARTED|Overall Study||63
2566606|NCT00456755|6293363|P1|STARTED|Overall Study||63
2566607|NCT00456625|6293371|P1|NOT COMPLETED|Overall Study||0
2566608|NCT00456625|6293371|P1|COMPLETED|Overall Study||76
2566609|NCT00456625|6293371|P1|STARTED|Overall Study||76
2566610|NCT00456612|6293377|P1|NOT COMPLETED|Overall Study||3
2566611|NCT00456612|6293377|P1|COMPLETED|Overall Study||1
2566612|NCT00456612|6293377|P1|STARTED|Overall Study||4
2566613|NCT00456599|6293382|P1|NOT COMPLETED|Overall Study||3
2566614|NCT00456599|6293382|P1|COMPLETED|Overall Study||68
2566615|NCT00456599|6293382|P1|Completed 4th Cycle of Chemotherapy|Overall Study|24 patients (63%) completed a fourth cycle of chemotherapy.|24
2566616|NCT00456599|6293382|P1|Post-Surgery Adjuvent Therapy|Overall Study|After resection, 26 patients (68%) initiated adjuvant therapy.|26
2566617|NCT00456599|6293382|P1|Completed Resection|Overall Study|43 patients underwent resection.|43
2566618|NCT00456599|6293382|P1|Completed Protocol Surgery|Overall Study|Forty-eight patients (71%) underwent laparotomy according to the protocol.|48
2566619|NCT00456599|6293382|P1|Initiated Cycle 2|Overall Study|5 patients were removed from study prior to initiation of a second cycle.|61
2566620|NCT00456599|6293382|P1|Completed Cycle 1|Overall Study|Of the 71 patients, 1 was removed for noncompliance; 2 withdrew; 2 did not complete cycle 1.|66
2566621|NCT00456599|6293382|P1|STARTED|Overall Study||71
2566622|NCT00456547|6293390|P2|NOT COMPLETED|Overall Study||0
2566623|NCT00456547|6293391|P1|NOT COMPLETED|Overall Study||0
2566624|NCT00456547|6293390|P2|COMPLETED|Overall Study||12
2566625|NCT00456547|6293391|P1|COMPLETED|Overall Study||12
2566626|NCT00456547|6293390|P2|STARTED|Overall Study||12
2566627|NCT00456547|6293391|P1|STARTED|Overall Study||12
2566628|NCT00456521|6293405|P2|NOT COMPLETED|Overall Study||84
2566629|NCT00456521|6293406|P1|NOT COMPLETED|Overall Study||249
2566630|NCT00456521|6293405|P2|COMPLETED|Overall Study||118
2566631|NCT00456521|6293406|P1|COMPLETED|Overall Study||342
2566632|NCT00456521|6293405|P2|STARTED|Overall Study||202
2566633|NCT00456521|6293406|P1|STARTED|Overall Study||591
2566634|NCT00456508|6293446|P1|NOT COMPLETED|Overall Study||0
2566635|NCT00456508|6293446|P1|COMPLETED|Overall Study||147
2566636|NCT00456508|6293446|P1|STARTED|Overall Study||147
2566637|NCT00456495|6293452|P1|NOT COMPLETED|Overall Study||2
2566638|NCT00456495|6293452|P1|COMPLETED|Overall Study||3
2566639|NCT00456495|6293452|P1|STARTED|Overall Study||5
2566640|NCT00456365|6293459|P2|NOT COMPLETED|Overall Study||12
2566641|NCT00456365|6293460|P1|NOT COMPLETED|Overall Study||7
2566642|NCT00456365|6293459|P2|COMPLETED|Overall Study||42
2566643|NCT00456365|6293460|P1|COMPLETED|Overall Study||49
2566644|NCT00456365|6293459|P2|STARTED|Overall Study||54
2566645|NCT00456365|6293460|P1|STARTED|Overall Study||56
2566646|NCT00456300|6293472|P2|NOT COMPLETED|Overall Study||0
2566647|NCT00456300|6293473|P1|NOT COMPLETED|Overall Study||1
2566648|NCT00456300|6293472|P2|COMPLETED|Overall Study||4
2566649|NCT00456300|6293473|P1|COMPLETED|Overall Study||4
2566650|NCT00456300|6293472|P2|STARTED|Overall Study||4
2566651|NCT00456300|6293473|P1|STARTED|Overall Study||5
2566652|NCT00456261|6293483|P2|NOT COMPLETED|Maintenance Therapy||0
2566653|NCT00456261|6293484|P1|NOT COMPLETED|Maintenance Therapy||0
2566654|NCT00456261|6293483|P2|COMPLETED|Maintenance Therapy||29
2566655|NCT00456261|6293484|P1|COMPLETED|Maintenance Therapy||3
2566656|NCT00456261|6293483|P2|STARTED|Maintenance Therapy||29
2566657|NCT00456261|6293484|P1|STARTED|Maintenance Therapy||3
2566658|NCT00456261|6293483|P2|NOT COMPLETED|Combination Therapy||26
2566659|NCT00456261|6293484|P1|NOT COMPLETED|Combination Therapy||52
2566660|NCT00456261|6293483|P2|COMPLETED|Combination Therapy||29
2566661|NCT00456261|6293484|P1|COMPLETED|Combination Therapy||3
2566662|NCT00456261|6293483|P2|STARTED|Combination Therapy||55
2566663|NCT00456261|6293484|P1|STARTED|Combination Therapy||55
2566664|NCT00456092|6293497|P5|NOT COMPLETED|Treatment Phase (12 Weeks)||0
2566665|NCT00456092|6293498|P4|NOT COMPLETED|Treatment Phase (12 Weeks)||0
2566666|NCT00456092|6293499|P3|NOT COMPLETED|Treatment Phase (12 Weeks)||18
2566667|NCT00456092|6293500|P2|NOT COMPLETED|Treatment Phase (12 Weeks)||14
2566668|NCT00456092|6293501|P1|NOT COMPLETED|Treatment Phase (12 Weeks)||7
2566669|NCT00456092|6293497|P5|COMPLETED|Treatment Phase (12 Weeks)||0
2566670|NCT00456092|6293498|P4|COMPLETED|Treatment Phase (12 Weeks)||0
2566671|NCT00456092|6293499|P3|COMPLETED|Treatment Phase (12 Weeks)||50
2566672|NCT00456092|6293500|P2|COMPLETED|Treatment Phase (12 Weeks)||55
2566673|NCT00456092|6293501|P1|COMPLETED|Treatment Phase (12 Weeks)||60
2566674|NCT00456092|6293497|P5|STARTED|Treatment Phase (12 Weeks)||0
2566675|NCT00456092|6293498|P4|STARTED|Treatment Phase (12 Weeks)||0
2566676|NCT00456092|6293499|P3|STARTED|Treatment Phase (12 Weeks)||68
2566677|NCT00456092|6293500|P2|STARTED|Treatment Phase (12 Weeks)||69
2566678|NCT00456092|6293501|P1|STARTED|Treatment Phase (12 Weeks)||67
2566679|NCT00456092|6293497|P5|NOT COMPLETED|Extension Phase||7
2566680|NCT00456092|6293498|P4|NOT COMPLETED|Extension Phase||1
2566681|NCT00456092|6293499|P3|NOT COMPLETED|Extension Phase||0
2566682|NCT00456092|6293500|P2|NOT COMPLETED|Extension Phase||4
2566683|NCT00456092|6293501|P1|NOT COMPLETED|Extension Phase||11
2566684|NCT00456092|6293497|P5|COMPLETED|Extension Phase||13
2566685|NCT00456092|6293498|P4|COMPLETED|Extension Phase||19
2566686|NCT00456092|6293499|P3|COMPLETED|Extension Phase||0
2566687|NCT00456092|6293500|P2|COMPLETED|Extension Phase||36
2566688|NCT00456092|6293501|P1|COMPLETED|Extension Phase||35
2566689|NCT00456092|6293497|P5|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|20
2566690|NCT00456092|6293498|P4|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|20
2566691|NCT00456092|6293499|P3|STARTED|Extension Phase||0
2566692|NCT00456092|6293500|P2|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|40
2566693|NCT00456092|6293501|P1|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|46
2566694|NCT00456014|6293651|P1|NOT COMPLETED|Tricyclic Phase||3
2566695|NCT00456014|6293651|P1|COMPLETED|Tricyclic Phase||1
2566696|NCT00456014|6293651|P1|STARTED|Tricyclic Phase|Only non-remitters from phase 1 were eligible for phase 2, and not all those eligible continued.|4
2566697|NCT00456014|6293651|P1|NOT COMPLETED|SSRI Phase||9
2566698|NCT00456014|6293651|P1|COMPLETED|SSRI Phase||28
2566699|NCT00456014|6293651|P1|STARTED|SSRI Phase||37
2566700|NCT00455975|6293659|P2|NOT COMPLETED|Overall Study||21
2566701|NCT00455975|6293660|P1|NOT COMPLETED|Overall Study||18
2566702|NCT00455975|6293659|P2|COMPLETED|Overall Study||40
2566703|NCT00455975|6293660|P1|COMPLETED|Overall Study||40
2566704|NCT00455975|6293659|P2|STARTED|Overall Study||61
2566705|NCT00455975|6293660|P1|STARTED|Overall Study||58
2566706|NCT00455962|6293674|P2|NOT COMPLETED|Overall Study||0
2566707|NCT00455962|6293675|P1|NOT COMPLETED|Overall Study||0
2566708|NCT00455962|6293674|P2|COMPLETED|Overall Study||13
2566709|NCT00455962|6293675|P1|COMPLETED|Overall Study||10
2566710|NCT00455962|6293674|P2|STARTED|Overall Study||13
2566711|NCT00455962|6293675|P1|STARTED|Overall Study||10
2566712|NCT00455923|6293683|P2|NOT COMPLETED|Overall Study||3
2566713|NCT00455923|6293684|P1|NOT COMPLETED|Overall Study||3
2566714|NCT00455923|6293683|P2|COMPLETED|Overall Study||47
2566715|NCT00455923|6293684|P1|COMPLETED|Overall Study||47
2566716|NCT00455923|6293683|P2|STARTED|Overall Study||50
2566717|NCT00455923|6293684|P1|STARTED|Overall Study||50
2566718|NCT00455858|6293700|P1|NOT COMPLETED|Overall Study||6
2566719|NCT00455858|6293700|P1|COMPLETED|Overall Study||81
2566720|NCT00455858|6293700|P1|STARTED|Overall Study|Enrolled in study and exposed to study drug|87
2566721|NCT00455741|6293710|P2|NOT COMPLETED|Overall Study||1
2566722|NCT00455741|6293711|P1|NOT COMPLETED|Overall Study||0
2566723|NCT00455741|6293710|P2|COMPLETED|Overall Study||11
2566724|NCT00455741|6293711|P1|COMPLETED|Overall Study||13
2566725|NCT00455741|6293710|P2|STARTED|Overall Study||12
2566726|NCT00455741|6293711|P1|STARTED|Overall Study||13
2566727|NCT00455702|6293729|P2|NOT COMPLETED|Overall Study||3
2566728|NCT00455702|6293730|P1|NOT COMPLETED|Overall Study||3
2566729|NCT00455702|6293729|P2|COMPLETED|Overall Study||16
2566730|NCT00455702|6293730|P1|COMPLETED|Overall Study||16
2566731|NCT00455702|6293729|P2|STARTED|Overall Study||19
2566732|NCT00455702|6293730|P1|STARTED|Overall Study||19
2566733|NCT00455689|6293740|P2|NOT COMPLETED|Overall Study||0
2566734|NCT00455689|6293741|P1|NOT COMPLETED|Overall Study||0
2566735|NCT00455689|6293740|P2|COMPLETED|Overall Study||6
2566736|NCT00455689|6293741|P1|COMPLETED|Overall Study||14
2566737|NCT00455689|6293740|P2|STARTED|Overall Study||6
2566738|NCT00455689|6293741|P1|STARTED|Overall Study||14
2566739|NCT00455663|6293751|P3|NOT COMPLETED|Overall Study||3
2566740|NCT00455663|6293752|P2|NOT COMPLETED|Overall Study||4
2566741|NCT00455663|6293753|P1|NOT COMPLETED|Overall Study||3
2566742|NCT00455663|6293751|P3|COMPLETED|Overall Study||29
2566743|NCT00455663|6293752|P2|COMPLETED|Overall Study||32
2566744|NCT00455663|6293753|P1|COMPLETED|Overall Study||34
2566745|NCT00455663|6293751|P3|STARTED|Overall Study||32
2566746|NCT00455663|6293752|P2|STARTED|Overall Study||36
2566747|NCT00455663|6293753|P1|STARTED|Overall Study||37
2566748|NCT00455650|6293772|P6|NOT COMPLETED|Week 3||0
2566749|NCT00455650|6293773|P5|NOT COMPLETED|Week 3||0
2566750|NCT00455650|6293774|P4|NOT COMPLETED|Week 3||0
2566751|NCT00455650|6293775|P3|NOT COMPLETED|Week 3||0
2566752|NCT00455650|6293776|P2|NOT COMPLETED|Week 3||0
2566753|NCT00455650|6293777|P1|NOT COMPLETED|Week 3||0
2566754|NCT00455650|6293772|P6|COMPLETED|Week 3||13
2566755|NCT00455650|6293773|P5|COMPLETED|Week 3||14
2566756|NCT00455650|6293774|P4|COMPLETED|Week 3||14
2566757|NCT00455650|6293775|P3|COMPLETED|Week 3||10
2566758|NCT00455650|6293776|P2|COMPLETED|Week 3||10
2566759|NCT00455650|6293777|P1|COMPLETED|Week 3||10
2566760|NCT00455650|6293772|P6|STARTED|Week 3||13
2566761|NCT00455650|6293773|P5|STARTED|Week 3||14
2566762|NCT00455650|6293774|P4|STARTED|Week 3||14
2566763|NCT00455650|6293775|P3|STARTED|Week 3||10
2566764|NCT00455650|6293776|P2|STARTED|Week 3||10
2566765|NCT00455650|6293777|P1|STARTED|Week 3||10
2566766|NCT00455650|6293772|P6|NOT COMPLETED|Week 2||0
2566767|NCT00455650|6293773|P5|NOT COMPLETED|Week 2||0
2566768|NCT00455650|6293774|P4|NOT COMPLETED|Week 2||0
2566769|NCT00455650|6293775|P3|NOT COMPLETED|Week 2||0
2566770|NCT00455650|6293776|P2|NOT COMPLETED|Week 2||0
2566771|NCT00455650|6293777|P1|NOT COMPLETED|Week 2||0
2566772|NCT00455650|6293772|P6|COMPLETED|Week 2||13
2566773|NCT00455650|6293773|P5|COMPLETED|Week 2||14
2566774|NCT00455650|6293774|P4|COMPLETED|Week 2||14
2566775|NCT00455650|6293775|P3|COMPLETED|Week 2||10
2566776|NCT00455650|6293776|P2|COMPLETED|Week 2||10
2566777|NCT00455650|6293777|P1|COMPLETED|Week 2||10
2566778|NCT00455650|6293772|P6|STARTED|Week 2||13
2566779|NCT00455650|6293773|P5|STARTED|Week 2||14
2566780|NCT00455650|6293774|P4|STARTED|Week 2||14
2566781|NCT00455650|6293775|P3|STARTED|Week 2||10
2566782|NCT00455650|6293776|P2|STARTED|Week 2||10
2566783|NCT00455650|6293777|P1|STARTED|Week 2||10
2566784|NCT00455650|6293772|P6|NOT COMPLETED|Week 1||0
2566785|NCT00455650|6293773|P5|NOT COMPLETED|Week 1||0
2566786|NCT00455650|6293774|P4|NOT COMPLETED|Week 1||0
2566787|NCT00455650|6293775|P3|NOT COMPLETED|Week 1||0
2566788|NCT00455650|6293776|P2|NOT COMPLETED|Week 1||0
2566789|NCT00455650|6293777|P1|NOT COMPLETED|Week 1||0
2566790|NCT00455650|6293772|P6|COMPLETED|Week 1||13
2566791|NCT00455650|6293773|P5|COMPLETED|Week 1||14
2566792|NCT00455650|6293774|P4|COMPLETED|Week 1||14
2566793|NCT00455650|6293775|P3|COMPLETED|Week 1||10
2566794|NCT00455650|6293776|P2|COMPLETED|Week 1||10
2566795|NCT00455650|6293777|P1|COMPLETED|Week 1||10
2566796|NCT00455650|6293772|P6|STARTED|Week 1||13
2566797|NCT00455650|6293773|P5|STARTED|Week 1||14
2566798|NCT00455650|6293774|P4|STARTED|Week 1||14
2566799|NCT00455650|6293775|P3|STARTED|Week 1||10
2566800|NCT00455650|6293776|P2|STARTED|Week 1||10
2566801|NCT00455650|6293777|P1|STARTED|Week 1||10
2566802|NCT00455533|6293807|P3|NOT COMPLETED|Period Two: Randomized Period||6
2566803|NCT00455533|6293808|P2|NOT COMPLETED|Period Two: Randomized Period||6
2566804|NCT00455533|6293809|P1|NOT COMPLETED|Period Two: Randomized Period||0
2566805|NCT00455533|6293807|P3|COMPLETED|Period Two: Randomized Period||138
2566806|NCT00455533|6293808|P2|COMPLETED|Period Two: Randomized Period||139
2566807|NCT00455533|6293809|P1|COMPLETED|Period Two: Randomized Period||0
2566808|NCT00455533|6293807|P3|STARTED|Period Two: Randomized Period|147 randomized, 144 randomized and treated with paclitaxel|144
2566809|NCT00455533|6293808|P2|STARTED|Period Two: Randomized Period|148 randomized, 145 randomized and treated with ixabepilone|145
2566810|NCT00455533|6293809|P1|STARTED|Period Two: Randomized Period||0
2566811|NCT00455533|6293807|P3|NOT COMPLETED|Period One: Initial Chemotherapy||0
2566812|NCT00455533|6293808|P2|NOT COMPLETED|Period One: Initial Chemotherapy||0
2566813|NCT00455533|6293809|P1|NOT COMPLETED|Period One: Initial Chemotherapy||18
2566814|NCT00455533|6293807|P3|COMPLETED|Period One: Initial Chemotherapy||0
2566815|NCT00455533|6293808|P2|COMPLETED|Period One: Initial Chemotherapy||0
2566816|NCT00455533|6293809|P1|COMPLETED|Period One: Initial Chemotherapy||295
2566817|NCT00455533|6293807|P3|STARTED|Period One: Initial Chemotherapy||0
2566818|NCT00455533|6293808|P2|STARTED|Period One: Initial Chemotherapy||0
2566819|NCT00455533|6293809|P1|STARTED|Period One: Initial Chemotherapy||313
2566820|NCT00455520|6293858|P2|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||62
2566821|NCT00455520|6293859|P1|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||63
2566822|NCT00455520|6293858|P2|COMPLETED|Double Blind Tapentadol ER vs Placebo||131
2566823|NCT00455520|6293859|P1|COMPLETED|Double Blind Tapentadol ER vs Placebo||133
2566824|NCT00455520|6293858|P2|STARTED|Double Blind Tapentadol ER vs Placebo|1 subject enrolled two separate times in this study, 2 subjects did not receive study medication|193
2566825|NCT00455520|6293859|P1|STARTED|Double Blind Tapentadol ER vs Placebo|2 subjects enrolled two separate times in this study, 1 subject did not receive study medication|196
2566826|NCT00455520|6293858|P2|NOT COMPLETED|Open Label Tapentadol Extended Release||0
2566827|NCT00455520|6293859|P1|NOT COMPLETED|Open Label Tapentadol Extended Release||196
2566828|NCT00455520|6293858|P2|COMPLETED|Open Label Tapentadol Extended Release||0
2566829|NCT00455520|6293859|P1|COMPLETED|Open Label Tapentadol Extended Release||395
2566830|NCT00455520|6293858|P2|STARTED|Open Label Tapentadol Extended Release||0
2566831|NCT00455520|6293859|P1|STARTED|Open Label Tapentadol Extended Release||591
2566832|NCT00455455|6293875|P2|NOT COMPLETED|Second Intervention||0
2566833|NCT00455455|6293876|P1|NOT COMPLETED|Second Intervention||0
2566834|NCT00455455|6293875|P2|COMPLETED|Second Intervention||24
2566835|NCT00455455|6293876|P1|COMPLETED|Second Intervention||24
2566836|NCT00455455|6293875|P2|STARTED|Second Intervention||24
2566837|NCT00455455|6293876|P1|STARTED|Second Intervention||24
2566838|NCT00455455|6293875|P2|NOT COMPLETED|Washout||0
2566839|NCT00455455|6293876|P1|NOT COMPLETED|Washout||1
2566840|NCT00455455|6293875|P2|COMPLETED|Washout||24
2566841|NCT00455455|6293876|P1|COMPLETED|Washout||24
2566842|NCT00455455|6293875|P2|STARTED|Washout||24
2566843|NCT00455455|6293876|P1|STARTED|Washout||25
2566844|NCT00455455|6293875|P2|NOT COMPLETED|First Intervention||0
2566845|NCT00455455|6293876|P1|NOT COMPLETED|First Intervention||0
2566846|NCT00455455|6293875|P2|COMPLETED|First Intervention||24
2566847|NCT00455455|6293876|P1|COMPLETED|First Intervention||25
2566848|NCT00455455|6293875|P2|STARTED|First Intervention||24
2566849|NCT00455455|6293876|P1|STARTED|First Intervention||25
2566850|NCT00455455|6293875|P2|NOT COMPLETED|Washout||1
2566851|NCT00455455|6293876|P1|NOT COMPLETED|Washout||0
2566852|NCT00455455|6293875|P2|COMPLETED|Washout||24
2566853|NCT00455455|6293876|P1|COMPLETED|Washout||25
2566854|NCT00455455|6293875|P2|STARTED|Washout||25
2566855|NCT00455455|6293876|P1|STARTED|Washout||25
2566856|NCT00455429|6293896|P4|NOT COMPLETED|Overall Study||14
2566857|NCT00455429|6293897|P3|NOT COMPLETED|Overall Study||1
2566858|NCT00455429|6293898|P2|NOT COMPLETED|Overall Study||5
2566859|NCT00455429|6293899|P1|NOT COMPLETED|Overall Study||2
2566860|NCT00455429|6293896|P4|COMPLETED|Overall Study||20
2566861|NCT00455429|6293897|P3|COMPLETED|Overall Study||16
2566862|NCT00455429|6293898|P2|COMPLETED|Overall Study||10
2566863|NCT00455429|6293899|P1|COMPLETED|Overall Study||16
2566864|NCT00455429|6293896|P4|Treated|Overall Study||32
2566865|NCT00455429|6293897|P3|Treated|Overall Study||17
2566866|NCT00455429|6293898|P2|Treated|Overall Study||15
2566867|NCT00455429|6293899|P1|Treated|Overall Study||18
2566868|NCT00455429|6293896|P4|STARTED|Overall Study||34
2566869|NCT00455429|6293897|P3|STARTED|Overall Study||17
2566870|NCT00455429|6293898|P2|STARTED|Overall Study||15
2566871|NCT00455429|6293899|P1|STARTED|Overall Study||18
2566872|NCT00455312|6293958|P2|NOT COMPLETED|Overall Study||1
2566873|NCT00455312|6293959|P1|NOT COMPLETED|Overall Study||0
2566874|NCT00455312|6293958|P2|COMPLETED|Overall Study||20
2566875|NCT00455312|6293959|P1|COMPLETED|Overall Study||15
2566876|NCT00455312|6293958|P2|STARTED|Overall Study||21
2566877|NCT00455312|6293959|P1|STARTED|Overall Study||15
2566878|NCT00455195|6293985|P2|NOT COMPLETED|Extension Study AGLU03206||0
2566879|NCT00455195|6293986|P1|NOT COMPLETED|Extension Study AGLU03206||0
2566880|NCT00455195|6293985|P2|COMPLETED|Extension Study AGLU03206||26
2566881|NCT00455195|6293986|P1|COMPLETED|Extension Study AGLU03206||55
2566882|NCT00455195|6293985|P2|STARTED|Extension Study AGLU03206|These 26 participants completed placebo double-blind treatment in the AGLU02704 (NCT00158600) study.|26
2566883|NCT00455195|6293986|P1|STARTED|Extension Study AGLU03206||55
2566884|NCT00455195|6293985|P2|NOT COMPLETED|Double-blind Study AGLU02704||4
2566885|NCT00455195|6293986|P1|NOT COMPLETED|Double-blind Study AGLU02704||5
2566886|NCT00455195|6293985|P2|COMPLETED|Double-blind Study AGLU02704||26
2566887|NCT00455195|6293986|P1|COMPLETED|Double-blind Study AGLU02704||55
2566888|NCT00455195|6293985|P2|STARTED|Double-blind Study AGLU02704|See study AGLU02704 (NCT00158600) for results while on placebo.|30
2566889|NCT00455195|6293986|P1|STARTED|Double-blind Study AGLU02704|Patients randomized to alglucosidase alfa treatment group in AGLU02704 (NCT00158600).|60
2566890|NCT00455143|6294000|P1|NOT COMPLETED|Overall Study||6
2566891|NCT00455143|6294000|P1|COMPLETED|Overall Study||21
2566892|NCT00455143|6294000|P1|STARTED|Overall Study||27
2566893|NCT00455013|6294024|P3|NOT COMPLETED|Long Term Extension (LTE)||7
2566894|NCT00455013|6294025|P2|NOT COMPLETED|Long Term Extension (LTE)||3
2566895|NCT00455013|6294026|P1|NOT COMPLETED|Long Term Extension (LTE)||2
2566896|NCT00455013|6294024|P3|COMPLETED|Long Term Extension (LTE)||20
2566897|NCT00455013|6294025|P2|COMPLETED|Long Term Extension (LTE)||16
2566898|NCT00455013|6294026|P1|COMPLETED|Long Term Extension (LTE)||25
2566899|NCT00455013|6294024|P3|STARTED|Long Term Extension (LTE)|1 Participant chose not to enter the LTE.|27
2566900|NCT00455013|6294025|P2|STARTED|Long Term Extension (LTE)|2 Participants chose not to enter the LTE.|19
2566901|NCT00455013|6294026|P1|STARTED|Long Term Extension (LTE)||27
2566902|NCT00455013|6294024|P3|NOT COMPLETED|Short Term Period||2
2566903|NCT00455013|6294025|P2|NOT COMPLETED|Short Term Period||5
2566904|NCT00455013|6294026|P1|NOT COMPLETED|Short Term Period||6
2566905|NCT00455013|6294024|P3|COMPLETED|Short Term Period|1 discontinued tacrolimus by Month 6 and 2 discontinued by Month 12 (1 more by Month 12)|28
2566906|NCT00455013|6294025|P2|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6; 10 additional switched from sirolimus to MMF.|21
2566907|NCT00455013|6294026|P1|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6 (1 more by Month 12), 2 switched from MMF to sirolimus.|27
2566908|NCT00455013|6294024|P3|STARTED|Short Term Period|31 randomized, 30 transplanted and treated|30
2566909|NCT00455013|6294025|P2|STARTED|Short Term Period|27 randomized, 26 transplanted and treated.|26
2566910|NCT00455013|6294026|P1|STARTED|Short Term Period|35 randomized, 33 transplanted and treated.|33
2566911|NCT00454987|6294094|P3|NOT COMPLETED|Year 4||0
2566912|NCT00454987|6294095|P2|NOT COMPLETED|Year 4||0
2566913|NCT00454987|6294096|P1|NOT COMPLETED|Year 4||0
2566914|NCT00454987|6294094|P3|COMPLETED|Year 4||0
2566915|NCT00454987|6294095|P2|COMPLETED|Year 4||62
2566916|NCT00454987|6294096|P1|COMPLETED|Year 4||206
2566917|NCT00454987|6294094|P3|STARTED|Year 4||0
2566918|NCT00454987|6294095|P2|STARTED|Year 4||62
2566919|NCT00454987|6294096|P1|STARTED|Year 4||206
2566920|NCT00454987|6294094|P3|NOT COMPLETED|Year 2||0
2566921|NCT00454987|6294095|P2|NOT COMPLETED|Year 2||0
2566922|NCT00454987|6294096|P1|NOT COMPLETED|Year 2||0
2566923|NCT00454987|6294094|P3|COMPLETED|Year 2||74
2566924|NCT00454987|6294095|P2|COMPLETED|Year 2||77
2566925|NCT00454987|6294096|P1|COMPLETED|Year 2||235
2566926|NCT00454987|6294094|P3|STARTED|Year 2||74
2566927|NCT00454987|6294095|P2|STARTED|Year 2||77
2566928|NCT00454987|6294096|P1|STARTED|Year 2||235
2566929|NCT00454987|6294094|P3|NOT COMPLETED|Year 1||0
2566930|NCT00454987|6294095|P2|NOT COMPLETED|Year 1||0
2566931|NCT00454987|6294096|P1|NOT COMPLETED|Year 1||0
2566932|NCT00454987|6294094|P3|COMPLETED|Year 1||0
2566933|NCT00454987|6294095|P2|COMPLETED|Year 1||67
2566934|NCT00454987|6294096|P1|COMPLETED|Year 1||221
2566935|NCT00454987|6294094|P3|STARTED|Year 1||0
2566936|NCT00454987|6294095|P2|STARTED|Year 1||67
2566937|NCT00454987|6294096|P1|STARTED|Year 1||221
2566938|NCT00454987|6294094|P3|NOT COMPLETED|Booster Period||0
2566939|NCT00454987|6294095|P2|NOT COMPLETED|Booster Period||1
2566940|NCT00454987|6294096|P1|NOT COMPLETED|Booster Period||2
2566941|NCT00454987|6294094|P3|COMPLETED|Booster Period||0
2566942|NCT00454987|6294095|P2|COMPLETED|Booster Period||116
2566943|NCT00454987|6294096|P1|COMPLETED|Booster Period||357
2566944|NCT00454987|6294094|P3|STARTED|Booster Period||0
2566945|NCT00454987|6294095|P2|STARTED|Booster Period||117
2566946|NCT00454987|6294096|P1|STARTED|Booster Period||359
2566947|NCT00454909|6294170|P3|NOT COMPLETED|Overall Study||2
2566948|NCT00454909|6294171|P2|NOT COMPLETED|Overall Study||3
2566949|NCT00454909|6294172|P1|NOT COMPLETED|Overall Study||7
2566950|NCT00454909|6294170|P3|COMPLETED|Overall Study||86
2566951|NCT00454909|6294171|P2|COMPLETED|Overall Study||194
2566952|NCT00454909|6294172|P1|COMPLETED|Overall Study||580
2566953|NCT00454909|6294170|P3|STARTED|Overall Study||88
2566954|NCT00454909|6294171|P2|STARTED|Overall Study||197
2566955|NCT00454909|6294172|P1|STARTED|Overall Study||587
2566956|NCT00454857|6294210|P1|NOT COMPLETED|Overall Study||54
2566957|NCT00454857|6294210|P1|COMPLETED|Overall Study||272
2566958|NCT00454857|6294210|P1|Completed ≥1 Observational Study Visit|Overall Study||319
2566959|NCT00454857|6294210|P1|Completed Retrospective Chart Review|Overall Study||324
2566960|NCT00454857|6294210|P1|STARTED|Overall Study||326
2566961|NCT00454818|6294235|P5|NOT COMPLETED|Phase 2: Randomized Double-blind||4
2566962|NCT00454818|6294236|P4|NOT COMPLETED|Phase 2: Randomized Double-blind||1
2566963|NCT00454818|6294237|P3|NOT COMPLETED|Phase 2: Randomized Double-blind||3
2566964|NCT00454818|6294238|P2|NOT COMPLETED|Phase 2: Randomized Double-blind||2
2566965|NCT00454818|6294239|P1|NOT COMPLETED|Phase 2: Randomized Double-blind||0
2566966|NCT00454818|6294235|P5|COMPLETED|Phase 2: Randomized Double-blind||10
2566967|NCT00454818|6294236|P4|COMPLETED|Phase 2: Randomized Double-blind||8
2566968|NCT00454818|6294237|P3|COMPLETED|Phase 2: Randomized Double-blind||5
2566969|NCT00454818|6294238|P2|COMPLETED|Phase 2: Randomized Double-blind||6
2566970|NCT00454818|6294239|P1|COMPLETED|Phase 2: Randomized Double-blind||0
2566971|NCT00454818|6294235|P5|STARTED|Phase 2: Randomized Double-blind||14
2566972|NCT00454818|6294236|P4|STARTED|Phase 2: Randomized Double-blind||9
2566973|NCT00454818|6294237|P3|STARTED|Phase 2: Randomized Double-blind||8
2566974|NCT00454818|6294238|P2|STARTED|Phase 2: Randomized Double-blind||8
2566975|NCT00454818|6294239|P1|STARTED|Phase 2: Randomized Double-blind||0
2566976|NCT00454818|6294235|P5|NOT COMPLETED|Phase I: Open-label Dose-escalation||0
2566977|NCT00454818|6294236|P4|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
2566978|NCT00454818|6294237|P3|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
2566979|NCT00454818|6294238|P2|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
2566980|NCT00454818|6294239|P1|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
2566981|NCT00454818|6294235|P5|COMPLETED|Phase I: Open-label Dose-escalation||0
2566982|NCT00454818|6294236|P4|COMPLETED|Phase I: Open-label Dose-escalation||2
2566983|NCT00454818|6294237|P3|COMPLETED|Phase I: Open-label Dose-escalation||2
2566984|NCT00454818|6294238|P2|COMPLETED|Phase I: Open-label Dose-escalation||2
2566985|NCT00454818|6294239|P1|COMPLETED|Phase I: Open-label Dose-escalation||2
2566986|NCT00454818|6294235|P5|STARTED|Phase I: Open-label Dose-escalation||0
2566987|NCT00454818|6294236|P4|STARTED|Phase I: Open-label Dose-escalation||3
2566988|NCT00454818|6294237|P3|STARTED|Phase I: Open-label Dose-escalation||3
2566989|NCT00454818|6294238|P2|STARTED|Phase I: Open-label Dose-escalation||3
2566990|NCT00454818|6294239|P1|STARTED|Phase I: Open-label Dose-escalation||3
2566991|NCT00454805|6294318|P2|NOT COMPLETED|Overall Study||23
2566992|NCT00454805|6294319|P1|NOT COMPLETED|Overall Study||26
2566993|NCT00454805|6294318|P2|COMPLETED|Overall Study|Ongoing at data cut-off|8
2566994|NCT00454805|6294319|P1|COMPLETED|Overall Study|Ongoing at data cut-off|5
2566995|NCT00454805|6294318|P2|STARTED|Overall Study|Randomised|31
2566996|NCT00454805|6294319|P1|STARTED|Overall Study|Randomised|31
2566997|NCT00454779|6294335|P2|NOT COMPLETED|Second-line Treatment Phase||3
2566998|NCT00454779|6294336|P1|NOT COMPLETED|Second-line Treatment Phase||0
2566999|NCT00454779|6294335|P2|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|27
2567000|NCT00454779|6294336|P1|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|0
2567001|NCT00454779|6294335|P2|STARTED|Second-line Treatment Phase|Second-line Panitumumab Monotherapy|30
2567002|NCT00454779|6294336|P1|STARTED|Second-line Treatment Phase|Subjects in this arm do not have second-line treatment period|0
2567003|NCT00454779|6294335|P2|NOT COMPLETED|First-line Treatment Phase||8
2567004|NCT00454779|6294336|P1|NOT COMPLETED|First-line Treatment Phase||5
2567005|NCT00454779|6294335|P2|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|49
2567006|NCT00454779|6294336|P1|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|51
2567007|NCT00454779|6294335|P2|Received Study Medication|First-line Treatment Phase||55
2567008|NCT00454779|6294336|P1|Received Study Medication|First-line Treatment Phase||56
2567009|NCT00454779|6294335|P2|STARTED|First-line Treatment Phase||57
2567010|NCT00454779|6294336|P1|STARTED|First-line Treatment Phase||56
2567011|NCT00454649|6294374|P10|NOT COMPLETED|Overall Study||5
2567012|NCT00454649|6294375|P9|NOT COMPLETED|Overall Study||20
2567013|NCT00454649|6294376|P8|NOT COMPLETED|Overall Study||19
2567014|NCT00454649|6294377|P7|NOT COMPLETED|Overall Study||9
2567015|NCT00454649|6294378|P6|NOT COMPLETED|Overall Study||7
2567016|NCT00454649|6294379|P5|NOT COMPLETED|Overall Study||1
2567017|NCT00454649|6294380|P4|NOT COMPLETED|Overall Study||6
2567018|NCT00454649|6294381|P3|NOT COMPLETED|Overall Study||19
2567019|NCT00454649|6294382|P2|NOT COMPLETED|Overall Study||4
2567020|NCT00454649|6294383|P1|NOT COMPLETED|Overall Study||3
2567021|NCT00454649|6294374|P10|COMPLETED|Overall Study||1
2567022|NCT00454649|6294375|P9|COMPLETED|Overall Study||1
2567023|NCT00454649|6294376|P8|COMPLETED|Overall Study||0
2567024|NCT00454649|6294377|P7|COMPLETED|Overall Study||0
2567025|NCT00454649|6294378|P6|COMPLETED|Overall Study||0
2567026|NCT00454649|6294379|P5|COMPLETED|Overall Study||0
2567027|NCT00454649|6294380|P4|COMPLETED|Overall Study||1
2567028|NCT00454649|6294381|P3|COMPLETED|Overall Study||1
2567029|NCT00454649|6294382|P2|COMPLETED|Overall Study||1
2567030|NCT00454649|6294383|P1|COMPLETED|Overall Study||0
2567031|NCT00454649|6294374|P10|STARTED|Overall Study||6
2567032|NCT00454649|6294375|P9|STARTED|Overall Study||21
2567033|NCT00454649|6294376|P8|STARTED|Overall Study||19
2567034|NCT00454649|6294377|P7|STARTED|Overall Study||9
2567035|NCT00454649|6294378|P6|STARTED|Overall Study||7
2567036|NCT00454649|6294379|P5|STARTED|Overall Study||1
2567037|NCT00454649|6294380|P4|STARTED|Overall Study||7
2567038|NCT00454649|6294381|P3|STARTED|Overall Study||20
2567039|NCT00454649|6294382|P2|STARTED|Overall Study||5
2567040|NCT00454649|6294383|P1|STARTED|Overall Study||3
2567041|NCT00454636|6294512|P4|NOT COMPLETED|Overall Study||32
2567042|NCT00454636|6294513|P3|NOT COMPLETED|Overall Study||20
2567043|NCT00454636|6294514|P2|NOT COMPLETED|Overall Study||23
2567044|NCT00454636|6294515|P1|NOT COMPLETED|Overall Study||31
2567045|NCT00454636|6294512|P4|COMPLETED|Overall Study||26
2567046|NCT00454636|6294513|P3|COMPLETED|Overall Study||7
2567047|NCT00454636|6294514|P2|COMPLETED|Overall Study||9
2567048|NCT00454636|6294515|P1|COMPLETED|Overall Study||10
2567049|NCT00454636|6294512|P4|STARTED|Overall Study||58
2567050|NCT00454636|6294513|P3|STARTED|Overall Study||27
2567051|NCT00454636|6294514|P2|STARTED|Overall Study||32
2567052|NCT00454636|6294515|P1|STARTED|Overall Study||41
2567053|NCT00454584|6294548|P6|NOT COMPLETED|After Controlled Period||32
2567054|NCT00454584|6294549|P5|NOT COMPLETED|After Controlled Period||12
2567055|NCT00454584|6294550|P4|NOT COMPLETED|After Controlled Period||26
2567056|NCT00454584|6294551|P3|NOT COMPLETED|After Controlled Period||0
2567057|NCT00454584|6294552|P2|NOT COMPLETED|After Controlled Period||0
2567058|NCT00454584|6294553|P1|NOT COMPLETED|After Controlled Period||0
2567059|NCT00454584|6294548|P6|COMPLETED|After Controlled Period||310
2567060|NCT00454584|6294549|P5|COMPLETED|After Controlled Period||189
2567061|NCT00454584|6294550|P4|COMPLETED|After Controlled Period||310
2567062|NCT00454584|6294551|P3|COMPLETED|After Controlled Period||0
2567063|NCT00454584|6294552|P2|COMPLETED|After Controlled Period||0
2567064|NCT00454584|6294553|P1|COMPLETED|After Controlled Period||0
2567065|NCT00454584|6294548|P6|STARTED|After Controlled Period||342
2567066|NCT00454584|6294549|P5|STARTED|After Controlled Period||201
2567067|NCT00454584|6294550|P4|STARTED|After Controlled Period||336
2567068|NCT00454584|6294551|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
2567069|NCT00454584|6294552|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
2567070|NCT00454584|6294553|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
2567071|NCT00454584|6294548|P6|NOT COMPLETED|Controlled Period||0
2567072|NCT00454584|6294549|P5|NOT COMPLETED|Controlled Period||0
2567073|NCT00454584|6294550|P4|NOT COMPLETED|Controlled Period||0
2567074|NCT00454584|6294551|P3|NOT COMPLETED|Controlled Period||5
2567075|NCT00454584|6294552|P2|NOT COMPLETED|Controlled Period||8
2567076|NCT00454584|6294553|P1|NOT COMPLETED|Controlled Period||11
2567077|NCT00454584|6294548|P6|COMPLETED|Controlled Period||0
2567078|NCT00454584|6294549|P5|COMPLETED|Controlled Period||0
2567079|NCT00454584|6294550|P4|COMPLETED|Controlled Period||0
2567080|NCT00454584|6294551|P3|COMPLETED|Controlled Period||342
2567081|NCT00454584|6294552|P2|COMPLETED|Controlled Period||201
2567082|NCT00454584|6294553|P1|COMPLETED|Controlled Period||336
2567083|NCT00454584|6294548|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
2567084|NCT00454584|6294549|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
2567085|NCT00454584|6294550|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
2567086|NCT00454584|6294551|P3|STARTED|Controlled Period||347
2567087|NCT00454584|6294552|P2|STARTED|Controlled Period||209
2567088|NCT00454584|6294553|P1|STARTED|Controlled Period||347
2567089|NCT00454571|6294575|P2|NOT COMPLETED|Overall Study||6
2567090|NCT00454571|6294576|P1|NOT COMPLETED|Overall Study||13
2567091|NCT00454571|6294575|P2|COMPLETED|Overall Study||13
2567092|NCT00454571|6294576|P1|COMPLETED|Overall Study||5
2567093|NCT00454571|6294575|P2|STARTED|Overall Study||19
2567094|NCT00454571|6294576|P1|STARTED|Overall Study||18
2567095|NCT00454532|6294588|P4|NOT COMPLETED|Overall Study||0
2567096|NCT00454532|6294589|P3|NOT COMPLETED|Overall Study||0
2567097|NCT00454532|6294590|P2|NOT COMPLETED|Overall Study||0
2567098|NCT00454532|6294591|P1|NOT COMPLETED|Overall Study||0
2567099|NCT00454532|6294588|P4|COMPLETED|Overall Study||7
2567100|NCT00454532|6294589|P3|COMPLETED|Overall Study||3
2567101|NCT00454532|6294590|P2|COMPLETED|Overall Study||6
2567102|NCT00454532|6294591|P1|COMPLETED|Overall Study||11
2567103|NCT00454532|6294588|P4|STARTED|Overall Study||7
2567104|NCT00454532|6294589|P3|STARTED|Overall Study||3
2567105|NCT00454532|6294590|P2|STARTED|Overall Study||6
2567106|NCT00454532|6294591|P1|STARTED|Overall Study||11
2567107|NCT00454363|6294611|P2|NOT COMPLETED|Overall Study||2
2567108|NCT00454363|6294612|P1|NOT COMPLETED|Overall Study||5
2567109|NCT00454363|6294611|P2|COMPLETED|Overall Study||29
2567110|NCT00454363|6294612|P1|COMPLETED|Overall Study||15
2567111|NCT00454363|6294611|P2|STARTED|Overall Study||31
2567112|NCT00454363|6294612|P1|STARTED|Overall Study||20
2567113|NCT00454324|6294621|P2|NOT COMPLETED|Overall Study||0
2567114|NCT00454324|6294622|P1|NOT COMPLETED|Overall Study||0
2567115|NCT00454324|6294621|P2|COMPLETED|Overall Study||13
2567116|NCT00454324|6294622|P1|COMPLETED|Overall Study||14
2567117|NCT00454324|6294621|P2|STARTED|Overall Study||13
2567118|NCT00454324|6294622|P1|STARTED|Overall Study||14
2567119|NCT00454246|6294637|P3|NOT COMPLETED|Overall Study||9
2567120|NCT00454246|6294638|P2|NOT COMPLETED|Overall Study||29
2567121|NCT00454246|6294639|P1|NOT COMPLETED|Overall Study||73
2567122|NCT00454246|6294637|P3|COMPLETED|Overall Study||0
2567123|NCT00454246|6294638|P2|COMPLETED|Overall Study||0
2567124|NCT00454246|6294639|P1|COMPLETED|Overall Study||0
2567125|NCT00454246|6294637|P3|STARTED|Overall Study||9
2567126|NCT00454246|6294638|P2|STARTED|Overall Study||29
2567127|NCT00454246|6294639|P1|STARTED|Overall Study||73
2567128|NCT00454207|6294655|P2|NOT COMPLETED|Overall Study||2
2567129|NCT00454207|6294656|P1|NOT COMPLETED|Overall Study||4
2567130|NCT00454207|6294655|P2|COMPLETED|Overall Study||21
2567131|NCT00454207|6294656|P1|COMPLETED|Overall Study|19 participants completed Part I period. 17 of 19 participants continued from part I into Part II.|17
2567132|NCT00454207|6294655|P2|STARTED|Overall Study||23
2567133|NCT00454207|6294656|P1|STARTED|Overall Study||21
2567134|NCT00454194|6294701|P2|NOT COMPLETED|Overall Study||14
2567135|NCT00454194|6294702|P1|NOT COMPLETED|Overall Study||22
2567136|NCT00454194|6294701|P2|COMPLETED|Overall Study||37
2567137|NCT00454194|6294702|P1|COMPLETED|Overall Study||25
2567138|NCT00454194|6294701|P2|STARTED|Overall Study||51
2567139|NCT00454194|6294702|P1|STARTED|Overall Study||47
2567140|NCT00454181|6294720|P2|NOT COMPLETED|Overall Study||3
2567141|NCT00454181|6294721|P1|NOT COMPLETED|Overall Study||15
2567142|NCT00454181|6294720|P2|COMPLETED|Overall Study||11
2567143|NCT00454181|6294721|P1|COMPLETED|Overall Study||30
2567144|NCT00454181|6294720|P2|STARTED|Overall Study||14
2567145|NCT00454181|6294721|P1|STARTED|Overall Study||45
2567146|NCT00454142|6294737|P1|NOT COMPLETED|Overall Study||1
2567147|NCT00454142|6294737|P1|COMPLETED|Overall Study||32
2567148|NCT00454142|6294737|P1|STARTED|Overall Study||33
2567149|NCT00454116|6294755|P3|NOT COMPLETED|Overall Study||28
2567150|NCT00454116|6294756|P2|NOT COMPLETED|Overall Study||29
2567151|NCT00454116|6294757|P1|NOT COMPLETED|Overall Study||27
2567152|NCT00454116|6294755|P3|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
2567153|NCT00454116|6294756|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
2567154|NCT00454116|6294757|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|8
2567155|NCT00454116|6294755|P3|STARTED|Overall Study|randomised patients|35
2567156|NCT00454116|6294756|P2|STARTED|Overall Study|randomised patients|36
2567157|NCT00454116|6294757|P1|STARTED|Overall Study|randomised patients|35
2567158|NCT00454051|6294767|P2|NOT COMPLETED|Overall Study||3
2567159|NCT00454051|6294768|P1|NOT COMPLETED|Overall Study||3
2567160|NCT00454051|6294767|P2|COMPLETED|Overall Study||8
2567161|NCT00454051|6294768|P1|COMPLETED|Overall Study||17
2567162|NCT00454051|6294767|P2|STARTED|Overall Study||11
2567163|NCT00454051|6294768|P1|STARTED|Overall Study||20
2567164|NCT00453999|6294801|P3|NOT COMPLETED|Overall Study||3
2567165|NCT00453999|6294802|P2|NOT COMPLETED|Overall Study||5
2567166|NCT00453999|6294803|P1|NOT COMPLETED|Overall Study||5
2567167|NCT00453999|6294801|P3|COMPLETED|Overall Study||43
2567168|NCT00453999|6294802|P2|COMPLETED|Overall Study||41
2567169|NCT00453999|6294803|P1|COMPLETED|Overall Study||40
2567170|NCT00453999|6294801|P3|STARTED|Overall Study||46
2567171|NCT00453999|6294802|P2|STARTED|Overall Study||46
2567172|NCT00453999|6294803|P1|STARTED|Overall Study||45
2567173|NCT00453986|6294831|P5|NOT COMPLETED|Overall Study||0
2567174|NCT00453986|6294832|P4|NOT COMPLETED|Overall Study||2
2567175|NCT00453986|6294833|P3|NOT COMPLETED|Overall Study||6
2567176|NCT00453986|6294834|P2|NOT COMPLETED|Overall Study||5
2567177|NCT00453986|6294835|P1|NOT COMPLETED|Overall Study||6
2567178|NCT00453986|6294831|P5|COMPLETED|Overall Study||105
2567179|NCT00453986|6294832|P4|COMPLETED|Overall Study||310
2567180|NCT00453986|6294833|P3|COMPLETED|Overall Study||307
2567181|NCT00453986|6294834|P2|COMPLETED|Overall Study||306
2567182|NCT00453986|6294835|P1|COMPLETED|Overall Study||305
2567183|NCT00453986|6294831|P5|STARTED|Overall Study||105
2567184|NCT00453986|6294832|P4|STARTED|Overall Study||312
2567185|NCT00453986|6294833|P3|STARTED|Overall Study||313
2567186|NCT00453986|6294834|P2|STARTED|Overall Study||311
2567187|NCT00453986|6294835|P1|STARTED|Overall Study||311
2567188|NCT00453973|6294928|P2|NOT COMPLETED|Overall Study||48
2567189|NCT00453973|6294929|P1|NOT COMPLETED|Overall Study||51
2567190|NCT00453973|6294928|P2|COMPLETED|Overall Study||15
2567191|NCT00453973|6294929|P1|COMPLETED|Overall Study||0
2567192|NCT00453973|6294928|P2|STARTED|Overall Study||63
2567193|NCT00453973|6294929|P1|STARTED|Overall Study||51
2567194|NCT00453921|6294939|P4|NOT COMPLETED|Overall Study||1
2567195|NCT00453921|6294940|P3|NOT COMPLETED|Overall Study||2
2567196|NCT00453921|6294941|P2|NOT COMPLETED|Overall Study||1
2567197|NCT00453921|6294942|P1|NOT COMPLETED|Overall Study||1
2567198|NCT00453921|6294939|P4|COMPLETED|Overall Study||18
2567199|NCT00453921|6294940|P3|COMPLETED|Overall Study||18
2567200|NCT00453921|6294941|P2|COMPLETED|Overall Study||17
2567201|NCT00453921|6294942|P1|COMPLETED|Overall Study||18
2567202|NCT00453921|6294939|P4|STARTED|Overall Study||19
2567203|NCT00453921|6294940|P3|STARTED|Overall Study||20
2567204|NCT00453921|6294941|P2|STARTED|Overall Study||18
2567205|NCT00453921|6294942|P1|STARTED|Overall Study||19
2567206|NCT00453895|6294976|P1|NOT COMPLETED|Overall Study||0
2567207|NCT00453895|6294976|P1|COMPLETED|Overall Study||39
2567208|NCT00453895|6294976|P1|STARTED|Overall Study||39
2567209|NCT00453479|6294987|P3|NOT COMPLETED|Overall Study||0
2567210|NCT00453479|6294988|P2|NOT COMPLETED|Overall Study||0
2567211|NCT00453479|6294989|P1|NOT COMPLETED|Overall Study||0
2567212|NCT00453479|6294987|P3|COMPLETED|Overall Study||8
2567213|NCT00453479|6294988|P2|COMPLETED|Overall Study||9
2567214|NCT00453479|6294989|P1|COMPLETED|Overall Study||6
2567215|NCT00453479|6294987|P3|STARTED|Overall Study||8
2567216|NCT00453479|6294988|P2|STARTED|Overall Study||9
2567217|NCT00453479|6294989|P1|STARTED|Overall Study||6
2567218|NCT00453388|6295064|P4|NOT COMPLETED|Overall Study||0
2567219|NCT00453388|6295065|P3|NOT COMPLETED|Overall Study||0
2567220|NCT00453388|6295066|P2|NOT COMPLETED|Overall Study||0
2567221|NCT00453388|6295067|P1|NOT COMPLETED|Overall Study||0
2567222|NCT00453388|6295064|P4|COMPLETED|Overall Study||0
2567223|NCT00453388|6295065|P3|COMPLETED|Overall Study||1
2567224|NCT00453388|6295066|P2|COMPLETED|Overall Study||5
2567225|NCT00453388|6295067|P1|COMPLETED|Overall Study||0
2567226|NCT00453388|6295064|P4|STARTED|Overall Study||0
2567227|NCT00453388|6295065|P3|STARTED|Overall Study||1
2567228|NCT00453388|6295066|P2|STARTED|Overall Study||5
2567229|NCT00453388|6295067|P1|STARTED|Overall Study||0
2567230|NCT00453362|6295089|P1|NOT COMPLETED|Overall Study||87
2567231|NCT00453362|6295089|P1|COMPLETED|Overall Study||1
2567232|NCT00453362|6295089|P1|FLT-PET Evaluable|Overall Study|Participants who completed all FLT-PET scans through day 56.|50
2567233|NCT00453362|6295089|P1|FDG-PET Evaluable|Overall Study|Participants who completed all FDG-PET scans through day 56.|51
2567234|NCT00453362|6295089|P1|Treated With Erlotinib|Overall Study||74
2567235|NCT00453362|6295089|P1|STARTED|Overall Study|14 participants consented but did not receive drug and are not represented in the baseline data|88
2567236|NCT00453349|6295115|P2|NOT COMPLETED|Completed Study||34
2567237|NCT00453349|6295116|P1|NOT COMPLETED|Completed Study||27
2567238|NCT00453349|6295115|P2|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|198
2567239|NCT00453349|6295116|P1|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|201
2567240|NCT00453349|6295115|P2|Completed Study Treatment|Completed Study|23 terminated prematurely|209
2567241|NCT00453349|6295116|P1|Completed Study Treatment|Completed Study|25 terminated prematurely|203
2567242|NCT00453349|6295115|P2|STARTED|Completed Study||232
2567243|NCT00453349|6295116|P1|STARTED|Completed Study||228
2567244|NCT00453349|6295115|P2|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||11
2567245|NCT00453349|6295116|P1|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||10
2567246|NCT00453349|6295115|P2|COMPLETED|Reaching of Primary Endpoint (TOC)||219
2567247|NCT00453349|6295116|P1|COMPLETED|Reaching of Primary Endpoint (TOC)|All PP patients and ITT patients with a clinical response with no missing information|215
2567248|NCT00453349|6295115|P2|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||190
2567249|NCT00453349|6295116|P1|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||194
2567250|NCT00453349|6295115|P2|STARTED|Reaching of Primary Endpoint (TOC)|i.e. the ITT population|230
2567251|NCT00453349|6295116|P1|STARTED|Reaching of Primary Endpoint (TOC)|Subjects who attended the TOC visit or at least had a clinical evaluation at TOC|225
2567252|NCT00453349|6295115|P2|NOT COMPLETED|Randomized||23
2567253|NCT00453349|6295116|P1|NOT COMPLETED|Randomized||25
2567254|NCT00453349|6295115|P2|COMPLETED|Randomized||209
2567255|NCT00453349|6295116|P1|COMPLETED|Randomized||203
2567256|NCT00453349|6295115|P2|STARTED|Randomized||232
2567257|NCT00453349|6295116|P1|STARTED|Randomized||228
2567258|NCT00453336|6295142|P1|NOT COMPLETED|Overall Study||0
2567259|NCT00453336|6295142|P1|COMPLETED|Overall Study||45
2567260|NCT00453336|6295142|P1|STARTED|Overall Study||45
2567261|NCT00453310|6295147|P1|NOT COMPLETED|Overall Study||10
2567262|NCT00453310|6295147|P1|COMPLETED|Overall Study||0
2567263|NCT00453310|6295147|P1|STARTED|Overall Study||10
2567264|NCT00453206|6295151|P1|NOT COMPLETED|Overall Study||1
2567265|NCT00453206|6295151|P1|COMPLETED|Overall Study||65
2567266|NCT00453206|6295151|P1|STARTED|Overall Study||66
2567267|NCT00453193|6295155|P1|NOT COMPLETED|Overall Study||0
2567268|NCT00453193|6295155|P1|COMPLETED|Overall Study||24
2567269|NCT00453193|6295155|P1|STARTED|Overall Study||24
2567270|NCT00453180|6295161|P2|NOT COMPLETED|Overall Study||3
2567271|NCT00453180|6295162|P1|NOT COMPLETED|Overall Study||3
2567272|NCT00453180|6295161|P2|COMPLETED|Overall Study||12
2567273|NCT00453180|6295162|P1|COMPLETED|Overall Study||13
2567274|NCT00453180|6295161|P2|STARTED|Overall Study||15
2567275|NCT00453180|6295162|P1|STARTED|Overall Study||16
2567276|NCT00453154|6295181|P4|NOT COMPLETED|Open Label Sunitinib Crossover||0
2567277|NCT00453154|6295182|P3|NOT COMPLETED|Open Label Sunitinib Crossover||0
2567278|NCT00453154|6295183|P2|NOT COMPLETED|Open Label Sunitinib Crossover||0
2567279|NCT00453154|6295184|P1|NOT COMPLETED|Open Label Sunitinib Crossover||0
2567280|NCT00453154|6295181|P4|COMPLETED|Open Label Sunitinib Crossover||0
2567281|NCT00453154|6295182|P3|COMPLETED|Open Label Sunitinib Crossover||18
2567282|NCT00453154|6295183|P2|COMPLETED|Open Label Sunitinib Crossover||0
2567283|NCT00453154|6295184|P1|COMPLETED|Open Label Sunitinib Crossover||0
2567284|NCT00453154|6295181|P4|STARTED|Open Label Sunitinib Crossover||0
2567285|NCT00453154|6295182|P3|STARTED|Open Label Sunitinib Crossover||18
2567286|NCT00453154|6295183|P2|STARTED|Open Label Sunitinib Crossover||0
2567287|NCT00453154|6295184|P1|STARTED|Open Label Sunitinib Crossover||0
2567288|NCT00453154|6295181|P4|NOT COMPLETED|Double BIind Maintenance||49
2567289|NCT00453154|6295182|P3|NOT COMPLETED|Double BIind Maintenance||46
2567290|NCT00453154|6295183|P2|NOT COMPLETED|Double BIind Maintenance||0
2567291|NCT00453154|6295184|P1|NOT COMPLETED|Double BIind Maintenance||0
2567292|NCT00453154|6295181|P4|COMPLETED|Double BIind Maintenance||0
2567293|NCT00453154|6295182|P3|COMPLETED|Double BIind Maintenance||0
2567294|NCT00453154|6295183|P2|COMPLETED|Double BIind Maintenance||0
2567295|NCT00453154|6295184|P1|COMPLETED|Double BIind Maintenance||0
2567296|NCT00453154|6295181|P4|STARTED|Double BIind Maintenance||49
2567297|NCT00453154|6295182|P3|STARTED|Double BIind Maintenance||46
2567298|NCT00453154|6295183|P2|STARTED|Double BIind Maintenance||0
2567299|NCT00453154|6295184|P1|STARTED|Double BIind Maintenance||0
2567300|NCT00453154|6295181|P4|NOT COMPLETED|Combination Chemotherapy||0
2567301|NCT00453154|6295182|P3|NOT COMPLETED|Combination Chemotherapy||0
2567302|NCT00453154|6295183|P2|NOT COMPLETED|Combination Chemotherapy||49
2567303|NCT00453154|6295184|P1|NOT COMPLETED|Combination Chemotherapy||0
2567304|NCT00453154|6295181|P4|COMPLETED|Combination Chemotherapy||0
2567305|NCT00453154|6295182|P3|COMPLETED|Combination Chemotherapy||0
2567306|NCT00453154|6295183|P2|COMPLETED|Combination Chemotherapy||95
2567307|NCT00453154|6295184|P1|COMPLETED|Combination Chemotherapy||12
2567308|NCT00453154|6295181|P4|STARTED|Combination Chemotherapy||0
2567309|NCT00453154|6295182|P3|STARTED|Combination Chemotherapy||0
2567310|NCT00453154|6295183|P2|STARTED|Combination Chemotherapy||144
2567311|NCT00453154|6295184|P1|STARTED|Combination Chemotherapy||12
2567312|NCT00453102|6295197|P1|NOT COMPLETED|Overall Study||2
2567313|NCT00453102|6295197|P1|COMPLETED|Overall Study||16
2567314|NCT00453102|6295197|P1|STARTED|Overall Study||18
2567315|NCT00453063|6295208|P2|NOT COMPLETED|Overall Study||3
2567316|NCT00453063|6295209|P1|NOT COMPLETED|Overall Study||3
2567317|NCT00453063|6295208|P2|COMPLETED|Overall Study||212
2567318|NCT00453063|6295209|P1|COMPLETED|Overall Study||208
2567319|NCT00453063|6295208|P2|STARTED|Overall Study||215
2567320|NCT00453063|6295209|P1|STARTED|Overall Study||211
2567321|NCT00452868|6295223|P1|NOT COMPLETED|Overall Study||2
2567322|NCT00452868|6295223|P1|COMPLETED|Overall Study||11
2567323|NCT00452868|6295223|P1|STARTED|Overall Study||13
2567324|NCT00452790|6295229|P2|NOT COMPLETED|Toddler Dose||2
2567325|NCT00452790|6295230|P1|NOT COMPLETED|Toddler Dose||0
2567326|NCT00452790|6295229|P2|COMPLETED|Toddler Dose||198
2567327|NCT00452790|6295230|P1|COMPLETED|Toddler Dose||198
2567328|NCT00452790|6295229|P2|STARTED|Toddler Dose||200
2567329|NCT00452790|6295230|P1|STARTED|Toddler Dose||198
2567330|NCT00452790|6295229|P2|NOT COMPLETED|After Infant Series||14
2567331|NCT00452790|6295230|P1|NOT COMPLETED|After Infant Series||21
2567332|NCT00452790|6295229|P2|COMPLETED|After Infant Series||200
2567333|NCT00452790|6295230|P1|COMPLETED|After Infant Series||198
2567334|NCT00452790|6295229|P2|STARTED|After Infant Series||214
2567335|NCT00452790|6295230|P1|STARTED|After Infant Series||219
2567336|NCT00452790|6295229|P2|NOT COMPLETED|Infant Series||141
2567337|NCT00452790|6295230|P1|NOT COMPLETED|Infant Series||135
2567338|NCT00452790|6295229|P2|COMPLETED|Infant Series||214
2567339|NCT00452790|6295230|P1|COMPLETED|Infant Series||219
2567340|NCT00452790|6295229|P2|Vaccinated Dose 3|Infant Series||218
2567341|NCT00452790|6295230|P1|Vaccinated Dose 3|Infant Series||221
2567342|NCT00452790|6295229|P2|Vaccinated Dose 2|Infant Series||300
2567343|NCT00452790|6295230|P1|Vaccinated Dose 2|Infant Series||300
2567344|NCT00452790|6295229|P2|Vaccinated Dose 1|Infant Series||353
2567345|NCT00452790|6295230|P1|Vaccinated Dose 1|Infant Series||353
2567346|NCT00452790|6295229|P2|STARTED|Infant Series||355
2567347|NCT00452790|6295230|P1|STARTED|Infant Series||354
2567348|NCT00452699|6295266|P2|NOT COMPLETED|Overall Study||73
2567349|NCT00452699|6295267|P1|NOT COMPLETED|Overall Study||81
2567350|NCT00452699|6295266|P2|COMPLETED|Overall Study||242
2567351|NCT00452699|6295267|P1|COMPLETED|Overall Study||225
2567352|NCT00452699|6295266|P2|STARTED|Overall Study||315
2567353|NCT00452699|6295267|P1|STARTED|Overall Study||306
2567354|NCT00452673|6295283|P5|NOT COMPLETED|Dose Expansion Period||21
2567355|NCT00452673|6295284|P4|NOT COMPLETED|Dose Expansion Period||0
2567356|NCT00452673|6295285|P3|NOT COMPLETED|Dose Expansion Period||0
2567357|NCT00452673|6295286|P2|NOT COMPLETED|Dose Expansion Period||0
2567358|NCT00452673|6295287|P1|NOT COMPLETED|Dose Expansion Period||0
2567359|NCT00452673|6295283|P5|COMPLETED|Dose Expansion Period||0
2567360|NCT00452673|6295284|P4|COMPLETED|Dose Expansion Period||0
2567361|NCT00452673|6295285|P3|COMPLETED|Dose Expansion Period||0
2567362|NCT00452673|6295286|P2|COMPLETED|Dose Expansion Period||0
2567363|NCT00452673|6295287|P1|COMPLETED|Dose Expansion Period||0
2567364|NCT00452673|6295283|P5|STARTED|Dose Expansion Period|The last dose level arm in the escalation period was selected for the dose expansion period.|21
2567365|NCT00452673|6295284|P4|STARTED|Dose Expansion Period||0
2567366|NCT00452673|6295285|P3|STARTED|Dose Expansion Period||0
2567367|NCT00452673|6295286|P2|STARTED|Dose Expansion Period||0
2567368|NCT00452673|6295287|P1|STARTED|Dose Expansion Period||0
2567369|NCT00452673|6295283|P5|NOT COMPLETED|Dose Escalation Period||0
2567370|NCT00452673|6295284|P4|NOT COMPLETED|Dose Escalation Period||9
2567371|NCT00452673|6295285|P3|NOT COMPLETED|Dose Escalation Period||6
2567372|NCT00452673|6295286|P2|NOT COMPLETED|Dose Escalation Period||9
2567373|NCT00452673|6295287|P1|NOT COMPLETED|Dose Escalation Period||7
2567374|NCT00452673|6295283|P5|COMPLETED|Dose Escalation Period||0
2567375|NCT00452673|6295284|P4|COMPLETED|Dose Escalation Period||0
2567376|NCT00452673|6295285|P3|COMPLETED|Dose Escalation Period||0
2567377|NCT00452673|6295286|P2|COMPLETED|Dose Escalation Period||0
2567378|NCT00452673|6295287|P1|COMPLETED|Dose Escalation Period||0
2567379|NCT00452673|6295283|P5|STARTED|Dose Escalation Period||0
2567380|NCT00452673|6295284|P4|STARTED|Dose Escalation Period||9
2567381|NCT00452673|6295285|P3|STARTED|Dose Escalation Period||6
2567382|NCT00452673|6295286|P2|STARTED|Dose Escalation Period||9
2567383|NCT00452673|6295287|P1|STARTED|Dose Escalation Period||7
2567384|NCT00452543|6295319|P2|NOT COMPLETED|Overall Study||6
2567385|NCT00452543|6295320|P1|NOT COMPLETED|Overall Study||5
2567386|NCT00452543|6295319|P2|COMPLETED|Overall Study||5
2567387|NCT00452543|6295320|P1|COMPLETED|Overall Study||7
2567388|NCT00452543|6295319|P2|STARTED|Overall Study||11
2567389|NCT00452543|6295320|P1|STARTED|Overall Study||12
2567390|NCT00452530|6295334|P2|NOT COMPLETED|Overall Study||136
2567391|NCT00452530|6295335|P1|NOT COMPLETED|Overall Study||136
2567392|NCT00452530|6295334|P2|COMPLETED|Overall Study||1393
2567393|NCT00452530|6295335|P1|COMPLETED|Overall Study||1392
2567394|NCT00452530|6295334|P2|Primary Participants|Overall Study||997
2567395|NCT00452530|6295335|P1|Primary Participants|Overall Study||976
2567396|NCT00452530|6295334|P2|Evaluable Participants|Overall Study||921
2567397|NCT00452530|6295335|P1|Evaluable Participants|Overall Study||907
2567398|NCT00452530|6295334|P2|Received Treatment|Overall Study||1508
2567399|NCT00452530|6295335|P1|Received Treatment|Overall Study||1501
2567400|NCT00452530|6295334|P2|STARTED|Overall Study|Randomized|1529
2567401|NCT00452530|6295335|P1|STARTED|Overall Study|Randomized|1528
2567402|NCT00452452|6295356|P3|NOT COMPLETED|Overall Study||1
2567403|NCT00452452|6295357|P2|NOT COMPLETED|Overall Study||0
2567404|NCT00452452|6295358|P1|NOT COMPLETED|Overall Study||2
2567405|NCT00452452|6295356|P3|COMPLETED|Overall Study||152
2567406|NCT00452452|6295357|P2|COMPLETED|Overall Study||112
2567407|NCT00452452|6295358|P1|COMPLETED|Overall Study||88
2567408|NCT00452452|6295356|P3|Vaccinated Dose 3|Overall Study||0
2567409|NCT00452452|6295357|P2|Vaccinated Dose 3|Overall Study||0
2567410|NCT00452452|6295358|P1|Vaccinated Dose 3|Overall Study||89
2567411|NCT00452452|6295356|P3|Vaccinated Dose 2|Overall Study||0
2567412|NCT00452452|6295357|P2|Vaccinated Dose 2|Overall Study||112
2567413|NCT00452452|6295358|P1|Vaccinated Dose 2|Overall Study||90
2567414|NCT00452452|6295356|P3|Vaccinated Dose 1|Overall Study||152
2567415|NCT00452452|6295357|P2|Vaccinated Dose 1|Overall Study||112
2567416|NCT00452452|6295358|P1|Vaccinated Dose 1|Overall Study||90
2567417|NCT00452452|6295356|P3|STARTED|Overall Study||153
2567418|NCT00452452|6295357|P2|STARTED|Overall Study||112
2567419|NCT00452452|6295358|P1|STARTED|Overall Study||90
2567420|NCT00452426|6295383|P2|NOT COMPLETED|Overall Study||11
2567421|NCT00452426|6295384|P1|NOT COMPLETED|Overall Study||7
2567422|NCT00452426|6295383|P2|COMPLETED|Overall Study||493
2567423|NCT00452426|6295384|P1|COMPLETED|Overall Study||489
2567424|NCT00452426|6295383|P2|STARTED|Overall Study||504
2567425|NCT00452426|6295384|P1|STARTED|Overall Study||496
2567426|NCT00452400|6295403|P5|NOT COMPLETED|Overall Study||3
2567427|NCT00452400|6295404|P4|NOT COMPLETED|Overall Study||1
2567428|NCT00452400|6295405|P3|NOT COMPLETED|Overall Study||7
2567429|NCT00452400|6295406|P2|NOT COMPLETED|Overall Study||1
2567430|NCT00452400|6295407|P1|NOT COMPLETED|Overall Study||5
2567431|NCT00452400|6295403|P5|COMPLETED|Overall Study||76
2567432|NCT00452400|6295404|P4|COMPLETED|Overall Study||85
2567433|NCT00452400|6295405|P3|COMPLETED|Overall Study||73
2567434|NCT00452400|6295406|P2|COMPLETED|Overall Study||80
2567435|NCT00452400|6295407|P1|COMPLETED|Overall Study||74
2567436|NCT00452400|6295403|P5|STARTED|Overall Study||79
2567437|NCT00452400|6295404|P4|STARTED|Overall Study||86
2567438|NCT00452400|6295405|P3|STARTED|Overall Study||80
2567439|NCT00452400|6295406|P2|STARTED|Overall Study||81
2567440|NCT00452400|6295407|P1|STARTED|Overall Study||79
2567441|NCT00452387|6295579|P1|NOT COMPLETED|Overall Study||0
2567442|NCT00452387|6295579|P1|COMPLETED|Overall Study||22
2567443|NCT00452387|6295579|P1|STARTED|Overall Study||22
2567444|NCT00452374|6295587|P1|NOT COMPLETED|Overall Study||0
2567445|NCT00452374|6295587|P1|COMPLETED|Overall Study||48
2567446|NCT00452374|6295587|P1|STARTED|Overall Study||48
2567447|NCT00452361|6295594|P2|NOT COMPLETED|Overall Study||10
2567448|NCT00452361|6295595|P1|NOT COMPLETED|Overall Study||21
2567449|NCT00452361|6295594|P2|COMPLETED|Overall Study||0
2567450|NCT00452361|6295595|P1|COMPLETED|Overall Study||0
2567451|NCT00452361|6295594|P2|STARTED|Overall Study||10
2567452|NCT00452361|6295595|P1|STARTED|Overall Study||21
2567453|NCT00452348|6295639|P2|NOT COMPLETED|Overall Study||84
2567454|NCT00452348|6295640|P1|NOT COMPLETED|Overall Study||79
2567455|NCT00452348|6295639|P2|COMPLETED|Overall Study||234
2567456|NCT00452348|6295640|P1|COMPLETED|Overall Study||231
2567457|NCT00452348|6295639|P2|STARTED|Overall Study||318
2567458|NCT00452348|6295640|P1|STARTED|Overall Study||310
2567459|NCT00452335|6295655|P3|NOT COMPLETED|Overall Study||9
2567460|NCT00452335|6295656|P2|NOT COMPLETED|Overall Study||4
2567461|NCT00452335|6295657|P1|NOT COMPLETED|Overall Study||2
2567462|NCT00452335|6295655|P3|COMPLETED|Overall Study||23
2567463|NCT00452335|6295656|P2|COMPLETED|Overall Study||61
2567464|NCT00452335|6295657|P1|COMPLETED|Overall Study||25
2567465|NCT00452335|6295655|P3|STARTED|Overall Study||32
2567466|NCT00452335|6295656|P2|STARTED|Overall Study||65
2567467|NCT00452335|6295657|P1|STARTED|Overall Study||27
2567468|NCT00452114|6295694|P2|NOT COMPLETED|Overall Study||3
2567469|NCT00452114|6295695|P1|NOT COMPLETED|Overall Study||3
2567470|NCT00452114|6295694|P2|COMPLETED|Overall Study||10
2567471|NCT00452114|6295695|P1|COMPLETED|Overall Study||12
2567472|NCT00452114|6295694|P2|STARTED|Overall Study||13
2567473|NCT00452114|6295695|P1|STARTED|Overall Study||15
2567474|NCT00451958|6295711|P5|NOT COMPLETED|CS21A (NCT00451958)||0
2567475|NCT00451958|6295712|P4|NOT COMPLETED|CS21A (NCT00451958)||39
2567476|NCT00451958|6295713|P3|NOT COMPLETED|CS21A (NCT00451958)||42
2567477|NCT00451958|6295714|P2|NOT COMPLETED|CS21A (NCT00451958)||77
2567478|NCT00451958|6295715|P1|NOT COMPLETED|CS21A (NCT00451958)||65
2567479|NCT00451958|6295711|P5|COMPLETED|CS21A (NCT00451958)||0
2567480|NCT00451958|6295712|P4|COMPLETED|CS21A (NCT00451958)||27
2567481|NCT00451958|6295713|P3|COMPLETED|CS21A (NCT00451958)||27
2567482|NCT00451958|6295714|P2|COMPLETED|CS21A (NCT00451958)||49
2567483|NCT00451958|6295715|P1|COMPLETED|CS21A (NCT00451958)||60
2567484|NCT00451958|6295711|P5|STARTED|CS21A (NCT00451958)|Participants were switched to the degarelix groups when CS21 was completed.|0
2567485|NCT00451958|6295712|P4|STARTED|CS21A (NCT00451958)|One of the enrolled participants never received any treatment, i.e. the CS21A ITT population=65.|66
2567486|NCT00451958|6295713|P3|STARTED|CS21A (NCT00451958)|CS21A ITT population.|69
2567487|NCT00451958|6295714|P2|STARTED|CS21A (NCT00451958)|CS21A ITT population.|126
2567488|NCT00451958|6295715|P1|STARTED|CS21A (NCT00451958)|CS21A intention-to-treat (ITT) population.|125
2567489|NCT00451958|6295711|P5|NOT COMPLETED|CS21 (NCT00295750)||32
2567490|NCT00451958|6295712|P4|NOT COMPLETED|CS21 (NCT00295750)||0
2567491|NCT00451958|6295713|P3|NOT COMPLETED|CS21 (NCT00295750)||0
2567492|NCT00451958|6295714|P2|NOT COMPLETED|CS21 (NCT00295750)||43
2567493|NCT00451958|6295715|P1|NOT COMPLETED|CS21 (NCT00295750)||41
2567494|NCT00451958|6295711|P5|COMPLETED|CS21 (NCT00295750)||172
2567495|NCT00451958|6295712|P4|COMPLETED|CS21 (NCT00295750)||0
2567496|NCT00451958|6295713|P3|COMPLETED|CS21 (NCT00295750)||0
2567497|NCT00451958|6295714|P2|COMPLETED|CS21 (NCT00295750)||163
2567498|NCT00451958|6295715|P1|COMPLETED|CS21 (NCT00295750)||169
2567499|NCT00451958|6295711|P5|STARTED|CS21 (NCT00295750)||204
2567500|NCT00451958|6295712|P4|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
2567501|NCT00451958|6295713|P3|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
2567502|NCT00451958|6295714|P2|STARTED|CS21 (NCT00295750)|CS21 ITT population.|206
2567503|NCT00451958|6295715|P1|STARTED|CS21 (NCT00295750)|CS21 intention-to-treat (ITT) population.|210
2567504|NCT00451906|6295745|P1|NOT COMPLETED|Overall Study||2239
2567505|NCT00451906|6295745|P1|COMPLETED|Overall Study||13
2567506|NCT00451906|6295745|P1|STARTED|Overall Study||2252
2567507|NCT00451698|6295755|P2|NOT COMPLETED|Overall Study||0
2567508|NCT00451698|6295756|P1|NOT COMPLETED|Overall Study||0
2567509|NCT00451698|6295755|P2|COMPLETED|Overall Study||6
2567510|NCT00451698|6295756|P1|COMPLETED|Overall Study||3
2567511|NCT00451698|6295755|P2|STARTED|Overall Study||6
2567512|NCT00451698|6295756|P1|STARTED|Overall Study||3
2567513|NCT00451555|6295773|P2|NOT COMPLETED|Overall Study||4
2567514|NCT00451555|6295774|P1|NOT COMPLETED|Overall Study||13
2567515|NCT00451555|6295773|P2|COMPLETED|Overall Study||56
2567516|NCT00451555|6295774|P1|COMPLETED|Overall Study||83
2567517|NCT00451555|6295773|P2|Death|Overall Study||0
2567518|NCT00451555|6295774|P1|Death|Overall Study||2
2567519|NCT00451555|6295773|P2|Progressive Disease|Overall Study||54
2567520|NCT00451555|6295774|P1|Progressive Disease|Overall Study||75
2567521|NCT00451555|6295773|P2|Enzastaurin Once Daily Dosing (QD)|Overall Study||0
2567522|NCT00451555|6295774|P1|Enzastaurin Once Daily Dosing (QD)|Overall Study||55
2567523|NCT00451555|6295773|P2|Enzastaurin Twice Daily Dosing (BID)|Overall Study||0
2567524|NCT00451555|6295774|P1|Enzastaurin Twice Daily Dosing (BID)|Overall Study||39
2567525|NCT00451555|6295773|P2|Received at Least One Dose of Study Drug|Overall Study||58
2567526|NCT00451555|6295774|P1|Received at Least One Dose of Study Drug|Overall Study||94
2567527|NCT00451555|6295773|P2|STARTED|Overall Study||60
2567528|NCT00451555|6295774|P1|STARTED|Overall Study||96
2567529|NCT00451451|6295808|P4|NOT COMPLETED|Overall Study||58
2567530|NCT00451451|6295809|P3|NOT COMPLETED|Overall Study||72
2567531|NCT00451451|6295810|P2|NOT COMPLETED|Overall Study||75
2567532|NCT00451451|6295811|P1|NOT COMPLETED|Overall Study||85
2567533|NCT00451451|6295808|P4|COMPLETED|Overall Study||292
2567534|NCT00451451|6295809|P3|COMPLETED|Overall Study||273
2567535|NCT00451451|6295810|P2|COMPLETED|Overall Study||284
2567536|NCT00451451|6295811|P1|COMPLETED|Overall Study||278
2567537|NCT00451451|6295808|P4|STARTED|Overall Study|350 participants were dosed; 360 participants were randomized|350
2567538|NCT00451451|6295809|P3|STARTED|Overall Study|345 participants were dosed; 345 participants were randomized|345
2567539|NCT00451451|6295810|P2|STARTED|Overall Study|359 participants were dosed; 362 participants were randomized|359
2567540|NCT00451451|6295811|P1|STARTED|Overall Study|363 participants were dosed; 363 participants were randomized|363
2567541|NCT00451321|6295846|P8|NOT COMPLETED|Overall Study||6
2567542|NCT00451321|6295847|P7|NOT COMPLETED|Overall Study||6
2567543|NCT00451321|6295848|P6|NOT COMPLETED|Overall Study||9
2567544|NCT00451321|6295849|P5|NOT COMPLETED|Overall Study||7
2567545|NCT00451321|6295850|P4|NOT COMPLETED|Overall Study||12
2567546|NCT00451321|6295851|P3|NOT COMPLETED|Overall Study||18
2567547|NCT00451321|6295852|P2|NOT COMPLETED|Overall Study||5
2567548|NCT00451321|6295853|P1|NOT COMPLETED|Overall Study||7
2567549|NCT00451321|6295846|P8|COMPLETED|Overall Study||0
2567550|NCT00451321|6295847|P7|COMPLETED|Overall Study||0
2567551|NCT00451321|6295848|P6|COMPLETED|Overall Study||0
2567552|NCT00451321|6295849|P5|COMPLETED|Overall Study||0
2567553|NCT00451321|6295850|P4|COMPLETED|Overall Study||7
2567554|NCT00451321|6295851|P3|COMPLETED|Overall Study||0
2567555|NCT00451321|6295852|P2|COMPLETED|Overall Study||10
2567556|NCT00451321|6295853|P1|COMPLETED|Overall Study||1
2567557|NCT00451321|6295846|P8|STARTED|Overall Study||6
2567558|NCT00451321|6295847|P7|STARTED|Overall Study||6
2567559|NCT00451321|6295848|P6|STARTED|Overall Study||9
2567560|NCT00451321|6295849|P5|STARTED|Overall Study||7
2567561|NCT00451321|6295850|P4|STARTED|Overall Study||19
2567562|NCT00451321|6295851|P3|STARTED|Overall Study||18
2567563|NCT00451321|6295852|P2|STARTED|Overall Study||15
2567564|NCT00451321|6295853|P1|STARTED|Overall Study||8
2567565|NCT00451282|6296025|P2|NOT COMPLETED|Overall Study||5
2567566|NCT00451282|6296026|P1|NOT COMPLETED|Overall Study||6
2567567|NCT00451282|6296025|P2|COMPLETED|Overall Study||34
2567568|NCT00451282|6296026|P1|COMPLETED|Overall Study||40
2567569|NCT00451282|6296025|P2|STARTED|Overall Study||39
2567570|NCT00451282|6296026|P1|STARTED|Overall Study||46
2567571|NCT00451217|6296042|P4|NOT COMPLETED|Overall Study||5
2567572|NCT00451217|6296043|P3|NOT COMPLETED|Overall Study||4
2567573|NCT00451217|6296044|P2|NOT COMPLETED|Overall Study||2
2567574|NCT00451217|6296045|P1|NOT COMPLETED|Overall Study||2
2567575|NCT00451217|6296042|P4|COMPLETED|Overall Study||44
2567576|NCT00451217|6296043|P3|COMPLETED|Overall Study||47
2567577|NCT00451217|6296044|P2|COMPLETED|Overall Study||47
2567578|NCT00451217|6296045|P1|COMPLETED|Overall Study||47
2567579|NCT00451217|6296042|P4|Treated|Overall Study||45
2567580|NCT00451217|6296043|P3|Treated|Overall Study||48
2567581|NCT00451217|6296044|P2|Treated|Overall Study||48
2567582|NCT00451217|6296045|P1|Treated|Overall Study||48
2567583|NCT00451217|6296042|P4|STARTED|Overall Study||49
2567584|NCT00451217|6296043|P3|STARTED|Overall Study||51
2567585|NCT00451217|6296044|P2|STARTED|Overall Study||49
2567586|NCT00451217|6296045|P1|STARTED|Overall Study||49
2567587|NCT00451204|6296073|P2|NOT COMPLETED|Overall Study||20
2567588|NCT00451204|6296074|P1|NOT COMPLETED|Overall Study||22
2567589|NCT00451204|6296073|P2|COMPLETED|Overall Study||56
2567590|NCT00451204|6296074|P1|COMPLETED|Overall Study|60 completed the study but 3 stopped study drug(s) early|60
2567591|NCT00451204|6296073|P2|STARTED|Overall Study||76
2567592|NCT00451204|6296074|P1|STARTED|Overall Study||82
2567593|NCT00451191|6296092|P2|NOT COMPLETED|Overall Study||11
2567594|NCT00451191|6296093|P1|NOT COMPLETED|Overall Study||15
2567595|NCT00451191|6296092|P2|COMPLETED|Overall Study||55
2567596|NCT00451191|6296093|P1|COMPLETED|Overall Study||53
2567597|NCT00451191|6296092|P2|STARTED|Overall Study||66
2567598|NCT00451191|6296093|P1|STARTED|Overall Study||68
2567599|NCT00451048|6296099|P1|NOT COMPLETED|Overall Study||0
2567600|NCT00451048|6296099|P1|COMPLETED|Overall Study||10
2567601|NCT00451048|6296099|P1|STARTED|Overall Study||10
2567602|NCT00450983|6296108|P1|NOT COMPLETED|Overall Study||0
2567603|NCT00450983|6296108|P1|COMPLETED|Overall Study||1
2567604|NCT00450983|6296108|P1|STARTED|Overall Study||1
2567605|NCT00450866|6296120|P2|NOT COMPLETED|Overall Study||3
2567606|NCT00450866|6296121|P1|NOT COMPLETED|Overall Study||7
2567607|NCT00450866|6296120|P2|COMPLETED|Overall Study||7
2567608|NCT00450866|6296121|P1|COMPLETED|Overall Study||38
2567609|NCT00450866|6296120|P2|STARTED|Overall Study||10
2567610|NCT00450866|6296121|P1|STARTED|Overall Study||45
2567611|NCT00450814|6296141|P11|NOT COMPLETED|Overall Study||0
2567612|NCT00450814|6296142|P10|NOT COMPLETED|Overall Study||1
2567613|NCT00450814|6296143|P9|NOT COMPLETED|Overall Study||0
2567614|NCT00450814|6296144|P8|NOT COMPLETED|Overall Study||0
2567615|NCT00450814|6296145|P7|NOT COMPLETED|Overall Study||0
2567616|NCT00450814|6296146|P6|NOT COMPLETED|Overall Study||1
2567617|NCT00450814|6296147|P5|NOT COMPLETED|Overall Study||1
2567618|NCT00450814|6296148|P4|NOT COMPLETED|Overall Study||1
2567619|NCT00450814|6296149|P3|NOT COMPLETED|Overall Study||0
2567620|NCT00450814|6296150|P2|NOT COMPLETED|Overall Study||0
2567621|NCT00450814|6296151|P1|NOT COMPLETED|Overall Study||0
2567622|NCT00450814|6296141|P11|COMPLETED|Overall Study||4
2567623|NCT00450814|6296142|P10|COMPLETED|Overall Study||11
2567624|NCT00450814|6296143|P9|COMPLETED|Overall Study||2
2567625|NCT00450814|6296144|P8|COMPLETED|Overall Study||3
2567626|NCT00450814|6296145|P7|COMPLETED|Overall Study||3
2567627|NCT00450814|6296146|P6|COMPLETED|Overall Study||6
2567628|NCT00450814|6296147|P5|COMPLETED|Overall Study||3
2567629|NCT00450814|6296148|P4|COMPLETED|Overall Study||3
2567630|NCT00450814|6296149|P3|COMPLETED|Overall Study||3
2567631|NCT00450814|6296150|P2|COMPLETED|Overall Study||3
2567632|NCT00450814|6296151|P1|COMPLETED|Overall Study||3
2567633|NCT00450814|6296141|P11|STARTED|Overall Study||4
2567634|NCT00450814|6296142|P10|STARTED|Overall Study||12
2567635|NCT00450814|6296143|P9|STARTED|Overall Study||2
2567636|NCT00450814|6296144|P8|STARTED|Overall Study||3
2567637|NCT00450814|6296145|P7|STARTED|Overall Study||3
2567638|NCT00450814|6296146|P6|STARTED|Overall Study||7
2567639|NCT00450814|6296147|P5|STARTED|Overall Study||4
2567640|NCT00450814|6296148|P4|STARTED|Overall Study||4
2567641|NCT00450814|6296149|P3|STARTED|Overall Study||3
2567642|NCT00450814|6296150|P2|STARTED|Overall Study||3
2567643|NCT00450814|6296151|P1|STARTED|Overall Study||3
2567644|NCT00450801|6296185|P1|NOT COMPLETED|Overall Study||1
2567645|NCT00450801|6296185|P1|COMPLETED|Overall Study||21
2567646|NCT00450801|6296185|P1|STARTED|Overall Study||22
2567647|NCT00450749|6296199|P3|NOT COMPLETED|Overall Study||2
2567648|NCT00450749|6296200|P2|NOT COMPLETED|Overall Study||1
2567649|NCT00450749|6296201|P1|NOT COMPLETED|Overall Study||0
2567650|NCT00450749|6296199|P3|COMPLETED|Overall Study||2
2567651|NCT00450749|6296200|P2|COMPLETED|Overall Study||2
2567652|NCT00450749|6296201|P1|COMPLETED|Overall Study||3
2567653|NCT00450749|6296199|P3|STARTED|Overall Study||4
2567654|NCT00450749|6296200|P2|STARTED|Overall Study||3
2567655|NCT00450749|6296201|P1|STARTED|Overall Study||3
2567656|NCT00450723|6296239|P1|NOT COMPLETED|Overall Study||5
2567657|NCT00450723|6296239|P1|COMPLETED|Overall Study||34
2567658|NCT00450723|6296239|P1|STARTED|Overall Study||39
2567659|NCT00450658|6296247|P2|NOT COMPLETED|Overall Study||90
2567660|NCT00450658|6296248|P1|NOT COMPLETED|Overall Study||143
2567661|NCT00450658|6296247|P2|COMPLETED|Overall Study||122
2567662|NCT00450658|6296248|P1|COMPLETED|Overall Study||272
2567663|NCT00450658|6296247|P2|STARTED|Overall Study||212
2567664|NCT00450658|6296248|P1|STARTED|Overall Study||415
2567665|NCT00450619|6296262|P2|NOT COMPLETED|Overall Study||1
2567666|NCT00450619|6296263|P1|NOT COMPLETED|Overall Study||4
2567667|NCT00450619|6296262|P2|COMPLETED|Overall Study||21
2567668|NCT00450619|6296263|P1|COMPLETED|Overall Study||18
2567669|NCT00450619|6296262|P2|STARTED|Overall Study||22
2567670|NCT00450619|6296263|P1|STARTED|Overall Study||22
2567671|NCT00450580|6296289|P2|NOT COMPLETED|Overall Study||16
2567672|NCT00450580|6296290|P1|NOT COMPLETED|Overall Study||16
2567673|NCT00450580|6296289|P2|COMPLETED|Overall Study||90
2567674|NCT00450580|6296290|P1|COMPLETED|Overall Study||90
2567675|NCT00450580|6296289|P2|STARTED|Overall Study||106
2567676|NCT00450580|6296290|P1|STARTED|Overall Study||106
2567677|NCT00450463|6296310|P2|NOT COMPLETED|Progressed to Receive Vaccine Alone||0
2567678|NCT00450463|6296311|P1|NOT COMPLETED|Progressed to Receive Vaccine Alone||0
2567679|NCT00450463|6296310|P2|COMPLETED|Progressed to Receive Vaccine Alone||0
2567680|NCT00450463|6296311|P1|COMPLETED|Progressed to Receive Vaccine Alone||11
2567681|NCT00450463|6296310|P2|STARTED|Progressed to Receive Vaccine Alone||0
2567682|NCT00450463|6296311|P1|STARTED|Progressed to Receive Vaccine Alone||11
2567683|NCT00450463|6296310|P2|NOT COMPLETED|Initial Drug Administration||0
2567684|NCT00450463|6296311|P1|NOT COMPLETED|Initial Drug Administration||0
2567685|NCT00450463|6296310|P2|COMPLETED|Initial Drug Administration||31
2567686|NCT00450463|6296311|P1|COMPLETED|Initial Drug Administration||33
2567687|NCT00450463|6296310|P2|STARTED|Initial Drug Administration||31
2567688|NCT00450463|6296311|P1|STARTED|Initial Drug Administration||33
2567689|NCT00450450|6296327|P2|NOT COMPLETED|Overall Study||3
2567690|NCT00450450|6296328|P1|NOT COMPLETED|Overall Study||5
2567691|NCT00450450|6296327|P2|COMPLETED|Overall Study||11
2567692|NCT00450450|6296328|P1|COMPLETED|Overall Study||8
2567693|NCT00450450|6296327|P2|STARTED|Overall Study||14
2567694|NCT00450450|6296328|P1|STARTED|Overall Study||13
2567695|NCT00450437|6296352|P4|NOT COMPLETED|Overall Study||11
2567696|NCT00450437|6296353|P3|NOT COMPLETED|Overall Study||24
2567697|NCT00450437|6296354|P2|NOT COMPLETED|Overall Study||16
2567698|NCT00450437|6296355|P1|NOT COMPLETED|Overall Study||46
2567699|NCT00450437|6296352|P4|COMPLETED|Overall Study||325
2567700|NCT00450437|6296353|P3|COMPLETED|Overall Study||999
2567701|NCT00450437|6296354|P2|COMPLETED|Overall Study||524
2567702|NCT00450437|6296355|P1|COMPLETED|Overall Study||1594
2567703|NCT00450437|6296352|P4|STARTED|Overall Study||336
2567704|NCT00450437|6296353|P3|STARTED|Overall Study||1023
2567705|NCT00450437|6296354|P2|STARTED|Overall Study||540
2567706|NCT00450437|6296355|P1|STARTED|Overall Study||1640
2567707|NCT00450424|6296379|P2|NOT COMPLETED|Overall Study||11
2567708|NCT00450424|6296380|P1|NOT COMPLETED|Overall Study||20
2567709|NCT00450424|6296379|P2|COMPLETED|Overall Study||106
2567710|NCT00450424|6296380|P1|COMPLETED|Overall Study||102
2567711|NCT00450424|6296379|P2|STARTED|Overall Study||117
2567712|NCT00450424|6296380|P1|STARTED|Overall Study||122
2567713|NCT00450411|6296386|P1|NOT COMPLETED|Overall Study||8
2567714|NCT00450411|6296386|P1|COMPLETED|Overall Study||92
2567715|NCT00450411|6296386|P1|STARTED|Overall Study||100
2567716|NCT00450385|6296391|P1|NOT COMPLETED|Overall Study||13
2567717|NCT00450385|6296391|P1|COMPLETED|Overall Study||44
2567718|NCT00450385|6296391|P1|STARTED|Overall Study||57
2567719|NCT00450372|6296400|P1|NOT COMPLETED|Overall Study||1
2567720|NCT00450372|6296400|P1|COMPLETED|Overall Study||37
2567721|NCT00450372|6296400|P1|STARTED|Overall Study||38
2567722|NCT00450333|6296413|P4|NOT COMPLETED|Overall Study||28
2567723|NCT00450333|6296414|P3|NOT COMPLETED|Overall Study||25
2567724|NCT00450333|6296415|P2|NOT COMPLETED|Overall Study||63
2567725|NCT00450333|6296416|P1|NOT COMPLETED|Overall Study||54
2567726|NCT00450333|6296413|P4|COMPLETED|Overall Study||74
2567727|NCT00450333|6296414|P3|COMPLETED|Overall Study||75
2567728|NCT00450333|6296415|P2|COMPLETED|Overall Study||44
2567729|NCT00450333|6296416|P1|COMPLETED|Overall Study||44
2567730|NCT00450333|6296413|P4|STARTED|Overall Study||102
2567731|NCT00450333|6296414|P3|STARTED|Overall Study||100
2567732|NCT00450333|6296415|P2|STARTED|Overall Study||107
2567733|NCT00450333|6296416|P1|STARTED|Overall Study||98
2567734|NCT00450294|6296434|P1|NOT COMPLETED|Overall Study||0
2567735|NCT00450294|6296434|P1|COMPLETED|Overall Study||10
2567736|NCT00450294|6296434|P1|STARTED|Overall Study||10
2567737|NCT00450255|6296439|P1|NOT COMPLETED|Overall Study||1
2567738|NCT00450255|6296439|P1|COMPLETED|Overall Study||40
2567739|NCT00450255|6296439|P1|STARTED|Overall Study||41
2567740|NCT00450242|6296449|P2|NOT COMPLETED|Overall Study||1
2567741|NCT00450242|6296450|P1|NOT COMPLETED|Overall Study||3
2567742|NCT00450242|6296449|P2|COMPLETED|Overall Study||6
2567743|NCT00450242|6296450|P1|COMPLETED|Overall Study||4
2567744|NCT00450242|6296449|P2|STARTED|Overall Study||7
2567745|NCT00450242|6296450|P1|STARTED|Overall Study||7
2567746|NCT00450216|6296464|P2|NOT COMPLETED|Overall Study||129
2567747|NCT00450216|6296465|P1|NOT COMPLETED|Overall Study||174
2567748|NCT00450216|6296464|P2|COMPLETED|Overall Study||170
2567749|NCT00450216|6296465|P1|COMPLETED|Overall Study||433
2567750|NCT00450216|6296464|P2|STARTED|Overall Study||299
2567751|NCT00450216|6296465|P1|STARTED|Overall Study||607
2567752|NCT00450190|6296477|P1|NOT COMPLETED|Overall Study||2
2567753|NCT00450190|6296477|P1|COMPLETED|Overall Study||18
2567754|NCT00450190|6296477|P1|STARTED|Overall Study||20
2567755|NCT00450177|6296487|P2|NOT COMPLETED|Overall Study||11
2567756|NCT00450177|6296488|P1|NOT COMPLETED|Overall Study||9
2567757|NCT00450177|6296487|P2|COMPLETED|Overall Study||92
2567758|NCT00450177|6296488|P1|COMPLETED|Overall Study||88
2567759|NCT00450177|6296487|P2|STARTED|Overall Study||103
2567760|NCT00450177|6296488|P1|STARTED|Overall Study||97
2567761|NCT00450112|6296514|P2|NOT COMPLETED|Overall Study||6
2567762|NCT00450112|6296515|P1|NOT COMPLETED|Overall Study||13
2567763|NCT00450112|6296514|P2|COMPLETED|Overall Study||71
2567764|NCT00450112|6296515|P1|COMPLETED|Overall Study||112
2567765|NCT00450112|6296514|P2|Analyzed Participants|Overall Study||74
2567766|NCT00450112|6296515|P1|Analyzed Participants|Overall Study|3 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|122
2567767|NCT00450112|6296514|P2|Received Injection|Overall Study||74
2567768|NCT00450112|6296515|P1|Received Injection|Overall Study||125
2567769|NCT00450112|6296514|P2|STARTED|Overall Study||77
2567770|NCT00450112|6296515|P1|STARTED|Overall Study||125
2567771|NCT00450073|6296540|P3|NOT COMPLETED|Overall Study||1
2567772|NCT00450073|6296541|P2|NOT COMPLETED|Overall Study||0
2567773|NCT00450073|6296542|P1|NOT COMPLETED|Overall Study||1
2567774|NCT00450073|6296540|P3|COMPLETED|Overall Study||9
2567775|NCT00450073|6296541|P2|COMPLETED|Overall Study||10
2567776|NCT00450073|6296542|P1|COMPLETED|Overall Study||9
2567777|NCT00450073|6296540|P3|STARTED|Overall Study||10
2567778|NCT00450073|6296541|P2|STARTED|Overall Study||10
2567779|NCT00450073|6296542|P1|STARTED|Overall Study||10
2567780|NCT00449956|6296553|P3|NOT COMPLETED|Overall Study||9
2567781|NCT00449956|6296554|P2|NOT COMPLETED|Overall Study||4
2567782|NCT00449956|6296555|P1|NOT COMPLETED|Overall Study||10
2567783|NCT00449956|6296553|P3|COMPLETED|Overall Study||184
2567784|NCT00449956|6296554|P2|COMPLETED|Overall Study||88
2567785|NCT00449956|6296555|P1|COMPLETED|Overall Study||179
2567786|NCT00449956|6296553|P3|STARTED|Overall Study||193
2567787|NCT00449956|6296554|P2|STARTED|Overall Study||92
2567788|NCT00449956|6296555|P1|STARTED|Overall Study||189
2567789|NCT00449930|6296571|P2|NOT COMPLETED|Overall Study||75
2567790|NCT00449930|6296572|P1|NOT COMPLETED|Overall Study||61
2567791|NCT00449930|6296571|P2|COMPLETED|Overall Study||447
2567792|NCT00449930|6296572|P1|COMPLETED|Overall Study||467
2567793|NCT00449930|6296571|P2|STARTED|Overall Study||522
2567794|NCT00449930|6296572|P1|STARTED|Overall Study||528
2567795|NCT00449865|6296588|P2|NOT COMPLETED|Overall Study||534
2567796|NCT00449865|6296589|P1|NOT COMPLETED|Overall Study||522
2567797|NCT00449865|6296588|P2|COMPLETED|Overall Study|477 Expected at Year 5|340
2567798|NCT00449865|6296589|P1|COMPLETED|Overall Study|478 Expected at Year 5|345
2567799|NCT00449865|6296588|P2|Completed Year 4|Overall Study|686 Expected at Year 4|523
2567800|NCT00449865|6296589|P1|Completed Year 4|Overall Study|679 Expected at Year 4|521
2567801|NCT00449865|6296588|P2|Completed Year 3|Overall Study|874 Expected at Year 3|715
2567802|NCT00449865|6296589|P1|Completed Year 3|Overall Study|867 Expected at Year 3|719
2567803|NCT00449865|6296588|P2|Completed Year 2|Overall Study|874 Expected at Year 2|766
2567804|NCT00449865|6296589|P1|Completed Year 2|Overall Study|867 Expected at Year 2|768
2567805|NCT00449865|6296588|P2|Completed Year 1|Overall Study|874 Expected at Year 1|822
2567806|NCT00449865|6296589|P1|Completed Year 1|Overall Study|867 Expected at Year 1|802
2567807|NCT00449865|6296588|P2|STARTED|Overall Study||874
2567808|NCT00449865|6296589|P1|STARTED|Overall Study||867
2567809|NCT00449787|6296597|P2|NOT COMPLETED|Overall Study||100
2567810|NCT00449787|6296598|P1|NOT COMPLETED|Overall Study||105
2567811|NCT00449787|6296597|P2|COMPLETED|Overall Study||98
2567812|NCT00449787|6296598|P1|COMPLETED|Overall Study||98
2567813|NCT00449787|6296597|P2|STARTED|Overall Study||198
2567814|NCT00449787|6296598|P1|STARTED|Overall Study||203
2567815|NCT00449748|6296608|P1|NOT COMPLETED|Overall Study||0
2567816|NCT00449748|6296608|P1|COMPLETED|Overall Study||10
2567817|NCT00449748|6296608|P1|STARTED|Overall Study||10
2567818|NCT00449696|6296614|P2|NOT COMPLETED|Overall Study||9
2567819|NCT00449696|6296615|P1|NOT COMPLETED|Overall Study||20
2567820|NCT00449696|6296614|P2|COMPLETED|Overall Study||119
2567821|NCT00449696|6296615|P1|COMPLETED|Overall Study||231
2567822|NCT00449696|6296614|P2|Analyzed Participants|Overall Study||128
2567823|NCT00449696|6296615|P1|Analyzed Participants|Overall Study|2 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|247
2567824|NCT00449696|6296614|P2|Received Injection|Overall Study||128
2567825|NCT00449696|6296615|P1|Received Injection|Overall Study||249
2567826|NCT00449696|6296614|P2|STARTED|Overall Study||128
2567827|NCT00449696|6296615|P1|STARTED|Overall Study||251
2567828|NCT00449644|6296641|P4|NOT COMPLETED|Overall Study||32
2567829|NCT00449644|6296642|P3|NOT COMPLETED|Overall Study||29
2567830|NCT00449644|6296643|P2|NOT COMPLETED|Overall Study||13
2567831|NCT00449644|6296644|P1|NOT COMPLETED|Overall Study||10
2567918|NCT00448864|6296890|P3|NOT COMPLETED|Overall Study||1
2567832|NCT00449644|6296641|P4|COMPLETED|Overall Study|After Week 24, 1 patient rolled over to treatment with TMC207 and was not completed or discontinued.|49
2567833|NCT00449644|6296642|P3|COMPLETED|Overall Study||50
2567834|NCT00449644|6296643|P2|COMPLETED|Overall Study||11
2567835|NCT00449644|6296644|P1|COMPLETED|Overall Study||13
2567836|NCT00449644|6296641|P4|Rollover|Overall Study||1
2567837|NCT00449644|6296642|P3|Rollover|Overall Study||0
2567838|NCT00449644|6296643|P2|Rollover|Overall Study||0
2567839|NCT00449644|6296644|P1|Rollover|Overall Study||0
2567840|NCT00449644|6296641|P4|STARTED|Overall Study||81
2567841|NCT00449644|6296642|P3|STARTED|Overall Study||79
2567842|NCT00449644|6296643|P2|STARTED|Overall Study||24
2567843|NCT00449644|6296644|P1|STARTED|Overall Study||23
2567844|NCT00449540|6296664|P3|NOT COMPLETED|Treatment Phase||17
2567845|NCT00449540|6296665|P2|NOT COMPLETED|Treatment Phase||20
2567846|NCT00449540|6296666|P1|NOT COMPLETED|Treatment Phase||0
2567847|NCT00449540|6296664|P3|COMPLETED|Treatment Phase||82
2567848|NCT00449540|6296665|P2|COMPLETED|Treatment Phase||82
2567849|NCT00449540|6296666|P1|COMPLETED|Treatment Phase||0
2567850|NCT00449540|6296664|P3|STARTED|Treatment Phase||99
2567851|NCT00449540|6296665|P2|STARTED|Treatment Phase||102
2567852|NCT00449540|6296666|P1|STARTED|Treatment Phase||0
2567853|NCT00449540|6296664|P3|NOT COMPLETED|Pretreatment Phase||0
2567854|NCT00449540|6296665|P2|NOT COMPLETED|Pretreatment Phase||0
2567855|NCT00449540|6296666|P1|NOT COMPLETED|Pretreatment Phase||66
2567856|NCT00449540|6296664|P3|COMPLETED|Pretreatment Phase||0
2567857|NCT00449540|6296665|P2|COMPLETED|Pretreatment Phase||0
2567858|NCT00449540|6296666|P1|COMPLETED|Pretreatment Phase||201
2567859|NCT00449540|6296664|P3|STARTED|Pretreatment Phase||0
2567860|NCT00449540|6296665|P2|STARTED|Pretreatment Phase||0
2567861|NCT00449540|6296666|P1|STARTED|Pretreatment Phase||267
2567862|NCT00449176|6296683|P3|NOT COMPLETED|Overall Study||167
2567863|NCT00449176|6296684|P2|NOT COMPLETED|Overall Study||195
2567864|NCT00449176|6296685|P1|NOT COMPLETED|Overall Study||152
2567865|NCT00449176|6296683|P3|COMPLETED|Overall Study||152
2567866|NCT00449176|6296684|P2|COMPLETED|Overall Study||133
2567867|NCT00449176|6296685|P1|COMPLETED|Overall Study||166
2567868|NCT00449176|6296683|P3|STARTED|Overall Study|5 randomly assigned to this group did not receive drug, 2 enrolled twice(of 326 subjects randomized)|319
2567869|NCT00449176|6296684|P2|STARTED|Overall Study|6 randomly assigned to this treatment group did not take drug (of 334 subjects initially randomized)|328
2567870|NCT00449176|6296685|P1|STARTED|Overall Study|3 randomly assigned to this treatment group did not take drug (of 321 subjects initially randomized)|318
2567871|NCT00449163|6296711|P1|NOT COMPLETED|Overall Study||3
2567872|NCT00449163|6296711|P1|COMPLETED|Overall Study||22
2567873|NCT00449163|6296711|P1|STARTED|Overall Study||25
2567874|NCT00449150|6296721|P3|NOT COMPLETED|Overall Study||47
2567875|NCT00449150|6296722|P2|NOT COMPLETED|Overall Study||53
2567876|NCT00449150|6296723|P1|NOT COMPLETED|Overall Study||46
2567877|NCT00449150|6296721|P3|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|171
2567878|NCT00449150|6296722|P2|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|177
2567879|NCT00449150|6296723|P1|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|173
2567880|NCT00449150|6296721|P3|STARTED|Overall Study||218
2567881|NCT00449150|6296722|P2|STARTED|Overall Study||230
2567882|NCT00449150|6296723|P1|STARTED|Overall Study||219
2567883|NCT00449072|6296736|P2|NOT COMPLETED|Overall Study||42
2567884|NCT00449072|6296737|P1|NOT COMPLETED|Overall Study||41
2567885|NCT00449072|6296736|P2|COMPLETED|Overall Study||109
2567886|NCT00449072|6296737|P1|COMPLETED|Overall Study||107
2567887|NCT00449072|6296736|P2|STARTED|Overall Study||151
2567888|NCT00449072|6296737|P1|STARTED|Overall Study||148
2567889|NCT00449046|6296761|P1|NOT COMPLETED|Overall Study||0
2567890|NCT00449046|6296761|P1|COMPLETED|Overall Study||40
2567891|NCT00449046|6296761|P1|STARTED|Overall Study||40
2567892|NCT00449033|6296774|P2|NOT COMPLETED|Follow-up Period||434
2567893|NCT00449033|6296775|P1|NOT COMPLETED|Follow-up Period||425
2567894|NCT00449033|6296774|P2|COMPLETED|Follow-up Period||0
2567895|NCT00449033|6296775|P1|COMPLETED|Follow-up Period||0
2567896|NCT00449033|6296774|P2|STARTED|Follow-up Period|434 entered, comprising 452 randomized less 12 deaths, 2 lost to follow-up & 4 ongoing on treatment|434
2567897|NCT00449033|6296775|P1|STARTED|Follow-up Period|425 entered, comprising 452 randomized less 21 deaths & 6 ongoing on treatment|425
2567898|NCT00449033|6296774|P2|NOT COMPLETED|Treatment Period||452
2567899|NCT00449033|6296775|P1|NOT COMPLETED|Treatment Period||452
2567900|NCT00449033|6296774|P2|COMPLETED|Treatment Period||0
2567901|NCT00449033|6296775|P1|COMPLETED|Treatment Period||0
2567902|NCT00449033|6296774|P2|Received Treatment|Treatment Period||449
2567903|NCT00449033|6296775|P1|Received Treatment|Treatment Period||452
2567904|NCT00449033|6296774|P2|STARTED|Treatment Period|Reasons for not treated: Adverse event (N=1); Consent withdrawn (N=1); Reason missing (N=1)|452
2567905|NCT00449033|6296775|P1|STARTED|Treatment Period||452
2567906|NCT00448916|6296813|P4|NOT COMPLETED|Overall Study||6
2567907|NCT00448916|6296814|P3|NOT COMPLETED|Overall Study||6
2567908|NCT00448916|6296815|P2|NOT COMPLETED|Overall Study||6
2567909|NCT00448916|6296816|P1|NOT COMPLETED|Overall Study||7
2567910|NCT00448916|6296813|P4|COMPLETED|Overall Study||5
2567911|NCT00448916|6296814|P3|COMPLETED|Overall Study||6
2567912|NCT00448916|6296815|P2|COMPLETED|Overall Study||9
2567913|NCT00448916|6296816|P1|COMPLETED|Overall Study||9
2567914|NCT00448916|6296813|P4|STARTED|Overall Study||11
2567915|NCT00448916|6296814|P3|STARTED|Overall Study||12
2567916|NCT00448916|6296815|P2|STARTED|Overall Study||15
2567917|NCT00448916|6296816|P1|STARTED|Overall Study||16
2567919|NCT00448864|6296891|P2|NOT COMPLETED|Overall Study||5
2567920|NCT00448864|6296892|P1|NOT COMPLETED|Overall Study||5
2567921|NCT00448864|6296890|P3|COMPLETED|Overall Study||18
2567922|NCT00448864|6296891|P2|COMPLETED|Overall Study||24
2567923|NCT00448864|6296892|P1|COMPLETED|Overall Study||22
2567924|NCT00448864|6296890|P3|Completed Post-operative Period|Overall Study||18
2567925|NCT00448864|6296891|P2|Completed Post-operative Period|Overall Study||25
2567926|NCT00448864|6296892|P1|Completed Post-operative Period|Overall Study||26
2567927|NCT00448864|6296890|P3|Started Post-operative Period|Overall Study||18
2567928|NCT00448864|6296891|P2|Started Post-operative Period|Overall Study||25
2567929|NCT00448864|6296892|P1|Started Post-operative Period|Overall Study||26
2567930|NCT00448864|6296890|P3|Received at Least 1 Dose of Study Drug|Overall Study||18
2567931|NCT00448864|6296891|P2|Received at Least 1 Dose of Study Drug|Overall Study||25
2567932|NCT00448864|6296892|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
2567933|NCT00448864|6296890|P3|STARTED|Overall Study||19
2567934|NCT00448864|6296891|P2|STARTED|Overall Study||29
2567935|NCT00448864|6296892|P1|STARTED|Overall Study||27
2567936|NCT00448760|6296908|P1|NOT COMPLETED|Overall Study||3
2567937|NCT00448760|6296908|P1|COMPLETED|Overall Study||26
2567938|NCT00448760|6296908|P1|STARTED|Overall Study||29
2567939|NCT00448747|6296917|P2|NOT COMPLETED|Overall Study||0
2567940|NCT00448747|6296918|P1|NOT COMPLETED|Overall Study||1
2567941|NCT00448747|6296917|P2|COMPLETED|Overall Study||48
2567942|NCT00448747|6296918|P1|COMPLETED|Overall Study||52
2567943|NCT00448747|6296917|P2|Per Protocol Population (PPS)|Overall Study||48
2567944|NCT00448747|6296918|P1|Per Protocol Population (PPS)|Overall Study||50
2567945|NCT00448747|6296917|P2|Received L-ARG-GHRH and AEZS-130|Overall Study||10
2567946|NCT00448747|6296918|P1|Received L-ARG-GHRH and AEZS-130|Overall Study||42
2567947|NCT00448747|6296917|P2|Received L-ARG-GHRH|Overall Study||10
2567948|NCT00448747|6296918|P1|Received L-ARG-GHRH|Overall Study||43
2567949|NCT00448747|6296917|P2|Received AEZS-130|Overall Study||48
2567950|NCT00448747|6296918|P1|Received AEZS-130|Overall Study||52
2567951|NCT00448747|6296917|P2|Received Second Drug Administration|Overall Study||10
2567952|NCT00448747|6296918|P1|Received Second Drug Administration|Overall Study||42
2567953|NCT00448747|6296917|P2|Received First Drug Administration|Overall Study||48
2567954|NCT00448747|6296918|P1|Received First Drug Administration|Overall Study||53
2567955|NCT00448747|6296917|P2|STARTED|Overall Study||48
2567956|NCT00448747|6296918|P1|STARTED|Overall Study||53
2567957|NCT00448708|6296936|P2|NOT COMPLETED|Overall Study||31
2567958|NCT00448708|6296937|P1|NOT COMPLETED|Overall Study||35
2567959|NCT00448708|6296936|P2|COMPLETED|Overall Study||79
2567960|NCT00448708|6296937|P1|COMPLETED|Overall Study||77
2567961|NCT00448708|6296936|P2|STARTED|Overall Study||110
2567962|NCT00448708|6296937|P1|STARTED|Overall Study||112
2567963|NCT00448682|6296945|P1|NOT COMPLETED|Overall Study||0
2567964|NCT00448682|6296945|P1|COMPLETED|Overall Study||25
2567965|NCT00448682|6296945|P1|STARTED|Overall Study||25
2567966|NCT00448669|6296953|P2|NOT COMPLETED|Overall Study||198
2567967|NCT00448669|6296954|P1|NOT COMPLETED|Overall Study||218
2567968|NCT00448669|6296953|P2|COMPLETED|Overall Study||410
2567969|NCT00448669|6296954|P1|COMPLETED|Overall Study||393
2567970|NCT00448669|6296953|P2|STARTED|Overall Study||608
2567971|NCT00448669|6296954|P1|STARTED|Overall Study||611
2567972|NCT00448630|6296970|P1|NOT COMPLETED|Overall Study||27
2567973|NCT00448630|6296970|P1|COMPLETED|Overall Study|Number of patients who remained on same medication to end of study.|301
2567974|NCT00448630|6296970|P1|STARTED|Overall Study||328
2567975|NCT00448591|6297015|P1|NOT COMPLETED|Overall Study||2296
2567976|NCT00448591|6297015|P1|COMPLETED|Overall Study||0
2567977|NCT00448591|6297015|P1|STARTED|Overall Study||2296
2567978|NCT00448539|6297026|P2|NOT COMPLETED|Overall Study||152
2567979|NCT00448539|6297027|P1|NOT COMPLETED|Overall Study||134
2567980|NCT00448539|6297026|P2|COMPLETED|Overall Study||0
2567981|NCT00448539|6297027|P1|COMPLETED|Overall Study||0
2567982|NCT00448539|6297026|P2|STARTED|Overall Study||152
2567983|NCT00448539|6297027|P1|STARTED|Overall Study||134
2567984|NCT00448448|6297035|P2|NOT COMPLETED|Overall Study||41
2567985|NCT00448448|6297036|P1|NOT COMPLETED|Overall Study||100
2567986|NCT00448448|6297035|P2|COMPLETED|Overall Study||96
2567987|NCT00448448|6297036|P1|COMPLETED|Overall Study||146
2567988|NCT00448448|6297035|P2|STARTED|Overall Study||137
2567989|NCT00448448|6297036|P1|STARTED|Overall Study||246
2567990|NCT00448435|6297042|P2|NOT COMPLETED|Extension Period - 20 Weeks||0
2567991|NCT00448435|6297043|P1|NOT COMPLETED|Extension Period - 20 Weeks||0
2567992|NCT00448435|6297042|P2|COMPLETED|Extension Period - 20 Weeks||0
2567993|NCT00448435|6297043|P1|COMPLETED|Extension Period - 20 Weeks||50
2567994|NCT00448435|6297042|P2|STARTED|Extension Period - 20 Weeks||0
2567995|NCT00448435|6297043|P1|STARTED|Extension Period - 20 Weeks||50
2567996|NCT00448435|6297042|P2|NOT COMPLETED|Treatment Period II - 4 Weeks||0
2567997|NCT00448435|6297043|P1|NOT COMPLETED|Treatment Period II - 4 Weeks||0
2567998|NCT00448435|6297042|P2|COMPLETED|Treatment Period II - 4 Weeks||25
2567999|NCT00448435|6297043|P1|COMPLETED|Treatment Period II - 4 Weeks||25
2568000|NCT00448435|6297042|P2|STARTED|Treatment Period II - 4 Weeks||25
2568001|NCT00448435|6297043|P1|STARTED|Treatment Period II - 4 Weeks||25
2568002|NCT00448435|6297042|P2|NOT COMPLETED|Washout Period - 2 Weeks||0
2568003|NCT00448435|6297043|P1|NOT COMPLETED|Washout Period - 2 Weeks||1
2568004|NCT00448435|6297042|P2|COMPLETED|Washout Period - 2 Weeks||25
2568005|NCT00448435|6297043|P1|COMPLETED|Washout Period - 2 Weeks||25
2568006|NCT00448435|6297042|P2|STARTED|Washout Period - 2 Weeks||25
2568007|NCT00448435|6297043|P1|STARTED|Washout Period - 2 Weeks||26
2568008|NCT00448435|6297042|P2|NOT COMPLETED|Treatment Period I - 4 Weeks||0
2568009|NCT00448435|6297043|P1|NOT COMPLETED|Treatment Period I - 4 Weeks||0
2568010|NCT00448435|6297042|P2|COMPLETED|Treatment Period I - 4 Weeks||25
2568011|NCT00448435|6297043|P1|COMPLETED|Treatment Period I - 4 Weeks||26
2568012|NCT00448435|6297042|P2|STARTED|Treatment Period I - 4 Weeks||25
2568013|NCT00448435|6297043|P1|STARTED|Treatment Period I - 4 Weeks||26
2568014|NCT00448357|6297069|P1|NOT COMPLETED|Overall Study||0
2568015|NCT00448357|6297069|P1|COMPLETED|Overall Study||54
2568016|NCT00448357|6297069|P1|STARTED|Overall Study||54
2568017|NCT00448344|6297094|P2|NOT COMPLETED|Overall Study||36
2568018|NCT00448344|6297095|P1|NOT COMPLETED|Overall Study||30
2568019|NCT00448344|6297094|P2|COMPLETED|Overall Study||200
2568020|NCT00448344|6297095|P1|COMPLETED|Overall Study||205
2568021|NCT00448344|6297094|P2|STARTED|Overall Study||236
2568022|NCT00448344|6297095|P1|STARTED|Overall Study||235
2568023|NCT00448279|6297105|P2|NOT COMPLETED|Overall Study||29
2568024|NCT00448279|6297106|P1|NOT COMPLETED|Overall Study||29
2568025|NCT00448279|6297105|P2|COMPLETED|Overall Study||0
2568026|NCT00448279|6297106|P1|COMPLETED|Overall Study||0
2568027|NCT00448279|6297105|P2|STARTED|Overall Study||29
2568028|NCT00448279|6297106|P1|STARTED|Overall Study||29
2568029|NCT00448227|6297122|P1|NOT COMPLETED|Overall Study||0
2568030|NCT00448227|6297122|P1|COMPLETED|Overall Study||18
2568031|NCT00448227|6297122|P1|STARTED|Overall Study||18
2568032|NCT00448201|6297149|P1|NOT COMPLETED|Overall Study||0
2568033|NCT00448201|6297149|P1|COMPLETED|Overall Study||71
2568034|NCT00448201|6297149|P1|STARTED|Overall Study||71
2568035|NCT00448175|6297160|P2|NOT COMPLETED|Continued PTNS Through 12 Months||0
2568036|NCT00448175|6297161|P1|NOT COMPLETED|Continued PTNS Through 12 Months||10
2568037|NCT00448175|6297160|P2|COMPLETED|Continued PTNS Through 12 Months||0
2568038|NCT00448175|6297161|P1|COMPLETED|Continued PTNS Through 12 Months||25
2568039|NCT00448175|6297160|P2|STARTED|Continued PTNS Through 12 Months||0
2568040|NCT00448175|6297161|P1|STARTED|Continued PTNS Through 12 Months||35
2568041|NCT00448175|6297160|P2|NOT COMPLETED|12 Weeks PTNS vs. Drug||7
2568042|NCT00448175|6297161|P1|NOT COMPLETED|12 Weeks PTNS vs. Drug||9
2568043|NCT00448175|6297160|P2|COMPLETED|12 Weeks PTNS vs. Drug||43
2568044|NCT00448175|6297161|P1|COMPLETED|12 Weeks PTNS vs. Drug||41
2568045|NCT00448175|6297160|P2|STARTED|12 Weeks PTNS vs. Drug||50
2568046|NCT00448175|6297161|P1|STARTED|12 Weeks PTNS vs. Drug||50
2568047|NCT00448136|6297169|P2|NOT COMPLETED|Overall Study||8
2568048|NCT00448136|6297170|P1|NOT COMPLETED|Overall Study||4
2568049|NCT00448136|6297169|P2|COMPLETED|Overall Study||41
2568050|NCT00448136|6297170|P1|COMPLETED|Overall Study||30
2568051|NCT00448136|6297169|P2|STARTED|Overall Study||49
2568052|NCT00448136|6297170|P1|STARTED|Overall Study||34
2568053|NCT00448123|6297208|P2|NOT COMPLETED|Overall Study||12
2568054|NCT00448123|6297209|P1|NOT COMPLETED|Overall Study||15
2568055|NCT00448123|6297208|P2|COMPLETED|Overall Study||53
2568056|NCT00448123|6297209|P1|COMPLETED|Overall Study||47
2568057|NCT00448123|6297208|P2|STARTED|Overall Study||65
2568058|NCT00448123|6297209|P1|STARTED|Overall Study||62
2568059|NCT00448019|6297219|P1|NOT COMPLETED|Overall Study||7
2568060|NCT00448019|6297219|P1|COMPLETED|Overall Study||57
2568061|NCT00448019|6297219|P1|STARTED|Overall Study||64
2568062|NCT00447902|6297227|P2|NOT COMPLETED|Overall Study||6
2568063|NCT00447902|6297228|P1|NOT COMPLETED|Overall Study||4
2568064|NCT00447902|6297227|P2|COMPLETED|Overall Study||0
2568065|NCT00447902|6297228|P1|COMPLETED|Overall Study||1
2568066|NCT00447902|6297227|P2|STARTED|Overall Study||6
2568067|NCT00447902|6297228|P1|STARTED|Overall Study||5
2568068|NCT00447876|6297270|P2|NOT COMPLETED|Overall Study||4
2568069|NCT00447876|6297271|P1|NOT COMPLETED|Overall Study||3
2568070|NCT00447876|6297270|P2|COMPLETED|Overall Study||16
2568071|NCT00447876|6297271|P1|COMPLETED|Overall Study||17
2568072|NCT00447876|6297270|P2|STARTED|Overall Study||20
2568073|NCT00447876|6297271|P1|STARTED|Overall Study||20
2568074|NCT00447772|6297301|P1|NOT COMPLETED|Overall Study||27
2568075|NCT00447772|6297301|P1|COMPLETED|Overall Study||489
2568076|NCT00447772|6297301|P1|STARTED|Overall Study||516
2568077|NCT00447603|6297321|P3|NOT COMPLETED|Filter Period||15
2568078|NCT00447603|6297322|P2|NOT COMPLETED|Filter Period||4
2568079|NCT00447603|6297323|P1|NOT COMPLETED|Filter Period||0
2568080|NCT00447603|6297321|P3|COMPLETED|Filter Period||0
2568081|NCT00447603|6297322|P2|COMPLETED|Filter Period||0
2568082|NCT00447603|6297323|P1|COMPLETED|Filter Period||0
2568083|NCT00447603|6297321|P3|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|15
2568084|NCT00447603|6297322|P2|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|4
2568085|NCT00447603|6297323|P1|STARTED|Filter Period||0
2568086|NCT00447603|6297321|P3|NOT COMPLETED|Screening||0
2568087|NCT00447603|6297322|P2|NOT COMPLETED|Screening||0
2568088|NCT00447603|6297323|P1|NOT COMPLETED|Screening||21
2568089|NCT00447603|6297321|P3|COMPLETED|Screening||0
2568090|NCT00447603|6297322|P2|COMPLETED|Screening||0
2568091|NCT00447603|6297323|P1|COMPLETED|Screening||19
2568092|NCT00447603|6297321|P3|STARTED|Screening||0
2568093|NCT00447603|6297322|P2|STARTED|Screening||0
2568094|NCT00447603|6297323|P1|STARTED|Screening||40
2568095|NCT00447590|6297343|P1|NOT COMPLETED|Overall Study||60
2568096|NCT00447590|6297343|P1|COMPLETED|Overall Study|Completing the study was defined as the number of participants in the study at month 60 (5 years).|93
2568180|NCT00447057|6297516|P4|STARTED|Overall Study||26
2568097|NCT00447590|6297343|P1|STARTED|Overall Study|153 participants were treated with the LAP-BAND System.|153
2568098|NCT00447499|6297352|P1|NOT COMPLETED|Overall Study||7
2568099|NCT00447499|6297352|P1|COMPLETED|Overall Study||52
2568100|NCT00447499|6297352|P1|STARTED|Overall Study||59
2568101|NCT00447421|6297362|P1|NOT COMPLETED|Overall Study||6
2568102|NCT00447421|6297362|P1|COMPLETED|Overall Study||3
2568103|NCT00447421|6297362|P1|STARTED|Overall Study||9
2568104|NCT00447382|6297374|P2|NOT COMPLETED|Overall Study||6
2568105|NCT00447382|6297375|P1|NOT COMPLETED|Overall Study||6
2568106|NCT00447382|6297374|P2|COMPLETED|Overall Study||160
2568107|NCT00447382|6297375|P1|COMPLETED|Overall Study||158
2568108|NCT00447382|6297374|P2|STARTED|Overall Study||166
2568109|NCT00447382|6297375|P1|STARTED|Overall Study||164
2568110|NCT00447330|6297427|P1|NOT COMPLETED|Overall Study||2
2568111|NCT00447330|6297427|P1|COMPLETED|Overall Study||58
2568112|NCT00447330|6297427|P1|STARTED|Overall Study|2 subjects signed the ICF, but were withdrawn from study prior to receiving any study drug|60
2568113|NCT00447278|6297436|P2|NOT COMPLETED|Period III (Optional 6 Month Extension)||15
2568114|NCT00447278|6297437|P1|NOT COMPLETED|Period III (Optional 6 Month Extension)||30
2568115|NCT00447278|6297436|P2|COMPLETED|Period III (Optional 6 Month Extension)||140
2568116|NCT00447278|6297437|P1|COMPLETED|Period III (Optional 6 Month Extension)||109
2568117|NCT00447278|6297436|P2|STARTED|Period III (Optional 6 Month Extension)|16 choose not to enter this optional period.|155
2568118|NCT00447278|6297437|P1|STARTED|Period III (Optional 6 Month Extension)|18 choose not to enter this optional period.|139
2568119|NCT00447278|6297436|P2|NOT COMPLETED|Period II (6 Month Open-Label)||29
2568120|NCT00447278|6297437|P1|NOT COMPLETED|Period II (6 Month Open-Label)||42
2568121|NCT00447278|6297436|P2|COMPLETED|Period II (6 Month Open-Label)||171
2568122|NCT00447278|6297437|P1|COMPLETED|Period II (6 Month Open-Label)||157
2568123|NCT00447278|6297436|P2|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)|1 patient withdrew due to parent/guardian decision prior to receiving study drug.|199
2568124|NCT00447278|6297437|P1|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)||199
2568125|NCT00447278|6297436|P2|STARTED|Period II (6 Month Open-Label)||200
2568126|NCT00447278|6297437|P1|STARTED|Period II (6 Month Open-Label)||199
2568127|NCT00447265|6297458|P2|NOT COMPLETED|Overall Study||0
2568128|NCT00447265|6297459|P1|NOT COMPLETED|Overall Study||1
2568129|NCT00447265|6297458|P2|COMPLETED|Overall Study||0
2568130|NCT00447265|6297459|P1|COMPLETED|Overall Study|The participant completed treatment and discontinued follow-up at week 39 after randomization|0
2568131|NCT00447265|6297458|P2|STARTED|Overall Study||0
2568132|NCT00447265|6297459|P1|STARTED|Overall Study||1
2568133|NCT00447226|6297472|P2|NOT COMPLETED|Double-blind Phase||3
2568134|NCT00447226|6297473|P1|NOT COMPLETED|Double-blind Phase||4
2568135|NCT00447226|6297472|P2|COMPLETED|Double-blind Phase||0
2568136|NCT00447226|6297473|P1|COMPLETED|Double-blind Phase||0
2568137|NCT00447226|6297472|P2|STARTED|Double-blind Phase||3
2568138|NCT00447226|6297473|P1|STARTED|Double-blind Phase||4
2568139|NCT00447226|6297472|P2|NOT COMPLETED|12-Week Open-label Phase||25
2568140|NCT00447226|6297473|P1|NOT COMPLETED|12-Week Open-label Phase||0
2568141|NCT00447226|6297472|P2|COMPLETED|12-Week Open-label Phase||7
2568142|NCT00447226|6297473|P1|COMPLETED|12-Week Open-label Phase||0
2568143|NCT00447226|6297472|P2|STARTED|12-Week Open-label Phase||32
2568144|NCT00447226|6297473|P1|STARTED|12-Week Open-label Phase||0
2568145|NCT00447122|6297491|P1|NOT COMPLETED|Overall Study||2
2568146|NCT00447122|6297491|P1|COMPLETED|Overall Study|29 evaluable thus 29 represented in efficacy and safety portion|29
2568147|NCT00447122|6297491|P1|STARTED|Overall Study||31
2568148|NCT00447083|6297497|P4|NOT COMPLETED|Phase II||1
2568149|NCT00447083|6297498|P3|NOT COMPLETED|Phase II||1
2568150|NCT00447083|6297499|P2|NOT COMPLETED|Phase II||0
2568151|NCT00447083|6297500|P1|NOT COMPLETED|Phase II||0
2568152|NCT00447083|6297497|P4|COMPLETED|Phase II||7
2568153|NCT00447083|6297498|P3|COMPLETED|Phase II||7
2568154|NCT00447083|6297499|P2|COMPLETED|Phase II||0
2568155|NCT00447083|6297500|P1|COMPLETED|Phase II||0
2568156|NCT00447083|6297497|P4|STARTED|Phase II|Only 8 participants qualified from the end of phase 1|8
2568157|NCT00447083|6297498|P3|STARTED|Phase II|Only 8 participants qualified from the end of phase 1|8
2568158|NCT00447083|6297499|P2|STARTED|Phase II|Participants in this group will then be randomized to a phase 2 group in phase2|0
2568159|NCT00447083|6297500|P1|STARTED|Phase II|Participants in this group will then be randomized to a phase 2 group in phase2|0
2568160|NCT00447083|6297497|P4|NOT COMPLETED|Phase I||0
2568161|NCT00447083|6297498|P3|NOT COMPLETED|Phase I||0
2568162|NCT00447083|6297499|P2|NOT COMPLETED|Phase I||0
2568163|NCT00447083|6297500|P1|NOT COMPLETED|Phase I||0
2568164|NCT00447083|6297497|P4|COMPLETED|Phase I||0
2568165|NCT00447083|6297498|P3|COMPLETED|Phase I||0
2568166|NCT00447083|6297499|P2|COMPLETED|Phase I|1 participant did not acclimate to phase II|9
2568167|NCT00447083|6297500|P1|COMPLETED|Phase I|2 participants did not acclimate to phase II|10
2568168|NCT00447083|6297497|P4|STARTED|Phase I||0
2568169|NCT00447083|6297498|P3|STARTED|Phase I||0
2568170|NCT00447083|6297499|P2|STARTED|Phase I||9
2568171|NCT00447083|6297500|P1|STARTED|Phase I||10
2568172|NCT00447057|6297516|P4|NOT COMPLETED|Overall Study||26
2568173|NCT00447057|6297517|P3|NOT COMPLETED|Overall Study||19
2568174|NCT00447057|6297518|P2|NOT COMPLETED|Overall Study||73
2568175|NCT00447057|6297519|P1|NOT COMPLETED|Overall Study||83
2568176|NCT00447057|6297516|P4|COMPLETED|Overall Study||0
2568177|NCT00447057|6297517|P3|COMPLETED|Overall Study||0
2568178|NCT00447057|6297518|P2|COMPLETED|Overall Study||3
2568179|NCT00447057|6297519|P1|COMPLETED|Overall Study||0
2568181|NCT00447057|6297517|P3|STARTED|Overall Study||19
2568182|NCT00447057|6297518|P2|STARTED|Overall Study||76
2568183|NCT00447057|6297519|P1|STARTED|Overall Study||83
2568184|NCT00447005|6297537|P1|NOT COMPLETED|Overall Study||12
2568185|NCT00447005|6297537|P1|COMPLETED|Overall Study||0
2568186|NCT00447005|6297537|P1|STARTED|Overall Study||12
2568187|NCT00446992|6297551|P1|NOT COMPLETED|Overall Study||16
2568188|NCT00446992|6297551|P1|COMPLETED|Overall Study|Intervention Completion|14
2568189|NCT00446992|6297551|P1|STARTED|Overall Study|Beginning of Intervention|30
2568190|NCT00446966|6297565|P2|NOT COMPLETED|Overall Study||7
2568191|NCT00446966|6297566|P1|NOT COMPLETED|Overall Study||10
2568192|NCT00446966|6297565|P2|COMPLETED|Overall Study||123
2568193|NCT00446966|6297566|P1|COMPLETED|Overall Study||120
2568194|NCT00446966|6297565|P2|STARTED|Overall Study||130
2568195|NCT00446966|6297566|P1|STARTED|Overall Study||130
2568196|NCT00446849|6297572|P1|NOT COMPLETED|Maintenance Phase||70
2568197|NCT00446849|6297572|P1|COMPLETED|Maintenance Phase||138
2568198|NCT00446849|6297572|P1|STARTED|Maintenance Phase||208
2568199|NCT00446849|6297572|P1|NOT COMPLETED|Acute Phase||82
2568200|NCT00446849|6297572|P1|COMPLETED|Acute Phase||56
2568201|NCT00446849|6297572|P1|STARTED|Acute Phase||138
2568202|NCT00446797|6297584|P2|NOT COMPLETED|Overall Study||12
2568203|NCT00446797|6297585|P1|NOT COMPLETED|Overall Study||8
2568204|NCT00446797|6297584|P2|COMPLETED|Overall Study||125
2568205|NCT00446797|6297585|P1|COMPLETED|Overall Study||133
2568206|NCT00446797|6297584|P2|STARTED|Overall Study||137
2568207|NCT00446797|6297585|P1|STARTED|Overall Study||141
2568208|NCT00446654|6297631|P2|NOT COMPLETED|Overall Study||0
2568209|NCT00446654|6297632|P1|NOT COMPLETED|Overall Study||2
2568210|NCT00446654|6297631|P2|COMPLETED|Overall Study||22
2568211|NCT00446654|6297632|P1|COMPLETED|Overall Study||19
2568212|NCT00446654|6297631|P2|STARTED|Overall Study||22
2568213|NCT00446654|6297632|P1|STARTED|Overall Study||21
2568214|NCT00446641|6297640|P2|NOT COMPLETED|Overall Study||10
2568215|NCT00446641|6297641|P1|NOT COMPLETED|Overall Study||17
2568216|NCT00446641|6297640|P2|COMPLETED|Overall Study||109
2568217|NCT00446641|6297641|P1|COMPLETED|Overall Study||108
2568218|NCT00446641|6297640|P2|STARTED|Overall Study||119
2568219|NCT00446641|6297641|P1|STARTED|Overall Study||125
2568220|NCT00446563|6297661|P2|NOT COMPLETED|Overall Study||9
2568221|NCT00446563|6297662|P1|NOT COMPLETED|Overall Study||7
2568222|NCT00446563|6297661|P2|COMPLETED|Overall Study||38
2568223|NCT00446563|6297662|P1|COMPLETED|Overall Study||36
2568224|NCT00446563|6297661|P2|STARTED|Overall Study||47
2568225|NCT00446563|6297662|P1|STARTED|Overall Study||43
2568226|NCT00446550|6297698|P2|NOT COMPLETED|Overall Study||0
2568227|NCT00446550|6297699|P1|NOT COMPLETED|Overall Study||1
2568228|NCT00446550|6297698|P2|COMPLETED|Overall Study||8
2568229|NCT00446550|6297699|P1|COMPLETED|Overall Study||10
2568230|NCT00446550|6297698|P2|PD Population|Overall Study||8
2568231|NCT00446550|6297699|P1|PD Population|Overall Study||11
2568232|NCT00446550|6297698|P2|Safety Population|Overall Study||8
2568233|NCT00446550|6297699|P1|Safety Population|Overall Study||11
2568234|NCT00446550|6297698|P2|STARTED|Overall Study||8
2568235|NCT00446550|6297699|P1|STARTED|Overall Study||11
2568236|NCT00446511|6297711|P4|NOT COMPLETED|Overall Study||6
2568237|NCT00446511|6297712|P3|NOT COMPLETED|Overall Study||7
2568238|NCT00446511|6297713|P2|NOT COMPLETED|Overall Study||2
2568239|NCT00446511|6297714|P1|NOT COMPLETED|Overall Study||10
2568240|NCT00446511|6297711|P4|COMPLETED|Overall Study||103
2568241|NCT00446511|6297712|P3|COMPLETED|Overall Study||96
2568242|NCT00446511|6297713|P2|COMPLETED|Overall Study||15
2568243|NCT00446511|6297714|P1|COMPLETED|Overall Study||11
2568244|NCT00446511|6297711|P4|STARTED|Overall Study||109
2568245|NCT00446511|6297712|P3|STARTED|Overall Study||103
2568246|NCT00446511|6297713|P2|STARTED|Overall Study||17
2568247|NCT00446511|6297714|P1|STARTED|Overall Study||21
2568248|NCT00446459|6297738|P1|NOT COMPLETED|12 Months||18
2568249|NCT00446459|6297738|P1|COMPLETED|12 Months|4 subjects remained at month 12|4
2568250|NCT00446459|6297738|P1|STARTED|12 Months|22 subjects remained on-study at month 8|22
2568251|NCT00446459|6297738|P1|NOT COMPLETED|8 Months||12
2568252|NCT00446459|6297738|P1|COMPLETED|8 Months|22 subjects were on study at month 8.|22
2568253|NCT00446459|6297738|P1|STARTED|8 Months|34 subjects received any amount of MMF.|34
2568254|NCT00446446|6297746|P1|NOT COMPLETED|Overall Study||24
2568255|NCT00446446|6297746|P1|COMPLETED|Overall Study|Participants who completed the 60-day safety visit|28
2568256|NCT00446446|6297746|P1|STARTED|Overall Study||52
2568257|NCT00446290|6297757|P1|NOT COMPLETED|Overall Study||0
2568258|NCT00446290|6297757|P1|COMPLETED|Overall Study||22
2568259|NCT00446290|6297757|P1|STARTED|Overall Study||22
2568260|NCT00446264|6297761|P1|NOT COMPLETED|Overall Study||0
2568261|NCT00446264|6297761|P1|COMPLETED|Overall Study||14
2568262|NCT00446264|6297761|P1|STARTED|Overall Study||14
2568263|NCT00446251|6297770|P1|NOT COMPLETED|Overall Study||5
2568264|NCT00446251|6297770|P1|COMPLETED|Overall Study||9
2568265|NCT00446251|6297770|P1|STARTED|Overall Study|14 subjects were enrolled in this Rituximab-mycophenolic mofetil group.|14
2568266|NCT00446199|6297780|P4|NOT COMPLETED|Overall Study||30
2568267|NCT00446199|6297781|P3|NOT COMPLETED|Overall Study||27
2568268|NCT00446199|6297782|P2|NOT COMPLETED|Overall Study||20
2568269|NCT00446199|6297783|P1|NOT COMPLETED|Overall Study||23
2568270|NCT00446199|6297780|P4|COMPLETED|Overall Study||153
2568271|NCT00446199|6297781|P3|COMPLETED|Overall Study||158
2568272|NCT00446199|6297782|P2|COMPLETED|Overall Study||164
2568273|NCT00446199|6297783|P1|COMPLETED|Overall Study||160
2568274|NCT00446199|6297780|P4|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|176
2568275|NCT00446199|6297781|P3|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|179
2568276|NCT00446199|6297782|P2|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|177
2568277|NCT00446199|6297783|P1|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|178
2568278|NCT00446199|6297780|P4|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|180
2568279|NCT00446199|6297781|P3|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|182
2568280|NCT00446199|6297782|P2|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|183
2568281|NCT00446199|6297783|P1|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|181
2568282|NCT00446199|6297780|P4|STARTED|Overall Study||183
2568283|NCT00446199|6297781|P3|STARTED|Overall Study||185
2568284|NCT00446199|6297782|P2|STARTED|Overall Study||184
2568285|NCT00446199|6297783|P1|STARTED|Overall Study||183
2568286|NCT00446147|6297863|P2|NOT COMPLETED|Overall Study||14
2568287|NCT00446147|6297864|P1|NOT COMPLETED|Overall Study||15
2568288|NCT00446147|6297863|P2|COMPLETED|Overall Study||180
2568289|NCT00446147|6297864|P1|COMPLETED|Overall Study||180
2568290|NCT00446147|6297863|P2|STARTED|Overall Study||194
2568291|NCT00446147|6297864|P1|STARTED|Overall Study||195
2568292|NCT00446134|6297876|P4|NOT COMPLETED|Overall Study||45
2568293|NCT00446134|6297877|P3|NOT COMPLETED|Overall Study||43
2568294|NCT00446134|6297878|P2|NOT COMPLETED|Overall Study||45
2568295|NCT00446134|6297879|P1|NOT COMPLETED|Overall Study||34
2568296|NCT00446134|6297876|P4|COMPLETED|Overall Study||25
2568297|NCT00446134|6297877|P3|COMPLETED|Overall Study||26
2568298|NCT00446134|6297878|P2|COMPLETED|Overall Study||25
2568299|NCT00446134|6297879|P1|COMPLETED|Overall Study||35
2568300|NCT00446134|6297876|P4|STARTED|Overall Study||70
2568301|NCT00446134|6297877|P3|STARTED|Overall Study|Includes 1 patient who did not receive study drug and was not included in any other analysis|69
2568302|NCT00446134|6297878|P2|STARTED|Overall Study||70
2568303|NCT00446134|6297879|P1|STARTED|Overall Study|Includes 2 patients who did not receive study drug and was not included in any other analysis|69
2568304|NCT00446095|6297906|P5|NOT COMPLETED|Phase I (28 Days)||3
2568305|NCT00446095|6297907|P4|NOT COMPLETED|Phase I (28 Days)||1
2568306|NCT00446095|6297908|P3|NOT COMPLETED|Phase I (28 Days)||0
2568307|NCT00446095|6297909|P2|NOT COMPLETED|Phase I (28 Days)||0
2568308|NCT00446095|6297910|P1|NOT COMPLETED|Phase I (28 Days)||0
2568309|NCT00446095|6297906|P5|COMPLETED|Phase I (28 Days)||4
2568310|NCT00446095|6297907|P4|COMPLETED|Phase I (28 Days)||5
2568311|NCT00446095|6297908|P3|COMPLETED|Phase I (28 Days)||0
2568312|NCT00446095|6297909|P2|COMPLETED|Phase I (28 Days)||0
2568313|NCT00446095|6297910|P1|COMPLETED|Phase I (28 Days)||0
2568314|NCT00446095|6297906|P5|STARTED|Phase I (28 Days)||7
2568315|NCT00446095|6297907|P4|STARTED|Phase I (28 Days)||6
2568316|NCT00446095|6297908|P3|STARTED|Phase I (28 Days)||0
2568317|NCT00446095|6297909|P2|STARTED|Phase I (28 Days)||0
2568318|NCT00446095|6297910|P1|STARTED|Phase I (28 Days)||0
2568319|NCT00446095|6297906|P5|NOT COMPLETED|Phase II (8 Weeks)||0
2568320|NCT00446095|6297907|P4|NOT COMPLETED|Phase II (8 Weeks)||0
2568321|NCT00446095|6297908|P3|NOT COMPLETED|Phase II (8 Weeks)||3
2568322|NCT00446095|6297909|P2|NOT COMPLETED|Phase II (8 Weeks)||3
2568323|NCT00446095|6297910|P1|NOT COMPLETED|Phase II (8 Weeks)||12
2568324|NCT00446095|6297906|P5|COMPLETED|Phase II (8 Weeks)||0
2568325|NCT00446095|6297907|P4|COMPLETED|Phase II (8 Weeks)||0
2568326|NCT00446095|6297908|P3|COMPLETED|Phase II (8 Weeks)||21
2568327|NCT00446095|6297909|P2|COMPLETED|Phase II (8 Weeks)||18
2568328|NCT00446095|6297910|P1|COMPLETED|Phase II (8 Weeks)||11
2568329|NCT00446095|6297906|P5|STARTED|Phase II (8 Weeks)||0
2568330|NCT00446095|6297907|P4|STARTED|Phase II (8 Weeks)||0
2568331|NCT00446095|6297908|P3|STARTED|Phase II (8 Weeks)||24
2568332|NCT00446095|6297909|P2|STARTED|Phase II (8 Weeks)||21
2568333|NCT00446095|6297910|P1|STARTED|Phase II (8 Weeks)||23
2568334|NCT00446030|6297933|P2|NOT COMPLETED|FOLLOW-UP (up to 2-years)||9
2568335|NCT00446030|6297934|P1|NOT COMPLETED|FOLLOW-UP (up to 2-years)||30
2568336|NCT00446030|6297933|P2|COMPLETED|FOLLOW-UP (up to 2-years)||25
2568337|NCT00446030|6297934|P1|COMPLETED|FOLLOW-UP (up to 2-years)||63
2568338|NCT00446030|6297933|P2|STARTED|FOLLOW-UP (up to 2-years)||34
2568339|NCT00446030|6297934|P1|STARTED|FOLLOW-UP (up to 2-years)|All participants, including those who discontinued treatment, continued to the follow-up period.|93
2568340|NCT00446030|6297933|P2|NOT COMPLETED|TREATMENT (up to 52 Weeks)||9
2568341|NCT00446030|6297934|P1|NOT COMPLETED|TREATMENT (up to 52 Weeks)||44
2568342|NCT00446030|6297933|P2|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|25
2568343|NCT00446030|6297934|P1|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|49
2568344|NCT00446030|6297933|P2|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||34
2568345|NCT00446030|6297934|P1|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||92
2568346|NCT00446030|6297933|P2|STARTED|TREATMENT (up to 52 Weeks)||34
2568347|NCT00446030|6297934|P1|STARTED|TREATMENT (up to 52 Weeks)||93
2568348|NCT00445939|6297945|P4|NOT COMPLETED|Period B - Week 4 - Week 8||1
2568349|NCT00445939|6297946|P3|NOT COMPLETED|Period B - Week 4 - Week 8||0
2568350|NCT00445939|6297947|P2|NOT COMPLETED|Period B - Week 4 - Week 8||0
2568351|NCT00445939|6297948|P1|NOT COMPLETED|Period B - Week 4 - Week 8||2
2568352|NCT00445939|6297945|P4|COMPLETED|Period B - Week 4 - Week 8||20
2568353|NCT00445939|6297946|P3|COMPLETED|Period B - Week 4 - Week 8||0
2568354|NCT00445939|6297947|P2|COMPLETED|Period B - Week 4 - Week 8||0
2568355|NCT00445939|6297948|P1|COMPLETED|Period B - Week 4 - Week 8||14
2568356|NCT00445939|6297945|P4|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 160/80 and 80/40 subjects allocated to 40/40 group.|21
2568357|NCT00445939|6297946|P3|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous placebo subjects allocated to 160/80 mg group.|0
2568358|NCT00445939|6297947|P2|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 80/40 mg subjects allocated to 40/40 mg group.|0
2568359|NCT00445939|6297948|P1|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 16 placebo subjects allocated to 160/80 mg group.|16
2568360|NCT00445939|6297945|P4|NOT COMPLETED|Period A - Week 0 - Week 4||0
2568361|NCT00445939|6297946|P3|NOT COMPLETED|Period A - Week 0 - Week 4||0
2568362|NCT00445939|6297947|P2|NOT COMPLETED|Period A - Week 0 - Week 4||2
2568363|NCT00445939|6297948|P1|NOT COMPLETED|Period A - Week 0 - Week 4||1
2568364|NCT00445939|6297945|P4|COMPLETED|Period A - Week 0 - Week 4||0
2568365|NCT00445939|6297946|P3|COMPLETED|Period A - Week 0 - Week 4|7 rated as responders and 16 rated as non-responders in evaluation on Week 4.|23
2568366|NCT00445939|6297947|P2|COMPLETED|Period A - Week 0 - Week 4|20 rated as responders and 12 rated as non-responders in evaluation on Week 4.|32
2568367|NCT00445939|6297948|P1|COMPLETED|Period A - Week 0 - Week 4|23 rated as responders and 9 rated as non-responders in evaluation on Week 4.|32
2568368|NCT00445939|6297945|P4|STARTED|Period A - Week 0 - Week 4||0
2568369|NCT00445939|6297946|P3|STARTED|Period A - Week 0 - Week 4||23
2568370|NCT00445939|6297947|P2|STARTED|Period A - Week 0 - Week 4||34
2568371|NCT00445939|6297948|P1|STARTED|Period A - Week 0 - Week 4||33
2568372|NCT00445887|6297973|P2|NOT COMPLETED|Overall Study||0
2568373|NCT00445887|6297974|P1|NOT COMPLETED|Overall Study||0
2568374|NCT00445887|6297973|P2|COMPLETED|Overall Study||31
2568375|NCT00445887|6297974|P1|COMPLETED|Overall Study||33
2568376|NCT00445887|6297973|P2|STARTED|Overall Study||31
2568377|NCT00445887|6297974|P1|STARTED|Overall Study||33
2568378|NCT00445848|6297996|P1|NOT COMPLETED|Overall Study||85
2568379|NCT00445848|6297996|P1|COMPLETED|Overall Study||0
2568380|NCT00445848|6297996|P1|STARTED|Overall Study||85
2568381|NCT00445770|6298006|P3|NOT COMPLETED|Overall Study||31
2568382|NCT00445770|6298007|P2|NOT COMPLETED|Overall Study||35
2568383|NCT00445770|6298008|P1|NOT COMPLETED|Overall Study||53
2568384|NCT00445770|6298006|P3|COMPLETED|Overall Study||151
2568385|NCT00445770|6298007|P2|COMPLETED|Overall Study||157
2568386|NCT00445770|6298008|P1|COMPLETED|Overall Study||123
2568387|NCT00445770|6298006|P3|STARTED|Overall Study||182
2568388|NCT00445770|6298007|P2|STARTED|Overall Study||192
2568389|NCT00445770|6298008|P1|STARTED|Overall Study||176
2568390|NCT00445744|6298075|P1|NOT COMPLETED|Overall Study||1
2568391|NCT00445744|6298075|P1|COMPLETED|Overall Study||51
2568392|NCT00445744|6298075|P1|STARTED|Overall Study||52
2568393|NCT00445705|6298084|P4|NOT COMPLETED|Overall Study||14
2568394|NCT00445705|6298085|P3|NOT COMPLETED|Overall Study||11
2568395|NCT00445705|6298086|P2|NOT COMPLETED|Overall Study||11
2568396|NCT00445705|6298087|P1|NOT COMPLETED|Overall Study||9
2568397|NCT00445705|6298084|P4|COMPLETED|Overall Study||39
2568398|NCT00445705|6298085|P3|COMPLETED|Overall Study||41
2568399|NCT00445705|6298086|P2|COMPLETED|Overall Study||42
2568400|NCT00445705|6298087|P1|COMPLETED|Overall Study||44
2568401|NCT00445705|6298084|P4|STARTED|Overall Study||53
2568402|NCT00445705|6298085|P3|STARTED|Overall Study||52
2568403|NCT00445705|6298086|P2|STARTED|Overall Study||53
2568404|NCT00445705|6298087|P1|STARTED|Overall Study||53
2568405|NCT00445692|6298109|P1|NOT COMPLETED|Overall Study||16
2568406|NCT00445692|6298109|P1|COMPLETED|Overall Study||15
2568407|NCT00445692|6298109|P1|STARTED|Overall Study||31
2568408|NCT00445679|6298119|P4|NOT COMPLETED|Overall Study||47
2568409|NCT00445679|6298120|P3|NOT COMPLETED|Overall Study||66
2568410|NCT00445679|6298121|P2|NOT COMPLETED|Overall Study||46
2568411|NCT00445679|6298122|P1|NOT COMPLETED|Overall Study||48
2568412|NCT00445679|6298119|P4|COMPLETED|Overall Study||149
2568413|NCT00445679|6298120|P3|COMPLETED|Overall Study||139
2568414|NCT00445679|6298121|P2|COMPLETED|Overall Study||157
2568415|NCT00445679|6298122|P1|COMPLETED|Overall Study||155
2568416|NCT00445679|6298119|P4|STARTED|Overall Study||196
2568417|NCT00445679|6298120|P3|STARTED|Overall Study||205
2568418|NCT00445679|6298121|P2|STARTED|Overall Study||203
2568419|NCT00445679|6298122|P1|STARTED|Overall Study||203
2568420|NCT00445601|6298158|P2|NOT COMPLETED|Overall Study||28
2568421|NCT00445601|6298159|P1|NOT COMPLETED|Overall Study||33
2568422|NCT00445601|6298158|P2|COMPLETED|Overall Study||177
2568423|NCT00445601|6298159|P1|COMPLETED|Overall Study||168
2568424|NCT00445601|6298158|P2|Received TURBT|Overall Study||193
2568425|NCT00445601|6298159|P1|Received TURBT|Overall Study||190
2568426|NCT00445601|6298158|P2|STARTED|Overall Study||205
2568427|NCT00445601|6298159|P1|STARTED|Overall Study||201
2568428|NCT00445588|6298171|P1|NOT COMPLETED|Overall Study||0
2568429|NCT00445588|6298171|P1|COMPLETED|Overall Study||56
2568430|NCT00445588|6298171|P1|STARTED|Overall Study||56
2568431|NCT00445549|6298176|P1|NOT COMPLETED|Overall Study||12
2568432|NCT00445549|6298176|P1|COMPLETED|Overall Study||0
2568433|NCT00445549|6298176|P1|STARTED|Overall Study||12
2568434|NCT00445484|6298183|P2|NOT COMPLETED|Overall Study||1
2568435|NCT00445484|6298184|P1|NOT COMPLETED|Overall Study||4
2568436|NCT00445484|6298183|P2|COMPLETED|Overall Study||10
2568437|NCT00445484|6298184|P1|COMPLETED|Overall Study||7
2568438|NCT00445484|6298183|P2|STARTED|Overall Study||11
2568439|NCT00445484|6298184|P1|STARTED|Overall Study||11
2568440|NCT00445458|6298200|P4|NOT COMPLETED|Overall Study||28
2568441|NCT00445458|6298201|P3|NOT COMPLETED|Overall Study||68
2568442|NCT00445458|6298202|P2|NOT COMPLETED|Overall Study||5
2568443|NCT00445458|6298203|P1|NOT COMPLETED|Overall Study||3
2568444|NCT00445458|6298200|P4|COMPLETED|Overall Study||3
2568445|NCT00445458|6298201|P3|COMPLETED|Overall Study||3
2568446|NCT00445458|6298202|P2|COMPLETED|Overall Study||0
2568447|NCT00445458|6298203|P1|COMPLETED|Overall Study||0
2568448|NCT00445458|6298200|P4|STARTED|Overall Study||31
2568449|NCT00445458|6298201|P3|STARTED|Overall Study||71
2568450|NCT00445458|6298202|P2|STARTED|Overall Study||5
2568451|NCT00445458|6298203|P1|STARTED|Overall Study||3
2568452|NCT00445432|6298221|P4|NOT COMPLETED|148 Weeks of Adalimumab Treatment||44
2568453|NCT00445432|6298222|P3|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
2568454|NCT00445432|6298223|P2|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
2568455|NCT00445432|6298224|P1|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
2568456|NCT00445432|6298221|P4|COMPLETED|148 Weeks of Adalimumab Treatment||35
2568457|NCT00445432|6298222|P3|COMPLETED|148 Weeks of Adalimumab Treatment||0
2568458|NCT00445432|6298223|P2|COMPLETED|148 Weeks of Adalimumab Treatment||0
2568459|NCT00445432|6298224|P1|COMPLETED|148 Weeks of Adalimumab Treatment||0
2568460|NCT00445432|6298221|P4|STARTED|148 Weeks of Adalimumab Treatment|3 participants discontinued while receiving double-blind placebo and never received any adalimumab|79
2568461|NCT00445432|6298222|P3|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
2568462|NCT00445432|6298223|P2|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
2568463|NCT00445432|6298224|P1|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
2568464|NCT00445432|6298221|P4|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
2568465|NCT00445432|6298222|P3|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||11
2568466|NCT00445432|6298223|P2|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||23
2568467|NCT00445432|6298224|P1|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||15
2568468|NCT00445432|6298221|P4|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
2568469|NCT00445432|6298222|P3|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||21
2568470|NCT00445432|6298223|P2|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||2
2568471|NCT00445432|6298224|P1|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||10
2568472|NCT00445432|6298221|P4|STARTED|Through Week 52 of NCT00445432 (M06-837)|This treatment group is not applicable for this period.|0
2568473|NCT00445432|6298222|P3|STARTED|Through Week 52 of NCT00445432 (M06-837)||32
2568474|NCT00445432|6298223|P2|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
2568475|NCT00445432|6298224|P1|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
2568476|NCT00445341|6298257|P1|NOT COMPLETED|Overall Study||2
2568477|NCT00445341|6298257|P1|COMPLETED|Overall Study||26
2568478|NCT00445341|6298257|P1|STARTED|Overall Study||28
2568479|NCT00445328|6298264|P2|NOT COMPLETED|Overall Study||6
2568480|NCT00445328|6298265|P1|NOT COMPLETED|Overall Study||3
2568481|NCT00445328|6298264|P2|COMPLETED|Overall Study||36
2568482|NCT00445328|6298265|P1|COMPLETED|Overall Study||39
2568483|NCT00445328|6298264|P2|Received Treatment|Overall Study||42
2568484|NCT00445328|6298265|P1|Received Treatment|Overall Study|1 subject discontinued after enrollment but prior to study treatment.|41
2568485|NCT00445328|6298264|P2|STARTED|Overall Study||42
2568486|NCT00445328|6298265|P1|STARTED|Overall Study||42
2568487|NCT00445315|6298288|P5|NOT COMPLETED|Overall Study||0
2568488|NCT00445315|6298289|P4|NOT COMPLETED|Overall Study||0
2568489|NCT00445315|6298290|P3|NOT COMPLETED|Overall Study||0
2568490|NCT00445315|6298291|P2|NOT COMPLETED|Overall Study||0
2568491|NCT00445315|6298292|P1|NOT COMPLETED|Overall Study||0
2568492|NCT00445315|6298288|P5|COMPLETED|Overall Study||8
2568493|NCT00445315|6298289|P4|COMPLETED|Overall Study||6
2568494|NCT00445315|6298290|P3|COMPLETED|Overall Study||6
2568495|NCT00445315|6298291|P2|COMPLETED|Overall Study||6
2568496|NCT00445315|6298292|P1|COMPLETED|Overall Study||6
2568497|NCT00445315|6298288|P5|STARTED|Overall Study||8
2568498|NCT00445315|6298289|P4|STARTED|Overall Study||6
2568499|NCT00445315|6298290|P3|STARTED|Overall Study||6
2568500|NCT00445315|6298291|P2|STARTED|Overall Study||6
2568501|NCT00445315|6298292|P1|STARTED|Overall Study||6
2568502|NCT00445302|6298386|P4|NOT COMPLETED|Overall Study||0
2568503|NCT00445302|6298387|P3|NOT COMPLETED|Overall Study||0
2568504|NCT00445302|6298388|P2|NOT COMPLETED|Overall Study||0
2568505|NCT00445302|6298389|P1|NOT COMPLETED|Overall Study||0
2568506|NCT00445302|6298386|P4|COMPLETED|Overall Study||6
2568507|NCT00445302|6298387|P3|COMPLETED|Overall Study||6
2568508|NCT00445302|6298388|P2|COMPLETED|Overall Study||5
2568509|NCT00445302|6298389|P1|COMPLETED|Overall Study||6
2568510|NCT00445302|6298386|P4|STARTED|Overall Study||6
2568511|NCT00445302|6298387|P3|STARTED|Overall Study||6
2568512|NCT00445302|6298388|P2|STARTED|Overall Study||5
2568513|NCT00445302|6298389|P1|STARTED|Overall Study||6
2568514|NCT00445263|6298417|P2|NOT COMPLETED|Overall Study||1
2568515|NCT00445263|6298418|P1|NOT COMPLETED|Overall Study||0
2568516|NCT00445263|6298417|P2|COMPLETED|Overall Study||86
2568517|NCT00445263|6298418|P1|COMPLETED|Overall Study||83
2568518|NCT00445263|6298417|P2|STARTED|Overall Study||87
2568519|NCT00445263|6298418|P1|STARTED|Overall Study||83
2568520|NCT00445224|6298426|P2|NOT COMPLETED|Combined Exercises||0
2568521|NCT00445224|6298427|P1|NOT COMPLETED|Combined Exercises||0
2568522|NCT00445224|6298426|P2|COMPLETED|Combined Exercises||13
2568523|NCT00445224|6298427|P1|COMPLETED|Combined Exercises||13
2568524|NCT00445224|6298426|P2|STARTED|Combined Exercises||13
2568525|NCT00445224|6298427|P1|STARTED|Combined Exercises||13
2568526|NCT00445224|6298426|P2|NOT COMPLETED|Specific Exercises||3
2568527|NCT00445224|6298427|P1|NOT COMPLETED|Specific Exercises||4
2568528|NCT00445224|6298426|P2|COMPLETED|Specific Exercises|No adverse event occurred|13
2568529|NCT00445224|6298427|P1|COMPLETED|Specific Exercises|No adverse event occurred|13
2568530|NCT00445224|6298426|P2|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|13
2568531|NCT00445224|6298427|P1|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|14
2568532|NCT00445224|6298426|P2|Baseline|Specific Exercises||16
2568533|NCT00445224|6298427|P1|Baseline|Specific Exercises||17
2568534|NCT00445224|6298426|P2|STARTED|Specific Exercises||16
2568535|NCT00445224|6298427|P1|STARTED|Specific Exercises||17
2568536|NCT00445211|6298439|P2|NOT COMPLETED|Overall Study||0
2568537|NCT00445211|6298440|P1|NOT COMPLETED|Overall Study||0
2568538|NCT00445211|6298439|P2|COMPLETED|Overall Study||23
2568539|NCT00445211|6298440|P1|COMPLETED|Overall Study||23
2568540|NCT00445211|6298439|P2|STARTED|Overall Study||23
2568541|NCT00445211|6298440|P1|STARTED|Overall Study||23
2568542|NCT00445146|6298454|P1|NOT COMPLETED|Overall Study||119
2568543|NCT00445146|6298454|P1|COMPLETED|Overall Study||73
2568544|NCT00445146|6298454|P1|STARTED|Overall Study||192
2568545|NCT00445003|6298476|P3|NOT COMPLETED|Overall Study||4
2568546|NCT00445003|6298477|P2|NOT COMPLETED|Overall Study||10
2568547|NCT00445003|6298478|P1|NOT COMPLETED|Overall Study||5
2568548|NCT00445003|6298476|P3|COMPLETED|Overall Study||105
2568549|NCT00445003|6298477|P2|COMPLETED|Overall Study||103
2568550|NCT00445003|6298478|P1|COMPLETED|Overall Study||118
2568551|NCT00445003|6298476|P3|STARTED|Overall Study||109
2568552|NCT00445003|6298477|P2|STARTED|Overall Study||113
2568553|NCT00445003|6298478|P1|STARTED|Overall Study||123
2568554|NCT00444951|6298510|P3|NOT COMPLETED|Overall Study||3
2568555|NCT00444951|6298511|P2|NOT COMPLETED|Overall Study||6
2568556|NCT00444951|6298512|P1|NOT COMPLETED|Overall Study||5
2568557|NCT00444951|6298510|P3|COMPLETED|Overall Study||160
2568558|NCT00444951|6298511|P2|COMPLETED|Overall Study||136
2568559|NCT00444951|6298512|P1|COMPLETED|Overall Study||140
2568560|NCT00444951|6298510|P3|STARTED|Overall Study||163
2568561|NCT00444951|6298511|P2|STARTED|Overall Study||142
2568562|NCT00444951|6298512|P1|STARTED|Overall Study||145
2568563|NCT00444925|6298529|P3|NOT COMPLETED|Double-blind Treatment Period||81
2568564|NCT00444925|6298530|P2|NOT COMPLETED|Double-blind Treatment Period||56
2568565|NCT00444925|6298531|P1|NOT COMPLETED|Double-blind Treatment Period||30
2568566|NCT00444925|6298529|P3|COMPLETED|Double-blind Treatment Period||598
2568567|NCT00444925|6298530|P2|COMPLETED|Double-blind Treatment Period||628
2568568|NCT00444925|6298531|P1|COMPLETED|Double-blind Treatment Period||304
2568569|NCT00444925|6298529|P3|STARTED|Double-blind Treatment Period||679
2568570|NCT00444925|6298530|P2|STARTED|Double-blind Treatment Period||684
2568571|NCT00444925|6298531|P1|STARTED|Double-blind Treatment Period||334
2568572|NCT00444925|6298529|P3|NOT COMPLETED|Randomized to Double-blind Treatment||6
2568573|NCT00444925|6298530|P2|NOT COMPLETED|Randomized to Double-blind Treatment||6
2568574|NCT00444925|6298531|P1|NOT COMPLETED|Randomized to Double-blind Treatment||3
2568575|NCT00444925|6298529|P3|COMPLETED|Randomized to Double-blind Treatment||679
2568576|NCT00444925|6298530|P2|COMPLETED|Randomized to Double-blind Treatment||684
2568577|NCT00444925|6298531|P1|COMPLETED|Randomized to Double-blind Treatment||334
2568578|NCT00444925|6298529|P3|STARTED|Randomized to Double-blind Treatment||685
2568579|NCT00444925|6298530|P2|STARTED|Randomized to Double-blind Treatment||690
2568580|NCT00444925|6298531|P1|STARTED|Randomized to Double-blind Treatment||337
2568581|NCT00444925|6298529|P3|NOT COMPLETED|Single-blind Placebo Run-In Period||0
2568582|NCT00444925|6298530|P2|NOT COMPLETED|Single-blind Placebo Run-In Period||0
2568583|NCT00444925|6298531|P1|NOT COMPLETED|Single-blind Placebo Run-In Period||734
2568584|NCT00444925|6298529|P3|COMPLETED|Single-blind Placebo Run-In Period||0
2568585|NCT00444925|6298530|P2|COMPLETED|Single-blind Placebo Run-In Period||0
2568586|NCT00444925|6298531|P1|COMPLETED|Single-blind Placebo Run-In Period|progressed to randomization in double-blind treatment period|1712
2568587|NCT00444925|6298529|P3|STARTED|Single-blind Placebo Run-In Period||0
2568588|NCT00444925|6298530|P2|STARTED|Single-blind Placebo Run-In Period||0
2568589|NCT00444925|6298531|P1|STARTED|Single-blind Placebo Run-In Period||2446
2568590|NCT00444912|6298595|P2|NOT COMPLETED|Overall Study||2
2568591|NCT00444912|6298596|P1|NOT COMPLETED|Overall Study||3
2568592|NCT00444912|6298595|P2|COMPLETED|Overall Study||13
2568593|NCT00444912|6298596|P1|COMPLETED|Overall Study||12
2568594|NCT00444912|6298595|P2|Received Transplant|Overall Study||14
2568595|NCT00444912|6298596|P1|Received Transplant|Overall Study||14
2568596|NCT00444912|6298595|P2|Received Plerixafor|Overall Study||15
2568597|NCT00444912|6298596|P1|Received Plerixafor|Overall Study||15
2568598|NCT00444912|6298595|P2|STARTED|Overall Study||15
2568599|NCT00444912|6298596|P1|STARTED|Overall Study||15
2568600|NCT00444821|6298626|P2|NOT COMPLETED|Overall Study||366
2568601|NCT00444821|6298627|P1|NOT COMPLETED|Overall Study||362
2568602|NCT00444821|6298626|P2|COMPLETED|Overall Study||0
2568603|NCT00444821|6298627|P1|COMPLETED|Overall Study||0
2568604|NCT00444821|6298626|P2|Received AAA Repair|Overall Study|Underwent AAA repair per protocol|326
2568605|NCT00444821|6298627|P1|Received AAA Repair|Overall Study|Crossed over to AAA repair|122
2568606|NCT00444821|6298626|P2|STARTED|Overall Study||366
2568607|NCT00444821|6298627|P1|STARTED|Overall Study||362
2568608|NCT00444795|6298637|P1|NOT COMPLETED|Overall Study||3
2568609|NCT00444795|6298637|P1|COMPLETED|Overall Study|Refer to the Safety Analysis Set.|617
2568610|NCT00444795|6298637|P1|STARTED|Overall Study||620
2568611|NCT00444626|6298642|P1|NOT COMPLETED|Repeat Treatment Period||0
2568612|NCT00444626|6298642|P1|COMPLETED|Repeat Treatment Period||105
2568613|NCT00444626|6298642|P1|STARTED|Repeat Treatment Period|23 subjects withdrew after completing the Initial Treatment and did not enter the Repeat Treatment|105
2568614|NCT00444626|6298642|P1|NOT COMPLETED|Initial Treatment Period||12
2568615|NCT00444626|6298642|P1|COMPLETED|Initial Treatment Period||128
2568616|NCT00444626|6298642|P1|STARTED|Initial Treatment Period||140
2568617|NCT00444600|6298672|P4|NOT COMPLETED|Overall Study||10
2568618|NCT00444600|6298673|P3|NOT COMPLETED|Overall Study||10
2568619|NCT00444600|6298674|P2|NOT COMPLETED|Overall Study||16
2568620|NCT00444600|6298675|P1|NOT COMPLETED|Overall Study||19
2568621|NCT00444600|6298672|P4|COMPLETED|Overall Study|Number of eyes|176
2568622|NCT00444600|6298673|P3|COMPLETED|Overall Study|Number of eyes|178
2568623|NCT00444600|6298674|P2|COMPLETED|Overall Study|Number of eyes|171
2568624|NCT00444600|6298675|P1|COMPLETED|Overall Study|Number of eyes|274
2568625|NCT00444600|6298672|P4|STARTED|Overall Study|Number of eyes|186
2568626|NCT00444600|6298673|P3|STARTED|Overall Study|Number of eyes|188
2568627|NCT00444600|6298674|P2|STARTED|Overall Study|Number of eyes|187
2568628|NCT00444600|6298675|P1|STARTED|Overall Study|Number of eyes|293
2568629|NCT00444587|6298767|P2|NOT COMPLETED|Overall Study||15
2568630|NCT00444587|6298768|P1|NOT COMPLETED|Overall Study||83
2568631|NCT00444587|6298767|P2|COMPLETED|Overall Study||1
2568632|NCT00444587|6298768|P1|COMPLETED|Overall Study||10
2568633|NCT00444587|6298767|P2|STARTED|Overall Study||16
2568634|NCT00444587|6298768|P1|STARTED|Overall Study||93
2568635|NCT00444535|6298789|P1|NOT COMPLETED|Overall Study||24
2568636|NCT00444535|6298789|P1|COMPLETED|Overall Study||28
2568637|NCT00444535|6298789|P1|STARTED|Overall Study||52
2568638|NCT00444457|6298800|P4|NOT COMPLETED|Toddler Dose||8
2568639|NCT00444457|6298801|P3|NOT COMPLETED|Toddler Dose||4
2568640|NCT00444457|6298802|P2|NOT COMPLETED|Toddler Dose||6
2568641|NCT00444457|6298803|P1|NOT COMPLETED|Toddler Dose||7
2568642|NCT00444457|6298800|P4|COMPLETED|Toddler Dose||200
2568643|NCT00444457|6298801|P3|COMPLETED|Toddler Dose||404
2568644|NCT00444457|6298802|P2|COMPLETED|Toddler Dose||391
2568645|NCT00444457|6298803|P1|COMPLETED|Toddler Dose||408
2568646|NCT00444457|6298800|P4|STARTED|Toddler Dose|Vaccinated toddler dose|208
2568647|NCT00444457|6298801|P3|STARTED|Toddler Dose|Vaccinated toddler dose|408
2568648|NCT00444457|6298802|P2|STARTED|Toddler Dose|Vaccinated toddler dose|397
2568649|NCT00444457|6298803|P1|STARTED|Toddler Dose|Vaccinated toddler dose|415
2568650|NCT00444457|6298800|P4|NOT COMPLETED|After Infant Series||10
2568651|NCT00444457|6298801|P3|NOT COMPLETED|After Infant Series||19
2568652|NCT00444457|6298802|P2|NOT COMPLETED|After Infant Series||30
2568653|NCT00444457|6298803|P1|NOT COMPLETED|After Infant Series||20
2568654|NCT00444457|6298800|P4|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|208
2568655|NCT00444457|6298801|P3|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|408
2568656|NCT00444457|6298802|P2|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|397
2568657|NCT00444457|6298803|P1|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|415
2568658|NCT00444457|6298800|P4|STARTED|After Infant Series||218
2568659|NCT00444457|6298801|P3|STARTED|After Infant Series||427
2568660|NCT00444457|6298802|P2|STARTED|After Infant Series||427
2568661|NCT00444457|6298803|P1|STARTED|After Infant Series||435
2568662|NCT00444457|6298800|P4|NOT COMPLETED|Infant Series||28
2568663|NCT00444457|6298801|P3|NOT COMPLETED|Infant Series||61
2568664|NCT00444457|6298802|P2|NOT COMPLETED|Infant Series||61
2568665|NCT00444457|6298803|P1|NOT COMPLETED|Infant Series||54
2568666|NCT00444457|6298800|P4|COMPLETED|Infant Series||218
2568667|NCT00444457|6298801|P3|COMPLETED|Infant Series||428
2568668|NCT00444457|6298802|P2|COMPLETED|Infant Series||427
2568669|NCT00444457|6298803|P1|COMPLETED|Infant Series||435
2568670|NCT00444457|6298800|P4|Vaccinated Dose 3|Infant Series||225
2568671|NCT00444457|6298801|P3|Vaccinated Dose 3|Infant Series||438
2568672|NCT00444457|6298802|P2|Vaccinated Dose 3|Infant Series||435
2568673|NCT00444457|6298803|P1|Vaccinated Dose 3|Infant Series||442
2568674|NCT00444457|6298800|P4|Vaccinated Dose 2|Infant Series||228
2568675|NCT00444457|6298801|P3|Vaccinated Dose 2|Infant Series||455
2568676|NCT00444457|6298802|P2|Vaccinated Dose 2|Infant Series||447
2568677|NCT00444457|6298803|P1|Vaccinated Dose 2|Infant Series||455
2568678|NCT00444457|6298800|P4|Vaccinated Dose 1|Infant Series||244
2568679|NCT00444457|6298801|P3|Vaccinated Dose 1|Infant Series||485
2568680|NCT00444457|6298802|P2|Vaccinated Dose 1|Infant Series||484
2568681|NCT00444457|6298803|P1|Vaccinated Dose 1|Infant Series||486
2568682|NCT00444457|6298800|P4|STARTED|Infant Series||246
2568683|NCT00444457|6298801|P3|STARTED|Infant Series||489
2568684|NCT00444457|6298802|P2|STARTED|Infant Series||488
2568685|NCT00444457|6298803|P1|STARTED|Infant Series||489
2568686|NCT00444275|6298868|P5|NOT COMPLETED|Maintenance Treatment Phase||179
2568687|NCT00444275|6298869|P4|NOT COMPLETED|Maintenance Treatment Phase||133
2568688|NCT00444275|6298870|P3|NOT COMPLETED|Maintenance Treatment Phase||161
2568689|NCT00444275|6298871|P2|NOT COMPLETED|Maintenance Treatment Phase||0
2568690|NCT00444275|6298872|P1|NOT COMPLETED|Maintenance Treatment Phase||0
2568691|NCT00444275|6298868|P5|COMPLETED|Maintenance Treatment Phase||701
2568692|NCT00444275|6298869|P4|COMPLETED|Maintenance Treatment Phase||764
2568693|NCT00444275|6298870|P3|COMPLETED|Maintenance Treatment Phase||747
2568694|NCT00444275|6298871|P2|COMPLETED|Maintenance Treatment Phase||0
2568695|NCT00444275|6298872|P1|COMPLETED|Maintenance Treatment Phase||0
2568696|NCT00444275|6298868|P5|STARTED|Maintenance Treatment Phase||880
2568697|NCT00444275|6298869|P4|STARTED|Maintenance Treatment Phase||897
2568698|NCT00444275|6298870|P3|STARTED|Maintenance Treatment Phase||908
2568699|NCT00444275|6298871|P2|STARTED|Maintenance Treatment Phase||0
2568700|NCT00444275|6298872|P1|STARTED|Maintenance Treatment Phase||0
2568701|NCT00444275|6298868|P5|NOT COMPLETED|Initial Treatment Phase||0
2568702|NCT00444275|6298869|P4|NOT COMPLETED|Initial Treatment Phase||0
2568703|NCT00444275|6298870|P3|NOT COMPLETED|Initial Treatment Phase||0
2568704|NCT00444275|6298871|P2|NOT COMPLETED|Initial Treatment Phase||96
2568705|NCT00444275|6298872|P1|NOT COMPLETED|Initial Treatment Phase||248
2568706|NCT00444275|6298868|P5|COMPLETED|Initial Treatment Phase||0
2568707|NCT00444275|6298869|P4|COMPLETED|Initial Treatment Phase||0
2568708|NCT00444275|6298870|P3|COMPLETED|Initial Treatment Phase||0
2568709|NCT00444275|6298871|P2|COMPLETED|Initial Treatment Phase||777
2568710|NCT00444275|6298872|P1|COMPLETED|Initial Treatment Phase||1908
2568711|NCT00444275|6298868|P5|STARTED|Initial Treatment Phase||0
2568712|NCT00444275|6298869|P4|STARTED|Initial Treatment Phase||0
2568713|NCT00444275|6298870|P3|STARTED|Initial Treatment Phase||0
2568714|NCT00444275|6298871|P2|STARTED|Initial Treatment Phase||873
2568715|NCT00444275|6298872|P1|STARTED|Initial Treatment Phase||2156
2568716|NCT00444145|6298922|P1|NOT COMPLETED|Overall Study||19
2568717|NCT00444145|6298922|P1|COMPLETED|Overall Study||19
2568718|NCT00444145|6298922|P1|STARTED|Overall Study||38
2568719|NCT00444106|6298929|P3|NOT COMPLETED|Overall Study||1
2568720|NCT00444106|6298930|P2|NOT COMPLETED|Overall Study||1
2568721|NCT00444106|6298931|P1|NOT COMPLETED|Overall Study||2
2568722|NCT00444106|6298929|P3|COMPLETED|Overall Study||52
2568723|NCT00444106|6298930|P2|COMPLETED|Overall Study||52
2568724|NCT00444106|6298931|P1|COMPLETED|Overall Study||157
2568725|NCT00444106|6298929|P3|Completed Treatment Period|Overall Study||53
2568726|NCT00444106|6298930|P2|Completed Treatment Period|Overall Study||53
2568727|NCT00444106|6298931|P1|Completed Treatment Period|Overall Study||159
2568728|NCT00444106|6298929|P3|STARTED|Overall Study||53
2568729|NCT00444106|6298930|P2|STARTED|Overall Study||53
2568730|NCT00444106|6298931|P1|STARTED|Overall Study||159
2568731|NCT00444067|6298948|P2|NOT COMPLETED|Overall Study||1
2568732|NCT00444067|6298949|P1|NOT COMPLETED|Overall Study||0
2568733|NCT00444067|6298948|P2|COMPLETED|Overall Study||23
2568734|NCT00444067|6298949|P1|COMPLETED|Overall Study||74
2568735|NCT00444067|6298948|P2|STARTED|Overall Study||24
2568736|NCT00444067|6298949|P1|STARTED|Overall Study||74
2568737|NCT00444028|6298965|P6|NOT COMPLETED|Overall Study||0
2568738|NCT00444028|6298966|P5|NOT COMPLETED|Overall Study||0
2568739|NCT00444028|6298967|P4|NOT COMPLETED|Overall Study||0
2568740|NCT00444028|6298968|P3|NOT COMPLETED|Overall Study||0
2568741|NCT00444028|6298969|P2|NOT COMPLETED|Overall Study||0
2568742|NCT00444028|6298970|P1|NOT COMPLETED|Overall Study||0
2568743|NCT00444028|6298965|P6|COMPLETED|Overall Study||8
2568744|NCT00444028|6298966|P5|COMPLETED|Overall Study||7
2568745|NCT00444028|6298967|P4|COMPLETED|Overall Study||6
2568746|NCT00444028|6298968|P3|COMPLETED|Overall Study||8
2568747|NCT00444028|6298969|P2|COMPLETED|Overall Study||7
2568748|NCT00444028|6298970|P1|COMPLETED|Overall Study||14
2568749|NCT00444028|6298965|P6|STARTED|Overall Study||8
2568750|NCT00444028|6298966|P5|STARTED|Overall Study||7
2568751|NCT00444028|6298967|P4|STARTED|Overall Study||6
2568752|NCT00444028|6298968|P3|STARTED|Overall Study||8
2568753|NCT00444028|6298969|P2|STARTED|Overall Study||7
2568754|NCT00444028|6298970|P1|STARTED|Overall Study||14
2568755|NCT00443898|6299012|P4|NOT COMPLETED|Overall Study||18
2568756|NCT00443898|6299013|P3|NOT COMPLETED|Overall Study||29
2568757|NCT00443898|6299014|P2|NOT COMPLETED|Overall Study||25
2568758|NCT00443898|6299015|P1|NOT COMPLETED|Overall Study||24
2568759|NCT00443898|6299012|P4|COMPLETED|Overall Study||110
2568760|NCT00443898|6299013|P3|COMPLETED|Overall Study||107
2568761|NCT00443898|6299014|P2|COMPLETED|Overall Study||103
2568762|NCT00443898|6299015|P1|COMPLETED|Overall Study||102
2568763|NCT00443898|6299012|P4|STARTED|Overall Study||128
2568764|NCT00443898|6299013|P3|STARTED|Overall Study||136
2568765|NCT00443898|6299014|P2|STARTED|Overall Study||128
2568766|NCT00443898|6299015|P1|STARTED|Overall Study||126
2568767|NCT00443872|6299037|P1|NOT COMPLETED|Overall Study||17
2568768|NCT00443872|6299037|P1|COMPLETED|Overall Study||60
2568769|NCT00443872|6299037|P1|STARTED|Overall Study||77
2568770|NCT00443846|6299052|P2|NOT COMPLETED|Overall Study||6
2568771|NCT00443846|6299053|P1|NOT COMPLETED|Overall Study||11
2568772|NCT00443846|6299052|P2|COMPLETED|Overall Study||117
2568773|NCT00443846|6299053|P1|COMPLETED|Overall Study||113
2568774|NCT00443846|6299052|P2|Vaccinated|Overall Study||123
2568775|NCT00443846|6299053|P1|Vaccinated|Overall Study||116
2568776|NCT00443846|6299052|P2|STARTED|Overall Study||123
2568777|NCT00443846|6299053|P1|STARTED|Overall Study||124
2568778|NCT00443820|6299063|P4|NOT COMPLETED|Overall Study||17
2568779|NCT00443820|6299064|P3|NOT COMPLETED|Overall Study||18
2568780|NCT00443820|6299065|P2|NOT COMPLETED|Overall Study||19
2568781|NCT00443820|6299066|P1|NOT COMPLETED|Overall Study||21
2568782|NCT00443820|6299063|P4|COMPLETED|Overall Study||111
2568783|NCT00443820|6299064|P3|COMPLETED|Overall Study||117
2568784|NCT00443820|6299065|P2|COMPLETED|Overall Study|A participant from this gr. discont'ed due to renal failure, was counted as an AE and also as a SAE.|111
2568785|NCT00443820|6299066|P1|COMPLETED|Overall Study||112
2568786|NCT00443820|6299063|P4|Safety Population|Overall Study||126
2568787|NCT00443820|6299064|P3|Safety Population|Overall Study||134
2568788|NCT00443820|6299065|P2|Safety Population|Overall Study||129
2568789|NCT00443820|6299066|P1|Safety Population|Overall Study|Participants who received study drug and had at least one post-baseline safety assessment.|131
2568790|NCT00443820|6299063|P4|STARTED|Overall Study||128
2568791|NCT00443820|6299064|P3|STARTED|Overall Study||135
2568792|NCT00443820|6299065|P2|STARTED|Overall Study||130
2568793|NCT00443820|6299066|P1|STARTED|Overall Study||133
2568794|NCT00443781|6299088|P1|NOT COMPLETED|Overall Study||25
2568795|NCT00443781|6299088|P1|COMPLETED|Overall Study||37
2568796|NCT00443781|6299088|P1|STARTED|Overall Study||62
2568797|NCT00443755|6299094|P2|NOT COMPLETED|Overall Study||1
2568798|NCT00443755|6299095|P1|NOT COMPLETED|Overall Study||2
2568799|NCT00443755|6299094|P2|COMPLETED|Overall Study||13
2568800|NCT00443755|6299095|P1|COMPLETED|Overall Study||12
2568801|NCT00443755|6299094|P2|STARTED|Overall Study||14
2568802|NCT00443755|6299095|P1|STARTED|Overall Study||14
2568803|NCT00443729|6299129|P2|NOT COMPLETED|Overall Study||7
2568804|NCT00443729|6299130|P1|NOT COMPLETED|Overall Study||10
2568805|NCT00443729|6299129|P2|COMPLETED|Overall Study||172
2568806|NCT00443729|6299130|P1|COMPLETED|Overall Study||166
2568807|NCT00443729|6299129|P2|Treated|Overall Study||178
2568808|NCT00443729|6299130|P1|Treated|Overall Study||176
2568809|NCT00443729|6299129|P2|STARTED|Overall Study||179
2568810|NCT00443729|6299130|P1|STARTED|Overall Study||176
2568811|NCT00443703|6299178|P2|NOT COMPLETED|Overall Study||18
2568812|NCT00443703|6299179|P1|NOT COMPLETED|Overall Study||28
2568813|NCT00443703|6299178|P2|COMPLETED|Overall Study||157
2568814|NCT00443703|6299179|P1|COMPLETED|Overall Study||149
2568815|NCT00443703|6299178|P2|Treated|Overall Study||174
2568816|NCT00443703|6299179|P1|Treated|Overall Study||174
2568817|NCT00443703|6299178|P2|STARTED|Overall Study||175
2568818|NCT00443703|6299179|P1|STARTED|Overall Study||177
2568819|NCT00443651|6299231|P2|NOT COMPLETED|Overall Study||58
2568820|NCT00443651|6299232|P1|NOT COMPLETED|Overall Study||95
2568821|NCT00443651|6299231|P2|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|118
2568822|NCT00443651|6299232|P1|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|306
2568823|NCT00443651|6299231|P2|Week 48|Overall Study||134
2568824|NCT00443651|6299232|P1|Week 48|Overall Study||338
2568825|NCT00443651|6299231|P2|Week 24|Overall Study||160
2568826|NCT00443651|6299232|P1|Week 24|Overall Study||376
2568827|NCT00443651|6299231|P2|STARTED|Overall Study||176
2568828|NCT00443651|6299232|P1|STARTED|Overall Study||401
2568835|NCT00443560|6299287|P2|NOT COMPLETED|Overall Study||30
2568836|NCT00443560|6299288|P1|NOT COMPLETED|Overall Study||60
2568837|NCT00443560|6299287|P2|COMPLETED|Overall Study||1051
2568838|NCT00443560|6299288|P1|COMPLETED|Overall Study||1021
2568839|NCT00443560|6299287|P2|STARTED|Overall Study||1081
2568840|NCT00443560|6299288|P1|STARTED|Overall Study||1081
2568841|NCT00443547|6299302|P4|NOT COMPLETED|Overall Study||2
2568842|NCT00443547|6299303|P3|NOT COMPLETED|Overall Study||21
2568843|NCT00443547|6299304|P2|NOT COMPLETED|Overall Study||42
2568844|NCT00443547|6299305|P1|NOT COMPLETED|Overall Study||45
2568845|NCT00443547|6299302|P4|COMPLETED|Overall Study||4
2568846|NCT00443547|6299303|P3|COMPLETED|Overall Study||27
2568847|NCT00443547|6299304|P2|COMPLETED|Overall Study||46
2568848|NCT00443547|6299305|P1|COMPLETED|Overall Study||44
2568849|NCT00443547|6299302|P4|Evaluated at 12 Months|Overall Study||5
2568850|NCT00443547|6299303|P3|Evaluated at 12 Months|Overall Study||37
2568851|NCT00443547|6299304|P2|Evaluated at 12 Months|Overall Study||55
2568852|NCT00443547|6299305|P1|Evaluated at 12 Months|Overall Study||58
2568853|NCT00443547|6299302|P4|STARTED|Overall Study|Enrolled and Treated Per Protocol|6
2568854|NCT00443547|6299303|P3|STARTED|Overall Study|Enrolled and Treated Per Protocol|48
2568855|NCT00443547|6299304|P2|STARTED|Overall Study|Enrolled and Treated Per Protocol|88
2568856|NCT00443547|6299305|P1|STARTED|Overall Study|Enrolled and Treated Per Protocol|89
2568857|NCT00443534|6299323|P1|NOT COMPLETED|Overall Study||123
2568858|NCT00443534|6299323|P1|COMPLETED|Overall Study||0
2568859|NCT00443534|6299323|P1|Treated|Overall Study||122
2568860|NCT00443534|6299323|P1|STARTED|Overall Study||123
2568861|NCT00443456|6299330|P1|NOT COMPLETED|Overall Study||18
2568862|NCT00443456|6299330|P1|COMPLETED|Overall Study||116
2568863|NCT00443456|6299330|P1|STARTED|Overall Study||134
2568864|NCT00443430|6299365|P2|NOT COMPLETED|Overall Study||4
2568865|NCT00443430|6299366|P1|NOT COMPLETED|Overall Study||4
2568866|NCT00443430|6299365|P2|COMPLETED|Overall Study||38
2568867|NCT00443430|6299366|P1|COMPLETED|Overall Study||39
2568868|NCT00443430|6299365|P2|STARTED|Overall Study||42
2568869|NCT00443430|6299366|P1|STARTED|Overall Study||43
2568870|NCT00443352|6299376|P1|NOT COMPLETED|Overall Study||5
2568871|NCT00443352|6299376|P1|COMPLETED|Overall Study||22
2568872|NCT00443352|6299376|P1|STARTED|Overall Study||27
2568873|NCT00443261|6299380|P1|NOT COMPLETED|Overall Study||1
2568874|NCT00443261|6299380|P1|COMPLETED|Overall Study|Study terminated due to poor accrual and only patient enrolled died|0
2568875|NCT00443261|6299380|P1|Accrual in 10 Months|Overall Study|Patient died due to progressive disease after cycle 1 of treatment|1
2568876|NCT00443261|6299380|P1|STARTED|Overall Study||1
2568877|NCT00443209|6299386|P2|NOT COMPLETED|Months 13 to 18 Treatment Period||47
2568878|NCT00443209|6299387|P1|NOT COMPLETED|Months 13 to 18 Treatment Period||99
2568879|NCT00443209|6299386|P2|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|39
2568880|NCT00443209|6299387|P1|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|87
2568881|NCT00443209|6299386|P2|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period was optional. 116 participants chose not to continue.|86
2568882|NCT00443209|6299387|P1|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period.was optional. 181 participants chose not to continue.|186
2568883|NCT00443209|6299386|P2|NOT COMPLETED|Months 1 to 12 Treatment Period||154
2568884|NCT00443209|6299387|P1|NOT COMPLETED|Months 1 to 12 Treatment Period||345
2568885|NCT00443209|6299386|P2|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|202
2568886|NCT00443209|6299387|P1|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|367
2568887|NCT00443209|6299386|P2|Treated|Months 1 to 12 Treatment Period||313
2568888|NCT00443209|6299387|P1|Treated|Months 1 to 12 Treatment Period||641
2568889|NCT00443209|6299386|P2|STARTED|Months 1 to 12 Treatment Period||356
2568890|NCT00443209|6299387|P1|STARTED|Months 1 to 12 Treatment Period||712
2568891|NCT00443118|6299404|P3|NOT COMPLETED|Overall Study||0
2568892|NCT00443118|6299405|P2|NOT COMPLETED|Overall Study||1
2568893|NCT00443118|6299406|P1|NOT COMPLETED|Overall Study||4
2568894|NCT00443118|6299404|P3|COMPLETED|Overall Study||226
2568895|NCT00443118|6299405|P2|COMPLETED|Overall Study||290
2568896|NCT00443118|6299406|P1|COMPLETED|Overall Study||511
2568897|NCT00443118|6299404|P3|STARTED|Overall Study||226
2568898|NCT00443118|6299405|P2|STARTED|Overall Study||291
2568899|NCT00443118|6299406|P1|STARTED|Overall Study||515
2568900|NCT00443053|6299455|P2|NOT COMPLETED|Overall Study||33
2568901|NCT00443053|6299456|P1|NOT COMPLETED|Overall Study||21
2568902|NCT00443053|6299455|P2|COMPLETED|Overall Study||1467
2568903|NCT00443053|6299456|P1|COMPLETED|Overall Study||1481
2568904|NCT00443053|6299455|P2|STARTED|Overall Study||1500
2568905|NCT00443053|6299456|P1|STARTED|Overall Study||1502
2568906|NCT00443040|6299477|P3|NOT COMPLETED|Overall Study||1
2568907|NCT00443040|6299478|P2|NOT COMPLETED|Overall Study||0
2568908|NCT00443040|6299479|P1|NOT COMPLETED|Overall Study||4
2568909|NCT00443040|6299477|P3|COMPLETED|Overall Study||9
2568910|NCT00443040|6299478|P2|COMPLETED|Overall Study||11
2568911|NCT00443040|6299479|P1|COMPLETED|Overall Study||10
2568912|NCT00443040|6299477|P3|STARTED|Overall Study||10
2568913|NCT00443040|6299478|P2|STARTED|Overall Study||11
2568914|NCT00443040|6299479|P1|STARTED|Overall Study||14
2568915|NCT00442962|6299487|P1|NOT COMPLETED|Overall Study||8
2568916|NCT00442962|6299487|P1|COMPLETED|Overall Study|Completed 48 weeks of follow-up.|46
2568917|NCT00442962|6299487|P1|Primary Outcome Evaluation|Overall Study|Primary outcome evaluation at week 24.|52
2568918|NCT00442962|6299487|P1|STARTED|Overall Study||54
2568919|NCT00442936|6299505|P4|NOT COMPLETED|Overall Study||1
2568920|NCT00442936|6299506|P3|NOT COMPLETED|Overall Study||1
2568921|NCT00442936|6299507|P2|NOT COMPLETED|Overall Study||0
2568922|NCT00442936|6299508|P1|NOT COMPLETED|Overall Study||1
2568923|NCT00442936|6299505|P4|COMPLETED|Overall Study||347
2568924|NCT00442936|6299506|P3|COMPLETED|Overall Study||344
2568925|NCT00442936|6299507|P2|COMPLETED|Overall Study||354
2568926|NCT00442936|6299508|P1|COMPLETED|Overall Study||332
2568927|NCT00442936|6299505|P4|STARTED|Overall Study||348
2568928|NCT00442936|6299506|P3|STARTED|Overall Study||345
2568929|NCT00442936|6299507|P2|STARTED|Overall Study||354
2568930|NCT00442936|6299508|P1|STARTED|Overall Study||333
2568931|NCT00442897|6299556|P2|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
2568932|NCT00442897|6299557|P1|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
2568933|NCT00442897|6299556|P2|COMPLETED|24 Weeks Follow-up (3 Centers)||28
2568934|NCT00442897|6299557|P1|COMPLETED|24 Weeks Follow-up (3 Centers)||29
2568935|NCT00442897|6299556|P2|STARTED|24 Weeks Follow-up (3 Centers)|65 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|34
2568936|NCT00442897|6299557|P1|STARTED|24 Weeks Follow-up (3 Centers)|66 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|35
2568937|NCT00442897|6299556|P2|NOT COMPLETED|Base Study (12 Week Follow-up)||12
2568938|NCT00442897|6299557|P1|NOT COMPLETED|Base Study (12 Week Follow-up)||17
2568939|NCT00442897|6299556|P2|COMPLETED|Base Study (12 Week Follow-up)||99
2568940|NCT00442897|6299557|P1|COMPLETED|Base Study (12 Week Follow-up)||101
2568941|NCT00442897|6299556|P2|STARTED|Base Study (12 Week Follow-up)||111
2568942|NCT00442897|6299557|P1|STARTED|Base Study (12 Week Follow-up)||118
2568943|NCT00442767|6299565|P1|NOT COMPLETED|Overall Study||0
2568944|NCT00442767|6299565|P1|COMPLETED|Overall Study||8
2568945|NCT00442767|6299565|P1|STARTED|Overall Study||8
2568946|NCT00442702|6299575|P2|NOT COMPLETED|Evaluation Period||4
2568947|NCT00442702|6299576|P1|NOT COMPLETED|Evaluation Period||5
2568948|NCT00442702|6299575|P2|COMPLETED|Evaluation Period||107
2568949|NCT00442702|6299576|P1|COMPLETED|Evaluation Period||97
2568950|NCT00442702|6299575|P2|STARTED|Evaluation Period||111
2568951|NCT00442702|6299576|P1|STARTED|Evaluation Period||102
2568952|NCT00442702|6299575|P2|NOT COMPLETED|Titration Period||3
2568953|NCT00442702|6299576|P1|NOT COMPLETED|Titration Period||12
2568954|NCT00442702|6299575|P2|COMPLETED|Titration Period||111
2568955|NCT00442702|6299576|P1|COMPLETED|Titration Period||102
2568956|NCT00442702|6299575|P2|Safety Population|Titration Period||113
2568957|NCT00442702|6299576|P1|Safety Population|Titration Period|One patient was randomized to darbepoetin alfa but treated by mistake with Mircera|115
2568958|NCT00442702|6299575|P2|STARTED|Titration Period||114
2568959|NCT00442702|6299576|P1|STARTED|Titration Period||114
2568960|NCT00442689|6299591|P3|NOT COMPLETED|Overall Study||9
2568961|NCT00442689|6299592|P2|NOT COMPLETED|Overall Study||11
2568962|NCT00442689|6299593|P1|NOT COMPLETED|Overall Study||10
2568963|NCT00442689|6299591|P3|COMPLETED|Overall Study||13
2568964|NCT00442689|6299592|P2|COMPLETED|Overall Study||13
2568965|NCT00442689|6299593|P1|COMPLETED|Overall Study||11
2568966|NCT00442689|6299591|P3|STARTED|Overall Study||22
2568967|NCT00442689|6299592|P2|STARTED|Overall Study||24
2568968|NCT00442689|6299593|P1|STARTED|Overall Study||21
2568969|NCT00442611|6299621|P2|NOT COMPLETED|Overall Study||0
2568970|NCT00442611|6299622|P1|NOT COMPLETED|Overall Study||1
2568971|NCT00442611|6299621|P2|COMPLETED|Overall Study||3
2568972|NCT00442611|6299622|P1|COMPLETED|Overall Study||6
2568973|NCT00442611|6299621|P2|STARTED|Overall Study||3
2568974|NCT00442611|6299622|P1|STARTED|Overall Study||7
2568975|NCT00442598|6299641|P3|NOT COMPLETED|Overall Study||0
2568976|NCT00442598|6299642|P2|NOT COMPLETED|Overall Study||8
2568977|NCT00442598|6299643|P1|NOT COMPLETED|Overall Study||6
2568978|NCT00442598|6299641|P3|COMPLETED|Overall Study||0
2568979|NCT00442598|6299642|P2|COMPLETED|Overall Study||2
2568980|NCT00442598|6299643|P1|COMPLETED|Overall Study||1
2568981|NCT00442598|6299641|P3|Two Cycles|Overall Study||0
2568982|NCT00442598|6299642|P2|Two Cycles|Overall Study||6
2568983|NCT00442598|6299643|P1|Two Cycles|Overall Study||5
2568984|NCT00442598|6299641|P3|STARTED|Overall Study||0
2568985|NCT00442598|6299642|P2|STARTED|Overall Study||10
2568986|NCT00442598|6299643|P1|STARTED|Overall Study||7
2568987|NCT00442572|6299661|P2|NOT COMPLETED|Overall Study||3
2568988|NCT00442572|6299662|P1|NOT COMPLETED|Overall Study||8
2568989|NCT00442572|6299661|P2|COMPLETED|Overall Study||1
2568990|NCT00442572|6299662|P1|COMPLETED|Overall Study||9
2568991|NCT00442572|6299661|P2|STARTED|Overall Study||4
2568992|NCT00442572|6299662|P1|STARTED|Overall Study||17
2568993|NCT00442559|6299702|P2|NOT COMPLETED|Overall Study||35
2568994|NCT00442559|6299703|P1|NOT COMPLETED|Overall Study||34
2568995|NCT00442559|6299702|P2|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|56
2568996|NCT00442559|6299703|P1|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|66
2568997|NCT00442559|6299702|P2|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|60
2568998|NCT00442559|6299703|P1|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|68
2568999|NCT00442559|6299702|P2|STARTED|Overall Study||91
2569000|NCT00442559|6299703|P1|STARTED|Overall Study||100
2569001|NCT00442546|6299718|P3|NOT COMPLETED|Overall Study||33
2569002|NCT00442546|6299719|P2|NOT COMPLETED|Overall Study||37
2569003|NCT00442546|6299720|P1|NOT COMPLETED|Overall Study||26
2569004|NCT00442546|6299718|P3|COMPLETED|Overall Study||71
2569005|NCT00442546|6299719|P2|COMPLETED|Overall Study||63
2569006|NCT00442546|6299720|P1|COMPLETED|Overall Study||77
2569007|NCT00442546|6299718|P3|Received Treatment|Overall Study||98
2569008|NCT00442546|6299719|P2|Received Treatment|Overall Study||96
2569009|NCT00442546|6299720|P1|Received Treatment|Overall Study||98
2569010|NCT00442546|6299718|P3|STARTED|Overall Study||104
2569011|NCT00442546|6299719|P2|STARTED|Overall Study||100
2569012|NCT00442546|6299720|P1|STARTED|Overall Study||103
2569013|NCT00442507|6299842|P1|NOT COMPLETED|Overall Study||0
2569014|NCT00442507|6299842|P1|COMPLETED|Overall Study||6
2569015|NCT00442507|6299842|P1|STARTED|Overall Study||6
2569016|NCT00442468|6299849|P1|NOT COMPLETED|Overall Study||183
2569017|NCT00442468|6299849|P1|COMPLETED|Overall Study||1100
2569018|NCT00442468|6299849|P1|STARTED|Overall Study||1283
2569019|NCT00442416|6299879|P2|NOT COMPLETED|Overall Study||39
2569020|NCT00442416|6299880|P1|NOT COMPLETED|Overall Study||37
2569021|NCT00442416|6299879|P2|COMPLETED|Overall Study||2
2569022|NCT00442416|6299880|P1|COMPLETED|Overall Study||2
2569023|NCT00442416|6299879|P2|STARTED|Overall Study||41
2569024|NCT00442416|6299880|P1|STARTED|Overall Study||39
2569025|NCT00442364|6299913|P1|NOT COMPLETED|Overall Study||0
2569026|NCT00442364|6299913|P1|COMPLETED|Overall Study||60
2569027|NCT00442364|6299913|P1|STARTED|Overall Study||60
2569028|NCT00442351|6299919|P2|NOT COMPLETED|Overall Study||6
2569029|NCT00442351|6299920|P1|NOT COMPLETED|Overall Study||7
2569030|NCT00442351|6299919|P2|COMPLETED|Overall Study||3
2569031|NCT00442351|6299920|P1|COMPLETED|Overall Study||10
2569032|NCT00442351|6299919|P2|STARTED|Overall Study||9
2569033|NCT00442351|6299920|P1|STARTED|Overall Study|Due to poor enrollment and a high screening failure rate, this study was terminated early.|17
2569034|NCT00442338|6299929|P3|NOT COMPLETED|Overall Study||0
2569035|NCT00442338|6299930|P2|NOT COMPLETED|Overall Study||0
2569036|NCT00442338|6299931|P1|NOT COMPLETED|Overall Study||0
2569037|NCT00442338|6299929|P3|COMPLETED|Overall Study||31
2569038|NCT00442338|6299930|P2|COMPLETED|Overall Study||30
2569039|NCT00442338|6299931|P1|COMPLETED|Overall Study||30
2569040|NCT00442338|6299929|P3|STARTED|Overall Study||31
2569041|NCT00442338|6299930|P2|STARTED|Overall Study||30
2569042|NCT00442338|6299931|P1|STARTED|Overall Study||30
2569043|NCT00442286|6299942|P2|NOT COMPLETED|Overall Study||2
2569044|NCT00442286|6299943|P1|NOT COMPLETED|Overall Study||7
2569045|NCT00442286|6299942|P2|COMPLETED|Overall Study||82
2569046|NCT00442286|6299943|P1|COMPLETED|Overall Study||174
2569047|NCT00442286|6299942|P2|12 Months|Overall Study||82
2569048|NCT00442286|6299943|P1|12 Months|Overall Study||174
2569049|NCT00442286|6299942|P2|6 Months|Overall Study||83
2569050|NCT00442286|6299943|P1|6 Months|Overall Study||177
2569051|NCT00442286|6299942|P2|STARTED|Overall Study||84
2569052|NCT00442286|6299943|P1|STARTED|Overall Study||181
2569053|NCT00442169|6299960|P6|NOT COMPLETED|Part 2||0
2569054|NCT00442169|6299961|P5|NOT COMPLETED|Part 2||0
2569055|NCT00442169|6299962|P4|NOT COMPLETED|Part 2||0
2569056|NCT00442169|6299963|P3|NOT COMPLETED|Part 2||0
2569057|NCT00442169|6299964|P2|NOT COMPLETED|Part 2||0
2569058|NCT00442169|6299965|P1|NOT COMPLETED|Part 2||0
2569059|NCT00442169|6299960|P6|COMPLETED|Part 2||57
2569060|NCT00442169|6299961|P5|COMPLETED|Part 2||25
2569061|NCT00442169|6299962|P4|COMPLETED|Part 2||0
2569062|NCT00442169|6299963|P3|COMPLETED|Part 2||0
2569063|NCT00442169|6299964|P2|COMPLETED|Part 2||0
2569064|NCT00442169|6299965|P1|COMPLETED|Part 2||0
2569065|NCT00442169|6299960|P6|STARTED|Part 2||57
2569066|NCT00442169|6299961|P5|STARTED|Part 2||25
2569067|NCT00442169|6299962|P4|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
2569068|NCT00442169|6299963|P3|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
2569069|NCT00442169|6299964|P2|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
2569070|NCT00442169|6299965|P1|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
2569071|NCT00442169|6299960|P6|NOT COMPLETED|Part 1||0
2569072|NCT00442169|6299961|P5|NOT COMPLETED|Part 1||0
2569073|NCT00442169|6299962|P4|NOT COMPLETED|Part 1||0
2569074|NCT00442169|6299963|P3|NOT COMPLETED|Part 1||0
2569075|NCT00442169|6299964|P2|NOT COMPLETED|Part 1||0
2569076|NCT00442169|6299965|P1|NOT COMPLETED|Part 1||0
2569077|NCT00442169|6299960|P6|COMPLETED|Part 1||0
2569078|NCT00442169|6299961|P5|COMPLETED|Part 1||0
2569079|NCT00442169|6299962|P4|COMPLETED|Part 1||31
2569080|NCT00442169|6299963|P3|COMPLETED|Part 1||40
2569081|NCT00442169|6299964|P2|COMPLETED|Part 1||24
2569082|NCT00442169|6299965|P1|COMPLETED|Part 1||17
2569083|NCT00442169|6299960|P6|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
2569084|NCT00442169|6299961|P5|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
2569085|NCT00442169|6299962|P4|STARTED|Part 1||31
2569086|NCT00442169|6299963|P3|STARTED|Part 1||40
2569087|NCT00442169|6299964|P2|STARTED|Part 1||24
2569088|NCT00442169|6299965|P1|STARTED|Part 1||17
2569089|NCT00442117|6300005|P2|NOT COMPLETED|Overall Study||38
2569090|NCT00442117|6300006|P1|NOT COMPLETED|Overall Study||38
2569091|NCT00442117|6300005|P2|COMPLETED|Overall Study||49
2569092|NCT00442117|6300006|P1|COMPLETED|Overall Study||47
2569093|NCT00442117|6300005|P2|STARTED|Overall Study||87
2569094|NCT00442117|6300006|P1|STARTED|Overall Study||85
2569095|NCT00442013|6300020|P2|NOT COMPLETED|Overall Study||17
2569096|NCT00442013|6300021|P1|NOT COMPLETED|Overall Study||26
2569097|NCT00442013|6300020|P2|COMPLETED|Overall Study||132
2569098|NCT00442013|6300021|P1|COMPLETED|Overall Study||131
2569099|NCT00442013|6300020|P2|STARTED|Overall Study||149
2569100|NCT00442013|6300021|P1|STARTED|Overall Study||157
2569101|NCT00441974|6300037|P1|NOT COMPLETED|Overall Study||128
2569102|NCT00441974|6300037|P1|COMPLETED|Overall Study||1342
2569103|NCT00441974|6300037|P1|STARTED|Overall Study||1470
2569104|NCT00441792|6300053|P2|NOT COMPLETED|Overall Study||2
2569105|NCT00441792|6300054|P1|NOT COMPLETED|Overall Study||0
2569106|NCT00441792|6300053|P2|COMPLETED|Overall Study|2 patients lost to follow up in Etomidate arm due to transfer to outside hospital.|61
2569107|NCT00441792|6300054|P1|COMPLETED|Overall Study||59
2569108|NCT00441792|6300053|P2|STARTED|Overall Study||63
2569109|NCT00441792|6300054|P1|STARTED|Overall Study||59
2569110|NCT00441766|6300066|P4|NOT COMPLETED|Overall Study||6
2569111|NCT00441766|6300067|P3|NOT COMPLETED|Overall Study||9
2569112|NCT00441766|6300068|P2|NOT COMPLETED|Overall Study||7
2569113|NCT00441766|6300069|P1|NOT COMPLETED|Overall Study||14
2569114|NCT00441766|6300066|P4|COMPLETED|Overall Study||48
2569115|NCT00441766|6300067|P3|COMPLETED|Overall Study||44
2569116|NCT00441766|6300068|P2|COMPLETED|Overall Study||46
2569117|NCT00441766|6300069|P1|COMPLETED|Overall Study||39
2569118|NCT00441766|6300066|P4|STARTED|Overall Study||54
2569119|NCT00441766|6300067|P3|STARTED|Overall Study||53
2569120|NCT00441766|6300068|P2|STARTED|Overall Study||53
2569121|NCT00441766|6300069|P1|STARTED|Overall Study||53
2569122|NCT00441727|6300094|P3|NOT COMPLETED|Overall Study||168
2569123|NCT00441727|6300095|P2|NOT COMPLETED|Overall Study||118
2569124|NCT00441727|6300096|P1|NOT COMPLETED|Overall Study||106
2569125|NCT00441727|6300094|P3|COMPLETED|Overall Study|ITT/randomised|637
2569126|NCT00441727|6300095|P2|COMPLETED|Overall Study|ITT/randomised|686
2569127|NCT00441727|6300096|P1|COMPLETED|Overall Study|ITT/randomised|711
2569128|NCT00441727|6300094|P3|STARTED|Overall Study|ITT/randomised|805
2569129|NCT00441727|6300095|P2|STARTED|Overall Study|ITT/randomised|804
2569130|NCT00441727|6300096|P1|STARTED|Overall Study|ITT/randomised|817
2569131|NCT00441701|6300129|P10|NOT COMPLETED|Overall Study||0
2569132|NCT00441701|6300130|P9|NOT COMPLETED|Overall Study||0
2569133|NCT00441701|6300131|P8|NOT COMPLETED|Overall Study||0
2569134|NCT00441701|6300132|P7|NOT COMPLETED|Overall Study||0
2569135|NCT00441701|6300133|P6|NOT COMPLETED|Overall Study||3
2569136|NCT00441701|6300134|P5|NOT COMPLETED|Overall Study||2
2569137|NCT00441701|6300135|P4|NOT COMPLETED|Overall Study||3
2569138|NCT00441701|6300136|P3|NOT COMPLETED|Overall Study||4
2569139|NCT00441701|6300137|P2|NOT COMPLETED|Overall Study||4
2569140|NCT00441701|6300138|P1|NOT COMPLETED|Overall Study||5
2569141|NCT00441701|6300129|P10|COMPLETED|Overall Study||0
2569142|NCT00441701|6300130|P9|COMPLETED|Overall Study||0
2569143|NCT00441701|6300131|P8|COMPLETED|Overall Study||0
2569144|NCT00441701|6300132|P7|COMPLETED|Overall Study||0
2569145|NCT00441701|6300133|P6|COMPLETED|Overall Study||8
2569146|NCT00441701|6300134|P5|COMPLETED|Overall Study||20
2569147|NCT00441701|6300135|P4|COMPLETED|Overall Study||8
2569148|NCT00441701|6300136|P3|COMPLETED|Overall Study||18
2569149|NCT00441701|6300137|P2|COMPLETED|Overall Study||7
2569150|NCT00441701|6300138|P1|COMPLETED|Overall Study||17
2569151|NCT00441701|6300129|P10|STARTED|Overall Study||0
2569152|NCT00441701|6300130|P9|STARTED|Overall Study||0
2569153|NCT00441701|6300131|P8|STARTED|Overall Study||0
2569154|NCT00441701|6300132|P7|STARTED|Overall Study||0
2569155|NCT00441701|6300133|P6|STARTED|Overall Study||11
2569156|NCT00441701|6300134|P5|STARTED|Overall Study||22
2569157|NCT00441701|6300135|P4|STARTED|Overall Study||11
2569158|NCT00441701|6300136|P3|STARTED|Overall Study||22
2569159|NCT00441701|6300137|P2|STARTED|Overall Study||11
2569160|NCT00441701|6300138|P1|STARTED|Overall Study||22
2569161|NCT00441584|6300220|P1|NOT COMPLETED|Overall Study||105
2569162|NCT00441584|6300220|P1|COMPLETED|Overall Study||12
2569163|NCT00441584|6300220|P1|STARTED|Overall Study||117
2569164|NCT00441558|6300224|P1|NOT COMPLETED|Overall Study||1056
2569165|NCT00441558|6300224|P1|COMPLETED|Overall Study||667
2569166|NCT00441558|6300224|P1|STARTED|Overall Study||1723
2569167|NCT00441545|6300228|P2|NOT COMPLETED|Second Intervention||7
2569168|NCT00441545|6300229|P1|NOT COMPLETED|Second Intervention||12
2569169|NCT00441545|6300228|P2|COMPLETED|Second Intervention||68
2569170|NCT00441545|6300229|P1|COMPLETED|Second Intervention||65
2569171|NCT00441545|6300228|P2|STARTED|Second Intervention||75
2569172|NCT00441545|6300229|P1|STARTED|Second Intervention||77
2569173|NCT00441545|6300228|P2|NOT COMPLETED|Washout||0
2569174|NCT00441545|6300229|P1|NOT COMPLETED|Washout||0
2569175|NCT00441545|6300228|P2|COMPLETED|Washout||75
2569176|NCT00441545|6300229|P1|COMPLETED|Washout||77
2569177|NCT00441545|6300228|P2|STARTED|Washout||75
2569178|NCT00441545|6300229|P1|STARTED|Washout||77
2569179|NCT00441545|6300228|P2|NOT COMPLETED|First Intervention||12
2569180|NCT00441545|6300229|P1|NOT COMPLETED|First Intervention||18
2569181|NCT00441545|6300228|P2|COMPLETED|First Intervention||75
2569182|NCT00441545|6300229|P1|COMPLETED|First Intervention||77
2569183|NCT00441545|6300228|P2|STARTED|First Intervention||87
2569184|NCT00441545|6300229|P1|STARTED|First Intervention||95
2569185|NCT00441480|6300243|P2|NOT COMPLETED|Overall Study||4
2569186|NCT00441480|6300244|P1|NOT COMPLETED|Overall Study||3
2569187|NCT00441480|6300243|P2|COMPLETED|Overall Study||41
2569188|NCT00441480|6300244|P1|COMPLETED|Overall Study||43
2569189|NCT00441480|6300243|P2|STARTED|Overall Study||45
2569190|NCT00441480|6300244|P1|STARTED|Overall Study||46
2569191|NCT00441467|6300276|P1|NOT COMPLETED|Overall Study||18
2569192|NCT00441467|6300276|P1|COMPLETED|Overall Study||4
2569193|NCT00441467|6300276|P1|4 Cycles|Overall Study||7
2569194|NCT00441467|6300276|P1|2 Cycles|Overall Study||17
2569195|NCT00441467|6300276|P1|STARTED|Overall Study||22
2569196|NCT00441441|6300284|P2|NOT COMPLETED|Overall Study||14
2569197|NCT00441441|6300285|P1|NOT COMPLETED|Overall Study||11
2569198|NCT00441441|6300284|P2|COMPLETED|Overall Study||163
2569199|NCT00441441|6300285|P1|COMPLETED|Overall Study||162
2569200|NCT00441441|6300284|P2|STARTED|Overall Study||177
2569201|NCT00441441|6300285|P1|STARTED|Overall Study||173
2569202|NCT00441363|6300345|P2|NOT COMPLETED|Overall Study||15
2569203|NCT00441363|6300346|P1|NOT COMPLETED|Overall Study||17
2569204|NCT00441363|6300345|P2|COMPLETED|Overall Study||19
2569205|NCT00441363|6300346|P1|COMPLETED|Overall Study|no subject withdrew early since the trial was terminated|15
2569206|NCT00441363|6300345|P2|STARTED|Overall Study||34
2569207|NCT00441363|6300346|P1|STARTED|Overall Study||32
2569208|NCT00441337|6300358|P4|NOT COMPLETED|Overall Study||21
2569209|NCT00441337|6300359|P3|NOT COMPLETED|Overall Study||6
2569210|NCT00441337|6300360|P2|NOT COMPLETED|Overall Study||6
2569211|NCT00441337|6300361|P1|NOT COMPLETED|Overall Study||6
2569212|NCT00441337|6300358|P4|COMPLETED|Overall Study||0
2569213|NCT00441337|6300359|P3|COMPLETED|Overall Study||0
2569214|NCT00441337|6300360|P2|COMPLETED|Overall Study||0
2569215|NCT00441337|6300361|P1|COMPLETED|Overall Study||0
2569216|NCT00441337|6300358|P4|STARTED|Overall Study||21
2569217|NCT00441337|6300359|P3|STARTED|Overall Study||6
2569218|NCT00441337|6300360|P2|STARTED|Overall Study||6
2569219|NCT00441337|6300361|P1|STARTED|Overall Study||6
2569220|NCT00441285|6300444|P5|NOT COMPLETED|Overall Study||0
2569221|NCT00441285|6300445|P4|NOT COMPLETED|Overall Study||0
2569222|NCT00441285|6300446|P3|NOT COMPLETED|Overall Study||0
2569223|NCT00441285|6300447|P2|NOT COMPLETED|Overall Study||0
2569224|NCT00441285|6300448|P1|NOT COMPLETED|Overall Study||0
2569225|NCT00441285|6300444|P5|COMPLETED|Overall Study||43
2569226|NCT00441285|6300445|P4|COMPLETED|Overall Study||40
2569227|NCT00441285|6300446|P3|COMPLETED|Overall Study||41
2569228|NCT00441285|6300447|P2|COMPLETED|Overall Study||16
2569229|NCT00441285|6300448|P1|COMPLETED|Overall Study||16
2569230|NCT00441285|6300444|P5|STARTED|Overall Study||43
2569231|NCT00441285|6300445|P4|STARTED|Overall Study||40
2569232|NCT00441285|6300446|P3|STARTED|Overall Study||41
2569233|NCT00441285|6300447|P2|STARTED|Overall Study||16
2569234|NCT00441285|6300448|P1|STARTED|Overall Study||16
2569235|NCT00441272|6300474|P2|NOT COMPLETED|Overall Study||25
2569236|NCT00441272|6300475|P1|NOT COMPLETED|Overall Study||25
2569237|NCT00441272|6300474|P2|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
2569238|NCT00441272|6300475|P1|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
2569239|NCT00441272|6300474|P2|STARTED|Overall Study||25
2569240|NCT00441272|6300475|P1|STARTED|Overall Study||25
2569241|NCT00441259|6300483|P2|NOT COMPLETED|Overall Study||0
2569242|NCT00441259|6300484|P1|NOT COMPLETED|Overall Study||0
2569243|NCT00441259|6300483|P2|COMPLETED|Overall Study||48
2569244|NCT00441259|6300484|P1|COMPLETED|Overall Study||48
2569245|NCT00441259|6300483|P2|STARTED|Overall Study||48
2569246|NCT00441259|6300484|P1|STARTED|Overall Study||48
2569247|NCT00441168|6300502|P2|NOT COMPLETED|Follow-up Period||9
2569248|NCT00441168|6300503|P1|NOT COMPLETED|Follow-up Period||12
2569249|NCT00441168|6300502|P2|COMPLETED|Follow-up Period||4
2569250|NCT00441168|6300503|P1|COMPLETED|Follow-up Period||5
2569251|NCT00441168|6300502|P2|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|13
2569252|NCT00441168|6300503|P1|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|17
2569253|NCT00441168|6300502|P2|NOT COMPLETED|Treatment Period||6
2569254|NCT00441168|6300503|P1|NOT COMPLETED|Treatment Period||11
2569255|NCT00441168|6300502|P2|COMPLETED|Treatment Period||7
2569256|NCT00441168|6300503|P1|COMPLETED|Treatment Period||6
2569257|NCT00441168|6300502|P2|TREATED|Treatment Period||13
2569258|NCT00441168|6300503|P1|TREATED|Treatment Period||16
2569259|NCT00441168|6300502|P2|STARTED|Treatment Period||13
2569260|NCT00441168|6300503|P1|STARTED|Treatment Period||17
2569261|NCT00441142|6300517|P4|NOT COMPLETED|Overall Study||68
2569262|NCT00441142|6300518|P3|NOT COMPLETED|Overall Study||22
2569263|NCT00441142|6300519|P2|NOT COMPLETED|Overall Study||7
2569264|NCT00441142|6300520|P1|NOT COMPLETED|Overall Study||6
2569265|NCT00441142|6300517|P4|COMPLETED|Overall Study||1
2569266|NCT00441142|6300518|P3|COMPLETED|Overall Study||7
2569267|NCT00441142|6300519|P2|COMPLETED|Overall Study||0
2569268|NCT00441142|6300520|P1|COMPLETED|Overall Study||0
2569269|NCT00441142|6300517|P4|STARTED|Overall Study||69
2569270|NCT00441142|6300518|P3|STARTED|Overall Study||29
2569271|NCT00441142|6300519|P2|STARTED|Overall Study||7
2569272|NCT00441142|6300520|P1|STARTED|Overall Study||6
2569273|NCT00441129|6300542|P2|NOT COMPLETED|Overall Study||14
2569274|NCT00441129|6300543|P1|NOT COMPLETED|Overall Study||6
2569275|NCT00441129|6300542|P2|COMPLETED|Overall Study||41
2569276|NCT00441129|6300543|P1|COMPLETED|Overall Study||54
2569277|NCT00441129|6300542|P2|STARTED|Overall Study||55
2569278|NCT00441129|6300543|P1|STARTED|Overall Study||60
2569279|NCT00441116|6300555|P2|NOT COMPLETED|Overall Study||2
2569280|NCT00441116|6300556|P1|NOT COMPLETED|Overall Study||3
2569281|NCT00441116|6300555|P2|COMPLETED|Overall Study||75
2569282|NCT00441116|6300556|P1|COMPLETED|Overall Study||73
2569283|NCT00441116|6300555|P2|STARTED|Overall Study||77
2569284|NCT00441116|6300556|P1|STARTED|Overall Study||76
2569285|NCT00441103|6300624|P2|NOT COMPLETED|Overall Study||4
2569286|NCT00441103|6300625|P1|NOT COMPLETED|Overall Study||11
2569287|NCT00441103|6300624|P2|COMPLETED|Overall Study||56
2569288|NCT00441103|6300625|P1|COMPLETED|Overall Study||109
2569289|NCT00441103|6300624|P2|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|60
2569290|NCT00441103|6300625|P1|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|120
2569291|NCT00441090|6300641|P5|NOT COMPLETED|Overall Study||0
2569292|NCT00441090|6300642|P4|NOT COMPLETED|Overall Study||2
2569293|NCT00441090|6300643|P3|NOT COMPLETED|Overall Study||2
2569294|NCT00441090|6300644|P2|NOT COMPLETED|Overall Study||1
2569295|NCT00441090|6300645|P1|NOT COMPLETED|Overall Study||2
2569296|NCT00441090|6300641|P5|COMPLETED|Overall Study||5
2569297|NCT00441090|6300642|P4|COMPLETED|Overall Study||13
2569298|NCT00441090|6300643|P3|COMPLETED|Overall Study||12
2569299|NCT00441090|6300644|P2|COMPLETED|Overall Study||14
2569300|NCT00441090|6300645|P1|COMPLETED|Overall Study||13
2569301|NCT00441090|6300641|P5|STARTED|Overall Study||5
2569302|NCT00441090|6300642|P4|STARTED|Overall Study||15
2569303|NCT00441090|6300643|P3|STARTED|Overall Study||14
2569304|NCT00441090|6300644|P2|STARTED|Overall Study||15
2569305|NCT00441090|6300645|P1|STARTED|Overall Study||15
2569306|NCT00441064|6300689|P2|NOT COMPLETED|Overall Study||7
2569307|NCT00441064|6300690|P1|NOT COMPLETED|Overall Study||10
2569308|NCT00441064|6300689|P2|COMPLETED|Overall Study||56
2569309|NCT00441064|6300690|P1|COMPLETED|Overall Study||59
2569310|NCT00441064|6300689|P2|Intent-to-treat (ITT) Population|Overall Study||57
2569311|NCT00441064|6300690|P1|Intent-to-treat (ITT) Population|Overall Study||61
2569312|NCT00441064|6300689|P2|Safety Population (SP)|Overall Study||63
2569313|NCT00441064|6300690|P1|Safety Population (SP)|Overall Study||69
2569314|NCT00441064|6300689|P2|STARTED|Overall Study||63
2569315|NCT00441064|6300690|P1|STARTED|Overall Study||69
2569316|NCT00441012|6300702|P2|NOT COMPLETED|Overall Study||13
2569317|NCT00441012|6300703|P1|NOT COMPLETED|Overall Study||18
2569318|NCT00441012|6300702|P2|COMPLETED|Overall Study||263
2569319|NCT00441012|6300703|P1|COMPLETED|Overall Study||252
2569320|NCT00441012|6300702|P2|Vaccination Visit 3|Overall Study||269
2569321|NCT00441012|6300703|P1|Vaccination Visit 3|Overall Study||265
2569322|NCT00441012|6300702|P2|Vaccination Visit 2|Overall Study||272
2569323|NCT00441012|6300703|P1|Vaccination Visit 2|Overall Study||267
2569411|NCT00440700|6300814|P1|STARTED|Overall Study||122
2569412|NCT00440557|6300837|P3|NOT COMPLETED|Overall Study||35
2569324|NCT00441012|6300702|P2|Vaccination Visit 1|Overall Study|3 participants were vaccinated but were never randomized in the COMVAX™ group|276
2569325|NCT00441012|6300703|P1|Vaccination Visit 1|Overall Study|1 participant was randomized but not vaccinated in the Modified Process Vaccine group|269
2569326|NCT00441012|6300702|P2|STARTED|Overall Study||276
2569327|NCT00441012|6300703|P1|STARTED|Overall Study||270
2569328|NCT00440947|6300717|P5|NOT COMPLETED|Optional 60-Week Extension Phase||26
2569329|NCT00440947|6300718|P4|NOT COMPLETED|Optional 60-Week Extension Phase||29
2569330|NCT00440947|6300719|P3|NOT COMPLETED|Optional 60-Week Extension Phase||0
2569331|NCT00440947|6300720|P2|NOT COMPLETED|Optional 60-Week Extension Phase||0
2569332|NCT00440947|6300721|P1|NOT COMPLETED|Optional 60-Week Extension Phase||0
2569333|NCT00440947|6300717|P5|COMPLETED|Optional 60-Week Extension Phase||154
2569334|NCT00440947|6300718|P4|COMPLETED|Optional 60-Week Extension Phase||160
2569335|NCT00440947|6300719|P3|COMPLETED|Optional 60-Week Extension Phase||0
2569336|NCT00440947|6300720|P2|COMPLETED|Optional 60-Week Extension Phase||0
2569337|NCT00440947|6300721|P1|COMPLETED|Optional 60-Week Extension Phase||0
2569338|NCT00440947|6300717|P5|STARTED|Optional 60-Week Extension Phase||180
2569339|NCT00440947|6300718|P4|STARTED|Optional 60-Week Extension Phase||189
2569340|NCT00440947|6300719|P3|STARTED|Optional 60-Week Extension Phase||0
2569341|NCT00440947|6300720|P2|STARTED|Optional 60-Week Extension Phase||0
2569342|NCT00440947|6300721|P1|STARTED|Optional 60-Week Extension Phase||0
2569343|NCT00440947|6300717|P5|NOT COMPLETED|48-Week Randomization Phase||0
2569344|NCT00440947|6300718|P4|NOT COMPLETED|48-Week Randomization Phase||0
2569345|NCT00440947|6300719|P3|NOT COMPLETED|48-Week Randomization Phase||24
2569346|NCT00440947|6300720|P2|NOT COMPLETED|48-Week Randomization Phase||16
2569347|NCT00440947|6300721|P1|NOT COMPLETED|48-Week Randomization Phase||0
2569348|NCT00440947|6300717|P5|COMPLETED|48-Week Randomization Phase||0
2569349|NCT00440947|6300718|P4|COMPLETED|48-Week Randomization Phase||0
2569350|NCT00440947|6300719|P3|COMPLETED|48-Week Randomization Phase||185
2569351|NCT00440947|6300720|P2|COMPLETED|48-Week Randomization Phase||194
2569352|NCT00440947|6300721|P1|COMPLETED|48-Week Randomization Phase||0
2569353|NCT00440947|6300717|P5|STARTED|48-Week Randomization Phase||0
2569354|NCT00440947|6300718|P4|STARTED|48-Week Randomization Phase||0
2569355|NCT00440947|6300719|P3|STARTED|48-Week Randomization Phase||209
2569356|NCT00440947|6300720|P2|STARTED|48-Week Randomization Phase||210
2569357|NCT00440947|6300721|P1|STARTED|48-Week Randomization Phase||0
2569358|NCT00440947|6300717|P5|NOT COMPLETED|36-Week Induction Phase||0
2569359|NCT00440947|6300718|P4|NOT COMPLETED|36-Week Induction Phase||0
2569360|NCT00440947|6300719|P3|NOT COMPLETED|36-Week Induction Phase||0
2569361|NCT00440947|6300720|P2|NOT COMPLETED|36-Week Induction Phase||0
2569362|NCT00440947|6300721|P1|NOT COMPLETED|36-Week Induction Phase||73
2569363|NCT00440947|6300717|P5|COMPLETED|36-Week Induction Phase||0
2569364|NCT00440947|6300718|P4|COMPLETED|36-Week Induction Phase||0
2569365|NCT00440947|6300719|P3|COMPLETED|36-Week Induction Phase||0
2569366|NCT00440947|6300720|P2|COMPLETED|36-Week Induction Phase||0
2569367|NCT00440947|6300721|P1|COMPLETED|36-Week Induction Phase|23 PAR without confirmed HIV-RNA<50c/mL prior to Wk 36 couldn’t be randomized but weren’t withdrawn.|442
2569368|NCT00440947|6300717|P5|STARTED|36-Week Induction Phase||0
2569369|NCT00440947|6300718|P4|STARTED|36-Week Induction Phase||0
2569370|NCT00440947|6300719|P3|STARTED|36-Week Induction Phase||0
2569371|NCT00440947|6300720|P2|STARTED|36-Week Induction Phase||0
2569372|NCT00440947|6300721|P1|STARTED|36-Week Induction Phase||515
2569373|NCT00440830|6300776|P4|NOT COMPLETED|Overall Study||0
2569374|NCT00440830|6300777|P3|NOT COMPLETED|Overall Study||0
2569375|NCT00440830|6300778|P2|NOT COMPLETED|Overall Study||0
2569376|NCT00440830|6300779|P1|NOT COMPLETED|Overall Study||0
2569377|NCT00440830|6300776|P4|COMPLETED|Overall Study||10
2569378|NCT00440830|6300777|P3|COMPLETED|Overall Study||30
2569379|NCT00440830|6300778|P2|COMPLETED|Overall Study||8
2569380|NCT00440830|6300779|P1|COMPLETED|Overall Study||20
2569381|NCT00440830|6300776|P4|STARTED|Overall Study||10
2569382|NCT00440830|6300777|P3|STARTED|Overall Study||30
2569383|NCT00440830|6300778|P2|STARTED|Overall Study||8
2569384|NCT00440830|6300779|P1|STARTED|Overall Study||20
2569403|NCT00440700|6300812|P3|NOT COMPLETED|Overall Study||4
2569404|NCT00440700|6300813|P2|NOT COMPLETED|Overall Study||8
2569405|NCT00440700|6300814|P1|NOT COMPLETED|Overall Study||8
2569406|NCT00440700|6300812|P3|COMPLETED|Overall Study||120
2569407|NCT00440700|6300813|P2|COMPLETED|Overall Study||110
2569408|NCT00440700|6300814|P1|COMPLETED|Overall Study||114
2569409|NCT00440700|6300812|P3|STARTED|Overall Study||124
2569410|NCT00440700|6300813|P2|STARTED|Overall Study||118
2569413|NCT00440557|6300838|P2|NOT COMPLETED|Overall Study||29
2569414|NCT00440557|6300839|P1|NOT COMPLETED|Overall Study||25
2569415|NCT00440557|6300837|P3|COMPLETED|Overall Study||90
2569416|NCT00440557|6300838|P2|COMPLETED|Overall Study||96
2569417|NCT00440557|6300839|P1|COMPLETED|Overall Study||98
2569418|NCT00440557|6300837|P3|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
2569419|NCT00440557|6300838|P2|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
2569420|NCT00440557|6300839|P1|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|123
2569421|NCT00440531|6300871|P3|NOT COMPLETED|Overall Study||7
2569422|NCT00440531|6300872|P2|NOT COMPLETED|Overall Study||5
2569423|NCT00440531|6300873|P1|NOT COMPLETED|Overall Study||10
2569424|NCT00440531|6300871|P3|COMPLETED|Overall Study||165
2569425|NCT00440531|6300872|P2|COMPLETED|Overall Study||178
2569426|NCT00440531|6300873|P1|COMPLETED|Overall Study||175
2569427|NCT00440531|6300871|P3|Vaccination 3|Overall Study||166
2569428|NCT00440531|6300872|P2|Vaccination 3|Overall Study||178
2569429|NCT00440531|6300873|P1|Vaccination 3|Overall Study||176
2569430|NCT00440531|6300871|P3|Vaccination 2|Overall Study||171
2569431|NCT00440531|6300872|P2|Vaccination 2|Overall Study||182
2569432|NCT00440531|6300873|P1|Vaccination 2|Overall Study||181
2569433|NCT00440531|6300871|P3|Vaccination 1|Overall Study||172
2569434|NCT00440531|6300872|P2|Vaccination 1|Overall Study||183
2569435|NCT00440531|6300873|P1|Vaccination 1|Overall Study||183
2569436|NCT00440531|6300871|P3|STARTED|Overall Study||172
2569437|NCT00440531|6300872|P2|STARTED|Overall Study||183
2569438|NCT00440531|6300873|P1|STARTED|Overall Study||185
2569439|NCT00440518|6300890|P3|NOT COMPLETED|Maintenance and Safety Follow-up Periods||15
2569440|NCT00440518|6300891|P2|NOT COMPLETED|Maintenance and Safety Follow-up Periods||12
2569441|NCT00440518|6300892|P1|NOT COMPLETED|Maintenance and Safety Follow-up Periods||7
2569442|NCT00440518|6300890|P3|COMPLETED|Maintenance and Safety Follow-up Periods||55
2569443|NCT00440518|6300891|P2|COMPLETED|Maintenance and Safety Follow-up Periods||51
2569444|NCT00440518|6300892|P1|COMPLETED|Maintenance and Safety Follow-up Periods||52
2569445|NCT00440518|6300890|P3|STARTED|Maintenance and Safety Follow-up Periods||70
2569446|NCT00440518|6300891|P2|STARTED|Maintenance and Safety Follow-up Periods||63
2569447|NCT00440518|6300892|P1|STARTED|Maintenance and Safety Follow-up Periods||59
2569448|NCT00440518|6300890|P3|NOT COMPLETED|Randomized /Titration Period||4
2569449|NCT00440518|6300891|P2|NOT COMPLETED|Randomized /Titration Period||9
2569450|NCT00440518|6300892|P1|NOT COMPLETED|Randomized /Titration Period||13
2569451|NCT00440518|6300890|P3|COMPLETED|Randomized /Titration Period||70
2569452|NCT00440518|6300891|P2|COMPLETED|Randomized /Titration Period||63
2569453|NCT00440518|6300892|P1|COMPLETED|Randomized /Titration Period||59
2569454|NCT00440518|6300890|P3|STARTED|Randomized /Titration Period||74
2569455|NCT00440518|6300891|P2|STARTED|Randomized /Titration Period||72
2569456|NCT00440518|6300892|P1|STARTED|Randomized /Titration Period||72
2569457|NCT00440505|6300912|P6|NOT COMPLETED|Third Intervention||0
2569458|NCT00440505|6300913|P5|NOT COMPLETED|Third Intervention||0
2569459|NCT00440505|6300914|P4|NOT COMPLETED|Third Intervention||1
2569460|NCT00440505|6300915|P3|NOT COMPLETED|Third Intervention||0
2569461|NCT00440505|6300916|P2|NOT COMPLETED|Third Intervention||0
2569462|NCT00440505|6300917|P1|NOT COMPLETED|Third Intervention||0
2569463|NCT00440505|6300912|P6|COMPLETED|Third Intervention||5
2569464|NCT00440505|6300913|P5|COMPLETED|Third Intervention||5
2569465|NCT00440505|6300914|P4|COMPLETED|Third Intervention||1
2569466|NCT00440505|6300915|P3|COMPLETED|Third Intervention||1
2569467|NCT00440505|6300916|P2|COMPLETED|Third Intervention||2
2569468|NCT00440505|6300917|P1|COMPLETED|Third Intervention||5
2569469|NCT00440505|6300912|P6|STARTED|Third Intervention||5
2569470|NCT00440505|6300913|P5|STARTED|Third Intervention||5
2569471|NCT00440505|6300914|P4|STARTED|Third Intervention||2
2569472|NCT00440505|6300915|P3|STARTED|Third Intervention||1
2569473|NCT00440505|6300916|P2|STARTED|Third Intervention||2
2569474|NCT00440505|6300917|P1|STARTED|Third Intervention||5
2569475|NCT00440505|6300912|P6|NOT COMPLETED|Second Intervention||0
2569476|NCT00440505|6300913|P5|NOT COMPLETED|Second Intervention||0
2569477|NCT00440505|6300914|P4|NOT COMPLETED|Second Intervention||0
2569478|NCT00440505|6300915|P3|NOT COMPLETED|Second Intervention||0
2569479|NCT00440505|6300916|P2|NOT COMPLETED|Second Intervention||0
2569480|NCT00440505|6300917|P1|NOT COMPLETED|Second Intervention||0
2569481|NCT00440505|6300912|P6|COMPLETED|Second Intervention||5
2569482|NCT00440505|6300913|P5|COMPLETED|Second Intervention||5
2569483|NCT00440505|6300914|P4|COMPLETED|Second Intervention||2
2569484|NCT00440505|6300915|P3|COMPLETED|Second Intervention||1
2569485|NCT00440505|6300916|P2|COMPLETED|Second Intervention||2
2569486|NCT00440505|6300917|P1|COMPLETED|Second Intervention||5
2569487|NCT00440505|6300912|P6|STARTED|Second Intervention||5
2569488|NCT00440505|6300913|P5|STARTED|Second Intervention||5
2569489|NCT00440505|6300914|P4|STARTED|Second Intervention||2
2569490|NCT00440505|6300915|P3|STARTED|Second Intervention||1
2569491|NCT00440505|6300916|P2|STARTED|Second Intervention||2
2569492|NCT00440505|6300917|P1|STARTED|Second Intervention||5
2569493|NCT00440505|6300912|P6|NOT COMPLETED|First Intervention||0
2569494|NCT00440505|6300913|P5|NOT COMPLETED|First Intervention||0
2569495|NCT00440505|6300914|P4|NOT COMPLETED|First Intervention||0
2569496|NCT00440505|6300915|P3|NOT COMPLETED|First Intervention||0
2569497|NCT00440505|6300916|P2|NOT COMPLETED|First Intervention||0
2569498|NCT00440505|6300917|P1|NOT COMPLETED|First Intervention||0
2569499|NCT00440505|6300912|P6|COMPLETED|First Intervention||5
2569500|NCT00440505|6300913|P5|COMPLETED|First Intervention||5
2569501|NCT00440505|6300914|P4|COMPLETED|First Intervention||2
2569502|NCT00440505|6300915|P3|COMPLETED|First Intervention||1
2569503|NCT00440505|6300916|P2|COMPLETED|First Intervention||2
2569504|NCT00440505|6300917|P1|COMPLETED|First Intervention||5
2569505|NCT00440505|6300912|P6|STARTED|First Intervention||5
2569506|NCT00440505|6300913|P5|STARTED|First Intervention||5
2569507|NCT00440505|6300914|P4|STARTED|First Intervention||2
2569508|NCT00440505|6300915|P3|STARTED|First Intervention||1
2569509|NCT00440505|6300916|P2|STARTED|First Intervention||2
2569510|NCT00440505|6300917|P1|STARTED|First Intervention||5
2569511|NCT00440466|6300937|P3|NOT COMPLETED|Overall Study||41
2569512|NCT00440466|6300938|P2|NOT COMPLETED|Overall Study||15
2569513|NCT00440466|6300939|P1|NOT COMPLETED|Overall Study||13
2569514|NCT00440466|6300937|P3|COMPLETED|Overall Study||174
2569515|NCT00440466|6300938|P2|COMPLETED|Overall Study||92
2569516|NCT00440466|6300939|P1|COMPLETED|Overall Study||95
2569517|NCT00440466|6300937|P3|STARTED|Overall Study||215
2569518|NCT00440466|6300938|P2|STARTED|Overall Study||107
2569519|NCT00440466|6300939|P1|STARTED|Overall Study||108
2569520|NCT00440401|6300973|P2|NOT COMPLETED|Overall Study||6
2569521|NCT00440401|6300974|P1|NOT COMPLETED|Overall Study||4
2569522|NCT00440401|6300973|P2|COMPLETED|Overall Study||54
2569523|NCT00440401|6300974|P1|COMPLETED|Overall Study||55
2569524|NCT00440401|6300973|P2|STARTED|Overall Study||60
2569525|NCT00440401|6300974|P1|STARTED|Overall Study||59
2569526|NCT00440310|6300984|P2|NOT COMPLETED|Overall Study||30
2569527|NCT00440310|6300985|P1|NOT COMPLETED|Overall Study||28
2569528|NCT00440310|6300984|P2|COMPLETED|Overall Study||209
2569529|NCT00440310|6300985|P1|COMPLETED|Overall Study||216
2569530|NCT00440310|6300984|P2|Treated|Overall Study||232
2569531|NCT00440310|6300985|P1|Treated|Overall Study||222
2569532|NCT00440310|6300984|P2|STARTED|Overall Study||239
2569533|NCT00440310|6300985|P1|STARTED|Overall Study||244
2569534|NCT00440297|6300993|P2|NOT COMPLETED|Overall Study||18
2569535|NCT00440297|6300994|P1|NOT COMPLETED|Overall Study||23
2569536|NCT00440297|6300993|P2|COMPLETED|Overall Study||120
2569537|NCT00440297|6300994|P1|COMPLETED|Overall Study||116
2569538|NCT00440297|6300993|P2|Vaccination Visit 4|Overall Study||122
2569539|NCT00440297|6300994|P1|Vaccination Visit 4|Overall Study||116
2569540|NCT00440297|6300993|P2|Vaccination Visit 3|Overall Study||125
2569541|NCT00440297|6300994|P1|Vaccination Visit 3|Overall Study||124
2569542|NCT00440297|6300993|P2|Vaccination Visit 2|Overall Study||134
2569543|NCT00440297|6300994|P1|Vaccination Visit 2|Overall Study||136
2569544|NCT00440297|6300993|P2|Vaccination Visit 1|Overall Study||138
2569545|NCT00440297|6300994|P1|Vaccination Visit 1|Overall Study||138
2569546|NCT00440297|6300993|P2|STARTED|Overall Study||138
2569547|NCT00440297|6300994|P1|STARTED|Overall Study||139
2569548|NCT00440271|6301010|P2|NOT COMPLETED|Overall Study||15
2569549|NCT00440271|6301011|P1|NOT COMPLETED|Overall Study||12
2569550|NCT00440271|6301010|P2|COMPLETED|Overall Study||3
2569551|NCT00440271|6301011|P1|COMPLETED|Overall Study||3
2569552|NCT00440271|6301010|P2|STARTED|Overall Study||18
2569553|NCT00440271|6301011|P1|STARTED|Overall Study||15
2569554|NCT00440232|6301045|P2|NOT COMPLETED|Overall Study||4
2569555|NCT00440232|6301046|P1|NOT COMPLETED|Overall Study||3
2569556|NCT00440232|6301045|P2|COMPLETED|Overall Study||34
2569557|NCT00440232|6301046|P1|COMPLETED|Overall Study||33
2569558|NCT00440232|6301045|P2|STARTED|Overall Study||38
2569559|NCT00440232|6301046|P1|STARTED|Overall Study||36
2569560|NCT00440193|6301056|P2|NOT COMPLETED|Observational Period||38
2569561|NCT00440193|6301057|P1|NOT COMPLETED|Observational Period||45
2569562|NCT00440193|6301056|P2|COMPLETED|Observational Period||1369
2569563|NCT00440193|6301057|P1|COMPLETED|Observational Period||1380
2569564|NCT00440193|6301056|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1407
2569565|NCT00440193|6301057|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1425
2569566|NCT00440193|6301056|P2|NOT COMPLETED|Treatment Period||351
2569567|NCT00440193|6301057|P1|NOT COMPLETED|Treatment Period||305
2569568|NCT00440193|6301056|P2|COMPLETED|Treatment Period||1367
2569569|NCT00440193|6301057|P1|COMPLETED|Treatment Period||1426
2569570|NCT00440193|6301056|P2|Participants Received Treatment|Treatment Period||1711
2569571|NCT00440193|6301057|P1|Participants Received Treatment|Treatment Period||1718
2569572|NCT00440193|6301056|P2|STARTED|Treatment Period||1718
2569573|NCT00440193|6301057|P1|STARTED|Treatment Period||1731
2569574|NCT00440180|6301093|P2|NOT COMPLETED|Overall Study||0
2569575|NCT00440180|6301094|P1|NOT COMPLETED|Overall Study||0
2569576|NCT00440180|6301093|P2|COMPLETED|Overall Study||10
2569577|NCT00440180|6301094|P1|COMPLETED|Overall Study||10
2569578|NCT00440180|6301093|P2|STARTED|Overall Study||10
2569579|NCT00440180|6301094|P1|STARTED|Overall Study||10
2569580|NCT00440115|6301103|P3|NOT COMPLETED|Overall Study||6
2569581|NCT00440115|6301104|P2|NOT COMPLETED|Overall Study||11
2569582|NCT00440115|6301105|P1|NOT COMPLETED|Overall Study||7
2569583|NCT00440115|6301103|P3|COMPLETED|Overall Study||244
2569584|NCT00440115|6301104|P2|COMPLETED|Overall Study||238
2569585|NCT00440115|6301105|P1|COMPLETED|Overall Study||244
2569586|NCT00440115|6301103|P3|STARTED|Overall Study||250
2569587|NCT00440115|6301104|P2|STARTED|Overall Study||249
2569588|NCT00440115|6301105|P1|STARTED|Overall Study||251
2569589|NCT00440050|6301121|P2|NOT COMPLETED|Overall Study||67
2569590|NCT00440050|6301122|P1|NOT COMPLETED|Overall Study||40
2569591|NCT00440050|6301121|P2|COMPLETED|Overall Study||171
2569592|NCT00440050|6301122|P1|COMPLETED|Overall Study||124
2569593|NCT00440050|6301121|P2|STARTED|Overall Study||238
2569594|NCT00440050|6301122|P1|STARTED|Overall Study||164
2569595|NCT00440037|6301134|P1|NOT COMPLETED|Overall Study||9
2569596|NCT00440037|6301134|P1|COMPLETED|Overall Study||35
2569597|NCT00440037|6301134|P1|STARTED|Overall Study||44
2569598|NCT00440011|6301144|P2|NOT COMPLETED|Overall Study||3
2569599|NCT00440011|6301145|P1|NOT COMPLETED|Overall Study||4
2569600|NCT00440011|6301144|P2|COMPLETED|Overall Study||132
2569601|NCT00440011|6301145|P1|COMPLETED|Overall Study||127
2569602|NCT00440011|6301144|P2|STARTED|Overall Study||135
2569603|NCT00440011|6301145|P1|STARTED|Overall Study||131
2569604|NCT00439946|6301153|P1|NOT COMPLETED|Overall Study||0
2569605|NCT00439946|6301153|P1|COMPLETED|Overall Study||8
2569606|NCT00439946|6301153|P1|STARTED|Overall Study||8
2569607|NCT00439777|6301172|P2|NOT COMPLETED|Observational Period||41
2569608|NCT00439777|6301173|P1|NOT COMPLETED|Observational Period||41
2569609|NCT00439777|6301172|P2|COMPLETED|Observational Period||2156
2569610|NCT00439777|6301173|P1|COMPLETED|Observational Period||2165
2569611|NCT00439777|6301172|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2197
2569612|NCT00439777|6301173|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2206
2569613|NCT00439777|6301172|P2|NOT COMPLETED|Treatment Period||459
2569614|NCT00439777|6301173|P1|NOT COMPLETED|Treatment Period||419
2569615|NCT00439777|6301172|P2|COMPLETED|Treatment Period||1954
2569616|NCT00439777|6301173|P1|COMPLETED|Treatment Period||2001
2569617|NCT00439777|6301172|P2|Participants Received Treatment|Treatment Period||2405
2569618|NCT00439777|6301173|P1|Participants Received Treatment|Treatment Period||2412
2569619|NCT00439777|6301172|P2|STARTED|Treatment Period||2413
2569620|NCT00439777|6301173|P1|STARTED|Treatment Period||2420
2569621|NCT00439738|6301211|P2|NOT COMPLETED|Overall Study||28
2569622|NCT00439738|6301212|P1|NOT COMPLETED|Overall Study||36
2569623|NCT00439738|6301211|P2|COMPLETED|Overall Study||178
2569624|NCT00439738|6301212|P1|COMPLETED|Overall Study||170
2569625|NCT00439738|6301211|P2|STARTED|Overall Study||206
2569626|NCT00439738|6301212|P1|STARTED|Overall Study||206
2569627|NCT00439725|6301230|P2|NOT COMPLETED|Observational Period||7
2569628|NCT00439725|6301231|P1|NOT COMPLETED|Observational Period||8
2569629|NCT00439725|6301230|P2|COMPLETED|Observational Period||553
2569630|NCT00439725|6301231|P1|COMPLETED|Observational Period||569
2569631|NCT00439725|6301230|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|560
2569632|NCT00439725|6301231|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|577
2569633|NCT00439725|6301230|P2|NOT COMPLETED|Treatment Period||246
2569634|NCT00439725|6301231|P1|NOT COMPLETED|Treatment Period||236
2569635|NCT00439725|6301230|P2|COMPLETED|Treatment Period||349
2569636|NCT00439725|6301231|P1|COMPLETED|Treatment Period||366
2569637|NCT00439725|6301230|P2|Participants Received Treatment|Treatment Period|Safety population|590
2569638|NCT00439725|6301231|P1|Participants Received Treatment|Treatment Period|Safety population|598
2569639|NCT00439725|6301230|P2|STARTED|Treatment Period||595
2569640|NCT00439725|6301231|P1|STARTED|Treatment Period||602
2569641|NCT00439673|6301275|P1|NOT COMPLETED|Overall Study||36
2569642|NCT00439673|6301275|P1|COMPLETED|Overall Study||26
2569643|NCT00439673|6301275|P1|STARTED|Overall Study||62
2569644|NCT00439647|6301282|P2|NOT COMPLETED|Overall Study||71
2569645|NCT00439647|6301283|P1|NOT COMPLETED|Overall Study||58
2569646|NCT00439647|6301282|P2|COMPLETED|Overall Study||540
2569647|NCT00439647|6301283|P1|COMPLETED|Overall Study||530
2569648|NCT00439647|6301282|P2|Modified Intent to Treat (mITT)|Overall Study||574
2569649|NCT00439647|6301283|P1|Modified Intent to Treat (mITT)|Overall Study||553
2569650|NCT00439647|6301282|P2|STARTED|Overall Study||611
2569651|NCT00439647|6301283|P1|STARTED|Overall Study|"Started indicates intent to treat (ITT) and safety set."|588
2569655|NCT00439569|6301320|P1|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||1
2569656|NCT00439569|6301320|P1|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
2569657|NCT00439569|6301320|P1|STARTED|Cohort 2 (500 mg/kg/Day)|2 new subjects in Cohort 2 were enrolled into the study after Cohort 1 completed the study.|2
2569658|NCT00439569|6301320|P1|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||4
2569659|NCT00439569|6301320|P1|COMPLETED|Cohort 1 (500 mg/kg/Day)||3
2569660|NCT00439569|6301320|P1|STARTED|Cohort 1 (500 mg/kg/Day)||7
2569661|NCT00439556|6301334|P3|NOT COMPLETED|Overall Study||0
2569662|NCT00439556|6301335|P2|NOT COMPLETED|Overall Study||1
2569663|NCT00439556|6301336|P1|NOT COMPLETED|Overall Study||0
2569664|NCT00439556|6301334|P3|COMPLETED|Overall Study||0
2569665|NCT00439556|6301335|P2|COMPLETED|Overall Study||3
2569666|NCT00439556|6301336|P1|COMPLETED|Overall Study||36
2569667|NCT00439556|6301334|P3|STARTED|Overall Study||0
2569668|NCT00439556|6301335|P2|STARTED|Overall Study||4
2569669|NCT00439556|6301336|P1|STARTED|Overall Study||36
2569670|NCT00439517|6301349|P2|NOT COMPLETED|Overall Study||0
2569671|NCT00439517|6301350|P1|NOT COMPLETED|Overall Study||2
2569672|NCT00439517|6301349|P2|COMPLETED|Overall Study||150
2569673|NCT00439517|6301350|P1|COMPLETED|Overall Study||150
2569674|NCT00439517|6301349|P2|STARTED|Overall Study||150
2569675|NCT00439517|6301350|P1|STARTED|Overall Study||152
2569676|NCT00439465|6301372|P1|NOT COMPLETED|Overall Study||4
2569677|NCT00439465|6301372|P1|COMPLETED|Overall Study||19
2569678|NCT00439465|6301372|P1|STARTED|Overall Study||23
2569679|NCT00439413|6301384|P2|NOT COMPLETED|Overall Study||37
2569680|NCT00439413|6301385|P1|NOT COMPLETED|Overall Study||31
2569681|NCT00439413|6301384|P2|COMPLETED|Overall Study||88
2569682|NCT00439413|6301385|P1|COMPLETED|Overall Study||90
2569683|NCT00439413|6301384|P2|STARTED|Overall Study||125
2569684|NCT00439413|6301385|P1|STARTED|Overall Study||121
2569685|NCT00439374|6301395|P2|NOT COMPLETED|Overall Study||0
2569686|NCT00439374|6301396|P1|NOT COMPLETED|Overall Study||0
2569687|NCT00439374|6301395|P2|COMPLETED|Overall Study||330
2569688|NCT00439374|6301396|P1|COMPLETED|Overall Study||327
2569689|NCT00439374|6301395|P2|STARTED|Overall Study||330
2569690|NCT00439374|6301396|P1|STARTED|Overall Study||327
2569691|NCT00439335|6301456|P2|NOT COMPLETED|Overall Study||0
2569692|NCT00439335|6301457|P1|NOT COMPLETED|Overall Study||2
2569693|NCT00439335|6301456|P2|COMPLETED|Overall Study||114
2569694|NCT00439335|6301457|P1|COMPLETED|Overall Study||111
2569695|NCT00439335|6301456|P2|STARTED|Overall Study||114
2569696|NCT00439335|6301457|P1|STARTED|Overall Study||113
2569697|NCT00439309|6301489|P2|NOT COMPLETED|Follow-Up||2
2569698|NCT00439309|6301490|P1|NOT COMPLETED|Follow-Up||3
2569699|NCT00439309|6301489|P2|COMPLETED|Follow-Up||13
2569700|NCT00439309|6301490|P1|COMPLETED|Follow-Up||51
2569701|NCT00439309|6301489|P2|STARTED|Follow-Up||15
2569702|NCT00439309|6301490|P1|STARTED|Follow-Up||54
2569703|NCT00439309|6301489|P2|NOT COMPLETED|Treatment||0
2569704|NCT00439309|6301490|P1|NOT COMPLETED|Treatment||0
2569705|NCT00439309|6301489|P2|COMPLETED|Treatment||15
2569706|NCT00439309|6301490|P1|COMPLETED|Treatment||54
2569707|NCT00439309|6301489|P2|STARTED|Treatment||15
2569708|NCT00439309|6301490|P1|STARTED|Treatment||54
2569709|NCT00439270|6301509|P5|NOT COMPLETED|Phase 2 (51.6 Months)||0
2569710|NCT00439270|6301510|P4|NOT COMPLETED|Phase 2 (51.6 Months)||34
2569711|NCT00439270|6301511|P3|NOT COMPLETED|Phase 2 (51.6 Months)||0
2569712|NCT00439270|6301512|P2|NOT COMPLETED|Phase 2 (51.6 Months)||0
2569713|NCT00439270|6301513|P1|NOT COMPLETED|Phase 2 (51.6 Months)||0
2569714|NCT00439270|6301509|P5|COMPLETED|Phase 2 (51.6 Months)||0
2569715|NCT00439270|6301510|P4|COMPLETED|Phase 2 (51.6 Months)||0
2569716|NCT00439270|6301511|P3|COMPLETED|Phase 2 (51.6 Months)||0
2569717|NCT00439270|6301512|P2|COMPLETED|Phase 2 (51.6 Months)||0
2569718|NCT00439270|6301513|P1|COMPLETED|Phase 2 (51.6 Months)||0
2569719|NCT00439270|6301509|P5|STARTED|Phase 2 (51.6 Months)||0
2569720|NCT00439270|6301510|P4|STARTED|Phase 2 (51.6 Months)|Includes 4 patients who completed Phase 1|34
2569721|NCT00439270|6301511|P3|STARTED|Phase 2 (51.6 Months)||0
2569722|NCT00439270|6301512|P2|STARTED|Phase 2 (51.6 Months)||0
2569723|NCT00439270|6301513|P1|STARTED|Phase 2 (51.6 Months)||0
2569724|NCT00439270|6301509|P5|NOT COMPLETED|Phase 1 (18.1 Months)||3
2569725|NCT00439270|6301510|P4|NOT COMPLETED|Phase 1 (18.1 Months)||0
2569726|NCT00439270|6301511|P3|NOT COMPLETED|Phase 1 (18.1 Months)||3
2569727|NCT00439270|6301512|P2|NOT COMPLETED|Phase 1 (18.1 Months)||3
2569728|NCT00439270|6301513|P1|NOT COMPLETED|Phase 1 (18.1 Months)||3
2569729|NCT00439270|6301509|P5|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
2569730|NCT00439270|6301510|P4|COMPLETED|Phase 1 (18.1 Months)|Remained on study|4
2569731|NCT00439270|6301511|P3|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
2569732|NCT00439270|6301512|P2|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
2569733|NCT00439270|6301513|P1|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
2569734|NCT00439270|6301509|P5|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
2569735|NCT00439270|6301510|P4|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|4
2569736|NCT00439270|6301511|P3|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
2569737|NCT00439270|6301512|P2|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
2569738|NCT00439270|6301513|P1|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
2569739|NCT00439244|6301555|P3|NOT COMPLETED|Overall Study||7
2569740|NCT00439244|6301556|P2|NOT COMPLETED|Overall Study||6
2569741|NCT00439244|6301557|P1|NOT COMPLETED|Overall Study||11
2569742|NCT00439244|6301555|P3|COMPLETED|Overall Study||131
2569743|NCT00439244|6301556|P2|COMPLETED|Overall Study||131
2569744|NCT00439244|6301557|P1|COMPLETED|Overall Study||126
2569745|NCT00439244|6301555|P3|Safety Population|Overall Study||137
2569746|NCT00439244|6301556|P2|Safety Population|Overall Study||137
2569747|NCT00439244|6301557|P1|Safety Population|Overall Study|Total safety population is 411. One patient was randomized, but never received any study medication.|137
2569748|NCT00439244|6301555|P3|STARTED|Overall Study||138
2569749|NCT00439244|6301556|P2|STARTED|Overall Study||137
2569750|NCT00439244|6301557|P1|STARTED|Overall Study|"Started indicates randomized as well as intent to treat (ITT) population enrolled to study."|137
2569751|NCT00439231|6301577|P1|NOT COMPLETED|Overall Study||28
2569752|NCT00439231|6301577|P1|COMPLETED|Overall Study|5 subjects had a partial response, 0 complete response, 28 completed off study,|5
2569753|NCT00439231|6301577|P1|STARTED|Overall Study||33
2569754|NCT00439218|6301581|P1|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||0
2569755|NCT00439218|6301581|P1|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
2569756|NCT00439218|6301581|P1|STARTED|Cohort 2 (500 mg/kg/Day)|One new subject was enrolled into the study after Cohort 1 completed the study.|1
2569757|NCT00439218|6301581|P1|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||1
2569758|NCT00439218|6301581|P1|COMPLETED|Cohort 1 (500 mg/kg/Day)|3 subjects completed the study in Cohort 1. Cohort 2 was then opened for new enrollments.|3
2569759|NCT00439218|6301581|P1|STARTED|Cohort 1 (500 mg/kg/Day)||4
2569772|NCT00439140|6301616|P3|NOT COMPLETED|Treatment Cycle 2||0
2569773|NCT00439140|6301617|P2|NOT COMPLETED|Treatment Cycle 2||1
2569774|NCT00439140|6301618|P1|NOT COMPLETED|Treatment Cycle 2||2
2569775|NCT00439140|6301616|P3|COMPLETED|Treatment Cycle 2||0
2569776|NCT00439140|6301617|P2|COMPLETED|Treatment Cycle 2||6
2569777|NCT00439140|6301618|P1|COMPLETED|Treatment Cycle 2||11
2569778|NCT00439140|6301616|P3|STARTED|Treatment Cycle 2|No patients received placebo in Cycle 2.|0
2569779|NCT00439140|6301617|P2|STARTED|Treatment Cycle 2|6 patients from the 300U arm plus 1 patient from the placebo arm in Cycle 1 entered Cycle 2.|7
2569780|NCT00439140|6301618|P1|STARTED|Treatment Cycle 2|8 patients from the 200U arm plus 5 patients from the placebo arm in Cycle 1 entered Cycle 2.|13
2569781|NCT00439140|6301616|P3|NOT COMPLETED|Treatment Cycle 1||1
2569782|NCT00439140|6301617|P2|NOT COMPLETED|Treatment Cycle 1||4
2569783|NCT00439140|6301618|P1|NOT COMPLETED|Treatment Cycle 1||1
2569784|NCT00439140|6301616|P3|COMPLETED|Treatment Cycle 1|5 patients did not enter Cycle 2. 6 patients received botulinum toxin Type A in Cycle 2.|11
2569785|NCT00439140|6301617|P2|COMPLETED|Treatment Cycle 1||10
2569786|NCT00439140|6301618|P1|COMPLETED|Treatment Cycle 1||14
2569787|NCT00439140|6301616|P3|STARTED|Treatment Cycle 1||12
2569788|NCT00439140|6301617|P2|STARTED|Treatment Cycle 1||14
2569789|NCT00439140|6301618|P1|STARTED|Treatment Cycle 1||15
2569790|NCT00438971|6301647|P1|NOT COMPLETED|Overall Study||2
2569791|NCT00438971|6301647|P1|COMPLETED|Overall Study||15
2569792|NCT00438971|6301647|P1|STARTED|Overall Study||17
2569793|NCT00438932|6301662|P4|NOT COMPLETED|Overall Study||0
2569794|NCT00438932|6301663|P3|NOT COMPLETED|Overall Study||0
2569795|NCT00438932|6301664|P2|NOT COMPLETED|Overall Study||0
2569796|NCT00438932|6301665|P1|NOT COMPLETED|Overall Study||0
2569797|NCT00438932|6301662|P4|COMPLETED|Overall Study||4
2569798|NCT00438932|6301663|P3|COMPLETED|Overall Study||4
2569799|NCT00438932|6301664|P2|COMPLETED|Overall Study||4
2569800|NCT00438932|6301665|P1|COMPLETED|Overall Study||4
2569801|NCT00438932|6301662|P4|STARTED|Overall Study||4
2569802|NCT00438932|6301663|P3|STARTED|Overall Study||4
2569803|NCT00438932|6301664|P2|STARTED|Overall Study||4
2569804|NCT00438932|6301665|P1|STARTED|Overall Study||4
2569805|NCT00438880|6301681|P2|NOT COMPLETED|Overall Study||0
2569806|NCT00438880|6301682|P1|NOT COMPLETED|Overall Study||0
2569807|NCT00438880|6301681|P2|COMPLETED|Overall Study||8
2569808|NCT00438880|6301682|P1|COMPLETED|Overall Study||30
2569809|NCT00438880|6301681|P2|STARTED|Overall Study||8
2569810|NCT00438880|6301682|P1|STARTED|Overall Study||30
2569811|NCT00438854|6301694|P1|NOT COMPLETED|Overall Study||0
2569812|NCT00438854|6301694|P1|COMPLETED|Overall Study||15
2569813|NCT00438854|6301694|P1|STARTED|Overall Study||15
2569814|NCT00438815|6301701|P1|NOT COMPLETED|Overall Study||70
2569815|NCT00438815|6301701|P1|COMPLETED|Overall Study||43
2569816|NCT00438815|6301701|P1|STARTED|Overall Study||113
2569817|NCT00438802|6301714|P3|NOT COMPLETED|Overall Study||0
2569818|NCT00438802|6301715|P2|NOT COMPLETED|Overall Study||0
2569819|NCT00438802|6301716|P1|NOT COMPLETED|Overall Study||0
2569820|NCT00438802|6301714|P3|COMPLETED|Overall Study||9
2569821|NCT00438802|6301715|P2|COMPLETED|Overall Study||8
2569822|NCT00438802|6301716|P1|COMPLETED|Overall Study||6
2569823|NCT00438802|6301714|P3|STARTED|Overall Study||9
2569824|NCT00438802|6301715|P2|STARTED|Overall Study||8
2569825|NCT00438802|6301716|P1|STARTED|Overall Study||6
2569826|NCT00438750|6301730|P2|NOT COMPLETED|Overall Study||9
2569827|NCT00438750|6301731|P1|NOT COMPLETED|Overall Study||9
2569828|NCT00438750|6301730|P2|COMPLETED|Overall Study||37
2569829|NCT00438750|6301731|P1|COMPLETED|Overall Study||39
2569830|NCT00438750|6301730|P2|STARTED|Overall Study||46
2569831|NCT00438750|6301731|P1|STARTED|Overall Study||48
2569832|NCT00438672|6301751|P2|NOT COMPLETED|Overall Study||9
2569833|NCT00438672|6301752|P1|NOT COMPLETED|Overall Study||7
2569834|NCT00438672|6301751|P2|COMPLETED|Overall Study||24
2569835|NCT00438672|6301752|P1|COMPLETED|Overall Study||24
2569836|NCT00438672|6301751|P2|STARTED|Overall Study||33
2569837|NCT00438672|6301752|P1|STARTED|Overall Study||31
2569838|NCT00438659|6301762|P2|NOT COMPLETED|Overall Study||4
2569839|NCT00438659|6301763|P1|NOT COMPLETED|Overall Study||6
2569840|NCT00438659|6301762|P2|COMPLETED|Overall Study||82
2569841|NCT00438659|6301763|P1|COMPLETED|Overall Study||84
2569842|NCT00438659|6301762|P2|STARTED|Overall Study||86
2569843|NCT00438659|6301763|P1|STARTED|Overall Study||90
2569844|NCT00438633|6301787|P2|NOT COMPLETED|Overall Study||17
2569845|NCT00438633|6301788|P1|NOT COMPLETED|Overall Study||16
2569846|NCT00438633|6301787|P2|COMPLETED|Overall Study||14
2569847|NCT00438633|6301788|P1|COMPLETED|Overall Study||16
2569848|NCT00438633|6301787|P2|3-month Follow-up|Overall Study||24
2569849|NCT00438633|6301788|P1|3-month Follow-up|Overall Study||26
2569850|NCT00438633|6301787|P2|STARTED|Overall Study||31
2569851|NCT00438633|6301788|P1|STARTED|Overall Study||32
2569852|NCT00438490|6301804|P2|NOT COMPLETED|Overall Study||0
2569853|NCT00438490|6301805|P1|NOT COMPLETED|Overall Study||0
2569854|NCT00438490|6301804|P2|COMPLETED|Overall Study||9
2569855|NCT00438490|6301805|P1|COMPLETED|Overall Study||12
2569856|NCT00438490|6301804|P2|STARTED|Overall Study||9
2569857|NCT00438490|6301805|P1|STARTED|Overall Study||12
2569858|NCT00438464|6301819|P2|NOT COMPLETED|Overall Study||7
2569859|NCT00438464|6301820|P1|NOT COMPLETED|Overall Study||14
2569860|NCT00438464|6301819|P2|COMPLETED|Overall Study||94
2569861|NCT00438464|6301820|P1|COMPLETED|Overall Study||89
2569862|NCT00438464|6301819|P2|Received Assigned Intervention|Overall Study||94
2569863|NCT00438464|6301820|P1|Received Assigned Intervention|Overall Study||89
2569864|NCT00438464|6301819|P2|STARTED|Overall Study||101
2569865|NCT00438464|6301820|P1|STARTED|Overall Study||103
2569866|NCT00438451|6301875|P3|NOT COMPLETED|Overall Study||53
2569867|NCT00438451|6301876|P2|NOT COMPLETED|Overall Study||66
2569868|NCT00438451|6301877|P1|NOT COMPLETED|Overall Study||47
2569869|NCT00438451|6301875|P3|COMPLETED|Overall Study||65
2569870|NCT00438451|6301876|P2|COMPLETED|Overall Study||55
2569871|NCT00438451|6301877|P1|COMPLETED|Overall Study||75
2569872|NCT00438451|6301875|P3|Maintenance Phase (Week 7-58)|Overall Study||93
2569873|NCT00438451|6301876|P2|Maintenance Phase (Week 7-58)|Overall Study||89
2569874|NCT00438451|6301877|P1|Maintenance Phase (Week 7-58)|Overall Study||93
2569875|NCT00438451|6301875|P3|ITT Population|Overall Study||117
2569876|NCT00438451|6301876|P2|ITT Population|Overall Study||120
2569877|NCT00438451|6301877|P1|ITT Population|Overall Study||122
2569878|NCT00438451|6301875|P3|Safety Population|Overall Study||117
2569879|NCT00438451|6301876|P2|Safety Population|Overall Study||121
2569880|NCT00438451|6301877|P1|Safety Population|Overall Study||122
2569881|NCT00438451|6301875|P3|STARTED|Overall Study||118
2569882|NCT00438451|6301876|P2|STARTED|Overall Study||121
2569883|NCT00438451|6301877|P1|STARTED|Overall Study||122
2569884|NCT00438399|6301921|P6|NOT COMPLETED|Overall Study||6
2569885|NCT00438399|6301922|P5|NOT COMPLETED|Overall Study||3
2569886|NCT00438399|6301923|P4|NOT COMPLETED|Overall Study||4
2569887|NCT00438399|6301924|P3|NOT COMPLETED|Overall Study||7
2569888|NCT00438399|6301925|P2|NOT COMPLETED|Overall Study||8
2569889|NCT00438399|6301926|P1|NOT COMPLETED|Overall Study||8
2569890|NCT00438399|6301921|P6|COMPLETED|Overall Study||31
2569891|NCT00438399|6301922|P5|COMPLETED|Overall Study||30
2569892|NCT00438399|6301923|P4|COMPLETED|Overall Study||32
2569893|NCT00438399|6301924|P3|COMPLETED|Overall Study||28
2569894|NCT00438399|6301925|P2|COMPLETED|Overall Study||32
2569895|NCT00438399|6301926|P1|COMPLETED|Overall Study||30
2569896|NCT00438399|6301921|P6|TREATED & ANALYZED|Overall Study||31
2569897|NCT00438399|6301922|P5|TREATED & ANALYZED|Overall Study||30
2569898|NCT00438399|6301923|P4|TREATED & ANALYZED|Overall Study||32
2569899|NCT00438399|6301924|P3|TREATED & ANALYZED|Overall Study||28
2569900|NCT00438399|6301925|P2|TREATED & ANALYZED|Overall Study||32
2569901|NCT00438399|6301926|P1|TREATED & ANALYZED|Overall Study||30
2569902|NCT00438399|6301921|P6|STARTED|Overall Study||37
2569903|NCT00438399|6301922|P5|STARTED|Overall Study||33
2569904|NCT00438399|6301923|P4|STARTED|Overall Study||36
2569905|NCT00438399|6301924|P3|STARTED|Overall Study||35
2569906|NCT00438399|6301925|P2|STARTED|Overall Study||40
2569907|NCT00438399|6301926|P1|STARTED|Overall Study||38
2569908|NCT00438360|6301937|P2|NOT COMPLETED|Overall Study||43
2569909|NCT00438360|6301938|P1|NOT COMPLETED|Overall Study||72
2569910|NCT00438360|6301937|P2|COMPLETED|Overall Study||38
2569911|NCT00438360|6301938|P1|COMPLETED|Overall Study||90
2569912|NCT00438360|6301937|P2|Intention to Treat (ITT) Population|Overall Study||79
2569913|NCT00438360|6301938|P1|Intention to Treat (ITT) Population|Overall Study|These numbers are different from those started (randomized) as 2 pts from each arm never took drug.|160
2569914|NCT00438360|6301937|P2|STARTED|Overall Study||81
2569915|NCT00438360|6301938|P1|STARTED|Overall Study|"Started indicates randomized patients."|162
2569916|NCT00438256|6301952|P4|NOT COMPLETED|Overall Study||9
2569917|NCT00438256|6301953|P3|NOT COMPLETED|Overall Study||1
2569918|NCT00438256|6301954|P2|NOT COMPLETED|Overall Study||1
2569919|NCT00438256|6301955|P1|NOT COMPLETED|Overall Study||2
2569920|NCT00438256|6301952|P4|COMPLETED|Overall Study||32
2569921|NCT00438256|6301953|P3|COMPLETED|Overall Study||2
2569922|NCT00438256|6301954|P2|COMPLETED|Overall Study||2
2569923|NCT00438256|6301955|P1|COMPLETED|Overall Study||1
2569924|NCT00438256|6301952|P4|Surgical Resection|Overall Study||34
2569925|NCT00438256|6301953|P3|Surgical Resection|Overall Study||2
2569926|NCT00438256|6301954|P2|Surgical Resection|Overall Study||2
2569927|NCT00438256|6301955|P1|Surgical Resection|Overall Study||1
2569928|NCT00438256|6301952|P4|STARTED|Overall Study||41
2569929|NCT00438256|6301953|P3|STARTED|Overall Study||3
2569930|NCT00438256|6301954|P2|STARTED|Overall Study||3
2569931|NCT00438256|6301955|P1|STARTED|Overall Study||3
2569932|NCT00438204|6301971|P1|NOT COMPLETED|Overall Study||0
2569933|NCT00438204|6301971|P1|COMPLETED|Overall Study||39
2569934|NCT00438204|6301971|P1|STARTED|Overall Study||39
2569935|NCT00438191|6301981|P2|NOT COMPLETED|Overall Study||14
2569936|NCT00438191|6301982|P1|NOT COMPLETED|Overall Study||11
2569937|NCT00438191|6301981|P2|COMPLETED|Overall Study||26
2569938|NCT00438191|6301982|P1|COMPLETED|Overall Study||32
2569939|NCT00438191|6301981|P2|STARTED|Overall Study||40
2569940|NCT00438191|6301982|P1|STARTED|Overall Study||43
2569941|NCT00438100|6301996|P2|NOT COMPLETED|Overall Study||4
2569942|NCT00438100|6301997|P1|NOT COMPLETED|Overall Study||2
2569943|NCT00438100|6301996|P2|COMPLETED|Overall Study||65
2569944|NCT00438100|6301997|P1|COMPLETED|Overall Study||71
2569945|NCT00438100|6301996|P2|STARTED|Overall Study||69
2569946|NCT00438100|6301997|P1|STARTED|Overall Study||73
2569947|NCT00437983|6302005|P2|NOT COMPLETED|Overall Study||13
2569948|NCT00437983|6302006|P1|NOT COMPLETED|Overall Study||13
2569949|NCT00437983|6302005|P2|COMPLETED|Overall Study||65
2569950|NCT00437983|6302006|P1|COMPLETED|Overall Study||66
2569951|NCT00437983|6302005|P2|STARTED|Overall Study||78
2569952|NCT00437983|6302006|P1|STARTED|Overall Study||79
2569953|NCT00437658|6302019|P3|NOT COMPLETED|Post-treatment Period (24 Weeks)||14
2569954|NCT00437658|6302020|P2|NOT COMPLETED|Post-treatment Period (24 Weeks)||8
2569955|NCT00437658|6302021|P1|NOT COMPLETED|Post-treatment Period (24 Weeks)||24
2569956|NCT00437658|6302019|P3|COMPLETED|Post-treatment Period (24 Weeks)||37
2569957|NCT00437658|6302020|P2|COMPLETED|Post-treatment Period (24 Weeks)||54
2569958|NCT00437658|6302021|P1|COMPLETED|Post-treatment Period (24 Weeks)||32
2569959|NCT00437658|6302019|P3|STARTED|Post-treatment Period (24 Weeks)||51
2569960|NCT00437658|6302020|P2|STARTED|Post-treatment Period (24 Weeks)||62
2569961|NCT00437658|6302021|P1|STARTED|Post-treatment Period (24 Weeks)||56
2569962|NCT00437658|6302019|P3|NOT COMPLETED|Treatment Period (24 Weeks)||33
2569963|NCT00437658|6302020|P2|NOT COMPLETED|Treatment Period (24 Weeks)||22
2569964|NCT00437658|6302021|P1|NOT COMPLETED|Treatment Period (24 Weeks)||28
2569965|NCT00437658|6302019|P3|COMPLETED|Treatment Period (24 Weeks)||51
2569966|NCT00437658|6302020|P2|COMPLETED|Treatment Period (24 Weeks)||62
2569967|NCT00437658|6302021|P1|COMPLETED|Treatment Period (24 Weeks)||56
2569968|NCT00437658|6302019|P3|Received Study Drug|Treatment Period (24 Weeks)||84
2569969|NCT00437658|6302020|P2|Received Study Drug|Treatment Period (24 Weeks)||84
2569970|NCT00437658|6302021|P1|Received Study Drug|Treatment Period (24 Weeks)||84
2569971|NCT00437658|6302019|P3|STARTED|Treatment Period (24 Weeks)||84
2569972|NCT00437658|6302020|P2|STARTED|Treatment Period (24 Weeks)||84
2569973|NCT00437658|6302021|P1|STARTED|Treatment Period (24 Weeks)||84
2569974|NCT00437645|6302115|P2|NOT COMPLETED|Overall Study||115
2569975|NCT00437645|6302116|P1|NOT COMPLETED|Overall Study||35
2569976|NCT00437645|6302115|P2|COMPLETED|Overall Study||476
2569977|NCT00437645|6302116|P1|COMPLETED|Overall Study||557
2569978|NCT00437645|6302115|P2|STARTED|Overall Study||591
2569979|NCT00437645|6302116|P1|STARTED|Overall Study||592
2569980|NCT00437489|6302132|P2|NOT COMPLETED|Overall Study||22
2569981|NCT00437489|6302133|P1|NOT COMPLETED|Overall Study||23
2569982|NCT00437489|6302132|P2|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
2569983|NCT00437489|6302133|P1|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
2569984|NCT00437489|6302132|P2|STARTED|Overall Study||24
2569985|NCT00437489|6302133|P1|STARTED|Overall Study||25
2569986|NCT00437398|6302145|P1|NOT COMPLETED|Overall Study||0
2569987|NCT00437398|6302145|P1|COMPLETED|Overall Study||2
2569988|NCT00437398|6302145|P1|STARTED|Overall Study||2
2569989|NCT00437281|6302170|P20|NOT COMPLETED|Overall Study||1
2569990|NCT00437281|6302171|P19|NOT COMPLETED|Overall Study||1
2569991|NCT00437281|6302172|P18|NOT COMPLETED|Overall Study||0
2569992|NCT00437281|6302173|P17|NOT COMPLETED|Overall Study||0
2569993|NCT00437281|6302174|P16|NOT COMPLETED|Overall Study||0
2569994|NCT00437281|6302175|P15|NOT COMPLETED|Overall Study||1
2569995|NCT00437281|6302176|P14|NOT COMPLETED|Overall Study||1
2569996|NCT00437281|6302177|P13|NOT COMPLETED|Overall Study||0
2569997|NCT00437281|6302178|P12|NOT COMPLETED|Overall Study||0
2569998|NCT00437281|6302179|P11|NOT COMPLETED|Overall Study||0
2569999|NCT00437281|6302180|P10|NOT COMPLETED|Overall Study||1
2570000|NCT00437281|6302181|P9|NOT COMPLETED|Overall Study||0
2570001|NCT00437281|6302182|P8|NOT COMPLETED|Overall Study||0
2570002|NCT00437281|6302183|P7|NOT COMPLETED|Overall Study||0
2570003|NCT00437281|6302184|P6|NOT COMPLETED|Overall Study||1
2570004|NCT00437281|6302185|P5|NOT COMPLETED|Overall Study||0
2570005|NCT00437281|6302186|P4|NOT COMPLETED|Overall Study||1
2570006|NCT00437281|6302187|P3|NOT COMPLETED|Overall Study||0
2570007|NCT00437281|6302188|P2|NOT COMPLETED|Overall Study||0
2570008|NCT00437281|6302189|P1|NOT COMPLETED|Overall Study||0
2570009|NCT00437281|6302170|P20|COMPLETED|Overall Study||2
2570010|NCT00437281|6302171|P19|COMPLETED|Overall Study||1
2570011|NCT00437281|6302172|P18|COMPLETED|Overall Study||4
2570012|NCT00437281|6302173|P17|COMPLETED|Overall Study||3
2570013|NCT00437281|6302174|P16|COMPLETED|Overall Study||3
2570014|NCT00437281|6302175|P15|COMPLETED|Overall Study||4
2570015|NCT00437281|6302176|P14|COMPLETED|Overall Study||2
2570016|NCT00437281|6302177|P13|COMPLETED|Overall Study||2
2570017|NCT00437281|6302178|P12|COMPLETED|Overall Study||3
2570018|NCT00437281|6302179|P11|COMPLETED|Overall Study||3
2570019|NCT00437281|6302180|P10|COMPLETED|Overall Study||4
2570020|NCT00437281|6302181|P9|COMPLETED|Overall Study||3
2570021|NCT00437281|6302182|P8|COMPLETED|Overall Study||3
2570022|NCT00437281|6302183|P7|COMPLETED|Overall Study||3
2570023|NCT00437281|6302184|P6|COMPLETED|Overall Study||3
2570024|NCT00437281|6302185|P5|COMPLETED|Overall Study||4
2570025|NCT00437281|6302186|P4|COMPLETED|Overall Study||2
2570026|NCT00437281|6302187|P3|COMPLETED|Overall Study||3
2570027|NCT00437281|6302188|P2|COMPLETED|Overall Study||3
2570028|NCT00437281|6302189|P1|COMPLETED|Overall Study||3
2570029|NCT00437281|6302170|P20|STARTED|Overall Study||3
2570030|NCT00437281|6302171|P19|STARTED|Overall Study||2
2570031|NCT00437281|6302172|P18|STARTED|Overall Study||4
2570032|NCT00437281|6302173|P17|STARTED|Overall Study||3
2570033|NCT00437281|6302174|P16|STARTED|Overall Study||3
2570034|NCT00437281|6302175|P15|STARTED|Overall Study||5
2570035|NCT00437281|6302176|P14|STARTED|Overall Study||3
2570036|NCT00437281|6302177|P13|STARTED|Overall Study||2
2570037|NCT00437281|6302178|P12|STARTED|Overall Study||3
2570038|NCT00437281|6302179|P11|STARTED|Overall Study||3
2570039|NCT00437281|6302180|P10|STARTED|Overall Study||5
2570040|NCT00437281|6302181|P9|STARTED|Overall Study||3
2570041|NCT00437281|6302182|P8|STARTED|Overall Study||3
2570042|NCT00437281|6302183|P7|STARTED|Overall Study||3
2570043|NCT00437281|6302184|P6|STARTED|Overall Study||4
2570044|NCT00437281|6302185|P5|STARTED|Overall Study||4
2570045|NCT00437281|6302186|P4|STARTED|Overall Study||3
2570046|NCT00437281|6302187|P3|STARTED|Overall Study||3
2570047|NCT00437281|6302188|P2|STARTED|Overall Study||3
2570048|NCT00437281|6302189|P1|STARTED|Overall Study||3
2570049|NCT00437203|6302493|P10|NOT COMPLETED|Overall Study||4
2570050|NCT00437203|6302494|P9|NOT COMPLETED|Overall Study||3
2570051|NCT00437203|6302495|P8|NOT COMPLETED|Overall Study||3
2570052|NCT00437203|6302496|P7|NOT COMPLETED|Overall Study||7
2570053|NCT00437203|6302497|P6|NOT COMPLETED|Overall Study||3
2570054|NCT00437203|6302498|P5|NOT COMPLETED|Overall Study||3
2570055|NCT00437203|6302499|P4|NOT COMPLETED|Overall Study||3
2570056|NCT00437203|6302500|P3|NOT COMPLETED|Overall Study||3
2570057|NCT00437203|6302501|P2|NOT COMPLETED|Overall Study||8
2570058|NCT00437203|6302502|P1|NOT COMPLETED|Overall Study||6
2570059|NCT00437203|6302493|P10|COMPLETED|Overall Study||0
2570060|NCT00437203|6302494|P9|COMPLETED|Overall Study||0
2570061|NCT00437203|6302495|P8|COMPLETED|Overall Study||0
2570062|NCT00437203|6302496|P7|COMPLETED|Overall Study||0
2570063|NCT00437203|6302497|P6|COMPLETED|Overall Study||0
2570064|NCT00437203|6302498|P5|COMPLETED|Overall Study||0
2570065|NCT00437203|6302499|P4|COMPLETED|Overall Study||0
2570066|NCT00437203|6302500|P3|COMPLETED|Overall Study||0
2570067|NCT00437203|6302501|P2|COMPLETED|Overall Study||0
2570068|NCT00437203|6302502|P1|COMPLETED|Overall Study||0
2570069|NCT00437203|6302493|P10|STARTED|Overall Study||4
2570070|NCT00437203|6302494|P9|STARTED|Overall Study||3
2570071|NCT00437203|6302495|P8|STARTED|Overall Study||3
2570072|NCT00437203|6302496|P7|STARTED|Overall Study||7
2570073|NCT00437203|6302497|P6|STARTED|Overall Study||3
2570074|NCT00437203|6302498|P5|STARTED|Overall Study||3
2570075|NCT00437203|6302499|P4|STARTED|Overall Study||3
2570076|NCT00437203|6302500|P3|STARTED|Overall Study||3
2570077|NCT00437203|6302501|P2|STARTED|Overall Study||8
2570078|NCT00437203|6302502|P1|STARTED|Overall Study||6
2570079|NCT00437125|6302606|P1|NOT COMPLETED|Overall Study||32
2570080|NCT00437125|6302606|P1|COMPLETED|Overall Study||119
2570081|NCT00437125|6302606|P1|STARTED|Overall Study||151
2570082|NCT00437073|6302627|P2|NOT COMPLETED|Overall Study||1
2570083|NCT00437073|6302628|P1|NOT COMPLETED|Overall Study||1
2570084|NCT00437073|6302627|P2|COMPLETED|Overall Study||8
2570085|NCT00437073|6302628|P1|COMPLETED|Overall Study||12
2570086|NCT00437073|6302627|P2|STARTED|Overall Study||9
2570087|NCT00437073|6302628|P1|STARTED|Overall Study||13
2570088|NCT00437034|6302656|P1|NOT COMPLETED|Overall Study||6
2570089|NCT00437034|6302656|P1|COMPLETED|Overall Study||0
2570090|NCT00437034|6302656|P1|STARTED|Overall Study||6
2570091|NCT00436982|6302662|P2|NOT COMPLETED|Overall Study||4
2570092|NCT00436982|6302663|P1|NOT COMPLETED|Overall Study||4
2570093|NCT00436982|6302662|P2|COMPLETED|Overall Study||26
2570094|NCT00436982|6302663|P1|COMPLETED|Overall Study||26
2570095|NCT00436982|6302662|P2|STARTED|Overall Study||30
2570096|NCT00436982|6302663|P1|STARTED|Overall Study||30
2570097|NCT00436969|6302685|P2|NOT COMPLETED|Overall Study||52
2570098|NCT00436969|6302686|P1|NOT COMPLETED|Overall Study||22
2570099|NCT00436969|6302685|P2|COMPLETED|Overall Study||134
2570100|NCT00436969|6302686|P1|COMPLETED|Overall Study||66
2570101|NCT00436969|6302685|P2|Randomized But Not Treated|Overall Study||3
2570102|NCT00436969|6302686|P1|Randomized But Not Treated|Overall Study||1
2570103|NCT00436969|6302685|P2|STARTED|Overall Study||186
2570104|NCT00436969|6302686|P1|STARTED|Overall Study||88
2570105|NCT00436956|6302734|P2|NOT COMPLETED|Overall Study||0
2570106|NCT00436956|6302735|P1|NOT COMPLETED|Overall Study||1
2570107|NCT00436956|6302734|P2|COMPLETED|Overall Study||23
2570108|NCT00436956|6302735|P1|COMPLETED|Overall Study|One pt was not evaluable due to a cord compression on day 2 of therapy; was removed from the trial.|35
2570109|NCT00436956|6302734|P2|STARTED|Overall Study||23
2570110|NCT00436956|6302735|P1|STARTED|Overall Study||36
2570111|NCT00436917|6302749|P1|NOT COMPLETED|Overall Study||21
2570112|NCT00436917|6302749|P1|COMPLETED|Overall Study||32
2570113|NCT00436917|6302749|P1|STARTED|Overall Study|7 participants (1 cancellation, 1 major violation, 5 ineligibles) were excluded from all analysis.|53
2570114|NCT00436904|6302764|P1|NOT COMPLETED|Overall Study||0
2570115|NCT00436904|6302764|P1|COMPLETED|Overall Study||30
2570116|NCT00436904|6302764|P1|STARTED|Overall Study||30
2570117|NCT00436852|6302775|P2|NOT COMPLETED|Overall Study||45
2570118|NCT00436852|6302776|P1|NOT COMPLETED|Overall Study||35
2570119|NCT00436852|6302775|P2|COMPLETED|Overall Study||2
2570120|NCT00436852|6302776|P1|COMPLETED|Overall Study||10
2570121|NCT00436852|6302775|P2|STARTED|Overall Study||47
2570122|NCT00436852|6302776|P1|STARTED|Overall Study||45
2570123|NCT00436826|6302795|P6|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||7
2570124|NCT00436826|6302796|P5|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||51
2570125|NCT00436826|6302797|P4|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
2570126|NCT00436826|6302798|P3|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
2570127|NCT00436826|6302799|P2|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
2570128|NCT00436826|6302800|P1|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
2570129|NCT00436826|6302795|P6|COMPLETED|Ext. Period (No Cladribine Treatment)||0
2570130|NCT00436826|6302796|P5|COMPLETED|Ext. Period (No Cladribine Treatment)||1
2570131|NCT00436826|6302797|P4|COMPLETED|Ext. Period (No Cladribine Treatment)||0
2570132|NCT00436826|6302798|P3|COMPLETED|Ext. Period (No Cladribine Treatment)||0
2570133|NCT00436826|6302799|P2|COMPLETED|Ext. Period (No Cladribine Treatment)||0
2570134|NCT00436826|6302800|P1|COMPLETED|Ext. Period (No Cladribine Treatment)||0
2570135|NCT00436826|6302795|P6|STARTED|Ext. Period (No Cladribine Treatment)||7
2570136|NCT00436826|6302796|P5|STARTED|Ext. Period (No Cladribine Treatment)||52
2570137|NCT00436826|6302797|P4|STARTED|Ext. Period (No Cladribine Treatment)||0
2570138|NCT00436826|6302798|P3|STARTED|Ext. Period (No Cladribine Treatment)||0
2570139|NCT00436826|6302799|P2|STARTED|Ext. Period (No Cladribine Treatment)||0
2570140|NCT00436826|6302800|P1|STARTED|Ext. Period (No Cladribine Treatment)||0
2570141|NCT00436826|6302795|P6|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
2570142|NCT00436826|6302796|P5|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
2570143|NCT00436826|6302797|P4|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||24
2570144|NCT00436826|6302798|P3|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||44
2570145|NCT00436826|6302799|P2|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
2570146|NCT00436826|6302800|P1|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
2570147|NCT00436826|6302795|P6|COMPLETED|Ext. Period (With Cladribine Treatment)||0
2570148|NCT00436826|6302796|P5|COMPLETED|Ext. Period (With Cladribine Treatment)||0
2570149|NCT00436826|6302797|P4|COMPLETED|Ext. Period (With Cladribine Treatment)||4
2570150|NCT00436826|6302798|P3|COMPLETED|Ext. Period (With Cladribine Treatment)||3
2570151|NCT00436826|6302799|P2|COMPLETED|Ext. Period (With Cladribine Treatment)||0
2570152|NCT00436826|6302800|P1|COMPLETED|Ext. Period (With Cladribine Treatment)||0
2570153|NCT00436826|6302795|P6|STARTED|Ext. Period (With Cladribine Treatment)||0
2570154|NCT00436826|6302796|P5|STARTED|Ext. Period (With Cladribine Treatment)||0
2570155|NCT00436826|6302797|P4|STARTED|Ext. Period (With Cladribine Treatment)||28
2570156|NCT00436826|6302798|P3|STARTED|Ext. Period (With Cladribine Treatment)||47
2570157|NCT00436826|6302799|P2|STARTED|Ext. Period (With Cladribine Treatment)||0
2570158|NCT00436826|6302800|P1|STARTED|Ext. Period (With Cladribine Treatment)||0
2570159|NCT00436826|6302795|P6|NOT COMPLETED|Double Blind Period||0
2570160|NCT00436826|6302796|P5|NOT COMPLETED|Double Blind Period||0
2570161|NCT00436826|6302797|P4|NOT COMPLETED|Double Blind Period||0
2570162|NCT00436826|6302798|P3|NOT COMPLETED|Double Blind Period||0
2570163|NCT00436826|6302799|P2|NOT COMPLETED|Double Blind Period||11
2570164|NCT00436826|6302800|P1|NOT COMPLETED|Double Blind Period||13
2570165|NCT00436826|6302795|P6|COMPLETED|Double Blind Period||0
2570166|NCT00436826|6302796|P5|COMPLETED|Double Blind Period||0
2570167|NCT00436826|6302797|P4|COMPLETED|Double Blind Period||0
2570168|NCT00436826|6302798|P3|COMPLETED|Double Blind Period||0
2570169|NCT00436826|6302799|P2|COMPLETED|Double Blind Period||37
2570170|NCT00436826|6302800|P1|COMPLETED|Double Blind Period||111
2570171|NCT00436826|6302795|P6|STARTED|Double Blind Period||0
2570172|NCT00436826|6302796|P5|STARTED|Double Blind Period||0
2570173|NCT00436826|6302797|P4|STARTED|Double Blind Period||0
2570174|NCT00436826|6302798|P3|STARTED|Double Blind Period||0
2570175|NCT00436826|6302799|P2|STARTED|Double Blind Period||48
2570176|NCT00436826|6302800|P1|STARTED|Double Blind Period||124
2570177|NCT00436748|6302822|P2|NOT COMPLETED|Overall Study||12
2570178|NCT00436748|6302823|P1|NOT COMPLETED|Overall Study||11
2570179|NCT00436748|6302822|P2|COMPLETED|Overall Study||45
2570180|NCT00436748|6302823|P1|COMPLETED|Overall Study||48
2570181|NCT00436748|6302822|P2|Received Treatment|Overall Study||56
2570182|NCT00436748|6302823|P1|Received Treatment|Overall Study||58
2570183|NCT00436748|6302822|P2|STARTED|Overall Study||57
2570184|NCT00436748|6302823|P1|STARTED|Overall Study||59
2570185|NCT00436644|6302857|P1|NOT COMPLETED|Overall Study||3
2570186|NCT00436644|6302857|P1|COMPLETED|Overall Study||15
2570187|NCT00436644|6302857|P1|STARTED|Overall Study||18
2570188|NCT00436618|6302867|P3|NOT COMPLETED|Overall Study||61
2570189|NCT00436618|6302868|P2|NOT COMPLETED|Overall Study||27
2570190|NCT00436618|6302869|P1|NOT COMPLETED|Overall Study||30
2570191|NCT00436618|6302867|P3|COMPLETED|Overall Study||46
2570192|NCT00436618|6302868|P2|COMPLETED|Overall Study||28
2570193|NCT00436618|6302869|P1|COMPLETED|Overall Study||84
2570194|NCT00436618|6302867|P3|STARTED|Overall Study||107
2570195|NCT00436618|6302868|P2|STARTED|Overall Study||55
2570196|NCT00436618|6302869|P1|STARTED|Overall Study||114
2570197|NCT00436605|6302886|P1|NOT COMPLETED|Overall Study||3
2570198|NCT00436605|6302886|P1|COMPLETED|Overall Study||36
2570199|NCT00436605|6302886|P1|STARTED|Overall Study||39
2570200|NCT00436566|6302891|P1|NOT COMPLETED|Overall Study||3
2570201|NCT00436566|6302891|P1|COMPLETED|Overall Study||109
2570202|NCT00436566|6302891|P1|STARTED|Overall Study||112
2570203|NCT00436553|6302898|P3|NOT COMPLETED|Overall Study||10
2570204|NCT00436553|6302899|P2|NOT COMPLETED|Overall Study||12
2570205|NCT00436553|6302900|P1|NOT COMPLETED|Overall Study||13
2570206|NCT00436553|6302898|P3|COMPLETED|Overall Study||102
2570207|NCT00436553|6302899|P2|COMPLETED|Overall Study||93
2570208|NCT00436553|6302900|P1|COMPLETED|Overall Study|Completed the 12 month study phase.|91
2570209|NCT00436553|6302898|P3|STARTED|Overall Study||112
2570210|NCT00436553|6302899|P2|STARTED|Overall Study||105
2570211|NCT00436553|6302900|P1|STARTED|Overall Study|"The table shows 12 month data. Started indicates Randomized set of population."|104
2570212|NCT00436501|6302921|P2|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||3
2570213|NCT00436501|6302922|P1|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
2570214|NCT00436501|6302921|P2|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||46
2570215|NCT00436501|6302922|P1|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
2570216|NCT00436501|6302921|P2|STARTED|Phase 2: MTD VEGF Trap + Docetaxel|After toxicity observations Phase 2 opened June 4, 2008 and closed to entry September 27, 2010.|49
2570217|NCT00436501|6302922|P1|STARTED|Phase 2: MTD VEGF Trap + Docetaxel||0
2570218|NCT00436501|6302921|P2|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
2570219|NCT00436501|6302922|P1|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
2570220|NCT00436501|6302921|P2|COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
2570221|NCT00436501|6302922|P1|COMPLETED|Phase 1: VEGF Trap Escalating Dose||9
2570222|NCT00436501|6302921|P2|STARTED|Phase 1: VEGF Trap Escalating Dose|Participants registered in next period.|0
2570223|NCT00436501|6302922|P1|STARTED|Phase 1: VEGF Trap Escalating Dose|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
2570224|NCT00436501|6302921|P2|NOT COMPLETED|Complete Study Participation||0
2570225|NCT00436501|6302922|P1|NOT COMPLETED|Complete Study Participation||0
2570226|NCT00436501|6302921|P2|COMPLETED|Complete Study Participation||49
2570227|NCT00436501|6302922|P1|COMPLETED|Complete Study Participation||9
2570228|NCT00436501|6302921|P2|STARTED|Complete Study Participation|After toxicity observations, Phase 2 opened June 4, 2008 and closed September 27, 2010.|49
2570229|NCT00436501|6302922|P1|STARTED|Complete Study Participation|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
2570230|NCT00436475|6302941|P4|NOT COMPLETED|Overall Study||2
2570231|NCT00436475|6302942|P3|NOT COMPLETED|Overall Study||1
2570232|NCT00436475|6302943|P2|NOT COMPLETED|Overall Study||1
2570233|NCT00436475|6302944|P1|NOT COMPLETED|Overall Study||0
2570234|NCT00436475|6302941|P4|COMPLETED|Overall Study||22
2570235|NCT00436475|6302942|P3|COMPLETED|Overall Study||21
2570236|NCT00436475|6302943|P2|COMPLETED|Overall Study||22
2570237|NCT00436475|6302944|P1|COMPLETED|Overall Study||23
2570238|NCT00436475|6302941|P4|STARTED|Overall Study||24
2570239|NCT00436475|6302942|P3|STARTED|Overall Study||22
2570240|NCT00436475|6302943|P2|STARTED|Overall Study||23
2570241|NCT00436475|6302944|P1|STARTED|Overall Study||23
2570242|NCT00436436|6302958|P1|NOT COMPLETED|Overall Study||12
2570243|NCT00436436|6302958|P1|COMPLETED|Overall Study||0
2570244|NCT00436436|6302958|P1|STARTED|Overall Study||12
2570245|NCT00436345|6302969|P2|NOT COMPLETED|Overall Study||0
2570246|NCT00436345|6302970|P1|NOT COMPLETED|Overall Study||3
2570247|NCT00436345|6302969|P2|COMPLETED|Overall Study||18
2570248|NCT00436345|6302970|P1|COMPLETED|Overall Study||18
2570249|NCT00436345|6302969|P2|STARTED|Overall Study||18
2570250|NCT00436345|6302970|P1|STARTED|Overall Study||21
2570251|NCT00436332|6303023|P1|NOT COMPLETED|Overall Study||83
2570252|NCT00436332|6303023|P1|COMPLETED|Overall Study||1
2570253|NCT00436332|6303023|P1|Eligible and Began Protocol Therapy|Overall Study||79
2570254|NCT00436332|6303023|P1|Eligible|Overall Study||82
2570255|NCT00436332|6303023|P1|STARTED|Overall Study||84
2570256|NCT00436215|6303030|P1|NOT COMPLETED|Overall Study||4
2570257|NCT00436215|6303030|P1|COMPLETED|Overall Study||51
2570258|NCT00436215|6303030|P1|STARTED|Overall Study||55
2570259|NCT00436163|6303036|P1|NOT COMPLETED|Overall Study||3
2570260|NCT00436163|6303036|P1|COMPLETED|Overall Study||36
2570261|NCT00436163|6303036|P1|STARTED|Overall Study||39
2570262|NCT00436046|6303050|P3|NOT COMPLETED|Overall Study||0
2570263|NCT00436046|6303051|P2|NOT COMPLETED|Overall Study||0
2570264|NCT00436046|6303052|P1|NOT COMPLETED|Overall Study||0
2570265|NCT00436046|6303050|P3|COMPLETED|Overall Study||31
2570266|NCT00436046|6303051|P2|COMPLETED|Overall Study||32
2570267|NCT00436046|6303052|P1|COMPLETED|Overall Study||32
2570268|NCT00436046|6303050|P3|STARTED|Overall Study||31
2570269|NCT00436046|6303051|P2|STARTED|Overall Study||32
2570270|NCT00436046|6303052|P1|STARTED|Overall Study||32
2570271|NCT00436007|6303084|P3|NOT COMPLETED|Overall Study||23
2570272|NCT00436007|6303085|P2|NOT COMPLETED|Overall Study||14
2570273|NCT00436007|6303086|P1|NOT COMPLETED|Overall Study||19
2570274|NCT00436007|6303084|P3|COMPLETED|Overall Study||148
2570275|NCT00436007|6303085|P2|COMPLETED|Overall Study||156
2570276|NCT00436007|6303086|P1|COMPLETED|Overall Study||151
2570277|NCT00436007|6303084|P3|STARTED|Overall Study||171
2570278|NCT00436007|6303085|P2|STARTED|Overall Study||170
2570279|NCT00436007|6303086|P1|STARTED|Overall Study||170
2570280|NCT00435994|6303134|P3|NOT COMPLETED|Overall Study||0
2570281|NCT00435994|6303135|P2|NOT COMPLETED|Overall Study||0
2570282|NCT00435994|6303136|P1|NOT COMPLETED|Overall Study||7
2570283|NCT00435994|6303134|P3|COMPLETED|Overall Study||12
2570284|NCT00435994|6303135|P2|COMPLETED|Overall Study||25
2570285|NCT00435994|6303136|P1|COMPLETED|Overall Study|7 of the subjects were consented and did not complete the study procedures.|15
2570286|NCT00435994|6303134|P3|STARTED|Overall Study||12
2570287|NCT00435994|6303135|P2|STARTED|Overall Study||25
2570288|NCT00435994|6303136|P1|STARTED|Overall Study||22
2570289|NCT00435942|6303147|P2|NOT COMPLETED|Overall Study||27
2570290|NCT00435942|6303148|P1|NOT COMPLETED|Overall Study||23
2570291|NCT00435942|6303147|P2|COMPLETED|Overall Study||33
2570292|NCT00435942|6303148|P1|COMPLETED|Overall Study||97
2570293|NCT00435942|6303147|P2|STARTED|Overall Study||60
2570294|NCT00435942|6303148|P1|STARTED|Overall Study||120
2570295|NCT00435929|6303157|P2|NOT COMPLETED|Overall Study||0
2570296|NCT00435929|6303158|P1|NOT COMPLETED|Overall Study||0
2570297|NCT00435929|6303157|P2|COMPLETED|Overall Study||9
2570298|NCT00435929|6303158|P1|COMPLETED|Overall Study||7
2570299|NCT00435929|6303157|P2|STARTED|Overall Study||9
2570300|NCT00435929|6303158|P1|STARTED|Overall Study||7
2570301|NCT00435825|6303188|P4|NOT COMPLETED|Overall Study||16
2570302|NCT00435825|6303189|P3|NOT COMPLETED|Overall Study||11
2570303|NCT00435825|6303190|P2|NOT COMPLETED|Overall Study||12
2570304|NCT00435825|6303191|P1|NOT COMPLETED|Overall Study||18
2570305|NCT00435825|6303188|P4|COMPLETED|Overall Study||120
2570306|NCT00435825|6303189|P3|COMPLETED|Overall Study||127
2570307|NCT00435825|6303190|P2|COMPLETED|Overall Study||124
2570308|NCT00435825|6303191|P1|COMPLETED|Overall Study|Completed is the number of participants who received study treatment and completed follow-up.|123
2570309|NCT00435825|6303188|P4|Completed 48 Weeks Treatment|Overall Study||117
2570310|NCT00435825|6303189|P3|Completed 48 Weeks Treatment|Overall Study||124
2570311|NCT00435825|6303190|P2|Completed 48 Weeks Treatment|Overall Study||0
2570312|NCT00435825|6303191|P1|Completed 48 Weeks Treatment|Overall Study||0
2570313|NCT00435825|6303188|P4|Completed 24 Weeks Treatment|Overall Study||131
2570314|NCT00435825|6303189|P3|Completed 24 Weeks Treatment|Overall Study||134
2570315|NCT00435825|6303190|P2|Completed 24 Weeks Treatment|Overall Study||126
2570316|NCT00435825|6303191|P1|Completed 24 Weeks Treatment|Overall Study||128
2570317|NCT00435825|6303188|P4|Entered Follow-up|Overall Study||133
2570318|NCT00435825|6303189|P3|Entered Follow-up|Overall Study||135
2570319|NCT00435825|6303190|P2|Entered Follow-up|Overall Study||132
2570320|NCT00435825|6303191|P1|Entered Follow-up|Overall Study||140
2570321|NCT00435825|6303188|P4|Received Study Drug|Overall Study||136
2570322|NCT00435825|6303189|P3|Received Study Drug|Overall Study||136
2570323|NCT00435825|6303190|P2|Received Study Drug|Overall Study||136
2570324|NCT00435825|6303191|P1|Received Study Drug|Overall Study||140
2570325|NCT00435825|6303188|P4|STARTED|Overall Study||136
2570326|NCT00435825|6303189|P3|STARTED|Overall Study||138
2570327|NCT00435825|6303190|P2|STARTED|Overall Study||136
2570328|NCT00435825|6303191|P1|STARTED|Overall Study||141
2570329|NCT00435812|6303247|P2|NOT COMPLETED|Overall Study||18
2570330|NCT00435812|6303248|P1|NOT COMPLETED|Overall Study||63
2570331|NCT00435812|6303247|P2|COMPLETED|Overall Study||590
2570332|NCT00435812|6303248|P1|COMPLETED|Overall Study||1757
2570333|NCT00435812|6303247|P2|STARTED|Overall Study||608
2570334|NCT00435812|6303248|P1|STARTED|Overall Study||1820
2570335|NCT00435591|6303260|P4|NOT COMPLETED|Overall Study||11
2570336|NCT00435591|6303261|P3|NOT COMPLETED|Overall Study||5
2570337|NCT00435591|6303262|P2|NOT COMPLETED|Overall Study||4
2570338|NCT00435591|6303263|P1|NOT COMPLETED|Overall Study||7
2570339|NCT00435591|6303260|P4|COMPLETED|Overall Study||19
2570340|NCT00435591|6303261|P3|COMPLETED|Overall Study||25
2570341|NCT00435591|6303262|P2|COMPLETED|Overall Study||27
2570342|NCT00435591|6303263|P1|COMPLETED|Overall Study||23
2570343|NCT00435591|6303260|P4|End of Treatment|Overall Study||23
2570344|NCT00435591|6303261|P3|End of Treatment|Overall Study||27
2570345|NCT00435591|6303262|P2|End of Treatment|Overall Study||27
2570346|NCT00435591|6303263|P1|End of Treatment|Overall Study||25
2570347|NCT00435591|6303260|P4|Full Analysis Set|Overall Study||29
2570348|NCT00435591|6303261|P3|Full Analysis Set|Overall Study||30
2570349|NCT00435591|6303262|P2|Full Analysis Set|Overall Study||29
2570350|NCT00435591|6303263|P1|Full Analysis Set|Overall Study||28
2570351|NCT00435591|6303260|P4|Safety Analysis Set|Overall Study||29
2570352|NCT00435591|6303261|P3|Safety Analysis Set|Overall Study||30
2570353|NCT00435591|6303262|P2|Safety Analysis Set|Overall Study||30
2570354|NCT00435591|6303263|P1|Safety Analysis Set|Overall Study||28
2570355|NCT00435591|6303260|P4|STARTED|Overall Study||30
2570356|NCT00435591|6303261|P3|STARTED|Overall Study||30
2570357|NCT00435591|6303262|P2|STARTED|Overall Study||31
2570358|NCT00435591|6303263|P1|STARTED|Overall Study||30
2570359|NCT00435539|6303293|P5|NOT COMPLETED|Overall Study||0
2570360|NCT00435539|6303294|P4|NOT COMPLETED|Overall Study||0
2570361|NCT00435539|6303295|P3|NOT COMPLETED|Overall Study||0
2570362|NCT00435539|6303296|P2|NOT COMPLETED|Overall Study||0
2570363|NCT00435539|6303297|P1|NOT COMPLETED|Overall Study||0
2570364|NCT00435539|6303293|P5|COMPLETED|Overall Study||12
2570365|NCT00435539|6303294|P4|COMPLETED|Overall Study||12
2570366|NCT00435539|6303295|P3|COMPLETED|Overall Study||11
2570367|NCT00435539|6303296|P2|COMPLETED|Overall Study||13
2570368|NCT00435539|6303297|P1|COMPLETED|Overall Study||12
2570369|NCT00435539|6303293|P5|STARTED|Overall Study||12
2570370|NCT00435539|6303294|P4|STARTED|Overall Study||12
2570371|NCT00435539|6303295|P3|STARTED|Overall Study||11
2570372|NCT00435539|6303296|P2|STARTED|Overall Study||13
2570373|NCT00435539|6303297|P1|STARTED|Overall Study||12
2570374|NCT00435487|6303314|P2|NOT COMPLETED|Overall Study||15
2570375|NCT00435487|6303315|P1|NOT COMPLETED|Overall Study||12
2570376|NCT00435487|6303314|P2|COMPLETED|Overall Study||71
2570377|NCT00435487|6303315|P1|COMPLETED|Overall Study||76
2570378|NCT00435487|6303314|P2|TREATED|Overall Study|One subject was mistakenly treated with Dalteparin, two subjects withdrew consent before treatment.|83
2570379|NCT00435487|6303315|P1|TREATED|Overall Study|One additional subject originally randomized to Unfractioned Heparin was treated with Dalteparin.|88
2570380|NCT00435487|6303314|P2|STARTED|Overall Study||86
2570381|NCT00435487|6303315|P1|STARTED|Overall Study|87 subjects were randomized however one additional subject originally randomized to UFH was treated.|88
2570382|NCT00435461|6303334|P3|NOT COMPLETED|Overall Study||24
2570383|NCT00435461|6303335|P2|NOT COMPLETED|Overall Study||14
2570384|NCT00435461|6303336|P1|NOT COMPLETED|Overall Study||23
2570385|NCT00435461|6303334|P3|COMPLETED|Overall Study||287
2570386|NCT00435461|6303335|P2|COMPLETED|Overall Study||298
2570387|NCT00435461|6303336|P1|COMPLETED|Overall Study||290
2570388|NCT00435461|6303334|P3|STARTED|Overall Study||311
2570389|NCT00435461|6303335|P2|STARTED|Overall Study||312
2570390|NCT00435461|6303336|P1|STARTED|Overall Study||313
2570391|NCT00435409|6303373|P3|NOT COMPLETED|Overall Study||78
2570392|NCT00435409|6303374|P2|NOT COMPLETED|Overall Study||143
2570393|NCT00435409|6303375|P1|NOT COMPLETED|Overall Study||221
2570394|NCT00435409|6303373|P3|COMPLETED|Overall Study||0
2570395|NCT00435409|6303374|P2|COMPLETED|Overall Study||0
2570396|NCT00435409|6303375|P1|COMPLETED|Overall Study||0
2570397|NCT00435409|6303373|P3|Treated|Overall Study||78
2570398|NCT00435409|6303374|P2|Treated|Overall Study||139
2570399|NCT00435409|6303375|P1|Treated|Overall Study||217
2570400|NCT00435409|6303373|P3|STARTED|Overall Study||78
2570401|NCT00435409|6303374|P2|STARTED|Overall Study||143
2570402|NCT00435409|6303375|P1|STARTED|Overall Study||221
2570403|NCT00435370|6303397|P2|NOT COMPLETED|Overall Study||20
2570404|NCT00435370|6303398|P1|NOT COMPLETED|Overall Study||22
2570405|NCT00435370|6303397|P2|COMPLETED|Overall Study|The entire recruitment has been completed in December, 2011.|69
2570406|NCT00435370|6303398|P1|COMPLETED|Overall Study||68
2570407|NCT00435370|6303397|P2|STARTED|Overall Study|The recruitment restarted in August, 2010.|89
2570408|NCT00435370|6303398|P1|STARTED|Overall Study||90
2570409|NCT00435188|6303406|P2|NOT COMPLETED|Overall Study||23
2570410|NCT00435188|6303407|P1|NOT COMPLETED|Overall Study||22
2570411|NCT00435188|6303406|P2|COMPLETED|Overall Study||176
2570412|NCT00435188|6303407|P1|COMPLETED|Overall Study||177
2570413|NCT00435188|6303406|P2|STARTED|Overall Study||199
2570414|NCT00435188|6303407|P1|STARTED|Overall Study||199
2570415|NCT00435162|6303450|P6|NOT COMPLETED|Period 2 (2 Weeks)||0
2570416|NCT00435162|6303451|P5|NOT COMPLETED|Period 2 (2 Weeks)||0
2570417|NCT00435162|6303452|P4|NOT COMPLETED|Period 2 (2 Weeks)||0
2570418|NCT00435162|6303453|P3|NOT COMPLETED|Period 2 (2 Weeks)||0
2570419|NCT00435162|6303454|P2|NOT COMPLETED|Period 2 (2 Weeks)||1
2570420|NCT00435162|6303455|P1|NOT COMPLETED|Period 2 (2 Weeks)||0
2570421|NCT00435162|6303450|P6|COMPLETED|Period 2 (2 Weeks)||15
2570422|NCT00435162|6303451|P5|COMPLETED|Period 2 (2 Weeks)||15
2570423|NCT00435162|6303452|P4|COMPLETED|Period 2 (2 Weeks)||8
2570424|NCT00435162|6303453|P3|COMPLETED|Period 2 (2 Weeks)||6
2570425|NCT00435162|6303454|P2|COMPLETED|Period 2 (2 Weeks)||14
2570426|NCT00435162|6303455|P1|COMPLETED|Period 2 (2 Weeks)||15
2570427|NCT00435162|6303450|P6|STARTED|Period 2 (2 Weeks)||15
2570428|NCT00435162|6303451|P5|STARTED|Period 2 (2 Weeks)||15
2570429|NCT00435162|6303452|P4|STARTED|Period 2 (2 Weeks)||8
2570430|NCT00435162|6303453|P3|STARTED|Period 2 (2 Weeks)||6
2570431|NCT00435162|6303454|P2|STARTED|Period 2 (2 Weeks)||15
2570432|NCT00435162|6303455|P1|STARTED|Period 2 (2 Weeks)||15
2570433|NCT00435162|6303450|P6|NOT COMPLETED|Period 1 (6 Weeks)||0
2570434|NCT00435162|6303451|P5|NOT COMPLETED|Period 1 (6 Weeks)||0
2570435|NCT00435162|6303452|P4|NOT COMPLETED|Period 1 (6 Weeks)||0
2570436|NCT00435162|6303453|P3|NOT COMPLETED|Period 1 (6 Weeks)||0
2570437|NCT00435162|6303454|P2|NOT COMPLETED|Period 1 (6 Weeks)||0
2570438|NCT00435162|6303455|P1|NOT COMPLETED|Period 1 (6 Weeks)||0
2570439|NCT00435162|6303450|P6|COMPLETED|Period 1 (6 Weeks)||15
2570440|NCT00435162|6303451|P5|COMPLETED|Period 1 (6 Weeks)||15
2570441|NCT00435162|6303452|P4|COMPLETED|Period 1 (6 Weeks)||8
2570442|NCT00435162|6303453|P3|COMPLETED|Period 1 (6 Weeks)||6
2570443|NCT00435162|6303454|P2|COMPLETED|Period 1 (6 Weeks)||15
2570444|NCT00435162|6303455|P1|COMPLETED|Period 1 (6 Weeks)||15
2570445|NCT00435162|6303450|P6|STARTED|Period 1 (6 Weeks)||15
2570446|NCT00435162|6303451|P5|STARTED|Period 1 (6 Weeks)||15
2570447|NCT00435162|6303452|P4|STARTED|Period 1 (6 Weeks)||8
2570448|NCT00435162|6303453|P3|STARTED|Period 1 (6 Weeks)||6
2570449|NCT00435162|6303454|P2|STARTED|Period 1 (6 Weeks)||15
2570450|NCT00435162|6303455|P1|STARTED|Period 1 (6 Weeks)||15
2570451|NCT00435045|6303475|P2|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||2
2570452|NCT00435045|6303476|P1|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||5
2570453|NCT00435045|6303475|P2|COMPLETED|Weeks 13-16 / 40mg Dose Level||111
2570454|NCT00435045|6303476|P1|COMPLETED|Weeks 13-16 / 40mg Dose Level||108
2570455|NCT00435045|6303475|P2|STARTED|Weeks 13-16 / 40mg Dose Level||113
2570456|NCT00435045|6303476|P1|STARTED|Weeks 13-16 / 40mg Dose Level||113
2570457|NCT00435045|6303475|P2|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
2570458|NCT00435045|6303476|P1|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
2570459|NCT00435045|6303475|P2|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
2570460|NCT00435045|6303476|P1|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
2570461|NCT00435045|6303475|P2|STARTED|Weeks 9-12 / 20mg Dose Level||118
2570462|NCT00435045|6303476|P1|STARTED|Weeks 9-12 / 20mg Dose Level||118
2570463|NCT00435045|6303475|P2|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||4
2570464|NCT00435045|6303476|P1|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||5
2570465|NCT00435045|6303475|P2|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
2570466|NCT00435045|6303476|P1|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
2570467|NCT00435045|6303475|P2|STARTED|Weeks 1-8 / 10 mg Dose Level||122
2570468|NCT00435045|6303476|P1|STARTED|Weeks 1-8 / 10 mg Dose Level||123
2570469|NCT00435019|6303532|P2|NOT COMPLETED|Overall Study||10
2570470|NCT00435019|6303533|P1|NOT COMPLETED|Overall Study||13
2570471|NCT00435019|6303532|P2|COMPLETED|Overall Study||161
2570472|NCT00435019|6303533|P1|COMPLETED|Overall Study||164
2570473|NCT00435019|6303532|P2|Exposed to Study Drug|Overall Study|One subject withdrew before receiving study drug, and thus not included in the full analysis set.|170
2570474|NCT00435019|6303533|P1|Exposed to Study Drug|Overall Study||177
2570475|NCT00435019|6303532|P2|STARTED|Overall Study|Randomised|171
2570476|NCT00435019|6303533|P1|STARTED|Overall Study|Randomised|177
2570477|NCT00434993|6303545|P2|NOT COMPLETED|Overall Study||0
2570478|NCT00434993|6303546|P1|NOT COMPLETED|Overall Study||0
2570479|NCT00434993|6303545|P2|COMPLETED|Overall Study||130
2570480|NCT00434993|6303546|P1|COMPLETED|Overall Study||152
2570481|NCT00434993|6303545|P2|STARTED|Overall Study||130
2570482|NCT00434993|6303546|P1|STARTED|Overall Study||152
2570483|NCT00434967|6303574|P4|NOT COMPLETED|Overall Study||14
2570484|NCT00434967|6303575|P3|NOT COMPLETED|Overall Study||9
2570485|NCT00434967|6303576|P2|NOT COMPLETED|Overall Study||8
2570486|NCT00434967|6303577|P1|NOT COMPLETED|Overall Study||7
2570487|NCT00434967|6303574|P4|COMPLETED|Overall Study||478
2570488|NCT00434967|6303575|P3|COMPLETED|Overall Study||461
2570489|NCT00434967|6303576|P2|COMPLETED|Overall Study||457
2570490|NCT00434967|6303577|P1|COMPLETED|Overall Study||90
2570491|NCT00434967|6303574|P4|STARTED|Overall Study||492
2570492|NCT00434967|6303575|P3|STARTED|Overall Study||470
2570493|NCT00434967|6303576|P2|STARTED|Overall Study||465
2570494|NCT00434967|6303577|P1|STARTED|Overall Study||97
2570495|NCT00434954|6303597|P2|NOT COMPLETED|Overall Study||71
2570496|NCT00434954|6303598|P1|NOT COMPLETED|Overall Study||82
2570497|NCT00434954|6303597|P2|COMPLETED|Overall Study||175
2570498|NCT00434954|6303598|P1|COMPLETED|Overall Study||166
2570499|NCT00434954|6303597|P2|Completed - Previous Treatment MET + SU|Overall Study||38
2570500|NCT00434954|6303598|P1|Completed - Previous Treatment MET + SU|Overall Study||31
2570501|NCT00434954|6303597|P2|Completed - Previous Treatment MET Only|Overall Study||137
2570502|NCT00434954|6303598|P1|Completed - Previous Treatment MET Only|Overall Study||135
2570503|NCT00434954|6303597|P2|FAS - Previous Treatment MET + SU|Overall Study||60
2570504|NCT00434954|6303598|P1|FAS - Previous Treatment MET + SU|Overall Study||66
2570505|NCT00434954|6303597|P2|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|173
2570506|NCT00434954|6303598|P1|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|181
2570507|NCT00434954|6303597|P2|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|233
2570508|NCT00434954|6303598|P1|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|247
2570509|NCT00434954|6303597|P2|Started - Previous Treatment MET + SU|Overall Study||65
2570510|NCT00434954|6303598|P1|Started - Previous Treatment MET + SU|Overall Study||66
2570511|NCT00434954|6303597|P2|Started - Previous Treatment MET Only|Overall Study||181
2570512|NCT00434954|6303598|P1|Started - Previous Treatment MET Only|Overall Study||182
2570513|NCT00434954|6303597|P2|STARTED|Overall Study||246
2570514|NCT00434954|6303598|P1|STARTED|Overall Study||248
2570515|NCT00434876|6303628|P2|NOT COMPLETED|Overall Study||1
2570516|NCT00434876|6303629|P1|NOT COMPLETED|Overall Study||1
2570517|NCT00434876|6303628|P2|COMPLETED|Overall Study||10
2570518|NCT00434876|6303629|P1|COMPLETED|Overall Study||10
2570519|NCT00434876|6303628|P2|STARTED|Overall Study||11
2570520|NCT00434876|6303629|P1|STARTED|Overall Study||11
2570521|NCT00434759|6303643|P2|NOT COMPLETED|Overall Study||5
2570522|NCT00434759|6303644|P1|NOT COMPLETED|Overall Study||24
2570523|NCT00434759|6303643|P2|COMPLETED|Overall Study||38
2570524|NCT00434759|6303644|P1|COMPLETED|Overall Study||22
2570525|NCT00434759|6303643|P2|STARTED|Overall Study||43
2570526|NCT00434759|6303644|P1|STARTED|Overall Study||46
2570527|NCT00434642|6303660|P2|NOT COMPLETED|Open-label Treatment Phase||11
2570528|NCT00434642|6303661|P1|NOT COMPLETED|Open-label Treatment Phase||0
2570529|NCT00434642|6303660|P2|COMPLETED|Open-label Treatment Phase||1
2570530|NCT00434642|6303661|P1|COMPLETED|Open-label Treatment Phase||0
2570531|NCT00434642|6303660|P2|STARTED|Open-label Treatment Phase|One participant did not continue into the open-label treatment phase.|12
2570532|NCT00434642|6303661|P1|STARTED|Open-label Treatment Phase||0
2570533|NCT00434642|6303660|P2|NOT COMPLETED|Blinded Treatment Phase||229
2570534|NCT00434642|6303661|P1|NOT COMPLETED|Blinded Treatment Phase||242
2570535|NCT00434642|6303660|P2|COMPLETED|Blinded Treatment Phase||13
2570536|NCT00434642|6303661|P1|COMPLETED|Blinded Treatment Phase||0
2570537|NCT00434642|6303660|P2|STARTED|Blinded Treatment Phase||242
2570538|NCT00434642|6303661|P1|STARTED|Blinded Treatment Phase||242
2570539|NCT00434590|6303679|P2|NOT COMPLETED|Overall Study||5
2570540|NCT00434590|6303680|P1|NOT COMPLETED|Overall Study||5
2570541|NCT00434590|6303679|P2|COMPLETED|Overall Study||0
2570542|NCT00434590|6303680|P1|COMPLETED|Overall Study|All patients randomized had study discontinued because of premature study termination.|0
2570543|NCT00434590|6303679|P2|STARTED|Overall Study||5
2570544|NCT00434590|6303680|P1|STARTED|Overall Study||5
2570545|NCT00434577|6303691|P5|NOT COMPLETED|Month 36||0
2570546|NCT00434577|6303692|P4|NOT COMPLETED|Month 36||0
2570547|NCT00434577|6303693|P3|NOT COMPLETED|Month 36||0
2570548|NCT00434577|6303694|P2|NOT COMPLETED|Month 36||0
2570549|NCT00434577|6303695|P1|NOT COMPLETED|Month 36||0
2570550|NCT00434577|6303691|P5|COMPLETED|Month 36||47
2570551|NCT00434577|6303692|P4|COMPLETED|Month 36||155
2570552|NCT00434577|6303693|P3|COMPLETED|Month 36||150
2570553|NCT00434577|6303694|P2|COMPLETED|Month 36||147
2570554|NCT00434577|6303695|P1|COMPLETED|Month 36||147
2570555|NCT00434577|6303691|P5|STARTED|Month 36||47
2570556|NCT00434577|6303692|P4|STARTED|Month 36||155
2570557|NCT00434577|6303693|P3|STARTED|Month 36||150
2570558|NCT00434577|6303694|P2|STARTED|Month 36||147
2570559|NCT00434577|6303695|P1|STARTED|Month 36||147
2570560|NCT00434577|6303691|P5|NOT COMPLETED|Month 24||0
2570561|NCT00434577|6303692|P4|NOT COMPLETED|Month 24||0
2570562|NCT00434577|6303693|P3|NOT COMPLETED|Month 24||0
2570563|NCT00434577|6303694|P2|NOT COMPLETED|Month 24||0
2570564|NCT00434577|6303695|P1|NOT COMPLETED|Month 24||0
2570565|NCT00434577|6303691|P5|COMPLETED|Month 24||49
2570566|NCT00434577|6303692|P4|COMPLETED|Month 24||157
2570567|NCT00434577|6303693|P3|COMPLETED|Month 24||154
2570568|NCT00434577|6303694|P2|COMPLETED|Month 24||155
2570569|NCT00434577|6303695|P1|COMPLETED|Month 24||150
2570570|NCT00434577|6303691|P5|STARTED|Month 24||49
2570571|NCT00434577|6303692|P4|STARTED|Month 24||157
2570572|NCT00434577|6303693|P3|STARTED|Month 24||154
2570573|NCT00434577|6303694|P2|STARTED|Month 24||155
2570574|NCT00434577|6303695|P1|STARTED|Month 24||150
2570575|NCT00434577|6303691|P5|NOT COMPLETED|Month 12||0
2570576|NCT00434577|6303692|P4|NOT COMPLETED|Month 12||0
2570577|NCT00434577|6303693|P3|NOT COMPLETED|Month 12||0
2570578|NCT00434577|6303694|P2|NOT COMPLETED|Month 12||0
2570579|NCT00434577|6303695|P1|NOT COMPLETED|Month 12||0
2570580|NCT00434577|6303691|P5|COMPLETED|Month 12||50
2570581|NCT00434577|6303692|P4|COMPLETED|Month 12||161
2570582|NCT00434577|6303693|P3|COMPLETED|Month 12||159
2570583|NCT00434577|6303694|P2|COMPLETED|Month 12||159
2570584|NCT00434577|6303695|P1|COMPLETED|Month 12||156
2570585|NCT00434577|6303691|P5|STARTED|Month 12||50
2570586|NCT00434577|6303692|P4|STARTED|Month 12||161
2570587|NCT00434577|6303693|P3|STARTED|Month 12||159
2570588|NCT00434577|6303694|P2|STARTED|Month 12||159
2570589|NCT00434577|6303695|P1|STARTED|Month 12||156
2570590|NCT00434577|6303691|P5|NOT COMPLETED|Months 0-3||3
2570591|NCT00434577|6303692|P4|NOT COMPLETED|Months 0-3||1
2570592|NCT00434577|6303693|P3|NOT COMPLETED|Months 0-3||4
2570593|NCT00434577|6303694|P2|NOT COMPLETED|Months 0-3||2
2570594|NCT00434577|6303695|P1|NOT COMPLETED|Months 0-3||3
2570595|NCT00434577|6303691|P5|COMPLETED|Months 0-3||51
2570596|NCT00434577|6303692|P4|COMPLETED|Months 0-3||164
2570597|NCT00434577|6303693|P3|COMPLETED|Months 0-3||161
2570598|NCT00434577|6303694|P2|COMPLETED|Months 0-3||164
2570599|NCT00434577|6303695|P1|COMPLETED|Months 0-3||161
2570600|NCT00434577|6303691|P5|STARTED|Months 0-3||54
2570601|NCT00434577|6303692|P4|STARTED|Months 0-3||165
2570602|NCT00434577|6303693|P3|STARTED|Months 0-3||165
2570603|NCT00434577|6303694|P2|STARTED|Months 0-3||166
2570604|NCT00434577|6303695|P1|STARTED|Months 0-3||164
2570605|NCT00434512|6303873|P6|NOT COMPLETED|Overall Study||1
2570606|NCT00434512|6303874|P5|NOT COMPLETED|Overall Study||1
2570607|NCT00434512|6303875|P4|NOT COMPLETED|Overall Study||1
2570608|NCT00434512|6303876|P3|NOT COMPLETED|Overall Study||0
2570609|NCT00434512|6303877|P2|NOT COMPLETED|Overall Study||1
2570610|NCT00434512|6303878|P1|NOT COMPLETED|Overall Study||0
2570611|NCT00434512|6303873|P6|COMPLETED|Overall Study||49
2570612|NCT00434512|6303874|P5|COMPLETED|Overall Study||49
2570613|NCT00434512|6303875|P4|COMPLETED|Overall Study||49
2570614|NCT00434512|6303876|P3|COMPLETED|Overall Study||10
2570615|NCT00434512|6303877|P2|COMPLETED|Overall Study||9
2570616|NCT00434512|6303878|P1|COMPLETED|Overall Study||10
2570617|NCT00434512|6303873|P6|STARTED|Overall Study||50
2570618|NCT00434512|6303874|P5|STARTED|Overall Study||50
2570619|NCT00434512|6303875|P4|STARTED|Overall Study||50
2570620|NCT00434512|6303876|P3|STARTED|Overall Study||10
2570621|NCT00434512|6303877|P2|STARTED|Overall Study||10
2570622|NCT00434512|6303878|P1|STARTED|Overall Study||10
2570623|NCT00434434|6303979|P3|NOT COMPLETED|Overall Study||1
2570624|NCT00434434|6303980|P2|NOT COMPLETED|Overall Study||0
2570625|NCT00434434|6303981|P1|NOT COMPLETED|Overall Study||2
2570626|NCT00434434|6303979|P3|COMPLETED|Overall Study||13
2570627|NCT00434434|6303980|P2|COMPLETED|Overall Study||24
2570628|NCT00434434|6303981|P1|COMPLETED|Overall Study||21
2570629|NCT00434434|6303979|P3|STARTED|Overall Study||14
2570630|NCT00434434|6303980|P2|STARTED|Overall Study||24
2570631|NCT00434434|6303981|P1|STARTED|Overall Study||23
2570632|NCT00434421|6303992|P1|NOT COMPLETED|Overall Study||2
2570633|NCT00434421|6303992|P1|COMPLETED|Overall Study||26
2570634|NCT00434421|6303992|P1|STARTED|Overall Study||28
2570635|NCT00434356|6303998|P2|NOT COMPLETED|Overall Study||23
2570636|NCT00434356|6303999|P1|NOT COMPLETED|Overall Study||23
2570637|NCT00434356|6303998|P2|COMPLETED|Overall Study||0
2570638|NCT00434356|6303999|P1|COMPLETED|Overall Study||0
2570639|NCT00434356|6303998|P2|STARTED|Overall Study||23
2570640|NCT00434356|6303999|P1|STARTED|Overall Study||23
2570641|NCT00434330|6304020|P6|NOT COMPLETED|Overall Study||1
2570642|NCT00434330|6304021|P5|NOT COMPLETED|Overall Study||1
2570643|NCT00434330|6304022|P4|NOT COMPLETED|Overall Study||2
2570644|NCT00434330|6304023|P3|NOT COMPLETED|Overall Study||3
2570645|NCT00434330|6304024|P2|NOT COMPLETED|Overall Study||0
2570646|NCT00434330|6304025|P1|NOT COMPLETED|Overall Study||1
2570647|NCT00434330|6304020|P6|COMPLETED|Overall Study||14
2570648|NCT00434330|6304021|P5|COMPLETED|Overall Study||14
2570649|NCT00434330|6304022|P4|COMPLETED|Overall Study||13
2570650|NCT00434330|6304023|P3|COMPLETED|Overall Study||13
2570651|NCT00434330|6304024|P2|COMPLETED|Overall Study||15
2570652|NCT00434330|6304025|P1|COMPLETED|Overall Study||14
2570653|NCT00434330|6304020|P6|STARTED|Overall Study||15
2570654|NCT00434330|6304021|P5|STARTED|Overall Study||15
2570655|NCT00434330|6304022|P4|STARTED|Overall Study||15
2570656|NCT00434330|6304023|P3|STARTED|Overall Study||16
2570657|NCT00434330|6304024|P2|STARTED|Overall Study||15
2570658|NCT00434330|6304025|P1|STARTED|Overall Study||15
2570659|NCT00434304|6304057|P1|NOT COMPLETED|Overall Study||20
2570660|NCT00434304|6304057|P1|COMPLETED|Overall Study||42
2570661|NCT00434304|6304057|P1|STARTED|Overall Study||62
2570662|NCT00434278|6304095|P2|NOT COMPLETED|Overall Study||0
2570663|NCT00434278|6304096|P1|NOT COMPLETED|Overall Study||2
2570664|NCT00434278|6304095|P2|COMPLETED|Overall Study||13
2570665|NCT00434278|6304096|P1|COMPLETED|Overall Study||12
2570666|NCT00434278|6304095|P2|STARTED|Overall Study||13
2570667|NCT00434278|6304096|P1|STARTED|Overall Study||14
2570668|NCT00434252|6304106|P2|NOT COMPLETED|Overall Study||131
2570669|NCT00434252|6304107|P1|NOT COMPLETED|Overall Study||64
2570670|NCT00434252|6304106|P2|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|12
2570671|NCT00434252|6304107|P1|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|7
2570672|NCT00434252|6304106|P2|Treated|Overall Study||143
2570673|NCT00434252|6304107|P1|Treated|Overall Study|One patient died and one patient withdrew prior to receiving study treatment|69
2570674|NCT00434252|6304106|P2|STARTED|Overall Study||143
2570675|NCT00434252|6304107|P1|STARTED|Overall Study||71
2570676|NCT00434226|6304129|P2|NOT COMPLETED|Overall Study||26
2570677|NCT00434226|6304130|P1|NOT COMPLETED|Overall Study||30
2570678|NCT00434226|6304129|P2|COMPLETED|Overall Study||0
2570679|NCT00434226|6304130|P1|COMPLETED|Overall Study||0
2570680|NCT00434226|6304129|P2|STARTED|Overall Study||26
2570681|NCT00434226|6304130|P1|STARTED|Overall Study||30
2570682|NCT00434213|6304141|P1|NOT COMPLETED|Overall Study||49
2570683|NCT00434213|6304141|P1|COMPLETED|Overall Study||260
2570684|NCT00434213|6304141|P1|STARTED|Overall Study||309
2570685|NCT00434161|6304149|P3|NOT COMPLETED|Overall Study||11
2570686|NCT00434161|6304150|P2|NOT COMPLETED|Overall Study||3
2570687|NCT00434161|6304151|P1|NOT COMPLETED|Overall Study||10
2570688|NCT00434161|6304149|P3|COMPLETED|Overall Study||104
2570689|NCT00434161|6304150|P2|COMPLETED|Overall Study||54
2570690|NCT00434161|6304151|P1|COMPLETED|Overall Study||99
2570691|NCT00434161|6304149|P3|STARTED|Overall Study||115
2570692|NCT00434161|6304150|P2|STARTED|Overall Study||57
2570693|NCT00434161|6304151|P1|STARTED|Overall Study||109
2570694|NCT00434148|6304195|P2|NOT COMPLETED|Overall Study||73
2570695|NCT00434148|6304196|P1|NOT COMPLETED|Overall Study||69
2570696|NCT00434148|6304195|P2|COMPLETED|Overall Study||7
2570697|NCT00434148|6304196|P1|COMPLETED|Overall Study||13
2570698|NCT00434148|6304195|P2|Completed Month 12; Entered Extension|Overall Study||32
2570699|NCT00434148|6304196|P1|Completed Month 12; Entered Extension|Overall Study||26
2570700|NCT00434148|6304195|P2|Completed m. 12; Did Not Enter Extension|Overall Study||7
2570701|NCT00434148|6304196|P1|Completed m. 12; Did Not Enter Extension|Overall Study||13
2570702|NCT00434148|6304195|P2|Completed Month 12|Overall Study||39
2570703|NCT00434148|6304196|P1|Completed Month 12|Overall Study||39
2570704|NCT00434148|6304195|P2|STARTED|Overall Study||80
2570705|NCT00434148|6304196|P1|STARTED|Overall Study|"Started indicates Full Analysis Set. Patients randomized and treated."|82
2570706|NCT00434122|6304232|P2|NOT COMPLETED|Overall Study||7
2570707|NCT00434122|6304233|P1|NOT COMPLETED|Overall Study||6
2570708|NCT00434122|6304232|P2|COMPLETED|Overall Study||36
2570709|NCT00434122|6304233|P1|COMPLETED|Overall Study||36
2570710|NCT00434122|6304232|P2|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
2570711|NCT00434122|6304233|P1|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
2570712|NCT00434122|6304232|P2|STARTED|Overall Study|Randomised|43
2570713|NCT00434122|6304233|P1|STARTED|Overall Study|Randomised|42
2570714|NCT00434109|6304242|P1|NOT COMPLETED|Overall Study||18
2570715|NCT00434109|6304242|P1|COMPLETED|Overall Study|Patients completing the maximum eight cycles of sunitinib.|21
2570716|NCT00434109|6304242|P1|STARTED|Overall Study||39
2570717|NCT00434057|6304251|P1|NOT COMPLETED|Overall Study||1
2570718|NCT00434057|6304251|P1|COMPLETED|Overall Study|One patient withdrew from the study after signing the Informed Consent Form|1382
2570719|NCT00434057|6304251|P1|STARTED|Overall Study||1383
2570720|NCT00434018|6304257|P2|NOT COMPLETED|Overall Study||12
2570721|NCT00434018|6304258|P1|NOT COMPLETED|Overall Study||17
2570722|NCT00434018|6304257|P2|COMPLETED|Overall Study||57
2570723|NCT00434018|6304258|P1|COMPLETED|Overall Study||52
2570724|NCT00434018|6304257|P2|STARTED|Overall Study||69
2570725|NCT00434018|6304258|P1|STARTED|Overall Study||69
2570726|NCT00433992|6304276|P2|NOT COMPLETED|Overall Study||8
2570727|NCT00433992|6304277|P1|NOT COMPLETED|Overall Study||9
2570728|NCT00433992|6304276|P2|COMPLETED|Overall Study||20
2570729|NCT00433992|6304277|P1|COMPLETED|Overall Study||19
2570730|NCT00433992|6304276|P2|STARTED|Overall Study||28
2570731|NCT00433992|6304277|P1|STARTED|Overall Study||28
2570732|NCT00433966|6304289|P4|NOT COMPLETED|Stent Intervention/Randomization||62
2570733|NCT00433966|6304290|P3|NOT COMPLETED|Stent Intervention/Randomization||154
2570734|NCT00433966|6304291|P2|NOT COMPLETED|Stent Intervention/Randomization||0
2570735|NCT00433966|6304292|P1|NOT COMPLETED|Stent Intervention/Randomization||0
2570736|NCT00433966|6304289|P4|COMPLETED|Stent Intervention/Randomization||687
2570737|NCT00433966|6304290|P3|COMPLETED|Stent Intervention/Randomization||2103
2570738|NCT00433966|6304291|P2|COMPLETED|Stent Intervention/Randomization||0
2570739|NCT00433966|6304292|P1|COMPLETED|Stent Intervention/Randomization||0
2570740|NCT00433966|6304289|P4|3-Year Follow-up|Stent Intervention/Randomization||687
2570741|NCT00433966|6304290|P3|3-Year Follow-up|Stent Intervention/Randomization||2103
2570742|NCT00433966|6304291|P2|3-Year Follow-up|Stent Intervention/Randomization||0
2570743|NCT00433966|6304292|P1|3-Year Follow-up|Stent Intervention/Randomization||0
2570744|NCT00433966|6304289|P4|1-Year Follow-up|Stent Intervention/Randomization||715
2570745|NCT00433966|6304290|P3|1-Year Follow-up|Stent Intervention/Randomization||2186
2570746|NCT00433966|6304291|P2|1-Year Follow-up|Stent Intervention/Randomization||0
2570747|NCT00433966|6304292|P1|1-Year Follow-up|Stent Intervention/Randomization||0
2570748|NCT00433966|6304289|P4|STARTED|Stent Intervention/Randomization||749
2570749|NCT00433966|6304290|P3|STARTED|Stent Intervention/Randomization||2257
2570750|NCT00433966|6304291|P2|STARTED|Stent Intervention/Randomization||0
2570751|NCT00433966|6304292|P1|STARTED|Stent Intervention/Randomization||0
2570752|NCT00433966|6304289|P4|NOT COMPLETED|Pharmacology Intervention/Randomization||0
2570753|NCT00433966|6304290|P3|NOT COMPLETED|Pharmacology Intervention/Randomization||0
2570754|NCT00433966|6304291|P2|NOT COMPLETED|Pharmacology Intervention/Randomization||174
2570755|NCT00433966|6304292|P1|NOT COMPLETED|Pharmacology Intervention/Randomization||166
2570756|NCT00433966|6304289|P4|COMPLETED|Pharmacology Intervention/Randomization||0
2570757|NCT00433966|6304290|P3|COMPLETED|Pharmacology Intervention/Randomization||0
2570758|NCT00433966|6304291|P2|COMPLETED|Pharmacology Intervention/Randomization||1628
2570759|NCT00433966|6304292|P1|COMPLETED|Pharmacology Intervention/Randomization||1634
2570760|NCT00433966|6304289|P4|3-Year Follow-up|Pharmacology Intervention/Randomization||0
2570761|NCT00433966|6304290|P3|3-Year Follow-up|Pharmacology Intervention/Randomization||0
2570762|NCT00433966|6304291|P2|3-Year Follow-up|Pharmacology Intervention/Randomization||1628
2570763|NCT00433966|6304292|P1|3-Year Follow-up|Pharmacology Intervention/Randomization||1634
2570764|NCT00433966|6304289|P4|1-Year Follow-up|Pharmacology Intervention/Randomization||0
2570765|NCT00433966|6304290|P3|1-Year Follow-up|Pharmacology Intervention/Randomization||0
2570766|NCT00433966|6304291|P2|1-Year Follow-up|Pharmacology Intervention/Randomization||1702
2570767|NCT00433966|6304292|P1|1-Year Follow-up|Pharmacology Intervention/Randomization||1696
2570768|NCT00433966|6304289|P4|30-Day Follow-up|Pharmacology Intervention/Randomization||0
2570769|NCT00433966|6304290|P3|30-Day Follow-up|Pharmacology Intervention/Randomization||0
2570770|NCT00433966|6304291|P2|30-Day Follow-up|Pharmacology Intervention/Randomization||1791
2570771|NCT00433966|6304292|P1|30-Day Follow-up|Pharmacology Intervention/Randomization||1787
2570772|NCT00433966|6304289|P4|STARTED|Pharmacology Intervention/Randomization||0
2570773|NCT00433966|6304290|P3|STARTED|Pharmacology Intervention/Randomization||0
2570774|NCT00433966|6304291|P2|STARTED|Pharmacology Intervention/Randomization||1802
2570775|NCT00433966|6304292|P1|STARTED|Pharmacology Intervention/Randomization||1800
2570776|NCT00433914|6304314|P2|NOT COMPLETED|Overall Study||3
2570777|NCT00433914|6304315|P1|NOT COMPLETED|Overall Study||0
2570778|NCT00433914|6304314|P2|COMPLETED|Overall Study||27
2570779|NCT00433914|6304315|P1|COMPLETED|Overall Study||30
2570780|NCT00433914|6304314|P2|STARTED|Overall Study||30
2570781|NCT00433914|6304315|P1|STARTED|Overall Study||30
2570782|NCT00433836|6304335|P2|NOT COMPLETED|Overall Study||6
2570783|NCT00433836|6304336|P1|NOT COMPLETED|Overall Study||13
2570784|NCT00433836|6304335|P2|COMPLETED|Overall Study||143
2570785|NCT00433836|6304336|P1|COMPLETED|Overall Study||138
2570786|NCT00433836|6304335|P2|STARTED|Overall Study||149
2570787|NCT00433836|6304336|P1|STARTED|Overall Study||151
2570788|NCT00433771|6304348|P1|NOT COMPLETED|Overall Study||19
2570789|NCT00433771|6304348|P1|COMPLETED|Overall Study|55 out of 58 patients were evaluable(had a stent placed and had at least 1 week of follow up)|55
2570790|NCT00433771|6304348|P1|STARTED|Overall Study|74 enrolled patients(signed an Informed Consent Form)were screened.58 were eligible(intent to treat)|74
2570791|NCT00433745|6304364|P1|NOT COMPLETED|Overall Study||0
2570792|NCT00433745|6304364|P1|COMPLETED|Overall Study||4
2570793|NCT00433745|6304364|P1|STARTED|Overall Study||4
2570794|NCT00433654|6304371|P2|NOT COMPLETED|Overall Study||5
2570795|NCT00433654|6304372|P1|NOT COMPLETED|Overall Study||15
2570796|NCT00433654|6304371|P2|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|201
2570797|NCT00433654|6304372|P1|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|243
2570798|NCT00433654|6304371|P2|STARTED|Overall Study||206
2570799|NCT00433654|6304372|P1|STARTED|Overall Study||258
2570800|NCT00433550|6304406|P3|NOT COMPLETED|Overall Study||0
2570801|NCT00433550|6304407|P2|NOT COMPLETED|Overall Study||0
2570802|NCT00433550|6304408|P1|NOT COMPLETED|Overall Study||0
2570803|NCT00433550|6304406|P3|COMPLETED|Overall Study||6
2570804|NCT00433550|6304407|P2|COMPLETED|Overall Study||10
2570805|NCT00433550|6304408|P1|COMPLETED|Overall Study||17
2570806|NCT00433550|6304406|P3|STARTED|Overall Study||6
2570807|NCT00433550|6304407|P2|STARTED|Overall Study||10
2570808|NCT00433550|6304408|P1|STARTED|Overall Study||17
2570809|NCT00433537|6304418|P3|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
2570810|NCT00433537|6304419|P2|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
2570811|NCT00433537|6304420|P1|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||16
2570812|NCT00433537|6304418|P3|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
2570813|NCT00433537|6304419|P2|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||22
2570814|NCT00433537|6304420|P1|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||29
2570815|NCT00433537|6304418|P3|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||0
2570816|NCT00433537|6304419|P2|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||22
2570817|NCT00433537|6304420|P1|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||44
2570818|NCT00433537|6304418|P3|STARTED|Step 2 - Maintenance Rituximab or ASCT|One patient completed VcR-CVAD and then withdrew from the study.|0
2570819|NCT00433537|6304419|P2|STARTED|Step 2 - Maintenance Rituximab or ASCT||22
2570820|NCT00433537|6304420|P1|STARTED|Step 2 - Maintenance Rituximab or ASCT|This included all treated patients regardless of eligibility.|45
2570821|NCT00433537|6304418|P3|NOT COMPLETED|Step 1 - VcR-CVAD Induction||9
2570822|NCT00433537|6304419|P2|NOT COMPLETED|Step 1 - VcR-CVAD Induction||0
2570823|NCT00433537|6304420|P1|NOT COMPLETED|Step 1 - VcR-CVAD Induction||1
2570824|NCT00433537|6304418|P3|COMPLETED|Step 1 - VcR-CVAD Induction||1
2570825|NCT00433537|6304419|P2|COMPLETED|Step 1 - VcR-CVAD Induction||22
2570826|NCT00433537|6304420|P1|COMPLETED|Step 1 - VcR-CVAD Induction||44
2570827|NCT00433537|6304418|P3|Eligible and Treated|Step 1 - VcR-CVAD Induction||9
2570828|NCT00433537|6304419|P2|Eligible and Treated|Step 1 - VcR-CVAD Induction||22
2570829|NCT00433537|6304420|P1|Eligible and Treated|Step 1 - VcR-CVAD Induction||44
2570830|NCT00433537|6304418|P3|STARTED|Step 1 - VcR-CVAD Induction||10
2570831|NCT00433537|6304419|P2|STARTED|Step 1 - VcR-CVAD Induction||22
2570832|NCT00433537|6304420|P1|STARTED|Step 1 - VcR-CVAD Induction||45
2570860|NCT00433446|6304448|P1|NOT COMPLETED|Overall Study||61
2570861|NCT00433446|6304448|P1|COMPLETED|Overall Study||1
2570862|NCT00433446|6304448|P1|Eligible and Began Protocol Therapy|Overall Study||53
2570863|NCT00433446|6304448|P1|Eligible|Overall Study||53
2570864|NCT00433446|6304448|P1|STARTED|Overall Study||62
2570865|NCT00433381|6304458|P2|NOT COMPLETED|Overall Study||3
2570866|NCT00433381|6304459|P1|NOT COMPLETED|Overall Study||3
2570867|NCT00433381|6304458|P2|COMPLETED|Overall Study||57
2570868|NCT00433381|6304459|P1|COMPLETED|Overall Study|Subjects contributing data to [the primary] analysis are considered to have completed the study.|60
2570869|NCT00433381|6304458|P2|STARTED|Overall Study||60
2570870|NCT00433381|6304459|P1|STARTED|Overall Study||63
2570871|NCT00433329|6304478|P1|NOT COMPLETED|Overall Study||21
2570872|NCT00433329|6304478|P1|COMPLETED|Overall Study||79
2570873|NCT00433329|6304478|P1|STARTED|Overall Study||100
2570874|NCT00433290|6304484|P2|NOT COMPLETED|Overall Study||17
2570875|NCT00433290|6304485|P1|NOT COMPLETED|Overall Study||35
2570876|NCT00433290|6304484|P2|COMPLETED|Overall Study||111
2570877|NCT00433290|6304485|P1|COMPLETED|Overall Study||93
2570878|NCT00433290|6304484|P2|STARTED|Overall Study||128
2570879|NCT00433290|6304485|P1|STARTED|Overall Study||128
2570880|NCT00433199|6304554|P2|NOT COMPLETED|Open-Label Period||34
2570881|NCT00433199|6304555|P1|NOT COMPLETED|Open-Label Period||0
2570882|NCT00433199|6304554|P2|COMPLETED|Open-Label Period||185
2570883|NCT00433199|6304555|P1|COMPLETED|Open-Label Period||0
2570884|NCT00433199|6304554|P2|STARTED|Open-Label Period||219
2570885|NCT00433199|6304555|P1|STARTED|Open-Label Period||0
2570886|NCT00433199|6304554|P2|NOT COMPLETED|Double-Blind Period||66
2570887|NCT00433199|6304555|P1|NOT COMPLETED|Double-Blind Period||12
2570888|NCT00433199|6304554|P2|COMPLETED|Double-Blind Period||168
2570889|NCT00433199|6304555|P1|COMPLETED|Double-Blind Period||28
2570890|NCT00433199|6304554|P2|STARTED|Double-Blind Period||234
2570891|NCT00433199|6304555|P1|STARTED|Double-Blind Period||40
2570892|NCT00433160|6304575|P2|NOT COMPLETED|104 Weeks, 28-Week OL Period||3
2570893|NCT00433160|6304576|P1|NOT COMPLETED|104 Weeks, 28-Week OL Period||10
2570894|NCT00433160|6304575|P2|COMPLETED|104 Weeks, 28-Week OL Period||47
2570895|NCT00433160|6304576|P1|COMPLETED|104 Weeks, 28-Week OL Period||92
2570896|NCT00433160|6304575|P2|Received Treatment|104 Weeks, 28-Week OL Period||50
2570897|NCT00433160|6304576|P1|Received Treatment|104 Weeks, 28-Week OL Period||102
2570898|NCT00433160|6304575|P2|STARTED|104 Weeks, 28-Week OL Period|Five participants withdrew at end of first OL period and did not continue on to second OL period.|50
2570899|NCT00433160|6304576|P1|STARTED|104 Weeks, 28-Week OL Period|Eleven participants withdrew at end of first OL period and did not continue on to second OL period.|102
2570900|NCT00433160|6304575|P2|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||4
2570901|NCT00433160|6304576|P1|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||6
2570902|NCT00433160|6304575|P2|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||55
2570903|NCT00433160|6304576|P1|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||113
2570904|NCT00433160|6304575|P2|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||59
2570905|NCT00433160|6304576|P1|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||119
2570906|NCT00433160|6304575|P2|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|59
2570907|NCT00433160|6304576|P1|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|119
2570908|NCT00433160|6304575|P2|NOT COMPLETED|52-Week Double-Blind (DB) Period||10
2570909|NCT00433160|6304576|P1|NOT COMPLETED|52-Week Double-Blind (DB) Period||17
2570910|NCT00433160|6304575|P2|COMPLETED|52-Week Double-Blind (DB) Period||60
2570911|NCT00433160|6304576|P1|COMPLETED|52-Week Double-Blind (DB) Period||120
2570912|NCT00433160|6304575|P2|Received Treatment|52-Week Double-Blind (DB) Period||68
2570913|NCT00433160|6304576|P1|Received Treatment|52-Week Double-Blind (DB) Period||136
2570914|NCT00433160|6304575|P2|STARTED|52-Week Double-Blind (DB) Period||70
2570915|NCT00433160|6304576|P1|STARTED|52-Week Double-Blind (DB) Period||137
2570916|NCT00433147|6304628|P4|NOT COMPLETED|Overall Study||0
2570917|NCT00433147|6304629|P3|NOT COMPLETED|Overall Study||0
2570918|NCT00433147|6304630|P2|NOT COMPLETED|Overall Study||1
2570919|NCT00433147|6304631|P1|NOT COMPLETED|Overall Study||0
2570920|NCT00433147|6304628|P4|COMPLETED|Overall Study||7
2570921|NCT00433147|6304629|P3|COMPLETED|Overall Study||9
2570922|NCT00433147|6304630|P2|COMPLETED|Overall Study||6
2570923|NCT00433147|6304631|P1|COMPLETED|Overall Study||7
2570924|NCT00433147|6304628|P4|Received at Least One Dose of Study Drug|Overall Study||7
2570925|NCT00433147|6304629|P3|Received at Least One Dose of Study Drug|Overall Study||9
2570926|NCT00433147|6304630|P2|Received at Least One Dose of Study Drug|Overall Study||7
2570927|NCT00433147|6304631|P1|Received at Least One Dose of Study Drug|Overall Study||7
2570928|NCT00433147|6304628|P4|PD Population|Overall Study||7
2570929|NCT00433147|6304629|P3|PD Population|Overall Study||9
2570930|NCT00433147|6304630|P2|PD Population|Overall Study||6
2570931|NCT00433147|6304631|P1|PD Population|Overall Study||7
2570932|NCT00433147|6304628|P4|Safety Population|Overall Study||7
2570933|NCT00433147|6304629|P3|Safety Population|Overall Study||9
2570934|NCT00433147|6304630|P2|Safety Population|Overall Study||7
2570935|NCT00433147|6304631|P1|Safety Population|Overall Study||7
2570936|NCT00433147|6304628|P4|STARTED|Overall Study||7
2570937|NCT00433147|6304629|P3|STARTED|Overall Study||9
2570938|NCT00433147|6304630|P2|STARTED|Overall Study||7
2570939|NCT00433147|6304631|P1|STARTED|Overall Study||7
2570940|NCT00433017|6304647|P2|NOT COMPLETED|Overall Study||101
2570941|NCT00433017|6304648|P1|NOT COMPLETED|Overall Study||96
2570942|NCT00433017|6304647|P2|COMPLETED|Overall Study||32
2570943|NCT00433017|6304648|P1|COMPLETED|Overall Study||26
2570944|NCT00433017|6304647|P2|Completed 12 Month Phase|Overall Study||126
2570945|NCT00433017|6304648|P1|Completed 12 Month Phase|Overall Study||114
2570946|NCT00433017|6304647|P2|STARTED|Overall Study||133
2570947|NCT00433017|6304648|P1|STARTED|Overall Study||122
2570948|NCT00433004|6304664|P2|NOT COMPLETED|Overall Study||7
2570949|NCT00433004|6304665|P1|NOT COMPLETED|Overall Study||5
2570950|NCT00433004|6304664|P2|COMPLETED|Overall Study||16
2570951|NCT00433004|6304665|P1|COMPLETED|Overall Study||22
2570952|NCT00433004|6304664|P2|STARTED|Overall Study||23
2570953|NCT00433004|6304665|P1|STARTED|Overall Study||27
2570954|NCT00432991|6304677|P2|NOT COMPLETED|Overall Study||12
2570955|NCT00432991|6304678|P1|NOT COMPLETED|Overall Study||7
2570956|NCT00432991|6304677|P2|COMPLETED|Overall Study||19
2570957|NCT00432991|6304678|P1|COMPLETED|Overall Study||15
2570958|NCT00432991|6304677|P2|STARTED|Overall Study||31
2570959|NCT00432991|6304678|P1|STARTED|Overall Study||22
2570960|NCT00432965|6304690|P2|NOT COMPLETED|Overall Study||86
2570961|NCT00432965|6304691|P1|NOT COMPLETED|Overall Study||94
2570962|NCT00432965|6304690|P2|COMPLETED|Overall Study||80
2570963|NCT00432965|6304691|P1|COMPLETED|Overall Study||75
2570964|NCT00432965|6304690|P2|STARTED|Overall Study||166
2570965|NCT00432965|6304691|P1|STARTED|Overall Study||169
2570966|NCT00432835|6304699|P2|NOT COMPLETED|Overall Study||7
2570967|NCT00432835|6304700|P1|NOT COMPLETED|Overall Study||6
2570968|NCT00432835|6304699|P2|COMPLETED|Overall Study|These 23 patients completed the entire 8 day protocol.|23
2570969|NCT00432835|6304700|P1|COMPLETED|Overall Study|These 22 patients completed the entire 8 day protocol.|22
2570970|NCT00432835|6304699|P2|Completed 2nd Intervention|Overall Study||23
2570971|NCT00432835|6304700|P1|Completed 2nd Intervention|Overall Study||22
2570972|NCT00432835|6304699|P2|Completed 1st Intervention|Overall Study||23
2570973|NCT00432835|6304700|P1|Completed 1st Intervention|Overall Study||22
2570974|NCT00432835|6304699|P2|STARTED|Overall Study||30
2570975|NCT00432835|6304700|P1|STARTED|Overall Study||28
2570976|NCT00432809|6304713|P3|NOT COMPLETED|2 Year Sub-study||1
2570977|NCT00432809|6304714|P2|NOT COMPLETED|2 Year Sub-study||2
2570978|NCT00432809|6304715|P1|NOT COMPLETED|2 Year Sub-study||3
2570979|NCT00432809|6304713|P3|COMPLETED|2 Year Sub-study||19
2570980|NCT00432809|6304714|P2|COMPLETED|2 Year Sub-study||18
2570981|NCT00432809|6304715|P1|COMPLETED|2 Year Sub-study||17
2570982|NCT00432809|6304713|P3|STARTED|2 Year Sub-study||20
2570983|NCT00432809|6304714|P2|STARTED|2 Year Sub-study||20
2570984|NCT00432809|6304715|P1|STARTED|2 Year Sub-study||20
2570985|NCT00432809|6304713|P3|NOT COMPLETED|1 Year Follow-up||1
2570986|NCT00432809|6304714|P2|NOT COMPLETED|1 Year Follow-up||0
2570987|NCT00432809|6304715|P1|NOT COMPLETED|1 Year Follow-up||9
2570988|NCT00432809|6304713|P3|COMPLETED|1 Year Follow-up||49
2570989|NCT00432809|6304714|P2|COMPLETED|1 Year Follow-up||50
2570990|NCT00432809|6304715|P1|COMPLETED|1 Year Follow-up||41
2570991|NCT00432809|6304713|P3|STARTED|1 Year Follow-up||50
2570992|NCT00432809|6304714|P2|STARTED|1 Year Follow-up||50
2570993|NCT00432809|6304715|P1|STARTED|1 Year Follow-up||50
2570994|NCT00432744|6304788|P2|NOT COMPLETED|Months 7 - 12||1
2570995|NCT00432744|6304789|P1|NOT COMPLETED|Months 7 - 12||1
2570996|NCT00432744|6304788|P2|COMPLETED|Months 7 - 12||7
2570997|NCT00432744|6304789|P1|COMPLETED|Months 7 - 12||6
2570998|NCT00432744|6304788|P2|STARTED|Months 7 - 12||8
2570999|NCT00432744|6304789|P1|STARTED|Months 7 - 12||7
2571000|NCT00432744|6304788|P2|NOT COMPLETED|Months 0-6||4
2571001|NCT00432744|6304789|P1|NOT COMPLETED|Months 0-6||5
2571002|NCT00432744|6304788|P2|COMPLETED|Months 0-6|"One patient in period 1 other reason for loss became too disabled to complete the 6 month test."|8
2571003|NCT00432744|6304789|P1|COMPLETED|Months 0-6||7
2571004|NCT00432744|6304788|P2|STARTED|Months 0-6||12
2571005|NCT00432744|6304789|P1|STARTED|Months 0-6||12
2571006|NCT00432679|6304801|P2|NOT COMPLETED|Overall Study||3
2571007|NCT00432679|6304802|P1|NOT COMPLETED|Overall Study||5
2571008|NCT00432679|6304801|P2|COMPLETED|Overall Study||72
2571009|NCT00432679|6304802|P1|COMPLETED|Overall Study||69
2571010|NCT00432679|6304801|P2|STARTED|Overall Study||75
2571011|NCT00432679|6304802|P1|STARTED|Overall Study||74
2571012|NCT00432666|6304826|P2|NOT COMPLETED|Open-Label Extension Period||0
2571013|NCT00432666|6304827|P1|NOT COMPLETED|Open-Label Extension Period||25
2571014|NCT00432666|6304826|P2|COMPLETED|Open-Label Extension Period||0
2571015|NCT00432666|6304827|P1|COMPLETED|Open-Label Extension Period||120
2571016|NCT00432666|6304826|P2|STARTED|Open-Label Extension Period|In the Open-Label Extension Period no placebo treatment arm was given.|0
2571017|NCT00432666|6304827|P1|STARTED|Open-Label Extension Period||145
2571018|NCT00432666|6304826|P2|NOT COMPLETED|Main Period||1
2571019|NCT00432666|6304827|P1|NOT COMPLETED|Main Period||2
2571020|NCT00432666|6304826|P2|COMPLETED|Main Period||74
2571021|NCT00432666|6304827|P1|COMPLETED|Main Period||71
2571022|NCT00432666|6304826|P2|STARTED|Main Period||75
2571023|NCT00432666|6304827|P1|STARTED|Main Period||73
2571024|NCT00432601|6304991|P2|NOT COMPLETED|Time 2 to Time 3||22
2571025|NCT00432601|6304992|P1|NOT COMPLETED|Time 2 to Time 3||19
2571026|NCT00432601|6304991|P2|COMPLETED|Time 2 to Time 3||122
2571027|NCT00432601|6304992|P1|COMPLETED|Time 2 to Time 3||122
2571028|NCT00432601|6304991|P2|STARTED|Time 2 to Time 3||144
2571029|NCT00432601|6304992|P1|STARTED|Time 2 to Time 3||141
2571030|NCT00432601|6304991|P2|NOT COMPLETED|Time 1 to Time 2||368
2571031|NCT00432601|6304992|P1|NOT COMPLETED|Time 1 to Time 2||369
2571032|NCT00432601|6304991|P2|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|144
2571033|NCT00432601|6304992|P1|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|141
2571034|NCT00432601|6304991|P2|STARTED|Time 1 to Time 2||512
2571035|NCT00432601|6304992|P1|STARTED|Time 1 to Time 2||510
2571036|NCT00432562|6305000|P2|NOT COMPLETED|Overall Study||0
2571037|NCT00432562|6305001|P1|NOT COMPLETED|Overall Study||3
2571038|NCT00432562|6305000|P2|COMPLETED|Overall Study||15
2571039|NCT00432562|6305001|P1|COMPLETED|Overall Study||13
2571040|NCT00432562|6305000|P2|STARTED|Overall Study||15
2571041|NCT00432562|6305001|P1|STARTED|Overall Study||16
2571042|NCT00432458|6305027|P2|NOT COMPLETED|Overall Study||1
2571043|NCT00432458|6305028|P1|NOT COMPLETED|Overall Study||5
2571044|NCT00432458|6305027|P2|COMPLETED|Overall Study||32
2571045|NCT00432458|6305028|P1|COMPLETED|Overall Study||30
2571046|NCT00432458|6305027|P2|STARTED|Overall Study||33
2571047|NCT00432458|6305028|P1|STARTED|Overall Study||35
2571048|NCT00432445|6305046|P1|NOT COMPLETED|Overall Study||0
2571049|NCT00432445|6305046|P1|COMPLETED|Overall Study||2
2571050|NCT00432445|6305046|P1|STARTED|Overall Study||2
2571051|NCT00432380|6305053|P3|NOT COMPLETED|Overall Study||1
2571052|NCT00432380|6305054|P2|NOT COMPLETED|Overall Study||4
2571053|NCT00432380|6305055|P1|NOT COMPLETED|Overall Study||4
2571054|NCT00432380|6305053|P3|COMPLETED|Overall Study||74
2571055|NCT00432380|6305054|P2|COMPLETED|Overall Study||146
2571056|NCT00432380|6305055|P1|COMPLETED|Overall Study||146
2571057|NCT00432380|6305053|P3|STARTED|Overall Study||75
2571058|NCT00432380|6305054|P2|STARTED|Overall Study||150
2571059|NCT00432380|6305055|P1|STARTED|Overall Study||150
2571060|NCT00432341|6305081|P2|NOT COMPLETED|Overall Study||0
2571061|NCT00432341|6305082|P1|NOT COMPLETED|Overall Study||0
2571062|NCT00432341|6305081|P2|COMPLETED|Overall Study||30
2571063|NCT00432341|6305082|P1|COMPLETED|Overall Study||24
2571064|NCT00432341|6305081|P2|STARTED|Overall Study||30
2571065|NCT00432341|6305082|P1|STARTED|Overall Study||24
2571066|NCT00432276|6305108|P2|NOT COMPLETED|Overall Study||156
2571067|NCT00432276|6305109|P1|NOT COMPLETED|Overall Study||121
2571068|NCT00432276|6305108|P2|COMPLETED|Overall Study||243
2571069|NCT00432276|6305109|P1|COMPLETED|Overall Study||283
2571070|NCT00432276|6305108|P2|Per Protocol Set|Overall Study||306
2571071|NCT00432276|6305109|P1|Per Protocol Set|Overall Study|Patients who received at least 1 dose of study medication and who had no major protocol violations.|303
2571072|NCT00432276|6305108|P2|STARTED|Overall Study||399
2571073|NCT00432276|6305109|P1|STARTED|Overall Study||404
2571074|NCT00432237|6305199|P4|NOT COMPLETED|Overall Study||124
2571075|NCT00432237|6305200|P3|NOT COMPLETED|Overall Study||109
2571076|NCT00432237|6305201|P2|NOT COMPLETED|Overall Study||101
2571077|NCT00432237|6305202|P1|NOT COMPLETED|Overall Study||67
2571078|NCT00432237|6305199|P4|COMPLETED|Overall Study||366
2571079|NCT00432237|6305200|P3|COMPLETED|Overall Study||375
2571080|NCT00432237|6305201|P2|COMPLETED|Overall Study||384
2571081|NCT00432237|6305202|P1|COMPLETED|Overall Study||177
2571249|NCT00430781|6305695|P1|Ongoing|Final Analysis; 31 July 2008||0
2571082|NCT00432237|6305199|P4|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
2571083|NCT00432237|6305200|P3|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|5
2571084|NCT00432237|6305201|P2|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|3
2571085|NCT00432237|6305202|P1|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
2571086|NCT00432237|6305199|P4|Completed--With Data|Overall Study||365
2571087|NCT00432237|6305200|P3|Completed--With Data|Overall Study||370
2571088|NCT00432237|6305201|P2|Completed--With Data|Overall Study||381
2571089|NCT00432237|6305202|P1|Completed--With Data|Overall Study||176
2571090|NCT00432237|6305199|P4|STARTED|Overall Study||490
2571091|NCT00432237|6305200|P3|STARTED|Overall Study|1 patient in the MK0974 300 mg group was treated but withdrew consent.|484
2571092|NCT00432237|6305201|P2|STARTED|Overall Study||485
2571093|NCT00432237|6305202|P1|STARTED|Overall Study|1 patient in the MK0974 50 mg group was treated but withdrew consent.|244
2571094|NCT00432172|6305244|P4|NOT COMPLETED|Overall Study||7
2571095|NCT00432172|6305245|P3|NOT COMPLETED|Overall Study||11
2571096|NCT00432172|6305246|P2|NOT COMPLETED|Overall Study||7
2571097|NCT00432172|6305247|P1|NOT COMPLETED|Overall Study||6
2571098|NCT00432172|6305244|P4|COMPLETED|Overall Study||41
2571099|NCT00432172|6305245|P3|COMPLETED|Overall Study||35
2571100|NCT00432172|6305246|P2|COMPLETED|Overall Study||41
2571101|NCT00432172|6305247|P1|COMPLETED|Overall Study||41
2571102|NCT00432172|6305244|P4|STARTED|Overall Study||48
2571103|NCT00432172|6305245|P3|STARTED|Overall Study||46
2571104|NCT00432172|6305246|P2|STARTED|Overall Study||48
2571105|NCT00432172|6305247|P1|STARTED|Overall Study||47
2571106|NCT00432159|6305272|P5|NOT COMPLETED|Overall Study||10
2571107|NCT00432159|6305273|P4|NOT COMPLETED|Overall Study||5
2571108|NCT00432159|6305274|P3|NOT COMPLETED|Overall Study||4
2571109|NCT00432159|6305275|P2|NOT COMPLETED|Overall Study||30
2571110|NCT00432159|6305276|P1|NOT COMPLETED|Overall Study||22
2571111|NCT00432159|6305272|P5|COMPLETED|Overall Study|Actual (Complete efficacy)|79
2571112|NCT00432159|6305273|P4|COMPLETED|Overall Study|Actual (Complete efficacy)|15
2571113|NCT00432159|6305274|P3|COMPLETED|Overall Study|Actual (Complete efficacy)|35
2571114|NCT00432159|6305275|P2|COMPLETED|Overall Study|Actual (Complete efficacy)|137
2571115|NCT00432159|6305276|P1|COMPLETED|Overall Study|Actual (Complete efficacy)|163
2571116|NCT00432159|6305272|P5|STARTED|Overall Study||89
2571117|NCT00432159|6305273|P4|STARTED|Overall Study||20
2571118|NCT00432159|6305274|P3|STARTED|Overall Study||39
2571119|NCT00432159|6305275|P2|STARTED|Overall Study||167
2571120|NCT00432159|6305276|P1|STARTED|Overall Study||185
2571121|NCT00432042|6305383|P3|NOT COMPLETED|Overall Study||2
2571122|NCT00432042|6305384|P2|NOT COMPLETED|Overall Study||1
2571123|NCT00432042|6305385|P1|NOT COMPLETED|Overall Study||7
2571124|NCT00432042|6305383|P3|COMPLETED|Overall Study||239
2571125|NCT00432042|6305384|P2|COMPLETED|Overall Study||234
2571126|NCT00432042|6305385|P1|COMPLETED|Overall Study||472
2571127|NCT00432042|6305383|P3|Vaccinated|Overall Study||240
2571128|NCT00432042|6305384|P2|Vaccinated|Overall Study||235
2571129|NCT00432042|6305385|P1|Vaccinated|Overall Study||477
2571130|NCT00432042|6305383|P3|STARTED|Overall Study|Number randomized.|241
2571131|NCT00432042|6305384|P2|STARTED|Overall Study|Number randomized.|235
2571132|NCT00432042|6305385|P1|STARTED|Overall Study|Number randomized.|479
2571133|NCT00431964|6305398|P2|NOT COMPLETED|Overall Study||8
2571134|NCT00431964|6305399|P1|NOT COMPLETED|Overall Study||6
2571135|NCT00431964|6305398|P2|COMPLETED|Overall Study||124
2571136|NCT00431964|6305399|P1|COMPLETED|Overall Study||125
2571137|NCT00431964|6305398|P2|Withdrew From Study|Overall Study||5
2571138|NCT00431964|6305399|P1|Withdrew From Study|Overall Study||6
2571139|NCT00431964|6305398|P2|Did Not Receive Drug|Overall Study||3
2571140|NCT00431964|6305399|P1|Did Not Receive Drug|Overall Study||0
2571141|NCT00431964|6305398|P2|Randomized/Received Drug|Overall Study||129
2571142|NCT00431964|6305399|P1|Randomized/Received Drug|Overall Study||131
2571143|NCT00431964|6305398|P2|STARTED|Overall Study||132
2571144|NCT00431964|6305399|P1|STARTED|Overall Study||131
2571145|NCT00431951|6305409|P4|NOT COMPLETED|Overall Study||2
2571146|NCT00431951|6305410|P3|NOT COMPLETED|Overall Study||2
2571147|NCT00431951|6305411|P2|NOT COMPLETED|Overall Study||2
2571148|NCT00431951|6305412|P1|NOT COMPLETED|Overall Study||1
2571149|NCT00431951|6305409|P4|COMPLETED|Overall Study||4
2571150|NCT00431951|6305410|P3|COMPLETED|Overall Study||6
2571151|NCT00431951|6305411|P2|COMPLETED|Overall Study||6
2571152|NCT00431951|6305412|P1|COMPLETED|Overall Study||7
2571153|NCT00431951|6305409|P4|STARTED|Overall Study||6
2571154|NCT00431951|6305410|P3|STARTED|Overall Study||8
2571155|NCT00431951|6305411|P2|STARTED|Overall Study||8
2571156|NCT00431951|6305412|P1|STARTED|Overall Study||8
2571157|NCT00431847|6305474|P5|NOT COMPLETED|Overall Study||1
2571158|NCT00431847|6305475|P4|NOT COMPLETED|Overall Study||14
2571159|NCT00431847|6305476|P3|NOT COMPLETED|Overall Study||4
2571160|NCT00431847|6305477|P2|NOT COMPLETED|Overall Study||3
2571161|NCT00431847|6305478|P1|NOT COMPLETED|Overall Study||6
2571162|NCT00431847|6305474|P5|COMPLETED|Overall Study||0
2571163|NCT00431847|6305475|P4|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|170
2571164|NCT00431847|6305476|P3|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|20
2571165|NCT00431847|6305477|P2|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|42
2571250|NCT00430781|6305693|P3|STARTED|Final Analysis; 31 July 2008||74
2571166|NCT00431847|6305478|P1|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|126
2571167|NCT00431847|6305474|P5|STARTED|Overall Study||1
2571168|NCT00431847|6305475|P4|STARTED|Overall Study||184
2571169|NCT00431847|6305476|P3|STARTED|Overall Study||24
2571170|NCT00431847|6305477|P2|STARTED|Overall Study||45
2571171|NCT00431847|6305478|P1|STARTED|Overall Study||132
2571172|NCT00431834|6305552|P1|NOT COMPLETED|Overall Study||13
2571173|NCT00431834|6305552|P1|COMPLETED|Overall Study||62
2571174|NCT00431834|6305552|P1|STARTED|Overall Study||75
2571175|NCT00431626|6305561|P2|NOT COMPLETED|Overall Study||0
2571176|NCT00431626|6305562|P1|NOT COMPLETED|Overall Study||0
2571177|NCT00431626|6305561|P2|COMPLETED|Overall Study||0
2571178|NCT00431626|6305562|P1|COMPLETED|Overall Study||4
2571179|NCT00431626|6305561|P2|STARTED|Overall Study||0
2571180|NCT00431626|6305562|P1|STARTED|Overall Study||4
2571181|NCT00431496|6305568|P1|NOT COMPLETED|Overall Study||11
2571182|NCT00431496|6305568|P1|COMPLETED|Overall Study||60
2571183|NCT00431496|6305568|P1|STARTED|Overall Study||71
2571184|NCT00431444|6305579|P2|NOT COMPLETED|Overall Study||7
2571185|NCT00431444|6305580|P1|NOT COMPLETED|Overall Study||5
2571186|NCT00431444|6305579|P2|COMPLETED|Overall Study||46
2571187|NCT00431444|6305580|P1|COMPLETED|Overall Study||51
2571188|NCT00431444|6305579|P2|STARTED|Overall Study|"Initially 110 randomized, 1 participant of Raloxifene group never took study drug."|53
2571189|NCT00431444|6305580|P1|STARTED|Overall Study||56
2571190|NCT00431184|6305606|P2|NOT COMPLETED|Second Intervention (Day 2)||0
2571191|NCT00431184|6305607|P1|NOT COMPLETED|Second Intervention (Day 2)||0
2571192|NCT00431184|6305606|P2|COMPLETED|Second Intervention (Day 2)||9
2571193|NCT00431184|6305607|P1|COMPLETED|Second Intervention (Day 2)||10
2571194|NCT00431184|6305606|P2|STARTED|Second Intervention (Day 2)||9
2571195|NCT00431184|6305607|P1|STARTED|Second Intervention (Day 2)||10
2571196|NCT00431184|6305606|P2|NOT COMPLETED|1st Intervention (Day 1)||0
2571197|NCT00431184|6305607|P1|NOT COMPLETED|1st Intervention (Day 1)||0
2571198|NCT00431184|6305606|P2|COMPLETED|1st Intervention (Day 1)||9
2571199|NCT00431184|6305607|P1|COMPLETED|1st Intervention (Day 1)||10
2571200|NCT00431184|6305606|P2|STARTED|1st Intervention (Day 1)||9
2571201|NCT00431184|6305607|P1|STARTED|1st Intervention (Day 1)||10
2571202|NCT00431132|6305615|P1|NOT COMPLETED|Overall Study||44
2571203|NCT00431132|6305615|P1|COMPLETED|Overall Study||292
2571204|NCT00431132|6305615|P1|STARTED|Overall Study||336
2571205|NCT00431067|6305620|P1|NOT COMPLETED|Overall Study||41
2571206|NCT00431067|6305620|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (22-Sep-2009)|0
2571207|NCT00431067|6305620|P1|STARTED|Overall Study|52 patients screened, 41 treated|41
2571208|NCT00431041|6305630|P2|NOT COMPLETED|Overall Study||24
2571209|NCT00431041|6305631|P1|NOT COMPLETED|Overall Study||16
2571210|NCT00431041|6305630|P2|COMPLETED|Overall Study||40
2571211|NCT00431041|6305631|P1|COMPLETED|Overall Study||52
2571212|NCT00431041|6305630|P2|STARTED|Overall Study|Data represents ITT Population: All randomized subjects|64
2571213|NCT00431041|6305631|P1|STARTED|Overall Study|Data represents Intention To Treat(ITT) Population: All randomized subjects|68
2571214|NCT00430989|6305645|P2|NOT COMPLETED|Overall Study||60
2571215|NCT00430989|6305646|P1|NOT COMPLETED|Overall Study||60
2571216|NCT00430989|6305645|P2|COMPLETED|Overall Study||3509
2571217|NCT00430989|6305646|P1|COMPLETED|Overall Study||3483
2571218|NCT00430989|6305645|P2|STARTED|Overall Study||3569
2571219|NCT00430989|6305646|P1|STARTED|Overall Study||3543
2571220|NCT00430950|6305666|P2|NOT COMPLETED|Overall Study||13
2571221|NCT00430950|6305667|P1|NOT COMPLETED|Overall Study||13
2571222|NCT00430950|6305666|P2|COMPLETED|Overall Study||495
2571223|NCT00430950|6305667|P1|COMPLETED|Overall Study||489
2571224|NCT00430950|6305666|P2|STARTED|Overall Study||508
2571225|NCT00430950|6305667|P1|STARTED|Overall Study||502
2571226|NCT00430937|6305681|P2|NOT COMPLETED|Overall Study||28
2571227|NCT00430937|6305682|P1|NOT COMPLETED|Overall Study||27
2571228|NCT00430937|6305681|P2|COMPLETED|Overall Study||64
2571229|NCT00430937|6305682|P1|COMPLETED|Overall Study||70
2571230|NCT00430937|6305681|P2|STARTED|Overall Study||92
2571231|NCT00430937|6305682|P1|STARTED|Overall Study|Additional 5 participants were randomized; however, they were not exposed to study drug by mistake.|97
2571232|NCT00430781|6305693|P3|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||20
2571233|NCT00430781|6305694|P2|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||18
2571234|NCT00430781|6305695|P1|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||24
2571235|NCT00430781|6305693|P3|COMPLETED|End-of-Study Analysis; 28 July 2011||54
2571236|NCT00430781|6305694|P2|COMPLETED|End-of-Study Analysis; 28 July 2011||59
2571237|NCT00430781|6305695|P1|COMPLETED|End-of-Study Analysis; 28 July 2011||53
2571238|NCT00430781|6305693|P3|STARTED|End-of-Study Analysis; 28 July 2011||74
2571239|NCT00430781|6305694|P2|STARTED|End-of-Study Analysis; 28 July 2011|1 participant randomized to lapatinib (final analysis table) actually received combination therapy.|77
2571240|NCT00430781|6305695|P1|STARTED|End-of-Study Analysis; 28 July 2011|Enrollment continued in this arm after data cut for Interim Analysis and before arm closed.|77
2571241|NCT00430781|6305693|P3|NOT COMPLETED|Final Analysis; 31 July 2008||48
2571242|NCT00430781|6305694|P2|NOT COMPLETED|Final Analysis; 31 July 2008||39
2571243|NCT00430781|6305695|P1|NOT COMPLETED|Final Analysis; 31 July 2008||0
2571244|NCT00430781|6305693|P3|COMPLETED|Final Analysis; 31 July 2008||26
2571245|NCT00430781|6305694|P2|COMPLETED|Final Analysis; 31 July 2008||39
2571246|NCT00430781|6305695|P1|COMPLETED|Final Analysis; 31 July 2008||0
2571247|NCT00430781|6305693|P3|Ongoing|Final Analysis; 31 July 2008||32
2571248|NCT00430781|6305694|P2|Ongoing|Final Analysis; 31 July 2008||29
2571251|NCT00430781|6305694|P2|STARTED|Final Analysis; 31 July 2008||78
2571252|NCT00430781|6305695|P1|STARTED|Final Analysis; 31 July 2008||0
2571253|NCT00430781|6305693|P3|NOT COMPLETED|Interim Analysis; 11 February 2008||60
2571254|NCT00430781|6305694|P2|NOT COMPLETED|Interim Analysis; 11 February 2008||58
2571255|NCT00430781|6305695|P1|NOT COMPLETED|Interim Analysis; 11 February 2008||59
2571256|NCT00430781|6305693|P3|COMPLETED|Interim Analysis; 11 February 2008||0
2571257|NCT00430781|6305694|P2|COMPLETED|Interim Analysis; 11 February 2008||0
2571258|NCT00430781|6305695|P1|COMPLETED|Interim Analysis; 11 February 2008||0
2571259|NCT00430781|6305693|P3|Ongoing|Interim Analysis; 11 February 2008||25
2571260|NCT00430781|6305694|P2|Ongoing|Interim Analysis; 11 February 2008||20
2571261|NCT00430781|6305695|P1|Ongoing|Interim Analysis; 11 February 2008||23
2571262|NCT00430781|6305693|P3|STARTED|Interim Analysis; 11 February 2008||60
2571263|NCT00430781|6305694|P2|STARTED|Interim Analysis; 11 February 2008||58
2571264|NCT00430781|6305695|P1|STARTED|Interim Analysis; 11 February 2008||59
2571265|NCT00430768|6305721|P3|NOT COMPLETED|Overall Study||0
2571266|NCT00430768|6305722|P2|NOT COMPLETED|Overall Study||0
2571267|NCT00430768|6305723|P1|NOT COMPLETED|Overall Study||0
2571268|NCT00430768|6305721|P3|COMPLETED|Overall Study||3
2571269|NCT00430768|6305722|P2|COMPLETED|Overall Study||3
2571270|NCT00430768|6305723|P1|COMPLETED|Overall Study||3
2571271|NCT00430768|6305721|P3|STARTED|Overall Study||3
2571272|NCT00430768|6305722|P2|STARTED|Overall Study||3
2571273|NCT00430768|6305723|P1|STARTED|Overall Study||3
2571274|NCT00430755|6305737|P1|NOT COMPLETED|Overall Study||53
2571275|NCT00430755|6305737|P1|COMPLETED|Overall Study||45
2571276|NCT00430755|6305737|P1|STARTED|Overall Study||98
2571277|NCT00430716|6305744|P3|NOT COMPLETED|Open Label Phase||7
2571278|NCT00430716|6305745|P2|NOT COMPLETED|Open Label Phase||7
2571279|NCT00430716|6305746|P1|NOT COMPLETED|Open Label Phase||9
2571280|NCT00430716|6305744|P3|COMPLETED|Open Label Phase||32
2571281|NCT00430716|6305745|P2|COMPLETED|Open Label Phase||31
2571282|NCT00430716|6305746|P1|COMPLETED|Open Label Phase||27
2571283|NCT00430716|6305744|P3|STARTED|Open Label Phase||39
2571284|NCT00430716|6305745|P2|STARTED|Open Label Phase||38
2571285|NCT00430716|6305746|P1|STARTED|Open Label Phase||36
2571286|NCT00430716|6305744|P3|NOT COMPLETED|Double Blind Phase||6
2571287|NCT00430716|6305745|P2|NOT COMPLETED|Double Blind Phase||5
2571288|NCT00430716|6305746|P1|NOT COMPLETED|Double Blind Phase||6
2571289|NCT00430716|6305744|P3|COMPLETED|Double Blind Phase||39
2571290|NCT00430716|6305745|P2|COMPLETED|Double Blind Phase||38
2571291|NCT00430716|6305746|P1|COMPLETED|Double Blind Phase||36
2571292|NCT00430716|6305744|P3|Treated|Double Blind Phase||45
2571293|NCT00430716|6305745|P2|Treated|Double Blind Phase||43
2571294|NCT00430716|6305746|P1|Treated|Double Blind Phase||41
2571295|NCT00430716|6305744|P3|STARTED|Double Blind Phase||45
2571296|NCT00430716|6305745|P2|STARTED|Double Blind Phase||43
2571297|NCT00430716|6305746|P1|STARTED|Double Blind Phase||42
2571298|NCT00430677|6305778|P3|NOT COMPLETED|Long-term Extension Period||63
2571299|NCT00430677|6305779|P2|NOT COMPLETED|Long-term Extension Period||58
2571300|NCT00430677|6305780|P1|NOT COMPLETED|Long-term Extension Period||60
2571301|NCT00430677|6305778|P3|COMPLETED|Long-term Extension Period|Completed the long-term extension period|11
2571302|NCT00430677|6305779|P2|COMPLETED|Long-term Extension Period|Completed the long-term extension period|9
2571303|NCT00430677|6305780|P1|COMPLETED|Long-term Extension Period|Completed the long-term extension period|10
2571304|NCT00430677|6305778|P3|STARTED|Long-term Extension Period||74
2571305|NCT00430677|6305779|P2|STARTED|Long-term Extension Period||67
2571306|NCT00430677|6305780|P1|STARTED|Long-term Extension Period||70
2571307|NCT00430677|6305778|P3|NOT COMPLETED|Short-term Period||22
2571308|NCT00430677|6305779|P2|NOT COMPLETED|Short-term Period||25
2571309|NCT00430677|6305780|P1|NOT COMPLETED|Short-term Period||23
2571310|NCT00430677|6305778|P3|COMPLETED|Short-term Period|Completed the short-term period|78
2571311|NCT00430677|6305779|P2|COMPLETED|Short-term Period|Completed the short-term period|74
2571312|NCT00430677|6305780|P1|COMPLETED|Short-term Period|Completed the short-term period|76
2571313|NCT00430677|6305778|P3|STARTED|Short-term Period||100
2571314|NCT00430677|6305779|P2|STARTED|Short-term Period|1 participant took infliximab on day 1 and was discontinued before receiving study medication.|99
2571315|NCT00430677|6305780|P1|STARTED|Short-term Period|1 participant died before receiving the first dose of study medication|99
2571316|NCT00430638|6305903|P2|NOT COMPLETED|Overall Study||48
2571317|NCT00430638|6305904|P1|NOT COMPLETED|Overall Study||78
2571318|NCT00430638|6305903|P2|COMPLETED|Overall Study||92
2571319|NCT00430638|6305904|P1|COMPLETED|Overall Study||60
2571320|NCT00430638|6305903|P2|STARTED|Overall Study|2 participants were erroneously assigned to olmesartan 40 mg instead of 20 mg|140
2571321|NCT00430638|6305904|P1|STARTED|Overall Study||138
2571322|NCT00430625|6305922|P2|NOT COMPLETED|Overall Study||0
2571323|NCT00430625|6305923|P1|NOT COMPLETED|Overall Study||0
2571324|NCT00430625|6305922|P2|COMPLETED|Overall Study||12
2571325|NCT00430625|6305923|P1|COMPLETED|Overall Study||13
2571326|NCT00430625|6305922|P2|STARTED|Overall Study||12
2571327|NCT00430625|6305923|P1|STARTED|Overall Study||13
2571328|NCT00430573|6305939|P1|NOT COMPLETED|Overall Study||5
2571329|NCT00430573|6305939|P1|COMPLETED|Overall Study|Only 5 took study drug on at least one occasion and 8 completed the baseline ASI.|5
2571330|NCT00430573|6305939|P1|STARTED|Overall Study||10
2571331|NCT00430521|6305952|P8|NOT COMPLETED|Overall Study||12
2571332|NCT00430521|6305953|P7|NOT COMPLETED|Overall Study||10
2571333|NCT00430521|6305954|P6|NOT COMPLETED|Overall Study||5
2571334|NCT00430521|6305955|P5|NOT COMPLETED|Overall Study||5
2571335|NCT00430521|6305956|P4|NOT COMPLETED|Overall Study||8
2571336|NCT00430521|6305957|P3|NOT COMPLETED|Overall Study||3
2571337|NCT00430521|6305958|P2|NOT COMPLETED|Overall Study||9
2571338|NCT00430521|6305959|P1|NOT COMPLETED|Overall Study||11
2571339|NCT00430521|6305952|P8|COMPLETED|Overall Study||51
2571340|NCT00430521|6305953|P7|COMPLETED|Overall Study||55
2571341|NCT00430521|6305954|P6|COMPLETED|Overall Study||59
2571342|NCT00430521|6305955|P5|COMPLETED|Overall Study||59
2571343|NCT00430521|6305956|P4|COMPLETED|Overall Study||55
2571344|NCT00430521|6305957|P3|COMPLETED|Overall Study||61
2571345|NCT00430521|6305958|P2|COMPLETED|Overall Study||57
2571346|NCT00430521|6305959|P1|COMPLETED|Overall Study||52
2571347|NCT00430521|6305952|P8|STARTED|Overall Study||63
2571348|NCT00430521|6305953|P7|STARTED|Overall Study||65
2571349|NCT00430521|6305954|P6|STARTED|Overall Study||64
2571350|NCT00430521|6305955|P5|STARTED|Overall Study||64
2571351|NCT00430521|6305956|P4|STARTED|Overall Study||63
2571352|NCT00430521|6305957|P3|STARTED|Overall Study||64
2571353|NCT00430521|6305958|P2|STARTED|Overall Study||66
2571354|NCT00430521|6305959|P1|STARTED|Overall Study||63
2571355|NCT00430508|6306201|P4|NOT COMPLETED|Overall Study||5
2571356|NCT00430508|6306202|P3|NOT COMPLETED|Overall Study||13
2571357|NCT00430508|6306203|P2|NOT COMPLETED|Overall Study||6
2571358|NCT00430508|6306204|P1|NOT COMPLETED|Overall Study||3
2571359|NCT00430508|6306201|P4|COMPLETED|Overall Study||269
2571360|NCT00430508|6306202|P3|COMPLETED|Overall Study||266
2571361|NCT00430508|6306203|P2|COMPLETED|Overall Study||272
2571362|NCT00430508|6306204|P1|COMPLETED|Overall Study||137
2571363|NCT00430508|6306201|P4|STARTED|Overall Study||274
2571364|NCT00430508|6306202|P3|STARTED|Overall Study||279
2571365|NCT00430508|6306203|P2|STARTED|Overall Study||278
2571366|NCT00430508|6306204|P1|STARTED|Overall Study||140
2571367|NCT00430495|6306242|P4|NOT COMPLETED|Overall Study||4
2571368|NCT00430495|6306243|P3|NOT COMPLETED|Overall Study||13
2571369|NCT00430495|6306244|P2|NOT COMPLETED|Overall Study||7
2571370|NCT00430495|6306245|P1|NOT COMPLETED|Overall Study||14
2571371|NCT00430495|6306242|P4|COMPLETED|Overall Study||60
2571372|NCT00430495|6306243|P3|COMPLETED|Overall Study||49
2571373|NCT00430495|6306244|P2|COMPLETED|Overall Study||59
2571374|NCT00430495|6306245|P1|COMPLETED|Overall Study||50
2571375|NCT00430495|6306242|P4|Treated|Overall Study||64
2571376|NCT00430495|6306243|P3|Treated|Overall Study||62
2571377|NCT00430495|6306244|P2|Treated|Overall Study||66
2571378|NCT00430495|6306245|P1|Treated|Overall Study||62
2571379|NCT00430495|6306242|P4|STARTED|Overall Study||64
2571380|NCT00430495|6306243|P3|STARTED|Overall Study||62
2571381|NCT00430495|6306244|P2|STARTED|Overall Study||66
2571382|NCT00430495|6306245|P1|STARTED|Overall Study||64
2571383|NCT00430482|6306285|P2|NOT COMPLETED|Completed 2 Follow-Up Visits||6
2571384|NCT00430482|6306286|P1|NOT COMPLETED|Completed 2 Follow-Up Visits||5
2571385|NCT00430482|6306285|P2|COMPLETED|Completed 2 Follow-Up Visits||20
2571386|NCT00430482|6306286|P1|COMPLETED|Completed 2 Follow-Up Visits||29
2571387|NCT00430482|6306285|P2|Completed ASI at Follow-Up #2|Completed 2 Follow-Up Visits||20
2571388|NCT00430482|6306286|P1|Completed ASI at Follow-Up #2|Completed 2 Follow-Up Visits||29
2571389|NCT00430482|6306285|P2|Completed ASI at Follow-Up #1|Completed 2 Follow-Up Visits||20
2571390|NCT00430482|6306286|P1|Completed ASI at Follow-Up #1|Completed 2 Follow-Up Visits||27
2571391|NCT00430482|6306285|P2|STARTED|Completed 2 Follow-Up Visits||26
2571392|NCT00430482|6306286|P1|STARTED|Completed 2 Follow-Up Visits||34
2571393|NCT00430482|6306285|P2|NOT COMPLETED|Completed Treatment||11
2571394|NCT00430482|6306286|P1|NOT COMPLETED|Completed Treatment||7
2571395|NCT00430482|6306285|P2|COMPLETED|Completed Treatment||26
2571396|NCT00430482|6306286|P1|COMPLETED|Completed Treatment||34
2571397|NCT00430482|6306285|P2|Completed ASI at Midpoint|Completed Treatment||29
2571398|NCT00430482|6306286|P1|Completed ASI at Midpoint|Completed Treatment||35
2571399|NCT00430482|6306285|P2|STARTED|Completed Treatment||37
2571400|NCT00430482|6306286|P1|STARTED|Completed Treatment||41
2571401|NCT00430352|6306294|P1|NOT COMPLETED|Overall Study||138
2571402|NCT00430352|6306294|P1|COMPLETED|Overall Study||407
2571403|NCT00430352|6306294|P1|STARTED|Overall Study||545
2571404|NCT00430300|6306312|P4|NOT COMPLETED|Overall Study||2
2571405|NCT00430300|6306313|P3|NOT COMPLETED|Overall Study||6
2571406|NCT00430300|6306314|P2|NOT COMPLETED|Overall Study||2
2571407|NCT00430300|6306315|P1|NOT COMPLETED|Overall Study||2
2571408|NCT00430300|6306312|P4|COMPLETED|Overall Study||15
2571409|NCT00430300|6306313|P3|COMPLETED|Overall Study||29
2571410|NCT00430300|6306314|P2|COMPLETED|Overall Study||16
2571411|NCT00430300|6306315|P1|COMPLETED|Overall Study||15
2571412|NCT00430300|6306312|P4|STARTED|Overall Study||17
2571413|NCT00430300|6306313|P3|STARTED|Overall Study||35
2571414|NCT00430300|6306314|P2|STARTED|Overall Study||18
2571415|NCT00430300|6306315|P1|STARTED|Overall Study||17
2571416|NCT00430248|6306420|P3|NOT COMPLETED|Overall Study||135
2571417|NCT00430248|6306421|P2|NOT COMPLETED|Overall Study||158
2571418|NCT00430248|6306422|P1|NOT COMPLETED|Overall Study||125
2571419|NCT00430248|6306420|P3|COMPLETED|Overall Study||621
2571420|NCT00430248|6306421|P2|COMPLETED|Overall Study||598
2571421|NCT00430248|6306422|P1|COMPLETED|Overall Study||632
2571422|NCT00430248|6306420|P3|STARTED|Overall Study||756
2571423|NCT00430248|6306421|P2|STARTED|Overall Study||756
2571424|NCT00430248|6306422|P1|STARTED|Overall Study||757
2571425|NCT00430183|6306480|P2|NOT COMPLETED|Overall Study||0
2571426|NCT00430183|6306481|P1|NOT COMPLETED|Overall Study||0
2571427|NCT00430183|6306480|P2|COMPLETED|Overall Study||397
2571428|NCT00430183|6306481|P1|COMPLETED|Overall Study||391
2571429|NCT00430183|6306480|P2|STARTED|Overall Study||397
2571430|NCT00430183|6306481|P1|STARTED|Overall Study||391
2571431|NCT00430092|6306490|P3|NOT COMPLETED|Overall Study||57
2571432|NCT00430092|6306491|P2|NOT COMPLETED|Overall Study||4
2571433|NCT00430092|6306492|P1|NOT COMPLETED|Overall Study||6
2571434|NCT00430092|6306490|P3|COMPLETED|Overall Study||56
2571435|NCT00430092|6306491|P2|COMPLETED|Overall Study||48
2571436|NCT00430092|6306492|P1|COMPLETED|Overall Study||48
2571437|NCT00430092|6306490|P3|STARTED|Overall Study||113
2571438|NCT00430092|6306491|P2|STARTED|Overall Study||52
2571439|NCT00430092|6306492|P1|STARTED|Overall Study||54
2571440|NCT00430027|6306497|P1|NOT COMPLETED|Overall Study||8
2571441|NCT00430027|6306497|P1|COMPLETED|Overall Study||0
2571442|NCT00430027|6306497|P1|STARTED|Overall Study||8
2571443|NCT00429949|6306501|P1|NOT COMPLETED|Overall Study||0
2571444|NCT00429949|6306501|P1|COMPLETED|Overall Study||21
2571445|NCT00429949|6306501|P1|STARTED|Overall Study||21
2571446|NCT00429923|6306514|P3|NOT COMPLETED|Overall Study||39
2571447|NCT00429923|6306515|P2|NOT COMPLETED|Overall Study||4
2571448|NCT00429923|6306516|P1|NOT COMPLETED|Overall Study||5
2571449|NCT00429923|6306514|P3|COMPLETED|Overall Study||68
2571450|NCT00429923|6306515|P2|COMPLETED|Overall Study||51
2571451|NCT00429923|6306516|P1|COMPLETED|Overall Study||52
2571452|NCT00429923|6306514|P3|STARTED|Overall Study||107
2571453|NCT00429923|6306515|P2|STARTED|Overall Study||55
2571454|NCT00429923|6306516|P1|STARTED|Overall Study||57
2571455|NCT00429793|6306521|P1|NOT COMPLETED|Overall Study||6
2571456|NCT00429793|6306521|P1|COMPLETED|Overall Study||54
2571457|NCT00429793|6306521|P1|STARTED|Overall Study||60
2571458|NCT00429702|6306537|P2|NOT COMPLETED|Overall Study||0
2571459|NCT00429702|6306538|P1|NOT COMPLETED|Overall Study||0
2571460|NCT00429702|6306537|P2|COMPLETED|Overall Study||4
2571461|NCT00429702|6306538|P1|COMPLETED|Overall Study||3
2571462|NCT00429702|6306537|P2|STARTED|Overall Study||4
2571463|NCT00429702|6306538|P1|STARTED|Overall Study||3
2571464|NCT00429663|6306548|P2|NOT COMPLETED|Overall Study||39
2571465|NCT00429663|6306549|P1|NOT COMPLETED|Overall Study||36
2571466|NCT00429663|6306548|P2|COMPLETED|Overall Study||41
2571467|NCT00429663|6306549|P1|COMPLETED|Overall Study||40
2571468|NCT00429663|6306548|P2|STARTED|Overall Study||80
2571469|NCT00429663|6306549|P1|STARTED|Overall Study||76
2571470|NCT00429572|6306563|P1|NOT COMPLETED|Overall Study||1
2571471|NCT00429572|6306563|P1|COMPLETED|Overall Study||18
2571472|NCT00429572|6306563|P1|STARTED|Overall Study||19
2571473|NCT00429507|6306571|P1|NOT COMPLETED|Overall Study||0
2571474|NCT00429507|6306571|P1|COMPLETED|Overall Study||12
2571475|NCT00429507|6306571|P1|STARTED|Overall Study||12
2571476|NCT00429494|6306575|P1|NOT COMPLETED|Overall Study||15
2571477|NCT00429494|6306575|P1|COMPLETED|Overall Study||44
2571478|NCT00429494|6306575|P1|STARTED|Overall Study||59
2571479|NCT00429416|6306579|P1|NOT COMPLETED|Overall Study||1
2571480|NCT00429416|6306579|P1|COMPLETED|Overall Study||13
2571481|NCT00429416|6306579|P1|STARTED|Overall Study||14
2571482|NCT00429403|6306589|P2|NOT COMPLETED|Overall Study||0
2571483|NCT00429403|6306590|P1|NOT COMPLETED|Overall Study||0
2571484|NCT00429403|6306589|P2|COMPLETED|Overall Study||0
2571485|NCT00429403|6306590|P1|COMPLETED|Overall Study||1
2571486|NCT00429403|6306589|P2|STARTED|Overall Study||0
2571487|NCT00429403|6306590|P1|STARTED|Overall Study||1
2571488|NCT00429364|6306598|P2|NOT COMPLETED|Overall Study||33
2571489|NCT00429364|6306599|P1|NOT COMPLETED|Overall Study||32
2571490|NCT00429364|6306598|P2|COMPLETED|Overall Study||272
2571491|NCT00429364|6306599|P1|COMPLETED|Overall Study||271
2571492|NCT00429364|6306598|P2|STARTED|Overall Study||305
2571493|NCT00429364|6306599|P1|STARTED|Overall Study||303
2571494|NCT00429299|6306658|P3|NOT COMPLETED|Overall Study||4
2571495|NCT00429299|6306659|P2|NOT COMPLETED|Overall Study||7
2571496|NCT00429299|6306660|P1|NOT COMPLETED|Overall Study||4
2571497|NCT00429299|6306658|P3|COMPLETED|Overall Study||42
2571498|NCT00429299|6306659|P2|COMPLETED|Overall Study||32
2571499|NCT00429299|6306660|P1|COMPLETED|Overall Study||32
2571500|NCT00429299|6306658|P3|STARTED|Overall Study||46
2571501|NCT00429299|6306659|P2|STARTED|Overall Study||39
2571502|NCT00429299|6306660|P1|STARTED|Overall Study||36
2571503|NCT00429273|6306692|P3|NOT COMPLETED|Overall Study||9
2571504|NCT00429273|6306693|P2|NOT COMPLETED|Overall Study||8
2571505|NCT00429273|6306694|P1|NOT COMPLETED|Overall Study||8
2571506|NCT00429273|6306692|P3|COMPLETED|Overall Study||61
2571507|NCT00429273|6306693|P2|COMPLETED|Overall Study||61
2571508|NCT00429273|6306694|P1|COMPLETED|Overall Study||60
2571509|NCT00429273|6306692|P3|STARTED|Overall Study||70
2571510|NCT00429273|6306693|P2|STARTED|Overall Study||69
2571511|NCT00429273|6306694|P1|STARTED|Overall Study||68
2571512|NCT00429182|6306702|P1|NOT COMPLETED|Overall Study||7
2571513|NCT00429182|6306702|P1|COMPLETED|Overall Study||25
2571514|NCT00429182|6306702|P1|STARTED|Overall Study||32
2571515|NCT00429169|6306709|P2|NOT COMPLETED|Overall Study||2
2571516|NCT00429169|6306710|P1|NOT COMPLETED|Overall Study||2
2571517|NCT00429169|6306709|P2|COMPLETED|Overall Study|2 subjects excluded: re-diagnosis/ineligibility (1), and did not return after randomization (1).|38
2571518|NCT00429169|6306710|P1|COMPLETED|Overall Study|2 subjects excluded due to re-diagnosis/ineligibility.|36
2571519|NCT00429169|6306709|P2|STARTED|Overall Study||40
2571520|NCT00429169|6306710|P1|STARTED|Overall Study||38
2571521|NCT00429143|6306722|P1|NOT COMPLETED|Overall Study||0
2571522|NCT00429143|6306722|P1|COMPLETED|Overall Study||27
2571523|NCT00429143|6306722|P1|STARTED|Overall Study||27
2571524|NCT00429104|6306730|P1|NOT COMPLETED|Overall Study||1
2571525|NCT00429104|6306730|P1|COMPLETED|Overall Study||17
2571526|NCT00429104|6306730|P1|STARTED|Overall Study||18
2571527|NCT00429026|6306735|P1|NOT COMPLETED|Overall Study||40
2571528|NCT00429026|6306735|P1|COMPLETED|Overall Study||0
2571529|NCT00429026|6306735|P1|STARTED|Overall Study||40
2571530|NCT00428974|6306743|P4|NOT COMPLETED|Overall Study||3
2571531|NCT00428974|6306744|P3|NOT COMPLETED|Overall Study||1
2571532|NCT00428974|6306745|P2|NOT COMPLETED|Overall Study||0
2571533|NCT00428974|6306746|P1|NOT COMPLETED|Overall Study||8
2571534|NCT00428974|6306743|P4|COMPLETED|Overall Study||16
2571535|NCT00428974|6306744|P3|COMPLETED|Overall Study||14
2571536|NCT00428974|6306745|P2|COMPLETED|Overall Study||17
2571537|NCT00428974|6306746|P1|COMPLETED|Overall Study||17
2571538|NCT00428974|6306743|P4|STARTED|Overall Study||19
2571539|NCT00428974|6306744|P3|STARTED|Overall Study||15
2571540|NCT00428974|6306745|P2|STARTED|Overall Study||17
2571541|NCT00428974|6306746|P1|STARTED|Overall Study|one patient was randomized but never received study treatment|25
2571542|NCT00428948|6306762|P2|NOT COMPLETED|Overall Study||67
2571543|NCT00428948|6306763|P1|NOT COMPLETED|Overall Study||221
2571544|NCT00428948|6306762|P2|COMPLETED|Overall Study||417
2571545|NCT00428948|6306763|P1|COMPLETED|Overall Study||740
2571546|NCT00428948|6306762|P2|Received Treatment|Overall Study||483
2571547|NCT00428948|6306763|P1|Received Treatment|Overall Study||961
2571548|NCT00428948|6306762|P2|STARTED|Overall Study||484
2571549|NCT00428948|6306763|P1|STARTED|Overall Study||961
2571550|NCT00428922|6306781|P1|NOT COMPLETED|Overall Study||0
2571551|NCT00428922|6306781|P1|COMPLETED|Overall Study||26
2571552|NCT00428922|6306781|P1|STARTED|Overall Study||26
2571553|NCT00428844|6306791|P3|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
2571554|NCT00428844|6306792|P2|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
2571555|NCT00428844|6306793|P1|NOT COMPLETED|Completed Test of Cure (TOC) Visit||3
2571556|NCT00428844|6306791|P3|COMPLETED|Completed Test of Cure (TOC) Visit||17
2571557|NCT00428844|6306792|P2|COMPLETED|Completed Test of Cure (TOC) Visit||16
2571558|NCT00428844|6306793|P1|COMPLETED|Completed Test of Cure (TOC) Visit||20
2571559|NCT00428844|6306791|P3|STARTED|Completed Test of Cure (TOC) Visit||19
2571560|NCT00428844|6306792|P2|STARTED|Completed Test of Cure (TOC) Visit||18
2571561|NCT00428844|6306793|P1|STARTED|Completed Test of Cure (TOC) Visit||23
2571562|NCT00428844|6306791|P3|NOT COMPLETED|Completed Study Drug Treatment||7
2571563|NCT00428844|6306792|P2|NOT COMPLETED|Completed Study Drug Treatment||6
2571564|NCT00428844|6306793|P1|NOT COMPLETED|Completed Study Drug Treatment||2
2571565|NCT00428844|6306791|P3|COMPLETED|Completed Study Drug Treatment||19
2571566|NCT00428844|6306792|P2|COMPLETED|Completed Study Drug Treatment||18
2571567|NCT00428844|6306793|P1|COMPLETED|Completed Study Drug Treatment||23
2571568|NCT00428844|6306791|P3|Received First Dose|Completed Study Drug Treatment||25
2571569|NCT00428844|6306792|P2|Received First Dose|Completed Study Drug Treatment||24
2571570|NCT00428844|6306793|P1|Received First Dose|Completed Study Drug Treatment||25
2571571|NCT00428844|6306791|P3|STARTED|Completed Study Drug Treatment||26
2571572|NCT00428844|6306792|P2|STARTED|Completed Study Drug Treatment||24
2571573|NCT00428844|6306793|P1|STARTED|Completed Study Drug Treatment||25
2571574|NCT00428792|6306816|P2|NOT COMPLETED|Overall Study||4
2571575|NCT00428792|6306817|P1|NOT COMPLETED|Overall Study||1
2571576|NCT00428792|6306816|P2|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|66
2571577|NCT00428792|6306817|P1|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|79
2571578|NCT00428792|6306816|P2|STARTED|Overall Study||70
2571579|NCT00428792|6306817|P1|STARTED|Overall Study||80
2571580|NCT00428610|6306844|P3|NOT COMPLETED|Overall Study||32
2571581|NCT00428610|6306845|P2|NOT COMPLETED|Overall Study||18
2571582|NCT00428610|6306846|P1|NOT COMPLETED|Overall Study||53
2571583|NCT00428610|6306844|P3|COMPLETED|Overall Study||0
2571584|NCT00428610|6306845|P2|COMPLETED|Overall Study||0
2571585|NCT00428610|6306846|P1|COMPLETED|Overall Study||0
2571586|NCT00428610|6306844|P3|Received at Least One Dose of Study Drug|Overall Study||32
2571587|NCT00428610|6306845|P2|Received at Least One Dose of Study Drug|Overall Study||18
2571588|NCT00428610|6306846|P1|Received at Least One Dose of Study Drug|Overall Study||53
2571589|NCT00428610|6306844|P3|STARTED|Overall Study||32
2571590|NCT00428610|6306845|P2|STARTED|Overall Study||18
2571591|NCT00428610|6306846|P1|STARTED|Overall Study||53
2571592|NCT00428597|6306880|P2|NOT COMPLETED|Overall Study||85
2571593|NCT00428597|6306881|P1|NOT COMPLETED|Overall Study||86
2571594|NCT00428597|6306880|P2|COMPLETED|Overall Study||0
2571595|NCT00428597|6306881|P1|COMPLETED|Overall Study||0
2571596|NCT00428597|6306880|P2|Received Treatment|Overall Study||82
2571597|NCT00428597|6306881|P1|Received Treatment|Overall Study||83
2571598|NCT00428597|6306880|P2|STARTED|Overall Study||85
2571599|NCT00428597|6306881|P1|STARTED|Overall Study||86
2571600|NCT00428584|6306923|P2|NOT COMPLETED|Extension Phase||29
2571601|NCT00428584|6306924|P1|NOT COMPLETED|Extension Phase||21
2571602|NCT00428584|6306923|P2|COMPLETED|Extension Phase||34
2571603|NCT00428584|6306924|P1|COMPLETED|Extension Phase||35
2571604|NCT00428584|6306923|P2|STARTED|Extension Phase||63
2571605|NCT00428584|6306924|P1|STARTED|Extension Phase|Extension Phase - new formulation of rebif to new formulation of rebif|56
2571606|NCT00428584|6306923|P2|NOT COMPLETED|Comparative Phase||1
2571607|NCT00428584|6306924|P1|NOT COMPLETED|Comparative Phase||9
2571608|NCT00428584|6306923|P2|COMPLETED|Comparative Phase||63
2571609|NCT00428584|6306924|P1|COMPLETED|Comparative Phase|Comparator Phase - new formulation of rebif and Betaseron|56
2571610|NCT00428584|6306923|P2|STARTED|Comparative Phase||64
2571611|NCT00428584|6306924|P1|STARTED|Comparative Phase||65
2571612|NCT00428441|6306948|P1|NOT COMPLETED|Overall Study||1
2571613|NCT00428441|6306948|P1|COMPLETED|Overall Study||74
2571614|NCT00428441|6306948|P1|STARTED|Overall Study||75
2571615|NCT00428389|6306954|P2|NOT COMPLETED|Extension Phase||26
2571616|NCT00428389|6306955|P1|NOT COMPLETED|Extension Phase||32
2571617|NCT00428389|6306954|P2|COMPLETED|Extension Phase||91
2571618|NCT00428389|6306955|P1|COMPLETED|Extension Phase||85
2571619|NCT00428389|6306954|P2|STARTED|Extension Phase||117
2571620|NCT00428389|6306955|P1|STARTED|Extension Phase|Participants were required to sign a separate informed consent prior to entering the extension phase|117
2571621|NCT00428389|6306954|P2|NOT COMPLETED|Core Phase||11
2571622|NCT00428389|6306955|P1|NOT COMPLETED|Core Phase||11
2571623|NCT00428389|6306954|P2|COMPLETED|Core Phase||120
2571624|NCT00428389|6306955|P1|COMPLETED|Core Phase||120
2571625|NCT00428389|6306954|P2|Intent-to-treat Population|Core Phase|1 patient was discontinued from the study the same day as randomization & excluded from all analyses|130
2571626|NCT00428389|6306955|P1|Intent-to-treat Population|Core Phase||131
2571627|NCT00428389|6306954|P2|STARTED|Core Phase||131
2571628|NCT00428389|6306955|P1|STARTED|Core Phase||131
2571629|NCT00428298|6306975|P2|NOT COMPLETED|Overall Study||11
2571630|NCT00428298|6306976|P1|NOT COMPLETED|Overall Study||14
2571631|NCT00428298|6306975|P2|COMPLETED|Overall Study||19
2571632|NCT00428298|6306976|P1|COMPLETED|Overall Study||16
2571633|NCT00428298|6306975|P2|Second RBANS at Study Exit|Overall Study||3
2571634|NCT00428298|6306976|P1|Second RBANS at Study Exit|Overall Study||3
2571635|NCT00428298|6306975|P2|STARTED|Overall Study||30
2571636|NCT00428298|6306976|P1|STARTED|Overall Study||30
2571637|NCT00428246|6306989|P3|NOT COMPLETED|Overall Study||1
2571638|NCT00428246|6306990|P2|NOT COMPLETED|Overall Study||0
2571639|NCT00428246|6306991|P1|NOT COMPLETED|Overall Study||1
2571640|NCT00428246|6306989|P3|COMPLETED|Overall Study||7
2571641|NCT00428246|6306990|P2|COMPLETED|Overall Study||8
2571642|NCT00428246|6306991|P1|COMPLETED|Overall Study||7
2571643|NCT00428246|6306989|P3|STARTED|Overall Study||8
2571644|NCT00428246|6306990|P2|STARTED|Overall Study||8
2571645|NCT00428246|6306991|P1|STARTED|Overall Study||8
2571646|NCT00428220|6306999|P1|NOT COMPLETED|Overall Study||223
2571647|NCT00428220|6306999|P1|COMPLETED|Overall Study||0
2571648|NCT00428220|6306999|P1|STARTED|Overall Study||223
2571649|NCT00428207|6307015|P2|NOT COMPLETED|Overall Study||0
2571650|NCT00428207|6307016|P1|NOT COMPLETED|Overall Study||0
2571651|NCT00428207|6307015|P2|COMPLETED|Overall Study||2
2571652|NCT00428207|6307016|P1|COMPLETED|Overall Study||2
2571653|NCT00428207|6307015|P2|STARTED|Overall Study||2
2571654|NCT00428207|6307016|P1|STARTED|Overall Study||2
2571655|NCT00428116|6307024|P2|NOT COMPLETED|Overall Study||0
2571656|NCT00428116|6307025|P1|NOT COMPLETED|Overall Study||3
2571657|NCT00428116|6307024|P2|COMPLETED|Overall Study||21
2571658|NCT00428116|6307025|P1|COMPLETED|Overall Study||18
2571659|NCT00428116|6307024|P2|STARTED|Overall Study||21
2571660|NCT00428116|6307025|P1|STARTED|Overall Study||21
2571661|NCT00428090|6307037|P4|NOT COMPLETED|Overall Study||28
2571662|NCT00428090|6307038|P3|NOT COMPLETED|Overall Study||38
2571663|NCT00428090|6307039|P2|NOT COMPLETED|Overall Study||31
2571664|NCT00428090|6307040|P1|NOT COMPLETED|Overall Study||34
2571665|NCT00428090|6307037|P4|COMPLETED|Overall Study||55
2571666|NCT00428090|6307038|P3|COMPLETED|Overall Study||127
2571667|NCT00428090|6307039|P2|COMPLETED|Overall Study||135
2571668|NCT00428090|6307040|P1|COMPLETED|Overall Study||131
2571669|NCT00428090|6307037|P4|STARTED|Overall Study||83
2571670|NCT00428090|6307038|P3|STARTED|Overall Study||165
2571671|NCT00428090|6307039|P2|STARTED|Overall Study||166
2571672|NCT00428090|6307040|P1|STARTED|Overall Study||165
2571673|NCT00428077|6307154|P1|NOT COMPLETED|Overall Study||0
2571674|NCT00428077|6307154|P1|COMPLETED|Overall Study||4
2571675|NCT00428077|6307154|P1|STARTED|Overall Study||4
2571676|NCT00427999|6307158|P1|NOT COMPLETED|Overall Study||32
2571677|NCT00427999|6307158|P1|COMPLETED|Overall Study||33
2571678|NCT00427999|6307158|P1|Extension Follow-up|Overall Study||19
2571679|NCT00427999|6307158|P1|Intent to Treat (ITT)|Overall Study||61
2571680|NCT00427999|6307158|P1|STARTED|Overall Study||65
2571681|NCT00427973|6307167|P1|NOT COMPLETED|Overall Study||0
2571682|NCT00427973|6307167|P1|COMPLETED|Overall Study||17
2571683|NCT00427973|6307167|P1|STARTED|Overall Study||17
2571684|NCT00427960|6307176|P2|NOT COMPLETED|Overall Study||4
2571685|NCT00427960|6307177|P1|NOT COMPLETED|Overall Study||2
2571686|NCT00427960|6307176|P2|COMPLETED|Overall Study||21
2571687|NCT00427960|6307177|P1|COMPLETED|Overall Study||28
2571688|NCT00427960|6307176|P2|STARTED|Overall Study||25
2571689|NCT00427960|6307177|P1|STARTED|Overall Study||30
2571690|NCT00427934|6307215|P4|NOT COMPLETED|Overall Study||15
2571691|NCT00427934|6307216|P3|NOT COMPLETED|Overall Study||23
2571692|NCT00427934|6307217|P2|NOT COMPLETED|Overall Study||0
2571693|NCT00427934|6307218|P1|NOT COMPLETED|Overall Study||1
2571694|NCT00427934|6307215|P4|COMPLETED|Overall Study||19
2571695|NCT00427934|6307216|P3|COMPLETED|Overall Study||55
2571696|NCT00427934|6307217|P2|COMPLETED|Overall Study||8
2571697|NCT00427934|6307218|P1|COMPLETED|Overall Study||7
2571698|NCT00427934|6307215|P4|Treated|Overall Study||33
2571699|NCT00427934|6307216|P3|Treated|Overall Study||77
2571700|NCT00427934|6307217|P2|Treated|Overall Study||8
2571701|NCT00427934|6307218|P1|Treated|Overall Study||8
2571702|NCT00427934|6307215|P4|STARTED|Overall Study||34
2571703|NCT00427934|6307216|P3|STARTED|Overall Study||78
2571704|NCT00427934|6307217|P2|STARTED|Overall Study||8
2571705|NCT00427934|6307218|P1|STARTED|Overall Study||8
2571706|NCT00427921|6307286|P1|NOT COMPLETED|Overall Study||50
2571707|NCT00427921|6307286|P1|COMPLETED|Overall Study||254
2571708|NCT00427921|6307286|P1|STARTED|Overall Study||304
2571709|NCT00427908|6307309|P4|NOT COMPLETED|Persistence Phase Year 5||0
2571710|NCT00427908|6307310|P3|NOT COMPLETED|Persistence Phase Year 5||0
2571711|NCT00427908|6307311|P2|NOT COMPLETED|Persistence Phase Year 5||0
2571712|NCT00427908|6307312|P1|NOT COMPLETED|Persistence Phase Year 5||0
2571713|NCT00427908|6307309|P4|COMPLETED|Persistence Phase Year 5||13
2571714|NCT00427908|6307310|P3|COMPLETED|Persistence Phase Year 5||12
2571715|NCT00427908|6307311|P2|COMPLETED|Persistence Phase Year 5||99
2571716|NCT00427908|6307312|P1|COMPLETED|Persistence Phase Year 5||52
2571717|NCT00427908|6307309|P4|STARTED|Persistence Phase Year 5||13
2571718|NCT00427908|6307310|P3|STARTED|Persistence Phase Year 5||12
2571719|NCT00427908|6307311|P2|STARTED|Persistence Phase Year 5||99
2571720|NCT00427908|6307312|P1|STARTED|Persistence Phase Year 5||52
2571721|NCT00427908|6307309|P4|NOT COMPLETED|Persistence Phase Year 4||0
2571722|NCT00427908|6307310|P3|NOT COMPLETED|Persistence Phase Year 4||0
2571723|NCT00427908|6307311|P2|NOT COMPLETED|Persistence Phase Year 4||0
2571724|NCT00427908|6307312|P1|NOT COMPLETED|Persistence Phase Year 4||0
2571725|NCT00427908|6307309|P4|COMPLETED|Persistence Phase Year 4||32
2571726|NCT00427908|6307310|P3|COMPLETED|Persistence Phase Year 4||34
2571727|NCT00427908|6307311|P2|COMPLETED|Persistence Phase Year 4||192
2571728|NCT00427908|6307312|P1|COMPLETED|Persistence Phase Year 4||165
2571729|NCT00427908|6307309|P4|STARTED|Persistence Phase Year 4||32
2571730|NCT00427908|6307310|P3|STARTED|Persistence Phase Year 4||34
2571731|NCT00427908|6307311|P2|STARTED|Persistence Phase Year 4||192
2571732|NCT00427908|6307312|P1|STARTED|Persistence Phase Year 4||165
2571733|NCT00427908|6307309|P4|NOT COMPLETED|Persistence Phase Year 3||0
2571734|NCT00427908|6307310|P3|NOT COMPLETED|Persistence Phase Year 3||0
2571735|NCT00427908|6307311|P2|NOT COMPLETED|Persistence Phase Year 3||0
2571736|NCT00427908|6307312|P1|NOT COMPLETED|Persistence Phase Year 3||0
2571737|NCT00427908|6307309|P4|COMPLETED|Persistence Phase Year 3||38
2571738|NCT00427908|6307310|P3|COMPLETED|Persistence Phase Year 3||38
2571739|NCT00427908|6307311|P2|COMPLETED|Persistence Phase Year 3||201
2571740|NCT00427908|6307312|P1|COMPLETED|Persistence Phase Year 3||185
2571741|NCT00427908|6307309|P4|STARTED|Persistence Phase Year 3||38
2571742|NCT00427908|6307310|P3|STARTED|Persistence Phase Year 3||38
2571743|NCT00427908|6307311|P2|STARTED|Persistence Phase Year 3||201
2571744|NCT00427908|6307312|P1|STARTED|Persistence Phase Year 3||185
2571745|NCT00427908|6307309|P4|NOT COMPLETED|Persistence Phase Year 2||0
2571746|NCT00427908|6307310|P3|NOT COMPLETED|Persistence Phase Year 2||0
2571747|NCT00427908|6307311|P2|NOT COMPLETED|Persistence Phase Year 2||0
2571748|NCT00427908|6307312|P1|NOT COMPLETED|Persistence Phase Year 2||0
2571749|NCT00427908|6307309|P4|COMPLETED|Persistence Phase Year 2||61
2571750|NCT00427908|6307310|P3|COMPLETED|Persistence Phase Year 2||53
2571751|NCT00427908|6307311|P2|COMPLETED|Persistence Phase Year 2||215
2571752|NCT00427908|6307312|P1|COMPLETED|Persistence Phase Year 2||208
2571753|NCT00427908|6307309|P4|STARTED|Persistence Phase Year 2||61
2571754|NCT00427908|6307310|P3|STARTED|Persistence Phase Year 2||53
2571755|NCT00427908|6307311|P2|STARTED|Persistence Phase Year 2||215
2571756|NCT00427908|6307312|P1|STARTED|Persistence Phase Year 2||208
2571757|NCT00427908|6307309|P4|NOT COMPLETED|Persistence Phase Year 1||0
2571758|NCT00427908|6307310|P3|NOT COMPLETED|Persistence Phase Year 1||0
2571759|NCT00427908|6307311|P2|NOT COMPLETED|Persistence Phase Year 1||0
2571760|NCT00427908|6307312|P1|NOT COMPLETED|Persistence Phase Year 1||0
2571761|NCT00427908|6307309|P4|COMPLETED|Persistence Phase Year 1||78
2571762|NCT00427908|6307310|P3|COMPLETED|Persistence Phase Year 1||71
2571763|NCT00427908|6307311|P2|COMPLETED|Persistence Phase Year 1||221
2571764|NCT00427908|6307312|P1|COMPLETED|Persistence Phase Year 1||222
2571765|NCT00427908|6307309|P4|STARTED|Persistence Phase Year 1||78
2571766|NCT00427908|6307310|P3|STARTED|Persistence Phase Year 1||71
2571767|NCT00427908|6307311|P2|STARTED|Persistence Phase Year 1||221
2571768|NCT00427908|6307312|P1|STARTED|Persistence Phase Year 1||222
2571769|NCT00427908|6307309|P4|NOT COMPLETED|Primary Phase||0
2571770|NCT00427908|6307310|P3|NOT COMPLETED|Primary Phase||3
2571771|NCT00427908|6307311|P2|NOT COMPLETED|Primary Phase||3
2571772|NCT00427908|6307312|P1|NOT COMPLETED|Primary Phase||5
2571773|NCT00427908|6307309|P4|COMPLETED|Primary Phase||78
2571774|NCT00427908|6307310|P3|COMPLETED|Primary Phase||72
2571775|NCT00427908|6307311|P2|COMPLETED|Primary Phase||228
2571776|NCT00427908|6307312|P1|COMPLETED|Primary Phase||224
2571777|NCT00427908|6307309|P4|STARTED|Primary Phase||78
2571778|NCT00427908|6307310|P3|STARTED|Primary Phase||75
2571779|NCT00427908|6307311|P2|STARTED|Primary Phase||231
2571780|NCT00427908|6307312|P1|STARTED|Primary Phase||229
2571781|NCT00427895|6307512|P8|NOT COMPLETED|Vax 2/Year 3 to 4||2
2571782|NCT00427895|6307513|P7|NOT COMPLETED|Vax 2/Year 3 to 4||0
2571783|NCT00427895|6307514|P6|NOT COMPLETED|Vax 2/Year 3 to 4||0
2571784|NCT00427895|6307515|P5|NOT COMPLETED|Vax 2/Year 3 to 4||1
2571785|NCT00427895|6307516|P4|NOT COMPLETED|Vax 2/Year 3 to 4||0
2571786|NCT00427895|6307517|P3|NOT COMPLETED|Vax 2/Year 3 to 4||0
2571787|NCT00427895|6307518|P2|NOT COMPLETED|Vax 2/Year 3 to 4||0
2571788|NCT00427895|6307519|P1|NOT COMPLETED|Vax 2/Year 3 to 4||0
2571789|NCT00427895|6307512|P8|COMPLETED|Vax 2/Year 3 to 4||212
2571790|NCT00427895|6307513|P7|COMPLETED|Vax 2/Year 3 to 4||189
2571791|NCT00427895|6307514|P6|COMPLETED|Vax 2/Year 3 to 4||108
2571792|NCT00427895|6307515|P5|COMPLETED|Vax 2/Year 3 to 4||107
2571793|NCT00427895|6307516|P4|COMPLETED|Vax 2/Year 3 to 4||0
2571794|NCT00427895|6307517|P3|COMPLETED|Vax 2/Year 3 to 4||0
2571795|NCT00427895|6307518|P2|COMPLETED|Vax 2/Year 3 to 4||0
2571796|NCT00427895|6307519|P1|COMPLETED|Vax 2/Year 3 to 4||0
2571797|NCT00427895|6307512|P8|STARTED|Vax 2/Year 3 to 4||214
2571798|NCT00427895|6307513|P7|STARTED|Vax 2/Year 3 to 4||189
2571799|NCT00427895|6307514|P6|STARTED|Vax 2/Year 3 to 4||108
2571800|NCT00427895|6307515|P5|STARTED|Vax 2/Year 3 to 4||108
2571801|NCT00427895|6307516|P4|STARTED|Vax 2/Year 3 to 4||0
2571802|NCT00427895|6307517|P3|STARTED|Vax 2/Year 3 to 4||0
2571803|NCT00427895|6307518|P2|STARTED|Vax 2/Year 3 to 4||0
2571804|NCT00427895|6307519|P1|STARTED|Vax 2/Year 3 to 4||0
2571805|NCT00427895|6307512|P8|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
2571806|NCT00427895|6307513|P7|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
2571807|NCT00427895|6307514|P6|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
2571808|NCT00427895|6307515|P5|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
2571809|NCT00427895|6307516|P4|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||469
2571810|NCT00427895|6307517|P3|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||159
2571811|NCT00427895|6307518|P2|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||207
2571812|NCT00427895|6307519|P1|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||188
2571813|NCT00427895|6307512|P8|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
2571814|NCT00427895|6307513|P7|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
2571815|NCT00427895|6307514|P6|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
2571816|NCT00427895|6307515|P5|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
2571817|NCT00427895|6307516|P4|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
2571818|NCT00427895|6307517|P3|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||214
2571819|NCT00427895|6307518|P2|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||189
2571820|NCT00427895|6307519|P1|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||216
2571821|NCT00427895|6307512|P8|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
2571822|NCT00427895|6307513|P7|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
2571823|NCT00427895|6307514|P6|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
2571824|NCT00427895|6307515|P5|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
2571825|NCT00427895|6307516|P4|STARTED|Between Year 1 - Vax 2/Year 3 to 4||469
2571826|NCT00427895|6307517|P3|STARTED|Between Year 1 - Vax 2/Year 3 to 4||373
2571827|NCT00427895|6307518|P2|STARTED|Between Year 1 - Vax 2/Year 3 to 4||396
2571828|NCT00427895|6307519|P1|STARTED|Between Year 1 - Vax 2/Year 3 to 4||404
2571829|NCT00427895|6307512|P8|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
2571830|NCT00427895|6307513|P7|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
2571831|NCT00427895|6307514|P6|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
2571832|NCT00427895|6307515|P5|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
2571833|NCT00427895|6307516|P4|NOT COMPLETED|Vax 1/Year 1 Follow-up||33
2571834|NCT00427895|6307517|P3|NOT COMPLETED|Vax 1/Year 1 Follow-up||19
2571835|NCT00427895|6307518|P2|NOT COMPLETED|Vax 1/Year 1 Follow-up||15
2571836|NCT00427895|6307519|P1|NOT COMPLETED|Vax 1/Year 1 Follow-up||7
2571837|NCT00427895|6307512|P8|COMPLETED|Vax 1/Year 1 Follow-up||0
2571838|NCT00427895|6307513|P7|COMPLETED|Vax 1/Year 1 Follow-up||0
2571839|NCT00427895|6307514|P6|COMPLETED|Vax 1/Year 1 Follow-up||0
2571840|NCT00427895|6307515|P5|COMPLETED|Vax 1/Year 1 Follow-up||0
2571841|NCT00427895|6307516|P4|COMPLETED|Vax 1/Year 1 Follow-up||469
2571842|NCT00427895|6307517|P3|COMPLETED|Vax 1/Year 1 Follow-up||373
2571843|NCT00427895|6307518|P2|COMPLETED|Vax 1/Year 1 Follow-up||396
2571844|NCT00427895|6307519|P1|COMPLETED|Vax 1/Year 1 Follow-up||404
2571845|NCT00427895|6307512|P8|STARTED|Vax 1/Year 1 Follow-up||0
2571846|NCT00427895|6307513|P7|STARTED|Vax 1/Year 1 Follow-up||0
2571847|NCT00427895|6307514|P6|STARTED|Vax 1/Year 1 Follow-up||0
2571848|NCT00427895|6307515|P5|STARTED|Vax 1/Year 1 Follow-up||0
2571849|NCT00427895|6307516|P4|STARTED|Vax 1/Year 1 Follow-up||502
2571850|NCT00427895|6307517|P3|STARTED|Vax 1/Year 1 Follow-up||392
2571851|NCT00427895|6307518|P2|STARTED|Vax 1/Year 1 Follow-up||411
2571852|NCT00427895|6307519|P1|STARTED|Vax 1/Year 1 Follow-up||411
2571853|NCT00427895|6307512|P8|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
2571854|NCT00427895|6307513|P7|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
2571855|NCT00427895|6307514|P6|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
2571856|NCT00427895|6307515|P5|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
2571857|NCT00427895|6307516|P4|NOT COMPLETED|Between 6-Month Follow-up - Year 1||352
2571858|NCT00427895|6307517|P3|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
2571859|NCT00427895|6307518|P2|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
2571860|NCT00427895|6307519|P1|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
2571861|NCT00427895|6307512|P8|COMPLETED|Between 6-Month Follow-up - Year 1||0
2571862|NCT00427895|6307513|P7|COMPLETED|Between 6-Month Follow-up - Year 1||0
2571863|NCT00427895|6307514|P6|COMPLETED|Between 6-Month Follow-up - Year 1||0
2571864|NCT00427895|6307515|P5|COMPLETED|Between 6-Month Follow-up - Year 1||0
2571865|NCT00427895|6307516|P4|COMPLETED|Between 6-Month Follow-up - Year 1||502
2571866|NCT00427895|6307517|P3|COMPLETED|Between 6-Month Follow-up - Year 1||392
2571867|NCT00427895|6307518|P2|COMPLETED|Between 6-Month Follow-up - Year 1||411
2571868|NCT00427895|6307519|P1|COMPLETED|Between 6-Month Follow-up - Year 1||411
2571869|NCT00427895|6307512|P8|STARTED|Between 6-Month Follow-up - Year 1||0
2571870|NCT00427895|6307513|P7|STARTED|Between 6-Month Follow-up - Year 1||0
2571871|NCT00427895|6307514|P6|STARTED|Between 6-Month Follow-up - Year 1||0
2571872|NCT00427895|6307515|P5|STARTED|Between 6-Month Follow-up - Year 1||0
2571873|NCT00427895|6307516|P4|STARTED|Between 6-Month Follow-up - Year 1||854
2571874|NCT00427895|6307517|P3|STARTED|Between 6-Month Follow-up - Year 1||392
2571875|NCT00427895|6307518|P2|STARTED|Between 6-Month Follow-up - Year 1||411
2571876|NCT00427895|6307519|P1|STARTED|Between 6-Month Follow-up - Year 1||411
2571877|NCT00427895|6307512|P8|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
2571878|NCT00427895|6307513|P7|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
2571879|NCT00427895|6307514|P6|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
2571880|NCT00427895|6307515|P5|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
2571881|NCT00427895|6307516|P4|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||46
2571882|NCT00427895|6307517|P3|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||14
2571883|NCT00427895|6307518|P2|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||6
2571884|NCT00427895|6307519|P1|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||7
2571885|NCT00427895|6307512|P8|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
2571886|NCT00427895|6307513|P7|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
2571887|NCT00427895|6307514|P6|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
2571888|NCT00427895|6307515|P5|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
2571889|NCT00427895|6307516|P4|COMPLETED|Vax 1 Baseline/6-Month Follow-up||854
2571890|NCT00427895|6307517|P3|COMPLETED|Vax 1 Baseline/6-Month Follow-up||392
2571891|NCT00427895|6307518|P2|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
2571892|NCT00427895|6307519|P1|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
2571893|NCT00427895|6307512|P8|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
2571894|NCT00427895|6307513|P7|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
2571895|NCT00427895|6307514|P6|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
2571896|NCT00427895|6307515|P5|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
2571897|NCT00427895|6307516|P4|Vaccinated|Vax 1 Baseline/6-Month Follow-up||899
2571898|NCT00427895|6307517|P3|Vaccinated|Vax 1 Baseline/6-Month Follow-up||404
2571899|NCT00427895|6307518|P2|Vaccinated|Vax 1 Baseline/6-Month Follow-up||414
2571900|NCT00427895|6307519|P1|Vaccinated|Vax 1 Baseline/6-Month Follow-up||417
2571901|NCT00427895|6307512|P8|STARTED|Vax 1 Baseline/6-Month Follow-up||0
2571902|NCT00427895|6307513|P7|STARTED|Vax 1 Baseline/6-Month Follow-up||0
2571903|NCT00427895|6307514|P6|STARTED|Vax 1 Baseline/6-Month Follow-up||0
2571904|NCT00427895|6307515|P5|STARTED|Vax 1 Baseline/6-Month Follow-up||0
2571905|NCT00427895|6307516|P4|STARTED|Vax 1 Baseline/6-Month Follow-up||900
2571906|NCT00427895|6307517|P3|STARTED|Vax 1 Baseline/6-Month Follow-up||406
2571907|NCT00427895|6307518|P2|STARTED|Vax 1 Baseline/6-Month Follow-up||417
2571908|NCT00427895|6307519|P1|STARTED|Vax 1 Baseline/6-Month Follow-up||418
2571909|NCT00427804|6307576|P2|NOT COMPLETED|Overall Study||0
2571910|NCT00427804|6307577|P1|NOT COMPLETED|Overall Study||0
2571911|NCT00427804|6307576|P2|COMPLETED|Overall Study||5
2571912|NCT00427804|6307577|P1|COMPLETED|Overall Study||4
2571913|NCT00427804|6307576|P2|STARTED|Overall Study||5
2571914|NCT00427804|6307577|P1|STARTED|Overall Study||4
2571915|NCT00427791|6307585|P2|NOT COMPLETED|Overall Study||0
2571916|NCT00427791|6307586|P1|NOT COMPLETED|Overall Study||0
2571917|NCT00427791|6307585|P2|COMPLETED|Overall Study||13
2571918|NCT00427791|6307586|P1|COMPLETED|Overall Study||10
2571919|NCT00427791|6307585|P2|STARTED|Overall Study||13
2571920|NCT00427791|6307586|P1|STARTED|Overall Study||10
2571921|NCT00427778|6307594|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
2571922|NCT00427778|6307595|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
2571923|NCT00427778|6307594|P2|COMPLETED|Second Intervention (4 Weeks)||14
2571924|NCT00427778|6307595|P1|COMPLETED|Second Intervention (4 Weeks)||10
2571925|NCT00427778|6307594|P2|STARTED|Second Intervention (4 Weeks)||14
2571926|NCT00427778|6307595|P1|STARTED|Second Intervention (4 Weeks)||10
2571927|NCT00427778|6307594|P2|NOT COMPLETED|Wash Out (2 Weeks)||0
2571928|NCT00427778|6307595|P1|NOT COMPLETED|Wash Out (2 Weeks)||0
2571929|NCT00427778|6307594|P2|COMPLETED|Wash Out (2 Weeks)||14
2571930|NCT00427778|6307595|P1|COMPLETED|Wash Out (2 Weeks)||10
2571931|NCT00427778|6307594|P2|STARTED|Wash Out (2 Weeks)||14
2571932|NCT00427778|6307595|P1|STARTED|Wash Out (2 Weeks)||10
2571933|NCT00427778|6307594|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
2571934|NCT00427778|6307595|P1|NOT COMPLETED|First Intervention (4 Weeks)||4
2571935|NCT00427778|6307594|P2|COMPLETED|First Intervention (4 Weeks)||14
2571936|NCT00427778|6307595|P1|COMPLETED|First Intervention (4 Weeks)||10
2571937|NCT00427778|6307594|P2|STARTED|First Intervention (4 Weeks)||15
2571938|NCT00427778|6307595|P1|STARTED|First Intervention (4 Weeks)||14
2571939|NCT00427765|6307614|P1|NOT COMPLETED|Overall Study||0
2571940|NCT00427765|6307614|P1|COMPLETED|Overall Study||164
2571941|NCT00427765|6307614|P1|STARTED|Overall Study||164
2571942|NCT00427700|6307620|P2|NOT COMPLETED|Overall Study||11
2571943|NCT00427700|6307621|P1|NOT COMPLETED|Overall Study||3
2571944|NCT00427700|6307620|P2|COMPLETED|Overall Study||31
2571945|NCT00427700|6307621|P1|COMPLETED|Overall Study||37
2571946|NCT00427700|6307620|P2|STARTED|Overall Study||42
2571947|NCT00427700|6307621|P1|STARTED|Overall Study||40
2571948|NCT00427661|6307629|P1|NOT COMPLETED|Overall Study||0
2571949|NCT00427661|6307629|P1|COMPLETED|Overall Study||8
2571950|NCT00427661|6307629|P1|STARTED|Overall Study||8
2571951|NCT00427635|6307637|P2|NOT COMPLETED|Study Completion to Safety Follow-up||1
2571952|NCT00427635|6307638|P1|NOT COMPLETED|Study Completion to Safety Follow-up||0
2571953|NCT00427635|6307637|P2|COMPLETED|Study Completion to Safety Follow-up|One participant lost to follow-up|25
2571954|NCT00427635|6307638|P1|COMPLETED|Study Completion to Safety Follow-up||25
2571955|NCT00427635|6307637|P2|STARTED|Study Completion to Safety Follow-up||26
2571956|NCT00427635|6307638|P1|STARTED|Study Completion to Safety Follow-up||25
2571957|NCT00427635|6307637|P2|NOT COMPLETED|Treatment Phase||0
2571958|NCT00427635|6307638|P1|NOT COMPLETED|Treatment Phase||1
2571959|NCT00427635|6307637|P2|COMPLETED|Treatment Phase|ITT population|26
2571960|NCT00427635|6307638|P1|COMPLETED|Treatment Phase|ITT population. One voluntary discontinuation by parent/guardian|25
2571961|NCT00427635|6307637|P2|STARTED|Treatment Phase|Randomised|26
2571962|NCT00427635|6307638|P1|STARTED|Treatment Phase|Randomised|26
2571963|NCT00427557|6307666|P1|NOT COMPLETED|Overall Study||0
2571964|NCT00427557|6307666|P1|COMPLETED|Overall Study||30
2571965|NCT00427557|6307666|P1|STARTED|Overall Study||30
2571966|NCT00427349|6307670|P1|NOT COMPLETED|Overall Study||46
2571967|NCT00427349|6307670|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity|0
2571968|NCT00427349|6307670|P1|Eligible and Treated|Overall Study||44
2571969|NCT00427349|6307670|P1|Treated|Overall Study||45
2571970|NCT00427349|6307670|P1|Eligible|Overall Study||45
2571971|NCT00427349|6307670|P1|STARTED|Overall Study||46
2571972|NCT00427336|6307676|P1|NOT COMPLETED|Overall Study||0
2571973|NCT00427336|6307676|P1|COMPLETED|Overall Study||9
2571974|NCT00427336|6307676|P1|STARTED|Overall Study||9
2571975|NCT00427297|6307682|P2|NOT COMPLETED|Overall Study||0
2571976|NCT00427297|6307683|P1|NOT COMPLETED|Overall Study||0
2571977|NCT00427297|6307682|P2|COMPLETED|Overall Study||17
2571978|NCT00427297|6307683|P1|COMPLETED|Overall Study||17
2571979|NCT00427297|6307682|P2|STARTED|Overall Study||17
2571980|NCT00427297|6307683|P1|STARTED|Overall Study||17
2571981|NCT00427193|6307697|P2|NOT COMPLETED|Overall Study||4
2571982|NCT00427193|6307698|P1|NOT COMPLETED|Overall Study||26
2571983|NCT00427193|6307697|P2|COMPLETED|Overall Study||71
2571984|NCT00427193|6307698|P1|COMPLETED|Overall Study||117
2571985|NCT00427193|6307697|P2|STARTED|Overall Study||75
2571986|NCT00427193|6307698|P1|STARTED|Overall Study||143
2571987|NCT00427037|6307718|P2|NOT COMPLETED|Overall Study||7
2571988|NCT00427037|6307719|P1|NOT COMPLETED|Overall Study||7
2571989|NCT00427037|6307718|P2|COMPLETED|Overall Study||10
2571990|NCT00427037|6307719|P1|COMPLETED|Overall Study||10
2571991|NCT00427037|6307718|P2|STARTED|Overall Study||17
2571992|NCT00427037|6307719|P1|STARTED|Overall Study||17
2571993|NCT00427011|6307727|P1|NOT COMPLETED|Overall Study||25
2571994|NCT00427011|6307727|P1|COMPLETED|Overall Study||0
2571995|NCT00427011|6307727|P1|STARTED|Overall Study||25
2571996|NCT00426855|6307738|P1|NOT COMPLETED|Overall Study||0
2571997|NCT00426855|6307738|P1|COMPLETED|Overall Study||12
2571998|NCT00426855|6307738|P1|STARTED|Overall Study||12
2571999|NCT00426842|6307742|P1|NOT COMPLETED|Overall Study||1
2572000|NCT00426842|6307742|P1|COMPLETED|Overall Study||10
2572001|NCT00426842|6307742|P1|STARTED|Overall Study||11
2572002|NCT00426764|6307748|P1|NOT COMPLETED|Overall Study||131
2572003|NCT00426764|6307748|P1|COMPLETED|Overall Study||0
2572004|NCT00426764|6307748|P1|Discontinued at End of or After Cycle 6|Overall Study||33
2572005|NCT00426764|6307748|P1|Discontinued Prior to or During Cycle 6|Overall Study||98
2572006|NCT00426764|6307748|P1|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|131
2572007|NCT00426751|6307765|P2|NOT COMPLETED|Overall Study||20
2572008|NCT00426751|6307766|P1|NOT COMPLETED|Overall Study||22
2572009|NCT00426751|6307765|P2|COMPLETED|Overall Study||183
2572010|NCT00426751|6307766|P1|COMPLETED|Overall Study||204
2572011|NCT00426751|6307765|P2|STARTED|Overall Study||203
2572012|NCT00426751|6307766|P1|STARTED|Overall Study||226
2572013|NCT00426660|6307810|P1|NOT COMPLETED|Overall Study||131
2572014|NCT00426660|6307810|P1|COMPLETED|Overall Study||916
2572015|NCT00426660|6307810|P1|Safety Analysis Set|Overall Study||1032
2572016|NCT00426660|6307810|P1|Treated|Overall Study||1032
2572017|NCT00426660|6307810|P1|STARTED|Overall Study||1047
2572018|NCT00426556|6307841|P4|NOT COMPLETED|Phase II - Extension Phase||23
2572019|NCT00426556|6307842|P3|NOT COMPLETED|Phase II - Extension Phase||0
2572020|NCT00426556|6307843|P2|NOT COMPLETED|Phase II - Extension Phase||0
2572021|NCT00426556|6307844|P1|NOT COMPLETED|Phase II - Extension Phase||0
2572022|NCT00426556|6307841|P4|COMPLETED|Phase II - Extension Phase|Completed means 'Ongoing'|1
2572023|NCT00426556|6307842|P3|COMPLETED|Phase II - Extension Phase||0
2572024|NCT00426556|6307843|P2|COMPLETED|Phase II - Extension Phase||0
2572025|NCT00426556|6307844|P1|COMPLETED|Phase II - Extension Phase||0
2572026|NCT00426556|6307841|P4|STARTED|Phase II - Extension Phase|4 patients did not enter the Extension phase.|24
2572027|NCT00426556|6307842|P3|STARTED|Phase II - Extension Phase||0
2572028|NCT00426556|6307843|P2|STARTED|Phase II - Extension Phase||0
2572029|NCT00426556|6307844|P1|STARTED|Phase II - Extension Phase||0
2572030|NCT00426556|6307841|P4|NOT COMPLETED|Phase II - Core Phase||27
2572031|NCT00426556|6307842|P3|NOT COMPLETED|Phase II - Core Phase||0
2572032|NCT00426556|6307843|P2|NOT COMPLETED|Phase II - Core Phase||0
2572033|NCT00426556|6307844|P1|NOT COMPLETED|Phase II - Core Phase||0
2572034|NCT00426556|6307841|P4|COMPLETED|Phase II - Core Phase||28
2572035|NCT00426556|6307842|P3|COMPLETED|Phase II - Core Phase||0
2572036|NCT00426556|6307843|P2|COMPLETED|Phase II - Core Phase||0
2572037|NCT00426556|6307844|P1|COMPLETED|Phase II - Core Phase||0
2572038|NCT00426556|6307841|P4|STARTED|Phase II - Core Phase||55
2572039|NCT00426556|6307842|P3|STARTED|Phase II - Core Phase||0
2572040|NCT00426556|6307843|P2|STARTED|Phase II - Core Phase||0
2572041|NCT00426556|6307844|P1|STARTED|Phase II - Core Phase||0
2572042|NCT00426556|6307841|P4|NOT COMPLETED|Phase I - Extension Phase||0
2572043|NCT00426556|6307842|P3|NOT COMPLETED|Phase I - Extension Phase||7
2572044|NCT00426556|6307843|P2|NOT COMPLETED|Phase I - Extension Phase||6
2572045|NCT00426556|6307844|P1|NOT COMPLETED|Phase I - Extension Phase||5
2572046|NCT00426556|6307841|P4|COMPLETED|Phase I - Extension Phase||0
2572047|NCT00426556|6307842|P3|COMPLETED|Phase I - Extension Phase||0
2572048|NCT00426556|6307843|P2|COMPLETED|Phase I - Extension Phase||1
2572049|NCT00426556|6307844|P1|COMPLETED|Phase I - Extension Phase||0
2572050|NCT00426556|6307841|P4|STARTED|Phase I - Extension Phase||0
2572051|NCT00426556|6307842|P3|STARTED|Phase I - Extension Phase||7
2572052|NCT00426556|6307843|P2|STARTED|Phase I - Extension Phase||7
2572053|NCT00426556|6307844|P1|STARTED|Phase I - Extension Phase||5
2572054|NCT00426556|6307841|P4|NOT COMPLETED|Phase I - Core Phase||0
2572055|NCT00426556|6307842|P3|NOT COMPLETED|Phase I - Core Phase||3
2572056|NCT00426556|6307843|P2|NOT COMPLETED|Phase I - Core Phase||10
2572057|NCT00426556|6307844|P1|NOT COMPLETED|Phase I - Core Phase||1
2572058|NCT00426556|6307841|P4|COMPLETED|Phase I - Core Phase||0
2572059|NCT00426556|6307842|P3|COMPLETED|Phase I - Core Phase||7
2572060|NCT00426556|6307843|P2|COMPLETED|Phase I - Core Phase||7
2572061|NCT00426556|6307844|P1|COMPLETED|Phase I - Core Phase||5
2572062|NCT00426556|6307841|P4|STARTED|Phase I - Core Phase||0
2572063|NCT00426556|6307842|P3|STARTED|Phase I - Core Phase||10
2572064|NCT00426556|6307843|P2|STARTED|Phase I - Core Phase||17
2572065|NCT00426556|6307844|P1|STARTED|Phase I - Core Phase||6
2572066|NCT00426361|6307869|P3|NOT COMPLETED|Overall Study||5
2572067|NCT00426361|6307870|P2|NOT COMPLETED|Overall Study||5
2572068|NCT00426361|6307871|P1|NOT COMPLETED|Overall Study||4
2572069|NCT00426361|6307869|P3|COMPLETED|Overall Study||243
2572070|NCT00426361|6307870|P2|COMPLETED|Overall Study||250
2572071|NCT00426361|6307871|P1|COMPLETED|Overall Study||244
2572072|NCT00426361|6307869|P3|STARTED|Overall Study||248
2572073|NCT00426361|6307870|P2|STARTED|Overall Study||255
2572074|NCT00426361|6307871|P1|STARTED|Overall Study||248
2572075|NCT00426283|6307923|P2|NOT COMPLETED|Overall Study||1
2572076|NCT00426283|6307924|P1|NOT COMPLETED|Overall Study||5
2572077|NCT00426283|6307923|P2|COMPLETED|Overall Study||13
2572078|NCT00426283|6307924|P1|COMPLETED|Overall Study||23
2572079|NCT00426283|6307923|P2|STARTED|Overall Study||14
2572080|NCT00426283|6307924|P1|STARTED|Overall Study||28
2572081|NCT00426270|6307930|P1|NOT COMPLETED|Overall Study||6
2572082|NCT00426270|6307930|P1|COMPLETED|Overall Study||110
2572083|NCT00426270|6307930|P1|STARTED|Overall Study||116
2572084|NCT00426231|6307940|P2|NOT COMPLETED|Overall Study||12
2572085|NCT00426231|6307941|P1|NOT COMPLETED|Overall Study||9
2572086|NCT00426231|6307940|P2|COMPLETED|Overall Study|For the 6-month endpoint|25
2572087|NCT00426231|6307941|P1|COMPLETED|Overall Study|For the 6 month endpoint|27
2572088|NCT00426231|6307940|P2|STARTED|Overall Study||37
2572089|NCT00426231|6307941|P1|STARTED|Overall Study||36
2572090|NCT00426153|6307951|P2|NOT COMPLETED|Overall Study||0
2572091|NCT00426153|6307952|P1|NOT COMPLETED|Overall Study||0
2572092|NCT00426153|6307951|P2|COMPLETED|Overall Study||14
2572093|NCT00426153|6307952|P1|COMPLETED|Overall Study||28
2572094|NCT00426153|6307951|P2|STARTED|Overall Study||14
2572095|NCT00426153|6307952|P1|STARTED|Overall Study|Participants were randomized in a 2:1 ratio, Octreotide LAR depot: Placebo|28
2572096|NCT00426127|6307964|P1|NOT COMPLETED|Overall Study||2
2572097|NCT00426127|6307964|P1|COMPLETED|Overall Study||0
2572098|NCT00426127|6307964|P1|STARTED|Overall Study||2
2572099|NCT00425945|6307972|P2|NOT COMPLETED|Overall Study||5
2572100|NCT00425945|6307973|P1|NOT COMPLETED|Overall Study||4
2572101|NCT00425945|6307972|P2|COMPLETED|Overall Study||61
2572102|NCT00425945|6307973|P1|COMPLETED|Overall Study||60
2572103|NCT00425945|6307972|P2|STARTED|Overall Study||66
2572104|NCT00425945|6307973|P1|STARTED|Overall Study||64
2572105|NCT00425854|6308011|P2|NOT COMPLETED|Overall Study||21
2572106|NCT00425854|6308012|P1|NOT COMPLETED|Overall Study||29
2572107|NCT00425854|6308011|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
2572108|NCT00425854|6308012|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
2572109|NCT00425854|6308011|P2|STARTED|Overall Study|Treated|21
2572110|NCT00425854|6308012|P1|STARTED|Overall Study|Treated|29
2572111|NCT00425802|6308033|P1|NOT COMPLETED|Overall Study||0
2572112|NCT00425802|6308033|P1|COMPLETED|Overall Study||61
2572113|NCT00425802|6308033|P1|STARTED|Overall Study||61
2572114|NCT00425750|6308045|P1|NOT COMPLETED|Overall Study||25
2572115|NCT00425750|6308045|P1|COMPLETED|Overall Study||0
2572116|NCT00425750|6308045|P1|STARTED|Overall Study||25
2572117|NCT00425698|6308053|P2|NOT COMPLETED|Overall Study||2
2572118|NCT00425698|6308054|P1|NOT COMPLETED|Overall Study||3
2572119|NCT00425698|6308053|P2|COMPLETED|Overall Study||42
2572120|NCT00425698|6308054|P1|COMPLETED|Overall Study||41
2572121|NCT00425698|6308053|P2|STARTED|Overall Study||44
2572122|NCT00425698|6308054|P1|STARTED|Overall Study||44
2572123|NCT00425672|6308060|P1|NOT COMPLETED|Overall Study||1
2572124|NCT00425672|6308060|P1|COMPLETED|Overall Study||14
2572125|NCT00425672|6308060|P1|STARTED|Overall Study||15
2572126|NCT00425607|6308069|P1|NOT COMPLETED|Overall Study||2
2572127|NCT00425607|6308069|P1|COMPLETED|Overall Study||27
2572128|NCT00425607|6308069|P1|Received Treatment|Overall Study||28
2572129|NCT00425607|6308069|P1|STARTED|Overall Study||29
2572130|NCT00425503|6308073|P1|NOT COMPLETED|Overall Study||3
2572131|NCT00425503|6308073|P1|COMPLETED|Overall Study||37
2572132|NCT00425503|6308073|P1|STARTED|Overall Study||40
2572133|NCT00425477|6308077|P1|NOT COMPLETED|Overall Study||13
2572134|NCT00425477|6308077|P1|COMPLETED|Overall Study||13
2572135|NCT00425477|6308077|P1|STARTED|Overall Study||26
2572136|NCT00425438|6308085|P2|NOT COMPLETED|Overall Study||27
2572137|NCT00425438|6308086|P1|NOT COMPLETED|Overall Study||25
2572138|NCT00425438|6308085|P2|COMPLETED|Overall Study||0
2572139|NCT00425438|6308086|P1|COMPLETED|Overall Study||0
2572140|NCT00425438|6308085|P2|STARTED|Overall Study||27
2572141|NCT00425438|6308086|P1|STARTED|Overall Study||25
2572142|NCT00425386|6308102|P1|NOT COMPLETED|Overall Study||3
2572143|NCT00425386|6308102|P1|COMPLETED|Overall Study||43
2572144|NCT00425386|6308102|P1|STARTED|Overall Study||46
2572145|NCT00425373|6308120|P9|NOT COMPLETED|Overall Study||18
2572146|NCT00425373|6308121|P8|NOT COMPLETED|Overall Study||10
2572147|NCT00425373|6308122|P7|NOT COMPLETED|Overall Study||7
2572148|NCT00425373|6308123|P6|NOT COMPLETED|Overall Study||9
2572149|NCT00425373|6308124|P5|NOT COMPLETED|Overall Study||10
2572150|NCT00425373|6308125|P4|NOT COMPLETED|Overall Study||2
2572151|NCT00425373|6308126|P3|NOT COMPLETED|Overall Study||3
2572152|NCT00425373|6308127|P2|NOT COMPLETED|Overall Study||3
2572153|NCT00425373|6308128|P1|NOT COMPLETED|Overall Study||5
2572154|NCT00425373|6308120|P9|COMPLETED|Overall Study||148
2572155|NCT00425373|6308121|P8|COMPLETED|Overall Study||151
2572156|NCT00425373|6308122|P7|COMPLETED|Overall Study||154
2572157|NCT00425373|6308123|P6|COMPLETED|Overall Study||154
2572158|NCT00425373|6308124|P5|COMPLETED|Overall Study||159
2572159|NCT00425373|6308125|P4|COMPLETED|Overall Study||160
2572160|NCT00425373|6308126|P3|COMPLETED|Overall Study||157
2572161|NCT00425373|6308127|P2|COMPLETED|Overall Study||164
2572162|NCT00425373|6308128|P1|COMPLETED|Overall Study||154
2572163|NCT00425373|6308120|P9|STARTED|Overall Study||166
2572164|NCT00425373|6308121|P8|STARTED|Overall Study||161
2572165|NCT00425373|6308122|P7|STARTED|Overall Study||161
2572166|NCT00425373|6308123|P6|STARTED|Overall Study||163
2572167|NCT00425373|6308124|P5|STARTED|Overall Study||169
2572168|NCT00425373|6308125|P4|STARTED|Overall Study||162
2572169|NCT00425373|6308126|P3|STARTED|Overall Study||160
2572170|NCT00425373|6308127|P2|STARTED|Overall Study||167
2572171|NCT00425373|6308128|P1|STARTED|Overall Study||159
2572172|NCT00425308|6308186|P2|NOT COMPLETED|Overall Study||1
2572173|NCT00425308|6308187|P1|NOT COMPLETED|Overall Study||4
2572174|NCT00425308|6308186|P2|COMPLETED|Overall Study||14
2572175|NCT00425308|6308187|P1|COMPLETED|Overall Study||11
2572176|NCT00425308|6308186|P2|STARTED|Overall Study||15
2572177|NCT00425308|6308187|P1|STARTED|Overall Study||15
2572178|NCT00425269|6308217|P2|NOT COMPLETED|Overall Study||20
2572179|NCT00425269|6308218|P1|NOT COMPLETED|Overall Study||19
2572180|NCT00425269|6308217|P2|COMPLETED|Overall Study||77
2572181|NCT00425269|6308218|P1|COMPLETED|Overall Study||82
2572182|NCT00425269|6308217|P2|STARTED|Overall Study||97
2572183|NCT00425269|6308218|P1|STARTED|Overall Study||101
2572184|NCT00425113|6308296|P2|NOT COMPLETED|Overall Study||2
2572185|NCT00425113|6308297|P1|NOT COMPLETED|Overall Study||2
2572186|NCT00425113|6308296|P2|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|16
2572187|NCT00425113|6308297|P1|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|15
2572188|NCT00425113|6308296|P2|Exposed to Study Drug|Overall Study||17
2572189|NCT00425113|6308297|P1|Exposed to Study Drug|Overall Study||16
2572190|NCT00425113|6308296|P2|STARTED|Overall Study||18
2572191|NCT00425113|6308297|P1|STARTED|Overall Study||17
2572192|NCT00425100|6308305|P1|NOT COMPLETED|Overall Study||53
2572193|NCT00425100|6308305|P1|COMPLETED|Overall Study||463
2572194|NCT00425100|6308305|P1|STARTED|Overall Study||516
2572195|NCT00425061|6308349|P7|NOT COMPLETED|Overall Study||19
2572196|NCT00425061|6308350|P6|NOT COMPLETED|Overall Study||4
2572197|NCT00425061|6308351|P5|NOT COMPLETED|Overall Study||26
2572198|NCT00425061|6308352|P4|NOT COMPLETED|Overall Study||2
2572199|NCT00425061|6308353|P3|NOT COMPLETED|Overall Study||0
2572200|NCT00425061|6308354|P2|NOT COMPLETED|Overall Study||2
2572201|NCT00425061|6308355|P1|NOT COMPLETED|Overall Study||2
2572202|NCT00425061|6308349|P7|COMPLETED|Overall Study||26
2572203|NCT00425061|6308350|P6|COMPLETED|Overall Study||0
2572204|NCT00425061|6308351|P5|COMPLETED|Overall Study||19
2572205|NCT00425061|6308352|P4|COMPLETED|Overall Study||14
2572206|NCT00425061|6308353|P3|COMPLETED|Overall Study||16
2572207|NCT00425061|6308354|P2|COMPLETED|Overall Study||15
2572208|NCT00425061|6308355|P1|COMPLETED|Overall Study||14
2572209|NCT00425061|6308349|P7|STARTED|Overall Study||45
2572210|NCT00425061|6308350|P6|STARTED|Overall Study||4
2572211|NCT00425061|6308351|P5|STARTED|Overall Study||45
2572212|NCT00425061|6308352|P4|STARTED|Overall Study||16
2572213|NCT00425061|6308353|P3|STARTED|Overall Study||16
2572214|NCT00425061|6308354|P2|STARTED|Overall Study||17
2572215|NCT00425061|6308355|P1|STARTED|Overall Study||16
2572216|NCT00424840|6308471|P3|NOT COMPLETED|Overall Study||0
2572217|NCT00424840|6308472|P2|NOT COMPLETED|Overall Study||0
2572218|NCT00424840|6308473|P1|NOT COMPLETED|Overall Study||0
2572219|NCT00424840|6308471|P3|COMPLETED|Overall Study||5
2572220|NCT00424840|6308472|P2|COMPLETED|Overall Study||4
2572221|NCT00424840|6308473|P1|COMPLETED|Overall Study||3
2572222|NCT00424840|6308471|P3|STARTED|Overall Study||5
2572223|NCT00424840|6308472|P2|STARTED|Overall Study||4
2572224|NCT00424840|6308473|P1|STARTED|Overall Study||3
2572225|NCT00424827|6308479|P1|NOT COMPLETED|Overall Study||1
2572226|NCT00424827|6308479|P1|COMPLETED|Overall Study||10
2572227|NCT00424827|6308479|P1|STARTED|Overall Study||11
2572228|NCT00424775|6308487|P2|NOT COMPLETED|Overall Study||0
2572229|NCT00424775|6308488|P1|NOT COMPLETED|Overall Study||3
2572230|NCT00424775|6308487|P2|COMPLETED|Overall Study||0
2572231|NCT00424775|6308488|P1|COMPLETED|Overall Study||0
2572232|NCT00424775|6308487|P2|STARTED|Overall Study||0
2572233|NCT00424775|6308488|P1|STARTED|Overall Study||3
2572234|NCT00424762|6308498|P2|NOT COMPLETED|Overall Study||22
2572235|NCT00424762|6308499|P1|NOT COMPLETED|Overall Study||20
2572236|NCT00424762|6308498|P2|COMPLETED|Overall Study||54
2572237|NCT00424762|6308499|P1|COMPLETED|Overall Study||54
2572238|NCT00424762|6308498|P2|STARTED|Overall Study||76
2572239|NCT00424762|6308499|P1|STARTED|Overall Study||74
2572240|NCT00424749|6308509|P1|NOT COMPLETED|Overall Study||1
2572241|NCT00424749|6308509|P1|COMPLETED|Overall Study||3
2572242|NCT00424749|6308509|P1|STARTED|Overall Study||4
2572243|NCT00424645|6308516|P2|NOT COMPLETED|Overall Study||0
2572244|NCT00424645|6308517|P1|NOT COMPLETED|Overall Study||1
2572245|NCT00424645|6308516|P2|COMPLETED|Overall Study||0
2572246|NCT00424645|6308517|P1|COMPLETED|Overall Study||2
2572247|NCT00424645|6308516|P2|STARTED|Overall Study||0
2572248|NCT00424645|6308517|P1|STARTED|Overall Study||3
2572249|NCT00424632|6308525|P10|NOT COMPLETED|Overall Study||6
2572250|NCT00424632|6308526|P9|NOT COMPLETED|Overall Study||16
2572251|NCT00424632|6308527|P8|NOT COMPLETED|Overall Study||3
2572252|NCT00424632|6308528|P7|NOT COMPLETED|Overall Study||7
2572253|NCT00424632|6308529|P6|NOT COMPLETED|Overall Study||15
2572254|NCT00424632|6308530|P5|NOT COMPLETED|Overall Study||3
2572255|NCT00424632|6308531|P4|NOT COMPLETED|Overall Study||4
2572256|NCT00424632|6308532|P3|NOT COMPLETED|Overall Study||1
2572257|NCT00424632|6308533|P2|NOT COMPLETED|Overall Study||1
2572258|NCT00424632|6308534|P1|NOT COMPLETED|Overall Study||1
2572259|NCT00424632|6308525|P10|COMPLETED|Overall Study||0
2572260|NCT00424632|6308526|P9|COMPLETED|Overall Study||0
2572261|NCT00424632|6308527|P8|COMPLETED|Overall Study||0
2572262|NCT00424632|6308528|P7|COMPLETED|Overall Study||0
2572263|NCT00424632|6308529|P6|COMPLETED|Overall Study||0
2572264|NCT00424632|6308530|P5|COMPLETED|Overall Study||0
2572265|NCT00424632|6308531|P4|COMPLETED|Overall Study||0
2572266|NCT00424632|6308532|P3|COMPLETED|Overall Study||0
2572267|NCT00424632|6308533|P2|COMPLETED|Overall Study||0
2572268|NCT00424632|6308534|P1|COMPLETED|Overall Study||0
2572269|NCT00424632|6308525|P10|STARTED|Overall Study||6
2572270|NCT00424632|6308526|P9|STARTED|Overall Study||16
2572271|NCT00424632|6308527|P8|STARTED|Overall Study||3
2572272|NCT00424632|6308528|P7|STARTED|Overall Study||7
2572273|NCT00424632|6308529|P6|STARTED|Overall Study||15
2572274|NCT00424632|6308530|P5|STARTED|Overall Study||3
2572275|NCT00424632|6308531|P4|STARTED|Overall Study||4
2572276|NCT00424632|6308532|P3|STARTED|Overall Study||1
2572277|NCT00424632|6308533|P2|STARTED|Overall Study||1
2572278|NCT00424632|6308534|P1|STARTED|Overall Study||1
2572279|NCT00424619|6308668|P3|NOT COMPLETED|3 Month||0
2572280|NCT00424619|6308669|P2|NOT COMPLETED|3 Month||0
2572281|NCT00424619|6308670|P1|NOT COMPLETED|3 Month||0
2572282|NCT00424619|6308668|P3|COMPLETED|3 Month||17
2572283|NCT00424619|6308669|P2|COMPLETED|3 Month||18
2572284|NCT00424619|6308670|P1|COMPLETED|3 Month||12
2572285|NCT00424619|6308668|P3|STARTED|3 Month||17
2572286|NCT00424619|6308669|P2|STARTED|3 Month||18
2572287|NCT00424619|6308670|P1|STARTED|3 Month||12
2572288|NCT00424619|6308668|P3|NOT COMPLETED|4 Week||0
2572289|NCT00424619|6308669|P2|NOT COMPLETED|4 Week||0
2572290|NCT00424619|6308670|P1|NOT COMPLETED|4 Week||0
2572291|NCT00424619|6308668|P3|COMPLETED|4 Week||17
2572292|NCT00424619|6308669|P2|COMPLETED|4 Week||17
2572293|NCT00424619|6308670|P1|COMPLETED|4 Week||18
2572294|NCT00424619|6308668|P3|STARTED|4 Week||17
2572295|NCT00424619|6308669|P2|STARTED|4 Week||17
2572296|NCT00424619|6308670|P1|STARTED|4 Week||18
2572297|NCT00424619|6308668|P3|NOT COMPLETED|Baseline||1
2572298|NCT00424619|6308669|P2|NOT COMPLETED|Baseline||0
2572299|NCT00424619|6308670|P1|NOT COMPLETED|Baseline||0
2572300|NCT00424619|6308668|P3|COMPLETED|Baseline||20
2572301|NCT00424619|6308669|P2|COMPLETED|Baseline||22
2572302|NCT00424619|6308670|P1|COMPLETED|Baseline||22
2572303|NCT00424619|6308668|P3|STARTED|Baseline|n=21 but one participant was lost as a screen failure|21
2572304|NCT00424619|6308669|P2|STARTED|Baseline||22
2572305|NCT00424619|6308670|P1|STARTED|Baseline||22
2572306|NCT00424593|6308704|P2|NOT COMPLETED|Dose-Blind Extension Period||0
2572307|NCT00424593|6308705|P1|NOT COMPLETED|Dose-Blind Extension Period||64
2572308|NCT00424593|6308704|P2|COMPLETED|Dose-Blind Extension Period||0
2572309|NCT00424593|6308705|P1|COMPLETED|Dose-Blind Extension Period||117
2572310|NCT00424593|6308704|P2|STARTED|Dose-Blind Extension Period|98 placebo patients from acute phase entered dose-blind period and received duloxetine.|0
2572311|NCT00424593|6308705|P1|STARTED|Dose-Blind Extension Period|83 duloxetine patients from the acute phase entered the dose-blind period.|181
2572312|NCT00424593|6308704|P2|NOT COMPLETED|Acute Double-Blind Period||23
2572313|NCT00424593|6308705|P1|NOT COMPLETED|Acute Double-Blind Period||31
2572314|NCT00424593|6308704|P2|COMPLETED|Acute Double-Blind Period||98
2572315|NCT00424593|6308705|P1|COMPLETED|Acute Double-Blind Period||84
2572316|NCT00424593|6308704|P2|STARTED|Acute Double-Blind Period||121
2572317|NCT00424593|6308705|P1|STARTED|Acute Double-Blind Period||115
2572318|NCT00424554|6308751|P2|NOT COMPLETED|Overall Study||0
2572319|NCT00424554|6308752|P1|NOT COMPLETED|Overall Study||0
2572320|NCT00424554|6308751|P2|COMPLETED|Overall Study||6
2572321|NCT00424554|6308752|P1|COMPLETED|Overall Study||34
2572322|NCT00424554|6308751|P2|STARTED|Overall Study||6
2572323|NCT00424554|6308752|P1|STARTED|Overall Study||34
2572324|NCT00424528|6308769|P3|NOT COMPLETED|Overall Study||4
2572325|NCT00424528|6308770|P2|NOT COMPLETED|Overall Study||4
2572326|NCT00424528|6308771|P1|NOT COMPLETED|Overall Study||5
2572327|NCT00424528|6308769|P3|COMPLETED|Overall Study||74
2572328|NCT00424528|6308770|P2|COMPLETED|Overall Study||76
2572329|NCT00424528|6308771|P1|COMPLETED|Overall Study||71
2572330|NCT00424528|6308769|P3|STARTED|Overall Study||78
2572331|NCT00424528|6308770|P2|STARTED|Overall Study||80
2572332|NCT00424528|6308771|P1|STARTED|Overall Study||76
2572333|NCT00424515|6308826|P2|NOT COMPLETED|Overall Study||13
2572334|NCT00424515|6308827|P1|NOT COMPLETED|Overall Study||11
2572335|NCT00424515|6308826|P2|COMPLETED|Overall Study||0
2572336|NCT00424515|6308827|P1|COMPLETED|Overall Study||0
2572337|NCT00424515|6308826|P2|STARTED|Overall Study||13
2572338|NCT00424515|6308827|P1|STARTED|Overall Study||11
2572339|NCT00424502|6308837|P1|NOT COMPLETED|Overall Study||0
2572340|NCT00424502|6308837|P1|COMPLETED|Overall Study||20
2572341|NCT00424502|6308837|P1|STARTED|Overall Study||20
2572342|NCT00424489|6308846|P1|NOT COMPLETED|Overall Study||3
2572343|NCT00424489|6308846|P1|COMPLETED|Overall Study||6
2572344|NCT00424489|6308846|P1|STARTED|Overall Study||9
2572345|NCT00424476|6308853|P3|NOT COMPLETED|Overall Study||49
2572346|NCT00424476|6308854|P2|NOT COMPLETED|Overall Study||48
2572347|NCT00424476|6308855|P1|NOT COMPLETED|Overall Study||61
2572348|NCT00424476|6308853|P3|COMPLETED|Overall Study||241
2572349|NCT00424476|6308854|P2|COMPLETED|Overall Study||240
2572350|NCT00424476|6308855|P1|COMPLETED|Overall Study||226
2572351|NCT00424476|6308853|P3|STARTED|Overall Study||290
2572352|NCT00424476|6308854|P2|STARTED|Overall Study||288
2572353|NCT00424476|6308855|P1|STARTED|Overall Study||287
2572354|NCT00424463|6308881|P3|NOT COMPLETED|Overall Study||16
2572355|NCT00424463|6308882|P2|NOT COMPLETED|Overall Study||14
2572356|NCT00424463|6308883|P1|NOT COMPLETED|Overall Study||7
2572357|NCT00424463|6308881|P3|COMPLETED|Overall Study||72
2572358|NCT00424463|6308882|P2|COMPLETED|Overall Study||34
2572359|NCT00424463|6308883|P1|COMPLETED|Overall Study||38
2572360|NCT00424463|6308881|P3|STARTED|Overall Study||88
2572361|NCT00424463|6308882|P2|STARTED|Overall Study||48
2572362|NCT00424463|6308883|P1|STARTED|Overall Study||45
2572363|NCT00424398|6308912|P3|NOT COMPLETED|Overall Study||0
2572364|NCT00424398|6308913|P2|NOT COMPLETED|Overall Study||1
2572365|NCT00424398|6308914|P1|NOT COMPLETED|Overall Study||3
2572366|NCT00424398|6308912|P3|COMPLETED|Overall Study||36
2572367|NCT00424398|6308913|P2|COMPLETED|Overall Study||35
2572368|NCT00424398|6308914|P1|COMPLETED|Overall Study||32
2572369|NCT00424398|6308912|P3|STARTED|Overall Study||36
2572370|NCT00424398|6308913|P2|STARTED|Overall Study||36
2572371|NCT00424398|6308914|P1|STARTED|Overall Study||35
2572372|NCT00424385|6308958|P1|NOT COMPLETED|Cohort 1||1
2572373|NCT00424385|6308958|P1|COMPLETED|Cohort 1||4
2572374|NCT00424385|6308958|P1|STARTED|Cohort 1||5
2572375|NCT00424385|6308958|P1|NOT COMPLETED|Cohort 0||6
2572376|NCT00424385|6308958|P1|COMPLETED|Cohort 0||6
2572377|NCT00424385|6308958|P1|STARTED|Cohort 0||12
2572378|NCT00424372|6308965|P1|NOT COMPLETED|Overall Study||31
2572379|NCT00424372|6308965|P1|COMPLETED|Overall Study||95
2572380|NCT00424372|6308965|P1|STARTED|Overall Study||126
2572381|NCT00424346|6308977|P4|NOT COMPLETED|Extension Phase||55
2572382|NCT00424346|6308978|P3|NOT COMPLETED|Extension Phase||55
2572383|NCT00424346|6308979|P2|NOT COMPLETED|Extension Phase||102
2572384|NCT00424346|6308980|P1|NOT COMPLETED|Extension Phase||0
2572385|NCT00424346|6308977|P4|COMPLETED|Extension Phase||3
2572386|NCT00424346|6308978|P3|COMPLETED|Extension Phase||4
2572387|NCT00424346|6308979|P2|COMPLETED|Extension Phase||8
2572388|NCT00424346|6308980|P1|COMPLETED|Extension Phase||0
2572389|NCT00424346|6308977|P4|STARTED|Extension Phase||58
2572390|NCT00424346|6308978|P3|STARTED|Extension Phase||59
2572391|NCT00424346|6308979|P2|STARTED|Extension Phase|Includes participants who completed the Core phase in the Canakinumab 600 mg IV + 300 mg q2wk group.|110
2572392|NCT00424346|6308980|P1|STARTED|Extension Phase|Participants are represented in the Canakinumab 300 mg q2wk treatment group.|0
2572393|NCT00424346|6308977|P4|NOT COMPLETED|Core Study||7
2572394|NCT00424346|6308978|P3|NOT COMPLETED|Core Study||4
2572395|NCT00424346|6308979|P2|NOT COMPLETED|Core Study||8
2572396|NCT00424346|6308980|P1|NOT COMPLETED|Core Study||9
2572397|NCT00424346|6308977|P4|COMPLETED|Core Study||63
2572398|NCT00424346|6308978|P3|COMPLETED|Core Study||65
2572399|NCT00424346|6308979|P2|COMPLETED|Core Study||56
2572400|NCT00424346|6308980|P1|COMPLETED|Core Study||62
2572401|NCT00424346|6308977|P4|STARTED|Core Study||70
2572402|NCT00424346|6308978|P3|STARTED|Core Study||69
2572403|NCT00424346|6308979|P2|STARTED|Core Study||64
2572404|NCT00424346|6308980|P1|STARTED|Core Study||71
2572405|NCT00424294|6309095|P2|NOT COMPLETED|Overall Study||15
2572406|NCT00424294|6309096|P1|NOT COMPLETED|Overall Study||8
2572407|NCT00424294|6309095|P2|COMPLETED|Overall Study||19
2572408|NCT00424294|6309096|P1|COMPLETED|Overall Study||28
2572409|NCT00424294|6309095|P2|Treated|Overall Study||34
2572410|NCT00424294|6309096|P1|Treated|Overall Study||35
2572411|NCT00424294|6309095|P2|STARTED|Overall Study||34
2572412|NCT00424294|6309096|P1|STARTED|Overall Study||36
2572413|NCT00424268|6309146|P2|NOT COMPLETED|Overall Study||39
2572414|NCT00424268|6309147|P1|NOT COMPLETED|Overall Study||62
2572415|NCT00424268|6309146|P2|COMPLETED|Overall Study||333
2572416|NCT00424268|6309147|P1|COMPLETED|Overall Study||309
2572417|NCT00424268|6309146|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|372
2572418|NCT00424268|6309147|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|371
2572419|NCT00424255|6309163|P2|NOT COMPLETED|Overall Study||346
2572420|NCT00424255|6309164|P1|NOT COMPLETED|Overall Study||342
2572421|NCT00424255|6309163|P2|COMPLETED|Overall Study||0
2572422|NCT00424255|6309164|P1|COMPLETED|Overall Study||0
2572423|NCT00424255|6309163|P2|STARTED|Overall Study||346
2572424|NCT00424255|6309164|P1|STARTED|Overall Study||342
2572425|NCT00424190|6309212|P2|NOT COMPLETED|Overall Study||30
2572426|NCT00424190|6309213|P1|NOT COMPLETED|Overall Study||22
2572427|NCT00424190|6309212|P2|COMPLETED|Overall Study||317
2572428|NCT00424190|6309213|P1|COMPLETED|Overall Study||329
2572429|NCT00424190|6309212|P2|STARTED|Overall Study||347
2572430|NCT00424190|6309213|P1|STARTED|Overall Study||351
2572431|NCT00424177|6309219|P1|NOT COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||3
2572432|NCT00424177|6309219|P1|COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||48
2572433|NCT00424177|6309219|P1|STARTED|Cycle 3: Eltrombopag 50 or 75 mg||51
2572434|NCT00424177|6309219|P1|NOT COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||4
2572435|NCT00424177|6309219|P1|COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||51
2572436|NCT00424177|6309219|P1|STARTED|Cycle 2: Eltrombopag 50 or 75 mg||55
2572437|NCT00424177|6309219|P1|NOT COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||11
2572438|NCT00424177|6309219|P1|COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||55
2572439|NCT00424177|6309219|P1|STARTED|Cycle 1: Eltrombopag 50 mg Starting Dose||66
2572440|NCT00424047|6309248|P2|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||8
2572441|NCT00424047|6309249|P1|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||21
2572442|NCT00424047|6309248|P2|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
2572443|NCT00424047|6309249|P1|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
2572444|NCT00424047|6309248|P2|STARTED|Long Term Extension (Up to 25 Jun 2013)|2 participants opted to receive dex alone, 3 crossed over to Len/Dex and 3 added Len at a later date|8
2572445|NCT00424047|6309249|P1|STARTED|Long Term Extension (Up to 25 Jun 2013)||21
2572446|NCT00424047|6309248|P2|NOT COMPLETED|On Study at Time of Unblinding||167
2572447|NCT00424047|6309249|P1|NOT COMPLETED|On Study at Time of Unblinding||155
2572448|NCT00424047|6309248|P2|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term dexamethasone|8
2572449|NCT00424047|6309249|P1|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term Lenalidomide and dexamethasone|21
2572450|NCT00424047|6309248|P2|STARTED|On Study at Time of Unblinding||175
2572451|NCT00424047|6309249|P1|STARTED|On Study at Time of Unblinding|Refers to original treatment group assignment in the study.|176
2572452|NCT00424047|6309248|P2|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||156
2572453|NCT00424047|6309249|P1|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||122
2572454|NCT00424047|6309248|P2|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|Ongoing and includes 15 participants who crossed over to lenalidomide/dexamethasone after unblinding|19
2572455|NCT00424047|6309249|P1|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|54 participants ongoing and continuing on lenalidomide/dexamethasone treatment|54
2572456|NCT00424047|6309248|P2|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|4 participants excluded because they had no baseline M-protein assessment|171
2572457|NCT00424047|6309249|P1|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|1 participant excluded because they had no baseline M-protein assessment|175
2572458|NCT00424047|6309248|P2|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|175
2572459|NCT00424047|6309249|P1|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|176
2572460|NCT00424047|6309248|P2|STARTED|Blinded Treatment (Up to 03 Aug 2005)||175
2572461|NCT00424047|6309249|P1|STARTED|Blinded Treatment (Up to 03 Aug 2005)||176
2572462|NCT00424021|6309281|P4|NOT COMPLETED|AMB-220-E Study Period||10
2572463|NCT00424021|6309282|P3|NOT COMPLETED|AMB-220-E Study Period||5
2572464|NCT00424021|6309283|P2|NOT COMPLETED|AMB-220-E Study Period||2
2572465|NCT00424021|6309284|P1|NOT COMPLETED|AMB-220-E Study Period||1
2572466|NCT00424021|6309281|P4|COMPLETED|AMB-220-E Study Period||16
2572467|NCT00424021|6309282|P3|COMPLETED|AMB-220-E Study Period||14
2572468|NCT00424021|6309283|P2|COMPLETED|AMB-220-E Study Period||5
2572469|NCT00424021|6309284|P1|COMPLETED|AMB-220-E Study Period||1
2572470|NCT00424021|6309281|P4|STARTED|AMB-220-E Study Period||26
2572471|NCT00424021|6309282|P3|STARTED|AMB-220-E Study Period||19
2572472|NCT00424021|6309283|P2|STARTED|AMB-220-E Study Period||7
2572473|NCT00424021|6309284|P1|STARTED|AMB-220-E Study Period||2
2572474|NCT00424021|6309281|P4|NOT COMPLETED|NCT00046319 Study Period||1
2572475|NCT00424021|6309282|P3|NOT COMPLETED|NCT00046319 Study Period||1
2572476|NCT00424021|6309283|P2|NOT COMPLETED|NCT00046319 Study Period||3
2572477|NCT00424021|6309284|P1|NOT COMPLETED|NCT00046319 Study Period||1
2572478|NCT00424021|6309281|P4|COMPLETED|NCT00046319 Study Period||12
2572479|NCT00424021|6309282|P3|COMPLETED|NCT00046319 Study Period||15
2572480|NCT00424021|6309283|P2|COMPLETED|NCT00046319 Study Period||16
2572481|NCT00424021|6309284|P1|COMPLETED|NCT00046319 Study Period||15
2572482|NCT00424021|6309281|P4|STARTED|NCT00046319 Study Period||13
2572483|NCT00424021|6309282|P3|STARTED|NCT00046319 Study Period||16
2572484|NCT00424021|6309283|P2|STARTED|NCT00046319 Study Period||19
2572485|NCT00424021|6309284|P1|STARTED|NCT00046319 Study Period||16
2572486|NCT00424008|6309327|P2|NOT COMPLETED|Overall Study||335
2572487|NCT00424008|6309328|P1|NOT COMPLETED|Overall Study||349
2572488|NCT00424008|6309327|P2|COMPLETED|Overall Study||16
2572489|NCT00424008|6309328|P1|COMPLETED|Overall Study||22
2572490|NCT00424008|6309327|P2|STARTED|Overall Study||351
2572491|NCT00424008|6309328|P1|STARTED|Overall Study||371
2572492|NCT00423943|6309343|P2|NOT COMPLETED|Overall Study||1
2572493|NCT00423943|6309344|P1|NOT COMPLETED|Overall Study||3
2572494|NCT00423943|6309343|P2|COMPLETED|Overall Study||13
2572495|NCT00423943|6309344|P1|COMPLETED|Overall Study||16
2572496|NCT00423943|6309343|P2|STARTED|Overall Study||14
2572497|NCT00423943|6309344|P1|STARTED|Overall Study||19
2572498|NCT00423930|6309358|P1|NOT COMPLETED|Overall Study||2
2572499|NCT00423930|6309358|P1|COMPLETED|Overall Study||42
2572500|NCT00423930|6309358|P1|STARTED|Overall Study||44
2572501|NCT00423917|6309363|P1|NOT COMPLETED|Overall Study||3
2572502|NCT00423917|6309363|P1|COMPLETED|Overall Study||33
2572503|NCT00423917|6309363|P1|STARTED|Overall Study||36
2572504|NCT00423891|6309376|P3|NOT COMPLETED|Post-Dosing Follow Up||2
2572505|NCT00423891|6309377|P2|NOT COMPLETED|Post-Dosing Follow Up||3
2572506|NCT00423891|6309378|P1|NOT COMPLETED|Post-Dosing Follow Up||2
2572507|NCT00423891|6309376|P3|COMPLETED|Post-Dosing Follow Up||3
2572508|NCT00423891|6309377|P2|COMPLETED|Post-Dosing Follow Up||15
2572509|NCT00423891|6309378|P1|COMPLETED|Post-Dosing Follow Up||20
2572510|NCT00423891|6309376|P3|STARTED|Post-Dosing Follow Up||5
2572511|NCT00423891|6309377|P2|STARTED|Post-Dosing Follow Up||18
2572512|NCT00423891|6309378|P1|STARTED|Post-Dosing Follow Up||22
2572513|NCT00423891|6309376|P3|NOT COMPLETED|Treatment||0
2572514|NCT00423891|6309377|P2|NOT COMPLETED|Treatment||0
2572515|NCT00423891|6309378|P1|NOT COMPLETED|Treatment||2
2572516|NCT00423891|6309376|P3|COMPLETED|Treatment||5
2572517|NCT00423891|6309377|P2|COMPLETED|Treatment||19
2572518|NCT00423891|6309378|P1|COMPLETED|Treatment||22
2572519|NCT00423891|6309376|P3|STARTED|Treatment||5
2572520|NCT00423891|6309377|P2|STARTED|Treatment||19
2572521|NCT00423891|6309378|P1|STARTED|Treatment||24
2572522|NCT00423891|6309376|P3|NOT COMPLETED|Enrolled||3
2572523|NCT00423891|6309377|P2|NOT COMPLETED|Enrolled||2
2572524|NCT00423891|6309378|P1|NOT COMPLETED|Enrolled||11
2572525|NCT00423891|6309376|P3|COMPLETED|Enrolled||5
2572526|NCT00423891|6309377|P2|COMPLETED|Enrolled||19
2572527|NCT00423891|6309378|P1|COMPLETED|Enrolled||24
2572528|NCT00423891|6309376|P3|STARTED|Enrolled||8
2572529|NCT00423891|6309377|P2|STARTED|Enrolled||21
2572530|NCT00423891|6309378|P1|STARTED|Enrolled||35
2572531|NCT00423878|6309447|P2|NOT COMPLETED|Overall Study||8
2572532|NCT00423878|6309448|P1|NOT COMPLETED|Overall Study||20
2572533|NCT00423878|6309447|P2|COMPLETED|Overall Study||98
2572534|NCT00423878|6309448|P1|COMPLETED|Overall Study||89
2572535|NCT00423878|6309447|P2|STARTED|Overall Study||106
2572536|NCT00423878|6309448|P1|STARTED|Overall Study||109
2572537|NCT00423852|6309456|P1|NOT COMPLETED|Overall Study||3
2572538|NCT00423852|6309456|P1|COMPLETED|Overall Study||23
2572539|NCT00423852|6309456|P1|STARTED|Overall Study||26
2572540|NCT00423813|6309464|P3|NOT COMPLETED|Overall Study||74
2572541|NCT00423813|6309465|P2|NOT COMPLETED|Overall Study||66
2572542|NCT00423813|6309466|P1|NOT COMPLETED|Overall Study||57
2572543|NCT00423813|6309464|P3|COMPLETED|Overall Study||116
2572544|NCT00423813|6309465|P2|COMPLETED|Overall Study||129
2572545|NCT00423813|6309466|P1|COMPLETED|Overall Study||131
2572546|NCT00423813|6309464|P3|Treated|Overall Study||189
2572547|NCT00423813|6309465|P2|Treated|Overall Study||194
2572548|NCT00423813|6309466|P1|Treated|Overall Study||188
2572549|NCT00423813|6309464|P3|STARTED|Overall Study||190
2572550|NCT00423813|6309465|P2|STARTED|Overall Study||195
2572551|NCT00423813|6309466|P1|STARTED|Overall Study||188
2572552|NCT00423800|6309476|P2|NOT COMPLETED|Overall Study||1
2572553|NCT00423800|6309477|P1|NOT COMPLETED|Overall Study||0
2572554|NCT00423800|6309476|P2|COMPLETED|Overall Study||1
2572555|NCT00423800|6309477|P1|COMPLETED|Overall Study||3
2572556|NCT00423800|6309476|P2|STARTED|Overall Study||2
2572557|NCT00423800|6309477|P1|STARTED|Overall Study||3
2572558|NCT00423735|6309489|P3|NOT COMPLETED|Overall Study||0
2572559|NCT00423735|6309490|P2|NOT COMPLETED|Overall Study||6
2572560|NCT00423735|6309491|P1|NOT COMPLETED|Overall Study||8
2572561|NCT00423735|6309489|P3|COMPLETED|Overall Study||0
2572562|NCT00423735|6309490|P2|COMPLETED|Overall Study||29
2572563|NCT00423735|6309491|P1|COMPLETED|Overall Study||21
2572564|NCT00423735|6309489|P3|STARTED|Overall Study||0
2572565|NCT00423735|6309490|P2|STARTED|Overall Study||35
2572566|NCT00423735|6309491|P1|STARTED|Overall Study||29
2572567|NCT00423722|6309514|P2|NOT COMPLETED|Overall Study||13
2572568|NCT00423722|6309515|P1|NOT COMPLETED|Overall Study||14
2572569|NCT00423722|6309514|P2|COMPLETED|Overall Study||53
2572570|NCT00423722|6309515|P1|COMPLETED|Overall Study||49
2572571|NCT00423722|6309514|P2|STARTED|Overall Study||66
2572572|NCT00423722|6309515|P1|STARTED|Overall Study||63
2572573|NCT00423683|6309537|P2|NOT COMPLETED|Overall Study||0
2572574|NCT00423683|6309538|P1|NOT COMPLETED|Overall Study||1
2572575|NCT00423683|6309537|P2|COMPLETED|Overall Study||33
2572576|NCT00423683|6309538|P1|COMPLETED|Overall Study||30
2572577|NCT00423683|6309537|P2|STARTED|Overall Study||33
2572578|NCT00423683|6309538|P1|STARTED|Overall Study||31
2572579|NCT00423670|6309557|P8|NOT COMPLETED|Follow-up Period||3
2572580|NCT00423670|6309558|P7|NOT COMPLETED|Follow-up Period||9
2572581|NCT00423670|6309559|P6|NOT COMPLETED|Follow-up Period||0
2572582|NCT00423670|6309560|P5|NOT COMPLETED|Follow-up Period||2
2572583|NCT00423670|6309561|P4|NOT COMPLETED|Follow-up Period||5
2572584|NCT00423670|6309562|P3|NOT COMPLETED|Follow-up Period||11
2572585|NCT00423670|6309563|P2|NOT COMPLETED|Follow-up Period||16
2572586|NCT00423670|6309564|P1|NOT COMPLETED|Follow-up Period||3
2572587|NCT00423670|6309557|P8|COMPLETED|Follow-up Period||32
2572588|NCT00423670|6309558|P7|COMPLETED|Follow-up Period||41
2572589|NCT00423670|6309559|P6|COMPLETED|Follow-up Period||14
2572590|NCT00423670|6309560|P5|COMPLETED|Follow-up Period||89
2572591|NCT00423670|6309561|P4|COMPLETED|Follow-up Period||91
2572592|NCT00423670|6309562|P3|COMPLETED|Follow-up Period||85
2572593|NCT00423670|6309563|P2|COMPLETED|Follow-up Period||84
2572594|NCT00423670|6309564|P1|COMPLETED|Follow-up Period||94
2572595|NCT00423670|6309557|P8|STARTED|Follow-up Period||35
2572596|NCT00423670|6309558|P7|STARTED|Follow-up Period||50
2572597|NCT00423670|6309559|P6|STARTED|Follow-up Period||14
2572598|NCT00423670|6309560|P5|STARTED|Follow-up Period||91
2572599|NCT00423670|6309561|P4|STARTED|Follow-up Period||96
2572600|NCT00423670|6309562|P3|STARTED|Follow-up Period||96
2572601|NCT00423670|6309563|P2|STARTED|Follow-up Period||100
2572602|NCT00423670|6309564|P1|STARTED|Follow-up Period||97
2572603|NCT00423670|6309557|P8|NOT COMPLETED|Treatment Period||21
2572604|NCT00423670|6309558|P7|NOT COMPLETED|Treatment Period||31
2572605|NCT00423670|6309559|P6|NOT COMPLETED|Treatment Period||8
2572606|NCT00423670|6309560|P5|NOT COMPLETED|Treatment Period||27
2572607|NCT00423670|6309561|P4|NOT COMPLETED|Treatment Period||40
2572608|NCT00423670|6309562|P3|NOT COMPLETED|Treatment Period||27
2572609|NCT00423670|6309563|P2|NOT COMPLETED|Treatment Period||30
2572610|NCT00423670|6309564|P1|NOT COMPLETED|Treatment Period||52
2572611|NCT00423670|6309557|P8|COMPLETED|Treatment Period||15
2572612|NCT00423670|6309558|P7|COMPLETED|Treatment Period||28
2572613|NCT00423670|6309559|P6|COMPLETED|Treatment Period||8
2572614|NCT00423670|6309560|P5|COMPLETED|Treatment Period||76
2572615|NCT00423670|6309561|P4|COMPLETED|Treatment Period||63
2572616|NCT00423670|6309562|P3|COMPLETED|Treatment Period||76
2572617|NCT00423670|6309563|P2|COMPLETED|Treatment Period||77
2572618|NCT00423670|6309564|P1|COMPLETED|Treatment Period||52
2572619|NCT00423670|6309557|P8|STARTED|Treatment Period|Arm 8 were Arm 1 participants that were positive for HCV-RNA at TW 24 and had the option to switch.|36
2572620|NCT00423670|6309558|P7|STARTED|Treatment Period||59
2572621|NCT00423670|6309559|P6|STARTED|Treatment Period||16
2572622|NCT00423670|6309560|P5|STARTED|Treatment Period||103
2572623|NCT00423670|6309561|P4|STARTED|Treatment Period||103
2572624|NCT00423670|6309562|P3|STARTED|Treatment Period||103
2572625|NCT00423670|6309563|P2|STARTED|Treatment Period||107
2572626|NCT00423670|6309564|P1|STARTED|Treatment Period||104
2572627|NCT00423657|6309622|P2|NOT COMPLETED|Overall Study||25
2572628|NCT00423657|6309623|P1|NOT COMPLETED|Overall Study||26
2572629|NCT00423657|6309622|P2|COMPLETED|Overall Study||313
2572630|NCT00423657|6309623|P1|COMPLETED|Overall Study||316
2572631|NCT00423657|6309622|P2|STARTED|Overall Study||338
2572632|NCT00423657|6309623|P1|STARTED|Overall Study||342
2572633|NCT00423605|6309629|P1|NOT COMPLETED|Overall Study||241
2572634|NCT00423605|6309629|P1|COMPLETED|Overall Study||319
2572635|NCT00423605|6309629|P1|STARTED|Overall Study||560
2572636|NCT00423592|6309633|P1|NOT COMPLETED|Overall Study||7
2572637|NCT00423592|6309633|P1|COMPLETED|Overall Study|Completed study|29
2572638|NCT00423592|6309633|P1|Completed Preliminary Analysis Cut-off|Overall Study|Preliminary analysis cut-off at Week 12 for primary/secondary endpoint analysis|34
2572639|NCT00423592|6309633|P1|STARTED|Overall Study|Enrolled|36
2572640|NCT00423579|6309654|P2|NOT COMPLETED|Overall Study||4
2572641|NCT00423579|6309655|P1|NOT COMPLETED|Overall Study||4
2572642|NCT00423579|6309654|P2|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
2572643|NCT00423579|6309655|P1|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
2572644|NCT00423579|6309654|P2|STARTED|Overall Study||60
2572645|NCT00423579|6309655|P1|STARTED|Overall Study|61 enrolled, however one subject was ineligible and was removed.|60
2572646|NCT00423488|6309663|P2|NOT COMPLETED|Overall Study||1
2572647|NCT00423488|6309664|P1|NOT COMPLETED|Overall Study||5
2572648|NCT00423488|6309663|P2|COMPLETED|Overall Study||50
2572649|NCT00423488|6309664|P1|COMPLETED|Overall Study||37
2572650|NCT00423488|6309663|P2|STARTED|Overall Study||51
2572651|NCT00423488|6309664|P1|STARTED|Overall Study||42
2572652|NCT00423449|6309670|P5|NOT COMPLETED|Overall Study||7
2572653|NCT00423449|6309671|P4|NOT COMPLETED|Overall Study||22
2572654|NCT00423449|6309672|P3|NOT COMPLETED|Overall Study||15
2572655|NCT00423449|6309673|P2|NOT COMPLETED|Overall Study||4
2572656|NCT00423449|6309674|P1|NOT COMPLETED|Overall Study||3
2572657|NCT00423449|6309670|P5|COMPLETED|Overall Study||0
2572658|NCT00423449|6309671|P4|COMPLETED|Overall Study||5
2572659|NCT00423449|6309672|P3|COMPLETED|Overall Study||2
2572660|NCT00423449|6309673|P2|COMPLETED|Overall Study||2
2572661|NCT00423449|6309674|P1|COMPLETED|Overall Study||1
2572662|NCT00423449|6309670|P5|STARTED|Overall Study||7
2572663|NCT00423449|6309671|P4|STARTED|Overall Study||27
2572664|NCT00423449|6309672|P3|STARTED|Overall Study||17
2572665|NCT00423449|6309673|P2|STARTED|Overall Study||6
2572666|NCT00423449|6309674|P1|STARTED|Overall Study||4
2572667|NCT00423436|6309699|P2|NOT COMPLETED|Overall Study||0
2572668|NCT00423436|6309700|P1|NOT COMPLETED|Overall Study||0
2572669|NCT00423436|6309699|P2|COMPLETED|Overall Study||33
2572670|NCT00423436|6309700|P1|COMPLETED|Overall Study||35
2572671|NCT00423436|6309699|P2|STARTED|Overall Study||33
2572672|NCT00423436|6309700|P1|STARTED|Overall Study||35
2572673|NCT00423358|6309708|P2|NOT COMPLETED|Overall Study||0
2572674|NCT00423358|6309709|P1|NOT COMPLETED|Overall Study||0
2572675|NCT00423358|6309708|P2|COMPLETED|Overall Study||11
2572676|NCT00423358|6309709|P1|COMPLETED|Overall Study||11
2572677|NCT00423358|6309708|P2|STARTED|Overall Study||11
2572678|NCT00423358|6309709|P1|STARTED|Overall Study||11
2572679|NCT00423332|6309721|P2|NOT COMPLETED|Overall Study||7
2572680|NCT00423332|6309722|P1|NOT COMPLETED|Overall Study||9
2572681|NCT00423332|6309721|P2|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|11
2572682|NCT00423332|6309722|P1|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|44
2572683|NCT00423332|6309721|P2|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|4
2572684|NCT00423332|6309722|P1|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|22
2572685|NCT00423332|6309721|P2|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|14
2572686|NCT00423332|6309722|P1|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|44
2572687|NCT00423332|6309721|P2|STARTED|Overall Study|Number randomised|18
2572688|NCT00423332|6309722|P1|STARTED|Overall Study|Randomised|53
2572689|NCT00423319|6309741|P2|NOT COMPLETED|Overall Study||252
2572690|NCT00423319|6309742|P1|NOT COMPLETED|Overall Study||224
2572691|NCT00423319|6309741|P2|COMPLETED|Overall Study||2447
2572692|NCT00423319|6309742|P1|COMPLETED|Overall Study||2484
2572693|NCT00423319|6309741|P2|Participants Who Received Treatment|Overall Study||2659
2572694|NCT00423319|6309742|P1|Participants Who Received Treatment|Overall Study||2673
2572695|NCT00423319|6309741|P2|STARTED|Overall Study|Randomized|2699
2572696|NCT00423319|6309742|P1|STARTED|Overall Study|Randomized|2708
2572697|NCT00423293|6309774|P1|NOT COMPLETED|Overall Study||11
2572698|NCT00423293|6309774|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
2572699|NCT00423293|6309774|P1|STARTED|Overall Study||63
2572700|NCT00423267|6309791|P2|NOT COMPLETED|Period B||0
2572701|NCT00423267|6309792|P1|NOT COMPLETED|Period B||0
2572702|NCT00423267|6309791|P2|COMPLETED|Period B||0
2572703|NCT00423267|6309792|P1|COMPLETED|Period B||12
2572704|NCT00423267|6309791|P2|STARTED|Period B||0
2572705|NCT00423267|6309792|P1|STARTED|Period B||12
2572706|NCT00423267|6309791|P2|NOT COMPLETED|Period A||1
2572707|NCT00423267|6309792|P1|NOT COMPLETED|Period A||2
2572708|NCT00423267|6309791|P2|COMPLETED|Period A||6
2572709|NCT00423267|6309792|P1|COMPLETED|Period A||7
2572710|NCT00423267|6309791|P2|STARTED|Period A||7
2572711|NCT00423267|6309792|P1|STARTED|Period A||9
2572712|NCT00423189|6309812|P3|NOT COMPLETED|Overall Study||0
2572713|NCT00423189|6309813|P2|NOT COMPLETED|Overall Study||1
2572714|NCT00423189|6309814|P1|NOT COMPLETED|Overall Study||0
2572715|NCT00423189|6309812|P3|COMPLETED|Overall Study||2
2572716|NCT00423189|6309813|P2|COMPLETED|Overall Study||2
2572717|NCT00423189|6309814|P1|COMPLETED|Overall Study||2
2572718|NCT00423189|6309812|P3|STARTED|Overall Study||2
2572719|NCT00423189|6309813|P2|STARTED|Overall Study||3
2572720|NCT00423189|6309814|P1|STARTED|Overall Study||2
2572721|NCT00423176|6309836|P2|NOT COMPLETED|Overall Study||29
2572722|NCT00423176|6309837|P1|NOT COMPLETED|Overall Study||16
2572723|NCT00423176|6309836|P2|COMPLETED|Overall Study||94
2572724|NCT00423176|6309837|P1|COMPLETED|Overall Study||98
2572725|NCT00423176|6309836|P2|STARTED|Overall Study||123
2572726|NCT00423176|6309837|P1|STARTED|Overall Study||114
2572727|NCT00423150|6309845|P1|NOT COMPLETED|Overall Study||86
2572728|NCT00423150|6309845|P1|COMPLETED|Overall Study||0
2572729|NCT00423150|6309845|P1|STARTED|Overall Study||86
2572730|NCT00423098|6309851|P2|NOT COMPLETED|Overall Study||4
2572731|NCT00423098|6309852|P1|NOT COMPLETED|Overall Study||3
2572732|NCT00423098|6309851|P2|COMPLETED|Overall Study||35
2572733|NCT00423098|6309852|P1|COMPLETED|Overall Study|Completed 24 weeks of study medication.|39
2572734|NCT00423098|6309851|P2|STARTED|Overall Study||39
2572735|NCT00423098|6309852|P1|STARTED|Overall Study|Total number of patients screened was 90, but the total number of randomized patients was 81.|42
2572736|NCT00423085|6309879|P4|NOT COMPLETED|52-Week Open-Label Extension Phase||163
2572737|NCT00423085|6309880|P3|NOT COMPLETED|52-Week Open-Label Extension Phase||0
2572738|NCT00423085|6309881|P2|NOT COMPLETED|52-Week Open-Label Extension Phase||0
2572739|NCT00423085|6309882|P1|NOT COMPLETED|52-Week Open-Label Extension Phase||0
2572740|NCT00423085|6309879|P4|COMPLETED|52-Week Open-Label Extension Phase||474
2572741|NCT00423085|6309880|P3|COMPLETED|52-Week Open-Label Extension Phase||0
2572742|NCT00423085|6309881|P2|COMPLETED|52-Week Open-Label Extension Phase||0
2572743|NCT00423085|6309882|P1|COMPLETED|52-Week Open-Label Extension Phase||0
2572744|NCT00423085|6309879|P4|STARTED|52-Week Open-Label Extension Phase|Patients who completed the 24-wk treatment phase were eligible to enroll in the open-label extension|637
2572745|NCT00423085|6309880|P3|STARTED|52-Week Open-Label Extension Phase||0
2572746|NCT00423085|6309881|P2|STARTED|52-Week Open-Label Extension Phase||0
2572747|NCT00423085|6309882|P1|STARTED|52-Week Open-Label Extension Phase||0
2572748|NCT00423085|6309879|P4|NOT COMPLETED|24-Week Double-Blind Treatment Phase||0
2572749|NCT00423085|6309880|P3|NOT COMPLETED|24-Week Double-Blind Treatment Phase||59
2572750|NCT00423085|6309881|P2|NOT COMPLETED|24-Week Double-Blind Treatment Phase||64
2572751|NCT00423085|6309882|P1|NOT COMPLETED|24-Week Double-Blind Treatment Phase||46
2572752|NCT00423085|6309879|P4|COMPLETED|24-Week Double-Blind Treatment Phase||0
2572753|NCT00423085|6309880|P3|COMPLETED|24-Week Double-Blind Treatment Phase||228
2572754|NCT00423085|6309881|P2|COMPLETED|24-Week Double-Blind Treatment Phase||220
2572755|NCT00423085|6309882|P1|COMPLETED|24-Week Double-Blind Treatment Phase||242
2572756|NCT00423085|6309879|P4|STARTED|24-Week Double-Blind Treatment Phase||0
2572757|NCT00423085|6309880|P3|STARTED|24-Week Double-Blind Treatment Phase||287
2572758|NCT00423085|6309881|P2|STARTED|24-Week Double-Blind Treatment Phase||284
2572759|NCT00423085|6309882|P1|STARTED|24-Week Double-Blind Treatment Phase||288
2572760|NCT00423046|6309911|P2|NOT COMPLETED|Overall Study||345
2572761|NCT00423046|6309912|P1|NOT COMPLETED|Overall Study||340
2572762|NCT00423046|6309911|P2|COMPLETED|Overall Study|Completed until Month 60|208
2572763|NCT00423046|6309912|P1|COMPLETED|Overall Study|Completed until Month 60|213
2572764|NCT00423046|6309911|P2|STARTED|Overall Study||553
2572765|NCT00423046|6309912|P1|STARTED|Overall Study||553
2572766|NCT00422942|6309978|P1|NOT COMPLETED|Overall Study||3
2572767|NCT00422942|6309978|P1|COMPLETED|Overall Study||0
2572768|NCT00422942|6309978|P1|STARTED|Overall Study||3
2572769|NCT00422903|6309997|P2|NOT COMPLETED|Overall Study||5
2572770|NCT00422903|6309998|P1|NOT COMPLETED|Overall Study||4
2572771|NCT00422903|6309997|P2|COMPLETED|Overall Study||38
2572772|NCT00422903|6309998|P1|COMPLETED|Overall Study||45
2572773|NCT00422903|6309997|P2|STARTED|Overall Study||43
2572774|NCT00422903|6309998|P1|STARTED|Overall Study||49
2572775|NCT00422812|6310026|P4|NOT COMPLETED|Overall Study||2
2572776|NCT00422812|6310027|P3|NOT COMPLETED|Overall Study||2
2572777|NCT00422812|6310028|P2|NOT COMPLETED|Overall Study||1
2572778|NCT00422812|6310029|P1|NOT COMPLETED|Overall Study||0
2572779|NCT00422812|6310026|P4|COMPLETED|Overall Study||103
2572780|NCT00422812|6310027|P3|COMPLETED|Overall Study||91
2572781|NCT00422812|6310028|P2|COMPLETED|Overall Study||103
2572782|NCT00422812|6310029|P1|COMPLETED|Overall Study||98
2572783|NCT00422812|6310026|P4|STARTED|Overall Study||105
2572784|NCT00422812|6310027|P3|STARTED|Overall Study||93
2572785|NCT00422812|6310028|P2|STARTED|Overall Study||104
2572786|NCT00422812|6310029|P1|STARTED|Overall Study||98
2572787|NCT00422799|6310047|P1|NOT COMPLETED|Overall Study||13
2572788|NCT00422799|6310047|P1|COMPLETED|Overall Study||50
2572789|NCT00422799|6310047|P1|STARTED|Overall Study||63
2572790|NCT00422734|6310056|P2|NOT COMPLETED|Overall Study||21
2572791|NCT00422734|6310057|P1|NOT COMPLETED|Overall Study||14
2572792|NCT00422734|6310056|P2|COMPLETED|Overall Study||243
2572793|NCT00422734|6310057|P1|COMPLETED|Overall Study||64
2572794|NCT00422734|6310056|P2|STARTED|Overall Study||264
2572795|NCT00422734|6310057|P1|STARTED|Overall Study||78
2572796|NCT00422695|6310091|P2|NOT COMPLETED|Overall Study||0
2572797|NCT00422695|6310092|P1|NOT COMPLETED|Overall Study||0
2572798|NCT00422695|6310091|P2|COMPLETED|Overall Study||38
2572799|NCT00422695|6310092|P1|COMPLETED|Overall Study||105
2572800|NCT00422695|6310091|P2|STARTED|Overall Study||38
2572801|NCT00422695|6310092|P1|STARTED|Overall Study||105
2572802|NCT00422669|6310103|P3|NOT COMPLETED|Overall Study||7
2572803|NCT00422669|6310104|P2|NOT COMPLETED|Overall Study||100
2572804|NCT00422669|6310105|P1|NOT COMPLETED|Overall Study||98
2572805|NCT00422669|6310103|P3|COMPLETED|Overall Study||0
2572806|NCT00422669|6310104|P2|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
2572807|NCT00422669|6310105|P1|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
2572808|NCT00422669|6310103|P3|STARTED|Overall Study||7
2572809|NCT00422669|6310104|P2|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|100
2572810|NCT00422669|6310105|P1|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|98
2572811|NCT00422656|6310126|P1|NOT COMPLETED|Overall Study||0
2572812|NCT00422656|6310126|P1|COMPLETED|Overall Study||37
2572813|NCT00422656|6310126|P1|STARTED|Overall Study||37
2572814|NCT00422591|6310133|P1|NOT COMPLETED|Overall Study||6
2572815|NCT00422591|6310133|P1|COMPLETED|Overall Study||169
2572816|NCT00422591|6310133|P1|STARTED|Overall Study||175
2572817|NCT00422513|6310141|P2|NOT COMPLETED|Overall Study||106
2572818|NCT00422513|6310142|P1|NOT COMPLETED|Overall Study||107
2572819|NCT00422513|6310141|P2|COMPLETED|Overall Study||24
2572820|NCT00422513|6310142|P1|COMPLETED|Overall Study||23
2572821|NCT00422513|6310141|P2|STARTED|Overall Study||130
2572822|NCT00422513|6310142|P1|STARTED|Overall Study||130
2572823|NCT00422448|6310154|P1|NOT COMPLETED|Overall Study||0
2572824|NCT00422448|6310154|P1|COMPLETED|Overall Study||43
2572825|NCT00422448|6310154|P1|STARTED|Overall Study|22 prospectively enrolled during study period and 21 retrospectively enrolled|43
2572826|NCT00422422|6310159|P1|NOT COMPLETED|Overall Study||10
2572827|NCT00422422|6310159|P1|COMPLETED|Overall Study||90
2572828|NCT00422422|6310159|P1|STARTED|Overall Study||100
2572829|NCT00422383|6310176|P5|NOT COMPLETED|Overall Study||3
2572830|NCT00422383|6310177|P4|NOT COMPLETED|Overall Study||2
2572831|NCT00422383|6310178|P3|NOT COMPLETED|Overall Study||4
2572832|NCT00422383|6310179|P2|NOT COMPLETED|Overall Study||14
2572833|NCT00422383|6310180|P1|NOT COMPLETED|Overall Study||15
2572834|NCT00422383|6310176|P5|COMPLETED|Overall Study||22
2572835|NCT00422383|6310177|P4|COMPLETED|Overall Study||4
2572836|NCT00422383|6310178|P3|COMPLETED|Overall Study||89
2572837|NCT00422383|6310179|P2|COMPLETED|Overall Study||106
2572838|NCT00422383|6310180|P1|COMPLETED|Overall Study||119
2572839|NCT00422383|6310176|P5|STARTED|Overall Study||25
2572840|NCT00422383|6310177|P4|STARTED|Overall Study||6
2572841|NCT00422383|6310178|P3|STARTED|Overall Study||93
2572842|NCT00422383|6310179|P2|STARTED|Overall Study||120
2572843|NCT00422383|6310180|P1|STARTED|Overall Study||134
2572844|NCT00422292|6310323|P4|NOT COMPLETED|Overall Study||24
2572845|NCT00422292|6310324|P3|NOT COMPLETED|Overall Study||22
2572846|NCT00422292|6310325|P2|NOT COMPLETED|Overall Study||66
2572847|NCT00422292|6310326|P1|NOT COMPLETED|Overall Study||18
2572848|NCT00422292|6310323|P4|COMPLETED|Overall Study||452
2572849|NCT00422292|6310324|P3|COMPLETED|Overall Study||224
2572850|NCT00422292|6310325|P2|COMPLETED|Overall Study||598
2572851|NCT00422292|6310326|P1|COMPLETED|Overall Study||239
2572852|NCT00422292|6310323|P4|STARTED|Overall Study||476
2572853|NCT00422292|6310324|P3|STARTED|Overall Study||246
2572854|NCT00422292|6310325|P2|STARTED|Overall Study||664
2572855|NCT00422292|6310326|P1|STARTED|Overall Study||257
2572856|NCT00422279|6310354|P2|NOT COMPLETED|Overall Study||0
2572857|NCT00422279|6310355|P1|NOT COMPLETED|Overall Study||0
2572858|NCT00422279|6310354|P2|COMPLETED|Overall Study||2
2572859|NCT00422279|6310355|P1|COMPLETED|Overall Study||2
2572860|NCT00422279|6310354|P2|24 Month After Loading Period|Overall Study||2
2572861|NCT00422279|6310355|P1|24 Month After Loading Period|Overall Study||2
2572862|NCT00422279|6310354|P2|STARTED|Overall Study||2
2572863|NCT00422279|6310355|P1|STARTED|Overall Study||2
2572864|NCT00422227|6310365|P2|NOT COMPLETED|Overall Study||15
2572865|NCT00422227|6310366|P1|NOT COMPLETED|Overall Study||4
2572866|NCT00422227|6310365|P2|COMPLETED|Overall Study||88
2572867|NCT00422227|6310366|P1|COMPLETED|Overall Study||193
2572868|NCT00422227|6310365|P2|STARTED|Overall Study||103
2572869|NCT00422227|6310366|P1|STARTED|Overall Study||197
2572870|NCT00422201|6310390|P1|NOT COMPLETED|Overall Study||11
2572871|NCT00422201|6310390|P1|COMPLETED|Overall Study||7
2572872|NCT00422201|6310390|P1|STARTED|Overall Study||18
2572873|NCT00422162|6310397|P2|NOT COMPLETED|Overall Study||30
2572874|NCT00422162|6310398|P1|NOT COMPLETED|Overall Study||24
2572875|NCT00422162|6310397|P2|COMPLETED|Overall Study||142
2572876|NCT00422162|6310398|P1|COMPLETED|Overall Study||143
2572877|NCT00422162|6310397|P2|Received Treatment|Overall Study||171
2572878|NCT00422162|6310398|P1|Received Treatment|Overall Study||167
2572879|NCT00422162|6310397|P2|STARTED|Overall Study||172
2572880|NCT00422162|6310398|P1|STARTED|Overall Study||167
2572881|NCT00422097|6310458|P8|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
2572882|NCT00422097|6310459|P7|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
2572883|NCT00422097|6310460|P6|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
2572884|NCT00422097|6310461|P5|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
2572885|NCT00422097|6310462|P4|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
2572886|NCT00422097|6310463|P3|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
2572887|NCT00422097|6310464|P2|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
2572888|NCT00422097|6310465|P1|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
2572889|NCT00422097|6310458|P8|COMPLETED|Ixabepilone With Famotidine or Food||7
2572890|NCT00422097|6310459|P7|COMPLETED|Ixabepilone With Famotidine or Food||8
2572891|NCT00422097|6310460|P6|COMPLETED|Ixabepilone With Famotidine or Food||0
2572892|NCT00422097|6310461|P5|COMPLETED|Ixabepilone With Famotidine or Food||0
2572893|NCT00422097|6310462|P4|COMPLETED|Ixabepilone With Famotidine or Food||0
2572894|NCT00422097|6310463|P3|COMPLETED|Ixabepilone With Famotidine or Food||0
2572895|NCT00422097|6310464|P2|COMPLETED|Ixabepilone With Famotidine or Food||0
2572896|NCT00422097|6310465|P1|COMPLETED|Ixabepilone With Famotidine or Food||0
2572897|NCT00422097|6310458|P8|STARTED|Ixabepilone With Famotidine or Food||7
2572898|NCT00422097|6310459|P7|STARTED|Ixabepilone With Famotidine or Food||8
2572899|NCT00422097|6310460|P6|STARTED|Ixabepilone With Famotidine or Food||0
2572900|NCT00422097|6310461|P5|STARTED|Ixabepilone With Famotidine or Food||0
2572901|NCT00422097|6310462|P4|STARTED|Ixabepilone With Famotidine or Food||0
2572902|NCT00422097|6310463|P3|STARTED|Ixabepilone With Famotidine or Food||0
2572903|NCT00422097|6310464|P2|STARTED|Ixabepilone With Famotidine or Food||0
2572904|NCT00422097|6310465|P1|STARTED|Ixabepilone With Famotidine or Food||0
2572905|NCT00422097|6310458|P8|NOT COMPLETED|Dose Level 6||0
2572906|NCT00422097|6310459|P7|NOT COMPLETED|Dose Level 6||0
2572907|NCT00422097|6310460|P6|NOT COMPLETED|Dose Level 6||0
2572908|NCT00422097|6310461|P5|NOT COMPLETED|Dose Level 6||0
2572909|NCT00422097|6310462|P4|NOT COMPLETED|Dose Level 6||0
2572910|NCT00422097|6310463|P3|NOT COMPLETED|Dose Level 6||0
2572911|NCT00422097|6310464|P2|NOT COMPLETED|Dose Level 6||0
2572912|NCT00422097|6310465|P1|NOT COMPLETED|Dose Level 6||0
2572913|NCT00422097|6310458|P8|COMPLETED|Dose Level 6||0
2572914|NCT00422097|6310459|P7|COMPLETED|Dose Level 6||0
2572915|NCT00422097|6310460|P6|COMPLETED|Dose Level 6||6
2572916|NCT00422097|6310461|P5|COMPLETED|Dose Level 6||0
2572917|NCT00422097|6310462|P4|COMPLETED|Dose Level 6||0
2572918|NCT00422097|6310463|P3|COMPLETED|Dose Level 6||0
2572919|NCT00422097|6310464|P2|COMPLETED|Dose Level 6||0
2572920|NCT00422097|6310465|P1|COMPLETED|Dose Level 6||0
2572921|NCT00422097|6310458|P8|STARTED|Dose Level 6||0
2572922|NCT00422097|6310459|P7|STARTED|Dose Level 6||0
2572923|NCT00422097|6310460|P6|STARTED|Dose Level 6||6
2572924|NCT00422097|6310461|P5|STARTED|Dose Level 6||0
2572925|NCT00422097|6310462|P4|STARTED|Dose Level 6||0
2572926|NCT00422097|6310463|P3|STARTED|Dose Level 6||0
2572927|NCT00422097|6310464|P2|STARTED|Dose Level 6||0
2572928|NCT00422097|6310465|P1|STARTED|Dose Level 6||0
2572929|NCT00422097|6310458|P8|NOT COMPLETED|Dose Level 5||0
2572930|NCT00422097|6310459|P7|NOT COMPLETED|Dose Level 5||0
2572931|NCT00422097|6310460|P6|NOT COMPLETED|Dose Level 5||0
2572932|NCT00422097|6310461|P5|NOT COMPLETED|Dose Level 5||0
2572933|NCT00422097|6310462|P4|NOT COMPLETED|Dose Level 5||0
2572934|NCT00422097|6310463|P3|NOT COMPLETED|Dose Level 5||0
2572935|NCT00422097|6310464|P2|NOT COMPLETED|Dose Level 5||0
2572936|NCT00422097|6310465|P1|NOT COMPLETED|Dose Level 5||0
2572937|NCT00422097|6310458|P8|COMPLETED|Dose Level 5||0
2572938|NCT00422097|6310459|P7|COMPLETED|Dose Level 5||0
2572939|NCT00422097|6310460|P6|COMPLETED|Dose Level 5||0
2572940|NCT00422097|6310461|P5|COMPLETED|Dose Level 5||23
2572941|NCT00422097|6310462|P4|COMPLETED|Dose Level 5||0
2572942|NCT00422097|6310463|P3|COMPLETED|Dose Level 5||0
2572943|NCT00422097|6310464|P2|COMPLETED|Dose Level 5||0
2572944|NCT00422097|6310465|P1|COMPLETED|Dose Level 5||0
2572945|NCT00422097|6310458|P8|STARTED|Dose Level 5||0
2572946|NCT00422097|6310459|P7|STARTED|Dose Level 5||0
2572947|NCT00422097|6310460|P6|STARTED|Dose Level 5||0
2572948|NCT00422097|6310461|P5|STARTED|Dose Level 5||23
2572949|NCT00422097|6310462|P4|STARTED|Dose Level 5||0
2572950|NCT00422097|6310463|P3|STARTED|Dose Level 5||0
2572951|NCT00422097|6310464|P2|STARTED|Dose Level 5||0
2572952|NCT00422097|6310465|P1|STARTED|Dose Level 5||0
2572953|NCT00422097|6310458|P8|NOT COMPLETED|Dose Level 4||0
2572954|NCT00422097|6310459|P7|NOT COMPLETED|Dose Level 4||0
2572955|NCT00422097|6310460|P6|NOT COMPLETED|Dose Level 4||0
2572956|NCT00422097|6310461|P5|NOT COMPLETED|Dose Level 4||0
2572957|NCT00422097|6310462|P4|NOT COMPLETED|Dose Level 4||0
2572958|NCT00422097|6310463|P3|NOT COMPLETED|Dose Level 4||0
2572959|NCT00422097|6310464|P2|NOT COMPLETED|Dose Level 4||0
2572960|NCT00422097|6310465|P1|NOT COMPLETED|Dose Level 4||0
2572961|NCT00422097|6310458|P8|COMPLETED|Dose Level 4||0
2572962|NCT00422097|6310459|P7|COMPLETED|Dose Level 4||0
2572963|NCT00422097|6310460|P6|COMPLETED|Dose Level 4||0
2572964|NCT00422097|6310461|P5|COMPLETED|Dose Level 4||0
2572965|NCT00422097|6310462|P4|COMPLETED|Dose Level 4||3
2572966|NCT00422097|6310463|P3|COMPLETED|Dose Level 4||0
2572967|NCT00422097|6310464|P2|COMPLETED|Dose Level 4||0
2572968|NCT00422097|6310465|P1|COMPLETED|Dose Level 4||0
2572969|NCT00422097|6310458|P8|STARTED|Dose Level 4||0
2572970|NCT00422097|6310459|P7|STARTED|Dose Level 4||0
2572971|NCT00422097|6310460|P6|STARTED|Dose Level 4||0
2572972|NCT00422097|6310461|P5|STARTED|Dose Level 4||0
2572973|NCT00422097|6310462|P4|STARTED|Dose Level 4||3
2572974|NCT00422097|6310463|P3|STARTED|Dose Level 4||0
2572975|NCT00422097|6310464|P2|STARTED|Dose Level 4||0
2572976|NCT00422097|6310465|P1|STARTED|Dose Level 4||0
2572977|NCT00422097|6310458|P8|NOT COMPLETED|Dose Level 3||0
2572978|NCT00422097|6310459|P7|NOT COMPLETED|Dose Level 3||0
2572979|NCT00422097|6310460|P6|NOT COMPLETED|Dose Level 3||0
2572980|NCT00422097|6310461|P5|NOT COMPLETED|Dose Level 3||0
2572981|NCT00422097|6310462|P4|NOT COMPLETED|Dose Level 3||0
2572982|NCT00422097|6310463|P3|NOT COMPLETED|Dose Level 3||0
2572983|NCT00422097|6310464|P2|NOT COMPLETED|Dose Level 3||0
2572984|NCT00422097|6310465|P1|NOT COMPLETED|Dose Level 3||0
2572985|NCT00422097|6310458|P8|COMPLETED|Dose Level 3||0
2572986|NCT00422097|6310459|P7|COMPLETED|Dose Level 3||0
2572987|NCT00422097|6310460|P6|COMPLETED|Dose Level 3||0
2572988|NCT00422097|6310461|P5|COMPLETED|Dose Level 3||0
2572989|NCT00422097|6310462|P4|COMPLETED|Dose Level 3||0
2572990|NCT00422097|6310463|P3|COMPLETED|Dose Level 3||3
2572991|NCT00422097|6310464|P2|COMPLETED|Dose Level 3||0
2572992|NCT00422097|6310465|P1|COMPLETED|Dose Level 3||0
2572993|NCT00422097|6310458|P8|STARTED|Dose Level 3||0
2572994|NCT00422097|6310459|P7|STARTED|Dose Level 3||0
2572995|NCT00422097|6310460|P6|STARTED|Dose Level 3||0
2572996|NCT00422097|6310461|P5|STARTED|Dose Level 3||0
2572997|NCT00422097|6310462|P4|STARTED|Dose Level 3||0
2572998|NCT00422097|6310463|P3|STARTED|Dose Level 3||3
2572999|NCT00422097|6310464|P2|STARTED|Dose Level 3||0
2573000|NCT00422097|6310465|P1|STARTED|Dose Level 3||0
2573001|NCT00422097|6310458|P8|NOT COMPLETED|Dose Level 2||0
2573002|NCT00422097|6310459|P7|NOT COMPLETED|Dose Level 2||0
2573003|NCT00422097|6310460|P6|NOT COMPLETED|Dose Level 2||0
2573004|NCT00422097|6310461|P5|NOT COMPLETED|Dose Level 2||0
2573005|NCT00422097|6310462|P4|NOT COMPLETED|Dose Level 2||0
2573006|NCT00422097|6310463|P3|NOT COMPLETED|Dose Level 2||0
2573007|NCT00422097|6310464|P2|NOT COMPLETED|Dose Level 2||1
2573008|NCT00422097|6310465|P1|NOT COMPLETED|Dose Level 2||0
2573009|NCT00422097|6310458|P8|COMPLETED|Dose Level 2||0
2573010|NCT00422097|6310459|P7|COMPLETED|Dose Level 2||0
2573011|NCT00422097|6310460|P6|COMPLETED|Dose Level 2||0
2573012|NCT00422097|6310461|P5|COMPLETED|Dose Level 2||0
2573013|NCT00422097|6310462|P4|COMPLETED|Dose Level 2||0
2573014|NCT00422097|6310463|P3|COMPLETED|Dose Level 2||0
2573015|NCT00422097|6310464|P2|COMPLETED|Dose Level 2||5
2573016|NCT00422097|6310465|P1|COMPLETED|Dose Level 2||0
2573017|NCT00422097|6310458|P8|STARTED|Dose Level 2||0
2573018|NCT00422097|6310459|P7|STARTED|Dose Level 2||0
2573019|NCT00422097|6310460|P6|STARTED|Dose Level 2||0
2573020|NCT00422097|6310461|P5|STARTED|Dose Level 2||0
2573021|NCT00422097|6310462|P4|STARTED|Dose Level 2||0
2573022|NCT00422097|6310463|P3|STARTED|Dose Level 2||0
2573023|NCT00422097|6310464|P2|STARTED|Dose Level 2||6
2573024|NCT00422097|6310465|P1|STARTED|Dose Level 2||0
2573025|NCT00422097|6310458|P8|NOT COMPLETED|Dose Level 1||0
2573026|NCT00422097|6310459|P7|NOT COMPLETED|Dose Level 1||0
2573027|NCT00422097|6310460|P6|NOT COMPLETED|Dose Level 1||0
2573028|NCT00422097|6310461|P5|NOT COMPLETED|Dose Level 1||0
2573029|NCT00422097|6310462|P4|NOT COMPLETED|Dose Level 1||0
2573030|NCT00422097|6310463|P3|NOT COMPLETED|Dose Level 1||0
2573031|NCT00422097|6310464|P2|NOT COMPLETED|Dose Level 1||0
2573032|NCT00422097|6310465|P1|NOT COMPLETED|Dose Level 1||0
2573033|NCT00422097|6310458|P8|COMPLETED|Dose Level 1||0
2573034|NCT00422097|6310459|P7|COMPLETED|Dose Level 1||0
2573035|NCT00422097|6310460|P6|COMPLETED|Dose Level 1||0
2573036|NCT00422097|6310461|P5|COMPLETED|Dose Level 1||0
2573037|NCT00422097|6310462|P4|COMPLETED|Dose Level 1||0
2573038|NCT00422097|6310463|P3|COMPLETED|Dose Level 1||0
2573039|NCT00422097|6310464|P2|COMPLETED|Dose Level 1||0
2573040|NCT00422097|6310465|P1|COMPLETED|Dose Level 1||3
2573041|NCT00422097|6310458|P8|STARTED|Dose Level 1||0
2573042|NCT00422097|6310459|P7|STARTED|Dose Level 1||0
2573043|NCT00422097|6310460|P6|STARTED|Dose Level 1||0
2573044|NCT00422097|6310461|P5|STARTED|Dose Level 1||0
2573045|NCT00422097|6310462|P4|STARTED|Dose Level 1||0
2573046|NCT00422097|6310463|P3|STARTED|Dose Level 1||0
2573047|NCT00422097|6310464|P2|STARTED|Dose Level 1||0
2573048|NCT00422097|6310465|P1|STARTED|Dose Level 1||3
2573049|NCT00422058|6310530|P6|NOT COMPLETED|Open-Label Extension, Week 20-104||34
2573050|NCT00422058|6310531|P5|NOT COMPLETED|Open-Label Extension, Week 20-104||35
2573051|NCT00422058|6310532|P4|NOT COMPLETED|Open-Label Extension, Week 20-104||28
2573052|NCT00422058|6310533|P3|NOT COMPLETED|Open-Label Extension, Week 20-104||36
2573053|NCT00422058|6310534|P2|NOT COMPLETED|Open-Label Extension, Week 20-104||39
2573054|NCT00422058|6310535|P1|NOT COMPLETED|Open-Label Extension, Week 20-104||32
2573055|NCT00422058|6310530|P6|COMPLETED|Open-Label Extension, Week 20-104||45
2573056|NCT00422058|6310531|P5|COMPLETED|Open-Label Extension, Week 20-104||47
2573057|NCT00422058|6310532|P4|COMPLETED|Open-Label Extension, Week 20-104||45
2573058|NCT00422058|6310533|P3|COMPLETED|Open-Label Extension, Week 20-104||38
2573059|NCT00422058|6310534|P2|COMPLETED|Open-Label Extension, Week 20-104||46
2573060|NCT00422058|6310535|P1|COMPLETED|Open-Label Extension, Week 20-104||47
2573061|NCT00422058|6310530|P6|Enrolled in Extension|Open-Label Extension, Week 20-104||67
2573062|NCT00422058|6310531|P5|Enrolled in Extension|Open-Label Extension, Week 20-104||72
2573063|NCT00422058|6310532|P4|Enrolled in Extension|Open-Label Extension, Week 20-104||65
2573064|NCT00422058|6310533|P3|Enrolled in Extension|Open-Label Extension, Week 20-104||59
2573065|NCT00422058|6310534|P2|Enrolled in Extension|Open-Label Extension, Week 20-104||68
2573066|NCT00422058|6310535|P1|Enrolled in Extension|Open-Label Extension, Week 20-104||67
2573067|NCT00422058|6310530|P6|STARTED|Open-Label Extension, Week 20-104||79
2573068|NCT00422058|6310531|P5|STARTED|Open-Label Extension, Week 20-104||82
2573069|NCT00422058|6310532|P4|STARTED|Open-Label Extension, Week 20-104||73
2573070|NCT00422058|6310533|P3|STARTED|Open-Label Extension, Week 20-104||74
2573071|NCT00422058|6310534|P2|STARTED|Open-Label Extension, Week 20-104||85
2573072|NCT00422058|6310535|P1|STARTED|Open-Label Extension, Week 20-104||79
2573073|NCT00422058|6310530|P6|NOT COMPLETED|Double-Blind, Week 0-20||16
2573074|NCT00422058|6310531|P5|NOT COMPLETED|Double-Blind, Week 0-20||11
2573075|NCT00422058|6310532|P4|NOT COMPLETED|Double-Blind, Week 0-20||20
2573076|NCT00422058|6310533|P3|NOT COMPLETED|Double-Blind, Week 0-20||16
2573077|NCT00422058|6310534|P2|NOT COMPLETED|Double-Blind, Week 0-20||10
2573078|NCT00422058|6310535|P1|NOT COMPLETED|Double-Blind, Week 0-20||19
2573079|NCT00422058|6310530|P6|COMPLETED|Double-Blind, Week 0-20||79
2573080|NCT00422058|6310531|P5|COMPLETED|Double-Blind, Week 0-20||82
2573081|NCT00422058|6310532|P4|COMPLETED|Double-Blind, Week 0-20||73
2573082|NCT00422058|6310533|P3|COMPLETED|Double-Blind, Week 0-20||74
2573083|NCT00422058|6310534|P2|COMPLETED|Double-Blind, Week 0-20||85
2573084|NCT00422058|6310535|P1|COMPLETED|Double-Blind, Week 0-20||79
2573085|NCT00422058|6310530|P6|STARTED|Double-Blind, Week 0-20||95
2573086|NCT00422058|6310531|P5|STARTED|Double-Blind, Week 0-20||93
2573087|NCT00422058|6310532|P4|STARTED|Double-Blind, Week 0-20||93
2573088|NCT00422058|6310533|P3|STARTED|Double-Blind, Week 0-20||90
2573089|NCT00422058|6310534|P2|STARTED|Double-Blind, Week 0-20||95
2573090|NCT00422058|6310535|P1|STARTED|Double-Blind, Week 0-20||98
2573091|NCT00422032|6310665|P2|NOT COMPLETED|Overall Study||0
2573092|NCT00422032|6310666|P1|NOT COMPLETED|Overall Study||0
2573093|NCT00422032|6310665|P2|COMPLETED|Overall Study||21
2573094|NCT00422032|6310666|P1|COMPLETED|Overall Study||37
2573095|NCT00422032|6310665|P2|STARTED|Overall Study||21
2573096|NCT00422032|6310666|P1|STARTED|Overall Study||37
2573097|NCT00421993|6310676|P4|NOT COMPLETED|Overall Study||57
2573098|NCT00421993|6310677|P3|NOT COMPLETED|Overall Study||52
2573099|NCT00421993|6310678|P2|NOT COMPLETED|Overall Study||49
2573100|NCT00421993|6310679|P1|NOT COMPLETED|Overall Study||53
2573101|NCT00421993|6310676|P4|COMPLETED|Overall Study||361
2573102|NCT00421993|6310677|P3|COMPLETED|Overall Study||363
2573103|NCT00421993|6310678|P2|COMPLETED|Overall Study||369
2573104|NCT00421993|6310679|P1|COMPLETED|Overall Study||366
2573105|NCT00421993|6310676|P4|STARTED|Overall Study||418
2573106|NCT00421993|6310677|P3|STARTED|Overall Study||415
2573107|NCT00421993|6310678|P2|STARTED|Overall Study||418
2573108|NCT00421993|6310679|P1|STARTED|Overall Study||419
2573109|NCT00421954|6310709|P1|NOT COMPLETED|Overall Study||0
2573110|NCT00421954|6310709|P1|COMPLETED|Overall Study||0
2573111|NCT00421954|6310709|P1|STARTED|Overall Study||0
2573112|NCT00421928|6310716|P3|NOT COMPLETED|Overall Study||134
2573113|NCT00421928|6310717|P2|NOT COMPLETED|Overall Study||224
2573114|NCT00421928|6310718|P1|NOT COMPLETED|Overall Study||163
2573115|NCT00421928|6310716|P3|COMPLETED|Overall Study||203
2573116|NCT00421928|6310717|P2|COMPLETED|Overall Study||118
2573117|NCT00421928|6310718|P1|COMPLETED|Overall Study||181
2573118|NCT00421928|6310716|P3|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|337
2573119|NCT00421928|6310717|P2|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug. One subject was enrolled twice.|342
2573120|NCT00421928|6310718|P1|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|344
2573121|NCT00421889|6310753|P9|NOT COMPLETED|Overall Study||11
2573122|NCT00421889|6310754|P8|NOT COMPLETED|Overall Study||2
2573123|NCT00421889|6310755|P7|NOT COMPLETED|Overall Study||4
2573124|NCT00421889|6310756|P6|NOT COMPLETED|Overall Study||35
2573125|NCT00421889|6310757|P5|NOT COMPLETED|Overall Study||6
2573126|NCT00421889|6310758|P4|NOT COMPLETED|Overall Study||4
2573127|NCT00421889|6310759|P3|NOT COMPLETED|Overall Study||3
2573128|NCT00421889|6310760|P2|NOT COMPLETED|Overall Study||5
2573129|NCT00421889|6310761|P1|NOT COMPLETED|Overall Study||5
2573130|NCT00421889|6310753|P9|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 4.27|4
2573131|NCT00421889|6310754|P8|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|1
2573132|NCT00421889|6310755|P7|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.50|0
2573133|NCT00421889|6310756|P6|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 7.69|0
2573134|NCT00421889|6310757|P5|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.00|0
2573135|NCT00421889|6310758|P4|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 9.25|0
2573136|NCT00421889|6310759|P3|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|0
2573137|NCT00421889|6310760|P2|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 8.20|0
2573138|NCT00421889|6310761|P1|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.20|0
2573139|NCT00421889|6310753|P9|STARTED|Overall Study||15
2573140|NCT00421889|6310754|P8|STARTED|Overall Study||3
2573141|NCT00421889|6310755|P7|STARTED|Overall Study||4
2573142|NCT00421889|6310756|P6|STARTED|Overall Study||35
2573143|NCT00421889|6310757|P5|STARTED|Overall Study||6
2573144|NCT00421889|6310758|P4|STARTED|Overall Study||4
2573145|NCT00421889|6310759|P3|STARTED|Overall Study||3
2573146|NCT00421889|6310760|P2|STARTED|Overall Study||5
2573147|NCT00421889|6310761|P1|STARTED|Overall Study||5
2573148|NCT00421733|6310806|P3|NOT COMPLETED|Overall Study||20
2573149|NCT00421733|6310807|P2|NOT COMPLETED|Overall Study||26
2573150|NCT00421733|6310808|P1|NOT COMPLETED|Overall Study||15
2573151|NCT00421733|6310806|P3|COMPLETED|Overall Study||73
2573152|NCT00421733|6310807|P2|COMPLETED|Overall Study||69
2573153|NCT00421733|6310808|P1|COMPLETED|Overall Study||78
2573154|NCT00421733|6310806|P3|STARTED|Overall Study||93
2573155|NCT00421733|6310807|P2|STARTED|Overall Study||95
2573156|NCT00421733|6310808|P1|STARTED|Overall Study||93
2573157|NCT00421707|6310828|P2|NOT COMPLETED|Period 3:Treatment Period 2||3
2573158|NCT00421707|6310829|P1|NOT COMPLETED|Period 3:Treatment Period 2||2
2573159|NCT00421707|6310828|P2|COMPLETED|Period 3:Treatment Period 2||49
2573160|NCT00421707|6310829|P1|COMPLETED|Period 3:Treatment Period 2||53
2573161|NCT00421707|6310828|P2|STARTED|Period 3:Treatment Period 2||52
2573162|NCT00421707|6310829|P1|STARTED|Period 3:Treatment Period 2||55
2573163|NCT00421707|6310828|P2|NOT COMPLETED|Period 2: Washout||4
2573164|NCT00421707|6310829|P1|NOT COMPLETED|Period 2: Washout||1
2573165|NCT00421707|6310828|P2|COMPLETED|Period 2: Washout||52
2573166|NCT00421707|6310829|P1|COMPLETED|Period 2: Washout||55
2573167|NCT00421707|6310828|P2|STARTED|Period 2: Washout||56
2573168|NCT00421707|6310829|P1|STARTED|Period 2: Washout||56
2573169|NCT00421707|6310828|P2|NOT COMPLETED|Period 1: Treatment Period 1||9
2573170|NCT00421707|6310829|P1|NOT COMPLETED|Period 1: Treatment Period 1||11
2573171|NCT00421707|6310828|P2|COMPLETED|Period 1: Treatment Period 1||56
2573172|NCT00421707|6310829|P1|COMPLETED|Period 1: Treatment Period 1||56
2573173|NCT00421707|6310828|P2|STARTED|Period 1: Treatment Period 1||65
2573174|NCT00421707|6310829|P1|STARTED|Period 1: Treatment Period 1||67
2573175|NCT00421603|6310871|P2|NOT COMPLETED|Overall Study||12
2573176|NCT00421603|6310872|P1|NOT COMPLETED|Overall Study||11
2573177|NCT00421603|6310871|P2|COMPLETED|Overall Study|Completed all 14 week sof trial|30
2573178|NCT00421603|6310872|P1|COMPLETED|Overall Study|Completed all 14 week sof trial|28
2573179|NCT00421603|6310871|P2|STARTED|Overall Study||42
2573180|NCT00421603|6310872|P1|STARTED|Overall Study||39
2573181|NCT00421408|6310880|P2|NOT COMPLETED|Overall Study||45
2573182|NCT00421408|6310881|P1|NOT COMPLETED|Overall Study||42
2573183|NCT00421408|6310880|P2|COMPLETED|Overall Study||61
2573184|NCT00421408|6310881|P1|COMPLETED|Overall Study||60
2573185|NCT00421408|6310880|P2|STARTED|Overall Study||106
2573186|NCT00421408|6310881|P1|STARTED|Overall Study||102
2573187|NCT00421343|6310899|P1|NOT COMPLETED|Overall Study||6
2573188|NCT00421343|6310899|P1|COMPLETED|Overall Study||23
2573189|NCT00421343|6310899|P1|STARTED|Overall Study||29
2573190|NCT00421174|6310905|P2|NOT COMPLETED|Overall Study||1
2573191|NCT00421174|6310906|P1|NOT COMPLETED|Overall Study||2
2573192|NCT00421174|6310905|P2|COMPLETED|Overall Study||18
2573193|NCT00421174|6310906|P1|COMPLETED|Overall Study||16
2573194|NCT00421174|6310905|P2|STARTED|Overall Study||19
2573195|NCT00421174|6310906|P1|STARTED|Overall Study||18
2573196|NCT00421148|6310954|P20|NOT COMPLETED|Overall Study||0
2573197|NCT00421148|6310955|P19|NOT COMPLETED|Overall Study||1
2573198|NCT00421148|6310956|P18|NOT COMPLETED|Overall Study||2
2573199|NCT00421148|6310957|P17|NOT COMPLETED|Overall Study||0
2573200|NCT00421148|6310958|P16|NOT COMPLETED|Overall Study||0
2573201|NCT00421148|6310959|P15|NOT COMPLETED|Overall Study||0
2573202|NCT00421148|6310960|P14|NOT COMPLETED|Overall Study||0
2573203|NCT00421148|6310961|P13|NOT COMPLETED|Overall Study||0
2573204|NCT00421148|6310962|P12|NOT COMPLETED|Overall Study||0
2573205|NCT00421148|6310963|P11|NOT COMPLETED|Overall Study||0
2573206|NCT00421148|6310964|P10|NOT COMPLETED|Overall Study||0
2573207|NCT00421148|6310965|P9|NOT COMPLETED|Overall Study||0
2573208|NCT00421148|6310966|P8|NOT COMPLETED|Overall Study||0
2573209|NCT00421148|6310967|P7|NOT COMPLETED|Overall Study||0
2573210|NCT00421148|6310968|P6|NOT COMPLETED|Overall Study||1
2573211|NCT00421148|6310969|P5|NOT COMPLETED|Overall Study||0
2573212|NCT00421148|6310970|P4|NOT COMPLETED|Overall Study||0
2573213|NCT00421148|6310971|P3|NOT COMPLETED|Overall Study||0
2573214|NCT00421148|6310972|P2|NOT COMPLETED|Overall Study||0
2573215|NCT00421148|6310973|P1|NOT COMPLETED|Overall Study||0
2573216|NCT00421148|6310954|P20|COMPLETED|Overall Study||6
2573217|NCT00421148|6310955|P19|COMPLETED|Overall Study||5
2573218|NCT00421148|6310956|P18|COMPLETED|Overall Study||4
2573219|NCT00421148|6310957|P17|COMPLETED|Overall Study||6
2573220|NCT00421148|6310958|P16|COMPLETED|Overall Study||6
2573221|NCT00421148|6310959|P15|COMPLETED|Overall Study||6
2573222|NCT00421148|6310960|P14|COMPLETED|Overall Study||6
2573223|NCT00421148|6310961|P13|COMPLETED|Overall Study||6
2573224|NCT00421148|6310962|P12|COMPLETED|Overall Study||6
2573225|NCT00421148|6310963|P11|COMPLETED|Overall Study||6
2573226|NCT00421148|6310964|P10|COMPLETED|Overall Study||5
2573227|NCT00421148|6310965|P9|COMPLETED|Overall Study||5
2573228|NCT00421148|6310966|P8|COMPLETED|Overall Study||5
2573229|NCT00421148|6310967|P7|COMPLETED|Overall Study||6
2573230|NCT00421148|6310968|P6|COMPLETED|Overall Study||4
2573231|NCT00421148|6310969|P5|COMPLETED|Overall Study||1
2573232|NCT00421148|6310970|P4|COMPLETED|Overall Study||1
2573233|NCT00421148|6310971|P3|COMPLETED|Overall Study||2
2573234|NCT00421148|6310972|P2|COMPLETED|Overall Study||2
2573235|NCT00421148|6310973|P1|COMPLETED|Overall Study||2
2573236|NCT00421148|6310954|P20|Treated|Overall Study||6
2573237|NCT00421148|6310955|P19|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|5
2573238|NCT00421148|6310956|P18|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|5
2573239|NCT00421148|6310957|P17|Treated|Overall Study||6
2573240|NCT00421148|6310958|P16|Treated|Overall Study||6
2573241|NCT00421148|6310959|P15|Treated|Overall Study||6
2573242|NCT00421148|6310960|P14|Treated|Overall Study||6
2573243|NCT00421148|6310961|P13|Treated|Overall Study||6
2573244|NCT00421148|6310962|P12|Treated|Overall Study|Includes 1 participant who was inadvertently randomized to group but received 5 mg/kg sugammadex|6
2573245|NCT00421148|6310963|P11|Treated|Overall Study||6
2573246|NCT00421148|6310964|P10|Treated|Overall Study|Includes 1 participant who was inadvertently randomized to group but was an adolescent|5
2573247|NCT00421148|6310965|P9|Treated|Overall Study||5
2573248|NCT00421148|6310966|P8|Treated|Overall Study||5
2573249|NCT00421148|6310967|P7|Treated|Overall Study||6
2573250|NCT00421148|6310968|P6|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|4
2573251|NCT00421148|6310969|P5|Treated|Overall Study||1
2573252|NCT00421148|6310970|P4|Treated|Overall Study||1
2573253|NCT00421148|6310971|P3|Treated|Overall Study||2
2573254|NCT00421148|6310972|P2|Treated|Overall Study||2
2573255|NCT00421148|6310973|P1|Treated|Overall Study||2
2573256|NCT00421148|6310954|P20|STARTED|Overall Study||6
2573257|NCT00421148|6310955|P19|STARTED|Overall Study||6
2573258|NCT00421148|6310956|P18|STARTED|Overall Study||6
2573259|NCT00421148|6310957|P17|STARTED|Overall Study||6
2573260|NCT00421148|6310958|P16|STARTED|Overall Study||6
2573261|NCT00421148|6310959|P15|STARTED|Overall Study||6
2573262|NCT00421148|6310960|P14|STARTED|Overall Study||6
2573263|NCT00421148|6310961|P13|STARTED|Overall Study||6
2573264|NCT00421148|6310962|P12|STARTED|Overall Study||6
2573265|NCT00421148|6310963|P11|STARTED|Overall Study||6
2573266|NCT00421148|6310964|P10|STARTED|Overall Study||5
2573267|NCT00421148|6310965|P9|STARTED|Overall Study||5
2573268|NCT00421148|6310966|P8|STARTED|Overall Study||5
2573269|NCT00421148|6310967|P7|STARTED|Overall Study||6
2573270|NCT00421148|6310968|P6|STARTED|Overall Study||5
2573271|NCT00421148|6310969|P5|STARTED|Overall Study||1
2573272|NCT00421148|6310970|P4|STARTED|Overall Study||1
2573273|NCT00421148|6310971|P3|STARTED|Overall Study||2
2573274|NCT00421148|6310972|P2|STARTED|Overall Study||2
2573275|NCT00421148|6310973|P1|STARTED|Overall Study||2
2573276|NCT00420992|6311057|P2|NOT COMPLETED|Maintenance Phase||75
2573277|NCT00420992|6311058|P1|NOT COMPLETED|Maintenance Phase||61
2573278|NCT00420992|6311057|P2|COMPLETED|Maintenance Phase||98
2573279|NCT00420992|6311058|P1|COMPLETED|Maintenance Phase||110
2573280|NCT00420992|6311057|P2|STARTED|Maintenance Phase||173
2573281|NCT00420992|6311058|P1|STARTED|Maintenance Phase||171
2573282|NCT00420992|6311057|P2|NOT COMPLETED|Titration Phase||0
2573283|NCT00420992|6311058|P1|NOT COMPLETED|Titration Phase||203
2573284|NCT00420992|6311057|P2|COMPLETED|Titration Phase||0
2573285|NCT00420992|6311058|P1|COMPLETED|Titration Phase||344
2573286|NCT00420992|6311057|P2|STARTED|Titration Phase||0
2573287|NCT00420992|6311058|P1|STARTED|Titration Phase|All patients received ALO-01 during open-label titration phase|547
2573288|NCT00420927|6311072|P7|NOT COMPLETED|Period 2||53
2573289|NCT00420927|6311073|P6|NOT COMPLETED|Period 2||15
2573290|NCT00420927|6311074|P5|NOT COMPLETED|Period 2||43
2573291|NCT00420927|6311075|P4|NOT COMPLETED|Period 2||10
2573292|NCT00420927|6311076|P3|NOT COMPLETED|Period 2||13
2573293|NCT00420927|6311077|P2|NOT COMPLETED|Period 2||0
2573294|NCT00420927|6311078|P1|NOT COMPLETED|Period 2||0
2573295|NCT00420927|6311072|P7|COMPLETED|Period 2||295
2573296|NCT00420927|6311073|P6|COMPLETED|Period 2||97
2573297|NCT00420927|6311074|P5|COMPLETED|Period 2||216
2573298|NCT00420927|6311075|P4|COMPLETED|Period 2||95
2573299|NCT00420927|6311076|P3|COMPLETED|Period 2||89
2573300|NCT00420927|6311077|P2|COMPLETED|Period 2||0
2573301|NCT00420927|6311078|P1|COMPLETED|Period 2||0
2573302|NCT00420927|6311072|P7|STARTED|Period 2||348
2573303|NCT00420927|6311073|P6|STARTED|Period 2||112
2573304|NCT00420927|6311074|P5|STARTED|Period 2||259
2573305|NCT00420927|6311075|P4|STARTED|Period 2||105
2573306|NCT00420927|6311076|P3|STARTED|Period 2||102
2573307|NCT00420927|6311077|P2|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
2573308|NCT00420927|6311078|P1|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
2573309|NCT00420927|6311072|P7|NOT COMPLETED|Period 1||0
2573310|NCT00420927|6311073|P6|NOT COMPLETED|Period 1||0
2573311|NCT00420927|6311074|P5|NOT COMPLETED|Period 1||0
2573312|NCT00420927|6311075|P4|NOT COMPLETED|Period 1||0
2573313|NCT00420927|6311076|P3|NOT COMPLETED|Period 1||0
2573314|NCT00420927|6311077|P2|NOT COMPLETED|Period 1||57
2573315|NCT00420927|6311078|P1|NOT COMPLETED|Period 1||49
2573316|NCT00420927|6311072|P7|COMPLETED|Period 1||0
2573317|NCT00420927|6311073|P6|COMPLETED|Period 1||0
2573318|NCT00420927|6311074|P5|COMPLETED|Period 1||0
2573319|NCT00420927|6311075|P4|COMPLETED|Period 1||0
2573320|NCT00420927|6311076|P3|COMPLETED|Period 1||0
2573321|NCT00420927|6311077|P2|COMPLETED|Period 1||460
2573322|NCT00420927|6311078|P1|COMPLETED|Period 1||466
2573323|NCT00420927|6311072|P7|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
2573324|NCT00420927|6311073|P6|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
2573325|NCT00420927|6311074|P5|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
2573326|NCT00420927|6311075|P4|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
2573327|NCT00420927|6311076|P3|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
2573328|NCT00420927|6311077|P2|STARTED|Period 1||517
2573329|NCT00420927|6311078|P1|STARTED|Period 1||515
2573330|NCT00420849|6311182|P1|NOT COMPLETED|Overall Study||331
2573331|NCT00420849|6311182|P1|COMPLETED|Overall Study|Participants completed the study upon commercial availability of lenalidomide|256
2573332|NCT00420849|6311182|P1|STARTED|Overall Study||587
2573333|NCT00420784|6311251|P4|NOT COMPLETED|Overall Study||78
2573334|NCT00420784|6311252|P3|NOT COMPLETED|Overall Study||53
2573335|NCT00420784|6311253|P2|NOT COMPLETED|Overall Study||58
2573336|NCT00420784|6311254|P1|NOT COMPLETED|Overall Study||29
2573337|NCT00420784|6311251|P4|COMPLETED|Overall Study||36
2573338|NCT00420784|6311252|P3|COMPLETED|Overall Study||58
2573339|NCT00420784|6311253|P2|COMPLETED|Overall Study||55
2573340|NCT00420784|6311254|P1|COMPLETED|Overall Study||86
2573341|NCT00420784|6311251|P4|STARTED|Overall Study||114
2573342|NCT00420784|6311252|P3|STARTED|Overall Study||111
2573343|NCT00420784|6311253|P2|STARTED|Overall Study||113
2573344|NCT00420784|6311254|P1|STARTED|Overall Study||115
2573345|NCT00420771|6311283|P2|NOT COMPLETED|Overall Study||4
2573346|NCT00420771|6311284|P1|NOT COMPLETED|Overall Study||3
2573347|NCT00420771|6311283|P2|COMPLETED|Overall Study||7
2573348|NCT00420771|6311284|P1|COMPLETED|Overall Study||5
2573349|NCT00420771|6311283|P2|STARTED|Overall Study||11
2573350|NCT00420771|6311284|P1|STARTED|Overall Study||8
2573351|NCT00420745|6311292|P2|NOT COMPLETED|Overall Study||6
2573352|NCT00420745|6311293|P1|NOT COMPLETED|Overall Study||15
2573353|NCT00420745|6311292|P2|COMPLETED|Overall Study||333
2573354|NCT00420745|6311293|P1|COMPLETED|Overall Study||655
2573355|NCT00420745|6311292|P2|STARTED|Overall Study||339
2573356|NCT00420745|6311293|P1|STARTED|Overall Study||670
2573357|NCT00420641|6311312|P3|NOT COMPLETED|Overall Study||44
2573358|NCT00420641|6311313|P2|NOT COMPLETED|Overall Study||72
2573359|NCT00420641|6311314|P1|NOT COMPLETED|Overall Study||45
2573360|NCT00420641|6311312|P3|COMPLETED|Overall Study||128
2573361|NCT00420641|6311313|P2|COMPLETED|Overall Study||100
2573362|NCT00420641|6311314|P1|COMPLETED|Overall Study||115
2573363|NCT00420641|6311312|P3|STARTED|Overall Study||172
2573364|NCT00420641|6311313|P2|STARTED|Overall Study||172
2573365|NCT00420641|6311314|P1|STARTED|Overall Study||160
2573366|NCT00420628|6311390|P2|NOT COMPLETED|Overall Study||4
2573367|NCT00420628|6311391|P1|NOT COMPLETED|Overall Study||9
2573368|NCT00420628|6311390|P2|COMPLETED|Overall Study||32
2573369|NCT00420628|6311391|P1|COMPLETED|Overall Study||63
2573370|NCT00420628|6311390|P2|STARTED|Overall Study||36
2573371|NCT00420628|6311391|P1|STARTED|Overall Study||72
2573372|NCT00420511|6311407|P2|NOT COMPLETED|Overall Study||1
2573373|NCT00420511|6311408|P1|NOT COMPLETED|Overall Study||2
2573374|NCT00420511|6311407|P2|COMPLETED|Overall Study||10
2573375|NCT00420511|6311408|P1|COMPLETED|Overall Study||8
2573376|NCT00420511|6311407|P2|STARTED|Overall Study||11
2573377|NCT00420511|6311408|P1|STARTED|Overall Study||10
2573378|NCT00420459|6311418|P1|NOT COMPLETED|Overall Study||0
2573379|NCT00420459|6311418|P1|COMPLETED|Overall Study||12
2573380|NCT00420459|6311418|P1|STARTED|Overall Study||12
2573381|NCT00420420|6311429|P2|NOT COMPLETED|Overall Study||4
2573382|NCT00420420|6311430|P1|NOT COMPLETED|Overall Study||8
2573383|NCT00420420|6311429|P2|COMPLETED|Overall Study||67
2573384|NCT00420420|6311430|P1|COMPLETED|Overall Study|One patient from the MK-0249 arm discontinued the trial due to an AE prior to receiving study drug.|65
2573385|NCT00420420|6311429|P2|STARTED|Overall Study|Number of patients randomized.|71
2573386|NCT00420420|6311430|P1|STARTED|Overall Study|Number of patients randomized.|73
2573387|NCT00420407|6311448|P2|NOT COMPLETED|Overall Study||6
2573388|NCT00420407|6311449|P1|NOT COMPLETED|Overall Study||4
2573389|NCT00420407|6311448|P2|COMPLETED|Overall Study||34
2573390|NCT00420407|6311449|P1|COMPLETED|Overall Study||37
2573391|NCT00420407|6311448|P2|STARTED|Overall Study||40
2573392|NCT00420407|6311449|P1|STARTED|Overall Study||41
2573393|NCT00420342|6311459|P3|NOT COMPLETED|Overall Study||1
2573394|NCT00420342|6311460|P2|NOT COMPLETED|Overall Study||2
2573395|NCT00420342|6311461|P1|NOT COMPLETED|Overall Study||1
2573396|NCT00420342|6311459|P3|COMPLETED|Overall Study||28
2573397|NCT00420342|6311460|P2|COMPLETED|Overall Study||31
2573398|NCT00420342|6311461|P1|COMPLETED|Overall Study||29
2573399|NCT00420342|6311459|P3|Received Treatment|Overall Study||29
2573400|NCT00420342|6311460|P2|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|32
2573401|NCT00420342|6311461|P1|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|29
2573402|NCT00420342|6311459|P3|STARTED|Overall Study||29
2573403|NCT00420342|6311460|P2|STARTED|Overall Study||33
2573404|NCT00420342|6311461|P1|STARTED|Overall Study||30
2573405|NCT00420316|6311504|P2|NOT COMPLETED|Overall Study||9
2573406|NCT00420316|6311505|P1|NOT COMPLETED|Overall Study||12
2573407|NCT00420316|6311504|P2|COMPLETED|Overall Study||522
2573408|NCT00420316|6311505|P1|COMPLETED|Overall Study||1070
2573409|NCT00420316|6311504|P2|STARTED|Overall Study||531
2573410|NCT00420316|6311505|P1|STARTED|Overall Study||1082
2573411|NCT00420303|6311529|P2|NOT COMPLETED|Overall Study||4
2573412|NCT00420303|6311530|P1|NOT COMPLETED|Overall Study||1
2573413|NCT00420303|6311529|P2|COMPLETED|Overall Study||8
2573414|NCT00420303|6311530|P1|COMPLETED|Overall Study||11
2573415|NCT00420303|6311529|P2|STARTED|Overall Study||12
2573416|NCT00420303|6311530|P1|STARTED|Overall Study||12
2573417|NCT00420290|6311542|P2|NOT COMPLETED|Overall Study||4
2573418|NCT00420290|6311543|P1|NOT COMPLETED|Overall Study||4
2573419|NCT00420290|6311542|P2|COMPLETED|Overall Study||7
2573420|NCT00420290|6311543|P1|COMPLETED|Overall Study||7
2573421|NCT00420290|6311542|P2|STARTED|Overall Study||11
2573422|NCT00420290|6311543|P1|STARTED|Overall Study||11
2573423|NCT00420238|6311559|P2|NOT COMPLETED|12 Week Open-Label Treatment Period 2||1
2573424|NCT00420238|6311560|P1|NOT COMPLETED|12 Week Open-Label Treatment Period 2||2
2573425|NCT00420238|6311559|P2|COMPLETED|12 Week Open-Label Treatment Period 2||38
2573426|NCT00420238|6311560|P1|COMPLETED|12 Week Open-Label Treatment Period 2||36
2573427|NCT00420238|6311559|P2|STARTED|12 Week Open-Label Treatment Period 2||39
2573428|NCT00420238|6311560|P1|STARTED|12 Week Open-Label Treatment Period 2||38
2573429|NCT00420238|6311559|P2|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||4
2573430|NCT00420238|6311560|P1|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||1
2573431|NCT00420238|6311559|P2|COMPLETED|12 Week Double-Blind Treatment Period 1||39
2573432|NCT00420238|6311560|P1|COMPLETED|12 Week Double-Blind Treatment Period 1||38
2573433|NCT00420238|6311559|P2|STARTED|12 Week Double-Blind Treatment Period 1||43
2573434|NCT00420238|6311560|P1|STARTED|12 Week Double-Blind Treatment Period 1||39
2573435|NCT00420212|6311699|P3|NOT COMPLETED|Overall Study||96
2573436|NCT00420212|6311700|P2|NOT COMPLETED|Overall Study||95
2573437|NCT00420212|6311701|P1|NOT COMPLETED|Overall Study||91
2573438|NCT00420212|6311699|P3|COMPLETED|Overall Study||320
2573439|NCT00420212|6311700|P2|COMPLETED|Overall Study||315
2573440|NCT00420212|6311701|P1|COMPLETED|Overall Study||317
2573441|NCT00420212|6311699|P3|STARTED|Overall Study|416 participants were dosed; 416 participants were randomized|416
2573442|NCT00420212|6311700|P2|STARTED|Overall Study|410 participants were dosed; 411 participants were randomized|410
2573443|NCT00420212|6311701|P1|STARTED|Overall Study|408 participants were dosed; 410 participants were randomized|408
2573444|NCT00420199|6311727|P2|NOT COMPLETED|Overall Study||0
2573445|NCT00420199|6311728|P1|NOT COMPLETED|Overall Study||1
2573446|NCT00420199|6311727|P2|COMPLETED|Overall Study||23
2573447|NCT00420199|6311728|P1|COMPLETED|Overall Study||26
2573448|NCT00420199|6311727|P2|STARTED|Overall Study||23
2573449|NCT00420199|6311728|P1|STARTED|Overall Study||27
2573450|NCT00420147|6311783|P2|NOT COMPLETED|Overall Study||0
2573451|NCT00420147|6311784|P1|NOT COMPLETED|Overall Study||0
2573452|NCT00420147|6311783|P2|COMPLETED|Overall Study||19
2573453|NCT00420147|6311784|P1|COMPLETED|Overall Study||19
2573454|NCT00420147|6311783|P2|STARTED|Overall Study||19
2573455|NCT00420147|6311784|P1|STARTED|Overall Study||19
2573456|NCT00420095|6311794|P2|NOT COMPLETED|Overall Study||1
2573457|NCT00420095|6311795|P1|NOT COMPLETED|Overall Study||3
2573458|NCT00420095|6311794|P2|COMPLETED|Overall Study||59
2573459|NCT00420095|6311795|P1|COMPLETED|Overall Study||54
2573460|NCT00420095|6311794|P2|STARTED|Overall Study||60
2573461|NCT00420095|6311795|P1|STARTED|Overall Study||57
2573462|NCT00420056|6311813|P1|NOT COMPLETED|Overall Study||17
2573463|NCT00420056|6311813|P1|COMPLETED|Overall Study||0
2573464|NCT00420056|6311813|P1|STARTED|Overall Study||17
2573465|NCT00420017|6311837|P2|NOT COMPLETED|Overall Study||0
2573466|NCT00420017|6311838|P1|NOT COMPLETED|Overall Study||2
2573467|NCT00420017|6311837|P2|COMPLETED|Overall Study||40
2573468|NCT00420017|6311838|P1|COMPLETED|Overall Study|40 completed analysis|38
2573469|NCT00420017|6311837|P2|STARTED|Overall Study||40
2573470|NCT00420017|6311838|P1|STARTED|Overall Study||40
2573471|NCT00420004|6311853|P3|NOT COMPLETED|Overall Study||32
2573472|NCT00420004|6311854|P2|NOT COMPLETED|Overall Study||71
2573473|NCT00420004|6311855|P1|NOT COMPLETED|Overall Study||129
2573474|NCT00420004|6311853|P3|COMPLETED|Overall Study||30
2573475|NCT00420004|6311854|P2|COMPLETED|Overall Study||67
2573476|NCT00420004|6311855|P1|COMPLETED|Overall Study||140
2573477|NCT00420004|6311853|P3|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|54
2573478|NCT00420004|6311854|P2|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|122
2573479|NCT00420004|6311855|P1|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|249
2573480|NCT00420004|6311853|P3|STARTED|Overall Study||62
2573481|NCT00420004|6311854|P2|STARTED|Overall Study||138
2573482|NCT00420004|6311855|P1|STARTED|Overall Study||269
2573483|NCT00419952|6311920|P2|NOT COMPLETED|Overall Study||125
2573484|NCT00419952|6311921|P1|NOT COMPLETED|Overall Study||149
2573485|NCT00419952|6311920|P2|COMPLETED|Overall Study||240
2573486|NCT00419952|6311921|P1|COMPLETED|Overall Study||228
2573487|NCT00419952|6311920|P2|STARTED|Overall Study||365
2573488|NCT00419952|6311921|P1|STARTED|Overall Study||377
2573489|NCT00419926|6311955|P2|NOT COMPLETED|Overall Study||10
2573490|NCT00419926|6311956|P1|NOT COMPLETED|Overall Study||14
2573491|NCT00419926|6311955|P2|COMPLETED|Overall Study||148
2573492|NCT00419926|6311956|P1|COMPLETED|Overall Study||141
2573493|NCT00419926|6311955|P2|STARTED|Overall Study|Intention to treat population, 154 is safety population.|158
2573494|NCT00419926|6311956|P1|STARTED|Overall Study|Intention to treat population, 150 is safety population.|155
2573495|NCT00419770|6311972|P2|NOT COMPLETED|Overall Study||1
2573496|NCT00419770|6311973|P1|NOT COMPLETED|Overall Study||5
2573497|NCT00419770|6311972|P2|COMPLETED|Overall Study||8
2573498|NCT00419770|6311973|P1|COMPLETED|Overall Study||6
2573499|NCT00419770|6311972|P2|STARTED|Overall Study||9
2573500|NCT00419770|6311973|P1|STARTED|Overall Study||11
2573501|NCT00419757|6311981|P2|NOT COMPLETED|Overall Study||21
2573502|NCT00419757|6311982|P1|NOT COMPLETED|Overall Study||18
2573503|NCT00419757|6311981|P2|COMPLETED|Overall Study|Randomized patients|102
2573504|NCT00419757|6311982|P1|COMPLETED|Overall Study|Randomized patients|109
2573505|NCT00419757|6311981|P2|STARTED|Overall Study|Randomized patients|123
2573506|NCT00419757|6311982|P1|STARTED|Overall Study|Randomized patients|127
2573507|NCT00419744|6312021|P3|NOT COMPLETED|Overall Study||133
2573508|NCT00419744|6312022|P2|NOT COMPLETED|Overall Study||118
2573509|NCT00419744|6312023|P1|NOT COMPLETED|Overall Study||117
2573510|NCT00419744|6312021|P3|COMPLETED|Overall Study||271
2573511|NCT00419744|6312022|P2|COMPLETED|Overall Study||290
2573512|NCT00419744|6312023|P1|COMPLETED|Overall Study||290
2573513|NCT00419744|6312021|P3|STARTED|Overall Study||404
2573514|NCT00419744|6312022|P2|STARTED|Overall Study||408
2573515|NCT00419744|6312023|P1|STARTED|Overall Study||407
2573516|NCT00419666|6312052|P1|NOT COMPLETED|Overall Study||0
2573517|NCT00419666|6312052|P1|COMPLETED|Overall Study||25
2573518|NCT00419666|6312052|P1|STARTED|Overall Study||25
2573525|NCT00419445|6312080|P3|NOT COMPLETED|Overall Study||1
2573526|NCT00419445|6312081|P2|NOT COMPLETED|Overall Study||2
2573527|NCT00419445|6312082|P1|NOT COMPLETED|Overall Study||1
2573528|NCT00419445|6312080|P3|COMPLETED|Overall Study||7
2573529|NCT00419445|6312081|P2|COMPLETED|Overall Study||14
2573530|NCT00419445|6312082|P1|COMPLETED|Overall Study||7
2573531|NCT00419445|6312080|P3|STARTED|Overall Study||8
2573532|NCT00419445|6312081|P2|STARTED|Overall Study||16
2573533|NCT00419445|6312082|P1|STARTED|Overall Study||8
2573534|NCT00419393|6312090|P1|NOT COMPLETED|Overall Study||24
2573535|NCT00419393|6312090|P1|COMPLETED|Overall Study||166
2573536|NCT00419393|6312090|P1|STARTED|Overall Study|One subject did not receive medication|190
2573537|NCT00419380|6312100|P2|NOT COMPLETED|Overall Study||10
2573538|NCT00419380|6312101|P1|NOT COMPLETED|Overall Study||1
2573539|NCT00419380|6312100|P2|COMPLETED|Overall Study||12
2573540|NCT00419380|6312101|P1|COMPLETED|Overall Study||18
2573541|NCT00419380|6312100|P2|STARTED|Overall Study||22
2573542|NCT00419380|6312101|P1|STARTED|Overall Study||19
2573543|NCT00419341|6312109|P1|NOT COMPLETED|Efficacy Period||10
2573544|NCT00419341|6312109|P1|COMPLETED|Efficacy Period||28
2573545|NCT00419341|6312109|P1|STARTED|Efficacy Period||38
2573546|NCT00419341|6312109|P1|NOT COMPLETED|Wash in/Wash Out Period||11
2573547|NCT00419341|6312109|P1|COMPLETED|Wash in/Wash Out Period||38
2573548|NCT00419341|6312109|P1|STARTED|Wash in/Wash Out Period||49
2573549|NCT00419315|6312132|P2|NOT COMPLETED|Overall Study||0
2573550|NCT00419315|6312133|P1|NOT COMPLETED|Overall Study||0
2573551|NCT00419315|6312132|P2|COMPLETED|Overall Study||78
2573552|NCT00419315|6312133|P1|COMPLETED|Overall Study||85
2573553|NCT00419315|6312132|P2|STARTED|Overall Study||78
2573554|NCT00419315|6312133|P1|STARTED|Overall Study||85
2573555|NCT00419263|6312144|P3|NOT COMPLETED|Overall Study||3
2573556|NCT00419263|6312145|P2|NOT COMPLETED|Overall Study||2
2573557|NCT00419263|6312146|P1|NOT COMPLETED|Overall Study||3
2573558|NCT00419263|6312144|P3|COMPLETED|Overall Study||112
2573559|NCT00419263|6312145|P2|COMPLETED|Overall Study||112
2573560|NCT00419263|6312146|P1|COMPLETED|Overall Study||112
2573561|NCT00419263|6312144|P3|STARTED|Overall Study||115
2573562|NCT00419263|6312145|P2|STARTED|Overall Study||114
2573563|NCT00419263|6312146|P1|STARTED|Overall Study||115
2573564|NCT00419159|6312175|P2|NOT COMPLETED|Overall Study||100
2573565|NCT00419159|6312176|P1|NOT COMPLETED|Overall Study||99
2573566|NCT00419159|6312175|P2|COMPLETED|Overall Study||0
2573567|NCT00419159|6312176|P1|COMPLETED|Overall Study||0
2573568|NCT00419159|6312175|P2|STARTED|Overall Study||100
2573569|NCT00419159|6312176|P1|STARTED|Overall Study|Full Analysis Set|99
2573570|NCT00419120|6312206|P1|NOT COMPLETED|Long Term Follow up Period||10
2573571|NCT00419120|6312206|P1|COMPLETED|Long Term Follow up Period||0
2573572|NCT00419120|6312206|P1|STARTED|Long Term Follow up Period|10 patients are being followed in long term follow up.|10
2573573|NCT00419120|6312206|P1|NOT COMPLETED|Primary Study Period||0
2573574|NCT00419120|6312206|P1|COMPLETED|Primary Study Period||10
2573575|NCT00419120|6312206|P1|STARTED|Primary Study Period||10
2573576|NCT00419094|6312213|P2|NOT COMPLETED|Overall Study||30
2573577|NCT00419094|6312214|P1|NOT COMPLETED|Overall Study||7
2573578|NCT00419094|6312213|P2|COMPLETED|Overall Study||141
2573579|NCT00419094|6312214|P1|COMPLETED|Overall Study||50
2573580|NCT00419094|6312213|P2|STARTED|Overall Study||171
2573581|NCT00419094|6312214|P1|STARTED|Overall Study|Number started refers to number randomized; 303 subjects were screened/enrolled and 228 randomized.|57
2573582|NCT00419003|6312228|P2|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||0
2573583|NCT00419003|6312229|P1|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||1
2573584|NCT00419003|6312228|P2|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||8
2573585|NCT00419003|6312229|P1|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||5
2573586|NCT00419003|6312228|P2|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn’t split up evenly (same way as phase I) in the riluzole/placebo phase.|8
2573587|NCT00419003|6312229|P1|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn’t split up evenly (same way as phase I) in the riluzole/placebo phase.|6
2573588|NCT00419003|6312228|P2|NOT COMPLETED|Phase I, Ketamine Infusion||6
2573589|NCT00419003|6312229|P1|NOT COMPLETED|Phase I, Ketamine Infusion||6
2573590|NCT00419003|6312228|P2|COMPLETED|Phase I, Ketamine Infusion||7
2573591|NCT00419003|6312229|P1|COMPLETED|Phase I, Ketamine Infusion||7
2573592|NCT00419003|6312228|P2|STARTED|Phase I, Ketamine Infusion||13
2573593|NCT00419003|6312229|P1|STARTED|Phase I, Ketamine Infusion||13
2573594|NCT00418977|6312240|P2|NOT COMPLETED|Overall Study||3
2573595|NCT00418977|6312241|P1|NOT COMPLETED|Overall Study||3
2573596|NCT00418977|6312240|P2|COMPLETED|Overall Study||13
2573597|NCT00418977|6312241|P1|COMPLETED|Overall Study||40
2573598|NCT00418977|6312240|P2|STARTED|Overall Study||16
2573599|NCT00418977|6312241|P1|STARTED|Overall Study||43
2573600|NCT00418964|6312258|P3|NOT COMPLETED|Overall Study||6
2573601|NCT00418964|6312259|P2|NOT COMPLETED|Overall Study||3
2573602|NCT00418964|6312260|P1|NOT COMPLETED|Overall Study||1
2573603|NCT00418964|6312258|P3|COMPLETED|Overall Study||14
2573604|NCT00418964|6312259|P2|COMPLETED|Overall Study||17
2573605|NCT00418964|6312260|P1|COMPLETED|Overall Study||21
2573606|NCT00418964|6312258|P3|STARTED|Overall Study||20
2573607|NCT00418964|6312259|P2|STARTED|Overall Study||20
2573608|NCT00418964|6312260|P1|STARTED|Overall Study||22
2573609|NCT00418951|6312271|P3|NOT COMPLETED|Overall Study||0
2573610|NCT00418951|6312272|P2|NOT COMPLETED|Overall Study||0
2573611|NCT00418951|6312273|P1|NOT COMPLETED|Overall Study||0
2573612|NCT00418951|6312271|P3|COMPLETED|Overall Study||40
2573613|NCT00418951|6312272|P2|COMPLETED|Overall Study||33
2573614|NCT00418951|6312273|P1|COMPLETED|Overall Study||39
2573615|NCT00418951|6312271|P3|STARTED|Overall Study||40
2573616|NCT00418951|6312272|P2|STARTED|Overall Study||33
2573617|NCT00418951|6312273|P1|STARTED|Overall Study||39
2573618|NCT00418938|6312283|P2|NOT COMPLETED|Overall Study||23
2573619|NCT00418938|6312284|P1|NOT COMPLETED|Overall Study||24
2573620|NCT00418938|6312283|P2|COMPLETED|Overall Study||108
2573621|NCT00418938|6312284|P1|COMPLETED|Overall Study||109
2573622|NCT00418938|6312283|P2|STARTED|Overall Study||131
2573623|NCT00418938|6312284|P1|STARTED|Overall Study||133
2573624|NCT00418886|6312304|P2|NOT COMPLETED|Overall Study||255
2573625|NCT00418886|6312305|P1|NOT COMPLETED|Overall Study||226
2573626|NCT00418886|6312304|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|23
2573627|NCT00418886|6312305|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|30
2573628|NCT00418886|6312304|P2|STARTED|Overall Study|randomised patients|278
2573629|NCT00418886|6312305|P1|STARTED|Overall Study|randomised patients|256
2573630|NCT00418834|6312331|P2|NOT COMPLETED|Overall Study||20
2573631|NCT00418834|6312332|P1|NOT COMPLETED|Overall Study||23
2573632|NCT00418834|6312331|P2|COMPLETED|Overall Study||507
2573633|NCT00418834|6312332|P1|COMPLETED|Overall Study||503
2573634|NCT00418834|6312331|P2|STARTED|Overall Study||527
2573635|NCT00418834|6312332|P1|STARTED|Overall Study||526
2573636|NCT00418717|6312392|P1|NOT COMPLETED|Treatment Period B - Weeks 5-12||2
2573637|NCT00418717|6312392|P1|COMPLETED|Treatment Period B - Weeks 5-12||39
2573638|NCT00418717|6312392|P1|STARTED|Treatment Period B - Weeks 5-12||41
2573639|NCT00418717|6312392|P1|NOT COMPLETED|Treatment Period A - Weeks 1-4||1
2573640|NCT00418717|6312392|P1|COMPLETED|Treatment Period A - Weeks 1-4||41
2573641|NCT00418717|6312392|P1|STARTED|Treatment Period A - Weeks 1-4||42
2573642|NCT00418691|6312400|P3|NOT COMPLETED|Overall Study||5
2573643|NCT00418691|6312401|P2|NOT COMPLETED|Overall Study||2
2573644|NCT00418691|6312402|P1|NOT COMPLETED|Overall Study||2
2573645|NCT00418691|6312400|P3|COMPLETED|Overall Study||5
2573646|NCT00418691|6312401|P2|COMPLETED|Overall Study||10
2573647|NCT00418691|6312402|P1|COMPLETED|Overall Study||9
2573648|NCT00418691|6312400|P3|STARTED|Overall Study||10
2573649|NCT00418691|6312401|P2|STARTED|Overall Study||12
2573650|NCT00418691|6312402|P1|STARTED|Overall Study||11
2573651|NCT00418665|6312413|P3|NOT COMPLETED|Treatment Extension||2
2573652|NCT00418665|6312414|P2|NOT COMPLETED|Treatment Extension||4
2573653|NCT00418665|6312415|P1|NOT COMPLETED|Treatment Extension||6
2573654|NCT00418665|6312413|P3|COMPLETED|Treatment Extension||7
2573655|NCT00418665|6312414|P2|COMPLETED|Treatment Extension||4
2573656|NCT00418665|6312415|P1|COMPLETED|Treatment Extension||1
2573657|NCT00418665|6312413|P3|STARTED|Treatment Extension||9
2573658|NCT00418665|6312414|P2|STARTED|Treatment Extension||8
2573659|NCT00418665|6312415|P1|STARTED|Treatment Extension||7
2573660|NCT00418665|6312413|P3|NOT COMPLETED|Treatment Period||4
2573661|NCT00418665|6312414|P2|NOT COMPLETED|Treatment Period||6
2573662|NCT00418665|6312415|P1|NOT COMPLETED|Treatment Period||5
2573663|NCT00418665|6312413|P3|COMPLETED|Treatment Period||9
2573664|NCT00418665|6312414|P2|COMPLETED|Treatment Period||8
2573665|NCT00418665|6312415|P1|COMPLETED|Treatment Period||7
2573666|NCT00418665|6312413|P3|Received Study Medication|Treatment Period||13
2573667|NCT00418665|6312414|P2|Received Study Medication|Treatment Period||13
2573668|NCT00418665|6312415|P1|Received Study Medication|Treatment Period||11
2573669|NCT00418665|6312413|P3|STARTED|Treatment Period||13
2573670|NCT00418665|6312414|P2|STARTED|Treatment Period||14
2573671|NCT00418665|6312415|P1|STARTED|Treatment Period||12
2573672|NCT00418574|6312434|P2|NOT COMPLETED|Overall Study||23
2573673|NCT00418574|6312435|P1|NOT COMPLETED|Overall Study||48
2573674|NCT00418574|6312434|P2|COMPLETED|Overall Study||272
2573675|NCT00418574|6312435|P1|COMPLETED|Overall Study||545
2573676|NCT00418574|6312434|P2|TREATED|Overall Study||294
2573677|NCT00418574|6312435|P1|TREATED|Overall Study||592
2573678|NCT00418574|6312434|P2|STARTED|Overall Study||295
2573679|NCT00418574|6312435|P1|STARTED|Overall Study||593
2573680|NCT00418561|6312449|P3|NOT COMPLETED|Overall Study||0
2573681|NCT00418561|6312450|P2|NOT COMPLETED|Overall Study||1
2573682|NCT00418561|6312451|P1|NOT COMPLETED|Overall Study||0
2573683|NCT00418561|6312449|P3|COMPLETED|Overall Study||4
2573684|NCT00418561|6312450|P2|COMPLETED|Overall Study||4
2573685|NCT00418561|6312451|P1|COMPLETED|Overall Study||4
2573686|NCT00418561|6312449|P3|STARTED|Overall Study||4
2573687|NCT00418561|6312450|P2|STARTED|Overall Study||5
2573688|NCT00418561|6312451|P1|STARTED|Overall Study||4
2573689|NCT00418522|6312521|P2|NOT COMPLETED|Overall Study||42
2573690|NCT00418522|6312522|P1|NOT COMPLETED|Overall Study||83
2573691|NCT00418522|6312521|P2|COMPLETED|Overall Study||152
2573692|NCT00418522|6312522|P1|COMPLETED|Overall Study||136
2573693|NCT00418522|6312521|P2|Received Treatment|Overall Study||190
2573694|NCT00418522|6312522|P1|Received Treatment|Overall Study||212
2573695|NCT00418522|6312521|P2|STARTED|Overall Study||194
2573696|NCT00418522|6312522|P1|STARTED|Overall Study||219
2573697|NCT00418379|6312569|P3|NOT COMPLETED|Year 5||3
2573698|NCT00418379|6312570|P2|NOT COMPLETED|Year 5||5
2573699|NCT00418379|6312571|P1|NOT COMPLETED|Year 5||2
2573700|NCT00418379|6312569|P3|COMPLETED|Year 5||131
2573701|NCT00418379|6312570|P2|COMPLETED|Year 5||115
2573702|NCT00418379|6312571|P1|COMPLETED|Year 5||126
2573703|NCT00418379|6312569|P3|STARTED|Year 5|20 patients withdrew between Year 4 and Year 5 study periods.|134
2573704|NCT00418379|6312570|P2|STARTED|Year 5|16 patients withdrew between Year 4 and Year 5 study periods.|120
2573705|NCT00418379|6312571|P1|STARTED|Year 5|14 patients withdrew between Year 4 and Year 5 study periods.|128
2573706|NCT00418379|6312569|P3|NOT COMPLETED|Year 4||2
2573707|NCT00418379|6312570|P2|NOT COMPLETED|Year 4||5
2573708|NCT00418379|6312571|P1|NOT COMPLETED|Year 4||3
2573709|NCT00418379|6312569|P3|COMPLETED|Year 4||154
2573710|NCT00418379|6312570|P2|COMPLETED|Year 4||136
2573711|NCT00418379|6312571|P1|COMPLETED|Year 4||142
2573712|NCT00418379|6312569|P3|STARTED|Year 4|7 patients withdrew between Year 3 and Year 4 study periods.|156
2573713|NCT00418379|6312570|P2|STARTED|Year 4|5 patients withdrew between Year 3 and Year 4 study periods.|141
2573714|NCT00418379|6312571|P1|STARTED|Year 4|3 patients withdrew between Year 3 and Year 4 study periods.|145
2573715|NCT00418379|6312569|P3|NOT COMPLETED|Year 3||3
2573716|NCT00418379|6312570|P2|NOT COMPLETED|Year 3||2
2573717|NCT00418379|6312571|P1|NOT COMPLETED|Year 3||3
2573718|NCT00418379|6312569|P3|COMPLETED|Year 3||163
2573719|NCT00418379|6312570|P2|COMPLETED|Year 3||146
2573720|NCT00418379|6312571|P1|COMPLETED|Year 3||148
2573721|NCT00418379|6312569|P3|STARTED|Year 3|6 patients withdrew between Year 2 and Year 3 treatment periods.|166
2573722|NCT00418379|6312570|P2|STARTED|Year 3|7 patients withdrew between Year 2 and Year 3 treatment periods.|148
2573723|NCT00418379|6312571|P1|STARTED|Year 3|8 patients withdrew between Year 2 and Year 3 treatment periods.|151
2573724|NCT00418379|6312569|P3|NOT COMPLETED|Year 2||10
2573725|NCT00418379|6312570|P2|NOT COMPLETED|Year 2||4
2573726|NCT00418379|6312571|P1|NOT COMPLETED|Year 2||8
2573727|NCT00418379|6312569|P3|COMPLETED|Year 2||172
2573728|NCT00418379|6312570|P2|COMPLETED|Year 2||155
2573729|NCT00418379|6312571|P1|COMPLETED|Year 2||159
2573730|NCT00418379|6312569|P3|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|182
2573731|NCT00418379|6312570|P2|STARTED|Year 2|20 patients withdrew between Year 1 and Year 2 treatment periods.|159
2573732|NCT00418379|6312571|P1|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|167
2573733|NCT00418379|6312569|P3|NOT COMPLETED|Year 1||15
2573734|NCT00418379|6312570|P2|NOT COMPLETED|Year 1||28
2573735|NCT00418379|6312571|P1|NOT COMPLETED|Year 1||18
2573736|NCT00418379|6312569|P3|COMPLETED|Year 1||204
2573737|NCT00418379|6312570|P2|COMPLETED|Year 1||179
2573738|NCT00418379|6312571|P1|COMPLETED|Year 1||189
2573739|NCT00418379|6312569|P3|STARTED|Year 1||219
2573740|NCT00418379|6312570|P2|STARTED|Year 1||207
2573741|NCT00418379|6312571|P1|STARTED|Year 1||207
2573742|NCT00418314|6312581|P2|NOT COMPLETED|Overall Study||2
2573743|NCT00418314|6312582|P1|NOT COMPLETED|Overall Study||1
2573744|NCT00418314|6312581|P2|COMPLETED|Overall Study||828
2573745|NCT00418314|6312582|P1|COMPLETED|Overall Study||816
2573746|NCT00418314|6312581|P2|STARTED|Overall Study||830
2573747|NCT00418314|6312582|P1|STARTED|Overall Study||817
2573748|NCT00418262|6312592|P1|NOT COMPLETED|Visits 8 Thru 10||5
2573749|NCT00418262|6312592|P1|COMPLETED|Visits 8 Thru 10||11
2573750|NCT00418262|6312592|P1|STARTED|Visits 8 Thru 10||16
2573751|NCT00418262|6312592|P1|NOT COMPLETED|Visits 5 Thru 8||9
2573752|NCT00418262|6312592|P1|COMPLETED|Visits 5 Thru 8||16
2573753|NCT00418262|6312592|P1|STARTED|Visits 5 Thru 8||25
2573754|NCT00418262|6312592|P1|NOT COMPLETED|Visits 1 (Baseline) Thru 5||2
2573755|NCT00418262|6312592|P1|COMPLETED|Visits 1 (Baseline) Thru 5||25
2573756|NCT00418262|6312592|P1|STARTED|Visits 1 (Baseline) Thru 5||27
2573757|NCT00418184|6312612|P2|NOT COMPLETED|Open-label Phase||5
2573758|NCT00418184|6312613|P1|NOT COMPLETED|Open-label Phase||5
2573759|NCT00418184|6312612|P2|COMPLETED|Open-label Phase|5 dropped out|43
2573760|NCT00418184|6312613|P1|COMPLETED|Open-label Phase|5 dropped out|97
2573761|NCT00418184|6312612|P2|STARTED|Open-label Phase|1 was not included due to low compliance in the double blind phase, 3 didn't want to participate.|48
2573762|NCT00418184|6312613|P1|STARTED|Open-label Phase|3 were not included due to low compliance in the double blind phase, 5 didn't want to participate.|102
2573763|NCT00418184|6312612|P2|NOT COMPLETED|Double-blind Phase||11
2573764|NCT00418184|6312613|P1|NOT COMPLETED|Double-blind Phase||27
2573765|NCT00418184|6312612|P2|COMPLETED|Double-blind Phase||52
2573766|NCT00418184|6312613|P1|COMPLETED|Double-blind Phase||110
2573767|NCT00418184|6312612|P2|STARTED|Double-blind Phase||63
2573768|NCT00418184|6312613|P1|STARTED|Double-blind Phase||137
2573769|NCT00418145|6312621|P1|NOT COMPLETED|Overall Study||6
2573770|NCT00418145|6312621|P1|COMPLETED|Overall Study||10
2573771|NCT00418145|6312621|P1|STARTED|Overall Study||16
2573772|NCT00418093|6312633|P1|NOT COMPLETED|Overall Study||0
2573773|NCT00418093|6312633|P1|COMPLETED|Overall Study||19
2573774|NCT00418093|6312633|P1|Completed Study|Overall Study||19
2573775|NCT00418093|6312633|P1|STARTED|Overall Study||19
2573776|NCT00418028|6312642|P2|NOT COMPLETED|Overall Study||1
2573777|NCT00418028|6312643|P1|NOT COMPLETED|Overall Study||2
2573778|NCT00418028|6312642|P2|COMPLETED|Overall Study||97
2573779|NCT00418028|6312643|P1|COMPLETED|Overall Study||95
2573780|NCT00418028|6312642|P2|STARTED|Overall Study||98
2573781|NCT00418028|6312643|P1|STARTED|Overall Study||97
2573782|NCT00418015|6312665|P4|NOT COMPLETED|Overall Study||0
2573783|NCT00418015|6312666|P3|NOT COMPLETED|Overall Study||0
2573784|NCT00418015|6312667|P2|NOT COMPLETED|Overall Study||0
2573785|NCT00418015|6312668|P1|NOT COMPLETED|Overall Study||0
2573786|NCT00418015|6312665|P4|COMPLETED|Overall Study||25
2573787|NCT00418015|6312666|P3|COMPLETED|Overall Study||78
2573788|NCT00418015|6312667|P2|COMPLETED|Overall Study||46
2573789|NCT00418015|6312668|P1|COMPLETED|Overall Study||144
2573790|NCT00418015|6312665|P4|STARTED|Overall Study||25
2573791|NCT00418015|6312666|P3|STARTED|Overall Study||78
2573792|NCT00418015|6312667|P2|STARTED|Overall Study||46
2573793|NCT00418015|6312668|P1|STARTED|Overall Study||144
2573794|NCT00417989|6312696|P2|NOT COMPLETED|Overall Study||22
2573795|NCT00417989|6312697|P1|NOT COMPLETED|Overall Study||20
2573796|NCT00417989|6312696|P2|COMPLETED|Overall Study||219
2573797|NCT00417989|6312697|P1|COMPLETED|Overall Study||224
2573798|NCT00417989|6312696|P2|STARTED|Overall Study||241
2573799|NCT00417989|6312697|P1|STARTED|Overall Study|Intent to Treat include safety population & subjects with baseline & 1 post baseline A1C measurement|244
2573800|NCT00417976|6312719|P1|NOT COMPLETED|Overall Study||3
2573801|NCT00417976|6312719|P1|COMPLETED|Overall Study||39
2573802|NCT00417976|6312719|P1|STARTED|Overall Study||42
2573803|NCT00417963|6312724|P1|NOT COMPLETED|Overall Study||41
2573804|NCT00417963|6312724|P1|COMPLETED|Overall Study|79 subjects completed in the roll-in cohort and 371 in the pivotal cohort.|445
2573805|NCT00417963|6312724|P1|STARTED|Overall Study|79 participants were enrolled in the roll-in cohort and 407 in the pivotal cohort.|486
2573806|NCT00417885|6312741|P1|NOT COMPLETED|Overall Study||6
2573807|NCT00417885|6312741|P1|COMPLETED|Overall Study||0
2573808|NCT00417885|6312741|P1|STARTED|Overall Study||6
2573809|NCT00417612|6312752|P2|NOT COMPLETED|Overall Study||3
2573810|NCT00417612|6312753|P1|NOT COMPLETED|Overall Study||3
2573811|NCT00417612|6312752|P2|COMPLETED|Overall Study||8
2573812|NCT00417612|6312753|P1|COMPLETED|Overall Study||19
2573813|NCT00417612|6312752|P2|STARTED|Overall Study||11
2573814|NCT00417612|6312753|P1|STARTED|Overall Study||22
2573815|NCT00417482|6312779|P3|NOT COMPLETED|Phase B 2nd 16 Weeks||3
2573816|NCT00417482|6312780|P2|NOT COMPLETED|Phase B 2nd 16 Weeks||13
2573817|NCT00417482|6312781|P1|NOT COMPLETED|Phase B 2nd 16 Weeks||3
2573818|NCT00417482|6312779|P3|COMPLETED|Phase B 2nd 16 Weeks||10
2573819|NCT00417482|6312780|P2|COMPLETED|Phase B 2nd 16 Weeks||14
2573820|NCT00417482|6312781|P1|COMPLETED|Phase B 2nd 16 Weeks||10
2573821|NCT00417482|6312779|P3|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|13
2573822|NCT00417482|6312780|P2|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|27
2573823|NCT00417482|6312781|P1|STARTED|Phase B 2nd 16 Weeks|Risperidone for 16 weeks.|13
2573824|NCT00417482|6312779|P3|NOT COMPLETED|Phase B 1st 16 Weeks||27
2573825|NCT00417482|6312780|P2|NOT COMPLETED|Phase B 1st 16 Weeks||11
2573826|NCT00417482|6312781|P1|NOT COMPLETED|Phase B 1st 16 Weeks||19
2573827|NCT00417482|6312779|P3|COMPLETED|Phase B 1st 16 Weeks||13
2573828|NCT00417482|6312780|P2|COMPLETED|Phase B 1st 16 Weeks||27
2573829|NCT00417482|6312781|P1|COMPLETED|Phase B 1st 16 Weeks||13
2573830|NCT00417482|6312779|P3|STARTED|Phase B 1st 16 Weeks|Placebo 16 weeks.|40
2573831|NCT00417482|6312780|P2|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|38
2573832|NCT00417482|6312781|P1|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|32
2573833|NCT00417417|6312807|P2|NOT COMPLETED|Overall Study||0
2573834|NCT00417417|6312808|P1|NOT COMPLETED|Overall Study||0
2573835|NCT00417417|6312807|P2|COMPLETED|Overall Study||6
2573836|NCT00417417|6312808|P1|COMPLETED|Overall Study||4
2573837|NCT00417417|6312807|P2|STARTED|Overall Study||6
2573838|NCT00417417|6312808|P1|STARTED|Overall Study||4
2573839|NCT00417274|6312816|P1|NOT COMPLETED|Overall Study||0
2573840|NCT00417274|6312816|P1|COMPLETED|Overall Study||31
2573841|NCT00417274|6312816|P1|STARTED|Overall Study||31
2573842|NCT00417248|6312820|P1|NOT COMPLETED|Overall Study||8
2573843|NCT00417248|6312820|P1|COMPLETED|Overall Study||0
2573844|NCT00417248|6312820|P1|STARTED|Overall Study||8
2573845|NCT00417170|6312827|P2|NOT COMPLETED|Overall Study||3
2573846|NCT00417170|6312828|P1|NOT COMPLETED|Overall Study||2
2573847|NCT00417170|6312827|P2|COMPLETED|Overall Study||22
2573848|NCT00417170|6312828|P1|COMPLETED|Overall Study||21
2573849|NCT00417170|6312827|P2|Pharmacodynamics Population|Overall Study||23
2573850|NCT00417170|6312828|P1|Pharmacodynamics Population|Overall Study||21
2573851|NCT00417170|6312827|P2|STARTED|Overall Study||25
2573852|NCT00417170|6312828|P1|STARTED|Overall Study|"Started indicates Safety population."|23
2573853|NCT00417079|6312844|P2|NOT COMPLETED|Overall Study||273
2573854|NCT00417079|6312845|P1|NOT COMPLETED|Overall Study||331
2573855|NCT00417079|6312844|P2|COMPLETED|Overall Study|Randomized patients|105
2573856|NCT00417079|6312845|P1|COMPLETED|Overall Study|Randomized patients|46
2573857|NCT00417079|6312844|P2|STARTED|Overall Study|Randomized patients|378
2573858|NCT00417079|6312845|P1|STARTED|Overall Study|Randomized patients|377
2573859|NCT00417027|6312868|P3|NOT COMPLETED|Overall Study||5
2573860|NCT00417027|6312869|P2|NOT COMPLETED|Overall Study||5
2573861|NCT00417027|6312870|P1|NOT COMPLETED|Overall Study||0
2573862|NCT00417027|6312868|P3|COMPLETED|Overall Study||54
2573863|NCT00417027|6312869|P2|COMPLETED|Overall Study||60
2573864|NCT00417027|6312870|P1|COMPLETED|Overall Study||66
2573865|NCT00417027|6312868|P3|STARTED|Overall Study||59
2573866|NCT00417027|6312869|P2|STARTED|Overall Study||65
2573867|NCT00417027|6312870|P1|STARTED|Overall Study||66
2573868|NCT00416949|6312896|P1|NOT COMPLETED|Overall Study||5
2573869|NCT00416949|6312896|P1|COMPLETED|Overall Study||4
2573870|NCT00416949|6312896|P1|STARTED|Overall Study||9
2573871|NCT00416884|6312900|P1|NOT COMPLETED|Overall Study||1
2573872|NCT00416884|6312900|P1|COMPLETED|Overall Study||0
2573873|NCT00416884|6312900|P1|STARTED|Overall Study||1
2573874|NCT00416793|6312904|P1|NOT COMPLETED|Overall Study||0
2573875|NCT00416793|6312904|P1|COMPLETED|Overall Study||9
2573876|NCT00416793|6312904|P1|STARTED|Overall Study||9
2573877|NCT00416715|6312909|P1|NOT COMPLETED|Overall Study||15
2573878|NCT00416715|6312909|P1|COMPLETED|Overall Study||85
2573879|NCT00416715|6312909|P1|STARTED|Overall Study||100
2573880|NCT00416624|6312920|P4|NOT COMPLETED|Overall Study||17
2573881|NCT00416624|6312921|P3|NOT COMPLETED|Overall Study||18
2573882|NCT00416624|6312922|P2|NOT COMPLETED|Overall Study||27
2573883|NCT00416624|6312923|P1|NOT COMPLETED|Overall Study||22
2573884|NCT00416624|6312920|P4|COMPLETED|Overall Study||40
2573885|NCT00416624|6312921|P3|COMPLETED|Overall Study||40
2573886|NCT00416624|6312922|P2|COMPLETED|Overall Study||33
2573887|NCT00416624|6312923|P1|COMPLETED|Overall Study||39
2573888|NCT00416624|6312920|P4|STARTED|Overall Study||57
2573889|NCT00416624|6312921|P3|STARTED|Overall Study||58
2573890|NCT00416624|6312922|P2|STARTED|Overall Study||60
2573891|NCT00416624|6312923|P1|STARTED|Overall Study||61
2573892|NCT00416598|6312977|P1|NOT COMPLETED|Decitabine Maintenance||72
2573893|NCT00416598|6312977|P1|COMPLETED|Decitabine Maintenance||62
2573894|NCT00416598|6312977|P1|STARTED|Decitabine Maintenance||134
2573895|NCT00416598|6312977|P1|NOT COMPLETED|Induction & Intensification||412
2573896|NCT00416598|6312977|P1|COMPLETED|Induction & Intensification||134
2573897|NCT00416598|6312977|P1|STARTED|Induction & Intensification||546
2573898|NCT00416572|6312985|P3|NOT COMPLETED|Overall Study||8
2573899|NCT00416572|6312986|P2|NOT COMPLETED|Overall Study||7
2573900|NCT00416572|6312987|P1|NOT COMPLETED|Overall Study||13
2573901|NCT00416572|6312985|P3|COMPLETED|Overall Study||76
2573902|NCT00416572|6312986|P2|COMPLETED|Overall Study||78
2573903|NCT00416572|6312987|P1|COMPLETED|Overall Study||70
2573904|NCT00416572|6312985|P3|STARTED|Overall Study||84
2573905|NCT00416572|6312986|P2|STARTED|Overall Study||85
2573906|NCT00416572|6312987|P1|STARTED|Overall Study||83
2573907|NCT00416520|6313003|P4|NOT COMPLETED|Placebo-controlled Withdrawal Period||5
2573908|NCT00416520|6313004|P3|NOT COMPLETED|Placebo-controlled Withdrawal Period||1
2573909|NCT00416520|6313005|P2|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
2573910|NCT00416520|6313006|P1|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
2573911|NCT00416520|6313003|P4|COMPLETED|Placebo-controlled Withdrawal Period||49
2573912|NCT00416520|6313004|P3|COMPLETED|Placebo-controlled Withdrawal Period||49
2573913|NCT00416520|6313005|P2|COMPLETED|Placebo-controlled Withdrawal Period||0
2573914|NCT00416520|6313006|P1|COMPLETED|Placebo-controlled Withdrawal Period||0
2573915|NCT00416520|6313003|P4|STARTED|Placebo-controlled Withdrawal Period||54
2573916|NCT00416520|6313004|P3|STARTED|Placebo-controlled Withdrawal Period||50
2573917|NCT00416520|6313005|P2|STARTED|Placebo-controlled Withdrawal Period||0
2573918|NCT00416520|6313006|P1|STARTED|Placebo-controlled Withdrawal Period||0
2573919|NCT00416520|6313003|P4|NOT COMPLETED|Open-label Period||0
2573920|NCT00416520|6313004|P3|NOT COMPLETED|Open-label Period||0
2573921|NCT00416520|6313005|P2|NOT COMPLETED|Open-label Period||32
2573922|NCT00416520|6313006|P1|NOT COMPLETED|Open-label Period||60
2573923|NCT00416520|6313003|P4|COMPLETED|Open-label Period||0
2573924|NCT00416520|6313004|P3|COMPLETED|Open-label Period||0
2573925|NCT00416520|6313005|P2|COMPLETED|Open-label Period||139
2573926|NCT00416520|6313006|P1|COMPLETED|Open-label Period||105
2573927|NCT00416520|6313003|P4|STARTED|Open-label Period||0
2573928|NCT00416520|6313004|P3|STARTED|Open-label Period||0
2573929|NCT00416520|6313005|P2|STARTED|Open-label Period||171
2573930|NCT00416520|6313006|P1|STARTED|Open-label Period||165
2573931|NCT00416494|6313018|P2|NOT COMPLETED|Overall Study||0
2573932|NCT00416494|6313019|P1|NOT COMPLETED|Overall Study||0
2573933|NCT00416494|6313018|P2|COMPLETED|Overall Study||31
2573934|NCT00416494|6313019|P1|COMPLETED|Overall Study||19
2573935|NCT00416494|6313018|P2|STARTED|Overall Study||31
2573936|NCT00416494|6313019|P1|STARTED|Overall Study||19
2573937|NCT00416455|6313035|P2|NOT COMPLETED|Overall Study||8
2573938|NCT00416455|6313036|P1|NOT COMPLETED|Overall Study||16
2573939|NCT00416455|6313035|P2|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|207
2573940|NCT00416455|6313036|P1|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|153
2573941|NCT00416455|6313035|P2|STARTED|Overall Study|This is a diagnostic imaging study.|215
2573942|NCT00416455|6313036|P1|STARTED|Overall Study|This is a diagnostic imaging study.|169
2573943|NCT00416312|6313071|P1|NOT COMPLETED|Overall Study||2
2573944|NCT00416312|6313071|P1|COMPLETED|Overall Study||7
2573945|NCT00416312|6313071|P1|Patient-specific Dosimetry|Overall Study||9
2573946|NCT00416312|6313071|P1|Conventional Dosimetry|Overall Study||9
2573947|NCT00416312|6313071|P1|STARTED|Overall Study||9
2573948|NCT00416195|6313077|P2|NOT COMPLETED|Overall Study||4
2573949|NCT00416195|6313078|P1|NOT COMPLETED|Overall Study||2
2573950|NCT00416195|6313077|P2|COMPLETED|Overall Study||34
2573951|NCT00416195|6313078|P1|COMPLETED|Overall Study||8
2573952|NCT00416195|6313077|P2|STARTED|Overall Study||38
2573953|NCT00416195|6313078|P1|STARTED|Overall Study||10
2573954|NCT00416182|6313088|P2|NOT COMPLETED|Overall Study||2
2573955|NCT00416182|6313089|P1|NOT COMPLETED|Overall Study||3
2573956|NCT00416182|6313088|P2|COMPLETED|Overall Study||6
2573957|NCT00416182|6313089|P1|COMPLETED|Overall Study||5
2573958|NCT00416182|6313088|P2|STARTED|Overall Study||8
2573959|NCT00416182|6313089|P1|STARTED|Overall Study||8
2573960|NCT00416078|6313103|P2|NOT COMPLETED|Overall Study||8
2573961|NCT00416078|6313104|P1|NOT COMPLETED|Overall Study||11
2573962|NCT00416078|6313103|P2|COMPLETED|Overall Study||16
2573963|NCT00416078|6313104|P1|COMPLETED|Overall Study||18
2573964|NCT00416078|6313103|P2|STARTED|Overall Study||24
2573965|NCT00416078|6313104|P1|STARTED|Overall Study||29
2573966|NCT00415909|6313120|P1|NOT COMPLETED|Overall Study||3
2573967|NCT00415909|6313120|P1|COMPLETED|Overall Study||0
2573968|NCT00415909|6313120|P1|STARTED|Overall Study||3
2573969|NCT00415870|6313126|P2|NOT COMPLETED|Overall Study||7
2573970|NCT00415870|6313127|P1|NOT COMPLETED|Overall Study||6
2573971|NCT00415870|6313126|P2|COMPLETED|Overall Study||26
2573972|NCT00415870|6313127|P1|COMPLETED|Overall Study||26
2573973|NCT00415870|6313126|P2|STARTED|Overall Study||33
2573974|NCT00415870|6313127|P1|STARTED|Overall Study||32
2573975|NCT00415857|6313139|P2|NOT COMPLETED|Overall Study||0
2573976|NCT00415857|6313140|P1|NOT COMPLETED|Overall Study||0
2573977|NCT00415857|6313139|P2|COMPLETED|Overall Study||3
2573978|NCT00415857|6313140|P1|COMPLETED|Overall Study||2
2573979|NCT00415857|6313139|P2|STARTED|Overall Study||3
2573980|NCT00415857|6313140|P1|STARTED|Overall Study||2
2573981|NCT00415636|6313154|P6|NOT COMPLETED|Overall Study||2
2573982|NCT00415636|6313155|P5|NOT COMPLETED|Overall Study||2
2573983|NCT00415636|6313156|P4|NOT COMPLETED|Overall Study||6
2573984|NCT00415636|6313157|P3|NOT COMPLETED|Overall Study||1
2573985|NCT00415636|6313158|P2|NOT COMPLETED|Overall Study||0
2573986|NCT00415636|6313159|P1|NOT COMPLETED|Overall Study||1
2573987|NCT00415636|6313154|P6|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|1
2573988|NCT00415636|6313155|P5|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|4
2573989|NCT00415636|6313156|P4|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|7
2573990|NCT00415636|6313157|P3|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|2
2573991|NCT00415636|6313158|P2|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|3
2573992|NCT00415636|6313159|P1|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|2
2573993|NCT00415636|6313154|P6|STARTED|Overall Study||3
2573994|NCT00415636|6313155|P5|STARTED|Overall Study||6
2573995|NCT00415636|6313156|P4|STARTED|Overall Study||13
2573996|NCT00415636|6313157|P3|STARTED|Overall Study||3
2573997|NCT00415636|6313158|P2|STARTED|Overall Study||3
2573998|NCT00415636|6313159|P1|STARTED|Overall Study||3
2573999|NCT00415623|6313193|P2|NOT COMPLETED|Overall Study||5
2574000|NCT00415623|6313194|P1|NOT COMPLETED|Overall Study||5
2574001|NCT00415623|6313193|P2|COMPLETED|Overall Study||146
2574002|NCT00415623|6313194|P1|COMPLETED|Overall Study||149
2574003|NCT00415623|6313193|P2|STARTED|Overall Study||151
2574004|NCT00415623|6313194|P1|STARTED|Overall Study||154
2574005|NCT00415610|6313221|P3|NOT COMPLETED|Overall Study||5
2574006|NCT00415610|6313222|P2|NOT COMPLETED|Overall Study||2
2574007|NCT00415610|6313223|P1|NOT COMPLETED|Overall Study||3
2574008|NCT00415610|6313221|P3|COMPLETED|Overall Study||17
2574009|NCT00415610|6313222|P2|COMPLETED|Overall Study||18
2574010|NCT00415610|6313223|P1|COMPLETED|Overall Study||15
2574011|NCT00415610|6313221|P3|STARTED|Overall Study||22
2574012|NCT00415610|6313222|P2|STARTED|Overall Study||20
2574013|NCT00415610|6313223|P1|STARTED|Overall Study||18
2574014|NCT00415597|6313243|P1|NOT COMPLETED|Treatment||305
2574015|NCT00415597|6313243|P1|COMPLETED|Treatment||160
2574016|NCT00415597|6313243|P1|STARTED|Treatment||465
2574017|NCT00415597|6313243|P1|NOT COMPLETED|Enrollment||2
2574018|NCT00415597|6313243|P1|COMPLETED|Enrollment||465
2574019|NCT00415597|6313243|P1|STARTED|Enrollment||467
2574020|NCT00415532|6313251|P2|NOT COMPLETED|Safety Follow Up Period||12
2574021|NCT00415532|6313252|P1|NOT COMPLETED|Safety Follow Up Period||9
2574022|NCT00415532|6313251|P2|COMPLETED|Safety Follow Up Period||18
2574023|NCT00415532|6313252|P1|COMPLETED|Safety Follow Up Period||34
2574024|NCT00415532|6313251|P2|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|30
2574025|NCT00415532|6313252|P1|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|43
2574026|NCT00415532|6313251|P2|NOT COMPLETED|Treatment Period||15
2574027|NCT00415532|6313252|P1|NOT COMPLETED|Treatment Period||17
2574028|NCT00415532|6313251|P2|COMPLETED|Treatment Period||142
2574029|NCT00415532|6313252|P1|COMPLETED|Treatment Period||60
2574030|NCT00415532|6313251|P2|Switched to Romiplostim Group|Treatment Period||0
2574031|NCT00415532|6313252|P1|Switched to Romiplostim Group|Treatment Period||2
2574032|NCT00415532|6313251|P2|Received Treatment|Treatment Period||154
2574033|NCT00415532|6313252|P1|Received Treatment|Treatment Period||75
2574034|NCT00415532|6313251|P2|STARTED|Treatment Period||157
2574035|NCT00415532|6313252|P1|STARTED|Treatment Period||77
2574036|NCT00415519|6313274|P2|NOT COMPLETED|Overall Study||0
2574037|NCT00415519|6313275|P1|NOT COMPLETED|Overall Study||4
2574038|NCT00415519|6313274|P2|COMPLETED|Overall Study||12
2574039|NCT00415519|6313275|P1|COMPLETED|Overall Study||9
2574040|NCT00415519|6313274|P2|STARTED|Overall Study||12
2574041|NCT00415519|6313275|P1|STARTED|Overall Study||13
2574042|NCT00415506|6313295|P2|NOT COMPLETED|Overall Study||1
2574043|NCT00415506|6313296|P1|NOT COMPLETED|Overall Study||3
2574044|NCT00415506|6313295|P2|COMPLETED|Overall Study||9
2574045|NCT00415506|6313296|P1|COMPLETED|Overall Study||9
2574046|NCT00415506|6313295|P2|STARTED|Overall Study||10
2574047|NCT00415506|6313296|P1|STARTED|Overall Study||12
2574048|NCT00415493|6313306|P2|NOT COMPLETED|Overall Study||0
2574049|NCT00415493|6313307|P1|NOT COMPLETED|Overall Study||0
2574050|NCT00415493|6313306|P2|COMPLETED|Overall Study||12
2574051|NCT00415493|6313307|P1|COMPLETED|Overall Study||12
2574052|NCT00415493|6313306|P2|STARTED|Overall Study||12
2574053|NCT00415493|6313307|P1|STARTED|Overall Study||12
2574054|NCT00415194|6313315|P2|NOT COMPLETED|Overall Study||342
2574055|NCT00415194|6313316|P1|NOT COMPLETED|Overall Study||328
2574056|NCT00415194|6313315|P2|COMPLETED|Overall Study||55
2574057|NCT00415194|6313316|P1|COMPLETED|Overall Study||70
2574058|NCT00415194|6313315|P2|Received at Least 1 Dose of Study Drug|Overall Study||385
2574059|NCT00415194|6313316|P1|Received at Least 1 Dose of Study Drug|Overall Study||392
2574060|NCT00415194|6313315|P2|STARTED|Overall Study||397
2574061|NCT00415194|6313316|P1|STARTED|Overall Study||398
2574062|NCT00415168|6313332|P1|NOT COMPLETED|Overall Study||52
2574063|NCT00415168|6313332|P1|COMPLETED|Overall Study||1
2574064|NCT00415168|6313332|P1|Completed Treatment|Overall Study||15
2574065|NCT00415168|6313332|P1|STARTED|Overall Study||53
2574066|NCT00415051|6313342|P1|NOT COMPLETED|Overall Study||1
2574067|NCT00415051|6313342|P1|COMPLETED|Overall Study||19
2574068|NCT00415051|6313342|P1|STARTED|Overall Study||20
2574069|NCT00414973|6313353|P4|NOT COMPLETED|Overall Study||0
2574070|NCT00414973|6313354|P3|NOT COMPLETED|Overall Study||3
2574071|NCT00414973|6313355|P2|NOT COMPLETED|Overall Study||10
2574072|NCT00414973|6313356|P1|NOT COMPLETED|Overall Study||28
2574073|NCT00414973|6313353|P4|COMPLETED|Overall Study||11
2574074|NCT00414973|6313354|P3|COMPLETED|Overall Study||21
2574075|NCT00414973|6313355|P2|COMPLETED|Overall Study||99
2574076|NCT00414973|6313356|P1|COMPLETED|Overall Study||190
2574077|NCT00414973|6313353|P4|STARTED|Overall Study||11
2574078|NCT00414973|6313354|P3|STARTED|Overall Study||24
2574079|NCT00414973|6313355|P2|STARTED|Overall Study||109
2574080|NCT00414973|6313356|P1|STARTED|Overall Study||218
2574081|NCT00414908|6313376|P2|NOT COMPLETED|Overall Study||1
2574082|NCT00414908|6313377|P1|NOT COMPLETED|Overall Study||1
2574083|NCT00414908|6313376|P2|COMPLETED|Overall Study||28
2574084|NCT00414908|6313377|P1|COMPLETED|Overall Study||24
2574085|NCT00414908|6313376|P2|STARTED|Overall Study||29
2574086|NCT00414908|6313377|P1|STARTED|Overall Study||25
2574087|NCT00414817|6313401|P2|NOT COMPLETED|Overall Study||3016
2574088|NCT00414817|6313402|P1|NOT COMPLETED|Overall Study||3130
2574089|NCT00414817|6313401|P2|COMPLETED|Overall Study|Qualified for primary analysis (3260 prior ICS users) or secondary analysis (755 new users) samples.|4015
2574090|NCT00414817|6313402|P1|COMPLETED|Overall Study|Qualified for primary analysis (3171 prior ICS users) or secondary analysis (732 new users) samples.|3903
2574091|NCT00414817|6313401|P2|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|184
2574092|NCT00414817|6313402|P1|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|175
2574093|NCT00414817|6313401|P2|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|123
2574094|NCT00414817|6313402|P1|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|117
2574095|NCT00414817|6313401|P2|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|900
2574096|NCT00414817|6313402|P1|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|922
2574097|NCT00414817|6313401|P2|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|417
2574098|NCT00414817|6313402|P1|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|451
2574190|NCT00414440|6313625|P1|COMPLETED|Extension Period|Extension|64
2574099|NCT00414817|6313401|P2|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1392
2574100|NCT00414817|6313402|P1|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1465
2574101|NCT00414817|6313401|P2|STARTED|Overall Study||7031
2574102|NCT00414817|6313402|P1|STARTED|Overall Study||7033
2574103|NCT00414726|6313414|P2|NOT COMPLETED|Overall Study||1
2574104|NCT00414726|6313415|P1|NOT COMPLETED|Overall Study||0
2574105|NCT00414726|6313414|P2|COMPLETED|Overall Study||41
2574106|NCT00414726|6313415|P1|COMPLETED|Overall Study||43
2574107|NCT00414726|6313414|P2|STARTED|Overall Study||42
2574108|NCT00414726|6313415|P1|STARTED|Overall Study||43
2574109|NCT00414700|6313425|P2|NOT COMPLETED|Overall Study||3
2574110|NCT00414700|6313426|P1|NOT COMPLETED|Overall Study||6
2574111|NCT00414700|6313425|P2|COMPLETED|Overall Study||58
2574112|NCT00414700|6313426|P1|COMPLETED|Overall Study||51
2574113|NCT00414700|6313425|P2|STARTED|Overall Study||61
2574114|NCT00414700|6313426|P1|STARTED|Overall Study||57
2574115|NCT00414661|6313450|P4|NOT COMPLETED|Overall Study||3
2574116|NCT00414661|6313451|P3|NOT COMPLETED|Overall Study||2
2574117|NCT00414661|6313452|P2|NOT COMPLETED|Overall Study||14
2574118|NCT00414661|6313453|P1|NOT COMPLETED|Overall Study||14
2574119|NCT00414661|6313450|P4|COMPLETED|Overall Study||0
2574120|NCT00414661|6313451|P3|COMPLETED|Overall Study||20
2574121|NCT00414661|6313452|P2|COMPLETED|Overall Study||75
2574122|NCT00414661|6313453|P1|COMPLETED|Overall Study||34
2574123|NCT00414661|6313450|P4|STARTED|Overall Study||3
2574124|NCT00414661|6313451|P3|STARTED|Overall Study||22
2574125|NCT00414661|6313452|P2|STARTED|Overall Study||89
2574126|NCT00414661|6313453|P1|STARTED|Overall Study||48
2574127|NCT00414635|6313477|P2|NOT COMPLETED|Overall Study||2
2574128|NCT00414635|6313478|P1|NOT COMPLETED|Overall Study||5
2574129|NCT00414635|6313477|P2|COMPLETED|Overall Study||28
2574130|NCT00414635|6313478|P1|COMPLETED|Overall Study||25
2574131|NCT00414635|6313477|P2|STARTED|Overall Study||30
2574132|NCT00414635|6313478|P1|STARTED|Overall Study||30
2574133|NCT00414609|6313498|P3|NOT COMPLETED|Extension Study||57
2574134|NCT00414609|6313499|P2|NOT COMPLETED|Extension Study||0
2574135|NCT00414609|6313500|P1|NOT COMPLETED|Extension Study||0
2574136|NCT00414609|6313498|P3|COMPLETED|Extension Study||365
2574137|NCT00414609|6313499|P2|COMPLETED|Extension Study||0
2574138|NCT00414609|6313500|P1|COMPLETED|Extension Study||0
2574139|NCT00414609|6313498|P3|Echocardiogram (ECHO) Analysis Set|Extension Study||400
2574140|NCT00414609|6313499|P2|Echocardiogram (ECHO) Analysis Set|Extension Study||0
2574141|NCT00414609|6313500|P1|Echocardiogram (ECHO) Analysis Set|Extension Study||0
2574142|NCT00414609|6313498|P3|STARTED|Extension Study|Patients of both core arms who completed core study and signed informed consent form for extension.|422
2574143|NCT00414609|6313499|P2|STARTED|Extension Study||0
2574144|NCT00414609|6313500|P1|STARTED|Extension Study||0
2574145|NCT00414609|6313498|P3|NOT COMPLETED|Core Study||0
2574146|NCT00414609|6313499|P2|NOT COMPLETED|Core Study||45
2574147|NCT00414609|6313500|P1|NOT COMPLETED|Core Study||34
2574148|NCT00414609|6313498|P3|COMPLETED|Core Study||0
2574149|NCT00414609|6313499|P2|COMPLETED|Core Study||378
2574150|NCT00414609|6313500|P1|COMPLETED|Core Study||363
2574151|NCT00414609|6313498|P3|Echocardiogram Evaluable Set|Core Study||0
2574152|NCT00414609|6313499|P2|Echocardiogram Evaluable Set|Core Study||343
2574153|NCT00414609|6313500|P1|Echocardiogram Evaluable Set|Core Study||330
2574154|NCT00414609|6313498|P3|Received Study Drug|Core Study||0
2574155|NCT00414609|6313499|P2|Received Study Drug|Core Study||422
2574156|NCT00414609|6313500|P1|Received Study Drug|Core Study||397
2574157|NCT00414609|6313498|P3|STARTED|Core Study||0
2574158|NCT00414609|6313499|P2|STARTED|Core Study||423
2574159|NCT00414609|6313500|P1|STARTED|Core Study||397
2574160|NCT00414596|6313523|P1|NOT COMPLETED|Overall Study||2
2574161|NCT00414596|6313523|P1|COMPLETED|Overall Study|April 2007|18
2574162|NCT00414596|6313523|P1|STARTED|Overall Study|December 2006|20
2574163|NCT00414544|6313532|P1|NOT COMPLETED|Overall Study||14
2574164|NCT00414544|6313532|P1|COMPLETED|Overall Study||131
2574165|NCT00414544|6313532|P1|STARTED|Overall Study||145
2574166|NCT00414518|6313540|P2|NOT COMPLETED|Overall Study||0
2574167|NCT00414518|6313541|P1|NOT COMPLETED|Overall Study||0
2574168|NCT00414518|6313540|P2|COMPLETED|Overall Study||9
2574169|NCT00414518|6313541|P1|COMPLETED|Overall Study||7
2574170|NCT00414518|6313540|P2|STARTED|Overall Study||9
2574171|NCT00414518|6313541|P1|STARTED|Overall Study||7
2574172|NCT00414466|6313555|P4|NOT COMPLETED|Overall Study||1
2574173|NCT00414466|6313556|P3|NOT COMPLETED|Overall Study||1
2574174|NCT00414466|6313557|P2|NOT COMPLETED|Overall Study||0
2574175|NCT00414466|6313558|P1|NOT COMPLETED|Overall Study||2
2574176|NCT00414466|6313555|P4|COMPLETED|Overall Study||42
2574177|NCT00414466|6313556|P3|COMPLETED|Overall Study||40
2574178|NCT00414466|6313557|P2|COMPLETED|Overall Study||42
2574179|NCT00414466|6313558|P1|COMPLETED|Overall Study||42
2574180|NCT00414466|6313555|P4|STARTED|Overall Study||43
2574181|NCT00414466|6313556|P3|STARTED|Overall Study||41
2574182|NCT00414466|6313557|P2|STARTED|Overall Study||42
2574183|NCT00414466|6313558|P1|STARTED|Overall Study||44
2574184|NCT00414453|6313576|P1|NOT COMPLETED|Overall Study||16
2574185|NCT00414453|6313576|P1|COMPLETED|Overall Study||3
2574186|NCT00414453|6313576|P1|STARTED|Overall Study||19
2574187|NCT00414440|6313624|P2|NOT COMPLETED|Extension Period||140
2574188|NCT00414440|6313625|P1|NOT COMPLETED|Extension Period||150
2574189|NCT00414440|6313624|P2|COMPLETED|Extension Period|Extension|77
2574191|NCT00414440|6313624|P2|STARTED|Extension Period|Extension|217
2574192|NCT00414440|6313625|P1|STARTED|Extension Period|Extension|214
2574193|NCT00414440|6313624|P2|NOT COMPLETED|Core Period||32
2574194|NCT00414440|6313625|P1|NOT COMPLETED|Core Period||70
2574195|NCT00414440|6313624|P2|COMPLETED|Core Period|Core period|185
2574196|NCT00414440|6313625|P1|COMPLETED|Core Period|Core period|144
2574197|NCT00414440|6313624|P2|STARTED|Core Period|Core period|217
2574198|NCT00414440|6313625|P1|STARTED|Core Period|Core period|214
2574199|NCT00414388|6313639|P1|NOT COMPLETED|Overall Study||1
2574200|NCT00414388|6313639|P1|COMPLETED|Overall Study||21
2574201|NCT00414388|6313639|P1|STARTED|Overall Study||22
2574202|NCT00414310|6313647|P2|NOT COMPLETED|Overall Study||0
2574203|NCT00414310|6313648|P1|NOT COMPLETED|Overall Study||1
2574204|NCT00414310|6313647|P2|COMPLETED|Overall Study||79
2574205|NCT00414310|6313648|P1|COMPLETED|Overall Study||70
2574206|NCT00414310|6313647|P2|STARTED|Overall Study||79
2574207|NCT00414310|6313648|P1|STARTED|Overall Study||71
2574208|NCT00414271|6313658|P1|NOT COMPLETED|Overall Study||0
2574209|NCT00414271|6313658|P1|COMPLETED|Overall Study||18
2574210|NCT00414271|6313658|P1|STARTED|Overall Study||18
2574211|NCT00414206|6313669|P3|NOT COMPLETED|Overall Study||55
2574212|NCT00414206|6313670|P2|NOT COMPLETED|Overall Study||56
2574213|NCT00414206|6313671|P1|NOT COMPLETED|Overall Study||58
2574214|NCT00414206|6313669|P3|COMPLETED|Overall Study||59
2574215|NCT00414206|6313670|P2|COMPLETED|Overall Study||58
2574216|NCT00414206|6313671|P1|COMPLETED|Overall Study||57
2574217|NCT00414206|6313669|P3|STARTED|Overall Study||114
2574218|NCT00414206|6313670|P2|STARTED|Overall Study||114
2574219|NCT00414206|6313671|P1|STARTED|Overall Study||115
2574220|NCT00414167|6313681|P2|NOT COMPLETED|Overall Study||3
2574221|NCT00414167|6313682|P1|NOT COMPLETED|Overall Study||4
2574222|NCT00414167|6313681|P2|COMPLETED|Overall Study||27
2574223|NCT00414167|6313682|P1|COMPLETED|Overall Study||27
2574224|NCT00414167|6313681|P2|STARTED|Overall Study||30
2574225|NCT00414167|6313682|P1|STARTED|Overall Study||31
2574226|NCT00414076|6313692|P2|NOT COMPLETED|Overall Study||5
2574227|NCT00414076|6313693|P1|NOT COMPLETED|Overall Study||3
2574228|NCT00414076|6313692|P2|COMPLETED|Overall Study||0
2574229|NCT00414076|6313693|P1|COMPLETED|Overall Study||1
2574230|NCT00414076|6313692|P2|STARTED|Overall Study||5
2574231|NCT00414076|6313693|P1|STARTED|Overall Study||4
2574232|NCT00414050|6313703|P4|NOT COMPLETED|Overall Study||8
2574233|NCT00414050|6313704|P3|NOT COMPLETED|Overall Study||6
2574234|NCT00414050|6313705|P2|NOT COMPLETED|Overall Study||8
2574235|NCT00414050|6313706|P1|NOT COMPLETED|Overall Study||9
2574236|NCT00414050|6313703|P4|COMPLETED|Overall Study||423
2574237|NCT00414050|6313704|P3|COMPLETED|Overall Study||423
2574238|NCT00414050|6313705|P2|COMPLETED|Overall Study||419
2574239|NCT00414050|6313706|P1|COMPLETED|Overall Study||422
2574240|NCT00414050|6313703|P4|Received Vaccination 3|Overall Study||424
2574241|NCT00414050|6313704|P3|Received Vaccination 3|Overall Study||425
2574242|NCT00414050|6313705|P2|Received Vaccination 3|Overall Study||419
2574243|NCT00414050|6313706|P1|Received Vaccination 3|Overall Study||424
2574244|NCT00414050|6313703|P4|Received Vaccination 2|Overall Study||425
2574245|NCT00414050|6313704|P3|Received Vaccination 2|Overall Study||425
2574246|NCT00414050|6313705|P2|Received Vaccination 2|Overall Study||421
2574247|NCT00414050|6313706|P1|Received Vaccination 2|Overall Study||425
2574248|NCT00414050|6313703|P4|Received Vaccination 1|Overall Study||431
2574249|NCT00414050|6313704|P3|Received Vaccination 1|Overall Study||429
2574250|NCT00414050|6313705|P2|Received Vaccination 1|Overall Study||426
2574251|NCT00414050|6313706|P1|Received Vaccination 1|Overall Study||431
2574252|NCT00414050|6313703|P4|STARTED|Overall Study||431
2574253|NCT00414050|6313704|P3|STARTED|Overall Study||429
2574254|NCT00414050|6313705|P2|STARTED|Overall Study||427
2574255|NCT00414050|6313706|P1|STARTED|Overall Study||431
2574256|NCT00414011|6313720|P1|NOT COMPLETED|Overall Study||5
2574257|NCT00414011|6313720|P1|COMPLETED|Overall Study||35
2574258|NCT00414011|6313720|P1|STARTED|Overall Study||40
2574259|NCT00413972|6313729|P4|NOT COMPLETED|Overall Study||3
2574260|NCT00413972|6313730|P3|NOT COMPLETED|Overall Study||10
2574261|NCT00413972|6313731|P2|NOT COMPLETED|Overall Study||8
2574262|NCT00413972|6313732|P1|NOT COMPLETED|Overall Study||7
2574263|NCT00413972|6313729|P4|COMPLETED|Overall Study||95
2574264|NCT00413972|6313730|P3|COMPLETED|Overall Study||88
2574265|NCT00413972|6313731|P2|COMPLETED|Overall Study||90
2574266|NCT00413972|6313732|P1|COMPLETED|Overall Study||91
2574267|NCT00413972|6313729|P4|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
2574268|NCT00413972|6313730|P3|STARTED|Overall Study||98
2574269|NCT00413972|6313731|P2|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
2574270|NCT00413972|6313732|P1|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
2574271|NCT00413959|6313742|P1|NOT COMPLETED|Overall Study||1
2574272|NCT00413959|6313742|P1|COMPLETED|Overall Study||11
2574273|NCT00413959|6313742|P1|STARTED|Overall Study||12
2574274|NCT00413920|6313749|P2|NOT COMPLETED|Overall Study||28
2574275|NCT00413920|6313750|P1|NOT COMPLETED|Overall Study||28
2574276|NCT00413920|6313749|P2|COMPLETED|Overall Study||82
2574277|NCT00413920|6313750|P1|COMPLETED|Overall Study||84
2574278|NCT00413920|6313749|P2|STARTED|Overall Study||110
2574279|NCT00413920|6313750|P1|STARTED|Overall Study||112
2574280|NCT00413894|6313765|P1|NOT COMPLETED|Overall Study||80
2574281|NCT00413894|6313765|P1|COMPLETED|Overall Study||344
2574282|NCT00413894|6313765|P1|STARTED|Overall Study||424
2574283|NCT00413777|6313782|P2|NOT COMPLETED|Extension Period||0
2574284|NCT00413777|6313783|P1|NOT COMPLETED|Extension Period||0
2574285|NCT00413777|6313782|P2|COMPLETED|Extension Period||18
2574286|NCT00413777|6313783|P1|COMPLETED|Extension Period||17
2574287|NCT00413777|6313782|P2|STARTED|Extension Period||18
2574288|NCT00413777|6313783|P1|STARTED|Extension Period||17
2574289|NCT00413777|6313782|P2|NOT COMPLETED|Fixed-dose Period||3
2574290|NCT00413777|6313783|P1|NOT COMPLETED|Fixed-dose Period||4
2574291|NCT00413777|6313782|P2|COMPLETED|Fixed-dose Period||21
2574292|NCT00413777|6313783|P1|COMPLETED|Fixed-dose Period||18
2574293|NCT00413777|6313782|P2|STARTED|Fixed-dose Period||24
2574294|NCT00413777|6313783|P1|STARTED|Fixed-dose Period||22
2574295|NCT00413699|6313831|P3|NOT COMPLETED|Extension Period||5
2574296|NCT00413699|6313832|P2|NOT COMPLETED|Extension Period||0
2574297|NCT00413699|6313833|P1|NOT COMPLETED|Extension Period||0
2574298|NCT00413699|6313831|P3|COMPLETED|Extension Period||43
2574299|NCT00413699|6313832|P2|COMPLETED|Extension Period||0
2574300|NCT00413699|6313833|P1|COMPLETED|Extension Period||0
2574301|NCT00413699|6313831|P3|STARTED|Extension Period||48
2574302|NCT00413699|6313832|P2|STARTED|Extension Period||0
2574303|NCT00413699|6313833|P1|STARTED|Extension Period||0
2574304|NCT00413699|6313831|P3|NOT COMPLETED|Initial Period||0
2574305|NCT00413699|6313832|P2|NOT COMPLETED|Initial Period||1705
2574306|NCT00413699|6313833|P1|NOT COMPLETED|Initial Period||639
2574307|NCT00413699|6313831|P3|COMPLETED|Initial Period||0
2574308|NCT00413699|6313832|P2|COMPLETED|Initial Period||1653
2574309|NCT00413699|6313833|P1|COMPLETED|Initial Period||484
2574310|NCT00413699|6313831|P3|STARTED|Initial Period||0
2574311|NCT00413699|6313832|P2|STARTED|Initial Period||3358
2574312|NCT00413699|6313833|P1|STARTED|Initial Period||1123
2574313|NCT00413660|6313915|P11|NOT COMPLETED|Post Week 12||1
2574314|NCT00413660|6313916|P10|NOT COMPLETED|Post Week 12||1
2574315|NCT00413660|6313917|P9|NOT COMPLETED|Post Week 12||0
2574316|NCT00413660|6313918|P8|NOT COMPLETED|Post Week 12||0
2574317|NCT00413660|6313919|P7|NOT COMPLETED|Post Week 12||3
2574318|NCT00413660|6313920|P6|NOT COMPLETED|Post Week 12||3
2574319|NCT00413660|6313921|P5|NOT COMPLETED|Post Week 12||6
2574320|NCT00413660|6313922|P4|NOT COMPLETED|Post Week 12||1
2574321|NCT00413660|6313923|P3|NOT COMPLETED|Post Week 12||8
2574322|NCT00413660|6313924|P2|NOT COMPLETED|Post Week 12||4
2574323|NCT00413660|6313925|P1|NOT COMPLETED|Post Week 12||3
2574324|NCT00413660|6313915|P11|COMPLETED|Post Week 12||17
2574325|NCT00413660|6313916|P10|COMPLETED|Post Week 12||12
2574326|NCT00413660|6313917|P9|COMPLETED|Post Week 12||13
2574327|NCT00413660|6313918|P8|COMPLETED|Post Week 12||21
2574328|NCT00413660|6313919|P7|COMPLETED|Post Week 12||37
2574329|NCT00413660|6313920|P6|COMPLETED|Post Week 12||54
2574330|NCT00413660|6313921|P5|COMPLETED|Post Week 12||60
2574331|NCT00413660|6313922|P4|COMPLETED|Post Week 12||66
2574332|NCT00413660|6313923|P3|COMPLETED|Post Week 12||56
2574333|NCT00413660|6313924|P2|COMPLETED|Post Week 12||44
2574334|NCT00413660|6313925|P1|COMPLETED|Post Week 12||40
2574335|NCT00413660|6313915|P11|STARTED|Post Week 12||18
2574336|NCT00413660|6313916|P10|STARTED|Post Week 12||13
2574337|NCT00413660|6313917|P9|STARTED|Post Week 12||13
2574338|NCT00413660|6313918|P8|STARTED|Post Week 12||21
2574339|NCT00413660|6313919|P7|STARTED|Post Week 12||40
2574340|NCT00413660|6313920|P6|STARTED|Post Week 12||57
2574341|NCT00413660|6313921|P5|STARTED|Post Week 12||66
2574342|NCT00413660|6313922|P4|STARTED|Post Week 12||67
2574343|NCT00413660|6313923|P3|STARTED|Post Week 12||64
2574344|NCT00413660|6313924|P2|STARTED|Post Week 12||48
2574345|NCT00413660|6313925|P1|STARTED|Post Week 12||43
2574346|NCT00413660|6313915|P11|NOT COMPLETED|Up To Week 12||0
2574347|NCT00413660|6313916|P10|NOT COMPLETED|Up To Week 12||0
2574348|NCT00413660|6313917|P9|NOT COMPLETED|Up To Week 12||0
2574349|NCT00413660|6313918|P8|NOT COMPLETED|Up To Week 12||0
2574350|NCT00413660|6313919|P7|NOT COMPLETED|Up To Week 12||11
2574351|NCT00413660|6313920|P6|NOT COMPLETED|Up To Week 12||10
2574352|NCT00413660|6313921|P5|NOT COMPLETED|Up To Week 12||9
2574353|NCT00413660|6313922|P4|NOT COMPLETED|Up To Week 12||8
2574354|NCT00413660|6313923|P3|NOT COMPLETED|Up To Week 12||7
2574355|NCT00413660|6313924|P2|NOT COMPLETED|Up To Week 12||7
2574356|NCT00413660|6313925|P1|NOT COMPLETED|Up To Week 12||7
2574357|NCT00413660|6313915|P11|COMPLETED|Up To Week 12||0
2574358|NCT00413660|6313916|P10|COMPLETED|Up To Week 12||0
2574359|NCT00413660|6313917|P9|COMPLETED|Up To Week 12||0
2574360|NCT00413660|6313918|P8|COMPLETED|Up To Week 12||0
2574361|NCT00413660|6313919|P7|COMPLETED|Up To Week 12||58
2574362|NCT00413660|6313920|P6|COMPLETED|Up To Week 12||70
2574363|NCT00413660|6313921|P5|COMPLETED|Up To Week 12||66
2574364|NCT00413660|6313922|P4|COMPLETED|Up To Week 12||67
2574365|NCT00413660|6313923|P3|COMPLETED|Up To Week 12||64
2574366|NCT00413660|6313924|P2|COMPLETED|Up To Week 12||61
2574367|NCT00413660|6313925|P1|COMPLETED|Up To Week 12||64
2574368|NCT00413660|6313915|P11|Treated|Up To Week 12||0
2574369|NCT00413660|6313916|P10|Treated|Up To Week 12||0
2574370|NCT00413660|6313917|P9|Treated|Up To Week 12||0
2574371|NCT00413660|6313918|P8|Treated|Up To Week 12||0
2574372|NCT00413660|6313919|P7|Treated|Up To Week 12||69
2574373|NCT00413660|6313920|P6|Treated|Up To Week 12||80
2574374|NCT00413660|6313921|P5|Treated|Up To Week 12||75
2574375|NCT00413660|6313922|P4|Treated|Up To Week 12||74
2574376|NCT00413660|6313923|P3|Treated|Up To Week 12||71
2574377|NCT00413660|6313924|P2|Treated|Up To Week 12||68
2574378|NCT00413660|6313925|P1|Treated|Up To Week 12||70
2574379|NCT00413660|6313915|P11|STARTED|Up To Week 12||0
2574380|NCT00413660|6313916|P10|STARTED|Up To Week 12||0
2574381|NCT00413660|6313917|P9|STARTED|Up To Week 12||0
2574382|NCT00413660|6313918|P8|STARTED|Up To Week 12||0
2574383|NCT00413660|6313919|P7|STARTED|Up To Week 12||69
2574384|NCT00413660|6313920|P6|STARTED|Up To Week 12||80
2574385|NCT00413660|6313921|P5|STARTED|Up To Week 12||75
2574386|NCT00413660|6313922|P4|STARTED|Up To Week 12||75
2574387|NCT00413660|6313923|P3|STARTED|Up To Week 12||71
2574388|NCT00413660|6313924|P2|STARTED|Up To Week 12||68
2574389|NCT00413660|6313925|P1|STARTED|Up To Week 12||71
2574390|NCT00413634|6314273|P2|NOT COMPLETED|Overall Study||0
2574391|NCT00413634|6314274|P1|NOT COMPLETED|Overall Study||0
2574392|NCT00413634|6314273|P2|COMPLETED|Overall Study||12
2574393|NCT00413634|6314274|P1|COMPLETED|Overall Study||12
2574394|NCT00413634|6314273|P2|STARTED|Overall Study||12
2574395|NCT00413634|6314274|P1|STARTED|Overall Study||12
2574396|NCT00413582|6314312|P2|NOT COMPLETED|Overall Study||0
2574397|NCT00413582|6314313|P1|NOT COMPLETED|Overall Study||0
2574398|NCT00413582|6314312|P2|COMPLETED|Overall Study|all enrolled completed|55
2574399|NCT00413582|6314313|P1|COMPLETED|Overall Study|all enrolled completed|55
2574400|NCT00413582|6314312|P2|Completion of Study|Overall Study|all enrolled completed|55
2574401|NCT00413582|6314313|P1|Completion of Study|Overall Study|all enrolled completed|55
2574402|NCT00413582|6314312|P2|STARTED|Overall Study|all enrolled completed|55
2574403|NCT00413582|6314313|P1|STARTED|Overall Study|all enrolled completed|55
2574404|NCT00413478|6314321|P1|NOT COMPLETED|Overall Study||0
2574405|NCT00413478|6314321|P1|COMPLETED|Overall Study||9
2574406|NCT00413478|6314321|P1|STARTED|Overall Study||9
2574407|NCT00413413|6314328|P3|NOT COMPLETED|Double-Blind||18
2574408|NCT00413413|6314329|P2|NOT COMPLETED|Double-Blind||14
2574409|NCT00413413|6314330|P1|NOT COMPLETED|Double-Blind||15
2574410|NCT00413413|6314328|P3|COMPLETED|Double-Blind||285
2574411|NCT00413413|6314329|P2|COMPLETED|Double-Blind||293
2574412|NCT00413413|6314330|P1|COMPLETED|Double-Blind||293
2574413|NCT00413413|6314328|P3|STARTED|Double-Blind||303
2574414|NCT00413413|6314329|P2|STARTED|Double-Blind||307
2574415|NCT00413413|6314330|P1|STARTED|Double-Blind||308
2574416|NCT00413413|6314328|P3|NOT COMPLETED|Single-Blind||0
2574417|NCT00413413|6314329|P2|NOT COMPLETED|Single-Blind||216
2574418|NCT00413413|6314330|P1|NOT COMPLETED|Single-Blind||0
2574419|NCT00413413|6314328|P3|COMPLETED|Single-Blind||0
2574420|NCT00413413|6314329|P2|COMPLETED|Single-Blind||918
2574421|NCT00413413|6314330|P1|COMPLETED|Single-Blind||0
2574422|NCT00413413|6314328|P3|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
2574423|NCT00413413|6314329|P2|STARTED|Single-Blind||1134
2574424|NCT00413413|6314330|P1|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
2574425|NCT00413400|6314352|P2|NOT COMPLETED|Overall Study||4
2574426|NCT00413400|6314353|P1|NOT COMPLETED|Overall Study||2
2574427|NCT00413400|6314352|P2|COMPLETED|Overall Study||12
2574428|NCT00413400|6314353|P1|COMPLETED|Overall Study||22
2574429|NCT00413400|6314352|P2|3 Month Visit|Overall Study||12
2574430|NCT00413400|6314353|P1|3 Month Visit|Overall Study||22
2574431|NCT00413400|6314352|P2|STARTED|Overall Study||16
2574432|NCT00413400|6314353|P1|STARTED|Overall Study||24
2574433|NCT00413374|6314383|P2|NOT COMPLETED|Overall Study||0
2574434|NCT00413374|6314384|P1|NOT COMPLETED|Overall Study||6
2574435|NCT00413374|6314383|P2|COMPLETED|Overall Study||80
2574436|NCT00413374|6314384|P1|COMPLETED|Overall Study||34
2574437|NCT00413374|6314383|P2|STARTED|Overall Study||80
2574438|NCT00413374|6314384|P1|STARTED|Overall Study||40
2574439|NCT00413335|6314396|P2|NOT COMPLETED|Overall Study||0
2574440|NCT00413335|6314397|P1|NOT COMPLETED|Overall Study||0
2574441|NCT00413335|6314396|P2|COMPLETED|Overall Study||9
2574442|NCT00413335|6314397|P1|COMPLETED|Overall Study||12
2574443|NCT00413335|6314396|P2|STARTED|Overall Study||9
2574444|NCT00413335|6314397|P1|STARTED|Overall Study||12
2574445|NCT00413283|6314415|P4|NOT COMPLETED|Overall Study||4
2574446|NCT00413283|6314416|P3|NOT COMPLETED|Overall Study||2
2574447|NCT00413283|6314417|P2|NOT COMPLETED|Overall Study||3
2574448|NCT00413283|6314418|P1|NOT COMPLETED|Overall Study||1
2574449|NCT00413283|6314415|P4|COMPLETED|Overall Study||13
2574450|NCT00413283|6314416|P3|COMPLETED|Overall Study||16
2574451|NCT00413283|6314417|P2|COMPLETED|Overall Study||13
2574452|NCT00413283|6314418|P1|COMPLETED|Overall Study||11
2574453|NCT00413283|6314415|P4|Received Study Drug|Overall Study||16
2574454|NCT00413283|6314416|P3|Received Study Drug|Overall Study||18
2574455|NCT00413283|6314417|P2|Received Study Drug|Overall Study||16
2574456|NCT00413283|6314418|P1|Received Study Drug|Overall Study||12
2574457|NCT00413283|6314415|P4|STARTED|Overall Study||17
2574458|NCT00413283|6314416|P3|STARTED|Overall Study||18
2574459|NCT00413283|6314417|P2|STARTED|Overall Study||16
2574460|NCT00413283|6314418|P1|STARTED|Overall Study||12
2574461|NCT00413244|6314450|P2|NOT COMPLETED|Overall Study||1
2574462|NCT00413244|6314451|P1|NOT COMPLETED|Overall Study||10
2574463|NCT00413244|6314450|P2|COMPLETED|Overall Study||19
2574464|NCT00413244|6314451|P1|COMPLETED|Overall Study||21
2574465|NCT00413244|6314450|P2|STARTED|Overall Study||20
2574466|NCT00413244|6314451|P1|STARTED|Overall Study||31
2574467|NCT00413231|6314479|P1|NOT COMPLETED|365-day to 60-month Post Treatment||46
2574468|NCT00413231|6314479|P1|COMPLETED|365-day to 60-month Post Treatment||93
2574469|NCT00413231|6314479|P1|STARTED|365-day to 60-month Post Treatment||139
2574470|NCT00413231|6314479|P1|NOT COMPLETED|30-day to 365-day Post Treatment||13
2574471|NCT00413231|6314479|P1|COMPLETED|30-day to 365-day Post Treatment||139
2574472|NCT00413231|6314479|P1|STARTED|30-day to 365-day Post Treatment||152
2574473|NCT00413231|6314479|P1|NOT COMPLETED|0 to 30-day Post Treatment||8
2574474|NCT00413231|6314479|P1|COMPLETED|0 to 30-day Post Treatment||152
2574475|NCT00413231|6314479|P1|STARTED|0 to 30-day Post Treatment||160
2574476|NCT00413218|6314511|P2|NOT COMPLETED|Overall Study||96
2574477|NCT00413218|6314512|P1|NOT COMPLETED|Overall Study||103
2574478|NCT00413218|6314511|P2|COMPLETED|Overall Study||131
2574479|NCT00413218|6314512|P1|COMPLETED|Overall Study||120
2574480|NCT00413218|6314511|P2|Intent to Treat Population (ITT)|Overall Study||219
2574481|NCT00413218|6314512|P1|Intent to Treat Population (ITT)|Overall Study||221
2574482|NCT00413218|6314511|P2|STARTED|Overall Study||227
2574483|NCT00413218|6314512|P1|STARTED|Overall Study||223
2574484|NCT00413192|6314538|P4|NOT COMPLETED|Overall Study||32
2574485|NCT00413192|6314539|P3|NOT COMPLETED|Overall Study||19
2574486|NCT00413192|6314540|P2|NOT COMPLETED|Overall Study||40
2574487|NCT00413192|6314541|P1|NOT COMPLETED|Overall Study||37
2574488|NCT00413192|6314538|P4|COMPLETED|Overall Study||0
2574489|NCT00413192|6314539|P3|COMPLETED|Overall Study||0
2574490|NCT00413192|6314540|P2|COMPLETED|Overall Study||0
2574491|NCT00413192|6314541|P1|COMPLETED|Overall Study||0
2574492|NCT00413192|6314538|P4|STARTED|Overall Study||32
2574493|NCT00413192|6314539|P3|STARTED|Overall Study||19
2574494|NCT00413192|6314540|P2|STARTED|Overall Study||40
2574495|NCT00413192|6314541|P1|STARTED|Overall Study||37
2574496|NCT00413166|6314582|P3|NOT COMPLETED|Overall Study||0
2574497|NCT00413166|6314583|P2|NOT COMPLETED|Overall Study||0
2574498|NCT00413166|6314584|P1|NOT COMPLETED|Overall Study||0
2574499|NCT00413166|6314582|P3|COMPLETED|Overall Study||16
2574500|NCT00413166|6314583|P2|COMPLETED|Overall Study||5
2574501|NCT00413166|6314584|P1|COMPLETED|Overall Study||57
2574502|NCT00413166|6314582|P3|STARTED|Overall Study||16
2574503|NCT00413166|6314583|P2|STARTED|Overall Study||5
2574504|NCT00413166|6314584|P1|STARTED|Overall Study||57
2574505|NCT00413153|6314594|P2|NOT COMPLETED|Overall Study||1
2574506|NCT00413153|6314595|P1|NOT COMPLETED|Overall Study||2
2574507|NCT00413153|6314594|P2|COMPLETED|Overall Study||7
2574508|NCT00413153|6314595|P1|COMPLETED|Overall Study||5
2574509|NCT00413153|6314594|P2|STARTED|Overall Study||8
2574510|NCT00413153|6314595|P1|STARTED|Overall Study||7
2574511|NCT00413062|6314619|P2|NOT COMPLETED|Overall Study||210
2574512|NCT00413062|6314620|P1|NOT COMPLETED|Overall Study||678
2574513|NCT00413062|6314619|P2|COMPLETED|Overall Study||344
2574514|NCT00413062|6314620|P1|COMPLETED|Overall Study||988
2574515|NCT00413062|6314619|P2|STARTED|Overall Study||554
2574516|NCT00413062|6314620|P1|STARTED|Overall Study||1666
2574517|NCT00413049|6314646|P2|NOT COMPLETED|Overall Study||18
2574518|NCT00413049|6314647|P1|NOT COMPLETED|Overall Study||24
2574519|NCT00413049|6314646|P2|COMPLETED|Overall Study||331
2574520|NCT00413049|6314647|P1|COMPLETED|Overall Study||325
2574521|NCT00413049|6314646|P2|STARTED|Overall Study||349
2574522|NCT00413049|6314647|P1|STARTED|Overall Study||349
2574523|NCT00413036|6314663|P1|NOT COMPLETED|Overall Study||217
2574524|NCT00413036|6314663|P1|COMPLETED|Overall Study|Participants remain on study drug until progressive disease or unacceptable adverse events develop.|0
2574525|NCT00413036|6314663|P1|STARTED|Overall Study||217
2574526|NCT00413010|6314673|P2|NOT COMPLETED|Overall Study||63
2574527|NCT00413010|6314674|P1|NOT COMPLETED|Overall Study||72
2574528|NCT00413010|6314673|P2|COMPLETED|Overall Study||113
2574529|NCT00413010|6314674|P1|COMPLETED|Overall Study||108
2574530|NCT00413010|6314673|P2|STARTED|Overall Study||176
2574531|NCT00413010|6314674|P1|STARTED|Overall Study||180
2574532|NCT00412984|6314696|P2|NOT COMPLETED|Overall Study||2493
2574533|NCT00412984|6314697|P1|NOT COMPLETED|Overall Study||2310
2574534|NCT00412984|6314696|P2|COMPLETED|Overall Study||6588
2574535|NCT00412984|6314697|P1|COMPLETED|Overall Study||6810
2574536|NCT00412984|6314696|P2|STARTED|Overall Study|Randomized participants|9081
2574537|NCT00412984|6314697|P1|STARTED|Overall Study|Randomized participants|9120
2574538|NCT00412971|6314741|P2|NOT COMPLETED|Overall Study||10
2574539|NCT00412971|6314742|P1|NOT COMPLETED|Overall Study||30
2574540|NCT00412971|6314741|P2|COMPLETED|Overall Study||108
2574541|NCT00412971|6314742|P1|COMPLETED|Overall Study||85
2574542|NCT00412971|6314741|P2|STARTED|Overall Study||118
2574543|NCT00412971|6314742|P1|STARTED|Overall Study||115
2574544|NCT00412958|6314755|P4|NOT COMPLETED|Overall Study||1
2574545|NCT00412958|6314756|P3|NOT COMPLETED|Overall Study||0
2574546|NCT00412958|6314757|P2|NOT COMPLETED|Overall Study||4
2574547|NCT00412958|6314758|P1|NOT COMPLETED|Overall Study||3
2574548|NCT00412958|6314755|P4|COMPLETED|Overall Study||30
2574549|NCT00412958|6314756|P3|COMPLETED|Overall Study||32
2574550|NCT00412958|6314757|P2|COMPLETED|Overall Study||29
2574551|NCT00412958|6314758|P1|COMPLETED|Overall Study||26
2574552|NCT00412958|6314755|P4|STARTED|Overall Study||31
2574553|NCT00412958|6314756|P3|STARTED|Overall Study||32
2574554|NCT00412958|6314757|P2|STARTED|Overall Study||33
2574555|NCT00412958|6314758|P1|STARTED|Overall Study||29
2574556|NCT00412932|6314768|P1|NOT COMPLETED|Olm+ Hydrochlorothiazide 25 mg||2
2574557|NCT00412932|6314768|P1|COMPLETED|Olm+ Hydrochlorothiazide 25 mg||123
2574558|NCT00412932|6314768|P1|STARTED|Olm+ Hydrochlorothiazide 25 mg|153 -28 met their blood pressure goal (stayed on olmesartan 40/hydrochlorothiazide 12.5) = 125|125
2574559|NCT00412932|6314768|P1|NOT COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||6
2574560|NCT00412932|6314768|P1|COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||153
2574561|NCT00412932|6314768|P1|STARTED|Olm+Hydrochlorothiazide 12.5 mg|161 -2 met blood pressure goal (stayed on olmesartan 40) = 159|159
2574562|NCT00412932|6314768|P1|NOT COMPLETED|Olmesartan 40 mg||8
2574563|NCT00412932|6314768|P1|COMPLETED|Olmesartan 40 mg||161
2574564|NCT00412932|6314768|P1|STARTED|Olmesartan 40 mg|171 -1 met blood pressure goal (stayed on olmesartan 20) -1 who erroneously skipped this step = 169.|169
2574565|NCT00412932|6314768|P1|NOT COMPLETED|Olmesartan (Olm) 20 mg||7
2574566|NCT00412932|6314768|P1|COMPLETED|Olmesartan (Olm) 20 mg||171
2574567|NCT00412932|6314768|P1|STARTED|Olmesartan (Olm) 20 mg||178
2574568|NCT00412893|6314779|P2|NOT COMPLETED|Overall Study||144
2574569|NCT00412893|6314780|P1|NOT COMPLETED|Overall Study||145
2574570|NCT00412893|6314779|P2|COMPLETED|Overall Study|Defined as completed treatment|120
2574571|NCT00412893|6314780|P1|COMPLETED|Overall Study|Defined as completed treatment|118
2574572|NCT00412893|6314779|P2|Received Treatment|Overall Study||258
2574573|NCT00412893|6314780|P1|Received Treatment|Overall Study|One participant randomized to this group received voriconazole treatment for the first 7 days|258
2574574|NCT00412893|6314779|P2|STARTED|Overall Study||264
2574575|NCT00412893|6314780|P1|STARTED|Overall Study||263
2574576|NCT00412867|6314806|P1|NOT COMPLETED|Overall Study||0
2574577|NCT00412867|6314806|P1|COMPLETED|Overall Study||58
2574578|NCT00412867|6314806|P1|STARTED|Overall Study||58
2574579|NCT00412854|6314818|P2|NOT COMPLETED|Overall Study||16
2574580|NCT00412854|6314819|P1|NOT COMPLETED|Overall Study||14
2574581|NCT00412854|6314818|P2|COMPLETED|Overall Study||314
2574582|NCT00412854|6314819|P1|COMPLETED|Overall Study||316
2574583|NCT00412854|6314818|P2|STARTED|Overall Study||330
2574584|NCT00412854|6314819|P1|STARTED|Overall Study||330
2574585|NCT00412841|6314847|P2|NOT COMPLETED|Overall Study||5
2574586|NCT00412841|6314848|P1|NOT COMPLETED|Overall Study||10
2574587|NCT00412841|6314847|P2|COMPLETED|Overall Study||16
2574588|NCT00412841|6314848|P1|COMPLETED|Overall Study||12
2574589|NCT00412841|6314847|P2|STARTED|Overall Study||21
2574590|NCT00412841|6314848|P1|STARTED|Overall Study||22
2574591|NCT00412750|6314863|P3|NOT COMPLETED|Overall Study||23
2574592|NCT00412750|6314864|P2|NOT COMPLETED|Overall Study||21
2574593|NCT00412750|6314865|P1|NOT COMPLETED|Overall Study||31
2574594|NCT00412750|6314863|P3|COMPLETED|Overall Study||31
2574595|NCT00412750|6314864|P2|COMPLETED|Overall Study||34
2574596|NCT00412750|6314865|P1|COMPLETED|Overall Study||19
2574597|NCT00412750|6314863|P3|STARTED|Overall Study||54
2574598|NCT00412750|6314864|P2|STARTED|Overall Study||55
2574599|NCT00412750|6314865|P1|STARTED|Overall Study||50
2574600|NCT00412737|6314890|P2|NOT COMPLETED|Overall Study||6
2574601|NCT00412737|6314891|P1|NOT COMPLETED|Overall Study||16
2574602|NCT00412737|6314890|P2|COMPLETED|Overall Study||232
2574603|NCT00412737|6314891|P1|COMPLETED|Overall Study||221
2574604|NCT00412737|6314890|P2|STARTED|Overall Study||238
2574605|NCT00412737|6314891|P1|STARTED|Overall Study||237
2574606|NCT00412607|6314909|P1|NOT COMPLETED|Overall Study||104
2574607|NCT00412607|6314909|P1|COMPLETED|Overall Study||145
2574608|NCT00412607|6314909|P1|Started Study Catheter|Overall Study||233
2574609|NCT00412607|6314909|P1|STARTED|Overall Study||249
2574610|NCT00412542|6314922|P2|NOT COMPLETED|Overall Study||3
2574611|NCT00412542|6314923|P1|NOT COMPLETED|Overall Study||0
2574612|NCT00412542|6314922|P2|COMPLETED|Overall Study||42
2574613|NCT00412542|6314923|P1|COMPLETED|Overall Study||33
2574614|NCT00412542|6314922|P2|STARTED|Overall Study||45
2574615|NCT00412542|6314923|P1|STARTED|Overall Study||33
2574616|NCT00412529|6314929|P2|NOT COMPLETED|Overall Study||0
2574617|NCT00412529|6314930|P1|NOT COMPLETED|Overall Study||0
2574618|NCT00412529|6314929|P2|COMPLETED|Overall Study||21
2574619|NCT00412529|6314930|P1|COMPLETED|Overall Study||23
2574620|NCT00412529|6314929|P2|STARTED|Overall Study||21
2574621|NCT00412529|6314930|P1|STARTED|Overall Study||23
2574622|NCT00412516|6314953|P3|NOT COMPLETED|Overall Study||0
2574623|NCT00412516|6314954|P2|NOT COMPLETED|Overall Study||0
2574624|NCT00412516|6314955|P1|NOT COMPLETED|Overall Study||0
2574625|NCT00412516|6314953|P3|COMPLETED|Overall Study||214
2574626|NCT00412516|6314954|P2|COMPLETED|Overall Study||212
2574627|NCT00412516|6314955|P1|COMPLETED|Overall Study||93
2574628|NCT00412516|6314953|P3|STARTED|Overall Study||214
2574629|NCT00412516|6314954|P2|STARTED|Overall Study||212
2574630|NCT00412516|6314955|P1|STARTED|Overall Study||93
2574631|NCT00412464|6314972|P1|NOT COMPLETED|Overall Study||0
2574632|NCT00412464|6314972|P1|COMPLETED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
2574633|NCT00412464|6314972|P1|STARTED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
2574634|NCT00412451|6314984|P4|NOT COMPLETED|Overall Study||2
2574635|NCT00412451|6314985|P3|NOT COMPLETED|Overall Study||1
2574636|NCT00412451|6314986|P2|NOT COMPLETED|Overall Study||0
2574637|NCT00412451|6314987|P1|NOT COMPLETED|Overall Study||0
2574638|NCT00412451|6314984|P4|COMPLETED|Overall Study||11
2574639|NCT00412451|6314985|P3|COMPLETED|Overall Study||14
2574640|NCT00412451|6314986|P2|COMPLETED|Overall Study||15
2574641|NCT00412451|6314987|P1|COMPLETED|Overall Study||8
2574642|NCT00412451|6314984|P4|STARTED|Overall Study||13
2574643|NCT00412451|6314985|P3|STARTED|Overall Study||15
2574644|NCT00412451|6314986|P2|STARTED|Overall Study||15
2574645|NCT00412451|6314987|P1|STARTED|Overall Study||8
2574646|NCT00412425|6314999|P2|NOT COMPLETED|Overall Study||0
2574647|NCT00412425|6315000|P1|NOT COMPLETED|Overall Study||0
2574648|NCT00412425|6314999|P2|COMPLETED|Overall Study||15
2574649|NCT00412425|6315000|P1|COMPLETED|Overall Study||15
2574650|NCT00412425|6314999|P2|STARTED|Overall Study||15
2574651|NCT00412425|6315000|P1|STARTED|Overall Study||15
2574652|NCT00412373|6315008|P2|NOT COMPLETED|Overall Study||77
2574653|NCT00412373|6315009|P1|NOT COMPLETED|Overall Study||41
2574654|NCT00412373|6315008|P2|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment..|134
2574655|NCT00412373|6315009|P1|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment.|52
2574656|NCT00412373|6315008|P2|STARTED|Overall Study|Number of Subjects Intent-to-Treat Analysis Set.|211
2574657|NCT00412373|6315009|P1|STARTED|Overall Study|Number of Subjects in Intent-to-Treat Analysis Set.|93
2574658|NCT00412360|6315051|P2|NOT COMPLETED|Overall Study||3
2574659|NCT00412360|6315052|P1|NOT COMPLETED|Overall Study||1
2574660|NCT00412360|6315051|P2|COMPLETED|Overall Study||108
2574661|NCT00412360|6315052|P1|COMPLETED|Overall Study||112
2574662|NCT00412360|6315051|P2|STARTED|Overall Study||111
2574663|NCT00412360|6315052|P1|STARTED|Overall Study||113
2574664|NCT00412243|6315076|P1|NOT COMPLETED|Overall Study||0
2574665|NCT00412243|6315076|P1|COMPLETED|Overall Study||50
2574666|NCT00412243|6315076|P1|STARTED|Overall Study||50
2574667|NCT00412217|6315082|P2|NOT COMPLETED|Overall Study||48
2574668|NCT00412217|6315083|P1|NOT COMPLETED|Overall Study||46
2574669|NCT00412217|6315082|P2|COMPLETED|Overall Study||0
2574670|NCT00412217|6315083|P1|COMPLETED|Overall Study||0
2574671|NCT00412217|6315082|P2|STARTED|Overall Study||48
2574672|NCT00412217|6315083|P1|STARTED|Overall Study||46
2574673|NCT00412113|6315097|P2|NOT COMPLETED|Overall Study||15
2574674|NCT00412113|6315098|P1|NOT COMPLETED|Overall Study||12
2574675|NCT00412113|6315097|P2|COMPLETED|Overall Study|15-April-2008|107
2574676|NCT00412113|6315098|P1|COMPLETED|Overall Study|15-April-2008|111
2574677|NCT00412113|6315097|P2|Received Treatment|Overall Study||122
2574678|NCT00412113|6315098|P1|Received Treatment|Overall Study|One subject assigned to Norvasc and TLC did not receive treatment and was excluded from all analyses|122
2574679|NCT00412113|6315097|P2|STARTED|Overall Study|15-January-2007|122
2574680|NCT00412113|6315098|P1|STARTED|Overall Study|15-January-2007|123
2574681|NCT00412087|6315152|P2|NOT COMPLETED|Overall Study||65
2574682|NCT00412087|6315153|P1|NOT COMPLETED|Overall Study||62
2574683|NCT00412087|6315152|P2|COMPLETED|Overall Study||66
2574684|NCT00412087|6315153|P1|COMPLETED|Overall Study||72
2574685|NCT00412087|6315152|P2|STARTED|Overall Study||131
2574686|NCT00412087|6315153|P1|STARTED|Overall Study||134
2574687|NCT00412074|6315164|P3|NOT COMPLETED|Overall Study||67
2574688|NCT00412074|6315165|P2|NOT COMPLETED|Overall Study||22
2574689|NCT00412074|6315166|P1|NOT COMPLETED|Overall Study||77
2574690|NCT00412074|6315164|P3|COMPLETED|Overall Study||128
2574691|NCT00412074|6315165|P2|COMPLETED|Overall Study||44
2574692|NCT00412074|6315166|P1|COMPLETED|Overall Study||122
2574693|NCT00412074|6315164|P3|STARTED|Overall Study||195
2574694|NCT00412074|6315165|P2|STARTED|Overall Study||66
2574695|NCT00412074|6315166|P1|STARTED|Overall Study||199
2574696|NCT00412061|6315182|P2|NOT COMPLETED|Open Label Phase||170
2574697|NCT00412061|6315183|P1|NOT COMPLETED|Open Label Phase||0
2574698|NCT00412061|6315182|P2|COMPLETED|Open Label Phase||0
2574699|NCT00412061|6315183|P1|COMPLETED|Open Label Phase||0
2574700|NCT00412061|6315182|P2|STARTED|Open Label Phase||170
2574701|NCT00412061|6315183|P1|STARTED|Open Label Phase||0
2574702|NCT00412061|6315182|P2|NOT COMPLETED|Double Blind Phase||213
2574703|NCT00412061|6315183|P1|NOT COMPLETED|Double Blind Phase||216
2574704|NCT00412061|6315182|P2|COMPLETED|Double Blind Phase||0
2574705|NCT00412061|6315183|P1|COMPLETED|Double Blind Phase||0
2574706|NCT00412061|6315182|P2|Safety Set|Double Blind Phase|1 pt randomized never took drug Another randomized did not have valid post BL safety assessment|211
2574707|NCT00412061|6315183|P1|Safety Set|Double Blind Phase|1 patient did not provide at laest one valid post baseline safety assessment.|215
2574708|NCT00412061|6315182|P2|STARTED|Double Blind Phase||213
2574709|NCT00412061|6315183|P1|STARTED|Double Blind Phase||216
2574710|NCT00411788|6315201|P1|NOT COMPLETED|Overall Study||2
2574711|NCT00411788|6315201|P1|COMPLETED|Overall Study||9
2574712|NCT00411788|6315201|P1|STARTED|Overall Study||11
2574713|NCT00411762|6315210|P1|NOT COMPLETED|Overall Study||5
2574714|NCT00411762|6315210|P1|COMPLETED|Overall Study||20
2574715|NCT00411762|6315210|P1|STARTED|Overall Study||25
2574716|NCT00411749|6315217|P2|NOT COMPLETED|Overall Study||0
2574717|NCT00411749|6315218|P1|NOT COMPLETED|Overall Study||0
2574718|NCT00411749|6315217|P2|COMPLETED|Overall Study|Completed at 1 month after vaccination series (Month 7). Subjects were followed until Month 7|25
2574719|NCT00411749|6315218|P1|COMPLETED|Overall Study|Completed at 24 month after vaccination series (Month 30). Subjects were followed until Month 30|82
2574720|NCT00411749|6315217|P2|Vaccinated|Overall Study||25
2574721|NCT00411749|6315218|P1|Vaccinated|Overall Study||82
2574722|NCT00411749|6315217|P2|STARTED|Overall Study||25
2574723|NCT00411749|6315218|P1|STARTED|Overall Study||82
2574724|NCT00411671|6315234|P1|NOT COMPLETED|Overall Study||20
2574725|NCT00411671|6315234|P1|COMPLETED|Overall Study||85
2574726|NCT00411671|6315234|P1|STARTED|Overall Study||105
2574727|NCT00411645|6315242|P2|NOT COMPLETED|Overall Study||164
2574728|NCT00411645|6315243|P1|NOT COMPLETED|Overall Study||81
2574729|NCT00411645|6315242|P2|COMPLETED|Overall Study||290
2574730|NCT00411645|6315243|P1|COMPLETED|Overall Study||146
2574731|NCT00411645|6315242|P2|STARTED|Overall Study||454
2574732|NCT00411645|6315243|P1|STARTED|Overall Study||227
2574733|NCT00411632|6315267|P1|NOT COMPLETED|Overall Study||1
2574734|NCT00411632|6315267|P1|COMPLETED|Overall Study||36
2574735|NCT00411632|6315267|P1|STARTED|Overall Study||37
2574736|NCT00411619|6315271|P1|NOT COMPLETED|Overall Study||6
2574737|NCT00411619|6315271|P1|COMPLETED|Overall Study||22
2574738|NCT00411619|6315271|P1|STARTED|Overall Study||28
2574739|NCT00411554|6315278|P2|NOT COMPLETED|Overall Study||9
2574740|NCT00411554|6315279|P1|NOT COMPLETED|Overall Study||8
2574741|NCT00411554|6315278|P2|COMPLETED|Overall Study||147
2574742|NCT00411554|6315279|P1|COMPLETED|Overall Study||155
2574743|NCT00411554|6315278|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|156
2574744|NCT00411554|6315279|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|163
2574745|NCT00411463|6315291|P2|NOT COMPLETED|Overall Study||3
2574746|NCT00411463|6315292|P1|NOT COMPLETED|Overall Study||3
2574747|NCT00411463|6315291|P2|COMPLETED|Overall Study||8
2574748|NCT00411463|6315292|P1|COMPLETED|Overall Study||11
2574749|NCT00411463|6315291|P2|STARTED|Overall Study||11
2574750|NCT00411463|6315292|P1|STARTED|Overall Study||14
2574751|NCT00411450|6315305|P1|NOT COMPLETED|Overall Study||3
2574752|NCT00411450|6315305|P1|COMPLETED|Overall Study|Ended second-line treatment|113
2574753|NCT00411450|6315305|P1|Received Treatment|Overall Study||115
2574754|NCT00411450|6315305|P1|STARTED|Overall Study||116
2574755|NCT00411411|6315333|P2|NOT COMPLETED|Overall Study||0
2574756|NCT00411411|6315334|P1|NOT COMPLETED|Overall Study||0
2574757|NCT00411411|6315333|P2|COMPLETED|Overall Study||25
2574758|NCT00411411|6315334|P1|COMPLETED|Overall Study||24
2574759|NCT00411411|6315333|P2|STARTED|Overall Study||25
2574760|NCT00411411|6315334|P1|STARTED|Overall Study||24
2574761|NCT00411398|6315342|P1|NOT COMPLETED|Overall Study||5
2574762|NCT00411398|6315342|P1|COMPLETED|Overall Study||10
2574763|NCT00411398|6315342|P1|STARTED|Overall Study||15
2574764|NCT00411216|6315348|P2|NOT COMPLETED|Overall Study||2
2574765|NCT00411216|6315349|P1|NOT COMPLETED|Overall Study||0
2574766|NCT00411216|6315348|P2|COMPLETED|Overall Study||8
2574767|NCT00411216|6315349|P1|COMPLETED|Overall Study||13
2574768|NCT00411216|6315348|P2|STARTED|Overall Study||10
2574769|NCT00411216|6315349|P1|STARTED|Overall Study||13
2574770|NCT00411151|6315355|P1|NOT COMPLETED|Overall Study||47
2574771|NCT00411151|6315355|P1|COMPLETED|Overall Study||5
2574772|NCT00411151|6315355|P1|STARTED|Overall Study||52
2574773|NCT00411086|6315365|P1|NOT COMPLETED|Overall Study||0
2574774|NCT00411086|6315365|P1|COMPLETED|Overall Study||52
2574775|NCT00411086|6315365|P1|STARTED|Overall Study||52
2574776|NCT00410904|6315373|P2|NOT COMPLETED|Overall Study||0
2574777|NCT00410904|6315374|P1|NOT COMPLETED|Overall Study||0
2574778|NCT00410904|6315373|P2|COMPLETED|Overall Study||20
2574779|NCT00410904|6315374|P1|COMPLETED|Overall Study||40
2574780|NCT00410904|6315373|P2|STARTED|Overall Study||20
2574781|NCT00410904|6315374|P1|STARTED|Overall Study||40
2574782|NCT00410891|6315382|P1|NOT COMPLETED|Overall Study||0
2574783|NCT00410891|6315382|P1|COMPLETED|Overall Study||129
2574784|NCT00410891|6315382|P1|STARTED|Overall Study||129
2574785|NCT00410826|6315388|P2|NOT COMPLETED|Overall Study||4
2574786|NCT00410826|6315389|P1|NOT COMPLETED|Overall Study||9
2574787|NCT00410826|6315388|P2|COMPLETED|Overall Study||95
2574788|NCT00410826|6315389|P1|COMPLETED|Overall Study||96
2574789|NCT00410826|6315388|P2|STARTED|Overall Study||99
2574790|NCT00410826|6315389|P1|STARTED|Overall Study||105
2574791|NCT00410813|6315399|P2|NOT COMPLETED|Overall Study||42
2574792|NCT00410813|6315400|P1|NOT COMPLETED|Overall Study||43
2574793|NCT00410813|6315399|P2|COMPLETED|Overall Study||0
2574794|NCT00410813|6315400|P1|COMPLETED|Overall Study|Patients treated until progression.|0
2574795|NCT00410813|6315399|P2|Eligible|Overall Study||38
2574796|NCT00410813|6315400|P1|Eligible|Overall Study||41
2574797|NCT00410813|6315399|P2|STARTED|Overall Study||42
2574798|NCT00410813|6315400|P1|STARTED|Overall Study||43
2574799|NCT00410761|6315437|P2|NOT COMPLETED|Overall Study||72
2574800|NCT00410761|6315438|P1|NOT COMPLETED|Overall Study||120
2574801|NCT00410761|6315437|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|28
2574802|NCT00410761|6315438|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|111
2574803|NCT00410761|6315437|P2|STARTED|Overall Study|randomised patients|100
2574804|NCT00410761|6315438|P1|STARTED|Overall Study|randomised patients|231
2574805|NCT00410605|6315458|P1|NOT COMPLETED|Overall Study||25
2574806|NCT00410605|6315458|P1|COMPLETED|Overall Study||14
2574807|NCT00410605|6315458|P1|STARTED|Overall Study||39
2574808|NCT00410514|6315470|P3|NOT COMPLETED|Overall Study||7
2574809|NCT00410514|6315471|P2|NOT COMPLETED|Overall Study||3
2574810|NCT00410514|6315472|P1|NOT COMPLETED|Overall Study||2
2574811|NCT00410514|6315470|P3|COMPLETED|Overall Study||58
2574812|NCT00410514|6315471|P2|COMPLETED|Overall Study||67
2574813|NCT00410514|6315472|P1|COMPLETED|Overall Study||63
2574814|NCT00410514|6315470|P3|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|58
2574815|NCT00410514|6315471|P2|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|64
2574816|NCT00410514|6315472|P1|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|63
2574817|NCT00410514|6315470|P3|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
2574818|NCT00410514|6315471|P2|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|70
2574819|NCT00410514|6315472|P1|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
2574820|NCT00410514|6315470|P3|STARTED|Overall Study||65
2574821|NCT00410514|6315471|P2|STARTED|Overall Study||70
2574822|NCT00410514|6315472|P1|STARTED|Overall Study||65
2574823|NCT00410488|6315533|P2|NOT COMPLETED|Overall Study||0
2574824|NCT00410488|6315534|P1|NOT COMPLETED|Overall Study||0
2574825|NCT00410488|6315533|P2|COMPLETED|Overall Study||34
2574826|NCT00410488|6315534|P1|COMPLETED|Overall Study||16
2574827|NCT00410488|6315533|P2|STARTED|Overall Study||34
2574828|NCT00410488|6315534|P1|STARTED|Overall Study||16
2574829|NCT00410423|6315539|P4|NOT COMPLETED|Phase 2||0
2574830|NCT00410423|6315540|P3|NOT COMPLETED|Phase 2||0
2574831|NCT00410423|6315541|P2|NOT COMPLETED|Phase 2||0
2574832|NCT00410423|6315542|P1|NOT COMPLETED|Phase 2||0
2574833|NCT00410423|6315539|P4|COMPLETED|Phase 2||44
2574834|NCT00410423|6315540|P3|COMPLETED|Phase 2||0
2574835|NCT00410423|6315541|P2|COMPLETED|Phase 2||0
2574836|NCT00410423|6315542|P1|COMPLETED|Phase 2||0
2574837|NCT00410423|6315539|P4|STARTED|Phase 2||44
2574838|NCT00410423|6315540|P3|STARTED|Phase 2||0
2574839|NCT00410423|6315541|P2|STARTED|Phase 2||0
2574840|NCT00410423|6315542|P1|STARTED|Phase 2||0
2574841|NCT00410423|6315539|P4|NOT COMPLETED|Phase 1 - Dose Level 3||0
2574842|NCT00410423|6315540|P3|NOT COMPLETED|Phase 1 - Dose Level 3||0
2574843|NCT00410423|6315541|P2|NOT COMPLETED|Phase 1 - Dose Level 3||0
2574844|NCT00410423|6315542|P1|NOT COMPLETED|Phase 1 - Dose Level 3||0
2574845|NCT00410423|6315539|P4|COMPLETED|Phase 1 - Dose Level 3||0
2574846|NCT00410423|6315540|P3|COMPLETED|Phase 1 - Dose Level 3||3
2574847|NCT00410423|6315541|P2|COMPLETED|Phase 1 - Dose Level 3||0
2574848|NCT00410423|6315542|P1|COMPLETED|Phase 1 - Dose Level 3||0
2574849|NCT00410423|6315539|P4|STARTED|Phase 1 - Dose Level 3||0
2574850|NCT00410423|6315540|P3|STARTED|Phase 1 - Dose Level 3||3
2574851|NCT00410423|6315541|P2|STARTED|Phase 1 - Dose Level 3||0
2574852|NCT00410423|6315542|P1|STARTED|Phase 1 - Dose Level 3||0
2574853|NCT00410423|6315539|P4|NOT COMPLETED|Phase 1 - Dose Level 2||0
2574854|NCT00410423|6315540|P3|NOT COMPLETED|Phase 1 - Dose Level 2||0
2574855|NCT00410423|6315541|P2|NOT COMPLETED|Phase 1 - Dose Level 2||0
2574856|NCT00410423|6315542|P1|NOT COMPLETED|Phase 1 - Dose Level 2||0
2574857|NCT00410423|6315539|P4|COMPLETED|Phase 1 - Dose Level 2||0
2574858|NCT00410423|6315540|P3|COMPLETED|Phase 1 - Dose Level 2||0
2574859|NCT00410423|6315541|P2|COMPLETED|Phase 1 - Dose Level 2||5
2574860|NCT00410423|6315542|P1|COMPLETED|Phase 1 - Dose Level 2||0
2574861|NCT00410423|6315539|P4|STARTED|Phase 1 - Dose Level 2||0
2574862|NCT00410423|6315540|P3|STARTED|Phase 1 - Dose Level 2||0
2574863|NCT00410423|6315541|P2|STARTED|Phase 1 - Dose Level 2||5
2574864|NCT00410423|6315542|P1|STARTED|Phase 1 - Dose Level 2||0
2574865|NCT00410423|6315539|P4|NOT COMPLETED|Phase 1 - Dose Level 1||0
2574866|NCT00410423|6315540|P3|NOT COMPLETED|Phase 1 - Dose Level 1||0
2574867|NCT00410423|6315541|P2|NOT COMPLETED|Phase 1 - Dose Level 1||0
2574868|NCT00410423|6315542|P1|NOT COMPLETED|Phase 1 - Dose Level 1||0
2574869|NCT00410423|6315539|P4|COMPLETED|Phase 1 - Dose Level 1||0
2574870|NCT00410423|6315540|P3|COMPLETED|Phase 1 - Dose Level 1||0
2574871|NCT00410423|6315541|P2|COMPLETED|Phase 1 - Dose Level 1||0
2574872|NCT00410423|6315542|P1|COMPLETED|Phase 1 - Dose Level 1||3
2574873|NCT00410423|6315539|P4|STARTED|Phase 1 - Dose Level 1||0
2574874|NCT00410423|6315540|P3|STARTED|Phase 1 - Dose Level 1||0
2574875|NCT00410423|6315541|P2|STARTED|Phase 1 - Dose Level 1||0
2574876|NCT00410423|6315542|P1|STARTED|Phase 1 - Dose Level 1||3
2574877|NCT00410410|6315555|P9|NOT COMPLETED|Open-Label Period (OL)||349
2574878|NCT00410410|6315556|P8|NOT COMPLETED|Open-Label Period (OL)||0
2574879|NCT00410410|6315557|P7|NOT COMPLETED|Open-Label Period (OL)||0
2574880|NCT00410410|6315558|P6|NOT COMPLETED|Open-Label Period (OL)||0
2574881|NCT00410410|6315559|P5|NOT COMPLETED|Open-Label Period (OL)||0
2574882|NCT00410410|6315560|P4|NOT COMPLETED|Open-Label Period (OL)||0
2574883|NCT00410410|6315561|P3|NOT COMPLETED|Open-Label Period (OL)||0
2574884|NCT00410410|6315562|P2|NOT COMPLETED|Open-Label Period (OL)||0
2574885|NCT00410410|6315563|P1|NOT COMPLETED|Open-Label Period (OL)||0
2574886|NCT00410410|6315555|P9|COMPLETED|Open-Label Period (OL)||0
2574887|NCT00410410|6315556|P8|COMPLETED|Open-Label Period (OL)||0
2574888|NCT00410410|6315557|P7|COMPLETED|Open-Label Period (OL)||0
2574889|NCT00410410|6315558|P6|COMPLETED|Open-Label Period (OL)||0
2574890|NCT00410410|6315559|P5|COMPLETED|Open-Label Period (OL)||0
2574891|NCT00410410|6315560|P4|COMPLETED|Open-Label Period (OL)||0
2574892|NCT00410410|6315561|P3|COMPLETED|Open-Label Period (OL)||0
2574893|NCT00410410|6315562|P2|COMPLETED|Open-Label Period (OL)||0
2574894|NCT00410410|6315563|P1|COMPLETED|Open-Label Period (OL)||0
2574895|NCT00410410|6315555|P9|STARTED|Open-Label Period (OL)|349 entered OL (those who completed IP but failed response criteria, or completed/relapsed on MP).|349
2574896|NCT00410410|6315556|P8|STARTED|Open-Label Period (OL)||0
2574897|NCT00410410|6315557|P7|STARTED|Open-Label Period (OL)||0
2574898|NCT00410410|6315558|P6|STARTED|Open-Label Period (OL)||0
2574899|NCT00410410|6315559|P5|STARTED|Open-Label Period (OL)||0
2574900|NCT00410410|6315560|P4|STARTED|Open-Label Period (OL)||0
2574901|NCT00410410|6315561|P3|STARTED|Open-Label Period (OL)||0
2574902|NCT00410410|6315562|P2|STARTED|Open-Label Period (OL)||0
2574903|NCT00410410|6315563|P1|STARTED|Open-Label Period (OL)||0
2574904|NCT00410410|6315555|P9|NOT COMPLETED|Maintenance Period (MP)||0
2574905|NCT00410410|6315556|P8|NOT COMPLETED|Maintenance Period (MP)||55
2574906|NCT00410410|6315557|P7|NOT COMPLETED|Maintenance Period (MP)||50
2574907|NCT00410410|6315558|P6|NOT COMPLETED|Maintenance Period (MP)||0
2574908|NCT00410410|6315559|P5|NOT COMPLETED|Maintenance Period (MP)||0
2574909|NCT00410410|6315560|P4|NOT COMPLETED|Maintenance Period (MP)||0
2574910|NCT00410410|6315561|P3|NOT COMPLETED|Maintenance Period (MP)||0
2574911|NCT00410410|6315562|P2|NOT COMPLETED|Maintenance Period (MP)||0
2574912|NCT00410410|6315563|P1|NOT COMPLETED|Maintenance Period (MP)||0
2574913|NCT00410410|6315555|P9|COMPLETED|Maintenance Period (MP)||0
2574914|NCT00410410|6315556|P8|COMPLETED|Maintenance Period (MP)||11
2574915|NCT00410410|6315557|P7|COMPLETED|Maintenance Period (MP)||15
2574916|NCT00410410|6315558|P6|COMPLETED|Maintenance Period (MP)||0
2574917|NCT00410410|6315559|P5|COMPLETED|Maintenance Period (MP)||0
2574918|NCT00410410|6315560|P4|COMPLETED|Maintenance Period (MP)||0
2574919|NCT00410410|6315561|P3|COMPLETED|Maintenance Period (MP)||0
2574920|NCT00410410|6315562|P2|COMPLETED|Maintenance Period (MP)||0
2574921|NCT00410410|6315563|P1|COMPLETED|Maintenance Period (MP)||0
2574922|NCT00410410|6315555|P9|STARTED|Maintenance Period (MP)||0
2574923|NCT00410410|6315556|P8|STARTED|Maintenance Period (MP)|At end of IP, 66 participants met response criteria and were randomly assigned to placebo in MP.|66
2574924|NCT00410410|6315557|P7|STARTED|Maintenance Period (MP)|At end of IP, 65 participants met response criteria and were randomly assigned to abatacept in MP.|65
2574925|NCT00410410|6315558|P6|STARTED|Maintenance Period (MP)||0
2574926|NCT00410410|6315559|P5|STARTED|Maintenance Period (MP)||0
2574927|NCT00410410|6315560|P4|STARTED|Maintenance Period (MP)||0
2574928|NCT00410410|6315561|P3|STARTED|Maintenance Period (MP)||0
2574929|NCT00410410|6315562|P2|STARTED|Maintenance Period (MP)||0
2574930|NCT00410410|6315563|P1|STARTED|Maintenance Period (MP)||0
2574931|NCT00410410|6315555|P9|NOT COMPLETED|Induction Period (IP)||0
2574932|NCT00410410|6315556|P8|NOT COMPLETED|Induction Period (IP)||0
2574933|NCT00410410|6315557|P7|NOT COMPLETED|Induction Period (IP)||0
2574934|NCT00410410|6315558|P6|NOT COMPLETED|Induction Period (IP)||29
2574935|NCT00410410|6315559|P5|NOT COMPLETED|Induction Period (IP)||32
2574936|NCT00410410|6315560|P4|NOT COMPLETED|Induction Period (IP)||20
2574937|NCT00410410|6315561|P3|NOT COMPLETED|Induction Period (IP)||17
2574938|NCT00410410|6315562|P2|NOT COMPLETED|Induction Period (IP)||35
2574939|NCT00410410|6315563|P1|NOT COMPLETED|Induction Period (IP)||35
2574940|NCT00410410|6315555|P9|COMPLETED|Induction Period (IP)||0
2574941|NCT00410410|6315556|P8|COMPLETED|Induction Period (IP)||0
2574942|NCT00410410|6315557|P7|COMPLETED|Induction Period (IP)||0
2574943|NCT00410410|6315558|P6|COMPLETED|Induction Period (IP)||21
2574944|NCT00410410|6315559|P5|COMPLETED|Induction Period (IP)||19
2574945|NCT00410410|6315560|P4|COMPLETED|Induction Period (IP)||120
2574946|NCT00410410|6315561|P3|COMPLETED|Induction Period (IP)||53
2574947|NCT00410410|6315562|P2|COMPLETED|Induction Period (IP)||104
2574948|NCT00410410|6315563|P1|COMPLETED|Induction Period (IP)||106
2574949|NCT00410410|6315555|P9|STARTED|Induction Period (IP)||0
2574950|NCT00410410|6315556|P8|STARTED|Induction Period (IP)||0
2574951|NCT00410410|6315557|P7|STARTED|Induction Period (IP)||0
2574952|NCT00410410|6315558|P6|STARTED|Induction Period (IP)||50
2574953|NCT00410410|6315559|P5|STARTED|Induction Period (IP)||51
2574954|NCT00410410|6315560|P4|STARTED|Induction Period (IP)||140
2574955|NCT00410410|6315561|P3|STARTED|Induction Period (IP)||70
2574956|NCT00410410|6315562|P2|STARTED|Induction Period (IP)||139
2574957|NCT00410410|6315563|P1|STARTED|Induction Period (IP)||141
2574958|NCT00410384|6315724|P3|NOT COMPLETED|Overall Study||82
2574959|NCT00410384|6315725|P2|NOT COMPLETED|Overall Study||72
2574960|NCT00410384|6315726|P1|NOT COMPLETED|Overall Study||89
2574961|NCT00410384|6315724|P3|COMPLETED|Overall Study||191
2574962|NCT00410384|6315725|P2|COMPLETED|Overall Study||199
2574963|NCT00410384|6315726|P1|COMPLETED|Overall Study||186
2574964|NCT00410384|6315724|P3|STARTED|Overall Study||273
2574965|NCT00410384|6315725|P2|STARTED|Overall Study||271
2574966|NCT00410384|6315726|P1|STARTED|Overall Study||275
2574967|NCT00410280|6315754|P2|NOT COMPLETED|Overall Study||0
2574968|NCT00410280|6315755|P1|NOT COMPLETED|Overall Study||0
2574969|NCT00410280|6315754|P2|COMPLETED|Overall Study||13
2574970|NCT00410280|6315755|P1|COMPLETED|Overall Study||14
2574971|NCT00410280|6315754|P2|STARTED|Overall Study||13
2574972|NCT00410280|6315755|P1|STARTED|Overall Study||14
2574973|NCT00410202|6315799|P3|NOT COMPLETED|Off-treatment Follow up||12
2574974|NCT00410202|6315800|P2|NOT COMPLETED|Off-treatment Follow up||8
2574975|NCT00410202|6315801|P1|NOT COMPLETED|Off-treatment Follow up||14
2574976|NCT00410202|6315799|P3|COMPLETED|Off-treatment Follow up||2
2574977|NCT00410202|6315800|P2|COMPLETED|Off-treatment Follow up||0
2574978|NCT00410202|6315801|P1|COMPLETED|Off-treatment Follow up||1
2574979|NCT00410202|6315799|P3|STARTED|Off-treatment Follow up||14
2574980|NCT00410202|6315800|P2|STARTED|Off-treatment Follow up||8
2574981|NCT00410202|6315801|P1|STARTED|Off-treatment Follow up||15
2574982|NCT00410202|6315799|P3|NOT COMPLETED|On-Treatment||71
2574983|NCT00410202|6315800|P2|NOT COMPLETED|On-Treatment||79
2574984|NCT00410202|6315801|P1|NOT COMPLETED|On-Treatment||75
2574985|NCT00410202|6315799|P3|COMPLETED|On-Treatment|Completed the 100 week dosing|66
2574986|NCT00410202|6315800|P2|COMPLETED|On-Treatment|Completed the 100 week dosing|61
2574987|NCT00410202|6315801|P1|COMPLETED|On-Treatment|Completed the 100 week dosing|63
2574988|NCT00410202|6315799|P3|Discontinued at or After Week 48 Visit|On-Treatment||3
2574989|NCT00410202|6315800|P2|Discontinued at or After Week 48 Visit|On-Treatment||6
2574990|NCT00410202|6315801|P1|Discontinued at or After Week 48 Visit|On-Treatment||2
2574991|NCT00410202|6315799|P3|Discontinued Prior to Week 48 Visit|On-Treatment||2
2574992|NCT00410202|6315800|P2|Discontinued Prior to Week 48 Visit|On-Treatment||2
2574993|NCT00410202|6315801|P1|Discontinued Prior to Week 48 Visit|On-Treatment||4
2574994|NCT00410202|6315799|P3|STARTED|On-Treatment||137
2574995|NCT00410202|6315800|P2|STARTED|On-Treatment||140
2574996|NCT00410202|6315801|P1|STARTED|On-Treatment||138
2574997|NCT00410189|6315881|P1|NOT COMPLETED|Overall Study||0
2574998|NCT00410189|6315881|P1|COMPLETED|Overall Study||54
2574999|NCT00410189|6315881|P1|STARTED|Overall Study||54
2575000|NCT00410163|6315888|P2|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
2575001|NCT00410163|6315889|P1|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
2575002|NCT00410163|6315888|P2|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||11
2575003|NCT00410163|6315889|P1|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
2575004|NCT00410163|6315888|P2|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|21
2575005|NCT00410163|6315889|P1|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|20
2575006|NCT00410163|6315888|P2|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||11
2575007|NCT00410163|6315889|P1|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||12
2575008|NCT00410163|6315888|P2|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
2575009|NCT00410163|6315889|P1|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
2575010|NCT00410163|6315888|P2|STARTED|Treatment and Follow-up Phase (2 Years)||30
2575011|NCT00410163|6315889|P1|STARTED|Treatment and Follow-up Phase (2 Years)||31
2575012|NCT00410150|6315933|P2|NOT COMPLETED|Overall Study||3
2575013|NCT00410150|6315934|P1|NOT COMPLETED|Overall Study||2
2575014|NCT00410150|6315933|P2|COMPLETED|Overall Study|3 study withdrawals (analyzed by intention-to-treat0|17
2575015|NCT00410150|6315934|P1|COMPLETED|Overall Study|2 study withdrawals (analyzed by intention-to-treat)|20
2575016|NCT00410150|6315933|P2|STARTED|Overall Study||20
2575017|NCT00410150|6315934|P1|STARTED|Overall Study||22
2575018|NCT00410124|6315942|P2|NOT COMPLETED|Extension Phase - Open Label (45 Months)||111
2575019|NCT00410124|6315943|P1|NOT COMPLETED|Extension Phase - Open Label (45 Months)||67
2575020|NCT00410124|6315942|P2|COMPLETED|Extension Phase - Open Label (45 Months)||0
2575021|NCT00410124|6315943|P1|COMPLETED|Extension Phase - Open Label (45 Months)||0
2575022|NCT00410124|6315942|P2|STARTED|Extension Phase - Open Label (45 Months)|Patients on placebo in core received RAD001 in extension phase.|111
2575023|NCT00410124|6315943|P1|STARTED|Extension Phase - Open Label (45 Months)||67
2575024|NCT00410124|6315942|P2|NOT COMPLETED|Core Phase Double Blind (15 Months)||133
2575025|NCT00410124|6315943|P1|NOT COMPLETED|Core Phase Double Blind (15 Months)||202
2575026|NCT00410124|6315942|P2|COMPLETED|Core Phase Double Blind (15 Months)|All patients ongoing/completed/not completed in core had option to enter extension taking RAD001.|6
2575027|NCT00410124|6315943|P1|COMPLETED|Core Phase Double Blind (15 Months)|Patients ongoing/completed double blind phase had option entering extension phase continuing RAD001.|75
2575028|NCT00410124|6315942|P2|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||2
2575029|NCT00410124|6315943|P1|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||62
2575030|NCT00410124|6315942|P2|Ongoing|Core Phase Double Blind (15 Months)||4
2575031|NCT00410124|6315943|P1|Ongoing|Core Phase Double Blind (15 Months)||13
2575032|NCT00410124|6315942|P2|STARTED|Core Phase Double Blind (15 Months)||139
2575033|NCT00410124|6315943|P1|STARTED|Core Phase Double Blind (15 Months)|Started indicates randomized (FAS) and treated|277
2575034|NCT00410072|6315974|P2|NOT COMPLETED|After Week 48 to Week 96||11
2575035|NCT00410072|6315975|P1|NOT COMPLETED|After Week 48 to Week 96||6
2575036|NCT00410072|6315974|P2|COMPLETED|After Week 48 to Week 96||174
2575037|NCT00410072|6315975|P1|COMPLETED|After Week 48 to Week 96||170
2575038|NCT00410072|6315974|P2|STARTED|After Week 48 to Week 96||185
2575039|NCT00410072|6315975|P1|STARTED|After Week 48 to Week 96||176
2575040|NCT00410072|6315974|P2|NOT COMPLETED|Day 1 to Week 48||12
2575041|NCT00410072|6315975|P1|NOT COMPLETED|Day 1 to Week 48||6
2575042|NCT00410072|6315974|P2|COMPLETED|Day 1 to Week 48||185
2575043|NCT00410072|6315975|P1|COMPLETED|Day 1 to Week 48||176
2575044|NCT00410072|6315974|P2|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 1 more was randomized but not treated.|197
2575045|NCT00410072|6315975|P1|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 4 more were randomized but not treated.|182
2575046|NCT00410059|6316011|P1|NOT COMPLETED|Overall Study||0
2575047|NCT00410059|6316011|P1|COMPLETED|Overall Study||59
2575048|NCT00410059|6316011|P1|STARTED|Overall Study||59
2575049|NCT00410046|6316015|P1|NOT COMPLETED|Overall Study||5
2575050|NCT00410046|6316015|P1|COMPLETED|Overall Study||79
2575051|NCT00410046|6316015|P1|STARTED|Overall Study||84
2575052|NCT00409838|6316046|P2|NOT COMPLETED|Long-term Extension Period||0
2575053|NCT00409838|6316047|P1|NOT COMPLETED|Long-term Extension Period||18
2575054|NCT00409838|6316046|P2|COMPLETED|Long-term Extension Period||0
2575055|NCT00409838|6316047|P1|COMPLETED|Long-term Extension Period||87
2575056|NCT00409838|6316046|P2|STARTED|Long-term Extension Period||0
2575057|NCT00409838|6316047|P1|STARTED|Long-term Extension Period||105
2575058|NCT00409838|6316046|P2|NOT COMPLETED|Short-term Period||5
2575059|NCT00409838|6316047|P1|NOT COMPLETED|Short-term Period||3
2575060|NCT00409838|6316046|P2|COMPLETED|Short-term Period|Participants who received placebo in this period received abatacept in next period.|52
2575061|NCT00409838|6316047|P1|COMPLETED|Short-term Period||53
2575062|NCT00409838|6316046|P2|Treated (Baseline) Population|Short-term Period||57
2575063|NCT00409838|6316047|P1|Treated (Baseline) Population|Short-term Period||55
2575064|NCT00409838|6316046|P2|STARTED|Short-term Period|Randomized|57
2575065|NCT00409838|6316047|P1|STARTED|Short-term Period|Randomized|56
2575066|NCT00409825|6316108|P1|NOT COMPLETED|Overall Study||0
2575067|NCT00409825|6316108|P1|COMPLETED|Overall Study||61
2575068|NCT00409825|6316108|P1|STARTED|Overall Study||61
2575069|NCT00409786|6316112|P1|NOT COMPLETED|Overall Study||3
2575070|NCT00409786|6316112|P1|COMPLETED|Overall Study||47
2575071|NCT00409786|6316112|P1|STARTED|Overall Study||50
2575072|NCT00409773|6316121|P5|NOT COMPLETED|Overall Study||10
2575073|NCT00409773|6316122|P4|NOT COMPLETED|Overall Study||12
2575074|NCT00409773|6316123|P3|NOT COMPLETED|Overall Study||9
2575075|NCT00409773|6316124|P2|NOT COMPLETED|Overall Study||7
2575076|NCT00409773|6316125|P1|NOT COMPLETED|Overall Study||9
2575077|NCT00409773|6316121|P5|COMPLETED|Overall Study||218
2575078|NCT00409773|6316122|P4|COMPLETED|Overall Study||216
2575079|NCT00409773|6316123|P3|COMPLETED|Overall Study||220
2575080|NCT00409773|6316124|P2|COMPLETED|Overall Study||222
2575081|NCT00409773|6316125|P1|COMPLETED|Overall Study||220
2575082|NCT00409773|6316121|P5|STARTED|Overall Study||228
2575083|NCT00409773|6316122|P4|STARTED|Overall Study||228
2575084|NCT00409773|6316123|P3|STARTED|Overall Study||229
2575085|NCT00409773|6316124|P2|STARTED|Overall Study||229
2575086|NCT00409773|6316125|P1|STARTED|Overall Study||229
2575087|NCT00409747|6316207|P1|NOT COMPLETED|Overall Study||1
2575088|NCT00409747|6316207|P1|COMPLETED|Overall Study||10
2575089|NCT00409747|6316207|P1|STARTED|Overall Study||11
2575090|NCT00409708|6316214|P2|NOT COMPLETED|Washout||10
2575091|NCT00409708|6316215|P1|NOT COMPLETED|Washout||21
2575092|NCT00409708|6316214|P2|COMPLETED|Washout||29
2575093|NCT00409708|6316215|P1|COMPLETED|Washout||17
2575094|NCT00409708|6316214|P2|STARTED|Washout||39
2575095|NCT00409708|6316215|P1|STARTED|Washout||38
2575096|NCT00409708|6316214|P2|NOT COMPLETED|Treatment||17
2575097|NCT00409708|6316215|P1|NOT COMPLETED|Treatment||15
2575098|NCT00409708|6316214|P2|COMPLETED|Treatment||39
2575099|NCT00409708|6316215|P1|COMPLETED|Treatment||38
2575100|NCT00409708|6316214|P2|STARTED|Treatment||56
2575101|NCT00409708|6316215|P1|STARTED|Treatment|A total of 142 participants were screened for the study but only 109 were randomized to treatment|53
2575102|NCT00409682|6316236|P3|NOT COMPLETED|EOW Double-blind Maintenance Period||27
2575103|NCT00409682|6316237|P2|NOT COMPLETED|EOW Double-blind Maintenance Period||37
2575104|NCT00409682|6316238|P1|NOT COMPLETED|EOW Double-blind Maintenance Period||0
2575105|NCT00409682|6316236|P3|COMPLETED|EOW Double-blind Maintenance Period||66
2575106|NCT00409682|6316237|P2|COMPLETED|EOW Double-blind Maintenance Period||58
2575107|NCT00409682|6316238|P1|COMPLETED|EOW Double-blind Maintenance Period||0
2575108|NCT00409682|6316236|P3|STARTED|EOW Double-blind Maintenance Period||93
2575109|NCT00409682|6316237|P2|STARTED|EOW Double-blind Maintenance Period||95
2575110|NCT00409682|6316238|P1|STARTED|EOW Double-blind Maintenance Period||0
2575111|NCT00409682|6316236|P3|NOT COMPLETED|Open-label Induction Period||0
2575112|NCT00409682|6316237|P2|NOT COMPLETED|Open-label Induction Period||0
2575113|NCT00409682|6316238|P1|NOT COMPLETED|Open-label Induction Period||4
2575114|NCT00409682|6316236|P3|COMPLETED|Open-label Induction Period||0
2575115|NCT00409682|6316237|P2|COMPLETED|Open-label Induction Period||0
2575116|NCT00409682|6316238|P1|COMPLETED|Open-label Induction Period||188
2575117|NCT00409682|6316236|P3|STARTED|Open-label Induction Period||0
2575118|NCT00409682|6316237|P2|STARTED|Open-label Induction Period||0
2575119|NCT00409682|6316238|P1|STARTED|Open-label Induction Period||192
2575120|NCT00409617|6316255|P1|NOT COMPLETED|Overall Study||160
2575121|NCT00409617|6316255|P1|COMPLETED|Overall Study||785
2575122|NCT00409617|6316255|P1|STARTED|Overall Study||945
2575123|NCT00409578|6316271|P4|NOT COMPLETED|Overall Study||67
2575124|NCT00409578|6316272|P3|NOT COMPLETED|Overall Study||54
2575125|NCT00409578|6316273|P2|NOT COMPLETED|Overall Study||70
2575126|NCT00409578|6316274|P1|NOT COMPLETED|Overall Study||52
2575127|NCT00409578|6316271|P4|COMPLETED|Overall Study||214
2575128|NCT00409578|6316272|P3|COMPLETED|Overall Study||215
2575129|NCT00409578|6316273|P2|COMPLETED|Overall Study||201
2575130|NCT00409578|6316274|P1|COMPLETED|Overall Study||228
2575131|NCT00409578|6316271|P4|STARTED|Overall Study||281
2575132|NCT00409578|6316272|P3|STARTED|Overall Study||269
2575133|NCT00409578|6316273|P2|STARTED|Overall Study||271
2575134|NCT00409578|6316274|P1|STARTED|Overall Study||280
2575135|NCT00409565|6316296|P1|NOT COMPLETED|Overall Study||1
2575136|NCT00409565|6316296|P1|COMPLETED|Overall Study||45
2575137|NCT00409565|6316296|P1|Overall Response Rate|Overall Study||7
2575138|NCT00409565|6316296|P1|STARTED|Overall Study||46
2575139|NCT00409539|6316309|P5|NOT COMPLETED|Overall Study||25
2575140|NCT00409539|6316310|P4|NOT COMPLETED|Overall Study||12
2575141|NCT00409539|6316311|P3|NOT COMPLETED|Overall Study||14
2575142|NCT00409539|6316312|P2|NOT COMPLETED|Overall Study||11
2575143|NCT00409539|6316313|P1|NOT COMPLETED|Overall Study||11
2575144|NCT00409539|6316309|P5|COMPLETED|Overall Study||85
2575145|NCT00409539|6316310|P4|COMPLETED|Overall Study||97
2575146|NCT00409539|6316311|P3|COMPLETED|Overall Study||95
2575147|NCT00409539|6316312|P2|COMPLETED|Overall Study||100
2575148|NCT00409539|6316313|P1|COMPLETED|Overall Study||100
2575149|NCT00409539|6316309|P5|STARTED|Overall Study||110
2575150|NCT00409539|6316310|P4|STARTED|Overall Study||109
2575151|NCT00409539|6316311|P3|STARTED|Overall Study||109
2575152|NCT00409539|6316312|P2|STARTED|Overall Study||111
2575153|NCT00409539|6316313|P1|STARTED|Overall Study||111
2575154|NCT00409409|6316332|P2|NOT COMPLETED|Overall Study||4
2575155|NCT00409409|6316333|P1|NOT COMPLETED|Overall Study||8
2575156|NCT00409409|6316332|P2|COMPLETED|Overall Study||135
2575157|NCT00409409|6316333|P1|COMPLETED|Overall Study||131
2575158|NCT00409409|6316332|P2|STARTED|Overall Study||139
2575159|NCT00409409|6316333|P1|STARTED|Overall Study||139
2575160|NCT00409344|6316341|P2|NOT COMPLETED|Overall Study||0
2575161|NCT00409344|6316342|P1|NOT COMPLETED|Overall Study||0
2575162|NCT00409344|6316341|P2|COMPLETED|Overall Study|No participants were enrolled to completion|0
2575163|NCT00409344|6316342|P1|COMPLETED|Overall Study|No participants were enrolled to completion|0
2575164|NCT00409344|6316341|P2|STARTED|Overall Study|No participants enrolled|0
2575165|NCT00409344|6316342|P1|STARTED|Overall Study|No participants enrolled|0
2575166|NCT00409331|6316360|P1|NOT COMPLETED|Overall Study||1
2575167|NCT00409331|6316360|P1|COMPLETED|Overall Study||0
2575168|NCT00409331|6316360|P1|STARTED|Overall Study||1
2575169|NCT00409292|6316364|P1|NOT COMPLETED|Overall Study||0
2575170|NCT00409292|6316364|P1|COMPLETED|Overall Study||33
2575171|NCT00409292|6316364|P1|STARTED|Overall Study||33
2575172|NCT00409240|6316373|P2|NOT COMPLETED|Overall Study||1
2575173|NCT00409240|6316374|P1|NOT COMPLETED|Overall Study||3
2575174|NCT00409240|6316373|P2|COMPLETED|Overall Study||49
2575175|NCT00409240|6316374|P1|COMPLETED|Overall Study||50
2575176|NCT00409240|6316373|P2|STARTED|Overall Study||50
2575177|NCT00409240|6316374|P1|STARTED|Overall Study||53
2575178|NCT00409188|6316382|P2|NOT COMPLETED|Overall Study||175
2575179|NCT00409188|6316383|P1|NOT COMPLETED|Overall Study||383
2575180|NCT00409188|6316382|P2|COMPLETED|Overall Study||332
2575181|NCT00409188|6316383|P1|COMPLETED|Overall Study||623
2575182|NCT00409188|6316382|P2|STARTED|Overall Study||507
2575183|NCT00409188|6316383|P1|STARTED|Overall Study||1006
2575184|NCT00409175|6316399|P2|NOT COMPLETED|Overall Study||19
2575185|NCT00409175|6316400|P1|NOT COMPLETED|Overall Study||18
2575186|NCT00409175|6316399|P2|COMPLETED|Overall Study||44
2575187|NCT00409175|6316400|P1|COMPLETED|Overall Study||47
2575188|NCT00409175|6316399|P2|STARTED|Overall Study||63
2575189|NCT00409175|6316400|P1|STARTED|Overall Study||65
2575190|NCT00409006|6316426|P2|NOT COMPLETED|Overall Study||12
2575191|NCT00409006|6316427|P1|NOT COMPLETED|Overall Study||20
2575192|NCT00409006|6316426|P2|COMPLETED|Overall Study||19
2575193|NCT00409006|6316427|P1|COMPLETED|Overall Study||19
2575194|NCT00409006|6316426|P2|STARTED|Overall Study||31
2575195|NCT00409006|6316427|P1|STARTED|Overall Study||39
2575196|NCT00408993|6316443|P2|NOT COMPLETED|Overall Study||17
2575197|NCT00408993|6316444|P1|NOT COMPLETED|Overall Study||19
2575198|NCT00408993|6316443|P2|COMPLETED|Overall Study||92
2575199|NCT00408993|6316444|P1|COMPLETED|Overall Study||87
2575200|NCT00408993|6316443|P2|STARTED|Overall Study||109
2575201|NCT00408993|6316444|P1|STARTED|Overall Study||106
2575202|NCT00408928|6316476|P1|NOT COMPLETED|Overall Study||3
2575203|NCT00408928|6316476|P1|COMPLETED|Overall Study||8
2575204|NCT00408928|6316476|P1|STARTED|Overall Study||11
2575205|NCT00408902|6316481|P1|NOT COMPLETED|Overall Study||10
2575206|NCT00408902|6316481|P1|COMPLETED|Overall Study||0
2575207|NCT00408902|6316481|P1|STARTED|Overall Study||10
2575208|NCT00408876|6316491|P4|NOT COMPLETED|Overall Study||35
2575209|NCT00408876|6316492|P3|NOT COMPLETED|Overall Study||50
2575210|NCT00408876|6316493|P2|NOT COMPLETED|Overall Study||36
2575211|NCT00408876|6316494|P1|NOT COMPLETED|Overall Study||16
2575212|NCT00408876|6316491|P4|COMPLETED|Overall Study||82
2575213|NCT00408876|6316492|P3|COMPLETED|Overall Study||62
2575214|NCT00408876|6316493|P2|COMPLETED|Overall Study||80
2575215|NCT00408876|6316494|P1|COMPLETED|Overall Study||43
2575216|NCT00408876|6316491|P4|STARTED|Overall Study||117
2575217|NCT00408876|6316492|P3|STARTED|Overall Study||112
2575218|NCT00408876|6316493|P2|STARTED|Overall Study||116
2575219|NCT00408876|6316494|P1|STARTED|Overall Study||59
2575220|NCT00408694|6316744|P1|NOT COMPLETED|Overall Study||2
2575221|NCT00408694|6316744|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
2575222|NCT00408694|6316744|P1|STARTED|Overall Study||46
2575223|NCT00408681|6316756|P1|NOT COMPLETED|Overall Study||9
2575224|NCT00408681|6316756|P1|COMPLETED|Overall Study|Completion was defined as administration of the study product for at least 28 days.|11
2575225|NCT00408681|6316756|P1|STARTED|Overall Study||20
2575226|NCT00408629|6316775|P2|NOT COMPLETED|Overall Study||125
2575227|NCT00408629|6316776|P1|NOT COMPLETED|Overall Study||97
2575228|NCT00408629|6316775|P2|COMPLETED|Overall Study||135
2575229|NCT00408629|6316776|P1|COMPLETED|Overall Study|1 ADA recipient did not receive study drug and discontinued due to other reasons.|161
2575230|NCT00408629|6316775|P2|STARTED|Overall Study|14 PLB recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (246).|260
2575231|NCT00408629|6316776|P1|STARTED|Overall Study|10 ADA recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (248).|258
2575232|NCT00408603|6316818|P3|NOT COMPLETED|Overall Study||40
2575233|NCT00408603|6316819|P2|NOT COMPLETED|Overall Study||2
2575234|NCT00408603|6316820|P1|NOT COMPLETED|Overall Study||4
2575235|NCT00408603|6316818|P3|COMPLETED|Overall Study||35
2575236|NCT00408603|6316819|P2|COMPLETED|Overall Study||37
2575237|NCT00408603|6316820|P1|COMPLETED|Overall Study||65
2575238|NCT00408603|6316818|P3|STARTED|Overall Study||75
2575239|NCT00408603|6316819|P2|STARTED|Overall Study||39
2575240|NCT00408603|6316820|P1|STARTED|Overall Study||69
2575241|NCT00408590|6316836|P9|NOT COMPLETED|Overall Study||0
2575242|NCT00408590|6316837|P8|NOT COMPLETED|Overall Study||0
2575243|NCT00408590|6316838|P7|NOT COMPLETED|Overall Study||0
2575244|NCT00408590|6316839|P6|NOT COMPLETED|Overall Study||0
2575245|NCT00408590|6316840|P5|NOT COMPLETED|Overall Study||0
2575246|NCT00408590|6316841|P4|NOT COMPLETED|Overall Study||0
2575247|NCT00408590|6316842|P3|NOT COMPLETED|Overall Study||0
2575248|NCT00408590|6316843|P2|NOT COMPLETED|Overall Study||0
2575249|NCT00408590|6316844|P1|NOT COMPLETED|Overall Study||0
2575250|NCT00408590|6316836|P9|COMPLETED|Overall Study||13
2575251|NCT00408590|6316837|P8|COMPLETED|Overall Study||3
2575252|NCT00408590|6316838|P7|COMPLETED|Overall Study||3
2575253|NCT00408590|6316839|P6|COMPLETED|Overall Study||3
2575254|NCT00408590|6316840|P5|COMPLETED|Overall Study||3
2575255|NCT00408590|6316841|P4|COMPLETED|Overall Study||3
2575256|NCT00408590|6316842|P3|COMPLETED|Overall Study||3
2575257|NCT00408590|6316843|P2|COMPLETED|Overall Study||3
2575258|NCT00408590|6316844|P1|COMPLETED|Overall Study||3
2575259|NCT00408590|6316836|P9|STARTED|Overall Study||13
2575260|NCT00408590|6316837|P8|STARTED|Overall Study||3
2575261|NCT00408590|6316838|P7|STARTED|Overall Study||3
2575262|NCT00408590|6316839|P6|STARTED|Overall Study||3
2575263|NCT00408590|6316840|P5|STARTED|Overall Study||3
2575264|NCT00408590|6316841|P4|STARTED|Overall Study||3
2575265|NCT00408590|6316842|P3|STARTED|Overall Study||3
2575266|NCT00408590|6316843|P2|STARTED|Overall Study||3
2575267|NCT00408590|6316844|P1|STARTED|Overall Study||3
2575268|NCT00408564|6316863|P1|NOT COMPLETED|Overall Study||0
2575269|NCT00408564|6316863|P1|COMPLETED|Overall Study||39
2575270|NCT00408564|6316863|P1|STARTED|Overall Study||39
2575271|NCT00408499|6316872|P5|NOT COMPLETED|Phase II- MTD Expansion||20
2575272|NCT00408499|6316873|P4|NOT COMPLETED|Phase II- MTD Expansion||0
2575273|NCT00408499|6316874|P3|NOT COMPLETED|Phase II- MTD Expansion||0
2575274|NCT00408499|6316875|P2|NOT COMPLETED|Phase II- MTD Expansion||0
2575275|NCT00408499|6316876|P1|NOT COMPLETED|Phase II- MTD Expansion||0
2575276|NCT00408499|6316872|P5|COMPLETED|Phase II- MTD Expansion||24
2575277|NCT00408499|6316873|P4|COMPLETED|Phase II- MTD Expansion||0
2575278|NCT00408499|6316874|P3|COMPLETED|Phase II- MTD Expansion||0
2575279|NCT00408499|6316875|P2|COMPLETED|Phase II- MTD Expansion||0
2575280|NCT00408499|6316876|P1|COMPLETED|Phase II- MTD Expansion||0
2575281|NCT00408499|6316872|P5|STARTED|Phase II- MTD Expansion||44
2575282|NCT00408499|6316873|P4|STARTED|Phase II- MTD Expansion||0
2575283|NCT00408499|6316874|P3|STARTED|Phase II- MTD Expansion||0
2575284|NCT00408499|6316875|P2|STARTED|Phase II- MTD Expansion||0
2575285|NCT00408499|6316876|P1|STARTED|Phase II- MTD Expansion||0
2575286|NCT00408499|6316872|P5|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
2575287|NCT00408499|6316873|P4|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
2575288|NCT00408499|6316874|P3|NOT COMPLETED|Phase 1: Dose Levels 1-4||1
2575289|NCT00408499|6316875|P2|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
2575290|NCT00408499|6316876|P1|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
2575291|NCT00408499|6316872|P5|COMPLETED|Phase 1: Dose Levels 1-4||0
2575292|NCT00408499|6316873|P4|COMPLETED|Phase 1: Dose Levels 1-4||6
2575293|NCT00408499|6316874|P3|COMPLETED|Phase 1: Dose Levels 1-4||2
2575294|NCT00408499|6316875|P2|COMPLETED|Phase 1: Dose Levels 1-4||5
2575295|NCT00408499|6316876|P1|COMPLETED|Phase 1: Dose Levels 1-4||2
2575296|NCT00408499|6316872|P5|STARTED|Phase 1: Dose Levels 1-4||0
2575297|NCT00408499|6316873|P4|STARTED|Phase 1: Dose Levels 1-4||6
2575298|NCT00408499|6316874|P3|STARTED|Phase 1: Dose Levels 1-4||3
2575299|NCT00408499|6316875|P2|STARTED|Phase 1: Dose Levels 1-4||7
2575300|NCT00408499|6316876|P1|STARTED|Phase 1: Dose Levels 1-4||4
2575301|NCT00408460|6316885|P1|NOT COMPLETED|Overall Study||0
2575302|NCT00408460|6316885|P1|COMPLETED|Overall Study||34
2575303|NCT00408460|6316885|P1|STARTED|Overall Study||34
2575304|NCT00408421|6316893|P3|NOT COMPLETED|Treatment Re-Randomization||5
2575305|NCT00408421|6316894|P2|NOT COMPLETED|Treatment Re-Randomization||7
2575306|NCT00408421|6316895|P1|NOT COMPLETED|Treatment Re-Randomization||7
2575307|NCT00408421|6316893|P3|COMPLETED|Treatment Re-Randomization||38
2575308|NCT00408421|6316894|P2|COMPLETED|Treatment Re-Randomization||39
2575309|NCT00408421|6316895|P1|COMPLETED|Treatment Re-Randomization||96
2575310|NCT00408421|6316893|P3|STARTED|Treatment Re-Randomization||43
2575311|NCT00408421|6316894|P2|STARTED|Treatment Re-Randomization||46
2575312|NCT00408421|6316895|P1|STARTED|Treatment Re-Randomization||103
2575313|NCT00408421|6316893|P3|NOT COMPLETED|Treatment Initial Randomization||0
2575314|NCT00408421|6316894|P2|NOT COMPLETED|Treatment Initial Randomization||22
2575315|NCT00408421|6316895|P1|NOT COMPLETED|Treatment Initial Randomization||17
2575316|NCT00408421|6316893|P3|COMPLETED|Treatment Initial Randomization|Patients weren't randomized to Duloxetine 120 mg until Visit 4.|0
2575317|NCT00408421|6316894|P2|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|89
2575318|NCT00408421|6316895|P1|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|103
2575319|NCT00408421|6316893|P3|STARTED|Treatment Initial Randomization||0
2575320|NCT00408421|6316894|P2|STARTED|Treatment Initial Randomization||111
2575321|NCT00408421|6316895|P1|STARTED|Treatment Initial Randomization||120
2575322|NCT00408408|6316975|P6|NOT COMPLETED|Overall Study||3
2575323|NCT00408408|6316976|P5|NOT COMPLETED|Overall Study||5
2575324|NCT00408408|6316977|P4|NOT COMPLETED|Overall Study||7
2575325|NCT00408408|6316978|P3|NOT COMPLETED|Overall Study||0
2575326|NCT00408408|6316979|P2|NOT COMPLETED|Overall Study||3
2575327|NCT00408408|6316980|P1|NOT COMPLETED|Overall Study||2
2575328|NCT00408408|6316975|P6|COMPLETED|Overall Study||201
2575329|NCT00408408|6316976|P5|COMPLETED|Overall Study||192
2575330|NCT00408408|6316977|P4|COMPLETED|Overall Study||194
2575331|NCT00408408|6316978|P3|COMPLETED|Overall Study||204
2575332|NCT00408408|6316979|P2|COMPLETED|Overall Study||196
2575333|NCT00408408|6316980|P1|COMPLETED|Overall Study||199
2575334|NCT00408408|6316975|P6|STARTED|Overall Study||204
2575335|NCT00408408|6316976|P5|STARTED|Overall Study||197
2575336|NCT00408408|6316977|P4|STARTED|Overall Study||201
2575337|NCT00408408|6316978|P3|STARTED|Overall Study||204
2575338|NCT00408408|6316979|P2|STARTED|Overall Study||199
2575339|NCT00408408|6316980|P1|STARTED|Overall Study||201
2575340|NCT00408317|6317042|P2|NOT COMPLETED|Second Intervention Period||2
2575341|NCT00408317|6317043|P1|NOT COMPLETED|Second Intervention Period||2
2575342|NCT00408317|6317042|P2|COMPLETED|Second Intervention Period||14
2575343|NCT00408317|6317043|P1|COMPLETED|Second Intervention Period||12
2575344|NCT00408317|6317042|P2|STARTED|Second Intervention Period||16
2575345|NCT00408317|6317043|P1|STARTED|Second Intervention Period||14
2575346|NCT00408317|6317042|P2|NOT COMPLETED|First Intervention Period||1
2575347|NCT00408317|6317043|P1|NOT COMPLETED|First Intervention Period||0
2575348|NCT00408317|6317042|P2|COMPLETED|First Intervention Period||16
2575349|NCT00408317|6317043|P1|COMPLETED|First Intervention Period||14
2575350|NCT00408317|6317042|P2|STARTED|First Intervention Period||17
2575351|NCT00408317|6317043|P1|STARTED|First Intervention Period||14
2575352|NCT00408200|6317057|P2|NOT COMPLETED|Overall Study||0
2575353|NCT00408200|6317058|P1|NOT COMPLETED|Overall Study||0
2575354|NCT00408200|6317057|P2|COMPLETED|Overall Study||53
2575355|NCT00408200|6317058|P1|COMPLETED|Overall Study||57
2575356|NCT00408200|6317057|P2|STARTED|Overall Study||53
2575357|NCT00408200|6317058|P1|STARTED|Overall Study||57
2575358|NCT00408070|6317066|P1|NOT COMPLETED|Overall Study||0
2575359|NCT00408070|6317066|P1|COMPLETED|Overall Study||5
2575360|NCT00408070|6317066|P1|STARTED|Overall Study||5
2575361|NCT00408005|6317076|P8|NOT COMPLETED|Post Induction Therapy by Tx Assignment||14
2575362|NCT00408005|6317077|P7|NOT COMPLETED|Post Induction Therapy by Tx Assignment||28
2575363|NCT00408005|6317078|P6|NOT COMPLETED|Post Induction Therapy by Tx Assignment||101
2575364|NCT00408005|6317079|P5|NOT COMPLETED|Post Induction Therapy by Tx Assignment||132
2575365|NCT00408005|6317080|P4|NOT COMPLETED|Post Induction Therapy by Tx Assignment||44
2575366|NCT00408005|6317081|P3|NOT COMPLETED|Post Induction Therapy by Tx Assignment||85
2575367|NCT00408005|6317082|P2|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
2575368|NCT00408005|6317083|P1|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
2575369|NCT00408005|6317076|P8|COMPLETED|Post Induction Therapy by Tx Assignment||48
2575370|NCT00408005|6317077|P7|COMPLETED|Post Induction Therapy by Tx Assignment||115
2575371|NCT00408005|6317078|P6|COMPLETED|Post Induction Therapy by Tx Assignment||118
2575372|NCT00408005|6317079|P5|COMPLETED|Post Induction Therapy by Tx Assignment||319
2575373|NCT00408005|6317080|P4|COMPLETED|Post Induction Therapy by Tx Assignment||103
2575374|NCT00408005|6317081|P3|COMPLETED|Post Induction Therapy by Tx Assignment||287
2575375|NCT00408005|6317082|P2|COMPLETED|Post Induction Therapy by Tx Assignment||0
2575376|NCT00408005|6317083|P1|COMPLETED|Post Induction Therapy by Tx Assignment||0
2575377|NCT00408005|6317076|P8|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||2
2575378|NCT00408005|6317077|P7|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
2575379|NCT00408005|6317078|P6|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
2575380|NCT00408005|6317079|P5|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
2575381|NCT00408005|6317080|P4|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
2575382|NCT00408005|6317081|P3|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
2575383|NCT00408005|6317082|P2|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
2575384|NCT00408005|6317083|P1|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
2575385|NCT00408005|6317076|P8|T-LLy High Risk|Post Induction Therapy by Tx Assignment||60
2575386|NCT00408005|6317077|P7|T-LLy High Risk|Post Induction Therapy by Tx Assignment||61
2575387|NCT00408005|6317078|P6|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
2575388|NCT00408005|6317079|P5|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
2575389|NCT00408005|6317080|P4|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
2575390|NCT00408005|6317081|P3|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
2575391|NCT00408005|6317082|P2|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
2575392|NCT00408005|6317083|P1|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
2575393|NCT00408005|6317076|P8|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
2575394|NCT00408005|6317077|P7|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||82
2575395|NCT00408005|6317078|P6|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
2575396|NCT00408005|6317079|P5|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
2575397|NCT00408005|6317080|P4|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
2575398|NCT00408005|6317081|P3|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
2575399|NCT00408005|6317082|P2|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
2575400|NCT00408005|6317083|P1|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
2575401|NCT00408005|6317076|P8|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
2575402|NCT00408005|6317077|P7|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
2575403|NCT00408005|6317078|P6|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||43
2575404|NCT00408005|6317079|P5|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
2575405|NCT00408005|6317080|P4|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
2575406|NCT00408005|6317081|P3|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
2575407|NCT00408005|6317082|P2|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
2575408|NCT00408005|6317083|P1|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
2575409|NCT00408005|6317076|P8|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
2575410|NCT00408005|6317077|P7|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
2575411|NCT00408005|6317078|P6|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||31
2575412|NCT00408005|6317079|P5|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||84
2575413|NCT00408005|6317080|P4|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
2575585|NCT00406653|6317513|P6|NOT COMPLETED|Open-Label Period||0
2575414|NCT00408005|6317081|P3|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
2575415|NCT00408005|6317082|P2|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
2575416|NCT00408005|6317083|P1|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
2575417|NCT00408005|6317076|P8|High Risk|Post Induction Therapy by Tx Assignment||0
2575418|NCT00408005|6317077|P7|High Risk|Post Induction Therapy by Tx Assignment||0
2575419|NCT00408005|6317078|P6|High Risk|Post Induction Therapy by Tx Assignment||52
2575420|NCT00408005|6317079|P5|High Risk|Post Induction Therapy by Tx Assignment||55
2575421|NCT00408005|6317080|P4|High Risk|Post Induction Therapy by Tx Assignment||52
2575422|NCT00408005|6317081|P3|High Risk|Post Induction Therapy by Tx Assignment||56
2575423|NCT00408005|6317082|P2|High Risk|Post Induction Therapy by Tx Assignment||0
2575424|NCT00408005|6317083|P1|High Risk|Post Induction Therapy by Tx Assignment||0
2575425|NCT00408005|6317076|P8|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
2575426|NCT00408005|6317077|P7|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
2575427|NCT00408005|6317078|P6|Intermediate Risk|Post Induction Therapy by Tx Assignment||93
2575428|NCT00408005|6317079|P5|Intermediate Risk|Post Induction Therapy by Tx Assignment||257
2575429|NCT00408005|6317080|P4|Intermediate Risk|Post Induction Therapy by Tx Assignment||95
2575430|NCT00408005|6317081|P3|Intermediate Risk|Post Induction Therapy by Tx Assignment||99
2575431|NCT00408005|6317082|P2|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
2575432|NCT00408005|6317083|P1|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
2575433|NCT00408005|6317076|P8|Low Risk|Post Induction Therapy by Tx Assignment||0
2575434|NCT00408005|6317077|P7|Low Risk|Post Induction Therapy by Tx Assignment||0
2575435|NCT00408005|6317078|P6|Low Risk|Post Induction Therapy by Tx Assignment||0
2575436|NCT00408005|6317079|P5|Low Risk|Post Induction Therapy by Tx Assignment||55
2575437|NCT00408005|6317080|P4|Low Risk|Post Induction Therapy by Tx Assignment||0
2575438|NCT00408005|6317081|P3|Low Risk|Post Induction Therapy by Tx Assignment||217
2575439|NCT00408005|6317082|P2|Low Risk|Post Induction Therapy by Tx Assignment||0
2575440|NCT00408005|6317083|P1|Low Risk|Post Induction Therapy by Tx Assignment||0
2575441|NCT00408005|6317076|P8|STARTED|Post Induction Therapy by Tx Assignment||62
2575442|NCT00408005|6317077|P7|STARTED|Post Induction Therapy by Tx Assignment||143
2575443|NCT00408005|6317078|P6|STARTED|Post Induction Therapy by Tx Assignment||219
2575444|NCT00408005|6317079|P5|STARTED|Post Induction Therapy by Tx Assignment||451
2575445|NCT00408005|6317080|P4|STARTED|Post Induction Therapy by Tx Assignment||147
2575446|NCT00408005|6317081|P3|STARTED|Post Induction Therapy by Tx Assignment||372
2575447|NCT00408005|6317082|P2|STARTED|Post Induction Therapy by Tx Assignment||0
2575448|NCT00408005|6317083|P1|STARTED|Post Induction Therapy by Tx Assignment||0
2575449|NCT00408005|6317076|P8|NOT COMPLETED|Induction||0
2575450|NCT00408005|6317077|P7|NOT COMPLETED|Induction||0
2575451|NCT00408005|6317078|P6|NOT COMPLETED|Induction||0
2575452|NCT00408005|6317079|P5|NOT COMPLETED|Induction||0
2575453|NCT00408005|6317080|P4|NOT COMPLETED|Induction||0
2575454|NCT00408005|6317081|P3|NOT COMPLETED|Induction||0
2575455|NCT00408005|6317082|P2|NOT COMPLETED|Induction||94
2575456|NCT00408005|6317083|P1|NOT COMPLETED|Induction||407
2575457|NCT00408005|6317076|P8|COMPLETED|Induction||0
2575458|NCT00408005|6317077|P7|COMPLETED|Induction||0
2575459|NCT00408005|6317078|P6|COMPLETED|Induction||0
2575460|NCT00408005|6317079|P5|COMPLETED|Induction||0
2575461|NCT00408005|6317080|P4|COMPLETED|Induction||0
2575462|NCT00408005|6317081|P3|COMPLETED|Induction||0
2575463|NCT00408005|6317082|P2|COMPLETED|Induction||205
2575464|NCT00408005|6317083|P1|COMPLETED|Induction||1189
2575465|NCT00408005|6317076|P8|STARTED|Induction||0
2575466|NCT00408005|6317077|P7|STARTED|Induction||0
2575467|NCT00408005|6317078|P6|STARTED|Induction||0
2575468|NCT00408005|6317079|P5|STARTED|Induction||0
2575469|NCT00408005|6317080|P4|STARTED|Induction||0
2575470|NCT00408005|6317081|P3|STARTED|Induction||0
2575471|NCT00408005|6317082|P2|STARTED|Induction||299
2575472|NCT00408005|6317083|P1|STARTED|Induction||1596
2575473|NCT00407966|6317113|P1|NOT COMPLETED|Overall Study||0
2575474|NCT00407966|6317113|P1|COMPLETED|Overall Study||45
2575475|NCT00407966|6317113|P1|CR|Overall Study||30
2575476|NCT00407966|6317113|P1|STARTED|Overall Study||45
2575477|NCT00407888|6317117|P1|NOT COMPLETED|Overall Study||0
2575478|NCT00407888|6317117|P1|COMPLETED|Overall Study||60
2575479|NCT00407888|6317117|P1|STARTED|Overall Study||60
2575480|NCT00407797|6317125|P1|NOT COMPLETED|Overall Study||18
2575481|NCT00407797|6317125|P1|COMPLETED|Overall Study||118
2575482|NCT00407797|6317125|P1|Full Analysis Set|Overall Study|At least 1 dose of study medication and had a baseline and at least 1 post-baseline measurement.|135
2575483|NCT00407797|6317125|P1|STARTED|Overall Study||136
2575484|NCT00407758|6317140|P1|NOT COMPLETED|Overall Study||1
2575485|NCT00407758|6317140|P1|COMPLETED|Overall Study||27
2575486|NCT00407758|6317140|P1|STARTED|Overall Study||28
2575487|NCT00407745|6317153|P2|NOT COMPLETED|Overall Study||17
2575488|NCT00407745|6317154|P1|NOT COMPLETED|Overall Study||19
2575489|NCT00407745|6317153|P2|COMPLETED|Overall Study||91
2575490|NCT00407745|6317154|P1|COMPLETED|Overall Study||93
2575491|NCT00407745|6317153|P2|Treated|Overall Study||107
2575492|NCT00407745|6317154|P1|Treated|Overall Study||112
2575493|NCT00407745|6317153|P2|STARTED|Overall Study||108
2575494|NCT00407745|6317154|P1|STARTED|Overall Study||112
2575495|NCT00407654|6317226|P1|NOT COMPLETED|Overall Study||0
2575496|NCT00407654|6317226|P1|COMPLETED|Overall Study||75
2575497|NCT00407654|6317226|P1|STARTED|Overall Study||75
2575498|NCT00407563|6317240|P1|NOT COMPLETED|Overall Study||1
2575499|NCT00407563|6317240|P1|COMPLETED|Overall Study|One patient remains on study treatment.|47
2575500|NCT00407563|6317240|P1|STARTED|Overall Study||48
2575501|NCT00407550|6317250|P2|NOT COMPLETED|Overall Study||4
2575502|NCT00407550|6317251|P1|NOT COMPLETED|Overall Study||3
2575503|NCT00407550|6317250|P2|COMPLETED|Overall Study||5
2575504|NCT00407550|6317251|P1|COMPLETED|Overall Study||7
2575505|NCT00407550|6317250|P2|STARTED|Overall Study||9
2575506|NCT00407550|6317251|P1|STARTED|Overall Study||10
2575507|NCT00407537|6317265|P2|NOT COMPLETED|Overall Study||44
2575508|NCT00407537|6317266|P1|NOT COMPLETED|Overall Study||93
2575509|NCT00407537|6317265|P2|COMPLETED|Overall Study||638
2575510|NCT00407537|6317266|P1|COMPLETED|Overall Study||686
2575511|NCT00407537|6317265|P2|Eligible for Efficacy Analysis|Overall Study||657
2575512|NCT00407537|6317266|P1|Eligible for Efficacy Analysis|Overall Study||760
2575513|NCT00407537|6317265|P2|STARTED|Overall Study|4 participants assigned to Caduet treatment received usual care only during the study|682
2575514|NCT00407537|6317266|P1|STARTED|Overall Study||779
2575515|NCT00407511|6317314|P1|NOT COMPLETED|Overall Study||22
2575516|NCT00407511|6317314|P1|COMPLETED|Overall Study||99
2575517|NCT00407511|6317314|P1|STARTED|Overall Study||121
2575518|NCT00407485|6317328|P1|NOT COMPLETED|Overall Study||0
2575519|NCT00407485|6317328|P1|COMPLETED|Overall Study||22
2575520|NCT00407485|6317328|P1|STARTED|Overall Study||22
2575521|NCT00407420|6317335|P2|NOT COMPLETED|Overall Study||6
2575522|NCT00407420|6317336|P1|NOT COMPLETED|Overall Study||9
2575523|NCT00407420|6317335|P2|COMPLETED|Overall Study||46
2575524|NCT00407420|6317336|P1|COMPLETED|Overall Study||45
2575525|NCT00407420|6317335|P2|STARTED|Overall Study||52
2575526|NCT00407420|6317336|P1|STARTED|Overall Study||54
2575527|NCT00407381|6317351|P3|NOT COMPLETED|Overall Study||2
2575528|NCT00407381|6317352|P2|NOT COMPLETED|Overall Study||4
2575529|NCT00407381|6317353|P1|NOT COMPLETED|Overall Study||3
2575530|NCT00407381|6317351|P3|COMPLETED|Overall Study||40
2575531|NCT00407381|6317352|P2|COMPLETED|Overall Study||38
2575532|NCT00407381|6317353|P1|COMPLETED|Overall Study||39
2575533|NCT00407381|6317351|P3|STARTED|Overall Study||42
2575534|NCT00407381|6317352|P2|STARTED|Overall Study||42
2575535|NCT00407381|6317353|P1|STARTED|Overall Study||42
2575536|NCT00407355|6317363|P2|NOT COMPLETED|Overall Study||11
2575537|NCT00407355|6317364|P1|NOT COMPLETED|Overall Study||10
2575538|NCT00407355|6317363|P2|COMPLETED|Overall Study||9
2575539|NCT00407355|6317364|P1|COMPLETED|Overall Study||10
2575540|NCT00407355|6317363|P2|STARTED|Overall Study||20
2575541|NCT00407355|6317364|P1|STARTED|Overall Study||20
2575542|NCT00407030|6317375|P3|NOT COMPLETED|Extension Period - up to 68 Weeks||0
2575543|NCT00407030|6317376|P2|NOT COMPLETED|Extension Period - up to 68 Weeks||29
2575544|NCT00407030|6317377|P1|NOT COMPLETED|Extension Period - up to 68 Weeks||27
2575545|NCT00407030|6317375|P3|COMPLETED|Extension Period - up to 68 Weeks||0
2575546|NCT00407030|6317376|P2|COMPLETED|Extension Period - up to 68 Weeks||74
2575547|NCT00407030|6317377|P1|COMPLETED|Extension Period - up to 68 Weeks||84
2575548|NCT00407030|6317375|P3|STARTED|Extension Period - up to 68 Weeks|After the Main Period all patients were randomly assigned to the 2 active treatment arms.|0
2575549|NCT00407030|6317376|P2|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|103
2575550|NCT00407030|6317377|P1|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|111
2575551|NCT00407030|6317375|P3|NOT COMPLETED|Main Period - 8 to 20 Weeks||6
2575552|NCT00407030|6317376|P2|NOT COMPLETED|Main Period - 8 to 20 Weeks||3
2575553|NCT00407030|6317377|P1|NOT COMPLETED|Main Period - 8 to 20 Weeks||5
2575554|NCT00407030|6317375|P3|COMPLETED|Main Period - 8 to 20 Weeks||68
2575555|NCT00407030|6317376|P2|COMPLETED|Main Period - 8 to 20 Weeks||75
2575556|NCT00407030|6317377|P1|COMPLETED|Main Period - 8 to 20 Weeks||76
2575557|NCT00407030|6317375|P3|STARTED|Main Period - 8 to 20 Weeks||74
2575558|NCT00407030|6317376|P2|STARTED|Main Period - 8 to 20 Weeks||78
2575559|NCT00407030|6317377|P1|STARTED|Main Period - 8 to 20 Weeks||81
2575560|NCT00406848|6317405|P2|NOT COMPLETED|Overall Study||54
2575561|NCT00406848|6317406|P1|NOT COMPLETED|Overall Study||93
2575562|NCT00406848|6317405|P2|COMPLETED|Overall Study||67
2575563|NCT00406848|6317406|P1|COMPLETED|Overall Study||156
2575564|NCT00406848|6317405|P2|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=95.|121
2575565|NCT00406848|6317406|P1|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=204.|249
2575566|NCT00406783|6317470|P2|NOT COMPLETED|Overall Study||15
2575567|NCT00406783|6317471|P1|NOT COMPLETED|Overall Study||14
2575568|NCT00406783|6317470|P2|COMPLETED|Overall Study||256
2575569|NCT00406783|6317471|P1|COMPLETED|Overall Study||262
2575570|NCT00406783|6317470|P2|STARTED|Overall Study||271
2575571|NCT00406783|6317471|P1|STARTED|Overall Study||276
2575572|NCT00406718|6317486|P3|NOT COMPLETED|Overall Study||8
2575573|NCT00406718|6317487|P2|NOT COMPLETED|Overall Study||14
2575574|NCT00406718|6317488|P1|NOT COMPLETED|Overall Study||4
2575575|NCT00406718|6317486|P3|COMPLETED|Overall Study||39
2575576|NCT00406718|6317487|P2|COMPLETED|Overall Study||34
2575577|NCT00406718|6317488|P1|COMPLETED|Overall Study||43
2575578|NCT00406718|6317486|P3|STARTED|Overall Study||47
2575579|NCT00406718|6317487|P2|STARTED|Overall Study||48
2575580|NCT00406718|6317488|P1|STARTED|Overall Study||47
2575581|NCT00406692|6317502|P1|NOT COMPLETED|Overall Study||7
2575582|NCT00406692|6317502|P1|COMPLETED|Overall Study||9
2575583|NCT00406692|6317502|P1|STARTED|Overall Study||16
2575584|NCT00406653|6317512|P7|NOT COMPLETED|Open-Label Period||324
2575586|NCT00406653|6317514|P5|NOT COMPLETED|Open-Label Period||0
2575587|NCT00406653|6317515|P4|NOT COMPLETED|Open-Label Period||0
2575588|NCT00406653|6317516|P3|NOT COMPLETED|Open-Label Period||0
2575589|NCT00406653|6317517|P2|NOT COMPLETED|Open-Label Period||0
2575590|NCT00406653|6317518|P1|NOT COMPLETED|Open-Label Period||0
2575591|NCT00406653|6317512|P7|COMPLETED|Open-Label Period||0
2575592|NCT00406653|6317513|P6|COMPLETED|Open-Label Period||0
2575593|NCT00406653|6317514|P5|COMPLETED|Open-Label Period||0
2575594|NCT00406653|6317515|P4|COMPLETED|Open-Label Period||0
2575595|NCT00406653|6317516|P3|COMPLETED|Open-Label Period||0
2575596|NCT00406653|6317517|P2|COMPLETED|Open-Label Period||0
2575597|NCT00406653|6317518|P1|COMPLETED|Open-Label Period||0
2575598|NCT00406653|6317512|P7|STARTED|Open-Label Period|All completing IP but failing response criteria and those completing or relapsing on MP entered OL.|324
2575599|NCT00406653|6317513|P6|STARTED|Open-Label Period||0
2575600|NCT00406653|6317514|P5|STARTED|Open-Label Period||0
2575601|NCT00406653|6317515|P4|STARTED|Open-Label Period||0
2575602|NCT00406653|6317516|P3|STARTED|Open-Label Period||0
2575603|NCT00406653|6317517|P2|STARTED|Open-Label Period||0
2575604|NCT00406653|6317518|P1|STARTED|Open-Label Period||0
2575605|NCT00406653|6317512|P7|NOT COMPLETED|Maintenance Period||0
2575606|NCT00406653|6317513|P6|NOT COMPLETED|Maintenance Period||36
2575607|NCT00406653|6317514|P5|NOT COMPLETED|Maintenance Period||30
2575608|NCT00406653|6317515|P4|NOT COMPLETED|Maintenance Period||0
2575609|NCT00406653|6317516|P3|NOT COMPLETED|Maintenance Period||0
2575610|NCT00406653|6317517|P2|NOT COMPLETED|Maintenance Period||0
2575611|NCT00406653|6317518|P1|NOT COMPLETED|Maintenance Period||0
2575612|NCT00406653|6317512|P7|COMPLETED|Maintenance Period||0
2575613|NCT00406653|6317513|P6|COMPLETED|Maintenance Period||10
2575614|NCT00406653|6317514|P5|COMPLETED|Maintenance Period||14
2575615|NCT00406653|6317515|P4|COMPLETED|Maintenance Period||0
2575616|NCT00406653|6317516|P3|COMPLETED|Maintenance Period||0
2575617|NCT00406653|6317517|P2|COMPLETED|Maintenance Period||0
2575618|NCT00406653|6317518|P1|COMPLETED|Maintenance Period||0
2575619|NCT00406653|6317512|P7|STARTED|Maintenance Period||0
2575620|NCT00406653|6317513|P6|STARTED|Maintenance Period|At end of IP, 46 participants met response criteria and were randomly assigned to placebo in MP.|46
2575621|NCT00406653|6317514|P5|STARTED|Maintenance Period|At end of IP, 44 participants met response criteria and were randomly assigned to abatacept in MP.|44
2575622|NCT00406653|6317515|P4|STARTED|Maintenance Period||0
2575623|NCT00406653|6317516|P3|STARTED|Maintenance Period||0
2575624|NCT00406653|6317517|P2|STARTED|Maintenance Period||0
2575625|NCT00406653|6317518|P1|STARTED|Maintenance Period||0
2575626|NCT00406653|6317512|P7|NOT COMPLETED|Induction Period||0
2575627|NCT00406653|6317513|P6|NOT COMPLETED|Induction Period||0
2575628|NCT00406653|6317514|P5|NOT COMPLETED|Induction Period||0
2575629|NCT00406653|6317515|P4|NOT COMPLETED|Induction Period||26
2575630|NCT00406653|6317516|P3|NOT COMPLETED|Induction Period||18
2575631|NCT00406653|6317517|P2|NOT COMPLETED|Induction Period||34
2575632|NCT00406653|6317518|P1|NOT COMPLETED|Induction Period||15
2575633|NCT00406653|6317512|P7|COMPLETED|Induction Period||0
2575634|NCT00406653|6317513|P6|COMPLETED|Induction Period||0
2575635|NCT00406653|6317514|P5|COMPLETED|Induction Period||0
2575636|NCT00406653|6317515|P4|COMPLETED|Induction Period||102
2575637|NCT00406653|6317516|P3|COMPLETED|Induction Period||112
2575638|NCT00406653|6317517|P2|COMPLETED|Induction Period||94
2575639|NCT00406653|6317518|P1|COMPLETED|Induction Period||50
2575640|NCT00406653|6317512|P7|STARTED|Induction Period||0
2575641|NCT00406653|6317513|P6|STARTED|Induction Period||0
2575642|NCT00406653|6317514|P5|STARTED|Induction Period||0
2575643|NCT00406653|6317515|P4|STARTED|Induction Period||128
2575644|NCT00406653|6317516|P3|STARTED|Induction Period||130
2575645|NCT00406653|6317517|P2|STARTED|Induction Period||128
2575646|NCT00406653|6317518|P1|STARTED|Induction Period||65
2575647|NCT00406640|6317599|P2|NOT COMPLETED|OL Extension Phase for Non-Responders||24
2575648|NCT00406640|6317600|P1|NOT COMPLETED|OL Extension Phase for Non-Responders||22
2575649|NCT00406640|6317599|P2|COMPLETED|OL Extension Phase for Non-Responders||36
2575650|NCT00406640|6317600|P1|COMPLETED|OL Extension Phase for Non-Responders||47
2575651|NCT00406640|6317599|P2|STARTED|OL Extension Phase for Non-Responders||60
2575652|NCT00406640|6317600|P1|STARTED|OL Extension Phase for Non-Responders||69
2575653|NCT00406640|6317599|P2|NOT COMPLETED|DB Continuation Phase for Responders||37
2575654|NCT00406640|6317600|P1|NOT COMPLETED|DB Continuation Phase for Responders||33
2575655|NCT00406640|6317599|P2|COMPLETED|DB Continuation Phase for Responders||151
2575656|NCT00406640|6317600|P1|COMPLETED|DB Continuation Phase for Responders||139
2575657|NCT00406640|6317599|P2|STARTED|DB Continuation Phase for Responders||188
2575658|NCT00406640|6317600|P1|STARTED|DB Continuation Phase for Responders||172
2575659|NCT00406640|6317599|P2|NOT COMPLETED|Acute Phase||43
2575660|NCT00406640|6317600|P1|NOT COMPLETED|Acute Phase||51
2575661|NCT00406640|6317599|P2|COMPLETED|Acute Phase||256
2575662|NCT00406640|6317600|P1|COMPLETED|Acute Phase||245
2575663|NCT00406640|6317599|P2|STARTED|Acute Phase||299
2575664|NCT00406640|6317600|P1|STARTED|Acute Phase||296
2575665|NCT00406393|6317632|P2|NOT COMPLETED|Overall Study||1
2575666|NCT00406393|6317633|P1|NOT COMPLETED|Overall Study||2
2575667|NCT00406393|6317632|P2|COMPLETED|Overall Study||152
2575668|NCT00406393|6317633|P1|COMPLETED|Overall Study||149
2575669|NCT00406393|6317632|P2|STARTED|Overall Study||153
2575670|NCT00406393|6317633|P1|STARTED|Overall Study||151
2575671|NCT00406367|6317663|P2|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
2575672|NCT00406367|6317664|P1|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||20
2575673|NCT00406367|6317663|P2|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
2575674|NCT00406367|6317664|P1|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||82
2575675|NCT00406367|6317663|P2|STARTED|Open-Label Ext. Period - up to 68 Weeks|In the Open-Label Extension Period no placebo treatment arm was given.|0
2575676|NCT00406367|6317664|P1|STARTED|Open-Label Ext. Period - up to 68 Weeks||102
2575677|NCT00406367|6317663|P2|NOT COMPLETED|Main Period - 6 to 20 Weeks||2
2575678|NCT00406367|6317664|P1|NOT COMPLETED|Main Period - 6 to 20 Weeks||5
2575679|NCT00406367|6317663|P2|COMPLETED|Main Period - 6 to 20 Weeks||32
2575680|NCT00406367|6317664|P1|COMPLETED|Main Period - 6 to 20 Weeks||70
2575681|NCT00406367|6317663|P2|STARTED|Main Period - 6 to 20 Weeks||34
2575682|NCT00406367|6317664|P1|STARTED|Main Period - 6 to 20 Weeks||75
2575683|NCT00406354|6317679|P3|NOT COMPLETED|All Randomized and Treated Patients||22
2575684|NCT00406354|6317680|P2|NOT COMPLETED|All Randomized and Treated Patients||13
2575685|NCT00406354|6317681|P1|NOT COMPLETED|All Randomized and Treated Patients||16
2575686|NCT00406354|6317679|P3|COMPLETED|All Randomized and Treated Patients||37
2575687|NCT00406354|6317680|P2|COMPLETED|All Randomized and Treated Patients||48
2575688|NCT00406354|6317681|P1|COMPLETED|All Randomized and Treated Patients||44
2575689|NCT00406354|6317679|P3|STARTED|All Randomized and Treated Patients||59
2575690|NCT00406354|6317680|P2|STARTED|All Randomized and Treated Patients||61
2575691|NCT00406354|6317681|P1|STARTED|All Randomized and Treated Patients||60
2575692|NCT00406354|6317679|P3|NOT COMPLETED|All Randomized Patients||1
2575693|NCT00406354|6317680|P2|NOT COMPLETED|All Randomized Patients||0
2575694|NCT00406354|6317681|P1|NOT COMPLETED|All Randomized Patients||0
2575695|NCT00406354|6317679|P3|COMPLETED|All Randomized Patients|One patient was randomized but never received study treatment.|59
2575696|NCT00406354|6317680|P2|COMPLETED|All Randomized Patients||61
2575697|NCT00406354|6317681|P1|COMPLETED|All Randomized Patients||60
2575698|NCT00406354|6317679|P3|STARTED|All Randomized Patients||60
2575699|NCT00406354|6317680|P2|STARTED|All Randomized Patients||61
2575700|NCT00406354|6317681|P1|STARTED|All Randomized Patients||60
2575701|NCT00406315|6317752|P1|NOT COMPLETED|Overall Study||141
2575702|NCT00406315|6317752|P1|COMPLETED|Overall Study||100
2575703|NCT00406315|6317752|P1|STARTED|Overall Study|Started = Treated|241
2575704|NCT00406276|6317770|P1|NOT COMPLETED|Overall Study||4
2575705|NCT00406276|6317770|P1|COMPLETED|Overall Study||24
2575706|NCT00406276|6317770|P1|STARTED|Overall Study||28
2575707|NCT00406133|6317779|P4|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
2575708|NCT00406133|6317780|P3|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
2575709|NCT00406133|6317781|P2|NOT COMPLETED|Phase 2 (Second 26 Week Period)||3
2575710|NCT00406133|6317782|P1|NOT COMPLETED|Phase 2 (Second 26 Week Period)||2
2575711|NCT00406133|6317779|P4|COMPLETED|Phase 2 (Second 26 Week Period)||60
2575712|NCT00406133|6317780|P3|COMPLETED|Phase 2 (Second 26 Week Period)||67
2575713|NCT00406133|6317781|P2|COMPLETED|Phase 2 (Second 26 Week Period)||152
2575714|NCT00406133|6317782|P1|COMPLETED|Phase 2 (Second 26 Week Period)||157
2575715|NCT00406133|6317779|P4|STARTED|Phase 2 (Second 26 Week Period)||60
2575716|NCT00406133|6317780|P3|STARTED|Phase 2 (Second 26 Week Period)||67
2575717|NCT00406133|6317781|P2|STARTED|Phase 2 (Second 26 Week Period)||155
2575718|NCT00406133|6317782|P1|STARTED|Phase 2 (Second 26 Week Period)|3 subjects completed phase 1 but elected not to go into phase 2.|159
2575719|NCT00406133|6317779|P4|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
2575720|NCT00406133|6317780|P3|NOT COMPLETED|Phase 1 (First 26 Week Period)||0
2575721|NCT00406133|6317781|P2|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
2575722|NCT00406133|6317782|P1|NOT COMPLETED|Phase 1 (First 26 Week Period)||3
2575723|NCT00406133|6317779|P4|COMPLETED|Phase 1 (First 26 Week Period)||60
2575724|NCT00406133|6317780|P3|COMPLETED|Phase 1 (First 26 Week Period)||67
2575725|NCT00406133|6317781|P2|COMPLETED|Phase 1 (First 26 Week Period)||155
2575726|NCT00406133|6317782|P1|COMPLETED|Phase 1 (First 26 Week Period)||162
2575727|NCT00406133|6317779|P4|STARTED|Phase 1 (First 26 Week Period)||62
2575728|NCT00406133|6317780|P3|STARTED|Phase 1 (First 26 Week Period)||67
2575729|NCT00406133|6317781|P2|STARTED|Phase 1 (First 26 Week Period)||157
2575730|NCT00406133|6317782|P1|STARTED|Phase 1 (First 26 Week Period)||165
2575731|NCT00406107|6317846|P2|NOT COMPLETED|Overall Study||1
2575732|NCT00406107|6317847|P1|NOT COMPLETED|Overall Study||1
2575733|NCT00406107|6317846|P2|COMPLETED|Overall Study||4
2575734|NCT00406107|6317847|P1|COMPLETED|Overall Study||14
2575735|NCT00406107|6317846|P2|STARTED|Overall Study||5
2575736|NCT00406107|6317847|P1|STARTED|Overall Study||15
2575737|NCT00406029|6317862|P5|NOT COMPLETED|Overall Study||8
2575738|NCT00406029|6317863|P4|NOT COMPLETED|Overall Study||17
2575739|NCT00406029|6317864|P3|NOT COMPLETED|Overall Study||10
2575740|NCT00406029|6317865|P2|NOT COMPLETED|Overall Study||8
2575741|NCT00406029|6317866|P1|NOT COMPLETED|Overall Study||16
2575742|NCT00406029|6317862|P5|COMPLETED|Overall Study||41
2575743|NCT00406029|6317863|P4|COMPLETED|Overall Study||40
2575744|NCT00406029|6317864|P3|COMPLETED|Overall Study||39
2575745|NCT00406029|6317865|P2|COMPLETED|Overall Study||41
2575746|NCT00406029|6317866|P1|COMPLETED|Overall Study||33
2575747|NCT00406029|6317862|P5|Treated|Overall Study||47
2575748|NCT00406029|6317863|P4|Treated|Overall Study||54
2575749|NCT00406029|6317864|P3|Treated|Overall Study||47
2575750|NCT00406029|6317865|P2|Treated|Overall Study||49
2575751|NCT00406029|6317866|P1|Treated|Overall Study||49
2575752|NCT00406029|6317862|P5|STARTED|Overall Study||49
2575753|NCT00406029|6317863|P4|STARTED|Overall Study||57
2575754|NCT00406029|6317864|P3|STARTED|Overall Study||49
2575755|NCT00406029|6317865|P2|STARTED|Overall Study||49
2575756|NCT00406029|6317866|P1|STARTED|Overall Study||49
2575757|NCT00405964|6317970|P2|NOT COMPLETED|Overall Study||95
2575758|NCT00405964|6317971|P1|NOT COMPLETED|Overall Study||59
2575759|NCT00405964|6317970|P2|COMPLETED|Overall Study||261
2575760|NCT00405964|6317971|P1|COMPLETED|Overall Study||301
2575761|NCT00405964|6317970|P2|STARTED|Overall Study||356
2575762|NCT00405964|6317971|P1|STARTED|Overall Study||360
2575763|NCT00405938|6317983|P2|NOT COMPLETED|Overall Study||0
2575764|NCT00405938|6317984|P1|NOT COMPLETED|Overall Study||0
2575765|NCT00405938|6317983|P2|COMPLETED|Overall Study||41
2575766|NCT00405938|6317984|P1|COMPLETED|Overall Study||38
2575767|NCT00405938|6317983|P2|STARTED|Overall Study||41
2575768|NCT00405938|6317984|P1|STARTED|Overall Study||38
2575769|NCT00405912|6317993|P3|NOT COMPLETED|Overall Study||16
2575770|NCT00405912|6317994|P2|NOT COMPLETED|Overall Study||19
2575771|NCT00405912|6317995|P1|NOT COMPLETED|Overall Study||16
2575772|NCT00405912|6317993|P3|COMPLETED|Overall Study||23
2575773|NCT00405912|6317994|P2|COMPLETED|Overall Study||21
2575774|NCT00405912|6317995|P1|COMPLETED|Overall Study||23
2575775|NCT00405912|6317993|P3|STARTED|Overall Study||39
2575776|NCT00405912|6317994|P2|STARTED|Overall Study||40
2575777|NCT00405912|6317995|P1|STARTED|Overall Study||39
2575778|NCT00405821|6318008|P2|NOT COMPLETED|Overall Study||22
2575779|NCT00405821|6318009|P1|NOT COMPLETED|Overall Study||22
2575780|NCT00405821|6318008|P2|COMPLETED|Overall Study||198
2575781|NCT00405821|6318009|P1|COMPLETED|Overall Study||198
2575782|NCT00405821|6318008|P2|STARTED|Overall Study||220
2575783|NCT00405821|6318009|P1|STARTED|Overall Study||220
2575784|NCT00405756|6318022|P3|NOT COMPLETED|Follow-up||88
2575785|NCT00405756|6318023|P2|NOT COMPLETED|Follow-up||90
2575786|NCT00405756|6318024|P1|NOT COMPLETED|Follow-up||75
2575787|NCT00405756|6318022|P3|COMPLETED|Follow-up||0
2575788|NCT00405756|6318023|P2|COMPLETED|Follow-up||0
2575789|NCT00405756|6318024|P1|COMPLETED|Follow-up||0
2575790|NCT00405756|6318022|P3|STARTED|Follow-up|52 participants from the Double-blind and 36 from the Open Label Extension|88
2575791|NCT00405756|6318023|P2|STARTED|Follow-up|65 participants from the Double-blind and 25 from the Open Label Extension|90
2575792|NCT00405756|6318024|P1|STARTED|Follow-up|66 participants from Double-blind and 9 from the Open Label Extension|75
2575793|NCT00405756|6318022|P3|NOT COMPLETED|Open-label Extension||72
2575794|NCT00405756|6318023|P2|NOT COMPLETED|Open-label Extension||47
2575795|NCT00405756|6318024|P1|NOT COMPLETED|Open-label Extension||19
2575796|NCT00405756|6318022|P3|COMPLETED|Open-label Extension||0
2575797|NCT00405756|6318023|P2|COMPLETED|Open-label Extension||0
2575798|NCT00405756|6318024|P1|COMPLETED|Open-label Extension|Participants continue until disease progression or other reason for discontinuing.|0
2575799|NCT00405756|6318022|P3|STARTED|Open-label Extension||72
2575800|NCT00405756|6318023|P2|STARTED|Open-label Extension||47
2575801|NCT00405756|6318024|P1|STARTED|Open-label Extension||19
2575802|NCT00405756|6318022|P3|NOT COMPLETED|Double-blind Treatment||154
2575803|NCT00405756|6318023|P2|NOT COMPLETED|Double-blind Treatment||153
2575804|NCT00405756|6318024|P1|NOT COMPLETED|Double-blind Treatment||152
2575805|NCT00405756|6318022|P3|COMPLETED|Double-blind Treatment||0
2575806|NCT00405756|6318023|P2|COMPLETED|Double-blind Treatment||0
2575807|NCT00405756|6318024|P1|COMPLETED|Double-blind Treatment|Double-blind Treatment Period had no defined completion.|0
2575808|NCT00405756|6318022|P3|Safety Population|Double-blind Treatment||153
2575809|NCT00405756|6318023|P2|Safety Population|Double-blind Treatment||152
2575810|NCT00405756|6318024|P1|Safety Population|Double-blind Treatment|Participants who took at least one dose of study drug.|150
2575811|NCT00405756|6318022|P3|STARTED|Double-blind Treatment||154
2575812|NCT00405756|6318023|P2|STARTED|Double-blind Treatment||153
2575813|NCT00405756|6318024|P1|STARTED|Double-blind Treatment|Intent to treat population of all randomized participants|152
2575814|NCT00405704|6318114|P2|NOT COMPLETED|Overall Study||46
2575815|NCT00405704|6318115|P1|NOT COMPLETED|Overall Study||41
2575816|NCT00405704|6318114|P2|COMPLETED|Overall Study||259
2575817|NCT00405704|6318115|P1|COMPLETED|Overall Study||261
2575818|NCT00405704|6318114|P2|Recurrent UTI With TMP-SMZ Panel|Overall Study||69
2575819|NCT00405704|6318115|P1|Recurrent UTI With TMP-SMZ Panel|Overall Study||38
2575820|NCT00405704|6318114|P2|Recurrent UTI With E. Coli|Overall Study||57
2575821|NCT00405704|6318115|P1|Recurrent UTI With E. Coli|Overall Study||30
2575822|NCT00405704|6318114|P2|Outcome Stool Assessed|Overall Study||210
2575823|NCT00405704|6318115|P1|Outcome Stool Assessed|Overall Study||203
2575824|NCT00405704|6318114|P2|Completed Assessments for New Scarring|Overall Study||227
2575825|NCT00405704|6318115|P1|Completed Assessments for New Scarring|Overall Study||220
2575826|NCT00405704|6318114|P2|Completed Outcome Renal Scan|Overall Study||235
2575827|NCT00405704|6318115|P1|Completed Outcome Renal Scan|Overall Study||227
2575828|NCT00405704|6318114|P2|STARTED|Overall Study||305
2575829|NCT00405704|6318115|P1|STARTED|Overall Study||302
2575830|NCT00405652|6318135|P1|NOT COMPLETED|Overall Study||4
2575831|NCT00405652|6318135|P1|COMPLETED|Overall Study||30
2575832|NCT00405652|6318135|P1|STARTED|Overall Study||34
2575833|NCT00405639|6318142|P2|NOT COMPLETED|Overall Study||0
2575834|NCT00405639|6318143|P1|NOT COMPLETED|Overall Study||3
2575835|NCT00405639|6318142|P2|COMPLETED|Overall Study||12
2575836|NCT00405639|6318143|P1|COMPLETED|Overall Study||22
2575837|NCT00405639|6318142|P2|STARTED|Overall Study||12
2575838|NCT00405639|6318143|P1|STARTED|Overall Study||25
2575839|NCT00405587|6318159|P4|NOT COMPLETED|Overall Study||20
2575840|NCT00405587|6318160|P3|NOT COMPLETED|Overall Study||22
2575841|NCT00405587|6318161|P2|NOT COMPLETED|Overall Study||28
2575842|NCT00405587|6318162|P1|NOT COMPLETED|Overall Study||26
2575843|NCT00405587|6318159|P4|COMPLETED|Overall Study||1
2575844|NCT00405587|6318160|P3|COMPLETED|Overall Study||10
2575845|NCT00405587|6318161|P2|COMPLETED|Overall Study||2
2575846|NCT00405587|6318162|P1|COMPLETED|Overall Study||0
2575847|NCT00405587|6318159|P4|STARTED|Overall Study||21
2575848|NCT00405587|6318160|P3|STARTED|Overall Study||32
2575849|NCT00405587|6318161|P2|STARTED|Overall Study||30
2575850|NCT00405587|6318162|P1|STARTED|Overall Study||26
2575851|NCT00405548|6318280|P2|NOT COMPLETED|Overall Study||1
2575852|NCT00405548|6318281|P1|NOT COMPLETED|Overall Study||4
2575853|NCT00405548|6318280|P2|COMPLETED|Overall Study||12
2575854|NCT00405548|6318281|P1|COMPLETED|Overall Study||24
2575855|NCT00405548|6318280|P2|STARTED|Overall Study||13
2575856|NCT00405548|6318281|P1|STARTED|Overall Study||28
2575857|NCT00405522|6318295|P2|NOT COMPLETED|Overall Study||0
2575858|NCT00405522|6318296|P1|NOT COMPLETED|Overall Study||0
2575859|NCT00405522|6318295|P2|COMPLETED|Overall Study||17
2575860|NCT00405522|6318296|P1|COMPLETED|Overall Study||17
2575861|NCT00405522|6318295|P2|STARTED|Overall Study||17
2575862|NCT00405522|6318296|P1|STARTED|Overall Study||17
2575863|NCT00405509|6318308|P2|NOT COMPLETED|Overall Study||0
2575864|NCT00405509|6318309|P1|NOT COMPLETED|Overall Study||0
2575865|NCT00405509|6318308|P2|COMPLETED|Overall Study||22
2575866|NCT00405509|6318309|P1|COMPLETED|Overall Study||11
2575867|NCT00405509|6318308|P2|STARTED|Overall Study||22
2575868|NCT00405509|6318309|P1|STARTED|Overall Study||11
2575869|NCT00405392|6318325|P2|NOT COMPLETED|Overall Study||27
2575870|NCT00405392|6318326|P1|NOT COMPLETED|Overall Study||30
2575871|NCT00405392|6318325|P2|COMPLETED|Overall Study||155
2575872|NCT00405392|6318326|P1|COMPLETED|Overall Study||153
2575873|NCT00405392|6318325|P2|STARTED|Overall Study||182
2575874|NCT00405392|6318326|P1|STARTED|Overall Study||183
2575875|NCT00405353|6318336|P1|NOT COMPLETED|Overall Study||0
2575876|NCT00405353|6318336|P1|COMPLETED|Overall Study||10
2575877|NCT00405353|6318336|P1|STARTED|Overall Study||10
2575878|NCT00405288|6318342|P2|NOT COMPLETED|Overall Study||0
2575879|NCT00405288|6318343|P1|NOT COMPLETED|Overall Study||0
2575880|NCT00405288|6318342|P2|COMPLETED|Overall Study||204
2575881|NCT00405288|6318343|P1|COMPLETED|Overall Study||204
2575882|NCT00405288|6318342|P2|STARTED|Overall Study||204
2575883|NCT00405288|6318343|P1|STARTED|Overall Study||204
2575884|NCT00405275|6318373|P2|NOT COMPLETED|Overall Study||19
2575885|NCT00405275|6318374|P1|NOT COMPLETED|Overall Study||23
2575886|NCT00405275|6318373|P2|COMPLETED|Overall Study||156
2575887|NCT00405275|6318374|P1|COMPLETED|Overall Study||155
2575888|NCT00405275|6318373|P2|24 Week (Switch)|Overall Study||44
2575889|NCT00405275|6318374|P1|24 Week (Switch)|Overall Study||44
2575890|NCT00405275|6318373|P2|24 Week (no Switch)|Overall Study||121
2575891|NCT00405275|6318374|P1|24 Week (no Switch)|Overall Study||119
2575892|NCT00405275|6318373|P2|24 Weeks (Total)|Overall Study||165
2575893|NCT00405275|6318374|P1|24 Weeks (Total)|Overall Study||163
2575894|NCT00405275|6318373|P2|STARTED|Overall Study||175
2575895|NCT00405275|6318374|P1|STARTED|Overall Study||178
2575896|NCT00405067|6318383|P3|NOT COMPLETED|Overall Study||5
2575897|NCT00405067|6318384|P2|NOT COMPLETED|Overall Study||9
2575898|NCT00405067|6318385|P1|NOT COMPLETED|Overall Study||4
2575899|NCT00405067|6318383|P3|COMPLETED|Overall Study||24
2575900|NCT00405067|6318384|P2|COMPLETED|Overall Study||19
2575901|NCT00405067|6318385|P1|COMPLETED|Overall Study||24
2575902|NCT00405067|6318383|P3|STARTED|Overall Study||29
2575903|NCT00405067|6318384|P2|STARTED|Overall Study||28
2575904|NCT00405067|6318385|P1|STARTED|Overall Study||28
2575905|NCT00404924|6318422|P2|NOT COMPLETED|Overall Study||306
2575906|NCT00404924|6318423|P1|NOT COMPLETED|Overall Study||603
2575907|NCT00404924|6318422|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|1
2575908|NCT00404924|6318423|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
2575909|NCT00404924|6318422|P2|STARTED|Overall Study|randomised patients|307
2575910|NCT00404924|6318423|P1|STARTED|Overall Study|randomised patients|617
2575911|NCT00404820|6318441|P2|NOT COMPLETED|Overall Study||24
2575912|NCT00404820|6318442|P1|NOT COMPLETED|Overall Study||19
2575913|NCT00404820|6318441|P2|COMPLETED|Overall Study||172
2575914|NCT00404820|6318442|P1|COMPLETED|Overall Study||389
2575915|NCT00404820|6318441|P2|Started Treatment|Overall Study|The reason why 2 patients did not start treatment is unavailable.|194
2575916|NCT00404820|6318442|P1|Started Treatment|Overall Study||408
2575917|NCT00404820|6318441|P2|STARTED|Overall Study||196
2575918|NCT00404820|6318442|P1|STARTED|Overall Study||408
2575919|NCT00404768|6318464|P4|NOT COMPLETED|Part C||14
2575920|NCT00404768|6318465|P3|NOT COMPLETED|Part C||8
2575921|NCT00404768|6318466|P2|NOT COMPLETED|Part C||0
2575922|NCT00404768|6318467|P1|NOT COMPLETED|Part C||0
2575923|NCT00404768|6318464|P4|COMPLETED|Part C||20
2575924|NCT00404768|6318465|P3|COMPLETED|Part C||22
2575925|NCT00404768|6318466|P2|COMPLETED|Part C||0
2575926|NCT00404768|6318467|P1|COMPLETED|Part C||0
2575927|NCT00404768|6318464|P4|STARTED|Part C||34
2575928|NCT00404768|6318465|P3|STARTED|Part C||30
2575929|NCT00404768|6318466|P2|STARTED|Part C||0
2575930|NCT00404768|6318467|P1|STARTED|Part C||0
2575931|NCT00404768|6318464|P4|NOT COMPLETED|Part A and B||0
2575932|NCT00404768|6318465|P3|NOT COMPLETED|Part A and B||0
2575933|NCT00404768|6318466|P2|NOT COMPLETED|Part A and B||1
2575934|NCT00404768|6318467|P1|NOT COMPLETED|Part A and B||1
2575935|NCT00404768|6318464|P4|COMPLETED|Part A and B||0
2575936|NCT00404768|6318465|P3|COMPLETED|Part A and B||0
2575937|NCT00404768|6318466|P2|COMPLETED|Part A and B||8
2575938|NCT00404768|6318467|P1|COMPLETED|Part A and B||19
2575939|NCT00404768|6318464|P4|STARTED|Part A and B||0
2575940|NCT00404768|6318465|P3|STARTED|Part A and B||0
2575941|NCT00404768|6318466|P2|STARTED|Part A and B||9
2575942|NCT00404768|6318467|P1|STARTED|Part A and B||20
2575943|NCT00404755|6318528|P1|NOT COMPLETED|Phase III (Imipramine)||0
2575944|NCT00404755|6318528|P1|COMPLETED|Phase III (Imipramine)||3
2575945|NCT00404755|6318528|P1|STARTED|Phase III (Imipramine)||3
2575946|NCT00404755|6318528|P1|NOT COMPLETED|Phase II (Escitalopram)||2
2575947|NCT00404755|6318528|P1|COMPLETED|Phase II (Escitalopram)||9
2575948|NCT00404755|6318528|P1|STARTED|Phase II (Escitalopram)||11
2575949|NCT00404755|6318528|P1|NOT COMPLETED|Phase I (Bupropion)||4
2575950|NCT00404755|6318528|P1|COMPLETED|Phase I (Bupropion)||13
2575951|NCT00404755|6318528|P1|STARTED|Phase I (Bupropion)|3 went directly into Phase II (intolerant of bupropion), 1 withdrew consent and 4 did not return|17
2575952|NCT00404651|6318543|P4|NOT COMPLETED|Overall Study||21
2575953|NCT00404651|6318544|P3|NOT COMPLETED|Overall Study||45
2575954|NCT00404651|6318545|P2|NOT COMPLETED|Overall Study||28
2575955|NCT00404651|6318546|P1|NOT COMPLETED|Overall Study||39
2575956|NCT00404651|6318543|P4|COMPLETED|Overall Study||146
2575957|NCT00404651|6318544|P3|COMPLETED|Overall Study||294
2575958|NCT00404651|6318545|P2|COMPLETED|Overall Study||315
2575959|NCT00404651|6318546|P1|COMPLETED|Overall Study||301
2575960|NCT00404651|6318543|P4|STARTED|Overall Study||167
2575961|NCT00404651|6318544|P3|STARTED|Overall Study||339
2575962|NCT00404651|6318545|P2|STARTED|Overall Study||343
2575963|NCT00404651|6318546|P1|STARTED|Overall Study||340
2575964|NCT00404547|6318574|P2|NOT COMPLETED|Overall Study||25
2575965|NCT00404547|6318575|P1|NOT COMPLETED|Overall Study||90
2575966|NCT00404547|6318574|P2|COMPLETED|Overall Study||334
2575967|NCT00404547|6318575|P1|COMPLETED|Overall Study||672
2575968|NCT00404547|6318574|P2|STARTED|Overall Study||359
2575969|NCT00404547|6318575|P1|STARTED|Overall Study||762
2575970|NCT00404495|6318585|P2|NOT COMPLETED|Overall Study||11
2575971|NCT00404495|6318586|P1|NOT COMPLETED|Overall Study||44
2575972|NCT00404495|6318585|P2|COMPLETED|Overall Study||6
2575973|NCT00404495|6318586|P1|COMPLETED|Overall Study||22
2575974|NCT00404495|6318585|P2|STARTED|Overall Study||17
2575975|NCT00404495|6318586|P1|STARTED|Overall Study||66
2575976|NCT00404352|6318605|P9|NOT COMPLETED|Open Label Extension (up to 36 Months)||2
2575977|NCT00404352|6318606|P8|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
2575978|NCT00404352|6318607|P7|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
2575979|NCT00404352|6318608|P6|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
2575980|NCT00404352|6318609|P5|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
2575981|NCT00404352|6318610|P4|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
2575982|NCT00404352|6318611|P3|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
2575983|NCT00404352|6318612|P2|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
2575984|NCT00404352|6318613|P1|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
2575985|NCT00404352|6318605|P9|COMPLETED|Open Label Extension (up to 36 Months)||9
2575986|NCT00404352|6318606|P8|COMPLETED|Open Label Extension (up to 36 Months)||4
2575987|NCT00404352|6318607|P7|COMPLETED|Open Label Extension (up to 36 Months)||3
2575988|NCT00404352|6318608|P6|COMPLETED|Open Label Extension (up to 36 Months)||0
2575989|NCT00404352|6318609|P5|COMPLETED|Open Label Extension (up to 36 Months)||0
2575990|NCT00404352|6318610|P4|COMPLETED|Open Label Extension (up to 36 Months)||0
2575991|NCT00404352|6318611|P3|COMPLETED|Open Label Extension (up to 36 Months)||0
2575992|NCT00404352|6318612|P2|COMPLETED|Open Label Extension (up to 36 Months)||0
2575993|NCT00404352|6318613|P1|COMPLETED|Open Label Extension (up to 36 Months)||0
2575994|NCT00404352|6318605|P9|STARTED|Open Label Extension (up to 36 Months)|11 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|11
2575995|NCT00404352|6318606|P8|STARTED|Open Label Extension (up to 36 Months)|5 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|5
2575996|NCT00404352|6318607|P7|STARTED|Open Label Extension (up to 36 Months)|4 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|4
2575997|NCT00404352|6318608|P6|STARTED|Open Label Extension (up to 36 Months)||0
2575998|NCT00404352|6318609|P5|STARTED|Open Label Extension (up to 36 Months)||0
2575999|NCT00404352|6318610|P4|STARTED|Open Label Extension (up to 36 Months)||0
2576000|NCT00404352|6318611|P3|STARTED|Open Label Extension (up to 36 Months)||0
2576001|NCT00404352|6318612|P2|STARTED|Open Label Extension (up to 36 Months)||0
2576002|NCT00404352|6318613|P1|STARTED|Open Label Extension (up to 36 Months)||0
2576003|NCT00404352|6318605|P9|NOT COMPLETED|Open Label (up to 24 Month)||0
2576004|NCT00404352|6318606|P8|NOT COMPLETED|Open Label (up to 24 Month)||0
2576005|NCT00404352|6318607|P7|NOT COMPLETED|Open Label (up to 24 Month)||0
2576006|NCT00404352|6318608|P6|NOT COMPLETED|Open Label (up to 24 Month)||7
2576007|NCT00404352|6318609|P5|NOT COMPLETED|Open Label (up to 24 Month)||2
2576008|NCT00404352|6318610|P4|NOT COMPLETED|Open Label (up to 24 Month)||3
2576009|NCT00404352|6318611|P3|NOT COMPLETED|Open Label (up to 24 Month)||0
2576010|NCT00404352|6318612|P2|NOT COMPLETED|Open Label (up to 24 Month)||0
2576011|NCT00404352|6318613|P1|NOT COMPLETED|Open Label (up to 24 Month)||0
2576012|NCT00404352|6318605|P9|COMPLETED|Open Label (up to 24 Month)||0
2576013|NCT00404352|6318606|P8|COMPLETED|Open Label (up to 24 Month)||0
2576014|NCT00404352|6318607|P7|COMPLETED|Open Label (up to 24 Month)||0
2576015|NCT00404352|6318608|P6|COMPLETED|Open Label (up to 24 Month)||52
2576016|NCT00404352|6318609|P5|COMPLETED|Open Label (up to 24 Month)||28
2576017|NCT00404352|6318610|P4|COMPLETED|Open Label (up to 24 Month)||28
2576018|NCT00404352|6318611|P3|COMPLETED|Open Label (up to 24 Month)||0
2576019|NCT00404352|6318612|P2|COMPLETED|Open Label (up to 24 Month)||0
2576020|NCT00404352|6318613|P1|COMPLETED|Open Label (up to 24 Month)||0
2576021|NCT00404352|6318605|P9|STARTED|Open Label (up to 24 Month)||0
2576022|NCT00404352|6318606|P8|STARTED|Open Label (up to 24 Month)||0
2576023|NCT00404352|6318607|P7|STARTED|Open Label (up to 24 Month)||0
2576024|NCT00404352|6318608|P6|STARTED|Open Label (up to 24 Month)|From DB period, 59 participants converted to CDMS and switched to OL period in this study|59
2576025|NCT00404352|6318609|P5|STARTED|Open Label (up to 24 Month)|From DB period, 30 participants converted to CDMS and switched to OL period in this study|30
2576026|NCT00404352|6318610|P4|STARTED|Open Label (up to 24 Month)|From DB period, 31 participants converted to CDMS and switched to OL period in this study|31
2576027|NCT00404352|6318611|P3|STARTED|Open Label (up to 24 Month)||0
2576028|NCT00404352|6318612|P2|STARTED|Open Label (up to 24 Month)||0
2576029|NCT00404352|6318613|P1|STARTED|Open Label (up to 24 Month)||0
2576030|NCT00404352|6318605|P9|NOT COMPLETED|Double Blind (up to 24 Month)||0
2576031|NCT00404352|6318606|P8|NOT COMPLETED|Double Blind (up to 24 Month)||0
2576032|NCT00404352|6318607|P7|NOT COMPLETED|Double Blind (up to 24 Month)||0
2576033|NCT00404352|6318608|P6|NOT COMPLETED|Double Blind (up to 24 Month)||0
2576034|NCT00404352|6318609|P5|NOT COMPLETED|Double Blind (up to 24 Month)||0
2576035|NCT00404352|6318610|P4|NOT COMPLETED|Double Blind (up to 24 Month)||0
2576036|NCT00404352|6318611|P3|NOT COMPLETED|Double Blind (up to 24 Month)||79
2576037|NCT00404352|6318612|P2|NOT COMPLETED|Double Blind (up to 24 Month)||47
2576038|NCT00404352|6318613|P1|NOT COMPLETED|Double Blind (up to 24 Month)||52
2576039|NCT00404352|6318605|P9|COMPLETED|Double Blind (up to 24 Month)||0
2576040|NCT00404352|6318606|P8|COMPLETED|Double Blind (up to 24 Month)||0
2576041|NCT00404352|6318607|P7|COMPLETED|Double Blind (up to 24 Month)||0
2576042|NCT00404352|6318608|P6|COMPLETED|Double Blind (up to 24 Month)||0
2576043|NCT00404352|6318609|P5|COMPLETED|Double Blind (up to 24 Month)||0
2576044|NCT00404352|6318610|P4|COMPLETED|Double Blind (up to 24 Month)||0
2576045|NCT00404352|6318611|P3|COMPLETED|Double Blind (up to 24 Month)||92
2576046|NCT00404352|6318612|P2|COMPLETED|Double Blind (up to 24 Month)||128
2576047|NCT00404352|6318613|P1|COMPLETED|Double Blind (up to 24 Month)||119
2576048|NCT00404352|6318605|P9|Treated|Double Blind (up to 24 Month)||0
2576049|NCT00404352|6318606|P8|Treated|Double Blind (up to 24 Month)||0
2576050|NCT00404352|6318607|P7|Treated|Double Blind (up to 24 Month)||0
2576051|NCT00404352|6318608|P6|Treated|Double Blind (up to 24 Month)||0
2576052|NCT00404352|6318609|P5|Treated|Double Blind (up to 24 Month)||0
2576053|NCT00404352|6318610|P4|Treated|Double Blind (up to 24 Month)||0
2576054|NCT00404352|6318611|P3|Treated|Double Blind (up to 24 Month)||171
2576055|NCT00404352|6318612|P2|Treated|Double Blind (up to 24 Month)||173
2576056|NCT00404352|6318613|P1|Treated|Double Blind (up to 24 Month)||171
2576057|NCT00404352|6318605|P9|STARTED|Double Blind (up to 24 Month)||0
2576058|NCT00404352|6318606|P8|STARTED|Double Blind (up to 24 Month)||0
2576059|NCT00404352|6318607|P7|STARTED|Double Blind (up to 24 Month)||0
2576060|NCT00404352|6318608|P6|STARTED|Double Blind (up to 24 Month)||0
2576061|NCT00404352|6318609|P5|STARTED|Double Blind (up to 24 Month)||0
2576062|NCT00404352|6318610|P4|STARTED|Double Blind (up to 24 Month)||0
2576063|NCT00404352|6318611|P3|STARTED|Double Blind (up to 24 Month)||171
2576064|NCT00404352|6318612|P2|STARTED|Double Blind (up to 24 Month)||175
2576065|NCT00404352|6318613|P1|STARTED|Double Blind (up to 24 Month)||171
2576066|NCT00404248|6318648|P9|NOT COMPLETED|Overall Study||0
2576067|NCT00404248|6318649|P8|NOT COMPLETED|Overall Study||0
2576068|NCT00404248|6318650|P7|NOT COMPLETED|Overall Study||0
2576069|NCT00404248|6318651|P6|NOT COMPLETED|Overall Study||0
2576070|NCT00404248|6318652|P5|NOT COMPLETED|Overall Study||0
2576071|NCT00404248|6318653|P4|NOT COMPLETED|Overall Study||0
2576072|NCT00404248|6318654|P3|NOT COMPLETED|Overall Study||0
2576073|NCT00404248|6318655|P2|NOT COMPLETED|Overall Study||1
2576074|NCT00404248|6318656|P1|NOT COMPLETED|Overall Study||0
2576075|NCT00404248|6318648|P9|COMPLETED|Overall Study||3
2576076|NCT00404248|6318649|P8|COMPLETED|Overall Study||6
2576077|NCT00404248|6318650|P7|COMPLETED|Overall Study||6
2576078|NCT00404248|6318651|P6|COMPLETED|Overall Study||3
2576079|NCT00404248|6318652|P5|COMPLETED|Overall Study||3
2576080|NCT00404248|6318653|P4|COMPLETED|Overall Study||2
2576081|NCT00404248|6318654|P3|COMPLETED|Overall Study||5
2576082|NCT00404248|6318655|P2|COMPLETED|Overall Study||3
2576083|NCT00404248|6318656|P1|COMPLETED|Overall Study||3
2576084|NCT00404248|6318648|P9|STARTED|Overall Study||3
2576085|NCT00404248|6318649|P8|STARTED|Overall Study||6
2576086|NCT00404248|6318650|P7|STARTED|Overall Study||6
2576087|NCT00404248|6318651|P6|STARTED|Overall Study||3
2576088|NCT00404248|6318652|P5|STARTED|Overall Study||3
2576089|NCT00404248|6318653|P4|STARTED|Overall Study||2
2576090|NCT00404248|6318654|P3|STARTED|Overall Study||5
2576091|NCT00404248|6318655|P2|STARTED|Overall Study||4
2576092|NCT00404248|6318656|P1|STARTED|Overall Study||3
2576093|NCT00404235|6318689|P2|NOT COMPLETED|Overall Study||2
2576094|NCT00404235|6318690|P1|NOT COMPLETED|Overall Study||1
2576095|NCT00404235|6318689|P2|COMPLETED|Overall Study||39
2576096|NCT00404235|6318690|P1|COMPLETED|Overall Study||34
2576097|NCT00404235|6318689|P2|STARTED|Overall Study||41
2576098|NCT00404235|6318690|P1|STARTED|Overall Study||35
2576099|NCT00404092|6318708|P4|NOT COMPLETED|Overall Study||0
2576100|NCT00404092|6318709|P3|NOT COMPLETED|Overall Study||1
2576101|NCT00404092|6318710|P2|NOT COMPLETED|Overall Study||0
2576102|NCT00404092|6318711|P1|NOT COMPLETED|Overall Study||1
2576103|NCT00404092|6318708|P4|COMPLETED|Overall Study||20
2576104|NCT00404092|6318709|P3|COMPLETED|Overall Study||8
2576105|NCT00404092|6318710|P2|COMPLETED|Overall Study||8
2576106|NCT00404092|6318711|P1|COMPLETED|Overall Study||8
2576107|NCT00404092|6318708|P4|STARTED|Overall Study||20
2576108|NCT00404092|6318709|P3|STARTED|Overall Study||9
2576109|NCT00404092|6318710|P2|STARTED|Overall Study||8
2576110|NCT00404092|6318711|P1|STARTED|Overall Study||9
2576111|NCT00404079|6318727|P2|NOT COMPLETED|Overall Study||20
2576112|NCT00404079|6318728|P1|NOT COMPLETED|Overall Study||22
2576113|NCT00404079|6318727|P2|COMPLETED|Overall Study||105
2576114|NCT00404079|6318728|P1|COMPLETED|Overall Study||103
2576115|NCT00404079|6318727|P2|STARTED|Overall Study||125
2576116|NCT00404079|6318728|P1|STARTED|Overall Study||125
2576117|NCT00404066|6318734|P1|NOT COMPLETED|Overall Study||3
2576118|NCT00404066|6318734|P1|COMPLETED|Overall Study||18
2576119|NCT00404066|6318734|P1|STARTED|Overall Study|1 subject started but withdrew after adriamycin+cytoxan, but before study drugs lapatinib+docetaxel.|21
2576120|NCT00403845|6318739|P4|NOT COMPLETED|Treatment Period 4||0
2576121|NCT00403845|6318740|P3|NOT COMPLETED|Treatment Period 4||0
2576122|NCT00403845|6318741|P2|NOT COMPLETED|Treatment Period 4||0
2576123|NCT00403845|6318742|P1|NOT COMPLETED|Treatment Period 4||0
2576124|NCT00403845|6318739|P4|COMPLETED|Treatment Period 4||11
2576125|NCT00403845|6318740|P3|COMPLETED|Treatment Period 4||11
2576126|NCT00403845|6318741|P2|COMPLETED|Treatment Period 4||13
2576127|NCT00403845|6318742|P1|COMPLETED|Treatment Period 4||10
2576128|NCT00403845|6318739|P4|STARTED|Treatment Period 4||11
2576129|NCT00403845|6318740|P3|STARTED|Treatment Period 4||11
2576130|NCT00403845|6318741|P2|STARTED|Treatment Period 4||13
2576131|NCT00403845|6318742|P1|STARTED|Treatment Period 4||10
2576132|NCT00403845|6318739|P4|NOT COMPLETED|Treatment Period 3||2
2576133|NCT00403845|6318740|P3|NOT COMPLETED|Treatment Period 3||0
2576134|NCT00403845|6318741|P2|NOT COMPLETED|Treatment Period 3||0
2576135|NCT00403845|6318742|P1|NOT COMPLETED|Treatment Period 3||0
2576136|NCT00403845|6318739|P4|COMPLETED|Treatment Period 3||11
2576137|NCT00403845|6318740|P3|COMPLETED|Treatment Period 3||11
2576138|NCT00403845|6318741|P2|COMPLETED|Treatment Period 3||13
2576139|NCT00403845|6318742|P1|COMPLETED|Treatment Period 3||10
2576140|NCT00403845|6318739|P4|STARTED|Treatment Period 3||13
2576141|NCT00403845|6318740|P3|STARTED|Treatment Period 3||11
2576142|NCT00403845|6318741|P2|STARTED|Treatment Period 3||13
2576143|NCT00403845|6318742|P1|STARTED|Treatment Period 3||10
2576144|NCT00403845|6318739|P4|NOT COMPLETED|Treatment Period 2||0
2576145|NCT00403845|6318740|P3|NOT COMPLETED|Treatment Period 2||0
2576146|NCT00403845|6318741|P2|NOT COMPLETED|Treatment Period 2||0
2576147|NCT00403845|6318742|P1|NOT COMPLETED|Treatment Period 2||1
2576148|NCT00403845|6318739|P4|COMPLETED|Treatment Period 2||13
2576149|NCT00403845|6318740|P3|COMPLETED|Treatment Period 2||11
2576150|NCT00403845|6318741|P2|COMPLETED|Treatment Period 2||13
2576151|NCT00403845|6318742|P1|COMPLETED|Treatment Period 2||10
2576152|NCT00403845|6318739|P4|STARTED|Treatment Period 2||13
2576153|NCT00403845|6318740|P3|STARTED|Treatment Period 2||11
2576154|NCT00403845|6318741|P2|STARTED|Treatment Period 2||13
2576155|NCT00403845|6318742|P1|STARTED|Treatment Period 2||11
2576156|NCT00403845|6318739|P4|NOT COMPLETED|Treatment Period 1||1
2576157|NCT00403845|6318740|P3|NOT COMPLETED|Treatment Period 1||0
2576158|NCT00403845|6318741|P2|NOT COMPLETED|Treatment Period 1||0
2576159|NCT00403845|6318742|P1|NOT COMPLETED|Treatment Period 1||1
2576160|NCT00403845|6318739|P4|COMPLETED|Treatment Period 1||13
2576161|NCT00403845|6318740|P3|COMPLETED|Treatment Period 1||11
2576162|NCT00403845|6318741|P2|COMPLETED|Treatment Period 1||13
2576163|NCT00403845|6318742|P1|COMPLETED|Treatment Period 1||11
2576164|NCT00403845|6318739|P4|STARTED|Treatment Period 1||14
2576165|NCT00403845|6318740|P3|STARTED|Treatment Period 1||11
2576166|NCT00403845|6318741|P2|STARTED|Treatment Period 1||13
2576167|NCT00403845|6318742|P1|STARTED|Treatment Period 1||12
2576168|NCT00403767|6318766|P2|NOT COMPLETED|Overall Study||2468
2576169|NCT00403767|6318767|P1|NOT COMPLETED|Overall Study||2520
2576170|NCT00403767|6318766|P2|COMPLETED|Overall Study||4657
2576171|NCT00403767|6318767|P1|COMPLETED|Overall Study||4591
2576172|NCT00403767|6318766|P2|STARTED|Overall Study||7125
2576173|NCT00403767|6318767|P1|STARTED|Overall Study||7111
2576174|NCT00403754|6318791|P4|NOT COMPLETED|Open Label: Salmeterol||0
2576175|NCT00403754|6318792|P3|NOT COMPLETED|Open Label: Salmeterol||0
2576176|NCT00403754|6318793|P2|NOT COMPLETED|Open Label: Salmeterol||0
2576177|NCT00403754|6318794|P1|NOT COMPLETED|Open Label: Salmeterol||0
2576178|NCT00403754|6318791|P4|COMPLETED|Open Label: Salmeterol||11
2576179|NCT00403754|6318792|P3|COMPLETED|Open Label: Salmeterol||8
2576180|NCT00403754|6318793|P2|COMPLETED|Open Label: Salmeterol||9
2576181|NCT00403754|6318794|P1|COMPLETED|Open Label: Salmeterol||11
2576182|NCT00403754|6318791|P4|STARTED|Open Label: Salmeterol||11
2576183|NCT00403754|6318792|P3|STARTED|Open Label: Salmeterol||8
2576184|NCT00403754|6318793|P2|STARTED|Open Label: Salmeterol||9
2576185|NCT00403754|6318794|P1|STARTED|Open Label: Salmeterol||11
2576186|NCT00403754|6318791|P4|NOT COMPLETED|Core Treatment Period 4||0
2576187|NCT00403754|6318792|P3|NOT COMPLETED|Core Treatment Period 4||0
2576188|NCT00403754|6318793|P2|NOT COMPLETED|Core Treatment Period 4||0
2576189|NCT00403754|6318794|P1|NOT COMPLETED|Core Treatment Period 4||0
2576190|NCT00403754|6318791|P4|COMPLETED|Core Treatment Period 4||11
2576191|NCT00403754|6318792|P3|COMPLETED|Core Treatment Period 4||8
2576192|NCT00403754|6318793|P2|COMPLETED|Core Treatment Period 4||9
2576193|NCT00403754|6318794|P1|COMPLETED|Core Treatment Period 4||11
2576194|NCT00403754|6318791|P4|STARTED|Core Treatment Period 4||11
2576195|NCT00403754|6318792|P3|STARTED|Core Treatment Period 4||8
2576196|NCT00403754|6318793|P2|STARTED|Core Treatment Period 4||9
2576197|NCT00403754|6318794|P1|STARTED|Core Treatment Period 4||11
2576198|NCT00403754|6318791|P4|NOT COMPLETED|Core Treatment Period 3||0
2576199|NCT00403754|6318792|P3|NOT COMPLETED|Core Treatment Period 3||0
2576200|NCT00403754|6318793|P2|NOT COMPLETED|Core Treatment Period 3||0
2576201|NCT00403754|6318794|P1|NOT COMPLETED|Core Treatment Period 3||0
2576202|NCT00403754|6318791|P4|COMPLETED|Core Treatment Period 3||11
2576203|NCT00403754|6318792|P3|COMPLETED|Core Treatment Period 3||8
2576204|NCT00403754|6318793|P2|COMPLETED|Core Treatment Period 3||9
2576205|NCT00403754|6318794|P1|COMPLETED|Core Treatment Period 3||11
2576206|NCT00403754|6318791|P4|STARTED|Core Treatment Period 3||11
2576207|NCT00403754|6318792|P3|STARTED|Core Treatment Period 3||8
2576208|NCT00403754|6318793|P2|STARTED|Core Treatment Period 3||9
2576209|NCT00403754|6318794|P1|STARTED|Core Treatment Period 3||11
2576210|NCT00403754|6318791|P4|NOT COMPLETED|Core Treatment Period 2||0
2576211|NCT00403754|6318792|P3|NOT COMPLETED|Core Treatment Period 2||1
2576212|NCT00403754|6318793|P2|NOT COMPLETED|Core Treatment Period 2||0
2576213|NCT00403754|6318794|P1|NOT COMPLETED|Core Treatment Period 2||0
2576214|NCT00403754|6318791|P4|COMPLETED|Core Treatment Period 2||11
2576215|NCT00403754|6318792|P3|COMPLETED|Core Treatment Period 2||8
2576216|NCT00403754|6318793|P2|COMPLETED|Core Treatment Period 2||9
2576217|NCT00403754|6318794|P1|COMPLETED|Core Treatment Period 2||11
2576218|NCT00403754|6318791|P4|STARTED|Core Treatment Period 2||11
2576219|NCT00403754|6318792|P3|STARTED|Core Treatment Period 2||9
2576220|NCT00403754|6318793|P2|STARTED|Core Treatment Period 2||9
2576221|NCT00403754|6318794|P1|STARTED|Core Treatment Period 2||11
2576222|NCT00403754|6318791|P4|NOT COMPLETED|Core Treatment Period 1||0
2576223|NCT00403754|6318792|P3|NOT COMPLETED|Core Treatment Period 1||0
2576224|NCT00403754|6318793|P2|NOT COMPLETED|Core Treatment Period 1||1
2576225|NCT00403754|6318794|P1|NOT COMPLETED|Core Treatment Period 1||0
2576226|NCT00403754|6318791|P4|COMPLETED|Core Treatment Period 1||11
2576227|NCT00403754|6318792|P3|COMPLETED|Core Treatment Period 1||9
2576228|NCT00403754|6318793|P2|COMPLETED|Core Treatment Period 1||9
2576229|NCT00403754|6318794|P1|COMPLETED|Core Treatment Period 1||11
2576230|NCT00403754|6318791|P4|STARTED|Core Treatment Period 1||11
2576231|NCT00403754|6318792|P3|STARTED|Core Treatment Period 1||9
2576232|NCT00403754|6318793|P2|STARTED|Core Treatment Period 1||10
2576233|NCT00403754|6318794|P1|STARTED|Core Treatment Period 1||11
2576234|NCT00403585|6318821|P1|NOT COMPLETED|Open-Label Phase; Extension Study||6
2576235|NCT00403585|6318821|P1|COMPLETED|Open-Label Phase; Extension Study||74
2576236|NCT00403585|6318821|P1|STARTED|Open-Label Phase; Extension Study|80 of 102 participants completing Study 103814 enrolled in extension (22 didn't continue medication)|80
2576237|NCT00403585|6318821|P1|NOT COMPLETED|Initial Treatment Phase||2
2576238|NCT00403585|6318821|P1|COMPLETED|Initial Treatment Phase||102
2576239|NCT00403585|6318821|P1|STARTED|Initial Treatment Phase||104
2576240|NCT00403546|6318832|P3|NOT COMPLETED|Randomized Trial||16
2576241|NCT00403546|6318833|P2|NOT COMPLETED|Randomized Trial||17
2576242|NCT00403546|6318834|P1|NOT COMPLETED|Randomized Trial||0
2576243|NCT00403546|6318832|P3|COMPLETED|Randomized Trial||21
2576244|NCT00403546|6318833|P2|COMPLETED|Randomized Trial||21
2576245|NCT00403546|6318834|P1|COMPLETED|Randomized Trial||0
2576246|NCT00403546|6318832|P3|STARTED|Randomized Trial||37
2576247|NCT00403546|6318833|P2|STARTED|Randomized Trial||38
2576248|NCT00403546|6318834|P1|STARTED|Randomized Trial|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|0
2576249|NCT00403546|6318832|P3|NOT COMPLETED|Screening Phase||0
2576250|NCT00403546|6318833|P2|NOT COMPLETED|Screening Phase||0
2576251|NCT00403546|6318834|P1|NOT COMPLETED|Screening Phase||28
2576252|NCT00403546|6318832|P3|COMPLETED|Screening Phase||0
2576253|NCT00403546|6318833|P2|COMPLETED|Screening Phase||0
2576254|NCT00403546|6318834|P1|COMPLETED|Screening Phase|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|75
2576255|NCT00403546|6318832|P3|STARTED|Screening Phase||0
2576256|NCT00403546|6318833|P2|STARTED|Screening Phase||0
2576257|NCT00403546|6318834|P1|STARTED|Screening Phase||103
2576258|NCT00403546|6318832|P3|NOT COMPLETED|Signed Informed Consent/Open-Label||0
2576259|NCT00403546|6318833|P2|NOT COMPLETED|Signed Informed Consent/Open-Label||0
2576260|NCT00403546|6318834|P1|NOT COMPLETED|Signed Informed Consent/Open-Label||28
2576261|NCT00403546|6318832|P3|COMPLETED|Signed Informed Consent/Open-Label||0
2576262|NCT00403546|6318833|P2|COMPLETED|Signed Informed Consent/Open-Label||0
2576263|NCT00403546|6318834|P1|COMPLETED|Signed Informed Consent/Open-Label||103
2576264|NCT00403546|6318832|P3|STARTED|Signed Informed Consent/Open-Label||0
2576265|NCT00403546|6318833|P2|STARTED|Signed Informed Consent/Open-Label||0
2576266|NCT00403546|6318834|P1|STARTED|Signed Informed Consent/Open-Label||131
2576267|NCT00403481|6318874|P1|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||2
2576268|NCT00403481|6318874|P1|COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||142
2576269|NCT00403481|6318874|P1|STARTED|Olm 40 mg + Hydrochlorothiazide 25 mg|168 -24 met their blood pressure goal (remained on olmesartan 40 mg/hydrochlorothiazide 12.5mg)= 144|144
2576270|NCT00403481|6318874|P1|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||5
2576271|NCT00403481|6318874|P1|COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||168
2576272|NCT00403481|6318874|P1|STARTED|Olm 40 mg + Hydrochlorothiazide 12.5 mg|177 -4 met their blood pressure goal (remained on olmesartan 40 mg)= 173|173
2576273|NCT00403481|6318874|P1|NOT COMPLETED|Olm 40 mg||5
2576274|NCT00403481|6318874|P1|COMPLETED|Olm 40 mg||177
2576275|NCT00403481|6318874|P1|STARTED|Olm 40 mg|186 -4 met their blood pressure goal (remained on olmesartan 20 mg) = 182|182
2576276|NCT00403481|6318874|P1|NOT COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||6
2576277|NCT00403481|6318874|P1|COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||186
2576278|NCT00403481|6318874|P1|STARTED|Olmesartan Medoxomil (Olm) 20 mg||192
2576279|NCT00403455|6318889|P1|NOT COMPLETED|Overall Study||1
2576280|NCT00403455|6318889|P1|COMPLETED|Overall Study||37
2576281|NCT00403455|6318889|P1|STARTED|Overall Study||38
2576282|NCT00403403|6318895|P2|NOT COMPLETED|Overall Study||0
2576283|NCT00403403|6318896|P1|NOT COMPLETED|Overall Study||0
2576284|NCT00403403|6318895|P2|COMPLETED|Overall Study||52
2576285|NCT00403403|6318896|P1|COMPLETED|Overall Study||50
2576286|NCT00403403|6318895|P2|Safety-Evaluable Patients|Overall Study||51
2576287|NCT00403403|6318896|P1|Safety-Evaluable Patients|Overall Study||47
2576288|NCT00403403|6318895|P2|STARTED|Overall Study||52
2576289|NCT00403403|6318896|P1|STARTED|Overall Study||50
2576290|NCT00403390|6318912|P2|NOT COMPLETED|Overall Study||0
2576291|NCT00403390|6318913|P1|NOT COMPLETED|Overall Study||3
2576292|NCT00403390|6318912|P2|COMPLETED|Overall Study||18
2576293|NCT00403390|6318913|P1|COMPLETED|Overall Study||13
2576294|NCT00403390|6318912|P2|STARTED|Overall Study||18
2576295|NCT00403390|6318913|P1|STARTED|Overall Study||16
2576296|NCT00403273|6318921|P2|NOT COMPLETED|Overall Study||4
2576297|NCT00403273|6318922|P1|NOT COMPLETED|Overall Study||3
2576298|NCT00403273|6318921|P2|COMPLETED|Overall Study||25
2576299|NCT00403273|6318922|P1|COMPLETED|Overall Study||22
2576300|NCT00403273|6318921|P2|STARTED|Overall Study||29
2576301|NCT00403273|6318922|P1|STARTED|Overall Study||25
2576302|NCT00403234|6318964|P4|NOT COMPLETED|Overall Study||0
2576303|NCT00403234|6318965|P3|NOT COMPLETED|Overall Study||1
2576304|NCT00403234|6318966|P2|NOT COMPLETED|Overall Study||1
2576305|NCT00403234|6318967|P1|NOT COMPLETED|Overall Study||1
2576306|NCT00403234|6318964|P4|COMPLETED|Overall Study||2
2576307|NCT00403234|6318965|P3|COMPLETED|Overall Study||2
2576308|NCT00403234|6318966|P2|COMPLETED|Overall Study||2
2576309|NCT00403234|6318967|P1|COMPLETED|Overall Study||1
2576310|NCT00403234|6318964|P4|STARTED|Overall Study||2
2576311|NCT00403234|6318965|P3|STARTED|Overall Study||3
2576312|NCT00403234|6318966|P2|STARTED|Overall Study||3
2576313|NCT00403234|6318967|P1|STARTED|Overall Study||2
2576314|NCT00403130|6318977|P1|NOT COMPLETED|Survival Follow-up up to 6 Years||10
2576315|NCT00403130|6318977|P1|COMPLETED|Survival Follow-up up to 6 Years||16
2576316|NCT00403130|6318977|P1|STARTED|Survival Follow-up up to 6 Years||26
2576317|NCT00403130|6318977|P1|NOT COMPLETED|2 Years From Start of Treatment||5
2576318|NCT00403130|6318977|P1|COMPLETED|2 Years From Start of Treatment||26
2576319|NCT00403130|6318977|P1|STARTED|2 Years From Start of Treatment||31
2576320|NCT00403117|6318984|P1|NOT COMPLETED|Overall Study||20
2576321|NCT00403117|6318984|P1|COMPLETED|Overall Study||29
2576322|NCT00403117|6318984|P1|STARTED|Overall Study||49
2576323|NCT00402987|6319030|P4|NOT COMPLETED|Overall Study||0
2576324|NCT00402987|6319031|P3|NOT COMPLETED|Overall Study||1
2576325|NCT00402987|6319032|P2|NOT COMPLETED|Overall Study||0
2576326|NCT00402987|6319033|P1|NOT COMPLETED|Overall Study||0
2576327|NCT00402987|6319030|P4|COMPLETED|Overall Study||89
2576328|NCT00402987|6319031|P3|COMPLETED|Overall Study||44
2576329|NCT00402987|6319032|P2|COMPLETED|Overall Study||45
2576330|NCT00402987|6319033|P1|COMPLETED|Overall Study||90
2576331|NCT00402987|6319030|P4|STARTED|Overall Study||89
2576332|NCT00402987|6319031|P3|STARTED|Overall Study||45
2576333|NCT00402987|6319032|P2|STARTED|Overall Study||45
2576334|NCT00402987|6319033|P1|STARTED|Overall Study||90
2576335|NCT00402896|6319195|P1|NOT COMPLETED|Overall Study||0
2576336|NCT00402896|6319195|P1|COMPLETED|Overall Study||20
2576337|NCT00402896|6319195|P1|STARTED|Overall Study||20
2576338|NCT00402883|6319199|P1|NOT COMPLETED|Maintenance Therapy||0
2576339|NCT00402883|6319199|P1|COMPLETED|Maintenance Therapy|All 5 patients received limited maintenance therapy due to early trial closure.|5
2576340|NCT00402883|6319199|P1|STARTED|Maintenance Therapy||5
2576341|NCT00402883|6319199|P1|NOT COMPLETED|Consolidation Therapy||0
2576342|NCT00402883|6319199|P1|COMPLETED|Consolidation Therapy||5
2576343|NCT00402883|6319199|P1|STARTED|Consolidation Therapy||5
2576344|NCT00402883|6319199|P1|NOT COMPLETED|Induction Therapy||0
2576345|NCT00402883|6319199|P1|COMPLETED|Induction Therapy||5
2576346|NCT00402883|6319199|P1|STARTED|Induction Therapy||5
2576347|NCT00402831|6319205|P2|NOT COMPLETED|Overall Study||3
2576348|NCT00402831|6319206|P1|NOT COMPLETED|Overall Study||1
2576349|NCT00402831|6319205|P2|COMPLETED|Overall Study||200
2576350|NCT00402831|6319206|P1|COMPLETED|Overall Study||201
2576351|NCT00402831|6319205|P2|ProQuad® Dose 1 (Day 30)|Overall Study||203
2576352|NCT00402831|6319206|P1|ProQuad® Dose 1 (Day 30)|Overall Study||202
2576353|NCT00402831|6319205|P2|ProQuad® Dose 1 (Day 1)|Overall Study||203
2576354|NCT00402831|6319206|P1|ProQuad® Dose 1 (Day 1)|Overall Study||202
2576355|NCT00402831|6319205|P2|STARTED|Overall Study||203
2576356|NCT00402831|6319206|P1|STARTED|Overall Study||202
2576357|NCT00402740|6319238|P1|NOT COMPLETED|Overall Study||80
2576358|NCT00402740|6319238|P1|COMPLETED|Overall Study||242
2576359|NCT00402740|6319238|P1|STARTED|Overall Study||322
2576360|NCT00402727|6319250|P2|NOT COMPLETED|Overall Study||34
2576361|NCT00402727|6319251|P1|NOT COMPLETED|Overall Study||42
2576362|NCT00402727|6319250|P2|COMPLETED|Overall Study||347
2576363|NCT00402727|6319251|P1|COMPLETED|Overall Study||390
2576364|NCT00402727|6319250|P2|Achieving Test Of Cure (TOC)|Overall Study||347
2576365|NCT00402727|6319251|P1|Achieving Test Of Cure (TOC)|Overall Study||390
2576366|NCT00402727|6319250|P2|Achieving End Of Treatment (EOT)|Overall Study||355
2576367|NCT00402727|6319251|P1|Achieving End Of Treatment (EOT)|Overall Study||408
2576368|NCT00402727|6319250|P2|STARTED|Overall Study||381
2576369|NCT00402727|6319251|P1|STARTED|Overall Study||432
2576370|NCT00402714|6319281|P2|NOT COMPLETED|Overall Study||0
2576371|NCT00402714|6319282|P1|NOT COMPLETED|Overall Study||0
2576372|NCT00402714|6319281|P2|COMPLETED|Overall Study||11
2576373|NCT00402714|6319282|P1|COMPLETED|Overall Study||3
2576374|NCT00402714|6319281|P2|STARTED|Overall Study||11
2576375|NCT00402714|6319282|P1|STARTED|Overall Study||3
2576376|NCT00402688|6319293|P3|NOT COMPLETED|Overall Study||15
2576377|NCT00402688|6319294|P2|NOT COMPLETED|Overall Study||16
2576378|NCT00402688|6319295|P1|NOT COMPLETED|Overall Study||21
2576379|NCT00402688|6319293|P3|COMPLETED|Overall Study||65
2576380|NCT00402688|6319294|P2|COMPLETED|Overall Study||65
2576381|NCT00402688|6319295|P1|COMPLETED|Overall Study||60
2576382|NCT00402688|6319293|P3|STARTED|Overall Study||80
2576383|NCT00402688|6319294|P2|STARTED|Overall Study||81
2576384|NCT00402688|6319295|P1|STARTED|Overall Study||81
2576385|NCT00402649|6319318|P1|NOT COMPLETED|Overall Study||2
2576386|NCT00402649|6319318|P1|COMPLETED|Overall Study||33
2576387|NCT00402649|6319318|P1|STARTED|Overall Study||35
2576388|NCT00402597|6319333|P5|NOT COMPLETED|Overall Study||124
2576389|NCT00402597|6319334|P4|NOT COMPLETED|Overall Study||74
2576390|NCT00402597|6319335|P3|NOT COMPLETED|Overall Study||212
2576391|NCT00402597|6319336|P2|NOT COMPLETED|Overall Study||46
2576392|NCT00402597|6319337|P1|NOT COMPLETED|Overall Study||191
2576393|NCT00402597|6319333|P5|COMPLETED|Overall Study||479
2576394|NCT00402597|6319334|P4|COMPLETED|Overall Study||279
2576395|NCT00402597|6319335|P3|COMPLETED|Overall Study||834
2576396|NCT00402597|6319336|P2|COMPLETED|Overall Study||261
2576397|NCT00402597|6319337|P1|COMPLETED|Overall Study||962
2576398|NCT00402597|6319333|P5|STARTED|Overall Study||603
2576399|NCT00402597|6319334|P4|STARTED|Overall Study||353
2576400|NCT00402597|6319335|P3|STARTED|Overall Study||1046
2576401|NCT00402597|6319336|P2|STARTED|Overall Study||307
2576402|NCT00402597|6319337|P1|STARTED|Overall Study||1153
2576403|NCT00402363|6319378|P4|NOT COMPLETED|Overall Study||10
2576404|NCT00402363|6319379|P3|NOT COMPLETED|Overall Study||6
2576405|NCT00402363|6319380|P2|NOT COMPLETED|Overall Study||30
2576406|NCT00402363|6319381|P1|NOT COMPLETED|Overall Study||33
2576407|NCT00402363|6319378|P4|COMPLETED|Overall Study||45
2576408|NCT00402363|6319379|P3|COMPLETED|Overall Study||60
2576409|NCT00402363|6319380|P2|COMPLETED|Overall Study||246
2576410|NCT00402363|6319381|P1|COMPLETED|Overall Study||233
2576411|NCT00402363|6319378|P4|STARTED|Overall Study||55
2576412|NCT00402363|6319379|P3|STARTED|Overall Study||66
2576413|NCT00402363|6319380|P2|STARTED|Overall Study||276
2576414|NCT00402363|6319381|P1|STARTED|Overall Study||266
2576415|NCT00402337|6319444|P5|NOT COMPLETED|Overall Study||8
2576416|NCT00402337|6319445|P4|NOT COMPLETED|Overall Study||12
2576417|NCT00402337|6319446|P3|NOT COMPLETED|Overall Study||4
2576418|NCT00402337|6319447|P2|NOT COMPLETED|Overall Study||6
2576419|NCT00402337|6319448|P1|NOT COMPLETED|Overall Study||5
2576420|NCT00402337|6319444|P5|COMPLETED|Overall Study||61
2576421|NCT00402337|6319445|P4|COMPLETED|Overall Study||51
2576422|NCT00402337|6319446|P3|COMPLETED|Overall Study||58
2576423|NCT00402337|6319447|P2|COMPLETED|Overall Study||51
2576424|NCT00402337|6319448|P1|COMPLETED|Overall Study||54
2576425|NCT00402337|6319444|P5|STARTED|Overall Study||69
2576426|NCT00402337|6319445|P4|STARTED|Overall Study||63
2576427|NCT00402337|6319446|P3|STARTED|Overall Study||62
2576428|NCT00402337|6319447|P2|STARTED|Overall Study||57
2576429|NCT00402337|6319448|P1|STARTED|Overall Study||59
2576430|NCT00402324|6319487|P2|NOT COMPLETED|Overall Study||41
2576431|NCT00402324|6319488|P1|NOT COMPLETED|Overall Study||43
2576432|NCT00402324|6319487|P2|COMPLETED|Overall Study||60
2576433|NCT00402324|6319488|P1|COMPLETED|Overall Study||58
2576434|NCT00402324|6319487|P2|STARTED|Overall Study||101
2576435|NCT00402324|6319488|P1|STARTED|Overall Study||101
2576436|NCT00402285|6319521|P3|NOT COMPLETED|Overall Study||2
2576437|NCT00402285|6319522|P2|NOT COMPLETED|Overall Study||6
2576438|NCT00402285|6319523|P1|NOT COMPLETED|Overall Study||7
2576439|NCT00402285|6319521|P3|COMPLETED|Overall Study||26
2576440|NCT00402285|6319522|P2|COMPLETED|Overall Study||21
2576441|NCT00402285|6319523|P1|COMPLETED|Overall Study||22
2576442|NCT00402285|6319521|P3|STARTED|Overall Study||28
2576443|NCT00402285|6319522|P2|STARTED|Overall Study||27
2576444|NCT00402285|6319523|P1|STARTED|Overall Study||29
2576445|NCT00402246|6319531|P2|NOT COMPLETED|Overall Study||234
2576446|NCT00402246|6319532|P1|NOT COMPLETED|Overall Study||220
2576447|NCT00402246|6319531|P2|COMPLETED|Overall Study||749
2576448|NCT00402246|6319532|P1|COMPLETED|Overall Study||794
2576449|NCT00402246|6319531|P2|STARTED|Overall Study||983
2576450|NCT00402246|6319532|P1|STARTED|Overall Study||1014
2576451|NCT00402233|6319566|P4|NOT COMPLETED|Overall Study||11
2576452|NCT00402233|6319567|P3|NOT COMPLETED|Overall Study||11
2576453|NCT00402233|6319568|P2|NOT COMPLETED|Overall Study||10
2576454|NCT00402233|6319569|P1|NOT COMPLETED|Overall Study||5
2576455|NCT00402233|6319566|P4|COMPLETED|Overall Study||62
2576456|NCT00402233|6319567|P3|COMPLETED|Overall Study||70
2576457|NCT00402233|6319568|P2|COMPLETED|Overall Study||70
2576458|NCT00402233|6319569|P1|COMPLETED|Overall Study||72
2576459|NCT00402233|6319566|P4|STARTED|Overall Study||73
2576460|NCT00402233|6319567|P3|STARTED|Overall Study||81
2576461|NCT00402233|6319568|P2|STARTED|Overall Study||80
2576462|NCT00402233|6319569|P1|STARTED|Overall Study||77
2576463|NCT00402194|6319593|P2|NOT COMPLETED|Overall Study||0
2576464|NCT00402194|6319594|P1|NOT COMPLETED|Overall Study||0
2576465|NCT00402194|6319593|P2|COMPLETED|Overall Study||8
2576466|NCT00402194|6319594|P1|COMPLETED|Overall Study||9
2576467|NCT00402194|6319593|P2|STARTED|Overall Study||8
2576468|NCT00402194|6319594|P1|STARTED|Overall Study||9
2576469|NCT00402168|6319604|P2|NOT COMPLETED|Switched From CNI to Belatacept in LT||0
2576470|NCT00402168|6319605|P1|NOT COMPLETED|Switched From CNI to Belatacept in LT||6
2576471|NCT00402168|6319604|P2|COMPLETED|Switched From CNI to Belatacept in LT||0
2576472|NCT00402168|6319605|P1|COMPLETED|Switched From CNI to Belatacept in LT||32
2576473|NCT00402168|6319604|P2|STARTED|Switched From CNI to Belatacept in LT|Out of 81 starting LT period in CNI group, 38 switched from CNI to Belatacept during the LT period.|0
2576474|NCT00402168|6319605|P1|STARTED|Switched From CNI to Belatacept in LT|Participants switched from CNI to Belatacept during LT period.|38
2576475|NCT00402168|6319604|P2|NOT COMPLETED|Long Term (LT)||17
2576476|NCT00402168|6319605|P1|NOT COMPLETED|Long Term (LT)||11
2576477|NCT00402168|6319604|P2|COMPLETED|Long Term (LT)||64
2576478|NCT00402168|6319605|P1|COMPLETED|Long Term (LT)||70
2576479|NCT00402168|6319604|P2|STARTED|Long Term (LT)|5 completed 12 months, did not enter long term: 1 AE, 1 lack of efficacy, 3 other(non-specified).|81
2576480|NCT00402168|6319605|P1|STARTED|Long Term (LT)||81
2576481|NCT00402168|6319604|P2|NOT COMPLETED|Treatment (up to 12 Months)||2
2576482|NCT00402168|6319605|P1|NOT COMPLETED|Treatment (up to 12 Months)||2
2576483|NCT00402168|6319604|P2|COMPLETED|Treatment (up to 12 Months)||86
2576484|NCT00402168|6319605|P1|COMPLETED|Treatment (up to 12 Months)||81
2576485|NCT00402168|6319604|P2|STARTED|Treatment (up to 12 Months)||88
2576486|NCT00402168|6319605|P1|STARTED|Treatment (up to 12 Months)||83
2576487|NCT00402168|6319604|P2|NOT COMPLETED|Randomized||1
2576488|NCT00402168|6319605|P1|NOT COMPLETED|Randomized||1
2576489|NCT00402168|6319604|P2|COMPLETED|Randomized||88
2576490|NCT00402168|6319605|P1|COMPLETED|Randomized||83
2576491|NCT00402168|6319604|P2|STARTED|Randomized||89
2576492|NCT00402168|6319605|P1|STARTED|Randomized||84
2576493|NCT00402103|6319662|P2|NOT COMPLETED|Overall Study||13
2576494|NCT00402103|6319663|P1|NOT COMPLETED|Overall Study||91
2576495|NCT00402103|6319662|P2|COMPLETED|Overall Study||73
2576496|NCT00402103|6319663|P1|COMPLETED|Overall Study||379
2576497|NCT00402103|6319662|P2|STARTED|Overall Study||86
2576498|NCT00402103|6319663|P1|STARTED|Overall Study||470
2576499|NCT00402051|6319679|P2|NOT COMPLETED|Overall Study||35
2576500|NCT00402051|6319680|P1|NOT COMPLETED|Overall Study||38
2576501|NCT00402051|6319679|P2|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|32
2576502|NCT00402051|6319680|P1|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|28
2576503|NCT00402051|6319679|P2|Received Treatment|Overall Study||65
2576504|NCT00402051|6319680|P1|Received Treatment|Overall Study||65
2576505|NCT00402051|6319679|P2|STARTED|Overall Study||67
2576506|NCT00402051|6319680|P1|STARTED|Overall Study||66
2576507|NCT00402025|6319697|P3|NOT COMPLETED|Overall Study||10
2576508|NCT00402025|6319698|P2|NOT COMPLETED|Overall Study||3
2576509|NCT00402025|6319699|P1|NOT COMPLETED|Overall Study||2
2576510|NCT00402025|6319697|P3|COMPLETED|Overall Study||0
2576511|NCT00402025|6319698|P2|COMPLETED|Overall Study||1
2576512|NCT00402025|6319699|P1|COMPLETED|Overall Study||1
2576513|NCT00402025|6319697|P3|STARTED|Overall Study||10
2576514|NCT00402025|6319698|P2|STARTED|Overall Study||4
2576515|NCT00402025|6319699|P1|STARTED|Overall Study||3
2576516|NCT00401973|6319725|P3|NOT COMPLETED|Overall Study||23
2576517|NCT00401973|6319726|P2|NOT COMPLETED|Overall Study||26
2576518|NCT00401973|6319727|P1|NOT COMPLETED|Overall Study||11
2576519|NCT00401973|6319725|P3|COMPLETED|Overall Study||50
2576520|NCT00401973|6319726|P2|COMPLETED|Overall Study||50
2576521|NCT00401973|6319727|P1|COMPLETED|Overall Study||39
2576522|NCT00401973|6319725|P3|STARTED|Overall Study||73
2576523|NCT00401973|6319726|P2|STARTED|Overall Study||76
2576524|NCT00401973|6319727|P1|STARTED|Overall Study||50
2576525|NCT00401960|6319766|P2|NOT COMPLETED|Overall Study||0
2576526|NCT00401960|6319767|P1|NOT COMPLETED|Overall Study||5
2576527|NCT00401960|6319766|P2|COMPLETED|Overall Study||1
2576528|NCT00401960|6319767|P1|COMPLETED|Overall Study||0
2576529|NCT00401960|6319766|P2|STARTED|Overall Study||1
2576530|NCT00401960|6319767|P1|STARTED|Overall Study||5
2576531|NCT00401882|6319777|P2|NOT COMPLETED|Overall Study||0
2576532|NCT00401882|6319778|P1|NOT COMPLETED|Overall Study||0
2576533|NCT00401882|6319777|P2|COMPLETED|Overall Study||5
2576534|NCT00401882|6319778|P1|COMPLETED|Overall Study||2
2576535|NCT00401882|6319777|P2|STARTED|Overall Study||5
2576536|NCT00401882|6319778|P1|STARTED|Overall Study||2
2576537|NCT00401843|6319797|P3|NOT COMPLETED|Overall Study||142
2576538|NCT00401843|6319798|P2|NOT COMPLETED|Overall Study||144
2576539|NCT00401843|6319799|P1|NOT COMPLETED|Overall Study||21
2576540|NCT00401843|6319797|P3|COMPLETED|Overall Study||0
2576541|NCT00401843|6319798|P2|COMPLETED|Overall Study||0
2576542|NCT00401843|6319799|P1|COMPLETED|Overall Study||0
2576543|NCT00401843|6319797|P3|Treated|Overall Study||139
2576544|NCT00401843|6319798|P2|Treated|Overall Study||142
2576545|NCT00401843|6319799|P1|Treated|Overall Study||21
2576546|NCT00401843|6319797|P3|STARTED|Overall Study||142
2576547|NCT00401843|6319798|P2|STARTED|Overall Study||144
2576548|NCT00401843|6319799|P1|STARTED|Overall Study||21
2576549|NCT00401830|6319817|P2|NOT COMPLETED|Overall Study||32
2576550|NCT00401830|6319818|P1|NOT COMPLETED|Overall Study||31
2576551|NCT00401830|6319817|P2|COMPLETED|Overall Study||46
2576552|NCT00401830|6319818|P1|COMPLETED|Overall Study||50
2576553|NCT00401830|6319817|P2|STARTED|Overall Study||78
2576554|NCT00401830|6319818|P1|STARTED|Overall Study||81
2576555|NCT00401817|6319850|P1|NOT COMPLETED|Overall Study||0
2576556|NCT00401817|6319850|P1|COMPLETED|Overall Study||11
2576557|NCT00401817|6319850|P1|STARTED|Overall Study||11
2576558|NCT00401778|6319860|P3|NOT COMPLETED|Overall Study||1
2576559|NCT00401778|6319861|P2|NOT COMPLETED|Overall Study||1
2576560|NCT00401778|6319862|P1|NOT COMPLETED|Overall Study||1
2576561|NCT00401778|6319860|P3|COMPLETED|Overall Study||10
2576562|NCT00401778|6319861|P2|COMPLETED|Overall Study||11
2576563|NCT00401778|6319862|P1|COMPLETED|Overall Study||9
2576564|NCT00401778|6319860|P3|STARTED|Overall Study||11
2576565|NCT00401778|6319861|P2|STARTED|Overall Study||12
2576566|NCT00401778|6319862|P1|STARTED|Overall Study||10
2576567|NCT00401752|6319876|P2|NOT COMPLETED|Overall Study||18
2576568|NCT00401752|6319877|P1|NOT COMPLETED|Overall Study||10
2576569|NCT00401752|6319876|P2|COMPLETED|Overall Study||94
2576570|NCT00401752|6319877|P1|COMPLETED|Overall Study||97
2576571|NCT00401752|6319876|P2|Patients Included in Per-Protocol Popula|Overall Study||99
2576572|NCT00401752|6319877|P1|Patients Included in Per-Protocol Popula|Overall Study||100
2576573|NCT00401752|6319876|P2|Patients Included in Safety Population|Overall Study||110
2576574|NCT00401752|6319877|P1|Patients Included in Safety Population|Overall Study||107
2576575|NCT00401752|6319876|P2|Patients Included in ITT Population|Overall Study||111
2576576|NCT00401752|6319877|P1|Patients Included in ITT Population|Overall Study||106
2576577|NCT00401752|6319876|P2|Number of Patients Received Treatment|Overall Study||111
2576578|NCT00401752|6319877|P1|Number of Patients Received Treatment|Overall Study||107
2576579|NCT00401752|6319876|P2|STARTED|Overall Study||112
2576580|NCT00401752|6319877|P1|STARTED|Overall Study||107
2576581|NCT00401726|6319895|P2|NOT COMPLETED|Overall Study||112
2576582|NCT00401726|6319896|P1|NOT COMPLETED|Overall Study||97
2576583|NCT00401726|6319895|P2|COMPLETED|Overall Study||156
2576584|NCT00401726|6319896|P1|COMPLETED|Overall Study||172
2576585|NCT00401726|6319895|P2|STARTED|Overall Study||268
2576586|NCT00401726|6319896|P1|STARTED|Overall Study||269
2576587|NCT00401622|6319918|P2|NOT COMPLETED|Overall Study||43
2576588|NCT00401622|6319919|P1|NOT COMPLETED|Overall Study||34
2576589|NCT00401622|6319918|P2|COMPLETED|Overall Study||117
2576590|NCT00401622|6319919|P1|COMPLETED|Overall Study||126
2576591|NCT00401622|6319918|P2|STARTED|Overall Study||160
2576592|NCT00401622|6319919|P1|STARTED|Overall Study||160
2576593|NCT00401544|6319931|P4|NOT COMPLETED|Overall Study||16
2576594|NCT00401544|6319932|P3|NOT COMPLETED|Overall Study||12
2576595|NCT00401544|6319933|P2|NOT COMPLETED|Overall Study||18
2576596|NCT00401544|6319934|P1|NOT COMPLETED|Overall Study||18
2576597|NCT00401544|6319931|P4|COMPLETED|Overall Study||44
2576598|NCT00401544|6319932|P3|COMPLETED|Overall Study||48
2576599|NCT00401544|6319933|P2|COMPLETED|Overall Study||44
2576600|NCT00401544|6319934|P1|COMPLETED|Overall Study||38
2576601|NCT00401544|6319931|P4|STARTED|Overall Study|Randomized and treated|60
2576602|NCT00401544|6319932|P3|STARTED|Overall Study|Randomized and treated|60
2576603|NCT00401544|6319933|P2|STARTED|Overall Study|Randomized and treated|62
2576604|NCT00401544|6319934|P1|STARTED|Overall Study|Randomized and treated|56
2576605|NCT00401531|6319974|P2|NOT COMPLETED|Overall Study||10
2576606|NCT00401531|6319975|P1|NOT COMPLETED|Overall Study||9
2576607|NCT00401531|6319974|P2|COMPLETED|Overall Study||196
2576608|NCT00401531|6319975|P1|COMPLETED|Overall Study||197
2576609|NCT00401531|6319974|P2|STARTED|Overall Study||206
2576610|NCT00401531|6319975|P1|STARTED|Overall Study||206
2576611|NCT00401414|6319994|P3|NOT COMPLETED|Overall Study||0
2576612|NCT00401414|6319995|P2|NOT COMPLETED|Overall Study||0
2576613|NCT00401414|6319996|P1|NOT COMPLETED|Overall Study||0
2576614|NCT00401414|6319994|P3|COMPLETED|Overall Study||79
2576615|NCT00401414|6319995|P2|COMPLETED|Overall Study||147
2576616|NCT00401414|6319996|P1|COMPLETED|Overall Study||118
2576617|NCT00401414|6319994|P3|STARTED|Overall Study||79
2576618|NCT00401414|6319995|P2|STARTED|Overall Study||147
2576619|NCT00401414|6319996|P1|STARTED|Overall Study||118
2576620|NCT00401401|6320020|P4|NOT COMPLETED|Overall Study||3
2576621|NCT00401401|6320021|P3|NOT COMPLETED|Overall Study||1
2576622|NCT00401401|6320022|P2|NOT COMPLETED|Overall Study||0
2576623|NCT00401401|6320023|P1|NOT COMPLETED|Overall Study||0
2576624|NCT00401401|6320020|P4|COMPLETED|Overall Study||9
2576625|NCT00401401|6320021|P3|COMPLETED|Overall Study||5
2576626|NCT00401401|6320022|P2|COMPLETED|Overall Study||6
2576627|NCT00401401|6320023|P1|COMPLETED|Overall Study||6
2576628|NCT00401401|6320020|P4|STARTED|Overall Study||12
2576629|NCT00401401|6320021|P3|STARTED|Overall Study||6
2576630|NCT00401401|6320022|P2|STARTED|Overall Study||6
2576631|NCT00401401|6320023|P1|STARTED|Overall Study||6
2576632|NCT00401375|6320048|P3|NOT COMPLETED|Overall Study||25
2576633|NCT00401375|6320049|P2|NOT COMPLETED|Overall Study||25
2576634|NCT00401375|6320050|P1|NOT COMPLETED|Overall Study||22
2576635|NCT00401375|6320048|P3|COMPLETED|Overall Study||149
2576636|NCT00401375|6320049|P2|COMPLETED|Overall Study||151
2576637|NCT00401375|6320050|P1|COMPLETED|Overall Study||152
2576638|NCT00401375|6320048|P3|Received at Least 1 Dose of Study Drug|Overall Study||171
2576639|NCT00401375|6320049|P2|Received at Least 1 Dose of Study Drug|Overall Study||173
2576640|NCT00401375|6320050|P1|Received at Least 1 Dose of Study Drug|Overall Study||171
2576641|NCT00401375|6320048|P3|STARTED|Overall Study||174
2576642|NCT00401375|6320049|P2|STARTED|Overall Study||176
2576643|NCT00401375|6320050|P1|STARTED|Overall Study||174
2576644|NCT00401258|6320067|P1|NOT COMPLETED|Overall Study||7
2576645|NCT00401258|6320067|P1|COMPLETED|Overall Study||8
2576646|NCT00401258|6320067|P1|STARTED|Overall Study||15
2576647|NCT00401245|6320082|P8|NOT COMPLETED|Double Blind Tapering Phase||7
2576648|NCT00401245|6320083|P7|NOT COMPLETED|Double Blind Tapering Phase||7
2576649|NCT00401245|6320084|P6|NOT COMPLETED|Double Blind Tapering Phase||4
2576650|NCT00401245|6320085|P5|NOT COMPLETED|Double Blind Tapering Phase||4
2576651|NCT00401245|6320086|P4|NOT COMPLETED|Double Blind Tapering Phase||0
2576652|NCT00401245|6320087|P3|NOT COMPLETED|Double Blind Tapering Phase||0
2576653|NCT00401245|6320088|P2|NOT COMPLETED|Double Blind Tapering Phase||0
2576654|NCT00401245|6320089|P1|NOT COMPLETED|Double Blind Tapering Phase||0
2576655|NCT00401245|6320082|P8|COMPLETED|Double Blind Tapering Phase||95
2576656|NCT00401245|6320083|P7|COMPLETED|Double Blind Tapering Phase||80
2576657|NCT00401245|6320084|P6|COMPLETED|Double Blind Tapering Phase||90
2576658|NCT00401245|6320085|P5|COMPLETED|Double Blind Tapering Phase||97
2576659|NCT00401245|6320086|P4|COMPLETED|Double Blind Tapering Phase||0
2576660|NCT00401245|6320087|P3|COMPLETED|Double Blind Tapering Phase||0
2576661|NCT00401245|6320088|P2|COMPLETED|Double Blind Tapering Phase||0
2576662|NCT00401245|6320089|P1|COMPLETED|Double Blind Tapering Phase||0
2576663|NCT00401245|6320082|P8|STARTED|Double Blind Tapering Phase||102
2576664|NCT00401245|6320083|P7|STARTED|Double Blind Tapering Phase||87
2576665|NCT00401245|6320084|P6|STARTED|Double Blind Tapering Phase||94
2576666|NCT00401245|6320085|P5|STARTED|Double Blind Tapering Phase||101
2576667|NCT00401245|6320086|P4|STARTED|Double Blind Tapering Phase||0
2576668|NCT00401245|6320087|P3|STARTED|Double Blind Tapering Phase||0
2576669|NCT00401245|6320088|P2|STARTED|Double Blind Tapering Phase||0
2576670|NCT00401245|6320089|P1|STARTED|Double Blind Tapering Phase||0
2576671|NCT00401245|6320082|P8|NOT COMPLETED|Open Label Phase||0
2576672|NCT00401245|6320083|P7|NOT COMPLETED|Open Label Phase||0
2576673|NCT00401245|6320084|P6|NOT COMPLETED|Open Label Phase||0
2576674|NCT00401245|6320085|P5|NOT COMPLETED|Open Label Phase||0
2576675|NCT00401245|6320086|P4|NOT COMPLETED|Open Label Phase||21
2576676|NCT00401245|6320087|P3|NOT COMPLETED|Open Label Phase||23
2576677|NCT00401245|6320088|P2|NOT COMPLETED|Open Label Phase||35
2576678|NCT00401245|6320089|P1|NOT COMPLETED|Open Label Phase||21
2576679|NCT00401245|6320082|P8|COMPLETED|Open Label Phase||0
2576680|NCT00401245|6320083|P7|COMPLETED|Open Label Phase||0
2576681|NCT00401245|6320084|P6|COMPLETED|Open Label Phase||0
2576682|NCT00401245|6320085|P5|COMPLETED|Open Label Phase||0
2576683|NCT00401245|6320086|P4|COMPLETED|Open Label Phase||84
2576684|NCT00401245|6320087|P3|COMPLETED|Open Label Phase||95
2576685|NCT00401245|6320088|P2|COMPLETED|Open Label Phase||81
2576686|NCT00401245|6320089|P1|COMPLETED|Open Label Phase||101
2576687|NCT00401245|6320082|P8|STARTED|Open Label Phase||0
2576688|NCT00401245|6320083|P7|STARTED|Open Label Phase||0
2576689|NCT00401245|6320084|P6|STARTED|Open Label Phase||0
2576690|NCT00401245|6320085|P5|STARTED|Open Label Phase||0
2576691|NCT00401245|6320086|P4|STARTED|Open Label Phase||105
2576692|NCT00401245|6320087|P3|STARTED|Open Label Phase||118
2576693|NCT00401245|6320088|P2|STARTED|Open Label Phase||116
2576694|NCT00401245|6320089|P1|STARTED|Open Label Phase||122
2576695|NCT00401245|6320082|P8|NOT COMPLETED|Between Titration and Open Label Phase||0
2576696|NCT00401245|6320083|P7|NOT COMPLETED|Between Titration and Open Label Phase||0
2576697|NCT00401245|6320084|P6|NOT COMPLETED|Between Titration and Open Label Phase||0
2576698|NCT00401245|6320085|P5|NOT COMPLETED|Between Titration and Open Label Phase||0
2576699|NCT00401245|6320086|P4|NOT COMPLETED|Between Titration and Open Label Phase||2
2576700|NCT00401245|6320087|P3|NOT COMPLETED|Between Titration and Open Label Phase||0
2576701|NCT00401245|6320088|P2|NOT COMPLETED|Between Titration and Open Label Phase||2
2576702|NCT00401245|6320089|P1|NOT COMPLETED|Between Titration and Open Label Phase||0
2576703|NCT00401245|6320082|P8|COMPLETED|Between Titration and Open Label Phase||0
2576704|NCT00401245|6320083|P7|COMPLETED|Between Titration and Open Label Phase||0
2576705|NCT00401245|6320084|P6|COMPLETED|Between Titration and Open Label Phase||0
2576706|NCT00401245|6320085|P5|COMPLETED|Between Titration and Open Label Phase||0
2576707|NCT00401245|6320086|P4|COMPLETED|Between Titration and Open Label Phase||105
2576708|NCT00401245|6320087|P3|COMPLETED|Between Titration and Open Label Phase||118
2576709|NCT00401245|6320088|P2|COMPLETED|Between Titration and Open Label Phase||116
2576710|NCT00401245|6320089|P1|COMPLETED|Between Titration and Open Label Phase||122
2576711|NCT00401245|6320082|P8|STARTED|Between Titration and Open Label Phase||0
2576712|NCT00401245|6320083|P7|STARTED|Between Titration and Open Label Phase||0
2576713|NCT00401245|6320084|P6|STARTED|Between Titration and Open Label Phase||0
2576714|NCT00401245|6320085|P5|STARTED|Between Titration and Open Label Phase||0
2576715|NCT00401245|6320086|P4|STARTED|Between Titration and Open Label Phase||107
2576716|NCT00401245|6320087|P3|STARTED|Between Titration and Open Label Phase||118
2576717|NCT00401245|6320088|P2|STARTED|Between Titration and Open Label Phase||118
2576718|NCT00401245|6320089|P1|STARTED|Between Titration and Open Label Phase||122
2576719|NCT00401245|6320082|P8|NOT COMPLETED|Double Blind Titration Phase||0
2576720|NCT00401245|6320083|P7|NOT COMPLETED|Double Blind Titration Phase||0
2576721|NCT00401245|6320084|P6|NOT COMPLETED|Double Blind Titration Phase||0
2576722|NCT00401245|6320085|P5|NOT COMPLETED|Double Blind Titration Phase||0
2576723|NCT00401245|6320086|P4|NOT COMPLETED|Double Blind Titration Phase||15
2576724|NCT00401245|6320087|P3|NOT COMPLETED|Double Blind Titration Phase||6
2576725|NCT00401245|6320088|P2|NOT COMPLETED|Double Blind Titration Phase||3
2576726|NCT00401245|6320089|P1|NOT COMPLETED|Double Blind Titration Phase||4
2576727|NCT00401245|6320082|P8|COMPLETED|Double Blind Titration Phase||0
2576728|NCT00401245|6320083|P7|COMPLETED|Double Blind Titration Phase||0
2576729|NCT00401245|6320084|P6|COMPLETED|Double Blind Titration Phase||0
2576730|NCT00401245|6320085|P5|COMPLETED|Double Blind Titration Phase||0
2576731|NCT00401245|6320086|P4|COMPLETED|Double Blind Titration Phase||107
2576732|NCT00401245|6320087|P3|COMPLETED|Double Blind Titration Phase||118
2576733|NCT00401245|6320088|P2|COMPLETED|Double Blind Titration Phase||118
2576734|NCT00401245|6320089|P1|COMPLETED|Double Blind Titration Phase||122
2576735|NCT00401245|6320082|P8|STARTED|Double Blind Titration Phase||0
2576736|NCT00401245|6320083|P7|STARTED|Double Blind Titration Phase||0
2576737|NCT00401245|6320084|P6|STARTED|Double Blind Titration Phase||0
2576738|NCT00401245|6320085|P5|STARTED|Double Blind Titration Phase||0
2576739|NCT00401245|6320086|P4|STARTED|Double Blind Titration Phase||122
2576740|NCT00401245|6320087|P3|STARTED|Double Blind Titration Phase||124
2576741|NCT00401245|6320088|P2|STARTED|Double Blind Titration Phase||121
2576742|NCT00401245|6320089|P1|STARTED|Double Blind Titration Phase||126
2576743|NCT00401193|6320157|P3|NOT COMPLETED|Overall Study||6
2576744|NCT00401193|6320158|P2|NOT COMPLETED|Overall Study||11
2576745|NCT00401193|6320159|P1|NOT COMPLETED|Overall Study||15
2576746|NCT00401193|6320157|P3|COMPLETED|Overall Study||63
2576747|NCT00401193|6320158|P2|COMPLETED|Overall Study||106
2576748|NCT00401193|6320159|P1|COMPLETED|Overall Study||103
2576749|NCT00401193|6320157|P3|Modified Intent to Treat Population|Overall Study||67
2576750|NCT00401193|6320158|P2|Modified Intent to Treat Population|Overall Study||115
2576751|NCT00401193|6320159|P1|Modified Intent to Treat Population|Overall Study||112
2576752|NCT00401193|6320157|P3|Intent to Treat Population|Overall Study||67
2576753|NCT00401193|6320158|P2|Intent to Treat Population|Overall Study||115
2576754|NCT00401193|6320159|P1|Intent to Treat Population|Overall Study||115
2576755|NCT00401193|6320157|P3|STARTED|Overall Study||69
2576756|NCT00401193|6320158|P2|STARTED|Overall Study||117
2576757|NCT00401193|6320159|P1|STARTED|Overall Study||118
2576758|NCT00401102|6320173|P1|NOT COMPLETED|Overall Study||7
2576759|NCT00401102|6320173|P1|COMPLETED|Overall Study||5
2576760|NCT00401102|6320173|P1|STARTED|Overall Study||12
2576761|NCT00400985|6320177|P1|NOT COMPLETED|Overall Study||52
2576762|NCT00400985|6320177|P1|COMPLETED|Overall Study||449
2576763|NCT00400985|6320177|P1|STARTED|Overall Study||501
2576764|NCT00400946|6320186|P5|NOT COMPLETED|Overall Study||38
2576765|NCT00400946|6320187|P4|NOT COMPLETED|Overall Study||47
2576766|NCT00400946|6320188|P3|NOT COMPLETED|Overall Study||2
2576767|NCT00400946|6320189|P2|NOT COMPLETED|Overall Study||11
2576768|NCT00400946|6320190|P1|NOT COMPLETED|Overall Study||14
2576769|NCT00400946|6320186|P5|COMPLETED|Overall Study||206
2576770|NCT00400946|6320187|P4|COMPLETED|Overall Study||4
2576771|NCT00400946|6320188|P3|COMPLETED|Overall Study||40
2576772|NCT00400946|6320189|P2|COMPLETED|Overall Study||221
2576773|NCT00400946|6320190|P1|COMPLETED|Overall Study||217
2576774|NCT00400946|6320186|P5|Eligible and Treated|Overall Study||243
2576775|NCT00400946|6320187|P4|Eligible and Treated|Overall Study||46
2576776|NCT00400946|6320188|P3|Eligible and Treated|Overall Study||42
2576777|NCT00400946|6320189|P2|Eligible and Treated|Overall Study||232
2576778|NCT00400946|6320190|P1|Eligible and Treated|Overall Study||231
2576779|NCT00400946|6320186|P5|Evaluable for Day 32 MRD|Overall Study||168
2576780|NCT00400946|6320187|P4|Evaluable for Day 32 MRD|Overall Study||12
2576781|NCT00400946|6320188|P3|Evaluable for Day 32 MRD|Overall Study||33
2576782|NCT00400946|6320189|P2|Evaluable for Day 32 MRD|Overall Study||167
2576783|NCT00400946|6320190|P1|Evaluable for Day 32 MRD|Overall Study||166
2576784|NCT00400946|6320186|P5|Evaluable for Day 18 Marrow Morphology|Overall Study||152
2576785|NCT00400946|6320187|P4|Evaluable for Day 18 Marrow Morphology|Overall Study||13
2576786|NCT00400946|6320188|P3|Evaluable for Day 18 Marrow Morphology|Overall Study||19
2576787|NCT00400946|6320189|P2|Evaluable for Day 18 Marrow Morphology|Overall Study||161
2576788|NCT00400946|6320190|P1|Evaluable for Day 18 Marrow Morphology|Overall Study||158
2576789|NCT00400946|6320186|P5|Evaluable for CNS Directed-Treatment|Overall Study||227
2576790|NCT00400946|6320187|P4|Evaluable for CNS Directed-Treatment|Overall Study||21
2576791|NCT00400946|6320188|P3|Evaluable for CNS Directed-Treatment|Overall Study||42
2576792|NCT00400946|6320189|P2|Evaluable for CNS Directed-Treatment|Overall Study||232
2576793|NCT00400946|6320190|P1|Evaluable for CNS Directed-Treatment|Overall Study||231
2576794|NCT00400946|6320186|P5|STARTED|Overall Study||244
2576795|NCT00400946|6320187|P4|STARTED|Overall Study||51
2576796|NCT00400946|6320188|P3|STARTED|Overall Study||42
2576797|NCT00400946|6320189|P2|STARTED|Overall Study||232
2576798|NCT00400946|6320190|P1|STARTED|Overall Study||231
2576799|NCT00400881|6320218|P2|NOT COMPLETED|Overall Study||0
2576800|NCT00400881|6320219|P1|NOT COMPLETED|Overall Study||0
2576801|NCT00400881|6320218|P2|COMPLETED|Overall Study||60
2576802|NCT00400881|6320219|P1|COMPLETED|Overall Study||62
2576803|NCT00400881|6320218|P2|STARTED|Overall Study||60
2576804|NCT00400881|6320219|P1|STARTED|Overall Study||62
2576805|NCT00400829|6320227|P1|NOT COMPLETED|Overall Study||0
2576806|NCT00400829|6320227|P1|COMPLETED|Overall Study||66
2576807|NCT00400829|6320227|P1|STARTED|Overall Study||66
2576808|NCT00400803|6320233|P1|NOT COMPLETED|Overall Study||0
2576809|NCT00400803|6320233|P1|COMPLETED|Overall Study||35
2576810|NCT00400803|6320233|P1|STARTED|Overall Study||35
2576811|NCT00400764|6320249|P5|NOT COMPLETED|Phase II||11
2576812|NCT00400764|6320250|P4|NOT COMPLETED|Phase II||26
2576813|NCT00400764|6320251|P3|NOT COMPLETED|Phase II||23
2576814|NCT00400764|6320252|P2|NOT COMPLETED|Phase II||0
2576815|NCT00400764|6320253|P1|NOT COMPLETED|Phase II||0
2576816|NCT00400764|6320249|P5|COMPLETED|Phase II||0
2576817|NCT00400764|6320250|P4|COMPLETED|Phase II||0
2576818|NCT00400764|6320251|P3|COMPLETED|Phase II||0
2576819|NCT00400764|6320252|P2|COMPLETED|Phase II||0
2576820|NCT00400764|6320253|P1|COMPLETED|Phase II||0
2576821|NCT00400764|6320249|P5|Treated|Phase II||11
2576822|NCT00400764|6320250|P4|Treated|Phase II||26
2576823|NCT00400764|6320251|P3|Treated|Phase II|One patient in the Rituximab arm withdrew prior to treatment|22
2576824|NCT00400764|6320252|P2|Treated|Phase II||0
2576825|NCT00400764|6320253|P1|Treated|Phase II||0
2576826|NCT00400764|6320249|P5|STARTED|Phase II||11
2576827|NCT00400764|6320250|P4|STARTED|Phase II||26
2576828|NCT00400764|6320251|P3|STARTED|Phase II||23
2576829|NCT00400764|6320252|P2|STARTED|Phase II||0
2576830|NCT00400764|6320253|P1|STARTED|Phase II||0
2576831|NCT00400764|6320249|P5|NOT COMPLETED|Phase Ib||0
2576832|NCT00400764|6320250|P4|NOT COMPLETED|Phase Ib||0
2576833|NCT00400764|6320251|P3|NOT COMPLETED|Phase Ib||0
2576834|NCT00400764|6320252|P2|NOT COMPLETED|Phase Ib||4
2576835|NCT00400764|6320253|P1|NOT COMPLETED|Phase Ib||6
2576836|NCT00400764|6320249|P5|COMPLETED|Phase Ib||0
2576837|NCT00400764|6320250|P4|COMPLETED|Phase Ib||0
2576838|NCT00400764|6320251|P3|COMPLETED|Phase Ib||0
2576839|NCT00400764|6320252|P2|COMPLETED|Phase Ib||2
2576840|NCT00400764|6320253|P1|COMPLETED|Phase Ib|One patient reported as discontinued due to an AE should have been reported as death.|0
2576841|NCT00400764|6320249|P5|Treated|Phase Ib||0
2576842|NCT00400764|6320250|P4|Treated|Phase Ib||0
2576843|NCT00400764|6320251|P3|Treated|Phase Ib||0
2576844|NCT00400764|6320252|P2|Treated|Phase Ib||6
2576845|NCT00400764|6320253|P1|Treated|Phase Ib||6
2576846|NCT00400764|6320249|P5|STARTED|Phase Ib||0
2576847|NCT00400764|6320250|P4|STARTED|Phase Ib||0
2576848|NCT00400764|6320251|P3|STARTED|Phase Ib||0
2576849|NCT00400764|6320252|P2|STARTED|Phase Ib||6
2576850|NCT00400764|6320253|P1|STARTED|Phase Ib||6
2576851|NCT00400712|6320306|P2|NOT COMPLETED|Overall Study||16
2576852|NCT00400712|6320307|P1|NOT COMPLETED|Overall Study||17
2576853|NCT00400712|6320306|P2|COMPLETED|Overall Study||35
2576854|NCT00400712|6320307|P1|COMPLETED|Overall Study||35
2576855|NCT00400712|6320306|P2|STARTED|Overall Study||51
2576856|NCT00400712|6320307|P1|STARTED|Overall Study||52
2576857|NCT00400686|6320325|P1|NOT COMPLETED|Overall Study||0
2576858|NCT00400686|6320325|P1|COMPLETED|Overall Study||31
2576859|NCT00400686|6320325|P1|STARTED|Overall Study||31
2576860|NCT00400634|6320333|P2|NOT COMPLETED|Overall Study||1
2576861|NCT00400634|6320334|P1|NOT COMPLETED|Overall Study||4
2576862|NCT00400634|6320333|P2|COMPLETED|Overall Study||19
2576863|NCT00400634|6320334|P1|COMPLETED|Overall Study||34
2576864|NCT00400634|6320333|P2|STARTED|Overall Study||20
2576865|NCT00400634|6320334|P1|STARTED|Overall Study||38
2576866|NCT00400569|6320342|P1|NOT COMPLETED|Overall Study||1
2576867|NCT00400569|6320342|P1|COMPLETED|Overall Study||47
2576868|NCT00400569|6320342|P1|STARTED|Overall Study||48
2576869|NCT00400517|6320353|P1|NOT COMPLETED|Overall Study||2
2576870|NCT00400517|6320353|P1|COMPLETED|Overall Study||26
2576871|NCT00400517|6320353|P1|STARTED|Overall Study|1 pt w/d consent. 1 pt found to have unresectable dx at time of sx and is exc. in tissue analysis.|28
2576872|NCT00400439|6320362|P2|NOT COMPLETED|Overall Study||2
2576873|NCT00400439|6320363|P1|NOT COMPLETED|Overall Study||5
2576874|NCT00400439|6320362|P2|COMPLETED|Overall Study||23
2576875|NCT00400439|6320363|P1|COMPLETED|Overall Study||47
2576876|NCT00400439|6320362|P2|STARTED|Overall Study||25
2576877|NCT00400439|6320363|P1|STARTED|Overall Study||52
2576878|NCT00400400|6320373|P2|NOT COMPLETED|Overall Study||15
2576879|NCT00400400|6320374|P1|NOT COMPLETED|Overall Study||14
2576880|NCT00400400|6320373|P2|COMPLETED|Overall Study||185
2576881|NCT00400400|6320374|P1|COMPLETED|Overall Study||186
2576882|NCT00400400|6320373|P2|Intent-to-Treat Population|Overall Study||197
2576883|NCT00400400|6320374|P1|Intent-to-Treat Population|Overall Study|Participants who received study drug.|199
2576884|NCT00400400|6320373|P2|STARTED|Overall Study||200
2576885|NCT00400400|6320374|P1|STARTED|Overall Study||200
2576886|NCT00400205|6320392|P1|NOT COMPLETED|Overall Study||5
2576887|NCT00400205|6320392|P1|COMPLETED|Overall Study||9
2576888|NCT00400205|6320392|P1|STARTED|Overall Study||14
2576889|NCT00400179|6320399|P2|NOT COMPLETED|Overall Study||18
2576890|NCT00400179|6320400|P1|NOT COMPLETED|Overall Study||6
2576891|NCT00400179|6320399|P2|COMPLETED|Overall Study||508
2576892|NCT00400179|6320400|P1|COMPLETED|Overall Study|Received Treatment|521
2576893|NCT00400179|6320399|P2|STARTED|Overall Study||526
2576894|NCT00400179|6320400|P1|STARTED|Overall Study|Signed informed consent form and randomized|527
2576895|NCT00400153|6320417|P3|NOT COMPLETED|Overall Study||61
2576896|NCT00400153|6320418|P2|NOT COMPLETED|Overall Study||55
2576897|NCT00400153|6320419|P1|NOT COMPLETED|Overall Study||48
2576898|NCT00400153|6320417|P3|COMPLETED|Overall Study||422
2576899|NCT00400153|6320418|P2|COMPLETED|Overall Study||436
2576900|NCT00400153|6320419|P1|COMPLETED|Overall Study||438
2576901|NCT00400153|6320417|P3|STARTED|Overall Study||483
2576902|NCT00400153|6320418|P2|STARTED|Overall Study||491
2576903|NCT00400153|6320419|P1|STARTED|Overall Study||486
2576904|NCT00399893|6320666|P2|NOT COMPLETED|Overall Study||0
2576905|NCT00399893|6320667|P1|NOT COMPLETED|Overall Study||1
2576906|NCT00399893|6320666|P2|COMPLETED|Overall Study||3
2576907|NCT00399893|6320667|P1|COMPLETED|Overall Study|Participant withdrew after 3 months but was included in results|1
2576908|NCT00399893|6320666|P2|STARTED|Overall Study||3
2576909|NCT00399893|6320667|P1|STARTED|Overall Study||2
2576910|NCT00399880|6320695|P2|NOT COMPLETED|Overall Study||0
2576911|NCT00399880|6320696|P1|NOT COMPLETED|Overall Study||0
2576912|NCT00399880|6320695|P2|COMPLETED|Overall Study||65
2576913|NCT00399880|6320696|P1|COMPLETED|Overall Study||65
2576914|NCT00399880|6320695|P2|STARTED|Overall Study||65
2576915|NCT00399880|6320696|P1|STARTED|Overall Study||65
2576916|NCT00399802|6320706|P2|NOT COMPLETED|Overall Study||3
2576917|NCT00399802|6320707|P1|NOT COMPLETED|Overall Study||0
2576918|NCT00399802|6320706|P2|COMPLETED|Overall Study||26
2576919|NCT00399802|6320707|P1|COMPLETED|Overall Study||14
2576920|NCT00399802|6320706|P2|STARTED|Overall Study||29
2576921|NCT00399802|6320707|P1|STARTED|Overall Study||14
2576922|NCT00399763|6320721|P2|NOT COMPLETED|Overall Study||3
2576923|NCT00399763|6320722|P1|NOT COMPLETED|Overall Study||2
2576924|NCT00399763|6320721|P2|COMPLETED|Overall Study||32
2576925|NCT00399763|6320722|P1|COMPLETED|Overall Study||33
2576926|NCT00399763|6320721|P2|STARTED|Overall Study||35
2576927|NCT00399763|6320722|P1|STARTED|Overall Study||35
2576928|NCT00399568|6320734|P2|NOT COMPLETED|Overall Study||9
2576929|NCT00399568|6320735|P1|NOT COMPLETED|Overall Study||12
2576930|NCT00399568|6320734|P2|COMPLETED|Overall Study||156
2576931|NCT00399568|6320735|P1|COMPLETED|Overall Study||154
2576932|NCT00399568|6320734|P2|STARTED|Overall Study||165
2576933|NCT00399568|6320735|P1|STARTED|Overall Study||166
2576934|NCT00399542|6320749|P2|NOT COMPLETED|Overall Study||43
2576935|NCT00399542|6320750|P1|NOT COMPLETED|Overall Study||84
2576936|NCT00399542|6320749|P2|COMPLETED|Overall Study||151
2576937|NCT00399542|6320750|P1|COMPLETED|Overall Study||303
2576938|NCT00399542|6320749|P2|STARTED|Overall Study||194
2576939|NCT00399542|6320750|P1|STARTED|Overall Study||387
2576940|NCT00399516|6320812|P1|NOT COMPLETED|Overall Study||2
2576941|NCT00399516|6320812|P1|COMPLETED|Overall Study||19
2576942|NCT00399516|6320812|P1|STARTED|Overall Study||21
2576943|NCT00399360|6320820|P4|NOT COMPLETED|Overall Study||6
2576944|NCT00399360|6320821|P3|NOT COMPLETED|Overall Study||3
2576945|NCT00399360|6320822|P2|NOT COMPLETED|Overall Study||3
2576946|NCT00399360|6320823|P1|NOT COMPLETED|Overall Study||2
2576947|NCT00399360|6320820|P4|COMPLETED|Overall Study||9
2576948|NCT00399360|6320821|P3|COMPLETED|Overall Study||10
2576949|NCT00399360|6320822|P2|COMPLETED|Overall Study||8
2576950|NCT00399360|6320823|P1|COMPLETED|Overall Study||9
2576951|NCT00399360|6320820|P4|STARTED|Overall Study||15
2576952|NCT00399360|6320821|P3|STARTED|Overall Study||13
2576953|NCT00399360|6320822|P2|STARTED|Overall Study||11
2576954|NCT00399360|6320823|P1|STARTED|Overall Study||11
2576955|NCT00399308|6320872|P3|NOT COMPLETED|Overall Study||1
2576956|NCT00399308|6320873|P2|NOT COMPLETED|Overall Study||0
2576957|NCT00399308|6320874|P1|NOT COMPLETED|Overall Study||0
2576958|NCT00399308|6320872|P3|COMPLETED|Overall Study|One patient withdrew: did not want to comply with study requirements|11
2576959|NCT00399308|6320873|P2|COMPLETED|Overall Study||15
2576960|NCT00399308|6320874|P1|COMPLETED|Overall Study||13
2576961|NCT00399308|6320872|P3|STARTED|Overall Study||12
2576962|NCT00399308|6320873|P2|STARTED|Overall Study||15
2576963|NCT00399308|6320874|P1|STARTED|Overall Study||13
2576964|NCT00399035|6320894|P3|NOT COMPLETED|Overall Study||252
2576965|NCT00399035|6320895|P2|NOT COMPLETED|Overall Study||158
2576966|NCT00399035|6320896|P1|NOT COMPLETED|Overall Study||313
2576967|NCT00399035|6320894|P3|COMPLETED|Overall Study||106
2576968|NCT00399035|6320895|P2|COMPLETED|Overall Study||58
2576969|NCT00399035|6320896|P1|COMPLETED|Overall Study||189
2576970|NCT00399035|6320894|P3|STARTED|Overall Study||358
2576971|NCT00399035|6320895|P2|STARTED|Overall Study||216
2576972|NCT00399035|6320896|P1|STARTED|Overall Study||502
2576973|NCT00398983|6320917|P2|NOT COMPLETED|Overall Study||0
2576974|NCT00398983|6320918|P1|NOT COMPLETED|Overall Study||0
2576975|NCT00398983|6320917|P2|COMPLETED|Overall Study||25
2576976|NCT00398983|6320918|P1|COMPLETED|Overall Study||20
2576977|NCT00398983|6320917|P2|STARTED|Overall Study||25
2576978|NCT00398983|6320918|P1|STARTED|Overall Study||20
2576979|NCT00398918|6320924|P1|NOT COMPLETED|Overall Study||0
2576980|NCT00398918|6320924|P1|COMPLETED|Overall Study||10
2576981|NCT00398918|6320924|P1|STARTED|Overall Study||10
2576982|NCT00398866|6320932|P3|NOT COMPLETED|Overall Study||8
2576983|NCT00398866|6320933|P2|NOT COMPLETED|Overall Study||8
2576984|NCT00398866|6320934|P1|NOT COMPLETED|Overall Study||14
2576985|NCT00398866|6320932|P3|COMPLETED|Overall Study||58
2576986|NCT00398866|6320933|P2|COMPLETED|Overall Study||60
2576987|NCT00398866|6320934|P1|COMPLETED|Overall Study||52
2576988|NCT00398866|6320932|P3|STARTED|Overall Study||66
2576989|NCT00398866|6320933|P2|STARTED|Overall Study||68
2576990|NCT00398866|6320934|P1|STARTED|Overall Study||66
2576991|NCT00398632|6320945|P1|NOT COMPLETED|Overall Study||2
2576992|NCT00398632|6320945|P1|COMPLETED|Overall Study|2/6 subjects withdrew at end of week 6; 1 for lack of efficacy, 1 because of time constraints.|4
2576993|NCT00398632|6320945|P1|STARTED|Overall Study||6
2576994|NCT00398567|6320953|P3|NOT COMPLETED|Overall Study||34
2576995|NCT00398567|6320954|P2|NOT COMPLETED|Overall Study||4
2576996|NCT00398567|6320955|P1|NOT COMPLETED|Overall Study||4
2576997|NCT00398567|6320953|P3|COMPLETED|Overall Study||3
2576998|NCT00398567|6320954|P2|COMPLETED|Overall Study||0
2576999|NCT00398567|6320955|P1|COMPLETED|Overall Study||0
2577000|NCT00398567|6320953|P3|STARTED|Overall Study||37
2577001|NCT00398567|6320954|P2|STARTED|Overall Study||4
2577002|NCT00398567|6320955|P1|STARTED|Overall Study||4
2577003|NCT00398476|6320967|P2|NOT COMPLETED|Treatment Period 2||0
2577004|NCT00398476|6320968|P1|NOT COMPLETED|Treatment Period 2||0
2577005|NCT00398476|6320967|P2|COMPLETED|Treatment Period 2||64
2577006|NCT00398476|6320968|P1|COMPLETED|Treatment Period 2||63
2577007|NCT00398476|6320967|P2|STARTED|Treatment Period 2||64
2577008|NCT00398476|6320968|P1|STARTED|Treatment Period 2||63
2577009|NCT00398476|6320967|P2|NOT COMPLETED|Washout Period (20 Minutes)||0
2577010|NCT00398476|6320968|P1|NOT COMPLETED|Washout Period (20 Minutes)||0
2577011|NCT00398476|6320967|P2|COMPLETED|Washout Period (20 Minutes)||64
2577012|NCT00398476|6320968|P1|COMPLETED|Washout Period (20 Minutes)||63
2577013|NCT00398476|6320967|P2|STARTED|Washout Period (20 Minutes)||64
2577014|NCT00398476|6320968|P1|STARTED|Washout Period (20 Minutes)||63
2577015|NCT00398476|6320967|P2|NOT COMPLETED|Treatment Period 1||0
2577016|NCT00398476|6320968|P1|NOT COMPLETED|Treatment Period 1||0
2577017|NCT00398476|6320967|P2|COMPLETED|Treatment Period 1||64
2577018|NCT00398476|6320968|P1|COMPLETED|Treatment Period 1||63
2577019|NCT00398476|6320967|P2|STARTED|Treatment Period 1||64
2577020|NCT00398476|6320968|P1|STARTED|Treatment Period 1||63
2577021|NCT00398411|6321009|P2|NOT COMPLETED|Overall Study||1
2577022|NCT00398411|6321010|P1|NOT COMPLETED|Overall Study||0
2577023|NCT00398411|6321009|P2|COMPLETED|Overall Study||31
2577024|NCT00398411|6321010|P1|COMPLETED|Overall Study||34
2577025|NCT00398411|6321009|P2|STARTED|Overall Study||32
2577026|NCT00398411|6321010|P1|STARTED|Overall Study||34
2577027|NCT00398398|6321026|P1|NOT COMPLETED|Overall Study||0
2577028|NCT00398398|6321026|P1|COMPLETED|Overall Study||44
2577029|NCT00398398|6321026|P1|STARTED|Overall Study||44
2577030|NCT00398320|6321033|P1|NOT COMPLETED|Overall Study||6
2577031|NCT00398320|6321033|P1|COMPLETED|Overall Study||34
2577032|NCT00398320|6321033|P1|STARTED|Overall Study||40
2577033|NCT00398216|6321046|P5|NOT COMPLETED|Overall Study||15
2577034|NCT00398216|6321047|P4|NOT COMPLETED|Overall Study||22
2577035|NCT00398216|6321048|P3|NOT COMPLETED|Overall Study||21
2577036|NCT00398216|6321049|P2|NOT COMPLETED|Overall Study||19
2577037|NCT00398216|6321050|P1|NOT COMPLETED|Overall Study||11
2577038|NCT00398216|6321046|P5|COMPLETED|Overall Study||157
2577039|NCT00398216|6321047|P4|COMPLETED|Overall Study||155
2577040|NCT00398216|6321048|P3|COMPLETED|Overall Study||164
2577041|NCT00398216|6321049|P2|COMPLETED|Overall Study||151
2577042|NCT00398216|6321050|P1|COMPLETED|Overall Study||181
2577043|NCT00398216|6321046|P5|STARTED|Overall Study||172
2577044|NCT00398216|6321047|P4|STARTED|Overall Study||177
2577045|NCT00398216|6321048|P3|STARTED|Overall Study||185
2577046|NCT00398216|6321049|P2|STARTED|Overall Study||170
2577047|NCT00398216|6321050|P1|STARTED|Overall Study||192
2577048|NCT00398138|6321077|P1|NOT COMPLETED|Overall Study||2
2577049|NCT00398138|6321077|P1|COMPLETED|Overall Study||10
2577050|NCT00398138|6321077|P1|STARTED|Overall Study||12
2577051|NCT00398112|6321082|P1|NOT COMPLETED|Overall Study||18
2577052|NCT00398112|6321082|P1|COMPLETED|Overall Study||0
2577053|NCT00398112|6321082|P1|STARTED|Overall Study||18
2577054|NCT00398086|6321093|P3|NOT COMPLETED|Overall Study||2
2577055|NCT00398086|6321094|P2|NOT COMPLETED|Overall Study||23
2577056|NCT00398086|6321095|P1|NOT COMPLETED|Overall Study||9
2577057|NCT00398086|6321093|P3|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|1
2577058|NCT00398086|6321094|P2|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|21
2577059|NCT00398086|6321095|P1|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|11
2577060|NCT00398086|6321093|P3|Phase 1, Dose Escalation Population|Overall Study||3
2577061|NCT00398086|6321094|P2|Phase 1, Dose Escalation Population|Overall Study||7
2577062|NCT00398086|6321095|P1|Phase 1, Dose Escalation Population|Overall Study||20
2577063|NCT00398086|6321093|P3|STARTED|Overall Study||3
2577064|NCT00398086|6321094|P2|STARTED|Overall Study||44
2577065|NCT00398086|6321095|P1|STARTED|Overall Study||20
2577066|NCT00398073|6321129|P2|NOT COMPLETED|Overall Study||0
2577067|NCT00398073|6321130|P1|NOT COMPLETED|Overall Study||1
2577068|NCT00398073|6321129|P2|COMPLETED|Overall Study||17
2577069|NCT00398073|6321130|P1|COMPLETED|Overall Study||17
2577070|NCT00398073|6321129|P2|STARTED|Overall Study||17
2577071|NCT00398073|6321130|P1|STARTED|Overall Study||18
2577072|NCT00398047|6321140|P1|NOT COMPLETED|Overall Study||3
2577073|NCT00398047|6321140|P1|COMPLETED|Overall Study|all three patients progressed before completing|0
2577074|NCT00398047|6321140|P1|STARTED|Overall Study||3
2577075|NCT00397982|6321150|P1|NOT COMPLETED|Overall Study||4
2577076|NCT00397982|6321150|P1|COMPLETED|Overall Study||13
2577077|NCT00397982|6321150|P1|STARTED|Overall Study||17
2577078|NCT00397943|6321164|P5|NOT COMPLETED|Overall Study||0
2577079|NCT00397943|6321165|P4|NOT COMPLETED|Overall Study||0
2577080|NCT00397943|6321166|P3|NOT COMPLETED|Overall Study||0
2577081|NCT00397943|6321167|P2|NOT COMPLETED|Overall Study||9
2577082|NCT00397943|6321168|P1|NOT COMPLETED|Overall Study||12
2577083|NCT00397943|6321164|P5|COMPLETED|Overall Study||10
2577084|NCT00397943|6321165|P4|COMPLETED|Overall Study||10
2577085|NCT00397943|6321166|P3|COMPLETED|Overall Study||10
2577086|NCT00397943|6321167|P2|COMPLETED|Overall Study||31
2577087|NCT00397943|6321168|P1|COMPLETED|Overall Study||28
2577088|NCT00397943|6321164|P5|STARTED|Overall Study||10
2577089|NCT00397943|6321165|P4|STARTED|Overall Study||10
2577090|NCT00397943|6321166|P3|STARTED|Overall Study||10
2577091|NCT00397943|6321167|P2|STARTED|Overall Study||40
2577092|NCT00397943|6321168|P1|STARTED|Overall Study||40
2577093|NCT00397930|6321324|P2|NOT COMPLETED|Overall Study||51
2577094|NCT00397930|6321325|P1|NOT COMPLETED|Overall Study||38
2577095|NCT00397930|6321324|P2|COMPLETED|Overall Study||153
2577096|NCT00397930|6321325|P1|COMPLETED|Overall Study||168
2577097|NCT00397930|6321324|P2|STARTED|Overall Study||204
2577098|NCT00397930|6321325|P1|STARTED|Overall Study||206
2577099|NCT00397904|6321331|P1|NOT COMPLETED|Overall Study||0
2577100|NCT00397904|6321331|P1|COMPLETED|Overall Study||16
2577101|NCT00397904|6321331|P1|STARTED|Overall Study||16
2577102|NCT00397891|6321340|P5|NOT COMPLETED|Overall Study||1
2577103|NCT00397891|6321341|P4|NOT COMPLETED|Overall Study||0
2577104|NCT00397891|6321342|P3|NOT COMPLETED|Overall Study||0
2577105|NCT00397891|6321343|P2|NOT COMPLETED|Overall Study||0
2577106|NCT00397891|6321344|P1|NOT COMPLETED|Overall Study||1
2577107|NCT00397891|6321340|P5|COMPLETED|Overall Study||7
2577108|NCT00397891|6321341|P4|COMPLETED|Overall Study||6
2577109|NCT00397891|6321342|P3|COMPLETED|Overall Study||6
2577110|NCT00397891|6321343|P2|COMPLETED|Overall Study||6
2577111|NCT00397891|6321344|P1|COMPLETED|Overall Study||5
2577112|NCT00397891|6321340|P5|STARTED|Overall Study||8
2577113|NCT00397891|6321341|P4|STARTED|Overall Study||6
2577114|NCT00397891|6321342|P3|STARTED|Overall Study||6
2577115|NCT00397891|6321343|P2|STARTED|Overall Study||6
2577116|NCT00397891|6321344|P1|STARTED|Overall Study||6
2577117|NCT00397878|6321442|P1|NOT COMPLETED|Overall Study||0
2577118|NCT00397878|6321442|P1|COMPLETED|Overall Study||10
2577119|NCT00397878|6321442|P1|STARTED|Overall Study||10
2577120|NCT00397839|6321451|P2|NOT COMPLETED|Overall Study||18
2577121|NCT00397839|6321452|P1|NOT COMPLETED|Overall Study||7
2577122|NCT00397839|6321451|P2|COMPLETED|Overall Study||69
2577123|NCT00397839|6321452|P1|COMPLETED|Overall Study||41
2577124|NCT00397839|6321451|P2|STARTED|Overall Study||87
2577125|NCT00397839|6321452|P1|STARTED|Overall Study||48
2577126|NCT00397813|6321472|P6|NOT COMPLETED|Overall Study||0
2577127|NCT00397813|6321473|P5|NOT COMPLETED|Overall Study||0
2577128|NCT00397813|6321474|P4|NOT COMPLETED|Overall Study||0
2577129|NCT00397813|6321475|P3|NOT COMPLETED|Overall Study||0
2577130|NCT00397813|6321476|P2|NOT COMPLETED|Overall Study||0
2577131|NCT00397813|6321477|P1|NOT COMPLETED|Overall Study||0
2577132|NCT00397813|6321472|P6|COMPLETED|Overall Study||24
2577133|NCT00397813|6321473|P5|COMPLETED|Overall Study||5
2577134|NCT00397813|6321474|P4|COMPLETED|Overall Study||12
2577135|NCT00397813|6321475|P3|COMPLETED|Overall Study||0
2577136|NCT00397813|6321476|P2|COMPLETED|Overall Study||0
2577137|NCT00397813|6321477|P1|COMPLETED|Overall Study||36
2577138|NCT00397813|6321472|P6|STARTED|Overall Study||24
2577139|NCT00397813|6321473|P5|STARTED|Overall Study||5
2577140|NCT00397813|6321474|P4|STARTED|Overall Study||12
2577141|NCT00397813|6321475|P3|STARTED|Overall Study||0
2577142|NCT00397813|6321476|P2|STARTED|Overall Study||0
2577143|NCT00397813|6321477|P1|STARTED|Overall Study||36
2577144|NCT00397631|6321517|P2|NOT COMPLETED|Overall Study||44
2577145|NCT00397631|6321518|P1|NOT COMPLETED|Overall Study||30
2577146|NCT00397631|6321517|P2|COMPLETED|Overall Study||215
2577147|NCT00397631|6321518|P1|COMPLETED|Overall Study||231
2577148|NCT00397631|6321517|P2|STARTED|Overall Study||259
2577149|NCT00397631|6321518|P1|STARTED|Overall Study|Randomization ratio was 1:1|261
2577150|NCT00397579|6321528|P1|NOT COMPLETED|Overall Study||0
2577151|NCT00397579|6321528|P1|COMPLETED|Overall Study||11
2577152|NCT00397579|6321528|P1|STARTED|Overall Study||11
2577153|NCT00397540|6321534|P2|NOT COMPLETED|Overall Study||0
2577154|NCT00397540|6321535|P1|NOT COMPLETED|Overall Study||1
2577155|NCT00397540|6321534|P2|COMPLETED|Overall Study||85
2577156|NCT00397540|6321535|P1|COMPLETED|Overall Study||59
2577157|NCT00397540|6321534|P2|STARTED|Overall Study||85
2577158|NCT00397540|6321535|P1|STARTED|Overall Study||60
2577159|NCT00397514|6321543|P1|NOT COMPLETED|Overall Study||9
2577160|NCT00397514|6321543|P1|COMPLETED|Overall Study||25
2577161|NCT00397514|6321543|P1|STARTED|Overall Study||34
2577162|NCT00397488|6321553|P1|NOT COMPLETED|Overall Study||7
2577163|NCT00397488|6321553|P1|COMPLETED|Overall Study||71
2577164|NCT00397488|6321553|P1|STARTED|Overall Study||78
2577165|NCT00397462|6321560|P3|NOT COMPLETED|Overall Study||0
2577166|NCT00397462|6321561|P2|NOT COMPLETED|Overall Study||0
2577167|NCT00397462|6321562|P1|NOT COMPLETED|Overall Study||0
2577168|NCT00397462|6321560|P3|COMPLETED|Overall Study||15
2577169|NCT00397462|6321561|P2|COMPLETED|Overall Study||13
2577170|NCT00397462|6321562|P1|COMPLETED|Overall Study||16
2577171|NCT00397462|6321560|P3|STARTED|Overall Study||15
2577172|NCT00397462|6321561|P2|STARTED|Overall Study||13
2577173|NCT00397462|6321562|P1|STARTED|Overall Study||16
2577174|NCT00397254|6321573|P2|NOT COMPLETED|Overall Study||2
2577175|NCT00397254|6321574|P1|NOT COMPLETED|Overall Study||2
2577176|NCT00397254|6321573|P2|COMPLETED|Overall Study||74
2577177|NCT00397254|6321574|P1|COMPLETED|Overall Study||77
2577178|NCT00397254|6321573|P2|STARTED|Overall Study||76
2577179|NCT00397254|6321574|P1|STARTED|Overall Study||79
2577180|NCT00397215|6321596|P4|NOT COMPLETED|Month 24 (Day 720)||0
2577181|NCT00397215|6321597|P3|NOT COMPLETED|Month 24 (Day 720)||0
2577182|NCT00397215|6321598|P2|NOT COMPLETED|Month 24 (Day 720)||0
2577183|NCT00397215|6321599|P1|NOT COMPLETED|Month 24 (Day 720)||0
2577184|NCT00397215|6321596|P4|COMPLETED|Month 24 (Day 720)||36
2577185|NCT00397215|6321597|P3|COMPLETED|Month 24 (Day 720)||117
2577186|NCT00397215|6321598|P2|COMPLETED|Month 24 (Day 720)||45
2577187|NCT00397215|6321599|P1|COMPLETED|Month 24 (Day 720)||122
2577188|NCT00397215|6321596|P4|STARTED|Month 24 (Day 720)||36
2577189|NCT00397215|6321597|P3|STARTED|Month 24 (Day 720)||117
2577190|NCT00397215|6321598|P2|STARTED|Month 24 (Day 720)||45
2577191|NCT00397215|6321599|P1|STARTED|Month 24 (Day 720)||122
2577192|NCT00397215|6321596|P4|NOT COMPLETED|Month 12 (Day 360)||0
2577193|NCT00397215|6321597|P3|NOT COMPLETED|Month 12 (Day 360)||0
2577194|NCT00397215|6321598|P2|NOT COMPLETED|Month 12 (Day 360)||0
2577195|NCT00397215|6321599|P1|NOT COMPLETED|Month 12 (Day 360)||0
2577196|NCT00397215|6321596|P4|COMPLETED|Month 12 (Day 360)||42
2577197|NCT00397215|6321597|P3|COMPLETED|Month 12 (Day 360)||125
2577198|NCT00397215|6321598|P2|COMPLETED|Month 12 (Day 360)||48
2577199|NCT00397215|6321599|P1|COMPLETED|Month 12 (Day 360)||130
2577200|NCT00397215|6321596|P4|STARTED|Month 12 (Day 360)||42
2577201|NCT00397215|6321597|P3|STARTED|Month 12 (Day 360)||125
2577202|NCT00397215|6321598|P2|STARTED|Month 12 (Day 360)||48
2577203|NCT00397215|6321599|P1|STARTED|Month 12 (Day 360)||130
2577204|NCT00397215|6321596|P4|NOT COMPLETED|Month 6 (Day 180)||0
2577205|NCT00397215|6321597|P3|NOT COMPLETED|Month 6 (Day 180)||5
2577206|NCT00397215|6321598|P2|NOT COMPLETED|Month 6 (Day 180)||3
2577207|NCT00397215|6321599|P1|NOT COMPLETED|Month 6 (Day 180)||2
2577208|NCT00397215|6321596|P4|COMPLETED|Month 6 (Day 180)||51
2577209|NCT00397215|6321597|P3|COMPLETED|Month 6 (Day 180)||153
2577210|NCT00397215|6321598|P2|COMPLETED|Month 6 (Day 180)||55
2577211|NCT00397215|6321599|P1|COMPLETED|Month 6 (Day 180)||162
2577212|NCT00397215|6321596|P4|STARTED|Month 6 (Day 180)||51
2577213|NCT00397215|6321597|P3|STARTED|Month 6 (Day 180)||158
2577214|NCT00397215|6321598|P2|STARTED|Month 6 (Day 180)||58
2577215|NCT00397215|6321599|P1|STARTED|Month 6 (Day 180)||164
2577216|NCT00397215|6321596|P4|NOT COMPLETED|Month 0 (Day 0)||4
2577217|NCT00397215|6321597|P3|NOT COMPLETED|Month 0 (Day 0)||6
2577218|NCT00397215|6321598|P2|NOT COMPLETED|Month 0 (Day 0)||5
2577219|NCT00397215|6321599|P1|NOT COMPLETED|Month 0 (Day 0)||7
2577220|NCT00397215|6321596|P4|COMPLETED|Month 0 (Day 0)||48
2577221|NCT00397215|6321597|P3|COMPLETED|Month 0 (Day 0)||153
2577222|NCT00397215|6321598|P2|COMPLETED|Month 0 (Day 0)||56
2577223|NCT00397215|6321599|P1|COMPLETED|Month 0 (Day 0)||158
2577224|NCT00397215|6321596|P4|STARTED|Month 0 (Day 0)||52
2577225|NCT00397215|6321597|P3|STARTED|Month 0 (Day 0)||159
2577226|NCT00397215|6321598|P2|STARTED|Month 0 (Day 0)||61
2577227|NCT00397215|6321599|P1|STARTED|Month 0 (Day 0)||165
2577228|NCT00397189|6321735|P2|NOT COMPLETED|Extension Period||43
2577229|NCT00397189|6321736|P1|NOT COMPLETED|Extension Period||113
2577230|NCT00397189|6321735|P2|COMPLETED|Extension Period||134
2577231|NCT00397189|6321736|P1|COMPLETED|Extension Period||421
2577232|NCT00397189|6321735|P2|STARTED|Extension Period|Please note randomization ratio in extension is 3:1|177
2577233|NCT00397189|6321736|P1|STARTED|Extension Period|Not all completers continued to extension as only patients who wished to proceed were randomized.|534
2577234|NCT00397189|6321735|P2|NOT COMPLETED|3 Weeks Period||22
2577235|NCT00397189|6321736|P1|NOT COMPLETED|3 Weeks Period||21
2577236|NCT00397189|6321735|P2|COMPLETED|3 Weeks Period|out of 373, 362 were included in the ITT population detailed in the Baseline Characteristics|373
2577237|NCT00397189|6321736|P1|COMPLETED|3 Weeks Period|out of 373, 360 were included in the ITT population detailed in the Baseline Characteristics.|373
2577238|NCT00397189|6321735|P2|STARTED|3 Weeks Period||395
2577239|NCT00397189|6321736|P1|STARTED|3 Weeks Period||394
2577240|NCT00397150|6321746|P2|NOT COMPLETED|Overall Study||145
2577241|NCT00397150|6321747|P1|NOT COMPLETED|Overall Study||135
2577242|NCT00397150|6321746|P2|COMPLETED|Overall Study||1111
2577243|NCT00397150|6321747|P1|COMPLETED|Overall Study||1188
2577244|NCT00397150|6321746|P2|STARTED|Overall Study||1256
2577245|NCT00397150|6321747|P1|STARTED|Overall Study||1323
2577246|NCT00397046|6321763|P4|NOT COMPLETED|Overall Study||5
2577247|NCT00397046|6321764|P3|NOT COMPLETED|Overall Study||10
2577248|NCT00397046|6321765|P2|NOT COMPLETED|Overall Study||3
2577249|NCT00397046|6321766|P1|NOT COMPLETED|Overall Study||3
2577250|NCT00397046|6321763|P4|COMPLETED|Overall Study||0
2577251|NCT00397046|6321764|P3|COMPLETED|Overall Study||0
2577252|NCT00397046|6321765|P2|COMPLETED|Overall Study||0
2577253|NCT00397046|6321766|P1|COMPLETED|Overall Study||0
2577254|NCT00397046|6321763|P4|STARTED|Overall Study||5
2577255|NCT00397046|6321764|P3|STARTED|Overall Study||10
2577256|NCT00397046|6321765|P2|STARTED|Overall Study||3
2577257|NCT00397046|6321766|P1|STARTED|Overall Study||3
2577258|NCT00397033|6321788|P3|NOT COMPLETED|Overall Study||23
2577259|NCT00397033|6321789|P2|NOT COMPLETED|Overall Study||37
2577260|NCT00397033|6321790|P1|NOT COMPLETED|Overall Study||44
2577261|NCT00397033|6321788|P3|COMPLETED|Overall Study||77
2577262|NCT00397033|6321789|P2|COMPLETED|Overall Study||72
2577263|NCT00397033|6321790|P1|COMPLETED|Overall Study||63
2577264|NCT00397033|6321788|P3|ITT Population|Overall Study||98
2577265|NCT00397033|6321789|P2|ITT Population|Overall Study||105
2577266|NCT00397033|6321790|P1|ITT Population|Overall Study||107
2577267|NCT00397033|6321788|P3|Safety Population: >= 1 Dose of Drug|Overall Study||98
2577268|NCT00397033|6321789|P2|Safety Population: >= 1 Dose of Drug|Overall Study||108
2577269|NCT00397033|6321790|P1|Safety Population: >= 1 Dose of Drug|Overall Study||107
2577270|NCT00397033|6321788|P3|STARTED|Overall Study||100
2577271|NCT00397033|6321789|P2|STARTED|Overall Study||109
2577272|NCT00397033|6321790|P1|STARTED|Overall Study||107
2577273|NCT00397020|6321851|P2|NOT COMPLETED|Overall Study||1
2577274|NCT00397020|6321852|P1|NOT COMPLETED|Overall Study||1
2577275|NCT00397020|6321851|P2|COMPLETED|Overall Study||15
2577276|NCT00397020|6321852|P1|COMPLETED|Overall Study||13
2577277|NCT00397020|6321851|P2|STARTED|Overall Study||16
2577278|NCT00397020|6321852|P1|STARTED|Overall Study||14
2577279|NCT00396981|6321860|P2|NOT COMPLETED|Overall Study||9
2577280|NCT00396981|6321861|P1|NOT COMPLETED|Overall Study||15
2577281|NCT00396981|6321860|P2|COMPLETED|Overall Study||306
2577282|NCT00396981|6321861|P1|COMPLETED|Overall Study||296
2577283|NCT00396981|6321860|P2|STARTED|Overall Study||315
2577284|NCT00396981|6321861|P1|STARTED|Overall Study||311
2577285|NCT00396877|6321881|P2|NOT COMPLETED|Overall Study||8
2577286|NCT00396877|6321882|P1|NOT COMPLETED|Overall Study||6
2577287|NCT00396877|6321881|P2|COMPLETED|Overall Study|Completed follow-up|459
2577288|NCT00396877|6321882|P1|COMPLETED|Overall Study|Completed follow-up|433
2577289|NCT00396877|6321881|P2|Completed Treatment|Overall Study||352
2577290|NCT00396877|6321882|P1|Completed Treatment|Overall Study||356
2577291|NCT00396877|6321881|P2|Treated|Overall Study||464
2577292|NCT00396877|6321882|P1|Treated|Overall Study||436
2577293|NCT00396877|6321881|P2|STARTED|Overall Study|Randomized|467
2577294|NCT00396877|6321882|P1|STARTED|Overall Study|Randomized|439
2577295|NCT00396812|6321892|P1|NOT COMPLETED|Overall Study||1
2577296|NCT00396812|6321892|P1|COMPLETED|Overall Study|4 subjects completed treatment, but 1 subject terminated early due to disease progression|3
2577297|NCT00396812|6321892|P1|STARTED|Overall Study||4
2577298|NCT00396656|6321904|P2|NOT COMPLETED|Second Treatment Period||1
2577299|NCT00396656|6321905|P1|NOT COMPLETED|Second Treatment Period||0
2577300|NCT00396656|6321904|P2|COMPLETED|Second Treatment Period||12
2577301|NCT00396656|6321905|P1|COMPLETED|Second Treatment Period||15
2577302|NCT00396656|6321904|P2|STARTED|Second Treatment Period||13
2577303|NCT00396656|6321905|P1|STARTED|Second Treatment Period||15
2577304|NCT00396656|6321904|P2|NOT COMPLETED|First Treatment Period||2
2577305|NCT00396656|6321905|P1|NOT COMPLETED|First Treatment Period||0
2577306|NCT00396656|6321904|P2|COMPLETED|First Treatment Period||13
2577307|NCT00396656|6321905|P1|COMPLETED|First Treatment Period||15
2577308|NCT00396656|6321904|P2|STARTED|First Treatment Period||15
2577309|NCT00396656|6321905|P1|STARTED|First Treatment Period||15
2577310|NCT00396630|6321923|P2|NOT COMPLETED|Overall Study||5
2577311|NCT00396630|6321924|P1|NOT COMPLETED|Overall Study||5
2577312|NCT00396630|6321923|P2|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
2577313|NCT00396630|6321924|P1|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
2577314|NCT00396630|6321923|P2|STARTED|Overall Study||100
2577315|NCT00396630|6321924|P1|STARTED|Overall Study||100
2577316|NCT00396591|6321944|P1|NOT COMPLETED|Overall Study||16
2577317|NCT00396591|6321944|P1|COMPLETED|Overall Study||0
2577318|NCT00396591|6321944|P1|STARTED|Overall Study||16
2577319|NCT00396565|6321957|P3|NOT COMPLETED|Overall Study||17
2577320|NCT00396565|6321958|P2|NOT COMPLETED|Overall Study||91
2577321|NCT00396565|6321959|P1|NOT COMPLETED|Overall Study||48
2577322|NCT00396565|6321957|P3|COMPLETED|Overall Study||30
2577323|NCT00396565|6321958|P2|COMPLETED|Overall Study||47
2577324|NCT00396565|6321959|P1|COMPLETED|Overall Study||88
2577325|NCT00396565|6321957|P3|STARTED|Overall Study||47
2577326|NCT00396565|6321958|P2|STARTED|Overall Study||138
2577327|NCT00396565|6321959|P1|STARTED|Overall Study||136
2577328|NCT00396409|6321984|P2|NOT COMPLETED|Period 2 - 2008||2
2577329|NCT00396409|6321985|P1|NOT COMPLETED|Period 2 - 2008||7
2577330|NCT00396409|6321984|P2|COMPLETED|Period 2 - 2008||53
2577331|NCT00396409|6321985|P1|COMPLETED|Period 2 - 2008||52
2577332|NCT00396409|6321984|P2|STARTED|Period 2 - 2008||55
2577333|NCT00396409|6321985|P1|STARTED|Period 2 - 2008||59
2577334|NCT00396409|6321984|P2|NOT COMPLETED|Between Period 1 and Period 2||2
2577335|NCT00396409|6321985|P1|NOT COMPLETED|Between Period 1 and Period 2||3
2577336|NCT00396409|6321984|P2|COMPLETED|Between Period 1 and Period 2||55
2577337|NCT00396409|6321985|P1|COMPLETED|Between Period 1 and Period 2||59
2577338|NCT00396409|6321984|P2|STARTED|Between Period 1 and Period 2||57
2577339|NCT00396409|6321985|P1|STARTED|Between Period 1 and Period 2||62
2577340|NCT00396409|6321984|P2|NOT COMPLETED|Period 1 - 2007||6
2577341|NCT00396409|6321985|P1|NOT COMPLETED|Period 1 - 2007||3
2577342|NCT00396409|6321984|P2|COMPLETED|Period 1 - 2007||57
2577343|NCT00396409|6321985|P1|COMPLETED|Period 1 - 2007||62
2577344|NCT00396409|6321984|P2|STARTED|Period 1 - 2007||63
2577345|NCT00396409|6321985|P1|STARTED|Period 1 - 2007||65
2577346|NCT00396383|6322015|P1|NOT COMPLETED|Overall Study||3
2577347|NCT00396383|6322015|P1|COMPLETED|Overall Study||6
2577348|NCT00396383|6322015|P1|STARTED|Overall Study||9
2577349|NCT00396331|6322028|P1|NOT COMPLETED|Overall Study||32
2577350|NCT00396331|6322028|P1|COMPLETED|Overall Study||68
2577351|NCT00396331|6322028|P1|Number of Participants Transplanted|Overall Study|7 participants had two transplants|87
2577352|NCT00396331|6322028|P1|Number of Participants Treated|Overall Study||100
2577353|NCT00396331|6322028|P1|STARTED|Overall Study||100
2577354|NCT00396318|6322081|P1|NOT COMPLETED|7-Day Post-Treatment Contact||1
2577355|NCT00396318|6322081|P1|COMPLETED|7-Day Post-Treatment Contact||240
2577356|NCT00396318|6322081|P1|STARTED|7-Day Post-Treatment Contact||241
2577357|NCT00396318|6322081|P1|NOT COMPLETED|48- to 96-Hour Follow-Up Period||5
2577358|NCT00396318|6322081|P1|COMPLETED|48- to 96-Hour Follow-Up Period||241
2577359|NCT00396318|6322081|P1|STARTED|48- to 96-Hour Follow-Up Period||246
2577360|NCT00396318|6322081|P1|NOT COMPLETED|At Least One Dose of Tenecteplase (MITT)||5
2577361|NCT00396318|6322081|P1|COMPLETED|At Least One Dose of Tenecteplase (MITT)||241
2577362|NCT00396318|6322081|P1|STARTED|At Least One Dose of Tenecteplase (MITT)||246
2577363|NCT00396292|6322094|P2|NOT COMPLETED|Overall Study||16
2577364|NCT00396292|6322095|P1|NOT COMPLETED|Overall Study||9
2577365|NCT00396292|6322094|P2|COMPLETED|Overall Study||162
2577366|NCT00396292|6322095|P1|COMPLETED|Overall Study||165
2577367|NCT00396292|6322094|P2|STARTED|Overall Study||178
2577368|NCT00396292|6322095|P1|STARTED|Overall Study||174
2577369|NCT00396279|6322101|P1|NOT COMPLETED|Overall Study||30
2577370|NCT00396279|6322101|P1|COMPLETED|Overall Study|Defined as participants with a complete resection|7
2577371|NCT00396279|6322101|P1|STARTED|Overall Study||37
2577372|NCT00396266|6322112|P2|NOT COMPLETED|Overall Study||0
2577373|NCT00396266|6322113|P1|NOT COMPLETED|Overall Study||0
2577374|NCT00396266|6322112|P2|COMPLETED|Overall Study||14
2577375|NCT00396266|6322113|P1|COMPLETED|Overall Study||8
2577376|NCT00396266|6322112|P2|STARTED|Overall Study||14
2577377|NCT00396266|6322113|P1|STARTED|Overall Study||8
2577378|NCT00396253|6322134|P1|NOT COMPLETED|Overall Study||13
2577379|NCT00396253|6322134|P1|COMPLETED|Overall Study||210
2577380|NCT00396253|6322134|P1|STARTED|Overall Study||223
2577381|NCT00396201|6322146|P1|NOT COMPLETED|Follow-up Period||0
2577382|NCT00396201|6322146|P1|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|21
2577383|NCT00396201|6322146|P1|STARTED|Follow-up Period|Participants who had transplants. One had insufficient collection of cells so no transplant.|21
2577384|NCT00396201|6322146|P1|NOT COMPLETED|Treatment Period||0
2577385|NCT00396201|6322146|P1|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|22
2577386|NCT00396201|6322146|P1|STARTED|Treatment Period||22
2577387|NCT00396162|6322165|P2|NOT COMPLETED|Overall Study||3
2577388|NCT00396162|6322166|P1|NOT COMPLETED|Overall Study||2
2577389|NCT00396162|6322165|P2|COMPLETED|Overall Study||35
2577390|NCT00396162|6322166|P1|COMPLETED|Overall Study||37
2577391|NCT00396162|6322165|P2|STARTED|Overall Study||38
2577392|NCT00396162|6322166|P1|STARTED|Overall Study||39
2577393|NCT00396136|6322178|P1|NOT COMPLETED|Overall Study||125
2577394|NCT00396136|6322178|P1|COMPLETED|Overall Study||96
2577395|NCT00396136|6322178|P1|STARTED|Overall Study||221
2577396|NCT00396097|6322185|P2|NOT COMPLETED|Overall Study||46
2577397|NCT00396097|6322186|P1|NOT COMPLETED|Overall Study||26
2577398|NCT00396097|6322185|P2|COMPLETED|Overall Study||156
2577399|NCT00396097|6322186|P1|COMPLETED|Overall Study||88
2577400|NCT00396097|6322185|P2|STARTED|Overall Study||202
2577401|NCT00396097|6322186|P1|STARTED|Overall Study|4 participants randomized to Individualized Dose, received Standard Dose throughout the study.|114
2577402|NCT00396084|6322214|P6|NOT COMPLETED|Overall Study||2
2577403|NCT00396084|6322215|P5|NOT COMPLETED|Overall Study||1
2577404|NCT00396084|6322216|P4|NOT COMPLETED|Overall Study||1
2577405|NCT00396084|6322217|P3|NOT COMPLETED|Overall Study||0
2577406|NCT00396084|6322218|P2|NOT COMPLETED|Overall Study||0
2577407|NCT00396084|6322219|P1|NOT COMPLETED|Overall Study||0
2577408|NCT00396084|6322214|P6|COMPLETED|Overall Study||18
2577409|NCT00396084|6322215|P5|COMPLETED|Overall Study||9
2577410|NCT00396084|6322216|P4|COMPLETED|Overall Study||9
2577411|NCT00396084|6322217|P3|COMPLETED|Overall Study||10
2577412|NCT00396084|6322218|P2|COMPLETED|Overall Study||10
2577413|NCT00396084|6322219|P1|COMPLETED|Overall Study||10
2577414|NCT00396084|6322214|P6|STARTED|Overall Study||20
2577415|NCT00396084|6322215|P5|STARTED|Overall Study||10
2577416|NCT00396084|6322216|P4|STARTED|Overall Study||10
2577417|NCT00396084|6322217|P3|STARTED|Overall Study||10
2577418|NCT00396084|6322218|P2|STARTED|Overall Study||10
2577419|NCT00396084|6322219|P1|STARTED|Overall Study||10
2577420|NCT00396032|6322294|P2|NOT COMPLETED|Overall Study||5
2577421|NCT00396032|6322295|P1|NOT COMPLETED|Overall Study||4
2577422|NCT00396032|6322294|P2|COMPLETED|Overall Study||71
2577423|NCT00396032|6322295|P1|COMPLETED|Overall Study||70
2577424|NCT00396032|6322294|P2|STARTED|Overall Study||76
2577425|NCT00396032|6322295|P1|STARTED|Overall Study||74
2577426|NCT00396019|6322312|P3|NOT COMPLETED|Overall Study||1
2577427|NCT00396019|6322313|P2|NOT COMPLETED|Overall Study||3
2577428|NCT00396019|6322314|P1|NOT COMPLETED|Overall Study||0
2577429|NCT00396019|6322312|P3|COMPLETED|Overall Study||29
2577430|NCT00396019|6322313|P2|COMPLETED|Overall Study||26
2577431|NCT00396019|6322314|P1|COMPLETED|Overall Study||27
2577432|NCT00396019|6322312|P3|STARTED|Overall Study||30
2577433|NCT00396019|6322313|P2|STARTED|Overall Study||29
2577434|NCT00396019|6322314|P1|STARTED|Overall Study||27
2577435|NCT00396006|6322324|P1|NOT COMPLETED|Overall Study||0
2577436|NCT00396006|6322324|P1|COMPLETED|Overall Study||13
2577437|NCT00396006|6322324|P1|STARTED|Overall Study||13
2577438|NCT00395993|6322341|P2|NOT COMPLETED|Overall Study||19
2577439|NCT00395993|6322342|P1|NOT COMPLETED|Overall Study||35
2577440|NCT00395993|6322341|P2|COMPLETED|Overall Study||212
2577441|NCT00395993|6322342|P1|COMPLETED|Overall Study||211
2577442|NCT00395993|6322341|P2|STARTED|Overall Study||231
2577443|NCT00395993|6322342|P1|STARTED|Overall Study||246
2577444|NCT00395967|6322348|P1|NOT COMPLETED|Follow-up Period||2
2577445|NCT00395967|6322348|P1|COMPLETED|Follow-up Period||3
2577446|NCT00395967|6322348|P1|STARTED|Follow-up Period|Participants who had transplants.|5
2577447|NCT00395967|6322348|P1|NOT COMPLETED|Treatment Period||1
2577448|NCT00395967|6322348|P1|COMPLETED|Treatment Period|Failed mobilization due to <2 fold yield after one day of plerixafor treatment|4
2577449|NCT00395967|6322348|P1|STARTED|Treatment Period||5
2577450|NCT00395876|6322359|P2|NOT COMPLETED|Overall Study||0
2577451|NCT00395876|6322360|P1|NOT COMPLETED|Overall Study||3
2577452|NCT00395876|6322359|P2|COMPLETED|Overall Study||50
2577453|NCT00395876|6322360|P1|COMPLETED|Overall Study||47
2577454|NCT00395876|6322359|P2|STARTED|Overall Study||50
2577455|NCT00395876|6322360|P1|STARTED|Overall Study||50
2577456|NCT00395863|6322388|P2|NOT COMPLETED|Overall Study||3
2577457|NCT00395863|6322389|P1|NOT COMPLETED|Overall Study||2
2577458|NCT00395863|6322388|P2|COMPLETED|Overall Study||20
2577459|NCT00395863|6322389|P1|COMPLETED|Overall Study||21
2577460|NCT00395863|6322388|P2|STARTED|Overall Study||23
2577461|NCT00395863|6322389|P1|STARTED|Overall Study||23
2577462|NCT00395850|6322424|P4|NOT COMPLETED|Disulfiram/Placebo Treatment||13
2577463|NCT00395850|6322425|P3|NOT COMPLETED|Disulfiram/Placebo Treatment||19
2577464|NCT00395850|6322426|P2|NOT COMPLETED|Disulfiram/Placebo Treatment||14
2577465|NCT00395850|6322427|P1|NOT COMPLETED|Disulfiram/Placebo Treatment||9
2577466|NCT00395850|6322424|P4|COMPLETED|Disulfiram/Placebo Treatment||8
2577467|NCT00395850|6322425|P3|COMPLETED|Disulfiram/Placebo Treatment||5
2577468|NCT00395850|6322426|P2|COMPLETED|Disulfiram/Placebo Treatment||9
2577469|NCT00395850|6322427|P1|COMPLETED|Disulfiram/Placebo Treatment||11
2577470|NCT00395850|6322424|P4|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|21
2577471|NCT00395850|6322425|P3|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|24
2577472|NCT00395850|6322426|P2|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|23
2577473|NCT00395850|6322427|P1|STARTED|Disulfiram/Placebo Treatment|Received >= 1 disulfiram dose. Two baseline/randomized subjects dropped out before receiving disulf|20
2577474|NCT00395850|6322424|P4|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||4
2577475|NCT00395850|6322425|P3|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||6
2577476|NCT00395850|6322426|P2|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||2
2577477|NCT00395850|6322427|P1|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||5
2577478|NCT00395850|6322424|P4|COMPLETED|Randomization to Disulfiram/ Pre-admin||21
2577479|NCT00395850|6322425|P3|COMPLETED|Randomization to Disulfiram/ Pre-admin||24
2577480|NCT00395850|6322426|P2|COMPLETED|Randomization to Disulfiram/ Pre-admin||23
2577481|NCT00395850|6322427|P1|COMPLETED|Randomization to Disulfiram/ Pre-admin||22
2577482|NCT00395850|6322424|P4|STARTED|Randomization to Disulfiram/ Pre-admin||25
2577483|NCT00395850|6322425|P3|STARTED|Randomization to Disulfiram/ Pre-admin||30
2577484|NCT00395850|6322426|P2|STARTED|Randomization to Disulfiram/ Pre-admin||25
2577485|NCT00395850|6322427|P1|STARTED|Randomization to Disulfiram/ Pre-admin||27
2577486|NCT00395850|6322424|P4|NOT COMPLETED|Pre-randomization Baseline/Induction||0
2577487|NCT00395850|6322425|P3|NOT COMPLETED|Pre-randomization Baseline/Induction||0
2577488|NCT00395850|6322426|P2|NOT COMPLETED|Pre-randomization Baseline/Induction||0
2577489|NCT00395850|6322427|P1|NOT COMPLETED|Pre-randomization Baseline/Induction||11
2577490|NCT00395850|6322424|P4|COMPLETED|Pre-randomization Baseline/Induction||0
2577491|NCT00395850|6322425|P3|COMPLETED|Pre-randomization Baseline/Induction||0
2577492|NCT00395850|6322426|P2|COMPLETED|Pre-randomization Baseline/Induction||0
2577493|NCT00395850|6322427|P1|COMPLETED|Pre-randomization Baseline/Induction||107
2577494|NCT00395850|6322424|P4|STARTED|Pre-randomization Baseline/Induction||0
2577495|NCT00395850|6322425|P3|STARTED|Pre-randomization Baseline/Induction||0
2577496|NCT00395850|6322426|P2|STARTED|Pre-randomization Baseline/Induction||0
2577497|NCT00395850|6322427|P1|STARTED|Pre-randomization Baseline/Induction|Pre-randomization and disulfiram (disulf) administration|118
2577498|NCT00395746|6322444|P3|NOT COMPLETED|Overall Study||22
2577499|NCT00395746|6322445|P2|NOT COMPLETED|Overall Study||4
2577500|NCT00395746|6322446|P1|NOT COMPLETED|Overall Study||10
2577501|NCT00395746|6322444|P3|COMPLETED|Overall Study|Completed 52 weeks treatment|66
2577502|NCT00395746|6322445|P2|COMPLETED|Overall Study|Completed 52 weeks treatment|84
2577503|NCT00395746|6322446|P1|COMPLETED|Overall Study|Completed 52 weeks treatment|78
2577504|NCT00395746|6322444|P3|STARTED|Overall Study|Exposed to study drug|88
2577505|NCT00395746|6322445|P2|STARTED|Overall Study|Exposed to study drug|88
2577506|NCT00395746|6322446|P1|STARTED|Overall Study|Exposed to study drug|88
2577507|NCT00395733|6322492|P2|NOT COMPLETED|Period 2||5
2577508|NCT00395733|6322493|P1|NOT COMPLETED|Period 2||2
2577509|NCT00395733|6322492|P2|COMPLETED|Period 2||37
2577510|NCT00395733|6322493|P1|COMPLETED|Period 2||39
2577511|NCT00395733|6322492|P2|STARTED|Period 2||42
2577512|NCT00395733|6322493|P1|STARTED|Period 2||41
2577513|NCT00395733|6322492|P2|NOT COMPLETED|Period 1||0
2577514|NCT00395733|6322493|P1|NOT COMPLETED|Period 1||0
2577515|NCT00395733|6322492|P2|COMPLETED|Period 1||42
2577516|NCT00395733|6322493|P1|COMPLETED|Period 1||41
2577517|NCT00395733|6322492|P2|STARTED|Period 1||42
2577518|NCT00395733|6322493|P1|STARTED|Period 1||41
2577519|NCT00395694|6322517|P2|NOT COMPLETED|Continuation Phase||13
2577520|NCT00395694|6322518|P1|NOT COMPLETED|Continuation Phase||15
2577521|NCT00395694|6322517|P2|COMPLETED|Continuation Phase||35
2577522|NCT00395694|6322518|P1|COMPLETED|Continuation Phase||34
2577523|NCT00395694|6322517|P2|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|48
2577524|NCT00395694|6322518|P1|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|49
2577525|NCT00395694|6322517|P2|NOT COMPLETED|Escalation Phase + Maintenance Phase||2
2577526|NCT00395694|6322518|P1|NOT COMPLETED|Escalation Phase + Maintenance Phase||1
2577527|NCT00395694|6322517|P2|COMPLETED|Escalation Phase + Maintenance Phase||49
2577528|NCT00395694|6322518|P1|COMPLETED|Escalation Phase + Maintenance Phase||50
2577529|NCT00395694|6322517|P2|STARTED|Escalation Phase + Maintenance Phase||51
2577530|NCT00395694|6322518|P1|STARTED|Escalation Phase + Maintenance Phase||51
2577531|NCT00395642|6322549|P1|NOT COMPLETED|Overall Study||13
2577532|NCT00395642|6322549|P1|COMPLETED|Overall Study||53
2577533|NCT00395642|6322549|P1|STARTED|Overall Study||66
2577534|NCT00395629|6322556|P3|NOT COMPLETED|Extension Study||3
2577535|NCT00395629|6322557|P2|NOT COMPLETED|Extension Study||0
2577536|NCT00395629|6322558|P1|NOT COMPLETED|Extension Study||0
2577537|NCT00395629|6322556|P3|COMPLETED|Extension Study||8
2577538|NCT00395629|6322557|P2|COMPLETED|Extension Study||6
2577539|NCT00395629|6322558|P1|COMPLETED|Extension Study||9
2577540|NCT00395629|6322556|P3|STARTED|Extension Study||11
2577541|NCT00395629|6322557|P2|STARTED|Extension Study||6
2577542|NCT00395629|6322558|P1|STARTED|Extension Study||9
2577543|NCT00395629|6322556|P3|NOT COMPLETED|Core Study||7
2577544|NCT00395629|6322557|P2|NOT COMPLETED|Core Study||4
2577545|NCT00395629|6322558|P1|NOT COMPLETED|Core Study||1
2577546|NCT00395629|6322556|P3|COMPLETED|Core Study||16
2577547|NCT00395629|6322557|P2|COMPLETED|Core Study||11
2577548|NCT00395629|6322558|P1|COMPLETED|Core Study||10
2577549|NCT00395629|6322556|P3|STARTED|Core Study||23
2577550|NCT00395629|6322557|P2|STARTED|Core Study||15
2577551|NCT00395629|6322558|P1|STARTED|Core Study||11
2577552|NCT00395538|6322575|P3|NOT COMPLETED|Overall Study||23
2577553|NCT00395538|6322576|P2|NOT COMPLETED|Overall Study||13
2577554|NCT00395538|6322577|P1|NOT COMPLETED|Overall Study||3
2577555|NCT00395538|6322575|P3|COMPLETED|Overall Study||0
2577556|NCT00395538|6322576|P2|COMPLETED|Overall Study||2
2577557|NCT00395538|6322577|P1|COMPLETED|Overall Study||5
2577558|NCT00395538|6322575|P3|Completed Bone Biopsy Year 4|Overall Study||1
2577559|NCT00395538|6322576|P2|Completed Bone Biopsy Year 4|Overall Study||1
2577560|NCT00395538|6322577|P1|Completed Bone Biopsy Year 4|Overall Study||0
2577561|NCT00395538|6322575|P3|Completed Bone Biopsy Year 2|Overall Study||3
2577562|NCT00395538|6322576|P2|Completed Bone Biopsy Year 2|Overall Study||2
2577563|NCT00395538|6322577|P1|Completed Bone Biopsy Year 2|Overall Study||0
2577564|NCT00395538|6322575|P3|Completed Bone Biopsy Year 1|Overall Study||4
2577565|NCT00395538|6322576|P2|Completed Bone Biopsy Year 1|Overall Study||1
2577566|NCT00395538|6322577|P1|Completed Bone Biopsy Year 1|Overall Study||0
2577567|NCT00395538|6322575|P3|Randomized to Bone Biospy Year 4|Overall Study||8
2577568|NCT00395538|6322576|P2|Randomized to Bone Biospy Year 4|Overall Study||2
2577569|NCT00395538|6322577|P1|Randomized to Bone Biospy Year 4|Overall Study||0
2577570|NCT00395538|6322575|P3|Randomized to Bone Biopsy Year 2|Overall Study||6
2577571|NCT00395538|6322576|P2|Randomized to Bone Biopsy Year 2|Overall Study||2
2577572|NCT00395538|6322577|P1|Randomized to Bone Biopsy Year 2|Overall Study||0
2577573|NCT00395538|6322575|P3|Randomized to Bone Biopsy Year 1|Overall Study||5
2577574|NCT00395538|6322576|P2|Randomized to Bone Biopsy Year 1|Overall Study||1
2577575|NCT00395538|6322577|P1|Randomized to Bone Biopsy Year 1|Overall Study||0
2577576|NCT00395538|6322575|P3|Received HPTH on New Protocol|Overall Study||19
2577577|NCT00395538|6322576|P2|Received HPTH on New Protocol|Overall Study||5
2577578|NCT00395538|6322577|P1|Received HPTH on New Protocol|Overall Study||7
2577579|NCT00395538|6322575|P3|Signed Consent to the New Protocol|Overall Study||23
2577580|NCT00395538|6322576|P2|Signed Consent to the New Protocol|Overall Study||5
2577581|NCT00395538|6322577|P1|Signed Consent to the New Protocol|Overall Study||7
2577582|NCT00395538|6322575|P3|STARTED|Overall Study||23
2577583|NCT00395538|6322576|P2|STARTED|Overall Study||15
2577584|NCT00395538|6322577|P1|STARTED|Overall Study||8
2577585|NCT00395512|6322650|P4|NOT COMPLETED|Overall Study||38
2577586|NCT00395512|6322651|P3|NOT COMPLETED|Overall Study||28
2577587|NCT00395512|6322652|P2|NOT COMPLETED|Overall Study||37
2577588|NCT00395512|6322653|P1|NOT COMPLETED|Overall Study||38
2577589|NCT00395512|6322650|P4|COMPLETED|Overall Study||126
2577590|NCT00395512|6322651|P3|COMPLETED|Overall Study||136
2577591|NCT00395512|6322652|P2|COMPLETED|Overall Study||126
2577592|NCT00395512|6322653|P1|COMPLETED|Overall Study||126
2577593|NCT00395512|6322650|P4|Safety Set|Overall Study|1 participant was lost to follow-up post visit 1. It is unknown if they took any study medication.|163
2577594|NCT00395512|6322651|P3|Safety Set|Overall Study||164
2577595|NCT00395512|6322652|P2|Safety Set|Overall Study||163
2577596|NCT00395512|6322653|P1|Safety Set|Overall Study||164
2577597|NCT00395512|6322650|P4|STARTED|Overall Study||164
2577598|NCT00395512|6322651|P3|STARTED|Overall Study||164
2577599|NCT00395512|6322652|P2|STARTED|Overall Study||163
2577600|NCT00395512|6322653|P1|STARTED|Overall Study||164
2577601|NCT00395486|6322825|P2|NOT COMPLETED|Overall Study||5
2577602|NCT00395486|6322826|P1|NOT COMPLETED|Overall Study||6
2577603|NCT00395486|6322825|P2|COMPLETED|Overall Study|Completed subjects|121
2577604|NCT00395486|6322826|P1|COMPLETED|Overall Study|Completed subjects|126
2577605|NCT00395486|6322825|P2|STARTED|Overall Study|Randomized subjects|126
2577606|NCT00395486|6322826|P1|STARTED|Overall Study|Randomized subjects|132
2577607|NCT00395460|6322856|P2|NOT COMPLETED|Overall Study||0
2577608|NCT00395460|6322857|P1|NOT COMPLETED|Overall Study||1
2577609|NCT00395460|6322856|P2|COMPLETED|Overall Study||75
2577610|NCT00395460|6322857|P1|COMPLETED|Overall Study||71
2577611|NCT00395460|6322856|P2|Received Treatment|Overall Study||75
2577612|NCT00395460|6322857|P1|Received Treatment|Overall Study|1 participant withdrew consent prior to study drug injection and did not receive any study drug.|71
2577613|NCT00395460|6322856|P2|STARTED|Overall Study||75
2577614|NCT00395460|6322857|P1|STARTED|Overall Study||72
2577615|NCT00395447|6322881|P2|NOT COMPLETED|Overall Study||111
2577616|NCT00395447|6322882|P1|NOT COMPLETED|Overall Study||121
2577617|NCT00395447|6322881|P2|COMPLETED|Overall Study||602
2577618|NCT00395447|6322882|P1|COMPLETED|Overall Study||910
2577619|NCT00395447|6322881|P2|STARTED|Overall Study||713
2577620|NCT00395447|6322882|P1|STARTED|Overall Study||1031
2577621|NCT00395343|6322890|P2|NOT COMPLETED|Overall Study||36
2577622|NCT00395343|6322891|P1|NOT COMPLETED|Overall Study||41
2577623|NCT00395343|6322890|P2|COMPLETED|Overall Study||283
2577624|NCT00395343|6322891|P1|COMPLETED|Overall Study||281
2577625|NCT00395343|6322890|P2|STARTED|Overall Study||319
2577626|NCT00395343|6322891|P1|STARTED|Overall Study||322
2577627|NCT00395304|6322909|P6|NOT COMPLETED|Treatment Period 3||1
2577628|NCT00395304|6322910|P5|NOT COMPLETED|Treatment Period 3||0
2577629|NCT00395304|6322911|P4|NOT COMPLETED|Treatment Period 3||2
2577630|NCT00395304|6322912|P3|NOT COMPLETED|Treatment Period 3||0
2577631|NCT00395304|6322913|P2|NOT COMPLETED|Treatment Period 3||2
2577632|NCT00395304|6322914|P1|NOT COMPLETED|Treatment Period 3||1
2577633|NCT00395304|6322909|P6|COMPLETED|Treatment Period 3||27
2577634|NCT00395304|6322910|P5|COMPLETED|Treatment Period 3||27
2577635|NCT00395304|6322911|P4|COMPLETED|Treatment Period 3||25
2577636|NCT00395304|6322912|P3|COMPLETED|Treatment Period 3||29
2577637|NCT00395304|6322913|P2|COMPLETED|Treatment Period 3||20
2577638|NCT00395304|6322914|P1|COMPLETED|Treatment Period 3||29
2577639|NCT00395304|6322909|P6|STARTED|Treatment Period 3||28
2577640|NCT00395304|6322910|P5|STARTED|Treatment Period 3||27
2577641|NCT00395304|6322911|P4|STARTED|Treatment Period 3||27
2577642|NCT00395304|6322912|P3|STARTED|Treatment Period 3||29
2577643|NCT00395304|6322913|P2|STARTED|Treatment Period 3||22
2577644|NCT00395304|6322914|P1|STARTED|Treatment Period 3||30
2577645|NCT00395304|6322909|P6|NOT COMPLETED|Treatment Period 2||2
2577646|NCT00395304|6322910|P5|NOT COMPLETED|Treatment Period 2||0
2577647|NCT00395304|6322911|P4|NOT COMPLETED|Treatment Period 2||1
2577648|NCT00395304|6322912|P3|NOT COMPLETED|Treatment Period 2||1
2577649|NCT00395304|6322913|P2|NOT COMPLETED|Treatment Period 2||4
2577650|NCT00395304|6322914|P1|NOT COMPLETED|Treatment Period 2||0
2577651|NCT00395304|6322909|P6|COMPLETED|Treatment Period 2||28
2577652|NCT00395304|6322910|P5|COMPLETED|Treatment Period 2||27
2577653|NCT00395304|6322911|P4|COMPLETED|Treatment Period 2||27
2577654|NCT00395304|6322912|P3|COMPLETED|Treatment Period 2||29
2577655|NCT00395304|6322913|P2|COMPLETED|Treatment Period 2||22
2577656|NCT00395304|6322914|P1|COMPLETED|Treatment Period 2||30
2577657|NCT00395304|6322909|P6|STARTED|Treatment Period 2||30
2577658|NCT00395304|6322910|P5|STARTED|Treatment Period 2||27
2577659|NCT00395304|6322911|P4|STARTED|Treatment Period 2||28
2577660|NCT00395304|6322912|P3|STARTED|Treatment Period 2||30
2577661|NCT00395304|6322913|P2|STARTED|Treatment Period 2||26
2577662|NCT00395304|6322914|P1|STARTED|Treatment Period 2||30
2577663|NCT00395304|6322909|P6|NOT COMPLETED|Treatment Period 1||2
2577664|NCT00395304|6322910|P5|NOT COMPLETED|Treatment Period 1||1
2577665|NCT00395304|6322911|P4|NOT COMPLETED|Treatment Period 1||3
2577666|NCT00395304|6322912|P3|NOT COMPLETED|Treatment Period 1||0
2577667|NCT00395304|6322913|P2|NOT COMPLETED|Treatment Period 1||4
2577668|NCT00395304|6322914|P1|NOT COMPLETED|Treatment Period 1||1
2577669|NCT00395304|6322909|P6|COMPLETED|Treatment Period 1||30
2577670|NCT00395304|6322910|P5|COMPLETED|Treatment Period 1||27
2577671|NCT00395304|6322911|P4|COMPLETED|Treatment Period 1||28
2577672|NCT00395304|6322912|P3|COMPLETED|Treatment Period 1||30
2577673|NCT00395304|6322913|P2|COMPLETED|Treatment Period 1||26
2577674|NCT00395304|6322914|P1|COMPLETED|Treatment Period 1||30
2577675|NCT00395304|6322909|P6|STARTED|Treatment Period 1||32
2577676|NCT00395304|6322910|P5|STARTED|Treatment Period 1||28
2577677|NCT00395304|6322911|P4|STARTED|Treatment Period 1||31
2577678|NCT00395304|6322912|P3|STARTED|Treatment Period 1||30
2577679|NCT00395304|6322913|P2|STARTED|Treatment Period 1||30
2577680|NCT00395304|6322914|P1|STARTED|Treatment Period 1||31
2577681|NCT00395291|6322957|P2|NOT COMPLETED|Second Intervention||0
2577682|NCT00395291|6322958|P1|NOT COMPLETED|Second Intervention||0
2577683|NCT00395291|6322957|P2|COMPLETED|Second Intervention||9
2577684|NCT00395291|6322958|P1|COMPLETED|Second Intervention||13
2577685|NCT00395291|6322957|P2|STARTED|Second Intervention||9
2577686|NCT00395291|6322958|P1|STARTED|Second Intervention||13
2577687|NCT00395291|6322957|P2|NOT COMPLETED|Washout Period for 30 Days||0
2577688|NCT00395291|6322958|P1|NOT COMPLETED|Washout Period for 30 Days||2
2577689|NCT00395291|6322957|P2|COMPLETED|Washout Period for 30 Days||9
2577690|NCT00395291|6322958|P1|COMPLETED|Washout Period for 30 Days||13
2577691|NCT00395291|6322957|P2|STARTED|Washout Period for 30 Days||9
2577692|NCT00395291|6322958|P1|STARTED|Washout Period for 30 Days||15
2577693|NCT00395291|6322957|P2|NOT COMPLETED|First Intervention||0
2577694|NCT00395291|6322958|P1|NOT COMPLETED|First Intervention||2
2577695|NCT00395291|6322957|P2|COMPLETED|First Intervention||9
2577696|NCT00395291|6322958|P1|COMPLETED|First Intervention||15
2577697|NCT00395291|6322957|P2|STARTED|First Intervention||9
2577698|NCT00395291|6322958|P1|STARTED|First Intervention||17
2577699|NCT00395226|6322990|P2|NOT COMPLETED|Overall Study||5
2577700|NCT00395226|6322991|P1|NOT COMPLETED|Overall Study||4
2577701|NCT00395226|6322990|P2|COMPLETED|Overall Study||22
2577702|NCT00395226|6322991|P1|COMPLETED|Overall Study||22
2577703|NCT00395226|6322990|P2|STARTED|Overall Study||27
2577704|NCT00395226|6322991|P1|STARTED|Overall Study||26
2577705|NCT00395161|6322999|P2|NOT COMPLETED|Overall Study||0
2577706|NCT00395161|6323000|P1|NOT COMPLETED|Overall Study||0
2577707|NCT00395161|6322999|P2|COMPLETED|Overall Study||144
2577708|NCT00395161|6323000|P1|COMPLETED|Overall Study||149
2577709|NCT00395161|6322999|P2|STARTED|Overall Study||144
2577710|NCT00395161|6323000|P1|STARTED|Overall Study||149
2577711|NCT00395135|6323016|P5|NOT COMPLETED|Year 2||190
2577712|NCT00395135|6323017|P4|NOT COMPLETED|Year 2||88
2577713|NCT00395135|6323018|P3|NOT COMPLETED|Year 2||147
2577714|NCT00395135|6323019|P2|NOT COMPLETED|Year 2||0
2577715|NCT00395135|6323020|P1|NOT COMPLETED|Year 2||0
2577716|NCT00395135|6323016|P5|COMPLETED|Year 2||507
2577717|NCT00395135|6323017|P4|COMPLETED|Year 2||195
2577718|NCT00395135|6323018|P3|COMPLETED|Year 2||426
2577719|NCT00395135|6323019|P2|COMPLETED|Year 2||0
2577720|NCT00395135|6323020|P1|COMPLETED|Year 2||0
2577721|NCT00395135|6323016|P5|STARTED|Year 2||697
2577722|NCT00395135|6323017|P4|STARTED|Year 2||283
2577723|NCT00395135|6323018|P3|STARTED|Year 2||573
2577724|NCT00395135|6323019|P2|STARTED|Year 2||0
2577725|NCT00395135|6323020|P1|STARTED|Year 2||0
2577726|NCT00395135|6323016|P5|NOT COMPLETED|Year 1||0
2577727|NCT00395135|6323017|P4|NOT COMPLETED|Year 1||0
2577728|NCT00395135|6323018|P3|NOT COMPLETED|Year 1||0
2577729|NCT00395135|6323019|P2|NOT COMPLETED|Year 1||871
2577730|NCT00395135|6323020|P1|NOT COMPLETED|Year 1||712
2577731|NCT00395135|6323016|P5|COMPLETED|Year 1||0
2577732|NCT00395135|6323017|P4|COMPLETED|Year 1||0
2577733|NCT00395135|6323018|P3|COMPLETED|Year 1||0
2577734|NCT00395135|6323019|P2|COMPLETED|Year 1||716
2577735|NCT00395135|6323020|P1|COMPLETED|Year 1||883
2577736|NCT00395135|6323016|P5|STARTED|Year 1||0
2577737|NCT00395135|6323017|P4|STARTED|Year 1||0
2577738|NCT00395135|6323018|P3|STARTED|Year 1||0
2577739|NCT00395135|6323019|P2|STARTED|Year 1||1587
2577740|NCT00395135|6323020|P1|STARTED|Year 1||1595
2577741|NCT00395083|6323038|P2|NOT COMPLETED|Overall Study||8
2577742|NCT00395083|6323039|P1|NOT COMPLETED|Overall Study||10
2577743|NCT00395083|6323038|P2|COMPLETED|Overall Study||201
2577744|NCT00395083|6323039|P1|COMPLETED|Overall Study||207
2577745|NCT00395083|6323038|P2|STARTED|Overall Study||209
2577746|NCT00395083|6323039|P1|STARTED|Overall Study||217
2577747|NCT00395057|6323055|P4|NOT COMPLETED|Overall Study||33
2577748|NCT00395057|6323056|P3|NOT COMPLETED|Overall Study||33
2577749|NCT00395057|6323057|P2|NOT COMPLETED|Overall Study||34
2577750|NCT00395057|6323058|P1|NOT COMPLETED|Overall Study||32
2577751|NCT00395057|6323055|P4|COMPLETED|Overall Study||1
2577752|NCT00395057|6323056|P3|COMPLETED|Overall Study||2
2577753|NCT00395057|6323057|P2|COMPLETED|Overall Study||1
2577754|NCT00395057|6323058|P1|COMPLETED|Overall Study||2
2577755|NCT00395057|6323055|P4|STARTED|Overall Study||34
2577756|NCT00395057|6323056|P3|STARTED|Overall Study||35
2577757|NCT00395057|6323057|P2|STARTED|Overall Study||35
2577758|NCT00395057|6323058|P1|STARTED|Overall Study||34
2577759|NCT00395044|6323086|P2|NOT COMPLETED|Overall Study||14
2577760|NCT00395044|6323087|P1|NOT COMPLETED|Overall Study||18
2577761|NCT00395044|6323086|P2|COMPLETED|Overall Study||11
2577762|NCT00395044|6323087|P1|COMPLETED|Overall Study||7
2577763|NCT00395044|6323086|P2|STARTED|Overall Study||25
2577764|NCT00395044|6323087|P1|STARTED|Overall Study||25
2577765|NCT00395018|6323105|P1|NOT COMPLETED|Off-Treatment Follow-up||4
2577766|NCT00395018|6323105|P1|COMPLETED|Off-Treatment Follow-up|"Completed means completed the study"|1
2577767|NCT00395018|6323105|P1|STARTED|Off-Treatment Follow-up|Treated participants who discontinued =<72 weeks and did not start other anti-HBV therapy|5
2577768|NCT00395018|6323105|P1|NOT COMPLETED|On-Treatment||10
2577769|NCT00395018|6323105|P1|COMPLETED|On-Treatment|"Completed means received treatment through Week 72"|55
2577770|NCT00395018|6323105|P1|DISCONTINUED AT OR AFTER WEEK 72 VISIT|On-Treatment||0
2577771|NCT00395018|6323105|P1|DISCONTINUED PRIOR TO WEEK 72 VISIT|On-Treatment||10
2577772|NCT00395018|6323105|P1|STARTED|On-Treatment|Started = treated (participants who received at least 1 dose of study therapy)|65
2577773|NCT00394953|6323126|P2|NOT COMPLETED|Second Treatment Period||74
2577774|NCT00394953|6323127|P1|NOT COMPLETED|Second Treatment Period||29
2577775|NCT00394953|6323126|P2|COMPLETED|Second Treatment Period||148
2577776|NCT00394953|6323127|P1|COMPLETED|Second Treatment Period||187
2577777|NCT00394953|6323126|P2|STARTED|Second Treatment Period||222
2577778|NCT00394953|6323127|P1|STARTED|Second Treatment Period||216
2577779|NCT00394953|6323126|P2|NOT COMPLETED|First Treatment Period||22
2577780|NCT00394953|6323127|P1|NOT COMPLETED|First Treatment Period||29
2577781|NCT00394953|6323126|P2|COMPLETED|First Treatment Period||222
2577782|NCT00394953|6323127|P1|COMPLETED|First Treatment Period||216
2577783|NCT00394953|6323126|P2|STARTED|First Treatment Period||244
2577784|NCT00394953|6323127|P1|STARTED|First Treatment Period||245
2577785|NCT00394914|6323145|P3|NOT COMPLETED|Treatment Period||6
2577786|NCT00394914|6323146|P2|NOT COMPLETED|Treatment Period||10
2577787|NCT00394914|6323147|P1|NOT COMPLETED|Treatment Period||0
2577788|NCT00394914|6323145|P3|COMPLETED|Treatment Period||151
2577789|NCT00394914|6323146|P2|COMPLETED|Treatment Period||144
2577790|NCT00394914|6323147|P1|COMPLETED|Treatment Period||0
2577791|NCT00394914|6323145|P3|STARTED|Treatment Period||157
2577792|NCT00394914|6323146|P2|STARTED|Treatment Period||154
2577793|NCT00394914|6323147|P1|STARTED|Treatment Period||0
2577794|NCT00394914|6323145|P3|NOT COMPLETED|Pre-exposure Period||0
2577795|NCT00394914|6323146|P2|NOT COMPLETED|Pre-exposure Period||0
2577796|NCT00394914|6323147|P1|NOT COMPLETED|Pre-exposure Period||0
2577797|NCT00394914|6323145|P3|COMPLETED|Pre-exposure Period||0
2577798|NCT00394914|6323146|P2|COMPLETED|Pre-exposure Period||0
2577799|NCT00394914|6323147|P1|COMPLETED|Pre-exposure Period||311
2577800|NCT00394914|6323145|P3|STARTED|Pre-exposure Period||0
2577801|NCT00394914|6323146|P2|STARTED|Pre-exposure Period||0
2577802|NCT00394914|6323147|P1|STARTED|Pre-exposure Period||311
2577803|NCT00394914|6323145|P3|NOT COMPLETED|Screening Period||0
2577804|NCT00394914|6323146|P2|NOT COMPLETED|Screening Period||0
2577805|NCT00394914|6323147|P1|NOT COMPLETED|Screening Period||0
2577806|NCT00394914|6323145|P3|COMPLETED|Screening Period||0
2577807|NCT00394914|6323146|P2|COMPLETED|Screening Period||0
2577808|NCT00394914|6323147|P1|COMPLETED|Screening Period||311
2577809|NCT00394914|6323145|P3|STARTED|Screening Period||0
2577810|NCT00394914|6323146|P2|STARTED|Screening Period||0
2577811|NCT00394914|6323147|P1|STARTED|Screening Period||311
2577812|NCT00394901|6323175|P4|NOT COMPLETED|Double-blind Phase||27
2577813|NCT00394901|6323176|P3|NOT COMPLETED|Double-blind Phase||18
2577814|NCT00394901|6323177|P2|NOT COMPLETED|Double-blind Phase||14
2577815|NCT00394901|6323178|P1|NOT COMPLETED|Double-blind Phase||15
2577816|NCT00394901|6323175|P4|COMPLETED|Double-blind Phase||70
2577817|NCT00394901|6323176|P3|COMPLETED|Double-blind Phase||71
2577818|NCT00394901|6323177|P2|COMPLETED|Double-blind Phase||73
2577819|NCT00394901|6323178|P1|COMPLETED|Double-blind Phase||83
2577820|NCT00394901|6323175|P4|STARTED|Double-blind Phase|Subjects treated with the study drug.|97
2577821|NCT00394901|6323176|P3|STARTED|Double-blind Phase|Subjects treated with the study drug.|89
2577822|NCT00394901|6323177|P2|STARTED|Double-blind Phase|Subjects treated with the study drug.|87
2577823|NCT00394901|6323178|P1|STARTED|Double-blind Phase|Subjects treated with the study drug.|98
2577824|NCT00394901|6323175|P4|NOT COMPLETED|Baseline Phase||0
2577825|NCT00394901|6323176|P3|NOT COMPLETED|Baseline Phase||1
2577826|NCT00394901|6323177|P2|NOT COMPLETED|Baseline Phase||0
2577827|NCT00394901|6323178|P1|NOT COMPLETED|Baseline Phase||0
2577828|NCT00394901|6323175|P4|COMPLETED|Baseline Phase||97
2577829|NCT00394901|6323176|P3|COMPLETED|Baseline Phase||89
2577830|NCT00394901|6323177|P2|COMPLETED|Baseline Phase||87
2577831|NCT00394901|6323178|P1|COMPLETED|Baseline Phase||98
2577832|NCT00394901|6323175|P4|STARTED|Baseline Phase|Subjects randomized|97
2577833|NCT00394901|6323176|P3|STARTED|Baseline Phase|Subjects randomized|90
2577834|NCT00394901|6323177|P2|STARTED|Baseline Phase|Subjects randomized|87
2577835|NCT00394901|6323178|P1|STARTED|Baseline Phase|Subjects randomized|98
2577836|NCT00394888|6323406|P3|NOT COMPLETED|Overall Study||0
2577837|NCT00394888|6323407|P2|NOT COMPLETED|Overall Study||0
2577838|NCT00394888|6323408|P1|NOT COMPLETED|Overall Study||0
2577839|NCT00394888|6323406|P3|COMPLETED|Overall Study||201
2577840|NCT00394888|6323407|P2|COMPLETED|Overall Study||48
2577841|NCT00394888|6323408|P1|COMPLETED|Overall Study||108
2577842|NCT00394888|6323406|P3|STARTED|Overall Study||201
2577843|NCT00394888|6323407|P2|STARTED|Overall Study||48
2577844|NCT00394888|6323408|P1|STARTED|Overall Study||108
2577845|NCT00394836|6323421|P2|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||53
2577846|NCT00394836|6323422|P1|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||20
2577847|NCT00394836|6323421|P2|COMPLETED|Extended Follow-up Phase (2-5 Years)||5
2577848|NCT00394836|6323422|P1|COMPLETED|Extended Follow-up Phase (2-5 Years)||0
2577849|NCT00394836|6323421|P2|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|58
2577850|NCT00394836|6323422|P1|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|20
2577851|NCT00394836|6323421|P2|NOT COMPLETED|Teatment or Follow-up Phase||78
2577852|NCT00394836|6323422|P1|NOT COMPLETED|Teatment or Follow-up Phase||28
2577853|NCT00394836|6323421|P2|COMPLETED|Teatment or Follow-up Phase||8
2577854|NCT00394836|6323422|P1|COMPLETED|Teatment or Follow-up Phase||2
2577855|NCT00394836|6323421|P2|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|8
2577856|NCT00394836|6323422|P1|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|4
2577857|NCT00394836|6323421|P2|STARTED|Teatment or Follow-up Phase||86
2577858|NCT00394836|6323422|P1|STARTED|Teatment or Follow-up Phase||30
2577859|NCT00394771|6323468|P4|NOT COMPLETED|Overall Study||39
2577860|NCT00394771|6323469|P3|NOT COMPLETED|Overall Study||47
2577861|NCT00394771|6323470|P2|NOT COMPLETED|Overall Study||34
2577862|NCT00394771|6323471|P1|NOT COMPLETED|Overall Study||41
2577863|NCT00394771|6323468|P4|COMPLETED|Overall Study||109
2577864|NCT00394771|6323469|P3|COMPLETED|Overall Study||96
2577865|NCT00394771|6323470|P2|COMPLETED|Overall Study||102
2577866|NCT00394771|6323471|P1|COMPLETED|Overall Study||99
2577867|NCT00394771|6323468|P4|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|120
2577868|NCT00394771|6323469|P3|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|108
2577869|NCT00394771|6323470|P2|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
2577870|NCT00394771|6323471|P1|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
2577871|NCT00394771|6323468|P4|STARTED|Overall Study|Safety population of treated participants|148
2577872|NCT00394771|6323469|P3|STARTED|Overall Study|Safety population of treated participants|143
2577873|NCT00394771|6323470|P2|STARTED|Overall Study|Safety population of treated participants|136
2577874|NCT00394771|6323471|P1|STARTED|Overall Study|Safety population of treated participants|140
2577875|NCT00394706|6323541|P8|NOT COMPLETED|Overall Study||0
2577876|NCT00394706|6323542|P7|NOT COMPLETED|Overall Study||3
2577877|NCT00394706|6323543|P6|NOT COMPLETED|Overall Study||7
2577878|NCT00394706|6323544|P5|NOT COMPLETED|Overall Study||2
2577879|NCT00394706|6323545|P4|NOT COMPLETED|Overall Study||1
2577880|NCT00394706|6323546|P3|NOT COMPLETED|Overall Study||9
2577881|NCT00394706|6323547|P2|NOT COMPLETED|Overall Study||2
2577882|NCT00394706|6323548|P1|NOT COMPLETED|Overall Study||4
2577883|NCT00394706|6323541|P8|COMPLETED|Overall Study||851
2577884|NCT00394706|6323542|P7|COMPLETED|Overall Study||926
2577885|NCT00394706|6323543|P6|COMPLETED|Overall Study||1377
2577886|NCT00394706|6323544|P5|COMPLETED|Overall Study||1634
2577887|NCT00394706|6323545|P4|COMPLETED|Overall Study||1632
2577888|NCT00394706|6323546|P3|COMPLETED|Overall Study||1615
2577889|NCT00394706|6323547|P2|COMPLETED|Overall Study||1860
2577890|NCT00394706|6323548|P1|COMPLETED|Overall Study||1815
2577891|NCT00394706|6323541|P8|STARTED|Overall Study||851
2577892|NCT00394706|6323542|P7|STARTED|Overall Study||929
2577893|NCT00394706|6323543|P6|STARTED|Overall Study||1384
2577894|NCT00394706|6323544|P5|STARTED|Overall Study||1636
2577895|NCT00394706|6323545|P4|STARTED|Overall Study||1633
2577896|NCT00394706|6323546|P3|STARTED|Overall Study||1624
2577897|NCT00394706|6323547|P2|STARTED|Overall Study||1862
2577898|NCT00394706|6323548|P1|STARTED|Overall Study||1819
2577899|NCT00394654|6323580|P2|NOT COMPLETED|Overall Study||0
2577900|NCT00394654|6323581|P1|NOT COMPLETED|Overall Study||2
2577901|NCT00394654|6323580|P2|COMPLETED|Overall Study||15
2577902|NCT00394654|6323581|P1|COMPLETED|Overall Study||13
2577903|NCT00394654|6323580|P2|STARTED|Overall Study||15
2577904|NCT00394654|6323581|P1|STARTED|Overall Study||15
2577905|NCT00394589|6323646|P3|NOT COMPLETED|Overall Study||7
2577906|NCT00394589|6323647|P2|NOT COMPLETED|Overall Study||3
2577907|NCT00394589|6323648|P1|NOT COMPLETED|Overall Study||8
2577908|NCT00394589|6323646|P3|COMPLETED|Overall Study||11
2577909|NCT00394589|6323647|P2|COMPLETED|Overall Study||8
2577910|NCT00394589|6323648|P1|COMPLETED|Overall Study||6
2577911|NCT00394589|6323646|P3|STARTED|Overall Study||18
2577912|NCT00394589|6323647|P2|STARTED|Overall Study||11
2577913|NCT00394589|6323648|P1|STARTED|Overall Study||14
2577914|NCT00394524|6323658|P2|NOT COMPLETED|Overall Study||4
2577915|NCT00394524|6323659|P1|NOT COMPLETED|Overall Study||3
2577916|NCT00394524|6323658|P2|COMPLETED|Overall Study||76
2577917|NCT00394524|6323659|P1|COMPLETED|Overall Study||77
2577918|NCT00394524|6323658|P2|STARTED|Overall Study||80
2577919|NCT00394524|6323659|P1|STARTED|Overall Study||80
2577920|NCT00394472|6323673|P2|NOT COMPLETED|Overall Study||11
2577921|NCT00394472|6323674|P1|NOT COMPLETED|Overall Study||9
2577922|NCT00394472|6323673|P2|COMPLETED|Overall Study||111
2577923|NCT00394472|6323674|P1|COMPLETED|Overall Study||113
2577924|NCT00394472|6323673|P2|STARTED|Overall Study||122
2577925|NCT00394472|6323674|P1|STARTED|Overall Study||122
2577926|NCT00394433|6323682|P1|NOT COMPLETED|Overall Study||3
2577927|NCT00394433|6323682|P1|COMPLETED|Overall Study||35
2577928|NCT00394433|6323682|P1|Evaluable and Treated|Overall Study||35
2577929|NCT00394433|6323682|P1|STARTED|Overall Study||38
2577930|NCT00394355|6323693|P4|NOT COMPLETED|Overall Study||31
2577931|NCT00394355|6323694|P3|NOT COMPLETED|Overall Study||38
2577932|NCT00394355|6323695|P2|NOT COMPLETED|Overall Study||34
2577933|NCT00394355|6323696|P1|NOT COMPLETED|Overall Study||35
2577934|NCT00394355|6323693|P4|COMPLETED|Overall Study||111
2577935|NCT00394355|6323694|P3|COMPLETED|Overall Study||109
2577936|NCT00394355|6323695|P2|COMPLETED|Overall Study||103
2577937|NCT00394355|6323696|P1|COMPLETED|Overall Study||105
2577938|NCT00394355|6323693|P4|STARTED|Overall Study||142
2577939|NCT00394355|6323694|P3|STARTED|Overall Study||147
2577940|NCT00394355|6323695|P2|STARTED|Overall Study||137
2577941|NCT00394355|6323696|P1|STARTED|Overall Study||140
2577942|NCT00394329|6323722|P4|NOT COMPLETED|Overall Study||24
2577943|NCT00394329|6323723|P3|NOT COMPLETED|Overall Study||13
2577944|NCT00394329|6323724|P2|NOT COMPLETED|Overall Study||9
2577945|NCT00394329|6323725|P1|NOT COMPLETED|Overall Study||8
2577946|NCT00394329|6323722|P4|COMPLETED|Overall Study||50
2577947|NCT00394329|6323723|P3|COMPLETED|Overall Study||58
2577948|NCT00394329|6323724|P2|COMPLETED|Overall Study||63
2577949|NCT00394329|6323725|P1|COMPLETED|Overall Study||63
2577950|NCT00394329|6323722|P4|STARTED|Overall Study||74
2577951|NCT00394329|6323723|P3|STARTED|Overall Study||71
2577952|NCT00394329|6323724|P2|STARTED|Overall Study||72
2577953|NCT00394329|6323725|P1|STARTED|Overall Study||71
2577954|NCT00394277|6323775|P4|NOT COMPLETED|Overall Study||125
2577955|NCT00394277|6323776|P3|NOT COMPLETED|Overall Study||120
2577956|NCT00394277|6323777|P2|NOT COMPLETED|Overall Study||60
2577957|NCT00394277|6323778|P1|NOT COMPLETED|Overall Study||58
2577958|NCT00394277|6323775|P4|COMPLETED|Overall Study||266
2577959|NCT00394277|6323776|P3|COMPLETED|Overall Study||273
2577960|NCT00394277|6323777|P2|COMPLETED|Overall Study||136
2577961|NCT00394277|6323778|P1|COMPLETED|Overall Study||137
2577962|NCT00394277|6323775|P4|STARTED|Overall Study||391
2577963|NCT00394277|6323776|P3|STARTED|Overall Study||393
2577964|NCT00394277|6323777|P2|STARTED|Overall Study||196
2577965|NCT00394277|6323778|P1|STARTED|Overall Study||195
2577966|NCT00394251|6323802|P2|NOT COMPLETED|Overall Study||38
2577967|NCT00394251|6323803|P1|NOT COMPLETED|Overall Study||37
2577968|NCT00394251|6323802|P2|COMPLETED|Overall Study||61
2577969|NCT00394251|6323803|P1|COMPLETED|Overall Study||61
2577970|NCT00394251|6323802|P2|At Least One Dose of Taxane|Overall Study||93
2577971|NCT00394251|6323803|P1|At Least One Dose of Taxane|Overall Study||93
2577972|NCT00394251|6323802|P2|STARTED|Overall Study||99
2577973|NCT00394251|6323803|P1|STARTED|Overall Study||98
2577974|NCT00394212|6323831|P2|NOT COMPLETED|Overall Study||1
2577975|NCT00394212|6323832|P1|NOT COMPLETED|Overall Study||7
2577976|NCT00394212|6323831|P2|COMPLETED|Overall Study||26
2577977|NCT00394212|6323832|P1|COMPLETED|Overall Study||43
2577978|NCT00394212|6323831|P2|6 Month Follow-up|Overall Study||26
2577979|NCT00394212|6323832|P1|6 Month Follow-up|Overall Study||43
2577980|NCT00394212|6323831|P2|3 Month Follow-up|Overall Study||26
2577981|NCT00394212|6323832|P1|3 Month Follow-up|Overall Study||45
2577982|NCT00394212|6323831|P2|6 Week Follow-up|Overall Study||26
2577983|NCT00394212|6323832|P1|6 Week Follow-up|Overall Study||45
2577984|NCT00394212|6323831|P2|STARTED|Overall Study||27
2578160|NCT00393042|6324174|P2|COMPLETED|Second Intervetion||19
2577985|NCT00394212|6323832|P1|STARTED|Overall Study|2 subjects assigned to suturing underwent sham procedure, results based on Intent-To-Treat (ITT)|50
2577986|NCT00394095|6323846|P2|NOT COMPLETED|Overall Study||0
2577987|NCT00394095|6323847|P1|NOT COMPLETED|Overall Study||1
2577988|NCT00394095|6323846|P2|COMPLETED|Overall Study||14
2577989|NCT00394095|6323847|P1|COMPLETED|Overall Study||16
2577990|NCT00394095|6323846|P2|Screened|Overall Study||14
2577991|NCT00394095|6323847|P1|Screened|Overall Study||17
2577992|NCT00394095|6323846|P2|STARTED|Overall Study||14
2577993|NCT00394095|6323847|P1|STARTED|Overall Study||17
2577994|NCT00394082|6323855|P1|NOT COMPLETED|Overall Study||26
2577995|NCT00394082|6323855|P1|COMPLETED|Overall Study|Treatment completed upon disease progression|24
2577996|NCT00394082|6323855|P1|At Least One Response Assessment|Overall Study||43
2577997|NCT00394082|6323855|P1|STARTED|Overall Study||50
2577998|NCT00393978|6323866|P2|NOT COMPLETED|Overall Study||20
2577999|NCT00393978|6323867|P1|NOT COMPLETED|Overall Study||16
2578000|NCT00393978|6323866|P2|COMPLETED|Overall Study||18
2578001|NCT00393978|6323867|P1|COMPLETED|Overall Study||21
2578002|NCT00393978|6323866|P2|STARTED|Overall Study||38
2578003|NCT00393978|6323867|P1|STARTED|Overall Study||37
2578004|NCT00393939|6323877|P2|NOT COMPLETED|Overall Study||297
2578005|NCT00393939|6323878|P1|NOT COMPLETED|Overall Study||296
2578006|NCT00393939|6323877|P2|COMPLETED|Overall Study||0
2578007|NCT00393939|6323878|P1|COMPLETED|Overall Study||0
2578008|NCT00393939|6323877|P2|Treated|Overall Study||293
2578009|NCT00393939|6323878|P1|Treated|Overall Study||295
2578010|NCT00393939|6323877|P2|STARTED|Overall Study||297
2578011|NCT00393939|6323878|P1|STARTED|Overall Study||296
2578012|NCT00393913|6323896|P1|NOT COMPLETED|CPAP Withdrawal||0
2578013|NCT00393913|6323896|P1|COMPLETED|CPAP Withdrawal||42
2578014|NCT00393913|6323896|P1|CPAP Compliance|CPAP Withdrawal|Only subjects with sufficient CPAP complaince (>4 hrs/night) were included.|42
2578015|NCT00393913|6323896|P1|STARTED|CPAP Withdrawal|Includes only subjects with good CPAP adherence|42
2578016|NCT00393913|6323896|P1|NOT COMPLETED|CPAP||7
2578017|NCT00393913|6323896|P1|COMPLETED|CPAP||93
2578018|NCT00393913|6323896|P1|STARTED|CPAP|Excludes normal volunteers without OSA|100
2578019|NCT00393913|6323896|P1|NOT COMPLETED|Initial Assessment||37
2578020|NCT00393913|6323896|P1|COMPLETED|Initial Assessment||107
2578021|NCT00393913|6323896|P1|STARTED|Initial Assessment||144
2578022|NCT00393887|6323904|P2|NOT COMPLETED|Overall Study||9
2578023|NCT00393887|6323905|P1|NOT COMPLETED|Overall Study||16
2578024|NCT00393887|6323904|P2|COMPLETED|Overall Study||41
2578025|NCT00393887|6323905|P1|COMPLETED|Overall Study||34
2578026|NCT00393887|6323904|P2|1 Year|Overall Study||50
2578027|NCT00393887|6323905|P1|1 Year|Overall Study||45
2578028|NCT00393887|6323904|P2|STARTED|Overall Study||50
2578029|NCT00393887|6323905|P1|STARTED|Overall Study||50
2578030|NCT00393874|6323914|P3|NOT COMPLETED|Overall Study||2
2578031|NCT00393874|6323915|P2|NOT COMPLETED|Overall Study||4
2578032|NCT00393874|6323916|P1|NOT COMPLETED|Overall Study||3
2578033|NCT00393874|6323914|P3|COMPLETED|Overall Study||13
2578034|NCT00393874|6323915|P2|COMPLETED|Overall Study||13
2578035|NCT00393874|6323916|P1|COMPLETED|Overall Study||15
2578036|NCT00393874|6323914|P3|STARTED|Overall Study||15
2578037|NCT00393874|6323915|P2|STARTED|Overall Study||17
2578038|NCT00393874|6323916|P1|STARTED|Overall Study||18
2578039|NCT00393861|6323933|P1|NOT COMPLETED|Overall Study||26
2578040|NCT00393861|6323933|P1|COMPLETED|Overall Study||3
2578041|NCT00393861|6323933|P1|STARTED|Overall Study||29
2578042|NCT00393848|6323944|P4|NOT COMPLETED|Overall Study||1
2578043|NCT00393848|6323945|P3|NOT COMPLETED|Overall Study||2
2578044|NCT00393848|6323946|P2|NOT COMPLETED|Overall Study||0
2578045|NCT00393848|6323947|P1|NOT COMPLETED|Overall Study||0
2578046|NCT00393848|6323944|P4|COMPLETED|Overall Study||8
2578047|NCT00393848|6323945|P3|COMPLETED|Overall Study||4
2578048|NCT00393848|6323946|P2|COMPLETED|Overall Study||9
2578049|NCT00393848|6323947|P1|COMPLETED|Overall Study||16
2578050|NCT00393848|6323944|P4|STARTED|Overall Study||9
2578051|NCT00393848|6323945|P3|STARTED|Overall Study||6
2578052|NCT00393848|6323946|P2|STARTED|Overall Study||9
2578053|NCT00393848|6323947|P1|STARTED|Overall Study||16
2578054|NCT00393796|6323961|P2|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
2578055|NCT00393796|6323962|P1|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
2578056|NCT00393796|6323961|P2|COMPLETED|Open Label Period - Placebo to SUTENT||16
2578057|NCT00393796|6323962|P1|COMPLETED|Open Label Period - Placebo to SUTENT||0
2578058|NCT00393796|6323961|P2|STARTED|Open Label Period - Placebo to SUTENT||16
2578059|NCT00393796|6323962|P1|STARTED|Open Label Period - Placebo to SUTENT||0
2578060|NCT00393796|6323961|P2|NOT COMPLETED|Double Blind Period||0
2578061|NCT00393796|6323962|P1|NOT COMPLETED|Double Blind Period||0
2578062|NCT00393796|6323961|P2|COMPLETED|Double Blind Period||28
2578063|NCT00393796|6323962|P1|COMPLETED|Double Blind Period||26
2578064|NCT00393796|6323961|P2|STARTED|Double Blind Period||28
2578065|NCT00393796|6323962|P1|STARTED|Double Blind Period||26
2578066|NCT00393718|6323970|P2|NOT COMPLETED|Overall Study||22
2578067|NCT00393718|6323971|P1|NOT COMPLETED|Overall Study||43
2578068|NCT00393718|6323970|P2|COMPLETED|Overall Study||110
2578069|NCT00393718|6323971|P1|COMPLETED|Overall Study||225
2578070|NCT00393718|6323970|P2|STARTED|Overall Study||132
2578071|NCT00393718|6323971|P1|STARTED|Overall Study||268
2578072|NCT00393705|6324003|P2|NOT COMPLETED|Overall Study||23
2578073|NCT00393705|6324004|P1|NOT COMPLETED|Overall Study||23
2578074|NCT00393705|6324003|P2|COMPLETED|Overall Study||128
2578075|NCT00393705|6324004|P1|COMPLETED|Overall Study||128
2578076|NCT00393705|6324003|P2|Received at Least One Dose of Study Drug|Overall Study||139
2578077|NCT00393705|6324004|P1|Received at Least One Dose of Study Drug|Overall Study||139
2578078|NCT00393705|6324003|P2|STARTED|Overall Study||151
2578079|NCT00393705|6324004|P1|STARTED|Overall Study||151
2578080|NCT00393523|6324033|P5|NOT COMPLETED|Overall Study||1
2578081|NCT00393523|6324034|P4|NOT COMPLETED|Overall Study||6
2578082|NCT00393523|6324035|P3|NOT COMPLETED|Overall Study||4
2578083|NCT00393523|6324036|P2|NOT COMPLETED|Overall Study||9
2578084|NCT00393523|6324037|P1|NOT COMPLETED|Overall Study||12
2578085|NCT00393523|6324033|P5|COMPLETED|Overall Study||19
2578086|NCT00393523|6324034|P4|COMPLETED|Overall Study||348
2578087|NCT00393523|6324035|P3|COMPLETED|Overall Study||349
2578088|NCT00393523|6324036|P2|COMPLETED|Overall Study||366
2578089|NCT00393523|6324037|P1|COMPLETED|Overall Study||364
2578090|NCT00393523|6324033|P5|Vaccination Visit 1|Overall Study||20
2578091|NCT00393523|6324034|P4|Vaccination Visit 1|Overall Study||352
2578092|NCT00393523|6324035|P3|Vaccination Visit 1|Overall Study||349
2578093|NCT00393523|6324036|P2|Vaccination Visit 1|Overall Study||375
2578094|NCT00393523|6324037|P1|Vaccination Visit 1|Overall Study||374
2578095|NCT00393523|6324033|P5|STARTED|Overall Study||20
2578096|NCT00393523|6324034|P4|STARTED|Overall Study||354
2578097|NCT00393523|6324035|P3|STARTED|Overall Study||353
2578098|NCT00393523|6324036|P2|STARTED|Overall Study||375
2578099|NCT00393523|6324037|P1|STARTED|Overall Study||376
2578100|NCT00393510|6324054|P2|NOT COMPLETED|Overall Study||9
2578101|NCT00393510|6324055|P1|NOT COMPLETED|Overall Study||3
2578102|NCT00393510|6324054|P2|COMPLETED|Overall Study||31
2578103|NCT00393510|6324055|P1|COMPLETED|Overall Study||37
2578104|NCT00393510|6324054|P2|STARTED|Overall Study||40
2578105|NCT00393510|6324055|P1|STARTED|Overall Study||40
2578106|NCT00393484|6324067|P2|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||23
2578107|NCT00393484|6324068|P1|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||8
2578108|NCT00393484|6324067|P2|COMPLETED|Open-label Period (Weeks 96 to 240)||21
2578109|NCT00393484|6324068|P1|COMPLETED|Open-label Period (Weeks 96 to 240)||40
2578110|NCT00393484|6324067|P2|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|2
2578111|NCT00393484|6324068|P1|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|0
2578112|NCT00393484|6324067|P2|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
2578113|NCT00393484|6324068|P1|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
2578114|NCT00393484|6324067|P2|STARTED|Open-label Period (Weeks 96 to 240)||44
2578115|NCT00393484|6324068|P1|STARTED|Open-label Period (Weeks 96 to 240)||48
2578116|NCT00393484|6324067|P2|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||12
2578117|NCT00393484|6324068|P1|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||2
2578118|NCT00393484|6324067|P2|COMPLETED|Double-blind Period (Day 1 to Week 96)||52
2578119|NCT00393484|6324068|P1|COMPLETED|Double-blind Period (Day 1 to Week 96)||54
2578120|NCT00393484|6324067|P2|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
2578121|NCT00393484|6324068|P1|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
2578122|NCT00393484|6324067|P2|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|64
2578123|NCT00393484|6324068|P1|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|56
2578124|NCT00393458|6324104|P4|NOT COMPLETED|Overall Study||137
2578125|NCT00393458|6324105|P3|NOT COMPLETED|Overall Study||112
2578126|NCT00393458|6324106|P2|NOT COMPLETED|Overall Study||102
2578127|NCT00393458|6324107|P1|NOT COMPLETED|Overall Study||99
2578128|NCT00393458|6324104|P4|COMPLETED|Overall Study||295
2578129|NCT00393458|6324105|P3|COMPLETED|Overall Study||323
2578130|NCT00393458|6324106|P2|COMPLETED|Overall Study||326
2578131|NCT00393458|6324107|P1|COMPLETED|Overall Study||338
2578132|NCT00393458|6324104|P4|Exposed to Study Medication or Placebo|Overall Study||432
2578133|NCT00393458|6324105|P3|Exposed to Study Medication or Placebo|Overall Study||434
2578134|NCT00393458|6324106|P2|Exposed to Study Medication or Placebo|Overall Study||425
2578135|NCT00393458|6324107|P1|Exposed to Study Medication or Placebo|Overall Study||437
2578136|NCT00393458|6324104|P4|STARTED|Overall Study||432
2578137|NCT00393458|6324105|P3|STARTED|Overall Study||435
2578138|NCT00393458|6324106|P2|STARTED|Overall Study||428
2578139|NCT00393458|6324107|P1|STARTED|Overall Study||437
2578140|NCT00393380|6324121|P1|NOT COMPLETED|Overall Study||0
2578141|NCT00393380|6324121|P1|COMPLETED|Overall Study||13
2578142|NCT00393380|6324121|P1|STARTED|Overall Study||13
2578143|NCT00393367|6324134|P2|NOT COMPLETED|Overall Study||7
2578144|NCT00393367|6324135|P1|NOT COMPLETED|Overall Study||2
2578145|NCT00393367|6324134|P2|COMPLETED|Overall Study||81
2578146|NCT00393367|6324135|P1|COMPLETED|Overall Study||89
2578147|NCT00393367|6324134|P2|STARTED|Overall Study||88
2578148|NCT00393367|6324135|P1|STARTED|Overall Study||91
2578149|NCT00393094|6324163|P1|NOT COMPLETED|Disease Progression After Trtmt: Onstudy||1
2578150|NCT00393094|6324163|P1|COMPLETED|Disease Progression After Trtmt: Onstudy||29
2578151|NCT00393094|6324163|P1|STARTED|Disease Progression After Trtmt: Onstudy||30
2578152|NCT00393094|6324163|P1|NOT COMPLETED|Period1Bevacizumab & Irinotecan Patients||1
2578153|NCT00393094|6324163|P1|COMPLETED|Period1Bevacizumab & Irinotecan Patients||30
2578154|NCT00393094|6324163|P1|STARTED|Period1Bevacizumab & Irinotecan Patients||31
2578155|NCT00393068|6324170|P1|NOT COMPLETED|Overall Study||18
2578156|NCT00393068|6324170|P1|COMPLETED|Overall Study||44
2578157|NCT00393068|6324170|P1|STARTED|Overall Study||62
2578158|NCT00393042|6324174|P2|NOT COMPLETED|Second Intervetion||8
2578159|NCT00393042|6324175|P1|NOT COMPLETED|Second Intervetion||2
2578161|NCT00393042|6324175|P1|COMPLETED|Second Intervetion||24
2578162|NCT00393042|6324174|P2|Completed 25/30 mg Dosage|Second Intervetion||20
2578163|NCT00393042|6324175|P1|Completed 25/30 mg Dosage|Second Intervetion||24
2578164|NCT00393042|6324174|P2|Completed the 20mg Dosage|Second Intervetion||21
2578165|NCT00393042|6324175|P1|Completed the 20mg Dosage|Second Intervetion||24
2578166|NCT00393042|6324174|P2|Completed 10 mg Dosage|Second Intervetion||24
2578167|NCT00393042|6324175|P1|Completed 10 mg Dosage|Second Intervetion||26
2578168|NCT00393042|6324174|P2|Completed Placebo Dosage|Second Intervetion||21
2578169|NCT00393042|6324175|P1|Completed Placebo Dosage|Second Intervetion||25
2578170|NCT00393042|6324174|P2|STARTED|Second Intervetion||27
2578171|NCT00393042|6324175|P1|STARTED|Second Intervetion||26
2578172|NCT00393042|6324174|P2|NOT COMPLETED|First Intervention||6
2578173|NCT00393042|6324175|P1|NOT COMPLETED|First Intervention||5
2578174|NCT00393042|6324174|P2|COMPLETED|First Intervention||27
2578175|NCT00393042|6324175|P1|COMPLETED|First Intervention||26
2578176|NCT00393042|6324174|P2|Completed 25/30mg Dosage|First Intervention||27
2578177|NCT00393042|6324175|P1|Completed 25/30mg Dosage|First Intervention||27
2578178|NCT00393042|6324174|P2|Completed 20 mg Dosage|First Intervention||28
2578179|NCT00393042|6324175|P1|Completed 20 mg Dosage|First Intervention||26
2578180|NCT00393042|6324174|P2|Completed 10mg Dosage|First Intervention||29
2578181|NCT00393042|6324175|P1|Completed 10mg Dosage|First Intervention||29
2578182|NCT00393042|6324174|P2|Completed the Placebo Dosage|First Intervention||29
2578183|NCT00393042|6324175|P1|Completed the Placebo Dosage|First Intervention||27
2578184|NCT00393042|6324174|P2|STARTED|First Intervention||33
2578185|NCT00393042|6324175|P1|STARTED|First Intervention||31
2578186|NCT00393029|6324247|P2|NOT COMPLETED|Overall Study||1
2578187|NCT00393029|6324248|P1|NOT COMPLETED|Overall Study||0
2578188|NCT00393029|6324247|P2|COMPLETED|Overall Study||9
2578189|NCT00393029|6324248|P1|COMPLETED|Overall Study||2
2578190|NCT00393029|6324247|P2|STARTED|Overall Study||10
2578191|NCT00393029|6324248|P1|STARTED|Overall Study||2
2578192|NCT00392990|6324259|P2|NOT COMPLETED|Follow up for 2 Years||0
2578193|NCT00392990|6324260|P1|NOT COMPLETED|Follow up for 2 Years||4
2578194|NCT00392990|6324259|P2|COMPLETED|Follow up for 2 Years||5
2578195|NCT00392990|6324260|P1|COMPLETED|Follow up for 2 Years||16
2578196|NCT00392990|6324259|P2|STARTED|Follow up for 2 Years||5
2578197|NCT00392990|6324260|P1|STARTED|Follow up for 2 Years||20
2578198|NCT00392990|6324259|P2|NOT COMPLETED|Treatment on Study||1
2578199|NCT00392990|6324260|P1|NOT COMPLETED|Treatment on Study||3
2578200|NCT00392990|6324259|P2|COMPLETED|Treatment on Study||4
2578201|NCT00392990|6324260|P1|COMPLETED|Treatment on Study||17
2578202|NCT00392990|6324259|P2|STARTED|Treatment on Study||5
2578203|NCT00392990|6324260|P1|STARTED|Treatment on Study||20
2578204|NCT00392951|6324272|P1|NOT COMPLETED|Overall Study||0
2578205|NCT00392951|6324272|P1|COMPLETED|Overall Study||30
2578206|NCT00392951|6324272|P1|STARTED|Overall Study||30
2578207|NCT00392925|6324284|P4|NOT COMPLETED|Randomization to Treatment Group Period||18
2578208|NCT00392925|6324285|P3|NOT COMPLETED|Randomization to Treatment Group Period||19
2578209|NCT00392925|6324286|P2|NOT COMPLETED|Randomization to Treatment Group Period||8
2578210|NCT00392925|6324287|P1|NOT COMPLETED|Randomization to Treatment Group Period||0
2578211|NCT00392925|6324284|P4|COMPLETED|Randomization to Treatment Group Period|At Week 20|38
2578212|NCT00392925|6324285|P3|COMPLETED|Randomization to Treatment Group Period|At Week 20|37
2578213|NCT00392925|6324286|P2|COMPLETED|Randomization to Treatment Group Period|AT Week 20|19
2578214|NCT00392925|6324287|P1|COMPLETED|Randomization to Treatment Group Period||0
2578215|NCT00392925|6324284|P4|STARTED|Randomization to Treatment Group Period||56
2578216|NCT00392925|6324285|P3|STARTED|Randomization to Treatment Group Period||56
2578217|NCT00392925|6324286|P2|STARTED|Randomization to Treatment Group Period||27
2578218|NCT00392925|6324287|P1|STARTED|Randomization to Treatment Group Period||0
2578219|NCT00392925|6324284|P4|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
2578220|NCT00392925|6324285|P3|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
2578221|NCT00392925|6324286|P2|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
2578222|NCT00392925|6324287|P1|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||38
2578223|NCT00392925|6324284|P4|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
2578224|NCT00392925|6324285|P3|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
2578225|NCT00392925|6324286|P2|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
2578226|NCT00392925|6324287|P1|COMPLETED|4 Week Lead-In Period - Non-Randomized||139
2578227|NCT00392925|6324284|P4|STARTED|4 Week Lead-In Period - Non-Randomized||0
2578228|NCT00392925|6324285|P3|STARTED|4 Week Lead-In Period - Non-Randomized||0
2578229|NCT00392925|6324286|P2|STARTED|4 Week Lead-In Period - Non-Randomized||0
2578230|NCT00392925|6324287|P1|STARTED|4 Week Lead-In Period - Non-Randomized||177
2578231|NCT00392860|6324375|P3|NOT COMPLETED|Overall Study||0
2578232|NCT00392860|6324376|P2|NOT COMPLETED|Overall Study||0
2578233|NCT00392860|6324377|P1|NOT COMPLETED|Overall Study||0
2578234|NCT00392860|6324375|P3|COMPLETED|Overall Study||1
2578235|NCT00392860|6324376|P2|COMPLETED|Overall Study||0
2578236|NCT00392860|6324377|P1|COMPLETED|Overall Study||3
2578237|NCT00392860|6324375|P3|STARTED|Overall Study||1
2578238|NCT00392860|6324376|P2|STARTED|Overall Study||0
2578239|NCT00392860|6324377|P1|STARTED|Overall Study||3
2578240|NCT00392834|6324385|P2|NOT COMPLETED|Overall Study||0
2578241|NCT00392834|6324386|P1|NOT COMPLETED|Overall Study||0
2578242|NCT00392834|6324385|P2|COMPLETED|Overall Study||32
2578243|NCT00392834|6324386|P1|COMPLETED|Overall Study||2
2578244|NCT00392834|6324385|P2|STARTED|Overall Study||32
2578245|NCT00392834|6324386|P1|STARTED|Overall Study||2
2578246|NCT00392821|6324392|P1|NOT COMPLETED|Overall Study||19
2578247|NCT00392821|6324392|P1|COMPLETED|Overall Study||59
2578248|NCT00392821|6324392|P1|STARTED|Overall Study||78
2578249|NCT00392808|6324401|P4|NOT COMPLETED|Overall Study||4
2578250|NCT00392808|6324402|P3|NOT COMPLETED|Overall Study||2
2578251|NCT00392808|6324403|P2|NOT COMPLETED|Overall Study||3
2578252|NCT00392808|6324404|P1|NOT COMPLETED|Overall Study||6
2578253|NCT00392808|6324401|P4|COMPLETED|Overall Study||100
2578254|NCT00392808|6324402|P3|COMPLETED|Overall Study||107
2578255|NCT00392808|6324403|P2|COMPLETED|Overall Study||86
2578256|NCT00392808|6324404|P1|COMPLETED|Overall Study||81
2578257|NCT00392808|6324401|P4|STARTED|Overall Study||104
2578258|NCT00392808|6324402|P3|STARTED|Overall Study||109
2578259|NCT00392808|6324403|P2|STARTED|Overall Study||89
2578260|NCT00392808|6324404|P1|STARTED|Overall Study||87
2578261|NCT00392782|6324418|P1|NOT COMPLETED|Overall Study||0
2578262|NCT00392782|6324418|P1|COMPLETED|Overall Study||24
2578263|NCT00392782|6324418|P1|STARTED|Overall Study||24
2578264|NCT00392769|6324428|P1|NOT COMPLETED|Overall Study||10
2578265|NCT00392769|6324428|P1|COMPLETED|Overall Study||23
2578266|NCT00392769|6324428|P1|STARTED|Overall Study||33
2578267|NCT00392704|6324432|P1|NOT COMPLETED|Combined Modality Therapy||5
2578268|NCT00392704|6324432|P1|COMPLETED|Combined Modality Therapy||49
2578269|NCT00392704|6324432|P1|STARTED|Combined Modality Therapy||54
2578270|NCT00392704|6324432|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||6
2578271|NCT00392704|6324432|P1|COMPLETED|Neoadjuvant Chemotherapy||54
2578272|NCT00392704|6324432|P1|STARTED|Neoadjuvant Chemotherapy||60
2578273|NCT00392678|6324441|P4|NOT COMPLETED|Overall Study||1
2578274|NCT00392678|6324442|P3|NOT COMPLETED|Overall Study||2
2578275|NCT00392678|6324443|P2|NOT COMPLETED|Overall Study||1
2578276|NCT00392678|6324444|P1|NOT COMPLETED|Overall Study||0
2578277|NCT00392678|6324441|P4|COMPLETED|Overall Study||26
2578278|NCT00392678|6324442|P3|COMPLETED|Overall Study||25
2578279|NCT00392678|6324443|P2|COMPLETED|Overall Study||26
2578280|NCT00392678|6324444|P1|COMPLETED|Overall Study||27
2578281|NCT00392678|6324441|P4|STARTED|Overall Study||27
2578282|NCT00392678|6324442|P3|STARTED|Overall Study||27
2578283|NCT00392678|6324443|P2|STARTED|Overall Study||27
2578284|NCT00392678|6324444|P1|STARTED|Overall Study||27
2578285|NCT00392665|6324480|P2|NOT COMPLETED|Overall Study||15
2578286|NCT00392665|6324481|P1|NOT COMPLETED|Overall Study||17
2578287|NCT00392665|6324480|P2|COMPLETED|Overall Study||3
2578288|NCT00392665|6324481|P1|COMPLETED|Overall Study||1
2578289|NCT00392665|6324480|P2|STARTED|Overall Study||18
2578290|NCT00392665|6324481|P1|STARTED|Overall Study||18
2578291|NCT00392496|6324493|P1|NOT COMPLETED|Overall Study||0
2578292|NCT00392496|6324493|P1|COMPLETED|Overall Study||19
2578293|NCT00392496|6324493|P1|STARTED|Overall Study||19
2578294|NCT00392444|6324497|P1|NOT COMPLETED|Overall Study||0
2578295|NCT00392444|6324497|P1|COMPLETED|Overall Study||39
2578296|NCT00392444|6324497|P1|STARTED|Overall Study||39
2578297|NCT00392392|6324501|P1|NOT COMPLETED|Overall Study||20
2578298|NCT00392392|6324501|P1|COMPLETED|Overall Study||9
2578299|NCT00392392|6324501|P1|STARTED|Overall Study||29
2578300|NCT00392379|6324507|P2|NOT COMPLETED|Overall Study||38
2578301|NCT00392379|6324508|P1|NOT COMPLETED|Overall Study||22
2578302|NCT00392379|6324507|P2|COMPLETED|Overall Study|Medication period|96
2578303|NCT00392379|6324508|P1|COMPLETED|Overall Study|Medication period|114
2578304|NCT00392379|6324507|P2|STARTED|Overall Study|Medication period|134
2578305|NCT00392379|6324508|P1|STARTED|Overall Study|Medication period|136
2578306|NCT00392288|6324521|P3|NOT COMPLETED|Overall Study||17
2578307|NCT00392288|6324522|P2|NOT COMPLETED|Overall Study||22
2578308|NCT00392288|6324523|P1|NOT COMPLETED|Overall Study||32
2578309|NCT00392288|6324521|P3|COMPLETED|Overall Study|ITT set = 172 patients|159
2578310|NCT00392288|6324522|P2|COMPLETED|Overall Study|ITT set = 166 patients|155
2578311|NCT00392288|6324523|P1|COMPLETED|Overall Study|ITT set = 163 patients|143
2578312|NCT00392288|6324521|P3|Treatment Period|Overall Study||175
2578313|NCT00392288|6324522|P2|Treatment Period|Overall Study||174
2578314|NCT00392288|6324523|P1|Treatment Period|Overall Study||172
2578315|NCT00392288|6324521|P3|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|176
2578316|NCT00392288|6324522|P2|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|177
2578317|NCT00392288|6324523|P1|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|175
2578318|NCT00392236|6324539|P2|NOT COMPLETED|Overall Study||6
2578319|NCT00392236|6324540|P1|NOT COMPLETED|Overall Study||12
2578320|NCT00392236|6324539|P2|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|12
2578321|NCT00392236|6324540|P1|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|8
2578322|NCT00392236|6324539|P2|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|18
2578323|NCT00392236|6324540|P1|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|20
2578324|NCT00392223|6324548|P2|NOT COMPLETED|Overall Study||13
2578325|NCT00392223|6324549|P1|NOT COMPLETED|Overall Study||9
2578326|NCT00392223|6324548|P2|COMPLETED|Overall Study||47
2578327|NCT00392223|6324549|P1|COMPLETED|Overall Study||49
2578328|NCT00392223|6324548|P2|STARTED|Overall Study||60
2578329|NCT00392223|6324549|P1|STARTED|Overall Study||58
2578330|NCT00392210|6324567|P2|NOT COMPLETED|Second Voiding Trial||0
2578331|NCT00392210|6324568|P1|NOT COMPLETED|Second Voiding Trial||0
2578332|NCT00392210|6324567|P2|COMPLETED|Second Voiding Trial||31
2578333|NCT00392210|6324568|P1|COMPLETED|Second Voiding Trial||34
2578334|NCT00392210|6324567|P2|STARTED|Second Voiding Trial||31
2578335|NCT00392210|6324568|P1|STARTED|Second Voiding Trial||34
2578336|NCT00392210|6324567|P2|NOT COMPLETED|First Voiding Trial||2
2578337|NCT00392210|6324568|P1|NOT COMPLETED|First Voiding Trial||2
2578338|NCT00392210|6324567|P2|COMPLETED|First Voiding Trial||31
2578339|NCT00392210|6324568|P1|COMPLETED|First Voiding Trial||34
2578340|NCT00392210|6324567|P2|STARTED|First Voiding Trial||33
2578341|NCT00392210|6324568|P1|STARTED|First Voiding Trial||36
2578342|NCT00392197|6324576|P2|NOT COMPLETED|Overall Study||30
2578343|NCT00392197|6324577|P1|NOT COMPLETED|Overall Study||21
2578344|NCT00392197|6324576|P2|COMPLETED|Overall Study||33
2578345|NCT00392197|6324577|P1|COMPLETED|Overall Study||27
2578346|NCT00392197|6324576|P2|STARTED|Overall Study||63
2578347|NCT00392197|6324577|P1|STARTED|Overall Study||48
2578348|NCT00392171|6324585|P1|NOT COMPLETED|Overall Study||105
2578349|NCT00392171|6324585|P1|COMPLETED|Overall Study||15
2578350|NCT00392171|6324585|P1|STARTED|Overall Study||120
2578351|NCT00392054|6324591|P2|NOT COMPLETED|Overall Study||0
2578352|NCT00392054|6324592|P1|NOT COMPLETED|Overall Study||0
2578353|NCT00392054|6324591|P2|COMPLETED|Overall Study||61
2578354|NCT00392054|6324592|P1|COMPLETED|Overall Study||66
2578355|NCT00392054|6324591|P2|Received Allocated Intervention|Overall Study||60
2578356|NCT00392054|6324592|P1|Received Allocated Intervention|Overall Study||65
2578357|NCT00392054|6324591|P2|STARTED|Overall Study|All participants randomized are included in final analysis|61
2578358|NCT00392054|6324592|P1|STARTED|Overall Study|All participants randomized are included in final analysis|66
2578359|NCT00391989|6324612|P1|NOT COMPLETED|Overall Study||2
2578360|NCT00391989|6324612|P1|COMPLETED|Overall Study||53
2578361|NCT00391989|6324612|P1|STARTED|Overall Study||55
2578362|NCT00391976|6324619|P3|NOT COMPLETED|Overall Study||35
2578363|NCT00391976|6324620|P2|NOT COMPLETED|Overall Study||25
2578364|NCT00391976|6324621|P1|NOT COMPLETED|Overall Study||27
2578365|NCT00391976|6324619|P3|COMPLETED|Overall Study||0
2578366|NCT00391976|6324620|P2|COMPLETED|Overall Study||18
2578367|NCT00391976|6324621|P1|COMPLETED|Overall Study||18
2578368|NCT00391976|6324619|P3|Safety Population|Overall Study||35
2578369|NCT00391976|6324620|P2|Safety Population|Overall Study||43
2578370|NCT00391976|6324621|P1|Safety Population|Overall Study|Patients who were enrolled and received at least one dose of study medication.|44
2578371|NCT00391976|6324619|P3|Randomized|Overall Study||0
2578372|NCT00391976|6324620|P2|Randomized|Overall Study||43
2578373|NCT00391976|6324621|P1|Randomized|Overall Study|Randomization occurred after 28 days of treatment & negative antibody test aeruginosa antibody test|45
2578374|NCT00391976|6324619|P3|STARTED|Overall Study||35
2578375|NCT00391976|6324620|P2|STARTED|Overall Study||43
2578376|NCT00391976|6324621|P1|STARTED|Overall Study|Started indicates all patients who were enrolled at Visit 1|45
2578377|NCT00391898|6324645|P2|NOT COMPLETED|Overall Study||10
2578378|NCT00391898|6324646|P1|NOT COMPLETED|Overall Study||11
2578379|NCT00391898|6324645|P2|COMPLETED|Overall Study||39
2578380|NCT00391898|6324646|P1|COMPLETED|Overall Study||35
2578381|NCT00391898|6324645|P2|STARTED|Overall Study||49
2578382|NCT00391898|6324646|P1|STARTED|Overall Study|Safety population for Levodopa/carbidopa/entacapone is 45, for Levodopa/carbidopa, per randomized.|46
2578383|NCT00391872|6324666|P2|NOT COMPLETED|Overall Study||255
2578384|NCT00391872|6324667|P1|NOT COMPLETED|Overall Study||307
2578385|NCT00391872|6324666|P2|COMPLETED|Overall Study||9036
2578386|NCT00391872|6324667|P1|COMPLETED|Overall Study||9026
2578387|NCT00391872|6324666|P2|STARTED|Overall Study||9291
2578388|NCT00391872|6324667|P1|STARTED|Overall Study||9333
2578389|NCT00391846|6324705|P2|NOT COMPLETED|Overall Study||7
2578390|NCT00391846|6324706|P1|NOT COMPLETED|Overall Study||8
2578391|NCT00391846|6324705|P2|COMPLETED|Overall Study|118 completed patients includes 5 CV related deaths|118
2578392|NCT00391846|6324706|P1|COMPLETED|Overall Study|119 completed patients includes 4 CV related deaths|119
2578393|NCT00391846|6324705|P2|STARTED|Overall Study|Of th 125 randomised patients 7 were discontinued|125
2578394|NCT00391846|6324706|P1|STARTED|Overall Study|Of the 127 randomised patients 8 were discontinued|127
2578395|NCT00391807|6324726|P1|NOT COMPLETED|Overall Study||715
2578396|NCT00391807|6324726|P1|COMPLETED|Overall Study||968
2578397|NCT00391807|6324726|P1|STARTED|Overall Study||1683
2578398|NCT00391768|6324753|P7|NOT COMPLETED|Overall Study||4
2578399|NCT00391768|6324754|P6|NOT COMPLETED|Overall Study||3
2578400|NCT00391768|6324755|P5|NOT COMPLETED|Overall Study||2
2578401|NCT00391768|6324756|P4|NOT COMPLETED|Overall Study||1
2578402|NCT00391768|6324757|P3|NOT COMPLETED|Overall Study||1
2578403|NCT00391768|6324758|P2|NOT COMPLETED|Overall Study||0
2578404|NCT00391768|6324759|P1|NOT COMPLETED|Overall Study||0
2578405|NCT00391768|6324753|P7|COMPLETED|Overall Study||19
2578406|NCT00391768|6324754|P6|COMPLETED|Overall Study||7
2578407|NCT00391768|6324755|P5|COMPLETED|Overall Study||22
2578408|NCT00391768|6324756|P4|COMPLETED|Overall Study||7
2578409|NCT00391768|6324757|P3|COMPLETED|Overall Study||6
2578410|NCT00391768|6324758|P2|COMPLETED|Overall Study||3
2578411|NCT00391768|6324759|P1|COMPLETED|Overall Study||12
2578412|NCT00391768|6324753|P7|STARTED|Overall Study||23
2578413|NCT00391768|6324754|P6|STARTED|Overall Study||10
2578414|NCT00391768|6324755|P5|STARTED|Overall Study||24
2578415|NCT00391768|6324756|P4|STARTED|Overall Study||8
2578416|NCT00391768|6324757|P3|STARTED|Overall Study||7
2578417|NCT00391768|6324758|P2|STARTED|Overall Study||3
2578418|NCT00391768|6324759|P1|STARTED|Overall Study||12
2578419|NCT00391716|6324827|P3|NOT COMPLETED|Overall Study||19
2578420|NCT00391716|6324828|P2|NOT COMPLETED|Overall Study||19
2578421|NCT00391716|6324829|P1|NOT COMPLETED|Overall Study||27
2578422|NCT00391716|6324827|P3|COMPLETED|Overall Study||30
2578423|NCT00391716|6324828|P2|COMPLETED|Overall Study||28
2578424|NCT00391716|6324829|P1|COMPLETED|Overall Study||27
2578425|NCT00391716|6324827|P3|STARTED|Overall Study||49
2578426|NCT00391716|6324828|P2|STARTED|Overall Study||47
2578427|NCT00391716|6324829|P1|STARTED|Overall Study||54
2578428|NCT00391625|6324846|P1|NOT COMPLETED|Month 84||0
2578429|NCT00391625|6324846|P1|COMPLETED|Month 84||8
2578430|NCT00391625|6324846|P1|STARTED|Month 84||8
2578431|NCT00391625|6324846|P1|NOT COMPLETED|Month 50||1
2578432|NCT00391625|6324846|P1|COMPLETED|Month 50||8
2578433|NCT00391625|6324846|P1|STARTED|Month 50||9
2578434|NCT00391625|6324846|P1|NOT COMPLETED|Month 14||1
2578435|NCT00391625|6324846|P1|COMPLETED|Month 14||9
2578436|NCT00391625|6324846|P1|STARTED|Month 14||10
2578437|NCT00391625|6324846|P1|NOT COMPLETED|Baseline||0
2578438|NCT00391625|6324846|P1|COMPLETED|Baseline||10
2578439|NCT00391625|6324846|P1|STARTED|Baseline||10
2578440|NCT00391599|6324888|P2|NOT COMPLETED|Overall Study||0
2578441|NCT00391599|6324889|P1|NOT COMPLETED|Overall Study||0
2578442|NCT00391599|6324888|P2|COMPLETED|Overall Study||65
2578443|NCT00391599|6324889|P1|COMPLETED|Overall Study||65
2578444|NCT00391599|6324888|P2|STARTED|Overall Study||65
2578445|NCT00391599|6324889|P1|STARTED|Overall Study||65
2578446|NCT00391586|6324899|P1|NOT COMPLETED|Overall Study||24
2578447|NCT00391586|6324899|P1|COMPLETED|Overall Study|These patients received at least 2 cycles of erlotinib|21
2578448|NCT00391586|6324899|P1|Received Platinum-based Chemotherapy|Overall Study|Total number of patients who received platinum-based chemotherapy after erlotinib treatment|10
2578449|NCT00391586|6324899|P1|Received First-line Erlotinib|Overall Study|These patients received at least one dose of on-study first-line erlotinib|43
2578450|NCT00391586|6324899|P1|STARTED|Overall Study||45
2578451|NCT00391469|6324908|P2|NOT COMPLETED|Overall Study||0
2578452|NCT00391469|6324909|P1|NOT COMPLETED|Overall Study||0
2578453|NCT00391469|6324908|P2|COMPLETED|Overall Study||671
2578454|NCT00391469|6324909|P1|COMPLETED|Overall Study|5 patients were found to be incarcerated at time of randomization, thus data was not included|688
2578455|NCT00391469|6324908|P2|STARTED|Overall Study||671
2578456|NCT00391469|6324909|P1|STARTED|Overall Study||688
2578457|NCT00391443|6324923|P2|NOT COMPLETED|Overall Study||0
2578458|NCT00391443|6324924|P1|NOT COMPLETED|Overall Study||0
2578459|NCT00391443|6324923|P2|COMPLETED|Overall Study||407
2578460|NCT00391443|6324924|P1|COMPLETED|Overall Study||209
2578461|NCT00391443|6324923|P2|STARTED|Overall Study||407
2578462|NCT00391443|6324924|P1|STARTED|Overall Study|1 patient in the bosentan arm did not receive treatment & was excluded from the Safety Population.|209
2578463|NCT00391391|6324936|P4|NOT COMPLETED|Overall Study||19
2578464|NCT00391391|6324937|P3|NOT COMPLETED|Overall Study||23
2578465|NCT00391391|6324938|P2|NOT COMPLETED|Overall Study||10
2578466|NCT00391391|6324939|P1|NOT COMPLETED|Overall Study||9
2578467|NCT00391391|6324936|P4|COMPLETED|Overall Study||145
2578468|NCT00391391|6324937|P3|COMPLETED|Overall Study||138
2578469|NCT00391391|6324938|P2|COMPLETED|Overall Study||87
2578470|NCT00391391|6324939|P1|COMPLETED|Overall Study||89
2578471|NCT00391391|6324936|P4|STARTED|Overall Study|1 participant was not vaccinated.|164
2578472|NCT00391391|6324937|P3|STARTED|Overall Study|1 participant was not vaccinated.|161
2578473|NCT00391391|6324938|P2|STARTED|Overall Study||97
2578474|NCT00391391|6324939|P1|STARTED|Overall Study|1 participant was not vaccinated.|98
2578475|NCT00391365|6324971|P2|NOT COMPLETED|Overall Study||19
2578476|NCT00391365|6324972|P1|NOT COMPLETED|Overall Study||25
2578477|NCT00391365|6324971|P2|COMPLETED|Overall Study||151
2578478|NCT00391365|6324972|P1|COMPLETED|Overall Study||78
2578479|NCT00391365|6324971|P2|STARTED|Overall Study||170
2578480|NCT00391365|6324972|P1|STARTED|Overall Study||103
2578481|NCT00391274|6324984|P2|NOT COMPLETED|Overall Study||57
2578482|NCT00391274|6324985|P1|NOT COMPLETED|Overall Study||61
2578483|NCT00391274|6324984|P2|COMPLETED|Overall Study||47
2578484|NCT00391274|6324985|P1|COMPLETED|Overall Study||46
2578485|NCT00391274|6324984|P2|Received at Least One Dose of Study Drug|Overall Study||102
2578486|NCT00391274|6324985|P1|Received at Least One Dose of Study Drug|Overall Study||106
2578487|NCT00391274|6324984|P2|STARTED|Overall Study||104
2578488|NCT00391274|6324985|P1|STARTED|Overall Study||107
2578489|NCT00391222|6325004|P4|NOT COMPLETED|Period III (Double-Blind Treatment)||0
2578490|NCT00391222|6325005|P3|NOT COMPLETED|Period III (Double-Blind Treatment)||23
2578491|NCT00391222|6325006|P2|NOT COMPLETED|Period III (Double-Blind Treatment)||22
2578492|NCT00391222|6325007|P1|NOT COMPLETED|Period III (Double-Blind Treatment)||28
2578493|NCT00391222|6325004|P4|COMPLETED|Period III (Double-Blind Treatment)||0
2578494|NCT00391222|6325005|P3|COMPLETED|Period III (Double-Blind Treatment)||108
2578495|NCT00391222|6325006|P2|COMPLETED|Period III (Double-Blind Treatment)||113
2578496|NCT00391222|6325007|P1|COMPLETED|Period III (Double-Blind Treatment)||104
2578497|NCT00391222|6325004|P4|STARTED|Period III (Double-Blind Treatment)||0
2578498|NCT00391222|6325005|P3|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|131
2578499|NCT00391222|6325006|P2|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|135
2578500|NCT00391222|6325007|P1|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|132
2578501|NCT00391222|6325004|P4|NOT COMPLETED|Period II (Open-label Risperidone LAI)||162
2578502|NCT00391222|6325005|P3|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
2578588|NCT00390780|6325342|P2|STARTED|Overall Study||287
2578503|NCT00391222|6325006|P2|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
2578504|NCT00391222|6325007|P1|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
2578505|NCT00391222|6325004|P4|COMPLETED|Period II (Open-label Risperidone LAI)||398
2578506|NCT00391222|6325005|P3|COMPLETED|Period II (Open-label Risperidone LAI)||0
2578507|NCT00391222|6325006|P2|COMPLETED|Period II (Open-label Risperidone LAI)||0
2578508|NCT00391222|6325007|P1|COMPLETED|Period II (Open-label Risperidone LAI)||0
2578509|NCT00391222|6325004|P4|STARTED|Period II (Open-label Risperidone LAI)|The 25 patients at the site of Dr. Parikh were excluded from the analysis due to GCP non-compliance|560
2578510|NCT00391222|6325005|P3|STARTED|Period II (Open-label Risperidone LAI)||0
2578511|NCT00391222|6325006|P2|STARTED|Period II (Open-label Risperidone LAI)||0
2578512|NCT00391222|6325007|P1|STARTED|Period II (Open-label Risperidone LAI)||0
2578513|NCT00391092|6325033|P2|NOT COMPLETED|Overall Study||216
2578514|NCT00391092|6325034|P1|NOT COMPLETED|Overall Study||208
2578515|NCT00391092|6325033|P2|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
2578516|NCT00391092|6325034|P1|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
2578517|NCT00391092|6325033|P2|Received Treatment|Overall Study||215
2578518|NCT00391092|6325034|P1|Received Treatment|Overall Study||206
2578519|NCT00391092|6325033|P2|STARTED|Overall Study||216
2578520|NCT00391092|6325034|P1|STARTED|Overall Study||208
2578521|NCT00391079|6325054|P2|NOT COMPLETED|Overall Study||16
2578522|NCT00391079|6325055|P1|NOT COMPLETED|Overall Study||26
2578523|NCT00391079|6325054|P2|COMPLETED|Overall Study||156
2578524|NCT00391079|6325055|P1|COMPLETED|Overall Study||141
2578525|NCT00391079|6325054|P2|STARTED|Overall Study||172
2578526|NCT00391079|6325055|P1|STARTED|Overall Study||167
2578527|NCT00391053|6325077|P4|NOT COMPLETED|Overall Study||10
2578528|NCT00391053|6325078|P3|NOT COMPLETED|Overall Study||2
2578529|NCT00391053|6325079|P2|NOT COMPLETED|Overall Study||1
2578530|NCT00391053|6325080|P1|NOT COMPLETED|Overall Study||9
2578531|NCT00391053|6325077|P4|COMPLETED|Overall Study||1252
2578532|NCT00391053|6325078|P3|COMPLETED|Overall Study||868
2578533|NCT00391053|6325079|P2|COMPLETED|Overall Study||847
2578534|NCT00391053|6325080|P1|COMPLETED|Overall Study||848
2578535|NCT00391053|6325077|P4|STARTED|Overall Study||1262
2578536|NCT00391053|6325078|P3|STARTED|Overall Study||870
2578537|NCT00391053|6325079|P2|STARTED|Overall Study||848
2578538|NCT00391053|6325080|P1|STARTED|Overall Study||857
2578539|NCT00391027|6325104|P2|NOT COMPLETED|Overall Study||12
2578540|NCT00391027|6325105|P1|NOT COMPLETED|Overall Study||25
2578541|NCT00391027|6325104|P2|COMPLETED|Overall Study||110
2578542|NCT00391027|6325105|P1|COMPLETED|Overall Study||110
2578543|NCT00391027|6325104|P2|STARTED|Overall Study|Full Analysis Set = 121; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|122
2578544|NCT00391027|6325105|P1|STARTED|Overall Study|Full Analysis Set = 134; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|135
2578545|NCT00390949|6325145|P2|NOT COMPLETED|Overall Study||2128
2578546|NCT00390949|6325146|P1|NOT COMPLETED|Overall Study||2098
2578547|NCT00390949|6325145|P2|COMPLETED|Overall Study||2664
2578548|NCT00390949|6325146|P1|COMPLETED|Overall Study||2564
2578549|NCT00390949|6325145|P2|STARTED|Overall Study||4792
2578550|NCT00390949|6325146|P1|STARTED|Overall Study||4662
2578551|NCT00390910|6325155|P3|NOT COMPLETED|Overall Study||10
2578552|NCT00390910|6325156|P2|NOT COMPLETED|Overall Study||4
2578553|NCT00390910|6325157|P1|NOT COMPLETED|Overall Study||2
2578554|NCT00390910|6325155|P3|COMPLETED|Overall Study||139
2578555|NCT00390910|6325156|P2|COMPLETED|Overall Study||83
2578556|NCT00390910|6325157|P1|COMPLETED|Overall Study||48
2578557|NCT00390910|6325155|P3|STARTED|Overall Study||149
2578558|NCT00390910|6325156|P2|STARTED|Overall Study||87
2578559|NCT00390910|6325157|P1|STARTED|Overall Study||50
2578560|NCT00390884|6325245|P2|NOT COMPLETED|Overall Study||2
2578561|NCT00390884|6325246|P1|NOT COMPLETED|Overall Study||2
2578562|NCT00390884|6325245|P2|COMPLETED|Overall Study||55
2578563|NCT00390884|6325246|P1|COMPLETED|Overall Study||114
2578564|NCT00390884|6325245|P2|STARTED|Overall Study||57
2578565|NCT00390884|6325246|P1|STARTED|Overall Study||116
2578566|NCT00390858|6325258|P2|NOT COMPLETED|Overall Study||7
2578567|NCT00390858|6325259|P1|NOT COMPLETED|Overall Study||9
2578568|NCT00390858|6325258|P2|COMPLETED|Overall Study|13 Participants completed the Extension Study|13
2578569|NCT00390858|6325259|P1|COMPLETED|Overall Study|11 participants Completed the Extension Study|11
2578570|NCT00390858|6325258|P2|Completed Core & Entered Extension Study|Overall Study||20
2578571|NCT00390858|6325259|P1|Completed Core & Entered Extension Study|Overall Study||19
2578572|NCT00390858|6325258|P2|STARTED|Overall Study|20 Participants started the Core Study|20
2578573|NCT00390858|6325259|P1|STARTED|Overall Study|20 participants started the Core Study|20
2578574|NCT00390806|6325273|P2|NOT COMPLETED|Overall Study||32
2578575|NCT00390806|6325274|P1|NOT COMPLETED|Overall Study||30
2578576|NCT00390806|6325273|P2|COMPLETED|Overall Study||204
2578577|NCT00390806|6325274|P1|COMPLETED|Overall Study||206
2578578|NCT00390806|6325273|P2|Ongoing|Overall Study||2
2578579|NCT00390806|6325274|P1|Ongoing|Overall Study||4
2578580|NCT00390806|6325273|P2|STARTED|Overall Study||236
2578581|NCT00390806|6325274|P1|STARTED|Overall Study||236
2578582|NCT00390780|6325342|P2|NOT COMPLETED|Overall Study||27
2578583|NCT00390780|6325343|P1|NOT COMPLETED|Overall Study||23
2578584|NCT00390780|6325342|P2|COMPLETED|Overall Study||260
2578585|NCT00390780|6325343|P1|COMPLETED|Overall Study||268
2578586|NCT00390780|6325342|P2|Treatment|Overall Study||287
2578587|NCT00390780|6325343|P1|Treatment|Overall Study|One patient randomized to miconazole lost study drug, never started treatment, and was discontinued.|290
2578589|NCT00390780|6325343|P1|STARTED|Overall Study||291
2578590|NCT00390689|6325376|P3|NOT COMPLETED|Overall Study||3
2578591|NCT00390689|6325377|P2|NOT COMPLETED|Overall Study||5
2578592|NCT00390689|6325378|P1|NOT COMPLETED|Overall Study||5
2578593|NCT00390689|6325376|P3|COMPLETED|Overall Study||50
2578594|NCT00390689|6325377|P2|COMPLETED|Overall Study||48
2578595|NCT00390689|6325378|P1|COMPLETED|Overall Study||43
2578596|NCT00390689|6325376|P3|STARTED|Overall Study||53
2578597|NCT00390689|6325377|P2|STARTED|Overall Study||53
2578598|NCT00390689|6325378|P1|STARTED|Overall Study||48
2578599|NCT00390611|6325438|P2|NOT COMPLETED|Maintenance Sorafenib to Month 12||0
2578600|NCT00390611|6325439|P1|NOT COMPLETED|Maintenance Sorafenib to Month 12||10
2578601|NCT00390611|6325438|P2|COMPLETED|Maintenance Sorafenib to Month 12||0
2578602|NCT00390611|6325439|P1|COMPLETED|Maintenance Sorafenib to Month 12||13
2578603|NCT00390611|6325438|P2|STARTED|Maintenance Sorafenib to Month 12|Patients in the Paclitaxel/carboplatin arm did not recieve maintenance sorafenib|0
2578604|NCT00390611|6325439|P1|STARTED|Maintenance Sorafenib to Month 12|11 patients came off-study between the end of cycle 6 and the start of maintenance|23
2578605|NCT00390611|6325438|P2|NOT COMPLETED|6 Cycles of Study Treatment||5
2578606|NCT00390611|6325439|P1|NOT COMPLETED|6 Cycles of Study Treatment||9
2578607|NCT00390611|6325438|P2|COMPLETED|6 Cycles of Study Treatment||37
2578608|NCT00390611|6325439|P1|COMPLETED|6 Cycles of Study Treatment||34
2578609|NCT00390611|6325438|P2|STARTED|6 Cycles of Study Treatment||42
2578610|NCT00390611|6325439|P1|STARTED|6 Cycles of Study Treatment||43
2578611|NCT00390572|6325453|P2|NOT COMPLETED|Overall Study||5
2578612|NCT00390572|6325454|P1|NOT COMPLETED|Overall Study||8
2578613|NCT00390572|6325453|P2|COMPLETED|Overall Study||64
2578614|NCT00390572|6325454|P1|COMPLETED|Overall Study||60
2578615|NCT00390572|6325453|P2|STARTED|Overall Study||69
2578616|NCT00390572|6325454|P1|STARTED|Overall Study||68
2578617|NCT00390559|6325468|P1|NOT COMPLETED|Overall Study||44
2578618|NCT00390559|6325468|P1|COMPLETED|Overall Study||80
2578619|NCT00390559|6325468|P1|ActiveP/PlaceboC|Overall Study||90
2578620|NCT00390559|6325468|P1|PlaceboP/PlaceboC|Overall Study||93
2578621|NCT00390559|6325468|P1|ActiveP/ActiveC|Overall Study||87
2578622|NCT00390559|6325468|P1|Received PlaceboP/Active C|Overall Study||93
2578623|NCT00390559|6325468|P1|STARTED|Overall Study||124
2578624|NCT00390546|6325480|P2|NOT COMPLETED|Overall Study||5
2578625|NCT00390546|6325481|P1|NOT COMPLETED|Overall Study||6
2578626|NCT00390546|6325480|P2|COMPLETED|Overall Study||34
2578627|NCT00390546|6325481|P1|COMPLETED|Overall Study||27
2578628|NCT00390546|6325480|P2|STARTED|Overall Study||39
2578629|NCT00390546|6325481|P1|STARTED|Overall Study||33
2578630|NCT00390468|6325491|P1|NOT COMPLETED|Overall Study||3
2578631|NCT00390468|6325491|P1|COMPLETED|Overall Study||15
2578632|NCT00390468|6325491|P1|STARTED|Overall Study||18
2578633|NCT00390455|6325497|P2|NOT COMPLETED|Overall Study||23
2578634|NCT00390455|6325498|P1|NOT COMPLETED|Overall Study||32
2578635|NCT00390455|6325497|P2|COMPLETED|Overall Study||124
2578636|NCT00390455|6325498|P1|COMPLETED|Overall Study||116
2578637|NCT00390455|6325497|P2|STARTED|Overall Study||147
2578638|NCT00390455|6325498|P1|STARTED|Overall Study||148
2578639|NCT00390429|6325519|P4|NOT COMPLETED|Overall Study||0
2578640|NCT00390429|6325520|P3|NOT COMPLETED|Overall Study||0
2578641|NCT00390429|6325521|P2|NOT COMPLETED|Overall Study||0
2578642|NCT00390429|6325522|P1|NOT COMPLETED|Overall Study||0
2578643|NCT00390429|6325519|P4|COMPLETED|Overall Study||39
2578644|NCT00390429|6325520|P3|COMPLETED|Overall Study||25
2578645|NCT00390429|6325521|P2|COMPLETED|Overall Study||12
2578646|NCT00390429|6325522|P1|COMPLETED|Overall Study||5
2578647|NCT00390429|6325519|P4|STARTED|Overall Study||39
2578648|NCT00390429|6325520|P3|STARTED|Overall Study||25
2578649|NCT00390429|6325521|P2|STARTED|Overall Study||12
2578650|NCT00390429|6325522|P1|STARTED|Overall Study||5
2578651|NCT00390416|6325543|P1|NOT COMPLETED|Overall Study||4
2578652|NCT00390416|6325543|P1|COMPLETED|Overall Study||44
2578653|NCT00390416|6325543|P1|STARTED|Overall Study||48
2578654|NCT00390364|6325549|P1|NOT COMPLETED|Overall Study||0
2578655|NCT00390364|6325549|P1|COMPLETED|Overall Study||1
2578656|NCT00390364|6325549|P1|STARTED|Overall Study||1
2578663|NCT00390299|6325581|P5|NOT COMPLETED|Overall Study||0
2578664|NCT00390299|6325582|P4|NOT COMPLETED|Overall Study||0
2578665|NCT00390299|6325583|P3|NOT COMPLETED|Overall Study||0
2578666|NCT00390299|6325584|P2|NOT COMPLETED|Overall Study||0
2578667|NCT00390299|6325585|P1|NOT COMPLETED|Overall Study||1
2578668|NCT00390299|6325581|P5|COMPLETED|Overall Study||10
2578669|NCT00390299|6325582|P4|COMPLETED|Overall Study||3
2578670|NCT00390299|6325583|P3|COMPLETED|Overall Study||3
2578671|NCT00390299|6325584|P2|COMPLETED|Overall Study||3
2578672|NCT00390299|6325585|P1|COMPLETED|Overall Study||3
2578673|NCT00390299|6325581|P5|STARTED|Overall Study||10
2578674|NCT00390299|6325582|P4|STARTED|Overall Study||3
2578675|NCT00390299|6325583|P3|STARTED|Overall Study||3
2578676|NCT00390299|6325584|P2|STARTED|Overall Study||3
2578677|NCT00390299|6325585|P1|STARTED|Overall Study||4
2578678|NCT00390234|6325605|P1|NOT COMPLETED|Overall Study||0
2578679|NCT00390234|6325605|P1|COMPLETED|Overall Study||63
2578680|NCT00390234|6325605|P1|STARTED|Overall Study||63
2578681|NCT00390221|6325616|P3|NOT COMPLETED|Overall Study||15
2578682|NCT00390221|6325617|P2|NOT COMPLETED|Overall Study||20
2578683|NCT00390221|6325618|P1|NOT COMPLETED|Overall Study||18
2578684|NCT00390221|6325616|P3|COMPLETED|Overall Study||194
2578685|NCT00390221|6325617|P2|COMPLETED|Overall Study||188
2578686|NCT00390221|6325618|P1|COMPLETED|Overall Study||186
2578687|NCT00390221|6325616|P3|STARTED|Overall Study||209
2578688|NCT00390221|6325617|P2|STARTED|Overall Study||208
2578689|NCT00390221|6325618|P1|STARTED|Overall Study||204
2578690|NCT00390182|6325639|P1|NOT COMPLETED|Overall Study||5
2578691|NCT00390182|6325639|P1|COMPLETED|Overall Study||33
2578692|NCT00390182|6325639|P1|STARTED|Overall Study||38
2578693|NCT00390013|6325648|P4|NOT COMPLETED|Phase 2 Second Treatment||0
2578694|NCT00390013|6325649|P3|NOT COMPLETED|Phase 2 Second Treatment||0
2578695|NCT00390013|6325650|P2|NOT COMPLETED|Phase 2 Second Treatment||0
2578696|NCT00390013|6325651|P1|NOT COMPLETED|Phase 2 Second Treatment||0
2578697|NCT00390013|6325648|P4|COMPLETED|Phase 2 Second Treatment||0
2578698|NCT00390013|6325649|P3|COMPLETED|Phase 2 Second Treatment||0
2578699|NCT00390013|6325650|P2|COMPLETED|Phase 2 Second Treatment||1
2578700|NCT00390013|6325651|P1|COMPLETED|Phase 2 Second Treatment||2
2578701|NCT00390013|6325648|P4|STARTED|Phase 2 Second Treatment||0
2578702|NCT00390013|6325649|P3|STARTED|Phase 2 Second Treatment||0
2578703|NCT00390013|6325650|P2|STARTED|Phase 2 Second Treatment||1
2578704|NCT00390013|6325651|P1|STARTED|Phase 2 Second Treatment||2
2578705|NCT00390013|6325648|P4|NOT COMPLETED|Phase 2 First Treatment||0
2578706|NCT00390013|6325649|P3|NOT COMPLETED|Phase 2 First Treatment||0
2578707|NCT00390013|6325650|P2|NOT COMPLETED|Phase 2 First Treatment||1
2578708|NCT00390013|6325651|P1|NOT COMPLETED|Phase 2 First Treatment||1
2578709|NCT00390013|6325648|P4|COMPLETED|Phase 2 First Treatment||0
2578710|NCT00390013|6325649|P3|COMPLETED|Phase 2 First Treatment||0
2578711|NCT00390013|6325650|P2|COMPLETED|Phase 2 First Treatment||1
2578712|NCT00390013|6325651|P1|COMPLETED|Phase 2 First Treatment||2
2578713|NCT00390013|6325648|P4|STARTED|Phase 2 First Treatment||0
2578714|NCT00390013|6325649|P3|STARTED|Phase 2 First Treatment||0
2578715|NCT00390013|6325650|P2|STARTED|Phase 2 First Treatment||2
2578716|NCT00390013|6325651|P1|STARTED|Phase 2 First Treatment||3
2578717|NCT00390013|6325648|P4|NOT COMPLETED|Phase 1||1
2578718|NCT00390013|6325649|P3|NOT COMPLETED|Phase 1||0
2578719|NCT00390013|6325650|P2|NOT COMPLETED|Phase 1||0
2578720|NCT00390013|6325651|P1|NOT COMPLETED|Phase 1||0
2578721|NCT00390013|6325648|P4|COMPLETED|Phase 1||1
2578722|NCT00390013|6325649|P3|COMPLETED|Phase 1||2
2578723|NCT00390013|6325650|P2|COMPLETED|Phase 1||0
2578724|NCT00390013|6325651|P1|COMPLETED|Phase 1||0
2578725|NCT00390013|6325648|P4|STARTED|Phase 1||2
2578726|NCT00390013|6325649|P3|STARTED|Phase 1||2
2578727|NCT00390013|6325650|P2|STARTED|Phase 1||0
2578728|NCT00390013|6325651|P1|STARTED|Phase 1||0
2578729|NCT00389974|6325657|P1|NOT COMPLETED|Overall Study||0
2578730|NCT00389974|6325657|P1|COMPLETED|Overall Study||19
2578731|NCT00389974|6325657|P1|STARTED|Overall Study||19
2578732|NCT00389857|6325663|P2|NOT COMPLETED|Overall Study||0
2578733|NCT00389857|6325664|P1|NOT COMPLETED|Overall Study||0
2578734|NCT00389857|6325663|P2|COMPLETED|Overall Study||17
2578735|NCT00389857|6325664|P1|COMPLETED|Overall Study||14
2578736|NCT00389857|6325663|P2|STARTED|Overall Study||17
2578737|NCT00389857|6325664|P1|STARTED|Overall Study||14
2578738|NCT00389831|6325676|P2|NOT COMPLETED|Overall Study||7
2578739|NCT00389831|6325677|P1|NOT COMPLETED|Overall Study||0
2578740|NCT00389831|6325676|P2|COMPLETED|Overall Study||27
2578741|NCT00389831|6325677|P1|COMPLETED|Overall Study||10
2578742|NCT00389831|6325676|P2|STARTED|Overall Study||34
2578743|NCT00389831|6325677|P1|STARTED|Overall Study||10
2578744|NCT00389818|6325703|P1|NOT COMPLETED|Overall Study||3
2578745|NCT00389818|6325703|P1|COMPLETED|Overall Study||40
2578746|NCT00389818|6325703|P1|STARTED|Overall Study||43
2578747|NCT00389805|6325709|P2|NOT COMPLETED|Phase II||0
2578748|NCT00389805|6325710|P1|NOT COMPLETED|Phase II||0
2578749|NCT00389805|6325709|P2|COMPLETED|Phase II||0
2578750|NCT00389805|6325710|P1|COMPLETED|Phase II||0
2578751|NCT00389805|6325709|P2|STARTED|Phase II|The Phase II study was not conducted.|0
2578752|NCT00389805|6325710|P1|STARTED|Phase II|The Phase II study was not conducted.|0
2578753|NCT00389805|6325709|P2|NOT COMPLETED|Phase I||0
2578754|NCT00389805|6325710|P1|NOT COMPLETED|Phase I||0
2578755|NCT00389805|6325709|P2|COMPLETED|Phase I||12
2578756|NCT00389805|6325710|P1|COMPLETED|Phase I||15
2578757|NCT00389805|6325709|P2|STARTED|Phase I||12
2578758|NCT00389805|6325710|P1|STARTED|Phase I||15
2578759|NCT00389597|6325740|P4|NOT COMPLETED|Overall Study||6
2578760|NCT00389597|6325741|P3|NOT COMPLETED|Overall Study||4
2578761|NCT00389597|6325742|P2|NOT COMPLETED|Overall Study||6
2578762|NCT00389597|6325743|P1|NOT COMPLETED|Overall Study||8
2578763|NCT00389597|6325740|P4|COMPLETED|Overall Study||99
2578764|NCT00389597|6325741|P3|COMPLETED|Overall Study||221
2578765|NCT00389597|6325742|P2|COMPLETED|Overall Study||75
2578766|NCT00389597|6325743|P1|COMPLETED|Overall Study||156
2578767|NCT00389597|6325740|P4|24 mo|Overall Study||99
2578768|NCT00389597|6325741|P3|24 mo|Overall Study||221
2578769|NCT00389597|6325742|P2|24 mo|Overall Study||75
2578770|NCT00389597|6325743|P1|24 mo|Overall Study||156
2578771|NCT00389597|6325740|P4|STARTED|Overall Study||105
2578772|NCT00389597|6325741|P3|STARTED|Overall Study||225
2578773|NCT00389597|6325742|P2|STARTED|Overall Study||81
2578774|NCT00389597|6325743|P1|STARTED|Overall Study||164
2578775|NCT00389532|6325755|P2|NOT COMPLETED|Overall Study||0
2578776|NCT00389532|6325756|P1|NOT COMPLETED|Overall Study||0
2578777|NCT00389532|6325755|P2|COMPLETED|Overall Study||56
2578778|NCT00389532|6325756|P1|COMPLETED|Overall Study|3 of the participants did not have valid post-vaccination serological results|60
2578779|NCT00389532|6325755|P2|STARTED|Overall Study||56
2578780|NCT00389532|6325756|P1|STARTED|Overall Study||60
2578781|NCT00389519|6325768|P4|NOT COMPLETED|Treated||4
2578782|NCT00389519|6325769|P3|NOT COMPLETED|Treated||0
2578783|NCT00389519|6325770|P2|NOT COMPLETED|Treated||1
2578784|NCT00389519|6325771|P1|NOT COMPLETED|Treated||2
2578785|NCT00389519|6325768|P4|COMPLETED|Treated||76
2578786|NCT00389519|6325769|P3|COMPLETED|Treated||40
2578787|NCT00389519|6325770|P2|COMPLETED|Treated||40
2578788|NCT00389519|6325771|P1|COMPLETED|Treated||79
2578789|NCT00389519|6325768|P4|STARTED|Treated||80
2578790|NCT00389519|6325769|P3|STARTED|Treated||40
2578791|NCT00389519|6325770|P2|STARTED|Treated||41
2578792|NCT00389519|6325771|P1|STARTED|Treated||81
2578793|NCT00389519|6325768|P4|NOT COMPLETED|Randomized||0
2578794|NCT00389519|6325769|P3|NOT COMPLETED|Randomized||0
2578795|NCT00389519|6325770|P2|NOT COMPLETED|Randomized||0
2578796|NCT00389519|6325771|P1|NOT COMPLETED|Randomized||2
2578797|NCT00389519|6325768|P4|COMPLETED|Randomized||80
2578798|NCT00389519|6325769|P3|COMPLETED|Randomized||40
2578799|NCT00389519|6325770|P2|COMPLETED|Randomized||41
2578800|NCT00389519|6325771|P1|COMPLETED|Randomized||81
2578801|NCT00389519|6325768|P4|STARTED|Randomized||80
2578802|NCT00389519|6325769|P3|STARTED|Randomized||40
2578803|NCT00389519|6325770|P2|STARTED|Randomized||41
2578804|NCT00389519|6325771|P1|STARTED|Randomized||83
2578805|NCT00389519|6325768|P4|NOT COMPLETED|Placebo Run-In||0
2578806|NCT00389519|6325769|P3|NOT COMPLETED|Placebo Run-In||0
2578807|NCT00389519|6325770|P2|NOT COMPLETED|Placebo Run-In||0
2578808|NCT00389519|6325771|P1|NOT COMPLETED|Placebo Run-In||178
2578809|NCT00389519|6325768|P4|COMPLETED|Placebo Run-In||0
2578810|NCT00389519|6325769|P3|COMPLETED|Placebo Run-In||0
2578811|NCT00389519|6325770|P2|COMPLETED|Placebo Run-In||0
2578812|NCT00389519|6325771|P1|COMPLETED|Placebo Run-In||244
2578813|NCT00389519|6325768|P4|STARTED|Placebo Run-In||0
2578814|NCT00389519|6325769|P3|STARTED|Placebo Run-In||0
2578815|NCT00389519|6325770|P2|STARTED|Placebo Run-In||0
2578816|NCT00389519|6325771|P1|STARTED|Placebo Run-In||422
2578817|NCT00389493|6325800|P3|NOT COMPLETED|Overall Study||3
2578818|NCT00389493|6325801|P2|NOT COMPLETED|Overall Study||8
2578819|NCT00389493|6325802|P1|NOT COMPLETED|Overall Study||3
2578820|NCT00389493|6325800|P3|COMPLETED|Overall Study||17
2578821|NCT00389493|6325801|P2|COMPLETED|Overall Study||32
2578822|NCT00389493|6325802|P1|COMPLETED|Overall Study||37
2578823|NCT00389493|6325800|P3|STARTED|Overall Study||20
2578824|NCT00389493|6325801|P2|STARTED|Overall Study||40
2578825|NCT00389493|6325802|P1|STARTED|Overall Study||40
2578826|NCT00389467|6325826|P4|NOT COMPLETED|Overall Study||0
2578827|NCT00389467|6325827|P3|NOT COMPLETED|Overall Study||0
2578828|NCT00389467|6325828|P2|NOT COMPLETED|Overall Study||0
2578829|NCT00389467|6325829|P1|NOT COMPLETED|Overall Study||0
2578830|NCT00389467|6325826|P4|COMPLETED|Overall Study||20
2578831|NCT00389467|6325827|P3|COMPLETED|Overall Study||30
2578832|NCT00389467|6325828|P2|COMPLETED|Overall Study||34
2578833|NCT00389467|6325829|P1|COMPLETED|Overall Study||34
2578834|NCT00389467|6325826|P4|STARTED|Overall Study||20
2578835|NCT00389467|6325827|P3|STARTED|Overall Study||30
2578836|NCT00389467|6325828|P2|STARTED|Overall Study||34
2578837|NCT00389467|6325829|P1|STARTED|Overall Study||34
2578838|NCT00389441|6325848|P1|NOT COMPLETED|Overall Study||52
2578839|NCT00389441|6325848|P1|COMPLETED|Overall Study||0
2578840|NCT00389441|6325848|P1|STARTED|Overall Study||52
2578841|NCT00389324|6325857|P1|NOT COMPLETED|Subcutaneous Phase||7
2578842|NCT00389324|6325857|P1|COMPLETED|Subcutaneous Phase||25
2578843|NCT00389324|6325857|P1|STARTED|Subcutaneous Phase||32
2578844|NCT00389324|6325857|P1|NOT COMPLETED|Intravenous Phase||0
2578845|NCT00389324|6325857|P1|COMPLETED|Intravenous Phase||32
2578846|NCT00389324|6325857|P1|STARTED|Intravenous Phase|18 subjects entered from the Run-in Phase and 14 new participants entered directly|32
2578847|NCT00389324|6325857|P1|NOT COMPLETED|Run-In Phase||3
2578848|NCT00389324|6325857|P1|COMPLETED|Run-In Phase||18
2578849|NCT00389324|6325857|P1|STARTED|Run-In Phase||21
2578850|NCT00389207|6325867|P3|NOT COMPLETED|Overall Study||41
2578851|NCT00389207|6325868|P2|NOT COMPLETED|Overall Study||72
2578852|NCT00389207|6325869|P1|NOT COMPLETED|Overall Study||63
2578853|NCT00389207|6325867|P3|COMPLETED|Overall Study||152
2578854|NCT00389207|6325868|P2|COMPLETED|Overall Study||116
2578855|NCT00389207|6325869|P1|COMPLETED|Overall Study||125
2578856|NCT00389207|6325867|P3|STARTED|Overall Study||193
2578857|NCT00389207|6325868|P2|STARTED|Overall Study|4 patients were randomized to NVP BID but not treated and so are not part of the FAS|188
2578858|NCT00389207|6325869|P1|STARTED|Overall Study|3 patients were randomized to NVP QD but not treated and so not part of the Full Analysis Set (FAS)|188
2578859|NCT00389168|6325973|P2|NOT COMPLETED|Overall Study||5
2578860|NCT00389168|6325974|P1|NOT COMPLETED|Overall Study||9
2578861|NCT00389168|6325973|P2|COMPLETED|Overall Study||53
2578862|NCT00389168|6325974|P1|COMPLETED|Overall Study||47
2578863|NCT00389168|6325973|P2|STARTED|Overall Study||58
2578864|NCT00389168|6325974|P1|STARTED|Overall Study||56
2578865|NCT00389064|6325992|P2|NOT COMPLETED|Overall Study||59
2578866|NCT00389064|6325993|P1|NOT COMPLETED|Overall Study||45
2578867|NCT00389064|6325992|P2|COMPLETED|Overall Study||168
2578868|NCT00389064|6325993|P1|COMPLETED|Overall Study||178
2578869|NCT00389064|6325992|P2|STARTED|Overall Study||227
2578870|NCT00389064|6325993|P1|STARTED|Overall Study||223
2578871|NCT00388973|6326021|P2|NOT COMPLETED|Overall Study||58
2578872|NCT00388973|6326022|P1|NOT COMPLETED|Overall Study||56
2578873|NCT00388973|6326021|P2|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|114
2578874|NCT00388973|6326022|P1|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|110
2578875|NCT00388973|6326021|P2|Completed Study|Overall Study||114
2578876|NCT00388973|6326022|P1|Completed Study|Overall Study||110
2578877|NCT00388973|6326021|P2|STARTED|Overall Study|Randomized|172
2578878|NCT00388973|6326022|P1|STARTED|Overall Study|Randomized|166
2578879|NCT00388947|6326042|P1|NOT COMPLETED|Overall Study||47
2578880|NCT00388947|6326042|P1|COMPLETED|Overall Study|47 patients excluded because no AMS prolapse device was noted.|1543
2578881|NCT00388947|6326042|P1|STARTED|Overall Study||1590
2578882|NCT00388804|6326049|P2|NOT COMPLETED|Overall Study||0
2578883|NCT00388804|6326050|P1|NOT COMPLETED|Overall Study||0
2578884|NCT00388804|6326049|P2|COMPLETED|Overall Study||21
2578885|NCT00388804|6326050|P1|COMPLETED|Overall Study||17
2578886|NCT00388804|6326049|P2|STARTED|Overall Study||21
2578887|NCT00388804|6326050|P1|STARTED|Overall Study||17
2578888|NCT00388726|6326058|P2|NOT COMPLETED|Overall Study||244
2578889|NCT00388726|6326059|P1|NOT COMPLETED|Overall Study||484
2578890|NCT00388726|6326058|P2|COMPLETED|Overall Study||10
2578891|NCT00388726|6326059|P1|COMPLETED|Overall Study||24
2578892|NCT00388726|6326058|P2|STARTED|Overall Study||254
2578893|NCT00388726|6326059|P1|STARTED|Overall Study||508
2578894|NCT00388674|6326075|P2|NOT COMPLETED|End of Study||2169
2578895|NCT00388674|6326076|P1|NOT COMPLETED|End of Study||1734
2578896|NCT00388674|6326075|P2|COMPLETED|End of Study|Completed=Reason of ‘other: end of study’|3993
2578897|NCT00388674|6326076|P1|COMPLETED|End of Study|Completed=Reason of ‘other: end of study’|4482
2578898|NCT00388674|6326075|P2|STARTED|End of Study||6162
2578899|NCT00388674|6326076|P1|STARTED|End of Study||6216
2578900|NCT00388674|6326075|P2|NOT COMPLETED|Initial Treatment||2586
2578901|NCT00388674|6326076|P1|NOT COMPLETED|Initial Treatment||1828
2578902|NCT00388674|6326075|P2|COMPLETED|Initial Treatment|Completed=discontinued initial treatment reason of “successful treatment” or “end of study”|3576
2578903|NCT00388674|6326076|P1|COMPLETED|Initial Treatment|Completed=Reason of ‘successful treatment’, ‘other: successful treatment’ or ‘other: end of study’|4388
2578904|NCT00388674|6326075|P2|STARTED|Initial Treatment||6162
2578905|NCT00388674|6326076|P1|STARTED|Initial Treatment||6216
2578906|NCT00388583|6326094|P2|NOT COMPLETED|Overall Study||4
2578907|NCT00388583|6326095|P1|NOT COMPLETED|Overall Study||6
2578908|NCT00388583|6326094|P2|COMPLETED|Overall Study||406
2578909|NCT00388583|6326095|P1|COMPLETED|Overall Study||401
2578910|NCT00388583|6326094|P2|STARTED|Overall Study||410
2578911|NCT00388583|6326095|P1|STARTED|Overall Study||407
2578912|NCT00388505|6326109|P2|NOT COMPLETED|Overall Study||38
2578913|NCT00388505|6326110|P1|NOT COMPLETED|Overall Study||83
2578914|NCT00388505|6326109|P2|COMPLETED|Overall Study||171
2578915|NCT00388505|6326110|P1|COMPLETED|Overall Study||225
2578916|NCT00388505|6326109|P2|STARTED|Overall Study|Randomized patients who received any amount of study medication|209
2578917|NCT00388505|6326110|P1|STARTED|Overall Study|Randomized patients who received any amount of study medication|308
2578918|NCT00388453|6326135|P3|NOT COMPLETED|Overall Study||0
2578919|NCT00388453|6326136|P2|NOT COMPLETED|Overall Study||0
2578920|NCT00388453|6326137|P1|NOT COMPLETED|Overall Study||0
2578921|NCT00388453|6326135|P3|COMPLETED|Overall Study||10
2578922|NCT00388453|6326136|P2|COMPLETED|Overall Study||17
2578923|NCT00388453|6326137|P1|COMPLETED|Overall Study||20
2578924|NCT00388453|6326135|P3|STARTED|Overall Study||10
2578925|NCT00388453|6326136|P2|STARTED|Overall Study||17
2578926|NCT00388453|6326137|P1|STARTED|Overall Study||20
2578927|NCT00388414|6326156|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
2578928|NCT00388414|6326157|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
2578929|NCT00388414|6326156|P2|COMPLETED|Second Intervention (8 Weeks)||7
2578930|NCT00388414|6326157|P1|COMPLETED|Second Intervention (8 Weeks)||7
2578931|NCT00388414|6326156|P2|STARTED|Second Intervention (8 Weeks)||7
2578932|NCT00388414|6326157|P1|STARTED|Second Intervention (8 Weeks)||7
2578933|NCT00388414|6326156|P2|NOT COMPLETED|Washout (1 Week)||0
2578934|NCT00388414|6326157|P1|NOT COMPLETED|Washout (1 Week)||0
2578935|NCT00388414|6326156|P2|COMPLETED|Washout (1 Week)||7
2578936|NCT00388414|6326157|P1|COMPLETED|Washout (1 Week)||7
2578937|NCT00388414|6326156|P2|STARTED|Washout (1 Week)||7
2578938|NCT00388414|6326157|P1|STARTED|Washout (1 Week)||7
2578939|NCT00388414|6326156|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
2578940|NCT00388414|6326157|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
2578941|NCT00388414|6326156|P2|COMPLETED|First Intervention (8 Weeks)||7
2578942|NCT00388414|6326157|P1|COMPLETED|First Intervention (8 Weeks)||7
2578943|NCT00388414|6326156|P2|STARTED|First Intervention (8 Weeks)||7
2578944|NCT00388414|6326157|P1|STARTED|First Intervention (8 Weeks)||7
2578945|NCT00388362|6326165|P1|NOT COMPLETED|Remained on Study Median of 514 Days||2
2578946|NCT00388362|6326165|P1|COMPLETED|Remained on Study Median of 514 Days||21
2578947|NCT00388362|6326165|P1|STARTED|Remained on Study Median of 514 Days||23
2578948|NCT00388362|6326165|P1|NOT COMPLETED|Enrolled||13
2578949|NCT00388362|6326165|P1|COMPLETED|Enrolled||23
2578950|NCT00388362|6326165|P1|STARTED|Enrolled||36
2578951|NCT00388349|6326170|P2|NOT COMPLETED|Phase 2 Dose Expansion||0
2578952|NCT00388349|6326171|P1|NOT COMPLETED|Phase 2 Dose Expansion||0
2578953|NCT00388349|6326170|P2|COMPLETED|Phase 2 Dose Expansion||0
2578954|NCT00388349|6326171|P1|COMPLETED|Phase 2 Dose Expansion||139
2578955|NCT00388349|6326170|P2|STARTED|Phase 2 Dose Expansion|No participants were treated in Phase 2 at 1500 mg/m2 gemcitabine (MTD exceeded)|0
2578956|NCT00388349|6326171|P1|STARTED|Phase 2 Dose Expansion|Includes the three phase 1 participants who received 1250 mg/m2 gemcitabine (MTD)|139
2578957|NCT00388349|6326170|P2|NOT COMPLETED|Phase I Dose Escalation||3
2578958|NCT00388349|6326171|P1|NOT COMPLETED|Phase I Dose Escalation||0
2578959|NCT00388349|6326170|P2|COMPLETED|Phase I Dose Escalation||1
2578960|NCT00388349|6326171|P1|COMPLETED|Phase I Dose Escalation||3
2578961|NCT00388349|6326170|P2|STARTED|Phase I Dose Escalation||4
2578962|NCT00388349|6326171|P1|STARTED|Phase I Dose Escalation||3
2578963|NCT00388297|6326184|P4|NOT COMPLETED|Overall Study||8
2578964|NCT00388297|6326185|P3|NOT COMPLETED|Overall Study||11
2578965|NCT00388297|6326186|P2|NOT COMPLETED|Overall Study||12
2578966|NCT00388297|6326187|P1|NOT COMPLETED|Overall Study||16
2578967|NCT00388297|6326184|P4|COMPLETED|Overall Study||253
2578968|NCT00388297|6326185|P3|COMPLETED|Overall Study||254
2578969|NCT00388297|6326186|P2|COMPLETED|Overall Study||326
2578970|NCT00388297|6326187|P1|COMPLETED|Overall Study||323
2578971|NCT00388297|6326184|P4|STARTED|Overall Study||261
2578972|NCT00388297|6326185|P3|STARTED|Overall Study||265
2578973|NCT00388297|6326186|P2|STARTED|Overall Study||338
2578974|NCT00388297|6326187|P1|STARTED|Overall Study||339
2578975|NCT00388154|6326297|P1|NOT COMPLETED|Overall Study||1
2578976|NCT00388154|6326297|P1|COMPLETED|Overall Study||20
2578977|NCT00388154|6326297|P1|STARTED|Overall Study||21
2578978|NCT00388037|6326302|P1|NOT COMPLETED|Overall Study||1
2578979|NCT00388037|6326302|P1|COMPLETED|Overall Study||30
2578980|NCT00388037|6326302|P1|STARTED|Overall Study||31
2578981|NCT00387959|6326306|P1|NOT COMPLETED|Overall Study||1
2578982|NCT00387959|6326306|P1|COMPLETED|Overall Study||16
2578983|NCT00387959|6326306|P1|STARTED|Overall Study||17
2578984|NCT00387894|6326310|P1|NOT COMPLETED|Overall Study||1
2578985|NCT00387894|6326310|P1|COMPLETED|Overall Study||5
2578986|NCT00387894|6326310|P1|STARTED|Overall Study||6
2578987|NCT00387881|6326317|P2|NOT COMPLETED|Overall Study||102
2578988|NCT00387881|6326318|P1|NOT COMPLETED|Overall Study||89
2578989|NCT00387881|6326317|P2|COMPLETED|Overall Study||243
2578990|NCT00387881|6326318|P1|COMPLETED|Overall Study||245
2578991|NCT00387881|6326317|P2|STARTED|Overall Study||345
2578992|NCT00387881|6326318|P1|STARTED|Overall Study||334
2578993|NCT00387829|6326342|P2|NOT COMPLETED|Intent-to-treat Population||30
2578994|NCT00387829|6326343|P1|NOT COMPLETED|Intent-to-treat Population||38
2578995|NCT00387829|6326342|P2|COMPLETED|Intent-to-treat Population||136
2578996|NCT00387829|6326343|P1|COMPLETED|Intent-to-treat Population||139
2578997|NCT00387829|6326342|P2|STARTED|Intent-to-treat Population||166
2578998|NCT00387829|6326343|P1|STARTED|Intent-to-treat Population||177
2578999|NCT00387829|6326342|P2|NOT COMPLETED|Safety Population||33
2579000|NCT00387829|6326343|P1|NOT COMPLETED|Safety Population||39
2579001|NCT00387829|6326342|P2|COMPLETED|Safety Population||136
2579002|NCT00387829|6326343|P1|COMPLETED|Safety Population||139
2579003|NCT00387829|6326342|P2|STARTED|Safety Population||169
2579004|NCT00387829|6326343|P1|STARTED|Safety Population||178
2579005|NCT00387790|6326351|P1|NOT COMPLETED|Overall Study||14
2579006|NCT00387790|6326351|P1|COMPLETED|Overall Study||50
2579007|NCT00387790|6326351|P1|STARTED|Overall Study||64
2579008|NCT00387764|6326357|P1|NOT COMPLETED|Overall Study||31
2579009|NCT00387764|6326357|P1|COMPLETED|Overall Study|Participants completed treatment (until disease progression), but may not have completed the study.|49
2579010|NCT00387764|6326357|P1|STARTED|Overall Study||80
2579011|NCT00387751|6326375|P1|NOT COMPLETED|Overall Study||0
2579012|NCT00387751|6326375|P1|COMPLETED|Overall Study||14
2579013|NCT00387751|6326375|P1|STARTED|Overall Study||14
2579014|NCT00387725|6326385|P4|NOT COMPLETED|Overall Study||2
2579015|NCT00387725|6326386|P3|NOT COMPLETED|Overall Study||2
2579016|NCT00387725|6326387|P2|NOT COMPLETED|Overall Study||1
2579017|NCT00387725|6326388|P1|NOT COMPLETED|Overall Study||1
2579018|NCT00387725|6326385|P4|COMPLETED|Overall Study||43
2579019|NCT00387725|6326386|P3|COMPLETED|Overall Study||43
2579020|NCT00387725|6326387|P2|COMPLETED|Overall Study||15
2579021|NCT00387725|6326388|P1|COMPLETED|Overall Study||20
2579022|NCT00387725|6326385|P4|STARTED|Overall Study||45
2579023|NCT00387725|6326386|P3|STARTED|Overall Study||45
2579024|NCT00387725|6326387|P2|STARTED|Overall Study||16
2579025|NCT00387725|6326388|P1|STARTED|Overall Study||21
2579026|NCT00387712|6326408|P2|NOT COMPLETED|Overall Study||36
2579027|NCT00387712|6326409|P1|NOT COMPLETED|Overall Study||29
2579028|NCT00387712|6326408|P2|COMPLETED|Overall Study||16
2579029|NCT00387712|6326409|P1|COMPLETED|Overall Study||18
2579030|NCT00387712|6326408|P2|STARTED|Overall Study||52
2579031|NCT00387712|6326409|P1|STARTED|Overall Study||47
2579032|NCT00387673|6326419|P3|NOT COMPLETED|Overall Study||0
2579033|NCT00387673|6326420|P2|NOT COMPLETED|Overall Study||0
2579034|NCT00387673|6326421|P1|NOT COMPLETED|Overall Study||0
2579035|NCT00387673|6326419|P3|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
2579036|NCT00387673|6326420|P2|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
2579037|NCT00387673|6326421|P1|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
2579038|NCT00387673|6326419|P3|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
2579039|NCT00387673|6326420|P2|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
2579131|NCT00387010|6326647|P1|NOT COMPLETED|Treatment Period||11
2579040|NCT00387673|6326421|P1|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
2579041|NCT00387660|6326429|P2|NOT COMPLETED|Overall Study||0
2579042|NCT00387660|6326430|P1|NOT COMPLETED|Overall Study||0
2579043|NCT00387660|6326429|P2|COMPLETED|Overall Study||40
2579044|NCT00387660|6326430|P1|COMPLETED|Overall Study||40
2579045|NCT00387660|6326429|P2|STARTED|Overall Study||40
2579046|NCT00387660|6326430|P1|STARTED|Overall Study||40
2579047|NCT00387647|6326440|P1|NOT COMPLETED|Overall Study||18
2579048|NCT00387647|6326440|P1|COMPLETED|Overall Study||6
2579049|NCT00387647|6326440|P1|STARTED|Overall Study||24
2579050|NCT00387621|6326449|P2|NOT COMPLETED|Second Intervention||0
2579051|NCT00387621|6326450|P1|NOT COMPLETED|Second Intervention||0
2579052|NCT00387621|6326449|P2|COMPLETED|Second Intervention||29
2579053|NCT00387621|6326450|P1|COMPLETED|Second Intervention||29
2579054|NCT00387621|6326449|P2|STARTED|Second Intervention||29
2579055|NCT00387621|6326450|P1|STARTED|Second Intervention||29
2579056|NCT00387621|6326449|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
2579057|NCT00387621|6326450|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
2579058|NCT00387621|6326449|P2|COMPLETED|Washout Period of 2 Weeks||29
2579059|NCT00387621|6326450|P1|COMPLETED|Washout Period of 2 Weeks||29
2579060|NCT00387621|6326449|P2|STARTED|Washout Period of 2 Weeks||29
2579061|NCT00387621|6326450|P1|STARTED|Washout Period of 2 Weeks||29
2579062|NCT00387621|6326449|P2|NOT COMPLETED|First Intervention||0
2579063|NCT00387621|6326450|P1|NOT COMPLETED|First Intervention||0
2579064|NCT00387621|6326449|P2|COMPLETED|First Intervention||29
2579065|NCT00387621|6326450|P1|COMPLETED|First Intervention||29
2579066|NCT00387621|6326449|P2|STARTED|First Intervention||29
2579067|NCT00387621|6326450|P1|STARTED|First Intervention||29
2579068|NCT00387465|6326483|P3|NOT COMPLETED|Overall Study||0
2579069|NCT00387465|6326484|P2|NOT COMPLETED|Overall Study||1
2579070|NCT00387465|6326485|P1|NOT COMPLETED|Overall Study||0
2579071|NCT00387465|6326483|P3|COMPLETED|Overall Study||35
2579072|NCT00387465|6326484|P2|COMPLETED|Overall Study||6
2579073|NCT00387465|6326485|P1|COMPLETED|Overall Study||3
2579074|NCT00387465|6326483|P3|STARTED|Overall Study||35
2579075|NCT00387465|6326484|P2|STARTED|Overall Study||7
2579076|NCT00387465|6326485|P1|STARTED|Overall Study||3
2579077|NCT00387426|6326502|P1|NOT COMPLETED|Overall Study||14
2579078|NCT00387426|6326502|P1|COMPLETED|Overall Study||0
2579079|NCT00387426|6326502|P1|STARTED|Overall Study||14
2579080|NCT00387348|6326509|P3|NOT COMPLETED|Overall Study||4
2579081|NCT00387348|6326510|P2|NOT COMPLETED|Overall Study||3
2579082|NCT00387348|6326511|P1|NOT COMPLETED|Overall Study||3
2579083|NCT00387348|6326509|P3|COMPLETED|Overall Study||7
2579084|NCT00387348|6326510|P2|COMPLETED|Overall Study||2
2579085|NCT00387348|6326511|P1|COMPLETED|Overall Study||5
2579086|NCT00387348|6326509|P3|STARTED|Overall Study||11
2579087|NCT00387348|6326510|P2|STARTED|Overall Study||5
2579088|NCT00387348|6326511|P1|STARTED|Overall Study||8
2579089|NCT00387335|6326527|P2|NOT COMPLETED|Overall Study||0
2579090|NCT00387335|6326528|P1|NOT COMPLETED|Overall Study||0
2579091|NCT00387335|6326527|P2|COMPLETED|Overall Study||7
2579092|NCT00387335|6326528|P1|COMPLETED|Overall Study||15
2579093|NCT00387335|6326527|P2|STARTED|Overall Study||7
2579094|NCT00387335|6326528|P1|STARTED|Overall Study||15
2579095|NCT00387153|6326540|P1|NOT COMPLETED|Overall Study||8
2579096|NCT00387153|6326540|P1|COMPLETED|Overall Study||0
2579097|NCT00387153|6326540|P1|STARTED|Overall Study||8
2579098|NCT00387127|6326546|P2|NOT COMPLETED|Overall Study||34
2579099|NCT00387127|6326547|P1|NOT COMPLETED|Overall Study||33
2579100|NCT00387127|6326546|P2|COMPLETED|Overall Study||0
2579101|NCT00387127|6326547|P1|COMPLETED|Overall Study||0
2579102|NCT00387127|6326546|P2|STARTED|Overall Study||34
2579103|NCT00387127|6326547|P1|STARTED|Overall Study||33
2579104|NCT00387088|6326589|P2|NOT COMPLETED|Overall Study||373
2579105|NCT00387088|6326590|P1|NOT COMPLETED|Overall Study||318
2579106|NCT00387088|6326589|P2|COMPLETED|Overall Study||1629
2579107|NCT00387088|6326590|P1|COMPLETED|Overall Study||1671
2579108|NCT00387088|6326589|P2|STARTED|Overall Study||2002
2579109|NCT00387088|6326590|P1|STARTED|Overall Study||1989
2579110|NCT00387036|6326634|P2|NOT COMPLETED|2-Week Crossover Second Intervention||0
2579111|NCT00387036|6326635|P1|NOT COMPLETED|2-Week Crossover Second Intervention||0
2579112|NCT00387036|6326634|P2|COMPLETED|2-Week Crossover Second Intervention||6
2579113|NCT00387036|6326635|P1|COMPLETED|2-Week Crossover Second Intervention||6
2579114|NCT00387036|6326634|P2|STARTED|2-Week Crossover Second Intervention||6
2579115|NCT00387036|6326635|P1|STARTED|2-Week Crossover Second Intervention||6
2579116|NCT00387036|6326634|P2|NOT COMPLETED|2-Week Placebo Washout||0
2579117|NCT00387036|6326635|P1|NOT COMPLETED|2-Week Placebo Washout||0
2579118|NCT00387036|6326634|P2|COMPLETED|2-Week Placebo Washout||6
2579119|NCT00387036|6326635|P1|COMPLETED|2-Week Placebo Washout||6
2579120|NCT00387036|6326634|P2|STARTED|2-Week Placebo Washout||6
2579121|NCT00387036|6326635|P1|STARTED|2-Week Placebo Washout||6
2579122|NCT00387036|6326634|P2|NOT COMPLETED|2-Week First Intervention||0
2579123|NCT00387036|6326635|P1|NOT COMPLETED|2-Week First Intervention||0
2579124|NCT00387036|6326634|P2|COMPLETED|2-Week First Intervention||6
2579125|NCT00387036|6326635|P1|COMPLETED|2-Week First Intervention||6
2579126|NCT00387036|6326634|P2|STARTED|2-Week First Intervention||6
2579127|NCT00387036|6326635|P1|STARTED|2-Week First Intervention||6
2579128|NCT00387023|6326643|P1|NOT COMPLETED|Overall Study||0
2579129|NCT00387023|6326643|P1|COMPLETED|Overall Study||12
2579130|NCT00387023|6326643|P1|STARTED|Overall Study||12
2579132|NCT00387010|6326647|P1|COMPLETED|Treatment Period||169
2579133|NCT00387010|6326647|P1|Full Analysis Set|Treatment Period|FAS: treated patients with at least 1 paired baseline and post baseline efficacy assessment|175
2579134|NCT00387010|6326647|P1|STARTED|Treatment Period||180
2579135|NCT00387010|6326647|P1|NOT COMPLETED|Dose Titration Period||38
2579136|NCT00387010|6326647|P1|COMPLETED|Dose Titration Period||180
2579137|NCT00387010|6326647|P1|STARTED|Dose Titration Period||218
2579138|NCT00386880|6326668|P2|NOT COMPLETED|Overall Study||0
2579139|NCT00386880|6326669|P1|NOT COMPLETED|Overall Study||0
2579140|NCT00386880|6326668|P2|COMPLETED|Overall Study||8
2579141|NCT00386880|6326669|P1|COMPLETED|Overall Study||30
2579142|NCT00386880|6326668|P2|STARTED|Overall Study||8
2579143|NCT00386880|6326669|P1|STARTED|Overall Study||30
2579144|NCT00386776|6326674|P1|NOT COMPLETED|Overall Study||8
2579145|NCT00386776|6326674|P1|COMPLETED|Overall Study||32
2579146|NCT00386776|6326674|P1|STARTED|Overall Study||40
2579147|NCT00386607|6326684|P2|NOT COMPLETED|Extension||17
2579148|NCT00386607|6326685|P1|NOT COMPLETED|Extension||0
2579149|NCT00386607|6326684|P2|COMPLETED|Extension||145
2579150|NCT00386607|6326685|P1|COMPLETED|Extension||0
2579151|NCT00386607|6326684|P2|STARTED|Extension||162
2579152|NCT00386607|6326685|P1|STARTED|Extension||0
2579153|NCT00386607|6326684|P2|NOT COMPLETED|Core||0
2579154|NCT00386607|6326685|P1|NOT COMPLETED|Core||115
2579155|NCT00386607|6326684|P2|COMPLETED|Core||0
2579156|NCT00386607|6326685|P1|COMPLETED|Core||486
2579157|NCT00386607|6326684|P2|STARTED|Core||0
2579158|NCT00386607|6326685|P1|STARTED|Core||601
2579159|NCT00386477|6326703|P2|NOT COMPLETED|Overall Study||0
2579160|NCT00386477|6326704|P1|NOT COMPLETED|Overall Study||0
2579161|NCT00386477|6326703|P2|COMPLETED|Overall Study||145
2579162|NCT00386477|6326704|P1|COMPLETED|Overall Study||155
2579163|NCT00386477|6326703|P2|STARTED|Overall Study||145
2579164|NCT00386477|6326704|P1|STARTED|Overall Study||155
2579165|NCT00386425|6326713|P3|NOT COMPLETED|Overall Study||0
2579166|NCT00386425|6326714|P2|NOT COMPLETED|Overall Study||1
2579167|NCT00386425|6326715|P1|NOT COMPLETED|Overall Study||3
2579168|NCT00386425|6326713|P3|COMPLETED|Overall Study||53
2579169|NCT00386425|6326714|P2|COMPLETED|Overall Study|33 severe protein C deficiency; 172 moderate protein C deficiency|205
2579170|NCT00386425|6326715|P1|COMPLETED|Overall Study|51 severe protein C deficiency; 173 moderate protein C deficiency|224
2579171|NCT00386425|6326713|P3|Received Study Drug|Overall Study||53
2579172|NCT00386425|6326714|P2|Received Study Drug|Overall Study||206
2579173|NCT00386425|6326715|P1|Received Study Drug|Overall Study||227
2579174|NCT00386425|6326713|P3|STARTED|Overall Study||53
2579175|NCT00386425|6326714|P2|STARTED|Overall Study|33 severe protein C deficiency; 173 moderate protein C deficiency|206
2579176|NCT00386425|6326715|P1|STARTED|Overall Study|51 severe protein C deficiency; 176 moderate protein C deficiency|227
2579177|NCT00386360|6326741|P2|NOT COMPLETED|Overall Study||17
2579178|NCT00386360|6326742|P1|NOT COMPLETED|Overall Study||9
2579179|NCT00386360|6326741|P2|COMPLETED|Overall Study||95
2579180|NCT00386360|6326742|P1|COMPLETED|Overall Study||40
2579181|NCT00386360|6326741|P2|Primary Efficacy|Overall Study||77
2579182|NCT00386360|6326742|P1|Primary Efficacy|Overall Study|Per-protocol patients with evaluable BVTV (trabecular bone volume/tissue volume) at baseline & M12.|36
2579183|NCT00386360|6326741|P2|Intent to Treat Population (ITT)|Overall Study||110
2579184|NCT00386360|6326742|P1|Intent to Treat Population (ITT)|Overall Study|Includes all patients randomized and took at least one dose of study drug.|49
2579185|NCT00386360|6326741|P2|STARTED|Overall Study||112
2579186|NCT00386360|6326742|P1|STARTED|Overall Study||49
2579187|NCT00386334|6326776|P2|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||1
2579188|NCT00386334|6326777|P1|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||3
2579189|NCT00386334|6326776|P2|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||144
2579190|NCT00386334|6326777|P1|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||143
2579191|NCT00386334|6326776|P2|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|145
2579192|NCT00386334|6326777|P1|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|146
2579193|NCT00386334|6326776|P2|NOT COMPLETED|Double Blind Period||47
2579194|NCT00386334|6326777|P1|NOT COMPLETED|Double Blind Period||46
2579195|NCT00386334|6326776|P2|COMPLETED|Double Blind Period||147
2579196|NCT00386334|6326777|P1|COMPLETED|Double Blind Period||148
2579197|NCT00386334|6326776|P2|STARTED|Double Blind Period||194
2579198|NCT00386334|6326777|P1|STARTED|Double Blind Period||194
2579199|NCT00386308|6326921|P2|NOT COMPLETED|Overall Study||19
2579200|NCT00386308|6326922|P1|NOT COMPLETED|Overall Study||29
2579201|NCT00386308|6326921|P2|COMPLETED|Overall Study||54
2579202|NCT00386308|6326922|P1|COMPLETED|Overall Study||94
2579203|NCT00386308|6326921|P2|Modified Intent to Treat Population|Overall Study||72
2579204|NCT00386308|6326922|P1|Modified Intent to Treat Population|Overall Study||115
2579205|NCT00386308|6326921|P2|Intent to Treat Population|Overall Study||72
2579206|NCT00386308|6326922|P1|Intent to Treat Population|Overall Study||117
2579207|NCT00386308|6326921|P2|STARTED|Overall Study||73
2579208|NCT00386308|6326922|P1|STARTED|Overall Study||123
2579209|NCT00386256|6326938|P4|NOT COMPLETED|Overall Study||0
2579210|NCT00386256|6326939|P3|NOT COMPLETED|Overall Study||0
2579211|NCT00386256|6326940|P2|NOT COMPLETED|Overall Study||0
2579212|NCT00386256|6326941|P1|NOT COMPLETED|Overall Study||0
2579213|NCT00386256|6326938|P4|COMPLETED|Overall Study||3
2579214|NCT00386256|6326939|P3|COMPLETED|Overall Study||4
2579215|NCT00386256|6326940|P2|COMPLETED|Overall Study||15
2579216|NCT00386256|6326941|P1|COMPLETED|Overall Study||16
2579217|NCT00386256|6326938|P4|STARTED|Overall Study||3
2579218|NCT00386256|6326939|P3|STARTED|Overall Study||4
2579219|NCT00386256|6326940|P2|STARTED|Overall Study||15
2579220|NCT00386256|6326941|P1|STARTED|Overall Study||16
2579221|NCT00386243|6326957|P2|NOT COMPLETED|Overall Study||13
2579222|NCT00386243|6326958|P1|NOT COMPLETED|Overall Study||7
2579223|NCT00386243|6326957|P2|COMPLETED|Overall Study||108
2579224|NCT00386243|6326958|P1|COMPLETED|Overall Study||114
2579225|NCT00386243|6326957|P2|STARTED|Overall Study||121
2579226|NCT00386243|6326958|P1|STARTED|Overall Study||121
2579227|NCT00386152|6326979|P3|NOT COMPLETED|Overall Study||33
2579228|NCT00386152|6326980|P2|NOT COMPLETED|Overall Study||40
2579229|NCT00386152|6326981|P1|NOT COMPLETED|Overall Study||44
2579230|NCT00386152|6326979|P3|COMPLETED|Overall Study||42
2579231|NCT00386152|6326980|P2|COMPLETED|Overall Study||37
2579232|NCT00386152|6326981|P1|COMPLETED|Overall Study||31
2579233|NCT00386152|6326979|P3|STARTED|Overall Study|number of subjects treated|75
2579234|NCT00386152|6326980|P2|STARTED|Overall Study|number of subjects treated|77
2579235|NCT00386152|6326981|P1|STARTED|Overall Study|number of subjects treated|75
2579236|NCT00386100|6327000|P2|NOT COMPLETED|Overall Study||131
2579237|NCT00386100|6327001|P1|NOT COMPLETED|Overall Study||154
2579238|NCT00386100|6327000|P2|COMPLETED|Overall Study||217
2579239|NCT00386100|6327001|P1|COMPLETED|Overall Study||186
2579240|NCT00386100|6327000|P2|STARTED|Overall Study||348
2579241|NCT00386100|6327001|P1|STARTED|Overall Study||340
2579242|NCT00386022|6327065|P2|NOT COMPLETED|Plus Estrogen||1
2579243|NCT00386022|6327066|P1|NOT COMPLETED|Plus Estrogen||2
2579244|NCT00386022|6327065|P2|COMPLETED|Plus Estrogen||8
2579245|NCT00386022|6327066|P1|COMPLETED|Plus Estrogen||8
2579246|NCT00386022|6327065|P2|All Doses GnRH|Plus Estrogen||8
2579247|NCT00386022|6327066|P1|All Doses GnRH|Plus Estrogen||8
2579248|NCT00386022|6327065|P2|Estrogen Patch|Plus Estrogen||9
2579249|NCT00386022|6327066|P1|Estrogen Patch|Plus Estrogen||8
2579250|NCT00386022|6327065|P2|STARTED|Plus Estrogen||9
2579251|NCT00386022|6327066|P1|STARTED|Plus Estrogen||10
2579252|NCT00386022|6327065|P2|NOT COMPLETED|Baseline||0
2579253|NCT00386022|6327066|P1|NOT COMPLETED|Baseline||0
2579254|NCT00386022|6327065|P2|COMPLETED|Baseline||9
2579255|NCT00386022|6327066|P1|COMPLETED|Baseline||10
2579256|NCT00386022|6327065|P2|All Doses of GnRH|Baseline||9
2579257|NCT00386022|6327066|P1|All Doses of GnRH|Baseline||10
2579258|NCT00386022|6327065|P2|STARTED|Baseline||9
2579259|NCT00386022|6327066|P1|STARTED|Baseline||10
2579260|NCT00386009|6327076|P2|NOT COMPLETED|Overall Study||10
2579261|NCT00386009|6327077|P1|NOT COMPLETED|Overall Study||9
2579262|NCT00386009|6327076|P2|COMPLETED|Overall Study||89
2579263|NCT00386009|6327077|P1|COMPLETED|Overall Study||92
2579264|NCT00386009|6327076|P2|STARTED|Overall Study||99
2579265|NCT00386009|6327077|P1|STARTED|Overall Study||101
2579266|NCT00385996|6327115|P1|NOT COMPLETED|Overall Study||0
2579267|NCT00385996|6327115|P1|COMPLETED|Overall Study||22
2579268|NCT00385996|6327115|P1|STARTED|Overall Study||22
2579269|NCT00385944|6327124|P3|NOT COMPLETED|2nd Maintenance Dose Period||0
2579270|NCT00385944|6327125|P2|NOT COMPLETED|2nd Maintenance Dose Period||3
2579271|NCT00385944|6327126|P1|NOT COMPLETED|2nd Maintenance Dose Period||2
2579272|NCT00385944|6327124|P3|COMPLETED|2nd Maintenance Dose Period||0
2579273|NCT00385944|6327125|P2|COMPLETED|2nd Maintenance Dose Period||19
2579274|NCT00385944|6327126|P1|COMPLETED|2nd Maintenance Dose Period||22
2579275|NCT00385944|6327124|P3|STARTED|2nd Maintenance Dose Period||0
2579276|NCT00385944|6327125|P2|STARTED|2nd Maintenance Dose Period|2 patients discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|22
2579277|NCT00385944|6327126|P1|STARTED|2nd Maintenance Dose Period|1 patient discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|24
2579278|NCT00385944|6327124|P3|NOT COMPLETED|1st Maintenance Dose Period||0
2579279|NCT00385944|6327125|P2|NOT COMPLETED|1st Maintenance Dose Period||1
2579280|NCT00385944|6327126|P1|NOT COMPLETED|1st Maintenance Dose Period||4
2579281|NCT00385944|6327124|P3|COMPLETED|1st Maintenance Dose Period||0
2579282|NCT00385944|6327125|P2|COMPLETED|1st Maintenance Dose Period||24
2579283|NCT00385944|6327126|P1|COMPLETED|1st Maintenance Dose Period||25
2579284|NCT00385944|6327124|P3|STARTED|1st Maintenance Dose Period||0
2579285|NCT00385944|6327125|P2|STARTED|1st Maintenance Dose Period|Two patients withdrew from the study after randomization but prior to receiving the 1st MD.|25
2579286|NCT00385944|6327126|P1|STARTED|1st Maintenance Dose Period||29
2579287|NCT00385944|6327124|P3|NOT COMPLETED|Loading Dose||0
2579288|NCT00385944|6327125|P2|NOT COMPLETED|Loading Dose||0
2579289|NCT00385944|6327126|P1|NOT COMPLETED|Loading Dose||0
2579290|NCT00385944|6327124|P3|COMPLETED|Loading Dose||56
2579291|NCT00385944|6327125|P2|COMPLETED|Loading Dose||0
2579292|NCT00385944|6327126|P1|COMPLETED|Loading Dose||0
2579293|NCT00385944|6327124|P3|STARTED|Loading Dose||56
2579294|NCT00385944|6327125|P2|STARTED|Loading Dose||0
2579295|NCT00385944|6327126|P1|STARTED|Loading Dose||0
2579296|NCT00385918|6327169|P3|NOT COMPLETED|Intervention Phase After Randomization||0
2579297|NCT00385918|6327170|P2|NOT COMPLETED|Intervention Phase After Randomization||0
2579298|NCT00385918|6327171|P1|NOT COMPLETED|Intervention Phase After Randomization||3
2579299|NCT00385918|6327169|P3|COMPLETED|Intervention Phase After Randomization||0
2579300|NCT00385918|6327170|P2|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month home-base intervention|6
2579301|NCT00385918|6327171|P1|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month training intervention|12
2579302|NCT00385918|6327169|P3|STARTED|Intervention Phase After Randomization||0
2579303|NCT00385918|6327170|P2|STARTED|Intervention Phase After Randomization|Participants successfully completed screening; this is the number in the home stretching arm.|6
2579304|NCT00385918|6327171|P1|STARTED|Intervention Phase After Randomization|Participant successfully completed screening; this is the number in the Lokomat training arm.|15
2579305|NCT00385918|6327169|P3|NOT COMPLETED|Feasibility & Baseline Measurement Phase||14
2579306|NCT00385918|6327170|P2|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
2579307|NCT00385918|6327171|P1|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
2579308|NCT00385918|6327169|P3|COMPLETED|Feasibility & Baseline Measurement Phase||21
2579309|NCT00385918|6327170|P2|COMPLETED|Feasibility & Baseline Measurement Phase||0
2579310|NCT00385918|6327171|P1|COMPLETED|Feasibility & Baseline Measurement Phase||0
2579311|NCT00385918|6327169|P3|Completed Baseline Tests|Feasibility & Baseline Measurement Phase|6 subjects did not complete all baseline tests.|21
2579312|NCT00385918|6327170|P2|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
2579313|NCT00385918|6327171|P1|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
2579314|NCT00385918|6327169|P3|Number Eligible|Feasibility & Baseline Measurement Phase|8 subjects failed screening.|27
2579315|NCT00385918|6327170|P2|Number Eligible|Feasibility & Baseline Measurement Phase||0
2579316|NCT00385918|6327171|P1|Number Eligible|Feasibility & Baseline Measurement Phase||0
2579317|NCT00385918|6327169|P3|STARTED|Feasibility & Baseline Measurement Phase|Total # of subjects screened.The screening occurred before randomization.|35
2579318|NCT00385918|6327170|P2|STARTED|Feasibility & Baseline Measurement Phase||0
2579319|NCT00385918|6327171|P1|STARTED|Feasibility & Baseline Measurement Phase||0
2579320|NCT00385840|6327195|P2|NOT COMPLETED|Overall Study||14
2579321|NCT00385840|6327196|P1|NOT COMPLETED|Overall Study||4
2579322|NCT00385840|6327195|P2|COMPLETED|Overall Study||531
2579323|NCT00385840|6327196|P1|COMPLETED|Overall Study||129
2579324|NCT00385840|6327195|P2|STARTED|Overall Study||545
2579325|NCT00385840|6327196|P1|STARTED|Overall Study||133
2579326|NCT00385827|6327219|P3|NOT COMPLETED|Part 2||48
2579327|NCT00385827|6327220|P2|NOT COMPLETED|Part 2||33
2579328|NCT00385827|6327221|P1|NOT COMPLETED|Part 2||0
2579329|NCT00385827|6327219|P3|COMPLETED|Part 2||0
2579330|NCT00385827|6327220|P2|COMPLETED|Part 2||16
2579331|NCT00385827|6327221|P1|COMPLETED|Part 2||0
2579332|NCT00385827|6327219|P3|Treated|Part 2||46
2579333|NCT00385827|6327220|P2|Treated|Part 2||47
2579334|NCT00385827|6327221|P1|Treated|Part 2||0
2579335|NCT00385827|6327219|P3|STARTED|Part 2||48
2579336|NCT00385827|6327220|P2|STARTED|Part 2||49
2579337|NCT00385827|6327221|P1|STARTED|Part 2||0
2579338|NCT00385827|6327219|P3|NOT COMPLETED|Part 1||0
2579339|NCT00385827|6327220|P2|NOT COMPLETED|Part 1||0
2579340|NCT00385827|6327221|P1|NOT COMPLETED|Part 1||9
2579341|NCT00385827|6327219|P3|COMPLETED|Part 1||0
2579342|NCT00385827|6327220|P2|COMPLETED|Part 1||0
2579343|NCT00385827|6327221|P1|COMPLETED|Part 1||0
2579344|NCT00385827|6327219|P3|Treated|Part 1||0
2579345|NCT00385827|6327220|P2|Treated|Part 1||0
2579346|NCT00385827|6327221|P1|Treated|Part 1||9
2579347|NCT00385827|6327219|P3|STARTED|Part 1||0
2579348|NCT00385827|6327220|P2|STARTED|Part 1||0
2579349|NCT00385827|6327221|P1|STARTED|Part 1||9
2579350|NCT00385801|6327243|P2|NOT COMPLETED|Overall Study||8
2579351|NCT00385801|6327244|P1|NOT COMPLETED|Overall Study||9
2579352|NCT00385801|6327243|P2|COMPLETED|Overall Study||8
2579353|NCT00385801|6327244|P1|COMPLETED|Overall Study||6
2579354|NCT00385801|6327243|P2|STARTED|Overall Study||16
2579355|NCT00385801|6327244|P1|STARTED|Overall Study||15
2579356|NCT00385788|6327258|P2|NOT COMPLETED|Overall Study||0
2579357|NCT00385788|6327259|P1|NOT COMPLETED|Overall Study||0
2579358|NCT00385788|6327258|P2|COMPLETED|Overall Study||40
2579359|NCT00385788|6327259|P1|COMPLETED|Overall Study||12
2579360|NCT00385788|6327258|P2|STARTED|Overall Study||40
2579361|NCT00385788|6327259|P1|STARTED|Overall Study||12
2579362|NCT00385762|6327265|P1|NOT COMPLETED|Overall Study||2
2579363|NCT00385762|6327265|P1|COMPLETED|Overall Study||33
2579364|NCT00385762|6327265|P1|STARTED|Overall Study||35
2579365|NCT00385736|6327275|P3|NOT COMPLETED|Safety Analysis Set||80
2579366|NCT00385736|6327276|P2|NOT COMPLETED|Safety Analysis Set||44
2579367|NCT00385736|6327277|P1|NOT COMPLETED|Safety Analysis Set||70
2579368|NCT00385736|6327275|P3|COMPLETED|Safety Analysis Set||143
2579369|NCT00385736|6327276|P2|COMPLETED|Safety Analysis Set||86
2579370|NCT00385736|6327277|P1|COMPLETED|Safety Analysis Set||153
2579371|NCT00385736|6327275|P3|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
2579372|NCT00385736|6327276|P2|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|130
2579373|NCT00385736|6327277|P1|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
2579374|NCT00385736|6327275|P3|NOT COMPLETED|Efficacy Analysis Set - Maintenance||80
2579375|NCT00385736|6327276|P2|NOT COMPLETED|Efficacy Analysis Set - Maintenance||44
2579376|NCT00385736|6327277|P1|NOT COMPLETED|Efficacy Analysis Set - Maintenance||69
2579377|NCT00385736|6327275|P3|COMPLETED|Efficacy Analysis Set - Maintenance||143
2579378|NCT00385736|6327276|P2|COMPLETED|Efficacy Analysis Set - Maintenance||86
2579379|NCT00385736|6327277|P1|COMPLETED|Efficacy Analysis Set - Maintenance||153
2579380|NCT00385736|6327275|P3|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|223
2579381|NCT00385736|6327276|P2|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|130
2579382|NCT00385736|6327277|P1|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|222
2579383|NCT00385736|6327275|P3|NOT COMPLETED|Efficacy Analysis Set - Induction||9
2579384|NCT00385736|6327276|P2|NOT COMPLETED|Efficacy Analysis Set - Induction||12
2579385|NCT00385736|6327277|P1|NOT COMPLETED|Efficacy Analysis Set - Induction||9
2579386|NCT00385736|6327275|P3|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
2579387|NCT00385736|6327276|P2|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|118
2579388|NCT00385736|6327277|P1|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
2579389|NCT00385736|6327275|P3|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
2579390|NCT00385736|6327276|P2|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
2579391|NCT00385736|6327277|P1|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
2579392|NCT00385723|6327322|P3|NOT COMPLETED|Overall Study||2
2579393|NCT00385723|6327323|P2|NOT COMPLETED|Overall Study||1
2579394|NCT00385723|6327324|P1|NOT COMPLETED|Overall Study||2
2579395|NCT00385723|6327322|P3|COMPLETED|Overall Study||44
2579396|NCT00385723|6327323|P2|COMPLETED|Overall Study||45
2579397|NCT00385723|6327324|P1|COMPLETED|Overall Study||44
2579398|NCT00385723|6327322|P3|STARTED|Overall Study||46
2579399|NCT00385723|6327323|P2|STARTED|Overall Study||46
2579400|NCT00385723|6327324|P1|STARTED|Overall Study||46
2579401|NCT00385684|6327338|P2|NOT COMPLETED|PHASE B||0
2579402|NCT00385684|6327339|P1|NOT COMPLETED|PHASE B||0
2579403|NCT00385684|6327338|P2|COMPLETED|PHASE B||3
2579404|NCT00385684|6327339|P1|COMPLETED|PHASE B||5
2579405|NCT00385684|6327338|P2|STARTED|PHASE B||3
2579406|NCT00385684|6327339|P1|STARTED|PHASE B||5
2579407|NCT00385684|6327338|P2|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||2
2579408|NCT00385684|6327339|P1|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||0
2579409|NCT00385684|6327338|P2|COMPLETED|SECOND INTERVENTION OF PHASE A||3
2579410|NCT00385684|6327339|P1|COMPLETED|SECOND INTERVENTION OF PHASE A||5
2579411|NCT00385684|6327338|P2|STARTED|SECOND INTERVENTION OF PHASE A||5
2579412|NCT00385684|6327339|P1|STARTED|SECOND INTERVENTION OF PHASE A||5
2579413|NCT00385684|6327338|P2|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||0
2579414|NCT00385684|6327339|P1|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||1
2579415|NCT00385684|6327338|P2|COMPLETED|FIRST INTERVENTION OF PHASE A||5
2579416|NCT00385684|6327339|P1|COMPLETED|FIRST INTERVENTION OF PHASE A||5
2579417|NCT00385684|6327338|P2|STARTED|FIRST INTERVENTION OF PHASE A||5
2579418|NCT00385684|6327339|P1|STARTED|FIRST INTERVENTION OF PHASE A||6
2579419|NCT00385671|6327348|P3|NOT COMPLETED|Overall Study||36
2579420|NCT00385671|6327349|P2|NOT COMPLETED|Overall Study||51
2579421|NCT00385671|6327350|P1|NOT COMPLETED|Overall Study||38
2579422|NCT00385671|6327348|P3|COMPLETED|Overall Study||99
2579423|NCT00385671|6327349|P2|COMPLETED|Overall Study||87
2579424|NCT00385671|6327350|P1|COMPLETED|Overall Study||96
2579425|NCT00385671|6327348|P3|STARTED|Overall Study||135
2579426|NCT00385671|6327349|P2|STARTED|Overall Study||138
2579427|NCT00385671|6327350|P1|STARTED|Overall Study||134
2579428|NCT00385593|6327506|P2|NOT COMPLETED|Overall Study||37
2579429|NCT00385593|6327507|P1|NOT COMPLETED|Overall Study||58
2579430|NCT00385593|6327506|P2|COMPLETED|Overall Study||289
2579431|NCT00385593|6327507|P1|COMPLETED|Overall Study||270
2579432|NCT00385593|6327506|P2|STARTED|Overall Study||326
2579433|NCT00385593|6327507|P1|STARTED|Overall Study||328
2579434|NCT00385580|6327525|P2|NOT COMPLETED|Overall Study||0
2579435|NCT00385580|6327526|P1|NOT COMPLETED|Overall Study||0
2579436|NCT00385580|6327525|P2|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|47
2579437|NCT00385580|6327526|P1|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|48
2579438|NCT00385580|6327525|P2|STARTED|Overall Study|Number of participants treated.|47
2579439|NCT00385580|6327526|P1|STARTED|Overall Study|Number of participants treated.|48
2579440|NCT00385541|6327617|P2|NOT COMPLETED|Overall Study||1
2579441|NCT00385541|6327618|P1|NOT COMPLETED|Overall Study||0
2579442|NCT00385541|6327617|P2|COMPLETED|Overall Study||24
2579443|NCT00385541|6327618|P1|COMPLETED|Overall Study||25
2579444|NCT00385541|6327617|P2|STARTED|Overall Study||25
2579445|NCT00385541|6327618|P1|STARTED|Overall Study||25
2579446|NCT00385515|6327634|P2|NOT COMPLETED|Overall Study||3
2579447|NCT00385515|6327635|P1|NOT COMPLETED|Overall Study||4
2579448|NCT00385515|6327634|P2|COMPLETED|Overall Study||21
2579449|NCT00385515|6327635|P1|COMPLETED|Overall Study||53
2579450|NCT00385515|6327634|P2|STARTED|Overall Study||24
2579451|NCT00385515|6327635|P1|STARTED|Overall Study||57
2579452|NCT00385268|6327643|P2|NOT COMPLETED|Overall Study||8
2579453|NCT00385268|6327644|P1|NOT COMPLETED|Overall Study||16
2579454|NCT00385268|6327643|P2|COMPLETED|Overall Study||18
2579455|NCT00385268|6327644|P1|COMPLETED|Overall Study||18
2579456|NCT00385268|6327643|P2|STARTED|Overall Study||26
2579457|NCT00385268|6327644|P1|STARTED|Overall Study||34
2579458|NCT00385255|6327654|P2|NOT COMPLETED|Overall Study||73
2579459|NCT00385255|6327655|P1|NOT COMPLETED|Overall Study||21
2579460|NCT00385255|6327654|P2|COMPLETED|Overall Study||785
2579461|NCT00385255|6327655|P1|COMPLETED|Overall Study||839
2579462|NCT00385255|6327654|P2|19-64 Years of Age (YOA) Cohort|Overall Study||749
2579463|NCT00385255|6327655|P1|19-64 Years of Age (YOA) Cohort|Overall Study||748
2579464|NCT00385255|6327654|P2|≥ 65 Years of Age (YOA) Cohort|Overall Study||109
2579465|NCT00385255|6327655|P1|≥ 65 Years of Age (YOA) Cohort|Overall Study||112
2579466|NCT00385255|6327654|P2|STARTED|Overall Study||858
2579467|NCT00385255|6327655|P1|STARTED|Overall Study||860
2579468|NCT00385216|6327719|P2|NOT COMPLETED|Second Intervention||0
2579469|NCT00385216|6327720|P1|NOT COMPLETED|Second Intervention||0
2579470|NCT00385216|6327719|P2|COMPLETED|Second Intervention||9
2579471|NCT00385216|6327720|P1|COMPLETED|Second Intervention||11
2579472|NCT00385216|6327719|P2|STARTED|Second Intervention||9
2579473|NCT00385216|6327720|P1|STARTED|Second Intervention||11
2579474|NCT00385216|6327719|P2|NOT COMPLETED|First Intervention||0
2579475|NCT00385216|6327720|P1|NOT COMPLETED|First Intervention||0
2579476|NCT00385216|6327719|P2|COMPLETED|First Intervention||9
2579477|NCT00385216|6327720|P1|COMPLETED|First Intervention||11
2579478|NCT00385216|6327719|P2|STARTED|First Intervention||9
2579479|NCT00385216|6327720|P1|STARTED|First Intervention||11
2579480|NCT00385203|6327734|P2|NOT COMPLETED|Overall Study||7
2579481|NCT00385203|6327735|P1|NOT COMPLETED|Overall Study||26
2579482|NCT00385203|6327734|P2|COMPLETED|Overall Study||3
2579483|NCT00385203|6327735|P1|COMPLETED|Overall Study||0
2579484|NCT00385203|6327734|P2|STARTED|Overall Study||10
2579485|NCT00385203|6327735|P1|STARTED|Overall Study||26
2579486|NCT00385138|6327755|P2|NOT COMPLETED|Overall Study||28
2579487|NCT00385138|6327756|P1|NOT COMPLETED|Overall Study||30
2579488|NCT00385138|6327755|P2|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2641
2579489|NCT00385138|6327756|P1|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2665
2579490|NCT00385138|6327755|P2|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2650
2579491|NCT00385138|6327756|P1|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2662
2579492|NCT00385138|6327755|P2|Modified Intent-to-treat (mITT)|Overall Study|Excludes 24 patients who either did not received study drug or have PCI.|2645
2579493|NCT00385138|6327756|P1|Modified Intent-to-treat (mITT)|Overall Study|Excludes 37 patients who either did not receive study drug or have PCI.|2656
2579494|NCT00385138|6327755|P2|Intent-to-treat (ITT)|Overall Study||2669
2579495|NCT00385138|6327756|P1|Intent-to-treat (ITT)|Overall Study|All patients randomized excluding two (2) who withdrew consent for using study data.|2693
2579496|NCT00385138|6327755|P2|STARTED|Overall Study||2669
2579497|NCT00385138|6327756|P1|STARTED|Overall Study||2695
2579498|NCT00385008|6327802|P2|NOT COMPLETED|Overall Study||0
2579499|NCT00385008|6327803|P1|NOT COMPLETED|Overall Study||0
2579500|NCT00385008|6327802|P2|COMPLETED|Overall Study||10
2579501|NCT00385008|6327803|P1|COMPLETED|Overall Study||10
2579502|NCT00385008|6327802|P2|In Presence of Migraine|Overall Study||5
2579503|NCT00385008|6327803|P1|In Presence of Migraine|Overall Study||5
2579504|NCT00385008|6327802|P2|In Absence of Migraine|Overall Study||10
2579505|NCT00385008|6327803|P1|In Absence of Migraine|Overall Study||10
2579506|NCT00385008|6327802|P2|STARTED|Overall Study||10
2579507|NCT00385008|6327803|P1|STARTED|Overall Study||10
2579508|NCT00384956|6327823|P1|NOT COMPLETED|Overall Study||3
2579509|NCT00384956|6327823|P1|COMPLETED|Overall Study||22
2579510|NCT00384956|6327823|P1|STARTED|Overall Study||25
2579511|NCT00384930|6327840|P5|NOT COMPLETED|Overall Study||47
2579512|NCT00384930|6327841|P4|NOT COMPLETED|Overall Study||41
2579513|NCT00384930|6327842|P3|NOT COMPLETED|Overall Study||30
2579514|NCT00384930|6327843|P2|NOT COMPLETED|Overall Study||27
2579515|NCT00384930|6327844|P1|NOT COMPLETED|Overall Study||27
2579516|NCT00384930|6327840|P5|COMPLETED|Overall Study||162
2579517|NCT00384930|6327841|P4|COMPLETED|Overall Study||175
2579518|NCT00384930|6327842|P3|COMPLETED|Overall Study||182
2579519|NCT00384930|6327843|P2|COMPLETED|Overall Study||182
2579520|NCT00384930|6327844|P1|COMPLETED|Overall Study||185
2579521|NCT00384930|6327840|P5|Received Double-Blind Study Drug|Overall Study||209
2579522|NCT00384930|6327841|P4|Received Double-Blind Study Drug|Overall Study||216
2579523|NCT00384930|6327842|P3|Received Double-Blind Study Drug|Overall Study||212
2579524|NCT00384930|6327843|P2|Received Double-Blind Study Drug|Overall Study||208
2579525|NCT00384930|6327844|P1|Received Double-Blind Study Drug|Overall Study||211
2579526|NCT00384930|6327840|P5|STARTED|Overall Study||209
2579527|NCT00384930|6327841|P4|STARTED|Overall Study||216
2579528|NCT00384930|6327842|P3|STARTED|Overall Study||212
2579529|NCT00384930|6327843|P2|STARTED|Overall Study||209
2579530|NCT00384930|6327844|P1|STARTED|Overall Study||212
2579531|NCT00384865|6327902|P4|NOT COMPLETED|Overall Study||0
2579532|NCT00384865|6327903|P3|NOT COMPLETED|Overall Study||0
2579533|NCT00384865|6327904|P2|NOT COMPLETED|Overall Study||0
2579534|NCT00384865|6327905|P1|NOT COMPLETED|Overall Study||0
2579535|NCT00384865|6327902|P4|COMPLETED|Overall Study||16
2579536|NCT00384865|6327903|P3|COMPLETED|Overall Study||16
2579537|NCT00384865|6327904|P2|COMPLETED|Overall Study||16
2579538|NCT00384865|6327905|P1|COMPLETED|Overall Study||16
2579539|NCT00384865|6327902|P4|Completed Six Month Assessment|Overall Study||11
2579540|NCT00384865|6327903|P3|Completed Six Month Assessment|Overall Study||15
2579541|NCT00384865|6327904|P2|Completed Six Month Assessment|Overall Study||12
2579542|NCT00384865|6327905|P1|Completed Six Month Assessment|Overall Study||11
2579543|NCT00384865|6327902|P4|STARTED|Overall Study||16
2579544|NCT00384865|6327903|P3|STARTED|Overall Study||16
2579545|NCT00384865|6327904|P2|STARTED|Overall Study||16
2579546|NCT00384865|6327905|P1|STARTED|Overall Study||16
2579547|NCT00384839|6327923|P1|NOT COMPLETED|Overall Study||8
2579548|NCT00384839|6327923|P1|COMPLETED|Overall Study||28
2579549|NCT00384839|6327923|P1|STARTED|Overall Study||36
2579550|NCT00384813|6327934|P2|NOT COMPLETED|Overall Study||0
2579551|NCT00384813|6327935|P1|NOT COMPLETED|Overall Study||2
2579552|NCT00384813|6327934|P2|COMPLETED|Overall Study||20
2579553|NCT00384813|6327935|P1|COMPLETED|Overall Study||21
2579554|NCT00384813|6327934|P2|STARTED|Overall Study||20
2579555|NCT00384813|6327935|P1|STARTED|Overall Study||23
2579556|NCT00384774|6327948|P7|NOT COMPLETED|Overall Study||0
2579557|NCT00384774|6327949|P6|NOT COMPLETED|Overall Study||0
2579558|NCT00384774|6327950|P5|NOT COMPLETED|Overall Study||0
2579559|NCT00384774|6327951|P4|NOT COMPLETED|Overall Study||0
2579560|NCT00384774|6327952|P3|NOT COMPLETED|Overall Study||0
2579561|NCT00384774|6327953|P2|NOT COMPLETED|Overall Study||0
2579562|NCT00384774|6327954|P1|NOT COMPLETED|Overall Study||0
2579563|NCT00384774|6327948|P7|COMPLETED|Overall Study||4
2579564|NCT00384774|6327949|P6|COMPLETED|Overall Study||16
2579565|NCT00384774|6327950|P5|COMPLETED|Overall Study||28
2579566|NCT00384774|6327951|P4|COMPLETED|Overall Study||24
2579567|NCT00384774|6327952|P3|COMPLETED|Overall Study||12
2579568|NCT00384774|6327953|P2|COMPLETED|Overall Study||4
2579569|NCT00384774|6327954|P1|COMPLETED|Overall Study||42
2579570|NCT00384774|6327948|P7|Received at Least 1 Dose of Study Drug|Overall Study||4
2579571|NCT00384774|6327949|P6|Received at Least 1 Dose of Study Drug|Overall Study||16
2579572|NCT00384774|6327950|P5|Received at Least 1 Dose of Study Drug|Overall Study||28
2579573|NCT00384774|6327951|P4|Received at Least 1 Dose of Study Drug|Overall Study||24
2579574|NCT00384774|6327952|P3|Received at Least 1 Dose of Study Drug|Overall Study||12
2579575|NCT00384774|6327953|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
2579576|NCT00384774|6327954|P1|Received at Least 1 Dose of Study Drug|Overall Study||42
2579577|NCT00384774|6327948|P7|STARTED|Overall Study||4
2579578|NCT00384774|6327949|P6|STARTED|Overall Study||16
2579579|NCT00384774|6327950|P5|STARTED|Overall Study||28
2579580|NCT00384774|6327951|P4|STARTED|Overall Study||24
2579581|NCT00384774|6327952|P3|STARTED|Overall Study||12
2579582|NCT00384774|6327953|P2|STARTED|Overall Study||4
2579583|NCT00384774|6327954|P1|STARTED|Overall Study||42
2579584|NCT00384748|6328028|P2|NOT COMPLETED|Overall Study||0
2579585|NCT00384748|6328029|P1|NOT COMPLETED|Overall Study||0
2579586|NCT00384748|6328028|P2|COMPLETED|Overall Study||23
2579587|NCT00384748|6328029|P1|COMPLETED|Overall Study||25
2579588|NCT00384748|6328028|P2|STARTED|Overall Study||23
2579589|NCT00384748|6328029|P1|STARTED|Overall Study||25
2579590|NCT00384670|6328035|P1|NOT COMPLETED|Overall Study||0
2579591|NCT00384670|6328035|P1|COMPLETED|Overall Study||7
2579592|NCT00384670|6328035|P1|STARTED|Overall Study||7
2579593|NCT00384449|6328045|P1|NOT COMPLETED|Overall Study||0
2579594|NCT00384449|6328045|P1|COMPLETED|Overall Study||1
2579595|NCT00384449|6328045|P1|STARTED|Overall Study||1
2579596|NCT00384397|6328056|P3|NOT COMPLETED|Overall Study||33
2579597|NCT00384397|6328057|P2|NOT COMPLETED|Overall Study||46
2579598|NCT00384397|6328058|P1|NOT COMPLETED|Overall Study||32
2579599|NCT00384397|6328056|P3|COMPLETED|Overall Study||385
2579600|NCT00384397|6328057|P2|COMPLETED|Overall Study||247
2579601|NCT00384397|6328058|P1|COMPLETED|Overall Study||375
2579602|NCT00384397|6328056|P3|STARTED|Overall Study||418
2579603|NCT00384397|6328057|P2|STARTED|Overall Study||293
2579604|NCT00384397|6328058|P1|STARTED|Overall Study||407
2579605|NCT00384332|6328077|P2|NOT COMPLETED|Overall Study||0
2579606|NCT00384332|6328078|P1|NOT COMPLETED|Overall Study||4
2579607|NCT00384332|6328077|P2|COMPLETED|Overall Study||10
2579608|NCT00384332|6328078|P1|COMPLETED|Overall Study||9
2579609|NCT00384332|6328077|P2|STARTED|Overall Study||10
2579610|NCT00384332|6328078|P1|STARTED|Overall Study||13
2579611|NCT00384293|6328088|P3|NOT COMPLETED|Post-randomization Period||219
2579612|NCT00384293|6328089|P2|NOT COMPLETED|Post-randomization Period||214
2579613|NCT00384293|6328090|P1|NOT COMPLETED|Post-randomization Period||0
2579614|NCT00384293|6328088|P3|COMPLETED|Post-randomization Period||0
2579615|NCT00384293|6328089|P2|COMPLETED|Post-randomization Period||0
2579616|NCT00384293|6328090|P1|COMPLETED|Post-randomization Period||0
2579617|NCT00384293|6328088|P3|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||218
2579618|NCT00384293|6328089|P2|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period|Received at least one dose of randomized study drug (All Patients as Treated Population)|214
2579619|NCT00384293|6328090|P1|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||0
2579620|NCT00384293|6328088|P3|STARTED|Post-randomization Period||219
2579621|NCT00384293|6328089|P2|STARTED|Post-randomization Period||214
2579622|NCT00384293|6328090|P1|STARTED|Post-randomization Period||0
2579623|NCT00384293|6328088|P3|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
2579624|NCT00384293|6328089|P2|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
2579625|NCT00384293|6328090|P1|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||504
2579626|NCT00384293|6328088|P3|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
2579627|NCT00384293|6328089|P2|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
2579628|NCT00384293|6328090|P1|COMPLETED|MK0524A Active Run-In, Pre-randomization||433
2579629|NCT00384293|6328088|P3|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
2579630|NCT00384293|6328089|P2|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
2579631|NCT00384293|6328090|P1|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization|MK0524A dose increased to 2 g in active run-in period|813
2579632|NCT00384293|6328088|P3|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
2579633|NCT00384293|6328089|P2|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
2579634|NCT00384293|6328090|P1|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization|Entered active run-in period and received MK0524A 1 g|937
2579635|NCT00384293|6328088|P3|STARTED|MK0524A Active Run-In, Pre-randomization||0
2579636|NCT00384293|6328089|P2|STARTED|MK0524A Active Run-In, Pre-randomization||0
2579637|NCT00384293|6328090|P1|STARTED|MK0524A Active Run-In, Pre-randomization||937
2579638|NCT00384241|6328103|P2|NOT COMPLETED|Overall Study||0
2579639|NCT00384241|6328104|P1|NOT COMPLETED|Overall Study||0
2579640|NCT00384241|6328103|P2|COMPLETED|Overall Study||599
2579641|NCT00384241|6328104|P1|COMPLETED|Overall Study||500
2579642|NCT00384241|6328103|P2|STARTED|Overall Study||599
2579643|NCT00384241|6328104|P1|STARTED|Overall Study||500
2579644|NCT00384189|6328114|P4|NOT COMPLETED|Overall Study||40
2579645|NCT00384189|6328115|P3|NOT COMPLETED|Overall Study||58
2579646|NCT00384189|6328116|P2|NOT COMPLETED|Overall Study||57
2579647|NCT00384189|6328117|P1|NOT COMPLETED|Overall Study||50
2579648|NCT00384189|6328114|P4|COMPLETED|Overall Study||110
2579649|NCT00384189|6328115|P3|COMPLETED|Overall Study||255
2579650|NCT00384189|6328116|P2|COMPLETED|Overall Study||255
2579651|NCT00384189|6328117|P1|COMPLETED|Overall Study||255
2579652|NCT00384189|6328114|P4|Actual Treatment Received|Overall Study||146
2579653|NCT00384189|6328115|P3|Actual Treatment Received|Overall Study|1 participants in the 160 μg arm actually received 40 μg and is moved to that arm.|310
2579654|NCT00384189|6328116|P2|Actual Treatment Received|Overall Study||312
2579655|NCT00384189|6328117|P1|Actual Treatment Received|Overall Study|1 participant randomized to 160 μg who actually received 40 μg is included.|305
2579656|NCT00384189|6328114|P4|Randomized, Not Treated|Overall Study||4
2579657|NCT00384189|6328115|P3|Randomized, Not Treated|Overall Study||2
2579658|NCT00384189|6328116|P2|Randomized, Not Treated|Overall Study||0
2579659|NCT00384189|6328117|P1|Randomized, Not Treated|Overall Study||1
2579660|NCT00384189|6328114|P4|STARTED|Overall Study||150
2579661|NCT00384189|6328115|P3|STARTED|Overall Study||313
2579662|NCT00384189|6328116|P2|STARTED|Overall Study||312
2579663|NCT00384189|6328117|P1|STARTED|Overall Study||305
2579664|NCT00384176|6328178|P3|NOT COMPLETED|Overall Study||132
2579665|NCT00384176|6328179|P2|NOT COMPLETED|Overall Study||319
2579666|NCT00384176|6328180|P1|NOT COMPLETED|Overall Study||312
2579667|NCT00384176|6328178|P3|COMPLETED|Overall Study||60
2579668|NCT00384176|6328179|P2|COMPLETED|Overall Study||394
2579669|NCT00384176|6328180|P1|COMPLETED|Overall Study||397
2579670|NCT00384176|6328178|P3|STARTED|Overall Study||192
2579671|NCT00384176|6328179|P2|STARTED|Overall Study||713
2579672|NCT00384176|6328180|P1|STARTED|Overall Study||709
2579673|NCT00384085|6328206|P3|NOT COMPLETED|Overall Study||56
2579674|NCT00384085|6328207|P2|NOT COMPLETED|Overall Study||46
2579675|NCT00384085|6328208|P1|NOT COMPLETED|Overall Study||39
2579676|NCT00384085|6328206|P3|COMPLETED|Overall Study|Based on the entire ITT population|141
2579677|NCT00384085|6328207|P2|COMPLETED|Overall Study|Based on the entire ITT population|150
2579678|NCT00384085|6328208|P1|COMPLETED|Overall Study|Based on the entire ITT population|156
2579679|NCT00384085|6328206|P3|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||189
2579680|NCT00384085|6328207|P2|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||186
2579681|NCT00384085|6328208|P1|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||187
2579682|NCT00384085|6328206|P3|Treated (Safety Population)|Overall Study||194
2579683|NCT00384085|6328207|P2|Treated (Safety Population)|Overall Study||194
2579684|NCT00384085|6328208|P1|Treated (Safety Population)|Overall Study||194
2579685|NCT00384085|6328206|P3|Intent-To-Treat (ITT)|Overall Study||197
2579686|NCT00384085|6328207|P2|Intent-To-Treat (ITT)|Overall Study||196
2579687|NCT00384085|6328208|P1|Intent-To-Treat (ITT)|Overall Study||195
2579688|NCT00384085|6328206|P3|STARTED|Overall Study|Randomized|197
2579689|NCT00384085|6328207|P2|STARTED|Overall Study|Randomized|196
2579690|NCT00384085|6328208|P1|STARTED|Overall Study|Randomized|195
2579691|NCT00384059|6328234|P2|NOT COMPLETED|Toddler Dose||2
2579692|NCT00384059|6328235|P1|NOT COMPLETED|Toddler Dose||1
2579693|NCT00384059|6328234|P2|COMPLETED|Toddler Dose||120
2579694|NCT00384059|6328235|P1|COMPLETED|Toddler Dose||130
2579695|NCT00384059|6328234|P2|STARTED|Toddler Dose||122
2579696|NCT00384059|6328235|P1|STARTED|Toddler Dose||131
2579697|NCT00384059|6328234|P2|NOT COMPLETED|After Infant Series||10
2579698|NCT00384059|6328235|P1|NOT COMPLETED|After Infant Series||4
2579699|NCT00384059|6328234|P2|COMPLETED|After Infant Series||122
2579700|NCT00384059|6328235|P1|COMPLETED|After Infant Series||131
2579701|NCT00384059|6328234|P2|STARTED|After Infant Series||132
2579702|NCT00384059|6328235|P1|STARTED|After Infant Series||135
2579703|NCT00384059|6328234|P2|NOT COMPLETED|Infant Series||13
2579704|NCT00384059|6328235|P1|NOT COMPLETED|Infant Series||6
2579705|NCT00384059|6328234|P2|COMPLETED|Infant Series||132
2579706|NCT00384059|6328235|P1|COMPLETED|Infant Series||135
2579707|NCT00384059|6328234|P2|Vaccinated Dose 2|Infant Series||135
2579708|NCT00384059|6328235|P1|Vaccinated Dose 2|Infant Series||136
2579709|NCT00384059|6328234|P2|Vaccinated Dose 1|Infant Series||139
2579710|NCT00384059|6328235|P1|Vaccinated Dose 1|Infant Series||139
2579711|NCT00384059|6328234|P2|STARTED|Infant Series||145
2579712|NCT00384059|6328235|P1|STARTED|Infant Series||141
2579713|NCT00384033|6328285|P4|NOT COMPLETED|Overall Study||40
2579714|NCT00384033|6328286|P3|NOT COMPLETED|Overall Study||43
2579715|NCT00384033|6328287|P2|NOT COMPLETED|Overall Study||35
2579716|NCT00384033|6328288|P1|NOT COMPLETED|Overall Study||41
2579717|NCT00384033|6328285|P4|COMPLETED|Overall Study||119
2579718|NCT00384033|6328286|P3|COMPLETED|Overall Study||117
2579719|NCT00384033|6328287|P2|COMPLETED|Overall Study||120
2579720|NCT00384033|6328288|P1|COMPLETED|Overall Study||123
2579721|NCT00384033|6328285|P4|Treated|Overall Study||157
2579722|NCT00384033|6328286|P3|Treated|Overall Study||150
2579723|NCT00384033|6328287|P2|Treated|Overall Study||148
2579724|NCT00384033|6328288|P1|Treated|Overall Study||161
2579725|NCT00384033|6328285|P4|STARTED|Overall Study||159
2579726|NCT00384033|6328286|P3|STARTED|Overall Study||160
2579727|NCT00384033|6328287|P2|STARTED|Overall Study||155
2579728|NCT00384033|6328288|P1|STARTED|Overall Study||164
2579729|NCT00383942|6328332|P2|NOT COMPLETED|Overall Study||0
2579730|NCT00383942|6328333|P1|NOT COMPLETED|Overall Study||0
2579731|NCT00383942|6328332|P2|COMPLETED|Overall Study||40
2579732|NCT00383942|6328333|P1|COMPLETED|Overall Study||40
2579733|NCT00383942|6328332|P2|STARTED|Overall Study||40
2579734|NCT00383942|6328333|P1|STARTED|Overall Study||40
2579735|NCT00383786|6328341|P2|NOT COMPLETED|Overall Study||12
2579736|NCT00383786|6328342|P1|NOT COMPLETED|Overall Study||4
2579737|NCT00383786|6328341|P2|COMPLETED|Overall Study||13
2579738|NCT00383786|6328342|P1|COMPLETED|Overall Study||18
2579739|NCT00383786|6328341|P2|STARTED|Overall Study||25
2579740|NCT00383786|6328342|P1|STARTED|Overall Study||22
2579741|NCT00383760|6328348|P1|NOT COMPLETED|Overall Study||0
2579742|NCT00383760|6328348|P1|COMPLETED|Overall Study||15
2579743|NCT00383760|6328348|P1|STARTED|Overall Study||15
2579744|NCT00383747|6328364|P4|NOT COMPLETED|Visit 2||0
2579745|NCT00383747|6328365|P3|NOT COMPLETED|Visit 2||0
2579746|NCT00383747|6328366|P2|NOT COMPLETED|Visit 2||0
2579747|NCT00383747|6328367|P1|NOT COMPLETED|Visit 2||0
2579748|NCT00383747|6328364|P4|COMPLETED|Visit 2||16
2579749|NCT00383747|6328365|P3|COMPLETED|Visit 2||16
2579750|NCT00383747|6328366|P2|COMPLETED|Visit 2||14
2579751|NCT00383747|6328367|P1|COMPLETED|Visit 2||14
2579752|NCT00383747|6328364|P4|STARTED|Visit 2||16
2579753|NCT00383747|6328365|P3|STARTED|Visit 2||16
2579754|NCT00383747|6328366|P2|STARTED|Visit 2||14
2579755|NCT00383747|6328367|P1|STARTED|Visit 2||14
2579756|NCT00383747|6328364|P4|NOT COMPLETED|Visit 1||0
2579757|NCT00383747|6328365|P3|NOT COMPLETED|Visit 1||0
2579758|NCT00383747|6328366|P2|NOT COMPLETED|Visit 1||0
2579759|NCT00383747|6328367|P1|NOT COMPLETED|Visit 1||0
2579760|NCT00383747|6328364|P4|COMPLETED|Visit 1||16
2579761|NCT00383747|6328365|P3|COMPLETED|Visit 1||16
2579762|NCT00383747|6328366|P2|COMPLETED|Visit 1||14
2579763|NCT00383747|6328367|P1|COMPLETED|Visit 1||14
2579764|NCT00383747|6328364|P4|STARTED|Visit 1||16
2579765|NCT00383747|6328365|P3|STARTED|Visit 1||16
2579766|NCT00383747|6328366|P2|STARTED|Visit 1||14
2579767|NCT00383747|6328367|P1|STARTED|Visit 1||14
2579768|NCT00383721|6328392|P5|NOT COMPLETED|26-Week Treatment Safety Extension||0
2579769|NCT00383721|6328393|P4|NOT COMPLETED|26-Week Treatment Safety Extension||17
2579770|NCT00383721|6328394|P3|NOT COMPLETED|26-Week Treatment Safety Extension||23
2579771|NCT00383721|6328395|P2|NOT COMPLETED|26-Week Treatment Safety Extension||17
2579772|NCT00383721|6328396|P1|NOT COMPLETED|26-Week Treatment Safety Extension||19
2579773|NCT00383721|6328392|P5|COMPLETED|26-Week Treatment Safety Extension||8
2579774|NCT00383721|6328393|P4|COMPLETED|26-Week Treatment Safety Extension||131
2579775|NCT00383721|6328394|P3|COMPLETED|26-Week Treatment Safety Extension||126
2579776|NCT00383721|6328395|P2|COMPLETED|26-Week Treatment Safety Extension||136
2579777|NCT00383721|6328396|P1|COMPLETED|26-Week Treatment Safety Extension||126
2579778|NCT00383721|6328392|P5|STARTED|26-Week Treatment Safety Extension||8
2579779|NCT00383721|6328393|P4|STARTED|26-Week Treatment Safety Extension||148
2579780|NCT00383721|6328394|P3|STARTED|26-Week Treatment Safety Extension||149
2579781|NCT00383721|6328395|P2|STARTED|26-Week Treatment Safety Extension||153
2579782|NCT00383721|6328396|P1|STARTED|26-Week Treatment Safety Extension||145
2579783|NCT00383721|6328392|P5|NOT COMPLETED|26-Week Double-Blind Treatment Period||67
2579784|NCT00383721|6328393|P4|NOT COMPLETED|26-Week Double-Blind Treatment Period||50
2579785|NCT00383721|6328394|P3|NOT COMPLETED|26-Week Double-Blind Treatment Period||51
2579786|NCT00383721|6328395|P2|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
2579787|NCT00383721|6328396|P1|NOT COMPLETED|26-Week Double-Blind Treatment Period||35
2579788|NCT00383721|6328392|P5|COMPLETED|26-Week Double-Blind Treatment Period||169
2579789|NCT00383721|6328393|P4|COMPLETED|26-Week Double-Blind Treatment Period||193
2579790|NCT00383721|6328394|P3|COMPLETED|26-Week Double-Blind Treatment Period||202
2579791|NCT00383721|6328395|P2|COMPLETED|26-Week Double-Blind Treatment Period||202
2579792|NCT00383721|6328396|P1|COMPLETED|26-Week Double-Blind Treatment Period|1 participant listed as “ongoing” since the participant status could not be formally confirmed.|190
2579793|NCT00383721|6328392|P5|STARTED|26-Week Double-Blind Treatment Period||236
2579794|NCT00383721|6328393|P4|STARTED|26-Week Double-Blind Treatment Period||243
2579795|NCT00383721|6328394|P3|STARTED|26-Week Double-Blind Treatment Period||253
2579796|NCT00383721|6328395|P2|STARTED|26-Week Double-Blind Treatment Period||239
2579797|NCT00383721|6328396|P1|STARTED|26-Week Double-Blind Treatment Period||225
2579798|NCT00383708|6328433|P1|NOT COMPLETED|Co-administration Period||5
2579799|NCT00383708|6328433|P1|COMPLETED|Co-administration Period||52
2579800|NCT00383708|6328433|P1|STARTED|Co-administration Period||57
2579801|NCT00383708|6328433|P1|NOT COMPLETED|Run-in Period||7
2579802|NCT00383708|6328433|P1|COMPLETED|Run-in Period||85
2579803|NCT00383708|6328433|P1|STARTED|Run-in Period||92
2579804|NCT00383708|6328433|P1|NOT COMPLETED|Enrolment Through Start Treatment||33
2579805|NCT00383708|6328433|P1|COMPLETED|Enrolment Through Start Treatment||92
2579806|NCT00383708|6328433|P1|STARTED|Enrolment Through Start Treatment||125
2579807|NCT00383643|6328470|P3|NOT COMPLETED|Overall Study||1
2579808|NCT00383643|6328471|P2|NOT COMPLETED|Overall Study||1
2579809|NCT00383643|6328472|P1|NOT COMPLETED|Overall Study||1
2579810|NCT00383643|6328470|P3|COMPLETED|Overall Study||13
2579811|NCT00383643|6328471|P2|COMPLETED|Overall Study||15
2579812|NCT00383643|6328472|P1|COMPLETED|Overall Study||17
2579813|NCT00383643|6328470|P3|STARTED|Overall Study||14
2579814|NCT00383643|6328471|P2|STARTED|Overall Study||16
2579815|NCT00383643|6328472|P1|STARTED|Overall Study||18
2579816|NCT00383630|6328492|P1|NOT COMPLETED|Overall Study||0
2579817|NCT00383630|6328492|P1|COMPLETED|Overall Study||1
2579818|NCT00383630|6328492|P1|STARTED|Overall Study||1
2579819|NCT00383565|6328498|P1|NOT COMPLETED|Overall Study||0
2579820|NCT00383565|6328498|P1|COMPLETED|Overall Study||9
2579821|NCT00383565|6328498|P1|STARTED|Overall Study||9
2579822|NCT00383552|6328508|P4|NOT COMPLETED|Overall Study||72
2579823|NCT00383552|6328509|P3|NOT COMPLETED|Overall Study||61
2579824|NCT00383552|6328510|P2|NOT COMPLETED|Overall Study||41
2579825|NCT00383552|6328511|P1|NOT COMPLETED|Overall Study||36
2579826|NCT00383552|6328508|P4|COMPLETED|Overall Study||116
2579827|NCT00383552|6328509|P3|COMPLETED|Overall Study||127
2579828|NCT00383552|6328510|P2|COMPLETED|Overall Study||147
2579829|NCT00383552|6328511|P1|COMPLETED|Overall Study||146
2579830|NCT00383552|6328508|P4|STARTED|Overall Study||188
2579831|NCT00383552|6328509|P3|STARTED|Overall Study||188
2579832|NCT00383552|6328510|P2|STARTED|Overall Study||188
2579833|NCT00383552|6328511|P1|STARTED|Overall Study||182
2579834|NCT00383500|6328553|P3|NOT COMPLETED|Overall Study||2
2579835|NCT00383500|6328554|P2|NOT COMPLETED|Overall Study||3
2579836|NCT00383500|6328555|P1|NOT COMPLETED|Overall Study||8
2579837|NCT00383500|6328553|P3|COMPLETED|Overall Study||22
2579838|NCT00383500|6328554|P2|COMPLETED|Overall Study||21
2579839|NCT00383500|6328555|P1|COMPLETED|Overall Study||19
2579840|NCT00383500|6328553|P3|STARTED|Overall Study||24
2579841|NCT00383500|6328554|P2|STARTED|Overall Study||24
2579842|NCT00383500|6328555|P1|STARTED|Overall Study||27
2579843|NCT00383448|6328566|P1|NOT COMPLETED|Overall Study||0
2579844|NCT00383448|6328566|P1|COMPLETED|Overall Study||38
2579845|NCT00383448|6328566|P1|STARTED|Overall Study||38
2579846|NCT00383435|6328579|P5|NOT COMPLETED|26-Week Treatment Safety Extension||3
2579847|NCT00383435|6328580|P4|NOT COMPLETED|26-Week Treatment Safety Extension||15
2579848|NCT00383435|6328581|P3|NOT COMPLETED|26-Week Treatment Safety Extension||16
2579849|NCT00383435|6328582|P2|NOT COMPLETED|26-Week Treatment Safety Extension||9
2579850|NCT00383435|6328583|P1|NOT COMPLETED|26-Week Treatment Safety Extension||14
2579851|NCT00383435|6328579|P5|COMPLETED|26-Week Treatment Safety Extension||10
2579852|NCT00383435|6328580|P4|COMPLETED|26-Week Treatment Safety Extension||116
2579853|NCT00383435|6328581|P3|COMPLETED|26-Week Treatment Safety Extension||108
2579854|NCT00383435|6328582|P2|COMPLETED|26-Week Treatment Safety Extension||121
2579855|NCT00383435|6328583|P1|COMPLETED|26-Week Treatment Safety Extension||117
2579856|NCT00383435|6328579|P5|STARTED|26-Week Treatment Safety Extension||13
2579857|NCT00383435|6328580|P4|STARTED|26-Week Treatment Safety Extension||131
2579858|NCT00383435|6328581|P3|STARTED|26-Week Treatment Safety Extension||124
2579859|NCT00383435|6328582|P2|STARTED|26-Week Treatment Safety Extension||130
2579860|NCT00383435|6328583|P1|STARTED|26-Week Treatment Safety Extension||131
2579861|NCT00383435|6328579|P5|NOT COMPLETED|26-Week Double-Blind Treatment Period||53
2579862|NCT00383435|6328580|P4|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
2579863|NCT00383435|6328581|P3|NOT COMPLETED|26-Week Double-Blind Treatment Period||46
2579864|NCT00383435|6328582|P2|NOT COMPLETED|26-Week Double-Blind Treatment Period||38
2579865|NCT00383435|6328583|P1|NOT COMPLETED|26-Week Double-Blind Treatment Period||41
2579866|NCT00383435|6328579|P5|COMPLETED|26-Week Double-Blind Treatment Period||159
2579867|NCT00383435|6328580|P4|COMPLETED|26-Week Double-Blind Treatment Period||172
2579868|NCT00383435|6328581|P3|COMPLETED|26-Week Double-Blind Treatment Period||164
2579869|NCT00383435|6328582|P2|COMPLETED|26-Week Double-Blind Treatment Period||169
2579870|NCT00383435|6328583|P1|COMPLETED|26-Week Double-Blind Treatment Period||176
2579871|NCT00383435|6328579|P5|STARTED|26-Week Double-Blind Treatment Period||212
2579872|NCT00383435|6328580|P4|STARTED|26-Week Double-Blind Treatment Period||209
2579873|NCT00383435|6328581|P3|STARTED|26-Week Double-Blind Treatment Period||210
2579874|NCT00383435|6328582|P2|STARTED|26-Week Double-Blind Treatment Period||207
2579875|NCT00383435|6328583|P1|STARTED|26-Week Double-Blind Treatment Period||217
2579876|NCT00383331|6328622|P2|NOT COMPLETED|Overall Study||1
2579877|NCT00383331|6328623|P1|NOT COMPLETED|Overall Study||0
2579878|NCT00383331|6328622|P2|COMPLETED|Overall Study||8
2579879|NCT00383331|6328623|P1|COMPLETED|Overall Study||10
2579880|NCT00383331|6328622|P2|STARTED|Overall Study||9
2579881|NCT00383331|6328623|P1|STARTED|Overall Study||10
2579882|NCT00383292|6328642|P3|NOT COMPLETED|Overall Study||8
2579883|NCT00383292|6328643|P2|NOT COMPLETED|Overall Study||6
2579884|NCT00383292|6328644|P1|NOT COMPLETED|Overall Study||15
2579885|NCT00383292|6328642|P3|COMPLETED|Overall Study||22
2579886|NCT00383292|6328643|P2|COMPLETED|Overall Study||26
2579887|NCT00383292|6328644|P1|COMPLETED|Overall Study||53
2579888|NCT00383292|6328642|P3|Received at Least One Dose of Study Drug|Overall Study||30
2579889|NCT00383292|6328643|P2|Received at Least One Dose of Study Drug|Overall Study||32
2579890|NCT00383292|6328644|P1|Received at Least One Dose of Study Drug|Overall Study||68
2579891|NCT00383292|6328642|P3|STARTED|Overall Study||30
2579892|NCT00383292|6328643|P2|STARTED|Overall Study||32
2579893|NCT00383292|6328644|P1|STARTED|Overall Study||68
2579894|NCT00383266|6328672|P1|NOT COMPLETED|Overall Study||0
2579895|NCT00383266|6328672|P1|COMPLETED|Overall Study||9
2579896|NCT00383266|6328672|P1|STARTED|Overall Study||9
2579897|NCT00383240|6328685|P4|NOT COMPLETED|Overall Study||77
2579898|NCT00383240|6328686|P3|NOT COMPLETED|Overall Study||85
2579899|NCT00383240|6328687|P2|NOT COMPLETED|Overall Study||33
2579900|NCT00383240|6328688|P1|NOT COMPLETED|Overall Study||35
2579901|NCT00383240|6328685|P4|COMPLETED|Overall Study||119
2579902|NCT00383240|6328686|P3|COMPLETED|Overall Study||117
2579903|NCT00383240|6328687|P2|COMPLETED|Overall Study||159
2579904|NCT00383240|6328688|P1|COMPLETED|Overall Study||156
2579905|NCT00383240|6328685|P4|STARTED|Overall Study||196
2579906|NCT00383240|6328686|P3|STARTED|Overall Study||202
2579907|NCT00383240|6328687|P2|STARTED|Overall Study||192
2579908|NCT00383240|6328688|P1|STARTED|Overall Study||191
2579909|NCT00383162|6328719|P2|NOT COMPLETED|Migraine Attack 2 (Period 2)||7
2579910|NCT00383162|6328720|P1|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
2579911|NCT00383162|6328719|P2|COMPLETED|Migraine Attack 2 (Period 2)||66
2579912|NCT00383162|6328720|P1|COMPLETED|Migraine Attack 2 (Period 2)||65
2579913|NCT00383162|6328719|P2|STARTED|Migraine Attack 2 (Period 2)||73
2579914|NCT00383162|6328720|P1|STARTED|Migraine Attack 2 (Period 2)||67
2579915|NCT00383162|6328719|P2|NOT COMPLETED|Migraine Attack 1 (Period 1)||13
2579916|NCT00383162|6328720|P1|NOT COMPLETED|Migraine Attack 1 (Period 1)||20
2579917|NCT00383162|6328719|P2|COMPLETED|Migraine Attack 1 (Period 1)|Participants not completing did not take investigational product.|73
2579918|NCT00383162|6328720|P1|COMPLETED|Migraine Attack 1 (Period 1)|Participants completing a period treated a migraine with investigational product.|67
2579919|NCT00383162|6328719|P2|STARTED|Migraine Attack 1 (Period 1)||86
2579920|NCT00383162|6328720|P1|STARTED|Migraine Attack 1 (Period 1)||87
2579921|NCT00383149|6328762|P1|NOT COMPLETED|Overall Study||54
2579922|NCT00383149|6328762|P1|COMPLETED|Overall Study||0
2579923|NCT00383149|6328762|P1|STARTED|Overall Study||54
2579924|NCT00383123|6328781|P2|NOT COMPLETED|Overall Study||86
2579925|NCT00383123|6328782|P1|NOT COMPLETED|Overall Study||111
2579926|NCT00383123|6328781|P2|COMPLETED|Overall Study||1124
2579927|NCT00383123|6328782|P1|COMPLETED|Overall Study||2004
2579928|NCT00383123|6328781|P2|STARTED|Overall Study||1210
2579929|NCT00383123|6328782|P1|STARTED|Overall Study||2115
2579930|NCT00383110|6328804|P2|NOT COMPLETED|Overall Study||0
2579931|NCT00383110|6328805|P1|NOT COMPLETED|Overall Study||0
2579932|NCT00383110|6328804|P2|COMPLETED|Overall Study||150
2579933|NCT00383110|6328805|P1|COMPLETED|Overall Study||150
2579934|NCT00383110|6328804|P2|STARTED|Overall Study||150
2579935|NCT00383110|6328805|P1|STARTED|Overall Study||150
2579936|NCT00383084|6328823|P2|NOT COMPLETED|Overall Study||10
2579937|NCT00383084|6328824|P1|NOT COMPLETED|Overall Study||12
2579938|NCT00383084|6328823|P2|COMPLETED|Overall Study||28
2579939|NCT00383084|6328824|P1|COMPLETED|Overall Study||34
2579940|NCT00383084|6328823|P2|STARTED|Overall Study||38
2579941|NCT00383084|6328824|P1|STARTED|Overall Study||46
2579942|NCT00383071|6328840|P4|NOT COMPLETED|Overall Study||3
2579943|NCT00383071|6328841|P3|NOT COMPLETED|Overall Study||7
2579944|NCT00383071|6328842|P2|NOT COMPLETED|Overall Study||4
2579945|NCT00383071|6328843|P1|NOT COMPLETED|Overall Study||0
2579946|NCT00383071|6328840|P4|COMPLETED|Overall Study||22
2579947|NCT00383071|6328841|P3|COMPLETED|Overall Study||44
2579948|NCT00383071|6328842|P2|COMPLETED|Overall Study||21
2579949|NCT00383071|6328843|P1|COMPLETED|Overall Study||25
2579950|NCT00383071|6328840|P4|STARTED|Overall Study||25
2579951|NCT00383071|6328841|P3|STARTED|Overall Study||51
2579952|NCT00383071|6328842|P2|STARTED|Overall Study||25
2579953|NCT00383071|6328843|P1|STARTED|Overall Study||25
2579954|NCT00383019|6328855|P2|NOT COMPLETED|Overall Study||2
2579955|NCT00383019|6328856|P1|NOT COMPLETED|Overall Study||5
2579956|NCT00383019|6328855|P2|COMPLETED|Overall Study||143
2579957|NCT00383019|6328856|P1|COMPLETED|Overall Study||139
2579958|NCT00383019|6328855|P2|STARTED|Overall Study||145
2579959|NCT00383019|6328856|P1|STARTED|Overall Study||144
2579960|NCT00382993|6328878|P2|NOT COMPLETED|Migraine Attack 2 (Period 2)||4
2579961|NCT00382993|6328879|P1|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
2579962|NCT00382993|6328878|P2|COMPLETED|Migraine Attack 2 (Period 2)||63
2579963|NCT00382993|6328879|P1|COMPLETED|Migraine Attack 2 (Period 2)||68
2579964|NCT00382993|6328878|P2|STARTED|Migraine Attack 2 (Period 2)||67
2579965|NCT00382993|6328879|P1|STARTED|Migraine Attack 2 (Period 2)||70
2579966|NCT00382993|6328878|P2|NOT COMPLETED|Migraine Attack 1 (Period 1)||18
2579967|NCT00382993|6328879|P1|NOT COMPLETED|Migraine Attack 1 (Period 1)||14
2579968|NCT00382993|6328878|P2|COMPLETED|Migraine Attack 1 (Period 1)||67
2579969|NCT00382993|6328879|P1|COMPLETED|Migraine Attack 1 (Period 1)|Participant considered to have completed period if treated a migraine with investigational product.|70
2579970|NCT00382993|6328878|P2|STARTED|Migraine Attack 1 (Period 1)||85
2579971|NCT00382993|6328879|P1|STARTED|Migraine Attack 1 (Period 1)||84
2579972|NCT00382967|6328923|P2|NOT COMPLETED|Overall Study||1
2579973|NCT00382967|6328924|P1|NOT COMPLETED|Overall Study||1
2579974|NCT00382967|6328923|P2|COMPLETED|Overall Study|Subject dosed in error, should not have received Datscan product|137
2579975|NCT00382967|6328924|P1|COMPLETED|Overall Study|Patient lost to followup and the data was not recorded.|121
2579976|NCT00382967|6328923|P2|STARTED|Overall Study||138
2579977|NCT00382967|6328924|P1|STARTED|Overall Study|135 subjects enrolled at the start of the study, however, 13 subjects withdrew prior to dosing.|122
2579978|NCT00382928|6328934|P2|NOT COMPLETED|Overall Study||0
2579979|NCT00382928|6328935|P1|NOT COMPLETED|Overall Study||0
2579980|NCT00382928|6328934|P2|COMPLETED|Overall Study||95
2579981|NCT00382928|6328935|P1|COMPLETED|Overall Study||97
2579982|NCT00382928|6328934|P2|STARTED|Overall Study||95
2579983|NCT00382928|6328935|P1|STARTED|Overall Study||97
2579984|NCT00382863|6328949|P2|NOT COMPLETED|Overall Study||36
2579985|NCT00382863|6328950|P1|NOT COMPLETED|Overall Study||15
2579986|NCT00382863|6328949|P2|COMPLETED|Overall Study||78
2579987|NCT00382863|6328950|P1|COMPLETED|Overall Study||81
2579988|NCT00382863|6328949|P2|STARTED|Overall Study||114
2579989|NCT00382863|6328950|P1|STARTED|Overall Study||96
2579990|NCT00382824|6329006|P2|NOT COMPLETED|Overall Study||13
2579991|NCT00382824|6329007|P1|NOT COMPLETED|Overall Study||12
2579992|NCT00382824|6329006|P2|COMPLETED|Overall Study||16
2579993|NCT00382824|6329007|P1|COMPLETED|Overall Study||20
2579994|NCT00382824|6329006|P2|STARTED|Overall Study||29
2579995|NCT00382824|6329007|P1|STARTED|Overall Study||32
2579996|NCT00382785|6329023|P2|NOT COMPLETED|Overall Study||0
2579997|NCT00382785|6329024|P1|NOT COMPLETED|Overall Study||0
2579998|NCT00382785|6329023|P2|COMPLETED|Overall Study||26
2579999|NCT00382785|6329024|P1|COMPLETED|Overall Study||25
2580000|NCT00382785|6329023|P2|STARTED|Overall Study||26
2580001|NCT00382785|6329024|P1|STARTED|Overall Study||25
2580002|NCT00382733|6329034|P5|NOT COMPLETED|Overall Study||0
2580003|NCT00382733|6329035|P4|NOT COMPLETED|Overall Study||0
2580004|NCT00382733|6329036|P3|NOT COMPLETED|Overall Study||0
2580005|NCT00382733|6329037|P2|NOT COMPLETED|Overall Study||1
2580006|NCT00382733|6329038|P1|NOT COMPLETED|Overall Study||0
2580007|NCT00382733|6329034|P5|COMPLETED|Overall Study||2
2580008|NCT00382733|6329035|P4|COMPLETED|Overall Study||14
2580009|NCT00382733|6329036|P3|COMPLETED|Overall Study||3
2580010|NCT00382733|6329037|P2|COMPLETED|Overall Study|1 subject withdrew consent before completing Cycle 1 - that subject was replaced|3
2580011|NCT00382733|6329038|P1|COMPLETED|Overall Study||3
2580012|NCT00382733|6329034|P5|STARTED|Overall Study||2
2580013|NCT00382733|6329035|P4|STARTED|Overall Study||14
2580014|NCT00382733|6329036|P3|STARTED|Overall Study||3
2580015|NCT00382733|6329037|P2|STARTED|Overall Study||4
2580016|NCT00382733|6329038|P1|STARTED|Overall Study||3
2580017|NCT00382720|6329059|P3|NOT COMPLETED|Overall Study||86
2580018|NCT00382720|6329060|P2|NOT COMPLETED|Overall Study||89
2580019|NCT00382720|6329061|P1|NOT COMPLETED|Overall Study||79
2580020|NCT00382720|6329059|P3|COMPLETED|Overall Study||0
2580021|NCT00382720|6329060|P2|COMPLETED|Overall Study||0
2580022|NCT00382720|6329061|P1|COMPLETED|Overall Study||0
2580023|NCT00382720|6329059|P3|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|82
2580024|NCT00382720|6329060|P2|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|88
2580025|NCT00382720|6329061|P1|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|78
2580026|NCT00382720|6329059|P3|Administered Optimal Dose (Parts I & II)|Overall Study||82
2580027|NCT00382720|6329060|P2|Administered Optimal Dose (Parts I & II)|Overall Study||88
2580028|NCT00382720|6329061|P1|Administered Optimal Dose (Parts I & II)|Overall Study||78
2580029|NCT00382720|6329059|P3|Administered Non-Optimal Dose (Part I)|Overall Study||0
2580030|NCT00382720|6329060|P2|Administered Non-Optimal Dose (Part I)|Overall Study||11
2580031|NCT00382720|6329061|P1|Administered Non-Optimal Dose (Part I)|Overall Study||10
2580032|NCT00382720|6329059|P3|STARTED|Overall Study||86
2580033|NCT00382720|6329060|P2|STARTED|Overall Study||89
2580034|NCT00382720|6329061|P1|STARTED|Overall Study||79
2580035|NCT00382590|6329077|P2|NOT COMPLETED|Overall Study||0
2580036|NCT00382590|6329078|P1|NOT COMPLETED|Overall Study||0
2580037|NCT00382590|6329077|P2|COMPLETED|Overall Study||6
2580038|NCT00382590|6329078|P1|COMPLETED|Overall Study||4
2580039|NCT00382590|6329077|P2|STARTED|Overall Study||6
2580040|NCT00382590|6329078|P1|STARTED|Overall Study||4
2580041|NCT00382408|6329086|P2|NOT COMPLETED|Overall Study||54
2580042|NCT00382408|6329087|P1|NOT COMPLETED|Overall Study||144
2580043|NCT00382408|6329086|P2|COMPLETED|Overall Study||955
2580044|NCT00382408|6329087|P1|COMPLETED|Overall Study||2887
2580045|NCT00382408|6329086|P2|STARTED|Overall Study||1009
2580046|NCT00382408|6329087|P1|STARTED|Overall Study||3031
2580047|NCT00382291|6329114|P3|NOT COMPLETED|Overall Study||8
2580048|NCT00382291|6329115|P2|NOT COMPLETED|Overall Study||7
2580049|NCT00382291|6329116|P1|NOT COMPLETED|Overall Study||4
2580050|NCT00382291|6329114|P3|COMPLETED|Overall Study||13
2580051|NCT00382291|6329115|P2|COMPLETED|Overall Study||10
2580052|NCT00382291|6329116|P1|COMPLETED|Overall Study||14
2580053|NCT00382291|6329114|P3|STARTED|Overall Study||21
2580054|NCT00382291|6329115|P2|STARTED|Overall Study||17
2580055|NCT00382291|6329116|P1|STARTED|Overall Study||18
2580056|NCT00382265|6329129|P2|NOT COMPLETED|Overall Study||6
2580057|NCT00382265|6329130|P1|NOT COMPLETED|Overall Study||9
2580058|NCT00382265|6329129|P2|COMPLETED|Overall Study||239
2580059|NCT00382265|6329130|P1|COMPLETED|Overall Study||258
2580060|NCT00382265|6329129|P2|STARTED|Overall Study||245
2580061|NCT00382265|6329130|P1|STARTED|Overall Study||267
2580062|NCT00382174|6329148|P3|NOT COMPLETED|Overall Study||21
2580063|NCT00382174|6329149|P2|NOT COMPLETED|Overall Study||17
2580064|NCT00382174|6329150|P1|NOT COMPLETED|Overall Study||4
2580065|NCT00382174|6329148|P3|COMPLETED|Overall Study||51
2580066|NCT00382174|6329149|P2|COMPLETED|Overall Study||37
2580067|NCT00382174|6329150|P1|COMPLETED|Overall Study||14
2580068|NCT00382174|6329148|P3|STARTED|Overall Study||72
2580069|NCT00382174|6329149|P2|STARTED|Overall Study||54
2580070|NCT00382174|6329150|P1|STARTED|Overall Study||18
2580071|NCT00382148|6329163|P2|NOT COMPLETED|Overall Study||0
2580072|NCT00382148|6329164|P1|NOT COMPLETED|Overall Study||1
2580073|NCT00382148|6329163|P2|COMPLETED|Overall Study||7
2580074|NCT00382148|6329164|P1|COMPLETED|Overall Study||3
2580075|NCT00382148|6329163|P2|STARTED|Overall Study||7
2580076|NCT00382148|6329164|P1|STARTED|Overall Study||4
2580077|NCT00382109|6329178|P2|NOT COMPLETED|Overall Study||4
2580078|NCT00382109|6329179|P1|NOT COMPLETED|Overall Study||12
2580079|NCT00382109|6329178|P2|COMPLETED|Overall Study||66
2580080|NCT00382109|6329179|P1|COMPLETED|Overall Study||64
2580081|NCT00382109|6329178|P2|STARTED|Overall Study||70
2580082|NCT00382109|6329179|P1|STARTED|Overall Study||76
2580083|NCT00382031|6329201|P2|NOT COMPLETED|Overall Study||0
2580084|NCT00382031|6329202|P1|NOT COMPLETED|Overall Study||0
2580085|NCT00382031|6329201|P2|COMPLETED|Overall Study||95
2580086|NCT00382031|6329202|P1|COMPLETED|Overall Study||191
2580087|NCT00382031|6329201|P2|STARTED|Overall Study|Of the 95 randomized patients 94 attended Visit2.|95
2580088|NCT00382031|6329202|P1|STARTED|Overall Study|Of the 191 randomized patients 189 received at least one infusion of zalutumumab|191
2580089|NCT00382018|6329218|P4|NOT COMPLETED|Overall Study||59
2580090|NCT00382018|6329219|P3|NOT COMPLETED|Overall Study||64
2580091|NCT00382018|6329220|P2|NOT COMPLETED|Overall Study||165
2580092|NCT00382018|6329221|P1|NOT COMPLETED|Overall Study||0
2580093|NCT00382018|6329218|P4|COMPLETED|Overall Study||0
2580094|NCT00382018|6329219|P3|COMPLETED|Overall Study||0
2580095|NCT00382018|6329220|P2|COMPLETED|Overall Study||0
2580096|NCT00382018|6329221|P1|COMPLETED|Overall Study|This group of patients did not receive protocol treatment.|276
2580097|NCT00382018|6329218|P4|STARTED|Overall Study||59
2580098|NCT00382018|6329219|P3|STARTED|Overall Study||64
2580099|NCT00382018|6329220|P2|STARTED|Overall Study||165
2580100|NCT00382018|6329221|P1|STARTED|Overall Study||276
2580101|NCT00381966|6329239|P1|NOT COMPLETED|Overall Study||0
2580102|NCT00381966|6329239|P1|COMPLETED|Overall Study||5
2580103|NCT00381966|6329239|P1|STARTED|Overall Study||5
2580104|NCT00381940|6329244|P1|NOT COMPLETED|Overall Study||5
2580105|NCT00381940|6329244|P1|COMPLETED|Overall Study||21
2580106|NCT00381940|6329244|P1|STARTED|Overall Study||26
2580107|NCT00381888|6329248|P1|NOT COMPLETED|Overall Study||17
2580108|NCT00381888|6329248|P1|COMPLETED|Overall Study||27
2580109|NCT00381888|6329248|P1|STARTED|Overall Study||44
2580110|NCT00381862|6329253|P1|NOT COMPLETED|Overall Study||10
2580111|NCT00381862|6329253|P1|COMPLETED|Overall Study||44
2580112|NCT00381862|6329253|P1|STARTED|Overall Study||54
2580113|NCT00381849|6329259|P2|NOT COMPLETED|Open-label||0
2580114|NCT00381849|6329260|P1|NOT COMPLETED|Open-label||0
2580115|NCT00381849|6329259|P2|COMPLETED|Open-label||9
2580116|NCT00381849|6329260|P1|COMPLETED|Open-label||10
2580117|NCT00381849|6329259|P2|STARTED|Open-label||9
2580118|NCT00381849|6329260|P1|STARTED|Open-label||10
2580119|NCT00381849|6329259|P2|NOT COMPLETED|Second Intervention||0
2580120|NCT00381849|6329260|P1|NOT COMPLETED|Second Intervention||0
2580121|NCT00381849|6329259|P2|COMPLETED|Second Intervention||9
2580122|NCT00381849|6329260|P1|COMPLETED|Second Intervention||10
2580123|NCT00381849|6329259|P2|STARTED|Second Intervention||9
2580124|NCT00381849|6329260|P1|STARTED|Second Intervention||10
2580125|NCT00381849|6329259|P2|NOT COMPLETED|Wash Out||1
2580126|NCT00381849|6329260|P1|NOT COMPLETED|Wash Out||0
2580127|NCT00381849|6329259|P2|COMPLETED|Wash Out||9
2580128|NCT00381849|6329260|P1|COMPLETED|Wash Out||10
2580129|NCT00381849|6329259|P2|STARTED|Wash Out||10
2580130|NCT00381849|6329260|P1|STARTED|Wash Out||10
2580131|NCT00381849|6329259|P2|NOT COMPLETED|First Intervention||0
2580132|NCT00381849|6329260|P1|NOT COMPLETED|First Intervention||0
2580133|NCT00381849|6329259|P2|COMPLETED|First Intervention||10
2580134|NCT00381849|6329260|P1|COMPLETED|First Intervention||10
2580135|NCT00381849|6329259|P2|STARTED|First Intervention||10
2580136|NCT00381849|6329260|P1|STARTED|First Intervention||10
2580137|NCT00381810|6329278|P1|NOT COMPLETED|B Cell Follow-up||7
2580138|NCT00381810|6329278|P1|COMPLETED|B Cell Follow-up||0
2580139|NCT00381810|6329278|P1|STARTED|B Cell Follow-up|Participants only entered the B cell follow-up period if their peripheral B cells were depleted.|7
2580140|NCT00381810|6329278|P1|NOT COMPLETED|Treatment and Safety Follow-up||15
2580141|NCT00381810|6329278|P1|COMPLETED|Treatment and Safety Follow-up||16
2580142|NCT00381810|6329278|P1|STARTED|Treatment and Safety Follow-up||31
2580143|NCT00381797|6329287|P5|NOT COMPLETED|Overall Study||2
2580144|NCT00381797|6329288|P4|NOT COMPLETED|Overall Study||1
2580145|NCT00381797|6329289|P3|NOT COMPLETED|Overall Study||0
2580146|NCT00381797|6329290|P2|NOT COMPLETED|Overall Study||1
2580147|NCT00381797|6329291|P1|NOT COMPLETED|Overall Study||1
2580148|NCT00381797|6329287|P5|COMPLETED|Overall Study||35
2580149|NCT00381797|6329288|P4|COMPLETED|Overall Study||14
2580150|NCT00381797|6329289|P3|COMPLETED|Overall Study||10
2580151|NCT00381797|6329290|P2|COMPLETED|Overall Study||16
2580152|NCT00381797|6329291|P1|COMPLETED|Overall Study||17
2580153|NCT00381797|6329287|P5|STARTED|Overall Study||37
2580154|NCT00381797|6329288|P4|STARTED|Overall Study||15
2580155|NCT00381797|6329289|P3|STARTED|Overall Study||10
2580156|NCT00381797|6329290|P2|STARTED|Overall Study||17
2580157|NCT00381797|6329291|P1|STARTED|Overall Study||18
2580158|NCT00381706|6329366|P3|NOT COMPLETED|Overall Study||1
2580159|NCT00381706|6329367|P2|NOT COMPLETED|Overall Study||2
2580160|NCT00381706|6329368|P1|NOT COMPLETED|Overall Study||7
2580161|NCT00381706|6329366|P3|COMPLETED|Overall Study||79
2580162|NCT00381706|6329367|P2|COMPLETED|Overall Study||81
2580163|NCT00381706|6329368|P1|COMPLETED|Overall Study||75
2580164|NCT00381706|6329366|P3|STARTED|Overall Study||80
2580165|NCT00381706|6329367|P2|STARTED|Overall Study||83
2580166|NCT00381706|6329368|P1|STARTED|Overall Study||82
2580167|NCT00381693|6329391|P1|NOT COMPLETED|Overall Study||8
2580168|NCT00381693|6329391|P1|COMPLETED|Overall Study||2
2580169|NCT00381693|6329391|P1|STARTED|Overall Study||10
2580170|NCT00381680|6329400|P2|NOT COMPLETED|Overall Study||50
2580171|NCT00381680|6329401|P1|NOT COMPLETED|Overall Study||125
2580172|NCT00381680|6329400|P2|COMPLETED|Overall Study||19
2580173|NCT00381680|6329401|P1|COMPLETED|Overall Study||81
2580174|NCT00381680|6329400|P2|STARTED|Overall Study||69
2580175|NCT00381680|6329401|P1|STARTED|Overall Study||206
2580176|NCT00381641|6329418|P2|NOT COMPLETED|Overall Study||2
2580177|NCT00381641|6329419|P1|NOT COMPLETED|Overall Study||0
2580178|NCT00381641|6329418|P2|COMPLETED|Overall Study||23
2580179|NCT00381641|6329419|P1|COMPLETED|Overall Study||38
2580180|NCT00381641|6329418|P2|STARTED|Overall Study||25
2580181|NCT00381641|6329419|P1|STARTED|Overall Study||38
2580182|NCT00381628|6329435|P4|NOT COMPLETED|Overall Study||0
2580183|NCT00381628|6329436|P3|NOT COMPLETED|Overall Study||0
2580184|NCT00381628|6329437|P2|NOT COMPLETED|Overall Study||0
2580185|NCT00381628|6329438|P1|NOT COMPLETED|Overall Study||0
2580186|NCT00381628|6329435|P4|COMPLETED|Overall Study||14
2580187|NCT00381628|6329436|P3|COMPLETED|Overall Study||0
2580188|NCT00381628|6329437|P2|COMPLETED|Overall Study||27
2580189|NCT00381628|6329438|P1|COMPLETED|Overall Study||18
2580190|NCT00381628|6329435|P4|STARTED|Overall Study||14
2580191|NCT00381628|6329436|P3|STARTED|Overall Study||0
2580192|NCT00381628|6329437|P2|STARTED|Overall Study||27
2580193|NCT00381628|6329438|P1|STARTED|Overall Study||18
2580194|NCT00381615|6329452|P4|NOT COMPLETED|Overall Study||2
2580195|NCT00381615|6329453|P3|NOT COMPLETED|Overall Study||1
2580196|NCT00381615|6329454|P2|NOT COMPLETED|Overall Study||5
2580197|NCT00381615|6329455|P1|NOT COMPLETED|Overall Study||4
2580198|NCT00381615|6329452|P4|COMPLETED|Overall Study||22
2580199|NCT00381615|6329453|P3|COMPLETED|Overall Study||24
2580200|NCT00381615|6329454|P2|COMPLETED|Overall Study||45
2580201|NCT00381615|6329455|P1|COMPLETED|Overall Study||44
2580202|NCT00381615|6329452|P4|STARTED|Overall Study||24
2580203|NCT00381615|6329453|P3|STARTED|Overall Study||25
2580204|NCT00381615|6329454|P2|STARTED|Overall Study||50
2580205|NCT00381615|6329455|P1|STARTED|Overall Study||48
2580206|NCT00381563|6329507|P2|NOT COMPLETED|Overall Study||6
2580207|NCT00381563|6329508|P1|NOT COMPLETED|Overall Study||7
2580208|NCT00381563|6329507|P2|COMPLETED|Overall Study||33
2580209|NCT00381563|6329508|P1|COMPLETED|Overall Study||34
2580210|NCT00381563|6329507|P2|STARTED|Overall Study||39
2580211|NCT00381563|6329508|P1|STARTED|Overall Study||41
2580212|NCT00381550|6329515|P1|NOT COMPLETED|Overall Study||0
2580213|NCT00381550|6329515|P1|COMPLETED|Overall Study||35
2580214|NCT00381550|6329515|P1|STARTED|Overall Study||35
2580215|NCT00381485|6329523|P4|NOT COMPLETED|Double-Blind Treatment Period||33
2580216|NCT00381485|6329524|P3|NOT COMPLETED|Double-Blind Treatment Period||25
2580217|NCT00381485|6329525|P2|NOT COMPLETED|Double-Blind Treatment Period||27
2580218|NCT00381485|6329526|P1|NOT COMPLETED|Double-Blind Treatment Period||0
2580219|NCT00381485|6329523|P4|COMPLETED|Double-Blind Treatment Period||207
2580220|NCT00381485|6329524|P3|COMPLETED|Double-Blind Treatment Period||208
2580221|NCT00381485|6329525|P2|COMPLETED|Double-Blind Treatment Period||228
2580222|NCT00381485|6329526|P1|COMPLETED|Double-Blind Treatment Period||0
2580223|NCT00381485|6329523|P4|STARTED|Double-Blind Treatment Period||240
2580224|NCT00381485|6329524|P3|STARTED|Double-Blind Treatment Period||233
2580225|NCT00381485|6329525|P2|STARTED|Double-Blind Treatment Period||255
2580226|NCT00381485|6329526|P1|STARTED|Double-Blind Treatment Period||0
2580227|NCT00381485|6329523|P4|NOT COMPLETED|Open-Label Run-In Period||0
2580228|NCT00381485|6329524|P3|NOT COMPLETED|Open-Label Run-In Period||0
2580229|NCT00381485|6329525|P2|NOT COMPLETED|Open-Label Run-In Period||0
2580230|NCT00381485|6329526|P1|NOT COMPLETED|Open-Label Run-In Period||106
2580231|NCT00381485|6329523|P4|COMPLETED|Open-Label Run-In Period||0
2580232|NCT00381485|6329524|P3|COMPLETED|Open-Label Run-In Period||0
2580233|NCT00381485|6329525|P2|COMPLETED|Open-Label Run-In Period||0
2580234|NCT00381485|6329526|P1|COMPLETED|Open-Label Run-In Period||728
2580235|NCT00381485|6329523|P4|STARTED|Open-Label Run-In Period||0
2580236|NCT00381485|6329524|P3|STARTED|Open-Label Run-In Period||0
2580237|NCT00381485|6329525|P2|STARTED|Open-Label Run-In Period||0
2580238|NCT00381485|6329526|P1|STARTED|Open-Label Run-In Period||834
2580239|NCT00381381|6329544|P1|NOT COMPLETED|Overall Study||64
2580240|NCT00381381|6329544|P1|COMPLETED|Overall Study||135
2580241|NCT00381381|6329544|P1|STARTED|Overall Study||199
2580242|NCT00381303|6329553|P2|NOT COMPLETED|Overall Study||33
2580243|NCT00381303|6329554|P1|NOT COMPLETED|Overall Study||94
2580244|NCT00381303|6329553|P2|COMPLETED|Overall Study||109
2580245|NCT00381303|6329554|P1|COMPLETED|Overall Study||193
2580246|NCT00381303|6329553|P2|STARTED|Overall Study||142
2580247|NCT00381303|6329554|P1|STARTED|Overall Study||287
2580248|NCT00381238|6329614|P1|NOT COMPLETED|Overall Study||12
2580249|NCT00381238|6329614|P1|COMPLETED|Overall Study||21
2580250|NCT00381238|6329614|P1|STARTED|Overall Study||33
2580251|NCT00381095|6329630|P2|NOT COMPLETED|Overall Study||21
2580252|NCT00381095|6329631|P1|NOT COMPLETED|Overall Study||13
2580253|NCT00381095|6329630|P2|COMPLETED|Overall Study||59
2580254|NCT00381095|6329631|P1|COMPLETED|Overall Study||59
2580255|NCT00381095|6329630|P2|STARTED|Overall Study||80
2580256|NCT00381095|6329631|P1|STARTED|Overall Study||72
2580257|NCT00381043|6329663|P2|NOT COMPLETED|Overall Study||8
2580258|NCT00381043|6329664|P1|NOT COMPLETED|Overall Study||12
2580259|NCT00381043|6329663|P2|COMPLETED|Overall Study||41
2580260|NCT00381043|6329664|P1|COMPLETED|Overall Study||39
2580261|NCT00381043|6329663|P2|STARTED|Overall Study||49
2580262|NCT00381043|6329664|P1|STARTED|Overall Study||51
2580263|NCT00381004|6329682|P1|NOT COMPLETED|Overall Study||0
2580264|NCT00381004|6329682|P1|COMPLETED|Overall Study||60
2580265|NCT00381004|6329682|P1|STARTED|Overall Study||60
2580266|NCT00380978|6329690|P2|NOT COMPLETED|Overall Study||10
2580267|NCT00380978|6329691|P1|NOT COMPLETED|Overall Study||2
2580268|NCT00380978|6329690|P2|COMPLETED|Overall Study||400
2580269|NCT00380978|6329691|P1|COMPLETED|Overall Study||406
2580270|NCT00380978|6329690|P2|STARTED|Overall Study||410
2580271|NCT00380978|6329691|P1|STARTED|Overall Study||408
2580272|NCT00380874|6329713|P2|NOT COMPLETED|Overall Study||10
2580273|NCT00380874|6329714|P1|NOT COMPLETED|Overall Study||13
2580274|NCT00380874|6329713|P2|COMPLETED|Overall Study||19
2580275|NCT00380874|6329714|P1|COMPLETED|Overall Study||19
2580276|NCT00380874|6329713|P2|STARTED|Overall Study||29
2580277|NCT00380874|6329714|P1|STARTED|Overall Study||32
2580278|NCT00380861|6329732|P2|NOT COMPLETED|Overall Study||17
2580279|NCT00380861|6329733|P1|NOT COMPLETED|Overall Study||18
2580280|NCT00380861|6329732|P2|COMPLETED|Overall Study||74
2580281|NCT00380861|6329733|P1|COMPLETED|Overall Study||75
2580282|NCT00380861|6329732|P2|STARTED|Overall Study|Two subjects received the PFC Sigma RP-F device but not the RP and their results are not included.|91
2580283|NCT00380861|6329733|P1|STARTED|Overall Study||93
2580284|NCT00380744|6329746|P7|NOT COMPLETED|Overall Study||1
2580285|NCT00380744|6329747|P6|NOT COMPLETED|Overall Study||0
2580286|NCT00380744|6329748|P5|NOT COMPLETED|Overall Study||0
2580287|NCT00380744|6329749|P4|NOT COMPLETED|Overall Study||0
2580288|NCT00380744|6329750|P3|NOT COMPLETED|Overall Study||0
2580289|NCT00380744|6329751|P2|NOT COMPLETED|Overall Study||0
2580290|NCT00380744|6329752|P1|NOT COMPLETED|Overall Study||1
2580291|NCT00380744|6329746|P7|COMPLETED|Overall Study||24
2580292|NCT00380744|6329747|P6|COMPLETED|Overall Study||25
2580293|NCT00380744|6329748|P5|COMPLETED|Overall Study||23
2580294|NCT00380744|6329749|P4|COMPLETED|Overall Study||4
2580295|NCT00380744|6329750|P3|COMPLETED|Overall Study||20
2580296|NCT00380744|6329751|P2|COMPLETED|Overall Study||4
2580297|NCT00380744|6329752|P1|COMPLETED|Overall Study||19
2580298|NCT00380744|6329746|P7|Received at Least 1 Dose of Study Drug|Overall Study||25
2580299|NCT00380744|6329747|P6|Received at Least 1 Dose of Study Drug|Overall Study||25
2580300|NCT00380744|6329748|P5|Received at Least 1 Dose of Study Drug|Overall Study||23
2580301|NCT00380744|6329749|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
2580302|NCT00380744|6329750|P3|Received at Least 1 Dose of Study Drug|Overall Study||20
2580303|NCT00380744|6329751|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
2580304|NCT00380744|6329752|P1|Received at Least 1 Dose of Study Drug|Overall Study||20
2580305|NCT00380744|6329746|P7|STARTED|Overall Study||25
2580306|NCT00380744|6329747|P6|STARTED|Overall Study||25
2580307|NCT00380744|6329748|P5|STARTED|Overall Study||23
2580308|NCT00380744|6329749|P4|STARTED|Overall Study||4
2580309|NCT00380744|6329750|P3|STARTED|Overall Study||20
2580310|NCT00380744|6329751|P2|STARTED|Overall Study||4
2580311|NCT00380744|6329752|P1|STARTED|Overall Study||20
2580312|NCT00380718|6329802|P1|NOT COMPLETED|Overall Study||18
2580313|NCT00380718|6329802|P1|COMPLETED|Overall Study||15
2580314|NCT00380718|6329802|P1|Received Escalated Dose in Cycle 2|Overall Study||25
2580315|NCT00380718|6329802|P1|Received at Least One Dose of Study Drug|Overall Study||33
2580316|NCT00380718|6329802|P1|STARTED|Overall Study||33
2580317|NCT00380692|6329814|P2|NOT COMPLETED|Study Period III - Open Label||12
2580318|NCT00380692|6329815|P1|NOT COMPLETED|Study Period III - Open Label||6
2580319|NCT00380692|6329814|P2|COMPLETED|Study Period III - Open Label||34
2580320|NCT00380692|6329815|P1|COMPLETED|Study Period III - Open Label||36
2580321|NCT00380692|6329814|P2|STARTED|Study Period III - Open Label||46
2580322|NCT00380692|6329815|P1|STARTED|Study Period III - Open Label|One patient who completed Study Period II did not enter Study Period III.|42
2580323|NCT00380692|6329814|P2|NOT COMPLETED|Study Period II - Double Blind||3
2580324|NCT00380692|6329815|P1|NOT COMPLETED|Study Period II - Double Blind||5
2580325|NCT00380692|6329814|P2|COMPLETED|Study Period II - Double Blind||46
2580326|NCT00380692|6329815|P1|COMPLETED|Study Period II - Double Blind||43
2580327|NCT00380692|6329814|P2|STARTED|Study Period II - Double Blind||49
2580328|NCT00380692|6329815|P1|STARTED|Study Period II - Double Blind||48
2580329|NCT00380588|6329863|P2|NOT COMPLETED|Overall Study||40
2580330|NCT00380588|6329864|P1|NOT COMPLETED|Overall Study||39
2580331|NCT00380588|6329863|P2|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|2
2580332|NCT00380588|6329864|P1|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|3
2580333|NCT00380588|6329863|P2|Received at Least One Dose of Study Drug|Overall Study||42
2580334|NCT00380588|6329864|P1|Received at Least One Dose of Study Drug|Overall Study||41
2580335|NCT00380588|6329863|P2|STARTED|Overall Study||42
2580336|NCT00380588|6329864|P1|STARTED|Overall Study||42
2580337|NCT00380393|6329878|P2|NOT COMPLETED|Month 14||56
2580338|NCT00380393|6329879|P1|NOT COMPLETED|Month 14||57
2580339|NCT00380393|6329878|P2|COMPLETED|Month 14||391
2580340|NCT00380393|6329879|P1|COMPLETED|Month 14||390
2580341|NCT00380393|6329878|P2|STARTED|Month 14||447
2580342|NCT00380393|6329879|P1|STARTED|Month 14||447
2580343|NCT00380393|6329878|P2|NOT COMPLETED|Month 8 (Cross-sectional Visit)||40
2580344|NCT00380393|6329879|P1|NOT COMPLETED|Month 8 (Cross-sectional Visit)||49
2580345|NCT00380393|6329878|P2|COMPLETED|Month 8 (Cross-sectional Visit)||407
2580346|NCT00380393|6329879|P1|COMPLETED|Month 8 (Cross-sectional Visit)||398
2580347|NCT00380393|6329878|P2|STARTED|Month 8 (Cross-sectional Visit)||447
2580348|NCT00380393|6329879|P1|STARTED|Month 8 (Cross-sectional Visit)||447
2580349|NCT00380367|6329927|P1|NOT COMPLETED|Overall Study||2
2580350|NCT00380367|6329927|P1|COMPLETED|Overall Study||108
2580351|NCT00380367|6329927|P1|STARTED|Overall Study||110
2580352|NCT00380250|6329934|P2|NOT COMPLETED|Overall Study||55
2580353|NCT00380250|6329935|P1|NOT COMPLETED|Overall Study||99
2580354|NCT00380250|6329934|P2|COMPLETED|Overall Study||139
2580355|NCT00380250|6329935|P1|COMPLETED|Overall Study||297
2580356|NCT00380250|6329934|P2|STARTED|Overall Study||194
2580357|NCT00380250|6329935|P1|STARTED|Overall Study||396
2580358|NCT00380081|6330003|P6|NOT COMPLETED|Overall Study||1
2580359|NCT00380081|6330004|P5|NOT COMPLETED|Overall Study||1
2580360|NCT00380081|6330005|P4|NOT COMPLETED|Overall Study||0
2580361|NCT00380081|6330006|P3|NOT COMPLETED|Overall Study||0
2580362|NCT00380081|6330007|P2|NOT COMPLETED|Overall Study||0
2580363|NCT00380081|6330008|P1|NOT COMPLETED|Overall Study||0
2580364|NCT00380081|6330003|P6|COMPLETED|Overall Study||13
2580365|NCT00380081|6330004|P5|COMPLETED|Overall Study||12
2580366|NCT00380081|6330005|P4|COMPLETED|Overall Study||15
2580367|NCT00380081|6330006|P3|COMPLETED|Overall Study||13
2580368|NCT00380081|6330007|P2|COMPLETED|Overall Study||13
2580369|NCT00380081|6330008|P1|COMPLETED|Overall Study||14
2580370|NCT00380081|6330003|P6|STARTED|Overall Study||14
2580371|NCT00380081|6330004|P5|STARTED|Overall Study||13
2580372|NCT00380081|6330005|P4|STARTED|Overall Study||15
2580373|NCT00380081|6330006|P3|STARTED|Overall Study||13
2580374|NCT00380081|6330007|P2|STARTED|Overall Study||13
2580375|NCT00380081|6330008|P1|STARTED|Overall Study||14
2580376|NCT00380068|6330058|P1|NOT COMPLETED|Overall Study||69
2580377|NCT00380068|6330058|P1|COMPLETED|Overall Study||155
2580378|NCT00380068|6330058|P1|STARTED|Overall Study||224
2580379|NCT00380029|6330078|P1|NOT COMPLETED|Overall Study||0
2580380|NCT00380029|6330078|P1|COMPLETED|Overall Study||20
2580381|NCT00380029|6330078|P1|STARTED|Overall Study||20
2580382|NCT00379912|6330090|P2|NOT COMPLETED|Overall Study||0
2580383|NCT00379912|6330091|P1|NOT COMPLETED|Overall Study||1
2580384|NCT00379912|6330090|P2|COMPLETED|Overall Study||8
2580385|NCT00379912|6330091|P1|COMPLETED|Overall Study||6
2580386|NCT00379912|6330090|P2|STARTED|Overall Study||8
2580387|NCT00379912|6330091|P1|STARTED|Overall Study||7
2580388|NCT00379899|6330113|P2|NOT COMPLETED|Overall Study||40
2580389|NCT00379899|6330114|P1|NOT COMPLETED|Overall Study||40
2580390|NCT00379899|6330113|P2|COMPLETED|Overall Study||140
2580391|NCT00379899|6330114|P1|COMPLETED|Overall Study||140
2580392|NCT00379899|6330113|P2|STARTED|Overall Study||180
2580393|NCT00379899|6330114|P1|STARTED|Overall Study||180
2580394|NCT00379834|6330142|P1|NOT COMPLETED|Overall Study||2
2580395|NCT00379834|6330142|P1|COMPLETED|Overall Study||8
2580396|NCT00379834|6330142|P1|STARTED|Overall Study||10
2580397|NCT00379821|6330150|P4|NOT COMPLETED|Overall Study||79
2580398|NCT00379821|6330151|P3|NOT COMPLETED|Overall Study||67
2580399|NCT00379821|6330152|P2|NOT COMPLETED|Overall Study||89
2580400|NCT00379821|6330153|P1|NOT COMPLETED|Overall Study||73
2580401|NCT00379821|6330150|P4|COMPLETED|Overall Study||81
2580402|NCT00379821|6330151|P3|COMPLETED|Overall Study||93
2580403|NCT00379821|6330152|P2|COMPLETED|Overall Study||71
2580404|NCT00379821|6330153|P1|COMPLETED|Overall Study||87
2580405|NCT00379821|6330150|P4|STARTED|Overall Study||160
2580406|NCT00379821|6330151|P3|STARTED|Overall Study||160
2580407|NCT00379821|6330152|P2|STARTED|Overall Study||160
2580408|NCT00379821|6330153|P1|STARTED|Overall Study||160
2580409|NCT00379808|6330294|P2|NOT COMPLETED|Intervention Period 2 (4 Weeks)||1
2580410|NCT00379808|6330295|P1|NOT COMPLETED|Intervention Period 2 (4 Weeks)||0
2580411|NCT00379808|6330294|P2|COMPLETED|Intervention Period 2 (4 Weeks)||10
2580412|NCT00379808|6330295|P1|COMPLETED|Intervention Period 2 (4 Weeks)||11
2580413|NCT00379808|6330294|P2|STARTED|Intervention Period 2 (4 Weeks)||11
2580414|NCT00379808|6330295|P1|STARTED|Intervention Period 2 (4 Weeks)||11
2580415|NCT00379808|6330294|P2|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
2580416|NCT00379808|6330295|P1|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
2580417|NCT00379808|6330294|P2|COMPLETED|Intervention Period 1 (4 Weeks)||11
2580418|NCT00379808|6330295|P1|COMPLETED|Intervention Period 1 (4 Weeks)||11
2580419|NCT00379808|6330294|P2|STARTED|Intervention Period 1 (4 Weeks)||11
2580420|NCT00379808|6330295|P1|STARTED|Intervention Period 1 (4 Weeks)||11
2580421|NCT00379795|6330316|P5|NOT COMPLETED|Overall Study||49
2580422|NCT00379795|6330317|P4|NOT COMPLETED|Overall Study||68
2580423|NCT00379795|6330318|P3|NOT COMPLETED|Overall Study||93
2580424|NCT00379795|6330319|P2|NOT COMPLETED|Overall Study||51
2580425|NCT00379795|6330320|P1|NOT COMPLETED|Overall Study||476
2580426|NCT00379795|6330316|P5|COMPLETED|Overall Study||14
2580427|NCT00379795|6330317|P4|COMPLETED|Overall Study||6
2580428|NCT00379795|6330318|P3|COMPLETED|Overall Study||23
2580429|NCT00379795|6330319|P2|COMPLETED|Overall Study||23
2580430|NCT00379795|6330320|P1|COMPLETED|Overall Study||50
2580431|NCT00379795|6330316|P5|Received Ranibizumab in Extension Study|Overall Study||0
2580432|NCT00379795|6330317|P4|Received Ranibizumab in Extension Study|Overall Study||55
2580433|NCT00379795|6330318|P3|Received Ranibizumab in Extension Study|Overall Study||113
2580434|NCT00379795|6330319|P2|Received Ranibizumab in Extension Study|Overall Study||41
2580435|NCT00379795|6330320|P1|Received Ranibizumab in Extension Study|Overall Study||377
2580436|NCT00379795|6330316|P5|STARTED|Overall Study||63
2580437|NCT00379795|6330317|P4|STARTED|Overall Study||74
2580438|NCT00379795|6330318|P3|STARTED|Overall Study||116
2580439|NCT00379795|6330319|P2|STARTED|Overall Study||74
2580440|NCT00379795|6330320|P1|STARTED|Overall Study||526
2580441|NCT00379769|6330350|P6|NOT COMPLETED|Observational Follow-up||148
2580442|NCT00379769|6330351|P5|NOT COMPLETED|Observational Follow-up||149
2580443|NCT00379769|6330352|P4|NOT COMPLETED|Observational Follow-up||0
2580444|NCT00379769|6330353|P3|NOT COMPLETED|Observational Follow-up||0
2580445|NCT00379769|6330354|P2|NOT COMPLETED|Observational Follow-up||0
2580446|NCT00379769|6330355|P1|NOT COMPLETED|Observational Follow-up||0
2580447|NCT00379769|6330350|P6|COMPLETED|Observational Follow-up||1102
2580448|NCT00379769|6330351|P5|COMPLETED|Observational Follow-up||1131
2580449|NCT00379769|6330352|P4|COMPLETED|Observational Follow-up||0
2580450|NCT00379769|6330353|P3|COMPLETED|Observational Follow-up||0
2580451|NCT00379769|6330354|P2|COMPLETED|Observational Follow-up||0
2580452|NCT00379769|6330355|P1|COMPLETED|Observational Follow-up||0
2580453|NCT00379769|6330350|P6|STARTED|Observational Follow-up|647 from “SU in Addition to Background MET” arm; 603 from “MET in Addition to Background SU” arm.|1250
2580454|NCT00379769|6330351|P5|STARTED|Observational Follow-up|665 from “RSG in Addition to Background MET” arm; 615 from “RGS in Addition to Background SU” arm.|1280
2580455|NCT00379769|6330352|P4|STARTED|Observational Follow-up||0
2580456|NCT00379769|6330353|P3|STARTED|Observational Follow-up||0
2580457|NCT00379769|6330354|P2|STARTED|Observational Follow-up||0
2580458|NCT00379769|6330355|P1|STARTED|Observational Follow-up||0
2580459|NCT00379769|6330350|P6|NOT COMPLETED|Main Study||0
2580460|NCT00379769|6330351|P5|NOT COMPLETED|Main Study||0
2580461|NCT00379769|6330352|P4|NOT COMPLETED|Main Study||230
2580462|NCT00379769|6330353|P3|NOT COMPLETED|Main Study||207
2580463|NCT00379769|6330354|P2|NOT COMPLETED|Main Study||199
2580464|NCT00379769|6330355|P1|NOT COMPLETED|Main Study||178
2580465|NCT00379769|6330350|P6|COMPLETED|Main Study||0
2580466|NCT00379769|6330351|P5|COMPLETED|Main Study||0
2580467|NCT00379769|6330352|P4|COMPLETED|Main Study||892
2580468|NCT00379769|6330353|P3|COMPLETED|Main Study||896
2580469|NCT00379769|6330354|P2|COMPLETED|Main Study||906
2580470|NCT00379769|6330355|P1|COMPLETED|Main Study||939
2580471|NCT00379769|6330350|P6|STARTED|Main Study||0
2580472|NCT00379769|6330351|P5|STARTED|Main Study||0
2580473|NCT00379769|6330352|P4|STARTED|Main Study||1122
2580474|NCT00379769|6330353|P3|STARTED|Main Study||1103
2580475|NCT00379769|6330354|P2|STARTED|Main Study||1105
2580476|NCT00379769|6330355|P1|STARTED|Main Study||1117
2580477|NCT00379639|6330514|P5|NOT COMPLETED|Overall Study||6
2580478|NCT00379639|6330515|P4|NOT COMPLETED|Overall Study||6
2580479|NCT00379639|6330516|P3|NOT COMPLETED|Overall Study||9
2580480|NCT00379639|6330517|P2|NOT COMPLETED|Overall Study||5
2580481|NCT00379639|6330518|P1|NOT COMPLETED|Overall Study||3
2580482|NCT00379639|6330514|P5|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
2580483|NCT00379639|6330515|P4|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
2580484|NCT00379639|6330516|P3|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|1
2580485|NCT00379639|6330517|P2|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|2
2580486|NCT00379639|6330518|P1|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|4
2580487|NCT00379639|6330514|P5|Completed 6 Cycles of Therapy|Overall Study||0
2580488|NCT00379639|6330515|P4|Completed 6 Cycles of Therapy|Overall Study||0
2580489|NCT00379639|6330516|P3|Completed 6 Cycles of Therapy|Overall Study||1
2580490|NCT00379639|6330517|P2|Completed 6 Cycles of Therapy|Overall Study||2
2580491|NCT00379639|6330518|P1|Completed 6 Cycles of Therapy|Overall Study||4
2580492|NCT00379639|6330514|P5|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|3
2580493|NCT00379639|6330515|P4|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|4
2580494|NCT00379639|6330516|P3|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
2580495|NCT00379639|6330517|P2|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
2580496|NCT00379639|6330518|P1|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|6
2580497|NCT00379639|6330514|P5|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
2580498|NCT00379639|6330515|P4|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
2580499|NCT00379639|6330516|P3|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|10
2580500|NCT00379639|6330517|P2|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
2580501|NCT00379639|6330518|P1|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
2580502|NCT00379587|6330540|P1|NOT COMPLETED|Overall Study||2
2580503|NCT00379587|6330540|P1|COMPLETED|Overall Study||63
2580504|NCT00379587|6330540|P1|STARTED|Overall Study||65
2580505|NCT00379574|6330547|P1|NOT COMPLETED|Overall Study||0
2580506|NCT00379574|6330547|P1|COMPLETED|Overall Study|Phase I (9) + Phase II (40)|49
2580507|NCT00379574|6330547|P1|STARTED|Overall Study|Phase I (9) + Phase II (40)|49
2580508|NCT00379353|6330554|P2|NOT COMPLETED|Overall Study||6
2580509|NCT00379353|6330555|P1|NOT COMPLETED|Overall Study||11
2580510|NCT00379353|6330554|P2|COMPLETED|Overall Study||9
2580511|NCT00379353|6330555|P1|COMPLETED|Overall Study||5
2580512|NCT00379353|6330554|P2|STARTED|Overall Study||15
2580513|NCT00379353|6330555|P1|STARTED|Overall Study||16
2580514|NCT00379340|6330590|P5|NOT COMPLETED|Overall Study||14
2580515|NCT00379340|6330591|P4|NOT COMPLETED|Overall Study||13
2580516|NCT00379340|6330592|P3|NOT COMPLETED|Overall Study||2
2580517|NCT00379340|6330593|P2|NOT COMPLETED|Overall Study||3
2580518|NCT00379340|6330594|P1|NOT COMPLETED|Overall Study||13
2580519|NCT00379340|6330590|P5|COMPLETED|Overall Study||9
2580520|NCT00379340|6330591|P4|COMPLETED|Overall Study||37
2580521|NCT00379340|6330592|P3|COMPLETED|Overall Study||50
2580522|NCT00379340|6330593|P2|COMPLETED|Overall Study||132
2580523|NCT00379340|6330594|P1|COMPLETED|Overall Study||107
2580524|NCT00379340|6330590|P5|STARTED|Overall Study||23
2580525|NCT00379340|6330591|P4|STARTED|Overall Study||50
2580526|NCT00379340|6330592|P3|STARTED|Overall Study||52
2580527|NCT00379340|6330593|P2|STARTED|Overall Study||135
2580528|NCT00379340|6330594|P1|STARTED|Overall Study||120
2580529|NCT00379288|6330611|P4|NOT COMPLETED|Overall Study||8
2580530|NCT00379288|6330612|P3|NOT COMPLETED|Overall Study||10
2580531|NCT00379288|6330613|P2|NOT COMPLETED|Overall Study||22
2580532|NCT00379288|6330614|P1|NOT COMPLETED|Overall Study||19
2580533|NCT00379288|6330611|P4|COMPLETED|Overall Study||57
2580534|NCT00379288|6330612|P3|COMPLETED|Overall Study||58
2580535|NCT00379288|6330613|P2|COMPLETED|Overall Study||108
2580536|NCT00379288|6330614|P1|COMPLETED|Overall Study||122
2580537|NCT00379288|6330611|P4|STARTED|Overall Study||65
2580538|NCT00379288|6330612|P3|STARTED|Overall Study||68
2580539|NCT00379288|6330613|P2|STARTED|Overall Study||130
2580540|NCT00379288|6330614|P1|STARTED|Overall Study||141
2580541|NCT00379236|6330626|P3|NOT COMPLETED|Open-label Extension||55
2580542|NCT00379236|6330627|P2|NOT COMPLETED|Open-label Extension||0
2580543|NCT00379236|6330628|P1|NOT COMPLETED|Open-label Extension||0
2580544|NCT00379236|6330626|P3|COMPLETED|Open-label Extension||378
2580545|NCT00379236|6330627|P2|COMPLETED|Open-label Extension||0
2580546|NCT00379236|6330628|P1|COMPLETED|Open-label Extension||0
2580547|NCT00379236|6330626|P3|STARTED|Open-label Extension||433
2580548|NCT00379236|6330627|P2|STARTED|Open-label Extension||0
2580549|NCT00379236|6330628|P1|STARTED|Open-label Extension||0
2580550|NCT00379236|6330626|P3|NOT COMPLETED|Double-blind||0
2580551|NCT00379236|6330627|P2|NOT COMPLETED|Double-blind||36
2580552|NCT00379236|6330628|P1|NOT COMPLETED|Double-blind||36
2580553|NCT00379236|6330626|P3|COMPLETED|Double-blind||0
2580554|NCT00379236|6330627|P2|COMPLETED|Double-blind|Data could not be retrieved for two participants|259
2580555|NCT00379236|6330628|P1|COMPLETED|Double-blind|Data could not be retrieved for two participants|257
2580556|NCT00379236|6330626|P3|STARTED|Double-blind||0
2580557|NCT00379236|6330627|P2|STARTED|Double-blind||295
2580558|NCT00379236|6330628|P1|STARTED|Double-blind||293
2580559|NCT00379210|6330673|P2|NOT COMPLETED|Overall Study||7
2580560|NCT00379210|6330674|P1|NOT COMPLETED|Overall Study||10
2580561|NCT00379210|6330673|P2|COMPLETED|Overall Study||23
2580562|NCT00379210|6330674|P1|COMPLETED|Overall Study||20
2580563|NCT00379210|6330673|P2|STARTED|Overall Study||30
2580564|NCT00379210|6330674|P1|STARTED|Overall Study||30
2580565|NCT00379197|6330680|P1|NOT COMPLETED|Overall Study||5
2580566|NCT00379197|6330680|P1|COMPLETED|Overall Study||8
2580567|NCT00379197|6330680|P1|STARTED|Overall Study||13
2580568|NCT00379145|6330685|P1|NOT COMPLETED|Overall Study||0
2580569|NCT00379145|6330685|P1|COMPLETED|Overall Study||20
2580570|NCT00379145|6330685|P1|STARTED|Overall Study||20
2580571|NCT00379080|6330697|P3|NOT COMPLETED|Overall Study||0
2580572|NCT00379080|6330698|P2|NOT COMPLETED|Overall Study||4
2580573|NCT00379080|6330699|P1|NOT COMPLETED|Overall Study||0
2580574|NCT00379080|6330697|P3|COMPLETED|Overall Study||31
2580575|NCT00379080|6330698|P2|COMPLETED|Overall Study||15
2580576|NCT00379080|6330699|P1|COMPLETED|Overall Study||6
2580577|NCT00379080|6330697|P3|STARTED|Overall Study||31
2580578|NCT00379080|6330698|P2|STARTED|Overall Study||19
2580579|NCT00379080|6330699|P1|STARTED|Overall Study||6
2580580|NCT00378898|6330744|P2|NOT COMPLETED|Overall Study||6
2580581|NCT00378898|6330745|P1|NOT COMPLETED|Overall Study||11
2580582|NCT00378898|6330744|P2|COMPLETED|Overall Study||11
2580583|NCT00378898|6330745|P1|COMPLETED|Overall Study||11
2580584|NCT00378898|6330744|P2|STARTED|Overall Study||17
2580585|NCT00378898|6330745|P1|STARTED|Overall Study||22
2580586|NCT00378703|6330757|P4|NOT COMPLETED|Overall Study||91
2580587|NCT00378703|6330758|P3|NOT COMPLETED|Overall Study||90
2580588|NCT00378703|6330759|P2|NOT COMPLETED|Overall Study||91
2580589|NCT00378703|6330760|P1|NOT COMPLETED|Overall Study||89
2580590|NCT00378703|6330757|P4|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
2580591|NCT00378703|6330758|P3|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
2580592|NCT00378703|6330759|P2|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
2580593|NCT00378703|6330760|P1|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
2580594|NCT00378703|6330757|P4|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
2580595|NCT00378703|6330758|P3|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|83
2580596|NCT00378703|6330759|P2|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|80
2580597|NCT00378703|6330760|P1|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
2580598|NCT00378703|6330757|P4|Treated|Overall Study|Number of patients included in the toxicity analysis.|91
2580599|NCT00378703|6330758|P3|Treated|Overall Study|Number of patients included in the toxicity analysis.|90
2580600|NCT00378703|6330759|P2|Treated|Overall Study|Number of patients included in the toxicity analysis.|86
2580601|NCT00378703|6330760|P1|Treated|Overall Study|Number of patients included in the toxicity analysis.|88
2580602|NCT00378703|6330757|P4|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
2580603|NCT00378703|6330758|P3|STARTED|Overall Study|Number of patients randomized to this treatment arm.|90
2580604|NCT00378703|6330759|P2|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
2580605|NCT00378703|6330760|P1|STARTED|Overall Study|Number of patients randomized to this treatment arm.|89
2580606|NCT00378599|6330782|P1|NOT COMPLETED|Overall Study||52
2580607|NCT00378599|6330782|P1|COMPLETED|Overall Study||73
2580608|NCT00378599|6330782|P1|STARTED|Overall Study||125
2580609|NCT00378573|6330786|P1|NOT COMPLETED|Follow-up||14
2580610|NCT00378573|6330786|P1|COMPLETED|Follow-up||3
2580611|NCT00378573|6330786|P1|STARTED|Follow-up||17
2580612|NCT00378573|6330786|P1|NOT COMPLETED|Treatment Period||17
2580613|NCT00378573|6330786|P1|COMPLETED|Treatment Period|Patients who did not complete treatment moved directly to the follow-up phase of the study.|0
2580614|NCT00378573|6330786|P1|STARTED|Treatment Period||17
2580615|NCT00378560|6330794|P2|NOT COMPLETED|Overall Study||58
2580616|NCT00378560|6330795|P1|NOT COMPLETED|Overall Study||56
2580617|NCT00378560|6330794|P2|COMPLETED|Overall Study||454
2580618|NCT00378560|6330795|P1|COMPLETED|Overall Study||453
2580619|NCT00378560|6330794|P2|Vaccinated|Overall Study||512
2580620|NCT00378560|6330795|P1|Vaccinated|Overall Study||509
2580621|NCT00378560|6330794|P2|STARTED|Overall Study||512
2580622|NCT00378560|6330795|P1|STARTED|Overall Study||509
2580623|NCT00378534|6330809|P1|NOT COMPLETED|Overall Study||60
2580624|NCT00378534|6330809|P1|COMPLETED|Overall Study|Transplantation Recipients|55
2580625|NCT00378534|6330809|P1|STARTED|Overall Study||115
2580626|NCT00378508|6330815|P2|NOT COMPLETED|Overall Study||3
2580627|NCT00378508|6330816|P1|NOT COMPLETED|Overall Study||2
2580628|NCT00378508|6330815|P2|COMPLETED|Overall Study||31
2580629|NCT00378508|6330816|P1|COMPLETED|Overall Study||27
2580630|NCT00378508|6330815|P2|Received Intervention/Placebo|Overall Study||31
2580631|NCT00378508|6330816|P1|Received Intervention/Placebo|Overall Study||28
2580632|NCT00378508|6330815|P2|Randomized|Overall Study||34
2580633|NCT00378508|6330816|P1|Randomized|Overall Study||29
2580634|NCT00378508|6330815|P2|STARTED|Overall Study||34
2580635|NCT00378508|6330816|P1|STARTED|Overall Study||29
2580636|NCT00378378|6330835|P3|NOT COMPLETED|Overall Study||2
2580637|NCT00378378|6330836|P2|NOT COMPLETED|Overall Study||1
2580638|NCT00378378|6330837|P1|NOT COMPLETED|Overall Study||0
2580639|NCT00378378|6330835|P3|COMPLETED|Overall Study||24
2580640|NCT00378378|6330836|P2|COMPLETED|Overall Study||49
2580641|NCT00378378|6330837|P1|COMPLETED|Overall Study||51
2580642|NCT00378378|6330835|P3|STARTED|Overall Study||26
2580643|NCT00378378|6330836|P2|STARTED|Overall Study||50
2580644|NCT00378378|6330837|P1|STARTED|Overall Study||51
2580645|NCT00378352|6330850|P6|NOT COMPLETED|Efficacy Phase||7
2580646|NCT00378352|6330851|P5|NOT COMPLETED|Efficacy Phase||11
2580647|NCT00378352|6330852|P4|NOT COMPLETED|Efficacy Phase||0
2580648|NCT00378352|6330853|P3|NOT COMPLETED|Efficacy Phase||0
2580649|NCT00378352|6330854|P2|NOT COMPLETED|Efficacy Phase||0
2580650|NCT00378352|6330855|P1|NOT COMPLETED|Efficacy Phase||0
2580651|NCT00378352|6330850|P6|COMPLETED|Efficacy Phase||59
2580652|NCT00378352|6330851|P5|COMPLETED|Efficacy Phase||54
2580653|NCT00378352|6330852|P4|COMPLETED|Efficacy Phase||0
2580654|NCT00378352|6330853|P3|COMPLETED|Efficacy Phase||0
2580655|NCT00378352|6330854|P2|COMPLETED|Efficacy Phase||0
2580656|NCT00378352|6330855|P1|COMPLETED|Efficacy Phase||0
2580657|NCT00378352|6330850|P6|Safety Analysis|Efficacy Phase||64
2580658|NCT00378352|6330851|P5|Safety Analysis|Efficacy Phase|Two participants randomized to placebo received 60,000 units Epoetin alfa|67
2580659|NCT00378352|6330852|P4|Safety Analysis|Efficacy Phase||0
2580660|NCT00378352|6330853|P3|Safety Analysis|Efficacy Phase||0
2580661|NCT00378352|6330854|P2|Safety Analysis|Efficacy Phase||0
2580662|NCT00378352|6330855|P1|Safety Analysis|Efficacy Phase||0
2580663|NCT00378352|6330850|P6|STARTED|Efficacy Phase||66
2580664|NCT00378352|6330851|P5|STARTED|Efficacy Phase||65
2580665|NCT00378352|6330852|P4|STARTED|Efficacy Phase||0
2580666|NCT00378352|6330853|P3|STARTED|Efficacy Phase||0
2580667|NCT00378352|6330854|P2|STARTED|Efficacy Phase||0
2580668|NCT00378352|6330855|P1|STARTED|Efficacy Phase||0
2580669|NCT00378352|6330850|P6|NOT COMPLETED|Dose Escalation 60,000 Units||0
2580670|NCT00378352|6330851|P5|NOT COMPLETED|Dose Escalation 60,000 Units||0
2580671|NCT00378352|6330852|P4|NOT COMPLETED|Dose Escalation 60,000 Units||1
2580672|NCT00378352|6330853|P3|NOT COMPLETED|Dose Escalation 60,000 Units||3
2580673|NCT00378352|6330854|P2|NOT COMPLETED|Dose Escalation 60,000 Units||0
2580674|NCT00378352|6330855|P1|NOT COMPLETED|Dose Escalation 60,000 Units||0
2580675|NCT00378352|6330850|P6|COMPLETED|Dose Escalation 60,000 Units||0
2580676|NCT00378352|6330851|P5|COMPLETED|Dose Escalation 60,000 Units||0
2580677|NCT00378352|6330852|P4|COMPLETED|Dose Escalation 60,000 Units||10
2580678|NCT00378352|6330853|P3|COMPLETED|Dose Escalation 60,000 Units||17
2580679|NCT00378352|6330854|P2|COMPLETED|Dose Escalation 60,000 Units||0
2580680|NCT00378352|6330855|P1|COMPLETED|Dose Escalation 60,000 Units||0
2580681|NCT00378352|6330850|P6|Safety Analysis|Dose Escalation 60,000 Units||0
2580682|NCT00378352|6330851|P5|Safety Analysis|Dose Escalation 60,000 Units||0
2580683|NCT00378352|6330852|P4|Safety Analysis|Dose Escalation 60,000 Units||11
2580684|NCT00378352|6330853|P3|Safety Analysis|Dose Escalation 60,000 Units||19
2580685|NCT00378352|6330854|P2|Safety Analysis|Dose Escalation 60,000 Units||0
2580686|NCT00378352|6330855|P1|Safety Analysis|Dose Escalation 60,000 Units||0
2580687|NCT00378352|6330850|P6|STARTED|Dose Escalation 60,000 Units||0
2580688|NCT00378352|6330851|P5|STARTED|Dose Escalation 60,000 Units||0
2580689|NCT00378352|6330852|P4|STARTED|Dose Escalation 60,000 Units||11
2580690|NCT00378352|6330853|P3|STARTED|Dose Escalation 60,000 Units||20
2580691|NCT00378352|6330854|P2|STARTED|Dose Escalation 60,000 Units||0
2580692|NCT00378352|6330855|P1|STARTED|Dose Escalation 60,000 Units||0
2580693|NCT00378352|6330850|P6|NOT COMPLETED|Dose Escalation 30,000 Units||0
2580694|NCT00378352|6330851|P5|NOT COMPLETED|Dose Escalation 30,000 Units||0
2580695|NCT00378352|6330852|P4|NOT COMPLETED|Dose Escalation 30,000 Units||2
2580696|NCT00378352|6330853|P3|NOT COMPLETED|Dose Escalation 30,000 Units||0
2580697|NCT00378352|6330854|P2|NOT COMPLETED|Dose Escalation 30,000 Units||3
2580698|NCT00378352|6330855|P1|NOT COMPLETED|Dose Escalation 30,000 Units||0
2580699|NCT00378352|6330850|P6|COMPLETED|Dose Escalation 30,000 Units||0
2580700|NCT00378352|6330851|P5|COMPLETED|Dose Escalation 30,000 Units||0
2580701|NCT00378352|6330852|P4|COMPLETED|Dose Escalation 30,000 Units||9
2580702|NCT00378352|6330853|P3|COMPLETED|Dose Escalation 30,000 Units||0
2580703|NCT00378352|6330854|P2|COMPLETED|Dose Escalation 30,000 Units||16
2580704|NCT00378352|6330855|P1|COMPLETED|Dose Escalation 30,000 Units||0
2580705|NCT00378352|6330850|P6|Safety Analysis|Dose Escalation 30,000 Units||0
2580706|NCT00378352|6330851|P5|Safety Analysis|Dose Escalation 30,000 Units||0
2580707|NCT00378352|6330852|P4|Safety Analysis|Dose Escalation 30,000 Units||11
2580708|NCT00378352|6330853|P3|Safety Analysis|Dose Escalation 30,000 Units||0
2580709|NCT00378352|6330854|P2|Safety Analysis|Dose Escalation 30,000 Units|One participant randomized to 60,000 units received 30,000 units|20
2580710|NCT00378352|6330855|P1|Safety Analysis|Dose Escalation 30,000 Units||0
2580711|NCT00378352|6330850|P6|STARTED|Dose Escalation 30,000 Units||0
2580712|NCT00378352|6330851|P5|STARTED|Dose Escalation 30,000 Units||0
2580713|NCT00378352|6330852|P4|STARTED|Dose Escalation 30,000 Units||11
2580714|NCT00378352|6330853|P3|STARTED|Dose Escalation 30,000 Units||0
2580715|NCT00378352|6330854|P2|STARTED|Dose Escalation 30,000 Units||19
2580716|NCT00378352|6330855|P1|STARTED|Dose Escalation 30,000 Units||0
2580717|NCT00378352|6330850|P6|NOT COMPLETED|Dose Escalation 15,000 Units||0
2580718|NCT00378352|6330851|P5|NOT COMPLETED|Dose Escalation 15,000 Units||0
2580719|NCT00378352|6330852|P4|NOT COMPLETED|Dose Escalation 15,000 Units||1
2580720|NCT00378352|6330853|P3|NOT COMPLETED|Dose Escalation 15,000 Units||0
2580721|NCT00378352|6330854|P2|NOT COMPLETED|Dose Escalation 15,000 Units||0
2580722|NCT00378352|6330855|P1|NOT COMPLETED|Dose Escalation 15,000 Units||5
2580723|NCT00378352|6330850|P6|COMPLETED|Dose Escalation 15,000 Units||0
2580724|NCT00378352|6330851|P5|COMPLETED|Dose Escalation 15,000 Units||0
2580725|NCT00378352|6330852|P4|COMPLETED|Dose Escalation 15,000 Units||10
2580726|NCT00378352|6330853|P3|COMPLETED|Dose Escalation 15,000 Units||0
2580727|NCT00378352|6330854|P2|COMPLETED|Dose Escalation 15,000 Units||0
2580728|NCT00378352|6330855|P1|COMPLETED|Dose Escalation 15,000 Units||15
2580729|NCT00378352|6330850|P6|Safety Analysis|Dose Escalation 15,000 Units||0
2580730|NCT00378352|6330851|P5|Safety Analysis|Dose Escalation 15,000 Units||0
2580731|NCT00378352|6330852|P4|Safety Analysis|Dose Escalation 15,000 Units||11
2580732|NCT00378352|6330853|P3|Safety Analysis|Dose Escalation 15,000 Units||0
2580733|NCT00378352|6330854|P2|Safety Analysis|Dose Escalation 15,000 Units||0
2580734|NCT00378352|6330855|P1|Safety Analysis|Dose Escalation 15,000 Units||19
2580735|NCT00378352|6330850|P6|STARTED|Dose Escalation 15,000 Units||0
2580736|NCT00378352|6330851|P5|STARTED|Dose Escalation 15,000 Units||0
2580737|NCT00378352|6330852|P4|STARTED|Dose Escalation 15,000 Units||11
2580738|NCT00378352|6330853|P3|STARTED|Dose Escalation 15,000 Units||0
2580739|NCT00378352|6330854|P2|STARTED|Dose Escalation 15,000 Units||0
2580740|NCT00378352|6330855|P1|STARTED|Dose Escalation 15,000 Units||20
2580741|NCT00378326|6330877|P1|NOT COMPLETED|Overall Study||0
2580742|NCT00378326|6330877|P1|COMPLETED|Overall Study||26
2580743|NCT00378326|6330877|P1|STARTED|Overall Study||26
2580744|NCT00378209|6330883|P1|NOT COMPLETED|Overall Study||22
2580745|NCT00378209|6330883|P1|COMPLETED|Overall Study|This included patients who completed at least 8 cycles of combination therapy with all drugs.|42
2580746|NCT00378209|6330883|P1|STARTED|Overall Study|1 patient who never started treatment was excluded in the analysis.|64
2580747|NCT00378105|6330893|P2|NOT COMPLETED|Overall Study||30
2580748|NCT00378105|6330894|P1|NOT COMPLETED|Overall Study||20
2580749|NCT00378105|6330893|P2|COMPLETED|Overall Study||5
2580750|NCT00378105|6330894|P1|COMPLETED|Overall Study||11
2580751|NCT00378105|6330893|P2|STARTED|Overall Study||35
2580752|NCT00378105|6330894|P1|STARTED|Overall Study|Out of 33 enrolled, two patients went off study before start of therapy.|31
2580753|NCT00378079|6330906|P3|NOT COMPLETED|Overall Study||0
2580754|NCT00378079|6330907|P2|NOT COMPLETED|Overall Study||1
2580755|NCT00378079|6330908|P1|NOT COMPLETED|Overall Study||6
2580756|NCT00378079|6330906|P3|COMPLETED|Overall Study||71
2580757|NCT00378079|6330907|P2|COMPLETED|Overall Study||69
2580758|NCT00378079|6330908|P1|COMPLETED|Overall Study||64
2580759|NCT00378079|6330906|P3|STARTED|Overall Study||71
2580760|NCT00378079|6330907|P2|STARTED|Overall Study||70
2580761|NCT00378079|6330908|P1|STARTED|Overall Study||70
2580762|NCT00378014|6330930|P2|NOT COMPLETED|Extension (Month 12 to Month 59)||14
2580763|NCT00378014|6330931|P1|NOT COMPLETED|Extension (Month 12 to Month 59)||14
2580764|NCT00378014|6330930|P2|COMPLETED|Extension (Month 12 to Month 59)||26
2580765|NCT00378014|6330931|P1|COMPLETED|Extension (Month 12 to Month 59)||27
2580766|NCT00378014|6330930|P2|STARTED|Extension (Month 12 to Month 59)||40
2580767|NCT00378014|6330931|P1|STARTED|Extension (Month 12 to Month 59)||41
2580768|NCT00378014|6330930|P2|NOT COMPLETED|Core (Randomization to Month 11)||12
2580769|NCT00378014|6330931|P1|NOT COMPLETED|Core (Randomization to Month 11)||14
2580770|NCT00378014|6330930|P2|COMPLETED|Core (Randomization to Month 11)||90
2580771|NCT00378014|6330931|P1|COMPLETED|Core (Randomization to Month 11)||87
2580772|NCT00378014|6330930|P2|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|98
2580773|NCT00378014|6330931|P1|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|96
2580774|NCT00378014|6330930|P2|STARTED|Core (Randomization to Month 11)||102
2580775|NCT00378014|6330931|P1|STARTED|Core (Randomization to Month 11)||101
2580776|NCT00377962|6330957|P2|NOT COMPLETED|Extension Study: 12-24 Months||4
2580777|NCT00377962|6330958|P1|NOT COMPLETED|Extension Study: 12-24 Months||10
2580778|NCT00377962|6330957|P2|COMPLETED|Extension Study: 12-24 Months||123
2580779|NCT00377962|6330958|P1|COMPLETED|Extension Study: 12-24 Months||98
2580780|NCT00377962|6330957|P2|STARTED|Extension Study: 12-24 Months||127
2580781|NCT00377962|6330958|P1|STARTED|Extension Study: 12-24 Months||108
2580782|NCT00377962|6330957|P2|NOT COMPLETED|Core Study: 0-12 Months||9
2580783|NCT00377962|6330958|P1|NOT COMPLETED|Core Study: 0-12 Months||28
2580784|NCT00377962|6330957|P2|COMPLETED|Core Study: 0-12 Months||133
2580785|NCT00377962|6330958|P1|COMPLETED|Core Study: 0-12 Months||112
2580786|NCT00377962|6330957|P2|STARTED|Core Study: 0-12 Months||142
2580787|NCT00377962|6330958|P1|STARTED|Core Study: 0-12 Months||140
2580788|NCT00377858|6330994|P2|NOT COMPLETED|Overall Study||27
2580789|NCT00377858|6330995|P1|NOT COMPLETED|Overall Study||31
2580790|NCT00377858|6330994|P2|COMPLETED|Overall Study||215
2580791|NCT00377858|6330995|P1|COMPLETED|Overall Study||211
2580792|NCT00377858|6330994|P2|Had at Least One Post-Baseline Value|Overall Study||240
2580793|NCT00377858|6330995|P1|Had at Least One Post-Baseline Value|Overall Study||239
2580794|NCT00377858|6330994|P2|STARTED|Overall Study||242
2580795|NCT00377858|6330995|P1|STARTED|Overall Study||242
2580796|NCT00377832|6331025|P2|NOT COMPLETED|Overall Study||0
2580797|NCT00377832|6331026|P1|NOT COMPLETED|Overall Study||0
2580798|NCT00377832|6331025|P2|COMPLETED|Overall Study||6
2580799|NCT00377832|6331026|P1|COMPLETED|Overall Study||7
2580800|NCT00377832|6331025|P2|STARTED|Overall Study||6
2580801|NCT00377832|6331026|P1|STARTED|Overall Study||7
2580802|NCT00377819|6331048|P2|NOT COMPLETED|Overall Study||10
2580803|NCT00377819|6331049|P1|NOT COMPLETED|Overall Study||13
2580804|NCT00377819|6331048|P2|COMPLETED|Overall Study||243
2580805|NCT00377819|6331049|P1|COMPLETED|Overall Study||238
2580806|NCT00377819|6331048|P2|Received Study Medication|Overall Study||253
2580807|NCT00377819|6331049|P1|Received Study Medication|Overall Study||249
2580808|NCT00377819|6331048|P2|STARTED|Overall Study||253
2580809|NCT00377819|6331049|P1|STARTED|Overall Study||251
2580810|NCT00377741|6331061|P2|NOT COMPLETED|Overall Study||0
2580811|NCT00377741|6331062|P1|NOT COMPLETED|Overall Study||0
2580812|NCT00377741|6331061|P2|COMPLETED|Overall Study||15
2580813|NCT00377741|6331062|P1|COMPLETED|Overall Study||16
2580814|NCT00377741|6331061|P2|STARTED|Overall Study||15
2580815|NCT00377741|6331062|P1|STARTED|Overall Study||16
2580816|NCT00377676|6331078|P2|NOT COMPLETED|Overall Study||322
2580817|NCT00377676|6331079|P1|NOT COMPLETED|Overall Study||961
2580818|NCT00377676|6331078|P2|COMPLETED|Overall Study||694
2580819|NCT00377676|6331079|P1|COMPLETED|Overall Study||1093
2580820|NCT00377676|6331078|P2|STARTED|Overall Study||1016
2580821|NCT00377676|6331079|P1|STARTED|Overall Study|25 subjects did not receive study drug - thus 3070 were randomized and received drug|2054
2580822|NCT00377637|6331095|P4|NOT COMPLETED|Maintenance Phase||57
2580823|NCT00377637|6331096|P3|NOT COMPLETED|Maintenance Phase||43
2580824|NCT00377637|6331097|P2|NOT COMPLETED|Maintenance Phase||0
2580825|NCT00377637|6331098|P1|NOT COMPLETED|Maintenance Phase||0
2580826|NCT00377637|6331095|P4|COMPLETED|Maintenance Phase||54
2580827|NCT00377637|6331096|P3|COMPLETED|Maintenance Phase||73
2580828|NCT00377637|6331097|P2|COMPLETED|Maintenance Phase||0
2580829|NCT00377637|6331098|P1|COMPLETED|Maintenance Phase||0
2580830|NCT00377637|6331095|P4|STARTED|Maintenance Phase||111
2580831|NCT00377637|6331096|P3|STARTED|Maintenance Phase||116
2580832|NCT00377637|6331097|P2|STARTED|Maintenance Phase||0
2580833|NCT00377637|6331098|P1|STARTED|Maintenance Phase||0
2580834|NCT00377637|6331095|P4|NOT COMPLETED|Induction Phase||0
2580835|NCT00377637|6331096|P3|NOT COMPLETED|Induction Phase||0
2580836|NCT00377637|6331097|P2|NOT COMPLETED|Induction Phase||35
2580837|NCT00377637|6331098|P1|NOT COMPLETED|Induction Phase||29
2580838|NCT00377637|6331095|P4|COMPLETED|Induction Phase||0
2580839|NCT00377637|6331096|P3|COMPLETED|Induction Phase||0
2580840|NCT00377637|6331097|P2|COMPLETED|Induction Phase||150
2580841|NCT00377637|6331098|P1|COMPLETED|Induction Phase||156
2580842|NCT00377637|6331095|P4|Safety Population|Induction Phase||0
2580843|NCT00377637|6331096|P3|Safety Population|Induction Phase||0
2580844|NCT00377637|6331097|P2|Safety Population|Induction Phase||184
2580845|NCT00377637|6331098|P1|Safety Population|Induction Phase||180
2580846|NCT00377637|6331095|P4|STARTED|Induction Phase||0
2580847|NCT00377637|6331096|P3|STARTED|Induction Phase||0
2580848|NCT00377637|6331097|P2|STARTED|Induction Phase|Intent-To-Treat|185
2580849|NCT00377637|6331098|P1|STARTED|Induction Phase|Intent-To-Treat|185
2580850|NCT00377611|6331134|P2|NOT COMPLETED|Overall Study||33
2580851|NCT00377611|6331135|P1|NOT COMPLETED|Overall Study||22
2580852|NCT00377611|6331134|P2|COMPLETED|Overall Study||1974
2580853|NCT00377611|6331135|P1|COMPLETED|Overall Study||1025
2580854|NCT00377611|6331134|P2|STARTED|Overall Study||2007
2580855|NCT00377611|6331135|P1|STARTED|Overall Study||1047
2580856|NCT00377572|6331198|P2|NOT COMPLETED|Overall Study||54
2580857|NCT00377572|6331199|P1|NOT COMPLETED|Overall Study||53
2580858|NCT00377572|6331198|P2|COMPLETED|Overall Study||157
2580859|NCT00377572|6331199|P1|COMPLETED|Overall Study||155
2580860|NCT00377572|6331198|P2|STARTED|Overall Study||211
2580861|NCT00377572|6331199|P1|STARTED|Overall Study||208
2580862|NCT00377520|6331237|P1|NOT COMPLETED|Overall Study||1
2580863|NCT00377520|6331237|P1|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|26
2580864|NCT00377520|6331237|P1|STARTED|Overall Study||27
2580865|NCT00377455|6331242|P1|NOT COMPLETED|Overall Study||1
2580866|NCT00377455|6331242|P1|COMPLETED|Overall Study||4
2580867|NCT00377455|6331242|P1|STARTED|Overall Study||5
2580868|NCT00377429|6331250|P1|NOT COMPLETED|Overall Study||15
2580869|NCT00377429|6331250|P1|COMPLETED|Overall Study|Completed main study|32
2580870|NCT00377429|6331250|P1|STARTED|Overall Study|Treated|47
2580871|NCT00377403|6331261|P2|NOT COMPLETED|Overall Study||7
2580872|NCT00377403|6331262|P1|NOT COMPLETED|Overall Study||4
2580873|NCT00377403|6331261|P2|COMPLETED|Overall Study|The number varied by day of follow-up from 71 to 77 in the symptomatic treatment only group.|74
2580874|NCT00377403|6331262|P1|COMPLETED|Overall Study|The number varied by day of follow-up from 80 to 82 in the intervention group.|81
2580875|NCT00377403|6331261|P2|Day 28 Assessment|Overall Study||77
2580876|NCT00377403|6331262|P1|Day 28 Assessment|Overall Study||82
2580877|NCT00377403|6331261|P2|Day 10 Assessment|Overall Study||71
2580878|NCT00377403|6331262|P1|Day 10 Assessment|Overall Study||81
2580879|NCT00377403|6331261|P2|Day 7 Assessment|Overall Study||75
2580880|NCT00377403|6331262|P1|Day 7 Assessment|Overall Study||80
2580881|NCT00377403|6331261|P2|Day -3 Assessment|Overall Study||74
2580882|NCT00377403|6331262|P1|Day -3 Assessment|Overall Study||81
2580883|NCT00377403|6331261|P2|STARTED|Overall Study||81
2580884|NCT00377403|6331262|P1|STARTED|Overall Study||85
2580885|NCT00377364|6331270|P2|NOT COMPLETED|Overall Study||0
2580886|NCT00377364|6331271|P1|NOT COMPLETED|Overall Study||2
2580887|NCT00377364|6331270|P2|COMPLETED|Overall Study||14
2580888|NCT00377364|6331271|P1|COMPLETED|Overall Study||14
2580889|NCT00377364|6331270|P2|STARTED|Overall Study||14
2580890|NCT00377364|6331271|P1|STARTED|Overall Study||16
2580891|NCT00377312|6331297|P2|NOT COMPLETED|Overall Study||1
2580892|NCT00377312|6331298|P1|NOT COMPLETED|Overall Study||1
2580893|NCT00377312|6331297|P2|COMPLETED|Overall Study||4
2580894|NCT00377312|6331298|P1|COMPLETED|Overall Study||5
2580895|NCT00377312|6331297|P2|STARTED|Overall Study||5
2580896|NCT00377312|6331298|P1|STARTED|Overall Study||6
2580897|NCT00377299|6331330|P2|NOT COMPLETED|Overall Study||24
2580898|NCT00377299|6331331|P1|NOT COMPLETED|Overall Study||19
2580899|NCT00377299|6331330|P2|COMPLETED|Overall Study||4
2580900|NCT00377299|6331331|P1|COMPLETED|Overall Study||13
2580901|NCT00377299|6331330|P2|STARTED|Overall Study||28
2580902|NCT00377299|6331331|P1|STARTED|Overall Study||32
2580903|NCT00377260|6331347|P2|NOT COMPLETED|Overall Study||5
2580904|NCT00377260|6331348|P1|NOT COMPLETED|Overall Study||2
2580905|NCT00377260|6331347|P2|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
2580906|NCT00377260|6331348|P1|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
2580907|NCT00377260|6331347|P2|STARTED|Overall Study||147
2580908|NCT00377260|6331348|P1|STARTED|Overall Study||144
2580909|NCT00377234|6331402|P2|NOT COMPLETED|Overall Study||31
2580910|NCT00377234|6331403|P1|NOT COMPLETED|Overall Study||34
2580911|NCT00377234|6331402|P2|COMPLETED|Overall Study||145
2580912|NCT00377234|6331403|P1|COMPLETED|Overall Study||146
2580913|NCT00377234|6331402|P2|Safety Analysis Set: Risedronate|Overall Study||174
2580914|NCT00377234|6331403|P1|Safety Analysis Set: Risedronate|Overall Study||153
2580915|NCT00377234|6331402|P2|Safety Analysis Set: Ibandronate|Overall Study||150
2580916|NCT00377234|6331403|P1|Safety Analysis Set: Ibandronate|Overall Study||177
2580917|NCT00377234|6331402|P2|Safety Analysis Set: Period 2|Overall Study||150
2580918|NCT00377234|6331403|P1|Safety Analysis Set: Period 2|Overall Study||153
2580919|NCT00377234|6331402|P2|Safety Analysis Set: Period 1|Overall Study||174
2580920|NCT00377234|6331403|P1|Safety Analysis Set: Period 1|Overall Study||177
2580921|NCT00377234|6331402|P2|Received Treatment|Overall Study||174
2580922|NCT00377234|6331403|P1|Received Treatment|Overall Study||177
2580923|NCT00377234|6331402|P2|Did Not Receive Study Treatment|Overall Study||2
2580924|NCT00377234|6331403|P1|Did Not Receive Study Treatment|Overall Study||3
2580925|NCT00377234|6331402|P2|Randomized|Overall Study||176
2580926|NCT00377234|6331403|P1|Randomized|Overall Study||180
2580927|NCT00377234|6331402|P2|STARTED|Overall Study||176
2580928|NCT00377234|6331403|P1|STARTED|Overall Study||180
2580929|NCT00377156|6331421|P2|NOT COMPLETED|Overall Study||54
2580930|NCT00377156|6331422|P1|NOT COMPLETED|Overall Study||48
2580931|NCT00377156|6331421|P2|COMPLETED|Overall Study||48
2580932|NCT00377156|6331422|P1|COMPLETED|Overall Study||63
2580933|NCT00377156|6331421|P2|STARTED|Overall Study||102
2580934|NCT00377156|6331422|P1|STARTED|Overall Study||111
2580935|NCT00376961|6331436|P2|NOT COMPLETED|Maintenance||23
2580936|NCT00376961|6331437|P1|NOT COMPLETED|Maintenance||0
2580937|NCT00376961|6331436|P2|COMPLETED|Maintenance||27
2580938|NCT00376961|6331437|P1|COMPLETED|Maintenance||0
2580939|NCT00376961|6331436|P2|Eligible|Maintenance||47
2580940|NCT00376961|6331437|P1|Eligible|Maintenance||0
2580941|NCT00376961|6331436|P2|STARTED|Maintenance||50
2580942|NCT00376961|6331437|P1|STARTED|Maintenance||0
2580943|NCT00376961|6331436|P2|NOT COMPLETED|Initial Registration||0
2580944|NCT00376961|6331437|P1|NOT COMPLETED|Initial Registration||7
2580945|NCT00376961|6331436|P2|COMPLETED|Initial Registration||0
2580946|NCT00376961|6331437|P1|COMPLETED|Initial Registration||61
2580947|NCT00376961|6331436|P2|Eligible|Initial Registration||0
2580948|NCT00376961|6331437|P1|Eligible|Initial Registration||65
2580949|NCT00376961|6331436|P2|STARTED|Initial Registration||0
2580950|NCT00376961|6331437|P1|STARTED|Initial Registration||68
2580951|NCT00376948|6331446|P1|NOT COMPLETED|Overall Study||0
2580952|NCT00376948|6331446|P1|COMPLETED|Overall Study||20
2580953|NCT00376948|6331446|P1|STARTED|Overall Study||20
2580954|NCT00376935|6331455|P4|NOT COMPLETED|Overall Study||0
2580955|NCT00376935|6331456|P3|NOT COMPLETED|Overall Study||0
2580956|NCT00376935|6331457|P2|NOT COMPLETED|Overall Study||0
2580957|NCT00376935|6331458|P1|NOT COMPLETED|Overall Study||0
2580958|NCT00376935|6331455|P4|COMPLETED|Overall Study||24
2580959|NCT00376935|6331456|P3|COMPLETED|Overall Study||25
2580960|NCT00376935|6331457|P2|COMPLETED|Overall Study||25
2580961|NCT00376935|6331458|P1|COMPLETED|Overall Study||25
2580962|NCT00376935|6331455|P4|STARTED|Overall Study||24
2580963|NCT00376935|6331456|P3|STARTED|Overall Study||25
2580964|NCT00376935|6331457|P2|STARTED|Overall Study||25
2580965|NCT00376935|6331458|P1|STARTED|Overall Study||25
2580966|NCT00376805|6331496|P1|NOT COMPLETED|Overall Study||0
2580967|NCT00376805|6331496|P1|COMPLETED|Overall Study||6
2580968|NCT00376805|6331496|P1|STARTED|Overall Study||6
2580972|NCT00376675|6331509|P2|NOT COMPLETED|Overall Study||14
2580973|NCT00376675|6331510|P1|NOT COMPLETED|Overall Study||20
2580974|NCT00376675|6331509|P2|COMPLETED|Overall Study||56
2580975|NCT00376675|6331510|P1|COMPLETED|Overall Study||49
2580976|NCT00376675|6331509|P2|STARTED|Overall Study||70
2580977|NCT00376675|6331510|P1|STARTED|Overall Study||69
2580978|NCT00376597|6331534|P2|NOT COMPLETED|Overall Study||3
2580979|NCT00376597|6331535|P1|NOT COMPLETED|Overall Study||11
2580980|NCT00376597|6331534|P2|COMPLETED|Overall Study||312
2580981|NCT00376597|6331535|P1|COMPLETED|Overall Study||242
2580982|NCT00376597|6331534|P2|STARTED|Overall Study||315
2580983|NCT00376597|6331535|P1|STARTED|Overall Study||253
2580984|NCT00376558|6331549|P2|NOT COMPLETED|Overall Study||0
2580985|NCT00376558|6331550|P1|NOT COMPLETED|Overall Study||0
2580986|NCT00376558|6331549|P2|COMPLETED|Overall Study||25
2580987|NCT00376558|6331550|P1|COMPLETED|Overall Study||25
2580988|NCT00376558|6331549|P2|STARTED|Overall Study||25
2580989|NCT00376558|6331550|P1|STARTED|Overall Study||25
2580990|NCT00376532|6331559|P2|NOT COMPLETED|Overall Study||6
2580991|NCT00376532|6331560|P1|NOT COMPLETED|Overall Study||6
2580992|NCT00376532|6331559|P2|COMPLETED|Overall Study|Last non-event subject enrolled 3/18/2008.|26
2580993|NCT00376532|6331560|P1|COMPLETED|Overall Study|Last event subject enrolled 2/22/2008|25
2580994|NCT00376532|6331559|P2|STARTED|Overall Study|Subjects without an event were enrolled beginning 09/15/2006.|32
2580995|NCT00376532|6331560|P1|STARTED|Overall Study|Subjects with an event were enrolled beginning 09/14/2006.|31
2580996|NCT00376506|6331570|P2|NOT COMPLETED|Overall Study||2
2580997|NCT00376506|6331571|P1|NOT COMPLETED|Overall Study||0
2580998|NCT00376506|6331570|P2|COMPLETED|Overall Study||4
2580999|NCT00376506|6331571|P1|COMPLETED|Overall Study||4
2581000|NCT00376506|6331570|P2|STARTED|Overall Study||6
2581001|NCT00376506|6331571|P1|STARTED|Overall Study||4
2581002|NCT00376363|6331589|P2|NOT COMPLETED|Overall Study||46
2581003|NCT00376363|6331590|P1|NOT COMPLETED|Overall Study||56
2581004|NCT00376363|6331589|P2|COMPLETED|Overall Study||87
2581005|NCT00376363|6331590|P1|COMPLETED|Overall Study||87
2581006|NCT00376363|6331589|P2|STARTED|Overall Study||133
2581007|NCT00376363|6331590|P1|STARTED|Overall Study||143
2581008|NCT00376259|6331602|P2|NOT COMPLETED|Overall Study||21
2581009|NCT00376259|6331603|P1|NOT COMPLETED|Overall Study||22
2581010|NCT00376259|6331602|P2|COMPLETED|Overall Study||0
2581011|NCT00376259|6331603|P1|COMPLETED|Overall Study||0
2581012|NCT00376259|6331602|P2|Received Study Drug|Overall Study||21
2581013|NCT00376259|6331603|P1|Received Study Drug|Overall Study||21
2581014|NCT00376259|6331602|P2|STARTED|Overall Study||21
2581015|NCT00376259|6331603|P1|STARTED|Overall Study||22
2581016|NCT00376246|6331615|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
2581017|NCT00376246|6331616|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
2581018|NCT00376246|6331615|P2|COMPLETED|Second Intervention (2 Weeks)||12
2581019|NCT00376246|6331616|P1|COMPLETED|Second Intervention (2 Weeks)||10
2581020|NCT00376246|6331615|P2|STARTED|Second Intervention (2 Weeks)||12
2581021|NCT00376246|6331616|P1|STARTED|Second Intervention (2 Weeks)||10
2581022|NCT00376246|6331615|P2|NOT COMPLETED|Washout (2 Weeks)||0
2581023|NCT00376246|6331616|P1|NOT COMPLETED|Washout (2 Weeks)||0
2581024|NCT00376246|6331615|P2|COMPLETED|Washout (2 Weeks)||12
2581025|NCT00376246|6331616|P1|COMPLETED|Washout (2 Weeks)||10
2581026|NCT00376246|6331615|P2|STARTED|Washout (2 Weeks)||12
2581027|NCT00376246|6331616|P1|STARTED|Washout (2 Weeks)||10
2581028|NCT00376246|6331615|P2|NOT COMPLETED|First Intervention (2 Weeks)||2
2581029|NCT00376246|6331616|P1|NOT COMPLETED|First Intervention (2 Weeks)||4
2581030|NCT00376246|6331615|P2|COMPLETED|First Intervention (2 Weeks)||12
2581031|NCT00376246|6331616|P1|COMPLETED|First Intervention (2 Weeks)||10
2581032|NCT00376246|6331615|P2|STARTED|First Intervention (2 Weeks)||14
2581033|NCT00376246|6331616|P1|STARTED|First Intervention (2 Weeks)||14
2581034|NCT00376220|6331626|P2|NOT COMPLETED|Overall Study||12
2581035|NCT00376220|6331627|P1|NOT COMPLETED|Overall Study||10
2581036|NCT00376220|6331626|P2|COMPLETED|Overall Study||35
2581037|NCT00376220|6331627|P1|COMPLETED|Overall Study||37
2581038|NCT00376220|6331626|P2|STARTED|Overall Study||47
2581039|NCT00376220|6331627|P1|STARTED|Overall Study||47
2581040|NCT00376168|6331635|P2|NOT COMPLETED|Overall Study||1
2581041|NCT00376168|6331636|P1|NOT COMPLETED|Overall Study||2
2581042|NCT00376168|6331635|P2|COMPLETED|Overall Study||15
2581043|NCT00376168|6331636|P1|COMPLETED|Overall Study||14
2581044|NCT00376168|6331635|P2|STARTED|Overall Study|One patient randomized but not treated|16
2581045|NCT00376168|6331636|P1|STARTED|Overall Study||16
2581046|NCT00375999|6331650|P1|NOT COMPLETED|Overall Study||2
2581047|NCT00375999|6331650|P1|COMPLETED|Overall Study||32
2581048|NCT00375999|6331650|P1|STARTED|Overall Study||34
2581049|NCT00375973|6331656|P2|NOT COMPLETED|Overall Study||2
2581050|NCT00375973|6331657|P1|NOT COMPLETED|Overall Study||10
2581051|NCT00375973|6331656|P2|COMPLETED|Overall Study||28
2581052|NCT00375973|6331657|P1|COMPLETED|Overall Study||20
2581053|NCT00375973|6331656|P2|STARTED|Overall Study||30
2581054|NCT00375973|6331657|P1|STARTED|Overall Study||30
2581055|NCT00375934|6331677|P2|NOT COMPLETED|Overall Study||6
2581056|NCT00375934|6331678|P1|NOT COMPLETED|Overall Study||3
2581057|NCT00375934|6331677|P2|COMPLETED|Overall Study||95
2581058|NCT00375934|6331678|P1|COMPLETED|Overall Study||96
2581059|NCT00375934|6331677|P2|STARTED|Overall Study||101
2581060|NCT00375934|6331678|P1|STARTED|Overall Study||99
2581061|NCT00375830|6331707|P3|NOT COMPLETED|Overall Study||0
2581062|NCT00375830|6331708|P2|NOT COMPLETED|Overall Study||0
2581063|NCT00375830|6331709|P1|NOT COMPLETED|Overall Study||0
2581064|NCT00375830|6331707|P3|COMPLETED|Overall Study||74
2581065|NCT00375830|6331708|P2|COMPLETED|Overall Study||30
2581066|NCT00375830|6331709|P1|COMPLETED|Overall Study||10
2581067|NCT00375830|6331707|P3|STARTED|Overall Study||74
2581068|NCT00375830|6331708|P2|STARTED|Overall Study||30
2581069|NCT00375830|6331709|P1|STARTED|Overall Study||10
2581070|NCT00375752|6331736|P2|NOT COMPLETED|Overall Study||15
2581071|NCT00375752|6331737|P1|NOT COMPLETED|Overall Study||12
2581072|NCT00375752|6331736|P2|COMPLETED|Overall Study||74
2581073|NCT00375752|6331737|P1|COMPLETED|Overall Study||67
2581074|NCT00375752|6331736|P2|STARTED|Overall Study||89
2581075|NCT00375752|6331737|P1|STARTED|Overall Study||79
2581076|NCT00375713|6331753|P2|NOT COMPLETED|Overall Study||23
2581077|NCT00375713|6331754|P1|NOT COMPLETED|Overall Study||20
2581078|NCT00375713|6331753|P2|COMPLETED|Overall Study|23 Patients were not treated or discontinued after randomization in Cetirizine group.|211
2581079|NCT00375713|6331754|P1|COMPLETED|Overall Study|20 Patients were not treated or discontinued after randomization in Levocetirizine group.|212
2581080|NCT00375713|6331753|P2|STARTED|Overall Study|Randomized population (N=234).|234
2581081|NCT00375713|6331754|P1|STARTED|Overall Study|Randomized population (N=232).|232
2581082|NCT00375674|6331768|P2|NOT COMPLETED|Overall Study||141
2581083|NCT00375674|6331769|P1|NOT COMPLETED|Overall Study||144
2581084|NCT00375674|6331768|P2|COMPLETED|Overall Study||165
2581085|NCT00375674|6331769|P1|COMPLETED|Overall Study||165
2581086|NCT00375674|6331768|P2|As-Treated Population|Overall Study|2 were randomized but not treated: 1 was screening failure & 1 discontinued due to new liver lesions|304
2581087|NCT00375674|6331769|P1|As-Treated Population|Overall Study|3 were randomized but not treated: 2 refused treatment & 1 withdrew before receiving study drug|306
2581088|NCT00375674|6331768|P2|Intent-to-Treat Population|Overall Study||306
2581089|NCT00375674|6331769|P1|Intent-to-Treat Population|Overall Study||309
2581090|NCT00375674|6331768|P2|STARTED|Overall Study||306
2581091|NCT00375674|6331769|P1|STARTED|Overall Study||309
2581092|NCT00375609|6331798|P3|NOT COMPLETED|Overall Study||1
2581093|NCT00375609|6331799|P2|NOT COMPLETED|Overall Study||7
2581094|NCT00375609|6331800|P1|NOT COMPLETED|Overall Study||4
2581095|NCT00375609|6331798|P3|COMPLETED|Overall Study||42
2581096|NCT00375609|6331799|P2|COMPLETED|Overall Study||77
2581097|NCT00375609|6331800|P1|COMPLETED|Overall Study||84
2581098|NCT00375609|6331798|P3|STARTED|Overall Study||43
2581099|NCT00375609|6331799|P2|STARTED|Overall Study||84
2581100|NCT00375609|6331800|P1|STARTED|Overall Study||88
2581101|NCT00375518|6331816|P2|NOT COMPLETED|Overall Study||17
2581102|NCT00375518|6331817|P1|NOT COMPLETED|Overall Study||8
2581103|NCT00375518|6331816|P2|COMPLETED|Overall Study||65
2581104|NCT00375518|6331817|P1|COMPLETED|Overall Study||72
2581105|NCT00375518|6331816|P2|STARTED|Overall Study||82
2581106|NCT00375518|6331817|P1|STARTED|Overall Study||80
2581107|NCT00375505|6331825|P2|NOT COMPLETED|Overall Study||2
2581108|NCT00375505|6331826|P1|NOT COMPLETED|Overall Study||1
2581109|NCT00375505|6331825|P2|COMPLETED|Overall Study||32
2581110|NCT00375505|6331826|P1|COMPLETED|Overall Study||35
2581111|NCT00375505|6331825|P2|STARTED|Overall Study||34
2581112|NCT00375505|6331826|P1|STARTED|Overall Study||36
2581113|NCT00375492|6331870|P2|NOT COMPLETED|Overall Study||26
2581114|NCT00375492|6331871|P1|NOT COMPLETED|Overall Study||26
2581115|NCT00375492|6331870|P2|COMPLETED|Overall Study||72
2581116|NCT00375492|6331871|P1|COMPLETED|Overall Study||70
2581117|NCT00375492|6331870|P2|STARTED|Overall Study||98
2581118|NCT00375492|6331871|P1|STARTED|Overall Study||96
2581119|NCT00375427|6331901|P2|NOT COMPLETED|Overall Study||74
2581120|NCT00375427|6331902|P1|NOT COMPLETED|Overall Study||60
2581121|NCT00375427|6331901|P2|COMPLETED|Overall Study||142
2581122|NCT00375427|6331902|P1|COMPLETED|Overall Study||149
2581123|NCT00375427|6331901|P2|STARTED|Overall Study||216
2581124|NCT00375427|6331902|P1|STARTED|Overall Study|Total enrollment was 430 but five patients were screened but not treated.|209
2581125|NCT00375219|6331927|P3|NOT COMPLETED|Overall Study||21
2581126|NCT00375219|6331928|P2|NOT COMPLETED|Overall Study||20
2581127|NCT00375219|6331929|P1|NOT COMPLETED|Overall Study||59
2581128|NCT00375219|6331927|P3|COMPLETED|Overall Study||0
2581129|NCT00375219|6331928|P2|COMPLETED|Overall Study||0
2581130|NCT00375219|6331929|P1|COMPLETED|Overall Study||3
2581131|NCT00375219|6331927|P3|STARTED|Overall Study||21
2581132|NCT00375219|6331928|P2|STARTED|Overall Study||20
2581133|NCT00375219|6331929|P1|STARTED|Overall Study||62
2581134|NCT00375167|6331997|P2|NOT COMPLETED|Overall Study||0
2581135|NCT00375167|6331998|P1|NOT COMPLETED|Overall Study||0
2581136|NCT00375167|6331997|P2|COMPLETED|Overall Study||17
2581137|NCT00375167|6331998|P1|COMPLETED|Overall Study||16
2581138|NCT00375167|6331997|P2|STARTED|Overall Study|Participants were already clients of ACT and continued receiving services following this period|17
2581139|NCT00375167|6331998|P1|STARTED|Overall Study|Clients were already receiving ACT services and this continued after study completion|16
2581140|NCT00374907|6332012|P2|NOT COMPLETED|116-Week Short-term + Long-term Period||14
2581141|NCT00374907|6332013|P1|NOT COMPLETED|116-Week Short-term + Long-term Period||13
2581142|NCT00374907|6332012|P2|COMPLETED|116-Week Short-term + Long-term Period||2
2581143|NCT00374907|6332013|P1|COMPLETED|116-Week Short-term + Long-term Period||7
2581144|NCT00374907|6332012|P2|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||15
2581145|NCT00374907|6332013|P1|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||17
2581146|NCT00374907|6332012|P2|STARTED|116-Week Short-term + Long-term Period||16
2581147|NCT00374907|6332013|P1|STARTED|116-Week Short-term + Long-term Period||20
2581148|NCT00374907|6332012|P2|NOT COMPLETED|12-Week Short-term Period||1
2581149|NCT00374907|6332013|P1|NOT COMPLETED|12-Week Short-term Period||3
2581150|NCT00374907|6332012|P2|COMPLETED|12-Week Short-term Period||15
2581151|NCT00374907|6332013|P1|COMPLETED|12-Week Short-term Period||17
2581152|NCT00374907|6332012|P2|STARTED|12-Week Short-term Period||16
2581153|NCT00374907|6332013|P1|STARTED|12-Week Short-term Period||20
2581154|NCT00374868|6332025|P1|NOT COMPLETED|Overall Study||36
2581155|NCT00374868|6332025|P1|COMPLETED|Overall Study||2
2581156|NCT00374868|6332025|P1|STARTED|Overall Study||38
2581157|NCT00374842|6332039|P3|NOT COMPLETED|Overall Study||0
2581158|NCT00374842|6332040|P2|NOT COMPLETED|Overall Study||0
2581159|NCT00374842|6332041|P1|NOT COMPLETED|Overall Study||0
2581160|NCT00374842|6332039|P3|COMPLETED|Overall Study||100
2581161|NCT00374842|6332040|P2|COMPLETED|Overall Study||100
2581162|NCT00374842|6332041|P1|COMPLETED|Overall Study||100
2581163|NCT00374842|6332039|P3|STARTED|Overall Study||100
2581164|NCT00374842|6332040|P2|STARTED|Overall Study||100
2581165|NCT00374842|6332041|P1|STARTED|Overall Study||100
2581166|NCT00374803|6332072|P2|NOT COMPLETED|Overall Study||0
2581167|NCT00374803|6332073|P1|NOT COMPLETED|Overall Study||0
2581168|NCT00374803|6332072|P2|COMPLETED|Overall Study||23
2581169|NCT00374803|6332073|P1|COMPLETED|Overall Study||22
2581170|NCT00374803|6332072|P2|STARTED|Overall Study||23
2581171|NCT00374803|6332073|P1|STARTED|Overall Study||22
2581172|NCT00374556|6332089|P2|NOT COMPLETED|Overall Study||1
2581173|NCT00374556|6332090|P1|NOT COMPLETED|Overall Study||1
2581174|NCT00374556|6332089|P2|COMPLETED|Overall Study||15
2581175|NCT00374556|6332090|P1|COMPLETED|Overall Study||13
2581176|NCT00374556|6332089|P2|STARTED|Overall Study||16
2581177|NCT00374556|6332090|P1|STARTED|Overall Study||14
2581178|NCT00374543|6332142|P2|NOT COMPLETED|Overall Study||0
2581179|NCT00374543|6332143|P1|NOT COMPLETED|Overall Study||0
2581180|NCT00374543|6332142|P2|COMPLETED|Overall Study||1
2581181|NCT00374543|6332143|P1|COMPLETED|Overall Study||2
2581182|NCT00374543|6332142|P2|STARTED|Overall Study||1
2581183|NCT00374543|6332143|P1|STARTED|Overall Study||2
2581184|NCT00374452|6332151|P2|NOT COMPLETED|Overall Study||5
2581185|NCT00374452|6332152|P1|NOT COMPLETED|Overall Study||5
2581186|NCT00374452|6332151|P2|COMPLETED|Overall Study||43
2581187|NCT00374452|6332152|P1|COMPLETED|Overall Study||29
2581188|NCT00374452|6332151|P2|Intervention Started|Overall Study||46
2581189|NCT00374452|6332152|P1|Intervention Started|Overall Study||30
2581190|NCT00374452|6332151|P2|STARTED|Overall Study||48
2581191|NCT00374452|6332152|P1|STARTED|Overall Study||34
2581192|NCT00374335|6332158|P1|NOT COMPLETED|Overall Study||0
2581193|NCT00374335|6332158|P1|COMPLETED|Overall Study||261
2581194|NCT00374335|6332158|P1|STARTED|Overall Study||261
2581195|NCT00374322|6332165|P2|NOT COMPLETED|Overall Study||1304
2581196|NCT00374322|6332166|P1|NOT COMPLETED|Overall Study||1257
2581197|NCT00374322|6332165|P2|COMPLETED|Overall Study||278
2581198|NCT00374322|6332166|P1|COMPLETED|Overall Study||322
2581199|NCT00374322|6332165|P2|Received >=1 Dose of Study Treatment|Overall Study||1576
2581200|NCT00374322|6332166|P1|Received >=1 Dose of Study Treatment|Overall Study||1571
2581201|NCT00374322|6332165|P2|STARTED|Overall Study||1582
2581202|NCT00374322|6332166|P1|STARTED|Overall Study||1579
2581203|NCT00374244|6332204|P2|NOT COMPLETED|Overall Study||0
2581204|NCT00374244|6332205|P1|NOT COMPLETED|Overall Study||0
2581205|NCT00374244|6332204|P2|COMPLETED|Overall Study||14
2581206|NCT00374244|6332205|P1|COMPLETED|Overall Study||14
2581207|NCT00374244|6332204|P2|STARTED|Overall Study||14
2581208|NCT00374244|6332205|P1|STARTED|Overall Study||14
2581209|NCT00374231|6332251|P1|NOT COMPLETED|Overall Study||0
2581210|NCT00374231|6332251|P1|COMPLETED|Overall Study||40
2581211|NCT00374231|6332251|P1|STARTED|Overall Study||40
2581212|NCT00374140|6332257|P1|NOT COMPLETED|Overall Study||2
2581213|NCT00374140|6332257|P1|COMPLETED|Overall Study||38
2581214|NCT00374140|6332257|P1|STARTED|Overall Study||40
2581215|NCT00374127|6332264|P1|NOT COMPLETED|Overall Study||11
2581216|NCT00374127|6332264|P1|COMPLETED|Overall Study||24
2581217|NCT00374127|6332264|P1|STARTED|Overall Study||35
2581218|NCT00374088|6332300|P2|NOT COMPLETED|Overall Study||1
2581219|NCT00374088|6332301|P1|NOT COMPLETED|Overall Study||1
2581220|NCT00374088|6332300|P2|COMPLETED|Overall Study||10
2581221|NCT00374088|6332301|P1|COMPLETED|Overall Study||9
2581222|NCT00374088|6332300|P2|STARTED|Overall Study||11
2581223|NCT00374088|6332301|P1|STARTED|Overall Study||10
2581224|NCT00373958|6332313|P2|NOT COMPLETED|Toddler Dose||38
2581225|NCT00373958|6332314|P1|NOT COMPLETED|Toddler Dose||30
2581226|NCT00373958|6332313|P2|COMPLETED|Toddler Dose||252
2581227|NCT00373958|6332314|P1|COMPLETED|Toddler Dose||264
2581228|NCT00373958|6332313|P2|Vaccinated Toddler Dose|Toddler Dose||265
2581229|NCT00373958|6332314|P1|Vaccinated Toddler Dose|Toddler Dose||272
2581230|NCT00373958|6332313|P2|Withdrawn After Infant Series|Toddler Dose||25
2581231|NCT00373958|6332314|P1|Withdrawn After Infant Series|Toddler Dose||22
2581232|NCT00373958|6332313|P2|STARTED|Toddler Dose||290
2581233|NCT00373958|6332314|P1|STARTED|Toddler Dose||294
2581234|NCT00373958|6332313|P2|NOT COMPLETED|Infant Series||42
2581235|NCT00373958|6332314|P1|NOT COMPLETED|Infant Series||40
2581236|NCT00373958|6332313|P2|COMPLETED|Infant Series||290
2581237|NCT00373958|6332314|P1|COMPLETED|Infant Series||294
2581238|NCT00373958|6332313|P2|Vaccinated Dose 3|Infant Series||300
2581239|NCT00373958|6332314|P1|Vaccinated Dose 3|Infant Series||298
2581240|NCT00373958|6332313|P2|Vaccinated Dose 2|Infant Series||305
2581241|NCT00373958|6332314|P1|Vaccinated Dose 2|Infant Series||309
2581242|NCT00373958|6332313|P2|Vaccinated Dose 1|Infant Series||331
2581243|NCT00373958|6332314|P1|Vaccinated Dose 1|Infant Series||332
2581244|NCT00373958|6332313|P2|STARTED|Infant Series||332
2581245|NCT00373958|6332314|P1|STARTED|Infant Series|One participant was prerandomized but not consented.|334
2581246|NCT00373880|6332362|P1|NOT COMPLETED|Overall Study||18
2581247|NCT00373880|6332362|P1|COMPLETED|Overall Study||8
2581248|NCT00373880|6332362|P1|STARTED|Overall Study||26
2581249|NCT00373698|6332392|P2|NOT COMPLETED|Overall Study||0
2581250|NCT00373698|6332393|P1|NOT COMPLETED|Overall Study||11
2581251|NCT00373698|6332392|P2|COMPLETED|Overall Study||99
2581252|NCT00373698|6332393|P1|COMPLETED|Overall Study||85
2581253|NCT00373698|6332392|P2|STARTED|Overall Study||99
2581254|NCT00373698|6332393|P1|STARTED|Overall Study||96
2581255|NCT00373685|6332407|P2|NOT COMPLETED|Overall Study||1421
2581256|NCT00373685|6332408|P1|NOT COMPLETED|Overall Study||1439
2581257|NCT00373685|6332407|P2|COMPLETED|Overall Study||2611
2581258|NCT00373685|6332408|P1|COMPLETED|Overall Study||2596
2581259|NCT00373685|6332407|P2|Treated|Overall Study||3955
2581260|NCT00373685|6332408|P1|Treated|Overall Study||3984
2581261|NCT00373685|6332407|P2|STARTED|Overall Study||4032
2581262|NCT00373685|6332408|P1|STARTED|Overall Study||4035
2581263|NCT00373529|6332442|P1|NOT COMPLETED|Overall Study||108
2581264|NCT00373529|6332442|P1|COMPLETED|Overall Study|Completed: initiated full 6 cycles of treatment. Not Completed: initiated <6 cycles of treatment|8
2581265|NCT00373529|6332442|P1|Full Analysis Set|Overall Study|3 Failed Independent Confirmation of AML; 1 consent violation|112
2581266|NCT00373529|6332442|P1|STARTED|Overall Study||116
2581267|NCT00373490|6332454|P2|NOT COMPLETED|Overall Study||6
2581268|NCT00373490|6332455|P1|NOT COMPLETED|Overall Study||9
2581269|NCT00373490|6332454|P2|COMPLETED|Overall Study||0
2581270|NCT00373490|6332455|P1|COMPLETED|Overall Study||1
2581271|NCT00373490|6332454|P2|STARTED|Overall Study||6
2581272|NCT00373490|6332455|P1|STARTED|Overall Study||10
2581273|NCT00373425|6332478|P5|NOT COMPLETED|Overall Study||72
2581274|NCT00373425|6332479|P4|NOT COMPLETED|Overall Study||11
2581275|NCT00373425|6332480|P3|NOT COMPLETED|Overall Study||134
2581276|NCT00373425|6332481|P2|NOT COMPLETED|Overall Study||153
2581277|NCT00373425|6332482|P1|NOT COMPLETED|Overall Study||370
2581278|NCT00373425|6332478|P5|COMPLETED|Overall Study|Completed 2 years of study treatment|60
2581279|NCT00373425|6332479|P4|COMPLETED|Overall Study|Completed 2 years of study treatment|0
2581280|NCT00373425|6332480|P3|COMPLETED|Overall Study|Completed 2 years of study treatment|0
2581281|NCT00373425|6332481|P2|COMPLETED|Overall Study|Completed 2 years of study treatment|197
2581282|NCT00373425|6332482|P1|COMPLETED|Overall Study|Completed 2 years of study treatment|253
2581283|NCT00373425|6332478|P5|Received Treatment|Overall Study||132
2581284|NCT00373425|6332479|P4|Received Treatment|Overall Study||7
2581285|NCT00373425|6332480|P3|Received Treatment|Overall Study||134
2581286|NCT00373425|6332481|P2|Received Treatment|Overall Study||342
2581287|NCT00373425|6332482|P1|Received Treatment|Overall Study||612
2581288|NCT00373425|6332478|P5|STARTED|Overall Study||132
2581289|NCT00373425|6332479|P4|STARTED|Overall Study||11
2581290|NCT00373425|6332480|P3|STARTED|Overall Study||134
2581291|NCT00373425|6332481|P2|STARTED|Overall Study||350
2581292|NCT00373425|6332482|P1|STARTED|Overall Study||623
2581293|NCT00373399|6332507|P6|NOT COMPLETED|Overall Study||0
2581294|NCT00373399|6332508|P5|NOT COMPLETED|Overall Study||0
2581295|NCT00373399|6332509|P4|NOT COMPLETED|Overall Study||0
2581296|NCT00373399|6332510|P3|NOT COMPLETED|Overall Study||0
2581297|NCT00373399|6332511|P2|NOT COMPLETED|Overall Study||0
2581298|NCT00373399|6332512|P1|NOT COMPLETED|Overall Study||0
2581299|NCT00373399|6332507|P6|COMPLETED|Overall Study||7
2581300|NCT00373399|6332508|P5|COMPLETED|Overall Study||7
2581301|NCT00373399|6332509|P4|COMPLETED|Overall Study||6
2581302|NCT00373399|6332510|P3|COMPLETED|Overall Study||4
2581303|NCT00373399|6332511|P2|COMPLETED|Overall Study||7
2581304|NCT00373399|6332512|P1|COMPLETED|Overall Study||5
2581305|NCT00373399|6332507|P6|STARTED|Overall Study||7
2581306|NCT00373399|6332508|P5|STARTED|Overall Study||7
2581307|NCT00373399|6332509|P4|STARTED|Overall Study||6
2581308|NCT00373399|6332510|P3|STARTED|Overall Study||4
2581309|NCT00373399|6332511|P2|STARTED|Overall Study||7
2581310|NCT00373399|6332512|P1|STARTED|Overall Study||5
2581311|NCT00373386|6332520|P1|NOT COMPLETED|Overall Study||0
2581312|NCT00373386|6332520|P1|COMPLETED|Overall Study||9
2581313|NCT00373386|6332520|P1|STARTED|Overall Study||9
2581314|NCT00373360|6332530|P1|NOT COMPLETED|Overall Study||0
2581315|NCT00373360|6332530|P1|COMPLETED|Overall Study||10
2581316|NCT00373360|6332530|P1|STARTED|Overall Study||10
2581317|NCT00373334|6332561|P3|NOT COMPLETED|Overall Study||13
2581318|NCT00373334|6332562|P2|NOT COMPLETED|Overall Study||18
2581319|NCT00373334|6332563|P1|NOT COMPLETED|Overall Study||10
2581320|NCT00373334|6332561|P3|COMPLETED|Overall Study||32
2581321|NCT00373334|6332562|P2|COMPLETED|Overall Study||32
2581322|NCT00373334|6332563|P1|COMPLETED|Overall Study||33
2581323|NCT00373334|6332561|P3|STARTED|Overall Study||45
2581324|NCT00373334|6332562|P2|STARTED|Overall Study||50
2581325|NCT00373334|6332563|P1|STARTED|Overall Study||43
2581326|NCT00373295|6332577|P6|NOT COMPLETED|Intervention 3 (8 Days)||0
2581327|NCT00373295|6332578|P5|NOT COMPLETED|Intervention 3 (8 Days)||0
2581328|NCT00373295|6332579|P4|NOT COMPLETED|Intervention 3 (8 Days)||0
2581329|NCT00373295|6332580|P3|NOT COMPLETED|Intervention 3 (8 Days)||0
2581330|NCT00373295|6332581|P2|NOT COMPLETED|Intervention 3 (8 Days)||0
2581331|NCT00373295|6332582|P1|NOT COMPLETED|Intervention 3 (8 Days)||0
2581332|NCT00373295|6332577|P6|COMPLETED|Intervention 3 (8 Days)||2
2581333|NCT00373295|6332578|P5|COMPLETED|Intervention 3 (8 Days)||2
2581334|NCT00373295|6332579|P4|COMPLETED|Intervention 3 (8 Days)||2
2581335|NCT00373295|6332580|P3|COMPLETED|Intervention 3 (8 Days)||1
2581336|NCT00373295|6332581|P2|COMPLETED|Intervention 3 (8 Days)||1
2581337|NCT00373295|6332582|P1|COMPLETED|Intervention 3 (8 Days)||2
2581338|NCT00373295|6332577|P6|STARTED|Intervention 3 (8 Days)||2
2581339|NCT00373295|6332578|P5|STARTED|Intervention 3 (8 Days)||2
2581340|NCT00373295|6332579|P4|STARTED|Intervention 3 (8 Days)||2
2581341|NCT00373295|6332580|P3|STARTED|Intervention 3 (8 Days)||1
2581342|NCT00373295|6332581|P2|STARTED|Intervention 3 (8 Days)||1
2581343|NCT00373295|6332582|P1|STARTED|Intervention 3 (8 Days)||2
2581344|NCT00373295|6332577|P6|NOT COMPLETED|Intervention 2 (8 Days)||0
2581345|NCT00373295|6332578|P5|NOT COMPLETED|Intervention 2 (8 Days)||0
2581346|NCT00373295|6332579|P4|NOT COMPLETED|Intervention 2 (8 Days)||0
2581347|NCT00373295|6332580|P3|NOT COMPLETED|Intervention 2 (8 Days)||0
2581348|NCT00373295|6332581|P2|NOT COMPLETED|Intervention 2 (8 Days)||0
2581349|NCT00373295|6332582|P1|NOT COMPLETED|Intervention 2 (8 Days)||0
2581350|NCT00373295|6332577|P6|COMPLETED|Intervention 2 (8 Days)||2
2581351|NCT00373295|6332578|P5|COMPLETED|Intervention 2 (8 Days)||2
2581352|NCT00373295|6332579|P4|COMPLETED|Intervention 2 (8 Days)||2
2581353|NCT00373295|6332580|P3|COMPLETED|Intervention 2 (8 Days)||1
2581354|NCT00373295|6332581|P2|COMPLETED|Intervention 2 (8 Days)||1
2581355|NCT00373295|6332582|P1|COMPLETED|Intervention 2 (8 Days)||2
2581356|NCT00373295|6332577|P6|STARTED|Intervention 2 (8 Days)||2
2581357|NCT00373295|6332578|P5|STARTED|Intervention 2 (8 Days)||2
2581358|NCT00373295|6332579|P4|STARTED|Intervention 2 (8 Days)||2
2581359|NCT00373295|6332580|P3|STARTED|Intervention 2 (8 Days)||1
2581360|NCT00373295|6332581|P2|STARTED|Intervention 2 (8 Days)||1
2581361|NCT00373295|6332582|P1|STARTED|Intervention 2 (8 Days)||2
2581362|NCT00373295|6332577|P6|NOT COMPLETED|Intervention 1 (8 Days)||0
2581363|NCT00373295|6332578|P5|NOT COMPLETED|Intervention 1 (8 Days)||1
2581364|NCT00373295|6332579|P4|NOT COMPLETED|Intervention 1 (8 Days)||0
2581365|NCT00373295|6332580|P3|NOT COMPLETED|Intervention 1 (8 Days)||0
2581366|NCT00373295|6332581|P2|NOT COMPLETED|Intervention 1 (8 Days)||2
2581367|NCT00373295|6332582|P1|NOT COMPLETED|Intervention 1 (8 Days)||0
2581368|NCT00373295|6332577|P6|COMPLETED|Intervention 1 (8 Days)||2
2581369|NCT00373295|6332578|P5|COMPLETED|Intervention 1 (8 Days)||2
2581370|NCT00373295|6332579|P4|COMPLETED|Intervention 1 (8 Days)||2
2581371|NCT00373295|6332580|P3|COMPLETED|Intervention 1 (8 Days)||1
2581372|NCT00373295|6332581|P2|COMPLETED|Intervention 1 (8 Days)||1
2581373|NCT00373295|6332582|P1|COMPLETED|Intervention 1 (8 Days)||2
2581374|NCT00373295|6332577|P6|STARTED|Intervention 1 (8 Days)||2
2581375|NCT00373295|6332578|P5|STARTED|Intervention 1 (8 Days)||3
2581376|NCT00373295|6332579|P4|STARTED|Intervention 1 (8 Days)||2
2581377|NCT00373295|6332580|P3|STARTED|Intervention 1 (8 Days)||1
2581378|NCT00373295|6332581|P2|STARTED|Intervention 1 (8 Days)||3
2581379|NCT00373295|6332582|P1|STARTED|Intervention 1 (8 Days)||2
2581380|NCT00373269|6332592|P2|NOT COMPLETED|Overall Study||0
2581381|NCT00373269|6332593|P1|NOT COMPLETED|Overall Study||0
2581382|NCT00373269|6332592|P2|COMPLETED|Overall Study||10
2581383|NCT00373269|6332593|P1|COMPLETED|Overall Study||11
2581384|NCT00373269|6332592|P2|STARTED|Overall Study||10
2581385|NCT00373269|6332593|P1|STARTED|Overall Study||11
2581386|NCT00373256|6332603|P2|NOT COMPLETED|Overall Study||247
2581387|NCT00373256|6332604|P1|NOT COMPLETED|Overall Study||241
2581388|NCT00373256|6332603|P2|COMPLETED|Overall Study||0
2581389|NCT00373256|6332604|P1|COMPLETED|Overall Study||0
2581390|NCT00373256|6332603|P2|Treated|Overall Study||236
2581391|NCT00373256|6332604|P1|Treated|Overall Study||235
2581392|NCT00373256|6332603|P2|STARTED|Overall Study||247
2581393|NCT00373256|6332604|P1|STARTED|Overall Study||241
2581394|NCT00373113|6332630|P2|NOT COMPLETED|Overall Study||244
2581395|NCT00373113|6332631|P1|NOT COMPLETED|Overall Study||238
2581396|NCT00373113|6332630|P2|COMPLETED|Overall Study||0
2581397|NCT00373113|6332631|P1|COMPLETED|Overall Study||0
2581398|NCT00373113|6332630|P2|Received Treatment|Overall Study||240
2581399|NCT00373113|6332631|P1|Received Treatment|Overall Study||238
2581400|NCT00373113|6332630|P2|STARTED|Overall Study||244
2581401|NCT00373113|6332631|P1|STARTED|Overall Study||238
2581402|NCT00372996|6332653|P4|NOT COMPLETED|Overall Study||20
2581403|NCT00372996|6332654|P3|NOT COMPLETED|Overall Study||28
2581404|NCT00372996|6332655|P2|NOT COMPLETED|Overall Study||14
2581405|NCT00372996|6332656|P1|NOT COMPLETED|Overall Study||37
2581406|NCT00372996|6332653|P4|COMPLETED|Overall Study||23
2581407|NCT00372996|6332654|P3|COMPLETED|Overall Study||33
2581408|NCT00372996|6332655|P2|COMPLETED|Overall Study||22
2581409|NCT00372996|6332656|P1|COMPLETED|Overall Study||42
2581410|NCT00372996|6332653|P4|STARTED|Overall Study||43
2581411|NCT00372996|6332654|P3|STARTED|Overall Study||61
2581412|NCT00372996|6332655|P2|STARTED|Overall Study||36
2581413|NCT00372996|6332656|P1|STARTED|Overall Study||79
2581414|NCT00372970|6332682|P2|NOT COMPLETED|Overall Study||0
2581415|NCT00372970|6332683|P1|NOT COMPLETED|Overall Study||0
2581416|NCT00372970|6332682|P2|COMPLETED|Overall Study||16
2581417|NCT00372970|6332683|P1|COMPLETED|Overall Study||16
2581418|NCT00372970|6332682|P2|STARTED|Overall Study||16
2581419|NCT00372970|6332683|P1|STARTED|Overall Study||16
2581420|NCT00372957|6332692|P3|NOT COMPLETED|Overall Study||0
2581421|NCT00372957|6332693|P2|NOT COMPLETED|Overall Study||0
2581422|NCT00372957|6332694|P1|NOT COMPLETED|Overall Study||0
2581423|NCT00372957|6332692|P3|COMPLETED|Overall Study||10
2581424|NCT00372957|6332693|P2|COMPLETED|Overall Study||10
2581425|NCT00372957|6332694|P1|COMPLETED|Overall Study||10
2581426|NCT00372957|6332692|P3|STARTED|Overall Study||10
2581427|NCT00372957|6332693|P2|STARTED|Overall Study||10
2581428|NCT00372957|6332694|P1|STARTED|Overall Study||10
2581429|NCT00372905|6332741|P4|NOT COMPLETED|Follow up Until Relapse or Progression||3
2581430|NCT00372905|6332742|P3|NOT COMPLETED|Follow up Until Relapse or Progression||0
2581431|NCT00372905|6332743|P2|NOT COMPLETED|Follow up Until Relapse or Progression||1
2581432|NCT00372905|6332744|P1|NOT COMPLETED|Follow up Until Relapse or Progression||0
2581433|NCT00372905|6332741|P4|COMPLETED|Follow up Until Relapse or Progression||5
2581434|NCT00372905|6332742|P3|COMPLETED|Follow up Until Relapse or Progression||3
2581435|NCT00372905|6332743|P2|COMPLETED|Follow up Until Relapse or Progression||2
2581436|NCT00372905|6332744|P1|COMPLETED|Follow up Until Relapse or Progression||3
2581437|NCT00372905|6332741|P4|STARTED|Follow up Until Relapse or Progression||8
2581438|NCT00372905|6332742|P3|STARTED|Follow up Until Relapse or Progression||3
2581439|NCT00372905|6332743|P2|STARTED|Follow up Until Relapse or Progression||3
2581440|NCT00372905|6332744|P1|STARTED|Follow up Until Relapse or Progression|All patients that are treated on study move into the follow up phase at the completion of therapy.|3
2581441|NCT00372905|6332741|P4|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||2
2581442|NCT00372905|6332742|P3|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
2581443|NCT00372905|6332743|P2|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
2581444|NCT00372905|6332744|P1|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
2581445|NCT00372905|6332741|P4|COMPLETED|Expansion Phase at Dose 1.3mg/m2||6
2581446|NCT00372905|6332742|P3|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
2581447|NCT00372905|6332743|P2|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
2581448|NCT00372905|6332744|P1|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
2581449|NCT00372905|6332741|P4|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||6
2581450|NCT00372905|6332742|P3|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
2581451|NCT00372905|6332743|P2|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
2581452|NCT00372905|6332744|P1|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
2581453|NCT00372905|6332741|P4|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||8
2581454|NCT00372905|6332742|P3|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
2581455|NCT00372905|6332743|P2|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
2581456|NCT00372905|6332744|P1|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
2581457|NCT00372905|6332741|P4|Registration|Expansion Phase at Dose 1.3mg/m2||8
2581458|NCT00372905|6332742|P3|Registration|Expansion Phase at Dose 1.3mg/m2||0
2581459|NCT00372905|6332743|P2|Registration|Expansion Phase at Dose 1.3mg/m2||0
2581460|NCT00372905|6332744|P1|Registration|Expansion Phase at Dose 1.3mg/m2||0
2581461|NCT00372905|6332741|P4|STARTED|Expansion Phase at Dose 1.3mg/m2||8
2581462|NCT00372905|6332742|P3|STARTED|Expansion Phase at Dose 1.3mg/m2||0
2581463|NCT00372905|6332743|P2|STARTED|Expansion Phase at Dose 1.3mg/m2||0
2581464|NCT00372905|6332744|P1|STARTED|Expansion Phase at Dose 1.3mg/m2||0
2581465|NCT00372905|6332741|P4|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
2581466|NCT00372905|6332742|P3|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||3
2581467|NCT00372905|6332743|P2|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
2581468|NCT00372905|6332744|P1|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
2581469|NCT00372905|6332741|P4|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
2581470|NCT00372905|6332742|P3|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||1
2581471|NCT00372905|6332743|P2|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
2581472|NCT00372905|6332744|P1|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
2581473|NCT00372905|6332741|P4|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
2581474|NCT00372905|6332742|P3|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||1
2581475|NCT00372905|6332743|P2|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
2581476|NCT00372905|6332744|P1|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
2581477|NCT00372905|6332741|P4|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
2581478|NCT00372905|6332742|P3|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||3
2581479|NCT00372905|6332743|P2|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
2581480|NCT00372905|6332744|P1|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
2581481|NCT00372905|6332741|P4|Registered|Cohort 3: Dose Level 1.6mg/m2||0
2581482|NCT00372905|6332742|P3|Registered|Cohort 3: Dose Level 1.6mg/m2||4
2581483|NCT00372905|6332743|P2|Registered|Cohort 3: Dose Level 1.6mg/m2||0
2581484|NCT00372905|6332744|P1|Registered|Cohort 3: Dose Level 1.6mg/m2||0
2581485|NCT00372905|6332741|P4|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
2581486|NCT00372905|6332742|P3|STARTED|Cohort 3: Dose Level 1.6mg/m2||4
2581487|NCT00372905|6332743|P2|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
2581488|NCT00372905|6332744|P1|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
2581489|NCT00372905|6332741|P4|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
2581490|NCT00372905|6332742|P3|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
2581491|NCT00372905|6332743|P2|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
2581492|NCT00372905|6332744|P1|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
2581493|NCT00372905|6332741|P4|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
2581494|NCT00372905|6332742|P3|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
2581495|NCT00372905|6332743|P2|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||3
2581496|NCT00372905|6332744|P1|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
2581497|NCT00372905|6332741|P4|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
2581498|NCT00372905|6332742|P3|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
2581499|NCT00372905|6332743|P2|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||3
2581500|NCT00372905|6332744|P1|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
2581501|NCT00372905|6332741|P4|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
2581502|NCT00372905|6332742|P3|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
2581503|NCT00372905|6332743|P2|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||3
2581504|NCT00372905|6332744|P1|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
2581505|NCT00372905|6332741|P4|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
2581506|NCT00372905|6332742|P3|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
2581507|NCT00372905|6332743|P2|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||3
2581508|NCT00372905|6332744|P1|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
2581509|NCT00372905|6332741|P4|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
2581510|NCT00372905|6332742|P3|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
2581511|NCT00372905|6332743|P2|STARTED|Cohort 2: Dose Level 1.3mg/m2||3
2581512|NCT00372905|6332744|P1|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
2581513|NCT00372905|6332741|P4|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
2581514|NCT00372905|6332742|P3|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
2581515|NCT00372905|6332743|P2|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
2581516|NCT00372905|6332744|P1|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||2
2581517|NCT00372905|6332741|P4|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
2581518|NCT00372905|6332742|P3|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
2581519|NCT00372905|6332743|P2|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
2581520|NCT00372905|6332744|P1|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||1
2581521|NCT00372905|6332741|P4|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
2581522|NCT00372905|6332742|P3|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
2581523|NCT00372905|6332743|P2|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
2581524|NCT00372905|6332744|P1|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||1
2581525|NCT00372905|6332741|P4|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
2581526|NCT00372905|6332742|P3|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
2581527|NCT00372905|6332743|P2|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
2581528|NCT00372905|6332744|P1|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||3
2581529|NCT00372905|6332741|P4|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
2581530|NCT00372905|6332742|P3|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
2581531|NCT00372905|6332743|P2|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
2581532|NCT00372905|6332744|P1|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||3
2581533|NCT00372905|6332741|P4|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
2581534|NCT00372905|6332742|P3|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
2581535|NCT00372905|6332743|P2|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
2581536|NCT00372905|6332744|P1|STARTED|Cohort 1: Dose Level 1.0mg/m2||3
2581537|NCT00372775|6332756|P1|NOT COMPLETED|Overall Study||63
2581538|NCT00372775|6332756|P1|COMPLETED|Overall Study||3
2581539|NCT00372775|6332756|P1|Received Treatment|Overall Study||64
2581540|NCT00372775|6332756|P1|STARTED|Overall Study||66
2581541|NCT00372697|6332778|P2|NOT COMPLETED|Overall Study||1
2581542|NCT00372697|6332779|P1|NOT COMPLETED|Overall Study||1
2581543|NCT00372697|6332778|P2|COMPLETED|Overall Study||11
2581544|NCT00372697|6332779|P1|COMPLETED|Overall Study||15
2581545|NCT00372697|6332778|P2|STARTED|Overall Study||12
2581546|NCT00372697|6332779|P1|STARTED|Overall Study||16
2581547|NCT00372619|6332804|P7|NOT COMPLETED|Overall Study||0
2581548|NCT00372619|6332805|P6|NOT COMPLETED|Overall Study||3
2581549|NCT00372619|6332806|P5|NOT COMPLETED|Overall Study||0
2581550|NCT00372619|6332807|P4|NOT COMPLETED|Overall Study||0
2581551|NCT00372619|6332808|P3|NOT COMPLETED|Overall Study||0
2581552|NCT00372619|6332809|P2|NOT COMPLETED|Overall Study||0
2581553|NCT00372619|6332810|P1|NOT COMPLETED|Overall Study||0
2581554|NCT00372619|6332804|P7|COMPLETED|Overall Study||2
2581555|NCT00372619|6332805|P6|COMPLETED|Overall Study||39
2581556|NCT00372619|6332806|P5|COMPLETED|Overall Study||7
2581557|NCT00372619|6332807|P4|COMPLETED|Overall Study||10
2581558|NCT00372619|6332808|P3|COMPLETED|Overall Study||3
2581559|NCT00372619|6332809|P2|COMPLETED|Overall Study||2
2581560|NCT00372619|6332810|P1|COMPLETED|Overall Study||8
2581561|NCT00372619|6332804|P7|STARTED|Overall Study||2
2581562|NCT00372619|6332805|P6|STARTED|Overall Study||42
2581563|NCT00372619|6332806|P5|STARTED|Overall Study||7
2581564|NCT00372619|6332807|P4|STARTED|Overall Study||10
2581565|NCT00372619|6332808|P3|STARTED|Overall Study||3
2581566|NCT00372619|6332809|P2|STARTED|Overall Study||2
2581567|NCT00372619|6332810|P1|STARTED|Overall Study||8
2581568|NCT00372593|6332843|P3|NOT COMPLETED|Overall Study||4
2581569|NCT00372593|6332844|P2|NOT COMPLETED|Overall Study||198
2581570|NCT00372593|6332845|P1|NOT COMPLETED|Overall Study||204
2581571|NCT00372593|6332843|P3|COMPLETED|Overall Study||3
2581572|NCT00372593|6332844|P2|COMPLETED|Overall Study||334
2581573|NCT00372593|6332845|P1|COMPLETED|Overall Study||327
2581574|NCT00372593|6332843|P3|STARTED|Overall Study||7
2581575|NCT00372593|6332844|P2|STARTED|Overall Study||532
2581576|NCT00372593|6332845|P1|STARTED|Overall Study||531
2581577|NCT00372567|6332874|P3|NOT COMPLETED|Phase 3 Study||12
2581578|NCT00372567|6332875|P2|NOT COMPLETED|Phase 3 Study||26
2581579|NCT00372567|6332876|P1|NOT COMPLETED|Phase 3 Study||31
2581580|NCT00372567|6332874|P3|COMPLETED|Phase 3 Study||0
2581581|NCT00372567|6332875|P2|COMPLETED|Phase 3 Study||0
2581582|NCT00372567|6332876|P1|COMPLETED|Phase 3 Study||0
2581583|NCT00372567|6332874|P3|Received Treatment|Phase 3 Study||12
2581584|NCT00372567|6332875|P2|Received Treatment|Phase 3 Study||25
2581585|NCT00372567|6332876|P1|Received Treatment|Phase 3 Study||31
2581586|NCT00372567|6332874|P3|STARTED|Phase 3 Study||12
2581587|NCT00372567|6332875|P2|STARTED|Phase 3 Study||26
2581588|NCT00372567|6332876|P1|STARTED|Phase 3 Study||31
2581589|NCT00372567|6332874|P3|NOT COMPLETED|Phase 1 Sub-study||0
2581590|NCT00372567|6332875|P2|NOT COMPLETED|Phase 1 Sub-study||0
2581591|NCT00372567|6332876|P1|NOT COMPLETED|Phase 1 Sub-study||0
2581592|NCT00372567|6332874|P3|COMPLETED|Phase 1 Sub-study||12
2581593|NCT00372567|6332875|P2|COMPLETED|Phase 1 Sub-study||0
2581594|NCT00372567|6332876|P1|COMPLETED|Phase 1 Sub-study||0
2581595|NCT00372567|6332874|P3|STARTED|Phase 1 Sub-study||12
2581596|NCT00372567|6332875|P2|STARTED|Phase 1 Sub-study||0
2581597|NCT00372567|6332876|P1|STARTED|Phase 1 Sub-study||0
2581598|NCT00372528|6332904|P1|NOT COMPLETED|Overall Study||21
2581599|NCT00372528|6332904|P1|COMPLETED|Overall Study||0
2581600|NCT00372528|6332904|P1|STARTED|Overall Study||21
2581601|NCT00372489|6332909|P1|NOT COMPLETED|Overall Study||79
2581602|NCT00372489|6332909|P1|COMPLETED|Overall Study||2
2581603|NCT00372489|6332909|P1|STARTED|Overall Study||81
2581604|NCT00372424|6332913|P1|NOT COMPLETED|Overall Study||26
2581605|NCT00372424|6332913|P1|COMPLETED|Overall Study||0
2581606|NCT00372424|6332913|P1|Treated|Overall Study||25
2581607|NCT00372424|6332913|P1|STARTED|Overall Study||26
2581608|NCT00372411|6332927|P3|NOT COMPLETED|Overall Study||3
2581609|NCT00372411|6332928|P2|NOT COMPLETED|Overall Study||8
2581610|NCT00372411|6332929|P1|NOT COMPLETED|Overall Study||5
2581611|NCT00372411|6332927|P3|COMPLETED|Overall Study||25
2581612|NCT00372411|6332928|P2|COMPLETED|Overall Study||42
2581613|NCT00372411|6332929|P1|COMPLETED|Overall Study||44
2581614|NCT00372411|6332927|P3|STARTED|Overall Study||28
2581615|NCT00372411|6332928|P2|STARTED|Overall Study||50
2581616|NCT00372411|6332929|P1|STARTED|Overall Study||49
2581617|NCT00372385|6332953|P4|NOT COMPLETED|Overall Study||8
2581618|NCT00372385|6332954|P3|NOT COMPLETED|Overall Study||10
2581619|NCT00372385|6332955|P2|NOT COMPLETED|Overall Study||20
2581620|NCT00372385|6332956|P1|NOT COMPLETED|Overall Study||33
2581621|NCT00372385|6332953|P4|COMPLETED|Overall Study||70
2581622|NCT00372385|6332954|P3|COMPLETED|Overall Study||72
2581623|NCT00372385|6332955|P2|COMPLETED|Overall Study||61
2581624|NCT00372385|6332956|P1|COMPLETED|Overall Study||49
2581625|NCT00372385|6332953|P4|STARTED|Overall Study||78
2581626|NCT00372385|6332954|P3|STARTED|Overall Study||82
2581627|NCT00372385|6332955|P2|STARTED|Overall Study||81
2581628|NCT00372385|6332956|P1|STARTED|Overall Study||82
2581629|NCT00372255|6332985|P2|NOT COMPLETED|Overall Study||1
2581630|NCT00372255|6332986|P1|NOT COMPLETED|Overall Study||2
2581631|NCT00372255|6332985|P2|COMPLETED|Overall Study||113
2581632|NCT00372255|6332986|P1|COMPLETED|Overall Study||108
2581633|NCT00372255|6332985|P2|STARTED|Overall Study||114
2581634|NCT00372255|6332986|P1|STARTED|Overall Study||110
2581635|NCT00372190|6333008|P2|NOT COMPLETED|Overall Study||1
2581636|NCT00372190|6333009|P1|NOT COMPLETED|Overall Study||3
2581637|NCT00372190|6333008|P2|COMPLETED|Overall Study||96
2581638|NCT00372190|6333009|P1|COMPLETED|Overall Study||90
2581639|NCT00372190|6333008|P2|STARTED|Overall Study|99 were allocated to conventional arm, however 2 never underwent any surgery|97
2581640|NCT00372190|6333009|P1|STARTED|Overall Study|95 were allocated to mesh group, however 2 never underwent any surgery|93
2581641|NCT00372112|6333025|P4|NOT COMPLETED|Overall Study||4
2581642|NCT00372112|6333026|P3|NOT COMPLETED|Overall Study||4
2581643|NCT00372112|6333027|P2|NOT COMPLETED|Overall Study||1
2581644|NCT00372112|6333028|P1|NOT COMPLETED|Overall Study||1
2581645|NCT00372112|6333025|P4|COMPLETED|Overall Study||14
2581646|NCT00372112|6333026|P3|COMPLETED|Overall Study||13
2581647|NCT00372112|6333027|P2|COMPLETED|Overall Study||15
2581648|NCT00372112|6333028|P1|COMPLETED|Overall Study||16
2581649|NCT00372112|6333025|P4|STARTED|Overall Study||18
2581650|NCT00372112|6333026|P3|STARTED|Overall Study||17
2581651|NCT00372112|6333027|P2|STARTED|Overall Study||16
2581652|NCT00372112|6333028|P1|STARTED|Overall Study||17
2581653|NCT00372060|6333159|P2|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||8
2581654|NCT00372060|6333160|P1|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||14
2581655|NCT00372060|6333159|P2|COMPLETED|Period II - Open-label (Weeks 12-52)||59
2581656|NCT00372060|6333160|P1|COMPLETED|Period II - Open-label (Weeks 12-52)||49
2581657|NCT00372060|6333159|P2|STARTED|Period II - Open-label (Weeks 12-52)||67
2581658|NCT00372060|6333160|P1|STARTED|Period II - Open-label (Weeks 12-52)||63
2581659|NCT00372060|6333159|P2|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||1
2581660|NCT00372060|6333160|P1|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||3
2581661|NCT00372060|6333159|P2|COMPLETED|Period I - Double-blind (Weeks 0-12)||67
2581662|NCT00372060|6333160|P1|COMPLETED|Period I - Double-blind (Weeks 0-12)||63
2581663|NCT00372060|6333159|P2|STARTED|Period I - Double-blind (Weeks 0-12)||68
2581664|NCT00372060|6333160|P1|STARTED|Period I - Double-blind (Weeks 0-12)|The planned number of enrolled patients was 130. The actual number of enrolled patients was 134.|66
2581665|NCT00371865|6333175|P2|NOT COMPLETED|Overall Study||14
2581666|NCT00371865|6333176|P1|NOT COMPLETED|Overall Study||15
2581667|NCT00371865|6333175|P2|COMPLETED|Overall Study|8 withdrew before starting the intervention. 6 withdrew after starting the intervention.|43
2581668|NCT00371865|6333176|P1|COMPLETED|Overall Study|7 withdrew before starting the intervention. 8 withdrew after starting the intervention.|42
2581669|NCT00371865|6333175|P2|STARTED|Overall Study||57
2581670|NCT00371865|6333176|P1|STARTED|Overall Study||57
2581671|NCT00371839|6333193|P3|NOT COMPLETED|Overall Study||2
2581672|NCT00371839|6333194|P2|NOT COMPLETED|Overall Study||7
2581673|NCT00371839|6333195|P1|NOT COMPLETED|Overall Study||17
2581674|NCT00371839|6333193|P3|COMPLETED|Overall Study||7
2581675|NCT00371839|6333194|P2|COMPLETED|Overall Study||13
2581676|NCT00371839|6333195|P1|COMPLETED|Overall Study||32
2581677|NCT00371839|6333193|P3|STARTED|Overall Study||9
2581678|NCT00371839|6333194|P2|STARTED|Overall Study||20
2581679|NCT00371839|6333195|P1|STARTED|Overall Study||49
2581680|NCT00371826|6333204|P3|NOT COMPLETED|Extension Phase (24 Months)||2
2581681|NCT00371826|6333205|P2|NOT COMPLETED|Extension Phase (24 Months)||10
2581682|NCT00371826|6333206|P1|NOT COMPLETED|Extension Phase (24 Months)||5
2581683|NCT00371826|6333204|P3|COMPLETED|Extension Phase (24 Months)||3
2581684|NCT00371826|6333205|P2|COMPLETED|Extension Phase (24 Months)||29
2581685|NCT00371826|6333206|P1|COMPLETED|Extension Phase (24 Months)||18
2581686|NCT00371826|6333204|P3|Safety Set|Extension Phase (24 Months)|Patient withdrawn as per DMC suggestion had no efficacy data, but was included in safety set.|5
2581687|NCT00371826|6333205|P2|Safety Set|Extension Phase (24 Months)|One patient mis-randomised to 1st arm but treated in this arm, evaluated for safety in this arm.|40
2581688|NCT00371826|6333206|P1|Safety Set|Extension Phase (24 Months)|One patient randomized to this arm, was treated with the control regimen (CNI+MPA+Steroid)|22
2581689|NCT00371826|6333204|P3|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)|One patient entered extension, was withdrawn (no efficacy data in extension) due to DMC suggestion|4
2581690|NCT00371826|6333205|P2|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||39
2581691|NCT00371826|6333206|P1|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||23
2581692|NCT00371826|6333204|P3|STARTED|Extension Phase (24 Months)|One patient completed core, did not wish to continue to extension.|5
2581693|NCT00371826|6333205|P2|STARTED|Extension Phase (24 Months)||39
2581694|NCT00371826|6333206|P1|STARTED|Extension Phase (24 Months)|2 patients who completed 12 month core did not wish to continue in extension.|23
2581695|NCT00371826|6333204|P3|NOT COMPLETED|Core Phase (12 Months)||24
2581696|NCT00371826|6333205|P2|NOT COMPLETED|Core Phase (12 Months)||8
2581697|NCT00371826|6333206|P1|NOT COMPLETED|Core Phase (12 Months)||24
2581698|NCT00371826|6333204|P3|COMPLETED|Core Phase (12 Months)||6
2581699|NCT00371826|6333205|P2|COMPLETED|Core Phase (12 Months)||39
2581700|NCT00371826|6333206|P1|COMPLETED|Core Phase (12 Months)|"Completed means patients were still on study medication by month 12."|25
2581701|NCT00371826|6333204|P3|Modified Intent to Treat (mITT)|Core Phase (12 Months)||6
2581702|NCT00371826|6333205|P2|Modified Intent to Treat (mITT)|Core Phase (12 Months)||39
2581703|NCT00371826|6333206|P1|Modified Intent to Treat (mITT)|Core Phase (12 Months)||27
2581704|NCT00371826|6333204|P3|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||20
2581705|NCT00371826|6333205|P2|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||44
2581706|NCT00371826|6333206|P1|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||46
2581707|NCT00371826|6333204|P3|STARTED|Core Phase (12 Months)||30
2581708|NCT00371826|6333205|P2|STARTED|Core Phase (12 Months)||47
2581709|NCT00371826|6333206|P1|STARTED|Core Phase (12 Months)|"Started indicates patients in Randomized, Intent to treat (ITT) and Safety set."|49
2581710|NCT00371787|6333330|P2|NOT COMPLETED|Overall Study||1
2581711|NCT00371787|6333331|P1|NOT COMPLETED|Overall Study||3
2581712|NCT00371787|6333330|P2|COMPLETED|Overall Study||11
2581713|NCT00371787|6333331|P1|COMPLETED|Overall Study||23
2581714|NCT00371787|6333330|P2|STARTED|Overall Study||12
2581715|NCT00371787|6333331|P1|STARTED|Overall Study||26
2581716|NCT00371761|6333345|P2|NOT COMPLETED|Overall Study||10
2581717|NCT00371761|6333346|P1|NOT COMPLETED|Overall Study||8
2581718|NCT00371761|6333345|P2|COMPLETED|Overall Study||2
2581719|NCT00371761|6333346|P1|COMPLETED|Overall Study||5
2581720|NCT00371761|6333345|P2|STARTED|Overall Study||12
2581721|NCT00371761|6333346|P1|STARTED|Overall Study||13
2581722|NCT00371683|6333354|P2|NOT COMPLETED|Follow-Up Period - Randomized Patients||72
2581723|NCT00371683|6333355|P1|NOT COMPLETED|Follow-Up Period - Randomized Patients||61
2581724|NCT00371683|6333354|P2|COMPLETED|Follow-Up Period - Randomized Patients||1461
2581725|NCT00371683|6333355|P1|COMPLETED|Follow-Up Period - Randomized Patients||1492
2581726|NCT00371683|6333354|P2|STARTED|Follow-Up Period - Randomized Patients||1533
2581727|NCT00371683|6333355|P1|STARTED|Follow-Up Period - Randomized Patients||1553
2581728|NCT00371683|6333354|P2|NOT COMPLETED|DB Treatment Period-Randomized Patients||107
2581729|NCT00371683|6333355|P1|NOT COMPLETED|DB Treatment Period-Randomized Patients||90
2581730|NCT00371683|6333354|P2|COMPLETED|DB Treatment Period-Randomized Patients||1489
2581731|NCT00371683|6333355|P1|COMPLETED|DB Treatment Period-Randomized Patients||1509
2581732|NCT00371683|6333354|P2|STARTED|DB Treatment Period-Randomized Patients||1596
2581733|NCT00371683|6333355|P1|STARTED|DB Treatment Period-Randomized Patients||1599
2581734|NCT00371644|6333409|P2|NOT COMPLETED|Overall Study||13
2581735|NCT00371644|6333410|P1|NOT COMPLETED|Overall Study||28
2581736|NCT00371644|6333409|P2|COMPLETED|Overall Study||44
2581737|NCT00371644|6333410|P1|COMPLETED|Overall Study||44
2581738|NCT00371644|6333409|P2|STARTED|Overall Study||57
2581739|NCT00371644|6333410|P1|STARTED|Overall Study||72
2581740|NCT00371631|6333416|P1|NOT COMPLETED|Overall Study||0
2581741|NCT00371631|6333416|P1|COMPLETED|Overall Study||13
2581742|NCT00371631|6333416|P1|STARTED|Overall Study||13
2581743|NCT00371566|6333423|P2|NOT COMPLETED|Follow Up Phase||7
2581744|NCT00371566|6333424|P1|NOT COMPLETED|Follow Up Phase||3
2581745|NCT00371566|6333423|P2|COMPLETED|Follow Up Phase||58
2581746|NCT00371566|6333424|P1|COMPLETED|Follow Up Phase||28
2581747|NCT00371566|6333423|P2|STARTED|Follow Up Phase||65
2581748|NCT00371566|6333424|P1|STARTED|Follow Up Phase||31
2581749|NCT00371566|6333423|P2|NOT COMPLETED|Chemoradiation Phase||3
2581750|NCT00371566|6333424|P1|NOT COMPLETED|Chemoradiation Phase||5
2581751|NCT00371566|6333423|P2|COMPLETED|Chemoradiation Phase||65
2581752|NCT00371566|6333424|P1|COMPLETED|Chemoradiation Phase||31
2581753|NCT00371566|6333423|P2|STARTED|Chemoradiation Phase||68
2581754|NCT00371566|6333424|P1|STARTED|Chemoradiation Phase||36
2581755|NCT00371566|6333423|P2|NOT COMPLETED|Treatment Phase||3
2581756|NCT00371566|6333424|P1|NOT COMPLETED|Treatment Phase||0
2581757|NCT00371566|6333423|P2|COMPLETED|Treatment Phase|1 screen failure included in the ITT population|68
2581758|NCT00371566|6333424|P1|COMPLETED|Treatment Phase||36
2581759|NCT00371566|6333423|P2|STARTED|Treatment Phase||71
2581760|NCT00371566|6333424|P1|STARTED|Treatment Phase||36
2581761|NCT00371540|6333496|P2|NOT COMPLETED|Overall Study||9
2581762|NCT00371540|6333497|P1|NOT COMPLETED|Overall Study||10
2581763|NCT00371540|6333496|P2|COMPLETED|Overall Study||87
2581764|NCT00371540|6333497|P1|COMPLETED|Overall Study||102
2581765|NCT00371540|6333496|P2|STARTED|Overall Study||96
2581766|NCT00371540|6333497|P1|STARTED|Overall Study||112
2581767|NCT00371462|6333509|P2|NOT COMPLETED|Overall Study||8
2581768|NCT00371462|6333510|P1|NOT COMPLETED|Overall Study||8
2581769|NCT00371462|6333509|P2|COMPLETED|Overall Study||27
2581770|NCT00371462|6333510|P1|COMPLETED|Overall Study||27
2581771|NCT00371462|6333509|P2|STARTED|Overall Study||35
2581772|NCT00371462|6333510|P1|STARTED|Overall Study||35
2581773|NCT00371449|6333516|P1|NOT COMPLETED|Overall Study||0
2581774|NCT00371449|6333516|P1|COMPLETED|Overall Study||120
2581775|NCT00371449|6333516|P1|STARTED|Overall Study||120
2581776|NCT00371436|6333527|P2|NOT COMPLETED|Overall Study||21
2581777|NCT00371436|6333528|P1|NOT COMPLETED|Overall Study||34
2581778|NCT00371436|6333527|P2|COMPLETED|Overall Study||68
2581779|NCT00371436|6333528|P1|COMPLETED|Overall Study||58
2581780|NCT00371436|6333527|P2|STARTED|Overall Study||89
2581781|NCT00371436|6333528|P1|STARTED|Overall Study||92
2581782|NCT00371397|6333534|P12|NOT COMPLETED|Session 3||0
2581783|NCT00371397|6333535|P11|NOT COMPLETED|Session 3||0
2581784|NCT00371397|6333536|P10|NOT COMPLETED|Session 3||0
2581785|NCT00371397|6333537|P9|NOT COMPLETED|Session 3||0
2581786|NCT00371397|6333538|P8|NOT COMPLETED|Session 3||0
2581787|NCT00371397|6333539|P7|NOT COMPLETED|Session 3||0
2581788|NCT00371397|6333540|P6|NOT COMPLETED|Session 3||0
2581789|NCT00371397|6333541|P5|NOT COMPLETED|Session 3||0
2581790|NCT00371397|6333542|P4|NOT COMPLETED|Session 3||0
2581791|NCT00371397|6333543|P3|NOT COMPLETED|Session 3||0
2581792|NCT00371397|6333544|P2|NOT COMPLETED|Session 3||0
2581793|NCT00371397|6333545|P1|NOT COMPLETED|Session 3||0
2581794|NCT00371397|6333534|P12|COMPLETED|Session 3||2
2581795|NCT00371397|6333535|P11|COMPLETED|Session 3||4
2581796|NCT00371397|6333536|P10|COMPLETED|Session 3||5
2581797|NCT00371397|6333537|P9|COMPLETED|Session 3||6
2581798|NCT00371397|6333538|P8|COMPLETED|Session 3||4
2581799|NCT00371397|6333539|P7|COMPLETED|Session 3||4
2581800|NCT00371397|6333540|P6|COMPLETED|Session 3||4
2581801|NCT00371397|6333541|P5|COMPLETED|Session 3||3
2581802|NCT00371397|6333542|P4|COMPLETED|Session 3||2
2581803|NCT00371397|6333543|P3|COMPLETED|Session 3||5
2581804|NCT00371397|6333544|P2|COMPLETED|Session 3||7
2581805|NCT00371397|6333545|P1|COMPLETED|Session 3||4
2581806|NCT00371397|6333534|P12|STARTED|Session 3||2
2581807|NCT00371397|6333535|P11|STARTED|Session 3||4
2581808|NCT00371397|6333536|P10|STARTED|Session 3||5
2581809|NCT00371397|6333537|P9|STARTED|Session 3||6
2581810|NCT00371397|6333538|P8|STARTED|Session 3||4
2581811|NCT00371397|6333539|P7|STARTED|Session 3||4
2581812|NCT00371397|6333540|P6|STARTED|Session 3||4
2581813|NCT00371397|6333541|P5|STARTED|Session 3||3
2581814|NCT00371397|6333542|P4|STARTED|Session 3||2
2581815|NCT00371397|6333543|P3|STARTED|Session 3||5
2581816|NCT00371397|6333544|P2|STARTED|Session 3||7
2581817|NCT00371397|6333545|P1|STARTED|Session 3||4
2581818|NCT00371397|6333534|P12|NOT COMPLETED|Session 2||0
2581819|NCT00371397|6333535|P11|NOT COMPLETED|Session 2||0
2581820|NCT00371397|6333536|P10|NOT COMPLETED|Session 2||0
2581821|NCT00371397|6333537|P9|NOT COMPLETED|Session 2||0
2581822|NCT00371397|6333538|P8|NOT COMPLETED|Session 2||0
2581823|NCT00371397|6333539|P7|NOT COMPLETED|Session 2||0
2581824|NCT00371397|6333540|P6|NOT COMPLETED|Session 2||0
2581825|NCT00371397|6333541|P5|NOT COMPLETED|Session 2||0
2581826|NCT00371397|6333542|P4|NOT COMPLETED|Session 2||0
2581827|NCT00371397|6333543|P3|NOT COMPLETED|Session 2||0
2581828|NCT00371397|6333544|P2|NOT COMPLETED|Session 2||0
2581829|NCT00371397|6333545|P1|NOT COMPLETED|Session 2||0
2581830|NCT00371397|6333534|P12|COMPLETED|Session 2||2
2581831|NCT00371397|6333535|P11|COMPLETED|Session 2||4
2581832|NCT00371397|6333536|P10|COMPLETED|Session 2||5
2581833|NCT00371397|6333537|P9|COMPLETED|Session 2||6
2581834|NCT00371397|6333538|P8|COMPLETED|Session 2||4
2581835|NCT00371397|6333539|P7|COMPLETED|Session 2||4
2581836|NCT00371397|6333540|P6|COMPLETED|Session 2||4
2581837|NCT00371397|6333541|P5|COMPLETED|Session 2||3
2581838|NCT00371397|6333542|P4|COMPLETED|Session 2||2
2581839|NCT00371397|6333543|P3|COMPLETED|Session 2||5
2581840|NCT00371397|6333544|P2|COMPLETED|Session 2||7
2581841|NCT00371397|6333545|P1|COMPLETED|Session 2||4
2581842|NCT00371397|6333534|P12|STARTED|Session 2||2
2581843|NCT00371397|6333535|P11|STARTED|Session 2||4
2581844|NCT00371397|6333536|P10|STARTED|Session 2||5
2581845|NCT00371397|6333537|P9|STARTED|Session 2||6
2581846|NCT00371397|6333538|P8|STARTED|Session 2||4
2581847|NCT00371397|6333539|P7|STARTED|Session 2||4
2581848|NCT00371397|6333540|P6|STARTED|Session 2||4
2581849|NCT00371397|6333541|P5|STARTED|Session 2||3
2581850|NCT00371397|6333542|P4|STARTED|Session 2||2
2581851|NCT00371397|6333543|P3|STARTED|Session 2||5
2581852|NCT00371397|6333544|P2|STARTED|Session 2||7
2581853|NCT00371397|6333545|P1|STARTED|Session 2||4
2581854|NCT00371397|6333534|P12|NOT COMPLETED|Session 1||0
2581855|NCT00371397|6333535|P11|NOT COMPLETED|Session 1||0
2581856|NCT00371397|6333536|P10|NOT COMPLETED|Session 1||0
2581857|NCT00371397|6333537|P9|NOT COMPLETED|Session 1||0
2581858|NCT00371397|6333538|P8|NOT COMPLETED|Session 1||1
2581859|NCT00371397|6333539|P7|NOT COMPLETED|Session 1||0
2581860|NCT00371397|6333540|P6|NOT COMPLETED|Session 1||0
2581861|NCT00371397|6333541|P5|NOT COMPLETED|Session 1||0
2581862|NCT00371397|6333542|P4|NOT COMPLETED|Session 1||0
2581863|NCT00371397|6333543|P3|NOT COMPLETED|Session 1||0
2581864|NCT00371397|6333544|P2|NOT COMPLETED|Session 1||0
2581865|NCT00371397|6333545|P1|NOT COMPLETED|Session 1||1
2581866|NCT00371397|6333534|P12|COMPLETED|Session 1||2
2581867|NCT00371397|6333535|P11|COMPLETED|Session 1||4
2581868|NCT00371397|6333536|P10|COMPLETED|Session 1||5
2581869|NCT00371397|6333537|P9|COMPLETED|Session 1||6
2581870|NCT00371397|6333538|P8|COMPLETED|Session 1||4
2581871|NCT00371397|6333539|P7|COMPLETED|Session 1||4
2581872|NCT00371397|6333540|P6|COMPLETED|Session 1||4
2581873|NCT00371397|6333541|P5|COMPLETED|Session 1||3
2581874|NCT00371397|6333542|P4|COMPLETED|Session 1||2
2581875|NCT00371397|6333543|P3|COMPLETED|Session 1||5
2581876|NCT00371397|6333544|P2|COMPLETED|Session 1||7
2581877|NCT00371397|6333545|P1|COMPLETED|Session 1||4
2581878|NCT00371397|6333534|P12|STARTED|Session 1||2
2581879|NCT00371397|6333535|P11|STARTED|Session 1||4
2581880|NCT00371397|6333536|P10|STARTED|Session 1||5
2581881|NCT00371397|6333537|P9|STARTED|Session 1||6
2581882|NCT00371397|6333538|P8|STARTED|Session 1||5
2581883|NCT00371397|6333539|P7|STARTED|Session 1||4
2581884|NCT00371397|6333540|P6|STARTED|Session 1||4
2581885|NCT00371397|6333541|P5|STARTED|Session 1||3
2581886|NCT00371397|6333542|P4|STARTED|Session 1||2
2581887|NCT00371397|6333543|P3|STARTED|Session 1||5
2581888|NCT00371397|6333544|P2|STARTED|Session 1||7
2581889|NCT00371397|6333545|P1|STARTED|Session 1||5
2581890|NCT00371345|6333553|P2|NOT COMPLETED|Overall Study||46
2581891|NCT00371345|6333554|P1|NOT COMPLETED|Overall Study||24
2581892|NCT00371345|6333553|P2|COMPLETED|Overall Study||0
2581893|NCT00371345|6333554|P1|COMPLETED|Overall Study||0
2581894|NCT00371345|6333553|P2|STARTED|Overall Study||46
2581895|NCT00371345|6333554|P1|STARTED|Overall Study||24
2581896|NCT00371293|6333614|P3|NOT COMPLETED|Overall Study||16
2581897|NCT00371293|6333615|P2|NOT COMPLETED|Overall Study||19
2581898|NCT00371293|6333616|P1|NOT COMPLETED|Overall Study||10
2581899|NCT00371293|6333614|P3|COMPLETED|Overall Study||46
2581900|NCT00371293|6333615|P2|COMPLETED|Overall Study||42
2581901|NCT00371293|6333616|P1|COMPLETED|Overall Study||48
2581902|NCT00371293|6333614|P3|STARTED|Overall Study||62
2581903|NCT00371293|6333615|P2|STARTED|Overall Study||61
2581904|NCT00371293|6333616|P1|STARTED|Overall Study||58
2581905|NCT00371267|6333638|P2|NOT COMPLETED|Overall Study||18
2581906|NCT00371267|6333639|P1|NOT COMPLETED|Overall Study||9
2581907|NCT00371267|6333638|P2|COMPLETED|Overall Study||32
2581908|NCT00371267|6333639|P1|COMPLETED|Overall Study||39
2581909|NCT00371267|6333638|P2|STARTED|Overall Study||50
2581910|NCT00371267|6333639|P1|STARTED|Overall Study||48
2581911|NCT00371254|6333655|P2|NOT COMPLETED|Overall Study||21
2581912|NCT00371254|6333656|P1|NOT COMPLETED|Overall Study||23
2581913|NCT00371254|6333655|P2|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
2581914|NCT00371254|6333656|P1|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
2581915|NCT00371254|6333655|P2|STARTED|Overall Study|Number of participants treated|21
2581916|NCT00371254|6333656|P1|STARTED|Overall Study|Number of participants treated|23
2581917|NCT00371176|6333708|P2|NOT COMPLETED|Overall Study||8
2581918|NCT00371176|6333709|P1|NOT COMPLETED|Overall Study||5
2581919|NCT00371176|6333708|P2|COMPLETED|Overall Study||5
2581920|NCT00371176|6333709|P1|COMPLETED|Overall Study||8
2581921|NCT00371176|6333708|P2|Completed Treatment|Overall Study||9
2581922|NCT00371176|6333709|P1|Completed Treatment|Overall Study||10
2581923|NCT00371176|6333708|P2|STARTED|Overall Study||13
2581924|NCT00371176|6333709|P1|STARTED|Overall Study||13
2581925|NCT00371150|6333739|P2|NOT COMPLETED|Overall Study||2
2581926|NCT00371150|6333740|P1|NOT COMPLETED|Overall Study||3
2581927|NCT00371150|6333739|P2|COMPLETED|Overall Study|"Completion of treatment” means received treatment through Week 52"|4
2581928|NCT00371150|6333740|P1|COMPLETED|Overall Study|"Completion of treatment” means received treatment through Week 52"|37
2581929|NCT00371150|6333739|P2|Discontinued at or After Week 48 Visit|Overall Study||1
2581930|NCT00371150|6333740|P1|Discontinued at or After Week 48 Visit|Overall Study||2
2581931|NCT00371150|6333739|P2|Discontinued Prior to Week 48 Visit|Overall Study||1
2581932|NCT00371150|6333740|P1|Discontinued Prior to Week 48 Visit|Overall Study||1
2581933|NCT00371150|6333739|P2|STARTED|Overall Study||6
2581934|NCT00371150|6333740|P1|STARTED|Overall Study||40
2581935|NCT00371137|6333775|P3|NOT COMPLETED|Overall Study||79
2581936|NCT00371137|6333776|P2|NOT COMPLETED|Overall Study||63
2581937|NCT00371137|6333777|P1|NOT COMPLETED|Overall Study||72
2581938|NCT00371137|6333775|P3|COMPLETED|Overall Study||104
2581939|NCT00371137|6333776|P2|COMPLETED|Overall Study||119
2581940|NCT00371137|6333777|P1|COMPLETED|Overall Study||111
2581941|NCT00371137|6333775|P3|Treated|Overall Study||182
2581942|NCT00371137|6333776|P2|Treated|Overall Study||182
2581943|NCT00371137|6333777|P1|Treated|Overall Study||183
2581944|NCT00371137|6333775|P3|STARTED|Overall Study||183
2581945|NCT00371137|6333776|P2|STARTED|Overall Study||182
2581946|NCT00371137|6333777|P1|STARTED|Overall Study||183
2581947|NCT00370994|6333787|P2|NOT COMPLETED|Overall Study||0
2581948|NCT00370994|6333788|P1|NOT COMPLETED|Overall Study||0
2581949|NCT00370994|6333787|P2|COMPLETED|Overall Study||60
2581950|NCT00370994|6333788|P1|COMPLETED|Overall Study||60
2581951|NCT00370994|6333787|P2|STARTED|Overall Study||60
2581952|NCT00370994|6333788|P1|STARTED|Overall Study|Sample size was 200, due to the difficulties of recruiting we changed to 120|60
2581953|NCT00370838|6333798|P2|NOT COMPLETED|Taper||0
2581954|NCT00370838|6333799|P1|NOT COMPLETED|Taper||0
2581955|NCT00370838|6333798|P2|COMPLETED|Taper||3
2581956|NCT00370838|6333799|P1|COMPLETED|Taper||7
2581957|NCT00370838|6333798|P2|STARTED|Taper||3
2581958|NCT00370838|6333799|P1|STARTED|Taper||7
2581959|NCT00370838|6333798|P2|NOT COMPLETED|Period 2 (Days 65-107)||0
2581960|NCT00370838|6333799|P1|NOT COMPLETED|Period 2 (Days 65-107)||0
2581961|NCT00370838|6333798|P2|COMPLETED|Period 2 (Days 65-107)||3
2581962|NCT00370838|6333799|P1|COMPLETED|Period 2 (Days 65-107)||7
2581963|NCT00370838|6333798|P2|STARTED|Period 2 (Days 65-107)||3
2581964|NCT00370838|6333799|P1|STARTED|Period 2 (Days 65-107)||7
2581965|NCT00370838|6333798|P2|NOT COMPLETED|Washout (Days 51-64)||0
2581966|NCT00370838|6333799|P1|NOT COMPLETED|Washout (Days 51-64)||0
2581967|NCT00370838|6333798|P2|COMPLETED|Washout (Days 51-64)||3
2581968|NCT00370838|6333799|P1|COMPLETED|Washout (Days 51-64)||7
2581969|NCT00370838|6333798|P2|STARTED|Washout (Days 51-64)||3
2581970|NCT00370838|6333799|P1|STARTED|Washout (Days 51-64)||7
2581971|NCT00370838|6333798|P2|NOT COMPLETED|Period 1 (Days 8-50)||0
2581972|NCT00370838|6333799|P1|NOT COMPLETED|Period 1 (Days 8-50)||0
2581973|NCT00370838|6333798|P2|COMPLETED|Period 1 (Days 8-50)||3
2581974|NCT00370838|6333799|P1|COMPLETED|Period 1 (Days 8-50)||7
2581975|NCT00370838|6333798|P2|STARTED|Period 1 (Days 8-50)||3
2581976|NCT00370838|6333799|P1|STARTED|Period 1 (Days 8-50)||7
2581977|NCT00370682|6333820|P3|NOT COMPLETED|Overall Study||1
2581978|NCT00370682|6333821|P2|NOT COMPLETED|Overall Study||3
2581979|NCT00370682|6333822|P1|NOT COMPLETED|Overall Study||0
2581980|NCT00370682|6333820|P3|COMPLETED|Overall Study||39
2581981|NCT00370682|6333821|P2|COMPLETED|Overall Study||37
2581982|NCT00370682|6333822|P1|COMPLETED|Overall Study||40
2581983|NCT00370682|6333820|P3|STARTED|Overall Study||40
2581984|NCT00370682|6333821|P2|STARTED|Overall Study||40
2581985|NCT00370682|6333822|P1|STARTED|Overall Study||40
2581986|NCT00370552|6333864|P3|NOT COMPLETED|Overall Study||32
2581987|NCT00370552|6333865|P2|NOT COMPLETED|Overall Study||45
2581988|NCT00370552|6333866|P1|NOT COMPLETED|Overall Study||46
2581989|NCT00370552|6333864|P3|COMPLETED|Overall Study||0
2581990|NCT00370552|6333865|P2|COMPLETED|Overall Study||0
2581991|NCT00370552|6333866|P1|COMPLETED|Overall Study||0
2581992|NCT00370552|6333864|P3|STARTED|Overall Study|Randomized|32
2581993|NCT00370552|6333865|P2|STARTED|Overall Study|Randomized|45
2581994|NCT00370552|6333866|P1|STARTED|Overall Study|Randomized|46
2581995|NCT00370396|6333907|P3|NOT COMPLETED|Overall Study||1
2581996|NCT00370396|6333908|P2|NOT COMPLETED|Overall Study||1
2581997|NCT00370396|6333909|P1|NOT COMPLETED|Overall Study||11
2581998|NCT00370396|6333907|P3|COMPLETED|Overall Study||282
2581999|NCT00370396|6333908|P2|COMPLETED|Overall Study||91
2582000|NCT00370396|6333909|P1|COMPLETED|Overall Study||726
2582001|NCT00370396|6333907|P3|STARTED|Overall Study||283
2582002|NCT00370396|6333908|P2|STARTED|Overall Study||92
2582003|NCT00370396|6333909|P1|STARTED|Overall Study||737
2582004|NCT00370331|6333963|P2|NOT COMPLETED|Overall Study||23
2582005|NCT00370331|6333964|P1|NOT COMPLETED|Overall Study||7
2582006|NCT00370331|6333963|P2|COMPLETED|Overall Study||112
2582007|NCT00370331|6333964|P1|COMPLETED|Overall Study||55
2582008|NCT00370331|6333963|P2|STARTED|Overall Study||135
2582009|NCT00370331|6333964|P1|STARTED|Overall Study||62
2582010|NCT00370292|6333990|P1|NOT COMPLETED|Overall Study||13
2582011|NCT00370292|6333990|P1|COMPLETED|Overall Study||6
2582012|NCT00370292|6333990|P1|STARTED|Overall Study||19
2582013|NCT00370149|6334003|P2|NOT COMPLETED|Overall Study||19
2582014|NCT00370149|6334004|P1|NOT COMPLETED|Overall Study||19
2582015|NCT00370149|6334003|P2|COMPLETED|Overall Study||142
2582016|NCT00370149|6334004|P1|COMPLETED|Overall Study||146
2582017|NCT00370149|6334003|P2|STARTED|Overall Study||161
2582018|NCT00370149|6334004|P1|STARTED|Overall Study||165
2582019|NCT00370071|6334014|P1|NOT COMPLETED|Overall Study||2
2582020|NCT00370071|6334014|P1|COMPLETED|Overall Study||37
2582021|NCT00370071|6334014|P1|STARTED|Overall Study||39
2582022|NCT00370032|6334031|P2|NOT COMPLETED|Follow-up Period||0
2582023|NCT00370032|6334032|P1|NOT COMPLETED|Follow-up Period||1
2582024|NCT00370032|6334031|P2|COMPLETED|Follow-up Period||22
2582025|NCT00370032|6334032|P1|COMPLETED|Follow-up Period||22
2582026|NCT00370032|6334031|P2|STARTED|Follow-up Period||22
2582027|NCT00370032|6334032|P1|STARTED|Follow-up Period||23
2582028|NCT00370032|6334031|P2|NOT COMPLETED|Treatment Period 2||0
2582029|NCT00370032|6334032|P1|NOT COMPLETED|Treatment Period 2||0
2582030|NCT00370032|6334031|P2|COMPLETED|Treatment Period 2||22
2582031|NCT00370032|6334032|P1|COMPLETED|Treatment Period 2||23
2582032|NCT00370032|6334031|P2|STARTED|Treatment Period 2||22
2582033|NCT00370032|6334032|P1|STARTED|Treatment Period 2||23
2582034|NCT00370032|6334031|P2|NOT COMPLETED|Washout Period||2
2582035|NCT00370032|6334032|P1|NOT COMPLETED|Washout Period||1
2582036|NCT00370032|6334031|P2|COMPLETED|Washout Period||22
2582037|NCT00370032|6334032|P1|COMPLETED|Washout Period||23
2582038|NCT00370032|6334031|P2|STARTED|Washout Period||24
2582039|NCT00370032|6334032|P1|STARTED|Washout Period||24
2582040|NCT00370032|6334031|P2|NOT COMPLETED|Treatment Period 1||1
2582041|NCT00370032|6334032|P1|NOT COMPLETED|Treatment Period 1||0
2582042|NCT00370032|6334031|P2|COMPLETED|Treatment Period 1||24
2582043|NCT00370032|6334032|P1|COMPLETED|Treatment Period 1||24
2582044|NCT00370032|6334031|P2|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|25
2582045|NCT00370032|6334032|P1|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|24
2582046|NCT00369967|6334052|P2|NOT COMPLETED|Overall Study||12
2582047|NCT00369967|6334053|P1|NOT COMPLETED|Overall Study||23
2582048|NCT00369967|6334052|P2|COMPLETED|Overall Study||5
2582049|NCT00369967|6334053|P1|COMPLETED|Overall Study||8
2582050|NCT00369967|6334052|P2|STARTED|Overall Study||17
2582051|NCT00369967|6334053|P1|STARTED|Overall Study||31
2582052|NCT00369941|6334071|P2|NOT COMPLETED|Overall Study||100
2582053|NCT00369941|6334072|P1|NOT COMPLETED|Overall Study||72
2582054|NCT00369941|6334071|P2|COMPLETED|Overall Study||184
2582055|NCT00369941|6334072|P1|COMPLETED|Overall Study||210
2582056|NCT00369941|6334071|P2|Treated|Overall Study||282
2582057|NCT00369941|6334072|P1|Treated|Overall Study||281
2582058|NCT00369941|6334071|P2|STARTED|Overall Study||284
2582059|NCT00369941|6334072|P1|STARTED|Overall Study||282
2582060|NCT00369928|6334225|P3|NOT COMPLETED|Overall Study||20
2582061|NCT00369928|6334226|P2|NOT COMPLETED|Overall Study||16
2582062|NCT00369928|6334227|P1|NOT COMPLETED|Overall Study||8
2582063|NCT00369928|6334225|P3|COMPLETED|Overall Study||66
2582064|NCT00369928|6334226|P2|COMPLETED|Overall Study||69
2582065|NCT00369928|6334227|P1|COMPLETED|Overall Study||77
2582066|NCT00369928|6334225|P3|STARTED|Overall Study||86
2582067|NCT00369928|6334226|P2|STARTED|Overall Study||85
2582068|NCT00369928|6334227|P1|STARTED|Overall Study||85
2582069|NCT00369915|6334237|P2|NOT COMPLETED|Overall Study||3
2582070|NCT00369915|6334238|P1|NOT COMPLETED|Overall Study||6
2582071|NCT00369915|6334237|P2|COMPLETED|Overall Study||4
2582072|NCT00369915|6334238|P1|COMPLETED|Overall Study||4
2582073|NCT00369915|6334237|P2|STARTED|Overall Study||7
2582074|NCT00369915|6334238|P1|STARTED|Overall Study||10
2582075|NCT00369824|6334252|P6|NOT COMPLETED|Overall Study||11
2582076|NCT00369824|6334253|P5|NOT COMPLETED|Overall Study||18
2582077|NCT00369824|6334254|P4|NOT COMPLETED|Overall Study||15
2582078|NCT00369824|6334255|P3|NOT COMPLETED|Overall Study||12
2582079|NCT00369824|6334256|P2|NOT COMPLETED|Overall Study||19
2582080|NCT00369824|6334257|P1|NOT COMPLETED|Overall Study||15
2582081|NCT00369824|6334252|P6|COMPLETED|Overall Study||204
2582082|NCT00369824|6334253|P5|COMPLETED|Overall Study||196
2582083|NCT00369824|6334254|P4|COMPLETED|Overall Study||199
2582084|NCT00369824|6334255|P3|COMPLETED|Overall Study||202
2582085|NCT00369824|6334256|P2|COMPLETED|Overall Study||195
2582086|NCT00369824|6334257|P1|COMPLETED|Overall Study||197
2582087|NCT00369824|6334252|P6|STARTED|Overall Study||215
2582088|NCT00369824|6334253|P5|STARTED|Overall Study||214
2582089|NCT00369824|6334254|P4|STARTED|Overall Study||214
2582090|NCT00369824|6334255|P3|STARTED|Overall Study||214
2582091|NCT00369824|6334256|P2|STARTED|Overall Study||214
2582092|NCT00369824|6334257|P1|STARTED|Overall Study||212
2582093|NCT00369785|6334357|P2|NOT COMPLETED|Overall Study||25
2582094|NCT00369785|6334358|P1|NOT COMPLETED|Overall Study||27
2582095|NCT00369785|6334357|P2|COMPLETED|Overall Study||74
2582096|NCT00369785|6334358|P1|COMPLETED|Overall Study||72
2582097|NCT00369785|6334357|P2|STARTED|Overall Study||99
2582098|NCT00369785|6334358|P1|STARTED|Overall Study||99
2582099|NCT00369746|6334368|P2|NOT COMPLETED|Overall Study||0
2582100|NCT00369746|6334369|P1|NOT COMPLETED|Overall Study||0
2582101|NCT00369746|6334368|P2|COMPLETED|Overall Study||536
2582102|NCT00369746|6334369|P1|COMPLETED|Overall Study||138
2582103|NCT00369746|6334368|P2|STARTED|Overall Study||536
2582104|NCT00369746|6334369|P1|STARTED|Overall Study||138
2582105|NCT00369707|6334379|P1|NOT COMPLETED|Follow up for 2 Years After Treatment||3
2582106|NCT00369707|6334379|P1|COMPLETED|Follow up for 2 Years After Treatment||38
2582107|NCT00369707|6334379|P1|STARTED|Follow up for 2 Years After Treatment||41
2582108|NCT00369707|6334379|P1|NOT COMPLETED|Maintenance Period (up to 4 Cycles)||8
2582109|NCT00369707|6334379|P1|COMPLETED|Maintenance Period (up to 4 Cycles)||27
2582110|NCT00369707|6334379|P1|STARTED|Maintenance Period (up to 4 Cycles)||35
2582111|NCT00369707|6334379|P1|NOT COMPLETED|Induction Part B (2 Cycles)||7
2582112|NCT00369707|6334379|P1|COMPLETED|Induction Part B (2 Cycles)||35
2582113|NCT00369707|6334379|P1|STARTED|Induction Part B (2 Cycles)||42
2582114|NCT00369707|6334379|P1|NOT COMPLETED|Induction Part A (1 Cycle -35 Days)||0
2582115|NCT00369707|6334379|P1|COMPLETED|Induction Part A (1 Cycle -35 Days)||42
2582116|NCT00369707|6334379|P1|STARTED|Induction Part A (1 Cycle -35 Days)||42
2582117|NCT00369681|6334392|P1|NOT COMPLETED|Overall Study||1
2582118|NCT00369681|6334392|P1|COMPLETED|Overall Study||49
2582119|NCT00369681|6334392|P1|STARTED|Overall Study||50
2582120|NCT00369668|6334402|P3|NOT COMPLETED|Overall Study||7
2582121|NCT00369668|6334403|P2|NOT COMPLETED|Overall Study||5
2582122|NCT00369668|6334404|P1|NOT COMPLETED|Overall Study||4
2582123|NCT00369668|6334402|P3|COMPLETED|Overall Study||3
2582124|NCT00369668|6334403|P2|COMPLETED|Overall Study||5
2582125|NCT00369668|6334404|P1|COMPLETED|Overall Study||6
2582126|NCT00369668|6334402|P3|STARTED|Overall Study||10
2582127|NCT00369668|6334403|P2|STARTED|Overall Study||10
2582128|NCT00369668|6334404|P1|STARTED|Overall Study|Original number of participants to be recruited for each group.|10
2582129|NCT00369655|6334418|P1|NOT COMPLETED|Overall Study||2
2582130|NCT00369655|6334418|P1|COMPLETED|Overall Study||19
2582131|NCT00369655|6334418|P1|STARTED|Overall Study||21
2582132|NCT00369629|6334427|P4|NOT COMPLETED|Follow up for 1 Year||0
2582133|NCT00369629|6334428|P3|NOT COMPLETED|Follow up for 1 Year||3
2582134|NCT00369629|6334429|P2|NOT COMPLETED|Follow up for 1 Year||2
2582135|NCT00369629|6334430|P1|NOT COMPLETED|Follow up for 1 Year||2
2582136|NCT00369629|6334427|P4|COMPLETED|Follow up for 1 Year||0
2582137|NCT00369629|6334428|P3|COMPLETED|Follow up for 1 Year||2
2582138|NCT00369629|6334429|P2|COMPLETED|Follow up for 1 Year||1
2582139|NCT00369629|6334430|P1|COMPLETED|Follow up for 1 Year||4
2582140|NCT00369629|6334427|P4|STARTED|Follow up for 1 Year||0
2582141|NCT00369629|6334428|P3|STARTED|Follow up for 1 Year||5
2582142|NCT00369629|6334429|P2|STARTED|Follow up for 1 Year||3
2582143|NCT00369629|6334430|P1|STARTED|Follow up for 1 Year|All patients treated on study go into the follow up period|6
2582144|NCT00369629|6334427|P4|NOT COMPLETED|Completed 4 More Cycles||0
2582145|NCT00369629|6334428|P3|NOT COMPLETED|Completed 4 More Cycles||2
2582146|NCT00369629|6334429|P2|NOT COMPLETED|Completed 4 More Cycles||2
2582147|NCT00369629|6334430|P1|NOT COMPLETED|Completed 4 More Cycles||4
2582148|NCT00369629|6334427|P4|COMPLETED|Completed 4 More Cycles||0
2582149|NCT00369629|6334428|P3|COMPLETED|Completed 4 More Cycles||0
2582150|NCT00369629|6334429|P2|COMPLETED|Completed 4 More Cycles||0
2582151|NCT00369629|6334430|P1|COMPLETED|Completed 4 More Cycles||0
2582152|NCT00369629|6334427|P4|STARTED|Completed 4 More Cycles||0
2582153|NCT00369629|6334428|P3|STARTED|Completed 4 More Cycles||2
2582154|NCT00369629|6334429|P2|STARTED|Completed 4 More Cycles||2
2582155|NCT00369629|6334430|P1|STARTED|Completed 4 More Cycles||4
2582156|NCT00369629|6334427|P4|NOT COMPLETED|Moved on to 4 More Cycles||0
2582157|NCT00369629|6334428|P3|NOT COMPLETED|Moved on to 4 More Cycles||1
2582158|NCT00369629|6334429|P2|NOT COMPLETED|Moved on to 4 More Cycles||0
2582159|NCT00369629|6334430|P1|NOT COMPLETED|Moved on to 4 More Cycles||0
2582160|NCT00369629|6334427|P4|COMPLETED|Moved on to 4 More Cycles||0
2582161|NCT00369629|6334428|P3|COMPLETED|Moved on to 4 More Cycles||2
2582162|NCT00369629|6334429|P2|COMPLETED|Moved on to 4 More Cycles||2
2582163|NCT00369629|6334430|P1|COMPLETED|Moved on to 4 More Cycles||4
2582164|NCT00369629|6334427|P4|STARTED|Moved on to 4 More Cycles||0
2582165|NCT00369629|6334428|P3|STARTED|Moved on to 4 More Cycles||3
2582166|NCT00369629|6334429|P2|STARTED|Moved on to 4 More Cycles||2
2582167|NCT00369629|6334430|P1|STARTED|Moved on to 4 More Cycles||4
2582168|NCT00369629|6334427|P4|NOT COMPLETED|Treated 2 Cycles/Reached First Response||0
2582169|NCT00369629|6334428|P3|NOT COMPLETED|Treated 2 Cycles/Reached First Response||2
2582170|NCT00369629|6334429|P2|NOT COMPLETED|Treated 2 Cycles/Reached First Response||1
2582171|NCT00369629|6334430|P1|NOT COMPLETED|Treated 2 Cycles/Reached First Response||2
2582172|NCT00369629|6334427|P4|COMPLETED|Treated 2 Cycles/Reached First Response||0
2582173|NCT00369629|6334428|P3|COMPLETED|Treated 2 Cycles/Reached First Response||3
2582174|NCT00369629|6334429|P2|COMPLETED|Treated 2 Cycles/Reached First Response||2
2582175|NCT00369629|6334430|P1|COMPLETED|Treated 2 Cycles/Reached First Response||4
2582176|NCT00369629|6334427|P4|STARTED|Treated 2 Cycles/Reached First Response|No patients were enrolled at this dose level as the study closed early due to lack of funding.|0
2582177|NCT00369629|6334428|P3|STARTED|Treated 2 Cycles/Reached First Response||5
2582178|NCT00369629|6334429|P2|STARTED|Treated 2 Cycles/Reached First Response||3
2582179|NCT00369629|6334430|P1|STARTED|Treated 2 Cycles/Reached First Response||6
2582180|NCT00369590|6334442|P2|NOT COMPLETED|Overall Study||0
2582181|NCT00369590|6334443|P1|NOT COMPLETED|Overall Study||0
2582182|NCT00369590|6334442|P2|COMPLETED|Overall Study||42
2582183|NCT00369590|6334443|P1|COMPLETED|Overall Study||16
2582184|NCT00369590|6334442|P2|STARTED|Overall Study||42
2582185|NCT00369590|6334443|P1|STARTED|Overall Study||16
2582186|NCT00369577|6334461|P3|NOT COMPLETED|Overall Study||1
2582187|NCT00369577|6334462|P2|NOT COMPLETED|Overall Study||0
2582188|NCT00369577|6334463|P1|NOT COMPLETED|Overall Study||0
2582189|NCT00369577|6334461|P3|COMPLETED|Overall Study||40
2582190|NCT00369577|6334462|P2|COMPLETED|Overall Study||45
2582191|NCT00369577|6334463|P1|COMPLETED|Overall Study||43
2582192|NCT00369577|6334461|P3|STARTED|Overall Study||41
2582193|NCT00369577|6334462|P2|STARTED|Overall Study||45
2582194|NCT00369577|6334463|P1|STARTED|Overall Study||43
2582195|NCT00369564|6334482|P2|NOT COMPLETED|Overall Study||23
2582196|NCT00369564|6334483|P1|NOT COMPLETED|Overall Study||43
2582197|NCT00369564|6334482|P2|COMPLETED|Overall Study||100
2582198|NCT00369564|6334483|P1|COMPLETED|Overall Study||84
2582199|NCT00369564|6334482|P2|STARTED|Overall Study||123
2582200|NCT00369564|6334483|P1|STARTED|Overall Study||127
2582201|NCT00369512|6334489|P1|NOT COMPLETED|Overall Study||0
2582202|NCT00369512|6334489|P1|COMPLETED|Overall Study||15
2582203|NCT00369512|6334489|P1|STARTED|Overall Study||15
2582204|NCT00369486|6334500|P5|NOT COMPLETED|34-Week Visit||3
2582205|NCT00369486|6334501|P4|NOT COMPLETED|34-Week Visit||3
2582206|NCT00369486|6334502|P3|NOT COMPLETED|34-Week Visit||1
2582207|NCT00369486|6334503|P2|NOT COMPLETED|34-Week Visit||1
2582208|NCT00369486|6334504|P1|NOT COMPLETED|34-Week Visit||0
2582209|NCT00369486|6334500|P5|COMPLETED|34-Week Visit|Number of eyes|22
2582210|NCT00369486|6334501|P4|COMPLETED|34-Week Visit|Number of eyes|19
2582211|NCT00369486|6334502|P3|COMPLETED|34-Week Visit|Number of eyes|22
2582212|NCT00369486|6334503|P2|COMPLETED|34-Week Visit|Number of eyes|20
2582213|NCT00369486|6334504|P1|COMPLETED|34-Week Visit|Number of eyes|38
2582214|NCT00369486|6334500|P5|STARTED|34-Week Visit|Number of eyes that|25
2582215|NCT00369486|6334501|P4|STARTED|34-Week Visit|Number of eyes|22
2582216|NCT00369486|6334502|P3|STARTED|34-Week Visit|Number of eyes|23
2582217|NCT00369486|6334503|P2|STARTED|34-Week Visit|Number of eyes|21
2582218|NCT00369486|6334504|P1|STARTED|34-Week Visit|Number of eyes|38
2582219|NCT00369486|6334500|P5|NOT COMPLETED|17-Week Visit||1
2582220|NCT00369486|6334501|P4|NOT COMPLETED|17-Week Visit||1
2582221|NCT00369486|6334502|P3|NOT COMPLETED|17-Week Visit||1
2582222|NCT00369486|6334503|P2|NOT COMPLETED|17-Week Visit||0
2582223|NCT00369486|6334504|P1|NOT COMPLETED|17-Week Visit||0
2582224|NCT00369486|6334500|P5|COMPLETED|17-Week Visit|Number of eyes|24
2582225|NCT00369486|6334501|P4|COMPLETED|17-Week Visit|Number of eyes|21
2582226|NCT00369486|6334502|P3|COMPLETED|17-Week Visit|Number of eyes|22
2582227|NCT00369486|6334503|P2|COMPLETED|17-Week Visit|Number of eyes|21
2582228|NCT00369486|6334504|P1|COMPLETED|17-Week Visit|Number of eyes|38
2582229|NCT00369486|6334500|P5|STARTED|17-Week Visit|Number of eyes|25
2582230|NCT00369486|6334501|P4|STARTED|17-Week Visit|Number of eyes|22
2582231|NCT00369486|6334502|P3|STARTED|17-Week Visit|Number of eyes|23
2582232|NCT00369486|6334503|P2|STARTED|17-Week Visit|Number of eyes|21
2582233|NCT00369486|6334504|P1|STARTED|17-Week Visit|Number of eyes|38
2582234|NCT00369486|6334500|P5|NOT COMPLETED|8-Week Visit||1
2582235|NCT00369486|6334501|P4|NOT COMPLETED|8-Week Visit||1
2582236|NCT00369486|6334502|P3|NOT COMPLETED|8-Week Visit||0
2582237|NCT00369486|6334503|P2|NOT COMPLETED|8-Week Visit||1
2582238|NCT00369486|6334504|P1|NOT COMPLETED|8-Week Visit||0
2582239|NCT00369486|6334500|P5|COMPLETED|8-Week Visit|Number of eyes|24
2582240|NCT00369486|6334501|P4|COMPLETED|8-Week Visit|Number of eyes|21
2582241|NCT00369486|6334502|P3|COMPLETED|8-Week Visit|Number of eyes|22
2582242|NCT00369486|6334503|P2|COMPLETED|8-Week Visit|Number of eyes|20
2582243|NCT00369486|6334504|P1|COMPLETED|8-Week Visit|Number of eyes|38
2582244|NCT00369486|6334500|P5|STARTED|8-Week Visit|Number of eyes|25
2582245|NCT00369486|6334501|P4|STARTED|8-Week Visit|Number of eyes|22
2582246|NCT00369486|6334502|P3|STARTED|8-Week Visit|Number of eyes|22
2582247|NCT00369486|6334503|P2|STARTED|8-Week Visit|Number of eyes|21
2582248|NCT00369486|6334504|P1|STARTED|8-Week Visit|Number of eyes|38
2582249|NCT00369486|6334500|P5|NOT COMPLETED|4-Week Visit||1
2582250|NCT00369486|6334501|P4|NOT COMPLETED|4-Week Visit||2
2582251|NCT00369486|6334502|P3|NOT COMPLETED|4-Week Visit||1
2582252|NCT00369486|6334503|P2|NOT COMPLETED|4-Week Visit||2
2582253|NCT00369486|6334504|P1|NOT COMPLETED|4-Week Visit||2
2582254|NCT00369486|6334500|P5|COMPLETED|4-Week Visit|Number of eyes|24
2582255|NCT00369486|6334501|P4|COMPLETED|4-Week Visit|Number of eyes|20
2582256|NCT00369486|6334502|P3|COMPLETED|4-Week Visit|Number of eyes|22
2582257|NCT00369486|6334503|P2|COMPLETED|4-Week Visit|Number of eyes;|19
2582258|NCT00369486|6334504|P1|COMPLETED|4-Week Visit|Number of eyes|36
2582259|NCT00369486|6334500|P5|STARTED|4-Week Visit|Number of eyes|25
2582260|NCT00369486|6334501|P4|STARTED|4-Week Visit|Number of eyes|22
2582261|NCT00369486|6334502|P3|STARTED|4-Week Visit|Number of eyes|23
2582262|NCT00369486|6334503|P2|STARTED|4-Week Visit|Number of eyes|21
2582263|NCT00369486|6334504|P1|STARTED|4-Week Visit|Number of eyes|38
2582264|NCT00369382|6334543|P2|NOT COMPLETED|Overall Study||3
2582265|NCT00369382|6334544|P1|NOT COMPLETED|Overall Study||10
2582266|NCT00369382|6334543|P2|COMPLETED|Overall Study||54
2582267|NCT00369382|6334544|P1|COMPLETED|Overall Study||49
2582268|NCT00369382|6334543|P2|Completed Assigned Treatment Regimen|Overall Study||33
2582269|NCT00369382|6334544|P1|Completed Assigned Treatment Regimen|Overall Study||48
2582270|NCT00369382|6334543|P2|Received Treatment|Overall Study||57
2582271|NCT00369382|6334544|P1|Received Treatment|Overall Study||57
2582272|NCT00369382|6334543|P2|STARTED|Overall Study||57
2582273|NCT00369382|6334544|P1|STARTED|Overall Study||59
2582274|NCT00369343|6334577|P2|NOT COMPLETED|Open-label Phase||30
2582275|NCT00369343|6334578|P1|NOT COMPLETED|Open-label Phase||57
2582276|NCT00369343|6334577|P2|COMPLETED|Open-label Phase||79
2582277|NCT00369343|6334578|P1|COMPLETED|Open-label Phase||155
2582278|NCT00369343|6334577|P2|STARTED|Open-label Phase||109
2582279|NCT00369343|6334578|P1|STARTED|Open-label Phase||212
2582280|NCT00369343|6334577|P2|NOT COMPLETED|Double-blind Phase||16
2582281|NCT00369343|6334578|P1|NOT COMPLETED|Double-blind Phase||44
2582282|NCT00369343|6334577|P2|COMPLETED|Double-blind Phase||109
2582283|NCT00369343|6334578|P1|COMPLETED|Double-blind Phase||212
2582284|NCT00369343|6334577|P2|STARTED|Double-blind Phase||125
2582285|NCT00369343|6334578|P1|STARTED|Double-blind Phase||256
2582286|NCT00369317|6334611|P1|NOT COMPLETED|Overall Study||20
2582287|NCT00369317|6334611|P1|COMPLETED|Overall Study||185
2582288|NCT00369317|6334611|P1|STARTED|Overall Study||205
2582289|NCT00369278|6334627|P2|NOT COMPLETED|Overall Study||21
2582290|NCT00369278|6334628|P1|NOT COMPLETED|Overall Study||24
2582291|NCT00369278|6334627|P2|COMPLETED|Overall Study||44
2582292|NCT00369278|6334628|P1|COMPLETED|Overall Study||39
2582293|NCT00369278|6334627|P2|STARTED|Overall Study||65
2582294|NCT00369278|6334628|P1|STARTED|Overall Study||63
2582295|NCT00369265|6334644|P2|NOT COMPLETED|Overall Study||7
2582296|NCT00369265|6334645|P1|NOT COMPLETED|Overall Study||4
2582297|NCT00369265|6334644|P2|COMPLETED|Overall Study||0
2582298|NCT00369265|6334645|P1|COMPLETED|Overall Study||0
2582299|NCT00369265|6334644|P2|STARTED|Overall Study||7
2582300|NCT00369265|6334645|P1|STARTED|Overall Study||4
2582301|NCT00369226|6334653|P2|NOT COMPLETED|Phase II (45 Days)||0
2582302|NCT00369226|6334654|P1|NOT COMPLETED|Phase II (45 Days)||0
2582303|NCT00369226|6334653|P2|COMPLETED|Phase II (45 Days)|This includes 10 patients treated at candidate MTD in Phase I.|32
2582304|NCT00369226|6334654|P1|COMPLETED|Phase II (45 Days)||0
2582305|NCT00369226|6334653|P2|STARTED|Phase II (45 Days)||32
2582306|NCT00369226|6334654|P1|STARTED|Phase II (45 Days)||0
2582307|NCT00369226|6334653|P2|NOT COMPLETED|Phase I (45 Days)||0
2582308|NCT00369226|6334654|P1|NOT COMPLETED|Phase I (45 Days)||0
2582309|NCT00369226|6334653|P2|COMPLETED|Phase I (45 Days)||0
2582310|NCT00369226|6334654|P1|COMPLETED|Phase I (45 Days)|Once MTD established, additional 10 patients were accrued at MTD to better estimate toxicity.|13
2582311|NCT00369226|6334653|P2|STARTED|Phase I (45 Days)||0
2582312|NCT00369226|6334654|P1|STARTED|Phase I (45 Days)||13
2582313|NCT00369161|6334666|P2|NOT COMPLETED|Overall Study||24
2582314|NCT00369161|6334667|P1|NOT COMPLETED|Overall Study||27
2582315|NCT00369161|6334666|P2|COMPLETED|Overall Study||95
2582316|NCT00369161|6334667|P1|COMPLETED|Overall Study||82
2582317|NCT00369161|6334666|P2|Intention to Treat (ITT)|Overall Study||117
2582318|NCT00369161|6334667|P1|Intention to Treat (ITT)|Overall Study||107
2582319|NCT00369161|6334666|P2|STARTED|Overall Study||119
2582320|NCT00369161|6334667|P1|STARTED|Overall Study|"Started indicates randomized and safety population."|109
2582321|NCT00369122|6334677|P1|NOT COMPLETED|Overall Study||11
2582322|NCT00369122|6334677|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|49
2582323|NCT00369122|6334677|P1|STARTED|Overall Study||60
2582324|NCT00368992|6334684|P1|NOT COMPLETED|Overall Study||110
2582325|NCT00368992|6334684|P1|COMPLETED|Overall Study||0
2582326|NCT00368992|6334684|P1|STARTED|Overall Study||110
2582327|NCT00368979|6334693|P2|NOT COMPLETED|Overall Study||30
2582328|NCT00368979|6334694|P1|NOT COMPLETED|Overall Study||25
2582329|NCT00368979|6334693|P2|COMPLETED|Overall Study||163
2582330|NCT00368979|6334694|P1|COMPLETED|Overall Study||160
2582331|NCT00368979|6334693|P2|STARTED|Overall Study||193
2582332|NCT00368979|6334694|P1|STARTED|Overall Study||185
2582333|NCT00368966|6334710|P2|NOT COMPLETED|Toddler Dose||3
2582334|NCT00368966|6334711|P1|NOT COMPLETED|Toddler Dose||1
2582335|NCT00368966|6334710|P2|COMPLETED|Toddler Dose||286
2582336|NCT00368966|6334711|P1|COMPLETED|Toddler Dose||292
2582337|NCT00368966|6334710|P2|STARTED|Toddler Dose||289
2582338|NCT00368966|6334711|P1|STARTED|Toddler Dose||293
2582339|NCT00368966|6334710|P2|NOT COMPLETED|After Infant||5
2582340|NCT00368966|6334711|P1|NOT COMPLETED|After Infant||6
2582341|NCT00368966|6334710|P2|COMPLETED|After Infant||289
2582342|NCT00368966|6334711|P1|COMPLETED|After Infant||293
2582343|NCT00368966|6334710|P2|STARTED|After Infant||294
2582344|NCT00368966|6334711|P1|STARTED|After Infant||299
2582345|NCT00368966|6334710|P2|NOT COMPLETED|Infant Series||10
2582346|NCT00368966|6334711|P1|NOT COMPLETED|Infant Series||16
2582347|NCT00368966|6334710|P2|COMPLETED|Infant Series||294
2582348|NCT00368966|6334711|P1|COMPLETED|Infant Series||299
2582349|NCT00368966|6334710|P2|Vaccinated Dose 3|Infant Series|1 randomized but incorrectly given 13vPnC|296
2582350|NCT00368966|6334711|P1|Vaccinated Dose 3|Infant Series||301
2582351|NCT00368966|6334710|P2|Vaccinated Dose 2|Infant Series||298
2582352|NCT00368966|6334711|P1|Vaccinated Dose 2|Infant Series|1 randomized but incorrectly given 7vPnC|307
2582353|NCT00368966|6334710|P2|Vaccinated Dose 1|Infant Series|1 randomized to 7vPnC but given 13vPnC vaccine; 1 was withdrawn before receiving 7vPnC vaccine|302
2582354|NCT00368966|6334711|P1|Vaccinated Dose 1|Infant Series||314
2582355|NCT00368966|6334710|P2|STARTED|Infant Series||304
2582356|NCT00368966|6334711|P1|STARTED|Infant Series||315
2582357|NCT00368940|6334767|P2|NOT COMPLETED|Completed 12-wk Treatment||5
2582358|NCT00368940|6334768|P1|NOT COMPLETED|Completed 12-wk Treatment||6
2582359|NCT00368940|6334767|P2|COMPLETED|Completed 12-wk Treatment||32
2582360|NCT00368940|6334768|P1|COMPLETED|Completed 12-wk Treatment||31
2582361|NCT00368940|6334767|P2|STARTED|Completed 12-wk Treatment||37
2582362|NCT00368940|6334768|P1|STARTED|Completed 12-wk Treatment||37
2582363|NCT00368940|6334767|P2|NOT COMPLETED|Intention-to-Treat||0
2582364|NCT00368940|6334768|P1|NOT COMPLETED|Intention-to-Treat||0
2582365|NCT00368940|6334767|P2|COMPLETED|Intention-to-Treat||37
2582366|NCT00368940|6334768|P1|COMPLETED|Intention-to-Treat||37
2582367|NCT00368940|6334767|P2|STARTED|Intention-to-Treat||37
2582368|NCT00368940|6334768|P1|STARTED|Intention-to-Treat||37
2582369|NCT00368927|6334782|P2|NOT COMPLETED|Overall Study||3
2582370|NCT00368927|6334783|P1|NOT COMPLETED|Overall Study||5
2582371|NCT00368927|6334782|P2|COMPLETED|Overall Study||27
2582372|NCT00368927|6334783|P1|COMPLETED|Overall Study||26
2582373|NCT00368927|6334782|P2|STARTED|Overall Study||30
2582374|NCT00368927|6334783|P1|STARTED|Overall Study||31
2582375|NCT00368875|6334791|P2|NOT COMPLETED|Overall Study||48
2582376|NCT00368875|6334792|P1|NOT COMPLETED|Overall Study||6
2582377|NCT00368875|6334791|P2|COMPLETED|Overall Study||0
2582378|NCT00368875|6334792|P1|COMPLETED|Overall Study||0
2582379|NCT00368875|6334791|P2|STARTED|Overall Study||48
2582380|NCT00368875|6334792|P1|STARTED|Overall Study||6
2582381|NCT00368849|6334800|P2|NOT COMPLETED|Overall Study||2
2582382|NCT00368849|6334801|P1|NOT COMPLETED|Overall Study||0
2582383|NCT00368849|6334800|P2|COMPLETED|Overall Study||8
2582384|NCT00368849|6334801|P1|COMPLETED|Overall Study||10
2582385|NCT00368849|6334800|P2|STARTED|Overall Study||10
2582386|NCT00368849|6334801|P1|STARTED|Overall Study||10
2582387|NCT00368745|6334817|P2|NOT COMPLETED|Double-blind Treatment Period||31
2582388|NCT00368745|6334818|P1|NOT COMPLETED|Double-blind Treatment Period||26
2582389|NCT00368745|6334817|P2|COMPLETED|Double-blind Treatment Period||19
2582390|NCT00368745|6334818|P1|COMPLETED|Double-blind Treatment Period||30
2582391|NCT00368745|6334817|P2|STARTED|Double-blind Treatment Period||50
2582392|NCT00368745|6334818|P1|STARTED|Double-blind Treatment Period||56
2582393|NCT00368745|6334817|P2|NOT COMPLETED|Randomized to Double-blind Treatment||1
2582394|NCT00368745|6334818|P1|NOT COMPLETED|Randomized to Double-blind Treatment||1
2582395|NCT00368745|6334817|P2|COMPLETED|Randomized to Double-blind Treatment|One subject did not want to participate in study.|50
2582396|NCT00368745|6334818|P1|COMPLETED|Randomized to Double-blind Treatment|One subject did not return following randomization; study drug not dispensed.|56
2582397|NCT00368745|6334817|P2|STARTED|Randomized to Double-blind Treatment||51
2582398|NCT00368745|6334818|P1|STARTED|Randomized to Double-blind Treatment||57
2582399|NCT00368654|6334852|P4|NOT COMPLETED|Overall Study||3
2582400|NCT00368654|6334853|P3|NOT COMPLETED|Overall Study||3
2582401|NCT00368654|6334854|P2|NOT COMPLETED|Overall Study||3
2582402|NCT00368654|6334855|P1|NOT COMPLETED|Overall Study||3
2582403|NCT00368654|6334852|P4|COMPLETED|Overall Study||0
2582404|NCT00368654|6334853|P3|COMPLETED|Overall Study||0
2582405|NCT00368654|6334854|P2|COMPLETED|Overall Study||0
2582406|NCT00368654|6334855|P1|COMPLETED|Overall Study||0
2582407|NCT00368654|6334852|P4|STARTED|Overall Study||3
2582408|NCT00368654|6334853|P3|STARTED|Overall Study||3
2582409|NCT00368654|6334854|P2|STARTED|Overall Study||3
2582410|NCT00368654|6334855|P1|STARTED|Overall Study||3
2582411|NCT00368641|6334871|P2|NOT COMPLETED|Overall Study||6
2582412|NCT00368641|6334872|P1|NOT COMPLETED|Overall Study||6
2582413|NCT00368641|6334871|P2|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
2582414|NCT00368641|6334872|P1|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
2582415|NCT00368641|6334871|P2|STARTED|Overall Study||6
2582416|NCT00368641|6334872|P1|STARTED|Overall Study||6
2582417|NCT00368550|6334880|P2|NOT COMPLETED|Overall Study||23
2582418|NCT00368550|6334881|P1|NOT COMPLETED|Overall Study||28
2582419|NCT00368550|6334880|P2|COMPLETED|Overall Study||48
2582420|NCT00368550|6334881|P1|COMPLETED|Overall Study||35
2582421|NCT00368550|6334880|P2|STARTED|Overall Study||71
2582422|NCT00368550|6334881|P1|STARTED|Overall Study||63
2582423|NCT00368537|6334893|P2|NOT COMPLETED|Baseline Participants||24
2582424|NCT00368537|6334894|P1|NOT COMPLETED|Baseline Participants||24
2582425|NCT00368537|6334893|P2|COMPLETED|Baseline Participants||239
2582426|NCT00368537|6334894|P1|COMPLETED|Baseline Participants||244
2582427|NCT00368537|6334893|P2|STARTED|Baseline Participants||263
2582428|NCT00368537|6334894|P1|STARTED|Baseline Participants||268
2582429|NCT00368537|6334893|P2|NOT COMPLETED|Randomization||6
2582430|NCT00368537|6334894|P1|NOT COMPLETED|Randomization||13
2582431|NCT00368537|6334893|P2|COMPLETED|Randomization||263
2582432|NCT00368537|6334894|P1|COMPLETED|Randomization||268
2582433|NCT00368537|6334893|P2|STARTED|Randomization||269
2582434|NCT00368537|6334894|P1|STARTED|Randomization||281
2582435|NCT00368472|6334908|P1|NOT COMPLETED|Overall Study||105
2582436|NCT00368472|6334908|P1|COMPLETED|Overall Study||33
2582437|NCT00368472|6334908|P1|STARTED|Overall Study||138
2582438|NCT00368459|6334916|P2|NOT COMPLETED|Overall Study||1
2582439|NCT00368459|6334917|P1|NOT COMPLETED|Overall Study||2
2582440|NCT00368459|6334916|P2|COMPLETED|Overall Study||20
2582441|NCT00368459|6334917|P1|COMPLETED|Overall Study||19
2582442|NCT00368459|6334916|P2|STARTED|Overall Study||21
2582443|NCT00368459|6334917|P1|STARTED|Overall Study||21
2582444|NCT00368355|6334943|P2|NOT COMPLETED|Overall Study||17
2582445|NCT00368355|6334944|P1|NOT COMPLETED|Overall Study||11
2582446|NCT00368355|6334943|P2|COMPLETED|Overall Study||11
2582447|NCT00368355|6334944|P1|COMPLETED|Overall Study||7
2582448|NCT00368355|6334943|P2|STARTED|Overall Study||28
2582449|NCT00368355|6334944|P1|STARTED|Overall Study||18
2582450|NCT00368316|6334960|P2|NOT COMPLETED|Overall Study||46
2582451|NCT00368316|6334961|P1|NOT COMPLETED|Overall Study||42
2582452|NCT00368316|6334960|P2|COMPLETED|Overall Study||1319
2582453|NCT00368316|6334961|P1|COMPLETED|Overall Study||1392
2582454|NCT00368316|6334960|P2|STARTED|Overall Study||1365
2582455|NCT00368316|6334961|P1|STARTED|Overall Study||1434
2582456|NCT00368290|6334973|P2|NOT COMPLETED|Overall Study||10
2582457|NCT00368290|6334974|P1|NOT COMPLETED|Overall Study||13
2582458|NCT00368290|6334973|P2|COMPLETED|Overall Study||37
2582459|NCT00368290|6334974|P1|COMPLETED|Overall Study||34
2582460|NCT00368290|6334973|P2|STARTED|Overall Study||47
2582461|NCT00368290|6334974|P1|STARTED|Overall Study||47
2582462|NCT00368277|6334984|P2|NOT COMPLETED|Overall Study||108
2582463|NCT00368277|6334985|P1|NOT COMPLETED|Overall Study||113
2582464|NCT00368277|6334984|P2|COMPLETED|Overall Study||336
2582465|NCT00368277|6334985|P1|COMPLETED|Overall Study||344
2582466|NCT00368277|6334984|P2|STARTED|Overall Study||444
2582467|NCT00368277|6334985|P1|STARTED|Overall Study||457
2582468|NCT00368251|6335000|P3|NOT COMPLETED|Overall Study||1
2582469|NCT00368251|6335001|P2|NOT COMPLETED|Overall Study||0
2582470|NCT00368251|6335002|P1|NOT COMPLETED|Overall Study||1
2582471|NCT00368251|6335000|P3|COMPLETED|Overall Study||17
2582472|NCT00368251|6335001|P2|COMPLETED|Overall Study||20
2582473|NCT00368251|6335002|P1|COMPLETED|Overall Study||17
2582474|NCT00368251|6335000|P3|STARTED|Overall Study||18
2582475|NCT00368251|6335001|P2|STARTED|Overall Study||20
2582476|NCT00368251|6335002|P1|STARTED|Overall Study||18
2582477|NCT00368108|6335025|P3|NOT COMPLETED|Overall Study||68
2582478|NCT00368108|6335026|P2|NOT COMPLETED|Overall Study||53
2582479|NCT00368108|6335027|P1|NOT COMPLETED|Overall Study||64
2582480|NCT00368108|6335025|P3|COMPLETED|Overall Study||182
2582481|NCT00368108|6335026|P2|COMPLETED|Overall Study||198
2582482|NCT00368108|6335027|P1|COMPLETED|Overall Study||187
2582483|NCT00368108|6335025|P3|STARTED|Overall Study||250
2582484|NCT00368108|6335026|P2|STARTED|Overall Study||251
2582485|NCT00368108|6335027|P1|STARTED|Overall Study|One subject had stopped medication prior to notifying staff. Remaining results will have 250.|251
2582486|NCT00368069|6335046|P2|NOT COMPLETED|Overall Study||7
2582487|NCT00368069|6335047|P1|NOT COMPLETED|Overall Study||8
2582488|NCT00368069|6335046|P2|COMPLETED|Overall Study||72
2582489|NCT00368069|6335047|P1|COMPLETED|Overall Study||71
2582490|NCT00368069|6335046|P2|STARTED|Overall Study||79
2582491|NCT00368069|6335047|P1|STARTED|Overall Study||79
2582492|NCT00367991|6335065|P2|NOT COMPLETED|Overall Study||2
2582493|NCT00367991|6335066|P1|NOT COMPLETED|Overall Study||2
2582494|NCT00367991|6335065|P2|COMPLETED|Overall Study||13
2582495|NCT00367991|6335066|P1|COMPLETED|Overall Study||27
2582496|NCT00367991|6335065|P2|STARTED|Overall Study||15
2582497|NCT00367991|6335066|P1|STARTED|Overall Study||29
2582498|NCT00367835|6335084|P2|NOT COMPLETED|Overall Study||31
2582499|NCT00367835|6335085|P1|NOT COMPLETED|Overall Study||29
2582500|NCT00367835|6335084|P2|COMPLETED|Overall Study||48
2582501|NCT00367835|6335085|P1|COMPLETED|Overall Study||109
2582502|NCT00367835|6335084|P2|STARTED|Overall Study||79
2582503|NCT00367835|6335085|P1|STARTED|Overall Study||138
2582504|NCT00367770|6335111|P1|NOT COMPLETED|Overall Study||2
2582505|NCT00367770|6335111|P1|COMPLETED|Overall Study||35
2582506|NCT00367770|6335111|P1|STARTED|Overall Study||37
2582507|NCT00367744|6335119|P2|NOT COMPLETED|Overall Study||5
2582508|NCT00367744|6335120|P1|NOT COMPLETED|Overall Study||4
2582509|NCT00367744|6335119|P2|COMPLETED|Overall Study||32
2582510|NCT00367744|6335120|P1|COMPLETED|Overall Study||30
2582511|NCT00367744|6335119|P2|STARTED|Overall Study||37
2582512|NCT00367744|6335120|P1|STARTED|Overall Study||34
2582513|NCT00367679|6335128|P1|NOT COMPLETED|Overall Study||0
2582514|NCT00367679|6335128|P1|COMPLETED|Overall Study||35
2582515|NCT00367679|6335128|P1|STARTED|Overall Study||35
2582516|NCT00367640|6335149|P4|NOT COMPLETED|Overall Study||10
2582517|NCT00367640|6335150|P3|NOT COMPLETED|Overall Study||19
2582518|NCT00367640|6335151|P2|NOT COMPLETED|Overall Study||22
2582519|NCT00367640|6335152|P1|NOT COMPLETED|Overall Study||18
2582520|NCT00367640|6335149|P4|COMPLETED|Overall Study||146
2582521|NCT00367640|6335150|P3|COMPLETED|Overall Study||141
2582522|NCT00367640|6335151|P2|COMPLETED|Overall Study||133
2582523|NCT00367640|6335152|P1|COMPLETED|Overall Study||139
2582524|NCT00367640|6335149|P4|STARTED|Overall Study||156
2582525|NCT00367640|6335150|P3|STARTED|Overall Study||160
2582526|NCT00367640|6335151|P2|STARTED|Overall Study||155
2582527|NCT00367640|6335152|P1|STARTED|Overall Study||157
2582528|NCT00367601|6335162|P1|NOT COMPLETED|Overall Study||0
2582529|NCT00367601|6335162|P1|COMPLETED|Overall Study||25
2582530|NCT00367601|6335162|P1|STARTED|Overall Study||25
2582531|NCT00367484|6335168|P1|NOT COMPLETED|Overall Study||17
2582532|NCT00367484|6335168|P1|COMPLETED|Overall Study|Safety population = 460 Intent To Treat (ITT) population = 458|443
2582533|NCT00367484|6335168|P1|STARTED|Overall Study||460
2582534|NCT00367432|6335172|P2|NOT COMPLETED|Second Period (up to 54 Months)||16
2582535|NCT00367432|6335173|P1|NOT COMPLETED|Second Period (up to 54 Months)||87
2582536|NCT00367432|6335172|P2|COMPLETED|Second Period (up to 54 Months)||69
2582537|NCT00367432|6335173|P1|COMPLETED|Second Period (up to 54 Months)||188
2582538|NCT00367432|6335172|P2|STARTED|Second Period (up to 54 Months)|85 subjects from N01020 [NCT00160615] entered Second Period of N01222|85
2582539|NCT00367432|6335173|P1|STARTED|Second Period (up to 54 Months)|275 subjects from N01221 [NCT00280696] completed First Period and entered Second Period of N01222|275
2582540|NCT00367432|6335172|P2|NOT COMPLETED|First Period (16 Weeks)||0
2582541|NCT00367432|6335173|P1|NOT COMPLETED|First Period (16 Weeks)||38
2582542|NCT00367432|6335172|P2|COMPLETED|First Period (16 Weeks)||0
2582543|NCT00367432|6335173|P1|COMPLETED|First Period (16 Weeks)||275
2582544|NCT00367432|6335172|P2|STARTED|First Period (16 Weeks)||0
2582633|NCT00366678|6335355|P1|NOT COMPLETED|Infant Series||14
2582545|NCT00367432|6335173|P1|STARTED|First Period (16 Weeks)|Eligible subjects from preceding study N01221 [NCT00280696] entered the First Period of N01222|313
2582546|NCT00367380|6335188|P3|NOT COMPLETED|Overall Study||0
2582547|NCT00367380|6335189|P2|NOT COMPLETED|Overall Study||0
2582548|NCT00367380|6335190|P1|NOT COMPLETED|Overall Study||0
2582549|NCT00367380|6335188|P3|COMPLETED|Overall Study||6
2582550|NCT00367380|6335189|P2|COMPLETED|Overall Study||6
2582551|NCT00367380|6335190|P1|COMPLETED|Overall Study||6
2582552|NCT00367380|6335188|P3|STARTED|Overall Study||6
2582553|NCT00367380|6335189|P2|STARTED|Overall Study||6
2582554|NCT00367380|6335190|P1|STARTED|Overall Study||6
2582555|NCT00367341|6335200|P2|NOT COMPLETED|Overall Study||0
2582556|NCT00367341|6335201|P1|NOT COMPLETED|Overall Study||2
2582557|NCT00367341|6335200|P2|COMPLETED|Overall Study||40
2582558|NCT00367341|6335201|P1|COMPLETED|Overall Study||40
2582559|NCT00367341|6335200|P2|STARTED|Overall Study||40
2582560|NCT00367341|6335201|P1|STARTED|Overall Study||42
2582561|NCT00367237|6335211|P2|NOT COMPLETED|Overall Study||11
2582562|NCT00367237|6335212|P1|NOT COMPLETED|Overall Study||10
2582563|NCT00367237|6335211|P2|COMPLETED|Overall Study||47
2582564|NCT00367237|6335212|P1|COMPLETED|Overall Study||47
2582565|NCT00367237|6335211|P2|STARTED|Overall Study|Number of subjects randomized|58
2582566|NCT00367237|6335212|P1|STARTED|Overall Study|Number of subjects randomized|57
2582567|NCT00367133|6335221|P3|NOT COMPLETED|3 Years||18
2582568|NCT00367133|6335222|P2|NOT COMPLETED|3 Years||23
2582569|NCT00367133|6335223|P1|NOT COMPLETED|3 Years||28
2582570|NCT00367133|6335221|P3|COMPLETED|3 Years||98
2582571|NCT00367133|6335222|P2|COMPLETED|3 Years||93
2582572|NCT00367133|6335223|P1|COMPLETED|3 Years||115
2582573|NCT00367133|6335221|P3|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
2582574|NCT00367133|6335222|P2|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
2582575|NCT00367133|6335223|P1|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|143
2582576|NCT00367133|6335221|P3|NOT COMPLETED|2 Years||49
2582577|NCT00367133|6335222|P2|NOT COMPLETED|2 Years||36
2582578|NCT00367133|6335223|P1|NOT COMPLETED|2 Years||58
2582579|NCT00367133|6335221|P3|COMPLETED|2 Years||205
2582580|NCT00367133|6335222|P2|COMPLETED|2 Years||220
2582581|NCT00367133|6335223|P1|COMPLETED|2 Years||272
2582582|NCT00367133|6335221|P3|STARTED|2 Years|Number of Eyes|254
2582583|NCT00367133|6335222|P2|STARTED|2 Years|Number of Eyes|256
2582584|NCT00367133|6335223|P1|STARTED|2 Years|Number of Eyes|330
2582585|NCT00367055|6335275|P2|NOT COMPLETED|Overall Study||11
2582586|NCT00367055|6335276|P1|NOT COMPLETED|Overall Study||11
2582587|NCT00367055|6335275|P2|COMPLETED|Overall Study||30
2582588|NCT00367055|6335276|P1|COMPLETED|Overall Study||32
2582589|NCT00367055|6335275|P2|STARTED|Overall Study||41
2582590|NCT00367055|6335276|P1|STARTED|Overall Study||43
2582591|NCT00366899|6335292|P2|NOT COMPLETED|Toddler Dose||1
2582592|NCT00366899|6335293|P1|NOT COMPLETED|Toddler Dose||2
2582593|NCT00366899|6335292|P2|COMPLETED|Toddler Dose||281
2582594|NCT00366899|6335293|P1|COMPLETED|Toddler Dose||285
2582595|NCT00366899|6335292|P2|STARTED|Toddler Dose||282
2582596|NCT00366899|6335293|P1|STARTED|Toddler Dose||287
2582597|NCT00366899|6335292|P2|NOT COMPLETED|After Infant Series||9
2582598|NCT00366899|6335293|P1|NOT COMPLETED|After Infant Series||7
2582599|NCT00366899|6335292|P2|COMPLETED|After Infant Series||282
2582600|NCT00366899|6335293|P1|COMPLETED|After Infant Series||287
2582601|NCT00366899|6335292|P2|STARTED|After Infant Series||291
2582602|NCT00366899|6335293|P1|STARTED|After Infant Series||294
2582603|NCT00366899|6335292|P2|NOT COMPLETED|Infant Series||12
2582604|NCT00366899|6335293|P1|NOT COMPLETED|Infant Series||9
2582605|NCT00366899|6335292|P2|COMPLETED|Infant Series||291
2582606|NCT00366899|6335293|P1|COMPLETED|Infant Series||294
2582607|NCT00366899|6335292|P2|Vaccinated Dose 2|Infant Series||293
2582608|NCT00366899|6335293|P1|Vaccinated Dose 2|Infant Series|1 participant randomized to 13vPnC, incorrectly received 7vPnC|296
2582609|NCT00366899|6335292|P2|Vaccinated Dose 1|Infant Series||302
2582610|NCT00366899|6335293|P1|Vaccinated Dose 1|Infant Series|2 participants randomized to 13vPnC, incorrectly received 7vPnC|302
2582611|NCT00366899|6335292|P2|STARTED|Infant Series|1 participant randomized to 7vPnC but never vaccinated|303
2582612|NCT00366899|6335293|P1|STARTED|Infant Series|1 participant was counted twice, 1 participant randomized to 13vPnC, incorrectly received 7vPnC|303
2582613|NCT00366678|6335353|P3|NOT COMPLETED|Toddler Dose||0
2582614|NCT00366678|6335354|P2|NOT COMPLETED|Toddler Dose||1
2582615|NCT00366678|6335355|P1|NOT COMPLETED|Toddler Dose||5
2582616|NCT00366678|6335353|P3|COMPLETED|Toddler Dose||137
2582617|NCT00366678|6335354|P2|COMPLETED|Toddler Dose||151
2582618|NCT00366678|6335355|P1|COMPLETED|Toddler Dose||268
2582619|NCT00366678|6335353|P3|STARTED|Toddler Dose||137
2582620|NCT00366678|6335354|P2|STARTED|Toddler Dose||152
2582621|NCT00366678|6335355|P1|STARTED|Toddler Dose||273
2582622|NCT00366678|6335353|P3|NOT COMPLETED|After Infant||0
2582623|NCT00366678|6335354|P2|NOT COMPLETED|After Infant||10
2582624|NCT00366678|6335355|P1|NOT COMPLETED|After Infant||17
2582625|NCT00366678|6335353|P3|COMPLETED|After Infant||0
2582626|NCT00366678|6335354|P2|COMPLETED|After Infant||289
2582627|NCT00366678|6335355|P1|COMPLETED|After Infant||273
2582628|NCT00366678|6335353|P3|STARTED|After Infant||0
2582629|NCT00366678|6335354|P2|STARTED|After Infant||299
2582630|NCT00366678|6335355|P1|STARTED|After Infant||290
2582631|NCT00366678|6335353|P3|NOT COMPLETED|Infant Series||0
2582632|NCT00366678|6335354|P2|NOT COMPLETED|Infant Series||10
2582634|NCT00366678|6335353|P3|COMPLETED|Infant Series||0
2582635|NCT00366678|6335354|P2|COMPLETED|Infant Series||299
2582636|NCT00366678|6335355|P1|COMPLETED|Infant Series||290
2582637|NCT00366678|6335353|P3|Vaccinated Dose 3|Infant Series||0
2582638|NCT00366678|6335354|P2|Vaccinated Dose 3|Infant Series||302
2582639|NCT00366678|6335355|P1|Vaccinated Dose 3|Infant Series||291
2582640|NCT00366678|6335353|P3|Vaccinated Dose 2|Infant Series||0
2582641|NCT00366678|6335354|P2|Vaccinated Dose 2|Infant Series||304
2582642|NCT00366678|6335355|P1|Vaccinated Dose 2|Infant Series||295
2582643|NCT00366678|6335353|P3|Vaccinated Dose 1|Infant Series||0
2582644|NCT00366678|6335354|P2|Vaccinated Dose 1|Infant Series||309
2582645|NCT00366678|6335355|P1|Vaccinated Dose 1|Infant Series||302
2582646|NCT00366678|6335353|P3|STARTED|Infant Series||0
2582647|NCT00366678|6335354|P2|STARTED|Infant Series||309
2582648|NCT00366678|6335355|P1|STARTED|Infant Series||304
2582649|NCT00366626|6335422|P2|NOT COMPLETED|Overall Study||0
2582650|NCT00366626|6335423|P1|NOT COMPLETED|Overall Study||0
2582651|NCT00366626|6335422|P2|COMPLETED|Overall Study||45
2582652|NCT00366626|6335423|P1|COMPLETED|Overall Study||38
2582653|NCT00366626|6335422|P2|STARTED|Overall Study||45
2582654|NCT00366626|6335423|P1|STARTED|Overall Study||38
2582655|NCT00366548|6335437|P2|NOT COMPLETED|Toddler Dose||0
2582656|NCT00366548|6335438|P1|NOT COMPLETED|Toddler Dose||0
2582657|NCT00366548|6335437|P2|COMPLETED|Toddler Dose||244
2582658|NCT00366548|6335438|P1|COMPLETED|Toddler Dose||240
2582659|NCT00366548|6335437|P2|STARTED|Toddler Dose||244
2582660|NCT00366548|6335438|P1|STARTED|Toddler Dose||240
2582661|NCT00366548|6335437|P2|NOT COMPLETED|After Infant Series||1
2582662|NCT00366548|6335438|P1|NOT COMPLETED|After Infant Series||6
2582663|NCT00366548|6335437|P2|COMPLETED|After Infant Series||244
2582664|NCT00366548|6335438|P1|COMPLETED|After Infant Series||240
2582665|NCT00366548|6335437|P2|STARTED|After Infant Series||245
2582666|NCT00366548|6335438|P1|STARTED|After Infant Series||246
2582667|NCT00366548|6335437|P2|NOT COMPLETED|Infant Series||5
2582668|NCT00366548|6335438|P1|NOT COMPLETED|Infant Series||4
2582669|NCT00366548|6335437|P2|COMPLETED|Infant Series||245
2582670|NCT00366548|6335438|P1|COMPLETED|Infant Series||246
2582671|NCT00366548|6335437|P2|Vaccinated Dose 3|Infant Series||247
2582672|NCT00366548|6335438|P1|Vaccinated Dose 3|Infant Series||246
2582673|NCT00366548|6335437|P2|Vaccinated Dose 2|Infant Series||249
2582674|NCT00366548|6335438|P1|Vaccinated Dose 2|Infant Series||246
2582675|NCT00366548|6335437|P2|Vaccinated Dose 1|Infant Series||250
2582676|NCT00366548|6335438|P1|Vaccinated Dose 1|Infant Series||250
2582677|NCT00366548|6335437|P2|STARTED|Infant Series||250
2582678|NCT00366548|6335438|P1|STARTED|Infant Series||250
2582679|NCT00366535|6335474|P2|NOT COMPLETED|Second Phase: 12 Weeks||3
2582680|NCT00366535|6335475|P1|NOT COMPLETED|Second Phase: 12 Weeks||3
2582681|NCT00366535|6335474|P2|COMPLETED|Second Phase: 12 Weeks||18
2582682|NCT00366535|6335475|P1|COMPLETED|Second Phase: 12 Weeks||21
2582683|NCT00366535|6335474|P2|STARTED|Second Phase: 12 Weeks||21
2582684|NCT00366535|6335475|P1|STARTED|Second Phase: 12 Weeks||24
2582685|NCT00366535|6335474|P2|NOT COMPLETED|Washout Period (at Least a Week)||0
2582686|NCT00366535|6335475|P1|NOT COMPLETED|Washout Period (at Least a Week)||0
2582687|NCT00366535|6335474|P2|COMPLETED|Washout Period (at Least a Week)||21
2582688|NCT00366535|6335475|P1|COMPLETED|Washout Period (at Least a Week)||24
2582689|NCT00366535|6335474|P2|STARTED|Washout Period (at Least a Week)||21
2582690|NCT00366535|6335475|P1|STARTED|Washout Period (at Least a Week)||24
2582691|NCT00366535|6335474|P2|NOT COMPLETED|First Phase: 12 Weeks||8
2582692|NCT00366535|6335475|P1|NOT COMPLETED|First Phase: 12 Weeks||3
2582693|NCT00366535|6335474|P2|COMPLETED|First Phase: 12 Weeks||21
2582694|NCT00366535|6335475|P1|COMPLETED|First Phase: 12 Weeks||24
2582695|NCT00366535|6335474|P2|STARTED|First Phase: 12 Weeks||29
2582696|NCT00366535|6335475|P1|STARTED|First Phase: 12 Weeks||27
2582697|NCT00366457|6335489|P1|NOT COMPLETED|Overall Study||2
2582698|NCT00366457|6335489|P1|COMPLETED|Overall Study||30
2582699|NCT00366457|6335489|P1|STARTED|Overall Study||32
2582700|NCT00366444|6335498|P2|NOT COMPLETED|Overall Study||2
2582701|NCT00366444|6335499|P1|NOT COMPLETED|Overall Study||1
2582702|NCT00366444|6335498|P2|COMPLETED|Overall Study||97
2582703|NCT00366444|6335499|P1|COMPLETED|Overall Study||101
2582704|NCT00366444|6335498|P2|STARTED|Overall Study||99
2582705|NCT00366444|6335499|P1|STARTED|Overall Study||102
2582706|NCT00366340|6335527|P2|NOT COMPLETED|Toddler Dose||1
2582707|NCT00366340|6335528|P1|NOT COMPLETED|Toddler Dose||1
2582708|NCT00366340|6335527|P2|COMPLETED|Toddler Dose||286
2582709|NCT00366340|6335528|P1|COMPLETED|Toddler Dose||289
2582710|NCT00366340|6335527|P2|STARTED|Toddler Dose||287
2582711|NCT00366340|6335528|P1|STARTED|Toddler Dose||290
2582712|NCT00366340|6335527|P2|NOT COMPLETED|After the Infant Series||6
2582713|NCT00366340|6335528|P1|NOT COMPLETED|After the Infant Series||3
2582714|NCT00366340|6335527|P2|COMPLETED|After the Infant Series||287
2582715|NCT00366340|6335528|P1|COMPLETED|After the Infant Series||290
2582716|NCT00366340|6335527|P2|STARTED|After the Infant Series||293
2582717|NCT00366340|6335528|P1|STARTED|After the Infant Series||293
2582718|NCT00366340|6335527|P2|NOT COMPLETED|Infant Series||10
2582719|NCT00366340|6335528|P1|NOT COMPLETED|Infant Series||8
2582720|NCT00366340|6335527|P2|COMPLETED|Infant Series||293
2582721|NCT00366340|6335528|P1|COMPLETED|Infant Series||293
2582722|NCT00366340|6335527|P2|Vaccinated Dose 3|Infant Series||293
2582723|NCT00366340|6335528|P1|Vaccinated Dose 3|Infant Series||294
2582724|NCT00366340|6335527|P2|Vaccinated Dose 2|Infant Series||297
2582725|NCT00366340|6335528|P1|Vaccinated Dose 2|Infant Series||296
2582726|NCT00366340|6335527|P2|Vaccinated Dose 1|Infant Series||303
2582727|NCT00366340|6335528|P1|Vaccinated Dose 1|Infant Series||300
2582728|NCT00366340|6335527|P2|STARTED|Infant Series||303
2582729|NCT00366340|6335528|P1|STARTED|Infant Series||301
2582730|NCT00366301|6335586|P4|NOT COMPLETED|Overall Study||8
2582731|NCT00366301|6335587|P3|NOT COMPLETED|Overall Study||4
2582732|NCT00366301|6335588|P2|NOT COMPLETED|Overall Study||6
2582733|NCT00366301|6335589|P1|NOT COMPLETED|Overall Study||8
2582734|NCT00366301|6335586|P4|COMPLETED|Overall Study||116
2582735|NCT00366301|6335587|P3|COMPLETED|Overall Study||122
2582736|NCT00366301|6335588|P2|COMPLETED|Overall Study||120
2582737|NCT00366301|6335589|P1|COMPLETED|Overall Study||116
2582738|NCT00366301|6335586|P4|Either 6W or 14W CRP Obtained|Overall Study||119
2582739|NCT00366301|6335587|P3|Either 6W or 14W CRP Obtained|Overall Study||124
2582740|NCT00366301|6335588|P2|Either 6W or 14W CRP Obtained|Overall Study||124
2582741|NCT00366301|6335589|P1|Either 6W or 14W CRP Obtained|Overall Study||120
2582742|NCT00366301|6335586|P4|STARTED|Overall Study||124
2582743|NCT00366301|6335587|P3|STARTED|Overall Study||126
2582744|NCT00366301|6335588|P2|STARTED|Overall Study||126
2582745|NCT00366301|6335589|P1|STARTED|Overall Study||124
2582746|NCT00366275|6335599|P1|NOT COMPLETED|Overall Study||6
2582747|NCT00366275|6335599|P1|COMPLETED|Overall Study||58
2582748|NCT00366275|6335599|P1|STARTED|Overall Study||64
2582749|NCT00366249|6335605|P2|NOT COMPLETED|Overall Study||78
2582750|NCT00366249|6335606|P1|NOT COMPLETED|Overall Study||131
2582751|NCT00366249|6335605|P2|COMPLETED|Overall Study||430
2582752|NCT00366249|6335606|P1|COMPLETED|Overall Study||422
2582753|NCT00366249|6335605|P2|STARTED|Overall Study||508
2582754|NCT00366249|6335606|P1|STARTED|Overall Study||553
2582755|NCT00366106|6335620|P1|NOT COMPLETED|Overall Study||0
2582756|NCT00366106|6335620|P1|COMPLETED|Overall Study||32
2582757|NCT00366106|6335620|P1|STARTED|Overall Study||32
2582758|NCT00366028|6335629|P2|NOT COMPLETED|Overall Study||0
2582759|NCT00366028|6335630|P1|NOT COMPLETED|Overall Study||0
2582760|NCT00366028|6335629|P2|COMPLETED|Overall Study||735
2582761|NCT00366028|6335630|P1|COMPLETED|Overall Study||889
2582762|NCT00366028|6335629|P2|STARTED|Overall Study||735
2582763|NCT00366028|6335630|P1|STARTED|Overall Study||889
2582764|NCT00365989|6335638|P1|NOT COMPLETED|Overall Study||2
2582765|NCT00365989|6335638|P1|COMPLETED|Overall Study||48
2582766|NCT00365989|6335638|P1|STARTED|Overall Study||50
2582767|NCT00365976|6335646|P2|NOT COMPLETED|Overall Study||5
2582768|NCT00365976|6335647|P1|NOT COMPLETED|Overall Study||1
2582769|NCT00365976|6335646|P2|COMPLETED|Overall Study||20
2582770|NCT00365976|6335647|P1|COMPLETED|Overall Study||32
2582771|NCT00365976|6335646|P2|STARTED|Overall Study||25
2582772|NCT00365976|6335647|P1|STARTED|Overall Study||33
2582773|NCT00365872|6335678|P3|NOT COMPLETED|Overall Study||0
2582774|NCT00365872|6335679|P2|NOT COMPLETED|Overall Study||0
2582775|NCT00365872|6335680|P1|NOT COMPLETED|Overall Study||0
2582776|NCT00365872|6335678|P3|COMPLETED|Overall Study||6
2582777|NCT00365872|6335679|P2|COMPLETED|Overall Study||6
2582778|NCT00365872|6335680|P1|COMPLETED|Overall Study||5
2582779|NCT00365872|6335678|P3|STARTED|Overall Study||6
2582780|NCT00365872|6335679|P2|STARTED|Overall Study||6
2582781|NCT00365872|6335680|P1|STARTED|Overall Study||5
2582782|NCT00365859|6335693|P4|NOT COMPLETED|Overall Study||131
2582783|NCT00365859|6335694|P3|NOT COMPLETED|Overall Study||67
2582784|NCT00365859|6335695|P2|NOT COMPLETED|Overall Study||33
2582785|NCT00365859|6335696|P1|NOT COMPLETED|Overall Study||31
2582786|NCT00365859|6335693|P4|COMPLETED|Overall Study||199
2582787|NCT00365859|6335694|P3|COMPLETED|Overall Study||107
2582788|NCT00365859|6335695|P2|COMPLETED|Overall Study||37
2582789|NCT00365859|6335696|P1|COMPLETED|Overall Study||55
2582790|NCT00365859|6335693|P4|Efficacy Population|Overall Study||322
2582791|NCT00365859|6335694|P3|Efficacy Population|Overall Study|3 lost to follow-up, 1 not included due to mild increased appetite, 1 to family emergency (total=5)|169
2582792|NCT00365859|6335695|P2|Efficacy Population|Overall Study|1 not included due to increased alanine aminotransferase (ALT) prior to treatment with aripiprazole|69
2582793|NCT00365859|6335696|P1|Efficacy Population|Overall Study|1 patient was lost to follow-up and 1 not included due to moderate sedation (total=2)|84
2582794|NCT00365859|6335693|P4|Safety Population|Overall Study||330
2582795|NCT00365859|6335694|P3|Safety Population|Overall Study||174
2582796|NCT00365859|6335695|P2|Safety Population|Overall Study||70
2582797|NCT00365859|6335696|P1|Safety Population|Overall Study||86
2582798|NCT00365859|6335693|P4|STARTED|Overall Study||330
2582799|NCT00365859|6335694|P3|STARTED|Overall Study||174
2582800|NCT00365859|6335695|P2|STARTED|Overall Study||70
2582801|NCT00365859|6335696|P1|STARTED|Overall Study||86
2582802|NCT00365846|6335785|P1|NOT COMPLETED|Overall Study||1
2582803|NCT00365846|6335785|P1|COMPLETED|Overall Study||28
2582804|NCT00365846|6335785|P1|STARTED|Overall Study||29
2582805|NCT00365794|6335794|P1|NOT COMPLETED|Overall Study||2
2582806|NCT00365794|6335794|P1|COMPLETED|Overall Study||20
2582807|NCT00365794|6335794|P1|STARTED|Overall Study|22 subjects were enrolled since only 20 completed all post treatment measures.|22
2582808|NCT00365768|6335809|P2|NOT COMPLETED|Overall Study||0
2582809|NCT00365768|6335810|P1|NOT COMPLETED|Overall Study||0
2582810|NCT00365768|6335809|P2|COMPLETED|Overall Study||25
2582811|NCT00365768|6335810|P1|COMPLETED|Overall Study||24
2582812|NCT00365768|6335809|P2|STARTED|Overall Study||25
2582813|NCT00365768|6335810|P1|STARTED|Overall Study||24
2582814|NCT00365716|6335823|P7|NOT COMPLETED|Extension 2||10
2582815|NCT00365716|6335824|P6|NOT COMPLETED|Extension 2||0
2582816|NCT00365716|6335825|P5|NOT COMPLETED|Extension 2||0
2582817|NCT00365716|6335826|P4|NOT COMPLETED|Extension 2||0
2582818|NCT00365716|6335827|P3|NOT COMPLETED|Extension 2||0
2582819|NCT00365716|6335828|P2|NOT COMPLETED|Extension 2||0
2582820|NCT00365716|6335829|P1|NOT COMPLETED|Extension 2||0
2582821|NCT00365716|6335823|P7|COMPLETED|Extension 2||7
2582822|NCT00365716|6335824|P6|COMPLETED|Extension 2||0
2582823|NCT00365716|6335825|P5|COMPLETED|Extension 2||0
2582824|NCT00365716|6335826|P4|COMPLETED|Extension 2||0
2582825|NCT00365716|6335827|P3|COMPLETED|Extension 2||0
2582826|NCT00365716|6335828|P2|COMPLETED|Extension 2||0
2582827|NCT00365716|6335829|P1|COMPLETED|Extension 2||0
2582828|NCT00365716|6335823|P7|STARTED|Extension 2|17 Participants continued into Extension 2 from Extension 1|17
2582829|NCT00365716|6335824|P6|STARTED|Extension 2||0
2582830|NCT00365716|6335825|P5|STARTED|Extension 2||0
2582831|NCT00365716|6335826|P4|STARTED|Extension 2||0
2582832|NCT00365716|6335827|P3|STARTED|Extension 2||0
2582833|NCT00365716|6335828|P2|STARTED|Extension 2||0
2582834|NCT00365716|6335829|P1|STARTED|Extension 2||0
2582835|NCT00365716|6335823|P7|NOT COMPLETED|Extension 1||0
2582836|NCT00365716|6335824|P6|NOT COMPLETED|Extension 1||22
2582837|NCT00365716|6335825|P5|NOT COMPLETED|Extension 1||0
2582838|NCT00365716|6335826|P4|NOT COMPLETED|Extension 1||0
2582839|NCT00365716|6335827|P3|NOT COMPLETED|Extension 1||0
2582840|NCT00365716|6335828|P2|NOT COMPLETED|Extension 1||0
2582841|NCT00365716|6335829|P1|NOT COMPLETED|Extension 1||0
2582842|NCT00365716|6335823|P7|COMPLETED|Extension 1||0
2582843|NCT00365716|6335824|P6|COMPLETED|Extension 1||219
2582844|NCT00365716|6335825|P5|COMPLETED|Extension 1||0
2582845|NCT00365716|6335826|P4|COMPLETED|Extension 1||0
2582846|NCT00365716|6335827|P3|COMPLETED|Extension 1||0
2582847|NCT00365716|6335828|P2|COMPLETED|Extension 1||0
2582848|NCT00365716|6335829|P1|COMPLETED|Extension 1||0
2582849|NCT00365716|6335823|P7|STARTED|Extension 1||0
2582850|NCT00365716|6335824|P6|STARTED|Extension 1||241
2582851|NCT00365716|6335825|P5|STARTED|Extension 1||0
2582852|NCT00365716|6335826|P4|STARTED|Extension 1||0
2582853|NCT00365716|6335827|P3|STARTED|Extension 1||0
2582854|NCT00365716|6335828|P2|STARTED|Extension 1||0
2582855|NCT00365716|6335829|P1|STARTED|Extension 1||0
2582856|NCT00365716|6335823|P7|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
2582857|NCT00365716|6335824|P6|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
2582858|NCT00365716|6335825|P5|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||82
2582859|NCT00365716|6335826|P4|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||79
2582860|NCT00365716|6335827|P3|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||20
2582861|NCT00365716|6335828|P2|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||15
2582862|NCT00365716|6335829|P1|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||132
2582863|NCT00365716|6335823|P7|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
2582864|NCT00365716|6335824|P6|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
2582865|NCT00365716|6335825|P5|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
2582866|NCT00365716|6335826|P4|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
2582867|NCT00365716|6335827|P3|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||251
2582868|NCT00365716|6335828|P2|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||245
2582869|NCT00365716|6335829|P1|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||137
2582870|NCT00365716|6335823|P7|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
2582871|NCT00365716|6335824|P6|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
2582872|NCT00365716|6335825|P5|STARTED|Long Term Follow-up (Month 7 toMonth 36)||139
2582873|NCT00365716|6335826|P4|STARTED|Long Term Follow-up (Month 7 toMonth 36)||136
2582874|NCT00365716|6335827|P3|STARTED|Long Term Follow-up (Month 7 toMonth 36)||271
2582875|NCT00365716|6335828|P2|STARTED|Long Term Follow-up (Month 7 toMonth 36)||260
2582876|NCT00365716|6335829|P1|STARTED|Long Term Follow-up (Month 7 toMonth 36)||269
2582877|NCT00365716|6335823|P7|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
2582878|NCT00365716|6335824|P6|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
2582879|NCT00365716|6335825|P5|NOT COMPLETED|Base Study (Day 1 to Month 7)||7
2582880|NCT00365716|6335826|P4|NOT COMPLETED|Base Study (Day 1 to Month 7)||10
2582881|NCT00365716|6335827|P3|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
2582882|NCT00365716|6335828|P2|NOT COMPLETED|Base Study (Day 1 to Month 7)||24
2582883|NCT00365716|6335829|P1|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
2582884|NCT00365716|6335823|P7|COMPLETED|Base Study (Day 1 to Month 7)||0
2582885|NCT00365716|6335824|P6|COMPLETED|Base Study (Day 1 to Month 7)||0
2582886|NCT00365716|6335825|P5|COMPLETED|Base Study (Day 1 to Month 7)||139
2582887|NCT00365716|6335826|P4|COMPLETED|Base Study (Day 1 to Month 7)||136
2582888|NCT00365716|6335827|P3|COMPLETED|Base Study (Day 1 to Month 7)||271
2582889|NCT00365716|6335828|P2|COMPLETED|Base Study (Day 1 to Month 7)||260
2582890|NCT00365716|6335829|P1|COMPLETED|Base Study (Day 1 to Month 7)||269
2582891|NCT00365716|6335823|P7|STARTED|Base Study (Day 1 to Month 7)||0
2582892|NCT00365716|6335824|P6|STARTED|Base Study (Day 1 to Month 7)||0
2582893|NCT00365716|6335825|P5|STARTED|Base Study (Day 1 to Month 7)||146
2582894|NCT00365716|6335826|P4|STARTED|Base Study (Day 1 to Month 7)||146
2582895|NCT00365716|6335827|P3|STARTED|Base Study (Day 1 to Month 7)||292
2582896|NCT00365716|6335828|P2|STARTED|Base Study (Day 1 to Month 7)||284
2582897|NCT00365716|6335829|P1|STARTED|Base Study (Day 1 to Month 7)||290
2582898|NCT00365599|6335844|P1|NOT COMPLETED|Overall Study||0
2582899|NCT00365599|6335844|P1|COMPLETED|Overall Study||43
2582900|NCT00365599|6335844|P1|STARTED|Overall Study||43
2582901|NCT00365547|6335850|P1|NOT COMPLETED|Overall Study||3
2582902|NCT00365547|6335850|P1|COMPLETED|Overall Study||43
2582903|NCT00365547|6335850|P1|STARTED|Overall Study||46
2582904|NCT00365508|6335860|P2|NOT COMPLETED|Overall Study||154
2582905|NCT00365508|6335861|P1|NOT COMPLETED|Overall Study||139
2582906|NCT00365508|6335860|P2|COMPLETED|Overall Study||167
2582907|NCT00365508|6335861|P1|COMPLETED|Overall Study||182
2582908|NCT00365508|6335860|P2|STARTED|Overall Study||321
2582909|NCT00365508|6335861|P1|STARTED|Overall Study||321
2582910|NCT00365456|6335869|P2|NOT COMPLETED|Trial Period III (12 Months)||5
2582911|NCT00365456|6335870|P1|NOT COMPLETED|Trial Period III (12 Months)||18
2582912|NCT00365456|6335869|P2|COMPLETED|Trial Period III (12 Months)||127
2582913|NCT00365456|6335870|P1|COMPLETED|Trial Period III (12 Months)||118
2582914|NCT00365456|6335869|P2|STARTED|Trial Period III (12 Months)||132
2582915|NCT00365456|6335870|P1|STARTED|Trial Period III (12 Months)||136
2582916|NCT00365456|6335869|P2|NOT COMPLETED|Trial Period II (12 Months)||14
2582917|NCT00365456|6335870|P1|NOT COMPLETED|Trial Period II (12 Months)||0
2582918|NCT00365456|6335869|P2|COMPLETED|Trial Period II (12 Months)||268
2582919|NCT00365456|6335870|P1|COMPLETED|Trial Period II (12 Months)||0
2582920|NCT00365456|6335869|P2|STARTED|Trial Period II (12 Months)||282
2582921|NCT00365456|6335870|P1|STARTED|Trial Period II (12 Months)||0
2582922|NCT00365456|6335869|P2|NOT COMPLETED|Trial Period I (12 Months)||0
2582923|NCT00365456|6335870|P1|NOT COMPLETED|Trial Period I (12 Months)||125
2582924|NCT00365456|6335869|P2|COMPLETED|Trial Period I (12 Months)||0
2582925|NCT00365456|6335870|P1|COMPLETED|Trial Period I (12 Months)||282
2582926|NCT00365456|6335869|P2|STARTED|Trial Period I (12 Months)||0
2582927|NCT00365456|6335870|P1|STARTED|Trial Period I (12 Months)||407
2582928|NCT00365417|6335876|P1|NOT COMPLETED|Overall Study||0
2582929|NCT00365417|6335876|P1|COMPLETED|Overall Study||45
2582930|NCT00365417|6335876|P1|STARTED|Overall Study||45
2582931|NCT00365391|6335887|P1|NOT COMPLETED|Overall Study||0
2582932|NCT00365391|6335887|P1|COMPLETED|Overall Study||27
2582933|NCT00365391|6335887|P1|STARTED|Overall Study||27
2582934|NCT00365378|6335897|P3|NOT COMPLETED|Extension||197
2582935|NCT00365378|6335898|P2|NOT COMPLETED|Extension||0
2582936|NCT00365378|6335899|P1|NOT COMPLETED|Extension||0
2582937|NCT00365378|6335897|P3|COMPLETED|Extension||203
2582938|NCT00365378|6335898|P2|COMPLETED|Extension||0
2582939|NCT00365378|6335899|P1|COMPLETED|Extension||0
2582940|NCT00365378|6335897|P3|STARTED|Extension||400
2582941|NCT00365378|6335898|P2|STARTED|Extension||0
2582942|NCT00365378|6335899|P1|STARTED|Extension||0
2582943|NCT00365378|6335897|P3|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||0
2582944|NCT00365378|6335898|P2|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||202
2582945|NCT00365378|6335899|P1|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||158
2582946|NCT00365378|6335897|P3|COMPLETED|Follow-up (Month 7 Though Month 48)||0
2582947|NCT00365378|6335898|P2|COMPLETED|Follow-up (Month 7 Though Month 48)||836
2582948|NCT00365378|6335899|P1|COMPLETED|Follow-up (Month 7 Though Month 48)||835
2582949|NCT00365378|6335897|P3|STARTED|Follow-up (Month 7 Though Month 48)||0
2582950|NCT00365378|6335898|P2|STARTED|Follow-up (Month 7 Though Month 48)||1038
2582951|NCT00365378|6335899|P1|STARTED|Follow-up (Month 7 Though Month 48)||993
2582952|NCT00365378|6335897|P3|NOT COMPLETED|Vaccination (Day 1 to Month 7)||0
2582953|NCT00365378|6335898|P2|NOT COMPLETED|Vaccination (Day 1 to Month 7)||167
2582954|NCT00365378|6335899|P1|NOT COMPLETED|Vaccination (Day 1 to Month 7)||211
2582955|NCT00365378|6335897|P3|COMPLETED|Vaccination (Day 1 to Month 7)||0
2582956|NCT00365378|6335898|P2|COMPLETED|Vaccination (Day 1 to Month 7)||1038
2582957|NCT00365378|6335899|P1|COMPLETED|Vaccination (Day 1 to Month 7)||993
2582958|NCT00365378|6335897|P3|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||0
2582959|NCT00365378|6335898|P2|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1198
2582960|NCT00365378|6335899|P1|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1193
2582961|NCT00365378|6335897|P3|STARTED|Vaccination (Day 1 to Month 7)||0
2582962|NCT00365378|6335898|P2|STARTED|Vaccination (Day 1 to Month 7)||1205
2582963|NCT00365378|6335899|P1|STARTED|Vaccination (Day 1 to Month 7)||1204
2582964|NCT00365365|6335913|P3|NOT COMPLETED|Overall Study||15
2582965|NCT00365365|6335914|P2|NOT COMPLETED|Overall Study||36
2582966|NCT00365365|6335915|P1|NOT COMPLETED|Overall Study||34
2582967|NCT00365365|6335913|P3|COMPLETED|Overall Study||44
2582968|NCT00365365|6335914|P2|COMPLETED|Overall Study||41
2582969|NCT00365365|6335915|P1|COMPLETED|Overall Study||44
2582970|NCT00365365|6335913|P3|COMPLETED TREATMENT|Overall Study||45
2582971|NCT00365365|6335914|P2|COMPLETED TREATMENT|Overall Study||36
2582972|NCT00365365|6335915|P1|COMPLETED TREATMENT|Overall Study||38
2582973|NCT00365365|6335913|P3|TREATED (SAFETY POPULATION)|Overall Study||59
2582974|NCT00365365|6335914|P2|TREATED (SAFETY POPULATION)|Overall Study||75
2582975|NCT00365365|6335915|P1|TREATED (SAFETY POPULATION)|Overall Study||78
2582976|NCT00365365|6335913|P3|STARTED|Overall Study||59
2582977|NCT00365365|6335914|P2|STARTED|Overall Study||77
2582978|NCT00365365|6335915|P1|STARTED|Overall Study||78
2582979|NCT00365352|6335932|P3|NOT COMPLETED|Overall Study||15
2582980|NCT00365352|6335933|P2|NOT COMPLETED|Overall Study||11
2582981|NCT00365352|6335934|P1|NOT COMPLETED|Overall Study||20
2582982|NCT00365352|6335932|P3|COMPLETED|Overall Study||98
2582983|NCT00365352|6335933|P2|COMPLETED|Overall Study||104
2582984|NCT00365352|6335934|P1|COMPLETED|Overall Study||77
2582985|NCT00365352|6335932|P3|Modified Intent-to-Treat Population|Overall Study||111
2582986|NCT00365352|6335933|P2|Modified Intent-to-Treat Population|Overall Study||114
2582987|NCT00365352|6335934|P1|Modified Intent-to-Treat Population|Overall Study||96
2582988|NCT00365352|6335932|P3|Safety Population|Overall Study||111
2582989|NCT00365352|6335933|P2|Safety Population|Overall Study||115
2582990|NCT00365352|6335934|P1|Safety Population|Overall Study||96
2582991|NCT00365352|6335932|P3|STARTED|Overall Study||113
2582992|NCT00365352|6335933|P2|STARTED|Overall Study||115
2582993|NCT00365352|6335934|P1|STARTED|Overall Study||97
2582994|NCT00365300|6336018|P2|NOT COMPLETED|Double-blind Phase||9
2582995|NCT00365300|6336019|P1|NOT COMPLETED|Double-blind Phase||11
2582996|NCT00365300|6336018|P2|COMPLETED|Double-blind Phase||45
2582997|NCT00365300|6336019|P1|COMPLETED|Double-blind Phase||43
2582998|NCT00365300|6336018|P2|STARTED|Double-blind Phase||54
2582999|NCT00365300|6336019|P1|STARTED|Double-blind Phase||54
2583000|NCT00365300|6336018|P2|NOT COMPLETED|Open-label Phase||0
2583001|NCT00365300|6336019|P1|NOT COMPLETED|Open-label Phase||22
2583002|NCT00365300|6336018|P2|COMPLETED|Open-label Phase||0
2583003|NCT00365300|6336019|P1|COMPLETED|Open-label Phase||107
2583004|NCT00365300|6336018|P2|STARTED|Open-label Phase||0
2583005|NCT00365300|6336019|P1|STARTED|Open-label Phase||129
2583006|NCT00365274|6336028|P1|NOT COMPLETED|Overall Study||0
2583007|NCT00365274|6336028|P1|COMPLETED|Overall Study||6
2583008|NCT00365274|6336028|P1|STARTED|Overall Study||6
2583009|NCT00365261|6336034|P2|NOT COMPLETED|Overall Study||3
2583010|NCT00365261|6336035|P1|NOT COMPLETED|Overall Study||3
2583011|NCT00365261|6336034|P2|COMPLETED|Overall Study||19
2583012|NCT00365261|6336035|P1|COMPLETED|Overall Study||20
2583013|NCT00365261|6336034|P2|STARTED|Overall Study||22
2583014|NCT00365261|6336035|P1|STARTED|Overall Study||23
2583015|NCT00365209|6336045|P1|NOT COMPLETED|Stage 2: Receiving 4g Curcumin||2
2583016|NCT00365209|6336045|P1|COMPLETED|Stage 2: Receiving 4g Curcumin||19
2583017|NCT00365209|6336045|P1|STARTED|Stage 2: Receiving 4g Curcumin||21
2583018|NCT00365209|6336045|P1|NOT COMPLETED|Stage 1: Receiving 2g Curcumin||2
2583019|NCT00365209|6336045|P1|COMPLETED|Stage 1: Receiving 2g Curcumin||21
2583020|NCT00365209|6336045|P1|STARTED|Stage 1: Receiving 2g Curcumin||23
2583021|NCT00365144|6336074|P1|NOT COMPLETED|Overall Study||0
2583022|NCT00365144|6336074|P1|COMPLETED|Overall Study||36
2583023|NCT00365144|6336074|P1|STARTED|Overall Study||36
2583024|NCT00365105|6336084|P2|NOT COMPLETED|Overall Study||8
2583025|NCT00365105|6336085|P1|NOT COMPLETED|Overall Study||5
2583026|NCT00365105|6336084|P2|COMPLETED|Overall Study||124
2583027|NCT00365105|6336085|P1|COMPLETED|Overall Study||124
2583028|NCT00365105|6336084|P2|Eligible With Adverse Event Data|Overall Study||124
2583029|NCT00365105|6336085|P1|Eligible With Adverse Event Data|Overall Study||123
2583030|NCT00365105|6336084|P2|Eligible|Overall Study||124
2583031|NCT00365105|6336085|P1|Eligible|Overall Study||124
2583032|NCT00365105|6336084|P2|STARTED|Overall Study||132
2583033|NCT00365105|6336085|P1|STARTED|Overall Study||129
2583034|NCT00365053|6336101|P1|NOT COMPLETED|Overall Study||0
2583035|NCT00365053|6336101|P1|COMPLETED|Overall Study||13
2583036|NCT00365053|6336101|P1|STARTED|Overall Study||13
2583037|NCT00364949|6336112|P2|NOT COMPLETED|Overall Study||0
2583038|NCT00364949|6336113|P1|NOT COMPLETED|Overall Study||0
2583039|NCT00364949|6336112|P2|COMPLETED|Overall Study||39
2583040|NCT00364949|6336113|P1|COMPLETED|Overall Study||31
2583041|NCT00364949|6336112|P2|STARTED|Overall Study||39
2583042|NCT00364949|6336113|P1|STARTED|Overall Study||31
2583043|NCT00364923|6336131|P1|NOT COMPLETED|Survival Follow-up, After Pralatrexate||24
2583044|NCT00364923|6336131|P1|COMPLETED|Survival Follow-up, After Pralatrexate|Pts who completed follow-up either died, were followed for 24 months, or withdrew|83
2583045|NCT00364923|6336131|P1|STARTED|Survival Follow-up, After Pralatrexate|Patients (pts) who stop treatment with pralatrexate are followed for survival|107
2583046|NCT00364923|6336131|P1|NOT COMPLETED|Treatment With Pralatrexate||4
2583047|NCT00364923|6336131|P1|COMPLETED|Treatment With Pralatrexate|Treatment duration not limited. After treatment ends, patients attend survival follow-up visits.|107
2583048|NCT00364923|6336131|P1|STARTED|Treatment With Pralatrexate|Received at least one dose of pralatrexate.|111
2583049|NCT00364858|6336140|P2|NOT COMPLETED|Overall Study||22
2583050|NCT00364858|6336141|P1|NOT COMPLETED|Overall Study||7
2583051|NCT00364858|6336140|P2|COMPLETED|Overall Study||40
2583052|NCT00364858|6336141|P1|COMPLETED|Overall Study||26
2583053|NCT00364858|6336140|P2|STARTED|Overall Study||62
2583054|NCT00364858|6336141|P1|STARTED|Overall Study||33
2583055|NCT00364845|6336156|P2|NOT COMPLETED|Overall Study||11
2583056|NCT00364845|6336157|P1|NOT COMPLETED|Overall Study||11
2583057|NCT00364845|6336156|P2|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|12
2583058|NCT00364845|6336157|P1|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|17
2583059|NCT00364845|6336156|P2|STARTED|Overall Study||23
2583060|NCT00364845|6336157|P1|STARTED|Overall Study||28
2583061|NCT00364832|6336178|P12|NOT COMPLETED|Extension Year 2||3
2583062|NCT00364832|6336179|P11|NOT COMPLETED|Extension Year 2||5
2583063|NCT00364832|6336180|P10|NOT COMPLETED|Extension Year 2||5
2583064|NCT00364832|6336181|P9|NOT COMPLETED|Extension Year 2||0
2583065|NCT00364832|6336182|P8|NOT COMPLETED|Extension Year 2||0
2583066|NCT00364832|6336183|P7|NOT COMPLETED|Extension Year 2||0
2583067|NCT00364832|6336184|P6|NOT COMPLETED|Extension Year 2||0
2583068|NCT00364832|6336185|P5|NOT COMPLETED|Extension Year 2||0
2583069|NCT00364832|6336186|P4|NOT COMPLETED|Extension Year 2||0
2583070|NCT00364832|6336187|P3|NOT COMPLETED|Extension Year 2||0
2583071|NCT00364832|6336188|P2|NOT COMPLETED|Extension Year 2||0
2583072|NCT00364832|6336189|P1|NOT COMPLETED|Extension Year 2||0
2583073|NCT00364832|6336178|P12|COMPLETED|Extension Year 2||11
2583074|NCT00364832|6336179|P11|COMPLETED|Extension Year 2||9
2583075|NCT00364832|6336180|P10|COMPLETED|Extension Year 2||9
2583076|NCT00364832|6336181|P9|COMPLETED|Extension Year 2||0
2583077|NCT00364832|6336182|P8|COMPLETED|Extension Year 2||0
2583078|NCT00364832|6336183|P7|COMPLETED|Extension Year 2||0
2583079|NCT00364832|6336184|P6|COMPLETED|Extension Year 2||0
2583080|NCT00364832|6336185|P5|COMPLETED|Extension Year 2||0
2583081|NCT00364832|6336186|P4|COMPLETED|Extension Year 2||0
2583082|NCT00364832|6336187|P3|COMPLETED|Extension Year 2||0
2583083|NCT00364832|6336188|P2|COMPLETED|Extension Year 2||0
2583084|NCT00364832|6336189|P1|COMPLETED|Extension Year 2||0
2583085|NCT00364832|6336178|P12|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
2583086|NCT00364832|6336179|P11|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
2583087|NCT00364832|6336180|P10|STARTED|Extension Year 2||14
2583088|NCT00364832|6336181|P9|STARTED|Extension Year 2||0
2583089|NCT00364832|6336182|P8|STARTED|Extension Year 2||0
2583090|NCT00364832|6336183|P7|STARTED|Extension Year 2||0
2583091|NCT00364832|6336184|P6|STARTED|Extension Year 2||0
2583092|NCT00364832|6336185|P5|STARTED|Extension Year 2||0
2583093|NCT00364832|6336186|P4|STARTED|Extension Year 2||0
2583094|NCT00364832|6336187|P3|STARTED|Extension Year 2||0
2583095|NCT00364832|6336188|P2|STARTED|Extension Year 2||0
2583096|NCT00364832|6336189|P1|STARTED|Extension Year 2||0
2583097|NCT00364832|6336178|P12|NOT COMPLETED|Extension Year 1||10
2583098|NCT00364832|6336179|P11|NOT COMPLETED|Extension Year 1||2
2583099|NCT00364832|6336180|P10|NOT COMPLETED|Extension Year 1||4
2583100|NCT00364832|6336181|P9|NOT COMPLETED|Extension Year 1||0
2583101|NCT00364832|6336182|P8|NOT COMPLETED|Extension Year 1||0
2583102|NCT00364832|6336183|P7|NOT COMPLETED|Extension Year 1||0
2583103|NCT00364832|6336184|P6|NOT COMPLETED|Extension Year 1||0
2583104|NCT00364832|6336185|P5|NOT COMPLETED|Extension Year 1||0
2583105|NCT00364832|6336186|P4|NOT COMPLETED|Extension Year 1||0
2583106|NCT00364832|6336187|P3|NOT COMPLETED|Extension Year 1||0
2583107|NCT00364832|6336188|P2|NOT COMPLETED|Extension Year 1||0
2583108|NCT00364832|6336189|P1|NOT COMPLETED|Extension Year 1||0
2583109|NCT00364832|6336178|P12|COMPLETED|Extension Year 1||17
2583110|NCT00364832|6336179|P11|COMPLETED|Extension Year 1||15
2583111|NCT00364832|6336180|P10|COMPLETED|Extension Year 1||14
2583112|NCT00364832|6336181|P9|COMPLETED|Extension Year 1||0
2583113|NCT00364832|6336182|P8|COMPLETED|Extension Year 1||0
2583114|NCT00364832|6336183|P7|COMPLETED|Extension Year 1||0
2583115|NCT00364832|6336184|P6|COMPLETED|Extension Year 1||0
2583116|NCT00364832|6336185|P5|COMPLETED|Extension Year 1||0
2583117|NCT00364832|6336186|P4|COMPLETED|Extension Year 1||0
2583118|NCT00364832|6336187|P3|COMPLETED|Extension Year 1||0
2583119|NCT00364832|6336188|P2|COMPLETED|Extension Year 1||0
2583120|NCT00364832|6336189|P1|COMPLETED|Extension Year 1||0
2583121|NCT00364832|6336178|P12|STARTED|Extension Year 1|Participants (Cohorts C, F, and I) who completed core, entered extension period (entry optional).|27
2583122|NCT00364832|6336179|P11|STARTED|Extension Year 1|Participants (Cohorts B, E, and H) who completed core, entered extension period (entry optional).|17
2583123|NCT00364832|6336180|P10|STARTED|Extension Year 1|Participants (Cohorts A, D, and G) who completed core, entered extension period (entry optional).|18
2583124|NCT00364832|6336181|P9|STARTED|Extension Year 1||0
2583125|NCT00364832|6336182|P8|STARTED|Extension Year 1||0
2583126|NCT00364832|6336183|P7|STARTED|Extension Year 1||0
2583127|NCT00364832|6336184|P6|STARTED|Extension Year 1||0
2583128|NCT00364832|6336185|P5|STARTED|Extension Year 1||0
2583129|NCT00364832|6336186|P4|STARTED|Extension Year 1||0
2583130|NCT00364832|6336187|P3|STARTED|Extension Year 1||0
2583131|NCT00364832|6336188|P2|STARTED|Extension Year 1||0
2583132|NCT00364832|6336189|P1|STARTED|Extension Year 1||0
2583133|NCT00364832|6336178|P12|NOT COMPLETED|Core Period||0
2583134|NCT00364832|6336179|P11|NOT COMPLETED|Core Period||0
2583135|NCT00364832|6336180|P10|NOT COMPLETED|Core Period||0
2583136|NCT00364832|6336181|P9|NOT COMPLETED|Core Period||0
2583137|NCT00364832|6336182|P8|NOT COMPLETED|Core Period||1
2583138|NCT00364832|6336183|P7|NOT COMPLETED|Core Period||4
2583139|NCT00364832|6336184|P6|NOT COMPLETED|Core Period||0
2583140|NCT00364832|6336185|P5|NOT COMPLETED|Core Period||0
2583141|NCT00364832|6336186|P4|NOT COMPLETED|Core Period||1
2583142|NCT00364832|6336187|P3|NOT COMPLETED|Core Period||1
2583143|NCT00364832|6336188|P2|NOT COMPLETED|Core Period||2
2583144|NCT00364832|6336189|P1|NOT COMPLETED|Core Period||2
2583145|NCT00364832|6336178|P12|COMPLETED|Core Period||0
2583146|NCT00364832|6336179|P11|COMPLETED|Core Period||0
2583147|NCT00364832|6336180|P10|COMPLETED|Core Period||0
2583148|NCT00364832|6336181|P9|COMPLETED|Core Period||16
2583149|NCT00364832|6336182|P8|COMPLETED|Core Period||14
2583150|NCT00364832|6336183|P7|COMPLETED|Core Period||12
2583151|NCT00364832|6336184|P6|COMPLETED|Core Period||12
2583152|NCT00364832|6336185|P5|COMPLETED|Core Period||16
2583153|NCT00364832|6336186|P4|COMPLETED|Core Period||15
2583154|NCT00364832|6336187|P3|COMPLETED|Core Period||14
2583155|NCT00364832|6336188|P2|COMPLETED|Core Period||13
2583156|NCT00364832|6336189|P1|COMPLETED|Core Period||14
2583157|NCT00364832|6336178|P12|STARTED|Core Period||0
2583158|NCT00364832|6336179|P11|STARTED|Core Period||0
2583159|NCT00364832|6336180|P10|STARTED|Core Period||0
2583160|NCT00364832|6336181|P9|STARTED|Core Period||16
2583161|NCT00364832|6336182|P8|STARTED|Core Period||15
2583162|NCT00364832|6336183|P7|STARTED|Core Period||16
2583163|NCT00364832|6336184|P6|STARTED|Core Period||12
2583164|NCT00364832|6336185|P5|STARTED|Core Period||16
2583165|NCT00364832|6336186|P4|STARTED|Core Period||16
2583166|NCT00364832|6336187|P3|STARTED|Core Period||15
2583167|NCT00364832|6336188|P2|STARTED|Core Period||15
2583168|NCT00364832|6336189|P1|STARTED|Core Period||16
2583169|NCT00364819|6336242|P1|NOT COMPLETED|Overall Study||0
2583170|NCT00364819|6336242|P1|COMPLETED|Overall Study||6
2583171|NCT00364819|6336242|P1|STARTED|Overall Study||6
2583172|NCT00364793|6336254|P4|NOT COMPLETED|Overall Study||3
2583173|NCT00364793|6336255|P3|NOT COMPLETED|Overall Study||4
2583174|NCT00364793|6336256|P2|NOT COMPLETED|Overall Study||5
2583175|NCT00364793|6336257|P1|NOT COMPLETED|Overall Study||8
2583176|NCT00364793|6336254|P4|COMPLETED|Overall Study||5
2583177|NCT00364793|6336255|P3|COMPLETED|Overall Study||0
2583178|NCT00364793|6336256|P2|COMPLETED|Overall Study||5
2583179|NCT00364793|6336257|P1|COMPLETED|Overall Study||7
2583180|NCT00364793|6336254|P4|STARTED|Overall Study||8
2583181|NCT00364793|6336255|P3|STARTED|Overall Study||4
2583182|NCT00364793|6336256|P2|STARTED|Overall Study||10
2583183|NCT00364793|6336257|P1|STARTED|Overall Study||15
2583184|NCT00364689|6336394|P1|NOT COMPLETED|Overall Study||1
2583185|NCT00364689|6336394|P1|COMPLETED|Overall Study||12
2583186|NCT00364689|6336394|P1|STARTED|Overall Study||13
2583187|NCT00364611|6336414|P2|NOT COMPLETED|Overall Study||21
2583188|NCT00364611|6336415|P1|NOT COMPLETED|Overall Study||51
2583189|NCT00364611|6336414|P2|COMPLETED|Overall Study||0
2583190|NCT00364611|6336415|P1|COMPLETED|Overall Study|Ongoing treatment (June 2011-initial analysis). Continued treatment till March 2012 (study closed).|1
2583191|NCT00364611|6336414|P2|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|20
2583192|NCT00364611|6336415|P1|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|52
2583193|NCT00364611|6336414|P2|STARTED|Overall Study||21
2583194|NCT00364611|6336415|P1|STARTED|Overall Study||52
2583195|NCT00364533|6336438|P5|NOT COMPLETED|Overall Study||51
2583196|NCT00364533|6336439|P4|NOT COMPLETED|Overall Study||31
2583197|NCT00364533|6336440|P3|NOT COMPLETED|Overall Study||45
2583198|NCT00364533|6336441|P2|NOT COMPLETED|Overall Study||40
2583199|NCT00364533|6336442|P1|NOT COMPLETED|Overall Study||42
2583200|NCT00364533|6336438|P5|COMPLETED|Overall Study||24
2583201|NCT00364533|6336439|P4|COMPLETED|Overall Study||36
2583202|NCT00364533|6336440|P3|COMPLETED|Overall Study||30
2583203|NCT00364533|6336441|P2|COMPLETED|Overall Study||31
2583204|NCT00364533|6336442|P1|COMPLETED|Overall Study||35
2583205|NCT00364533|6336438|P5|STARTED|Overall Study||75
2583206|NCT00364533|6336439|P4|STARTED|Overall Study||67
2583207|NCT00364533|6336440|P3|STARTED|Overall Study||75
2583208|NCT00364533|6336441|P2|STARTED|Overall Study||71
2583209|NCT00364533|6336442|P1|STARTED|Overall Study||77
2583210|NCT00364377|6336466|P2|NOT COMPLETED|Overall Study||0
2583211|NCT00364377|6336467|P1|NOT COMPLETED|Overall Study||0
2583212|NCT00364377|6336466|P2|COMPLETED|Overall Study||11
2583213|NCT00364377|6336467|P1|COMPLETED|Overall Study||11
2583214|NCT00364377|6336466|P2|STARTED|Overall Study||11
2583215|NCT00364377|6336467|P1|STARTED|Overall Study||11
2583216|NCT00364351|6336475|P2|NOT COMPLETED|Overall Study||583
2583217|NCT00364351|6336476|P1|NOT COMPLETED|Overall Study||592
2583218|NCT00364351|6336475|P2|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|34
2583219|NCT00364351|6336476|P1|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|31
2583220|NCT00364351|6336475|P2|STARTED|Overall Study|randomised patients|617
2583221|NCT00364351|6336476|P1|STARTED|Overall Study|randomised patients|623
2583222|NCT00364286|6336494|P1|NOT COMPLETED|Overall Study||3
2583223|NCT00364286|6336494|P1|COMPLETED|Overall Study||14
2583224|NCT00364286|6336494|P1|STARTED|Overall Study||17
2583225|NCT00364182|6336501|P3|NOT COMPLETED|Fourth Intervention||0
2583226|NCT00364182|6336502|P2|NOT COMPLETED|Fourth Intervention||0
2583227|NCT00364182|6336503|P1|NOT COMPLETED|Fourth Intervention||0
2583228|NCT00364182|6336501|P3|COMPLETED|Fourth Intervention||22
2583229|NCT00364182|6336502|P2|COMPLETED|Fourth Intervention||19
2583230|NCT00364182|6336503|P1|COMPLETED|Fourth Intervention||0
2583231|NCT00364182|6336501|P3|STARTED|Fourth Intervention||22
2583232|NCT00364182|6336502|P2|STARTED|Fourth Intervention||19
2583233|NCT00364182|6336503|P1|STARTED|Fourth Intervention||0
2583234|NCT00364182|6336501|P3|NOT COMPLETED|Third Intervention||1
2583235|NCT00364182|6336502|P2|NOT COMPLETED|Third Intervention||1
2583236|NCT00364182|6336503|P1|NOT COMPLETED|Third Intervention||0
2583237|NCT00364182|6336501|P3|COMPLETED|Third Intervention||22
2583238|NCT00364182|6336502|P2|COMPLETED|Third Intervention||19
2583239|NCT00364182|6336503|P1|COMPLETED|Third Intervention||0
2583240|NCT00364182|6336501|P3|STARTED|Third Intervention||23
2583241|NCT00364182|6336502|P2|STARTED|Third Intervention||20
2583242|NCT00364182|6336503|P1|STARTED|Third Intervention||0
2583243|NCT00364182|6336501|P3|NOT COMPLETED|Second Intervention||2
2583244|NCT00364182|6336502|P2|NOT COMPLETED|Second Intervention||2
2583245|NCT00364182|6336503|P1|NOT COMPLETED|Second Intervention||0
2583246|NCT00364182|6336501|P3|COMPLETED|Second Intervention||23
2583247|NCT00364182|6336502|P2|COMPLETED|Second Intervention||20
2583248|NCT00364182|6336503|P1|COMPLETED|Second Intervention||0
2583249|NCT00364182|6336501|P3|Randomized|Second Intervention||25
2583250|NCT00364182|6336502|P2|Randomized|Second Intervention||22
2583251|NCT00364182|6336503|P1|Randomized|Second Intervention||0
2583252|NCT00364182|6336501|P3|STARTED|Second Intervention||25
2583253|NCT00364182|6336502|P2|STARTED|Second Intervention||22
2583254|NCT00364182|6336503|P1|STARTED|Second Intervention||0
2583255|NCT00364182|6336501|P3|NOT COMPLETED|First Intervention||0
2583256|NCT00364182|6336502|P2|NOT COMPLETED|First Intervention||0
2583257|NCT00364182|6336503|P1|NOT COMPLETED|First Intervention||3
2583258|NCT00364182|6336501|P3|COMPLETED|First Intervention||25
2583259|NCT00364182|6336502|P2|COMPLETED|First Intervention||22
2583260|NCT00364182|6336503|P1|COMPLETED|First Intervention||0
2583261|NCT00364182|6336501|P3|STARTED|First Intervention||25
2583262|NCT00364182|6336502|P2|STARTED|First Intervention||22
2583263|NCT00364182|6336503|P1|STARTED|First Intervention||3
2583264|NCT00364156|6336537|P2|NOT COMPLETED|Overall Study||81
2583265|NCT00364156|6336538|P1|NOT COMPLETED|Overall Study||79
2583266|NCT00364156|6336537|P2|COMPLETED|Overall Study||205
2583267|NCT00364156|6336538|P1|COMPLETED|Overall Study||203
2583268|NCT00364156|6336537|P2|STARTED|Overall Study||286
2583269|NCT00364156|6336538|P1|STARTED|Overall Study||282
2583270|NCT00364130|6336546|P2|NOT COMPLETED|Post Intervention Follow-up Period||11
2583271|NCT00364130|6336547|P1|NOT COMPLETED|Post Intervention Follow-up Period||5
2583272|NCT00364130|6336546|P2|COMPLETED|Post Intervention Follow-up Period||50
2583273|NCT00364130|6336547|P1|COMPLETED|Post Intervention Follow-up Period||55
2583274|NCT00364130|6336546|P2|STARTED|Post Intervention Follow-up Period||61
2583275|NCT00364130|6336547|P1|STARTED|Post Intervention Follow-up Period||60
2583276|NCT00364130|6336546|P2|NOT COMPLETED|Intervention Period||8
2583277|NCT00364130|6336547|P1|NOT COMPLETED|Intervention Period||9
2583278|NCT00364130|6336546|P2|COMPLETED|Intervention Period||61
2583279|NCT00364130|6336547|P1|COMPLETED|Intervention Period||60
2583280|NCT00364130|6336546|P2|STARTED|Intervention Period||69
2583281|NCT00364130|6336547|P1|STARTED|Intervention Period||69
2583282|NCT00364013|6336569|P2|NOT COMPLETED|Overall Study||95
2583283|NCT00364013|6336570|P1|NOT COMPLETED|Overall Study||101
2583284|NCT00364013|6336569|P2|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|495
2583285|NCT00364013|6336570|P1|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|492
2583286|NCT00364013|6336569|P2|Received Study Drug|Overall Study||583
2583287|NCT00364013|6336570|P1|Received Study Drug|Overall Study|One participant randomized to this group did not receive any panitumumab|586
2583288|NCT00364013|6336569|P2|STARTED|Overall Study||590
2583289|NCT00364013|6336570|P1|STARTED|Overall Study||593
2583290|NCT00363896|6336598|P2|NOT COMPLETED|Overall Study||47
2583291|NCT00363896|6336599|P1|NOT COMPLETED|Overall Study||89
2583292|NCT00363896|6336598|P2|COMPLETED|Overall Study||169
2583293|NCT00363896|6336599|P1|COMPLETED|Overall Study||538
2583294|NCT00363896|6336598|P2|STARTED|Overall Study||216
2583295|NCT00363896|6336599|P1|STARTED|Overall Study||627
2583296|NCT00363883|6336611|P1|NOT COMPLETED|Overall Study||0
2583297|NCT00363883|6336611|P1|COMPLETED|Overall Study||14
2583298|NCT00363883|6336611|P1|STARTED|Overall Study||14
2583299|NCT00363805|6336620|P3|NOT COMPLETED|Overall Study||3
2583300|NCT00363805|6336621|P2|NOT COMPLETED|Overall Study||6
2583301|NCT00363805|6336622|P1|NOT COMPLETED|Overall Study||4
2583302|NCT00363805|6336620|P3|COMPLETED|Overall Study||70
2583303|NCT00363805|6336621|P2|COMPLETED|Overall Study||57
2583304|NCT00363805|6336622|P1|COMPLETED|Overall Study||38
2583305|NCT00363805|6336620|P3|STARTED|Overall Study||73
2583306|NCT00363805|6336621|P2|STARTED|Overall Study||63
2583307|NCT00363805|6336622|P1|STARTED|Overall Study||42
2583308|NCT00363779|6336633|P1|NOT COMPLETED|Overall Study||0
2583309|NCT00363779|6336633|P1|COMPLETED|Overall Study||5
2583310|NCT00363779|6336633|P1|STARTED|Overall Study||5
2583311|NCT00363766|6336640|P2|NOT COMPLETED|Overall Study||20
2583312|NCT00363766|6336641|P1|NOT COMPLETED|Overall Study||32
2583313|NCT00363766|6336640|P2|COMPLETED|Overall Study||0
2583314|NCT00363766|6336641|P1|COMPLETED|Overall Study||0
2583315|NCT00363766|6336640|P2|STARTED|Overall Study||20
2583316|NCT00363766|6336641|P1|STARTED|Overall Study||32
2583317|NCT00363675|6336661|P1|NOT COMPLETED|Overall Study||0
2583318|NCT00363675|6336661|P1|COMPLETED|Overall Study||3
2583319|NCT00363675|6336661|P1|Completed Testing|Overall Study||3
2583320|NCT00363675|6336661|P1|STARTED|Overall Study||3
2583321|NCT00363649|6336670|P2|NOT COMPLETED|Overall Study||1
2583322|NCT00363649|6336671|P1|NOT COMPLETED|Overall Study||7
2583323|NCT00363649|6336670|P2|COMPLETED|Overall Study||15
2583324|NCT00363649|6336671|P1|COMPLETED|Overall Study||11
2583325|NCT00363649|6336670|P2|Did Not Cross Over|Overall Study||3
2583326|NCT00363649|6336671|P1|Did Not Cross Over|Overall Study||2
2583327|NCT00363649|6336670|P2|Crossed Over to Arm A|Overall Study||12
2583328|NCT00363649|6336671|P1|Crossed Over to Arm A|Overall Study||0
2583329|NCT00363649|6336670|P2|Crossed Over to Arm B|Overall Study||0
2583330|NCT00363649|6336671|P1|Crossed Over to Arm B|Overall Study||9
2583331|NCT00363649|6336670|P2|STARTED|Overall Study||16
2583332|NCT00363649|6336671|P1|STARTED|Overall Study||18
2583333|NCT00363545|6336687|P2|NOT COMPLETED|Overall Study||57
2583334|NCT00363545|6336688|P1|NOT COMPLETED|Overall Study||44
2583335|NCT00363545|6336687|P2|COMPLETED|Overall Study||581
2583336|NCT00363545|6336688|P1|COMPLETED|Overall Study||592
2583337|NCT00363545|6336687|P2|STARTED|Overall Study||638
2583338|NCT00363545|6336688|P1|STARTED|Overall Study||636
2583339|NCT00363480|6336706|P1|NOT COMPLETED|Overall Study||17
2583340|NCT00363480|6336706|P1|COMPLETED|Overall Study||204
2583341|NCT00363480|6336706|P1|STARTED|Overall Study||221
2583342|NCT00363467|6336726|P1|NOT COMPLETED|Overall Study||1
2583343|NCT00363467|6336726|P1|COMPLETED|Overall Study||2
2583344|NCT00363467|6336726|P1|STARTED|Overall Study||3
2583345|NCT00363415|6336736|P2|NOT COMPLETED|Overall Study||249
2583346|NCT00363415|6336737|P1|NOT COMPLETED|Overall Study||361
2583347|NCT00363415|6336736|P2|COMPLETED|Overall Study||206
2583348|NCT00363415|6336737|P1|COMPLETED|Overall Study||92
2583349|NCT00363415|6336736|P2|Received at Least One Dose of Study Drug|Overall Study||447
2583350|NCT00363415|6336737|P1|Received at Least One Dose of Study Drug|Overall Study||433
2583351|NCT00363415|6336736|P2|STARTED|Overall Study||455
2583352|NCT00363415|6336737|P1|STARTED|Overall Study||453
2583353|NCT00363311|6336755|P2|NOT COMPLETED|Overall Study||45
2583354|NCT00363311|6336756|P1|NOT COMPLETED|Overall Study||76
2583355|NCT00363311|6336755|P2|COMPLETED|Overall Study||102
2583356|NCT00363311|6336756|P1|COMPLETED|Overall Study||79
2583357|NCT00363311|6336755|P2|STARTED|Overall Study||147
2583358|NCT00363311|6336756|P1|STARTED|Overall Study||155
2583359|NCT00363298|6336822|P2|NOT COMPLETED|4-week Study Continuation Phase||0
2583360|NCT00363298|6336823|P1|NOT COMPLETED|4-week Study Continuation Phase||1
2583361|NCT00363298|6336822|P2|COMPLETED|4-week Study Continuation Phase||7
2583362|NCT00363298|6336823|P1|COMPLETED|4-week Study Continuation Phase||5
2583363|NCT00363298|6336822|P2|STARTED|4-week Study Continuation Phase||7
2583364|NCT00363298|6336823|P1|STARTED|4-week Study Continuation Phase||6
2583365|NCT00363298|6336822|P2|NOT COMPLETED|First Study Week||5
2583366|NCT00363298|6336823|P1|NOT COMPLETED|First Study Week||6
2583367|NCT00363298|6336822|P2|COMPLETED|First Study Week|At end of week 1, 7/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|7
2583368|NCT00363298|6336823|P1|COMPLETED|First Study Week|At end of week 1, 6/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|6
2583369|NCT00363298|6336822|P2|STARTED|First Study Week||12
2583370|NCT00363298|6336823|P1|STARTED|First Study Week||12
2583371|NCT00363246|6336831|P1|NOT COMPLETED|Overall Study||97
2583372|NCT00363246|6336831|P1|COMPLETED|Overall Study||669
2583373|NCT00363246|6336831|P1|STARTED|Overall Study||766
2583374|NCT00363168|6336838|P2|NOT COMPLETED|Overall Study||0
2583375|NCT00363168|6336839|P1|NOT COMPLETED|Overall Study||0
2583376|NCT00363168|6336838|P2|COMPLETED|Overall Study||2
2583377|NCT00363168|6336839|P1|COMPLETED|Overall Study||5
2583378|NCT00363168|6336838|P2|STARTED|Overall Study||2
2583379|NCT00363168|6336839|P1|STARTED|Overall Study||5
2583380|NCT00363142|6336849|P2|NOT COMPLETED|Overall Study||3
2583381|NCT00363142|6336850|P1|NOT COMPLETED|Overall Study||7
2583382|NCT00363142|6336849|P2|COMPLETED|Overall Study||66
2583383|NCT00363142|6336850|P1|COMPLETED|Overall Study||133
2583384|NCT00363142|6336849|P2|STARTED|Overall Study||69
2583385|NCT00363142|6336850|P1|STARTED|Overall Study||140
2583386|NCT00363129|6336879|P2|NOT COMPLETED|Overall Study||33
2583387|NCT00363129|6336880|P1|NOT COMPLETED|Overall Study||29
2583388|NCT00363129|6336879|P2|COMPLETED|Overall Study||60
2583389|NCT00363129|6336880|P1|COMPLETED|Overall Study||67
2583390|NCT00363129|6336879|P2|STARTED|Overall Study||93
2583391|NCT00363129|6336880|P1|STARTED|Overall Study||96
2583392|NCT00363077|6336896|P2|NOT COMPLETED|Overall Study||0
2583393|NCT00363077|6336897|P1|NOT COMPLETED|Overall Study||0
2583394|NCT00363077|6336896|P2|COMPLETED|Overall Study||75
2583395|NCT00363077|6336897|P1|COMPLETED|Overall Study||75
2583396|NCT00363077|6336896|P2|STARTED|Overall Study||75
2583397|NCT00363077|6336897|P1|STARTED|Overall Study||75
2583398|NCT00363051|6336923|P2|NOT COMPLETED|Overall Study||22
2583399|NCT00363051|6336924|P1|NOT COMPLETED|Overall Study||38
2583400|NCT00363051|6336923|P2|COMPLETED|Overall Study||23
2583401|NCT00363051|6336924|P1|COMPLETED|Overall Study|Patients with documented disease progression per RECIST criteria|77
2583402|NCT00363051|6336923|P2|STARTED|Overall Study||45
2583403|NCT00363051|6336924|P1|STARTED|Overall Study||115
2583404|NCT00363038|6336941|P1|NOT COMPLETED|Overall Study||0
2583405|NCT00363038|6336941|P1|COMPLETED|Overall Study||16
2583406|NCT00363038|6336941|P1|STARTED|Overall Study||16
2583407|NCT00362882|6336947|P2|NOT COMPLETED|Overall Study||0
2583408|NCT00362882|6336948|P1|NOT COMPLETED|Overall Study||0
2583409|NCT00362882|6336947|P2|COMPLETED|Overall Study||41
2583410|NCT00362882|6336948|P1|COMPLETED|Overall Study||40
2583411|NCT00362882|6336947|P2|STARTED|Overall Study||41
2583412|NCT00362882|6336948|P1|STARTED|Overall Study||40
2583413|NCT00362817|6336960|P1|NOT COMPLETED|Overall Study||0
2583414|NCT00362817|6336960|P1|COMPLETED|Overall Study||17
2583415|NCT00362817|6336960|P1|STARTED|Overall Study||17
2583416|NCT00362648|6336973|P4|NOT COMPLETED|Overall Study||11
2583417|NCT00362648|6336974|P3|NOT COMPLETED|Overall Study||9
2583418|NCT00362648|6336975|P2|NOT COMPLETED|Overall Study||134
2583419|NCT00362648|6336976|P1|NOT COMPLETED|Overall Study||126
2583420|NCT00362648|6336973|P4|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1007
2583421|NCT00362648|6336974|P3|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1009
2583422|NCT00362648|6336975|P2|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2601
2583423|NCT00362648|6336976|P1|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2607
2583424|NCT00362648|6336973|P4|Vaccinated at Visit 3|Overall Study||1007
2583425|NCT00362648|6336974|P3|Vaccinated at Visit 3|Overall Study||1009
2583426|NCT00362648|6336975|P2|Vaccinated at Visit 3|Overall Study||2612
2583427|NCT00362648|6336976|P1|Vaccinated at Visit 3|Overall Study||2613
2583428|NCT00362648|6336973|P4|Vaccinated at Visit 2|Overall Study||1009
2583429|NCT00362648|6336974|P3|Vaccinated at Visit 2|Overall Study||1013
2583430|NCT00362648|6336975|P2|Vaccinated at Visit 2|Overall Study||2666
2583431|NCT00362648|6336976|P1|Vaccinated at Visit 2|Overall Study||2657
2583432|NCT00362648|6336973|P4|Vaccinated at Visit 1|Overall Study||1018
2583433|NCT00362648|6336974|P3|Vaccinated at Visit 1|Overall Study||1018
2583434|NCT00362648|6336975|P2|Vaccinated at Visit 1|Overall Study||2735
2583435|NCT00362648|6336976|P1|Vaccinated at Visit 1|Overall Study||2733
2583436|NCT00362648|6336973|P4|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
2583437|NCT00362648|6336974|P3|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
2583438|NCT00362648|6336975|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2735
2583439|NCT00362648|6336976|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2733
2583440|NCT00362609|6336994|P2|NOT COMPLETED|Overall Study||2
2583441|NCT00362609|6336995|P1|NOT COMPLETED|Overall Study||0
2583442|NCT00362609|6336994|P2|COMPLETED|Overall Study||38
2583443|NCT00362609|6336995|P1|COMPLETED|Overall Study||19
2583444|NCT00362609|6336994|P2|STARTED|Overall Study||40
2583445|NCT00362609|6336995|P1|STARTED|Overall Study||19
2583446|NCT00362466|6337009|P2|NOT COMPLETED|Overall Study||0
2583447|NCT00362466|6337010|P1|NOT COMPLETED|Overall Study||0
2583448|NCT00362466|6337009|P2|COMPLETED|Overall Study||1
2583449|NCT00362466|6337010|P1|COMPLETED|Overall Study||2
2583450|NCT00362466|6337009|P2|STARTED|Overall Study||1
2583451|NCT00362466|6337010|P1|STARTED|Overall Study||2
2583452|NCT00362453|6337032|P2|NOT COMPLETED|Overall Study||0
2583453|NCT00362453|6337033|P1|NOT COMPLETED|Overall Study||0
2583454|NCT00362453|6337032|P2|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
2583455|NCT00362453|6337033|P1|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
2583456|NCT00362453|6337032|P2|STARTED|Overall Study||20
2583457|NCT00362453|6337033|P1|STARTED|Overall Study||20
2583458|NCT00362440|6337065|P2|NOT COMPLETED|Overall Study||1
2583459|NCT00362440|6337066|P1|NOT COMPLETED|Overall Study||2
2583460|NCT00362440|6337065|P2|COMPLETED|Overall Study||3
2583461|NCT00362440|6337066|P1|COMPLETED|Overall Study||3
2583462|NCT00362440|6337065|P2|STARTED|Overall Study||4
2583463|NCT00362440|6337066|P1|STARTED|Overall Study||5
2583464|NCT00362414|6337076|P1|NOT COMPLETED|Overall Study||3
2583465|NCT00362414|6337076|P1|COMPLETED|Overall Study||12
2583466|NCT00362414|6337076|P1|STARTED|Overall Study||15
2583467|NCT00362401|6337096|P3|NOT COMPLETED|Overall Study||0
2583468|NCT00362401|6337097|P2|NOT COMPLETED|Overall Study||0
2583469|NCT00362401|6337098|P1|NOT COMPLETED|Overall Study||0
2583470|NCT00362401|6337096|P3|COMPLETED|Overall Study||40
2583471|NCT00362401|6337097|P2|COMPLETED|Overall Study||29
2583472|NCT00362401|6337098|P1|COMPLETED|Overall Study||15
2583473|NCT00362401|6337096|P3|STARTED|Overall Study||40
2583474|NCT00362401|6337097|P2|STARTED|Overall Study||29
2583475|NCT00362401|6337098|P1|STARTED|Overall Study||15
2583476|NCT00362375|6337105|P2|NOT COMPLETED|Overall Study||35
2583477|NCT00362375|6337106|P1|NOT COMPLETED|Overall Study||40
2583478|NCT00362375|6337105|P2|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|117
2583479|NCT00362375|6337106|P1|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|121
2583480|NCT00362375|6337105|P2|STARTED|Overall Study|Number eligible and randomized|152
2583481|NCT00362375|6337106|P1|STARTED|Overall Study|Number eligible and randomized|161
2583482|NCT00362336|6337123|P3|NOT COMPLETED|Overall Study||3
2583483|NCT00362336|6337124|P2|NOT COMPLETED|Overall Study||7
2583484|NCT00362336|6337125|P1|NOT COMPLETED|Overall Study||10
2583485|NCT00362336|6337123|P3|COMPLETED|Overall Study||134
2583486|NCT00362336|6337124|P2|COMPLETED|Overall Study||235
2583487|NCT00362336|6337125|P1|COMPLETED|Overall Study||233
2583488|NCT00362336|6337123|P3|STARTED|Overall Study||137
2583489|NCT00362336|6337124|P2|STARTED|Overall Study||242
2583490|NCT00362336|6337125|P1|STARTED|Overall Study||243
2583491|NCT00362297|6337153|P2|NOT COMPLETED|Arm 2 (Cross-over to Other Dose)||0
2583492|NCT00362297|6337154|P1|NOT COMPLETED|Arm 2 (Cross-over to Other Dose)||0
2583493|NCT00362297|6337153|P2|COMPLETED|Arm 2 (Cross-over to Other Dose)||11
2583494|NCT00362297|6337154|P1|COMPLETED|Arm 2 (Cross-over to Other Dose)||16
2583495|NCT00362297|6337153|P2|STARTED|Arm 2 (Cross-over to Other Dose)||11
2583496|NCT00362297|6337154|P1|STARTED|Arm 2 (Cross-over to Other Dose)||16
2583497|NCT00362297|6337153|P2|NOT COMPLETED|Arm 1 (Initial Drug Assignment)||4
2583498|NCT00362297|6337154|P1|NOT COMPLETED|Arm 1 (Initial Drug Assignment)||0
2583499|NCT00362297|6337153|P2|COMPLETED|Arm 1 (Initial Drug Assignment)||11
2583500|NCT00362297|6337154|P1|COMPLETED|Arm 1 (Initial Drug Assignment)||16
2583501|NCT00362297|6337153|P2|STARTED|Arm 1 (Initial Drug Assignment)||15
2583502|NCT00362297|6337154|P1|STARTED|Arm 1 (Initial Drug Assignment)||16
2583503|NCT00362232|6337162|P2|NOT COMPLETED|Follow-up (30 (+ 5) Days)||39
2583504|NCT00362232|6337163|P1|NOT COMPLETED|Follow-up (30 (+ 5) Days)||38
2583505|NCT00362232|6337162|P2|COMPLETED|Follow-up (30 (+ 5) Days)||1416
2583506|NCT00362232|6337163|P1|COMPLETED|Follow-up (30 (+ 5) Days)||1433
2583507|NCT00362232|6337162|P2|STARTED|Follow-up (30 (+ 5) Days)||1455
2583508|NCT00362232|6337163|P1|STARTED|Follow-up (30 (+ 5) Days)||1471
2583509|NCT00362232|6337162|P2|NOT COMPLETED|Treatment (12 +/- 2 Days)||151
2583510|NCT00362232|6337163|P1|NOT COMPLETED|Treatment (12 +/- 2 Days)||159
2583511|NCT00362232|6337162|P2|COMPLETED|Treatment (12 +/- 2 Days)||1413
2583512|NCT00362232|6337163|P1|COMPLETED|Treatment (12 +/- 2 Days)||1425
2583513|NCT00362232|6337162|P2|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1508
2583514|NCT00362232|6337163|P1|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1526
2583515|NCT00362232|6337162|P2|STARTED|Treatment (12 +/- 2 Days)||1564
2583516|NCT00362232|6337163|P1|STARTED|Treatment (12 +/- 2 Days)||1584
2583517|NCT00362180|6337208|P9|NOT COMPLETED|20 Week Safety Follow-up||0
2583518|NCT00362180|6337209|P8|NOT COMPLETED|20 Week Safety Follow-up||0
2583519|NCT00362180|6337210|P7|NOT COMPLETED|20 Week Safety Follow-up||0
2583520|NCT00362180|6337211|P6|NOT COMPLETED|20 Week Safety Follow-up||0
2583521|NCT00362180|6337212|P5|NOT COMPLETED|20 Week Safety Follow-up||0
2583522|NCT00362180|6337213|P4|NOT COMPLETED|20 Week Safety Follow-up||0
2583523|NCT00362180|6337214|P3|NOT COMPLETED|20 Week Safety Follow-up||0
2583524|NCT00362180|6337215|P2|NOT COMPLETED|20 Week Safety Follow-up||0
2583525|NCT00362180|6337216|P1|NOT COMPLETED|20 Week Safety Follow-up||0
2583526|NCT00362180|6337208|P9|COMPLETED|20 Week Safety Follow-up||1
2583527|NCT00362180|6337209|P8|COMPLETED|20 Week Safety Follow-up||3
2583528|NCT00362180|6337210|P7|COMPLETED|20 Week Safety Follow-up||0
2583529|NCT00362180|6337211|P6|COMPLETED|20 Week Safety Follow-up||9
2583530|NCT00362180|6337212|P5|COMPLETED|20 Week Safety Follow-up||11
2583531|NCT00362180|6337213|P4|COMPLETED|20 Week Safety Follow-up||0
2583532|NCT00362180|6337214|P3|COMPLETED|20 Week Safety Follow-up||1
2583533|NCT00362180|6337215|P2|COMPLETED|20 Week Safety Follow-up||2
2583534|NCT00362180|6337216|P1|COMPLETED|20 Week Safety Follow-up||3
2583535|NCT00362180|6337208|P9|STARTED|20 Week Safety Follow-up||1
2583536|NCT00362180|6337209|P8|STARTED|20 Week Safety Follow-up||3
2583537|NCT00362180|6337210|P7|STARTED|20 Week Safety Follow-up|This observational cohort did not include a safety follow-up period.|0
2583538|NCT00362180|6337211|P6|STARTED|20 Week Safety Follow-up||9
2583539|NCT00362180|6337212|P5|STARTED|20 Week Safety Follow-up||11
2583540|NCT00362180|6337213|P4|STARTED|20 Week Safety Follow-up||0
2583541|NCT00362180|6337214|P3|STARTED|20 Week Safety Follow-up||1
2583542|NCT00362180|6337215|P2|STARTED|20 Week Safety Follow-up||2
2583543|NCT00362180|6337216|P1|STARTED|20 Week Safety Follow-up||3
2583544|NCT00362180|6337208|P9|NOT COMPLETED|Treated Period||0
2583545|NCT00362180|6337209|P8|NOT COMPLETED|Treated Period||1
2583546|NCT00362180|6337210|P7|NOT COMPLETED|Treated Period||0
2583547|NCT00362180|6337211|P6|NOT COMPLETED|Treated Period||1
2583548|NCT00362180|6337212|P5|NOT COMPLETED|Treated Period||0
2583549|NCT00362180|6337213|P4|NOT COMPLETED|Treated Period||0
2583550|NCT00362180|6337214|P3|NOT COMPLETED|Treated Period||0
2583551|NCT00362180|6337215|P2|NOT COMPLETED|Treated Period||0
2583552|NCT00362180|6337216|P1|NOT COMPLETED|Treated Period||1
2583553|NCT00362180|6337208|P9|COMPLETED|Treated Period||1
2583554|NCT00362180|6337209|P8|COMPLETED|Treated Period||2
2583555|NCT00362180|6337210|P7|COMPLETED|Treated Period||6
2583556|NCT00362180|6337211|P6|COMPLETED|Treated Period||9
2583557|NCT00362180|6337212|P5|COMPLETED|Treated Period||11
2583558|NCT00362180|6337213|P4|COMPLETED|Treated Period||0
2583559|NCT00362180|6337214|P3|COMPLETED|Treated Period||1
2583560|NCT00362180|6337215|P2|COMPLETED|Treated Period||2
2583561|NCT00362180|6337216|P1|COMPLETED|Treated Period||3
2583562|NCT00362180|6337208|P9|STARTED|Treated Period||1
2583563|NCT00362180|6337209|P8|STARTED|Treated Period||3
2583564|NCT00362180|6337210|P7|STARTED|Treated Period||6
2583565|NCT00362180|6337211|P6|STARTED|Treated Period||10
2583566|NCT00362180|6337212|P5|STARTED|Treated Period||11
2583567|NCT00362180|6337213|P4|STARTED|Treated Period||0
2583568|NCT00362180|6337214|P3|STARTED|Treated Period||1
2583569|NCT00362180|6337215|P2|STARTED|Treated Period||2
2583570|NCT00362180|6337216|P1|STARTED|Treated Period||4
2583571|NCT00362128|6337277|P1|NOT COMPLETED|Overall Study||0
2583572|NCT00362128|6337277|P1|COMPLETED|Overall Study|Enrollment was completed in October 2009.|2072
2583573|NCT00362128|6337277|P1|STARTED|Overall Study|Enrollment was initiated in 2007.|2072
2583574|NCT00362115|6337288|P7|NOT COMPLETED|Overall Study||12
2583575|NCT00362115|6337289|P6|NOT COMPLETED|Overall Study||7
2583576|NCT00362115|6337290|P5|NOT COMPLETED|Overall Study||7
2583577|NCT00362115|6337291|P4|NOT COMPLETED|Overall Study||4
2583578|NCT00362115|6337292|P3|NOT COMPLETED|Overall Study||7
2583579|NCT00362115|6337293|P2|NOT COMPLETED|Overall Study||6
2583580|NCT00362115|6337294|P1|NOT COMPLETED|Overall Study||2
2583581|NCT00362115|6337288|P7|COMPLETED|Overall Study||52
2583582|NCT00362115|6337289|P6|COMPLETED|Overall Study||57
2583583|NCT00362115|6337290|P5|COMPLETED|Overall Study||57
2583584|NCT00362115|6337291|P4|COMPLETED|Overall Study||59
2583585|NCT00362115|6337292|P3|COMPLETED|Overall Study||57
2583586|NCT00362115|6337293|P2|COMPLETED|Overall Study||59
2583587|NCT00362115|6337294|P1|COMPLETED|Overall Study||63
2583588|NCT00362115|6337288|P7|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
2583589|NCT00362115|6337289|P6|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
2583590|NCT00362115|6337290|P5|STARTED|Overall Study||64
2583591|NCT00362115|6337291|P4|STARTED|Overall Study|1 participant failed to receive double-blind medication.|63
2583592|NCT00362115|6337292|P3|STARTED|Overall Study||64
2583593|NCT00362115|6337293|P2|STARTED|Overall Study|1 participant failed to receive double-blind medication.|65
2583594|NCT00362115|6337294|P1|STARTED|Overall Study||65
2583595|NCT00361972|6337445|P2|NOT COMPLETED|Overall Study||0
2583596|NCT00361972|6337446|P1|NOT COMPLETED|Overall Study||0
2583597|NCT00361972|6337445|P2|COMPLETED|Overall Study||9
2583598|NCT00361972|6337446|P1|COMPLETED|Overall Study||8
2583599|NCT00361972|6337445|P2|STARTED|Overall Study||9
2583600|NCT00361972|6337446|P1|STARTED|Overall Study||8
2583601|NCT00361712|6337456|P2|NOT COMPLETED|Overall Study||0
2583602|NCT00361712|6337457|P1|NOT COMPLETED|Overall Study||0
2583603|NCT00361712|6337456|P2|COMPLETED|Overall Study||21
2583604|NCT00361712|6337457|P1|COMPLETED|Overall Study||20
2583605|NCT00361712|6337456|P2|STARTED|Overall Study||21
2583606|NCT00361712|6337457|P1|STARTED|Overall Study||20
2583607|NCT00361634|6337467|P1|NOT COMPLETED|Overall Study||2
2583608|NCT00361634|6337467|P1|COMPLETED|Overall Study||12
2583609|NCT00361634|6337467|P1|Treated|Overall Study|The safety analysis set consisted of all patients who received at least one dose of etanercept.|13
2583610|NCT00361634|6337467|P1|STARTED|Overall Study||14
2583611|NCT00361595|6337485|P1|NOT COMPLETED|Overall Study||0
2583612|NCT00361595|6337485|P1|COMPLETED|Overall Study||35
2583613|NCT00361595|6337485|P1|STARTED|Overall Study||35
2583614|NCT00361569|6337496|P4|NOT COMPLETED|Overall Study||21
2583615|NCT00361569|6337497|P3|NOT COMPLETED|Overall Study||18
2583616|NCT00361569|6337498|P2|NOT COMPLETED|Overall Study||11
2583617|NCT00361569|6337499|P1|NOT COMPLETED|Overall Study||12
2583618|NCT00361569|6337496|P4|COMPLETED|Overall Study||135
2583619|NCT00361569|6337497|P3|COMPLETED|Overall Study||137
2583620|NCT00361569|6337498|P2|COMPLETED|Overall Study||150
2583621|NCT00361569|6337499|P1|COMPLETED|Overall Study||138
2583622|NCT00361569|6337496|P4|STARTED|Overall Study||156
2583623|NCT00361569|6337497|P3|STARTED|Overall Study||155
2583624|NCT00361569|6337498|P2|STARTED|Overall Study||161
2583625|NCT00361569|6337499|P1|STARTED|Overall Study||150
2583626|NCT00361504|6337523|P2|NOT COMPLETED|Overall Study||145
2583627|NCT00361504|6337524|P1|NOT COMPLETED|Overall Study||481
2583628|NCT00361504|6337523|P2|COMPLETED|Overall Study||78
2583629|NCT00361504|6337524|P1|COMPLETED|Overall Study||413
2583630|NCT00361504|6337523|P2|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|223
2583631|NCT00361504|6337524|P1|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|894
2583632|NCT00361439|6337534|P2|NOT COMPLETED|Overall Study||0
2583633|NCT00361439|6337535|P1|NOT COMPLETED|Overall Study||0
2583634|NCT00361439|6337534|P2|COMPLETED|Overall Study||9
2583635|NCT00361439|6337535|P1|COMPLETED|Overall Study||8
2583636|NCT00361439|6337534|P2|STARTED|Overall Study||9
2583637|NCT00361439|6337535|P1|STARTED|Overall Study||8
2583638|NCT00361374|6337550|P3|NOT COMPLETED|Overall Study||12
2583639|NCT00361374|6337551|P2|NOT COMPLETED|Overall Study||15
2583640|NCT00361374|6337552|P1|NOT COMPLETED|Overall Study||15
2583641|NCT00361374|6337550|P3|COMPLETED|Overall Study||53
2583642|NCT00361374|6337551|P2|COMPLETED|Overall Study||50
2583643|NCT00361374|6337552|P1|COMPLETED|Overall Study||51
2583644|NCT00361374|6337550|P3|STARTED|Overall Study||65
2583645|NCT00361374|6337551|P2|STARTED|Overall Study||65
2583646|NCT00361374|6337552|P1|STARTED|Overall Study||66
2583647|NCT00361335|6337565|P7|NOT COMPLETED|SC Period: Week E0 to Week E24||9
2583648|NCT00361335|6337566|P6|NOT COMPLETED|SC Period: Week E0 to Week E24||1
2583649|NCT00361335|6337567|P5|NOT COMPLETED|SC Period: Week E0 to Week E24||0
2583650|NCT00361335|6337568|P4|NOT COMPLETED|SC Period: Week E0 to Week E24||4
2583651|NCT00361335|6337569|P3|NOT COMPLETED|SC Period: Week E0 to Week E24||5
2583652|NCT00361335|6337570|P2|NOT COMPLETED|SC Period: Week E0 to Week E24||3
2583653|NCT00361335|6337571|P1|NOT COMPLETED|SC Period: Week E0 to Week E24||2
2583654|NCT00361335|6337565|P7|COMPLETED|SC Period: Week E0 to Week E24||164
2583655|NCT00361335|6337566|P6|COMPLETED|SC Period: Week E0 to Week E24||23
2583656|NCT00361335|6337567|P5|COMPLETED|SC Period: Week E0 to Week E24||3
2583657|NCT00361335|6337568|P4|COMPLETED|SC Period: Week E0 to Week E24||59
2583658|NCT00361335|6337569|P3|COMPLETED|SC Period: Week E0 to Week E24||99
2583659|NCT00361335|6337570|P2|COMPLETED|SC Period: Week E0 to Week E24||56
2583660|NCT00361335|6337571|P1|COMPLETED|SC Period: Week E0 to Week E24||80
2583661|NCT00361335|6337565|P7|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|173
2583662|NCT00361335|6337566|P6|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|24
2583663|NCT00361335|6337567|P5|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|3
2583664|NCT00361335|6337568|P4|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|63
2583665|NCT00361335|6337569|P3|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|104
2583666|NCT00361335|6337570|P2|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|59
2583667|NCT00361335|6337571|P1|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|82
2583668|NCT00361335|6337565|P7|NOT COMPLETED|IV Period: Baseline to E0||0
2583669|NCT00361335|6337566|P6|NOT COMPLETED|IV Period: Baseline to E0||0
2583670|NCT00361335|6337567|P5|NOT COMPLETED|IV Period: Baseline to E0||24
2583671|NCT00361335|6337568|P4|NOT COMPLETED|IV Period: Baseline to E0||27
2583672|NCT00361335|6337569|P3|NOT COMPLETED|IV Period: Baseline to E0||21
2583673|NCT00361335|6337570|P2|NOT COMPLETED|IV Period: Baseline to E0||29
2583674|NCT00361335|6337571|P1|NOT COMPLETED|IV Period: Baseline to E0||20
2583675|NCT00361335|6337565|P7|COMPLETED|IV Period: Baseline to E0||0
2583676|NCT00361335|6337566|P6|COMPLETED|IV Period: Baseline to E0||0
2583677|NCT00361335|6337567|P5|COMPLETED|IV Period: Baseline to E0||105
2583678|NCT00361335|6337568|P4|COMPLETED|IV Period: Baseline to E0||102
2583679|NCT00361335|6337569|P3|COMPLETED|IV Period: Baseline to E0||107
2583680|NCT00361335|6337570|P2|COMPLETED|IV Period: Baseline to E0||99
2583681|NCT00361335|6337571|P1|COMPLETED|IV Period: Baseline to E0||109
2583682|NCT00361335|6337565|P7|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
2583683|NCT00361335|6337566|P6|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
2583684|NCT00361335|6337567|P5|STARTED|IV Period: Baseline to E0||129
2583685|NCT00361335|6337568|P4|STARTED|IV Period: Baseline to E0||129
2583686|NCT00361335|6337569|P3|STARTED|IV Period: Baseline to E0||128
2583687|NCT00361335|6337570|P2|STARTED|IV Period: Baseline to E0||128
2583688|NCT00361335|6337571|P1|STARTED|IV Period: Baseline to E0||129
2583689|NCT00361296|6337615|P1|NOT COMPLETED|Overall Study||3
2583690|NCT00361296|6337615|P1|COMPLETED|Overall Study||2
2583691|NCT00361296|6337615|P1|STARTED|Overall Study||5
2583692|NCT00361283|6337622|P1|NOT COMPLETED|Overall Study||27
2583693|NCT00361283|6337622|P1|COMPLETED|Overall Study||81
2583694|NCT00361283|6337622|P1|STARTED|Overall Study||108
2583695|NCT00361270|6337630|P4|NOT COMPLETED|Overall Study||13
2583696|NCT00361270|6337631|P3|NOT COMPLETED|Overall Study||10
2583697|NCT00361270|6337632|P2|NOT COMPLETED|Overall Study||14
2583698|NCT00361270|6337633|P1|NOT COMPLETED|Overall Study||24
2583699|NCT00361270|6337630|P4|COMPLETED|Overall Study||25
2583700|NCT00361270|6337631|P3|COMPLETED|Overall Study||25
2583701|NCT00361270|6337632|P2|COMPLETED|Overall Study||25
2583702|NCT00361270|6337633|P1|COMPLETED|Overall Study||25
2583703|NCT00361270|6337630|P4|STARTED|Overall Study||38
2583704|NCT00361270|6337631|P3|STARTED|Overall Study||35
2583705|NCT00361270|6337632|P2|STARTED|Overall Study||39
2583706|NCT00361270|6337633|P1|STARTED|Overall Study||49
2583707|NCT00361257|6337653|P2|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
2583708|NCT00361257|6337654|P1|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
2583709|NCT00361257|6337653|P2|COMPLETED|Step 2: Minocycline(Open Label) for All||19
2583710|NCT00361257|6337654|P1|COMPLETED|Step 2: Minocycline(Open Label) for All||13
2583711|NCT00361257|6337653|P2|STARTED|Step 2: Minocycline(Open Label) for All|43 participants completed Step 1; however, 9 decided not to enroll Step 2,so 43-9=34 started Step 2.|34
2583712|NCT00361257|6337654|P1|STARTED|Step 2: Minocycline(Open Label) for All|40 participants completed Step 1; however,12 decided not to enroll Step 2,so 40-12=28 started Step 2|28
2583713|NCT00361257|6337653|P2|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
2583714|NCT00361257|6337654|P1|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
2583715|NCT00361257|6337653|P2|COMPLETED|Step 1: Minocycline vs. Placebo||43
2583716|NCT00361257|6337654|P1|COMPLETED|Step 1: Minocycline vs. Placebo||40
2583717|NCT00361257|6337653|P2|STARTED|Step 1: Minocycline vs. Placebo||55
2583718|NCT00361257|6337654|P1|STARTED|Step 1: Minocycline vs. Placebo||52
2583719|NCT00361231|6337706|P1|NOT COMPLETED|Overall Study||34
2583720|NCT00361231|6337706|P1|COMPLETED|Overall Study||1
2583721|NCT00361231|6337706|P1|STARTED|Overall Study||35
2583722|NCT00361218|6337711|P1|NOT COMPLETED|Overall Study||23
2583723|NCT00361218|6337711|P1|COMPLETED|Overall Study||30
2583724|NCT00361218|6337711|P1|Completed Baseline Assessment|Overall Study||47
2583725|NCT00361218|6337711|P1|STARTED|Overall Study|met eligibility criteria and enrolled in the study|53
2583726|NCT00361140|6337719|P3|NOT COMPLETED|Overall Study||0
2583727|NCT00361140|6337720|P2|NOT COMPLETED|Overall Study||0
2583728|NCT00361140|6337721|P1|NOT COMPLETED|Overall Study||0
2583729|NCT00361140|6337719|P3|COMPLETED|Overall Study||3
2583730|NCT00361140|6337720|P2|COMPLETED|Overall Study||29
2583731|NCT00361140|6337721|P1|COMPLETED|Overall Study||40
2583732|NCT00361140|6337719|P3|STARTED|Overall Study||3
2583733|NCT00361140|6337720|P2|STARTED|Overall Study||29
2583734|NCT00361140|6337721|P1|STARTED|Overall Study||40
2583735|NCT00360971|6337734|P2|NOT COMPLETED|Overall Study||0
2583736|NCT00360971|6337735|P1|NOT COMPLETED|Overall Study||0
2583737|NCT00360971|6337734|P2|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|11
2583738|NCT00360971|6337735|P1|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|10
2583739|NCT00360971|6337734|P2|STARTED|Overall Study||11
2583740|NCT00360971|6337735|P1|STARTED|Overall Study||10
2583741|NCT00360828|6337751|P1|NOT COMPLETED|Overall Study||1
2583742|NCT00360828|6337751|P1|COMPLETED|Overall Study||9
2583743|NCT00360828|6337751|P1|STARTED|Overall Study||10
2583744|NCT00360724|6337761|P2|NOT COMPLETED|Overall Study||4
2583745|NCT00360724|6337762|P1|NOT COMPLETED|Overall Study||4
2583746|NCT00360724|6337761|P2|COMPLETED|Overall Study||28
2583747|NCT00360724|6337762|P1|COMPLETED|Overall Study||29
2583748|NCT00360724|6337761|P2|STARTED|Overall Study||32
2583749|NCT00360724|6337762|P1|STARTED|Overall Study||33
2583750|NCT00360698|6337790|P2|NOT COMPLETED|Treatment Period||1
2583751|NCT00360698|6337791|P1|NOT COMPLETED|Treatment Period||1
2583752|NCT00360698|6337790|P2|COMPLETED|Treatment Period||56
2583753|NCT00360698|6337791|P1|COMPLETED|Treatment Period||48
2583754|NCT00360698|6337790|P2|STARTED|Treatment Period||57
2583755|NCT00360698|6337791|P1|STARTED|Treatment Period||49
2583756|NCT00360698|6337790|P2|NOT COMPLETED|Run-In||10
2583757|NCT00360698|6337791|P1|NOT COMPLETED|Run-In||0
2583758|NCT00360698|6337790|P2|COMPLETED|Run-In|19 patients completed the run-in but were not eligible for randomization in the treatment period|125
2583759|NCT00360698|6337791|P1|COMPLETED|Run-In||0
2583760|NCT00360698|6337790|P2|STARTED|Run-In||135
2583761|NCT00360698|6337791|P1|STARTED|Run-In||0
2583762|NCT00360685|6337819|P2|NOT COMPLETED|Overall Study||0
2583763|NCT00360685|6337820|P1|NOT COMPLETED|Overall Study||0
2583764|NCT00360685|6337819|P2|COMPLETED|Overall Study||42
2583765|NCT00360685|6337820|P1|COMPLETED|Overall Study||47
2583766|NCT00360685|6337819|P2|STARTED|Overall Study||42
2583767|NCT00360685|6337820|P1|STARTED|Overall Study||47
2583768|NCT00360672|6337830|P1|NOT COMPLETED|Overall Study||0
2583769|NCT00360672|6337830|P1|COMPLETED|Overall Study||27
2583770|NCT00360672|6337830|P1|STARTED|Overall Study||27
2583771|NCT00360568|6337836|P2|NOT COMPLETED|Overall Study||5
2583772|NCT00360568|6337837|P1|NOT COMPLETED|Overall Study||2
2583773|NCT00360568|6337836|P2|COMPLETED|Overall Study||24
2583774|NCT00360568|6337837|P1|COMPLETED|Overall Study||31
2583775|NCT00360568|6337836|P2|STARTED|Overall Study||29
2583776|NCT00360568|6337837|P1|STARTED|Overall Study||33
2583777|NCT00360555|6337948|P4|NOT COMPLETED|Overall Study||112
2583778|NCT00360555|6337949|P3|NOT COMPLETED|Overall Study||145
2583779|NCT00360555|6337950|P2|NOT COMPLETED|Overall Study||134
2583780|NCT00360555|6337951|P1|NOT COMPLETED|Overall Study||122
2583781|NCT00360555|6337948|P4|COMPLETED|Overall Study||287
2583782|NCT00360555|6337949|P3|COMPLETED|Overall Study||251
2583783|NCT00360555|6337950|P2|COMPLETED|Overall Study||259
2583784|NCT00360555|6337951|P1|COMPLETED|Overall Study||274
2583785|NCT00360555|6337948|P4|STARTED|Overall Study||399
2583786|NCT00360555|6337949|P3|STARTED|Overall Study||396
2583787|NCT00360555|6337950|P2|STARTED|Overall Study||393
2583788|NCT00360555|6337951|P1|STARTED|Overall Study||396
2583789|NCT00360529|6337968|P3|NOT COMPLETED|Overall Study||91
2583790|NCT00360529|6337969|P2|NOT COMPLETED|Overall Study||65
2583791|NCT00360529|6337970|P1|NOT COMPLETED|Overall Study||61
2583792|NCT00360529|6337968|P3|COMPLETED|Overall Study||199
2583793|NCT00360529|6337969|P2|COMPLETED|Overall Study||230
2583794|NCT00360529|6337970|P1|COMPLETED|Overall Study||234
2583795|NCT00360529|6337968|P3|STARTED|Overall Study||290
2583796|NCT00360529|6337969|P2|STARTED|Overall Study||295
2583797|NCT00360529|6337970|P1|STARTED|Overall Study||295
2583798|NCT00360490|6337998|P2|NOT COMPLETED|Overall Study||11
2583799|NCT00360490|6337999|P1|NOT COMPLETED|Overall Study||9
2583800|NCT00360490|6337998|P2|COMPLETED|Overall Study||72
2583801|NCT00360490|6337999|P1|COMPLETED|Overall Study||73
2583802|NCT00360490|6337998|P2|STARTED|Overall Study||83
2583803|NCT00360490|6337999|P1|STARTED|Overall Study||82
2583804|NCT00360412|6338034|P2|NOT COMPLETED|Overall Study||662
2583805|NCT00360412|6338035|P1|NOT COMPLETED|Overall Study||333
2583806|NCT00360412|6338034|P2|COMPLETED|Overall Study||2
2583807|NCT00360412|6338035|P1|COMPLETED|Overall Study||0
2583808|NCT00360412|6338034|P2|STARTED|Overall Study||664
2583809|NCT00360412|6338035|P1|STARTED|Overall Study||333
2583810|NCT00360399|6338050|P3|NOT COMPLETED|Overall Study||46
2583811|NCT00360399|6338051|P2|NOT COMPLETED|Overall Study||36
2583812|NCT00360399|6338052|P1|NOT COMPLETED|Overall Study||28
2583813|NCT00360399|6338050|P3|COMPLETED|Overall Study||69
2583814|NCT00360399|6338051|P2|COMPLETED|Overall Study||79
2583815|NCT00360399|6338052|P1|COMPLETED|Overall Study||86
2583816|NCT00360399|6338050|P3|Had Post-randomization Assessment|Overall Study||105
2583817|NCT00360399|6338051|P2|Had Post-randomization Assessment|Overall Study||106
2583818|NCT00360399|6338052|P1|Had Post-randomization Assessment|Overall Study||105
2583819|NCT00360399|6338050|P3|STARTED|Overall Study||115
2583820|NCT00360399|6338051|P2|STARTED|Overall Study||115
2583821|NCT00360399|6338052|P1|STARTED|Overall Study||114
2583822|NCT00360360|6338075|P1|NOT COMPLETED|Overall Study||6
2583823|NCT00360360|6338075|P1|COMPLETED|Overall Study||54
2583824|NCT00360360|6338075|P1|STARTED|Overall Study||60
2583825|NCT00360334|6338082|P2|NOT COMPLETED|Overall Study||13
2583826|NCT00360334|6338083|P1|NOT COMPLETED|Overall Study||19
2583827|NCT00360334|6338082|P2|COMPLETED|Overall Study||104
2583828|NCT00360334|6338083|P1|COMPLETED|Overall Study||99
2583829|NCT00360334|6338082|P2|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|116
2583830|NCT00360334|6338083|P1|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|118
2583831|NCT00360334|6338082|P2|STARTED|Overall Study||117
2583832|NCT00360334|6338083|P1|STARTED|Overall Study||118
2583833|NCT00360308|6338146|P3|NOT COMPLETED|Overall Study||88
2583834|NCT00360308|6338147|P2|NOT COMPLETED|Overall Study||79
2583835|NCT00360308|6338148|P1|NOT COMPLETED|Overall Study||76
2583836|NCT00360308|6338146|P3|COMPLETED|Overall Study||154
2583837|NCT00360308|6338147|P2|COMPLETED|Overall Study||155
2583838|NCT00360308|6338148|P1|COMPLETED|Overall Study||171
2583839|NCT00360308|6338146|P3|STARTED|Overall Study||242
2583840|NCT00360308|6338147|P2|STARTED|Overall Study||234
2583841|NCT00360308|6338148|P1|STARTED|Overall Study||247
2583842|NCT00360282|6338165|P4|NOT COMPLETED|Second Intervention||0
2583843|NCT00360282|6338166|P3|NOT COMPLETED|Second Intervention||0
2583844|NCT00360282|6338167|P2|NOT COMPLETED|Second Intervention||1
2583845|NCT00360282|6338168|P1|NOT COMPLETED|Second Intervention||0
2583846|NCT00360282|6338165|P4|COMPLETED|Second Intervention||6
2583847|NCT00360282|6338166|P3|COMPLETED|Second Intervention||6
2583848|NCT00360282|6338167|P2|COMPLETED|Second Intervention||7
2583849|NCT00360282|6338168|P1|COMPLETED|Second Intervention||6
2583850|NCT00360282|6338165|P4|STARTED|Second Intervention||6
2583851|NCT00360282|6338166|P3|STARTED|Second Intervention||6
2583852|NCT00360282|6338167|P2|STARTED|Second Intervention||8
2583853|NCT00360282|6338168|P1|STARTED|Second Intervention||6
2583854|NCT00360282|6338165|P4|NOT COMPLETED|Washout 1-3 Weeks||0
2583855|NCT00360282|6338166|P3|NOT COMPLETED|Washout 1-3 Weeks||1
2583856|NCT00360282|6338167|P2|NOT COMPLETED|Washout 1-3 Weeks||0
2583857|NCT00360282|6338168|P1|NOT COMPLETED|Washout 1-3 Weeks||0
2583858|NCT00360282|6338165|P4|COMPLETED|Washout 1-3 Weeks||6
2583859|NCT00360282|6338166|P3|COMPLETED|Washout 1-3 Weeks||6
2583860|NCT00360282|6338167|P2|COMPLETED|Washout 1-3 Weeks||8
2583861|NCT00360282|6338168|P1|COMPLETED|Washout 1-3 Weeks||6
2583862|NCT00360282|6338165|P4|STARTED|Washout 1-3 Weeks||6
2583863|NCT00360282|6338166|P3|STARTED|Washout 1-3 Weeks||7
2583864|NCT00360282|6338167|P2|STARTED|Washout 1-3 Weeks||8
2583865|NCT00360282|6338168|P1|STARTED|Washout 1-3 Weeks||6
2583866|NCT00360282|6338165|P4|NOT COMPLETED|First Intervention||0
2583867|NCT00360282|6338166|P3|NOT COMPLETED|First Intervention||0
2583868|NCT00360282|6338167|P2|NOT COMPLETED|First Intervention||0
2583869|NCT00360282|6338168|P1|NOT COMPLETED|First Intervention||0
2583870|NCT00360282|6338165|P4|COMPLETED|First Intervention||6
2583871|NCT00360282|6338166|P3|COMPLETED|First Intervention||7
2583872|NCT00360282|6338167|P2|COMPLETED|First Intervention||8
2583873|NCT00360282|6338168|P1|COMPLETED|First Intervention||6
2583874|NCT00360282|6338165|P4|STARTED|First Intervention||6
2583875|NCT00360282|6338166|P3|STARTED|First Intervention||7
2583876|NCT00360282|6338167|P2|STARTED|First Intervention||8
2583877|NCT00360282|6338168|P1|STARTED|First Intervention||6
2583878|NCT00360269|6338180|P2|NOT COMPLETED|Overall Study||12
2583879|NCT00360269|6338181|P1|NOT COMPLETED|Overall Study||10
2583880|NCT00360269|6338180|P2|COMPLETED|Overall Study||7
2583881|NCT00360269|6338181|P1|COMPLETED|Overall Study||9
2583882|NCT00360269|6338180|P2|STARTED|Overall Study||19
2583883|NCT00360269|6338181|P1|STARTED|Overall Study||19
2583884|NCT00360243|6338199|P4|NOT COMPLETED|Overall Study||125
2583885|NCT00360243|6338200|P3|NOT COMPLETED|Overall Study||156
2583886|NCT00360243|6338201|P2|NOT COMPLETED|Overall Study||120
2583887|NCT00360243|6338202|P1|NOT COMPLETED|Overall Study||102
2583888|NCT00360243|6338199|P4|COMPLETED|Overall Study||224
2583889|NCT00360243|6338200|P3|COMPLETED|Overall Study||180
2583890|NCT00360243|6338201|P2|COMPLETED|Overall Study||243
2583891|NCT00360243|6338202|P1|COMPLETED|Overall Study||235
2583892|NCT00360243|6338199|P4|STARTED|Overall Study||349
2583893|NCT00360243|6338200|P3|STARTED|Overall Study||336
2583894|NCT00360243|6338201|P2|STARTED|Overall Study||363
2583895|NCT00360243|6338202|P1|STARTED|Overall Study||337
2583896|NCT00360230|6338223|P7|NOT COMPLETED|Overall Study||2
2583897|NCT00360230|6338224|P6|NOT COMPLETED|Overall Study||4
2583898|NCT00360230|6338225|P5|NOT COMPLETED|Overall Study||5
2583899|NCT00360230|6338226|P4|NOT COMPLETED|Overall Study||2
2583900|NCT00360230|6338227|P3|NOT COMPLETED|Overall Study||3
2583901|NCT00360230|6338228|P2|NOT COMPLETED|Overall Study||3
2583902|NCT00360230|6338229|P1|NOT COMPLETED|Overall Study||6
2583903|NCT00360230|6338223|P7|COMPLETED|Overall Study||43
2583904|NCT00360230|6338224|P6|COMPLETED|Overall Study||86
2583905|NCT00360230|6338225|P5|COMPLETED|Overall Study||85
2583906|NCT00360230|6338226|P4|COMPLETED|Overall Study||88
2583907|NCT00360230|6338227|P3|COMPLETED|Overall Study||42
2583908|NCT00360230|6338228|P2|COMPLETED|Overall Study||87
2583909|NCT00360230|6338229|P1|COMPLETED|Overall Study||84
2583910|NCT00360230|6338223|P7|STARTED|Overall Study||45
2583911|NCT00360230|6338224|P6|STARTED|Overall Study||90
2583912|NCT00360230|6338225|P5|STARTED|Overall Study||90
2583913|NCT00360230|6338226|P4|STARTED|Overall Study||90
2583914|NCT00360230|6338227|P3|STARTED|Overall Study||45
2583915|NCT00360230|6338228|P2|STARTED|Overall Study||90
2583916|NCT00360230|6338229|P1|STARTED|Overall Study||90
2583917|NCT00360126|6338280|P1|NOT COMPLETED|Overall Study||0
2583918|NCT00360126|6338280|P1|COMPLETED|Overall Study||11
2583919|NCT00360126|6338280|P1|STARTED|Overall Study||11
2583920|NCT00360009|6338287|P3|NOT COMPLETED|Overall Study||3
2583921|NCT00360009|6338288|P2|NOT COMPLETED|Overall Study||4
2583922|NCT00360009|6338289|P1|NOT COMPLETED|Overall Study||0
2583923|NCT00360009|6338287|P3|COMPLETED|Overall Study||23
2583924|NCT00360009|6338288|P2|COMPLETED|Overall Study||22
2583925|NCT00360009|6338289|P1|COMPLETED|Overall Study||10
2583926|NCT00360009|6338287|P3|STARTED|Overall Study||26
2583927|NCT00360009|6338288|P2|STARTED|Overall Study||26
2583928|NCT00360009|6338289|P1|STARTED|Overall Study||10
2583929|NCT00359983|6338330|P3|NOT COMPLETED|Year 5 Persistence Follow-up||0
2583930|NCT00359983|6338331|P2|NOT COMPLETED|Year 5 Persistence Follow-up||0
2583931|NCT00359983|6338332|P1|NOT COMPLETED|Year 5 Persistence Follow-up||0
2583932|NCT00359983|6338330|P3|COMPLETED|Year 5 Persistence Follow-up||42
2583933|NCT00359983|6338331|P2|COMPLETED|Year 5 Persistence Follow-up||44
2583934|NCT00359983|6338332|P1|COMPLETED|Year 5 Persistence Follow-up||95
2583935|NCT00359983|6338330|P3|STARTED|Year 5 Persistence Follow-up||42
2583936|NCT00359983|6338331|P2|STARTED|Year 5 Persistence Follow-up||44
2583937|NCT00359983|6338332|P1|STARTED|Year 5 Persistence Follow-up||95
2583938|NCT00359983|6338330|P3|NOT COMPLETED|Year 3 Persistence Follow-up||0
2583939|NCT00359983|6338331|P2|NOT COMPLETED|Year 3 Persistence Follow-up||0
2583940|NCT00359983|6338332|P1|NOT COMPLETED|Year 3 Persistence Follow-up||0
2583941|NCT00359983|6338330|P3|COMPLETED|Year 3 Persistence Follow-up||51
2583942|NCT00359983|6338331|P2|COMPLETED|Year 3 Persistence Follow-up||47
2583943|NCT00359983|6338332|P1|COMPLETED|Year 3 Persistence Follow-up||103
2583944|NCT00359983|6338330|P3|STARTED|Year 3 Persistence Follow-up||51
2583945|NCT00359983|6338331|P2|STARTED|Year 3 Persistence Follow-up||47
2583946|NCT00359983|6338332|P1|STARTED|Year 3 Persistence Follow-up||103
2583947|NCT00359983|6338330|P3|NOT COMPLETED|Year 1 Persistence Follow-up||0
2583948|NCT00359983|6338331|P2|NOT COMPLETED|Year 1 Persistence Follow-up||0
2583949|NCT00359983|6338332|P1|NOT COMPLETED|Year 1 Persistence Follow-up||0
2583950|NCT00359983|6338330|P3|COMPLETED|Year 1 Persistence Follow-up||62
2583951|NCT00359983|6338331|P2|COMPLETED|Year 1 Persistence Follow-up||70
2583952|NCT00359983|6338332|P1|COMPLETED|Year 1 Persistence Follow-up||138
2583953|NCT00359983|6338330|P3|STARTED|Year 1 Persistence Follow-up||62
2583954|NCT00359983|6338331|P2|STARTED|Year 1 Persistence Follow-up||70
2583955|NCT00359983|6338332|P1|STARTED|Year 1 Persistence Follow-up||138
2583956|NCT00359944|6338367|P3|NOT COMPLETED|Overall Study||19
2583957|NCT00359944|6338368|P2|NOT COMPLETED|Overall Study||19
2583958|NCT00359944|6338369|P1|NOT COMPLETED|Overall Study||16
2583959|NCT00359944|6338367|P3|COMPLETED|Overall Study||38
2583960|NCT00359944|6338368|P2|COMPLETED|Overall Study||28
2583961|NCT00359944|6338369|P1|COMPLETED|Overall Study||34
2583962|NCT00359944|6338367|P3|STARTED|Overall Study||57
2583963|NCT00359944|6338368|P2|STARTED|Overall Study||47
2583964|NCT00359944|6338369|P1|STARTED|Overall Study||50
2583965|NCT00359801|6338385|P2|NOT COMPLETED|Overall Study||220
2583966|NCT00359801|6338386|P1|NOT COMPLETED|Overall Study||305
2583967|NCT00359801|6338385|P2|COMPLETED|Overall Study|4 additional subjects had missing data and final status (completed/discontinued) is unknown.|769
2583968|NCT00359801|6338386|P1|COMPLETED|Overall Study|7 additional subjects had missing data and final status (completed/discontinued) is unknown.|682
2583969|NCT00359801|6338385|P2|STARTED|Overall Study||989
2583970|NCT00359801|6338386|P1|STARTED|Overall Study||987
2583971|NCT00359788|6338420|P2|NOT COMPLETED|Overall Study||17
2583972|NCT00359788|6338421|P1|NOT COMPLETED|Overall Study||23
2583973|NCT00359788|6338420|P2|COMPLETED|Overall Study||159
2583974|NCT00359788|6338421|P1|COMPLETED|Overall Study||150
2583975|NCT00359788|6338420|P2|STARTED|Overall Study||176
2583976|NCT00359788|6338421|P1|STARTED|Overall Study||173
2583977|NCT00359762|6338655|P5|NOT COMPLETED|Period I||0
2583978|NCT00359762|6338656|P4|NOT COMPLETED|Period I||0
2583979|NCT00359762|6338657|P3|NOT COMPLETED|Period I||0
2583980|NCT00359762|6338658|P2|NOT COMPLETED|Period I||0
2583981|NCT00359762|6338659|P1|NOT COMPLETED|Period I||0
2583982|NCT00359762|6338655|P5|COMPLETED|Period I||0
2583983|NCT00359762|6338656|P4|COMPLETED|Period I||0
2583984|NCT00359762|6338657|P3|COMPLETED|Period I||0
2583985|NCT00359762|6338658|P2|COMPLETED|Period I||0
2583986|NCT00359762|6338659|P1|COMPLETED|Period I||0
2583987|NCT00359762|6338655|P5|STARTED|Period I||0
2583988|NCT00359762|6338656|P4|STARTED|Period I||0
2583989|NCT00359762|6338657|P3|STARTED|Period I||0
2583990|NCT00359762|6338658|P2|STARTED|Period I||0
2583991|NCT00359762|6338659|P1|STARTED|Period I||0
2583992|NCT00359762|6338655|P5|NOT COMPLETED|Period III||0
2583993|NCT00359762|6338656|P4|NOT COMPLETED|Period III||65
2583994|NCT00359762|6338657|P3|NOT COMPLETED|Period III||30
2583995|NCT00359762|6338658|P2|NOT COMPLETED|Period III||29
2583996|NCT00359762|6338659|P1|NOT COMPLETED|Period III||0
2583997|NCT00359762|6338655|P5|COMPLETED|Period III||0
2583998|NCT00359762|6338656|P4|COMPLETED|Period III||101
2583999|NCT00359762|6338657|P3|COMPLETED|Period III||47
2584000|NCT00359762|6338658|P2|COMPLETED|Period III||48
2584001|NCT00359762|6338659|P1|COMPLETED|Period III||0
2584002|NCT00359762|6338655|P5|Extension ITT Efficacy Population|Period III||0
2584003|NCT00359762|6338656|P4|Extension ITT Efficacy Population|Period III||164
2584004|NCT00359762|6338657|P3|Extension ITT Efficacy Population|Period III||75
2584005|NCT00359762|6338658|P2|Extension ITT Efficacy Population|Period III||73
2584006|NCT00359762|6338659|P1|Extension ITT Efficacy Population|Period III||0
2584007|NCT00359762|6338655|P5|Extension ITT Safety Population|Period III||0
2584008|NCT00359762|6338656|P4|Extension ITT Safety Population|Period III||166
2584009|NCT00359762|6338657|P3|Extension ITT Safety Population|Period III||76
2584010|NCT00359762|6338658|P2|Extension ITT Safety Population|Period III||74
2584011|NCT00359762|6338659|P1|Extension ITT Safety Population|Period III||0
2584012|NCT00359762|6338655|P5|STARTED|Period III||0
2584013|NCT00359762|6338656|P4|STARTED|Period III||166
2584014|NCT00359762|6338657|P3|STARTED|Period III||77
2584015|NCT00359762|6338658|P2|STARTED|Period III||77
2584016|NCT00359762|6338659|P1|STARTED|Period III||0
2584017|NCT00359762|6338655|P5|NOT COMPLETED|Period II||174
2584018|NCT00359762|6338656|P4|NOT COMPLETED|Period II||0
2584019|NCT00359762|6338657|P3|NOT COMPLETED|Period II||0
2584020|NCT00359762|6338658|P2|NOT COMPLETED|Period II||0
2584021|NCT00359762|6338659|P1|NOT COMPLETED|Period II||128
2584022|NCT00359762|6338655|P5|COMPLETED|Period II||341
2584023|NCT00359762|6338656|P4|COMPLETED|Period II||0
2584024|NCT00359762|6338657|P3|COMPLETED|Period II||0
2584025|NCT00359762|6338658|P2|COMPLETED|Period II||0
2584026|NCT00359762|6338659|P1|COMPLETED|Period II||386
2584027|NCT00359762|6338655|P5|Without Treatment Failure|Period II||138
2584028|NCT00359762|6338656|P4|Without Treatment Failure|Period II||0
2584029|NCT00359762|6338657|P3|Without Treatment Failure|Period II||0
2584030|NCT00359762|6338658|P2|Without Treatment Failure|Period II||0
2584031|NCT00359762|6338659|P1|Without Treatment Failure|Period II||124
2584032|NCT00359762|6338655|P5|Met Primary Endpoint|Period II||203
2584033|NCT00359762|6338656|P4|Met Primary Endpoint|Period II||0
2584034|NCT00359762|6338657|P3|Met Primary Endpoint|Period II||0
2584035|NCT00359762|6338658|P2|Met Primary Endpoint|Period II||0
2584036|NCT00359762|6338659|P1|Met Primary Endpoint|Period II||262
2584037|NCT00359762|6338655|P5|ITT Efficacy Population|Period II||490
2584038|NCT00359762|6338656|P4|ITT Efficacy Population|Period II||0
2584039|NCT00359762|6338657|P3|ITT Efficacy Population|Period II||0
2584040|NCT00359762|6338658|P2|ITT Efficacy Population|Period II||0
2584041|NCT00359762|6338659|P1|ITT Efficacy Population|Period II||487
2584042|NCT00359762|6338655|P5|Intent to Treat (ITT) Safety Population|Period II||511
2584043|NCT00359762|6338656|P4|Intent to Treat (ITT) Safety Population|Period II||0
2584044|NCT00359762|6338657|P3|Intent to Treat (ITT) Safety Population|Period II||0
2584045|NCT00359762|6338658|P2|Intent to Treat (ITT) Safety Population|Period II||0
2584046|NCT00359762|6338659|P1|Intent to Treat (ITT) Safety Population|Period II||508
2584047|NCT00359762|6338655|P5|STARTED|Period II||515
2584048|NCT00359762|6338656|P4|STARTED|Period II||0
2584049|NCT00359762|6338657|P3|STARTED|Period II||0
2584050|NCT00359762|6338658|P2|STARTED|Period II||0
2584051|NCT00359762|6338659|P1|STARTED|Period II||514
2584052|NCT00359736|6338722|P2|NOT COMPLETED|Overall Study||0
2584053|NCT00359736|6338723|P1|NOT COMPLETED|Overall Study||0
2584054|NCT00359736|6338722|P2|COMPLETED|Overall Study||15
2584055|NCT00359736|6338723|P1|COMPLETED|Overall Study||14
2584056|NCT00359736|6338722|P2|STARTED|Overall Study||15
2584057|NCT00359736|6338723|P1|STARTED|Overall Study||14
2584058|NCT00359632|6338733|P2|NOT COMPLETED|Overall Study||0
2584059|NCT00359632|6338734|P1|NOT COMPLETED|Overall Study||4
2584060|NCT00359632|6338733|P2|COMPLETED|Overall Study||9
2584061|NCT00359632|6338734|P1|COMPLETED|Overall Study||20
2584062|NCT00359632|6338733|P2|STARTED|Overall Study||9
2584063|NCT00359632|6338734|P1|STARTED|Overall Study||24
2584064|NCT00359619|6338748|P7|NOT COMPLETED|Overall Study||4
2584065|NCT00359619|6338749|P6|NOT COMPLETED|Overall Study||5
2584066|NCT00359619|6338750|P5|NOT COMPLETED|Overall Study||3
2584067|NCT00359619|6338751|P4|NOT COMPLETED|Overall Study||3
2584068|NCT00359619|6338752|P3|NOT COMPLETED|Overall Study||7
2584069|NCT00359619|6338753|P2|NOT COMPLETED|Overall Study||5
2584070|NCT00359619|6338754|P1|NOT COMPLETED|Overall Study||8
2584071|NCT00359619|6338748|P7|COMPLETED|Overall Study||46
2584072|NCT00359619|6338749|P6|COMPLETED|Overall Study||45
2584073|NCT00359619|6338750|P5|COMPLETED|Overall Study||45
2584074|NCT00359619|6338751|P4|COMPLETED|Overall Study||45
2584075|NCT00359619|6338752|P3|COMPLETED|Overall Study||42
2584076|NCT00359619|6338753|P2|COMPLETED|Overall Study||45
2584077|NCT00359619|6338754|P1|COMPLETED|Overall Study||80
2584078|NCT00359619|6338748|P7|STARTED|Overall Study||50
2584079|NCT00359619|6338749|P6|STARTED|Overall Study||50
2584080|NCT00359619|6338750|P5|STARTED|Overall Study||48
2584081|NCT00359619|6338751|P4|STARTED|Overall Study||48
2584082|NCT00359619|6338752|P3|STARTED|Overall Study||49
2584083|NCT00359619|6338753|P2|STARTED|Overall Study||50
2584084|NCT00359619|6338754|P1|STARTED|Overall Study||88
2584085|NCT00359424|6338884|P2|NOT COMPLETED|Overall Study||67
2584086|NCT00359424|6338885|P1|NOT COMPLETED|Overall Study||130
2584087|NCT00359424|6338884|P2|COMPLETED|Overall Study||155
2584088|NCT00359424|6338885|P1|COMPLETED|Overall Study||304
2584089|NCT00359424|6338884|P2|270 Day Follow up|Overall Study||159
2584090|NCT00359424|6338885|P1|270 Day Follow up|Overall Study||313
2584091|NCT00359424|6338884|P2|180 Day Follow up|Overall Study||167
2584092|NCT00359424|6338885|P1|180 Day Follow up|Overall Study||325
2584093|NCT00359424|6338884|P2|90 Day Follow up|Overall Study||172
2584094|NCT00359424|6338885|P1|90 Day Follow up|Overall Study||343
2584095|NCT00359424|6338884|P2|STARTED|Overall Study||222
2584096|NCT00359424|6338885|P1|STARTED|Overall Study||434
2584097|NCT00359281|6338924|P9|NOT COMPLETED|Overall Study||0
2584098|NCT00359281|6338925|P8|NOT COMPLETED|Overall Study||0
2584099|NCT00359281|6338926|P7|NOT COMPLETED|Overall Study||2
2584100|NCT00359281|6338927|P6|NOT COMPLETED|Overall Study||0
2584101|NCT00359281|6338928|P5|NOT COMPLETED|Overall Study||0
2584102|NCT00359281|6338929|P4|NOT COMPLETED|Overall Study||0
2584103|NCT00359281|6338930|P3|NOT COMPLETED|Overall Study||0
2584104|NCT00359281|6338931|P2|NOT COMPLETED|Overall Study||0
2584105|NCT00359281|6338932|P1|NOT COMPLETED|Overall Study||1
2584106|NCT00359281|6338924|P9|COMPLETED|Overall Study||20
2584107|NCT00359281|6338925|P8|COMPLETED|Overall Study||15
2584108|NCT00359281|6338926|P7|COMPLETED|Overall Study||16
2584109|NCT00359281|6338927|P6|COMPLETED|Overall Study||15
2584110|NCT00359281|6338928|P5|COMPLETED|Overall Study||10
2584111|NCT00359281|6338929|P4|COMPLETED|Overall Study||10
2584112|NCT00359281|6338930|P3|COMPLETED|Overall Study||10
2584113|NCT00359281|6338931|P2|COMPLETED|Overall Study||15
2584114|NCT00359281|6338932|P1|COMPLETED|Overall Study||15
2584115|NCT00359281|6338924|P9|STARTED|Overall Study||20
2584116|NCT00359281|6338925|P8|STARTED|Overall Study||15
2584117|NCT00359281|6338926|P7|STARTED|Overall Study||18
2584118|NCT00359281|6338927|P6|STARTED|Overall Study||15
2584119|NCT00359281|6338928|P5|STARTED|Overall Study||10
2584120|NCT00359281|6338929|P4|STARTED|Overall Study||10
2584121|NCT00359281|6338930|P3|STARTED|Overall Study||10
2584122|NCT00359281|6338931|P2|STARTED|Overall Study||15
2584123|NCT00359281|6338932|P1|STARTED|Overall Study||16
2584124|NCT00359216|6338964|P2|NOT COMPLETED|Overall Study||1
2584125|NCT00359216|6338965|P1|NOT COMPLETED|Overall Study||0
2584126|NCT00359216|6338964|P2|COMPLETED|Overall Study|Completed treatment but simultaneously partaking in other study,final study procedures not performed|9
2584127|NCT00359216|6338965|P1|COMPLETED|Overall Study||20
2584128|NCT00359216|6338964|P2|STARTED|Overall Study||10
2584129|NCT00359216|6338965|P1|STARTED|Overall Study||20
2584130|NCT00359203|6338973|P2|NOT COMPLETED|Overall Study||0
2584131|NCT00359203|6338974|P1|NOT COMPLETED|Overall Study||0
2584132|NCT00359203|6338973|P2|COMPLETED|Overall Study||38
2584133|NCT00359203|6338974|P1|COMPLETED|Overall Study||39
2584134|NCT00359203|6338973|P2|STARTED|Overall Study||38
2584135|NCT00359203|6338974|P1|STARTED|Overall Study||39
2584136|NCT00359138|6338983|P3|NOT COMPLETED|Overall Study||0
2584137|NCT00359138|6338984|P2|NOT COMPLETED|Overall Study||0
2584138|NCT00359138|6338985|P1|NOT COMPLETED|Overall Study||0
2584139|NCT00359138|6338983|P3|COMPLETED|Overall Study||12
2584140|NCT00359138|6338984|P2|COMPLETED|Overall Study||12
2584141|NCT00359138|6338985|P1|COMPLETED|Overall Study||12
2584142|NCT00359138|6338983|P3|STARTED|Overall Study||12
2584143|NCT00359138|6338984|P2|STARTED|Overall Study||12
2584144|NCT00359138|6338985|P1|STARTED|Overall Study||12
2584145|NCT00359073|6338995|P2|NOT COMPLETED|Overall Study||2
2584146|NCT00359073|6338996|P1|NOT COMPLETED|Overall Study||4
2584147|NCT00359073|6338995|P2|COMPLETED|Overall Study||11
2584148|NCT00359073|6338996|P1|COMPLETED|Overall Study||8
2584149|NCT00359073|6338995|P2|STARTED|Overall Study||13
2584150|NCT00359073|6338996|P1|STARTED|Overall Study||12
2584151|NCT00359021|6339008|P2|NOT COMPLETED|Overall Study||52
2584152|NCT00359021|6339009|P1|NOT COMPLETED|Overall Study||81
2584153|NCT00359021|6339008|P2|COMPLETED|Overall Study||195
2584154|NCT00359021|6339009|P1|COMPLETED|Overall Study||175
2584155|NCT00359021|6339008|P2|STARTED|Overall Study||247
2584156|NCT00359021|6339009|P1|STARTED|Overall Study||256
2584157|NCT00358956|6339021|P1|NOT COMPLETED|Overall Study||8
2584158|NCT00358956|6339021|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|11
2584159|NCT00358956|6339021|P1|STARTED|Overall Study||19
2584160|NCT00358917|6339033|P2|NOT COMPLETED|Overall Study||69
2584161|NCT00358917|6339034|P1|NOT COMPLETED|Overall Study||66
2584162|NCT00358917|6339033|P2|COMPLETED|Overall Study||230
2584163|NCT00358917|6339034|P1|COMPLETED|Overall Study||234
2584164|NCT00358917|6339033|P2|STARTED|Overall Study||299
2584165|NCT00358917|6339034|P1|STARTED|Overall Study||300
2584166|NCT00358826|6339052|P8|NOT COMPLETED|MDCT Substudy||0
2584167|NCT00358826|6339053|P7|NOT COMPLETED|MDCT Substudy||0
2584168|NCT00358826|6339054|P6|NOT COMPLETED|MDCT Substudy||2
2584169|NCT00358826|6339055|P5|NOT COMPLETED|MDCT Substudy||1
2584170|NCT00358826|6339056|P4|NOT COMPLETED|MDCT Substudy||0
2584171|NCT00358826|6339057|P3|NOT COMPLETED|MDCT Substudy||0
2584172|NCT00358826|6339058|P2|NOT COMPLETED|MDCT Substudy||0
2584173|NCT00358826|6339059|P1|NOT COMPLETED|MDCT Substudy||0
2584174|NCT00358826|6339052|P8|COMPLETED|MDCT Substudy||27
2584175|NCT00358826|6339053|P7|COMPLETED|MDCT Substudy||19
2584176|NCT00358826|6339054|P6|COMPLETED|MDCT Substudy||20
2584177|NCT00358826|6339055|P5|COMPLETED|MDCT Substudy||24
2584178|NCT00358826|6339056|P4|COMPLETED|MDCT Substudy||0
2584179|NCT00358826|6339057|P3|COMPLETED|MDCT Substudy||0
2584180|NCT00358826|6339058|P2|COMPLETED|MDCT Substudy||0
2584181|NCT00358826|6339059|P1|COMPLETED|MDCT Substudy||0
2584182|NCT00358826|6339052|P8|STARTED|MDCT Substudy||27
2584183|NCT00358826|6339053|P7|STARTED|MDCT Substudy||19
2584184|NCT00358826|6339054|P6|STARTED|MDCT Substudy||22
2584185|NCT00358826|6339055|P5|STARTED|MDCT Substudy||25
2584186|NCT00358826|6339056|P4|STARTED|MDCT Substudy||0
2584187|NCT00358826|6339057|P3|STARTED|MDCT Substudy||0
2584188|NCT00358826|6339058|P2|STARTED|MDCT Substudy||0
2584189|NCT00358826|6339059|P1|STARTED|MDCT Substudy||0
2584190|NCT00358826|6339052|P8|NOT COMPLETED|Core Study||0
2584191|NCT00358826|6339053|P7|NOT COMPLETED|Core Study||0
2584192|NCT00358826|6339054|P6|NOT COMPLETED|Core Study||0
2584193|NCT00358826|6339055|P5|NOT COMPLETED|Core Study||0
2584194|NCT00358826|6339056|P4|NOT COMPLETED|Core Study||2
2584195|NCT00358826|6339057|P3|NOT COMPLETED|Core Study||2
2584196|NCT00358826|6339058|P2|NOT COMPLETED|Core Study||5
2584197|NCT00358826|6339059|P1|NOT COMPLETED|Core Study||3
2584198|NCT00358826|6339052|P8|COMPLETED|Core Study||0
2584199|NCT00358826|6339053|P7|COMPLETED|Core Study||0
2584200|NCT00358826|6339054|P6|COMPLETED|Core Study||0
2584201|NCT00358826|6339055|P5|COMPLETED|Core Study||0
2584202|NCT00358826|6339056|P4|COMPLETED|Core Study||50
2584203|NCT00358826|6339057|P3|COMPLETED|Core Study||42
2584204|NCT00358826|6339058|P2|COMPLETED|Core Study||41
2584205|NCT00358826|6339059|P1|COMPLETED|Core Study||46
2584206|NCT00358826|6339052|P8|STARTED|Core Study||0
2584207|NCT00358826|6339053|P7|STARTED|Core Study||0
2584208|NCT00358826|6339054|P6|STARTED|Core Study||0
2584209|NCT00358826|6339055|P5|STARTED|Core Study||0
2584210|NCT00358826|6339056|P4|STARTED|Core Study||52
2584211|NCT00358826|6339057|P3|STARTED|Core Study||44
2584212|NCT00358826|6339058|P2|STARTED|Core Study||46
2584213|NCT00358826|6339059|P1|STARTED|Core Study||49
2584214|NCT00358735|6339095|P2|NOT COMPLETED|Overall Study||17
2584215|NCT00358735|6339096|P1|NOT COMPLETED|Overall Study||8
2584216|NCT00358735|6339095|P2|COMPLETED|Overall Study|Efficacy|190
2584217|NCT00358735|6339096|P1|COMPLETED|Overall Study|Efficacy|196
2584218|NCT00358735|6339095|P2|Not Completed Safety|Overall Study||13
2584219|NCT00358735|6339096|P1|Not Completed Safety|Overall Study||6
2584220|NCT00358735|6339095|P2|Completed Safety|Overall Study||194
2584221|NCT00358735|6339096|P1|Completed Safety|Overall Study||198
2584222|NCT00358735|6339095|P2|STARTED|Overall Study||207
2584223|NCT00358735|6339096|P1|STARTED|Overall Study||204
2584224|NCT00358670|6339126|P2|NOT COMPLETED|Overall Study||219
2584225|NCT00358670|6339127|P1|NOT COMPLETED|Overall Study||222
2584226|NCT00358670|6339126|P2|COMPLETED|Overall Study||0
2584227|NCT00358670|6339127|P1|COMPLETED|Overall Study||0
2584228|NCT00358670|6339126|P2|STARTED|Overall Study||219
2584229|NCT00358670|6339127|P1|STARTED|Overall Study||222
2584230|NCT00358644|6339141|P1|NOT COMPLETED|Overall Study||50
2584231|NCT00358644|6339141|P1|COMPLETED|Overall Study||5
2584232|NCT00358644|6339141|P1|STARTED|Overall Study||55
2584233|NCT00358579|6339147|P2|NOT COMPLETED|Overall Study||0
2584234|NCT00358579|6339148|P1|NOT COMPLETED|Overall Study||0
2584235|NCT00358579|6339147|P2|COMPLETED|Overall Study||374
2584236|NCT00358579|6339148|P1|COMPLETED|Overall Study||353
2584237|NCT00358579|6339147|P2|STARTED|Overall Study||374
2584238|NCT00358579|6339148|P1|STARTED|Overall Study||353
2584239|NCT00358527|6339164|P2|NOT COMPLETED|Overall Study||3
2584240|NCT00358527|6339165|P1|NOT COMPLETED|Overall Study||13
2584241|NCT00358527|6339164|P2|COMPLETED|Overall Study||131
2584242|NCT00358527|6339165|P1|COMPLETED|Overall Study||254
2584243|NCT00358527|6339164|P2|STARTED|Overall Study||134
2584244|NCT00358527|6339165|P1|STARTED|Overall Study||267
2584245|NCT00358501|6339175|P2|NOT COMPLETED|Overall Study||0
2584246|NCT00358501|6339176|P1|NOT COMPLETED|Overall Study||0
2584247|NCT00358501|6339175|P2|COMPLETED|Overall Study||32
2584248|NCT00358501|6339176|P1|COMPLETED|Overall Study||102
2584249|NCT00358501|6339175|P2|STARTED|Overall Study||32
2584250|NCT00358501|6339176|P1|STARTED|Overall Study||102
2584251|NCT00358462|6339191|P2|NOT COMPLETED|Overall Study||64
2584252|NCT00358462|6339192|P1|NOT COMPLETED|Overall Study||59
2584253|NCT00358462|6339191|P2|COMPLETED|Overall Study||238
2584254|NCT00358462|6339192|P1|COMPLETED|Overall Study||245
2584255|NCT00358462|6339191|P2|STARTED|Overall Study||302
2584256|NCT00358462|6339192|P1|STARTED|Overall Study||304
2584257|NCT00358449|6339215|P3|NOT COMPLETED|Overall Study||2
2584258|NCT00358449|6339216|P2|NOT COMPLETED|Overall Study||1
2584259|NCT00358449|6339217|P1|NOT COMPLETED|Overall Study||4
2584260|NCT00358449|6339215|P3|COMPLETED|Overall Study||18
2584261|NCT00358449|6339216|P2|COMPLETED|Overall Study||19
2584262|NCT00358449|6339217|P1|COMPLETED|Overall Study||15
2584263|NCT00358449|6339215|P3|STARTED|Overall Study||20
2584264|NCT00358449|6339216|P2|STARTED|Overall Study||20
2584265|NCT00358449|6339217|P1|STARTED|Overall Study||19
2584266|NCT00358436|6339320|P2|NOT COMPLETED|Overall Study||86
2584267|NCT00358436|6339321|P1|NOT COMPLETED|Overall Study||154
2584268|NCT00358436|6339320|P2|COMPLETED|Overall Study||118
2584269|NCT00358436|6339321|P1|COMPLETED|Overall Study||446
2584270|NCT00358436|6339320|P2|STARTED|Overall Study||204
2584271|NCT00358436|6339321|P1|STARTED|Overall Study||600
2584272|NCT00358332|6339337|P4|NOT COMPLETED|Overall Study||0
2584273|NCT00358332|6339338|P3|NOT COMPLETED|Overall Study||1
2584274|NCT00358332|6339339|P2|NOT COMPLETED|Overall Study||3
2584275|NCT00358332|6339340|P1|NOT COMPLETED|Overall Study||0
2584276|NCT00358332|6339337|P4|COMPLETED|Overall Study||25
2584277|NCT00358332|6339338|P3|COMPLETED|Overall Study||29
2584278|NCT00358332|6339339|P2|COMPLETED|Overall Study||27
2584279|NCT00358332|6339340|P1|COMPLETED|Overall Study||15
2584280|NCT00358332|6339337|P4|STARTED|Overall Study||25
2584281|NCT00358332|6339338|P3|STARTED|Overall Study||30
2584282|NCT00358332|6339339|P2|STARTED|Overall Study||30
2584283|NCT00358332|6339340|P1|STARTED|Overall Study||15
2584284|NCT00358215|6339392|P2|NOT COMPLETED|Overall Study||652
2584285|NCT00358215|6339393|P1|NOT COMPLETED|Overall Study||679
2584286|NCT00358215|6339392|P2|COMPLETED|Overall Study|Participants who completed investigational product|484
2584287|NCT00358215|6339393|P1|COMPLETED|Overall Study|Participants who completed investigational product|463
2584288|NCT00358215|6339392|P2|Received Investigational Product|Overall Study||1133
2584289|NCT00358215|6339393|P1|Received Investigational Product|Overall Study||1140
2584290|NCT00358215|6339392|P2|STARTED|Overall Study||1136
2584291|NCT00358215|6339393|P1|STARTED|Overall Study||1142
2584292|NCT00358150|6339407|P1|NOT COMPLETED|Overall Study||7
2584293|NCT00358150|6339407|P1|COMPLETED|Overall Study||19
2584294|NCT00358150|6339407|P1|STARTED|Overall Study||26
2584295|NCT00358007|6339429|P1|NOT COMPLETED|Overall Study||2
2584296|NCT00358007|6339429|P1|COMPLETED|Overall Study||28
2584297|NCT00358007|6339429|P1|STARTED|Overall Study||30
2584298|NCT00357994|6339436|P2|NOT COMPLETED|Overall Study||3
2584299|NCT00357994|6339437|P1|NOT COMPLETED|Overall Study||2
2584300|NCT00357994|6339436|P2|COMPLETED|Overall Study||31
2584301|NCT00357994|6339437|P1|COMPLETED|Overall Study||35
2584302|NCT00357994|6339436|P2|STARTED|Overall Study||34
2584303|NCT00357994|6339437|P1|STARTED|Overall Study||37
2584304|NCT00357968|6339491|P2|NOT COMPLETED|Crossover Maintenance Dose Phase||0
2584305|NCT00357968|6339492|P1|NOT COMPLETED|Crossover Maintenance Dose Phase||0
2584306|NCT00357968|6339491|P2|COMPLETED|Crossover Maintenance Dose Phase||55
2584307|NCT00357968|6339492|P1|COMPLETED|Crossover Maintenance Dose Phase||54
2584308|NCT00357968|6339491|P2|STARTED|Crossover Maintenance Dose Phase||55
2584309|NCT00357968|6339492|P1|STARTED|Crossover Maintenance Dose Phase|1 subject discontinued study drug-did not take clopidogrel during the 2nd phase but completed study|54
2584310|NCT00357968|6339491|P2|NOT COMPLETED|First Maintenance Dose Phase||44
2584311|NCT00357968|6339492|P1|NOT COMPLETED|First Maintenance Dose Phase||48
2584312|NCT00357968|6339491|P2|COMPLETED|First Maintenance Dose Phase||55
2584313|NCT00357968|6339492|P1|COMPLETED|First Maintenance Dose Phase||54
2584314|NCT00357968|6339491|P2|Started Maintenance Dose|First Maintenance Dose Phase||55
2584315|NCT00357968|6339492|P1|Started Maintenance Dose|First Maintenance Dose Phase||55
2584316|NCT00357968|6339491|P2|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||57
2584317|NCT00357968|6339492|P1|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||55
2584318|NCT00357968|6339491|P2|Received Loading Dose|First Maintenance Dose Phase||99
2584319|NCT00357968|6339492|P1|Received Loading Dose|First Maintenance Dose Phase||102
2584320|NCT00357968|6339491|P2|STARTED|First Maintenance Dose Phase||99
2584321|NCT00357968|6339492|P1|STARTED|First Maintenance Dose Phase||102
2584322|NCT00357955|6339536|P2|NOT COMPLETED|Overall Study||3
2584323|NCT00357955|6339537|P1|NOT COMPLETED|Overall Study||6
2584324|NCT00357955|6339536|P2|COMPLETED|Overall Study||51
2584325|NCT00357955|6339537|P1|COMPLETED|Overall Study||58
2584326|NCT00357955|6339536|P2|STARTED|Overall Study||54
2584327|NCT00357955|6339537|P1|STARTED|Overall Study||64
2584328|NCT00357903|6339545|P2|NOT COMPLETED|Overall Study||43
2584329|NCT00357903|6339546|P1|NOT COMPLETED|Overall Study||363
2584330|NCT00357903|6339545|P2|COMPLETED|Overall Study||15
2584331|NCT00357903|6339546|P1|COMPLETED|Overall Study||218
2584332|NCT00357903|6339545|P2|STARTED|Overall Study||58
2584333|NCT00357903|6339546|P1|STARTED|Overall Study||581
2584334|NCT00357877|6339586|P2|NOT COMPLETED|Overall Study||30
2584335|NCT00357877|6339587|P1|NOT COMPLETED|Overall Study||26
2584336|NCT00357877|6339586|P2|COMPLETED|Overall Study||460
2584337|NCT00357877|6339587|P1|COMPLETED|Overall Study||467
2584338|NCT00357877|6339586|P2|STARTED|Overall Study||490
2584339|NCT00357877|6339587|P1|STARTED|Overall Study||493
2584340|NCT00357760|6339601|P2|NOT COMPLETED|Overall Study||35
2584341|NCT00357760|6339602|P1|NOT COMPLETED|Overall Study||59
2584342|NCT00357760|6339601|P2|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
2584343|NCT00357760|6339602|P1|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
2584344|NCT00357760|6339601|P2|Patients Who Undergo Dose Escalation|Overall Study||16
2584345|NCT00357760|6339602|P1|Patients Who Undergo Dose Escalation|Overall Study|Only patients who progressed on the low dose (Arm B) had the opportunity to undergo dose escalation.|0
2584346|NCT00357760|6339601|P2|Eligible and Treated Patients|Overall Study||32
2584347|NCT00357760|6339602|P1|Eligible and Treated Patients|Overall Study||57
2584348|NCT00357760|6339601|P2|Patients Who Started Treatment|Overall Study||34
2584349|NCT00357760|6339602|P1|Patients Who Started Treatment|Overall Study||57
2584350|NCT00357760|6339601|P2|STARTED|Overall Study||35
2584351|NCT00357760|6339602|P1|STARTED|Overall Study||59
2584352|NCT00357734|6339612|P1|NOT COMPLETED|Overall Study||4
2584353|NCT00357734|6339612|P1|COMPLETED|Overall Study||10
2584354|NCT00357734|6339612|P1|Patient Received 500 mg of ZD1839|Overall Study||1
2584355|NCT00357734|6339612|P1|Patients Received 250 mg of ZD1839|Overall Study||13
2584356|NCT00357734|6339612|P1|STARTED|Overall Study||14
2584357|NCT00357656|6339623|P2|NOT COMPLETED|Overall Study||3
2584358|NCT00357656|6339624|P1|NOT COMPLETED|Overall Study||0
2584359|NCT00357656|6339623|P2|COMPLETED|Overall Study||29
2584360|NCT00357656|6339624|P1|COMPLETED|Overall Study||31
2584361|NCT00357656|6339623|P2|STARTED|Overall Study||32
2584362|NCT00357656|6339624|P1|STARTED|Overall Study||31
2584363|NCT00357552|6339675|P1|NOT COMPLETED|Weeks 24 to 104||5
2584364|NCT00357552|6339675|P1|COMPLETED|Weeks 24 to 104||117
2584365|NCT00357552|6339675|P1|STARTED|Weeks 24 to 104||122
2584366|NCT00357552|6339675|P1|NOT COMPLETED|Weeks 0 to 24||1
2584367|NCT00357552|6339675|P1|COMPLETED|Weeks 0 to 24|One subject died prior to week 24.|122
2584368|NCT00357552|6339675|P1|STARTED|Weeks 0 to 24||123
2584369|NCT00357552|6339675|P1|NOT COMPLETED|Screening||84
2584370|NCT00357552|6339675|P1|COMPLETED|Screening|The number of participants who completed this period, is the number of participants who enrolled.|123
2584371|NCT00357552|6339675|P1|STARTED|Screening|The number of participants who started this period, is the number of participants who screened.|207
2584372|NCT00357500|6339690|P1|NOT COMPLETED|Overall Study||77
2584373|NCT00357500|6339690|P1|COMPLETED|Overall Study||24
2584374|NCT00357500|6339690|P1|Began Protocol Therapy|Overall Study|4 pts did not start treatment due either to removal of consent or inability to get insurance.|97
2584375|NCT00357500|6339690|P1|STARTED|Overall Study||101
2584376|NCT00357396|6339699|P2|NOT COMPLETED|Overall Study||0
2584377|NCT00357396|6339700|P1|NOT COMPLETED|Overall Study||1
2584378|NCT00357396|6339699|P2|COMPLETED|Overall Study||4
2584379|NCT00357396|6339700|P1|COMPLETED|Overall Study||5
2584380|NCT00357396|6339699|P2|STARTED|Overall Study||4
2584381|NCT00357396|6339700|P1|STARTED|Overall Study||6
2584382|NCT00357370|6339708|P3|NOT COMPLETED|Cohort 2||2
2584383|NCT00357370|6339709|P2|NOT COMPLETED|Cohort 2||7
2584384|NCT00357370|6339710|P1|NOT COMPLETED|Cohort 2||2
2584385|NCT00357370|6339708|P3|COMPLETED|Cohort 2||22
2584386|NCT00357370|6339709|P2|COMPLETED|Cohort 2||16
2584387|NCT00357370|6339710|P1|COMPLETED|Cohort 2||22
2584388|NCT00357370|6339708|P3|STARTED|Cohort 2||24
2584389|NCT00357370|6339709|P2|STARTED|Cohort 2||23
2584390|NCT00357370|6339710|P1|STARTED|Cohort 2||24
2584391|NCT00357370|6339708|P3|NOT COMPLETED|Cohort 1||0
2584392|NCT00357370|6339709|P2|NOT COMPLETED|Cohort 1||0
2584393|NCT00357370|6339710|P1|NOT COMPLETED|Cohort 1||0
2584394|NCT00357370|6339708|P3|COMPLETED|Cohort 1||0
2584395|NCT00357370|6339709|P2|COMPLETED|Cohort 1||0
2584396|NCT00357370|6339710|P1|COMPLETED|Cohort 1||4
2584397|NCT00357370|6339708|P3|STARTED|Cohort 1||0
2584398|NCT00357370|6339709|P2|STARTED|Cohort 1||0
2584399|NCT00357370|6339710|P1|STARTED|Cohort 1||4
2584400|NCT00357331|6339735|P2|NOT COMPLETED|Overall Study||0
2584401|NCT00357331|6339736|P1|NOT COMPLETED|Overall Study||0
2584402|NCT00357331|6339735|P2|COMPLETED|Overall Study||41
2584403|NCT00357331|6339736|P1|COMPLETED|Overall Study||42
2584404|NCT00357331|6339735|P2|STARTED|Overall Study||41
2584405|NCT00357331|6339736|P1|STARTED|Overall Study||42
2584418|NCT00357162|6339763|P1|NOT COMPLETED|Overall Study||0
2584419|NCT00357162|6339763|P1|COMPLETED|Overall Study||21
2584420|NCT00357162|6339763|P1|STARTED|Overall Study||21
2584421|NCT00357110|6339773|P2|NOT COMPLETED|Overall Study||5
2584422|NCT00357110|6339774|P1|NOT COMPLETED|Overall Study||5
2584423|NCT00357110|6339773|P2|COMPLETED|Overall Study||2
2584424|NCT00357110|6339774|P1|COMPLETED|Overall Study||1
2584425|NCT00357110|6339773|P2|STARTED|Overall Study||7
2584426|NCT00357110|6339774|P1|STARTED|Overall Study||6
2584427|NCT00357097|6339782|P2|NOT COMPLETED|Overall Study||29
2584428|NCT00357097|6339783|P1|NOT COMPLETED|Overall Study||54
2584429|NCT00357097|6339782|P2|COMPLETED|Overall Study||38
2584430|NCT00357097|6339783|P1|COMPLETED|Overall Study||145
2584431|NCT00357097|6339782|P2|STARTED|Overall Study||67
2584432|NCT00357097|6339783|P1|STARTED|Overall Study|199 were randomized. Only 198 took investigational product.|199
2584433|NCT00357032|6339827|P1|NOT COMPLETED|Overall Study||0
2584434|NCT00357032|6339827|P1|COMPLETED|Overall Study||12
2584435|NCT00357032|6339827|P1|STARTED|Overall Study||12
2584436|NCT00357006|6339837|P3|NOT COMPLETED|Overall Study||3
2584437|NCT00357006|6339838|P2|NOT COMPLETED|Overall Study||5
2584438|NCT00357006|6339839|P1|NOT COMPLETED|Overall Study||2
2584439|NCT00357006|6339837|P3|COMPLETED|Overall Study||59
2584440|NCT00357006|6339838|P2|COMPLETED|Overall Study||51
2584441|NCT00357006|6339839|P1|COMPLETED|Overall Study||60
2584442|NCT00357006|6339837|P3|STARTED|Overall Study||62
2584443|NCT00357006|6339838|P2|STARTED|Overall Study||56
2584444|NCT00357006|6339839|P1|STARTED|Overall Study||62
2584445|NCT00356993|6339847|P1|NOT COMPLETED|Overall Study||3921
2584446|NCT00356993|6339847|P1|COMPLETED|Overall Study||2088
2584447|NCT00356993|6339847|P1|STARTED|Overall Study||6009
2584448|NCT00356915|6339854|P3|NOT COMPLETED|Overall Study||42
2584449|NCT00356915|6339855|P2|NOT COMPLETED|Overall Study||94
2584450|NCT00356915|6339856|P1|NOT COMPLETED|Overall Study||76
2584451|NCT00356915|6339854|P3|COMPLETED|Overall Study||156
2584452|NCT00356915|6339855|P2|COMPLETED|Overall Study||496
2584453|NCT00356915|6339856|P1|COMPLETED|Overall Study||517
2584454|NCT00356915|6339854|P3|STARTED|Overall Study||198
2584455|NCT00356915|6339855|P2|STARTED|Overall Study||590
2584456|NCT00356915|6339856|P1|STARTED|Overall Study||593
2584457|NCT00356889|6339873|P1|NOT COMPLETED|Overall Study||3
2584458|NCT00356889|6339873|P1|COMPLETED|Overall Study||53
2584459|NCT00356889|6339873|P1|STARTED|Overall Study||56
2584460|NCT00356863|6339882|P2|NOT COMPLETED|Overall Study||75
2584461|NCT00356863|6339883|P1|NOT COMPLETED|Overall Study||92
2584462|NCT00356863|6339882|P2|COMPLETED|Overall Study||445
2584463|NCT00356863|6339883|P1|COMPLETED|Overall Study||412
2584464|NCT00356863|6339882|P2|STARTED|Overall Study||520
2584465|NCT00356863|6339883|P1|STARTED|Overall Study||504
2584466|NCT00356811|6339909|P1|NOT COMPLETED|Overall Study||49
2584467|NCT00356811|6339909|P1|COMPLETED|Overall Study||8
2584468|NCT00356811|6339909|P1|STARTED|Overall Study||57
2584469|NCT00356759|6339924|P2|NOT COMPLETED|Overall Study||10
2584470|NCT00356759|6339925|P1|NOT COMPLETED|Overall Study||14
2584471|NCT00356759|6339924|P2|COMPLETED|Overall Study||114
2584472|NCT00356759|6339925|P1|COMPLETED|Overall Study||112
2584473|NCT00356759|6339924|P2|STARTED|Overall Study||124
2584474|NCT00356759|6339925|P1|STARTED|Overall Study||126
2584475|NCT00356603|6339943|P2|NOT COMPLETED|Overall Study||3
2584476|NCT00356603|6339944|P1|NOT COMPLETED|Overall Study||6
2584477|NCT00356603|6339943|P2|COMPLETED|Overall Study||33
2584478|NCT00356603|6339944|P1|COMPLETED|Overall Study||33
2584479|NCT00356603|6339943|P2|STARTED|Overall Study||36
2584480|NCT00356603|6339944|P1|STARTED|Overall Study||39
2584481|NCT00356590|6339958|P1|NOT COMPLETED|Overall Study||274
2584482|NCT00356590|6339958|P1|COMPLETED|Overall Study||194
2584483|NCT00356590|6339958|P1|STARTED|Overall Study||468
2584484|NCT00356525|6339994|P4|NOT COMPLETED|Overall Study||9
2584485|NCT00356525|6339995|P3|NOT COMPLETED|Overall Study||7
2584486|NCT00356525|6339996|P2|NOT COMPLETED|Overall Study||11
2584487|NCT00356525|6339997|P1|NOT COMPLETED|Overall Study||14
2584488|NCT00356525|6339994|P4|COMPLETED|Overall Study||0
2584489|NCT00356525|6339995|P3|COMPLETED|Overall Study||0
2584490|NCT00356525|6339996|P2|COMPLETED|Overall Study||0
2584491|NCT00356525|6339997|P1|COMPLETED|Overall Study||0
2584492|NCT00356525|6339994|P4|STARTED|Overall Study||9
2584493|NCT00356525|6339995|P3|STARTED|Overall Study||7
2584494|NCT00356525|6339996|P2|STARTED|Overall Study||11
2584495|NCT00356525|6339997|P1|STARTED|Overall Study||14
2584496|NCT00356434|6340025|P2|NOT COMPLETED|Overall Study||0
2584497|NCT00356434|6340026|P1|NOT COMPLETED|Overall Study||0
2584498|NCT00356434|6340025|P2|COMPLETED|Overall Study||7
2584499|NCT00356434|6340026|P1|COMPLETED|Overall Study||4
2584500|NCT00356434|6340025|P2|STARTED|Overall Study||7
2584501|NCT00356434|6340026|P1|STARTED|Overall Study||4
2584502|NCT00356421|6340038|P2|NOT COMPLETED|Overall Study||17
2584503|NCT00356421|6340039|P1|NOT COMPLETED|Overall Study||32
2584504|NCT00356421|6340038|P2|COMPLETED|Overall Study||3
2584505|NCT00356421|6340039|P1|COMPLETED|Overall Study||6
2584506|NCT00356421|6340038|P2|STARTED|Overall Study||20
2584507|NCT00356421|6340039|P1|STARTED|Overall Study||38
2584508|NCT00356408|6340079|P1|NOT COMPLETED|Overall Study||60
2584509|NCT00356408|6340079|P1|COMPLETED|Overall Study||43
2584510|NCT00356408|6340079|P1|STARTED|Overall Study|106 subjects enrolled, however only 103 were included in the Intent to Treat (ITT) population.|103
2584511|NCT00356369|6340096|P2|NOT COMPLETED|Year 5||0
2584512|NCT00356369|6340097|P1|NOT COMPLETED|Year 5||0
2584513|NCT00356369|6340096|P2|COMPLETED|Year 5||105
2584514|NCT00356369|6340097|P1|COMPLETED|Year 5||299
2584515|NCT00356369|6340096|P2|STARTED|Year 5||105
2584516|NCT00356369|6340097|P1|STARTED|Year 5||299
2584517|NCT00356369|6340096|P2|NOT COMPLETED|Year 4||0
2584518|NCT00356369|6340097|P1|NOT COMPLETED|Year 4||0
2584519|NCT00356369|6340096|P2|COMPLETED|Year 4||109
2584520|NCT00356369|6340097|P1|COMPLETED|Year 4||317
2584521|NCT00356369|6340096|P2|STARTED|Year 4||109
2584522|NCT00356369|6340097|P1|STARTED|Year 4||317
2584523|NCT00356369|6340096|P2|NOT COMPLETED|Year 3||0
2584524|NCT00356369|6340097|P1|NOT COMPLETED|Year 3||0
2584525|NCT00356369|6340096|P2|COMPLETED|Year 3||116
2584526|NCT00356369|6340097|P1|COMPLETED|Year 3||344
2584527|NCT00356369|6340096|P2|STARTED|Year 3||116
2584528|NCT00356369|6340097|P1|STARTED|Year 3||344
2584529|NCT00356369|6340096|P2|NOT COMPLETED|Year 2||0
2584530|NCT00356369|6340097|P1|NOT COMPLETED|Year 2||0
2584531|NCT00356369|6340096|P2|COMPLETED|Year 2||117
2584532|NCT00356369|6340097|P1|COMPLETED|Year 2||354
2584533|NCT00356369|6340096|P2|STARTED|Year 2||117
2584534|NCT00356369|6340097|P1|STARTED|Year 2||354
2584535|NCT00356369|6340096|P2|NOT COMPLETED|Year 1||0
2584536|NCT00356369|6340097|P1|NOT COMPLETED|Year 1||0
2584537|NCT00356369|6340096|P2|COMPLETED|Year 1||121
2584538|NCT00356369|6340097|P1|COMPLETED|Year 1||364
2584539|NCT00356369|6340096|P2|STARTED|Year 1||121
2584540|NCT00356369|6340097|P1|STARTED|Year 1||364
2584541|NCT00356369|6340096|P2|NOT COMPLETED|Active Phase||1
2584542|NCT00356369|6340097|P1|NOT COMPLETED|Active Phase||2
2584543|NCT00356369|6340096|P2|COMPLETED|Active Phase||125
2584544|NCT00356369|6340097|P1|COMPLETED|Active Phase||372
2584545|NCT00356369|6340096|P2|STARTED|Active Phase||126
2584546|NCT00356369|6340097|P1|STARTED|Active Phase||374
2584547|NCT00356304|6340167|P2|NOT COMPLETED|Overall Study||4
2584548|NCT00356304|6340168|P1|NOT COMPLETED|Overall Study||2
2584549|NCT00356304|6340167|P2|COMPLETED|Overall Study||20
2584550|NCT00356304|6340168|P1|COMPLETED|Overall Study||24
2584551|NCT00356304|6340167|P2|STARTED|Overall Study||24
2584552|NCT00356304|6340168|P1|STARTED|Overall Study||26
2584553|NCT00356278|6340179|P3|NOT COMPLETED|Overall Study||19
2584554|NCT00356278|6340180|P2|NOT COMPLETED|Overall Study||15
2584555|NCT00356278|6340181|P1|NOT COMPLETED|Overall Study||25
2584556|NCT00356278|6340179|P3|COMPLETED|Overall Study||34
2584557|NCT00356278|6340180|P2|COMPLETED|Overall Study||35
2584558|NCT00356278|6340181|P1|COMPLETED|Overall Study||28
2584559|NCT00356278|6340179|P3|STARTED|Overall Study||53
2584560|NCT00356278|6340180|P2|STARTED|Overall Study||50
2584561|NCT00356278|6340181|P1|STARTED|Overall Study||53
2584562|NCT00356265|6340219|P3|NOT COMPLETED|Overall Study||1
2584563|NCT00356265|6340220|P2|NOT COMPLETED|Overall Study||0
2584564|NCT00356265|6340221|P1|NOT COMPLETED|Overall Study||0
2584565|NCT00356265|6340219|P3|COMPLETED|Overall Study||5
2584566|NCT00356265|6340220|P2|COMPLETED|Overall Study||2
2584567|NCT00356265|6340221|P1|COMPLETED|Overall Study||7
2584568|NCT00356265|6340219|P3|STARTED|Overall Study||6
2584569|NCT00356265|6340220|P2|STARTED|Overall Study||2
2584570|NCT00356265|6340221|P1|STARTED|Overall Study||7
2584571|NCT00356200|6340233|P2|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||2
2584572|NCT00356200|6340234|P1|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
2584573|NCT00356200|6340233|P2|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||3
2584574|NCT00356200|6340234|P1|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
2584575|NCT00356200|6340233|P2|STARTED|Cohort 2: 100 ug/ml (New Patients)||5
2584576|NCT00356200|6340234|P1|STARTED|Cohort 2: 100 ug/ml (New Patients)||0
2584577|NCT00356200|6340233|P2|NOT COMPLETED|Cohort 1: 10 ug/ml||0
2584578|NCT00356200|6340234|P1|NOT COMPLETED|Cohort 1: 10 ug/ml||1
2584579|NCT00356200|6340233|P2|COMPLETED|Cohort 1: 10 ug/ml||0
2584580|NCT00356200|6340234|P1|COMPLETED|Cohort 1: 10 ug/ml||4
2584581|NCT00356200|6340233|P2|STARTED|Cohort 1: 10 ug/ml||0
2584582|NCT00356200|6340234|P1|STARTED|Cohort 1: 10 ug/ml||5
2584583|NCT00356187|6340248|P2|NOT COMPLETED|Overall Study||0
2584584|NCT00356187|6340249|P1|NOT COMPLETED|Overall Study||0
2584585|NCT00356187|6340248|P2|COMPLETED|Overall Study||0
2584586|NCT00356187|6340249|P1|COMPLETED|Overall Study||0
2584587|NCT00356187|6340248|P2|STARTED|Overall Study||0
2584588|NCT00356187|6340249|P1|STARTED|Overall Study||0
2584589|NCT00356148|6340263|P2|NOT COMPLETED|Overall Study||1
2584590|NCT00356148|6340264|P1|NOT COMPLETED|Overall Study||2
2584591|NCT00356148|6340263|P2|COMPLETED|Overall Study||182
2584592|NCT00356148|6340264|P1|COMPLETED|Overall Study||187
2584593|NCT00356148|6340263|P2|STARTED|Overall Study||183
2584594|NCT00356148|6340264|P1|STARTED|Overall Study||189
2584595|NCT00356135|6340275|P3|NOT COMPLETED|Overall Study||5
2584596|NCT00356135|6340276|P2|NOT COMPLETED|Overall Study||2
2584597|NCT00356135|6340277|P1|NOT COMPLETED|Overall Study||4
2584598|NCT00356135|6340275|P3|COMPLETED|Overall Study||39
2584599|NCT00356135|6340276|P2|COMPLETED|Overall Study||46
2584600|NCT00356135|6340277|P1|COMPLETED|Overall Study||43
2584601|NCT00356135|6340275|P3|STARTED|Overall Study||44
2584602|NCT00356135|6340276|P2|STARTED|Overall Study||48
2584603|NCT00356135|6340277|P1|STARTED|Overall Study||47
2584604|NCT00356122|6340299|P1|NOT COMPLETED|FOLLOW-UP||41
2584605|NCT00356122|6340299|P1|COMPLETED|FOLLOW-UP||12
2584606|NCT00356122|6340299|P1|STARTED|FOLLOW-UP||53
2584607|NCT00356122|6340299|P1|NOT COMPLETED|TREATMENT||45
2584608|NCT00356122|6340299|P1|COMPLETED|TREATMENT||8
2584609|NCT00356122|6340299|P1|STARTED|TREATMENT||53
2584610|NCT00356057|6340310|P3|NOT COMPLETED|Overall Study||12
2584611|NCT00356057|6340311|P2|NOT COMPLETED|Overall Study||14
2584612|NCT00356057|6340312|P1|NOT COMPLETED|Overall Study||13
2584613|NCT00356057|6340310|P3|COMPLETED|Overall Study||22
2584614|NCT00356057|6340311|P2|COMPLETED|Overall Study||47
2584615|NCT00356057|6340312|P1|COMPLETED|Overall Study||45
2584616|NCT00356057|6340310|P3|IMPLANTED|Overall Study||25
2584617|NCT00356057|6340311|P2|IMPLANTED|Overall Study||52
2584618|NCT00356057|6340312|P1|IMPLANTED|Overall Study||49
2584619|NCT00356057|6340310|P3|STARTED|Overall Study||34
2584620|NCT00356057|6340311|P2|STARTED|Overall Study||61
2584621|NCT00356057|6340312|P1|STARTED|Overall Study||58
2584622|NCT00356031|6340350|P1|NOT COMPLETED|Overall Study||0
2584623|NCT00356031|6340350|P1|COMPLETED|Overall Study||20
2584624|NCT00356031|6340350|P1|STARTED|Overall Study||20
2584625|NCT00355914|6340361|P2|NOT COMPLETED|Overall Study||0
2584626|NCT00355914|6340362|P1|NOT COMPLETED|Overall Study||0
2584627|NCT00355914|6340361|P2|COMPLETED|Overall Study||60
2584628|NCT00355914|6340362|P1|COMPLETED|Overall Study||60
2584629|NCT00355914|6340361|P2|STARTED|Overall Study||60
2584630|NCT00355914|6340362|P1|STARTED|Overall Study||60
2584631|NCT00355797|6340373|P3|NOT COMPLETED|Overall Study||142
2584632|NCT00355797|6340374|P2|NOT COMPLETED|Overall Study||148
2584633|NCT00355797|6340375|P1|NOT COMPLETED|Overall Study||240
2584634|NCT00355797|6340373|P3|COMPLETED|Overall Study||239
2584635|NCT00355797|6340374|P2|COMPLETED|Overall Study||221
2584636|NCT00355797|6340375|P1|COMPLETED|Overall Study||501
2584637|NCT00355797|6340373|P3|STARTED|Overall Study||381
2584638|NCT00355797|6340374|P2|STARTED|Overall Study||369
2584639|NCT00355797|6340375|P1|STARTED|Overall Study||741
2584640|NCT00355784|6340407|P3|NOT COMPLETED|Overall Study||2
2584641|NCT00355784|6340408|P2|NOT COMPLETED|Overall Study||0
2584642|NCT00355784|6340409|P1|NOT COMPLETED|Overall Study||0
2584643|NCT00355784|6340407|P3|COMPLETED|Overall Study||5
2584644|NCT00355784|6340408|P2|COMPLETED|Overall Study||8
2584645|NCT00355784|6340409|P1|COMPLETED|Overall Study||9
2584646|NCT00355784|6340407|P3|STARTED|Overall Study||7
2584647|NCT00355784|6340408|P2|STARTED|Overall Study||8
2584648|NCT00355784|6340409|P1|STARTED|Overall Study||9
2584649|NCT00355706|6340443|P2|NOT COMPLETED|Overall Study||0
2584650|NCT00355706|6340444|P1|NOT COMPLETED|Overall Study||0
2584651|NCT00355706|6340443|P2|COMPLETED|Overall Study||50
2584652|NCT00355706|6340444|P1|COMPLETED|Overall Study||50
2584653|NCT00355706|6340443|P2|STARTED|Overall Study||50
2584654|NCT00355706|6340444|P1|STARTED|Overall Study||50
2584655|NCT00355615|6340458|P5|NOT COMPLETED|40-week Rosuvastatin Open Label Period||9
2584656|NCT00355615|6340459|P4|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
2584657|NCT00355615|6340460|P3|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
2584658|NCT00355615|6340461|P2|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
2584659|NCT00355615|6340462|P1|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
2584660|NCT00355615|6340458|P5|COMPLETED|40-week Rosuvastatin Open Label Period||164
2584661|NCT00355615|6340459|P4|COMPLETED|40-week Rosuvastatin Open Label Period||0
2584662|NCT00355615|6340460|P3|COMPLETED|40-week Rosuvastatin Open Label Period||0
2584663|NCT00355615|6340461|P2|COMPLETED|40-week Rosuvastatin Open Label Period||0
2584664|NCT00355615|6340462|P1|COMPLETED|40-week Rosuvastatin Open Label Period||0
2584665|NCT00355615|6340458|P5|STARTED|40-week Rosuvastatin Open Label Period||173
2584666|NCT00355615|6340459|P4|STARTED|40-week Rosuvastatin Open Label Period||0
2584667|NCT00355615|6340460|P3|STARTED|40-week Rosuvastatin Open Label Period||0
2584668|NCT00355615|6340461|P2|STARTED|40-week Rosuvastatin Open Label Period||0
2584669|NCT00355615|6340462|P1|STARTED|40-week Rosuvastatin Open Label Period||0
2584670|NCT00355615|6340458|P5|NOT COMPLETED|Randomized Double Blind Period||0
2584671|NCT00355615|6340459|P4|NOT COMPLETED|Randomized Double Blind Period||1
2584672|NCT00355615|6340460|P3|NOT COMPLETED|Randomized Double Blind Period||1
2584673|NCT00355615|6340461|P2|NOT COMPLETED|Randomized Double Blind Period||0
2584674|NCT00355615|6340462|P1|NOT COMPLETED|Randomized Double Blind Period||1
2584675|NCT00355615|6340458|P5|COMPLETED|Randomized Double Blind Period||0
2584676|NCT00355615|6340459|P4|COMPLETED|Randomized Double Blind Period|1 dropped out due to an adverse event|45
2584677|NCT00355615|6340460|P3|COMPLETED|Randomized Double Blind Period|45 were randomized but 1 never received drug|44
2584678|NCT00355615|6340461|P2|COMPLETED|Randomized Double Blind Period||44
2584679|NCT00355615|6340462|P1|COMPLETED|Randomized Double Blind Period|1 dropped out due to adverse event|41
2584680|NCT00355615|6340458|P5|STARTED|Randomized Double Blind Period|open label phase followed the randomized phase|0
2584681|NCT00355615|6340459|P4|STARTED|Randomized Double Blind Period||46
2584682|NCT00355615|6340460|P3|STARTED|Randomized Double Blind Period||45
2584683|NCT00355615|6340461|P2|STARTED|Randomized Double Blind Period||44
2584684|NCT00355615|6340462|P1|STARTED|Randomized Double Blind Period||42
2584685|NCT00355472|6340521|P1|NOT COMPLETED|Overall Study||1
2584686|NCT00355472|6340521|P1|COMPLETED|Overall Study||15
2584687|NCT00355472|6340521|P1|STARTED|Overall Study||16
2584688|NCT00355394|6340548|P2|NOT COMPLETED|Overall Study||0
2584689|NCT00355394|6340549|P1|NOT COMPLETED|Overall Study||0
2584690|NCT00355394|6340548|P2|COMPLETED|Overall Study||16
2584691|NCT00355394|6340549|P1|COMPLETED|Overall Study||15
2584692|NCT00355394|6340548|P2|STARTED|Overall Study||16
2584693|NCT00355394|6340549|P1|STARTED|Overall Study||15
2584694|NCT00355368|6340567|P2|NOT COMPLETED|Overall Study||9
2584695|NCT00355368|6340568|P1|NOT COMPLETED|Overall Study||10
2584696|NCT00355368|6340567|P2|COMPLETED|Overall Study||201
2584697|NCT00355368|6340568|P1|COMPLETED|Overall Study||200
2584698|NCT00355368|6340567|P2|STARTED|Overall Study||210
2584699|NCT00355368|6340568|P1|STARTED|Overall Study||210
2584700|NCT00355342|6340582|P2|NOT COMPLETED|Overall Study||36
2584701|NCT00355342|6340583|P1|NOT COMPLETED|Overall Study||39
2584702|NCT00355342|6340582|P2|COMPLETED|Overall Study||56
2584703|NCT00355342|6340583|P1|COMPLETED|Overall Study||55
2584704|NCT00355342|6340582|P2|STARTED|Overall Study||92
2584705|NCT00355342|6340583|P1|STARTED|Overall Study||94
2584706|NCT00355199|6340593|P2|NOT COMPLETED|Overall Study||4
2584707|NCT00355199|6340594|P1|NOT COMPLETED|Overall Study||7
2584708|NCT00355199|6340593|P2|COMPLETED|Overall Study||122
2584709|NCT00355199|6340594|P1|COMPLETED|Overall Study||113
2584710|NCT00355199|6340593|P2|STARTED|Overall Study||126
2584711|NCT00355199|6340594|P1|STARTED|Overall Study||120
2584712|NCT00355147|6340610|P2|NOT COMPLETED|Overall Study||20
2584713|NCT00355147|6340611|P1|NOT COMPLETED|Overall Study||18
2584714|NCT00355147|6340610|P2|COMPLETED|Overall Study||67
2584715|NCT00355147|6340611|P1|COMPLETED|Overall Study||69
2584716|NCT00355147|6340610|P2|STARTED|Overall Study||87
2584717|NCT00355147|6340611|P1|STARTED|Overall Study||87
2584718|NCT00355134|6340630|P5|NOT COMPLETED|Extension Phase||19
2584719|NCT00355134|6340631|P4|NOT COMPLETED|Extension Phase||16
2584720|NCT00355134|6340632|P3|NOT COMPLETED|Extension Phase||0
2584721|NCT00355134|6340633|P2|NOT COMPLETED|Extension Phase||37
2584722|NCT00355134|6340634|P1|NOT COMPLETED|Extension Phase||31
2584723|NCT00355134|6340630|P5|COMPLETED|Extension Phase||88
2584724|NCT00355134|6340631|P4|COMPLETED|Extension Phase||89
2584725|NCT00355134|6340632|P3|COMPLETED|Extension Phase||0
2584726|NCT00355134|6340633|P2|COMPLETED|Extension Phase||180
2584727|NCT00355134|6340634|P1|COMPLETED|Extension Phase||172
2584728|NCT00355134|6340630|P5|STARTED|Extension Phase||107
2584729|NCT00355134|6340631|P4|STARTED|Extension Phase||105
2584730|NCT00355134|6340632|P3|STARTED|Extension Phase||0
2584731|NCT00355134|6340633|P2|STARTED|Extension Phase||217
2584732|NCT00355134|6340634|P1|STARTED|Extension Phase||203
2584733|NCT00355134|6340630|P5|NOT COMPLETED|Core Phase||0
2584734|NCT00355134|6340631|P4|NOT COMPLETED|Core Phase||0
2584735|NCT00355134|6340632|P3|NOT COMPLETED|Core Phase||100
2584736|NCT00355134|6340633|P2|NOT COMPLETED|Core Phase||86
2584737|NCT00355134|6340634|P1|NOT COMPLETED|Core Phase||119
2584738|NCT00355134|6340630|P5|COMPLETED|Core Phase||0
2584739|NCT00355134|6340631|P4|COMPLETED|Core Phase||0
2584740|NCT00355134|6340632|P3|COMPLETED|Core Phase||255
2584741|NCT00355134|6340633|P2|COMPLETED|Core Phase||272
2584742|NCT00355134|6340634|P1|COMPLETED|Core Phase||251
2584743|NCT00355134|6340630|P5|STARTED|Core Phase||0
2584744|NCT00355134|6340631|P4|STARTED|Core Phase||0
2584745|NCT00355134|6340632|P3|STARTED|Core Phase||355
2584746|NCT00355134|6340633|P2|STARTED|Core Phase||358
2584747|NCT00355134|6340634|P1|STARTED|Core Phase||370
2584748|NCT00355121|6340677|P3|NOT COMPLETED|Overall Study||5
2584749|NCT00355121|6340678|P2|NOT COMPLETED|Overall Study||29
2584750|NCT00355121|6340679|P1|NOT COMPLETED|Overall Study||21
2584751|NCT00355121|6340677|P3|COMPLETED|Overall Study||170
2584752|NCT00355121|6340678|P2|COMPLETED|Overall Study||324
2584753|NCT00355121|6340679|P1|COMPLETED|Overall Study||332
2584754|NCT00355121|6340677|P3|STARTED|Overall Study||175
2584755|NCT00355121|6340678|P2|STARTED|Overall Study||353
2584756|NCT00355121|6340679|P1|STARTED|Overall Study||353
2584757|NCT00355082|6340710|P3|NOT COMPLETED|Continuation Phase||3
2584758|NCT00355082|6340711|P2|NOT COMPLETED|Continuation Phase||0
2584759|NCT00355082|6340712|P1|NOT COMPLETED|Continuation Phase||24
2584760|NCT00355082|6340710|P3|COMPLETED|Continuation Phase||8
2584761|NCT00355082|6340711|P2|COMPLETED|Continuation Phase||0
2584762|NCT00355082|6340712|P1|COMPLETED|Continuation Phase||160
2584763|NCT00355082|6340710|P3|STARTED|Continuation Phase|"See Pre-assign. Details for reasons why number starting CP does not equal number completing TP."|11
2584764|NCT00355082|6340711|P2|STARTED|Continuation Phase||0
2584765|NCT00355082|6340712|P1|STARTED|Continuation Phase|83 and 101 participants from the 250 and 300 mg groups (DB Phase), respectively, entered the CP.|184
2584766|NCT00355082|6340710|P3|NOT COMPLETED|Double-Blind (DB) Treatment Phase||0
2584767|NCT00355082|6340711|P2|NOT COMPLETED|Double-Blind (DB) Treatment Phase||34
2584768|NCT00355082|6340712|P1|NOT COMPLETED|Double-Blind (DB) Treatment Phase||19
2584769|NCT00355082|6340710|P3|COMPLETED|Double-Blind (DB) Treatment Phase||0
2584770|NCT00355082|6340711|P2|COMPLETED|Double-Blind (DB) Treatment Phase||79
2584771|NCT00355082|6340712|P1|COMPLETED|Double-Blind (DB) Treatment Phase||94
2584772|NCT00355082|6340710|P3|STARTED|Double-Blind (DB) Treatment Phase||0
2584773|NCT00355082|6340711|P2|STARTED|Double-Blind (DB) Treatment Phase|111 participants have baseline data; 2 participants did not receive study drug.|113
2584774|NCT00355082|6340712|P1|STARTED|Double-Blind (DB) Treatment Phase|112 participants have baseline data; 1 participant did not receive study drug.|113
2584775|NCT00355030|6340734|P2|NOT COMPLETED|Study Period 2 Long Term Follow-Up||2
2584776|NCT00355030|6340735|P1|NOT COMPLETED|Study Period 2 Long Term Follow-Up||1
2584777|NCT00355030|6340734|P2|COMPLETED|Study Period 2 Long Term Follow-Up||17
2584778|NCT00355030|6340735|P1|COMPLETED|Study Period 2 Long Term Follow-Up||19
2584779|NCT00355030|6340734|P2|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|19
2584866|NCT00354159|6340916|P1|STARTED|Randomized Study Period||202
2584780|NCT00355030|6340735|P1|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|20
2584781|NCT00355030|6340734|P2|NOT COMPLETED|Study Period 1 Treatment||44
2584782|NCT00355030|6340735|P1|NOT COMPLETED|Study Period 1 Treatment||45
2584783|NCT00355030|6340734|P2|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
2584784|NCT00355030|6340735|P1|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
2584785|NCT00355030|6340734|P2|Received At Least One Dose of Study Drug|Study Period 1 Treatment|2 non-eligible participants received somatropin from previous control group|43
2584786|NCT00355030|6340735|P1|Received At Least One Dose of Study Drug|Study Period 1 Treatment|1 non-eligible participant received somatropin from previous control group|45
2584787|NCT00355030|6340734|P2|STARTED|Study Period 1 Treatment||45
2584788|NCT00355030|6340735|P1|STARTED|Study Period 1 Treatment||46
2584789|NCT00354978|6340757|P1|NOT COMPLETED|Overall Study||0
2584790|NCT00354978|6340757|P1|COMPLETED|Overall Study||43
2584791|NCT00354978|6340757|P1|STARTED|Overall Study||43
2584792|NCT00354913|6340761|P1|NOT COMPLETED|Overall Study||0
2584793|NCT00354913|6340761|P1|COMPLETED|Overall Study||21
2584794|NCT00354913|6340761|P1|STARTED|Overall Study||21
2584795|NCT00354887|6340768|P1|NOT COMPLETED|Overall Study||1
2584796|NCT00354887|6340768|P1|COMPLETED|Overall Study||29
2584797|NCT00354887|6340768|P1|STARTED|Overall Study||30
2584798|NCT00354835|6340774|P2|NOT COMPLETED|Overall Study||61
2584799|NCT00354835|6340775|P1|NOT COMPLETED|Overall Study||52
2584800|NCT00354835|6340774|P2|COMPLETED|Overall Study||181
2584801|NCT00354835|6340775|P1|COMPLETED|Overall Study||187
2584802|NCT00354835|6340774|P2|STARTED|Overall Study||242
2584803|NCT00354835|6340775|P1|STARTED|Overall Study||239
2584804|NCT00354770|6340807|P2|NOT COMPLETED|Overall Study||3
2584805|NCT00354770|6340808|P1|NOT COMPLETED|Overall Study||3
2584806|NCT00354770|6340807|P2|COMPLETED|Overall Study||22
2584807|NCT00354770|6340808|P1|COMPLETED|Overall Study||22
2584808|NCT00354770|6340807|P2|STARTED|Overall Study||25
2584809|NCT00354770|6340808|P1|STARTED|Overall Study||25
2584810|NCT00354744|6340814|P1|NOT COMPLETED|Overall Study||42
2584811|NCT00354744|6340814|P1|COMPLETED|Overall Study||67
2584812|NCT00354744|6340814|P1|STARTED|Overall Study||109
2584813|NCT00354679|6340820|P1|NOT COMPLETED|Overall Study||1
2584814|NCT00354679|6340820|P1|COMPLETED|Overall Study||33
2584815|NCT00354679|6340820|P1|STARTED|Overall Study||34
2584816|NCT00354640|6340824|P1|NOT COMPLETED|Overall Study||0
2584817|NCT00354640|6340824|P1|COMPLETED|Overall Study||11
2584818|NCT00354640|6340824|P1|STARTED|Overall Study||11
2584819|NCT00354614|6340829|P1|NOT COMPLETED|Overall Study||28
2584820|NCT00354614|6340829|P1|COMPLETED|Overall Study||53
2584821|NCT00354614|6340829|P1|STARTED|Overall Study||81
2584822|NCT00354601|6340833|P1|NOT COMPLETED|Overall Study||2
2584823|NCT00354601|6340833|P1|COMPLETED|Overall Study||0
2584824|NCT00354601|6340833|P1|STARTED|Overall Study||2
2584825|NCT00354484|6340842|P2|NOT COMPLETED|Overall Study||3
2584826|NCT00354484|6340843|P1|NOT COMPLETED|Overall Study||4
2584827|NCT00354484|6340842|P2|COMPLETED|Overall Study||144
2584828|NCT00354484|6340843|P1|COMPLETED|Overall Study||138
2584829|NCT00354484|6340842|P2|STARTED|Overall Study||147
2584830|NCT00354484|6340843|P1|STARTED|Overall Study||142
2584831|NCT00354432|6340853|P4|NOT COMPLETED|Overall Study||10
2584832|NCT00354432|6340854|P3|NOT COMPLETED|Overall Study||10
2584833|NCT00354432|6340855|P2|NOT COMPLETED|Overall Study||8
2584834|NCT00354432|6340856|P1|NOT COMPLETED|Overall Study||6
2584835|NCT00354432|6340853|P4|COMPLETED|Overall Study||20
2584836|NCT00354432|6340854|P3|COMPLETED|Overall Study||20
2584837|NCT00354432|6340855|P2|COMPLETED|Overall Study||22
2584838|NCT00354432|6340856|P1|COMPLETED|Overall Study||24
2584839|NCT00354432|6340853|P4|STARTED|Overall Study||30
2584840|NCT00354432|6340854|P3|STARTED|Overall Study||30
2584841|NCT00354432|6340855|P2|STARTED|Overall Study||30
2584842|NCT00354432|6340856|P1|STARTED|Overall Study||30
2584843|NCT00354341|6340872|P2|NOT COMPLETED|Overall Study||7
2584844|NCT00354341|6340873|P1|NOT COMPLETED|Overall Study||3
2584845|NCT00354341|6340872|P2|COMPLETED|Overall Study||75
2584846|NCT00354341|6340873|P1|COMPLETED|Overall Study||85
2584847|NCT00354341|6340872|P2|STARTED|Overall Study||82
2584848|NCT00354341|6340873|P1|STARTED|Overall Study||88
2584849|NCT00354224|6340889|P1|NOT COMPLETED|Overall Study||0
2584850|NCT00354224|6340889|P1|COMPLETED|Overall Study||10
2584851|NCT00354224|6340889|P1|STARTED|Overall Study||10
2584852|NCT00354172|6340895|P1|NOT COMPLETED|Overall Study||1
2584853|NCT00354172|6340895|P1|COMPLETED|Overall Study|1 patient did not reach umbilical cord blood transplant|15
2584854|NCT00354172|6340895|P1|STARTED|Overall Study||16
2584855|NCT00354159|6340915|P2|NOT COMPLETED|Long-term Follow-up||176
2584856|NCT00354159|6340916|P1|NOT COMPLETED|Long-term Follow-up||180
2584857|NCT00354159|6340915|P2|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
2584858|NCT00354159|6340916|P1|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
2584859|NCT00354159|6340915|P2|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|176
2584860|NCT00354159|6340916|P1|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|180
2584861|NCT00354159|6340915|P2|NOT COMPLETED|Randomized Study Period||22
2584862|NCT00354159|6340916|P1|NOT COMPLETED|Randomized Study Period||22
2584863|NCT00354159|6340915|P2|COMPLETED|Randomized Study Period||176
2584864|NCT00354159|6340916|P1|COMPLETED|Randomized Study Period||180
2584865|NCT00354159|6340915|P2|STARTED|Randomized Study Period||198
2584867|NCT00354107|6340959|P1|NOT COMPLETED|Overall Study||5
2584868|NCT00354107|6340959|P1|COMPLETED|Overall Study||0
2584869|NCT00354107|6340959|P1|STARTED|Overall Study||5
2584870|NCT00354029|6340969|P2|NOT COMPLETED|Overall Study||2
2584871|NCT00354029|6340970|P1|NOT COMPLETED|Overall Study||4
2584872|NCT00354029|6340969|P2|COMPLETED|Overall Study||38
2584873|NCT00354029|6340970|P1|COMPLETED|Overall Study||39
2584874|NCT00354029|6340969|P2|STARTED|Overall Study||40
2584875|NCT00354029|6340970|P1|STARTED|Overall Study||43
2584876|NCT00353977|6340976|P1|NOT COMPLETED|Overall Study||0
2584877|NCT00353977|6340976|P1|COMPLETED|Overall Study||38
2584878|NCT00353977|6340976|P1|STARTED|Overall Study||38
2584879|NCT00353873|6340982|P2|NOT COMPLETED|Overall Study||3
2584880|NCT00353873|6340983|P1|NOT COMPLETED|Overall Study||6
2584881|NCT00353873|6340982|P2|COMPLETED|Overall Study||147
2584882|NCT00353873|6340983|P1|COMPLETED|Overall Study||147
2584883|NCT00353873|6340982|P2|STARTED|Overall Study||150
2584884|NCT00353873|6340983|P1|STARTED|Overall Study||153
2584885|NCT00353834|6340997|P2|NOT COMPLETED|Overall Study||0
2584886|NCT00353834|6340998|P1|NOT COMPLETED|Overall Study||0
2584887|NCT00353834|6340997|P2|COMPLETED|Overall Study||27
2584888|NCT00353834|6340998|P1|COMPLETED|Overall Study||26
2584889|NCT00353834|6340997|P2|STARTED|Overall Study||27
2584890|NCT00353834|6340998|P1|STARTED|Overall Study||26
2584891|NCT00353795|6341006|P1|NOT COMPLETED|Overall Study||0
2584892|NCT00353795|6341006|P1|COMPLETED|Overall Study||179
2584893|NCT00353795|6341006|P1|STARTED|Overall Study||179
2584894|NCT00353704|6341012|P2|NOT COMPLETED|Overall Study||1
2584895|NCT00353704|6341013|P1|NOT COMPLETED|Overall Study||3
2584896|NCT00353704|6341012|P2|COMPLETED|Overall Study||24
2584897|NCT00353704|6341013|P1|COMPLETED|Overall Study||22
2584898|NCT00353704|6341012|P2|STARTED|Overall Study||25
2584899|NCT00353704|6341013|P1|STARTED|Overall Study||25
2584900|NCT00353652|6341023|P8|NOT COMPLETED|Third Intervention – 3 Months||0
2584901|NCT00353652|6341024|P7|NOT COMPLETED|Third Intervention – 3 Months||0
2584902|NCT00353652|6341025|P6|NOT COMPLETED|Third Intervention – 3 Months||0
2584903|NCT00353652|6341026|P5|NOT COMPLETED|Third Intervention – 3 Months||0
2584904|NCT00353652|6341027|P4|NOT COMPLETED|Third Intervention – 3 Months||1
2584905|NCT00353652|6341028|P3|NOT COMPLETED|Third Intervention – 3 Months||0
2584906|NCT00353652|6341029|P2|NOT COMPLETED|Third Intervention – 3 Months||0
2584907|NCT00353652|6341030|P1|NOT COMPLETED|Third Intervention – 3 Months||0
2584908|NCT00353652|6341023|P8|COMPLETED|Third Intervention – 3 Months||0
2584909|NCT00353652|6341024|P7|COMPLETED|Third Intervention – 3 Months||1
2584910|NCT00353652|6341025|P6|COMPLETED|Third Intervention – 3 Months||0
2584911|NCT00353652|6341026|P5|COMPLETED|Third Intervention – 3 Months||3
2584912|NCT00353652|6341027|P4|COMPLETED|Third Intervention – 3 Months||6
2584913|NCT00353652|6341028|P3|COMPLETED|Third Intervention – 3 Months||6
2584914|NCT00353652|6341029|P2|COMPLETED|Third Intervention – 3 Months||0
2584915|NCT00353652|6341030|P1|COMPLETED|Third Intervention – 3 Months||0
2584916|NCT00353652|6341023|P8|STARTED|Third Intervention – 3 Months||0
2584917|NCT00353652|6341024|P7|STARTED|Third Intervention – 3 Months||1
2584918|NCT00353652|6341025|P6|STARTED|Third Intervention – 3 Months||0
2584919|NCT00353652|6341026|P5|STARTED|Third Intervention – 3 Months||3
2584920|NCT00353652|6341027|P4|STARTED|Third Intervention – 3 Months||7
2584921|NCT00353652|6341028|P3|STARTED|Third Intervention – 3 Months||6
2584922|NCT00353652|6341029|P2|STARTED|Third Intervention – 3 Months||0
2584923|NCT00353652|6341030|P1|STARTED|Third Intervention – 3 Months||0
2584924|NCT00353652|6341023|P8|NOT COMPLETED|Second Intervention – 3 Months||0
2584925|NCT00353652|6341024|P7|NOT COMPLETED|Second Intervention – 3 Months||0
2584926|NCT00353652|6341025|P6|NOT COMPLETED|Second Intervention – 3 Months||0
2584927|NCT00353652|6341026|P5|NOT COMPLETED|Second Intervention – 3 Months||0
2584928|NCT00353652|6341027|P4|NOT COMPLETED|Second Intervention – 3 Months||0
2584929|NCT00353652|6341028|P3|NOT COMPLETED|Second Intervention – 3 Months||0
2584930|NCT00353652|6341029|P2|NOT COMPLETED|Second Intervention – 3 Months||0
2584931|NCT00353652|6341030|P1|NOT COMPLETED|Second Intervention – 3 Months||0
2584932|NCT00353652|6341023|P8|COMPLETED|Second Intervention – 3 Months||0
2584933|NCT00353652|6341024|P7|COMPLETED|Second Intervention – 3 Months||1
2584934|NCT00353652|6341025|P6|COMPLETED|Second Intervention – 3 Months||0
2584935|NCT00353652|6341026|P5|COMPLETED|Second Intervention – 3 Months||3
2584936|NCT00353652|6341027|P4|COMPLETED|Second Intervention – 3 Months||7
2584937|NCT00353652|6341028|P3|COMPLETED|Second Intervention – 3 Months||6
2584938|NCT00353652|6341029|P2|COMPLETED|Second Intervention – 3 Months||11
2584939|NCT00353652|6341030|P1|COMPLETED|Second Intervention – 3 Months||12
2584940|NCT00353652|6341023|P8|STARTED|Second Intervention – 3 Months||0
2584941|NCT00353652|6341024|P7|STARTED|Second Intervention – 3 Months||1
2584942|NCT00353652|6341025|P6|STARTED|Second Intervention – 3 Months||0
2584943|NCT00353652|6341026|P5|STARTED|Second Intervention – 3 Months||3
2584944|NCT00353652|6341027|P4|STARTED|Second Intervention – 3 Months||7
2584945|NCT00353652|6341028|P3|STARTED|Second Intervention – 3 Months||6
2584946|NCT00353652|6341029|P2|STARTED|Second Intervention – 3 Months||11
2584947|NCT00353652|6341030|P1|STARTED|Second Intervention – 3 Months||12
2584948|NCT00353652|6341023|P8|NOT COMPLETED|First Intervention – 3 Months||0
2584949|NCT00353652|6341024|P7|NOT COMPLETED|First Intervention – 3 Months||0
2584950|NCT00353652|6341025|P6|NOT COMPLETED|First Intervention – 3 Months||0
2584951|NCT00353652|6341026|P5|NOT COMPLETED|First Intervention – 3 Months||0
2584952|NCT00353652|6341027|P4|NOT COMPLETED|First Intervention – 3 Months||0
2584953|NCT00353652|6341028|P3|NOT COMPLETED|First Intervention – 3 Months||0
2584954|NCT00353652|6341029|P2|NOT COMPLETED|First Intervention – 3 Months||4
2584955|NCT00353652|6341030|P1|NOT COMPLETED|First Intervention – 3 Months||3
2584956|NCT00353652|6341023|P8|COMPLETED|First Intervention – 3 Months||0
2584957|NCT00353652|6341024|P7|COMPLETED|First Intervention – 3 Months||1
2584958|NCT00353652|6341025|P6|COMPLETED|First Intervention – 3 Months||0
2584959|NCT00353652|6341026|P5|COMPLETED|First Intervention – 3 Months||3
2584960|NCT00353652|6341027|P4|COMPLETED|First Intervention – 3 Months||7
2584961|NCT00353652|6341028|P3|COMPLETED|First Intervention – 3 Months||6
2584962|NCT00353652|6341029|P2|COMPLETED|First Intervention – 3 Months||11
2584963|NCT00353652|6341030|P1|COMPLETED|First Intervention – 3 Months||12
2584964|NCT00353652|6341023|P8|STARTED|First Intervention – 3 Months||0
2584965|NCT00353652|6341024|P7|STARTED|First Intervention – 3 Months||1
2584966|NCT00353652|6341025|P6|STARTED|First Intervention – 3 Months||0
2584967|NCT00353652|6341026|P5|STARTED|First Intervention – 3 Months||3
2584968|NCT00353652|6341027|P4|STARTED|First Intervention – 3 Months||7
2584969|NCT00353652|6341028|P3|STARTED|First Intervention – 3 Months||6
2584970|NCT00353652|6341029|P2|STARTED|First Intervention – 3 Months||15
2584971|NCT00353652|6341030|P1|STARTED|First Intervention – 3 Months||15
2584972|NCT00353522|6341064|P2|NOT COMPLETED|Overall Study||9
2584973|NCT00353522|6341065|P1|NOT COMPLETED|Overall Study||15
2584974|NCT00353522|6341064|P2|COMPLETED|Overall Study||37
2584975|NCT00353522|6341065|P1|COMPLETED|Overall Study||74
2584976|NCT00353522|6341064|P2|STARTED|Overall Study||46
2584977|NCT00353522|6341065|P1|STARTED|Overall Study||89
2584978|NCT00353496|6341083|P2|NOT COMPLETED|Overall Study||17
2584979|NCT00353496|6341084|P1|NOT COMPLETED|Overall Study||16
2584980|NCT00353496|6341083|P2|COMPLETED|Overall Study||86
2584981|NCT00353496|6341084|P1|COMPLETED|Overall Study|Patients who completed specified assessments or met primary efficacy endpoint criteria for an event.|85
2584982|NCT00353496|6341083|P2|STARTED|Overall Study||103
2584983|NCT00353496|6341084|P1|STARTED|Overall Study||101
2584984|NCT00353431|6341101|P2|NOT COMPLETED|Overall Study||0
2584985|NCT00353431|6341102|P1|NOT COMPLETED|Overall Study||0
2584986|NCT00353431|6341101|P2|COMPLETED|Overall Study||67
2584987|NCT00353431|6341102|P1|COMPLETED|Overall Study||63
2584988|NCT00353431|6341101|P2|STARTED|Overall Study||67
2584989|NCT00353431|6341102|P1|STARTED|Overall Study||63
2584990|NCT00353418|6341118|P2|NOT COMPLETED|Overall Study||158
2584991|NCT00353418|6341119|P1|NOT COMPLETED|Overall Study||83
2584992|NCT00353418|6341118|P2|COMPLETED|Overall Study||119
2584993|NCT00353418|6341119|P1|COMPLETED|Overall Study||55
2584994|NCT00353418|6341118|P2|STARTED|Overall Study||277
2584995|NCT00353418|6341119|P1|STARTED|Overall Study||138
2584996|NCT00353366|6341137|P1|NOT COMPLETED|Overall Study||143
2584997|NCT00353366|6341137|P1|COMPLETED|Overall Study||1289
2584998|NCT00353366|6341137|P1|STARTED|Overall Study||1432
2584999|NCT00353301|6341144|P1|NOT COMPLETED|Overall Study||0
2585000|NCT00353301|6341144|P1|COMPLETED|Overall Study||25
2585001|NCT00353301|6341144|P1|STARTED|Overall Study||25
2585002|NCT00353275|6341151|P2|NOT COMPLETED|Overall Study||0
2585003|NCT00353275|6341152|P1|NOT COMPLETED|Overall Study||0
2585004|NCT00353275|6341151|P2|COMPLETED|Overall Study||3
2585005|NCT00353275|6341152|P1|COMPLETED|Overall Study||2
2585006|NCT00353275|6341151|P2|STARTED|Overall Study||3
2585007|NCT00353275|6341152|P1|STARTED|Overall Study||2
2585008|NCT00353262|6341164|P1|NOT COMPLETED|Overall Study||29
2585009|NCT00353262|6341164|P1|COMPLETED|Overall Study||7
2585010|NCT00353262|6341164|P1|STARTED|Overall Study||36
2585011|NCT00353119|6341183|P2|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
2585012|NCT00353119|6341184|P1|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
2585013|NCT00353119|6341183|P2|COMPLETED|Second Intervention Week 12 to Week 28||10
2585014|NCT00353119|6341184|P1|COMPLETED|Second Intervention Week 12 to Week 28||5
2585015|NCT00353119|6341183|P2|STARTED|Second Intervention Week 12 to Week 28||10
2585016|NCT00353119|6341184|P1|STARTED|Second Intervention Week 12 to Week 28||5
2585017|NCT00353119|6341183|P2|NOT COMPLETED|First Intervention Day 0 to Week 12||0
2585018|NCT00353119|6341184|P1|NOT COMPLETED|First Intervention Day 0 to Week 12||0
2585019|NCT00353119|6341183|P2|COMPLETED|First Intervention Day 0 to Week 12||10
2585020|NCT00353119|6341184|P1|COMPLETED|First Intervention Day 0 to Week 12||5
2585021|NCT00353119|6341183|P2|STARTED|First Intervention Day 0 to Week 12||10
2585022|NCT00353119|6341184|P1|STARTED|First Intervention Day 0 to Week 12||5
2585023|NCT00352911|6341196|P2|NOT COMPLETED|300mg Twice Daily (14 Days)||0
2585024|NCT00352911|6341197|P1|NOT COMPLETED|300mg Twice Daily (14 Days)||1
2585025|NCT00352911|6341196|P2|COMPLETED|300mg Twice Daily (14 Days)||3
2585026|NCT00352911|6341197|P1|COMPLETED|300mg Twice Daily (14 Days)||15
2585027|NCT00352911|6341196|P2|STARTED|300mg Twice Daily (14 Days)||3
2585028|NCT00352911|6341197|P1|STARTED|300mg Twice Daily (14 Days)||16
2585029|NCT00352911|6341196|P2|NOT COMPLETED|150mg Twice Daily (14 Days)||0
2585030|NCT00352911|6341197|P1|NOT COMPLETED|150mg Twice Daily (14 Days)||0
2585031|NCT00352911|6341196|P2|COMPLETED|150mg Twice Daily (14 Days)||3
2585032|NCT00352911|6341197|P1|COMPLETED|150mg Twice Daily (14 Days)||16
2585033|NCT00352911|6341196|P2|STARTED|150mg Twice Daily (14 Days)||3
2585034|NCT00352911|6341197|P1|STARTED|150mg Twice Daily (14 Days)||16
2585035|NCT00352885|6341205|P2|NOT COMPLETED|Overall Study||7
2585036|NCT00352885|6341206|P1|NOT COMPLETED|Overall Study||6
2585037|NCT00352885|6341205|P2|COMPLETED|Overall Study||4
2585038|NCT00352885|6341206|P1|COMPLETED|Overall Study||3
2585039|NCT00352885|6341205|P2|Completed Cycle 3 of IL-2 Treatment|Overall Study||7
2585040|NCT00352885|6341206|P1|Completed Cycle 3 of IL-2 Treatment|Overall Study||4
2585041|NCT00352885|6341205|P2|Completed Cycle 2 of IL-2 Treatment|Overall Study||9
2585042|NCT00352885|6341206|P1|Completed Cycle 2 of IL-2 Treatment|Overall Study||8
2585043|NCT00352885|6341205|P2|Completed Cycle 1 of IL-2 Treatment|Overall Study||11
2585044|NCT00352885|6341206|P1|Completed Cycle 1 of IL-2 Treatment|Overall Study||9
2585045|NCT00352885|6341205|P2|STARTED|Overall Study||11
2585046|NCT00352885|6341206|P1|STARTED|Overall Study||9
2585047|NCT00352846|6341224|P2|NOT COMPLETED|Overall Study||13
2585048|NCT00352846|6341225|P1|NOT COMPLETED|Overall Study||8
2585049|NCT00352846|6341224|P2|COMPLETED|Overall Study||24
2585050|NCT00352846|6341225|P1|COMPLETED|Overall Study||29
2585051|NCT00352846|6341224|P2|STARTED|Overall Study||37
2585052|NCT00352846|6341225|P1|STARTED|Overall Study||37
2585053|NCT00352794|6341231|P1|NOT COMPLETED|Overall Study||0
2585054|NCT00352794|6341231|P1|COMPLETED|Overall Study||40
2585055|NCT00352794|6341231|P1|STARTED|Overall Study||40
2585056|NCT00352781|6341235|P1|NOT COMPLETED|Overall Study||883
2585057|NCT00352781|6341235|P1|COMPLETED|Overall Study||884
2585058|NCT00352781|6341235|P1|STARTED|Overall Study||1767
2585059|NCT00352755|6341240|P1|NOT COMPLETED|Overall Study||2
2585060|NCT00352755|6341240|P1|COMPLETED|Overall Study||16
2585061|NCT00352755|6341240|P1|STARTED|Overall Study||18
2585062|NCT00352690|6341250|P2|NOT COMPLETED|Overall Study||0
2585063|NCT00352690|6341251|P1|NOT COMPLETED|Overall Study||2
2585064|NCT00352690|6341250|P2|COMPLETED|Overall Study||0
2585065|NCT00352690|6341251|P1|COMPLETED|Overall Study||8
2585066|NCT00352690|6341250|P2|STARTED|Overall Study||0
2585067|NCT00352690|6341251|P1|STARTED|Overall Study||10
2585068|NCT00352664|6341271|P2|NOT COMPLETED|Overall Study||0
2585069|NCT00352664|6341272|P1|NOT COMPLETED|Overall Study||7
2585070|NCT00352664|6341271|P2|COMPLETED|Overall Study||0
2585071|NCT00352664|6341272|P1|COMPLETED|Overall Study||20
2585072|NCT00352664|6341271|P2|STARTED|Overall Study||0
2585073|NCT00352664|6341272|P1|STARTED|Overall Study||27
2585074|NCT00352612|6341280|P2|NOT COMPLETED|Overall Study||0
2585075|NCT00352612|6341281|P1|NOT COMPLETED|Overall Study||0
2585076|NCT00352612|6341280|P2|COMPLETED|Overall Study||100
2585077|NCT00352612|6341281|P1|COMPLETED|Overall Study||100
2585078|NCT00352612|6341280|P2|STARTED|Overall Study||100
2585079|NCT00352612|6341281|P1|STARTED|Overall Study||100
2585080|NCT00352534|6341289|P7|NOT COMPLETED|Final Risk Group Assignment||39
2585081|NCT00352534|6341290|P6|NOT COMPLETED|Final Risk Group Assignment||45
2585082|NCT00352534|6341291|P5|NOT COMPLETED|Final Risk Group Assignment||1
2585083|NCT00352534|6341292|P4|NOT COMPLETED|Final Risk Group Assignment||3
2585084|NCT00352534|6341293|P3|NOT COMPLETED|Final Risk Group Assignment||3
2585085|NCT00352534|6341294|P2|NOT COMPLETED|Final Risk Group Assignment||0
2585086|NCT00352534|6341295|P1|NOT COMPLETED|Final Risk Group Assignment||0
2585087|NCT00352534|6341289|P7|COMPLETED|Final Risk Group Assignment||1
2585088|NCT00352534|6341290|P6|COMPLETED|Final Risk Group Assignment||503
2585089|NCT00352534|6341291|P5|COMPLETED|Final Risk Group Assignment||31
2585090|NCT00352534|6341292|P4|COMPLETED|Final Risk Group Assignment||49
2585091|NCT00352534|6341293|P3|COMPLETED|Final Risk Group Assignment||116
2585092|NCT00352534|6341294|P2|COMPLETED|Final Risk Group Assignment||0
2585093|NCT00352534|6341295|P1|COMPLETED|Final Risk Group Assignment||0
2585094|NCT00352534|6341289|P7|STARTED|Final Risk Group Assignment||40
2585095|NCT00352534|6341290|P6|STARTED|Final Risk Group Assignment||548
2585096|NCT00352534|6341291|P5|STARTED|Final Risk Group Assignment||32
2585097|NCT00352534|6341292|P4|STARTED|Final Risk Group Assignment||52
2585098|NCT00352534|6341293|P3|STARTED|Final Risk Group Assignment||119
2585099|NCT00352534|6341294|P2|STARTED|Final Risk Group Assignment||0
2585100|NCT00352534|6341295|P1|STARTED|Final Risk Group Assignment||0
2585101|NCT00352534|6341289|P7|NOT COMPLETED|Initial Staging||0
2585102|NCT00352534|6341290|P6|NOT COMPLETED|Initial Staging||0
2585103|NCT00352534|6341291|P5|NOT COMPLETED|Initial Staging||0
2585104|NCT00352534|6341292|P4|NOT COMPLETED|Initial Staging||0
2585105|NCT00352534|6341293|P3|NOT COMPLETED|Initial Staging||0
2585106|NCT00352534|6341294|P2|NOT COMPLETED|Initial Staging||9
2585107|NCT00352534|6341295|P1|NOT COMPLETED|Initial Staging||8
2585108|NCT00352534|6341289|P7|COMPLETED|Initial Staging||0
2585109|NCT00352534|6341290|P6|COMPLETED|Initial Staging||0
2585110|NCT00352534|6341291|P5|COMPLETED|Initial Staging||0
2585111|NCT00352534|6341292|P4|COMPLETED|Initial Staging||0
2585112|NCT00352534|6341293|P3|COMPLETED|Initial Staging||0
2585113|NCT00352534|6341294|P2|COMPLETED|Initial Staging||588
2585114|NCT00352534|6341295|P1|COMPLETED|Initial Staging||203
2585115|NCT00352534|6341289|P7|STARTED|Initial Staging||0
2585116|NCT00352534|6341290|P6|STARTED|Initial Staging||0
2585117|NCT00352534|6341291|P5|STARTED|Initial Staging||0
2585118|NCT00352534|6341292|P4|STARTED|Initial Staging||0
2585119|NCT00352534|6341293|P3|STARTED|Initial Staging||0
2585120|NCT00352534|6341294|P2|STARTED|Initial Staging||597
2585121|NCT00352534|6341295|P1|STARTED|Initial Staging||211
2585122|NCT00352417|6341312|P2|NOT COMPLETED|Overall Study||5
2585123|NCT00352417|6341313|P1|NOT COMPLETED|Overall Study||5
2585124|NCT00352417|6341312|P2|COMPLETED|Overall Study||21
2585125|NCT00352417|6341313|P1|COMPLETED|Overall Study||19
2585126|NCT00352417|6341312|P2|STARTED|Overall Study||26
2585127|NCT00352417|6341313|P1|STARTED|Overall Study||24
2585128|NCT00352365|6341327|P1|NOT COMPLETED|Maintenance Therapy||12
2585129|NCT00352365|6341327|P1|COMPLETED|Maintenance Therapy||0
2585130|NCT00352365|6341327|P1|Eligible and Began Protocol Therapy|Maintenance Therapy||8
2585131|NCT00352365|6341327|P1|STARTED|Maintenance Therapy||12
2585132|NCT00352365|6341327|P1|NOT COMPLETED|Induction Therapy||27
2585133|NCT00352365|6341327|P1|COMPLETED|Induction Therapy||14
2585134|NCT00352365|6341327|P1|Eligible and Began Protocol Therapy|Induction Therapy||37
2585135|NCT00352365|6341327|P1|Eligible|Induction Therapy||38
2585136|NCT00352365|6341327|P1|STARTED|Induction Therapy||41
2585137|NCT00352118|6341337|P1|NOT COMPLETED|Overall Study||4
2585138|NCT00352118|6341337|P1|COMPLETED|Overall Study||0
2585139|NCT00352118|6341337|P1|STARTED|Overall Study||4
2585140|NCT00352105|6341347|P1|NOT COMPLETED|Overall Study||40
2585141|NCT00352105|6341347|P1|COMPLETED|Overall Study||20
2585142|NCT00352105|6341347|P1|STARTED|Overall Study||60
2585143|NCT00352053|6341358|P2|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||2
2585144|NCT00352053|6341359|P1|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||1
2585145|NCT00352053|6341358|P2|COMPLETED|Third Extension Phase (Weeks 240-294)||2
2585146|NCT00352053|6341359|P1|COMPLETED|Third Extension Phase (Weeks 240-294)||0
2585147|NCT00352053|6341358|P2|STARTED|Third Extension Phase (Weeks 240-294)|5 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|4
2585148|NCT00352053|6341359|P1|STARTED|Third Extension Phase (Weeks 240-294)|3 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|1
2585149|NCT00352053|6341358|P2|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
2585150|NCT00352053|6341359|P1|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
2585151|NCT00352053|6341358|P2|COMPLETED|Second Extension Phase (Weeks 144-240)||9
2585152|NCT00352053|6341359|P1|COMPLETED|Second Extension Phase (Weeks 144-240)||4
2585153|NCT00352053|6341358|P2|STARTED|Second Extension Phase (Weeks 144-240)|5 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|14
2585154|NCT00352053|6341359|P1|STARTED|Second Extension Phase (Weeks 144-240)|3 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|9
2585155|NCT00352053|6341358|P2|NOT COMPLETED|First Extension Phase (Weeks 48-144)||17
2585156|NCT00352053|6341359|P1|NOT COMPLETED|First Extension Phase (Weeks 48-144)||12
2585157|NCT00352053|6341358|P2|COMPLETED|First Extension Phase (Weeks 48-144)||19
2585158|NCT00352053|6341359|P1|COMPLETED|First Extension Phase (Weeks 48-144)||12
2585159|NCT00352053|6341358|P2|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|36
2585160|NCT00352053|6341359|P1|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|24
2585161|NCT00352053|6341358|P2|NOT COMPLETED|Double-Blind Phase (Through Week 48)||13
2585162|NCT00352053|6341359|P1|NOT COMPLETED|Double-Blind Phase (Through Week 48)||18
2585163|NCT00352053|6341358|P2|COMPLETED|Double-Blind Phase (Through Week 48)|The 10 participants discontinued for virologic failure enrolled early in the open-label extension.|29
2585164|NCT00352053|6341359|P1|COMPLETED|Double-Blind Phase (Through Week 48)||27
2585165|NCT00352053|6341358|P2|STARTED|Double-Blind Phase (Through Week 48)||42
2585166|NCT00352053|6341359|P1|STARTED|Double-Blind Phase (Through Week 48)||45
2585167|NCT00352027|6341526|P1|NOT COMPLETED|Overall Study||3
2585168|NCT00352027|6341526|P1|COMPLETED|Overall Study||77
2585169|NCT00352027|6341526|P1|STARTED|Overall Study||80
2585170|NCT00352001|6341795|P1|NOT COMPLETED|Overall Study||0
2585171|NCT00352001|6341795|P1|COMPLETED|Overall Study||37
2585172|NCT00352001|6341795|P1|Azacitidine 75mg/Lenalidomide 10mg-14day|Overall Study||3
2585173|NCT00352001|6341795|P1|Azacitidine 75mg/Lenalidomide 5mg-21 Day|Overall Study||3
2585174|NCT00352001|6341795|P1|Azacitidine 75mg/Lenalidomide 5mg-14 Day|Overall Study||3
2585175|NCT00352001|6341795|P1|STARTED|Overall Study||37
2585176|NCT00351936|6341806|P1|NOT COMPLETED|Overall Study||0
2585177|NCT00351936|6341806|P1|COMPLETED|Overall Study||15
2585178|NCT00351936|6341806|P1|STARTED|Overall Study||15
2585179|NCT00351819|6341825|P2|NOT COMPLETED|Overall Study||12
2585180|NCT00351819|6341826|P1|NOT COMPLETED|Overall Study||7
2585181|NCT00351819|6341825|P2|COMPLETED|Overall Study||29
2585182|NCT00351819|6341826|P1|COMPLETED|Overall Study||36
2585183|NCT00351819|6341825|P2|STARTED|Overall Study||41
2585184|NCT00351819|6341826|P1|STARTED|Overall Study||43
2585185|NCT00351741|6341876|P2|NOT COMPLETED|Overall Study||0
2585186|NCT00351741|6341877|P1|NOT COMPLETED|Overall Study||0
2585187|NCT00351741|6341876|P2|COMPLETED|Overall Study||31
2585188|NCT00351741|6341877|P1|COMPLETED|Overall Study||31
2585189|NCT00351741|6341876|P2|STARTED|Overall Study||31
2585190|NCT00351741|6341877|P1|STARTED|Overall Study||31
2585191|NCT00351533|6341897|P2|NOT COMPLETED|Overall Study||5
2585192|NCT00351533|6341898|P1|NOT COMPLETED|Overall Study||2
2585193|NCT00351533|6341897|P2|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|44
2585194|NCT00351533|6341898|P1|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|39
2585195|NCT00351533|6341897|P2|STARTED|Overall Study||49
2585196|NCT00351533|6341898|P1|STARTED|Overall Study||41
2585197|NCT00351468|6341958|P1|NOT COMPLETED|Overall Study||167
2585198|NCT00351468|6341958|P1|COMPLETED|Overall Study||135
2585199|NCT00351468|6341958|P1|Unknown - Not From Previous Trial|Overall Study|Mistakenly enrolled (not in any of the 3 trials) On 50 mg/d eltrombopag for 18 days and withdrawn|1
2585200|NCT00351468|6341958|P1|Subjects From TRA108057 Repeat|Overall Study||43
2585201|NCT00351468|6341958|P1|Subjects From TRA102537 Raise|Overall Study||146
2585202|NCT00351468|6341958|P1|Subjects From TRA100773B|Overall Study||61
2585203|NCT00351468|6341958|P1|Subjects From TRA100773A|Overall Study||51
2585204|NCT00351468|6341958|P1|STARTED|Overall Study||302
2585205|NCT00351416|6341975|P2|NOT COMPLETED|Overall Study||0
2585206|NCT00351416|6341976|P1|NOT COMPLETED|Overall Study||0
2585207|NCT00351416|6341975|P2|COMPLETED|Overall Study||9
2585208|NCT00351416|6341976|P1|COMPLETED|Overall Study||6
2585209|NCT00351416|6341975|P2|STARTED|Overall Study||9
2585210|NCT00351416|6341976|P1|STARTED|Overall Study||6
2585211|NCT00351377|6341982|P1|NOT COMPLETED|Overall Study||7
2585212|NCT00351377|6341982|P1|COMPLETED|Overall Study||104
2585213|NCT00351377|6341982|P1|STARTED|Overall Study||111
2585214|NCT00351351|6341996|P2|NOT COMPLETED|Overall Study||4
2585215|NCT00351351|6341997|P1|NOT COMPLETED|Overall Study||9
2585216|NCT00351351|6341996|P2|COMPLETED|Overall Study||32
2585217|NCT00351351|6341997|P1|COMPLETED|Overall Study||25
2585218|NCT00351351|6341996|P2|STARTED|Overall Study||36
2585219|NCT00351351|6341997|P1|STARTED|Overall Study||34
2585220|NCT00351299|6342005|P2|NOT COMPLETED|Overall Study||0
2585221|NCT00351299|6342006|P1|NOT COMPLETED|Overall Study||0
2585222|NCT00351299|6342005|P2|COMPLETED|Overall Study||28
2585223|NCT00351299|6342006|P1|COMPLETED|Overall Study||25
2585224|NCT00351299|6342005|P2|STARTED|Overall Study||28
2585225|NCT00351299|6342006|P1|STARTED|Overall Study||25
2585226|NCT00351273|6342023|P3|NOT COMPLETED|Overall Study||5
2585227|NCT00351273|6342024|P2|NOT COMPLETED|Overall Study||2
2585228|NCT00351273|6342025|P1|NOT COMPLETED|Overall Study||1
2585229|NCT00351273|6342023|P3|COMPLETED|Overall Study||10
2585230|NCT00351273|6342024|P2|COMPLETED|Overall Study||10
2585231|NCT00351273|6342025|P1|COMPLETED|Overall Study||14
2585232|NCT00351273|6342023|P3|STARTED|Overall Study||15
2585233|NCT00351273|6342024|P2|STARTED|Overall Study||12
2585234|NCT00351273|6342025|P1|STARTED|Overall Study||15
2585235|NCT00351039|6342048|P1|NOT COMPLETED|Overall Study||0
2585236|NCT00351039|6342048|P1|COMPLETED|Overall Study|The study was halted before Phase II was initiated.|8
2585237|NCT00351039|6342048|P1|STARTED|Overall Study||8
2585238|NCT00351000|6342057|P1|NOT COMPLETED|Overall Study||3
2585239|NCT00351000|6342057|P1|COMPLETED|Overall Study||21
2585240|NCT00351000|6342057|P1|STARTED|Overall Study||24
2585241|NCT00350870|6342068|P4|NOT COMPLETED|Overall Study||15
2585242|NCT00350870|6342069|P3|NOT COMPLETED|Overall Study||16
2585243|NCT00350870|6342070|P2|NOT COMPLETED|Overall Study||17
2585244|NCT00350870|6342071|P1|NOT COMPLETED|Overall Study||22
2585245|NCT00350870|6342068|P4|COMPLETED|Overall Study||7
2585246|NCT00350870|6342069|P3|COMPLETED|Overall Study||6
2585247|NCT00350870|6342070|P2|COMPLETED|Overall Study||11
2585248|NCT00350870|6342071|P1|COMPLETED|Overall Study||5
2585249|NCT00350870|6342068|P4|Had at Least 1 Day of Med|Overall Study||19
2585250|NCT00350870|6342069|P3|Had at Least 1 Day of Med|Overall Study||18
2585251|NCT00350870|6342070|P2|Had at Least 1 Day of Med|Overall Study||24
2585252|NCT00350870|6342071|P1|Had at Least 1 Day of Med|Overall Study||19
2585253|NCT00350870|6342068|P4|STARTED|Overall Study||22
2585254|NCT00350870|6342069|P3|STARTED|Overall Study||22
2585255|NCT00350870|6342070|P2|STARTED|Overall Study||28
2585256|NCT00350870|6342071|P1|STARTED|Overall Study||27
2585257|NCT00350844|6342085|P1|NOT COMPLETED|Overall Study||1
2585258|NCT00350844|6342085|P1|COMPLETED|Overall Study||5
2585259|NCT00350844|6342085|P1|STARTED|Overall Study||6
2585260|NCT00350792|6342089|P1|NOT COMPLETED|Overall Study||33
2585261|NCT00350792|6342089|P1|COMPLETED|Overall Study||29
2585262|NCT00350792|6342089|P1|STARTED|Overall Study||62
2585263|NCT00350779|6342099|P2|NOT COMPLETED|Overall Study||21
2585264|NCT00350779|6342100|P1|NOT COMPLETED|Overall Study||22
2585265|NCT00350779|6342099|P2|COMPLETED|Overall Study||71
2585266|NCT00350779|6342100|P1|COMPLETED|Overall Study||148
2585267|NCT00350779|6342099|P2|STARTED|Overall Study||92
2585268|NCT00350779|6342100|P1|STARTED|Overall Study||170
2585269|NCT00350727|6342121|P3|NOT COMPLETED|Phase II||22
2585270|NCT00350727|6342122|P2|NOT COMPLETED|Phase II||19
2585271|NCT00350727|6342123|P1|NOT COMPLETED|Phase II||0
2585272|NCT00350727|6342121|P3|COMPLETED|Phase II||0
2585273|NCT00350727|6342122|P2|COMPLETED|Phase II||0
2585274|NCT00350727|6342123|P1|COMPLETED|Phase II||0
2585275|NCT00350727|6342121|P3|STARTED|Phase II||22
2585276|NCT00350727|6342122|P2|STARTED|Phase II||19
2585277|NCT00350727|6342123|P1|STARTED|Phase II||0
2585278|NCT00350727|6342121|P3|NOT COMPLETED|Phase I: Dose Escalation||0
2585279|NCT00350727|6342122|P2|NOT COMPLETED|Phase I: Dose Escalation||0
2585280|NCT00350727|6342123|P1|NOT COMPLETED|Phase I: Dose Escalation||34
2585281|NCT00350727|6342121|P3|COMPLETED|Phase I: Dose Escalation||0
2585282|NCT00350727|6342122|P2|COMPLETED|Phase I: Dose Escalation||0
2585283|NCT00350727|6342123|P1|COMPLETED|Phase I: Dose Escalation||0
2585284|NCT00350727|6342121|P3|STARTED|Phase I: Dose Escalation||0
2585285|NCT00350727|6342122|P2|STARTED|Phase I: Dose Escalation||0
2585286|NCT00350727|6342123|P1|STARTED|Phase I: Dose Escalation||34
2585287|NCT00350636|6342267|P2|NOT COMPLETED|Overall Study||45
2585288|NCT00350636|6342268|P1|NOT COMPLETED|Overall Study||43
2585289|NCT00350636|6342267|P2|COMPLETED|Overall Study||355
2585290|NCT00350636|6342268|P1|COMPLETED|Overall Study||346
2585291|NCT00350636|6342267|P2|STARTED|Overall Study||400
2585292|NCT00350636|6342268|P1|STARTED|Overall Study||389
2585293|NCT00350623|6342287|P3|NOT COMPLETED|Overall Study||6
2585294|NCT00350623|6342288|P2|NOT COMPLETED|Overall Study||4
2585295|NCT00350623|6342289|P1|NOT COMPLETED|Overall Study||8
2585296|NCT00350623|6342287|P3|COMPLETED|Overall Study||62
2585297|NCT00350623|6342288|P2|COMPLETED|Overall Study||67
2585298|NCT00350623|6342289|P1|COMPLETED|Overall Study||63
2585299|NCT00350623|6342287|P3|STARTED|Overall Study||68
2585300|NCT00350623|6342288|P2|STARTED|Overall Study||71
2585301|NCT00350623|6342289|P1|STARTED|Overall Study||71
2585302|NCT00350545|6342297|P1|NOT COMPLETED|Overall Study||2
2585303|NCT00350545|6342297|P1|COMPLETED|Overall Study||35
2585304|NCT00350545|6342297|P1|STARTED|Overall Study||37
2585305|NCT00350532|6342307|P2|NOT COMPLETED|Overall Study||0
2585306|NCT00350532|6342308|P1|NOT COMPLETED|Overall Study||0
2585307|NCT00350532|6342307|P2|COMPLETED|Overall Study||19
2585308|NCT00350532|6342308|P1|COMPLETED|Overall Study||24
2585309|NCT00350532|6342307|P2|STARTED|Overall Study||19
2585310|NCT00350532|6342308|P1|STARTED|Overall Study||24
2585311|NCT00350519|6342316|P2|NOT COMPLETED|Overall Study||6
2585312|NCT00350519|6342317|P1|NOT COMPLETED|Overall Study||4
2585313|NCT00350519|6342316|P2|COMPLETED|Overall Study||13
2585314|NCT00350519|6342317|P1|COMPLETED|Overall Study||14
2585315|NCT00350519|6342316|P2|STARTED|Overall Study||19
2585316|NCT00350519|6342317|P1|STARTED|Overall Study||18
2585317|NCT00350402|6342331|P2|NOT COMPLETED|Overall Study||1
2585318|NCT00350402|6342332|P1|NOT COMPLETED|Overall Study||1
2585319|NCT00350402|6342331|P2|COMPLETED|Overall Study||20
2585320|NCT00350402|6342332|P1|COMPLETED|Overall Study||20
2585321|NCT00350402|6342331|P2|STARTED|Overall Study||21
2585322|NCT00350402|6342332|P1|STARTED|Overall Study||21
2585323|NCT00350363|6342344|P1|NOT COMPLETED|Overall Study||0
2585324|NCT00350363|6342344|P1|COMPLETED|Overall Study||60
2585325|NCT00350363|6342344|P1|STARTED|Overall Study||60
2585326|NCT00350337|6342352|P4|NOT COMPLETED|Overall Study||0
2585327|NCT00350337|6342353|P3|NOT COMPLETED|Overall Study||3
2585328|NCT00350337|6342354|P2|NOT COMPLETED|Overall Study||3
2585329|NCT00350337|6342355|P1|NOT COMPLETED|Overall Study||5
2585330|NCT00350337|6342352|P4|COMPLETED|Overall Study||21
2585331|NCT00350337|6342353|P3|COMPLETED|Overall Study||18
2585332|NCT00350337|6342354|P2|COMPLETED|Overall Study||19
2585333|NCT00350337|6342355|P1|COMPLETED|Overall Study||17
2585334|NCT00350337|6342352|P4|STARTED|Overall Study||21
2585335|NCT00350337|6342353|P3|STARTED|Overall Study||21
2585336|NCT00350337|6342354|P2|STARTED|Overall Study||22
2585337|NCT00350337|6342355|P1|STARTED|Overall Study||22
2585338|NCT00350272|6342405|P2|NOT COMPLETED|Open-Label 84 Week Treatment||8
2585339|NCT00350272|6342406|P1|NOT COMPLETED|Open-Label 84 Week Treatment||9
2585340|NCT00350272|6342405|P2|COMPLETED|Open-Label 84 Week Treatment||27
2585341|NCT00350272|6342406|P1|COMPLETED|Open-Label 84 Week Treatment||21
2585342|NCT00350272|6342405|P2|STARTED|Open-Label 84 Week Treatment||35
2585343|NCT00350272|6342406|P1|STARTED|Open-Label 84 Week Treatment||30
2585344|NCT00350272|6342405|P2|NOT COMPLETED|Blinded 12 Week Treatment||2
2585345|NCT00350272|6342406|P1|NOT COMPLETED|Blinded 12 Week Treatment||9
2585346|NCT00350272|6342405|P2|COMPLETED|Blinded 12 Week Treatment||35
2585347|NCT00350272|6342406|P1|COMPLETED|Blinded 12 Week Treatment||30
2585348|NCT00350272|6342405|P2|STARTED|Blinded 12 Week Treatment||37
2585349|NCT00350272|6342406|P1|STARTED|Blinded 12 Week Treatment||39
2585350|NCT00350220|6342416|P2|NOT COMPLETED|Overall Study||0
2585351|NCT00350220|6342417|P1|NOT COMPLETED|Overall Study||0
2585352|NCT00350220|6342416|P2|COMPLETED|Overall Study||30
2585353|NCT00350220|6342417|P1|COMPLETED|Overall Study||30
2585354|NCT00350220|6342416|P2|STARTED|Overall Study||30
2585355|NCT00350220|6342417|P1|STARTED|Overall Study||30
2585356|NCT00350207|6342428|P3|NOT COMPLETED|Overall Study||7
2585357|NCT00350207|6342429|P2|NOT COMPLETED|Overall Study||6
2585358|NCT00350207|6342430|P1|NOT COMPLETED|Overall Study||8
2585359|NCT00350207|6342428|P3|COMPLETED|Overall Study||119
2585360|NCT00350207|6342429|P2|COMPLETED|Overall Study||128
2585361|NCT00350207|6342430|P1|COMPLETED|Overall Study||120
2585362|NCT00350207|6342428|P3|STARTED|Overall Study||126
2585363|NCT00350207|6342429|P2|STARTED|Overall Study||134
2585364|NCT00350207|6342430|P1|STARTED|Overall Study||128
2585365|NCT00350142|6342624|P1|NOT COMPLETED|Overall Study||0
2585366|NCT00350142|6342624|P1|COMPLETED|Overall Study||20
2585367|NCT00350142|6342624|P1|STARTED|Overall Study||20
2585368|NCT00350025|6342631|P2|NOT COMPLETED|Overall Study||2
2585369|NCT00350025|6342632|P1|NOT COMPLETED|Overall Study||0
2585370|NCT00350025|6342631|P2|COMPLETED|Overall Study||28
2585371|NCT00350025|6342632|P1|COMPLETED|Overall Study||11
2585372|NCT00350025|6342631|P2|STARTED|Overall Study||30
2585373|NCT00350025|6342632|P1|STARTED|Overall Study||11
2585374|NCT00349973|6342642|P2|NOT COMPLETED|Overall Study||3
2585375|NCT00349973|6342643|P1|NOT COMPLETED|Overall Study||4
2585376|NCT00349973|6342642|P2|COMPLETED|Overall Study||5
2585377|NCT00349973|6342643|P1|COMPLETED|Overall Study||8
2585378|NCT00349973|6342642|P2|STARTED|Overall Study||8
2585379|NCT00349973|6342643|P1|STARTED|Overall Study||12
2585380|NCT00349921|6342657|P4|NOT COMPLETED|Second Spinal Injection||0
2585381|NCT00349921|6342658|P3|NOT COMPLETED|Second Spinal Injection||0
2585382|NCT00349921|6342659|P2|NOT COMPLETED|Second Spinal Injection||0
2585383|NCT00349921|6342660|P1|NOT COMPLETED|Second Spinal Injection||0
2585384|NCT00349921|6342657|P4|COMPLETED|Second Spinal Injection||1
2585385|NCT00349921|6342658|P3|COMPLETED|Second Spinal Injection||0
2585386|NCT00349921|6342659|P2|COMPLETED|Second Spinal Injection||10
2585387|NCT00349921|6342660|P1|COMPLETED|Second Spinal Injection||9
2585388|NCT00349921|6342657|P4|STARTED|Second Spinal Injection||1
2585389|NCT00349921|6342658|P3|STARTED|Second Spinal Injection||0
2585390|NCT00349921|6342659|P2|STARTED|Second Spinal Injection||10
2585391|NCT00349921|6342660|P1|STARTED|Second Spinal Injection|One patient experienced an adverse event after period one and did not participate in period two|9
2585392|NCT00349921|6342657|P4|NOT COMPLETED|First Spinal Injection||0
2585393|NCT00349921|6342658|P3|NOT COMPLETED|First Spinal Injection||1
2585394|NCT00349921|6342659|P2|NOT COMPLETED|First Spinal Injection||0
2585395|NCT00349921|6342660|P1|NOT COMPLETED|First Spinal Injection||1
2585396|NCT00349921|6342657|P4|COMPLETED|First Spinal Injection||1
2585397|NCT00349921|6342658|P3|COMPLETED|First Spinal Injection||0
2585398|NCT00349921|6342659|P2|COMPLETED|First Spinal Injection||10
2585399|NCT00349921|6342660|P1|COMPLETED|First Spinal Injection||9
2585400|NCT00349921|6342657|P4|STARTED|First Spinal Injection||1
2585401|NCT00349921|6342658|P3|STARTED|First Spinal Injection||1
2585402|NCT00349921|6342659|P2|STARTED|First Spinal Injection||10
2585403|NCT00349921|6342660|P1|STARTED|First Spinal Injection||10
2585404|NCT00349908|6342671|P2|NOT COMPLETED|Overall Study||4
2585405|NCT00349908|6342672|P1|NOT COMPLETED|Overall Study||0
2585406|NCT00349908|6342671|P2|COMPLETED|Overall Study|9 returned for 30 day follow-up, 7 returned for 6 month and 6/7 had 6 month angiogram|6
2585407|NCT00349908|6342672|P1|COMPLETED|Overall Study||10
2585408|NCT00349908|6342671|P2|STARTED|Overall Study||10
2585409|NCT00349908|6342672|P1|STARTED|Overall Study||10
2585410|NCT00349778|6342690|P1|NOT COMPLETED|Overall Study||0
2585411|NCT00349778|6342690|P1|COMPLETED|Overall Study||102
2585412|NCT00349778|6342690|P1|STARTED|Overall Study||102
2585413|NCT00349752|6342698|P2|NOT COMPLETED|Overall Study||64
2585414|NCT00349752|6342699|P1|NOT COMPLETED|Overall Study||59
2585415|NCT00349752|6342698|P2|COMPLETED|Overall Study||23
2585416|NCT00349752|6342699|P1|COMPLETED|Overall Study||28
2585417|NCT00349752|6342698|P2|STARTED|Overall Study||87
2585418|NCT00349752|6342699|P1|STARTED|Overall Study||87
2585419|NCT00349713|6342728|P3|NOT COMPLETED|Overall Study||0
2585420|NCT00349713|6342729|P2|NOT COMPLETED|Overall Study||0
2585421|NCT00349713|6342730|P1|NOT COMPLETED|Overall Study||0
2585422|NCT00349713|6342728|P3|COMPLETED|Overall Study||20
2585423|NCT00349713|6342729|P2|COMPLETED|Overall Study||20
2585424|NCT00349713|6342730|P1|COMPLETED|Overall Study||20
2585425|NCT00349713|6342728|P3|STARTED|Overall Study||20
2585426|NCT00349713|6342729|P2|STARTED|Overall Study||20
2585427|NCT00349713|6342730|P1|STARTED|Overall Study||20
2585428|NCT00349622|6342752|P2|NOT COMPLETED|Overall Study||96
2585429|NCT00349622|6342753|P1|NOT COMPLETED|Overall Study||178
2585430|NCT00349622|6342752|P2|COMPLETED|Overall Study||77
2585431|NCT00349622|6342753|P1|COMPLETED|Overall Study||162
2585432|NCT00349622|6342752|P2|STARTED|Overall Study||173
2585433|NCT00349622|6342753|P1|STARTED|Overall Study||340
2585434|NCT00349466|6342771|P2|NOT COMPLETED|Overall Study||3
2585435|NCT00349466|6342772|P1|NOT COMPLETED|Overall Study||9
2585436|NCT00349466|6342771|P2|COMPLETED|Overall Study||35
2585437|NCT00349466|6342772|P1|COMPLETED|Overall Study||33
2585438|NCT00349466|6342771|P2|STARTED|Overall Study||38
2585439|NCT00349466|6342772|P1|STARTED|Overall Study||42
2585440|NCT00349388|6342780|P2|NOT COMPLETED|Overall Study||0
2585441|NCT00349388|6342781|P1|NOT COMPLETED|Overall Study||0
2585442|NCT00349388|6342780|P2|COMPLETED|Overall Study||1
2585443|NCT00349388|6342781|P1|COMPLETED|Overall Study|no patients enrolled , therefore no patients completed|0
2585444|NCT00349388|6342780|P2|STARTED|Overall Study||1
2585445|NCT00349388|6342781|P1|STARTED|Overall Study|no patients enrolled|0
2585446|NCT00349349|6342792|P3|NOT COMPLETED|Overall Study||6
2585447|NCT00349349|6342793|P2|NOT COMPLETED|Overall Study||62
2585448|NCT00349349|6342794|P1|NOT COMPLETED|Overall Study||53
2585449|NCT00349349|6342792|P3|COMPLETED|Overall Study||10
2585450|NCT00349349|6342793|P2|COMPLETED|Overall Study||50
2585451|NCT00349349|6342794|P1|COMPLETED|Overall Study||42
2585452|NCT00349349|6342792|P3|STARTED|Overall Study||16
2585453|NCT00349349|6342793|P2|STARTED|Overall Study||112
2585454|NCT00349349|6342794|P1|STARTED|Overall Study||95
2585455|NCT00349336|6342860|P2|NOT COMPLETED|Overall Study||14
2585456|NCT00349336|6342861|P1|NOT COMPLETED|Overall Study||13
2585457|NCT00349336|6342860|P2|COMPLETED|Overall Study||18
2585458|NCT00349336|6342861|P1|COMPLETED|Overall Study||19
2585459|NCT00349336|6342860|P2|STARTED|Overall Study||32
2585460|NCT00349336|6342861|P1|STARTED|Overall Study||32
2585461|NCT00348933|6342883|P1|NOT COMPLETED|Overall Study||25
2585462|NCT00348933|6342883|P1|COMPLETED|Overall Study||65
2585463|NCT00348933|6342883|P1|STARTED|Overall Study||90
2585464|NCT00348881|6342891|P2|NOT COMPLETED|Overall Study||12
2585465|NCT00348881|6342892|P1|NOT COMPLETED|Overall Study||17
2585466|NCT00348881|6342891|P2|COMPLETED|Overall Study||697
2585467|NCT00348881|6342892|P1|COMPLETED|Overall Study||1407
2585468|NCT00348881|6342891|P2|STARTED|Overall Study||709
2585469|NCT00348881|6342892|P1|STARTED|Overall Study||1424
2585470|NCT00348816|6342904|P1|NOT COMPLETED|Overall Study||1
2585471|NCT00348816|6342904|P1|COMPLETED|Overall Study||19
2585472|NCT00348816|6342904|P1|STARTED|Overall Study||20
2585473|NCT00348790|6342911|P1|NOT COMPLETED|Completed Treatment||25
2585474|NCT00348790|6342911|P1|COMPLETED|Completed Treatment||0
2585475|NCT00348790|6342911|P1|STARTED|Completed Treatment||25
2585476|NCT00348790|6342911|P1|NOT COMPLETED|Began Treatment||0
2585477|NCT00348790|6342911|P1|COMPLETED|Began Treatment||25
2585478|NCT00348790|6342911|P1|STARTED|Began Treatment||25
2585479|NCT00348686|6342923|P1|NOT COMPLETED|Overall Study||66
2585480|NCT00348686|6342923|P1|COMPLETED|Overall Study||249
2585481|NCT00348686|6342923|P1|STARTED|Overall Study||315
2585482|NCT00348673|6342940|P9|NOT COMPLETED|Stage 2||0
2585483|NCT00348673|6342941|P8|NOT COMPLETED|Stage 2||0
2585484|NCT00348673|6342942|P7|NOT COMPLETED|Stage 2||0
2585485|NCT00348673|6342943|P6|NOT COMPLETED|Stage 2||0
2585486|NCT00348673|6342944|P5|NOT COMPLETED|Stage 2||0
2585487|NCT00348673|6342945|P4|NOT COMPLETED|Stage 2||0
2585488|NCT00348673|6342946|P3|NOT COMPLETED|Stage 2||0
2585489|NCT00348673|6342947|P2|NOT COMPLETED|Stage 2||0
2585490|NCT00348673|6342948|P1|NOT COMPLETED|Stage 2||0
2585491|NCT00348673|6342940|P9|COMPLETED|Stage 2||2
2585492|NCT00348673|6342941|P8|COMPLETED|Stage 2||6
2585493|NCT00348673|6342942|P7|COMPLETED|Stage 2||6
2585494|NCT00348673|6342943|P6|COMPLETED|Stage 2||6
2585495|NCT00348673|6342944|P5|COMPLETED|Stage 2||0
2585496|NCT00348673|6342945|P4|COMPLETED|Stage 2||0
2585497|NCT00348673|6342946|P3|COMPLETED|Stage 2||0
2585498|NCT00348673|6342947|P2|COMPLETED|Stage 2||0
2585499|NCT00348673|6342948|P1|COMPLETED|Stage 2||0
2585500|NCT00348673|6342940|P9|STARTED|Stage 2||2
2585501|NCT00348673|6342941|P8|STARTED|Stage 2||6
2585502|NCT00348673|6342942|P7|STARTED|Stage 2||6
2585503|NCT00348673|6342943|P6|STARTED|Stage 2||6
2585504|NCT00348673|6342944|P5|STARTED|Stage 2||0
2585505|NCT00348673|6342945|P4|STARTED|Stage 2||0
2585506|NCT00348673|6342946|P3|STARTED|Stage 2||0
2585507|NCT00348673|6342947|P2|STARTED|Stage 2||0
2585508|NCT00348673|6342948|P1|STARTED|Stage 2||0
2585509|NCT00348673|6342940|P9|NOT COMPLETED|Stage 1||0
2585510|NCT00348673|6342941|P8|NOT COMPLETED|Stage 1||0
2585511|NCT00348673|6342942|P7|NOT COMPLETED|Stage 1||0
2585512|NCT00348673|6342943|P6|NOT COMPLETED|Stage 1||0
2585513|NCT00348673|6342944|P5|NOT COMPLETED|Stage 1||0
2585514|NCT00348673|6342945|P4|NOT COMPLETED|Stage 1||0
2585515|NCT00348673|6342946|P3|NOT COMPLETED|Stage 1||1
2585516|NCT00348673|6342947|P2|NOT COMPLETED|Stage 1||0
2585517|NCT00348673|6342948|P1|NOT COMPLETED|Stage 1||0
2585518|NCT00348673|6342940|P9|COMPLETED|Stage 1||0
2585519|NCT00348673|6342941|P8|COMPLETED|Stage 1||0
2585520|NCT00348673|6342942|P7|COMPLETED|Stage 1||0
2585521|NCT00348673|6342943|P6|COMPLETED|Stage 1||0
2585522|NCT00348673|6342944|P5|COMPLETED|Stage 1||4
2585523|NCT00348673|6342945|P4|COMPLETED|Stage 1||6
2585524|NCT00348673|6342946|P3|COMPLETED|Stage 1||6
2585525|NCT00348673|6342947|P2|COMPLETED|Stage 1||6
2585526|NCT00348673|6342948|P1|COMPLETED|Stage 1||6
2585527|NCT00348673|6342940|P9|Treated|Stage 1||0
2585528|NCT00348673|6342941|P8|Treated|Stage 1||0
2585529|NCT00348673|6342942|P7|Treated|Stage 1||0
2585530|NCT00348673|6342943|P6|Treated|Stage 1||0
2585531|NCT00348673|6342944|P5|Treated|Stage 1||4
2585532|NCT00348673|6342945|P4|Treated|Stage 1||6
2585533|NCT00348673|6342946|P3|Treated|Stage 1||6
2585534|NCT00348673|6342947|P2|Treated|Stage 1||6
2585535|NCT00348673|6342948|P1|Treated|Stage 1||6
2585536|NCT00348673|6342940|P9|STARTED|Stage 1||0
2585537|NCT00348673|6342941|P8|STARTED|Stage 1||0
2585538|NCT00348673|6342942|P7|STARTED|Stage 1||0
2585539|NCT00348673|6342943|P6|STARTED|Stage 1||0
2585540|NCT00348673|6342944|P5|STARTED|Stage 1||4
2585541|NCT00348673|6342945|P4|STARTED|Stage 1||6
2585542|NCT00348673|6342946|P3|STARTED|Stage 1||7
2585543|NCT00348673|6342947|P2|STARTED|Stage 1||6
2585544|NCT00348673|6342948|P1|STARTED|Stage 1||6
2585545|NCT00348595|6342997|P2|NOT COMPLETED|Overall Study||8
2585546|NCT00348595|6342998|P1|NOT COMPLETED|Overall Study||5
2585547|NCT00348595|6342997|P2|COMPLETED|Overall Study||26
2585548|NCT00348595|6342998|P1|COMPLETED|Overall Study||21
2585549|NCT00348595|6342997|P2|STARTED|Overall Study||34
2585550|NCT00348595|6342998|P1|STARTED|Overall Study||26
2585551|NCT00348556|6343010|P1|NOT COMPLETED|Overall Study||1
2585552|NCT00348556|6343010|P1|COMPLETED|Overall Study||3
2585553|NCT00348556|6343010|P1|STARTED|Overall Study||4
2585554|NCT00348374|6343017|P2|NOT COMPLETED|Overall Study||32
2585555|NCT00348374|6343018|P1|NOT COMPLETED|Overall Study||19
2585556|NCT00348374|6343017|P2|COMPLETED|Overall Study||71
2585557|NCT00348374|6343018|P1|COMPLETED|Overall Study||69
2585558|NCT00348374|6343017|P2|Received Study Treatment|Overall Study||96
2585559|NCT00348374|6343018|P1|Received Study Treatment|Overall Study||88
2585560|NCT00348374|6343017|P2|STARTED|Overall Study||103
2585561|NCT00348374|6343018|P1|STARTED|Overall Study||88
2585562|NCT00348348|6343065|P2|NOT COMPLETED|Overall Study||27
2585563|NCT00348348|6343066|P1|NOT COMPLETED|Overall Study||25
2585564|NCT00348348|6343065|P2|COMPLETED|Overall Study||555
2585565|NCT00348348|6343066|P1|COMPLETED|Overall Study||554
2585566|NCT00348348|6343065|P2|STARTED|Overall Study|Received at least one drop of study medication(Safety Population)|582
2585567|NCT00348348|6343066|P1|STARTED|Overall Study|Received at least one drop of study medication (Safety Population)|579
2585568|NCT00348309|6343081|P3|NOT COMPLETED|Overall Study||143
2585569|NCT00348309|6343082|P2|NOT COMPLETED|Overall Study||98
2585570|NCT00348309|6343083|P1|NOT COMPLETED|Overall Study||134
2585571|NCT00348309|6343081|P3|COMPLETED|Overall Study||346
2585572|NCT00348309|6343082|P2|COMPLETED|Overall Study||396
2585573|NCT00348309|6343083|P1|COMPLETED|Overall Study||362
2585574|NCT00348309|6343081|P3|STARTED|Overall Study||489
2585575|NCT00348309|6343082|P2|STARTED|Overall Study||494
2585576|NCT00348309|6343083|P1|STARTED|Overall Study||496
2585577|NCT00348283|6343156|P2|NOT COMPLETED|Open Label||34
2585578|NCT00348283|6343157|P1|NOT COMPLETED|Open Label||0
2585579|NCT00348283|6343156|P2|COMPLETED|Open Label||66
2585580|NCT00348283|6343157|P1|COMPLETED|Open Label||0
2585581|NCT00348283|6343156|P2|STARTED|Open Label|14 subjects completed the Double Blind portion of the study but did not enter the Open Label period.|100
2585582|NCT00348283|6343157|P1|STARTED|Open Label|No comparator was used in the Open Label portion of the study.|0
2585583|NCT00348283|6343156|P2|NOT COMPLETED|Double Blind||10
2585584|NCT00348283|6343157|P1|NOT COMPLETED|Double Blind||5
2585585|NCT00348283|6343156|P2|COMPLETED|Double Blind||54
2585586|NCT00348283|6343157|P1|COMPLETED|Double Blind||60
2585587|NCT00348283|6343156|P2|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|64
2585588|NCT00348283|6343157|P1|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|65
2585589|NCT00348283|6343156|P2|NOT COMPLETED|Induction||6
2585590|NCT00348283|6343157|P1|NOT COMPLETED|Induction||0
2585591|NCT00348283|6343156|P2|COMPLETED|Induction|Subjects provided more than one reason for discontinuing during induction.|129
2585592|NCT00348283|6343157|P1|COMPLETED|Induction||0
2585593|NCT00348283|6343156|P2|STARTED|Induction|Subjects received an open- label dose of 80 mg adalimumab at Week 2 (induction dose).|135
2585594|NCT00348283|6343157|P1|STARTED|Induction||0
2585595|NCT00348140|6343176|P3|NOT COMPLETED|Overall Study||163
2585596|NCT00348140|6343177|P2|NOT COMPLETED|Overall Study||139
2585597|NCT00348140|6343178|P1|NOT COMPLETED|Overall Study||126
2585598|NCT00348140|6343176|P3|COMPLETED|Overall Study||328
2585599|NCT00348140|6343177|P2|COMPLETED|Overall Study||351
2585600|NCT00348140|6343178|P1|COMPLETED|Overall Study||361
2585601|NCT00348140|6343176|P3|STARTED|Overall Study||491
2585602|NCT00348140|6343177|P2|STARTED|Overall Study||490
2585603|NCT00348140|6343178|P1|STARTED|Overall Study||487
2585604|NCT00347958|6343276|P1|NOT COMPLETED|Overall Study||4
2585605|NCT00347958|6343276|P1|COMPLETED|Overall Study||540
2585606|NCT00347958|6343276|P1|STARTED|Overall Study||544
2585607|NCT00347932|6343285|P2|NOT COMPLETED|Overall Study||52
2585608|NCT00347932|6343286|P1|NOT COMPLETED|Overall Study||31
2585609|NCT00347932|6343285|P2|COMPLETED|Overall Study||430
2585610|NCT00347932|6343286|P1|COMPLETED|Overall Study||444
2585611|NCT00347932|6343285|P2|STARTED|Overall Study|As Randomized Population - received at least one dose of study medication|482
2585612|NCT00347932|6343286|P1|STARTED|Overall Study|As Randomized population - received at least one dose of study medication|475
2585613|NCT00347919|6343301|P3|NOT COMPLETED|Overall Study||38
2585614|NCT00347919|6343302|P2|NOT COMPLETED|Overall Study||76
2585615|NCT00347919|6343303|P1|NOT COMPLETED|Overall Study||71
2585616|NCT00347919|6343301|P3|COMPLETED|Overall Study||2
2585617|NCT00347919|6343302|P2|COMPLETED|Overall Study||0
2585618|NCT00347919|6343303|P1|COMPLETED|Overall Study||2
2585619|NCT00347919|6343301|P3|STARTED|Overall Study|Safety Population|40
2585620|NCT00347919|6343302|P2|STARTED|Overall Study|Safety Population|76
2585621|NCT00347919|6343303|P1|STARTED|Overall Study|Safety Population|73
2585622|NCT00347776|6343326|P3|NOT COMPLETED|12 Month Follow-up||19
2585623|NCT00347776|6343327|P2|NOT COMPLETED|12 Month Follow-up||16
2585624|NCT00347776|6343328|P1|NOT COMPLETED|12 Month Follow-up||23
2585625|NCT00347776|6343326|P3|COMPLETED|12 Month Follow-up||436
2585626|NCT00347776|6343327|P2|COMPLETED|12 Month Follow-up||446
2585627|NCT00347776|6343328|P1|COMPLETED|12 Month Follow-up||425
2585628|NCT00347776|6343326|P3|STARTED|12 Month Follow-up||455
2585629|NCT00347776|6343327|P2|STARTED|12 Month Follow-up||462
2585630|NCT00347776|6343328|P1|STARTED|12 Month Follow-up||448
2585631|NCT00347776|6343326|P3|NOT COMPLETED|6 Month Follow-up||18
2585632|NCT00347776|6343327|P2|NOT COMPLETED|6 Month Follow-up||13
2585633|NCT00347776|6343328|P1|NOT COMPLETED|6 Month Follow-up||22
2585634|NCT00347776|6343326|P3|COMPLETED|6 Month Follow-up|452 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|455
2585635|NCT00347776|6343327|P2|COMPLETED|6 Month Follow-up|459 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|462
2585636|NCT00347776|6343328|P1|COMPLETED|6 Month Follow-up|440 had no recurrence.8 were lost to follow-up but were still eligible for follow-up at next visits|448
2585637|NCT00347776|6343326|P3|STARTED|6 Month Follow-up||473
2585638|NCT00347776|6343327|P2|STARTED|6 Month Follow-up||475
2585639|NCT00347776|6343328|P1|STARTED|6 Month Follow-up||470
2585640|NCT00347776|6343326|P3|NOT COMPLETED|1.5 Month Follow-up||12
2585641|NCT00347776|6343327|P2|NOT COMPLETED|1.5 Month Follow-up||8
2585642|NCT00347776|6343328|P1|NOT COMPLETED|1.5 Month Follow-up||14
2585643|NCT00347776|6343326|P3|COMPLETED|1.5 Month Follow-up|472 had no recurrence.1 was lost to follow-up but was still eligible for follow-up at next visits|473
2585644|NCT00347776|6343327|P2|COMPLETED|1.5 Month Follow-up|473 had no recurrence.2 were lost to follow-up but were still eligible for follow-up at next visits|475
2585645|NCT00347776|6343328|P1|COMPLETED|1.5 Month Follow-up||470
2585646|NCT00347776|6343326|P3|STARTED|1.5 Month Follow-up||485
2585647|NCT00347776|6343327|P2|STARTED|1.5 Month Follow-up||483
2585648|NCT00347776|6343328|P1|STARTED|1.5 Month Follow-up||484
2585649|NCT00347438|6343340|P1|NOT COMPLETED|Overall Study||2
2585650|NCT00347438|6343340|P1|COMPLETED|Overall Study||16
2585651|NCT00347438|6343340|P1|STARTED|Overall Study||18
2585652|NCT00347360|6343362|P15|NOT COMPLETED|Overall Study||4
2585653|NCT00347360|6343363|P14|NOT COMPLETED|Overall Study||8
2585654|NCT00347360|6343364|P13|NOT COMPLETED|Overall Study||10
2585655|NCT00347360|6343365|P12|NOT COMPLETED|Overall Study||6
2585656|NCT00347360|6343366|P11|NOT COMPLETED|Overall Study||5
2585657|NCT00347360|6343367|P10|NOT COMPLETED|Overall Study||9
2585658|NCT00347360|6343368|P9|NOT COMPLETED|Overall Study||6
2585659|NCT00347360|6343369|P8|NOT COMPLETED|Overall Study||3
2585660|NCT00347360|6343370|P7|NOT COMPLETED|Overall Study||7
2585661|NCT00347360|6343371|P6|NOT COMPLETED|Overall Study||8
2585662|NCT00347360|6343372|P5|NOT COMPLETED|Overall Study||5
2585663|NCT00347360|6343373|P4|NOT COMPLETED|Overall Study||13
2585664|NCT00347360|6343374|P3|NOT COMPLETED|Overall Study||6
2585665|NCT00347360|6343375|P2|NOT COMPLETED|Overall Study||8
2585666|NCT00347360|6343376|P1|NOT COMPLETED|Overall Study||5
2585667|NCT00347360|6343362|P15|COMPLETED|Overall Study||39
2585668|NCT00347360|6343363|P14|COMPLETED|Overall Study||36
2585669|NCT00347360|6343364|P13|COMPLETED|Overall Study||34
2585670|NCT00347360|6343365|P12|COMPLETED|Overall Study||37
2585671|NCT00347360|6343366|P11|COMPLETED|Overall Study||39
2585672|NCT00347360|6343367|P10|COMPLETED|Overall Study||35
2585673|NCT00347360|6343368|P9|COMPLETED|Overall Study||38
2585674|NCT00347360|6343369|P8|COMPLETED|Overall Study||40
2585675|NCT00347360|6343370|P7|COMPLETED|Overall Study||37
2585676|NCT00347360|6343371|P6|COMPLETED|Overall Study||36
2585677|NCT00347360|6343372|P5|COMPLETED|Overall Study||39
2585678|NCT00347360|6343373|P4|COMPLETED|Overall Study||30
2585679|NCT00347360|6343374|P3|COMPLETED|Overall Study||37
2585680|NCT00347360|6343375|P2|COMPLETED|Overall Study||35
2585681|NCT00347360|6343376|P1|COMPLETED|Overall Study||39
2585682|NCT00347360|6343362|P15|STARTED|Overall Study||43
2585683|NCT00347360|6343363|P14|STARTED|Overall Study||44
2585684|NCT00347360|6343364|P13|STARTED|Overall Study||44
2585685|NCT00347360|6343365|P12|STARTED|Overall Study||43
2585686|NCT00347360|6343366|P11|STARTED|Overall Study||44
2585687|NCT00347360|6343367|P10|STARTED|Overall Study||44
2585688|NCT00347360|6343368|P9|STARTED|Overall Study||44
2585689|NCT00347360|6343369|P8|STARTED|Overall Study||43
2585690|NCT00347360|6343370|P7|STARTED|Overall Study||44
2585691|NCT00347360|6343371|P6|STARTED|Overall Study||44
2585692|NCT00347360|6343372|P5|STARTED|Overall Study||44
2585693|NCT00347360|6343373|P4|STARTED|Overall Study||43
2585694|NCT00347360|6343374|P3|STARTED|Overall Study||43
2585695|NCT00347360|6343375|P2|STARTED|Overall Study||43
2585696|NCT00347360|6343376|P1|STARTED|Overall Study||44
2585697|NCT00347308|6343558|P1|NOT COMPLETED|Overall Study||0
2585698|NCT00347308|6343558|P1|COMPLETED|Overall Study||40
2585699|NCT00347308|6343558|P1|STARTED|Overall Study||40
2585700|NCT00347269|6343564|P2|NOT COMPLETED|Overall Study||106
2585701|NCT00347269|6343565|P1|NOT COMPLETED|Overall Study||94
2585702|NCT00347269|6343564|P2|COMPLETED|Overall Study||395
2585703|NCT00347269|6343565|P1|COMPLETED|Overall Study||409
2585704|NCT00347269|6343564|P2|STARTED|Overall Study||501
2585705|NCT00347269|6343565|P1|STARTED|Overall Study||503
2585706|NCT00347022|6343573|P2|NOT COMPLETED|Overall Study||5
2585707|NCT00347022|6343574|P1|NOT COMPLETED|Overall Study||12
2585708|NCT00347022|6343573|P2|COMPLETED|Overall Study||66
2585709|NCT00347022|6343574|P1|COMPLETED|Overall Study||62
2585710|NCT00347022|6343573|P2|STARTED|Overall Study||71
2585711|NCT00347022|6343574|P1|STARTED|Overall Study||74
2585712|NCT00347009|6343580|P1|NOT COMPLETED|Overall Study||27
2585713|NCT00347009|6343580|P1|COMPLETED|Overall Study||128
2585714|NCT00347009|6343580|P1|STARTED|Overall Study||155
2585715|NCT00346905|6343597|P1|NOT COMPLETED|Overall Study||4
2585716|NCT00346905|6343597|P1|COMPLETED|Overall Study||12
2585717|NCT00346905|6343597|P1|STARTED|Overall Study||16
2585718|NCT00346775|6343601|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
2585719|NCT00346775|6343602|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
2585720|NCT00346775|6343601|P2|COMPLETED|Period 3: Intervention Period 2||45
2585721|NCT00346775|6343602|P1|COMPLETED|Period 3: Intervention Period 2||44
2585722|NCT00346775|6343601|P2|STARTED|Period 3: Intervention Period 2||45
2585723|NCT00346775|6343602|P1|STARTED|Period 3: Intervention Period 2||44
2585724|NCT00346775|6343601|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
2585725|NCT00346775|6343602|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
2585726|NCT00346775|6343601|P2|COMPLETED|Period 2: Washout Period (7 Days)||45
2585727|NCT00346775|6343602|P1|COMPLETED|Period 2: Washout Period (7 Days)||44
2585728|NCT00346775|6343601|P2|STARTED|Period 2: Washout Period (7 Days)||45
2585729|NCT00346775|6343602|P1|STARTED|Period 2: Washout Period (7 Days)||44
2585730|NCT00346775|6343601|P2|NOT COMPLETED|Period 1: Intervention Period 1||3
2585731|NCT00346775|6343602|P1|NOT COMPLETED|Period 1: Intervention Period 1||5
2585732|NCT00346775|6343601|P2|COMPLETED|Period 1: Intervention Period 1||45
2585733|NCT00346775|6343602|P1|COMPLETED|Period 1: Intervention Period 1||44
2585734|NCT00346775|6343601|P2|STARTED|Period 1: Intervention Period 1||48
2585735|NCT00346775|6343602|P1|STARTED|Period 1: Intervention Period 1||49
2585736|NCT00346697|6343614|P2|NOT COMPLETED|Overall Study||1
2585737|NCT00346697|6343615|P1|NOT COMPLETED|Overall Study||0
2585738|NCT00346697|6343614|P2|COMPLETED|Overall Study||23
2585739|NCT00346697|6343615|P1|COMPLETED|Overall Study||24
2585740|NCT00346697|6343614|P2|STARTED|Overall Study||24
2585741|NCT00346697|6343615|P1|STARTED|Overall Study||24
2585742|NCT00346632|6343651|P10|NOT COMPLETED|Overall Study||3
2585743|NCT00346632|6343652|P9|NOT COMPLETED|Overall Study||4
2585744|NCT00346632|6343653|P8|NOT COMPLETED|Overall Study||4
2585745|NCT00346632|6343654|P7|NOT COMPLETED|Overall Study||5
2585746|NCT00346632|6343655|P6|NOT COMPLETED|Overall Study||2
2585747|NCT00346632|6343656|P5|NOT COMPLETED|Overall Study||4
2585748|NCT00346632|6343657|P4|NOT COMPLETED|Overall Study||3
2585749|NCT00346632|6343658|P3|NOT COMPLETED|Overall Study||6
2585750|NCT00346632|6343659|P2|NOT COMPLETED|Overall Study||3
2585751|NCT00346632|6343660|P1|NOT COMPLETED|Overall Study||3
2585752|NCT00346632|6343651|P10|COMPLETED|Overall Study||0
2585753|NCT00346632|6343652|P9|COMPLETED|Overall Study||0
2585754|NCT00346632|6343653|P8|COMPLETED|Overall Study||0
2585755|NCT00346632|6343654|P7|COMPLETED|Overall Study||0
2585756|NCT00346632|6343655|P6|COMPLETED|Overall Study||0
2585757|NCT00346632|6343656|P5|COMPLETED|Overall Study||0
2585758|NCT00346632|6343657|P4|COMPLETED|Overall Study||0
2585759|NCT00346632|6343658|P3|COMPLETED|Overall Study||0
2585760|NCT00346632|6343659|P2|COMPLETED|Overall Study||0
2585761|NCT00346632|6343660|P1|COMPLETED|Overall Study||0
2585762|NCT00346632|6343651|P10|STARTED|Overall Study||3
2585763|NCT00346632|6343652|P9|STARTED|Overall Study||4
2585764|NCT00346632|6343653|P8|STARTED|Overall Study||4
2585765|NCT00346632|6343654|P7|STARTED|Overall Study||5
2585766|NCT00346632|6343655|P6|STARTED|Overall Study||2
2585767|NCT00346632|6343656|P5|STARTED|Overall Study||4
2585768|NCT00346632|6343657|P4|STARTED|Overall Study||3
2585769|NCT00346632|6343658|P3|STARTED|Overall Study||6
2585770|NCT00346632|6343659|P2|STARTED|Overall Study||3
2585771|NCT00346632|6343660|P1|STARTED|Overall Study||3
2585772|NCT00346476|6343803|P1|NOT COMPLETED|Overall Study||0
2585773|NCT00346476|6343803|P1|COMPLETED|Overall Study||1250
2585774|NCT00346476|6343803|P1|STARTED|Overall Study||1250
2585775|NCT00346398|6343810|P2|NOT COMPLETED|Overall Study||2
2585776|NCT00346398|6343811|P1|NOT COMPLETED|Overall Study||3
2585777|NCT00346398|6343810|P2|COMPLETED|Overall Study||24
2585778|NCT00346398|6343811|P1|COMPLETED|Overall Study||22
2585779|NCT00346398|6343810|P2|STARTED|Overall Study||26
2585780|NCT00346398|6343811|P1|STARTED|Overall Study||25
2585781|NCT00346333|6343823|P2|NOT COMPLETED|Overall Study||8
2585782|NCT00346333|6343824|P1|NOT COMPLETED|Overall Study||5
2585783|NCT00346333|6343823|P2|COMPLETED|Overall Study||111
2585784|NCT00346333|6343824|P1|COMPLETED|Overall Study||116
2585785|NCT00346333|6343823|P2|STARTED|Overall Study||119
2585786|NCT00346333|6343824|P1|STARTED|Overall Study||121
2585787|NCT00346268|6343840|P2|NOT COMPLETED|Overall Study||3
2585788|NCT00346268|6343841|P1|NOT COMPLETED|Overall Study||2
2585789|NCT00346268|6343840|P2|COMPLETED|Overall Study||50
2585790|NCT00346268|6343841|P1|COMPLETED|Overall Study||50
2585791|NCT00346268|6343840|P2|STARTED|Overall Study||53
2585792|NCT00346268|6343841|P1|STARTED|Overall Study||52
2585793|NCT00346216|6343876|P3|NOT COMPLETED|Overall Study||2348
2585794|NCT00346216|6343877|P2|NOT COMPLETED|Overall Study||2460
2585795|NCT00346216|6343878|P1|NOT COMPLETED|Overall Study||2408
2585796|NCT00346216|6343876|P3|COMPLETED|Overall Study||5621
2585797|NCT00346216|6343877|P2|COMPLETED|Overall Study||5580
2585798|NCT00346216|6343878|P1|COMPLETED|Overall Study||5664
2585799|NCT00346216|6343876|P3|STARTED|Overall Study||7969
2585800|NCT00346216|6343877|P2|STARTED|Overall Study||8040
2585801|NCT00346216|6343878|P1|STARTED|Overall Study||8072
2585802|NCT00346164|6343899|P4|NOT COMPLETED|Overall Study||106
2585803|NCT00346164|6343900|P3|NOT COMPLETED|Overall Study||26
2585804|NCT00346164|6343901|P2|NOT COMPLETED|Overall Study||7
2585805|NCT00346164|6343902|P1|NOT COMPLETED|Overall Study||17
2585806|NCT00346164|6343899|P4|COMPLETED|Overall Study||117
2585807|NCT00346164|6343900|P3|COMPLETED|Overall Study||96
2585808|NCT00346164|6343901|P2|COMPLETED|Overall Study||14
2585809|NCT00346164|6343902|P1|COMPLETED|Overall Study||205
2585810|NCT00346164|6343899|P4|STARTED|Overall Study||223
2585811|NCT00346164|6343900|P3|STARTED|Overall Study||122
2585812|NCT00346164|6343901|P2|STARTED|Overall Study||21
2585813|NCT00346164|6343902|P1|STARTED|Overall Study||222
2585814|NCT00346151|6343937|P1|NOT COMPLETED|Overall Study||3
2585815|NCT00346151|6343937|P1|COMPLETED|Overall Study||2
2585816|NCT00346151|6343937|P1|STARTED|Overall Study||5
2585817|NCT00346073|6343957|P2|NOT COMPLETED|Overall Study||24
2585818|NCT00346073|6343958|P1|NOT COMPLETED|Overall Study||41
2585819|NCT00346073|6343957|P2|COMPLETED|Overall Study||738
2585820|NCT00346073|6343958|P1|COMPLETED|Overall Study||1481
2585821|NCT00346073|6343957|P2|STARTED|Overall Study||762
2585822|NCT00346073|6343958|P1|STARTED|Overall Study||1522
2585823|NCT00346034|6343992|P1|NOT COMPLETED|Overall Study||57
2585824|NCT00346034|6343992|P1|COMPLETED|Overall Study||300
2585825|NCT00346034|6343992|P1|STARTED|Overall Study||357
2585826|NCT00345969|6343999|P2|NOT COMPLETED|Overall Study||2
2585827|NCT00345969|6344000|P1|NOT COMPLETED|Overall Study||1
2585828|NCT00345969|6343999|P2|COMPLETED|Overall Study||11
2585829|NCT00345969|6344000|P1|COMPLETED|Overall Study||11
2585830|NCT00345969|6343999|P2|STARTED|Overall Study||13
2585831|NCT00345969|6344000|P1|STARTED|Overall Study||12
2585832|NCT00345878|6344032|P2|NOT COMPLETED|Overall Study||1
2585833|NCT00345878|6344033|P1|NOT COMPLETED|Overall Study||4
2585834|NCT00345878|6344032|P2|COMPLETED|Overall Study||135
2585835|NCT00345878|6344033|P1|COMPLETED|Overall Study||131
2585836|NCT00345878|6344032|P2|STARTED|Overall Study||136
2585837|NCT00345878|6344033|P1|STARTED|Overall Study||135
2585838|NCT00345839|6344051|P2|NOT COMPLETED|Overall Study||159
2585839|NCT00345839|6344052|P1|NOT COMPLETED|Overall Study||149
2585840|NCT00345839|6344051|P2|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1776
2585841|NCT00345839|6344052|P1|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1799
2585842|NCT00345839|6344051|P2|STARTED|Overall Study|Randomized to placebo|1935
2585843|NCT00345839|6344052|P1|STARTED|Overall Study|Randomized to cinacalcet|1948
2585844|NCT00345683|6344078|P2|NOT COMPLETED|Overall Study||9
2585845|NCT00345683|6344079|P1|NOT COMPLETED|Overall Study||25
2585846|NCT00345683|6344078|P2|COMPLETED|Overall Study||1001
2585847|NCT00345683|6344079|P1|COMPLETED|Overall Study||2985
2585848|NCT00345683|6344078|P2|STARTED|Overall Study||1010
2585849|NCT00345683|6344079|P1|STARTED|Overall Study||3010
2585850|NCT00345631|6344102|P3|NOT COMPLETED|Overall Study||6
2585851|NCT00345631|6344103|P2|NOT COMPLETED|Overall Study||8
2585852|NCT00345631|6344104|P1|NOT COMPLETED|Overall Study||4
2585853|NCT00345631|6344102|P3|COMPLETED|Overall Study||128
2585854|NCT00345631|6344103|P2|COMPLETED|Overall Study||259
2585855|NCT00345631|6344104|P1|COMPLETED|Overall Study||83
2585856|NCT00345631|6344102|P3|STARTED|Overall Study||134
2585857|NCT00345631|6344103|P2|STARTED|Overall Study||267
2585858|NCT00345631|6344104|P1|STARTED|Overall Study||87
2585859|NCT00345605|6344136|P2|NOT COMPLETED|Arm 2, Opposite Treatment||0
2585860|NCT00345605|6344137|P1|NOT COMPLETED|Arm 2, Opposite Treatment||1
2585861|NCT00345605|6344136|P2|COMPLETED|Arm 2, Opposite Treatment||6
2585862|NCT00345605|6344137|P1|COMPLETED|Arm 2, Opposite Treatment||5
2585863|NCT00345605|6344136|P2|STARTED|Arm 2, Opposite Treatment||6
2585864|NCT00345605|6344137|P1|STARTED|Arm 2, Opposite Treatment||6
2585865|NCT00345605|6344136|P2|NOT COMPLETED|Crossover Wash-out||0
2585866|NCT00345605|6344137|P1|NOT COMPLETED|Crossover Wash-out||0
2585867|NCT00345605|6344136|P2|COMPLETED|Crossover Wash-out||6
2585868|NCT00345605|6344137|P1|COMPLETED|Crossover Wash-out||6
2585869|NCT00345605|6344136|P2|STARTED|Crossover Wash-out||6
2585870|NCT00345605|6344137|P1|STARTED|Crossover Wash-out||6
2585871|NCT00345605|6344136|P2|NOT COMPLETED|Interval||0
2585872|NCT00345605|6344137|P1|NOT COMPLETED|Interval||0
2585873|NCT00345605|6344136|P2|COMPLETED|Interval||6
2585874|NCT00345605|6344137|P1|COMPLETED|Interval||6
2585875|NCT00345605|6344136|P2|STARTED|Interval||6
2585876|NCT00345605|6344137|P1|STARTED|Interval||6
2585877|NCT00345605|6344136|P2|NOT COMPLETED|Arm 1||1
2585878|NCT00345605|6344137|P1|NOT COMPLETED|Arm 1||0
2585879|NCT00345605|6344136|P2|COMPLETED|Arm 1||5
2585880|NCT00345605|6344137|P1|COMPLETED|Arm 1||6
2585881|NCT00345605|6344136|P2|STARTED|Arm 1||6
2585882|NCT00345605|6344137|P1|STARTED|Arm 1||6
2585883|NCT00345605|6344136|P2|NOT COMPLETED|Initial Washout||0
2585884|NCT00345605|6344137|P1|NOT COMPLETED|Initial Washout||0
2585885|NCT00345605|6344136|P2|COMPLETED|Initial Washout||6
2585886|NCT00345605|6344137|P1|COMPLETED|Initial Washout||6
2585887|NCT00345605|6344136|P2|STARTED|Initial Washout||6
2585888|NCT00345605|6344137|P1|STARTED|Initial Washout||6
2585889|NCT00345592|6344157|P2|NOT COMPLETED|Overall Study||24
2585890|NCT00345592|6344158|P1|NOT COMPLETED|Overall Study||25
2585891|NCT00345592|6344157|P2|COMPLETED|Overall Study||173
2585892|NCT00345592|6344158|P1|COMPLETED|Overall Study||174
2585893|NCT00345592|6344157|P2|STARTED|Overall Study||197
2585894|NCT00345592|6344158|P1|STARTED|Overall Study||199
2585895|NCT00345579|6344166|P2|NOT COMPLETED|Overall Study||65
2585896|NCT00345579|6344167|P1|NOT COMPLETED|Overall Study||164
2585897|NCT00345579|6344166|P2|COMPLETED|Overall Study||1048
2585898|NCT00345579|6344167|P1|COMPLETED|Overall Study||3114
2585899|NCT00345579|6344166|P2|STARTED|Overall Study||1113
2585900|NCT00345579|6344167|P1|STARTED|Overall Study||3278
2585901|NCT00345540|6344187|P1|NOT COMPLETED|Overall Study||1
2585902|NCT00345540|6344187|P1|COMPLETED|Overall Study||15
2585903|NCT00345540|6344187|P1|STARTED|Overall Study|1 subject enrolled but not treated (off-trial for patient discretion)|16
2585904|NCT00345397|6344193|P1|NOT COMPLETED|Overall Study||1
2585905|NCT00345397|6344193|P1|COMPLETED|Overall Study||6
2585906|NCT00345397|6344193|P1|STARTED|Overall Study||7
2585907|NCT00345384|6344200|P2|NOT COMPLETED|Overall Study||0
2585908|NCT00345384|6344201|P1|NOT COMPLETED|Overall Study||0
2585909|NCT00345384|6344200|P2|COMPLETED|Overall Study||19
2585910|NCT00345384|6344201|P1|COMPLETED|Overall Study||19
2585911|NCT00345384|6344200|P2|STARTED|Overall Study||19
2585912|NCT00345384|6344201|P1|STARTED|Overall Study||19
2585913|NCT00345371|6344211|P2|NOT COMPLETED|Overall Study||33
2585914|NCT00345371|6344212|P1|NOT COMPLETED|Overall Study||30
2585915|NCT00345371|6344211|P2|COMPLETED|Overall Study||38
2585916|NCT00345371|6344212|P1|COMPLETED|Overall Study||39
2585917|NCT00345371|6344211|P2|STARTED|Overall Study||71
2585918|NCT00345371|6344212|P1|STARTED|Overall Study||69
2585919|NCT00345358|6344224|P4|NOT COMPLETED|Booster Vaccination Phase||0
2585920|NCT00345358|6344225|P3|NOT COMPLETED|Booster Vaccination Phase||0
2585921|NCT00345358|6344226|P2|NOT COMPLETED|Booster Vaccination Phase||0
2585922|NCT00345358|6344227|P1|NOT COMPLETED|Booster Vaccination Phase||4
2585923|NCT00345358|6344224|P4|COMPLETED|Booster Vaccination Phase||0
2585924|NCT00345358|6344225|P3|COMPLETED|Booster Vaccination Phase||0
2585925|NCT00345358|6344226|P2|COMPLETED|Booster Vaccination Phase||145
2585926|NCT00345358|6344227|P1|COMPLETED|Booster Vaccination Phase||141
2585927|NCT00345358|6344224|P4|STARTED|Booster Vaccination Phase||0
2585928|NCT00345358|6344225|P3|STARTED|Booster Vaccination Phase||0
2585929|NCT00345358|6344226|P2|STARTED|Booster Vaccination Phase||145
2585930|NCT00345358|6344227|P1|STARTED|Booster Vaccination Phase||145
2585931|NCT00345358|6344224|P4|NOT COMPLETED|Primary Vaccination Phase||2
2585932|NCT00345358|6344225|P3|NOT COMPLETED|Primary Vaccination Phase||8
2585933|NCT00345358|6344226|P2|NOT COMPLETED|Primary Vaccination Phase||4
2585934|NCT00345358|6344227|P1|NOT COMPLETED|Primary Vaccination Phase||5
2585935|NCT00345358|6344224|P4|COMPLETED|Primary Vaccination Phase||148
2585936|NCT00345358|6344225|P3|COMPLETED|Primary Vaccination Phase||142
2585937|NCT00345358|6344226|P2|COMPLETED|Primary Vaccination Phase||146
2585938|NCT00345358|6344227|P1|COMPLETED|Primary Vaccination Phase||145
2585939|NCT00345358|6344224|P4|STARTED|Primary Vaccination Phase||150
2585940|NCT00345358|6344225|P3|STARTED|Primary Vaccination Phase||150
2585941|NCT00345358|6344226|P2|STARTED|Primary Vaccination Phase||150
2585942|NCT00345358|6344227|P1|STARTED|Primary Vaccination Phase||150
2585943|NCT00345345|6344302|P1|NOT COMPLETED|Overall Study||2
2585944|NCT00345345|6344302|P1|COMPLETED|Overall Study||27
2585945|NCT00345345|6344302|P1|STARTED|Overall Study||29
2585946|NCT00345332|6344308|P2|NOT COMPLETED|Overall Study||0
2585947|NCT00345332|6344309|P1|NOT COMPLETED|Overall Study||0
2585948|NCT00345332|6344308|P2|COMPLETED|Overall Study||20
2585949|NCT00345332|6344309|P1|COMPLETED|Overall Study||11
2585950|NCT00345332|6344308|P2|STARTED|Overall Study||20
2585951|NCT00345332|6344309|P1|STARTED|Overall Study||11
2585952|NCT00345293|6344317|P2|NOT COMPLETED|Overall Study||0
2585953|NCT00345293|6344318|P1|NOT COMPLETED|Overall Study||2
2585954|NCT00345293|6344317|P2|COMPLETED|Overall Study||3
2585955|NCT00345293|6344318|P1|COMPLETED|Overall Study||8
2585956|NCT00345293|6344317|P2|STARTED|Overall Study||3
2585957|NCT00345293|6344318|P1|STARTED|Overall Study||10
2585958|NCT00345254|6344327|P2|NOT COMPLETED|Overall Study||0
2585959|NCT00345254|6344328|P1|NOT COMPLETED|Overall Study||0
2585960|NCT00345254|6344327|P2|COMPLETED|Overall Study||30
2585961|NCT00345254|6344328|P1|COMPLETED|Overall Study||30
2585962|NCT00345254|6344327|P2|STARTED|Overall Study||30
2585963|NCT00345254|6344328|P1|STARTED|Overall Study||30
2585964|NCT00345176|6344338|P4|NOT COMPLETED|Overall Study||10
2585965|NCT00345176|6344339|P3|NOT COMPLETED|Overall Study||6
2585966|NCT00345176|6344340|P2|NOT COMPLETED|Overall Study||6
2585967|NCT00345176|6344341|P1|NOT COMPLETED|Overall Study||5
2585968|NCT00345176|6344338|P4|COMPLETED|Overall Study||1069
2585969|NCT00345176|6344339|P3|COMPLETED|Overall Study||1062
2585970|NCT00345176|6344340|P2|COMPLETED|Overall Study||1038
2585971|NCT00345176|6344341|P1|COMPLETED|Overall Study||1007
2585972|NCT00345176|6344338|P4|STARTED|Overall Study||1079
2585973|NCT00345176|6344339|P3|STARTED|Overall Study||1068
2585974|NCT00345176|6344340|P2|STARTED|Overall Study||1044
2585975|NCT00345176|6344341|P1|STARTED|Overall Study||1012
2585976|NCT00345046|6344364|P3|NOT COMPLETED|Overall Study||2
2585977|NCT00345046|6344365|P2|NOT COMPLETED|Overall Study||1
2585978|NCT00345046|6344366|P1|NOT COMPLETED|Overall Study||1
2585979|NCT00345046|6344364|P3|COMPLETED|Overall Study||14
2585980|NCT00345046|6344365|P2|COMPLETED|Overall Study||21
2585981|NCT00345046|6344366|P1|COMPLETED|Overall Study||17
2585982|NCT00345046|6344364|P3|STARTED|Overall Study||16
2585983|NCT00345046|6344365|P2|STARTED|Overall Study||22
2585984|NCT00345046|6344366|P1|STARTED|Overall Study||18
2585985|NCT00345033|6344376|P2|NOT COMPLETED|Overall Study||4
2585986|NCT00345033|6344377|P1|NOT COMPLETED|Overall Study||4
2585987|NCT00345033|6344376|P2|COMPLETED|Overall Study||14
2585988|NCT00345033|6344377|P1|COMPLETED|Overall Study||16
2585989|NCT00345033|6344376|P2|STARTED|Overall Study||18
2585990|NCT00345033|6344377|P1|STARTED|Overall Study||20
2585991|NCT00344968|6344396|P3|NOT COMPLETED|Overall Study||116
2585992|NCT00344968|6344397|P2|NOT COMPLETED|Overall Study||102
2585993|NCT00344968|6344398|P1|NOT COMPLETED|Overall Study||59
2585994|NCT00344968|6344396|P3|COMPLETED|Overall Study||279
2585995|NCT00344968|6344397|P2|COMPLETED|Overall Study||274
2585996|NCT00344968|6344398|P1|COMPLETED|Overall Study||126
2585997|NCT00344968|6344396|P3|STARTED|Overall Study||395
2585998|NCT00344968|6344397|P2|STARTED|Overall Study||376
2585999|NCT00344968|6344398|P1|STARTED|Overall Study||185
2586000|NCT00344773|6344409|P1|NOT COMPLETED|Overall Study||21
2586001|NCT00344773|6344409|P1|COMPLETED|Overall Study||25
2586002|NCT00344773|6344409|P1|STARTED|Overall Study||46
2586003|NCT00344682|6344417|P2|NOT COMPLETED|Overall Study||1
2586004|NCT00344682|6344418|P1|NOT COMPLETED|Overall Study||4
2586005|NCT00344682|6344417|P2|COMPLETED|Overall Study||14
2586006|NCT00344682|6344418|P1|COMPLETED|Overall Study||12
2586007|NCT00344682|6344417|P2|STARTED|Overall Study||15
2586008|NCT00344682|6344418|P1|STARTED|Overall Study||16
2586009|NCT00344500|6344432|P3|NOT COMPLETED|Overall Study||2
2586010|NCT00344500|6344433|P2|NOT COMPLETED|Overall Study||35
2586011|NCT00344500|6344434|P1|NOT COMPLETED|Overall Study||23
2586012|NCT00344500|6344432|P3|COMPLETED|Overall Study||12
2586013|NCT00344500|6344433|P2|COMPLETED|Overall Study||25
2586014|NCT00344500|6344434|P1|COMPLETED|Overall Study||25
2586015|NCT00344500|6344432|P3|STARTED|Overall Study||14
2586016|NCT00344500|6344433|P2|STARTED|Overall Study||60
2586017|NCT00344500|6344434|P1|STARTED|Overall Study||48
2586018|NCT00344487|6344445|P1|NOT COMPLETED|Overall Study||1
2586019|NCT00344487|6344445|P1|COMPLETED|Overall Study|One subject was withdrawn at month 9 because he was considered an immunologic failure on study.|2
2586020|NCT00344487|6344445|P1|STARTED|Overall Study||3
2586021|NCT00344461|6344449|P1|NOT COMPLETED|Overall Study||21
2586022|NCT00344461|6344449|P1|COMPLETED|Overall Study||33
2586023|NCT00344461|6344449|P1|STARTED|Overall Study||54
2586024|NCT00344448|6344460|P2|NOT COMPLETED|Open Label||1
2586025|NCT00344448|6344461|P1|NOT COMPLETED|Open Label||2
2586026|NCT00344448|6344460|P2|COMPLETED|Open Label||2
2586027|NCT00344448|6344461|P1|COMPLETED|Open Label||2
2586028|NCT00344448|6344460|P2|STARTED|Open Label||3
2586029|NCT00344448|6344461|P1|STARTED|Open Label||4
2586030|NCT00344448|6344460|P2|NOT COMPLETED|Double Blind, Placebo Controlled||0
2586031|NCT00344448|6344461|P1|NOT COMPLETED|Double Blind, Placebo Controlled||2
2586032|NCT00344448|6344460|P2|COMPLETED|Double Blind, Placebo Controlled||3
2586033|NCT00344448|6344461|P1|COMPLETED|Double Blind, Placebo Controlled||4
2586034|NCT00344448|6344460|P2|STARTED|Double Blind, Placebo Controlled||3
2586035|NCT00344448|6344461|P1|STARTED|Double Blind, Placebo Controlled||6
2586036|NCT00344448|6344460|P2|NOT COMPLETED|Screening||1
2586037|NCT00344448|6344461|P1|NOT COMPLETED|Screening||0
2586038|NCT00344448|6344460|P2|COMPLETED|Screening||3
2586039|NCT00344448|6344461|P1|COMPLETED|Screening||6
2586040|NCT00344448|6344460|P2|STARTED|Screening||4
2586041|NCT00344448|6344461|P1|STARTED|Screening|No randomization during the screening phase|6
2586042|NCT00344370|6344469|P2|NOT COMPLETED|Overall Study||3
2586043|NCT00344370|6344470|P1|NOT COMPLETED|Overall Study||15
2586044|NCT00344370|6344469|P2|COMPLETED|Overall Study||68
2586045|NCT00344370|6344470|P1|COMPLETED|Overall Study||128
2586046|NCT00344370|6344469|P2|STARTED|Overall Study||71
2586047|NCT00344370|6344470|P1|STARTED|Overall Study||143
2586048|NCT00344318|6344482|P4|NOT COMPLETED|Overall Study||3
2586049|NCT00344318|6344483|P3|NOT COMPLETED|Overall Study||1
2586050|NCT00344318|6344484|P2|NOT COMPLETED|Overall Study||5
2586051|NCT00344318|6344485|P1|NOT COMPLETED|Overall Study||4
2586052|NCT00344318|6344482|P4|COMPLETED|Overall Study||100
2586053|NCT00344318|6344483|P3|COMPLETED|Overall Study||99
2586054|NCT00344318|6344484|P2|COMPLETED|Overall Study||298
2586055|NCT00344318|6344485|P1|COMPLETED|Overall Study||296
2586056|NCT00344318|6344482|P4|STARTED|Overall Study||103
2586057|NCT00344318|6344483|P3|STARTED|Overall Study||100
2586058|NCT00344318|6344484|P2|STARTED|Overall Study||303
2586059|NCT00344318|6344485|P1|STARTED|Overall Study||300
2586060|NCT00344305|6344607|P2|NOT COMPLETED|Overall Study||1
2586061|NCT00344305|6344608|P1|NOT COMPLETED|Overall Study||2
2586062|NCT00344305|6344607|P2|COMPLETED|Overall Study||99
2586063|NCT00344305|6344608|P1|COMPLETED|Overall Study||98
2586064|NCT00344305|6344607|P2|STARTED|Overall Study||100
2586065|NCT00344305|6344608|P1|STARTED|Overall Study||100
2586066|NCT00344175|6344645|P2|NOT COMPLETED|Overall Study||10
2586067|NCT00344175|6344646|P1|NOT COMPLETED|Overall Study||12
2586068|NCT00344175|6344645|P2|COMPLETED|Overall Study||47
2586069|NCT00344175|6344646|P1|COMPLETED|Overall Study||109
2586070|NCT00344175|6344645|P2|STARTED|Overall Study||57
2586071|NCT00344175|6344646|P1|STARTED|Overall Study||121
2586072|NCT00344032|6344658|P2|NOT COMPLETED|Overall Study||10
2586073|NCT00344032|6344659|P1|NOT COMPLETED|Overall Study||14
2586074|NCT00344032|6344658|P2|COMPLETED|Overall Study||168
2586075|NCT00344032|6344659|P1|COMPLETED|Overall Study||162
2586076|NCT00344032|6344658|P2|STARTED|Overall Study||178
2586077|NCT00344032|6344659|P1|STARTED|Overall Study||176
2586078|NCT00344019|6344678|P3|NOT COMPLETED|Overall Study||74
2586079|NCT00344019|6344679|P2|NOT COMPLETED|Overall Study||0
2586080|NCT00344019|6344680|P1|NOT COMPLETED|Overall Study||0
2586081|NCT00344019|6344678|P3|COMPLETED|Overall Study||0
2586082|NCT00344019|6344679|P2|COMPLETED|Overall Study||11
2586083|NCT00344019|6344680|P1|COMPLETED|Overall Study||12
2586084|NCT00344019|6344678|P3|STARTED|Overall Study||74
2586085|NCT00344019|6344679|P2|STARTED|Overall Study||11
2586086|NCT00344019|6344680|P1|STARTED|Overall Study||12
2586087|NCT00343915|6344698|P2|NOT COMPLETED|Month 66 Follow-up||0
2586088|NCT00343915|6344699|P1|NOT COMPLETED|Month 66 Follow-up||0
2586089|NCT00343915|6344698|P2|COMPLETED|Month 66 Follow-up||76
2586090|NCT00343915|6344699|P1|COMPLETED|Month 66 Follow-up||158
2586091|NCT00343915|6344698|P2|STARTED|Month 66 Follow-up||76
2586092|NCT00343915|6344699|P1|STARTED|Month 66 Follow-up|Subjects, previously vaccinated, that returned for the Month 66 follow-up.|158
2586093|NCT00343915|6344698|P2|NOT COMPLETED|Month 54 Follow-up||0
2586094|NCT00343915|6344699|P1|NOT COMPLETED|Month 54 Follow-up||0
2586095|NCT00343915|6344698|P2|COMPLETED|Month 54 Follow-up||79
2586096|NCT00343915|6344699|P1|COMPLETED|Month 54 Follow-up||166
2586097|NCT00343915|6344698|P2|STARTED|Month 54 Follow-up||79
2586098|NCT00343915|6344699|P1|STARTED|Month 54 Follow-up|Subjects, previously vaccinated, that returned for the Month 54 follow-up.|166
2586099|NCT00343915|6344698|P2|NOT COMPLETED|Month 42 Follow-up||0
2586100|NCT00343915|6344699|P1|NOT COMPLETED|Month 42 Follow-up||0
2586101|NCT00343915|6344698|P2|COMPLETED|Month 42 Follow-up||84
2586102|NCT00343915|6344699|P1|COMPLETED|Month 42 Follow-up||174
2586103|NCT00343915|6344698|P2|STARTED|Month 42 Follow-up||84
2586104|NCT00343915|6344699|P1|STARTED|Month 42 Follow-up|Subjects, previously vaccinated, that returned for the Month 42 follow-up.|174
2586105|NCT00343915|6344698|P2|NOT COMPLETED|Month 30 Follow-up||0
2586106|NCT00343915|6344699|P1|NOT COMPLETED|Month 30 Follow-up||0
2586107|NCT00343915|6344698|P2|COMPLETED|Month 30 Follow-up||88
2586108|NCT00343915|6344699|P1|COMPLETED|Month 30 Follow-up||179
2586109|NCT00343915|6344698|P2|STARTED|Month 30 Follow-up||88
2586110|NCT00343915|6344699|P1|STARTED|Month 30 Follow-up|Subjects, previously vaccinated, that returned for the Month 30 follow-up.|179
2586111|NCT00343915|6344698|P2|NOT COMPLETED|Primary Study||3
2586112|NCT00343915|6344699|P1|NOT COMPLETED|Primary Study||4
2586113|NCT00343915|6344698|P2|COMPLETED|Primary Study||123
2586114|NCT00343915|6344699|P1|COMPLETED|Primary Study||254
2586115|NCT00343915|6344698|P2|STARTED|Primary Study||126
2586116|NCT00343915|6344699|P1|STARTED|Primary Study||258
2586117|NCT00343889|6344725|P2|NOT COMPLETED|Overall Study||1
2586118|NCT00343889|6344726|P1|NOT COMPLETED|Overall Study||3
2586119|NCT00343889|6344725|P2|COMPLETED|Overall Study||188
2586120|NCT00343889|6344726|P1|COMPLETED|Overall Study||187
2586121|NCT00343889|6344725|P2|STARTED|Overall Study||189
2586122|NCT00343889|6344726|P1|STARTED|Overall Study||190
2586123|NCT00343863|6344744|P2|NOT COMPLETED|Overall Study||0
2586124|NCT00343863|6344745|P1|NOT COMPLETED|Overall Study||0
2586125|NCT00343863|6344744|P2|COMPLETED|Overall Study||34
2586126|NCT00343863|6344745|P1|COMPLETED|Overall Study||7
2586127|NCT00343863|6344744|P2|STARTED|Overall Study||34
2586128|NCT00343863|6344745|P1|STARTED|Overall Study||7
2586129|NCT00343785|6344767|P1|NOT COMPLETED|Overall Study||0
2586130|NCT00343785|6344767|P1|COMPLETED|Overall Study||21
2586131|NCT00343785|6344767|P1|STARTED|Overall Study||21
2586132|NCT00343564|6344784|P11|NOT COMPLETED|Overall Study||0
2586133|NCT00343564|6344785|P10|NOT COMPLETED|Overall Study||0
2586134|NCT00343564|6344786|P9|NOT COMPLETED|Overall Study||0
2586135|NCT00343564|6344787|P8|NOT COMPLETED|Overall Study||0
2586136|NCT00343564|6344788|P7|NOT COMPLETED|Overall Study||0
2586137|NCT00343564|6344789|P6|NOT COMPLETED|Overall Study||0
2586138|NCT00343564|6344790|P5|NOT COMPLETED|Overall Study||0
2586139|NCT00343564|6344791|P4|NOT COMPLETED|Overall Study||0
2586140|NCT00343564|6344792|P3|NOT COMPLETED|Overall Study||0
2586141|NCT00343564|6344793|P2|NOT COMPLETED|Overall Study||0
2586142|NCT00343564|6344794|P1|NOT COMPLETED|Overall Study||0
2586143|NCT00343564|6344784|P11|COMPLETED|Overall Study||8
2586144|NCT00343564|6344785|P10|COMPLETED|Overall Study||8
2586145|NCT00343564|6344786|P9|COMPLETED|Overall Study||3
2586146|NCT00343564|6344787|P8|COMPLETED|Overall Study||3
2586147|NCT00343564|6344788|P7|COMPLETED|Overall Study||4
2586148|NCT00343564|6344789|P6|COMPLETED|Overall Study||9
2586149|NCT00343564|6344790|P5|COMPLETED|Overall Study||10
2586150|NCT00343564|6344791|P4|COMPLETED|Overall Study||7
2586151|NCT00343564|6344792|P3|COMPLETED|Overall Study||3
2586152|NCT00343564|6344793|P2|COMPLETED|Overall Study||7
2586153|NCT00343564|6344794|P1|COMPLETED|Overall Study||6
2586154|NCT00343564|6344784|P11|STARTED|Overall Study||8
2586155|NCT00343564|6344785|P10|STARTED|Overall Study||8
2586156|NCT00343564|6344786|P9|STARTED|Overall Study||3
2586157|NCT00343564|6344787|P8|STARTED|Overall Study||3
2586158|NCT00343564|6344788|P7|STARTED|Overall Study||4
2586159|NCT00343564|6344789|P6|STARTED|Overall Study||9
2586160|NCT00343564|6344790|P5|STARTED|Overall Study||10
2586161|NCT00343564|6344791|P4|STARTED|Overall Study||7
2586162|NCT00343564|6344792|P3|STARTED|Overall Study||3
2586163|NCT00343564|6344793|P2|STARTED|Overall Study||7
2586164|NCT00343564|6344794|P1|STARTED|Overall Study||6
2586165|NCT00343512|6344890|P1|NOT COMPLETED|Overall Study||2
2586166|NCT00343512|6344890|P1|COMPLETED|Overall Study||32
2586167|NCT00343512|6344890|P1|STARTED|Overall Study||34
2586168|NCT00343460|6344902|P3|NOT COMPLETED|Cycle 2 - 4||0
2586169|NCT00343460|6344903|P2|NOT COMPLETED|Cycle 2 - 4||50
2586170|NCT00343460|6344904|P1|NOT COMPLETED|Cycle 2 - 4||56
2586171|NCT00343460|6344902|P3|COMPLETED|Cycle 2 - 4||0
2586172|NCT00343460|6344903|P2|COMPLETED|Cycle 2 - 4||515
2586173|NCT00343460|6344904|P1|COMPLETED|Cycle 2 - 4||528
2586174|NCT00343460|6344902|P3|STARTED|Cycle 2 - 4||0
2586175|NCT00343460|6344903|P2|STARTED|Cycle 2 - 4||565
2586176|NCT00343460|6344904|P1|STARTED|Cycle 2 - 4||584
2586177|NCT00343460|6344902|P3|NOT COMPLETED|Cycle 1||18
2586178|NCT00343460|6344903|P2|NOT COMPLETED|Cycle 1||22
2586179|NCT00343460|6344904|P1|NOT COMPLETED|Cycle 1||22
2586180|NCT00343460|6344902|P3|COMPLETED|Cycle 1||454
2586181|NCT00343460|6344903|P2|COMPLETED|Cycle 1||459
2586182|NCT00343460|6344904|P1|COMPLETED|Cycle 1||453
2586183|NCT00343460|6344902|P3|STARTED|Cycle 1||472
2586184|NCT00343460|6344903|P2|STARTED|Cycle 1||481
2586185|NCT00343460|6344904|P1|STARTED|Cycle 1||475
2586186|NCT00343382|6344978|P3|NOT COMPLETED|Overall Study||17
2586187|NCT00343382|6344979|P2|NOT COMPLETED|Overall Study||14
2586188|NCT00343382|6344980|P1|NOT COMPLETED|Overall Study||4
2586189|NCT00343382|6344978|P3|COMPLETED|Overall Study||49
2586190|NCT00343382|6344979|P2|COMPLETED|Overall Study||51
2586191|NCT00343382|6344980|P1|COMPLETED|Overall Study||60
2586192|NCT00343382|6344978|P3|STARTED|Overall Study||66
2586193|NCT00343382|6344979|P2|STARTED|Overall Study||65
2586194|NCT00343382|6344980|P1|STARTED|Overall Study||64
2586195|NCT00343291|6344999|P2|NOT COMPLETED|Overall Study||56
2586196|NCT00343291|6345000|P1|NOT COMPLETED|Overall Study||57
2586197|NCT00343291|6344999|P2|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|5
2586198|NCT00343291|6345000|P1|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|3
2586199|NCT00343291|6344999|P2|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
2586200|NCT00343291|6345000|P1|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
2586201|NCT00343291|6344999|P2|STARTED|Overall Study||61
2586202|NCT00343291|6345000|P1|STARTED|Overall Study||60
2586203|NCT00343252|6345016|P2|NOT COMPLETED|18 Months (All Treated Participants)||81
2586204|NCT00343252|6345017|P1|NOT COMPLETED|18 Months (All Treated Participants)||101
2586205|NCT00343252|6345016|P2|COMPLETED|18 Months (All Treated Participants)||269
2586206|NCT00343252|6345017|P1|COMPLETED|18 Months (All Treated Participants)||259
2586207|NCT00343252|6345016|P2|STARTED|18 Months (All Treated Participants)||350
2586208|NCT00343252|6345017|P1|STARTED|18 Months (All Treated Participants)||360
2586209|NCT00343252|6345016|P2|NOT COMPLETED|12 Months (All Treated Participants)||69
2586210|NCT00343252|6345017|P1|NOT COMPLETED|12 Months (All Treated Participants)||86
2586211|NCT00343252|6345016|P2|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|281
2586212|NCT00343252|6345017|P1|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|274
2586213|NCT00343252|6345016|P2|STARTED|12 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
2586214|NCT00343252|6345017|P1|STARTED|12 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
2586215|NCT00343252|6345016|P2|NOT COMPLETED|6 Months (All Treated Participants)||44
2586216|NCT00343252|6345017|P1|NOT COMPLETED|6 Months (All Treated Participants)||56
2586217|NCT00343252|6345016|P2|COMPLETED|6 Months (All Treated Participants)||306
2586218|NCT00343252|6345017|P1|COMPLETED|6 Months (All Treated Participants)||304
2586219|NCT00343252|6345016|P2|STARTED|6 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
2586220|NCT00343252|6345017|P1|STARTED|6 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
2586221|NCT00343252|6345016|P2|NOT COMPLETED|All Randomized Participants||82
2586222|NCT00343252|6345017|P1|NOT COMPLETED|All Randomized Participants||102
2586223|NCT00343252|6345016|P2|COMPLETED|All Randomized Participants||269
2586224|NCT00343252|6345017|P1|COMPLETED|All Randomized Participants||259
2586225|NCT00343252|6345016|P2|STARTED|All Randomized Participants||351
2586226|NCT00343252|6345017|P1|STARTED|All Randomized Participants||361
2586227|NCT00343083|6345063|P1|NOT COMPLETED|Overall Study||21
2586228|NCT00343083|6345063|P1|COMPLETED|Overall Study||22
2586229|NCT00343083|6345063|P1|STARTED|Overall Study||43
2586230|NCT00343044|6345072|P1|NOT COMPLETED|Overall Study||0
2586231|NCT00343044|6345072|P1|COMPLETED|Overall Study||40
2586232|NCT00343044|6345072|P1|STARTED|Overall Study||40
2586233|NCT00342628|6345082|P3|NOT COMPLETED|Overall Study||19
2586234|NCT00342628|6345083|P2|NOT COMPLETED|Overall Study||21
2586235|NCT00342628|6345084|P1|NOT COMPLETED|Overall Study||20
2586236|NCT00342628|6345082|P3|COMPLETED|Overall Study|97 completed 3 injections of DTP alone, 16 were lost-to-followup for blood drawing at 12 months.|81
2586237|NCT00342628|6345083|P2|COMPLETED|Overall Study|83 completed 4 injections, 3 were lost-to-followup after 4th injection|80
2586238|NCT00342628|6345084|P1|COMPLETED|Overall Study|84 completed 4 injections, 4 were lost-to-followup after the 4th injection|80
2586239|NCT00342628|6345082|P3|STARTED|Overall Study||100
2586240|NCT00342628|6345083|P2|STARTED|Overall Study||101
2586241|NCT00342628|6345084|P1|STARTED|Overall Study||100
2586242|NCT00342563|6345105|P4|NOT COMPLETED|Overall Study||6
2586243|NCT00342563|6345106|P3|NOT COMPLETED|Overall Study||14
2586244|NCT00342563|6345107|P2|NOT COMPLETED|Overall Study||8
2586245|NCT00342563|6345108|P1|NOT COMPLETED|Overall Study||6
2586246|NCT00342563|6345105|P4|COMPLETED|Overall Study||22
2586247|NCT00342563|6345106|P3|COMPLETED|Overall Study||26
2586248|NCT00342563|6345107|P2|COMPLETED|Overall Study||19
2586249|NCT00342563|6345108|P1|COMPLETED|Overall Study||35
2586250|NCT00342563|6345105|P4|STARTED|Overall Study||28
2586251|NCT00342563|6345106|P3|STARTED|Overall Study||40
2586252|NCT00342563|6345107|P2|STARTED|Overall Study||27
2586253|NCT00342563|6345108|P1|STARTED|Overall Study||41
2586254|NCT00342355|6345128|P4|NOT COMPLETED|Overall Study||0
2586255|NCT00342355|6345129|P3|NOT COMPLETED|Overall Study||0
2586256|NCT00342355|6345130|P2|NOT COMPLETED|Overall Study||0
2586257|NCT00342355|6345131|P1|NOT COMPLETED|Overall Study||0
2586258|NCT00342355|6345128|P4|COMPLETED|Overall Study||443
2586259|NCT00342355|6345129|P3|COMPLETED|Overall Study||444
2586260|NCT00342355|6345130|P2|COMPLETED|Overall Study||440
2586261|NCT00342355|6345131|P1|COMPLETED|Overall Study||444
2586262|NCT00342355|6345128|P4|STARTED|Overall Study||443
2586263|NCT00342355|6345129|P3|STARTED|Overall Study||444
2586264|NCT00342355|6345130|P2|STARTED|Overall Study||440
2586265|NCT00342355|6345131|P1|STARTED|Overall Study||444
2586266|NCT00340834|6345150|P5|NOT COMPLETED|Extension Phase of Study||44
2586267|NCT00340834|6345151|P4|NOT COMPLETED|Extension Phase of Study||53
2586268|NCT00340834|6345152|P3|NOT COMPLETED|Extension Phase of Study||0
2586269|NCT00340834|6345153|P2|NOT COMPLETED|Extension Phase of Study||76
2586270|NCT00340834|6345154|P1|NOT COMPLETED|Extension Phase of Study||85
2586271|NCT00340834|6345150|P5|COMPLETED|Extension Phase of Study||123
2586272|NCT00340834|6345151|P4|COMPLETED|Extension Phase of Study||123
2586273|NCT00340834|6345152|P3|COMPLETED|Extension Phase of Study||0
2586274|NCT00340834|6345153|P2|COMPLETED|Extension Phase of Study||281
2586275|NCT00340834|6345154|P1|COMPLETED|Extension Phase of Study||245
2586276|NCT00340834|6345150|P5|Received Study Drug|Extension Phase of Study||167
2586277|NCT00340834|6345151|P4|Received Study Drug|Extension Phase of Study||174
2586278|NCT00340834|6345152|P3|Received Study Drug|Extension Phase of Study||0
2586279|NCT00340834|6345153|P2|Received Study Drug|Extension Phase of Study||356
2586280|NCT00340834|6345154|P1|Received Study Drug|Extension Phase of Study||330
2586281|NCT00340834|6345150|P5|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|167
2586282|NCT00340834|6345151|P4|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|176
2586283|NCT00340834|6345152|P3|STARTED|Extension Phase of Study|This group did not exist in the extension phase of the study.|0
2586284|NCT00340834|6345153|P2|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|357
2586285|NCT00340834|6345154|P1|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|330
2586286|NCT00340834|6345150|P5|NOT COMPLETED|Core Phase of Study||0
2586287|NCT00340834|6345151|P4|NOT COMPLETED|Core Phase of Study||0
2586288|NCT00340834|6345152|P3|NOT COMPLETED|Core Phase of Study||49
2586289|NCT00340834|6345153|P2|NOT COMPLETED|Core Phase of Study||33
2586290|NCT00340834|6345154|P1|NOT COMPLETED|Core Phase of Study||57
2586291|NCT00340834|6345150|P5|COMPLETED|Core Phase of Study||0
2586292|NCT00340834|6345151|P4|COMPLETED|Core Phase of Study||0
2586293|NCT00340834|6345152|P3|COMPLETED|Core Phase of Study|On study drug: 380, Off study drug: 6|386
2586294|NCT00340834|6345153|P2|COMPLETED|Core Phase of Study|On study drug: 385, Off study drug: 13|398
2586295|NCT00340834|6345154|P1|COMPLETED|Core Phase of Study|On study drug: 358, Off study drug: 11|369
2586296|NCT00340834|6345150|P5|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
2586297|NCT00340834|6345151|P4|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
2586298|NCT00340834|6345152|P3|STARTED|Core Phase of Study||435
2586299|NCT00340834|6345153|P2|STARTED|Core Phase of Study||431
2586300|NCT00340834|6345154|P1|STARTED|Core Phase of Study||426
2586301|NCT00340704|6345188|P9|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||29
2586302|NCT00340704|6345189|P8|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||12
2586303|NCT00340704|6345190|P7|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||53
2586304|NCT00340704|6345191|P6|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||7
2586305|NCT00340704|6345192|P5|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||5
2586306|NCT00340704|6345193|P4|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||2
2586307|NCT00340704|6345194|P3|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
2586308|NCT00340704|6345195|P2|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
2586309|NCT00340704|6345196|P1|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
2586310|NCT00340704|6345188|P9|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
2586311|NCT00340704|6345189|P8|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
2586312|NCT00340704|6345190|P7|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
2586313|NCT00340704|6345191|P6|COMPLETED|Group D- Denovo & 527.51 Rollover Study||30
2586314|NCT00340704|6345192|P5|COMPLETED|Group D- Denovo & 527.51 Rollover Study||16
2586315|NCT00340704|6345193|P4|COMPLETED|Group D- Denovo & 527.51 Rollover Study||27
2586316|NCT00340704|6345194|P3|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
2586317|NCT00340704|6345195|P2|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
2586318|NCT00340704|6345196|P1|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
2586319|NCT00340704|6345188|P9|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
2586320|NCT00340704|6345189|P8|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
2586321|NCT00340704|6345190|P7|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
2586322|NCT00340704|6345191|P6|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||18
2586323|NCT00340704|6345192|P5|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||5
2586324|NCT00340704|6345193|P4|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||7
2586325|NCT00340704|6345194|P3|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
2586326|NCT00340704|6345195|P2|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
2586327|NCT00340704|6345196|P1|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
2586328|NCT00340704|6345188|P9|STARTED|Group D- Denovo & 527.51 Rollover Study||29
2586329|NCT00340704|6345189|P8|STARTED|Group D- Denovo & 527.51 Rollover Study||13
2586330|NCT00340704|6345190|P7|STARTED|Group D- Denovo & 527.51 Rollover Study||54
2586331|NCT00340704|6345191|P6|STARTED|Group D- Denovo & 527.51 Rollover Study||37
2586332|NCT00340704|6345192|P5|STARTED|Group D- Denovo & 527.51 Rollover Study||21
2586333|NCT00340704|6345193|P4|STARTED|Group D- Denovo & 527.51 Rollover Study||29
2586334|NCT00340704|6345194|P3|STARTED|Group D- Denovo & 527.51 Rollover Study||0
2586335|NCT00340704|6345195|P2|STARTED|Group D- Denovo & 527.51 Rollover Study||0
2586336|NCT00340704|6345196|P1|STARTED|Group D- Denovo & 527.51 Rollover Study||0
2586337|NCT00340704|6345188|P9|NOT COMPLETED|PK Study||0
2586338|NCT00340704|6345189|P8|NOT COMPLETED|PK Study||0
2586339|NCT00340704|6345190|P7|NOT COMPLETED|PK Study||0
2586340|NCT00340704|6345191|P6|NOT COMPLETED|PK Study||0
2586341|NCT00340704|6345192|P5|NOT COMPLETED|PK Study||0
2586342|NCT00340704|6345193|P4|NOT COMPLETED|PK Study||0
2586343|NCT00340704|6345194|P3|NOT COMPLETED|PK Study||1
2586344|NCT00340704|6345195|P2|NOT COMPLETED|PK Study||1
2586345|NCT00340704|6345196|P1|NOT COMPLETED|PK Study||0
2586346|NCT00340704|6345188|P9|COMPLETED|PK Study||0
2586347|NCT00340704|6345189|P8|COMPLETED|PK Study||0
2586348|NCT00340704|6345190|P7|COMPLETED|PK Study||0
2586349|NCT00340704|6345191|P6|COMPLETED|PK Study||0
2586350|NCT00340704|6345192|P5|COMPLETED|PK Study||0
2586351|NCT00340704|6345193|P4|COMPLETED|PK Study||0
2586352|NCT00340704|6345194|P3|COMPLETED|PK Study||10
2586353|NCT00340704|6345195|P2|COMPLETED|PK Study||9
2586354|NCT00340704|6345196|P1|COMPLETED|PK Study||10
2586355|NCT00340704|6345188|P9|STARTED|PK Study||0
2586356|NCT00340704|6345189|P8|STARTED|PK Study||0
2586357|NCT00340704|6345190|P7|STARTED|PK Study||0
2586358|NCT00340704|6345191|P6|STARTED|PK Study||0
2586359|NCT00340704|6345192|P5|STARTED|PK Study||0
2586360|NCT00340704|6345193|P4|STARTED|PK Study||0
2586361|NCT00340704|6345194|P3|STARTED|PK Study||11
2586362|NCT00340704|6345195|P2|STARTED|PK Study||10
2586363|NCT00340704|6345196|P1|STARTED|PK Study||10
2586364|NCT00340678|6345302|P4|NOT COMPLETED|Overall Study||0
2586365|NCT00340678|6345303|P3|NOT COMPLETED|Overall Study||0
2586366|NCT00340678|6345304|P2|NOT COMPLETED|Overall Study||0
2586367|NCT00340678|6345305|P1|NOT COMPLETED|Overall Study||1
2586368|NCT00340678|6345302|P4|COMPLETED|Overall Study||39
2586369|NCT00340678|6345303|P3|COMPLETED|Overall Study||39
2586370|NCT00340678|6345304|P2|COMPLETED|Overall Study||46
2586371|NCT00340678|6345305|P1|COMPLETED|Overall Study||45
2586372|NCT00340678|6345302|P4|STARTED|Overall Study||39
2586373|NCT00340678|6345303|P3|STARTED|Overall Study||39
2586374|NCT00340678|6345304|P2|STARTED|Overall Study||46
2586375|NCT00340678|6345305|P1|STARTED|Overall Study||46
2586376|NCT00340379|6345319|P2|NOT COMPLETED|Overall Study||9
2586377|NCT00340379|6345320|P1|NOT COMPLETED|Overall Study||8
2586378|NCT00340379|6345319|P2|COMPLETED|Overall Study||28
2586379|NCT00340379|6345320|P1|COMPLETED|Overall Study||27
2586380|NCT00340379|6345319|P2|STARTED|Overall Study||37
2586381|NCT00340379|6345320|P1|STARTED|Overall Study||35
2586382|NCT00339833|6345332|P2|NOT COMPLETED|Overall Study||8
2586383|NCT00339833|6345333|P1|NOT COMPLETED|Overall Study||6
2586384|NCT00339833|6345332|P2|COMPLETED|Overall Study||18
2586385|NCT00339833|6345333|P1|COMPLETED|Overall Study||22
2586386|NCT00339833|6345332|P2|STARTED|Overall Study||26
2586387|NCT00339833|6345333|P1|STARTED|Overall Study||28
2586388|NCT00339183|6345343|P2|NOT COMPLETED|Overall Study||105
2586389|NCT00339183|6345344|P1|NOT COMPLETED|Overall Study||121
2586390|NCT00339183|6345343|P2|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|490
2586391|NCT00339183|6345344|P1|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|470
2586392|NCT00339183|6345343|P2|Received Study Drug|Overall Study||593
2586393|NCT00339183|6345344|P1|Received Study Drug|Overall Study|Includes one participant who received FOLFIRI Alone|588
2586394|NCT00339183|6345343|P2|STARTED|Overall Study||595
2586395|NCT00339183|6345344|P1|STARTED|Overall Study||591
2586396|NCT00339144|6345373|P3|NOT COMPLETED|Overall Study||4
2586397|NCT00339144|6345374|P2|NOT COMPLETED|Overall Study||3
2586398|NCT00339144|6345375|P1|NOT COMPLETED|Overall Study||9
2586399|NCT00339144|6345373|P3|COMPLETED|Overall Study||0
2586400|NCT00339144|6345374|P2|COMPLETED|Overall Study||0
2586401|NCT00339144|6345375|P1|COMPLETED|Overall Study||0
2586402|NCT00339144|6345373|P3|STARTED|Overall Study|Number of participants enrolled and treated|4
2586403|NCT00339144|6345374|P2|STARTED|Overall Study|Number of participants enrolled and treated|3
2586404|NCT00339144|6345375|P1|STARTED|Overall Study|Number of participants enrolled and treated|9
2586405|NCT00339079|6345461|P4|NOT COMPLETED|Overall Study||24
2586406|NCT00339079|6345462|P3|NOT COMPLETED|Overall Study||18
2586407|NCT00339079|6345463|P2|NOT COMPLETED|Overall Study||23
2586408|NCT00339079|6345464|P1|NOT COMPLETED|Overall Study||33
2586409|NCT00339079|6345461|P4|COMPLETED|Overall Study||29
2586410|NCT00339079|6345462|P3|COMPLETED|Overall Study||27
2586411|NCT00339079|6345463|P2|COMPLETED|Overall Study||21
2586412|NCT00339079|6345464|P1|COMPLETED|Overall Study||20
2586413|NCT00339079|6345461|P4|STARTED|Overall Study||53
2586414|NCT00339079|6345462|P3|STARTED|Overall Study||45
2586415|NCT00339079|6345463|P2|STARTED|Overall Study||44
2586416|NCT00339079|6345464|P1|STARTED|Overall Study||53
2586417|NCT00339040|6345480|P2|NOT COMPLETED|Stage II||2
2586418|NCT00339040|6345481|P1|NOT COMPLETED|Stage II||10
2586419|NCT00339040|6345480|P2|COMPLETED|Stage II||27
2586420|NCT00339040|6345481|P1|COMPLETED|Stage II||84
2586421|NCT00339040|6345480|P2|Vaccination 6 at Week 120|Stage II||27
2586422|NCT00339040|6345481|P1|Vaccination 6 at Week 120|Stage II||0
2586423|NCT00339040|6345480|P2|Vaccination 5 at Week 104|Stage II||28
2586424|NCT00339040|6345481|P1|Vaccination 5 at Week 104|Stage II||0
2586425|NCT00339040|6345480|P2|Vaccination 4 at Week 96|Stage II||29
2586426|NCT00339040|6345481|P1|Vaccination 4 at Week 96|Stage II||84
2586427|NCT00339040|6345480|P2|STARTED|Stage II||29
2586428|NCT00339040|6345481|P1|STARTED|Stage II||94
2586429|NCT00339040|6345480|P2|NOT COMPLETED|Stage I||1
2586430|NCT00339040|6345481|P1|NOT COMPLETED|Stage I||2
2586431|NCT00339040|6345480|P2|COMPLETED|Stage I||29
2586432|NCT00339040|6345481|P1|COMPLETED|Stage I||94
2586433|NCT00339040|6345480|P2|Vaccination 3 at Week 24|Stage I||30
2586434|NCT00339040|6345481|P1|Vaccination 3 at Week 24|Stage I||94
2586435|NCT00339040|6345480|P2|Vaccination 2 at Week 8|Stage I||30
2586436|NCT00339040|6345481|P1|Vaccination 2 at Week 8|Stage I||95
2586437|NCT00339040|6345480|P2|Vaccination 1 at Week 0|Stage I||30
2586438|NCT00339040|6345481|P1|Vaccination 1 at Week 0|Stage I||96
2586439|NCT00339040|6345480|P2|STARTED|Stage I||30
2586440|NCT00339040|6345481|P1|STARTED|Stage I||96
2586441|NCT00338988|6345499|P1|NOT COMPLETED|Overall Study||1
2586442|NCT00338988|6345499|P1|COMPLETED|Overall Study||43
2586443|NCT00338988|6345499|P1|STARTED|Overall Study||44
2586444|NCT00338962|6345508|P4|NOT COMPLETED|Overall Study||3
2586445|NCT00338962|6345509|P3|NOT COMPLETED|Overall Study||6
2586446|NCT00338962|6345510|P2|NOT COMPLETED|Overall Study||4
2586447|NCT00338962|6345511|P1|NOT COMPLETED|Overall Study||8
2586448|NCT00338962|6345508|P4|COMPLETED|Overall Study||21
2586449|NCT00338962|6345509|P3|COMPLETED|Overall Study||16
2586450|NCT00338962|6345510|P2|COMPLETED|Overall Study||16
2586451|NCT00338962|6345511|P1|COMPLETED|Overall Study||14
2586452|NCT00338962|6345508|P4|STARTED|Overall Study||24
2586453|NCT00338962|6345509|P3|STARTED|Overall Study||22
2586454|NCT00338962|6345510|P2|STARTED|Overall Study||20
2586455|NCT00338962|6345511|P1|STARTED|Overall Study||22
2586456|NCT00338884|6345533|P1|NOT COMPLETED|Overall Study||78
2586457|NCT00338884|6345533|P1|COMPLETED|Overall Study||42
2586458|NCT00338884|6345533|P1|Received Treatment|Overall Study||119
2586459|NCT00338884|6345533|P1|STARTED|Overall Study||120
2586460|NCT00338806|6345567|P2|NOT COMPLETED|Follow-up||3
2586461|NCT00338806|6345568|P1|NOT COMPLETED|Follow-up||1
2586462|NCT00338806|6345567|P2|COMPLETED|Follow-up||1
2586463|NCT00338806|6345568|P1|COMPLETED|Follow-up||1
2586464|NCT00338806|6345567|P2|STARTED|Follow-up||4
2586465|NCT00338806|6345568|P1|STARTED|Follow-up||2
2586466|NCT00338806|6345567|P2|NOT COMPLETED|Acute Phase||1
2586467|NCT00338806|6345568|P1|NOT COMPLETED|Acute Phase||0
2586468|NCT00338806|6345567|P2|COMPLETED|Acute Phase||4
2586469|NCT00338806|6345568|P1|COMPLETED|Acute Phase||2
2586470|NCT00338806|6345567|P2|STARTED|Acute Phase||5
2586471|NCT00338806|6345568|P1|STARTED|Acute Phase||2
2586472|NCT00338741|6345630|P2|NOT COMPLETED|Overall Study||0
2586473|NCT00338741|6345631|P1|NOT COMPLETED|Overall Study||2
2586474|NCT00338741|6345630|P2|COMPLETED|Overall Study||2
2586475|NCT00338741|6345631|P1|COMPLETED|Overall Study||32
2586476|NCT00338741|6345630|P2|STARTED|Overall Study||2
2586477|NCT00338741|6345631|P1|STARTED|Overall Study|2 subjects signed a consent form but no data were received for either subject|34
2586478|NCT00338728|6345639|P1|NOT COMPLETED|Overall Study||14
2586479|NCT00338728|6345639|P1|COMPLETED|Overall Study||45
2586480|NCT00338728|6345639|P1|STARTED|Overall Study||59
2586481|NCT00338598|6345646|P2|NOT COMPLETED|Overall Study||2
2586482|NCT00338598|6345647|P1|NOT COMPLETED|Overall Study||0
2586483|NCT00338598|6345646|P2|COMPLETED|Overall Study||8
2586484|NCT00338598|6345647|P1|COMPLETED|Overall Study||10
2586485|NCT00338598|6345646|P2|STARTED|Overall Study||10
2586486|NCT00338598|6345647|P1|STARTED|Overall Study||10
2586487|NCT00338455|6345667|P2|NOT COMPLETED|Overall Study||1
2586488|NCT00338455|6345668|P1|NOT COMPLETED|Overall Study||3
2586489|NCT00338455|6345667|P2|COMPLETED|Overall Study||6
2586490|NCT00338455|6345668|P1|COMPLETED|Overall Study||6
2586491|NCT00338455|6345667|P2|Administered Study Drug|Overall Study||7
2586492|NCT00338455|6345668|P1|Administered Study Drug|Overall Study||8
2586493|NCT00338455|6345667|P2|STARTED|Overall Study||7
2586494|NCT00338455|6345668|P1|STARTED|Overall Study||9
2586495|NCT00338286|6345682|P2|NOT COMPLETED|Overall Study||213
2586496|NCT00338286|6345683|P1|NOT COMPLETED|Overall Study||233
2586497|NCT00338286|6345682|P2|COMPLETED|Overall Study||837
2586498|NCT00338286|6345683|P1|COMPLETED|Overall Study||815
2586499|NCT00338286|6345682|P2|STARTED|Overall Study||1050
2586500|NCT00338286|6345683|P1|STARTED|Overall Study||1048
2586501|NCT00338104|6345700|P3|NOT COMPLETED|Overall Study||3
2586502|NCT00338104|6345701|P2|NOT COMPLETED|Overall Study||1
2586503|NCT00338104|6345702|P1|NOT COMPLETED|Overall Study||2
2586504|NCT00338104|6345700|P3|COMPLETED|Overall Study||22
2586505|NCT00338104|6345701|P2|COMPLETED|Overall Study||24
2586506|NCT00338104|6345702|P1|COMPLETED|Overall Study||23
2586507|NCT00338104|6345700|P3|STARTED|Overall Study||25
2586508|NCT00338104|6345701|P2|STARTED|Overall Study||25
2586509|NCT00338104|6345702|P1|STARTED|Overall Study||25
2586510|NCT00338039|6345713|P1|NOT COMPLETED|Overall Study||0
2586511|NCT00338039|6345713|P1|COMPLETED|Overall Study||69
2586512|NCT00338039|6345713|P1|STARTED|Overall Study||69
2586513|NCT00337987|6345718|P1|NOT COMPLETED|Overall Study||0
2586514|NCT00337987|6345718|P1|COMPLETED|Overall Study||49
2586515|NCT00337987|6345718|P1|STARTED|Overall Study||49
2586516|NCT00337935|6345725|P2|NOT COMPLETED|Overall Study||27
2586517|NCT00337935|6345726|P1|NOT COMPLETED|Overall Study||10
2586518|NCT00337935|6345725|P2|COMPLETED|Overall Study||91
2586519|NCT00337935|6345726|P1|COMPLETED|Overall Study||29
2586520|NCT00337935|6345725|P2|STARTED|Overall Study||118
2586521|NCT00337935|6345726|P1|STARTED|Overall Study||39
2586522|NCT00337818|6345739|P3|NOT COMPLETED|Overall Study||107
2586523|NCT00337818|6345740|P2|NOT COMPLETED|Overall Study||91
2586524|NCT00337818|6345741|P1|NOT COMPLETED|Overall Study||289
2586525|NCT00337818|6345739|P3|COMPLETED|Overall Study||51
2586526|NCT00337818|6345740|P2|COMPLETED|Overall Study||63
2586527|NCT00337818|6345741|P1|COMPLETED|Overall Study||169
2586528|NCT00337818|6345739|P3|STARTED|Overall Study||158
2586529|NCT00337818|6345740|P2|STARTED|Overall Study||154
2586530|NCT00337818|6345741|P1|STARTED|Overall Study||458
2586531|NCT00337779|6345763|P2|NOT COMPLETED|Overall Study||79
2586532|NCT00337779|6345764|P1|NOT COMPLETED|Overall Study||52
2586533|NCT00337779|6345763|P2|COMPLETED|Overall Study||490
2586534|NCT00337779|6345764|P1|COMPLETED|Overall Study||534
2586535|NCT00337779|6345763|P2|STARTED|Overall Study||569
2586536|NCT00337779|6345764|P1|STARTED|Overall Study||586
2586537|NCT00337727|6345776|P2|NOT COMPLETED|Overall Study||12
2586538|NCT00337727|6345777|P1|NOT COMPLETED|Overall Study||18
2586539|NCT00337727|6345776|P2|COMPLETED|Overall Study||406
2586540|NCT00337727|6345777|P1|COMPLETED|Overall Study||412
2586541|NCT00337727|6345776|P2|STARTED|Overall Study||418
2586542|NCT00337727|6345777|P1|STARTED|Overall Study||430
2586543|NCT00337675|6345788|P3|NOT COMPLETED|Overall Study||99
2586544|NCT00337675|6345789|P2|NOT COMPLETED|Overall Study||103
2586545|NCT00337675|6345790|P1|NOT COMPLETED|Overall Study||97
2586546|NCT00337675|6345788|P3|COMPLETED|Overall Study||492
2586547|NCT00337675|6345789|P2|COMPLETED|Overall Study||488
2586548|NCT00337675|6345790|P1|COMPLETED|Overall Study||492
2586549|NCT00337675|6345788|P3|STARTED|Overall Study||591
2586550|NCT00337675|6345789|P2|STARTED|Overall Study||591
2586551|NCT00337675|6345790|P1|STARTED|Overall Study||589
2586552|NCT00337662|6345807|P4|NOT COMPLETED|Study Period III||0
2586553|NCT00337662|6345808|P3|NOT COMPLETED|Study Period III||44
2586554|NCT00337662|6345809|P2|NOT COMPLETED|Study Period III||58
2586555|NCT00337662|6345810|P1|NOT COMPLETED|Study Period III||60
2586556|NCT00337662|6345807|P4|COMPLETED|Study Period III||0
2586557|NCT00337662|6345808|P3|COMPLETED|Study Period III||100
2586558|NCT00337662|6345809|P2|COMPLETED|Study Period III||134
2586559|NCT00337662|6345810|P1|COMPLETED|Study Period III||126
2586560|NCT00337662|6345807|P4|STARTED|Study Period III||0
2586561|NCT00337662|6345808|P3|STARTED|Study Period III||144
2586562|NCT00337662|6345809|P2|STARTED|Study Period III||192
2586563|NCT00337662|6345810|P1|STARTED|Study Period III||186
2586564|NCT00337662|6345807|P4|NOT COMPLETED|Study Period II||106
2586565|NCT00337662|6345808|P3|NOT COMPLETED|Study Period II||0
2586566|NCT00337662|6345809|P2|NOT COMPLETED|Study Period II||0
2586567|NCT00337662|6345810|P1|NOT COMPLETED|Study Period II||0
2586568|NCT00337662|6345807|P4|COMPLETED|Study Period II||522
2586569|NCT00337662|6345808|P3|COMPLETED|Study Period II||0
2586570|NCT00337662|6345809|P2|COMPLETED|Study Period II||0
2586571|NCT00337662|6345810|P1|COMPLETED|Study Period II||0
2586572|NCT00337662|6345807|P4|STARTED|Study Period II||628
2586573|NCT00337662|6345808|P3|STARTED|Study Period II||0
2586574|NCT00337662|6345809|P2|STARTED|Study Period II||0
2586575|NCT00337662|6345810|P1|STARTED|Study Period II||0
2586576|NCT00337610|6345864|P2|NOT COMPLETED|Overall Study||14
2586577|NCT00337610|6345865|P1|NOT COMPLETED|Overall Study||17
2586578|NCT00337610|6345864|P2|COMPLETED|Overall Study||80
2586579|NCT00337610|6345865|P1|COMPLETED|Overall Study||79
2586580|NCT00337610|6345864|P2|Completed Week 18|Overall Study||82
2586581|NCT00337610|6345865|P1|Completed Week 18|Overall Study||89
2586582|NCT00337610|6345864|P2|STARTED|Overall Study||94
2586583|NCT00337610|6345865|P1|STARTED|Overall Study||96
2586584|NCT00337571|6345881|P4|NOT COMPLETED|Overall Study||7
2586585|NCT00337571|6345882|P3|NOT COMPLETED|Overall Study||10
2586586|NCT00337571|6345883|P2|NOT COMPLETED|Overall Study||9
2586587|NCT00337571|6345884|P1|NOT COMPLETED|Overall Study||14
2586588|NCT00337571|6345881|P4|COMPLETED|Overall Study||47
2586589|NCT00337571|6345882|P3|COMPLETED|Overall Study||49
2586590|NCT00337571|6345883|P2|COMPLETED|Overall Study||44
2586591|NCT00337571|6345884|P1|COMPLETED|Overall Study||38
2586592|NCT00337571|6345881|P4|STARTED|Overall Study||54
2586593|NCT00337571|6345882|P3|STARTED|Overall Study||59
2586594|NCT00337571|6345883|P2|STARTED|Overall Study||53
2586595|NCT00337571|6345884|P1|STARTED|Overall Study||52
2586596|NCT00337467|6345922|P1|NOT COMPLETED|Overall Study||10
2586597|NCT00337467|6345922|P1|COMPLETED|Overall Study||51
2586598|NCT00337467|6345922|P1|Discontinued Prior to Week 96|Overall Study|5 of these participants discontinued prior to Week 48|10
2586599|NCT00337467|6345922|P1|STARTED|Overall Study||61
2586600|NCT00337428|6345941|P2|NOT COMPLETED|Overall Study||3
2586601|NCT00337428|6345942|P1|NOT COMPLETED|Overall Study||4
2586602|NCT00337428|6345941|P2|COMPLETED|Overall Study||421
2586603|NCT00337428|6345942|P1|COMPLETED|Overall Study||415
2586604|NCT00337428|6345941|P2|STARTED|Overall Study||424
2586605|NCT00337428|6345942|P1|STARTED|Overall Study||419
2586606|NCT00337350|6345982|P2|NOT COMPLETED|Overall Study||1
2586607|NCT00337350|6345983|P1|NOT COMPLETED|Overall Study||1
2586608|NCT00337350|6345982|P2|COMPLETED|Overall Study||10
2586609|NCT00337350|6345983|P1|COMPLETED|Overall Study||8
2586610|NCT00337350|6345982|P2|STARTED|Overall Study||11
2586611|NCT00337350|6345983|P1|STARTED|Overall Study||9
2586612|NCT00337285|6345993|P1|NOT COMPLETED|Overall Study||158
2586613|NCT00337285|6345993|P1|COMPLETED|Overall Study||191
2586614|NCT00337285|6345993|P1|STARTED|Overall Study||349
2586615|NCT00337272|6346001|P2|NOT COMPLETED|Withdrawal Period||1
2586616|NCT00337272|6346002|P1|NOT COMPLETED|Withdrawal Period||0
2586617|NCT00337272|6346001|P2|COMPLETED|Withdrawal Period||6
2586618|NCT00337272|6346002|P1|COMPLETED|Withdrawal Period||6
2586619|NCT00337272|6346001|P2|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|7
2586620|NCT00337272|6346002|P1|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|6
2586621|NCT00337272|6346001|P2|NOT COMPLETED|Treatment Period||2
2586622|NCT00337272|6346002|P1|NOT COMPLETED|Treatment Period||1
2586623|NCT00337272|6346001|P2|COMPLETED|Treatment Period||7
2586624|NCT00337272|6346002|P1|COMPLETED|Treatment Period||6
2586625|NCT00337272|6346001|P2|Randomization|Treatment Period||9
2586626|NCT00337272|6346002|P1|Randomization|Treatment Period||7
2586627|NCT00337272|6346001|P2|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|9
2586628|NCT00337272|6346002|P1|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|7
2586629|NCT00337272|6346001|P2|NOT COMPLETED|Screening Period (Pre-randomization)||0
2586630|NCT00337272|6346002|P1|NOT COMPLETED|Screening Period (Pre-randomization)||6
2586631|NCT00337272|6346001|P2|COMPLETED|Screening Period (Pre-randomization)||0
2586632|NCT00337272|6346002|P1|COMPLETED|Screening Period (Pre-randomization)|16 subjects completed the screening period and were eligible for randomization.|16
2586633|NCT00337272|6346001|P2|STARTED|Screening Period (Pre-randomization)||0
2586634|NCT00337272|6346002|P1|STARTED|Screening Period (Pre-randomization)|22 subjects were consented. All subjects received placebo during the 2 week screening period.|22
2586635|NCT00337207|6346022|P1|NOT COMPLETED|Overall Study||3
2586636|NCT00337207|6346022|P1|COMPLETED|Overall Study||52
2586637|NCT00337207|6346022|P1|STARTED|Overall Study||55
2586638|NCT00337194|6346030|P2|NOT COMPLETED|Overall Study||4
2586639|NCT00337194|6346031|P1|NOT COMPLETED|Overall Study||12
2586640|NCT00337194|6346030|P2|COMPLETED|Overall Study||3
2586641|NCT00337194|6346031|P1|COMPLETED|Overall Study||11
2586642|NCT00337194|6346030|P2|STARTED|Overall Study||7
2586643|NCT00337194|6346031|P1|STARTED|Overall Study||23
2586644|NCT00337181|6346048|P2|NOT COMPLETED|Overall Study||0
2586645|NCT00337181|6346049|P1|NOT COMPLETED|Overall Study||0
2586646|NCT00337181|6346048|P2|COMPLETED|Overall Study||65
2586647|NCT00337181|6346049|P1|COMPLETED|Overall Study||49
2586648|NCT00337181|6346048|P2|STARTED|Overall Study||65
2586649|NCT00337181|6346049|P1|STARTED|Overall Study||49
2586650|NCT00337168|6346055|P1|NOT COMPLETED|Overall Study||8
2586651|NCT00337168|6346055|P1|COMPLETED|Overall Study||29
2586652|NCT00337168|6346055|P1|Eligible and Treated|Overall Study||36
2586653|NCT00337168|6346055|P1|Eligible|Overall Study||37
2586654|NCT00337168|6346055|P1|STARTED|Overall Study||37
2586655|NCT00337129|6346062|P1|NOT COMPLETED|Overall Study||40
2586656|NCT00337129|6346062|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until discontinuation criterion is met.|0
2586657|NCT00337129|6346062|P1|STARTED|Overall Study||40
2586658|NCT00337103|6346071|P2|NOT COMPLETED|Overall Study||543
2586659|NCT00337103|6346072|P1|NOT COMPLETED|Overall Study||549
2586660|NCT00337103|6346071|P2|COMPLETED|Overall Study||5
2586661|NCT00337103|6346072|P1|COMPLETED|Overall Study||5
2586662|NCT00337103|6346071|P2|STARTED|Overall Study||548
2586663|NCT00337103|6346072|P1|STARTED|Overall Study||554
2586664|NCT00337077|6346083|P3|NOT COMPLETED|Overall Study||25
2586665|NCT00337077|6346084|P2|NOT COMPLETED|Overall Study||53
2586666|NCT00337077|6346085|P1|NOT COMPLETED|Overall Study||43
2586667|NCT00337077|6346083|P3|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
2586668|NCT00337077|6346084|P2|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
2586669|NCT00337077|6346085|P1|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
2586670|NCT00337077|6346083|P3|Patients With Measurable Disease|Overall Study||13
2586671|NCT00337077|6346084|P2|Patients With Measurable Disease|Overall Study||38
2586672|NCT00337077|6346085|P1|Patients With Measurable Disease|Overall Study||26
2586673|NCT00337077|6346083|P3|Eligible and Treated|Overall Study||24
2586674|NCT00337077|6346084|P2|Eligible and Treated|Overall Study||51
2586675|NCT00337077|6346085|P1|Eligible and Treated|Overall Study||41
2586676|NCT00337077|6346083|P3|Toxicity Assessed|Overall Study||25
2586677|NCT00337077|6346084|P2|Toxicity Assessed|Overall Study||51
2586678|NCT00337077|6346085|P1|Toxicity Assessed|Overall Study||42
2586679|NCT00337077|6346083|P3|Treated|Overall Study||25
2586680|NCT00337077|6346084|P2|Treated|Overall Study||52
2586681|NCT00337077|6346085|P1|Treated|Overall Study||42
2586682|NCT00337077|6346083|P3|STARTED|Overall Study||25
2586683|NCT00337077|6346084|P2|STARTED|Overall Study||53
2586684|NCT00337077|6346085|P1|STARTED|Overall Study||43
2586685|NCT00336973|6346094|P1|NOT COMPLETED|Overall Study||33
2586686|NCT00336973|6346094|P1|COMPLETED|Overall Study||33
2586687|NCT00336973|6346094|P1|STARTED|Overall Study||66
2586688|NCT00336895|6346100|P1|NOT COMPLETED|Overall Study||4
2586689|NCT00336895|6346100|P1|COMPLETED|Overall Study||26
2586690|NCT00336895|6346100|P1|STARTED|Overall Study||30
2586691|NCT00336856|6346106|P1|NOT COMPLETED|Overall Study||4
2586692|NCT00336856|6346106|P1|COMPLETED|Overall Study||31
2586693|NCT00336856|6346106|P1|STARTED|Overall Study|Number of patients consented and registered for the study|35
2586694|NCT00336817|6346114|P2|NOT COMPLETED|Overall Study||2
2586695|NCT00336817|6346115|P1|NOT COMPLETED|Overall Study||1
2586696|NCT00336817|6346114|P2|COMPLETED|Overall Study||13
2586697|NCT00336817|6346115|P1|COMPLETED|Overall Study||14
2586698|NCT00336817|6346114|P2|STARTED|Overall Study||15
2586699|NCT00336817|6346115|P1|STARTED|Overall Study||15
2586700|NCT00336700|6346145|P1|NOT COMPLETED|Overall Study||0
2586701|NCT00336700|6346145|P1|COMPLETED|Overall Study||25
2586702|NCT00336700|6346145|P1|STARTED|Overall Study||25
2586703|NCT00336583|6346154|P1|NOT COMPLETED|Overall Study||2
2586704|NCT00336583|6346154|P1|COMPLETED|Overall Study||25
2586705|NCT00336583|6346154|P1|STARTED|Overall Study||27
2586706|NCT00336544|6346161|P2|NOT COMPLETED|Overall Study||22
2586707|NCT00336544|6346162|P1|NOT COMPLETED|Overall Study||19
2586708|NCT00336544|6346161|P2|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|238
2586709|NCT00336544|6346162|P1|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|242
2586710|NCT00336544|6346161|P2|STARTED|Overall Study|All subjects who were randomized and dosed.|260
2586711|NCT00336544|6346162|P1|STARTED|Overall Study|All subjects who were randomized and dosed.|261
2586712|NCT00336505|6346176|P2|NOT COMPLETED|Overall Study||27
2586713|NCT00336505|6346177|P1|NOT COMPLETED|Overall Study||37
2586714|NCT00336505|6346176|P2|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|264
2586715|NCT00336505|6346177|P1|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|254
2586716|NCT00336505|6346176|P2|STARTED|Overall Study|All subjects who were randomized and dosed.|291
2586717|NCT00336505|6346177|P1|STARTED|Overall Study|All subjects who were randomized and dosed.|291
2586718|NCT00336492|6346192|P3|NOT COMPLETED|Overall Study||11
2586719|NCT00336492|6346193|P2|NOT COMPLETED|Overall Study||4
2586720|NCT00336492|6346194|P1|NOT COMPLETED|Overall Study||15
2586721|NCT00336492|6346192|P3|COMPLETED|Overall Study||12
2586722|NCT00336492|6346193|P2|COMPLETED|Overall Study||18
2586723|NCT00336492|6346194|P1|COMPLETED|Overall Study||0
2586724|NCT00336492|6346192|P3|STARTED|Overall Study||23
2586725|NCT00336492|6346193|P2|STARTED|Overall Study||22
2586726|NCT00336492|6346194|P1|STARTED|Overall Study||15
2586727|NCT00336479|6346206|P4|NOT COMPLETED|Overall Study||4
2586728|NCT00336479|6346207|P3|NOT COMPLETED|Overall Study||26
2586729|NCT00336479|6346208|P2|NOT COMPLETED|Overall Study||25
2586730|NCT00336479|6346209|P1|NOT COMPLETED|Overall Study||37
2586731|NCT00336479|6346206|P4|COMPLETED|Overall Study||13
2586732|NCT00336479|6346207|P3|COMPLETED|Overall Study||53
2586733|NCT00336479|6346208|P2|COMPLETED|Overall Study||54
2586734|NCT00336479|6346209|P1|COMPLETED|Overall Study||38
2586735|NCT00336479|6346206|P4|STARTED|Overall Study||17
2586736|NCT00336479|6346207|P3|STARTED|Overall Study||79
2586737|NCT00336479|6346208|P2|STARTED|Overall Study||79
2586738|NCT00336479|6346209|P1|STARTED|Overall Study||75
2586739|NCT00336323|6346237|P5|NOT COMPLETED|Overall Study||3
2586740|NCT00336323|6346238|P4|NOT COMPLETED|Overall Study||0
2586741|NCT00336323|6346239|P3|NOT COMPLETED|Overall Study||1
2586742|NCT00336323|6346240|P2|NOT COMPLETED|Overall Study||1
2586743|NCT00336323|6346241|P1|NOT COMPLETED|Overall Study||0
2586744|NCT00336323|6346237|P5|COMPLETED|Overall Study||19
2586745|NCT00336323|6346238|P4|COMPLETED|Overall Study||22
2586746|NCT00336323|6346239|P3|COMPLETED|Overall Study||23
2586747|NCT00336323|6346240|P2|COMPLETED|Overall Study||21
2586748|NCT00336323|6346241|P1|COMPLETED|Overall Study||19
2586749|NCT00336323|6346237|P5|24 Week Visit|Overall Study||19
2586750|NCT00336323|6346238|P4|24 Week Visit|Overall Study||22
2586751|NCT00336323|6346239|P3|24 Week Visit|Overall Study|1 patient was dropped from the study|22
2586752|NCT00336323|6346240|P2|24 Week Visit|Overall Study|1 patient was dropped from the study|20
2586753|NCT00336323|6346241|P1|24 Week Visit|Overall Study||18
2586754|NCT00336323|6346237|P5|18 Week Visit|Overall Study|1 patient was dropped from the study|18
2586755|NCT00336323|6346238|P4|18 Week Visit|Overall Study||21
2586756|NCT00336323|6346239|P3|18 Week Visit|Overall Study||23
2586757|NCT00336323|6346240|P2|18 Week Visit|Overall Study||22
2586758|NCT00336323|6346241|P1|18 Week Visit|Overall Study||19
2586759|NCT00336323|6346237|P5|12 Week Visit|Overall Study|1 patient was dropped from study|20
2586760|NCT00336323|6346238|P4|12 Week Visit|Overall Study||22
2586761|NCT00336323|6346239|P3|12 Week Visit|Overall Study||24
2586762|NCT00336323|6346240|P2|12 Week Visit|Overall Study||21
2586763|NCT00336323|6346241|P1|12 Week Visit|Overall Study||19
2586764|NCT00336323|6346237|P5|9 Week Visit|Overall Study||19
2586765|NCT00336323|6346238|P4|9 Week Visit|Overall Study||21
2586766|NCT00336323|6346239|P3|9 Week Visit|Overall Study||23
2586767|NCT00336323|6346240|P2|9 Week Visit|Overall Study||21
2586768|NCT00336323|6346241|P1|9 Week Visit|Overall Study||18
2586769|NCT00336323|6346237|P5|6 Week Visit|Overall Study|1 patient was dropped - injection was given late at 9 wks for one patient|20
2586770|NCT00336323|6346238|P4|6 Week Visit|Overall Study||22
2586771|NCT00336323|6346239|P3|6 Week Visit|Overall Study||24
2586772|NCT00336323|6346240|P2|6 Week Visit|Overall Study||22
2586773|NCT00336323|6346241|P1|6 Week Visit|Overall Study||18
2586774|NCT00336323|6346237|P5|3 Week Visit|Overall Study|Laser given late at six weeks for one patient|20
2586775|NCT00336323|6346238|P4|3 Week Visit|Overall Study||22
2586776|NCT00336323|6346239|P3|3 Week Visit|Overall Study||24
2586777|NCT00336323|6346240|P2|3 Week Visit|Overall Study||21
2586778|NCT00336323|6346241|P1|3 Week Visit|Overall Study||18
2586779|NCT00336323|6346237|P5|STARTED|Overall Study||22
2586780|NCT00336323|6346238|P4|STARTED|Overall Study||22
2586781|NCT00336323|6346239|P3|STARTED|Overall Study||24
2586782|NCT00336323|6346240|P2|STARTED|Overall Study||22
2586783|NCT00336323|6346241|P1|STARTED|Overall Study||19
2586784|NCT00336284|6346298|P2|NOT COMPLETED|Overall Study||151
2586785|NCT00336284|6346299|P1|NOT COMPLETED|Overall Study||236
2586786|NCT00336284|6346298|P2|COMPLETED|Overall Study||322
2586787|NCT00336284|6346299|P1|COMPLETED|Overall Study||741
2586788|NCT00336284|6346298|P2|STARTED|Overall Study||473
2586789|NCT00336284|6346299|P1|STARTED|Overall Study||977
2586790|NCT00336232|6346311|P1|NOT COMPLETED|High Vitamin K (500mcg Daily)||0
2586791|NCT00336232|6346311|P1|COMPLETED|High Vitamin K (500mcg Daily)||42
2586792|NCT00336232|6346311|P1|STARTED|High Vitamin K (500mcg Daily)||42
2586793|NCT00336232|6346311|P1|NOT COMPLETED|Low Vitamin K (10mcg Daily)||0
2586794|NCT00336232|6346311|P1|COMPLETED|Low Vitamin K (10mcg Daily)||42
2586795|NCT00336232|6346311|P1|STARTED|Low Vitamin K (10mcg Daily)||42
2586796|NCT00336232|6346311|P1|NOT COMPLETED|Baseline (200mcg Daily)||17
2586797|NCT00336232|6346311|P1|COMPLETED|Baseline (200mcg Daily)||42
2586798|NCT00336232|6346311|P1|STARTED|Baseline (200mcg Daily)||59
2586799|NCT00336024|6346317|P2|NOT COMPLETED|Overall Study||19
2586800|NCT00336024|6346318|P1|NOT COMPLETED|Overall Study||20
2586801|NCT00336024|6346317|P2|COMPLETED|Overall Study||26
2586802|NCT00336024|6346318|P1|COMPLETED|Overall Study||26
2586803|NCT00336024|6346317|P2|STARTED|Overall Study||45
2586804|NCT00336024|6346318|P1|STARTED|Overall Study||46
2586805|NCT00335972|6346352|P2|NOT COMPLETED|Overall Study||3
2586806|NCT00335972|6346353|P1|NOT COMPLETED|Overall Study||0
2586807|NCT00335972|6346352|P2|COMPLETED|Overall Study||68
2586808|NCT00335972|6346353|P1|COMPLETED|Overall Study||71
2586809|NCT00335972|6346352|P2|STARTED|Overall Study||71
2586810|NCT00335972|6346353|P1|STARTED|Overall Study||71
2586811|NCT00335959|6346363|P1|NOT COMPLETED|Overall Study||3
2586812|NCT00335959|6346363|P1|COMPLETED|Overall Study||4
2586813|NCT00335959|6346363|P1|Eligible and Began Protocol Therapy|Overall Study||6
2586814|NCT00335959|6346363|P1|Eligible|Overall Study||6
2586815|NCT00335959|6346363|P1|STARTED|Overall Study||7
2586816|NCT00335829|6346368|P1|NOT COMPLETED|Overall Study||3
2586817|NCT00335829|6346368|P1|COMPLETED|Overall Study||23
2586818|NCT00335829|6346368|P1|Received First TACE|Overall Study|1 patient left after receiving bevacizumab but prior to first TACE|25
2586819|NCT00335829|6346368|P1|Received Bevacizumab|Overall Study||26
2586820|NCT00335829|6346368|P1|STARTED|Overall Study||26
2586821|NCT00335777|6346382|P1|NOT COMPLETED|Treated 2 Headaches Per Protocol||13
2586822|NCT00335777|6346382|P1|COMPLETED|Treated 2 Headaches Per Protocol||22
2586823|NCT00335777|6346382|P1|STARTED|Treated 2 Headaches Per Protocol||35
2586824|NCT00335777|6346382|P1|NOT COMPLETED|Enrolled and Dispensed Study Medication||29
2586825|NCT00335777|6346382|P1|COMPLETED|Enrolled and Dispensed Study Medication||35
2586826|NCT00335777|6346382|P1|STARTED|Enrolled and Dispensed Study Medication|64 subjects enrolled. 35 treated 2 headaches, but 22/35 at appropriate times, as per protocol.|64
2586827|NCT00335764|6346392|P5|NOT COMPLETED|Overall Study||1
2586828|NCT00335764|6346393|P4|NOT COMPLETED|Overall Study||0
2586829|NCT00335764|6346394|P3|NOT COMPLETED|Overall Study||0
2586830|NCT00335764|6346395|P2|NOT COMPLETED|Overall Study||0
2586831|NCT00335764|6346396|P1|NOT COMPLETED|Overall Study||1
2586832|NCT00335764|6346392|P5|COMPLETED|Overall Study||18
2586833|NCT00335764|6346393|P4|COMPLETED|Overall Study||19
2586834|NCT00335764|6346394|P3|COMPLETED|Overall Study||24
2586835|NCT00335764|6346395|P2|COMPLETED|Overall Study||13
2586836|NCT00335764|6346396|P1|COMPLETED|Overall Study||16
2586837|NCT00335764|6346392|P5|STARTED|Overall Study||19
2586838|NCT00335764|6346393|P4|STARTED|Overall Study||19
2586839|NCT00335764|6346394|P3|STARTED|Overall Study||24
2586840|NCT00335764|6346395|P2|STARTED|Overall Study||13
2586841|NCT00335764|6346396|P1|STARTED|Overall Study||17
2586842|NCT00335738|6346445|P2|NOT COMPLETED|Overall Study||4
2586843|NCT00335738|6346446|P1|NOT COMPLETED|Overall Study||11
2586844|NCT00335738|6346445|P2|COMPLETED|Overall Study||219
2586845|NCT00335738|6346446|P1|COMPLETED|Overall Study||97
2586846|NCT00335738|6346445|P2|STARTED|Overall Study||223
2586847|NCT00335738|6346446|P1|STARTED|Overall Study||108
2586848|NCT00335725|6346463|P2|NOT COMPLETED|Overall Study||5
2586849|NCT00335725|6346464|P1|NOT COMPLETED|Overall Study||4
2586850|NCT00335725|6346463|P2|COMPLETED|Overall Study||71
2586851|NCT00335725|6346464|P1|COMPLETED|Overall Study||71
2586852|NCT00335725|6346463|P2|STARTED|Overall Study||76
2586853|NCT00335725|6346464|P1|STARTED|Overall Study||75
2586854|NCT00335556|6346478|P6|NOT COMPLETED|Overall Study||1
2586855|NCT00335556|6346479|P5|NOT COMPLETED|Overall Study||1
2586856|NCT00335556|6346480|P4|NOT COMPLETED|Overall Study||5
2586857|NCT00335556|6346481|P3|NOT COMPLETED|Overall Study||5
2586858|NCT00335556|6346482|P2|NOT COMPLETED|Overall Study||34
2586859|NCT00335556|6346483|P1|NOT COMPLETED|Overall Study||2
2586860|NCT00335556|6346478|P6|COMPLETED|Overall Study||29
2586861|NCT00335556|6346479|P5|COMPLETED|Overall Study||77
2586862|NCT00335556|6346480|P4|COMPLETED|Overall Study||5
2586863|NCT00335556|6346481|P3|COMPLETED|Overall Study||2
2586864|NCT00335556|6346482|P2|COMPLETED|Overall Study||64
2586865|NCT00335556|6346483|P1|COMPLETED|Overall Study||66
2586866|NCT00335556|6346478|P6|STARTED|Overall Study||30
2586867|NCT00335556|6346479|P5|STARTED|Overall Study||78
2586868|NCT00335556|6346480|P4|STARTED|Overall Study||10
2586869|NCT00335556|6346481|P3|STARTED|Overall Study||7
2586870|NCT00335556|6346482|P2|STARTED|Overall Study||98
2586871|NCT00335556|6346483|P1|STARTED|Overall Study||68
2586872|NCT00335517|6346504|P1|NOT COMPLETED|Overall Study||2
2586873|NCT00335517|6346504|P1|COMPLETED|Overall Study|Due to pharmacy error two patients were enolled and recieved EREM, but were not included in analysis|98
2586874|NCT00335517|6346504|P1|STARTED|Overall Study||100
2586875|NCT00335504|6346512|P4|NOT COMPLETED|Overall Study||0
2586876|NCT00335504|6346513|P3|NOT COMPLETED|Overall Study||0
2586877|NCT00335504|6346514|P2|NOT COMPLETED|Overall Study||0
2586878|NCT00335504|6346515|P1|NOT COMPLETED|Overall Study||0
2586879|NCT00335504|6346512|P4|COMPLETED|Overall Study||22
2586880|NCT00335504|6346513|P3|COMPLETED|Overall Study||20
2586881|NCT00335504|6346514|P2|COMPLETED|Overall Study||21
2586882|NCT00335504|6346515|P1|COMPLETED|Overall Study||22
2586883|NCT00335504|6346512|P4|STARTED|Overall Study||22
2586884|NCT00335504|6346513|P3|STARTED|Overall Study||20
2586885|NCT00335504|6346514|P2|STARTED|Overall Study||21
2586886|NCT00335504|6346515|P1|STARTED|Overall Study||22
2586887|NCT00335478|6346537|P1|NOT COMPLETED|Overall Study||24
2586888|NCT00335478|6346537|P1|COMPLETED|Overall Study||30
2586889|NCT00335478|6346537|P1|STARTED|Overall Study||54
2586890|NCT00335452|6346545|P4|NOT COMPLETED|Overall Study||131
2586891|NCT00335452|6346546|P3|NOT COMPLETED|Overall Study||159
2586892|NCT00335452|6346547|P2|NOT COMPLETED|Overall Study||147
2586893|NCT00335452|6346548|P1|NOT COMPLETED|Overall Study||158
2586894|NCT00335452|6346545|P4|COMPLETED|Overall Study|Completed 30 days follow-up period|6122
2586895|NCT00335452|6346546|P3|COMPLETED|Overall Study|Completed 30 days follow-up period|6108
2586896|NCT00335452|6346547|P2|COMPLETED|Overall Study|Completed 30 days follow-up period|6107
2586897|NCT00335452|6346548|P1|COMPLETED|Overall Study|Completed 30 days follow-up period|6154
2586898|NCT00335452|6346545|P4|TREATED WITH ASA|Overall Study||6247
2586899|NCT00335452|6346546|P3|TREATED WITH ASA|Overall Study||6261
2586900|NCT00335452|6346547|P2|TREATED WITH ASA|Overall Study||6251
2586901|NCT00335452|6346548|P1|TREATED WITH ASA|Overall Study||6302
2586902|NCT00335452|6346545|P4|TREATED WITH CLOPIDOGREL|Overall Study||6217
2586903|NCT00335452|6346546|P3|TREATED WITH CLOPIDOGREL|Overall Study||6228
2586904|NCT00335452|6346547|P2|TREATED WITH CLOPIDOGREL|Overall Study||6218
2586905|NCT00335452|6346548|P1|TREATED WITH CLOPIDOGREL|Overall Study||6271
2586906|NCT00335452|6346545|P4|STARTED|Overall Study|Randomized|6253
2586907|NCT00335452|6346546|P3|STARTED|Overall Study|Randomized|6267
2586908|NCT00335452|6346547|P2|STARTED|Overall Study|Randomized|6254
2586909|NCT00335452|6346548|P1|STARTED|Overall Study|Randomized|6312
2586910|NCT00335322|6346573|P3|NOT COMPLETED|Overall Study||2
2586911|NCT00335322|6346574|P2|NOT COMPLETED|Overall Study||2
2586912|NCT00335322|6346575|P1|NOT COMPLETED|Overall Study||1
2586913|NCT00335322|6346573|P3|COMPLETED|Overall Study||103
2586914|NCT00335322|6346574|P2|COMPLETED|Overall Study||105
2586915|NCT00335322|6346575|P1|COMPLETED|Overall Study||114
2586916|NCT00335322|6346573|P3|STARTED|Overall Study||105
2586917|NCT00335322|6346574|P2|STARTED|Overall Study||107
2586918|NCT00335322|6346575|P1|STARTED|Overall Study||115
2586919|NCT00335283|6346588|P2|NOT COMPLETED|Overall Study||5
2586920|NCT00335283|6346589|P1|NOT COMPLETED|Overall Study||6
2586921|NCT00335283|6346588|P2|COMPLETED|Overall Study||34
2586922|NCT00335283|6346589|P1|COMPLETED|Overall Study||30
2586923|NCT00335283|6346588|P2|STARTED|Overall Study||39
2586924|NCT00335283|6346589|P1|STARTED|Overall Study||36
2586925|NCT00335257|6346604|P3|NOT COMPLETED|Overall Study||0
2586926|NCT00335257|6346605|P2|NOT COMPLETED|Overall Study||0
2586927|NCT00335257|6346606|P1|NOT COMPLETED|Overall Study||0
2586928|NCT00335257|6346604|P3|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|60190
2586929|NCT00335257|6346605|P2|COMPLETED|Overall Study||9377
2586930|NCT00335257|6346606|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|15542
2586931|NCT00335257|6346604|P3|STARTED|Overall Study||60190
2586932|NCT00335257|6346605|P2|STARTED|Overall Study||9377
2586933|NCT00335257|6346606|P1|STARTED|Overall Study||15542
2586934|NCT00335153|6346623|P1|NOT COMPLETED|Post-PEG-J Long-Term Treatment Period||52
2586935|NCT00335153|6346623|P1|COMPLETED|Post-PEG-J Long-Term Treatment Period||272
2586936|NCT00335153|6346623|P1|STARTED|Post-PEG-J Long-Term Treatment Period||324
2586937|NCT00335153|6346623|P1|NOT COMPLETED|Nasojejunal (NJ) Test Period||30
2586938|NCT00335153|6346623|P1|COMPLETED|Nasojejunal (NJ) Test Period||324
2586939|NCT00335153|6346623|P1|STARTED|Nasojejunal (NJ) Test Period||354
2586940|NCT00335140|6346660|P1|NOT COMPLETED|Overall Study||1
2586941|NCT00335140|6346660|P1|COMPLETED|Overall Study||25
2586942|NCT00335140|6346660|P1|Treated|Overall Study||25
2586943|NCT00335140|6346660|P1|Eligible|Overall Study||25
2586944|NCT00335140|6346660|P1|STARTED|Overall Study||26
2586945|NCT00334958|6346666|P2|NOT COMPLETED|Overall Study||24
2586946|NCT00334958|6346667|P1|NOT COMPLETED|Overall Study||37
2586947|NCT00334958|6346666|P2|COMPLETED|Overall Study||156
2586948|NCT00334958|6346667|P1|COMPLETED|Overall Study||139
2586949|NCT00334958|6346666|P2|STARTED|Overall Study|1 subject withdrawn prior to study drug dosing due to not obtaining labs|180
2586950|NCT00334958|6346667|P1|STARTED|Overall Study||176
2586951|NCT00334893|6346681|P2|NOT COMPLETED|Overall Study||0
2586952|NCT00334893|6346682|P1|NOT COMPLETED|Overall Study||1
2586953|NCT00334893|6346681|P2|COMPLETED|Overall Study||37
2586954|NCT00334893|6346682|P1|COMPLETED|Overall Study||36
2586955|NCT00334893|6346681|P2|STARTED|Overall Study||37
2586956|NCT00334893|6346682|P1|STARTED|Overall Study||37
2586957|NCT00334815|6346692|P2|NOT COMPLETED|Overall Study||10
2586958|NCT00334815|6346693|P1|NOT COMPLETED|Overall Study||7
2586959|NCT00334815|6346692|P2|COMPLETED|Overall Study||3
2586960|NCT00334815|6346693|P1|COMPLETED|Overall Study||9
2586961|NCT00334815|6346692|P2|STARTED|Overall Study||13
2586962|NCT00334815|6346693|P1|STARTED|Overall Study||16
2586963|NCT00334802|6346707|P2|NOT COMPLETED|Overall Study||40
2586964|NCT00334802|6346708|P1|NOT COMPLETED|Overall Study||6
2586965|NCT00334802|6346707|P2|COMPLETED|Overall Study||16
2586966|NCT00334802|6346708|P1|COMPLETED|Overall Study||0
2586967|NCT00334802|6346707|P2|STARTED|Overall Study||56
2586968|NCT00334802|6346708|P1|STARTED|Overall Study||6
2586969|NCT00334737|6346728|P3|NOT COMPLETED|Follow up Phase||6
2586970|NCT00334737|6346729|P2|NOT COMPLETED|Follow up Phase||3
2586971|NCT00334737|6346730|P1|NOT COMPLETED|Follow up Phase||5
2586972|NCT00334737|6346728|P3|COMPLETED|Follow up Phase||24
2586973|NCT00334737|6346729|P2|COMPLETED|Follow up Phase||29
2586974|NCT00334737|6346730|P1|COMPLETED|Follow up Phase||27
2586975|NCT00334737|6346728|P3|STARTED|Follow up Phase||30
2586976|NCT00334737|6346729|P2|STARTED|Follow up Phase||32
2586977|NCT00334737|6346730|P1|STARTED|Follow up Phase||32
2586978|NCT00334737|6346728|P3|NOT COMPLETED|Hospital Phase||4
2586979|NCT00334737|6346729|P2|NOT COMPLETED|Hospital Phase||2
2586980|NCT00334737|6346730|P1|NOT COMPLETED|Hospital Phase||2
2586981|NCT00334737|6346728|P3|COMPLETED|Hospital Phase||30
2586982|NCT00334737|6346729|P2|COMPLETED|Hospital Phase||32
2586983|NCT00334737|6346730|P1|COMPLETED|Hospital Phase||32
2586984|NCT00334737|6346728|P3|STARTED|Hospital Phase||34
2586985|NCT00334737|6346729|P2|STARTED|Hospital Phase||34
2586986|NCT00334737|6346730|P1|STARTED|Hospital Phase||34
2586987|NCT00334633|6346765|P3|NOT COMPLETED|Overall Study||82
2586988|NCT00334633|6346766|P2|NOT COMPLETED|Overall Study||82
2586989|NCT00334633|6346767|P1|NOT COMPLETED|Overall Study||80
2586990|NCT00334633|6346765|P3|COMPLETED|Overall Study||114
2586991|NCT00334633|6346766|P2|COMPLETED|Overall Study||118
2586992|NCT00334633|6346767|P1|COMPLETED|Overall Study||117
2586993|NCT00334633|6346765|P3|STARTED|Overall Study||196
2586994|NCT00334633|6346766|P2|STARTED|Overall Study||200
2586995|NCT00334633|6346767|P1|STARTED|Overall Study||197
2586996|NCT00334542|6346778|P1|NOT COMPLETED|Overall Study||5
2586997|NCT00334542|6346778|P1|COMPLETED|Overall Study||45
2586998|NCT00334542|6346778|P1|STARTED|Overall Study||50
2586999|NCT00334295|6346785|P1|NOT COMPLETED|Overall Study||5
2587000|NCT00334295|6346785|P1|COMPLETED|Overall Study||30
2587001|NCT00334295|6346785|P1|STARTED|Overall Study||35
2587002|NCT00334282|6346795|P2|NOT COMPLETED|Overall Study||108
2587003|NCT00334282|6346796|P1|NOT COMPLETED|Overall Study||222
2587004|NCT00334282|6346795|P2|COMPLETED|Overall Study||37
2587005|NCT00334282|6346796|P1|COMPLETED|Overall Study||68
2587006|NCT00334282|6346795|P2|STARTED|Overall Study||145
2587007|NCT00334282|6346796|P1|STARTED|Overall Study||290
2587008|NCT00334204|6346819|P1|NOT COMPLETED|Overall Study||2
2587009|NCT00334204|6346819|P1|COMPLETED|Overall Study||56
2587010|NCT00334204|6346819|P1|STARTED|Overall Study||58
2587011|NCT00334113|6346827|P2|NOT COMPLETED|Overall Study||3
2587012|NCT00334113|6346828|P1|NOT COMPLETED|Overall Study||2
2587013|NCT00334113|6346827|P2|COMPLETED|Overall Study||31
2587014|NCT00334113|6346828|P1|COMPLETED|Overall Study||30
2587015|NCT00334113|6346827|P2|STARTED|Overall Study||34
2587016|NCT00334113|6346828|P1|STARTED|Overall Study||32
2587017|NCT00334074|6346834|P1|NOT COMPLETED|Overall Study||0
2587018|NCT00334074|6346834|P1|COMPLETED|Overall Study||30
2587019|NCT00334074|6346834|P1|STARTED|Overall Study||30
2587020|NCT00334061|6346839|P1|NOT COMPLETED|Overall Study||0
2587021|NCT00334061|6346839|P1|COMPLETED|Overall Study|November 2007|125
2587022|NCT00334061|6346839|P1|STARTED|Overall Study|June 2006|125
2587023|NCT00333983|6346851|P3|NOT COMPLETED|Overall Study||2
2587024|NCT00333983|6346852|P2|NOT COMPLETED|Overall Study||5
2587025|NCT00333983|6346853|P1|NOT COMPLETED|Overall Study||3
2587026|NCT00333983|6346851|P3|COMPLETED|Overall Study||19
2587027|NCT00333983|6346852|P2|COMPLETED|Overall Study||16
2587028|NCT00333983|6346853|P1|COMPLETED|Overall Study||17
2587029|NCT00333983|6346851|P3|STARTED|Overall Study||21
2587030|NCT00333983|6346852|P2|STARTED|Overall Study||21
2587031|NCT00333983|6346853|P1|STARTED|Overall Study||20
2587032|NCT00333970|6346863|P2|NOT COMPLETED|Overall Study||7
2587033|NCT00333970|6346864|P1|NOT COMPLETED|Overall Study||13
2587034|NCT00333970|6346863|P2|COMPLETED|Overall Study||18
2587035|NCT00333970|6346864|P1|COMPLETED|Overall Study||37
2587036|NCT00333970|6346863|P2|STARTED|Overall Study||25
2587037|NCT00333970|6346864|P1|STARTED|Overall Study||50
2587038|NCT00333879|6346870|P1|NOT COMPLETED|Overall Study||0
2587039|NCT00333879|6346870|P1|COMPLETED|Overall Study||4
2587040|NCT00333879|6346870|P1|STARTED|Overall Study||4
2587041|NCT00333866|6346879|P4|NOT COMPLETED|Overall Study||66
2587042|NCT00333866|6346880|P3|NOT COMPLETED|Overall Study||51
2587043|NCT00333866|6346881|P2|NOT COMPLETED|Overall Study||64
2587044|NCT00333866|6346882|P1|NOT COMPLETED|Overall Study||48
2587045|NCT00333866|6346879|P4|COMPLETED|Overall Study||121
2587046|NCT00333866|6346880|P3|COMPLETED|Overall Study||133
2587047|NCT00333866|6346881|P2|COMPLETED|Overall Study||123
2587048|NCT00333866|6346882|P1|COMPLETED|Overall Study||141
2587049|NCT00333866|6346879|P4|TREATED|Overall Study||186
2587050|NCT00333866|6346880|P3|TREATED|Overall Study||182
2587051|NCT00333866|6346881|P2|TREATED|Overall Study||184
2587052|NCT00333866|6346882|P1|TREATED|Overall Study||184
2587053|NCT00333866|6346879|P4|STARTED|Overall Study||187
2587054|NCT00333866|6346880|P3|STARTED|Overall Study||184
2587055|NCT00333866|6346881|P2|STARTED|Overall Study||187
2587056|NCT00333866|6346882|P1|STARTED|Overall Study||189
2587057|NCT00333840|6346942|P4|NOT COMPLETED|Second-line Treatment Period||188
2587058|NCT00333840|6346943|P3|NOT COMPLETED|Second-line Treatment Period||14
2587059|NCT00333840|6346944|P2|NOT COMPLETED|Second-line Treatment Period||0
2587060|NCT00333840|6346945|P1|NOT COMPLETED|Second-line Treatment Period||0
2587061|NCT00333840|6346942|P4|COMPLETED|Second-line Treatment Period||175
2587062|NCT00333840|6346943|P3|COMPLETED|Second-line Treatment Period||0
2587063|NCT00333840|6346944|P2|COMPLETED|Second-line Treatment Period||0
2587064|NCT00333840|6346945|P1|COMPLETED|Second-line Treatment Period||0
2587065|NCT00333840|6346942|P4|STARTED|Second-line Treatment Period||363
2587066|NCT00333840|6346943|P3|STARTED|Second-line Treatment Period||14
2587067|NCT00333840|6346944|P2|STARTED|Second-line Treatment Period||0
2587068|NCT00333840|6346945|P1|STARTED|Second-line Treatment Period||0
2587069|NCT00333840|6346942|P4|NOT COMPLETED|First-line Treatment Period||0
2587070|NCT00333840|6346943|P3|NOT COMPLETED|First-line Treatment Period||0
2587071|NCT00333840|6346944|P2|NOT COMPLETED|First-line Treatment Period||546
2587072|NCT00333840|6346945|P1|NOT COMPLETED|First-line Treatment Period||286
2587073|NCT00333840|6346942|P4|COMPLETED|First-line Treatment Period||0
2587074|NCT00333840|6346943|P3|COMPLETED|First-line Treatment Period||0
2587075|NCT00333840|6346944|P2|COMPLETED|First-line Treatment Period||7
2587076|NCT00333840|6346945|P1|COMPLETED|First-line Treatment Period||267
2587077|NCT00333840|6346942|P4|Safety Population; Received Study Drug|First-line Treatment Period||0
2587078|NCT00333840|6346943|P3|Safety Population; Received Study Drug|First-line Treatment Period||0
2587079|NCT00333840|6346944|P2|Safety Population; Received Study Drug|First-line Treatment Period||533
2587080|NCT00333840|6346945|P1|Safety Population; Received Study Drug|First-line Treatment Period||551
2587081|NCT00333840|6346942|P4|STARTED|First-line Treatment Period||0
2587082|NCT00333840|6346943|P3|STARTED|First-line Treatment Period||0
2587083|NCT00333840|6346944|P2|STARTED|First-line Treatment Period||553
2587084|NCT00333840|6346945|P1|STARTED|First-line Treatment Period||553
2587085|NCT00333814|6346973|P3|NOT COMPLETED|Overall Study||5
2587086|NCT00333814|6346974|P2|NOT COMPLETED|Overall Study||4
2587087|NCT00333814|6346975|P1|NOT COMPLETED|Overall Study||3
2587088|NCT00333814|6346973|P3|COMPLETED|Overall Study||71
2587089|NCT00333814|6346974|P2|COMPLETED|Overall Study||73
2587090|NCT00333814|6346975|P1|COMPLETED|Overall Study||73
2587091|NCT00333814|6346973|P3|STARTED|Overall Study||76
2587092|NCT00333814|6346974|P2|STARTED|Overall Study||77
2587093|NCT00333814|6346975|P1|STARTED|Overall Study||76
2587094|NCT00333801|6346991|P2|NOT COMPLETED|Overall Study||6
2587095|NCT00333801|6346992|P1|NOT COMPLETED|Overall Study||8
2587096|NCT00333801|6346991|P2|COMPLETED|Overall Study||36
2587097|NCT00333801|6346992|P1|COMPLETED|Overall Study||35
2587098|NCT00333801|6346991|P2|STARTED|Overall Study||42
2587099|NCT00333801|6346992|P1|STARTED|Overall Study||43
2587100|NCT00333788|6347010|P1|NOT COMPLETED|Overall Study||162
2587101|NCT00333788|6347010|P1|COMPLETED|Overall Study||71
2587102|NCT00333788|6347010|P1|STARTED|Overall Study|Participant flow based on All Subjects population; Baseline characteristics based on ITT population.|233
2587103|NCT00333775|6347040|P3|NOT COMPLETED|Overall Study||247
2587104|NCT00333775|6347041|P2|NOT COMPLETED|Overall Study||248
2587105|NCT00333775|6347042|P1|NOT COMPLETED|Overall Study||241
2587106|NCT00333775|6347040|P3|COMPLETED|Overall Study||0
2587107|NCT00333775|6347041|P2|COMPLETED|Overall Study||0
2587108|NCT00333775|6347042|P1|COMPLETED|Overall Study||0
2587109|NCT00333775|6347040|P3|Received Treatment|Overall Study||245
2587110|NCT00333775|6347041|P2|Received Treatment|Overall Study||247
2587111|NCT00333775|6347042|P1|Received Treatment|Overall Study||238
2587112|NCT00333775|6347040|P3|STARTED|Overall Study||247
2587113|NCT00333775|6347041|P2|STARTED|Overall Study||248
2587114|NCT00333775|6347042|P1|STARTED|Overall Study||241
2587115|NCT00333762|6347062|P1|NOT COMPLETED|Overall Study||4
2587116|NCT00333762|6347062|P1|COMPLETED|Overall Study||0
2587117|NCT00333762|6347062|P1|STARTED|Overall Study||4
2587118|NCT00333710|6347069|P3|NOT COMPLETED|Overall Study||1
2587119|NCT00333710|6347070|P2|NOT COMPLETED|Overall Study||4
2587120|NCT00333710|6347071|P1|NOT COMPLETED|Overall Study||11
2587121|NCT00333710|6347069|P3|COMPLETED|Overall Study||15
2587122|NCT00333710|6347070|P2|COMPLETED|Overall Study||14
2587123|NCT00333710|6347071|P1|COMPLETED|Overall Study||8
2587124|NCT00333710|6347069|P3|STARTED|Overall Study||16
2587125|NCT00333710|6347070|P2|STARTED|Overall Study||18
2587126|NCT00333710|6347071|P1|STARTED|Overall Study||19
2587127|NCT00333619|6347081|P2|NOT COMPLETED|Overall Study||10
2587128|NCT00333619|6347082|P1|NOT COMPLETED|Overall Study||21
2587129|NCT00333619|6347081|P2|COMPLETED|Overall Study||99
2587130|NCT00333619|6347082|P1|COMPLETED|Overall Study||89
2587131|NCT00333619|6347081|P2|3-month Follow-up|Overall Study||105
2587132|NCT00333619|6347082|P1|3-month Follow-up|Overall Study||101
2587133|NCT00333619|6347081|P2|Post-treatment|Overall Study||109
2587134|NCT00333619|6347082|P1|Post-treatment|Overall Study||109
2587135|NCT00333619|6347081|P2|STARTED|Overall Study||109
2587136|NCT00333619|6347082|P1|STARTED|Overall Study||110
2587137|NCT00333606|6347092|P2|NOT COMPLETED|Overall Study||0
2587138|NCT00333606|6347093|P1|NOT COMPLETED|Overall Study||0
2587139|NCT00333606|6347092|P2|COMPLETED|Overall Study||30
2587140|NCT00333606|6347093|P1|COMPLETED|Overall Study||30
2587141|NCT00333606|6347092|P2|STARTED|Overall Study||30
2587142|NCT00333606|6347093|P1|STARTED|Overall Study||30
2587143|NCT00333437|6347101|P1|NOT COMPLETED|Overall Study||0
2587144|NCT00333437|6347101|P1|COMPLETED|Overall Study||7
2587145|NCT00333437|6347101|P1|STARTED|Overall Study||7
2587146|NCT00333359|6347111|P2|NOT COMPLETED|Overall Study||122
2587147|NCT00333359|6347112|P1|NOT COMPLETED|Overall Study||73
2587148|NCT00333359|6347111|P2|COMPLETED|Overall Study||260
2587149|NCT00333359|6347112|P1|COMPLETED|Overall Study||126
2587150|NCT00333359|6347111|P2|STARTED|Overall Study||382
2587151|NCT00333359|6347112|P1|STARTED|Overall Study||199
2587152|NCT00333229|6347155|P2|NOT COMPLETED|Overall Study||1
2587153|NCT00333229|6347156|P1|NOT COMPLETED|Overall Study||0
2587154|NCT00333229|6347155|P2|COMPLETED|Overall Study||4
2587155|NCT00333229|6347156|P1|COMPLETED|Overall Study||6
2587156|NCT00333229|6347155|P2|STARTED|Overall Study||5
2587157|NCT00333229|6347156|P1|STARTED|Overall Study||6
2587158|NCT00333138|6347173|P3|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
2587159|NCT00333138|6347174|P2|NOT COMPLETED|Extension Study (Month6 to End of Study)||42
2587160|NCT00333138|6347175|P1|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
2587161|NCT00333138|6347173|P3|COMPLETED|Extension Study (Month6 to End of Study)||37
2587162|NCT00333138|6347174|P2|COMPLETED|Extension Study (Month6 to End of Study)||45
2587163|NCT00333138|6347175|P1|COMPLETED|Extension Study (Month6 to End of Study)||40
2587164|NCT00333138|6347173|P3|STARTED|Extension Study (Month6 to End of Study)||80
2587165|NCT00333138|6347174|P2|STARTED|Extension Study (Month6 to End of Study)||87
2587166|NCT00333138|6347175|P1|STARTED|Extension Study (Month6 to End of Study)||83
2587167|NCT00333138|6347173|P3|NOT COMPLETED|Core Study (6 Months)||12
2587168|NCT00333138|6347174|P2|NOT COMPLETED|Core Study (6 Months)||6
2587169|NCT00333138|6347175|P1|NOT COMPLETED|Core Study (6 Months)||7
2587170|NCT00333138|6347173|P3|COMPLETED|Core Study (6 Months)||82
2587171|NCT00333138|6347174|P2|COMPLETED|Core Study (6 Months)||88
2587172|NCT00333138|6347175|P1|COMPLETED|Core Study (6 Months)||86
2587173|NCT00333138|6347173|P3|STARTED|Core Study (6 Months)||94
2587174|NCT00333138|6347174|P2|STARTED|Core Study (6 Months)||94
2587175|NCT00333138|6347175|P1|STARTED|Core Study (6 Months)||93
2587176|NCT00332839|6347214|P2|NOT COMPLETED|Follow-up (Months 12 - 60)||3
2587177|NCT00332839|6347215|P1|NOT COMPLETED|Follow-up (Months 12 - 60)||4
2587178|NCT00332839|6347214|P2|COMPLETED|Follow-up (Months 12 - 60)||31
2587179|NCT00332839|6347215|P1|COMPLETED|Follow-up (Months 12 - 60)||29
2587180|NCT00332839|6347214|P2|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|34
2587181|NCT00332839|6347215|P1|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|33
2587182|NCT00332839|6347214|P2|NOT COMPLETED|Core (Months 0 - 12)||18
2587183|NCT00332839|6347215|P1|NOT COMPLETED|Core (Months 0 - 12)||10
2587184|NCT00332839|6347214|P2|COMPLETED|Core (Months 0 - 12)||28
2587185|NCT00332839|6347215|P1|COMPLETED|Core (Months 0 - 12)||37
2587186|NCT00332839|6347214|P2|Safety Set|Core (Months 0 - 12)||46
2587187|NCT00332839|6347215|P1|Safety Set|Core (Months 0 - 12)||47
2587188|NCT00332839|6347214|P2|STARTED|Core (Months 0 - 12)||46
2587189|NCT00332839|6347215|P1|STARTED|Core (Months 0 - 12)||47
2587190|NCT00332722|6347235|P2|NOT COMPLETED|Overall Study||0
2587191|NCT00332722|6347236|P1|NOT COMPLETED|Overall Study||0
2587192|NCT00332722|6347235|P2|COMPLETED|Overall Study||60
2587193|NCT00332722|6347236|P1|COMPLETED|Overall Study||60
2587194|NCT00332722|6347235|P2|STARTED|Overall Study||60
2587195|NCT00332722|6347236|P1|STARTED|Overall Study||60
2587196|NCT00332709|6347246|P2|NOT COMPLETED|Overall Study||20
2587197|NCT00332709|6347247|P1|NOT COMPLETED|Overall Study||16
2587198|NCT00332709|6347246|P2|COMPLETED|Overall Study||21
2587199|NCT00332709|6347247|P1|COMPLETED|Overall Study||24
2587200|NCT00332709|6347246|P2|STARTED|Overall Study||41
2587201|NCT00332709|6347247|P1|STARTED|Overall Study||40
2587202|NCT00332696|6347271|P2|NOT COMPLETED|Overall Study||30
2587203|NCT00332696|6347272|P1|NOT COMPLETED|Overall Study||30
2587204|NCT00332696|6347271|P2|COMPLETED|Overall Study||2
2587205|NCT00332696|6347272|P1|COMPLETED|Overall Study|Completed Month 3 Visit|2
2587206|NCT00332696|6347271|P2|Completed Day 14 Visit|Overall Study||15
2587207|NCT00332696|6347272|P1|Completed Day 14 Visit|Overall Study|Primary Endpoint|21
2587208|NCT00332696|6347271|P2|STARTED|Overall Study||32
2587209|NCT00332696|6347272|P1|STARTED|Overall Study||32
2587210|NCT00332644|6347304|P6|NOT COMPLETED|Overall Study||15
2587211|NCT00332644|6347305|P5|NOT COMPLETED|Overall Study||12
2587212|NCT00332644|6347306|P4|NOT COMPLETED|Overall Study||20
2587213|NCT00332644|6347307|P3|NOT COMPLETED|Overall Study||9
2587214|NCT00332644|6347308|P2|NOT COMPLETED|Overall Study||22
2587215|NCT00332644|6347309|P1|NOT COMPLETED|Overall Study||12
2587216|NCT00332644|6347304|P6|COMPLETED|Overall Study||174
2587217|NCT00332644|6347305|P5|COMPLETED|Overall Study||250
2587218|NCT00332644|6347306|P4|COMPLETED|Overall Study||244
2587219|NCT00332644|6347307|P3|COMPLETED|Overall Study||258
2587220|NCT00332644|6347308|P2|COMPLETED|Overall Study||238
2587221|NCT00332644|6347309|P1|COMPLETED|Overall Study||250
2587222|NCT00332644|6347304|P6|STARTED|Overall Study||189
2587223|NCT00332644|6347305|P5|STARTED|Overall Study||262
2587224|NCT00332644|6347306|P4|STARTED|Overall Study||264
2587225|NCT00332644|6347307|P3|STARTED|Overall Study||267
2587226|NCT00332644|6347308|P2|STARTED|Overall Study||260
2587227|NCT00332644|6347309|P1|STARTED|Overall Study||262
2587228|NCT00332605|6347326|P3|NOT COMPLETED|Overall Study||8
2587229|NCT00332605|6347327|P2|NOT COMPLETED|Overall Study||2
2587230|NCT00332605|6347328|P1|NOT COMPLETED|Overall Study||2
2587231|NCT00332605|6347326|P3|COMPLETED|Overall Study||9
2587232|NCT00332605|6347327|P2|COMPLETED|Overall Study||12
2587233|NCT00332605|6347328|P1|COMPLETED|Overall Study||12
2587234|NCT00332605|6347326|P3|STARTED|Overall Study||17
2587235|NCT00332605|6347327|P2|STARTED|Overall Study||14
2587236|NCT00332605|6347328|P1|STARTED|Overall Study||14
2587237|NCT00332579|6347338|P2|NOT COMPLETED|Overall Study||1
2587238|NCT00332579|6347339|P1|NOT COMPLETED|Overall Study||1
2587239|NCT00332579|6347338|P2|COMPLETED|Overall Study||12
2587240|NCT00332579|6347339|P1|COMPLETED|Overall Study||11
2587241|NCT00332579|6347338|P2|STARTED|Overall Study||13
2587242|NCT00332579|6347339|P1|STARTED|Overall Study||12
2587243|NCT00332488|6347348|P3|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||21
2587244|NCT00332488|6347349|P2|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||2
2587245|NCT00332488|6347350|P1|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||2
2587246|NCT00332488|6347348|P3|COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||233
2587247|NCT00332488|6347349|P2|COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||70
2587248|NCT00332488|6347350|P1|COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||27
2587249|NCT00332488|6347348|P3|STARTED|Transfer Treatment Phase (Weeks 12 – 24)|Subjects in this arm who met HbA1c criteria + subjects from other arms who did not|254
2587250|NCT00332488|6347349|P2|STARTED|Transfer Treatment Phase (Weeks 12 – 24)|Subjects on treatment who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|72
2587251|NCT00332488|6347350|P1|STARTED|Transfer Treatment Phase (Weeks 12 – 24)|Subjects on TI who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|29
2587252|NCT00332488|6347348|P3|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||56
2587253|NCT00332488|6347349|P2|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||18
2587254|NCT00332488|6347350|P1|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||50
2587255|NCT00332488|6347348|P3|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||119
2587256|NCT00332488|6347349|P2|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||152
2587257|NCT00332488|6347350|P1|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||133
2587258|NCT00332488|6347348|P3|STARTED|Initial Treatment Phase (Weeks 0 - 12)||175
2587259|NCT00332488|6347349|P2|STARTED|Initial Treatment Phase (Weeks 0 - 12)||170
2587260|NCT00332488|6347350|P1|STARTED|Initial Treatment Phase (Weeks 0 - 12)||183
2587261|NCT00332462|6347362|P1|NOT COMPLETED|Overall Study||16
2587262|NCT00332462|6347362|P1|COMPLETED|Overall Study||18
2587263|NCT00332462|6347362|P1|Patients Treated With Sandimmun® Optoral|Overall Study||29
2587264|NCT00332462|6347362|P1|Patients Treated With Sandimmun® i.v.|Overall Study||34
2587265|NCT00332462|6347362|P1|STARTED|Overall Study|Safety and Intention to treat population.|34
2587266|NCT00332332|6347369|P1|NOT COMPLETED|Overall Study||68
2587267|NCT00332332|6347369|P1|COMPLETED|Overall Study||178
2587268|NCT00332332|6347369|P1|Received Study Medication|Overall Study||230
2587269|NCT00332332|6347369|P1|STARTED|Overall Study||246
2587270|NCT00332241|6347378|P2|NOT COMPLETED|Overall Study||8
2587271|NCT00332241|6347379|P1|NOT COMPLETED|Overall Study||15
2587272|NCT00332241|6347378|P2|COMPLETED|Overall Study||39
2587273|NCT00332241|6347379|P1|COMPLETED|Overall Study||36
2587274|NCT00332241|6347378|P2|STARTED|Overall Study||47
2587275|NCT00332241|6347379|P1|STARTED|Overall Study||51
2587276|NCT00332202|6347401|P2|NOT COMPLETED|Overall Study||125
2587277|NCT00332202|6347402|P1|NOT COMPLETED|Overall Study||241
2587278|NCT00332202|6347401|P2|COMPLETED|Overall Study||129
2587279|NCT00332202|6347402|P1|COMPLETED|Overall Study||263
2587280|NCT00332202|6347401|P2|Received At Least One Dose of Study Drug|Overall Study||249
2587281|NCT00332202|6347402|P1|Received At Least One Dose of Study Drug|Overall Study||493
2587282|NCT00332202|6347401|P2|STARTED|Overall Study||254
2587283|NCT00332202|6347402|P1|STARTED|Overall Study||504
2587284|NCT00332189|6347431|P1|NOT COMPLETED|Overall Study||21
2587285|NCT00332189|6347431|P1|COMPLETED|Overall Study|Subjects in this extension study continued until there was market approval in their region.|90
2587286|NCT00332189|6347431|P1|STARTED|Overall Study||111
2587287|NCT00332163|6347438|P2|NOT COMPLETED|Overall Study||0
2587288|NCT00332163|6347439|P1|NOT COMPLETED|Overall Study||0
2587289|NCT00332163|6347438|P2|COMPLETED|Overall Study||47
2587290|NCT00332163|6347439|P1|COMPLETED|Overall Study||48
2587291|NCT00332163|6347438|P2|Received Treatment|Overall Study||47
2587292|NCT00332163|6347439|P1|Received Treatment|Overall Study||48
2587293|NCT00332163|6347438|P2|STARTED|Overall Study||47
2587294|NCT00332163|6347439|P1|STARTED|Overall Study||48
2587295|NCT00331864|6347473|P2|NOT COMPLETED|Overall Study||4
2587296|NCT00331864|6347474|P1|NOT COMPLETED|Overall Study||58
2587297|NCT00331864|6347473|P2|COMPLETED|Overall Study||14
2587298|NCT00331864|6347474|P1|COMPLETED|Overall Study||455
2587299|NCT00331864|6347473|P2|STARTED|Overall Study||18
2587300|NCT00331864|6347474|P1|STARTED|Overall Study||513
2587301|NCT00331799|6347493|P1|NOT COMPLETED|Overall Study||3
2587302|NCT00331799|6347493|P1|COMPLETED|Overall Study||15
2587303|NCT00331799|6347493|P1|STARTED|Overall Study||18
2587304|NCT00331773|6347499|P2|NOT COMPLETED|Overall Study||7
2587305|NCT00331773|6347500|P1|NOT COMPLETED|Overall Study||16
2587306|NCT00331773|6347499|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|550
2587307|NCT00331773|6347500|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|542
2587308|NCT00331773|6347499|P2|STARTED|Overall Study||557
2587309|NCT00331773|6347500|P1|STARTED|Overall Study||558
2587310|NCT00331760|6347530|P2|NOT COMPLETED|Overall Study||8
2587311|NCT00331760|6347531|P1|NOT COMPLETED|Overall Study||15
2587312|NCT00331760|6347530|P2|COMPLETED|Overall Study||40
2587313|NCT00331760|6347531|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|43
2587314|NCT00331760|6347530|P2|STARTED|Overall Study||48
2587315|NCT00331760|6347531|P1|STARTED|Overall Study||58
2587316|NCT00331682|6347552|P1|NOT COMPLETED|Overall Study||1
2587317|NCT00331682|6347552|P1|COMPLETED|Overall Study||9
2587318|NCT00331682|6347552|P1|STARTED|Overall Study||10
2587319|NCT00331552|6347560|P2|NOT COMPLETED|Period 3: Phase II||0
2587320|NCT00331552|6347561|P1|NOT COMPLETED|Period 3: Phase II||2
2587321|NCT00331552|6347560|P2|COMPLETED|Period 3: Phase II||0
2587322|NCT00331552|6347561|P1|COMPLETED|Period 3: Phase II||22
2587323|NCT00331552|6347560|P2|STARTED|Period 3: Phase II||0
2587324|NCT00331552|6347561|P1|STARTED|Period 3: Phase II||24
2587325|NCT00331552|6347560|P2|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
2587326|NCT00331552|6347561|P1|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
2587327|NCT00331552|6347560|P2|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
2587328|NCT00331552|6347561|P1|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
2587329|NCT00331552|6347560|P2|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
2587330|NCT00331552|6347561|P1|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
2587331|NCT00331552|6347560|P2|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
2587332|NCT00331552|6347561|P1|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
2587333|NCT00331552|6347560|P2|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
2587334|NCT00331552|6347561|P1|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
2587335|NCT00331552|6347560|P2|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
2587336|NCT00331552|6347561|P1|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
2587337|NCT00331422|6347575|P1|NOT COMPLETED|Overall Study||5
2587338|NCT00331422|6347575|P1|COMPLETED|Overall Study|Completed all 6 courses of chemotherapy and had surgery to remove all tumor lesions.|2
2587339|NCT00331422|6347575|P1|STARTED|Overall Study|Patients who met study criteria and received at least one dose of study drug.|7
2587340|NCT00331409|6347584|P1|NOT COMPLETED|Overall Study||4
2587341|NCT00331409|6347584|P1|COMPLETED|Overall Study|15 patients accrued to the first stage;if>9 were progression-free at 3 months,enrollment continued.|15
2587342|NCT00331409|6347584|P1|STARTED|Overall Study|19 patients were enrolled in the first stage due to 4 patients who withdrew early.|19
2587343|NCT00331344|6347592|P9|NOT COMPLETED|Phase II||4
2587344|NCT00331344|6347593|P8|NOT COMPLETED|Phase II||0
2587345|NCT00331344|6347594|P7|NOT COMPLETED|Phase II||0
2587346|NCT00331344|6347595|P6|NOT COMPLETED|Phase II||0
2587347|NCT00331344|6347596|P5|NOT COMPLETED|Phase II||0
2587348|NCT00331344|6347597|P4|NOT COMPLETED|Phase II||0
2587349|NCT00331344|6347598|P3|NOT COMPLETED|Phase II||0
2587350|NCT00331344|6347599|P2|NOT COMPLETED|Phase II||0
2587351|NCT00331344|6347600|P1|NOT COMPLETED|Phase II||0
2587352|NCT00331344|6347592|P9|COMPLETED|Phase II||48
2587353|NCT00331344|6347593|P8|COMPLETED|Phase II||6
2587354|NCT00331344|6347594|P7|COMPLETED|Phase II||0
2587355|NCT00331344|6347595|P6|COMPLETED|Phase II||0
2587356|NCT00331344|6347596|P5|COMPLETED|Phase II||0
2587357|NCT00331344|6347597|P4|COMPLETED|Phase II||0
2587358|NCT00331344|6347598|P3|COMPLETED|Phase II||0
2587359|NCT00331344|6347599|P2|COMPLETED|Phase II||0
2587360|NCT00331344|6347600|P1|COMPLETED|Phase II||0
2587361|NCT00331344|6347592|P9|STARTED|Phase II|Protocol enrollment (63) minus 11 ineligible prior to receiving treatment.|52
2587454|NCT00330733|6347718|P1|Received Study Medication|Overall Study||36
2587362|NCT00331344|6347593|P8|STARTED|Phase II|6 patients in Phase I Group VIa continued to the Phase II period.|6
2587363|NCT00331344|6347594|P7|STARTED|Phase II||0
2587364|NCT00331344|6347595|P6|STARTED|Phase II||0
2587365|NCT00331344|6347596|P5|STARTED|Phase II||0
2587366|NCT00331344|6347597|P4|STARTED|Phase II||0
2587367|NCT00331344|6347598|P3|STARTED|Phase II||0
2587368|NCT00331344|6347599|P2|STARTED|Phase II||0
2587369|NCT00331344|6347600|P1|STARTED|Phase II||0
2587370|NCT00331344|6347592|P9|NOT COMPLETED|Phase I||0
2587371|NCT00331344|6347593|P8|NOT COMPLETED|Phase I||1
2587372|NCT00331344|6347594|P7|NOT COMPLETED|Phase I||0
2587373|NCT00331344|6347595|P6|NOT COMPLETED|Phase I||2
2587374|NCT00331344|6347596|P5|NOT COMPLETED|Phase I||2
2587375|NCT00331344|6347597|P4|NOT COMPLETED|Phase I||1
2587376|NCT00331344|6347598|P3|NOT COMPLETED|Phase I||0
2587377|NCT00331344|6347599|P2|NOT COMPLETED|Phase I||0
2587378|NCT00331344|6347600|P1|NOT COMPLETED|Phase I||0
2587379|NCT00331344|6347592|P9|COMPLETED|Phase I||0
2587380|NCT00331344|6347593|P8|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
2587381|NCT00331344|6347594|P7|COMPLETED|Phase I||4
2587382|NCT00331344|6347595|P6|COMPLETED|Phase I|2 participants reached dose limiting toxicity|3
2587383|NCT00331344|6347596|P5|COMPLETED|Phase I|2 participants reached dose limiting toxicity|4
2587384|NCT00331344|6347597|P4|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
2587385|NCT00331344|6347598|P3|COMPLETED|Phase I||3
2587386|NCT00331344|6347599|P2|COMPLETED|Phase I||3
2587387|NCT00331344|6347600|P1|COMPLETED|Phase I||3
2587388|NCT00331344|6347592|P9|STARTED|Phase I||0
2587389|NCT00331344|6347593|P8|STARTED|Phase I|1 participant who was enrolled died prior to initiating protocol therapy.|6
2587390|NCT00331344|6347594|P7|STARTED|Phase I||4
2587391|NCT00331344|6347595|P6|STARTED|Phase I||5
2587392|NCT00331344|6347596|P5|STARTED|Phase I||6
2587393|NCT00331344|6347597|P4|STARTED|Phase I||6
2587394|NCT00331344|6347598|P3|STARTED|Phase I||3
2587395|NCT00331344|6347599|P2|STARTED|Phase I||3
2587396|NCT00331344|6347600|P1|STARTED|Phase I||3
2587397|NCT00331162|6347616|P2|NOT COMPLETED|Overall Study||0
2587398|NCT00331162|6347617|P1|NOT COMPLETED|Overall Study||0
2587399|NCT00331162|6347616|P2|COMPLETED|Overall Study||109
2587400|NCT00331162|6347617|P1|COMPLETED|Overall Study||113
2587401|NCT00331162|6347616|P2|STARTED|Overall Study||109
2587402|NCT00331162|6347617|P1|STARTED|Overall Study||113
2587403|NCT00331006|6347637|P1|NOT COMPLETED|Follow-Up Phase II||3
2587404|NCT00331006|6347637|P1|COMPLETED|Follow-Up Phase II||11
2587405|NCT00331006|6347637|P1|STARTED|Follow-Up Phase II||14
2587406|NCT00331006|6347637|P1|NOT COMPLETED|Follow-Up Phase I||1
2587407|NCT00331006|6347637|P1|COMPLETED|Follow-Up Phase I||14
2587408|NCT00331006|6347637|P1|STARTED|Follow-Up Phase I||15
2587409|NCT00331006|6347637|P1|NOT COMPLETED|Treatment Phase||1
2587410|NCT00331006|6347637|P1|COMPLETED|Treatment Phase||15
2587411|NCT00331006|6347637|P1|STARTED|Treatment Phase||16
2587412|NCT00331006|6347637|P1|NOT COMPLETED|Screening Phase||7
2587413|NCT00331006|6347637|P1|COMPLETED|Screening Phase|subjects eligible for the treatment phase if inhibitor titer following Factor VIII was at least 5 BU|16
2587414|NCT00331006|6347637|P1|STARTED|Screening Phase||23
2587415|NCT00330967|6347650|P2|NOT COMPLETED|Overall Study||14
2587416|NCT00330967|6347651|P1|NOT COMPLETED|Overall Study||0
2587417|NCT00330967|6347650|P2|COMPLETED|Overall Study||11
2587418|NCT00330967|6347651|P1|COMPLETED|Overall Study||0
2587419|NCT00330967|6347650|P2|STARTED|Overall Study||25
2587420|NCT00330967|6347651|P1|STARTED|Overall Study||0
2587421|NCT00330928|6347662|P1|NOT COMPLETED|Overall Study||17
2587422|NCT00330928|6347662|P1|COMPLETED|Overall Study||89
2587423|NCT00330928|6347662|P1|1 Year Phone Contact|Overall Study||89
2587424|NCT00330928|6347662|P1|7 Day Phone Contact|Overall Study||99
2587425|NCT00330928|6347662|P1|STARTED|Overall Study|Subjects that signed consent and were subject to research procedures.|106
2587426|NCT00330915|6347667|P1|NOT COMPLETED|Overall Study||0
2587427|NCT00330915|6347667|P1|COMPLETED|Overall Study||37
2587428|NCT00330915|6347667|P1|STARTED|Overall Study||37
2587429|NCT00330876|6347674|P2|NOT COMPLETED|Overall Study||13
2587430|NCT00330876|6347675|P1|NOT COMPLETED|Overall Study||71
2587431|NCT00330876|6347674|P2|COMPLETED|Overall Study||77
2587432|NCT00330876|6347675|P1|COMPLETED|Overall Study||378
2587433|NCT00330876|6347674|P2|STARTED|Overall Study||90
2587434|NCT00330876|6347675|P1|STARTED|Overall Study||449
2587435|NCT00330863|6347685|P2|NOT COMPLETED|Overall Study||80
2587436|NCT00330863|6347686|P1|NOT COMPLETED|Overall Study||81
2587437|NCT00330863|6347685|P2|COMPLETED|Overall Study||72
2587438|NCT00330863|6347686|P1|COMPLETED|Overall Study||72
2587439|NCT00330863|6347685|P2|STARTED|Overall Study||152
2587440|NCT00330863|6347686|P1|STARTED|Overall Study||153
2587441|NCT00330759|6347704|P2|NOT COMPLETED|Overall Study||706
2587442|NCT00330759|6347705|P1|NOT COMPLETED|Overall Study||712
2587443|NCT00330759|6347704|P2|COMPLETED|Overall Study||180
2587444|NCT00330759|6347705|P1|COMPLETED|Overall Study||178
2587445|NCT00330759|6347704|P2|Received Investigational Product|Overall Study||878
2587446|NCT00330759|6347705|P1|Received Investigational Product|Overall Study||878
2587447|NCT00330759|6347704|P2|STARTED|Overall Study||886
2587448|NCT00330759|6347705|P1|STARTED|Overall Study||890
2587449|NCT00330733|6347717|P2|NOT COMPLETED|Overall Study||5
2587450|NCT00330733|6347718|P1|NOT COMPLETED|Overall Study||7
2587451|NCT00330733|6347717|P2|COMPLETED|Overall Study||29
2587452|NCT00330733|6347718|P1|COMPLETED|Overall Study||30
2587453|NCT00330733|6347717|P2|Received Study Medication|Overall Study||34
2587455|NCT00330733|6347717|P2|STARTED|Overall Study||34
2587456|NCT00330733|6347718|P1|STARTED|Overall Study||37
2587457|NCT00330681|6347738|P2|NOT COMPLETED|Overall Study||14
2587458|NCT00330681|6347739|P1|NOT COMPLETED|Overall Study||9
2587459|NCT00330681|6347738|P2|COMPLETED|Overall Study||90
2587460|NCT00330681|6347739|P1|COMPLETED|Overall Study||93
2587461|NCT00330681|6347738|P2|STARTED|Overall Study||104
2587462|NCT00330681|6347739|P1|STARTED|Overall Study||102
2587463|NCT00330668|6347761|P1|NOT COMPLETED|Overall Study||114
2587464|NCT00330668|6347761|P1|COMPLETED|Overall Study||0
2587465|NCT00330668|6347761|P1|STARTED|Overall Study||114
2587466|NCT00330616|6347768|P1|NOT COMPLETED|Overall Study||21
2587467|NCT00330616|6347768|P1|COMPLETED|Overall Study||14
2587468|NCT00330616|6347768|P1|STARTED|Overall Study||35
2587469|NCT00330564|6347787|P1|NOT COMPLETED|Overall Study||0
2587470|NCT00330564|6347787|P1|COMPLETED|Overall Study||15
2587471|NCT00330564|6347787|P1|STARTED|Overall Study||15
2587472|NCT00330460|6347794|P2|NOT COMPLETED|Overall Study||33
2587473|NCT00330460|6347795|P1|NOT COMPLETED|Overall Study||42
2587474|NCT00330460|6347794|P2|COMPLETED|Overall Study||561
2587475|NCT00330460|6347795|P1|COMPLETED|Overall Study||553
2587476|NCT00330460|6347794|P2|STARTED|Overall Study||594
2587477|NCT00330460|6347795|P1|STARTED|Overall Study||595
2587478|NCT00330421|6347809|P2|NOT COMPLETED|Overall Study||0
2587479|NCT00330421|6347810|P1|NOT COMPLETED|Overall Study||0
2587480|NCT00330421|6347809|P2|COMPLETED|Overall Study||0
2587481|NCT00330421|6347810|P1|COMPLETED|Overall Study||15
2587482|NCT00330421|6347809|P2|STARTED|Overall Study||0
2587483|NCT00330421|6347810|P1|STARTED|Overall Study||15
2587484|NCT00330382|6347816|P2|NOT COMPLETED|Overall Study||17
2587485|NCT00330382|6347817|P1|NOT COMPLETED|Overall Study||24
2587486|NCT00330382|6347816|P2|COMPLETED|Overall Study||48
2587487|NCT00330382|6347817|P1|COMPLETED|Overall Study||43
2587488|NCT00330382|6347816|P2|STARTED|Overall Study||65
2587489|NCT00330382|6347817|P1|STARTED|Overall Study||67
2587490|NCT00330343|6347838|P1|NOT COMPLETED|Overall Study||5
2587491|NCT00330343|6347838|P1|COMPLETED|Overall Study||59
2587492|NCT00330343|6347838|P1|STARTED|Overall Study||64
2587493|NCT00330187|6347846|P4|NOT COMPLETED|Overall Study||14
2587494|NCT00330187|6347847|P3|NOT COMPLETED|Overall Study||18
2587495|NCT00330187|6347848|P2|NOT COMPLETED|Overall Study||18
2587496|NCT00330187|6347849|P1|NOT COMPLETED|Overall Study||20
2587497|NCT00330187|6347846|P4|COMPLETED|Overall Study||18
2587498|NCT00330187|6347847|P3|COMPLETED|Overall Study||11
2587499|NCT00330187|6347848|P2|COMPLETED|Overall Study||18
2587500|NCT00330187|6347849|P1|COMPLETED|Overall Study||17
2587501|NCT00330187|6347846|P4|STARTED|Overall Study||32
2587502|NCT00330187|6347847|P3|STARTED|Overall Study||29
2587503|NCT00330187|6347848|P2|STARTED|Overall Study||36
2587504|NCT00330187|6347849|P1|STARTED|Overall Study||37
2587505|NCT00330174|6347861|P2|NOT COMPLETED|Overall Study||19
2587506|NCT00330174|6347862|P1|NOT COMPLETED|Overall Study||22
2587507|NCT00330174|6347861|P2|COMPLETED|Overall Study||26
2587508|NCT00330174|6347862|P1|COMPLETED|Overall Study||23
2587509|NCT00330174|6347861|P2|STARTED|Overall Study||45
2587510|NCT00330174|6347862|P1|STARTED|Overall Study||45
2587511|NCT00330161|6347874|P1|NOT COMPLETED|Overall Study||0
2587512|NCT00330161|6347874|P1|COMPLETED|Overall Study||29
2587513|NCT00330161|6347874|P1|STARTED|Overall Study||29
2587514|NCT00329901|6347886|P3|NOT COMPLETED|Overall Study||4
2587515|NCT00329901|6347887|P2|NOT COMPLETED|Overall Study||5
2587516|NCT00329901|6347888|P1|NOT COMPLETED|Overall Study||9
2587517|NCT00329901|6347886|P3|COMPLETED|Overall Study||353
2587518|NCT00329901|6347887|P2|COMPLETED|Overall Study||349
2587519|NCT00329901|6347888|P1|COMPLETED|Overall Study||352
2587520|NCT00329901|6347886|P3|STARTED|Overall Study||357
2587521|NCT00329901|6347887|P2|STARTED|Overall Study||354
2587522|NCT00329901|6347888|P1|STARTED|Overall Study||361
2587523|NCT00329849|6347918|P2|NOT COMPLETED|Overall Study||4
2587524|NCT00329849|6347919|P1|NOT COMPLETED|Overall Study||6
2587525|NCT00329849|6347918|P2|COMPLETED|Overall Study||546
2587526|NCT00329849|6347919|P1|COMPLETED|Overall Study||944
2587527|NCT00329849|6347918|P2|STARTED|Overall Study||550
2587528|NCT00329849|6347919|P1|STARTED|Overall Study||950
2587529|NCT00329836|6347939|P1|NOT COMPLETED|Overall Study||0
2587530|NCT00329836|6347939|P1|COMPLETED|Overall Study||41
2587531|NCT00329836|6347939|P1|STARTED|Overall Study||41
2587532|NCT00329797|6347945|P2|NOT COMPLETED|Overall Study||6
2587533|NCT00329797|6347946|P1|NOT COMPLETED|Overall Study||7
2587534|NCT00329797|6347945|P2|COMPLETED|Overall Study||46
2587535|NCT00329797|6347946|P1|COMPLETED|Overall Study||50
2587536|NCT00329797|6347945|P2|STARTED|Overall Study||52
2587537|NCT00329797|6347946|P1|STARTED|Overall Study||57
2587538|NCT00329784|6347962|P4|NOT COMPLETED|Overall Study||0
2587539|NCT00329784|6347963|P3|NOT COMPLETED|Overall Study||0
2587540|NCT00329784|6347964|P2|NOT COMPLETED|Overall Study||5
2587541|NCT00329784|6347965|P1|NOT COMPLETED|Overall Study||5
2587542|NCT00329784|6347962|P4|COMPLETED|Overall Study||47
2587543|NCT00329784|6347963|P3|COMPLETED|Overall Study||51
2587544|NCT00329784|6347964|P2|COMPLETED|Overall Study||267
2587545|NCT00329784|6347965|P1|COMPLETED|Overall Study||265
2587546|NCT00329784|6347962|P4|STARTED|Overall Study||47
2587547|NCT00329784|6347963|P3|STARTED|Overall Study||51
2587548|NCT00329784|6347964|P2|STARTED|Overall Study||272
2587549|NCT00329784|6347965|P1|STARTED|Overall Study||270
2587550|NCT00329771|6347987|P1|NOT COMPLETED|Overall Study||3
2587814|NCT00327717|6350702|P1|STARTED|Overall Study||120
2587551|NCT00329771|6347987|P1|COMPLETED|Overall Study|3 subjects withdrew or were lost to follow-up|25
2587552|NCT00329771|6347987|P1|STARTED|Overall Study||28
2587553|NCT00329745|6347993|P2|NOT COMPLETED|Overall Study||102
2587554|NCT00329745|6347994|P1|NOT COMPLETED|Overall Study||87
2587555|NCT00329745|6347993|P2|COMPLETED|Overall Study||4226
2587556|NCT00329745|6347994|P1|COMPLETED|Overall Study||4272
2587557|NCT00329745|6347993|P2|STARTED|Overall Study||4328
2587558|NCT00329745|6347994|P1|STARTED|Overall Study||4359
2587559|NCT00329732|6348004|P2|NOT COMPLETED|Overall Study||0
2587560|NCT00329732|6348005|P1|NOT COMPLETED|Overall Study||0
2587561|NCT00329732|6348004|P2|COMPLETED|Overall Study||0
2587562|NCT00329732|6348005|P1|COMPLETED|Overall Study||2
2587563|NCT00329732|6348004|P2|STARTED|Overall Study||0
2587564|NCT00329732|6348005|P1|STARTED|Overall Study||2
2587565|NCT00329719|6348014|P4|NOT COMPLETED|Overall Study||1
2587566|NCT00329719|6348015|P3|NOT COMPLETED|Overall Study||0
2587567|NCT00329719|6348016|P2|NOT COMPLETED|Overall Study||0
2587568|NCT00329719|6348017|P1|NOT COMPLETED|Overall Study||0
2587569|NCT00329719|6348014|P4|COMPLETED|Overall Study||44
2587570|NCT00329719|6348015|P3|COMPLETED|Overall Study||9
2587571|NCT00329719|6348016|P2|COMPLETED|Overall Study||49
2587572|NCT00329719|6348017|P1|COMPLETED|Overall Study||12
2587573|NCT00329719|6348014|P4|STARTED|Overall Study||45
2587574|NCT00329719|6348015|P3|STARTED|Overall Study||9
2587575|NCT00329719|6348016|P2|STARTED|Overall Study||49
2587576|NCT00329719|6348017|P1|STARTED|Overall Study||12
2587577|NCT00329641|6348039|P1|NOT COMPLETED|Overall Study||6
2587578|NCT00329641|6348039|P1|COMPLETED|Overall Study||19
2587579|NCT00329641|6348039|P1|Eligible and Received Treatment|Overall Study||24
2587580|NCT00329641|6348039|P1|Eligible|Overall Study||25
2587581|NCT00329641|6348039|P1|STARTED|Overall Study||25
2587582|NCT00329602|6348048|P3|NOT COMPLETED|40-Week Open-Label Treatment Phase||36
2587583|NCT00329602|6348049|P2|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
2587584|NCT00329602|6348050|P1|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
2587585|NCT00329602|6348048|P3|COMPLETED|40-Week Open-Label Treatment Phase||233
2587586|NCT00329602|6348049|P2|COMPLETED|40-Week Open-Label Treatment Phase||0
2587587|NCT00329602|6348050|P1|COMPLETED|40-Week Open-Label Treatment Phase||0
2587588|NCT00329602|6348048|P3|STARTED|40-Week Open-Label Treatment Phase|148 and 121 par. randomized to DB placebo and ropinirole IR, respectively, entered the OL phase.|269
2587589|NCT00329602|6348049|P2|STARTED|40-Week Open-Label Treatment Phase||0
2587590|NCT00329602|6348050|P1|STARTED|40-Week Open-Label Treatment Phase||0
2587591|NCT00329602|6348048|P3|NOT COMPLETED|26-Week Double-Blind Treatment Phase||0
2587592|NCT00329602|6348049|P2|NOT COMPLETED|26-Week Double-Blind Treatment Phase||99
2587593|NCT00329602|6348050|P1|NOT COMPLETED|26-Week Double-Blind Treatment Phase||119
2587594|NCT00329602|6348048|P3|COMPLETED|26-Week Double-Blind Treatment Phase||0
2587595|NCT00329602|6348049|P2|COMPLETED|26-Week Double-Blind Treatment Phase||98
2587596|NCT00329602|6348050|P1|COMPLETED|26-Week Double-Blind Treatment Phase||88
2587597|NCT00329602|6348048|P3|STARTED|26-Week Double-Blind Treatment Phase||0
2587598|NCT00329602|6348049|P2|STARTED|26-Week Double-Blind Treatment Phase||197
2587599|NCT00329602|6348050|P1|STARTED|26-Week Double-Blind Treatment Phase|"Numbers of participants in the Participant Flow section are based on the Safety Population."|207
2587600|NCT00329550|6348088|P3|NOT COMPLETED|Overall Study||4
2587601|NCT00329550|6348089|P2|NOT COMPLETED|Overall Study||4
2587602|NCT00329550|6348090|P1|NOT COMPLETED|Overall Study||4
2587603|NCT00329550|6348088|P3|COMPLETED|Overall Study||12
2587604|NCT00329550|6348089|P2|COMPLETED|Overall Study||11
2587605|NCT00329550|6348090|P1|COMPLETED|Overall Study||5
2587606|NCT00329550|6348088|P3|STARTED|Overall Study|1 subject in Safety Set is not in Full Analysis Set due to Good Clinical Practice non-compliance.|16
2587607|NCT00329550|6348089|P2|STARTED|Overall Study||15
2587608|NCT00329550|6348090|P1|STARTED|Overall Study||9
2587609|NCT00329524|6348337|P1|NOT COMPLETED|Overall Study||0
2587610|NCT00329524|6348337|P1|COMPLETED|Overall Study||5
2587611|NCT00329524|6348337|P1|STARTED|Overall Study||5
2587612|NCT00329433|6348345|P2|NOT COMPLETED|Overall Study||0
2587613|NCT00329433|6348346|P1|NOT COMPLETED|Overall Study||0
2587614|NCT00329433|6348345|P2|COMPLETED|Overall Study||59
2587615|NCT00329433|6348346|P1|COMPLETED|Overall Study||61
2587616|NCT00329433|6348345|P2|STARTED|Overall Study||59
2587617|NCT00329433|6348346|P1|STARTED|Overall Study||61
2587618|NCT00329420|6348359|P3|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||1
2587619|NCT00329420|6348360|P2|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||2
2587620|NCT00329420|6348361|P1|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||4
2587621|NCT00329420|6348359|P3|COMPLETED|4-weekly Dosing Phase (Responders Only)||6
2587622|NCT00329420|6348360|P2|COMPLETED|4-weekly Dosing Phase (Responders Only)||5
2587623|NCT00329420|6348361|P1|COMPLETED|4-weekly Dosing Phase (Responders Only)||8
2587624|NCT00329420|6348359|P3|STARTED|4-weekly Dosing Phase (Responders Only)||7
2587625|NCT00329420|6348360|P2|STARTED|4-weekly Dosing Phase (Responders Only)||7
2587626|NCT00329420|6348361|P1|STARTED|4-weekly Dosing Phase (Responders Only)||12
2587627|NCT00329420|6348359|P3|NOT COMPLETED|Re-induction Phase||8
2587628|NCT00329420|6348360|P2|NOT COMPLETED|Re-induction Phase||6
2587629|NCT00329420|6348361|P1|NOT COMPLETED|Re-induction Phase||6
2587630|NCT00329420|6348359|P3|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
2587631|NCT00329420|6348360|P2|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
2587815|NCT00327470|6350728|P2|NOT COMPLETED|Overall Study||63
2587632|NCT00329420|6348361|P1|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|12
2587633|NCT00329420|6348359|P3|STARTED|Re-induction Phase||15
2587634|NCT00329420|6348360|P2|STARTED|Re-induction Phase||13
2587635|NCT00329420|6348361|P1|STARTED|Re-induction Phase||18
2587636|NCT00329407|6348740|P1|NOT COMPLETED|Overall Study||1
2587637|NCT00329407|6348740|P1|COMPLETED|Overall Study||9
2587638|NCT00329407|6348740|P1|STARTED|Overall Study||10
2587639|NCT00329303|6348747|P2|NOT COMPLETED|Overall Study||2
2587640|NCT00329303|6348748|P1|NOT COMPLETED|Overall Study||2
2587641|NCT00329303|6348747|P2|COMPLETED|Overall Study||35
2587642|NCT00329303|6348748|P1|COMPLETED|Overall Study||32
2587643|NCT00329303|6348747|P2|STARTED|Overall Study||37
2587644|NCT00329303|6348748|P1|STARTED|Overall Study||34
2587645|NCT00329238|6348910|P2|NOT COMPLETED|Overall Study||281
2587646|NCT00329238|6348911|P1|NOT COMPLETED|Overall Study||276
2587647|NCT00329238|6348910|P2|COMPLETED|Overall Study||1145
2587648|NCT00329238|6348911|P1|COMPLETED|Overall Study||1154
2587649|NCT00329238|6348910|P2|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1426
2587650|NCT00329238|6348911|P1|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1430
2587651|NCT00329160|6348947|P1|NOT COMPLETED|Overall Study||88
2587652|NCT00329160|6348947|P1|COMPLETED|Overall Study||126
2587653|NCT00329160|6348947|P1|Treatment Period|Overall Study||214
2587654|NCT00329160|6348947|P1|Observation Period|Overall Study||214
2587655|NCT00329160|6348947|P1|STARTED|Overall Study||214
2587656|NCT00329108|6348956|P2|NOT COMPLETED|Overall Study||12
2587657|NCT00329108|6348957|P1|NOT COMPLETED|Overall Study||10
2587658|NCT00329108|6348956|P2|COMPLETED|Overall Study||2
2587659|NCT00329108|6348957|P1|COMPLETED|Overall Study||5
2587660|NCT00329108|6348956|P2|STARTED|Overall Study|study terminated due to poor recruitment|14
2587661|NCT00329108|6348957|P1|STARTED|Overall Study|study terminated due to poor recruitment|15
2587662|NCT00329030|6348965|P2|NOT COMPLETED|Overall Study||6
2587663|NCT00329030|6348966|P1|NOT COMPLETED|Overall Study||8
2587664|NCT00329030|6348965|P2|COMPLETED|Overall Study||107
2587665|NCT00329030|6348966|P1|COMPLETED|Overall Study||103
2587666|NCT00329030|6348965|P2|STARTED|Overall Study||113
2587667|NCT00329030|6348966|P1|STARTED|Overall Study||111
2587668|NCT00328926|6348997|P3|NOT COMPLETED|Overall Study||2
2587669|NCT00328926|6348998|P2|NOT COMPLETED|Overall Study||3
2587670|NCT00328926|6348999|P1|NOT COMPLETED|Overall Study||2
2587671|NCT00328926|6348997|P3|COMPLETED|Overall Study||1
2587672|NCT00328926|6348998|P2|COMPLETED|Overall Study||0
2587673|NCT00328926|6348999|P1|COMPLETED|Overall Study||3
2587674|NCT00328926|6348997|P3|STARTED|Overall Study||3
2587675|NCT00328926|6348998|P2|STARTED|Overall Study||3
2587676|NCT00328926|6348999|P1|STARTED|Overall Study||5
2587677|NCT00328861|6349015|P2|NOT COMPLETED|Overall Study||0
2587678|NCT00328861|6349016|P1|NOT COMPLETED|Overall Study||0
2587679|NCT00328861|6349015|P2|COMPLETED|Overall Study||1
2587680|NCT00328861|6349016|P1|COMPLETED|Overall Study||7
2587681|NCT00328861|6349015|P2|STARTED|Overall Study||1
2587682|NCT00328861|6349016|P1|STARTED|Overall Study||7
2587683|NCT00328783|6349024|P1|NOT COMPLETED|Overall Study||26
2587684|NCT00328783|6349024|P1|COMPLETED|Overall Study||86
2587685|NCT00328783|6349024|P1|STARTED|Overall Study||112
2587686|NCT00328770|6349032|P1|NOT COMPLETED|Overall Study||0
2587687|NCT00328770|6349032|P1|COMPLETED|Overall Study||70
2587688|NCT00328770|6349032|P1|STARTED|Overall Study||70
2587689|NCT00328627|6349050|P12|NOT COMPLETED|Overall Study||16
2587690|NCT00328627|6349051|P11|NOT COMPLETED|Overall Study||18
2587691|NCT00328627|6349052|P10|NOT COMPLETED|Overall Study||32
2587692|NCT00328627|6349053|P9|NOT COMPLETED|Overall Study||17
2587693|NCT00328627|6349054|P8|NOT COMPLETED|Overall Study||14
2587694|NCT00328627|6349055|P7|NOT COMPLETED|Overall Study||35
2587695|NCT00328627|6349056|P6|NOT COMPLETED|Overall Study||20
2587696|NCT00328627|6349057|P5|NOT COMPLETED|Overall Study||15
2587697|NCT00328627|6349058|P4|NOT COMPLETED|Overall Study||37
2587698|NCT00328627|6349059|P3|NOT COMPLETED|Overall Study||28
2587699|NCT00328627|6349060|P2|NOT COMPLETED|Overall Study||31
2587700|NCT00328627|6349061|P1|NOT COMPLETED|Overall Study||59
2587701|NCT00328627|6349050|P12|COMPLETED|Overall Study||114
2587702|NCT00328627|6349051|P11|COMPLETED|Overall Study||112
2587703|NCT00328627|6349052|P10|COMPLETED|Overall Study||97
2587704|NCT00328627|6349053|P9|COMPLETED|Overall Study||113
2587705|NCT00328627|6349054|P8|COMPLETED|Overall Study||116
2587706|NCT00328627|6349055|P7|COMPLETED|Overall Study||94
2587707|NCT00328627|6349056|P6|COMPLETED|Overall Study||110
2587708|NCT00328627|6349057|P5|COMPLETED|Overall Study||115
2587709|NCT00328627|6349058|P4|COMPLETED|Overall Study||93
2587710|NCT00328627|6349059|P3|COMPLETED|Overall Study||101
2587711|NCT00328627|6349060|P2|COMPLETED|Overall Study||97
2587712|NCT00328627|6349061|P1|COMPLETED|Overall Study||70
2587713|NCT00328627|6349050|P12|Safety Set|Overall Study||130
2587714|NCT00328627|6349051|P11|Safety Set|Overall Study||130
2587715|NCT00328627|6349052|P10|Safety Set|Overall Study||129
2587716|NCT00328627|6349053|P9|Safety Set|Overall Study||130
2587717|NCT00328627|6349054|P8|Safety Set|Overall Study||130
2587718|NCT00328627|6349055|P7|Safety Set|Overall Study||129
2587719|NCT00328627|6349056|P6|Safety Set|Overall Study||130
2587720|NCT00328627|6349057|P5|Safety Set|Overall Study||130
2587721|NCT00328627|6349058|P4|Safety Set|Overall Study||129
2587722|NCT00328627|6349059|P3|Safety Set|Overall Study||129
2587723|NCT00328627|6349060|P2|Safety Set|Overall Study||128
2587724|NCT00328627|6349061|P1|Safety Set|Overall Study|All patients who took at least 1 dose of double-blind study drug.|129
2587725|NCT00328627|6349050|P12|STARTED|Overall Study||130
2587726|NCT00328627|6349051|P11|STARTED|Overall Study||130
2587727|NCT00328627|6349052|P10|STARTED|Overall Study||129
2587728|NCT00328627|6349053|P9|STARTED|Overall Study||130
2587729|NCT00328627|6349054|P8|STARTED|Overall Study||130
2587730|NCT00328627|6349055|P7|STARTED|Overall Study||129
2587731|NCT00328627|6349056|P6|STARTED|Overall Study||130
2587732|NCT00328627|6349057|P5|STARTED|Overall Study||130
2587733|NCT00328627|6349058|P4|STARTED|Overall Study||130
2587734|NCT00328627|6349059|P3|STARTED|Overall Study||129
2587735|NCT00328627|6349060|P2|STARTED|Overall Study||128
2587736|NCT00328627|6349061|P1|STARTED|Overall Study||129
2587737|NCT00328614|6350584|P6|NOT COMPLETED|Overall Study||1
2587738|NCT00328614|6350585|P5|NOT COMPLETED|Overall Study||1
2587739|NCT00328614|6350586|P4|NOT COMPLETED|Overall Study||1
2587740|NCT00328614|6350587|P3|NOT COMPLETED|Overall Study||0
2587741|NCT00328614|6350588|P2|NOT COMPLETED|Overall Study||0
2587742|NCT00328614|6350589|P1|NOT COMPLETED|Overall Study||0
2587743|NCT00328614|6350584|P6|COMPLETED|Overall Study||5
2587744|NCT00328614|6350585|P5|COMPLETED|Overall Study||5
2587745|NCT00328614|6350586|P4|COMPLETED|Overall Study||5
2587746|NCT00328614|6350587|P3|COMPLETED|Overall Study||6
2587747|NCT00328614|6350588|P2|COMPLETED|Overall Study||4
2587748|NCT00328614|6350589|P1|COMPLETED|Overall Study||4
2587749|NCT00328614|6350584|P6|STARTED|Overall Study||6
2587750|NCT00328614|6350585|P5|STARTED|Overall Study||6
2587751|NCT00328614|6350586|P4|STARTED|Overall Study||6
2587752|NCT00328614|6350587|P3|STARTED|Overall Study||6
2587753|NCT00328614|6350588|P2|STARTED|Overall Study||4
2587754|NCT00328614|6350589|P1|STARTED|Overall Study||4
2587755|NCT00328562|6350598|P1|NOT COMPLETED|Overall Study||1
2587756|NCT00328562|6350598|P1|COMPLETED|Overall Study||12
2587757|NCT00328562|6350598|P1|STARTED|Overall Study||13
2587758|NCT00328510|6350607|P2|NOT COMPLETED|Overall Study||4
2587759|NCT00328510|6350608|P1|NOT COMPLETED|Overall Study||10
2587760|NCT00328510|6350607|P2|COMPLETED|Overall Study||37
2587761|NCT00328510|6350608|P1|COMPLETED|Overall Study||32
2587762|NCT00328510|6350607|P2|STARTED|Overall Study||41
2587763|NCT00328510|6350608|P1|STARTED|Overall Study||42
2587764|NCT00328263|6350616|P2|NOT COMPLETED|Overall Study||4
2587765|NCT00328263|6350617|P1|NOT COMPLETED|Overall Study||3
2587766|NCT00328263|6350616|P2|COMPLETED|Overall Study|4 deaths occured during the study. None of the deaths were causally related to the study product.|217
2587767|NCT00328263|6350617|P1|COMPLETED|Overall Study|3 deaths occured during the study. None of the deaths were causally related to the study product.|213
2587768|NCT00328263|6350616|P2|STARTED|Overall Study||221
2587769|NCT00328263|6350617|P1|STARTED|Overall Study||216
2587770|NCT00328198|6350623|P1|NOT COMPLETED|Follow-up||35
2587771|NCT00328198|6350623|P1|COMPLETED|Follow-up||43
2587772|NCT00328198|6350623|P1|STARTED|Follow-up|Eight participants did not enter Follow-up|78
2587773|NCT00328198|6350623|P1|NOT COMPLETED|Treatment||38
2587774|NCT00328198|6350623|P1|COMPLETED|Treatment|Depending upon protocol version, completed treatment was either 12 or 18 weeks in duration.|48
2587775|NCT00328198|6350623|P1|STARTED|Treatment|16 participants escalated the dose. 70 participants started at the 30 mg target dose.|86
2587776|NCT00328172|6350638|P5|NOT COMPLETED|Overall Study||5
2587777|NCT00328172|6350639|P4|NOT COMPLETED|Overall Study||13
2587778|NCT00328172|6350640|P3|NOT COMPLETED|Overall Study||10
2587779|NCT00328172|6350641|P2|NOT COMPLETED|Overall Study||14
2587780|NCT00328172|6350642|P1|NOT COMPLETED|Overall Study||22
2587781|NCT00328172|6350638|P5|COMPLETED|Overall Study||60
2587782|NCT00328172|6350639|P4|COMPLETED|Overall Study||42
2587783|NCT00328172|6350640|P3|COMPLETED|Overall Study||47
2587784|NCT00328172|6350641|P2|COMPLETED|Overall Study||44
2587785|NCT00328172|6350642|P1|COMPLETED|Overall Study||45
2587786|NCT00328172|6350638|P5|STARTED|Overall Study||65
2587787|NCT00328172|6350639|P4|STARTED|Overall Study||55
2587788|NCT00328172|6350640|P3|STARTED|Overall Study||57
2587789|NCT00328172|6350641|P2|STARTED|Overall Study||58
2587790|NCT00328172|6350642|P1|STARTED|Overall Study||67
2587791|NCT00328094|6350666|P2|NOT COMPLETED|Overall Study||3
2587792|NCT00328094|6350667|P1|NOT COMPLETED|Overall Study||3
2587793|NCT00328094|6350666|P2|COMPLETED|Overall Study|3 did not receive interevention. 1 post induction arrest. 1 case cancelled.|122
2587794|NCT00328094|6350667|P1|COMPLETED|Overall Study|2 did not receive intervention. 1 patient refusal|114
2587795|NCT00328094|6350666|P2|STARTED|Overall Study||125
2587796|NCT00328094|6350667|P1|STARTED|Overall Study||117
2587797|NCT00328042|6350677|P2|NOT COMPLETED|Overall Study||2
2587798|NCT00328042|6350678|P1|NOT COMPLETED|Overall Study||0
2587799|NCT00328042|6350677|P2|COMPLETED|Overall Study||63
2587800|NCT00328042|6350678|P1|COMPLETED|Overall Study||69
2587801|NCT00328042|6350677|P2|STARTED|Overall Study||65
2587802|NCT00328042|6350678|P1|STARTED|Overall Study||69
2587803|NCT00328016|6350688|P2|NOT COMPLETED|Overall Study||0
2587804|NCT00328016|6350689|P1|NOT COMPLETED|Overall Study||0
2587805|NCT00328016|6350688|P2|COMPLETED|Overall Study||21
2587806|NCT00328016|6350689|P1|COMPLETED|Overall Study||23
2587807|NCT00328016|6350688|P2|STARTED|Overall Study||21
2587808|NCT00328016|6350689|P1|STARTED|Overall Study||23
2587809|NCT00327717|6350701|P2|NOT COMPLETED|Overall Study||14
2587810|NCT00327717|6350702|P1|NOT COMPLETED|Overall Study||9
2587811|NCT00327717|6350701|P2|COMPLETED|Overall Study||106
2587812|NCT00327717|6350702|P1|COMPLETED|Overall Study||111
2587813|NCT00327717|6350701|P2|STARTED|Overall Study||120
2587816|NCT00327470|6350729|P1|NOT COMPLETED|Overall Study||29
2587817|NCT00327470|6350728|P2|COMPLETED|Overall Study||118
2587818|NCT00327470|6350729|P1|COMPLETED|Overall Study||78
2587819|NCT00327470|6350728|P2|Treated|Overall Study||179
2587820|NCT00327470|6350729|P1|Treated|Overall Study||107
2587821|NCT00327470|6350728|P2|STARTED|Overall Study||181
2587822|NCT00327470|6350729|P1|STARTED|Overall Study||107
2587823|NCT00327444|6350749|P2|NOT COMPLETED|Open Label Treatment (OL) Period||10
2587824|NCT00327444|6350750|P1|NOT COMPLETED|Open Label Treatment (OL) Period||11
2587825|NCT00327444|6350749|P2|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
2587826|NCT00327444|6350750|P1|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
2587827|NCT00327444|6350749|P2|ONGOING TREATMENT|Open Label Treatment (OL) Period||0
2587828|NCT00327444|6350750|P1|ONGOING TREATMENT|Open Label Treatment (OL) Period||1
2587829|NCT00327444|6350749|P2|STARTED|Open Label Treatment (OL) Period||10
2587830|NCT00327444|6350750|P1|STARTED|Open Label Treatment (OL) Period||11
2587831|NCT00327444|6350749|P2|NOT COMPLETED|Double Blind Treatment (DB) Period||29
2587832|NCT00327444|6350750|P1|NOT COMPLETED|Double Blind Treatment (DB) Period||26
2587833|NCT00327444|6350749|P2|COMPLETED|Double Blind Treatment (DB) Period||0
2587834|NCT00327444|6350750|P1|COMPLETED|Double Blind Treatment (DB) Period||0
2587835|NCT00327444|6350749|P2|SAFETY|Double Blind Treatment (DB) Period|Includes 1 from Placebo who received aflibercept in DB period|30
2587836|NCT00327444|6350750|P1|SAFETY|Double Blind Treatment (DB) Period|Excludes one participant from the Placebo arm who received aflibercept in error in the DB period.|25
2587837|NCT00327444|6350749|P2|STARTED|Double Blind Treatment (DB) Period||29
2587838|NCT00327444|6350750|P1|STARTED|Double Blind Treatment (DB) Period||26
2587839|NCT00327392|6350762|P1|NOT COMPLETED|Overall Study||0
2587840|NCT00327392|6350762|P1|COMPLETED|Overall Study||123
2587841|NCT00327392|6350762|P1|STARTED|Overall Study||123
2587842|NCT00327340|6350768|P2|NOT COMPLETED|Overall Study||30
2587843|NCT00327340|6350769|P1|NOT COMPLETED|Overall Study||15
2587844|NCT00327340|6350768|P2|COMPLETED|Overall Study||16
2587845|NCT00327340|6350769|P1|COMPLETED|Overall Study||8
2587846|NCT00327340|6350768|P2|STARTED|Overall Study||46
2587847|NCT00327340|6350769|P1|STARTED|Overall Study||23
2587848|NCT00327171|6350783|P2|NOT COMPLETED|Overall Study||109
2587849|NCT00327171|6350784|P1|NOT COMPLETED|Overall Study||108
2587850|NCT00327171|6350783|P2|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|0
2587851|NCT00327171|6350784|P1|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|1
2587852|NCT00327171|6350783|P2|STARTED|Overall Study||109
2587853|NCT00327171|6350784|P1|STARTED|Overall Study||109
2587854|NCT00327015|6350816|P4|NOT COMPLETED|Overall Study||109
2587855|NCT00327015|6350817|P3|NOT COMPLETED|Overall Study||126
2587856|NCT00327015|6350818|P2|NOT COMPLETED|Overall Study||92
2587857|NCT00327015|6350819|P1|NOT COMPLETED|Overall Study||91
2587858|NCT00327015|6350816|P4|COMPLETED|Overall Study||219
2587859|NCT00327015|6350817|P3|COMPLETED|Overall Study||209
2587860|NCT00327015|6350818|P2|COMPLETED|Overall Study||231
2587861|NCT00327015|6350819|P1|COMPLETED|Overall Study||229
2587862|NCT00327015|6350816|P4|Completed Study Without Being Rescued|Overall Study||144
2587863|NCT00327015|6350817|P3|Completed Study Without Being Rescued|Overall Study||113
2587864|NCT00327015|6350818|P2|Completed Study Without Being Rescued|Overall Study||177
2587865|NCT00327015|6350819|P1|Completed Study Without Being Rescued|Overall Study||179
2587866|NCT00327015|6350816|P4|STARTED|Overall Study||328
2587867|NCT00327015|6350817|P3|STARTED|Overall Study||335
2587868|NCT00327015|6350818|P2|STARTED|Overall Study||323
2587869|NCT00327015|6350819|P1|STARTED|Overall Study||320
2587870|NCT00326963|6350861|P1|NOT COMPLETED|Overall Study||33
2587871|NCT00326963|6350861|P1|COMPLETED|Overall Study||107
2587872|NCT00326963|6350861|P1|STARTED|Overall Study||140
2587873|NCT00326950|6350881|P1|NOT COMPLETED|Overall Study||1
2587874|NCT00326950|6350881|P1|COMPLETED|Overall Study||14
2587875|NCT00326950|6350881|P1|STARTED|Overall Study||15
2587876|NCT00326924|6350888|P2|NOT COMPLETED|Overall Study||1
2587877|NCT00326924|6350889|P1|NOT COMPLETED|Overall Study||1
2587878|NCT00326924|6350888|P2|COMPLETED|Overall Study||188
2587879|NCT00326924|6350889|P1|COMPLETED|Overall Study||187
2587880|NCT00326924|6350888|P2|STARTED|Overall Study||189
2587881|NCT00326924|6350889|P1|STARTED|Overall Study||188
2587882|NCT00326911|6350903|P2|NOT COMPLETED|Overall Study||2
2587883|NCT00326911|6350904|P1|NOT COMPLETED|Overall Study||1
2587884|NCT00326911|6350903|P2|COMPLETED|Overall Study|This number reflects all treated patients.|29
2587885|NCT00326911|6350904|P1|COMPLETED|Overall Study|This number reflects all treated patients.|29
2587886|NCT00326911|6350903|P2|STARTED|Overall Study|This number reflects all randomized patients.|31
2587887|NCT00326911|6350904|P1|STARTED|Overall Study|This number reflects all randomized patients.|30
2587888|NCT00326898|6350957|P3|NOT COMPLETED|Overall Study||203
2587889|NCT00326898|6350958|P2|NOT COMPLETED|Overall Study||343
2587890|NCT00326898|6350959|P1|NOT COMPLETED|Overall Study||351
2587891|NCT00326898|6350957|P3|COMPLETED|Overall Study||444
2587892|NCT00326898|6350958|P2|COMPLETED|Overall Study||306
2587893|NCT00326898|6350959|P1|COMPLETED|Overall Study||296
2587894|NCT00326898|6350957|P3|Patients With >=1 Follow-up MUGA Scan|Overall Study||580
2587895|NCT00326898|6350958|P2|Patients With >=1 Follow-up MUGA Scan|Overall Study||510
2587896|NCT00326898|6350959|P1|Patients With >=1 Follow-up MUGA Scan|Overall Study||513
2587897|NCT00326898|6350957|P3|Patients With Clear Cell Histology|Overall Study||540
2587898|NCT00326898|6350958|P2|Patients With Clear Cell Histology|Overall Study||540
2587899|NCT00326898|6350959|P1|Patients With Clear Cell Histology|Overall Study||542
2587900|NCT00326898|6350957|P3|Patients With Toxicity Data|Overall Study||626
2587901|NCT00326898|6350958|P2|Patients With Toxicity Data|Overall Study||628
2587902|NCT00326898|6350959|P1|Patients With Toxicity Data|Overall Study||625
2587903|NCT00326898|6350957|P3|STARTED|Overall Study||647
2587904|NCT00326898|6350958|P2|STARTED|Overall Study||649
2587905|NCT00326898|6350959|P1|STARTED|Overall Study||647
2587906|NCT00326885|6350976|P1|NOT COMPLETED|Overall Study||7
2587907|NCT00326885|6350976|P1|COMPLETED|Overall Study||25
2587908|NCT00326885|6350976|P1|STARTED|Overall Study||32
2587909|NCT00326872|6350985|P1|NOT COMPLETED|Overall Study||0
2587910|NCT00326872|6350985|P1|COMPLETED|Overall Study||26
2587911|NCT00326872|6350985|P1|STARTED|Overall Study||26
2587912|NCT00326781|6350996|P2|NOT COMPLETED|Overall Study||32
2587913|NCT00326781|6350997|P1|NOT COMPLETED|Overall Study||42
2587914|NCT00326781|6350996|P2|COMPLETED|Overall Study||298
2587915|NCT00326781|6350997|P1|COMPLETED|Overall Study||302
2587916|NCT00326781|6350996|P2|STARTED|Overall Study||330
2587917|NCT00326781|6350997|P1|STARTED|Overall Study||344
2587918|NCT00326716|6351007|P4|NOT COMPLETED|Infants||0
2587919|NCT00326716|6351008|P3|NOT COMPLETED|Infants||0
2587920|NCT00326716|6351009|P2|NOT COMPLETED|Infants||0
2587921|NCT00326716|6351010|P1|NOT COMPLETED|Infants||0
2587922|NCT00326716|6351007|P4|COMPLETED|Infants||20
2587923|NCT00326716|6351008|P3|COMPLETED|Infants||20
2587924|NCT00326716|6351009|P2|COMPLETED|Infants||0
2587925|NCT00326716|6351010|P1|COMPLETED|Infants||0
2587926|NCT00326716|6351007|P4|STARTED|Infants|All infants were followed. One mother withdrew consent pre-delivery and her infant was not followed.|20
2587927|NCT00326716|6351008|P3|STARTED|Infants|All infants were followed.|20
2587928|NCT00326716|6351009|P2|STARTED|Infants||0
2587929|NCT00326716|6351010|P1|STARTED|Infants||0
2587930|NCT00326716|6351007|P4|NOT COMPLETED|Pre-Natal Mothers||0
2587931|NCT00326716|6351008|P3|NOT COMPLETED|Pre-Natal Mothers||0
2587932|NCT00326716|6351009|P2|NOT COMPLETED|Pre-Natal Mothers||2
2587933|NCT00326716|6351010|P1|NOT COMPLETED|Pre-Natal Mothers||1
2587934|NCT00326716|6351007|P4|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
2587935|NCT00326716|6351008|P3|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
2587936|NCT00326716|6351009|P2|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
2587937|NCT00326716|6351010|P1|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
2587938|NCT00326716|6351007|P4|STARTED|Pre-Natal Mothers||0
2587939|NCT00326716|6351008|P3|STARTED|Pre-Natal Mothers||0
2587940|NCT00326716|6351009|P2|STARTED|Pre-Natal Mothers||21
2587941|NCT00326716|6351010|P1|STARTED|Pre-Natal Mothers||20
2587942|NCT00326612|6351082|P2|NOT COMPLETED|Overall Study||137
2587943|NCT00326612|6351083|P1|NOT COMPLETED|Overall Study||129
2587944|NCT00326612|6351082|P2|COMPLETED|Overall Study||42
2587945|NCT00326612|6351083|P1|COMPLETED|Overall Study||50
2587946|NCT00326612|6351082|P2|STARTED|Overall Study||179
2587947|NCT00326612|6351083|P1|STARTED|Overall Study||179
2587948|NCT00326599|6351105|P4|NOT COMPLETED|Overall Study||19
2587949|NCT00326599|6351106|P3|NOT COMPLETED|Overall Study||53
2587950|NCT00326599|6351107|P2|NOT COMPLETED|Overall Study||1
2587951|NCT00326599|6351108|P1|NOT COMPLETED|Overall Study||6
2587952|NCT00326599|6351105|P4|COMPLETED|Overall Study||10
2587953|NCT00326599|6351106|P3|COMPLETED|Overall Study||5
2587954|NCT00326599|6351107|P2|COMPLETED|Overall Study||2
2587955|NCT00326599|6351108|P1|COMPLETED|Overall Study||0
2587956|NCT00326599|6351105|P4|STARTED|Overall Study||29
2587957|NCT00326599|6351106|P3|STARTED|Overall Study||58
2587958|NCT00326599|6351107|P2|STARTED|Overall Study||3
2587959|NCT00326599|6351108|P1|STARTED|Overall Study||6
2587960|NCT00326495|6351127|P1|NOT COMPLETED|Overall Study||5
2587961|NCT00326495|6351127|P1|COMPLETED|Overall Study||46
2587962|NCT00326495|6351127|P1|STARTED|Overall Study||51
2587963|NCT00326417|6351134|P4|NOT COMPLETED|Overall Study||3
2587964|NCT00326417|6351135|P3|NOT COMPLETED|Overall Study||1
2587965|NCT00326417|6351136|P2|NOT COMPLETED|Overall Study||0
2587966|NCT00326417|6351137|P1|NOT COMPLETED|Overall Study||14
2587967|NCT00326417|6351134|P4|COMPLETED|Overall Study|Arm was closed to accrual after 3 patients experienced graft failure.|0
2587968|NCT00326417|6351135|P3|COMPLETED|Overall Study||38
2587969|NCT00326417|6351136|P2|COMPLETED|Overall Study||41
2587970|NCT00326417|6351137|P1|COMPLETED|Overall Study|Dose level was closed for excessive toxicity after 8 patients in Phase II accrued.|0
2587971|NCT00326417|6351134|P4|Phase II|Overall Study||0
2587972|NCT00326417|6351135|P3|Phase II|Overall Study||33
2587973|NCT00326417|6351136|P2|Phase II|Overall Study||35
2587974|NCT00326417|6351137|P1|Phase II|Overall Study||8
2587975|NCT00326417|6351134|P4|Phase I|Overall Study||3
2587976|NCT00326417|6351135|P3|Phase I|Overall Study||6
2587977|NCT00326417|6351136|P2|Phase I|Overall Study||6
2587978|NCT00326417|6351137|P1|Phase I|Overall Study||6
2587979|NCT00326417|6351134|P4|STARTED|Overall Study||3
2587980|NCT00326417|6351135|P3|STARTED|Overall Study||39
2587981|NCT00326417|6351136|P2|STARTED|Overall Study||41
2587982|NCT00326417|6351137|P1|STARTED|Overall Study||14
2587983|NCT00326209|6351153|P1|NOT COMPLETED|Overall Study||282
2587984|NCT00326209|6351153|P1|COMPLETED|Overall Study||111
2587985|NCT00326209|6351153|P1|Safety Population|Overall Study||388
2587986|NCT00326209|6351153|P1|STARTED|Overall Study||393
2587987|NCT00326196|6351162|P2|NOT COMPLETED|Overall Study||0
2587988|NCT00326196|6351163|P1|NOT COMPLETED|Overall Study||0
2587989|NCT00326196|6351162|P2|COMPLETED|Overall Study||97
2587990|NCT00326196|6351163|P1|COMPLETED|Overall Study||101
2587991|NCT00326196|6351162|P2|STARTED|Overall Study||97
2587992|NCT00326196|6351163|P1|STARTED|Overall Study||101
2587993|NCT00326183|6351171|P2|NOT COMPLETED|Overall Study||83
2587994|NCT00326183|6351172|P1|NOT COMPLETED|Overall Study||200
2587995|NCT00326183|6351171|P2|COMPLETED|Overall Study||264
2587996|NCT00326183|6351172|P1|COMPLETED|Overall Study||1253
2587997|NCT00326183|6351171|P2|Postvaccination 2 Post-safety Follow-up|Overall Study||271
2587998|NCT00326183|6351172|P1|Postvaccination 2 Post-safety Follow-up|Overall Study||1265
2587999|NCT00326183|6351171|P2|Vaccination 2 + Safety Follow-up|Overall Study||292
2588000|NCT00326183|6351172|P1|Vaccination 2 + Safety Follow-up|Overall Study||1301
2588001|NCT00326183|6351171|P2|Postvaccination 1 Post-safety Follow-up|Overall Study||325
2588002|NCT00326183|6351172|P1|Postvaccination 1 Post-safety Follow-up|Overall Study||1393
2588003|NCT00326183|6351171|P2|Vaccination 1 + Safety Follow-up|Overall Study||347
2588004|NCT00326183|6351172|P1|Vaccination 1 + Safety Follow-up|Overall Study||1453
2588005|NCT00326183|6351171|P2|STARTED|Overall Study||347
2588006|NCT00326183|6351172|P1|STARTED|Overall Study||1453
2588007|NCT00326170|6351198|P1|NOT COMPLETED|Overall Study||0
2588008|NCT00326170|6351198|P1|COMPLETED|Overall Study||34
2588009|NCT00326170|6351198|P1|STARTED|Overall Study||34
2588010|NCT00326118|6351204|P2|NOT COMPLETED|Year 5 Follow up||0
2588011|NCT00326118|6351205|P1|NOT COMPLETED|Year 5 Follow up||0
2588012|NCT00326118|6351204|P2|COMPLETED|Year 5 Follow up||78
2588013|NCT00326118|6351205|P1|COMPLETED|Year 5 Follow up||217
2588014|NCT00326118|6351204|P2|STARTED|Year 5 Follow up||78
2588015|NCT00326118|6351205|P1|STARTED|Year 5 Follow up||217
2588016|NCT00326118|6351204|P2|NOT COMPLETED|Year 4 Follow-up||0
2588017|NCT00326118|6351205|P1|NOT COMPLETED|Year 4 Follow-up||0
2588018|NCT00326118|6351204|P2|COMPLETED|Year 4 Follow-up||80
2588019|NCT00326118|6351205|P1|COMPLETED|Year 4 Follow-up||228
2588020|NCT00326118|6351204|P2|STARTED|Year 4 Follow-up||80
2588021|NCT00326118|6351205|P1|STARTED|Year 4 Follow-up||228
2588022|NCT00326118|6351204|P2|NOT COMPLETED|Year 3 Follow-up||0
2588023|NCT00326118|6351205|P1|NOT COMPLETED|Year 3 Follow-up||0
2588024|NCT00326118|6351204|P2|COMPLETED|Year 3 Follow-up||89
2588025|NCT00326118|6351205|P1|COMPLETED|Year 3 Follow-up||256
2588026|NCT00326118|6351204|P2|STARTED|Year 3 Follow-up||89
2588027|NCT00326118|6351205|P1|STARTED|Year 3 Follow-up||256
2588028|NCT00326118|6351204|P2|NOT COMPLETED|Year 2 Follow-up||0
2588029|NCT00326118|6351205|P1|NOT COMPLETED|Year 2 Follow-up||0
2588030|NCT00326118|6351204|P2|COMPLETED|Year 2 Follow-up||92
2588031|NCT00326118|6351205|P1|COMPLETED|Year 2 Follow-up||270
2588032|NCT00326118|6351204|P2|STARTED|Year 2 Follow-up||92
2588033|NCT00326118|6351205|P1|STARTED|Year 2 Follow-up||270
2588034|NCT00326118|6351204|P2|NOT COMPLETED|Year 1 Follow-up||0
2588035|NCT00326118|6351205|P1|NOT COMPLETED|Year 1 Follow-up||0
2588036|NCT00326118|6351204|P2|COMPLETED|Year 1 Follow-up||100
2588037|NCT00326118|6351205|P1|COMPLETED|Year 1 Follow-up||295
2588038|NCT00326118|6351204|P2|STARTED|Year 1 Follow-up||100
2588039|NCT00326118|6351205|P1|STARTED|Year 1 Follow-up||295
2588040|NCT00326118|6351204|P2|NOT COMPLETED|Active Phase||1
2588041|NCT00326118|6351205|P1|NOT COMPLETED|Active Phase||4
2588042|NCT00326118|6351204|P2|COMPLETED|Active Phase||108
2588043|NCT00326118|6351205|P1|COMPLETED|Active Phase||320
2588044|NCT00326118|6351204|P2|STARTED|Active Phase||109
2588045|NCT00326118|6351205|P1|STARTED|Active Phase||324
2588046|NCT00326001|6351241|P2|NOT COMPLETED|Overall Study||8
2588047|NCT00326001|6351242|P1|NOT COMPLETED|Overall Study||7
2588048|NCT00326001|6351241|P2|COMPLETED|Overall Study||219
2588049|NCT00326001|6351242|P1|COMPLETED|Overall Study||229
2588050|NCT00326001|6351241|P2|STARTED|Overall Study||227
2588051|NCT00326001|6351242|P1|STARTED|Overall Study||236
2588052|NCT00325897|6351256|P2|NOT COMPLETED|Overall Study||13
2588053|NCT00325897|6351257|P1|NOT COMPLETED|Overall Study||12
2588054|NCT00325897|6351256|P2|COMPLETED|Overall Study||559
2588055|NCT00325897|6351257|P1|COMPLETED|Overall Study||558
2588056|NCT00325897|6351256|P2|STARTED|Overall Study||572
2588057|NCT00325897|6351257|P1|STARTED|Overall Study||570
2588058|NCT00325819|6351277|P2|NOT COMPLETED|Overall Study||13
2588059|NCT00325819|6351278|P1|NOT COMPLETED|Overall Study||9
2588060|NCT00325819|6351277|P2|COMPLETED|Overall Study||176
2588061|NCT00325819|6351278|P1|COMPLETED|Overall Study||176
2588062|NCT00325819|6351277|P2|STARTED|Overall Study||189
2588063|NCT00325819|6351278|P1|STARTED|Overall Study||185
2588064|NCT00325780|6351298|P1|NOT COMPLETED|Overall Study||155
2588065|NCT00325780|6351298|P1|COMPLETED|Overall Study||1200
2588066|NCT00325780|6351298|P1|Safety Population|Overall Study|Patients who received at least one dose of study treatment in this extension study.|1353
2588067|NCT00325780|6351298|P1|STARTED|Overall Study||1355
2588068|NCT00325754|6351305|P2|NOT COMPLETED|Overall Study||1
2588069|NCT00325754|6351306|P1|NOT COMPLETED|Overall Study||4
2588070|NCT00325754|6351305|P2|COMPLETED|Overall Study||10
2588071|NCT00325754|6351306|P1|COMPLETED|Overall Study||7
2588072|NCT00325754|6351305|P2|STARTED|Overall Study||11
2588073|NCT00325754|6351306|P1|STARTED|Overall Study||11
2588074|NCT00325598|6351322|P2|NOT COMPLETED|Overall Study||0
2588075|NCT00325598|6351323|P1|NOT COMPLETED|Overall Study||0
2588076|NCT00325598|6351322|P2|COMPLETED|Overall Study||50
2588077|NCT00325598|6351323|P1|COMPLETED|Overall Study||50
2588078|NCT00325598|6351322|P2|STARTED|Overall Study||50
2588079|NCT00325598|6351323|P1|STARTED|Overall Study||50
2588080|NCT00325572|6351349|P2|NOT COMPLETED|PHASE ii||0
2588081|NCT00325572|6351350|P1|NOT COMPLETED|PHASE ii||0
2588082|NCT00325572|6351349|P2|COMPLETED|PHASE ii||0
2588083|NCT00325572|6351350|P1|COMPLETED|PHASE ii||0
2588084|NCT00325572|6351349|P2|STARTED|PHASE ii||0
2588085|NCT00325572|6351350|P1|STARTED|PHASE ii||0
2588086|NCT00325572|6351349|P2|NOT COMPLETED|PHASE I||0
2588087|NCT00325572|6351350|P1|NOT COMPLETED|PHASE I||0
2588088|NCT00325572|6351349|P2|COMPLETED|PHASE I||44
2588089|NCT00325572|6351350|P1|COMPLETED|PHASE I||45
2588090|NCT00325572|6351349|P2|STARTED|PHASE I||44
2588091|NCT00325572|6351350|P1|STARTED|PHASE I||45
2588092|NCT00325468|6351361|P5|NOT COMPLETED|Overall Study||8
2588093|NCT00325468|6351362|P4|NOT COMPLETED|Overall Study||34
2588094|NCT00325468|6351363|P3|NOT COMPLETED|Overall Study||4
2588095|NCT00325468|6351364|P2|NOT COMPLETED|Overall Study||5
2588096|NCT00325468|6351365|P1|NOT COMPLETED|Overall Study||11
2588097|NCT00325468|6351361|P5|COMPLETED|Overall Study||14
2588098|NCT00325468|6351362|P4|COMPLETED|Overall Study||90
2588099|NCT00325468|6351363|P3|COMPLETED|Overall Study||10
2588100|NCT00325468|6351364|P2|COMPLETED|Overall Study||12
2588101|NCT00325468|6351365|P1|COMPLETED|Overall Study||12
2588102|NCT00325468|6351361|P5|STARTED|Overall Study||22
2588103|NCT00325468|6351362|P4|STARTED|Overall Study||124
2588104|NCT00325468|6351363|P3|STARTED|Overall Study||14
2588105|NCT00325468|6351364|P2|STARTED|Overall Study||17
2588106|NCT00325468|6351365|P1|STARTED|Overall Study||23
2588107|NCT00325442|6351400|P2|NOT COMPLETED|Overall Study||21
2588108|NCT00325442|6351401|P1|NOT COMPLETED|Overall Study||9
2588109|NCT00325442|6351400|P2|COMPLETED|Overall Study||153
2588110|NCT00325442|6351401|P1|COMPLETED|Overall Study||167
2588111|NCT00325442|6351400|P2|STARTED|Overall Study||174
2588112|NCT00325442|6351401|P1|STARTED|Overall Study||176
2588113|NCT00325416|6351448|P2|NOT COMPLETED|Phase II: Treatment at MTD||2
2588114|NCT00325416|6351449|P1|NOT COMPLETED|Phase II: Treatment at MTD||0
2588115|NCT00325416|6351448|P2|COMPLETED|Phase II: Treatment at MTD||40
2588116|NCT00325416|6351449|P1|COMPLETED|Phase II: Treatment at MTD||78
2588117|NCT00325416|6351448|P2|Enrolled During Phase II|Phase II: Treatment at MTD||8
2588118|NCT00325416|6351449|P1|Enrolled During Phase II|Phase II: Treatment at MTD||40
2588119|NCT00325416|6351448|P2|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||34
2588120|NCT00325416|6351449|P1|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||38
2588121|NCT00325416|6351448|P2|STARTED|Phase II: Treatment at MTD||42
2588122|NCT00325416|6351449|P1|STARTED|Phase II: Treatment at MTD||78
2588123|NCT00325416|6351448|P2|NOT COMPLETED|Phase I: Dose Escalation||16
2588124|NCT00325416|6351449|P1|NOT COMPLETED|Phase I: Dose Escalation||22
2588125|NCT00325416|6351448|P2|COMPLETED|Phase I: Dose Escalation||44
2588126|NCT00325416|6351449|P1|COMPLETED|Phase I: Dose Escalation||48
2588127|NCT00325416|6351448|P2|STARTED|Phase I: Dose Escalation||60
2588128|NCT00325416|6351449|P1|STARTED|Phase I: Dose Escalation||70
2588129|NCT00325403|6351463|P2|NOT COMPLETED|Overall Study||51
2588130|NCT00325403|6351464|P1|NOT COMPLETED|Overall Study||18
2588131|NCT00325403|6351463|P2|COMPLETED|Overall Study|182 subjects receiving oral treprostinil completed the study on study drug|182
2588132|NCT00325403|6351464|P1|COMPLETED|Overall Study|98 subjects receiving placebo completed the study on study drug|98
2588133|NCT00325403|6351463|P2|STARTED|Overall Study||233
2588134|NCT00325403|6351464|P1|STARTED|Overall Study||116
2588135|NCT00325234|6351502|P2|NOT COMPLETED|Overall Study||66
2588136|NCT00325234|6351503|P1|NOT COMPLETED|Overall Study||69
2588137|NCT00325234|6351502|P2|COMPLETED|Overall Study||0
2588138|NCT00325234|6351503|P1|COMPLETED|Overall Study||0
2588139|NCT00325234|6351502|P2|Received At Least 1 Dose of Study Drug|Overall Study||66
2588140|NCT00325234|6351503|P1|Received At Least 1 Dose of Study Drug|Overall Study||65
2588141|NCT00325234|6351502|P2|STARTED|Overall Study||66
2588142|NCT00325234|6351503|P1|STARTED|Overall Study||69
2588143|NCT00325195|6351522|P3|NOT COMPLETED|Received Intervention: ITT Population||4
2588144|NCT00325195|6351523|P2|NOT COMPLETED|Received Intervention: ITT Population||25
2588145|NCT00325195|6351524|P1|NOT COMPLETED|Received Intervention: ITT Population||26
2588146|NCT00325195|6351522|P3|COMPLETED|Received Intervention: ITT Population||39
2588147|NCT00325195|6351523|P2|COMPLETED|Received Intervention: ITT Population||59
2588148|NCT00325195|6351524|P1|COMPLETED|Received Intervention: ITT Population||59
2588149|NCT00325195|6351522|P3|STARTED|Received Intervention: ITT Population||43
2588150|NCT00325195|6351523|P2|STARTED|Received Intervention: ITT Population||84
2588151|NCT00325195|6351524|P1|STARTED|Received Intervention: ITT Population||85
2588152|NCT00325195|6351522|P3|NOT COMPLETED|Randomized||3
2588153|NCT00325195|6351523|P2|NOT COMPLETED|Randomized||5
2588154|NCT00325195|6351524|P1|NOT COMPLETED|Randomized||5
2588155|NCT00325195|6351522|P3|COMPLETED|Randomized||43
2588156|NCT00325195|6351523|P2|COMPLETED|Randomized||84
2588157|NCT00325195|6351524|P1|COMPLETED|Randomized||85
2588158|NCT00325195|6351522|P3|STARTED|Randomized||46
2588159|NCT00325195|6351523|P2|STARTED|Randomized||89
2588160|NCT00325195|6351524|P1|STARTED|Randomized||90
2588161|NCT00325156|6351547|P1|NOT COMPLETED|Overall Study||112
2588162|NCT00325156|6351547|P1|COMPLETED|Overall Study||2478
2588163|NCT00325156|6351547|P1|STARTED|Overall Study||2590
2588164|NCT00325143|6351554|P1|NOT COMPLETED|Overall Study||26
2588165|NCT00325143|6351554|P1|COMPLETED|Overall Study||676
2588166|NCT00325143|6351554|P1|STARTED|Overall Study||702
2588167|NCT00325130|6351564|P2|NOT COMPLETED|Overall Study||30
2588168|NCT00325130|6351565|P1|NOT COMPLETED|Overall Study||19
2588169|NCT00325130|6351564|P2|COMPLETED|Overall Study||494
2588170|NCT00325130|6351565|P1|COMPLETED|Overall Study||499
2588171|NCT00325130|6351564|P2|STARTED|Overall Study||524
2588172|NCT00325130|6351565|P1|STARTED|Overall Study||518
2588173|NCT00325078|6351608|P3|NOT COMPLETED|Overall Study||2
2588174|NCT00325078|6351609|P2|NOT COMPLETED|Overall Study||5
2588175|NCT00325078|6351610|P1|NOT COMPLETED|Overall Study||5
2588176|NCT00325078|6351608|P3|COMPLETED|Overall Study||23
2588177|NCT00325078|6351609|P2|COMPLETED|Overall Study||2
2588178|NCT00325078|6351610|P1|COMPLETED|Overall Study||3
2588179|NCT00325078|6351608|P3|STARTED|Overall Study||25
2588180|NCT00325078|6351609|P2|STARTED|Overall Study||7
2588181|NCT00325078|6351610|P1|STARTED|Overall Study||8
2588182|NCT00325039|6351622|P2|NOT COMPLETED|Overall Study||14
2588183|NCT00325039|6351623|P1|NOT COMPLETED|Overall Study||18
2588184|NCT00325039|6351622|P2|COMPLETED|Overall Study||285
2588185|NCT00325039|6351623|P1|COMPLETED|Overall Study||280
2588186|NCT00325039|6351622|P2|STARTED|Overall Study||299
2588187|NCT00325039|6351623|P1|STARTED|Overall Study||298
2588188|NCT00324987|6351639|P2|NOT COMPLETED|Overall Study||6
2588189|NCT00324987|6351640|P1|NOT COMPLETED|Overall Study||6
2588190|NCT00324987|6351639|P2|COMPLETED|Overall Study|Patients were to be treated until progression|0
2588191|NCT00324987|6351640|P1|COMPLETED|Overall Study|Patients were to be treated until progression|0
2588192|NCT00324987|6351639|P2|STARTED|Overall Study||6
2588193|NCT00324987|6351640|P1|STARTED|Overall Study||6
2588194|NCT00324961|6351654|P1|NOT COMPLETED|Overall Study||43
2588195|NCT00324961|6351654|P1|COMPLETED|Overall Study||490
2588196|NCT00324961|6351654|P1|STARTED|Overall Study||533
2588197|NCT00324896|6351669|P2|NOT COMPLETED|Overall Study||8
2588198|NCT00324896|6351670|P1|NOT COMPLETED|Overall Study||3
2588199|NCT00324896|6351669|P2|COMPLETED|Overall Study||7
2588200|NCT00324896|6351670|P1|COMPLETED|Overall Study||12
2588201|NCT00324896|6351669|P2|STARTED|Overall Study||15
2588202|NCT00324896|6351670|P1|STARTED|Overall Study||15
2588203|NCT00324870|6351678|P1|NOT COMPLETED|Overall Study||0
2588204|NCT00324870|6351678|P1|COMPLETED|Overall Study||37
2588205|NCT00324870|6351678|P1|STARTED|Overall Study||37
2588206|NCT00324857|6351686|P4|NOT COMPLETED|Overall Study||5
2588207|NCT00324857|6351687|P3|NOT COMPLETED|Overall Study||7
2588208|NCT00324857|6351688|P2|NOT COMPLETED|Overall Study||6
2588209|NCT00324857|6351689|P1|NOT COMPLETED|Overall Study||6
2588210|NCT00324857|6351686|P4|COMPLETED|Overall Study||158
2588211|NCT00324857|6351687|P3|COMPLETED|Overall Study||158
2588212|NCT00324857|6351688|P2|COMPLETED|Overall Study||162
2588213|NCT00324857|6351689|P1|COMPLETED|Overall Study||161
2588214|NCT00324857|6351686|P4|STARTED|Overall Study||163
2588215|NCT00324857|6351687|P3|STARTED|Overall Study||165
2588216|NCT00324857|6351688|P2|STARTED|Overall Study||168
2588217|NCT00324857|6351689|P1|STARTED|Overall Study||167
2588218|NCT00324805|6351705|P2|NOT COMPLETED|Overall Study||483
2588219|NCT00324805|6351706|P1|NOT COMPLETED|Overall Study||150
2588220|NCT00324805|6351705|P2|COMPLETED|Overall Study||269
2588221|NCT00324805|6351706|P1|COMPLETED|Overall Study||599
2588222|NCT00324805|6351705|P2|Started Assigned Therapy|Overall Study||735
2588223|NCT00324805|6351706|P1|Started Assigned Therapy|Overall Study||737
2588224|NCT00324805|6351705|P2|STARTED|Overall Study||752
2588225|NCT00324805|6351706|P1|STARTED|Overall Study||749
2588226|NCT00324753|6351720|P2|NOT COMPLETED|Overall Study||0
2588227|NCT00324753|6351721|P1|NOT COMPLETED|Overall Study||0
2588228|NCT00324753|6351720|P2|COMPLETED|Overall Study||264
2588229|NCT00324753|6351721|P1|COMPLETED|Overall Study||190
2588230|NCT00324753|6351720|P2|STARTED|Overall Study||264
2588231|NCT00324753|6351721|P1|STARTED|Overall Study||190
2588232|NCT00324740|6351731|P3|NOT COMPLETED|Overall Study||1
2588233|NCT00324740|6351732|P2|NOT COMPLETED|Overall Study||0
2588234|NCT00324740|6351733|P1|NOT COMPLETED|Overall Study||1
2588235|NCT00324740|6351731|P3|COMPLETED|Overall Study||3
2588236|NCT00324740|6351732|P2|COMPLETED|Overall Study||3
2588237|NCT00324740|6351733|P1|COMPLETED|Overall Study||6
2588238|NCT00324740|6351731|P3|STARTED|Overall Study||4
2588239|NCT00324740|6351732|P2|STARTED|Overall Study||3
2588240|NCT00324740|6351733|P1|STARTED|Overall Study||7
2588241|NCT00324701|6351742|P2|NOT COMPLETED|Overall Study||17
2588242|NCT00324701|6351743|P1|NOT COMPLETED|Overall Study||20
2588243|NCT00324701|6351742|P2|COMPLETED|Overall Study||104
2588244|NCT00324701|6351743|P1|COMPLETED|Overall Study||100
2588245|NCT00324701|6351742|P2|Week 8 Assessment|Overall Study||107
2588246|NCT00324701|6351743|P1|Week 8 Assessment|Overall Study||108
2588247|NCT00324701|6351742|P2|STARTED|Overall Study||121
2588248|NCT00324701|6351743|P1|STARTED|Overall Study||120
2588249|NCT00324675|6351753|P2|NOT COMPLETED|Overall Study||0
2588250|NCT00324675|6351754|P1|NOT COMPLETED|Overall Study||1
2588251|NCT00324675|6351753|P2|COMPLETED|Overall Study||14
2588252|NCT00324675|6351754|P1|COMPLETED|Overall Study||13
2588253|NCT00324675|6351753|P2|STARTED|Overall Study||14
2588254|NCT00324675|6351754|P1|STARTED|Overall Study||14
2588255|NCT00324649|6351762|P2|NOT COMPLETED|Overall Study||5
2588256|NCT00324649|6351763|P1|NOT COMPLETED|Overall Study||2
2588257|NCT00324649|6351762|P2|COMPLETED|Overall Study||36
2588258|NCT00324649|6351763|P1|COMPLETED|Overall Study||37
2588259|NCT00324649|6351762|P2|STARTED|Overall Study||41
2588260|NCT00324649|6351763|P1|STARTED|Overall Study||39
2588261|NCT00324415|6351803|P1|NOT COMPLETED|Overall Study||0
2588262|NCT00324415|6351803|P1|COMPLETED|Overall Study||45
2588263|NCT00324415|6351803|P1|STARTED|Overall Study||45
2588264|NCT00324350|6351818|P2|NOT COMPLETED|Overall Study||0
2588265|NCT00324350|6351819|P1|NOT COMPLETED|Overall Study||0
2588266|NCT00324350|6351818|P2|COMPLETED|Overall Study||3632
2588267|NCT00324350|6351819|P1|COMPLETED|Overall Study||3655
2588268|NCT00324350|6351818|P2|Falls Follow-Up|Overall Study||3418
2588269|NCT00324350|6351819|P1|Falls Follow-Up|Overall Study||3364
2588270|NCT00324350|6351818|P2|Non-Vertebral Fracture Follow-Up|Overall Study||3632
2588271|NCT00324350|6351819|P1|Non-Vertebral Fracture Follow-Up|Overall Study||3655
2588272|NCT00324350|6351818|P2|STARTED|Overall Study||3632
2588273|NCT00324350|6351819|P1|STARTED|Overall Study||3655
2588274|NCT00324272|6351833|P4|NOT COMPLETED|Overall Study||0
2588275|NCT00324272|6351834|P3|NOT COMPLETED|Overall Study||0
2588276|NCT00324272|6351835|P2|NOT COMPLETED|Overall Study||0
2588277|NCT00324272|6351836|P1|NOT COMPLETED|Overall Study||0
2588278|NCT00324272|6351833|P4|COMPLETED|Overall Study||18
2588279|NCT00324272|6351834|P3|COMPLETED|Overall Study||18
2588280|NCT00324272|6351835|P2|COMPLETED|Overall Study||20
2588281|NCT00324272|6351836|P1|COMPLETED|Overall Study||18
2588282|NCT00324272|6351833|P4|STARTED|Overall Study||18
2588283|NCT00324272|6351834|P3|STARTED|Overall Study||18
2588284|NCT00324272|6351835|P2|STARTED|Overall Study||20
2588285|NCT00324272|6351836|P1|STARTED|Overall Study||18
2588286|NCT00324259|6351872|P2|NOT COMPLETED|Overall Study||0
2588287|NCT00324259|6351873|P1|NOT COMPLETED|Overall Study||0
2588288|NCT00324259|6351872|P2|COMPLETED|Overall Study||32
2588289|NCT00324259|6351873|P1|COMPLETED|Overall Study||34
2588290|NCT00324259|6351872|P2|STARTED|Overall Study||32
2588291|NCT00324259|6351873|P1|STARTED|Overall Study||34
2588292|NCT00324233|6351894|P2|NOT COMPLETED|Second Period||7
2588293|NCT00324233|6351895|P1|NOT COMPLETED|Second Period||5
2588294|NCT00324233|6351894|P2|COMPLETED|Second Period||11
2588295|NCT00324233|6351895|P1|COMPLETED|Second Period||12
2588296|NCT00324233|6351894|P2|STARTED|Second Period||18
2588297|NCT00324233|6351895|P1|STARTED|Second Period||17
2588298|NCT00324233|6351894|P2|NOT COMPLETED|First Period||0
2588299|NCT00324233|6351895|P1|NOT COMPLETED|First Period||1
2588300|NCT00324233|6351894|P2|COMPLETED|First Period||18
2588301|NCT00324233|6351895|P1|COMPLETED|First Period||17
2588302|NCT00324233|6351894|P2|STARTED|First Period||18
2588303|NCT00324233|6351895|P1|STARTED|First Period||18
2588304|NCT00324168|6351903|P2|NOT COMPLETED|Overall Study||30
2588305|NCT00324168|6351904|P1|NOT COMPLETED|Overall Study||28
2588306|NCT00324168|6351903|P2|COMPLETED|Overall Study||220
2588307|NCT00324168|6351904|P1|COMPLETED|Overall Study||222
2588308|NCT00324168|6351903|P2|STARTED|Overall Study||250
2588309|NCT00324168|6351904|P1|STARTED|Overall Study||250
2588310|NCT00324155|6351932|P2|NOT COMPLETED|Follow-up Phase||6
2588311|NCT00324155|6351933|P1|NOT COMPLETED|Follow-up Phase||11
2588312|NCT00324155|6351932|P2|COMPLETED|Follow-up Phase||245
2588313|NCT00324155|6351933|P1|COMPLETED|Follow-up Phase||236
2588314|NCT00324155|6351932|P2|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|251
2588315|NCT00324155|6351933|P1|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|247
2588316|NCT00324155|6351932|P2|NOT COMPLETED|Received Treatment in Maintenance Phase||47
2588317|NCT00324155|6351933|P1|NOT COMPLETED|Received Treatment in Maintenance Phase||32
2588318|NCT00324155|6351932|P2|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure. 6 participants in Maintenance Phase not yet summarized.|6
2588319|NCT00324155|6351933|P1|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure at this time. 11 in Maintenance Phase not yet summarized.|11
2588320|NCT00324155|6351932|P2|STARTED|Received Treatment in Maintenance Phase|1 completed Induction Phase but did not enter Maintenance Phase|53
2588321|NCT00324155|6351933|P1|STARTED|Received Treatment in Maintenance Phase|2 completed Induction Phase but did not enter Maintenance Phase|43
2588322|NCT00324155|6351932|P2|NOT COMPLETED|Received Treatment in Induction Phase||197
2588323|NCT00324155|6351933|P1|NOT COMPLETED|Received Treatment in Induction Phase||202
2588324|NCT00324155|6351932|P2|COMPLETED|Received Treatment in Induction Phase|54 participants on treatment at end of Induction Phase. Study undergoing closure.|54
2588325|NCT00324155|6351933|P1|COMPLETED|Received Treatment in Induction Phase|45 participants on treatment at end of Induction Phase. Study undergoing closure.|45
2588326|NCT00324155|6351932|P2|STARTED|Received Treatment in Induction Phase||251
2588327|NCT00324155|6351933|P1|STARTED|Received Treatment in Induction Phase||247
2588328|NCT00324155|6351932|P2|NOT COMPLETED|Enrolled and Randomized||1
2588329|NCT00324155|6351933|P1|NOT COMPLETED|Enrolled and Randomized||3
2588330|NCT00324155|6351932|P2|COMPLETED|Enrolled and Randomized|1 randomized but who did not receive treatment (lost to follow-up).|251
2588331|NCT00324155|6351933|P1|COMPLETED|Enrolled and Randomized|3 randomized but who did not receive treatment (no longer met study criteria).|247
2588332|NCT00324155|6351932|P2|STARTED|Enrolled and Randomized||252
2588333|NCT00324155|6351933|P1|STARTED|Enrolled and Randomized||250
2588334|NCT00324116|6351963|P1|NOT COMPLETED|Overall Study||32
2588335|NCT00324116|6351963|P1|COMPLETED|Overall Study||49
2588336|NCT00324116|6351963|P1|STARTED|Overall Study|subjects received treatment|81
2588337|NCT00324038|6351975|P2|NOT COMPLETED|Overall Study||51
2588338|NCT00324038|6351976|P1|NOT COMPLETED|Overall Study||49
2588339|NCT00324038|6351975|P2|COMPLETED|Overall Study||58
2588340|NCT00324038|6351976|P1|COMPLETED|Overall Study||61
2588341|NCT00324038|6351975|P2|STARTED|Overall Study||109
2588342|NCT00324038|6351976|P1|STARTED|Overall Study||110
2588343|NCT00323882|6351987|P5|NOT COMPLETED|Overall Study||32
2588344|NCT00323882|6351988|P4|NOT COMPLETED|Overall Study||7
2588345|NCT00323882|6351989|P3|NOT COMPLETED|Overall Study||13
2588346|NCT00323882|6351990|P2|NOT COMPLETED|Overall Study||6
2588347|NCT00323882|6351991|P1|NOT COMPLETED|Overall Study||8
2588348|NCT00323882|6351987|P5|COMPLETED|Overall Study||2
2588349|NCT00323882|6351988|P4|COMPLETED|Overall Study||0
2588350|NCT00323882|6351989|P3|COMPLETED|Overall Study||3
2588351|NCT00323882|6351990|P2|COMPLETED|Overall Study||0
2588352|NCT00323882|6351991|P1|COMPLETED|Overall Study||0
2588353|NCT00323882|6351987|P5|STARTED|Overall Study||34
2588354|NCT00323882|6351988|P4|STARTED|Overall Study||7
2588355|NCT00323882|6351989|P3|STARTED|Overall Study||16
2588356|NCT00323882|6351990|P2|STARTED|Overall Study||6
2588357|NCT00323882|6351991|P1|STARTED|Overall Study||8
2588358|NCT00323869|6352062|P1|NOT COMPLETED|Overall Study||1
2588359|NCT00323869|6352062|P1|COMPLETED|Overall Study||47
2588360|NCT00323869|6352062|P1|Treatment Initiation|Overall Study|One participant died before receiving therapy, not included in analysis|47
2588361|NCT00323869|6352062|P1|STARTED|Overall Study|Enrollment|48
2588362|NCT00323739|6352074|P1|NOT COMPLETED|Overall Study||0
2588363|NCT00323739|6352074|P1|COMPLETED|Overall Study||80
2588364|NCT00323739|6352074|P1|STARTED|Overall Study||80
2588365|NCT00323635|6352081|P2|NOT COMPLETED|Overall Study||0
2588366|NCT00323635|6352082|P1|NOT COMPLETED|Overall Study||0
2588367|NCT00323635|6352081|P2|COMPLETED|Overall Study||9
2588368|NCT00323635|6352082|P1|COMPLETED|Overall Study||10
2588369|NCT00323635|6352081|P2|STARTED|Overall Study||9
2588370|NCT00323635|6352082|P1|STARTED|Overall Study||10
2588371|NCT00323622|6352118|P8|NOT COMPLETED|Overall Study||15
2588372|NCT00323622|6352119|P7|NOT COMPLETED|Overall Study||5
2588373|NCT00323622|6352120|P6|NOT COMPLETED|Overall Study||74
2588374|NCT00323622|6352121|P5|NOT COMPLETED|Overall Study||39
2588375|NCT00323622|6352122|P4|NOT COMPLETED|Overall Study||12
2588376|NCT00323622|6352123|P3|NOT COMPLETED|Overall Study||4
2588377|NCT00323622|6352124|P2|NOT COMPLETED|Overall Study||92
2588378|NCT00323622|6352125|P1|NOT COMPLETED|Overall Study||31
2588379|NCT00323622|6352118|P8|COMPLETED|Overall Study||125
2588380|NCT00323622|6352119|P7|COMPLETED|Overall Study||38
2588381|NCT00323622|6352120|P6|COMPLETED|Overall Study||454
2588382|NCT00323622|6352121|P5|COMPLETED|Overall Study||120
2588383|NCT00323622|6352122|P4|COMPLETED|Overall Study||122
2588384|NCT00323622|6352123|P3|COMPLETED|Overall Study||38
2588385|NCT00323622|6352124|P2|COMPLETED|Overall Study||423
2588386|NCT00323622|6352125|P1|COMPLETED|Overall Study||145
2588387|NCT00323622|6352118|P8|STARTED|Overall Study||140
2588388|NCT00323622|6352119|P7|STARTED|Overall Study||43
2588389|NCT00323622|6352120|P6|STARTED|Overall Study||528
2588390|NCT00323622|6352121|P5|STARTED|Overall Study||159
2588391|NCT00323622|6352122|P4|STARTED|Overall Study||134
2588392|NCT00323622|6352123|P3|STARTED|Overall Study||42
2588393|NCT00323622|6352124|P2|STARTED|Overall Study||515
2588394|NCT00323622|6352125|P1|STARTED|Overall Study||176
2588395|NCT00323609|6352167|P4|NOT COMPLETED|Overall Study||15
2588396|NCT00323609|6352168|P3|NOT COMPLETED|Overall Study||8
2588397|NCT00323609|6352169|P2|NOT COMPLETED|Overall Study||99
2588398|NCT00323609|6352170|P1|NOT COMPLETED|Overall Study||91
2588399|NCT00323609|6352167|P4|COMPLETED|Overall Study||0
2588400|NCT00323609|6352168|P3|COMPLETED|Overall Study||0
2588401|NCT00323609|6352169|P2|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|91
2588402|NCT00323609|6352170|P1|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|100
2588403|NCT00323609|6352167|P4|STARTED|Overall Study||15
2588404|NCT00323609|6352168|P3|STARTED|Overall Study||8
2588405|NCT00323609|6352169|P2|STARTED|Overall Study||190
2588406|NCT00323609|6352170|P1|STARTED|Overall Study||191
2588407|NCT00323557|6352206|P2|NOT COMPLETED|Overall Study||0
2588408|NCT00323557|6352207|P1|NOT COMPLETED|Overall Study||1
2588409|NCT00323557|6352206|P2|COMPLETED|Overall Study||7
2588410|NCT00323557|6352207|P1|COMPLETED|Overall Study||24
2588411|NCT00323557|6352206|P2|STARTED|Overall Study||7
2588412|NCT00323557|6352207|P1|STARTED|Overall Study|GM-CSF pre and post vaccine.|25
2588413|NCT00323492|6352216|P3|NOT COMPLETED|Study Phase 2||1
2588414|NCT00323492|6352217|P2|NOT COMPLETED|Study Phase 2||1
2588415|NCT00323492|6352218|P1|NOT COMPLETED|Study Phase 2||4
2588416|NCT00323492|6352216|P3|COMPLETED|Study Phase 2||24
2588417|NCT00323492|6352217|P2|COMPLETED|Study Phase 2||17
2588418|NCT00323492|6352218|P1|COMPLETED|Study Phase 2||40
2588419|NCT00323492|6352216|P3|STARTED|Study Phase 2|N=25 switched to Truvada in Phase 2.|25
2588420|NCT00323492|6352217|P2|STARTED|Study Phase 2|2/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=20 (no switch to Truvada)|18
2588421|NCT00323492|6352218|P1|STARTED|Study Phase 2|1/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=46|44
2588422|NCT00323492|6352216|P3|NOT COMPLETED|Study Phase 1||0
2588423|NCT00323492|6352217|P2|NOT COMPLETED|Study Phase 1||0
2588424|NCT00323492|6352218|P1|NOT COMPLETED|Study Phase 1||2
2588425|NCT00323492|6352216|P3|COMPLETED|Study Phase 1||0
2588426|NCT00323492|6352217|P2|COMPLETED|Study Phase 1||45
2588427|NCT00323492|6352218|P1|COMPLETED|Study Phase 1||45
2588428|NCT00323492|6352216|P3|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||0
2588429|NCT00323492|6352217|P2|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||45
2588430|NCT00323492|6352218|P1|Intent-to-Treat (ITT) Analysis Set|Study Phase 1|One subject was excluded from ITT analysis set due to protocol violation.|46
2588431|NCT00323492|6352216|P3|STARTED|Study Phase 1|Not applicable to Phase 1.|0
2588432|NCT00323492|6352217|P2|STARTED|Study Phase 1||45
2588433|NCT00323492|6352218|P1|STARTED|Study Phase 1||47
2588434|NCT00323479|6352249|P1|NOT COMPLETED|Overall Study||8
2588435|NCT00323479|6352249|P1|COMPLETED|Overall Study|with at least 1 evaluation for primary efficacy endpoint|106
2588436|NCT00323479|6352249|P1|Safety Population|Overall Study|Patients who taken at least one dose of treatment|110
2588437|NCT00323479|6352249|P1|STARTED|Overall Study||114
2588438|NCT00323453|6352260|P2|NOT COMPLETED|Overall Study||0
2588439|NCT00323453|6352261|P1|NOT COMPLETED|Overall Study||0
2588440|NCT00323453|6352260|P2|COMPLETED|Overall Study||48
2588441|NCT00323453|6352261|P1|COMPLETED|Overall Study||61
2588442|NCT00323453|6352260|P2|STARTED|Overall Study||48
2588443|NCT00323453|6352261|P1|STARTED|Overall Study||61
2588444|NCT00323427|6352269|P2|NOT COMPLETED|Overall Study||23
2588445|NCT00323427|6352270|P1|NOT COMPLETED|Overall Study||31
2588446|NCT00323427|6352269|P2|COMPLETED|Overall Study||43
2588447|NCT00323427|6352270|P1|COMPLETED|Overall Study||38
2588448|NCT00323427|6352269|P2|STARTED|Overall Study||66
2588449|NCT00323427|6352270|P1|STARTED|Overall Study||69
2588450|NCT00323414|6352282|P2|NOT COMPLETED|Overall Study||1
2588451|NCT00323414|6352283|P1|NOT COMPLETED|Overall Study||0
2588452|NCT00323414|6352282|P2|COMPLETED|Overall Study||18
2588453|NCT00323414|6352283|P1|COMPLETED|Overall Study||18
2588454|NCT00323414|6352282|P2|STARTED|Overall Study||19
2588455|NCT00323414|6352283|P1|STARTED|Overall Study||18
2588456|NCT00323362|6352299|P1|NOT COMPLETED|Overall Study||0
2588457|NCT00323362|6352299|P1|COMPLETED|Overall Study||17
2588458|NCT00323362|6352299|P1|STARTED|Overall Study||17
2588459|NCT00323310|6352305|P1|NOT COMPLETED|Overall Study||3
2588460|NCT00323310|6352305|P1|COMPLETED|Overall Study||89
2588461|NCT00323310|6352305|P1|STARTED|Overall Study||92
2588462|NCT00323297|6352320|P2|NOT COMPLETED|Part B (Open-label)||12
2588463|NCT00323297|6352321|P1|NOT COMPLETED|Part B (Open-label)||9
2588464|NCT00323297|6352320|P2|COMPLETED|Part B (Open-label)||31
2588465|NCT00323297|6352321|P1|COMPLETED|Part B (Open-label)||39
2588466|NCT00323297|6352320|P2|STARTED|Part B (Open-label)||43
2588467|NCT00323297|6352321|P1|STARTED|Part B (Open-label)||48
2588468|NCT00323297|6352320|P2|NOT COMPLETED|Part A (Double Blind Randomized)||7
2588469|NCT00323297|6352321|P1|NOT COMPLETED|Part A (Double Blind Randomized)||5
2588470|NCT00323297|6352320|P2|COMPLETED|Part A (Double Blind Randomized)||43
2588471|NCT00323297|6352321|P1|COMPLETED|Part A (Double Blind Randomized)||48
2588472|NCT00323297|6352320|P2|STARTED|Part A (Double Blind Randomized)||50
2588473|NCT00323297|6352321|P1|STARTED|Part A (Double Blind Randomized)||53
2588474|NCT00323284|6352339|P2|NOT COMPLETED|24 Months Follow-up||22
2588475|NCT00323284|6352340|P1|NOT COMPLETED|24 Months Follow-up||18
2588476|NCT00323284|6352339|P2|COMPLETED|24 Months Follow-up||101
2588477|NCT00323284|6352340|P1|COMPLETED|24 Months Follow-up||98
2588478|NCT00323284|6352339|P2|STARTED|24 Months Follow-up||123
2588479|NCT00323284|6352340|P1|STARTED|24 Months Follow-up||116
2588480|NCT00323284|6352339|P2|NOT COMPLETED|12 Months Follow-up||9
2588481|NCT00323284|6352340|P1|NOT COMPLETED|12 Months Follow-up||5
2588482|NCT00323284|6352339|P2|COMPLETED|12 Months Follow-up||114
2588483|NCT00323284|6352340|P1|COMPLETED|12 Months Follow-up||111
2588484|NCT00323284|6352339|P2|STARTED|12 Months Follow-up||123
2588485|NCT00323284|6352340|P1|STARTED|12 Months Follow-up||116
2588486|NCT00323271|6352350|P2|NOT COMPLETED|Overall Study||3
2588487|NCT00323271|6352351|P1|NOT COMPLETED|Overall Study||2
2588488|NCT00323271|6352350|P2|COMPLETED|Overall Study||9
2588489|NCT00323271|6352351|P1|COMPLETED|Overall Study||11
2588490|NCT00323271|6352350|P2|STARTED|Overall Study||12
2588491|NCT00323271|6352351|P1|STARTED|Overall Study||13
2588492|NCT00323258|6352361|P2|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
2588493|NCT00323258|6352362|P1|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
2588494|NCT00323258|6352361|P2|COMPLETED|Secondary Outcome (6 Mon Refill Records)||58
2588495|NCT00323258|6352362|P1|COMPLETED|Secondary Outcome (6 Mon Refill Records)||57
2588496|NCT00323258|6352361|P2|STARTED|Secondary Outcome (6 Mon Refill Records)||72
2588497|NCT00323258|6352362|P1|STARTED|Secondary Outcome (6 Mon Refill Records)||71
2588498|NCT00323258|6352361|P2|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||19
2588499|NCT00323258|6352362|P1|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||16
2588500|NCT00323258|6352361|P2|COMPLETED|Primary Outcome (Phone Call at 6 Months)||53
2588501|NCT00323258|6352362|P1|COMPLETED|Primary Outcome (Phone Call at 6 Months)||55
2588502|NCT00323258|6352361|P2|STARTED|Primary Outcome (Phone Call at 6 Months)||72
2588503|NCT00323258|6352362|P1|STARTED|Primary Outcome (Phone Call at 6 Months)||71
2588504|NCT00323193|6352378|P2|NOT COMPLETED|Overall Study||15
2588505|NCT00323193|6352379|P1|NOT COMPLETED|Overall Study||23
2588506|NCT00323193|6352378|P2|COMPLETED|Overall Study||41
2588507|NCT00323193|6352379|P1|COMPLETED|Overall Study||30
2588508|NCT00323193|6352378|P2|STARTED|Overall Study||56
2588509|NCT00323193|6352379|P1|STARTED|Overall Study||53
2588510|NCT00323115|6352387|P1|NOT COMPLETED|Adjuvant Therapy & Survival Follow-Up||8
2588511|NCT00323115|6352387|P1|COMPLETED|Adjuvant Therapy & Survival Follow-Up||2
2588512|NCT00323115|6352387|P1|STARTED|Adjuvant Therapy & Survival Follow-Up||10
2588513|NCT00323115|6352387|P1|NOT COMPLETED|Vaccine Administration||1
2588514|NCT00323115|6352387|P1|COMPLETED|Vaccine Administration||10
2588515|NCT00323115|6352387|P1|STARTED|Vaccine Administration||11
2588516|NCT00323063|6352414|P2|NOT COMPLETED|Overall Study||0
2588517|NCT00323063|6352415|P1|NOT COMPLETED|Overall Study||2
2588518|NCT00323063|6352414|P2|COMPLETED|Overall Study||23
2588519|NCT00323063|6352415|P1|COMPLETED|Overall Study||24
2588520|NCT00323063|6352414|P2|STARTED|Overall Study||23
2588521|NCT00323063|6352415|P1|STARTED|Overall Study||26
2588522|NCT00323037|6352427|P2|NOT COMPLETED|Overall Study||27
2588523|NCT00323037|6352428|P1|NOT COMPLETED|Overall Study||33
2588524|NCT00323037|6352427|P2|COMPLETED|Overall Study||126
2588525|NCT00323037|6352428|P1|COMPLETED|Overall Study||132
2588526|NCT00323037|6352427|P2|STARTED|Overall Study|Number randomized|153
2588527|NCT00323037|6352428|P1|STARTED|Overall Study|Number randomized|165
2588528|NCT00322881|6352432|P1|NOT COMPLETED|Overall Study||5
2588529|NCT00322881|6352432|P1|COMPLETED|Overall Study||7
2588530|NCT00322881|6352432|P1|STARTED|Overall Study||12
2588531|NCT00322868|6352436|P1|NOT COMPLETED|Overall Study||1
2588532|NCT00322868|6352436|P1|COMPLETED|Overall Study||20
2588533|NCT00322868|6352436|P1|STARTED|Overall Study||21
2588534|NCT00322855|6352455|P1|NOT COMPLETED|Overall Study||0
2588535|NCT00322855|6352455|P1|COMPLETED|Overall Study||1
2588536|NCT00322855|6352455|P1|STARTED|Overall Study||1
2588537|NCT00322842|6352461|P2|NOT COMPLETED|Overall Study||2
2588538|NCT00322842|6352462|P1|NOT COMPLETED|Overall Study||2
2588539|NCT00322842|6352461|P2|COMPLETED|Overall Study|One participant d/c treatment early, received a transplant, and was lost to follow-up after 6 months|29
2588540|NCT00322842|6352462|P1|COMPLETED|Overall Study|One participant discontinued (d/c) treatment early, received a transplant, and completed the study.|2
2588541|NCT00322842|6352461|P2|STARTED|Overall Study||31
2588542|NCT00322842|6352462|P1|STARTED|Overall Study||4
2588543|NCT00322777|6352489|P2|NOT COMPLETED|Overall Study||0
2588544|NCT00322777|6352490|P1|NOT COMPLETED|Overall Study||0
2588545|NCT00322777|6352489|P2|COMPLETED|Overall Study||45
2588546|NCT00322777|6352490|P1|COMPLETED|Overall Study||39
2588547|NCT00322777|6352489|P2|Data Collection at Week 24|Overall Study||45
2588548|NCT00322777|6352490|P1|Data Collection at Week 24|Overall Study||39
2588549|NCT00322777|6352489|P2|Data Collection at Week 16|Overall Study||45
2588550|NCT00322777|6352490|P1|Data Collection at Week 16|Overall Study||39
2588551|NCT00322777|6352489|P2|Data Collection at Week 8|Overall Study||45
2588552|NCT00322777|6352490|P1|Data Collection at Week 8|Overall Study||39
2588553|NCT00322777|6352489|P2|"Data Collection at BASELINE|"|Overall Study||45
2588554|NCT00322777|6352490|P1|"Data Collection at BASELINE|"|Overall Study||39
2588555|NCT00322777|6352489|P2|STARTED|Overall Study||45
2588556|NCT00322777|6352490|P1|STARTED|Overall Study||39
2588557|NCT00322712|6352500|P1|NOT COMPLETED|Overall Study||1
2588558|NCT00322712|6352500|P1|COMPLETED|Overall Study||11
2588559|NCT00322712|6352500|P1|STARTED|Overall Study||12
2588560|NCT00322621|6352504|P3|NOT COMPLETED|Period III - Maintenance / Rescue Phase||36
2588561|NCT00322621|6352505|P2|NOT COMPLETED|Period III - Maintenance / Rescue Phase||29
2588562|NCT00322621|6352506|P1|NOT COMPLETED|Period III - Maintenance / Rescue Phase||0
2588563|NCT00322621|6352504|P3|COMPLETED|Period III - Maintenance / Rescue Phase||33
2588564|NCT00322621|6352505|P2|COMPLETED|Period III - Maintenance / Rescue Phase||86
2588565|NCT00322621|6352506|P1|COMPLETED|Period III - Maintenance / Rescue Phase||0
2588566|NCT00322621|6352504|P3|STARTED|Period III - Maintenance / Rescue Phase||69
2588567|NCT00322621|6352505|P2|STARTED|Period III - Maintenance / Rescue Phase||115
2588568|NCT00322621|6352506|P1|STARTED|Period III - Maintenance / Rescue Phase||0
2588569|NCT00322621|6352504|P3|NOT COMPLETED|Period II - Acute Therapy Phase||0
2588570|NCT00322621|6352505|P2|NOT COMPLETED|Period II - Acute Therapy Phase||0
2588571|NCT00322621|6352506|P1|NOT COMPLETED|Period II - Acute Therapy Phase||32
2588572|NCT00322621|6352504|P3|COMPLETED|Period II - Acute Therapy Phase||0
2588573|NCT00322621|6352505|P2|COMPLETED|Period II - Acute Therapy Phase||0
2588574|NCT00322621|6352506|P1|COMPLETED|Period II - Acute Therapy Phase||184
2588575|NCT00322621|6352504|P3|STARTED|Period II - Acute Therapy Phase||0
2588576|NCT00322621|6352505|P2|STARTED|Period II - Acute Therapy Phase||0
2588577|NCT00322621|6352506|P1|STARTED|Period II - Acute Therapy Phase||216
2588578|NCT00322556|6352558|P1|NOT COMPLETED|Overall Study||12
2588579|NCT00322556|6352558|P1|COMPLETED|Overall Study||43
2588580|NCT00322556|6352558|P1|STARTED|Overall Study||55
2588581|NCT00322491|6352574|P2|NOT COMPLETED|Overall Study||2
2588582|NCT00322491|6352575|P1|NOT COMPLETED|Overall Study||2
2588583|NCT00322491|6352574|P2|COMPLETED|Overall Study||24
2588584|NCT00322491|6352575|P1|COMPLETED|Overall Study||21
2588585|NCT00322491|6352574|P2|STARTED|Overall Study||26
2588586|NCT00322491|6352575|P1|STARTED|Overall Study||23
2588587|NCT00322465|6352601|P4|NOT COMPLETED|Overall Study||26
2588588|NCT00322465|6352602|P3|NOT COMPLETED|Overall Study||26
2588589|NCT00322465|6352603|P2|NOT COMPLETED|Overall Study||24
2588590|NCT00322465|6352604|P1|NOT COMPLETED|Overall Study||20
2588591|NCT00322465|6352601|P4|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|53
2588592|NCT00322465|6352602|P3|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|51
2588593|NCT00322465|6352603|P2|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|49
2588594|NCT00322465|6352604|P1|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|56
2588595|NCT00322465|6352601|P4|STARTED|Overall Study|Randomized|79
2588596|NCT00322465|6352602|P3|STARTED|Overall Study|Randomized|77
2588597|NCT00322465|6352603|P2|STARTED|Overall Study|Randomized|73
2588598|NCT00322465|6352604|P1|STARTED|Overall Study|Randomized|76
2588599|NCT00322452|6352665|P2|NOT COMPLETED|Overall Study||276
2588600|NCT00322452|6352666|P1|NOT COMPLETED|Overall Study||247
2588601|NCT00322452|6352665|P2|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 84 remained at OS DCO (14 June 2010)|332
2588602|NCT00322452|6352666|P1|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 97 remained at OS DCO (14 June 2010)|362
2588603|NCT00322452|6352665|P2|STARTED|Overall Study|Number of patients randomized|608
2588604|NCT00322452|6352666|P1|STARTED|Overall Study|Number of patients randomized|609
2588605|NCT00322439|6352702|P1|NOT COMPLETED|Overall Study||1056
2588606|NCT00322439|6352702|P1|COMPLETED|Overall Study||1455
2588607|NCT00322439|6352702|P1|Received at Least 1 Dose of Etanercept|Overall Study||2510
2588608|NCT00322439|6352702|P1|STARTED|Overall Study||2511
2588609|NCT00322387|6352717|P2|NOT COMPLETED|Follow-up Period||3
2588610|NCT00322387|6352718|P1|NOT COMPLETED|Follow-up Period||2
2588611|NCT00322387|6352717|P2|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|23
2588612|NCT00322387|6352718|P1|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|12
2588613|NCT00322387|6352717|P2|STARTED|Follow-up Period|Participants who had transplants. One participant did not complete therapy but had a transplant.|26
2588614|NCT00322387|6352718|P1|STARTED|Follow-up Period|Participants who had transplants|14
2588615|NCT00322387|6352717|P2|NOT COMPLETED|Treatment Period||1
2588616|NCT00322387|6352718|P1|NOT COMPLETED|Treatment Period||0
2588617|NCT00322387|6352717|P2|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|25
2588618|NCT00322387|6352718|P1|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|14
2588619|NCT00322387|6352717|P2|STARTED|Treatment Period|Plerixafor PM=12, Plerixafor AM=9, Low CD34+ Count/Plerixafor PM=1, and Plerixafor After Chemo=4|26
2588620|NCT00322387|6352718|P1|STARTED|Treatment Period|Plerixafor PM=7, Plerixafor AM=6, Low CD34+ Count/Plerixafor PM=0, and Plerixafor After Chemo=1|14
2588621|NCT00322374|6352752|P4|NOT COMPLETED|Second Escalation||0
2588622|NCT00322374|6352753|P3|NOT COMPLETED|Second Escalation||6
2588623|NCT00322374|6352754|P2|NOT COMPLETED|Second Escalation||0
2588624|NCT00322374|6352755|P1|NOT COMPLETED|Second Escalation||0
2588625|NCT00322374|6352752|P4|COMPLETED|Second Escalation||0
2588626|NCT00322374|6352753|P3|COMPLETED|Second Escalation||0
2588627|NCT00322374|6352754|P2|COMPLETED|Second Escalation||0
2588628|NCT00322374|6352755|P1|COMPLETED|Second Escalation||0
2588629|NCT00322374|6352752|P4|STARTED|Second Escalation||0
2588630|NCT00322374|6352753|P3|STARTED|Second Escalation||6
2588631|NCT00322374|6352754|P2|STARTED|Second Escalation||0
2588632|NCT00322374|6352755|P1|STARTED|Second Escalation||0
2588633|NCT00322374|6352752|P4|NOT COMPLETED|First Escalation||0
2588634|NCT00322374|6352753|P3|NOT COMPLETED|First Escalation||0
2588635|NCT00322374|6352754|P2|NOT COMPLETED|First Escalation||30
2588636|NCT00322374|6352755|P1|NOT COMPLETED|First Escalation||0
2588637|NCT00322374|6352752|P4|COMPLETED|First Escalation||0
2588638|NCT00322374|6352753|P3|COMPLETED|First Escalation||0
2588639|NCT00322374|6352754|P2|COMPLETED|First Escalation||0
2588640|NCT00322374|6352755|P1|COMPLETED|First Escalation||0
2588641|NCT00322374|6352752|P4|STARTED|First Escalation||0
2588642|NCT00322374|6352753|P3|STARTED|First Escalation||0
2588643|NCT00322374|6352754|P2|STARTED|First Escalation||30
2588644|NCT00322374|6352755|P1|STARTED|First Escalation||0
2588645|NCT00322374|6352752|P4|NOT COMPLETED|Starting Dose||0
2588646|NCT00322374|6352753|P3|NOT COMPLETED|Starting Dose||0
2588647|NCT00322374|6352754|P2|NOT COMPLETED|Starting Dose||0
2588648|NCT00322374|6352755|P1|NOT COMPLETED|Starting Dose||6
2588649|NCT00322374|6352752|P4|COMPLETED|Starting Dose||0
2588650|NCT00322374|6352753|P3|COMPLETED|Starting Dose||0
2588651|NCT00322374|6352754|P2|COMPLETED|Starting Dose||0
2588652|NCT00322374|6352755|P1|COMPLETED|Starting Dose||0
2588653|NCT00322374|6352752|P4|STARTED|Starting Dose||0
2588654|NCT00322374|6352753|P3|STARTED|Starting Dose||0
2588655|NCT00322374|6352754|P2|STARTED|Starting Dose||0
2588656|NCT00322374|6352755|P1|STARTED|Starting Dose||6
2588657|NCT00322374|6352752|P4|NOT COMPLETED|Enrollment||0
2588658|NCT00322374|6352753|P3|NOT COMPLETED|Enrollment||0
2588659|NCT00322374|6352754|P2|NOT COMPLETED|Enrollment||0
2588660|NCT00322374|6352755|P1|NOT COMPLETED|Enrollment||0
2588661|NCT00322374|6352752|P4|COMPLETED|Enrollment||42
2588662|NCT00322374|6352753|P3|COMPLETED|Enrollment||0
2588663|NCT00322374|6352754|P2|COMPLETED|Enrollment||0
2588664|NCT00322374|6352755|P1|COMPLETED|Enrollment||0
2588665|NCT00322374|6352752|P4|STARTED|Enrollment||42
2588666|NCT00322374|6352753|P3|STARTED|Enrollment||0
2588667|NCT00322374|6352754|P2|STARTED|Enrollment||0
2588668|NCT00322374|6352755|P1|STARTED|Enrollment||0
2588669|NCT00322348|6352805|P2|NOT COMPLETED|Overall Study||33
2588670|NCT00322348|6352806|P1|NOT COMPLETED|Overall Study||37
2588671|NCT00322348|6352805|P2|COMPLETED|Overall Study|Number of participants completed up to Week 96|16
2588672|NCT00322348|6352806|P1|COMPLETED|Overall Study|Number of participants completed up to Week 96|12
2588673|NCT00322348|6352805|P2|Received Study Treatment|Overall Study||48
2588674|NCT00322348|6352806|P1|Received Study Treatment|Overall Study||50
2588675|NCT00322348|6352805|P2|STARTED|Overall Study||49
2588676|NCT00322348|6352806|P1|STARTED|Overall Study||49
2588677|NCT00322335|6352825|P3|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
2588678|NCT00322335|6352826|P2|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
2588679|NCT00322335|6352827|P1|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
2588680|NCT00322335|6352825|P3|COMPLETED|Subjects 66 Months After Booster Dose||53
2588681|NCT00322335|6352826|P2|COMPLETED|Subjects 66 Months After Booster Dose||104
2588682|NCT00322335|6352827|P1|COMPLETED|Subjects 66 Months After Booster Dose||48
2588683|NCT00322335|6352825|P3|STARTED|Subjects 66 Months After Booster Dose||53
2588684|NCT00322335|6352826|P2|STARTED|Subjects 66 Months After Booster Dose||104
2588685|NCT00322335|6352827|P1|STARTED|Subjects 66 Months After Booster Dose||48
2588686|NCT00322335|6352825|P3|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
2588687|NCT00322335|6352826|P2|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
2588688|NCT00322335|6352827|P1|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
2588689|NCT00322335|6352825|P3|COMPLETED|Subjects 54 Months After Booster Dose||56
2588690|NCT00322335|6352826|P2|COMPLETED|Subjects 54 Months After Booster Dose||108
2588691|NCT00322335|6352827|P1|COMPLETED|Subjects 54 Months After Booster Dose||50
2588692|NCT00322335|6352825|P3|STARTED|Subjects 54 Months After Booster Dose||56
2588693|NCT00322335|6352826|P2|STARTED|Subjects 54 Months After Booster Dose||108
2588694|NCT00322335|6352827|P1|STARTED|Subjects 54 Months After Booster Dose||50
2588695|NCT00322335|6352825|P3|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
2588696|NCT00322335|6352826|P2|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
2588697|NCT00322335|6352827|P1|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
2588698|NCT00322335|6352825|P3|COMPLETED|Subjects 42 Months After Booster Dose||56
2588699|NCT00322335|6352826|P2|COMPLETED|Subjects 42 Months After Booster Dose||113
2588700|NCT00322335|6352827|P1|COMPLETED|Subjects 42 Months After Booster Dose||51
2588701|NCT00322335|6352825|P3|STARTED|Subjects 42 Months After Booster Dose||56
2588702|NCT00322335|6352826|P2|STARTED|Subjects 42 Months After Booster Dose||113
2588703|NCT00322335|6352827|P1|STARTED|Subjects 42 Months After Booster Dose||51
2588704|NCT00322335|6352825|P3|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
2588705|NCT00322335|6352826|P2|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
2588706|NCT00322335|6352827|P1|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
2588707|NCT00322335|6352825|P3|COMPLETED|Subjects 30 Months After Booster Dose||57
2588708|NCT00322335|6352826|P2|COMPLETED|Subjects 30 Months After Booster Dose||119
2588709|NCT00322335|6352827|P1|COMPLETED|Subjects 30 Months After Booster Dose||54
2588710|NCT00322335|6352825|P3|STARTED|Subjects 30 Months After Booster Dose|Subjects eliminated from previous timepoint were included again from this timepoint onwards|57
2588711|NCT00322335|6352826|P2|STARTED|Subjects 30 Months After Booster Dose||119
2588712|NCT00322335|6352827|P1|STARTED|Subjects 30 Months After Booster Dose||54
2588713|NCT00322335|6352825|P3|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
2588714|NCT00322335|6352826|P2|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
2588715|NCT00322335|6352827|P1|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
2588716|NCT00322335|6352825|P3|COMPLETED|Subjects 18 Months After Booster Dose||3
2588717|NCT00322335|6352826|P2|COMPLETED|Subjects 18 Months After Booster Dose||123
2588718|NCT00322335|6352827|P1|COMPLETED|Subjects 18 Months After Booster Dose||58
2588719|NCT00322335|6352825|P3|STARTED|Subjects 18 Months After Booster Dose|Subjects who received Meningitec booster outside scope study NCT00323050 eliminated from this period|3
2588720|NCT00322335|6352826|P2|STARTED|Subjects 18 Months After Booster Dose||123
2588721|NCT00322335|6352827|P1|STARTED|Subjects 18 Months After Booster Dose||58
2588722|NCT00322309|6352867|P2|NOT COMPLETED|Overall Study||4
2588723|NCT00322309|6352868|P1|NOT COMPLETED|Overall Study||2
2588724|NCT00322309|6352867|P2|COMPLETED|Overall Study||9
2588725|NCT00322309|6352868|P1|COMPLETED|Overall Study||9
2588726|NCT00322309|6352867|P2|STARTED|Overall Study||13
2588727|NCT00322309|6352868|P1|STARTED|Overall Study||11
2588728|NCT00322231|6352884|P2|NOT COMPLETED|Period 2||0
2588729|NCT00322231|6352885|P1|NOT COMPLETED|Period 2||0
2588730|NCT00322231|6352884|P2|COMPLETED|Period 2||49
2588731|NCT00322231|6352885|P1|COMPLETED|Period 2||51
2588732|NCT00322231|6352884|P2|STARTED|Period 2|One participant was lost between Period 1 and Period 2|49
2588733|NCT00322231|6352885|P1|STARTED|Period 2||51
2588734|NCT00322231|6352884|P2|NOT COMPLETED|Period 1||0
2588735|NCT00322231|6352885|P1|NOT COMPLETED|Period 1||0
2588736|NCT00322231|6352884|P2|COMPLETED|Period 1||50
2588737|NCT00322231|6352885|P1|COMPLETED|Period 1||51
2588738|NCT00322231|6352884|P2|STARTED|Period 1||50
2588739|NCT00322231|6352885|P1|STARTED|Period 1||51
2588740|NCT00322153|6352897|P2|NOT COMPLETED|Overall Study||69
2588741|NCT00322153|6352898|P1|NOT COMPLETED|Overall Study||63
2588742|NCT00322153|6352897|P2|COMPLETED|Overall Study||273
2588743|NCT00322153|6352898|P1|COMPLETED|Overall Study||272
2588744|NCT00322153|6352897|P2|SAFETY POPULATION|Overall Study|Safety population: one patient was randomized but did not receive double-blind study drug.|341
2588745|NCT00322153|6352898|P1|SAFETY POPULATION|Overall Study|Safety population defined as all patients who took at least one dose of double-blind study drug.|335
2588746|NCT00322153|6352897|P2|STARTED|Overall Study|Randomized to Memantine ER|342
2588747|NCT00322153|6352898|P1|STARTED|Overall Study|Randomized to placebo|335
2588748|NCT00322101|6352910|P2|NOT COMPLETED|Overall Study||0
2588749|NCT00322101|6352911|P1|NOT COMPLETED|Overall Study||0
2588750|NCT00322101|6352910|P2|COMPLETED|Overall Study||11
2588751|NCT00322101|6352911|P1|COMPLETED|Overall Study||14
2588752|NCT00322101|6352910|P2|STARTED|Overall Study||11
2588753|NCT00322101|6352911|P1|STARTED|Overall Study||14
2588754|NCT00322049|6352931|P4|NOT COMPLETED|Overall Study||1
2588755|NCT00322049|6352932|P3|NOT COMPLETED|Overall Study||0
2588756|NCT00322049|6352933|P2|NOT COMPLETED|Overall Study||1
2588757|NCT00322049|6352934|P1|NOT COMPLETED|Overall Study||0
2588758|NCT00322049|6352931|P4|COMPLETED|Overall Study||16
2588759|NCT00322049|6352932|P3|COMPLETED|Overall Study||20
2588760|NCT00322049|6352933|P2|COMPLETED|Overall Study||9
2588761|NCT00322049|6352934|P1|COMPLETED|Overall Study||4
2588762|NCT00322049|6352931|P4|STARTED|Overall Study||17
2588763|NCT00322049|6352932|P3|STARTED|Overall Study||20
2588764|NCT00322049|6352933|P2|STARTED|Overall Study||10
2588765|NCT00322049|6352934|P1|STARTED|Overall Study||4
2588766|NCT00321984|6352967|P3|NOT COMPLETED|Overall Study||26
2588767|NCT00321984|6352968|P2|NOT COMPLETED|Overall Study||21
2588768|NCT00321984|6352969|P1|NOT COMPLETED|Overall Study||27
2588769|NCT00321984|6352967|P3|COMPLETED|Overall Study||289
2588770|NCT00321984|6352968|P2|COMPLETED|Overall Study||294
2588771|NCT00321984|6352969|P1|COMPLETED|Overall Study||290
2588772|NCT00321984|6352967|P3|STARTED|Overall Study||315
2588773|NCT00321984|6352968|P2|STARTED|Overall Study||315
2588774|NCT00321984|6352969|P1|STARTED|Overall Study||317
2588775|NCT00321971|6352988|P2|NOT COMPLETED|Overall Study||11
2588776|NCT00321971|6352989|P1|NOT COMPLETED|Overall Study||8
2588777|NCT00321971|6352988|P2|COMPLETED|Overall Study||26
2588778|NCT00321971|6352989|P1|COMPLETED|Overall Study||28
2588779|NCT00321971|6352988|P2|STARTED|Overall Study||37
2588780|NCT00321971|6352989|P1|STARTED|Overall Study|Subject recruitment began in February 2007 and ended in December 2011|36
2588781|NCT00321932|6352997|P2|NOT COMPLETED|Overall Study||21
2588782|NCT00321932|6352998|P1|NOT COMPLETED|Overall Study||10
2588783|NCT00321932|6352997|P2|COMPLETED|Overall Study||11
2588784|NCT00321932|6352998|P1|COMPLETED|Overall Study||19
2588785|NCT00321932|6352997|P2|STARTED|Overall Study||32
2588786|NCT00321932|6352998|P1|STARTED|Overall Study||29
2588787|NCT00321919|6353022|P2|NOT COMPLETED|Overall Study||52
2588788|NCT00321919|6353023|P1|NOT COMPLETED|Overall Study||75
2588789|NCT00321919|6353022|P2|COMPLETED|Overall Study||250
2588790|NCT00321919|6353023|P1|COMPLETED|Overall Study||226
2588791|NCT00321919|6353022|P2|STARTED|Overall Study||302
2588792|NCT00321919|6353023|P1|STARTED|Overall Study||301
2588793|NCT00321906|6353065|P2|NOT COMPLETED|Overall Study||56
2588794|NCT00321906|6353066|P1|NOT COMPLETED|Overall Study||46
2588795|NCT00321906|6353065|P2|COMPLETED|Overall Study||31
2588796|NCT00321906|6353066|P1|COMPLETED|Overall Study||48
2588797|NCT00321906|6353065|P2|STARTED|Overall Study||87
2588798|NCT00321906|6353066|P1|STARTED|Overall Study||94
2588799|NCT00321893|6353088|P2|NOT COMPLETED|Overall Study||14
2588800|NCT00321893|6353089|P1|NOT COMPLETED|Overall Study||24
2588801|NCT00321893|6353088|P2|COMPLETED|Overall Study||87
2588802|NCT00321893|6353089|P1|COMPLETED|Overall Study||77
2588803|NCT00321893|6353088|P2|STARTED|Overall Study||101
2588804|NCT00321893|6353089|P1|STARTED|Overall Study||101
2588805|NCT00321854|6353103|P2|NOT COMPLETED|Overall Study||82
2588806|NCT00321854|6353104|P1|NOT COMPLETED|Overall Study||63
2588807|NCT00321854|6353103|P2|COMPLETED|Overall Study||192
2588808|NCT00321854|6353104|P1|COMPLETED|Overall Study||198
2588809|NCT00321854|6353103|P2|STARTED|Overall Study||274
2588810|NCT00321854|6353104|P1|STARTED|Overall Study||261
2588811|NCT00321828|6353222|P1|NOT COMPLETED|Overall Study||4
2588812|NCT00321828|6353222|P1|COMPLETED|Overall Study||86
2588813|NCT00321828|6353222|P1|STARTED|Overall Study||90
2588814|NCT00321789|6353228|P2|NOT COMPLETED|Overall Study||16
2588815|NCT00321789|6353229|P1|NOT COMPLETED|Overall Study||15
2588816|NCT00321789|6353228|P2|COMPLETED|Overall Study||112
2588817|NCT00321789|6353229|P1|COMPLETED|Overall Study||112
2588818|NCT00321789|6353228|P2|STARTED|Overall Study||128
2588819|NCT00321789|6353229|P1|STARTED|Overall Study||127
2588820|NCT00321763|6353261|P4|NOT COMPLETED|Overall Study||5
2588821|NCT00321763|6353262|P3|NOT COMPLETED|Overall Study||6
2588822|NCT00321763|6353263|P2|NOT COMPLETED|Overall Study||2
2588823|NCT00321763|6353264|P1|NOT COMPLETED|Overall Study||6
2588824|NCT00321763|6353261|P4|COMPLETED|Overall Study||565
2588825|NCT00321763|6353262|P3|COMPLETED|Overall Study||848
2588826|NCT00321763|6353263|P2|COMPLETED|Overall Study||848
2588827|NCT00321763|6353264|P1|COMPLETED|Overall Study||844
2588828|NCT00321763|6353261|P4|STARTED|Overall Study||570
2588829|NCT00321763|6353262|P3|STARTED|Overall Study||854
2588830|NCT00321763|6353263|P2|STARTED|Overall Study||850
2588831|NCT00321763|6353264|P1|STARTED|Overall Study||850
2588832|NCT00321737|6353324|P3|NOT COMPLETED|Overall Study||54
2588833|NCT00321737|6353325|P2|NOT COMPLETED|Overall Study||48
2588834|NCT00321737|6353326|P1|NOT COMPLETED|Overall Study||122
2588835|NCT00321737|6353324|P3|COMPLETED|Overall Study||104
2588836|NCT00321737|6353325|P2|COMPLETED|Overall Study||92
2588837|NCT00321737|6353326|P1|COMPLETED|Overall Study||25
2588838|NCT00321737|6353324|P3|STARTED|Overall Study||158
2588839|NCT00321737|6353325|P2|STARTED|Overall Study||140
2588840|NCT00321737|6353326|P1|STARTED|Overall Study||147
2588841|NCT00321711|6353354|P5|NOT COMPLETED|Part B||5
2588842|NCT00321711|6353355|P4|NOT COMPLETED|Part B||6
2588843|NCT00321711|6353356|P3|NOT COMPLETED|Part B||0
2588844|NCT00321711|6353357|P2|NOT COMPLETED|Part B||0
2588845|NCT00321711|6353358|P1|NOT COMPLETED|Part B||0
2588846|NCT00321711|6353354|P5|COMPLETED|Part B||10
2588847|NCT00321711|6353355|P4|COMPLETED|Part B||8
2588848|NCT00321711|6353356|P3|COMPLETED|Part B||0
2588849|NCT00321711|6353357|P2|COMPLETED|Part B||0
2588850|NCT00321711|6353358|P1|COMPLETED|Part B||0
2588851|NCT00321711|6353354|P5|STARTED|Part B||15
2588852|NCT00321711|6353355|P4|STARTED|Part B||14
2588853|NCT00321711|6353356|P3|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
2588854|NCT00321711|6353357|P2|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
2588855|NCT00321711|6353358|P1|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
2588856|NCT00321711|6353354|P5|NOT COMPLETED|Part A||0
2588857|NCT00321711|6353355|P4|NOT COMPLETED|Part A||0
2588858|NCT00321711|6353356|P3|NOT COMPLETED|Part A||11
2588859|NCT00321711|6353357|P2|NOT COMPLETED|Part A||10
2588860|NCT00321711|6353358|P1|NOT COMPLETED|Part A||5
2588861|NCT00321711|6353354|P5|COMPLETED|Part A||0
2588862|NCT00321711|6353355|P4|COMPLETED|Part A||0
2588863|NCT00321711|6353356|P3|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
2588864|NCT00321711|6353357|P2|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
2588865|NCT00321711|6353358|P1|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|8
2588866|NCT00321711|6353354|P5|STARTED|Part A||0
2588867|NCT00321711|6353355|P4|STARTED|Part A||0
2588868|NCT00321711|6353356|P3|STARTED|Part A||14
2588869|NCT00321711|6353357|P2|STARTED|Part A||13
2588870|NCT00321711|6353358|P1|STARTED|Part A||13
2588871|NCT00321698|6353390|P5|NOT COMPLETED|Phase II, MTD Dose||0
2588872|NCT00321698|6353391|P4|NOT COMPLETED|Phase II, MTD Dose||0
2588873|NCT00321698|6353392|P3|NOT COMPLETED|Phase II, MTD Dose||0
2588874|NCT00321698|6353393|P2|NOT COMPLETED|Phase II, MTD Dose||0
2588875|NCT00321698|6353394|P1|NOT COMPLETED|Phase II, MTD Dose||0
2588876|NCT00321698|6353390|P5|COMPLETED|Phase II, MTD Dose||13
2588877|NCT00321698|6353391|P4|COMPLETED|Phase II, MTD Dose||0
2588878|NCT00321698|6353392|P3|COMPLETED|Phase II, MTD Dose||0
2588879|NCT00321698|6353393|P2|COMPLETED|Phase II, MTD Dose||0
2588880|NCT00321698|6353394|P1|COMPLETED|Phase II, MTD Dose||0
2588881|NCT00321698|6353390|P5|STARTED|Phase II, MTD Dose|+1 screen failure|13
2588882|NCT00321698|6353391|P4|STARTED|Phase II, MTD Dose||0
2588883|NCT00321698|6353392|P3|STARTED|Phase II, MTD Dose||0
2588884|NCT00321698|6353393|P2|STARTED|Phase II, MTD Dose||0
2588885|NCT00321698|6353394|P1|STARTED|Phase II, MTD Dose||0
2588886|NCT00321698|6353390|P5|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
2588887|NCT00321698|6353391|P4|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
2588888|NCT00321698|6353392|P3|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
2588889|NCT00321698|6353393|P2|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
2588890|NCT00321698|6353394|P1|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
2588891|NCT00321698|6353390|P5|COMPLETED|Phase I, Rad Only & Dose 1-3||0
2588892|NCT00321698|6353391|P4|COMPLETED|Phase I, Rad Only & Dose 1-3||3
2588893|NCT00321698|6353392|P3|COMPLETED|Phase I, Rad Only & Dose 1-3||3
2588894|NCT00321698|6353393|P2|COMPLETED|Phase I, Rad Only & Dose 1-3||3
2588895|NCT00321698|6353394|P1|COMPLETED|Phase I, Rad Only & Dose 1-3||3
2588896|NCT00321698|6353390|P5|STARTED|Phase I, Rad Only & Dose 1-3||0
2588897|NCT00321698|6353391|P4|STARTED|Phase I, Rad Only & Dose 1-3||3
2588898|NCT00321698|6353392|P3|STARTED|Phase I, Rad Only & Dose 1-3||3
2588899|NCT00321698|6353393|P2|STARTED|Phase I, Rad Only & Dose 1-3||3
2588900|NCT00321698|6353394|P1|STARTED|Phase I, Rad Only & Dose 1-3||3
2588901|NCT00321685|6353408|P1|NOT COMPLETED|Overall Study||39
2588902|NCT00321685|6353408|P1|COMPLETED|Overall Study||18
2588903|NCT00321685|6353408|P1|Eligible and Treated|Overall Study||53
2588904|NCT00321685|6353408|P1|Started Protocol Therapy|Overall Study||55
2588905|NCT00321685|6353408|P1|Eligible|Overall Study||55
2588906|NCT00321685|6353408|P1|STARTED|Overall Study||57
2588907|NCT00321672|6353420|P4|NOT COMPLETED|Overall Study||2
2588908|NCT00321672|6353421|P3|NOT COMPLETED|Overall Study||11
2588909|NCT00321672|6353422|P2|NOT COMPLETED|Overall Study||8
2588910|NCT00321672|6353423|P1|NOT COMPLETED|Overall Study||12
2588911|NCT00321672|6353420|P4|COMPLETED|Overall Study||71
2588912|NCT00321672|6353421|P3|COMPLETED|Overall Study||156
2588913|NCT00321672|6353422|P2|COMPLETED|Overall Study||81
2588914|NCT00321672|6353423|P1|COMPLETED|Overall Study||153
2588915|NCT00321672|6353420|P4|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|73
2588916|NCT00321672|6353421|P3|STARTED|Overall Study||167
2588917|NCT00321672|6353422|P2|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|89
2588918|NCT00321672|6353423|P1|STARTED|Overall Study||165
2588919|NCT00321646|6353449|P1|NOT COMPLETED|Prostatectomy||0
2588920|NCT00321646|6353449|P1|COMPLETED|Prostatectomy||37
2588921|NCT00321646|6353449|P1|STARTED|Prostatectomy||37
2588922|NCT00321646|6353449|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||4
2588923|NCT00321646|6353449|P1|COMPLETED|Neoadjuvant Chemotherapy|1 pt withdrew before start of therapy, 38 completed 6 cycles neoadjuvant therapy.|38
2588924|NCT00321646|6353449|P1|STARTED|Neoadjuvant Chemotherapy||42
2588925|NCT00321620|6353456|P2|NOT COMPLETED|Overall Study||722
2588926|NCT00321620|6353457|P1|NOT COMPLETED|Overall Study||743
2588927|NCT00321620|6353456|P2|COMPLETED|Overall Study||228
2588928|NCT00321620|6353457|P1|COMPLETED|Overall Study||208
2588929|NCT00321620|6353456|P2|Received Investigational Product|Overall Study||942
2588930|NCT00321620|6353457|P1|Received Investigational Product|Overall Study||946
2588931|NCT00321620|6353456|P2|STARTED|Overall Study||950
2588932|NCT00321620|6353457|P1|STARTED|Overall Study||951
2588933|NCT00321594|6353469|P5|NOT COMPLETED|Phase II, MTD Dose||0
2588934|NCT00321594|6353470|P4|NOT COMPLETED|Phase II, MTD Dose||0
2588935|NCT00321594|6353471|P3|NOT COMPLETED|Phase II, MTD Dose||0
2588936|NCT00321594|6353472|P2|NOT COMPLETED|Phase II, MTD Dose||0
2588937|NCT00321594|6353473|P1|NOT COMPLETED|Phase II, MTD Dose||0
2588938|NCT00321594|6353469|P5|COMPLETED|Phase II, MTD Dose||36
2588939|NCT00321594|6353470|P4|COMPLETED|Phase II, MTD Dose||6
2588940|NCT00321594|6353471|P3|COMPLETED|Phase II, MTD Dose||0
2588941|NCT00321594|6353472|P2|COMPLETED|Phase II, MTD Dose||0
2588942|NCT00321594|6353473|P1|COMPLETED|Phase II, MTD Dose||0
2588943|NCT00321594|6353469|P5|STARTED|Phase II, MTD Dose|last six patients in Phase I, Level 4 include in Phase II MTD Dose total number = 6 + 36 = 42|36
2588944|NCT00321594|6353470|P4|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|6
2588945|NCT00321594|6353471|P3|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
2588946|NCT00321594|6353472|P2|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
2588947|NCT00321594|6353473|P1|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
2588948|NCT00321594|6353469|P5|NOT COMPLETED|Phase I, Level 1-4||0
2588949|NCT00321594|6353470|P4|NOT COMPLETED|Phase I, Level 1-4||0
2588950|NCT00321594|6353471|P3|NOT COMPLETED|Phase I, Level 1-4||0
2588951|NCT00321594|6353472|P2|NOT COMPLETED|Phase I, Level 1-4||0
2588952|NCT00321594|6353473|P1|NOT COMPLETED|Phase I, Level 1-4||0
2588953|NCT00321594|6353469|P5|COMPLETED|Phase I, Level 1-4||0
2588954|NCT00321594|6353470|P4|COMPLETED|Phase I, Level 1-4||6
2588955|NCT00321594|6353471|P3|COMPLETED|Phase I, Level 1-4||6
2588956|NCT00321594|6353472|P2|COMPLETED|Phase I, Level 1-4||3
2588957|NCT00321594|6353473|P1|COMPLETED|Phase I, Level 1-4||3
2588958|NCT00321594|6353469|P5|STARTED|Phase I, Level 1-4||0
2588959|NCT00321594|6353470|P4|STARTED|Phase I, Level 1-4||6
2588960|NCT00321594|6353471|P3|STARTED|Phase I, Level 1-4||6
2588961|NCT00321594|6353472|P2|STARTED|Phase I, Level 1-4||3
2588962|NCT00321594|6353473|P1|STARTED|Phase I, Level 1-4||3
2588963|NCT00321555|6353485|P1|NOT COMPLETED|Overall Study||6
2588964|NCT00321555|6353485|P1|COMPLETED|Overall Study||9
2588965|NCT00321555|6353485|P1|STARTED|Overall Study||15
2588966|NCT00321464|6353493|P2|NOT COMPLETED|Overall Study||558
2588967|NCT00321464|6353494|P1|NOT COMPLETED|Overall Study||559
2588968|NCT00321464|6353493|P2|COMPLETED|Overall Study||468
2588969|NCT00321464|6353494|P1|COMPLETED|Overall Study||461
2588970|NCT00321464|6353493|P2|Received Investigational Product|Overall Study||1019
2588971|NCT00321464|6353494|P1|Received Investigational Product|Overall Study||1014
2588972|NCT00321464|6353493|P2|STARTED|Overall Study||1026
2588973|NCT00321464|6353494|P1|STARTED|Overall Study||1020
2588974|NCT00321373|6353507|P3|NOT COMPLETED|Overall Study||3
2588975|NCT00321373|6353508|P2|NOT COMPLETED|Overall Study||0
2588976|NCT00321373|6353509|P1|NOT COMPLETED|Overall Study||2
2588977|NCT00321373|6353507|P3|COMPLETED|Overall Study||404
2588978|NCT00321373|6353508|P2|COMPLETED|Overall Study||406
2588979|NCT00321373|6353509|P1|COMPLETED|Overall Study||405
2588980|NCT00321373|6353507|P3|STARTED|Overall Study||407
2588981|NCT00321373|6353508|P2|STARTED|Overall Study||406
2588982|NCT00321373|6353509|P1|STARTED|Overall Study||407
2588983|NCT00321321|6353532|P1|NOT COMPLETED|Overall Study||0
2588984|NCT00321321|6353532|P1|COMPLETED|Overall Study||12
2588985|NCT00321321|6353532|P1|STARTED|Overall Study||12
2588986|NCT00321269|6353538|P2|NOT COMPLETED|Overall Study||6
2588987|NCT00321269|6353539|P1|NOT COMPLETED|Overall Study||8
2588988|NCT00321269|6353538|P2|COMPLETED|Overall Study||68
2588989|NCT00321269|6353539|P1|COMPLETED|Overall Study||66
2588990|NCT00321269|6353538|P2|STARTED|Overall Study||74
2588991|NCT00321269|6353539|P1|STARTED|Overall Study||74
2588992|NCT00321048|6353549|P2|NOT COMPLETED|Overall Study||8
2588993|NCT00321048|6353550|P1|NOT COMPLETED|Overall Study||6
2588994|NCT00321048|6353549|P2|COMPLETED|Overall Study||21
2588995|NCT00321048|6353550|P1|COMPLETED|Overall Study||22
2588996|NCT00321048|6353549|P2|STARTED|Overall Study||29
2588997|NCT00321048|6353550|P1|STARTED|Overall Study||28
2588998|NCT00320801|6353558|P4|NOT COMPLETED|Extension Phase||48
2588999|NCT00320801|6353559|P3|NOT COMPLETED|Extension Phase||0
2589000|NCT00320801|6353560|P2|NOT COMPLETED|Extension Phase||0
2589001|NCT00320801|6353561|P1|NOT COMPLETED|Extension Phase||0
2589002|NCT00320801|6353558|P4|COMPLETED|Extension Phase||7
2589003|NCT00320801|6353559|P3|COMPLETED|Extension Phase||0
2589004|NCT00320801|6353560|P2|COMPLETED|Extension Phase||0
2589005|NCT00320801|6353561|P1|COMPLETED|Extension Phase||0
2589006|NCT00320801|6353558|P4|STARTED|Extension Phase||55
2589007|NCT00320801|6353559|P3|STARTED|Extension Phase||0
2589008|NCT00320801|6353560|P2|STARTED|Extension Phase||0
2589009|NCT00320801|6353561|P1|STARTED|Extension Phase||0
2589010|NCT00320801|6353558|P4|NOT COMPLETED|Double-blind Phase||0
2589011|NCT00320801|6353559|P3|NOT COMPLETED|Double-blind Phase||14
2589012|NCT00320801|6353560|P2|NOT COMPLETED|Double-blind Phase||11
2589013|NCT00320801|6353561|P1|NOT COMPLETED|Double-blind Phase||0
2589014|NCT00320801|6353558|P4|COMPLETED|Double-blind Phase||0
2589015|NCT00320801|6353559|P3|COMPLETED|Double-blind Phase||35
2589016|NCT00320801|6353560|P2|COMPLETED|Double-blind Phase||36
2589017|NCT00320801|6353561|P1|COMPLETED|Double-blind Phase||0
2589018|NCT00320801|6353558|P4|STARTED|Double-blind Phase||0
2589019|NCT00320801|6353559|P3|STARTED|Double-blind Phase||49
2589020|NCT00320801|6353560|P2|STARTED|Double-blind Phase||47
2589021|NCT00320801|6353561|P1|STARTED|Double-blind Phase||0
2589022|NCT00320801|6353558|P4|NOT COMPLETED|Open-label Run-in Period||0
2589023|NCT00320801|6353559|P3|NOT COMPLETED|Open-label Run-in Period||0
2589024|NCT00320801|6353560|P2|NOT COMPLETED|Open-label Run-in Period||0
2589025|NCT00320801|6353561|P1|NOT COMPLETED|Open-label Run-in Period||92
2589026|NCT00320801|6353558|P4|COMPLETED|Open-label Run-in Period||0
2589027|NCT00320801|6353559|P3|COMPLETED|Open-label Run-in Period||0
2589028|NCT00320801|6353560|P2|COMPLETED|Open-label Run-in Period||0
2589029|NCT00320801|6353561|P1|COMPLETED|Open-label Run-in Period||96
2589030|NCT00320801|6353558|P4|STARTED|Open-label Run-in Period||0
2589031|NCT00320801|6353559|P3|STARTED|Open-label Run-in Period||0
2589032|NCT00320801|6353560|P2|STARTED|Open-label Run-in Period||0
2589033|NCT00320801|6353561|P1|STARTED|Open-label Run-in Period||188
2589034|NCT00320788|6353576|P5|NOT COMPLETED|Overall Study||5
2589035|NCT00320788|6353577|P4|NOT COMPLETED|Overall Study||5
2589036|NCT00320788|6353578|P3|NOT COMPLETED|Overall Study||3
2589037|NCT00320788|6353579|P2|NOT COMPLETED|Overall Study||6
2589038|NCT00320788|6353580|P1|NOT COMPLETED|Overall Study||6
2589039|NCT00320788|6353576|P5|COMPLETED|Overall Study||26
2589040|NCT00320788|6353577|P4|COMPLETED|Overall Study||27
2589041|NCT00320788|6353578|P3|COMPLETED|Overall Study||29
2589042|NCT00320788|6353579|P2|COMPLETED|Overall Study||26
2589043|NCT00320788|6353580|P1|COMPLETED|Overall Study||26
2589044|NCT00320788|6353576|P5|Participants Received Treatment (SAF)|Overall Study||31
2589045|NCT00320788|6353577|P4|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
2589046|NCT00320788|6353578|P3|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
2589047|NCT00320788|6353579|P2|Participants Received Treatment (SAF)|Overall Study||32
2589048|NCT00320788|6353580|P1|Participants Received Treatment (SAF)|Overall Study||32
2589049|NCT00320788|6353576|P5|STARTED|Overall Study||31
2589050|NCT00320788|6353577|P4|STARTED|Overall Study|Participants Randomized|32
2589051|NCT00320788|6353578|P3|STARTED|Overall Study||32
2589052|NCT00320788|6353579|P2|STARTED|Overall Study||32
2589053|NCT00320788|6353580|P1|STARTED|Overall Study||32
2589054|NCT00320749|6353623|P3|NOT COMPLETED|Overall Study||9
2589055|NCT00320749|6353624|P2|NOT COMPLETED|Overall Study||2
2589056|NCT00320749|6353625|P1|NOT COMPLETED|Overall Study||0
2589057|NCT00320749|6353623|P3|COMPLETED|Overall Study||1
2589058|NCT00320749|6353624|P2|COMPLETED|Overall Study||6
2589059|NCT00320749|6353625|P1|COMPLETED|Overall Study||3
2589060|NCT00320749|6353623|P3|STARTED|Overall Study||10
2589061|NCT00320749|6353624|P2|STARTED|Overall Study||8
2589062|NCT00320749|6353625|P1|STARTED|Overall Study||3
2589063|NCT00320710|6353634|P3|NOT COMPLETED|Overall Study||5
2589064|NCT00320710|6353635|P2|NOT COMPLETED|Overall Study||76
2589065|NCT00320710|6353636|P1|NOT COMPLETED|Overall Study||94
2589066|NCT00320710|6353634|P3|COMPLETED|Overall Study||8
2589067|NCT00320710|6353635|P2|COMPLETED|Overall Study||127
2589068|NCT00320710|6353636|P1|COMPLETED|Overall Study||106
2589069|NCT00320710|6353634|P3|Treated (Safety Set)|Overall Study||13
2589070|NCT00320710|6353635|P2|Treated (Safety Set)|Overall Study||202
2589071|NCT00320710|6353636|P1|Treated (Safety Set)|Overall Study||198
2589072|NCT00320710|6353634|P3|STARTED|Overall Study||13
2589073|NCT00320710|6353635|P2|STARTED|Overall Study||203
2589074|NCT00320710|6353636|P1|STARTED|Overall Study||200
2589075|NCT00320671|6353659|P2|NOT COMPLETED|Overall Study||38
2589076|NCT00320671|6353660|P1|NOT COMPLETED|Overall Study||33
2589077|NCT00320671|6353659|P2|COMPLETED|Overall Study||58
2589078|NCT00320671|6353660|P1|COMPLETED|Overall Study||69
2589079|NCT00320671|6353659|P2|STARTED|Overall Study||96
2589080|NCT00320671|6353660|P1|STARTED|Overall Study||102
2589081|NCT00320606|6353666|P1|NOT COMPLETED|Overall Study||3
2589082|NCT00320606|6353666|P1|COMPLETED|Overall Study||17
2589083|NCT00320606|6353666|P1|STARTED|Overall Study||20
2589084|NCT00320593|6353682|P2|NOT COMPLETED|Overall Study||1
2589085|NCT00320593|6353683|P1|NOT COMPLETED|Overall Study||7
2589086|NCT00320593|6353682|P2|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|58
2589087|NCT00320593|6353683|P1|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|52
2589088|NCT00320593|6353682|P2|STARTED|Overall Study||59
2589089|NCT00320593|6353683|P1|STARTED|Overall Study||59
2589090|NCT00320541|6353707|P2|NOT COMPLETED|Overall Study||57
2589091|NCT00320541|6353708|P1|NOT COMPLETED|Overall Study||50
2589092|NCT00320541|6353707|P2|COMPLETED|Overall Study||36
2589093|NCT00320541|6353708|P1|COMPLETED|Overall Study||44
2589094|NCT00320541|6353707|P2|STARTED|Overall Study||93
2589095|NCT00320541|6353708|P1|STARTED|Overall Study||94
2589096|NCT00320528|6353735|P3|NOT COMPLETED|Study Period III||106
2589097|NCT00320528|6353736|P2|NOT COMPLETED|Study Period III||31
2589098|NCT00320528|6353737|P1|NOT COMPLETED|Study Period III||87
2589099|NCT00320528|6353735|P3|COMPLETED|Study Period III||2
2589100|NCT00320528|6353736|P2|COMPLETED|Study Period III||0
2589101|NCT00320528|6353737|P1|COMPLETED|Study Period III||0
2589102|NCT00320528|6353735|P3|STARTED|Study Period III||108
2589103|NCT00320528|6353736|P2|STARTED|Study Period III||31
2589104|NCT00320528|6353737|P1|STARTED|Study Period III||87
2589105|NCT00320528|6353735|P3|NOT COMPLETED|Study Period II||22
2589106|NCT00320528|6353736|P2|NOT COMPLETED|Study Period II||10
2589107|NCT00320528|6353737|P1|NOT COMPLETED|Study Period II||11
2589108|NCT00320528|6353735|P3|COMPLETED|Study Period II||108
2589109|NCT00320528|6353736|P2|COMPLETED|Study Period II||31
2589110|NCT00320528|6353737|P1|COMPLETED|Study Period II||87
2589111|NCT00320528|6353735|P3|Received at Least One Dose of Study Drug|Study Period II||128
2589112|NCT00320528|6353736|P2|Received at Least One Dose of Study Drug|Study Period II||38
2589113|NCT00320528|6353737|P1|Received at Least One Dose of Study Drug|Study Period II||97
2589114|NCT00320528|6353735|P3|STARTED|Study Period II||130
2589115|NCT00320528|6353736|P2|STARTED|Study Period II||41
2589116|NCT00320528|6353737|P1|STARTED|Study Period II||98
2589117|NCT00320515|6353772|P1|NOT COMPLETED|Overall Study||49
2589118|NCT00320515|6353772|P1|COMPLETED|Overall Study||20
2589119|NCT00320515|6353772|P1|STARTED|Overall Study||69
2589120|NCT00320489|6353781|P2|NOT COMPLETED|Overall Study||136
2589121|NCT00320489|6353782|P1|NOT COMPLETED|Overall Study||145
2589122|NCT00320489|6353781|P2|COMPLETED|Overall Study||124
2589123|NCT00320489|6353782|P1|COMPLETED|Overall Study||119
2589124|NCT00320489|6353781|P2|STARTED|Overall Study||260
2589125|NCT00320489|6353782|P1|STARTED|Overall Study||264
2589126|NCT00320424|6353838|P1|NOT COMPLETED|Overall Study||6
2589127|NCT00320424|6353838|P1|COMPLETED|Overall Study||42
2589128|NCT00320424|6353838|P1|STARTED|Overall Study||48
2589129|NCT00320411|6353852|P1|NOT COMPLETED|Overall Study||4
2589130|NCT00320411|6353852|P1|COMPLETED|Overall Study||58
2589131|NCT00320411|6353852|P1|STARTED|Overall Study||62
2589132|NCT00320398|6353875|P2|NOT COMPLETED|Overall Study||4
2589133|NCT00320398|6353876|P1|NOT COMPLETED|Overall Study||2
2589134|NCT00320398|6353875|P2|COMPLETED|Overall Study||52
2589135|NCT00320398|6353876|P1|COMPLETED|Overall Study||56
2589136|NCT00320398|6353875|P2|STARTED|Overall Study||56
2589137|NCT00320398|6353876|P1|STARTED|Overall Study||58
2589138|NCT00320385|6353904|P2|NOT COMPLETED|Overall Study||22
2589139|NCT00320385|6353905|P1|NOT COMPLETED|Overall Study||18
2589140|NCT00320385|6353904|P2|COMPLETED|Overall Study||126
2589141|NCT00320385|6353905|P1|COMPLETED|Overall Study||130
2589142|NCT00320385|6353904|P2|STARTED|Overall Study||148
2589143|NCT00320385|6353905|P1|STARTED|Overall Study||148
2589144|NCT00320372|6353928|P2|NOT COMPLETED|Overall Study||163
2589145|NCT00320372|6353929|P1|NOT COMPLETED|Overall Study||195
2589146|NCT00320372|6353928|P2|COMPLETED|Overall Study||138
2589147|NCT00320372|6353929|P1|COMPLETED|Overall Study||299
2589148|NCT00320372|6353928|P2|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||0
2589149|NCT00320372|6353929|P1|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||159
2589150|NCT00320372|6353928|P2|VNS Therapy D-23 Original|Overall Study||0
2589151|NCT00320372|6353929|P1|VNS Therapy D-23 Original|Overall Study||335
2589152|NCT00320372|6353928|P2|STARTED|Overall Study||301
2589153|NCT00320372|6353929|P1|STARTED|Overall Study||494
2589154|NCT00320281|6353956|P2|NOT COMPLETED|Overall Study||0
2589155|NCT00320281|6353957|P1|NOT COMPLETED|Overall Study||0
2589156|NCT00320281|6353956|P2|COMPLETED|Overall Study||9
2589157|NCT00320281|6353957|P1|COMPLETED|Overall Study||10
2589158|NCT00320281|6353956|P2|STARTED|Overall Study||9
2589159|NCT00320281|6353957|P1|STARTED|Overall Study||10
2589160|NCT00320255|6353969|P6|NOT COMPLETED|Overall Study||0
2589161|NCT00320255|6353970|P5|NOT COMPLETED|Overall Study||0
2589162|NCT00320255|6353971|P4|NOT COMPLETED|Overall Study||8
2589163|NCT00320255|6353972|P3|NOT COMPLETED|Overall Study||6
2589164|NCT00320255|6353973|P2|NOT COMPLETED|Overall Study||7
2589165|NCT00320255|6353974|P1|NOT COMPLETED|Overall Study||11
2589166|NCT00320255|6353969|P6|COMPLETED|Overall Study||3
2589167|NCT00320255|6353970|P5|COMPLETED|Overall Study||2
2589168|NCT00320255|6353971|P4|COMPLETED|Overall Study||25
2589169|NCT00320255|6353972|P3|COMPLETED|Overall Study||24
2589170|NCT00320255|6353973|P2|COMPLETED|Overall Study||25
2589171|NCT00320255|6353974|P1|COMPLETED|Overall Study||19
2589172|NCT00320255|6353969|P6|Received Treatment|Overall Study||3
2589173|NCT00320255|6353970|P5|Received Treatment|Overall Study||2
2589174|NCT00320255|6353971|P4|Received Treatment|Overall Study||32
2589175|NCT00320255|6353972|P3|Received Treatment|Overall Study||29
2589176|NCT00320255|6353973|P2|Received Treatment|Overall Study||32
2589177|NCT00320255|6353974|P1|Received Treatment|Overall Study||29
2589178|NCT00320255|6353969|P6|STARTED|Overall Study||3
2589179|NCT00320255|6353970|P5|STARTED|Overall Study||2
2589180|NCT00320255|6353971|P4|STARTED|Overall Study||33
2589181|NCT00320255|6353972|P3|STARTED|Overall Study||30
2589182|NCT00320255|6353973|P2|STARTED|Overall Study||32
2589183|NCT00320255|6353974|P1|STARTED|Overall Study||30
2589184|NCT00320242|6354054|P2|NOT COMPLETED|Overall Study||4
2589185|NCT00320242|6354055|P1|NOT COMPLETED|Overall Study||2
2589186|NCT00320242|6354054|P2|COMPLETED|Overall Study||12
2589187|NCT00320242|6354055|P1|COMPLETED|Overall Study||14
2589188|NCT00320242|6354054|P2|STARTED|Overall Study||16
2589189|NCT00320242|6354055|P1|STARTED|Overall Study||16
2589190|NCT00320216|6354067|P5|NOT COMPLETED|Overall Study||6
2589191|NCT00320216|6354068|P4|NOT COMPLETED|Overall Study||3
2589192|NCT00320216|6354069|P3|NOT COMPLETED|Overall Study||6
2589193|NCT00320216|6354070|P2|NOT COMPLETED|Overall Study||10
2589194|NCT00320216|6354071|P1|NOT COMPLETED|Overall Study||16
2589195|NCT00320216|6354067|P5|COMPLETED|Overall Study||58
2589196|NCT00320216|6354068|P4|COMPLETED|Overall Study||61
2589197|NCT00320216|6354069|P3|COMPLETED|Overall Study||58
2589198|NCT00320216|6354070|P2|COMPLETED|Overall Study||54
2589199|NCT00320216|6354071|P1|COMPLETED|Overall Study||48
2589200|NCT00320216|6354067|P5|STARTED|Overall Study||64
2589201|NCT00320216|6354068|P4|STARTED|Overall Study||64
2589202|NCT00320216|6354069|P3|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
2589203|NCT00320216|6354070|P2|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
2589204|NCT00320216|6354071|P1|STARTED|Overall Study||64
2589205|NCT00320190|6354105|P2|NOT COMPLETED|Long-term (12-month) Extension||2
2589206|NCT00320190|6354106|P1|NOT COMPLETED|Long-term (12-month) Extension||9
2589207|NCT00320190|6354105|P2|COMPLETED|Long-term (12-month) Extension||1
2589208|NCT00320190|6354106|P1|COMPLETED|Long-term (12-month) Extension||2
2589209|NCT00320190|6354105|P2|STARTED|Long-term (12-month) Extension||3
2589210|NCT00320190|6354106|P1|STARTED|Long-term (12-month) Extension||11
2589211|NCT00320190|6354105|P2|NOT COMPLETED|First 12 Months||10
2589212|NCT00320190|6354106|P1|NOT COMPLETED|First 12 Months||8
2589213|NCT00320190|6354105|P2|COMPLETED|First 12 Months||3
2589214|NCT00320190|6354106|P1|COMPLETED|First 12 Months||11
2589215|NCT00320190|6354105|P2|STARTED|First 12 Months||13
2589216|NCT00320190|6354106|P1|STARTED|First 12 Months||19
2589217|NCT00320112|6354126|P2|NOT COMPLETED|Overall Study||5
2589218|NCT00320112|6354127|P1|NOT COMPLETED|Overall Study||8
2589219|NCT00320112|6354126|P2|COMPLETED|Overall Study||114
2589220|NCT00320112|6354127|P1|COMPLETED|Overall Study||117
2589221|NCT00320112|6354126|P2|STARTED|Overall Study||119
2589222|NCT00320112|6354127|P1|STARTED|Overall Study||125
2589223|NCT00319982|6354141|P2|NOT COMPLETED|Overall Study||0
2589224|NCT00319982|6354142|P1|NOT COMPLETED|Overall Study||1
2589225|NCT00319982|6354141|P2|COMPLETED|Overall Study||20
2589226|NCT00319982|6354142|P1|COMPLETED|Overall Study||18
2589227|NCT00319982|6354141|P2|STARTED|Overall Study||20
2589228|NCT00319982|6354142|P1|STARTED|Overall Study||19
2589229|NCT00319956|6354162|P2|NOT COMPLETED|Overall Study||24
2589230|NCT00319956|6354163|P1|NOT COMPLETED|Overall Study||20
2589231|NCT00319956|6354162|P2|COMPLETED|Overall Study||85
2589232|NCT00319956|6354163|P1|COMPLETED|Overall Study||91
2589233|NCT00319956|6354162|P2|STARTED|Overall Study||109
2589234|NCT00319956|6354163|P1|STARTED|Overall Study||111
2589235|NCT00319839|6354175|P1|NOT COMPLETED|Overall Study||6
2589236|NCT00319839|6354175|P1|COMPLETED|Overall Study||1
2589237|NCT00319839|6354175|P1|STARTED|Overall Study||7
2589238|NCT00319748|6354181|P1|NOT COMPLETED|Overall Study||0
2589239|NCT00319748|6354181|P1|COMPLETED|Overall Study||13
2589240|NCT00319748|6354181|P1|STARTED|Overall Study||13
2589241|NCT00319735|6354191|P1|NOT COMPLETED|Overall Study||2
2589242|NCT00319735|6354191|P1|COMPLETED|Overall Study||39
2589243|NCT00319735|6354191|P1|STARTED|Overall Study||41
2589244|NCT00319696|6354204|P1|NOT COMPLETED|Overall Study||60
2589245|NCT00319696|6354204|P1|COMPLETED|Overall Study||56
2589246|NCT00319696|6354204|P1|STARTED|Overall Study||116
2589247|NCT00319644|6354230|P2|NOT COMPLETED|Overall Study||0
2589248|NCT00319644|6354231|P1|NOT COMPLETED|Overall Study||0
2589249|NCT00319644|6354230|P2|COMPLETED|Overall Study||16
2589250|NCT00319644|6354231|P1|COMPLETED|Overall Study||21
2589251|NCT00319644|6354230|P2|STARTED|Overall Study||16
2589252|NCT00319644|6354231|P1|STARTED|Overall Study||21
2589253|NCT00319592|6354241|P2|NOT COMPLETED|Overall Study||1
2589254|NCT00319592|6354242|P1|NOT COMPLETED|Overall Study||1
2589255|NCT00319592|6354241|P2|COMPLETED|Overall Study||29
2589256|NCT00319592|6354242|P1|COMPLETED|Overall Study||29
2589257|NCT00319592|6354241|P2|STARTED|Overall Study||30
2589258|NCT00319592|6354242|P1|STARTED|Overall Study||30
2589259|NCT00319553|6354258|P2|NOT COMPLETED|Overall Study||4
2589260|NCT00319553|6354259|P1|NOT COMPLETED|Overall Study||4
2589261|NCT00319553|6354258|P2|COMPLETED|Overall Study||317
2589262|NCT00319553|6354259|P1|COMPLETED|Overall Study||319
2589263|NCT00319553|6354258|P2|STARTED|Overall Study||321
2589264|NCT00319553|6354259|P1|STARTED|Overall Study||323
2589265|NCT00319501|6354273|P2|NOT COMPLETED|Open-label Extension Period||0
2589266|NCT00319501|6354274|P1|NOT COMPLETED|Open-label Extension Period||51
2589267|NCT00319501|6354273|P2|COMPLETED|Open-label Extension Period||0
2589268|NCT00319501|6354274|P1|COMPLETED|Open-label Extension Period||0
2589269|NCT00319501|6354273|P2|Received Treatment|Open-label Extension Period||0
2589270|NCT00319501|6354274|P1|Received Treatment|Open-label Extension Period||33
2589271|NCT00319501|6354273|P2|STARTED|Open-label Extension Period||0
2589272|NCT00319501|6354274|P1|STARTED|Open-label Extension Period|Eligible participants who chose to continue treatment|51
2589273|NCT00319501|6354273|P2|NOT COMPLETED|Open-label Period||0
2589274|NCT00319501|6354274|P1|NOT COMPLETED|Open-label Period||116
2589275|NCT00319501|6354273|P2|COMPLETED|Open-label Period||0
2589276|NCT00319501|6354274|P1|COMPLETED|Open-label Period|Competed=continuing treatment|45
2589277|NCT00319501|6354273|P2|Received Treatment|Open-label Period||0
2589278|NCT00319501|6354274|P1|Received Treatment|Open-label Period||128
2589279|NCT00319501|6354273|P2|STARTED|Open-label Period||0
2589280|NCT00319501|6354274|P1|STARTED|Open-label Period|Participants who continued to meet eligibility requirements|161
2589281|NCT00319501|6354273|P2|NOT COMPLETED|Double-blind Period||32
2589282|NCT00319501|6354274|P1|NOT COMPLETED|Double-blind Period||43
2589283|NCT00319501|6354273|P2|COMPLETED|Double-blind Period||78
2589284|NCT00319501|6354274|P1|COMPLETED|Double-blind Period||81
2589285|NCT00319501|6354273|P2|Received Treatment|Double-blind Period||81
2589286|NCT00319501|6354274|P1|Received Treatment|Double-blind Period||82
2589287|NCT00319501|6354273|P2|STARTED|Double-blind Period|Randomized participants|110
2589288|NCT00319501|6354274|P1|STARTED|Double-blind Period|Randomized participants|124
2589289|NCT00319449|6354300|P2|NOT COMPLETED|Overall Study||0
2589290|NCT00319449|6354301|P1|NOT COMPLETED|Overall Study||2
2589291|NCT00319449|6354300|P2|COMPLETED|Overall Study||12
2589292|NCT00319449|6354301|P1|COMPLETED|Overall Study||8
2589293|NCT00319449|6354300|P2|STARTED|Overall Study||12
2589294|NCT00319449|6354301|P1|STARTED|Overall Study||10
2589295|NCT00319436|6354313|P2|NOT COMPLETED|Overall Study||7
2589296|NCT00319436|6354314|P1|NOT COMPLETED|Overall Study||6
2589297|NCT00319436|6354313|P2|COMPLETED|Overall Study||17
2589298|NCT00319436|6354314|P1|COMPLETED|Overall Study||17
2589299|NCT00319436|6354313|P2|STARTED|Overall Study||24
2589300|NCT00319436|6354314|P1|STARTED|Overall Study||23
2589301|NCT00319254|6354332|P1|NOT COMPLETED|Overall Study||54
2589302|NCT00319254|6354332|P1|COMPLETED|Overall Study||21
2589303|NCT00319254|6354332|P1|Treated|Overall Study||73
2589304|NCT00319254|6354332|P1|STARTED|Overall Study||75
2589305|NCT00319111|6354345|P1|NOT COMPLETED|Overall Study||47
2589306|NCT00319111|6354345|P1|COMPLETED|Overall Study||104
2589307|NCT00319111|6354345|P1|STARTED|Overall Study|148 patients enrolled in BENEFIT OL & 3 prematurely discontinued from BENEFIT (NCT00313222)|151
2589308|NCT00319098|6354359|P2|NOT COMPLETED|Overall Study||32
2589309|NCT00319098|6354360|P1|NOT COMPLETED|Overall Study||135
2589310|NCT00319098|6354359|P2|COMPLETED|Overall Study||1237
2589311|NCT00319098|6354360|P1|COMPLETED|Overall Study||3667
2589312|NCT00319098|6354359|P2|STARTED|Overall Study||1269
2589313|NCT00319098|6354360|P1|STARTED|Overall Study||3802
2589314|NCT00319046|6354418|P1|NOT COMPLETED|Overall Study||8
2589315|NCT00319046|6354418|P1|COMPLETED|Overall Study||34
2589316|NCT00319046|6354418|P1|STARTED|Overall Study|One patient was excluded from analysis as the baseline liver volume not available|42
2589317|NCT00319020|6354427|P2|NOT COMPLETED|Overall Study||13
2589318|NCT00319020|6354428|P1|NOT COMPLETED|Overall Study||7
2589319|NCT00319020|6354427|P2|COMPLETED|Overall Study||8
2589320|NCT00319020|6354428|P1|COMPLETED|Overall Study||8
2589321|NCT00319020|6354427|P2|Enrollment in FUTURE 2 (F-2)|Overall Study||20
2589322|NCT00319020|6354428|P1|Enrollment in FUTURE 2 (F-2)|Overall Study||13
2589323|NCT00319020|6354427|P2|STARTED|Overall Study||21
2589324|NCT00319020|6354428|P1|STARTED|Overall Study||15
2589325|NCT00318929|6354457|P1|NOT COMPLETED|Overall Study||0
2589326|NCT00318929|6354457|P1|COMPLETED|Overall Study||14
2589327|NCT00318929|6354457|P1|STARTED|Overall Study||14
2589328|NCT00318812|6354466|P2|NOT COMPLETED|Overall Study||0
2589329|NCT00318812|6354467|P1|NOT COMPLETED|Overall Study||0
2589330|NCT00318812|6354466|P2|COMPLETED|Overall Study||22
2589331|NCT00318812|6354467|P1|COMPLETED|Overall Study||18
2589332|NCT00318812|6354466|P2|STARTED|Overall Study||22
2589333|NCT00318812|6354467|P1|STARTED|Overall Study||18
2589334|NCT00318708|6354479|P2|NOT COMPLETED|Overall Study||5
2589335|NCT00318708|6354480|P1|NOT COMPLETED|Overall Study||8
2589336|NCT00318708|6354479|P2|COMPLETED|Overall Study||40
2589337|NCT00318708|6354480|P1|COMPLETED|Overall Study||39
2589338|NCT00318708|6354479|P2|8-week Milestone|Overall Study||42
2589339|NCT00318708|6354480|P1|8-week Milestone|Overall Study||42
2589340|NCT00318708|6354479|P2|STARTED|Overall Study||45
2589341|NCT00318708|6354480|P1|STARTED|Overall Study||47
2589342|NCT00318656|6354500|P2|NOT COMPLETED|Overall Study||2
2589343|NCT00318656|6354501|P1|NOT COMPLETED|Overall Study||0
2589344|NCT00318656|6354500|P2|COMPLETED|Overall Study|1 patient received by error avandamet treatment and 1 patient did not receive any treatment.|9
2589345|NCT00318656|6354501|P1|COMPLETED|Overall Study||12
2589346|NCT00318656|6354500|P2|STARTED|Overall Study||11
2589347|NCT00318656|6354501|P1|STARTED|Overall Study||12
2589348|NCT00318591|6354539|P2|NOT COMPLETED|Overall Study||45
2589349|NCT00318591|6354540|P1|NOT COMPLETED|Overall Study||60
2589350|NCT00318591|6354539|P2|COMPLETED|Overall Study||69
2589351|NCT00318591|6354540|P1|COMPLETED|Overall Study||45
2589352|NCT00318591|6354539|P2|STARTED|Overall Study||114
2589353|NCT00318591|6354540|P1|STARTED|Overall Study||105
2589354|NCT00318565|6354558|P1|NOT COMPLETED|Overall Study||24
2589355|NCT00318565|6354558|P1|COMPLETED|Overall Study||267
2589356|NCT00318565|6354558|P1|STARTED|Overall Study||291
2589357|NCT00318474|6354565|P2|NOT COMPLETED|Overall Study||17
2589358|NCT00318474|6354566|P1|NOT COMPLETED|Overall Study||18
2589359|NCT00318474|6354565|P2|COMPLETED|Overall Study||10
2589360|NCT00318474|6354566|P1|COMPLETED|Overall Study||7
2589361|NCT00318474|6354565|P2|STARTED|Overall Study||27
2589362|NCT00318474|6354566|P1|STARTED|Overall Study||25
2589363|NCT00318461|6354577|P5|NOT COMPLETED|Open-Label Extension, 18 Months||97
2589364|NCT00318461|6354578|P4|NOT COMPLETED|Open-Label Extension, 18 Months||43
2589365|NCT00318461|6354579|P3|NOT COMPLETED|Open-Label Extension, 18 Months||73
2589366|NCT00318461|6354580|P2|NOT COMPLETED|Open-Label Extension, 18 Months||60
2589367|NCT00318461|6354581|P1|NOT COMPLETED|Open-Label Extension, 18 Months||78
2589368|NCT00318461|6354577|P5|COMPLETED|Open-Label Extension, 18 Months||113
2589369|NCT00318461|6354578|P4|COMPLETED|Open-Label Extension, 18 Months||31
2589370|NCT00318461|6354579|P3|COMPLETED|Open-Label Extension, 18 Months||118
2589371|NCT00318461|6354580|P2|COMPLETED|Open-Label Extension, 18 Months||137
2589372|NCT00318461|6354581|P1|COMPLETED|Open-Label Extension, 18 Months||130
2589373|NCT00318461|6354577|P5|STARTED|Open-Label Extension, 18 Months||210
2589374|NCT00318461|6354578|P4|STARTED|Open-Label Extension, 18 Months||74
2589375|NCT00318461|6354579|P3|STARTED|Open-Label Extension, 18 Months||191
2589376|NCT00318461|6354580|P2|STARTED|Open-Label Extension, 18 Months||197
2589377|NCT00318461|6354581|P1|STARTED|Open-Label Extension, 18 Months||208
2589378|NCT00318461|6354577|P5|NOT COMPLETED|Double-Blind, 6 Months||34
2589379|NCT00318461|6354578|P4|NOT COMPLETED|Double-Blind, 6 Months||48
2589380|NCT00318461|6354579|P3|NOT COMPLETED|Double-Blind, 6 Months||51
2589381|NCT00318461|6354580|P2|NOT COMPLETED|Double-Blind, 6 Months||44
2589382|NCT00318461|6354581|P1|NOT COMPLETED|Double-Blind, 6 Months||34
2589383|NCT00318461|6354577|P5|COMPLETED|Double-Blind, 6 Months||210
2589384|NCT00318461|6354578|P4|COMPLETED|Double-Blind, 6 Months||74
2589385|NCT00318461|6354579|P3|COMPLETED|Double-Blind, 6 Months||191
2589386|NCT00318461|6354580|P2|COMPLETED|Double-Blind, 6 Months||197
2589387|NCT00318461|6354581|P1|COMPLETED|Double-Blind, 6 Months||208
2589388|NCT00318461|6354577|P5|Exposed to Study Drug|Double-Blind, 6 Months|Subjects withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|242
2589389|NCT00318461|6354578|P4|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|121
2589390|NCT00318461|6354579|P3|Exposed to Study Drug|Double-Blind, 6 Months||242
2589391|NCT00318461|6354580|P2|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|240
2589392|NCT00318461|6354581|P1|Exposed to Study Drug|Double-Blind, 6 Months||242
2589393|NCT00318461|6354577|P5|STARTED|Double-Blind, 6 Months|Randomised|244
2589394|NCT00318461|6354578|P4|STARTED|Double-Blind, 6 Months|Randomised|122
2589395|NCT00318461|6354579|P3|STARTED|Double-Blind, 6 Months|Randomised|242
2589396|NCT00318461|6354580|P2|STARTED|Double-Blind, 6 Months|Randomised|241
2589397|NCT00318461|6354581|P1|STARTED|Double-Blind, 6 Months|Randomised|242
2589398|NCT00318409|6354660|P2|NOT COMPLETED|Overall Study||1
2589399|NCT00318409|6354661|P1|NOT COMPLETED|Overall Study||2
2589400|NCT00318409|6354660|P2|COMPLETED|Overall Study||9
2589401|NCT00318409|6354661|P1|COMPLETED|Overall Study||18
2589402|NCT00318409|6354660|P2|STARTED|Overall Study||10
2589403|NCT00318409|6354661|P1|STARTED|Overall Study||20
2589404|NCT00318370|6354680|P3|NOT COMPLETED|Period 3||33
2589405|NCT00318370|6354681|P2|NOT COMPLETED|Period 3||0
2589406|NCT00318370|6354682|P1|NOT COMPLETED|Period 3||0
2589407|NCT00318370|6354680|P3|COMPLETED|Period 3||3
2589408|NCT00318370|6354681|P2|COMPLETED|Period 3||0
2589409|NCT00318370|6354682|P1|COMPLETED|Period 3||0
2589410|NCT00318370|6354680|P3|STARTED|Period 3||36
2589411|NCT00318370|6354681|P2|STARTED|Period 3||0
2589412|NCT00318370|6354682|P1|STARTED|Period 3||0
2589413|NCT00318370|6354680|P3|NOT COMPLETED|Period 2||0
2589414|NCT00318370|6354681|P2|NOT COMPLETED|Period 2||11
2589415|NCT00318370|6354682|P1|NOT COMPLETED|Period 2||0
2589416|NCT00318370|6354680|P3|COMPLETED|Period 2||0
2589417|NCT00318370|6354681|P2|COMPLETED|Period 2||36
2589418|NCT00318370|6354682|P1|COMPLETED|Period 2||0
2589419|NCT00318370|6354680|P3|STARTED|Period 2||0
2589420|NCT00318370|6354681|P2|STARTED|Period 2|26 participants enrolled directly into Chemo Plus Far plus 21 participants from Far Only.|47
2589421|NCT00318370|6354682|P1|STARTED|Period 2||0
2589422|NCT00318370|6354680|P3|NOT COMPLETED|Period 1||0
2589423|NCT00318370|6354681|P2|NOT COMPLETED|Period 1||0
2589424|NCT00318370|6354682|P1|NOT COMPLETED|Period 1||7
2589425|NCT00318370|6354680|P3|COMPLETED|Period 1||0
2589426|NCT00318370|6354681|P2|COMPLETED|Period 1||0
2589427|NCT00318370|6354682|P1|COMPLETED|Period 1|21 participants proceeded from Far Only to Chemo Plus Far.|21
2589428|NCT00318370|6354680|P3|STARTED|Period 1||0
2589429|NCT00318370|6354681|P2|STARTED|Period 1||0
2589430|NCT00318370|6354682|P1|STARTED|Period 1||28
2589431|NCT00318357|6354694|P2|NOT COMPLETED|Overall Study||32
2589432|NCT00318357|6354695|P1|NOT COMPLETED|Overall Study||39
2589433|NCT00318357|6354694|P2|COMPLETED|Overall Study||104
2589434|NCT00318357|6354695|P1|COMPLETED|Overall Study||134
2589435|NCT00318357|6354694|P2|STARTED|Overall Study||136
2589436|NCT00318357|6354695|P1|STARTED|Overall Study||173
2589437|NCT00318292|6354703|P2|NOT COMPLETED|Overall Study||0
2589438|NCT00318292|6354704|P1|NOT COMPLETED|Overall Study||0
2589439|NCT00318292|6354703|P2|COMPLETED|Overall Study||45
2589440|NCT00318292|6354704|P1|COMPLETED|Overall Study||45
2589441|NCT00318292|6354703|P2|STARTED|Overall Study||45
2589442|NCT00318292|6354704|P1|STARTED|Overall Study||45
2589443|NCT00318149|6354716|P6|NOT COMPLETED|Overall Study||2
2589444|NCT00318149|6354717|P5|NOT COMPLETED|Overall Study||0
2589445|NCT00318149|6354718|P4|NOT COMPLETED|Overall Study||0
2589446|NCT00318149|6354719|P3|NOT COMPLETED|Overall Study||0
2589447|NCT00318149|6354720|P2|NOT COMPLETED|Overall Study||0
2589448|NCT00318149|6354721|P1|NOT COMPLETED|Overall Study||0
2589449|NCT00318149|6354716|P6|COMPLETED|Overall Study||73
2589450|NCT00318149|6354717|P5|COMPLETED|Overall Study||75
2589451|NCT00318149|6354718|P4|COMPLETED|Overall Study||75
2589452|NCT00318149|6354719|P3|COMPLETED|Overall Study||75
2589453|NCT00318149|6354720|P2|COMPLETED|Overall Study||50
2589454|NCT00318149|6354721|P1|COMPLETED|Overall Study||75
2589455|NCT00318149|6354716|P6|STARTED|Overall Study||75
2589456|NCT00318149|6354717|P5|STARTED|Overall Study||75
2589457|NCT00318149|6354718|P4|STARTED|Overall Study||75
2589458|NCT00318149|6354719|P3|STARTED|Overall Study||75
2589459|NCT00318149|6354720|P2|STARTED|Overall Study||50
2589460|NCT00318149|6354721|P1|STARTED|Overall Study||75
2589461|NCT00318136|6354807|P1|NOT COMPLETED|Overall Study||45
2589462|NCT00318136|6354807|P1|COMPLETED|Overall Study||2
2589463|NCT00318136|6354807|P1|STARTED|Overall Study||47
2589464|NCT00317941|6354816|P3|NOT COMPLETED|Overall Study||8
2589465|NCT00317941|6354817|P2|NOT COMPLETED|Overall Study||5
2589466|NCT00317941|6354818|P1|NOT COMPLETED|Overall Study||7
2589467|NCT00317941|6354816|P3|COMPLETED|Overall Study||60
2589468|NCT00317941|6354817|P2|COMPLETED|Overall Study||74
2589469|NCT00317941|6354818|P1|COMPLETED|Overall Study||66
2589470|NCT00317941|6354816|P3|Fulfilled Requirements PP Population|Overall Study||63
2589471|NCT00317941|6354817|P2|Fulfilled Requirements PP Population|Overall Study||76
2589472|NCT00317941|6354818|P1|Fulfilled Requirements PP Population|Overall Study||66
2589473|NCT00317941|6354816|P3|Fulfilled Requirement Safety Population|Overall Study||65
2589474|NCT00317941|6354817|P2|Fulfilled Requirement Safety Population|Overall Study||77
2589475|NCT00317941|6354818|P1|Fulfilled Requirement Safety Population|Overall Study||73
2589476|NCT00317941|6354816|P3|Participants Received Treatment|Overall Study||68
2589477|NCT00317941|6354817|P2|Participants Received Treatment|Overall Study||79
2589478|NCT00317941|6354818|P1|Participants Received Treatment|Overall Study||73
2589479|NCT00317941|6354816|P3|STARTED|Overall Study||68
2589480|NCT00317941|6354817|P2|STARTED|Overall Study||79
2589481|NCT00317941|6354818|P1|STARTED|Overall Study||73
2589482|NCT00317720|6354859|P2|NOT COMPLETED|Overall Study||0
2589483|NCT00317720|6354860|P1|NOT COMPLETED|Overall Study||0
2589484|NCT00317720|6354859|P2|COMPLETED|Overall Study||7
2589485|NCT00317720|6354860|P1|COMPLETED|Overall Study||40
2589486|NCT00317720|6354859|P2|STARTED|Overall Study||7
2589487|NCT00317720|6354860|P1|STARTED|Overall Study||40
2589488|NCT00317642|6354867|P2|NOT COMPLETED|Overall Study||135
2589489|NCT00317642|6354868|P1|NOT COMPLETED|Overall Study||122
2589490|NCT00317642|6354867|P2|COMPLETED|Overall Study|achieved remission and completed consolidation|28
2589491|NCT00317642|6354868|P1|COMPLETED|Overall Study|achieved remission and completed consolidation|41
2589492|NCT00317642|6354867|P2|Received >= 1 Study Drug (Safety Set)|Overall Study||155
2589493|NCT00317642|6354868|P1|Received >= 1 Study Drug (Safety Set)|Overall Study||161
2589494|NCT00317642|6354867|P2|Full Analysis Set|Overall Study|AML Centrally Confirmed|158
2589495|NCT00317642|6354868|P1|Full Analysis Set|Overall Study|AML Centrally Confirmed|162
2589496|NCT00317642|6354867|P2|STARTED|Overall Study||163
2589497|NCT00317642|6354868|P1|STARTED|Overall Study||163
2589498|NCT00317473|6354947|P6|NOT COMPLETED|Overall Study||3
2589499|NCT00317473|6354948|P5|NOT COMPLETED|Overall Study||8
2589500|NCT00317473|6354949|P4|NOT COMPLETED|Overall Study||2
2589501|NCT00317473|6354950|P3|NOT COMPLETED|Overall Study||3
2589502|NCT00317473|6354951|P2|NOT COMPLETED|Overall Study||3
2589503|NCT00317473|6354952|P1|NOT COMPLETED|Overall Study||4
2589504|NCT00317473|6354947|P6|COMPLETED|Overall Study||12
2589505|NCT00317473|6354948|P5|COMPLETED|Overall Study||22
2589506|NCT00317473|6354949|P4|COMPLETED|Overall Study||13
2589507|NCT00317473|6354950|P3|COMPLETED|Overall Study||27
2589508|NCT00317473|6354951|P2|COMPLETED|Overall Study||12
2589509|NCT00317473|6354952|P1|COMPLETED|Overall Study||26
2589510|NCT00317473|6354947|P6|STARTED|Overall Study||15
2589511|NCT00317473|6354948|P5|STARTED|Overall Study||30
2589512|NCT00317473|6354949|P4|STARTED|Overall Study||15
2589513|NCT00317473|6354950|P3|STARTED|Overall Study||30
2589514|NCT00317473|6354951|P2|STARTED|Overall Study||15
2589515|NCT00317473|6354952|P1|STARTED|Overall Study||30
2589516|NCT00317239|6354978|P2|NOT COMPLETED|Overall Study||19
2589517|NCT00317239|6354979|P1|NOT COMPLETED|Overall Study||13
2589518|NCT00317239|6354978|P2|COMPLETED|Overall Study||84
2589519|NCT00317239|6354979|P1|COMPLETED|Overall Study||134
2589520|NCT00317239|6354978|P2|STARTED|Overall Study||103
2589521|NCT00317239|6354979|P1|STARTED|Overall Study||147
2589522|NCT00317226|6354985|P1|NOT COMPLETED|Overall Study||23
2589523|NCT00317226|6354985|P1|COMPLETED|Overall Study||104
2589524|NCT00317226|6354985|P1|STARTED|Overall Study||127
2589525|NCT00317109|6354991|P2|NOT COMPLETED|Overall Study||0
2589526|NCT00317109|6354992|P1|NOT COMPLETED|Overall Study||3
2589527|NCT00317109|6354991|P2|COMPLETED|Overall Study||84
2589528|NCT00317109|6354992|P1|COMPLETED|Overall Study||81
2589529|NCT00317109|6354991|P2|STARTED|Overall Study||84
2589530|NCT00317109|6354992|P1|STARTED|Overall Study||84
2589531|NCT00317044|6355029|P3|NOT COMPLETED|Overall Study||45
2589532|NCT00317044|6355030|P2|NOT COMPLETED|Overall Study||40
2589533|NCT00317044|6355031|P1|NOT COMPLETED|Overall Study||48
2589534|NCT00317044|6355029|P3|COMPLETED|Overall Study||283
2589535|NCT00317044|6355030|P2|COMPLETED|Overall Study||273
2589536|NCT00317044|6355031|P1|COMPLETED|Overall Study||272
2589537|NCT00317044|6355029|P3|STARTED|Overall Study||328
2589538|NCT00317044|6355030|P2|STARTED|Overall Study||313
2589539|NCT00317044|6355031|P1|STARTED|Overall Study||320
2589540|NCT00316914|6355077|P2|NOT COMPLETED|Overall Study||36
2589541|NCT00316914|6355078|P1|NOT COMPLETED|Overall Study||33
2589542|NCT00316914|6355077|P2|COMPLETED|Overall Study||16
2589543|NCT00316914|6355078|P1|COMPLETED|Overall Study||17
2589544|NCT00316914|6355077|P2|STARTED|Overall Study||52
2589545|NCT00316914|6355078|P1|STARTED|Overall Study||50
2589546|NCT00316888|6355108|P2|NOT COMPLETED|Overall Study||8
2589547|NCT00316888|6355109|P1|NOT COMPLETED|Overall Study||6
2589548|NCT00316888|6355108|P2|COMPLETED|Overall Study||27
2589549|NCT00316888|6355109|P1|COMPLETED|Overall Study||22
2589550|NCT00316888|6355108|P2|Started Chemo+Radiation+Cetuximab|Overall Study||34
2589551|NCT00316888|6355109|P1|Started Chemo+Radiation+Cetuximab|Overall Study|One patient did not start chemo+radiation therapy after completing induction therapy|27
2589552|NCT00316888|6355108|P2|Started Induction Chemotherapy|Overall Study|Induction chemotherapy was removed for patients on this arm|0
2589553|NCT00316888|6355109|P1|Started Induction Chemotherapy|Overall Study||28
2589554|NCT00316888|6355108|P2|Treated|Overall Study||34
2589555|NCT00316888|6355109|P1|Treated|Overall Study|Received induction and/or chemo+radiation therapy|28
2589556|NCT00316888|6355108|P2|Eligible|Overall Study||35
2589557|NCT00316888|6355109|P1|Eligible|Overall Study||28
2589558|NCT00316888|6355108|P2|STARTED|Overall Study||35
2589559|NCT00316888|6355109|P1|STARTED|Overall Study||28
2589560|NCT00316862|6355123|P1|NOT COMPLETED|Overall Study||0
2589561|NCT00316862|6355123|P1|COMPLETED|Overall Study||82
2589562|NCT00316862|6355123|P1|STARTED|Overall Study||82
2589563|NCT00316719|6355131|P2|NOT COMPLETED|Overall Study||6
2589564|NCT00316719|6355132|P1|NOT COMPLETED|Overall Study||2
2589565|NCT00316719|6355131|P2|COMPLETED|Overall Study||47
2589566|NCT00316719|6355132|P1|COMPLETED|Overall Study||50
2589567|NCT00316719|6355131|P2|STARTED|Overall Study||53
2589568|NCT00316719|6355132|P1|STARTED|Overall Study||52
2589569|NCT00316706|6355158|P2|NOT COMPLETED|Overall Study||48
2589570|NCT00316706|6355159|P1|NOT COMPLETED|Overall Study||38
2589571|NCT00316706|6355158|P2|COMPLETED|Overall Study|Subjects in Havrix group that completed the study at Month 24|571
2589572|NCT00316706|6355159|P1|COMPLETED|Overall Study|Subjects in Cervarix group that completed the study at Month 48|588
2589573|NCT00316706|6355158|P2|STARTED|Overall Study||619
2589574|NCT00316706|6355159|P1|STARTED|Overall Study||626
2589575|NCT00316693|6355175|P2|NOT COMPLETED|Overall Study||85
2589576|NCT00316693|6355176|P1|NOT COMPLETED|Overall Study||77
2589577|NCT00316693|6355175|P2|COMPLETED|Overall Study||436
2589578|NCT00316693|6355176|P1|COMPLETED|Overall Study||442
2589579|NCT00316693|6355175|P2|STARTED|Overall Study||521
2589580|NCT00316693|6355176|P1|STARTED|Overall Study||519
2589581|NCT00316602|6355218|P2|NOT COMPLETED|Overall Study||25
2589582|NCT00316602|6355219|P1|NOT COMPLETED|Overall Study||10
2589583|NCT00316602|6355218|P2|COMPLETED|Overall Study||325
2589584|NCT00316602|6355219|P1|COMPLETED|Overall Study||272
2589585|NCT00316602|6355218|P2|STARTED|Overall Study||350
2589586|NCT00316602|6355219|P1|STARTED|Overall Study||282
2589587|NCT00316589|6355251|P4|NOT COMPLETED|Overall Study||5
2589588|NCT00316589|6355252|P3|NOT COMPLETED|Overall Study||1
2589589|NCT00316589|6355253|P2|NOT COMPLETED|Overall Study||24
2589590|NCT00316589|6355254|P1|NOT COMPLETED|Overall Study||1
2589591|NCT00316589|6355251|P4|COMPLETED|Overall Study||127
2589592|NCT00316589|6355252|P3|COMPLETED|Overall Study||8
2589593|NCT00316589|6355253|P2|COMPLETED|Overall Study||328
2589594|NCT00316589|6355254|P1|COMPLETED|Overall Study||87
2589595|NCT00316589|6355251|P4|STARTED|Overall Study||132
2589596|NCT00316589|6355252|P3|STARTED|Overall Study||9
2589597|NCT00316589|6355253|P2|STARTED|Overall Study||352
2589598|NCT00316589|6355254|P1|STARTED|Overall Study||88
2589599|NCT00316524|6355322|P4|NOT COMPLETED|Overall Study||0
2589600|NCT00316524|6355323|P3|NOT COMPLETED|Overall Study||6
2589601|NCT00316524|6355324|P2|NOT COMPLETED|Overall Study||8
2589602|NCT00316524|6355325|P1|NOT COMPLETED|Overall Study||8
2589603|NCT00316524|6355322|P4|COMPLETED|Overall Study||200
2589604|NCT00316524|6355323|P3|COMPLETED|Overall Study||175
2589605|NCT00316524|6355324|P2|COMPLETED|Overall Study||173
2589606|NCT00316524|6355325|P1|COMPLETED|Overall Study||175
2589607|NCT00316524|6355322|P4|STARTED|Overall Study||200
2589608|NCT00316524|6355323|P3|STARTED|Overall Study||181
2589609|NCT00316524|6355324|P2|STARTED|Overall Study||181
2589610|NCT00316524|6355325|P1|STARTED|Overall Study||183
2589611|NCT00316355|6355377|P2|NOT COMPLETED|Overall Study||7
2589612|NCT00316355|6355378|P1|NOT COMPLETED|Overall Study||5
2589613|NCT00316355|6355377|P2|COMPLETED|Overall Study||12
2589614|NCT00316355|6355378|P1|COMPLETED|Overall Study||10
2589615|NCT00316355|6355377|P2|Started Treatment|Overall Study||18
2589616|NCT00316355|6355378|P1|Started Treatment|Overall Study||12
2589617|NCT00316355|6355377|P2|STARTED|Overall Study||19
2589618|NCT00316355|6355378|P1|STARTED|Overall Study||15
2589619|NCT00316303|6355388|P2|NOT COMPLETED|Overall Study||16
2589620|NCT00316303|6355389|P1|NOT COMPLETED|Overall Study||11
2589621|NCT00316303|6355388|P2|COMPLETED|Overall Study||102
2589622|NCT00316303|6355389|P1|COMPLETED|Overall Study||107
2589623|NCT00316303|6355388|P2|STARTED|Overall Study||118
2589624|NCT00316303|6355389|P1|STARTED|Overall Study||118
2589625|NCT00316277|6355405|P2|NOT COMPLETED|Phase 2 (24 Weeks)||19
2589626|NCT00316277|6355406|P1|NOT COMPLETED|Phase 2 (24 Weeks)||19
2589627|NCT00316277|6355405|P2|COMPLETED|Phase 2 (24 Weeks)||161
2589628|NCT00316277|6355406|P1|COMPLETED|Phase 2 (24 Weeks)||161
2589629|NCT00316277|6355405|P2|STARTED|Phase 2 (24 Weeks)||180
2589630|NCT00316277|6355406|P1|STARTED|Phase 2 (24 Weeks)||180
2589631|NCT00316277|6355405|P2|NOT COMPLETED|Phase 1 (12 Weeks)||300
2589632|NCT00316277|6355406|P1|NOT COMPLETED|Phase 1 (12 Weeks)||310
2589633|NCT00316277|6355405|P2|COMPLETED|Phase 1 (12 Weeks)||24
2589634|NCT00316277|6355406|P1|COMPLETED|Phase 1 (12 Weeks)||19
2589635|NCT00316277|6355405|P2|STARTED|Phase 1 (12 Weeks)||324
2589636|NCT00316277|6355406|P1|STARTED|Phase 1 (12 Weeks)||329
2589637|NCT00316264|6355427|P3|NOT COMPLETED|Overall Study||6
2589638|NCT00316264|6355428|P2|NOT COMPLETED|Overall Study||7
2589639|NCT00316264|6355429|P1|NOT COMPLETED|Overall Study||6
2589640|NCT00316264|6355427|P3|COMPLETED|Overall Study||87
2589641|NCT00316264|6355428|P2|COMPLETED|Overall Study||77
2589642|NCT00316264|6355429|P1|COMPLETED|Overall Study||77
2589643|NCT00316264|6355427|P3|STARTED|Overall Study||93
2589644|NCT00316264|6355428|P2|STARTED|Overall Study||84
2589645|NCT00316264|6355429|P1|STARTED|Overall Study||83
2589646|NCT00316225|6355497|P1|NOT COMPLETED|Overall Study||25
2589647|NCT00316225|6355497|P1|COMPLETED|Overall Study||6
2589648|NCT00316225|6355497|P1|STARTED|Overall Study||31
2589649|NCT00316199|6355506|P1|NOT COMPLETED|Overall Study||12
2589650|NCT00316199|6355506|P1|COMPLETED|Overall Study||48
2589651|NCT00316199|6355506|P1|STARTED|Overall Study||60
2589652|NCT00316186|6355514|P1|NOT COMPLETED|Overall Study||12
2589653|NCT00316186|6355514|P1|COMPLETED|Overall Study||21
2589654|NCT00316186|6355514|P1|STARTED|Overall Study||33
2589655|NCT00316173|6355528|P2|NOT COMPLETED|Treatment Phase||42
2589656|NCT00316173|6355529|P1|NOT COMPLETED|Treatment Phase||0
2589657|NCT00316173|6355528|P2|COMPLETED|Treatment Phase||13
2589658|NCT00316173|6355529|P1|COMPLETED|Treatment Phase||0
2589659|NCT00316173|6355528|P2|STARTED|Treatment Phase||55
2589660|NCT00316173|6355529|P1|STARTED|Treatment Phase||0
2589661|NCT00316173|6355528|P2|NOT COMPLETED|Run-in Phase||0
2589662|NCT00316173|6355529|P1|NOT COMPLETED|Run-in Phase||7
2589663|NCT00316173|6355528|P2|COMPLETED|Run-in Phase||0
2589664|NCT00316173|6355529|P1|COMPLETED|Run-in Phase||15
2589665|NCT00316173|6355528|P2|STARTED|Run-in Phase||0
2589666|NCT00316173|6355529|P1|STARTED|Run-in Phase||22
2589667|NCT00316121|6355542|P2|NOT COMPLETED|Overall Study||9
2589668|NCT00316121|6355543|P1|NOT COMPLETED|Overall Study||22
2589669|NCT00316121|6355542|P2|COMPLETED|Overall Study||37
2589670|NCT00316121|6355543|P1|COMPLETED|Overall Study||70
2589671|NCT00316121|6355542|P2|STARTED|Overall Study||46
2589672|NCT00316121|6355543|P1|STARTED|Overall Study||92
2589673|NCT00316082|6355554|P5|NOT COMPLETED|Overall Study||26
2589674|NCT00316082|6355555|P4|NOT COMPLETED|Overall Study||26
2589675|NCT00316082|6355556|P3|NOT COMPLETED|Overall Study||27
2589676|NCT00316082|6355557|P2|NOT COMPLETED|Overall Study||22
2589677|NCT00316082|6355558|P1|NOT COMPLETED|Overall Study||33
2589678|NCT00316082|6355554|P5|COMPLETED|Overall Study||48
2589679|NCT00316082|6355555|P4|COMPLETED|Overall Study||46
2589680|NCT00316082|6355556|P3|COMPLETED|Overall Study||44
2589681|NCT00316082|6355557|P2|COMPLETED|Overall Study||52
2589682|NCT00316082|6355558|P1|COMPLETED|Overall Study||41
2589683|NCT00316082|6355554|P5|Completed Study Without Being Rescued|Overall Study||31
2589684|NCT00316082|6355555|P4|Completed Study Without Being Rescued|Overall Study||27
2589685|NCT00316082|6355556|P3|Completed Study Without Being Rescued|Overall Study||29
2589686|NCT00316082|6355557|P2|Completed Study Without Being Rescued|Overall Study||35
2589687|NCT00316082|6355558|P1|Completed Study Without Being Rescued|Overall Study||25
2589688|NCT00316082|6355554|P5|STARTED|Overall Study||74
2589689|NCT00316082|6355555|P4|STARTED|Overall Study||72
2589690|NCT00316082|6355556|P3|STARTED|Overall Study||71
2589691|NCT00316082|6355557|P2|STARTED|Overall Study||74
2589692|NCT00316082|6355558|P1|STARTED|Overall Study||74
2589693|NCT00316017|6355589|P3|NOT COMPLETED|Overall Study||19
2589694|NCT00316017|6355590|P2|NOT COMPLETED|Overall Study||13
2589695|NCT00316017|6355591|P1|NOT COMPLETED|Overall Study||11
2589696|NCT00316017|6355589|P3|COMPLETED|Overall Study||376
2589697|NCT00316017|6355590|P2|COMPLETED|Overall Study||256
2589698|NCT00316017|6355591|P1|COMPLETED|Overall Study||220
2589699|NCT00316017|6355589|P3|STARTED|Overall Study|19 of 19 not complete due to BONG|395
2589700|NCT00316017|6355590|P2|STARTED|Overall Study|12 of 13 not completed due to BONG; 1 not completed was a prisoner who was excluded|269
2589701|NCT00316017|6355591|P1|STARTED|Overall Study|"11 of 11 not completed due to Bag Opened Not Given (BONG)"|231
2589702|NCT00316004|6355665|P3|NOT COMPLETED|Overall Study||21
2589703|NCT00316004|6355666|P2|NOT COMPLETED|Overall Study||14
2589704|NCT00316004|6355667|P1|NOT COMPLETED|Overall Study||14
2589705|NCT00316004|6355665|P3|COMPLETED|Overall Study||582
2589706|NCT00316004|6355666|P2|COMPLETED|Overall Study||341
2589707|NCT00316004|6355667|P1|COMPLETED|Overall Study||359
2589708|NCT00316004|6355665|P3|STARTED|Overall Study||603
2589709|NCT00316004|6355666|P2|STARTED|Overall Study||355
2589710|NCT00316004|6355667|P1|STARTED|Overall Study||373
2589711|NCT00315939|6355722|P2|NOT COMPLETED|Admission 3 (3 Months)||2
2589712|NCT00315939|6355723|P1|NOT COMPLETED|Admission 3 (3 Months)||4
2589713|NCT00315939|6355722|P2|COMPLETED|Admission 3 (3 Months)||49
2589714|NCT00315939|6355723|P1|COMPLETED|Admission 3 (3 Months)||48
2589715|NCT00315939|6355722|P2|STARTED|Admission 3 (3 Months)||51
2589716|NCT00315939|6355723|P1|STARTED|Admission 3 (3 Months)||52
2589717|NCT00315939|6355722|P2|NOT COMPLETED|Admission 2 (3 Months)||4
2589718|NCT00315939|6355723|P1|NOT COMPLETED|Admission 2 (3 Months)||4
2589719|NCT00315939|6355722|P2|COMPLETED|Admission 2 (3 Months)||51
2589720|NCT00315939|6355723|P1|COMPLETED|Admission 2 (3 Months)||52
2589721|NCT00315939|6355722|P2|STARTED|Admission 2 (3 Months)||55
2589722|NCT00315939|6355723|P1|STARTED|Admission 2 (3 Months)||56
2589723|NCT00315939|6355722|P2|NOT COMPLETED|Admission 1 (3 Months)||6
2589724|NCT00315939|6355723|P1|NOT COMPLETED|Admission 1 (3 Months)||3
2589725|NCT00315939|6355722|P2|COMPLETED|Admission 1 (3 Months)||55
2589726|NCT00315939|6355723|P1|COMPLETED|Admission 1 (3 Months)||56
2589727|NCT00315939|6355722|P2|STARTED|Admission 1 (3 Months)||61
2589728|NCT00315939|6355723|P1|STARTED|Admission 1 (3 Months)||59
2589729|NCT00315822|6355731|P2|NOT COMPLETED|Overall Study||0
2589730|NCT00315822|6355732|P1|NOT COMPLETED|Overall Study||0
2589731|NCT00315822|6355731|P2|COMPLETED|Overall Study||202
2589732|NCT00315822|6355732|P1|COMPLETED|Overall Study||198
2589733|NCT00315822|6355731|P2|STARTED|Overall Study||202
2589734|NCT00315822|6355732|P1|STARTED|Overall Study||198
2589735|NCT00315731|6355738|P1|NOT COMPLETED|Overall Study||6
2589736|NCT00315731|6355738|P1|COMPLETED|Overall Study||9
2589737|NCT00315731|6355738|P1|STARTED|Overall Study||15
2589738|NCT00315705|6355766|P1|NOT COMPLETED|Phase 2||25
2589739|NCT00315705|6355766|P1|COMPLETED|Phase 2|No Phase 2 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
2589740|NCT00315705|6355766|P1|STARTED|Phase 2|Phase 1 and phase 2 are separate populations|25
2589741|NCT00315705|6355766|P1|NOT COMPLETED|Phase 1||25
2589742|NCT00315705|6355766|P1|COMPLETED|Phase 1|No Phase 1 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
2589743|NCT00315705|6355766|P1|STARTED|Phase 1||25
2589744|NCT00315627|6355803|P1|NOT COMPLETED|Overall Study||0
2589745|NCT00315627|6355803|P1|COMPLETED|Overall Study||3
2589746|NCT00315627|6355803|P1|STARTED|Overall Study||3
2589747|NCT00315614|6355811|P1|NOT COMPLETED|Overall Study||0
2589748|NCT00315614|6355811|P1|COMPLETED|Overall Study||3
2589749|NCT00315614|6355811|P1|STARTED|Overall Study||3
2589750|NCT00315588|6355818|P1|NOT COMPLETED|Overall Study||0
2589751|NCT00315588|6355818|P1|COMPLETED|Overall Study||7
2589752|NCT00315588|6355818|P1|STARTED|Overall Study||7
2589753|NCT00315458|6355827|P4|NOT COMPLETED|Overall Study||29
2589754|NCT00315458|6355828|P3|NOT COMPLETED|Overall Study||52
2589755|NCT00315458|6355829|P2|NOT COMPLETED|Overall Study||12
2589756|NCT00315458|6355830|P1|NOT COMPLETED|Overall Study||3
2589757|NCT00315458|6355827|P4|COMPLETED|Overall Study||10
2589758|NCT00315458|6355828|P3|COMPLETED|Overall Study||107
2589759|NCT00315458|6355829|P2|COMPLETED|Overall Study||44
2589760|NCT00315458|6355830|P1|COMPLETED|Overall Study||48
2589761|NCT00315458|6355827|P4|STARTED|Overall Study||39
2589762|NCT00315458|6355828|P3|STARTED|Overall Study||159
2589763|NCT00315458|6355829|P2|STARTED|Overall Study||56
2589764|NCT00315458|6355830|P1|STARTED|Overall Study||51
2589765|NCT00315445|6355843|P3|NOT COMPLETED|Overall Study||24
2589766|NCT00315445|6355844|P2|NOT COMPLETED|Overall Study||16
2589767|NCT00315445|6355845|P1|NOT COMPLETED|Overall Study||27
2589768|NCT00315445|6355843|P3|COMPLETED|Overall Study||22
2589769|NCT00315445|6355844|P2|COMPLETED|Overall Study||27
2589770|NCT00315445|6355845|P1|COMPLETED|Overall Study||18
2589771|NCT00315445|6355843|P3|STARTED|Overall Study||46
2589772|NCT00315445|6355844|P2|STARTED|Overall Study||43
2589773|NCT00315445|6355845|P1|STARTED|Overall Study||45
2589774|NCT00315341|6355918|P2|NOT COMPLETED|Overall Study||138
2589775|NCT00315341|6355919|P1|NOT COMPLETED|Overall Study||400
2589776|NCT00315341|6355918|P2|COMPLETED|Overall Study||391
2589777|NCT00315341|6355919|P1|COMPLETED|Overall Study||340
2589778|NCT00315341|6355918|P2|STARTED|Overall Study||529
2589779|NCT00315341|6355919|P1|STARTED|Overall Study||740
2589780|NCT00315328|6355929|P4|NOT COMPLETED|Overall Study||2
2589781|NCT00315328|6355930|P3|NOT COMPLETED|Overall Study||5
2589782|NCT00315328|6355931|P2|NOT COMPLETED|Overall Study||7
2589783|NCT00315328|6355932|P1|NOT COMPLETED|Overall Study||14
2589784|NCT00315328|6355929|P4|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|20
2589785|NCT00315328|6355930|P3|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|13
2589786|NCT00315328|6355931|P2|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|88
2589787|NCT00315328|6355932|P1|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|84
2589788|NCT00315328|6355929|P4|5 Week Visit|Overall Study||19
2589789|NCT00315328|6355930|P3|5 Week Visit|Overall Study||17
2589790|NCT00315328|6355931|P2|5 Week Visit|Overall Study||89
2589791|NCT00315328|6355932|P1|5 Week Visit|Overall Study||91
2589792|NCT00315328|6355929|P4|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|22
2589793|NCT00315328|6355930|P3|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|18
2589794|NCT00315328|6355931|P2|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|95
2589795|NCT00315328|6355932|P1|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|98
2589796|NCT00315302|6356002|P4|NOT COMPLETED|Overall Study||3
2589797|NCT00315302|6356003|P3|NOT COMPLETED|Overall Study||2
2589798|NCT00315302|6356004|P2|NOT COMPLETED|Overall Study||2
2589799|NCT00315302|6356005|P1|NOT COMPLETED|Overall Study||6
2589800|NCT00315302|6356002|P4|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|31
2589801|NCT00315302|6356003|P3|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|24
2589802|NCT00315302|6356004|P2|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|88
2589803|NCT00315302|6356005|P1|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|84
2589804|NCT00315302|6356002|P4|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|11
2589805|NCT00315302|6356003|P3|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|9
2589806|NCT00315302|6356004|P2|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|13
2589807|NCT00315302|6356005|P1|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|16
2589808|NCT00315302|6356002|P4|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|31
2589809|NCT00315302|6356003|P3|18 Week Primary Outcome Visit|Overall Study||24
2589810|NCT00315302|6356004|P2|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|88
2589811|NCT00315302|6356005|P1|18 Week Primary Outcome Visit|Overall Study||84
2589812|NCT00315302|6356002|P4|10 Week Visit|Overall Study||29
2589813|NCT00315302|6356003|P3|10 Week Visit|Overall Study||24
2589814|NCT00315302|6356004|P2|10 Week Visit|Overall Study||85
2589815|NCT00315302|6356005|P1|10 Week Visit|Overall Study|Can be higher as includes subjects who may have missed the 5 week visit|86
2589816|NCT00315302|6356002|P4|5 Week Visit|Overall Study||30
2589817|NCT00315302|6356003|P3|5 Week Visit|Overall Study||26
2589818|NCT00315302|6356004|P2|5 Week Visit|Overall Study||86
2589819|NCT00315302|6356005|P1|5 Week Visit|Overall Study||85
2589820|NCT00315302|6356002|P4|STARTED|Overall Study||34
2589821|NCT00315302|6356003|P3|STARTED|Overall Study||26
2589822|NCT00315302|6356004|P2|STARTED|Overall Study||90
2589823|NCT00315302|6356005|P1|STARTED|Overall Study||90
2589824|NCT00315146|6356051|P4|NOT COMPLETED|Overall Study||0
2589825|NCT00315146|6356052|P3|NOT COMPLETED|Overall Study||2
2589826|NCT00315146|6356053|P2|NOT COMPLETED|Overall Study||3
2589827|NCT00315146|6356054|P1|NOT COMPLETED|Overall Study||2
2589828|NCT00315146|6356051|P4|COMPLETED|Overall Study||22
2589829|NCT00315146|6356052|P3|COMPLETED|Overall Study||20
2589830|NCT00315146|6356053|P2|COMPLETED|Overall Study||19
2589831|NCT00315146|6356054|P1|COMPLETED|Overall Study||20
2589832|NCT00315146|6356051|P4|STARTED|Overall Study||22
2589833|NCT00315146|6356052|P3|STARTED|Overall Study||22
2589834|NCT00315146|6356053|P2|STARTED|Overall Study||22
2589835|NCT00315146|6356054|P1|STARTED|Overall Study||22
2589836|NCT00315120|6356072|P4|NOT COMPLETED|Overall Study||0
2589837|NCT00315120|6356073|P3|NOT COMPLETED|Overall Study||0
2589838|NCT00315120|6356074|P2|NOT COMPLETED|Overall Study||0
2589839|NCT00315120|6356075|P1|NOT COMPLETED|Overall Study||0
2589840|NCT00315120|6356072|P4|COMPLETED|Overall Study||107
2589841|NCT00315120|6356073|P3|COMPLETED|Overall Study||115
2589842|NCT00315120|6356074|P2|COMPLETED|Overall Study||118
2589843|NCT00315120|6356075|P1|COMPLETED|Overall Study||115
2589844|NCT00315120|6356072|P4|STARTED|Overall Study||107
2589845|NCT00315120|6356073|P3|STARTED|Overall Study||115
2589846|NCT00315120|6356074|P2|STARTED|Overall Study||118
2589847|NCT00315120|6356075|P1|STARTED|Overall Study||115
2589848|NCT00315055|6356135|P2|NOT COMPLETED|Overall Study||5
2589849|NCT00315055|6356136|P1|NOT COMPLETED|Overall Study||3
2589850|NCT00315055|6356135|P2|COMPLETED|Overall Study||150
2589851|NCT00315055|6356136|P1|COMPLETED|Overall Study||152
2589852|NCT00315055|6356135|P2|STARTED|Overall Study||155
2589853|NCT00315055|6356136|P1|STARTED|Overall Study||155
2589854|NCT00314951|6356154|P2|NOT COMPLETED|Follow-up||34
2589855|NCT00314951|6356155|P1|NOT COMPLETED|Follow-up||44
2589856|NCT00314951|6356154|P2|COMPLETED|Follow-up||255
2589857|NCT00314951|6356155|P1|COMPLETED|Follow-up||263
2589858|NCT00314951|6356154|P2|STARTED|Follow-up||289
2589859|NCT00314951|6356155|P1|STARTED|Follow-up||307
2589860|NCT00314951|6356154|P2|NOT COMPLETED|Treatment||11
2589861|NCT00314951|6356155|P1|NOT COMPLETED|Treatment||16
2589862|NCT00314951|6356154|P2|COMPLETED|Treatment||289
2589863|NCT00314951|6356155|P1|COMPLETED|Treatment||307
2589864|NCT00314951|6356154|P2|STARTED|Treatment||300
2589865|NCT00314951|6356155|P1|STARTED|Treatment||323
2589866|NCT00314951|6356154|P2|NOT COMPLETED|Enrollment||6
2589867|NCT00314951|6356155|P1|NOT COMPLETED|Enrollment||0
2589868|NCT00314951|6356154|P2|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|300
2589869|NCT00314951|6356155|P1|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|323
2589870|NCT00314951|6356154|P2|STARTED|Enrollment||306
2589871|NCT00314951|6356155|P1|STARTED|Enrollment||323
2589872|NCT00314808|6356165|P1|NOT COMPLETED|Overall Study||8
2589873|NCT00314808|6356165|P1|COMPLETED|Overall Study|Completed 2 cycles of Dronabinol or terminated early due to treatment-related adverse events (AE)|25
2589874|NCT00314808|6356165|P1|STARTED|Overall Study||33
2589875|NCT00314795|6356173|P1|NOT COMPLETED|Overall Study||20
2589876|NCT00314795|6356173|P1|COMPLETED|Overall Study||2
2589877|NCT00314795|6356173|P1|STARTED|Overall Study||22
2589878|NCT00314574|6356183|P2|NOT COMPLETED|Overall Study||83
2589879|NCT00314574|6356184|P1|NOT COMPLETED|Overall Study||94
2589880|NCT00314574|6356183|P2|COMPLETED|Overall Study||344
2589881|NCT00314574|6356184|P1|COMPLETED|Overall Study||329
2589882|NCT00314574|6356183|P2|Safety Population|Overall Study||428
2589883|NCT00314574|6356184|P1|Safety Population|Overall Study|1 patient in the placebo arm received Xolair and was added to the Xolair arm for Safety analyses.|420
2589884|NCT00314574|6356183|P2|Received at Least One Dose of Study Drug|Overall Study||427
2589885|NCT00314574|6356184|P1|Received at Least One Dose of Study Drug|Overall Study||421
2589886|NCT00314574|6356183|P2|STARTED|Overall Study||427
2589887|NCT00314574|6356184|P1|STARTED|Overall Study||423
2589888|NCT00314366|6356200|P2|NOT COMPLETED|Overall Study||0
2589889|NCT00314366|6356201|P1|NOT COMPLETED|Overall Study||1
2589890|NCT00314366|6356200|P2|COMPLETED|Overall Study||10
2589891|NCT00314366|6356201|P1|COMPLETED|Overall Study||10
2589892|NCT00314366|6356200|P2|STARTED|Overall Study||10
2589893|NCT00314366|6356201|P1|STARTED|Overall Study||11
2589894|NCT00314353|6356231|P2|NOT COMPLETED|Follow-up||0
2589895|NCT00314353|6356232|P1|NOT COMPLETED|Follow-up||0
2589896|NCT00314353|6356231|P2|COMPLETED|Follow-up||0
2589897|NCT00314353|6356232|P1|COMPLETED|Follow-up||3
2589898|NCT00314353|6356231|P2|STARTED|Follow-up||0
2589899|NCT00314353|6356232|P1|STARTED|Follow-up|2 participants who completed 8 cycles plus 1 participant who did not complete 8 cycles therapy.|3
2589900|NCT00314353|6356231|P2|NOT COMPLETED|Protocol Therapy (8 Cycles)||3
2589901|NCT00314353|6356232|P1|NOT COMPLETED|Protocol Therapy (8 Cycles)||2
2589902|NCT00314353|6356231|P2|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|0
2589903|NCT00314353|6356232|P1|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|2
2589904|NCT00314353|6356231|P2|STARTED|Protocol Therapy (8 Cycles)||3
2589905|NCT00314353|6356232|P1|STARTED|Protocol Therapy (8 Cycles)||4
2589906|NCT00314340|6356246|P1|NOT COMPLETED|Overall Study||1
2589907|NCT00314340|6356246|P1|COMPLETED|Overall Study||11
2589908|NCT00314340|6356246|P1|Placebo|Overall Study||12
2589909|NCT00314340|6356246|P1|Hydrocodone Plus APAP|Overall Study||12
2589910|NCT00314340|6356246|P1|ER Morphine|Overall Study||11
2589911|NCT00314340|6356246|P1|STARTED|Overall Study||12
2589912|NCT00314327|6356252|P1|NOT COMPLETED|Overall Study||1
2589913|NCT00314327|6356252|P1|COMPLETED|Overall Study||0
2589914|NCT00314327|6356252|P1|STARTED|Overall Study||1
2589915|NCT00314262|6356257|P1|NOT COMPLETED|Overall Study||5
2589916|NCT00314262|6356257|P1|COMPLETED|Overall Study||7
2589917|NCT00314262|6356257|P1|STARTED|Overall Study||12
2589918|NCT00314249|6356265|P2|NOT COMPLETED|Overall Study||163
2589919|NCT00314249|6356266|P1|NOT COMPLETED|Overall Study||152
2589920|NCT00314249|6356265|P2|COMPLETED|Overall Study||353
2589921|NCT00314249|6356266|P1|COMPLETED|Overall Study||357
2589922|NCT00314249|6356265|P2|STARTED|Overall Study||516
2589923|NCT00314249|6356266|P1|STARTED|Overall Study||509
2589924|NCT00314236|6356284|P2|NOT COMPLETED|Overall Study||2
2589925|NCT00314236|6356285|P1|NOT COMPLETED|Overall Study||0
2589926|NCT00314236|6356284|P2|COMPLETED|Overall Study||37
2589927|NCT00314236|6356285|P1|COMPLETED|Overall Study||41
2589928|NCT00314236|6356284|P2|STARTED|Overall Study||39
2589929|NCT00314236|6356285|P1|STARTED|Overall Study||41
2589930|NCT00314145|6356299|P2|NOT COMPLETED|Overall Study||29
2589931|NCT00314145|6356300|P1|NOT COMPLETED|Overall Study||21
2589932|NCT00314145|6356299|P2|COMPLETED|Overall Study||381
2589933|NCT00314145|6356300|P1|COMPLETED|Overall Study||389
2589934|NCT00314145|6356299|P2|STARTED|Overall Study||410
2589935|NCT00314145|6356300|P1|STARTED|Overall Study||410
2589936|NCT00314132|6356314|P2|NOT COMPLETED|Overall Study||18
2589937|NCT00314132|6356315|P1|NOT COMPLETED|Overall Study||8
2589938|NCT00314132|6356314|P2|COMPLETED|Overall Study||1583
2589939|NCT00314132|6356315|P1|COMPLETED|Overall Study||395
2589940|NCT00314132|6356314|P2|STARTED|Overall Study||1601
2589941|NCT00314132|6356315|P1|STARTED|Overall Study||403
2589942|NCT00314106|6356325|P2|NOT COMPLETED|Overall Study||0
2589943|NCT00314106|6356326|P1|NOT COMPLETED|Overall Study||0
2589944|NCT00314106|6356325|P2|COMPLETED|Overall Study||8
2589945|NCT00314106|6356326|P1|COMPLETED|Overall Study||18
2589946|NCT00314106|6356325|P2|STARTED|Overall Study||8
2589947|NCT00314106|6356326|P1|STARTED|Overall Study||18
2589948|NCT00314093|6356334|P1|NOT COMPLETED|Overall Study||0
2589949|NCT00314093|6356334|P1|COMPLETED|Overall Study||0
2589950|NCT00314093|6356334|P1|STARTED|Overall Study||0
2589951|NCT00313911|6356342|P2|NOT COMPLETED|Overall Study||41
2589952|NCT00313911|6356343|P1|NOT COMPLETED|Overall Study||94
2589953|NCT00313911|6356342|P2|COMPLETED|Overall Study||670
2589954|NCT00313911|6356343|P1|COMPLETED|Overall Study||1328
2589955|NCT00313911|6356342|P2|STARTED|Overall Study|A participant in this group mistakenly got Group 1 vaccine. N in outcomes adjusted accordingly.|711
2589956|NCT00313911|6356343|P1|STARTED|Overall Study|N for outcomes adjusted to include participant in Group 2 that got vaccine assigned to this group.|1422
2589957|NCT00313846|6356357|P2|NOT COMPLETED|Overall Study||11
2589958|NCT00313846|6356358|P1|NOT COMPLETED|Overall Study||5
2589959|NCT00313846|6356357|P2|COMPLETED|Overall Study||153
2589960|NCT00313846|6356358|P1|COMPLETED|Overall Study||157
2589961|NCT00313846|6356357|P2|STARTED|Overall Study|327 subjects were randomized: 1 subject was lost to follow-up (N = 326).|164
2589962|NCT00313846|6356358|P1|STARTED|Overall Study||162
2589963|NCT00313820|6356369|P2|NOT COMPLETED|Pregabalin or Placebo Treatment Period||19
2589964|NCT00313820|6356370|P1|NOT COMPLETED|Pregabalin or Placebo Treatment Period||17
2589965|NCT00313820|6356369|P2|COMPLETED|Pregabalin or Placebo Treatment Period||90
2589966|NCT00313820|6356370|P1|COMPLETED|Pregabalin or Placebo Treatment Period||93
2589967|NCT00313820|6356369|P2|STARTED|Pregabalin or Placebo Treatment Period||109
2589968|NCT00313820|6356370|P1|STARTED|Pregabalin or Placebo Treatment Period||110
2589969|NCT00313820|6356369|P2|NOT COMPLETED|Assigned to Treatment||0
2589970|NCT00313820|6356370|P1|NOT COMPLETED|Assigned to Treatment||1
2589971|NCT00313820|6356369|P2|COMPLETED|Assigned to Treatment||109
2589972|NCT00313820|6356370|P1|COMPLETED|Assigned to Treatment||110
2589973|NCT00313820|6356369|P2|STARTED|Assigned to Treatment||109
2589974|NCT00313820|6356370|P1|STARTED|Assigned to Treatment||111
2589975|NCT00313781|6356408|P3|NOT COMPLETED|After Crossover||27
2589976|NCT00313781|6356409|P2|NOT COMPLETED|After Crossover||0
2589977|NCT00313781|6356410|P1|NOT COMPLETED|After Crossover||0
2589978|NCT00313781|6356408|P3|COMPLETED|After Crossover||10
2589979|NCT00313781|6356409|P2|COMPLETED|After Crossover||0
2589980|NCT00313781|6356410|P1|COMPLETED|After Crossover||0
2589981|NCT00313781|6356408|P3|STARTED|After Crossover||37
2589982|NCT00313781|6356409|P2|STARTED|After Crossover||0
2589983|NCT00313781|6356410|P1|STARTED|After Crossover||0
2589984|NCT00313781|6356408|P3|NOT COMPLETED|Before Crossover||0
2589985|NCT00313781|6356409|P2|NOT COMPLETED|Before Crossover||79
2589986|NCT00313781|6356410|P1|NOT COMPLETED|Before Crossover||75
2589987|NCT00313781|6356408|P3|COMPLETED|Before Crossover||0
2589988|NCT00313781|6356409|P2|COMPLETED|Before Crossover||23
2589989|NCT00313781|6356410|P1|COMPLETED|Before Crossover||27
2589990|NCT00313781|6356408|P3|Treated|Before Crossover||0
2589991|NCT00313781|6356409|P2|Treated|Before Crossover||102
2589992|NCT00313781|6356410|P1|Treated|Before Crossover||97
2589993|NCT00313781|6356408|P3|STARTED|Before Crossover||0
2589994|NCT00313781|6356409|P2|STARTED|Before Crossover||102
2589995|NCT00313781|6356410|P1|STARTED|Before Crossover||102
2589996|NCT00313729|6356444|P1|NOT COMPLETED|Overall Study||0
2589997|NCT00313729|6356444|P1|COMPLETED|Overall Study||120
2589998|NCT00313729|6356444|P1|STARTED|Overall Study||120
2589999|NCT00313716|6356456|P6|NOT COMPLETED|Overall Study||13
2590000|NCT00313716|6356457|P5|NOT COMPLETED|Overall Study||6
2590001|NCT00313716|6356458|P4|NOT COMPLETED|Overall Study||4
2590002|NCT00313716|6356459|P3|NOT COMPLETED|Overall Study||12
2590003|NCT00313716|6356460|P2|NOT COMPLETED|Overall Study||8
2590004|NCT00313716|6356461|P1|NOT COMPLETED|Overall Study||5
2590005|NCT00313716|6356456|P6|COMPLETED|Overall Study||35
2590006|NCT00313716|6356457|P5|COMPLETED|Overall Study||27
2590007|NCT00313716|6356458|P4|COMPLETED|Overall Study||16
2590008|NCT00313716|6356459|P3|COMPLETED|Overall Study||38
2590009|NCT00313716|6356460|P2|COMPLETED|Overall Study||23
2590010|NCT00313716|6356461|P1|COMPLETED|Overall Study||13
2590011|NCT00313716|6356456|P6|STARTED|Overall Study||48
2590012|NCT00313716|6356457|P5|STARTED|Overall Study||33
2590013|NCT00313716|6356458|P4|STARTED|Overall Study||20
2590014|NCT00313716|6356459|P3|STARTED|Overall Study||50
2590015|NCT00313716|6356460|P2|STARTED|Overall Study||31
2590016|NCT00313716|6356461|P1|STARTED|Overall Study||18
2590017|NCT00313703|6356488|P4|NOT COMPLETED|Overall Study||12
2590018|NCT00313703|6356489|P3|NOT COMPLETED|Overall Study||5
2590019|NCT00313703|6356490|P2|NOT COMPLETED|Overall Study||2
2590020|NCT00313703|6356491|P1|NOT COMPLETED|Overall Study||11
2590021|NCT00313703|6356488|P4|COMPLETED|Overall Study|Outcomes not reported due to heterogeneity of this group|0
2590022|NCT00313703|6356489|P3|COMPLETED|Overall Study|Some subjects lost-to-follow-up|72
2590023|NCT00313703|6356490|P2|COMPLETED|Overall Study|Some subjects lost-to follow-up|32
2590024|NCT00313703|6356491|P1|COMPLETED|Overall Study|Some subjects lost to follow-up|175
2590025|NCT00313703|6356488|P4|STARTED|Overall Study||12
2590026|NCT00313703|6356489|P3|STARTED|Overall Study||77
2590027|NCT00313703|6356490|P2|STARTED|Overall Study||34
2590028|NCT00313703|6356491|P1|STARTED|Overall Study||186
2590029|NCT00313612|6356507|P2|NOT COMPLETED|Overall Study||1
2590030|NCT00313612|6356508|P1|NOT COMPLETED|Overall Study||0
2590031|NCT00313612|6356507|P2|COMPLETED|Overall Study||19
2590032|NCT00313612|6356508|P1|COMPLETED|Overall Study||19
2590033|NCT00313612|6356507|P2|STARTED|Overall Study||20
2590034|NCT00313612|6356508|P1|STARTED|Overall Study||19
2590035|NCT00313586|6356520|P4|NOT COMPLETED|Overall Study||23
2590036|NCT00313586|6356521|P3|NOT COMPLETED|Overall Study||24
2590037|NCT00313586|6356522|P2|NOT COMPLETED|Overall Study||70
2590038|NCT00313586|6356523|P1|NOT COMPLETED|Overall Study||70
2590039|NCT00313586|6356520|P4|COMPLETED|Overall Study||0
2590040|NCT00313586|6356521|P3|COMPLETED|Overall Study||0
2590041|NCT00313586|6356522|P2|COMPLETED|Overall Study||5
2590042|NCT00313586|6356523|P1|COMPLETED|Overall Study||5
2590043|NCT00313586|6356520|P4|Treated|Overall Study||23
2590044|NCT00313586|6356521|P3|Treated|Overall Study||24
2590045|NCT00313586|6356522|P2|Treated|Overall Study||75
2590046|NCT00313586|6356523|P1|Treated|Overall Study||74
2590047|NCT00313586|6356520|P4|STARTED|Overall Study||23
2590048|NCT00313586|6356521|P3|STARTED|Overall Study||24
2590049|NCT00313586|6356522|P2|STARTED|Overall Study||75
2590050|NCT00313586|6356523|P1|STARTED|Overall Study||75
2590051|NCT00313560|6356531|P1|NOT COMPLETED|Overall Study||0
2590052|NCT00313560|6356531|P1|COMPLETED|Overall Study||48
2590053|NCT00313560|6356531|P1|STARTED|Overall Study||48
2590054|NCT00313443|6356535|P1|NOT COMPLETED|Overall Study||0
2590055|NCT00313443|6356535|P1|COMPLETED|Overall Study||30
2590056|NCT00313443|6356535|P1|STARTED|Overall Study||30
2590057|NCT00313313|6356546|P3|NOT COMPLETED|Overall Study||82
2590058|NCT00313313|6356547|P2|NOT COMPLETED|Overall Study||66
2590059|NCT00313313|6356548|P1|NOT COMPLETED|Overall Study||63
2590060|NCT00313313|6356546|P3|COMPLETED|Overall Study|26 subjects completed the study without being rescued|185
2590061|NCT00313313|6356547|P2|COMPLETED|Overall Study|55 subjects completed the study without being rescued|187
2590062|NCT00313313|6356548|P1|COMPLETED|Overall Study|61 subjects completed the study without being rescued|185
2590063|NCT00313313|6356546|P3|STARTED|Overall Study||267
2590064|NCT00313313|6356547|P2|STARTED|Overall Study||253
2590065|NCT00313313|6356548|P1|STARTED|Overall Study||248
2590066|NCT00313300|6356570|P5|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
2590067|NCT00313300|6356571|P4|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||5
2590068|NCT00313300|6356572|P3|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
2590069|NCT00313300|6356573|P2|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||0
2590070|NCT00313300|6356574|P1|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||3
2590071|NCT00313300|6356570|P5|COMPLETED|Follow-Up(30days)-Randomized Phase B||199
2590072|NCT00313300|6356571|P4|COMPLETED|Follow-Up(30days)-Randomized Phase B||217
2590073|NCT00313300|6356572|P3|COMPLETED|Follow-Up(30days)-Randomized Phase B||117
2590074|NCT00313300|6356573|P2|COMPLETED|Follow-Up(30days)-Randomized Phase B||123
2590075|NCT00313300|6356574|P1|COMPLETED|Follow-Up(30days)-Randomized Phase B||380
2590076|NCT00313300|6356570|P5|STARTED|Follow-Up(30days)-Randomized Phase B||201
2590077|NCT00313300|6356571|P4|STARTED|Follow-Up(30days)-Randomized Phase B||222
2590078|NCT00313300|6356572|P3|STARTED|Follow-Up(30days)-Randomized Phase B||119
2590079|NCT00313300|6356573|P2|STARTED|Follow-Up(30days)-Randomized Phase B||123
2590080|NCT00313300|6356574|P1|STARTED|Follow-Up(30days)-Randomized Phase B||383
2590081|NCT00313300|6356570|P5|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
2590082|NCT00313300|6356571|P4|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
2590083|NCT00313300|6356572|P3|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||2
2590084|NCT00313300|6356573|P2|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||6
2590085|NCT00313300|6356574|P1|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||5
2590086|NCT00313300|6356570|P5|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
2590087|NCT00313300|6356571|P4|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
2590088|NCT00313300|6356572|P3|COMPLETED|Follow-Up(30days)-Randomized Phase A||172
2590089|NCT00313300|6356573|P2|COMPLETED|Follow-Up(30days)-Randomized Phase A||156
2590090|NCT00313300|6356574|P1|COMPLETED|Follow-Up(30days)-Randomized Phase A||158
2590091|NCT00313300|6356570|P5|STARTED|Follow-Up(30days)-Randomized Phase A||0
2590092|NCT00313300|6356571|P4|STARTED|Follow-Up(30days)-Randomized Phase A||0
2590093|NCT00313300|6356572|P3|STARTED|Follow-Up(30days)-Randomized Phase A||174
2590094|NCT00313300|6356573|P2|STARTED|Follow-Up(30days)-Randomized Phase A||162
2590095|NCT00313300|6356574|P1|STARTED|Follow-Up(30days)-Randomized Phase A||163
2590096|NCT00313300|6356570|P5|NOT COMPLETED|Randomized in Phase B (26 Weeks)||208
2590097|NCT00313300|6356571|P4|NOT COMPLETED|Randomized in Phase B (26 Weeks)||233
2590098|NCT00313300|6356572|P3|NOT COMPLETED|Randomized in Phase B (26 Weeks)||40
2590099|NCT00313300|6356573|P2|NOT COMPLETED|Randomized in Phase B (26 Weeks)||33
2590100|NCT00313300|6356574|P1|NOT COMPLETED|Randomized in Phase B (26 Weeks)||94
2590101|NCT00313300|6356570|P5|COMPLETED|Randomized in Phase B (26 Weeks)||13
2590102|NCT00313300|6356571|P4|COMPLETED|Randomized in Phase B (26 Weeks)||15
2590103|NCT00313300|6356572|P3|COMPLETED|Randomized in Phase B (26 Weeks)||94
2590104|NCT00313300|6356573|P2|COMPLETED|Randomized in Phase B (26 Weeks)||105
2590105|NCT00313300|6356574|P1|COMPLETED|Randomized in Phase B (26 Weeks)||333
2590106|NCT00313300|6356570|P5|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||221
2590107|NCT00313300|6356571|P4|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||248
2590108|NCT00313300|6356572|P3|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||110
2590109|NCT00313300|6356573|P2|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||120
2590110|NCT00313300|6356574|P1|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||368
2590111|NCT00313300|6356570|P5|STARTED|Randomized in Phase B (26 Weeks)||221
2590112|NCT00313300|6356571|P4|STARTED|Randomized in Phase B (26 Weeks)||248
2590113|NCT00313300|6356572|P3|STARTED|Randomized in Phase B (26 Weeks)||134
2590114|NCT00313300|6356573|P2|STARTED|Randomized in Phase B (26 Weeks)||138
2590115|NCT00313300|6356574|P1|STARTED|Randomized in Phase B (26 Weeks)||427
2590116|NCT00313300|6356570|P5|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
2590117|NCT00313300|6356571|P4|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
2590118|NCT00313300|6356572|P3|NOT COMPLETED|Randomized in Phase A (26 Weeks)||35
2590119|NCT00313300|6356573|P2|NOT COMPLETED|Randomized in Phase A (26 Weeks)||39
2590120|NCT00313300|6356574|P1|NOT COMPLETED|Randomized in Phase A (26 Weeks)||54
2590121|NCT00313300|6356570|P5|COMPLETED|Randomized in Phase A (26 Weeks)||0
2590122|NCT00313300|6356571|P4|COMPLETED|Randomized in Phase A (26 Weeks)||0
2590123|NCT00313300|6356572|P3|COMPLETED|Randomized in Phase A (26 Weeks)||149
2590124|NCT00313300|6356573|P2|COMPLETED|Randomized in Phase A (26 Weeks)||140
2590125|NCT00313300|6356574|P1|COMPLETED|Randomized in Phase A (26 Weeks)||130
2590126|NCT00313300|6356570|P5|STARTED|Randomized in Phase A (26 Weeks)||0
2590127|NCT00313300|6356571|P4|STARTED|Randomized in Phase A (26 Weeks)||0
2590128|NCT00313300|6356572|P3|STARTED|Randomized in Phase A (26 Weeks)||184
2590129|NCT00313300|6356573|P2|STARTED|Randomized in Phase A (26 Weeks)||179
2590130|NCT00313300|6356574|P1|STARTED|Randomized in Phase A (26 Weeks)||184
2590131|NCT00313209|6356626|P2|NOT COMPLETED|Overall Study||82
2590132|NCT00313209|6356627|P1|NOT COMPLETED|Overall Study||107
2590133|NCT00313209|6356626|P2|COMPLETED|Overall Study||385
2590134|NCT00313209|6356627|P1|COMPLETED|Overall Study||359
2590135|NCT00313209|6356626|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|467
2590136|NCT00313209|6356627|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|466
2590137|NCT00313170|6356644|P3|NOT COMPLETED|Overall Study||32
2590138|NCT00313170|6356645|P2|NOT COMPLETED|Overall Study||34
2590139|NCT00313170|6356646|P1|NOT COMPLETED|Overall Study||36
2590140|NCT00313170|6356644|P3|COMPLETED|Overall Study||14
2590141|NCT00313170|6356645|P2|COMPLETED|Overall Study||17
2590142|NCT00313170|6356646|P1|COMPLETED|Overall Study||11
2590143|NCT00313170|6356644|P3|STARTED|Overall Study||46
2590144|NCT00313170|6356645|P2|STARTED|Overall Study||51
2590145|NCT00313170|6356646|P1|STARTED|Overall Study||47
2590146|NCT00313144|6356665|P1|NOT COMPLETED|Overall Study||110
2590147|NCT00313144|6356665|P1|COMPLETED|Overall Study||17
2590148|NCT00313144|6356665|P1|STARTED|Overall Study||127
2590149|NCT00313014|6356752|P3|NOT COMPLETED|Overall Study||61
2590150|NCT00313014|6356753|P2|NOT COMPLETED|Overall Study||73
2590151|NCT00313014|6356754|P1|NOT COMPLETED|Overall Study||93
2590152|NCT00313014|6356752|P3|COMPLETED|Overall Study||159
2590153|NCT00313014|6356753|P2|COMPLETED|Overall Study||146
2590154|NCT00313014|6356754|P1|COMPLETED|Overall Study||128
2590155|NCT00313014|6356752|P3|STARTED|Overall Study||220
2590156|NCT00313014|6356753|P2|STARTED|Overall Study||219
2590157|NCT00313014|6356754|P1|STARTED|Overall Study||221
2590158|NCT00312923|6356774|P2|NOT COMPLETED|Overall Study||6
2590159|NCT00312923|6356775|P1|NOT COMPLETED|Overall Study||9
2590160|NCT00312923|6356774|P2|COMPLETED|Overall Study||20
2590161|NCT00312923|6356775|P1|COMPLETED|Overall Study||19
2590162|NCT00312923|6356774|P2|STARTED|Overall Study||26
2590163|NCT00312923|6356775|P1|STARTED|Overall Study||28
2590164|NCT00312897|6356785|P2|NOT COMPLETED|Overall Study||6
2590165|NCT00312897|6356786|P1|NOT COMPLETED|Overall Study||6
2590166|NCT00312897|6356785|P2|COMPLETED|Overall Study||18
2590167|NCT00312897|6356786|P1|COMPLETED|Overall Study||21
2590168|NCT00312897|6356785|P2|STARTED|Overall Study||24
2590169|NCT00312897|6356786|P1|STARTED|Overall Study||27
2590170|NCT00312884|6356796|P2|NOT COMPLETED|Overall Study||12
2590171|NCT00312884|6356797|P1|NOT COMPLETED|Overall Study||17
2590172|NCT00312884|6356796|P2|COMPLETED|Overall Study||79
2590173|NCT00312884|6356797|P1|COMPLETED|Overall Study||74
2590174|NCT00312884|6356796|P2|STARTED|Overall Study||91
2590175|NCT00312884|6356797|P1|STARTED|Overall Study||91
2590176|NCT00312858|6356811|P2|NOT COMPLETED|Overall Study||93
2590177|NCT00312858|6356812|P1|NOT COMPLETED|Overall Study||68
2590178|NCT00312858|6356811|P2|COMPLETED|Overall Study||230
2590179|NCT00312858|6356812|P1|COMPLETED|Overall Study||262
2590180|NCT00312858|6356811|P2|Visit 4|Overall Study||240
2590181|NCT00312858|6356812|P1|Visit 4|Overall Study||262
2590182|NCT00312858|6356811|P2|Visit 3|Overall Study||261
2590183|NCT00312858|6356812|P1|Visit 3|Overall Study||273
2590184|NCT00312858|6356811|P2|Visit 2|Overall Study||294
2590185|NCT00312858|6356812|P1|Visit 2|Overall Study||305
2590186|NCT00312858|6356811|P2|Visit 1|Overall Study||323
2590187|NCT00312858|6356812|P1|Visit 1|Overall Study||330
2590188|NCT00312858|6356811|P2|STARTED|Overall Study||323
2590189|NCT00312858|6356812|P1|STARTED|Overall Study||330
2590190|NCT00312845|6356866|P2|NOT COMPLETED|Overall Study||95
2590191|NCT00312845|6356867|P1|NOT COMPLETED|Overall Study||99
2590192|NCT00312845|6356866|P2|COMPLETED|Overall Study||245
2590193|NCT00312845|6356867|P1|COMPLETED|Overall Study||237
2590194|NCT00312845|6356866|P2|STARTED|Overall Study||340
2590195|NCT00312845|6356867|P1|STARTED|Overall Study||336
2590196|NCT00312728|6356875|P1|NOT COMPLETED|Overall Study||110
2590197|NCT00312728|6356875|P1|COMPLETED|Overall Study||5
2590198|NCT00312728|6356875|P1|STARTED|Overall Study||115
2590199|NCT00312702|6356887|P3|NOT COMPLETED|Challenge Phase||0
2590200|NCT00312702|6356888|P2|NOT COMPLETED|Challenge Phase||0
2590201|NCT00312702|6356889|P1|NOT COMPLETED|Challenge Phase||0
2590202|NCT00312702|6356887|P3|COMPLETED|Challenge Phase||1
2590203|NCT00312702|6356888|P2|COMPLETED|Challenge Phase||12
2590204|NCT00312702|6356889|P1|COMPLETED|Challenge Phase||0
2590205|NCT00312702|6356887|P3|STARTED|Challenge Phase|1 non-immunized subjects participated in the challenge phase.|1
2590206|NCT00312702|6356888|P2|STARTED|Challenge Phase|12 subjects from the high dose group participated in the challenge phase|12
2590207|NCT00312702|6356889|P1|STARTED|Challenge Phase|low dose subjects didn't participate in the challenge phase|0
2590208|NCT00312702|6356887|P3|NOT COMPLETED|Immunization Phase||0
2590209|NCT00312702|6356888|P2|NOT COMPLETED|Immunization Phase||1
2590210|NCT00312702|6356889|P1|NOT COMPLETED|Immunization Phase||0
2590211|NCT00312702|6356887|P3|COMPLETED|Immunization Phase||0
2590212|NCT00312702|6356888|P2|COMPLETED|Immunization Phase||12
2590213|NCT00312702|6356889|P1|COMPLETED|Immunization Phase||5
2590214|NCT00312702|6356887|P3|STARTED|Immunization Phase||0
2590215|NCT00312702|6356888|P2|STARTED|Immunization Phase||13
2590216|NCT00312702|6356889|P1|STARTED|Immunization Phase||5
2590217|NCT00312663|6356902|P3|NOT COMPLETED|Challenge Phase||0
2590218|NCT00312663|6356903|P2|NOT COMPLETED|Challenge Phase||0
2590219|NCT00312663|6356904|P1|NOT COMPLETED|Challenge Phase||0
2590220|NCT00312663|6356902|P3|COMPLETED|Challenge Phase||6
2590221|NCT00312663|6356903|P2|COMPLETED|Challenge Phase||10
2590222|NCT00312663|6356904|P1|COMPLETED|Challenge Phase||0
2590223|NCT00312663|6356902|P3|STARTED|Challenge Phase|6 non-immunized subjects participated in the challenge phase|6
2590224|NCT00312663|6356903|P2|STARTED|Challenge Phase|10 subjects from the high dose group participated in the challenge phase|10
2590225|NCT00312663|6356904|P1|STARTED|Challenge Phase|low dose subjects didn't participate in the challenge phase|0
2590226|NCT00312663|6356902|P3|NOT COMPLETED|Immunization Phase||0
2590227|NCT00312663|6356903|P2|NOT COMPLETED|Immunization Phase||1
2590228|NCT00312663|6356904|P1|NOT COMPLETED|Immunization Phase||0
2590229|NCT00312663|6356902|P3|COMPLETED|Immunization Phase||0
2590230|NCT00312663|6356903|P2|COMPLETED|Immunization Phase||12
2590231|NCT00312663|6356904|P1|COMPLETED|Immunization Phase||5
2590232|NCT00312663|6356902|P3|STARTED|Immunization Phase||0
2590233|NCT00312663|6356903|P2|STARTED|Immunization Phase||13
2590234|NCT00312663|6356904|P1|STARTED|Immunization Phase||5
2590235|NCT00312572|6356917|P2|NOT COMPLETED|Overall Study||21
2590236|NCT00312572|6356918|P1|NOT COMPLETED|Overall Study||16
2590237|NCT00312572|6356917|P2|COMPLETED|Overall Study||82
2590238|NCT00312572|6356918|P1|COMPLETED|Overall Study||85
2590239|NCT00312572|6356917|P2|STARTED|Overall Study||103
2590240|NCT00312572|6356918|P1|STARTED|Overall Study||101
2590241|NCT00312494|6356929|P3|NOT COMPLETED|Overall Study||43
2590242|NCT00312494|6356930|P2|NOT COMPLETED|Overall Study||58
2590243|NCT00312494|6356931|P1|NOT COMPLETED|Overall Study||71
2590244|NCT00312494|6356929|P3|COMPLETED|Overall Study||179
2590245|NCT00312494|6356930|P2|COMPLETED|Overall Study||168
2590246|NCT00312494|6356931|P1|COMPLETED|Overall Study|1 subject randomized to higher dose; received lower dose baseline and/or week 1; higher dose week 2.|161
2590247|NCT00312494|6356929|P3|Received Study Treatment|Overall Study||217
2590248|NCT00312494|6356930|P2|Received Study Treatment|Overall Study||216
2590249|NCT00312494|6356931|P1|Received Study Treatment|Overall Study|1 subject randomized to higher dose; received lower dose at baseline, higher dose weeks 1 and 2.|223
2590250|NCT00312494|6356929|P3|STARTED|Overall Study||222
2590251|NCT00312494|6356930|P2|STARTED|Overall Study||226
2590252|NCT00312494|6356931|P1|STARTED|Overall Study||232
2590253|NCT00312377|6356965|P2|NOT COMPLETED|Overall Study||668
2590254|NCT00312377|6356966|P1|NOT COMPLETED|Overall Study||644
2590255|NCT00312377|6356965|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|29
2590256|NCT00312377|6356966|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|50
2590257|NCT00312377|6356965|P2|STARTED|Overall Study|randomised patients|697
2590258|NCT00312377|6356966|P1|STARTED|Overall Study|randomised patients|694
2590259|NCT00312338|6356990|P2|NOT COMPLETED|Overall Study||3
2590260|NCT00312338|6356991|P1|NOT COMPLETED|Overall Study||22
2590261|NCT00312338|6356990|P2|COMPLETED|Overall Study||54
2590262|NCT00312338|6356991|P1|COMPLETED|Overall Study||83
2590263|NCT00312338|6356990|P2|STARTED|Overall Study||57
2590264|NCT00312338|6356991|P1|STARTED|Overall Study||105
2590265|NCT00312221|6357004|P4|NOT COMPLETED|Double-blind Phase||70
2590266|NCT00312221|6357005|P3|NOT COMPLETED|Double-blind Phase||72
2590267|NCT00312221|6357006|P2|NOT COMPLETED|Double-blind Phase||59
2590268|NCT00312221|6357007|P1|NOT COMPLETED|Double-blind Phase||0
2590269|NCT00312221|6357004|P4|COMPLETED|Double-blind Phase||63
2590270|NCT00312221|6357005|P3|COMPLETED|Double-blind Phase||77
2590271|NCT00312221|6357006|P2|COMPLETED|Double-blind Phase||77
2590272|NCT00312221|6357007|P1|COMPLETED|Double-blind Phase||0
2590273|NCT00312221|6357004|P4|STARTED|Double-blind Phase||133
2590274|NCT00312221|6357005|P3|STARTED|Double-blind Phase||149
2590275|NCT00312221|6357006|P2|STARTED|Double-blind Phase||136
2590276|NCT00312221|6357007|P1|STARTED|Double-blind Phase||0
2590277|NCT00312221|6357004|P4|NOT COMPLETED|Open-label Run-in Period||0
2590278|NCT00312221|6357005|P3|NOT COMPLETED|Open-label Run-in Period||0
2590279|NCT00312221|6357006|P2|NOT COMPLETED|Open-label Run-in Period||0
2590280|NCT00312221|6357007|P1|NOT COMPLETED|Open-label Run-in Period||234
2590281|NCT00312221|6357004|P4|COMPLETED|Open-label Run-in Period||0
2590282|NCT00312221|6357005|P3|COMPLETED|Open-label Run-in Period||0
2590283|NCT00312221|6357006|P2|COMPLETED|Open-label Run-in Period||0
2590284|NCT00312221|6357007|P1|COMPLETED|Open-label Run-in Period||418
2590285|NCT00312221|6357004|P4|STARTED|Open-label Run-in Period||0
2590286|NCT00312221|6357005|P3|STARTED|Open-label Run-in Period||0
2590287|NCT00312221|6357006|P2|STARTED|Open-label Run-in Period||0
2590288|NCT00312221|6357007|P1|STARTED|Open-label Run-in Period||652
2590289|NCT00312208|6357027|P2|NOT COMPLETED|Overall Study||123
2590290|NCT00312208|6357028|P1|NOT COMPLETED|Overall Study||172
2590291|NCT00312208|6357027|P2|COMPLETED|Overall Study||1526
2590292|NCT00312208|6357028|P1|COMPLETED|Overall Study||1477
2590293|NCT00312208|6357027|P2|STARTED|Overall Study|1649 patients randomized 1635 patients treated|1649
2590294|NCT00312208|6357028|P1|STARTED|Overall Study|1649 patients randomized, 1634 patients treated|1649
2590295|NCT00312195|6357038|P2|NOT COMPLETED|Overall Study||6
2590296|NCT00312195|6357039|P1|NOT COMPLETED|Overall Study||6
2590297|NCT00312195|6357038|P2|COMPLETED|Overall Study||123
2590298|NCT00312195|6357039|P1|COMPLETED|Overall Study||132
2590299|NCT00312195|6357038|P2|STARTED|Overall Study||129
2590300|NCT00312195|6357039|P1|STARTED|Overall Study||138
2590301|NCT00311766|6357055|P2|NOT COMPLETED|Overall Study||5
2590302|NCT00311766|6357056|P1|NOT COMPLETED|Overall Study||0
2590303|NCT00311766|6357055|P2|COMPLETED|Overall Study||17
2590304|NCT00311766|6357056|P1|COMPLETED|Overall Study||8
2590305|NCT00311766|6357055|P2|STARTED|Overall Study||22
2590306|NCT00311766|6357056|P1|STARTED|Overall Study||8
2590307|NCT00311623|6357067|P3|NOT COMPLETED|Overall Study||2
2590308|NCT00311623|6357068|P2|NOT COMPLETED|Overall Study||0
2590309|NCT00311623|6357069|P1|NOT COMPLETED|Overall Study||0
2590310|NCT00311623|6357067|P3|COMPLETED|Overall Study||0
2590311|NCT00311623|6357068|P2|COMPLETED|Overall Study||20
2590312|NCT00311623|6357069|P1|COMPLETED|Overall Study||10
2590313|NCT00311623|6357067|P3|STARTED|Overall Study||2
2590314|NCT00311623|6357068|P2|STARTED|Overall Study||20
2590315|NCT00311623|6357069|P1|STARTED|Overall Study||10
2590316|NCT00311584|6357111|P2|NOT COMPLETED|Overall Study||23
2590317|NCT00311584|6357112|P1|NOT COMPLETED|Overall Study||20
2590318|NCT00311584|6357111|P2|COMPLETED|Overall Study||7
2590319|NCT00311584|6357112|P1|COMPLETED|Overall Study||9
2590320|NCT00311584|6357111|P2|STARTED|Overall Study||30
2590321|NCT00311584|6357112|P1|STARTED|Overall Study||29
2590322|NCT00311402|6357120|P2|NOT COMPLETED|Overall Study||177
2590323|NCT00311402|6357121|P1|NOT COMPLETED|Overall Study||210
2590324|NCT00311402|6357120|P2|COMPLETED|Overall Study||462
2590325|NCT00311402|6357121|P1|COMPLETED|Overall Study||445
2590326|NCT00311402|6357120|P2|STARTED|Overall Study||639
2590327|NCT00311402|6357121|P1|STARTED|Overall Study||655
2590328|NCT00311376|6357148|P3|NOT COMPLETED|Treatment Cycle 2||0
2590329|NCT00311376|6357149|P2|NOT COMPLETED|Treatment Cycle 2||13
2590330|NCT00311376|6357150|P1|NOT COMPLETED|Treatment Cycle 2||9
2590331|NCT00311376|6357148|P3|COMPLETED|Treatment Cycle 2||0
2590332|NCT00311376|6357149|P2|COMPLETED|Treatment Cycle 2||112
2590333|NCT00311376|6357150|P1|COMPLETED|Treatment Cycle 2||106
2590334|NCT00311376|6357148|P3|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200U in Cycle 2|0
2590335|NCT00311376|6357149|P2|STARTED|Treatment Cycle 2|74 from the 200U group + 51 from the Placebo group entered Cycle 2|125
2590336|NCT00311376|6357150|P1|STARTED|Treatment Cycle 2|69 from the 300U group + 46 from the Placebo group entered Cycle 2|115
2590337|NCT00311376|6357148|P3|NOT COMPLETED|Treatment Cycle 1||17
2590338|NCT00311376|6357149|P2|NOT COMPLETED|Treatment Cycle 1||17
2590339|NCT00311376|6357150|P1|NOT COMPLETED|Treatment Cycle 1||27
2590340|NCT00311376|6357148|P3|COMPLETED|Treatment Cycle 1||132
2590341|NCT00311376|6357149|P2|COMPLETED|Treatment Cycle 1||118
2590342|NCT00311376|6357150|P1|COMPLETED|Treatment Cycle 1||105
2590343|NCT00311376|6357148|P3|STARTED|Treatment Cycle 1||149
2590344|NCT00311376|6357149|P2|STARTED|Treatment Cycle 1||135
2590345|NCT00311376|6357150|P1|STARTED|Treatment Cycle 1||132
2590346|NCT00311363|6357170|P3|NOT COMPLETED|12-Week Double-Blind Treatment Period||12
2590347|NCT00311363|6357171|P2|NOT COMPLETED|12-Week Double-Blind Treatment Period||14
2590348|NCT00311363|6357172|P1|NOT COMPLETED|12-Week Double-Blind Treatment Period||0
2590349|NCT00311363|6357170|P3|COMPLETED|12-Week Double-Blind Treatment Period||84
2590350|NCT00311363|6357171|P2|COMPLETED|12-Week Double-Blind Treatment Period||84
2590351|NCT00311363|6357172|P1|COMPLETED|12-Week Double-Blind Treatment Period||0
2590352|NCT00311363|6357170|P3|STARTED|12-Week Double-Blind Treatment Period||96
2590353|NCT00311363|6357171|P2|STARTED|12-Week Double-Blind Treatment Period||98
2590354|NCT00311363|6357172|P1|STARTED|12-Week Double-Blind Treatment Period||0
2590355|NCT00311363|6357170|P3|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
2590356|NCT00311363|6357171|P2|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
2590357|NCT00311363|6357172|P1|NOT COMPLETED|24-Week Single-Blind Treatment Period||106
2590358|NCT00311363|6357170|P3|COMPLETED|24-Week Single-Blind Treatment Period||0
2590359|NCT00311363|6357171|P2|COMPLETED|24-Week Single-Blind Treatment Period||0
2590360|NCT00311363|6357172|P1|COMPLETED|24-Week Single-Blind Treatment Period||221
2590361|NCT00311363|6357170|P3|STARTED|24-Week Single-Blind Treatment Period||0
2590362|NCT00311363|6357171|P2|STARTED|24-Week Single-Blind Treatment Period||0
2590363|NCT00311363|6357172|P1|STARTED|24-Week Single-Blind Treatment Period||327
2590364|NCT00311311|6357232|P2|NOT COMPLETED|Overall Study||9
2590365|NCT00311311|6357233|P1|NOT COMPLETED|Overall Study||8
2590366|NCT00311311|6357232|P2|COMPLETED|Overall Study||26
2590367|NCT00311311|6357233|P1|COMPLETED|Overall Study||29
2590368|NCT00311311|6357232|P2|STARTED|Overall Study||35
2590369|NCT00311311|6357233|P1|STARTED|Overall Study||37
2590370|NCT00311181|6357283|P1|NOT COMPLETED|Overall Study||96
2590371|NCT00311181|6357283|P1|COMPLETED|Overall Study||121
2590372|NCT00311181|6357283|P1|STARTED|Overall Study||217
2590373|NCT00311155|6357289|P1|NOT COMPLETED|Overall Study||93
2590374|NCT00311155|6357289|P1|COMPLETED|Overall Study|Some participants had multiple reasons for discontinuation|601
2590375|NCT00311155|6357289|P1|STARTED|Overall Study||694
2590376|NCT00310856|6357301|P3|NOT COMPLETED|Overall Study||8
2590377|NCT00310856|6357302|P2|NOT COMPLETED|Overall Study||5
2590378|NCT00310856|6357303|P1|NOT COMPLETED|Overall Study||5
2590379|NCT00310856|6357301|P3|COMPLETED|Overall Study||42
2590380|NCT00310856|6357302|P2|COMPLETED|Overall Study||56
2590381|NCT00310856|6357303|P1|COMPLETED|Overall Study||59
2590382|NCT00310856|6357301|P3|STARTED|Overall Study||50
2590383|NCT00310856|6357302|P2|STARTED|Overall Study||61
2590384|NCT00310856|6357303|P1|STARTED|Overall Study||64
2590385|NCT00310817|6357327|P4|NOT COMPLETED|Overall Study||8
2590386|NCT00310817|6357328|P3|NOT COMPLETED|Overall Study||8
2590387|NCT00310817|6357329|P2|NOT COMPLETED|Overall Study||8
2590388|NCT00310817|6357330|P1|NOT COMPLETED|Overall Study||11
2590389|NCT00310817|6357327|P4|COMPLETED|Overall Study||74
2590390|NCT00310817|6357328|P3|COMPLETED|Overall Study||120
2590391|NCT00310817|6357329|P2|COMPLETED|Overall Study||198
2590392|NCT00310817|6357330|P1|COMPLETED|Overall Study||196
2590393|NCT00310817|6357327|P4|STARTED|Overall Study||82
2590394|NCT00310817|6357328|P3|STARTED|Overall Study||128
2590395|NCT00310817|6357329|P2|STARTED|Overall Study||206
2590396|NCT00310817|6357330|P1|STARTED|Overall Study||207
2590397|NCT00310804|6357418|P2|NOT COMPLETED|Overall Study||0
2590398|NCT00310804|6357419|P1|NOT COMPLETED|Overall Study||5
2590399|NCT00310804|6357418|P2|COMPLETED|Overall Study||171
2590400|NCT00310804|6357419|P1|COMPLETED|Overall Study||1024
2590401|NCT00310804|6357418|P2|STARTED|Overall Study||171
2590402|NCT00310804|6357419|P1|STARTED|Overall Study||1029
2590403|NCT00310791|6357454|P2|NOT COMPLETED|Overall Study||10
2590404|NCT00310791|6357455|P1|NOT COMPLETED|Overall Study||10
2590405|NCT00310791|6357454|P2|COMPLETED|Overall Study||30
2590406|NCT00310791|6357455|P1|COMPLETED|Overall Study||30
2590407|NCT00310791|6357454|P2|STARTED|Overall Study||40
2590408|NCT00310791|6357455|P1|STARTED|Overall Study||40
2590409|NCT00310466|6357463|P2|NOT COMPLETED|Overall Study||12
2590410|NCT00310466|6357464|P1|NOT COMPLETED|Overall Study||18
2590411|NCT00310466|6357463|P2|COMPLETED|Overall Study||101
2590412|NCT00310466|6357464|P1|COMPLETED|Overall Study||95
2590413|NCT00310466|6357463|P2|STARTED|Overall Study||113
2590414|NCT00310466|6357464|P1|STARTED|Overall Study||113
2590415|NCT00310440|6357478|P2|NOT COMPLETED|Overall Study||13
2590416|NCT00310440|6357479|P1|NOT COMPLETED|Overall Study||26
2590417|NCT00310440|6357478|P2|COMPLETED|Overall Study||141
2590418|NCT00310440|6357479|P1|COMPLETED|Overall Study||139
2590419|NCT00310440|6357478|P2|STARTED|Overall Study||154
2590420|NCT00310440|6357479|P1|STARTED|Overall Study||165
2590421|NCT00310427|6357505|P2|NOT COMPLETED|Overall Study||1
2590422|NCT00310427|6357506|P1|NOT COMPLETED|Overall Study||2
2590423|NCT00310427|6357505|P2|COMPLETED|Overall Study||25
2590424|NCT00310427|6357506|P1|COMPLETED|Overall Study||25
2590425|NCT00310427|6357505|P2|STARTED|Overall Study||26
2590426|NCT00310427|6357506|P1|STARTED|Overall Study||27
2590427|NCT00310401|6357528|P2|NOT COMPLETED|Overall Study||0
2590428|NCT00310401|6357529|P1|NOT COMPLETED|Overall Study||0
2590429|NCT00310401|6357528|P2|COMPLETED|Overall Study||246
2590430|NCT00310401|6357529|P1|COMPLETED|Overall Study||260
2590431|NCT00310401|6357528|P2|STARTED|Overall Study||246
2590432|NCT00310401|6357529|P1|STARTED|Overall Study||260
2590433|NCT00310388|6357543|P2|NOT COMPLETED|Safety Follow-up Continuation Phase||13
2590434|NCT00310388|6357544|P1|NOT COMPLETED|Safety Follow-up Continuation Phase||0
2590435|NCT00310388|6357543|P2|COMPLETED|Safety Follow-up Continuation Phase||13
2590436|NCT00310388|6357544|P1|COMPLETED|Safety Follow-up Continuation Phase||0
2590437|NCT00310388|6357543|P2|STARTED|Safety Follow-up Continuation Phase||26
2590438|NCT00310388|6357544|P1|STARTED|Safety Follow-up Continuation Phase||0
2590439|NCT00310388|6357543|P2|NOT COMPLETED|Primary Reporting Phase||0
2590440|NCT00310388|6357544|P1|NOT COMPLETED|Primary Reporting Phase||346
2590441|NCT00310388|6357543|P2|COMPLETED|Primary Reporting Phase||0
2590442|NCT00310388|6357544|P1|COMPLETED|Primary Reporting Phase||30
2590443|NCT00310388|6357543|P2|STARTED|Primary Reporting Phase||0
2590444|NCT00310388|6357544|P1|STARTED|Primary Reporting Phase||376
2590445|NCT00310375|6357586|P3|NOT COMPLETED|Safety Follow-up Continuation Phase||1
2590446|NCT00310375|6357587|P2|NOT COMPLETED|Safety Follow-up Continuation Phase||0
2590447|NCT00310375|6357588|P1|NOT COMPLETED|Safety Follow-up Continuation Phase||0
2590448|NCT00310375|6357586|P3|COMPLETED|Safety Follow-up Continuation Phase|Met the protocol defined stopping criteria|18
2590449|NCT00310375|6357587|P2|COMPLETED|Safety Follow-up Continuation Phase||0
2590450|NCT00310375|6357588|P1|COMPLETED|Safety Follow-up Continuation Phase||0
2590451|NCT00310375|6357586|P3|STARTED|Safety Follow-up Continuation Phase||19
2590452|NCT00310375|6357587|P2|STARTED|Safety Follow-up Continuation Phase||0
2590453|NCT00310375|6357588|P1|STARTED|Safety Follow-up Continuation Phase||0
2590454|NCT00310375|6357586|P3|NOT COMPLETED|Primary Reporting Phase||0
2590455|NCT00310375|6357587|P2|NOT COMPLETED|Primary Reporting Phase||68
2590456|NCT00310375|6357588|P1|NOT COMPLETED|Primary Reporting Phase||91
2590457|NCT00310375|6357586|P3|COMPLETED|Primary Reporting Phase||0
2590458|NCT00310375|6357587|P2|COMPLETED|Primary Reporting Phase||11
2590459|NCT00310375|6357588|P1|COMPLETED|Primary Reporting Phase||11
2590460|NCT00310375|6357586|P3|STARTED|Primary Reporting Phase||0
2590461|NCT00310375|6357587|P2|STARTED|Primary Reporting Phase||79
2590462|NCT00310375|6357588|P1|STARTED|Primary Reporting Phase||102
2590463|NCT00310362|6357633|P3|NOT COMPLETED|Overall Study||0
2590464|NCT00310362|6357634|P2|NOT COMPLETED|Overall Study||0
2590465|NCT00310362|6357635|P1|NOT COMPLETED|Overall Study||0
2590466|NCT00310362|6357633|P3|COMPLETED|Overall Study||1206
2590467|NCT00310362|6357634|P2|COMPLETED|Overall Study||1205
2590468|NCT00310362|6357635|P1|COMPLETED|Overall Study||1199
2590469|NCT00310362|6357633|P3|STARTED|Overall Study||1206
2590470|NCT00310362|6357634|P2|STARTED|Overall Study||1205
2590471|NCT00310362|6357635|P1|STARTED|Overall Study||1199
2590472|NCT00310310|6357645|P2|NOT COMPLETED|Overall Study||20
2590473|NCT00310310|6357646|P1|NOT COMPLETED|Overall Study||30
2590474|NCT00310310|6357645|P2|COMPLETED|Overall Study||100
2590475|NCT00310310|6357646|P1|COMPLETED|Overall Study||90
2590476|NCT00310310|6357645|P2|STARTED|Overall Study||120
2590477|NCT00310310|6357646|P1|STARTED|Overall Study||120
2590502|NCT00310076|6357707|P1|NOT COMPLETED|Overall Study||3
2590503|NCT00310076|6357707|P1|COMPLETED|Overall Study||26
2590504|NCT00310076|6357707|P1|STARTED|Overall Study||29
2590505|NCT00310050|6357713|P1|NOT COMPLETED|Overall Study||1
2590506|NCT00310050|6357713|P1|COMPLETED|Overall Study||3
2590507|NCT00310050|6357713|P1|STARTED|Overall Study||4
2590508|NCT00310037|6357724|P2|NOT COMPLETED|Overall Study||17
2590509|NCT00310037|6357725|P1|NOT COMPLETED|Overall Study||18
2590510|NCT00310037|6357724|P2|COMPLETED|Overall Study||33
2590511|NCT00310037|6357725|P1|COMPLETED|Overall Study||34
2590512|NCT00310037|6357724|P2|STARTED|Overall Study||50
2590513|NCT00310037|6357725|P1|STARTED|Overall Study||52
2590514|NCT00309985|6357739|P2|NOT COMPLETED|Overall Study||1
2590515|NCT00309985|6357740|P1|NOT COMPLETED|Overall Study||62
2590516|NCT00309985|6357739|P2|COMPLETED|Overall Study|"Arm B tx info was not collected so only 1 patient w/o follow-up data was considered not completed."|392
2590517|NCT00309985|6357740|P1|COMPLETED|Overall Study||335
2590518|NCT00309985|6357739|P2|Both Baseline and 3-month FACT-P Evals|Overall Study||299
2590519|NCT00309985|6357740|P1|Both Baseline and 3-month FACT-P Evals|Overall Study||334
2590520|NCT00309985|6357739|P2|Toxicity Analysis|Overall Study||392
2590521|NCT00309985|6357740|P1|Toxicity Analysis|Overall Study||390
2590522|NCT00309985|6357739|P2|STARTED|Overall Study||393
2590523|NCT00309985|6357740|P1|STARTED|Overall Study||397
2590524|NCT00309959|6357756|P1|NOT COMPLETED|Overall Study||2
2590525|NCT00309959|6357756|P1|COMPLETED|Overall Study||35
2590526|NCT00309959|6357756|P1|STARTED|Overall Study||37
2590527|NCT00309946|6357765|P1|NOT COMPLETED|Overall Study||1
2590528|NCT00309946|6357765|P1|COMPLETED|Overall Study||50
2590529|NCT00309946|6357765|P1|STARTED|Overall Study||51
2590530|NCT00309907|6357771|P1|NOT COMPLETED|Overall Study||20
2590531|NCT00309907|6357771|P1|COMPLETED|Overall Study||19
2590532|NCT00309907|6357771|P1|STARTED|Overall Study||39
2590533|NCT00309777|6357784|P4|NOT COMPLETED|Overall Study||4
2590534|NCT00309777|6357785|P3|NOT COMPLETED|Overall Study||19
2590535|NCT00309777|6357786|P2|NOT COMPLETED|Overall Study||9
2590536|NCT00309777|6357787|P1|NOT COMPLETED|Overall Study||23
2590537|NCT00309777|6357784|P4|COMPLETED|Overall Study||107
2590538|NCT00309777|6357785|P3|COMPLETED|Overall Study||304
2590539|NCT00309777|6357786|P2|COMPLETED|Overall Study||99
2590540|NCT00309777|6357787|P1|COMPLETED|Overall Study||292
2590541|NCT00309777|6357784|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|110
2590542|NCT00309777|6357785|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|320
2590543|NCT00309777|6357786|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|107
2590544|NCT00309777|6357787|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|311
2590545|NCT00309777|6357784|P4|STARTED|Overall Study||111
2590546|NCT00309777|6357785|P3|STARTED|Overall Study||323
2590547|NCT00309777|6357786|P2|STARTED|Overall Study||108
2590548|NCT00309777|6357787|P1|STARTED|Overall Study||315
2590549|NCT00309751|6357803|P2|NOT COMPLETED|Overall Study||15
2590550|NCT00309751|6357804|P1|NOT COMPLETED|Overall Study||31
2590551|NCT00309751|6357803|P2|COMPLETED|Overall Study||124
2590552|NCT00309751|6357804|P1|COMPLETED|Overall Study||248
2590553|NCT00309751|6357803|P2|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|137
2590554|NCT00309751|6357804|P1|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|275
2590555|NCT00309751|6357803|P2|STARTED|Overall Study||139
2590556|NCT00309751|6357804|P1|STARTED|Overall Study||279
2590557|NCT00309738|6357814|P2|NOT COMPLETED|Overall Study||12
2590558|NCT00309738|6357815|P1|NOT COMPLETED|Overall Study||13
2590559|NCT00309738|6357814|P2|COMPLETED|Overall Study||107
2590560|NCT00309738|6357815|P1|COMPLETED|Overall Study||223
2590561|NCT00309738|6357814|P2|Safety Population|Overall Study|Subjects who received at least one dose of study medication|119
2590562|NCT00309738|6357815|P1|Safety Population|Overall Study|Subjects who received at least one dose of study medication|233
2590563|NCT00309738|6357814|P2|STARTED|Overall Study||119
2590564|NCT00309738|6357815|P1|STARTED|Overall Study||236
2590565|NCT00309608|6357828|P5|NOT COMPLETED|Overall Study||4
2590566|NCT00309608|6357829|P4|NOT COMPLETED|Overall Study||6
2590567|NCT00309608|6357830|P3|NOT COMPLETED|Overall Study||10
2590568|NCT00309608|6357831|P2|NOT COMPLETED|Overall Study||13
2590569|NCT00309608|6357832|P1|NOT COMPLETED|Overall Study||14
2590570|NCT00309608|6357828|P5|COMPLETED|Overall Study||61
2590571|NCT00309608|6357829|P4|COMPLETED|Overall Study||60
2590572|NCT00309608|6357830|P3|COMPLETED|Overall Study||56
2590573|NCT00309608|6357831|P2|COMPLETED|Overall Study||52
2590574|NCT00309608|6357832|P1|COMPLETED|Overall Study||57
2590575|NCT00309608|6357828|P5|STARTED|Overall Study||65
2590576|NCT00309608|6357829|P4|STARTED|Overall Study||66
2590577|NCT00309608|6357830|P3|STARTED|Overall Study||66
2590578|NCT00309608|6357831|P2|STARTED|Overall Study||65
2590579|NCT00309608|6357832|P1|STARTED|Overall Study||71
2590580|NCT00309465|6357859|P6|NOT COMPLETED|Overall Study||0
2590581|NCT00309465|6357860|P5|NOT COMPLETED|Overall Study||0
2590582|NCT00309465|6357861|P4|NOT COMPLETED|Overall Study||1
2590583|NCT00309465|6357862|P3|NOT COMPLETED|Overall Study||0
2590584|NCT00309465|6357863|P2|NOT COMPLETED|Overall Study||0
2590585|NCT00309465|6357864|P1|NOT COMPLETED|Overall Study||0
2590586|NCT00309465|6357859|P6|COMPLETED|Overall Study||76
2590587|NCT00309465|6357860|P5|COMPLETED|Overall Study||76
2590588|NCT00309465|6357861|P4|COMPLETED|Overall Study|One subject was excluded due to eligibility error.|75
2590589|NCT00309465|6357862|P3|COMPLETED|Overall Study||58
2590590|NCT00309465|6357863|P2|COMPLETED|Overall Study||58
2590591|NCT00309465|6357864|P1|COMPLETED|Overall Study||58
2590592|NCT00309465|6357859|P6|STARTED|Overall Study||76
2590593|NCT00309465|6357860|P5|STARTED|Overall Study||76
2590594|NCT00309465|6357861|P4|STARTED|Overall Study||76
2590595|NCT00309465|6357862|P3|STARTED|Overall Study||58
2590596|NCT00309465|6357863|P2|STARTED|Overall Study||58
2590597|NCT00309465|6357864|P1|STARTED|Overall Study||58
2590598|NCT00309452|6357880|P2|NOT COMPLETED|Overall Study||0
2590599|NCT00309452|6357881|P1|NOT COMPLETED|Overall Study||3
2590600|NCT00309452|6357880|P2|COMPLETED|Overall Study||60
2590601|NCT00309452|6357881|P1|COMPLETED|Overall Study||57
2590602|NCT00309452|6357880|P2|STARTED|Overall Study||60
2590603|NCT00309452|6357881|P1|STARTED|Overall Study||60
2590604|NCT00309387|6357909|P2|NOT COMPLETED|Overall Study||159
2590605|NCT00309387|6357910|P1|NOT COMPLETED|Overall Study||142
2590606|NCT00309387|6357909|P2|COMPLETED|Overall Study||351
2590607|NCT00309387|6357910|P1|COMPLETED|Overall Study||368
2590608|NCT00309387|6357909|P2|STARTED|Overall Study||510
2590609|NCT00309387|6357910|P1|STARTED|Overall Study||510
2590610|NCT00309244|6357928|P2|NOT COMPLETED|Overall Study||97
2590611|NCT00309244|6357929|P1|NOT COMPLETED|Overall Study||118
2590612|NCT00309244|6357928|P2|COMPLETED|Overall Study||246
2590613|NCT00309244|6357929|P1|COMPLETED|Overall Study||216
2590614|NCT00309244|6357928|P2|STARTED|Overall Study||343
2590615|NCT00309244|6357929|P1|STARTED|Overall Study||334
2590616|NCT00309166|6357951|P2|NOT COMPLETED|Overall Study||3
2590617|NCT00309166|6357952|P1|NOT COMPLETED|Overall Study||5
2590618|NCT00309166|6357951|P2|COMPLETED|Overall Study||86
2590619|NCT00309166|6357952|P1|COMPLETED|Overall Study||176
2590620|NCT00309166|6357951|P2|STARTED|Overall Study||89
2590621|NCT00309166|6357952|P1|STARTED|Overall Study||181
2590622|NCT00308997|6357980|P2|NOT COMPLETED|Overall Study||1
2590623|NCT00308997|6357981|P1|NOT COMPLETED|Overall Study||1
2590624|NCT00308997|6357980|P2|COMPLETED|Overall Study||28
2590625|NCT00308997|6357981|P1|COMPLETED|Overall Study||55
2590626|NCT00308997|6357980|P2|STARTED|Overall Study||29
2590627|NCT00308997|6357981|P1|STARTED|Overall Study||56
2590628|NCT00308737|6358000|P3|NOT COMPLETED|Overall Study||37
2590629|NCT00308737|6358001|P2|NOT COMPLETED|Overall Study||289
2590630|NCT00308737|6358002|P1|NOT COMPLETED|Overall Study||463
2590631|NCT00308737|6358000|P3|COMPLETED|Overall Study||127
2590632|NCT00308737|6358001|P2|COMPLETED|Overall Study||662
2590633|NCT00308737|6358002|P1|COMPLETED|Overall Study||475
2590634|NCT00308737|6358000|P3|STARTED|Overall Study||164
2590635|NCT00308737|6358001|P2|STARTED|Overall Study||951
2590636|NCT00308737|6358002|P1|STARTED|Overall Study||938
2590637|NCT00308711|6358042|P3|NOT COMPLETED|Overall Study||5
2590638|NCT00308711|6358043|P2|NOT COMPLETED|Overall Study||4
2590639|NCT00308711|6358044|P1|NOT COMPLETED|Overall Study||2
2590640|NCT00308711|6358042|P3|COMPLETED|Overall Study||431
2590641|NCT00308711|6358043|P2|COMPLETED|Overall Study||440
2590642|NCT00308711|6358044|P1|COMPLETED|Overall Study||426
2590643|NCT00308711|6358042|P3|STARTED|Overall Study||436
2590644|NCT00308711|6358043|P2|STARTED|Overall Study||444
2590645|NCT00308711|6358044|P1|STARTED|Overall Study||428
2590646|NCT00308620|6358079|P3|NOT COMPLETED|Overall Study||1
2590647|NCT00308620|6358080|P2|NOT COMPLETED|Overall Study||1
2590648|NCT00308620|6358081|P1|NOT COMPLETED|Overall Study||1
2590649|NCT00308620|6358079|P3|COMPLETED|Overall Study||5
2590650|NCT00308620|6358080|P2|COMPLETED|Overall Study||3
2590651|NCT00308620|6358081|P1|COMPLETED|Overall Study||2
2590652|NCT00308620|6358079|P3|STARTED|Overall Study||6
2590653|NCT00308620|6358080|P2|STARTED|Overall Study||4
2590654|NCT00308620|6358081|P1|STARTED|Overall Study||3
2590655|NCT00308581|6358090|P3|NOT COMPLETED|Randomized Maintenance Phase||0
2590656|NCT00308581|6358091|P2|NOT COMPLETED|Randomized Maintenance Phase||103
2590657|NCT00308581|6358092|P1|NOT COMPLETED|Randomized Maintenance Phase||105
2590658|NCT00308581|6358090|P3|COMPLETED|Randomized Maintenance Phase||0
2590659|NCT00308581|6358091|P2|COMPLETED|Randomized Maintenance Phase||83
2590660|NCT00308581|6358092|P1|COMPLETED|Randomized Maintenance Phase||82
2590661|NCT00308581|6358090|P3|STARTED|Randomized Maintenance Phase||0
2590662|NCT00308581|6358091|P2|STARTED|Randomized Maintenance Phase||186
2590663|NCT00308581|6358092|P1|STARTED|Randomized Maintenance Phase||187
2590664|NCT00308581|6358090|P3|NOT COMPLETED|Induction Phase||166
2590665|NCT00308581|6358091|P2|NOT COMPLETED|Induction Phase||0
2590666|NCT00308581|6358092|P1|NOT COMPLETED|Induction Phase||0
2590667|NCT00308581|6358090|P3|COMPLETED|Induction Phase||373
2590668|NCT00308581|6358091|P2|COMPLETED|Induction Phase|Not applicable in this period|0
2590669|NCT00308581|6358092|P1|COMPLETED|Induction Phase|Not applicable in this period|0
2590670|NCT00308581|6358090|P3|STARTED|Induction Phase||539
2590671|NCT00308581|6358091|P2|STARTED|Induction Phase|Not applicable in this period|0
2590672|NCT00308581|6358092|P1|STARTED|Induction Phase|Not applicable in this period|0
2590673|NCT00308555|6358218|P2|NOT COMPLETED|Overall Study||0
2590674|NCT00308555|6358219|P1|NOT COMPLETED|Overall Study||3
2590675|NCT00308555|6358218|P2|COMPLETED|Overall Study||11
2590676|NCT00308555|6358219|P1|COMPLETED|Overall Study||10
2590677|NCT00308555|6358218|P2|STARTED|Overall Study||11
2590678|NCT00308555|6358219|P1|STARTED|Overall Study||13
2590679|NCT00308516|6358227|P2|NOT COMPLETED|Overall Study||21
2590680|NCT00308516|6358228|P1|NOT COMPLETED|Overall Study||29
2590681|NCT00308516|6358227|P2|COMPLETED|Overall Study||10
2590682|NCT00308516|6358228|P1|COMPLETED|Overall Study||6
2590683|NCT00308516|6358227|P2|STARTED|Overall Study||31
2590684|NCT00308516|6358228|P1|STARTED|Overall Study||35
2590685|NCT00308308|6358236|P2|NOT COMPLETED|Overall Study||68
2590686|NCT00308308|6358237|P1|NOT COMPLETED|Overall Study||103
2590687|NCT00308308|6358236|P2|COMPLETED|Overall Study||220
2590688|NCT00308308|6358237|P1|COMPLETED|Overall Study||198
2590689|NCT00308308|6358236|P2|STARTED|Overall Study||288
2590690|NCT00308308|6358237|P1|STARTED|Overall Study||301
2590691|NCT00308282|6358261|P4|NOT COMPLETED|Overall Study||2
2590692|NCT00308282|6358262|P3|NOT COMPLETED|Overall Study||1
2590693|NCT00308282|6358263|P2|NOT COMPLETED|Overall Study||4
2590694|NCT00308282|6358264|P1|NOT COMPLETED|Overall Study||3
2590695|NCT00308282|6358261|P4|COMPLETED|Overall Study||32
2590696|NCT00308282|6358262|P3|COMPLETED|Overall Study||33
2590697|NCT00308282|6358263|P2|COMPLETED|Overall Study||30
2590698|NCT00308282|6358264|P1|COMPLETED|Overall Study||31
2590699|NCT00308282|6358261|P4|Received at Least One Dose of Study Drug|Overall Study||34
2590700|NCT00308282|6358262|P3|Received at Least One Dose of Study Drug|Overall Study||34
2590701|NCT00308282|6358263|P2|Received at Least One Dose of Study Drug|Overall Study||34
2590702|NCT00308282|6358264|P1|Received at Least One Dose of Study Drug|Overall Study||34
2590703|NCT00308282|6358261|P4|STARTED|Overall Study||34
2590704|NCT00308282|6358262|P3|STARTED|Overall Study||34
2590705|NCT00308282|6358263|P2|STARTED|Overall Study||34
2590706|NCT00308282|6358264|P1|STARTED|Overall Study||34
2590707|NCT00308230|6358304|P3|NOT COMPLETED|Overall Study||0
2590708|NCT00308230|6358305|P2|NOT COMPLETED|Overall Study||0
2590709|NCT00308230|6358306|P1|NOT COMPLETED|Overall Study||0
2590710|NCT00308230|6358304|P3|COMPLETED|Overall Study||20
2590711|NCT00308230|6358305|P2|COMPLETED|Overall Study||8
2590712|NCT00308230|6358306|P1|COMPLETED|Overall Study||6
2590713|NCT00308230|6358304|P3|STARTED|Overall Study||20
2590714|NCT00308230|6358305|P2|STARTED|Overall Study||8
2590715|NCT00308230|6358306|P1|STARTED|Overall Study||6
2590716|NCT00308139|6358316|P2|NOT COMPLETED|Overall Study||87
2590717|NCT00308139|6358317|P1|NOT COMPLETED|Overall Study||94
2590718|NCT00308139|6358316|P2|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|64
2590719|NCT00308139|6358317|P1|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|58
2590720|NCT00308139|6358316|P2|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|130
2590721|NCT00308139|6358317|P1|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|128
2590722|NCT00308139|6358316|P2|Evaluable Meal Tolerance Cohort|Overall Study||24
2590723|NCT00308139|6358317|P1|Evaluable Meal Tolerance Cohort|Overall Study||27
2590724|NCT00308139|6358316|P2|Pharmacokinetics Population|Overall Study||0
2590725|NCT00308139|6358317|P1|Pharmacokinetics Population|Overall Study||129
2590726|NCT00308139|6358316|P2|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|145
2590727|NCT00308139|6358317|P1|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|148
2590728|NCT00308139|6358316|P2|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|147
2590729|NCT00308139|6358317|P1|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|148
2590730|NCT00308139|6358316|P2|STARTED|Overall Study||151
2590731|NCT00308139|6358317|P1|STARTED|Overall Study||152
2590732|NCT00308113|6358391|P4|NOT COMPLETED|Overall Study||1
2590733|NCT00308113|6358392|P3|NOT COMPLETED|Overall Study||0
2590734|NCT00308113|6358393|P2|NOT COMPLETED|Overall Study||0
2590735|NCT00308113|6358394|P1|NOT COMPLETED|Overall Study||0
2590736|NCT00308113|6358391|P4|COMPLETED|Overall Study||1
2590737|NCT00308113|6358392|P3|COMPLETED|Overall Study||1
2590738|NCT00308113|6358393|P2|COMPLETED|Overall Study||0
2590739|NCT00308113|6358394|P1|COMPLETED|Overall Study||0
2590740|NCT00308113|6358391|P4|STARTED|Overall Study||2
2590741|NCT00308113|6358392|P3|STARTED|Overall Study||1
2590742|NCT00308113|6358393|P2|STARTED|Overall Study||0
2590743|NCT00308113|6358394|P1|STARTED|Overall Study||0
2590744|NCT00308087|6358414|P2|NOT COMPLETED|Overall Study||37
2590745|NCT00308087|6358415|P1|NOT COMPLETED|Overall Study||36
2590746|NCT00308087|6358414|P2|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
2590747|NCT00308087|6358415|P1|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
2590748|NCT00308087|6358414|P2|STARTED|Overall Study||38
2590749|NCT00308087|6358415|P1|STARTED|Overall Study||37
2590750|NCT00308074|6358431|P1|NOT COMPLETED|Overall Study||1
2590751|NCT00308074|6358431|P1|COMPLETED|Overall Study||13
2590752|NCT00308074|6358431|P1|STARTED|Overall Study||14
2590753|NCT00308061|6358440|P2|NOT COMPLETED|Overall Study||0
2590754|NCT00308061|6358441|P1|NOT COMPLETED|Overall Study||0
2590755|NCT00308061|6358440|P2|COMPLETED|Overall Study||20
2590756|NCT00308061|6358441|P1|COMPLETED|Overall Study||20
2590757|NCT00308061|6358440|P2|STARTED|Overall Study||20
2590758|NCT00308061|6358441|P1|STARTED|Overall Study||20
2590759|NCT00307931|6358448|P1|NOT COMPLETED|Overall Study||1
2590760|NCT00307931|6358448|P1|COMPLETED|Overall Study|Number of subjects who completed the Week 12 visit|15
2590761|NCT00307931|6358448|P1|STARTED|Overall Study|Number of subjects who entered the study and have been treated|16
2590762|NCT00307801|6358465|P2|NOT COMPLETED|Overall Study||17
2590763|NCT00307801|6358466|P1|NOT COMPLETED|Overall Study||32
2590764|NCT00307801|6358465|P2|COMPLETED|Overall Study||65
2590765|NCT00307801|6358466|P1|COMPLETED|Overall Study||117
2590766|NCT00307801|6358465|P2|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|77
2590767|NCT00307801|6358466|P1|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|141
2590768|NCT00307801|6358465|P2|Cycle 3, Visit 7, Treatment Day 84|Overall Study||71
2590769|NCT00307801|6358466|P1|Cycle 3, Visit 7, Treatment Day 84|Overall Study||130
2590770|NCT00307801|6358465|P2|Cycle 1, Visit 5, Baseline|Overall Study||81
2590771|NCT00307801|6358466|P1|Cycle 1, Visit 5, Baseline|Overall Study||145
2590772|NCT00307801|6358465|P2|Subjects Received Treatment|Overall Study||81
2590773|NCT00307801|6358466|P1|Subjects Received Treatment|Overall Study||145
2590774|NCT00307801|6358465|P2|STARTED|Overall Study||82
2590775|NCT00307801|6358466|P1|STARTED|Overall Study||149
2590776|NCT00307736|6358578|P4|NOT COMPLETED|Overall Study||3
2590777|NCT00307736|6358579|P3|NOT COMPLETED|Overall Study||3
2590778|NCT00307736|6358580|P2|NOT COMPLETED|Overall Study||0
2590779|NCT00307736|6358581|P1|NOT COMPLETED|Overall Study||0
2590780|NCT00307736|6358578|P4|COMPLETED|Overall Study||20
2590781|NCT00307736|6358579|P3|COMPLETED|Overall Study||0
2590782|NCT00307736|6358580|P2|COMPLETED|Overall Study||3
2590783|NCT00307736|6358581|P1|COMPLETED|Overall Study||3
2590784|NCT00307736|6358578|P4|STARTED|Overall Study||23
2590785|NCT00307736|6358579|P3|STARTED|Overall Study||3
2590786|NCT00307736|6358580|P2|STARTED|Overall Study||3
2590787|NCT00307736|6358581|P1|STARTED|Overall Study||3
2590788|NCT00307684|6358592|P3|NOT COMPLETED|Double Blind Phase||0
2590789|NCT00307684|6358593|P2|NOT COMPLETED|Double Blind Phase||5
2590790|NCT00307684|6358594|P1|NOT COMPLETED|Double Blind Phase||2
2590791|NCT00307684|6358592|P3|COMPLETED|Double Blind Phase||0
2590792|NCT00307684|6358593|P2|COMPLETED|Double Blind Phase||17
2590793|NCT00307684|6358594|P1|COMPLETED|Double Blind Phase||21
2590794|NCT00307684|6358592|P3|STARTED|Double Blind Phase||0
2590795|NCT00307684|6358593|P2|STARTED|Double Blind Phase||22
2590796|NCT00307684|6358594|P1|STARTED|Double Blind Phase||23
2590797|NCT00307684|6358592|P3|NOT COMPLETED|Open Label Phase||56
2590798|NCT00307684|6358593|P2|NOT COMPLETED|Open Label Phase||0
2590799|NCT00307684|6358594|P1|NOT COMPLETED|Open Label Phase||0
2590800|NCT00307684|6358592|P3|COMPLETED|Open Label Phase||99
2590801|NCT00307684|6358593|P2|COMPLETED|Open Label Phase||0
2590802|NCT00307684|6358594|P1|COMPLETED|Open Label Phase||0
2590803|NCT00307684|6358592|P3|STARTED|Open Label Phase|1 screening failure|155
2590804|NCT00307684|6358593|P2|STARTED|Open Label Phase||0
2590805|NCT00307684|6358594|P1|STARTED|Open Label Phase||0
2590806|NCT00307489|6358622|P2|NOT COMPLETED|Week 48 Through Week 168||6
2590807|NCT00307489|6358623|P1|NOT COMPLETED|Week 48 Through Week 168||6
2590808|NCT00307489|6358622|P2|COMPLETED|Week 48 Through Week 168|5 of the 44 subjects switched to open-label FTC/TDF prior to Week 168.|44
2590809|NCT00307489|6358623|P1|COMPLETED|Week 48 Through Week 168|11 of the 46 subjects switched to open-label FTC/TDF prior to Week 168.|46
2590810|NCT00307489|6358622|P2|STARTED|Week 48 Through Week 168||50
2590811|NCT00307489|6358623|P1|STARTED|Week 48 Through Week 168||52
2590812|NCT00307489|6358622|P2|NOT COMPLETED|Baseline Through Week 48||2
2590813|NCT00307489|6358623|P1|NOT COMPLETED|Baseline Through Week 48||1
2590814|NCT00307489|6358622|P2|COMPLETED|Baseline Through Week 48|9 of the 50 subjects switched to open-label FTC/TDF prior to Week 48.|50
2590815|NCT00307489|6358623|P1|COMPLETED|Baseline Through Week 48|16 of the 52 subjects switched to open-label FTC/TDF prior to Week 48.|52
2590816|NCT00307489|6358622|P2|STARTED|Baseline Through Week 48||52
2590817|NCT00307489|6358623|P1|STARTED|Baseline Through Week 48||53
2590818|NCT00307437|6358668|P7|NOT COMPLETED|After Controlled Period||113
2590819|NCT00307437|6358669|P6|NOT COMPLETED|After Controlled Period||122
2590820|NCT00307437|6358670|P5|NOT COMPLETED|After Controlled Period||55
2590821|NCT00307437|6358671|P4|NOT COMPLETED|After Controlled Period||58
2590822|NCT00307437|6358672|P3|NOT COMPLETED|After Controlled Period||0
2590823|NCT00307437|6358673|P2|NOT COMPLETED|After Controlled Period||0
2590824|NCT00307437|6358674|P1|NOT COMPLETED|After Controlled Period||0
2590825|NCT00307437|6358668|P7|COMPLETED|After Controlled Period||289
2590826|NCT00307437|6358669|P6|COMPLETED|After Controlled Period||281
2590827|NCT00307437|6358670|P5|COMPLETED|After Controlled Period||140
2590828|NCT00307437|6358671|P4|COMPLETED|After Controlled Period||139
2590829|NCT00307437|6358672|P3|COMPLETED|After Controlled Period||0
2590830|NCT00307437|6358673|P2|COMPLETED|After Controlled Period||0
2590831|NCT00307437|6358674|P1|COMPLETED|After Controlled Period||0
2590832|NCT00307437|6358668|P7|STARTED|After Controlled Period||402
2590833|NCT00307437|6358669|P6|STARTED|After Controlled Period||403
2590834|NCT00307437|6358670|P5|STARTED|After Controlled Period|2 participants from placebo group in CP did not crossover to this group after CP.|195
2590835|NCT00307437|6358671|P4|STARTED|After Controlled Period||197
2590836|NCT00307437|6358672|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
2590837|NCT00307437|6358673|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
2590838|NCT00307437|6358674|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
2590839|NCT00307437|6358668|P7|NOT COMPLETED|Controlled Period||0
2590840|NCT00307437|6358669|P6|NOT COMPLETED|Controlled Period||0
2590841|NCT00307437|6358670|P5|NOT COMPLETED|Controlled Period||0
2590842|NCT00307437|6358671|P4|NOT COMPLETED|Controlled Period||0
2590843|NCT00307437|6358672|P3|NOT COMPLETED|Controlled Period||9
2590844|NCT00307437|6358673|P2|NOT COMPLETED|Controlled Period||6
2590845|NCT00307437|6358674|P1|NOT COMPLETED|Controlled Period||16
2590846|NCT00307437|6358668|P7|COMPLETED|Controlled Period||0
2590847|NCT00307437|6358669|P6|COMPLETED|Controlled Period||0
2590848|NCT00307437|6358670|P5|COMPLETED|Controlled Period||0
2590849|NCT00307437|6358671|P4|COMPLETED|Controlled Period||0
2590850|NCT00307437|6358672|P3|COMPLETED|Controlled Period||402
2590851|NCT00307437|6358673|P2|COMPLETED|Controlled Period||403
2590852|NCT00307437|6358674|P1|COMPLETED|Controlled Period||394
2590853|NCT00307437|6358668|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
2590854|NCT00307437|6358669|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
2590855|NCT00307437|6358670|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
2590856|NCT00307437|6358671|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
2590857|NCT00307437|6358672|P3|STARTED|Controlled Period||411
2590858|NCT00307437|6358673|P2|STARTED|Controlled Period||409
2590859|NCT00307437|6358674|P1|STARTED|Controlled Period||410
2590860|NCT00307333|6358700|P2|NOT COMPLETED|Overall Study||3
2590861|NCT00307333|6358701|P1|NOT COMPLETED|Overall Study||11
2590862|NCT00307333|6358700|P2|COMPLETED|Overall Study||1489
2590863|NCT00307333|6358701|P1|COMPLETED|Overall Study||1500
2590864|NCT00307333|6358700|P2|STARTED|Overall Study||1492
2590865|NCT00307333|6358701|P1|STARTED|Overall Study||1511
2590866|NCT00307294|6358713|P1|NOT COMPLETED|Overall Study||1
2590867|NCT00307294|6358713|P1|COMPLETED|Overall Study||39
2590868|NCT00307294|6358713|P1|STARTED|Overall Study||40
2590869|NCT00307164|6358722|P2|NOT COMPLETED|Overall Study||14
2590870|NCT00307164|6358723|P1|NOT COMPLETED|Overall Study||15
2590871|NCT00307164|6358722|P2|COMPLETED|Overall Study||68
2590872|NCT00307164|6358723|P1|COMPLETED|Overall Study||68
2590873|NCT00307164|6358722|P2|STARTED|Overall Study||82
2590874|NCT00307164|6358723|P1|STARTED|Overall Study||83
2590875|NCT00307151|6358763|P4|NOT COMPLETED|Overall Study||11
2590876|NCT00307151|6358764|P3|NOT COMPLETED|Overall Study||20
2590877|NCT00307151|6358765|P2|NOT COMPLETED|Overall Study||7
2590878|NCT00307151|6358766|P1|NOT COMPLETED|Overall Study||11
2590879|NCT00307151|6358763|P4|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|129
2590880|NCT00307151|6358764|P3|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|127
2590881|NCT00307151|6358765|P2|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|75
2590882|NCT00307151|6358766|P1|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|71
2590971|NCT00306995|6359027|P5|COMPLETED|Study Part I||55
2590883|NCT00307151|6358763|P4|STARTED|Overall Study|One participant never started treatment, were not followed and not included in analysis.|140
2590884|NCT00307151|6358764|P3|STARTED|Overall Study||147
2590885|NCT00307151|6358765|P2|STARTED|Overall Study||82
2590886|NCT00307151|6358766|P1|STARTED|Overall Study||82
2590887|NCT00307125|6358810|P3|NOT COMPLETED|Pilot Phase||1
2590888|NCT00307125|6358811|P2|NOT COMPLETED|Pilot Phase||2
2590889|NCT00307125|6358812|P1|NOT COMPLETED|Pilot Phase||0
2590890|NCT00307125|6358810|P3|COMPLETED|Pilot Phase|1 participant had reduced follow-up|6
2590891|NCT00307125|6358811|P2|COMPLETED|Pilot Phase|2 participants had reduced follow-up|13
2590892|NCT00307125|6358812|P1|COMPLETED|Pilot Phase||0
2590893|NCT00307125|6358810|P3|STARTED|Pilot Phase||7
2590894|NCT00307125|6358811|P2|STARTED|Pilot Phase||15
2590895|NCT00307125|6358812|P1|STARTED|Pilot Phase||0
2590896|NCT00307125|6358810|P3|NOT COMPLETED|Screening Phase||0
2590897|NCT00307125|6358811|P2|NOT COMPLETED|Screening Phase||0
2590898|NCT00307125|6358812|P1|NOT COMPLETED|Screening Phase||454
2590899|NCT00307125|6358810|P3|COMPLETED|Screening Phase||0
2590900|NCT00307125|6358811|P2|COMPLETED|Screening Phase||0
2590901|NCT00307125|6358812|P1|COMPLETED|Screening Phase||303
2590902|NCT00307125|6358810|P3|STARTED|Screening Phase||0
2590903|NCT00307125|6358811|P2|STARTED|Screening Phase||0
2590904|NCT00307125|6358812|P1|STARTED|Screening Phase||757
2590905|NCT00307086|6358834|P1|NOT COMPLETED|Overall Study||5
2590906|NCT00307086|6358834|P1|COMPLETED|Overall Study||25
2590907|NCT00307086|6358834|P1|STARTED|Overall Study||30
2590908|NCT00307047|6358840|P2|NOT COMPLETED|Overall Study||49
2590909|NCT00307047|6358841|P1|NOT COMPLETED|Overall Study||69
2590910|NCT00307047|6358840|P2|COMPLETED|Overall Study||1180
2590911|NCT00307047|6358841|P1|COMPLETED|Overall Study||2389
2590912|NCT00307047|6358840|P2|STARTED|Overall Study||1229
2590913|NCT00307047|6358841|P1|STARTED|Overall Study||2458
2590914|NCT00307034|6358979|P2|NOT COMPLETED|Overall Study||7
2590915|NCT00307034|6358980|P1|NOT COMPLETED|Overall Study||2
2590916|NCT00307034|6358979|P2|COMPLETED|Overall Study||169
2590917|NCT00307034|6358980|P1|COMPLETED|Overall Study||173
2590918|NCT00307034|6358979|P2|STARTED|Overall Study||176
2590919|NCT00307034|6358980|P1|STARTED|Overall Study||175
2590920|NCT00306995|6359025|P7|NOT COMPLETED|Study Part II for Subset 2||0
2590921|NCT00306995|6359026|P6|NOT COMPLETED|Study Part II for Subset 2||0
2590922|NCT00306995|6359027|P5|NOT COMPLETED|Study Part II for Subset 2||0
2590923|NCT00306995|6359028|P4|NOT COMPLETED|Study Part II for Subset 2||0
2590924|NCT00306995|6359029|P3|NOT COMPLETED|Study Part II for Subset 2||0
2590925|NCT00306995|6359030|P2|NOT COMPLETED|Study Part II for Subset 2||1
2590926|NCT00306995|6359031|P1|NOT COMPLETED|Study Part II for Subset 2||0
2590927|NCT00306995|6359025|P7|COMPLETED|Study Part II for Subset 2||24
2590928|NCT00306995|6359026|P6|COMPLETED|Study Part II for Subset 2||26
2590929|NCT00306995|6359027|P5|COMPLETED|Study Part II for Subset 2||23
2590930|NCT00306995|6359028|P4|COMPLETED|Study Part II for Subset 2||22
2590931|NCT00306995|6359029|P3|COMPLETED|Study Part II for Subset 2||23
2590932|NCT00306995|6359030|P2|COMPLETED|Study Part II for Subset 2||23
2590933|NCT00306995|6359031|P1|COMPLETED|Study Part II for Subset 2||23
2590934|NCT00306995|6359025|P7|STARTED|Study Part II for Subset 2||24
2590935|NCT00306995|6359026|P6|STARTED|Study Part II for Subset 2||26
2590936|NCT00306995|6359027|P5|STARTED|Study Part II for Subset 2||23
2590937|NCT00306995|6359028|P4|STARTED|Study Part II for Subset 2||22
2590938|NCT00306995|6359029|P3|STARTED|Study Part II for Subset 2||23
2590939|NCT00306995|6359030|P2|STARTED|Study Part II for Subset 2||24
2590940|NCT00306995|6359031|P1|STARTED|Study Part II for Subset 2||23
2590941|NCT00306995|6359025|P7|NOT COMPLETED|Study Part II for Subset 1||0
2590942|NCT00306995|6359026|P6|NOT COMPLETED|Study Part II for Subset 1||0
2590943|NCT00306995|6359027|P5|NOT COMPLETED|Study Part II for Subset 1||0
2590944|NCT00306995|6359028|P4|NOT COMPLETED|Study Part II for Subset 1||0
2590945|NCT00306995|6359029|P3|NOT COMPLETED|Study Part II for Subset 1||0
2590946|NCT00306995|6359030|P2|NOT COMPLETED|Study Part II for Subset 1||0
2590947|NCT00306995|6359031|P1|NOT COMPLETED|Study Part II for Subset 1||0
2590948|NCT00306995|6359025|P7|COMPLETED|Study Part II for Subset 1||23
2590949|NCT00306995|6359026|P6|COMPLETED|Study Part II for Subset 1||26
2590950|NCT00306995|6359027|P5|COMPLETED|Study Part II for Subset 1||27
2590951|NCT00306995|6359028|P4|COMPLETED|Study Part II for Subset 1||27
2590952|NCT00306995|6359029|P3|COMPLETED|Study Part II for Subset 1||27
2590953|NCT00306995|6359030|P2|COMPLETED|Study Part II for Subset 1||26
2590954|NCT00306995|6359031|P1|COMPLETED|Study Part II for Subset 1||27
2590955|NCT00306995|6359025|P7|STARTED|Study Part II for Subset 1||23
2590956|NCT00306995|6359026|P6|STARTED|Study Part II for Subset 1||26
2590957|NCT00306995|6359027|P5|STARTED|Study Part II for Subset 1||27
2590958|NCT00306995|6359028|P4|STARTED|Study Part II for Subset 1||27
2590959|NCT00306995|6359029|P3|STARTED|Study Part II for Subset 1||27
2590960|NCT00306995|6359030|P2|STARTED|Study Part II for Subset 1||26
2590961|NCT00306995|6359031|P1|STARTED|Study Part II for Subset 1||27
2590962|NCT00306995|6359025|P7|NOT COMPLETED|Study Part I||1
2590963|NCT00306995|6359026|P6|NOT COMPLETED|Study Part I||0
2590964|NCT00306995|6359027|P5|NOT COMPLETED|Study Part I||0
2590965|NCT00306995|6359028|P4|NOT COMPLETED|Study Part I||0
2590966|NCT00306995|6359029|P3|NOT COMPLETED|Study Part I||0
2590967|NCT00306995|6359030|P2|NOT COMPLETED|Study Part I||0
2590968|NCT00306995|6359031|P1|NOT COMPLETED|Study Part I||0
2590969|NCT00306995|6359025|P7|COMPLETED|Study Part I||54
2590970|NCT00306995|6359026|P6|COMPLETED|Study Part I||55
2590972|NCT00306995|6359028|P4|COMPLETED|Study Part I||55
2590973|NCT00306995|6359029|P3|COMPLETED|Study Part I||55
2590974|NCT00306995|6359030|P2|COMPLETED|Study Part I||55
2590975|NCT00306995|6359031|P1|COMPLETED|Study Part I||55
2590976|NCT00306995|6359025|P7|STARTED|Study Part I||55
2590977|NCT00306995|6359026|P6|STARTED|Study Part I||55
2590978|NCT00306995|6359027|P5|STARTED|Study Part I||55
2590979|NCT00306995|6359028|P4|STARTED|Study Part I||55
2590980|NCT00306995|6359029|P3|STARTED|Study Part I||55
2590981|NCT00306995|6359030|P2|STARTED|Study Part I||55
2590982|NCT00306995|6359031|P1|STARTED|Study Part I||55
2590983|NCT00306917|6359413|P2|NOT COMPLETED|Overall Study||109
2590984|NCT00306917|6359414|P1|NOT COMPLETED|Overall Study||108
2590985|NCT00306917|6359413|P2|COMPLETED|Overall Study||15
2590986|NCT00306917|6359414|P1|COMPLETED|Overall Study||13
2590987|NCT00306917|6359413|P2|60 Month Follow up|Overall Study||15
2590988|NCT00306917|6359414|P1|60 Month Follow up|Overall Study||13
2590989|NCT00306917|6359413|P2|48 Month Follow up|Overall Study||22
2590990|NCT00306917|6359414|P1|48 Month Follow up|Overall Study||29
2590991|NCT00306917|6359413|P2|36 Month Follow up|Overall Study||42
2590992|NCT00306917|6359414|P1|36 Month Follow up|Overall Study||56
2590993|NCT00306917|6359413|P2|24 Month Follow up|Overall Study||71
2590994|NCT00306917|6359414|P1|24 Month Follow up|Overall Study||60
2590995|NCT00306917|6359413|P2|12 Month Follow|Overall Study||94
2590996|NCT00306917|6359414|P1|12 Month Follow|Overall Study||86
2590997|NCT00306917|6359413|P2|Postoperative to 6 Month Follow up|Overall Study||100
2590998|NCT00306917|6359414|P1|Postoperative to 6 Month Follow up|Overall Study||93
2590999|NCT00306917|6359413|P2|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|124
2591000|NCT00306917|6359414|P1|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|121
2591001|NCT00306891|6359424|P4|NOT COMPLETED|Part B||17
2591002|NCT00306891|6359425|P3|NOT COMPLETED|Part B||11
2591003|NCT00306891|6359426|P2|NOT COMPLETED|Part B||0
2591004|NCT00306891|6359427|P1|NOT COMPLETED|Part B||0
2591005|NCT00306891|6359424|P4|COMPLETED|Part B||14
2591006|NCT00306891|6359425|P3|COMPLETED|Part B||5
2591007|NCT00306891|6359426|P2|COMPLETED|Part B||0
2591008|NCT00306891|6359427|P1|COMPLETED|Part B||0
2591009|NCT00306891|6359424|P4|STARTED|Part B|in Part B: Cediranib Dose Escalation 11 new patients were randomized.|31
2591010|NCT00306891|6359425|P3|STARTED|Part B|In Part B: Cediranib 45 mg Fixed Dose 4 new patients were randomized|16
2591011|NCT00306891|6359426|P2|STARTED|Part B||0
2591012|NCT00306891|6359427|P1|STARTED|Part B||0
2591013|NCT00306891|6359424|P4|NOT COMPLETED|Part A||0
2591014|NCT00306891|6359425|P3|NOT COMPLETED|Part A||0
2591015|NCT00306891|6359426|P2|NOT COMPLETED|Part A||6
2591016|NCT00306891|6359427|P1|NOT COMPLETED|Part A||5
2591017|NCT00306891|6359424|P4|COMPLETED|Part A||0
2591018|NCT00306891|6359425|P3|COMPLETED|Part A||0
2591019|NCT00306891|6359426|P2|COMPLETED|Part A||16
2591020|NCT00306891|6359427|P1|COMPLETED|Part A||18
2591021|NCT00306891|6359424|P4|STARTED|Part A||0
2591022|NCT00306891|6359425|P3|STARTED|Part A||0
2591023|NCT00306891|6359426|P2|STARTED|Part A||22
2591024|NCT00306891|6359427|P1|STARTED|Part A||23
2591025|NCT00306852|6359450|P2|NOT COMPLETED|Overall Study||38
2591026|NCT00306852|6359451|P1|NOT COMPLETED|Overall Study||29
2591027|NCT00306852|6359450|P2|COMPLETED|Overall Study||69
2591028|NCT00306852|6359451|P1|COMPLETED|Overall Study||76
2591029|NCT00306852|6359450|P2|STARTED|Overall Study||107
2591030|NCT00306852|6359451|P1|STARTED|Overall Study||105
2591031|NCT00306787|6359469|P2|NOT COMPLETED|Overall Study||241
2591032|NCT00306787|6359470|P1|NOT COMPLETED|Overall Study||234
2591033|NCT00306787|6359469|P2|COMPLETED|Overall Study||359
2591034|NCT00306787|6359470|P1|COMPLETED|Overall Study||345
2591035|NCT00306787|6359469|P2|Intent to Treat (ITT) Population|Overall Study||381
2591036|NCT00306787|6359470|P1|Intent to Treat (ITT) Population|Overall Study||370
2591037|NCT00306787|6359469|P2|Received Study Drug (Safety Population)|Overall Study||385
2591038|NCT00306787|6359470|P1|Received Study Drug (Safety Population)|Overall Study||371
2591039|NCT00306787|6359469|P2|STARTED|Overall Study||600
2591040|NCT00306787|6359470|P1|STARTED|Overall Study||579
2591041|NCT00306670|6359488|P2|NOT COMPLETED|Overall Study||2
2591042|NCT00306670|6359489|P1|NOT COMPLETED|Overall Study||0
2591043|NCT00306670|6359488|P2|COMPLETED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued study before treatment initiated|0
2591044|NCT00306670|6359489|P1|COMPLETED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
2591045|NCT00306670|6359488|P2|STARTED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued trial before treatment started|2
2591046|NCT00306670|6359489|P1|STARTED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
2591047|NCT00306592|6359495|P2|NOT COMPLETED|Overall Study||58
2591048|NCT00306592|6359496|P1|NOT COMPLETED|Overall Study||31
2591049|NCT00306592|6359495|P2|COMPLETED|Overall Study||632
2591050|NCT00306592|6359496|P1|COMPLETED|Overall Study||373
2591051|NCT00306592|6359495|P2|Entered 101-MS-321 Extension Study|Overall Study|pertains to participants transitioning from 101-MS-322 (NCT00306592) study only|0
2591052|NCT00306592|6359496|P1|Entered 101-MS-321 Extension Study|Overall Study||22
2591053|NCT00306592|6359495|P2|Completed at 48 Weeks|Overall Study||632
2591054|NCT00306592|6359496|P1|Completed at 48 Weeks|Overall Study||81
2591055|NCT00306592|6359495|P2|Completed Between 24 and 48 Weeks|Overall Study||0
2591056|NCT00306592|6359496|P1|Completed Between 24 and 48 Weeks|Overall Study||85
2591057|NCT00306592|6359495|P2|Completed at 24 Weeks|Overall Study||0
2591058|NCT00306592|6359496|P1|Completed at 24 Weeks|Overall Study||207
2591059|NCT00306592|6359495|P2|STARTED|Overall Study||690
2591060|NCT00306592|6359496|P1|STARTED|Overall Study||404
2591061|NCT00306527|6359506|P4|NOT COMPLETED|Overall Study||6
2591062|NCT00306527|6359507|P3|NOT COMPLETED|Overall Study||5
2591063|NCT00306527|6359508|P2|NOT COMPLETED|Overall Study||7
2591064|NCT00306527|6359509|P1|NOT COMPLETED|Overall Study||6
2591065|NCT00306527|6359506|P4|COMPLETED|Overall Study||590
2591066|NCT00306527|6359507|P3|COMPLETED|Overall Study|3 of 4 deaths in the elderly subjects resulted in premature discontinuation. Refer to OM2 .|567
2591067|NCT00306527|6359508|P2|COMPLETED|Overall Study||527
2591068|NCT00306527|6359509|P1|COMPLETED|Overall Study||527
2591069|NCT00306527|6359506|P4|STARTED|Overall Study||596
2591070|NCT00306527|6359507|P3|STARTED|Overall Study||572
2591071|NCT00306527|6359508|P2|STARTED|Overall Study||534
2591072|NCT00306527|6359509|P1|STARTED|Overall Study||533
2591073|NCT00306488|6359563|P2|NOT COMPLETED|Overall Study||1
2591074|NCT00306488|6359564|P1|NOT COMPLETED|Overall Study||1
2591075|NCT00306488|6359563|P2|COMPLETED|Overall Study||10
2591076|NCT00306488|6359564|P1|COMPLETED|Overall Study||10
2591077|NCT00306488|6359563|P2|STARTED|Overall Study||11
2591078|NCT00306488|6359564|P1|STARTED|Overall Study||11
2591079|NCT00306384|6359578|P3|NOT COMPLETED|Overall Study||277
2591080|NCT00306384|6359579|P2|NOT COMPLETED|Overall Study||508
2591081|NCT00306384|6359580|P1|NOT COMPLETED|Overall Study||542
2591082|NCT00306384|6359578|P3|COMPLETED|Overall Study||251
2591083|NCT00306384|6359579|P2|COMPLETED|Overall Study||891
2591084|NCT00306384|6359580|P1|COMPLETED|Overall Study||854
2591085|NCT00306384|6359578|P3|Safety Set|Overall Study|Patients who received at least one dose of study drug|527
2591086|NCT00306384|6359579|P2|Safety Set|Overall Study|Patients who received at least one dose of study drug|1398
2591087|NCT00306384|6359580|P1|Safety Set|Overall Study|Patients who received at least one dose of study drug|1395
2591088|NCT00306384|6359578|P3|STARTED|Overall Study||528
2591089|NCT00306384|6359579|P2|STARTED|Overall Study||1399
2591090|NCT00306384|6359580|P1|STARTED|Overall Study||1396
2591091|NCT00306293|6359612|P2|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||1
2591092|NCT00306293|6359613|P1|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||3
2591093|NCT00306293|6359612|P2|COMPLETED|Period 2 (Day 67 to Day 126 )||26
2591094|NCT00306293|6359613|P1|COMPLETED|Period 2 (Day 67 to Day 126 )||24
2591095|NCT00306293|6359612|P2|STARTED|Period 2 (Day 67 to Day 126 )||27
2591096|NCT00306293|6359613|P1|STARTED|Period 2 (Day 67 to Day 126 )||27
2591097|NCT00306293|6359612|P2|NOT COMPLETED|Washout (Day 61 to Day 66)||0
2591098|NCT00306293|6359613|P1|NOT COMPLETED|Washout (Day 61 to Day 66)||0
2591099|NCT00306293|6359612|P2|COMPLETED|Washout (Day 61 to Day 66)||27
2591100|NCT00306293|6359613|P1|COMPLETED|Washout (Day 61 to Day 66)||27
2591101|NCT00306293|6359612|P2|STARTED|Washout (Day 61 to Day 66)||27
2591102|NCT00306293|6359613|P1|STARTED|Washout (Day 61 to Day 66)||27
2591103|NCT00306293|6359612|P2|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8
2591104|NCT00306293|6359613|P1|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8
2591105|NCT00306293|6359612|P2|COMPLETED|Period 1 (Day 1 to Day 60)||27
2591106|NCT00306293|6359613|P1|COMPLETED|Period 1 (Day 1 to Day 60)||27
2591107|NCT00306293|6359612|P2|STARTED|Period 1 (Day 1 to Day 60)||35
2591108|NCT00306293|6359613|P1|STARTED|Period 1 (Day 1 to Day 60)||35
2591109|NCT00306202|6359634|P3|NOT COMPLETED|Overall Study||0
2591110|NCT00306202|6359635|P2|NOT COMPLETED|Overall Study||1
2591111|NCT00306202|6359636|P1|NOT COMPLETED|Overall Study||6
2591112|NCT00306202|6359634|P3|COMPLETED|Overall Study|Completed = Off-treatment|24
2591113|NCT00306202|6359635|P2|COMPLETED|Overall Study|Completed = Off-treatment|16
2591114|NCT00306202|6359636|P1|COMPLETED|Overall Study|Completed = Off-treatment|11
2591115|NCT00306202|6359634|P3|STARTED|Overall Study|Started = Treated. 24 were enrolled; 1 no longer met study criteria and was never treated|24
2591116|NCT00306202|6359635|P2|STARTED|Overall Study|Started=Treated. 20 were enrolled;3 never treated(2 no longer met study criteria;1 withdrew consent)|17
2591117|NCT00306202|6359636|P1|STARTED|Overall Study|Started = Treated. 18 were enrolled; 1 no longer met study criteria and was never treated|17
2591118|NCT00306189|6359796|P4|NOT COMPLETED|Overall Study||5
2591119|NCT00306189|6359797|P3|NOT COMPLETED|Overall Study||11
2591120|NCT00306189|6359798|P2|NOT COMPLETED|Overall Study||6
2591121|NCT00306189|6359799|P1|NOT COMPLETED|Overall Study||9
2591122|NCT00306189|6359796|P4|COMPLETED|Overall Study||52
2591123|NCT00306189|6359797|P3|COMPLETED|Overall Study||45
2591124|NCT00306189|6359798|P2|COMPLETED|Overall Study||50
2591125|NCT00306189|6359799|P1|COMPLETED|Overall Study||48
2591126|NCT00306189|6359796|P4|STARTED|Overall Study||57
2591127|NCT00306189|6359797|P3|STARTED|Overall Study||56
2591128|NCT00306189|6359798|P2|STARTED|Overall Study||56
2591129|NCT00306189|6359799|P1|STARTED|Overall Study||57
2591130|NCT00306163|6359811|P2|NOT COMPLETED|Overall Study||0
2591131|NCT00306163|6359812|P1|NOT COMPLETED|Overall Study||0
2591132|NCT00306163|6359811|P2|COMPLETED|Overall Study||18
2591133|NCT00306163|6359812|P1|COMPLETED|Overall Study||19
2591134|NCT00306163|6359811|P2|STARTED|Overall Study||18
2591135|NCT00306163|6359812|P1|STARTED|Overall Study||19
2591136|NCT00305942|6359818|P1|NOT COMPLETED|Overall Study||38
2591137|NCT00305942|6359818|P1|COMPLETED|Overall Study||23
2591138|NCT00305942|6359818|P1|STARTED|Overall Study||61
2591139|NCT00305877|6359826|P2|NOT COMPLETED|Overall Study||34
2591140|NCT00305877|6359827|P1|NOT COMPLETED|Overall Study||24
2591141|NCT00305877|6359826|P2|COMPLETED|Overall Study||34
2591142|NCT00305877|6359827|P1|COMPLETED|Overall Study||45
2591143|NCT00305877|6359826|P2|Included in Efficacy Analysis|Overall Study||62
2591144|NCT00305877|6359827|P1|Included in Efficacy Analysis|Overall Study||65
2591145|NCT00305877|6359826|P2|Eligible|Overall Study||66
2591146|NCT00305877|6359827|P1|Eligible|Overall Study||66
2591147|NCT00305877|6359826|P2|Treated|Overall Study||63
2591148|NCT00305877|6359827|P1|Treated|Overall Study||67
2591149|NCT00305877|6359826|P2|STARTED|Overall Study||68
2591150|NCT00305877|6359827|P1|STARTED|Overall Study||69
2591151|NCT00305864|6359841|P4|NOT COMPLETED|Overall Study||13
2591152|NCT00305864|6359842|P3|NOT COMPLETED|Overall Study||1
2591153|NCT00305864|6359843|P2|NOT COMPLETED|Overall Study||1
2591154|NCT00305864|6359844|P1|NOT COMPLETED|Overall Study||0
2591155|NCT00305864|6359841|P4|COMPLETED|Overall Study||81
2591156|NCT00305864|6359842|P3|COMPLETED|Overall Study||6
2591157|NCT00305864|6359843|P2|COMPLETED|Overall Study||9
2591158|NCT00305864|6359844|P1|COMPLETED|Overall Study||7
2591159|NCT00305864|6359841|P4|STARTED|Overall Study||94
2591160|NCT00305864|6359842|P3|STARTED|Overall Study||7
2591161|NCT00305864|6359843|P2|STARTED|Overall Study||10
2591162|NCT00305864|6359844|P1|STARTED|Overall Study||7
2591163|NCT00305773|6359857|P2|NOT COMPLETED|Overall Study||18
2591164|NCT00305773|6359858|P1|NOT COMPLETED|Overall Study||14
2591165|NCT00305773|6359857|P2|COMPLETED|Overall Study||4
2591166|NCT00305773|6359858|P1|COMPLETED|Overall Study||1
2591167|NCT00305773|6359857|P2|STARTED|Overall Study||22
2591168|NCT00305773|6359858|P1|STARTED|Overall Study||15
2591172|NCT00305643|6359878|P2|NOT COMPLETED|Overall Study||0
2591173|NCT00305643|6359879|P1|NOT COMPLETED|Overall Study||0
2591174|NCT00305643|6359878|P2|COMPLETED|Overall Study||5
2591175|NCT00305643|6359879|P1|COMPLETED|Overall Study||6
2591176|NCT00305643|6359878|P2|STARTED|Overall Study||5
2591177|NCT00305643|6359879|P1|STARTED|Overall Study||6
2591178|NCT00305604|6359889|P2|NOT COMPLETED|Overall Study||47
2591179|NCT00305604|6359890|P1|NOT COMPLETED|Overall Study||32
2591180|NCT00305604|6359889|P2|COMPLETED|Overall Study||57
2591181|NCT00305604|6359890|P1|COMPLETED|Overall Study||70
2591182|NCT00305604|6359889|P2|STARTED|Overall Study||104
2591183|NCT00305604|6359890|P1|STARTED|Overall Study||102
2591184|NCT00305578|6359904|P2|NOT COMPLETED|Overall Study||2
2591185|NCT00305578|6359905|P1|NOT COMPLETED|Overall Study||3
2591186|NCT00305578|6359904|P2|COMPLETED|Overall Study||12
2591187|NCT00305578|6359905|P1|COMPLETED|Overall Study||12
2591188|NCT00305578|6359904|P2|STARTED|Overall Study||14
2591189|NCT00305578|6359905|P1|STARTED|Overall Study||15
2591190|NCT00305565|6359914|P3|NOT COMPLETED|Overall Study (ITT Population)||5
2591191|NCT00305565|6359915|P2|NOT COMPLETED|Overall Study (ITT Population)||11
2591192|NCT00305565|6359916|P1|NOT COMPLETED|Overall Study (ITT Population)||13
2591193|NCT00305565|6359914|P3|COMPLETED|Overall Study (ITT Population)||102
2591194|NCT00305565|6359915|P2|COMPLETED|Overall Study (ITT Population)||90
2591195|NCT00305565|6359916|P1|COMPLETED|Overall Study (ITT Population)||89
2591196|NCT00305565|6359914|P3|STARTED|Overall Study (ITT Population)||107
2591197|NCT00305565|6359915|P2|STARTED|Overall Study (ITT Population)||101
2591198|NCT00305565|6359916|P1|STARTED|Overall Study (ITT Population)||102
2591199|NCT00305565|6359914|P3|NOT COMPLETED|Overall Study (Safety Population)||7
2591200|NCT00305565|6359915|P2|NOT COMPLETED|Overall Study (Safety Population)||12
2591201|NCT00305565|6359916|P1|NOT COMPLETED|Overall Study (Safety Population)||14
2591202|NCT00305565|6359914|P3|COMPLETED|Overall Study (Safety Population)||106
2591203|NCT00305565|6359915|P2|COMPLETED|Overall Study (Safety Population)||95
2591204|NCT00305565|6359916|P1|COMPLETED|Overall Study (Safety Population)||97
2591205|NCT00305565|6359914|P3|STARTED|Overall Study (Safety Population)||113
2591206|NCT00305565|6359915|P2|STARTED|Overall Study (Safety Population)||107
2591207|NCT00305565|6359916|P1|STARTED|Overall Study (Safety Population)||111
2591208|NCT00305448|6360034|P3|NOT COMPLETED|Overall Study||33
2591209|NCT00305448|6360035|P2|NOT COMPLETED|Overall Study||34
2591210|NCT00305448|6360036|P1|NOT COMPLETED|Overall Study||31
2591211|NCT00305448|6360034|P3|COMPLETED|Overall Study||14
2591212|NCT00305448|6360035|P2|COMPLETED|Overall Study||17
2591213|NCT00305448|6360036|P1|COMPLETED|Overall Study||14
2591214|NCT00305448|6360034|P3|STARTED|Overall Study||47
2591215|NCT00305448|6360035|P2|STARTED|Overall Study||51
2591216|NCT00305448|6360036|P1|STARTED|Overall Study||45
2591217|NCT00305344|6360052|P1|NOT COMPLETED|Overall Study||0
2591218|NCT00305344|6360052|P1|COMPLETED|Overall Study||23
2591219|NCT00305344|6360052|P1|STARTED|Overall Study||23
2591220|NCT00305253|6360058|P2|NOT COMPLETED|Overall Study||1
2591221|NCT00305253|6360059|P1|NOT COMPLETED|Overall Study||0
2591222|NCT00305253|6360058|P2|COMPLETED|Overall Study||558
2591223|NCT00305253|6360059|P1|COMPLETED|Overall Study||432
2591224|NCT00305253|6360058|P2|STARTED|Overall Study||559
2591225|NCT00305253|6360059|P1|STARTED|Overall Study||432
2591226|NCT00305227|6360071|P2|NOT COMPLETED|Overall Study||6
2591227|NCT00305227|6360072|P1|NOT COMPLETED|Overall Study||7
2591228|NCT00305227|6360071|P2|COMPLETED|Overall Study|with at least 8 weeks of observation|44
2591229|NCT00305227|6360072|P1|COMPLETED|Overall Study|with at least 8 weeks of observation|43
2591230|NCT00305227|6360071|P2|STARTED|Overall Study||50
2591231|NCT00305227|6360072|P1|STARTED|Overall Study||50
2591232|NCT00305162|6360080|P2|NOT COMPLETED|1 Year Follow-up Period||65
2591233|NCT00305162|6360081|P1|NOT COMPLETED|1 Year Follow-up Period||55
2591234|NCT00305162|6360080|P2|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4382
2591235|NCT00305162|6360081|P1|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4380
2591236|NCT00305162|6360080|P2|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|444
2591237|NCT00305162|6360081|P1|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|446
2591238|NCT00305162|6360080|P2|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3818
2591239|NCT00305162|6360081|P1|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3851
2591240|NCT00305162|6360080|P2|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|504
2591241|NCT00305162|6360081|P1|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|480
2591242|NCT00305162|6360080|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3878
2591243|NCT00305162|6360081|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3900
2591244|NCT00305162|6360080|P2|STARTED|1 Year Follow-up Period||4447
2591245|NCT00305162|6360081|P1|STARTED|1 Year Follow-up Period||4435
2591246|NCT00305162|6360080|P2|NOT COMPLETED|30-day Follow-up Period||63
2591247|NCT00305162|6360081|P1|NOT COMPLETED|30-day Follow-up Period||62
2591248|NCT00305162|6360080|P2|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4384
2591249|NCT00305162|6360081|P1|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4373
2591250|NCT00305162|6360080|P2|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|444
2591251|NCT00305162|6360081|P1|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|438
2591252|NCT00305162|6360080|P2|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3827
2591253|NCT00305162|6360081|P1|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3860
2591254|NCT00305162|6360080|P2|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|501
2591255|NCT00305162|6360081|P1|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|471
2591256|NCT00305162|6360080|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3883
2591257|NCT00305162|6360081|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3902
2591258|NCT00305162|6360080|P2|STARTED|30-day Follow-up Period||4447
2591259|NCT00305162|6360081|P1|STARTED|30-day Follow-up Period||4435
2591260|NCT00305162|6360080|P2|NOT COMPLETED|48 Hour Follow-up Period||16
2591261|NCT00305162|6360081|P1|NOT COMPLETED|48 Hour Follow-up Period||20
2591262|NCT00305162|6360080|P2|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4431
2591263|NCT00305162|6360081|P1|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4415
2591264|NCT00305162|6360080|P2|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4365
2591265|NCT00305162|6360081|P1|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4374
2591266|NCT00305162|6360080|P2|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|447
2591267|NCT00305162|6360081|P1|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|446
2591268|NCT00305162|6360080|P2|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3865
2591269|NCT00305162|6360081|P1|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3889
2591270|NCT00305162|6360080|P2|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|507
2591271|NCT00305162|6360081|P1|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|482
2591272|NCT00305162|6360080|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3924
2591273|NCT00305162|6360081|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3933
2591274|NCT00305162|6360080|P2|STARTED|48 Hour Follow-up Period||4447
2591275|NCT00305162|6360081|P1|STARTED|48 Hour Follow-up Period||4435
2591276|NCT00305110|6360119|P1|NOT COMPLETED|Overall Study||29
2591277|NCT00305110|6360119|P1|COMPLETED|Overall Study||269
2591278|NCT00305110|6360119|P1|All Necessary Data Collected|Overall Study||269
2591279|NCT00305110|6360119|P1|STARTED|Overall Study||298
2591280|NCT00305084|6360133|P5|NOT COMPLETED|Overall Study||0
2591281|NCT00305084|6360134|P4|NOT COMPLETED|Overall Study||0
2591282|NCT00305084|6360135|P3|NOT COMPLETED|Overall Study||0
2591283|NCT00305084|6360136|P2|NOT COMPLETED|Overall Study||0
2591284|NCT00305084|6360137|P1|NOT COMPLETED|Overall Study||0
2591285|NCT00305084|6360133|P5|COMPLETED|Overall Study||3
2591286|NCT00305084|6360134|P4|COMPLETED|Overall Study||3
2591287|NCT00305084|6360135|P3|COMPLETED|Overall Study||3
2591288|NCT00305084|6360136|P2|COMPLETED|Overall Study||3
2591289|NCT00305084|6360137|P1|COMPLETED|Overall Study||3
2591290|NCT00305084|6360133|P5|STARTED|Overall Study||3
2591291|NCT00305084|6360134|P4|STARTED|Overall Study||3
2591292|NCT00305084|6360135|P3|STARTED|Overall Study||3
2591293|NCT00305084|6360136|P2|STARTED|Overall Study||3
2591294|NCT00305084|6360137|P1|STARTED|Overall Study||3
2591295|NCT00305058|6360192|P2|NOT COMPLETED|Overall Study||4
2591296|NCT00305058|6360193|P1|NOT COMPLETED|Overall Study||7
2591297|NCT00305058|6360192|P2|COMPLETED|Overall Study||93
2591298|NCT00305058|6360193|P1|COMPLETED|Overall Study||90
2591299|NCT00305058|6360192|P2|Data Collection Forms Filed for Analysis|Overall Study||93
2591300|NCT00305058|6360193|P1|Data Collection Forms Filed for Analysis|Overall Study||90
2591301|NCT00305058|6360192|P2|All Outcome Data Collected|Overall Study||95
2591302|NCT00305058|6360193|P1|All Outcome Data Collected|Overall Study||93
2591303|NCT00305058|6360192|P2|Inclusion/Exclusion Verification|Overall Study||97
2591304|NCT00305058|6360193|P1|Inclusion/Exclusion Verification|Overall Study||96
2591305|NCT00305058|6360192|P2|STARTED|Overall Study||97
2591306|NCT00305058|6360193|P1|STARTED|Overall Study||97
2591307|NCT00304954|6360209|P4|NOT COMPLETED|Overall Study||0
2591308|NCT00304954|6360210|P3|NOT COMPLETED|Overall Study||1
2591309|NCT00304954|6360211|P2|NOT COMPLETED|Overall Study||0
2591310|NCT00304954|6360212|P1|NOT COMPLETED|Overall Study||1
2591311|NCT00304954|6360209|P4|COMPLETED|Overall Study||3
2591312|NCT00304954|6360210|P3|COMPLETED|Overall Study||2
2591313|NCT00304954|6360211|P2|COMPLETED|Overall Study||3
2591314|NCT00304954|6360212|P1|COMPLETED|Overall Study||3
2591315|NCT00304954|6360209|P4|STARTED|Overall Study||3
2591316|NCT00304954|6360210|P3|STARTED|Overall Study||3
2591317|NCT00304954|6360211|P2|STARTED|Overall Study||3
2591318|NCT00304954|6360212|P1|STARTED|Overall Study||4
2591319|NCT00304915|6360232|P2|NOT COMPLETED|Overall Study||16
2591320|NCT00304915|6360233|P1|NOT COMPLETED|Overall Study||18
2591321|NCT00304915|6360232|P2|COMPLETED|Overall Study||110
2591322|NCT00304915|6360233|P1|COMPLETED|Overall Study||105
2591323|NCT00304915|6360232|P2|STARTED|Overall Study||126
2591324|NCT00304915|6360233|P1|STARTED|Overall Study||123
2591325|NCT00304746|6360241|P2|NOT COMPLETED|Overall Study||0
2591326|NCT00304746|6360242|P1|NOT COMPLETED|Overall Study||0
2591327|NCT00304746|6360241|P2|COMPLETED|Overall Study||50
2591328|NCT00304746|6360242|P1|COMPLETED|Overall Study||50
2591329|NCT00304746|6360241|P2|STARTED|Overall Study||50
2591330|NCT00304746|6360242|P1|STARTED|Overall Study||50
2591331|NCT00304707|6360252|P2|NOT COMPLETED|Overall Study||6
2591332|NCT00304707|6360253|P1|NOT COMPLETED|Overall Study||7
2591333|NCT00304707|6360252|P2|COMPLETED|Overall Study||64
2591334|NCT00304707|6360253|P1|COMPLETED|Overall Study||66
2591335|NCT00304707|6360252|P2|STARTED|Overall Study||70
2591336|NCT00304707|6360253|P1|STARTED|Overall Study||73
2591337|NCT00304512|6360262|P3|NOT COMPLETED|Extension Period||0
2591338|NCT00304512|6360263|P2|NOT COMPLETED|Extension Period||0
2591339|NCT00304512|6360264|P1|NOT COMPLETED|Extension Period||0
2591340|NCT00304512|6360262|P3|COMPLETED|Extension Period||3
2591341|NCT00304512|6360263|P2|COMPLETED|Extension Period||4
2591342|NCT00304512|6360264|P1|COMPLETED|Extension Period||2
2591343|NCT00304512|6360262|P3|STARTED|Extension Period||3
2591344|NCT00304512|6360263|P2|STARTED|Extension Period||4
2591345|NCT00304512|6360264|P1|STARTED|Extension Period||2
2591346|NCT00304512|6360262|P3|NOT COMPLETED|Treatment Period||0
2591347|NCT00304512|6360263|P2|NOT COMPLETED|Treatment Period||0
2591348|NCT00304512|6360264|P1|NOT COMPLETED|Treatment Period||0
2591349|NCT00304512|6360262|P3|COMPLETED|Treatment Period||3
2591350|NCT00304512|6360263|P2|COMPLETED|Treatment Period||4
2591351|NCT00304512|6360264|P1|COMPLETED|Treatment Period||2
2591352|NCT00304512|6360262|P3|Pharmacodynamic (PD) Population|Treatment Period||3
2591353|NCT00304512|6360263|P2|Pharmacodynamic (PD) Population|Treatment Period||4
2591354|NCT00304512|6360264|P1|Pharmacodynamic (PD) Population|Treatment Period||2
2591355|NCT00304512|6360262|P3|Pharmacokinetic (PK) Population|Treatment Period||3
2591356|NCT00304512|6360263|P2|Pharmacokinetic (PK) Population|Treatment Period||4
2591357|NCT00304512|6360264|P1|Pharmacokinetic (PK) Population|Treatment Period||2
2591358|NCT00304512|6360262|P3|Safety Population|Treatment Period||3
2591359|NCT00304512|6360263|P2|Safety Population|Treatment Period||4
2591360|NCT00304512|6360264|P1|Safety Population|Treatment Period||2
2591361|NCT00304512|6360262|P3|STARTED|Treatment Period||3
2591362|NCT00304512|6360263|P2|STARTED|Treatment Period||4
2591363|NCT00304512|6360264|P1|STARTED|Treatment Period||2
2591364|NCT00304356|6360278|P1|NOT COMPLETED|Nitazoxanide||5
2591365|NCT00304356|6360278|P1|COMPLETED|Nitazoxanide||22
2591366|NCT00304356|6360278|P1|STARTED|Nitazoxanide||27
2591367|NCT00304356|6360278|P1|NOT COMPLETED|Nitazoxanide||5
2591368|NCT00304356|6360278|P1|COMPLETED|Nitazoxanide||22
2591369|NCT00304356|6360278|P1|STARTED|Nitazoxanide||27
2591370|NCT00304278|6360282|P1|NOT COMPLETED|Overall Study||2
2591371|NCT00304278|6360282|P1|COMPLETED|Overall Study||19
2591372|NCT00304278|6360282|P1|STARTED|Overall Study||21
2591373|NCT00304265|6360289|P2|NOT COMPLETED|Overall Study||0
2591374|NCT00304265|6360290|P1|NOT COMPLETED|Overall Study||0
2591375|NCT00304265|6360289|P2|COMPLETED|Overall Study||98
2591376|NCT00304265|6360290|P1|COMPLETED|Overall Study||117
2591377|NCT00304265|6360289|P2|STARTED|Overall Study||98
2591378|NCT00304265|6360290|P1|STARTED|Overall Study||117
2591379|NCT00304187|6360298|P2|NOT COMPLETED|Overall Study||1
2591380|NCT00304187|6360299|P1|NOT COMPLETED|Overall Study||2
2591381|NCT00304187|6360298|P2|COMPLETED|Overall Study||13
2591382|NCT00304187|6360299|P1|COMPLETED|Overall Study||13
2591383|NCT00304187|6360298|P2|STARTED|Overall Study||14
2591384|NCT00304187|6360299|P1|STARTED|Overall Study||15
2591385|NCT00304161|6360309|P2|NOT COMPLETED|Overall Study||6
2591386|NCT00304161|6360310|P1|NOT COMPLETED|Overall Study||6
2591387|NCT00304161|6360309|P2|COMPLETED|Overall Study||21
2591388|NCT00304161|6360310|P1|COMPLETED|Overall Study||22
2591389|NCT00304161|6360309|P2|STARTED|Overall Study||27
2591390|NCT00304161|6360310|P1|STARTED|Overall Study||28
2591391|NCT00304096|6360320|P2|NOT COMPLETED|Overall Study||0
2591392|NCT00304096|6360321|P1|NOT COMPLETED|Overall Study||0
2591393|NCT00304096|6360320|P2|COMPLETED|Overall Study|6 patients enrolled, 1 not treated|5
2591394|NCT00304096|6360321|P1|COMPLETED|Overall Study||6
2591395|NCT00304096|6360320|P2|STARTED|Overall Study||5
2591396|NCT00304096|6360321|P1|STARTED|Overall Study||6
2591397|NCT00304083|6360331|P2|NOT COMPLETED|Overall Study||8
2591398|NCT00304083|6360332|P1|NOT COMPLETED|Overall Study||22
2591399|NCT00304083|6360331|P2|COMPLETED|Overall Study||6
2591400|NCT00304083|6360332|P1|COMPLETED|Overall Study||12
2591401|NCT00304083|6360331|P2|Patients Had Neither RT or Surgery|Overall Study||1
2591402|NCT00304083|6360332|P1|Patients Had Neither RT or Surgery|Overall Study||6
2591403|NCT00304083|6360331|P2|Patients Treated With RT Only|Overall Study||2
2591404|NCT00304083|6360332|P1|Patients Treated With RT Only|Overall Study||4
2591405|NCT00304083|6360331|P2|Patients Treated With Surgery and RT|Overall Study||1
2591406|NCT00304083|6360332|P1|Patients Treated With Surgery and RT|Overall Study||5
2591407|NCT00304083|6360331|P2|Patients Treated With Surgery|Overall Study||3
2591408|NCT00304083|6360332|P1|Patients Treated With Surgery|Overall Study||7
2591409|NCT00304083|6360331|P2|Completed 4 Cycles|Overall Study||7
2591410|NCT00304083|6360332|P1|Completed 4 Cycles|Overall Study||22
2591411|NCT00304083|6360331|P2|STARTED|Overall Study||14
2591412|NCT00304083|6360332|P1|STARTED|Overall Study||34
2591413|NCT00304070|6360351|P3|NOT COMPLETED|Overall Study||12
2591414|NCT00304070|6360352|P2|NOT COMPLETED|Overall Study||7
2591415|NCT00304070|6360353|P1|NOT COMPLETED|Overall Study||3
2591416|NCT00304070|6360351|P3|COMPLETED|Overall Study||27
2591417|NCT00304070|6360352|P2|COMPLETED|Overall Study||8
2591418|NCT00304070|6360353|P1|COMPLETED|Overall Study||21
2591419|NCT00304070|6360351|P3|STARTED|Overall Study||39
2591420|NCT00304070|6360352|P2|STARTED|Overall Study||15
2591421|NCT00304070|6360353|P1|STARTED|Overall Study||24
2591422|NCT00304031|6360368|P3|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||2
2591423|NCT00304031|6360369|P2|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
2591424|NCT00304031|6360370|P1|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
2591425|NCT00304031|6360368|P3|COMPLETED|Randomization to Adjuvant TMZ Arm|Subjects contributing data to the primary analysis are considered to have completed the study|420
2591426|NCT00304031|6360369|P2|COMPLETED|Randomization to Adjuvant TMZ Arm|Subjects contributing data to the primary analysis are considered to have completed the study.|411
2591427|NCT00304031|6360370|P1|COMPLETED|Randomization to Adjuvant TMZ Arm||0
2591428|NCT00304031|6360368|P3|STARTED|Randomization to Adjuvant TMZ Arm|Patients who met requirements were randomized to an adjuvant TMZ arm after concomitant treatment.|422
2591429|NCT00304031|6360369|P2|STARTED|Randomization to Adjuvant TMZ Arm|Patients who met requirements were randomized to an adjuvant TMZ arm after concomitant treatment.|411
2591430|NCT00304031|6360370|P1|STARTED|Randomization to Adjuvant TMZ Arm|Patients who met requirements were randomized to an adjuvant TMZ arm after concomitant treatment.|0
2591431|NCT00304031|6360368|P3|NOT COMPLETED|Concomitant Radiation Therapy and TMZ||0
2591432|NCT00304031|6360369|P2|NOT COMPLETED|Concomitant Radiation Therapy and TMZ||0
2591433|NCT00304031|6360370|P1|NOT COMPLETED|Concomitant Radiation Therapy and TMZ||292
2591434|NCT00304031|6360368|P3|COMPLETED|Concomitant Radiation Therapy and TMZ||0
2591435|NCT00304031|6360369|P2|COMPLETED|Concomitant Radiation Therapy and TMZ||0
2591436|NCT00304031|6360370|P1|COMPLETED|Concomitant Radiation Therapy and TMZ|These patients successfully completed concomitant treatment and met requirements for randomization.|833
2591437|NCT00304031|6360368|P3|STARTED|Concomitant Radiation Therapy and TMZ|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
2591438|NCT00304031|6360369|P2|STARTED|Concomitant Radiation Therapy and TMZ|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
2591439|NCT00304031|6360370|P1|STARTED|Concomitant Radiation Therapy and TMZ|All patients were registered to concomitant treatment; randomized after completing this treatment.|1125
2591440|NCT00304031|6360368|P3|NOT COMPLETED|Registration||0
2591441|NCT00304031|6360369|P2|NOT COMPLETED|Registration||0
2591442|NCT00304031|6360370|P1|NOT COMPLETED|Registration||48
2591443|NCT00304031|6360368|P3|COMPLETED|Registration||0
2591444|NCT00304031|6360369|P2|COMPLETED|Registration||0
2591445|NCT00304031|6360370|P1|COMPLETED|Registration|Patients determined to be ineligible after registration were excluded.|1125
2591446|NCT00304031|6360368|P3|STARTED|Registration|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
2591447|NCT00304031|6360369|P2|STARTED|Registration|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
2591448|NCT00304031|6360370|P1|STARTED|Registration|All patients were registered to concomitant treatment; randomized after completing this treatment.|1173
2591449|NCT00303979|6360380|P3|NOT COMPLETED|Overall Study||0
2591450|NCT00303979|6360381|P2|NOT COMPLETED|Overall Study||0
2591451|NCT00303979|6360382|P1|NOT COMPLETED|Overall Study||7572
2591452|NCT00303979|6360380|P3|COMPLETED|Overall Study|at 18 months|9641
2591453|NCT00303979|6360381|P2|COMPLETED|Overall Study|at 6 months|9992
2591454|NCT00303979|6360382|P1|COMPLETED|Overall Study|at 24 Months|7605
2591455|NCT00303979|6360380|P3|STARTED|Overall Study|at 18 months|9641
2591456|NCT00303979|6360381|P2|STARTED|Overall Study|at 6 months|9992
2591457|NCT00303979|6360382|P1|STARTED|Overall Study|at baseline|15177
2591458|NCT00303966|6360400|P1|NOT COMPLETED|Overall Study||0
2591459|NCT00303966|6360400|P1|COMPLETED|Overall Study||5
2591460|NCT00303966|6360400|P1|STARTED|Overall Study||5
2591461|NCT00303953|6360409|P1|NOT COMPLETED|Overall Study||19
2591462|NCT00303953|6360409|P1|COMPLETED|Overall Study||3
2591463|NCT00303953|6360409|P1|Eligible and Treated|Overall Study||20
2591464|NCT00303953|6360409|P1|Eligible|Overall Study||21
2591465|NCT00303953|6360409|P1|STARTED|Overall Study||22
2591466|NCT00303901|6360415|P1|NOT COMPLETED|Overall Study||0
2591467|NCT00303901|6360415|P1|COMPLETED|Overall Study||40
2591468|NCT00303901|6360415|P1|STARTED|Overall Study||40
2591469|NCT00303862|6360420|P1|NOT COMPLETED|Overall Study||0
2591470|NCT00303862|6360420|P1|COMPLETED|Overall Study||10
2591471|NCT00303862|6360420|P1|STARTED|Overall Study||10
2591472|NCT00303823|6360429|P2|NOT COMPLETED|Overall Study||10
2591473|NCT00303823|6360430|P1|NOT COMPLETED|Overall Study||15
2591474|NCT00303823|6360429|P2|COMPLETED|Overall Study||38
2591475|NCT00303823|6360430|P1|COMPLETED|Overall Study||35
2591476|NCT00303823|6360429|P2|STARTED|Overall Study||48
2591477|NCT00303823|6360430|P1|STARTED|Overall Study||50
2591478|NCT00303667|6360444|P2|NOT COMPLETED|Overall Study||4
2591479|NCT00303667|6360445|P1|NOT COMPLETED|Overall Study||0
2591480|NCT00303667|6360444|P2|COMPLETED|Overall Study|Completed = remained alive and on study through Day 0 (day of transplant)|35
2591481|NCT00303667|6360445|P1|COMPLETED|Overall Study||8
2591482|NCT00303667|6360444|P2|STARTED|Overall Study||39
2591483|NCT00303667|6360445|P1|STARTED|Overall Study||8
2591484|NCT00303628|6360469|P2|NOT COMPLETED|Overall Study||73
2591485|NCT00303628|6360470|P1|NOT COMPLETED|Overall Study||50
2591486|NCT00303628|6360469|P2|COMPLETED|Overall Study||106
2591487|NCT00303628|6360470|P1|COMPLETED|Overall Study||126
2591488|NCT00303628|6360469|P2|Treated|Overall Study||174
2591489|NCT00303628|6360470|P1|Treated|Overall Study||173
2591490|NCT00303628|6360469|P2|Eligible|Overall Study||177
2591491|NCT00303628|6360470|P1|Eligible|Overall Study||171
2591492|NCT00303628|6360469|P2|STARTED|Overall Study||179
2591493|NCT00303628|6360470|P1|STARTED|Overall Study||176
2591494|NCT00303602|6360488|P2|NOT COMPLETED|Overall Study||15
2591495|NCT00303602|6360489|P1|NOT COMPLETED|Overall Study||19
2591496|NCT00303602|6360488|P2|COMPLETED|Overall Study||50
2591497|NCT00303602|6360489|P1|COMPLETED|Overall Study||65
2591498|NCT00303602|6360488|P2|STARTED|Overall Study||65
2591499|NCT00303602|6360489|P1|STARTED|Overall Study||84
2591500|NCT00303511|6360529|P1|NOT COMPLETED|Overall Study||0
2591501|NCT00303511|6360529|P1|COMPLETED|Overall Study||10
2591502|NCT00303511|6360529|P1|STARTED|Overall Study||10
2591503|NCT00303485|6360535|P2|NOT COMPLETED|Overall Study||2
2591504|NCT00303485|6360536|P1|NOT COMPLETED|Overall Study||1
2591505|NCT00303485|6360535|P2|COMPLETED|Overall Study||15
2591506|NCT00303485|6360536|P1|COMPLETED|Overall Study||48
2591507|NCT00303485|6360535|P2|STARTED|Overall Study||17
2591508|NCT00303485|6360536|P1|STARTED|Overall Study||49
2591509|NCT00303472|6360567|P7|NOT COMPLETED|Treatment Extension (Optional)||0
2591510|NCT00303472|6360568|P6|NOT COMPLETED|Treatment Extension (Optional)||1
2591511|NCT00303472|6360569|P5|NOT COMPLETED|Treatment Extension (Optional)||4
2591512|NCT00303472|6360570|P4|NOT COMPLETED|Treatment Extension (Optional)||8
2591513|NCT00303472|6360571|P3|NOT COMPLETED|Treatment Extension (Optional)||9
2591514|NCT00303472|6360572|P2|NOT COMPLETED|Treatment Extension (Optional)||6
2591515|NCT00303472|6360573|P1|NOT COMPLETED|Treatment Extension (Optional)||5
2591516|NCT00303472|6360567|P7|COMPLETED|Treatment Extension (Optional)||1
2591517|NCT00303472|6360568|P6|COMPLETED|Treatment Extension (Optional)||4
2591518|NCT00303472|6360569|P5|COMPLETED|Treatment Extension (Optional)||1
2591519|NCT00303472|6360570|P4|COMPLETED|Treatment Extension (Optional)||5
2591520|NCT00303472|6360571|P3|COMPLETED|Treatment Extension (Optional)||2
2591521|NCT00303472|6360572|P2|COMPLETED|Treatment Extension (Optional)||5
2591522|NCT00303472|6360573|P1|COMPLETED|Treatment Extension (Optional)||1
2591523|NCT00303472|6360567|P7|STARTED|Treatment Extension (Optional)||1
2591524|NCT00303472|6360568|P6|STARTED|Treatment Extension (Optional)||5
2591525|NCT00303472|6360569|P5|STARTED|Treatment Extension (Optional)||5
2591526|NCT00303472|6360570|P4|STARTED|Treatment Extension (Optional)||13
2591527|NCT00303472|6360571|P3|STARTED|Treatment Extension (Optional)||11
2591528|NCT00303472|6360572|P2|STARTED|Treatment Extension (Optional)||11
2591529|NCT00303472|6360573|P1|STARTED|Treatment Extension (Optional)||6
2591530|NCT00303472|6360567|P7|NOT COMPLETED|Treatment Period||2
2591531|NCT00303472|6360568|P6|NOT COMPLETED|Treatment Period||1
2591532|NCT00303472|6360569|P5|NOT COMPLETED|Treatment Period||3
2591533|NCT00303472|6360570|P4|NOT COMPLETED|Treatment Period||2
2591534|NCT00303472|6360571|P3|NOT COMPLETED|Treatment Period||0
2591535|NCT00303472|6360572|P2|NOT COMPLETED|Treatment Period||0
2591536|NCT00303472|6360573|P1|NOT COMPLETED|Treatment Period||0
2591537|NCT00303472|6360567|P7|COMPLETED|Treatment Period||3
2591538|NCT00303472|6360568|P6|COMPLETED|Treatment Period||11
2591539|NCT00303472|6360569|P5|COMPLETED|Treatment Period||8
2591540|NCT00303472|6360570|P4|COMPLETED|Treatment Period||14
2591541|NCT00303472|6360571|P3|COMPLETED|Treatment Period||11
2591542|NCT00303472|6360572|P2|COMPLETED|Treatment Period||11
2591543|NCT00303472|6360573|P1|COMPLETED|Treatment Period||6
2591544|NCT00303472|6360567|P7|STARTED|Treatment Period||5
2591545|NCT00303472|6360568|P6|STARTED|Treatment Period||12
2591546|NCT00303472|6360569|P5|STARTED|Treatment Period||11
2591547|NCT00303472|6360570|P4|STARTED|Treatment Period||16
2591548|NCT00303472|6360571|P3|STARTED|Treatment Period||11
2591549|NCT00303472|6360572|P2|STARTED|Treatment Period||11
2591550|NCT00303472|6360573|P1|STARTED|Treatment Period||6
2591551|NCT00303459|6360633|P2|NOT COMPLETED|Overall Study||89
2591552|NCT00303459|6360634|P1|NOT COMPLETED|Overall Study||83
2591553|NCT00303459|6360633|P2|COMPLETED|Overall Study||86
2591554|NCT00303459|6360634|P1|COMPLETED|Overall Study||76
2591555|NCT00303459|6360633|P2|STARTED|Overall Study|One subject randomized to placebo did not receive study treatment|175
2591556|NCT00303459|6360634|P1|STARTED|Overall Study||159
2591557|NCT00303446|6360660|P2|NOT COMPLETED|Overall Study||4
2591558|NCT00303446|6360661|P1|NOT COMPLETED|Overall Study||2
2591559|NCT00303446|6360660|P2|COMPLETED|Overall Study||21
2591560|NCT00303446|6360661|P1|COMPLETED|Overall Study||23
2591561|NCT00303446|6360660|P2|STARTED|Overall Study||25
2591562|NCT00303446|6360661|P1|STARTED|Overall Study||25
2591563|NCT00303329|6360697|P2|NOT COMPLETED|Overall Study||62
2591564|NCT00303329|6360698|P1|NOT COMPLETED|Overall Study||35
2591565|NCT00303329|6360697|P2|COMPLETED|Overall Study||37
2591566|NCT00303329|6360698|P1|COMPLETED|Overall Study||50
2591567|NCT00303329|6360697|P2|STARTED|Overall Study||99
2591568|NCT00303329|6360698|P1|STARTED|Overall Study||85
2591569|NCT00303316|6360712|P2|NOT COMPLETED|Overall Study||3
2591570|NCT00303316|6360713|P1|NOT COMPLETED|Overall Study||2
2591571|NCT00303316|6360712|P2|COMPLETED|Overall Study||223
2591572|NCT00303316|6360713|P1|COMPLETED|Overall Study||230
2591573|NCT00303316|6360712|P2|STARTED|Overall Study||226
2591574|NCT00303316|6360713|P1|STARTED|Overall Study||232
2591575|NCT00303186|6360725|P1|NOT COMPLETED|Overall Study||52
2591576|NCT00303186|6360725|P1|COMPLETED|Overall Study||55
2591577|NCT00303186|6360725|P1|STARTED|Overall Study||107
2591578|NCT00303108|6360759|P3|NOT COMPLETED|Overall Study||16
2591579|NCT00303108|6360760|P2|NOT COMPLETED|Overall Study||9
2591580|NCT00303108|6360761|P1|NOT COMPLETED|Overall Study||12
2591581|NCT00303108|6360759|P3|COMPLETED|Overall Study||31
2591582|NCT00303108|6360760|P2|COMPLETED|Overall Study||37
2591583|NCT00303108|6360761|P1|COMPLETED|Overall Study||31
2591584|NCT00303108|6360759|P3|STARTED|Overall Study||47
2591585|NCT00303108|6360760|P2|STARTED|Overall Study||46
2591586|NCT00303108|6360761|P1|STARTED|Overall Study||43
2591587|NCT00303069|6360781|P4|NOT COMPLETED|Overall Study||2
2591588|NCT00303069|6360782|P3|NOT COMPLETED|Overall Study||1
2591589|NCT00303069|6360783|P2|NOT COMPLETED|Overall Study||0
2591590|NCT00303069|6360784|P1|NOT COMPLETED|Overall Study||2
2591591|NCT00303069|6360781|P4|COMPLETED|Overall Study||29
2591592|NCT00303069|6360782|P3|COMPLETED|Overall Study||33
2591593|NCT00303069|6360783|P2|COMPLETED|Overall Study||28
2591594|NCT00303069|6360784|P1|COMPLETED|Overall Study||29
2591595|NCT00303069|6360781|P4|STARTED|Overall Study||31
2591596|NCT00303069|6360782|P3|STARTED|Overall Study||34
2591597|NCT00303069|6360783|P2|STARTED|Overall Study||28
2591598|NCT00303069|6360784|P1|STARTED|Overall Study||31
2591599|NCT00302952|6360804|P2|NOT COMPLETED|Overall Study||5
2591600|NCT00302952|6360805|P1|NOT COMPLETED|Overall Study||3
2591601|NCT00302952|6360804|P2|COMPLETED|Overall Study||25
2591602|NCT00302952|6360805|P1|COMPLETED|Overall Study||31
2591603|NCT00302952|6360804|P2|Completed Intent-to-Treat (ITT)|Overall Study|One participant did not have a baseline C-reactive Protein and was excluded from the ITT population.|29
2591604|NCT00302952|6360805|P1|Completed Intent-to-Treat (ITT)|Overall Study||34
2591605|NCT00302952|6360804|P2|Started Intent-to-Treat (ITT)|Overall Study||30
2591606|NCT00302952|6360805|P1|Started Intent-to-Treat (ITT)|Overall Study||34
2591607|NCT00302952|6360804|P2|STARTED|Overall Study||30
2591608|NCT00302952|6360805|P1|STARTED|Overall Study||34
2591609|NCT00302848|6360842|P3|NOT COMPLETED|Overall Study||579
2591610|NCT00302848|6360843|P2|NOT COMPLETED|Overall Study||419
2591611|NCT00302848|6360844|P1|NOT COMPLETED|Overall Study||401
2591612|NCT00302848|6360842|P3|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|25762
2591613|NCT00302848|6360843|P2|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|15009
2591614|NCT00302848|6360844|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|16133
2591615|NCT00302848|6360842|P3|STARTED|Overall Study||26341
2591616|NCT00302848|6360843|P2|STARTED|Overall Study||15428
2591617|NCT00302848|6360844|P1|STARTED|Overall Study||16534
2591618|NCT00302731|6360855|P4|NOT COMPLETED|Overall Study||0
2591619|NCT00302731|6360856|P3|NOT COMPLETED|Overall Study||3
2591620|NCT00302731|6360857|P2|NOT COMPLETED|Overall Study||5
2591621|NCT00302731|6360858|P1|NOT COMPLETED|Overall Study||4
2591622|NCT00302731|6360855|P4|COMPLETED|Overall Study||4
2591623|NCT00302731|6360856|P3|COMPLETED|Overall Study||2
2591624|NCT00302731|6360857|P2|COMPLETED|Overall Study||1
2591625|NCT00302731|6360858|P1|COMPLETED|Overall Study||2
2591626|NCT00302731|6360855|P4|STARTED|Overall Study||4
2591627|NCT00302731|6360856|P3|STARTED|Overall Study||5
2591628|NCT00302731|6360857|P2|STARTED|Overall Study||6
2591629|NCT00302731|6360858|P1|STARTED|Overall Study||6
2591630|NCT00302718|6360884|P4|NOT COMPLETED|Overall Study||2
2591631|NCT00302718|6360885|P3|NOT COMPLETED|Overall Study||2
2591632|NCT00302718|6360886|P2|NOT COMPLETED|Overall Study||1
2591633|NCT00302718|6360887|P1|NOT COMPLETED|Overall Study||1
2591634|NCT00302718|6360884|P4|COMPLETED|Overall Study||19
2591635|NCT00302718|6360885|P3|COMPLETED|Overall Study||19
2591636|NCT00302718|6360886|P2|COMPLETED|Overall Study||20
2591637|NCT00302718|6360887|P1|COMPLETED|Overall Study||19
2591638|NCT00302718|6360884|P4|STARTED|Overall Study||21
2591639|NCT00302718|6360885|P3|STARTED|Overall Study||21
2591640|NCT00302718|6360886|P2|STARTED|Overall Study||21
2591641|NCT00302718|6360887|P1|STARTED|Overall Study||20
2591642|NCT00302458|6360953|P1|NOT COMPLETED|Overall Study||3
2591643|NCT00302458|6360953|P1|COMPLETED|Overall Study||26
2591644|NCT00302458|6360953|P1|STARTED|Overall Study||29
2591645|NCT00302328|6360964|P3|NOT COMPLETED|Overall Study||0
2591646|NCT00302328|6360965|P2|NOT COMPLETED|Overall Study||1
2591647|NCT00302328|6360966|P1|NOT COMPLETED|Overall Study||0
2591648|NCT00302328|6360964|P3|COMPLETED|Overall Study||18
2591649|NCT00302328|6360965|P2|COMPLETED|Overall Study|developed cancer during the study|34
2591650|NCT00302328|6360966|P1|COMPLETED|Overall Study||25
2591651|NCT00302328|6360964|P3|STARTED|Overall Study||18
2591652|NCT00302328|6360965|P2|STARTED|Overall Study||35
2591653|NCT00302328|6360966|P1|STARTED|Overall Study||25
2591654|NCT00302211|6360983|P5|NOT COMPLETED|Open Label-Patients From Double-Blind||8
2591655|NCT00302211|6360984|P4|NOT COMPLETED|Open Label-Patients From Double-Blind||8
2591656|NCT00302211|6360985|P3|NOT COMPLETED|Open Label-Patients From Double-Blind||0
2591657|NCT00302211|6360986|P2|NOT COMPLETED|Open Label-Patients From Double-Blind||0
2591658|NCT00302211|6360987|P1|NOT COMPLETED|Open Label-Patients From Double-Blind||0
2591659|NCT00302211|6360983|P5|COMPLETED|Open Label-Patients From Double-Blind||24
2591660|NCT00302211|6360984|P4|COMPLETED|Open Label-Patients From Double-Blind||18
2591661|NCT00302211|6360985|P3|COMPLETED|Open Label-Patients From Double-Blind||0
2591662|NCT00302211|6360986|P2|COMPLETED|Open Label-Patients From Double-Blind||0
2591663|NCT00302211|6360987|P1|COMPLETED|Open Label-Patients From Double-Blind||0
2591664|NCT00302211|6360983|P5|STARTED|Open Label-Patients From Double-Blind|26 pts in 4x/day + placebo 2x/day DB phase & 6 pts in placebo 6x/day DB phase enrolled in OL 4x/day|32
2591665|NCT00302211|6360984|P4|STARTED|Open Label-Patients From Double-Blind|21 patients (pts) in 6x/day DB phase & 5 patients in placebo 6x/day DB phase enrolled in OL 6x/day|26
2591666|NCT00302211|6360985|P3|STARTED|Open Label-Patients From Double-Blind||0
2591667|NCT00302211|6360986|P2|STARTED|Open Label-Patients From Double-Blind||0
2591668|NCT00302211|6360987|P1|STARTED|Open Label-Patients From Double-Blind||0
2591669|NCT00302211|6360983|P5|NOT COMPLETED|Double Blind Period (New Patients)||0
2591670|NCT00302211|6360984|P4|NOT COMPLETED|Double Blind Period (New Patients)||0
2591671|NCT00302211|6360985|P3|NOT COMPLETED|Double Blind Period (New Patients)||4
2591672|NCT00302211|6360986|P2|NOT COMPLETED|Double Blind Period (New Patients)||2
2591673|NCT00302211|6360987|P1|NOT COMPLETED|Double Blind Period (New Patients)||3
2591674|NCT00302211|6360983|P5|COMPLETED|Double Blind Period (New Patients)||0
2591675|NCT00302211|6360984|P4|COMPLETED|Double Blind Period (New Patients)||0
2591676|NCT00302211|6360985|P3|COMPLETED|Double Blind Period (New Patients)||10
2591677|NCT00302211|6360986|P2|COMPLETED|Double Blind Period (New Patients)||25
2591678|NCT00302211|6360987|P1|COMPLETED|Double Blind Period (New Patients)||23
2591679|NCT00302211|6360983|P5|STARTED|Double Blind Period (New Patients)||0
2591680|NCT00302211|6360984|P4|STARTED|Double Blind Period (New Patients)||0
2591681|NCT00302211|6360985|P3|STARTED|Double Blind Period (New Patients)|These subjects could receive either iloprost 4x/day or 6x/day in the OL period|14
2591682|NCT00302211|6360986|P2|STARTED|Double Blind Period (New Patients)|These subjects had the option to continue with the same dose of iloprost during the OL period|27
2591683|NCT00302211|6360987|P1|STARTED|Double Blind Period (New Patients)|These subjects had the option to continue with the same dose of iloprost during the OL period|26
2591684|NCT00302159|6361013|P1|NOT COMPLETED|Overall Study||2
2591685|NCT00302159|6361013|P1|COMPLETED|Overall Study||41
2591686|NCT00302159|6361013|P1|STARTED|Overall Study||43
2591687|NCT00302133|6361024|P2|NOT COMPLETED|Overall Study||4
2591688|NCT00302133|6361025|P1|NOT COMPLETED|Overall Study||4
2591689|NCT00302133|6361024|P2|COMPLETED|Overall Study||5
2591690|NCT00302133|6361025|P1|COMPLETED|Overall Study||5
2591691|NCT00302133|6361024|P2|STARTED|Overall Study||9
2591692|NCT00302133|6361025|P1|STARTED|Overall Study||9
2591693|NCT00302107|6361035|P2|NOT COMPLETED|Overall Study||9
2591694|NCT00302107|6361036|P1|NOT COMPLETED|Overall Study||8
2591695|NCT00302107|6361035|P2|COMPLETED|Overall Study||30
2591696|NCT00302107|6361036|P1|COMPLETED|Overall Study||31
2591697|NCT00302107|6361035|P2|STARTED|Overall Study||39
2591698|NCT00302107|6361036|P1|STARTED|Overall Study||39
2591699|NCT00302081|6361045|P3|NOT COMPLETED|Overall Study||52
2591700|NCT00302081|6361046|P2|NOT COMPLETED|Overall Study||43
2591701|NCT00302081|6361047|P1|NOT COMPLETED|Overall Study||56
2591702|NCT00302081|6361045|P3|COMPLETED|Overall Study||178
2591703|NCT00302081|6361046|P2|COMPLETED|Overall Study||186
2591704|NCT00302081|6361047|P1|COMPLETED|Overall Study||181
2591705|NCT00302081|6361045|P3|STARTED|Overall Study||230
2591706|NCT00302081|6361046|P2|STARTED|Overall Study||229
2591707|NCT00302081|6361047|P1|STARTED|Overall Study||237
2591708|NCT00302068|6361058|P3|NOT COMPLETED|Overall Study||1
2591709|NCT00302068|6361059|P2|NOT COMPLETED|Overall Study||4
2591710|NCT00302068|6361060|P1|NOT COMPLETED|Overall Study||1
2591711|NCT00302068|6361058|P3|COMPLETED|Overall Study||23
2591712|NCT00302068|6361059|P2|COMPLETED|Overall Study||36
2591713|NCT00302068|6361060|P1|COMPLETED|Overall Study||36
2591714|NCT00302068|6361058|P3|STARTED|Overall Study||24
2591715|NCT00302068|6361059|P2|STARTED|Overall Study||40
2591716|NCT00302068|6361060|P1|STARTED|Overall Study||37
2591717|NCT00302055|6361088|P2|NOT COMPLETED|Overall Study||13
2591718|NCT00302055|6361089|P1|NOT COMPLETED|Overall Study||9
2591719|NCT00302055|6361088|P2|COMPLETED|Overall Study||36
2591720|NCT00302055|6361089|P1|COMPLETED|Overall Study||14
2591721|NCT00302055|6361088|P2|STARTED|Overall Study||49
2591722|NCT00302055|6361089|P1|STARTED|Overall Study||23
2591723|NCT00302042|6361097|P2|NOT COMPLETED|Overall Study||8
2591724|NCT00302042|6361098|P1|NOT COMPLETED|Overall Study||7
2591725|NCT00302042|6361097|P2|COMPLETED|Overall Study||38
2591726|NCT00302042|6361098|P1|COMPLETED|Overall Study||39
2591727|NCT00302042|6361097|P2|STARTED|Overall Study||46
2591728|NCT00302042|6361098|P1|STARTED|Overall Study||46
2591729|NCT00302003|6361104|P1|NOT COMPLETED|Overall Study||80
2591730|NCT00302003|6361104|P1|COMPLETED|Overall Study||207
2591731|NCT00302003|6361104|P1|STARTED|Overall Study||287
2591732|NCT00301964|6361111|P1|NOT COMPLETED|Overall Study||4
2591733|NCT00301964|6361111|P1|COMPLETED|Overall Study|Total number of eligible and evaluable participants|52
2591734|NCT00301964|6361111|P1|STARTED|Overall Study||56
2591735|NCT00301873|6361126|P1|NOT COMPLETED|Overall Study||0
2591736|NCT00301873|6361126|P1|COMPLETED|Overall Study||59
2591737|NCT00301873|6361126|P1|STARTED|Overall Study||59
2591738|NCT00301834|6361132|P1|NOT COMPLETED|Overall Study||1
2591739|NCT00301834|6361132|P1|COMPLETED|Overall Study||34
2591740|NCT00301834|6361132|P1|STARTED|Overall Study||35
2591741|NCT00301821|6361141|P1|NOT COMPLETED|Overall Study||26
2591742|NCT00301821|6361141|P1|COMPLETED|Overall Study||81
2591743|NCT00301821|6361141|P1|STARTED|Overall Study||107
2591744|NCT00301808|6361148|P1|NOT COMPLETED|Overall Study||12
2591745|NCT00301808|6361148|P1|COMPLETED|Overall Study||17
2591746|NCT00301808|6361148|P1|STARTED|Overall Study||29
2591747|NCT00301756|6361155|P1|NOT COMPLETED|Overall Study||0
2591748|NCT00301756|6361155|P1|COMPLETED|Overall Study||32
2591749|NCT00301756|6361155|P1|STARTED|Overall Study||32
2591750|NCT00301418|6361167|P1|NOT COMPLETED|Overall Study||0
2591751|NCT00301418|6361167|P1|COMPLETED|Overall Study||11
2591752|NCT00301418|6361167|P1|STARTED|Overall Study||11
2591753|NCT00301366|6361173|P1|NOT COMPLETED|Overall Study||1
2591754|NCT00301366|6361173|P1|COMPLETED|Overall Study||37
2591755|NCT00301366|6361173|P1|STARTED|Overall Study||38
2591756|NCT00301262|6361179|P2|NOT COMPLETED|Open Label Phase (OL)||2
2591757|NCT00301262|6361180|P1|NOT COMPLETED|Open Label Phase (OL)||4
2591758|NCT00301262|6361179|P2|COMPLETED|Open Label Phase (OL)||67
2591759|NCT00301262|6361180|P1|COMPLETED|Open Label Phase (OL)||79
2591760|NCT00301262|6361179|P2|STARTED|Open Label Phase (OL)||69
2591761|NCT00301262|6361180|P1|STARTED|Open Label Phase (OL)||83
2591762|NCT00301262|6361179|P2|NOT COMPLETED|Double Blind Phase (DB)||13
2591763|NCT00301262|6361180|P1|NOT COMPLETED|Double Blind Phase (DB)||10
2591764|NCT00301262|6361179|P2|COMPLETED|Double Blind Phase (DB)||69
2591765|NCT00301262|6361180|P1|COMPLETED|Double Blind Phase (DB)||84
2591766|NCT00301262|6361179|P2|STARTED|Double Blind Phase (DB)||82
2591767|NCT00301262|6361180|P1|STARTED|Double Blind Phase (DB)||94
2591768|NCT00301080|6361338|P5|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
2591769|NCT00301080|6361339|P4|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
2591770|NCT00301080|6361340|P3|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
2591771|NCT00301080|6361341|P2|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
2591772|NCT00301080|6361342|P1|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
2591773|NCT00301080|6361338|P5|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
2591774|NCT00301080|6361339|P4|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
2591775|NCT00301080|6361340|P3|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
2591776|NCT00301080|6361341|P2|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
2591777|NCT00301080|6361342|P1|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
2591778|NCT00301080|6361338|P5|STARTED|Revised Version (3 Arms & 12 Weeks)||0
2591779|NCT00301080|6361339|P4|STARTED|Revised Version (3 Arms & 12 Weeks)||0
2591780|NCT00301080|6361340|P3|STARTED|Revised Version (3 Arms & 12 Weeks)||0
2591781|NCT00301080|6361341|P2|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
2591782|NCT00301080|6361342|P1|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
2591783|NCT00301080|6361338|P5|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
2591784|NCT00301080|6361339|P4|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
2591785|NCT00301080|6361340|P3|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
2591786|NCT00301080|6361341|P2|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
2591787|NCT00301080|6361342|P1|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||1
2591788|NCT00301080|6361338|P5|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
2591789|NCT00301080|6361339|P4|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
2591790|NCT00301080|6361340|P3|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
2591791|NCT00301080|6361341|P2|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
2591792|NCT00301080|6361342|P1|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
2591793|NCT00301080|6361338|P5|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
2591794|NCT00301080|6361339|P4|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
2591795|NCT00301080|6361340|P3|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
2591796|NCT00301080|6361341|P2|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
2591797|NCT00301080|6361342|P1|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
2591798|NCT00301080|6361338|P5|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
2591799|NCT00301080|6361339|P4|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
2591800|NCT00301080|6361340|P3|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
2591801|NCT00301080|6361341|P2|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
2591802|NCT00301080|6361342|P1|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
2591803|NCT00301080|6361338|P5|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
2591804|NCT00301080|6361339|P4|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
2591805|NCT00301080|6361340|P3|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
2591806|NCT00301080|6361341|P2|STARTED|Original Version (2 Arms & 4 Weeks)||3
2591807|NCT00301080|6361342|P1|STARTED|Original Version (2 Arms & 4 Weeks)||4
2591808|NCT00301067|6361371|P4|NOT COMPLETED|Follow up Until Death||1
2591809|NCT00301067|6361372|P3|NOT COMPLETED|Follow up Until Death||0
2591810|NCT00301067|6361373|P2|NOT COMPLETED|Follow up Until Death||0
2591811|NCT00301067|6361374|P1|NOT COMPLETED|Follow up Until Death||1
2591812|NCT00301067|6361371|P4|COMPLETED|Follow up Until Death||2
2591813|NCT00301067|6361372|P3|COMPLETED|Follow up Until Death||3
2591814|NCT00301067|6361373|P2|COMPLETED|Follow up Until Death||3
2591815|NCT00301067|6361374|P1|COMPLETED|Follow up Until Death||3
2591816|NCT00301067|6361371|P4|STARTED|Follow up Until Death||3
2591817|NCT00301067|6361372|P3|STARTED|Follow up Until Death||3
2591818|NCT00301067|6361373|P2|STARTED|Follow up Until Death||3
2591819|NCT00301067|6361374|P1|STARTED|Follow up Until Death||4
2591820|NCT00301067|6361371|P4|NOT COMPLETED|Completed 12 Cycles of Treatment||2
2591821|NCT00301067|6361372|P3|NOT COMPLETED|Completed 12 Cycles of Treatment||0
2591822|NCT00301067|6361373|P2|NOT COMPLETED|Completed 12 Cycles of Treatment||1
2591823|NCT00301067|6361374|P1|NOT COMPLETED|Completed 12 Cycles of Treatment||0
2591824|NCT00301067|6361371|P4|COMPLETED|Completed 12 Cycles of Treatment||0
2591825|NCT00301067|6361372|P3|COMPLETED|Completed 12 Cycles of Treatment||0
2591826|NCT00301067|6361373|P2|COMPLETED|Completed 12 Cycles of Treatment||0
2591827|NCT00301067|6361374|P1|COMPLETED|Completed 12 Cycles of Treatment||0
2591828|NCT00301067|6361371|P4|STARTED|Completed 12 Cycles of Treatment||2
2591829|NCT00301067|6361372|P3|STARTED|Completed 12 Cycles of Treatment||0
2591830|NCT00301067|6361373|P2|STARTED|Completed 12 Cycles of Treatment||1
2591831|NCT00301067|6361374|P1|STARTED|Completed 12 Cycles of Treatment||0
2591832|NCT00301067|6361371|P4|NOT COMPLETED|Completed 4 Cycles of Treatment||5
2591833|NCT00301067|6361372|P3|NOT COMPLETED|Completed 4 Cycles of Treatment||2
2591834|NCT00301067|6361373|P2|NOT COMPLETED|Completed 4 Cycles of Treatment||1
2591835|NCT00301067|6361374|P1|NOT COMPLETED|Completed 4 Cycles of Treatment||1
2591836|NCT00301067|6361371|P4|COMPLETED|Completed 4 Cycles of Treatment||2
2591837|NCT00301067|6361372|P3|COMPLETED|Completed 4 Cycles of Treatment||0
2591838|NCT00301067|6361373|P2|COMPLETED|Completed 4 Cycles of Treatment||1
2591839|NCT00301067|6361374|P1|COMPLETED|Completed 4 Cycles of Treatment||0
2591840|NCT00301067|6361371|P4|STARTED|Completed 4 Cycles of Treatment||7
2591841|NCT00301067|6361372|P3|STARTED|Completed 4 Cycles of Treatment||2
2591842|NCT00301067|6361373|P2|STARTED|Completed 4 Cycles of Treatment||2
2591843|NCT00301067|6361374|P1|STARTED|Completed 4 Cycles of Treatment||1
2591844|NCT00301067|6361371|P4|NOT COMPLETED|Reached 1st Response/2 Cycles||2
2591845|NCT00301067|6361372|P3|NOT COMPLETED|Reached 1st Response/2 Cycles||1
2591846|NCT00301067|6361373|P2|NOT COMPLETED|Reached 1st Response/2 Cycles||1
2591847|NCT00301067|6361374|P1|NOT COMPLETED|Reached 1st Response/2 Cycles||2
2591848|NCT00301067|6361371|P4|COMPLETED|Reached 1st Response/2 Cycles||7
2591849|NCT00301067|6361372|P3|COMPLETED|Reached 1st Response/2 Cycles||2
2591850|NCT00301067|6361373|P2|COMPLETED|Reached 1st Response/2 Cycles||2
2591851|NCT00301067|6361374|P1|COMPLETED|Reached 1st Response/2 Cycles||1
2591852|NCT00301067|6361371|P4|STARTED|Reached 1st Response/2 Cycles||9
2591853|NCT00301067|6361372|P3|STARTED|Reached 1st Response/2 Cycles||3
2591854|NCT00301067|6361373|P2|STARTED|Reached 1st Response/2 Cycles||3
2591855|NCT00301067|6361374|P1|STARTED|Reached 1st Response/2 Cycles||3
2591856|NCT00301067|6361371|P4|NOT COMPLETED|Completed DLT Period/1st Cycle||1
2591857|NCT00301067|6361372|P3|NOT COMPLETED|Completed DLT Period/1st Cycle||0
2591858|NCT00301067|6361373|P2|NOT COMPLETED|Completed DLT Period/1st Cycle||0
2591859|NCT00301067|6361374|P1|NOT COMPLETED|Completed DLT Period/1st Cycle||1
2591860|NCT00301067|6361371|P4|COMPLETED|Completed DLT Period/1st Cycle||9
2591861|NCT00301067|6361372|P3|COMPLETED|Completed DLT Period/1st Cycle||3
2591862|NCT00301067|6361373|P2|COMPLETED|Completed DLT Period/1st Cycle||3
2591863|NCT00301067|6361374|P1|COMPLETED|Completed DLT Period/1st Cycle||3
2591864|NCT00301067|6361371|P4|STARTED|Completed DLT Period/1st Cycle|Patients did not participate in the DLT portion of the trial, they completed 1st cycle of treatment.|10
2591865|NCT00301067|6361372|P3|STARTED|Completed DLT Period/1st Cycle||3
2591866|NCT00301067|6361373|P2|STARTED|Completed DLT Period/1st Cycle||3
2591867|NCT00301067|6361374|P1|STARTED|Completed DLT Period/1st Cycle||4
2591868|NCT00301028|6361393|P1|NOT COMPLETED|Overall Study||0
2591869|NCT00301028|6361393|P1|COMPLETED|Overall Study||47
2591870|NCT00301028|6361393|P1|STARTED|Overall Study||47
2591871|NCT00300885|6361399|P2|NOT COMPLETED|Follow-up||195
2591872|NCT00300885|6361400|P1|NOT COMPLETED|Follow-up||178
2591873|NCT00300885|6361399|P2|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|174
2591874|NCT00300885|6361400|P1|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|176
2591875|NCT00300885|6361399|P2|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|369
2591876|NCT00300885|6361400|P1|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|354
2591877|NCT00300885|6361399|P2|NOT COMPLETED|Treatment||374
2591878|NCT00300885|6361400|P1|NOT COMPLETED|Treatment||373
2591879|NCT00300885|6361399|P2|COMPLETED|Treatment||88
2591880|NCT00300885|6361400|P1|COMPLETED|Treatment||91
2591881|NCT00300885|6361399|P2|Received Treatment|Treatment||459
2591882|NCT00300885|6361400|P1|Received Treatment|Treatment||463
2591883|NCT00300885|6361399|P2|STARTED|Treatment|ongoing in double -blind treatment at data cut-off|462
2591884|NCT00300885|6361400|P1|STARTED|Treatment||464
2591885|NCT00300781|6361418|P2|NOT COMPLETED|Overall Study||62
2591886|NCT00300781|6361419|P1|NOT COMPLETED|Overall Study||63
2591887|NCT00300781|6361418|P2|COMPLETED|Overall Study||8
2591888|NCT00300781|6361419|P1|COMPLETED|Overall Study||3
2591889|NCT00300781|6361418|P2|STARTED|Overall Study||70
2591890|NCT00300781|6361419|P1|STARTED|Overall Study||66
2591891|NCT00300755|6361434|P3|NOT COMPLETED|Overall Study||2
2591892|NCT00300755|6361435|P2|NOT COMPLETED|Overall Study||4
2591893|NCT00300755|6361436|P1|NOT COMPLETED|Overall Study||1
2591894|NCT00300755|6361434|P3|COMPLETED|Overall Study||19
2591895|NCT00300755|6361435|P2|COMPLETED|Overall Study||17
2591896|NCT00300755|6361436|P1|COMPLETED|Overall Study||17
2591897|NCT00300755|6361434|P3|STARTED|Overall Study||21
2591898|NCT00300755|6361435|P2|STARTED|Overall Study||21
2591899|NCT00300755|6361436|P1|STARTED|Overall Study||18
2591900|NCT00300742|6361453|P1|NOT COMPLETED|Overall Study||2
2591901|NCT00300742|6361453|P1|COMPLETED|Overall Study||3
2591902|NCT00300742|6361453|P1|STARTED|Overall Study||5
2591903|NCT00300677|6361461|P1|NOT COMPLETED|Overall Study||0
2591904|NCT00300677|6361461|P1|COMPLETED|Overall Study||12
2591905|NCT00300677|6361461|P1|STARTED|Overall Study||12
2591906|NCT00300495|6361470|P2|NOT COMPLETED|Overall Study||1
2591907|NCT00300495|6361471|P1|NOT COMPLETED|Overall Study||4
2591908|NCT00300495|6361470|P2|COMPLETED|Overall Study||8
2591909|NCT00300495|6361471|P1|COMPLETED|Overall Study||6
2591910|NCT00300495|6361470|P2|STARTED|Overall Study||9
2591911|NCT00300495|6361471|P1|STARTED|Overall Study||10
2591912|NCT00300482|6361485|P6|NOT COMPLETED|Overall Study||16
2591913|NCT00300482|6361486|P5|NOT COMPLETED|Overall Study||23
2591914|NCT00300482|6361487|P4|NOT COMPLETED|Overall Study||24
2591915|NCT00300482|6361488|P3|NOT COMPLETED|Overall Study||51
2591916|NCT00300482|6361489|P2|NOT COMPLETED|Overall Study||41
2591917|NCT00300482|6361490|P1|NOT COMPLETED|Overall Study||41
2591918|NCT00300482|6361485|P6|COMPLETED|Overall Study||115
2591919|NCT00300482|6361486|P5|COMPLETED|Overall Study||243
2591920|NCT00300482|6361487|P4|COMPLETED|Overall Study||237
2591921|NCT00300482|6361488|P3|COMPLETED|Overall Study||208
2591922|NCT00300482|6361489|P2|COMPLETED|Overall Study||220
2591923|NCT00300482|6361490|P1|COMPLETED|Overall Study||220
2591924|NCT00300482|6361485|P6|STARTED|Overall Study||131
2591925|NCT00300482|6361486|P5|STARTED|Overall Study||266
2591926|NCT00300482|6361487|P4|STARTED|Overall Study||261
2591927|NCT00300482|6361488|P3|STARTED|Overall Study||259
2591928|NCT00300482|6361489|P2|STARTED|Overall Study||261
2591929|NCT00300482|6361490|P1|STARTED|Overall Study|"For all arms, started means treated."|261
2591930|NCT00300469|6361552|P6|NOT COMPLETED|Overall Study||9
2591931|NCT00300469|6361553|P5|NOT COMPLETED|Overall Study||14
2591932|NCT00300469|6361554|P4|NOT COMPLETED|Overall Study||9
2591933|NCT00300469|6361555|P3|NOT COMPLETED|Overall Study||17
2591934|NCT00300469|6361556|P2|NOT COMPLETED|Overall Study||21
2591935|NCT00300469|6361557|P1|NOT COMPLETED|Overall Study||21
2591936|NCT00300469|6361552|P6|COMPLETED|Overall Study||46
2591937|NCT00300469|6361553|P5|COMPLETED|Overall Study||95
2591938|NCT00300469|6361554|P4|COMPLETED|Overall Study||104
2591939|NCT00300469|6361555|P3|COMPLETED|Overall Study||95
2591940|NCT00300469|6361556|P2|COMPLETED|Overall Study||89
2591941|NCT00300469|6361557|P1|COMPLETED|Overall Study||89
2591942|NCT00300469|6361552|P6|STARTED|Overall Study||55
2591943|NCT00300469|6361553|P5|STARTED|Overall Study||109
2591944|NCT00300469|6361554|P4|STARTED|Overall Study||113
2591945|NCT00300469|6361555|P3|STARTED|Overall Study||112
2591946|NCT00300469|6361556|P2|STARTED|Overall Study||110
2591947|NCT00300469|6361557|P1|STARTED|Overall Study|"For all arms, started means treated."|110
2591948|NCT00300456|6361619|P6|NOT COMPLETED|Overall Study||11
2591949|NCT00300456|6361620|P5|NOT COMPLETED|Overall Study||17
2591950|NCT00300456|6361621|P4|NOT COMPLETED|Overall Study||14
2591951|NCT00300456|6361622|P3|NOT COMPLETED|Overall Study||21
2591952|NCT00300456|6361623|P2|NOT COMPLETED|Overall Study||16
2591953|NCT00300456|6361624|P1|NOT COMPLETED|Overall Study||16
2591954|NCT00300456|6361619|P6|COMPLETED|Overall Study||48
2591955|NCT00300456|6361620|P5|COMPLETED|Overall Study||99
2591956|NCT00300456|6361621|P4|COMPLETED|Overall Study||105
2591957|NCT00300456|6361622|P3|COMPLETED|Overall Study||98
2591958|NCT00300456|6361623|P2|COMPLETED|Overall Study||102
2591959|NCT00300456|6361624|P1|COMPLETED|Overall Study||103
2591960|NCT00300456|6361619|P6|STARTED|Overall Study||59
2591961|NCT00300456|6361620|P5|STARTED|Overall Study||116
2591962|NCT00300456|6361621|P4|STARTED|Overall Study||119
2591963|NCT00300456|6361622|P3|STARTED|Overall Study||119
2591964|NCT00300456|6361623|P2|STARTED|Overall Study||118
2591965|NCT00300456|6361624|P1|STARTED|Overall Study|"For all arms, started means treated."|119
2591966|NCT00300430|6361683|P3|NOT COMPLETED|Overall Study||151
2591967|NCT00300430|6361684|P2|NOT COMPLETED|Overall Study||169
2591968|NCT00300430|6361685|P1|NOT COMPLETED|Overall Study||367
2591969|NCT00300430|6361683|P3|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|350
2591970|NCT00300430|6361684|P2|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|345
2591971|NCT00300430|6361685|P1|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|819
2591972|NCT00300430|6361683|P3|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|501
2591973|NCT00300430|6361684|P2|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|514
2591974|NCT00300430|6361685|P1|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|1186
2591975|NCT00300391|6361719|P2|NOT COMPLETED|Overall Study||0
2591976|NCT00300391|6361720|P1|NOT COMPLETED|Overall Study||0
2591977|NCT00300391|6361719|P2|COMPLETED|Overall Study||14
2591978|NCT00300391|6361720|P1|COMPLETED|Overall Study||16
2591979|NCT00300391|6361719|P2|STARTED|Overall Study||14
2591980|NCT00300391|6361720|P1|STARTED|Overall Study||16
2591981|NCT00300365|6361738|P2|NOT COMPLETED|Overall Study||2
2591982|NCT00300365|6361739|P1|NOT COMPLETED|Overall Study||4
2591983|NCT00300365|6361738|P2|COMPLETED|Overall Study||38
2591984|NCT00300365|6361739|P1|COMPLETED|Overall Study||34
2591985|NCT00300365|6361738|P2|STARTED|Overall Study||40
2591986|NCT00300365|6361739|P1|STARTED|Overall Study||38
2591987|NCT00300274|6361748|P3|NOT COMPLETED|Overall Study||45
2591988|NCT00300274|6361749|P2|NOT COMPLETED|Overall Study||27
2591989|NCT00300274|6361750|P1|NOT COMPLETED|Overall Study||46
2591990|NCT00300274|6361748|P3|COMPLETED|Overall Study||226
2591991|NCT00300274|6361749|P2|COMPLETED|Overall Study||141
2591992|NCT00300274|6361750|P1|COMPLETED|Overall Study||236
2591993|NCT00300274|6361748|P3|Completed 12 Month|Overall Study||248
2591994|NCT00300274|6361749|P2|Completed 12 Month|Overall Study||149
2591995|NCT00300274|6361750|P1|Completed 12 Month|Overall Study||250
2591996|NCT00300274|6361748|P3|STARTED|Overall Study||271
2591997|NCT00300274|6361749|P2|STARTED|Overall Study||168
2591998|NCT00300274|6361750|P1|STARTED|Overall Study||282
2591999|NCT00300235|6361790|P5|NOT COMPLETED|Overall Study||0
2592000|NCT00300235|6361791|P4|NOT COMPLETED|Overall Study||0
2592001|NCT00300235|6361792|P3|NOT COMPLETED|Overall Study||0
2592002|NCT00300235|6361793|P2|NOT COMPLETED|Overall Study||0
2592003|NCT00300235|6361794|P1|NOT COMPLETED|Overall Study||0
2592004|NCT00300235|6361790|P5|COMPLETED|Overall Study||251
2592005|NCT00300235|6361791|P4|COMPLETED|Overall Study||362
2592006|NCT00300235|6361792|P3|COMPLETED|Overall Study||398
2592007|NCT00300235|6361793|P2|COMPLETED|Overall Study||240
2592008|NCT00300235|6361794|P1|COMPLETED|Overall Study||208
2592009|NCT00300235|6361790|P5|STARTED|Overall Study||251
2592010|NCT00300235|6361791|P4|STARTED|Overall Study||362
2592011|NCT00300235|6361792|P3|STARTED|Overall Study||398
2592012|NCT00300235|6361793|P2|STARTED|Overall Study||240
2592013|NCT00300235|6361794|P1|STARTED|Overall Study||208
2592014|NCT00299988|6361808|P2|NOT COMPLETED|Overall Study||0
2592015|NCT00299988|6361809|P1|NOT COMPLETED|Overall Study||0
2592016|NCT00299988|6361808|P2|COMPLETED|Overall Study||8
2592017|NCT00299988|6361809|P1|COMPLETED|Overall Study||16
2592018|NCT00299988|6361808|P2|STARTED|Overall Study||8
2592019|NCT00299988|6361809|P1|STARTED|Overall Study||16
2592020|NCT00299975|6361820|P3|NOT COMPLETED|Overall Study||8
2592021|NCT00299975|6361821|P2|NOT COMPLETED|Overall Study||1
2592022|NCT00299975|6361822|P1|NOT COMPLETED|Overall Study||3
2592023|NCT00299975|6361820|P3|COMPLETED|Overall Study||25
2592024|NCT00299975|6361821|P2|COMPLETED|Overall Study||31
2592025|NCT00299975|6361822|P1|COMPLETED|Overall Study||29
2592026|NCT00299975|6361820|P3|Received Allocated Intervention|Overall Study||32
2592027|NCT00299975|6361821|P2|Received Allocated Intervention|Overall Study||32
2592028|NCT00299975|6361822|P1|Received Allocated Intervention|Overall Study||32
2592029|NCT00299975|6361820|P3|STARTED|Overall Study||33
2592030|NCT00299975|6361821|P2|STARTED|Overall Study||32
2592031|NCT00299975|6361822|P1|STARTED|Overall Study||32
2592032|NCT00299741|6361872|P1|NOT COMPLETED|Overall Study||0
2592033|NCT00299741|6361872|P1|COMPLETED|Overall Study||36
2592034|NCT00299741|6361872|P1|STARTED|Overall Study||36
2592035|NCT00299702|6361879|P2|NOT COMPLETED|Overall Study||50
2592036|NCT00299702|6361880|P1|NOT COMPLETED|Overall Study||53
2592037|NCT00299702|6361879|P2|COMPLETED|Overall Study||126
2592038|NCT00299702|6361880|P1|COMPLETED|Overall Study||126
2592039|NCT00299702|6361879|P2|STARTED|Overall Study||176
2592040|NCT00299702|6361880|P1|STARTED|Overall Study||179
2592041|NCT00299689|6361888|P1|NOT COMPLETED|Overall Study||0
2592042|NCT00299689|6361888|P1|COMPLETED|Overall Study||69
2592043|NCT00299689|6361888|P1|STARTED|Overall Study||69
2592044|NCT00299546|6361895|P3|NOT COMPLETED|Overall Study||86
2592045|NCT00299546|6361896|P2|NOT COMPLETED|Overall Study||92
2592046|NCT00299546|6361897|P1|NOT COMPLETED|Overall Study||100
2592047|NCT00299546|6361895|P3|COMPLETED|Overall Study||67
2592048|NCT00299546|6361896|P2|COMPLETED|Overall Study||61
2592049|NCT00299546|6361897|P1|COMPLETED|Overall Study||55
2592050|NCT00299546|6361895|P3|STARTED|Overall Study||153
2592051|NCT00299546|6361896|P2|STARTED|Overall Study||153
2592052|NCT00299546|6361897|P1|STARTED|Overall Study||155
2592053|NCT00299494|6361928|P6|NOT COMPLETED|Overall Study||26
2592054|NCT00299494|6361929|P5|NOT COMPLETED|Overall Study||27
2592055|NCT00299494|6361930|P4|NOT COMPLETED|Overall Study||10
2592056|NCT00299494|6361931|P3|NOT COMPLETED|Overall Study||4
2592057|NCT00299494|6361932|P2|NOT COMPLETED|Overall Study||1
2592058|NCT00299494|6361933|P1|NOT COMPLETED|Overall Study||3
2592059|NCT00299494|6361928|P6|COMPLETED|Overall Study||4
2592060|NCT00299494|6361929|P5|COMPLETED|Overall Study||13
2592061|NCT00299494|6361930|P4|COMPLETED|Overall Study||24
2592062|NCT00299494|6361931|P3|COMPLETED|Overall Study||3
2592063|NCT00299494|6361932|P2|COMPLETED|Overall Study||2
2592064|NCT00299494|6361933|P1|COMPLETED|Overall Study||2
2592065|NCT00299494|6361928|P6|STARTED|Overall Study||30
2592066|NCT00299494|6361929|P5|STARTED|Overall Study|1 participant received rituximab only, and did not receive inotuzumab ozogamicin|40
2592067|NCT00299494|6361930|P4|STARTED|Overall Study||34
2592068|NCT00299494|6361931|P3|STARTED|Overall Study||7
2592069|NCT00299494|6361932|P2|STARTED|Overall Study||3
2592070|NCT00299494|6361933|P1|STARTED|Overall Study||5
2592071|NCT00299416|6362036|P1|NOT COMPLETED|Overall Study||0
2592072|NCT00299416|6362036|P1|COMPLETED|Overall Study||30
2592073|NCT00299416|6362036|P1|STARTED|Overall Study||30
2592074|NCT00299221|6362044|P2|NOT COMPLETED|Overall Study||0
2592075|NCT00299221|6362045|P1|NOT COMPLETED|Overall Study||0
2592076|NCT00299221|6362044|P2|COMPLETED|Overall Study||71
2592077|NCT00299221|6362045|P1|COMPLETED|Overall Study||79
2592078|NCT00299221|6362044|P2|STARTED|Overall Study||71
2592079|NCT00299221|6362045|P1|STARTED|Overall Study||79
2592080|NCT00299156|6362062|P3|NOT COMPLETED|Period 2 (Randomized)||0
2592081|NCT00299156|6362063|P2|NOT COMPLETED|Period 2 (Randomized)||1
2592082|NCT00299156|6362064|P1|NOT COMPLETED|Period 2 (Randomized)||0
2592083|NCT00299156|6362062|P3|COMPLETED|Period 2 (Randomized)||16
2592084|NCT00299156|6362063|P2|COMPLETED|Period 2 (Randomized)||16
2592085|NCT00299156|6362064|P1|COMPLETED|Period 2 (Randomized)||0
2592086|NCT00299156|6362062|P3|STARTED|Period 2 (Randomized)||16
2592087|NCT00299156|6362063|P2|STARTED|Period 2 (Randomized)||17
2592088|NCT00299156|6362064|P1|STARTED|Period 2 (Randomized)||0
2592089|NCT00299156|6362062|P3|NOT COMPLETED|Period 1 (Non-Randomized)||0
2592090|NCT00299156|6362063|P2|NOT COMPLETED|Period 1 (Non-Randomized)||0
2592091|NCT00299156|6362064|P1|NOT COMPLETED|Period 1 (Non-Randomized)||0
2592092|NCT00299156|6362062|P3|COMPLETED|Period 1 (Non-Randomized)||0
2592093|NCT00299156|6362063|P2|COMPLETED|Period 1 (Non-Randomized)||0
2592094|NCT00299156|6362064|P1|COMPLETED|Period 1 (Non-Randomized)||32
2592095|NCT00299156|6362062|P3|STARTED|Period 1 (Non-Randomized)||0
2592096|NCT00299156|6362063|P2|STARTED|Period 1 (Non-Randomized)||0
2592097|NCT00299156|6362064|P1|STARTED|Period 1 (Non-Randomized)||32
2592098|NCT00299130|6362075|P3|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||6
2592099|NCT00299130|6362076|P2|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||8
2592100|NCT00299130|6362077|P1|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
2592101|NCT00299130|6362075|P3|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||38
2592102|NCT00299130|6362076|P2|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||74
2592103|NCT00299130|6362077|P1|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
2592104|NCT00299130|6362075|P3|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||44
2592105|NCT00299130|6362076|P2|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||82
2592106|NCT00299130|6362077|P1|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||0
2592107|NCT00299130|6362075|P3|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
2592108|NCT00299130|6362076|P2|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
2592109|NCT00299130|6362077|P1|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
2592110|NCT00299130|6362075|P3|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||123
2592111|NCT00299130|6362076|P2|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||120
2592112|NCT00299130|6362077|P1|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||122
2592113|NCT00299130|6362075|P3|STARTED|Safety Follow-up (SFU) (48 Weeks)||168
2592114|NCT00299130|6362076|P2|STARTED|Safety Follow-up (SFU) (48 Weeks)||165
2592115|NCT00299130|6362077|P1|STARTED|Safety Follow-up (SFU) (48 Weeks)||167
2592116|NCT00299130|6362075|P3|NOT COMPLETED|Treatment Period (up to 5 Years)||50
2592117|NCT00299130|6362076|P2|NOT COMPLETED|Treatment Period (up to 5 Years)||43
2592118|NCT00299130|6362077|P1|NOT COMPLETED|Treatment Period (up to 5 Years)||53
2592119|NCT00299130|6362075|P3|COMPLETED|Treatment Period (up to 5 Years)||121
2592120|NCT00299130|6362076|P2|COMPLETED|Treatment Period (up to 5 Years)||125
2592121|NCT00299130|6362077|P1|COMPLETED|Treatment Period (up to 5 Years)||119
2592122|NCT00299130|6362075|P3|Completed 144 Weeks|Treatment Period (up to 5 Years)||132
2592123|NCT00299130|6362076|P2|Completed 144 Weeks|Treatment Period (up to 5 Years)||138
2592124|NCT00299130|6362077|P1|Completed 144 Weeks|Treatment Period (up to 5 Years)||133
2592125|NCT00299130|6362075|P3|Completed 48 Weeks|Treatment Period (up to 5 Years)||158
2592126|NCT00299130|6362076|P2|Completed 48 Weeks|Treatment Period (up to 5 Years)||157
2592127|NCT00299130|6362077|P1|Completed 48 Weeks|Treatment Period (up to 5 Years)||155
2592128|NCT00299130|6362075|P3|Completed 24 Weeks|Treatment Period (up to 5 Years)||166
2592129|NCT00299130|6362076|P2|Completed 24 Weeks|Treatment Period (up to 5 Years)||162
2592130|NCT00299130|6362077|P1|Completed 24 Weeks|Treatment Period (up to 5 Years)||159
2592131|NCT00299130|6362075|P3|Treated|Treatment Period (up to 5 Years)||170
2592132|NCT00299130|6362076|P2|Treated|Treatment Period (up to 5 Years)||167
2592133|NCT00299130|6362077|P1|Treated|Treatment Period (up to 5 Years)|155 participants in placebo arm switched to active therapy (rituximab 2 x 0.5g) between Weeks 16-48.|172
2592134|NCT00299130|6362075|P3|STARTED|Treatment Period (up to 5 Years)||171
2592135|NCT00299130|6362076|P2|STARTED|Treatment Period (up to 5 Years)||168
2592136|NCT00299130|6362077|P1|STARTED|Treatment Period (up to 5 Years)||172
2592137|NCT00299104|6362182|P3|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||12
2592138|NCT00299104|6362183|P2|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||9
2592139|NCT00299104|6362184|P1|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||5
2592140|NCT00299104|6362182|P3|COMPLETED|Extended Safety Follow-Up (ESFU) Period||39
2592141|NCT00299104|6362183|P2|COMPLETED|Extended Safety Follow-Up (ESFU) Period||31
2592142|NCT00299104|6362184|P1|COMPLETED|Extended Safety Follow-Up (ESFU) Period||29
2592143|NCT00299104|6362182|P3|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|51
2592144|NCT00299104|6362183|P2|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|40
2592145|NCT00299104|6362184|P1|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|34
2592146|NCT00299104|6362182|P3|NOT COMPLETED|Safety Follow-Up (SFU) Period||37
2592147|NCT00299104|6362183|P2|NOT COMPLETED|Safety Follow-Up (SFU) Period||41
2592148|NCT00299104|6362184|P1|NOT COMPLETED|Safety Follow-Up (SFU) Period||55
2592149|NCT00299104|6362182|P3|COMPLETED|Safety Follow-Up (SFU) Period||176
2592150|NCT00299104|6362183|P2|COMPLETED|Safety Follow-Up (SFU) Period||171
2592151|NCT00299104|6362184|P1|COMPLETED|Safety Follow-Up (SFU) Period||129
2592152|NCT00299104|6362182|P3|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|213
2592153|NCT00299104|6362183|P2|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|212
2592154|NCT00299104|6362184|P1|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|184
2592155|NCT00299104|6362182|P3|NOT COMPLETED|Treatment Period||172
2592156|NCT00299104|6362183|P2|NOT COMPLETED|Treatment Period||175
2592157|NCT00299104|6362184|P1|NOT COMPLETED|Treatment Period||189
2592158|NCT00299104|6362182|P3|COMPLETED|Treatment Period||80
2592159|NCT00299104|6362183|P2|COMPLETED|Treatment Period||77
2592160|NCT00299104|6362184|P1|COMPLETED|Treatment Period|Completed Week 152|62
2592161|NCT00299104|6362182|P3|Completed Week 104|Treatment Period||216
2592162|NCT00299104|6362183|P2|Completed Week 104|Treatment Period||213
2592163|NCT00299104|6362184|P1|Completed Week 104|Treatment Period||178
2592164|NCT00299104|6362182|P3|Completed Week 52|Treatment Period||232
2592165|NCT00299104|6362183|P2|Completed Week 52|Treatment Period||227
2592166|NCT00299104|6362184|P1|Completed Week 52|Treatment Period||213
2592167|NCT00299104|6362182|P3|Completed Week 24|Treatment Period||241
2592168|NCT00299104|6362183|P2|Completed Week 24|Treatment Period||240
2592169|NCT00299104|6362184|P1|Completed Week 24|Treatment Period||227
2592170|NCT00299104|6362182|P3|Safety/ITT: Received Study Drug|Treatment Period||250
2592171|NCT00299104|6362183|P2|Safety/ITT: Received Study Drug|Treatment Period||249
2592172|NCT00299104|6362184|P1|Safety/ITT: Received Study Drug|Treatment Period||249
2592173|NCT00299104|6362182|P3|STARTED|Treatment Period||252
2592174|NCT00299104|6362183|P2|STARTED|Treatment Period||252
2592175|NCT00299104|6362184|P1|STARTED|Treatment Period||251
2592176|NCT00299000|6362281|P2|NOT COMPLETED|Overall Study||0
2592177|NCT00299000|6362282|P1|NOT COMPLETED|Overall Study||0
2592178|NCT00299000|6362281|P2|COMPLETED|Overall Study||2
2592179|NCT00299000|6362282|P1|COMPLETED|Overall Study||2
2592180|NCT00299000|6362281|P2|STARTED|Overall Study||2
2592181|NCT00299000|6362282|P1|STARTED|Overall Study||2
2592182|NCT00298896|6362294|P1|NOT COMPLETED|Overall Study||50
2592183|NCT00298896|6362294|P1|COMPLETED|Overall Study||5
2592184|NCT00298896|6362294|P1|STARTED|Overall Study||55
2592185|NCT00298831|6362299|P1|NOT COMPLETED|Overall Study||32
2592186|NCT00298831|6362299|P1|COMPLETED|Overall Study||192
2592187|NCT00298831|6362299|P1|Treated|Overall Study||197
2592188|NCT00298831|6362299|P1|STARTED|Overall Study||224
2592189|NCT00298766|6362308|P1|NOT COMPLETED|Overall Study||46
2592190|NCT00298766|6362308|P1|COMPLETED|Overall Study||24
2592191|NCT00298766|6362308|P1|STARTED|Overall Study||70
2592192|NCT00298740|6362317|P1|NOT COMPLETED|Overall Study||9
2592193|NCT00298740|6362317|P1|COMPLETED|Overall Study||3
2592194|NCT00298740|6362317|P1|STARTED|Overall Study||12
2592195|NCT00298610|6362321|P1|NOT COMPLETED|Overall Study||0
2592196|NCT00298610|6362321|P1|COMPLETED|Overall Study||30
2592197|NCT00298610|6362321|P1|STARTED|Overall Study||30
2592198|NCT00298558|6362335|P4|NOT COMPLETED|10th Annual (A10)||163
2592199|NCT00298558|6362336|P3|NOT COMPLETED|10th Annual (A10)||171
2592200|NCT00298558|6362337|P2|NOT COMPLETED|10th Annual (A10)||153
2592201|NCT00298558|6362338|P1|NOT COMPLETED|10th Annual (A10)||172
2592202|NCT00298558|6362335|P4|COMPLETED|10th Annual (A10)||285
2592203|NCT00298558|6362336|P3|COMPLETED|10th Annual (A10)||319
2592204|NCT00298558|6362337|P2|COMPLETED|10th Annual (A10)||316
2592205|NCT00298558|6362338|P1|COMPLETED|10th Annual (A10)||300
2592206|NCT00298558|6362335|P4|STARTED|10th Annual (A10)||448
2592207|NCT00298558|6362336|P3|STARTED|10th Annual (A10)||490
2592208|NCT00298558|6362337|P2|STARTED|10th Annual (A10)||469
2592209|NCT00298558|6362338|P1|STARTED|10th Annual (A10)||472
2592210|NCT00298558|6362335|P4|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||104
2592211|NCT00298558|6362336|P3|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||84
2592212|NCT00298558|6362337|P2|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||86
2592213|NCT00298558|6362338|P1|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||91
2592214|NCT00298558|6362335|P4|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||448
2592215|NCT00298558|6362336|P3|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||490
2592216|NCT00298558|6362337|P2|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||469
2592217|NCT00298558|6362338|P1|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||472
2592218|NCT00298558|6362335|P4|STARTED|3rd Annual (A3) and 5th Annual (A5)||552
2592219|NCT00298558|6362336|P3|STARTED|3rd Annual (A3) and 5th Annual (A5)||574
2592220|NCT00298558|6362337|P2|STARTED|3rd Annual (A3) and 5th Annual (A5)||555
2592221|NCT00298558|6362338|P1|STARTED|3rd Annual (A3) and 5th Annual (A5)||563
2592222|NCT00298558|6362335|P4|NOT COMPLETED|3rd Annual Booster||0
2592223|NCT00298558|6362336|P3|NOT COMPLETED|3rd Annual Booster||140
2592224|NCT00298558|6362337|P2|NOT COMPLETED|3rd Annual Booster||128
2592225|NCT00298558|6362338|P1|NOT COMPLETED|3rd Annual Booster||122
2592226|NCT00298558|6362335|P4|COMPLETED|3rd Annual Booster||0
2592227|NCT00298558|6362336|P3|COMPLETED|3rd Annual Booster||230
2592228|NCT00298558|6362337|P2|COMPLETED|3rd Annual Booster||243
2592229|NCT00298558|6362338|P1|COMPLETED|3rd Annual Booster||250
2592230|NCT00298558|6362335|P4|STARTED|3rd Annual Booster||0
2592231|NCT00298558|6362336|P3|STARTED|3rd Annual Booster||370
2592232|NCT00298558|6362337|P2|STARTED|3rd Annual Booster||371
2592233|NCT00298558|6362338|P1|STARTED|3rd Annual Booster||372
2592234|NCT00298558|6362335|P4|NOT COMPLETED|2nd Annual (A2)||32
2592235|NCT00298558|6362336|P3|NOT COMPLETED|2nd Annual (A2)||27
2592236|NCT00298558|6362337|P2|NOT COMPLETED|2nd Annual (A2)||11
2592237|NCT00298558|6362338|P1|NOT COMPLETED|2nd Annual (A2)||22
2592238|NCT00298558|6362335|P4|COMPLETED|2nd Annual (A2)||552
2592239|NCT00298558|6362336|P3|COMPLETED|2nd Annual (A2)||574
2592240|NCT00298558|6362337|P2|COMPLETED|2nd Annual (A2)||555
2592241|NCT00298558|6362338|P1|COMPLETED|2nd Annual (A2)||563
2592242|NCT00298558|6362335|P4|STARTED|2nd Annual (A2)||584
2592243|NCT00298558|6362336|P3|STARTED|2nd Annual (A2)||601
2592244|NCT00298558|6362337|P2|STARTED|2nd Annual (A2)||566
2592245|NCT00298558|6362338|P1|STARTED|2nd Annual (A2)||585
2592246|NCT00298558|6362335|P4|NOT COMPLETED|1st Annual (A1)||55
2592247|NCT00298558|6362336|P3|NOT COMPLETED|1st Annual (A1)||52
2592248|NCT00298558|6362337|P2|NOT COMPLETED|1st Annual (A1)||63
2592249|NCT00298558|6362338|P1|NOT COMPLETED|1st Annual (A1)||55
2592250|NCT00298558|6362335|P4|COMPLETED|1st Annual (A1)||584
2592251|NCT00298558|6362336|P3|COMPLETED|1st Annual (A1)||601
2592252|NCT00298558|6362337|P2|COMPLETED|1st Annual (A1)||566
2592253|NCT00298558|6362338|P1|COMPLETED|1st Annual (A1)||585
2592254|NCT00298558|6362335|P4|STARTED|1st Annual (A1)||639
2592255|NCT00298558|6362336|P3|STARTED|1st Annual (A1)||653
2592256|NCT00298558|6362337|P2|STARTED|1st Annual (A1)||629
2592257|NCT00298558|6362338|P1|STARTED|1st Annual (A1)||640
2592258|NCT00298558|6362335|P4|NOT COMPLETED|Booster||0
2592259|NCT00298558|6362336|P3|NOT COMPLETED|Booster||75
2592260|NCT00298558|6362337|P2|NOT COMPLETED|Booster||70
2592261|NCT00298558|6362338|P1|NOT COMPLETED|Booster||89
2592262|NCT00298558|6362335|P4|COMPLETED|Booster||0
2592263|NCT00298558|6362336|P3|COMPLETED|Booster||295
2592264|NCT00298558|6362337|P2|COMPLETED|Booster||301
2592265|NCT00298558|6362338|P1|COMPLETED|Booster||283
2592266|NCT00298558|6362335|P4|STARTED|Booster||0
2592267|NCT00298558|6362336|P3|STARTED|Booster||370
2592268|NCT00298558|6362337|P2|STARTED|Booster||371
2592269|NCT00298558|6362338|P1|STARTED|Booster||372
2592270|NCT00298558|6362335|P4|NOT COMPLETED|Immediate Post Test||65
2592271|NCT00298558|6362336|P3|NOT COMPLETED|Immediate Post Test||59
2592272|NCT00298558|6362337|P2|NOT COMPLETED|Immediate Post Test||76
2592273|NCT00298558|6362338|P1|NOT COMPLETED|Immediate Post Test||71
2592274|NCT00298558|6362335|P4|COMPLETED|Immediate Post Test||639
2592275|NCT00298558|6362336|P3|COMPLETED|Immediate Post Test||653
2592276|NCT00298558|6362337|P2|COMPLETED|Immediate Post Test||629
2592277|NCT00298558|6362338|P1|COMPLETED|Immediate Post Test||640
2592278|NCT00298558|6362335|P4|STARTED|Immediate Post Test||704
2592279|NCT00298558|6362336|P3|STARTED|Immediate Post Test||712
2592280|NCT00298558|6362337|P2|STARTED|Immediate Post Test||705
2592281|NCT00298558|6362338|P1|STARTED|Immediate Post Test||711
2592282|NCT00298558|6362335|P4|NOT COMPLETED|Intervention||419
2592283|NCT00298558|6362336|P3|NOT COMPLETED|Intervention||75
2592284|NCT00298558|6362337|P2|NOT COMPLETED|Intervention||78
2592285|NCT00298558|6362338|P1|NOT COMPLETED|Intervention||91
2592286|NCT00298558|6362335|P4|COMPLETED|Intervention||285
2592287|NCT00298558|6362336|P3|COMPLETED|Intervention||637
2592288|NCT00298558|6362337|P2|COMPLETED|Intervention||627
2592289|NCT00298558|6362338|P1|COMPLETED|Intervention||620
2592290|NCT00298558|6362335|P4|STARTED|Intervention||704
2592291|NCT00298558|6362336|P3|STARTED|Intervention||712
2592292|NCT00298558|6362337|P2|STARTED|Intervention||705
2592293|NCT00298558|6362338|P1|STARTED|Intervention||711
2592294|NCT00298558|6362335|P4|NOT COMPLETED|Baseline||0
2592295|NCT00298558|6362336|P3|NOT COMPLETED|Baseline||0
2592296|NCT00298558|6362337|P2|NOT COMPLETED|Baseline||0
2592297|NCT00298558|6362338|P1|NOT COMPLETED|Baseline||0
2592298|NCT00298558|6362335|P4|COMPLETED|Baseline||704
2592299|NCT00298558|6362336|P3|COMPLETED|Baseline||712
2592300|NCT00298558|6362337|P2|COMPLETED|Baseline||705
2592301|NCT00298558|6362338|P1|COMPLETED|Baseline||711
2592302|NCT00298558|6362335|P4|STARTED|Baseline||704
2592303|NCT00298558|6362336|P3|STARTED|Baseline||712
2592304|NCT00298558|6362337|P2|STARTED|Baseline||705
2592305|NCT00298558|6362338|P1|STARTED|Baseline||711
2592306|NCT00298389|6362371|P3|NOT COMPLETED|Overall Study||0
2592307|NCT00298389|6362372|P2|NOT COMPLETED|Overall Study||0
2592308|NCT00298389|6362373|P1|NOT COMPLETED|Overall Study||0
2592309|NCT00298389|6362371|P3|COMPLETED|Overall Study||19
2592310|NCT00298389|6362372|P2|COMPLETED|Overall Study||17
2592311|NCT00298389|6362373|P1|COMPLETED|Overall Study||20
2592312|NCT00298389|6362371|P3|STARTED|Overall Study||19
2592313|NCT00298389|6362372|P2|STARTED|Overall Study||17
2592314|NCT00298389|6362373|P1|STARTED|Overall Study||20
2592315|NCT00298363|6362387|P3|NOT COMPLETED|Overall Study||6
2592316|NCT00298363|6362388|P2|NOT COMPLETED|Overall Study||8
2592317|NCT00298363|6362389|P1|NOT COMPLETED|Overall Study||17
2592318|NCT00298363|6362387|P3|COMPLETED|Overall Study|13 completed while taking DB ETV; 3 completed following switch from DB ETV to OL FTC/TDF.|16
2592319|NCT00298363|6362388|P2|COMPLETED|Overall Study|34 completed while taking DB FTC/TDF; 3 completed following switch from DB TDF to OL FTC/TDF.|37
2592320|NCT00298363|6362389|P1|COMPLETED|Overall Study|22 completed while taking DB TDF; 6 completed following switch from DB TDF to OL FTC/TDF.|28
2592321|NCT00298363|6362387|P3|STARTED|Overall Study||22
2592322|NCT00298363|6362388|P2|STARTED|Overall Study||45
2592323|NCT00298363|6362389|P1|STARTED|Overall Study||45
2592324|NCT00298272|6362547|P2|NOT COMPLETED|Safety Follow-up Phase||4
2592325|NCT00298272|6362548|P1|NOT COMPLETED|Safety Follow-up Phase||4
2592326|NCT00298272|6362547|P2|COMPLETED|Safety Follow-up Phase||13
2592327|NCT00298272|6362548|P1|COMPLETED|Safety Follow-up Phase||18
2592328|NCT00298272|6362547|P2|STARTED|Safety Follow-up Phase||17
2592329|NCT00298272|6362548|P1|STARTED|Safety Follow-up Phase||22
2592330|NCT00298272|6362547|P2|NOT COMPLETED|Open Label Retreatment Phase||4
2592331|NCT00298272|6362548|P1|NOT COMPLETED|Open Label Retreatment Phase||9
2592332|NCT00298272|6362547|P2|COMPLETED|Open Label Retreatment Phase||12
2592333|NCT00298272|6362548|P1|COMPLETED|Open Label Retreatment Phase||13
2592334|NCT00298272|6362547|P2|Completed to Week 56|Open Label Retreatment Phase||12
2592335|NCT00298272|6362548|P1|Completed to Week 56|Open Label Retreatment Phase||13
2592336|NCT00298272|6362547|P2|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|15
2592337|NCT00298272|6362548|P1|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|22
2592338|NCT00298272|6362547|P2|STARTED|Open Label Retreatment Phase||16
2592339|NCT00298272|6362548|P1|STARTED|Open Label Retreatment Phase||22
2592340|NCT00298272|6362547|P2|NOT COMPLETED|Double-blind Phase||0
2592341|NCT00298272|6362548|P1|NOT COMPLETED|Double-blind Phase||8
2592342|NCT00298272|6362547|P2|COMPLETED|Double-blind Phase||18
2592343|NCT00298272|6362548|P1|COMPLETED|Double-blind Phase||28
2592344|NCT00298272|6362547|P2|Completed to Week 56|Double-blind Phase||3
2592345|NCT00298272|6362548|P1|Completed to Week 56|Double-blind Phase||8
2592346|NCT00298272|6362547|P2|Completed to Week 24|Double-blind Phase|received full course of placebo therapy|18
2592347|NCT00298272|6362548|P1|Completed to Week 24|Double-blind Phase|received full course of rituximab therapy|31
2592348|NCT00298272|6362547|P2|Safety Population|Double-blind Phase||18
2592349|NCT00298272|6362548|P1|Safety Population|Double-blind Phase|received treatment|33
2592350|NCT00298272|6362547|P2|STARTED|Double-blind Phase||18
2592351|NCT00298272|6362548|P1|STARTED|Double-blind Phase|enrolled and randomized (2:1 scheme)|36
2592352|NCT00298233|6362571|P4|NOT COMPLETED|Overall Study||0
2592353|NCT00298233|6362572|P3|NOT COMPLETED|Overall Study||0
2592354|NCT00298233|6362573|P2|NOT COMPLETED|Overall Study||0
2592355|NCT00298233|6362574|P1|NOT COMPLETED|Overall Study||0
2592356|NCT00298233|6362571|P4|COMPLETED|Overall Study||124
2592357|NCT00298233|6362572|P3|COMPLETED|Overall Study||122
2592358|NCT00298233|6362573|P2|COMPLETED|Overall Study||41
2592359|NCT00298233|6362574|P1|COMPLETED|Overall Study||39
2592360|NCT00298233|6362571|P4|STARTED|Overall Study||124
2592361|NCT00298233|6362572|P3|STARTED|Overall Study||122
2592362|NCT00298233|6362573|P2|STARTED|Overall Study||41
2592363|NCT00298233|6362574|P1|STARTED|Overall Study||39
2592364|NCT00298155|6362593|P3|NOT COMPLETED|Overall Study||0
2592365|NCT00298155|6362594|P2|NOT COMPLETED|Overall Study||0
2592366|NCT00298155|6362595|P1|NOT COMPLETED|Overall Study||0
2592367|NCT00298155|6362593|P3|COMPLETED|Overall Study||13
2592368|NCT00298155|6362594|P2|COMPLETED|Overall Study||10
2592369|NCT00298155|6362595|P1|COMPLETED|Overall Study||12
2592370|NCT00298155|6362593|P3|STARTED|Overall Study||13
2592371|NCT00298155|6362594|P2|STARTED|Overall Study||10
2592372|NCT00298155|6362595|P1|STARTED|Overall Study||12
2592373|NCT00298090|6362606|P1|NOT COMPLETED|Overall Study||18
2592374|NCT00298090|6362606|P1|COMPLETED|Overall Study|Eighteen subjects were not included in final analysis due to incomplete data sets|29
2592375|NCT00298090|6362606|P1|STARTED|Overall Study||47
2592376|NCT00298038|6362612|P2|NOT COMPLETED|Overall Study||93
2592377|NCT00298038|6362613|P1|NOT COMPLETED|Overall Study||52
2592378|NCT00298038|6362612|P2|COMPLETED|Overall Study||66
2592379|NCT00298038|6362613|P1|COMPLETED|Overall Study||88
2592380|NCT00298038|6362612|P2|Received At Least 1 Dose Of Study Drug|Overall Study||159
2592381|NCT00298038|6362613|P1|Received At Least 1 Dose Of Study Drug|Overall Study||140
2592382|NCT00298038|6362612|P2|STARTED|Overall Study||159
2592383|NCT00298038|6362613|P1|STARTED|Overall Study||140
2592384|NCT00297830|6362632|P3|NOT COMPLETED|12 Month Visit||0
2592385|NCT00297830|6362633|P2|NOT COMPLETED|12 Month Visit||6
2592386|NCT00297830|6362634|P1|NOT COMPLETED|12 Month Visit||1
2592387|NCT00297830|6362632|P3|COMPLETED|12 Month Visit||24
2592388|NCT00297830|6362633|P2|COMPLETED|12 Month Visit||35
2592389|NCT00297830|6362634|P1|COMPLETED|12 Month Visit||37
2592390|NCT00297830|6362632|P3|STARTED|12 Month Visit||24
2592391|NCT00297830|6362633|P2|STARTED|12 Month Visit||41
2592392|NCT00297830|6362634|P1|STARTED|12 Month Visit||38
2592393|NCT00297830|6362632|P3|NOT COMPLETED|6 Month Visit||3
2592394|NCT00297830|6362633|P2|NOT COMPLETED|6 Month Visit||2
2592395|NCT00297830|6362634|P1|NOT COMPLETED|6 Month Visit||3
2592396|NCT00297830|6362632|P3|COMPLETED|6 Month Visit||24
2592397|NCT00297830|6362633|P2|COMPLETED|6 Month Visit||41
2592398|NCT00297830|6362634|P1|COMPLETED|6 Month Visit||38
2592399|NCT00297830|6362632|P3|STARTED|6 Month Visit||27
2592400|NCT00297830|6362633|P2|STARTED|6 Month Visit||43
2592401|NCT00297830|6362634|P1|STARTED|6 Month Visit||41
2592402|NCT00297830|6362632|P3|NOT COMPLETED|Baseline||0
2592403|NCT00297830|6362633|P2|NOT COMPLETED|Baseline||0
2592404|NCT00297830|6362634|P1|NOT COMPLETED|Baseline||0
2592405|NCT00297830|6362632|P3|COMPLETED|Baseline||27
2592406|NCT00297830|6362633|P2|COMPLETED|Baseline||43
2592407|NCT00297830|6362634|P1|COMPLETED|Baseline||41
2592408|NCT00297830|6362632|P3|STARTED|Baseline||27
2592409|NCT00297830|6362633|P2|STARTED|Baseline||43
2592410|NCT00297830|6362634|P1|STARTED|Baseline||41
2592411|NCT00297778|6362653|P2|NOT COMPLETED|Overall Study||20
2592412|NCT00297778|6362654|P1|NOT COMPLETED|Overall Study||19
2592413|NCT00297778|6362653|P2|COMPLETED|Overall Study||124
2592414|NCT00297778|6362654|P1|COMPLETED|Overall Study||133
2592415|NCT00297778|6362653|P2|STARTED|Overall Study||144
2592416|NCT00297778|6362654|P1|STARTED|Overall Study||152
2592417|NCT00297648|6362688|P1|NOT COMPLETED|Overall Study||36
2592418|NCT00297648|6362688|P1|COMPLETED|Overall Study||53
2592419|NCT00297648|6362688|P1|STARTED|Overall Study||89
2592420|NCT00297596|6362727|P1|NOT COMPLETED|Overall Study||0
2592421|NCT00297596|6362727|P1|COMPLETED|Overall Study||25
2592422|NCT00297596|6362727|P1|STARTED|Overall Study||25
2592423|NCT00297492|6362734|P3|NOT COMPLETED|6 Month Follow-up||27
2592424|NCT00297492|6362735|P2|NOT COMPLETED|6 Month Follow-up||49
2592425|NCT00297492|6362736|P1|NOT COMPLETED|6 Month Follow-up||63
2592426|NCT00297492|6362734|P3|COMPLETED|6 Month Follow-up||118
2592427|NCT00297492|6362735|P2|COMPLETED|6 Month Follow-up||237
2592428|NCT00297492|6362736|P1|COMPLETED|6 Month Follow-up||227
2592429|NCT00297492|6362734|P3|STARTED|6 Month Follow-up||145
2592430|NCT00297492|6362735|P2|STARTED|6 Month Follow-up||286
2592431|NCT00297492|6362736|P1|STARTED|6 Month Follow-up||290
2592432|NCT00297492|6362734|P3|NOT COMPLETED|Set Quit Date||5
2592433|NCT00297492|6362735|P2|NOT COMPLETED|Set Quit Date||13
2592434|NCT00297492|6362736|P1|NOT COMPLETED|Set Quit Date||7
2592435|NCT00297492|6362734|P3|COMPLETED|Set Quit Date||145
2592436|NCT00297492|6362735|P2|COMPLETED|Set Quit Date||286
2592437|NCT00297492|6362736|P1|COMPLETED|Set Quit Date||290
2592438|NCT00297492|6362734|P3|STARTED|Set Quit Date||150
2592439|NCT00297492|6362735|P2|STARTED|Set Quit Date||299
2592440|NCT00297492|6362736|P1|STARTED|Set Quit Date||297
2592441|NCT00297427|6362746|P2|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||0
2592442|NCT00297427|6362747|P1|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||34
2592443|NCT00297427|6362746|P2|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
2592444|NCT00297427|6362747|P1|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Subjects who completed=/>1 follow-up visits and were evaluated for booster acupuncture|60
2592445|NCT00297427|6362746|P2|STARTED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
2592446|NCT00297427|6362747|P1|STARTED|Phase 3: Follow-up Post-True Acupuncture||94
2592447|NCT00297427|6362746|P2|NOT COMPLETED|Phase 2: Optional Crossover for Sham||0
2592448|NCT00297427|6362747|P1|NOT COMPLETED|Phase 2: Optional Crossover for Sham||16
2592449|NCT00297427|6362746|P2|COMPLETED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
2592450|NCT00297427|6362747|P1|COMPLETED|Phase 2: Optional Crossover for Sham||38
2592451|NCT00297427|6362746|P2|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
2592452|NCT00297427|6362747|P1|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|54 subjects completed the sham acupuncture & were offered the opportunity to cross-over; 12 declined|42
2592453|NCT00297427|6362746|P2|STARTED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
2592454|NCT00297427|6362747|P1|STARTED|Phase 2: Optional Crossover for Sham||54
2592455|NCT00297427|6362746|P2|NOT COMPLETED|Phase 1: Initial Intervention||9
2592456|NCT00297427|6362747|P1|NOT COMPLETED|Phase 1: Initial Intervention||8
2592457|NCT00297427|6362746|P2|COMPLETED|Phase 1: Initial Intervention||54
2592458|NCT00297427|6362747|P1|COMPLETED|Phase 1: Initial Intervention||56
2592459|NCT00297427|6362746|P2|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|63
2592460|NCT00297427|6362747|P1|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|64
2592461|NCT00297258|6362788|P1|NOT COMPLETED|Overall Study||142
2592462|NCT00297258|6362788|P1|COMPLETED|Overall Study||0
2592463|NCT00297258|6362788|P1|STARTED|Overall Study||142
2592464|NCT00297232|6362807|P1|NOT COMPLETED|Overall Study||605
2592465|NCT00297232|6362807|P1|COMPLETED|Overall Study||489
2592466|NCT00297232|6362807|P1|STARTED|Overall Study||1094
2592467|NCT00297167|6362813|P3|NOT COMPLETED|Open-label Dose Normalization Period 2||0
2592468|NCT00297167|6362814|P2|NOT COMPLETED|Open-label Dose Normalization Period 2||0
2592469|NCT00297167|6362815|P1|NOT COMPLETED|Open-label Dose Normalization Period 2||0
2592470|NCT00297167|6362813|P3|COMPLETED|Open-label Dose Normalization Period 2||31
2592471|NCT00297167|6362814|P2|COMPLETED|Open-label Dose Normalization Period 2||0
2592472|NCT00297167|6362815|P1|COMPLETED|Open-label Dose Normalization Period 2||0
2592473|NCT00297167|6362813|P3|STARTED|Open-label Dose Normalization Period 2||31
2592474|NCT00297167|6362814|P2|STARTED|Open-label Dose Normalization Period 2||0
2592475|NCT00297167|6362815|P1|STARTED|Open-label Dose Normalization Period 2||0
2592476|NCT00297167|6362813|P3|NOT COMPLETED|Second Double-blind Intervention Period||0
2592477|NCT00297167|6362814|P2|NOT COMPLETED|Second Double-blind Intervention Period||0
2592478|NCT00297167|6362815|P1|NOT COMPLETED|Second Double-blind Intervention Period||1
2592479|NCT00297167|6362813|P3|COMPLETED|Second Double-blind Intervention Period||0
2592480|NCT00297167|6362814|P2|COMPLETED|Second Double-blind Intervention Period||15
2592481|NCT00297167|6362815|P1|COMPLETED|Second Double-blind Intervention Period||16
2592482|NCT00297167|6362813|P3|STARTED|Second Double-blind Intervention Period||0
2592483|NCT00297167|6362814|P2|STARTED|Second Double-blind Intervention Period||15
2592484|NCT00297167|6362815|P1|STARTED|Second Double-blind Intervention Period||17
2592485|NCT00297167|6362813|P3|NOT COMPLETED|Open-label Dose Normalization Period 1||1
2592486|NCT00297167|6362814|P2|NOT COMPLETED|Open-label Dose Normalization Period 1||0
2592487|NCT00297167|6362815|P1|NOT COMPLETED|Open-label Dose Normalization Period 1||0
2592488|NCT00297167|6362813|P3|COMPLETED|Open-label Dose Normalization Period 1||32
2592489|NCT00297167|6362814|P2|COMPLETED|Open-label Dose Normalization Period 1||0
2592490|NCT00297167|6362815|P1|COMPLETED|Open-label Dose Normalization Period 1||0
2592491|NCT00297167|6362813|P3|STARTED|Open-label Dose Normalization Period 1||33
2592492|NCT00297167|6362814|P2|STARTED|Open-label Dose Normalization Period 1||0
2592493|NCT00297167|6362815|P1|STARTED|Open-label Dose Normalization Period 1||0
2592494|NCT00297167|6362813|P3|NOT COMPLETED|First Double-blind Intervention Period||0
2592495|NCT00297167|6362814|P2|NOT COMPLETED|First Double-blind Intervention Period||0
2592496|NCT00297167|6362815|P1|NOT COMPLETED|First Double-blind Intervention Period||0
2592497|NCT00297167|6362813|P3|COMPLETED|First Double-blind Intervention Period||0
2592498|NCT00297167|6362814|P2|COMPLETED|First Double-blind Intervention Period||16
2592499|NCT00297167|6362815|P1|COMPLETED|First Double-blind Intervention Period||17
2592500|NCT00297167|6362813|P3|STARTED|First Double-blind Intervention Period||0
2592501|NCT00297167|6362814|P2|STARTED|First Double-blind Intervention Period||16
2592502|NCT00297167|6362815|P1|STARTED|First Double-blind Intervention Period||17
2592503|NCT00297115|6362841|P2|NOT COMPLETED|Overall Study||246
2592504|NCT00297115|6362842|P1|NOT COMPLETED|Overall Study||245
2592505|NCT00297115|6362841|P2|COMPLETED|Overall Study||550
2592506|NCT00297115|6362842|P1|COMPLETED|Overall Study||527
2592507|NCT00297115|6362841|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|796
2592508|NCT00297115|6362842|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|772
2592509|NCT00297102|6362860|P2|NOT COMPLETED|Overall Study||233
2592510|NCT00297102|6362861|P1|NOT COMPLETED|Overall Study||263
2592511|NCT00297102|6362860|P2|COMPLETED|Overall Study||525
2592512|NCT00297102|6362861|P1|COMPLETED|Overall Study||502
2592513|NCT00297102|6362860|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|758
2592514|NCT00297102|6362861|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|765
2592515|NCT00297037|6362879|P2|NOT COMPLETED|Overall Study||0
2592516|NCT00297037|6362880|P1|NOT COMPLETED|Overall Study||2
2592517|NCT00297037|6362879|P2|COMPLETED|Overall Study||11
2592518|NCT00297037|6362880|P1|COMPLETED|Overall Study||8
2592519|NCT00297037|6362879|P2|STARTED|Overall Study||11
2592520|NCT00297037|6362880|P1|STARTED|Overall Study||10
2592521|NCT00296816|6362892|P1|NOT COMPLETED|Overall Study||74
2592522|NCT00296816|6362892|P1|COMPLETED|Overall Study|Completed study treatment for a minimum of three years|58
2592523|NCT00296816|6362892|P1|STARTED|Overall Study||132
2592524|NCT00296725|6362904|P1|NOT COMPLETED|Phase 2: Imipramine (1-6 Weeks)||1
2592525|NCT00296725|6362904|P1|COMPLETED|Phase 2: Imipramine (1-6 Weeks)||7
2592526|NCT00296725|6362904|P1|STARTED|Phase 2: Imipramine (1-6 Weeks)||8
2592527|NCT00296725|6362904|P1|NOT COMPLETED|Phase 1: Fluoxetine (1-12 Weeks)||5
2592528|NCT00296725|6362904|P1|COMPLETED|Phase 1: Fluoxetine (1-12 Weeks)||12
2592529|NCT00296725|6362904|P1|STARTED|Phase 1: Fluoxetine (1-12 Weeks)||17
2592530|NCT00296647|6362917|P5|NOT COMPLETED|Overall Study||20
2592531|NCT00296647|6362918|P4|NOT COMPLETED|Overall Study||17
2592532|NCT00296647|6362919|P3|NOT COMPLETED|Overall Study||34
2592533|NCT00296647|6362920|P2|NOT COMPLETED|Overall Study||28
2592534|NCT00296647|6362921|P1|NOT COMPLETED|Overall Study||32
2592535|NCT00296647|6362917|P5|COMPLETED|Overall Study||248
2592536|NCT00296647|6362918|P4|COMPLETED|Overall Study||262
2592537|NCT00296647|6362919|P3|COMPLETED|Overall Study||222
2592538|NCT00296647|6362920|P2|COMPLETED|Overall Study||233
2592539|NCT00296647|6362921|P1|COMPLETED|Overall Study||250
2592540|NCT00296647|6362917|P5|STARTED|Overall Study||268
2592541|NCT00296647|6362918|P4|STARTED|Overall Study||279
2592542|NCT00296647|6362919|P3|STARTED|Overall Study||256
2592543|NCT00296647|6362920|P2|STARTED|Overall Study||261
2592544|NCT00296647|6362921|P1|STARTED|Overall Study||282
2592545|NCT00296517|6362935|P2|NOT COMPLETED|Dose Level 3 - Weeks 3-12||62
2592546|NCT00296517|6362936|P1|NOT COMPLETED|Dose Level 3 - Weeks 3-12||45
2592547|NCT00296517|6362935|P2|COMPLETED|Dose Level 3 - Weeks 3-12||99
2592548|NCT00296517|6362936|P1|COMPLETED|Dose Level 3 - Weeks 3-12||112
2592549|NCT00296517|6362935|P2|STARTED|Dose Level 3 - Weeks 3-12||161
2592550|NCT00296517|6362936|P1|STARTED|Dose Level 3 - Weeks 3-12||157
2592551|NCT00296517|6362935|P2|NOT COMPLETED|Dose Level 2 - Week 2||5
2592552|NCT00296517|6362936|P1|NOT COMPLETED|Dose Level 2 - Week 2||2
2592553|NCT00296517|6362935|P2|COMPLETED|Dose Level 2 - Week 2||161
2592554|NCT00296517|6362936|P1|COMPLETED|Dose Level 2 - Week 2||157
2592555|NCT00296517|6362935|P2|STARTED|Dose Level 2 - Week 2||166
2592556|NCT00296517|6362936|P1|STARTED|Dose Level 2 - Week 2||159
2592557|NCT00296517|6362935|P2|NOT COMPLETED|Dose Level 1 - Week 1||0
2592558|NCT00296517|6362936|P1|NOT COMPLETED|Dose Level 1 - Week 1||0
2592559|NCT00296517|6362935|P2|COMPLETED|Dose Level 1 - Week 1||166
2592560|NCT00296517|6362936|P1|COMPLETED|Dose Level 1 - Week 1||159
2592561|NCT00296517|6362935|P2|STARTED|Dose Level 1 - Week 1||166
2592562|NCT00296517|6362936|P1|STARTED|Dose Level 1 - Week 1||159
2592563|NCT00296504|6362972|P9|NOT COMPLETED|Final Analysis||21
2592564|NCT00296504|6362973|P8|NOT COMPLETED|Final Analysis||0
2592565|NCT00296504|6362974|P7|NOT COMPLETED|Final Analysis||0
2592566|NCT00296504|6362975|P6|NOT COMPLETED|Final Analysis||0
2592567|NCT00296504|6362976|P5|NOT COMPLETED|Final Analysis||0
2592568|NCT00296504|6362977|P4|NOT COMPLETED|Final Analysis||0
2592569|NCT00296504|6362978|P3|NOT COMPLETED|Final Analysis||0
2592570|NCT00296504|6362979|P2|NOT COMPLETED|Final Analysis||0
2592571|NCT00296504|6362980|P1|NOT COMPLETED|Final Analysis||0
2592572|NCT00296504|6362972|P9|COMPLETED|Final Analysis||90
2592573|NCT00296504|6362973|P8|COMPLETED|Final Analysis||0
2592574|NCT00296504|6362974|P7|COMPLETED|Final Analysis||0
2592575|NCT00296504|6362975|P6|COMPLETED|Final Analysis||0
2592576|NCT00296504|6362976|P5|COMPLETED|Final Analysis||0
2592577|NCT00296504|6362977|P4|COMPLETED|Final Analysis||0
2592578|NCT00296504|6362978|P3|COMPLETED|Final Analysis||0
2592579|NCT00296504|6362979|P2|COMPLETED|Final Analysis||0
2592580|NCT00296504|6362980|P1|COMPLETED|Final Analysis||0
2592581|NCT00296504|6362972|P9|STARTED|Final Analysis|Continued in study; commercial supplies of FPV were unavailable locally at end of Interim Analysis.|111
2592582|NCT00296504|6362973|P8|STARTED|Final Analysis||0
2592583|NCT00296504|6362974|P7|STARTED|Final Analysis||0
2592584|NCT00296504|6362975|P6|STARTED|Final Analysis||0
2592585|NCT00296504|6362976|P5|STARTED|Final Analysis||0
2592586|NCT00296504|6362977|P4|STARTED|Final Analysis||0
2592587|NCT00296504|6362978|P3|STARTED|Final Analysis||0
2592588|NCT00296504|6362979|P2|STARTED|Final Analysis||0
2592589|NCT00296504|6362980|P1|STARTED|Final Analysis||0
2592590|NCT00296504|6362972|P9|NOT COMPLETED|Interim Analysis||0
2592591|NCT00296504|6362973|P8|NOT COMPLETED|Interim Analysis||49
2592592|NCT00296504|6362974|P7|NOT COMPLETED|Interim Analysis||74
2592593|NCT00296504|6362975|P6|NOT COMPLETED|Interim Analysis||37
2592594|NCT00296504|6362976|P5|NOT COMPLETED|Interim Analysis||37
2592595|NCT00296504|6362977|P4|NOT COMPLETED|Interim Analysis||43
2592596|NCT00296504|6362978|P3|NOT COMPLETED|Interim Analysis||105
2592597|NCT00296504|6362979|P2|NOT COMPLETED|Interim Analysis||18
2592598|NCT00296504|6362980|P1|NOT COMPLETED|Interim Analysis||76
2592599|NCT00296504|6362972|P9|COMPLETED|Interim Analysis||0
2592600|NCT00296504|6362973|P8|COMPLETED|Interim Analysis||37
2592601|NCT00296504|6362974|P7|COMPLETED|Interim Analysis||30
2592602|NCT00296504|6362975|P6|COMPLETED|Interim Analysis||41
2592603|NCT00296504|6362976|P5|COMPLETED|Interim Analysis||36
2592604|NCT00296504|6362977|P4|COMPLETED|Interim Analysis||11
2592605|NCT00296504|6362978|P3|COMPLETED|Interim Analysis||116
2592606|NCT00296504|6362979|P2|COMPLETED|Interim Analysis||0
2592607|NCT00296504|6362980|P1|COMPLETED|Interim Analysis||43
2592608|NCT00296504|6362972|P9|Ongoing|Interim Analysis||0
2592609|NCT00296504|6362973|P8|Ongoing|Interim Analysis||1
2592610|NCT00296504|6362974|P7|Ongoing|Interim Analysis||30
2592611|NCT00296504|6362975|P6|Ongoing|Interim Analysis||0
2592612|NCT00296504|6362976|P5|Ongoing|Interim Analysis||0
2592613|NCT00296504|6362977|P4|Ongoing|Interim Analysis||22
2592614|NCT00296504|6362978|P3|Ongoing|Interim Analysis||16
2592615|NCT00296504|6362979|P2|Ongoing|Interim Analysis||12
2592616|NCT00296504|6362980|P1|Ongoing|Interim Analysis||32
2592617|NCT00296504|6362972|P9|STARTED|Interim Analysis||0
2592618|NCT00296504|6362973|P8|STARTED|Interim Analysis||86
2592619|NCT00296504|6362974|P7|STARTED|Interim Analysis||104
2592620|NCT00296504|6362975|P6|STARTED|Interim Analysis||78
2592621|NCT00296504|6362976|P5|STARTED|Interim Analysis||73
2592622|NCT00296504|6362977|P4|STARTED|Interim Analysis||54
2592623|NCT00296504|6362978|P3|STARTED|Interim Analysis||221
2592624|NCT00296504|6362979|P2|STARTED|Interim Analysis||18
2592625|NCT00296504|6362980|P1|STARTED|Interim Analysis||119
2592626|NCT00296491|6363073|P4|NOT COMPLETED|Overall Study||43
2592627|NCT00296491|6363074|P3|NOT COMPLETED|Overall Study||43
2592628|NCT00296491|6363075|P2|NOT COMPLETED|Overall Study||53
2592629|NCT00296491|6363076|P1|NOT COMPLETED|Overall Study||42
2592630|NCT00296491|6363073|P4|COMPLETED|Overall Study||138
2592631|NCT00296491|6363074|P3|COMPLETED|Overall Study||137
2592632|NCT00296491|6363075|P2|COMPLETED|Overall Study||129
2592633|NCT00296491|6363076|P1|COMPLETED|Overall Study||140
2592634|NCT00296491|6363073|P4|STARTED|Overall Study||181
2592635|NCT00296491|6363074|P3|STARTED|Overall Study||180
2592636|NCT00296491|6363075|P2|STARTED|Overall Study||182
2592637|NCT00296491|6363076|P1|STARTED|Overall Study|Please note: Outcome Measures generally conducts analysis of 2 of the 4 Arms at a time.|182
2592638|NCT00296400|6363105|P3|NOT COMPLETED|Overall Study||13
2592639|NCT00296400|6363106|P2|NOT COMPLETED|Overall Study||18
2592640|NCT00296400|6363107|P1|NOT COMPLETED|Overall Study||17
2592641|NCT00296400|6363105|P3|COMPLETED|Overall Study||67
2592642|NCT00296400|6363106|P2|COMPLETED|Overall Study||69
2592643|NCT00296400|6363107|P1|COMPLETED|Overall Study||53
2592644|NCT00296400|6363105|P3|STARTED|Overall Study||80
2592645|NCT00296400|6363106|P2|STARTED|Overall Study||87
2592646|NCT00296400|6363107|P1|STARTED|Overall Study||70
2592647|NCT00296374|6363331|P3|NOT COMPLETED|Overall Study||29
2592648|NCT00296374|6363332|P2|NOT COMPLETED|Overall Study||23
2592649|NCT00296374|6363333|P1|NOT COMPLETED|Overall Study||25
2592650|NCT00296374|6363331|P3|COMPLETED|Overall Study||82
2592651|NCT00296374|6363332|P2|COMPLETED|Overall Study||101
2592652|NCT00296374|6363333|P1|COMPLETED|Overall Study||93
2592653|NCT00296374|6363331|P3|STARTED|Overall Study||111
2592654|NCT00296374|6363332|P2|STARTED|Overall Study||124
2592655|NCT00296374|6363333|P1|STARTED|Overall Study||118
2592656|NCT00296335|6363556|P2|NOT COMPLETED|Overall Study||122
2592657|NCT00296335|6363557|P1|NOT COMPLETED|Overall Study||30
2592658|NCT00296335|6363556|P2|COMPLETED|Overall Study||309
2592659|NCT00296335|6363557|P1|COMPLETED|Overall Study||394
2592660|NCT00296335|6363556|P2|STARTED|Overall Study||431
2592661|NCT00296335|6363557|P1|STARTED|Overall Study||424
2592662|NCT00296322|6363569|P2|NOT COMPLETED|Overall Study||79
2592663|NCT00296322|6363570|P1|NOT COMPLETED|Overall Study||21
2592664|NCT00296322|6363569|P2|COMPLETED|Overall Study||184
2592665|NCT00296322|6363570|P1|COMPLETED|Overall Study||237
2592666|NCT00296322|6363569|P2|STARTED|Overall Study||263
2592667|NCT00296322|6363570|P1|STARTED|Overall Study||258
2592668|NCT00296296|6363582|P2|NOT COMPLETED|Overall Study||13
2592669|NCT00296296|6363583|P1|NOT COMPLETED|Overall Study||2
2592670|NCT00296296|6363582|P2|COMPLETED|Overall Study||5
2592671|NCT00296296|6363583|P1|COMPLETED|Overall Study||9
2592672|NCT00296296|6363582|P2|STARTED|Overall Study||18
2592673|NCT00296296|6363583|P1|STARTED|Overall Study||11
2592674|NCT00296244|6363597|P2|NOT COMPLETED|Overall Study||1
2592675|NCT00296244|6363598|P1|NOT COMPLETED|Overall Study||0
2592676|NCT00296244|6363597|P2|COMPLETED|Overall Study||19
2592677|NCT00296244|6363598|P1|COMPLETED|Overall Study||20
2592678|NCT00296244|6363597|P2|STARTED|Overall Study||20
2592679|NCT00296244|6363598|P1|STARTED|Overall Study||20
2592680|NCT00296231|6363614|P1|NOT COMPLETED|Overall Study||0
2592681|NCT00296231|6363614|P1|COMPLETED|Overall Study||14
2592682|NCT00296231|6363614|P1|STARTED|Overall Study||14
2592683|NCT00296192|6363624|P5|NOT COMPLETED|Overall Study||0
2592684|NCT00296192|6363625|P4|NOT COMPLETED|Overall Study||0
2592685|NCT00296192|6363626|P3|NOT COMPLETED|Overall Study||0
2592686|NCT00296192|6363627|P2|NOT COMPLETED|Overall Study||0
2592687|NCT00296192|6363628|P1|NOT COMPLETED|Overall Study||0
2592688|NCT00296192|6363624|P5|COMPLETED|Overall Study||16
2592689|NCT00296192|6363625|P4|COMPLETED|Overall Study||17
2592690|NCT00296192|6363626|P3|COMPLETED|Overall Study||16
2592691|NCT00296192|6363627|P2|COMPLETED|Overall Study||16
2592692|NCT00296192|6363628|P1|COMPLETED|Overall Study||17
2592693|NCT00296192|6363624|P5|STARTED|Overall Study||16
2592694|NCT00296192|6363625|P4|STARTED|Overall Study||17
2592695|NCT00296192|6363626|P3|STARTED|Overall Study||16
2592696|NCT00296192|6363627|P2|STARTED|Overall Study||16
2592697|NCT00296192|6363628|P1|STARTED|Overall Study||17
2592698|NCT00296140|6363662|P2|NOT COMPLETED|Overall Study||0
2592699|NCT00296140|6363663|P1|NOT COMPLETED|Overall Study||3
2592700|NCT00296140|6363662|P2|COMPLETED|Overall Study||33
2592701|NCT00296140|6363663|P1|COMPLETED|Overall Study||30
2592702|NCT00296140|6363662|P2|STARTED|Overall Study||33
2592703|NCT00296140|6363663|P1|STARTED|Overall Study||33
2592704|NCT00296036|6363675|P6|NOT COMPLETED|Overall Study||4
2592705|NCT00296036|6363676|P5|NOT COMPLETED|Overall Study||2
2592706|NCT00296036|6363677|P4|NOT COMPLETED|Overall Study||1
2592707|NCT00296036|6363678|P3|NOT COMPLETED|Overall Study||2
2592708|NCT00296036|6363679|P2|NOT COMPLETED|Overall Study||0
2592709|NCT00296036|6363680|P1|NOT COMPLETED|Overall Study||1
2592710|NCT00296036|6363675|P6|COMPLETED|Overall Study||28
2592711|NCT00296036|6363676|P5|COMPLETED|Overall Study||31
2592712|NCT00296036|6363677|P4|COMPLETED|Overall Study||16
2592713|NCT00296036|6363678|P3|COMPLETED|Overall Study||16
2592714|NCT00296036|6363679|P2|COMPLETED|Overall Study||18
2592715|NCT00296036|6363680|P1|COMPLETED|Overall Study||18
2592716|NCT00296036|6363675|P6|STARTED|Overall Study||32
2592717|NCT00296036|6363676|P5|STARTED|Overall Study||33
2592718|NCT00296036|6363677|P4|STARTED|Overall Study||17
2592719|NCT00296036|6363678|P3|STARTED|Overall Study||18
2592720|NCT00296036|6363679|P2|STARTED|Overall Study||18
2592721|NCT00296036|6363680|P1|STARTED|Overall Study||19
2592722|NCT00295932|6363717|P11|NOT COMPLETED|Overall Study||1
2592723|NCT00295932|6363718|P10|NOT COMPLETED|Overall Study||0
2592724|NCT00295932|6363719|P9|NOT COMPLETED|Overall Study||0
2592725|NCT00295932|6363720|P8|NOT COMPLETED|Overall Study||0
2592726|NCT00295932|6363721|P7|NOT COMPLETED|Overall Study||0
2592727|NCT00295932|6363722|P6|NOT COMPLETED|Overall Study||0
2592728|NCT00295932|6363723|P5|NOT COMPLETED|Overall Study||0
2592729|NCT00295932|6363724|P4|NOT COMPLETED|Overall Study||0
2592730|NCT00295932|6363725|P3|NOT COMPLETED|Overall Study||0
2592731|NCT00295932|6363726|P2|NOT COMPLETED|Overall Study||0
2592732|NCT00295932|6363727|P1|NOT COMPLETED|Overall Study||0
2592733|NCT00295932|6363717|P11|COMPLETED|Overall Study||12
2592734|NCT00295932|6363718|P10|COMPLETED|Overall Study||12
2592735|NCT00295932|6363719|P9|COMPLETED|Overall Study||10
2592736|NCT00295932|6363720|P8|COMPLETED|Overall Study||4
2592737|NCT00295932|6363721|P7|COMPLETED|Overall Study||3
2592738|NCT00295932|6363722|P6|COMPLETED|Overall Study||18
2592739|NCT00295932|6363723|P5|COMPLETED|Overall Study||2
2592740|NCT00295932|6363724|P4|COMPLETED|Overall Study||4
2592741|NCT00295932|6363725|P3|COMPLETED|Overall Study||3
2592742|NCT00295932|6363726|P2|COMPLETED|Overall Study||6
2592743|NCT00295932|6363727|P1|COMPLETED|Overall Study||4
2592744|NCT00295932|6363717|P11|STARTED|Overall Study||13
2592745|NCT00295932|6363718|P10|STARTED|Overall Study||12
2592746|NCT00295932|6363719|P9|STARTED|Overall Study||10
2592747|NCT00295932|6363720|P8|STARTED|Overall Study||4
2592748|NCT00295932|6363721|P7|STARTED|Overall Study||3
2592749|NCT00295932|6363722|P6|STARTED|Overall Study||18
2592750|NCT00295932|6363723|P5|STARTED|Overall Study||2
2592751|NCT00295932|6363724|P4|STARTED|Overall Study||4
2592752|NCT00295932|6363725|P3|STARTED|Overall Study||3
2592753|NCT00295932|6363726|P2|STARTED|Overall Study||6
2592754|NCT00295932|6363727|P1|STARTED|Overall Study||4
2592755|NCT00295880|6363761|P1|NOT COMPLETED|Overall Study||2
2592756|NCT00295880|6363761|P1|COMPLETED|Overall Study||10
2592757|NCT00295880|6363761|P1|STARTED|Overall Study||12
2592758|NCT00295854|6363775|P3|NOT COMPLETED|Overall Study||15
2592759|NCT00295854|6363776|P2|NOT COMPLETED|Overall Study||21
2592760|NCT00295854|6363777|P1|NOT COMPLETED|Overall Study||18
2592761|NCT00295854|6363775|P3|COMPLETED|Overall Study||87
2592762|NCT00295854|6363776|P2|COMPLETED|Overall Study||87
2592763|NCT00295854|6363777|P1|COMPLETED|Overall Study||77
2592764|NCT00295854|6363775|P3|ITT Population (N=296)|Overall Study||99
2592765|NCT00295854|6363776|P2|ITT Population (N=296)|Overall Study||105
2592766|NCT00295854|6363777|P1|ITT Population (N=296)|Overall Study||92
2592767|NCT00295854|6363775|P3|Safety Population (N=304)|Overall Study||101
2592768|NCT00295854|6363776|P2|Safety Population (N=304)|Overall Study||108
2592769|NCT00295854|6363777|P1|Safety Population (N=304)|Overall Study||95
2592770|NCT00295854|6363775|P3|STARTED|Overall Study||102
2592771|NCT00295854|6363776|P2|STARTED|Overall Study||108
2592772|NCT00295854|6363777|P1|STARTED|Overall Study||95
2592773|NCT00295750|6363791|P3|NOT COMPLETED|Overall Study||32
2592774|NCT00295750|6363792|P2|NOT COMPLETED|Overall Study||41
2592775|NCT00295750|6363793|P1|NOT COMPLETED|Overall Study||43
2592776|NCT00295750|6363791|P3|COMPLETED|Overall Study||172
2592777|NCT00295750|6363792|P2|COMPLETED|Overall Study||169
2592778|NCT00295750|6363793|P1|COMPLETED|Overall Study||163
2592779|NCT00295750|6363791|P3|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|201
2592780|NCT00295750|6363792|P2|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|207
2592781|NCT00295750|6363793|P1|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|202
2592782|NCT00295750|6363791|P3|STARTED|Overall Study|randomized|204
2592783|NCT00295750|6363792|P2|STARTED|Overall Study|randomized|210
2592784|NCT00295750|6363793|P1|STARTED|Overall Study|randomized|206
2592785|NCT00295633|6363828|P3|NOT COMPLETED|Overall Study||76
2592786|NCT00295633|6363829|P2|NOT COMPLETED|Overall Study||67
2592787|NCT00295633|6363830|P1|NOT COMPLETED|Overall Study||62
2592788|NCT00295633|6363828|P3|COMPLETED|Overall Study||108
2592789|NCT00295633|6363829|P2|COMPLETED|Overall Study||119
2592790|NCT00295633|6363830|P1|COMPLETED|Overall Study||133
2592791|NCT00295633|6363828|P3|Completed Study Without Being Rescued|Overall Study||51
2592792|NCT00295633|6363829|P2|Completed Study Without Being Rescued|Overall Study||82
2592793|NCT00295633|6363830|P1|Completed Study Without Being Rescued|Overall Study||88
2592794|NCT00295633|6363828|P3|STARTED|Overall Study||184
2592795|NCT00295633|6363829|P2|STARTED|Overall Study||186
2592796|NCT00295633|6363830|P1|STARTED|Overall Study||195
2592797|NCT00295620|6363849|P2|NOT COMPLETED|Overall Study||896
2592798|NCT00295620|6363850|P1|NOT COMPLETED|Overall Study||872
2592799|NCT00295620|6363849|P2|COMPLETED|Overall Study||842
2592800|NCT00295620|6363850|P1|COMPLETED|Overall Study||860
2592801|NCT00295620|6363849|P2|Safety Analysis Set|Overall Study||1710
2592802|NCT00295620|6363850|P1|Safety Analysis Set|Overall Study||1705
2592803|NCT00295620|6363849|P2|STARTED|Overall Study||1738
2592804|NCT00295620|6363850|P1|STARTED|Overall Study||1732
2592805|NCT00295503|6363864|P1|NOT COMPLETED|Overall Study||0
2592806|NCT00295503|6363864|P1|COMPLETED|Overall Study||53
2592807|NCT00295503|6363864|P1|STARTED|Overall Study||53
2592808|NCT00295490|6363874|P4|NOT COMPLETED|Overall Study||5
2592809|NCT00295490|6363875|P3|NOT COMPLETED|Overall Study||4
2592810|NCT00295490|6363876|P2|NOT COMPLETED|Overall Study||4
2592811|NCT00295490|6363877|P1|NOT COMPLETED|Overall Study||1
2592812|NCT00295490|6363874|P4|COMPLETED|Overall Study||12
2592813|NCT00295490|6363875|P3|COMPLETED|Overall Study||12
2592814|NCT00295490|6363876|P2|COMPLETED|Overall Study||15
2592815|NCT00295490|6363877|P1|COMPLETED|Overall Study||14
2592816|NCT00295490|6363874|P4|STARTED|Overall Study||17
2592817|NCT00295490|6363875|P3|STARTED|Overall Study||16
2592818|NCT00295490|6363876|P2|STARTED|Overall Study||19
2592819|NCT00295490|6363877|P1|STARTED|Overall Study||15
2592820|NCT00295061|6363917|P2|NOT COMPLETED|Overall Study||0
2592821|NCT00295061|6363918|P1|NOT COMPLETED|Overall Study||0
2592822|NCT00295061|6363917|P2|COMPLETED|Overall Study||12
2592823|NCT00295061|6363918|P1|COMPLETED|Overall Study||12
2592824|NCT00295061|6363917|P2|STARTED|Overall Study||12
2592825|NCT00295061|6363918|P1|STARTED|Overall Study||12
2592826|NCT00295022|6363927|P3|NOT COMPLETED|Overall Study||5
2592827|NCT00295022|6363928|P2|NOT COMPLETED|Overall Study||1
2592828|NCT00295022|6363929|P1|NOT COMPLETED|Overall Study||1
2592829|NCT00295022|6363927|P3|COMPLETED|Overall Study||151
2592830|NCT00295022|6363928|P2|COMPLETED|Overall Study||156
2592831|NCT00295022|6363929|P1|COMPLETED|Overall Study||104
2592832|NCT00295022|6363927|P3|STARTED|Overall Study||156
2592833|NCT00295022|6363928|P2|STARTED|Overall Study||157
2592834|NCT00295022|6363929|P1|STARTED|Overall Study||105
2592835|NCT00295009|6364018|P6|NOT COMPLETED|Overall Study||269
2592836|NCT00295009|6364019|P5|NOT COMPLETED|Overall Study||58
2592837|NCT00295009|6364020|P4|NOT COMPLETED|Overall Study||25
2592838|NCT00295009|6364021|P3|NOT COMPLETED|Overall Study||12
2592839|NCT00295009|6364022|P2|NOT COMPLETED|Overall Study||49
2592840|NCT00295009|6364023|P1|NOT COMPLETED|Overall Study||41
2592841|NCT00295009|6364018|P6|COMPLETED|Overall Study|Continued Access patients were only followed out to 24 months|0
2592842|NCT00295009|6364019|P5|COMPLETED|Overall Study|Completed 60 month visit|116
2592843|NCT00295009|6364020|P4|COMPLETED|Overall Study|Completed 60 month visit|57
2592844|NCT00295009|6364021|P3|COMPLETED|Overall Study|Completed 60 month visit|39
2592845|NCT00295009|6364022|P2|COMPLETED|Overall Study|Completed 60 month visit|134
2592846|NCT00295009|6364023|P1|COMPLETED|Overall Study|Completed 60 month visit|52
2592847|NCT00295009|6364018|P6|Completed 24 Month Analysis|Overall Study||198
2592848|NCT00295009|6364019|P5|Completed 24 Month Analysis|Overall Study||133
2592849|NCT00295009|6364020|P4|Completed 24 Month Analysis|Overall Study||60
2592850|NCT00295009|6364021|P3|Completed 24 Month Analysis|Overall Study||45
2592851|NCT00295009|6364022|P2|Completed 24 Month Analysis|Overall Study||148
2592852|NCT00295009|6364023|P1|Completed 24 Month Analysis|Overall Study||71
2592853|NCT00295009|6364018|P6|Treated|Overall Study||259
2592854|NCT00295009|6364019|P5|Treated|Overall Study||165
2592855|NCT00295009|6364020|P4|Treated|Overall Study||72
2592856|NCT00295009|6364021|P3|Treated|Overall Study||50
2592857|NCT00295009|6364022|P2|Treated|Overall Study||162
2592858|NCT00295009|6364023|P1|Treated|Overall Study||80
2592859|NCT00295009|6364018|P6|STARTED|Overall Study||269
2592860|NCT00295009|6364019|P5|STARTED|Overall Study||174
2592861|NCT00295009|6364020|P4|STARTED|Overall Study||82
2592862|NCT00295009|6364021|P3|STARTED|Overall Study||51
2592863|NCT00295009|6364022|P2|STARTED|Overall Study||183
2592864|NCT00295009|6364023|P1|STARTED|Overall Study||93
2592865|NCT00294762|6364045|P2|NOT COMPLETED|Overall Study||3
2592866|NCT00294762|6364046|P1|NOT COMPLETED|Overall Study||3
2592867|NCT00294762|6364045|P2|COMPLETED|Overall Study||68
2592868|NCT00294762|6364046|P1|COMPLETED|Overall Study||69
2592869|NCT00294762|6364045|P2|STARTED|Overall Study||71
2592870|NCT00294762|6364046|P1|STARTED|Overall Study||72
2592871|NCT00294723|6364065|P3|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||20
2592872|NCT00294723|6364066|P2|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||21
2592873|NCT00294723|6364067|P1|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||28
2592874|NCT00294723|6364065|P3|COMPLETED|Additional Open-Label Extension 91 Weeks||8
2592875|NCT00294723|6364066|P2|COMPLETED|Additional Open-Label Extension 91 Weeks||32
2592876|NCT00294723|6364067|P1|COMPLETED|Additional Open-Label Extension 91 Weeks||34
2592877|NCT00294723|6364065|P3|STARTED|Additional Open-Label Extension 91 Weeks|69 subjects did not continue into the extension period|28
2592878|NCT00294723|6364066|P2|STARTED|Additional Open-Label Extension 91 Weeks|57 subjects did not continue into the extension period|53
2592879|NCT00294723|6364067|P1|STARTED|Additional Open-Label Extension 91 Weeks|52 subjects did not continue into the extension period|62
2592880|NCT00294723|6364065|P3|NOT COMPLETED|Open-Label Extension 52 Weeks||40
2592881|NCT00294723|6364066|P2|NOT COMPLETED|Open-Label Extension 52 Weeks||39
2592882|NCT00294723|6364067|P1|NOT COMPLETED|Open-Label Extension 52 Weeks||40
2592883|NCT00294723|6364065|P3|COMPLETED|Open-Label Extension 52 Weeks||97
2592884|NCT00294723|6364066|P2|COMPLETED|Open-Label Extension 52 Weeks||110
2592885|NCT00294723|6364067|P1|COMPLETED|Open-Label Extension 52 Weeks||114
2592886|NCT00294723|6364065|P3|STARTED|Open-Label Extension 52 Weeks|15 subjects did not continue into the extension period|137
2592887|NCT00294723|6364066|P2|STARTED|Open-Label Extension 52 Weeks|13 subjects did not continue into the extension period|149
2592888|NCT00294723|6364067|P1|STARTED|Open-Label Extension 52 Weeks|19 subjects did not continue into the extension period|154
2592889|NCT00294723|6364065|P3|NOT COMPLETED|Double-Blind Period 52 Weeks||96
2592890|NCT00294723|6364066|P2|NOT COMPLETED|Double-Blind Period 52 Weeks||89
2592891|NCT00294723|6364067|P1|NOT COMPLETED|Double-Blind Period 52 Weeks||74
2592892|NCT00294723|6364065|P3|COMPLETED|Double-Blind Period 52 Weeks||152
2592893|NCT00294723|6364066|P2|COMPLETED|Double-Blind Period 52 Weeks||162
2592894|NCT00294723|6364067|P1|COMPLETED|Double-Blind Period 52 Weeks||173
2592895|NCT00294723|6364065|P3|Exposed to Study Drug|Double-Blind Period 52 Weeks||248
2592896|NCT00294723|6364066|P2|Exposed to Study Drug|Double-Blind Period 52 Weeks||251
2592897|NCT00294723|6364067|P1|Exposed to Study Drug|Double-Blind Period 52 Weeks|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|246
2592898|NCT00294723|6364065|P3|STARTED|Double-Blind Period 52 Weeks|Randomised|248
2592899|NCT00294723|6364066|P2|STARTED|Double-Blind Period 52 Weeks|Randomised|251
2592900|NCT00294723|6364067|P1|STARTED|Double-Blind Period 52 Weeks|Randomised|247
2592901|NCT00294684|6364128|P2|NOT COMPLETED|Overall Study||8
2592902|NCT00294684|6364129|P1|NOT COMPLETED|Overall Study||5
2592903|NCT00294684|6364128|P2|COMPLETED|Overall Study||62
2592904|NCT00294684|6364129|P1|COMPLETED|Overall Study||65
2592905|NCT00294684|6364128|P2|STARTED|Overall Study||70
2592906|NCT00294684|6364129|P1|STARTED|Overall Study||70
2592907|NCT00294671|6364169|P2|NOT COMPLETED|Overall Study||40
2592908|NCT00294671|6364170|P1|NOT COMPLETED|Overall Study||27
2592909|NCT00294671|6364169|P2|COMPLETED|Overall Study||26
2592910|NCT00294671|6364170|P1|COMPLETED|Overall Study||37
2592911|NCT00294671|6364169|P2|STARTED|Overall Study||66
2592912|NCT00294671|6364170|P1|STARTED|Overall Study||64
2592913|NCT00294658|6364186|P2|NOT COMPLETED|Overall Study||9
2592914|NCT00294658|6364187|P1|NOT COMPLETED|Overall Study||6
2592915|NCT00294658|6364186|P2|COMPLETED|Overall Study||51
2592916|NCT00294658|6364187|P1|COMPLETED|Overall Study||60
2592917|NCT00294658|6364186|P2|STARTED|Overall Study||60
2592918|NCT00294658|6364187|P1|STARTED|Overall Study||66
2592919|NCT00294645|6364251|P2|NOT COMPLETED|Overall Study||92
2592920|NCT00294645|6364252|P1|NOT COMPLETED|Overall Study||48
2592921|NCT00294645|6364251|P2|COMPLETED|Overall Study||510
2592922|NCT00294645|6364252|P1|COMPLETED|Overall Study||247
2592923|NCT00294645|6364251|P2|STARTED|Overall Study||602
2592924|NCT00294645|6364252|P1|STARTED|Overall Study||295
2592945|NCT00294554|6364296|P2|NOT COMPLETED|Overall Study||2
2592946|NCT00294554|6364297|P1|NOT COMPLETED|Overall Study||0
2592947|NCT00294554|6364296|P2|COMPLETED|Overall Study|"1 S withdrew @ 20 wks for lack perceived benefit~1 S withdrawn @ 13 wks b/o extreme agitation"|8
2592948|NCT00294554|6364297|P1|COMPLETED|Overall Study||10
2592949|NCT00294554|6364296|P2|STARTED|Overall Study||10
2592950|NCT00294554|6364297|P1|STARTED|Overall Study||10
2592951|NCT00294515|6364307|P2|NOT COMPLETED|Overall Study||28
2592952|NCT00294515|6364308|P1|NOT COMPLETED|Overall Study||34
2592953|NCT00294515|6364307|P2|COMPLETED|Overall Study||132
2592954|NCT00294515|6364308|P1|COMPLETED|Overall Study||132
2592955|NCT00294515|6364307|P2|STARTED|Overall Study|Randomized|160
2592956|NCT00294515|6364308|P1|STARTED|Overall Study|Randomized|166
2592957|NCT00294398|6364324|P2|NOT COMPLETED|Overall Study||26
2592958|NCT00294398|6364325|P1|NOT COMPLETED|Overall Study||21
2592959|NCT00294398|6364324|P2|COMPLETED|Overall Study||48
2592960|NCT00294398|6364325|P1|COMPLETED|Overall Study||57
2592961|NCT00294398|6364324|P2|STARTED|Overall Study||74
2592962|NCT00294398|6364325|P1|STARTED|Overall Study||78
2592963|NCT00294060|6364333|P1|NOT COMPLETED|Overall Study||1173
2592964|NCT00294060|6364333|P1|COMPLETED|Overall Study||840
2592965|NCT00294060|6364333|P1|STARTED|Overall Study||2013
2592966|NCT00294047|6364341|P2|NOT COMPLETED|Month 84||989
2592967|NCT00294047|6364342|P1|NOT COMPLETED|Month 84||973
2592968|NCT00294047|6364341|P2|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Aluminium Hydroxide Group = 2116|1881
2592969|NCT00294047|6364342|P1|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Cervarix Group = 2146|1904
2592970|NCT00294047|6364341|P2|STARTED|Month 84||2870
2592971|NCT00294047|6364342|P1|STARTED|Month 84||2877
2592972|NCT00294047|6364341|P2|NOT COMPLETED|Month 48||433
2592973|NCT00294047|6364342|P1|NOT COMPLETED|Month 48||425
2592974|NCT00294047|6364341|P2|COMPLETED|Month 48||2438
2592975|NCT00294047|6364342|P1|COMPLETED|Month 48||2456
2592976|NCT00294047|6364341|P2|Participated up to Month 48|Month 48||2281
2592977|NCT00294047|6364342|P1|Participated up to Month 48|Month 48||2305
2592978|NCT00294047|6364341|P2|STARTED|Month 48||2871
2592979|NCT00294047|6364342|P1|STARTED|Month 48||2881
2592980|NCT00293813|6364447|P3|NOT COMPLETED|Overall Study||8
2592981|NCT00293813|6364448|P2|NOT COMPLETED|Overall Study||9
2592982|NCT00293813|6364449|P1|NOT COMPLETED|Overall Study||13
2592983|NCT00293813|6364447|P3|COMPLETED|Overall Study||74
2592984|NCT00293813|6364448|P2|COMPLETED|Overall Study||74
2592985|NCT00293813|6364449|P1|COMPLETED|Overall Study||69
2592986|NCT00293813|6364447|P3|STARTED|Overall Study||82
2592987|NCT00293813|6364448|P2|STARTED|Overall Study||83
2592988|NCT00293813|6364449|P1|STARTED|Overall Study||82
2592989|NCT00293722|6364460|P1|NOT COMPLETED|Overall Study||427
2592990|NCT00293722|6364460|P1|COMPLETED|Overall Study||864
2592991|NCT00293722|6364460|P1|STARTED|Overall Study||1291
2592992|NCT00293709|6364474|P1|NOT COMPLETED|Overall Study||47
2592993|NCT00293709|6364474|P1|COMPLETED|Overall Study||102
2592994|NCT00293709|6364474|P1|STARTED|Overall Study||149
2592995|NCT00293579|6364488|P1|NOT COMPLETED|Overall Study||1
2592996|NCT00293579|6364488|P1|COMPLETED|Overall Study||4
2592997|NCT00293579|6364488|P1|STARTED|Overall Study||5
2592998|NCT00293540|6364497|P2|NOT COMPLETED|Overall Study||8
2592999|NCT00293540|6364498|P1|NOT COMPLETED|Overall Study||7
2593000|NCT00293540|6364497|P2|COMPLETED|Overall Study||119
2593001|NCT00293540|6364498|P1|COMPLETED|Overall Study||115
2593002|NCT00293540|6364497|P2|STARTED|Overall Study||127
2593003|NCT00293540|6364498|P1|STARTED|Overall Study||122
2593004|NCT00293462|6364507|P3|NOT COMPLETED|Overall Study||10
2593005|NCT00293462|6364508|P2|NOT COMPLETED|Overall Study||8
2593006|NCT00293462|6364509|P1|NOT COMPLETED|Overall Study||7
2593007|NCT00293462|6364507|P3|COMPLETED|Overall Study||21
2593008|NCT00293462|6364508|P2|COMPLETED|Overall Study||21
2593009|NCT00293462|6364509|P1|COMPLETED|Overall Study||24
2593010|NCT00293462|6364507|P3|STARTED|Overall Study||31
2593011|NCT00293462|6364508|P2|STARTED|Overall Study||29
2593012|NCT00293462|6364509|P1|STARTED|Overall Study||31
2593013|NCT00293397|6364528|P1|NOT COMPLETED|Overall Study||2
2593014|NCT00293397|6364528|P1|COMPLETED|Overall Study|1 patient death within 30 days post-TACE - not attributed to TACE procedure|18
2593015|NCT00293397|6364528|P1|Received First DEB-TACE|Overall Study|1 patient death after baseline inclusion screening and before first treatment|19
2593016|NCT00293397|6364528|P1|STARTED|Overall Study||20
2593017|NCT00293384|6364538|P1|NOT COMPLETED|Overall Study||5
2593018|NCT00293384|6364538|P1|COMPLETED|Overall Study||35
2593019|NCT00293384|6364538|P1|STARTED|Overall Study||40
2593020|NCT00293293|6364547|P2|NOT COMPLETED|Overall Study||2
2593021|NCT00293293|6364548|P1|NOT COMPLETED|Overall Study||2
2593022|NCT00293293|6364547|P2|COMPLETED|Overall Study||21
2593023|NCT00293293|6364548|P1|COMPLETED|Overall Study||18
2593024|NCT00293293|6364547|P2|STARTED|Overall Study||23
2593025|NCT00293293|6364548|P1|STARTED|Overall Study||20
2593026|NCT00293267|6364576|P2|NOT COMPLETED|Open-Label Post Virologic Failure Phase||37
2593027|NCT00293267|6364577|P1|NOT COMPLETED|Open-Label Post Virologic Failure Phase||33
2593028|NCT00293267|6364576|P2|COMPLETED|Open-Label Post Virologic Failure Phase||29
2593029|NCT00293267|6364577|P1|COMPLETED|Open-Label Post Virologic Failure Phase||15
2593030|NCT00293267|6364576|P2|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|66
2593031|NCT00293267|6364577|P1|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|48
2593032|NCT00293267|6364576|P2|NOT COMPLETED|Extension - Open-Label Week 157-240||2
2593033|NCT00293267|6364577|P1|NOT COMPLETED|Extension - Open-Label Week 157-240||20
2593034|NCT00293267|6364576|P2|COMPLETED|Extension - Open-Label Week 157-240||26
2593035|NCT00293267|6364577|P1|COMPLETED|Extension - Open-Label Week 157-240||111
2593036|NCT00293267|6364576|P2|STARTED|Extension - Open-Label Week 157-240|7 of 35 participants who completed the double-blind phase did not enter this open-label phase|28
2593037|NCT00293267|6364577|P1|STARTED|Extension - Open-Label Week 157-240|8 of 139 participants who completed the double-blind phase did not enter this open-label phase|131
2593038|NCT00293267|6364576|P2|NOT COMPLETED|Extension - Double-Blind Week 49-156||15
2593039|NCT00293267|6364577|P1|NOT COMPLETED|Extension - Double-Blind Week 49-156||52
2593040|NCT00293267|6364576|P2|COMPLETED|Extension - Double-Blind Week 49-156||35
2593041|NCT00293267|6364577|P1|COMPLETED|Extension - Double-Blind Week 49-156||139
2593042|NCT00293267|6364576|P2|STARTED|Extension - Double-Blind Week 49-156||50
2593043|NCT00293267|6364577|P1|STARTED|Extension - Double-Blind Week 49-156|2 participants who completed Week 48 did not enter the extension study|191
2593044|NCT00293267|6364576|P2|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||68
2593045|NCT00293267|6364577|P1|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||41
2593046|NCT00293267|6364576|P2|COMPLETED|Primary Study - Double-Blind Week 0-48||50
2593047|NCT00293267|6364577|P1|COMPLETED|Primary Study - Double-Blind Week 0-48||193
2593048|NCT00293267|6364576|P2|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48||50
2593049|NCT00293267|6364577|P1|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the open-label post virological failure (OLPVF) phase|193
2593050|NCT00293267|6364576|P2|Treated|Primary Study - Double-Blind Week 0-48||118
2593051|NCT00293267|6364577|P1|Treated|Primary Study - Double-Blind Week 0-48||232
2593052|NCT00293267|6364576|P2|STARTED|Primary Study - Double-Blind Week 0-48||118
2593053|NCT00293267|6364577|P1|STARTED|Primary Study - Double-Blind Week 0-48||234
2593054|NCT00293254|6364617|P2|NOT COMPLETED|Open-Label Post Virologic Failure Phase||27
2593055|NCT00293254|6364618|P1|NOT COMPLETED|Open-Label Post Virologic Failure Phase||31
2593056|NCT00293254|6364617|P2|COMPLETED|Open-Label Post Virologic Failure Phase||37
2593057|NCT00293254|6364618|P1|COMPLETED|Open-Label Post Virologic Failure Phase||19
2593058|NCT00293254|6364617|P2|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|64
2593059|NCT00293254|6364618|P1|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|50
2593060|NCT00293254|6364617|P2|NOT COMPLETED|Extension - Open-Label Week 157-240||1
2593061|NCT00293254|6364618|P1|NOT COMPLETED|Extension - Open-Label Week 157-240||10
2593062|NCT00293254|6364617|P2|COMPLETED|Extension - Open-Label Week 157-240||18
2593063|NCT00293254|6364618|P1|COMPLETED|Extension - Open-Label Week 157-240||110
2593064|NCT00293254|6364617|P2|STARTED|Extension - Open-Label Week 157-240|6 of 25 participants who completed the double-blind phase did not enter this open-label phase.|19
2593065|NCT00293254|6364618|P1|STARTED|Extension - Open-Label Week 157-240||120
2593066|NCT00293254|6364617|P2|NOT COMPLETED|Extension - Double-Blind Week 49-156||29
2593067|NCT00293254|6364618|P1|NOT COMPLETED|Extension - Double-Blind Week 49-156||57
2593068|NCT00293254|6364617|P2|COMPLETED|Extension - Double-Blind Week 49-156||25
2593069|NCT00293254|6364618|P1|COMPLETED|Extension - Double-Blind Week 49-156||120
2593070|NCT00293254|6364617|P2|STARTED|Extension - Double-Blind Week 49-156|1 of 55 participants who completed Week 48 did not enter the extension study.|54
2593071|NCT00293254|6364618|P1|STARTED|Extension - Double-Blind Week 49-156||177
2593072|NCT00293254|6364617|P2|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||64
2593073|NCT00293254|6364618|P1|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||55
2593074|NCT00293254|6364617|P2|COMPLETED|Primary Study - Double-Blind Week 0-48||55
2593075|NCT00293254|6364618|P1|COMPLETED|Primary Study - Double-Blind Week 0-48||177
2593076|NCT00293254|6364617|P2|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the OLPVF phase|55
2593077|NCT00293254|6364618|P1|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the Open-Label Post-Virologic Failure (OLPVF) Phase|177
2593078|NCT00293254|6364617|P2|Treated|Primary Study - Double-Blind Week 0-48||119
2593079|NCT00293254|6364618|P1|Treated|Primary Study - Double-Blind Week 0-48||230
2593080|NCT00293254|6364617|P2|STARTED|Primary Study - Double-Blind Week 0-48||119
2593081|NCT00293254|6364618|P1|STARTED|Primary Study - Double-Blind Week 0-48||232
2593082|NCT00293241|6364658|P2|NOT COMPLETED|Overall Study||41
2593083|NCT00293241|6364659|P1|NOT COMPLETED|Overall Study||36
2593084|NCT00293241|6364658|P2|COMPLETED|Overall Study||265
2593085|NCT00293241|6364659|P1|COMPLETED|Overall Study||263
2593086|NCT00293241|6364658|P2|STARTED|Overall Study||306
2593087|NCT00293241|6364659|P1|STARTED|Overall Study||299
2593088|NCT00293059|6364703|P2|NOT COMPLETED|Overall Study||19
2593089|NCT00293059|6364704|P1|NOT COMPLETED|Overall Study||35
2593090|NCT00293059|6364703|P2|COMPLETED|Overall Study||51
2593091|NCT00293059|6364704|P1|COMPLETED|Overall Study||85
2593092|NCT00293059|6364703|P2|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|62
2593093|NCT00293059|6364704|P1|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|113
2593094|NCT00293059|6364703|P2|Cycle 3/Treatment Day 84|Overall Study||55
2593095|NCT00293059|6364704|P1|Cycle 3/Treatment Day 84|Overall Study||100
2593096|NCT00293059|6364703|P2|Cycle 1/Treatment Day 28|Overall Study||64
2593097|NCT00293059|6364704|P1|Cycle 1/Treatment Day 28|Overall Study||115
2593098|NCT00293059|6364703|P2|Subjects Received Treatment|Overall Study||66
2593099|NCT00293059|6364704|P1|Subjects Received Treatment|Overall Study||119
2593100|NCT00293059|6364703|P2|STARTED|Overall Study||70
2593101|NCT00293059|6364704|P1|STARTED|Overall Study||120
2593102|NCT00293033|6364816|P1|NOT COMPLETED|Double-blind Treatment Period||12
2593103|NCT00293033|6364816|P1|COMPLETED|Double-blind Treatment Period||70
2593104|NCT00293033|6364816|P1|STARTED|Double-blind Treatment Period|82 randomized; 1 didn't take double-blind drug; 1 didn't report a pain assessment within 30 minutes|82
2593105|NCT00293033|6364816|P1|NOT COMPLETED|Open-label Titration Period||69
2593106|NCT00293033|6364816|P1|COMPLETED|Open-label Titration Period||82
2593107|NCT00293033|6364816|P1|STARTED|Open-label Titration Period|152 subjects enrolled; 151 subjects received at least one dose of study drug|151
2593108|NCT00293020|6364919|P1|NOT COMPLETED|Overall Study||162
2593109|NCT00293020|6364919|P1|COMPLETED|Overall Study||82
2593110|NCT00293020|6364919|P1|STARTED|Overall Study||244
2593111|NCT00292981|6364923|P1|NOT COMPLETED|Overall Study||39
2593112|NCT00292981|6364923|P1|COMPLETED|Overall Study||18
2593113|NCT00292981|6364923|P1|STARTED|Overall Study||57
2593114|NCT00292942|6364934|P4|NOT COMPLETED|Overall Study||1
2593115|NCT00292942|6364935|P3|NOT COMPLETED|Overall Study||1
2593116|NCT00292942|6364936|P2|NOT COMPLETED|Overall Study||0
2593117|NCT00292942|6364937|P1|NOT COMPLETED|Overall Study||0
2593118|NCT00292942|6364934|P4|COMPLETED|Overall Study||6
2593119|NCT00292942|6364935|P3|COMPLETED|Overall Study||6
2593120|NCT00292942|6364936|P2|COMPLETED|Overall Study||6
2593121|NCT00292942|6364937|P1|COMPLETED|Overall Study||6
2593122|NCT00292942|6364934|P4|STARTED|Overall Study||7
2593123|NCT00292942|6364935|P3|STARTED|Overall Study||7
2593124|NCT00292942|6364936|P2|STARTED|Overall Study||6
2593125|NCT00292942|6364937|P1|STARTED|Overall Study||6
2593126|NCT00292591|6364971|P3|NOT COMPLETED|Overall Study||58
2593127|NCT00292591|6364972|P2|NOT COMPLETED|Overall Study||56
2593128|NCT00292591|6364973|P1|NOT COMPLETED|Overall Study||64
2593129|NCT00292591|6364971|P3|COMPLETED|Overall Study||110
2593130|NCT00292591|6364972|P2|COMPLETED|Overall Study||111
2593131|NCT00292591|6364973|P1|COMPLETED|Overall Study||102
2593132|NCT00292591|6364971|P3|STARTED|Overall Study||168
2593133|NCT00292591|6364972|P2|STARTED|Overall Study||167
2593134|NCT00292591|6364973|P1|STARTED|Overall Study||166
2593135|NCT00292461|6364983|P2|NOT COMPLETED|Overall Study||6
2593136|NCT00292461|6364984|P1|NOT COMPLETED|Overall Study||10
2593137|NCT00292461|6364983|P2|COMPLETED|Overall Study||24
2593138|NCT00292461|6364984|P1|COMPLETED|Overall Study||24
2593139|NCT00292461|6364983|P2|STARTED|Overall Study||30
2593140|NCT00292461|6364984|P1|STARTED|Overall Study||34
2593141|NCT00292370|6364999|P3|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||7
2593142|NCT00292370|6365000|P2|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||4
2593143|NCT00292370|6365001|P1|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
2593144|NCT00292370|6364999|P3|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||18
2593145|NCT00292370|6365000|P2|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||21
2593146|NCT00292370|6365001|P1|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
2593147|NCT00292370|6364999|P3|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
2593148|NCT00292370|6365000|P2|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
2593149|NCT00292370|6365001|P1|STARTED|Phase II: OLP + DB Quetiapine or Placebo|"78 Completed Ph I~28 Excluded Ph II:~20 responded~7 declined~1 medical~50 to Arm 2 & 3"|0
2593150|NCT00292370|6364999|P3|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
2593151|NCT00292370|6365000|P2|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
2593152|NCT00292370|6365001|P1|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||46
2593153|NCT00292370|6364999|P3|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
2593154|NCT00292370|6365000|P2|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
2593155|NCT00292370|6365001|P1|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||78
2593156|NCT00292370|6364999|P3|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
2593157|NCT00292370|6365000|P2|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
2593158|NCT00292370|6365001|P1|STARTED|Phase I - Open-Label Paroxetine (OLP)||124
2593159|NCT00292318|6365026|P2|NOT COMPLETED|Overall Study||1
2593160|NCT00292318|6365027|P1|NOT COMPLETED|Overall Study||2
2593161|NCT00292318|6365026|P2|COMPLETED|Overall Study||2
2593162|NCT00292318|6365027|P1|COMPLETED|Overall Study||2
2593163|NCT00292318|6365026|P2|STARTED|Overall Study||3
2593164|NCT00292318|6365027|P1|STARTED|Overall Study||4
2593165|NCT00292227|6365037|P3|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
2593166|NCT00292227|6365038|P2|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
2593167|NCT00292227|6365039|P1|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
2593168|NCT00292227|6365037|P3|COMPLETED|Cross-over Period 2 (Day 39)||30
2593169|NCT00292227|6365038|P2|COMPLETED|Cross-over Period 2 (Day 39)||31
2593170|NCT00292227|6365039|P1|COMPLETED|Cross-over Period 2 (Day 39)||65
2593171|NCT00292227|6365037|P3|STARTED|Cross-over Period 2 (Day 39)||30
2593172|NCT00292227|6365038|P2|STARTED|Cross-over Period 2 (Day 39)||31
2593173|NCT00292227|6365039|P1|STARTED|Cross-over Period 2 (Day 39)||65
2593174|NCT00292227|6365037|P3|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
2593175|NCT00292227|6365038|P2|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
2593176|NCT00292227|6365039|P1|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
2593177|NCT00292227|6365037|P3|COMPLETED|Cross-over Period 1 (Day 32)||30
2593178|NCT00292227|6365038|P2|COMPLETED|Cross-over Period 1 (Day 32)||31
2593179|NCT00292227|6365039|P1|COMPLETED|Cross-over Period 1 (Day 32)||65
2593180|NCT00292227|6365037|P3|STARTED|Cross-over Period 1 (Day 32)||30
2593181|NCT00292227|6365038|P2|STARTED|Cross-over Period 1 (Day 32)||31
2593182|NCT00292227|6365039|P1|STARTED|Cross-over Period 1 (Day 32)||65
2593183|NCT00292227|6365037|P3|NOT COMPLETED|Patch Period||3
2593184|NCT00292227|6365038|P2|NOT COMPLETED|Patch Period||0
2593185|NCT00292227|6365039|P1|NOT COMPLETED|Patch Period||1
2593186|NCT00292227|6365037|P3|COMPLETED|Patch Period||30
2593187|NCT00292227|6365038|P2|COMPLETED|Patch Period||31
2593188|NCT00292227|6365039|P1|COMPLETED|Patch Period||65
2593189|NCT00292227|6365037|P3|STARTED|Patch Period||33
2593190|NCT00292227|6365038|P2|STARTED|Patch Period||31
2593191|NCT00292227|6365039|P1|STARTED|Patch Period||66
2593192|NCT00292188|6365121|P3|NOT COMPLETED|Double-Blind||29
2593193|NCT00292188|6365122|P2|NOT COMPLETED|Double-Blind||31
2593194|NCT00292188|6365123|P1|NOT COMPLETED|Double-Blind||0
2593195|NCT00292188|6365121|P3|COMPLETED|Double-Blind||98
2593196|NCT00292188|6365122|P2|COMPLETED|Double-Blind||96
2593197|NCT00292188|6365123|P1|COMPLETED|Double-Blind||0
2593198|NCT00292188|6365121|P3|STARTED|Double-Blind||127
2593199|NCT00292188|6365122|P2|STARTED|Double-Blind||127
2593200|NCT00292188|6365123|P1|STARTED|Double-Blind||0
2593201|NCT00292188|6365121|P3|NOT COMPLETED|Single-Blind||0
2593202|NCT00292188|6365122|P2|NOT COMPLETED|Single-Blind||0
2593203|NCT00292188|6365123|P1|NOT COMPLETED|Single-Blind||114
2593204|NCT00292188|6365121|P3|COMPLETED|Single-Blind||0
2593205|NCT00292188|6365122|P2|COMPLETED|Single-Blind||0
2593206|NCT00292188|6365123|P1|COMPLETED|Single-Blind||254
2593207|NCT00292188|6365121|P3|Received Treatment|Single-Blind||0
2593208|NCT00292188|6365122|P2|Received Treatment|Single-Blind||0
2593209|NCT00292188|6365123|P1|Received Treatment|Single-Blind||367
2593210|NCT00292188|6365121|P3|STARTED|Single-Blind||0
2593211|NCT00292188|6365122|P2|STARTED|Single-Blind||0
2593212|NCT00292188|6365123|P1|STARTED|Single-Blind||368
2593213|NCT00292162|6365184|P2|NOT COMPLETED|Overall Study||2
2593214|NCT00292162|6365185|P1|NOT COMPLETED|Overall Study||1
2593215|NCT00292162|6365184|P2|COMPLETED|Overall Study||20
2593216|NCT00292162|6365185|P1|COMPLETED|Overall Study||18
2593217|NCT00292162|6365184|P2|STARTED|Overall Study||22
2593218|NCT00292162|6365185|P1|STARTED|Overall Study||19
2593219|NCT00291876|6365201|P1|NOT COMPLETED|Month 246||0
2593220|NCT00291876|6365201|P1|COMPLETED|Month 246||116
2593221|NCT00291876|6365201|P1|STARTED|Month 246||116
2593222|NCT00291876|6365201|P1|NOT COMPLETED|Month 234||0
2593223|NCT00291876|6365201|P1|COMPLETED|Month 234||110
2593224|NCT00291876|6365201|P1|STARTED|Month 234||110
2593225|NCT00291876|6365201|P1|NOT COMPLETED|Month 222||0
2593226|NCT00291876|6365201|P1|COMPLETED|Month 222||114
2593227|NCT00291876|6365201|P1|STARTED|Month 222||114
2593228|NCT00291876|6365201|P1|NOT COMPLETED|Month 210||0
2593229|NCT00291876|6365201|P1|COMPLETED|Month 210||124
2593230|NCT00291876|6365201|P1|STARTED|Month 210||124
2593231|NCT00291876|6365201|P1|NOT COMPLETED|Month 198||0
2593232|NCT00291876|6365201|P1|COMPLETED|Month 198||135
2593233|NCT00291876|6365201|P1|STARTED|Month 198||135
2593234|NCT00291876|6365201|P1|NOT COMPLETED|Month 186||0
2593235|NCT00291876|6365201|P1|COMPLETED|Month 186||129
2593236|NCT00291876|6365201|P1|STARTED|Month 186||129
2593237|NCT00291876|6365201|P1|NOT COMPLETED|Month 174||0
2593238|NCT00291876|6365201|P1|COMPLETED|Month 174||127
2593239|NCT00291876|6365201|P1|STARTED|Month 174||127
2593240|NCT00291876|6365201|P1|NOT COMPLETED|Month 162||0
2593241|NCT00291876|6365201|P1|COMPLETED|Month 162||127
2593242|NCT00291876|6365201|P1|STARTED|Month 162||127
2593243|NCT00291876|6365201|P1|NOT COMPLETED|Month 150||0
2593244|NCT00291876|6365201|P1|COMPLETED|Month 150||117
2593245|NCT00291876|6365201|P1|STARTED|Month 150||117
2593246|NCT00291876|6365201|P1|NOT COMPLETED|Month 138||0
2593247|NCT00291876|6365201|P1|COMPLETED|Month 138||107
2593248|NCT00291876|6365201|P1|STARTED|Month 138||107
2593249|NCT00291694|6365215|P2|NOT COMPLETED|Overall Study||5
2593250|NCT00291694|6365216|P1|NOT COMPLETED|Overall Study||3
2593251|NCT00291694|6365215|P2|COMPLETED|Overall Study||43
2593252|NCT00291694|6365216|P1|COMPLETED|Overall Study||21
2593253|NCT00291694|6365215|P2|STARTED|Overall Study||48
2593254|NCT00291694|6365216|P1|STARTED|Overall Study||24
2593255|NCT00291655|6365230|P1|NOT COMPLETED|Overall Study||15
2593256|NCT00291655|6365230|P1|COMPLETED|Overall Study||115
2593257|NCT00291655|6365230|P1|STARTED|Overall Study||130
2593258|NCT00291642|6365240|P5|NOT COMPLETED|Overall Study||1
2593259|NCT00291642|6365241|P4|NOT COMPLETED|Overall Study||0
2593260|NCT00291642|6365242|P3|NOT COMPLETED|Overall Study||2
2593261|NCT00291642|6365243|P2|NOT COMPLETED|Overall Study||0
2593262|NCT00291642|6365244|P1|NOT COMPLETED|Overall Study||2
2593263|NCT00291642|6365240|P5|COMPLETED|Overall Study||118
2593264|NCT00291642|6365241|P4|COMPLETED|Overall Study||119
2593265|NCT00291642|6365242|P3|COMPLETED|Overall Study||117
2593266|NCT00291642|6365243|P2|COMPLETED|Overall Study||116
2593267|NCT00291642|6365244|P1|COMPLETED|Overall Study||76
2593268|NCT00291642|6365240|P5|STARTED|Overall Study||119
2593269|NCT00291642|6365241|P4|STARTED|Overall Study||119
2593270|NCT00291642|6365242|P3|STARTED|Overall Study||119
2593271|NCT00291642|6365243|P2|STARTED|Overall Study||116
2593272|NCT00291642|6365244|P1|STARTED|Overall Study||78
2593273|NCT00291577|6365296|P1|NOT COMPLETED|Overall Study||21
2593274|NCT00291577|6365296|P1|COMPLETED|Overall Study|Subject End of Study=Completed; not per protocol reason. PI reason=withdrawn during active treatment|1
2593275|NCT00291577|6365296|P1|STARTED|Overall Study||22
2593276|NCT00291551|6365315|P1|NOT COMPLETED|Overall Study||13
2593277|NCT00291551|6365315|P1|COMPLETED|Overall Study||26
2593278|NCT00291551|6365315|P1|STARTED|Overall Study||39
2593279|NCT00291343|6365332|P2|NOT COMPLETED|Overall Study||0
2593280|NCT00291343|6365333|P1|NOT COMPLETED|Overall Study||0
2593281|NCT00291343|6365332|P2|COMPLETED|Overall Study||93
2593282|NCT00291343|6365333|P1|COMPLETED|Overall Study||203
2593283|NCT00291343|6365332|P2|STARTED|Overall Study||93
2593284|NCT00291343|6365333|P1|STARTED|Overall Study||203
2593285|NCT00291330|6365363|P2|NOT COMPLETED|Overall Study||97
2593286|NCT00291330|6365364|P1|NOT COMPLETED|Overall Study||101
2593287|NCT00291330|6365363|P2|COMPLETED|Overall Study|Completed planned observation time|1169
2593288|NCT00291330|6365364|P1|COMPLETED|Overall Study|Completed planned observation time|1172
2593289|NCT00291330|6365363|P2|STARTED|Overall Study|Started Treatment|1266
2593290|NCT00291330|6365364|P1|STARTED|Overall Study|Started Treatment|1273
2593291|NCT00291317|6365386|P1|NOT COMPLETED|Overall Study||0
2593292|NCT00291317|6365386|P1|COMPLETED|Overall Study||6
2593293|NCT00291317|6365386|P1|STARTED|Overall Study||6
2593294|NCT00291226|6365393|P2|NOT COMPLETED|Overall Study||1
2593295|NCT00291226|6365394|P1|NOT COMPLETED|Overall Study||1
2593296|NCT00291226|6365393|P2|COMPLETED|Overall Study||3
2593297|NCT00291226|6365394|P1|COMPLETED|Overall Study||3
2593298|NCT00291226|6365393|P2|STARTED|Overall Study||4
2593299|NCT00291226|6365394|P1|STARTED|Overall Study||4
2593300|NCT00291187|6365406|P4|NOT COMPLETED|Overall Study||0
2593301|NCT00291187|6365407|P3|NOT COMPLETED|Overall Study||1
2593302|NCT00291187|6365408|P2|NOT COMPLETED|Overall Study||0
2593303|NCT00291187|6365409|P1|NOT COMPLETED|Overall Study||0
2593304|NCT00291187|6365406|P4|COMPLETED|Overall Study||106
2593305|NCT00291187|6365407|P3|COMPLETED|Overall Study||102
2593306|NCT00291187|6365408|P2|COMPLETED|Overall Study||100
2593307|NCT00291187|6365409|P1|COMPLETED|Overall Study||103
2593308|NCT00291187|6365406|P4|STARTED|Overall Study||106
2593309|NCT00291187|6365407|P3|STARTED|Overall Study||103
2593310|NCT00291187|6365408|P2|STARTED|Overall Study||100
2593311|NCT00291187|6365409|P1|STARTED|Overall Study||103
2593312|NCT00291161|6365435|P4|NOT COMPLETED|Overall Study||65
2593313|NCT00291161|6365436|P3|NOT COMPLETED|Overall Study||93
2593314|NCT00291161|6365437|P2|NOT COMPLETED|Overall Study||58
2593315|NCT00291161|6365438|P1|NOT COMPLETED|Overall Study||81
2593316|NCT00291161|6365435|P4|COMPLETED|Overall Study||122
2593317|NCT00291161|6365436|P3|COMPLETED|Overall Study||206
2593318|NCT00291161|6365437|P2|COMPLETED|Overall Study||134
2593319|NCT00291161|6365438|P1|COMPLETED|Overall Study||235
2593320|NCT00291161|6365435|P4|STARTED|Overall Study||187
2593321|NCT00291161|6365436|P3|STARTED|Overall Study||299
2593322|NCT00291161|6365437|P2|STARTED|Overall Study||192
2593323|NCT00291161|6365438|P1|STARTED|Overall Study||316
2593324|NCT00291135|6365446|P1|NOT COMPLETED|Overall Study||0
2593325|NCT00291135|6365446|P1|COMPLETED|Overall Study||42
2593326|NCT00291135|6365446|P1|STARTED|Overall Study||42
2593327|NCT00291018|6365453|P3|NOT COMPLETED|Overall Study||43
2593328|NCT00291018|6365454|P2|NOT COMPLETED|Overall Study||42
2593329|NCT00291018|6365455|P1|NOT COMPLETED|Overall Study||25
2593330|NCT00291018|6365453|P3|COMPLETED|Overall Study|Evaluated at 84 Months|93
2593331|NCT00291018|6365454|P2|COMPLETED|Overall Study|Evaluated at 84 Months|64
2593332|NCT00291018|6365455|P1|COMPLETED|Overall Study|Evaluated at 84 Months|78
2593333|NCT00291018|6365453|P3|Evaluated at 24 Months|Overall Study||105
2593334|NCT00291018|6365454|P2|Evaluated at 24 Months|Overall Study||92
2593335|NCT00291018|6365455|P1|Evaluated at 24 Months|Overall Study||99
2593336|NCT00291018|6365453|P3|STARTED|Overall Study|Enrolled and Treated. 140 PDC-CA subjects were Enrolled but only 136 were Treated.|136
2593337|NCT00291018|6365454|P2|STARTED|Overall Study|Enrolled and Treated. 117 ACDF subjects were Enrolled but only 106 were Treated.|106
2593338|NCT00291018|6365455|P1|STARTED|Overall Study|Enrolled and Treated. 111 PDC subjects were Enrolled but only 103 were Treated.|103
2593339|NCT00290888|6365495|P2|NOT COMPLETED|Overall Study||1
2593340|NCT00290888|6365496|P1|NOT COMPLETED|Overall Study||3
2593341|NCT00290888|6365495|P2|COMPLETED|Overall Study||44
2593342|NCT00290888|6365496|P1|COMPLETED|Overall Study||38
2593343|NCT00290888|6365495|P2|STARTED|Overall Study||45
2593344|NCT00290888|6365496|P1|STARTED|Overall Study||41
2593345|NCT00290810|6365504|P1|NOT COMPLETED|Overall Study||0
2593346|NCT00290810|6365504|P1|COMPLETED|Overall Study||12
2593347|NCT00290810|6365504|P1|STARTED|Overall Study||12
2593348|NCT00290771|6365513|P2|NOT COMPLETED|Overall Study||97
2593349|NCT00290771|6365514|P1|NOT COMPLETED|Overall Study||127
2593350|NCT00290771|6365513|P2|COMPLETED|Overall Study||3
2593351|NCT00290771|6365514|P1|COMPLETED|Overall Study||4
2593352|NCT00290771|6365513|P2|STARTED|Overall Study||100
2593353|NCT00290771|6365514|P1|STARTED|Overall Study||131
2593354|NCT00290758|6365538|P2|NOT COMPLETED|Post Intervention rFNA||5
2593355|NCT00290758|6365539|P1|NOT COMPLETED|Post Intervention rFNA||6
2593356|NCT00290758|6365538|P2|COMPLETED|Post Intervention rFNA||49
2593357|NCT00290758|6365539|P1|COMPLETED|Post Intervention rFNA||49
2593358|NCT00290758|6365538|P2|STARTED|Post Intervention rFNA||54
2593359|NCT00290758|6365539|P1|STARTED|Post Intervention rFNA||55
2593360|NCT00290758|6365538|P2|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||10
2593361|NCT00290758|6365539|P1|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||7
2593362|NCT00290758|6365538|P2|COMPLETED|Pre-Intervention rFNA Through Follow-Up||54
2593363|NCT00290758|6365539|P1|COMPLETED|Pre-Intervention rFNA Through Follow-Up||55
2593364|NCT00290758|6365538|P2|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||54
2593365|NCT00290758|6365539|P1|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||55
2593366|NCT00290758|6365538|P2|Treatment|Pre-Intervention rFNA Through Follow-Up||64
2593367|NCT00290758|6365539|P1|Treatment|Pre-Intervention rFNA Through Follow-Up||61
2593368|NCT00290758|6365538|P2|Randomization|Pre-Intervention rFNA Through Follow-Up||62
2593369|NCT00290758|6365539|P1|Randomization|Pre-Intervention rFNA Through Follow-Up||62
2593370|NCT00290758|6365538|P2|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||64
2593371|NCT00290758|6365539|P1|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||62
2593372|NCT00290758|6365538|P2|STARTED|Pre-Intervention rFNA Through Follow-Up||64
2593373|NCT00290758|6365539|P1|STARTED|Pre-Intervention rFNA Through Follow-Up||62
2593374|NCT00290732|6365561|P5|NOT COMPLETED|Overall Study||0
2593375|NCT00290732|6365562|P4|NOT COMPLETED|Overall Study||0
2593376|NCT00290732|6365563|P3|NOT COMPLETED|Overall Study||1
2593377|NCT00290732|6365564|P2|NOT COMPLETED|Overall Study||1
2593378|NCT00290732|6365565|P1|NOT COMPLETED|Overall Study||0
2593379|NCT00290732|6365561|P5|COMPLETED|Overall Study||3
2593380|NCT00290732|6365562|P4|COMPLETED|Overall Study||6
2593381|NCT00290732|6365563|P3|COMPLETED|Overall Study||3
2593382|NCT00290732|6365564|P2|COMPLETED|Overall Study||3
2593383|NCT00290732|6365565|P1|COMPLETED|Overall Study||3
2593384|NCT00290732|6365561|P5|STARTED|Overall Study||3
2593385|NCT00290732|6365562|P4|STARTED|Overall Study||6
2593386|NCT00290732|6365563|P3|STARTED|Overall Study||4
2593387|NCT00290732|6365564|P2|STARTED|Overall Study||4
2593388|NCT00290732|6365565|P1|STARTED|Overall Study||3
2593389|NCT00290706|6365587|P4|NOT COMPLETED|Overall Study||12
2593390|NCT00290706|6365588|P3|NOT COMPLETED|Overall Study||6
2593391|NCT00290706|6365589|P2|NOT COMPLETED|Overall Study||6
2593392|NCT00290706|6365590|P1|NOT COMPLETED|Overall Study||5
2593393|NCT00290706|6365587|P4|COMPLETED|Overall Study||2
2593394|NCT00290706|6365588|P3|COMPLETED|Overall Study||1
2593395|NCT00290706|6365589|P2|COMPLETED|Overall Study||0
2593396|NCT00290706|6365590|P1|COMPLETED|Overall Study||0
2593397|NCT00290706|6365587|P4|Reached 1st Response/Cycle 3|Overall Study||2
2593398|NCT00290706|6365588|P3|Reached 1st Response/Cycle 3|Overall Study||1
2593399|NCT00290706|6365589|P2|Reached 1st Response/Cycle 3|Overall Study||0
2593400|NCT00290706|6365590|P1|Reached 1st Response/Cycle 3|Overall Study||0
2593401|NCT00290706|6365587|P4|Attempted1st Cycle|Overall Study||14
2593402|NCT00290706|6365588|P3|Attempted1st Cycle|Overall Study||7
2593403|NCT00290706|6365589|P2|Attempted1st Cycle|Overall Study||6
2593404|NCT00290706|6365590|P1|Attempted1st Cycle|Overall Study||5
2593405|NCT00290706|6365587|P4|STARTED|Overall Study||14
2593406|NCT00290706|6365588|P3|STARTED|Overall Study||7
2593407|NCT00290706|6365589|P2|STARTED|Overall Study||6
2593408|NCT00290706|6365590|P1|STARTED|Overall Study||5
2593409|NCT00290693|6365609|P1|NOT COMPLETED|Overall Study||2
2593410|NCT00290693|6365609|P1|COMPLETED|Overall Study||43
2593411|NCT00290693|6365609|P1|STARTED|Overall Study||45
2593412|NCT00290654|6365617|P1|NOT COMPLETED|Overall Study||0
2593413|NCT00290654|6365617|P1|COMPLETED|Overall Study||41
2593414|NCT00290654|6365617|P1|STARTED|Overall Study||41
2593415|NCT00290615|6365628|P1|NOT COMPLETED|Overall Study||0
2593416|NCT00290615|6365628|P1|COMPLETED|Overall Study||30
2593417|NCT00290615|6365628|P1|STARTED|Overall Study||30
2593418|NCT00290589|6365637|P2|NOT COMPLETED|Overall Study||2
2593419|NCT00290589|6365638|P1|NOT COMPLETED|Overall Study||2
2593420|NCT00290589|6365637|P2|COMPLETED|Overall Study||41
2593421|NCT00290589|6365638|P1|COMPLETED|Overall Study||37
2593422|NCT00290589|6365637|P2|STARTED|Overall Study||43
2593423|NCT00290589|6365638|P1|STARTED|Overall Study||39
2593424|NCT00290537|6365648|P2|NOT COMPLETED|Overall Study||0
2593425|NCT00290537|6365649|P1|NOT COMPLETED|Overall Study||0
2593426|NCT00290537|6365648|P2|COMPLETED|Overall Study||0
2593427|NCT00290537|6365649|P1|COMPLETED|Overall Study||4
2593428|NCT00290537|6365648|P2|STARTED|Overall Study||0
2593429|NCT00290537|6365649|P1|STARTED|Overall Study||4
2593430|NCT00290472|6365657|P3|NOT COMPLETED|Overall Study||0
2593431|NCT00290472|6365658|P2|NOT COMPLETED|Overall Study||0
2593432|NCT00290472|6365659|P1|NOT COMPLETED|Overall Study||0
2593433|NCT00290472|6365657|P3|COMPLETED|Overall Study||18
2593434|NCT00290472|6365658|P2|COMPLETED|Overall Study||39
2593435|NCT00290472|6365659|P1|COMPLETED|Overall Study||32
2593436|NCT00290472|6365657|P3|STARTED|Overall Study||18
2593437|NCT00290472|6365658|P2|STARTED|Overall Study||39
2593438|NCT00290472|6365659|P1|STARTED|Overall Study||32
2593439|NCT00290407|6365671|P1|NOT COMPLETED|Overall Study||2
2593440|NCT00290407|6365671|P1|COMPLETED|Overall Study||0
2593441|NCT00290407|6365671|P1|STARTED|Overall Study||2
2593442|NCT00290355|6365678|P2|NOT COMPLETED|Overall Study||5
2593443|NCT00290355|6365679|P1|NOT COMPLETED|Overall Study||17
2593444|NCT00290355|6365678|P2|COMPLETED|Overall Study||55
2593445|NCT00290355|6365679|P1|COMPLETED|Overall Study||105
2593446|NCT00290355|6365678|P2|STARTED|Overall Study||60
2593447|NCT00290355|6365679|P1|STARTED|Overall Study||122
2593448|NCT00290342|6365723|P2|NOT COMPLETED|Overall Study||5
2593449|NCT00290342|6365724|P1|NOT COMPLETED|Overall Study||7
2593450|NCT00290342|6365723|P2|COMPLETED|Overall Study||223
2593451|NCT00290342|6365724|P1|COMPLETED|Overall Study||217
2593452|NCT00290342|6365723|P2|STARTED|Overall Study||228
2593453|NCT00290342|6365724|P1|STARTED|Overall Study||224
2593454|NCT00290329|6365755|P3|NOT COMPLETED|Overall Study||0
2593455|NCT00290329|6365756|P2|NOT COMPLETED|Overall Study||0
2593456|NCT00290329|6365757|P1|NOT COMPLETED|Overall Study||0
2593457|NCT00290329|6365755|P3|COMPLETED|Overall Study||61
2593458|NCT00290329|6365756|P2|COMPLETED|Overall Study||86
2593459|NCT00290329|6365757|P1|COMPLETED|Overall Study||102
2593460|NCT00290329|6365755|P3|STARTED|Overall Study||61
2593461|NCT00290329|6365756|P2|STARTED|Overall Study||86
2593462|NCT00290329|6365757|P1|STARTED|Overall Study||102
2593463|NCT00290290|6365779|P2|NOT COMPLETED|Overall Study||18
2593464|NCT00290290|6365780|P1|NOT COMPLETED|Overall Study||18
2593465|NCT00290290|6365779|P2|COMPLETED|Overall Study||391
2593466|NCT00290290|6365780|P1|COMPLETED|Overall Study||422
2593467|NCT00290290|6365779|P2|STARTED|Overall Study||409
2593468|NCT00290290|6365780|P1|STARTED|Overall Study||440
2593469|NCT00290251|6365786|P3|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
2593470|NCT00290251|6365787|P2|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
2593471|NCT00290251|6365788|P1|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
2593472|NCT00290251|6365786|P3|COMPLETED|Elective Extension (to 12 Months no Rx)||5
2593473|NCT00290251|6365787|P2|COMPLETED|Elective Extension (to 12 Months no Rx)||3
2593474|NCT00290251|6365788|P1|COMPLETED|Elective Extension (to 12 Months no Rx)||5
2593475|NCT00290251|6365786|P3|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|5
2593476|NCT00290251|6365787|P2|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|3
2593477|NCT00290251|6365788|P1|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|5
2593478|NCT00290251|6365786|P3|NOT COMPLETED|Treatment 2 (Months 4 - 6)||0
2593479|NCT00290251|6365787|P2|NOT COMPLETED|Treatment 2 (Months 4 - 6)||0
2593480|NCT00290251|6365788|P1|NOT COMPLETED|Treatment 2 (Months 4 - 6)||2
2593481|NCT00290251|6365786|P3|COMPLETED|Treatment 2 (Months 4 - 6)||0
2593482|NCT00290251|6365787|P2|COMPLETED|Treatment 2 (Months 4 - 6)||5
2593483|NCT00290251|6365788|P1|COMPLETED|Treatment 2 (Months 4 - 6)||6
2593484|NCT00290251|6365786|P3|STARTED|Treatment 2 (Months 4 - 6)|Women were randomized from PLC to ulipristal acetate or continued same dose ulipristal acetate|0
2593485|NCT00290251|6365787|P2|STARTED|Treatment 2 (Months 4 - 6)|2 crossed over from placebo; others in treatment 1 PLC or ulipristal acetate 10 grp did not continue|5
2593486|NCT00290251|6365788|P1|STARTED|Treatment 2 (Months 4 - 6)|2 crossed over from placebo; others in treatment 1 PLC or ulipristal acetate 20 did not continue|8
2593487|NCT00290251|6365786|P3|NOT COMPLETED|Treatment 1 (Months 1 - 3)||2
2593488|NCT00290251|6365787|P2|NOT COMPLETED|Treatment 1 (Months 1 - 3)||1
2593489|NCT00290251|6365788|P1|NOT COMPLETED|Treatment 1 (Months 1 - 3)||1
2593490|NCT00290251|6365786|P3|COMPLETED|Treatment 1 (Months 1 - 3)||12
2593491|NCT00290251|6365787|P2|COMPLETED|Treatment 1 (Months 1 - 3)||13
2593492|NCT00290251|6365788|P1|COMPLETED|Treatment 1 (Months 1 - 3)||13
2593493|NCT00290251|6365786|P3|STARTED|Treatment 1 (Months 1 - 3)||14
2593494|NCT00290251|6365787|P2|STARTED|Treatment 1 (Months 1 - 3)||14
2593495|NCT00290251|6365788|P1|STARTED|Treatment 1 (Months 1 - 3)||14
2593496|NCT00290238|6365800|P2|NOT COMPLETED|Overall Study||41
2593497|NCT00290238|6365801|P1|NOT COMPLETED|Overall Study||42
2593498|NCT00290238|6365800|P2|COMPLETED|Overall Study||24
2593499|NCT00290238|6365801|P1|COMPLETED|Overall Study||15
2593500|NCT00290238|6365800|P2|STARTED|Overall Study|One subject had an invalid birth date and was excluded from the Age Categorical counts.|65
2593501|NCT00290238|6365801|P1|STARTED|Overall Study||57
2593502|NCT00290199|6365811|P2|NOT COMPLETED|Overall Study||0
2593503|NCT00290199|6365812|P1|NOT COMPLETED|Overall Study||0
2593504|NCT00290199|6365811|P2|COMPLETED|Overall Study||82
2593505|NCT00290199|6365812|P1|COMPLETED|Overall Study||87
2593506|NCT00290199|6365811|P2|STARTED|Overall Study||82
2593507|NCT00290199|6365812|P1|STARTED|Overall Study||87
2593508|NCT00290186|6365826|P2|NOT COMPLETED|Overall Study||5
2593509|NCT00290186|6365827|P1|NOT COMPLETED|Overall Study||5
2593510|NCT00290186|6365826|P2|COMPLETED|Overall Study||19
2593511|NCT00290186|6365827|P1|COMPLETED|Overall Study||20
2593512|NCT00290186|6365826|P2|Completed 6-month Followup Assessments|Overall Study||19
2593513|NCT00290186|6365827|P1|Completed 6-month Followup Assessments|Overall Study||20
2593514|NCT00290186|6365826|P2|Completed 3-month Followup Assessments|Overall Study||21
2593515|NCT00290186|6365827|P1|Completed 3-month Followup Assessments|Overall Study||20
2593516|NCT00290186|6365826|P2|Completed Post-treatment Assessments|Overall Study||22
2593517|NCT00290186|6365827|P1|Completed Post-treatment Assessments|Overall Study||24
2593518|NCT00290186|6365826|P2|Completed 8 Weeks of Treatment|Overall Study||22
2593519|NCT00290186|6365827|P1|Completed 8 Weeks of Treatment|Overall Study||24
2593520|NCT00290186|6365826|P2|Completed Baseline Assessments|Overall Study||24
2593521|NCT00290186|6365827|P1|Completed Baseline Assessments|Overall Study||25
2593522|NCT00290186|6365826|P2|STARTED|Overall Study||24
2593523|NCT00290186|6365827|P1|STARTED|Overall Study||25
2593524|NCT00290147|6365867|P2|NOT COMPLETED|Overall Study||0
2593525|NCT00290147|6365868|P1|NOT COMPLETED|Overall Study||0
2593526|NCT00290147|6365867|P2|COMPLETED|Overall Study||12
2593527|NCT00290147|6365868|P1|COMPLETED|Overall Study||10
2593528|NCT00290147|6365867|P2|STARTED|Overall Study||12
2593529|NCT00290147|6365868|P1|STARTED|Overall Study||10
2593530|NCT00289991|6365878|P2|NOT COMPLETED|Overall Study||80
2593531|NCT00289991|6365879|P1|NOT COMPLETED|Overall Study||58
2593532|NCT00289991|6365878|P2|COMPLETED|Overall Study||175
2593533|NCT00289991|6365879|P1|COMPLETED|Overall Study||176
2593534|NCT00289991|6365878|P2|STARTED|Overall Study||255
2593535|NCT00289991|6365879|P1|STARTED|Overall Study||234
2593536|NCT00289978|6365904|P3|NOT COMPLETED|Overall Study||86
2593537|NCT00289978|6365905|P2|NOT COMPLETED|Overall Study||56
2593538|NCT00289978|6365906|P1|NOT COMPLETED|Overall Study||97
2593539|NCT00289978|6365904|P3|COMPLETED|Overall Study|303 completed on study drug, 29 completed off study drug.|332
2593540|NCT00289978|6365905|P2|COMPLETED|Overall Study|345 completed on study drug, 24 completed off study drug.|369
2593541|NCT00289978|6365906|P1|COMPLETED|Overall Study|296 completed on study drug, 35 completed off study drug.|332
2593542|NCT00289978|6365904|P3|STARTED|Overall Study||418
2593543|NCT00289978|6365905|P2|STARTED|Overall Study||425
2593544|NCT00289978|6365906|P1|STARTED|Overall Study||429
2593545|NCT00289913|6365925|P5|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
2593546|NCT00289913|6365926|P4|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
2593547|NCT00289913|6365927|P3|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
2593548|NCT00289913|6365928|P2|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
2593549|NCT00289913|6365929|P1|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
2593550|NCT00289913|6365925|P5|COMPLETED|Visit 4 (Stage I and Stage II)||597
2593551|NCT00289913|6365926|P4|COMPLETED|Visit 4 (Stage I and Stage II)||131
2593552|NCT00289913|6365927|P3|COMPLETED|Visit 4 (Stage I and Stage II)||138
2593553|NCT00289913|6365928|P2|COMPLETED|Visit 4 (Stage I and Stage II)||106
2593554|NCT00289913|6365929|P1|COMPLETED|Visit 4 (Stage I and Stage II)||122
2593555|NCT00289913|6365925|P5|STARTED|Visit 4 (Stage I and Stage II)||597
2593556|NCT00289913|6365926|P4|STARTED|Visit 4 (Stage I and Stage II)||131
2593557|NCT00289913|6365927|P3|STARTED|Visit 4 (Stage I and Stage II)||138
2593558|NCT00289913|6365928|P2|STARTED|Visit 4 (Stage I and Stage II)||106
2593559|NCT00289913|6365929|P1|STARTED|Visit 4 (Stage I and Stage II)||122
2593560|NCT00289913|6365925|P5|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
2593561|NCT00289913|6365926|P4|NOT COMPLETED|Visit 3 (Stage I and Stage II)||4
2593562|NCT00289913|6365927|P3|NOT COMPLETED|Visit 3 (Stage I and Stage II)||2
2593563|NCT00289913|6365928|P2|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
2593564|NCT00289913|6365929|P1|NOT COMPLETED|Visit 3 (Stage I and Stage II)||9
2593565|NCT00289913|6365925|P5|COMPLETED|Visit 3 (Stage I and Stage II)||597
2593566|NCT00289913|6365926|P4|COMPLETED|Visit 3 (Stage I and Stage II)||131
2593567|NCT00289913|6365927|P3|COMPLETED|Visit 3 (Stage I and Stage II)||138
2593568|NCT00289913|6365928|P2|COMPLETED|Visit 3 (Stage I and Stage II)||106
2593569|NCT00289913|6365929|P1|COMPLETED|Visit 3 (Stage I and Stage II)||122
2593570|NCT00289913|6365925|P5|STARTED|Visit 3 (Stage I and Stage II)||605
2593571|NCT00289913|6365926|P4|STARTED|Visit 3 (Stage I and Stage II)||135
2593572|NCT00289913|6365927|P3|STARTED|Visit 3 (Stage I and Stage II)||140
2593573|NCT00289913|6365928|P2|STARTED|Visit 3 (Stage I and Stage II)||114
2593574|NCT00289913|6365929|P1|STARTED|Visit 3 (Stage I and Stage II)||131
2593575|NCT00289913|6365925|P5|NOT COMPLETED|Visit 2 (Stage I and Stage II)||40
2593576|NCT00289913|6365926|P4|NOT COMPLETED|Visit 2 (Stage I and Stage II)||6
2593577|NCT00289913|6365927|P3|NOT COMPLETED|Visit 2 (Stage I and Stage II)||10
2593578|NCT00289913|6365928|P2|NOT COMPLETED|Visit 2 (Stage I and Stage II)||21
2593579|NCT00289913|6365929|P1|NOT COMPLETED|Visit 2 (Stage I and Stage II)||15
2593580|NCT00289913|6365925|P5|COMPLETED|Visit 2 (Stage I and Stage II)||605
2593581|NCT00289913|6365926|P4|COMPLETED|Visit 2 (Stage I and Stage II)||135
2593582|NCT00289913|6365927|P3|COMPLETED|Visit 2 (Stage I and Stage II)||140
2593583|NCT00289913|6365928|P2|COMPLETED|Visit 2 (Stage I and Stage II)||114
2593584|NCT00289913|6365929|P1|COMPLETED|Visit 2 (Stage I and Stage II)||131
2593585|NCT00289913|6365925|P5|STARTED|Visit 2 (Stage I and Stage II)|No vaccine administered at Visit 2 (Stage II), therefore there was no safety F/U period.|645
2593586|NCT00289913|6365926|P4|STARTED|Visit 2 (Stage I and Stage II)||141
2593587|NCT00289913|6365927|P3|STARTED|Visit 2 (Stage I and Stage II)||150
2593588|NCT00289913|6365928|P2|STARTED|Visit 2 (Stage I and Stage II)||135
2593589|NCT00289913|6365929|P1|STARTED|Visit 2 (Stage I and Stage II)||146
2593590|NCT00289913|6365925|P5|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
2593591|NCT00289913|6365926|P4|NOT COMPLETED|Visit 1 (Stage I and Stage II)||11
2593592|NCT00289913|6365927|P3|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
2593593|NCT00289913|6365928|P2|NOT COMPLETED|Visit 1 (Stage I and Stage II)||16
2593594|NCT00289913|6365929|P1|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
2593595|NCT00289913|6365925|P5|COMPLETED|Visit 1 (Stage I and Stage II)||645
2593596|NCT00289913|6365926|P4|COMPLETED|Visit 1 (Stage I and Stage II)||141
2593597|NCT00289913|6365927|P3|COMPLETED|Visit 1 (Stage I and Stage II)||150
2593598|NCT00289913|6365928|P2|COMPLETED|Visit 1 (Stage I and Stage II)||135
2593599|NCT00289913|6365929|P1|COMPLETED|Visit 1 (Stage I and Stage II)||146
2593600|NCT00289913|6365925|P5|STARTED|Visit 1 (Stage I and Stage II)|Participants were enrolled during Stage II.|654
2593601|NCT00289913|6365926|P4|STARTED|Visit 1 (Stage I and Stage II)||152
2593602|NCT00289913|6365927|P3|STARTED|Visit 1 (Stage I and Stage II)||159
2593603|NCT00289913|6365928|P2|STARTED|Visit 1 (Stage I and Stage II)||151
2593604|NCT00289913|6365929|P1|STARTED|Visit 1 (Stage I and Stage II)||155
2593605|NCT00289900|6365960|P6|NOT COMPLETED|Overall Study||61
2593606|NCT00289900|6365961|P5|NOT COMPLETED|Overall Study||45
2593607|NCT00289900|6365962|P4|NOT COMPLETED|Overall Study||59
2593608|NCT00289900|6365963|P3|NOT COMPLETED|Overall Study||33
2593609|NCT00289900|6365964|P2|NOT COMPLETED|Overall Study||120
2593610|NCT00289900|6365965|P1|NOT COMPLETED|Overall Study||68
2593611|NCT00289900|6365960|P6|COMPLETED|Overall Study||372
2593612|NCT00289900|6365961|P5|COMPLETED|Overall Study||392
2593613|NCT00289900|6365962|P4|COMPLETED|Overall Study||380
2593614|NCT00289900|6365963|P3|COMPLETED|Overall Study||265
2593615|NCT00289900|6365964|P2|COMPLETED|Overall Study||316
2593616|NCT00289900|6365965|P1|COMPLETED|Overall Study||229
2593617|NCT00289900|6365960|P6|Treated|Overall Study||433
2593618|NCT00289900|6365961|P5|Treated|Overall Study||437
2593619|NCT00289900|6365962|P4|Treated|Overall Study||439
2593620|NCT00289900|6365963|P3|Treated|Overall Study||298
2593621|NCT00289900|6365964|P2|Treated|Overall Study||435
2593622|NCT00289900|6365965|P1|Treated|Overall Study||297
2593623|NCT00289900|6365960|P6|STARTED|Overall Study||433
2593624|NCT00289900|6365961|P5|STARTED|Overall Study||437
2593625|NCT00289900|6365962|P4|STARTED|Overall Study||439
2593626|NCT00289900|6365963|P3|STARTED|Overall Study||298
2593627|NCT00289900|6365964|P2|STARTED|Overall Study||436
2593628|NCT00289900|6365965|P1|STARTED|Overall Study||297
2593629|NCT00289887|6366069|P2|NOT COMPLETED|Overall Study||29
2593630|NCT00289887|6366070|P1|NOT COMPLETED|Overall Study||22
2593631|NCT00289887|6366069|P2|COMPLETED|Overall Study||105
2593632|NCT00289887|6366070|P1|COMPLETED|Overall Study||105
2593633|NCT00289887|6366069|P2|STARTED|Overall Study||134
2593634|NCT00289887|6366070|P1|STARTED|Overall Study||127
2593635|NCT00289874|6366088|P2|NOT COMPLETED|Overall Study||8
2593636|NCT00289874|6366089|P1|NOT COMPLETED|Overall Study||6
2593637|NCT00289874|6366088|P2|COMPLETED|Overall Study||210
2593638|NCT00289874|6366089|P1|COMPLETED|Overall Study||197
2593639|NCT00289874|6366088|P2|STARTED|Overall Study||218
2593640|NCT00289874|6366089|P1|STARTED|Overall Study||203
2593641|NCT00289848|6366099|P2|NOT COMPLETED|Overall Study||45
2593642|NCT00289848|6366100|P1|NOT COMPLETED|Overall Study||46
2593643|NCT00289848|6366099|P2|COMPLETED|Overall Study||133
2593644|NCT00289848|6366100|P1|COMPLETED|Overall Study||306
2593645|NCT00289848|6366099|P2|STARTED|Overall Study||178
2593646|NCT00289848|6366100|P1|STARTED|Overall Study||352
2593647|NCT00289783|6366112|P2|NOT COMPLETED|Fourth Dose Phase||24
2593648|NCT00289783|6366113|P1|NOT COMPLETED|Fourth Dose Phase||87
2593649|NCT00289783|6366112|P2|COMPLETED|Fourth Dose Phase||899
2593650|NCT00289783|6366113|P1|COMPLETED|Fourth Dose Phase||2682
2593651|NCT00289783|6366112|P2|STARTED|Fourth Dose Phase||923
2593652|NCT00289783|6366113|P1|STARTED|Fourth Dose Phase||2769
2593653|NCT00289783|6366112|P2|NOT COMPLETED|Primary Phase||83
2593654|NCT00289783|6366113|P1|NOT COMPLETED|Primary Phase||248
2593655|NCT00289783|6366112|P2|COMPLETED|Primary Phase||961
2593656|NCT00289783|6366113|P1|COMPLETED|Primary Phase||2888
2593657|NCT00289783|6366112|P2|STARTED|Primary Phase||1044
2593658|NCT00289783|6366113|P1|STARTED|Primary Phase||3136
2593659|NCT00289770|6366291|P1|NOT COMPLETED|Year 15||1
2593660|NCT00289770|6366291|P1|COMPLETED|Year 15||49
2593661|NCT00289770|6366291|P1|STARTED|Year 15||50
2593662|NCT00289770|6366291|P1|NOT COMPLETED|Year 14||0
2593663|NCT00289770|6366291|P1|COMPLETED|Year 14||43
2593664|NCT00289770|6366291|P1|STARTED|Year 14||43
2593665|NCT00289770|6366291|P1|NOT COMPLETED|Year 13||0
2593666|NCT00289770|6366291|P1|COMPLETED|Year 13||37
2593667|NCT00289770|6366291|P1|STARTED|Year 13||37
2593668|NCT00289770|6366291|P1|NOT COMPLETED|Year 12||0
2593669|NCT00289770|6366291|P1|COMPLETED|Year 12||40
2593670|NCT00289770|6366291|P1|STARTED|Year 12||40
2593671|NCT00289770|6366291|P1|NOT COMPLETED|Year 11||0
2593672|NCT00289770|6366291|P1|COMPLETED|Year 11||37
2593673|NCT00289770|6366291|P1|STARTED|Year 11||37
2593674|NCT00289757|6366303|P1|NOT COMPLETED|Overall Study||0
2593675|NCT00289757|6366303|P1|COMPLETED|Overall Study||78
2593676|NCT00289757|6366303|P1|STARTED|Overall Study||78
2593677|NCT00289744|6366314|P3|NOT COMPLETED|Additional Dose Phase||0
2593678|NCT00289744|6366315|P2|NOT COMPLETED|Additional Dose Phase||0
2593679|NCT00289744|6366316|P1|NOT COMPLETED|Additional Dose Phase||0
2593680|NCT00289744|6366314|P3|COMPLETED|Additional Dose Phase||6
2593681|NCT00289744|6366315|P2|COMPLETED|Additional Dose Phase||19
2593682|NCT00289744|6366316|P1|COMPLETED|Additional Dose Phase||0
2593683|NCT00289744|6366314|P3|STARTED|Additional Dose Phase||6
2593684|NCT00289744|6366315|P2|STARTED|Additional Dose Phase||19
2593685|NCT00289744|6366316|P1|STARTED|Additional Dose Phase||0
2593686|NCT00289744|6366314|P3|NOT COMPLETED|Year 10 Long-term Follow-up||0
2593687|NCT00289744|6366315|P2|NOT COMPLETED|Year 10 Long-term Follow-up||0
2593688|NCT00289744|6366316|P1|NOT COMPLETED|Year 10 Long-term Follow-up||0
2593689|NCT00289744|6366314|P3|COMPLETED|Year 10 Long-term Follow-up||0
2593690|NCT00289744|6366315|P2|COMPLETED|Year 10 Long-term Follow-up||0
2593691|NCT00289744|6366316|P1|COMPLETED|Year 10 Long-term Follow-up||171
2593692|NCT00289744|6366314|P3|STARTED|Year 10 Long-term Follow-up||0
2593693|NCT00289744|6366315|P2|STARTED|Year 10 Long-term Follow-up||0
2593694|NCT00289744|6366316|P1|STARTED|Year 10 Long-term Follow-up|Subjects who came back at Year 10 blood sampling time-point|171
2593695|NCT00289744|6366314|P3|NOT COMPLETED|Year 9 Long-term Follow-up||0
2593696|NCT00289744|6366315|P2|NOT COMPLETED|Year 9 Long-term Follow-up||0
2593697|NCT00289744|6366316|P1|NOT COMPLETED|Year 9 Long-term Follow-up||0
2593698|NCT00289744|6366314|P3|COMPLETED|Year 9 Long-term Follow-up||0
2593699|NCT00289744|6366315|P2|COMPLETED|Year 9 Long-term Follow-up||0
2593700|NCT00289744|6366316|P1|COMPLETED|Year 9 Long-term Follow-up||173
2593701|NCT00289744|6366314|P3|STARTED|Year 9 Long-term Follow-up||0
2593702|NCT00289744|6366315|P2|STARTED|Year 9 Long-term Follow-up||0
2593703|NCT00289744|6366316|P1|STARTED|Year 9 Long-term Follow-up|Subjects who came back at Year 9 blood sampling time-point|173
2593704|NCT00289744|6366314|P3|NOT COMPLETED|Year 8 Long-term Follow-up||0
2593705|NCT00289744|6366315|P2|NOT COMPLETED|Year 8 Long-term Follow-up||0
2593706|NCT00289744|6366316|P1|NOT COMPLETED|Year 8 Long-term Follow-up||0
2593707|NCT00289744|6366314|P3|COMPLETED|Year 8 Long-term Follow-up||0
2593708|NCT00289744|6366315|P2|COMPLETED|Year 8 Long-term Follow-up||0
2593709|NCT00289744|6366316|P1|COMPLETED|Year 8 Long-term Follow-up||174
2593710|NCT00289744|6366314|P3|STARTED|Year 8 Long-term Follow-up||0
2593711|NCT00289744|6366315|P2|STARTED|Year 8 Long-term Follow-up||0
2593712|NCT00289744|6366316|P1|STARTED|Year 8 Long-term Follow-up|Subjects who came back at Year 8 blood sampling time-point|174
2593713|NCT00289744|6366314|P3|NOT COMPLETED|Year 7 Long-term Follow-up||0
2593714|NCT00289744|6366315|P2|NOT COMPLETED|Year 7 Long-term Follow-up||0
2593715|NCT00289744|6366316|P1|NOT COMPLETED|Year 7 Long-term Follow-up||0
2593716|NCT00289744|6366314|P3|COMPLETED|Year 7 Long-term Follow-up||0
2593717|NCT00289744|6366315|P2|COMPLETED|Year 7 Long-term Follow-up||0
2593718|NCT00289744|6366316|P1|COMPLETED|Year 7 Long-term Follow-up||175
2593719|NCT00289744|6366314|P3|STARTED|Year 7 Long-term Follow-up||0
2593720|NCT00289744|6366315|P2|STARTED|Year 7 Long-term Follow-up||0
2593721|NCT00289744|6366316|P1|STARTED|Year 7 Long-term Follow-up|Subjects who came back at Year 7 blood sampling time-point|175
2593722|NCT00289744|6366314|P3|NOT COMPLETED|Year 6 Long-term Follow-up||0
2593723|NCT00289744|6366315|P2|NOT COMPLETED|Year 6 Long-term Follow-up||0
2593724|NCT00289744|6366316|P1|NOT COMPLETED|Year 6 Long-term Follow-up||0
2593725|NCT00289744|6366314|P3|COMPLETED|Year 6 Long-term Follow-up||0
2593726|NCT00289744|6366315|P2|COMPLETED|Year 6 Long-term Follow-up||0
2593727|NCT00289744|6366316|P1|COMPLETED|Year 6 Long-term Follow-up||178
2593728|NCT00289744|6366314|P3|STARTED|Year 6 Long-term Follow-up||0
2593729|NCT00289744|6366315|P2|STARTED|Year 6 Long-term Follow-up||0
2593730|NCT00289744|6366316|P1|STARTED|Year 6 Long-term Follow-up|Number of subjects who come back at Year 6 blood sampling time-point|178
2593731|NCT00289731|6366337|P3|NOT COMPLETED|Overall Study||2
2593732|NCT00289731|6366338|P2|NOT COMPLETED|Overall Study||2
2593733|NCT00289731|6366339|P1|NOT COMPLETED|Overall Study||2
2593734|NCT00289731|6366337|P3|COMPLETED|Overall Study||195
2593735|NCT00289731|6366338|P2|COMPLETED|Overall Study||198
2593736|NCT00289731|6366339|P1|COMPLETED|Overall Study||197
2593737|NCT00289731|6366337|P3|STARTED|Overall Study||197
2593738|NCT00289731|6366338|P2|STARTED|Overall Study||200
2593739|NCT00289731|6366339|P1|STARTED|Overall Study||199
2593740|NCT00289718|6366431|P1|NOT COMPLETED|Overall Study||0
2593741|NCT00289718|6366431|P1|COMPLETED|Overall Study||51
2593742|NCT00289718|6366431|P1|STARTED|Overall Study||51
2593743|NCT00289653|6366446|P1|NOT COMPLETED|Overall Study||11
2593744|NCT00289653|6366446|P1|COMPLETED|Overall Study||12
2593745|NCT00289653|6366446|P1|STARTED|Overall Study||23
2593746|NCT00289536|6366451|P3|NOT COMPLETED|Period 3||1
2593747|NCT00289536|6366452|P2|NOT COMPLETED|Period 3||0
2593748|NCT00289536|6366453|P1|NOT COMPLETED|Period 3||0
2593749|NCT00289536|6366451|P3|COMPLETED|Period 3||9
2593750|NCT00289536|6366452|P2|COMPLETED|Period 3||9
2593751|NCT00289536|6366453|P1|COMPLETED|Period 3||7
2593752|NCT00289536|6366451|P3|STARTED|Period 3|5 participants received Low Dose and 5 participants received Medium Dose in Period 2|10
2593753|NCT00289536|6366452|P2|STARTED|Period 3|5 participants received Low Dose and 4 participants received High Dose in Period 2|9
2593754|NCT00289536|6366453|P1|STARTED|Period 3|3 participants received Medium Dose and 4 participants received High Dose in Period 2|7
2593755|NCT00289536|6366451|P3|NOT COMPLETED|Period 2||0
2593756|NCT00289536|6366452|P2|NOT COMPLETED|Period 2||0
2593757|NCT00289536|6366453|P1|NOT COMPLETED|Period 2||0
2593758|NCT00289536|6366451|P3|COMPLETED|Period 2||7
2593759|NCT00289536|6366452|P2|COMPLETED|Period 2||9
2593760|NCT00289536|6366453|P1|COMPLETED|Period 2||10
2593761|NCT00289536|6366451|P3|STARTED|Period 2|4 participants received Low Dose and 3 participants received Medium Dose in Period 1|7
2593762|NCT00289536|6366452|P2|STARTED|Period 2|5 participants received Low Dose and 4 participants received High Dose in Period 1|9
2593763|NCT00289536|6366453|P1|STARTED|Period 2|5 participants received Medium Dose and 5 participants received High Dose in Period 1|10
2593764|NCT00289536|6366451|P3|NOT COMPLETED|Period 1||0
2593765|NCT00289536|6366452|P2|NOT COMPLETED|Period 1||0
2593766|NCT00289536|6366453|P1|NOT COMPLETED|Period 1||0
2593767|NCT00289536|6366451|P3|COMPLETED|Period 1||9
2593768|NCT00289536|6366452|P2|COMPLETED|Period 1||8
2593769|NCT00289536|6366453|P1|COMPLETED|Period 1||9
2593770|NCT00289536|6366451|P3|STARTED|Period 1||9
2593771|NCT00289536|6366452|P2|STARTED|Period 1||8
2593772|NCT00289536|6366453|P1|STARTED|Period 1||9
2593773|NCT00289471|6366492|P1|NOT COMPLETED|Overall Study||0
2593774|NCT00289471|6366492|P1|COMPLETED|Overall Study||630
2593775|NCT00289471|6366492|P1|STARTED|Overall Study||630
2593776|NCT00289458|6366499|P3|NOT COMPLETED|Overall Study||6
2593777|NCT00289458|6366500|P2|NOT COMPLETED|Overall Study||6
2593778|NCT00289458|6366501|P1|NOT COMPLETED|Overall Study||6
2593779|NCT00289458|6366499|P3|COMPLETED|Overall Study||22
2593780|NCT00289458|6366500|P2|COMPLETED|Overall Study||20
2593781|NCT00289458|6366501|P1|COMPLETED|Overall Study||19
2593782|NCT00289458|6366499|P3|STARTED|Overall Study||28
2593783|NCT00289458|6366500|P2|STARTED|Overall Study||26
2593784|NCT00289458|6366501|P1|STARTED|Overall Study||25
2593785|NCT00289341|6366526|P2|NOT COMPLETED|Overall Study||0
2593786|NCT00289341|6366527|P1|NOT COMPLETED|Overall Study||0
2593787|NCT00289341|6366526|P2|COMPLETED|Overall Study||12
2593788|NCT00289341|6366527|P1|COMPLETED|Overall Study||12
2593789|NCT00289341|6366526|P2|STARTED|Overall Study||12
2593790|NCT00289341|6366527|P1|STARTED|Overall Study||12
2593791|NCT00289315|6366540|P3|NOT COMPLETED|Overall Study||140
2593792|NCT00289315|6366541|P2|NOT COMPLETED|Overall Study||122
2593793|NCT00289315|6366542|P1|NOT COMPLETED|Overall Study||101
2593794|NCT00289315|6366540|P3|COMPLETED|Overall Study||447
2593795|NCT00289315|6366541|P2|COMPLETED|Overall Study||638
2593796|NCT00289315|6366542|P1|COMPLETED|Overall Study||612
2593797|NCT00289315|6366540|P3|STARTED|Overall Study||587
2593798|NCT00289315|6366541|P2|STARTED|Overall Study||760
2593799|NCT00289315|6366542|P1|STARTED|Overall Study||713
2593800|NCT00289289|6366562|P3|NOT COMPLETED|Overall Study||49
2593801|NCT00289289|6366563|P2|NOT COMPLETED|Overall Study||10
2593802|NCT00289289|6366564|P1|NOT COMPLETED|Overall Study||19
2593803|NCT00289289|6366562|P3|COMPLETED|Overall Study||95
2593804|NCT00289289|6366563|P2|COMPLETED|Overall Study||114
2593805|NCT00289289|6366564|P1|COMPLETED|Overall Study||113
2593806|NCT00289289|6366562|P3|STARTED|Overall Study||144
2593807|NCT00289289|6366563|P2|STARTED|Overall Study||124
2593808|NCT00289289|6366564|P1|STARTED|Overall Study||132
2593809|NCT00289276|6366579|P2|NOT COMPLETED|Second Part of FAST Study (Expansion)||3
2593810|NCT00289276|6366580|P1|NOT COMPLETED|Second Part of FAST Study (Expansion)||0
2593811|NCT00289276|6366579|P2|COMPLETED|Second Part of FAST Study (Expansion)||106
2593812|NCT00289276|6366580|P1|COMPLETED|Second Part of FAST Study (Expansion)||0
2593813|NCT00289276|6366579|P2|STARTED|Second Part of FAST Study (Expansion)||109
2593814|NCT00289276|6366580|P1|STARTED|Second Part of FAST Study (Expansion)||0
2593815|NCT00289276|6366579|P2|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
2593816|NCT00289276|6366580|P1|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
2593817|NCT00289276|6366579|P2|COMPLETED|First Part of FAST Study (Pivotal)||0
2593818|NCT00289276|6366580|P1|COMPLETED|First Part of FAST Study (Pivotal)||47
2593819|NCT00289276|6366579|P2|STARTED|First Part of FAST Study (Pivotal)||0
2593820|NCT00289276|6366580|P1|STARTED|First Part of FAST Study (Pivotal)|11 patients were re-consented under version 7 of the CIP, but are included in Pivotal results only|47
2593821|NCT00289211|6366595|P3|NOT COMPLETED|Overall Study||10
2593822|NCT00289211|6366596|P2|NOT COMPLETED|Overall Study||1
2593823|NCT00289211|6366597|P1|NOT COMPLETED|Overall Study||0
2593824|NCT00289211|6366595|P3|COMPLETED|Overall Study||2
2593825|NCT00289211|6366596|P2|COMPLETED|Overall Study||34
2593826|NCT00289211|6366597|P1|COMPLETED|Overall Study||36
2593827|NCT00289211|6366595|P3|STARTED|Overall Study||12
2593828|NCT00289211|6366596|P2|STARTED|Overall Study||35
2593829|NCT00289211|6366597|P1|STARTED|Overall Study||36
2593830|NCT00289198|6366615|P2|NOT COMPLETED|Overall Study||30
2593831|NCT00289198|6366616|P1|NOT COMPLETED|Overall Study||31
2593832|NCT00289198|6366615|P2|COMPLETED|Overall Study||121
2593833|NCT00289198|6366616|P1|COMPLETED|Overall Study||120
2593834|NCT00289198|6366615|P2|STARTED|Overall Study||151
2593835|NCT00289198|6366616|P1|STARTED|Overall Study||151
2593836|NCT00289185|6366666|P2|NOT COMPLETED|Overall Study||26
2593837|NCT00289185|6366667|P1|NOT COMPLETED|Overall Study||28
2593838|NCT00289185|6366666|P2|COMPLETED|Overall Study||144
2593839|NCT00289185|6366667|P1|COMPLETED|Overall Study||142
2593840|NCT00289185|6366666|P2|STARTED|Overall Study||170
2593841|NCT00289185|6366667|P1|STARTED|Overall Study||170
2593842|NCT00289133|6366714|P2|NOT COMPLETED|Overall Study||298
2593843|NCT00289133|6366715|P1|NOT COMPLETED|Overall Study||272
2593844|NCT00289133|6366714|P2|COMPLETED|Overall Study||179
2593845|NCT00289133|6366715|P1|COMPLETED|Overall Study||189
2593846|NCT00289133|6366714|P2|STARTED|Overall Study||477
2593847|NCT00289133|6366715|P1|STARTED|Overall Study||461
2593848|NCT00289120|6366737|P1|NOT COMPLETED|Overall Study||0
2593849|NCT00289120|6366737|P1|COMPLETED|Overall Study||13
2593850|NCT00289120|6366737|P1|STARTED|Overall Study||13
2593851|NCT00289107|6366755|P2|NOT COMPLETED|Overall Study||44
2593852|NCT00289107|6366756|P1|NOT COMPLETED|Overall Study||53
2593853|NCT00289107|6366755|P2|COMPLETED|Overall Study||28
2593854|NCT00289107|6366756|P1|COMPLETED|Overall Study||24
2593855|NCT00289107|6366755|P2|STARTED|Overall Study||72
2593856|NCT00289107|6366756|P1|STARTED|Overall Study||77
2593857|NCT00289094|6366764|P2|NOT COMPLETED|Overall Study||47
2593858|NCT00289094|6366765|P1|NOT COMPLETED|Overall Study||47
2593859|NCT00289094|6366764|P2|COMPLETED|Overall Study||2
2593860|NCT00289094|6366765|P1|COMPLETED|Overall Study||3
2593861|NCT00289094|6366764|P2|STARTED|Overall Study||49
2593862|NCT00289094|6366765|P1|STARTED|Overall Study||50
2593863|NCT00289016|6366771|P1|NOT COMPLETED|Overall Study||37
2593864|NCT00289016|6366771|P1|COMPLETED|Overall Study||13
2593865|NCT00289016|6366771|P1|STARTED|Overall Study||50
2593866|NCT00288912|6366783|P3|NOT COMPLETED|Overall Study||28
2593867|NCT00288912|6366784|P2|NOT COMPLETED|Overall Study||17
2593868|NCT00288912|6366785|P1|NOT COMPLETED|Overall Study||17
2593869|NCT00288912|6366783|P3|COMPLETED|Overall Study||146
2593870|NCT00288912|6366784|P2|COMPLETED|Overall Study||157
2593871|NCT00288912|6366785|P1|COMPLETED|Overall Study||158
2593872|NCT00288912|6366783|P3|STARTED|Overall Study||174
2593873|NCT00288912|6366784|P2|STARTED|Overall Study||174
2593874|NCT00288912|6366785|P1|STARTED|Overall Study||175
2593875|NCT00288886|6366804|P2|NOT COMPLETED|Overall Study||11
2593876|NCT00288886|6366805|P1|NOT COMPLETED|Overall Study||11
2593877|NCT00288886|6366804|P2|COMPLETED|Overall Study||81
2593878|NCT00288886|6366805|P1|COMPLETED|Overall Study||80
2593879|NCT00288886|6366804|P2|12-month Follow Up|Overall Study||81
2593880|NCT00288886|6366805|P1|12-month Follow Up|Overall Study||80
2593881|NCT00288886|6366804|P2|6-month Follow Up|Overall Study||84
2593882|NCT00288886|6366805|P1|6-month Follow Up|Overall Study||85
2593883|NCT00288886|6366804|P2|3-month Follow Up|Overall Study||85
2593884|NCT00288886|6366805|P1|3-month Follow Up|Overall Study||82
2593885|NCT00288886|6366804|P2|STARTED|Overall Study||92
2593886|NCT00288886|6366805|P1|STARTED|Overall Study||91
2593887|NCT00288860|6366825|P2|NOT COMPLETED|Overall Study||97
2593888|NCT00288860|6366826|P1|NOT COMPLETED|Overall Study||102
2593889|NCT00288860|6366825|P2|COMPLETED|Overall Study|328 completed 4 or 12 month survey. Used all with intake (n=417) in intent to treat.|328
2593890|NCT00288860|6366826|P1|COMPLETED|Overall Study|310 completed either 4 or 12 month survey. Used all with intake (n = 408) in intent-to-treat.|310
2593891|NCT00288860|6366825|P2|Completed 12 Month fu Survey|Overall Study||281
2593892|NCT00288860|6366826|P1|Completed 12 Month fu Survey|Overall Study||257
2593893|NCT00288860|6366825|P2|Completed 4 Month fu Survey|Overall Study||299
2593894|NCT00288860|6366826|P1|Completed 4 Month fu Survey|Overall Study||275
2593895|NCT00288860|6366825|P2|Completed Intake Survey|Overall Study||417
2593896|NCT00288860|6366826|P1|Completed Intake Survey|Overall Study||408
2593897|NCT00288860|6366825|P2|STARTED|Overall Study||425
2593898|NCT00288860|6366826|P1|STARTED|Overall Study||412
2593899|NCT00288704|6366839|P3|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||20
2593900|NCT00288704|6366840|P2|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
2593901|NCT00288704|6366841|P1|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
2593902|NCT00288704|6366839|P3|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||81
2593903|NCT00288704|6366840|P2|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
2593904|NCT00288704|6366841|P1|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
2593905|NCT00288704|6366839|P3|STARTED|Open-Label Extension (OLE) Weeks 24-117||101
2593906|NCT00288704|6366840|P2|STARTED|Open-Label Extension (OLE) Weeks 24-117||0
2593907|NCT00288704|6366841|P1|STARTED|Open-Label Extension (OLE) Weeks 24-117|After week 24, all subjects are treated with Open label rilonacept.|0
2593908|NCT00288704|6366839|P3|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
2593909|NCT00288704|6366840|P2|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||1
2593910|NCT00288704|6366841|P1|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
2593911|NCT00288704|6366839|P3|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
2593912|NCT00288704|6366840|P2|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||21
2593913|NCT00288704|6366841|P1|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||23
2593914|NCT00288704|6366839|P3|STARTED|Part B, Randomized Withdrawal, Wks 15-24||0
2593915|NCT00288704|6366840|P2|STARTED|Part B, Randomized Withdrawal, Wks 15-24||22
2593916|NCT00288704|6366841|P1|STARTED|Part B, Randomized Withdrawal, Wks 15-24|1 subject discontinued during weeks 6-14 due to non-compliance with study drug dosing procedures.|23
2593917|NCT00288704|6366839|P3|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
2593918|NCT00288704|6366840|P2|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||1
2593919|NCT00288704|6366841|P1|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
2593920|NCT00288704|6366839|P3|COMPLETED|Part A, Double Blind, Weeks 1-6||0
2593921|NCT00288704|6366840|P2|COMPLETED|Part A, Double Blind, Weeks 1-6||22
2593922|NCT00288704|6366841|P1|COMPLETED|Part A, Double Blind, Weeks 1-6||24
2593923|NCT00288704|6366839|P3|STARTED|Part A, Double Blind, Weeks 1-6|Subjects enrolled into the open-label phase do not complete this part of the study.|0
2593924|NCT00288704|6366840|P2|STARTED|Part A, Double Blind, Weeks 1-6||23
2593925|NCT00288704|6366841|P1|STARTED|Part A, Double Blind, Weeks 1-6||24
2593926|NCT00288639|6366868|P1|NOT COMPLETED|Overall Study||12
2593927|NCT00288639|6366868|P1|COMPLETED|Overall Study||86
2593928|NCT00288639|6366868|P1|STARTED|Overall Study||98
2593929|NCT00288626|6366885|P1|NOT COMPLETED|Overall Study||7
2593930|NCT00288626|6366885|P1|COMPLETED|Overall Study||17
2593931|NCT00288626|6366885|P1|STARTED|Overall Study||24
2593932|NCT00288600|6366910|P2|NOT COMPLETED|Overall Study||0
2593933|NCT00288600|6366911|P1|NOT COMPLETED|Overall Study||0
2593934|NCT00288600|6366910|P2|COMPLETED|Overall Study||46
2593935|NCT00288600|6366911|P1|COMPLETED|Overall Study||46
2593936|NCT00288600|6366910|P2|STARTED|Overall Study||46
2593937|NCT00288600|6366911|P1|STARTED|Overall Study||46
2593938|NCT00288587|6366919|P2|NOT COMPLETED|Overall Study||10
2593939|NCT00288587|6366920|P1|NOT COMPLETED|Overall Study||5
2593940|NCT00288587|6366919|P2|COMPLETED|Overall Study||7
2593941|NCT00288587|6366920|P1|COMPLETED|Overall Study||14
2593942|NCT00288587|6366919|P2|STARTED|Overall Study||17
2593943|NCT00288587|6366920|P1|STARTED|Overall Study||19
2593944|NCT00288574|6366936|P2|NOT COMPLETED|Overall Study||0
2593945|NCT00288574|6366937|P1|NOT COMPLETED|Overall Study||0
2593946|NCT00288574|6366936|P2|COMPLETED|Overall Study||44
2593947|NCT00288574|6366937|P1|COMPLETED|Overall Study||49
2593948|NCT00288574|6366936|P2|STARTED|Overall Study||44
2593949|NCT00288574|6366937|P1|STARTED|Overall Study||49
2593950|NCT00288509|6366963|P1|NOT COMPLETED|Treatment Cycle 4||8
2593951|NCT00288509|6366963|P1|COMPLETED|Treatment Cycle 4||80
2593952|NCT00288509|6366963|P1|STARTED|Treatment Cycle 4|3 subjects completed Cycle 3 but withdrew before Cycle 4, treatment stopped according to protocol|88
2593953|NCT00288509|6366963|P1|NOT COMPLETED|Treatment Cycle 3||5
2593954|NCT00288509|6366963|P1|COMPLETED|Treatment Cycle 3||91
2593955|NCT00288509|6366963|P1|STARTED|Treatment Cycle 3|One subject completed Cycle 2 but withdrew before Cycle 3 due to insufficient clinical response|96
2593956|NCT00288509|6366963|P1|NOT COMPLETED|Treatment Cycle 2||3
2593957|NCT00288509|6366963|P1|COMPLETED|Treatment Cycle 2||97
2593958|NCT00288509|6366963|P1|STARTED|Treatment Cycle 2|2 subjects completed Cycle 1 but withdrew before Cycle 2 due to insufficient clinical response|100
2593959|NCT00288509|6366963|P1|NOT COMPLETED|Treatment Cycle 1||6
2593960|NCT00288509|6366963|P1|COMPLETED|Treatment Cycle 1||102
2593961|NCT00288509|6366963|P1|STARTED|Treatment Cycle 1||108
2593962|NCT00288366|6366972|P2|NOT COMPLETED|Overall Study||0
2593963|NCT00288366|6366973|P1|NOT COMPLETED|Overall Study||0
2593964|NCT00288366|6366972|P2|COMPLETED|Overall Study||26
2593965|NCT00288366|6366973|P1|COMPLETED|Overall Study||23
2593966|NCT00288366|6366972|P2|STARTED|Overall Study||26
2593967|NCT00288366|6366973|P1|STARTED|Overall Study||23
2593968|NCT00288080|6366981|P2|NOT COMPLETED|Overall Study||23
2593969|NCT00288080|6366982|P1|NOT COMPLETED|Overall Study||26
2593970|NCT00288080|6366981|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|282
2593971|NCT00288080|6366982|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|281
2593972|NCT00288080|6366981|P2|STARTED|Overall Study||305
2593973|NCT00288080|6366982|P1|STARTED|Overall Study||307
2593974|NCT00288067|6366998|P1|NOT COMPLETED|Overall Study||0
2593975|NCT00288067|6366998|P1|COMPLETED|Overall Study||32
2593976|NCT00288067|6366998|P1|STARTED|Overall Study||32
2593977|NCT00288054|6367004|P1|NOT COMPLETED|Overall Study||24
2593978|NCT00288054|6367004|P1|COMPLETED|Overall Study||0
2593979|NCT00288054|6367004|P1|STARTED|Overall Study||24
2593980|NCT00288015|6367012|P1|NOT COMPLETED|Follow up for Survival x 2 Years||26
2593981|NCT00288015|6367012|P1|COMPLETED|Follow up for Survival x 2 Years||3
2593982|NCT00288015|6367012|P1|STARTED|Follow up for Survival x 2 Years||29
2593983|NCT00288015|6367012|P1|NOT COMPLETED|Continued Bevacizumab Cycle 3+||7
2593984|NCT00288015|6367012|P1|COMPLETED|Continued Bevacizumab Cycle 3+||19
2593985|NCT00288015|6367012|P1|STARTED|Continued Bevacizumab Cycle 3+||26
2593986|NCT00288015|6367012|P1|NOT COMPLETED|First Response Assessment||4
2593987|NCT00288015|6367012|P1|COMPLETED|First Response Assessment||26
2593988|NCT00288015|6367012|P1|STARTED|First Response Assessment||30
2593989|NCT00288015|6367012|P1|NOT COMPLETED|Bevacizumab Treatment Cycles 1-2||2
2593990|NCT00288015|6367012|P1|COMPLETED|Bevacizumab Treatment Cycles 1-2||30
2593991|NCT00288015|6367012|P1|STARTED|Bevacizumab Treatment Cycles 1-2||32
2593992|NCT00288015|6367012|P1|NOT COMPLETED|Registered to Study||0
2593993|NCT00288015|6367012|P1|COMPLETED|Registered to Study||32
2593994|NCT00288015|6367012|P1|STARTED|Registered to Study||32
2593995|NCT00287989|6367024|P3|NOT COMPLETED|Overall Study||0
2593996|NCT00287989|6367025|P2|NOT COMPLETED|Overall Study||0
2593997|NCT00287989|6367026|P1|NOT COMPLETED|Overall Study||0
2593998|NCT00287989|6367024|P3|COMPLETED|Overall Study||29
2593999|NCT00287989|6367025|P2|COMPLETED|Overall Study||29
2594000|NCT00287989|6367026|P1|COMPLETED|Overall Study||28
2594001|NCT00287989|6367024|P3|STARTED|Overall Study||29
2594002|NCT00287989|6367025|P2|STARTED|Overall Study||29
2594003|NCT00287989|6367026|P1|STARTED|Overall Study||28
2594004|NCT00287872|6367037|P1|NOT COMPLETED|Overall Study||0
2594005|NCT00287872|6367037|P1|COMPLETED|Overall Study||30
2594006|NCT00287872|6367037|P1|STARTED|Overall Study||30
2594007|NCT00287729|6367047|P2|NOT COMPLETED|Overall Study||31
2594008|NCT00287729|6367048|P1|NOT COMPLETED|Overall Study||34
2594009|NCT00287729|6367047|P2|COMPLETED|Overall Study||142
2594010|NCT00287729|6367048|P1|COMPLETED|Overall Study||137
2594011|NCT00287729|6367047|P2|STARTED|Overall Study||173
2594012|NCT00287729|6367048|P1|STARTED|Overall Study||171
2594013|NCT00287716|6367071|P3|NOT COMPLETED|Overall Study||31
2594014|NCT00287716|6367072|P2|NOT COMPLETED|Overall Study||17
2594015|NCT00287716|6367073|P1|NOT COMPLETED|Overall Study||38
2594016|NCT00287716|6367071|P3|COMPLETED|Overall Study||143
2594017|NCT00287716|6367072|P2|COMPLETED|Overall Study||70
2594018|NCT00287716|6367073|P1|COMPLETED|Overall Study||136
2594019|NCT00287716|6367071|P3|STARTED|Overall Study||174
2594020|NCT00287716|6367072|P2|STARTED|Overall Study||87
2594021|NCT00287716|6367073|P1|STARTED|Overall Study||174
2594022|NCT00287690|6367104|P2|NOT COMPLETED|Overall Study||26
2594023|NCT00287690|6367105|P1|NOT COMPLETED|Overall Study||20
2594024|NCT00287690|6367104|P2|COMPLETED|Overall Study||12
2594025|NCT00287690|6367105|P1|COMPLETED|Overall Study||13
2594026|NCT00287690|6367104|P2|STARTED|Overall Study||38
2594027|NCT00287690|6367105|P1|STARTED|Overall Study||33
2594028|NCT00287586|6367117|P2|NOT COMPLETED|Overall Study||52
2594029|NCT00287586|6367118|P1|NOT COMPLETED|Overall Study||45
2594030|NCT00287586|6367117|P2|COMPLETED|Overall Study||100
2594031|NCT00287586|6367118|P1|COMPLETED|Overall Study||111
2594032|NCT00287586|6367117|P2|Intent-to-treat: Received Study Drug|Overall Study||151
2594033|NCT00287586|6367118|P1|Intent-to-treat: Received Study Drug|Overall Study||155
2594034|NCT00287586|6367117|P2|STARTED|Overall Study||152
2594035|NCT00287586|6367118|P1|STARTED|Overall Study||156
2594036|NCT00287469|6367156|P2|NOT COMPLETED|Overall Study||214
2594037|NCT00287469|6367157|P1|NOT COMPLETED|Overall Study||220
2594038|NCT00287469|6367156|P2|COMPLETED|Overall Study||786
2594039|NCT00287469|6367157|P1|COMPLETED|Overall Study||780
2594040|NCT00287469|6367156|P2|STARTED|Overall Study||1000
2594041|NCT00287469|6367157|P1|STARTED|Overall Study||1000
2594042|NCT00287365|6367167|P1|NOT COMPLETED|Overall Study||13
2594043|NCT00287365|6367167|P1|COMPLETED|Overall Study||12
2594044|NCT00287365|6367167|P1|STARTED|Overall Study||25
2594045|NCT00287339|6367178|P2|NOT COMPLETED|Overall Study||0
2594046|NCT00287339|6367179|P1|NOT COMPLETED|Overall Study||0
2594047|NCT00287339|6367178|P2|COMPLETED|Overall Study||18
2594048|NCT00287339|6367179|P1|COMPLETED|Overall Study||22
2594049|NCT00287339|6367178|P2|STARTED|Overall Study||18
2594050|NCT00287339|6367179|P1|STARTED|Overall Study||22
2594051|NCT00287222|6367185|P1|NOT COMPLETED|Overall Study||0
2594052|NCT00287222|6367185|P1|COMPLETED|Overall Study||21
2594053|NCT00287222|6367185|P1|STARTED|Overall Study||21
2594054|NCT00287118|6367189|P1|NOT COMPLETED|Overall Study||52
2594055|NCT00287118|6367189|P1|COMPLETED|Overall Study||137
2594056|NCT00287118|6367189|P1|STARTED|Overall Study||189
2594057|NCT00287079|6367195|P2|NOT COMPLETED|Overall Study||1
2594058|NCT00287079|6367196|P1|NOT COMPLETED|Overall Study||22
2594059|NCT00287079|6367195|P2|COMPLETED|Overall Study||2
2594060|NCT00287079|6367196|P1|COMPLETED|Overall Study||10
2594061|NCT00287079|6367195|P2|STARTED|Overall Study||3
2594062|NCT00287079|6367196|P1|STARTED|Overall Study||32
2594063|NCT00287053|6367208|P2|NOT COMPLETED|Overall Study||1
2594064|NCT00287053|6367209|P1|NOT COMPLETED|Overall Study||4
2594065|NCT00287053|6367208|P2|COMPLETED|Overall Study||26
2594066|NCT00287053|6367209|P1|COMPLETED|Overall Study||26
2594067|NCT00287053|6367208|P2|STARTED|Overall Study||27
2594068|NCT00287053|6367209|P1|STARTED|Overall Study||30
2594069|NCT00286949|6367215|P1|NOT COMPLETED|Overall Study||0
2594070|NCT00286949|6367215|P1|COMPLETED|Overall Study||12
2594071|NCT00286949|6367215|P1|STARTED|Overall Study||12
2594072|NCT00286754|6367224|P3|NOT COMPLETED|Overall Study||10
2594073|NCT00286754|6367225|P2|NOT COMPLETED|Overall Study||18
2594074|NCT00286754|6367226|P1|NOT COMPLETED|Overall Study||20
2594075|NCT00286754|6367224|P3|COMPLETED|Overall Study||170
2594076|NCT00286754|6367225|P2|COMPLETED|Overall Study||159
2594077|NCT00286754|6367226|P1|COMPLETED|Overall Study||156
2594078|NCT00286754|6367224|P3|STARTED|Overall Study||180
2594079|NCT00286754|6367225|P2|STARTED|Overall Study||177
2594080|NCT00286754|6367226|P1|STARTED|Overall Study||176
2594081|NCT00286741|6367260|P2|NOT COMPLETED|Overall Study||17
2594082|NCT00286741|6367261|P1|NOT COMPLETED|Overall Study||11
2594083|NCT00286741|6367260|P2|COMPLETED|Overall Study||89
2594084|NCT00286741|6367261|P1|COMPLETED|Overall Study||122
2594085|NCT00286741|6367260|P2|STARTED|Overall Study||106
2594086|NCT00286741|6367261|P1|STARTED|Overall Study||133
2594087|NCT00286728|6367273|P2|NOT COMPLETED|Overall Study||29
2594088|NCT00286728|6367274|P1|NOT COMPLETED|Overall Study||36
2594089|NCT00286728|6367273|P2|COMPLETED|Overall Study||116
2594090|NCT00286728|6367274|P1|COMPLETED|Overall Study||106
2594091|NCT00286728|6367273|P2|STARTED|Overall Study||145
2594092|NCT00286728|6367274|P1|STARTED|Overall Study||142
2594093|NCT00286494|6367285|P3|NOT COMPLETED|Overall Study||39
2594094|NCT00286494|6367286|P2|NOT COMPLETED|Overall Study||44
2594095|NCT00286494|6367287|P1|NOT COMPLETED|Overall Study||26
2594096|NCT00286494|6367285|P3|COMPLETED|Overall Study||160
2594097|NCT00286494|6367286|P2|COMPLETED|Overall Study||153
2594098|NCT00286494|6367287|P1|COMPLETED|Overall Study||71
2594099|NCT00286494|6367285|P3|STARTED|Overall Study||199
2594100|NCT00286494|6367286|P2|STARTED|Overall Study||197
2594101|NCT00286494|6367287|P1|STARTED|Overall Study||97
2594102|NCT00286468|6367448|P3|NOT COMPLETED|Overall Study||50
2594103|NCT00286468|6367449|P2|NOT COMPLETED|Overall Study||50
2594104|NCT00286468|6367450|P1|NOT COMPLETED|Overall Study||37
2594105|NCT00286468|6367448|P3|COMPLETED|Overall Study||148
2594106|NCT00286468|6367449|P2|COMPLETED|Overall Study||153
2594107|NCT00286468|6367450|P1|COMPLETED|Overall Study||62
2594108|NCT00286468|6367448|P3|STARTED|Overall Study||198
2594109|NCT00286468|6367449|P2|STARTED|Overall Study||203
2594110|NCT00286468|6367450|P1|STARTED|Overall Study||99
2594111|NCT00286455|6367611|P3|NOT COMPLETED|Overall Study||24
2594112|NCT00286455|6367612|P2|NOT COMPLETED|Overall Study||28
2594113|NCT00286455|6367613|P1|NOT COMPLETED|Overall Study||25
2594114|NCT00286455|6367611|P3|COMPLETED|Overall Study||107
2594115|NCT00286455|6367612|P2|COMPLETED|Overall Study||105
2594116|NCT00286455|6367613|P1|COMPLETED|Overall Study||40
2594117|NCT00286455|6367611|P3|STARTED|Overall Study||131
2594118|NCT00286455|6367612|P2|STARTED|Overall Study||133
2594119|NCT00286455|6367613|P1|STARTED|Overall Study||65
2594120|NCT00286442|6367792|P3|NOT COMPLETED|Overall Study||32
2594121|NCT00286442|6367793|P2|NOT COMPLETED|Overall Study||45
2594122|NCT00286442|6367794|P1|NOT COMPLETED|Overall Study||37
2594123|NCT00286442|6367792|P3|COMPLETED|Overall Study||72
2594124|NCT00286442|6367793|P2|COMPLETED|Overall Study||165
2594125|NCT00286442|6367794|P1|COMPLETED|Overall Study||176
2594126|NCT00286442|6367792|P3|STARTED|Overall Study||104
2594127|NCT00286442|6367793|P2|STARTED|Overall Study||210
2594128|NCT00286442|6367794|P1|STARTED|Overall Study||213
2594129|NCT00286429|6367955|P3|NOT COMPLETED|Overall Study||52
2594130|NCT00286429|6367956|P2|NOT COMPLETED|Overall Study||48
2594131|NCT00286429|6367957|P1|NOT COMPLETED|Overall Study||75
2594132|NCT00286429|6367955|P3|COMPLETED|Overall Study||77
2594133|NCT00286429|6367956|P2|COMPLETED|Overall Study||83
2594134|NCT00286429|6367957|P1|COMPLETED|Overall Study||55
2594135|NCT00286429|6367955|P3|STARTED|Overall Study||129
2594136|NCT00286429|6367956|P2|STARTED|Overall Study||131
2594137|NCT00286429|6367957|P1|STARTED|Overall Study||130
2594138|NCT00286325|6368061|P1|NOT COMPLETED|Overall Study||0
2594139|NCT00286325|6368061|P1|COMPLETED|Overall Study||8
2594140|NCT00286325|6368061|P1|STARTED|Overall Study||8
2594141|NCT00286221|6368073|P4|NOT COMPLETED|Overall Study||6
2594142|NCT00286221|6368074|P3|NOT COMPLETED|Overall Study||9
2594143|NCT00286221|6368075|P2|NOT COMPLETED|Overall Study||5
2594144|NCT00286221|6368076|P1|NOT COMPLETED|Overall Study||10
2594145|NCT00286221|6368073|P4|COMPLETED|Overall Study||34
2594146|NCT00286221|6368074|P3|COMPLETED|Overall Study||31
2594147|NCT00286221|6368075|P2|COMPLETED|Overall Study||35
2594148|NCT00286221|6368076|P1|COMPLETED|Overall Study||29
2594149|NCT00286221|6368073|P4|STARTED|Overall Study||40
2594150|NCT00286221|6368074|P3|STARTED|Overall Study||40
2594151|NCT00286221|6368075|P2|STARTED|Overall Study||40
2594152|NCT00286221|6368076|P1|STARTED|Overall Study||39
2594153|NCT00286182|6368092|P2|NOT COMPLETED|Overall Study||3
2594154|NCT00286182|6368093|P1|NOT COMPLETED|Overall Study||5
2594155|NCT00286182|6368092|P2|COMPLETED|Overall Study||25
2594156|NCT00286182|6368093|P1|COMPLETED|Overall Study||23
2594157|NCT00286182|6368092|P2|STARTED|Overall Study||28
2594158|NCT00286182|6368093|P1|STARTED|Overall Study||28
2594159|NCT00286156|6368102|P3|NOT COMPLETED|Overall Study||1
2594160|NCT00286156|6368103|P2|NOT COMPLETED|Overall Study||1
2594161|NCT00286156|6368104|P1|NOT COMPLETED|Overall Study||2
2594162|NCT00286156|6368102|P3|COMPLETED|Overall Study||9
2594163|NCT00286156|6368103|P2|COMPLETED|Overall Study||9
2594164|NCT00286156|6368104|P1|COMPLETED|Overall Study||8
2594165|NCT00286156|6368102|P3|STARTED|Overall Study||10
2594166|NCT00286156|6368103|P2|STARTED|Overall Study||10
2594167|NCT00286156|6368104|P1|STARTED|Overall Study||10
2594168|NCT00286091|6368117|P2|NOT COMPLETED|Open-label Treatment Phase||71
2594169|NCT00286091|6368118|P1|NOT COMPLETED|Open-label Treatment Phase||77
2594170|NCT00286091|6368117|P2|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
2594171|NCT00286091|6368118|P1|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
2594172|NCT00286091|6368117|P2|Received Treatment|Open-label Treatment Phase||101
2594173|NCT00286091|6368118|P1|Received Treatment|Open-label Treatment Phase||109
2594174|NCT00286091|6368117|P2|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|104
2594175|NCT00286091|6368118|P1|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|110
2594176|NCT00286091|6368117|P2|NOT COMPLETED|Double-blind Treatment Phase||593
2594177|NCT00286091|6368118|P1|NOT COMPLETED|Double-blind Treatment Phase||584
2594178|NCT00286091|6368117|P2|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|123
2594179|NCT00286091|6368118|P1|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|132
2594180|NCT00286091|6368117|P2|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|174
2594181|NCT00286091|6368118|P1|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|164
2594182|NCT00286091|6368117|P2|Received Treatment|Double-blind Treatment Phase||716
2594183|NCT00286091|6368118|P1|Received Treatment|Double-blind Treatment Phase|4 participants received ≥ 1 dose of denosumab in error|709
2594184|NCT00286091|6368117|P2|STARTED|Double-blind Treatment Phase||716
2594185|NCT00286091|6368118|P1|STARTED|Double-blind Treatment Phase||716
2594186|NCT00286078|6368132|P2|NOT COMPLETED|Overall Study||34
2594187|NCT00286078|6368133|P1|NOT COMPLETED|Overall Study||32
2594188|NCT00286078|6368132|P2|COMPLETED|Overall Study||34
2594189|NCT00286078|6368133|P1|COMPLETED|Overall Study||40
2594190|NCT00286078|6368132|P2|12 Weeks|Overall Study||62
2594191|NCT00286078|6368133|P1|12 Weeks|Overall Study||63
2594192|NCT00286078|6368132|P2|STARTED|Overall Study||68
2594193|NCT00286078|6368133|P1|STARTED|Overall Study||72
2594194|NCT00285857|6368141|P1|NOT COMPLETED|Overall Study||4
2594195|NCT00285857|6368141|P1|COMPLETED|Overall Study||26
2594196|NCT00285857|6368141|P1|STARTED|Overall Study||30
2594197|NCT00285818|6368154|P2|NOT COMPLETED|Overall Study||2
2594198|NCT00285818|6368155|P1|NOT COMPLETED|Overall Study||4
2594199|NCT00285818|6368154|P2|COMPLETED|Overall Study||3
2594200|NCT00285818|6368155|P1|COMPLETED|Overall Study||2
2594201|NCT00285818|6368154|P2|STARTED|Overall Study||5
2594202|NCT00285818|6368155|P1|STARTED|Overall Study||6
2594203|NCT00285779|6368163|P2|NOT COMPLETED|Follow-up Period (wk 24-32)||0
2594204|NCT00285779|6368164|P1|NOT COMPLETED|Follow-up Period (wk 24-32)||1
2594205|NCT00285779|6368163|P2|COMPLETED|Follow-up Period (wk 24-32)||10
2594206|NCT00285779|6368164|P1|COMPLETED|Follow-up Period (wk 24-32)||8
2594207|NCT00285779|6368163|P2|STARTED|Follow-up Period (wk 24-32)||10
2594208|NCT00285779|6368164|P1|STARTED|Follow-up Period (wk 24-32)||9
2594209|NCT00285779|6368163|P2|NOT COMPLETED|Open Label Period (wk 12-24)||2
2594210|NCT00285779|6368164|P1|NOT COMPLETED|Open Label Period (wk 12-24)||2
2594211|NCT00285779|6368163|P2|COMPLETED|Open Label Period (wk 12-24)||10
2594212|NCT00285779|6368164|P1|COMPLETED|Open Label Period (wk 12-24)||9
2594213|NCT00285779|6368163|P2|STARTED|Open Label Period (wk 12-24)||12
2594214|NCT00285779|6368164|P1|STARTED|Open Label Period (wk 12-24)||11
2594215|NCT00285779|6368163|P2|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||1
2594216|NCT00285779|6368164|P1|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||3
2594217|NCT00285779|6368163|P2|COMPLETED|Placebo-controlled Period (wk 1-12)||12
2594218|NCT00285779|6368164|P1|COMPLETED|Placebo-controlled Period (wk 1-12)||11
2594219|NCT00285779|6368163|P2|STARTED|Placebo-controlled Period (wk 1-12)||13
2594220|NCT00285779|6368164|P1|STARTED|Placebo-controlled Period (wk 1-12)||14
2594221|NCT00285649|6368200|P3|NOT COMPLETED|Overall Study||6
2594222|NCT00285649|6368201|P2|NOT COMPLETED|Overall Study||6
2594223|NCT00285649|6368202|P1|NOT COMPLETED|Overall Study||9
2594224|NCT00285649|6368200|P3|COMPLETED|Overall Study||42
2594225|NCT00285649|6368201|P2|COMPLETED|Overall Study||66
2594226|NCT00285649|6368202|P1|COMPLETED|Overall Study||63
2594227|NCT00285649|6368200|P3|STARTED|Overall Study||48
2594228|NCT00285649|6368201|P2|STARTED|Overall Study||72
2594229|NCT00285649|6368202|P1|STARTED|Overall Study||72
2594230|NCT00285584|6368212|P2|NOT COMPLETED|Month 9||3
2594231|NCT00285584|6368213|P1|NOT COMPLETED|Month 9||1
2594232|NCT00285584|6368212|P2|COMPLETED|Month 9||14
2594233|NCT00285584|6368213|P1|COMPLETED|Month 9||15
2594234|NCT00285584|6368212|P2|STARTED|Month 9||17
2594235|NCT00285584|6368213|P1|STARTED|Month 9||16
2594236|NCT00285584|6368212|P2|NOT COMPLETED|Month 6||1
2594237|NCT00285584|6368213|P1|NOT COMPLETED|Month 6||0
2594238|NCT00285584|6368212|P2|COMPLETED|Month 6||17
2594239|NCT00285584|6368213|P1|COMPLETED|Month 6||16
2594240|NCT00285584|6368212|P2|STARTED|Month 6||18
2594241|NCT00285584|6368213|P1|STARTED|Month 6||16
2594242|NCT00285584|6368212|P2|NOT COMPLETED|Month 3||3
2594243|NCT00285584|6368213|P1|NOT COMPLETED|Month 3||4
2594244|NCT00285584|6368212|P2|COMPLETED|Month 3||18
2594245|NCT00285584|6368213|P1|COMPLETED|Month 3||16
2594246|NCT00285584|6368212|P2|STARTED|Month 3||21
2594247|NCT00285584|6368213|P1|STARTED|Month 3||20
2594248|NCT00285584|6368212|P2|NOT COMPLETED|Enrollment (Month 0)||0
2594249|NCT00285584|6368213|P1|NOT COMPLETED|Enrollment (Month 0)||0
2594250|NCT00285584|6368212|P2|COMPLETED|Enrollment (Month 0)||21
2594251|NCT00285584|6368213|P1|COMPLETED|Enrollment (Month 0)||20
2594252|NCT00285584|6368212|P2|STARTED|Enrollment (Month 0)||21
2594253|NCT00285584|6368213|P1|STARTED|Enrollment (Month 0)||20
2594254|NCT00285467|6368227|P2|NOT COMPLETED|Overall Study||0
2594255|NCT00285467|6368228|P1|NOT COMPLETED|Overall Study||0
2594256|NCT00285467|6368227|P2|COMPLETED|Overall Study||22
2594257|NCT00285467|6368228|P1|COMPLETED|Overall Study||25
2594258|NCT00285467|6368227|P2|STARTED|Overall Study||22
2594259|NCT00285467|6368228|P1|STARTED|Overall Study||25
2594260|NCT00285246|6368236|P1|NOT COMPLETED|Overall Study||48
2594261|NCT00285246|6368236|P1|COMPLETED|Overall Study|Number of participants who were eligible and completed at least one phase of data collection|790
2594262|NCT00285246|6368236|P1|STARTED|Overall Study||838
2594263|NCT00285207|6368245|P2|NOT COMPLETED|Overall Study||6
2594264|NCT00285207|6368246|P1|NOT COMPLETED|Overall Study||9
2594265|NCT00285207|6368245|P2|COMPLETED|Overall Study||71
2594266|NCT00285207|6368246|P1|COMPLETED|Overall Study||61
2594267|NCT00285207|6368245|P2|Treated|Overall Study||75
2594268|NCT00285207|6368246|P1|Treated|Overall Study||63
2594269|NCT00285207|6368245|P2|STARTED|Overall Study||77
2594270|NCT00285207|6368246|P1|STARTED|Overall Study||70
2594271|NCT00285012|6368254|P2|NOT COMPLETED|Received Study Tx||94
2594272|NCT00285012|6368255|P1|NOT COMPLETED|Received Study Tx||72
2594273|NCT00285012|6368254|P2|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|157
2594274|NCT00285012|6368255|P1|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|176
2594275|NCT00285012|6368254|P2|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=14 AE;3 Lack of efficacy;10 Lost to follow up;25 subject withdrawal;6 other, unknown|58
2594276|NCT00285012|6368255|P1|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=12 Adverse Event (AE); 10 Lost to follow up; 13 subject withdrawal; 6 other, unknown|41
2594277|NCT00285012|6368254|P2|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|193
2594278|NCT00285012|6368255|P1|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|207
2594279|NCT00285012|6368254|P2|STARTED|Received Study Tx||251
2594280|NCT00285012|6368255|P1|STARTED|Received Study Tx||248
2594281|NCT00285012|6368254|P2|NOT COMPLETED|Assigned to Study Treatment (Tx)||3
2594282|NCT00285012|6368255|P1|NOT COMPLETED|Assigned to Study Treatment (Tx)||2
2594283|NCT00285012|6368254|P2|COMPLETED|Assigned to Study Treatment (Tx)||251
2594284|NCT00285012|6368255|P1|COMPLETED|Assigned to Study Treatment (Tx)||248
2594285|NCT00285012|6368254|P2|STARTED|Assigned to Study Treatment (Tx)||254
2594286|NCT00285012|6368255|P1|STARTED|Assigned to Study Treatment (Tx)||250
2594287|NCT00284934|6368281|P2|NOT COMPLETED|Overall Study||3
2594288|NCT00284934|6368282|P1|NOT COMPLETED|Overall Study||4
2594289|NCT00284934|6368281|P2|COMPLETED|Overall Study||43
2594290|NCT00284934|6368282|P1|COMPLETED|Overall Study||44
2594291|NCT00284934|6368281|P2|Intent-to-treat Population (ITT)|Overall Study||45
2594292|NCT00284934|6368282|P1|Intent-to-treat Population (ITT)|Overall Study||47
2594293|NCT00284934|6368281|P2|STARTED|Overall Study||46
2594294|NCT00284934|6368282|P1|STARTED|Overall Study||48
2594295|NCT00284856|6368297|P3|NOT COMPLETED|Overall Study||60
2594296|NCT00284856|6368298|P2|NOT COMPLETED|Overall Study||50
2594297|NCT00284856|6368299|P1|NOT COMPLETED|Overall Study||51
2594298|NCT00284856|6368297|P3|COMPLETED|Overall Study||276
2594299|NCT00284856|6368298|P2|COMPLETED|Overall Study||286
2594300|NCT00284856|6368299|P1|COMPLETED|Overall Study||296
2594301|NCT00284856|6368297|P3|STARTED|Overall Study||336
2594302|NCT00284856|6368298|P2|STARTED|Overall Study||336
2594303|NCT00284856|6368299|P1|STARTED|Overall Study||347
2594304|NCT00284739|6368315|P2|NOT COMPLETED|Overall Study||0
2594305|NCT00284739|6368316|P1|NOT COMPLETED|Overall Study||0
2594306|NCT00284739|6368315|P2|COMPLETED|Overall Study||9
2594307|NCT00284739|6368316|P1|COMPLETED|Overall Study||11
2594308|NCT00284739|6368315|P2|STARTED|Overall Study||9
2594309|NCT00284739|6368316|P1|STARTED|Overall Study||11
2594310|NCT00284557|6368328|P2|NOT COMPLETED|Overall Study||13
2594311|NCT00284557|6368329|P1|NOT COMPLETED|Overall Study||9
2594312|NCT00284557|6368328|P2|COMPLETED|Overall Study||50
2594313|NCT00284557|6368329|P1|COMPLETED|Overall Study||58
2594314|NCT00284557|6368328|P2|STARTED|Overall Study||63
2594315|NCT00284557|6368329|P1|STARTED|Overall Study||67
2594316|NCT00284518|6368341|P4|NOT COMPLETED|Overall Study||33
2594317|NCT00284518|6368342|P3|NOT COMPLETED|Overall Study||28
2594318|NCT00284518|6368343|P2|NOT COMPLETED|Overall Study||28
2594319|NCT00284518|6368344|P1|NOT COMPLETED|Overall Study||26
2594320|NCT00284518|6368341|P4|COMPLETED|Overall Study||61
2594321|NCT00284518|6368342|P3|COMPLETED|Overall Study||67
2594322|NCT00284518|6368343|P2|COMPLETED|Overall Study||66
2594323|NCT00284518|6368344|P1|COMPLETED|Overall Study||71
2594324|NCT00284518|6368341|P4|STARTED|Overall Study||94
2594325|NCT00284518|6368342|P3|STARTED|Overall Study||95
2594326|NCT00284518|6368343|P2|STARTED|Overall Study||94
2594327|NCT00284518|6368344|P1|STARTED|Overall Study||97
2594328|NCT00284180|6368384|P2|NOT COMPLETED|Overall Study||4
2594329|NCT00284180|6368385|P1|NOT COMPLETED|Overall Study||0
2594330|NCT00284180|6368384|P2|COMPLETED|Overall Study||17
2594331|NCT00284180|6368385|P1|COMPLETED|Overall Study||11
2594332|NCT00284180|6368384|P2|STARTED|Overall Study||21
2594333|NCT00284180|6368385|P1|STARTED|Overall Study||11
2594334|NCT00284154|6368391|P1|NOT COMPLETED|Overall Study||42
2594335|NCT00284154|6368391|P1|COMPLETED|Overall Study||9
2594336|NCT00284154|6368391|P1|STARTED|Overall Study||51
2594337|NCT00284141|6368398|P1|NOT COMPLETED|Overall Study||98
2594338|NCT00284141|6368398|P1|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were still ongoing treatment.|0
2594339|NCT00284141|6368398|P1|ONGOING TREATMENT|Overall Study|Participants were still on study treatment at the clinical database cut-off date.|2
2594340|NCT00284141|6368398|P1|TREATED|Overall Study|Participants received at least part of one dose of Aflibercept.|96
2594341|NCT00284141|6368398|P1|STARTED|Overall Study||98
2594342|NCT00284089|6368421|P4|NOT COMPLETED|Extension Phase||12
2594343|NCT00284089|6368422|P3|NOT COMPLETED|Extension Phase||6
2594344|NCT00284089|6368423|P2|NOT COMPLETED|Extension Phase||0
2594345|NCT00284089|6368424|P1|NOT COMPLETED|Extension Phase||2
2594346|NCT00284089|6368421|P4|COMPLETED|Extension Phase||21
2594347|NCT00284089|6368422|P3|COMPLETED|Extension Phase||22
2594348|NCT00284089|6368423|P2|COMPLETED|Extension Phase||6
2594349|NCT00284089|6368424|P1|COMPLETED|Extension Phase||1
2594350|NCT00284089|6368421|P4|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|33
2594351|NCT00284089|6368422|P3|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|28
2594352|NCT00284089|6368423|P2|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|6
2594353|NCT00284089|6368424|P1|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|3
2594354|NCT00284089|6368421|P4|NOT COMPLETED|Multiple Dose Phase||4
2594355|NCT00284089|6368422|P3|NOT COMPLETED|Multiple Dose Phase||4
2594356|NCT00284089|6368423|P2|NOT COMPLETED|Multiple Dose Phase||0
2594357|NCT00284089|6368424|P1|NOT COMPLETED|Multiple Dose Phase||1
2594358|NCT00284089|6368421|P4|COMPLETED|Multiple Dose Phase||37
2594359|NCT00284089|6368422|P3|COMPLETED|Multiple Dose Phase||31
2594360|NCT00284089|6368423|P2|COMPLETED|Multiple Dose Phase||6
2594361|NCT00284089|6368424|P1|COMPLETED|Multiple Dose Phase||4
2594362|NCT00284089|6368421|P4|STARTED|Multiple Dose Phase||41
2594363|NCT00284089|6368422|P3|STARTED|Multiple Dose Phase||35
2594364|NCT00284089|6368423|P2|STARTED|Multiple Dose Phase||6
2594365|NCT00284089|6368424|P1|STARTED|Multiple Dose Phase|1 subject chose to receive other treatment & discontinued before starting the multiple dose phase.|5
2594366|NCT00284089|6368421|P4|NOT COMPLETED|Single Dose Phase||0
2594367|NCT00284089|6368422|P3|NOT COMPLETED|Single Dose Phase||0
2594368|NCT00284089|6368423|P2|NOT COMPLETED|Single Dose Phase||0
2594369|NCT00284089|6368424|P1|NOT COMPLETED|Single Dose Phase||0
2594370|NCT00284089|6368421|P4|COMPLETED|Single Dose Phase||0
2594371|NCT00284089|6368422|P3|COMPLETED|Single Dose Phase||0
2594372|NCT00284089|6368423|P2|COMPLETED|Single Dose Phase||6
2594373|NCT00284089|6368424|P1|COMPLETED|Single Dose Phase||6
2594374|NCT00284089|6368421|P4|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
2594375|NCT00284089|6368422|P3|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
2594376|NCT00284089|6368423|P2|STARTED|Single Dose Phase||6
2594377|NCT00284089|6368424|P1|STARTED|Single Dose Phase||6
2594378|NCT00284050|6368453|P3|NOT COMPLETED|Overall Study||9
2594379|NCT00284050|6368454|P2|NOT COMPLETED|Overall Study||5
2594380|NCT00284050|6368455|P1|NOT COMPLETED|Overall Study||5
2594381|NCT00284050|6368453|P3|COMPLETED|Overall Study||40
2594382|NCT00284050|6368454|P2|COMPLETED|Overall Study||46
2594383|NCT00284050|6368455|P1|COMPLETED|Overall Study||46
2594384|NCT00284050|6368453|P3|STARTED|Overall Study||49
2594385|NCT00284050|6368454|P2|STARTED|Overall Study||51
2594386|NCT00284050|6368455|P1|STARTED|Overall Study||51
2594387|NCT00283959|6368469|P1|NOT COMPLETED|Extension Period||1
2594388|NCT00283959|6368469|P1|COMPLETED|Extension Period||3
2594389|NCT00283959|6368469|P1|STARTED|Extension Period||4
2594390|NCT00283959|6368469|P1|NOT COMPLETED|Treatment Period||0
2594391|NCT00283959|6368469|P1|COMPLETED|Treatment Period||4
2594392|NCT00283959|6368469|P1|Pharmacodynamics (PD) Population|Treatment Period||4
2594393|NCT00283959|6368469|P1|Safety Population|Treatment Period||4
2594394|NCT00283959|6368469|P1|STARTED|Treatment Period||4
2594395|NCT00283933|6368474|P1|NOT COMPLETED|Extension Period||0
2594396|NCT00283933|6368474|P1|COMPLETED|Extension Period||5
2594397|NCT00283933|6368474|P1|STARTED|Extension Period||5
2594398|NCT00283933|6368474|P1|NOT COMPLETED|Treatment Period||0
2594399|NCT00283933|6368474|P1|COMPLETED|Treatment Period||5
2594400|NCT00283933|6368474|P1|Pharmacodynamic (PD) Population|Treatment Period||5
2594401|NCT00283933|6368474|P1|Safety Population|Treatment Period||5
2594402|NCT00283933|6368474|P1|STARTED|Treatment Period||5
2594403|NCT00283868|6368481|P2|NOT COMPLETED|Overall Study||8
2594404|NCT00283868|6368482|P1|NOT COMPLETED|Overall Study||7
2594405|NCT00283868|6368481|P2|COMPLETED|Overall Study||103
2594406|NCT00283868|6368482|P1|COMPLETED|Overall Study||104
2594407|NCT00283868|6368481|P2|STARTED|Overall Study||111
2594408|NCT00283868|6368482|P1|STARTED|Overall Study||111
2594409|NCT00283842|6368499|P5|NOT COMPLETED|Overall Study||15
2594410|NCT00283842|6368500|P4|NOT COMPLETED|Overall Study||27
2594411|NCT00283842|6368501|P3|NOT COMPLETED|Overall Study||31
2594412|NCT00283842|6368502|P2|NOT COMPLETED|Overall Study||18
2594413|NCT00283842|6368503|P1|NOT COMPLETED|Overall Study||12
2594414|NCT00283842|6368499|P5|COMPLETED|Overall Study||75
2594415|NCT00283842|6368500|P4|COMPLETED|Overall Study||42
2594416|NCT00283842|6368501|P3|COMPLETED|Overall Study||68
2594417|NCT00283842|6368502|P2|COMPLETED|Overall Study||69
2594418|NCT00283842|6368503|P1|COMPLETED|Overall Study||51
2594419|NCT00283842|6368499|P5|STARTED|Overall Study||90
2594420|NCT00283842|6368500|P4|STARTED|Overall Study||69
2594421|NCT00283842|6368501|P3|STARTED|Overall Study||99
2594422|NCT00283842|6368502|P2|STARTED|Overall Study||87
2594423|NCT00283842|6368503|P1|STARTED|Overall Study||63
2594424|NCT00283816|6368522|P2|NOT COMPLETED|Overall Study||2
2594425|NCT00283816|6368523|P1|NOT COMPLETED|Overall Study||2
2594426|NCT00283816|6368522|P2|COMPLETED|Overall Study||16
2594427|NCT00283816|6368523|P1|COMPLETED|Overall Study||16
2594428|NCT00283816|6368522|P2|STARTED|Overall Study||18
2594429|NCT00283816|6368523|P1|STARTED|Overall Study||18
2594430|NCT00283803|6368535|P1|NOT COMPLETED|Overall Study||13
2594431|NCT00283803|6368535|P1|COMPLETED|Overall Study||19
2594432|NCT00283803|6368535|P1|STARTED|Overall Study||32
2594433|NCT00283712|6368543|P2|NOT COMPLETED|Overall Study||1
2594434|NCT00283712|6368544|P1|NOT COMPLETED|Overall Study||0
2594435|NCT00283712|6368543|P2|COMPLETED|Overall Study|One subject in placebo arm died prior to study completion.|9
2594436|NCT00283712|6368544|P1|COMPLETED|Overall Study||10
2594437|NCT00283712|6368543|P2|Per-Protocol Sample|Overall Study||7
2594438|NCT00283712|6368544|P1|Per-Protocol Sample|Overall Study||6
2594439|NCT00283712|6368543|P2|Safety Sample|Overall Study||10
2594440|NCT00283712|6368544|P1|Safety Sample|Overall Study||10
2594441|NCT00283712|6368543|P2|Intent-to-treat Sample|Overall Study||10
2594442|NCT00283712|6368544|P1|Intent-to-treat Sample|Overall Study||10
2594443|NCT00283712|6368543|P2|STARTED|Overall Study||10
2594444|NCT00283712|6368544|P1|STARTED|Overall Study||10
2594445|NCT00283686|6368582|P4|NOT COMPLETED|Overall Study||32
2594446|NCT00283686|6368583|P3|NOT COMPLETED|Overall Study||33
2594447|NCT00283686|6368584|P2|NOT COMPLETED|Overall Study||41
2594448|NCT00283686|6368585|P1|NOT COMPLETED|Overall Study||29
2594449|NCT00283686|6368582|P4|COMPLETED|Overall Study||109
2594450|NCT00283686|6368583|P3|COMPLETED|Overall Study||111
2594451|NCT00283686|6368584|P2|COMPLETED|Overall Study||92
2594452|NCT00283686|6368585|P1|COMPLETED|Overall Study||111
2594453|NCT00283686|6368582|P4|STARTED|Overall Study||141
2594454|NCT00283686|6368583|P3|STARTED|Overall Study||144
2594455|NCT00283686|6368584|P2|STARTED|Overall Study||133
2594456|NCT00283686|6368585|P1|STARTED|Overall Study||140
2594457|NCT00283595|6368629|P2|NOT COMPLETED|Overall Study||2
2594458|NCT00283595|6368630|P1|NOT COMPLETED|Overall Study||1
2594459|NCT00283595|6368629|P2|COMPLETED|Overall Study||9
2594460|NCT00283595|6368630|P1|COMPLETED|Overall Study||9
2594461|NCT00283595|6368629|P2|STARTED|Overall Study||11
2594462|NCT00283595|6368630|P1|STARTED|Overall Study||10
2594463|NCT00283504|6368640|P2|NOT COMPLETED|Overall Study||0
2594464|NCT00283504|6368641|P1|NOT COMPLETED|Overall Study||0
2594465|NCT00283504|6368640|P2|COMPLETED|Overall Study||6
2594466|NCT00283504|6368641|P1|COMPLETED|Overall Study||7
2594467|NCT00283504|6368640|P2|STARTED|Overall Study||6
2594468|NCT00283504|6368641|P1|STARTED|Overall Study||7
2594469|NCT00283439|6368655|P4|NOT COMPLETED|Overall Study||9
2594470|NCT00283439|6368656|P3|NOT COMPLETED|Overall Study||11
2594471|NCT00283439|6368657|P2|NOT COMPLETED|Overall Study||11
2594472|NCT00283439|6368658|P1|NOT COMPLETED|Overall Study||8
2594473|NCT00283439|6368655|P4|COMPLETED|Overall Study||0
2594474|NCT00283439|6368656|P3|COMPLETED|Overall Study||0
2594475|NCT00283439|6368657|P2|COMPLETED|Overall Study||0
2594476|NCT00283439|6368658|P1|COMPLETED|Overall Study||0
2594477|NCT00283439|6368655|P4|STARTED|Overall Study||9
2594478|NCT00283439|6368656|P3|STARTED|Overall Study||11
2594479|NCT00283439|6368657|P2|STARTED|Overall Study||11
2594480|NCT00283439|6368658|P1|STARTED|Overall Study||8
2594481|NCT00283400|6368684|P4|NOT COMPLETED|Overall Study||0
2594482|NCT00283400|6368685|P3|NOT COMPLETED|Overall Study||1
2594483|NCT00283400|6368686|P2|NOT COMPLETED|Overall Study||1
2594484|NCT00283400|6368687|P1|NOT COMPLETED|Overall Study||2
2594485|NCT00283400|6368684|P4|COMPLETED|Overall Study||0
2594486|NCT00283400|6368685|P3|COMPLETED|Overall Study||6
2594487|NCT00283400|6368686|P2|COMPLETED|Overall Study||19
2594488|NCT00283400|6368687|P1|COMPLETED|Overall Study||18
2594489|NCT00283400|6368684|P4|STARTED|Overall Study||0
2594490|NCT00283400|6368685|P3|STARTED|Overall Study||7
2594491|NCT00283400|6368686|P2|STARTED|Overall Study||20
2594492|NCT00283400|6368687|P1|STARTED|Overall Study||20
2594493|NCT00283387|6368705|P2|NOT COMPLETED|Second Intervention||0
2594494|NCT00283387|6368706|P1|NOT COMPLETED|Second Intervention||0
2594495|NCT00283387|6368705|P2|COMPLETED|Second Intervention||5
2594496|NCT00283387|6368706|P1|COMPLETED|Second Intervention||5
2594497|NCT00283387|6368705|P2|STARTED|Second Intervention||5
2594498|NCT00283387|6368706|P1|STARTED|Second Intervention||5
2594499|NCT00283387|6368705|P2|NOT COMPLETED|Washout Period of 2 Months||0
2594500|NCT00283387|6368706|P1|NOT COMPLETED|Washout Period of 2 Months||0
2594501|NCT00283387|6368705|P2|COMPLETED|Washout Period of 2 Months||5
2594502|NCT00283387|6368706|P1|COMPLETED|Washout Period of 2 Months||5
2594503|NCT00283387|6368705|P2|STARTED|Washout Period of 2 Months||5
2594504|NCT00283387|6368706|P1|STARTED|Washout Period of 2 Months||5
2594505|NCT00283387|6368705|P2|NOT COMPLETED|First Intervention||2
2594506|NCT00283387|6368706|P1|NOT COMPLETED|First Intervention||1
2594507|NCT00283387|6368705|P2|COMPLETED|First Intervention||5
2594508|NCT00283387|6368706|P1|COMPLETED|First Intervention||5
2594509|NCT00283387|6368705|P2|STARTED|First Intervention||7
2594510|NCT00283387|6368706|P1|STARTED|First Intervention||6
2594511|NCT00283296|6368712|P1|NOT COMPLETED|Overall Study||5
2594512|NCT00283296|6368712|P1|COMPLETED|Overall Study|Completed in-lab and in-home trial.|9
2594513|NCT00283296|6368712|P1|STARTED|Overall Study||14
2594514|NCT00283244|6368721|P3|NOT COMPLETED|Overall Study||51
2594515|NCT00283244|6368722|P2|NOT COMPLETED|Overall Study||51
2594516|NCT00283244|6368723|P1|NOT COMPLETED|Overall Study||18
2594517|NCT00283244|6368721|P3|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 9 patients received 2nd line therapy|0
2594518|NCT00283244|6368722|P2|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 12 patients received 2nd line therapy|0
2594519|NCT00283244|6368723|P1|COMPLETED|Overall Study|19 patients went on to receive second line Erlotinib|26
2594520|NCT00283244|6368721|P3|STARTED|Overall Study||51
2594521|NCT00283244|6368722|P2|STARTED|Overall Study||51
2594522|NCT00283244|6368723|P1|STARTED|Overall Study||44
2594523|NCT00283075|6368743|P2|NOT COMPLETED|Overall Study||0
2594524|NCT00283075|6368744|P1|NOT COMPLETED|Overall Study||0
2594525|NCT00283075|6368743|P2|COMPLETED|Overall Study||6
2594526|NCT00283075|6368744|P1|COMPLETED|Overall Study||25
2594527|NCT00283075|6368743|P2|STARTED|Overall Study||6
2594528|NCT00283075|6368744|P1|STARTED|Overall Study||25
2594529|NCT00283062|6368759|P4|NOT COMPLETED|Overall Study||49
2594530|NCT00283062|6368760|P3|NOT COMPLETED|Overall Study||41
2594531|NCT00283062|6368761|P2|NOT COMPLETED|Overall Study||7
2594532|NCT00283062|6368762|P1|NOT COMPLETED|Overall Study||12
2594533|NCT00283062|6368759|P4|COMPLETED|Overall Study||13
2594534|NCT00283062|6368760|P3|COMPLETED|Overall Study||15
2594535|NCT00283062|6368761|P2|COMPLETED|Overall Study||48
2594536|NCT00283062|6368762|P1|COMPLETED|Overall Study||43
2594537|NCT00283062|6368759|P4|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
2594538|NCT00283062|6368760|P3|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||15
2594539|NCT00283062|6368761|P2|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
2594540|NCT00283062|6368762|P1|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||43
2594541|NCT00283062|6368759|P4|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||13
2594542|NCT00283062|6368760|P3|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||15
2594543|NCT00283062|6368761|P2|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||48
2594544|NCT00283062|6368762|P1|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||44
2594545|NCT00283062|6368759|P4|ADMINISTERED STUDY TREATMENT|Overall Study||17
2594546|NCT00283062|6368760|P3|ADMINISTERED STUDY TREATMENT|Overall Study||20
2594547|NCT00283062|6368761|P2|ADMINISTERED STUDY TREATMENT|Overall Study||51
2594548|NCT00283062|6368762|P1|ADMINISTERED STUDY TREATMENT|Overall Study||50
2594549|NCT00283062|6368759|P4|STARTED|Overall Study||62
2594550|NCT00283062|6368760|P3|STARTED|Overall Study||56
2594551|NCT00283062|6368761|P2|STARTED|Overall Study||55
2594552|NCT00283062|6368762|P1|STARTED|Overall Study||55
2594553|NCT00283049|6368795|P3|NOT COMPLETED|Overall Study||54
2594554|NCT00283049|6368796|P2|NOT COMPLETED|Overall Study||45
2594555|NCT00283049|6368797|P1|NOT COMPLETED|Overall Study||58
2594556|NCT00283049|6368795|P3|COMPLETED|Overall Study||76
2594557|NCT00283049|6368796|P2|COMPLETED|Overall Study||83
2594558|NCT00283049|6368797|P1|COMPLETED|Overall Study||70
2594559|NCT00283049|6368795|P3|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|130
2594560|NCT00283049|6368796|P2|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|128
2594561|NCT00283049|6368797|P1|STARTED|Overall Study|2 randomized patients did not receive study drug and were not included in the safety population|128
2594562|NCT00282984|6368825|P2|NOT COMPLETED|Overall Study||61
2594563|NCT00282984|6368826|P1|NOT COMPLETED|Overall Study||51
2594564|NCT00282984|6368825|P2|COMPLETED|Overall Study||289
2594565|NCT00282984|6368826|P1|COMPLETED|Overall Study||302
2594566|NCT00282984|6368825|P2|STARTED|Overall Study||350
2594567|NCT00282984|6368826|P1|STARTED|Overall Study||353
2594568|NCT00282971|6368852|P2|NOT COMPLETED|Overall Study||22
2594569|NCT00282971|6368853|P1|NOT COMPLETED|Overall Study||34
2594570|NCT00282971|6368852|P2|COMPLETED|Overall Study||149
2594571|NCT00282971|6368853|P1|COMPLETED|Overall Study||146
2594572|NCT00282971|6368852|P2|STARTED|Overall Study||171
2594573|NCT00282971|6368853|P1|STARTED|Overall Study||180
2594574|NCT00282919|6368863|P1|NOT COMPLETED|Overall Study||7
2594575|NCT00282919|6368863|P1|COMPLETED|Overall Study||103
2594576|NCT00282919|6368863|P1|STARTED|Overall Study||110
2594577|NCT00282867|6368878|P3|NOT COMPLETED|Overall Study||0
2594578|NCT00282867|6368879|P2|NOT COMPLETED|Overall Study||1
2594579|NCT00282867|6368880|P1|NOT COMPLETED|Overall Study||1
2594580|NCT00282867|6368878|P3|COMPLETED|Overall Study||25
2594581|NCT00282867|6368879|P2|COMPLETED|Overall Study||24
2594582|NCT00282867|6368880|P1|COMPLETED|Overall Study||23
2594583|NCT00282867|6368878|P3|STARTED|Overall Study||25
2594584|NCT00282867|6368879|P2|STARTED|Overall Study||25
2594585|NCT00282867|6368880|P1|STARTED|Overall Study||24
2594586|NCT00282841|6368894|P1|NOT COMPLETED|Overall Study||0
2594587|NCT00282841|6368894|P1|COMPLETED|Overall Study||61
2594588|NCT00282841|6368894|P1|STARTED|Overall Study|Anticipated recruitment 400; stopped due to funding and poor recruitment.|61
2594589|NCT00282828|6368902|P3|NOT COMPLETED|Overall Study||9
2594590|NCT00282828|6368903|P2|NOT COMPLETED|Overall Study||12
2594591|NCT00282828|6368904|P1|NOT COMPLETED|Overall Study||6
2594592|NCT00282828|6368902|P3|COMPLETED|Overall Study||50
2594593|NCT00282828|6368903|P2|COMPLETED|Overall Study||47
2594594|NCT00282828|6368904|P1|COMPLETED|Overall Study||57
2594595|NCT00282828|6368902|P3|STARTED|Overall Study||59
2594596|NCT00282828|6368903|P2|STARTED|Overall Study||59
2594597|NCT00282828|6368904|P1|STARTED|Overall Study||63
2594598|NCT00282815|6368917|P2|NOT COMPLETED|Overall Study||6
2594599|NCT00282815|6368918|P1|NOT COMPLETED|Overall Study||7
2594600|NCT00282815|6368917|P2|COMPLETED|Overall Study||11
2594601|NCT00282815|6368918|P1|COMPLETED|Overall Study||8
2594602|NCT00282815|6368917|P2|STARTED|Overall Study||17
2594603|NCT00282815|6368918|P1|STARTED|Overall Study||15
2594604|NCT00282672|6368931|P4|NOT COMPLETED|5 Year: Follow up||5
2594605|NCT00282672|6368932|P3|NOT COMPLETED|5 Year: Follow up||0
2594606|NCT00282672|6368933|P2|NOT COMPLETED|5 Year: Follow up||5
2594607|NCT00282672|6368934|P1|NOT COMPLETED|5 Year: Follow up||1
2594608|NCT00282672|6368931|P4|COMPLETED|5 Year: Follow up||20
2594609|NCT00282672|6368932|P3|COMPLETED|5 Year: Follow up||12
2594610|NCT00282672|6368933|P2|COMPLETED|5 Year: Follow up||27
2594611|NCT00282672|6368934|P1|COMPLETED|5 Year: Follow up||14
2594612|NCT00282672|6368931|P4|STARTED|5 Year: Follow up|11 withdrew|25
2594613|NCT00282672|6368932|P3|STARTED|5 Year: Follow up|3 withdrew|12
2594614|NCT00282672|6368933|P2|STARTED|5 Year: Follow up|7 withdrew|32
2594615|NCT00282672|6368934|P1|STARTED|5 Year: Follow up|1 withdrew|15
2594616|NCT00282672|6368931|P4|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||2
2594617|NCT00282672|6368932|P3|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
2594618|NCT00282672|6368933|P2|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
2594619|NCT00282672|6368934|P1|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||3
2594620|NCT00282672|6368931|P4|COMPLETED|2 Year: Sham Crossed Over to RFA||36
2594621|NCT00282672|6368932|P3|COMPLETED|2 Year: Sham Crossed Over to RFA||15
2594622|NCT00282672|6368933|P2|COMPLETED|2 Year: Sham Crossed Over to RFA||39
2594623|NCT00282672|6368934|P1|COMPLETED|2 Year: Sham Crossed Over to RFA||16
2594624|NCT00282672|6368931|P4|STARTED|2 Year: Sham Crossed Over to RFA||38
2594625|NCT00282672|6368932|P3|STARTED|2 Year: Sham Crossed Over to RFA|16 Crossed over to RFA treatment|16
2594626|NCT00282672|6368933|P2|STARTED|2 Year: Sham Crossed Over to RFA||40
2594627|NCT00282672|6368934|P1|STARTED|2 Year: Sham Crossed Over to RFA|19 crossed over to RFA treatment|19
2594628|NCT00282672|6368931|P4|NOT COMPLETED|1 Year||4
2594629|NCT00282672|6368932|P3|NOT COMPLETED|1 Year||1
2594630|NCT00282672|6368933|P2|NOT COMPLETED|1 Year||2
2594631|NCT00282672|6368934|P1|NOT COMPLETED|1 Year||3
2594632|NCT00282672|6368931|P4|COMPLETED|1 Year||38
2594633|NCT00282672|6368932|P3|COMPLETED|1 Year||20
2594634|NCT00282672|6368933|P2|COMPLETED|1 Year||40
2594635|NCT00282672|6368934|P1|COMPLETED|1 Year||19
2594636|NCT00282672|6368931|P4|STARTED|1 Year||42
2594637|NCT00282672|6368932|P3|STARTED|1 Year||21
2594638|NCT00282672|6368933|P2|STARTED|1 Year||42
2594639|NCT00282672|6368934|P1|STARTED|1 Year||22
2594640|NCT00282568|6368982|P1|NOT COMPLETED|Extended Treatment Period||24
2594641|NCT00282568|6368982|P1|COMPLETED|Extended Treatment Period||42
2594642|NCT00282568|6368982|P1|STARTED|Extended Treatment Period|One patient who completed the PK period did not enter the extended treatment period.|66
2594643|NCT00282568|6368982|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||3
2594644|NCT00282568|6368982|P1|COMPLETED|Pharmacokinetic Treatment Period||67
2594645|NCT00282568|6368982|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||67
2594646|NCT00282568|6368982|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||68
2594647|NCT00282568|6368982|P1|STARTED|Pharmacokinetic Treatment Period||70
2594648|NCT00282464|6369008|P2|NOT COMPLETED|Overall Study||62
2594649|NCT00282464|6369009|P1|NOT COMPLETED|Overall Study||73
2594650|NCT00282464|6369008|P2|COMPLETED|Overall Study||134
2594651|NCT00282464|6369009|P1|COMPLETED|Overall Study||112
2594652|NCT00282464|6369008|P2|STARTED|Overall Study||196
2594653|NCT00282464|6369009|P1|STARTED|Overall Study||185
2594654|NCT00282438|6369059|P2|NOT COMPLETED|Overall Study||1
2594655|NCT00282438|6369060|P1|NOT COMPLETED|Overall Study||1
2594656|NCT00282438|6369059|P2|COMPLETED|Overall Study||0
2594657|NCT00282438|6369060|P1|COMPLETED|Overall Study||0
2594658|NCT00282438|6369059|P2|STARTED|Overall Study||1
2594659|NCT00282438|6369060|P1|STARTED|Overall Study||1
2594660|NCT00282412|6369070|P1|NOT COMPLETED|Overall Study||2
2594661|NCT00282412|6369070|P1|COMPLETED|Overall Study|Two late deaths non-treatment related. One from pulmonary embolism and one from late leukemia.|2
2594662|NCT00282412|6369070|P1|STARTED|Overall Study||4
2594663|NCT00282347|6369076|P2|NOT COMPLETED|B Cell Follow-up Period||0
2594664|NCT00282347|6369077|P1|NOT COMPLETED|B Cell Follow-up Period||5
2594665|NCT00282347|6369076|P2|COMPLETED|B Cell Follow-up Period||4
2594666|NCT00282347|6369077|P1|COMPLETED|B Cell Follow-up Period||15
2594667|NCT00282347|6369076|P2|STARTED|B Cell Follow-up Period||4
2594668|NCT00282347|6369077|P1|STARTED|B Cell Follow-up Period||20
2594669|NCT00282347|6369076|P2|NOT COMPLETED|Safety Follow-up Period||6
2594670|NCT00282347|6369077|P1|NOT COMPLETED|Safety Follow-up Period||3
2594671|NCT00282347|6369076|P2|COMPLETED|Safety Follow-up Period||57
2594672|NCT00282347|6369077|P1|COMPLETED|Safety Follow-up Period||64
2594673|NCT00282347|6369076|P2|STARTED|Safety Follow-up Period||63
2594674|NCT00282347|6369077|P1|STARTED|Safety Follow-up Period||67
2594675|NCT00282347|6369076|P2|NOT COMPLETED|Treatment Period||9
2594676|NCT00282347|6369077|P1|NOT COMPLETED|Treatment Period||5
2594677|NCT00282347|6369076|P2|COMPLETED|Treatment Period||63
2594678|NCT00282347|6369077|P1|COMPLETED|Treatment Period||67
2594679|NCT00282347|6369076|P2|STARTED|Treatment Period||72
2594680|NCT00282347|6369077|P1|STARTED|Treatment Period||72
2594681|NCT00282334|6369103|P2|NOT COMPLETED|Overall Study||5
2594682|NCT00282334|6369104|P1|NOT COMPLETED|Overall Study||8
2594683|NCT00282334|6369103|P2|COMPLETED|Overall Study||118
2594684|NCT00282334|6369104|P1|COMPLETED|Overall Study||105
2594685|NCT00282334|6369103|P2|STARTED|Overall Study||123
2594686|NCT00282334|6369104|P1|STARTED|Overall Study||113
2594687|NCT00282308|6369112|P3|NOT COMPLETED|Safety Follow-up Period||19
2594688|NCT00282308|6369113|P2|NOT COMPLETED|Safety Follow-up Period||0
2594689|NCT00282308|6369114|P1|NOT COMPLETED|Safety Follow-up Period||0
2594690|NCT00282308|6369112|P3|COMPLETED|Safety Follow-up Period||81
2594691|NCT00282308|6369113|P2|COMPLETED|Safety Follow-up Period||0
2594692|NCT00282308|6369114|P1|COMPLETED|Safety Follow-up Period||0
2594693|NCT00282308|6369112|P3|STARTED|Safety Follow-up Period|Some patients entered this Safety Follow-up Period directly from the Treatment Period.|100
2594694|NCT00282308|6369113|P2|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
2594695|NCT00282308|6369114|P1|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
2594696|NCT00282308|6369112|P3|NOT COMPLETED|Optional Extension Re-treatment Period||6
2594697|NCT00282308|6369113|P2|NOT COMPLETED|Optional Extension Re-treatment Period||0
2594698|NCT00282308|6369114|P1|NOT COMPLETED|Optional Extension Re-treatment Period||0
2594699|NCT00282308|6369112|P3|COMPLETED|Optional Extension Re-treatment Period||72
2594700|NCT00282308|6369113|P2|COMPLETED|Optional Extension Re-treatment Period||0
2594701|NCT00282308|6369114|P1|COMPLETED|Optional Extension Re-treatment Period||0
2594702|NCT00282308|6369112|P3|STARTED|Optional Extension Re-treatment Period|Not all patients who completed the Treatment Period entered this Optional Re-treatment Period.|78
2594703|NCT00282308|6369113|P2|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
2594704|NCT00282308|6369114|P1|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
2594705|NCT00282308|6369112|P3|NOT COMPLETED|Treatment Period||0
2594706|NCT00282308|6369113|P2|NOT COMPLETED|Treatment Period||6
2594707|NCT00282308|6369114|P1|NOT COMPLETED|Treatment Period||4
2594708|NCT00282308|6369112|P3|COMPLETED|Treatment Period||0
2594709|NCT00282308|6369113|P2|COMPLETED|Treatment Period||28
2594710|NCT00282308|6369114|P1|COMPLETED|Treatment Period||65
2594711|NCT00282308|6369112|P3|STARTED|Treatment Period|Participant Flow is reported separately for the treatment groups for this Period.|0
2594712|NCT00282308|6369113|P2|STARTED|Treatment Period||34
2594713|NCT00282308|6369114|P1|STARTED|Treatment Period||69
2594714|NCT00282295|6369144|P3|NOT COMPLETED|Overall Study||8
2594715|NCT00282295|6369145|P2|NOT COMPLETED|Overall Study||17
2594716|NCT00282295|6369146|P1|NOT COMPLETED|Overall Study||3
2594717|NCT00282295|6369144|P3|COMPLETED|Overall Study||441
2594718|NCT00282295|6369145|P2|COMPLETED|Overall Study||429
2594719|NCT00282295|6369146|P1|COMPLETED|Overall Study||443
2594720|NCT00282295|6369144|P3|STARTED|Overall Study||449
2594721|NCT00282295|6369145|P2|STARTED|Overall Study||446
2594722|NCT00282295|6369146|P1|STARTED|Overall Study||446
2594723|NCT00282282|6369195|P1|NOT COMPLETED|Overall Study||0
2594724|NCT00282282|6369195|P1|COMPLETED|Overall Study||29
2594725|NCT00282282|6369195|P1|STARTED|Overall Study|31 patients enrolled but 2 patients did not go through with transplant|29
2594726|NCT00282256|6369201|P1|NOT COMPLETED|Extension Treatment Period||2
2594727|NCT00282256|6369201|P1|COMPLETED|Extension Treatment Period||16
2594728|NCT00282256|6369201|P1|STARTED|Extension Treatment Period||18
2594729|NCT00282256|6369201|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||1
2594730|NCT00282256|6369201|P1|COMPLETED|Pharmacokinetic Treatment Period||18
2594731|NCT00282256|6369201|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||18
2594732|NCT00282256|6369201|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||19
2594733|NCT00282256|6369201|P1|STARTED|Pharmacokinetic Treatment Period||19
2594734|NCT00282243|6369222|P1|NOT COMPLETED|Extension Treatment Period||22
2594735|NCT00282243|6369222|P1|COMPLETED|Extension Treatment Period||43
2594736|NCT00282243|6369222|P1|STARTED|Extension Treatment Period||65
2594737|NCT00282243|6369222|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||5
2594738|NCT00282243|6369222|P1|COMPLETED|Pharmacokinetic Treatment Period||65
2594739|NCT00282243|6369222|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||69
2594740|NCT00282243|6369222|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||70
2594741|NCT00282243|6369222|P1|STARTED|Pharmacokinetic Treatment Period||70
2594742|NCT00282152|6369248|P2|NOT COMPLETED|Overall Study||0
2594743|NCT00282152|6369249|P1|NOT COMPLETED|Overall Study||1
2594744|NCT00282152|6369248|P2|COMPLETED|Overall Study||15
2594745|NCT00282152|6369249|P1|COMPLETED|Overall Study||14
2594746|NCT00282152|6369248|P2|STARTED|Overall Study||15
2594747|NCT00282152|6369249|P1|STARTED|Overall Study||15
2594748|NCT00282113|6369270|P3|NOT COMPLETED|Overall Study||0
2594749|NCT00282113|6369271|P2|NOT COMPLETED|Overall Study||0
2594750|NCT00282113|6369272|P1|NOT COMPLETED|Overall Study||1
2594751|NCT00282113|6369270|P3|COMPLETED|Overall Study||29
2594752|NCT00282113|6369271|P2|COMPLETED|Overall Study||30
2594753|NCT00282113|6369272|P1|COMPLETED|Overall Study||30
2594754|NCT00282113|6369270|P3|STARTED|Overall Study||29
2594755|NCT00282113|6369271|P2|STARTED|Overall Study||30
2594756|NCT00282113|6369272|P1|STARTED|Overall Study||31
2594757|NCT00282087|6369286|P1|NOT COMPLETED|Overall Study||1
2594758|NCT00282087|6369286|P1|COMPLETED|Overall Study|One patient died during cycle 1 of treatment because of infectious complications of AIDS.|46
2594759|NCT00282087|6369286|P1|STARTED|Overall Study||47
2594760|NCT00282048|6369299|P1|NOT COMPLETED|Overall Study||62
2594761|NCT00282048|6369299|P1|COMPLETED|Overall Study||0
2594762|NCT00282048|6369299|P1|STARTED|Overall Study||62
2594763|NCT00281957|6369313|P2|NOT COMPLETED|Overall Study||42
2594764|NCT00281957|6369314|P1|NOT COMPLETED|Overall Study||67
2594765|NCT00281957|6369313|P2|COMPLETED|Overall Study||0
2594766|NCT00281957|6369314|P1|COMPLETED|Overall Study||0
2594767|NCT00281957|6369313|P2|Eligible and Received Treatment|Overall Study||39
2594768|NCT00281957|6369314|P1|Eligible and Received Treatment|Overall Study||63
2594769|NCT00281957|6369313|P2|Eligible|Overall Study||40
2594770|NCT00281957|6369314|P1|Eligible|Overall Study||66
2594771|NCT00281957|6369313|P2|STARTED|Overall Study||42
2594772|NCT00281957|6369314|P1|STARTED|Overall Study||67
2594773|NCT00281918|6369328|P2|NOT COMPLETED|Overall Study||108
2594774|NCT00281918|6369329|P1|NOT COMPLETED|Overall Study||142
2594775|NCT00281918|6369328|P2|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|300
2594776|NCT00281918|6369329|P1|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|267
2594777|NCT00281918|6369328|P2|Safety Population; Received Study Drug|Overall Study||402
2594778|NCT00281918|6369329|P1|Safety Population; Received Study Drug|Overall Study||398
2594779|NCT00281918|6369328|P2|STARTED|Overall Study|Informed consent unavailable for 5 patients at time of analysis; intent-to-treat population was 403.|408
2594780|NCT00281918|6369329|P1|STARTED|Overall Study|Informed consent unavailable for 2 patients at time of analysis; intent-to-treat population was 407.|409
2594781|NCT00281879|6369363|P8|NOT COMPLETED|Overall Study||1
2594782|NCT00281879|6369364|P7|NOT COMPLETED|Overall Study||0
2594783|NCT00281879|6369365|P6|NOT COMPLETED|Overall Study||9
2594784|NCT00281879|6369366|P5|NOT COMPLETED|Overall Study||6
2594785|NCT00281879|6369367|P4|NOT COMPLETED|Overall Study||0
2594786|NCT00281879|6369368|P3|NOT COMPLETED|Overall Study||20
2594787|NCT00281879|6369369|P2|NOT COMPLETED|Overall Study||36
2594788|NCT00281879|6369370|P1|NOT COMPLETED|Overall Study||128
2594789|NCT00281879|6369363|P8|COMPLETED|Overall Study||0
2594790|NCT00281879|6369364|P7|COMPLETED|Overall Study||0
2594791|NCT00281879|6369365|P6|COMPLETED|Overall Study||0
2594792|NCT00281879|6369366|P5|COMPLETED|Overall Study||0
2594793|NCT00281879|6369367|P4|COMPLETED|Overall Study||0
2594794|NCT00281879|6369368|P3|COMPLETED|Overall Study||0
2594795|NCT00281879|6369369|P2|COMPLETED|Overall Study||0
2594796|NCT00281879|6369370|P1|COMPLETED|Overall Study||0
2594797|NCT00281879|6369363|P8|STARTED|Overall Study||1
2594798|NCT00281879|6369364|P7|STARTED|Overall Study||0
2594799|NCT00281879|6369365|P6|STARTED|Overall Study||9
2594800|NCT00281879|6369366|P5|STARTED|Overall Study||6
2594801|NCT00281879|6369367|P4|STARTED|Overall Study||0
2594802|NCT00281879|6369368|P3|STARTED|Overall Study||20
2594803|NCT00281879|6369369|P2|STARTED|Overall Study||36
2594804|NCT00281879|6369370|P1|STARTED|Overall Study||128
2594805|NCT00281840|6369388|P1|NOT COMPLETED|Overall Study||25
2594806|NCT00281840|6369388|P1|COMPLETED|Overall Study||5
2594807|NCT00281840|6369388|P1|STARTED|Overall Study||30
2594808|NCT00281827|6369393|P1|NOT COMPLETED|Overall Study||0
2594809|NCT00281827|6369393|P1|COMPLETED|Overall Study|All patients received 3 cycles of therapy; 2 did not receive all 3 thalidomide cycles|22
2594810|NCT00281827|6369393|P1|STARTED|Overall Study||22
2594811|NCT00281697|6369404|P2|NOT COMPLETED|Overall Study||197
2594812|NCT00281697|6369405|P1|NOT COMPLETED|Overall Study||401
2594813|NCT00281697|6369404|P2|COMPLETED|Overall Study||28
2594814|NCT00281697|6369405|P1|COMPLETED|Overall Study||58
2594815|NCT00281697|6369404|P2|STARTED|Overall Study||225
2594816|NCT00281697|6369405|P1|STARTED|Overall Study||459
2594817|NCT00281684|6369425|P4|NOT COMPLETED|Overall Study||0
2594818|NCT00281684|6369426|P3|NOT COMPLETED|Overall Study||1
2594819|NCT00281684|6369427|P2|NOT COMPLETED|Overall Study||0
2594820|NCT00281684|6369428|P1|NOT COMPLETED|Overall Study||1
2594821|NCT00281684|6369425|P4|COMPLETED|Overall Study||38
2594822|NCT00281684|6369426|P3|COMPLETED|Overall Study||33
2594823|NCT00281684|6369427|P2|COMPLETED|Overall Study||36
2594824|NCT00281684|6369428|P1|COMPLETED|Overall Study||36
2594825|NCT00281684|6369425|P4|STARTED|Overall Study||38
2594826|NCT00281684|6369426|P3|STARTED|Overall Study||34
2594827|NCT00281684|6369427|P2|STARTED|Overall Study||36
2594828|NCT00281684|6369428|P1|STARTED|Overall Study||37
2594829|NCT00281658|6369502|P3|NOT COMPLETED|Open-label Monotherapy Extension Phase||101
2594830|NCT00281658|6369503|P2|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
2594831|NCT00281658|6369504|P1|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
2594832|NCT00281658|6369502|P3|COMPLETED|Open-label Monotherapy Extension Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|48
2594833|NCT00281658|6369503|P2|COMPLETED|Open-label Monotherapy Extension Phase||0
2594834|NCT00281658|6369504|P1|COMPLETED|Open-label Monotherapy Extension Phase||0
2594835|NCT00281658|6369502|P3|STARTED|Open-label Monotherapy Extension Phase||149
2594836|NCT00281658|6369503|P2|STARTED|Open-label Monotherapy Extension Phase||0
2594837|NCT00281658|6369504|P1|STARTED|Open-label Monotherapy Extension Phase||0
2594838|NCT00281658|6369502|P3|NOT COMPLETED|Double-blind, Randomized Phase||0
2594839|NCT00281658|6369503|P2|NOT COMPLETED|Double-blind, Randomized Phase||54
2594840|NCT00281658|6369504|P1|NOT COMPLETED|Double-blind, Randomized Phase||137
2594841|NCT00281658|6369502|P3|COMPLETED|Double-blind, Randomized Phase||0
2594842|NCT00281658|6369503|P2|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|168
2594843|NCT00281658|6369504|P1|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|85
2594844|NCT00281658|6369502|P3|STARTED|Double-blind, Randomized Phase||0
2594845|NCT00281658|6369503|P2|STARTED|Double-blind, Randomized Phase|Of these participants, 149 entered the open-label extension phase.|222
2594846|NCT00281658|6369504|P1|STARTED|Double-blind, Randomized Phase||222
2594847|NCT00281632|6369521|P1|NOT COMPLETED|Overall Study||36
2594848|NCT00281632|6369521|P1|COMPLETED|Overall Study|Three participants were ongoing in the study at the time of the data cut-off (30 Apr 2008).|0
2594849|NCT00281632|6369521|P1|STARTED|Overall Study||36
2594850|NCT00281580|6369563|P16|NOT COMPLETED|Overall Study||13
2594851|NCT00281580|6369564|P15|NOT COMPLETED|Overall Study||7
2594852|NCT00281580|6369565|P14|NOT COMPLETED|Overall Study||7
2594853|NCT00281580|6369566|P13|NOT COMPLETED|Overall Study||13
2594854|NCT00281580|6369567|P12|NOT COMPLETED|Overall Study||10
2594855|NCT00281580|6369568|P11|NOT COMPLETED|Overall Study||4
2594856|NCT00281580|6369569|P10|NOT COMPLETED|Overall Study||12
2594857|NCT00281580|6369570|P9|NOT COMPLETED|Overall Study||8
2594858|NCT00281580|6369571|P8|NOT COMPLETED|Overall Study||1
2594859|NCT00281580|6369572|P7|NOT COMPLETED|Overall Study||5
2594860|NCT00281580|6369573|P6|NOT COMPLETED|Overall Study||3
2594861|NCT00281580|6369574|P5|NOT COMPLETED|Overall Study||4
2594862|NCT00281580|6369575|P4|NOT COMPLETED|Overall Study||17
2594863|NCT00281580|6369576|P3|NOT COMPLETED|Overall Study||5
2594864|NCT00281580|6369577|P2|NOT COMPLETED|Overall Study||1
2594865|NCT00281580|6369578|P1|NOT COMPLETED|Overall Study||7
2594866|NCT00281580|6369563|P16|COMPLETED|Overall Study||116
2594867|NCT00281580|6369564|P15|COMPLETED|Overall Study||133
2594868|NCT00281580|6369565|P14|COMPLETED|Overall Study||43
2594869|NCT00281580|6369566|P13|COMPLETED|Overall Study||129
2594870|NCT00281580|6369567|P12|COMPLETED|Overall Study||136
2594871|NCT00281580|6369568|P11|COMPLETED|Overall Study||44
2594872|NCT00281580|6369569|P10|COMPLETED|Overall Study||117
2594873|NCT00281580|6369570|P9|COMPLETED|Overall Study||135
2594874|NCT00281580|6369571|P8|COMPLETED|Overall Study||46
2594875|NCT00281580|6369572|P7|COMPLETED|Overall Study||39
2594876|NCT00281580|6369573|P6|COMPLETED|Overall Study||43
2594877|NCT00281580|6369574|P5|COMPLETED|Overall Study||40
2594878|NCT00281580|6369575|P4|COMPLETED|Overall Study||118
2594879|NCT00281580|6369576|P3|COMPLETED|Overall Study||125
2594880|NCT00281580|6369577|P2|COMPLETED|Overall Study||41
2594881|NCT00281580|6369578|P1|COMPLETED|Overall Study||39
2594882|NCT00281580|6369563|P16|STARTED|Overall Study||129
2594883|NCT00281580|6369564|P15|STARTED|Overall Study||140
2594884|NCT00281580|6369565|P14|STARTED|Overall Study||50
2594885|NCT00281580|6369566|P13|STARTED|Overall Study||142
2594886|NCT00281580|6369567|P12|STARTED|Overall Study||146
2594887|NCT00281580|6369568|P11|STARTED|Overall Study||48
2594888|NCT00281580|6369569|P10|STARTED|Overall Study||129
2594889|NCT00281580|6369570|P9|STARTED|Overall Study||143
2594890|NCT00281580|6369571|P8|STARTED|Overall Study||47
2594891|NCT00281580|6369572|P7|STARTED|Overall Study||44
2594892|NCT00281580|6369573|P6|STARTED|Overall Study||46
2594893|NCT00281580|6369574|P5|STARTED|Overall Study||44
2594894|NCT00281580|6369575|P4|STARTED|Overall Study||135
2594895|NCT00281580|6369576|P3|STARTED|Overall Study||130
2594896|NCT00281580|6369577|P2|STARTED|Overall Study||42
2594897|NCT00281580|6369578|P1|STARTED|Overall Study||46
2594898|NCT00281528|6369925|P3|NOT COMPLETED|Overall Study||79
2594899|NCT00281528|6369926|P2|NOT COMPLETED|Overall Study||54
2594900|NCT00281528|6369927|P1|NOT COMPLETED|Overall Study||75
2594901|NCT00281528|6369925|P3|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
2594902|NCT00281528|6369926|P2|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
2594903|NCT00281528|6369927|P1|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
2594904|NCT00281528|6369925|P3|STARTED|Overall Study||79
2594905|NCT00281528|6369926|P2|STARTED|Overall Study||54
2594906|NCT00281528|6369927|P1|STARTED|Overall Study||75
2594907|NCT00281463|6369971|P1|NOT COMPLETED|Overall Study||0
2594908|NCT00281463|6369971|P1|COMPLETED|Overall Study||45
2594909|NCT00281463|6369971|P1|STARTED|Overall Study||45
2594910|NCT00281320|6369978|P2|NOT COMPLETED|Overall Study||21
2594911|NCT00281320|6369979|P1|NOT COMPLETED|Overall Study||25
2594912|NCT00281320|6369978|P2|COMPLETED|Overall Study||40
2594913|NCT00281320|6369979|P1|COMPLETED|Overall Study||36
2594914|NCT00281320|6369978|P2|STARTED|Overall Study||61
2594915|NCT00281320|6369979|P1|STARTED|Overall Study||61
2594916|NCT00281099|6370001|P2|NOT COMPLETED|Overall Study||222
2594917|NCT00281099|6370002|P1|NOT COMPLETED|Overall Study||205
2594918|NCT00281099|6370001|P2|COMPLETED|Overall Study||296
2594919|NCT00281099|6370002|P1|COMPLETED|Overall Study||308
2594920|NCT00281099|6370001|P2|STARTED|Overall Study||518
2594921|NCT00281099|6370002|P1|STARTED|Overall Study||513
2594922|NCT00281021|6370043|P1|NOT COMPLETED|Overall Study||2
2594923|NCT00281021|6370043|P1|COMPLETED|Overall Study||24
2594924|NCT00281021|6370043|P1|STARTED|Overall Study||26
2594925|NCT00280917|6370051|P4|NOT COMPLETED|Overall Study||2
2594926|NCT00280917|6370052|P3|NOT COMPLETED|Overall Study||6
2594927|NCT00280917|6370053|P2|NOT COMPLETED|Overall Study||6
2594928|NCT00280917|6370054|P1|NOT COMPLETED|Overall Study||2
2594929|NCT00280917|6370051|P4|COMPLETED|Overall Study||61
2594930|NCT00280917|6370052|P3|COMPLETED|Overall Study||57
2594931|NCT00280917|6370053|P2|COMPLETED|Overall Study||57
2594932|NCT00280917|6370054|P1|COMPLETED|Overall Study||63
2594933|NCT00280917|6370051|P4|STARTED|Overall Study||63
2594934|NCT00280917|6370052|P3|STARTED|Overall Study||63
2594935|NCT00280917|6370053|P2|STARTED|Overall Study||63
2594936|NCT00280917|6370054|P1|STARTED|Overall Study||65
2594937|NCT00280904|6370064|P1|NOT COMPLETED|Overall Study||0
2594938|NCT00280904|6370064|P1|COMPLETED|Overall Study||433
2594939|NCT00280904|6370064|P1|STARTED|Overall Study||433
2594940|NCT00280826|6370069|P1|NOT COMPLETED|Overall Study||0
2594941|NCT00280826|6370069|P1|COMPLETED|Overall Study||6
2594942|NCT00280826|6370069|P1|STARTED|Overall Study||6
2594943|NCT00280748|6370077|P1|NOT COMPLETED|Overall Study||4
2594944|NCT00280748|6370077|P1|COMPLETED|Overall Study||6
2594945|NCT00280748|6370077|P1|STARTED|Overall Study||10
2594946|NCT00280735|6370087|P1|NOT COMPLETED|Overall Study||18
2594947|NCT00280735|6370087|P1|COMPLETED|Overall Study||57
2594948|NCT00280735|6370087|P1|Received Adequate Exposure|Overall Study||57
2594949|NCT00280735|6370087|P1|Received Treatment|Overall Study||72
2594950|NCT00280735|6370087|P1|STARTED|Overall Study||75
2594951|NCT00280683|6370099|P2|NOT COMPLETED|Overall Study||3
2594952|NCT00280683|6370100|P1|NOT COMPLETED|Overall Study||2
2594953|NCT00280683|6370099|P2|COMPLETED|Overall Study||7
2594954|NCT00280683|6370100|P1|COMPLETED|Overall Study|Reasons for subjects discontinuing included inability to adhere to the schedule or adverse event.|8
2594955|NCT00280683|6370099|P2|STARTED|Overall Study||10
2594956|NCT00280683|6370100|P1|STARTED|Overall Study||10
2594957|NCT00280566|6370110|P3|NOT COMPLETED|Period 2 Double Blind||57
2594958|NCT00280566|6370111|P2|NOT COMPLETED|Period 2 Double Blind||43
2594959|NCT00280566|6370112|P1|NOT COMPLETED|Period 2 Double Blind||0
2594960|NCT00280566|6370110|P3|COMPLETED|Period 2 Double Blind||54
2594961|NCT00280566|6370111|P2|COMPLETED|Period 2 Double Blind||84
2594962|NCT00280566|6370112|P1|COMPLETED|Period 2 Double Blind||0
2594963|NCT00280566|6370110|P3|STARTED|Period 2 Double Blind||111
2594964|NCT00280566|6370111|P2|STARTED|Period 2 Double Blind||127
2594965|NCT00280566|6370112|P1|STARTED|Period 2 Double Blind|1 subject in Period 1 did not want to be randomized into Period 2|0
2594966|NCT00280566|6370110|P3|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
2594967|NCT00280566|6370111|P2|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
2594968|NCT00280566|6370112|P1|NOT COMPLETED|Period 1 Open Label Ziprasidone||343
2594969|NCT00280566|6370110|P3|COMPLETED|Period 1 Open Label Ziprasidone||0
2594970|NCT00280566|6370111|P2|COMPLETED|Period 1 Open Label Ziprasidone||0
2594971|NCT00280566|6370112|P1|COMPLETED|Period 1 Open Label Ziprasidone|Subject excluded as described above is counted as 2; enrolled in 2 sites (2 identification numbers)|241
2594972|NCT00280566|6370110|P3|STARTED|Period 1 Open Label Ziprasidone||0
2594973|NCT00280566|6370111|P2|STARTED|Period 1 Open Label Ziprasidone||0
2594974|NCT00280566|6370112|P1|STARTED|Period 1 Open Label Ziprasidone|1 subject inappropriately randomized into 2 different sites. Data from this subject was excluded.|584
2594975|NCT00280397|6370137|P1|NOT COMPLETED|Overall Study||1
2594976|NCT00280397|6370137|P1|COMPLETED|Overall Study||26
2594977|NCT00280397|6370137|P1|STARTED|Overall Study||27
2594978|NCT00280384|6370152|P8|NOT COMPLETED|Overall Study||0
2594979|NCT00280384|6370153|P7|NOT COMPLETED|Overall Study||0
2594980|NCT00280384|6370154|P6|NOT COMPLETED|Overall Study||0
2594981|NCT00280384|6370155|P5|NOT COMPLETED|Overall Study||0
2594982|NCT00280384|6370156|P4|NOT COMPLETED|Overall Study||0
2594983|NCT00280384|6370157|P3|NOT COMPLETED|Overall Study||0
2594984|NCT00280384|6370158|P2|NOT COMPLETED|Overall Study||0
2594985|NCT00280384|6370159|P1|NOT COMPLETED|Overall Study||0
2594986|NCT00280384|6370152|P8|COMPLETED|Overall Study||6
2594987|NCT00280384|6370153|P7|COMPLETED|Overall Study||6
2594988|NCT00280384|6370154|P6|COMPLETED|Overall Study||6
2594989|NCT00280384|6370155|P5|COMPLETED|Overall Study||6
2594990|NCT00280384|6370156|P4|COMPLETED|Overall Study||6
2594991|NCT00280384|6370157|P3|COMPLETED|Overall Study||6
2594992|NCT00280384|6370158|P2|COMPLETED|Overall Study||6
2594993|NCT00280384|6370159|P1|COMPLETED|Overall Study||6
2594994|NCT00280384|6370152|P8|STARTED|Overall Study||6
2594995|NCT00280384|6370153|P7|STARTED|Overall Study||6
2594996|NCT00280384|6370154|P6|STARTED|Overall Study||6
2594997|NCT00280384|6370155|P5|STARTED|Overall Study||6
2594998|NCT00280384|6370156|P4|STARTED|Overall Study||6
2594999|NCT00280384|6370157|P3|STARTED|Overall Study||6
2595000|NCT00280384|6370158|P2|STARTED|Overall Study||6
2595001|NCT00280384|6370159|P1|STARTED|Overall Study||6
2595002|NCT00280293|6370203|P2|NOT COMPLETED|Overall Study||23
2595003|NCT00280293|6370204|P1|NOT COMPLETED|Overall Study||26
2595004|NCT00280293|6370203|P2|COMPLETED|Overall Study||34
2595005|NCT00280293|6370204|P1|COMPLETED|Overall Study||29
2595006|NCT00280293|6370203|P2|STARTED|Overall Study||57
2595007|NCT00280293|6370204|P1|STARTED|Overall Study||55
2595008|NCT00280241|6370216|P1|NOT COMPLETED|Overall Study||10
2595009|NCT00280241|6370216|P1|COMPLETED|Overall Study||55
2595010|NCT00280241|6370216|P1|STARTED|Overall Study||65
2595011|NCT00280150|6370227|P4|NOT COMPLETED|Overall Study||10
2595012|NCT00280150|6370228|P3|NOT COMPLETED|Overall Study||5
2595013|NCT00280150|6370229|P2|NOT COMPLETED|Overall Study||1
2595014|NCT00280150|6370230|P1|NOT COMPLETED|Overall Study||3
2595015|NCT00280150|6370227|P4|COMPLETED|Overall Study||20
2595016|NCT00280150|6370228|P3|COMPLETED|Overall Study||1
2595017|NCT00280150|6370229|P2|COMPLETED|Overall Study||4
2595018|NCT00280150|6370230|P1|COMPLETED|Overall Study||2
2595019|NCT00280150|6370227|P4|Consolidation Therapy|Overall Study|Phase II participants did not receive consolidation therapy.|0
2595020|NCT00280150|6370228|P3|Consolidation Therapy|Overall Study||3
2595021|NCT00280150|6370229|P2|Consolidation Therapy|Overall Study||5
2595022|NCT00280150|6370230|P1|Consolidation Therapy|Overall Study||2
2595023|NCT00280150|6370227|P4|Cohort Induction|Overall Study||30
2595024|NCT00280150|6370228|P3|Cohort Induction|Overall Study||6
2595025|NCT00280150|6370229|P2|Cohort Induction|Overall Study||5
2595026|NCT00280150|6370230|P1|Cohort Induction|Overall Study||5
2595027|NCT00280150|6370227|P4|STARTED|Overall Study||30
2595028|NCT00280150|6370228|P3|STARTED|Overall Study||6
2595029|NCT00280150|6370229|P2|STARTED|Overall Study||5
2595030|NCT00280150|6370230|P1|STARTED|Overall Study||5
2595031|NCT00280059|6370245|P2|NOT COMPLETED|Extension Phase||38
2595032|NCT00280059|6370246|P1|NOT COMPLETED|Extension Phase||49
2595033|NCT00280059|6370245|P2|COMPLETED|Extension Phase||177
2595034|NCT00280059|6370246|P1|COMPLETED|Extension Phase||145
2595035|NCT00280059|6370245|P2|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|215
2595036|NCT00280059|6370246|P1|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|194
2595037|NCT00280059|6370245|P2|NOT COMPLETED|Efficacy Assessment Phase||80
2595038|NCT00280059|6370246|P1|NOT COMPLETED|Efficacy Assessment Phase||94
2595039|NCT00280059|6370245|P2|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|250
2595040|NCT00280059|6370246|P1|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|236
2595041|NCT00280059|6370245|P2|STARTED|Efficacy Assessment Phase||330
2595042|NCT00280059|6370246|P1|STARTED|Efficacy Assessment Phase||330
2595043|NCT00279955|6370295|P3|NOT COMPLETED|Overall Study||0
2595044|NCT00279955|6370296|P2|NOT COMPLETED|Overall Study||0
2595045|NCT00279955|6370297|P1|NOT COMPLETED|Overall Study||0
2595046|NCT00279955|6370295|P3|COMPLETED|Overall Study|They are still counted as completes, though they are never used for the analyses of objectives.|358
2595047|NCT00279955|6370296|P2|COMPLETED|Overall Study||486
2595048|NCT00279955|6370297|P1|COMPLETED|Overall Study||157
2595049|NCT00279955|6370295|P3|STARTED|Overall Study||358
2595050|NCT00279955|6370296|P2|STARTED|Overall Study||486
2595051|NCT00279955|6370297|P1|STARTED|Overall Study||157
2595052|NCT00279916|6370310|P2|NOT COMPLETED|Overall Study||5
2595053|NCT00279916|6370311|P1|NOT COMPLETED|Overall Study||7
2595054|NCT00279916|6370310|P2|COMPLETED|Overall Study||41
2595055|NCT00279916|6370311|P1|COMPLETED|Overall Study||38
2595056|NCT00279916|6370310|P2|STARTED|Overall Study||46
2595057|NCT00279916|6370311|P1|STARTED|Overall Study||45
2595058|NCT00279812|6370337|P6|NOT COMPLETED|Overall Study||1
2595059|NCT00279812|6370338|P5|NOT COMPLETED|Overall Study||3
2595060|NCT00279812|6370339|P4|NOT COMPLETED|Overall Study||0
2595061|NCT00279812|6370340|P3|NOT COMPLETED|Overall Study||3
2595062|NCT00279812|6370341|P2|NOT COMPLETED|Overall Study||6
2595063|NCT00279812|6370342|P1|NOT COMPLETED|Overall Study||1
2595064|NCT00279812|6370337|P6|COMPLETED|Overall Study||18
2595065|NCT00279812|6370338|P5|COMPLETED|Overall Study||17
2595066|NCT00279812|6370339|P4|COMPLETED|Overall Study||23
2595067|NCT00279812|6370340|P3|COMPLETED|Overall Study||21
2595068|NCT00279812|6370341|P2|COMPLETED|Overall Study||20
2595069|NCT00279812|6370342|P1|COMPLETED|Overall Study||20
2595070|NCT00279812|6370337|P6|STARTED|Overall Study||19
2595071|NCT00279812|6370338|P5|STARTED|Overall Study||20
2595072|NCT00279812|6370339|P4|STARTED|Overall Study||23
2595073|NCT00279812|6370340|P3|STARTED|Overall Study||24
2595074|NCT00279812|6370341|P2|STARTED|Overall Study||26
2595075|NCT00279812|6370342|P1|STARTED|Overall Study||21
2595076|NCT00279708|6370370|P2|NOT COMPLETED|Overall Study||4
2595077|NCT00279708|6370371|P1|NOT COMPLETED|Overall Study||3
2595078|NCT00279708|6370370|P2|COMPLETED|Overall Study||24
2595079|NCT00279708|6370371|P1|COMPLETED|Overall Study||24
2595080|NCT00279708|6370370|P2|STARTED|Overall Study||28
2595081|NCT00279708|6370371|P1|STARTED|Overall Study|"Started meaning randomized"|27
2595082|NCT00279591|6370379|P2|NOT COMPLETED|Overall Study||0
2595083|NCT00279591|6370380|P1|NOT COMPLETED|Overall Study||0
2595084|NCT00279591|6370379|P2|COMPLETED|Overall Study||46
2595085|NCT00279591|6370380|P1|COMPLETED|Overall Study||48
2595086|NCT00279591|6370379|P2|STARTED|Overall Study||46
2595087|NCT00279591|6370380|P1|STARTED|Overall Study||48
2595088|NCT00279500|6370394|P1|NOT COMPLETED|Overall Study||0
2595089|NCT00279500|6370394|P1|COMPLETED|Overall Study|6 patients treated|6
2595090|NCT00279500|6370394|P1|STARTED|Overall Study|6 patients treated|6
2595091|NCT00279305|6370400|P2|NOT COMPLETED|Overall Study||1
2595092|NCT00279305|6370401|P1|NOT COMPLETED|Overall Study||8
2595093|NCT00279305|6370400|P2|COMPLETED|Overall Study||29
2595094|NCT00279305|6370401|P1|COMPLETED|Overall Study||49
2595095|NCT00279305|6370400|P2|STARTED|Overall Study||30
2595096|NCT00279305|6370401|P1|STARTED|Overall Study||57
2595097|NCT00279214|6370409|P2|NOT COMPLETED|Overall Study||2
2595098|NCT00279214|6370410|P1|NOT COMPLETED|Overall Study||3
2595099|NCT00279214|6370409|P2|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
2595100|NCT00279214|6370410|P1|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
2595101|NCT00279214|6370409|P2|STARTED|Overall Study||21
2595102|NCT00279214|6370410|P1|STARTED|Overall Study||22
2595103|NCT00279201|6370440|P6|NOT COMPLETED|Intensification Addendum||37
2595104|NCT00279201|6370441|P5|NOT COMPLETED|Intensification Addendum||29
2595105|NCT00279201|6370442|P4|NOT COMPLETED|Intensification Addendum||28
2595106|NCT00279201|6370443|P3|NOT COMPLETED|Intensification Addendum||23
2595107|NCT00279201|6370444|P2|NOT COMPLETED|Intensification Addendum||0
2595108|NCT00279201|6370445|P1|NOT COMPLETED|Intensification Addendum||0
2595109|NCT00279201|6370440|P6|COMPLETED|Intensification Addendum||162
2595110|NCT00279201|6370441|P5|COMPLETED|Intensification Addendum||142
2595111|NCT00279201|6370442|P4|COMPLETED|Intensification Addendum||172
2595112|NCT00279201|6370443|P3|COMPLETED|Intensification Addendum||151
2595113|NCT00279201|6370444|P2|COMPLETED|Intensification Addendum||0
2595114|NCT00279201|6370445|P1|COMPLETED|Intensification Addendum||0
2595115|NCT00279201|6370440|P6|STARTED|Intensification Addendum||199
2595116|NCT00279201|6370441|P5|STARTED|Intensification Addendum||171
2595117|NCT00279201|6370442|P4|STARTED|Intensification Addendum||200
2595118|NCT00279201|6370443|P3|STARTED|Intensification Addendum||174
2595119|NCT00279201|6370444|P2|STARTED|Intensification Addendum||0
2595120|NCT00279201|6370445|P1|STARTED|Intensification Addendum||0
2595121|NCT00279201|6370440|P6|NOT COMPLETED|Maintenance||0
2595122|NCT00279201|6370441|P5|NOT COMPLETED|Maintenance||0
2595123|NCT00279201|6370442|P4|NOT COMPLETED|Maintenance||0
2595124|NCT00279201|6370443|P3|NOT COMPLETED|Maintenance||0
2595125|NCT00279201|6370444|P2|NOT COMPLETED|Maintenance||234
2595126|NCT00279201|6370445|P1|NOT COMPLETED|Maintenance||231
2595127|NCT00279201|6370440|P6|COMPLETED|Maintenance||0
2595128|NCT00279201|6370441|P5|COMPLETED|Maintenance||0
2595129|NCT00279201|6370442|P4|COMPLETED|Maintenance||0
2595130|NCT00279201|6370443|P3|COMPLETED|Maintenance||0
2595131|NCT00279201|6370444|P2|COMPLETED|Maintenance||239
2595132|NCT00279201|6370445|P1|COMPLETED|Maintenance||188
2595133|NCT00279201|6370440|P6|STARTED|Maintenance||0
2595134|NCT00279201|6370441|P5|STARTED|Maintenance||0
2595135|NCT00279201|6370442|P4|STARTED|Maintenance||0
2595136|NCT00279201|6370443|P3|STARTED|Maintenance||0
2595137|NCT00279201|6370444|P2|STARTED|Maintenance|82 left the study after initiation. 345 had HbA1c>7% and enrolled in intensification addendum.|473
2595138|NCT00279201|6370445|P1|STARTED|Maintenance|100 left the study after initiation. 399 had HbA1c>7% and enrolled in intensification addendum.|419
2595139|NCT00279201|6370440|P6|NOT COMPLETED|Initiation||0
2595140|NCT00279201|6370441|P5|NOT COMPLETED|Initiation||0
2595141|NCT00279201|6370442|P4|NOT COMPLETED|Initiation||0
2595142|NCT00279201|6370443|P3|NOT COMPLETED|Initiation||0
2595143|NCT00279201|6370444|P2|NOT COMPLETED|Initiation||145
2595144|NCT00279201|6370445|P1|NOT COMPLETED|Initiation||128
2595145|NCT00279201|6370440|P6|COMPLETED|Initiation||0
2595146|NCT00279201|6370441|P5|COMPLETED|Initiation||0
2595147|NCT00279201|6370442|P4|COMPLETED|Initiation||0
2595148|NCT00279201|6370443|P3|COMPLETED|Initiation||0
2595149|NCT00279201|6370444|P2|COMPLETED|Initiation||900
2595150|NCT00279201|6370445|P1|COMPLETED|Initiation||918
2595151|NCT00279201|6370440|P6|STARTED|Initiation||0
2595152|NCT00279201|6370441|P5|STARTED|Initiation||0
2595153|NCT00279201|6370442|P4|STARTED|Initiation||0
2595154|NCT00279201|6370443|P3|STARTED|Initiation||0
2595155|NCT00279201|6370444|P2|STARTED|Initiation||1045
2595156|NCT00279201|6370445|P1|STARTED|Initiation||1046
2595157|NCT00278993|6370589|P1|NOT COMPLETED|Overall Study||107
2595158|NCT00278993|6370589|P1|COMPLETED|Overall Study||1
2595159|NCT00278993|6370589|P1|STARTED|Overall Study||108
2595160|NCT00278954|6370597|P1|NOT COMPLETED|Overall Study||5
2595161|NCT00278954|6370597|P1|COMPLETED|Overall Study||45
2595162|NCT00278954|6370597|P1|STARTED|Overall Study||50
2595163|NCT00278915|6370605|P1|NOT COMPLETED|Overall Study||1
2595164|NCT00278915|6370605|P1|COMPLETED|Overall Study||29
2595165|NCT00278915|6370605|P1|STARTED|Overall Study|First 6 patients were dosed at 2mg/kg then increased to 4 mg/kg. Remaining 24 were dosed at 4mg/kg.|30
2595166|NCT00278889|6370641|P3|NOT COMPLETED|Overall Study||20
2595167|NCT00278889|6370642|P2|NOT COMPLETED|Overall Study||27
2595168|NCT00278889|6370643|P1|NOT COMPLETED|Overall Study||25
2595169|NCT00278889|6370641|P3|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
2595170|NCT00278889|6370642|P2|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|47
2595171|NCT00278889|6370643|P1|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
2595172|NCT00278889|6370641|P3|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|19
2595173|NCT00278889|6370642|P2|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|20
2595174|NCT00278889|6370643|P1|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|16
2595175|NCT00278889|6370641|P3|STARTED|Overall Study|Randomised|68
2595176|NCT00278889|6370642|P2|STARTED|Overall Study|Randomised|74
2595177|NCT00278889|6370643|P1|STARTED|Overall Study|Randomised|73
2595178|NCT00278876|6370669|P1|NOT COMPLETED|Overall Study||9
2595179|NCT00278876|6370669|P1|COMPLETED|Overall Study||38
2595180|NCT00278876|6370669|P1|STARTED|Overall Study||47
2595181|NCT00278863|6370677|P2|NOT COMPLETED|Overall Study||2
2595182|NCT00278863|6370678|P1|NOT COMPLETED|Overall Study||5
2595183|NCT00278863|6370677|P2|COMPLETED|Overall Study||45
2595184|NCT00278863|6370678|P1|COMPLETED|Overall Study||44
2595185|NCT00278863|6370677|P2|STARTED|Overall Study||47
2595186|NCT00278863|6370678|P1|STARTED|Overall Study||49
2595187|NCT00278655|6370686|P1|NOT COMPLETED|Overall Study||0
2595188|NCT00278655|6370686|P1|COMPLETED|Overall Study||21
2595189|NCT00278655|6370686|P1|STARTED|Overall Study||21
2595190|NCT00278564|6370691|P1|NOT COMPLETED|Overall Study||4
2595191|NCT00278564|6370691|P1|COMPLETED|Overall Study||3
2595192|NCT00278564|6370691|P1|STARTED|Overall Study||7
2595193|NCT00278525|6370697|P2|NOT COMPLETED|Overall Study||0
2595194|NCT00278525|6370698|P1|NOT COMPLETED|Overall Study||0
2595195|NCT00278525|6370697|P2|COMPLETED|Overall Study|7 participant crossed over to the HSCT arm and underwent HSCT, in accordance with the protocol.|10
2595196|NCT00278525|6370698|P1|COMPLETED|Overall Study|7 participants crossed to HSCT arm in accordance with the protocol|9
2595197|NCT00278525|6370697|P2|STARTED|Overall Study||10
2595198|NCT00278525|6370698|P1|STARTED|Overall Study||9
2595199|NCT00278512|6370708|P2|NOT COMPLETED|Overall Study||0
2595200|NCT00278512|6370709|P1|NOT COMPLETED|Overall Study||1
2595201|NCT00278512|6370708|P2|COMPLETED|Overall Study||0
2595202|NCT00278512|6370709|P1|COMPLETED|Overall Study||6
2595203|NCT00278512|6370708|P2|STARTED|Overall Study||0
2595204|NCT00278512|6370709|P1|STARTED|Overall Study||7
2595205|NCT00278473|6370717|P2|NOT COMPLETED|Overall Study||3
2595206|NCT00278473|6370718|P1|NOT COMPLETED|Overall Study||4
2595207|NCT00278473|6370717|P2|COMPLETED|Overall Study||40
2595208|NCT00278473|6370718|P1|COMPLETED|Overall Study||41
2595209|NCT00278473|6370717|P2|STARTED|Overall Study||43
2595210|NCT00278473|6370718|P1|STARTED|Overall Study||45
2595211|NCT00278395|6370734|P1|NOT COMPLETED|Overall Study||3
2595212|NCT00278395|6370734|P1|COMPLETED|Overall Study||11
2595213|NCT00278395|6370734|P1|STARTED|Overall Study||14
2595214|NCT00278343|6370741|P1|NOT COMPLETED|Overall Study||0
2595215|NCT00278343|6370741|P1|COMPLETED|Overall Study||74
2595216|NCT00278343|6370741|P1|STARTED|Overall Study||74
2595217|NCT00278200|6370752|P2|NOT COMPLETED|Overall Study||4
2595218|NCT00278200|6370753|P1|NOT COMPLETED|Overall Study||1
2595219|NCT00278200|6370752|P2|COMPLETED|Overall Study||8
2595220|NCT00278200|6370753|P1|COMPLETED|Overall Study||1
2595221|NCT00278200|6370752|P2|STARTED|Overall Study||12
2595222|NCT00278200|6370753|P1|STARTED|Overall Study||2
2595223|NCT00278161|6370762|P1|NOT COMPLETED|Overall Study||11
2595224|NCT00278161|6370762|P1|COMPLETED|Overall Study||70
2595225|NCT00278161|6370762|P1|STARTED|Overall Study||81
2595230|NCT00277524|6370772|P4|NOT COMPLETED|Overall Study||0
2595231|NCT00277524|6370773|P3|NOT COMPLETED|Overall Study||0
2595232|NCT00277524|6370774|P2|NOT COMPLETED|Overall Study||0
2595233|NCT00277524|6370775|P1|NOT COMPLETED|Overall Study||0
2595234|NCT00277524|6370772|P4|COMPLETED|Overall Study||850
2595235|NCT00277524|6370773|P3|COMPLETED|Overall Study||1088
2595236|NCT00277524|6370774|P2|COMPLETED|Overall Study||324
2595237|NCT00277524|6370775|P1|COMPLETED|Overall Study||621
2595238|NCT00277524|6370772|P4|STARTED|Overall Study||850
2595239|NCT00277524|6370773|P3|STARTED|Overall Study||1088
2595240|NCT00277524|6370774|P2|STARTED|Overall Study||324
2595241|NCT00277524|6370775|P1|STARTED|Overall Study||621
2595242|NCT00277446|6370793|P1|NOT COMPLETED|Overall Study||0
2595243|NCT00277446|6370793|P1|COMPLETED|Overall Study||13
2595244|NCT00277446|6370793|P1|STARTED|Overall Study||13
2595245|NCT00277394|6370801|P2|NOT COMPLETED|Overall Study||24
2595246|NCT00277394|6370802|P1|NOT COMPLETED|Overall Study||37
2595247|NCT00277394|6370801|P2|COMPLETED|Overall Study||246
2595248|NCT00277394|6370802|P1|COMPLETED|Overall Study||232
2595249|NCT00277394|6370801|P2|STARTED|Overall Study||270
2595250|NCT00277394|6370802|P1|STARTED|Overall Study||269
2595251|NCT00277355|6370814|P2|NOT COMPLETED|Overall Study||5
2595252|NCT00277355|6370815|P1|NOT COMPLETED|Overall Study||14
2595253|NCT00277355|6370814|P2|COMPLETED|Overall Study||22
2595254|NCT00277355|6370815|P1|COMPLETED|Overall Study||73
2595255|NCT00277355|6370814|P2|STARTED|Overall Study||27
2595256|NCT00277355|6370815|P1|STARTED|Overall Study||87
2595257|NCT00277212|6370823|P3|NOT COMPLETED|Phase 2 - Double-Blind Treatment||113
2595258|NCT00277212|6370824|P2|NOT COMPLETED|Phase 2 - Double-Blind Treatment||120
2595259|NCT00277212|6370825|P1|NOT COMPLETED|Phase 2 - Double-Blind Treatment||0
2595260|NCT00277212|6370823|P3|COMPLETED|Phase 2 - Double-Blind Treatment||65
2595261|NCT00277212|6370824|P2|COMPLETED|Phase 2 - Double-Blind Treatment||53
2595262|NCT00277212|6370825|P1|COMPLETED|Phase 2 - Double-Blind Treatment||0
2595263|NCT00277212|6370823|P3|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||174
2595264|NCT00277212|6370824|P2|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||164
2595265|NCT00277212|6370825|P1|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||0
2595266|NCT00277212|6370823|P3|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||176
2595267|NCT00277212|6370824|P2|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||165
2595268|NCT00277212|6370825|P1|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||0
2595269|NCT00277212|6370823|P3|STARTED|Phase 2 - Double-Blind Treatment|1 participant did not want to continue in the study for personal reasons, and did not enter Phase 2.|178
2595270|NCT00277212|6370824|P2|STARTED|Phase 2 - Double-Blind Treatment||173
2595271|NCT00277212|6370825|P1|STARTED|Phase 2 - Double-Blind Treatment||0
2595272|NCT00277212|6370823|P3|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
2595273|NCT00277212|6370824|P2|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
2595274|NCT00277212|6370825|P1|NOT COMPLETED|Phase 1 - Single-Blind Treatment||435
2595275|NCT00277212|6370823|P3|COMPLETED|Phase 1 - Single-Blind Treatment||0
2595276|NCT00277212|6370824|P2|COMPLETED|Phase 1 - Single-Blind Treatment||0
2595277|NCT00277212|6370825|P1|COMPLETED|Phase 1 - Single-Blind Treatment||352
2595278|NCT00277212|6370823|P3|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
2595279|NCT00277212|6370824|P2|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
2595280|NCT00277212|6370825|P1|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||756
2595281|NCT00277212|6370823|P3|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
2595282|NCT00277212|6370824|P2|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
2595283|NCT00277212|6370825|P1|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||787
2595284|NCT00277212|6370823|P3|STARTED|Phase 1 - Single-Blind Treatment||0
2595285|NCT00277212|6370824|P2|STARTED|Phase 1 - Single-Blind Treatment||0
2595286|NCT00277212|6370825|P1|STARTED|Phase 1 - Single-Blind Treatment||787
2595287|NCT00277095|6370863|P1|NOT COMPLETED|Overall Study||21
2595288|NCT00277095|6370863|P1|COMPLETED|Overall Study|Details of patients who did not complete study are given below.|103
2595289|NCT00277095|6370863|P1|STARTED|Overall Study|Anatomy of 1 patient did not allow ProACT to be implanted, hence only 123 patients were implanted.|124
2595290|NCT00276861|6370867|P1|NOT COMPLETED|Overall Study||0
2595291|NCT00276861|6370867|P1|COMPLETED|Overall Study||10
2595292|NCT00276861|6370867|P1|STARTED|Overall Study||10
2595293|NCT00276744|6370872|P1|NOT COMPLETED|PART B||0
2595294|NCT00276744|6370872|P1|COMPLETED|PART B||0
2595295|NCT00276744|6370872|P1|STARTED|PART B|This study was terminated before participants could reach this stage of the study.|0
2595296|NCT00276744|6370872|P1|NOT COMPLETED|PART A||98
2595297|NCT00276744|6370872|P1|COMPLETED|PART A||142
2595298|NCT00276744|6370872|P1|STARTED|PART A||240
2595299|NCT00276614|6370876|P1|NOT COMPLETED|Overall Study||3
2595300|NCT00276614|6370876|P1|COMPLETED|Overall Study||1
2595301|NCT00276614|6370876|P1|STARTED|Overall Study||4
2595302|NCT00276549|6370880|P1|NOT COMPLETED|Overall Study||0
2595303|NCT00276549|6370880|P1|COMPLETED|Overall Study||35
2595304|NCT00276549|6370880|P1|STARTED|Overall Study||35
2595305|NCT00276484|6370887|P2|NOT COMPLETED|Overall Study||13
2595306|NCT00276484|6370888|P1|NOT COMPLETED|Overall Study||9
2595307|NCT00276484|6370887|P2|COMPLETED|Overall Study||278
2595308|NCT00276484|6370888|P1|COMPLETED|Overall Study||279
2595309|NCT00276484|6370887|P2|STARTED|Overall Study||291
2595310|NCT00276484|6370888|P1|STARTED|Overall Study||288
2595311|NCT00276458|6370920|P2|NOT COMPLETED|Overall Study||7
2595312|NCT00276458|6370921|P1|NOT COMPLETED|Overall Study||6
2595313|NCT00276458|6370920|P2|COMPLETED|Overall Study||91
2595314|NCT00276458|6370921|P1|COMPLETED|Overall Study||92
2595315|NCT00276458|6370920|P2|STARTED|Overall Study||98
2595316|NCT00276458|6370921|P1|STARTED|Overall Study||98
2595317|NCT00276419|6370955|P2|NOT COMPLETED|Second Intervention||0
2595318|NCT00276419|6370956|P1|NOT COMPLETED|Second Intervention||0
2595319|NCT00276419|6370955|P2|COMPLETED|Second Intervention||8
2595320|NCT00276419|6370956|P1|COMPLETED|Second Intervention||7
2595321|NCT00276419|6370955|P2|STARTED|Second Intervention||8
2595322|NCT00276419|6370956|P1|STARTED|Second Intervention||7
2595323|NCT00276419|6370955|P2|NOT COMPLETED|Wash-out Phase||0
2595324|NCT00276419|6370956|P1|NOT COMPLETED|Wash-out Phase||0
2595325|NCT00276419|6370955|P2|COMPLETED|Wash-out Phase||8
2595326|NCT00276419|6370956|P1|COMPLETED|Wash-out Phase||7
2595327|NCT00276419|6370955|P2|STARTED|Wash-out Phase||8
2595328|NCT00276419|6370956|P1|STARTED|Wash-out Phase||7
2595329|NCT00276419|6370955|P2|NOT COMPLETED|First Intervention||2
2595330|NCT00276419|6370956|P1|NOT COMPLETED|First Intervention||1
2595331|NCT00276419|6370955|P2|COMPLETED|First Intervention||8
2595332|NCT00276419|6370956|P1|COMPLETED|First Intervention||7
2595333|NCT00276419|6370955|P2|STARTED|First Intervention||10
2595334|NCT00276419|6370956|P1|STARTED|First Intervention||8
2595335|NCT00276406|6370968|P2|NOT COMPLETED|Overall Study||0
2595336|NCT00276406|6370969|P1|NOT COMPLETED|Overall Study||0
2595337|NCT00276406|6370968|P2|COMPLETED|Overall Study||14
2595338|NCT00276406|6370969|P1|COMPLETED|Overall Study|14 of 16 subjects tolerated 360mg daily, while 2 of 16 tolerated 180mg daily.|16
2595339|NCT00276406|6370968|P2|STARTED|Overall Study||14
2595340|NCT00276406|6370969|P1|STARTED|Overall Study||16
2595341|NCT00276380|6370999|P2|NOT COMPLETED|Overall Study||14
2595342|NCT00276380|6371000|P1|NOT COMPLETED|Overall Study||14
2595343|NCT00276380|6370999|P2|COMPLETED|Overall Study||88
2595344|NCT00276380|6371000|P1|COMPLETED|Overall Study||88
2595345|NCT00276380|6370999|P2|STARTED|Overall Study||102
2595346|NCT00276380|6371000|P1|STARTED|Overall Study||102
2595347|NCT00276250|6371021|P3|NOT COMPLETED|Overall Study||0
2595348|NCT00276250|6371022|P2|NOT COMPLETED|Overall Study||0
2595349|NCT00276250|6371023|P1|NOT COMPLETED|Overall Study||0
2595350|NCT00276250|6371021|P3|COMPLETED|Overall Study||0
2595351|NCT00276250|6371022|P2|COMPLETED|Overall Study||1
2595352|NCT00276250|6371023|P1|COMPLETED|Overall Study||4
2595353|NCT00276250|6371021|P3|STARTED|Overall Study||0
2595354|NCT00276250|6371022|P2|STARTED|Overall Study||1
2595355|NCT00276250|6371023|P1|STARTED|Overall Study||4
2595356|NCT00276159|6371055|P1|NOT COMPLETED|Overall Study||6
2595357|NCT00276159|6371055|P1|COMPLETED|Overall Study||0
2595358|NCT00276159|6371055|P1|STARTED|Overall Study||6
2595359|NCT00276094|6371065|P3|NOT COMPLETED|Overall Study||38
2595360|NCT00276094|6371066|P2|NOT COMPLETED|Overall Study||42
2595361|NCT00276094|6371067|P1|NOT COMPLETED|Overall Study||57
2595362|NCT00276094|6371065|P3|COMPLETED|Overall Study||230
2595363|NCT00276094|6371066|P2|COMPLETED|Overall Study||234
2595364|NCT00276094|6371067|P1|COMPLETED|Overall Study||225
2595365|NCT00276094|6371065|P3|STARTED|Overall Study||268
2595366|NCT00276094|6371066|P2|STARTED|Overall Study||276
2595367|NCT00276094|6371067|P1|STARTED|Overall Study||282
2595368|NCT00276016|6371120|P6|NOT COMPLETED|Intervention 3||0
2595369|NCT00276016|6371121|P5|NOT COMPLETED|Intervention 3||0
2595370|NCT00276016|6371122|P4|NOT COMPLETED|Intervention 3||0
2595371|NCT00276016|6371123|P3|NOT COMPLETED|Intervention 3||0
2595372|NCT00276016|6371124|P2|NOT COMPLETED|Intervention 3||0
2595373|NCT00276016|6371125|P1|NOT COMPLETED|Intervention 3||0
2595374|NCT00276016|6371120|P6|COMPLETED|Intervention 3||6
2595375|NCT00276016|6371121|P5|COMPLETED|Intervention 3||6
2595376|NCT00276016|6371122|P4|COMPLETED|Intervention 3||6
2595377|NCT00276016|6371123|P3|COMPLETED|Intervention 3||7
2595378|NCT00276016|6371124|P2|COMPLETED|Intervention 3||6
2595379|NCT00276016|6371125|P1|COMPLETED|Intervention 3||7
2595380|NCT00276016|6371120|P6|STARTED|Intervention 3||6
2595381|NCT00276016|6371121|P5|STARTED|Intervention 3||6
2595382|NCT00276016|6371122|P4|STARTED|Intervention 3||6
2595383|NCT00276016|6371123|P3|STARTED|Intervention 3||7
2595384|NCT00276016|6371124|P2|STARTED|Intervention 3||6
2595385|NCT00276016|6371125|P1|STARTED|Intervention 3||7
2595386|NCT00276016|6371120|P6|NOT COMPLETED|Wash Out 2||0
2595387|NCT00276016|6371121|P5|NOT COMPLETED|Wash Out 2||0
2595388|NCT00276016|6371122|P4|NOT COMPLETED|Wash Out 2||0
2595389|NCT00276016|6371123|P3|NOT COMPLETED|Wash Out 2||0
2595390|NCT00276016|6371124|P2|NOT COMPLETED|Wash Out 2||0
2595391|NCT00276016|6371125|P1|NOT COMPLETED|Wash Out 2||0
2595392|NCT00276016|6371120|P6|COMPLETED|Wash Out 2||6
2595393|NCT00276016|6371121|P5|COMPLETED|Wash Out 2||6
2595394|NCT00276016|6371122|P4|COMPLETED|Wash Out 2||6
2595395|NCT00276016|6371123|P3|COMPLETED|Wash Out 2||7
2595396|NCT00276016|6371124|P2|COMPLETED|Wash Out 2||6
2595397|NCT00276016|6371125|P1|COMPLETED|Wash Out 2||7
2595398|NCT00276016|6371120|P6|STARTED|Wash Out 2||6
2595399|NCT00276016|6371121|P5|STARTED|Wash Out 2||6
2595400|NCT00276016|6371122|P4|STARTED|Wash Out 2||6
2595401|NCT00276016|6371123|P3|STARTED|Wash Out 2||7
2595402|NCT00276016|6371124|P2|STARTED|Wash Out 2||6
2595403|NCT00276016|6371125|P1|STARTED|Wash Out 2||7
2595404|NCT00276016|6371120|P6|NOT COMPLETED|Intervention 2||0
2595405|NCT00276016|6371121|P5|NOT COMPLETED|Intervention 2||0
2595406|NCT00276016|6371122|P4|NOT COMPLETED|Intervention 2||0
2595407|NCT00276016|6371123|P3|NOT COMPLETED|Intervention 2||0
2595408|NCT00276016|6371124|P2|NOT COMPLETED|Intervention 2||0
2595409|NCT00276016|6371125|P1|NOT COMPLETED|Intervention 2||0
2595410|NCT00276016|6371120|P6|COMPLETED|Intervention 2||6
2595411|NCT00276016|6371121|P5|COMPLETED|Intervention 2||6
2595412|NCT00276016|6371122|P4|COMPLETED|Intervention 2||6
2595413|NCT00276016|6371123|P3|COMPLETED|Intervention 2||7
2595414|NCT00276016|6371124|P2|COMPLETED|Intervention 2||6
2595415|NCT00276016|6371125|P1|COMPLETED|Intervention 2||7
2595416|NCT00276016|6371120|P6|STARTED|Intervention 2||6
2595417|NCT00276016|6371121|P5|STARTED|Intervention 2||6
2595418|NCT00276016|6371122|P4|STARTED|Intervention 2||6
2595419|NCT00276016|6371123|P3|STARTED|Intervention 2||7
2595420|NCT00276016|6371124|P2|STARTED|Intervention 2||6
2595421|NCT00276016|6371125|P1|STARTED|Intervention 2||7
2595422|NCT00276016|6371120|P6|NOT COMPLETED|Wash Out 1||0
2595423|NCT00276016|6371121|P5|NOT COMPLETED|Wash Out 1||0
2595424|NCT00276016|6371122|P4|NOT COMPLETED|Wash Out 1||0
2595425|NCT00276016|6371123|P3|NOT COMPLETED|Wash Out 1||0
2595426|NCT00276016|6371124|P2|NOT COMPLETED|Wash Out 1||0
2595427|NCT00276016|6371125|P1|NOT COMPLETED|Wash Out 1||0
2595428|NCT00276016|6371120|P6|COMPLETED|Wash Out 1||6
2595429|NCT00276016|6371121|P5|COMPLETED|Wash Out 1||6
2595430|NCT00276016|6371122|P4|COMPLETED|Wash Out 1||6
2595431|NCT00276016|6371123|P3|COMPLETED|Wash Out 1||7
2595432|NCT00276016|6371124|P2|COMPLETED|Wash Out 1||6
2595433|NCT00276016|6371125|P1|COMPLETED|Wash Out 1||7
2595434|NCT00276016|6371120|P6|STARTED|Wash Out 1||6
2595435|NCT00276016|6371121|P5|STARTED|Wash Out 1||6
2595436|NCT00276016|6371122|P4|STARTED|Wash Out 1||6
2595437|NCT00276016|6371123|P3|STARTED|Wash Out 1||7
2595438|NCT00276016|6371124|P2|STARTED|Wash Out 1||6
2595439|NCT00276016|6371125|P1|STARTED|Wash Out 1||7
2595440|NCT00276016|6371120|P6|NOT COMPLETED|Intervention 1||0
2595441|NCT00276016|6371121|P5|NOT COMPLETED|Intervention 1||0
2595442|NCT00276016|6371122|P4|NOT COMPLETED|Intervention 1||0
2595443|NCT00276016|6371123|P3|NOT COMPLETED|Intervention 1||0
2595444|NCT00276016|6371124|P2|NOT COMPLETED|Intervention 1||1
2595445|NCT00276016|6371125|P1|NOT COMPLETED|Intervention 1||0
2595446|NCT00276016|6371120|P6|COMPLETED|Intervention 1||6
2595447|NCT00276016|6371121|P5|COMPLETED|Intervention 1||6
2595448|NCT00276016|6371122|P4|COMPLETED|Intervention 1||6
2595449|NCT00276016|6371123|P3|COMPLETED|Intervention 1||7
2595450|NCT00276016|6371124|P2|COMPLETED|Intervention 1||6
2595451|NCT00276016|6371125|P1|COMPLETED|Intervention 1||7
2595452|NCT00276016|6371120|P6|STARTED|Intervention 1||6
2595453|NCT00276016|6371121|P5|STARTED|Intervention 1||6
2595454|NCT00276016|6371122|P4|STARTED|Intervention 1||6
2595455|NCT00276016|6371123|P3|STARTED|Intervention 1||7
2595456|NCT00276016|6371124|P2|STARTED|Intervention 1||7
2595457|NCT00276016|6371125|P1|STARTED|Intervention 1||7
2595458|NCT00275834|6371137|P3|NOT COMPLETED|Overall Study||1
2595459|NCT00275834|6371138|P2|NOT COMPLETED|Overall Study||3
2595460|NCT00275834|6371139|P1|NOT COMPLETED|Overall Study||3
2595461|NCT00275834|6371137|P3|COMPLETED|Overall Study||74
2595462|NCT00275834|6371138|P2|COMPLETED|Overall Study||73
2595463|NCT00275834|6371139|P1|COMPLETED|Overall Study||71
2595464|NCT00275834|6371137|P3|Completed Study While on Study Drug|Overall Study||62
2595465|NCT00275834|6371138|P2|Completed Study While on Study Drug|Overall Study||51
2595466|NCT00275834|6371139|P1|Completed Study While on Study Drug|Overall Study||54
2595467|NCT00275834|6371137|P3|STARTED|Overall Study||75
2595468|NCT00275834|6371138|P2|STARTED|Overall Study||76
2595469|NCT00275834|6371139|P1|STARTED|Overall Study||74
2595470|NCT00275821|6371171|P3|NOT COMPLETED|Overall Study||12
2595471|NCT00275821|6371172|P2|NOT COMPLETED|Overall Study||23
2595472|NCT00275821|6371173|P1|NOT COMPLETED|Overall Study||14
2595473|NCT00275821|6371171|P3|COMPLETED|Overall Study||103
2595474|NCT00275821|6371172|P2|COMPLETED|Overall Study||95
2595475|NCT00275821|6371173|P1|COMPLETED|Overall Study||106
2595476|NCT00275821|6371171|P3|STARTED|Overall Study||115
2595477|NCT00275821|6371172|P2|STARTED|Overall Study||118
2595478|NCT00275821|6371173|P1|STARTED|Overall Study||120
2595479|NCT00275561|6371192|P2|NOT COMPLETED|Overall Study||6
2595480|NCT00275561|6371193|P1|NOT COMPLETED|Overall Study||2
2595481|NCT00275561|6371192|P2|COMPLETED|Overall Study||15
2595482|NCT00275561|6371193|P1|COMPLETED|Overall Study||19
2595483|NCT00275561|6371192|P2|STARTED|Overall Study||21
2595484|NCT00275561|6371193|P1|STARTED|Overall Study||21
2595485|NCT00275509|6371205|P2|NOT COMPLETED|Overall Study||1
2595486|NCT00275509|6371206|P1|NOT COMPLETED|Overall Study||0
2595487|NCT00275509|6371205|P2|COMPLETED|Overall Study||25
2595488|NCT00275509|6371206|P1|COMPLETED|Overall Study||30
2595489|NCT00275509|6371205|P2|STARTED|Overall Study||26
2595490|NCT00275509|6371206|P1|STARTED|Overall Study||30
2595491|NCT00275392|6371218|P2|NOT COMPLETED|Overall Study||2
2595492|NCT00275392|6371219|P1|NOT COMPLETED|Overall Study||0
2595493|NCT00275392|6371218|P2|COMPLETED|Overall Study||17
2595494|NCT00275392|6371219|P1|COMPLETED|Overall Study||20
2595495|NCT00275392|6371218|P2|STARTED|Overall Study||19
2595496|NCT00275392|6371219|P1|STARTED|Overall Study||20
2595497|NCT00275340|6371229|P2|NOT COMPLETED|Overall Study||4
2595498|NCT00275340|6371230|P1|NOT COMPLETED|Overall Study||2
2595499|NCT00275340|6371229|P2|COMPLETED|Overall Study||45
2595500|NCT00275340|6371230|P1|COMPLETED|Overall Study||50
2595501|NCT00275340|6371229|P2|STARTED|Overall Study||49
2595502|NCT00275340|6371230|P1|STARTED|Overall Study||52
2595503|NCT00275301|6371234|P1|NOT COMPLETED|Overall Study||5
2595504|NCT00275301|6371234|P1|COMPLETED|Overall Study||14
2595505|NCT00275301|6371234|P1|STARTED|Overall Study||19
2595506|NCT00275275|6371241|P3|NOT COMPLETED|Overall Study||6
2595507|NCT00275275|6371242|P2|NOT COMPLETED|Overall Study||2
2595508|NCT00275275|6371243|P1|NOT COMPLETED|Overall Study||6
2595509|NCT00275275|6371241|P3|COMPLETED|Overall Study||15
2595510|NCT00275275|6371242|P2|COMPLETED|Overall Study||18
2595511|NCT00275275|6371243|P1|COMPLETED|Overall Study||14
2595512|NCT00275275|6371241|P3|STARTED|Overall Study|One participant was removed after enrollment and before any data was collected for him.|21
2595513|NCT00275275|6371242|P2|STARTED|Overall Study||20
2595514|NCT00275275|6371243|P1|STARTED|Overall Study||20
2595515|NCT00275262|6371253|P2|NOT COMPLETED|Overall Study||9
2595516|NCT00275262|6371254|P1|NOT COMPLETED|Overall Study||6
2595517|NCT00275262|6371253|P2|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|4
2595518|NCT00275262|6371254|P1|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|6
2595519|NCT00275262|6371253|P2|STARTED|Overall Study||13
2595520|NCT00275262|6371254|P1|STARTED|Overall Study||12
2595521|NCT00275028|6371268|P1|NOT COMPLETED|Overall Study||47
2595522|NCT00275028|6371268|P1|COMPLETED|Overall Study|Participants are treated until one of the below milestones is reached. Completion is N/A.|0
2595523|NCT00275028|6371268|P1|STARTED|Overall Study||47
2595524|NCT00275002|6371275|P2|NOT COMPLETED|Overall Study||16
2595525|NCT00275002|6371276|P1|NOT COMPLETED|Overall Study||22
2595526|NCT00275002|6371275|P2|COMPLETED|Overall Study||0
2595527|NCT00275002|6371276|P1|COMPLETED|Overall Study||3
2595528|NCT00275002|6371275|P2|STARTED|Overall Study||16
2595529|NCT00275002|6371276|P1|STARTED|Overall Study||25
2595530|NCT00274937|6371284|P1|NOT COMPLETED|Overall Study||20
2595531|NCT00274937|6371284|P1|COMPLETED|Overall Study||91
2595532|NCT00274937|6371284|P1|STARTED|Overall Study||111
2595533|NCT00274924|6371296|P3|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
2595534|NCT00274924|6371297|P2|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||18
2595535|NCT00274924|6371298|P1|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||7
2595536|NCT00274924|6371296|P3|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
2595537|NCT00274924|6371297|P2|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||58
2595538|NCT00274924|6371298|P1|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||10
2595539|NCT00274924|6371296|P3|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||0
2595540|NCT00274924|6371297|P2|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||61
2595541|NCT00274924|6371298|P1|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||13
2595542|NCT00274924|6371296|P3|STARTED|Step 2 (Tx Based on Mid-treatment PET)||0
2595543|NCT00274924|6371297|P2|STARTED|Step 2 (Tx Based on Mid-treatment PET)|One patient withdrew from the study after step 1 treatment.|76
2595544|NCT00274924|6371298|P1|STARTED|Step 2 (Tx Based on Mid-treatment PET)|All patients who started step 2 therapy were included regardless of eligibility.|17
2595545|NCT00274924|6371296|P3|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||6
2595546|NCT00274924|6371297|P2|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||14
2595547|NCT00274924|6371298|P1|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||4
2595548|NCT00274924|6371296|P3|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||0
2595549|NCT00274924|6371297|P2|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||63
2595550|NCT00274924|6371298|P1|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||13
2595551|NCT00274924|6371296|P3|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||4
2595552|NCT00274924|6371297|P2|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||63
2595553|NCT00274924|6371298|P1|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||13
2595554|NCT00274924|6371296|P3|Treated|Step 1 (R-CHOP X 3 Cycles)||5
2595555|NCT00274924|6371297|P2|Treated|Step 1 (R-CHOP X 3 Cycles)||77
2595556|NCT00274924|6371298|P1|Treated|Step 1 (R-CHOP X 3 Cycles)||17
2595557|NCT00274924|6371296|P3|STARTED|Step 1 (R-CHOP X 3 Cycles)||6
2595558|NCT00274924|6371297|P2|STARTED|Step 1 (R-CHOP X 3 Cycles)||77
2595559|NCT00274924|6371298|P1|STARTED|Step 1 (R-CHOP X 3 Cycles)||17
2595560|NCT00274846|6371307|P1|NOT COMPLETED|Overall Study||1
2595561|NCT00274846|6371307|P1|COMPLETED|Overall Study|Evaluable patients - received adequate natural killer (NK) cells|20
2595562|NCT00274846|6371307|P1|STARTED|Overall Study||21
2595563|NCT00274781|6371315|P1|NOT COMPLETED|Overall Study||0
2595564|NCT00274781|6371315|P1|COMPLETED|Overall Study||30
2595565|NCT00274781|6371315|P1|STARTED|Overall Study||30
2595566|NCT00274768|6371321|P1|NOT COMPLETED|Overall Study||0
2595567|NCT00274768|6371321|P1|COMPLETED|Overall Study||26
2595568|NCT00274768|6371321|P1|STARTED|Overall Study||26
2595569|NCT00274742|6371336|P6|NOT COMPLETED|Overall Study||3
2595570|NCT00274742|6371337|P5|NOT COMPLETED|Overall Study||16
2595571|NCT00274742|6371338|P4|NOT COMPLETED|Overall Study||5
2595572|NCT00274742|6371339|P3|NOT COMPLETED|Overall Study||2
2595573|NCT00274742|6371340|P2|NOT COMPLETED|Overall Study||8
2595574|NCT00274742|6371341|P1|NOT COMPLETED|Overall Study||0
2595575|NCT00274742|6371336|P6|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|1
2595576|NCT00274742|6371337|P5|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|16
2595577|NCT00274742|6371338|P4|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
2595578|NCT00274742|6371339|P3|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
2595579|NCT00274742|6371340|P2|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|5
2595580|NCT00274742|6371341|P1|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|12
2595581|NCT00274742|6371336|P6|STARTED|Overall Study||4
2595582|NCT00274742|6371337|P5|STARTED|Overall Study||32
2595583|NCT00274742|6371338|P4|STARTED|Overall Study||9
2595584|NCT00274742|6371339|P3|STARTED|Overall Study||6
2595585|NCT00274742|6371340|P2|STARTED|Overall Study||13
2595586|NCT00274742|6371341|P1|STARTED|Overall Study||12
2595587|NCT00274716|6371379|P6|NOT COMPLETED|Phase B||1
2595588|NCT00274716|6371380|P5|NOT COMPLETED|Phase B||0
2595589|NCT00274716|6371381|P4|NOT COMPLETED|Phase B||1
2595590|NCT00274716|6371382|P3|NOT COMPLETED|Phase B||3
2595591|NCT00274716|6371383|P2|NOT COMPLETED|Phase B||4
2595592|NCT00274716|6371384|P1|NOT COMPLETED|Phase B||1
2595593|NCT00274716|6371379|P6|COMPLETED|Phase B||14
2595594|NCT00274716|6371380|P5|COMPLETED|Phase B||16
2595595|NCT00274716|6371381|P4|COMPLETED|Phase B||41
2595596|NCT00274716|6371382|P3|COMPLETED|Phase B||41
2595597|NCT00274716|6371383|P2|COMPLETED|Phase B||40
2595598|NCT00274716|6371384|P1|COMPLETED|Phase B||42
2595599|NCT00274716|6371379|P6|STARTED|Phase B||15
2595600|NCT00274716|6371380|P5|STARTED|Phase B||16
2595601|NCT00274716|6371381|P4|STARTED|Phase B||42
2595602|NCT00274716|6371382|P3|STARTED|Phase B||44
2595603|NCT00274716|6371383|P2|STARTED|Phase B||44
2595604|NCT00274716|6371384|P1|STARTED|Phase B||43
2595605|NCT00274716|6371379|P6|NOT COMPLETED|Phase A||4
2595606|NCT00274716|6371380|P5|NOT COMPLETED|Phase A||3
2595607|NCT00274716|6371381|P4|NOT COMPLETED|Phase A||9
2595608|NCT00274716|6371382|P3|NOT COMPLETED|Phase A||8
2595609|NCT00274716|6371383|P2|NOT COMPLETED|Phase A||10
2595610|NCT00274716|6371384|P1|NOT COMPLETED|Phase A||11
2595611|NCT00274716|6371379|P6|COMPLETED|Phase A||15
2595612|NCT00274716|6371380|P5|COMPLETED|Phase A||16
2595613|NCT00274716|6371381|P4|COMPLETED|Phase A||42
2595614|NCT00274716|6371382|P3|COMPLETED|Phase A||44
2595615|NCT00274716|6371383|P2|COMPLETED|Phase A||44
2595616|NCT00274716|6371384|P1|COMPLETED|Phase A||43
2595617|NCT00274716|6371379|P6|STARTED|Phase A||19
2595618|NCT00274716|6371380|P5|STARTED|Phase A||19
2595619|NCT00274716|6371381|P4|STARTED|Phase A||51
2595620|NCT00274716|6371382|P3|STARTED|Phase A||52
2595621|NCT00274716|6371383|P2|STARTED|Phase A||54
2595622|NCT00274716|6371384|P1|STARTED|Phase A||54
2595623|NCT00274651|6371446|P2|NOT COMPLETED|Overall Study||20
2595624|NCT00274651|6371447|P1|NOT COMPLETED|Overall Study||28
2595625|NCT00274651|6371446|P2|COMPLETED|Overall Study||4
2595626|NCT00274651|6371447|P1|COMPLETED|Overall Study||1
2595627|NCT00274651|6371446|P2|STARTED|Overall Study||24
2595628|NCT00274651|6371447|P1|STARTED|Overall Study||29
2595629|NCT00274625|6371462|P2|NOT COMPLETED|Overall Study||62
2595630|NCT00274625|6371463|P1|NOT COMPLETED|Overall Study||60
2595631|NCT00274625|6371462|P2|COMPLETED|Overall Study||141
2595632|NCT00274625|6371463|P1|COMPLETED|Overall Study||139
2595633|NCT00274625|6371462|P2|STARTED|Overall Study||203
2595634|NCT00274625|6371463|P1|STARTED|Overall Study||199
2595635|NCT00274469|6371471|P2|NOT COMPLETED|Overall Study||93
2595636|NCT00274469|6371472|P1|NOT COMPLETED|Overall Study||79
2595637|NCT00274469|6371471|P2|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|10
2595638|NCT00274469|6371472|P1|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|23
2595639|NCT00274469|6371471|P2|STARTED|Overall Study|Number of patients randomized|103
2595640|NCT00274469|6371472|P1|STARTED|Overall Study|Number of patients randomized|102
2595641|NCT00274456|6371492|P4|NOT COMPLETED|Overall Study||45
2595642|NCT00274456|6371493|P3|NOT COMPLETED|Overall Study||35
2595643|NCT00274456|6371494|P2|NOT COMPLETED|Overall Study||27
2595644|NCT00274456|6371495|P1|NOT COMPLETED|Overall Study||37
2595645|NCT00274456|6371492|P4|COMPLETED|Overall Study|Treatment completed upon progressive disease|29
2595646|NCT00274456|6371493|P3|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
2595647|NCT00274456|6371494|P2|COMPLETED|Overall Study|Treatment completed upon progressive disease|49
2595648|NCT00274456|6371495|P1|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
2595649|NCT00274456|6371492|P4|At Least One Response Assessment|Overall Study||70
2595650|NCT00274456|6371493|P3|At Least One Response Assessment|Overall Study||73
2595651|NCT00274456|6371494|P2|At Least One Response Assessment|Overall Study||76
2595652|NCT00274456|6371495|P1|At Least One Response Assessment|Overall Study||73
2595653|NCT00274456|6371492|P4|STARTED|Overall Study||74
2595654|NCT00274456|6371493|P3|STARTED|Overall Study||74
2595655|NCT00274456|6371494|P2|STARTED|Overall Study||76
2595656|NCT00274456|6371495|P1|STARTED|Overall Study||76
2595657|NCT00274287|6371537|P1|NOT COMPLETED|Overall Study||2
2595658|NCT00274287|6371537|P1|COMPLETED|Overall Study||13
2595659|NCT00274287|6371537|P1|STARTED|Overall Study||15
2595660|NCT00274261|6371547|P2|NOT COMPLETED|Overall Study||337
2595661|NCT00274261|6371548|P1|NOT COMPLETED|Overall Study||489
2595662|NCT00274261|6371547|P2|COMPLETED|Overall Study||296
2595663|NCT00274261|6371548|P1|COMPLETED|Overall Study||443
2595664|NCT00274261|6371547|P2|STARTED|Overall Study||633
2595665|NCT00274261|6371548|P1|STARTED|Overall Study||932
2595666|NCT00273910|6371562|P6|NOT COMPLETED|Overall Study||0
2595667|NCT00273910|6371563|P5|NOT COMPLETED|Overall Study||0
2595668|NCT00273910|6371564|P4|NOT COMPLETED|Overall Study||0
2595669|NCT00273910|6371565|P3|NOT COMPLETED|Overall Study||0
2595670|NCT00273910|6371566|P2|NOT COMPLETED|Overall Study||0
2595671|NCT00273910|6371567|P1|NOT COMPLETED|Overall Study||0
2595672|NCT00273910|6371562|P6|COMPLETED|Overall Study||14
2595673|NCT00273910|6371563|P5|COMPLETED|Overall Study||15
2595674|NCT00273910|6371564|P4|COMPLETED|Overall Study||19
2595675|NCT00273910|6371565|P3|COMPLETED|Overall Study||18
2595676|NCT00273910|6371566|P2|COMPLETED|Overall Study||19
2595677|NCT00273910|6371567|P1|COMPLETED|Overall Study||19
2595678|NCT00273910|6371562|P6|STARTED|Overall Study||14
2595679|NCT00273910|6371563|P5|STARTED|Overall Study||15
2595680|NCT00273910|6371564|P4|STARTED|Overall Study||19
2595681|NCT00273910|6371565|P3|STARTED|Overall Study||18
2595682|NCT00273910|6371566|P2|STARTED|Overall Study||19
2595683|NCT00273910|6371567|P1|STARTED|Overall Study||19
2595684|NCT00273858|6371587|P1|NOT COMPLETED|Overall Study||537
2595685|NCT00273858|6371587|P1|COMPLETED|Overall Study||343
2595686|NCT00273858|6371587|P1|STARTED|Overall Study||880
2595687|NCT00273793|6371602|P6|NOT COMPLETED|Overall Study||0
2595688|NCT00273793|6371603|P5|NOT COMPLETED|Overall Study||0
2595689|NCT00273793|6371604|P4|NOT COMPLETED|Overall Study||0
2595690|NCT00273793|6371605|P3|NOT COMPLETED|Overall Study||0
2595691|NCT00273793|6371606|P2|NOT COMPLETED|Overall Study||0
2595692|NCT00273793|6371607|P1|NOT COMPLETED|Overall Study||0
2595693|NCT00273793|6371602|P6|COMPLETED|Overall Study||29
2595694|NCT00273793|6371603|P5|COMPLETED|Overall Study||58
2595695|NCT00273793|6371604|P4|COMPLETED|Overall Study||60
2595696|NCT00273793|6371605|P3|COMPLETED|Overall Study||18
2595697|NCT00273793|6371606|P2|COMPLETED|Overall Study||38
2595698|NCT00273793|6371607|P1|COMPLETED|Overall Study||36
2595699|NCT00273793|6371602|P6|STARTED|Overall Study||29
2595700|NCT00273793|6371603|P5|STARTED|Overall Study||58
2595701|NCT00273793|6371604|P4|STARTED|Overall Study||60
2595702|NCT00273793|6371605|P3|STARTED|Overall Study||18
2595703|NCT00273793|6371606|P2|STARTED|Overall Study||38
2595704|NCT00273793|6371607|P1|STARTED|Overall Study||36
2595705|NCT00273754|6371629|P2|NOT COMPLETED|Overall Study||0
2595706|NCT00273754|6371630|P1|NOT COMPLETED|Overall Study||0
2595707|NCT00273754|6371629|P2|COMPLETED|Overall Study||36
2595708|NCT00273754|6371630|P1|COMPLETED|Overall Study||36
2595709|NCT00273754|6371629|P2|STARTED|Overall Study||36
2595710|NCT00273754|6371630|P1|STARTED|Overall Study||36
2595711|NCT00273182|6371646|P1|NOT COMPLETED|Overall Study||985
2595712|NCT00273182|6371646|P1|COMPLETED|Overall Study||1014
2595713|NCT00273182|6371646|P1|STARTED|Overall Study||1999
2595714|NCT00273052|6371656|P2|NOT COMPLETED|Overall Study||88
2595715|NCT00273052|6371657|P1|NOT COMPLETED|Overall Study||69
2595716|NCT00273052|6371656|P2|COMPLETED|Overall Study||190
2595717|NCT00273052|6371657|P1|COMPLETED|Overall Study||221
2595718|NCT00273052|6371656|P2|STARTED|Overall Study||278
2595719|NCT00273052|6371657|P1|STARTED|Overall Study||290
2595720|NCT00272987|6371692|P3|NOT COMPLETED|Overall Study||19
2595721|NCT00272987|6371693|P2|NOT COMPLETED|Overall Study||14
2595722|NCT00272987|6371694|P1|NOT COMPLETED|Overall Study||21
2595723|NCT00272987|6371692|P3|COMPLETED|Overall Study||1
2595724|NCT00272987|6371693|P2|COMPLETED|Overall Study||0
2595725|NCT00272987|6371694|P1|COMPLETED|Overall Study||8
2595726|NCT00272987|6371692|P3|Ongoing|Overall Study||15
2595727|NCT00272987|6371693|P2|Ongoing|Overall Study||14
2595728|NCT00272987|6371694|P1|Ongoing|Overall Study||20
2595729|NCT00272987|6371692|P3|STARTED|Overall Study||20
2595730|NCT00272987|6371693|P2|STARTED|Overall Study||14
2595731|NCT00272987|6371694|P1|STARTED|Overall Study||29
2595732|NCT00272961|6371758|P5|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
2595733|NCT00272961|6371759|P4|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||3
2595734|NCT00272961|6371760|P3|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
2595735|NCT00272961|6371761|P2|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
2595736|NCT00272961|6371762|P1|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||2
2595737|NCT00272961|6371758|P5|COMPLETED|Treatment Phase: Week 3 Up to Week 12||6
2595738|NCT00272961|6371759|P4|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
2595739|NCT00272961|6371760|P3|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
2595740|NCT00272961|6371761|P2|COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
2595741|NCT00272961|6371762|P1|COMPLETED|Treatment Phase: Week 3 Up to Week 12||8
2595742|NCT00272961|6371758|P5|STARTED|Treatment Phase: Week 3 Up to Week 12||10
2595743|NCT00272961|6371759|P4|STARTED|Treatment Phase: Week 3 Up to Week 12||10
2595744|NCT00272961|6371760|P3|STARTED|Treatment Phase: Week 3 Up to Week 12||11
2595745|NCT00272961|6371761|P2|STARTED|Treatment Phase: Week 3 Up to Week 12||8
2595746|NCT00272961|6371762|P1|STARTED|Treatment Phase: Week 3 Up to Week 12||10
2595747|NCT00272961|6371758|P5|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
2595748|NCT00272961|6371759|P4|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
2595749|NCT00272961|6371760|P3|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
2595750|NCT00272961|6371761|P2|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
2595751|NCT00272961|6371762|P1|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||11
2595752|NCT00272961|6371758|P5|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
2595753|NCT00272961|6371759|P4|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
2595754|NCT00272961|6371760|P3|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
2595755|NCT00272961|6371761|P2|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
2595756|NCT00272961|6371762|P1|COMPLETED|Placebo Run-in Phase: Up to Week 2||49
2595757|NCT00272961|6371758|P5|STARTED|Placebo Run-in Phase: Up to Week 2||0
2595758|NCT00272961|6371759|P4|STARTED|Placebo Run-in Phase: Up to Week 2||0
2595759|NCT00272961|6371760|P3|STARTED|Placebo Run-in Phase: Up to Week 2||0
2595760|NCT00272961|6371761|P2|STARTED|Placebo Run-in Phase: Up to Week 2||0
2595761|NCT00272961|6371762|P1|STARTED|Placebo Run-in Phase: Up to Week 2||60
2595762|NCT00272844|6371819|P1|NOT COMPLETED|Overall Study||5
2595763|NCT00272844|6371819|P1|COMPLETED|Overall Study||18
2595764|NCT00272844|6371819|P1|STARTED|Overall Study||23
2595765|NCT00272792|6371827|P2|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||3
2595766|NCT00272792|6371828|P1|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||1
2595767|NCT00272792|6371827|P2|COMPLETED|Part 2: Blinded, Placebo Control Period||9
2595768|NCT00272792|6371828|P1|COMPLETED|Part 2: Blinded, Placebo Control Period||32
2595769|NCT00272792|6371827|P2|STARTED|Part 2: Blinded, Placebo Control Period||12
2595770|NCT00272792|6371828|P1|STARTED|Part 2: Blinded, Placebo Control Period||33
2595771|NCT00272792|6371827|P2|NOT COMPLETED|Part 1: Responsiveness||0
2595772|NCT00272792|6371828|P1|NOT COMPLETED|Part 1: Responsiveness||1
2595773|NCT00272792|6371827|P2|COMPLETED|Part 1: Responsiveness||0
2595774|NCT00272792|6371828|P1|COMPLETED|Part 1: Responsiveness||89
2595775|NCT00272792|6371827|P2|STARTED|Part 1: Responsiveness||0
2595776|NCT00272792|6371828|P1|STARTED|Part 1: Responsiveness||90
2595777|NCT00272779|6371838|P2|NOT COMPLETED|Baseline Through Week 96||136
2595778|NCT00272779|6371839|P1|NOT COMPLETED|Baseline Through Week 96||139
2595779|NCT00272779|6371838|P2|COMPLETED|Baseline Through Week 96||307
2595780|NCT00272779|6371839|P1|COMPLETED|Baseline Through Week 96||301
2595781|NCT00272779|6371838|P2|RECEIVED ANY TREATMENT|Baseline Through Week 96|3 participants received ATV instead of LPV (treatment error) and 3 participants never treated|437
2595782|NCT00272779|6371839|P1|RECEIVED ANY TREATMENT|Baseline Through Week 96|1 participant randomized to LPV received ATV instead (treatment error)|441
2595783|NCT00272779|6371838|P2|STARTED|Baseline Through Week 96|Number randomized to LPV|443
2595784|NCT00272779|6371839|P1|STARTED|Baseline Through Week 96|Number randomized to ATV|440
2595785|NCT00272779|6371838|P2|NOT COMPLETED|Baseline Through Week 48||443
2595786|NCT00272779|6371839|P1|NOT COMPLETED|Baseline Through Week 48||440
2595787|NCT00272779|6371838|P2|COMPLETED|Baseline Through Week 48||0
2595788|NCT00272779|6371839|P1|COMPLETED|Baseline Through Week 48||0
2595789|NCT00272779|6371838|P2|STILL ON TREATMENT|Baseline Through Week 48||368
2595790|NCT00272779|6371839|P1|STILL ON TREATMENT|Baseline Through Week 48||385
2595791|NCT00272779|6371838|P2|Discontinued on or After Week 48|Baseline Through Week 48||14
2595792|NCT00272779|6371839|P1|Discontinued on or After Week 48|Baseline Through Week 48||14
2595793|NCT00272779|6371838|P2|Discontinued Before Week 48|Baseline Through Week 48||58
2595794|NCT00272779|6371839|P1|Discontinued Before Week 48|Baseline Through Week 48||39
2595795|NCT00272779|6371838|P2|TREATED AS RANDOMIZED|Baseline Through Week 48||440
2595796|NCT00272779|6371839|P1|TREATED AS RANDOMIZED|Baseline Through Week 48||438
2595797|NCT00272779|6371838|P2|RECEIVED ANY TREATMENT|Baseline Through Week 48|3 participants received ATV instead of LPV (treatment error), 3 participants never treated with LPV|437
2595798|NCT00272779|6371839|P1|RECEIVED ANY TREATMENT|Baseline Through Week 48|1 participant randomized to LPV received ATV instead (treatment error)|441
2595799|NCT00272779|6371838|P2|STARTED|Baseline Through Week 48|Number of participants randomized to LPV|443
2595800|NCT00272779|6371839|P1|STARTED|Baseline Through Week 48|Number of participants randomized to ATV|440
2595801|NCT00272337|6372023|P5|NOT COMPLETED|Overall Study||0
2595802|NCT00272337|6372024|P4|NOT COMPLETED|Overall Study||0
2595803|NCT00272337|6372025|P3|NOT COMPLETED|Overall Study||0
2595804|NCT00272337|6372026|P2|NOT COMPLETED|Overall Study||0
2595805|NCT00272337|6372027|P1|NOT COMPLETED|Overall Study||0
2595806|NCT00272337|6372023|P5|COMPLETED|Overall Study||8
2595807|NCT00272337|6372024|P4|COMPLETED|Overall Study||7
2595808|NCT00272337|6372025|P3|COMPLETED|Overall Study||7
2595809|NCT00272337|6372026|P2|COMPLETED|Overall Study||7
2595810|NCT00272337|6372027|P1|COMPLETED|Overall Study||8
2595811|NCT00272337|6372023|P5|STARTED|Overall Study||8
2595812|NCT00272337|6372024|P4|STARTED|Overall Study||7
2595813|NCT00272337|6372025|P3|STARTED|Overall Study||7
2595814|NCT00272337|6372026|P2|STARTED|Overall Study||7
2595815|NCT00272337|6372027|P1|STARTED|Overall Study||8
2595816|NCT00272311|6372054|P5|NOT COMPLETED|Overall Study||0
2595817|NCT00272311|6372055|P4|NOT COMPLETED|Overall Study||0
2595818|NCT00272311|6372056|P3|NOT COMPLETED|Overall Study||0
2595819|NCT00272311|6372057|P2|NOT COMPLETED|Overall Study||0
2595820|NCT00272311|6372058|P1|NOT COMPLETED|Overall Study||0
2595821|NCT00272311|6372054|P5|COMPLETED|Overall Study||14
2595822|NCT00272311|6372055|P4|COMPLETED|Overall Study||14
2595823|NCT00272311|6372056|P3|COMPLETED|Overall Study||14
2595824|NCT00272311|6372057|P2|COMPLETED|Overall Study||14
2595825|NCT00272311|6372058|P1|COMPLETED|Overall Study||14
2595826|NCT00272311|6372054|P5|STARTED|Overall Study||14
2595827|NCT00272311|6372055|P4|STARTED|Overall Study||14
2595828|NCT00272311|6372056|P3|STARTED|Overall Study||14
2595829|NCT00272311|6372057|P2|STARTED|Overall Study||14
2595830|NCT00272311|6372058|P1|STARTED|Overall Study||14
2595831|NCT00272168|6372082|P2|NOT COMPLETED|Overall Study||10
2595832|NCT00272168|6372083|P1|NOT COMPLETED|Overall Study||10
2595833|NCT00272168|6372082|P2|COMPLETED|Overall Study||31
2595834|NCT00272168|6372083|P1|COMPLETED|Overall Study||37
2595835|NCT00272168|6372082|P2|STARTED|Overall Study||41
2595836|NCT00272168|6372083|P1|STARTED|Overall Study||47
2595837|NCT00272038|6372099|P1|NOT COMPLETED|Overall Study||7
2595838|NCT00272038|6372099|P1|COMPLETED|Overall Study||22
2595839|NCT00272038|6372099|P1|STARTED|Overall Study||29
2595840|NCT00271947|6372105|P1|NOT COMPLETED|Overall Study||1
2595841|NCT00271947|6372105|P1|COMPLETED|Overall Study||0
2595842|NCT00271947|6372105|P1|STARTED|Overall Study||1
2595843|NCT00271856|6372111|P2|NOT COMPLETED|Overall Study||18
2595844|NCT00271856|6372112|P1|NOT COMPLETED|Overall Study||11
2595845|NCT00271856|6372111|P2|COMPLETED|Overall Study||70
2595846|NCT00271856|6372112|P1|COMPLETED|Overall Study||78
2595847|NCT00271856|6372111|P2|STARTED|Overall Study||88
2595848|NCT00271856|6372112|P1|STARTED|Overall Study||89
2595849|NCT00271817|6372131|P3|NOT COMPLETED|Part 2||84
2595850|NCT00271817|6372132|P2|NOT COMPLETED|Part 2||32
2595851|NCT00271817|6372133|P1|NOT COMPLETED|Part 2||0
2595852|NCT00271817|6372131|P3|COMPLETED|Part 2||401
2595853|NCT00271817|6372132|P2|COMPLETED|Part 2||234
2595854|NCT00271817|6372133|P1|COMPLETED|Part 2||0
2595855|NCT00271817|6372131|P3|STARTED|Part 2|Includes 105 patients re-allocated from the niacin group in Part 1|485
2595856|NCT00271817|6372132|P2|STARTED|Part 2|Includes 54 patients re-allocated from the niacin group in Part 1|266
2595857|NCT00271817|6372133|P1|STARTED|Part 2|Patients completing the niacin group in Part 1, were re-allocated to one of the two arms in Part 2|0
2595858|NCT00271817|6372131|P3|NOT COMPLETED|Part 1||285
2595859|NCT00271817|6372132|P2|NOT COMPLETED|Part 1||59
2595860|NCT00271817|6372133|P1|NOT COMPLETED|Part 1||106
2595861|NCT00271817|6372131|P3|COMPLETED|Part 1|11 patients who completed Part 1 did not continue to Part 2|391
2595862|NCT00271817|6372132|P2|COMPLETED|Part 1|1 patient who completed Part 1 did not continue to Part 2|213
2595863|NCT00271817|6372133|P1|COMPLETED|Part 1|6 patients who completed Part 1 did not continue to Part 2; 1 patient never received drug in Part 2|166
2595864|NCT00271817|6372131|P3|STARTED|Part 1||676
2595865|NCT00271817|6372132|P2|STARTED|Part 1||272
2595866|NCT00271817|6372133|P1|STARTED|Part 1||272
2595867|NCT00271739|6372162|P2|NOT COMPLETED|Overall Study||105
2595868|NCT00271739|6372163|P1|NOT COMPLETED|Overall Study||115
2595869|NCT00271739|6372162|P2|COMPLETED|Overall Study||716
2595870|NCT00271739|6372163|P1|COMPLETED|Overall Study||729
2595871|NCT00271739|6372162|P2|STARTED|Overall Study||821
2595872|NCT00271739|6372163|P1|STARTED|Overall Study||844
2595873|NCT00271609|6372175|P2|NOT COMPLETED|Overall Study||3
2595874|NCT00271609|6372176|P1|NOT COMPLETED|Overall Study||13
2595875|NCT00271609|6372175|P2|COMPLETED|Overall Study||29
2595876|NCT00271609|6372176|P1|COMPLETED|Overall Study||43
2595877|NCT00271609|6372175|P2|STARTED|Overall Study||32
2595878|NCT00271609|6372176|P1|STARTED|Overall Study||56
2595879|NCT00271596|6372186|P2|NOT COMPLETED|Overall Study||1
2595880|NCT00271596|6372187|P1|NOT COMPLETED|Overall Study||1
2595881|NCT00271596|6372186|P2|COMPLETED|Overall Study||15
2595882|NCT00271596|6372187|P1|COMPLETED|Overall Study||16
2595883|NCT00271596|6372186|P2|STARTED|Overall Study||16
2595884|NCT00271596|6372187|P1|STARTED|Overall Study||17
2595885|NCT00271570|6372213|P2|NOT COMPLETED|Overall Study||0
2595886|NCT00271570|6372214|P1|NOT COMPLETED|Overall Study||0
2595887|NCT00271570|6372213|P2|COMPLETED|Overall Study||12
2595888|NCT00271570|6372214|P1|COMPLETED|Overall Study||12
2595889|NCT00271570|6372213|P2|STARTED|Overall Study||12
2595890|NCT00271570|6372214|P1|STARTED|Overall Study||12
2595891|NCT00271544|6372222|P1|NOT COMPLETED|Overall Study||20
2595892|NCT00271544|6372222|P1|COMPLETED|Overall Study|Total number subjects successfully implanted 4196 lead.|170
2595893|NCT00271544|6372222|P1|Model 4196 Lead Attempted|Overall Study|Total number of subjects attempted Model 4196 lead.|177
2595894|NCT00271544|6372222|P1|Implant Attempted|Overall Study|Total number of subjects completed baseline and underwent system implant attempt.|186
2595895|NCT00271544|6372222|P1|STARTED|Overall Study|Total number of subjects enrolled.|190
2595896|NCT00271375|6372246|P3|NOT COMPLETED|Overall Study||0
2595897|NCT00271375|6372247|P2|NOT COMPLETED|Overall Study||0
2595898|NCT00271375|6372248|P1|NOT COMPLETED|Overall Study||0
2595899|NCT00271375|6372246|P3|COMPLETED|Overall Study||57
2595900|NCT00271375|6372247|P2|COMPLETED|Overall Study||83
2595901|NCT00271375|6372248|P1|COMPLETED|Overall Study||114
2595902|NCT00271375|6372246|P3|STARTED|Overall Study||57
2595903|NCT00271375|6372247|P2|STARTED|Overall Study||83
2595904|NCT00271375|6372248|P1|STARTED|Overall Study||114
2595905|NCT00271219|6372286|P2|NOT COMPLETED|Overall Study||28
2595906|NCT00271219|6372287|P1|NOT COMPLETED|Overall Study||16
2595907|NCT00271219|6372286|P2|COMPLETED|Overall Study||58
2595908|NCT00271219|6372287|P1|COMPLETED|Overall Study||73
2595909|NCT00271219|6372286|P2|STARTED|Overall Study||86
2595910|NCT00271219|6372287|P1|STARTED|Overall Study||89
2595911|NCT00271154|6372313|P2|NOT COMPLETED|Overall Study||0
2595912|NCT00271154|6372314|P1|NOT COMPLETED|Overall Study||0
2595913|NCT00271154|6372313|P2|COMPLETED|Overall Study||419
2595914|NCT00271154|6372314|P1|COMPLETED|Overall Study||191
2595915|NCT00271154|6372313|P2|STARTED|Overall Study||419
2595916|NCT00271154|6372314|P1|STARTED|Overall Study||191
2595917|NCT00271102|6372325|P2|NOT COMPLETED|Overall Study||5
2595918|NCT00271102|6372326|P1|NOT COMPLETED|Overall Study||5
2595919|NCT00271102|6372325|P2|COMPLETED|Overall Study||30
2595920|NCT00271102|6372326|P1|COMPLETED|Overall Study||30
2595921|NCT00271102|6372325|P2|STARTED|Overall Study||35
2595922|NCT00271102|6372326|P1|STARTED|Overall Study||35
2595923|NCT00271024|6372336|P4|NOT COMPLETED|Overall Study||24
2595924|NCT00271024|6372337|P3|NOT COMPLETED|Overall Study||23
2595925|NCT00271024|6372338|P2|NOT COMPLETED|Overall Study||26
2595926|NCT00271024|6372339|P1|NOT COMPLETED|Overall Study||22
2595927|NCT00271024|6372336|P4|COMPLETED|Overall Study|Discontinued: 9 smoking related, 2 reaction to tablet, 4 time commitment, 1 other, 3 unspecified|64
2595928|NCT00271024|6372337|P3|COMPLETED|Overall Study|Discontinued: 5 smoking related, 4 reaction to tablet, 4 time commitment, 3 other, 4 unspecified|65
2595929|NCT00271024|6372338|P2|COMPLETED|Overall Study|Discontinued: 5 smoking related, 3 reaction to tablet, 2 time commitment, 1 other, 9 unspecified|51
2595930|NCT00271024|6372339|P1|COMPLETED|Overall Study|Discontinued: 1 smoking related, 1 reaction to tablet, 6 time commitment, 2 other, 8 unspecified|58
2595931|NCT00271024|6372336|P4|Received Study Treatment|Overall Study|n=5 did not start treatment (2 health problems, 1 wanted diff. treatment method, 2 lost interest)|83
2595932|NCT00271024|6372337|P3|Received Study Treatment|Overall Study|n=3 did not start treatment (2 lost interest, 1 unknown)|85
2595933|NCT00271024|6372338|P2|Received Study Treatment|Overall Study|n=6 did not start treatment (1 diff treat. desired, 3 lost interest, 1 began psych meds, 1 unknown)|71
2595934|NCT00271024|6372339|P1|Received Study Treatment|Overall Study|n=4 did not start treatment (3 lost interest, 1 unknown)|76
2595935|NCT00271024|6372336|P4|STARTED|Overall Study||88
2595936|NCT00271024|6372337|P3|STARTED|Overall Study||88
2595937|NCT00271024|6372338|P2|STARTED|Overall Study||77
2595938|NCT00271024|6372339|P1|STARTED|Overall Study||80
2595939|NCT00271011|6372381|P1|NOT COMPLETED|Overall Study||0
2595940|NCT00271011|6372381|P1|COMPLETED|Overall Study||13
2595941|NCT00271011|6372381|P1|STARTED|Overall Study||13
2595942|NCT00270998|6372389|P3|NOT COMPLETED|12 Month Follow-up||21
2595943|NCT00270998|6372390|P2|NOT COMPLETED|12 Month Follow-up||25
2595944|NCT00270998|6372391|P1|NOT COMPLETED|12 Month Follow-up||14
2595945|NCT00270998|6372389|P3|COMPLETED|12 Month Follow-up||111
2595946|NCT00270998|6372390|P2|COMPLETED|12 Month Follow-up||99
2595947|NCT00270998|6372391|P1|COMPLETED|12 Month Follow-up||96
2595948|NCT00270998|6372389|P3|STARTED|12 Month Follow-up||132
2595949|NCT00270998|6372390|P2|STARTED|12 Month Follow-up||124
2595950|NCT00270998|6372391|P1|STARTED|12 Month Follow-up||110
2595951|NCT00270998|6372389|P3|NOT COMPLETED|3 Month Follow-up||18
2595952|NCT00270998|6372390|P2|NOT COMPLETED|3 Month Follow-up||22
2595953|NCT00270998|6372391|P1|NOT COMPLETED|3 Month Follow-up||39
2595954|NCT00270998|6372389|P3|COMPLETED|3 Month Follow-up||132
2595955|NCT00270998|6372390|P2|COMPLETED|3 Month Follow-up||124
2595956|NCT00270998|6372391|P1|COMPLETED|3 Month Follow-up||110
2595957|NCT00270998|6372389|P3|STARTED|3 Month Follow-up|1 participant randomized to combined found ineligible at first treatment visit, removed from study.|150
2595958|NCT00270998|6372390|P2|STARTED|3 Month Follow-up||146
2595959|NCT00270998|6372391|P1|STARTED|3 Month Follow-up||149
2595960|NCT00270894|6372420|P1|NOT COMPLETED|Overall Study||2
2595961|NCT00270894|6372420|P1|COMPLETED|Overall Study||28
2595962|NCT00270894|6372420|P1|STARTED|Overall Study||30
2595963|NCT00270855|6372432|P2|NOT COMPLETED|Overall Study||8
2595964|NCT00270855|6372433|P1|NOT COMPLETED|Overall Study||8
2595965|NCT00270855|6372432|P2|COMPLETED|Overall Study||6
2595966|NCT00270855|6372433|P1|COMPLETED|Overall Study||7
2595967|NCT00270855|6372432|P2|STARTED|Overall Study||14
2595968|NCT00270855|6372433|P1|STARTED|Overall Study||15
2595969|NCT00270842|6372492|P3|NOT COMPLETED|Overall Study||16
2595970|NCT00270842|6372493|P2|NOT COMPLETED|Overall Study||16
2595971|NCT00270842|6372494|P1|NOT COMPLETED|Overall Study||15
2595972|NCT00270842|6372492|P3|COMPLETED|Overall Study||18
2595973|NCT00270842|6372493|P2|COMPLETED|Overall Study||18
2595974|NCT00270842|6372494|P1|COMPLETED|Overall Study||18
2595975|NCT00270842|6372492|P3|STARTED|Overall Study||34
2595976|NCT00270842|6372493|P2|STARTED|Overall Study||34
2595977|NCT00270842|6372494|P1|STARTED|Overall Study||33
2595978|NCT00270790|6372505|P1|NOT COMPLETED|Overall Study||5
2595979|NCT00270790|6372505|P1|COMPLETED|Overall Study||16
2595980|NCT00270790|6372505|P1|STARTED|Overall Study||21
2595981|NCT00270634|6372514|P4|NOT COMPLETED|Overall Study||5
2595982|NCT00270634|6372515|P3|NOT COMPLETED|Overall Study||22
2595983|NCT00270634|6372516|P2|NOT COMPLETED|Overall Study||13
2595984|NCT00270634|6372517|P1|NOT COMPLETED|Overall Study||17
2595985|NCT00270634|6372514|P4|COMPLETED|Overall Study||81
2595986|NCT00270634|6372515|P3|COMPLETED|Overall Study||62
2595987|NCT00270634|6372516|P2|COMPLETED|Overall Study||64
2595988|NCT00270634|6372517|P1|COMPLETED|Overall Study||70
2595989|NCT00270634|6372514|P4|STARTED|Overall Study||86
2595990|NCT00270634|6372515|P3|STARTED|Overall Study||84
2595991|NCT00270634|6372516|P2|STARTED|Overall Study||77
2595992|NCT00270634|6372517|P1|STARTED|Overall Study||87
2595993|NCT00270296|6372554|P3|NOT COMPLETED|Overall Study||61
2595994|NCT00270296|6372555|P2|NOT COMPLETED|Overall Study||90
2595995|NCT00270296|6372556|P1|NOT COMPLETED|Overall Study||99
2595996|NCT00270296|6372554|P3|COMPLETED|Overall Study||109
2595997|NCT00270296|6372555|P2|COMPLETED|Overall Study||185
2595998|NCT00270296|6372556|P1|COMPLETED|Overall Study||186
2595999|NCT00270296|6372554|P3|STARTED|Overall Study||170
2596000|NCT00270296|6372555|P2|STARTED|Overall Study||275
2596001|NCT00270296|6372556|P1|STARTED|Overall Study||285
2596002|NCT00270257|6372569|P2|NOT COMPLETED|Overall Study||424
2596003|NCT00270257|6372570|P1|NOT COMPLETED|Overall Study||412
2596004|NCT00270257|6372569|P2|COMPLETED|Overall Study||204
2596005|NCT00270257|6372570|P1|COMPLETED|Overall Study||211
2596006|NCT00270257|6372569|P2|Visit 104|Overall Study||204
2596007|NCT00270257|6372570|P1|Visit 104|Overall Study||211
2596008|NCT00270257|6372569|P2|Week 78|Overall Study||285
2596009|NCT00270257|6372570|P1|Week 78|Overall Study||283
2596010|NCT00270257|6372569|P2|Week 52|Overall Study||340
2596011|NCT00270257|6372570|P1|Week 52|Overall Study||362
2596012|NCT00270257|6372569|P2|Week 26|Overall Study||440
2596013|NCT00270257|6372570|P1|Week 26|Overall Study||460
2596014|NCT00270257|6372569|P2|Week 8|Overall Study||443
2596015|NCT00270257|6372570|P1|Week 8|Overall Study||510
2596016|NCT00270257|6372569|P2|STARTED|Overall Study|1 excluded from analysis (enrollment date exceeded eligibility window by 13 days)|628
2596017|NCT00270257|6372570|P1|STARTED|Overall Study||623
2596018|NCT00270231|6372588|P2|NOT COMPLETED|Second Intervention||1
2596019|NCT00270231|6372589|P1|NOT COMPLETED|Second Intervention||0
2596020|NCT00270231|6372588|P2|COMPLETED|Second Intervention||30
2596021|NCT00270231|6372589|P1|COMPLETED|Second Intervention||30
2596022|NCT00270231|6372588|P2|STARTED|Second Intervention||31
2596023|NCT00270231|6372589|P1|STARTED|Second Intervention||30
2596024|NCT00270231|6372588|P2|NOT COMPLETED|Washout Period||0
2596025|NCT00270231|6372589|P1|NOT COMPLETED|Washout Period||1
2596026|NCT00270231|6372588|P2|COMPLETED|Washout Period||31
2596027|NCT00270231|6372589|P1|COMPLETED|Washout Period||30
2596028|NCT00270231|6372588|P2|STARTED|Washout Period||31
2596029|NCT00270231|6372589|P1|STARTED|Washout Period||31
2596030|NCT00270231|6372588|P2|NOT COMPLETED|First Intervention||1
2596031|NCT00270231|6372589|P1|NOT COMPLETED|First Intervention||1
2596032|NCT00270231|6372588|P2|COMPLETED|First Intervention||31
2596033|NCT00270231|6372589|P1|COMPLETED|First Intervention||31
2596034|NCT00270231|6372588|P2|STARTED|First Intervention||32
2596035|NCT00270231|6372589|P1|STARTED|First Intervention||32
2596036|NCT00270205|6372599|P4|NOT COMPLETED|Overall Study||1
2596037|NCT00270205|6372600|P3|NOT COMPLETED|Overall Study||0
2596038|NCT00270205|6372601|P2|NOT COMPLETED|Overall Study||0
2596039|NCT00270205|6372602|P1|NOT COMPLETED|Overall Study||1
2596040|NCT00270205|6372599|P4|COMPLETED|Overall Study||6
2596041|NCT00270205|6372600|P3|COMPLETED|Overall Study||6
2596042|NCT00270205|6372601|P2|COMPLETED|Overall Study||6
2596043|NCT00270205|6372602|P1|COMPLETED|Overall Study||5
2596044|NCT00270205|6372599|P4|STARTED|Overall Study||7
2596045|NCT00270205|6372600|P3|STARTED|Overall Study||6
2596046|NCT00270205|6372601|P2|STARTED|Overall Study|7 participants enrolled. One never started study vaccination and was excluded from all analyses.|6
2596047|NCT00270205|6372602|P1|STARTED|Overall Study||6
2596048|NCT00269919|6372720|P1|NOT COMPLETED|Overall Study||27
2596049|NCT00269919|6372720|P1|COMPLETED|Overall Study||13
2596050|NCT00269919|6372720|P1|Treated|Overall Study||39
2596051|NCT00269919|6372720|P1|STARTED|Overall Study||40
2596052|NCT00269633|6372739|P2|NOT COMPLETED|Overall Study||0
2596053|NCT00269633|6372740|P1|NOT COMPLETED|Overall Study||1
2596054|NCT00269633|6372739|P2|COMPLETED|Overall Study||5
2596055|NCT00269633|6372740|P1|COMPLETED|Overall Study||3
2596056|NCT00269633|6372739|P2|STARTED|Overall Study||5
2596057|NCT00269633|6372740|P1|STARTED|Overall Study||4
2596058|NCT00269477|6372750|P4|NOT COMPLETED|Overall Study||0
2596059|NCT00269477|6372751|P3|NOT COMPLETED|Overall Study||1
2596060|NCT00269477|6372752|P2|NOT COMPLETED|Overall Study||6
2596061|NCT00269477|6372753|P1|NOT COMPLETED|Overall Study||5
2596062|NCT00269477|6372750|P4|COMPLETED|Overall Study||60
2596063|NCT00269477|6372751|P3|COMPLETED|Overall Study||57
2596064|NCT00269477|6372752|P2|COMPLETED|Overall Study||12
2596065|NCT00269477|6372753|P1|COMPLETED|Overall Study||4
2596066|NCT00269477|6372750|P4|STARTED|Overall Study||60
2596067|NCT00269477|6372751|P3|STARTED|Overall Study||58
2596068|NCT00269477|6372752|P2|STARTED|Overall Study||18
2596069|NCT00269477|6372753|P1|STARTED|Overall Study||9
2596070|NCT00269399|6372769|P2|NOT COMPLETED|Overall Study||27
2596071|NCT00269399|6372770|P1|NOT COMPLETED|Overall Study||41
2596072|NCT00269399|6372769|P2|COMPLETED|Overall Study||91
2596073|NCT00269399|6372770|P1|COMPLETED|Overall Study||78
2596074|NCT00269399|6372769|P2|STARTED|Overall Study||118
2596075|NCT00269399|6372770|P1|STARTED|Overall Study||119
2596076|NCT00269152|6372780|P2|NOT COMPLETED|Overall Study||10
2596077|NCT00269152|6372781|P1|NOT COMPLETED|Overall Study||18
2596078|NCT00269152|6372780|P2|COMPLETED|Overall Study||49
2596079|NCT00269152|6372781|P1|COMPLETED|Overall Study||45
2596080|NCT00269152|6372780|P2|STARTED|Overall Study|4 were randomized without receiving any study drug.|59
2596081|NCT00269152|6372781|P1|STARTED|Overall Study|One participant in Pemetrexed+Carboplatin actually received Pemetrexed+Cisplatin|63
2596082|NCT00269113|6372797|P2|NOT COMPLETED|Overall Study||37
2596083|NCT00269113|6372798|P1|NOT COMPLETED|Overall Study||74
2596084|NCT00269113|6372797|P2|COMPLETED|Overall Study||146
2596085|NCT00269113|6372798|P1|COMPLETED|Overall Study||103
2596086|NCT00269113|6372797|P2|STARTED|Overall Study||183
2596087|NCT00269113|6372798|P1|STARTED|Overall Study||177
2596088|NCT00269087|6372816|P1|NOT COMPLETED|Overall Study||34
2596089|NCT00269087|6372816|P1|COMPLETED|Overall Study||88
2596090|NCT00269087|6372816|P1|STARTED|Overall Study||122
2596091|NCT00268996|6372846|P2|NOT COMPLETED|Overall Study||20
2596092|NCT00268996|6372847|P1|NOT COMPLETED|Overall Study||21
2596093|NCT00268996|6372846|P2|COMPLETED|Overall Study||152
2596094|NCT00268996|6372847|P1|COMPLETED|Overall Study||130
2596095|NCT00268996|6372846|P2|STARTED|Overall Study||172
2596096|NCT00268996|6372847|P1|STARTED|Overall Study||151
2596097|NCT00268983|6372891|P2|NOT COMPLETED|Overall Study||0
2596098|NCT00268983|6372892|P1|NOT COMPLETED|Overall Study||3
2596099|NCT00268983|6372891|P2|COMPLETED|Overall Study||8
2596100|NCT00268983|6372892|P1|COMPLETED|Overall Study||3
2596101|NCT00268983|6372891|P2|STARTED|Overall Study||8
2596102|NCT00268983|6372892|P1|STARTED|Overall Study||6
2596103|NCT00268905|6372935|P3|NOT COMPLETED|Overall Study||12
2596104|NCT00268905|6372936|P2|NOT COMPLETED|Overall Study||9
2596105|NCT00268905|6372937|P1|NOT COMPLETED|Overall Study||43
2596106|NCT00268905|6372935|P3|COMPLETED|Overall Study||0
2596107|NCT00268905|6372936|P2|COMPLETED|Overall Study||0
2596108|NCT00268905|6372937|P1|COMPLETED|Overall Study||0
2596109|NCT00268905|6372935|P3|STARTED|Overall Study||12
2596110|NCT00268905|6372936|P2|STARTED|Overall Study||9
2596111|NCT00268905|6372937|P1|STARTED|Overall Study||43
2596112|NCT00268892|6372954|P3|NOT COMPLETED|Overall Study||39
2596113|NCT00268892|6372955|P2|NOT COMPLETED|Overall Study||42
2596114|NCT00268892|6372956|P1|NOT COMPLETED|Overall Study||39
2596115|NCT00268892|6372954|P3|COMPLETED|Overall Study||54
2596116|NCT00268892|6372955|P2|COMPLETED|Overall Study||53
2596117|NCT00268892|6372956|P1|COMPLETED|Overall Study||51
2596118|NCT00268892|6372954|P3|Switched to Higher Dose|Overall Study||76
2596119|NCT00268892|6372955|P2|Switched to Higher Dose|Overall Study||68
2596120|NCT00268892|6372956|P1|Switched to Higher Dose|Overall Study||59
2596121|NCT00268892|6372954|P3|STARTED|Overall Study||93
2596122|NCT00268892|6372955|P2|STARTED|Overall Study||95
2596123|NCT00268892|6372956|P1|STARTED|Overall Study||90
2596124|NCT00268762|6372967|P1|NOT COMPLETED|Overall Study||0
2596125|NCT00268762|6372967|P1|COMPLETED|Overall Study||65
2596126|NCT00268762|6372967|P1|STARTED|Overall Study||65
2596127|NCT00268463|6372975|P2|NOT COMPLETED|Overall Study||12
2596128|NCT00268463|6372976|P1|NOT COMPLETED|Overall Study||10
2596129|NCT00268463|6372975|P2|COMPLETED|Overall Study||0
2596130|NCT00268463|6372976|P1|COMPLETED|Overall Study||0
2596131|NCT00268463|6372975|P2|STARTED|Overall Study||12
2596132|NCT00268463|6372976|P1|STARTED|Overall Study||10
2596133|NCT00268450|6372982|P1|NOT COMPLETED|Overall Study||0
2596134|NCT00268450|6372982|P1|COMPLETED|Overall Study||21
2596135|NCT00268450|6372982|P1|STARTED|Overall Study||21
2596136|NCT00268437|6372992|P1|NOT COMPLETED|Overall Study||1
2596137|NCT00268437|6372992|P1|COMPLETED|Overall Study||26
2596138|NCT00268437|6372992|P1|STARTED|Overall Study||27
2596139|NCT00268346|6372999|P2|NOT COMPLETED|Overall Study||3
2596140|NCT00268346|6373000|P1|NOT COMPLETED|Overall Study||0
2596141|NCT00268346|6372999|P2|COMPLETED|Overall Study||37
2596142|NCT00268346|6373000|P1|COMPLETED|Overall Study||18
2596143|NCT00268346|6372999|P2|Started Treatment|Overall Study||40
2596144|NCT00268346|6373000|P1|Started Treatment|Overall Study||18
2596145|NCT00268346|6372999|P2|STARTED|Overall Study||40
2596146|NCT00268346|6373000|P1|STARTED|Overall Study||18
2596147|NCT00268242|6373006|P1|NOT COMPLETED|Overall Study||1
2596148|NCT00268242|6373006|P1|COMPLETED|Overall Study||23
2596149|NCT00268242|6373006|P1|STARTED|Overall Study||24
2596150|NCT00268203|6373015|P1|NOT COMPLETED|Overall Study||647
2596151|NCT00268203|6373015|P1|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|118
2596152|NCT00268203|6373015|P1|Completed 2 Years of Follow-up|Overall Study||62
2596153|NCT00268203|6373015|P1|STARTED|Overall Study||765
2596154|NCT00267969|6373029|P7|NOT COMPLETED|After Controlled Period||72
2596155|NCT00267969|6373030|P6|NOT COMPLETED|After Controlled Period||82
2596156|NCT00267969|6373031|P5|NOT COMPLETED|After Controlled Period||35
2596157|NCT00267969|6373032|P4|NOT COMPLETED|After Controlled Period||36
2596158|NCT00267969|6373033|P3|NOT COMPLETED|After Controlled Period||0
2596159|NCT00267969|6373034|P2|NOT COMPLETED|After Controlled Period||0
2596160|NCT00267969|6373035|P1|NOT COMPLETED|After Controlled Period||0
2596161|NCT00267969|6373029|P7|COMPLETED|After Controlled Period||173
2596162|NCT00267969|6373030|P6|COMPLETED|After Controlled Period||172
2596163|NCT00267969|6373031|P5|COMPLETED|After Controlled Period||85
2596164|NCT00267969|6373032|P4|COMPLETED|After Controlled Period||87
2596165|NCT00267969|6373033|P3|COMPLETED|After Controlled Period||0
2596166|NCT00267969|6373034|P2|COMPLETED|After Controlled Period||0
2596167|NCT00267969|6373035|P1|COMPLETED|After Controlled Period||0
2596168|NCT00267969|6373029|P7|STARTED|After Controlled Period||245
2596169|NCT00267969|6373030|P6|STARTED|After Controlled Period||254
2596170|NCT00267969|6373031|P5|STARTED|After Controlled Period||120
2596171|NCT00267969|6373032|P4|STARTED|After Controlled Period||123
2596172|NCT00267969|6373033|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
2596173|NCT00267969|6373034|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
2596174|NCT00267969|6373035|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
2596175|NCT00267969|6373029|P7|NOT COMPLETED|Controlled Period||0
2596176|NCT00267969|6373030|P6|NOT COMPLETED|Controlled Period||0
2596177|NCT00267969|6373031|P5|NOT COMPLETED|Controlled Period||0
2596178|NCT00267969|6373032|P4|NOT COMPLETED|Controlled Period||0
2596179|NCT00267969|6373033|P3|NOT COMPLETED|Controlled Period||11
2596180|NCT00267969|6373034|P2|NOT COMPLETED|Controlled Period||1
2596181|NCT00267969|6373035|P1|NOT COMPLETED|Controlled Period||12
2596182|NCT00267969|6373029|P7|COMPLETED|Controlled Period||0
2596183|NCT00267969|6373030|P6|COMPLETED|Controlled Period||0
2596184|NCT00267969|6373031|P5|COMPLETED|Controlled Period||0
2596185|NCT00267969|6373032|P4|COMPLETED|Controlled Period||0
2596186|NCT00267969|6373033|P3|COMPLETED|Controlled Period||245
2596187|NCT00267969|6373034|P2|COMPLETED|Controlled Period||254
2596188|NCT00267969|6373035|P1|COMPLETED|Controlled Period||243
2596189|NCT00267969|6373029|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
2596190|NCT00267969|6373030|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
2596191|NCT00267969|6373031|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
2596192|NCT00267969|6373032|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
2596193|NCT00267969|6373033|P3|STARTED|Controlled Period|Number of patients randomized|256
2596194|NCT00267969|6373034|P2|STARTED|Controlled Period|Number of patients randomized|255
2596195|NCT00267969|6373035|P1|STARTED|Controlled Period|Number of patients randomized|255
2596196|NCT00267956|6373061|P4|NOT COMPLETED|After Controlled Period||2
2596197|NCT00267956|6373062|P3|NOT COMPLETED|After Controlled Period||5
2596198|NCT00267956|6373063|P2|NOT COMPLETED|After Controlled Period||0
2596199|NCT00267956|6373064|P1|NOT COMPLETED|After Controlled Period||0
2596200|NCT00267956|6373061|P4|COMPLETED|After Controlled Period||70
2596201|NCT00267956|6373062|P3|COMPLETED|After Controlled Period||52
2596202|NCT00267956|6373063|P2|COMPLETED|After Controlled Period||0
2596203|NCT00267956|6373064|P1|COMPLETED|After Controlled Period||0
2596204|NCT00267956|6373061|P4|STARTED|After Controlled Period||72
2596205|NCT00267956|6373062|P3|STARTED|After Controlled Period||57
2596206|NCT00267956|6373063|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
2596207|NCT00267956|6373064|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
2596208|NCT00267956|6373061|P4|NOT COMPLETED|Controlled Period||0
2596209|NCT00267956|6373062|P3|NOT COMPLETED|Controlled Period||0
2596210|NCT00267956|6373063|P2|NOT COMPLETED|Controlled Period||4
2596211|NCT00267956|6373064|P1|NOT COMPLETED|Controlled Period||13
2596212|NCT00267956|6373061|P4|COMPLETED|Controlled Period||0
2596213|NCT00267956|6373062|P3|COMPLETED|Controlled Period||0
2596214|NCT00267956|6373063|P2|COMPLETED|Controlled Period||72
2596215|NCT00267956|6373064|P1|COMPLETED|Controlled Period||57
2596216|NCT00267956|6373061|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
2596217|NCT00267956|6373062|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
2596218|NCT00267956|6373063|P2|STARTED|Controlled Period||76
2596219|NCT00267956|6373064|P1|STARTED|Controlled Period||70
2596220|NCT00267774|6373084|P2|NOT COMPLETED|Overall Study||0
2596221|NCT00267774|6373085|P1|NOT COMPLETED|Overall Study||0
2596222|NCT00267774|6373084|P2|COMPLETED|Overall Study||496
2596223|NCT00267774|6373085|P1|COMPLETED|Overall Study||509
2596224|NCT00267774|6373084|P2|STARTED|Overall Study||496
2596225|NCT00267774|6373085|P1|STARTED|Overall Study||509
2596226|NCT00267748|6373096|P3|NOT COMPLETED|Randomized Period||132
2596227|NCT00267748|6373097|P2|NOT COMPLETED|Randomized Period||127
2596228|NCT00267748|6373098|P1|NOT COMPLETED|Randomized Period||0
2596229|NCT00267748|6373096|P3|COMPLETED|Randomized Period||14
2596230|NCT00267748|6373097|P2|COMPLETED|Randomized Period||19
2596231|NCT00267748|6373098|P1|COMPLETED|Randomized Period||0
2596232|NCT00267748|6373096|P3|Treated|Randomized Period||143
2596233|NCT00267748|6373097|P2|Treated|Randomized Period||146
2596234|NCT00267748|6373098|P1|Treated|Randomized Period||0
2596235|NCT00267748|6373096|P3|STARTED|Randomized Period||146
2596236|NCT00267748|6373097|P2|STARTED|Randomized Period||146
2596237|NCT00267748|6373098|P1|STARTED|Randomized Period||0
2596238|NCT00267748|6373096|P3|NOT COMPLETED|Non-randomized Period||0
2596239|NCT00267748|6373097|P2|NOT COMPLETED|Non-randomized Period||0
2596240|NCT00267748|6373098|P1|NOT COMPLETED|Non-randomized Period||23
2596241|NCT00267748|6373096|P3|COMPLETED|Non-randomized Period||0
2596242|NCT00267748|6373097|P2|COMPLETED|Non-randomized Period||0
2596243|NCT00267748|6373098|P1|COMPLETED|Non-randomized Period||2
2596244|NCT00267748|6373096|P3|STARTED|Non-randomized Period||0
2596245|NCT00267748|6373097|P2|STARTED|Non-randomized Period||0
2596246|NCT00267748|6373098|P1|STARTED|Non-randomized Period||25
2596247|NCT00267696|6373115|P1|NOT COMPLETED|Overall Study||0
2596248|NCT00267696|6373115|P1|COMPLETED|Overall Study||45
2596249|NCT00267696|6373115|P1|STARTED|Overall Study||45
2596250|NCT00267670|6373122|P2|NOT COMPLETED|Overall Study||0
2596251|NCT00267670|6373123|P1|NOT COMPLETED|Overall Study||4
2596252|NCT00267670|6373122|P2|COMPLETED|Overall Study||7
2596253|NCT00267670|6373123|P1|COMPLETED|Overall Study||15
2596254|NCT00267670|6373122|P2|STARTED|Overall Study||7
2596255|NCT00267670|6373123|P1|STARTED|Overall Study||19
2596256|NCT00267644|6373137|P2|NOT COMPLETED|Overall Study||0
2596257|NCT00267644|6373138|P1|NOT COMPLETED|Overall Study||0
2596258|NCT00267644|6373137|P2|COMPLETED|Overall Study||63
2596259|NCT00267644|6373138|P1|COMPLETED|Overall Study||13
2596260|NCT00267644|6373137|P2|STARTED|Overall Study||63
2596261|NCT00267644|6373138|P1|STARTED|Overall Study||13
2596262|NCT00267631|6373148|P2|NOT COMPLETED|Overall Study||0
2596263|NCT00267631|6373149|P1|NOT COMPLETED|Overall Study||0
2596264|NCT00267631|6373148|P2|COMPLETED|Overall Study||3031
2596265|NCT00267631|6373149|P1|COMPLETED|Overall Study||2361
2596266|NCT00267631|6373148|P2|STARTED|Overall Study||3031
2596267|NCT00267631|6373149|P1|STARTED|Overall Study||2361
2596268|NCT00267488|6373155|P1|NOT COMPLETED|Overall Study||11
2596269|NCT00267488|6373155|P1|COMPLETED|Overall Study||26
2596270|NCT00267488|6373155|P1|STARTED|Overall Study||37
2596271|NCT00267293|6373167|P3|NOT COMPLETED|Overall Study||0
2596272|NCT00267293|6373168|P2|NOT COMPLETED|Overall Study||0
2596273|NCT00267293|6373169|P1|NOT COMPLETED|Overall Study||0
2596274|NCT00267293|6373167|P3|COMPLETED|Overall Study||20
2596275|NCT00267293|6373168|P2|COMPLETED|Overall Study||20
2596276|NCT00267293|6373169|P1|COMPLETED|Overall Study||20
2596277|NCT00267293|6373167|P3|STARTED|Overall Study||20
2596278|NCT00267293|6373168|P2|STARTED|Overall Study||20
2596279|NCT00267293|6373169|P1|STARTED|Overall Study||20
2596280|NCT00267202|6373179|P2|NOT COMPLETED|Overall Study||34
2596281|NCT00267202|6373180|P1|NOT COMPLETED|Overall Study||53
2596282|NCT00267202|6373179|P2|COMPLETED|Overall Study||105
2596283|NCT00267202|6373180|P1|COMPLETED|Overall Study||83
2596284|NCT00267202|6373179|P2|STARTED|Overall Study||139
2596285|NCT00267202|6373180|P1|STARTED|Overall Study||136
2596286|NCT00267189|6373201|P2|NOT COMPLETED|Overall Study||1
2596287|NCT00267189|6373202|P1|NOT COMPLETED|Overall Study||5
2596288|NCT00267189|6373201|P2|COMPLETED|Overall Study||72
2596289|NCT00267189|6373202|P1|COMPLETED|Overall Study|"Completed indicates completed study."|67
2596290|NCT00267189|6373201|P2|Completed Study Medication|Overall Study||72
2596291|NCT00267189|6373202|P1|Completed Study Medication|Overall Study||54
2596292|NCT00267189|6373201|P2|STARTED|Overall Study||73
2596293|NCT00267189|6373202|P1|STARTED|Overall Study|Intention to treat (ITT) population.|72
2596294|NCT00267150|6373212|P1|NOT COMPLETED|Overall Study||1
2596295|NCT00267150|6373212|P1|COMPLETED|Overall Study||30
2596296|NCT00267150|6373212|P1|STARTED|Overall Study||31
2596297|NCT00267111|6373219|P2|NOT COMPLETED|Overall Study||0
2596298|NCT00267111|6373220|P1|NOT COMPLETED|Overall Study||0
2596299|NCT00267111|6373219|P2|COMPLETED|Overall Study||55
2596300|NCT00267111|6373220|P1|COMPLETED|Overall Study||55
2596301|NCT00267111|6373219|P2|STARTED|Overall Study||55
2596302|NCT00267111|6373220|P1|STARTED|Overall Study||55
2596303|NCT00267098|6373236|P8|NOT COMPLETED|Overall Study||15
2596304|NCT00267098|6373237|P7|NOT COMPLETED|Overall Study||46
2596305|NCT00267098|6373238|P6|NOT COMPLETED|Overall Study||40
2596306|NCT00267098|6373239|P5|NOT COMPLETED|Overall Study||37
2596307|NCT00267098|6373240|P4|NOT COMPLETED|Overall Study||106
2596308|NCT00267098|6373241|P3|NOT COMPLETED|Overall Study||94
2596309|NCT00267098|6373242|P2|NOT COMPLETED|Overall Study||51
2596310|NCT00267098|6373243|P1|NOT COMPLETED|Overall Study||109
2596311|NCT00267098|6373236|P8|COMPLETED|Overall Study||5
2596312|NCT00267098|6373237|P7|COMPLETED|Overall Study||55
2596313|NCT00267098|6373238|P6|COMPLETED|Overall Study||66
2596314|NCT00267098|6373239|P5|COMPLETED|Overall Study||10
2596315|NCT00267098|6373240|P4|COMPLETED|Overall Study||135
2596316|NCT00267098|6373241|P3|COMPLETED|Overall Study||149
2596317|NCT00267098|6373242|P2|COMPLETED|Overall Study||0
2596318|NCT00267098|6373243|P1|COMPLETED|Overall Study||0
2596319|NCT00267098|6373236|P8|STARTED|Overall Study||20
2596320|NCT00267098|6373237|P7|STARTED|Overall Study||101
2596321|NCT00267098|6373238|P6|STARTED|Overall Study||106
2596322|NCT00267098|6373239|P5|STARTED|Overall Study||47
2596323|NCT00267098|6373240|P4|STARTED|Overall Study||241
2596324|NCT00267098|6373241|P3|STARTED|Overall Study||243
2596325|NCT00267098|6373242|P2|STARTED|Overall Study||51
2596326|NCT00267098|6373243|P1|STARTED|Overall Study||109
2596327|NCT00267085|6373376|P1|NOT COMPLETED|Overall Study||0
2596328|NCT00267085|6373376|P1|COMPLETED|Overall Study||10
2596329|NCT00267085|6373376|P1|STARTED|Overall Study||10
2596330|NCT00267059|6373380|P1|NOT COMPLETED|Overall Study||0
2596331|NCT00267059|6373380|P1|COMPLETED|Overall Study||44
2596332|NCT00267059|6373380|P1|STARTED|Overall Study||44
2596333|NCT00267046|6373386|P2|NOT COMPLETED|Overall Study||11
2596334|NCT00267046|6373387|P1|NOT COMPLETED|Overall Study||12
2596335|NCT00267046|6373386|P2|COMPLETED|Overall Study||5
2596336|NCT00267046|6373387|P1|COMPLETED|Overall Study||20
2596337|NCT00267046|6373386|P2|STARTED|Overall Study||16
2596338|NCT00267046|6373387|P1|STARTED|Overall Study||32
2596339|NCT00267007|6373397|P2|NOT COMPLETED|Overall Study||1
2596340|NCT00267007|6373398|P1|NOT COMPLETED|Overall Study||8
2596341|NCT00267007|6373397|P2|COMPLETED|Overall Study||10
2596342|NCT00267007|6373398|P1|COMPLETED|Overall Study||11
2596343|NCT00267007|6373397|P2|STARTED|Overall Study||11
2596344|NCT00267007|6373398|P1|STARTED|Overall Study|2 additional patients were randomized but never received study medication and no data were collected|19
2596345|NCT00266877|6373409|P3|NOT COMPLETED|Overall Study||28
2596346|NCT00266877|6373410|P2|NOT COMPLETED|Overall Study||48
2596347|NCT00266877|6373411|P1|NOT COMPLETED|Overall Study||91
2596348|NCT00266877|6373409|P3|COMPLETED|Overall Study||0
2596349|NCT00266877|6373410|P2|COMPLETED|Overall Study||0
2596350|NCT00266877|6373411|P1|COMPLETED|Overall Study||0
2596351|NCT00266877|6373409|P3|STARTED|Overall Study||28
2596352|NCT00266877|6373410|P2|STARTED|Overall Study||48
2596353|NCT00266877|6373411|P1|STARTED|Overall Study||91
2596354|NCT00266864|6373430|P2|NOT COMPLETED|Overall Study||2
2596355|NCT00266864|6373431|P1|NOT COMPLETED|Overall Study||5
2596356|NCT00266864|6373430|P2|COMPLETED|Overall Study||11
2596357|NCT00266864|6373431|P1|COMPLETED|Overall Study||13
2596358|NCT00266864|6373430|P2|STARTED|Overall Study||13
2596359|NCT00266864|6373431|P1|STARTED|Overall Study||18
2596360|NCT00266851|6373441|P3|NOT COMPLETED|Overall Study||0
2596361|NCT00266851|6373442|P2|NOT COMPLETED|Overall Study||0
2596362|NCT00266851|6373443|P1|NOT COMPLETED|Overall Study||0
2596363|NCT00266851|6373441|P3|COMPLETED|Overall Study||22
2596364|NCT00266851|6373442|P2|COMPLETED|Overall Study||38
2596365|NCT00266851|6373443|P1|COMPLETED|Overall Study||37
2596366|NCT00266851|6373441|P3|Completed 12 Month Follow up|Overall Study||13
2596367|NCT00266851|6373442|P2|Completed 12 Month Follow up|Overall Study||19
2596368|NCT00266851|6373443|P1|Completed 12 Month Follow up|Overall Study||25
2596369|NCT00266851|6373441|P3|Completed 9 Month Follow up|Overall Study||15
2596370|NCT00266851|6373442|P2|Completed 9 Month Follow up|Overall Study||23
2596371|NCT00266851|6373443|P1|Completed 9 Month Follow up|Overall Study||22
2596372|NCT00266851|6373441|P3|Completed 6 Month Follow up|Overall Study||17
2596373|NCT00266851|6373442|P2|Completed 6 Month Follow up|Overall Study||22
2596374|NCT00266851|6373443|P1|Completed 6 Month Follow up|Overall Study||27
2596375|NCT00266851|6373441|P3|Completed 3 Month Follow up|Overall Study||15
2596376|NCT00266851|6373442|P2|Completed 3 Month Follow up|Overall Study||22
2596377|NCT00266851|6373443|P1|Completed 3 Month Follow up|Overall Study||26
2596378|NCT00266851|6373441|P3|STARTED|Overall Study||22
2596379|NCT00266851|6373442|P2|STARTED|Overall Study||38
2596380|NCT00266851|6373443|P1|STARTED|Overall Study||37
2596381|NCT00266825|6373462|P2|NOT COMPLETED|Completed Follow-Up||24
2596382|NCT00266825|6373463|P1|NOT COMPLETED|Completed Follow-Up||25
2596383|NCT00266825|6373462|P2|COMPLETED|Completed Follow-Up||154
2596384|NCT00266825|6373463|P1|COMPLETED|Completed Follow-Up||147
2596385|NCT00266825|6373462|P2|STARTED|Completed Follow-Up||178
2596386|NCT00266825|6373463|P1|STARTED|Completed Follow-Up||172
2596387|NCT00266825|6373462|P2|NOT COMPLETED|Enrolled and Allocated Intervention||0
2596388|NCT00266825|6373463|P1|NOT COMPLETED|Enrolled and Allocated Intervention||0
2596389|NCT00266825|6373462|P2|COMPLETED|Enrolled and Allocated Intervention||178
2596390|NCT00266825|6373463|P1|COMPLETED|Enrolled and Allocated Intervention||172
2596391|NCT00266825|6373462|P2|STARTED|Enrolled and Allocated Intervention||178
2596392|NCT00266825|6373463|P1|STARTED|Enrolled and Allocated Intervention||172
2596393|NCT00266812|6373489|P2|NOT COMPLETED|Overall Study||11
2596394|NCT00266812|6373490|P1|NOT COMPLETED|Overall Study||21
2596395|NCT00266812|6373489|P2|COMPLETED|Overall Study||2
2596396|NCT00266812|6373490|P1|COMPLETED|Overall Study||1
2596397|NCT00266812|6373489|P2|STARTED|Overall Study||13
2596398|NCT00266812|6373490|P1|STARTED|Overall Study||22
2596399|NCT00266799|6373498|P2|NOT COMPLETED|Overall Study||34
2596400|NCT00266799|6373499|P1|NOT COMPLETED|Overall Study||36
2596401|NCT00266799|6373498|P2|COMPLETED|Overall Study||68
2596402|NCT00266799|6373499|P1|COMPLETED|Overall Study||62
2596403|NCT00266799|6373498|P2|STARTED|Overall Study||102
2596404|NCT00266799|6373499|P1|STARTED|Overall Study||98
2596405|NCT00266708|6373515|P2|NOT COMPLETED|Overall Study||9
2596406|NCT00266708|6373516|P1|NOT COMPLETED|Overall Study||4
2596407|NCT00266708|6373515|P2|COMPLETED|Overall Study||13
2596408|NCT00266708|6373516|P1|COMPLETED|Overall Study||16
2596409|NCT00266708|6373515|P2|STARTED|Overall Study||22
2596410|NCT00266708|6373516|P1|STARTED|Overall Study||20
2596411|NCT00266695|6373556|P1|NOT COMPLETED|Overall Study||29
2596412|NCT00266695|6373556|P1|COMPLETED|Overall Study||174
2596413|NCT00266695|6373556|P1|STARTED|Overall Study||203
2596414|NCT00266656|6373568|P2|NOT COMPLETED|Overall Study||13
2596415|NCT00266656|6373569|P1|NOT COMPLETED|Overall Study||14
2596416|NCT00266656|6373568|P2|COMPLETED|Overall Study||20
2596417|NCT00266656|6373569|P1|COMPLETED|Overall Study||22
2596418|NCT00266656|6373568|P2|STARTED|Overall Study||33
2596419|NCT00266656|6373569|P1|STARTED|Overall Study||36
2596420|NCT00266630|6373593|P2|NOT COMPLETED|Overall Study||28
2596421|NCT00266630|6373594|P1|NOT COMPLETED|Overall Study||42
2596422|NCT00266630|6373593|P2|COMPLETED|Overall Study||11
2596423|NCT00266630|6373594|P1|COMPLETED|Overall Study||58
2596424|NCT00266630|6373593|P2|STARTED|Overall Study||39
2596425|NCT00266630|6373594|P1|STARTED|Overall Study||100
2596426|NCT00266409|6373636|P4|NOT COMPLETED|Overall Study||22
2596427|NCT00266409|6373637|P3|NOT COMPLETED|Overall Study||17
2596428|NCT00266409|6373638|P2|NOT COMPLETED|Overall Study||46
2596429|NCT00266409|6373639|P1|NOT COMPLETED|Overall Study||45
2596430|NCT00266409|6373636|P4|COMPLETED|Overall Study||49
2596431|NCT00266409|6373637|P3|COMPLETED|Overall Study||55
2596432|NCT00266409|6373638|P2|COMPLETED|Overall Study||92
2596433|NCT00266409|6373639|P1|COMPLETED|Overall Study||92
2596434|NCT00266409|6373636|P4|STARTED|Overall Study||71
2596435|NCT00266409|6373637|P3|STARTED|Overall Study||72
2596436|NCT00266409|6373638|P2|STARTED|Overall Study||138
2596437|NCT00266409|6373639|P1|STARTED|Overall Study||137
2596438|NCT00266279|6373921|P1|NOT COMPLETED|Overall Study||2
2596439|NCT00266279|6373921|P1|COMPLETED|Overall Study||15
2596440|NCT00266279|6373921|P1|STARTED|Overall Study||17
2596441|NCT00266227|6373927|P3|NOT COMPLETED|Retreatment: Week 48 to Week 72||0
2596442|NCT00266227|6373928|P2|NOT COMPLETED|Retreatment: Week 48 to Week 72||42
2596443|NCT00266227|6373929|P1|NOT COMPLETED|Retreatment: Week 48 to Week 72||64
2596444|NCT00266227|6373927|P3|COMPLETED|Retreatment: Week 48 to Week 72||0
2596445|NCT00266227|6373928|P2|COMPLETED|Retreatment: Week 48 to Week 72||92
2596446|NCT00266227|6373929|P1|COMPLETED|Retreatment: Week 48 to Week 72||227
2596447|NCT00266227|6373927|P3|STARTED|Retreatment: Week 48 to Week 72||0
2596448|NCT00266227|6373928|P2|STARTED|Retreatment: Week 48 to Week 72||134
2596449|NCT00266227|6373929|P1|STARTED|Retreatment: Week 48 to Week 72||291
2596450|NCT00266227|6373927|P3|NOT COMPLETED|Retreatment: Up to Week 48||0
2596451|NCT00266227|6373928|P2|NOT COMPLETED|Retreatment: Up to Week 48||23
2596452|NCT00266227|6373929|P1|NOT COMPLETED|Retreatment: Up to Week 48||27
2596453|NCT00266227|6373927|P3|COMPLETED|Retreatment: Up to Week 48||0
2596454|NCT00266227|6373928|P2|COMPLETED|Retreatment: Up to Week 48||134
2596455|NCT00266227|6373929|P1|COMPLETED|Retreatment: Up to Week 48||291
2596456|NCT00266227|6373927|P3|STARTED|Retreatment: Up to Week 48||0
2596457|NCT00266227|6373928|P2|STARTED|Retreatment: Up to Week 48||157
2596458|NCT00266227|6373929|P1|STARTED|Retreatment: Up to Week 48||318
2596459|NCT00266227|6373927|P3|NOT COMPLETED|Initial Treatment||77
2596460|NCT00266227|6373928|P2|NOT COMPLETED|Initial Treatment||0
2596461|NCT00266227|6373929|P1|NOT COMPLETED|Initial Treatment||0
2596462|NCT00266227|6373927|P3|COMPLETED|Initial Treatment||482
2596463|NCT00266227|6373928|P2|COMPLETED|Initial Treatment||0
2596464|NCT00266227|6373929|P1|COMPLETED|Initial Treatment||0
2596465|NCT00266227|6373927|P3|STARTED|Initial Treatment||559
2596466|NCT00266227|6373928|P2|STARTED|Initial Treatment||0
2596467|NCT00266227|6373929|P1|STARTED|Initial Treatment||0
2596468|NCT00266110|6373974|P1|NOT COMPLETED|Overall Study||7
2596469|NCT00266110|6373974|P1|COMPLETED|Overall Study||10
2596470|NCT00266110|6373974|P1|STARTED|Overall Study||17
2596471|NCT00266032|6373983|P3|NOT COMPLETED|Open-label Safety Extension||25
2596472|NCT00266032|6373984|P2|NOT COMPLETED|Open-label Safety Extension||14
2596473|NCT00266032|6373985|P1|NOT COMPLETED|Open-label Safety Extension||41
2596474|NCT00266032|6373983|P3|COMPLETED|Open-label Safety Extension||140
2596475|NCT00266032|6373984|P2|COMPLETED|Open-label Safety Extension||115
2596476|NCT00266032|6373985|P1|COMPLETED|Open-label Safety Extension||448
2596477|NCT00266032|6373983|P3|STARTED|Open-label Safety Extension|21 subjects continued their treatment in second period (safety extension)|165
2596478|NCT00266032|6373984|P2|STARTED|Open-label Safety Extension|7 subjects continued their treatment in second period (safety extension)|129
2596479|NCT00266032|6373985|P1|STARTED|Open-label Safety Extension|treatment for subjects of all 3 treatment groups in 2nd period, except for 28 in subgroups|489
2596480|NCT00266032|6373983|P3|NOT COMPLETED|Treatment||47
2596481|NCT00266032|6373984|P2|NOT COMPLETED|Treatment||64
2596482|NCT00266032|6373985|P1|NOT COMPLETED|Treatment||111
2596483|NCT00266032|6373983|P3|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|192
2596484|NCT00266032|6373984|P2|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|172
2596485|NCT00266032|6373985|P1|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|580
2596486|NCT00266032|6373983|P3|Patients Treated and in FAS|Treatment|FAS|216
2596487|NCT00266032|6373984|P2|Patients Treated and in FAS|Treatment|FAS|209
2596488|NCT00266032|6373985|P1|Patients Treated and in FAS|Treatment|FAS|642
2596489|NCT00266032|6373983|P3|Patients Treated|Treatment||229
2596490|NCT00266032|6373984|P2|Patients Treated|Treatment||221
2596491|NCT00266032|6373985|P1|Patients Treated|Treatment||684
2596492|NCT00266032|6373983|P3|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|239
2596493|NCT00266032|6373984|P2|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|236
2596494|NCT00266032|6373985|P1|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|691
2596495|NCT00265980|6374013|P1|NOT COMPLETED|Overall Study||0
2596496|NCT00265980|6374013|P1|COMPLETED|Overall Study||22
2596497|NCT00265980|6374013|P1|Weight -10% Leptin|Overall Study||22
2596498|NCT00265980|6374013|P1|Weight -10% Placebo|Overall Study||22
2596499|NCT00265980|6374013|P1|Weight Initial|Overall Study||22
2596500|NCT00265980|6374013|P1|STARTED|Overall Study||22
2596501|NCT00265941|6374020|P2|NOT COMPLETED|Overall Study||26
2596502|NCT00265941|6374021|P1|NOT COMPLETED|Overall Study||23
2596503|NCT00265941|6374020|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|444
2596504|NCT00265941|6374021|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|447
2596505|NCT00265941|6374020|P2|STARTED|Overall Study||470
2596506|NCT00265941|6374021|P1|STARTED|Overall Study||470
2596507|NCT00265889|6374053|P1|NOT COMPLETED|Overall Study||5
2596508|NCT00265889|6374053|P1|COMPLETED|Overall Study||37
2596509|NCT00265889|6374053|P1|Cycle 2: 2nd Regimen/Transplant|Overall Study||37
2596510|NCT00265889|6374053|P1|Cycle 1: 1st Regimen/Transplant|Overall Study||37
2596511|NCT00265889|6374053|P1|STARTED|Overall Study||42
2596512|NCT00265850|6374062|P3|NOT COMPLETED|Overall Study||0
2596513|NCT00265850|6374063|P2|NOT COMPLETED|Overall Study||0
2596514|NCT00265850|6374064|P1|NOT COMPLETED|Overall Study||0
2596515|NCT00265850|6374062|P3|COMPLETED|Overall Study||533
2596516|NCT00265850|6374063|P2|COMPLETED|Overall Study||902
2596517|NCT00265850|6374064|P1|COMPLETED|Overall Study||899
2596518|NCT00265850|6374062|P3|STARTED|Overall Study||533
2596519|NCT00265850|6374063|P2|STARTED|Overall Study||902
2596520|NCT00265850|6374064|P1|STARTED|Overall Study||899
2596521|NCT00265798|6374074|P1|NOT COMPLETED|Overall Study||0
2596522|NCT00265798|6374074|P1|COMPLETED|Overall Study||38
2596523|NCT00265798|6374074|P1|STARTED|Overall Study||38
2596524|NCT00265785|6374080|P1|NOT COMPLETED|Overall Study||27
2596525|NCT00265785|6374080|P1|COMPLETED|Overall Study||0
2596526|NCT00265785|6374080|P1|Eligible and Began Protocol Treatment|Overall Study||24
2596527|NCT00265785|6374080|P1|Eligible|Overall Study||26
2596528|NCT00265785|6374080|P1|STARTED|Overall Study||27
2596529|NCT00265759|6374093|P4|NOT COMPLETED|Overall Study||9
2596530|NCT00265759|6374094|P3|NOT COMPLETED|Overall Study||2
2596531|NCT00265759|6374095|P2|NOT COMPLETED|Overall Study||1
2596532|NCT00265759|6374096|P1|NOT COMPLETED|Overall Study||0
2596533|NCT00265759|6374093|P4|COMPLETED|Overall Study||236
2596534|NCT00265759|6374094|P3|COMPLETED|Overall Study||123
2596535|NCT00265759|6374095|P2|COMPLETED|Overall Study||127
2596536|NCT00265759|6374096|P1|COMPLETED|Overall Study||124
2596537|NCT00265759|6374093|P4|STARTED|Overall Study||245
2596538|NCT00265759|6374094|P3|STARTED|Overall Study||125
2596539|NCT00265759|6374095|P2|STARTED|Overall Study||128
2596540|NCT00265759|6374096|P1|STARTED|Overall Study||124
2596541|NCT00265616|6374127|P2|NOT COMPLETED|Overall Study||0
2596542|NCT00265616|6374128|P1|NOT COMPLETED|Overall Study||0
2596543|NCT00265616|6374127|P2|COMPLETED|Overall Study||9
2596544|NCT00265616|6374128|P1|COMPLETED|Overall Study||14
2596545|NCT00265616|6374127|P2|STARTED|Overall Study||9
2596546|NCT00265616|6374128|P1|STARTED|Overall Study||14
2596547|NCT00265512|6374146|P2|NOT COMPLETED|Overall Study||95
2596548|NCT00265512|6374147|P1|NOT COMPLETED|Overall Study||45
2596549|NCT00265512|6374146|P2|COMPLETED|Overall Study||359
2596550|NCT00265512|6374147|P1|COMPLETED|Overall Study||168
2596551|NCT00265512|6374146|P2|STARTED|Overall Study||454
2596552|NCT00265512|6374147|P1|STARTED|Overall Study||213
2596553|NCT00265473|6374157|P1|NOT COMPLETED|Overall Study||0
2596554|NCT00265473|6374157|P1|COMPLETED|Overall Study||5
2596555|NCT00265473|6374157|P1|STARTED|Overall Study||5
2596556|NCT00265395|6374167|P2|NOT COMPLETED|Overall Study||17
2596557|NCT00265395|6374168|P1|NOT COMPLETED|Overall Study||8
2596558|NCT00265395|6374167|P2|COMPLETED|Overall Study||56
2596559|NCT00265395|6374168|P1|COMPLETED|Overall Study||78
2596560|NCT00265395|6374167|P2|STARTED|Overall Study||73
2596561|NCT00265395|6374168|P1|STARTED|Overall Study||86
2596562|NCT00265382|6374173|P1|NOT COMPLETED|Overall Study||145
2596563|NCT00265382|6374173|P1|COMPLETED|Overall Study||76
2596564|NCT00265382|6374173|P1|STARTED|Overall Study||221
2596565|NCT00265343|6374193|P2|NOT COMPLETED|Overall Study||19
2596566|NCT00265343|6374194|P1|NOT COMPLETED|Overall Study||21
2596567|NCT00265343|6374193|P2|COMPLETED|Overall Study||153
2596568|NCT00265343|6374194|P1|COMPLETED|Overall Study||113
2596569|NCT00265343|6374193|P2|STARTED|Overall Study||172
2596570|NCT00265343|6374194|P1|STARTED|Overall Study||134
2596571|NCT00265330|6374202|P1|NOT COMPLETED|Overall Study||95
2596572|NCT00265330|6374202|P1|COMPLETED|Overall Study||67
2596573|NCT00265330|6374202|P1|STARTED|Overall Study||162
2596574|NCT00265317|6374228|P4|NOT COMPLETED|Phase 2||65
2596575|NCT00265317|6374229|P3|NOT COMPLETED|Phase 2||64
2596576|NCT00265317|6374230|P2|NOT COMPLETED|Phase 2||0
2596577|NCT00265317|6374231|P1|NOT COMPLETED|Phase 2||0
2596578|NCT00265317|6374228|P4|COMPLETED|Phase 2||2
2596579|NCT00265317|6374229|P3|COMPLETED|Phase 2||1
2596580|NCT00265317|6374230|P2|COMPLETED|Phase 2||0
2596581|NCT00265317|6374231|P1|COMPLETED|Phase 2||0
2596582|NCT00265317|6374228|P4|STARTED|Phase 2||67
2596583|NCT00265317|6374229|P3|STARTED|Phase 2||65
2596584|NCT00265317|6374230|P2|STARTED|Phase 2||0
2596585|NCT00265317|6374231|P1|STARTED|Phase 2||0
2596586|NCT00265317|6374228|P4|NOT COMPLETED|Lead-In||0
2596587|NCT00265317|6374229|P3|NOT COMPLETED|Lead-In||0
2596588|NCT00265317|6374230|P2|NOT COMPLETED|Lead-In||17
2596589|NCT00265317|6374231|P1|NOT COMPLETED|Lead-In||12
2596590|NCT00265317|6374228|P4|COMPLETED|Lead-In||0
2596591|NCT00265317|6374229|P3|COMPLETED|Lead-In||0
2596592|NCT00265317|6374230|P2|COMPLETED|Lead-In||0
2596593|NCT00265317|6374231|P1|COMPLETED|Lead-In||1
2596594|NCT00265317|6374228|P4|STARTED|Lead-In||0
2596595|NCT00265317|6374229|P3|STARTED|Lead-In||0
2596596|NCT00265317|6374230|P2|STARTED|Lead-In||17
2596597|NCT00265317|6374231|P1|STARTED|Lead-In||13
2596598|NCT00265239|6374346|P2|NOT COMPLETED|Overall Study||1
2596599|NCT00265239|6374347|P1|NOT COMPLETED|Overall Study||2
2596600|NCT00265239|6374346|P2|COMPLETED|Overall Study||51
2596601|NCT00265239|6374347|P1|COMPLETED|Overall Study||50
2596602|NCT00265239|6374346|P2|STARTED|Overall Study||52
2596603|NCT00265239|6374347|P1|STARTED|Overall Study||52
2596604|NCT00265200|6374359|P1|NOT COMPLETED|Overall Study||4
2596605|NCT00265200|6374359|P1|COMPLETED|Overall Study||24
2596606|NCT00265200|6374359|P1|STARTED|Overall Study||28
2596607|NCT00265122|6374369|P6|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
2596608|NCT00265122|6374370|P5|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||5
2596609|NCT00265122|6374371|P4|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
2596610|NCT00265122|6374372|P3|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
2596611|NCT00265122|6374373|P2|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
2596612|NCT00265122|6374374|P1|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||7
2596613|NCT00265122|6374369|P6|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||12
2596614|NCT00265122|6374370|P5|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||8
2596615|NCT00265122|6374371|P4|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||20
2596616|NCT00265122|6374372|P3|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||18
2596617|NCT00265122|6374373|P2|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||22
2596618|NCT00265122|6374374|P1|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||17
2596619|NCT00265122|6374369|P6|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
2596620|NCT00265122|6374370|P5|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
2596621|NCT00265122|6374371|P4|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
2596622|NCT00265122|6374372|P3|STARTED|Intervention Period 2 (Weeks 8 to 28):||22
2596623|NCT00265122|6374373|P2|STARTED|Intervention Period 2 (Weeks 8 to 28):||23
2596624|NCT00265122|6374374|P1|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
2596625|NCT00265122|6374369|P6|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||0
2596626|NCT00265122|6374370|P5|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||1
2596627|NCT00265122|6374371|P4|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
2596628|NCT00265122|6374372|P3|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||5
2596629|NCT00265122|6374373|P2|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
2596630|NCT00265122|6374374|P1|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
2596631|NCT00265122|6374369|P6|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
2596632|NCT00265122|6374370|P5|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
2596633|NCT00265122|6374371|P4|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
2596634|NCT00265122|6374372|P3|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||22
2596635|NCT00265122|6374373|P2|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||23
2596636|NCT00265122|6374374|P1|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
2596637|NCT00265122|6374369|P6|STARTED|Intervention Period 1 (Weeks 0 to 8):||13
2596638|NCT00265122|6374370|P5|STARTED|Intervention Period 1 (Weeks 0 to 8):||14
2596639|NCT00265122|6374371|P4|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
2596640|NCT00265122|6374372|P3|STARTED|Intervention Period 1 (Weeks 0 to 8):||27
2596641|NCT00265122|6374373|P2|STARTED|Intervention Period 1 (Weeks 0 to 8):||25
2596642|NCT00265122|6374374|P1|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
2596643|NCT00265109|6374396|P1|NOT COMPLETED|Overall Study||6
2596644|NCT00265109|6374396|P1|COMPLETED|Overall Study||11
2596645|NCT00265109|6374396|P1|STARTED|Overall Study||17
2596646|NCT00265096|6374415|P3|NOT COMPLETED|Overall Study||39
2596647|NCT00265096|6374416|P2|NOT COMPLETED|Overall Study||51
2596648|NCT00265096|6374417|P1|NOT COMPLETED|Overall Study||36
2596649|NCT00265096|6374415|P3|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|107
2596650|NCT00265096|6374416|P2|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|95
2596651|NCT00265096|6374417|P1|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|77
2596652|NCT00265096|6374415|P3|STARTED|Overall Study||146
2596653|NCT00265096|6374416|P2|STARTED|Overall Study||146
2596654|NCT00265096|6374417|P1|STARTED|Overall Study||113
2596655|NCT00265083|6374449|P3|NOT COMPLETED|Overall Study||42
2596656|NCT00265083|6374450|P2|NOT COMPLETED|Overall Study||42
2596657|NCT00265083|6374451|P1|NOT COMPLETED|Overall Study||17
2596658|NCT00265083|6374449|P3|COMPLETED|Overall Study||98
2596659|NCT00265083|6374450|P2|COMPLETED|Overall Study|One patient did not receive study agent.|96
2596660|NCT00265083|6374451|P1|COMPLETED|Overall Study||61
2596661|NCT00265083|6374449|P3|STARTED|Overall Study||140
2596662|NCT00265083|6374450|P2|STARTED|Overall Study|One patient did not receive study agent.|138
2596663|NCT00265083|6374451|P1|STARTED|Overall Study||78
2596664|NCT00264875|6374472|P1|NOT COMPLETED|Overall Study||30
2596665|NCT00264875|6374472|P1|COMPLETED|Overall Study||190
2596666|NCT00264875|6374472|P1|STARTED|Overall Study||220
2596667|NCT00264849|6374478|P2|NOT COMPLETED|Overall Study||25
2596668|NCT00264849|6374479|P1|NOT COMPLETED|Overall Study||22
2596669|NCT00264849|6374478|P2|COMPLETED|Overall Study||106
2596670|NCT00264849|6374479|P1|COMPLETED|Overall Study||253
2596671|NCT00264849|6374478|P2|STARTED|Overall Study||131
2596672|NCT00264849|6374479|P1|STARTED|Overall Study||275
2596673|NCT00264810|6374513|P2|NOT COMPLETED|Open Label Evaluation Period||6
2596674|NCT00264810|6374514|P1|NOT COMPLETED|Open Label Evaluation Period||6
2596675|NCT00264810|6374513|P2|COMPLETED|Open Label Evaluation Period||86
2596676|NCT00264810|6374514|P1|COMPLETED|Open Label Evaluation Period||89
2596677|NCT00264810|6374513|P2|1-year Post-implant|Open Label Evaluation Period||90
2596678|NCT00264810|6374514|P1|1-year Post-implant|Open Label Evaluation Period||92
2596679|NCT00264810|6374513|P2|STARTED|Open Label Evaluation Period||92
2596680|NCT00264810|6374514|P1|STARTED|Open Label Evaluation Period||95
2596681|NCT00264810|6374513|P2|NOT COMPLETED|Blinded Evaluation Period||1
2596682|NCT00264810|6374514|P1|NOT COMPLETED|Blinded Evaluation Period||1
2596683|NCT00264810|6374513|P2|COMPLETED|Blinded Evaluation Period||92
2596684|NCT00264810|6374514|P1|COMPLETED|Blinded Evaluation Period||95
2596685|NCT00264810|6374513|P2|STARTED|Blinded Evaluation Period||93
2596686|NCT00264810|6374514|P1|STARTED|Blinded Evaluation Period||96
2596687|NCT00264810|6374513|P2|NOT COMPLETED|Stimulation Optimization Period||1
2596688|NCT00264810|6374514|P1|NOT COMPLETED|Stimulation Optimization Period||1
2596689|NCT00264810|6374513|P2|COMPLETED|Stimulation Optimization Period||93
2596690|NCT00264810|6374514|P1|COMPLETED|Stimulation Optimization Period||96
2596691|NCT00264810|6374513|P2|STARTED|Stimulation Optimization Period||94
2596692|NCT00264810|6374514|P1|STARTED|Stimulation Optimization Period||97
2596693|NCT00264810|6374513|P2|NOT COMPLETED|Post-Operative Stabilization Period||0
2596694|NCT00264810|6374514|P1|NOT COMPLETED|Post-Operative Stabilization Period||0
2596695|NCT00264810|6374513|P2|COMPLETED|Post-Operative Stabilization Period||94
2596696|NCT00264810|6374514|P1|COMPLETED|Post-Operative Stabilization Period||97
2596697|NCT00264810|6374513|P2|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
2596698|NCT00264810|6374514|P1|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
2596699|NCT00264810|6374513|P2|NOT COMPLETED|Baseline||26
2596700|NCT00264810|6374514|P1|NOT COMPLETED|Baseline||23
2596701|NCT00264810|6374513|P2|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
2596702|NCT00264810|6374514|P1|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
2596703|NCT00264810|6374513|P2|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
2596704|NCT00264810|6374514|P1|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
2596705|NCT00264797|6374524|P2|NOT COMPLETED|Overall Study||43
2596706|NCT00264797|6374525|P1|NOT COMPLETED|Overall Study||33
2596707|NCT00264797|6374524|P2|COMPLETED|Overall Study||109
2596708|NCT00264797|6374525|P1|COMPLETED|Overall Study||118
2596709|NCT00264797|6374524|P2|STARTED|Overall Study||152
2596710|NCT00264797|6374525|P1|STARTED|Overall Study||151
2596711|NCT00264641|6374539|P2|NOT COMPLETED|Overall Study||0
2596712|NCT00264641|6374540|P1|NOT COMPLETED|Overall Study||0
2596713|NCT00264641|6374539|P2|COMPLETED|Overall Study||10
2596714|NCT00264641|6374540|P1|COMPLETED|Overall Study||10
2596715|NCT00264641|6374539|P2|Initiation of the Study|Overall Study||10
2596716|NCT00264641|6374540|P1|Initiation of the Study|Overall Study||10
2596717|NCT00264641|6374539|P2|STARTED|Overall Study||10
2596718|NCT00264641|6374540|P1|STARTED|Overall Study||10
2596719|NCT00264576|6374547|P2|NOT COMPLETED|Overall Study||1
2596720|NCT00264576|6374548|P1|NOT COMPLETED|Overall Study||1
2596721|NCT00264576|6374547|P2|COMPLETED|Overall Study||304
2596722|NCT00264576|6374548|P1|COMPLETED|Overall Study||307
2596723|NCT00264576|6374547|P2|STARTED|Overall Study||305
2596724|NCT00264576|6374548|P1|STARTED|Overall Study||308
2596725|NCT00264550|6374572|P4|NOT COMPLETED|Overall Study||30
2596726|NCT00264550|6374573|P3|NOT COMPLETED|Overall Study||17
2596727|NCT00264550|6374574|P2|NOT COMPLETED|Overall Study||41
2596728|NCT00264550|6374575|P1|NOT COMPLETED|Overall Study||43
2596729|NCT00264550|6374572|P4|COMPLETED|Overall Study||59
2596730|NCT00264550|6374573|P3|COMPLETED|Overall Study||72
2596731|NCT00264550|6374574|P2|COMPLETED|Overall Study||92
2596732|NCT00264550|6374575|P1|COMPLETED|Overall Study||90
2596733|NCT00264550|6374572|P4|STARTED|Overall Study||89
2596734|NCT00264550|6374573|P3|STARTED|Overall Study||89
2596735|NCT00264550|6374574|P2|STARTED|Overall Study||133
2596736|NCT00264550|6374575|P1|STARTED|Overall Study||133
2596737|NCT00264537|6374614|P4|NOT COMPLETED|Overall Study||60
2596738|NCT00264537|6374615|P3|NOT COMPLETED|Overall Study||50
2596739|NCT00264537|6374616|P2|NOT COMPLETED|Overall Study||58
2596740|NCT00264537|6374617|P1|NOT COMPLETED|Overall Study||50
2596741|NCT00264537|6374614|P4|COMPLETED|Overall Study||99
2596742|NCT00264537|6374615|P3|COMPLETED|Overall Study||109
2596743|NCT00264537|6374616|P2|COMPLETED|Overall Study||101
2596744|NCT00264537|6374617|P1|COMPLETED|Overall Study||110
2596745|NCT00264537|6374614|P4|STARTED|Overall Study||159
2596746|NCT00264537|6374615|P3|STARTED|Overall Study||159
2596747|NCT00264537|6374616|P2|STARTED|Overall Study||159
2596748|NCT00264537|6374617|P1|STARTED|Overall Study||160
2596749|NCT00264498|6374649|P2|NOT COMPLETED|Crossover Treatment||9
2596750|NCT00264498|6374650|P1|NOT COMPLETED|Crossover Treatment||6
2596751|NCT00264498|6374649|P2|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
2596752|NCT00264498|6374650|P1|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
2596753|NCT00264498|6374649|P2|STARTED|Crossover Treatment||9
2596754|NCT00264498|6374650|P1|STARTED|Crossover Treatment||6
2596755|NCT00264498|6374649|P2|NOT COMPLETED|Randomized Treatment||18
2596756|NCT00264498|6374650|P1|NOT COMPLETED|Randomized Treatment||17
2596757|NCT00264498|6374649|P2|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
2596758|NCT00264498|6374650|P1|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
2596759|NCT00264498|6374649|P2|STARTED|Randomized Treatment||18
2596760|NCT00264498|6374650|P1|STARTED|Randomized Treatment||17
2596761|NCT00264381|6374658|P2|NOT COMPLETED|Overall Study||0
2596762|NCT00264381|6374659|P1|NOT COMPLETED|Overall Study||0
2596763|NCT00264381|6374658|P2|COMPLETED|Overall Study||37
2596764|NCT00264381|6374659|P1|COMPLETED|Overall Study||35
2596765|NCT00264381|6374658|P2|STARTED|Overall Study||37
2596766|NCT00264381|6374659|P1|STARTED|Overall Study||35
2596767|NCT00264303|6374673|P2|NOT COMPLETED|Overall Study||29
2596768|NCT00264303|6374674|P1|NOT COMPLETED|Overall Study||25
2596769|NCT00264303|6374673|P2|COMPLETED|Overall Study||419
2596770|NCT00264303|6374674|P1|COMPLETED|Overall Study||413
2596771|NCT00264303|6374673|P2|STARTED|Overall Study||448
2596772|NCT00264303|6374674|P1|STARTED|Overall Study||438
2596773|NCT00264290|6374692|P2|NOT COMPLETED|Observation (4 Weeks)||0
2596774|NCT00264290|6374693|P1|NOT COMPLETED|Observation (4 Weeks)||0
2596775|NCT00264290|6374692|P2|COMPLETED|Observation (4 Weeks)||14
2596776|NCT00264290|6374693|P1|COMPLETED|Observation (4 Weeks)||15
2596777|NCT00264290|6374692|P2|STARTED|Observation (4 Weeks)||14
2596778|NCT00264290|6374693|P1|STARTED|Observation (4 Weeks)||15
2596779|NCT00264290|6374692|P2|NOT COMPLETED|Intervention (8 Weeks)||0
2596780|NCT00264290|6374693|P1|NOT COMPLETED|Intervention (8 Weeks)||1
2596781|NCT00264290|6374692|P2|COMPLETED|Intervention (8 Weeks)||14
2596782|NCT00264290|6374693|P1|COMPLETED|Intervention (8 Weeks)||15
2596783|NCT00264290|6374692|P2|STARTED|Intervention (8 Weeks)||14
2596784|NCT00264290|6374693|P1|STARTED|Intervention (8 Weeks)||16
2596785|NCT00264238|6374699|P1|NOT COMPLETED|Overall Study||1
2596786|NCT00264238|6374699|P1|COMPLETED|Overall Study||14
2596787|NCT00264238|6374699|P1|STARTED|Overall Study||15
2596788|NCT00264147|6374711|P6|NOT COMPLETED|Treatment II Period||33
2596789|NCT00264147|6374712|P5|NOT COMPLETED|Treatment II Period||33
2596790|NCT00264147|6374713|P4|NOT COMPLETED|Treatment II Period||0
2596791|NCT00264147|6374714|P3|NOT COMPLETED|Treatment II Period||0
2596792|NCT00264147|6374715|P2|NOT COMPLETED|Treatment II Period||0
2596793|NCT00264147|6374716|P1|NOT COMPLETED|Treatment II Period||0
2596794|NCT00264147|6374711|P6|COMPLETED|Treatment II Period||116
2596795|NCT00264147|6374712|P5|COMPLETED|Treatment II Period||147
2596796|NCT00264147|6374713|P4|COMPLETED|Treatment II Period||0
2596797|NCT00264147|6374714|P3|COMPLETED|Treatment II Period||0
2596798|NCT00264147|6374715|P2|COMPLETED|Treatment II Period||0
2596799|NCT00264147|6374716|P1|COMPLETED|Treatment II Period||0
2596800|NCT00264147|6374711|P6|STARTED|Treatment II Period|Etoricoxib 10 mg (34), 30 mg (37), 60 mg (29), and placebo (49) reassigned to diclofenac (149)|149
2596801|NCT00264147|6374712|P5|STARTED|Treatment II Period|Etoricoxib 10 mg (38), 30 mg (28), 60 mg (33), 90 mg (45) and placebo (36) reassigned to 90 mg (180)|180
2596802|NCT00264147|6374713|P4|STARTED|Treatment II Period||0
2596803|NCT00264147|6374714|P3|STARTED|Treatment II Period||0
2596804|NCT00264147|6374715|P2|STARTED|Treatment II Period||0
2596805|NCT00264147|6374716|P1|STARTED|Treatment II Period||0
2596806|NCT00264147|6374711|P6|NOT COMPLETED|Treatment I Period||0
2596807|NCT00264147|6374712|P5|NOT COMPLETED|Treatment I Period||56
2596808|NCT00264147|6374713|P4|NOT COMPLETED|Treatment I Period||72
2596809|NCT00264147|6374714|P3|NOT COMPLETED|Treatment I Period||77
2596810|NCT00264147|6374715|P2|NOT COMPLETED|Treatment I Period||83
2596811|NCT00264147|6374716|P1|NOT COMPLETED|Treatment I Period||98
2596812|NCT00264147|6374711|P6|COMPLETED|Treatment I Period||0
2596813|NCT00264147|6374712|P5|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|99
2596814|NCT00264147|6374713|P4|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|68
2596815|NCT00264147|6374714|P3|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|74
2596816|NCT00264147|6374715|P2|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|71
2596817|NCT00264147|6374716|P1|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|63
2596818|NCT00264147|6374711|P6|STARTED|Treatment I Period||0
2596819|NCT00264147|6374712|P5|STARTED|Treatment I Period||155
2596820|NCT00264147|6374713|P4|STARTED|Treatment I Period||140
2596821|NCT00264147|6374714|P3|STARTED|Treatment I Period||151
2596822|NCT00264147|6374715|P2|STARTED|Treatment I Period||154
2596823|NCT00264147|6374716|P1|STARTED|Treatment I Period||161
2596824|NCT00264004|6374759|P4|NOT COMPLETED|Overall Study||15
2596825|NCT00264004|6374760|P3|NOT COMPLETED|Overall Study||14
2596826|NCT00264004|6374761|P2|NOT COMPLETED|Overall Study||11
2596827|NCT00264004|6374762|P1|NOT COMPLETED|Overall Study||17
2596828|NCT00264004|6374759|P4|COMPLETED|Overall Study|Completed 12 weeks treatment|19
2596829|NCT00264004|6374760|P3|COMPLETED|Overall Study|Completed 12 weeks treatment|16
2596830|NCT00264004|6374761|P2|COMPLETED|Overall Study|Completed 12 weeks treatment|21
2596831|NCT00264004|6374762|P1|COMPLETED|Overall Study|Completed 12 weeks treatment|13
2596832|NCT00264004|6374759|P4|STARTED|Overall Study|Randomised|34
2596833|NCT00264004|6374760|P3|STARTED|Overall Study|Randomised|30
2596834|NCT00264004|6374761|P2|STARTED|Overall Study|Randomised|32
2596835|NCT00264004|6374762|P1|STARTED|Overall Study|Randomised|30
2596836|NCT00263887|6374790|P2|NOT COMPLETED|Overall Study||7
2596837|NCT00263887|6374791|P1|NOT COMPLETED|Overall Study||3
2596838|NCT00263887|6374790|P2|COMPLETED|Overall Study||32
2596839|NCT00263887|6374791|P1|COMPLETED|Overall Study||35
2596840|NCT00263887|6374790|P2|STARTED|Overall Study||39
2596841|NCT00263887|6374791|P1|STARTED|Overall Study||38
2596842|NCT00263757|6374799|P2|NOT COMPLETED|Overall Study||8
2596843|NCT00263757|6374800|P1|NOT COMPLETED|Overall Study||8
2596844|NCT00263757|6374799|P2|COMPLETED|Overall Study||5
2596845|NCT00263757|6374800|P1|COMPLETED|Overall Study||4
2596846|NCT00263757|6374799|P2|STARTED|Overall Study||13
2596847|NCT00263757|6374800|P1|STARTED|Overall Study||12
2596848|NCT00263666|6374812|P2|NOT COMPLETED|Overall Study||11
2596849|NCT00263666|6374813|P1|NOT COMPLETED|Overall Study||7
2596850|NCT00263666|6374812|P2|COMPLETED|Overall Study||39
2596851|NCT00263666|6374813|P1|COMPLETED|Overall Study||43
2596852|NCT00263666|6374812|P2|STARTED|Overall Study||50
2596853|NCT00263666|6374813|P1|STARTED|Overall Study||50
2596854|NCT00263588|6374866|P2|NOT COMPLETED|Overall Study||132
2596855|NCT00263588|6374867|P1|NOT COMPLETED|Overall Study||81
2596856|NCT00263588|6374866|P2|COMPLETED|Overall Study||15
2596857|NCT00263588|6374867|P1|COMPLETED|Overall Study||14
2596858|NCT00263588|6374866|P2|STARTED|Overall Study||147
2596859|NCT00263588|6374867|P1|STARTED|Overall Study||95
2596860|NCT00263328|6374893|P3|NOT COMPLETED|Overall Study||7
2596861|NCT00263328|6374894|P2|NOT COMPLETED|Overall Study||2
2596862|NCT00263328|6374895|P1|NOT COMPLETED|Overall Study||8
2596863|NCT00263328|6374893|P3|COMPLETED|Overall Study||6
2596864|NCT00263328|6374894|P2|COMPLETED|Overall Study||12
2596865|NCT00263328|6374895|P1|COMPLETED|Overall Study||10
2596866|NCT00263328|6374893|P3|STARTED|Overall Study||13
2596867|NCT00263328|6374894|P2|STARTED|Overall Study||14
2596868|NCT00263328|6374895|P1|STARTED|Overall Study||18
2596869|NCT00263211|6375053|P2|NOT COMPLETED|Overall Study||1
2596870|NCT00263211|6375054|P1|NOT COMPLETED|Overall Study||5
2596871|NCT00263211|6375053|P2|COMPLETED|Overall Study||23
2596872|NCT00263211|6375054|P1|COMPLETED|Overall Study||19
2596873|NCT00263211|6375053|P2|STARTED|Overall Study||24
2596874|NCT00263211|6375054|P1|STARTED|Overall Study||24
2596875|NCT00262964|6375072|P4|NOT COMPLETED|Overall Study||0
2596876|NCT00262964|6375073|P3|NOT COMPLETED|Overall Study||0
2596877|NCT00262964|6375074|P2|NOT COMPLETED|Overall Study||0
2596878|NCT00262964|6375075|P1|NOT COMPLETED|Overall Study||0
2596879|NCT00262964|6375072|P4|COMPLETED|Overall Study||12
2596880|NCT00262964|6375073|P3|COMPLETED|Overall Study||17
2596881|NCT00262964|6375074|P2|COMPLETED|Overall Study||11
2596882|NCT00262964|6375075|P1|COMPLETED|Overall Study||11
2596883|NCT00262964|6375072|P4|STARTED|Overall Study||12
2596884|NCT00262964|6375073|P3|STARTED|Overall Study||17
2596885|NCT00262964|6375074|P2|STARTED|Overall Study||11
2596886|NCT00262964|6375075|P1|STARTED|Overall Study||11
2596887|NCT00262951|6375105|P1|NOT COMPLETED|Overall Study||16
2596888|NCT00262951|6375105|P1|COMPLETED|Overall Study||7
2596889|NCT00262951|6375105|P1|STARTED|Overall Study||23
2596890|NCT00262925|6375110|P1|NOT COMPLETED|Overall Study||11
2596891|NCT00262925|6375110|P1|COMPLETED|Overall Study||1
2596892|NCT00262925|6375110|P1|STARTED|Overall Study|7 patients were enrolled to step 1, and 5 patients were enrolled to step 2|12
2596893|NCT00262873|6375116|P1|NOT COMPLETED|Overall Study||8
2596894|NCT00262873|6375116|P1|COMPLETED|Overall Study||0
2596895|NCT00262873|6375116|P1|STARTED|Overall Study||8
2596896|NCT00262860|6375127|P1|NOT COMPLETED|Overall Study||2
2596897|NCT00262860|6375127|P1|COMPLETED|Overall Study||16
2596898|NCT00262860|6375127|P1|STARTED|Overall Study||18
2596899|NCT00262847|6375136|P3|NOT COMPLETED|Overall Study||396
2596900|NCT00262847|6375137|P2|NOT COMPLETED|Overall Study||513
2596901|NCT00262847|6375138|P1|NOT COMPLETED|Overall Study||518
2596902|NCT00262847|6375136|P3|COMPLETED|Overall Study||227
2596903|NCT00262847|6375137|P2|COMPLETED|Overall Study||112
2596904|NCT00262847|6375138|P1|COMPLETED|Overall Study||107
2596905|NCT00262847|6375136|P3|STARTED|Overall Study|Total enrolled and included in efficacy analysis|623
2596906|NCT00262847|6375137|P2|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
2596907|NCT00262847|6375138|P1|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
2596914|NCT00262821|6375171|P2|NOT COMPLETED|Overall Study||19
2596915|NCT00262821|6375172|P1|NOT COMPLETED|Overall Study||4
2596916|NCT00262821|6375171|P2|COMPLETED|Overall Study||185
2596917|NCT00262821|6375172|P1|COMPLETED|Overall Study||194
2596918|NCT00262821|6375171|P2|STARTED|Overall Study||204
2596919|NCT00262821|6375172|P1|STARTED|Overall Study||198
2596920|NCT00262743|6375184|P2|NOT COMPLETED|Overall Study||12
2596921|NCT00262743|6375185|P1|NOT COMPLETED|Overall Study||0
2596922|NCT00262743|6375184|P2|COMPLETED|Overall Study||30
2596923|NCT00262743|6375185|P1|COMPLETED|Overall Study||27
2596924|NCT00262743|6375184|P2|STARTED|Overall Study||42
2596925|NCT00262743|6375185|P1|STARTED|Overall Study||27
2596926|NCT00262730|6375192|P1|NOT COMPLETED|Overall Study||0
2596927|NCT00262730|6375192|P1|COMPLETED|Overall Study||97
2596928|NCT00262730|6375192|P1|STARTED|Overall Study||97
2596929|NCT00262639|6375200|P4|NOT COMPLETED|Overall Study||0
2596930|NCT00262639|6375201|P3|NOT COMPLETED|Overall Study||0
2596931|NCT00262639|6375202|P2|NOT COMPLETED|Overall Study||0
2596932|NCT00262639|6375203|P1|NOT COMPLETED|Overall Study||0
2596933|NCT00262639|6375200|P4|COMPLETED|Overall Study||7
2596934|NCT00262639|6375201|P3|COMPLETED|Overall Study||9
2596935|NCT00262639|6375202|P2|COMPLETED|Overall Study||26
2596936|NCT00262639|6375203|P1|COMPLETED|Overall Study||18
2596937|NCT00262639|6375200|P4|STARTED|Overall Study||7
2596938|NCT00262639|6375201|P3|STARTED|Overall Study||9
2596939|NCT00262639|6375202|P2|STARTED|Overall Study||26
2596940|NCT00262639|6375203|P1|STARTED|Overall Study||18
2596941|NCT00262600|6375220|P3|NOT COMPLETED|Overall Study||266
2596942|NCT00262600|6375221|P2|NOT COMPLETED|Overall Study||252
2596943|NCT00262600|6375222|P1|NOT COMPLETED|Overall Study||235
2596944|NCT00262600|6375220|P3|COMPLETED|Overall Study||5756
2596945|NCT00262600|6375221|P2|COMPLETED|Overall Study||5824
2596946|NCT00262600|6375222|P1|COMPLETED|Overall Study||5780
2596947|NCT00262600|6375220|P3|STARTED|Overall Study||6022
2596948|NCT00262600|6375221|P2|STARTED|Overall Study||6076
2596949|NCT00262600|6375222|P1|STARTED|Overall Study||6015
2596950|NCT00262522|6375249|P4|NOT COMPLETED|Study Start Through 96 Weeks||0
2596951|NCT00262522|6375250|P3|NOT COMPLETED|Study Start Through 96 Weeks||77
2596952|NCT00262522|6375251|P2|NOT COMPLETED|Study Start Through 96 Weeks||0
2596953|NCT00262522|6375252|P1|NOT COMPLETED|Study Start Through 96 Weeks||77
2596954|NCT00262522|6375249|P4|COMPLETED|Study Start Through 96 Weeks||0
2596955|NCT00262522|6375250|P3|COMPLETED|Study Start Through 96 Weeks||254
2596956|NCT00262522|6375251|P2|COMPLETED|Study Start Through 96 Weeks||0
2596957|NCT00262522|6375252|P1|COMPLETED|Study Start Through 96 Weeks||256
2596958|NCT00262522|6375249|P4|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
2596959|NCT00262522|6375250|P3|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|331
2596960|NCT00262522|6375251|P2|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
2596961|NCT00262522|6375252|P1|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|333
2596962|NCT00262522|6375249|P4|NOT COMPLETED|Study Start Through 48 Weeks||0
2596963|NCT00262522|6375250|P3|NOT COMPLETED|Study Start Through 48 Weeks||55
2596964|NCT00262522|6375251|P2|NOT COMPLETED|Study Start Through 48 Weeks||0
2596965|NCT00262522|6375252|P1|NOT COMPLETED|Study Start Through 48 Weeks||49
2596966|NCT00262522|6375249|P4|COMPLETED|Study Start Through 48 Weeks||0
2596967|NCT00262522|6375250|P3|COMPLETED|Study Start Through 48 Weeks||276
2596968|NCT00262522|6375251|P2|COMPLETED|Study Start Through 48 Weeks||0
2596969|NCT00262522|6375252|P1|COMPLETED|Study Start Through 48 Weeks||284
2596970|NCT00262522|6375249|P4|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
2596971|NCT00262522|6375250|P3|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|331
2596972|NCT00262522|6375251|P2|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
2596973|NCT00262522|6375252|P1|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|333
2596974|NCT00262522|6375249|P4|NOT COMPLETED|Study Start Through 8 Weeks||5
2596975|NCT00262522|6375250|P3|NOT COMPLETED|Study Start Through 8 Weeks||11
2596976|NCT00262522|6375251|P2|NOT COMPLETED|Study Start Through 8 Weeks||5
2596977|NCT00262522|6375252|P1|NOT COMPLETED|Study Start Through 8 Weeks||4
2596978|NCT00262522|6375249|P4|COMPLETED|Study Start Through 8 Weeks||160
2596979|NCT00262522|6375250|P3|COMPLETED|Study Start Through 8 Weeks||155
2596980|NCT00262522|6375251|P2|COMPLETED|Study Start Through 8 Weeks||161
2596981|NCT00262522|6375252|P1|COMPLETED|Study Start Through 8 Weeks||163
2596982|NCT00262522|6375249|P4|STARTED|Study Start Through 8 Weeks||165
2596983|NCT00262522|6375250|P3|STARTED|Study Start Through 8 Weeks||166
2596984|NCT00262522|6375251|P2|STARTED|Study Start Through 8 Weeks||166
2596985|NCT00262522|6375252|P1|STARTED|Study Start Through 8 Weeks||167
2596986|NCT00262509|6375274|P2|NOT COMPLETED|Overall Study||0
2596987|NCT00262509|6375275|P1|NOT COMPLETED|Overall Study||0
2596988|NCT00262509|6375274|P2|COMPLETED|Overall Study||9
2596989|NCT00262509|6375275|P1|COMPLETED|Overall Study||8
2596990|NCT00262509|6375274|P2|STARTED|Overall Study||9
2596991|NCT00262509|6375275|P1|STARTED|Overall Study||8
2596992|NCT00262314|6375281|P1|NOT COMPLETED|Overall Study||337
2596993|NCT00262314|6375281|P1|COMPLETED|Overall Study|Patients in the study for 5 years +/-3 months are considered to have completed the 5-year study|172
2596994|NCT00262314|6375281|P1|STARTED|Overall Study|Patients with validated data who received at least 1 dose of Novantrone®|509
2596995|NCT00262301|6375299|P3|NOT COMPLETED|Open-label Phase||0
2596996|NCT00262301|6375300|P2|NOT COMPLETED|Open-label Phase||0
2596997|NCT00262301|6375301|P1|NOT COMPLETED|Open-label Phase||0
2596998|NCT00262301|6375299|P3|COMPLETED|Open-label Phase||57
2596999|NCT00262301|6375300|P2|COMPLETED|Open-label Phase||0
2597000|NCT00262301|6375301|P1|COMPLETED|Open-label Phase||0
2597001|NCT00262301|6375299|P3|STARTED|Open-label Phase|"14/57 patients crossed over from the double-blind phase (7/14 were treated with 100 U/kg rhC1INH)"|57
2597002|NCT00262301|6375300|P2|STARTED|Open-label Phase||0
2597003|NCT00262301|6375301|P1|STARTED|Open-label Phase||0
2597004|NCT00262301|6375299|P3|NOT COMPLETED|Double-blind Phase||0
2597005|NCT00262301|6375300|P2|NOT COMPLETED|Double-blind Phase||1
2597006|NCT00262301|6375301|P1|NOT COMPLETED|Double-blind Phase||1
2597007|NCT00262301|6375299|P3|COMPLETED|Double-blind Phase||0
2597008|NCT00262301|6375300|P2|COMPLETED|Double-blind Phase||15
2597009|NCT00262301|6375301|P1|COMPLETED|Double-blind Phase||15
2597010|NCT00262301|6375299|P3|STARTED|Double-blind Phase||0
2597011|NCT00262301|6375300|P2|STARTED|Double-blind Phase||16
2597012|NCT00262301|6375301|P1|STARTED|Double-blind Phase||16
2597013|NCT00262223|6375314|P2|NOT COMPLETED|12-month Post-treatment Follow-up||7
2597014|NCT00262223|6375315|P1|NOT COMPLETED|12-month Post-treatment Follow-up||7
2597015|NCT00262223|6375314|P2|COMPLETED|12-month Post-treatment Follow-up||22
2597016|NCT00262223|6375315|P1|COMPLETED|12-month Post-treatment Follow-up||21
2597017|NCT00262223|6375314|P2|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
2597018|NCT00262223|6375315|P1|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
2597019|NCT00262223|6375314|P2|NOT COMPLETED|6-month Post-treatment Follow-up||1
2597020|NCT00262223|6375315|P1|NOT COMPLETED|6-month Post-treatment Follow-up||6
2597021|NCT00262223|6375314|P2|COMPLETED|6-month Post-treatment Follow-up||28
2597022|NCT00262223|6375315|P1|COMPLETED|6-month Post-treatment Follow-up||22
2597023|NCT00262223|6375314|P2|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
2597024|NCT00262223|6375315|P1|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
2597025|NCT00262223|6375314|P2|NOT COMPLETED|1-week Post-treatment Follow-up||4
2597026|NCT00262223|6375315|P1|NOT COMPLETED|1-week Post-treatment Follow-up||4
2597027|NCT00262223|6375314|P2|COMPLETED|1-week Post-treatment Follow-up||25
2597028|NCT00262223|6375315|P1|COMPLETED|1-week Post-treatment Follow-up||24
2597029|NCT00262223|6375314|P2|STARTED|1-week Post-treatment Follow-up||29
2597030|NCT00262223|6375315|P1|STARTED|1-week Post-treatment Follow-up||28
2597031|NCT00262223|6375314|P2|NOT COMPLETED|Treatment Phase||8
2597032|NCT00262223|6375315|P1|NOT COMPLETED|Treatment Phase||4
2597033|NCT00262223|6375314|P2|COMPLETED|Treatment Phase||29
2597034|NCT00262223|6375315|P1|COMPLETED|Treatment Phase||28
2597035|NCT00262223|6375314|P2|STARTED|Treatment Phase||37
2597036|NCT00262223|6375315|P1|STARTED|Treatment Phase||32
2597037|NCT00262119|6375326|P3|NOT COMPLETED|Overall Study||58
2597038|NCT00262119|6375327|P2|NOT COMPLETED|Overall Study||70
2597039|NCT00262119|6375328|P1|NOT COMPLETED|Overall Study||58
2597040|NCT00262119|6375326|P3|COMPLETED|Overall Study||325
2597041|NCT00262119|6375327|P2|COMPLETED|Overall Study||328
2597042|NCT00262119|6375328|P1|COMPLETED|Overall Study||327
2597043|NCT00262119|6375326|P3|STARTED|Overall Study||383
2597044|NCT00262119|6375327|P2|STARTED|Overall Study||398
2597045|NCT00262119|6375328|P1|STARTED|Overall Study||385
2597046|NCT00262080|6375348|P3|NOT COMPLETED|Repeat Dose Treatment Period||5
2597047|NCT00262080|6375349|P2|NOT COMPLETED|Repeat Dose Treatment Period||1
2597048|NCT00262080|6375350|P1|NOT COMPLETED|Repeat Dose Treatment Period||4
2597049|NCT00262080|6375348|P3|COMPLETED|Repeat Dose Treatment Period||14
2597050|NCT00262080|6375349|P2|COMPLETED|Repeat Dose Treatment Period||25
2597051|NCT00262080|6375350|P1|COMPLETED|Repeat Dose Treatment Period|Some patients participated in only the double-blind or the open label phase.|18
2597052|NCT00262080|6375348|P3|STARTED|Repeat Dose Treatment Period|This arm represents new patients, not treated in the double-blind part of the study.|19
2597053|NCT00262080|6375349|P2|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|26
2597054|NCT00262080|6375350|P1|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|22
2597055|NCT00262080|6375348|P3|NOT COMPLETED|Double Blind Treatment Period||0
2597056|NCT00262080|6375349|P2|NOT COMPLETED|Double Blind Treatment Period||0
2597057|NCT00262080|6375350|P1|NOT COMPLETED|Double Blind Treatment Period||1
2597058|NCT00262080|6375348|P3|COMPLETED|Double Blind Treatment Period||0
2597059|NCT00262080|6375349|P2|COMPLETED|Double Blind Treatment Period||36
2597060|NCT00262080|6375350|P1|COMPLETED|Double Blind Treatment Period||35
2597061|NCT00262080|6375348|P3|STARTED|Double Blind Treatment Period||0
2597062|NCT00262080|6375349|P2|STARTED|Double Blind Treatment Period|One patient was randomized to receive placebo but was treated with ecallantide.|36
2597063|NCT00262080|6375350|P1|STARTED|Double Blind Treatment Period|One patient was randomized to receive ecallantide but was treated with placebo.|36
2597064|NCT00262067|6375370|P4|NOT COMPLETED|Overall Study||113
2597065|NCT00262067|6375371|P3|NOT COMPLETED|Overall Study||216
2597066|NCT00262067|6375372|P2|NOT COMPLETED|Overall Study||100
2597067|NCT00262067|6375373|P1|NOT COMPLETED|Overall Study||219
2597068|NCT00262067|6375370|P4|COMPLETED|Overall Study||93
2597069|NCT00262067|6375371|P3|COMPLETED|Overall Study||193
2597070|NCT00262067|6375372|P2|COMPLETED|Overall Study||107
2597071|NCT00262067|6375373|P1|COMPLETED|Overall Study||196
2597072|NCT00262067|6375370|P4|STARTED|Overall Study||206
2597073|NCT00262067|6375371|P3|STARTED|Overall Study||409
2597074|NCT00262067|6375372|P2|STARTED|Overall Study||207
2597075|NCT00262067|6375373|P1|STARTED|Overall Study||415
2597076|NCT00262041|6375407|P3|NOT COMPLETED|Overall Study||6
2597077|NCT00262041|6375408|P2|NOT COMPLETED|Overall Study||4
2597078|NCT00262041|6375409|P1|NOT COMPLETED|Overall Study||2
2597079|NCT00262041|6375407|P3|COMPLETED|Overall Study||203
2597080|NCT00262041|6375408|P2|COMPLETED|Overall Study||147
2597081|NCT00262041|6375409|P1|COMPLETED|Overall Study||162
2597082|NCT00262041|6375407|P3|STARTED|Overall Study||209
2597083|NCT00262041|6375408|P2|STARTED|Overall Study||151
2597084|NCT00262041|6375409|P1|STARTED|Overall Study||164
2597085|NCT00262028|6375438|P9|NOT COMPLETED|Overall Study||19
2597086|NCT00262028|6375439|P8|NOT COMPLETED|Overall Study||18
2597087|NCT00262028|6375440|P7|NOT COMPLETED|Overall Study||12
2597088|NCT00262028|6375441|P6|NOT COMPLETED|Overall Study||13
2597089|NCT00262028|6375442|P5|NOT COMPLETED|Overall Study||12
2597090|NCT00262028|6375443|P4|NOT COMPLETED|Overall Study||23
2597091|NCT00262028|6375444|P3|NOT COMPLETED|Overall Study||20
2597092|NCT00262028|6375445|P2|NOT COMPLETED|Overall Study||27
2597093|NCT00262028|6375446|P1|NOT COMPLETED|Overall Study||24
2597094|NCT00262028|6375438|P9|COMPLETED|Overall Study||81
2597095|NCT00262028|6375439|P8|COMPLETED|Overall Study||55
2597096|NCT00262028|6375440|P7|COMPLETED|Overall Study||59
2597097|NCT00262028|6375441|P6|COMPLETED|Overall Study||60
2597098|NCT00262028|6375442|P5|COMPLETED|Overall Study||62
2597099|NCT00262028|6375443|P4|COMPLETED|Overall Study||134
2597100|NCT00262028|6375444|P3|COMPLETED|Overall Study||137
2597101|NCT00262028|6375445|P2|COMPLETED|Overall Study||126
2597102|NCT00262028|6375446|P1|COMPLETED|Overall Study||128
2597103|NCT00262028|6375438|P9|STARTED|Overall Study||100
2597104|NCT00262028|6375439|P8|STARTED|Overall Study||73
2597105|NCT00262028|6375440|P7|STARTED|Overall Study||71
2597106|NCT00262028|6375441|P6|STARTED|Overall Study||73
2597107|NCT00262028|6375442|P5|STARTED|Overall Study||74
2597108|NCT00262028|6375443|P4|STARTED|Overall Study||157
2597109|NCT00262028|6375444|P3|STARTED|Overall Study||157
2597110|NCT00262028|6375445|P2|STARTED|Overall Study||153
2597111|NCT00262028|6375446|P1|STARTED|Overall Study||152
2597112|NCT00262002|6375508|P7|NOT COMPLETED|Overall Study||6
2597113|NCT00262002|6375509|P6|NOT COMPLETED|Overall Study||7
2597114|NCT00262002|6375510|P5|NOT COMPLETED|Overall Study||7
2597115|NCT00262002|6375511|P4|NOT COMPLETED|Overall Study||5
2597116|NCT00262002|6375512|P3|NOT COMPLETED|Overall Study||0
2597117|NCT00262002|6375513|P2|NOT COMPLETED|Overall Study||6
2597118|NCT00262002|6375514|P1|NOT COMPLETED|Overall Study||11
2597119|NCT00262002|6375508|P7|COMPLETED|Overall Study||84
2597120|NCT00262002|6375509|P6|COMPLETED|Overall Study||83
2597121|NCT00262002|6375510|P5|COMPLETED|Overall Study||91
2597122|NCT00262002|6375511|P4|COMPLETED|Overall Study||93
2597123|NCT00262002|6375512|P3|COMPLETED|Overall Study||45
2597124|NCT00262002|6375513|P2|COMPLETED|Overall Study||84
2597125|NCT00262002|6375514|P1|COMPLETED|Overall Study||79
2597126|NCT00262002|6375508|P7|STARTED|Overall Study||90
2597127|NCT00262002|6375509|P6|STARTED|Overall Study||90
2597128|NCT00262002|6375510|P5|STARTED|Overall Study||98
2597129|NCT00262002|6375511|P4|STARTED|Overall Study||98
2597130|NCT00262002|6375512|P3|STARTED|Overall Study||45
2597131|NCT00262002|6375513|P2|STARTED|Overall Study||90
2597132|NCT00262002|6375514|P1|STARTED|Overall Study||90
2597133|NCT00261950|6375607|P1|NOT COMPLETED|Overall Study||26
2597134|NCT00261950|6375607|P1|COMPLETED|Overall Study||84
2597135|NCT00261950|6375607|P1|STARTED|Overall Study||110
2597136|NCT00261846|6375632|P12|NOT COMPLETED|Period 2: Part 2 (Efficacy)||23
2597137|NCT00261846|6375633|P11|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
2597138|NCT00261846|6375634|P10|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
2597139|NCT00261846|6375635|P9|NOT COMPLETED|Period 2: Part 2 (Efficacy)||14
2597140|NCT00261846|6375636|P8|NOT COMPLETED|Period 2: Part 2 (Efficacy)||29
2597141|NCT00261846|6375637|P7|NOT COMPLETED|Period 2: Part 2 (Efficacy)||22
2597142|NCT00261846|6375638|P6|NOT COMPLETED|Period 2: Part 2 (Efficacy)||2
2597143|NCT00261846|6375639|P5|NOT COMPLETED|Period 2: Part 2 (Efficacy)||50
2597144|NCT00261846|6375640|P4|NOT COMPLETED|Period 2: Part 2 (Efficacy)||135
2597145|NCT00261846|6375641|P3|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
2597146|NCT00261846|6375642|P2|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
2597147|NCT00261846|6375643|P1|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
2597148|NCT00261846|6375632|P12|COMPLETED|Period 2: Part 2 (Efficacy)||1
2597149|NCT00261846|6375633|P11|COMPLETED|Period 2: Part 2 (Efficacy)||15
2597150|NCT00261846|6375634|P10|COMPLETED|Period 2: Part 2 (Efficacy)||30
2597151|NCT00261846|6375635|P9|COMPLETED|Period 2: Part 2 (Efficacy)||12
2597152|NCT00261846|6375636|P8|COMPLETED|Period 2: Part 2 (Efficacy)||21
2597153|NCT00261846|6375637|P7|COMPLETED|Period 2: Part 2 (Efficacy)||16
2597154|NCT00261846|6375638|P6|COMPLETED|Period 2: Part 2 (Efficacy)||3
2597155|NCT00261846|6375639|P5|COMPLETED|Period 2: Part 2 (Efficacy)||39
2597156|NCT00261846|6375640|P4|COMPLETED|Period 2: Part 2 (Efficacy)||60
2597157|NCT00261846|6375641|P3|COMPLETED|Period 2: Part 2 (Efficacy)||0
2597158|NCT00261846|6375642|P2|COMPLETED|Period 2: Part 2 (Efficacy)||0
2597159|NCT00261846|6375643|P1|COMPLETED|Period 2: Part 2 (Efficacy)||0
2597160|NCT00261846|6375632|P12|STARTED|Period 2: Part 2 (Efficacy)||24
2597161|NCT00261846|6375633|P11|STARTED|Period 2: Part 2 (Efficacy)||64
2597162|NCT00261846|6375634|P10|STARTED|Period 2: Part 2 (Efficacy)|1 participant from Part 1 (Bosutinib 600mg cohort) continued in Part 2 of the study.|79
2597163|NCT00261846|6375635|P9|STARTED|Period 2: Part 2 (Efficacy)||26
2597164|NCT00261846|6375636|P8|STARTED|Period 2: Part 2 (Efficacy)||50
2597165|NCT00261846|6375637|P7|STARTED|Period 2: Part 2 (Efficacy)||38
2597166|NCT00261846|6375638|P6|STARTED|Period 2: Part 2 (Efficacy)||5
2597167|NCT00261846|6375639|P5|STARTED|Period 2: Part 2 (Efficacy)||89
2597168|NCT00261846|6375640|P4|STARTED|Period 2: Part 2 (Efficacy)|17 participants from Part 1 (Bosutinib 400mg, 500mg, 600mg cohort) continued in Part 2 of the study.|195
2597169|NCT00261846|6375641|P3|STARTED|Period 2: Part 2 (Efficacy)||0
2597170|NCT00261846|6375642|P2|STARTED|Period 2: Part 2 (Efficacy)||0
2597171|NCT00261846|6375643|P1|STARTED|Period 2: Part 2 (Efficacy)||0
2597172|NCT00261846|6375632|P12|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2597173|NCT00261846|6375633|P11|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2597174|NCT00261846|6375634|P10|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2597175|NCT00261846|6375635|P9|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2597176|NCT00261846|6375636|P8|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2597177|NCT00261846|6375637|P7|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2597178|NCT00261846|6375638|P6|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2597179|NCT00261846|6375639|P5|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2597180|NCT00261846|6375640|P4|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2597181|NCT00261846|6375641|P3|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||12
2597182|NCT00261846|6375642|P2|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
2597183|NCT00261846|6375643|P1|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
2597184|NCT00261846|6375632|P12|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2597185|NCT00261846|6375633|P11|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2597186|NCT00261846|6375634|P10|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2597187|NCT00261846|6375635|P9|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2597188|NCT00261846|6375636|P8|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2597189|NCT00261846|6375637|P7|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2597190|NCT00261846|6375638|P6|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2597191|NCT00261846|6375639|P5|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2597192|NCT00261846|6375640|P4|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2597193|NCT00261846|6375641|P3|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2597194|NCT00261846|6375642|P2|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2597195|NCT00261846|6375643|P1|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
2597196|NCT00261846|6375632|P12|STARTED|Period 1: Part 1 (Dose Escalation)||0
2597197|NCT00261846|6375633|P11|STARTED|Period 1: Part 1 (Dose Escalation)||0
2597198|NCT00261846|6375634|P10|STARTED|Period 1: Part 1 (Dose Escalation)||0
2597199|NCT00261846|6375635|P9|STARTED|Period 1: Part 1 (Dose Escalation)||0
2597200|NCT00261846|6375636|P8|STARTED|Period 1: Part 1 (Dose Escalation)||0
2597201|NCT00261846|6375637|P7|STARTED|Period 1: Part 1 (Dose Escalation)||0
2597202|NCT00261846|6375638|P6|STARTED|Period 1: Part 1 (Dose Escalation)||0
2597203|NCT00261846|6375639|P5|STARTED|Period 1: Part 1 (Dose Escalation)||0
2597204|NCT00261846|6375640|P4|STARTED|Period 1: Part 1 (Dose Escalation)||0
2597205|NCT00261846|6375641|P3|STARTED|Period 1: Part 1 (Dose Escalation)||12
2597206|NCT00261846|6375642|P2|STARTED|Period 1: Part 1 (Dose Escalation)||3
2597207|NCT00261846|6375643|P1|STARTED|Period 1: Part 1 (Dose Escalation)||3
2597208|NCT00261833|6375902|P2|NOT COMPLETED|Overall Study||18
2597209|NCT00261833|6375903|P1|NOT COMPLETED|Overall Study||9
2597210|NCT00261833|6375902|P2|COMPLETED|Overall Study||69
2597211|NCT00261833|6375903|P1|COMPLETED|Overall Study||84
2597212|NCT00261833|6375902|P2|STARTED|Overall Study||87
2597213|NCT00261833|6375903|P1|STARTED|Overall Study||93
2597214|NCT00261716|6375937|P2|NOT COMPLETED|Overall Study||10
2597215|NCT00261716|6375938|P1|NOT COMPLETED|Overall Study||6
2597216|NCT00261716|6375937|P2|COMPLETED|Overall Study||11
2597217|NCT00261716|6375938|P1|COMPLETED|Overall Study||11
2597218|NCT00261716|6375937|P2|STARTED|Overall Study||21
2597219|NCT00261716|6375938|P1|STARTED|Overall Study||17
2597220|NCT00261495|6375958|P2|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
2597221|NCT00261495|6375959|P1|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||10
2597222|NCT00261495|6375958|P2|COMPLETED|Extension Phase (Weeks 24 to 52)||47
2597223|NCT00261495|6375959|P1|COMPLETED|Extension Phase (Weeks 24 to 52)||50
2597224|NCT00261495|6375958|P2|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (85 subjects).|52
2597225|NCT00261495|6375959|P1|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (80 subjects).|60
2597226|NCT00261495|6375958|P2|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||48
2597227|NCT00261495|6375959|P1|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||66
2597228|NCT00261495|6375958|P2|COMPLETED|Maintenance Phase (Weeks 4 to 24)||137
2597229|NCT00261495|6375959|P1|COMPLETED|Maintenance Phase (Weeks 4 to 24)||140
2597230|NCT00261495|6375958|P2|STARTED|Maintenance Phase (Weeks 4 to 24)||185
2597231|NCT00261495|6375959|P1|STARTED|Maintenance Phase (Weeks 4 to 24)||206
2597232|NCT00261495|6375958|P2|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||65
2597233|NCT00261495|6375959|P1|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||48
2597234|NCT00261495|6375958|P2|COMPLETED|Titration Phase (Weeks 0 to 4)||185
2597235|NCT00261495|6375959|P1|COMPLETED|Titration Phase (Weeks 0 to 4)||206
2597236|NCT00261495|6375958|P2|STARTED|Titration Phase (Weeks 0 to 4)||250
2597237|NCT00261495|6375959|P1|STARTED|Titration Phase (Weeks 0 to 4)||254
2597238|NCT00261443|6376123|P3|NOT COMPLETED|4: Extension Phase||2
2597239|NCT00261443|6376124|P2|NOT COMPLETED|4: Extension Phase||3
2597240|NCT00261443|6376125|P1|NOT COMPLETED|4: Extension Phase||0
2597241|NCT00261443|6376123|P3|COMPLETED|4: Extension Phase||21
2597242|NCT00261443|6376124|P2|COMPLETED|4: Extension Phase||16
2597243|NCT00261443|6376125|P1|COMPLETED|4: Extension Phase||0
2597244|NCT00261443|6376123|P3|STARTED|4: Extension Phase||23
2597245|NCT00261443|6376124|P2|STARTED|4: Extension Phase||19
2597246|NCT00261443|6376125|P1|STARTED|4: Extension Phase||0
2597247|NCT00261443|6376123|P3|NOT COMPLETED|3: Assessment of Relapse||65
2597248|NCT00261443|6376124|P2|NOT COMPLETED|3: Assessment of Relapse||80
2597249|NCT00261443|6376125|P1|NOT COMPLETED|3: Assessment of Relapse||0
2597250|NCT00261443|6376123|P3|COMPLETED|3: Assessment of Relapse||103
2597251|NCT00261443|6376124|P2|COMPLETED|3: Assessment of Relapse||89
2597252|NCT00261443|6376125|P1|COMPLETED|3: Assessment of Relapse||0
2597253|NCT00261443|6376123|P3|STARTED|3: Assessment of Relapse||168
2597254|NCT00261443|6376124|P2|STARTED|3: Assessment of Relapse||169
2597255|NCT00261443|6376125|P1|STARTED|3: Assessment of Relapse||0
2597256|NCT00261443|6376123|P3|NOT COMPLETED|2: Stability & Maintenance of Stability||0
2597257|NCT00261443|6376124|P2|NOT COMPLETED|2: Stability & Maintenance of Stability||0
2597258|NCT00261443|6376125|P1|NOT COMPLETED|2: Stability & Maintenance of Stability||340
2597259|NCT00261443|6376123|P3|COMPLETED|2: Stability & Maintenance of Stability||0
2597260|NCT00261443|6376124|P2|COMPLETED|2: Stability & Maintenance of Stability||0
2597261|NCT00261443|6376125|P1|COMPLETED|2: Stability & Maintenance of Stability||346
2597262|NCT00261443|6376123|P3|STARTED|2: Stability & Maintenance of Stability||0
2597263|NCT00261443|6376124|P2|STARTED|2: Stability & Maintenance of Stability||0
2597264|NCT00261443|6376125|P1|STARTED|2: Stability & Maintenance of Stability||686
2597265|NCT00261443|6376123|P3|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
2597266|NCT00261443|6376124|P2|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
2597267|NCT00261443|6376125|P1|NOT COMPLETED|1: Confirmation of Partial Nonresponse||584
2597268|NCT00261443|6376123|P3|COMPLETED|1: Confirmation of Partial Nonresponse||0
2597269|NCT00261443|6376124|P2|COMPLETED|1: Confirmation of Partial Nonresponse||0
2597270|NCT00261443|6376125|P1|COMPLETED|1: Confirmation of Partial Nonresponse||686
2597271|NCT00261443|6376123|P3|STARTED|1: Confirmation of Partial Nonresponse||0
2597272|NCT00261443|6376124|P2|STARTED|1: Confirmation of Partial Nonresponse||0
2597273|NCT00261443|6376125|P1|STARTED|1: Confirmation of Partial Nonresponse||1270
2597274|NCT00260962|6376382|P2|NOT COMPLETED|Overall Study||2
2597275|NCT00260962|6376383|P1|NOT COMPLETED|Overall Study||4
2597276|NCT00260962|6376382|P2|COMPLETED|Overall Study||14
2597277|NCT00260962|6376383|P1|COMPLETED|Overall Study||14
2597278|NCT00260962|6376382|P2|STARTED|Overall Study||16
2597279|NCT00260962|6376383|P1|STARTED|Overall Study||18
2597280|NCT00260832|6376393|P2|NOT COMPLETED|Overall Study||211
2597281|NCT00260832|6376394|P1|NOT COMPLETED|Overall Study||228
2597282|NCT00260832|6376393|P2|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|31
2597283|NCT00260832|6376394|P1|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|15
2597284|NCT00260832|6376393|P2|STARTED|Overall Study||242
2597285|NCT00260832|6376394|P1|STARTED|Overall Study||243
2597286|NCT00260689|6376405|P3|NOT COMPLETED|Overall Study||15
2597287|NCT00260689|6376406|P2|NOT COMPLETED|Overall Study||49
2597288|NCT00260689|6376407|P1|NOT COMPLETED|Overall Study||41
2597289|NCT00260689|6376405|P3|COMPLETED|Overall Study||1
2597290|NCT00260689|6376406|P2|COMPLETED|Overall Study||11
2597291|NCT00260689|6376407|P1|COMPLETED|Overall Study||19
2597292|NCT00260689|6376405|P3|STARTED|Overall Study||16
2597293|NCT00260689|6376406|P2|STARTED|Overall Study||60
2597294|NCT00260689|6376407|P1|STARTED|Overall Study||60
2597295|NCT00260533|6376423|P2|NOT COMPLETED|Overall Study||3
2597296|NCT00260533|6376424|P1|NOT COMPLETED|Overall Study||3
2597297|NCT00260533|6376423|P2|COMPLETED|Overall Study||10
2597298|NCT00260533|6376424|P1|COMPLETED|Overall Study||11
2597299|NCT00260533|6376423|P2|STARTED|Overall Study||13
2597300|NCT00260533|6376424|P1|STARTED|Overall Study||14
2597301|NCT00260429|6376432|P2|NOT COMPLETED|Overall Study||0
2597302|NCT00260429|6376433|P1|NOT COMPLETED|Overall Study||2
2597303|NCT00260429|6376432|P2|COMPLETED|Overall Study||12
2597304|NCT00260429|6376433|P1|COMPLETED|Overall Study||21
2597305|NCT00260429|6376432|P2|STARTED|Overall Study||12
2597306|NCT00260429|6376433|P1|STARTED|Overall Study||23
2597307|NCT00260208|6376441|P2|NOT COMPLETED|Overall Study||34
2597308|NCT00260208|6376442|P1|NOT COMPLETED|Overall Study||47
2597309|NCT00260208|6376441|P2|COMPLETED|Overall Study||138
2597310|NCT00260208|6376442|P1|COMPLETED|Overall Study||137
2597311|NCT00260208|6376441|P2|Modified ITT|Overall Study||96
2597312|NCT00260208|6376442|P1|Modified ITT|Overall Study||101
2597313|NCT00260208|6376441|P2|Intent to Treat (ITT) Population|Overall Study||169
2597314|NCT00260208|6376442|P1|Intent to Treat (ITT) Population|Overall Study||182
2597315|NCT00260208|6376441|P2|STARTED|Overall Study||172
2597316|NCT00260208|6376442|P1|STARTED|Overall Study|"Started indicates safety population."|184
2597317|NCT00260195|6376472|P2|NOT COMPLETED|Overall Study||0
2597318|NCT00260195|6376473|P1|NOT COMPLETED|Overall Study||0
2597319|NCT00260195|6376472|P2|COMPLETED|Overall Study||37
2597320|NCT00260195|6376473|P1|COMPLETED|Overall Study||39
2597321|NCT00260195|6376472|P2|STARTED|Overall Study||37
2597322|NCT00260195|6376473|P1|STARTED|Overall Study||39
2597323|NCT00260065|6376485|P1|NOT COMPLETED|Overall Study||93
2597324|NCT00260065|6376485|P1|COMPLETED|Overall Study||6
2597325|NCT00260065|6376485|P1|STARTED|Overall Study||99
2597326|NCT00259857|6376492|P2|NOT COMPLETED|24 Months Treatment||3
2597327|NCT00259857|6376493|P1|NOT COMPLETED|24 Months Treatment||0
2597328|NCT00259857|6376492|P2|COMPLETED|24 Months Treatment||6
2597329|NCT00259857|6376493|P1|COMPLETED|24 Months Treatment||10
2597330|NCT00259857|6376492|P2|STARTED|24 Months Treatment||9
2597331|NCT00259857|6376493|P1|STARTED|24 Months Treatment||10
2597332|NCT00259857|6376492|P2|NOT COMPLETED|12 Months Treatment||2
2597333|NCT00259857|6376493|P1|NOT COMPLETED|12 Months Treatment||1
2597334|NCT00259857|6376492|P2|COMPLETED|12 Months Treatment||9
2597335|NCT00259857|6376493|P1|COMPLETED|12 Months Treatment||10
2597336|NCT00259857|6376492|P2|STARTED|12 Months Treatment||11
2597337|NCT00259857|6376493|P1|STARTED|12 Months Treatment||11
2597338|NCT00259740|6376511|P2|NOT COMPLETED|Overall Study||53
2597339|NCT00259740|6376512|P1|NOT COMPLETED|Overall Study||43
2597340|NCT00259740|6376511|P2|COMPLETED|Overall Study||0
2597341|NCT00259740|6376512|P1|COMPLETED|Overall Study||0
2597342|NCT00259740|6376511|P2|Received Study Medication|Overall Study||53
2597343|NCT00259740|6376512|P1|Received Study Medication|Overall Study||42
2597344|NCT00259740|6376511|P2|STARTED|Overall Study||53
2597345|NCT00259740|6376512|P1|STARTED|Overall Study||43
2597346|NCT00259649|6376522|P1|NOT COMPLETED|Overall Study||10
2597347|NCT00259649|6376522|P1|COMPLETED|Overall Study||61
2597348|NCT00259649|6376522|P1|STARTED|Overall Study||71
2597349|NCT00259610|6376530|P4|NOT COMPLETED|Overall Study||43
2597350|NCT00259610|6376531|P3|NOT COMPLETED|Overall Study||73
2597351|NCT00259610|6376532|P2|NOT COMPLETED|Overall Study||46
2597352|NCT00259610|6376533|P1|NOT COMPLETED|Overall Study||76
2597353|NCT00259610|6376530|P4|COMPLETED|Overall Study||81
2597354|NCT00259610|6376531|P3|COMPLETED|Overall Study||182
2597355|NCT00259610|6376532|P2|COMPLETED|Overall Study||86
2597356|NCT00259610|6376533|P1|COMPLETED|Overall Study||168
2597357|NCT00259610|6376530|P4|STARTED|Overall Study||124
2597358|NCT00259610|6376531|P3|STARTED|Overall Study||255
2597359|NCT00259610|6376532|P2|STARTED|Overall Study||132
2597360|NCT00259610|6376533|P1|STARTED|Overall Study||244
2597361|NCT00259298|6376547|P1|NOT COMPLETED|Overall Study||3
2597362|NCT00259298|6376547|P1|COMPLETED|Overall Study||9
2597363|NCT00259298|6376547|P1|Received at Least 1 Dose of Study Drug|Overall Study||10
2597364|NCT00259298|6376547|P1|STARTED|Overall Study||12
2597365|NCT00259285|6376555|P1|NOT COMPLETED|Overall Study||0
2597366|NCT00259285|6376555|P1|COMPLETED|Overall Study||10
2597367|NCT00259285|6376555|P1|STARTED|Overall Study||10
2597368|NCT00259272|6376565|P4|NOT COMPLETED|Overall Study||21
2597369|NCT00259272|6376566|P3|NOT COMPLETED|Overall Study||5
2597370|NCT00259272|6376567|P2|NOT COMPLETED|Overall Study||7
2597371|NCT00259272|6376568|P1|NOT COMPLETED|Overall Study||15
2597372|NCT00259272|6376565|P4|COMPLETED|Overall Study||27
2597373|NCT00259272|6376566|P3|COMPLETED|Overall Study||21
2597374|NCT00259272|6376567|P2|COMPLETED|Overall Study||24
2597375|NCT00259272|6376568|P1|COMPLETED|Overall Study||21
2597376|NCT00259272|6376565|P4|STARTED|Overall Study||48
2597377|NCT00259272|6376566|P3|STARTED|Overall Study||26
2597378|NCT00259272|6376567|P2|STARTED|Overall Study||31
2597379|NCT00259272|6376568|P1|STARTED|Overall Study||36
2597380|NCT00259090|6376646|P3|NOT COMPLETED|Overall Study||0
2597381|NCT00259090|6376647|P2|NOT COMPLETED|Overall Study||0
2597382|NCT00259090|6376648|P1|NOT COMPLETED|Overall Study||0
2597383|NCT00259090|6376646|P3|COMPLETED|Overall Study||37
2597384|NCT00259090|6376647|P2|COMPLETED|Overall Study||31
2597385|NCT00259090|6376648|P1|COMPLETED|Overall Study||35
2597386|NCT00259090|6376646|P3|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|37
2597387|NCT00259090|6376647|P2|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|31
2597388|NCT00259090|6376648|P1|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|35
2597389|NCT00259012|6376664|P2|NOT COMPLETED|Overall Study||4
2597390|NCT00259012|6376665|P1|NOT COMPLETED|Overall Study||2
2597391|NCT00259012|6376664|P2|COMPLETED|Overall Study||30
2597392|NCT00259012|6376665|P1|COMPLETED|Overall Study||31
2597393|NCT00259012|6376664|P2|STARTED|Overall Study||34
2597394|NCT00259012|6376665|P1|STARTED|Overall Study||33
2597395|NCT00258960|6376697|P1|NOT COMPLETED|Overall Study||17
2597396|NCT00258960|6376697|P1|COMPLETED|Overall Study||32
2597397|NCT00258960|6376697|P1|STARTED|Overall Study|49 patients included but 1 is not considered due to not receive any treatment and died before start|49
2597398|NCT00258908|6376705|P1|NOT COMPLETED|Overall Study||0
2597399|NCT00258908|6376705|P1|COMPLETED|Overall Study||112
2597400|NCT00258908|6376705|P1|STARTED|Overall Study|3 participants were not vaccinated and were not included in the final analysis and in this report.|112
2597401|NCT00258895|6376713|P2|NOT COMPLETED|Overall Study||3
2597402|NCT00258895|6376714|P1|NOT COMPLETED|Overall Study||10
2597403|NCT00258895|6376713|P2|COMPLETED|Overall Study||159
2597404|NCT00258895|6376714|P1|COMPLETED|Overall Study||477
2597405|NCT00258895|6376713|P2|STARTED|Overall Study||162
2597406|NCT00258895|6376714|P1|STARTED|Overall Study||487
2597407|NCT00258882|6376730|P2|NOT COMPLETED|Pregnancy Surveillance||0
2597408|NCT00258882|6376731|P1|NOT COMPLETED|Pregnancy Surveillance||0
2597409|NCT00258882|6376730|P2|COMPLETED|Pregnancy Surveillance||675
2597410|NCT00258882|6376731|P1|COMPLETED|Pregnancy Surveillance||225
2597411|NCT00258882|6376730|P2|STARTED|Pregnancy Surveillance|Non-vaccinated age-matched subjects with first positive pregnancy test in the same month (± 1 month)|675
2597412|NCT00258882|6376731|P1|STARTED|Pregnancy Surveillance|Adacel recipients who were pregnant at the time of vaccination or within 28 days thereafter.|225
2597413|NCT00258882|6376730|P2|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
2597414|NCT00258882|6376731|P1|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
2597415|NCT00258882|6376730|P2|COMPLETED|Adacel Recipients-Risk Interval Method||0
2597416|NCT00258882|6376731|P1|COMPLETED|Adacel Recipients-Risk Interval Method||124139
2597417|NCT00258882|6376730|P2|STARTED|Adacel Recipients-Risk Interval Method|Study participants served as their own controls for this analysis|0
2597418|NCT00258882|6376731|P1|STARTED|Adacel Recipients-Risk Interval Method||124139
2597419|NCT00258882|6376730|P2|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
2597420|NCT00258882|6376731|P1|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
2597421|NCT00258882|6376730|P2|COMPLETED|Adacel Recipients Historic Cohort Method||203154
2597422|NCT00258882|6376731|P1|COMPLETED|Adacel Recipients Historic Cohort Method||124139
2597423|NCT00258882|6376730|P2|STARTED|Adacel Recipients Historic Cohort Method||203154
2597424|NCT00258882|6376731|P1|STARTED|Adacel Recipients Historic Cohort Method||124139
2597425|NCT00258856|6376750|P4|NOT COMPLETED|Overall Study||1
2597426|NCT00258856|6376751|P3|NOT COMPLETED|Overall Study||2
2597427|NCT00258856|6376752|P2|NOT COMPLETED|Overall Study||0
2597428|NCT00258856|6376753|P1|NOT COMPLETED|Overall Study||3
2597429|NCT00258856|6376750|P4|COMPLETED|Overall Study||58
2597430|NCT00258856|6376751|P3|COMPLETED|Overall Study||56
2597431|NCT00258856|6376752|P2|COMPLETED|Overall Study||58
2597432|NCT00258856|6376753|P1|COMPLETED|Overall Study||56
2597433|NCT00258856|6376750|P4|STARTED|Overall Study||59
2597434|NCT00258856|6376751|P3|STARTED|Overall Study||58
2597435|NCT00258856|6376752|P2|STARTED|Overall Study||58
2597436|NCT00258856|6376753|P1|STARTED|Overall Study||59
2597437|NCT00258830|6376765|P2|NOT COMPLETED|Overall Study||0
2597438|NCT00258830|6376766|P1|NOT COMPLETED|Overall Study||0
2597439|NCT00258830|6376765|P2|COMPLETED|Overall Study||60
2597440|NCT00258830|6376766|P1|COMPLETED|Overall Study||60
2597441|NCT00258830|6376765|P2|STARTED|Overall Study||60
2597442|NCT00258830|6376766|P1|STARTED|Overall Study||60
2597443|NCT00258817|6376780|P2|NOT COMPLETED|Overall Study||0
2597444|NCT00258817|6376781|P1|NOT COMPLETED|Overall Study||0
2597445|NCT00258817|6376780|P2|COMPLETED|Overall Study||15
2597446|NCT00258817|6376781|P1|COMPLETED|Overall Study||15
2597447|NCT00258817|6376780|P2|STARTED|Overall Study||15
2597448|NCT00258817|6376781|P1|STARTED|Overall Study||15
2597449|NCT00258674|6376794|P3|NOT COMPLETED|Overall Study||34
2597450|NCT00258674|6376795|P2|NOT COMPLETED|Overall Study||53
2597451|NCT00258674|6376796|P1|NOT COMPLETED|Overall Study||32
2597452|NCT00258674|6376794|P3|COMPLETED|Overall Study||568
2597453|NCT00258674|6376795|P2|COMPLETED|Overall Study||758
2597454|NCT00258674|6376796|P1|COMPLETED|Overall Study||565
2597455|NCT00258674|6376794|P3|STARTED|Overall Study||602
2597456|NCT00258674|6376795|P2|STARTED|Overall Study||811
2597457|NCT00258674|6376796|P1|STARTED|Overall Study||597
2597458|NCT00258440|6376855|P3|NOT COMPLETED|Overall Study||1
2597459|NCT00258440|6376856|P2|NOT COMPLETED|Overall Study||0
2597460|NCT00258440|6376857|P1|NOT COMPLETED|Overall Study||0
2597461|NCT00258440|6376855|P3|COMPLETED|Overall Study||5
2597462|NCT00258440|6376856|P2|COMPLETED|Overall Study||0
2597463|NCT00258440|6376857|P1|COMPLETED|Overall Study||1
2597464|NCT00258440|6376855|P3|STARTED|Overall Study||6
2597465|NCT00258440|6376856|P2|STARTED|Overall Study||0
2597466|NCT00258440|6376857|P1|STARTED|Overall Study||1
2597467|NCT00258362|6376868|P1|NOT COMPLETED|Overall Study||0
2597468|NCT00258362|6376868|P1|COMPLETED|Overall Study||41
2597469|NCT00258362|6376868|P1|STARTED|Overall Study||41
2597470|NCT00258349|6376873|P1|NOT COMPLETED|Overall Study||0
2597471|NCT00258349|6376873|P1|COMPLETED|Overall Study||16
2597472|NCT00258349|6376873|P1|HER2-positive by Central Review|Overall Study||10
2597473|NCT00258349|6376873|P1|STARTED|Overall Study||16
2597474|NCT00258310|6376880|P1|NOT COMPLETED|Overall Study||0
2597475|NCT00258310|6376880|P1|COMPLETED|Overall Study||35
2597476|NCT00258310|6376880|P1|STARTED|Overall Study||35
2597477|NCT00258206|6376884|P1|NOT COMPLETED|Overall Study||0
2597478|NCT00258206|6376884|P1|COMPLETED|Overall Study||21
2597479|NCT00258206|6376884|P1|STARTED|Overall Study||21
2597480|NCT00258180|6376888|P1|NOT COMPLETED|Overall Study||0
2597481|NCT00258180|6376888|P1|COMPLETED|Overall Study||2
2597482|NCT00258180|6376888|P1|STARTED|Overall Study||2
2597483|NCT00258154|6376895|P2|NOT COMPLETED|Overall Study||7
2597484|NCT00258154|6376896|P1|NOT COMPLETED|Overall Study||9
2597485|NCT00258154|6376895|P2|COMPLETED|Overall Study|Subjects who completed the study.|195
2597486|NCT00258154|6376896|P1|COMPLETED|Overall Study|Subjects who completed the study.|192
2597487|NCT00258154|6376895|P2|Vaccinated at Visit 3|Overall Study||197
2597488|NCT00258154|6376896|P1|Vaccinated at Visit 3|Overall Study||195
2597489|NCT00258154|6376895|P2|Vaccinated at Visit 2|Overall Study||198
2597490|NCT00258154|6376896|P1|Vaccinated at Visit 2|Overall Study||198
2597491|NCT00258154|6376895|P2|Vaccinated at Visit 1|Overall Study||202
2597492|NCT00258154|6376896|P1|Vaccinated at Visit 1|Overall Study||201
2597493|NCT00258154|6376895|P2|STARTED|Overall Study|Healthy infants who started in the Placebo concomitantly with INFANRIX™ hexa group.|202
2597494|NCT00258154|6376896|P1|STARTED|Overall Study|Healthy infants who started in the RotaTeq™ concomitantly with INFANRIX™ hexa group.|201
2597495|NCT00258128|6376966|P2|NOT COMPLETED|Overall Study||0
2597496|NCT00258128|6376967|P1|NOT COMPLETED|Overall Study||0
2597497|NCT00258128|6376966|P2|COMPLETED|Overall Study||9
2597498|NCT00258128|6376967|P1|COMPLETED|Overall Study||8
2597499|NCT00258128|6376966|P2|STARTED|Overall Study||9
2597500|NCT00258128|6376967|P1|STARTED|Overall Study||8
2597501|NCT00258011|6376975|P1|NOT COMPLETED|Overall Study||0
2597502|NCT00258011|6376975|P1|COMPLETED|Overall Study||3
2597503|NCT00258011|6376975|P1|STARTED|Overall Study||3
2597504|NCT00257933|6376982|P2|NOT COMPLETED|Overall Study||0
2597505|NCT00257933|6376983|P1|NOT COMPLETED|Overall Study||0
2597506|NCT00257933|6376982|P2|COMPLETED|Overall Study||78
2597507|NCT00257933|6376983|P1|COMPLETED|Overall Study||74
2597508|NCT00257933|6376982|P2|STARTED|Overall Study||78
2597509|NCT00257933|6376983|P1|STARTED|Overall Study||74
2597510|NCT00257920|6376991|P2|NOT COMPLETED|Period: Second Intervention||1
2597511|NCT00257920|6376992|P1|NOT COMPLETED|Period: Second Intervention||2
2597512|NCT00257920|6376991|P2|COMPLETED|Period: Second Intervention||18
2597513|NCT00257920|6376992|P1|COMPLETED|Period: Second Intervention||19
2597514|NCT00257920|6376991|P2|STARTED|Period: Second Intervention||19
2597515|NCT00257920|6376992|P1|STARTED|Period: Second Intervention||21
2597516|NCT00257920|6376991|P2|NOT COMPLETED|Period: Washout Period of Two Weeks||1
2597517|NCT00257920|6376992|P1|NOT COMPLETED|Period: Washout Period of Two Weeks||0
2597518|NCT00257920|6376991|P2|COMPLETED|Period: Washout Period of Two Weeks||19
2597519|NCT00257920|6376992|P1|COMPLETED|Period: Washout Period of Two Weeks||21
2597520|NCT00257920|6376991|P2|STARTED|Period: Washout Period of Two Weeks||20
2597521|NCT00257920|6376992|P1|STARTED|Period: Washout Period of Two Weeks||21
2597522|NCT00257920|6376991|P2|NOT COMPLETED|Period: First Intervention||0
2597523|NCT00257920|6376992|P1|NOT COMPLETED|Period: First Intervention||0
2597524|NCT00257920|6376991|P2|COMPLETED|Period: First Intervention||20
2597525|NCT00257920|6376992|P1|COMPLETED|Period: First Intervention||21
2597526|NCT00257920|6376991|P2|STARTED|Period: First Intervention||20
2597527|NCT00257920|6376992|P1|STARTED|Period: First Intervention||21
2597528|NCT00257894|6377002|P2|NOT COMPLETED|Overall Study||5
2597529|NCT00257894|6377003|P1|NOT COMPLETED|Overall Study||4
2597530|NCT00257894|6377002|P2|COMPLETED|Overall Study||15
2597531|NCT00257894|6377003|P1|COMPLETED|Overall Study||17
2597532|NCT00257894|6377002|P2|STARTED|Overall Study||20
2597533|NCT00257894|6377003|P1|STARTED|Overall Study||21
2597534|NCT00257686|6377021|P6|NOT COMPLETED|Overall Study||9
2597535|NCT00257686|6377022|P5|NOT COMPLETED|Overall Study||22
2597536|NCT00257686|6377023|P4|NOT COMPLETED|Overall Study||11
2597537|NCT00257686|6377024|P3|NOT COMPLETED|Overall Study||18
2597538|NCT00257686|6377025|P2|NOT COMPLETED|Overall Study||19
2597539|NCT00257686|6377026|P1|NOT COMPLETED|Overall Study||21
2597540|NCT00257686|6377021|P6|COMPLETED|Overall Study||95
2597541|NCT00257686|6377022|P5|COMPLETED|Overall Study||194
2597542|NCT00257686|6377023|P4|COMPLETED|Overall Study||88
2597543|NCT00257686|6377024|P3|COMPLETED|Overall Study||208
2597544|NCT00257686|6377025|P2|COMPLETED|Overall Study||89
2597545|NCT00257686|6377026|P1|COMPLETED|Overall Study||188
2597546|NCT00257686|6377021|P6|Safety Population|Overall Study|Subjects who received at least one dose of study medication|102
2597547|NCT00257686|6377022|P5|Safety Population|Overall Study|Subjects who received at least one dose of study medication|210
2597548|NCT00257686|6377023|P4|Safety Population|Overall Study|Subjects who received at least one dose of study medication|96
2597549|NCT00257686|6377024|P3|Safety Population|Overall Study|Subjects who received at least one dose of study medication|224
2597550|NCT00257686|6377025|P2|Safety Population|Overall Study|Subjects who received at least one dose of study medication|103
2597551|NCT00257686|6377026|P1|Safety Population|Overall Study|Subjects who received at least one dose of study medication|207
2597552|NCT00257686|6377021|P6|STARTED|Overall Study||104
2597553|NCT00257686|6377022|P5|STARTED|Overall Study||216
2597554|NCT00257686|6377023|P4|STARTED|Overall Study||99
2597555|NCT00257686|6377024|P3|STARTED|Overall Study||226
2597556|NCT00257686|6377025|P2|STARTED|Overall Study||108
2597557|NCT00257686|6377026|P1|STARTED|Overall Study||209
2597558|NCT00257660|6377048|P2|NOT COMPLETED|Overall Study||23
2597559|NCT00257660|6377049|P1|NOT COMPLETED|Overall Study||10
2597560|NCT00257660|6377048|P2|COMPLETED|Overall Study||38
2597561|NCT00257660|6377049|P1|COMPLETED|Overall Study||45
2597562|NCT00257660|6377048|P2|STARTED|Overall Study||61
2597563|NCT00257660|6377049|P1|STARTED|Overall Study||55
2597564|NCT00257608|6377079|P3|NOT COMPLETED|Post Chemotherapy Phase||244
2597565|NCT00257608|6377080|P2|NOT COMPLETED|Post Chemotherapy Phase||264
2597566|NCT00257608|6377081|P1|NOT COMPLETED|Post Chemotherapy Phase||0
2597567|NCT00257608|6377079|P3|COMPLETED|Post Chemotherapy Phase||126
2597568|NCT00257608|6377080|P2|COMPLETED|Post Chemotherapy Phase||109
2597569|NCT00257608|6377081|P1|COMPLETED|Post Chemotherapy Phase||0
2597570|NCT00257608|6377079|P3|STARTED|Post Chemotherapy Phase||370
2597571|NCT00257608|6377080|P2|STARTED|Post Chemotherapy Phase||373
2597572|NCT00257608|6377081|P1|STARTED|Post Chemotherapy Phase||0
2597573|NCT00257608|6377079|P3|NOT COMPLETED|Chemotherapy Phase||0
2597574|NCT00257608|6377080|P2|NOT COMPLETED|Chemotherapy Phase||0
2597575|NCT00257608|6377081|P1|NOT COMPLETED|Chemotherapy Phase||376
2597576|NCT00257608|6377079|P3|COMPLETED|Chemotherapy Phase||0
2597577|NCT00257608|6377080|P2|COMPLETED|Chemotherapy Phase||0
2597578|NCT00257608|6377081|P1|COMPLETED|Chemotherapy Phase||769
2597579|NCT00257608|6377079|P3|STARTED|Chemotherapy Phase||0
2597580|NCT00257608|6377080|P2|STARTED|Chemotherapy Phase||0
2597581|NCT00257608|6377081|P1|STARTED|Chemotherapy Phase||1145
2597582|NCT00257556|6377107|P2|NOT COMPLETED|Overall Study||10
2597583|NCT00257556|6377108|P1|NOT COMPLETED|Overall Study||14
2597584|NCT00257556|6377107|P2|COMPLETED|Overall Study||32
2597585|NCT00257556|6377108|P1|COMPLETED|Overall Study||24
2597586|NCT00257556|6377107|P2|All Patients Treated Population|Overall Study|Also the safety population. Three randomized patients did not receive study medication.|39
2597587|NCT00257556|6377108|P1|All Patients Treated Population|Overall Study|Also the safety population. One randomized patient did not receive study medication.|37
2597588|NCT00257556|6377107|P2|STARTED|Overall Study||42
2597589|NCT00257556|6377108|P1|STARTED|Overall Study||38
2597590|NCT00257322|6377134|P1|NOT COMPLETED|Overall Study||4
2597591|NCT00257322|6377134|P1|COMPLETED|Overall Study|4 subjects withdrew from this study.|16
2597592|NCT00257322|6377134|P1|STARTED|Overall Study|20 subjects accrued.|20
2597593|NCT00257309|6377141|P2|NOT COMPLETED|Overall Study||2
2597594|NCT00257309|6377142|P1|NOT COMPLETED|Overall Study||2
2597595|NCT00257309|6377141|P2|COMPLETED|Overall Study||130
2597596|NCT00257309|6377142|P1|COMPLETED|Overall Study||132
2597597|NCT00257309|6377141|P2|STARTED|Overall Study||132
2597598|NCT00257309|6377142|P1|STARTED|Overall Study||134
2597599|NCT00257192|6377152|P2|NOT COMPLETED|Overall Study||39
2597600|NCT00257192|6377153|P1|NOT COMPLETED|Overall Study||58
2597601|NCT00257192|6377152|P2|COMPLETED|Overall Study||52
2597602|NCT00257192|6377153|P1|COMPLETED|Overall Study||135
2597603|NCT00257192|6377152|P2|Received Study Treatment|Overall Study||90
2597604|NCT00257192|6377153|P1|Received Study Treatment|Overall Study||193
2597605|NCT00257192|6377152|P2|STARTED|Overall Study|Includes 1 subject randomized but not treated|91
2597606|NCT00257192|6377153|P1|STARTED|Overall Study||193
2597607|NCT00257166|6377197|P2|NOT COMPLETED|Overall Study||37
2597608|NCT00257166|6377198|P1|NOT COMPLETED|Overall Study||53
2597609|NCT00257166|6377197|P2|COMPLETED|Overall Study||51
2597610|NCT00257166|6377198|P1|COMPLETED|Overall Study||97
2597611|NCT00257166|6377197|P2|Treated|Overall Study||88
2597612|NCT00257166|6377198|P1|Treated|Overall Study||149
2597613|NCT00257166|6377197|P2|STARTED|Overall Study||88
2597614|NCT00257166|6377198|P1|STARTED|Overall Study||150
2597615|NCT00257010|6377210|P1|NOT COMPLETED|Overall Study||128
2597616|NCT00257010|6377210|P1|COMPLETED|Overall Study||319
2597617|NCT00257010|6377210|P1|STARTED|Overall Study||447
2597618|NCT00256997|6377221|P2|NOT COMPLETED|Overall Study||55
2597619|NCT00256997|6377222|P1|NOT COMPLETED|Overall Study||48
2597620|NCT00256997|6377221|P2|COMPLETED|Overall Study||31
2597621|NCT00256997|6377222|P1|COMPLETED|Overall Study||33
2597622|NCT00256997|6377221|P2|Treated|Overall Study||86
2597623|NCT00256997|6377222|P1|Treated|Overall Study||79
2597624|NCT00256997|6377221|P2|STARTED|Overall Study||86
2597625|NCT00256997|6377222|P1|STARTED|Overall Study||81
2597626|NCT00256984|6377246|P1|NOT COMPLETED|Overall Study||16
2597627|NCT00256984|6377246|P1|COMPLETED|Overall Study||59
2597628|NCT00256984|6377246|P1|STARTED|Overall Study||75
2597629|NCT00256867|6377264|P8|NOT COMPLETED|Overall Study||11
2597630|NCT00256867|6377265|P7|NOT COMPLETED|Overall Study||5
2597631|NCT00256867|6377266|P6|NOT COMPLETED|Overall Study||6
2597632|NCT00256867|6377267|P5|NOT COMPLETED|Overall Study||7
2597633|NCT00256867|6377268|P4|NOT COMPLETED|Overall Study||6
2597634|NCT00256867|6377269|P3|NOT COMPLETED|Overall Study||5
2597635|NCT00256867|6377270|P2|NOT COMPLETED|Overall Study||5
2597636|NCT00256867|6377271|P1|NOT COMPLETED|Overall Study||2
2597637|NCT00256867|6377264|P8|COMPLETED|Overall Study||36
2597638|NCT00256867|6377265|P7|COMPLETED|Overall Study||41
2597639|NCT00256867|6377266|P6|COMPLETED|Overall Study||40
2597640|NCT00256867|6377267|P5|COMPLETED|Overall Study||41
2597641|NCT00256867|6377268|P4|COMPLETED|Overall Study||40
2597642|NCT00256867|6377269|P3|COMPLETED|Overall Study||40
2597643|NCT00256867|6377270|P2|COMPLETED|Overall Study||39
2597644|NCT00256867|6377271|P1|COMPLETED|Overall Study||45
2597645|NCT00256867|6377264|P8|STARTED|Overall Study||47
2597646|NCT00256867|6377265|P7|STARTED|Overall Study||46
2597647|NCT00256867|6377266|P6|STARTED|Overall Study||46
2597648|NCT00256867|6377267|P5|STARTED|Overall Study||48
2597649|NCT00256867|6377268|P4|STARTED|Overall Study||46
2597650|NCT00256867|6377269|P3|STARTED|Overall Study||45
2597651|NCT00256867|6377270|P2|STARTED|Overall Study||44
2597652|NCT00256867|6377271|P1|STARTED|Overall Study||47
2597653|NCT00256854|6377361|P6|NOT COMPLETED|Overall Study||1
2597654|NCT00256854|6377362|P5|NOT COMPLETED|Overall Study||1
2597655|NCT00256854|6377363|P4|NOT COMPLETED|Overall Study||3
2597656|NCT00256854|6377364|P3|NOT COMPLETED|Overall Study||3
2597657|NCT00256854|6377365|P2|NOT COMPLETED|Overall Study||4
2597658|NCT00256854|6377366|P1|NOT COMPLETED|Overall Study||3
2597659|NCT00256854|6377361|P6|COMPLETED|Overall Study||13
2597660|NCT00256854|6377362|P5|COMPLETED|Overall Study||15
2597661|NCT00256854|6377363|P4|COMPLETED|Overall Study||24
2597662|NCT00256854|6377364|P3|COMPLETED|Overall Study||23
2597663|NCT00256854|6377365|P2|COMPLETED|Overall Study||22
2597664|NCT00256854|6377366|P1|COMPLETED|Overall Study||23
2597665|NCT00256854|6377361|P6|STARTED|Overall Study||14
2597666|NCT00256854|6377362|P5|STARTED|Overall Study||16
2597667|NCT00256854|6377363|P4|STARTED|Overall Study||27
2597668|NCT00256854|6377364|P3|STARTED|Overall Study||26
2597669|NCT00256854|6377365|P2|STARTED|Overall Study||26
2597670|NCT00256854|6377366|P1|STARTED|Overall Study||26
2597671|NCT00256750|6377425|P3|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||28
2597672|NCT00256750|6377426|P2|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||30
2597673|NCT00256750|6377427|P1|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||47
2597674|NCT00256750|6377425|P3|COMPLETED|Long Term Extension (LTE; 84 Months)||127
2597675|NCT00256750|6377426|P2|COMPLETED|Long Term Extension (LTE; 84 Months)||136
2597676|NCT00256750|6377427|P1|COMPLETED|Long Term Extension (LTE; 84 Months)||89
2597677|NCT00256750|6377425|P3|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 3 withdrew or refused.|155
2597678|NCT00256750|6377426|P2|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 4 withdrew or refused.|166
2597679|NCT00256750|6377427|P1|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 eligible to enroll in LTE; 2 ineligible, 5 withdrew or refused|136
2597680|NCT00256750|6377425|P3|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
2597681|NCT00256750|6377426|P2|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
2597682|NCT00256750|6377427|P1|NOT COMPLETED|Post-Transplant Treated (36 Months)||10
2597683|NCT00256750|6377425|P3|COMPLETED|Post-Transplant Treated (36 Months)||158
2597684|NCT00256750|6377426|P2|COMPLETED|Post-Transplant Treated (36 Months)||170
2597685|NCT00256750|6377427|P1|COMPLETED|Post-Transplant Treated (36 Months)||143
2597686|NCT00256750|6377425|P3|STARTED|Post-Transplant Treated (36 Months)||164
2597687|NCT00256750|6377426|P2|STARTED|Post-Transplant Treated (36 Months)||176
2597688|NCT00256750|6377427|P1|STARTED|Post-Transplant Treated (36 Months)||153
2597689|NCT00256750|6377425|P3|NOT COMPLETED|Post-Transplant Treated (24 Months)||9
2597690|NCT00256750|6377426|P2|NOT COMPLETED|Post-Transplant Treated (24 Months)||7
2597691|NCT00256750|6377427|P1|NOT COMPLETED|Post-Transplant Treated (24 Months)||21
2597692|NCT00256750|6377425|P3|COMPLETED|Post-Transplant Treated (24 Months)||164
2597693|NCT00256750|6377426|P2|COMPLETED|Post-Transplant Treated (24 Months)||176
2597694|NCT00256750|6377427|P1|COMPLETED|Post-Transplant Treated (24 Months)||153
2597695|NCT00256750|6377425|P3|STARTED|Post-Transplant Treated (24 Months)||173
2597696|NCT00256750|6377426|P2|STARTED|Post-Transplant Treated (24 Months)||183
2597697|NCT00256750|6377427|P1|STARTED|Post-Transplant Treated (24 Months)||174
2597698|NCT00256750|6377425|P3|NOT COMPLETED|Post-Transplant Treated (12 Months)||46
2597699|NCT00256750|6377426|P2|NOT COMPLETED|Post-Transplant Treated (12 Months)||43
2597700|NCT00256750|6377427|P1|NOT COMPLETED|Post-Transplant Treated (12 Months)||41
2597701|NCT00256750|6377425|P3|COMPLETED|Post-Transplant Treated (12 Months)||173
2597702|NCT00256750|6377426|P2|COMPLETED|Post-Transplant Treated (12 Months)||183
2597703|NCT00256750|6377427|P1|COMPLETED|Post-Transplant Treated (12 Months)||174
2597704|NCT00256750|6377425|P3|STARTED|Post-Transplant Treated (12 Months)||219
2597705|NCT00256750|6377426|P2|STARTED|Post-Transplant Treated (12 Months)||226
2597706|NCT00256750|6377427|P1|STARTED|Post-Transplant Treated (12 Months)||215
2597707|NCT00256750|6377425|P3|NOT COMPLETED|Transplanted Pre-Treatment||0
2597708|NCT00256750|6377426|P2|NOT COMPLETED|Transplanted Pre-Treatment||0
2597709|NCT00256750|6377427|P1|NOT COMPLETED|Transplanted Pre-Treatment||6
2597710|NCT00256750|6377425|P3|COMPLETED|Transplanted Pre-Treatment||219
2597711|NCT00256750|6377426|P2|COMPLETED|Transplanted Pre-Treatment||226
2597712|NCT00256750|6377427|P1|COMPLETED|Transplanted Pre-Treatment||215
2597713|NCT00256750|6377425|P3|STARTED|Transplanted Pre-Treatment||219
2597714|NCT00256750|6377426|P2|STARTED|Transplanted Pre-Treatment||226
2597715|NCT00256750|6377427|P1|STARTED|Transplanted Pre-Treatment||221
2597716|NCT00256724|6377563|P2|NOT COMPLETED|Overall Study||8
2597717|NCT00256724|6377564|P1|NOT COMPLETED|Overall Study||5
2597718|NCT00256724|6377563|P2|COMPLETED|Overall Study||16
2597719|NCT00256724|6377564|P1|COMPLETED|Overall Study||18
2597720|NCT00256724|6377563|P2|STARTED|Overall Study||24
2597721|NCT00256724|6377564|P1|STARTED|Overall Study||23
2597722|NCT00256698|6377574|P2|NOT COMPLETED|Overall Study||172
2597723|NCT00256698|6377575|P1|NOT COMPLETED|Overall Study||167
2597724|NCT00256698|6377574|P2|COMPLETED|Overall Study||84
2597725|NCT00256698|6377575|P1|COMPLETED|Overall Study||91
2597726|NCT00256698|6377574|P2|STARTED|Overall Study||256
2597727|NCT00256698|6377575|P1|STARTED|Overall Study||258
2597728|NCT00256451|6377593|P4|NOT COMPLETED|Session4||0
2597729|NCT00256451|6377594|P3|NOT COMPLETED|Session4||0
2597730|NCT00256451|6377595|P2|NOT COMPLETED|Session4||0
2597731|NCT00256451|6377596|P1|NOT COMPLETED|Session4||0
2597732|NCT00256451|6377593|P4|COMPLETED|Session4||8
2597733|NCT00256451|6377594|P3|COMPLETED|Session4||10
2597734|NCT00256451|6377595|P2|COMPLETED|Session4||8
2597735|NCT00256451|6377596|P1|COMPLETED|Session4||9
2597736|NCT00256451|6377593|P4|STARTED|Session4||8
2597737|NCT00256451|6377594|P3|STARTED|Session4||10
2597738|NCT00256451|6377595|P2|STARTED|Session4||8
2597739|NCT00256451|6377596|P1|STARTED|Session4||9
2597740|NCT00256451|6377593|P4|NOT COMPLETED|Session3||0
2597741|NCT00256451|6377594|P3|NOT COMPLETED|Session3||0
2597742|NCT00256451|6377595|P2|NOT COMPLETED|Session3||0
2597743|NCT00256451|6377596|P1|NOT COMPLETED|Session3||0
2597744|NCT00256451|6377593|P4|COMPLETED|Session3||9
2597745|NCT00256451|6377594|P3|COMPLETED|Session3||10
2597746|NCT00256451|6377595|P2|COMPLETED|Session3||9
2597747|NCT00256451|6377596|P1|COMPLETED|Session3||9
2597748|NCT00256451|6377593|P4|STARTED|Session3||9
2597749|NCT00256451|6377594|P3|STARTED|Session3||10
2597750|NCT00256451|6377595|P2|STARTED|Session3||9
2597751|NCT00256451|6377596|P1|STARTED|Session3||9
2597752|NCT00256451|6377593|P4|NOT COMPLETED|Session2||0
2597753|NCT00256451|6377594|P3|NOT COMPLETED|Session2||0
2597754|NCT00256451|6377595|P2|NOT COMPLETED|Session2||0
2597755|NCT00256451|6377596|P1|NOT COMPLETED|Session2||0
2597756|NCT00256451|6377593|P4|COMPLETED|Session2||10
2597757|NCT00256451|6377594|P3|COMPLETED|Session2||10
2597758|NCT00256451|6377595|P2|COMPLETED|Session2||11
2597759|NCT00256451|6377596|P1|COMPLETED|Session2||9
2597760|NCT00256451|6377593|P4|STARTED|Session2||10
2597761|NCT00256451|6377594|P3|STARTED|Session2||10
2597762|NCT00256451|6377595|P2|STARTED|Session2||11
2597763|NCT00256451|6377596|P1|STARTED|Session2||9
2597764|NCT00256451|6377593|P4|NOT COMPLETED|Session1||0
2597765|NCT00256451|6377594|P3|NOT COMPLETED|Session1||0
2597766|NCT00256451|6377595|P2|NOT COMPLETED|Session1||0
2597767|NCT00256451|6377596|P1|NOT COMPLETED|Session1||0
2597768|NCT00256451|6377593|P4|COMPLETED|Session1||11
2597769|NCT00256451|6377594|P3|COMPLETED|Session1||11
2597770|NCT00256451|6377595|P2|COMPLETED|Session1||11
2597771|NCT00256451|6377596|P1|COMPLETED|Session1||10
2597772|NCT00256451|6377593|P4|STARTED|Session1||11
2597773|NCT00256451|6377594|P3|STARTED|Session1||11
2597774|NCT00256451|6377595|P2|STARTED|Session1||11
2597775|NCT00256451|6377596|P1|STARTED|Session1||10
2597776|NCT00256308|6377622|P1|NOT COMPLETED|Overall Study||2
2597777|NCT00256308|6377622|P1|COMPLETED|Overall Study||4
2597778|NCT00256308|6377622|P1|STARTED|Overall Study||6
2597779|NCT00256295|6377630|P1|NOT COMPLETED|Overall Study||4
2597780|NCT00256295|6377630|P1|COMPLETED|Overall Study||3
2597781|NCT00256295|6377630|P1|STARTED|Overall Study|Of the 8 subjects consented, 1 withdrew prior to treatment.|7
2597782|NCT00256282|6377636|P1|NOT COMPLETED|Overall Study||16
2597783|NCT00256282|6377636|P1|COMPLETED|Overall Study||36
2597784|NCT00256282|6377636|P1|STARTED|Overall Study||52
2597785|NCT00256243|6377641|P1|NOT COMPLETED|Overall Study||10
2597786|NCT00256243|6377641|P1|COMPLETED|Overall Study||38
2597787|NCT00256243|6377641|P1|STARTED|Overall Study||48
2597788|NCT00256204|6377650|P4|NOT COMPLETED|Overall Study||49
2597789|NCT00256204|6377651|P3|NOT COMPLETED|Overall Study||54
2597790|NCT00256204|6377652|P2|NOT COMPLETED|Overall Study||50
2597791|NCT00256204|6377653|P1|NOT COMPLETED|Overall Study||67
2597792|NCT00256204|6377650|P4|COMPLETED|Overall Study||244
2597793|NCT00256204|6377651|P3|COMPLETED|Overall Study||241
2597794|NCT00256204|6377652|P2|COMPLETED|Overall Study||238
2597795|NCT00256204|6377653|P1|COMPLETED|Overall Study||231
2597796|NCT00256204|6377650|P4|STARTED|Overall Study||293
2597797|NCT00256204|6377651|P3|STARTED|Overall Study||295
2597798|NCT00256204|6377652|P2|STARTED|Overall Study||288
2597799|NCT00256204|6377653|P1|STARTED|Overall Study||298
2597800|NCT00256126|6377668|P2|NOT COMPLETED|Overall Study||2
2597801|NCT00256126|6377669|P1|NOT COMPLETED|Overall Study||2
2597802|NCT00256126|6377668|P2|COMPLETED|Overall Study||167
2597803|NCT00256126|6377669|P1|COMPLETED|Overall Study||147
2597804|NCT00256126|6377668|P2|STARTED|Overall Study||169
2597805|NCT00256126|6377669|P1|STARTED|Overall Study||149
2597806|NCT00255970|6377687|P2|NOT COMPLETED|Overall Study||0
2597807|NCT00255970|6377688|P1|NOT COMPLETED|Overall Study||0
2597808|NCT00255970|6377687|P2|COMPLETED|Overall Study||19
2597809|NCT00255970|6377688|P1|COMPLETED|Overall Study||21
2597810|NCT00255970|6377687|P2|Final Visit Week 24|Overall Study||19
2597811|NCT00255970|6377688|P1|Final Visit Week 24|Overall Study||21
2597812|NCT00255970|6377687|P2|Screening Visit|Overall Study||19
2597813|NCT00255970|6377688|P1|Screening Visit|Overall Study||21
2597814|NCT00255970|6377687|P2|STARTED|Overall Study||19
2597815|NCT00255970|6377688|P1|STARTED|Overall Study||21
2597816|NCT00255840|6377708|P2|NOT COMPLETED|Overall Study||70
2597817|NCT00255840|6377709|P1|NOT COMPLETED|Overall Study||63
2597818|NCT00255840|6377708|P2|COMPLETED|Overall Study||334
2597819|NCT00255840|6377709|P1|COMPLETED|Overall Study||345
2597820|NCT00255840|6377708|P2|STARTED|Overall Study||404
2597821|NCT00255840|6377709|P1|STARTED|Overall Study||408
2597822|NCT00255801|6377715|P1|NOT COMPLETED|Overall Study||0
2597823|NCT00255801|6377715|P1|COMPLETED|Overall Study||37
2597824|NCT00255801|6377715|P1|STARTED|Overall Study||37
2597825|NCT00255723|6377722|P2|NOT COMPLETED|Overall Study||2
2597826|NCT00255723|6377723|P1|NOT COMPLETED|Overall Study||2
2597827|NCT00255723|6377722|P2|COMPLETED|Overall Study||39
2597828|NCT00255723|6377723|P1|COMPLETED|Overall Study||54
2597829|NCT00255723|6377722|P2|STARTED|Overall Study||41
2597830|NCT00255723|6377723|P1|STARTED|Overall Study||56
2597831|NCT00255684|6377729|P1|NOT COMPLETED|Overall Study||0
2597832|NCT00255684|6377729|P1|COMPLETED|Overall Study||16
2597833|NCT00255684|6377729|P1|STARTED|Overall Study||16
2597834|NCT00255346|6377739|P5|NOT COMPLETED|Overall Study||0
2597835|NCT00255346|6377740|P4|NOT COMPLETED|Overall Study||0
2597836|NCT00255346|6377741|P3|NOT COMPLETED|Overall Study||0
2597837|NCT00255346|6377742|P2|NOT COMPLETED|Overall Study||0
2597838|NCT00255346|6377743|P1|NOT COMPLETED|Overall Study||1
2597839|NCT00255346|6377739|P5|COMPLETED|Overall Study||33
2597840|NCT00255346|6377740|P4|COMPLETED|Overall Study||11
2597841|NCT00255346|6377741|P3|COMPLETED|Overall Study||8
2597842|NCT00255346|6377742|P2|COMPLETED|Overall Study||6
2597843|NCT00255346|6377743|P1|COMPLETED|Overall Study||9
2597844|NCT00255346|6377739|P5|STARTED|Overall Study||33
2597845|NCT00255346|6377740|P4|STARTED|Overall Study||11
2597846|NCT00255346|6377741|P3|STARTED|Overall Study||8
2597847|NCT00255346|6377742|P2|STARTED|Overall Study||6
2597848|NCT00255346|6377743|P1|STARTED|Overall Study||10
2597849|NCT00255190|6377758|P2|NOT COMPLETED|Overall Study||157
2597850|NCT00255190|6377759|P1|NOT COMPLETED|Overall Study||50
2597851|NCT00255190|6377758|P2|COMPLETED|Overall Study||281
2597852|NCT00255190|6377759|P1|COMPLETED|Overall Study||103
2597853|NCT00255190|6377758|P2|STARTED|Overall Study||438
2597854|NCT00255190|6377759|P1|STARTED|Overall Study||153
2597855|NCT00255177|6377827|P4|NOT COMPLETED|Overall Study||2
2597856|NCT00255177|6377828|P3|NOT COMPLETED|Overall Study||1
2597857|NCT00255177|6377829|P2|NOT COMPLETED|Overall Study||1
2597858|NCT00255177|6377830|P1|NOT COMPLETED|Overall Study||2
2597859|NCT00255177|6377827|P4|COMPLETED|Overall Study||4
2597860|NCT00255177|6377828|P3|COMPLETED|Overall Study||12
2597861|NCT00255177|6377829|P2|COMPLETED|Overall Study||13
2597862|NCT00255177|6377830|P1|COMPLETED|Overall Study||9
2597863|NCT00255177|6377827|P4|STARTED|Overall Study||6
2597864|NCT00255177|6377828|P3|STARTED|Overall Study||13
2597865|NCT00255177|6377829|P2|STARTED|Overall Study||14
2597866|NCT00255177|6377830|P1|STARTED|Overall Study||11
2597867|NCT00255164|6377843|P3|NOT COMPLETED|Overall Study||49
2597868|NCT00255164|6377844|P2|NOT COMPLETED|Overall Study||49
2597869|NCT00255164|6377845|P1|NOT COMPLETED|Overall Study||123
2597870|NCT00255164|6377843|P3|COMPLETED|Overall Study||103
2597871|NCT00255164|6377844|P2|COMPLETED|Overall Study||110
2597872|NCT00255164|6377845|P1|COMPLETED|Overall Study||17
2597873|NCT00255164|6377843|P3|STARTED|Overall Study||152
2597874|NCT00255164|6377844|P2|STARTED|Overall Study||159
2597875|NCT00255164|6377845|P1|STARTED|Overall Study||140
2597876|NCT00255151|6377871|P3|NOT COMPLETED|Overall Study||49
2597877|NCT00255151|6377872|P2|NOT COMPLETED|Overall Study||49
2597878|NCT00255151|6377873|P1|NOT COMPLETED|Overall Study||123
2597879|NCT00255151|6377871|P3|COMPLETED|Overall Study||103
2597880|NCT00255151|6377872|P2|COMPLETED|Overall Study||110
2597881|NCT00255151|6377873|P1|COMPLETED|Overall Study||17
2597882|NCT00255151|6377871|P3|STARTED|Overall Study||152
2597883|NCT00255151|6377872|P2|STARTED|Overall Study||159
2597884|NCT00255151|6377873|P1|STARTED|Overall Study||140
2597885|NCT00255125|6377898|P2|NOT COMPLETED|Overall Study||0
2597886|NCT00255125|6377899|P1|NOT COMPLETED|Overall Study||0
2597887|NCT00255125|6377898|P2|COMPLETED|Overall Study||44
2597888|NCT00255125|6377899|P1|COMPLETED|Overall Study||42
2597889|NCT00255125|6377898|P2|STARTED|Overall Study||44
2597890|NCT00255125|6377899|P1|STARTED|Overall Study||42
2597891|NCT00255086|6377911|P2|NOT COMPLETED|Overall Study||2
2597892|NCT00255086|6377912|P1|NOT COMPLETED|Overall Study||2
2597893|NCT00255086|6377911|P2|COMPLETED|Overall Study||6
2597894|NCT00255086|6377912|P1|COMPLETED|Overall Study||7
2597895|NCT00255086|6377911|P2|STARTED|Overall Study||8
2597896|NCT00255086|6377912|P1|STARTED|Overall Study||9
2597897|NCT00255047|6377924|P4|NOT COMPLETED|Overall Study||46
2597898|NCT00255047|6377925|P3|NOT COMPLETED|Overall Study||50
2597899|NCT00255047|6377926|P2|NOT COMPLETED|Overall Study||48
2597900|NCT00255047|6377927|P1|NOT COMPLETED|Overall Study||48
2597901|NCT00255047|6377924|P4|COMPLETED|Overall Study||502
2597902|NCT00255047|6377925|P3|COMPLETED|Overall Study||496
2597903|NCT00255047|6377926|P2|COMPLETED|Overall Study||487
2597904|NCT00255047|6377927|P1|COMPLETED|Overall Study||490
2597905|NCT00255047|6377924|P4|STARTED|Overall Study||548
2597906|NCT00255047|6377925|P3|STARTED|Overall Study||546
2597907|NCT00255047|6377926|P2|STARTED|Overall Study||535
2597908|NCT00255047|6377927|P1|STARTED|Overall Study||538
2597909|NCT00255034|6377951|P2|NOT COMPLETED|Overall Study||38
2597910|NCT00255034|6377952|P1|NOT COMPLETED|Overall Study||15
2597911|NCT00255034|6377951|P2|COMPLETED|Overall Study||26
2597912|NCT00255034|6377952|P1|COMPLETED|Overall Study||64
2597913|NCT00255034|6377951|P2|STARTED|Overall Study||64
2597914|NCT00255034|6377952|P1|STARTED|Overall Study||79
2597915|NCT00255008|6377962|P4|NOT COMPLETED|Overall Study||22
2597916|NCT00255008|6377963|P3|NOT COMPLETED|Overall Study||16
2597917|NCT00255008|6377964|P2|NOT COMPLETED|Overall Study||9
2597918|NCT00255008|6377965|P1|NOT COMPLETED|Overall Study||32
2597919|NCT00255008|6377962|P4|COMPLETED|Overall Study||12
2597920|NCT00255008|6377963|P3|COMPLETED|Overall Study||17
2597921|NCT00255008|6377964|P2|COMPLETED|Overall Study||0
2597922|NCT00255008|6377965|P1|COMPLETED|Overall Study|The study was terminated early and as a result only 42 patients completed the study.|13
2597923|NCT00255008|6377962|P4|STARTED|Overall Study||34
2597924|NCT00255008|6377963|P3|STARTED|Overall Study||33
2597925|NCT00255008|6377964|P2|STARTED|Overall Study||9
2597926|NCT00255008|6377965|P1|STARTED|Overall Study||45
2597927|NCT00254995|6377977|P2|NOT COMPLETED|Overall Study||0
2597928|NCT00254995|6377978|P1|NOT COMPLETED|Overall Study||0
2597929|NCT00254995|6377977|P2|COMPLETED|Overall Study||31065
2597930|NCT00254995|6377978|P1|COMPLETED|Overall Study||31561
2597931|NCT00254995|6377977|P2|STARTED|Overall Study||31065
2597932|NCT00254995|6377978|P1|STARTED|Overall Study||31561
2597933|NCT00254982|6378001|P2|NOT COMPLETED|Overall Study||31
2597934|NCT00254982|6378002|P1|NOT COMPLETED|Overall Study||36
2597935|NCT00254982|6378001|P2|COMPLETED|Overall Study||265
2597936|NCT00254982|6378002|P1|COMPLETED|Overall Study||261
2597937|NCT00254982|6378001|P2|STARTED|Overall Study||296
2597938|NCT00254982|6378002|P1|STARTED|Overall Study||297
2597939|NCT00254592|6378008|P1|NOT COMPLETED|Overall Study||2
2597940|NCT00254592|6378008|P1|COMPLETED|Overall Study||41
2597941|NCT00254592|6378008|P1|STARTED|Overall Study||43
2597942|NCT00254566|6378014|P2|NOT COMPLETED|Overall Study||26
2597943|NCT00254566|6378015|P1|NOT COMPLETED|Overall Study||31
2597944|NCT00254566|6378014|P2|COMPLETED|Overall Study||172
2597945|NCT00254566|6378015|P1|COMPLETED|Overall Study||167
2597946|NCT00254566|6378014|P2|STARTED|Overall Study||198
2597947|NCT00254566|6378015|P1|STARTED|Overall Study||198
2597948|NCT00254540|6378039|P2|NOT COMPLETED|Overall Study||22
2597949|NCT00254540|6378040|P1|NOT COMPLETED|Overall Study||19
2597950|NCT00254540|6378039|P2|COMPLETED|Overall Study||4
2597951|NCT00254540|6378040|P1|COMPLETED|Overall Study||6
2597952|NCT00254540|6378039|P2|STARTED|Overall Study|All 26 subjects enrolled were included in Intent-To Treat population.|26
2597953|NCT00254540|6378040|P1|STARTED|Overall Study|All 25 subjects enrolled were included in Intent-To Treat population.|25
2597954|NCT00254501|6378069|P2|NOT COMPLETED|Overall Study||1
2597955|NCT00254501|6378070|P1|NOT COMPLETED|Overall Study||1
2597956|NCT00254501|6378069|P2|COMPLETED|Overall Study||36
2597957|NCT00254501|6378070|P1|COMPLETED|Overall Study||31
2597958|NCT00254501|6378069|P2|STARTED|Overall Study||37
2597959|NCT00254501|6378070|P1|STARTED|Overall Study||32
2597960|NCT00254488|6378084|P2|NOT COMPLETED|Overall Study||49
2597961|NCT00254488|6378085|P1|NOT COMPLETED|Overall Study||57
2597962|NCT00254488|6378084|P2|COMPLETED|Overall Study||63
2597963|NCT00254488|6378085|P1|COMPLETED|Overall Study||55
2597964|NCT00254488|6378084|P2|STARTED|Overall Study||112
2597965|NCT00254488|6378085|P1|STARTED|Overall Study||112
2597966|NCT00254462|6378095|P2|NOT COMPLETED|Overall Study||10
2597967|NCT00254462|6378096|P1|NOT COMPLETED|Overall Study||8
2597968|NCT00254462|6378095|P2|COMPLETED|Overall Study||39
2597969|NCT00254462|6378096|P1|COMPLETED|Overall Study||36
2597970|NCT00254462|6378095|P2|STARTED|Overall Study||49
2597971|NCT00254462|6378096|P1|STARTED|Overall Study||44
2597972|NCT00254410|6378104|P1|NOT COMPLETED|Overall Study||0
2597973|NCT00254410|6378104|P1|COMPLETED|Overall Study||30
2597974|NCT00254410|6378104|P1|STARTED|Overall Study||30
2597975|NCT00254397|6378115|P4|NOT COMPLETED|Overall Study||25
2597976|NCT00254397|6378116|P3|NOT COMPLETED|Overall Study||19
2597977|NCT00254397|6378117|P2|NOT COMPLETED|Overall Study||1
2597978|NCT00254397|6378118|P1|NOT COMPLETED|Overall Study||6
2597979|NCT00254397|6378115|P4|COMPLETED|Overall Study||20
2597980|NCT00254397|6378116|P3|COMPLETED|Overall Study||18
2597981|NCT00254397|6378117|P2|COMPLETED|Overall Study||5
2597982|NCT00254397|6378118|P1|COMPLETED|Overall Study||4
2597983|NCT00254397|6378115|P4|STARTED|Overall Study||45
2597984|NCT00254397|6378116|P3|STARTED|Overall Study||37
2597985|NCT00254397|6378117|P2|STARTED|Overall Study||6
2597986|NCT00254397|6378118|P1|STARTED|Overall Study||10
2597987|NCT00254293|6378142|P7|NOT COMPLETED|LTE Open Label Fixed Dosing||13
2597988|NCT00254293|6378143|P6|NOT COMPLETED|LTE Open Label Fixed Dosing||0
2597989|NCT00254293|6378144|P5|NOT COMPLETED|LTE Open Label Fixed Dosing||0
2597990|NCT00254293|6378145|P4|NOT COMPLETED|LTE Open Label Fixed Dosing||0
2597991|NCT00254293|6378146|P3|NOT COMPLETED|LTE Open Label Fixed Dosing||0
2597992|NCT00254293|6378147|P2|NOT COMPLETED|LTE Open Label Fixed Dosing||0
2597993|NCT00254293|6378148|P1|NOT COMPLETED|LTE Open Label Fixed Dosing||0
2597994|NCT00254293|6378142|P7|COMPLETED|LTE Open Label Fixed Dosing||35
2597995|NCT00254293|6378143|P6|COMPLETED|LTE Open Label Fixed Dosing||0
2597996|NCT00254293|6378144|P5|COMPLETED|LTE Open Label Fixed Dosing||0
2597997|NCT00254293|6378145|P4|COMPLETED|LTE Open Label Fixed Dosing||0
2597998|NCT00254293|6378146|P3|COMPLETED|LTE Open Label Fixed Dosing||0
2597999|NCT00254293|6378147|P2|COMPLETED|LTE Open Label Fixed Dosing||0
2598000|NCT00254293|6378148|P1|COMPLETED|LTE Open Label Fixed Dosing||0
2598001|NCT00254293|6378142|P7|STARTED|LTE Open Label Fixed Dosing||48
2598002|NCT00254293|6378143|P6|STARTED|LTE Open Label Fixed Dosing||0
2598003|NCT00254293|6378144|P5|STARTED|LTE Open Label Fixed Dosing||0
2598004|NCT00254293|6378145|P4|STARTED|LTE Open Label Fixed Dosing||0
2598005|NCT00254293|6378146|P3|STARTED|LTE Open Label Fixed Dosing||0
2598006|NCT00254293|6378147|P2|STARTED|LTE Open Label Fixed Dosing||0
2598007|NCT00254293|6378148|P1|STARTED|LTE Open Label Fixed Dosing||0
2598008|NCT00254293|6378142|P7|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
2598009|NCT00254293|6378143|P6|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
2598010|NCT00254293|6378144|P5|NOT COMPLETED|LTE Open Label Variable SC Dosing||2
2598011|NCT00254293|6378145|P4|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
2598012|NCT00254293|6378146|P3|NOT COMPLETED|LTE Open Label Variable SC Dosing||10
2598013|NCT00254293|6378147|P2|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
2598014|NCT00254293|6378148|P1|NOT COMPLETED|LTE Open Label Variable SC Dosing||3
2598015|NCT00254293|6378142|P7|COMPLETED|LTE Open Label Variable SC Dosing||0
2598016|NCT00254293|6378143|P6|COMPLETED|LTE Open Label Variable SC Dosing||0
2598017|NCT00254293|6378144|P5|COMPLETED|LTE Open Label Variable SC Dosing||8
2598018|NCT00254293|6378145|P4|COMPLETED|LTE Open Label Variable SC Dosing||0
2598019|NCT00254293|6378146|P3|COMPLETED|LTE Open Label Variable SC Dosing||32
2598020|NCT00254293|6378147|P2|COMPLETED|LTE Open Label Variable SC Dosing||0
2598021|NCT00254293|6378148|P1|COMPLETED|LTE Open Label Variable SC Dosing||8
2598022|NCT00254293|6378142|P7|STARTED|LTE Open Label Variable SC Dosing|Participant rolled over from LTE (Variable Dose Period) to LTE (Fixed Dose Period).|0
2598023|NCT00254293|6378143|P6|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to a variable SC dose group of 75, 125 or 200 mg Weekly by body weight.|0
2598024|NCT00254293|6378144|P5|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to variable SC dose group (by body weight, >100kg).|10
2598025|NCT00254293|6378145|P4|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
2598026|NCT00254293|6378146|P3|STARTED|LTE Open Label Variable SC Dosing|Variable SC dose group: 125 mg Weekly, body weight <60 to >100kg (Groups 2, 3, 4 in ST Period).|42
2598027|NCT00254293|6378147|P2|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
2598028|NCT00254293|6378148|P1|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to 75mg SC dose group (by body weight, <60kg).|11
2598029|NCT00254293|6378142|P7|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
2598030|NCT00254293|6378143|P6|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
2598031|NCT00254293|6378144|P5|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
2598032|NCT00254293|6378145|P4|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
2598033|NCT00254293|6378146|P3|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||3
2598034|NCT00254293|6378147|P2|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
2598035|NCT00254293|6378148|P1|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
2598036|NCT00254293|6378142|P7|COMPLETED|Short Term (12 Week) Randomized Dosing||0
2598037|NCT00254293|6378143|P6|COMPLETED|Short Term (12 Week) Randomized Dosing||17
2598038|NCT00254293|6378144|P5|COMPLETED|Short Term (12 Week) Randomized Dosing||5
2598039|NCT00254293|6378145|P4|COMPLETED|Short Term (12 Week) Randomized Dosing||5
2598040|NCT00254293|6378146|P3|COMPLETED|Short Term (12 Week) Randomized Dosing||26
2598041|NCT00254293|6378147|P2|COMPLETED|Short Term (12 Week) Randomized Dosing||3
2598042|NCT00254293|6378148|P1|COMPLETED|Short Term (12 Week) Randomized Dosing||7
2598043|NCT00254293|6378142|P7|STARTED|Short Term (12 Week) Randomized Dosing||0
2598044|NCT00254293|6378143|P6|STARTED|Short Term (12 Week) Randomized Dosing|2, 2, 9, 2, and 2 were randomized to placebo in body weight Groups 1, 2, 3, 4, 5, respectively.|17
2598045|NCT00254293|6378144|P5|STARTED|Short Term (12 Week) Randomized Dosing||5
2598046|NCT00254293|6378145|P4|STARTED|Short Term (12 Week) Randomized Dosing||6
2598047|NCT00254293|6378146|P3|STARTED|Short Term (12 Week) Randomized Dosing||29
2598048|NCT00254293|6378147|P2|STARTED|Short Term (12 Week) Randomized Dosing||4
2598049|NCT00254293|6378148|P1|STARTED|Short Term (12 Week) Randomized Dosing||7
2598050|NCT00254163|6378231|P2|NOT COMPLETED|Overall Study||46
2598051|NCT00254163|6378232|P1|NOT COMPLETED|Overall Study||45
2598052|NCT00254163|6378231|P2|COMPLETED|Overall Study||46
2598053|NCT00254163|6378232|P1|COMPLETED|Overall Study||47
2598054|NCT00254163|6378231|P2|STARTED|Overall Study||92
2598055|NCT00254163|6378232|P1|STARTED|Overall Study||92
2598056|NCT00254072|6378256|P2|NOT COMPLETED|Overall Study||0
2598057|NCT00254072|6378257|P1|NOT COMPLETED|Overall Study||0
2598058|NCT00254072|6378256|P2|COMPLETED|Overall Study||175
2598059|NCT00254072|6378257|P1|COMPLETED|Overall Study||180
2598060|NCT00254072|6378256|P2|STARTED|Overall Study||175
2598061|NCT00254072|6378257|P1|STARTED|Overall Study||180
2598062|NCT00253981|6378265|P2|NOT COMPLETED|Overall Study||0
2598063|NCT00253981|6378266|P1|NOT COMPLETED|Overall Study||0
2598064|NCT00253981|6378265|P2|COMPLETED|Overall Study||14
2598065|NCT00253981|6378266|P1|COMPLETED|Overall Study||16
2598066|NCT00253981|6378265|P2|STARTED|Overall Study||14
2598067|NCT00253981|6378266|P1|STARTED|Overall Study||16
2598068|NCT00253890|6378274|P2|NOT COMPLETED|Overall Study||7
2598069|NCT00253890|6378275|P1|NOT COMPLETED|Overall Study||7
2598070|NCT00253890|6378274|P2|COMPLETED|Overall Study||61
2598071|NCT00253890|6378275|P1|COMPLETED|Overall Study||62
2598072|NCT00253890|6378274|P2|STARTED|Overall Study||68
2598073|NCT00253890|6378275|P1|STARTED|Overall Study||69
2598074|NCT00253747|6378283|P2|NOT COMPLETED|Overall Study||27
2598075|NCT00253747|6378284|P1|NOT COMPLETED|Overall Study||24
2598076|NCT00253747|6378283|P2|COMPLETED|Overall Study||101
2598077|NCT00253747|6378284|P1|COMPLETED|Overall Study||103
2598078|NCT00253747|6378283|P2|STARTED|Overall Study||128
2598079|NCT00253747|6378284|P1|STARTED|Overall Study||127
2598080|NCT00253708|6378305|P3|NOT COMPLETED|Overall Study||1
2598081|NCT00253708|6378306|P2|NOT COMPLETED|Overall Study||0
2598082|NCT00253708|6378307|P1|NOT COMPLETED|Overall Study||0
2598083|NCT00253708|6378305|P3|COMPLETED|Overall Study||8
2598084|NCT00253708|6378306|P2|COMPLETED|Overall Study||10
2598085|NCT00253708|6378307|P1|COMPLETED|Overall Study||20
2598086|NCT00253708|6378305|P3|STARTED|Overall Study||9
2598087|NCT00253708|6378306|P2|STARTED|Overall Study||10
2598088|NCT00253708|6378307|P1|STARTED|Overall Study||20
2598089|NCT00253643|6378337|P4|NOT COMPLETED|Overall Study||3
2598090|NCT00253643|6378338|P3|NOT COMPLETED|Overall Study||1
2598091|NCT00253643|6378339|P2|NOT COMPLETED|Overall Study||0
2598092|NCT00253643|6378340|P1|NOT COMPLETED|Overall Study||0
2598093|NCT00253643|6378337|P4|COMPLETED|Overall Study||28
2598094|NCT00253643|6378338|P3|COMPLETED|Overall Study||28
2598095|NCT00253643|6378339|P2|COMPLETED|Overall Study||15
2598096|NCT00253643|6378340|P1|COMPLETED|Overall Study||14
2598097|NCT00253643|6378337|P4|STARTED|Overall Study||31
2598098|NCT00253643|6378338|P3|STARTED|Overall Study||29
2598099|NCT00253643|6378339|P2|STARTED|Overall Study||15
2598100|NCT00253643|6378340|P1|STARTED|Overall Study||14
2598101|NCT00253630|6378354|P1|NOT COMPLETED|Overall Study||2
2598102|NCT00253630|6378354|P1|COMPLETED|Overall Study||35
2598103|NCT00253630|6378354|P1|STARTED|Overall Study||37
2598104|NCT00253513|6378363|P1|NOT COMPLETED|Overall Study||0
2598105|NCT00253513|6378363|P1|COMPLETED|Overall Study||60
2598106|NCT00253513|6378363|P1|STARTED|Overall Study||60
2598107|NCT00253448|6378370|P1|NOT COMPLETED|Overall Study||1
2598108|NCT00253448|6378370|P1|COMPLETED|Overall Study||34
2598109|NCT00253448|6378370|P1|STARTED|Overall Study||35
2598110|NCT00253435|6378376|P2|NOT COMPLETED|Overall Study||0
2598111|NCT00253435|6378377|P1|NOT COMPLETED|Overall Study||0
2598112|NCT00253435|6378376|P2|COMPLETED|Overall Study|Eight evaluable patients enrolled.|8
2598113|NCT00253435|6378377|P1|COMPLETED|Overall Study|Forty-two evaluable poor risk patients enrolled.|42
2598114|NCT00253435|6378376|P2|3rd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
2598115|NCT00253435|6378377|P1|3rd Interim Analysis|Overall Study|Third interim analysis: need 4+ responses in first 35 patients. Goal met study continued.|10
2598116|NCT00253435|6378376|P2|2nd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
2598117|NCT00253435|6378377|P1|2nd Interim Analysis|Overall Study|Second interim analysis: need 3+ responses in first 25 patients. Goal met study continued.|10
2598118|NCT00253435|6378376|P2|1st Interim Analysis|Overall Study|Only interim analysis: need 1+ response in first 10 patients.|8
2598119|NCT00253435|6378377|P1|1st Interim Analysis|Overall Study|First interim analysis: need 2+ responses in first 15 patients. Goal met study continued.|15
2598120|NCT00253435|6378376|P2|STARTED|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|8
2598121|NCT00253435|6378377|P1|STARTED|Overall Study|Total number is 42|42
2598122|NCT00253370|6378389|P1|NOT COMPLETED|Overall Study||43
2598123|NCT00253370|6378389|P1|COMPLETED|Overall Study||1
2598124|NCT00253370|6378389|P1|STARTED|Overall Study||44
2598125|NCT00253019|6378398|P3|NOT COMPLETED|Overall Study||18
2598126|NCT00253019|6378399|P2|NOT COMPLETED|Overall Study||31
2598127|NCT00253019|6378400|P1|NOT COMPLETED|Overall Study||29
2598128|NCT00253019|6378398|P3|COMPLETED|Overall Study||83
2598129|NCT00253019|6378399|P2|COMPLETED|Overall Study||78
2598130|NCT00253019|6378400|P1|COMPLETED|Overall Study||82
2598131|NCT00253019|6378398|P3|STARTED|Overall Study||101
2598132|NCT00253019|6378399|P2|STARTED|Overall Study||109
2598133|NCT00253019|6378400|P1|STARTED|Overall Study||111
2598134|NCT00252967|6378410|P2|NOT COMPLETED|Overall Study||0
2598135|NCT00252967|6378411|P1|NOT COMPLETED|Overall Study||0
2598136|NCT00252967|6378410|P2|COMPLETED|Overall Study||33
2598137|NCT00252967|6378411|P1|COMPLETED|Overall Study||31
2598138|NCT00252967|6378410|P2|STARTED|Overall Study||33
2598139|NCT00252967|6378411|P1|STARTED|Overall Study||31
2598140|NCT00252733|6378435|P2|NOT COMPLETED|Overall Study||92
2598141|NCT00252733|6378436|P1|NOT COMPLETED|Overall Study||106
2598142|NCT00252733|6378435|P2|COMPLETED|Overall Study||618
2598143|NCT00252733|6378436|P1|COMPLETED|Overall Study||605
2598144|NCT00252733|6378435|P2|STARTED|Overall Study||710
2598145|NCT00252733|6378436|P1|STARTED|Overall Study||711
2598146|NCT00252720|6378446|P2|NOT COMPLETED|Overall Study||165
2598147|NCT00252720|6378447|P1|NOT COMPLETED|Overall Study||132
2598148|NCT00252720|6378446|P2|COMPLETED|Overall Study||789
2598149|NCT00252720|6378447|P1|COMPLETED|Overall Study||819
2598150|NCT00252720|6378446|P2|STARTED|Overall Study||954
2598151|NCT00252720|6378447|P1|STARTED|Overall Study||951
2598152|NCT00252694|6378461|P2|NOT COMPLETED|Overall Study||154
2598153|NCT00252694|6378462|P1|NOT COMPLETED|Overall Study||144
2598154|NCT00252694|6378461|P2|COMPLETED|Overall Study||800
2598155|NCT00252694|6378462|P1|COMPLETED|Overall Study||807
2598156|NCT00252694|6378461|P2|STARTED|Overall Study||954
2598157|NCT00252694|6378462|P1|STARTED|Overall Study||951
2598158|NCT00252629|6378477|P3|NOT COMPLETED|Overall Study||0
2598159|NCT00252629|6378478|P2|NOT COMPLETED|Overall Study||0
2598160|NCT00252629|6378479|P1|NOT COMPLETED|Overall Study||1
2598161|NCT00252629|6378477|P3|COMPLETED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
2598162|NCT00252629|6378478|P2|COMPLETED|Overall Study||9
2598163|NCT00252629|6378479|P1|COMPLETED|Overall Study|One participant assigned to therapeutic CPAP was excluded from the trial before starting treatment.|8
2598164|NCT00252629|6378477|P3|STARTED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
2598165|NCT00252629|6378478|P2|STARTED|Overall Study||9
2598166|NCT00252629|6378479|P1|STARTED|Overall Study||9
2598167|NCT00252590|6378495|P3|NOT COMPLETED|Overall Study||3
2598168|NCT00252590|6378496|P2|NOT COMPLETED|Overall Study||2
2598169|NCT00252590|6378497|P1|NOT COMPLETED|Overall Study||2
2598170|NCT00252590|6378495|P3|COMPLETED|Overall Study||31
2598171|NCT00252590|6378496|P2|COMPLETED|Overall Study||28
2598172|NCT00252590|6378497|P1|COMPLETED|Overall Study||33
2598173|NCT00252590|6378495|P3|STARTED|Overall Study||34
2598174|NCT00252590|6378496|P2|STARTED|Overall Study||30
2598175|NCT00252590|6378497|P1|STARTED|Overall Study||35
2598176|NCT00252577|6378508|P1|NOT COMPLETED|Overall Study||20
2598177|NCT00252577|6378508|P1|COMPLETED|Overall Study||110
2598178|NCT00252577|6378508|P1|STARTED|Overall Study||130
2598179|NCT00252564|6378514|P2|NOT COMPLETED|Overall Study||44
2598180|NCT00252564|6378515|P1|NOT COMPLETED|Overall Study||39
2598181|NCT00252564|6378514|P2|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|79
2598182|NCT00252564|6378515|P1|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|85
2598183|NCT00252564|6378514|P2|STARTED|Overall Study|From randomization|123
2598184|NCT00252564|6378515|P1|STARTED|Overall Study|From randomization|124
2598185|NCT00252538|6378527|P2|NOT COMPLETED|Overall Study||0
2598186|NCT00252538|6378528|P1|NOT COMPLETED|Overall Study||0
2598187|NCT00252538|6378527|P2|COMPLETED|Overall Study||114
2598188|NCT00252538|6378528|P1|COMPLETED|Overall Study||19
2598189|NCT00252538|6378527|P2|STARTED|Overall Study||114
2598190|NCT00252538|6378528|P1|STARTED|Overall Study||19
2598191|NCT00252512|6378535|P2|NOT COMPLETED|12 Month Follow up||1
2598192|NCT00252512|6378536|P1|NOT COMPLETED|12 Month Follow up||9
2598193|NCT00252512|6378535|P2|COMPLETED|12 Month Follow up||121
2598194|NCT00252512|6378536|P1|COMPLETED|12 Month Follow up||123
2598195|NCT00252512|6378535|P2|STARTED|12 Month Follow up||122
2598196|NCT00252512|6378536|P1|STARTED|12 Month Follow up||132
2598197|NCT00252512|6378535|P2|NOT COMPLETED|Six Month Follow up||12
2598198|NCT00252512|6378536|P1|NOT COMPLETED|Six Month Follow up||4
2598199|NCT00252512|6378535|P2|COMPLETED|Six Month Follow up||122
2598200|NCT00252512|6378536|P1|COMPLETED|Six Month Follow up||132
2598201|NCT00252512|6378535|P2|STARTED|Six Month Follow up||134
2598202|NCT00252512|6378536|P1|STARTED|Six Month Follow up||136
2598203|NCT00252512|6378535|P2|NOT COMPLETED|Intervention||31
2598204|NCT00252512|6378536|P1|NOT COMPLETED|Intervention||29
2598205|NCT00252512|6378535|P2|COMPLETED|Intervention||134
2598206|NCT00252512|6378536|P1|COMPLETED|Intervention||136
2598207|NCT00252512|6378535|P2|STARTED|Intervention||165
2598208|NCT00252512|6378536|P1|STARTED|Intervention||165
2598209|NCT00252499|6378555|P3|NOT COMPLETED|Overall Study||0
2598210|NCT00252499|6378556|P2|NOT COMPLETED|Overall Study||0
2598211|NCT00252499|6378557|P1|NOT COMPLETED|Overall Study||1
2598212|NCT00252499|6378555|P3|COMPLETED|Overall Study||6
2598213|NCT00252499|6378556|P2|COMPLETED|Overall Study||2
2598214|NCT00252499|6378557|P1|COMPLETED|Overall Study||4
2598215|NCT00252499|6378555|P3|STARTED|Overall Study||6
2598216|NCT00252499|6378556|P2|STARTED|Overall Study||2
2598217|NCT00252499|6378557|P1|STARTED|Overall Study||5
2598218|NCT00252382|6378580|P1|NOT COMPLETED|Overall Study||26
2598219|NCT00252382|6378580|P1|COMPLETED|Overall Study||5
2598220|NCT00252382|6378580|P1|STARTED|Overall Study||31
2598221|NCT00252239|6378589|P4|NOT COMPLETED|Overall Study||1
2598222|NCT00252239|6378590|P3|NOT COMPLETED|Overall Study||2
2598223|NCT00252239|6378591|P2|NOT COMPLETED|Overall Study||0
2598224|NCT00252239|6378592|P1|NOT COMPLETED|Overall Study||1
2598225|NCT00252239|6378589|P4|COMPLETED|Overall Study||30
2598226|NCT00252239|6378590|P3|COMPLETED|Overall Study||17
2598227|NCT00252239|6378591|P2|COMPLETED|Overall Study||31
2598228|NCT00252239|6378592|P1|COMPLETED|Overall Study||30
2598229|NCT00252239|6378589|P4|STARTED|Overall Study||31
2598230|NCT00252239|6378590|P3|STARTED|Overall Study||19
2598231|NCT00252239|6378591|P2|STARTED|Overall Study||31
2598232|NCT00252239|6378592|P1|STARTED|Overall Study||31
2598233|NCT00252187|6378604|P2|NOT COMPLETED|Overall Study||1
2598234|NCT00252187|6378605|P1|NOT COMPLETED|Overall Study||4
2598235|NCT00252187|6378604|P2|COMPLETED|Overall Study||20
2598236|NCT00252187|6378605|P1|COMPLETED|Overall Study||20
2598237|NCT00252187|6378604|P2|STARTED|Overall Study||21
2598238|NCT00252187|6378605|P1|STARTED|Overall Study||24
2598239|NCT00252174|6378628|P3|NOT COMPLETED|Overall Study||0
2598240|NCT00252174|6378629|P2|NOT COMPLETED|Overall Study||1
2598241|NCT00252174|6378630|P1|NOT COMPLETED|Overall Study||0
2598242|NCT00252174|6378628|P3|COMPLETED|Overall Study||0
2598243|NCT00252174|6378629|P2|COMPLETED|Overall Study||1
2598244|NCT00252174|6378630|P1|COMPLETED|Overall Study||0
2598245|NCT00252174|6378628|P3|STARTED|Overall Study|No subjects entered Stage 2|0
2598246|NCT00252174|6378629|P2|STARTED|Overall Study|2 subjects entered the control arm in total|2
2598247|NCT00252174|6378630|P1|STARTED|Overall Study|No subjects were randomized into Active Arm as only 2 subjects were randomized into the Control Arm.|0
2598248|NCT00252057|6378670|P2|NOT COMPLETED|Overall Study||8
2598249|NCT00252057|6378671|P1|NOT COMPLETED|Overall Study||3
2598250|NCT00252057|6378670|P2|COMPLETED|Overall Study||368
2598251|NCT00252057|6378671|P1|COMPLETED|Overall Study||370
2598252|NCT00252057|6378670|P2|STARTED|Overall Study||376
2598253|NCT00252057|6378671|P1|STARTED|Overall Study||373
2598254|NCT00251979|6378679|P2|NOT COMPLETED|Overall Study||40
2598255|NCT00251979|6378680|P1|NOT COMPLETED|Overall Study||38
2598256|NCT00251979|6378679|P2|COMPLETED|Overall Study||349
2598257|NCT00251979|6378680|P1|COMPLETED|Overall Study||337
2598258|NCT00251979|6378679|P2|STARTED|Overall Study|ITT population|389
2598259|NCT00251979|6378680|P1|STARTED|Overall Study|ITT population|375
2598260|NCT00251927|6378712|P2|NOT COMPLETED|Overall Study||74
2598261|NCT00251927|6378713|P1|NOT COMPLETED|Overall Study||108
2598262|NCT00251927|6378712|P2|COMPLETED|Overall Study|Completed 5 year visit|192
2598263|NCT00251927|6378713|P1|COMPLETED|Overall Study|Completed 5 year visit|180
2598264|NCT00251927|6378712|P2|STARTED|Overall Study|Randomised|266
2598265|NCT00251927|6378713|P1|STARTED|Overall Study|Randomised|288
2598266|NCT00251862|6378743|P3|NOT COMPLETED|Overall Study||0
2598267|NCT00251862|6378744|P2|NOT COMPLETED|Overall Study||0
2598268|NCT00251862|6378745|P1|NOT COMPLETED|Overall Study||0
2598269|NCT00251862|6378743|P3|COMPLETED|Overall Study||276
2598270|NCT00251862|6378744|P2|COMPLETED|Overall Study||269
2598271|NCT00251862|6378745|P1|COMPLETED|Overall Study||280
2598272|NCT00251862|6378743|P3|STARTED|Overall Study||276
2598273|NCT00251862|6378744|P2|STARTED|Overall Study||269
2598274|NCT00251862|6378745|P1|STARTED|Overall Study||280
2598275|NCT00251758|6378765|P3|NOT COMPLETED|Overall Study||27
2598276|NCT00251758|6378766|P2|NOT COMPLETED|Overall Study||27
2598277|NCT00251758|6378767|P1|NOT COMPLETED|Overall Study||28
2598278|NCT00251758|6378765|P3|COMPLETED|Overall Study||277
2598279|NCT00251758|6378766|P2|COMPLETED|Overall Study||285
2598280|NCT00251758|6378767|P1|COMPLETED|Overall Study||264
2598281|NCT00251758|6378765|P3|STARTED|Overall Study||304
2598282|NCT00251758|6378766|P2|STARTED|Overall Study||312
2598283|NCT00251758|6378767|P1|STARTED|Overall Study||292
2598284|NCT00251745|6378787|P3|NOT COMPLETED|Overall Study||27
2598285|NCT00251745|6378788|P2|NOT COMPLETED|Overall Study||27
2598286|NCT00251745|6378789|P1|NOT COMPLETED|Overall Study||28
2598287|NCT00251745|6378787|P3|COMPLETED|Overall Study||277
2598288|NCT00251745|6378788|P2|COMPLETED|Overall Study||285
2598289|NCT00251745|6378789|P1|COMPLETED|Overall Study||264
2598290|NCT00251745|6378787|P3|STARTED|Overall Study||304
2598291|NCT00251745|6378788|P2|STARTED|Overall Study||312
2598292|NCT00251745|6378789|P1|STARTED|Overall Study||292
2598293|NCT00251719|6378809|P3|NOT COMPLETED|Overall Study||30
2598294|NCT00251719|6378810|P2|NOT COMPLETED|Overall Study||45
2598295|NCT00251719|6378811|P1|NOT COMPLETED|Overall Study||53
2598296|NCT00251719|6378809|P3|COMPLETED|Overall Study||643
2598297|NCT00251719|6378810|P2|COMPLETED|Overall Study||642
2598298|NCT00251719|6378811|P1|COMPLETED|Overall Study||641
2598299|NCT00251719|6378809|P3|STARTED|Overall Study||673
2598300|NCT00251719|6378810|P2|STARTED|Overall Study||687
2598301|NCT00251719|6378811|P1|STARTED|Overall Study||694
2598302|NCT00251693|6378837|P3|NOT COMPLETED|Overall Study||46
2598303|NCT00251693|6378838|P2|NOT COMPLETED|Overall Study||44
2598304|NCT00251693|6378839|P1|NOT COMPLETED|Overall Study||51
2598305|NCT00251693|6378837|P3|COMPLETED|Overall Study||644
2598306|NCT00251693|6378838|P2|COMPLETED|Overall Study||624
2598307|NCT00251693|6378839|P1|COMPLETED|Overall Study||629
2598308|NCT00251693|6378837|P3|STARTED|Overall Study||690
2598309|NCT00251693|6378838|P2|STARTED|Overall Study||668
2598310|NCT00251693|6378839|P1|STARTED|Overall Study||680
2598311|NCT00251641|6378864|P2|NOT COMPLETED|Overall Study||88
2598312|NCT00251641|6378865|P1|NOT COMPLETED|Overall Study||112
2598313|NCT00251641|6378864|P2|COMPLETED|Overall Study||127
2598314|NCT00251641|6378865|P1|COMPLETED|Overall Study||541
2598315|NCT00251641|6378864|P2|STARTED|Overall Study||215
2598316|NCT00251641|6378865|P1|STARTED|Overall Study||653
2598317|NCT00251589|6378883|P4|NOT COMPLETED|Overall Study||2
2598318|NCT00251589|6378884|P3|NOT COMPLETED|Overall Study||2
2598319|NCT00251589|6378885|P2|NOT COMPLETED|Overall Study||3
2598320|NCT00251589|6378886|P1|NOT COMPLETED|Overall Study||15
2598321|NCT00251589|6378883|P4|COMPLETED|Overall Study||0
2598322|NCT00251589|6378884|P3|COMPLETED|Overall Study||0
2598323|NCT00251589|6378885|P2|COMPLETED|Overall Study||0
2598324|NCT00251589|6378886|P1|COMPLETED|Overall Study||1
2598325|NCT00251589|6378883|P4|STARTED|Overall Study||2
2598326|NCT00251589|6378884|P3|STARTED|Overall Study||2
2598327|NCT00251589|6378885|P2|STARTED|Overall Study||3
2598328|NCT00251589|6378886|P1|STARTED|Overall Study|4 of the 16 patients participated in Phase I and II portions. 12 participated in Phase II only.|16
2598329|NCT00251316|6378923|P2|NOT COMPLETED|Overall Study||3
2598330|NCT00251316|6378924|P1|NOT COMPLETED|Overall Study||2
2598331|NCT00251316|6378923|P2|COMPLETED|Overall Study||14
2598332|NCT00251316|6378924|P1|COMPLETED|Overall Study||15
2598333|NCT00251316|6378923|P2|STARTED|Overall Study||17
2598334|NCT00251316|6378924|P1|STARTED|Overall Study||17
2598335|NCT00251303|6378932|P2|NOT COMPLETED|Overall Study||1
2598336|NCT00251303|6378933|P1|NOT COMPLETED|Overall Study||8
2598337|NCT00251303|6378932|P2|COMPLETED|Overall Study||29
2598338|NCT00251303|6378933|P1|COMPLETED|Overall Study||22
2598339|NCT00251303|6378932|P2|STARTED|Overall Study||30
2598340|NCT00251303|6378933|P1|STARTED|Overall Study|78 subjects signed any consent. 60 started drug (30 riluzole & 30 placebo).|30
2598341|NCT00251238|6378943|P2|NOT COMPLETED|Overall Study||0
2598342|NCT00251238|6378944|P1|NOT COMPLETED|Overall Study||0
2598343|NCT00251238|6378943|P2|COMPLETED|Overall Study||20
2598344|NCT00251238|6378944|P1|COMPLETED|Overall Study||21
2598345|NCT00251238|6378943|P2|STARTED|Overall Study||20
2598346|NCT00251238|6378944|P1|STARTED|Overall Study||21
2598347|NCT00251225|6378954|P1|NOT COMPLETED|Overall Study||0
2598348|NCT00251225|6378954|P1|COMPLETED|Overall Study||49
2598349|NCT00251225|6378954|P1|STARTED|Overall Study||49
2598350|NCT00251004|6378963|P3|NOT COMPLETED|Overall Study||31
2598351|NCT00251004|6378964|P2|NOT COMPLETED|Overall Study||41
2598352|NCT00251004|6378965|P1|NOT COMPLETED|Overall Study||45
2598353|NCT00251004|6378963|P3|COMPLETED|Overall Study||246
2598354|NCT00251004|6378964|P2|COMPLETED|Overall Study||238
2598355|NCT00251004|6378965|P1|COMPLETED|Overall Study||232
2598356|NCT00251004|6378963|P3|24 Month Analysis|Overall Study|Under 24 month analysis under group 3, 185 Completed study medication.|246
2598357|NCT00251004|6378964|P2|24 Month Analysis|Overall Study|Under 24 month analysis under group 2, 161 Completed study medication.|238
2598358|NCT00251004|6378965|P1|24 Month Analysis|Overall Study|Under 24 month analysis under group 1, 167 Completed study medication.|232
2598359|NCT00251004|6378963|P3|12 Month Analysis|Overall Study|Under 12 month analysis under group 3, 200 Completed study medication.|253
2598360|NCT00251004|6378964|P2|12 Month Analysis|Overall Study|Under 12 month analysis under group 2, 175 Completed study medication.|249
2598361|NCT00251004|6378965|P1|12 Month Analysis|Overall Study|Under 12 month analysis under group 1, 179 Completed study medication.|241
2598362|NCT00251004|6378963|P3|STARTED|Overall Study||277
2598363|NCT00251004|6378964|P2|STARTED|Overall Study||279
2598364|NCT00251004|6378965|P1|STARTED|Overall Study||277
2598365|NCT00250926|6378982|P1|NOT COMPLETED|Overall Study||0
2598366|NCT00250926|6378982|P1|COMPLETED|Overall Study||23
2598367|NCT00250926|6378982|P1|STARTED|Overall Study||23
2598368|NCT00250835|6378989|P1|NOT COMPLETED|Overall Study||1
2598369|NCT00250835|6378989|P1|COMPLETED|Overall Study||37
2598370|NCT00250835|6378989|P1|STARTED|Overall Study||38
2598371|NCT00250718|6378998|P1|NOT COMPLETED|Overall Study||3
2598372|NCT00250718|6378998|P1|COMPLETED|Overall Study||14
2598373|NCT00250718|6378998|P1|Received Treatment|Overall Study||16
2598374|NCT00250718|6378998|P1|STARTED|Overall Study||17
2598375|NCT00250705|6379003|P1|NOT COMPLETED|Overall Study||2
2598376|NCT00250705|6379003|P1|COMPLETED|Overall Study||10
2598377|NCT00250705|6379003|P1|STARTED|Overall Study||12
2598378|NCT00250679|6379014|P3|NOT COMPLETED|Overall Study||44
2598379|NCT00250679|6379015|P2|NOT COMPLETED|Overall Study||49
2598380|NCT00250679|6379016|P1|NOT COMPLETED|Overall Study||39
2598381|NCT00250679|6379014|P3|COMPLETED|Overall Study||103
2598382|NCT00250679|6379015|P2|COMPLETED|Overall Study||100
2598383|NCT00250679|6379016|P1|COMPLETED|Overall Study||108
2598384|NCT00250679|6379014|P3|STARTED|Overall Study||147
2598385|NCT00250679|6379015|P2|STARTED|Overall Study||149
2598386|NCT00250679|6379016|P1|STARTED|Overall Study||147
2598387|NCT00250588|6379117|P3|NOT COMPLETED|Overall Study||13
2598388|NCT00250588|6379118|P2|NOT COMPLETED|Overall Study||19
2598389|NCT00250588|6379119|P1|NOT COMPLETED|Overall Study||9
2598390|NCT00250588|6379117|P3|COMPLETED|Overall Study||74
2598391|NCT00250588|6379118|P2|COMPLETED|Overall Study||65
2598392|NCT00250588|6379119|P1|COMPLETED|Overall Study||72
2598393|NCT00250588|6379117|P3|STARTED|Overall Study||87
2598394|NCT00250588|6379118|P2|STARTED|Overall Study||84
2598395|NCT00250588|6379119|P1|STARTED|Overall Study||81
2598396|NCT00250497|6379135|P2|NOT COMPLETED|Overall Study||15
2598397|NCT00250497|6379136|P1|NOT COMPLETED|Overall Study||5
2598398|NCT00250497|6379135|P2|COMPLETED|Overall Study||159
2598399|NCT00250497|6379136|P1|COMPLETED|Overall Study||177
2598400|NCT00250497|6379135|P2|STARTED|Overall Study||174
2598401|NCT00250497|6379136|P1|STARTED|Overall Study||182
2598402|NCT00250484|6379154|P2|NOT COMPLETED|Overall Study||0
2598403|NCT00250484|6379155|P1|NOT COMPLETED|Overall Study||0
2598404|NCT00250484|6379154|P2|COMPLETED|Overall Study||8
2598405|NCT00250484|6379155|P1|COMPLETED|Overall Study||9
2598406|NCT00250484|6379154|P2|STARTED|Overall Study||8
2598407|NCT00250484|6379155|P1|STARTED|Overall Study||9
2598408|NCT00250458|6379167|P2|NOT COMPLETED|Overall Study||17
2598409|NCT00250458|6379168|P1|NOT COMPLETED|Overall Study||32
2598410|NCT00250458|6379167|P2|COMPLETED|Overall Study||97
2598411|NCT00250458|6379168|P1|COMPLETED|Overall Study||200
2598412|NCT00250458|6379167|P2|STARTED|Overall Study||114
2598413|NCT00250458|6379168|P1|STARTED|Overall Study||232
2598414|NCT00250432|6379178|P2|NOT COMPLETED|Overall Study||47
2598415|NCT00250432|6379179|P1|NOT COMPLETED|Overall Study||45
2598416|NCT00250432|6379178|P2|COMPLETED|Overall Study||53
2598417|NCT00250432|6379179|P1|COMPLETED|Overall Study||59
2598418|NCT00250432|6379178|P2|STARTED|Overall Study||100
2598419|NCT00250432|6379179|P1|STARTED|Overall Study||104
2598420|NCT00250276|6379191|P4|NOT COMPLETED|Overall Study||19
2598421|NCT00250276|6379192|P3|NOT COMPLETED|Overall Study||19
2598422|NCT00250276|6379193|P2|NOT COMPLETED|Overall Study||21
2598423|NCT00250276|6379194|P1|NOT COMPLETED|Overall Study||17
2598424|NCT00250276|6379191|P4|COMPLETED|Overall Study||181
2598425|NCT00250276|6379192|P3|COMPLETED|Overall Study||182
2598426|NCT00250276|6379193|P2|COMPLETED|Overall Study||177
2598427|NCT00250276|6379194|P1|COMPLETED|Overall Study||182
2598428|NCT00250276|6379191|P4|STARTED|Overall Study||200
2598429|NCT00250276|6379192|P3|STARTED|Overall Study||201
2598430|NCT00250276|6379193|P2|STARTED|Overall Study||198
2598431|NCT00250276|6379194|P1|STARTED|Overall Study||199
2598432|NCT00249873|6379274|P2|NOT COMPLETED|Overall Study||1254
2598433|NCT00249873|6379275|P1|NOT COMPLETED|Overall Study||1330
2598434|NCT00249873|6379274|P2|COMPLETED|Overall Study|started and completed study drug|2528
2598435|NCT00249873|6379275|P1|COMPLETED|Overall Study|started and completed study drug|2442
2598436|NCT00249873|6379274|P2|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3782
2598437|NCT00249873|6379275|P1|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3772
2598438|NCT00249834|6379295|P8|NOT COMPLETED|Overall Study||0
2598439|NCT00249834|6379296|P7|NOT COMPLETED|Overall Study||1
2598440|NCT00249834|6379297|P6|NOT COMPLETED|Overall Study||2
2598441|NCT00249834|6379298|P5|NOT COMPLETED|Overall Study||5
2598442|NCT00249834|6379299|P4|NOT COMPLETED|Overall Study||8
2598443|NCT00249834|6379300|P3|NOT COMPLETED|Overall Study||14
2598444|NCT00249834|6379301|P2|NOT COMPLETED|Overall Study||19
2598445|NCT00249834|6379302|P1|NOT COMPLETED|Overall Study||1
2598446|NCT00249834|6379295|P8|COMPLETED|Overall Study||2
2598447|NCT00249834|6379296|P7|COMPLETED|Overall Study||1
2598448|NCT00249834|6379297|P6|COMPLETED|Overall Study||8
2598449|NCT00249834|6379298|P5|COMPLETED|Overall Study||19
2598450|NCT00249834|6379299|P4|COMPLETED|Overall Study||26
2598451|NCT00249834|6379300|P3|COMPLETED|Overall Study||31
2598452|NCT00249834|6379301|P2|COMPLETED|Overall Study||29
2598453|NCT00249834|6379302|P1|COMPLETED|Overall Study||0
2598454|NCT00249834|6379295|P8|STARTED|Overall Study||2
2598455|NCT00249834|6379296|P7|STARTED|Overall Study||2
2598456|NCT00249834|6379297|P6|STARTED|Overall Study||10
2598457|NCT00249834|6379298|P5|STARTED|Overall Study||24
2598458|NCT00249834|6379299|P4|STARTED|Overall Study||34
2598459|NCT00249834|6379300|P3|STARTED|Overall Study||45
2598460|NCT00249834|6379301|P2|STARTED|Overall Study||48
2598461|NCT00249834|6379302|P1|STARTED|Overall Study||1
2598462|NCT00249821|6379351|P2|NOT COMPLETED|Overall Study||1
2598463|NCT00249821|6379352|P1|NOT COMPLETED|Overall Study||0
2598464|NCT00249821|6379351|P2|COMPLETED|Overall Study||11
2598465|NCT00249821|6379352|P1|COMPLETED|Overall Study||10
2598466|NCT00249821|6379351|P2|STARTED|Overall Study||12
2598467|NCT00249821|6379352|P1|STARTED|Overall Study||10
2598468|NCT00249808|6379372|P1|NOT COMPLETED|Overall Study||182
2598469|NCT00249808|6379372|P1|COMPLETED|Overall Study||1084
2598470|NCT00249808|6379372|P1|STARTED|Overall Study||1266
2598471|NCT00249795|6379380|P2|NOT COMPLETED|Overall Study||1390
2598472|NCT00249795|6379381|P1|NOT COMPLETED|Overall Study||1394
2598473|NCT00249795|6379380|P2|COMPLETED|Overall Study|started and completed study drug|3108
2598474|NCT00249795|6379381|P1|COMPLETED|Overall Study|started and completed study drug|3124
2598475|NCT00249795|6379380|P2|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4498
2598476|NCT00249795|6379381|P1|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4518
2598477|NCT00249613|6379401|P2|NOT COMPLETED|12 Month Follow-up||15
2598478|NCT00249613|6379402|P1|NOT COMPLETED|12 Month Follow-up||17
2598479|NCT00249613|6379401|P2|COMPLETED|12 Month Follow-up||124
2598480|NCT00249613|6379402|P1|COMPLETED|12 Month Follow-up||135
2598481|NCT00249613|6379401|P2|STARTED|12 Month Follow-up||139
2598482|NCT00249613|6379402|P1|STARTED|12 Month Follow-up||152
2598483|NCT00249613|6379401|P2|NOT COMPLETED|Baseline||0
2598484|NCT00249613|6379402|P1|NOT COMPLETED|Baseline||0
2598485|NCT00249613|6379401|P2|COMPLETED|Baseline||139
2598486|NCT00249613|6379402|P1|COMPLETED|Baseline||152
2598487|NCT00249613|6379401|P2|STARTED|Baseline||139
2598488|NCT00249613|6379402|P1|STARTED|Baseline||152
2598489|NCT00249496|6379413|P2|NOT COMPLETED|Overall Study||1
2598490|NCT00249496|6379414|P1|NOT COMPLETED|Overall Study||0
2598491|NCT00249496|6379413|P2|COMPLETED|Overall Study||26
2598492|NCT00249496|6379414|P1|COMPLETED|Overall Study||24
2598493|NCT00249496|6379413|P2|STARTED|Overall Study||27
2598494|NCT00249496|6379414|P1|STARTED|Overall Study||24
2598495|NCT00249470|6379430|P2|NOT COMPLETED|Overall Study||0
2598496|NCT00249470|6379431|P1|NOT COMPLETED|Overall Study||0
2598497|NCT00249470|6379430|P2|COMPLETED|Overall Study||28
2598498|NCT00249470|6379431|P1|COMPLETED|Overall Study||28
2598499|NCT00249470|6379430|P2|STARTED|Overall Study||28
2598500|NCT00249470|6379431|P1|STARTED|Overall Study||28
2598501|NCT00249444|6379443|P2|NOT COMPLETED|Overall Study||15
2598502|NCT00249444|6379444|P1|NOT COMPLETED|Overall Study||12
2598503|NCT00249444|6379443|P2|COMPLETED|Overall Study||29
2598504|NCT00249444|6379444|P1|COMPLETED|Overall Study||30
2598505|NCT00249444|6379443|P2|STARTED|Overall Study||44
2598506|NCT00249444|6379444|P1|STARTED|Overall Study||42
2598507|NCT00249379|6379454|P2|NOT COMPLETED|Overall Study||8
2598508|NCT00249379|6379455|P1|NOT COMPLETED|Overall Study||8
2598509|NCT00249379|6379454|P2|COMPLETED|Overall Study||4
2598510|NCT00249379|6379455|P1|COMPLETED|Overall Study||6
2598511|NCT00249379|6379454|P2|STARTED|Overall Study||12
2598512|NCT00249379|6379455|P1|STARTED|Overall Study||14
2598513|NCT00249288|6379469|P2|NOT COMPLETED|Overall Study||5
2598514|NCT00249288|6379470|P1|NOT COMPLETED|Overall Study||5
2598515|NCT00249288|6379469|P2|COMPLETED|Overall Study||14
2598516|NCT00249288|6379470|P1|COMPLETED|Overall Study||14
2598517|NCT00249288|6379469|P2|Initiated Treatment|Overall Study||15
2598518|NCT00249288|6379470|P1|Initiated Treatment|Overall Study||17
2598519|NCT00249288|6379469|P2|STARTED|Overall Study||19
2598520|NCT00249288|6379470|P1|STARTED|Overall Study||19
2598521|NCT00249249|6379505|P4|NOT COMPLETED|Overall Study||3
2598522|NCT00249249|6379506|P3|NOT COMPLETED|Overall Study||15
2598523|NCT00249249|6379507|P2|NOT COMPLETED|Overall Study||5
2598524|NCT00249249|6379508|P1|NOT COMPLETED|Overall Study||20
2598525|NCT00249249|6379505|P4|COMPLETED|Overall Study||100
2598526|NCT00249249|6379506|P3|COMPLETED|Overall Study||288
2598527|NCT00249249|6379507|P2|COMPLETED|Overall Study||98
2598528|NCT00249249|6379508|P1|COMPLETED|Overall Study||301
2598529|NCT00249249|6379505|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|103
2598530|NCT00249249|6379506|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|300
2598531|NCT00249249|6379507|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|102
2598532|NCT00249249|6379508|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|316
2598533|NCT00249249|6379505|P4|STARTED|Overall Study||103
2598534|NCT00249249|6379506|P3|STARTED|Overall Study||303
2598535|NCT00249249|6379507|P2|STARTED|Overall Study||103
2598536|NCT00249249|6379508|P1|STARTED|Overall Study||321
2598537|NCT00249002|6379562|P1|NOT COMPLETED|Overall Study||7
2598538|NCT00249002|6379562|P1|COMPLETED|Overall Study||2
2598539|NCT00249002|6379562|P1|STARTED|Overall Study||9
2598540|NCT00248833|6379581|P3|NOT COMPLETED|Overall Study||2
2598541|NCT00248833|6379582|P2|NOT COMPLETED|Overall Study||3
2598542|NCT00248833|6379583|P1|NOT COMPLETED|Overall Study||3
2598543|NCT00248833|6379581|P3|COMPLETED|Overall Study||9
2598544|NCT00248833|6379582|P2|COMPLETED|Overall Study||8
2598545|NCT00248833|6379583|P1|COMPLETED|Overall Study||9
2598546|NCT00248833|6379581|P3|STARTED|Overall Study||11
2598547|NCT00248833|6379582|P2|STARTED|Overall Study||11
2598548|NCT00248833|6379583|P1|STARTED|Overall Study||12
2598549|NCT00248807|6379601|P2|NOT COMPLETED|Overall Study||0
2598550|NCT00248807|6379602|P1|NOT COMPLETED|Overall Study||0
2598551|NCT00248807|6379601|P2|COMPLETED|Overall Study||11
2598552|NCT00248807|6379602|P1|COMPLETED|Overall Study||19
2598553|NCT00248807|6379601|P2|STARTED|Overall Study||11
2598554|NCT00248807|6379602|P1|STARTED|Overall Study||19
2598555|NCT00248794|6379619|P3|NOT COMPLETED|Overall Study||3
2598556|NCT00248794|6379620|P2|NOT COMPLETED|Overall Study||8
2598557|NCT00248794|6379621|P1|NOT COMPLETED|Overall Study||6
2598558|NCT00248794|6379619|P3|COMPLETED|Overall Study||7
2598559|NCT00248794|6379620|P2|COMPLETED|Overall Study||16
2598560|NCT00248794|6379621|P1|COMPLETED|Overall Study||19
2598561|NCT00248794|6379619|P3|STARTED|Overall Study||10
2598562|NCT00248794|6379620|P2|STARTED|Overall Study||24
2598563|NCT00248794|6379621|P1|STARTED|Overall Study||25
2598564|NCT00248781|6379643|P2|NOT COMPLETED|Overall Study||4
2598565|NCT00248781|6379644|P1|NOT COMPLETED|Overall Study||10
2598566|NCT00248781|6379643|P2|COMPLETED|Overall Study||47
2598567|NCT00248781|6379644|P1|COMPLETED|Overall Study||42
2598568|NCT00248781|6379643|P2|STARTED|Overall Study||51
2598569|NCT00248781|6379644|P1|STARTED|Overall Study||52
2598570|NCT00248651|6379671|P3|NOT COMPLETED|Overall Study||32
2598571|NCT00248651|6379672|P2|NOT COMPLETED|Overall Study||40
2598572|NCT00248651|6379673|P1|NOT COMPLETED|Overall Study||28
2598573|NCT00248651|6379671|P3|COMPLETED|Overall Study||65
2598574|NCT00248651|6379672|P2|COMPLETED|Overall Study||58
2598575|NCT00248651|6379673|P1|COMPLETED|Overall Study||69
2598576|NCT00248651|6379671|P3|Completed 12 Weeks of Treatment|Overall Study||75
2598577|NCT00248651|6379672|P2|Completed 12 Weeks of Treatment|Overall Study||66
2598578|NCT00248651|6379673|P1|Completed 12 Weeks of Treatment|Overall Study||78
2598579|NCT00248651|6379671|P3|STARTED|Overall Study||97
2598580|NCT00248651|6379672|P2|STARTED|Overall Study||98
2598581|NCT00248651|6379673|P1|STARTED|Overall Study||97
2598582|NCT00248638|6379692|P2|NOT COMPLETED|Overall Study||0
2598583|NCT00248638|6379693|P1|NOT COMPLETED|Overall Study||0
2598584|NCT00248638|6379692|P2|COMPLETED|Overall Study||75
2598585|NCT00248638|6379693|P1|COMPLETED|Overall Study||75
2598586|NCT00248638|6379692|P2|STARTED|Overall Study||75
2598587|NCT00248638|6379693|P1|STARTED|Overall Study||75
2598588|NCT00248625|6379709|P2|NOT COMPLETED|Overall Study||2
2598589|NCT00248625|6379710|P1|NOT COMPLETED|Overall Study||0
2598590|NCT00248625|6379709|P2|COMPLETED|Overall Study||90
2598591|NCT00248625|6379710|P1|COMPLETED|Overall Study||92
2598592|NCT00248625|6379709|P2|STARTED|Overall Study||92
2598593|NCT00248625|6379710|P1|STARTED|Overall Study||92
2598594|NCT00248612|6379734|P4|NOT COMPLETED|Overall Study||0
2598595|NCT00248612|6379735|P3|NOT COMPLETED|Overall Study||0
2598596|NCT00248612|6379736|P2|NOT COMPLETED|Overall Study||0
2598597|NCT00248612|6379737|P1|NOT COMPLETED|Overall Study||0
2598598|NCT00248612|6379734|P4|COMPLETED|Overall Study||22
2598599|NCT00248612|6379735|P3|COMPLETED|Overall Study||14
2598600|NCT00248612|6379736|P2|COMPLETED|Overall Study||21
2598601|NCT00248612|6379737|P1|COMPLETED|Overall Study||24
2598602|NCT00248612|6379734|P4|STARTED|Overall Study||22
2598603|NCT00248612|6379735|P3|STARTED|Overall Study||14
2598604|NCT00248612|6379736|P2|STARTED|Overall Study||21
2598605|NCT00248612|6379737|P1|STARTED|Overall Study||24
2598606|NCT00248560|6379779|P1|NOT COMPLETED|Overall Study||0
2598607|NCT00248560|6379779|P1|COMPLETED|Overall Study||36
2598608|NCT00248560|6379779|P1|STARTED|Overall Study||36
2598609|NCT00248547|6379788|P2|NOT COMPLETED|Overall Study||0
2598610|NCT00248547|6379789|P1|NOT COMPLETED|Overall Study||0
2598611|NCT00248547|6379788|P2|COMPLETED|Overall Study||20
2598612|NCT00248547|6379789|P1|COMPLETED|Overall Study||20
2598613|NCT00248547|6379788|P2|STARTED|Overall Study||20
2598614|NCT00248547|6379789|P1|STARTED|Overall Study||20
2598615|NCT00248534|6379795|P1|NOT COMPLETED|Overall Study||0
2598616|NCT00248534|6379795|P1|COMPLETED|Overall Study||16
2598617|NCT00248534|6379795|P1|STARTED|Overall Study||16
2598618|NCT00248495|6379802|P1|NOT COMPLETED|Overall Study||1
2598619|NCT00248495|6379802|P1|COMPLETED|Overall Study||37
2598620|NCT00248495|6379802|P1|STARTED|Overall Study||38
2598627|NCT00248170|6379828|P2|NOT COMPLETED|Overall Study||808
2598628|NCT00248170|6379829|P1|NOT COMPLETED|Overall Study||761
2598629|NCT00248170|6379828|P2|COMPLETED|Overall Study||1286
2598630|NCT00248170|6379829|P1|COMPLETED|Overall Study||1317
2598631|NCT00248170|6379828|P2|Safety Set|Overall Study||2062
2598632|NCT00248170|6379829|P1|Safety Set|Overall Study||2049
2598633|NCT00248170|6379828|P2|Intent-to-treat (ITT)|Overall Study||2075
2598634|NCT00248170|6379829|P1|Intent-to-treat (ITT)|Overall Study||2061
2598635|NCT00248170|6379828|P2|STARTED|Overall Study||2094
2598636|NCT00248170|6379829|P1|STARTED|Overall Study||2078
2598637|NCT00247962|6379851|P2|NOT COMPLETED|Overall Study||19
2598638|NCT00247962|6379852|P1|NOT COMPLETED|Overall Study||26
2598639|NCT00247962|6379851|P2|COMPLETED|Overall Study||168
2598640|NCT00247962|6379852|P1|COMPLETED|Overall Study||353
2598641|NCT00247962|6379851|P2|STARTED|Overall Study||187
2598642|NCT00247962|6379852|P1|STARTED|Overall Study||379
2598643|NCT00247676|6379860|P1|NOT COMPLETED|Overall Study||36
2598644|NCT00247676|6379860|P1|COMPLETED|Overall Study||1
2598645|NCT00247676|6379860|P1|STARTED|Overall Study||37
2598646|NCT00247624|6379890|P2|NOT COMPLETED|Overall Study||4
2598647|NCT00247624|6379891|P1|NOT COMPLETED|Overall Study||5
2598648|NCT00247624|6379890|P2|COMPLETED|Overall Study||26
2598649|NCT00247624|6379891|P1|COMPLETED|Overall Study||25
2598650|NCT00247624|6379890|P2|STARTED|Overall Study||30
2598651|NCT00247624|6379891|P1|STARTED|Overall Study||30
2598652|NCT00247611|6379905|P2|NOT COMPLETED|On Protocol Sample||125
2598653|NCT00247611|6379906|P1|NOT COMPLETED|On Protocol Sample||111
2598654|NCT00247611|6379905|P2|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|152
2598655|NCT00247611|6379906|P1|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|176
2598656|NCT00247611|6379905|P2|STARTED|On Protocol Sample|ITT sample participants|277
2598657|NCT00247611|6379906|P1|STARTED|On Protocol Sample|ITT sample participants|287
2598658|NCT00247611|6379905|P2|NOT COMPLETED|Intention to Treat Sample||13
2598659|NCT00247611|6379906|P1|NOT COMPLETED|Intention to Treat Sample||17
2598660|NCT00247611|6379905|P2|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|277
2598661|NCT00247611|6379906|P1|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|287
2598662|NCT00247611|6379905|P2|STARTED|Intention to Treat Sample|Participants randomized|290
2598663|NCT00247611|6379906|P1|STARTED|Intention to Treat Sample|Participants randomized|304
2598664|NCT00247611|6379905|P2|NOT COMPLETED|Baselined||13
2598665|NCT00247611|6379906|P1|NOT COMPLETED|Baselined||17
2598666|NCT00247611|6379905|P2|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|277
2598667|NCT00247611|6379906|P1|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|287
2598668|NCT00247611|6379905|P2|STARTED|Baselined|Participants randomized|290
2598669|NCT00247611|6379906|P1|STARTED|Baselined|Participants randomized|304
2598670|NCT00247416|6379924|P2|NOT COMPLETED|Overall Study||2
2598671|NCT00247416|6379925|P1|NOT COMPLETED|Overall Study||1
2598672|NCT00247416|6379924|P2|COMPLETED|Overall Study||31
2598673|NCT00247416|6379925|P1|COMPLETED|Overall Study||25
2598674|NCT00247416|6379924|P2|STARTED|Overall Study||33
2598675|NCT00247416|6379925|P1|STARTED|Overall Study||26
2598676|NCT00247377|6379939|P2|NOT COMPLETED|Overall Study||0
2598677|NCT00247377|6379940|P1|NOT COMPLETED|Overall Study||0
2598678|NCT00247377|6379939|P2|COMPLETED|Overall Study||86
2598679|NCT00247377|6379940|P1|COMPLETED|Overall Study||111
2598680|NCT00247377|6379939|P2|STARTED|Overall Study||86
2598681|NCT00247377|6379940|P1|STARTED|Overall Study||111
2598682|NCT00247273|6379966|P2|NOT COMPLETED|Overall Study||137
2598683|NCT00247273|6379967|P1|NOT COMPLETED|Overall Study||146
2598684|NCT00247273|6379966|P2|COMPLETED|Overall Study||513
2598685|NCT00247273|6379967|P1|COMPLETED|Overall Study||498
2598686|NCT00247273|6379966|P2|Intent to Treat Population|Overall Study||650
2598687|NCT00247273|6379967|P1|Intent to Treat Population|Overall Study|Two subjects not included as they did not take any study medication.|642
2598688|NCT00247273|6379966|P2|STARTED|Overall Study||650
2598689|NCT00247273|6379967|P1|STARTED|Overall Study||644
2598690|NCT00246805|6380013|P2|NOT COMPLETED|Phase 2||0
2598691|NCT00246805|6380014|P1|NOT COMPLETED|Phase 2||0
2598692|NCT00246805|6380013|P2|COMPLETED|Phase 2||33
2598693|NCT00246805|6380014|P1|COMPLETED|Phase 2||33
2598694|NCT00246805|6380013|P2|STARTED|Phase 2||33
2598695|NCT00246805|6380014|P1|STARTED|Phase 2||33
2598696|NCT00246805|6380013|P2|NOT COMPLETED|Phase 1||0
2598697|NCT00246805|6380014|P1|NOT COMPLETED|Phase 1||1
2598698|NCT00246805|6380013|P2|COMPLETED|Phase 1||33
2598699|NCT00246805|6380014|P1|COMPLETED|Phase 1||33
2598700|NCT00246805|6380013|P2|STARTED|Phase 1||33
2598701|NCT00246805|6380014|P1|STARTED|Phase 1||34
2598702|NCT00246753|6380020|P1|NOT COMPLETED|Overall Study||8
2598703|NCT00246753|6380020|P1|COMPLETED|Overall Study||21
2598704|NCT00246753|6380020|P1|STARTED|Overall Study||29
2598705|NCT00246740|6380028|P2|NOT COMPLETED|Experimental Phase||0
2598706|NCT00246740|6380029|P1|NOT COMPLETED|Experimental Phase||0
2598707|NCT00246740|6380028|P2|COMPLETED|Experimental Phase||20
2598708|NCT00246740|6380029|P1|COMPLETED|Experimental Phase||22
2598709|NCT00246740|6380028|P2|STARTED|Experimental Phase||20
2598710|NCT00246740|6380029|P1|STARTED|Experimental Phase||22
2598711|NCT00246740|6380028|P2|NOT COMPLETED|Initial Enrollment||8
2598712|NCT00246740|6380029|P1|NOT COMPLETED|Initial Enrollment||6
2598713|NCT00246740|6380028|P2|COMPLETED|Initial Enrollment||20
2598714|NCT00246740|6380029|P1|COMPLETED|Initial Enrollment||22
2598715|NCT00246740|6380028|P2|STARTED|Initial Enrollment||28
2598716|NCT00246740|6380029|P1|STARTED|Initial Enrollment||28
2598717|NCT00246571|6380053|P2|NOT COMPLETED|Overall Study||104
2598718|NCT00246571|6380054|P1|NOT COMPLETED|Overall Study||113
2598719|NCT00246571|6380053|P2|COMPLETED|Overall Study||0
2598720|NCT00246571|6380054|P1|COMPLETED|Overall Study||0
2598721|NCT00246571|6380053|P2|Randomized But Not Treated|Overall Study||1
2598722|NCT00246571|6380054|P1|Randomized But Not Treated|Overall Study||3
2598723|NCT00246571|6380053|P2|STARTED|Overall Study||104
2598724|NCT00246571|6380054|P1|STARTED|Overall Study||113
2598725|NCT00246519|6380094|P2|NOT COMPLETED|Overall Study||64
2598726|NCT00246519|6380095|P1|NOT COMPLETED|Overall Study||56
2598727|NCT00246519|6380094|P2|COMPLETED|Overall Study||382
2598728|NCT00246519|6380095|P1|COMPLETED|Overall Study||386
2598729|NCT00246519|6380094|P2|STARTED|Overall Study||446
2598730|NCT00246519|6380095|P1|STARTED|Overall Study||442
2598731|NCT00246441|6380103|P2|NOT COMPLETED|Overall Study||0
2598732|NCT00246441|6380104|P1|NOT COMPLETED|Overall Study||1
2598733|NCT00246441|6380103|P2|COMPLETED|Overall Study||22
2598734|NCT00246441|6380104|P1|COMPLETED|Overall Study||19
2598735|NCT00246441|6380103|P2|STARTED|Overall Study||22
2598736|NCT00246441|6380104|P1|STARTED|Overall Study||20
2598737|NCT00246376|6380119|P5|NOT COMPLETED|Overall Study||17
2598738|NCT00246376|6380120|P4|NOT COMPLETED|Overall Study||26
2598739|NCT00246376|6380121|P3|NOT COMPLETED|Overall Study||16
2598740|NCT00246376|6380122|P2|NOT COMPLETED|Overall Study||19
2598741|NCT00246376|6380123|P1|NOT COMPLETED|Overall Study||15
2598742|NCT00246376|6380119|P5|COMPLETED|Overall Study||28
2598743|NCT00246376|6380120|P4|COMPLETED|Overall Study||21
2598744|NCT00246376|6380121|P3|COMPLETED|Overall Study||29
2598745|NCT00246376|6380122|P2|COMPLETED|Overall Study||24
2598746|NCT00246376|6380123|P1|COMPLETED|Overall Study||26
2598747|NCT00246376|6380119|P5|After Dietary run-in at Two Weeks|Overall Study||42
2598748|NCT00246376|6380120|P4|After Dietary run-in at Two Weeks|Overall Study||40
2598749|NCT00246376|6380121|P3|After Dietary run-in at Two Weeks|Overall Study||41
2598750|NCT00246376|6380122|P2|After Dietary run-in at Two Weeks|Overall Study||38
2598751|NCT00246376|6380123|P1|After Dietary run-in at Two Weeks|Overall Study||30
2598752|NCT00246376|6380119|P5|STARTED|Overall Study||45
2598753|NCT00246376|6380120|P4|STARTED|Overall Study||47
2598754|NCT00246376|6380121|P3|STARTED|Overall Study||45
2598755|NCT00246376|6380122|P2|STARTED|Overall Study||43
2598756|NCT00246376|6380123|P1|STARTED|Overall Study||41
2598757|NCT00246337|6380174|P9|NOT COMPLETED|Overall Study||11
2598758|NCT00246337|6380175|P8|NOT COMPLETED|Overall Study||13
2598759|NCT00246337|6380176|P7|NOT COMPLETED|Overall Study||9
2598760|NCT00246337|6380177|P6|NOT COMPLETED|Overall Study||15
2598761|NCT00246337|6380178|P5|NOT COMPLETED|Overall Study||4
2598762|NCT00246337|6380179|P4|NOT COMPLETED|Overall Study||1
2598763|NCT00246337|6380180|P3|NOT COMPLETED|Overall Study||3
2598764|NCT00246337|6380181|P2|NOT COMPLETED|Overall Study||2
2598765|NCT00246337|6380182|P1|NOT COMPLETED|Overall Study||32
2598766|NCT00246337|6380174|P9|COMPLETED|Overall Study||34
2598767|NCT00246337|6380175|P8|COMPLETED|Overall Study||40
2598768|NCT00246337|6380176|P7|COMPLETED|Overall Study||45
2598769|NCT00246337|6380177|P6|COMPLETED|Overall Study||39
2598770|NCT00246337|6380178|P5|COMPLETED|Overall Study||12
2598771|NCT00246337|6380179|P4|COMPLETED|Overall Study||16
2598772|NCT00246337|6380180|P3|COMPLETED|Overall Study||15
2598773|NCT00246337|6380181|P2|COMPLETED|Overall Study||14
2598774|NCT00246337|6380182|P1|COMPLETED|Overall Study||115
2598775|NCT00246337|6380174|P9|Completed Period (Both Doses)|Overall Study||15
2598776|NCT00246337|6380175|P8|Completed Period (Both Doses)|Overall Study||13
2598777|NCT00246337|6380176|P7|Completed Period (Both Doses)|Overall Study||16
2598778|NCT00246337|6380177|P6|Completed Period (Both Doses)|Overall Study||10
2598779|NCT00246337|6380178|P5|Completed Period (Both Doses)|Overall Study||4
2598780|NCT00246337|6380179|P4|Completed Period (Both Doses)|Overall Study||11
2598781|NCT00246337|6380180|P3|Completed Period (Both Doses)|Overall Study||6
2598782|NCT00246337|6380181|P2|Completed Period (Both Doses)|Overall Study||10
2598783|NCT00246337|6380182|P1|Completed Period (Both Doses)|Overall Study||69
2598784|NCT00246337|6380174|P9|Completed Period (Initial Dose)|Overall Study||19
2598785|NCT00246337|6380175|P8|Completed Period (Initial Dose)|Overall Study||27
2598786|NCT00246337|6380176|P7|Completed Period (Initial Dose)|Overall Study||29
2598787|NCT00246337|6380177|P6|Completed Period (Initial Dose)|Overall Study||29
2598788|NCT00246337|6380178|P5|Completed Period (Initial Dose)|Overall Study||8
2598789|NCT00246337|6380179|P4|Completed Period (Initial Dose)|Overall Study||5
2598790|NCT00246337|6380180|P3|Completed Period (Initial Dose)|Overall Study||9
2598791|NCT00246337|6380181|P2|Completed Period (Initial Dose)|Overall Study||4
2598792|NCT00246337|6380182|P1|Completed Period (Initial Dose)|Overall Study||46
2598793|NCT00246337|6380174|P9|STARTED|Overall Study||45
2598794|NCT00246337|6380175|P8|STARTED|Overall Study||53
2598795|NCT00246337|6380176|P7|STARTED|Overall Study||54
2598796|NCT00246337|6380177|P6|STARTED|Overall Study||54
2598797|NCT00246337|6380178|P5|STARTED|Overall Study||16
2598798|NCT00246337|6380179|P4|STARTED|Overall Study||17
2598799|NCT00246337|6380180|P3|STARTED|Overall Study||18
2598800|NCT00246337|6380181|P2|STARTED|Overall Study||16
2598801|NCT00246337|6380182|P1|STARTED|Overall Study||147
2598802|NCT00246324|6380229|P1|NOT COMPLETED|Overall Study||1
2598803|NCT00246324|6380229|P1|COMPLETED|Overall Study||15
2598804|NCT00246324|6380229|P1|STARTED|Overall Study||16
2598805|NCT00246259|6380236|P2|NOT COMPLETED|Overall Study||26
2598806|NCT00246259|6380237|P1|NOT COMPLETED|Overall Study||28
2598807|NCT00246259|6380236|P2|COMPLETED|Overall Study||15
2598808|NCT00246259|6380237|P1|COMPLETED|Overall Study||16
2598809|NCT00246259|6380236|P2|Eligible for Intent-to-treat (ITT)|Overall Study||35
2598810|NCT00246259|6380237|P1|Eligible for Intent-to-treat (ITT)|Overall Study||42
2598811|NCT00246259|6380236|P2|STARTED|Overall Study||41
2598812|NCT00246259|6380237|P1|STARTED|Overall Study||44
2598813|NCT00246090|6380271|P1|NOT COMPLETED|Overall Study||295
2598814|NCT00246090|6380271|P1|COMPLETED|Overall Study||3
2598815|NCT00246090|6380271|P1|STARTED|Overall Study||298
2598816|NCT00246025|6380280|P4|NOT COMPLETED|Overall Study||13
2598817|NCT00246025|6380281|P3|NOT COMPLETED|Overall Study||10
2598818|NCT00246025|6380282|P2|NOT COMPLETED|Overall Study||9
2598819|NCT00246025|6380283|P1|NOT COMPLETED|Overall Study||10
2598820|NCT00246025|6380280|P4|COMPLETED|Overall Study||116
2598821|NCT00246025|6380281|P3|COMPLETED|Overall Study||116
2598822|NCT00246025|6380282|P2|COMPLETED|Overall Study||124
2598823|NCT00246025|6380283|P1|COMPLETED|Overall Study||114
2598824|NCT00246025|6380280|P4|STARTED|Overall Study||129
2598825|NCT00246025|6380281|P3|STARTED|Overall Study||126
2598826|NCT00246025|6380282|P2|STARTED|Overall Study||133
2598827|NCT00246025|6380283|P1|STARTED|Overall Study||124
2598828|NCT00246012|6380342|P9|NOT COMPLETED|Overall Study||28
2598829|NCT00246012|6380343|P8|NOT COMPLETED|Overall Study||28
2598830|NCT00246012|6380344|P7|NOT COMPLETED|Overall Study||31
2598831|NCT00246012|6380345|P6|NOT COMPLETED|Overall Study||28
2598832|NCT00246012|6380346|P5|NOT COMPLETED|Overall Study||3
2598833|NCT00246012|6380347|P4|NOT COMPLETED|Overall Study||3
2598834|NCT00246012|6380348|P3|NOT COMPLETED|Overall Study||2
2598835|NCT00246012|6380349|P2|NOT COMPLETED|Overall Study||1
2598836|NCT00246012|6380350|P1|NOT COMPLETED|Overall Study||3
2598837|NCT00246012|6380342|P9|COMPLETED|Overall Study||4
2598838|NCT00246012|6380343|P8|COMPLETED|Overall Study||5
2598839|NCT00246012|6380344|P7|COMPLETED|Overall Study||1
2598840|NCT00246012|6380345|P6|COMPLETED|Overall Study||4
2598841|NCT00246012|6380346|P5|COMPLETED|Overall Study||0
2598842|NCT00246012|6380347|P4|COMPLETED|Overall Study||0
2598843|NCT00246012|6380348|P3|COMPLETED|Overall Study||1
2598844|NCT00246012|6380349|P2|COMPLETED|Overall Study||2
2598845|NCT00246012|6380350|P1|COMPLETED|Overall Study||0
2598846|NCT00246012|6380342|P9|Treated|Overall Study||32
2598847|NCT00246012|6380343|P8|Treated|Overall Study||33
2598848|NCT00246012|6380344|P7|Treated|Overall Study||31
2598849|NCT00246012|6380345|P6|Treated|Overall Study||31
2598850|NCT00246012|6380346|P5|Treated|Overall Study||3
2598851|NCT00246012|6380347|P4|Treated|Overall Study||3
2598852|NCT00246012|6380348|P3|Treated|Overall Study||3
2598853|NCT00246012|6380349|P2|Treated|Overall Study||3
2598854|NCT00246012|6380350|P1|Treated|Overall Study||3
2598855|NCT00246012|6380342|P9|STARTED|Overall Study||32
2598856|NCT00246012|6380343|P8|STARTED|Overall Study||33
2598857|NCT00246012|6380344|P7|STARTED|Overall Study||32
2598858|NCT00246012|6380345|P6|STARTED|Overall Study||32
2598859|NCT00246012|6380346|P5|STARTED|Overall Study||3
2598860|NCT00246012|6380347|P4|STARTED|Overall Study||3
2598861|NCT00246012|6380348|P3|STARTED|Overall Study||3
2598862|NCT00246012|6380349|P2|STARTED|Overall Study||3
2598863|NCT00246012|6380350|P1|STARTED|Overall Study||3
2598864|NCT00245960|6380445|P2|NOT COMPLETED|Overall Study||28
2598865|NCT00245960|6380446|P1|NOT COMPLETED|Overall Study||29
2598866|NCT00245960|6380445|P2|COMPLETED|Overall Study||345
2598867|NCT00245960|6380446|P1|COMPLETED|Overall Study||350
2598868|NCT00245960|6380445|P2|STARTED|Overall Study||373
2598869|NCT00245960|6380446|P1|STARTED|Overall Study||379
2598870|NCT00245856|6380454|P2|NOT COMPLETED|Period Two||1
2598871|NCT00245856|6380455|P1|NOT COMPLETED|Period Two||0
2598872|NCT00245856|6380454|P2|COMPLETED|Period Two||38
2598873|NCT00245856|6380455|P1|COMPLETED|Period Two||0
2598874|NCT00245856|6380454|P2|STARTED|Period Two||39
2598875|NCT00245856|6380455|P1|STARTED|Period Two||0
2598876|NCT00245856|6380454|P2|NOT COMPLETED|Period One||0
2598877|NCT00245856|6380455|P1|NOT COMPLETED|Period One||0
2598878|NCT00245856|6380454|P2|COMPLETED|Period One||0
2598879|NCT00245856|6380455|P1|COMPLETED|Period One||28
2598880|NCT00245856|6380454|P2|STARTED|Period One||0
2598881|NCT00245856|6380455|P1|STARTED|Period One||28
2598882|NCT00245765|6380465|P3|NOT COMPLETED|Overall Study||8
2598883|NCT00245765|6380466|P2|NOT COMPLETED|Overall Study||14
2598884|NCT00245765|6380467|P1|NOT COMPLETED|Overall Study||32
2598885|NCT00245765|6380465|P3|COMPLETED|Overall Study||50
2598886|NCT00245765|6380466|P2|COMPLETED|Overall Study||45
2598887|NCT00245765|6380467|P1|COMPLETED|Overall Study||27
2598888|NCT00245765|6380465|P3|Safety Population|Overall Study|One subject in the 400 mg group was randomized by mistake but did not receive study medication.|57
2598889|NCT00245765|6380466|P2|Safety Population|Overall Study|For safety analysis, the PBO group subj. who received CDP870 was considered to be in the 200mg group|60
2598890|NCT00245765|6380467|P1|Safety Population|Overall Study|One subject in the Placebo (PBO) group received one injection of CDP870 200 mg on one occasion.|58
2598891|NCT00245765|6380465|P3|STARTED|Overall Study||58
2598892|NCT00245765|6380466|P2|STARTED|Overall Study||59
2598893|NCT00245765|6380467|P1|STARTED|Overall Study||59
2598894|NCT00245635|6380507|P2|NOT COMPLETED|Overall Study||0
2598895|NCT00245635|6380508|P1|NOT COMPLETED|Overall Study||0
2598896|NCT00245635|6380507|P2|COMPLETED|Overall Study||18
2598897|NCT00245635|6380508|P1|COMPLETED|Overall Study||25
2598898|NCT00245635|6380507|P2|STARTED|Overall Study||18
2598899|NCT00245635|6380508|P1|STARTED|Overall Study||25
2598900|NCT00245583|6380516|P2|NOT COMPLETED|Overall Study||9
2598901|NCT00245583|6380517|P1|NOT COMPLETED|Overall Study||6
2598902|NCT00245583|6380516|P2|COMPLETED|Overall Study||13
2598903|NCT00245583|6380517|P1|COMPLETED|Overall Study||14
2598904|NCT00245583|6380516|P2|STARTED|Overall Study||22
2598905|NCT00245583|6380517|P1|STARTED|Overall Study||20
2598906|NCT00245570|6380537|P6|NOT COMPLETED|Treatment Period IV||0
2598907|NCT00245570|6380538|P5|NOT COMPLETED|Treatment Period IV||0
2598908|NCT00245570|6380539|P4|NOT COMPLETED|Treatment Period IV||0
2598909|NCT00245570|6380540|P3|NOT COMPLETED|Treatment Period IV||0
2598910|NCT00245570|6380541|P2|NOT COMPLETED|Treatment Period IV||0
2598911|NCT00245570|6380542|P1|NOT COMPLETED|Treatment Period IV||0
2598912|NCT00245570|6380537|P6|COMPLETED|Treatment Period IV||8
2598913|NCT00245570|6380538|P5|COMPLETED|Treatment Period IV||8
2598914|NCT00245570|6380539|P4|COMPLETED|Treatment Period IV||8
2598915|NCT00245570|6380540|P3|COMPLETED|Treatment Period IV||8
2598916|NCT00245570|6380541|P2|COMPLETED|Treatment Period IV||7
2598917|NCT00245570|6380542|P1|COMPLETED|Treatment Period IV||7
2598918|NCT00245570|6380537|P6|STARTED|Treatment Period IV||8
2598919|NCT00245570|6380538|P5|STARTED|Treatment Period IV||8
2598920|NCT00245570|6380539|P4|STARTED|Treatment Period IV||8
2598921|NCT00245570|6380540|P3|STARTED|Treatment Period IV||8
2598922|NCT00245570|6380541|P2|STARTED|Treatment Period IV||7
2598923|NCT00245570|6380542|P1|STARTED|Treatment Period IV||7
2598924|NCT00245570|6380537|P6|NOT COMPLETED|Washout Between Periods III and IV||0
2598925|NCT00245570|6380538|P5|NOT COMPLETED|Washout Between Periods III and IV||0
2598926|NCT00245570|6380539|P4|NOT COMPLETED|Washout Between Periods III and IV||0
2598927|NCT00245570|6380540|P3|NOT COMPLETED|Washout Between Periods III and IV||0
2598928|NCT00245570|6380541|P2|NOT COMPLETED|Washout Between Periods III and IV||1
2598929|NCT00245570|6380542|P1|NOT COMPLETED|Washout Between Periods III and IV||0
2598930|NCT00245570|6380537|P6|COMPLETED|Washout Between Periods III and IV||8
2598931|NCT00245570|6380538|P5|COMPLETED|Washout Between Periods III and IV||8
2598932|NCT00245570|6380539|P4|COMPLETED|Washout Between Periods III and IV||8
2598933|NCT00245570|6380540|P3|COMPLETED|Washout Between Periods III and IV||8
2598934|NCT00245570|6380541|P2|COMPLETED|Washout Between Periods III and IV||7
2598935|NCT00245570|6380542|P1|COMPLETED|Washout Between Periods III and IV||7
2598936|NCT00245570|6380537|P6|STARTED|Washout Between Periods III and IV||8
2598937|NCT00245570|6380538|P5|STARTED|Washout Between Periods III and IV||8
2598938|NCT00245570|6380539|P4|STARTED|Washout Between Periods III and IV||8
2598939|NCT00245570|6380540|P3|STARTED|Washout Between Periods III and IV||8
2598940|NCT00245570|6380541|P2|STARTED|Washout Between Periods III and IV|1 pt in the montelukast/placebo/salmeterol group discontinued during washout period 2 after placebo|8
2598941|NCT00245570|6380542|P1|STARTED|Washout Between Periods III and IV||7
2598942|NCT00245570|6380537|P6|NOT COMPLETED|Treatment Period III||0
2598943|NCT00245570|6380538|P5|NOT COMPLETED|Treatment Period III||0
2598944|NCT00245570|6380539|P4|NOT COMPLETED|Treatment Period III||0
2598945|NCT00245570|6380540|P3|NOT COMPLETED|Treatment Period III||0
2598946|NCT00245570|6380541|P2|NOT COMPLETED|Treatment Period III||0
2598947|NCT00245570|6380542|P1|NOT COMPLETED|Treatment Period III||0
2598948|NCT00245570|6380537|P6|COMPLETED|Treatment Period III||8
2598949|NCT00245570|6380538|P5|COMPLETED|Treatment Period III||8
2598950|NCT00245570|6380539|P4|COMPLETED|Treatment Period III||8
2598951|NCT00245570|6380540|P3|COMPLETED|Treatment Period III||8
2598952|NCT00245570|6380541|P2|COMPLETED|Treatment Period III||8
2598953|NCT00245570|6380542|P1|COMPLETED|Treatment Period III||7
2598954|NCT00245570|6380537|P6|STARTED|Treatment Period III||8
2598955|NCT00245570|6380538|P5|STARTED|Treatment Period III||8
2598956|NCT00245570|6380539|P4|STARTED|Treatment Period III||8
2598957|NCT00245570|6380540|P3|STARTED|Treatment Period III||8
2598958|NCT00245570|6380541|P2|STARTED|Treatment Period III||8
2598959|NCT00245570|6380542|P1|STARTED|Treatment Period III||7
2598960|NCT00245570|6380537|P6|NOT COMPLETED|Washout Between Periods II and III||0
2598961|NCT00245570|6380538|P5|NOT COMPLETED|Washout Between Periods II and III||0
2598962|NCT00245570|6380539|P4|NOT COMPLETED|Washout Between Periods II and III||0
2598963|NCT00245570|6380540|P3|NOT COMPLETED|Washout Between Periods II and III||0
2598964|NCT00245570|6380541|P2|NOT COMPLETED|Washout Between Periods II and III||0
2598965|NCT00245570|6380542|P1|NOT COMPLETED|Washout Between Periods II and III||0
2598966|NCT00245570|6380537|P6|COMPLETED|Washout Between Periods II and III||8
2598967|NCT00245570|6380538|P5|COMPLETED|Washout Between Periods II and III||8
2598968|NCT00245570|6380539|P4|COMPLETED|Washout Between Periods II and III||8
2598969|NCT00245570|6380540|P3|COMPLETED|Washout Between Periods II and III||8
2598970|NCT00245570|6380541|P2|COMPLETED|Washout Between Periods II and III||8
2598971|NCT00245570|6380542|P1|COMPLETED|Washout Between Periods II and III||7
2598972|NCT00245570|6380537|P6|STARTED|Washout Between Periods II and III||8
2598973|NCT00245570|6380538|P5|STARTED|Washout Between Periods II and III||8
2598974|NCT00245570|6380539|P4|STARTED|Washout Between Periods II and III||8
2598975|NCT00245570|6380540|P3|STARTED|Washout Between Periods II and III||8
2598976|NCT00245570|6380541|P2|STARTED|Washout Between Periods II and III||8
2598977|NCT00245570|6380542|P1|STARTED|Washout Between Periods II and III||7
2598978|NCT00245570|6380537|P6|NOT COMPLETED|Treatment Period II||0
2598979|NCT00245570|6380538|P5|NOT COMPLETED|Treatment Period II||0
2598980|NCT00245570|6380539|P4|NOT COMPLETED|Treatment Period II||0
2598981|NCT00245570|6380540|P3|NOT COMPLETED|Treatment Period II||0
2598982|NCT00245570|6380541|P2|NOT COMPLETED|Treatment Period II||0
2598983|NCT00245570|6380542|P1|NOT COMPLETED|Treatment Period II||0
2598984|NCT00245570|6380537|P6|COMPLETED|Treatment Period II||8
2598985|NCT00245570|6380538|P5|COMPLETED|Treatment Period II||8
2598986|NCT00245570|6380539|P4|COMPLETED|Treatment Period II||8
2598987|NCT00245570|6380540|P3|COMPLETED|Treatment Period II||8
2598988|NCT00245570|6380541|P2|COMPLETED|Treatment Period II||8
2598989|NCT00245570|6380542|P1|COMPLETED|Treatment Period II||7
2598990|NCT00245570|6380537|P6|STARTED|Treatment Period II||8
2598991|NCT00245570|6380538|P5|STARTED|Treatment Period II||8
2598992|NCT00245570|6380539|P4|STARTED|Treatment Period II||8
2598993|NCT00245570|6380540|P3|STARTED|Treatment Period II||8
2598994|NCT00245570|6380541|P2|STARTED|Treatment Period II||8
2598995|NCT00245570|6380542|P1|STARTED|Treatment Period II||7
2598996|NCT00245557|6380588|P2|NOT COMPLETED|Overall Study||16
2598997|NCT00245557|6380589|P1|NOT COMPLETED|Overall Study||6
2598998|NCT00245557|6380588|P2|COMPLETED|Overall Study||10
2598999|NCT00245557|6380589|P1|COMPLETED|Overall Study||11
2599000|NCT00245557|6380588|P2|STARTED|Overall Study||26
2599001|NCT00245557|6380589|P1|STARTED|Overall Study||17
2599002|NCT00245518|6380602|P2|NOT COMPLETED|Overall Study||0
2599003|NCT00245518|6380603|P1|NOT COMPLETED|Overall Study||0
2599004|NCT00245518|6380602|P2|COMPLETED|Overall Study||16
2599005|NCT00245518|6380603|P1|COMPLETED|Overall Study||17
2599006|NCT00245518|6380602|P2|STARTED|Overall Study||16
2599007|NCT00245518|6380603|P1|STARTED|Overall Study||17
2599008|NCT00245466|6380676|P3|NOT COMPLETED|Overall Study||37
2599009|NCT00245466|6380677|P2|NOT COMPLETED|Overall Study||44
2599010|NCT00245466|6380678|P1|NOT COMPLETED|Overall Study||36
2599011|NCT00245466|6380676|P3|COMPLETED|Overall Study||3
2599012|NCT00245466|6380677|P2|COMPLETED|Overall Study||2
2599013|NCT00245466|6380678|P1|COMPLETED|Overall Study|Defined as those participants ongoing when the extension study was terminated|7
2599014|NCT00245466|6380676|P3|Started FE200486 CS02A|Overall Study||26
2599015|NCT00245466|6380677|P2|Started FE200486 CS02A|Overall Study||30
2599016|NCT00245466|6380678|P1|Started FE200486 CS02A|Overall Study||32
2599017|NCT00245466|6380676|P3|STARTED|Overall Study||40
2599018|NCT00245466|6380677|P2|STARTED|Overall Study||46
2599019|NCT00245466|6380678|P1|STARTED|Overall Study||43
2599020|NCT00245219|6380695|P3|NOT COMPLETED|Overall Study||2
2599021|NCT00245219|6380696|P2|NOT COMPLETED|Overall Study||6
2599022|NCT00245219|6380697|P1|NOT COMPLETED|Overall Study||6
2599023|NCT00245219|6380695|P3|COMPLETED|Overall Study||58
2599024|NCT00245219|6380696|P2|COMPLETED|Overall Study||88
2599025|NCT00245219|6380697|P1|COMPLETED|Overall Study||85
2599026|NCT00245219|6380695|P3|STARTED|Overall Study||60
2599027|NCT00245219|6380696|P2|STARTED|Overall Study||94
2599028|NCT00245219|6380697|P1|STARTED|Overall Study||91
2599029|NCT00245128|6380711|P1|NOT COMPLETED|Overall Study||10
2599030|NCT00245128|6380711|P1|COMPLETED|Overall Study||0
2599031|NCT00245128|6380711|P1|STARTED|Overall Study||10
2599032|NCT00245102|6380721|P6|NOT COMPLETED|Overall Study||4
2599033|NCT00245102|6380722|P5|NOT COMPLETED|Overall Study||0
2599034|NCT00245102|6380723|P4|NOT COMPLETED|Overall Study||3
2599035|NCT00245102|6380724|P3|NOT COMPLETED|Overall Study||7
2599036|NCT00245102|6380725|P2|NOT COMPLETED|Overall Study||4
2599037|NCT00245102|6380726|P1|NOT COMPLETED|Overall Study||7
2599038|NCT00245102|6380721|P6|COMPLETED|Overall Study||19
2599039|NCT00245102|6380722|P5|COMPLETED|Overall Study||5
2599040|NCT00245102|6380723|P4|COMPLETED|Overall Study||10
2599041|NCT00245102|6380724|P3|COMPLETED|Overall Study||39
2599042|NCT00245102|6380725|P2|COMPLETED|Overall Study||12
2599043|NCT00245102|6380726|P1|COMPLETED|Overall Study||37
2599044|NCT00245102|6380721|P6|STARTED|Overall Study||23
2599045|NCT00245102|6380722|P5|STARTED|Overall Study||5
2599046|NCT00245102|6380723|P4|STARTED|Overall Study||13
2599047|NCT00245102|6380724|P3|STARTED|Overall Study||46
2599048|NCT00245102|6380725|P2|STARTED|Overall Study||16
2599049|NCT00245102|6380726|P1|STARTED|Overall Study||44
2599050|NCT00245063|6380742|P2|NOT COMPLETED|Overall Study||5
2599051|NCT00245063|6380743|P1|NOT COMPLETED|Overall Study||7
2599052|NCT00245063|6380742|P2|COMPLETED|Overall Study||8
2599053|NCT00245063|6380743|P1|COMPLETED|Overall Study||5
2599054|NCT00245063|6380742|P2|STARTED|Overall Study||13
2599055|NCT00245063|6380743|P1|STARTED|Overall Study||12
2599056|NCT00245050|6380751|P2|NOT COMPLETED|Overall Study||2
2599057|NCT00245050|6380752|P1|NOT COMPLETED|Overall Study||3
2599058|NCT00245050|6380751|P2|COMPLETED|Overall Study||14
2599059|NCT00245050|6380752|P1|COMPLETED|Overall Study||15
2599060|NCT00245050|6380751|P2|STARTED|Overall Study||16
2599061|NCT00245050|6380752|P1|STARTED|Overall Study||18
2599062|NCT00245037|6380760|P1|NOT COMPLETED|Overall Study||17
2599063|NCT00245037|6380760|P1|COMPLETED|Overall Study|17 participants died from infectious complications.|130
2599064|NCT00245037|6380760|P1|STARTED|Overall Study||147
2599065|NCT00245011|6380770|P1|NOT COMPLETED|Overall Study||1
2599066|NCT00245011|6380770|P1|COMPLETED|Overall Study|Subject had disease progression prior to completing study.|10
2599067|NCT00245011|6380770|P1|STARTED|Overall Study||11
2599068|NCT00244985|6380774|P1|NOT COMPLETED|Overall Study||0
2599069|NCT00244985|6380774|P1|COMPLETED|Overall Study||42
2599070|NCT00244985|6380774|P1|STARTED|Overall Study||42
2599071|NCT00244933|6380782|P1|NOT COMPLETED|Overall Study||2
2599072|NCT00244933|6380782|P1|COMPLETED|Overall Study||17
2599073|NCT00244933|6380782|P1|STARTED|Overall Study||19
2599074|NCT00244881|6380786|P1|NOT COMPLETED|Overall Study||3
2599075|NCT00244881|6380786|P1|COMPLETED|Overall Study||23
2599076|NCT00244881|6380786|P1|STARTED|Overall Study||26
2599077|NCT00244855|6380794|P2|NOT COMPLETED|Overall Study||1
2599078|NCT00244855|6380795|P1|NOT COMPLETED|Overall Study||0
2599079|NCT00244855|6380794|P2|COMPLETED|Overall Study||24
2599080|NCT00244855|6380795|P1|COMPLETED|Overall Study||7
2599081|NCT00244855|6380794|P2|STARTED|Overall Study||25
2599082|NCT00244855|6380795|P1|STARTED|Overall Study||7
2599083|NCT00244764|6380803|P1|NOT COMPLETED|Overall Study||96
2599084|NCT00244764|6380803|P1|COMPLETED|Overall Study||129
2599085|NCT00244764|6380803|P1|STARTED|Overall Study||225
2599086|NCT00244751|6380813|P3|NOT COMPLETED|Overall Study||10
2599087|NCT00244751|6380814|P2|NOT COMPLETED|Overall Study||15
2599088|NCT00244751|6380815|P1|NOT COMPLETED|Overall Study||16
2599089|NCT00244751|6380813|P3|COMPLETED|Overall Study||78
2599090|NCT00244751|6380814|P2|COMPLETED|Overall Study||74
2599091|NCT00244751|6380815|P1|COMPLETED|Overall Study||72
2599092|NCT00244751|6380813|P3|STARTED|Overall Study||88
2599093|NCT00244751|6380814|P2|STARTED|Overall Study||89
2599094|NCT00244751|6380815|P1|STARTED|Overall Study||88
2599095|NCT00244725|6380916|P4|NOT COMPLETED|Overall Study||21
2599096|NCT00244725|6380917|P3|NOT COMPLETED|Overall Study||24
2599097|NCT00244725|6380918|P2|NOT COMPLETED|Overall Study||19
2599098|NCT00244725|6380919|P1|NOT COMPLETED|Overall Study||23
2599099|NCT00244725|6380916|P4|COMPLETED|Overall Study||216
2599100|NCT00244725|6380917|P3|COMPLETED|Overall Study||215
2599101|NCT00244725|6380918|P2|COMPLETED|Overall Study||226
2599102|NCT00244725|6380919|P1|COMPLETED|Overall Study||214
2599103|NCT00244725|6380916|P4|STARTED|Overall Study||237
2599104|NCT00244725|6380917|P3|STARTED|Overall Study||239
2599105|NCT00244725|6380918|P2|STARTED|Overall Study||245
2599106|NCT00244725|6380919|P1|STARTED|Overall Study||237
2599107|NCT00244712|6380975|P2|NOT COMPLETED|Overall Study||124
2599108|NCT00244712|6380976|P1|NOT COMPLETED|Overall Study||109
2599109|NCT00244712|6380975|P2|COMPLETED|Overall Study||221
2599110|NCT00244712|6380976|P1|COMPLETED|Overall Study||234
2599111|NCT00244712|6380975|P2|STARTED|Overall Study||345
2599112|NCT00244712|6380976|P1|STARTED|Overall Study||343
2599113|NCT00244621|6381011|P3|NOT COMPLETED|Open-label Treatment Period||2
2599114|NCT00244621|6381012|P2|NOT COMPLETED|Open-label Treatment Period||1
2599115|NCT00244621|6381013|P1|NOT COMPLETED|Open-label Treatment Period||1
2599116|NCT00244621|6381011|P3|COMPLETED|Open-label Treatment Period||28
2599117|NCT00244621|6381012|P2|COMPLETED|Open-label Treatment Period||28
2599118|NCT00244621|6381013|P1|COMPLETED|Open-label Treatment Period||25
2599119|NCT00244621|6381011|P3|STARTED|Open-label Treatment Period||30
2599120|NCT00244621|6381012|P2|STARTED|Open-label Treatment Period||29
2599121|NCT00244621|6381013|P1|STARTED|Open-label Treatment Period|One participant discontinued study due to Adverse Event after completing the double-blind period.|26
2599122|NCT00244621|6381011|P3|NOT COMPLETED|Double-blind Treatment Period||2
2599123|NCT00244621|6381012|P2|NOT COMPLETED|Double-blind Treatment Period||3
2599124|NCT00244621|6381013|P1|NOT COMPLETED|Double-blind Treatment Period||2
2599125|NCT00244621|6381011|P3|COMPLETED|Double-blind Treatment Period||30
2599126|NCT00244621|6381012|P2|COMPLETED|Double-blind Treatment Period||29
2599127|NCT00244621|6381013|P1|COMPLETED|Double-blind Treatment Period||27
2599128|NCT00244621|6381011|P3|STARTED|Double-blind Treatment Period||32
2599129|NCT00244621|6381012|P2|STARTED|Double-blind Treatment Period||32
2599130|NCT00244621|6381013|P1|STARTED|Double-blind Treatment Period||29
2599131|NCT00244374|6381030|P5|NOT COMPLETED|Vaccine Adherence Cohort||0
2599132|NCT00244374|6381031|P4|NOT COMPLETED|Vaccine Adherence Cohort||0
2599133|NCT00244374|6381032|P3|NOT COMPLETED|Vaccine Adherence Cohort||0
2599134|NCT00244374|6381033|P2|NOT COMPLETED|Vaccine Adherence Cohort||0
2599135|NCT00244374|6381034|P1|NOT COMPLETED|Vaccine Adherence Cohort||0
2599136|NCT00244374|6381030|P5|COMPLETED|Vaccine Adherence Cohort||41
2599137|NCT00244374|6381031|P4|COMPLETED|Vaccine Adherence Cohort||36
2599138|NCT00244374|6381032|P3|COMPLETED|Vaccine Adherence Cohort||43
2599139|NCT00244374|6381033|P2|COMPLETED|Vaccine Adherence Cohort||47
2599140|NCT00244374|6381034|P1|COMPLETED|Vaccine Adherence Cohort||0
2599141|NCT00244374|6381030|P5|STARTED|Vaccine Adherence Cohort||41
2599142|NCT00244374|6381031|P4|STARTED|Vaccine Adherence Cohort||36
2599143|NCT00244374|6381032|P3|STARTED|Vaccine Adherence Cohort||43
2599144|NCT00244374|6381033|P2|STARTED|Vaccine Adherence Cohort||47
2599145|NCT00244374|6381034|P1|STARTED|Vaccine Adherence Cohort|Eligible and willing cross-sectional study participants progressed to adherence cohort randomization|0
2599146|NCT00244374|6381030|P5|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
2599147|NCT00244374|6381031|P4|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
2599148|NCT00244374|6381032|P3|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
2599149|NCT00244374|6381033|P2|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
2599150|NCT00244374|6381034|P1|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||273
2599151|NCT00244374|6381030|P5|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
2599152|NCT00244374|6381031|P4|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
2599153|NCT00244374|6381032|P3|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
2599154|NCT00244374|6381033|P2|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
2599155|NCT00244374|6381034|P1|COMPLETED|Evaluation for Vaccine Adherence Cohort||167
2599156|NCT00244374|6381030|P5|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
2599157|NCT00244374|6381031|P4|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
2599158|NCT00244374|6381032|P3|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
2599159|NCT00244374|6381033|P2|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
2599160|NCT00244374|6381034|P1|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||217
2599161|NCT00244374|6381030|P5|STARTED|Evaluation for Vaccine Adherence Cohort||0
2599162|NCT00244374|6381031|P4|STARTED|Evaluation for Vaccine Adherence Cohort||0
2599163|NCT00244374|6381032|P3|STARTED|Evaluation for Vaccine Adherence Cohort||0
2599164|NCT00244374|6381033|P2|STARTED|Evaluation for Vaccine Adherence Cohort||0
2599165|NCT00244374|6381034|P1|STARTED|Evaluation for Vaccine Adherence Cohort|440 study participants enrolled prior to 3/31/2007 were evaluated for vaccine adherence cohort|440
2599166|NCT00244374|6381030|P5|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
2599167|NCT00244374|6381031|P4|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
2599168|NCT00244374|6381032|P3|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
2599169|NCT00244374|6381033|P2|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
2599170|NCT00244374|6381034|P1|NOT COMPLETED|Pre-Randomization Cross-sectional Study||137
2599171|NCT00244374|6381030|P5|COMPLETED|Pre-Randomization Cross-sectional Study||0
2599172|NCT00244374|6381031|P4|COMPLETED|Pre-Randomization Cross-sectional Study||0
2599173|NCT00244374|6381032|P3|COMPLETED|Pre-Randomization Cross-sectional Study||0
2599174|NCT00244374|6381033|P2|COMPLETED|Pre-Randomization Cross-sectional Study||0
2599175|NCT00244374|6381034|P1|COMPLETED|Pre-Randomization Cross-sectional Study||409
2599176|NCT00244374|6381030|P5|STARTED|Pre-Randomization Cross-sectional Study||0
2599177|NCT00244374|6381031|P4|STARTED|Pre-Randomization Cross-sectional Study||0
2599178|NCT00244374|6381032|P3|STARTED|Pre-Randomization Cross-sectional Study||0
2599179|NCT00244374|6381033|P2|STARTED|Pre-Randomization Cross-sectional Study||0
2599180|NCT00244374|6381034|P1|STARTED|Pre-Randomization Cross-sectional Study||546
2599181|NCT00244140|6381052|P2|NOT COMPLETED|Overall Study||0
2599182|NCT00244140|6381053|P1|NOT COMPLETED|Overall Study||0
2599183|NCT00244140|6381052|P2|COMPLETED|Overall Study||22
2599184|NCT00244140|6381053|P1|COMPLETED|Overall Study||412
2599185|NCT00244140|6381052|P2|STARTED|Overall Study||22
2599186|NCT00244140|6381053|P1|STARTED|Overall Study||412
2599187|NCT00244101|6381068|P3|NOT COMPLETED|Overall Study||0
2599188|NCT00244101|6381069|P2|NOT COMPLETED|Overall Study||0
2599189|NCT00244101|6381070|P1|NOT COMPLETED|Overall Study||0
2599190|NCT00244101|6381068|P3|COMPLETED|Overall Study||216
2599191|NCT00244101|6381069|P2|COMPLETED|Overall Study||223
2599192|NCT00244101|6381070|P1|COMPLETED|Overall Study||209
2599193|NCT00244101|6381068|P3|STARTED|Overall Study||216
2599194|NCT00244101|6381069|P2|STARTED|Overall Study||223
2599195|NCT00244101|6381070|P1|STARTED|Overall Study||209
2599196|NCT00244010|6381080|P2|NOT COMPLETED|Overall Study||0
2599197|NCT00244010|6381081|P1|NOT COMPLETED|Overall Study||0
2599198|NCT00244010|6381080|P2|COMPLETED|Overall Study||2
2599199|NCT00244010|6381081|P1|COMPLETED|Overall Study||2
2599200|NCT00244010|6381080|P2|STARTED|Overall Study||2
2599201|NCT00244010|6381081|P1|STARTED|Overall Study||2
2599202|NCT00243932|6381090|P3|NOT COMPLETED|Stage 2: Efficacy||0
2599203|NCT00243932|6381091|P2|NOT COMPLETED|Stage 2: Efficacy||0
2599204|NCT00243932|6381092|P1|NOT COMPLETED|Stage 2: Efficacy||0
2599205|NCT00243932|6381090|P3|COMPLETED|Stage 2: Efficacy||0
2599206|NCT00243932|6381091|P2|COMPLETED|Stage 2: Efficacy||40
2599207|NCT00243932|6381092|P1|COMPLETED|Stage 2: Efficacy||40
2599208|NCT00243932|6381090|P3|STARTED|Stage 2: Efficacy|No new pts. randomized because selection procedure in Stage 1 selected the 2,700 mg dose.|0
2599209|NCT00243932|6381091|P2|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
2599210|NCT00243932|6381092|P1|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
2599211|NCT00243932|6381090|P3|NOT COMPLETED|Stage 1: Dose Selection||0
2599212|NCT00243932|6381091|P2|NOT COMPLETED|Stage 1: Dose Selection||0
2599213|NCT00243932|6381092|P1|NOT COMPLETED|Stage 1: Dose Selection||2
2599214|NCT00243932|6381090|P3|COMPLETED|Stage 1: Dose Selection||35
2599215|NCT00243932|6381091|P2|COMPLETED|Stage 1: Dose Selection||35
2599216|NCT00243932|6381092|P1|COMPLETED|Stage 1: Dose Selection||33
2599217|NCT00243932|6381090|P3|STARTED|Stage 1: Dose Selection||35
2599218|NCT00243932|6381091|P2|STARTED|Stage 1: Dose Selection||35
2599219|NCT00243932|6381092|P1|STARTED|Stage 1: Dose Selection||35
2599220|NCT00243919|6381103|P3|NOT COMPLETED|Overall Study||11
2599221|NCT00243919|6381104|P2|NOT COMPLETED|Overall Study||18
2599222|NCT00243919|6381105|P1|NOT COMPLETED|Overall Study||17
2599223|NCT00243919|6381103|P3|COMPLETED|Overall Study||115
2599224|NCT00243919|6381104|P2|COMPLETED|Overall Study||125
2599225|NCT00243919|6381105|P1|COMPLETED|Overall Study||122
2599226|NCT00243919|6381103|P3|STARTED|Overall Study||126
2599227|NCT00243919|6381104|P2|STARTED|Overall Study||143
2599228|NCT00243919|6381105|P1|STARTED|Overall Study||139
2599229|NCT00243841|6381149|P6|NOT COMPLETED|Overall Study||2
2599230|NCT00243841|6381150|P5|NOT COMPLETED|Overall Study||0
2599231|NCT00243841|6381151|P4|NOT COMPLETED|Overall Study||0
2599232|NCT00243841|6381152|P3|NOT COMPLETED|Overall Study||1
2599233|NCT00243841|6381153|P2|NOT COMPLETED|Overall Study||0
2599234|NCT00243841|6381154|P1|NOT COMPLETED|Overall Study||0
2599235|NCT00243841|6381149|P6|COMPLETED|Overall Study||19
2599236|NCT00243841|6381150|P5|COMPLETED|Overall Study||39
2599237|NCT00243841|6381151|P4|COMPLETED|Overall Study||3
2599238|NCT00243841|6381152|P3|COMPLETED|Overall Study||4
2599239|NCT00243841|6381153|P2|COMPLETED|Overall Study||6
2599240|NCT00243841|6381154|P1|COMPLETED|Overall Study||3
2599241|NCT00243841|6381149|P6|STARTED|Overall Study||21
2599242|NCT00243841|6381150|P5|STARTED|Overall Study||39
2599243|NCT00243841|6381151|P4|STARTED|Overall Study||3
2599244|NCT00243841|6381152|P3|STARTED|Overall Study||5
2599245|NCT00243841|6381153|P2|STARTED|Overall Study||6
2599246|NCT00243841|6381154|P1|STARTED|Overall Study||3
2599247|NCT00243659|6381176|P2|NOT COMPLETED|Overall Study||3
2599248|NCT00243659|6381177|P1|NOT COMPLETED|Overall Study||2
2599249|NCT00243659|6381176|P2|COMPLETED|Overall Study||5
2599250|NCT00243659|6381177|P1|COMPLETED|Overall Study||20
2599251|NCT00243659|6381176|P2|STARTED|Overall Study||8
2599252|NCT00243659|6381177|P1|STARTED|Overall Study||22
2599253|NCT00243503|6381185|P1|NOT COMPLETED|Overall Study||58
2599254|NCT00243503|6381185|P1|COMPLETED|Overall Study||2
2599255|NCT00243503|6381185|P1|STARTED|Overall Study|3 participants discontinued and only took Trastuzumab.|60
2599256|NCT00243412|6381202|P2|NOT COMPLETED|Overall Study||11
2599257|NCT00243412|6381203|P1|NOT COMPLETED|Overall Study||10
2599258|NCT00243412|6381202|P2|COMPLETED|Overall Study|Completed Week 104|10
2599259|NCT00243412|6381203|P1|COMPLETED|Overall Study|Completed Week 104|11
2599260|NCT00243412|6381202|P2|Safety Evaluable|Overall Study||20
2599261|NCT00243412|6381203|P1|Safety Evaluable|Overall Study||21
2599262|NCT00243412|6381202|P2|STARTED|Overall Study|Intent to treat|21
2599263|NCT00243412|6381203|P1|STARTED|Overall Study|Intent to treat|21
2599264|NCT00243386|6381229|P3|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
2599265|NCT00243386|6381230|P2|NOT COMPLETED|PK-Driven or Standard Prophylaxis||3
2599266|NCT00243386|6381231|P1|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
2599267|NCT00243386|6381229|P3|COMPLETED|PK-Driven or Standard Prophylaxis||32
2599268|NCT00243386|6381230|P2|COMPLETED|PK-Driven or Standard Prophylaxis||31
2599269|NCT00243386|6381231|P1|COMPLETED|PK-Driven or Standard Prophylaxis||0
2599270|NCT00243386|6381229|P3|STARTED|PK-Driven or Standard Prophylaxis||32
2599271|NCT00243386|6381230|P2|STARTED|PK-Driven or Standard Prophylaxis||34
2599272|NCT00243386|6381231|P1|STARTED|PK-Driven or Standard Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
2599273|NCT00243386|6381229|P3|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
2599274|NCT00243386|6381230|P2|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
2599275|NCT00243386|6381231|P1|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||3
2599276|NCT00243386|6381229|P3|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
2599277|NCT00243386|6381230|P2|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
2599278|NCT00243386|6381231|P1|COMPLETED|End of Part 1, But Prior to Prophylaxis||66
2599279|NCT00243386|6381229|P3|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
2599280|NCT00243386|6381230|P2|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
2599281|NCT00243386|6381231|P1|STARTED|End of Part 1, But Prior to Prophylaxis||69
2599282|NCT00243386|6381229|P3|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
2599283|NCT00243386|6381230|P2|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
2599284|NCT00243386|6381231|P1|NOT COMPLETED|On-Demand Regimen (Study Part 1)||4
2599285|NCT00243386|6381229|P3|COMPLETED|On-Demand Regimen (Study Part 1)||0
2599286|NCT00243386|6381230|P2|COMPLETED|On-Demand Regimen (Study Part 1)||0
2599287|NCT00243386|6381231|P1|COMPLETED|On-Demand Regimen (Study Part 1)||69
2599288|NCT00243386|6381229|P3|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
2599289|NCT00243386|6381230|P2|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
2599290|NCT00243386|6381231|P1|STARTED|On-Demand Regimen (Study Part 1)||73
2599291|NCT00243347|6381296|P1|NOT COMPLETED|Overall Study||19
2599292|NCT00243347|6381296|P1|COMPLETED|Overall Study|Completed study|0
2599293|NCT00243347|6381296|P1|STARTED|Overall Study|Treated|19
2599294|NCT00243269|6381305|P4|NOT COMPLETED|Overall Study||4
2599295|NCT00243269|6381306|P3|NOT COMPLETED|Overall Study||1
2599296|NCT00243269|6381307|P2|NOT COMPLETED|Overall Study||1
2599297|NCT00243269|6381308|P1|NOT COMPLETED|Overall Study||3
2599298|NCT00243269|6381305|P4|COMPLETED|Overall Study||25
2599299|NCT00243269|6381306|P3|COMPLETED|Overall Study||11
2599300|NCT00243269|6381307|P2|COMPLETED|Overall Study||10
2599301|NCT00243269|6381308|P1|COMPLETED|Overall Study||28
2599302|NCT00243269|6381305|P4|STARTED|Overall Study||29
2599303|NCT00243269|6381306|P3|STARTED|Overall Study||12
2599304|NCT00243269|6381307|P2|STARTED|Overall Study||11
2599305|NCT00243269|6381308|P1|STARTED|Overall Study||31
2599306|NCT00243243|6381324|P2|NOT COMPLETED|Overall Study||0
2599307|NCT00243243|6381325|P1|NOT COMPLETED|Overall Study||0
2599308|NCT00243243|6381324|P2|COMPLETED|Overall Study||10
2599309|NCT00243243|6381325|P1|COMPLETED|Overall Study||10
2599310|NCT00243243|6381324|P2|STARTED|Overall Study||10
2599311|NCT00243243|6381325|P1|STARTED|Overall Study||10
2599312|NCT00243191|6381331|P1|NOT COMPLETED|Overall Study||0
2599313|NCT00243191|6381331|P1|COMPLETED|Overall Study||18
2599314|NCT00243191|6381331|P1|STARTED|Overall Study||18
2599315|NCT00243152|6381335|P2|NOT COMPLETED|Overall Study||0
2599316|NCT00243152|6381336|P1|NOT COMPLETED|Overall Study||0
2599317|NCT00243152|6381335|P2|COMPLETED|Overall Study||3
2599318|NCT00243152|6381336|P1|COMPLETED|Overall Study||3
2599319|NCT00243152|6381335|P2|Scan 2: Placebo or Drug|Overall Study||3
2599320|NCT00243152|6381336|P1|Scan 2: Placebo or Drug|Overall Study||3
2599321|NCT00243152|6381335|P2|Scan 1: Drug or Placebo|Overall Study||3
2599322|NCT00243152|6381336|P1|Scan 1: Drug or Placebo|Overall Study||3
2599323|NCT00243152|6381335|P2|STARTED|Overall Study||3
2599324|NCT00243152|6381336|P1|STARTED|Overall Study||3
2599325|NCT00243074|6381343|P1|NOT COMPLETED|Overall Study||54
2599326|NCT00243074|6381343|P1|COMPLETED|Overall Study||0
2599327|NCT00243074|6381343|P1|STARTED|Overall Study||54
2599328|NCT00243061|6381353|P1|NOT COMPLETED|Overall Study||0
2599329|NCT00243061|6381353|P1|COMPLETED|Overall Study||24
2599330|NCT00243061|6381353|P1|STARTED|Overall Study||24
2599331|NCT00243022|6381369|P2|NOT COMPLETED|Overall Study||1
2599332|NCT00243022|6381370|P1|NOT COMPLETED|Overall Study||2
2599333|NCT00243022|6381369|P2|COMPLETED|Overall Study||4
2599334|NCT00243022|6381370|P1|COMPLETED|Overall Study||5
2599335|NCT00243022|6381369|P2|STARTED|Overall Study||5
2599336|NCT00243022|6381370|P1|STARTED|Overall Study||7
2599337|NCT00242710|6381394|P4|NOT COMPLETED|Study Extension (up to Year 2)||10
2599338|NCT00242710|6381395|P3|NOT COMPLETED|Study Extension (up to Year 2)||15
2599339|NCT00242710|6381396|P2|NOT COMPLETED|Study Extension (up to Year 2)||29
2599340|NCT00242710|6381397|P1|NOT COMPLETED|Study Extension (up to Year 2)||27
2599341|NCT00242710|6381394|P4|COMPLETED|Study Extension (up to Year 2)||84
2599342|NCT00242710|6381395|P3|COMPLETED|Study Extension (up to Year 2)||69
2599343|NCT00242710|6381396|P2|COMPLETED|Study Extension (up to Year 2)||148
2599344|NCT00242710|6381397|P1|COMPLETED|Study Extension (up to Year 2)||141
2599345|NCT00242710|6381394|P4|STARTED|Study Extension (up to Year 2)||94
2599346|NCT00242710|6381395|P3|STARTED|Study Extension (up to Year 2)||84
2599347|NCT00242710|6381396|P2|STARTED|Study Extension (up to Year 2)||177
2599348|NCT00242710|6381397|P1|STARTED|Study Extension (up to Year 2)||168
2599349|NCT00242710|6381394|P4|NOT COMPLETED|Period Between Core Study and Extension||49
2599350|NCT00242710|6381395|P3|NOT COMPLETED|Period Between Core Study and Extension||48
2599351|NCT00242710|6381396|P2|NOT COMPLETED|Period Between Core Study and Extension||112
2599352|NCT00242710|6381397|P1|NOT COMPLETED|Period Between Core Study and Extension||119
2599353|NCT00242710|6381394|P4|COMPLETED|Period Between Core Study and Extension||94
2599354|NCT00242710|6381395|P3|COMPLETED|Period Between Core Study and Extension||84
2599355|NCT00242710|6381396|P2|COMPLETED|Period Between Core Study and Extension||177
2599356|NCT00242710|6381397|P1|COMPLETED|Period Between Core Study and Extension||168
2599357|NCT00242710|6381394|P4|STARTED|Period Between Core Study and Extension||143
2599358|NCT00242710|6381395|P3|STARTED|Period Between Core Study and Extension||132
2599359|NCT00242710|6381396|P2|STARTED|Period Between Core Study and Extension||289
2599360|NCT00242710|6381397|P1|STARTED|Period Between Core Study and Extension||287
2599361|NCT00242710|6381394|P4|NOT COMPLETED|Core Study (up to Year 1)||31
2599362|NCT00242710|6381395|P3|NOT COMPLETED|Core Study (up to Year 1)||51
2599363|NCT00242710|6381396|P2|NOT COMPLETED|Core Study (up to Year 1)||64
2599364|NCT00242710|6381397|P1|NOT COMPLETED|Core Study (up to Year 1)||86
2599365|NCT00242710|6381394|P4|COMPLETED|Core Study (up to Year 1)||143
2599366|NCT00242710|6381395|P3|COMPLETED|Core Study (up to Year 1)||132
2599367|NCT00242710|6381396|P2|COMPLETED|Core Study (up to Year 1)||289
2599368|NCT00242710|6381397|P1|COMPLETED|Core Study (up to Year 1)||287
2599369|NCT00242710|6381394|P4|Treated|Core Study (up to Year 1)||172
2599370|NCT00242710|6381395|P3|Treated|Core Study (up to Year 1)||179
2599371|NCT00242710|6381396|P2|Treated|Core Study (up to Year 1)||349
2599372|NCT00242710|6381397|P1|Treated|Core Study (up to Year 1)||361
2599373|NCT00242710|6381394|P4|STARTED|Core Study (up to Year 1)||174
2599374|NCT00242710|6381395|P3|STARTED|Core Study (up to Year 1)||183
2599375|NCT00242710|6381396|P2|STARTED|Core Study (up to Year 1)||353
2599376|NCT00242710|6381397|P1|STARTED|Core Study (up to Year 1)||373
2599377|NCT00242684|6381447|P1|NOT COMPLETED|Overall Study||0
2599378|NCT00242684|6381447|P1|COMPLETED|Overall Study||446
2599379|NCT00242684|6381447|P1|STARTED|Overall Study||446
2599380|NCT00242658|6381454|P2|NOT COMPLETED|Overall Study||19
2599381|NCT00242658|6381455|P1|NOT COMPLETED|Overall Study||22
2599382|NCT00242658|6381454|P2|COMPLETED|Overall Study||188
2599383|NCT00242658|6381455|P1|COMPLETED|Overall Study||165
2599384|NCT00242658|6381454|P2|STARTED|Overall Study||207
2599385|NCT00242658|6381455|P1|STARTED|Overall Study||187
2599386|NCT00242632|6381465|P2|NOT COMPLETED|Overall Study||0
2599387|NCT00242632|6381466|P1|NOT COMPLETED|Overall Study||0
2599388|NCT00242632|6381465|P2|COMPLETED|Overall Study||11
2599389|NCT00242632|6381466|P1|COMPLETED|Overall Study||11
2599390|NCT00242632|6381465|P2|STARTED|Overall Study||11
2599391|NCT00242632|6381466|P1|STARTED|Overall Study||11
2599392|NCT00242619|6381474|P2|NOT COMPLETED|Overall Study||0
2599393|NCT00242619|6381475|P1|NOT COMPLETED|Overall Study||0
2599394|NCT00242619|6381474|P2|COMPLETED|Overall Study||4
2599395|NCT00242619|6381475|P1|COMPLETED|Overall Study||8
2599396|NCT00242619|6381474|P2|STARTED|Overall Study||4
2599397|NCT00242619|6381475|P1|STARTED|Overall Study||8
2599398|NCT00242580|6381486|P3|NOT COMPLETED|Overall Study||14
2599399|NCT00242580|6381487|P2|NOT COMPLETED|Overall Study||12
2599400|NCT00242580|6381488|P1|NOT COMPLETED|Overall Study||10
2599401|NCT00242580|6381486|P3|COMPLETED|Overall Study||24
2599402|NCT00242580|6381487|P2|COMPLETED|Overall Study||29
2599403|NCT00242580|6381488|P1|COMPLETED|Overall Study|"Completed indicates 12 month data."|22
2599404|NCT00242580|6381486|P3|STARTED|Overall Study||38
2599405|NCT00242580|6381487|P2|STARTED|Overall Study||41
2599406|NCT00242580|6381488|P1|STARTED|Overall Study||32
2599407|NCT00242567|6381513|P2|NOT COMPLETED|Overall Study||140
2599408|NCT00242567|6381514|P1|NOT COMPLETED|Overall Study||166
2599409|NCT00242567|6381513|P2|COMPLETED|Overall Study||123
2599410|NCT00242567|6381514|P1|COMPLETED|Overall Study||93
2599411|NCT00242567|6381513|P2|Never Received Study Drug|Overall Study||191
2599412|NCT00242567|6381514|P1|Never Received Study Drug|Overall Study||0
2599413|NCT00242567|6381513|P2|Received at Least 1 Dose of Study Drug|Overall Study||72
2599414|NCT00242567|6381514|P1|Received at Least 1 Dose of Study Drug|Overall Study||259
2599415|NCT00242567|6381513|P2|STARTED|Overall Study||263
2599416|NCT00242567|6381514|P1|STARTED|Overall Study||259
2599417|NCT00242502|6381530|P1|NOT COMPLETED|Overall Study||0
2599418|NCT00242502|6381530|P1|COMPLETED|Overall Study||59
2599419|NCT00242502|6381530|P1|STARTED|Overall Study||59
2599420|NCT00242385|6381534|P2|NOT COMPLETED|Period 2||0
2599421|NCT00242385|6381535|P1|NOT COMPLETED|Period 2||0
2599422|NCT00242385|6381534|P2|COMPLETED|Period 2||11
2599423|NCT00242385|6381535|P1|COMPLETED|Period 2||14
2599424|NCT00242385|6381534|P2|STARTED|Period 2||11
2599425|NCT00242385|6381535|P1|STARTED|Period 2||14
2599426|NCT00242385|6381534|P2|NOT COMPLETED|Period 1||0
2599427|NCT00242385|6381535|P1|NOT COMPLETED|Period 1||0
2599428|NCT00242385|6381534|P2|COMPLETED|Period 1||11
2599429|NCT00242385|6381535|P1|COMPLETED|Period 1||14
2599430|NCT00242385|6381534|P2|STARTED|Period 1||11
2599431|NCT00242385|6381535|P1|STARTED|Period 1||14
2599432|NCT00242216|6381561|P2|NOT COMPLETED|Overall Study||22
2599433|NCT00242216|6381562|P1|NOT COMPLETED|Overall Study||18
2599434|NCT00242216|6381561|P2|COMPLETED|Overall Study||15
2599435|NCT00242216|6381562|P1|COMPLETED|Overall Study||21
2599436|NCT00242216|6381561|P2|STARTED|Overall Study||37
2599437|NCT00242216|6381562|P1|STARTED|Overall Study||39
2599438|NCT00241969|6381572|P2|NOT COMPLETED|Overall Study||0
2599439|NCT00241969|6381573|P1|NOT COMPLETED|Overall Study||0
2599440|NCT00241969|6381572|P2|COMPLETED|Overall Study||42
2599441|NCT00241969|6381573|P1|COMPLETED|Overall Study||36
2599442|NCT00241969|6381572|P2|STARTED|Overall Study||42
2599443|NCT00241969|6381573|P1|STARTED|Overall Study||36
2599444|NCT00241904|6381585|P2|NOT COMPLETED|Overall Study||24
2599445|NCT00241904|6381586|P1|NOT COMPLETED|Overall Study||34
2599446|NCT00241904|6381585|P2|COMPLETED|Overall Study||240
2599447|NCT00241904|6381586|P1|COMPLETED|Overall Study||227
2599448|NCT00241904|6381585|P2|STARTED|Overall Study||264
2599449|NCT00241904|6381586|P1|STARTED|Overall Study||261
2599450|NCT00241839|6381600|P2|NOT COMPLETED|Overall Study||18
2599451|NCT00241839|6381601|P1|NOT COMPLETED|Overall Study||19
2599452|NCT00241839|6381600|P2|COMPLETED|Overall Study|N=53 represents number with both baseline and 8-10 week data. N<53 implies missing data.|53
2599453|NCT00241839|6381601|P1|COMPLETED|Overall Study|N=52 represents number with both baseline and 8-10 week data. N<52 implies missing data.|52
2599454|NCT00241839|6381600|P2|STARTED|Overall Study||71
2599455|NCT00241839|6381601|P1|STARTED|Overall Study||71
2599456|NCT00241644|6381617|P4|NOT COMPLETED|Second Efficacy Period (Year 2)||118
2599457|NCT00241644|6381618|P3|NOT COMPLETED|Second Efficacy Period (Year 2)||64
2599458|NCT00241644|6381619|P2|NOT COMPLETED|Second Efficacy Period (Year 2)||57
2599459|NCT00241644|6381620|P1|NOT COMPLETED|Second Efficacy Period (Year 2)||61
2599460|NCT00241644|6381617|P4|COMPLETED|Second Efficacy Period (Year 2)||1407
2599461|NCT00241644|6381618|P3|COMPLETED|Second Efficacy Period (Year 2)||682
2599462|NCT00241644|6381619|P2|COMPLETED|Second Efficacy Period (Year 2)||697
2599463|NCT00241644|6381620|P1|COMPLETED|Second Efficacy Period (Year 2)||710
2599464|NCT00241644|6381617|P4|STARTED|Second Efficacy Period (Year 2)||1525
2599465|NCT00241644|6381618|P3|STARTED|Second Efficacy Period (Year 2)||746
2599466|NCT00241644|6381619|P2|STARTED|Second Efficacy Period (Year 2)||754
2599467|NCT00241644|6381620|P1|STARTED|Second Efficacy Period (Year 2)||771
2599468|NCT00241644|6381617|P4|NOT COMPLETED|First Efficacy Period (Year 1)||495
2599469|NCT00241644|6381618|P3|NOT COMPLETED|First Efficacy Period (Year 1)||249
2599470|NCT00241644|6381619|P2|NOT COMPLETED|First Efficacy Period (Year 1)||268
2599471|NCT00241644|6381620|P1|NOT COMPLETED|First Efficacy Period (Year 1)||227
2599472|NCT00241644|6381617|P4|COMPLETED|First Efficacy Period (Year 1)||2803
2599473|NCT00241644|6381618|P3|COMPLETED|First Efficacy Period (Year 1)||1392
2599474|NCT00241644|6381619|P2|COMPLETED|First Efficacy Period (Year 1)||1383
2599475|NCT00241644|6381620|P1|COMPLETED|First Efficacy Period (Year 1)||1420
2599476|NCT00241644|6381617|P4|STARTED|First Efficacy Period (Year 1)||3298
2599477|NCT00241644|6381618|P3|STARTED|First Efficacy Period (Year 1)||1641
2599478|NCT00241644|6381619|P2|STARTED|First Efficacy Period (Year 1)||1651
2599479|NCT00241644|6381620|P1|STARTED|First Efficacy Period (Year 1)||1647
2599480|NCT00241631|6381704|P2|NOT COMPLETED|Phase 2 (4 Weeks)||0
2599481|NCT00241631|6381705|P1|NOT COMPLETED|Phase 2 (4 Weeks)||0
2599482|NCT00241631|6381704|P2|COMPLETED|Phase 2 (4 Weeks)||16
2599483|NCT00241631|6381705|P1|COMPLETED|Phase 2 (4 Weeks)||14
2599484|NCT00241631|6381704|P2|STARTED|Phase 2 (4 Weeks)||16
2599485|NCT00241631|6381705|P1|STARTED|Phase 2 (4 Weeks)||14
2599486|NCT00241631|6381704|P2|NOT COMPLETED|Wash Out (2 Weeks)||0
2599487|NCT00241631|6381705|P1|NOT COMPLETED|Wash Out (2 Weeks)||0
2599488|NCT00241631|6381704|P2|COMPLETED|Wash Out (2 Weeks)||16
2599489|NCT00241631|6381705|P1|COMPLETED|Wash Out (2 Weeks)||14
2599490|NCT00241631|6381704|P2|STARTED|Wash Out (2 Weeks)||16
2599491|NCT00241631|6381705|P1|STARTED|Wash Out (2 Weeks)||14
2599492|NCT00241631|6381704|P2|NOT COMPLETED|Phase 1 (4 Weeks)||5
2599493|NCT00241631|6381705|P1|NOT COMPLETED|Phase 1 (4 Weeks)||8
2599494|NCT00241631|6381704|P2|COMPLETED|Phase 1 (4 Weeks)||16
2599495|NCT00241631|6381705|P1|COMPLETED|Phase 1 (4 Weeks)||14
2599496|NCT00241631|6381704|P2|STARTED|Phase 1 (4 Weeks)||21
2599497|NCT00241631|6381705|P1|STARTED|Phase 1 (4 Weeks)||22
2599498|NCT00241631|6381704|P2|NOT COMPLETED|Run in (2 Weeks)||3
2599499|NCT00241631|6381705|P1|NOT COMPLETED|Run in (2 Weeks)||3
2599500|NCT00241631|6381704|P2|COMPLETED|Run in (2 Weeks)||21
2599501|NCT00241631|6381705|P1|COMPLETED|Run in (2 Weeks)||22
2599502|NCT00241631|6381704|P2|STARTED|Run in (2 Weeks)||24
2599503|NCT00241631|6381705|P1|STARTED|Run in (2 Weeks)||25
2599504|NCT00241358|6381718|P3|NOT COMPLETED|Overall Study||1
2599505|NCT00241358|6381719|P2|NOT COMPLETED|Overall Study||1
2599506|NCT00241358|6381720|P1|NOT COMPLETED|Overall Study||0
2599507|NCT00241358|6381718|P3|COMPLETED|Overall Study||20
2599508|NCT00241358|6381719|P2|COMPLETED|Overall Study||45
2599509|NCT00241358|6381720|P1|COMPLETED|Overall Study||25
2599510|NCT00241358|6381718|P3|STARTED|Overall Study||21
2599511|NCT00241358|6381719|P2|STARTED|Overall Study||46
2599512|NCT00241358|6381720|P1|STARTED|Overall Study||25
2599513|NCT00241280|6381753|P2|NOT COMPLETED|Overall Study||68
2599514|NCT00241280|6381754|P1|NOT COMPLETED|Overall Study||48
2599515|NCT00241280|6381753|P2|COMPLETED|Overall Study||186
2599516|NCT00241280|6381754|P1|COMPLETED|Overall Study||199
2599517|NCT00241280|6381753|P2|STARTED|Overall Study||254
2599518|NCT00241280|6381754|P1|STARTED|Overall Study||247
2599519|NCT00241176|6381762|P1|NOT COMPLETED|Overall Study||0
2599520|NCT00241176|6381762|P1|COMPLETED|Overall Study||11
2599521|NCT00241176|6381762|P1|STARTED|Overall Study||11
2599522|NCT00240994|6381769|P1|NOT COMPLETED|Overall Study||3
2599523|NCT00240994|6381769|P1|COMPLETED|Overall Study||32
2599524|NCT00240994|6381769|P1|STARTED|Overall Study||35
2599525|NCT00240981|6381775|P2|NOT COMPLETED|Overall Study||33
2599526|NCT00240981|6381776|P1|NOT COMPLETED|Overall Study||38
2599527|NCT00240981|6381775|P2|COMPLETED|Overall Study||70
2599528|NCT00240981|6381776|P1|COMPLETED|Overall Study||68
2599529|NCT00240981|6381775|P2|Intent to Treat Sample|Overall Study||83
2599530|NCT00240981|6381776|P1|Intent to Treat Sample|Overall Study||82
2599531|NCT00240981|6381775|P2|STARTED|Overall Study||103
2599532|NCT00240981|6381776|P1|STARTED|Overall Study||106
2599533|NCT00240539|6381804|P4|NOT COMPLETED|Overall Study||0
2599534|NCT00240539|6381805|P3|NOT COMPLETED|Overall Study||0
2599535|NCT00240539|6381806|P2|NOT COMPLETED|Overall Study||0
2599536|NCT00240539|6381807|P1|NOT COMPLETED|Overall Study||0
2599537|NCT00240539|6381804|P4|COMPLETED|Overall Study||1
2599538|NCT00240539|6381805|P3|COMPLETED|Overall Study||31
2599539|NCT00240539|6381806|P2|COMPLETED|Overall Study||2
2599540|NCT00240539|6381807|P1|COMPLETED|Overall Study||2
2599541|NCT00240539|6381804|P4|STARTED|Overall Study||1
2599542|NCT00240539|6381805|P3|STARTED|Overall Study||31
2599543|NCT00240539|6381806|P2|STARTED|Overall Study||2
2599544|NCT00240539|6381807|P1|STARTED|Overall Study||2
2599545|NCT00240526|6381829|P4|NOT COMPLETED|Year 20||0
2599546|NCT00240526|6381830|P3|NOT COMPLETED|Year 20||0
2599547|NCT00240526|6381831|P2|NOT COMPLETED|Year 20||0
2599548|NCT00240526|6381832|P1|NOT COMPLETED|Year 20||0
2599549|NCT00240526|6381829|P4|COMPLETED|Year 20||20
2599550|NCT00240526|6381830|P3|COMPLETED|Year 20||13
2599551|NCT00240526|6381831|P2|COMPLETED|Year 20||17
2599552|NCT00240526|6381832|P1|COMPLETED|Year 20||19
2599553|NCT00240526|6381829|P4|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|20
2599554|NCT00240526|6381830|P3|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|13
2599555|NCT00240526|6381831|P2|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|17
2599556|NCT00240526|6381832|P1|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|19
2599557|NCT00240526|6381829|P4|NOT COMPLETED|Year 19||0
2599558|NCT00240526|6381830|P3|NOT COMPLETED|Year 19||0
2599559|NCT00240526|6381831|P2|NOT COMPLETED|Year 19||0
2599560|NCT00240526|6381832|P1|NOT COMPLETED|Year 19||0
2599561|NCT00240526|6381829|P4|COMPLETED|Year 19||18
2599562|NCT00240526|6381830|P3|COMPLETED|Year 19||12
2599563|NCT00240526|6381831|P2|COMPLETED|Year 19||16
2599564|NCT00240526|6381832|P1|COMPLETED|Year 19||17
2599565|NCT00240526|6381829|P4|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|18
2599566|NCT00240526|6381830|P3|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|12
2599567|NCT00240526|6381831|P2|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|16
2599651|NCT00240162|6381939|P1|COMPLETED|Overall Study||21
2599568|NCT00240526|6381832|P1|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|17
2599569|NCT00240526|6381829|P4|NOT COMPLETED|Year 18||0
2599570|NCT00240526|6381830|P3|NOT COMPLETED|Year 18||0
2599571|NCT00240526|6381831|P2|NOT COMPLETED|Year 18||0
2599572|NCT00240526|6381832|P1|NOT COMPLETED|Year 18||0
2599573|NCT00240526|6381829|P4|COMPLETED|Year 18||20
2599574|NCT00240526|6381830|P3|COMPLETED|Year 18||14
2599575|NCT00240526|6381831|P2|COMPLETED|Year 18||17
2599576|NCT00240526|6381832|P1|COMPLETED|Year 18||16
2599577|NCT00240526|6381829|P4|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|20
2599578|NCT00240526|6381830|P3|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|14
2599579|NCT00240526|6381831|P2|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|17
2599580|NCT00240526|6381832|P1|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|16
2599581|NCT00240526|6381829|P4|NOT COMPLETED|Year 17||0
2599582|NCT00240526|6381830|P3|NOT COMPLETED|Year 17||0
2599583|NCT00240526|6381831|P2|NOT COMPLETED|Year 17||0
2599584|NCT00240526|6381832|P1|NOT COMPLETED|Year 17||0
2599585|NCT00240526|6381829|P4|COMPLETED|Year 17||20
2599586|NCT00240526|6381830|P3|COMPLETED|Year 17||13
2599587|NCT00240526|6381831|P2|COMPLETED|Year 17||17
2599588|NCT00240526|6381832|P1|COMPLETED|Year 17||19
2599589|NCT00240526|6381829|P4|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|20
2599590|NCT00240526|6381830|P3|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|13
2599591|NCT00240526|6381831|P2|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|17
2599592|NCT00240526|6381832|P1|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|19
2599593|NCT00240526|6381829|P4|NOT COMPLETED|Year 16||0
2599594|NCT00240526|6381830|P3|NOT COMPLETED|Year 16||0
2599595|NCT00240526|6381831|P2|NOT COMPLETED|Year 16||0
2599596|NCT00240526|6381832|P1|NOT COMPLETED|Year 16||0
2599597|NCT00240526|6381829|P4|COMPLETED|Year 16||22
2599598|NCT00240526|6381830|P3|COMPLETED|Year 16||16
2599599|NCT00240526|6381831|P2|COMPLETED|Year 16||19
2599600|NCT00240526|6381832|P1|COMPLETED|Year 16||17
2599601|NCT00240526|6381829|P4|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|22
2599602|NCT00240526|6381830|P3|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|16
2599603|NCT00240526|6381831|P2|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|19
2599604|NCT00240526|6381832|P1|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|17
2599605|NCT00240526|6381829|P4|NOT COMPLETED|Year 15||0
2599606|NCT00240526|6381830|P3|NOT COMPLETED|Year 15||0
2599607|NCT00240526|6381831|P2|NOT COMPLETED|Year 15||0
2599608|NCT00240526|6381832|P1|NOT COMPLETED|Year 15||0
2599609|NCT00240526|6381829|P4|COMPLETED|Year 15||21
2599610|NCT00240526|6381830|P3|COMPLETED|Year 15||14
2599611|NCT00240526|6381831|P2|COMPLETED|Year 15||19
2599612|NCT00240526|6381832|P1|COMPLETED|Year 15||19
2599613|NCT00240526|6381829|P4|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|21
2599614|NCT00240526|6381830|P3|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|14
2599615|NCT00240526|6381831|P2|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
2599616|NCT00240526|6381832|P1|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
2599617|NCT00240500|6381868|P6|NOT COMPLETED|Overall Study||1
2599618|NCT00240500|6381869|P5|NOT COMPLETED|Overall Study||3
2599619|NCT00240500|6381870|P4|NOT COMPLETED|Overall Study||4
2599620|NCT00240500|6381871|P3|NOT COMPLETED|Overall Study||3
2599621|NCT00240500|6381872|P2|NOT COMPLETED|Overall Study||3
2599622|NCT00240500|6381873|P1|NOT COMPLETED|Overall Study||1
2599623|NCT00240500|6381868|P6|COMPLETED|Overall Study||2
2599624|NCT00240500|6381869|P5|COMPLETED|Overall Study||26
2599625|NCT00240500|6381870|P4|COMPLETED|Overall Study||19
2599626|NCT00240500|6381871|P3|COMPLETED|Overall Study||14
2599627|NCT00240500|6381872|P2|COMPLETED|Overall Study||17
2599628|NCT00240500|6381873|P1|COMPLETED|Overall Study||16
2599629|NCT00240500|6381868|P6|STARTED|Overall Study||3
2599630|NCT00240500|6381869|P5|STARTED|Overall Study||29
2599631|NCT00240500|6381870|P4|STARTED|Overall Study||23
2599632|NCT00240500|6381871|P3|STARTED|Overall Study||17
2599633|NCT00240500|6381872|P2|STARTED|Overall Study||20
2599634|NCT00240500|6381873|P1|STARTED|Overall Study||17
2599635|NCT00240487|6381895|P2|NOT COMPLETED|Overall Study||0
2599636|NCT00240487|6381896|P1|NOT COMPLETED|Overall Study||0
2599637|NCT00240487|6381895|P2|COMPLETED|Overall Study||28
2599638|NCT00240487|6381896|P1|COMPLETED|Overall Study||24
2599639|NCT00240487|6381895|P2|STARTED|Overall Study||28
2599640|NCT00240487|6381896|P1|STARTED|Overall Study||24
2599641|NCT00240331|6381904|P2|NOT COMPLETED|Overall Study||134
2599642|NCT00240331|6381905|P1|NOT COMPLETED|Overall Study||126
2599643|NCT00240331|6381904|P2|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1250
2599644|NCT00240331|6381905|P1|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1263
2599645|NCT00240331|6381904|P2|STARTED|Overall Study|One patient was incorrectly randomised and not included in the analyses|1384
2599646|NCT00240331|6381905|P1|STARTED|Overall Study|Two patients were incorrectly randomised and not included in the analyses.|1389
2599647|NCT00240227|6381923|P1|NOT COMPLETED|Overall Study||0
2599648|NCT00240227|6381923|P1|COMPLETED|Overall Study||8
2599649|NCT00240227|6381923|P1|STARTED|Overall Study||8
2599650|NCT00240162|6381939|P1|NOT COMPLETED|Overall Study||0
2599652|NCT00240162|6381939|P1|STARTED|Overall Study||21
2599653|NCT00240110|6381948|P2|NOT COMPLETED|Overall Study||7
2599654|NCT00240110|6381949|P1|NOT COMPLETED|Overall Study||6
2599655|NCT00240110|6381948|P2|COMPLETED|Overall Study||6
2599656|NCT00240110|6381949|P1|COMPLETED|Overall Study||7
2599657|NCT00240110|6381948|P2|STARTED|Overall Study||13
2599658|NCT00240110|6381949|P1|STARTED|Overall Study||13
2599659|NCT00240097|6381957|P1|NOT COMPLETED|Part II||23
2599660|NCT00240097|6381957|P1|COMPLETED|Part II||3
2599661|NCT00240097|6381957|P1|STARTED|Part II||26
2599662|NCT00240097|6381957|P1|NOT COMPLETED|Part I||4
2599663|NCT00240097|6381957|P1|COMPLETED|Part I||26
2599664|NCT00240097|6381957|P1|STARTED|Part I||30
2599665|NCT00240071|6381967|P1|NOT COMPLETED|Overall Study||3
2599666|NCT00240071|6381967|P1|COMPLETED|Overall Study|3 patients withdrew consent after 29, 5 and 3 1/2 months on study.|27
2599667|NCT00240071|6381967|P1|STARTED|Overall Study||30
2599668|NCT00239928|6381972|P1|NOT COMPLETED|Overall Study||10
2599669|NCT00239928|6381972|P1|COMPLETED|Overall Study||51
2599670|NCT00239928|6381972|P1|STARTED|Overall Study||61
2599671|NCT00239837|6381984|P2|NOT COMPLETED|Overall Study||7
2599672|NCT00239837|6381985|P1|NOT COMPLETED|Overall Study||3
2599673|NCT00239837|6381984|P2|COMPLETED|Overall Study|3-year follow-up|45
2599674|NCT00239837|6381985|P1|COMPLETED|Overall Study|3-year follow-up|45
2599675|NCT00239837|6381984|P2|6 Months|Overall Study||50
2599676|NCT00239837|6381985|P1|6 Months|Overall Study||48
2599677|NCT00239837|6381984|P2|STARTED|Overall Study||52
2599678|NCT00239837|6381985|P1|STARTED|Overall Study||48
2599679|NCT00239733|6382005|P1|NOT COMPLETED|Overall Study||0
2599680|NCT00239733|6382005|P1|COMPLETED|Overall Study||6
2599681|NCT00239733|6382005|P1|STARTED|Overall Study||6
2599682|NCT00239720|6382012|P2|NOT COMPLETED|Overall Study||1
2599683|NCT00239720|6382013|P1|NOT COMPLETED|Overall Study||1
2599684|NCT00239720|6382012|P2|COMPLETED|Overall Study|One participant lost to follow-up|0
2599685|NCT00239720|6382013|P1|COMPLETED|Overall Study|One participant discontinued due to an adverse event|2
2599686|NCT00239720|6382012|P2|STARTED|Overall Study||1
2599687|NCT00239720|6382013|P1|STARTED|Overall Study||3
2599688|NCT00239681|6382021|P2|NOT COMPLETED|Overall Study||715
2599689|NCT00239681|6382022|P1|NOT COMPLETED|Overall Study||693
2599690|NCT00239681|6382021|P2|COMPLETED|Overall Study||8186
2599691|NCT00239681|6382022|P1|COMPLETED|Overall Study||8208
2599692|NCT00239681|6382021|P2|Randomized and Treated (Safety Pop)|Overall Study||8864
2599693|NCT00239681|6382022|P1|Randomized and Treated (Safety Pop)|Overall Study||8869
2599694|NCT00239681|6382021|P2|STARTED|Overall Study||8901
2599695|NCT00239681|6382022|P1|STARTED|Overall Study||8901
2599696|NCT00239642|6382041|P3|NOT COMPLETED|Overall Study||2
2599697|NCT00239642|6382042|P2|NOT COMPLETED|Overall Study||0
2599698|NCT00239642|6382043|P1|NOT COMPLETED|Overall Study||2
2599699|NCT00239642|6382041|P3|COMPLETED|Overall Study||47
2599700|NCT00239642|6382042|P2|COMPLETED|Overall Study||47
2599701|NCT00239642|6382043|P1|COMPLETED|Overall Study||47
2599702|NCT00239642|6382041|P3|STARTED|Overall Study||49
2599703|NCT00239642|6382042|P2|STARTED|Overall Study||47
2599704|NCT00239642|6382043|P1|STARTED|Overall Study||49
2599705|NCT00239590|6382075|P2|NOT COMPLETED|Completed Study Protocol||2
2599706|NCT00239590|6382076|P1|NOT COMPLETED|Completed Study Protocol||1
2599707|NCT00239590|6382075|P2|COMPLETED|Completed Study Protocol||10
2599708|NCT00239590|6382076|P1|COMPLETED|Completed Study Protocol||13
2599709|NCT00239590|6382075|P2|STARTED|Completed Study Protocol||12
2599710|NCT00239590|6382076|P1|STARTED|Completed Study Protocol||14
2599711|NCT00239590|6382075|P2|NOT COMPLETED|Started Intervention After Randomization||0
2599712|NCT00239590|6382076|P1|NOT COMPLETED|Started Intervention After Randomization||0
2599713|NCT00239590|6382075|P2|COMPLETED|Started Intervention After Randomization||12
2599714|NCT00239590|6382076|P1|COMPLETED|Started Intervention After Randomization||14
2599715|NCT00239590|6382075|P2|STARTED|Started Intervention After Randomization||12
2599716|NCT00239590|6382076|P1|STARTED|Started Intervention After Randomization||14
2599717|NCT00239590|6382075|P2|NOT COMPLETED|Randomized||2
2599718|NCT00239590|6382076|P1|NOT COMPLETED|Randomized||0
2599719|NCT00239590|6382075|P2|COMPLETED|Randomized||12
2599720|NCT00239590|6382076|P1|COMPLETED|Randomized||14
2599721|NCT00239590|6382075|P2|STARTED|Randomized||14
2599722|NCT00239590|6382076|P1|STARTED|Randomized||14
2599723|NCT00239577|6382088|P4|NOT COMPLETED|Booster Phase||0
2599724|NCT00239577|6382089|P3|NOT COMPLETED|Booster Phase||0
2599725|NCT00239577|6382090|P2|NOT COMPLETED|Booster Phase||0
2599726|NCT00239577|6382091|P1|NOT COMPLETED|Booster Phase||0
2599727|NCT00239577|6382088|P4|COMPLETED|Booster Phase|The subjects belonging to this group did not receive an additional dose of Placebo.|0
2599728|NCT00239577|6382089|P3|COMPLETED|Booster Phase||12
2599729|NCT00239577|6382090|P2|COMPLETED|Booster Phase||9
2599730|NCT00239577|6382091|P1|COMPLETED|Booster Phase|The subjects belonging to this group did not receive a booster dose of Dengue vaccine.|0
2599731|NCT00239577|6382088|P4|STARTED|Booster Phase|The subjects belonging to this group did not receive an additional dose of Placebo.|0
2599732|NCT00239577|6382089|P3|STARTED|Booster Phase||12
2599733|NCT00239577|6382090|P2|STARTED|Booster Phase||9
2599734|NCT00239577|6382091|P1|STARTED|Booster Phase|The subjects belonging to this group did not receive a booster dose of Dengue vaccine.|0
2599735|NCT00239577|6382088|P4|NOT COMPLETED|Primary Phase||0
2599736|NCT00239577|6382089|P3|NOT COMPLETED|Primary Phase||3
2599737|NCT00239577|6382090|P2|NOT COMPLETED|Primary Phase||3
2599738|NCT00239577|6382091|P1|NOT COMPLETED|Primary Phase||5
2599739|NCT00239577|6382088|P4|COMPLETED|Primary Phase||21
2599740|NCT00239577|6382089|P3|COMPLETED|Primary Phase||18
2599741|NCT00239577|6382090|P2|COMPLETED|Primary Phase||19
2599742|NCT00239577|6382091|P1|COMPLETED|Primary Phase||17
2599743|NCT00239577|6382088|P4|STARTED|Primary Phase||21
2599744|NCT00239577|6382089|P3|STARTED|Primary Phase||21
2599745|NCT00239577|6382090|P2|STARTED|Primary Phase||22
2599746|NCT00239577|6382091|P1|STARTED|Primary Phase||22
2599747|NCT00239356|6382195|P2|NOT COMPLETED|Overall Study||9
2599748|NCT00239356|6382196|P1|NOT COMPLETED|Overall Study||39
2599749|NCT00239356|6382195|P2|COMPLETED|Overall Study||11
2599750|NCT00239356|6382196|P1|COMPLETED|Overall Study||58
2599751|NCT00239356|6382195|P2|STARTED|Overall Study||20
2599752|NCT00239356|6382196|P1|STARTED|Overall Study||97
2599753|NCT00239226|6382218|P4|NOT COMPLETED|Overall Study||3
2599754|NCT00239226|6382219|P3|NOT COMPLETED|Overall Study||1
2599755|NCT00239226|6382220|P2|NOT COMPLETED|Overall Study||0
2599756|NCT00239226|6382221|P1|NOT COMPLETED|Overall Study||1
2599757|NCT00239226|6382218|P4|COMPLETED|Overall Study||14
2599758|NCT00239226|6382219|P3|COMPLETED|Overall Study||36
2599759|NCT00239226|6382220|P2|COMPLETED|Overall Study||18
2599760|NCT00239226|6382221|P1|COMPLETED|Overall Study||29
2599761|NCT00239226|6382218|P4|STARTED|Overall Study||17
2599762|NCT00239226|6382219|P3|STARTED|Overall Study||37
2599763|NCT00239226|6382220|P2|STARTED|Overall Study||18
2599764|NCT00239226|6382221|P1|STARTED|Overall Study||30
2599765|NCT00239005|6382233|P2|NOT COMPLETED|Overall Study||12
2599766|NCT00239005|6382234|P1|NOT COMPLETED|Overall Study||12
2599767|NCT00239005|6382233|P2|COMPLETED|Overall Study||53
2599768|NCT00239005|6382234|P1|COMPLETED|Overall Study||57
2599769|NCT00239005|6382233|P2|Intention-to-treat Population (ITT)|Overall Study||61
2599770|NCT00239005|6382234|P1|Intention-to-treat Population (ITT)|Overall Study||68
2599771|NCT00239005|6382233|P2|STARTED|Overall Study||65
2599772|NCT00239005|6382234|P1|STARTED|Overall Study||69
2599773|NCT00238615|6382244|P1|NOT COMPLETED|Overall Study||0
2599774|NCT00238615|6382244|P1|COMPLETED|Overall Study||13
2599775|NCT00238615|6382244|P1|STARTED|Overall Study||13
2599776|NCT00238433|6382250|P1|NOT COMPLETED|Overall Study||3
2599777|NCT00238433|6382250|P1|COMPLETED|Overall Study||34
2599778|NCT00238433|6382250|P1|STARTED|Overall Study||37
2599785|NCT00238355|6382268|P1|NOT COMPLETED|Overall Study||3
2599786|NCT00238355|6382268|P1|COMPLETED|Overall Study||10
2599787|NCT00238355|6382268|P1|STARTED|Overall Study||13
2599788|NCT00238303|6382275|P3|NOT COMPLETED|Overall Study||9
2599789|NCT00238303|6382276|P2|NOT COMPLETED|Overall Study||2
2599790|NCT00238303|6382277|P1|NOT COMPLETED|Overall Study||15
2599791|NCT00238303|6382275|P3|COMPLETED|Overall Study||11
2599792|NCT00238303|6382276|P2|COMPLETED|Overall Study||13
2599793|NCT00238303|6382277|P1|COMPLETED|Overall Study||53
2599794|NCT00238303|6382275|P3|STARTED|Overall Study||20
2599795|NCT00238303|6382276|P2|STARTED|Overall Study||15
2599796|NCT00238303|6382277|P1|STARTED|Overall Study||68
2599797|NCT00238264|6382294|P1|NOT COMPLETED|Overall Study||36
2599798|NCT00238264|6382294|P1|COMPLETED|Overall Study||56
2599799|NCT00238264|6382294|P1|STARTED|Overall Study||92
2599800|NCT00238238|6382307|P3|NOT COMPLETED|Overall Study||0
2599801|NCT00238238|6382308|P2|NOT COMPLETED|Overall Study||3
2599802|NCT00238238|6382309|P1|NOT COMPLETED|Overall Study||0
2599803|NCT00238238|6382307|P3|COMPLETED|Overall Study||46
2599804|NCT00238238|6382308|P2|COMPLETED|Overall Study||45
2599805|NCT00238238|6382309|P1|COMPLETED|Overall Study||3
2599806|NCT00238238|6382307|P3|STARTED|Overall Study||46
2599807|NCT00238238|6382308|P2|STARTED|Overall Study||48
2599808|NCT00238238|6382309|P1|STARTED|Overall Study||3
2599809|NCT00238121|6382322|P2|NOT COMPLETED|Overall Study||2
2599810|NCT00238121|6382323|P1|NOT COMPLETED|Overall Study||3
2599811|NCT00238121|6382322|P2|COMPLETED|Overall Study||14
2599812|NCT00238121|6382323|P1|COMPLETED|Overall Study||37
2599813|NCT00238121|6382322|P2|STARTED|Overall Study||16
2599814|NCT00238121|6382323|P1|STARTED|Overall Study||40
2599815|NCT00238108|6382336|P2|NOT COMPLETED|Overall Study||0
2599816|NCT00238108|6382337|P1|NOT COMPLETED|Overall Study||0
2599817|NCT00238108|6382336|P2|COMPLETED|Overall Study||8
2599818|NCT00238108|6382337|P1|COMPLETED|Overall Study||8
2599819|NCT00238108|6382336|P2|STARTED|Overall Study||8
2599820|NCT00238108|6382337|P1|STARTED|Overall Study||8
2599821|NCT00237809|6382349|P4|NOT COMPLETED|Overall Study||9
2599822|NCT00237809|6382350|P3|NOT COMPLETED|Overall Study||9
2599823|NCT00237809|6382351|P2|NOT COMPLETED|Overall Study||10
2599824|NCT00237809|6382352|P1|NOT COMPLETED|Overall Study||11
2599825|NCT00237809|6382349|P4|COMPLETED|Overall Study||17
2599826|NCT00237809|6382350|P3|COMPLETED|Overall Study||15
2599827|NCT00237809|6382351|P2|COMPLETED|Overall Study||17
2599828|NCT00237809|6382352|P1|COMPLETED|Overall Study||16
2599829|NCT00237809|6382349|P4|STARTED|Overall Study||26
2599830|NCT00237809|6382350|P3|STARTED|Overall Study||24
2599831|NCT00237809|6382351|P2|STARTED|Overall Study||27
2599832|NCT00237809|6382352|P1|STARTED|Overall Study||27
2599833|NCT00237796|6382388|P2|NOT COMPLETED|Overall Study||5
2599834|NCT00237796|6382389|P1|NOT COMPLETED|Overall Study||10
2599835|NCT00237796|6382388|P2|COMPLETED|Overall Study||33
2599836|NCT00237796|6382389|P1|COMPLETED|Overall Study||31
2599837|NCT00237796|6382388|P2|STARTED|Overall Study||38
2599838|NCT00237796|6382389|P1|STARTED|Overall Study||41
2599839|NCT00237770|6382409|P2|NOT COMPLETED|Overall Study||0
2599840|NCT00237770|6382410|P1|NOT COMPLETED|Overall Study||0
2599841|NCT00237770|6382409|P2|COMPLETED|Overall Study||7
2599842|NCT00237770|6382410|P1|COMPLETED|Overall Study||9
2599843|NCT00237770|6382409|P2|STARTED|Overall Study||7
2599844|NCT00237770|6382410|P1|STARTED|Overall Study||9
2599845|NCT00237744|6382423|P3|NOT COMPLETED|Overall Study||0
2599846|NCT00237744|6382424|P2|NOT COMPLETED|Overall Study||1
2599847|NCT00237744|6382425|P1|NOT COMPLETED|Overall Study||3
2599848|NCT00237744|6382423|P3|COMPLETED|Overall Study||18
2599849|NCT00237744|6382424|P2|COMPLETED|Overall Study||10
2599850|NCT00237744|6382425|P1|COMPLETED|Overall Study||8
2599851|NCT00237744|6382423|P3|STARTED|Overall Study||18
2599852|NCT00237744|6382424|P2|STARTED|Overall Study||11
2599853|NCT00237744|6382425|P1|STARTED|Overall Study||11
2599854|NCT00237718|6382438|P2|NOT COMPLETED|Overall Study||41
2599855|NCT00237718|6382439|P1|NOT COMPLETED|Overall Study||46
2599856|NCT00237718|6382438|P2|COMPLETED|Overall Study||124
2599857|NCT00237718|6382439|P1|COMPLETED|Overall Study||114
2599858|NCT00237718|6382438|P2|STARTED|Overall Study||165
2599859|NCT00237718|6382439|P1|STARTED|Overall Study||160
2599860|NCT00237692|6382451|P4|NOT COMPLETED|Overall Study||19
2599861|NCT00237692|6382452|P3|NOT COMPLETED|Overall Study||22
2599862|NCT00237692|6382453|P2|NOT COMPLETED|Overall Study||14
2599863|NCT00237692|6382454|P1|NOT COMPLETED|Overall Study||18
2599864|NCT00237692|6382451|P4|COMPLETED|Overall Study||128
2599865|NCT00237692|6382452|P3|COMPLETED|Overall Study||127
2599866|NCT00237692|6382453|P2|COMPLETED|Overall Study||134
2599867|NCT00237692|6382454|P1|COMPLETED|Overall Study||129
2599868|NCT00237692|6382451|P4|18 Month f/u|Overall Study||122
2599869|NCT00237692|6382452|P3|18 Month f/u|Overall Study||126
2599870|NCT00237692|6382453|P2|18 Month f/u|Overall Study||131
2599871|NCT00237692|6382454|P1|18 Month f/u|Overall Study||124
2599872|NCT00237692|6382451|P4|12 Month f/u|Overall Study||127
2599873|NCT00237692|6382452|P3|12 Month f/u|Overall Study||132
2599874|NCT00237692|6382453|P2|12 Month f/u|Overall Study||127
2599875|NCT00237692|6382454|P1|12 Month f/u|Overall Study||137
2599876|NCT00237692|6382451|P4|6 Month f/u|Overall Study||134
2599877|NCT00237692|6382452|P3|6 Month f/u|Overall Study||135
2599878|NCT00237692|6382453|P2|6 Month f/u|Overall Study||134
2599879|NCT00237692|6382454|P1|6 Month f/u|Overall Study||132
2599880|NCT00237692|6382451|P4|STARTED|Overall Study||147
2599881|NCT00237692|6382452|P3|STARTED|Overall Study||149
2599882|NCT00237692|6382453|P2|STARTED|Overall Study||148
2599883|NCT00237692|6382454|P1|STARTED|Overall Study||147
2599884|NCT00237666|6382484|P1|NOT COMPLETED|Overall Study||6
2599885|NCT00237666|6382484|P1|COMPLETED|Overall Study||24
2599886|NCT00237666|6382484|P1|STARTED|Overall Study||30
2599887|NCT00237458|6382494|P1|NOT COMPLETED|Overall Study||3
2599888|NCT00237458|6382494|P1|COMPLETED|Overall Study||4
2599889|NCT00237458|6382494|P1|STARTED|Overall Study||7
2599890|NCT00237185|6382512|P2|NOT COMPLETED|Extension||19
2599891|NCT00237185|6382513|P1|NOT COMPLETED|Extension||16
2599892|NCT00237185|6382512|P2|COMPLETED|Extension||13
2599893|NCT00237185|6382513|P1|COMPLETED|Extension||8
2599894|NCT00237185|6382512|P2|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|32
2599895|NCT00237185|6382513|P1|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|24
2599896|NCT00237185|6382512|P2|NOT COMPLETED|Core||37
2599897|NCT00237185|6382513|P1|NOT COMPLETED|Core||44
2599898|NCT00237185|6382512|P2|COMPLETED|Core||37
2599899|NCT00237185|6382513|P1|COMPLETED|Core||30
2599900|NCT00237185|6382512|P2|Treated Participants|Core||74
2599901|NCT00237185|6382513|P1|Treated Participants|Core||73
2599902|NCT00237185|6382512|P2|STARTED|Core||74
2599903|NCT00237185|6382513|P1|STARTED|Core||74
2599904|NCT00237042|6382544|P3|NOT COMPLETED|Long Term (12 Month) Follow up||9
2599905|NCT00237042|6382545|P2|NOT COMPLETED|Long Term (12 Month) Follow up||9
2599906|NCT00237042|6382546|P1|NOT COMPLETED|Long Term (12 Month) Follow up||11
2599907|NCT00237042|6382544|P3|COMPLETED|Long Term (12 Month) Follow up||48
2599908|NCT00237042|6382545|P2|COMPLETED|Long Term (12 Month) Follow up||46
2599909|NCT00237042|6382546|P1|COMPLETED|Long Term (12 Month) Follow up||48
2599910|NCT00237042|6382544|P3|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
2599911|NCT00237042|6382545|P2|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
2599912|NCT00237042|6382546|P1|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
2599913|NCT00237042|6382544|P3|NOT COMPLETED|Short Term (6 Month) Follow up||11
2599914|NCT00237042|6382545|P2|NOT COMPLETED|Short Term (6 Month) Follow up||8
2599915|NCT00237042|6382546|P1|NOT COMPLETED|Short Term (6 Month) Follow up||9
2599916|NCT00237042|6382544|P3|COMPLETED|Short Term (6 Month) Follow up||46
2599917|NCT00237042|6382545|P2|COMPLETED|Short Term (6 Month) Follow up||47
2599918|NCT00237042|6382546|P1|COMPLETED|Short Term (6 Month) Follow up||50
2599919|NCT00237042|6382544|P3|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
2599920|NCT00237042|6382545|P2|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
2600013|NCT00235989|6382702|P5|NOT COMPLETED|Core Treatment Period (CT)||0
2599921|NCT00237042|6382546|P1|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
2599922|NCT00237042|6382544|P3|NOT COMPLETED|Treatment||38
2599923|NCT00237042|6382545|P2|NOT COMPLETED|Treatment||7
2599924|NCT00237042|6382546|P1|NOT COMPLETED|Treatment||6
2599925|NCT00237042|6382544|P3|COMPLETED|Treatment||36
2599926|NCT00237042|6382545|P2|COMPLETED|Treatment||50
2599927|NCT00237042|6382546|P1|COMPLETED|Treatment||54
2599928|NCT00237042|6382544|P3|STARTED|Treatment||74
2599929|NCT00237042|6382545|P2|STARTED|Treatment||57
2599930|NCT00237042|6382546|P1|STARTED|Treatment||60
2599931|NCT00236977|6382565|P2|NOT COMPLETED|Overall Study||19
2599932|NCT00236977|6382566|P1|NOT COMPLETED|Overall Study||21
2599933|NCT00236977|6382565|P2|COMPLETED|Overall Study||72
2599934|NCT00236977|6382566|P1|COMPLETED|Overall Study||70
2599935|NCT00236977|6382565|P2|STARTED|Overall Study||91
2599936|NCT00236977|6382566|P1|STARTED|Overall Study||91
2599937|NCT00236951|6382588|P4|NOT COMPLETED|Overall Study||31
2599938|NCT00236951|6382589|P3|NOT COMPLETED|Overall Study||19
2599939|NCT00236951|6382590|P2|NOT COMPLETED|Overall Study||31
2599940|NCT00236951|6382591|P1|NOT COMPLETED|Overall Study||26
2599941|NCT00236951|6382588|P4|COMPLETED|Overall Study||17
2599942|NCT00236951|6382589|P3|COMPLETED|Overall Study||21
2599943|NCT00236951|6382590|P2|COMPLETED|Overall Study||46
2599944|NCT00236951|6382591|P1|COMPLETED|Overall Study||33
2599945|NCT00236951|6382588|P4|STARTED|Overall Study||48
2599946|NCT00236951|6382589|P3|STARTED|Overall Study||40
2599947|NCT00236951|6382590|P2|STARTED|Overall Study||77
2599948|NCT00236951|6382591|P1|STARTED|Overall Study||59
2599949|NCT00236938|6382603|P2|NOT COMPLETED|Overall Study||20
2599950|NCT00236938|6382604|P1|NOT COMPLETED|Overall Study||13
2599951|NCT00236938|6382603|P2|COMPLETED|Overall Study||26
2599952|NCT00236938|6382604|P1|COMPLETED|Overall Study||62
2599953|NCT00236938|6382603|P2|STARTED|Overall Study||46
2599954|NCT00236938|6382604|P1|STARTED|Overall Study||75
2599955|NCT00236899|6382620|P4|NOT COMPLETED|Overall Study||40
2599956|NCT00236899|6382621|P3|NOT COMPLETED|Overall Study||44
2599957|NCT00236899|6382622|P2|NOT COMPLETED|Overall Study||40
2599958|NCT00236899|6382623|P1|NOT COMPLETED|Overall Study||42
2599959|NCT00236899|6382620|P4|COMPLETED|Overall Study||19
2599960|NCT00236899|6382621|P3|COMPLETED|Overall Study||14
2599961|NCT00236899|6382622|P2|COMPLETED|Overall Study||24
2599962|NCT00236899|6382623|P1|COMPLETED|Overall Study||18
2599963|NCT00236899|6382620|P4|STARTED|Overall Study||59
2599964|NCT00236899|6382621|P3|STARTED|Overall Study||58
2599965|NCT00236899|6382622|P2|STARTED|Overall Study||64
2599966|NCT00236899|6382623|P1|STARTED|Overall Study||60
2599967|NCT00236197|6382655|P2|NOT COMPLETED|Overall Study||14
2599968|NCT00236197|6382656|P1|NOT COMPLETED|Overall Study||5
2599969|NCT00236197|6382655|P2|COMPLETED|Overall Study||293
2599970|NCT00236197|6382656|P1|COMPLETED|Overall Study||307
2599971|NCT00236197|6382655|P2|STARTED|Overall Study||307
2599972|NCT00236197|6382656|P1|STARTED|Overall Study||312
2599973|NCT00236184|6382664|P2|NOT COMPLETED|Overall Study||11
2599974|NCT00236184|6382665|P1|NOT COMPLETED|Overall Study||18
2599975|NCT00236184|6382664|P2|COMPLETED|Overall Study||308
2599976|NCT00236184|6382665|P1|COMPLETED|Overall Study||292
2599977|NCT00236184|6382664|P2|STARTED|Overall Study||319
2599978|NCT00236184|6382665|P1|STARTED|Overall Study||310
2599979|NCT00236080|6382676|P5|NOT COMPLETED|Overall Study||1
2599980|NCT00236080|6382677|P4|NOT COMPLETED|Overall Study||2
2599981|NCT00236080|6382678|P3|NOT COMPLETED|Overall Study||5
2599982|NCT00236080|6382679|P2|NOT COMPLETED|Overall Study||1
2599983|NCT00236080|6382680|P1|NOT COMPLETED|Overall Study||2
2599984|NCT00236080|6382676|P5|COMPLETED|Overall Study||26
2599985|NCT00236080|6382677|P4|COMPLETED|Overall Study||23
2599986|NCT00236080|6382678|P3|COMPLETED|Overall Study||22
2599987|NCT00236080|6382679|P2|COMPLETED|Overall Study||27
2599988|NCT00236080|6382680|P1|COMPLETED|Overall Study||27
2599989|NCT00236080|6382676|P5|STARTED|Overall Study||27
2599990|NCT00236080|6382677|P4|STARTED|Overall Study||25
2599991|NCT00236080|6382678|P3|STARTED|Overall Study||27
2599992|NCT00236080|6382679|P2|STARTED|Overall Study||28
2599993|NCT00236080|6382680|P1|STARTED|Overall Study||29
2599994|NCT00235989|6382701|P6|NOT COMPLETED|Extension Treatment Period (ET)||0
2599995|NCT00235989|6382702|P5|NOT COMPLETED|Extension Treatment Period (ET)||0
2599996|NCT00235989|6382703|P4|NOT COMPLETED|Extension Treatment Period (ET)||6
2599997|NCT00235989|6382704|P3|NOT COMPLETED|Extension Treatment Period (ET)||5
2599998|NCT00235989|6382705|P2|NOT COMPLETED|Extension Treatment Period (ET)||4
2599999|NCT00235989|6382706|P1|NOT COMPLETED|Extension Treatment Period (ET)||8
2600000|NCT00235989|6382701|P6|COMPLETED|Extension Treatment Period (ET)||0
2600001|NCT00235989|6382702|P5|COMPLETED|Extension Treatment Period (ET)||0
2600002|NCT00235989|6382703|P4|COMPLETED|Extension Treatment Period (ET)||14
2600003|NCT00235989|6382704|P3|COMPLETED|Extension Treatment Period (ET)||14
2600004|NCT00235989|6382705|P2|COMPLETED|Extension Treatment Period (ET)||2
2600005|NCT00235989|6382706|P1|COMPLETED|Extension Treatment Period (ET)||8
2600006|NCT00235989|6382701|P6|STARTED|Extension Treatment Period (ET)||0
2600007|NCT00235989|6382702|P5|STARTED|Extension Treatment Period (ET)||0
2600008|NCT00235989|6382703|P4|STARTED|Extension Treatment Period (ET)||20
2600009|NCT00235989|6382704|P3|STARTED|Extension Treatment Period (ET)||19
2600010|NCT00235989|6382705|P2|STARTED|Extension Treatment Period (ET)||6
2600011|NCT00235989|6382706|P1|STARTED|Extension Treatment Period (ET)||16
2600012|NCT00235989|6382701|P6|NOT COMPLETED|Core Treatment Period (CT)||2
2600014|NCT00235989|6382703|P4|NOT COMPLETED|Core Treatment Period (CT)||0
2600015|NCT00235989|6382704|P3|NOT COMPLETED|Core Treatment Period (CT)||0
2600016|NCT00235989|6382705|P2|NOT COMPLETED|Core Treatment Period (CT)||0
2600017|NCT00235989|6382706|P1|NOT COMPLETED|Core Treatment Period (CT)||0
2600018|NCT00235989|6382701|P6|COMPLETED|Core Treatment Period (CT)||25
2600019|NCT00235989|6382702|P5|COMPLETED|Core Treatment Period (CT)||36
2600020|NCT00235989|6382703|P4|COMPLETED|Core Treatment Period (CT)||0
2600021|NCT00235989|6382704|P3|COMPLETED|Core Treatment Period (CT)||0
2600022|NCT00235989|6382705|P2|COMPLETED|Core Treatment Period (CT)||0
2600023|NCT00235989|6382706|P1|COMPLETED|Core Treatment Period (CT)||0
2600024|NCT00235989|6382701|P6|STARTED|Core Treatment Period (CT)||27
2600025|NCT00235989|6382702|P5|STARTED|Core Treatment Period (CT)||36
2600026|NCT00235989|6382703|P4|STARTED|Core Treatment Period (CT)||0
2600027|NCT00235989|6382704|P3|STARTED|Core Treatment Period (CT)||0
2600028|NCT00235989|6382705|P2|STARTED|Core Treatment Period (CT)||0
2600029|NCT00235989|6382706|P1|STARTED|Core Treatment Period (CT)||0
2600030|NCT00235872|6382720|P1|NOT COMPLETED|Overall Study||147
2600031|NCT00235872|6382720|P1|COMPLETED|Overall Study||162
2600032|NCT00235872|6382720|P1|STARTED|Overall Study||309
2600033|NCT00235833|6382735|P1|NOT COMPLETED|Overall Study||16
2600034|NCT00235833|6382735|P1|COMPLETED|Overall Study||9
2600035|NCT00235833|6382735|P1|STARTED|Overall Study||25
2600036|NCT00235755|6382751|P3|NOT COMPLETED|12-Week Maintenance Phase||31
2600037|NCT00235755|6382752|P2|NOT COMPLETED|12-Week Maintenance Phase||27
2600038|NCT00235755|6382753|P1|NOT COMPLETED|12-Week Maintenance Phase||16
2600039|NCT00235755|6382751|P3|COMPLETED|12-Week Maintenance Phase||122
2600040|NCT00235755|6382752|P2|COMPLETED|12-Week Maintenance Phase||135
2600041|NCT00235755|6382753|P1|COMPLETED|12-Week Maintenance Phase||152
2600042|NCT00235755|6382751|P3|STARTED|12-Week Maintenance Phase||153
2600043|NCT00235755|6382752|P2|STARTED|12-Week Maintenance Phase||162
2600044|NCT00235755|6382753|P1|STARTED|12-Week Maintenance Phase||168
2600045|NCT00235755|6382751|P3|NOT COMPLETED|4-Week Titration Phase||26
2600046|NCT00235755|6382752|P2|NOT COMPLETED|4-Week Titration Phase||19
2600047|NCT00235755|6382753|P1|NOT COMPLETED|4-Week Titration Phase||11
2600048|NCT00235755|6382751|P3|COMPLETED|4-Week Titration Phase||153
2600049|NCT00235755|6382752|P2|COMPLETED|4-Week Titration Phase||162
2600050|NCT00235755|6382753|P1|COMPLETED|4-Week Titration Phase||168
2600051|NCT00235755|6382751|P3|STARTED|4-Week Titration Phase||179
2600052|NCT00235755|6382752|P2|STARTED|4-Week Titration Phase||181
2600053|NCT00235755|6382753|P1|STARTED|4-Week Titration Phase||179
2600054|NCT00235716|6382831|P4|NOT COMPLETED|Overall Study||62
2600055|NCT00235716|6382832|P3|NOT COMPLETED|Overall Study||65
2600056|NCT00235716|6382833|P2|NOT COMPLETED|Overall Study||67
2600057|NCT00235716|6382834|P1|NOT COMPLETED|Overall Study||62
2600058|NCT00235716|6382831|P4|COMPLETED|Overall Study||90
2600059|NCT00235716|6382832|P3|COMPLETED|Overall Study||89
2600060|NCT00235716|6382833|P2|COMPLETED|Overall Study||88
2600061|NCT00235716|6382834|P1|COMPLETED|Overall Study||90
2600062|NCT00235716|6382831|P4|STARTED|Overall Study||152
2600063|NCT00235716|6382832|P3|STARTED|Overall Study||154
2600064|NCT00235716|6382833|P2|STARTED|Overall Study||155
2600065|NCT00235716|6382834|P1|STARTED|Overall Study||152
2600066|NCT00235573|6382868|P1|NOT COMPLETED|Overall Study||0
2600067|NCT00235573|6382868|P1|COMPLETED|Overall Study||21
2600068|NCT00235573|6382868|P1|STARTED|Overall Study|35 subjects screened; 14 not eligible; 21 started and completed study|21
2600069|NCT00235547|6382874|P2|NOT COMPLETED|6 Month Follow-up Survey||68
2600070|NCT00235547|6382875|P1|NOT COMPLETED|6 Month Follow-up Survey||71
2600071|NCT00235547|6382874|P2|COMPLETED|6 Month Follow-up Survey||76
2600072|NCT00235547|6382875|P1|COMPLETED|6 Month Follow-up Survey||83
2600073|NCT00235547|6382874|P2|STARTED|6 Month Follow-up Survey||144
2600074|NCT00235547|6382875|P1|STARTED|6 Month Follow-up Survey||154
2600075|NCT00235547|6382874|P2|NOT COMPLETED|2 Month Follow-up Survey||40
2600076|NCT00235547|6382875|P1|NOT COMPLETED|2 Month Follow-up Survey||46
2600077|NCT00235547|6382874|P2|COMPLETED|2 Month Follow-up Survey||104
2600078|NCT00235547|6382875|P1|COMPLETED|2 Month Follow-up Survey||108
2600079|NCT00235547|6382874|P2|STARTED|2 Month Follow-up Survey||144
2600080|NCT00235547|6382875|P1|STARTED|2 Month Follow-up Survey||154
2600081|NCT00235495|6382885|P2|NOT COMPLETED|Overall Study||68
2600082|NCT00235495|6382886|P1|NOT COMPLETED|Overall Study||68
2600083|NCT00235495|6382885|P2|COMPLETED|Overall Study||351
2600084|NCT00235495|6382886|P1|COMPLETED|Overall Study||354
2600085|NCT00235495|6382885|P2|STARTED|Overall Study||419
2600086|NCT00235495|6382886|P1|STARTED|Overall Study||422
2600087|NCT00235456|6382936|P2|NOT COMPLETED|Overall Study||7
2600088|NCT00235456|6382937|P1|NOT COMPLETED|Overall Study||2
2600089|NCT00235456|6382936|P2|COMPLETED|Overall Study||143
2600090|NCT00235456|6382937|P1|COMPLETED|Overall Study||148
2600091|NCT00235456|6382936|P2|STARTED|Overall Study||150
2600092|NCT00235456|6382937|P1|STARTED|Overall Study||150
2600093|NCT00235443|6382959|P6|NOT COMPLETED|Overall Study||45
2600094|NCT00235443|6382960|P5|NOT COMPLETED|Overall Study||30
2600095|NCT00235443|6382961|P4|NOT COMPLETED|Overall Study||97
2600096|NCT00235443|6382962|P3|NOT COMPLETED|Overall Study||62
2600097|NCT00235443|6382963|P2|NOT COMPLETED|Overall Study||38
2600098|NCT00235443|6382964|P1|NOT COMPLETED|Overall Study||8
2600099|NCT00235443|6382959|P6|COMPLETED|Overall Study||9
2600100|NCT00235443|6382960|P5|COMPLETED|Overall Study||9
2600101|NCT00235443|6382961|P4|COMPLETED|Overall Study||108
2600102|NCT00235443|6382962|P3|COMPLETED|Overall Study||23
2600103|NCT00235443|6382963|P2|COMPLETED|Overall Study||19
2600104|NCT00235443|6382964|P1|COMPLETED|Overall Study||3
2600105|NCT00235443|6382959|P6|STARTED|Overall Study||54
2600106|NCT00235443|6382960|P5|STARTED|Overall Study||39
2600107|NCT00235443|6382961|P4|STARTED|Overall Study||205
2600108|NCT00235443|6382962|P3|STARTED|Overall Study||85
2600109|NCT00235443|6382963|P2|STARTED|Overall Study||57
2600110|NCT00235443|6382964|P1|STARTED|Overall Study||11
2600111|NCT00235391|6383105|P6|NOT COMPLETED|Overall Study||4
2600112|NCT00235391|6383106|P5|NOT COMPLETED|Overall Study||12
2600113|NCT00235391|6383107|P4|NOT COMPLETED|Overall Study||220
2600114|NCT00235391|6383108|P3|NOT COMPLETED|Overall Study||24
2600115|NCT00235391|6383109|P2|NOT COMPLETED|Overall Study||18
2600116|NCT00235391|6383110|P1|NOT COMPLETED|Overall Study||12
2600117|NCT00235391|6383105|P6|COMPLETED|Overall Study||3
2600118|NCT00235391|6383106|P5|COMPLETED|Overall Study||31
2600119|NCT00235391|6383107|P4|COMPLETED|Overall Study||944
2600120|NCT00235391|6383108|P3|COMPLETED|Overall Study||148
2600121|NCT00235391|6383109|P2|COMPLETED|Overall Study||182
2600122|NCT00235391|6383110|P1|COMPLETED|Overall Study||85
2600123|NCT00235391|6383105|P6|Deferasirox Treatment|Overall Study||7
2600124|NCT00235391|6383106|P5|Deferasirox Treatment|Overall Study||43
2600125|NCT00235391|6383107|P4|Deferasirox Treatment|Overall Study||1164
2600126|NCT00235391|6383108|P3|Deferasirox Treatment|Overall Study||172
2600127|NCT00235391|6383109|P2|Deferasirox Treatment|Overall Study||200
2600128|NCT00235391|6383110|P1|Deferasirox Treatment|Overall Study||97
2600129|NCT00235391|6383105|P6|STARTED|Overall Study||7
2600130|NCT00235391|6383106|P5|STARTED|Overall Study||43
2600131|NCT00235391|6383107|P4|STARTED|Overall Study||1164
2600132|NCT00235391|6383108|P3|STARTED|Overall Study||172
2600133|NCT00235391|6383109|P2|STARTED|Overall Study||200
2600134|NCT00235391|6383110|P1|STARTED|Overall Study||97
2600135|NCT00235326|6383127|P2|NOT COMPLETED|Overall Study||1400
2600136|NCT00235326|6383128|P1|NOT COMPLETED|Overall Study||746
2600137|NCT00235326|6383127|P2|COMPLETED|Overall Study||1586
2600138|NCT00235326|6383128|P1|COMPLETED|Overall Study||829
2600139|NCT00235326|6383127|P2|STARTED|Overall Study||2986
2600140|NCT00235326|6383128|P1|STARTED|Overall Study||1575
2600141|NCT00234884|6383132|P1|NOT COMPLETED|Overall Study||1630
2600142|NCT00234884|6383132|P1|COMPLETED|Overall Study||1805
2600143|NCT00234884|6383132|P1|STARTED|Overall Study||3435
2600144|NCT00234832|6383142|P2|NOT COMPLETED|Overall Study||996
2600145|NCT00234832|6383143|P1|NOT COMPLETED|Overall Study||1016
2600146|NCT00234832|6383142|P2|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3902
2600147|NCT00234832|6383143|P1|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3890
2600148|NCT00234832|6383142|P2|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4898
2600149|NCT00234832|6383143|P1|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4906
2600150|NCT00234533|6383168|P1|NOT COMPLETED|Overall Study||11
2600151|NCT00234533|6383168|P1|COMPLETED|Overall Study||240
2600152|NCT00234533|6383168|P1|STARTED|Overall Study||251
2600153|NCT00234494|6383187|P1|NOT COMPLETED|Overall Study||2
2600154|NCT00234494|6383187|P1|COMPLETED|Overall Study||43
2600155|NCT00234494|6383187|P1|STARTED|Overall Study||45
2600156|NCT00234286|6383194|P1|NOT COMPLETED|Overall Study||0
2600157|NCT00234286|6383194|P1|COMPLETED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
2600158|NCT00234286|6383194|P1|STARTED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
2600159|NCT00234104|6383233|P4|NOT COMPLETED|Overall Study||8
2600160|NCT00234104|6383234|P3|NOT COMPLETED|Overall Study||5
2600161|NCT00234104|6383235|P2|NOT COMPLETED|Overall Study||1
2600162|NCT00234104|6383236|P1|NOT COMPLETED|Overall Study||4
2600163|NCT00234104|6383233|P4|COMPLETED|Overall Study||21
2600164|NCT00234104|6383234|P3|COMPLETED|Overall Study||29
2600165|NCT00234104|6383235|P2|COMPLETED|Overall Study||28
2600166|NCT00234104|6383236|P1|COMPLETED|Overall Study||26
2600167|NCT00234104|6383233|P4|STARTED|Overall Study||29
2600168|NCT00234104|6383234|P3|STARTED|Overall Study||34
2600169|NCT00234104|6383235|P2|STARTED|Overall Study||29
2600170|NCT00234104|6383236|P1|STARTED|Overall Study||30
2600171|NCT00234078|6383250|P4|NOT COMPLETED|Overall Study||4
2600172|NCT00234078|6383251|P3|NOT COMPLETED|Overall Study||10
2600173|NCT00234078|6383252|P2|NOT COMPLETED|Overall Study||9
2600174|NCT00234078|6383253|P1|NOT COMPLETED|Overall Study||6
2600175|NCT00234078|6383250|P4|COMPLETED|Overall Study||68
2600176|NCT00234078|6383251|P3|COMPLETED|Overall Study||64
2600177|NCT00234078|6383252|P2|COMPLETED|Overall Study||63
2600178|NCT00234078|6383253|P1|COMPLETED|Overall Study||66
2600179|NCT00234078|6383250|P4|STARTED|Overall Study||72
2600180|NCT00234078|6383251|P3|STARTED|Overall Study||74
2600181|NCT00234078|6383252|P2|STARTED|Overall Study||72
2600182|NCT00234078|6383253|P1|STARTED|Overall Study||72
2600183|NCT00234065|6383277|P2|NOT COMPLETED|Overall Study||356
2600184|NCT00234065|6383278|P1|NOT COMPLETED|Overall Study||475
2600185|NCT00234065|6383277|P2|COMPLETED|Overall Study||1004
2600186|NCT00234065|6383278|P1|COMPLETED|Overall Study||881
2600187|NCT00234065|6383277|P2|STARTED|Overall Study||1360
2600188|NCT00234065|6383278|P1|STARTED|Overall Study||1356
2600189|NCT00234052|6383294|P1|NOT COMPLETED|Follow-up for 5 Years||49
2600190|NCT00234052|6383294|P1|COMPLETED|Follow-up for 5 Years||1
2600191|NCT00234052|6383294|P1|STARTED|Follow-up for 5 Years|All patients that are treated on study go into the follow up period.|50
2600192|NCT00234052|6383294|P1|NOT COMPLETED|Treatment||21
2600193|NCT00234052|6383294|P1|COMPLETED|Treatment||30
2600194|NCT00234052|6383294|P1|Went Into Maintenance Phase|Treatment||30
2600195|NCT00234052|6383294|P1|Completed 6 Cycles|Treatment||33
2600196|NCT00234052|6383294|P1|Started Treatment|Treatment||50
2600197|NCT00234052|6383294|P1|STARTED|Treatment||51
2600198|NCT00234039|6383304|P1|NOT COMPLETED|Overall Study||50
2600199|NCT00234039|6383304|P1|COMPLETED|Overall Study||8
2600200|NCT00234039|6383304|P1|Eligible and Began Protocol Therapy|Overall Study||47
2600201|NCT00234039|6383304|P1|Eligible|Overall Study||49
2600202|NCT00234039|6383304|P1|STARTED|Overall Study||58
2600203|NCT00233987|6383311|P1|NOT COMPLETED|Overall Study||15
2600204|NCT00233987|6383311|P1|COMPLETED|Overall Study||83
2600205|NCT00233987|6383311|P1|Eligible and Treated|Overall Study||92
2600206|NCT00233987|6383311|P1|Eligible|Overall Study||94
2600207|NCT00233987|6383311|P1|STARTED|Overall Study||98
2600208|NCT00233948|6383320|P6|NOT COMPLETED|Overall Study||0
2600209|NCT00233948|6383321|P5|NOT COMPLETED|Overall Study||0
2600210|NCT00233948|6383322|P4|NOT COMPLETED|Overall Study||0
2600211|NCT00233948|6383323|P3|NOT COMPLETED|Overall Study||0
2600212|NCT00233948|6383324|P2|NOT COMPLETED|Overall Study||0
2600213|NCT00233948|6383325|P1|NOT COMPLETED|Overall Study||1
2600214|NCT00233948|6383320|P6|COMPLETED|Overall Study||12
2600215|NCT00233948|6383321|P5|COMPLETED|Overall Study||4
2600216|NCT00233948|6383322|P4|COMPLETED|Overall Study||3
2600217|NCT00233948|6383323|P3|COMPLETED|Overall Study||3
2600218|NCT00233948|6383324|P2|COMPLETED|Overall Study||3
2600219|NCT00233948|6383325|P1|COMPLETED|Overall Study||3
2600220|NCT00233948|6383320|P6|STARTED|Overall Study||12
2600221|NCT00233948|6383321|P5|STARTED|Overall Study||4
2600222|NCT00233948|6383322|P4|STARTED|Overall Study||3
2600223|NCT00233948|6383323|P3|STARTED|Overall Study||3
2600224|NCT00233948|6383324|P2|STARTED|Overall Study||3
2600225|NCT00233948|6383325|P1|STARTED|Overall Study||4
2600226|NCT00233519|6383342|P2|NOT COMPLETED|Overall Study||1
2600227|NCT00233519|6383343|P1|NOT COMPLETED|Overall Study||1
2600228|NCT00233519|6383342|P2|COMPLETED|Overall Study||9
2600229|NCT00233519|6383343|P1|COMPLETED|Overall Study||6
2600230|NCT00233519|6383342|P2|STARTED|Overall Study||10
2600231|NCT00233519|6383343|P1|STARTED|Overall Study||7
2600232|NCT00233454|6383349|P1|NOT COMPLETED|Overall Study||6
2600233|NCT00233454|6383349|P1|COMPLETED|Overall Study||20
2600234|NCT00233454|6383349|P1|2 Months (for Response Rate)|Overall Study||26
2600235|NCT00233454|6383349|P1|STARTED|Overall Study||26
2600236|NCT00233402|6383357|P2|NOT COMPLETED|Overall Study||124
2600237|NCT00233402|6383358|P1|NOT COMPLETED|Overall Study||104
2600238|NCT00233402|6383357|P2|COMPLETED|Overall Study||271
2600239|NCT00233402|6383358|P1|COMPLETED|Overall Study||280
2600240|NCT00233402|6383357|P2|STARTED|Overall Study||395
2600241|NCT00233402|6383358|P1|STARTED|Overall Study||384
2600242|NCT00233324|6383373|P4|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||11
2600243|NCT00233324|6383374|P3|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||18
2600244|NCT00233324|6383375|P2|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||14
2600245|NCT00233324|6383376|P1|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||13
2600246|NCT00233324|6383373|P4|COMPLETED|Follow up at 18-22 Months Corrected Age||269
2600247|NCT00233324|6383374|P3|COMPLETED|Follow up at 18-22 Months Corrected Age||256
2600248|NCT00233324|6383375|P2|COMPLETED|Follow up at 18-22 Months Corrected Age||261
2600249|NCT00233324|6383376|P1|COMPLETED|Follow up at 18-22 Months Corrected Age||237
2600250|NCT00233324|6383373|P4|STARTED|Follow up at 18-22 Months Corrected Age||280
2600251|NCT00233324|6383374|P3|STARTED|Follow up at 18-22 Months Corrected Age||274
2600252|NCT00233324|6383375|P2|STARTED|Follow up at 18-22 Months Corrected Age||275
2600253|NCT00233324|6383376|P1|STARTED|Follow up at 18-22 Months Corrected Age||250
2600254|NCT00233324|6383373|P4|NOT COMPLETED|Main Study||47
2600255|NCT00233324|6383374|P3|NOT COMPLETED|Main Study||62
2600256|NCT00233324|6383375|P2|NOT COMPLETED|Main Study||60
2600257|NCT00233324|6383376|P1|NOT COMPLETED|Main Study||68
2600258|NCT00233324|6383373|P4|COMPLETED|Main Study||280
2600259|NCT00233324|6383374|P3|COMPLETED|Main Study||274
2600260|NCT00233324|6383375|P2|COMPLETED|Main Study||275
2600261|NCT00233324|6383376|P1|COMPLETED|Main Study||250
2600262|NCT00233324|6383373|P4|STARTED|Main Study||327
2600263|NCT00233324|6383374|P3|STARTED|Main Study||336
2600264|NCT00233324|6383375|P2|STARTED|Main Study||335
2600265|NCT00233324|6383376|P1|STARTED|Main Study||318
2600266|NCT00233103|6383460|P2|NOT COMPLETED|Overall Study||6
2600267|NCT00233103|6383461|P1|NOT COMPLETED|Overall Study||5
2600268|NCT00233103|6383460|P2|COMPLETED|Overall Study||19
2600269|NCT00233103|6383461|P1|COMPLETED|Overall Study||22
2600270|NCT00233103|6383460|P2|STARTED|Overall Study||25
2600271|NCT00233103|6383461|P1|STARTED|Overall Study||27
2600272|NCT00233090|6383475|P2|NOT COMPLETED|Overall Study||0
2600273|NCT00233090|6383476|P1|NOT COMPLETED|Overall Study||0
2600274|NCT00233090|6383475|P2|COMPLETED|Overall Study||9
2600275|NCT00233090|6383476|P1|COMPLETED|Overall Study||12
2600276|NCT00233090|6383475|P2|STARTED|Overall Study||9
2600277|NCT00233090|6383476|P1|STARTED|Overall Study||12
2600278|NCT00233064|6383498|P2|NOT COMPLETED|Overall Study||12
2600279|NCT00233064|6383499|P1|NOT COMPLETED|Overall Study||14
2600280|NCT00233064|6383498|P2|COMPLETED|Overall Study||190
2600281|NCT00233064|6383499|P1|COMPLETED|Overall Study||197
2600282|NCT00233064|6383498|P2|STARTED|Overall Study||202
2600283|NCT00233064|6383499|P1|STARTED|Overall Study||211
2600284|NCT00232739|6383506|P1|NOT COMPLETED|Overall Study||9
2600285|NCT00232739|6383506|P1|COMPLETED|Overall Study||91
2600286|NCT00232739|6383506|P1|STARTED|Overall Study||100
2600287|NCT00232596|6383525|P2|NOT COMPLETED|12-Week Maintenance Phase||28
2600288|NCT00232596|6383526|P1|NOT COMPLETED|12-Week Maintenance Phase||12
2600289|NCT00232596|6383525|P2|COMPLETED|12-Week Maintenance Phase||97
2600290|NCT00232596|6383526|P1|COMPLETED|12-Week Maintenance Phase|One participant withdrew after being considered a “completer” and is listed as an early withdraw.|126
2600291|NCT00232596|6383525|P2|STARTED|12-Week Maintenance Phase||125
2600292|NCT00232596|6383526|P1|STARTED|12-Week Maintenance Phase||138
2600293|NCT00232596|6383525|P2|NOT COMPLETED|6-Week Titration Phase||29
2600294|NCT00232596|6383526|P1|NOT COMPLETED|6-Week Titration Phase||14
2600295|NCT00232596|6383525|P2|COMPLETED|6-Week Titration Phase||125
2600296|NCT00232596|6383526|P1|COMPLETED|6-Week Titration Phase||138
2600297|NCT00232596|6383525|P2|STARTED|6-Week Titration Phase||154
2600298|NCT00232596|6383526|P1|STARTED|6-Week Titration Phase||152
2600299|NCT00232583|6383578|P2|NOT COMPLETED|Overall Study||13
2600300|NCT00232583|6383579|P1|NOT COMPLETED|Overall Study||10
2600301|NCT00232583|6383578|P2|COMPLETED|Overall Study||16
2600302|NCT00232583|6383579|P1|COMPLETED|Overall Study||19
2600303|NCT00232583|6383578|P2|STARTED|Overall Study||29
2600304|NCT00232583|6383579|P1|STARTED|Overall Study||29
2600305|NCT00232557|6383617|P2|NOT COMPLETED|Overall Study||5
2600306|NCT00232557|6383618|P1|NOT COMPLETED|Overall Study||3
2600307|NCT00232557|6383617|P2|COMPLETED|Overall Study||60
2600308|NCT00232557|6383618|P1|COMPLETED|Overall Study||68
2600309|NCT00232557|6383617|P2|STARTED|Overall Study||65
2600310|NCT00232557|6383618|P1|STARTED|Overall Study||71
2600311|NCT00232544|6383628|P2|NOT COMPLETED|Overall Study||15
2600312|NCT00232544|6383629|P1|NOT COMPLETED|Overall Study||20
2600313|NCT00232544|6383628|P2|COMPLETED|Overall Study||111
2600314|NCT00232544|6383629|P1|COMPLETED|Overall Study||104
2600315|NCT00232544|6383628|P2|STARTED|Overall Study||126
2600316|NCT00232544|6383629|P1|STARTED|Overall Study||124
2600317|NCT00232505|6383639|P2|NOT COMPLETED|Overall Study||11
2600318|NCT00232505|6383640|P1|NOT COMPLETED|Overall Study||5
2600319|NCT00232505|6383639|P2|COMPLETED|Overall Study||60
2600320|NCT00232505|6383640|P1|COMPLETED|Overall Study||26
2600321|NCT00232505|6383639|P2|Off Protocol|Overall Study||0
2600322|NCT00232505|6383640|P1|Off Protocol|Overall Study||5
2600323|NCT00232505|6383639|P2|Early Progressors|Overall Study||5
2600324|NCT00232505|6383640|P1|Early Progressors|Overall Study||2
2600325|NCT00232505|6383639|P2|Not Evaluable|Overall Study||6
2600326|NCT00232505|6383640|P1|Not Evaluable|Overall Study||0
2600327|NCT00232505|6383639|P2|STARTED|Overall Study||71
2600328|NCT00232505|6383640|P1|STARTED|Overall Study||31
2600329|NCT00232479|6383653|P1|NOT COMPLETED|Overall Study||0
2600330|NCT00232479|6383653|P1|COMPLETED|Overall Study||44
2600331|NCT00232479|6383653|P1|STARTED|Overall Study||44
2600332|NCT00232180|6383660|P3|NOT COMPLETED|Open Label Phase||148
2600333|NCT00232180|6383661|P2|NOT COMPLETED|Open Label Phase||0
2600334|NCT00232180|6383662|P1|NOT COMPLETED|Open Label Phase||0
2600335|NCT00232180|6383660|P3|COMPLETED|Open Label Phase||1098
2600336|NCT00232180|6383661|P2|COMPLETED|Open Label Phase||0
2600337|NCT00232180|6383662|P1|COMPLETED|Open Label Phase||0
2600338|NCT00232180|6383660|P3|Treated|Open Label Phase||1245
2600339|NCT00232180|6383661|P2|Treated|Open Label Phase||0
2600340|NCT00232180|6383662|P1|Treated|Open Label Phase||0
2600341|NCT00232180|6383660|P3|STARTED|Open Label Phase||1246
2600342|NCT00232180|6383661|P2|STARTED|Open Label Phase||0
2600343|NCT00232180|6383662|P1|STARTED|Open Label Phase||0
2600344|NCT00232180|6383660|P3|NOT COMPLETED|Double-blind (DB) Phase||0
2600345|NCT00232180|6383661|P2|NOT COMPLETED|Double-blind (DB) Phase||605
2600346|NCT00232180|6383662|P1|NOT COMPLETED|Double-blind (DB) Phase||541
2600347|NCT00232180|6383660|P3|COMPLETED|Double-blind (DB) Phase||0
2600348|NCT00232180|6383661|P2|COMPLETED|Double-blind (DB) Phase||771
2600349|NCT00232180|6383662|P1|COMPLETED|Double-blind (DB) Phase||826
2600350|NCT00232180|6383660|P3|Treated|Double-blind (DB) Phase||0
2600351|NCT00232180|6383661|P2|Treated|Double-blind (DB) Phase||1372
2600352|NCT00232180|6383662|P1|Treated|Double-blind (DB) Phase||1364
2600353|NCT00232180|6383660|P3|STARTED|Double-blind (DB) Phase||0
2600354|NCT00232180|6383661|P2|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1376
2600355|NCT00232180|6383662|P1|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1367
2600356|NCT00232141|6383707|P2|NOT COMPLETED|Overall Study||26
2600357|NCT00232141|6383708|P1|NOT COMPLETED|Overall Study||31
2600358|NCT00232141|6383707|P2|COMPLETED|Overall Study||125
2600359|NCT00232141|6383708|P1|COMPLETED|Overall Study||120
2600360|NCT00232141|6383707|P2|STARTED|Overall Study||151
2600361|NCT00232141|6383708|P1|STARTED|Overall Study||151
2600362|NCT00231894|6383778|P2|NOT COMPLETED|Overall Study||1
2600363|NCT00231894|6383779|P1|NOT COMPLETED|Overall Study||1
2600364|NCT00231894|6383778|P2|COMPLETED|Overall Study||24
2600365|NCT00231894|6383779|P1|COMPLETED|Overall Study||30
2600366|NCT00231894|6383778|P2|STARTED|Overall Study||25
2600367|NCT00231894|6383779|P1|STARTED|Overall Study||31
2600368|NCT00231842|6383801|P1|NOT COMPLETED|Overall Study||11
2600369|NCT00231842|6383801|P1|COMPLETED|Overall Study||19
2600370|NCT00231842|6383801|P1|Completed Full Prescribed Therapy|Overall Study||19
2600371|NCT00231842|6383801|P1|Completed Prescribed RT|Overall Study||27
2600372|NCT00231842|6383801|P1|Completed First 3 Cycles|Overall Study||27
2600373|NCT00231842|6383801|P1|Initiated Therapy|Overall Study||27
2600374|NCT00231842|6383801|P1|STARTED|Overall Study||30
2600375|NCT00231816|6383808|P2|NOT COMPLETED|Overall Study||12
2600376|NCT00231816|6383809|P1|NOT COMPLETED|Overall Study||16
2600377|NCT00231816|6383808|P2|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|369
2600378|NCT00231816|6383809|P1|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|366
2600379|NCT00231816|6383808|P2|Vaccinated at Visit 2|Overall Study||371
2600380|NCT00231816|6383809|P1|Vaccinated at Visit 2|Overall Study||369
2600381|NCT00231816|6383808|P2|Vaccinated at Visit 1|Overall Study|One participant was randomized but not vaccinated|380
2600382|NCT00231816|6383809|P1|Vaccinated at Visit 1|Overall Study||382
2600383|NCT00231816|6383808|P2|STARTED|Overall Study||381
2600384|NCT00231816|6383809|P1|STARTED|Overall Study||382
2600385|NCT00231777|6383824|P2|NOT COMPLETED|Overall Study||2
2600386|NCT00231777|6383825|P1|NOT COMPLETED|Overall Study||6
2600387|NCT00231777|6383824|P2|COMPLETED|Overall Study||44
2600388|NCT00231777|6383825|P1|COMPLETED|Overall Study||164
2600389|NCT00231777|6383824|P2|STARTED|Overall Study||46
2600390|NCT00231777|6383825|P1|STARTED|Overall Study||170
2600391|NCT00231478|6383839|P2|NOT COMPLETED|Overall Study||6
2600392|NCT00231478|6383840|P1|NOT COMPLETED|Overall Study||8
2600393|NCT00231478|6383839|P2|COMPLETED|Overall Study||78
2600394|NCT00231478|6383840|P1|COMPLETED|Overall Study||79
2600395|NCT00231478|6383839|P2|STARTED|Overall Study||84
2600396|NCT00231478|6383840|P1|STARTED|Overall Study||87
2600397|NCT00231465|6383852|P1|NOT COMPLETED|Overall Study||2
2600398|NCT00231465|6383852|P1|COMPLETED|Overall Study||42
2600399|NCT00231465|6383852|P1|STARTED|Overall Study||44
2600400|NCT00231413|6383865|P7|NOT COMPLETED|Overall Study||4
2600401|NCT00231413|6383866|P6|NOT COMPLETED|Overall Study||5
2600402|NCT00231413|6383867|P5|NOT COMPLETED|Overall Study||3
2600403|NCT00231413|6383868|P4|NOT COMPLETED|Overall Study||3
2600404|NCT00231413|6383869|P3|NOT COMPLETED|Overall Study||7
2600405|NCT00231413|6383870|P2|NOT COMPLETED|Overall Study||5
2600406|NCT00231413|6383871|P1|NOT COMPLETED|Overall Study||8
2600407|NCT00231413|6383865|P7|COMPLETED|Overall Study||46
2600408|NCT00231413|6383866|P6|COMPLETED|Overall Study||45
2600409|NCT00231413|6383867|P5|COMPLETED|Overall Study||45
2600410|NCT00231413|6383868|P4|COMPLETED|Overall Study||45
2600411|NCT00231413|6383869|P3|COMPLETED|Overall Study||42
2600412|NCT00231413|6383870|P2|COMPLETED|Overall Study||45
2600413|NCT00231413|6383871|P1|COMPLETED|Overall Study||80
2600414|NCT00231413|6383865|P7|STARTED|Overall Study||50
2600415|NCT00231413|6383866|P6|STARTED|Overall Study||50
2600416|NCT00231413|6383867|P5|STARTED|Overall Study||48
2600417|NCT00231413|6383868|P4|STARTED|Overall Study||48
2600418|NCT00231413|6383869|P3|STARTED|Overall Study||49
2600419|NCT00231413|6383870|P2|STARTED|Overall Study||50
2600420|NCT00231413|6383871|P1|STARTED|Overall Study||88
2600421|NCT00231309|6384027|P1|NOT COMPLETED|Overall Study||0
2600422|NCT00231309|6384027|P1|COMPLETED|Overall Study||10
2600423|NCT00231309|6384027|P1|STARTED|Overall Study||10
2600424|NCT00231283|6384032|P1|NOT COMPLETED|Overall Study||5
2600425|NCT00231283|6384032|P1|COMPLETED|Overall Study||95
2600426|NCT00231283|6384032|P1|STARTED|Overall Study||100
2600427|NCT00231179|6384041|P2|NOT COMPLETED|Overall Study||24
2600428|NCT00231179|6384042|P1|NOT COMPLETED|Overall Study||24
2600429|NCT00231179|6384041|P2|COMPLETED|Overall Study|126 (93%) in the control group completed the five year follow-up visit.|126
2600430|NCT00231179|6384042|P1|COMPLETED|Overall Study|128 (95%) in intervention group completed the five year follow-up visit.|128
2600431|NCT00231179|6384041|P2|STARTED|Overall Study||150
2600432|NCT00231179|6384042|P1|STARTED|Overall Study||152
2600433|NCT00231153|6384058|P2|NOT COMPLETED|Overall Study||188
2600434|NCT00231153|6384059|P1|NOT COMPLETED|Overall Study||217
2600435|NCT00231153|6384058|P2|COMPLETED|Overall Study||720
2600436|NCT00231153|6384059|P1|COMPLETED|Overall Study||690
2600437|NCT00231153|6384058|P2|STARTED|Overall Study|Subjects randomized to povidone-iodine who received at least one dose of study treatment.|908
2600438|NCT00231153|6384059|P1|STARTED|Overall Study|Subjects randomized to omiganan 1% gel who received at least one dose of study treatment.|907
2600439|NCT00231114|6384069|P2|NOT COMPLETED|Post-Treatment Period||1
2600440|NCT00231114|6384070|P1|NOT COMPLETED|Post-Treatment Period||8
2600441|NCT00231114|6384069|P2|COMPLETED|Post-Treatment Period||97
2600442|NCT00231114|6384070|P1|COMPLETED|Post-Treatment Period||181
2600443|NCT00231114|6384069|P2|STARTED|Post-Treatment Period||98
2600444|NCT00231114|6384070|P1|STARTED|Post-Treatment Period||189
2600445|NCT00231114|6384069|P2|NOT COMPLETED|Treatment Period||0
2600446|NCT00231114|6384070|P1|NOT COMPLETED|Treatment Period||1
2600447|NCT00231114|6384069|P2|COMPLETED|Treatment Period||98
2600448|NCT00231114|6384070|P1|COMPLETED|Treatment Period||189
2600449|NCT00231114|6384069|P2|STARTED|Treatment Period||98
2600450|NCT00231114|6384070|P1|STARTED|Treatment Period||190
2600451|NCT00231114|6384069|P2|NOT COMPLETED|Randomized||3
2600452|NCT00231114|6384070|P1|NOT COMPLETED|Randomized||6
2600453|NCT00231114|6384069|P2|COMPLETED|Randomized||98
2600454|NCT00231114|6384070|P1|COMPLETED|Randomized||190
2600455|NCT00231114|6384069|P2|STARTED|Randomized||101
2600456|NCT00231114|6384070|P1|STARTED|Randomized||196
2600457|NCT00231062|6384106|P1|NOT COMPLETED|Overall Study||6
2600458|NCT00231062|6384106|P1|COMPLETED|Overall Study||109
2600459|NCT00231062|6384106|P1|STARTED|Overall Study||115
2600460|NCT00230971|6384114|P2|NOT COMPLETED|Baseline Participants||19
2600461|NCT00230971|6384115|P1|NOT COMPLETED|Baseline Participants||22
2600462|NCT00230971|6384114|P2|COMPLETED|Baseline Participants||216
2600463|NCT00230971|6384115|P1|COMPLETED|Baseline Participants||210
2600464|NCT00230971|6384114|P2|STARTED|Baseline Participants||235
2600465|NCT00230971|6384115|P1|STARTED|Baseline Participants||232
2600466|NCT00230971|6384114|P2|NOT COMPLETED|Randomization||3
2600467|NCT00230971|6384115|P1|NOT COMPLETED|Randomization||3
2600468|NCT00230971|6384114|P2|COMPLETED|Randomization||235
2600469|NCT00230971|6384115|P1|COMPLETED|Randomization||232
2600470|NCT00230971|6384114|P2|STARTED|Randomization||238
2600471|NCT00230971|6384115|P1|STARTED|Randomization||235
2600472|NCT00230802|6384129|P2|NOT COMPLETED|Overall Study||0
2600473|NCT00230802|6384130|P1|NOT COMPLETED|Overall Study||0
2600474|NCT00230802|6384129|P2|COMPLETED|Overall Study||23
2600475|NCT00230802|6384130|P1|COMPLETED|Overall Study||25
2600476|NCT00230802|6384129|P2|STARTED|Overall Study||23
2600477|NCT00230802|6384130|P1|STARTED|Overall Study||25
2600478|NCT00230737|6384143|P3|NOT COMPLETED|Overall Study||0
2600479|NCT00230737|6384144|P2|NOT COMPLETED|Overall Study||0
2600480|NCT00230737|6384145|P1|NOT COMPLETED|Overall Study||0
2600481|NCT00230737|6384143|P3|COMPLETED|Overall Study||8
2600482|NCT00230737|6384144|P2|COMPLETED|Overall Study||10
2600483|NCT00230737|6384145|P1|COMPLETED|Overall Study||9
2600484|NCT00230737|6384143|P3|STARTED|Overall Study||8
2600485|NCT00230737|6384144|P2|STARTED|Overall Study||10
2600486|NCT00230737|6384145|P1|STARTED|Overall Study||9
2600487|NCT00230282|6384153|P1|NOT COMPLETED|Maintanence Therapy With Alemtuzumab||0
2600488|NCT00230282|6384153|P1|COMPLETED|Maintanence Therapy With Alemtuzumab||17
2600489|NCT00230282|6384153|P1|STARTED|Maintanence Therapy With Alemtuzumab||17
2600490|NCT00230282|6384153|P1|NOT COMPLETED|Fludarabine + Cyclophosphamide||8
2600491|NCT00230282|6384153|P1|COMPLETED|Fludarabine + Cyclophosphamide||17
2600492|NCT00230282|6384153|P1|STARTED|Fludarabine + Cyclophosphamide||25
2600493|NCT00230178|6384161|P3|NOT COMPLETED|Overall Study||7
2600494|NCT00230178|6384162|P2|NOT COMPLETED|Overall Study||7
2600495|NCT00230178|6384163|P1|NOT COMPLETED|Overall Study||4
2600496|NCT00230178|6384161|P3|COMPLETED|Overall Study||86
2600497|NCT00230178|6384162|P2|COMPLETED|Overall Study||86
2600498|NCT00230178|6384163|P1|COMPLETED|Overall Study||90
2600499|NCT00230178|6384161|P3|Treated|Overall Study||91
2600500|NCT00230178|6384162|P2|Treated|Overall Study||92
2600501|NCT00230178|6384163|P1|Treated|Overall Study|Modified ITT population: ITT patients with at least 1 dose of study drug|92
2600502|NCT00230178|6384161|P3|STARTED|Overall Study||93
2600503|NCT00230178|6384162|P2|STARTED|Overall Study||93
2600504|NCT00230178|6384163|P1|STARTED|Overall Study|Intent-to-treat (ITT)population: randomized patients|94
2600505|NCT00230126|6384179|P2|NOT COMPLETED|Overall Study||1
2600506|NCT00230126|6384180|P1|NOT COMPLETED|Overall Study||2
2600507|NCT00230126|6384179|P2|COMPLETED|Overall Study||27
2600508|NCT00230126|6384180|P1|COMPLETED|Overall Study||28
2600509|NCT00230126|6384179|P2|STARTED|Overall Study||28
2600510|NCT00230126|6384180|P1|STARTED|Overall Study||30
2600511|NCT00230100|6384192|P2|NOT COMPLETED|Overall Study||0
2600512|NCT00230100|6384193|P1|NOT COMPLETED|Overall Study||0
2600513|NCT00230100|6384192|P2|COMPLETED|Overall Study||17
2600514|NCT00230100|6384193|P1|COMPLETED|Overall Study||29
2600515|NCT00230100|6384192|P2|STARTED|Overall Study||17
2600516|NCT00230100|6384193|P1|STARTED|Overall Study||29
2600517|NCT00230048|6384215|P2|NOT COMPLETED|Overall Study||18
2600518|NCT00230048|6384216|P1|NOT COMPLETED|Overall Study||13
2600519|NCT00230048|6384215|P2|COMPLETED|Overall Study||37
2600520|NCT00230048|6384216|P1|COMPLETED|Overall Study||39
2600521|NCT00230048|6384215|P2|Completed Intervention/Control Session|Overall Study||55
2600522|NCT00230048|6384216|P1|Completed Intervention/Control Session|Overall Study||52
2600523|NCT00230048|6384215|P2|STARTED|Overall Study||55
2600524|NCT00230048|6384216|P1|STARTED|Overall Study||52
2600525|NCT00230022|6384226|P2|NOT COMPLETED|Overall Study||0
2600526|NCT00230022|6384227|P1|NOT COMPLETED|Overall Study||0
2600527|NCT00230022|6384226|P2|COMPLETED|Overall Study||15
2600528|NCT00230022|6384227|P1|COMPLETED|Overall Study||15
2600529|NCT00230022|6384226|P2|STARTED|Overall Study||15
2600530|NCT00230022|6384227|P1|STARTED|Overall Study||15
2600531|NCT00230009|6384235|P2|NOT COMPLETED|Follow-up||26
2600532|NCT00230009|6384236|P1|NOT COMPLETED|Follow-up||31
2600533|NCT00230009|6384235|P2|COMPLETED|Follow-up||24
2600534|NCT00230009|6384236|P1|COMPLETED|Follow-up||19
2600535|NCT00230009|6384235|P2|STARTED|Follow-up||50
2600536|NCT00230009|6384236|P1|STARTED|Follow-up||50
2600537|NCT00230009|6384235|P2|NOT COMPLETED|Single Session Intervention/Control||0
2600538|NCT00230009|6384236|P1|NOT COMPLETED|Single Session Intervention/Control||0
2600539|NCT00230009|6384235|P2|COMPLETED|Single Session Intervention/Control||50
2600540|NCT00230009|6384236|P1|COMPLETED|Single Session Intervention/Control||50
2600541|NCT00230009|6384235|P2|STARTED|Single Session Intervention/Control||50
2600542|NCT00230009|6384236|P1|STARTED|Single Session Intervention/Control||50
2600543|NCT00229970|6384253|P3|NOT COMPLETED|Overall Study||0
2600544|NCT00229970|6384254|P2|NOT COMPLETED|Overall Study||0
2600545|NCT00229970|6384255|P1|NOT COMPLETED|Overall Study||0
2600546|NCT00229970|6384253|P3|COMPLETED|Overall Study||75
2600547|NCT00229970|6384254|P2|COMPLETED|Overall Study||72
2600548|NCT00229970|6384255|P1|COMPLETED|Overall Study||78
2600549|NCT00229970|6384253|P3|STARTED|Overall Study||75
2600550|NCT00229970|6384254|P2|STARTED|Overall Study||72
2600551|NCT00229970|6384255|P1|STARTED|Overall Study||78
2600552|NCT00229957|6384265|P2|NOT COMPLETED|Overall Study||12
2600553|NCT00229957|6384266|P1|NOT COMPLETED|Overall Study||20
2600554|NCT00229957|6384265|P2|COMPLETED|Overall Study||139
2600555|NCT00229957|6384266|P1|COMPLETED|Overall Study||132
2600556|NCT00229957|6384265|P2|STARTED|Overall Study||151
2600557|NCT00229957|6384266|P1|STARTED|Overall Study||152
2600558|NCT00229931|6384274|P2|NOT COMPLETED|Overall Study||2
2600559|NCT00229931|6384275|P1|NOT COMPLETED|Overall Study||4
2600560|NCT00229931|6384274|P2|COMPLETED|Overall Study||3
2600561|NCT00229931|6384275|P1|COMPLETED|Overall Study||2
2600562|NCT00229931|6384274|P2|STARTED|Overall Study||5
2600563|NCT00229931|6384275|P1|STARTED|Overall Study||6
2600564|NCT00229723|6384290|P7|NOT COMPLETED|Maintenance Phase||10
2600565|NCT00229723|6384291|P6|NOT COMPLETED|Maintenance Phase||19
2600566|NCT00229723|6384292|P5|NOT COMPLETED|Maintenance Phase||15
2600567|NCT00229723|6384293|P4|NOT COMPLETED|Maintenance Phase||17
2600568|NCT00229723|6384294|P3|NOT COMPLETED|Maintenance Phase||9
2600569|NCT00229723|6384295|P2|NOT COMPLETED|Maintenance Phase||14
2600570|NCT00229723|6384296|P1|NOT COMPLETED|Maintenance Phase||25
2600571|NCT00229723|6384290|P7|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
2600572|NCT00229723|6384291|P6|COMPLETED|Maintenance Phase|Completed study on randomized treatment|12
2600573|NCT00229723|6384292|P5|COMPLETED|Maintenance Phase|Completed study on randomized treatment|7
2600574|NCT00229723|6384293|P4|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
2600575|NCT00229723|6384294|P3|COMPLETED|Maintenance Phase|Completed study on randomized treatment|16
2600576|NCT00229723|6384295|P2|COMPLETED|Maintenance Phase|Completed study on randomized treatment|5
2600577|NCT00229723|6384296|P1|COMPLETED|Maintenance Phase|Completed study on randomized treatment|25
2600578|NCT00229723|6384290|P7|STARTED|Maintenance Phase||19
2600579|NCT00229723|6384291|P6|STARTED|Maintenance Phase||31
2600580|NCT00229723|6384292|P5|STARTED|Maintenance Phase||22
2600581|NCT00229723|6384293|P4|STARTED|Maintenance Phase||26
2600582|NCT00229723|6384294|P3|STARTED|Maintenance Phase||25
2600583|NCT00229723|6384295|P2|STARTED|Maintenance Phase||19
2600584|NCT00229723|6384296|P1|STARTED|Maintenance Phase||50
2600585|NCT00229723|6384290|P7|NOT COMPLETED|Concomitant Phase||3
2600586|NCT00229723|6384291|P6|NOT COMPLETED|Concomitant Phase||3
2600587|NCT00229723|6384292|P5|NOT COMPLETED|Concomitant Phase||2
2600588|NCT00229723|6384293|P4|NOT COMPLETED|Concomitant Phase||5
2600589|NCT00229723|6384294|P3|NOT COMPLETED|Concomitant Phase||6
2600590|NCT00229723|6384295|P2|NOT COMPLETED|Concomitant Phase||5
2600591|NCT00229723|6384296|P1|NOT COMPLETED|Concomitant Phase||10
2600592|NCT00229723|6384290|P7|COMPLETED|Concomitant Phase||19
2600593|NCT00229723|6384291|P6|COMPLETED|Concomitant Phase||31
2600594|NCT00229723|6384292|P5|COMPLETED|Concomitant Phase||22
2600595|NCT00229723|6384293|P4|COMPLETED|Concomitant Phase||26
2600596|NCT00229723|6384294|P3|COMPLETED|Concomitant Phase||25
2600597|NCT00229723|6384295|P2|COMPLETED|Concomitant Phase||19
2600598|NCT00229723|6384296|P1|COMPLETED|Concomitant Phase||50
2600599|NCT00229723|6384290|P7|STARTED|Concomitant Phase|Received randomized treatment|22
2600600|NCT00229723|6384291|P6|STARTED|Concomitant Phase|Received randomized treatment|34
2600601|NCT00229723|6384292|P5|STARTED|Concomitant Phase|Received randomized treatment|24
2600602|NCT00229723|6384293|P4|STARTED|Concomitant Phase|Received randomized treatment|31
2600603|NCT00229723|6384294|P3|STARTED|Concomitant Phase|Received randomized treatment|31
2600604|NCT00229723|6384295|P2|STARTED|Concomitant Phase|Received randomized treatment|24
2600605|NCT00229723|6384296|P1|STARTED|Concomitant Phase|Received randomized treatment|60
2600606|NCT00229658|6384349|P2|NOT COMPLETED|Overall Study||167
2600607|NCT00229658|6384350|P1|NOT COMPLETED|Overall Study||225
2600608|NCT00229658|6384349|P2|COMPLETED|Overall Study||364
2600609|NCT00229658|6384350|P1|COMPLETED|Overall Study||541
2600610|NCT00229658|6384349|P2|STARTED|Overall Study||531
2600611|NCT00229658|6384350|P1|STARTED|Overall Study||766
2600612|NCT00229619|6384378|P1|NOT COMPLETED|Overall Study||0
2600613|NCT00229619|6384378|P1|COMPLETED|Overall Study||11
2600614|NCT00229619|6384378|P1|STARTED|Overall Study||11
2600615|NCT00229203|6384386|P2|NOT COMPLETED|Overall Study||19
2600616|NCT00229203|6384387|P1|NOT COMPLETED|Overall Study||32
2600617|NCT00229203|6384386|P2|COMPLETED|Overall Study||0
2600618|NCT00229203|6384387|P1|COMPLETED|Overall Study||0
2600619|NCT00229203|6384386|P2|STARTED|Overall Study||19
2600620|NCT00229203|6384387|P1|STARTED|Overall Study||32
2600621|NCT00228943|6384399|P1|NOT COMPLETED|Week 2||1
2600622|NCT00228943|6384399|P1|COMPLETED|Week 2||27
2600623|NCT00228943|6384399|P1|STARTED|Week 2||28
2600624|NCT00228943|6384399|P1|NOT COMPLETED|Week 1||0
2600625|NCT00228943|6384399|P1|COMPLETED|Week 1||28
2600626|NCT00228943|6384399|P1|STARTED|Week 1||28
2600651|NCT00228813|6384468|P1|NOT COMPLETED|Overall Study||4
2600652|NCT00228813|6384468|P1|COMPLETED|Overall Study||4
2600653|NCT00228813|6384468|P1|STARTED|Overall Study||8
2600654|NCT00228566|6384474|P1|NOT COMPLETED|Overall Study||71
2600655|NCT00228566|6384474|P1|COMPLETED|Overall Study||176
2600656|NCT00228566|6384474|P1|STARTED|Overall Study||247
2600657|NCT00228553|6384478|P1|NOT COMPLETED|Overall Study||430
2600658|NCT00228553|6384478|P1|COMPLETED|Overall Study||313
2600659|NCT00228553|6384478|P1|STARTED|Overall Study||743
2600660|NCT00228384|6384484|P2|NOT COMPLETED|Overall Study||29
2600661|NCT00228384|6384485|P1|NOT COMPLETED|Overall Study||29
2600662|NCT00228384|6384484|P2|COMPLETED|Overall Study||47
2600663|NCT00228384|6384485|P1|COMPLETED|Overall Study||43
2600664|NCT00228384|6384484|P2|Three Year Follow-up (Final)|Overall Study||47
2600665|NCT00228384|6384485|P1|Three Year Follow-up (Final)|Overall Study||43
2600666|NCT00228384|6384484|P2|30-Day Follow-up (Safety Outcome)|Overall Study||72
2600667|NCT00228384|6384485|P1|30-Day Follow-up (Safety Outcome)|Overall Study||69
2600668|NCT00228384|6384484|P2|Baseline|Overall Study||76
2600669|NCT00228384|6384485|P1|Baseline|Overall Study||72
2600670|NCT00228384|6384484|P2|STARTED|Overall Study||76
2600671|NCT00228384|6384485|P1|STARTED|Overall Study||72
2600672|NCT00227994|6384525|P2|NOT COMPLETED|Overall Study||7
2600673|NCT00227994|6384526|P1|NOT COMPLETED|Overall Study||7
2600674|NCT00227994|6384525|P2|COMPLETED|Overall Study||13
2600675|NCT00227994|6384526|P1|COMPLETED|Overall Study||13
2600676|NCT00227994|6384525|P2|STARTED|Overall Study||20
2600677|NCT00227994|6384526|P1|STARTED|Overall Study||20
2600678|NCT00227903|6384536|P2|NOT COMPLETED|Overall Study||10
2600679|NCT00227903|6384537|P1|NOT COMPLETED|Overall Study||5
2600680|NCT00227903|6384536|P2|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|82
2600681|NCT00227903|6384537|P1|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|86
2600682|NCT00227903|6384536|P2|Received ≥ 1 Follow-up Assessment|Overall Study|4 participants did not receive any treatment sessions.|82
2600683|NCT00227903|6384537|P1|Received ≥ 1 Follow-up Assessment|Overall Study|1 participant did not receive any treatment sessions.|86
2600684|NCT00227903|6384536|P2|STARTED|Overall Study||92
2600685|NCT00227903|6384537|P1|STARTED|Overall Study||91
2600686|NCT00227877|6384601|P4|NOT COMPLETED|12-months Follow-up||26
2600687|NCT00227877|6384602|P3|NOT COMPLETED|12-months Follow-up||31
2600688|NCT00227877|6384603|P2|NOT COMPLETED|12-months Follow-up||263
2600689|NCT00227877|6384604|P1|NOT COMPLETED|12-months Follow-up||310
2600690|NCT00227877|6384601|P4|COMPLETED|12-months Follow-up||266
2600691|NCT00227877|6384602|P3|COMPLETED|12-months Follow-up||266
2600692|NCT00227877|6384603|P2|COMPLETED|12-months Follow-up||765
2600693|NCT00227877|6384604|P1|COMPLETED|12-months Follow-up||758
2600694|NCT00227877|6384601|P4|STARTED|12-months Follow-up||292
2600695|NCT00227877|6384602|P3|STARTED|12-months Follow-up||297
2600696|NCT00227877|6384603|P2|STARTED|12-months Follow-up||1028
2600697|NCT00227877|6384604|P1|STARTED|12-months Follow-up||1068
2600698|NCT00227877|6384601|P4|NOT COMPLETED|3-months Follow-up||21
2600699|NCT00227877|6384602|P3|NOT COMPLETED|3-months Follow-up||52
2600700|NCT00227877|6384603|P2|NOT COMPLETED|3-months Follow-up||267
2600701|NCT00227877|6384604|P1|NOT COMPLETED|3-months Follow-up||313
2600702|NCT00227877|6384601|P4|COMPLETED|3-months Follow-up||271
2600703|NCT00227877|6384602|P3|COMPLETED|3-months Follow-up||245
2600704|NCT00227877|6384603|P2|COMPLETED|3-months Follow-up||761
2600705|NCT00227877|6384604|P1|COMPLETED|3-months Follow-up||755
2600706|NCT00227877|6384601|P4|STARTED|3-months Follow-up||292
2600707|NCT00227877|6384602|P3|STARTED|3-months Follow-up||297
2600708|NCT00227877|6384603|P2|STARTED|3-months Follow-up||1028
2600709|NCT00227877|6384604|P1|STARTED|3-months Follow-up||1068
2600710|NCT00227877|6384601|P4|NOT COMPLETED|Post-visit Checklist||0
2600711|NCT00227877|6384602|P3|NOT COMPLETED|Post-visit Checklist||1
2600712|NCT00227877|6384603|P2|NOT COMPLETED|Post-visit Checklist||13
2600713|NCT00227877|6384604|P1|NOT COMPLETED|Post-visit Checklist||24
2600714|NCT00227877|6384601|P4|COMPLETED|Post-visit Checklist||292
2600715|NCT00227877|6384602|P3|COMPLETED|Post-visit Checklist||296
2600716|NCT00227877|6384603|P2|COMPLETED|Post-visit Checklist||1015
2600717|NCT00227877|6384604|P1|COMPLETED|Post-visit Checklist||1044
2600718|NCT00227877|6384601|P4|STARTED|Post-visit Checklist||292
2600719|NCT00227877|6384602|P3|STARTED|Post-visit Checklist||297
2600720|NCT00227877|6384603|P2|STARTED|Post-visit Checklist||1028
2600721|NCT00227877|6384604|P1|STARTED|Post-visit Checklist||1068
2600722|NCT00227877|6384601|P4|NOT COMPLETED|Pre-visit Assessment||0
2600723|NCT00227877|6384602|P3|NOT COMPLETED|Pre-visit Assessment||0
2600724|NCT00227877|6384603|P2|NOT COMPLETED|Pre-visit Assessment||3
2600725|NCT00227877|6384604|P1|NOT COMPLETED|Pre-visit Assessment||7
2600726|NCT00227877|6384601|P4|COMPLETED|Pre-visit Assessment|Final analysis sample|292
2600727|NCT00227877|6384602|P3|COMPLETED|Pre-visit Assessment|Final analysis sample|297
2600728|NCT00227877|6384603|P2|COMPLETED|Pre-visit Assessment|Final analysis sample|1028
2600729|NCT00227877|6384604|P1|COMPLETED|Pre-visit Assessment|Final analysis sample|1068
2600730|NCT00227877|6384601|P4|STARTED|Pre-visit Assessment||292
2600731|NCT00227877|6384602|P3|STARTED|Pre-visit Assessment||297
2600732|NCT00227877|6384603|P2|STARTED|Pre-visit Assessment||1031
2600733|NCT00227877|6384604|P1|STARTED|Pre-visit Assessment||1075
2600734|NCT00227760|6384634|P1|NOT COMPLETED|Overall Study||0
2600735|NCT00227760|6384634|P1|COMPLETED|Overall Study||44
2600736|NCT00227760|6384634|P1|STARTED|Overall Study||44
2600737|NCT00227721|6384640|P1|NOT COMPLETED|Overall Study||1
2600738|NCT00227721|6384640|P1|COMPLETED|Overall Study||29
2600739|NCT00227721|6384640|P1|STARTED|Overall Study||30
2600740|NCT00227617|6384644|P3|NOT COMPLETED|Stage 2||0
2600741|NCT00227617|6384645|P2|NOT COMPLETED|Stage 2||0
2600742|NCT00227617|6384646|P1|NOT COMPLETED|Stage 2||0
2600743|NCT00227617|6384644|P3|COMPLETED|Stage 2||0
2600744|NCT00227617|6384645|P2|COMPLETED|Stage 2||0
2600745|NCT00227617|6384646|P1|COMPLETED|Stage 2||0
2600746|NCT00227617|6384644|P3|STARTED|Stage 2||0
2600747|NCT00227617|6384645|P2|STARTED|Stage 2||0
2600748|NCT00227617|6384646|P1|STARTED|Stage 2||0
2600749|NCT00227617|6384644|P3|NOT COMPLETED|Stage 1||0
2600750|NCT00227617|6384645|P2|NOT COMPLETED|Stage 1||0
2600751|NCT00227617|6384646|P1|NOT COMPLETED|Stage 1||0
2600752|NCT00227617|6384644|P3|COMPLETED|Stage 1||2
2600753|NCT00227617|6384645|P2|COMPLETED|Stage 1||12
2600754|NCT00227617|6384646|P1|COMPLETED|Stage 1||22
2600755|NCT00227617|6384644|P3|STARTED|Stage 1||2
2600756|NCT00227617|6384645|P2|STARTED|Stage 1||12
2600757|NCT00227617|6384646|P1|STARTED|Stage 1||22
2600758|NCT00227591|6384662|P1|NOT COMPLETED|Overall Study||1
2600759|NCT00227591|6384662|P1|COMPLETED|Overall Study||47
2600760|NCT00227591|6384662|P1|Began Treatment|Overall Study||47
2600761|NCT00227591|6384662|P1|STARTED|Overall Study|48 pts registered to the study|48
2600762|NCT00227539|6384666|P1|NOT COMPLETED|Overall Study||1
2600763|NCT00227539|6384666|P1|COMPLETED|Overall Study||24
2600764|NCT00227539|6384666|P1|STARTED|Overall Study||25
2600765|NCT00227370|6384674|P2|NOT COMPLETED|Overall Study||24
2600766|NCT00227370|6384675|P1|NOT COMPLETED|Overall Study||21
2600767|NCT00227370|6384674|P2|COMPLETED|Overall Study||46
2600768|NCT00227370|6384675|P1|COMPLETED|Overall Study||45
2600769|NCT00227370|6384674|P2|STARTED|Overall Study|Treatment Group|70
2600770|NCT00227370|6384675|P1|STARTED|Overall Study|Placebo Group|66
2600771|NCT00227344|6384695|P2|NOT COMPLETED|Overall Study||5
2600772|NCT00227344|6384696|P1|NOT COMPLETED|Overall Study||12
2600773|NCT00227344|6384695|P2|COMPLETED|Overall Study||37
2600774|NCT00227344|6384696|P1|COMPLETED|Overall Study||75
2600775|NCT00227344|6384695|P2|STARTED|Overall Study||42
2600776|NCT00227344|6384696|P1|STARTED|Overall Study||87
2600777|NCT00227305|6384716|P1|NOT COMPLETED|Overall Study||144
2600778|NCT00227305|6384716|P1|COMPLETED|Overall Study|Completed 26 weeks|237
2600779|NCT00227305|6384716|P1|Drug Received|Overall Study|safety population|380
2600780|NCT00227305|6384716|P1|STARTED|Overall Study|enrolled|381
2600781|NCT00227266|6384733|P3|NOT COMPLETED|Overall Study||4
2600782|NCT00227266|6384734|P2|NOT COMPLETED|Overall Study||0
2600783|NCT00227266|6384735|P1|NOT COMPLETED|Overall Study||1
2600784|NCT00227266|6384733|P3|COMPLETED|Overall Study||29
2600785|NCT00227266|6384734|P2|COMPLETED|Overall Study||30
2600786|NCT00227266|6384735|P1|COMPLETED|Overall Study||30
2600787|NCT00227266|6384733|P3|STARTED|Overall Study||33
2600788|NCT00227266|6384734|P2|STARTED|Overall Study||30
2600789|NCT00227266|6384735|P1|STARTED|Overall Study||31
2600790|NCT00227019|6384755|P1|NOT COMPLETED|Overall Study||0
2600791|NCT00227019|6384755|P1|COMPLETED|Overall Study||16
2600792|NCT00227019|6384755|P1|STARTED|Overall Study||16
2600793|NCT00226941|6384765|P4|NOT COMPLETED|Overall Study||2
2600794|NCT00226941|6384766|P3|NOT COMPLETED|Overall Study||0
2600795|NCT00226941|6384767|P2|NOT COMPLETED|Overall Study||0
2600796|NCT00226941|6384768|P1|NOT COMPLETED|Overall Study||0
2600797|NCT00226941|6384765|P4|COMPLETED|Overall Study||5
2600798|NCT00226941|6384766|P3|COMPLETED|Overall Study||4
2600799|NCT00226941|6384767|P2|COMPLETED|Overall Study||6
2600800|NCT00226941|6384768|P1|COMPLETED|Overall Study||6
2600801|NCT00226941|6384765|P4|STARTED|Overall Study||7
2600802|NCT00226941|6384766|P3|STARTED|Overall Study||4
2600803|NCT00226941|6384767|P2|STARTED|Overall Study||6
2600804|NCT00226941|6384768|P1|STARTED|Overall Study||6
2600805|NCT00226811|6384802|P1|NOT COMPLETED|Overall Study||76
2600806|NCT00226811|6384802|P1|COMPLETED|Overall Study||2
2600807|NCT00226811|6384802|P1|STARTED|Overall Study||78
2600808|NCT00226655|6384812|P1|NOT COMPLETED|Overall Study||79
2600809|NCT00226655|6384812|P1|COMPLETED|Overall Study||33
2600810|NCT00226655|6384812|P1|STARTED|Overall Study||112
2600811|NCT00226590|6384816|P1|NOT COMPLETED|Overall Study||0
2600812|NCT00226590|6384816|P1|COMPLETED|Overall Study||39
2600813|NCT00226590|6384816|P1|STARTED|Overall Study||39
2600814|NCT00226577|6384823|P1|NOT COMPLETED|Overall Study||0
2600815|NCT00226577|6384823|P1|COMPLETED|Overall Study||52
2600816|NCT00226577|6384823|P1|STARTED|Overall Study||52
2600817|NCT00226499|6384834|P3|NOT COMPLETED|Overall Study||359
2600818|NCT00226499|6384835|P2|NOT COMPLETED|Overall Study||1072
2600819|NCT00226499|6384836|P1|NOT COMPLETED|Overall Study||1074
2600820|NCT00226499|6384834|P3|COMPLETED|Overall Study||468
2600821|NCT00226499|6384835|P2|COMPLETED|Overall Study||1415
2600822|NCT00226499|6384836|P1|COMPLETED|Overall Study||1415
2600823|NCT00226499|6384834|P3|STARTED|Overall Study||827
2600824|NCT00226499|6384835|P2|STARTED|Overall Study||2487
2600825|NCT00226499|6384836|P1|STARTED|Overall Study||2489
2600826|NCT00226239|6384951|P1|NOT COMPLETED|Maintenance Cetuximab||14
2600827|NCT00226239|6384951|P1|COMPLETED|Maintenance Cetuximab||17
2600828|NCT00226239|6384951|P1|STARTED|Maintenance Cetuximab||31
2600829|NCT00226239|6384951|P1|NOT COMPLETED|XPE, Definitive Therapy||4
2600830|NCT00226239|6384951|P1|COMPLETED|XPE, Definitive Therapy||33
2600831|NCT00226239|6384951|P1|STARTED|XPE, Definitive Therapy||37
2600832|NCT00226239|6384951|P1|NOT COMPLETED|TPE, Induction Therapy||2
2600833|NCT00226239|6384951|P1|COMPLETED|TPE, Induction Therapy||37
2600834|NCT00226239|6384951|P1|STARTED|TPE, Induction Therapy||39
2600835|NCT00225784|6384960|P1|NOT COMPLETED|Overall Study||4
2600836|NCT00225784|6384960|P1|COMPLETED|Overall Study||33
2600837|NCT00225784|6384960|P1|STARTED|Overall Study||37
2600838|NCT00225758|6384971|P1|NOT COMPLETED|Overall Study||4
2600839|NCT00225758|6384971|P1|COMPLETED|Overall Study||23
2600840|NCT00225758|6384971|P1|STARTED|Overall Study||27
2600841|NCT00225732|6384981|P2|NOT COMPLETED|Overall Study||0
2600842|NCT00225732|6384982|P1|NOT COMPLETED|Overall Study||0
2600843|NCT00225732|6384981|P2|COMPLETED|Overall Study||166
2600844|NCT00225732|6384982|P1|COMPLETED|Overall Study||153
2600845|NCT00225732|6384981|P2|STARTED|Overall Study||166
2600846|NCT00225732|6384982|P1|STARTED|Overall Study||153
2600847|NCT00225498|6384988|P1|NOT COMPLETED|Overall Study||0
2600848|NCT00225498|6384988|P1|COMPLETED|Overall Study|The only analyses with adequate statistical power were of the 10 ziprasidone nonresponders.|10
2600849|NCT00225498|6384988|P1|STARTED|Overall Study||10
2600850|NCT00225420|6384992|P3|NOT COMPLETED|Overall Study||0
2600851|NCT00225420|6384993|P2|NOT COMPLETED|Overall Study||0
2600852|NCT00225420|6384994|P1|NOT COMPLETED|Overall Study||0
2600853|NCT00225420|6384992|P3|COMPLETED|Overall Study||3
2600854|NCT00225420|6384993|P2|COMPLETED|Overall Study||6
2600855|NCT00225420|6384994|P1|COMPLETED|Overall Study||9
2600856|NCT00225420|6384992|P3|STARTED|Overall Study||3
2600857|NCT00225420|6384993|P2|STARTED|Overall Study||6
2600858|NCT00225420|6384994|P1|STARTED|Overall Study||9
2600859|NCT00225277|6385003|P2|NOT COMPLETED|Overall Study||95
2600860|NCT00225277|6385004|P1|NOT COMPLETED|Overall Study||97
2600861|NCT00225277|6385003|P2|COMPLETED|Overall Study||178
2600862|NCT00225277|6385004|P1|COMPLETED|Overall Study||177
2600863|NCT00225277|6385003|P2|STARTED|Overall Study|Mean treatment durations were 56.3 weeks (glimepiride) and 56.5 weeks (pioglitazone).|273
2600864|NCT00225277|6385004|P1|STARTED|Overall Study|274 subjects randomized, but four subjects did not receive drug.|274
2600865|NCT00225251|6385022|P2|NOT COMPLETED|Overall Study||1
2600866|NCT00225251|6385023|P1|NOT COMPLETED|Overall Study||1
2600867|NCT00225251|6385022|P2|COMPLETED|Overall Study||6
2600868|NCT00225251|6385023|P1|COMPLETED|Overall Study||10
2600869|NCT00225251|6385022|P2|STARTED|Overall Study||7
2600870|NCT00225251|6385023|P1|STARTED|Overall Study||11
2600871|NCT00225212|6385037|P1|NOT COMPLETED|Overall Study||6
2600872|NCT00225212|6385037|P1|COMPLETED|Overall Study||29
2600873|NCT00225212|6385037|P1|STARTED|Overall Study||35
2600874|NCT00225147|6385046|P4|NOT COMPLETED|Open-label Phase||10
2600875|NCT00225147|6385047|P3|NOT COMPLETED|Open-label Phase||0
2600876|NCT00225147|6385048|P2|NOT COMPLETED|Open-label Phase||0
2600877|NCT00225147|6385049|P1|NOT COMPLETED|Open-label Phase||0
2600878|NCT00225147|6385046|P4|COMPLETED|Open-label Phase||52
2600879|NCT00225147|6385047|P3|COMPLETED|Open-label Phase||0
2600880|NCT00225147|6385048|P2|COMPLETED|Open-label Phase||0
2600881|NCT00225147|6385049|P1|COMPLETED|Open-label Phase||0
2600882|NCT00225147|6385046|P4|STARTED|Open-label Phase||62
2600883|NCT00225147|6385047|P3|STARTED|Open-label Phase||0
2600884|NCT00225147|6385048|P2|STARTED|Open-label Phase||0
2600885|NCT00225147|6385049|P1|STARTED|Open-label Phase||0
2600886|NCT00225147|6385046|P4|NOT COMPLETED|Double-blind Phase||0
2600887|NCT00225147|6385047|P3|NOT COMPLETED|Double-blind Phase||0
2600888|NCT00225147|6385048|P2|NOT COMPLETED|Double-blind Phase||0
2600889|NCT00225147|6385049|P1|NOT COMPLETED|Double-blind Phase||0
2600890|NCT00225147|6385046|P4|COMPLETED|Double-blind Phase||0
2600891|NCT00225147|6385047|P3|COMPLETED|Double-blind Phase||13
2600892|NCT00225147|6385048|P2|COMPLETED|Double-blind Phase||12
2600893|NCT00225147|6385049|P1|COMPLETED|Double-blind Phase||13
2600894|NCT00225147|6385046|P4|STARTED|Double-blind Phase||0
2600895|NCT00225147|6385047|P3|STARTED|Double-blind Phase||13
2600896|NCT00225147|6385048|P2|STARTED|Double-blind Phase||12
2600897|NCT00225147|6385049|P1|STARTED|Double-blind Phase||13
2600898|NCT00225017|6385065|P2|NOT COMPLETED|Overall Study||1
2600899|NCT00225017|6385066|P1|NOT COMPLETED|Overall Study||0
2600900|NCT00225017|6385065|P2|COMPLETED|Overall Study|1 subject did not complete week 24 assessments|23
2600901|NCT00225017|6385066|P1|COMPLETED|Overall Study||26
2600902|NCT00225017|6385065|P2|STARTED|Overall Study||24
2600903|NCT00225017|6385066|P1|STARTED|Overall Study||26
2600904|NCT00224952|6385079|P3|NOT COMPLETED|Overall Study||0
2600905|NCT00224952|6385080|P2|NOT COMPLETED|Overall Study||0
2600906|NCT00224952|6385081|P1|NOT COMPLETED|Overall Study||0
2600907|NCT00224952|6385079|P3|COMPLETED|Overall Study||134
2600908|NCT00224952|6385080|P2|COMPLETED|Overall Study||87
2600909|NCT00224952|6385081|P1|COMPLETED|Overall Study||53
2600910|NCT00224952|6385079|P3|STARTED|Overall Study||134
2600911|NCT00224952|6385080|P2|STARTED|Overall Study||87
2600912|NCT00224952|6385081|P1|STARTED|Overall Study||53
2600913|NCT00224874|6385096|P4|NOT COMPLETED|Overall Study||0
2600914|NCT00224874|6385097|P3|NOT COMPLETED|Overall Study||1
2600915|NCT00224874|6385098|P2|NOT COMPLETED|Overall Study||0
2600916|NCT00224874|6385099|P1|NOT COMPLETED|Overall Study||0
2600917|NCT00224874|6385096|P4|COMPLETED|Overall Study||42
2600918|NCT00224874|6385097|P3|COMPLETED|Overall Study||46
2600919|NCT00224874|6385098|P2|COMPLETED|Overall Study||45
2600920|NCT00224874|6385099|P1|COMPLETED|Overall Study||46
2600921|NCT00224874|6385096|P4|STARTED|Overall Study||42
2600922|NCT00224874|6385097|P3|STARTED|Overall Study||47
2600923|NCT00224874|6385098|P2|STARTED|Overall Study||45
2600924|NCT00224874|6385099|P1|STARTED|Overall Study||46
2600925|NCT00224770|6385144|P3|NOT COMPLETED|Overall Study||0
2600926|NCT00224770|6385145|P2|NOT COMPLETED|Overall Study||2
2600927|NCT00224770|6385146|P1|NOT COMPLETED|Overall Study||4
2600928|NCT00224770|6385144|P3|COMPLETED|Overall Study||14
2600929|NCT00224770|6385145|P2|COMPLETED|Overall Study||52
2600930|NCT00224770|6385146|P1|COMPLETED|Overall Study||38
2600931|NCT00224770|6385144|P3|STARTED|Overall Study||14
2600932|NCT00224770|6385145|P2|STARTED|Overall Study||54
2600933|NCT00224770|6385146|P1|STARTED|Overall Study||42
2600934|NCT00224484|6385181|P3|NOT COMPLETED|Overall Study||62
2600935|NCT00224484|6385182|P2|NOT COMPLETED|Overall Study||65
2600936|NCT00224484|6385183|P1|NOT COMPLETED|Overall Study||146
2600937|NCT00224484|6385181|P3|COMPLETED|Overall Study||1425
2600938|NCT00224484|6385182|P2|COMPLETED|Overall Study||1426
2600939|NCT00224484|6385183|P1|COMPLETED|Overall Study||2831
2600940|NCT00224484|6385181|P3|STARTED|Overall Study||1487
2600941|NCT00224484|6385182|P2|STARTED|Overall Study||1491
2600942|NCT00224484|6385183|P1|STARTED|Overall Study||2977
2600943|NCT00224289|6385242|P1|NOT COMPLETED|Overall Study||0
2600944|NCT00224289|6385242|P1|COMPLETED|Overall Study||17
2600945|NCT00224289|6385242|P1|STARTED|Overall Study||17
2600946|NCT00224133|6385247|P1|NOT COMPLETED|Overall Study||226
2600947|NCT00224133|6385247|P1|COMPLETED|Overall Study||435
2600948|NCT00224133|6385247|P1|STARTED|Overall Study||661
2600949|NCT00224120|6385253|P2|NOT COMPLETED|Overall Study||24
2600950|NCT00224120|6385254|P1|NOT COMPLETED|Overall Study||22
2600951|NCT00224120|6385253|P2|COMPLETED|Overall Study||205
2600952|NCT00224120|6385254|P1|COMPLETED|Overall Study||211
2600953|NCT00224120|6385253|P2|STARTED|Overall Study||229
2600954|NCT00224120|6385254|P1|STARTED|Overall Study||233
2600955|NCT00224107|6385264|P2|NOT COMPLETED|Overall Study||14
2600956|NCT00224107|6385265|P1|NOT COMPLETED|Overall Study||31
2600957|NCT00224107|6385264|P2|COMPLETED|Overall Study||214
2600958|NCT00224107|6385265|P1|COMPLETED|Overall Study||202
2600959|NCT00224107|6385264|P2|STARTED|Overall Study||228
2600960|NCT00224107|6385265|P1|STARTED|Overall Study||233
2600961|NCT00224055|6385275|P2|NOT COMPLETED|Overall Study||14
2600962|NCT00224055|6385276|P1|NOT COMPLETED|Overall Study||15
2600963|NCT00224055|6385275|P2|COMPLETED|Overall Study||31
2600964|NCT00224055|6385276|P1|COMPLETED|Overall Study||29
2600965|NCT00224055|6385275|P2|STARTED|Overall Study||45
2600966|NCT00224055|6385276|P1|STARTED|Overall Study||44
2600967|NCT00224042|6385286|P2|NOT COMPLETED|Overall Study||6
2600968|NCT00224042|6385287|P1|NOT COMPLETED|Overall Study||6
2600969|NCT00224042|6385286|P2|COMPLETED|Overall Study||20
2600970|NCT00224042|6385287|P1|COMPLETED|Overall Study||20
2600971|NCT00224042|6385286|P2|STARTED|Overall Study||26
2600972|NCT00224042|6385287|P1|STARTED|Overall Study||26
2600973|NCT00224029|6385299|P1|NOT COMPLETED|Overall Study||6
2600974|NCT00224029|6385299|P1|COMPLETED|Overall Study||18
2600975|NCT00224029|6385299|P1|STARTED|Overall Study||24
2600976|NCT00224016|6385305|P2|NOT COMPLETED|Follow-Up Period||0
2600977|NCT00224016|6385306|P1|NOT COMPLETED|Follow-Up Period||0
2600978|NCT00224016|6385305|P2|COMPLETED|Follow-Up Period||0
2600979|NCT00224016|6385306|P1|COMPLETED|Follow-Up Period||35
2600980|NCT00224016|6385305|P2|STARTED|Follow-Up Period|This group of subjects did not proceed to follow-up period.|0
2600981|NCT00224016|6385306|P1|STARTED|Follow-Up Period||35
2600982|NCT00224016|6385305|P2|NOT COMPLETED|Maintenance Period||1
2600983|NCT00224016|6385306|P1|NOT COMPLETED|Maintenance Period||2
2600984|NCT00224016|6385305|P2|COMPLETED|Maintenance Period||14
2600985|NCT00224016|6385306|P1|COMPLETED|Maintenance Period||36
2600986|NCT00224016|6385305|P2|STARTED|Maintenance Period||15
2600987|NCT00224016|6385306|P1|STARTED|Maintenance Period||38
2600988|NCT00224016|6385305|P2|NOT COMPLETED|Titration Period||1
2600989|NCT00224016|6385306|P1|NOT COMPLETED|Titration Period||1
2600990|NCT00224016|6385305|P2|COMPLETED|Titration Period||15
2600991|NCT00224016|6385306|P1|COMPLETED|Titration Period||38
2600992|NCT00224016|6385305|P2|STARTED|Titration Period||16
2600993|NCT00224016|6385306|P1|STARTED|Titration Period||39
2600994|NCT00224003|6385314|P1|NOT COMPLETED|Overall Study||7
2600995|NCT00224003|6385314|P1|COMPLETED|Overall Study|Last patient out: March 31, 2004|16
2600996|NCT00224003|6385314|P1|STARTED|Overall Study|First patient in: April 2, 2003|23
2600997|NCT00223977|6385321|P3|NOT COMPLETED|Overall Study||3
2600998|NCT00223977|6385322|P2|NOT COMPLETED|Overall Study||11
2600999|NCT00223977|6385323|P1|NOT COMPLETED|Overall Study||9
2601000|NCT00223977|6385321|P3|COMPLETED|Overall Study||39
2601001|NCT00223977|6385322|P2|COMPLETED|Overall Study||47
2601002|NCT00223977|6385323|P1|COMPLETED|Overall Study||37
2601003|NCT00223977|6385321|P3|STARTED|Overall Study||42
2601004|NCT00223977|6385322|P2|STARTED|Overall Study||58
2601005|NCT00223977|6385323|P1|STARTED|Overall Study||46
2601006|NCT00223821|6385345|P2|NOT COMPLETED|Overall Study||10
2601007|NCT00223821|6385346|P1|NOT COMPLETED|Overall Study||4
2601008|NCT00223821|6385345|P2|COMPLETED|Overall Study||22
2601009|NCT00223821|6385346|P1|COMPLETED|Overall Study||28
2601010|NCT00223821|6385345|P2|Completed 6-month Follow-up|Overall Study||25
2601011|NCT00223821|6385346|P1|Completed 6-month Follow-up|Overall Study||28
2601012|NCT00223821|6385345|P2|Completed Post-treatment Assessment|Overall Study||27
2601013|NCT00223821|6385346|P1|Completed Post-treatment Assessment|Overall Study||31
2601014|NCT00223821|6385345|P2|Completed Therapy|Overall Study||28
2601015|NCT00223821|6385346|P1|Completed Therapy|Overall Study||31
2601016|NCT00223821|6385345|P2|STARTED|Overall Study||32
2601017|NCT00223821|6385346|P1|STARTED|Overall Study||32
2601018|NCT00223808|6385357|P3|NOT COMPLETED|Overall Study||5
2601019|NCT00223808|6385358|P2|NOT COMPLETED|Overall Study||5
2601020|NCT00223808|6385359|P1|NOT COMPLETED|Overall Study||3
2601021|NCT00223808|6385357|P3|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|18
2601022|NCT00223808|6385358|P2|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|17
2601023|NCT00223808|6385359|P1|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|19
2601024|NCT00223808|6385357|P3|STARTED|Overall Study||23
2601025|NCT00223808|6385358|P2|STARTED|Overall Study||22
2601026|NCT00223808|6385359|P1|STARTED|Overall Study||22
2601027|NCT00223795|6385376|P2|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
2601028|NCT00223795|6385377|P1|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
2601029|NCT00223795|6385376|P2|COMPLETED|Second Intervention - All Use Canes 4 mo||17
2601030|NCT00223795|6385377|P1|COMPLETED|Second Intervention - All Use Canes 4 mo||18
2601031|NCT00223795|6385376|P2|STARTED|Second Intervention - All Use Canes 4 mo||18
2601032|NCT00223795|6385377|P1|STARTED|Second Intervention - All Use Canes 4 mo||19
2601033|NCT00223795|6385376|P2|NOT COMPLETED|First Intervention - Eight Weeks||9
2601034|NCT00223795|6385377|P1|NOT COMPLETED|First Intervention - Eight Weeks||7
2601035|NCT00223795|6385376|P2|COMPLETED|First Intervention - Eight Weeks||18
2601036|NCT00223795|6385377|P1|COMPLETED|First Intervention - Eight Weeks||19
2601037|NCT00223795|6385376|P2|STARTED|First Intervention - Eight Weeks||27
2601038|NCT00223795|6385377|P1|STARTED|First Intervention - Eight Weeks||26
2601039|NCT00223704|6385387|P3|NOT COMPLETED|Overall Study||0
2601040|NCT00223704|6385388|P2|NOT COMPLETED|Overall Study||0
2601041|NCT00223704|6385389|P1|NOT COMPLETED|Overall Study||0
2601042|NCT00223704|6385387|P3|COMPLETED|Overall Study||40
2601043|NCT00223704|6385388|P2|COMPLETED|Overall Study||37
2601044|NCT00223704|6385389|P1|COMPLETED|Overall Study||38
2601045|NCT00223704|6385387|P3|STARTED|Overall Study||40
2601046|NCT00223704|6385388|P2|STARTED|Overall Study||37
2601047|NCT00223704|6385389|P1|STARTED|Overall Study||38
2601048|NCT00223678|6385411|P2|NOT COMPLETED|Overall Study||0
2601049|NCT00223678|6385412|P1|NOT COMPLETED|Overall Study||0
2601050|NCT00223678|6385411|P2|COMPLETED|Overall Study||7
2601051|NCT00223678|6385412|P1|COMPLETED|Overall Study||13
2601052|NCT00223678|6385411|P2|STARTED|Overall Study||7
2601053|NCT00223678|6385412|P1|STARTED|Overall Study||13
2601054|NCT00223665|6385418|P1|NOT COMPLETED|Overall Study||0
2601055|NCT00223665|6385418|P1|COMPLETED|Overall Study||102
2601056|NCT00223665|6385418|P1|STARTED|Overall Study||102
2601057|NCT00223652|6385438|P2|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||4
2601058|NCT00223652|6385439|P1|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||1
2601059|NCT00223652|6385438|P2|COMPLETED|T-CBT and TAU 6 Month Follow-up||37
2601060|NCT00223652|6385439|P1|COMPLETED|T-CBT and TAU 6 Month Follow-up||39
2601061|NCT00223652|6385438|P2|STARTED|T-CBT and TAU 6 Month Follow-up||41
2601062|NCT00223652|6385439|P1|STARTED|T-CBT and TAU 6 Month Follow-up||40
2601063|NCT00223652|6385438|P2|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
2601064|NCT00223652|6385439|P1|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
2601065|NCT00223652|6385438|P2|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||41
2601066|NCT00223652|6385439|P1|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||40
2601067|NCT00223652|6385438|P2|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||41
2601068|NCT00223652|6385439|P1|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||40
2601069|NCT00223652|6385438|P2|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||3
2601070|NCT00223652|6385439|P1|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||1
2601071|NCT00223652|6385438|P2|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||41
2601072|NCT00223652|6385439|P1|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||40
2601073|NCT00223652|6385438|P2|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||44
2601074|NCT00223652|6385439|P1|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||41
2601075|NCT00223496|6385455|P1|NOT COMPLETED|Overall Study||22
2601076|NCT00223496|6385455|P1|COMPLETED|Overall Study||10
2601077|NCT00223496|6385455|P1|STARTED|Overall Study|32 people consented, 19 were baselined|32
2601078|NCT00223262|6385461|P2|NOT COMPLETED|Overall Study||1
2601079|NCT00223262|6385462|P1|NOT COMPLETED|Overall Study||8
2601080|NCT00223262|6385461|P2|COMPLETED|Overall Study||11
2601081|NCT00223262|6385462|P1|COMPLETED|Overall Study||8
2601082|NCT00223262|6385461|P2|STARTED|Overall Study||12
2601083|NCT00223262|6385462|P1|STARTED|Overall Study||16
2601084|NCT00223236|6385470|P2|NOT COMPLETED|Overall Study||14
2601085|NCT00223236|6385471|P1|NOT COMPLETED|Overall Study||7
2601086|NCT00223236|6385470|P2|COMPLETED|Overall Study|4 completed 12 week trial.|4
2601087|NCT00223236|6385471|P1|COMPLETED|Overall Study|9 completed 12 week trial.|9
2601088|NCT00223236|6385470|P2|STARTED|Overall Study|21 completed baseline assessment but 18 completed at least one treatment visit.|18
2601089|NCT00223236|6385471|P1|STARTED|Overall Study|23 completed baseline assessment but 16 completed at least one treatment visit.|16
2601090|NCT00223080|6385485|P2|NOT COMPLETED|Overall Study||797
2601091|NCT00223080|6385486|P1|NOT COMPLETED|Overall Study||796
2601092|NCT00223080|6385485|P2|COMPLETED|Overall Study||7401
2601093|NCT00223080|6385486|P1|COMPLETED|Overall Study||7401
2601094|NCT00223080|6385485|P2|STARTED|Overall Study||8198
2601095|NCT00223080|6385486|P1|STARTED|Overall Study||8197
2601096|NCT00222729|6385504|P1|NOT COMPLETED|Overall Study||3
2601097|NCT00222729|6385504|P1|COMPLETED|Overall Study||37
2601098|NCT00222729|6385504|P1|STARTED|Overall Study||40
2601099|NCT00222131|6385513|P2|NOT COMPLETED|Overall Study||0
2601100|NCT00222131|6385514|P1|NOT COMPLETED|Overall Study||0
2601101|NCT00222131|6385513|P2|COMPLETED|Overall Study||35
2601102|NCT00222131|6385514|P1|COMPLETED|Overall Study||38
2601103|NCT00222131|6385513|P2|STARTED|Overall Study||35
2601104|NCT00222131|6385514|P1|STARTED|Overall Study||38
2601105|NCT00222105|6385522|P1|NOT COMPLETED|Overall Study||14
2601106|NCT00222105|6385522|P1|COMPLETED|Overall Study||11
2601107|NCT00222105|6385522|P1|STARTED|Overall Study||25
2601108|NCT00221299|6385530|P4|NOT COMPLETED|Overall Study||1
2601109|NCT00221299|6385531|P3|NOT COMPLETED|Overall Study||0
2601110|NCT00221299|6385532|P2|NOT COMPLETED|Overall Study||2
2601111|NCT00221299|6385533|P1|NOT COMPLETED|Overall Study||1
2601112|NCT00221299|6385530|P4|COMPLETED|Overall Study||10
2601113|NCT00221299|6385531|P3|COMPLETED|Overall Study||14
2601114|NCT00221299|6385532|P2|COMPLETED|Overall Study||11
2601115|NCT00221299|6385533|P1|COMPLETED|Overall Study||10
2601116|NCT00221299|6385530|P4|STARTED|Overall Study||11
2601117|NCT00221299|6385531|P3|STARTED|Overall Study||14
2601118|NCT00221299|6385532|P2|STARTED|Overall Study||13
2601119|NCT00221299|6385533|P1|STARTED|Overall Study||11
2601120|NCT00221195|6385543|P2|NOT COMPLETED|Overall Study||3
2601121|NCT00221195|6385544|P1|NOT COMPLETED|Overall Study||5
2601122|NCT00221195|6385543|P2|COMPLETED|Overall Study||14
2601123|NCT00221195|6385544|P1|COMPLETED|Overall Study||12
2601124|NCT00221195|6385543|P2|STARTED|Overall Study||17
2601125|NCT00221195|6385544|P1|STARTED|Overall Study||17
2601126|NCT00221117|6385553|P2|NOT COMPLETED|Overall Study||0
2601127|NCT00221117|6385554|P1|NOT COMPLETED|Overall Study||0
2601128|NCT00221117|6385553|P2|COMPLETED|Overall Study||9
2601129|NCT00221117|6385554|P1|COMPLETED|Overall Study||12
2601130|NCT00221117|6385553|P2|STARTED|Overall Study|One participant dropped out of the study after signing consent but prior to baseline assessments.|9
2601131|NCT00221117|6385554|P1|STARTED|Overall Study||12
2601132|NCT00221104|6385566|P2|NOT COMPLETED|Overall Study||76
2601133|NCT00221104|6385567|P1|NOT COMPLETED|Overall Study||83
2601134|NCT00221104|6385566|P2|COMPLETED|Overall Study||709
2601135|NCT00221104|6385567|P1|COMPLETED|Overall Study||710
2601136|NCT00221104|6385566|P2|STARTED|Overall Study||785
2601137|NCT00221104|6385567|P1|STARTED|Overall Study||793
2601138|NCT00220961|6385583|P2|NOT COMPLETED|Overall Study||90
2601139|NCT00220961|6385584|P1|NOT COMPLETED|Overall Study||71
2601140|NCT00220961|6385583|P2|COMPLETED|Overall Study||213
2601141|NCT00220961|6385584|P1|COMPLETED|Overall Study||228
2601142|NCT00220961|6385583|P2|STARTED|Overall Study||303
2601143|NCT00220961|6385584|P1|STARTED|Overall Study||299
2601144|NCT00220805|6385600|P2|NOT COMPLETED|Overall Study||11
2601145|NCT00220805|6385601|P1|NOT COMPLETED|Overall Study||8
2601146|NCT00220805|6385600|P2|COMPLETED|Overall Study||16
2601147|NCT00220805|6385601|P1|COMPLETED|Overall Study||22
2601148|NCT00220805|6385600|P2|STARTED|Overall Study||27
2601149|NCT00220805|6385601|P1|STARTED|Overall Study||30
2601150|NCT00220779|6385622|P3|NOT COMPLETED|Overall Study||4
2601151|NCT00220779|6385623|P2|NOT COMPLETED|Overall Study||4
2601152|NCT00220779|6385624|P1|NOT COMPLETED|Overall Study||7
2601153|NCT00220779|6385622|P3|COMPLETED|Overall Study||37
2601154|NCT00220779|6385623|P2|COMPLETED|Overall Study||38
2601155|NCT00220779|6385624|P1|COMPLETED|Overall Study||38
2601156|NCT00220779|6385622|P3|STARTED|Overall Study||41
2601157|NCT00220779|6385623|P2|STARTED|Overall Study||42
2601158|NCT00220779|6385624|P1|STARTED|Overall Study||45
2601159|NCT00220740|6385634|P2|NOT COMPLETED|Withdrawal Period||15
2601160|NCT00220740|6385635|P1|NOT COMPLETED|Withdrawal Period||6
2601161|NCT00220740|6385634|P2|COMPLETED|Withdrawal Period||16
2601162|NCT00220740|6385635|P1|COMPLETED|Withdrawal Period||37
2601163|NCT00220740|6385634|P2|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|31
2601164|NCT00220740|6385635|P1|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|43
2601165|NCT00220740|6385634|P2|NOT COMPLETED|Rescue Treatment||18
2601166|NCT00220740|6385635|P1|NOT COMPLETED|Rescue Treatment||19
2601167|NCT00220740|6385634|P2|COMPLETED|Rescue Treatment||5
2601168|NCT00220740|6385635|P1|COMPLETED|Rescue Treatment||26
2601169|NCT00220740|6385634|P2|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|23
2601170|NCT00220740|6385635|P1|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|45
2601171|NCT00220740|6385634|P2|NOT COMPLETED|Efficacy Period||46
2601172|NCT00220740|6385635|P1|NOT COMPLETED|Efficacy Period||26
2601173|NCT00220740|6385634|P2|COMPLETED|Efficacy Period||12
2601174|NCT00220740|6385635|P1|COMPLETED|Efficacy Period||33
2601175|NCT00220740|6385634|P2|STARTED|Efficacy Period||58
2601176|NCT00220740|6385635|P1|STARTED|Efficacy Period||59
2601177|NCT00220727|6385649|P2|NOT COMPLETED|Second Infusion (Week <6)||0
2601178|NCT00220727|6385650|P1|NOT COMPLETED|Second Infusion (Week <6)||1
2601179|NCT00220727|6385649|P2|COMPLETED|Second Infusion (Week <6)||4
2601180|NCT00220727|6385650|P1|COMPLETED|Second Infusion (Week <6)||3
2601181|NCT00220727|6385649|P2|STARTED|Second Infusion (Week <6)||4
2601182|NCT00220727|6385650|P1|STARTED|Second Infusion (Week <6)||4
2601183|NCT00220727|6385649|P2|NOT COMPLETED|First Infusion (Week 0)||0
2601184|NCT00220727|6385650|P1|NOT COMPLETED|First Infusion (Week 0)||0
2601185|NCT00220727|6385649|P2|COMPLETED|First Infusion (Week 0)||4
2601186|NCT00220727|6385650|P1|COMPLETED|First Infusion (Week 0)||4
2601187|NCT00220727|6385649|P2|STARTED|First Infusion (Week 0)||4
2601188|NCT00220727|6385650|P1|STARTED|First Infusion (Week 0)||4
2601189|NCT00220701|6385666|P2|NOT COMPLETED|Overall Study||4
2601190|NCT00220701|6385667|P1|NOT COMPLETED|Overall Study||5
2601191|NCT00220701|6385666|P2|COMPLETED|Overall Study||13
2601192|NCT00220701|6385667|P1|COMPLETED|Overall Study||12
2601193|NCT00220701|6385666|P2|STARTED|Overall Study||17
2601194|NCT00220701|6385667|P1|STARTED|Overall Study||17
2601195|NCT00220636|6385683|P1|NOT COMPLETED|Overall Study||4
2601196|NCT00220636|6385683|P1|COMPLETED|Overall Study||11
2601197|NCT00220636|6385683|P1|STARTED|Overall Study||15
2601198|NCT00219557|6385693|P3|NOT COMPLETED|Phase 2||33
2601199|NCT00219557|6385694|P2|NOT COMPLETED|Phase 2||69
2601200|NCT00219557|6385695|P1|NOT COMPLETED|Phase 2||0
2601201|NCT00219557|6385693|P3|COMPLETED|Phase 2||1
2601202|NCT00219557|6385694|P2|COMPLETED|Phase 2||0
2601203|NCT00219557|6385695|P1|COMPLETED|Phase 2||0
2601204|NCT00219557|6385693|P3|Treated|Phase 2||31
2601205|NCT00219557|6385694|P2|Treated|Phase 2||68
2601206|NCT00219557|6385695|P1|Treated|Phase 2||0
2601207|NCT00219557|6385693|P3|STARTED|Phase 2||34
2601208|NCT00219557|6385694|P2|STARTED|Phase 2||69
2601209|NCT00219557|6385695|P1|STARTED|Phase 2||0
2601210|NCT00219557|6385693|P3|NOT COMPLETED|Phase 1||0
2601211|NCT00219557|6385694|P2|NOT COMPLETED|Phase 1||0
2601212|NCT00219557|6385695|P1|NOT COMPLETED|Phase 1||7
2601213|NCT00219557|6385693|P3|COMPLETED|Phase 1||0
2601214|NCT00219557|6385694|P2|COMPLETED|Phase 1||0
2601215|NCT00219557|6385695|P1|COMPLETED|Phase 1||1
2601216|NCT00219557|6385693|P3|STARTED|Phase 1||0
2601217|NCT00219557|6385694|P2|STARTED|Phase 1||0
2601218|NCT00219557|6385695|P1|STARTED|Phase 1||8
2601219|NCT00219544|6385723|P2|NOT COMPLETED|Double Blind Treatment Period||0
2601220|NCT00219544|6385724|P1|NOT COMPLETED|Double Blind Treatment Period||0
2601221|NCT00219544|6385723|P2|COMPLETED|Double Blind Treatment Period||77
2601222|NCT00219544|6385724|P1|COMPLETED|Double Blind Treatment Period||80
2601223|NCT00219544|6385723|P2|STARTED|Double Blind Treatment Period||77
2601224|NCT00219544|6385724|P1|STARTED|Double Blind Treatment Period||80
2601225|NCT00219544|6385723|P2|NOT COMPLETED|Single Blind Treatment Period||0
2601226|NCT00219544|6385724|P1|NOT COMPLETED|Single Blind Treatment Period||22
2601227|NCT00219544|6385723|P2|COMPLETED|Single Blind Treatment Period||0
2601228|NCT00219544|6385724|P1|COMPLETED|Single Blind Treatment Period||234
2601229|NCT00219544|6385723|P2|STARTED|Single Blind Treatment Period||0
2601230|NCT00219544|6385724|P1|STARTED|Single Blind Treatment Period||256
2601231|NCT00219349|6385762|P1|NOT COMPLETED|Escitalopram Phase||3
2601232|NCT00219349|6385762|P1|COMPLETED|Escitalopram Phase||4
2601233|NCT00219349|6385762|P1|STARTED|Escitalopram Phase|7 responders to CBT were ineligible to start and 1 declined, leaving 7 who started escitalopram|7
2601234|NCT00219349|6385762|P1|NOT COMPLETED|Cognitive Behavioral Therapy Phase||10
2601235|NCT00219349|6385762|P1|COMPLETED|Cognitive Behavioral Therapy Phase||15
2601236|NCT00219349|6385762|P1|STARTED|Cognitive Behavioral Therapy Phase||25
2601237|NCT00219284|6385775|P2|NOT COMPLETED|Extension Phase - 8 Weeks||7
2601238|NCT00219284|6385776|P1|NOT COMPLETED|Extension Phase - 8 Weeks||2
2601239|NCT00219284|6385775|P2|COMPLETED|Extension Phase - 8 Weeks||99
2601240|NCT00219284|6385776|P1|COMPLETED|Extension Phase - 8 Weeks||112
2601241|NCT00219284|6385775|P2|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|106
2601242|NCT00219284|6385776|P1|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|114
2601243|NCT00219284|6385775|P2|NOT COMPLETED|Treatment Phase - 16 Weeks||51
2601244|NCT00219284|6385776|P1|NOT COMPLETED|Treatment Phase - 16 Weeks||44
2601245|NCT00219284|6385775|P2|COMPLETED|Treatment Phase - 16 Weeks||128
2601246|NCT00219284|6385776|P1|COMPLETED|Treatment Phase - 16 Weeks||136
2601247|NCT00219284|6385775|P2|STARTED|Treatment Phase - 16 Weeks||179
2601248|NCT00219284|6385776|P1|STARTED|Treatment Phase - 16 Weeks||180
2601249|NCT00219141|6385801|P3|NOT COMPLETED|Overall Study||12
2601250|NCT00219141|6385802|P2|NOT COMPLETED|Overall Study||21
2601251|NCT00219141|6385803|P1|NOT COMPLETED|Overall Study||14
2601252|NCT00219141|6385801|P3|COMPLETED|Overall Study||142
2601253|NCT00219141|6385802|P2|COMPLETED|Overall Study||131
2601254|NCT00219141|6385803|P1|COMPLETED|Overall Study||140
2601255|NCT00219141|6385801|P3|STARTED|Overall Study||154
2601256|NCT00219141|6385802|P2|STARTED|Overall Study||152
2601257|NCT00219141|6385803|P1|STARTED|Overall Study||154
2601258|NCT00218634|6385849|P2|NOT COMPLETED|Overall Study||15
2601259|NCT00218634|6385850|P1|NOT COMPLETED|Overall Study||8
2601260|NCT00218634|6385849|P2|COMPLETED|Overall Study||30
2601261|NCT00218634|6385850|P1|COMPLETED|Overall Study||36
2601262|NCT00218634|6385849|P2|STARTED|Overall Study||45
2601263|NCT00218634|6385850|P1|STARTED|Overall Study||44
2601264|NCT00218543|6385870|P1|NOT COMPLETED|Overall Study||15
2601265|NCT00218543|6385870|P1|COMPLETED|Overall Study|13 reached the maintenance dose phase of treatment; 9 completed at least six weeks of treatment.|5
2601266|NCT00218543|6385870|P1|STARTED|Overall Study||20
2601267|NCT00218491|6385878|P3|NOT COMPLETED|Overall Study||0
2601268|NCT00218491|6385879|P2|NOT COMPLETED|Overall Study||0
2601269|NCT00218491|6385880|P1|NOT COMPLETED|Overall Study||0
2601270|NCT00218491|6385878|P3|COMPLETED|Overall Study||38
2601271|NCT00218491|6385879|P2|COMPLETED|Overall Study||33
2601272|NCT00218491|6385880|P1|COMPLETED|Overall Study||40
2601273|NCT00218491|6385878|P3|STARTED|Overall Study||38
2601274|NCT00218491|6385879|P2|STARTED|Overall Study||33
2601275|NCT00218491|6385880|P1|STARTED|Overall Study||40
2601276|NCT00218465|6385890|P2|NOT COMPLETED|Overall Study||18
2601277|NCT00218465|6385891|P1|NOT COMPLETED|Overall Study||17
2601278|NCT00218465|6385890|P2|COMPLETED|Overall Study||30
2601279|NCT00218465|6385891|P1|COMPLETED|Overall Study||33
2601280|NCT00218465|6385890|P2|STARTED|Overall Study||48
2601281|NCT00218465|6385891|P1|STARTED|Overall Study||50
2601282|NCT00218439|6385903|P2|NOT COMPLETED|Second Intervention (4 Weeks)||5
2601283|NCT00218439|6385904|P1|NOT COMPLETED|Second Intervention (4 Weeks)||7
2601284|NCT00218439|6385903|P2|COMPLETED|Second Intervention (4 Weeks)||30
2601285|NCT00218439|6385904|P1|COMPLETED|Second Intervention (4 Weeks)||33
2601286|NCT00218439|6385903|P2|STARTED|Second Intervention (4 Weeks)||35
2601287|NCT00218439|6385904|P1|STARTED|Second Intervention (4 Weeks)||40
2601288|NCT00218439|6385903|P2|NOT COMPLETED|First Intervention (4 Weeks)||12
2601289|NCT00218439|6385904|P1|NOT COMPLETED|First Intervention (4 Weeks)||18
2601290|NCT00218439|6385903|P2|COMPLETED|First Intervention (4 Weeks)||35
2601291|NCT00218439|6385904|P1|COMPLETED|First Intervention (4 Weeks)||40
2601292|NCT00218439|6385903|P2|STARTED|First Intervention (4 Weeks)||47
2601293|NCT00218439|6385904|P1|STARTED|First Intervention (4 Weeks)||58
2601294|NCT00218426|6385921|P3|NOT COMPLETED|Overall Study||91
2601295|NCT00218426|6385922|P2|NOT COMPLETED|Overall Study||86
2601296|NCT00218426|6385923|P1|NOT COMPLETED|Overall Study||48
2601297|NCT00218426|6385921|P3|COMPLETED|Overall Study||11
2601298|NCT00218426|6385922|P2|COMPLETED|Overall Study||16
2601299|NCT00218426|6385923|P1|COMPLETED|Overall Study||54
2601300|NCT00218426|6385921|P3|STARTED|Overall Study||102
2601301|NCT00218426|6385922|P2|STARTED|Overall Study||102
2601302|NCT00218426|6385923|P1|STARTED|Overall Study||102
2601303|NCT00218387|6385964|P3|NOT COMPLETED|Overall Study||23
2601304|NCT00218387|6385965|P2|NOT COMPLETED|Overall Study||18
2601305|NCT00218387|6385966|P1|NOT COMPLETED|Overall Study||15
2601306|NCT00218387|6385964|P3|COMPLETED|Overall Study||17
2601307|NCT00218387|6385965|P2|COMPLETED|Overall Study||25
2601308|NCT00218387|6385966|P1|COMPLETED|Overall Study||25
2601309|NCT00218387|6385964|P3|STARTED|Overall Study||40
2601310|NCT00218387|6385965|P2|STARTED|Overall Study||43
2601311|NCT00218387|6385966|P1|STARTED|Overall Study||40
2601312|NCT00218335|6385981|P4|NOT COMPLETED|Overall Study||36
2601313|NCT00218335|6385982|P3|NOT COMPLETED|Overall Study||54
2601314|NCT00218335|6385983|P2|NOT COMPLETED|Overall Study||3
2601315|NCT00218335|6385984|P1|NOT COMPLETED|Overall Study||6
2601316|NCT00218335|6385981|P4|COMPLETED|Overall Study||388
2601317|NCT00218335|6385982|P3|COMPLETED|Overall Study||319
2601318|NCT00218335|6385983|P2|COMPLETED|Overall Study||110
2601319|NCT00218335|6385984|P1|COMPLETED|Overall Study||108
2601320|NCT00218335|6385981|P4|18 Month Follow-up|Overall Study||368
2601321|NCT00218335|6385982|P3|18 Month Follow-up|Overall Study||296
2601322|NCT00218335|6385983|P2|18 Month Follow-up|Overall Study||108
2601323|NCT00218335|6385984|P1|18 Month Follow-up|Overall Study||101
2601324|NCT00218335|6385981|P4|12 Month Follow-up|Overall Study||303
2601325|NCT00218335|6385982|P3|12 Month Follow-up|Overall Study||244
2601326|NCT00218335|6385983|P2|12 Month Follow-up|Overall Study||102
2601327|NCT00218335|6385984|P1|12 Month Follow-up|Overall Study||95
2601328|NCT00218335|6385981|P4|6 Month Follow-up|Overall Study||301
2601329|NCT00218335|6385982|P3|6 Month Follow-up|Overall Study||219
2601330|NCT00218335|6385983|P2|6 Month Follow-up|Overall Study||99
2601331|NCT00218335|6385984|P1|6 Month Follow-up|Overall Study||103
2601332|NCT00218335|6385981|P4|STARTED|Overall Study||424
2601333|NCT00218335|6385982|P3|STARTED|Overall Study||373
2601334|NCT00218335|6385983|P2|STARTED|Overall Study||113
2601335|NCT00218335|6385984|P1|STARTED|Overall Study||114
2601336|NCT00218296|6386048|P2|NOT COMPLETED|Overall Study||121
2601337|NCT00218296|6386049|P1|NOT COMPLETED|Overall Study||111
2601338|NCT00218296|6386048|P2|COMPLETED|Overall Study||48
2601339|NCT00218296|6386049|P1|COMPLETED|Overall Study||52
2601340|NCT00218296|6386048|P2|Attended Visti|Overall Study||102
2601341|NCT00218296|6386049|P1|Attended Visti|Overall Study||97
2601342|NCT00218296|6386048|P2|STARTED|Overall Study||169
2601343|NCT00218296|6386049|P1|STARTED|Overall Study||163
2601344|NCT00218062|6386069|P4|NOT COMPLETED|Overall Study||13
2601345|NCT00218062|6386070|P3|NOT COMPLETED|Overall Study||12
2601346|NCT00218062|6386071|P2|NOT COMPLETED|Overall Study||16
2601347|NCT00218062|6386072|P1|NOT COMPLETED|Overall Study||15
2601348|NCT00218062|6386069|P4|COMPLETED|Overall Study||3
2601349|NCT00218062|6386070|P3|COMPLETED|Overall Study||3
2601350|NCT00218062|6386071|P2|COMPLETED|Overall Study||4
2601351|NCT00218062|6386072|P1|COMPLETED|Overall Study||7
2601352|NCT00218062|6386069|P4|Received First Dose of Study Medication|Overall Study||12
2601353|NCT00218062|6386070|P3|Received First Dose of Study Medication|Overall Study||10
2601354|NCT00218062|6386071|P2|Received First Dose of Study Medication|Overall Study||11
2601355|NCT00218062|6386072|P1|Received First Dose of Study Medication|Overall Study||16
2601356|NCT00218062|6386069|P4|STARTED|Overall Study||16
2601357|NCT00218062|6386070|P3|STARTED|Overall Study||15
2601358|NCT00218062|6386071|P2|STARTED|Overall Study||20
2601359|NCT00218062|6386072|P1|STARTED|Overall Study||22
2601360|NCT00218036|6386103|P5|NOT COMPLETED|Overall Study||6
2601361|NCT00218036|6386104|P4|NOT COMPLETED|Overall Study||6
2601362|NCT00218036|6386105|P3|NOT COMPLETED|Overall Study||8
2601363|NCT00218036|6386106|P2|NOT COMPLETED|Overall Study||3
2601364|NCT00218036|6386107|P1|NOT COMPLETED|Overall Study||5
2601365|NCT00218036|6386103|P5|COMPLETED|Overall Study||3
2601366|NCT00218036|6386104|P4|COMPLETED|Overall Study||6
2601367|NCT00218036|6386105|P3|COMPLETED|Overall Study||5
2601368|NCT00218036|6386106|P2|COMPLETED|Overall Study||3
2601369|NCT00218036|6386107|P1|COMPLETED|Overall Study||6
2601370|NCT00218036|6386103|P5|STARTED|Overall Study||9
2601371|NCT00218036|6386104|P4|STARTED|Overall Study||12
2601372|NCT00218036|6386105|P3|STARTED|Overall Study||13
2601373|NCT00218036|6386106|P2|STARTED|Overall Study||6
2601374|NCT00218036|6386107|P1|STARTED|Overall Study||11
2601375|NCT00218023|6386133|P4|NOT COMPLETED|Overall Study||7
2601376|NCT00218023|6386134|P3|NOT COMPLETED|Overall Study||10
2601377|NCT00218023|6386135|P2|NOT COMPLETED|Overall Study||15
2601378|NCT00218023|6386136|P1|NOT COMPLETED|Overall Study||13
2601379|NCT00218023|6386133|P4|COMPLETED|Overall Study||11
2601380|NCT00218023|6386134|P3|COMPLETED|Overall Study||6
2601381|NCT00218023|6386135|P2|COMPLETED|Overall Study||10
2601382|NCT00218023|6386136|P1|COMPLETED|Overall Study||9
2601383|NCT00218023|6386133|P4|Received Drug or Placebo in Phase II|Overall Study||18
2601384|NCT00218023|6386134|P3|Received Drug or Placebo in Phase II|Overall Study||15
2601385|NCT00218023|6386135|P2|Received Drug or Placebo in Phase II|Overall Study||24
2601386|NCT00218023|6386136|P1|Received Drug or Placebo in Phase II|Overall Study||18
2601387|NCT00218023|6386133|P4|STARTED|Overall Study||18
2601388|NCT00218023|6386134|P3|STARTED|Overall Study||16
2601389|NCT00218023|6386135|P2|STARTED|Overall Study||25
2601390|NCT00218023|6386136|P1|STARTED|Overall Study||22
2601391|NCT00217971|6386152|P2|NOT COMPLETED|Overall Study||33
2601392|NCT00217971|6386153|P1|NOT COMPLETED|Overall Study||24
2601393|NCT00217971|6386152|P2|COMPLETED|Overall Study||44
2601394|NCT00217971|6386153|P1|COMPLETED|Overall Study||55
2601395|NCT00217971|6386152|P2|STARTED|Overall Study||77
2601396|NCT00217971|6386153|P1|STARTED|Overall Study||79
2601397|NCT00217724|6386159|P2|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||0
2601398|NCT00217724|6386160|P1|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||1
2601399|NCT00217724|6386159|P2|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||5
2601400|NCT00217724|6386160|P1|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||8
2601401|NCT00217724|6386159|P2|STARTED|Course 2, (Glutamine/Placebo Crossover)||5
2601402|NCT00217724|6386160|P1|STARTED|Course 2, (Glutamine/Placebo Crossover)||9
2601403|NCT00217724|6386159|P2|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||1
2601404|NCT00217724|6386160|P1|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||3
2601405|NCT00217724|6386159|P2|COMPLETED|Course 1, (Glutamine/Placebo Arms)||9
2601406|NCT00217724|6386160|P1|COMPLETED|Course 1, (Glutamine/Placebo Arms)||5
2601407|NCT00217724|6386159|P2|STARTED|Course 1, (Glutamine/Placebo Arms)||10
2601408|NCT00217724|6386160|P1|STARTED|Course 1, (Glutamine/Placebo Arms)||8
2601409|NCT00217672|6386168|P2|NOT COMPLETED|Follow-up||0
2601410|NCT00217672|6386169|P1|NOT COMPLETED|Follow-up||5
2601411|NCT00217672|6386168|P2|COMPLETED|Follow-up||0
2601412|NCT00217672|6386169|P1|COMPLETED|Follow-up||69
2601413|NCT00217672|6386168|P2|STARTED|Follow-up||0
2601414|NCT00217672|6386169|P1|STARTED|Follow-up|when bevacizumab became available, converted to a 1-arm open-label trial (67+7=74)|74
2601415|NCT00217672|6386168|P2|NOT COMPLETED|Treatment||7
2601416|NCT00217672|6386169|P1|NOT COMPLETED|Treatment||67
2601417|NCT00217672|6386168|P2|COMPLETED|Treatment||0
2601418|NCT00217672|6386169|P1|COMPLETED|Treatment||0
2601419|NCT00217672|6386168|P2|STARTED|Treatment|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
2601420|NCT00217672|6386169|P1|STARTED|Treatment||67
2601421|NCT00217672|6386168|P2|NOT COMPLETED|Allocation||0
2601422|NCT00217672|6386169|P1|NOT COMPLETED|Allocation||2
2601423|NCT00217672|6386168|P2|COMPLETED|Allocation||7
2601424|NCT00217672|6386169|P1|COMPLETED|Allocation||67
2601425|NCT00217672|6386168|P2|STARTED|Allocation|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
2601426|NCT00217672|6386169|P1|STARTED|Allocation||69
2601427|NCT00217620|6386175|P1|NOT COMPLETED|Overall Study||51
2601428|NCT00217620|6386175|P1|COMPLETED|Overall Study||0
2601429|NCT00217620|6386175|P1|Eligible and Began Protocol Therapy|Overall Study||37
2601430|NCT00217620|6386175|P1|Eligible|Overall Study||38
2601431|NCT00217620|6386175|P1|STARTED|Overall Study||51
2601432|NCT00217594|6386186|P1|NOT COMPLETED|Overall Study||0
2601433|NCT00217594|6386186|P1|COMPLETED|Overall Study||31
2601434|NCT00217594|6386186|P1|STARTED|Overall Study||31
2601435|NCT00217581|6386190|P1|NOT COMPLETED|Overall Study||1
2601436|NCT00217581|6386190|P1|COMPLETED|Overall Study||38
2601437|NCT00217581|6386190|P1|STARTED|Overall Study||39
2601438|NCT00217490|6386202|P4|NOT COMPLETED|Overall Study||23
2601439|NCT00217490|6386203|P3|NOT COMPLETED|Overall Study||24
2601440|NCT00217490|6386204|P2|NOT COMPLETED|Overall Study||25
2601441|NCT00217490|6386205|P1|NOT COMPLETED|Overall Study||17
2601442|NCT00217490|6386202|P4|COMPLETED|Overall Study||130
2601443|NCT00217490|6386203|P3|COMPLETED|Overall Study||131
2601444|NCT00217490|6386204|P2|COMPLETED|Overall Study||128
2601445|NCT00217490|6386205|P1|COMPLETED|Overall Study||137
2601446|NCT00217490|6386202|P4|STARTED|Overall Study||153
2601447|NCT00217490|6386203|P3|STARTED|Overall Study||155
2601448|NCT00217490|6386204|P2|STARTED|Overall Study||153
2601449|NCT00217490|6386205|P1|STARTED|Overall Study||154
2601450|NCT00217464|6386219|P1|NOT COMPLETED|Overall Study||17
2601451|NCT00217464|6386219|P1|COMPLETED|Overall Study||0
2601452|NCT00217464|6386219|P1|STARTED|Overall Study||17
2601453|NCT00217438|6386226|P2|NOT COMPLETED|Overall Study||1
2601454|NCT00217438|6386227|P1|NOT COMPLETED|Overall Study||0
2601455|NCT00217438|6386226|P2|COMPLETED|Overall Study|One patient did not complete Day 80-120 evaluation tests after returning to referring physician.|63
2601456|NCT00217438|6386227|P1|COMPLETED|Overall Study||66
2601457|NCT00217438|6386226|P2|STARTED|Overall Study||64
2601458|NCT00217438|6386227|P1|STARTED|Overall Study||66
2601459|NCT00217425|6386235|P1|NOT COMPLETED|Overall Study||37
2601460|NCT00217425|6386235|P1|COMPLETED|Overall Study||9
2601461|NCT00217425|6386235|P1|Eligible and Treated|Overall Study||39
2601462|NCT00217425|6386235|P1|Treated|Overall Study||44
2601463|NCT00217425|6386235|P1|STARTED|Overall Study||46
2601464|NCT00217399|6386241|P1|NOT COMPLETED|Overall Study||0
2601465|NCT00217399|6386241|P1|COMPLETED|Overall Study||35
2601466|NCT00217399|6386241|P1|STARTED|Overall Study||35
2601467|NCT00217087|6386249|P2|NOT COMPLETED|Overall Study||20
2601468|NCT00217087|6386250|P1|NOT COMPLETED|Overall Study||11
2601469|NCT00217087|6386249|P2|COMPLETED|Overall Study||17
2601470|NCT00217087|6386250|P1|COMPLETED|Overall Study||25
2601471|NCT00217087|6386249|P2|STARTED|Overall Study||37
2601472|NCT00217087|6386250|P1|STARTED|Overall Study||36
2601473|NCT00217022|6386264|P2|NOT COMPLETED|Overall Study||1
2601474|NCT00217022|6386265|P1|NOT COMPLETED|Overall Study||1
2601475|NCT00217022|6386264|P2|COMPLETED|Overall Study||3
2601476|NCT00217022|6386265|P1|COMPLETED|Overall Study||11
2601477|NCT00217022|6386264|P2|STARTED|Overall Study||4
2601478|NCT00217022|6386265|P1|STARTED|Overall Study||12
2601479|NCT00216736|6386275|P2|NOT COMPLETED|Overall Study||1
2601480|NCT00216736|6386276|P1|NOT COMPLETED|Overall Study||1
2601481|NCT00216736|6386275|P2|COMPLETED|Overall Study||30
2601482|NCT00216736|6386276|P1|COMPLETED|Overall Study||31
2601483|NCT00216736|6386275|P2|STARTED|Overall Study||31
2601484|NCT00216736|6386276|P1|STARTED|Overall Study||32
2601485|NCT00216671|6386290|P2|NOT COMPLETED|Overall Study||50
2601486|NCT00216671|6386291|P1|NOT COMPLETED|Overall Study||35
2601487|NCT00216671|6386290|P2|COMPLETED|Overall Study||60
2601488|NCT00216671|6386291|P1|COMPLETED|Overall Study||75
2601489|NCT00216671|6386290|P2|STARTED|Overall Study||110
2601490|NCT00216671|6386291|P1|STARTED|Overall Study||110
2601491|NCT00216476|6386309|P3|NOT COMPLETED|Overall Study||17
2601492|NCT00216476|6386310|P2|NOT COMPLETED|Overall Study||107
2601493|NCT00216476|6386311|P1|NOT COMPLETED|Overall Study||105
2601494|NCT00216476|6386309|P3|COMPLETED|Overall Study||28
2601495|NCT00216476|6386310|P2|COMPLETED|Overall Study||230
2601496|NCT00216476|6386311|P1|COMPLETED|Overall Study||224
2601497|NCT00216476|6386309|P3|STARTED|Overall Study||45
2601498|NCT00216476|6386310|P2|STARTED|Overall Study||337
2601499|NCT00216476|6386311|P1|STARTED|Overall Study||329
2601500|NCT00216320|6386331|P3|NOT COMPLETED|Phase 2 (Weeks 6 -12)||1
2601501|NCT00216320|6386332|P2|NOT COMPLETED|Phase 2 (Weeks 6 -12)||4
2601502|NCT00216320|6386333|P1|NOT COMPLETED|Phase 2 (Weeks 6 -12)||5
2601503|NCT00216320|6386331|P3|COMPLETED|Phase 2 (Weeks 6 -12)||24
2601504|NCT00216320|6386332|P2|COMPLETED|Phase 2 (Weeks 6 -12)||31
2601505|NCT00216320|6386333|P1|COMPLETED|Phase 2 (Weeks 6 -12)||38
2601506|NCT00216320|6386331|P3|STARTED|Phase 2 (Weeks 6 -12)||25
2601507|NCT00216320|6386332|P2|STARTED|Phase 2 (Weeks 6 -12)||35
2601508|NCT00216320|6386333|P1|STARTED|Phase 2 (Weeks 6 -12)||43
2601509|NCT00216320|6386331|P3|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||5
2601510|NCT00216320|6386332|P2|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||4
2601511|NCT00216320|6386333|P1|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||0
2601512|NCT00216320|6386331|P3|COMPLETED|Phase 1 (Weeks 0 - 6)||25
2601513|NCT00216320|6386332|P2|COMPLETED|Phase 1 (Weeks 0 - 6)||35
2601514|NCT00216320|6386333|P1|COMPLETED|Phase 1 (Weeks 0 - 6)||43
2601515|NCT00216320|6386331|P3|STARTED|Phase 1 (Weeks 0 - 6)||30
2601516|NCT00216320|6386332|P2|STARTED|Phase 1 (Weeks 0 - 6)||39
2601517|NCT00216320|6386333|P1|STARTED|Phase 1 (Weeks 0 - 6)||43
2601518|NCT00216203|6386348|P1|NOT COMPLETED|Overall Study||2
2601519|NCT00216203|6386348|P1|COMPLETED|Overall Study||34
2601520|NCT00216203|6386348|P1|STARTED|Overall Study||36
2601521|NCT00216125|6386356|P3|NOT COMPLETED|Randomization Phase||8
2601522|NCT00216125|6386357|P2|NOT COMPLETED|Randomization Phase||11
2601523|NCT00216125|6386358|P1|NOT COMPLETED|Randomization Phase||0
2601524|NCT00216125|6386356|P3|COMPLETED|Randomization Phase||74
2601525|NCT00216125|6386357|P2|COMPLETED|Randomization Phase||73
2601526|NCT00216125|6386358|P1|COMPLETED|Randomization Phase||0
2601527|NCT00216125|6386356|P3|DSMB Cohort for Futility|Randomization Phase||74
2601528|NCT00216125|6386357|P2|DSMB Cohort for Futility|Randomization Phase||73
2601529|NCT00216125|6386358|P1|DSMB Cohort for Futility|Randomization Phase||0
2601530|NCT00216125|6386356|P3|STARTED|Randomization Phase||82
2601531|NCT00216125|6386357|P2|STARTED|Randomization Phase||84
2601532|NCT00216125|6386358|P1|STARTED|Randomization Phase||0
2601533|NCT00216125|6386356|P3|NOT COMPLETED|Pre-Randomization Phase||0
2601534|NCT00216125|6386357|P2|NOT COMPLETED|Pre-Randomization Phase||0
2601535|NCT00216125|6386358|P1|NOT COMPLETED|Pre-Randomization Phase||77
2601536|NCT00216125|6386356|P3|COMPLETED|Pre-Randomization Phase||0
2601537|NCT00216125|6386357|P2|COMPLETED|Pre-Randomization Phase||0
2601538|NCT00216125|6386358|P1|COMPLETED|Pre-Randomization Phase||166
2601539|NCT00216125|6386356|P3|DSMB Cohort for Futility|Pre-Randomization Phase||0
2601540|NCT00216125|6386357|P2|DSMB Cohort for Futility|Pre-Randomization Phase||0
2601541|NCT00216125|6386358|P1|DSMB Cohort for Futility|Pre-Randomization Phase||203
2601542|NCT00216125|6386356|P3|STARTED|Pre-Randomization Phase||0
2601543|NCT00216125|6386357|P2|STARTED|Pre-Randomization Phase||0
2601544|NCT00216125|6386358|P1|STARTED|Pre-Randomization Phase||243
2601545|NCT00216099|6386367|P1|NOT COMPLETED|Overall Study||1
2601546|NCT00216099|6386367|P1|COMPLETED|Overall Study||48
2601547|NCT00216099|6386367|P1|Response Analysis|Overall Study||48
2601548|NCT00216099|6386367|P1|Toxicity Analysis|Overall Study||49
2601549|NCT00216099|6386367|P1|STARTED|Overall Study||49
2601550|NCT00216086|6386378|P1|NOT COMPLETED|Overall Study||4
2601551|NCT00216086|6386378|P1|COMPLETED|Overall Study||18
2601552|NCT00216086|6386378|P1|STARTED|Overall Study||22
2601553|NCT00216060|6386387|P2|NOT COMPLETED|Overall Study||0
2601554|NCT00216060|6386388|P1|NOT COMPLETED|Overall Study||0
2601555|NCT00216060|6386387|P2|COMPLETED|Overall Study||31
2601556|NCT00216060|6386388|P1|COMPLETED|Overall Study||32
2601557|NCT00216060|6386387|P2|STARTED|Overall Study||31
2601558|NCT00216060|6386388|P1|STARTED|Overall Study||32
2601559|NCT00215943|6386410|P2|NOT COMPLETED|Overall Study||14
2601560|NCT00215943|6386411|P1|NOT COMPLETED|Overall Study||9
2601561|NCT00215943|6386410|P2|COMPLETED|Overall Study||23
2601562|NCT00215943|6386411|P1|COMPLETED|Overall Study||27
2601563|NCT00215943|6386410|P2|STARTED|Overall Study||37
2601564|NCT00215943|6386411|P1|STARTED|Overall Study||36
2601565|NCT00215930|6386423|P1|NOT COMPLETED|Overall Study||0
2601566|NCT00215930|6386423|P1|COMPLETED|Overall Study||53
2601567|NCT00215930|6386423|P1|STARTED|Overall Study||53
2601568|NCT00215787|6386429|P1|NOT COMPLETED|Overall Study||0
2601569|NCT00215787|6386429|P1|COMPLETED|Overall Study||20
2601570|NCT00215787|6386429|P1|STARTED|Overall Study||20
2601571|NCT00215683|6386436|P3|NOT COMPLETED|Overall Study||32
2601572|NCT00215683|6386437|P2|NOT COMPLETED|Overall Study||26
2601573|NCT00215683|6386438|P1|NOT COMPLETED|Overall Study||29
2601574|NCT00215683|6386436|P3|COMPLETED|Overall Study||12
2601575|NCT00215683|6386437|P2|COMPLETED|Overall Study||22
2601576|NCT00215683|6386438|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|16
2601577|NCT00215683|6386436|P3|Switched to 160 mg|Overall Study||36
2601578|NCT00215683|6386437|P2|Switched to 160 mg|Overall Study||41
2601579|NCT00215683|6386438|P1|Switched to 160 mg|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL) for all participants|32
2601580|NCT00215683|6386436|P3|STARTED|Overall Study||44
2601581|NCT00215683|6386437|P2|STARTED|Overall Study||48
2601582|NCT00215683|6386438|P1|STARTED|Overall Study|Safety analysis set|45
2601583|NCT00215657|6386457|P8|NOT COMPLETED|Overall Study||16
2601584|NCT00215657|6386458|P7|NOT COMPLETED|Overall Study||23
2601585|NCT00215657|6386459|P6|NOT COMPLETED|Overall Study||20
2601586|NCT00215657|6386460|P5|NOT COMPLETED|Overall Study||23
2601587|NCT00215657|6386461|P4|NOT COMPLETED|Overall Study||18
2601588|NCT00215657|6386462|P3|NOT COMPLETED|Overall Study||11
2601589|NCT00215657|6386463|P2|NOT COMPLETED|Overall Study||11
2601590|NCT00215657|6386464|P1|NOT COMPLETED|Overall Study||22
2601591|NCT00215657|6386457|P8|COMPLETED|Overall Study||11
2601592|NCT00215657|6386458|P7|COMPLETED|Overall Study||4
2601593|NCT00215657|6386459|P6|COMPLETED|Overall Study||4
2601594|NCT00215657|6386460|P5|COMPLETED|Overall Study||4
2601595|NCT00215657|6386461|P4|COMPLETED|Overall Study||6
2601596|NCT00215657|6386462|P3|COMPLETED|Overall Study||2
2601597|NCT00215657|6386463|P2|COMPLETED|Overall Study||1
2601598|NCT00215657|6386464|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study.|4
2601599|NCT00215657|6386457|P8|Started FE200486 CS07A|Overall Study||23
2601600|NCT00215657|6386458|P7|Started FE200486 CS07A|Overall Study||14
2601601|NCT00215657|6386459|P6|Started FE200486 CS07A|Overall Study||20
2601602|NCT00215657|6386460|P5|Started FE200486 CS07A|Overall Study||17
2601603|NCT00215657|6386461|P4|Started FE200486 CS07A|Overall Study||24
2601604|NCT00215657|6386462|P3|Started FE200486 CS07A|Overall Study||7
2601605|NCT00215657|6386463|P2|Started FE200486 CS07A|Overall Study||6
2601606|NCT00215657|6386464|P1|Started FE200486 CS07A|Overall Study||20
2601607|NCT00215657|6386457|P8|Intention-to-treat Population|Overall Study||27
2601608|NCT00215657|6386458|P7|Intention-to-treat Population|Overall Study||24
2601609|NCT00215657|6386459|P6|Intention-to-treat Population|Overall Study||24
2601610|NCT00215657|6386460|P5|Intention-to-treat Population|Overall Study||24
2601611|NCT00215657|6386461|P4|Intention-to-treat Population|Overall Study||24
2601612|NCT00215657|6386462|P3|Intention-to-treat Population|Overall Study||12
2601613|NCT00215657|6386463|P2|Intention-to-treat Population|Overall Study||12
2601614|NCT00215657|6386464|P1|Intention-to-treat Population|Overall Study||25
2601615|NCT00215657|6386457|P8|STARTED|Overall Study||27
2601616|NCT00215657|6386458|P7|STARTED|Overall Study||27
2601617|NCT00215657|6386459|P6|STARTED|Overall Study||24
2601618|NCT00215657|6386460|P5|STARTED|Overall Study||27
2601619|NCT00215657|6386461|P4|STARTED|Overall Study||24
2601620|NCT00215657|6386462|P3|STARTED|Overall Study||13
2601621|NCT00215657|6386463|P2|STARTED|Overall Study||12
2601622|NCT00215657|6386464|P1|STARTED|Overall Study||26
2601623|NCT00215644|6386492|P2|NOT COMPLETED|Overall Study||36
2601624|NCT00215644|6386493|P1|NOT COMPLETED|Overall Study||36
2601625|NCT00215644|6386492|P2|COMPLETED|Overall Study||0
2601626|NCT00215644|6386493|P1|COMPLETED|Overall Study||0
2601627|NCT00215644|6386492|P2|Treated|Overall Study||36
2601628|NCT00215644|6386493|P1|Treated|Overall Study||35
2601629|NCT00215644|6386492|P2|STARTED|Overall Study||36
2601630|NCT00215644|6386493|P1|STARTED|Overall Study||36
2601631|NCT00215553|6386520|P7|NOT COMPLETED|Overall Study||0
2601632|NCT00215553|6386521|P6|NOT COMPLETED|Overall Study||6
2601633|NCT00215553|6386522|P5|NOT COMPLETED|Overall Study||2
2601634|NCT00215553|6386523|P4|NOT COMPLETED|Overall Study||1
2601635|NCT00215553|6386524|P3|NOT COMPLETED|Overall Study||2
2601636|NCT00215553|6386525|P2|NOT COMPLETED|Overall Study||1
2601637|NCT00215553|6386526|P1|NOT COMPLETED|Overall Study||0
2601638|NCT00215553|6386520|P7|COMPLETED|Overall Study||36
2601639|NCT00215553|6386521|P6|COMPLETED|Overall Study||32
2601640|NCT00215553|6386522|P5|COMPLETED|Overall Study||26
2601641|NCT00215553|6386523|P4|COMPLETED|Overall Study||4
2601642|NCT00215553|6386524|P3|COMPLETED|Overall Study||4
2601643|NCT00215553|6386525|P2|COMPLETED|Overall Study||5
2601644|NCT00215553|6386526|P1|COMPLETED|Overall Study||5
2601645|NCT00215553|6386520|P7|STARTED|Overall Study||36
2601646|NCT00215553|6386521|P6|STARTED|Overall Study||38
2601647|NCT00215553|6386522|P5|STARTED|Overall Study||28
2601648|NCT00215553|6386523|P4|STARTED|Overall Study||5
2601649|NCT00215553|6386524|P3|STARTED|Overall Study||6
2601650|NCT00215553|6386525|P2|STARTED|Overall Study||6
2601651|NCT00215553|6386526|P1|STARTED|Overall Study||5
2601652|NCT00215540|6386559|P3|NOT COMPLETED|Overall Study||0
2601653|NCT00215540|6386560|P2|NOT COMPLETED|Overall Study||0
2601654|NCT00215540|6386561|P1|NOT COMPLETED|Overall Study||1
2601655|NCT00215540|6386559|P3|COMPLETED|Overall Study||44
2601656|NCT00215540|6386560|P2|COMPLETED|Overall Study||47
2601657|NCT00215540|6386561|P1|COMPLETED|Overall Study||44
2601658|NCT00215540|6386559|P3|STARTED|Overall Study||44
2601659|NCT00215540|6386560|P2|STARTED|Overall Study||47
2601660|NCT00215540|6386561|P1|STARTED|Overall Study||45
2601661|NCT00215150|6386596|P1|NOT COMPLETED|Randomization Phase Placebo||1
2601662|NCT00215150|6386596|P1|COMPLETED|Randomization Phase Placebo||10
2601663|NCT00215150|6386596|P1|STARTED|Randomization Phase Placebo||11
2601664|NCT00215150|6386596|P1|NOT COMPLETED|Randomization Phase Ziprasidone||3
2601665|NCT00215150|6386596|P1|COMPLETED|Randomization Phase Ziprasidone||7
2601666|NCT00215150|6386596|P1|STARTED|Randomization Phase Ziprasidone||10
2601667|NCT00215150|6386596|P1|NOT COMPLETED|Open Label Phase||30
2601668|NCT00215150|6386596|P1|COMPLETED|Open Label Phase||21
2601669|NCT00215150|6386596|P1|STARTED|Open Label Phase|Number of subjects consented|51
2601670|NCT00215137|6386604|P3|NOT COMPLETED|Randomization Period||0
2601671|NCT00215137|6386605|P2|NOT COMPLETED|Randomization Period||2
2601672|NCT00215137|6386606|P1|NOT COMPLETED|Randomization Period||0
2601673|NCT00215137|6386604|P3|COMPLETED|Randomization Period||5
2601674|NCT00215137|6386605|P2|COMPLETED|Randomization Period||5
2601675|NCT00215137|6386606|P1|COMPLETED|Randomization Period||0
2601676|NCT00215137|6386604|P3|STARTED|Randomization Period||5
2601677|NCT00215137|6386605|P2|STARTED|Randomization Period||7
2601678|NCT00215137|6386606|P1|STARTED|Randomization Period||0
2601679|NCT00215137|6386604|P3|NOT COMPLETED|Open Label Escitalopram||0
2601680|NCT00215137|6386605|P2|NOT COMPLETED|Open Label Escitalopram||0
2601681|NCT00215137|6386606|P1|NOT COMPLETED|Open Label Escitalopram||1
2601682|NCT00215137|6386604|P3|COMPLETED|Open Label Escitalopram||0
2601683|NCT00215137|6386605|P2|COMPLETED|Open Label Escitalopram||0
2601684|NCT00215137|6386606|P1|COMPLETED|Open Label Escitalopram||13
2601685|NCT00215137|6386604|P3|STARTED|Open Label Escitalopram||0
2601686|NCT00215137|6386605|P2|STARTED|Open Label Escitalopram||0
2601687|NCT00215137|6386606|P1|STARTED|Open Label Escitalopram||14
2601688|NCT00214903|6386618|P4|NOT COMPLETED|Overall Study||0
2601689|NCT00214903|6386619|P3|NOT COMPLETED|Overall Study||0
2601690|NCT00214903|6386620|P2|NOT COMPLETED|Overall Study||0
2601691|NCT00214903|6386621|P1|NOT COMPLETED|Overall Study||0
2601692|NCT00214903|6386618|P4|COMPLETED|Overall Study||3057
2601693|NCT00214903|6386619|P3|COMPLETED|Overall Study||4113
2601694|NCT00214903|6386620|P2|COMPLETED|Overall Study||13384
2601695|NCT00214903|6386621|P1|COMPLETED|Overall Study||10043
2601696|NCT00214903|6386618|P4|STARTED|Overall Study||3057
2601697|NCT00214903|6386619|P3|STARTED|Overall Study||4113
2601698|NCT00214903|6386620|P2|STARTED|Overall Study||13384
2601699|NCT00214903|6386621|P1|STARTED|Overall Study||10043
2601700|NCT00214786|6386635|P1|NOT COMPLETED|Overall Study||3
2601701|NCT00214786|6386635|P1|COMPLETED|Overall Study||1
2601702|NCT00214786|6386635|P1|STARTED|Overall Study||4
2601703|NCT00214539|6386650|P2|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
2601704|NCT00214539|6386651|P1|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
2601705|NCT00214539|6386650|P2|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||17
2601706|NCT00214539|6386651|P1|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||15
2601707|NCT00214539|6386650|P2|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||17
2601708|NCT00214539|6386651|P1|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||15
2601709|NCT00214539|6386650|P2|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
2601710|NCT00214539|6386651|P1|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
2601711|NCT00214539|6386650|P2|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||17
2601712|NCT00214539|6386651|P1|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||15
2601713|NCT00214539|6386650|P2|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||17
2601714|NCT00214539|6386651|P1|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||15
2601715|NCT00214539|6386650|P2|NOT COMPLETED|Treatment Period||0
2601716|NCT00214539|6386651|P1|NOT COMPLETED|Treatment Period||0
2601717|NCT00214539|6386650|P2|COMPLETED|Treatment Period||17
2601718|NCT00214539|6386651|P1|COMPLETED|Treatment Period||15
2601719|NCT00214539|6386650|P2|STARTED|Treatment Period||17
2601720|NCT00214539|6386651|P1|STARTED|Treatment Period||15
2601721|NCT00214539|6386650|P2|NOT COMPLETED|Randomized||0
2601722|NCT00214539|6386651|P1|NOT COMPLETED|Randomized||2
2601723|NCT00214539|6386650|P2|COMPLETED|Randomized||17
2601724|NCT00214539|6386651|P1|COMPLETED|Randomized||15
2601725|NCT00214539|6386650|P2|STARTED|Randomized||17
2601726|NCT00214539|6386651|P1|STARTED|Randomized||17
2601727|NCT00214526|6386677|P2|NOT COMPLETED|Post-Treatment Period||0
2601728|NCT00214526|6386678|P1|NOT COMPLETED|Post-Treatment Period||1
2601729|NCT00214526|6386677|P2|COMPLETED|Post-Treatment Period||49
2601730|NCT00214526|6386678|P1|COMPLETED|Post-Treatment Period||52
2601731|NCT00214526|6386677|P2|STARTED|Post-Treatment Period||49
2601732|NCT00214526|6386678|P1|STARTED|Post-Treatment Period||53
2601733|NCT00214526|6386677|P2|NOT COMPLETED|Treatment Period||5
2601734|NCT00214526|6386678|P1|NOT COMPLETED|Treatment Period||2
2601735|NCT00214526|6386677|P2|COMPLETED|Treatment Period||49
2601736|NCT00214526|6386678|P1|COMPLETED|Treatment Period||53
2601737|NCT00214526|6386677|P2|STARTED|Treatment Period||54
2601738|NCT00214526|6386678|P1|STARTED|Treatment Period||55
2601739|NCT00214526|6386677|P2|NOT COMPLETED|Randomized||2
2601740|NCT00214526|6386678|P1|NOT COMPLETED|Randomized||1
2601741|NCT00214526|6386677|P2|COMPLETED|Randomized||54
2601742|NCT00214526|6386678|P1|COMPLETED|Randomized||55
2601743|NCT00214526|6386677|P2|STARTED|Randomized||56
2601744|NCT00214526|6386678|P1|STARTED|Randomized||56
2601745|NCT00214500|6386704|P1|NOT COMPLETED|Extension Period||2
2601746|NCT00214500|6386704|P1|COMPLETED|Extension Period||6
2601747|NCT00214500|6386704|P1|STARTED|Extension Period||8
2601748|NCT00214500|6386704|P1|NOT COMPLETED|Treatment Period||1
2601749|NCT00214500|6386704|P1|COMPLETED|Treatment Period||8
2601750|NCT00214500|6386704|P1|Pharmacodynamic (PD) Population|Treatment Period||9
2601751|NCT00214500|6386704|P1|Pharmacokinetic (PK) Population|Treatment Period||9
2601752|NCT00214500|6386704|P1|Safety Population|Treatment Period||9
2601753|NCT00214500|6386704|P1|STARTED|Treatment Period|All eligible-enrolled participants who received at least 1 dose of study drug|9
2601754|NCT00214487|6386714|P2|NOT COMPLETED|Overall Study||3
2601755|NCT00214487|6386715|P1|NOT COMPLETED|Overall Study||5
2601756|NCT00214487|6386714|P2|COMPLETED|Overall Study||40
2601757|NCT00214487|6386715|P1|COMPLETED|Overall Study||38
2601758|NCT00214487|6386714|P2|STARTED|Overall Study||43
2601759|NCT00214487|6386715|P1|STARTED|Overall Study||43
2601760|NCT00214461|6386725|P4|NOT COMPLETED|Overall Study||1
2601761|NCT00214461|6386726|P3|NOT COMPLETED|Overall Study||2
2601762|NCT00214461|6386727|P2|NOT COMPLETED|Overall Study||0
2601763|NCT00214461|6386728|P1|NOT COMPLETED|Overall Study||0
2601764|NCT00214461|6386725|P4|COMPLETED|Overall Study||11
2601765|NCT00214461|6386726|P3|COMPLETED|Overall Study||10
2601766|NCT00214461|6386727|P2|COMPLETED|Overall Study||12
2601767|NCT00214461|6386728|P1|COMPLETED|Overall Study||12
2601768|NCT00214461|6386725|P4|STARTED|Overall Study||12
2601769|NCT00214461|6386726|P3|STARTED|Overall Study||12
2601770|NCT00214461|6386727|P2|STARTED|Overall Study||12
2601771|NCT00214461|6386728|P1|STARTED|Overall Study||12
2601772|NCT00214422|6386745|P3|NOT COMPLETED|Overall Study||1
2601773|NCT00214422|6386746|P2|NOT COMPLETED|Overall Study||1
2601774|NCT00214422|6386747|P1|NOT COMPLETED|Overall Study||5
2601775|NCT00214422|6386745|P3|COMPLETED|Overall Study||3
2601776|NCT00214422|6386746|P2|COMPLETED|Overall Study||2
2601777|NCT00214422|6386747|P1|COMPLETED|Overall Study||7
2601778|NCT00214422|6386745|P3|STARTED|Overall Study||4
2601779|NCT00214422|6386746|P2|STARTED|Overall Study||3
2601780|NCT00214422|6386747|P1|STARTED|Overall Study||12
2601781|NCT00214383|6386770|P2|NOT COMPLETED|Overall Study||26
2601782|NCT00214383|6386771|P1|NOT COMPLETED|Overall Study||16
2601783|NCT00214383|6386770|P2|COMPLETED|Overall Study||127
2601784|NCT00214383|6386771|P1|COMPLETED|Overall Study||132
2601785|NCT00214383|6386770|P2|STARTED|Overall Study||153
2601786|NCT00214383|6386771|P1|STARTED|Overall Study||148
2601787|NCT00214201|6386783|P2|NOT COMPLETED|Overall Study||2
2601788|NCT00214201|6386784|P1|NOT COMPLETED|Overall Study||2
2601789|NCT00214201|6386783|P2|COMPLETED|Overall Study||18
2601790|NCT00214201|6386784|P1|COMPLETED|Overall Study||18
2601791|NCT00214201|6386783|P2|STARTED|Overall Study||20
2601792|NCT00214201|6386784|P1|STARTED|Overall Study||20
2601793|NCT00214149|6386794|P1|NOT COMPLETED|Overall Study||127
2601794|NCT00214149|6386794|P1|COMPLETED|Overall Study|No data are available; study was terminated and PI has left the institution.|0
2601795|NCT00214149|6386794|P1|STARTED|Overall Study||127
2601796|NCT00214136|6386799|P1|NOT COMPLETED|Overall Study||5
2601797|NCT00214136|6386799|P1|COMPLETED|Overall Study||25
2601798|NCT00214136|6386799|P1|STARTED|Overall Study||30
2601799|NCT00214097|6386807|P3|NOT COMPLETED|Overall Study||0
2601800|NCT00214097|6386808|P2|NOT COMPLETED|Overall Study||0
2601801|NCT00214097|6386809|P1|NOT COMPLETED|Overall Study||0
2601802|NCT00214097|6386807|P3|COMPLETED|Overall Study||135
2601803|NCT00214097|6386808|P2|COMPLETED|Overall Study||111
2601804|NCT00214097|6386809|P1|COMPLETED|Overall Study||101
2601805|NCT00214097|6386807|P3|STARTED|Overall Study||135
2601806|NCT00214097|6386808|P2|STARTED|Overall Study|Escalation to the next higher level will occur when > 20 pt yrs of F/U and > 5 pts followed >1 yr|111
2601807|NCT00214097|6386809|P1|STARTED|Overall Study|Escalation to the next higher level will occur when > 20 pt yrs of F/U and > 5 pts followed >1 yr|101
2601808|NCT00214045|6386837|P2|NOT COMPLETED|Overall Study||0
2601809|NCT00214045|6386838|P1|NOT COMPLETED|Overall Study||0
2601810|NCT00214045|6386837|P2|COMPLETED|Overall Study||18
2601811|NCT00214045|6386838|P1|COMPLETED|Overall Study||18
2601812|NCT00214045|6386837|P2|STARTED|Overall Study||18
2601813|NCT00214045|6386838|P1|STARTED|Overall Study||18
2601814|NCT00214019|6386844|P1|NOT COMPLETED|Overall Study||30
2601815|NCT00214019|6386844|P1|COMPLETED|Overall Study||6
2601816|NCT00214019|6386844|P1|Fluticason/Salmeterol Arm|Overall Study||6
2601817|NCT00214019|6386844|P1|Fluticasone/Placebo Arm|Overall Study||6
2601818|NCT00214019|6386844|P1|Placebo/Salmeterol Arm|Overall Study||6
2601819|NCT00214019|6386844|P1|Placebo/Placebo Arm|Overall Study||6
2601820|NCT00214019|6386844|P1|STARTED|Overall Study||36
2601821|NCT00213980|6386853|P2|NOT COMPLETED|Overall Study||7
2601822|NCT00213980|6386854|P1|NOT COMPLETED|Overall Study||6
2601823|NCT00213980|6386853|P2|COMPLETED|Overall Study||29
2601824|NCT00213980|6386854|P1|COMPLETED|Overall Study||26
2601825|NCT00213980|6386853|P2|STARTED|Overall Study||36
2601826|NCT00213980|6386854|P1|STARTED|Overall Study||32
2601827|NCT00213239|6386868|P2|NOT COMPLETED|Overall Study||0
2601828|NCT00213239|6386869|P1|NOT COMPLETED|Overall Study||0
2601829|NCT00213239|6386868|P2|COMPLETED|Overall Study||32
2601830|NCT00213239|6386869|P1|COMPLETED|Overall Study||32
2601831|NCT00213239|6386868|P2|STARTED|Overall Study||32
2601832|NCT00213239|6386869|P1|STARTED|Overall Study||32
2601833|NCT00213148|6386881|P5|NOT COMPLETED|Cycle 3 (1 Month)||1
2601834|NCT00213148|6386882|P4|NOT COMPLETED|Cycle 3 (1 Month)||1
2601835|NCT00213148|6386883|P3|NOT COMPLETED|Cycle 3 (1 Month)||1
2601836|NCT00213148|6386884|P2|NOT COMPLETED|Cycle 3 (1 Month)||2
2601837|NCT00213148|6386885|P1|NOT COMPLETED|Cycle 3 (1 Month)||0
2601838|NCT00213148|6386881|P5|COMPLETED|Cycle 3 (1 Month)||21
2601839|NCT00213148|6386882|P4|COMPLETED|Cycle 3 (1 Month)||23
2601840|NCT00213148|6386883|P3|COMPLETED|Cycle 3 (1 Month)||25
2601841|NCT00213148|6386884|P2|COMPLETED|Cycle 3 (1 Month)||8
2601842|NCT00213148|6386885|P1|COMPLETED|Cycle 3 (1 Month)||23
2601843|NCT00213148|6386881|P5|STARTED|Cycle 3 (1 Month)||22
2601844|NCT00213148|6386882|P4|STARTED|Cycle 3 (1 Month)||24
2601845|NCT00213148|6386883|P3|STARTED|Cycle 3 (1 Month)||26
2601846|NCT00213148|6386884|P2|STARTED|Cycle 3 (1 Month)||10
2601847|NCT00213148|6386885|P1|STARTED|Cycle 3 (1 Month)||23
2601848|NCT00213148|6386881|P5|NOT COMPLETED|Cycle 2 (1 Month)||30
2601849|NCT00213148|6386882|P4|NOT COMPLETED|Cycle 2 (1 Month)||19
2601850|NCT00213148|6386883|P3|NOT COMPLETED|Cycle 2 (1 Month)||14
2601851|NCT00213148|6386884|P2|NOT COMPLETED|Cycle 2 (1 Month)||6
2601852|NCT00213148|6386885|P1|NOT COMPLETED|Cycle 2 (1 Month)||14
2601853|NCT00213148|6386881|P5|COMPLETED|Cycle 2 (1 Month)||11
2601854|NCT00213148|6386882|P4|COMPLETED|Cycle 2 (1 Month)||33
2601855|NCT00213148|6386883|P3|COMPLETED|Cycle 2 (1 Month)||28
2601856|NCT00213148|6386884|P2|COMPLETED|Cycle 2 (1 Month)||4
2601857|NCT00213148|6386885|P1|COMPLETED|Cycle 2 (1 Month)||29
2601858|NCT00213148|6386881|P5|STARTED|Cycle 2 (1 Month)||41
2601859|NCT00213148|6386882|P4|STARTED|Cycle 2 (1 Month)||52
2601860|NCT00213148|6386883|P3|STARTED|Cycle 2 (1 Month)||42
2601861|NCT00213148|6386884|P2|STARTED|Cycle 2 (1 Month)||10
2601862|NCT00213148|6386885|P1|STARTED|Cycle 2 (1 Month)||43
2601863|NCT00213148|6386881|P5|NOT COMPLETED|Cycle 1 (1 Month)||22
2601864|NCT00213148|6386882|P4|NOT COMPLETED|Cycle 1 (1 Month)||18
2601865|NCT00213148|6386883|P3|NOT COMPLETED|Cycle 1 (1 Month)||19
2601866|NCT00213148|6386884|P2|NOT COMPLETED|Cycle 1 (1 Month)||0
2601867|NCT00213148|6386885|P1|NOT COMPLETED|Cycle 1 (1 Month)||24
2601868|NCT00213148|6386881|P5|COMPLETED|Cycle 1 (1 Month)||17
2601869|NCT00213148|6386882|P4|COMPLETED|Cycle 1 (1 Month)||58
2601870|NCT00213148|6386883|P3|COMPLETED|Cycle 1 (1 Month)||60
2601871|NCT00213148|6386884|P2|COMPLETED|Cycle 1 (1 Month)||0
2601872|NCT00213148|6386885|P1|COMPLETED|Cycle 1 (1 Month)||53
2601873|NCT00213148|6386881|P5|STARTED|Cycle 1 (1 Month)||39
2601874|NCT00213148|6386882|P4|STARTED|Cycle 1 (1 Month)||76
2601875|NCT00213148|6386883|P3|STARTED|Cycle 1 (1 Month)||79
2601876|NCT00213148|6386884|P2|STARTED|Cycle 1 (1 Month)||0
2601877|NCT00213148|6386885|P1|STARTED|Cycle 1 (1 Month)||77
2601878|NCT00213135|6386912|P3|NOT COMPLETED|Overall Study||57
2601879|NCT00213135|6386913|P2|NOT COMPLETED|Overall Study||35
2601880|NCT00213135|6386914|P1|NOT COMPLETED|Overall Study||50
2601881|NCT00213135|6386912|P3|COMPLETED|Overall Study||380
2601882|NCT00213135|6386913|P2|COMPLETED|Overall Study||398
2601883|NCT00213135|6386914|P1|COMPLETED|Overall Study||406
2601884|NCT00213135|6386912|P3|STARTED|Overall Study||437
2601885|NCT00213135|6386913|P2|STARTED|Overall Study||433
2601886|NCT00213135|6386914|P1|STARTED|Overall Study||456
2601887|NCT00212888|6386934|P3|NOT COMPLETED|Overall Study||1
2601888|NCT00212888|6386935|P2|NOT COMPLETED|Overall Study||0
2601889|NCT00212888|6386936|P1|NOT COMPLETED|Overall Study||3
2601890|NCT00212888|6386934|P3|COMPLETED|Overall Study||14
2601891|NCT00212888|6386935|P2|COMPLETED|Overall Study||18
2601892|NCT00212888|6386936|P1|COMPLETED|Overall Study||16
2601893|NCT00212888|6386934|P3|STARTED|Overall Study||15
2601894|NCT00212888|6386935|P2|STARTED|Overall Study||18
2601895|NCT00212888|6386936|P1|STARTED|Overall Study||19
2601896|NCT00212758|6386957|P2|NOT COMPLETED|Standard Therapy of GH (12 Months)||1
2601897|NCT00212758|6386958|P1|NOT COMPLETED|Standard Therapy of GH (12 Months)||2
2601898|NCT00212758|6386957|P2|COMPLETED|Standard Therapy of GH (12 Months)||8
2601899|NCT00212758|6386958|P1|COMPLETED|Standard Therapy of GH (12 Months)||6
2601900|NCT00212758|6386957|P2|STARTED|Standard Therapy of GH (12 Months)||9
2601901|NCT00212758|6386958|P1|STARTED|Standard Therapy of GH (12 Months)||8
2601902|NCT00212758|6386957|P2|NOT COMPLETED|Second Intervention (7 Days)||0
2601903|NCT00212758|6386958|P1|NOT COMPLETED|Second Intervention (7 Days)||0
2601904|NCT00212758|6386957|P2|COMPLETED|Second Intervention (7 Days)||9
2601905|NCT00212758|6386958|P1|COMPLETED|Second Intervention (7 Days)||8
2601906|NCT00212758|6386957|P2|STARTED|Second Intervention (7 Days)||9
2601907|NCT00212758|6386958|P1|STARTED|Second Intervention (7 Days)||8
2601908|NCT00212758|6386957|P2|NOT COMPLETED|Wash Out Period (2 Weeks)||0
2601909|NCT00212758|6386958|P1|NOT COMPLETED|Wash Out Period (2 Weeks)||0
2601910|NCT00212758|6386957|P2|COMPLETED|Wash Out Period (2 Weeks)||9
2601911|NCT00212758|6386958|P1|COMPLETED|Wash Out Period (2 Weeks)||8
2601912|NCT00212758|6386957|P2|STARTED|Wash Out Period (2 Weeks)||9
2601913|NCT00212758|6386958|P1|STARTED|Wash Out Period (2 Weeks)||8
2601914|NCT00212758|6386957|P2|NOT COMPLETED|First Intervention (7 Days)||0
2601915|NCT00212758|6386958|P1|NOT COMPLETED|First Intervention (7 Days)||0
2601916|NCT00212758|6386957|P2|COMPLETED|First Intervention (7 Days)||9
2601917|NCT00212758|6386958|P1|COMPLETED|First Intervention (7 Days)||8
2601918|NCT00212758|6386957|P2|STARTED|First Intervention (7 Days)||9
2601919|NCT00212758|6386958|P1|STARTED|First Intervention (7 Days)||8
2601920|NCT00212446|6386964|P1|NOT COMPLETED|Overall Study||0
2601921|NCT00212446|6386964|P1|COMPLETED|Overall Study||8
2601922|NCT00212446|6386964|P1|STARTED|Overall Study||8
2601923|NCT00212355|6386974|P1|NOT COMPLETED|Overall Study||3
2601924|NCT00212355|6386974|P1|COMPLETED|Overall Study||34
2601925|NCT00212355|6386974|P1|STARTED|Overall Study||37
2601926|NCT00212264|6386981|P3|NOT COMPLETED|Overall Study||4
2601927|NCT00212264|6386982|P2|NOT COMPLETED|Overall Study||16
2601928|NCT00212264|6386983|P1|NOT COMPLETED|Overall Study||12
2601929|NCT00212264|6386981|P3|COMPLETED|Overall Study||64
2601930|NCT00212264|6386982|P2|COMPLETED|Overall Study||54
2601931|NCT00212264|6386983|P1|COMPLETED|Overall Study||58
2601932|NCT00212264|6386981|P3|STARTED|Overall Study||68
2601933|NCT00212264|6386982|P2|STARTED|Overall Study||70
2601934|NCT00212264|6386983|P1|STARTED|Overall Study||70
2601935|NCT00212134|6386995|P2|NOT COMPLETED|Phase 3 (Age 10 Years)||21
2601936|NCT00212134|6386996|P1|NOT COMPLETED|Phase 3 (Age 10 Years)||21
2601937|NCT00212134|6386995|P2|COMPLETED|Phase 3 (Age 10 Years)||35
2601938|NCT00212134|6386996|P1|COMPLETED|Phase 3 (Age 10 Years)||36
2601939|NCT00212134|6386995|P2|STARTED|Phase 3 (Age 10 Years)||56
2601940|NCT00212134|6386996|P1|STARTED|Phase 3 (Age 10 Years)||57
2601941|NCT00212134|6386995|P2|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||1
2601942|NCT00212134|6386996|P1|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||0
2601943|NCT00212134|6386995|P2|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)|Patient lost to follow-up.|56
2601944|NCT00212134|6386996|P1|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||57
2601945|NCT00212134|6386995|P2|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
2601946|NCT00212134|6386996|P1|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
2601947|NCT00212134|6386995|P2|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
2601948|NCT00212134|6386996|P1|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
2601949|NCT00212134|6386995|P2|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
2601950|NCT00212134|6386996|P1|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
2601951|NCT00212134|6386995|P2|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
2601952|NCT00212134|6386996|P1|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
2601953|NCT00212134|6386995|P2|STARTED|Phase 1 (to Age 1 Year)||57
2601954|NCT00212134|6386996|P1|STARTED|Phase 1 (to Age 1 Year)||57
2601955|NCT00211887|6387017|P3|NOT COMPLETED|Overall Study||36
2601956|NCT00211887|6387018|P2|NOT COMPLETED|Overall Study||56
2601957|NCT00211887|6387019|P1|NOT COMPLETED|Overall Study||102
2601958|NCT00211887|6387017|P3|COMPLETED|Overall Study||223
2601959|NCT00211887|6387018|P2|COMPLETED|Overall Study||194
2601960|NCT00211887|6387019|P1|COMPLETED|Overall Study||397
2601961|NCT00211887|6387017|P3|STARTED|Overall Study||259
2601962|NCT00211887|6387018|P2|STARTED|Overall Study||250
2601963|NCT00211887|6387019|P1|STARTED|Overall Study||499
2601964|NCT00211809|6387036|P1|NOT COMPLETED|Overall Study||6
2601965|NCT00211809|6387036|P1|COMPLETED|Overall Study||11
2601966|NCT00211809|6387036|P1|STARTED|Overall Study||17
2601967|NCT00211757|6387052|P2|NOT COMPLETED|Overall Study||2
2601968|NCT00211757|6387053|P1|NOT COMPLETED|Overall Study||1
2601969|NCT00211757|6387052|P2|COMPLETED|Overall Study||14
2601970|NCT00211757|6387053|P1|COMPLETED|Overall Study||10
2601971|NCT00211757|6387052|P2|STARTED|Overall Study||16
2601972|NCT00211757|6387053|P1|STARTED|Overall Study||11
2601973|NCT00211692|6387063|P2|NOT COMPLETED|Overall Study||0
2601974|NCT00211692|6387064|P1|NOT COMPLETED|Overall Study||0
2601975|NCT00211692|6387063|P2|COMPLETED|Overall Study||31
2601976|NCT00211692|6387064|P1|COMPLETED|Overall Study||33
2601977|NCT00211692|6387063|P2|STARTED|Overall Study||31
2601978|NCT00211692|6387064|P1|STARTED|Overall Study||33
2601979|NCT00211536|6387074|P2|NOT COMPLETED|Overall Study||7
2601980|NCT00211536|6387075|P1|NOT COMPLETED|Overall Study||4
2601981|NCT00211536|6387074|P2|COMPLETED|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|47
2601982|NCT00211536|6387075|P1|COMPLETED|Overall Study||49
2601983|NCT00211536|6387074|P2|As Treated Data Analysis Set|Overall Study||48
2601984|NCT00211536|6387075|P1|As Treated Data Analysis Set|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|52
2601985|NCT00211536|6387074|P2|STARTED|Overall Study||54
2601986|NCT00211536|6387075|P1|STARTED|Overall Study||53
2601987|NCT00211510|6387091|P2|NOT COMPLETED|Overall Study||2
2601988|NCT00211510|6387092|P1|NOT COMPLETED|Overall Study||6
2601989|NCT00211510|6387091|P2|COMPLETED|Overall Study||72
2601990|NCT00211510|6387092|P1|COMPLETED|Overall Study||66
2601991|NCT00211510|6387091|P2|STARTED|Overall Study||74
2601992|NCT00211510|6387092|P1|STARTED|Overall Study||72
2601993|NCT00211237|6387110|P3|NOT COMPLETED|12 Months||6
2601994|NCT00211237|6387111|P2|NOT COMPLETED|12 Months||2
2601995|NCT00211237|6387112|P1|NOT COMPLETED|12 Months||9
2601996|NCT00211237|6387110|P3|COMPLETED|12 Months||28
2601997|NCT00211237|6387111|P2|COMPLETED|12 Months||6
2601998|NCT00211237|6387112|P1|COMPLETED|12 Months||40
2601999|NCT00211237|6387110|P3|STARTED|12 Months||34
2602000|NCT00211237|6387111|P2|STARTED|12 Months|1 patient crossed over Balloon Kyphoplasty|8
2602001|NCT00211237|6387112|P1|STARTED|12 Months||49
2602002|NCT00211237|6387110|P3|NOT COMPLETED|6 Months||3
2602003|NCT00211237|6387111|P2|NOT COMPLETED|6 Months||2
2602004|NCT00211237|6387112|P1|NOT COMPLETED|6 Months||8
2602005|NCT00211237|6387110|P3|COMPLETED|6 Months||33
2602006|NCT00211237|6387111|P2|COMPLETED|6 Months||9
2602007|NCT00211237|6387112|P1|COMPLETED|6 Months||49
2602008|NCT00211237|6387110|P3|STARTED|6 Months||36
2602009|NCT00211237|6387111|P2|STARTED|6 Months|3 patients crossed over Balloon Kyphoplasty|11
2602010|NCT00211237|6387112|P1|STARTED|6 Months||57
2602011|NCT00211237|6387110|P3|NOT COMPLETED|3 Months||1
2602012|NCT00211237|6387111|P2|NOT COMPLETED|3 Months||4
2602013|NCT00211237|6387112|P1|NOT COMPLETED|3 Months||8
2602014|NCT00211237|6387110|P3|COMPLETED|3 Months||33
2602015|NCT00211237|6387111|P2|COMPLETED|3 Months||14
2602016|NCT00211237|6387112|P1|COMPLETED|3 Months||57
2602017|NCT00211237|6387110|P3|STARTED|3 Months||34
2602018|NCT00211237|6387111|P2|STARTED|3 Months|34 patients crossed over to Balloon Kyphoplasty.|18
2602019|NCT00211237|6387112|P1|STARTED|3 Months||65
2602020|NCT00211237|6387110|P3|NOT COMPLETED|1 Month||0
2602021|NCT00211237|6387111|P2|NOT COMPLETED|1 Month||9
2602022|NCT00211237|6387112|P1|NOT COMPLETED|1 Month||3
2602023|NCT00211237|6387110|P3|COMPLETED|1 Month||0
2602024|NCT00211237|6387111|P2|COMPLETED|1 Month||52
2602025|NCT00211237|6387112|P1|COMPLETED|1 Month||65
2602026|NCT00211237|6387110|P3|STARTED|1 Month||0
2602027|NCT00211237|6387111|P2|STARTED|1 Month||61
2602028|NCT00211237|6387112|P1|STARTED|1 Month||68
2602029|NCT00211237|6387110|P3|NOT COMPLETED|Baseline||0
2602030|NCT00211237|6387111|P2|NOT COMPLETED|Baseline||3
2602031|NCT00211237|6387112|P1|NOT COMPLETED|Baseline||2
2602032|NCT00211237|6387110|P3|COMPLETED|Baseline||0
2602033|NCT00211237|6387111|P2|COMPLETED|Baseline||61
2602034|NCT00211237|6387112|P1|COMPLETED|Baseline||68
2602035|NCT00211237|6387110|P3|STARTED|Baseline||0
2602036|NCT00211237|6387111|P2|STARTED|Baseline||64
2602037|NCT00211237|6387112|P1|STARTED|Baseline||70
2602038|NCT00211172|6387204|P2|NOT COMPLETED|Overall Study||32
2602039|NCT00211172|6387205|P1|NOT COMPLETED|Overall Study||39
2602040|NCT00211172|6387204|P2|COMPLETED|Overall Study|32 patients died or lost health plan eligibility|426
2602041|NCT00211172|6387205|P1|COMPLETED|Overall Study|39 patients died or lost health plan eligibility|410
2602042|NCT00211172|6387204|P2|STARTED|Overall Study||458
2602043|NCT00211172|6387205|P1|STARTED|Overall Study||449
2602044|NCT00211081|6387211|P1|NOT COMPLETED|Overall Study||2
2602045|NCT00211081|6387211|P1|COMPLETED|Overall Study||10
2602046|NCT00211081|6387211|P1|STARTED|Overall Study||12
2602047|NCT00210639|6387223|P2|NOT COMPLETED|Overall Study||42
2602048|NCT00210639|6387224|P1|NOT COMPLETED|Overall Study||63
2602049|NCT00210639|6387223|P2|COMPLETED|Overall Study||41
2602050|NCT00210639|6387224|P1|COMPLETED|Overall Study||61
2602051|NCT00210639|6387223|P2|STARTED|Overall Study||83
2602052|NCT00210639|6387224|P1|STARTED|Overall Study||124
2602053|NCT00210626|6387232|P2|NOT COMPLETED|Overall Study||45
2602054|NCT00210626|6387233|P1|NOT COMPLETED|Overall Study||48
2602055|NCT00210626|6387232|P2|COMPLETED|Overall Study||50
2602056|NCT00210626|6387233|P1|COMPLETED|Overall Study||49
2602057|NCT00210626|6387232|P2|STARTED|Overall Study||95
2602058|NCT00210626|6387233|P1|STARTED|Overall Study||97
2602059|NCT00210470|6387241|P1|NOT COMPLETED|Overall Study||1
2602060|NCT00210470|6387241|P1|COMPLETED|Overall Study||26
2602061|NCT00210470|6387241|P1|STARTED|Overall Study||27
2602062|NCT00210353|6387248|P3|NOT COMPLETED|Overall Study||26
2602063|NCT00210353|6387249|P2|NOT COMPLETED|Overall Study||45
2602064|NCT00210353|6387250|P1|NOT COMPLETED|Overall Study||38
2602065|NCT00210353|6387248|P3|COMPLETED|Overall Study||125
2602066|NCT00210353|6387249|P2|COMPLETED|Overall Study||107
2602067|NCT00210353|6387250|P1|COMPLETED|Overall Study||113
2602068|NCT00210353|6387248|P3|STARTED|Overall Study||151
2602069|NCT00210353|6387249|P2|STARTED|Overall Study||152
2602070|NCT00210353|6387250|P1|STARTED|Overall Study||151
2602071|NCT00209560|6387272|P2|NOT COMPLETED|Overall Study||0
2602072|NCT00209560|6387273|P1|NOT COMPLETED|Overall Study||1
2602073|NCT00209560|6387272|P2|COMPLETED|Overall Study||42
2602074|NCT00209560|6387273|P1|COMPLETED|Overall Study||120
2602075|NCT00209560|6387272|P2|STARTED|Overall Study||42
2602076|NCT00209560|6387273|P1|STARTED|Overall Study||121
2602077|NCT00209417|6387283|P2|NOT COMPLETED|Overall Study||0
2602078|NCT00209417|6387284|P1|NOT COMPLETED|Overall Study||0
2602079|NCT00209417|6387283|P2|COMPLETED|Overall Study||327
2602080|NCT00209417|6387284|P1|COMPLETED|Overall Study||321
2602081|NCT00209417|6387283|P2|STARTED|Overall Study||327
2602082|NCT00209417|6387284|P1|STARTED|Overall Study||321
2602083|NCT00209339|6387292|P1|NOT COMPLETED|At 5 Years Follow-up||8
2602084|NCT00209339|6387292|P1|COMPLETED|At 5 Years Follow-up||15
2602085|NCT00209339|6387292|P1|STARTED|At 5 Years Follow-up||23
2602086|NCT00209339|6387292|P1|NOT COMPLETED|At 4 Years Follow-up||5
2602087|NCT00209339|6387292|P1|COMPLETED|At 4 Years Follow-up||23
2602088|NCT00209339|6387292|P1|STARTED|At 4 Years Follow-up||28
2602089|NCT00209339|6387292|P1|NOT COMPLETED|At 3 Years Follow-up||1
2602090|NCT00209339|6387292|P1|COMPLETED|At 3 Years Follow-up||28
2602091|NCT00209339|6387292|P1|STARTED|At 3 Years Follow-up||29
2602092|NCT00209339|6387292|P1|NOT COMPLETED|At 24 Months Follow-up||11
2602093|NCT00209339|6387292|P1|COMPLETED|At 24 Months Follow-up||29
2602094|NCT00209339|6387292|P1|STARTED|At 24 Months Follow-up||40
2602095|NCT00209339|6387292|P1|NOT COMPLETED|At 12 Months Follow-up||15
2602096|NCT00209339|6387292|P1|COMPLETED|At 12 Months Follow-up||40
2602097|NCT00209339|6387292|P1|STARTED|At 12 Months Follow-up||55
2602098|NCT00209274|6387376|P2|NOT COMPLETED|Overall Study||47
2602099|NCT00209274|6387377|P1|NOT COMPLETED|Overall Study||71
2602100|NCT00209274|6387376|P2|COMPLETED|Overall Study||48
2602101|NCT00209274|6387377|P1|COMPLETED|Overall Study||113
2602102|NCT00209274|6387376|P2|STARTED|Overall Study||95
2602103|NCT00209274|6387377|P1|STARTED|Overall Study||184
2602104|NCT00209170|6387697|P2|NOT COMPLETED|Overall Study||3
2602105|NCT00209170|6387698|P1|NOT COMPLETED|Overall Study||2
2602106|NCT00209170|6387697|P2|COMPLETED|Overall Study||4
2602107|NCT00209170|6387698|P1|COMPLETED|Overall Study||5
2602108|NCT00209170|6387697|P2|STARTED|Overall Study||7
2602109|NCT00209170|6387698|P1|STARTED|Overall Study||7
2602110|NCT00209131|6387706|P2|NOT COMPLETED|Overall Study||11
2602111|NCT00209131|6387707|P1|NOT COMPLETED|Overall Study||15
2602112|NCT00209131|6387706|P2|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
2602113|NCT00209131|6387707|P1|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
2602114|NCT00209131|6387706|P2|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|11
2602115|NCT00209131|6387707|P1|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|15
2602116|NCT00209092|6387717|P2|NOT COMPLETED|Overall Study||2
2602117|NCT00209092|6387718|P1|NOT COMPLETED|Overall Study||8
2602118|NCT00209092|6387717|P2|COMPLETED|Overall Study||24
2602119|NCT00209092|6387718|P1|COMPLETED|Overall Study||17
2602120|NCT00209092|6387717|P2|STARTED|Overall Study||26
2602121|NCT00209092|6387718|P1|STARTED|Overall Study||25
2602122|NCT00209027|6387728|P2|NOT COMPLETED|Overall Study||0
2602123|NCT00209027|6387729|P1|NOT COMPLETED|Overall Study||10
2602124|NCT00209027|6387728|P2|COMPLETED|Overall Study||10
2602125|NCT00209027|6387729|P1|COMPLETED|Overall Study||0
2602126|NCT00209027|6387728|P2|STARTED|Overall Study||10
2602127|NCT00209027|6387729|P1|STARTED|Overall Study||10
2602128|NCT00208975|6387735|P1|NOT COMPLETED|Overall Study||0
2602129|NCT00208975|6387735|P1|COMPLETED|Overall Study||15
2602130|NCT00208975|6387735|P1|STARTED|Overall Study||15
2602131|NCT00208949|6387742|P2|NOT COMPLETED|Overall Study||0
2602132|NCT00208949|6387743|P1|NOT COMPLETED|Overall Study||0
2602133|NCT00208949|6387742|P2|COMPLETED|Overall Study||25
2602134|NCT00208949|6387743|P1|COMPLETED|Overall Study||25
2602135|NCT00208949|6387742|P2|STARTED|Overall Study||25
2602136|NCT00208949|6387743|P1|STARTED|Overall Study||25
2602137|NCT00208767|6387753|P2|NOT COMPLETED|Overall Study||7
2602138|NCT00208767|6387754|P1|NOT COMPLETED|Overall Study||27
2602139|NCT00208767|6387753|P2|COMPLETED|Overall Study||33
2602140|NCT00208767|6387754|P1|COMPLETED|Overall Study||53
2602141|NCT00208767|6387753|P2|STARTED|Overall Study||40
2602142|NCT00208767|6387754|P1|STARTED|Overall Study||80
2602143|NCT00208507|6387762|P2|NOT COMPLETED|Overall Study||8
2602144|NCT00208507|6387763|P1|NOT COMPLETED|Overall Study||14
2602145|NCT00208507|6387762|P2|COMPLETED|Overall Study||79
2602146|NCT00208507|6387763|P1|COMPLETED|Overall Study||163
2602147|NCT00208507|6387762|P2|STARTED|Overall Study||87
2602148|NCT00208507|6387763|P1|STARTED|Overall Study||177
2602149|NCT00208494|6387771|P2|NOT COMPLETED|Overall Study||34
2602150|NCT00208494|6387772|P1|NOT COMPLETED|Overall Study||30
2602151|NCT00208494|6387771|P2|COMPLETED|Overall Study||162
2602152|NCT00208494|6387772|P1|COMPLETED|Overall Study||164
2602153|NCT00208494|6387771|P2|STARTED|Overall Study||196
2602154|NCT00208494|6387772|P1|STARTED|Overall Study||194
2602155|NCT00208325|6387782|P4|NOT COMPLETED|Overall Study||14
2602156|NCT00208325|6387783|P3|NOT COMPLETED|Overall Study||14
2602157|NCT00208325|6387784|P2|NOT COMPLETED|Overall Study||54
2602158|NCT00208325|6387785|P1|NOT COMPLETED|Overall Study||51
2602159|NCT00208325|6387782|P4|COMPLETED|Overall Study||147
2602160|NCT00208325|6387783|P3|COMPLETED|Overall Study||156
2602161|NCT00208325|6387784|P2|COMPLETED|Overall Study||142
2602162|NCT00208325|6387785|P1|COMPLETED|Overall Study||142
2602163|NCT00208325|6387782|P4|STARTED|Overall Study||161
2602164|NCT00208325|6387783|P3|STARTED|Overall Study||170
2602165|NCT00208325|6387784|P2|STARTED|Overall Study||196
2602166|NCT00208325|6387785|P1|STARTED|Overall Study||193
2602167|NCT00208091|6387893|P1|NOT COMPLETED|Overall Study||0
2602168|NCT00208091|6387893|P1|COMPLETED|Overall Study||16
2602169|NCT00208091|6387893|P1|STARTED|Overall Study||16
2602170|NCT00208026|6387901|P1|NOT COMPLETED|Overall Study||0
2602171|NCT00208026|6387901|P1|COMPLETED|Overall Study||3
2602172|NCT00208026|6387901|P1|STARTED|Overall Study||3
2602173|NCT00207883|6387909|P2|NOT COMPLETED|Overall Study||0
2602174|NCT00207883|6387910|P1|NOT COMPLETED|Overall Study||0
2602175|NCT00207883|6387909|P2|COMPLETED|Overall Study||119
2602176|NCT00207883|6387910|P1|COMPLETED|Overall Study||93
2602177|NCT00207883|6387909|P2|STARTED|Overall Study||119
2602178|NCT00207883|6387910|P1|STARTED|Overall Study||93
2602179|NCT00207740|6387922|P4|NOT COMPLETED|Overall Study||43
2602180|NCT00207740|6387923|P3|NOT COMPLETED|Overall Study||40
2602181|NCT00207740|6387924|P2|NOT COMPLETED|Overall Study||41
2602182|NCT00207740|6387925|P1|NOT COMPLETED|Overall Study||29
2602183|NCT00207740|6387922|P4|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|35
2602184|NCT00207740|6387923|P3|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
2602185|NCT00207740|6387924|P2|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
2602186|NCT00207740|6387925|P1|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|49
2602187|NCT00207740|6387922|P4|STARTED|Overall Study||78
2602188|NCT00207740|6387923|P3|STARTED|Overall Study||76
2602189|NCT00207740|6387924|P2|STARTED|Overall Study||77
2602190|NCT00207740|6387925|P1|STARTED|Overall Study||78
2602191|NCT00207727|6387971|P5|NOT COMPLETED|Overall Study||34
2602192|NCT00207727|6387972|P4|NOT COMPLETED|Overall Study||37
2602193|NCT00207727|6387973|P3|NOT COMPLETED|Overall Study||41
2602194|NCT00207727|6387974|P2|NOT COMPLETED|Overall Study||42
2602195|NCT00207727|6387975|P1|NOT COMPLETED|Overall Study||38
2602196|NCT00207727|6387971|P5|COMPLETED|Overall Study||16
2602197|NCT00207727|6387972|P4|COMPLETED|Overall Study||13
2602198|NCT00207727|6387973|P3|COMPLETED|Overall Study||9
2602199|NCT00207727|6387974|P2|COMPLETED|Overall Study||8
2602200|NCT00207727|6387975|P1|COMPLETED|Overall Study||11
2602201|NCT00207727|6387971|P5|STARTED|Overall Study||50
2602202|NCT00207727|6387972|P4|STARTED|Overall Study||50
2602203|NCT00207727|6387973|P3|STARTED|Overall Study||50
2602204|NCT00207727|6387974|P2|STARTED|Overall Study||50
2602205|NCT00207727|6387975|P1|STARTED|Overall Study||49
2602206|NCT00207714|6388002|P5|NOT COMPLETED|Overall Study||5
2602207|NCT00207714|6388003|P4|NOT COMPLETED|Overall Study||8
2602208|NCT00207714|6388004|P3|NOT COMPLETED|Overall Study||10
2602209|NCT00207714|6388005|P2|NOT COMPLETED|Overall Study||7
2602210|NCT00207714|6388006|P1|NOT COMPLETED|Overall Study||14
2602211|NCT00207714|6388002|P5|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|29
2602212|NCT00207714|6388003|P4|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|26
2602213|NCT00207714|6388004|P3|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|24
2602214|NCT00207714|6388005|P2|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|28
2602215|NCT00207714|6388006|P1|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|21
2602216|NCT00207714|6388002|P5|STARTED|Overall Study||34
2602217|NCT00207714|6388003|P4|STARTED|Overall Study||34
2602218|NCT00207714|6388004|P3|STARTED|Overall Study||34
2602219|NCT00207714|6388005|P2|STARTED|Overall Study||35
2602220|NCT00207714|6388006|P1|STARTED|Overall Study||35
2602221|NCT00207142|6388028|P4|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
2602222|NCT00207142|6388029|P3|NOT COMPLETED|Maintenance Phase/Rescue Phase||13
2602223|NCT00207142|6388030|P2|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
2602224|NCT00207142|6388031|P1|NOT COMPLETED|Maintenance Phase/Rescue Phase||0
2602225|NCT00207142|6388028|P4|COMPLETED|Maintenance Phase/Rescue Phase||41
2602226|NCT00207142|6388029|P3|COMPLETED|Maintenance Phase/Rescue Phase||72
2602227|NCT00207142|6388030|P2|COMPLETED|Maintenance Phase/Rescue Phase||78
2602228|NCT00207142|6388031|P1|COMPLETED|Maintenance Phase/Rescue Phase||0
2602229|NCT00207142|6388028|P4|STARTED|Maintenance Phase/Rescue Phase||50
2602230|NCT00207142|6388029|P3|STARTED|Maintenance Phase/Rescue Phase||85
2602231|NCT00207142|6388030|P2|STARTED|Maintenance Phase/Rescue Phase||87
2602232|NCT00207142|6388031|P1|STARTED|Maintenance Phase/Rescue Phase||0
2602233|NCT00207142|6388028|P4|NOT COMPLETED|Induction Phase||0
2602234|NCT00207142|6388029|P3|NOT COMPLETED|Induction Phase||0
2602235|NCT00207142|6388030|P2|NOT COMPLETED|Induction Phase||0
2602236|NCT00207142|6388031|P1|NOT COMPLETED|Induction Phase||30
2602237|NCT00207142|6388028|P4|COMPLETED|Induction Phase||0
2602238|NCT00207142|6388029|P3|COMPLETED|Induction Phase||0
2602239|NCT00207142|6388030|P2|COMPLETED|Induction Phase||0
2602240|NCT00207142|6388031|P1|COMPLETED|Induction Phase|Subjects randomized into Maintenance Phase=172 (87 ATV +85 ATV/RTV); Rescue Phase subjects=50|222
2602241|NCT00207142|6388028|P4|STARTED|Induction Phase||0
2602242|NCT00207142|6388029|P3|STARTED|Induction Phase||0
2602243|NCT00207142|6388030|P2|STARTED|Induction Phase||0
2602244|NCT00207142|6388031|P1|STARTED|Induction Phase||252
2602245|NCT00207090|6388068|P1|NOT COMPLETED|Overall Study||7
2602246|NCT00207090|6388068|P1|COMPLETED|Overall Study||8
2602247|NCT00207090|6388068|P1|STARTED|Overall Study|Number of participants treated|15
2602248|NCT00206726|6388097|P1|NOT COMPLETED|Overall Study||51
2602249|NCT00206726|6388097|P1|COMPLETED|Overall Study|4-6 cycles of treatment with assessments at 2, 6, and 9 months post last dose|9
2602250|NCT00206726|6388097|P1|4 Cycles Completed|Overall Study|per protocol population|41
2602251|NCT00206726|6388097|P1|Treatment Started|Overall Study|Safety population (3 withdrew consent prior to receiving study drug)|57
2602252|NCT00206726|6388097|P1|STARTED|Overall Study||60
2602253|NCT00206518|6388108|P2|NOT COMPLETED|Overall Study||6
2602254|NCT00206518|6388109|P1|NOT COMPLETED|Overall Study||10
2602255|NCT00206518|6388108|P2|COMPLETED|Overall Study||78
2602256|NCT00206518|6388109|P1|COMPLETED|Overall Study||73
2602257|NCT00206518|6388108|P2|STARTED|Overall Study||84
2602258|NCT00206518|6388109|P1|STARTED|Overall Study||83
2602259|NCT00206440|6388121|P2|NOT COMPLETED|Overall Study||4
2602260|NCT00206440|6388122|P1|NOT COMPLETED|Overall Study||5
2602261|NCT00206440|6388121|P2|COMPLETED|Overall Study||18
2602262|NCT00206440|6388122|P1|COMPLETED|Overall Study||16
2602263|NCT00206440|6388121|P2|STARTED|Overall Study||22
2602264|NCT00206440|6388122|P1|STARTED|Overall Study||21
2602265|NCT00206427|6388128|P1|NOT COMPLETED|Overall Study||2
2602266|NCT00206427|6388128|P1|COMPLETED|Overall Study|Complete 6-week therapy|47
2602267|NCT00206427|6388128|P1|STARTED|Overall Study|Received First Dose|49
2602268|NCT00206336|6388132|P1|NOT COMPLETED|Overall Study||0
2602269|NCT00206336|6388132|P1|COMPLETED|Overall Study||20
2602270|NCT00206336|6388132|P1|STARTED|Overall Study||20
2602271|NCT00206323|6388138|P2|NOT COMPLETED|Overall Study||3
2602272|NCT00206323|6388139|P1|NOT COMPLETED|Overall Study||6
2602273|NCT00206323|6388138|P2|COMPLETED|Overall Study||12
2602274|NCT00206323|6388139|P1|COMPLETED|Overall Study||8
2602275|NCT00206323|6388138|P2|STARTED|Overall Study||15
2602276|NCT00206323|6388139|P1|STARTED|Overall Study||14
2602277|NCT00206102|6388147|P2|NOT COMPLETED|Overall Study||315
2602278|NCT00206102|6388148|P1|NOT COMPLETED|Overall Study||408
2602279|NCT00206102|6388147|P2|COMPLETED|Overall Study||187
2602280|NCT00206102|6388148|P1|COMPLETED|Overall Study||188
2602281|NCT00206102|6388147|P2|STARTED|Overall Study||502
2602282|NCT00206102|6388148|P1|STARTED|Overall Study||596
2602283|NCT00206076|6388184|P2|NOT COMPLETED|Overall Study||1
2602284|NCT00206076|6388185|P1|NOT COMPLETED|Overall Study||3
2602285|NCT00206076|6388184|P2|COMPLETED|Overall Study||9
2602286|NCT00206076|6388185|P1|COMPLETED|Overall Study||6
2602287|NCT00206076|6388184|P2|STARTED|Overall Study||10
2602288|NCT00206076|6388185|P1|STARTED|Overall Study||9
2602289|NCT00205881|6388195|P1|NOT COMPLETED|Overall Study||16
2602290|NCT00205881|6388195|P1|COMPLETED|Overall Study|32 enrolled. 1 unilateral. 25 bilateral for data analysis at 8 months. 16 completed study.|16
2602291|NCT00205881|6388195|P1|STARTED|Overall Study||32
2602292|NCT00205855|6388200|P1|NOT COMPLETED|Overall Study||21
2602293|NCT00205855|6388200|P1|COMPLETED|Overall Study||44
2602294|NCT00205855|6388200|P1|STARTED|Overall Study||65
2602295|NCT00205803|6388206|P2|NOT COMPLETED|Toddler Dose||3
2602296|NCT00205803|6388207|P1|NOT COMPLETED|Toddler Dose||2
2602297|NCT00205803|6388206|P2|COMPLETED|Toddler Dose||100
2602298|NCT00205803|6388207|P1|COMPLETED|Toddler Dose||84
2602299|NCT00205803|6388206|P2|STARTED|Toddler Dose||103
2602300|NCT00205803|6388207|P1|STARTED|Toddler Dose||86
2602301|NCT00205803|6388206|P2|NOT COMPLETED|After Infant Series||13
2602302|NCT00205803|6388207|P1|NOT COMPLETED|After Infant Series||18
2602303|NCT00205803|6388206|P2|COMPLETED|After Infant Series||103
2602304|NCT00205803|6388207|P1|COMPLETED|After Infant Series||86
2602305|NCT00205803|6388206|P2|STARTED|After Infant Series||116
2602306|NCT00205803|6388207|P1|STARTED|After Infant Series||104
2602307|NCT00205803|6388206|P2|NOT COMPLETED|Infant Series||11
2602308|NCT00205803|6388207|P1|NOT COMPLETED|Infant Series||18
2602309|NCT00205803|6388206|P2|COMPLETED|Infant Series||116
2602310|NCT00205803|6388207|P1|COMPLETED|Infant Series||104
2602311|NCT00205803|6388206|P2|Vaccinated Dose 3|Infant Series||118
2602312|NCT00205803|6388207|P1|Vaccinated Dose 3|Infant Series||110
2602313|NCT00205803|6388206|P2|Vaccinated Dose 2|Infant Series||122
2602314|NCT00205803|6388207|P1|Vaccinated Dose 2|Infant Series||115
2602315|NCT00205803|6388206|P2|Vaccinated Dose 1|Infant Series||126
2602316|NCT00205803|6388207|P1|Vaccinated Dose 1|Infant Series||121
2602317|NCT00205803|6388206|P2|STARTED|Infant Series||127
2602318|NCT00205803|6388207|P1|STARTED|Infant Series||122
2602319|NCT00205777|6388263|P6|NOT COMPLETED|Study Extension II||282
2602320|NCT00205777|6388264|P5|NOT COMPLETED|Study Extension II||0
2602321|NCT00205777|6388265|P4|NOT COMPLETED|Study Extension II||149
2602322|NCT00205777|6388266|P3|NOT COMPLETED|Study Extension II||0
2602323|NCT00205777|6388267|P2|NOT COMPLETED|Study Extension II||0
2602324|NCT00205777|6388268|P1|NOT COMPLETED|Study Extension II||0
2602325|NCT00205777|6388263|P6|COMPLETED|Study Extension II||860
2602326|NCT00205777|6388264|P5|COMPLETED|Study Extension II||0
2602327|NCT00205777|6388265|P4|COMPLETED|Study Extension II||441
2602328|NCT00205777|6388266|P3|COMPLETED|Study Extension II||0
2602329|NCT00205777|6388267|P2|COMPLETED|Study Extension II||0
2602330|NCT00205777|6388268|P1|COMPLETED|Study Extension II||0
2602331|NCT00205777|6388263|P6|TREATED|Study Extension II||1011
2602332|NCT00205777|6388264|P5|TREATED|Study Extension II||0
2602333|NCT00205777|6388265|P4|TREATED|Study Extension II||519
2602334|NCT00205777|6388266|P3|TREATED|Study Extension II||0
2602335|NCT00205777|6388267|P2|TREATED|Study Extension II||0
2602336|NCT00205777|6388268|P1|TREATED|Study Extension II||0
2602337|NCT00205777|6388263|P6|STARTED|Study Extension II||1142
2602338|NCT00205777|6388264|P5|STARTED|Study Extension II||0
2602339|NCT00205777|6388265|P4|STARTED|Study Extension II||590
2602340|NCT00205777|6388266|P3|STARTED|Study Extension II||0
2602341|NCT00205777|6388267|P2|STARTED|Study Extension II||0
2602342|NCT00205777|6388268|P1|STARTED|Study Extension II||0
2602343|NCT00205777|6388263|P6|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
2602344|NCT00205777|6388264|P5|NOT COMPLETED|Completed SE I, Entered Extension SE II||258
2602345|NCT00205777|6388265|P4|NOT COMPLETED|Completed SE I, Entered Extension SE II||240
2602346|NCT00205777|6388266|P3|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
2602347|NCT00205777|6388267|P2|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
2602348|NCT00205777|6388268|P1|NOT COMPLETED|Completed SE I, Entered Extension SE II||273
2602349|NCT00205777|6388263|P6|COMPLETED|Completed SE I, Entered Extension SE II||0
2602350|NCT00205777|6388264|P5|COMPLETED|Completed SE I, Entered Extension SE II||582
2602351|NCT00205777|6388265|P4|COMPLETED|Completed SE I, Entered Extension SE II||590
2602352|NCT00205777|6388266|P3|COMPLETED|Completed SE I, Entered Extension SE II||0
2602353|NCT00205777|6388267|P2|COMPLETED|Completed SE I, Entered Extension SE II||0
2602354|NCT00205777|6388268|P1|COMPLETED|Completed SE I, Entered Extension SE II||560
2602355|NCT00205777|6388263|P6|STARTED|Completed SE I, Entered Extension SE II||0
2602356|NCT00205777|6388264|P5|STARTED|Completed SE I, Entered Extension SE II||840
2602357|NCT00205777|6388265|P4|STARTED|Completed SE I, Entered Extension SE II||830
2602358|NCT00205777|6388266|P3|STARTED|Completed SE I, Entered Extension SE II||0
2602359|NCT00205777|6388267|P2|STARTED|Completed SE I, Entered Extension SE II||0
2602360|NCT00205777|6388268|P1|STARTED|Completed SE I, Entered Extension SE II||833
2602361|NCT00205777|6388263|P6|NOT COMPLETED|Study Extension I||0
2602362|NCT00205777|6388264|P5|NOT COMPLETED|Study Extension I||201
2602363|NCT00205777|6388265|P4|NOT COMPLETED|Study Extension I||228
2602364|NCT00205777|6388266|P3|NOT COMPLETED|Study Extension I||1070
2602365|NCT00205777|6388267|P2|NOT COMPLETED|Study Extension I||0
2602366|NCT00205777|6388268|P1|NOT COMPLETED|Study Extension I||214
2602367|NCT00205777|6388263|P6|COMPLETED|Study Extension I||0
2602368|NCT00205777|6388264|P5|COMPLETED|Study Extension I||840
2602369|NCT00205777|6388265|P4|COMPLETED|Study Extension I||830
2602370|NCT00205777|6388266|P3|COMPLETED|Study Extension I||0
2602371|NCT00205777|6388267|P2|COMPLETED|Study Extension I||0
2602372|NCT00205777|6388268|P1|COMPLETED|Study Extension I||833
2602373|NCT00205777|6388263|P6|STARTED|Study Extension I||0
2602374|NCT00205777|6388264|P5|STARTED|Study Extension I||1041
2602375|NCT00205777|6388265|P4|STARTED|Study Extension I||1058
2602376|NCT00205777|6388266|P3|STARTED|Study Extension I||1070
2602377|NCT00205777|6388267|P2|STARTED|Study Extension I||0
2602378|NCT00205777|6388268|P1|STARTED|Study Extension I||1047
2602379|NCT00205777|6388263|P6|NOT COMPLETED|Completed Core Study, Entered SE I||0
2602380|NCT00205777|6388264|P5|NOT COMPLETED|Completed Core Study, Entered SE I||0
2602381|NCT00205777|6388265|P4|NOT COMPLETED|Completed Core Study, Entered SE I||224
2602382|NCT00205777|6388266|P3|NOT COMPLETED|Completed Core Study, Entered SE I||207
2602383|NCT00205777|6388267|P2|NOT COMPLETED|Completed Core Study, Entered SE I||204
2602384|NCT00205777|6388268|P1|NOT COMPLETED|Completed Core Study, Entered SE I||232
2602385|NCT00205777|6388263|P6|COMPLETED|Completed Core Study, Entered SE I||0
2602386|NCT00205777|6388264|P5|COMPLETED|Completed Core Study, Entered SE I||0
2602387|NCT00205777|6388265|P4|COMPLETED|Completed Core Study, Entered SE I||1058
2602388|NCT00205777|6388266|P3|COMPLETED|Completed Core Study, Entered SE I||1070
2602389|NCT00205777|6388267|P2|COMPLETED|Completed Core Study, Entered SE I||1041
2602390|NCT00205777|6388268|P1|COMPLETED|Completed Core Study, Entered SE I||1047
2602391|NCT00205777|6388263|P6|STARTED|Completed Core Study, Entered SE I||0
2602392|NCT00205777|6388264|P5|STARTED|Completed Core Study, Entered SE I||0
2602393|NCT00205777|6388265|P4|STARTED|Completed Core Study, Entered SE I||1282
2602394|NCT00205777|6388266|P3|STARTED|Completed Core Study, Entered SE I||1277
2602395|NCT00205777|6388267|P2|STARTED|Completed Core Study, Entered SE I||1245
2602396|NCT00205777|6388268|P1|STARTED|Completed Core Study, Entered SE I||1279
2602397|NCT00205777|6388263|P6|NOT COMPLETED|Core Study (Up to 3 Years)||0
2602398|NCT00205777|6388264|P5|NOT COMPLETED|Core Study (Up to 3 Years)||0
2602399|NCT00205777|6388265|P4|NOT COMPLETED|Core Study (Up to 3 Years)||632
2602400|NCT00205777|6388266|P3|NOT COMPLETED|Core Study (Up to 3 Years)||607
2602401|NCT00205777|6388267|P2|NOT COMPLETED|Core Study (Up to 3 Years)||659
2602402|NCT00205777|6388268|P1|NOT COMPLETED|Core Study (Up to 3 Years)||628
2602403|NCT00205777|6388263|P6|COMPLETED|Core Study (Up to 3 Years)||0
2602404|NCT00205777|6388264|P5|COMPLETED|Core Study (Up to 3 Years)||0
2602405|NCT00205777|6388265|P4|COMPLETED|Core Study (Up to 3 Years)||1282
2602406|NCT00205777|6388266|P3|COMPLETED|Core Study (Up to 3 Years)||1277
2602407|NCT00205777|6388267|P2|COMPLETED|Core Study (Up to 3 Years)||1245
2602408|NCT00205777|6388268|P1|COMPLETED|Core Study (Up to 3 Years)||1279
2602409|NCT00205777|6388263|P6|TREATED|Core Study (Up to 3 Years)||0
2602410|NCT00205777|6388264|P5|TREATED|Core Study (Up to 3 Years)||0
2602411|NCT00205777|6388265|P4|TREATED|Core Study (Up to 3 Years)||1885
2602412|NCT00205777|6388266|P3|TREATED|Core Study (Up to 3 Years)||1849
2602413|NCT00205777|6388267|P2|TREATED|Core Study (Up to 3 Years)||1872
2602414|NCT00205777|6388268|P1|TREATED|Core Study (Up to 3 Years)||1886
2602415|NCT00205777|6388263|P6|STARTED|Core Study (Up to 3 Years)||0
2602416|NCT00205777|6388264|P5|STARTED|Core Study (Up to 3 Years)||0
2602417|NCT00205777|6388265|P4|STARTED|Core Study (Up to 3 Years)||1914
2602418|NCT00205777|6388266|P3|STARTED|Core Study (Up to 3 Years)||1884
2602419|NCT00205777|6388267|P2|STARTED|Core Study (Up to 3 Years)||1904
2602420|NCT00205777|6388268|P1|STARTED|Core Study (Up to 3 Years)||1907
2602421|NCT00205712|6388477|P2|NOT COMPLETED|Overall Study||1
2602422|NCT00205712|6388478|P1|NOT COMPLETED|Overall Study||0
2602423|NCT00205712|6388477|P2|COMPLETED|Overall Study||19
2602424|NCT00205712|6388478|P1|COMPLETED|Overall Study||20
2602425|NCT00205712|6388477|P2|STARTED|Overall Study||20
2602426|NCT00205712|6388478|P1|STARTED|Overall Study||20
2602427|NCT00205699|6388491|P3|NOT COMPLETED|Overall Study||6
2602428|NCT00205699|6388492|P2|NOT COMPLETED|Overall Study||6
2602429|NCT00205699|6388493|P1|NOT COMPLETED|Overall Study||3
2602430|NCT00205699|6388491|P3|COMPLETED|Overall Study||43
2602431|NCT00205699|6388492|P2|COMPLETED|Overall Study||40
2602432|NCT00205699|6388493|P1|COMPLETED|Overall Study||46
2602433|NCT00205699|6388491|P3|STARTED|Overall Study||49
2602434|NCT00205699|6388492|P2|STARTED|Overall Study||46
2602435|NCT00205699|6388493|P1|STARTED|Overall Study||49
2602436|NCT00205660|6388518|P2|NOT COMPLETED|Overall Study||2
2602437|NCT00205660|6388519|P1|NOT COMPLETED|Overall Study||2
2602438|NCT00205660|6388518|P2|COMPLETED|Overall Study||35
2602439|NCT00205660|6388519|P1|COMPLETED|Overall Study||12
2602440|NCT00205660|6388518|P2|STARTED|Overall Study||37
2602441|NCT00205660|6388519|P1|STARTED|Overall Study||14
2602442|NCT00205504|6388531|P2|NOT COMPLETED|Overall Study||0
2602443|NCT00205504|6388532|P1|NOT COMPLETED|Overall Study||7
2602444|NCT00205504|6388531|P2|COMPLETED|Overall Study||15
2602445|NCT00205504|6388532|P1|COMPLETED|Overall Study||14
2602446|NCT00205504|6388531|P2|STARTED|Overall Study||15
2602447|NCT00205504|6388532|P1|STARTED|Overall Study||21
2602448|NCT00205374|6388558|P2|NOT COMPLETED|Overall Study||0
2602449|NCT00205374|6388559|P1|NOT COMPLETED|Overall Study||0
2602450|NCT00205374|6388558|P2|COMPLETED|Overall Study||9
2602451|NCT00205374|6388559|P1|COMPLETED|Overall Study||10
2602452|NCT00205374|6388558|P2|STARTED|Overall Study||9
2602453|NCT00205374|6388559|P1|STARTED|Overall Study||10
2602454|NCT00205348|6388567|P1|NOT COMPLETED|Overall Study||30
2602455|NCT00205348|6388567|P1|COMPLETED|Overall Study||116
2602456|NCT00205348|6388567|P1|STARTED|Overall Study||146
2602457|NCT00205179|6388573|P2|NOT COMPLETED|Overall Study||4
2602458|NCT00205179|6388574|P1|NOT COMPLETED|Overall Study||2
2602459|NCT00205179|6388573|P2|COMPLETED|Overall Study||29
2602460|NCT00205179|6388574|P1|COMPLETED|Overall Study||30
2602461|NCT00205179|6388573|P2|STARTED|Overall Study||33
2602462|NCT00205179|6388574|P1|STARTED|Overall Study||32
2602463|NCT00205049|6388638|P2|NOT COMPLETED|Overall Study||0
2602464|NCT00205049|6388639|P1|NOT COMPLETED|Overall Study||0
2602465|NCT00205049|6388638|P2|COMPLETED|Overall Study||0
2602466|NCT00205049|6388639|P1|COMPLETED|Overall Study||0
2602467|NCT00205049|6388638|P2|STARTED|Overall Study||0
2602468|NCT00205049|6388639|P1|STARTED|Overall Study||0
2602469|NCT00204932|6388647|P2|NOT COMPLETED|Overall Study||6
2602470|NCT00204932|6388648|P1|NOT COMPLETED|Overall Study||2
2602471|NCT00204932|6388647|P2|COMPLETED|Overall Study||18
2602472|NCT00204932|6388648|P1|COMPLETED|Overall Study||22
2602473|NCT00204932|6388647|P2|STARTED|Overall Study||24
2602474|NCT00204932|6388648|P1|STARTED|Overall Study||24
2602475|NCT00204373|6388654|P1|NOT COMPLETED|Overall Study||0
2602476|NCT00204373|6388654|P1|COMPLETED|Overall Study||72
2602477|NCT00204373|6388654|P1|STARTED|Overall Study||72
2602478|NCT00203996|6388665|P10|NOT COMPLETED|Overall Study||1
2602479|NCT00203996|6388666|P9|NOT COMPLETED|Overall Study||0
2602480|NCT00203996|6388667|P8|NOT COMPLETED|Overall Study||2
2602481|NCT00203996|6388668|P7|NOT COMPLETED|Overall Study||0
2602482|NCT00203996|6388669|P6|NOT COMPLETED|Overall Study||0
2602483|NCT00203996|6388670|P5|NOT COMPLETED|Overall Study||1
2602484|NCT00203996|6388671|P4|NOT COMPLETED|Overall Study||10
2602485|NCT00203996|6388672|P3|NOT COMPLETED|Overall Study||0
2602486|NCT00203996|6388673|P2|NOT COMPLETED|Overall Study||0
2602487|NCT00203996|6388674|P1|NOT COMPLETED|Overall Study||0
2602488|NCT00203996|6388665|P10|COMPLETED|Overall Study||2
2602489|NCT00203996|6388666|P9|COMPLETED|Overall Study||2
2602490|NCT00203996|6388667|P8|COMPLETED|Overall Study||2
2602491|NCT00203996|6388668|P7|COMPLETED|Overall Study||2
2602492|NCT00203996|6388669|P6|COMPLETED|Overall Study||3
2602493|NCT00203996|6388670|P5|COMPLETED|Overall Study||3
2602494|NCT00203996|6388671|P4|COMPLETED|Overall Study||9
2602495|NCT00203996|6388672|P3|COMPLETED|Overall Study||0
2602496|NCT00203996|6388673|P2|COMPLETED|Overall Study||0
2602497|NCT00203996|6388674|P1|COMPLETED|Overall Study||0
2602498|NCT00203996|6388665|P10|Aim 3 Only: Third Intervention|Overall Study||2
2602499|NCT00203996|6388666|P9|Aim 3 Only: Third Intervention|Overall Study||2
2602500|NCT00203996|6388667|P8|Aim 3 Only: Third Intervention|Overall Study||2
2602501|NCT00203996|6388668|P7|Aim 3 Only: Third Intervention|Overall Study||2
2602502|NCT00203996|6388669|P6|Aim 3 Only: Third Intervention|Overall Study||3
2602503|NCT00203996|6388670|P5|Aim 3 Only: Third Intervention|Overall Study||0
2602504|NCT00203996|6388671|P4|Aim 3 Only: Third Intervention|Overall Study||0
2602505|NCT00203996|6388672|P3|Aim 3 Only: Third Intervention|Overall Study||0
2602506|NCT00203996|6388673|P2|Aim 3 Only: Third Intervention|Overall Study||0
2602507|NCT00203996|6388674|P1|Aim 3 Only: Third Intervention|Overall Study||0
2602508|NCT00203996|6388665|P10|Aim 3 Only: Second Washout|Overall Study||2
2602509|NCT00203996|6388666|P9|Aim 3 Only: Second Washout|Overall Study||2
2602510|NCT00203996|6388667|P8|Aim 3 Only: Second Washout|Overall Study||2
2602511|NCT00203996|6388668|P7|Aim 3 Only: Second Washout|Overall Study||2
2602512|NCT00203996|6388669|P6|Aim 3 Only: Second Washout|Overall Study||3
2602513|NCT00203996|6388670|P5|Aim 3 Only: Second Washout|Overall Study||0
2602514|NCT00203996|6388671|P4|Aim 3 Only: Second Washout|Overall Study||0
2602515|NCT00203996|6388672|P3|Aim 3 Only: Second Washout|Overall Study||0
2602516|NCT00203996|6388673|P2|Aim 3 Only: Second Washout|Overall Study||0
2602517|NCT00203996|6388674|P1|Aim 3 Only: Second Washout|Overall Study||0
2602518|NCT00203996|6388665|P10|Aim 3 Only: Second Intervention|Overall Study||2
2602519|NCT00203996|6388666|P9|Aim 3 Only: Second Intervention|Overall Study||2
2602520|NCT00203996|6388667|P8|Aim 3 Only: Second Intervention|Overall Study||2
2602521|NCT00203996|6388668|P7|Aim 3 Only: Second Intervention|Overall Study||2
2602522|NCT00203996|6388669|P6|Aim 3 Only: Second Intervention|Overall Study||3
2602523|NCT00203996|6388670|P5|Aim 3 Only: Second Intervention|Overall Study||0
2602524|NCT00203996|6388671|P4|Aim 3 Only: Second Intervention|Overall Study||0
2602525|NCT00203996|6388672|P3|Aim 3 Only: Second Intervention|Overall Study||0
2602526|NCT00203996|6388673|P2|Aim 3 Only: Second Intervention|Overall Study||0
2602527|NCT00203996|6388674|P1|Aim 3 Only: Second Intervention|Overall Study||0
2602528|NCT00203996|6388665|P10|Aim 3 Only: Washout|Overall Study||2
2602529|NCT00203996|6388666|P9|Aim 3 Only: Washout|Overall Study||2
2602530|NCT00203996|6388667|P8|Aim 3 Only: Washout|Overall Study||2
2602531|NCT00203996|6388668|P7|Aim 3 Only: Washout|Overall Study||2
2602532|NCT00203996|6388669|P6|Aim 3 Only: Washout|Overall Study||3
2602533|NCT00203996|6388670|P5|Aim 3 Only: Washout|Overall Study||0
2602534|NCT00203996|6388671|P4|Aim 3 Only: Washout|Overall Study||0
2602535|NCT00203996|6388672|P3|Aim 3 Only: Washout|Overall Study||0
2602536|NCT00203996|6388673|P2|Aim 3 Only: Washout|Overall Study||0
2602537|NCT00203996|6388674|P1|Aim 3 Only: Washout|Overall Study||0
2602538|NCT00203996|6388665|P10|Aim 3 Only: First Intervention|Overall Study||3
2602539|NCT00203996|6388666|P9|Aim 3 Only: First Intervention|Overall Study||2
2602540|NCT00203996|6388667|P8|Aim 3 Only: First Intervention|Overall Study||4
2602541|NCT00203996|6388668|P7|Aim 3 Only: First Intervention|Overall Study||2
2602542|NCT00203996|6388669|P6|Aim 3 Only: First Intervention|Overall Study||3
2602543|NCT00203996|6388670|P5|Aim 3 Only: First Intervention|Overall Study||0
2602544|NCT00203996|6388671|P4|Aim 3 Only: First Intervention|Overall Study||0
2602545|NCT00203996|6388672|P3|Aim 3 Only: First Intervention|Overall Study||0
2602546|NCT00203996|6388673|P2|Aim 3 Only: First Intervention|Overall Study||0
2602547|NCT00203996|6388674|P1|Aim 3 Only: First Intervention|Overall Study||0
2602548|NCT00203996|6388665|P10|STARTED|Overall Study||3
2602549|NCT00203996|6388666|P9|STARTED|Overall Study||2
2602550|NCT00203996|6388667|P8|STARTED|Overall Study||4
2602551|NCT00203996|6388668|P7|STARTED|Overall Study||2
2602552|NCT00203996|6388669|P6|STARTED|Overall Study||3
2602553|NCT00203996|6388670|P5|STARTED|Overall Study||4
2602554|NCT00203996|6388671|P4|STARTED|Overall Study||19
2602555|NCT00203996|6388672|P3|STARTED|Overall Study||0
2602556|NCT00203996|6388673|P2|STARTED|Overall Study||0
2602557|NCT00203996|6388674|P1|STARTED|Overall Study||0
2602558|NCT00203931|6388723|P2|NOT COMPLETED|Overall Study||5
2602559|NCT00203931|6388724|P1|NOT COMPLETED|Overall Study||7
2602560|NCT00203931|6388723|P2|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|23
2602561|NCT00203931|6388724|P1|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|20
2602562|NCT00203931|6388723|P2|STARTED|Overall Study||28
2602563|NCT00203931|6388724|P1|STARTED|Overall Study||27
2602564|NCT00203892|6388741|P3|NOT COMPLETED|Overall Study||0
2602565|NCT00203892|6388742|P2|NOT COMPLETED|Overall Study||2
2602566|NCT00203892|6388743|P1|NOT COMPLETED|Overall Study||2
2602567|NCT00203892|6388741|P3|COMPLETED|Overall Study||6
2602568|NCT00203892|6388742|P2|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|8
2602569|NCT00203892|6388743|P1|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|5
2602570|NCT00203892|6388741|P3|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|4
2602571|NCT00203892|6388742|P2|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
2602572|NCT00203892|6388743|P1|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
2602573|NCT00203892|6388741|P3|STARTED|Overall Study||6
2602574|NCT00203892|6388742|P2|STARTED|Overall Study||10
2602575|NCT00203892|6388743|P1|STARTED|Overall Study||7
2602576|NCT00203502|6388754|P1|NOT COMPLETED|Overall Study||1
2602577|NCT00203502|6388754|P1|COMPLETED|Overall Study||39
2602578|NCT00203502|6388754|P1|STARTED|Overall Study||40
2602579|NCT00203476|6388765|P3|NOT COMPLETED|Overall Study||0
2602580|NCT00203476|6388766|P2|NOT COMPLETED|Overall Study||1
2602581|NCT00203476|6388767|P1|NOT COMPLETED|Overall Study||1
2602582|NCT00203476|6388765|P3|COMPLETED|Overall Study||10
2602583|NCT00203476|6388766|P2|COMPLETED|Overall Study||9
2602584|NCT00203476|6388767|P1|COMPLETED|Overall Study||9
2602585|NCT00203476|6388765|P3|STARTED|Overall Study||10
2602586|NCT00203476|6388766|P2|STARTED|Overall Study||10
2602587|NCT00203476|6388767|P1|STARTED|Overall Study||10
2602588|NCT00203424|6388784|P1|NOT COMPLETED|Follow-up Period||6
2602589|NCT00203424|6388784|P1|COMPLETED|Follow-up Period||10
2602590|NCT00203424|6388784|P1|STARTED|Follow-up Period|followup includes 11 pts that completed treatment + 5 pts who stopped treatment due to adverse event|16
2602591|NCT00203424|6388784|P1|NOT COMPLETED|Treatment Period||11
2602592|NCT00203424|6388784|P1|COMPLETED|Treatment Period|Of 11 pts that did not complete treatment,5 stopped due to adverse event and entered followup period|11
2602593|NCT00203424|6388784|P1|STARTED|Treatment Period|23 subjects registered for treatment, 1 withdrew consent after registration,22 received treatment.|22
2602594|NCT00203411|6388791|P1|NOT COMPLETED|Follow-up||4
2602595|NCT00203411|6388791|P1|COMPLETED|Follow-up||41
2602596|NCT00203411|6388791|P1|STARTED|Follow-up||45
2602597|NCT00203411|6388791|P1|NOT COMPLETED|Treatment Period||0
2602598|NCT00203411|6388791|P1|COMPLETED|Treatment Period||45
2602599|NCT00203411|6388791|P1|STARTED|Treatment Period||45
2602600|NCT00203307|6388800|P2|NOT COMPLETED|Second Intervention||0
2602601|NCT00203307|6388801|P1|NOT COMPLETED|Second Intervention||0
2602602|NCT00203307|6388800|P2|COMPLETED|Second Intervention||0
2602603|NCT00203307|6388801|P1|COMPLETED|Second Intervention||1
2602604|NCT00203307|6388800|P2|STARTED|Second Intervention||0
2602605|NCT00203307|6388801|P1|STARTED|Second Intervention|2 subjects dropped out of the 1st intervention period, due to fatugue.|1
2602606|NCT00203307|6388800|P2|NOT COMPLETED|First Intervention||0
2602607|NCT00203307|6388801|P1|NOT COMPLETED|First Intervention||2
2602608|NCT00203307|6388800|P2|COMPLETED|First Intervention||0
2602609|NCT00203307|6388801|P1|COMPLETED|First Intervention||1
2602610|NCT00203307|6388800|P2|STARTED|First Intervention||0
2602611|NCT00203307|6388801|P1|STARTED|First Intervention|Double-blind cross-over design. Study terminated early. Results not analyzed.|3
2602612|NCT00203294|6388809|P2|NOT COMPLETED|Overall Study||13
2602613|NCT00203294|6388810|P1|NOT COMPLETED|Overall Study||8
2602614|NCT00203294|6388809|P2|COMPLETED|Overall Study||10
2602615|NCT00203294|6388810|P1|COMPLETED|Overall Study||14
2602616|NCT00203294|6388809|P2|STARTED|Overall Study||23
2602617|NCT00203294|6388810|P1|STARTED|Overall Study||22
2602618|NCT00203268|6388816|P1|NOT COMPLETED|Late Treatment||0
2602619|NCT00203268|6388816|P1|COMPLETED|Late Treatment||9
2602620|NCT00203268|6388816|P1|STARTED|Late Treatment||9
2602621|NCT00203268|6388816|P1|NOT COMPLETED|Early Treatment||4
2602622|NCT00203268|6388816|P1|COMPLETED|Early Treatment||9
2602623|NCT00203268|6388816|P1|STARTED|Early Treatment||13
2602624|NCT00203242|6388822|P1|NOT COMPLETED|Overall Study||1
2602625|NCT00203242|6388822|P1|COMPLETED|Overall Study||14
2602626|NCT00203242|6388822|P1|STARTED|Overall Study||15
2602627|NCT00203229|6388828|P2|NOT COMPLETED|Overall Study||3
2602628|NCT00203229|6388829|P1|NOT COMPLETED|Overall Study||3
2602629|NCT00203229|6388828|P2|COMPLETED|Overall Study||7
2602630|NCT00203229|6388829|P1|COMPLETED|Overall Study||7
2602631|NCT00203229|6388828|P2|STARTED|Overall Study||10
2602632|NCT00203229|6388829|P1|STARTED|Overall Study||10
2602633|NCT00203216|6388835|P1|NOT COMPLETED|Overall Study||4
2602634|NCT00203216|6388835|P1|COMPLETED|Overall Study||27
2602635|NCT00203216|6388835|P1|STARTED|Overall Study||31
2602636|NCT00203203|6388841|P2|NOT COMPLETED|Overall Study||0
2602637|NCT00203203|6388842|P1|NOT COMPLETED|Overall Study||1
2602638|NCT00203203|6388841|P2|COMPLETED|Overall Study||20
2602639|NCT00203203|6388842|P1|COMPLETED|Overall Study||9
2602640|NCT00203203|6388841|P2|STARTED|Overall Study||20
2602641|NCT00203203|6388842|P1|STARTED|Overall Study||10
2602642|NCT00203047|6388874|P2|NOT COMPLETED|Overall Study||203
2602643|NCT00203047|6388875|P1|NOT COMPLETED|Overall Study||191
2602644|NCT00203047|6388874|P2|COMPLETED|Overall Study||7
2602645|NCT00203047|6388875|P1|COMPLETED|Overall Study||13
2602646|NCT00203047|6388874|P2|In Database as of January 29, 2009|Overall Study||209
2602647|NCT00203047|6388875|P1|In Database as of January 29, 2009|Overall Study||199
2602648|NCT00203047|6388874|P2|STARTED|Overall Study||210
2602649|NCT00203047|6388875|P1|STARTED|Overall Study||204
2602658|NCT00202878|6388900|P2|NOT COMPLETED|Overall Study||2217
2602659|NCT00202878|6388901|P1|NOT COMPLETED|Overall Study||2199
2602660|NCT00202878|6388900|P2|COMPLETED|Overall Study||6860
2602661|NCT00202878|6388901|P1|COMPLETED|Overall Study||6868
2602662|NCT00202878|6388900|P2|STARTED|Overall Study||9077
2602663|NCT00202878|6388901|P1|STARTED|Overall Study||9067
2602664|NCT00202839|6388915|P2|NOT COMPLETED|Overall Study||10
2602665|NCT00202839|6388916|P1|NOT COMPLETED|Overall Study||24
2602666|NCT00202839|6388915|P2|COMPLETED|Overall Study||72
2602667|NCT00202839|6388916|P1|COMPLETED|Overall Study||54
2602668|NCT00202839|6388915|P2|STARTED|Overall Study||82
2602669|NCT00202839|6388916|P1|STARTED|Overall Study||78
2602670|NCT00202722|6388924|P1|NOT COMPLETED|Overall Study||0
2602671|NCT00202722|6388924|P1|COMPLETED|Overall Study||41
2602672|NCT00202722|6388924|P1|STARTED|Overall Study||41
2602673|NCT00202644|6388931|P2|NOT COMPLETED|Overall Study||27
2602674|NCT00202644|6388932|P1|NOT COMPLETED|Overall Study||35
2602675|NCT00202644|6388931|P2|COMPLETED|Overall Study||43
2602676|NCT00202644|6388932|P1|COMPLETED|Overall Study||41
2602677|NCT00202644|6388931|P2|STARTED|Overall Study||70
2602678|NCT00202644|6388932|P1|STARTED|Overall Study|One participant not randomized but treated.|76
2602679|NCT00202449|6388959|P3|NOT COMPLETED|Overall Study||12
2602680|NCT00202449|6388960|P2|NOT COMPLETED|Overall Study||11
2602681|NCT00202449|6388961|P1|NOT COMPLETED|Overall Study||11
2602682|NCT00202449|6388959|P3|COMPLETED|Overall Study||9
2602683|NCT00202449|6388960|P2|COMPLETED|Overall Study||9
2602684|NCT00202449|6388961|P1|COMPLETED|Overall Study||7
2602685|NCT00202449|6388959|P3|STARTED|Overall Study||21
2602686|NCT00202449|6388960|P2|STARTED|Overall Study||20
2602687|NCT00202449|6388961|P1|STARTED|Overall Study||18
2602688|NCT00201877|6388975|P1|NOT COMPLETED|Overall Study||0
2602689|NCT00201877|6388975|P1|COMPLETED|Overall Study||25
2602690|NCT00201877|6388975|P1|STARTED|Overall Study||25
2602691|NCT00201864|6388982|P1|NOT COMPLETED|Overall Study||0
2602692|NCT00201864|6388982|P1|COMPLETED|Overall Study||40
2602693|NCT00201864|6388982|P1|STARTED|Overall Study||40
2602694|NCT00201851|6388993|P3|NOT COMPLETED|Overall Study||1
2602695|NCT00201851|6388994|P2|NOT COMPLETED|Overall Study||2
2602696|NCT00201851|6388995|P1|NOT COMPLETED|Overall Study||8
2602697|NCT00201851|6388993|P3|COMPLETED|Overall Study||230
2602698|NCT00201851|6388994|P2|COMPLETED|Overall Study||255
2602699|NCT00201851|6388995|P1|COMPLETED|Overall Study||244
2602700|NCT00201851|6388993|P3|STARTED|Overall Study||231
2602701|NCT00201851|6388994|P2|STARTED|Overall Study||257
2602702|NCT00201851|6388995|P1|STARTED|Overall Study||252
2602703|NCT00201838|6389005|P2|NOT COMPLETED|Overall Study||0
2602704|NCT00201838|6389006|P1|NOT COMPLETED|Overall Study||0
2602705|NCT00201838|6389005|P2|COMPLETED|Overall Study||8
2602706|NCT00201838|6389006|P1|COMPLETED|Overall Study||30
2602707|NCT00201838|6389005|P2|Treatment Cohort|Overall Study||8
2602708|NCT00201838|6389006|P1|Treatment Cohort|Overall Study||30
2602709|NCT00201838|6389005|P2|STARTED|Overall Study||8
2602710|NCT00201838|6389006|P1|STARTED|Overall Study||30
2602711|NCT00201825|6389020|P1|NOT COMPLETED|Overall Study||0
2602712|NCT00201825|6389020|P1|COMPLETED|Overall Study||29
2602713|NCT00201825|6389020|P1|STARTED|Overall Study||29
2602714|NCT00201773|6389027|P1|NOT COMPLETED|Overall Study||6
2602715|NCT00201773|6389027|P1|COMPLETED|Overall Study||16
2602716|NCT00201773|6389027|P1|Stopped Exemestane After 4 Weeks|Overall Study||1
2602717|NCT00201773|6389027|P1|Received All Exemestane Therapy|Overall Study||5
2602718|NCT00201773|6389027|P1|Completed 8 Weeks of Planned Therapy|Overall Study||16
2602719|NCT00201773|6389027|P1|STARTED|Overall Study||22
2602720|NCT00201760|6389036|P2|NOT COMPLETED|Overall Study||0
2602721|NCT00201760|6389037|P1|NOT COMPLETED|Overall Study||0
2602722|NCT00201760|6389036|P2|COMPLETED|Overall Study||5
2602723|NCT00201760|6389037|P1|COMPLETED|Overall Study||5
2602724|NCT00201760|6389036|P2|STARTED|Overall Study||5
2602725|NCT00201760|6389037|P1|STARTED|Overall Study||5
2602726|NCT00201734|6389049|P2|NOT COMPLETED|Overall Study||0
2602727|NCT00201734|6389050|P1|NOT COMPLETED|Overall Study||3
2602728|NCT00201734|6389049|P2|COMPLETED|Overall Study||25
2602729|NCT00201734|6389050|P1|COMPLETED|Overall Study||29
2602730|NCT00201734|6389049|P2|Patients Not Evaluable|Overall Study||0
2602731|NCT00201734|6389050|P1|Patients Not Evaluable|Overall Study||3
2602732|NCT00201734|6389049|P2|STARTED|Overall Study||25
2602733|NCT00201734|6389050|P1|STARTED|Overall Study||32
2602734|NCT00201643|6389067|P2|NOT COMPLETED|Overall Study||4
2602735|NCT00201643|6389068|P1|NOT COMPLETED|Overall Study||5
2602736|NCT00201643|6389067|P2|COMPLETED|Overall Study||210
2602737|NCT00201643|6389068|P1|COMPLETED|Overall Study||218
2602738|NCT00201643|6389067|P2|STARTED|Overall Study||214
2602739|NCT00201643|6389068|P1|STARTED|Overall Study||223
2602740|NCT00201448|6389092|P2|NOT COMPLETED|Overall Study||0
2602741|NCT00201448|6389093|P1|NOT COMPLETED|Overall Study||0
2602742|NCT00201448|6389092|P2|COMPLETED|Overall Study||40
2602743|NCT00201448|6389093|P1|COMPLETED|Overall Study||42
2602744|NCT00201448|6389092|P2|STARTED|Overall Study||40
2602745|NCT00201448|6389093|P1|STARTED|Overall Study||42
2602746|NCT00201409|6389103|P2|NOT COMPLETED|Overall Study||1
2602747|NCT00201409|6389104|P1|NOT COMPLETED|Overall Study||1
2602748|NCT00201409|6389103|P2|COMPLETED|Overall Study||66
2602749|NCT00201409|6389104|P1|COMPLETED|Overall Study||64
2602750|NCT00201409|6389103|P2|STARTED|Overall Study||67
2602751|NCT00201409|6389104|P1|STARTED|Overall Study||65
2602752|NCT00201240|6389114|P1|NOT COMPLETED|Overall Study||3
2602753|NCT00201240|6389114|P1|COMPLETED|Overall Study||44
2602754|NCT00201240|6389114|P1|STARTED|Overall Study||47
2602755|NCT00201201|6389132|P2|NOT COMPLETED|Overall Study||7
2602756|NCT00201201|6389133|P1|NOT COMPLETED|Overall Study||5
2602757|NCT00201201|6389132|P2|COMPLETED|Overall Study||66
2602758|NCT00201201|6389133|P1|COMPLETED|Overall Study||82
2602759|NCT00201201|6389132|P2|STARTED|Overall Study||73
2602760|NCT00201201|6389133|P1|STARTED|Overall Study||87
2602761|NCT00201123|6389152|P3|NOT COMPLETED|Overall Study||9
2602762|NCT00201123|6389153|P2|NOT COMPLETED|Overall Study||4
2602763|NCT00201123|6389154|P1|NOT COMPLETED|Overall Study||6
2602764|NCT00201123|6389152|P3|COMPLETED|Overall Study||23
2602765|NCT00201123|6389153|P2|COMPLETED|Overall Study||28
2602766|NCT00201123|6389154|P1|COMPLETED|Overall Study||26
2602767|NCT00201123|6389152|P3|Did Not Meet Continuation Criteria|Overall Study||5
2602768|NCT00201123|6389153|P2|Did Not Meet Continuation Criteria|Overall Study||0
2602769|NCT00201123|6389154|P1|Did Not Meet Continuation Criteria|Overall Study||2
2602770|NCT00201123|6389152|P3|STARTED|Overall Study||32
2602771|NCT00201123|6389153|P2|STARTED|Overall Study||32
2602772|NCT00201123|6389154|P1|STARTED|Overall Study||32
2602773|NCT00201006|6389171|P3|NOT COMPLETED|Overall Study||4
2602774|NCT00201006|6389172|P2|NOT COMPLETED|Overall Study||2
2602775|NCT00201006|6389173|P1|NOT COMPLETED|Overall Study||8
2602776|NCT00201006|6389171|P3|COMPLETED|Overall Study||75
2602777|NCT00201006|6389172|P2|COMPLETED|Overall Study||70
2602778|NCT00201006|6389173|P1|COMPLETED|Overall Study||75
2602779|NCT00201006|6389171|P3|STARTED|Overall Study||79
2602780|NCT00201006|6389172|P2|STARTED|Overall Study||72
2602781|NCT00201006|6389173|P1|STARTED|Overall Study||83
2602782|NCT00200967|6389183|P2|NOT COMPLETED|Run-out Period||0
2602783|NCT00200967|6389184|P1|NOT COMPLETED|Run-out Period||1
2602784|NCT00200967|6389183|P2|COMPLETED|Run-out Period||41
2602785|NCT00200967|6389184|P1|COMPLETED|Run-out Period||34
2602786|NCT00200967|6389183|P2|STARTED|Run-out Period||41
2602787|NCT00200967|6389184|P1|STARTED|Run-out Period||35
2602788|NCT00200967|6389183|P2|NOT COMPLETED|Second Treatment Period||2
2602789|NCT00200967|6389184|P1|NOT COMPLETED|Second Treatment Period||1
2602790|NCT00200967|6389183|P2|COMPLETED|Second Treatment Period||41
2602791|NCT00200967|6389184|P1|COMPLETED|Second Treatment Period||35
2602792|NCT00200967|6389183|P2|STARTED|Second Treatment Period||43
2602793|NCT00200967|6389184|P1|STARTED|Second Treatment Period||36
2602794|NCT00200967|6389183|P2|NOT COMPLETED|Wash-out Period||1
2602795|NCT00200967|6389184|P1|NOT COMPLETED|Wash-out Period||0
2602796|NCT00200967|6389183|P2|COMPLETED|Wash-out Period||43
2602797|NCT00200967|6389184|P1|COMPLETED|Wash-out Period||36
2602798|NCT00200967|6389183|P2|STARTED|Wash-out Period||44
2602799|NCT00200967|6389184|P1|STARTED|Wash-out Period||36
2602800|NCT00200967|6389183|P2|NOT COMPLETED|First Treatment Period||1
2602801|NCT00200967|6389184|P1|NOT COMPLETED|First Treatment Period||6
2602802|NCT00200967|6389183|P2|COMPLETED|First Treatment Period||44
2602803|NCT00200967|6389184|P1|COMPLETED|First Treatment Period||36
2602804|NCT00200967|6389183|P2|First Treatment Period|First Treatment Period||45
2602805|NCT00200967|6389184|P1|First Treatment Period|First Treatment Period||42
2602806|NCT00200967|6389183|P2|STARTED|First Treatment Period||45
2602807|NCT00200967|6389184|P1|STARTED|First Treatment Period||42
2602808|NCT00200902|6389215|P3|NOT COMPLETED|Overall Study||8
2602809|NCT00200902|6389216|P2|NOT COMPLETED|Overall Study||3
2602810|NCT00200902|6389217|P1|NOT COMPLETED|Overall Study||10
2602811|NCT00200902|6389215|P3|COMPLETED|Overall Study||12
2602812|NCT00200902|6389216|P2|COMPLETED|Overall Study||26
2602813|NCT00200902|6389217|P1|COMPLETED|Overall Study||29
2602814|NCT00200902|6389215|P3|STARTED|Overall Study||20
2602815|NCT00200902|6389216|P2|STARTED|Overall Study||29
2602816|NCT00200902|6389217|P1|STARTED|Overall Study||39
2602817|NCT00200850|6389234|P3|NOT COMPLETED|Overall Study||6
2602818|NCT00200850|6389235|P2|NOT COMPLETED|Overall Study||1
2602819|NCT00200850|6389236|P1|NOT COMPLETED|Overall Study||3
2602820|NCT00200850|6389234|P3|COMPLETED|Overall Study||5
2602821|NCT00200850|6389235|P2|COMPLETED|Overall Study||9
2602822|NCT00200850|6389236|P1|COMPLETED|Overall Study||7
2602823|NCT00200850|6389234|P3|STARTED|Overall Study||11
2602824|NCT00200850|6389235|P2|STARTED|Overall Study||10
2602825|NCT00200850|6389236|P1|STARTED|Overall Study||10
2602826|NCT00200785|6389246|P2|NOT COMPLETED|Second Intervention||0
2602827|NCT00200785|6389247|P1|NOT COMPLETED|Second Intervention||0
2602828|NCT00200785|6389246|P2|COMPLETED|Second Intervention||6
2602829|NCT00200785|6389247|P1|COMPLETED|Second Intervention||9
2602830|NCT00200785|6389246|P2|STARTED|Second Intervention||6
2602831|NCT00200785|6389247|P1|STARTED|Second Intervention||9
2602832|NCT00200785|6389246|P2|NOT COMPLETED|Washout Period of 1 Week||0
2602833|NCT00200785|6389247|P1|NOT COMPLETED|Washout Period of 1 Week||0
2602834|NCT00200785|6389246|P2|COMPLETED|Washout Period of 1 Week||6
2602835|NCT00200785|6389247|P1|COMPLETED|Washout Period of 1 Week||9
2602836|NCT00200785|6389246|P2|STARTED|Washout Period of 1 Week||6
2602837|NCT00200785|6389247|P1|STARTED|Washout Period of 1 Week||9
2602838|NCT00200785|6389246|P2|NOT COMPLETED|First Intervention||0
2602839|NCT00200785|6389247|P1|NOT COMPLETED|First Intervention||0
2602840|NCT00200785|6389246|P2|COMPLETED|First Intervention||6
2602841|NCT00200785|6389247|P1|COMPLETED|First Intervention||9
2602842|NCT00200785|6389246|P2|STARTED|First Intervention||6
2602843|NCT00200785|6389247|P1|STARTED|First Intervention||9
2602844|NCT00200356|6389257|P2|NOT COMPLETED|Overall Study||7
2602845|NCT00200356|6389258|P1|NOT COMPLETED|Overall Study||8
2602846|NCT00200356|6389257|P2|COMPLETED|Overall Study||195
2602847|NCT00200356|6389258|P1|COMPLETED|Overall Study||191
2602848|NCT00200356|6389257|P2|Safety Analysis Set|Overall Study||198
2602849|NCT00200356|6389258|P1|Safety Analysis Set|Overall Study||194
2602850|NCT00200356|6389257|P2|STARTED|Overall Study||202
2602851|NCT00200356|6389258|P1|STARTED|Overall Study||199
2602852|NCT00200343|6389285|P3|NOT COMPLETED|Overall Study||13
2602853|NCT00200343|6389286|P2|NOT COMPLETED|Overall Study||8
2602854|NCT00200343|6389287|P1|NOT COMPLETED|Overall Study||16
2602855|NCT00200343|6389285|P3|COMPLETED|Overall Study||184
2602856|NCT00200343|6389286|P2|COMPLETED|Overall Study||192
2602857|NCT00200343|6389287|P1|COMPLETED|Overall Study||183
2602858|NCT00200343|6389285|P3|STARTED|Overall Study||197
2602859|NCT00200343|6389286|P2|STARTED|Overall Study||200
2602860|NCT00200343|6389287|P1|STARTED|Overall Study||199
2602861|NCT00200161|6389312|P2|NOT COMPLETED|Overall Study||0
2602862|NCT00200161|6389313|P1|NOT COMPLETED|Overall Study||0
2602863|NCT00200161|6389312|P2|COMPLETED|Overall Study||42
2602864|NCT00200161|6389313|P1|COMPLETED|Overall Study||43
2602865|NCT00200161|6389312|P2|STARTED|Overall Study||42
2602866|NCT00200161|6389313|P1|STARTED|Overall Study||43
2602867|NCT00200057|6389325|P1|NOT COMPLETED|Overall Study||9
2602868|NCT00200057|6389325|P1|COMPLETED|Overall Study||111
2602869|NCT00200057|6389325|P1|12 Month Follow-up|Overall Study||111
2602870|NCT00200057|6389325|P1|6 Month Follow-up|Overall Study||114
2602871|NCT00200057|6389325|P1|3 Month Follow-up|Overall Study||116
2602872|NCT00200057|6389325|P1|1 Month Follow-up|Overall Study||117
2602873|NCT00200057|6389325|P1|STARTED|Overall Study||120
2602874|NCT00199914|6389337|P2|NOT COMPLETED|Overall Study||6
2602875|NCT00199914|6389338|P1|NOT COMPLETED|Overall Study||3
2602876|NCT00199914|6389337|P2|COMPLETED|Overall Study||54
2602877|NCT00199914|6389338|P1|COMPLETED|Overall Study||50
2602878|NCT00199914|6389337|P2|STARTED|Overall Study||60
2602879|NCT00199914|6389338|P1|STARTED|Overall Study||53
2602880|NCT00199875|6389349|P5|NOT COMPLETED|Overall Study||1
2602881|NCT00199875|6389350|P4|NOT COMPLETED|Overall Study||0
2602882|NCT00199875|6389351|P3|NOT COMPLETED|Overall Study||0
2602883|NCT00199875|6389352|P2|NOT COMPLETED|Overall Study||0
2602884|NCT00199875|6389353|P1|NOT COMPLETED|Overall Study||0
2602885|NCT00199875|6389349|P5|COMPLETED|Overall Study||2
2602886|NCT00199875|6389350|P4|COMPLETED|Overall Study||3
2602887|NCT00199875|6389351|P3|COMPLETED|Overall Study||6
2602888|NCT00199875|6389352|P2|COMPLETED|Overall Study||3
2602889|NCT00199875|6389353|P1|COMPLETED|Overall Study||3
2602890|NCT00199875|6389349|P5|STARTED|Overall Study||3
2602891|NCT00199875|6389350|P4|STARTED|Overall Study||3
2602892|NCT00199875|6389351|P3|STARTED|Overall Study||6
2602893|NCT00199875|6389352|P2|STARTED|Overall Study||3
2602894|NCT00199875|6389353|P1|STARTED|Overall Study||3
2602895|NCT00199381|6389375|P1|NOT COMPLETED|Overall Study||504
2602896|NCT00199381|6389375|P1|COMPLETED|Overall Study|Premature study termination by the Sponsor.|0
2602897|NCT00199381|6389375|P1|STARTED|Overall Study||504
2602898|NCT00198822|6389382|P3|NOT COMPLETED|Overall Study||21
2602899|NCT00198822|6389383|P2|NOT COMPLETED|Overall Study||20
2602900|NCT00198822|6389384|P1|NOT COMPLETED|Overall Study||14
2602901|NCT00198822|6389382|P3|COMPLETED|Overall Study|No. of consented pregnant women in beta-catorene arm with vital status known at 12 weeks postpartum|19998
2602902|NCT00198822|6389383|P2|COMPLETED|Overall Study|No. of consented pregnant women in vitamin A arm with vital status known at 12 weeks postpartum|19806
2602903|NCT00198822|6389384|P1|COMPLETED|Overall Study|No. of consented pregnant women in placebo arm with vital status known at 12 weeks postpartum|19862
2602904|NCT00198822|6389382|P3|STARTED|Overall Study|No. of consenting pregnant women in the beta-catorene arm of trial cohort|20019
2602905|NCT00198822|6389383|P2|STARTED|Overall Study|No. of consenting pregnant women in the vitamin A arm of trial cohort|19826
2602906|NCT00198822|6389384|P1|STARTED|Overall Study|No. of consenting pregnant women in the placebo arm of trial cohort|19876
2602907|NCT00198133|6389403|P2|NOT COMPLETED|Overall Study||8
2602908|NCT00198133|6389404|P1|NOT COMPLETED|Overall Study||5
2602909|NCT00198133|6389403|P2|COMPLETED|Overall Study||3
2602910|NCT00198133|6389404|P1|COMPLETED|Overall Study||11
2602911|NCT00198133|6389403|P2|STARTED|Overall Study||11
2602912|NCT00198133|6389404|P1|STARTED|Overall Study||16
2602913|NCT00198107|6389416|P3|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||2
2602914|NCT00198107|6389417|P2|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
2602915|NCT00198107|6389418|P1|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
2602916|NCT00198107|6389416|P3|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||8
2602917|NCT00198107|6389417|P2|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
2602918|NCT00198107|6389418|P1|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
2602919|NCT00198107|6389416|P3|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||10
2602920|NCT00198107|6389417|P2|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||0
2602921|NCT00198107|6389418|P1|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||0
2602922|NCT00198107|6389416|P3|NOT COMPLETED|Double-Blind Period||0
2602923|NCT00198107|6389417|P2|NOT COMPLETED|Double-Blind Period||3
2602924|NCT00198107|6389418|P1|NOT COMPLETED|Double-Blind Period||6
2602925|NCT00198107|6389416|P3|COMPLETED|Double-Blind Period||0
2602926|NCT00198107|6389417|P2|COMPLETED|Double-Blind Period||37
2602927|NCT00198107|6389418|P1|COMPLETED|Double-Blind Period||35
2602928|NCT00198107|6389416|P3|1 or More Follow-up Visits|Double-Blind Period||0
2602929|NCT00198107|6389417|P2|1 or More Follow-up Visits|Double-Blind Period||38
2602930|NCT00198107|6389418|P1|1 or More Follow-up Visits|Double-Blind Period||40
2602931|NCT00198107|6389416|P3|STARTED|Double-Blind Period||0
2602932|NCT00198107|6389417|P2|STARTED|Double-Blind Period||40
2602933|NCT00198107|6389418|P1|STARTED|Double-Blind Period||41
2602934|NCT00198081|6389455|P2|NOT COMPLETED|Overall Study||0
2602935|NCT00198081|6389456|P1|NOT COMPLETED|Overall Study||1
2602936|NCT00198081|6389455|P2|COMPLETED|Overall Study|No enrollment on this arm.|0
2602937|NCT00198081|6389456|P1|COMPLETED|Overall Study||4
2602938|NCT00198081|6389455|P2|STARTED|Overall Study|No enrollment on this arm.|0
2602939|NCT00198081|6389456|P1|STARTED|Overall Study|Eight (8) persons consented to participate but 3 withdrew prior to beginning protocol treatment.|5
2602940|NCT00198042|6389482|P1|NOT COMPLETED|Overall Study||0
2602941|NCT00198042|6389482|P1|COMPLETED|Overall Study||18
2602942|NCT00198042|6389482|P1|STARTED|Overall Study||18
2602943|NCT00198029|6389486|P1|NOT COMPLETED|Overall Study||4
2602944|NCT00198029|6389486|P1|COMPLETED|Overall Study||28
2602945|NCT00198029|6389486|P1|STARTED|Overall Study||32
2602946|NCT00197496|6389493|P2|NOT COMPLETED|Follow-up||1
2602947|NCT00197496|6389494|P1|NOT COMPLETED|Follow-up||2
2602948|NCT00197496|6389493|P2|COMPLETED|Follow-up||4
2602949|NCT00197496|6389494|P1|COMPLETED|Follow-up||10
2602950|NCT00197496|6389493|P2|STARTED|Follow-up||5
2602951|NCT00197496|6389494|P1|STARTED|Follow-up||12
2602952|NCT00197496|6389493|P2|NOT COMPLETED|Baseline to Discharge||2
2602953|NCT00197496|6389494|P1|NOT COMPLETED|Baseline to Discharge||2
2602954|NCT00197496|6389493|P2|COMPLETED|Baseline to Discharge||5
2602955|NCT00197496|6389494|P1|COMPLETED|Baseline to Discharge||12
2602956|NCT00197496|6389493|P2|STARTED|Baseline to Discharge||7
2602957|NCT00197496|6389494|P1|STARTED|Baseline to Discharge||14
2602958|NCT00197392|6389509|P2|NOT COMPLETED|Overall Study||86
2602959|NCT00197392|6389510|P1|NOT COMPLETED|Overall Study||88
2602960|NCT00197392|6389509|P2|COMPLETED|Overall Study||134
2602961|NCT00197392|6389510|P1|COMPLETED|Overall Study||126
2602962|NCT00197392|6389509|P2|Per Protocol|Overall Study||134
2602963|NCT00197392|6389510|P1|Per Protocol|Overall Study||126
2602964|NCT00197392|6389509|P2|Evaluable|Overall Study||181
2602965|NCT00197392|6389510|P1|Evaluable|Overall Study||176
2602966|NCT00197392|6389509|P2|Modified Intent to Treat|Overall Study||210
2602967|NCT00197392|6389510|P1|Modified Intent to Treat|Overall Study||209
2602968|NCT00197392|6389509|P2|Safety Population|Overall Study||220
2602969|NCT00197392|6389510|P1|Safety Population|Overall Study||214
2602970|NCT00197392|6389509|P2|STARTED|Overall Study||220
2602971|NCT00197392|6389510|P1|STARTED|Overall Study||214
2602972|NCT00197236|6389542|P3|NOT COMPLETED|Overall Study||23
2602973|NCT00197236|6389543|P2|NOT COMPLETED|Overall Study||17
2602974|NCT00197236|6389544|P1|NOT COMPLETED|Overall Study||14
2602975|NCT00197236|6389542|P3|COMPLETED|Overall Study||109
2602976|NCT00197236|6389543|P2|COMPLETED|Overall Study||110
2602977|NCT00197236|6389544|P1|COMPLETED|Overall Study||121
2602978|NCT00197236|6389542|P3|STARTED|Overall Study||132
2602979|NCT00197236|6389543|P2|STARTED|Overall Study||127
2602980|NCT00197236|6389544|P1|STARTED|Overall Study||135
2602981|NCT00197184|6389593|P2|NOT COMPLETED|Overall Study||0
2602982|NCT00197184|6389594|P1|NOT COMPLETED|Overall Study||0
2602983|NCT00197184|6389593|P2|COMPLETED|Overall Study||137
2602984|NCT00197184|6389594|P1|COMPLETED|Overall Study||139
2602985|NCT00197184|6389593|P2|STARTED|Overall Study||137
2602986|NCT00197184|6389594|P1|STARTED|Overall Study||139
2602987|NCT00197145|6389618|P2|NOT COMPLETED|Period 2 : Open Label Phase||0
2602988|NCT00197145|6389619|P1|NOT COMPLETED|Period 2 : Open Label Phase||10
2602989|NCT00197145|6389618|P2|COMPLETED|Period 2 : Open Label Phase||0
2602990|NCT00197145|6389619|P1|COMPLETED|Period 2 : Open Label Phase||0
2602991|NCT00197145|6389618|P2|STARTED|Period 2 : Open Label Phase||0
2602992|NCT00197145|6389619|P1|STARTED|Period 2 : Open Label Phase||10
2602993|NCT00197145|6389618|P2|NOT COMPLETED|Period 1: Randomized Treatment Phase||11
2602994|NCT00197145|6389619|P1|NOT COMPLETED|Period 1: Randomized Treatment Phase||13
2602995|NCT00197145|6389618|P2|COMPLETED|Period 1: Randomized Treatment Phase||0
2602996|NCT00197145|6389619|P1|COMPLETED|Period 1: Randomized Treatment Phase||0
2602997|NCT00197145|6389618|P2|STARTED|Period 1: Randomized Treatment Phase||11
2602998|NCT00197145|6389619|P1|STARTED|Period 1: Randomized Treatment Phase||13
2602999|NCT00197119|6389677|P2|NOT COMPLETED|Year 10||0
2603000|NCT00197119|6389678|P1|NOT COMPLETED|Year 10||0
2603001|NCT00197119|6389677|P2|COMPLETED|Year 10||108
2603002|NCT00197119|6389678|P1|COMPLETED|Year 10||120
2603003|NCT00197119|6389677|P2|STARTED|Year 10|Six subjects participating in the Year 9 time point did not return for the current time point.|108
2603004|NCT00197119|6389678|P1|STARTED|Year 10|One subject participating in the Year 9 time point did not return for the current time point.|120
2603005|NCT00197119|6389677|P2|NOT COMPLETED|Year 9||0
2603006|NCT00197119|6389678|P1|NOT COMPLETED|Year 9||0
2603007|NCT00197119|6389677|P2|COMPLETED|Year 9||114
2603008|NCT00197119|6389678|P1|COMPLETED|Year 9||121
2603009|NCT00197119|6389677|P2|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|114
2603010|NCT00197119|6389678|P1|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|121
2603011|NCT00197119|6389677|P2|NOT COMPLETED|Year 8||0
2603012|NCT00197119|6389678|P1|NOT COMPLETED|Year 8||0
2603013|NCT00197119|6389677|P2|COMPLETED|Year 8||115
2603014|NCT00197119|6389678|P1|COMPLETED|Year 8||122
2603015|NCT00197119|6389677|P2|STARTED|Year 8|One additional subject (compared to Year 7) participated in the current follow-up time point.|115
2603016|NCT00197119|6389678|P1|STARTED|Year 8||122
2603017|NCT00197119|6389677|P2|NOT COMPLETED|Year 7||0
2603018|NCT00197119|6389678|P1|NOT COMPLETED|Year 7||0
2603019|NCT00197119|6389677|P2|COMPLETED|Year 7||114
2603020|NCT00197119|6389678|P1|COMPLETED|Year 7||122
2603021|NCT00197119|6389677|P2|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|114
2603022|NCT00197119|6389678|P1|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|122
2603023|NCT00197119|6389677|P2|NOT COMPLETED|Year 6||0
2603024|NCT00197119|6389678|P1|NOT COMPLETED|Year 6||0
2603025|NCT00197119|6389677|P2|COMPLETED|Year 6||118
2603026|NCT00197119|6389678|P1|COMPLETED|Year 6||126
2603027|NCT00197119|6389677|P2|STARTED|Year 6||118
2603028|NCT00197119|6389678|P1|STARTED|Year 6||126
2603029|NCT00197106|6389690|P3|NOT COMPLETED|Overall Treatment Period||6
2603030|NCT00197106|6389691|P2|NOT COMPLETED|Overall Treatment Period||1
2603031|NCT00197106|6389692|P1|NOT COMPLETED|Overall Treatment Period||0
2603032|NCT00197106|6389690|P3|COMPLETED|Overall Treatment Period||74
2603033|NCT00197106|6389691|P2|COMPLETED|Overall Treatment Period||77
2603034|NCT00197106|6389692|P1|COMPLETED|Overall Treatment Period||0
2603035|NCT00197106|6389690|P3|STARTED|Overall Treatment Period||80
2603036|NCT00197106|6389691|P2|STARTED|Overall Treatment Period||78
2603037|NCT00197106|6389692|P1|STARTED|Overall Treatment Period||0
2603038|NCT00197106|6389690|P3|NOT COMPLETED|4-Week Run-In Period||0
2603039|NCT00197106|6389691|P2|NOT COMPLETED|4-Week Run-In Period||0
2603040|NCT00197106|6389692|P1|NOT COMPLETED|4-Week Run-In Period||99
2603041|NCT00197106|6389690|P3|COMPLETED|4-Week Run-In Period||0
2603042|NCT00197106|6389691|P2|COMPLETED|4-Week Run-In Period||0
2603043|NCT00197106|6389692|P1|COMPLETED|4-Week Run-In Period||158
2603044|NCT00197106|6389690|P3|STARTED|4-Week Run-In Period||0
2603045|NCT00197106|6389691|P2|STARTED|4-Week Run-In Period||0
2603046|NCT00197106|6389692|P1|STARTED|4-Week Run-In Period||257
2603047|NCT00197028|6389728|P2|NOT COMPLETED|Overall Study||21
2603048|NCT00197028|6389729|P1|NOT COMPLETED|Overall Study||16
2603049|NCT00197028|6389728|P2|COMPLETED|Overall Study||86
2603050|NCT00197028|6389729|P1|COMPLETED|Overall Study||91
2603051|NCT00197028|6389728|P2|STARTED|Overall Study||107
2603052|NCT00197028|6389729|P1|STARTED|Overall Study||107
2603053|NCT00197015|6389772|P3|NOT COMPLETED|Overall Study||77
2603054|NCT00197015|6389773|P2|NOT COMPLETED|Overall Study||89
2603055|NCT00197015|6389774|P1|NOT COMPLETED|Overall Study||50
2603056|NCT00197015|6389772|P3|COMPLETED|Overall Study||385
2603057|NCT00197015|6389773|P2|COMPLETED|Overall Study||366
2603058|NCT00197015|6389774|P1|COMPLETED|Overall Study||274
2603059|NCT00197015|6389772|P3|STARTED|Overall Study||462
2603060|NCT00197015|6389773|P2|STARTED|Overall Study||455
2603061|NCT00197015|6389774|P1|STARTED|Overall Study||324
2603062|NCT00197002|6389833|P3|NOT COMPLETED|Overall Study||17
2603063|NCT00197002|6389834|P2|NOT COMPLETED|Overall Study||18
2603064|NCT00197002|6389835|P1|NOT COMPLETED|Overall Study||22
2603065|NCT00197002|6389833|P3|COMPLETED|Overall Study||132
2603066|NCT00197002|6389834|P2|COMPLETED|Overall Study||119
2603067|NCT00197002|6389835|P1|COMPLETED|Overall Study||125
2603068|NCT00197002|6389833|P3|STARTED|Overall Study||149
2603069|NCT00197002|6389834|P2|STARTED|Overall Study||137
2603070|NCT00197002|6389835|P1|STARTED|Overall Study||147
2603071|NCT00196976|6389886|P14|NOT COMPLETED|Booster Study||0
2603072|NCT00196976|6389887|P13|NOT COMPLETED|Booster Study||0
2603073|NCT00196976|6389888|P12|NOT COMPLETED|Booster Study||2
2603074|NCT00196976|6389889|P11|NOT COMPLETED|Booster Study||2
2603075|NCT00196976|6389890|P10|NOT COMPLETED|Booster Study||0
2603076|NCT00196976|6389891|P9|NOT COMPLETED|Booster Study||0
2603077|NCT00196976|6389892|P8|NOT COMPLETED|Booster Study||0
2603078|NCT00196976|6389893|P7|NOT COMPLETED|Booster Study||0
2603079|NCT00196976|6389894|P6|NOT COMPLETED|Booster Study||0
2603080|NCT00196976|6389895|P5|NOT COMPLETED|Booster Study||0
2603081|NCT00196976|6389896|P4|NOT COMPLETED|Booster Study||0
2603082|NCT00196976|6389897|P3|NOT COMPLETED|Booster Study||0
2603083|NCT00196976|6389898|P2|NOT COMPLETED|Booster Study||0
2603084|NCT00196976|6389899|P1|NOT COMPLETED|Booster Study||0
2603085|NCT00196976|6389886|P14|COMPLETED|Booster Study||43
2603086|NCT00196976|6389887|P13|COMPLETED|Booster Study||45
2603087|NCT00196976|6389888|P12|COMPLETED|Booster Study||30
2603088|NCT00196976|6389889|P11|COMPLETED|Booster Study||31
2603089|NCT00196976|6389890|P10|COMPLETED|Booster Study||0
2603090|NCT00196976|6389891|P9|COMPLETED|Booster Study||0
2603091|NCT00196976|6389892|P8|COMPLETED|Booster Study||0
2603092|NCT00196976|6389893|P7|COMPLETED|Booster Study||0
2603093|NCT00196976|6389894|P6|COMPLETED|Booster Study||0
2603094|NCT00196976|6389895|P5|COMPLETED|Booster Study||0
2603095|NCT00196976|6389896|P4|COMPLETED|Booster Study||0
2603096|NCT00196976|6389897|P3|COMPLETED|Booster Study||0
2603097|NCT00196976|6389898|P2|COMPLETED|Booster Study||0
2603098|NCT00196976|6389899|P1|COMPLETED|Booster Study||0
2603099|NCT00196976|6389886|P14|STARTED|Booster Study||43
2603100|NCT00196976|6389887|P13|STARTED|Booster Study||45
2603101|NCT00196976|6389888|P12|STARTED|Booster Study||32
2603102|NCT00196976|6389889|P11|STARTED|Booster Study||33
2603103|NCT00196976|6389890|P10|STARTED|Booster Study||0
2603104|NCT00196976|6389891|P9|STARTED|Booster Study||0
2603105|NCT00196976|6389892|P8|STARTED|Booster Study||0
2603106|NCT00196976|6389893|P7|STARTED|Booster Study||0
2603107|NCT00196976|6389894|P6|STARTED|Booster Study||0
2603108|NCT00196976|6389895|P5|STARTED|Booster Study||0
2603109|NCT00196976|6389896|P4|STARTED|Booster Study||0
2603110|NCT00196976|6389897|P3|STARTED|Booster Study||0
2603111|NCT00196976|6389898|P2|STARTED|Booster Study||0
2603112|NCT00196976|6389899|P1|STARTED|Booster Study||0
2603113|NCT00196976|6389886|P14|NOT COMPLETED|Primary Study||0
2603114|NCT00196976|6389887|P13|NOT COMPLETED|Primary Study||0
2603115|NCT00196976|6389888|P12|NOT COMPLETED|Primary Study||0
2603116|NCT00196976|6389889|P11|NOT COMPLETED|Primary Study||0
2603117|NCT00196976|6389890|P10|NOT COMPLETED|Primary Study||1
2603118|NCT00196976|6389891|P9|NOT COMPLETED|Primary Study||0
2603119|NCT00196976|6389892|P8|NOT COMPLETED|Primary Study||3
2603120|NCT00196976|6389893|P7|NOT COMPLETED|Primary Study||0
2603121|NCT00196976|6389894|P6|NOT COMPLETED|Primary Study||2
2603122|NCT00196976|6389895|P5|NOT COMPLETED|Primary Study||3
2603123|NCT00196976|6389896|P4|NOT COMPLETED|Primary Study||1
2603124|NCT00196976|6389897|P3|NOT COMPLETED|Primary Study||4
2603125|NCT00196976|6389898|P2|NOT COMPLETED|Primary Study||1
2603126|NCT00196976|6389899|P1|NOT COMPLETED|Primary Study||1
2603127|NCT00196976|6389886|P14|COMPLETED|Primary Study||0
2603128|NCT00196976|6389887|P13|COMPLETED|Primary Study||0
2603129|NCT00196976|6389888|P12|COMPLETED|Primary Study||0
2603130|NCT00196976|6389889|P11|COMPLETED|Primary Study||0
2603131|NCT00196976|6389890|P10|COMPLETED|Primary Study||51
2603132|NCT00196976|6389891|P9|COMPLETED|Primary Study||52
2603133|NCT00196976|6389892|P8|COMPLETED|Primary Study||49
2603134|NCT00196976|6389893|P7|COMPLETED|Primary Study||50
2603135|NCT00196976|6389894|P6|COMPLETED|Primary Study||52
2603136|NCT00196976|6389895|P5|COMPLETED|Primary Study||37
2603137|NCT00196976|6389896|P4|COMPLETED|Primary Study||39
2603138|NCT00196976|6389897|P3|COMPLETED|Primary Study||37
2603139|NCT00196976|6389898|P2|COMPLETED|Primary Study||40
2603140|NCT00196976|6389899|P1|COMPLETED|Primary Study||38
2603141|NCT00196976|6389886|P14|STARTED|Primary Study||0
2603142|NCT00196976|6389887|P13|STARTED|Primary Study||0
2603143|NCT00196976|6389888|P12|STARTED|Primary Study||0
2603144|NCT00196976|6389889|P11|STARTED|Primary Study||0
2603145|NCT00196976|6389890|P10|STARTED|Primary Study||52
2603146|NCT00196976|6389891|P9|STARTED|Primary Study||52
2603147|NCT00196976|6389892|P8|STARTED|Primary Study||52
2603148|NCT00196976|6389893|P7|STARTED|Primary Study||50
2603149|NCT00196976|6389894|P6|STARTED|Primary Study||54
2603150|NCT00196976|6389895|P5|STARTED|Primary Study||40
2603151|NCT00196976|6389896|P4|STARTED|Primary Study||40
2603152|NCT00196976|6389897|P3|STARTED|Primary Study||41
2603153|NCT00196976|6389898|P2|STARTED|Primary Study||41
2603154|NCT00196976|6389899|P1|STARTED|Primary Study||39
2603155|NCT00196937|6390095|P3|NOT COMPLETED|Overall Study||7
2603156|NCT00196937|6390096|P2|NOT COMPLETED|Overall Study||5
2603157|NCT00196937|6390097|P1|NOT COMPLETED|Overall Study||9
2603158|NCT00196937|6390095|P3|COMPLETED|Overall Study||204
2603159|NCT00196937|6390096|P2|COMPLETED|Overall Study||221
2603160|NCT00196937|6390097|P1|COMPLETED|Overall Study||220
2603161|NCT00196937|6390095|P3|STARTED|Overall Study||211
2603162|NCT00196937|6390096|P2|STARTED|Overall Study||226
2603163|NCT00196937|6390097|P1|STARTED|Overall Study||229
2603164|NCT00196716|6390141|P1|NOT COMPLETED|0.3 mg/kg Period||0
2603165|NCT00196716|6390141|P1|COMPLETED|0.3 mg/kg Period||21
2603166|NCT00196716|6390141|P1|STARTED|0.3 mg/kg Period||21
2603167|NCT00196716|6390141|P1|NOT COMPLETED|1.0 mg/kg Period||0
2603168|NCT00196716|6390141|P1|COMPLETED|1.0 mg/kg Period||21
2603169|NCT00196716|6390141|P1|STARTED|1.0 mg/kg Period||21
2603170|NCT00196326|6390151|P1|NOT COMPLETED|Overall Study||986
2603171|NCT00196326|6390151|P1|COMPLETED|Overall Study||1249
2603172|NCT00196326|6390151|P1|Pregnancy Intent-to-treat Cohort (PITT)|Overall Study|Completed one cycle and 18-35 years old|1735
2603173|NCT00196326|6390151|P1|Safety Population|Overall Study|Treated participants|2185
2603174|NCT00196326|6390151|P1|STARTED|Overall Study|Took at least one dose of study medication|2235
2603175|NCT00196313|6390159|P2|NOT COMPLETED|Overall Study||8
2603176|NCT00196313|6390160|P1|NOT COMPLETED|Overall Study||11
2603177|NCT00196313|6390159|P2|COMPLETED|Overall Study||40
2603178|NCT00196313|6390160|P1|COMPLETED|Overall Study||36
2603179|NCT00196313|6390159|P2|STARTED|Overall Study||48
2603180|NCT00196313|6390160|P1|STARTED|Overall Study||47
2603181|NCT00196196|6390174|P1|NOT COMPLETED|Overall Study||7
2603182|NCT00196196|6390174|P1|COMPLETED|Overall Study||267
2603183|NCT00196196|6390174|P1|STARTED|Overall Study||274
2603184|NCT00196105|6390182|P3|NOT COMPLETED|Overall Study||7
2603185|NCT00196105|6390183|P2|NOT COMPLETED|Overall Study||5
2603186|NCT00196105|6390184|P1|NOT COMPLETED|Overall Study||4
2603187|NCT00196105|6390182|P3|COMPLETED|Overall Study||82
2603188|NCT00196105|6390183|P2|COMPLETED|Overall Study||83
2603189|NCT00196105|6390184|P1|COMPLETED|Overall Study||60
2603190|NCT00196105|6390182|P3|STARTED|Overall Study||89
2603191|NCT00196105|6390183|P2|STARTED|Overall Study||88
2603192|NCT00196105|6390184|P1|STARTED|Overall Study||64
2603193|NCT00195819|6390204|P2|NOT COMPLETED|Open-label||20
2603194|NCT00195819|6390205|P1|NOT COMPLETED|Open-label||0
2603195|NCT00195819|6390204|P2|COMPLETED|Open-label||62
2603196|NCT00195819|6390205|P1|COMPLETED|Open-label||0
2603197|NCT00195819|6390204|P2|STARTED|Open-label||82
2603198|NCT00195819|6390205|P1|STARTED|Open-label||0
2603199|NCT00195819|6390204|P2|NOT COMPLETED|Double-Blind||0
2603200|NCT00195819|6390205|P1|NOT COMPLETED|Double-Blind||2
2603201|NCT00195819|6390204|P2|COMPLETED|Double-Blind||38
2603202|NCT00195819|6390205|P1|COMPLETED|Double-Blind||42
2603203|NCT00195819|6390204|P2|STARTED|Double-Blind||38
2603204|NCT00195819|6390205|P1|STARTED|Double-Blind||44
2603205|NCT00195715|6390255|P1|NOT COMPLETED|Overall Study||377
2603206|NCT00195715|6390255|P1|COMPLETED|Overall Study||400
2603207|NCT00195715|6390255|P1|STARTED|Overall Study||777
2603208|NCT00195702|6390286|P6|NOT COMPLETED|Open-label Extension Phase||78
2603209|NCT00195702|6390287|P5|NOT COMPLETED|Open-label Extension Phase||78
2603210|NCT00195702|6390288|P4|NOT COMPLETED|Open-label Extension Phase||99
2603211|NCT00195702|6390289|P3|NOT COMPLETED|Open-label Extension Phase||0
2603212|NCT00195702|6390290|P2|NOT COMPLETED|Open-label Extension Phase||0
2603213|NCT00195702|6390291|P1|NOT COMPLETED|Open-label Extension Phase||0
2603214|NCT00195702|6390286|P6|COMPLETED|Open-label Extension Phase||56
2603215|NCT00195702|6390287|P5|COMPLETED|Open-label Extension Phase||80
2603216|NCT00195702|6390288|P4|COMPLETED|Open-label Extension Phase||66
2603217|NCT00195702|6390289|P3|COMPLETED|Open-label Extension Phase||0
2603218|NCT00195702|6390290|P2|COMPLETED|Open-label Extension Phase||0
2603219|NCT00195702|6390291|P1|COMPLETED|Open-label Extension Phase||0
2603220|NCT00195702|6390286|P6|STARTED|Open-label Extension Phase|6 subjects completed the double-blind phase but did not enter the open-label extension phase.|134
2603221|NCT00195702|6390287|P5|STARTED|Open-label Extension Phase|1 subject completed the double-blind phase but did not enter the open-label extension phase.|158
2603222|NCT00195702|6390288|P4|STARTED|Open-label Extension Phase|3 subjects completed the double-blind phase but did not enter the open-label extension phase.|165
2603223|NCT00195702|6390289|P3|STARTED|Open-label Extension Phase||0
2603224|NCT00195702|6390290|P2|STARTED|Open-label Extension Phase||0
2603225|NCT00195702|6390291|P1|STARTED|Open-label Extension Phase||0
2603226|NCT00195702|6390286|P6|NOT COMPLETED|Double-blind Phase||0
2603227|NCT00195702|6390287|P5|NOT COMPLETED|Double-blind Phase||0
2603228|NCT00195702|6390288|P4|NOT COMPLETED|Double-blind Phase||0
2603229|NCT00195702|6390289|P3|NOT COMPLETED|Double-blind Phase||60
2603230|NCT00195702|6390290|P2|NOT COMPLETED|Double-blind Phase||48
2603231|NCT00195702|6390291|P1|NOT COMPLETED|Double-blind Phase||44
2603232|NCT00195702|6390286|P6|COMPLETED|Double-blind Phase||0
2603233|NCT00195702|6390287|P5|COMPLETED|Double-blind Phase||0
2603234|NCT00195702|6390288|P4|COMPLETED|Double-blind Phase||0
2603235|NCT00195702|6390289|P3|COMPLETED|Double-blind Phase||140
2603236|NCT00195702|6390290|P2|COMPLETED|Double-blind Phase||159
2603237|NCT00195702|6390291|P1|COMPLETED|Double-blind Phase||168
2603238|NCT00195702|6390286|P6|STARTED|Double-blind Phase||0
2603239|NCT00195702|6390287|P5|STARTED|Double-blind Phase||0
2603240|NCT00195702|6390288|P4|STARTED|Double-blind Phase||0
2603241|NCT00195702|6390289|P3|STARTED|Double-blind Phase||200
2603242|NCT00195702|6390290|P2|STARTED|Double-blind Phase||207
2603243|NCT00195702|6390291|P1|STARTED|Double-blind Phase|For all groups, started indicates when the subjects entered the 52-week double-blind phase.|212
2603244|NCT00195676|6390355|P1|NOT COMPLETED|Period R - Retreatment 16 Weeks||35
2603245|NCT00195676|6390355|P1|COMPLETED|Period R - Retreatment 16 Weeks||490
2603330|NCT00195429|6390548|P1|STARTED|Overall Study||24
2603246|NCT00195676|6390355|P1|STARTED|Period R - Retreatment 16 Weeks|Number who entered from Period W, including those who did and did not relapse in that period.|525
2603247|NCT00195676|6390355|P1|NOT COMPLETED|Period W (Withdrawal) - No Treatment||608
2603248|NCT00195676|6390355|P1|COMPLETED|Period W (Withdrawal) - No Treatment|Non-completers may have entered Period R, whether or not they relapsed (PGA >= 3).|0
2603249|NCT00195676|6390355|P1|STARTED|Period W (Withdrawal) - No Treatment|Period O completers with a Physician's Global Assessment =<2 who continued into Periods W and R.|608
2603250|NCT00195676|6390355|P1|NOT COMPLETED|Period O - Open-label Treatment||606
2603251|NCT00195676|6390355|P1|COMPLETED|Period O - Open-label Treatment|254 Period O completers did not consent or were not eligible to continue into Period W and Period R.|862
2603252|NCT00195676|6390355|P1|STARTED|Period O - Open-label Treatment|Number receiving adalimumab in Period O (1 additional participant enrolled but did not receive drug)|1468
2603253|NCT00195663|6390369|P3|NOT COMPLETED|Open-Label Extension Period||97
2603254|NCT00195663|6390370|P2|NOT COMPLETED|Open-Label Extension Period||74
2603255|NCT00195663|6390371|P1|NOT COMPLETED|Open-Label Extension Period||76
2603256|NCT00195663|6390369|P3|COMPLETED|Open-Label Extension Period||86
2603257|NCT00195663|6390370|P2|COMPLETED|Open-Label Extension Period||85
2603258|NCT00195663|6390371|P1|COMPLETED|Open-Label Extension Period||79
2603259|NCT00195663|6390369|P3|STARTED|Open-Label Extension Period||183
2603260|NCT00195663|6390370|P2|STARTED|Open-Label Extension Period||159
2603261|NCT00195663|6390371|P1|STARTED|Open-Label Extension Period||155
2603262|NCT00195663|6390369|P3|NOT COMPLETED|2-year Double-blind Treatment Period||72
2603263|NCT00195663|6390370|P2|NOT COMPLETED|2-year Double-blind Treatment Period||108
2603264|NCT00195663|6390371|P1|NOT COMPLETED|2-year Double-blind Treatment Period||93
2603265|NCT00195663|6390369|P3|COMPLETED|2-year Double-blind Treatment Period||196
2603266|NCT00195663|6390370|P2|COMPLETED|2-year Double-blind Treatment Period||166
2603267|NCT00195663|6390371|P1|COMPLETED|2-year Double-blind Treatment Period||164
2603268|NCT00195663|6390369|P3|STARTED|2-year Double-blind Treatment Period||268
2603269|NCT00195663|6390370|P2|STARTED|2-year Double-blind Treatment Period||274
2603270|NCT00195663|6390371|P1|STARTED|2-year Double-blind Treatment Period||257
2603271|NCT00195650|6390465|P1|NOT COMPLETED|Overall Study||525
2603272|NCT00195650|6390465|P1|COMPLETED|Overall Study||321
2603273|NCT00195650|6390465|P1|STARTED|Overall Study|Participants who received at least 1 adalimumab dose in study;3 enrolled did not receive adalimumab.|846
2603274|NCT00195624|6390481|P2|NOT COMPLETED|Overall Study||0
2603275|NCT00195624|6390482|P1|NOT COMPLETED|Overall Study||0
2603276|NCT00195624|6390481|P2|COMPLETED|Overall Study||42
2603277|NCT00195624|6390482|P1|COMPLETED|Overall Study||5
2603278|NCT00195624|6390481|P2|STARTED|Overall Study||42
2603279|NCT00195624|6390482|P1|STARTED|Overall Study||5
2603280|NCT00195507|6390490|P2|NOT COMPLETED|Overall Study||118
2603281|NCT00195507|6390491|P1|NOT COMPLETED|Overall Study||99
2603282|NCT00195507|6390490|P2|COMPLETED|Overall Study||245
2603283|NCT00195507|6390491|P1|COMPLETED|Overall Study||258
2603284|NCT00195507|6390490|P2|STARTED|Overall Study||363
2603285|NCT00195507|6390491|P1|STARTED|Overall Study||357
2603286|NCT00195494|6390505|P6|NOT COMPLETED|Year 2||0
2603287|NCT00195494|6390506|P5|NOT COMPLETED|Year 2||0
2603288|NCT00195494|6390507|P4|NOT COMPLETED|Year 2||23
2603289|NCT00195494|6390508|P3|NOT COMPLETED|Year 2||18
2603290|NCT00195494|6390509|P2|NOT COMPLETED|Year 2||16
2603291|NCT00195494|6390510|P1|NOT COMPLETED|Year 2||7
2603292|NCT00195494|6390505|P6|COMPLETED|Year 2||0
2603293|NCT00195494|6390506|P5|COMPLETED|Year 2||0
2603294|NCT00195494|6390507|P4|COMPLETED|Year 2||76
2603295|NCT00195494|6390508|P3|COMPLETED|Year 2||93
2603296|NCT00195494|6390509|P2|COMPLETED|Year 2||74
2603297|NCT00195494|6390510|P1|COMPLETED|Year 2||104
2603298|NCT00195494|6390505|P6|STARTED|Year 2||0
2603299|NCT00195494|6390506|P5|STARTED|Year 2||0
2603300|NCT00195494|6390507|P4|STARTED|Year 2||99
2603301|NCT00195494|6390508|P3|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
2603302|NCT00195494|6390509|P2|STARTED|Year 2||90
2603303|NCT00195494|6390510|P1|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
2603304|NCT00195494|6390505|P6|NOT COMPLETED|Year 1||53
2603305|NCT00195494|6390506|P5|NOT COMPLETED|Year 1||79
2603306|NCT00195494|6390507|P4|NOT COMPLETED|Year 1||0
2603307|NCT00195494|6390508|P3|NOT COMPLETED|Year 1||0
2603308|NCT00195494|6390509|P2|NOT COMPLETED|Year 1||0
2603309|NCT00195494|6390510|P1|NOT COMPLETED|Year 1||0
2603310|NCT00195494|6390505|P6|COMPLETED|Year 1||221
2603311|NCT00195494|6390506|P5|COMPLETED|Year 1||189
2603312|NCT00195494|6390507|P4|COMPLETED|Year 1||0
2603313|NCT00195494|6390508|P3|COMPLETED|Year 1||0
2603314|NCT00195494|6390509|P2|COMPLETED|Year 1||0
2603315|NCT00195494|6390510|P1|COMPLETED|Year 1||0
2603316|NCT00195494|6390505|P6|STARTED|Year 1||274
2603317|NCT00195494|6390506|P5|STARTED|Year 1||268
2603318|NCT00195494|6390507|P4|STARTED|Year 1||0
2603319|NCT00195494|6390508|P3|STARTED|Year 1||0
2603320|NCT00195494|6390509|P2|STARTED|Year 1||0
2603321|NCT00195494|6390510|P1|STARTED|Year 1||0
2603322|NCT00195442|6390528|P1|NOT COMPLETED|Overall Study||136
2603323|NCT00195442|6390528|P1|COMPLETED|Overall Study||152
2603324|NCT00195442|6390528|P1|STARTED|Overall Study||288
2603325|NCT00195429|6390547|P2|NOT COMPLETED|Overall Study||5
2603326|NCT00195429|6390548|P1|NOT COMPLETED|Overall Study||5
2603327|NCT00195429|6390547|P2|COMPLETED|Overall Study||18
2603328|NCT00195429|6390548|P1|COMPLETED|Overall Study||19
2603329|NCT00195429|6390547|P2|STARTED|Overall Study||23
2603331|NCT00195403|6390556|P1|NOT COMPLETED|Overall Study||0
2603332|NCT00195403|6390556|P1|COMPLETED|Overall Study||1014
2603333|NCT00195403|6390556|P1|STARTED|Overall Study||1014
2603334|NCT00195351|6390564|P2|NOT COMPLETED|Overall Study||16
2603335|NCT00195351|6390565|P1|NOT COMPLETED|Overall Study||21
2603336|NCT00195351|6390564|P2|COMPLETED|Overall Study||215
2603337|NCT00195351|6390565|P1|COMPLETED|Overall Study||215
2603338|NCT00195351|6390564|P2|STARTED|Overall Study||231
2603339|NCT00195351|6390565|P1|STARTED|Overall Study||236
2603340|NCT00195338|6390575|P1|NOT COMPLETED|Overall Study||12
2603341|NCT00195338|6390575|P1|COMPLETED|Overall Study||13
2603342|NCT00195338|6390575|P1|STARTED|Overall Study||25
2603343|NCT00195273|6390585|P2|NOT COMPLETED|Overall Study||14
2603344|NCT00195273|6390586|P1|NOT COMPLETED|Overall Study||21
2603345|NCT00195273|6390585|P2|COMPLETED|Overall Study||16
2603346|NCT00195273|6390586|P1|COMPLETED|Overall Study||10
2603347|NCT00195273|6390585|P2|STARTED|Overall Study||30
2603348|NCT00195273|6390586|P1|STARTED|Overall Study||31
2603349|NCT00195260|6390600|P11|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||23
2603350|NCT00195260|6390601|P10|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||38
2603351|NCT00195260|6390602|P9|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||33
2603352|NCT00195260|6390603|P8|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2603353|NCT00195260|6390604|P7|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2603354|NCT00195260|6390605|P6|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2603355|NCT00195260|6390606|P5|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2603356|NCT00195260|6390607|P4|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2603357|NCT00195260|6390608|P3|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2603358|NCT00195260|6390609|P2|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2603359|NCT00195260|6390610|P1|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2603360|NCT00195260|6390600|P11|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||2
2603361|NCT00195260|6390601|P10|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2603362|NCT00195260|6390602|P9|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||4
2603363|NCT00195260|6390603|P8|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2603364|NCT00195260|6390604|P7|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2603365|NCT00195260|6390605|P6|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2603366|NCT00195260|6390606|P5|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2603367|NCT00195260|6390607|P4|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2603368|NCT00195260|6390608|P3|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2603369|NCT00195260|6390609|P2|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2603370|NCT00195260|6390610|P1|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2603371|NCT00195260|6390600|P11|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||25
2603372|NCT00195260|6390601|P10|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||38
2603373|NCT00195260|6390602|P9|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||37
2603374|NCT00195260|6390603|P8|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2603375|NCT00195260|6390604|P7|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2603376|NCT00195260|6390605|P6|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2603377|NCT00195260|6390606|P5|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2603378|NCT00195260|6390607|P4|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2603379|NCT00195260|6390608|P3|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2603380|NCT00195260|6390609|P2|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2603381|NCT00195260|6390610|P1|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
2603382|NCT00195260|6390600|P11|NOT COMPLETED|Part 1: Dose Escalation||0
2603383|NCT00195260|6390601|P10|NOT COMPLETED|Part 1: Dose Escalation||0
2603384|NCT00195260|6390602|P9|NOT COMPLETED|Part 1: Dose Escalation||0
2603385|NCT00195260|6390603|P8|NOT COMPLETED|Part 1: Dose Escalation||6
2603386|NCT00195260|6390604|P7|NOT COMPLETED|Part 1: Dose Escalation||10
2603387|NCT00195260|6390605|P6|NOT COMPLETED|Part 1: Dose Escalation||7
2603388|NCT00195260|6390606|P5|NOT COMPLETED|Part 1: Dose Escalation||7
2603389|NCT00195260|6390607|P4|NOT COMPLETED|Part 1: Dose Escalation||7
2603390|NCT00195260|6390608|P3|NOT COMPLETED|Part 1: Dose Escalation||6
2603391|NCT00195260|6390609|P2|NOT COMPLETED|Part 1: Dose Escalation||4
2603392|NCT00195260|6390610|P1|NOT COMPLETED|Part 1: Dose Escalation||4
2603393|NCT00195260|6390600|P11|COMPLETED|Part 1: Dose Escalation||0
2603394|NCT00195260|6390601|P10|COMPLETED|Part 1: Dose Escalation||0
2603395|NCT00195260|6390602|P9|COMPLETED|Part 1: Dose Escalation||0
2603396|NCT00195260|6390603|P8|COMPLETED|Part 1: Dose Escalation||0
2603397|NCT00195260|6390604|P7|COMPLETED|Part 1: Dose Escalation||0
2603398|NCT00195260|6390605|P6|COMPLETED|Part 1: Dose Escalation||0
2603399|NCT00195260|6390606|P5|COMPLETED|Part 1: Dose Escalation||0
2603400|NCT00195260|6390607|P4|COMPLETED|Part 1: Dose Escalation||0
2603401|NCT00195260|6390608|P3|COMPLETED|Part 1: Dose Escalation||0
2603402|NCT00195260|6390609|P2|COMPLETED|Part 1: Dose Escalation||0
2603403|NCT00195260|6390610|P1|COMPLETED|Part 1: Dose Escalation||0
2603404|NCT00195260|6390600|P11|STARTED|Part 1: Dose Escalation||0
2603405|NCT00195260|6390601|P10|STARTED|Part 1: Dose Escalation||0
2603406|NCT00195260|6390602|P9|STARTED|Part 1: Dose Escalation||0
2603407|NCT00195260|6390603|P8|STARTED|Part 1: Dose Escalation||6
2603408|NCT00195260|6390604|P7|STARTED|Part 1: Dose Escalation||10
2603409|NCT00195260|6390605|P6|STARTED|Part 1: Dose Escalation||7
2603410|NCT00195260|6390606|P5|STARTED|Part 1: Dose Escalation||7
2603411|NCT00195260|6390607|P4|STARTED|Part 1: Dose Escalation||7
2603412|NCT00195260|6390608|P3|STARTED|Part 1: Dose Escalation||6
2603413|NCT00195260|6390609|P2|STARTED|Part 1: Dose Escalation||4
2603414|NCT00195260|6390610|P1|STARTED|Part 1: Dose Escalation||4
2603415|NCT00195039|6390756|P1|NOT COMPLETED|Overall Study||0
2603416|NCT00195039|6390756|P1|COMPLETED|Overall Study||47
2603417|NCT00195039|6390756|P1|STARTED|Overall Study||47
2603418|NCT00195013|6390769|P2|NOT COMPLETED|Overall Study||1
2603419|NCT00195013|6390770|P1|NOT COMPLETED|Overall Study||2
2603420|NCT00195013|6390769|P2|COMPLETED|Overall Study||15
2603421|NCT00195013|6390770|P1|COMPLETED|Overall Study||12
2603422|NCT00195013|6390769|P2|STARTED|Overall Study||16
2603423|NCT00195013|6390770|P1|STARTED|Overall Study||14
2603424|NCT00194987|6390778|P2|NOT COMPLETED|Overall Study||3
2603425|NCT00194987|6390779|P1|NOT COMPLETED|Overall Study||0
2603426|NCT00194987|6390778|P2|COMPLETED|Overall Study|"3 women chose to withdraw because they felt the study was too inconvenient."|48
2603427|NCT00194987|6390779|P1|COMPLETED|Overall Study||51
2603428|NCT00194987|6390778|P2|STARTED|Overall Study||51
2603429|NCT00194987|6390779|P1|STARTED|Overall Study||51
2603430|NCT00194896|6390795|P4|NOT COMPLETED|Overall Study||12
2603431|NCT00194896|6390796|P3|NOT COMPLETED|Overall Study||6
2603432|NCT00194896|6390797|P2|NOT COMPLETED|Overall Study||5
2603433|NCT00194896|6390798|P1|NOT COMPLETED|Overall Study||11
2603434|NCT00194896|6390795|P4|COMPLETED|Overall Study||9
2603435|NCT00194896|6390796|P3|COMPLETED|Overall Study||7
2603436|NCT00194896|6390797|P2|COMPLETED|Overall Study||10
2603437|NCT00194896|6390798|P1|COMPLETED|Overall Study||4
2603438|NCT00194896|6390795|P4|STARTED|Overall Study||21
2603439|NCT00194896|6390796|P3|STARTED|Overall Study||13
2603440|NCT00194896|6390797|P2|STARTED|Overall Study||15
2603441|NCT00194896|6390798|P1|STARTED|Overall Study||15
2603442|NCT00194792|6390812|P1|NOT COMPLETED|Overall Study||1
2603443|NCT00194792|6390812|P1|COMPLETED|Overall Study||27
2603444|NCT00194792|6390812|P1|STARTED|Overall Study||28
2603445|NCT00194779|6390822|P1|NOT COMPLETED|Overall Study||0
2603446|NCT00194779|6390822|P1|COMPLETED|Overall Study||50
2603447|NCT00194779|6390822|P1|STARTED|Overall Study||50
2603448|NCT00194675|6390836|P2|NOT COMPLETED|Overall Study||2
2603449|NCT00194675|6390837|P1|NOT COMPLETED|Overall Study||5
2603450|NCT00194675|6390836|P2|COMPLETED|Overall Study||24
2603451|NCT00194675|6390837|P1|COMPLETED|Overall Study||22
2603452|NCT00194675|6390836|P2|STARTED|Overall Study||26
2603453|NCT00194675|6390837|P1|STARTED|Overall Study||27
2603454|NCT00194610|6390855|P2|NOT COMPLETED|Overall Study||0
2603455|NCT00194610|6390856|P1|NOT COMPLETED|Overall Study||0
2603456|NCT00194610|6390855|P2|COMPLETED|Overall Study||9
2603457|NCT00194610|6390856|P1|COMPLETED|Overall Study||11
2603458|NCT00194610|6390855|P2|STARTED|Overall Study||9
2603459|NCT00194610|6390856|P1|STARTED|Overall Study||11
2603460|NCT00194532|6390864|P2|NOT COMPLETED|Overall Study||0
2603461|NCT00194532|6390865|P1|NOT COMPLETED|Overall Study||0
2603462|NCT00194532|6390864|P2|COMPLETED|Overall Study||150
2603463|NCT00194532|6390865|P1|COMPLETED|Overall Study||150
2603464|NCT00194532|6390864|P2|STARTED|Overall Study||150
2603465|NCT00194532|6390865|P1|STARTED|Overall Study||150
2603466|NCT00194129|6390875|P2|NOT COMPLETED|Overall Study||13
2603467|NCT00194129|6390876|P1|NOT COMPLETED|Overall Study||10
2603468|NCT00194129|6390875|P2|COMPLETED|Overall Study||3
2603469|NCT00194129|6390876|P1|COMPLETED|Overall Study||5
2603470|NCT00194129|6390875|P2|STARTED|Overall Study||16
2603471|NCT00194129|6390876|P1|STARTED|Overall Study||15
2603472|NCT00194116|6390891|P2|NOT COMPLETED|Overall Study||15
2603473|NCT00194116|6390892|P1|NOT COMPLETED|Overall Study||13
2603474|NCT00194116|6390891|P2|COMPLETED|Overall Study||13
2603475|NCT00194116|6390892|P1|COMPLETED|Overall Study||13
2603476|NCT00194116|6390891|P2|STARTED|Overall Study||28
2603477|NCT00194116|6390892|P1|STARTED|Overall Study||26
2603478|NCT00194077|6390912|P2|NOT COMPLETED|Overall Study||30
2603479|NCT00194077|6390913|P1|NOT COMPLETED|Overall Study||24
2603480|NCT00194077|6390912|P2|COMPLETED|Overall Study|"Lack of efficacy:~hypomania n=17 Cycling n=6 Mania n=5 Mixed state n=1 Concern regarding tx n=1"|0
2603481|NCT00194077|6390913|P1|COMPLETED|Overall Study|"Lack of efficacy:~Hypomania n=12 Cycling n=5 Mixed state=4 Mania n=1"|6
2603482|NCT00194077|6390912|P2|STARTED|Overall Study||30
2603483|NCT00194077|6390913|P1|STARTED|Overall Study||30
2603484|NCT00194025|6390919|P1|NOT COMPLETED|Overall Study||5
2603485|NCT00194025|6390919|P1|COMPLETED|Overall Study|5 participants withdrew prematurely|15
2603486|NCT00194025|6390919|P1|STARTED|Overall Study|The intent-to-treat population received at least one dose of valproate semisodium.|20
2603487|NCT00194012|6390934|P2|NOT COMPLETED|Open Label Extension (OLE)||6
2603488|NCT00194012|6390935|P1|NOT COMPLETED|Open Label Extension (OLE)||5
2603489|NCT00194012|6390934|P2|COMPLETED|Open Label Extension (OLE)||15
2603490|NCT00194012|6390935|P1|COMPLETED|Open Label Extension (OLE)||17
2603491|NCT00194012|6390934|P2|STARTED|Open Label Extension (OLE)|Participants from placebo group started OLE (eligible even if randomized period not completed).|21
2603492|NCT00194012|6390935|P1|STARTED|Open Label Extension (OLE)|Participants from aripiprazole group started OLE (eligible even if randomized period not completed).|22
2603493|NCT00194012|6390934|P2|NOT COMPLETED|Randomized Phase||25
2603494|NCT00194012|6390935|P1|NOT COMPLETED|Randomized Phase||16
2603495|NCT00194012|6390934|P2|COMPLETED|Randomized Phase||6
2603496|NCT00194012|6390935|P1|COMPLETED|Randomized Phase||15
2603497|NCT00194012|6390934|P2|Received More Than One Dose|Randomized Phase||29
2603498|NCT00194012|6390935|P1|Received More Than One Dose|Randomized Phase||30
2603499|NCT00194012|6390934|P2|STARTED|Randomized Phase||31
2603500|NCT00194012|6390935|P1|STARTED|Randomized Phase||31
2603501|NCT00193609|6390971|P1|NOT COMPLETED|Overall Study||4
2603502|NCT00193609|6390971|P1|COMPLETED|Overall Study||44
2603503|NCT00193609|6390971|P1|STARTED|Overall Study||48
2603504|NCT00193596|6390978|P2|NOT COMPLETED|Overall Study||66
2603505|NCT00193596|6390979|P1|NOT COMPLETED|Overall Study||56
2603506|NCT00193596|6390978|P2|COMPLETED|Overall Study||39
2603507|NCT00193596|6390979|P1|COMPLETED|Overall Study||37
2603508|NCT00193596|6390978|P2|STARTED|Overall Study||105
2603509|NCT00193596|6390979|P1|STARTED|Overall Study||93
2603510|NCT00193492|6390989|P2|NOT COMPLETED|Overall Study||15
2603511|NCT00193492|6390990|P1|NOT COMPLETED|Overall Study||17
2603512|NCT00193492|6390989|P2|COMPLETED|Overall Study||14
2603513|NCT00193492|6390990|P1|COMPLETED|Overall Study||14
2603514|NCT00193492|6390989|P2|STARTED|Overall Study||29
2603515|NCT00193492|6390990|P1|STARTED|Overall Study||31
2603516|NCT00193479|6390998|P1|NOT COMPLETED|Maintenance Rituximab||0
2603517|NCT00193479|6390998|P1|COMPLETED|Maintenance Rituximab||44
2603518|NCT00193479|6390998|P1|STARTED|Maintenance Rituximab||44
2603519|NCT00193479|6390998|P1|NOT COMPLETED|Induction Chemotherapy||3
2603520|NCT00193479|6390998|P1|COMPLETED|Induction Chemotherapy||48
2603521|NCT00193479|6390998|P1|STARTED|Induction Chemotherapy||51
2603522|NCT00193453|6391002|P1|NOT COMPLETED|Overall Study||48
2603523|NCT00193453|6391002|P1|COMPLETED|Overall Study||21
2603524|NCT00193453|6391002|P1|STARTED|Overall Study||69
2603525|NCT00193427|6391008|P1|NOT COMPLETED|Overall Study||49
2603526|NCT00193427|6391008|P1|COMPLETED|Overall Study||26
2603527|NCT00193427|6391008|P1|STARTED|Overall Study||75
2603528|NCT00193414|6391015|P1|NOT COMPLETED|Overall Study||58
2603529|NCT00193414|6391015|P1|COMPLETED|Overall Study||14
2603530|NCT00193414|6391015|P1|STARTED|Overall Study||72
2603531|NCT00193375|6391021|P1|NOT COMPLETED|Overall Study||19
2603532|NCT00193375|6391021|P1|COMPLETED|Overall Study||41
2603533|NCT00193375|6391021|P1|STARTED|Overall Study||60
2603534|NCT00193258|6391027|P1|NOT COMPLETED|Overall Study||0
2603535|NCT00193258|6391027|P1|COMPLETED|Overall Study||94
2603536|NCT00193258|6391027|P1|STARTED|Overall Study||94
2603537|NCT00193219|6391033|P1|NOT COMPLETED|Overall Study||30
2603538|NCT00193219|6391033|P1|COMPLETED|Overall Study||6
2603539|NCT00193219|6391033|P1|STARTED|Overall Study||36
2603540|NCT00193206|6391039|P1|NOT COMPLETED|Postoperative Therapy||14
2603541|NCT00193206|6391039|P1|COMPLETED|Postoperative Therapy||102
2603542|NCT00193206|6391039|P1|STARTED|Postoperative Therapy||116
2603543|NCT00193206|6391039|P1|NOT COMPLETED|Surgery||0
2603544|NCT00193206|6391039|P1|COMPLETED|Surgery||116
2603545|NCT00193206|6391039|P1|STARTED|Surgery||116
2603546|NCT00193206|6391039|P1|NOT COMPLETED|Preoperative Therapy||7
2603547|NCT00193206|6391039|P1|COMPLETED|Preoperative Therapy||116
2603548|NCT00193206|6391039|P1|STARTED|Preoperative Therapy||123
2603549|NCT00193180|6391043|P1|NOT COMPLETED|Overall Study||10
2603550|NCT00193180|6391043|P1|COMPLETED|Overall Study||27
2603551|NCT00193180|6391043|P1|STARTED|Overall Study||37
2603552|NCT00193128|6391051|P2|NOT COMPLETED|Overall Study||10
2603553|NCT00193128|6391052|P1|NOT COMPLETED|Overall Study||0
2603554|NCT00193128|6391051|P2|COMPLETED|Overall Study||39
2603555|NCT00193128|6391052|P1|COMPLETED|Overall Study||10
2603556|NCT00193128|6391051|P2|STARTED|Overall Study||49
2603557|NCT00193128|6391052|P1|STARTED|Overall Study||10
2603558|NCT00193063|6391058|P1|NOT COMPLETED|Overall Study||4
2603559|NCT00193063|6391058|P1|COMPLETED|Overall Study||37
2603560|NCT00193063|6391058|P1|STARTED|Overall Study||41
2603561|NCT00193050|6391064|P1|NOT COMPLETED|Adjuvant||10
2603562|NCT00193050|6391064|P1|COMPLETED|Adjuvant||77
2603563|NCT00193050|6391064|P1|STARTED|Adjuvant|16 patients never initiated postoperative adjuvant therapy|87
2603564|NCT00193050|6391064|P1|NOT COMPLETED|Surgery||0
2603565|NCT00193050|6391064|P1|COMPLETED|Surgery||103
2603566|NCT00193050|6391064|P1|STARTED|Surgery|2 patients had surgery after 2 cycles of neoadjuvant treatment|103
2603567|NCT00193050|6391064|P1|NOT COMPLETED|Neoadjuvant Treatment||9
2603568|NCT00193050|6391064|P1|COMPLETED|Neoadjuvant Treatment||101
2603569|NCT00193050|6391064|P1|STARTED|Neoadjuvant Treatment||110
2603570|NCT00193037|6391070|P2|NOT COMPLETED|Crossover Treatment||0
2603571|NCT00193037|6391071|P1|NOT COMPLETED|Crossover Treatment||0
2603572|NCT00193037|6391070|P2|COMPLETED|Crossover Treatment||24
2603573|NCT00193037|6391071|P1|COMPLETED|Crossover Treatment||32
2603574|NCT00193037|6391070|P2|STARTED|Crossover Treatment||24
2603575|NCT00193037|6391071|P1|STARTED|Crossover Treatment||32
2603576|NCT00193037|6391070|P2|NOT COMPLETED|Randomized Treatment||28
2603577|NCT00193037|6391071|P1|NOT COMPLETED|Randomized Treatment||18
2603578|NCT00193037|6391070|P2|COMPLETED|Randomized Treatment||24
2603579|NCT00193037|6391071|P1|COMPLETED|Randomized Treatment||32
2603580|NCT00193037|6391070|P2|STARTED|Randomized Treatment||52
2603581|NCT00193037|6391071|P1|STARTED|Randomized Treatment||50
2603582|NCT00192647|6391081|P2|NOT COMPLETED|Overall Study||146
2603583|NCT00192647|6391082|P1|NOT COMPLETED|Overall Study||128
2603584|NCT00192647|6391081|P2|COMPLETED|Overall Study||302
2603585|NCT00192647|6391082|P1|COMPLETED|Overall Study||320
2603586|NCT00192647|6391081|P2|Treated|Overall Study||438
2603587|NCT00192647|6391082|P1|Treated|Overall Study||433
2603588|NCT00192647|6391081|P2|STARTED|Overall Study||448
2603589|NCT00192647|6391082|P1|STARTED|Overall Study||448
2603590|NCT00192296|6391102|P4|NOT COMPLETED|Overall Study||0
2603591|NCT00192296|6391103|P3|NOT COMPLETED|Overall Study||0
2603592|NCT00192296|6391104|P2|NOT COMPLETED|Overall Study||1
2603593|NCT00192296|6391105|P1|NOT COMPLETED|Overall Study||0
2603594|NCT00192296|6391102|P4|COMPLETED|Overall Study||6
2603595|NCT00192296|6391103|P3|COMPLETED|Overall Study||6
2603596|NCT00192296|6391104|P2|COMPLETED|Overall Study||5
2603597|NCT00192296|6391105|P1|COMPLETED|Overall Study||6
2603598|NCT00192296|6391102|P4|STARTED|Overall Study||6
2603599|NCT00192296|6391103|P3|STARTED|Overall Study||6
2603600|NCT00192296|6391104|P2|STARTED|Overall Study||6
2603601|NCT00192296|6391105|P1|STARTED|Overall Study||6
2603602|NCT00192075|6391161|P2|NOT COMPLETED|Overall Study||19
2603603|NCT00192075|6391162|P1|NOT COMPLETED|Overall Study||39
2603604|NCT00192075|6391161|P2|COMPLETED|Overall Study||23
2603605|NCT00192075|6391162|P1|COMPLETED|Overall Study||3
2603606|NCT00192075|6391161|P2|STARTED|Overall Study||42
2603607|NCT00192075|6391162|P1|STARTED|Overall Study||42
2603608|NCT00192036|6391187|P1|NOT COMPLETED|Overall Study||21
2603609|NCT00192036|6391187|P1|COMPLETED|Overall Study||28
2603610|NCT00192036|6391187|P1|STARTED|Overall Study||49
2603611|NCT00192023|6391197|P2|NOT COMPLETED|Period IV - Optional Open-Label||0
2603612|NCT00192023|6391198|P1|NOT COMPLETED|Period IV - Optional Open-Label||75
2603613|NCT00192023|6391197|P2|COMPLETED|Period IV - Optional Open-Label||0
2603614|NCT00192023|6391198|P1|COMPLETED|Period IV - Optional Open-Label||49
2603615|NCT00192023|6391197|P2|STARTED|Period IV - Optional Open-Label|Placebo patients received atomoxetine during the optional open-label period.|0
2603616|NCT00192023|6391198|P1|STARTED|Period IV - Optional Open-Label||124
2603617|NCT00192023|6391197|P2|NOT COMPLETED|Period III - Double-Blind||0
2603618|NCT00192023|6391198|P1|NOT COMPLETED|Period III - Double-Blind||7
2603619|NCT00192023|6391197|P2|COMPLETED|Period III - Double-Blind|2 patients who completed the protocol did not enter the optional open-label period.|32
2603620|NCT00192023|6391198|P1|COMPLETED|Period III - Double-Blind|6 patients who completed the protocol did not enter optional open-label period.|100
2603621|NCT00192023|6391197|P2|STARTED|Period III - Double-Blind||32
2603622|NCT00192023|6391198|P1|STARTED|Period III - Double-Blind||107
2603623|NCT00191984|6391220|P1|NOT COMPLETED|Overall Study||39
2603624|NCT00191984|6391220|P1|COMPLETED|Overall Study||7
2603625|NCT00191984|6391220|P1|STARTED|Overall Study||46
2603626|NCT00191945|6391230|P2|NOT COMPLETED|Open-Label Treatment Extension||0
2603627|NCT00191945|6391231|P1|NOT COMPLETED|Open-Label Treatment Extension||0
2603628|NCT00191945|6391230|P2|COMPLETED|Open-Label Treatment Extension||48
2603629|NCT00191945|6391231|P1|COMPLETED|Open-Label Treatment Extension||94
2603630|NCT00191945|6391230|P2|STARTED|Open-Label Treatment Extension||48
2603631|NCT00191945|6391231|P1|STARTED|Open-Label Treatment Extension||94
2603632|NCT00191945|6391230|P2|NOT COMPLETED|Double-Blind Acute Treatment||3
2603633|NCT00191945|6391231|P1|NOT COMPLETED|Double-Blind Acute Treatment||6
2603634|NCT00191945|6391230|P2|COMPLETED|Double-Blind Acute Treatment||48
2603635|NCT00191945|6391231|P1|COMPLETED|Double-Blind Acute Treatment||94
2603636|NCT00191945|6391230|P2|STARTED|Double-Blind Acute Treatment||51
2603637|NCT00191945|6391231|P1|STARTED|Double-Blind Acute Treatment||100
2603638|NCT00191906|6391267|P4|NOT COMPLETED|Study Period III||0
2603639|NCT00191906|6391268|P3|NOT COMPLETED|Study Period III||0
2603640|NCT00191906|6391269|P2|NOT COMPLETED|Study Period III||4
2603641|NCT00191906|6391270|P1|NOT COMPLETED|Study Period III||5
2603642|NCT00191906|6391267|P4|COMPLETED|Study Period III||0
2603643|NCT00191906|6391268|P3|COMPLETED|Study Period III||0
2603644|NCT00191906|6391269|P2|COMPLETED|Study Period III||7
2603645|NCT00191906|6391270|P1|COMPLETED|Study Period III||9
2603646|NCT00191906|6391267|P4|STARTED|Study Period III||0
2603647|NCT00191906|6391268|P3|STARTED|Study Period III||0
2603648|NCT00191906|6391269|P2|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|11
2603649|NCT00191906|6391270|P1|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|14
2603650|NCT00191906|6391267|P4|NOT COMPLETED|Study Period II||0
2603651|NCT00191906|6391268|P3|NOT COMPLETED|Study Period II||1
2603652|NCT00191906|6391269|P2|NOT COMPLETED|Study Period II||5
2603653|NCT00191906|6391270|P1|NOT COMPLETED|Study Period II||0
2603654|NCT00191906|6391267|P4|COMPLETED|Study Period II||18
2603655|NCT00191906|6391268|P3|COMPLETED|Study Period II||26
2603656|NCT00191906|6391269|P2|COMPLETED|Study Period II||32
2603657|NCT00191906|6391270|P1|COMPLETED|Study Period II||39
2603658|NCT00191906|6391267|P4|STARTED|Study Period II||18
2603659|NCT00191906|6391268|P3|STARTED|Study Period II||27
2603660|NCT00191906|6391269|P2|STARTED|Study Period II||37
2603661|NCT00191906|6391270|P1|STARTED|Study Period II||39
2603662|NCT00191854|6391313|P3|NOT COMPLETED|Overall Study||39
2603663|NCT00191854|6391314|P2|NOT COMPLETED|Overall Study||30
2603664|NCT00191854|6391315|P1|NOT COMPLETED|Overall Study||37
2603665|NCT00191854|6391313|P3|COMPLETED|Overall Study||12
2603666|NCT00191854|6391314|P2|COMPLETED|Overall Study||17
2603667|NCT00191854|6391315|P1|COMPLETED|Overall Study||12
2603668|NCT00191854|6391313|P3|Received at Least One Dose of Study Drug|Overall Study|Screen failure: discontinued prior to receiving study drug.|50
2603669|NCT00191854|6391314|P2|Received at Least One Dose of Study Drug|Overall Study||47
2603670|NCT00191854|6391315|P1|Received at Least One Dose of Study Drug|Overall Study||49
2603671|NCT00191854|6391313|P3|STARTED|Overall Study||51
2603672|NCT00191854|6391314|P2|STARTED|Overall Study||47
2603673|NCT00191854|6391315|P1|STARTED|Overall Study||49
2603674|NCT00191815|6391335|P1|NOT COMPLETED|Overall Study||40
2603675|NCT00191815|6391335|P1|COMPLETED|Overall Study||30
2603676|NCT00191815|6391335|P1|Treated|Overall Study||67
2603677|NCT00191815|6391335|P1|STARTED|Overall Study||70
2603678|NCT00191789|6391347|P1|NOT COMPLETED|Overall Study||25
2603679|NCT00191789|6391347|P1|COMPLETED|Overall Study||40
2603680|NCT00191789|6391347|P1|STARTED|Overall Study||65
2603681|NCT00191724|6391364|P5|NOT COMPLETED|Overall Study||3
2603682|NCT00191724|6391365|P4|NOT COMPLETED|Overall Study||3
2603683|NCT00191724|6391366|P3|NOT COMPLETED|Overall Study||1
2603684|NCT00191724|6391367|P2|NOT COMPLETED|Overall Study||1
2603685|NCT00191724|6391368|P1|NOT COMPLETED|Overall Study||1
2603686|NCT00191724|6391364|P5|COMPLETED|Overall Study||12
2603687|NCT00191724|6391365|P4|COMPLETED|Overall Study||5
2603688|NCT00191724|6391366|P3|COMPLETED|Overall Study||8
2603689|NCT00191724|6391367|P2|COMPLETED|Overall Study||8
2603690|NCT00191724|6391368|P1|COMPLETED|Overall Study||5
2603691|NCT00191724|6391364|P5|STARTED|Overall Study||15
2603692|NCT00191724|6391365|P4|STARTED|Overall Study||8
2603693|NCT00191724|6391366|P3|STARTED|Overall Study||9
2603694|NCT00191724|6391367|P2|STARTED|Overall Study||9
2603695|NCT00191724|6391368|P1|STARTED|Overall Study||6
2603696|NCT00191646|6391397|P2|NOT COMPLETED|Overall Study||153
2603697|NCT00191646|6391398|P1|NOT COMPLETED|Overall Study||171
2603698|NCT00191646|6391397|P2|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|261
2603699|NCT00191646|6391398|P1|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|246
2603700|NCT00191646|6391397|P2|Received Crossover Therapy|Overall Study||78
2603701|NCT00191646|6391398|P1|Received Crossover Therapy|Overall Study||77
2603702|NCT00191646|6391397|P2|Received Consolidation Therapy|Overall Study||183
2603703|NCT00191646|6391398|P1|Received Consolidation Therapy|Overall Study||169
2603704|NCT00191646|6391397|P2|Received Induction Therapy|Overall Study||409
2603705|NCT00191646|6391398|P1|Received Induction Therapy|Overall Study||411
2603706|NCT00191646|6391397|P2|STARTED|Overall Study||414
2603707|NCT00191646|6391398|P1|STARTED|Overall Study||417
2603708|NCT00191477|6391418|P2|NOT COMPLETED|Overall Study||129
2603709|NCT00191477|6391419|P1|NOT COMPLETED|Overall Study||138
2603710|NCT00191477|6391418|P2|COMPLETED|Overall Study||47
2603711|NCT00191477|6391419|P1|COMPLETED|Overall Study||41
2603712|NCT00191477|6391418|P2|Received Study Drug|Overall Study||162
2603713|NCT00191477|6391419|P1|Received Study Drug|Overall Study||166
2603714|NCT00191477|6391418|P2|STARTED|Overall Study||176
2603715|NCT00191477|6391419|P1|STARTED|Overall Study||179
2603716|NCT00191451|6391438|P3|NOT COMPLETED|Overall Study||14
2603717|NCT00191451|6391439|P2|NOT COMPLETED|Overall Study||14
2603718|NCT00191451|6391440|P1|NOT COMPLETED|Overall Study||7
2603719|NCT00191451|6391438|P3|COMPLETED|Overall Study||35
2603720|NCT00191451|6391439|P2|COMPLETED|Overall Study||37
2603721|NCT00191451|6391440|P1|COMPLETED|Overall Study||43
2603722|NCT00191451|6391438|P3|Received at Least One Dose of Study Drug|Overall Study||47
2603723|NCT00191451|6391439|P2|Received at Least One Dose of Study Drug|Overall Study||48
2603724|NCT00191451|6391440|P1|Received at Least One Dose of Study Drug|Overall Study||50
2603725|NCT00191451|6391438|P3|STARTED|Overall Study||49
2603726|NCT00191451|6391439|P2|STARTED|Overall Study||51
2603727|NCT00191451|6391440|P1|STARTED|Overall Study||50
2603728|NCT00191386|6391460|P1|NOT COMPLETED|Overall Study||160
2603729|NCT00191386|6391460|P1|COMPLETED|Overall Study||68
2603730|NCT00191386|6391460|P1|3 Years|Overall Study||65
2603731|NCT00191386|6391460|P1|2 Years|Overall Study||105
2603732|NCT00191386|6391460|P1|12 Months|Overall Study||149
2603733|NCT00191386|6391460|P1|6 Months|Overall Study||183
2603734|NCT00191386|6391460|P1|STARTED|Overall Study||228
2603735|NCT00191334|6391467|P1|NOT COMPLETED|Overall Study||17
2603736|NCT00191334|6391467|P1|COMPLETED|Overall Study||33
2603737|NCT00191334|6391467|P1|STARTED|Overall Study||50
2603738|NCT00191308|6391475|P1|NOT COMPLETED|Overall Study||1
2603739|NCT00191308|6391475|P1|COMPLETED|Overall Study||29
2603740|NCT00191308|6391475|P1|STARTED|Overall Study||30
2603741|NCT00191282|6391485|P2|NOT COMPLETED|Overall Study||212
2603742|NCT00191282|6391486|P1|NOT COMPLETED|Overall Study||220
2603743|NCT00191282|6391485|P2|COMPLETED|Overall Study||346
2603744|NCT00191282|6391486|P1|COMPLETED|Overall Study||338
2603745|NCT00191282|6391485|P2|STARTED|Overall Study||558
2603746|NCT00191282|6391486|P1|STARTED|Overall Study||558
2603747|NCT00191269|6391546|P2|NOT COMPLETED|Overall Study||58
2603748|NCT00191269|6391547|P1|NOT COMPLETED|Overall Study||6
2603749|NCT00191269|6391546|P2|COMPLETED|Overall Study||4
2603750|NCT00191269|6391547|P1|COMPLETED|Overall Study||0
2603751|NCT00191269|6391546|P2|STARTED|Overall Study||62
2603752|NCT00191269|6391547|P1|STARTED|Overall Study||6
2603753|NCT00191191|6391563|P2|NOT COMPLETED|Overall Study||112
2603754|NCT00191191|6391564|P1|NOT COMPLETED|Overall Study||114
2603755|NCT00191191|6391563|P2|COMPLETED|Overall Study||0
2603756|NCT00191191|6391564|P1|COMPLETED|Overall Study||0
2603757|NCT00191191|6391563|P2|Full Analysis Set Population|Overall Study||108
2603758|NCT00191191|6391564|P1|Full Analysis Set Population|Overall Study||108
2603759|NCT00191191|6391563|P2|Safety Analysis Population|Overall Study||111
2603760|NCT00191191|6391564|P1|Safety Analysis Population|Overall Study||114
2603761|NCT00191191|6391563|P2|STARTED|Overall Study||112
2603762|NCT00191191|6391564|P1|STARTED|Overall Study||114
2603763|NCT00191165|6391580|P2|NOT COMPLETED|Overall Study||2
2603764|NCT00191165|6391581|P1|NOT COMPLETED|Overall Study||2
2603765|NCT00191165|6391580|P2|COMPLETED|Overall Study||11
2603766|NCT00191165|6391581|P1|COMPLETED|Overall Study||12
2603767|NCT00191165|6391580|P2|STARTED|Overall Study||13
2603768|NCT00191165|6391581|P1|STARTED|Overall Study||14
2603769|NCT00191152|6391593|P2|NOT COMPLETED|Crossover Treatment||28
2603770|NCT00191152|6391594|P1|NOT COMPLETED|Crossover Treatment||27
2603771|NCT00191152|6391593|P2|COMPLETED|Crossover Treatment||53
2603772|NCT00191152|6391594|P1|COMPLETED|Crossover Treatment||50
2603773|NCT00191152|6391593|P2|Received Treatment|Crossover Treatment||80
2603774|NCT00191152|6391594|P1|Received Treatment|Crossover Treatment||76
2603775|NCT00191152|6391593|P2|STARTED|Crossover Treatment||81
2603776|NCT00191152|6391594|P1|STARTED|Crossover Treatment||77
2603777|NCT00191152|6391593|P2|NOT COMPLETED|Initial Treatment||153
2603778|NCT00191152|6391594|P1|NOT COMPLETED|Initial Treatment||141
2603779|NCT00191152|6391593|P2|COMPLETED|Initial Treatment||83
2603780|NCT00191152|6391594|P1|COMPLETED|Initial Treatment||98
2603781|NCT00191152|6391593|P2|Received Initial Treatment|Initial Treatment||227
2603782|NCT00191152|6391594|P1|Received Initial Treatment|Initial Treatment||236
2603783|NCT00191152|6391593|P2|STARTED|Initial Treatment||236
2603784|NCT00191152|6391594|P1|STARTED|Initial Treatment||239
2603785|NCT00191139|6391626|P2|NOT COMPLETED|Overall Study||12
2603786|NCT00191139|6391627|P1|NOT COMPLETED|Overall Study||5
2603787|NCT00191139|6391626|P2|COMPLETED|Overall Study||20
2603788|NCT00191139|6391627|P1|COMPLETED|Overall Study||27
2603789|NCT00191139|6391626|P2|STARTED|Overall Study||32
2603790|NCT00191139|6391627|P1|STARTED|Overall Study||32
2603791|NCT00191113|6391643|P2|NOT COMPLETED|Addendum 3||0
2603792|NCT00191113|6391644|P1|NOT COMPLETED|Addendum 3||0
2603793|NCT00191113|6391643|P2|COMPLETED|Addendum 3||37
2603794|NCT00191113|6391644|P1|COMPLETED|Addendum 3||20
2603795|NCT00191113|6391643|P2|STARTED|Addendum 3||37
2603796|NCT00191113|6391644|P1|STARTED|Addendum 3||20
2603797|NCT00191113|6391643|P2|NOT COMPLETED|Addendum 2||17
2603798|NCT00191113|6391644|P1|NOT COMPLETED|Addendum 2||10
2603799|NCT00191113|6391643|P2|COMPLETED|Addendum 2||31
2603800|NCT00191113|6391644|P1|COMPLETED|Addendum 2||18
2603801|NCT00191113|6391643|P2|STARTED|Addendum 2||48
2603802|NCT00191113|6391644|P1|STARTED|Addendum 2||28
2603803|NCT00191113|6391643|P2|NOT COMPLETED|Addendum 1||0
2603804|NCT00191113|6391644|P1|NOT COMPLETED|Addendum 1||0
2603805|NCT00191113|6391643|P2|COMPLETED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
2603806|NCT00191113|6391644|P1|COMPLETED|Addendum 1||2
2603807|NCT00191113|6391643|P2|STARTED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
2603808|NCT00191113|6391644|P1|STARTED|Addendum 1||2
2603809|NCT00191113|6391643|P2|NOT COMPLETED|Core Study||15
2603810|NCT00191113|6391644|P1|NOT COMPLETED|Core Study||35
2603811|NCT00191113|6391643|P2|COMPLETED|Core Study||61
2603812|NCT00191113|6391644|P1|COMPLETED|Core Study||43
2603813|NCT00191113|6391643|P2|STARTED|Core Study||76
2603814|NCT00191113|6391644|P1|STARTED|Core Study||78
2603815|NCT00191100|6391686|P2|NOT COMPLETED|Overall Study||12
2603816|NCT00191100|6391687|P1|NOT COMPLETED|Overall Study||42
2603817|NCT00191100|6391686|P2|COMPLETED|Overall Study||244
2603818|NCT00191100|6391687|P1|COMPLETED|Overall Study||217
2603819|NCT00191100|6391686|P2|STARTED|Overall Study||256
2603820|NCT00191100|6391687|P1|STARTED|Overall Study||259
2603821|NCT00190983|6391703|P1|NOT COMPLETED|Overall Study||2
2603822|NCT00190983|6391703|P1|COMPLETED|Overall Study|Completed means patient received treatment and was evaluable for response.|27
2603823|NCT00190983|6391703|P1|STARTED|Overall Study||29
2603824|NCT00190775|6391712|P2|NOT COMPLETED|Overall Study||100
2603825|NCT00190775|6391713|P1|NOT COMPLETED|Overall Study||149
2603826|NCT00190775|6391712|P2|COMPLETED|Overall Study||134
2603827|NCT00190775|6391713|P1|COMPLETED|Overall Study||119
2603828|NCT00190775|6391712|P2|Received Study Drug|Overall Study||234
2603829|NCT00190775|6391713|P1|Received Study Drug|Overall Study||266
2603830|NCT00190775|6391712|P2|STARTED|Overall Study||234
2603831|NCT00190775|6391713|P1|STARTED|Overall Study||268
2603832|NCT00190749|6391784|P2|NOT COMPLETED|Overall Study||31
2603833|NCT00190749|6391785|P1|NOT COMPLETED|Overall Study||26
2603834|NCT00190749|6391784|P2|COMPLETED|Overall Study||31
2603835|NCT00190749|6391785|P1|COMPLETED|Overall Study||42
2603836|NCT00190749|6391784|P2|STARTED|Overall Study||62
2603837|NCT00190749|6391785|P1|STARTED|Overall Study||68
2603838|NCT00190684|6391849|P1|NOT COMPLETED|Overall Study||1489
2603839|NCT00190684|6391849|P1|COMPLETED|Overall Study|Number of patients that completed overall study (through Period VI)|64
2603840|NCT00190684|6391849|P1|Received at Least 1 Dose of Study Drug|Overall Study|1553 patients entered the study; 1551 were enrolled and received study drug.|1551
2603841|NCT00190684|6391849|P1|STARTED|Overall Study||1553
2603842|NCT00190671|6391870|P2|NOT COMPLETED|Overall Study||42
2603843|NCT00190671|6391871|P1|NOT COMPLETED|Overall Study||27
2603844|NCT00190671|6391870|P2|COMPLETED|Overall Study||19
2603845|NCT00190671|6391871|P1|COMPLETED|Overall Study||15
2603846|NCT00190671|6391870|P2|STARTED|Overall Study||61
2603847|NCT00190671|6391871|P1|STARTED|Overall Study||42
2603848|NCT00189540|6391891|P2|NOT COMPLETED|Overall Study||1
2603849|NCT00189540|6391892|P1|NOT COMPLETED|Overall Study||7
2603850|NCT00189540|6391891|P2|COMPLETED|Overall Study||5
2603851|NCT00189540|6391892|P1|COMPLETED|Overall Study||14
2603852|NCT00189540|6391891|P2|STARTED|Overall Study||6
2603853|NCT00189540|6391892|P1|STARTED|Overall Study||21
2603854|NCT00189488|6391910|P2|NOT COMPLETED|Overall Study||22
2603855|NCT00189488|6391911|P1|NOT COMPLETED|Overall Study||15
2603856|NCT00189488|6391910|P2|COMPLETED|Overall Study||55
2603857|NCT00189488|6391911|P1|COMPLETED|Overall Study||63
2603858|NCT00189488|6391910|P2|Received Palifermin/Placebo|Overall Study||76
2603859|NCT00189488|6391911|P1|Received Palifermin/Placebo|Overall Study||75
2603860|NCT00189488|6391910|P2|STARTED|Overall Study||77
2603861|NCT00189488|6391911|P1|STARTED|Overall Study||78
2603862|NCT00189475|6391933|P2|NOT COMPLETED|Overall Study||0
2603863|NCT00189475|6391934|P1|NOT COMPLETED|Overall Study||0
2603864|NCT00189475|6391933|P2|COMPLETED|Overall Study||42
2603865|NCT00189475|6391934|P1|COMPLETED|Overall Study||42
2603866|NCT00189475|6391933|P2|STARTED|Overall Study||42
2603867|NCT00189475|6391934|P1|STARTED|Overall Study||42
2603868|NCT00189462|6391942|P2|NOT COMPLETED|Overall Study||21
2603869|NCT00189462|6391943|P1|NOT COMPLETED|Overall Study||23
2603870|NCT00189462|6391942|P2|COMPLETED|Overall Study||28
2603871|NCT00189462|6391943|P1|COMPLETED|Overall Study||27
2603872|NCT00189462|6391942|P2|STARTED|Overall Study||49
2603873|NCT00189462|6391943|P1|STARTED|Overall Study||50
2603874|NCT00189436|6391951|P2|NOT COMPLETED|Overall Study||5
2603875|NCT00189436|6391952|P1|NOT COMPLETED|Overall Study||8
2603876|NCT00189436|6391951|P2|COMPLETED|Overall Study||25
2603877|NCT00189436|6391952|P1|COMPLETED|Overall Study||23
2603878|NCT00189436|6391951|P2|STARTED|Overall Study||30
2603879|NCT00189436|6391952|P1|STARTED|Overall Study||31
2603880|NCT00189423|6391960|P2|NOT COMPLETED|Overall Study||766
2603881|NCT00189423|6391961|P1|NOT COMPLETED|Overall Study||765
2603882|NCT00189423|6391960|P2|COMPLETED|Overall Study||74
2603883|NCT00189423|6391961|P1|COMPLETED|Overall Study||48
2603884|NCT00189423|6391960|P2|STARTED|Overall Study||840
2603885|NCT00189423|6391961|P1|STARTED|Overall Study||813
2603886|NCT00189306|6391983|P1|NOT COMPLETED|Long-Term Follow-up||38
2603887|NCT00189306|6391983|P1|COMPLETED|Long-Term Follow-up||119
2603888|NCT00189306|6391983|P1|STARTED|Long-Term Follow-up||157
2603889|NCT00189306|6391983|P1|NOT COMPLETED|Posttreatment Period||12
2603890|NCT00189306|6391983|P1|COMPLETED|Posttreatment Period|11 subjects discontinued during the 12-week Posttreatment Period|157
2603891|NCT00189306|6391983|P1|STARTED|Posttreatment Period|5 of the 169 discontinued, but 4 returned for the Posttreatment Period|169
2603892|NCT00189306|6391983|P1|NOT COMPLETED|Treatment Period||5
2603893|NCT00189306|6391983|P1|COMPLETED|Treatment Period|5 subjects discontinued during treatment - 4 subjects returned for the Posttreatment Period|164
2603894|NCT00189306|6391983|P1|STARTED|Treatment Period||169
2603895|NCT00189228|6391988|P1|NOT COMPLETED|Overall Study||0
2603896|NCT00189228|6391988|P1|COMPLETED|Overall Study||18
2603897|NCT00189228|6391988|P1|STARTED|Overall Study||18
2603898|NCT00189202|6391992|P1|NOT COMPLETED|Overall Study||5
2603899|NCT00189202|6391992|P1|COMPLETED|Overall Study||44
2603900|NCT00189202|6391992|P1|STARTED|Overall Study||49
2603901|NCT00189137|6392003|P2|NOT COMPLETED|Overall Study||0
2603902|NCT00189137|6392004|P1|NOT COMPLETED|Overall Study||0
2603903|NCT00189137|6392003|P2|COMPLETED|Overall Study||43
2603904|NCT00189137|6392004|P1|COMPLETED|Overall Study||37
2603905|NCT00189137|6392003|P2|STARTED|Overall Study||43
2603906|NCT00189137|6392004|P1|STARTED|Overall Study||37
2603907|NCT00189098|6392014|P2|NOT COMPLETED|Overall Study||6
2603908|NCT00189098|6392015|P1|NOT COMPLETED|Overall Study||5
2603909|NCT00189098|6392014|P2|COMPLETED|Overall Study||44
2603910|NCT00189098|6392015|P1|COMPLETED|Overall Study||46
2603911|NCT00189098|6392014|P2|STARTED|Overall Study||50
2603912|NCT00189098|6392015|P1|STARTED|Overall Study||51
2603913|NCT00187889|6392033|P2|NOT COMPLETED|Overall Study||4
2603914|NCT00187889|6392034|P1|NOT COMPLETED|Overall Study||6
2603915|NCT00187889|6392033|P2|COMPLETED|Overall Study||22
2603916|NCT00187889|6392034|P1|COMPLETED|Overall Study||19
2603917|NCT00187889|6392033|P2|STARTED|Overall Study||26
2603918|NCT00187889|6392034|P1|STARTED|Overall Study||25
2603919|NCT00187876|6392044|P2|NOT COMPLETED|Overall Study||0
2603920|NCT00187876|6392045|P1|NOT COMPLETED|Overall Study||0
2603921|NCT00187876|6392044|P2|COMPLETED|Overall Study||43
2603922|NCT00187876|6392045|P1|COMPLETED|Overall Study||24
2603923|NCT00187876|6392044|P2|STARTED|Overall Study||43
2603924|NCT00187876|6392045|P1|STARTED|Overall Study||24
2603925|NCT00187720|6392053|P2|NOT COMPLETED|Overall Study||0
2603926|NCT00187720|6392054|P1|NOT COMPLETED|Overall Study||0
2603927|NCT00187720|6392053|P2|COMPLETED|Overall Study||14
2603928|NCT00187720|6392054|P1|COMPLETED|Overall Study||9
2603929|NCT00187720|6392053|P2|STARTED|Overall Study||14
2603930|NCT00187720|6392054|P1|STARTED|Overall Study||9
2603931|NCT00187681|6392062|P2|NOT COMPLETED|Overall Study||0
2603932|NCT00187681|6392063|P1|NOT COMPLETED|Overall Study||0
2603933|NCT00187681|6392062|P2|COMPLETED|Overall Study||8
2603934|NCT00187681|6392063|P1|COMPLETED|Overall Study||12
2603935|NCT00187681|6392062|P2|STARTED|Overall Study||8
2603936|NCT00187681|6392063|P1|STARTED|Overall Study||12
2603937|NCT00187655|6392071|P1|NOT COMPLETED|Overall Study||0
2603938|NCT00187655|6392071|P1|COMPLETED|Overall Study||24
2603939|NCT00187655|6392071|P1|STARTED|Overall Study||24
2603940|NCT00187486|6392076|P1|NOT COMPLETED|Overall Study||1
2603941|NCT00187486|6392076|P1|COMPLETED|Overall Study||65
2603942|NCT00187486|6392076|P1|STARTED|Overall Study||66
2603943|NCT00187226|6392087|P6|NOT COMPLETED|Overall Study||0
2603944|NCT00187226|6392088|P5|NOT COMPLETED|Overall Study||0
2603945|NCT00187226|6392089|P4|NOT COMPLETED|Overall Study||0
2603946|NCT00187226|6392090|P3|NOT COMPLETED|Overall Study||0
2603947|NCT00187226|6392091|P2|NOT COMPLETED|Overall Study||0
2603948|NCT00187226|6392092|P1|NOT COMPLETED|Overall Study||0
2603949|NCT00187226|6392087|P6|COMPLETED|Overall Study||1
2603950|NCT00187226|6392088|P5|COMPLETED|Overall Study||34
2603951|NCT00187226|6392089|P4|COMPLETED|Overall Study||2
2603952|NCT00187226|6392090|P3|COMPLETED|Overall Study||28
2603953|NCT00187226|6392091|P2|COMPLETED|Overall Study||49
2603954|NCT00187226|6392092|P1|COMPLETED|Overall Study||88
2603955|NCT00187226|6392087|P6|STARTED|Overall Study||1
2603956|NCT00187226|6392088|P5|STARTED|Overall Study||34
2603957|NCT00187226|6392089|P4|STARTED|Overall Study||2
2603958|NCT00187226|6392090|P3|STARTED|Overall Study||28
2603959|NCT00187226|6392091|P2|STARTED|Overall Study||49
2603960|NCT00187226|6392092|P1|STARTED|Overall Study||88
2603961|NCT00187200|6392108|P2|NOT COMPLETED|Overall Study||18
2603962|NCT00187200|6392109|P1|NOT COMPLETED|Overall Study||18
2603963|NCT00187200|6392108|P2|COMPLETED|Overall Study||26
2603964|NCT00187200|6392109|P1|COMPLETED|Overall Study||31
2603965|NCT00187200|6392108|P2|STARTED|Overall Study||44
2603966|NCT00187200|6392109|P1|STARTED|Overall Study||49
2603967|NCT00187135|6392127|P6|NOT COMPLETED|Visit Three||6
2603968|NCT00187135|6392128|P5|NOT COMPLETED|Visit Three||8
2603969|NCT00187135|6392129|P4|NOT COMPLETED|Visit Three||9
2603970|NCT00187135|6392130|P3|NOT COMPLETED|Visit Three||9
2603971|NCT00187135|6392131|P2|NOT COMPLETED|Visit Three||7
2603972|NCT00187135|6392132|P1|NOT COMPLETED|Visit Three||7
2603973|NCT00187135|6392127|P6|COMPLETED|Visit Three||12
2603974|NCT00187135|6392128|P5|COMPLETED|Visit Three||11
2603975|NCT00187135|6392129|P4|COMPLETED|Visit Three||9
2603976|NCT00187135|6392130|P3|COMPLETED|Visit Three||14
2603977|NCT00187135|6392131|P2|COMPLETED|Visit Three||17
2603978|NCT00187135|6392132|P1|COMPLETED|Visit Three||14
2603979|NCT00187135|6392127|P6|STARTED|Visit Three||18
2603980|NCT00187135|6392128|P5|STARTED|Visit Three||19
2603981|NCT00187135|6392129|P4|STARTED|Visit Three||18
2603982|NCT00187135|6392130|P3|STARTED|Visit Three||23
2603983|NCT00187135|6392131|P2|STARTED|Visit Three||24
2603984|NCT00187135|6392132|P1|STARTED|Visit Three||21
2603985|NCT00187135|6392127|P6|NOT COMPLETED|Visit Two||8
2603986|NCT00187135|6392128|P5|NOT COMPLETED|Visit Two||6
2603987|NCT00187135|6392129|P4|NOT COMPLETED|Visit Two||8
2603988|NCT00187135|6392130|P3|NOT COMPLETED|Visit Two||2
2603989|NCT00187135|6392131|P2|NOT COMPLETED|Visit Two||3
2603990|NCT00187135|6392132|P1|NOT COMPLETED|Visit Two||5
2603991|NCT00187135|6392127|P6|COMPLETED|Visit Two||18
2603992|NCT00187135|6392128|P5|COMPLETED|Visit Two||19
2603993|NCT00187135|6392129|P4|COMPLETED|Visit Two||18
2603994|NCT00187135|6392130|P3|COMPLETED|Visit Two||23
2603995|NCT00187135|6392131|P2|COMPLETED|Visit Two||24
2603996|NCT00187135|6392132|P1|COMPLETED|Visit Two||21
2603997|NCT00187135|6392127|P6|STARTED|Visit Two||26
2603998|NCT00187135|6392128|P5|STARTED|Visit Two||25
2603999|NCT00187135|6392129|P4|STARTED|Visit Two||26
2604000|NCT00187135|6392130|P3|STARTED|Visit Two||25
2604001|NCT00187135|6392131|P2|STARTED|Visit Two||27
2604002|NCT00187135|6392132|P1|STARTED|Visit Two||26
2604003|NCT00187135|6392127|P6|NOT COMPLETED|Visit One||2
2604004|NCT00187135|6392128|P5|NOT COMPLETED|Visit One||0
2604005|NCT00187135|6392129|P4|NOT COMPLETED|Visit One||0
2604006|NCT00187135|6392130|P3|NOT COMPLETED|Visit One||0
2604007|NCT00187135|6392131|P2|NOT COMPLETED|Visit One||1
2604008|NCT00187135|6392132|P1|NOT COMPLETED|Visit One||4
2604009|NCT00187135|6392127|P6|COMPLETED|Visit One||26
2604010|NCT00187135|6392128|P5|COMPLETED|Visit One||25
2604011|NCT00187135|6392129|P4|COMPLETED|Visit One||26
2604012|NCT00187135|6392130|P3|COMPLETED|Visit One||25
2604013|NCT00187135|6392131|P2|COMPLETED|Visit One||27
2604014|NCT00187135|6392132|P1|COMPLETED|Visit One||26
2604015|NCT00187135|6392127|P6|STARTED|Visit One||28
2604016|NCT00187135|6392128|P5|STARTED|Visit One||25
2604017|NCT00187135|6392129|P4|STARTED|Visit One||26
2604018|NCT00187135|6392130|P3|STARTED|Visit One||25
2604019|NCT00187135|6392131|P2|STARTED|Visit One||28
2604020|NCT00187135|6392132|P1|STARTED|Visit One||30
2604021|NCT00187096|6392155|P3|NOT COMPLETED|Overall Study||1
2604022|NCT00187096|6392156|P2|NOT COMPLETED|Overall Study||0
2604023|NCT00187096|6392157|P1|NOT COMPLETED|Overall Study||0
2604024|NCT00187096|6392155|P3|COMPLETED|Overall Study||11
2604025|NCT00187096|6392156|P2|COMPLETED|Overall Study||3
2604026|NCT00187096|6392157|P1|COMPLETED|Overall Study||10
2604027|NCT00187096|6392155|P3|STARTED|Overall Study||12
2604028|NCT00187096|6392156|P2|STARTED|Overall Study||3
2604029|NCT00187096|6392157|P1|STARTED|Overall Study||10
2604030|NCT00186901|6392195|P3|NOT COMPLETED|Overall Study||149
2604031|NCT00186901|6392196|P2|NOT COMPLETED|Overall Study||45
2604032|NCT00186901|6392197|P1|NOT COMPLETED|Overall Study||49
2604033|NCT00186901|6392195|P3|COMPLETED|Overall Study||0
2604034|NCT00186901|6392196|P2|COMPLETED|Overall Study||96
2604035|NCT00186901|6392197|P1|COMPLETED|Overall Study||85
2604036|NCT00186901|6392195|P3|24 Month Follow-up|Overall Study||0
2604037|NCT00186901|6392196|P2|24 Month Follow-up|Overall Study||107
2604038|NCT00186901|6392197|P1|24 Month Follow-up|Overall Study||106
2604039|NCT00186901|6392195|P3|12 Month Follow-up|Overall Study||0
2604040|NCT00186901|6392196|P2|12 Month Follow-up|Overall Study||122
2604041|NCT00186901|6392197|P1|12 Month Follow-up|Overall Study||117
2604042|NCT00186901|6392195|P3|Baseline|Overall Study||0
2604043|NCT00186901|6392196|P2|Baseline|Overall Study||141
2604044|NCT00186901|6392197|P1|Baseline|Overall Study||134
2604045|NCT00186901|6392195|P3|STARTED|Overall Study||149
2604046|NCT00186901|6392196|P2|STARTED|Overall Study||141
2604047|NCT00186901|6392197|P1|STARTED|Overall Study||134
2604048|NCT00186888|6392237|P3|NOT COMPLETED|Overall Study||0
2604049|NCT00186888|6392238|P2|NOT COMPLETED|Overall Study||3
2604050|NCT00186888|6392239|P1|NOT COMPLETED|Overall Study||4
2604051|NCT00186888|6392237|P3|COMPLETED|Overall Study||55
2604052|NCT00186888|6392238|P2|COMPLETED|Overall Study||24
2604053|NCT00186888|6392239|P1|COMPLETED|Overall Study||19
2604054|NCT00186888|6392237|P3|Window Therapy|Overall Study||0
2604055|NCT00186888|6392238|P2|Window Therapy|Overall Study||27
2604056|NCT00186888|6392239|P1|Window Therapy|Overall Study||0
2604057|NCT00186888|6392237|P3|STARTED|Overall Study||55
2604058|NCT00186888|6392238|P2|STARTED|Overall Study||27
2604059|NCT00186888|6392239|P1|STARTED|Overall Study||23
2604060|NCT00186875|6392316|P2|NOT COMPLETED|Overall Study||0
2604061|NCT00186875|6392317|P1|NOT COMPLETED|Overall Study||0
2604062|NCT00186875|6392316|P2|COMPLETED|Overall Study||14
2604063|NCT00186875|6392317|P1|COMPLETED|Overall Study||26
2604064|NCT00186875|6392316|P2|STARTED|Overall Study||14
2604065|NCT00186875|6392317|P1|STARTED|Overall Study||26
2604066|NCT00186628|6392331|P1|NOT COMPLETED|Overall Study||3
2604067|NCT00186628|6392331|P1|COMPLETED|Overall Study||33
2604068|NCT00186628|6392331|P1|STARTED|Overall Study||36
2604069|NCT00186537|6392342|P3|NOT COMPLETED|Overall Study||3
2604070|NCT00186537|6392343|P2|NOT COMPLETED|Overall Study||0
2604071|NCT00186537|6392344|P1|NOT COMPLETED|Overall Study||7
2604072|NCT00186537|6392342|P3|COMPLETED|Overall Study||13
2604073|NCT00186537|6392343|P2|COMPLETED|Overall Study||12
2604074|NCT00186537|6392344|P1|COMPLETED|Overall Study||12
2604075|NCT00186537|6392342|P3|STARTED|Overall Study||16
2604076|NCT00186537|6392343|P2|STARTED|Overall Study||12
2604077|NCT00186537|6392344|P1|STARTED|Overall Study||19
2604078|NCT00186498|6392360|P2|NOT COMPLETED|Overall Study||2
2604079|NCT00186498|6392361|P1|NOT COMPLETED|Overall Study||2
2604080|NCT00186498|6392360|P2|COMPLETED|Overall Study||3
2604081|NCT00186498|6392361|P1|COMPLETED|Overall Study||4
2604082|NCT00186498|6392360|P2|STARTED|Overall Study||5
2604083|NCT00186498|6392361|P1|STARTED|Overall Study||6
2604084|NCT00186485|6392367|P1|NOT COMPLETED|Overall Study||3
2604085|NCT00186485|6392367|P1|COMPLETED|Overall Study||25
2604086|NCT00186485|6392367|P1|STARTED|Overall Study||28
2604087|NCT00186446|6392373|P1|NOT COMPLETED|Overall Study||9
2604088|NCT00186446|6392373|P1|COMPLETED|Overall Study||11
2604089|NCT00186446|6392373|P1|STARTED|Overall Study||20
2604090|NCT00186186|6392379|P1|NOT COMPLETED|Overall Study||8
2604091|NCT00186186|6392379|P1|COMPLETED|Overall Study||20
2604092|NCT00186186|6392379|P1|STARTED|Overall Study||28
2604093|NCT00186121|6392384|P1|NOT COMPLETED|Overall Study||3
2604094|NCT00186121|6392384|P1|COMPLETED|Overall Study||32
2604095|NCT00186121|6392384|P1|STARTED|Overall Study||35
2604096|NCT00186069|6392396|P2|NOT COMPLETED|Overall Study||0
2604097|NCT00186069|6392397|P1|NOT COMPLETED|Overall Study||0
2604098|NCT00186069|6392396|P2|COMPLETED|Overall Study||15
2604099|NCT00186069|6392397|P1|COMPLETED|Overall Study||15
2604100|NCT00186069|6392396|P2|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
2604101|NCT00186069|6392397|P1|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
2604102|NCT00186056|6392409|P2|NOT COMPLETED|Overall Study||1
2604103|NCT00186056|6392410|P1|NOT COMPLETED|Overall Study||2
2604104|NCT00186056|6392409|P2|COMPLETED|Overall Study||16
2604105|NCT00186056|6392410|P1|COMPLETED|Overall Study||12
2604106|NCT00186056|6392409|P2|STARTED|Overall Study||17
2604107|NCT00186056|6392410|P1|STARTED|Overall Study||14
2604108|NCT00186043|6392418|P2|NOT COMPLETED|Overall Study||13
2604109|NCT00186043|6392419|P1|NOT COMPLETED|Overall Study||15
2604110|NCT00186043|6392418|P2|COMPLETED|Overall Study||12
2604111|NCT00186043|6392419|P1|COMPLETED|Overall Study||15
2604112|NCT00186043|6392418|P2|STARTED|Overall Study||25
2604113|NCT00186043|6392419|P1|STARTED|Overall Study||30
2604114|NCT00186017|6392431|P2|NOT COMPLETED|Overall Study||3
2604115|NCT00186017|6392432|P1|NOT COMPLETED|Overall Study||2
2604116|NCT00186017|6392431|P2|COMPLETED|Overall Study||22
2604117|NCT00186017|6392432|P1|COMPLETED|Overall Study||23
2604118|NCT00186017|6392431|P2|STARTED|Overall Study||25
2604119|NCT00186017|6392432|P1|STARTED|Overall Study||25
2604120|NCT00185965|6392446|P2|NOT COMPLETED|Overall Study||1
2604121|NCT00185965|6392447|P1|NOT COMPLETED|Overall Study||0
2604122|NCT00185965|6392446|P2|COMPLETED|Overall Study||14
2604123|NCT00185965|6392447|P1|COMPLETED|Overall Study||15
2604124|NCT00185965|6392446|P2|STARTED|Overall Study||15
2604125|NCT00185965|6392447|P1|STARTED|Overall Study||15
2604126|NCT00185900|6392455|P2|NOT COMPLETED|Overall Study||0
2604127|NCT00185900|6392456|P1|NOT COMPLETED|Overall Study||0
2604128|NCT00185900|6392455|P2|COMPLETED|Overall Study||100
2604129|NCT00185900|6392456|P1|COMPLETED|Overall Study||92
2604130|NCT00185900|6392455|P2|STARTED|Overall Study||100
2604131|NCT00185900|6392456|P1|STARTED|Overall Study||92
2604132|NCT00185731|6392472|P1|NOT COMPLETED|Overall Study||2
2604133|NCT00185731|6392472|P1|COMPLETED|Overall Study||23
2604134|NCT00185731|6392472|P1|STARTED|Overall Study||25
2604135|NCT00185692|6392478|P1|NOT COMPLETED|Overall Study||16
2604136|NCT00185692|6392478|P1|COMPLETED|Overall Study||0
2604137|NCT00185692|6392478|P1|STARTED|Overall Study||16
2604138|NCT00185679|6392483|P1|NOT COMPLETED|Overall Study||0
2604139|NCT00185679|6392483|P1|COMPLETED|Overall Study||13
2604140|NCT00185679|6392483|P1|STARTED|Overall Study||13
2604141|NCT00185640|6392489|P1|NOT COMPLETED|Overall Study||145
2604142|NCT00185640|6392489|P1|COMPLETED|Overall Study||158
2604143|NCT00185640|6392489|P1|90 Days Post-transplant|Overall Study||161
2604144|NCT00185640|6392489|P1|Transplanted|Overall Study||296
2604145|NCT00185640|6392489|P1|STARTED|Overall Study||303
2604146|NCT00185614|6392498|P1|NOT COMPLETED|Allogenic HCT (Allo-HCT)||0
2604147|NCT00185614|6392498|P1|COMPLETED|Allogenic HCT (Allo-HCT)||59
2604148|NCT00185614|6392498|P1|STARTED|Allogenic HCT (Allo-HCT)||59
2604149|NCT00185614|6392498|P1|NOT COMPLETED|Inter-treatment Period||4
2604150|NCT00185614|6392498|P1|COMPLETED|Inter-treatment Period||59
2604151|NCT00185614|6392498|P1|STARTED|Inter-treatment Period|Not all participants who received autologous transplant continued to receive allogeneic transplant.|63
2604152|NCT00185614|6392498|P1|NOT COMPLETED|Autologous HCT (Auto-HCT)||0
2604153|NCT00185614|6392498|P1|COMPLETED|Autologous HCT (Auto-HCT)||63
2604154|NCT00185614|6392498|P1|STARTED|Autologous HCT (Auto-HCT)||63
2604155|NCT00185588|6392510|P4|NOT COMPLETED|Overall Study||4
2604156|NCT00185588|6392511|P3|NOT COMPLETED|Overall Study||6
2604157|NCT00185588|6392512|P2|NOT COMPLETED|Overall Study||2
2604158|NCT00185588|6392513|P1|NOT COMPLETED|Overall Study||3
2604159|NCT00185588|6392510|P4|COMPLETED|Overall Study||13
2604160|NCT00185588|6392511|P3|COMPLETED|Overall Study||0
2604161|NCT00185588|6392512|P2|COMPLETED|Overall Study||2
2604162|NCT00185588|6392513|P1|COMPLETED|Overall Study||3
2604163|NCT00185588|6392510|P4|STARTED|Overall Study||17
2604164|NCT00185588|6392511|P3|STARTED|Overall Study||6
2604165|NCT00185588|6392512|P2|STARTED|Overall Study||4
2604166|NCT00185588|6392513|P1|STARTED|Overall Study||6
2604167|NCT00185458|6392527|P1|NOT COMPLETED|HRT Phase||27
2604168|NCT00185458|6392527|P1|COMPLETED|HRT Phase||141
2604169|NCT00185458|6392527|P1|STARTED|HRT Phase|168 subjects were eligible for the HRT phase out 336 who completed contraception phase.|168
2604170|NCT00185458|6392527|P1|NOT COMPLETED|Contraception Phase||58
2604171|NCT00185458|6392527|P1|COMPLETED|Contraception Phase||336
2604172|NCT00185458|6392527|P1|STARTED|Contraception Phase||394
2604173|NCT00185380|6392590|P3|NOT COMPLETED|Overall Study||74
2604174|NCT00185380|6392591|P2|NOT COMPLETED|Overall Study||72
2604175|NCT00185380|6392592|P1|NOT COMPLETED|Overall Study||66
2604176|NCT00185380|6392590|P3|COMPLETED|Overall Study||182
2604177|NCT00185380|6392591|P2|COMPLETED|Overall Study||174
2604178|NCT00185380|6392592|P1|COMPLETED|Overall Study||174
2604179|NCT00185380|6392590|P3|Subjects Received Treatment|Overall Study||254
2604180|NCT00185380|6392591|P2|Subjects Received Treatment|Overall Study||245
2604181|NCT00185380|6392592|P1|Subjects Received Treatment|Overall Study||239
2604182|NCT00185380|6392590|P3|STARTED|Overall Study||256
2604183|NCT00185380|6392591|P2|STARTED|Overall Study||246
2604184|NCT00185380|6392592|P1|STARTED|Overall Study||240
2604185|NCT00185211|6392620|P2|NOT COMPLETED|Follow-up Study (91031 - This Study)||34
2604186|NCT00185211|6392621|P1|NOT COMPLETED|Follow-up Study (91031 - This Study)||26
2604187|NCT00185211|6392620|P2|COMPLETED|Follow-up Study (91031 - This Study)||123
2604188|NCT00185211|6392621|P1|COMPLETED|Follow-up Study (91031 - This Study)||235
2604189|NCT00185211|6392620|P2|STARTED|Follow-up Study (91031 - This Study)|9 of the 166 subjects completing the placebo-controlled study did not consent to the Follow-up.|157
2604190|NCT00185211|6392621|P1|STARTED|Follow-up Study (91031 - This Study)|10 of the 271 subjects completing the placebo-controlled study did not consent to the Follow-up.|261
2604191|NCT00185211|6392620|P2|NOT COMPLETED|Placebo-controlled Study (92012)||10
2604192|NCT00185211|6392621|P1|NOT COMPLETED|Placebo-controlled Study (92012)||21
2604193|NCT00185211|6392620|P2|COMPLETED|Placebo-controlled Study (92012)||166
2604194|NCT00185211|6392621|P1|COMPLETED|Placebo-controlled Study (92012)||271
2604195|NCT00185211|6392620|P2|STARTED|Placebo-controlled Study (92012)||176
2604196|NCT00185211|6392621|P1|STARTED|Placebo-controlled Study (92012)||292
2604197|NCT00184717|6392649|P5|NOT COMPLETED|Extension Period (GHLIQUID-1517)||5
2604198|NCT00184717|6392650|P4|NOT COMPLETED|Extension Period (GHLIQUID-1517)||3
2604199|NCT00184717|6392651|P3|NOT COMPLETED|Extension Period (GHLIQUID-1517)||0
2604200|NCT00184717|6392652|P2|NOT COMPLETED|Extension Period (GHLIQUID-1517)||6
2604201|NCT00184717|6392653|P1|NOT COMPLETED|Extension Period (GHLIQUID-1517)||10
2604202|NCT00184717|6392649|P5|COMPLETED|Extension Period (GHLIQUID-1517)||5
2604203|NCT00184717|6392650|P4|COMPLETED|Extension Period (GHLIQUID-1517)||7
2604204|NCT00184717|6392651|P3|COMPLETED|Extension Period (GHLIQUID-1517)||0
2604205|NCT00184717|6392652|P2|COMPLETED|Extension Period (GHLIQUID-1517)||27
2604206|NCT00184717|6392653|P1|COMPLETED|Extension Period (GHLIQUID-1517)||23
2604207|NCT00184717|6392649|P5|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
2604208|NCT00184717|6392650|P4|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
2604209|NCT00184717|6392651|P3|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised to receive 0.033 or 0.067 mg|0
2604210|NCT00184717|6392652|P2|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
2604211|NCT00184717|6392653|P1|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
2604212|NCT00184717|6392649|P5|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
2604213|NCT00184717|6392650|P4|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
2604214|NCT00184717|6392651|P3|NOT COMPLETED|Main Period (GHLIQUID-1516)||1
2604215|NCT00184717|6392652|P2|NOT COMPLETED|Main Period (GHLIQUID-1516)||2
2604216|NCT00184717|6392653|P1|NOT COMPLETED|Main Period (GHLIQUID-1516)||3
2604217|NCT00184717|6392649|P5|COMPLETED|Main Period (GHLIQUID-1516)||0
2604218|NCT00184717|6392650|P4|COMPLETED|Main Period (GHLIQUID-1516)||0
2604219|NCT00184717|6392651|P3|COMPLETED|Main Period (GHLIQUID-1516)||20
2604220|NCT00184717|6392652|P2|COMPLETED|Main Period (GHLIQUID-1516)||36
2604221|NCT00184717|6392653|P1|COMPLETED|Main Period (GHLIQUID-1516)||36
2604222|NCT00184717|6392649|P5|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
2604223|NCT00184717|6392650|P4|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
2604224|NCT00184717|6392651|P3|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||21
2604225|NCT00184717|6392652|P2|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
2604226|NCT00184717|6392653|P1|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
2604227|NCT00184717|6392649|P5|STARTED|Main Period (GHLIQUID-1516)||0
2604228|NCT00184717|6392650|P4|STARTED|Main Period (GHLIQUID-1516)||0
2604229|NCT00184717|6392651|P3|STARTED|Main Period (GHLIQUID-1516)||21
2604230|NCT00184717|6392652|P2|STARTED|Main Period (GHLIQUID-1516)||38
2604231|NCT00184717|6392653|P1|STARTED|Main Period (GHLIQUID-1516)||39
2604232|NCT00184600|6392694|P3|NOT COMPLETED|Overall Study||34
2604233|NCT00184600|6392695|P2|NOT COMPLETED|Overall Study||51
2604234|NCT00184600|6392696|P1|NOT COMPLETED|Overall Study||45
2604235|NCT00184600|6392694|P3|COMPLETED|Overall Study||201
2604236|NCT00184600|6392695|P2|COMPLETED|Overall Study||188
2604237|NCT00184600|6392696|P1|COMPLETED|Overall Study||189
2604238|NCT00184600|6392694|P3|STARTED|Overall Study||235
2604239|NCT00184600|6392695|P2|STARTED|Overall Study||239
2604240|NCT00184600|6392696|P1|STARTED|Overall Study||234
2604241|NCT00184548|6392750|P4|NOT COMPLETED|Overall Study||7
2604242|NCT00184548|6392751|P3|NOT COMPLETED|Overall Study||3
2604243|NCT00184548|6392752|P2|NOT COMPLETED|Overall Study||13
2604244|NCT00184548|6392753|P1|NOT COMPLETED|Overall Study||8
2604245|NCT00184548|6392750|P4|COMPLETED|Overall Study||38
2604246|NCT00184548|6392751|P3|COMPLETED|Overall Study||44
2604247|NCT00184548|6392752|P2|COMPLETED|Overall Study||242
2604248|NCT00184548|6392753|P1|COMPLETED|Overall Study||218
2604249|NCT00184548|6392750|P4|Exposed|Overall Study|Four subjects withdrew due to ineligibility, one subject died. Excluded from safety analysis set|40
2604250|NCT00184548|6392751|P3|Exposed|Overall Study|One subject withdrew due to ineligibility. Excluded from safety analysis set|46
2604251|NCT00184548|6392752|P2|Exposed|Overall Study|Three subjects withdrew due to ineligibility, two subjects died. Excluded from safety analysis set|250
2604252|NCT00184548|6392753|P1|Exposed|Overall Study|Two subjects withdrew due to ineligibility. Excluded from safety analysis set|224
2604253|NCT00184548|6392750|P4|STARTED|Overall Study||45
2604254|NCT00184548|6392751|P3|STARTED|Overall Study||47
2604255|NCT00184548|6392752|P2|STARTED|Overall Study||255
2604256|NCT00184548|6392753|P1|STARTED|Overall Study||226
2604257|NCT00184093|6392787|P1|NOT COMPLETED|Overall Study||9
2604258|NCT00184093|6392787|P1|COMPLETED|Overall Study||26
2604259|NCT00184093|6392787|P1|STARTED|Overall Study|Phase 1 participants = 6 Phase 2 participants = 29|35
2604260|NCT00184054|6392792|P1|NOT COMPLETED|Overall Study||1
2604261|NCT00184054|6392792|P1|COMPLETED|Overall Study||10
2604262|NCT00184054|6392792|P1|STARTED|Overall Study||11
2604263|NCT00184028|6392797|P1|NOT COMPLETED|Overall Study||10
2604264|NCT00184028|6392797|P1|COMPLETED|Overall Study||2
2604265|NCT00184028|6392797|P1|STARTED|Overall Study||12
2604266|NCT00184002|6392802|P1|NOT COMPLETED|Overall Study||17
2604267|NCT00184002|6392802|P1|COMPLETED|Overall Study||51
2604268|NCT00184002|6392802|P1|STARTED|Overall Study||68
2604269|NCT00183963|6392811|P4|NOT COMPLETED|Overall Study||1
2604270|NCT00183963|6392812|P3|NOT COMPLETED|Overall Study||1
2604271|NCT00183963|6392813|P2|NOT COMPLETED|Overall Study||1
2604272|NCT00183963|6392814|P1|NOT COMPLETED|Overall Study||1
2604273|NCT00183963|6392811|P4|COMPLETED|Overall Study||0
2604274|NCT00183963|6392812|P3|COMPLETED|Overall Study||0
2604275|NCT00183963|6392813|P2|COMPLETED|Overall Study||0
2604276|NCT00183963|6392814|P1|COMPLETED|Overall Study||0
2604277|NCT00183963|6392811|P4|STARTED|Overall Study||1
2604278|NCT00183963|6392812|P3|STARTED|Overall Study||1
2604279|NCT00183963|6392813|P2|STARTED|Overall Study||1
2604280|NCT00183963|6392814|P1|STARTED|Overall Study||1
2604281|NCT00183872|6392828|P1|NOT COMPLETED|Overall Study||16
2604282|NCT00183872|6392828|P1|COMPLETED|Overall Study||24
2604283|NCT00183872|6392828|P1|STARTED|Overall Study||40
2604284|NCT00183794|6392833|P1|NOT COMPLETED|Overall Study||0
2604285|NCT00183794|6392833|P1|COMPLETED|Overall Study||20
2604286|NCT00183794|6392833|P1|STARTED|Overall Study||20
2604287|NCT00183729|6392840|P2|NOT COMPLETED|Overall Study||5
2604288|NCT00183729|6392841|P1|NOT COMPLETED|Overall Study||3
2604289|NCT00183729|6392840|P2|COMPLETED|Overall Study||13
2604290|NCT00183729|6392841|P1|COMPLETED|Overall Study||14
2604291|NCT00183729|6392840|P2|STARTED|Overall Study||18
2604292|NCT00183729|6392841|P1|STARTED|Overall Study||17
2604293|NCT00183677|6392851|P1|NOT COMPLETED|Overall Study||44
2604294|NCT00183677|6392851|P1|COMPLETED|Overall Study||53
2604295|NCT00183677|6392851|P1|STARTED|Overall Study||97
2604296|NCT00183625|6392857|P4|NOT COMPLETED|Overall Study||14
2604297|NCT00183625|6392858|P3|NOT COMPLETED|Overall Study||19
2604298|NCT00183625|6392859|P2|NOT COMPLETED|Overall Study||18
2604299|NCT00183625|6392860|P1|NOT COMPLETED|Overall Study||18
2604300|NCT00183625|6392857|P4|COMPLETED|Overall Study||10
2604301|NCT00183625|6392858|P3|COMPLETED|Overall Study||9
2604302|NCT00183625|6392859|P2|COMPLETED|Overall Study||10
2604303|NCT00183625|6392860|P1|COMPLETED|Overall Study||9
2604304|NCT00183625|6392857|P4|Obtained Employment|Overall Study||14
2604305|NCT00183625|6392858|P3|Obtained Employment|Overall Study||14
2604306|NCT00183625|6392859|P2|Obtained Employment|Overall Study||18
2604307|NCT00183625|6392860|P1|Obtained Employment|Overall Study||21
2604308|NCT00183625|6392857|P4|STARTED|Overall Study||24
2604309|NCT00183625|6392858|P3|STARTED|Overall Study||28
2604310|NCT00183625|6392859|P2|STARTED|Overall Study||28
2604311|NCT00183625|6392860|P1|STARTED|Overall Study||27
2604312|NCT00183469|6392870|P2|NOT COMPLETED|Overall Study||29
2604313|NCT00183469|6392871|P1|NOT COMPLETED|Overall Study||28
2604314|NCT00183469|6392870|P2|COMPLETED|Overall Study||16
2604315|NCT00183469|6392871|P1|COMPLETED|Overall Study||13
2604316|NCT00183469|6392870|P2|STARTED|Overall Study||45
2604317|NCT00183469|6392871|P1|STARTED|Overall Study||41
2604318|NCT00183456|6392881|P4|NOT COMPLETED|Overall Study||28
2604319|NCT00183456|6392882|P3|NOT COMPLETED|Overall Study||16
2604320|NCT00183456|6392883|P2|NOT COMPLETED|Overall Study||1
2604321|NCT00183456|6392884|P1|NOT COMPLETED|Overall Study||3
2604322|NCT00183456|6392881|P4|COMPLETED|Overall Study|total # of non-randomized index participants that completed any follow-up|220
2604323|NCT00183456|6392882|P3|COMPLETED|Overall Study|total # of network participants that completed any follow-up|313
2604324|NCT00183456|6392883|P2|COMPLETED|Overall Study|total # of comparison condition participants that completed any follow-up|83
2604325|NCT00183456|6392884|P1|COMPLETED|Overall Study|total # of intervention participants that completed any follow-up (6, 12, or 18 month Follow-up)|82
2604326|NCT00183456|6392881|P4|18 Month Follow-up|Overall Study||207
2604327|NCT00183456|6392882|P3|18 Month Follow-up|Overall Study||303
2604328|NCT00183456|6392883|P2|18 Month Follow-up|Overall Study||81
2604329|NCT00183456|6392884|P1|18 Month Follow-up|Overall Study||80
2604330|NCT00183456|6392881|P4|12 Month Follow-up|Overall Study||186
2604331|NCT00183456|6392882|P3|12 Month Follow-up|Overall Study||267
2604332|NCT00183456|6392883|P2|12 Month Follow-up|Overall Study||74
2604333|NCT00183456|6392884|P1|12 Month Follow-up|Overall Study||76
2604334|NCT00183456|6392881|P4|6 Month Follow-up|Overall Study||175
2604335|NCT00183456|6392882|P3|6 Month Follow-up|Overall Study||278
2604336|NCT00183456|6392883|P2|6 Month Follow-up|Overall Study||77
2604337|NCT00183456|6392884|P1|6 Month Follow-up|Overall Study||74
2604338|NCT00183456|6392881|P4|STARTED|Overall Study||248
2604339|NCT00183456|6392882|P3|STARTED|Overall Study||329
2604340|NCT00183456|6392883|P2|STARTED|Overall Study||84
2604341|NCT00183456|6392884|P1|STARTED|Overall Study||85
2604342|NCT00183443|6392933|P3|NOT COMPLETED|Overall Study||0
2604343|NCT00183443|6392934|P2|NOT COMPLETED|Overall Study||0
2604344|NCT00183443|6392935|P1|NOT COMPLETED|Overall Study||0
2604345|NCT00183443|6392933|P3|COMPLETED|Overall Study|4 eligible participants were offered enrollment in the continuation phase|25
2604346|NCT00183443|6392934|P2|COMPLETED|Overall Study|8 eligible participants were offered enrollment in the continuation phase|26
2604347|NCT00183443|6392935|P1|COMPLETED|Overall Study|13 eligible participants were offered enrollment in the continuation phase|24
2604348|NCT00183443|6392933|P3|STARTED|Overall Study||25
2604349|NCT00183443|6392934|P2|STARTED|Overall Study||26
2604350|NCT00183443|6392935|P1|STARTED|Overall Study||24
2604351|NCT00183430|6392957|P2|NOT COMPLETED|Overall Study||0
2604352|NCT00183430|6392958|P1|NOT COMPLETED|Overall Study||6
2604353|NCT00183430|6392957|P2|COMPLETED|Overall Study||11
2604354|NCT00183430|6392958|P1|COMPLETED|Overall Study||3
2604355|NCT00183430|6392957|P2|STARTED|Overall Study||11
2604356|NCT00183430|6392958|P1|STARTED|Overall Study||9
2604357|NCT00183391|6392970|P2|NOT COMPLETED|Block 2 - 5 Weeks||2
2604358|NCT00183391|6392971|P1|NOT COMPLETED|Block 2 - 5 Weeks||4
2604359|NCT00183391|6392970|P2|COMPLETED|Block 2 - 5 Weeks||108
2604360|NCT00183391|6392971|P1|COMPLETED|Block 2 - 5 Weeks||91
2604361|NCT00183391|6392970|P2|STARTED|Block 2 - 5 Weeks||110
2604362|NCT00183391|6392971|P1|STARTED|Block 2 - 5 Weeks||95
2604363|NCT00183391|6392970|P2|NOT COMPLETED|Crossover Placebo - 2 Weeks||0
2604364|NCT00183391|6392971|P1|NOT COMPLETED|Crossover Placebo - 2 Weeks||0
2604365|NCT00183391|6392970|P2|COMPLETED|Crossover Placebo - 2 Weeks||110
2604366|NCT00183391|6392971|P1|COMPLETED|Crossover Placebo - 2 Weeks||95
2604367|NCT00183391|6392970|P2|STARTED|Crossover Placebo - 2 Weeks||110
2604368|NCT00183391|6392971|P1|STARTED|Crossover Placebo - 2 Weeks||95
2604369|NCT00183391|6392970|P2|NOT COMPLETED|Block 1 - 5 Weeks||14
2604370|NCT00183391|6392971|P1|NOT COMPLETED|Block 1 - 5 Weeks||13
2604371|NCT00183391|6392970|P2|COMPLETED|Block 1 - 5 Weeks||110
2604372|NCT00183391|6392971|P1|COMPLETED|Block 1 - 5 Weeks||95
2604373|NCT00183391|6392970|P2|STARTED|Block 1 - 5 Weeks||124
2604374|NCT00183391|6392971|P1|STARTED|Block 1 - 5 Weeks||108
2604375|NCT00183339|6393031|P2|NOT COMPLETED|Overall Study||4
2604376|NCT00183339|6393032|P1|NOT COMPLETED|Overall Study||6
2604377|NCT00183339|6393031|P2|COMPLETED|Overall Study||4
2604378|NCT00183339|6393032|P1|COMPLETED|Overall Study||4
2604379|NCT00183339|6393031|P2|STARTED|Overall Study||8
2604380|NCT00183339|6393032|P1|STARTED|Overall Study||10
2604381|NCT00183274|6393044|P6|NOT COMPLETED|Phase 3: Double-Blind||4
2604382|NCT00183274|6393045|P5|NOT COMPLETED|Phase 3: Double-Blind||20
2604383|NCT00183274|6393046|P4|NOT COMPLETED|Phase 3: Double-Blind||2
2604384|NCT00183274|6393047|P3|NOT COMPLETED|Phase 3: Double-Blind||0
2604385|NCT00183274|6393048|P2|NOT COMPLETED|Phase 3: Double-Blind||0
2604386|NCT00183274|6393049|P1|NOT COMPLETED|Phase 3: Double-Blind||0
2604387|NCT00183274|6393044|P6|COMPLETED|Phase 3: Double-Blind|2 lost to relapse and 2 lost to dropout|6
2604388|NCT00183274|6393045|P5|COMPLETED|Phase 3: Double-Blind|11 lost to relapse and 9 lost to dropout|14
2604389|NCT00183274|6393046|P4|COMPLETED|Phase 3: Double-Blind|1 lost to relapse and 1 lost to dropout|13
2604390|NCT00183274|6393047|P3|COMPLETED|Phase 3: Double-Blind||0
2604391|NCT00183274|6393048|P2|COMPLETED|Phase 3: Double-Blind||0
2604392|NCT00183274|6393049|P1|COMPLETED|Phase 3: Double-Blind||0
2604393|NCT00183274|6393044|P6|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|10
2604394|NCT00183274|6393045|P5|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|34
2604395|NCT00183274|6393046|P4|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|15
2604396|NCT00183274|6393047|P3|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
2604397|NCT00183274|6393048|P2|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
2604398|NCT00183274|6393049|P1|STARTED|Phase 3: Double-Blind||0
2604399|NCT00183274|6393044|P6|NOT COMPLETED|Phase 2: Double-Blind||0
2604400|NCT00183274|6393045|P5|NOT COMPLETED|Phase 2: Double-Blind||0
2604401|NCT00183274|6393046|P4|NOT COMPLETED|Phase 2: Double-Blind||0
2604402|NCT00183274|6393047|P3|NOT COMPLETED|Phase 2: Double-Blind||43
2604403|NCT00183274|6393048|P2|NOT COMPLETED|Phase 2: Double-Blind||26
2604404|NCT00183274|6393049|P1|NOT COMPLETED|Phase 2: Double-Blind||0
2604405|NCT00183274|6393044|P6|COMPLETED|Phase 2: Double-Blind||0
2604406|NCT00183274|6393045|P5|COMPLETED|Phase 2: Double-Blind||0
2604407|NCT00183274|6393046|P4|COMPLETED|Phase 2: Double-Blind||0
2604408|NCT00183274|6393047|P3|COMPLETED|Phase 2: Double-Blind|29 lost to relapse, 14 lost to dropout|11
2604409|NCT00183274|6393048|P2|COMPLETED|Phase 2: Double-Blind|8 lost to relapse, 18 lost to dropout|56
2604410|NCT00183274|6393049|P1|COMPLETED|Phase 2: Double-Blind||0
2604411|NCT00183274|6393044|P6|STARTED|Phase 2: Double-Blind||0
2604412|NCT00183274|6393045|P5|STARTED|Phase 2: Double-Blind||0
2604413|NCT00183274|6393046|P4|STARTED|Phase 2: Double-Blind||0
2604414|NCT00183274|6393047|P3|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|54
2604415|NCT00183274|6393048|P2|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|82
2604416|NCT00183274|6393049|P1|STARTED|Phase 2: Double-Blind|This phase ended after 6 months. There were no longer participants in this phase.|0
2604417|NCT00183274|6393044|P6|NOT COMPLETED|Phase 1: Open-Label||0
2604418|NCT00183274|6393045|P5|NOT COMPLETED|Phase 1: Open-Label||0
2604419|NCT00183274|6393046|P4|NOT COMPLETED|Phase 1: Open-Label||0
2604420|NCT00183274|6393047|P3|NOT COMPLETED|Phase 1: Open-Label||0
2604421|NCT00183274|6393048|P2|NOT COMPLETED|Phase 1: Open-Label||0
2604422|NCT00183274|6393049|P1|NOT COMPLETED|Phase 1: Open-Label||110
2604423|NCT00183274|6393044|P6|COMPLETED|Phase 1: Open-Label||0
2604424|NCT00183274|6393045|P5|COMPLETED|Phase 1: Open-Label||0
2604425|NCT00183274|6393046|P4|COMPLETED|Phase 1: Open-Label||0
2604426|NCT00183274|6393047|P3|COMPLETED|Phase 1: Open-Label||0
2604427|NCT00183274|6393048|P2|COMPLETED|Phase 1: Open-Label||0
2604428|NCT00183274|6393049|P1|COMPLETED|Phase 1: Open-Label|110 dropouts during phase 1|158
2604429|NCT00183274|6393044|P6|STARTED|Phase 1: Open-Label||0
2604430|NCT00183274|6393045|P5|STARTED|Phase 1: Open-Label||0
2604431|NCT00183274|6393046|P4|STARTED|Phase 1: Open-Label||0
2604432|NCT00183274|6393047|P3|STARTED|Phase 1: Open-Label||0
2604433|NCT00183274|6393048|P2|STARTED|Phase 1: Open-Label||0
2604434|NCT00183274|6393049|P1|STARTED|Phase 1: Open-Label||268
2604435|NCT00183248|6393066|P2|NOT COMPLETED|Overall Study||1
2604436|NCT00183248|6393067|P1|NOT COMPLETED|Overall Study||1
2604437|NCT00183248|6393066|P2|COMPLETED|Overall Study||4
2604438|NCT00183248|6393067|P1|COMPLETED|Overall Study||3
2604439|NCT00183248|6393066|P2|STARTED|Overall Study||5
2604440|NCT00183248|6393067|P1|STARTED|Overall Study||4
2604441|NCT00183196|6393088|P3|NOT COMPLETED|Overall Study||18
2604442|NCT00183196|6393089|P2|NOT COMPLETED|Overall Study||15
2604443|NCT00183196|6393090|P1|NOT COMPLETED|Overall Study||20
2604444|NCT00183196|6393088|P3|COMPLETED|Overall Study||32
2604445|NCT00183196|6393089|P2|COMPLETED|Overall Study||35
2604446|NCT00183196|6393090|P1|COMPLETED|Overall Study||30
2604447|NCT00183196|6393088|P3|STARTED|Overall Study|1 subject had no post-randomization data|50
2604448|NCT00183196|6393089|P2|STARTED|Overall Study|1 subject had no post-randomization data|50
2604449|NCT00183196|6393090|P1|STARTED|Overall Study|2 subjects had no post-randomization data|50
2604450|NCT00183092|6393100|P4|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
2604451|NCT00183092|6393101|P3|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
2604452|NCT00183092|6393102|P2|NOT COMPLETED|Open-label Period (Month 2 Until Death)||14
2604453|NCT00183092|6393103|P1|NOT COMPLETED|Open-label Period (Month 2 Until Death)||10
2604454|NCT00183092|6393100|P4|COMPLETED|Open-label Period (Month 2 Until Death)||0
2604455|NCT00183092|6393101|P3|COMPLETED|Open-label Period (Month 2 Until Death)||0
2604456|NCT00183092|6393102|P2|COMPLETED|Open-label Period (Month 2 Until Death)||0
2604457|NCT00183092|6393103|P1|COMPLETED|Open-label Period (Month 2 Until Death)||0
2604458|NCT00183092|6393100|P4|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Placebo opted to continue assigned drug during open-label period|1
2604459|NCT00183092|6393101|P3|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Quinacrine opted to continue assigned drug during open-label period|1
2604460|NCT00183092|6393102|P2|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Placebo opted to begin open-label Quinacrine at Month 2|14
2604461|NCT00183092|6393103|P1|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Quinacrine opted to begin open-label Quinacrine at Month 2|10
2604462|NCT00183092|6393100|P4|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
2604463|NCT00183092|6393101|P3|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
2604464|NCT00183092|6393102|P2|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
2604465|NCT00183092|6393103|P1|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
2604466|NCT00183092|6393100|P4|COMPLETED|Double-blind (Baseline - Month 2)||0
2604467|NCT00183092|6393101|P3|COMPLETED|Double-blind (Baseline - Month 2)||0
2604468|NCT00183092|6393102|P2|COMPLETED|Double-blind (Baseline - Month 2)||16
2604469|NCT00183092|6393103|P1|COMPLETED|Double-blind (Baseline - Month 2)||11
2604470|NCT00183092|6393100|P4|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
2604471|NCT00183092|6393101|P3|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
2604472|NCT00183092|6393102|P2|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||16
2604473|NCT00183092|6393103|P1|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||10
2604474|NCT00183092|6393100|P4|Alive at Month 2|Double-blind (Baseline - Month 2)||0
2604567|NCT00181766|6393277|P1|NOT COMPLETED|Overall Study||12
2604475|NCT00183092|6393101|P3|Alive at Month 2|Double-blind (Baseline - Month 2)||0
2604476|NCT00183092|6393102|P2|Alive at Month 2|Double-blind (Baseline - Month 2)||19
2604477|NCT00183092|6393103|P1|Alive at Month 2|Double-blind (Baseline - Month 2)||13
2604478|NCT00183092|6393100|P4|STARTED|Double-blind (Baseline - Month 2)||0
2604479|NCT00183092|6393101|P3|STARTED|Double-blind (Baseline - Month 2)||0
2604480|NCT00183092|6393102|P2|STARTED|Double-blind (Baseline - Month 2)||28
2604481|NCT00183092|6393103|P1|STARTED|Double-blind (Baseline - Month 2)||23
2604482|NCT00182793|6393124|P1|NOT COMPLETED|Overall Study||0
2604483|NCT00182793|6393124|P1|COMPLETED|Overall Study||32
2604484|NCT00182793|6393124|P1|STARTED|Overall Study||32
2604485|NCT00182767|6393129|P5|NOT COMPLETED|Overall Study||0
2604486|NCT00182767|6393130|P4|NOT COMPLETED|Overall Study||0
2604487|NCT00182767|6393131|P3|NOT COMPLETED|Overall Study||0
2604488|NCT00182767|6393132|P2|NOT COMPLETED|Overall Study||0
2604489|NCT00182767|6393133|P1|NOT COMPLETED|Overall Study||0
2604490|NCT00182767|6393129|P5|COMPLETED|Overall Study||24
2604491|NCT00182767|6393130|P4|COMPLETED|Overall Study||3
2604492|NCT00182767|6393131|P3|COMPLETED|Overall Study||6
2604493|NCT00182767|6393132|P2|COMPLETED|Overall Study||6
2604494|NCT00182767|6393133|P1|COMPLETED|Overall Study||6
2604495|NCT00182767|6393129|P5|STARTED|Overall Study||24
2604496|NCT00182767|6393130|P4|STARTED|Overall Study||3
2604497|NCT00182767|6393131|P3|STARTED|Overall Study||6
2604498|NCT00182767|6393132|P2|STARTED|Overall Study||6
2604499|NCT00182767|6393133|P1|STARTED|Overall Study||6
2604500|NCT00182754|6393150|P2|NOT COMPLETED|Overall Study||0
2604501|NCT00182754|6393151|P1|NOT COMPLETED|Overall Study||0
2604502|NCT00182754|6393150|P2|COMPLETED|Overall Study||17
2604503|NCT00182754|6393151|P1|COMPLETED|Overall Study||16
2604504|NCT00182754|6393150|P2|STARTED|Overall Study||17
2604505|NCT00182754|6393151|P1|STARTED|Overall Study||16
2604506|NCT00182728|6393161|P1|NOT COMPLETED|Overall Study||0
2604507|NCT00182728|6393161|P1|COMPLETED|Overall Study||71
2604508|NCT00182728|6393161|P1|STARTED|Overall Study||71
2604509|NCT00182689|6393173|P2|NOT COMPLETED|Overall Study||49
2604510|NCT00182689|6393174|P1|NOT COMPLETED|Overall Study||40
2604511|NCT00182689|6393173|P2|COMPLETED|Overall Study||0
2604512|NCT00182689|6393174|P1|COMPLETED|Overall Study||0
2604513|NCT00182689|6393173|P2|Eligible and Began Protocol Therapy|Overall Study||45
2604514|NCT00182689|6393174|P1|Eligible and Began Protocol Therapy|Overall Study||38
2604515|NCT00182689|6393173|P2|Eligible|Overall Study||45
2604516|NCT00182689|6393174|P1|Eligible|Overall Study||39
2604517|NCT00182689|6393173|P2|STARTED|Overall Study||49
2604518|NCT00182689|6393174|P1|STARTED|Overall Study||40
2604519|NCT00182637|6393184|P1|NOT COMPLETED|Overall Study||3
2604520|NCT00182637|6393184|P1|COMPLETED|Overall Study|off study date|2
2604521|NCT00182637|6393184|P1|STARTED|Overall Study|active/on treatment date|5
2604522|NCT00182325|6393192|P2|NOT COMPLETED|Overall Study||53
2604523|NCT00182325|6393193|P1|NOT COMPLETED|Overall Study||34
2604524|NCT00182325|6393192|P2|COMPLETED|Overall Study|43 completed survey, 89 included in intention-to-treat analysis|43
2604525|NCT00182325|6393193|P1|COMPLETED|Overall Study|63 completed survey, 85 included in intention-to-treat analysis|63
2604526|NCT00182325|6393192|P2|STARTED|Overall Study||96
2604527|NCT00182325|6393193|P1|STARTED|Overall Study||97
2604528|NCT00182091|6393221|P4|NOT COMPLETED|Overall Study||0
2604529|NCT00182091|6393222|P3|NOT COMPLETED|Overall Study||0
2604530|NCT00182091|6393223|P2|NOT COMPLETED|Overall Study||0
2604531|NCT00182091|6393224|P1|NOT COMPLETED|Overall Study||1
2604532|NCT00182091|6393221|P4|COMPLETED|Overall Study||20
2604533|NCT00182091|6393222|P3|COMPLETED|Overall Study||25
2604534|NCT00182091|6393223|P2|COMPLETED|Overall Study||15
2604535|NCT00182091|6393224|P1|COMPLETED|Overall Study||14
2604536|NCT00182091|6393221|P4|STARTED|Overall Study||20
2604537|NCT00182091|6393222|P3|STARTED|Overall Study||25
2604538|NCT00182091|6393223|P2|STARTED|Overall Study||15
2604539|NCT00182091|6393224|P1|STARTED|Overall Study||15
2604540|NCT00182078|6393240|P2|NOT COMPLETED|Overall Study||0
2604541|NCT00182078|6393241|P1|NOT COMPLETED|Overall Study||1
2604542|NCT00182078|6393240|P2|COMPLETED|Overall Study||17
2604543|NCT00182078|6393241|P1|COMPLETED|Overall Study||8
2604544|NCT00182078|6393240|P2|STARTED|Overall Study||17
2604545|NCT00182078|6393241|P1|STARTED|Overall Study||9
2604546|NCT00182000|6393253|P2|NOT COMPLETED|Overall Study||2
2604547|NCT00182000|6393254|P1|NOT COMPLETED|Overall Study||5
2604548|NCT00182000|6393253|P2|COMPLETED|Overall Study||13
2604549|NCT00182000|6393254|P1|COMPLETED|Overall Study||9
2604550|NCT00182000|6393253|P2|STARTED|Overall Study||15
2604551|NCT00182000|6393254|P1|STARTED|Overall Study||14
2604552|NCT00181961|6393262|P2|NOT COMPLETED|Overall Study||5
2604553|NCT00181961|6393263|P1|NOT COMPLETED|Overall Study||1
2604554|NCT00181961|6393262|P2|COMPLETED|Overall Study||4
2604555|NCT00181961|6393263|P1|COMPLETED|Overall Study||6
2604556|NCT00181961|6393262|P2|STARTED|Overall Study||9
2604557|NCT00181961|6393263|P1|STARTED|Overall Study||7
2604558|NCT00181883|6393269|P1|NOT COMPLETED|Overall Study||10
2604559|NCT00181883|6393269|P1|COMPLETED|Overall Study||20
2604560|NCT00181883|6393269|P1|STARTED|Overall Study||30
2604561|NCT00181844|6393273|P1|NOT COMPLETED|Exposed to Study Medication||17
2604562|NCT00181844|6393273|P1|COMPLETED|Exposed to Study Medication||22
2604563|NCT00181844|6393273|P1|STARTED|Exposed to Study Medication||39
2604564|NCT00181844|6393273|P1|NOT COMPLETED|Signed Consent||12
2604565|NCT00181844|6393273|P1|COMPLETED|Signed Consent||39
2604566|NCT00181844|6393273|P1|STARTED|Signed Consent||51
2604568|NCT00181766|6393277|P1|COMPLETED|Overall Study|Completed the trial.|33
2604569|NCT00181766|6393277|P1|STARTED|Overall Study|Number of subjects enrolled and treated with Atomoxetine.|45
2604570|NCT00181714|6393282|P1|NOT COMPLETED|Began Treatment With OROS-MPH||124
2604571|NCT00181714|6393282|P1|COMPLETED|Began Treatment With OROS-MPH||30
2604572|NCT00181714|6393282|P1|STARTED|Began Treatment With OROS-MPH||154
2604573|NCT00181714|6393282|P1|NOT COMPLETED|Signed Consent/Enrolled||49
2604574|NCT00181714|6393282|P1|COMPLETED|Signed Consent/Enrolled||154
2604575|NCT00181714|6393282|P1|STARTED|Signed Consent/Enrolled||203
2604576|NCT00181623|6393286|P1|NOT COMPLETED|Overall Study||1
2604577|NCT00181623|6393286|P1|COMPLETED|Overall Study||5
2604578|NCT00181623|6393286|P1|STARTED|Overall Study||6
2604579|NCT00181610|6393294|P3|NOT COMPLETED|Overall Study||0
2604580|NCT00181610|6393295|P2|NOT COMPLETED|Overall Study||1
2604581|NCT00181610|6393296|P1|NOT COMPLETED|Overall Study||0
2604582|NCT00181610|6393294|P3|COMPLETED|Overall Study||3
2604583|NCT00181610|6393295|P2|COMPLETED|Overall Study||3
2604584|NCT00181610|6393296|P1|COMPLETED|Overall Study||4
2604585|NCT00181610|6393294|P3|STARTED|Overall Study||3
2604586|NCT00181610|6393295|P2|STARTED|Overall Study||4
2604587|NCT00181610|6393296|P1|STARTED|Overall Study||4
2604588|NCT00181363|6393307|P1|NOT COMPLETED|Overall Study||0
2604589|NCT00181363|6393307|P1|COMPLETED|Overall Study||10
2604590|NCT00181363|6393307|P1|STARTED|Overall Study|10|10
2604591|NCT00181285|6393322|P2|NOT COMPLETED|Overall Study||0
2604592|NCT00181285|6393323|P1|NOT COMPLETED|Overall Study||0
2604593|NCT00181285|6393322|P2|COMPLETED|Overall Study||25
2604594|NCT00181285|6393323|P1|COMPLETED|Overall Study||27
2604595|NCT00181285|6393322|P2|STARTED|Overall Study||25
2604596|NCT00181285|6393323|P1|STARTED|Overall Study||27
2604597|NCT00181207|6393333|P2|NOT COMPLETED|Overall Study||0
2604598|NCT00181207|6393334|P1|NOT COMPLETED|Overall Study||0
2604599|NCT00181207|6393333|P2|COMPLETED|Overall Study||26
2604600|NCT00181207|6393334|P1|COMPLETED|Overall Study||24
2604601|NCT00181207|6393333|P2|STARTED|Overall Study||26
2604602|NCT00181207|6393334|P1|STARTED|Overall Study||24
2604603|NCT00181168|6393344|P2|NOT COMPLETED|Overall Study||0
2604604|NCT00181168|6393345|P1|NOT COMPLETED|Overall Study||0
2604605|NCT00181168|6393344|P2|COMPLETED|Overall Study||33
2604606|NCT00181168|6393345|P1|COMPLETED|Overall Study||30
2604607|NCT00181168|6393344|P2|STARTED|Overall Study||33
2604608|NCT00181168|6393345|P1|STARTED|Overall Study||30
2604609|NCT00181155|6393351|P2|NOT COMPLETED|Overall Study||0
2604610|NCT00181155|6393352|P1|NOT COMPLETED|Overall Study||2
2604611|NCT00181155|6393351|P2|COMPLETED|Overall Study||3
2604612|NCT00181155|6393352|P1|COMPLETED|Overall Study||13
2604613|NCT00181155|6393351|P2|STARTED|Overall Study||3
2604614|NCT00181155|6393352|P1|STARTED|Overall Study||15
2604615|NCT00180713|6393362|P2|NOT COMPLETED|Overall Study||3
2604616|NCT00180713|6393363|P1|NOT COMPLETED|Overall Study||5
2604617|NCT00180713|6393362|P2|COMPLETED|Overall Study||16
2604618|NCT00180713|6393363|P1|COMPLETED|Overall Study||18
2604619|NCT00180713|6393362|P2|STARTED|Overall Study||19
2604620|NCT00180713|6393363|P1|STARTED|Overall Study||23
2604621|NCT00180687|6393381|P4|NOT COMPLETED|Overall Study||0
2604622|NCT00180687|6393382|P3|NOT COMPLETED|Overall Study||0
2604623|NCT00180687|6393383|P2|NOT COMPLETED|Overall Study||0
2604624|NCT00180687|6393384|P1|NOT COMPLETED|Overall Study||0
2604625|NCT00180687|6393381|P4|COMPLETED|Overall Study||20
2604626|NCT00180687|6393382|P3|COMPLETED|Overall Study||20
2604627|NCT00180687|6393383|P2|COMPLETED|Overall Study||20
2604628|NCT00180687|6393384|P1|COMPLETED|Overall Study||20
2604629|NCT00180687|6393381|P4|STARTED|Overall Study||20
2604630|NCT00180687|6393382|P3|STARTED|Overall Study||20
2604631|NCT00180687|6393383|P2|STARTED|Overall Study||20
2604632|NCT00180687|6393384|P1|STARTED|Overall Study||20
2604633|NCT00180661|6393408|P2|NOT COMPLETED|Overall Study||0
2604634|NCT00180661|6393409|P1|NOT COMPLETED|Overall Study||0
2604635|NCT00180661|6393408|P2|COMPLETED|Overall Study||20
2604636|NCT00180661|6393409|P1|COMPLETED|Overall Study||19
2604637|NCT00180661|6393408|P2|STARTED|Overall Study||20
2604638|NCT00180661|6393409|P1|STARTED|Overall Study||19
2604639|NCT00180479|6393427|P2|NOT COMPLETED|Overall Study||13
2604640|NCT00180479|6393428|P1|NOT COMPLETED|Overall Study||16
2604641|NCT00180479|6393427|P2|COMPLETED|Overall Study||320
2604642|NCT00180479|6393428|P1|COMPLETED|Overall Study||653
2604643|NCT00180479|6393427|P2|STARTED|Overall Study|1 patient randomized never signed consent, therefore no data collected. Analysis group = 332.|333
2604644|NCT00180479|6393428|P1|STARTED|Overall Study||669
2604645|NCT00180323|6393520|P1|NOT COMPLETED|Overall Study||0
2604646|NCT00180323|6393520|P1|COMPLETED|Overall Study||43
2604647|NCT00180323|6393520|P1|STARTED|Overall Study||43
2604648|NCT00180271|6393529|P2|NOT COMPLETED|Overall Study||0
2604649|NCT00180271|6393530|P1|NOT COMPLETED|Overall Study||0
2604650|NCT00180271|6393529|P2|COMPLETED|Overall Study||731
2604651|NCT00180271|6393530|P1|COMPLETED|Overall Study||1089
2604652|NCT00180271|6393529|P2|STARTED|Overall Study||731
2604653|NCT00180271|6393530|P1|STARTED|Overall Study||1089
2604654|NCT00179998|6393540|P2|NOT COMPLETED|Crossover Period - 6 Months||2
2604655|NCT00179998|6393541|P1|NOT COMPLETED|Crossover Period - 6 Months||0
2604656|NCT00179998|6393540|P2|COMPLETED|Crossover Period - 6 Months||10
2604657|NCT00179998|6393541|P1|COMPLETED|Crossover Period - 6 Months||12
2604658|NCT00179998|6393540|P2|STARTED|Crossover Period - 6 Months||12
2604659|NCT00179998|6393541|P1|STARTED|Crossover Period - 6 Months||12
2604660|NCT00179998|6393540|P2|NOT COMPLETED|Initial Period - 6 Months||0
2604661|NCT00179998|6393541|P1|NOT COMPLETED|Initial Period - 6 Months||0
2604662|NCT00179998|6393540|P2|COMPLETED|Initial Period - 6 Months||12
2604663|NCT00179998|6393541|P1|COMPLETED|Initial Period - 6 Months||12
2604664|NCT00179998|6393540|P2|STARTED|Initial Period - 6 Months||12
2604665|NCT00179998|6393541|P1|STARTED|Initial Period - 6 Months||12
2604666|NCT00179959|6393553|P2|NOT COMPLETED|Overall Study||3
2604667|NCT00179959|6393554|P1|NOT COMPLETED|Overall Study||6
2604668|NCT00179959|6393553|P2|COMPLETED|Overall Study||13
2604669|NCT00179959|6393554|P1|COMPLETED|Overall Study||9
2604670|NCT00179959|6393553|P2|STARTED|Overall Study||16
2604671|NCT00179959|6393554|P1|STARTED|Overall Study||15
2604672|NCT00179673|6393560|P1|NOT COMPLETED|Overall Study||43
2604673|NCT00179673|6393560|P1|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
2604674|NCT00179673|6393560|P1|Received Study Drug|Overall Study||43
2604675|NCT00179673|6393560|P1|STARTED|Overall Study||43
2604676|NCT00179660|6393568|P1|NOT COMPLETED|Overall Study||50
2604677|NCT00179660|6393568|P1|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
2604678|NCT00179660|6393568|P1|Completed 12 Cycles of Treatment|Overall Study||12
2604679|NCT00179660|6393568|P1|Received Study Drug|Overall Study||49
2604680|NCT00179660|6393568|P1|STARTED|Overall Study||50
2604681|NCT00179647|6393577|P1|NOT COMPLETED|Overall Study||1913
2604682|NCT00179647|6393577|P1|COMPLETED|Overall Study|Subjects participated in study until they presented with reason for discontinuation.|0
2604683|NCT00179647|6393577|P1|STARTED|Overall Study||1913
2604684|NCT00179621|6393584|P4|NOT COMPLETED|Open-Label Period||43
2604685|NCT00179621|6393585|P3|NOT COMPLETED|Open-Label Period||28
2604686|NCT00179621|6393586|P2|NOT COMPLETED|Open-Label Period||28
2604687|NCT00179621|6393587|P1|NOT COMPLETED|Open-Label Period||0
2604688|NCT00179621|6393584|P4|COMPLETED|Open-Label Period||13
2604689|NCT00179621|6393585|P3|COMPLETED|Open-Label Period||19
2604690|NCT00179621|6393586|P2|COMPLETED|Open-Label Period||14
2604691|NCT00179621|6393587|P1|COMPLETED|Open-Label Period||0
2604692|NCT00179621|6393584|P4|STARTED|Open-Label Period|'Started' includes 1 participant who completed double-blind and 55 who discontinued double-blind.|56
2604693|NCT00179621|6393585|P3|STARTED|Open-Label Period|'Started' includes 39 participants who completed double-blind and 8 who discontinued double-blind.|47
2604694|NCT00179621|6393586|P2|STARTED|Open-Label Period|'Started' includes 23 participants who completed double-blind and 19 who discontinued double-blind.|42
2604695|NCT00179621|6393587|P1|STARTED|Open-Label Period||0
2604696|NCT00179621|6393584|P4|NOT COMPLETED|Double-Blind Period||0
2604697|NCT00179621|6393585|P3|NOT COMPLETED|Double-Blind Period||30
2604698|NCT00179621|6393586|P2|NOT COMPLETED|Double-Blind Period||46
2604699|NCT00179621|6393587|P1|NOT COMPLETED|Double-Blind Period||64
2604700|NCT00179621|6393584|P4|COMPLETED|Double-Blind Period||0
2604701|NCT00179621|6393585|P3|COMPLETED|Double-Blind Period||39
2604702|NCT00179621|6393586|P2|COMPLETED|Double-Blind Period||23
2604703|NCT00179621|6393587|P1|COMPLETED|Double-Blind Period||3
2604704|NCT00179621|6393584|P4|STARTED|Double-Blind Period||0
2604705|NCT00179621|6393585|P3|STARTED|Double-Blind Period||69
2604706|NCT00179621|6393586|P2|STARTED|Double-Blind Period||69
2604707|NCT00179621|6393587|P1|STARTED|Double-Blind Period||67
2604708|NCT00179517|6393640|P2|NOT COMPLETED|Overall Study||1
2604709|NCT00179517|6393641|P1|NOT COMPLETED|Overall Study||2
2604710|NCT00179517|6393640|P2|COMPLETED|Overall Study||19
2604711|NCT00179517|6393641|P1|COMPLETED|Overall Study||18
2604712|NCT00179517|6393640|P2|STARTED|Overall Study||20
2604713|NCT00179517|6393641|P1|STARTED|Overall Study||20
2604714|NCT00179478|6393665|P2|NOT COMPLETED|Overall Study||15
2604715|NCT00179478|6393666|P1|NOT COMPLETED|Overall Study||13
2604716|NCT00179478|6393665|P2|COMPLETED|Overall Study||59
2604717|NCT00179478|6393666|P1|COMPLETED|Overall Study||68
2604718|NCT00179478|6393665|P2|STARTED|Overall Study||74
2604719|NCT00179478|6393666|P1|STARTED|Overall Study||81
2604720|NCT00179413|6393679|P2|NOT COMPLETED|Overall Study||115
2604721|NCT00179413|6393680|P1|NOT COMPLETED|Overall Study||125
2604722|NCT00179413|6393679|P2|COMPLETED|Overall Study||152
2604723|NCT00179413|6393680|P1|COMPLETED|Overall Study||157
2604724|NCT00179413|6393679|P2|STARTED|Overall Study||267
2604725|NCT00179413|6393680|P1|STARTED|Overall Study||282
2604726|NCT00179309|6393692|P2|NOT COMPLETED|Crossover||0
2604727|NCT00179309|6393693|P1|NOT COMPLETED|Crossover||0
2604728|NCT00179309|6393692|P2|COMPLETED|Crossover||3
2604729|NCT00179309|6393693|P1|COMPLETED|Crossover||0
2604730|NCT00179309|6393692|P2|STARTED|Crossover|Crossover was allowed so that patients randomized to B could receive the vaccine upon progression.|3
2604731|NCT00179309|6393693|P1|STARTED|Crossover||0
2604732|NCT00179309|6393692|P2|NOT COMPLETED|Treatment||5
2604733|NCT00179309|6393693|P1|NOT COMPLETED|Treatment||4
2604734|NCT00179309|6393692|P2|COMPLETED|Treatment||18
2604735|NCT00179309|6393693|P1|COMPLETED|Treatment||21
2604736|NCT00179309|6393692|P2|STARTED|Treatment||23
2604737|NCT00179309|6393693|P1|STARTED|Treatment||25
2604738|NCT00179127|6393703|P2|NOT COMPLETED|Overall Study||0
2604739|NCT00179127|6393704|P1|NOT COMPLETED|Overall Study||0
2604740|NCT00179127|6393703|P2|COMPLETED|Overall Study||0
2604741|NCT00179127|6393704|P1|COMPLETED|Overall Study||0
2604742|NCT00179127|6393703|P2|STARTED|Overall Study||0
2604743|NCT00179127|6393704|P1|STARTED|Overall Study||0
2604744|NCT00179010|6393716|P2|NOT COMPLETED|Overall Study||2
2604745|NCT00179010|6393717|P1|NOT COMPLETED|Overall Study||1
2604746|NCT00179010|6393716|P2|COMPLETED|Overall Study||5
2604747|NCT00179010|6393717|P1|COMPLETED|Overall Study||5
2604748|NCT00179010|6393716|P2|STARTED|Overall Study||7
2604749|NCT00179010|6393717|P1|STARTED|Overall Study||6
2604750|NCT00178919|6393727|P2|NOT COMPLETED|Overall Study||25
2604751|NCT00178919|6393728|P1|NOT COMPLETED|Overall Study||0
2604752|NCT00178919|6393727|P2|COMPLETED|Overall Study||68
2604753|NCT00178919|6393728|P1|COMPLETED|Overall Study||19
2604754|NCT00178919|6393727|P2|STARTED|Overall Study||93
2604755|NCT00178919|6393728|P1|STARTED|Overall Study||19
2604756|NCT00178841|6393736|P1|NOT COMPLETED|Overall Study||0
2604757|NCT00178841|6393736|P1|COMPLETED|Overall Study||4
2604758|NCT00178841|6393736|P1|STARTED|Overall Study||4
2604759|NCT00178711|6393744|P2|NOT COMPLETED|Overall Study||0
2604760|NCT00178711|6393745|P1|NOT COMPLETED|Overall Study||0
2604761|NCT00178711|6393744|P2|COMPLETED|Overall Study||45
2604762|NCT00178711|6393745|P1|COMPLETED|Overall Study||52
2604763|NCT00178711|6393744|P2|STARTED|Overall Study||45
2604764|NCT00178711|6393745|P1|STARTED|Overall Study||52
2604765|NCT00178685|6393756|P3|NOT COMPLETED|Overall Study||196
2604766|NCT00178685|6393757|P2|NOT COMPLETED|Overall Study||204
2604767|NCT00178685|6393758|P1|NOT COMPLETED|Overall Study||111
2604768|NCT00178685|6393756|P3|COMPLETED|Overall Study||128
2604769|NCT00178685|6393757|P2|COMPLETED|Overall Study||120
2604770|NCT00178685|6393758|P1|COMPLETED|Overall Study||61
2604771|NCT00178685|6393756|P3|STARTED|Overall Study||324
2604772|NCT00178685|6393757|P2|STARTED|Overall Study||324
2604773|NCT00178685|6393758|P1|STARTED|Overall Study||172
2604774|NCT00178633|6393769|P1|NOT COMPLETED|Overall Study||6
2604775|NCT00178633|6393769|P1|COMPLETED|Overall Study||37
2604776|NCT00178633|6393769|P1|STARTED|Overall Study||43
2604777|NCT00178503|6393777|P1|NOT COMPLETED|MPH Trial: High Dose||0
2604778|NCT00178503|6393777|P1|COMPLETED|MPH Trial: High Dose||24
2604779|NCT00178503|6393777|P1|STARTED|MPH Trial: High Dose||24
2604780|NCT00178503|6393777|P1|NOT COMPLETED|MPH Trial: Med Dose||0
2604781|NCT00178503|6393777|P1|COMPLETED|MPH Trial: Med Dose||24
2604782|NCT00178503|6393777|P1|STARTED|MPH Trial: Med Dose||24
2604783|NCT00178503|6393777|P1|NOT COMPLETED|MPH Trial: Low Dose||0
2604784|NCT00178503|6393777|P1|COMPLETED|MPH Trial: Low Dose||24
2604785|NCT00178503|6393777|P1|STARTED|MPH Trial: Low Dose||24
2604786|NCT00178503|6393777|P1|NOT COMPLETED|MPH Trial: Placebo||0
2604787|NCT00178503|6393777|P1|COMPLETED|MPH Trial: Placebo||24
2604788|NCT00178503|6393777|P1|STARTED|MPH Trial: Placebo||24
2604789|NCT00178477|6393795|P1|NOT COMPLETED|Overall Study||5
2604790|NCT00178477|6393795|P1|COMPLETED|Overall Study||5
2604791|NCT00178477|6393795|P1|STARTED|Overall Study||10
2604792|NCT00178464|6393799|P1|NOT COMPLETED|Overall Study||2
2604793|NCT00178464|6393799|P1|COMPLETED|Overall Study||9
2604794|NCT00178464|6393799|P1|STARTED|Overall Study||11
2604795|NCT00178399|6393804|P1|NOT COMPLETED|Overall Study||13
2604796|NCT00178399|6393804|P1|COMPLETED|Overall Study||115
2604797|NCT00178399|6393804|P1|STARTED|Overall Study||128
2604798|NCT00178256|6393811|P4|NOT COMPLETED|Overall Study||2
2604799|NCT00178256|6393812|P3|NOT COMPLETED|Overall Study||0
2604800|NCT00178256|6393813|P2|NOT COMPLETED|Overall Study||1
2604801|NCT00178256|6393814|P1|NOT COMPLETED|Overall Study||4
2604802|NCT00178256|6393811|P4|COMPLETED|Overall Study||16
2604803|NCT00178256|6393812|P3|COMPLETED|Overall Study||6
2604804|NCT00178256|6393813|P2|COMPLETED|Overall Study||6
2604805|NCT00178256|6393814|P1|COMPLETED|Overall Study||6
2604806|NCT00178256|6393811|P4|STARTED|Overall Study||18
2604807|NCT00178256|6393812|P3|STARTED|Overall Study||6
2604808|NCT00178256|6393813|P2|STARTED|Overall Study||7
2604809|NCT00178256|6393814|P1|STARTED|Overall Study||10
2604810|NCT00178191|6393824|P3|NOT COMPLETED|Overall Study||0
2604811|NCT00178191|6393825|P2|NOT COMPLETED|Overall Study||0
2604812|NCT00178191|6393826|P1|NOT COMPLETED|Overall Study||0
2604813|NCT00178191|6393824|P3|COMPLETED|Overall Study||7
2604814|NCT00178191|6393825|P2|COMPLETED|Overall Study||10
2604815|NCT00178191|6393826|P1|COMPLETED|Overall Study||11
2604816|NCT00178191|6393824|P3|STARTED|Overall Study||7
2604817|NCT00178191|6393825|P2|STARTED|Overall Study||10
2604818|NCT00178191|6393826|P1|STARTED|Overall Study||11
2604819|NCT00178178|6393838|P4|NOT COMPLETED|Overall Study||0
2604820|NCT00178178|6393839|P3|NOT COMPLETED|Overall Study||0
2604821|NCT00178178|6393840|P2|NOT COMPLETED|Overall Study||0
2604822|NCT00178178|6393841|P1|NOT COMPLETED|Overall Study||0
2604823|NCT00178178|6393838|P4|COMPLETED|Overall Study||24
2604824|NCT00178178|6393839|P3|COMPLETED|Overall Study||24
2604825|NCT00178178|6393840|P2|COMPLETED|Overall Study||24
2604826|NCT00178178|6393841|P1|COMPLETED|Overall Study||24
2604827|NCT00178178|6393838|P4|STARTED|Overall Study||24
2604828|NCT00178178|6393839|P3|STARTED|Overall Study||24
2604829|NCT00178178|6393840|P2|STARTED|Overall Study||24
2604830|NCT00178178|6393841|P1|STARTED|Overall Study||24
2604831|NCT00178126|6393853|P2|NOT COMPLETED|Overall Study||27
2604832|NCT00178126|6393854|P1|NOT COMPLETED|Overall Study||25
2604833|NCT00178126|6393853|P2|COMPLETED|Overall Study||86
2604834|NCT00178126|6393854|P1|COMPLETED|Overall Study||94
2604835|NCT00178126|6393853|P2|STARTED|Overall Study||113
2604836|NCT00178126|6393854|P1|STARTED|Overall Study||119
2604837|NCT00177970|6393862|P2|NOT COMPLETED|Overall Study||0
2604838|NCT00177970|6393863|P1|NOT COMPLETED|Overall Study||0
2604839|NCT00177970|6393862|P2|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
2604840|NCT00177970|6393863|P1|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
2604841|NCT00177970|6393862|P2|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
2604842|NCT00177970|6393863|P1|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
2604843|NCT00177866|6393885|P2|NOT COMPLETED|Overall Study||0
2604844|NCT00177866|6393886|P1|NOT COMPLETED|Overall Study||0
2604845|NCT00177866|6393885|P2|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
2604846|NCT00177866|6393886|P1|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
2604847|NCT00177866|6393885|P2|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
2604848|NCT00177866|6393886|P1|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
2604849|NCT00177671|6393896|P2|NOT COMPLETED|Overall Study||14
2604850|NCT00177671|6393897|P1|NOT COMPLETED|Overall Study||25
2604851|NCT00177671|6393896|P2|COMPLETED|Overall Study||49
2604852|NCT00177671|6393897|P1|COMPLETED|Overall Study||42
2604853|NCT00177671|6393896|P2|Month 24|Overall Study||49
2604854|NCT00177671|6393897|P1|Month 24|Overall Study||42
2604855|NCT00177671|6393896|P2|Month 12|Overall Study||57
2604856|NCT00177671|6393897|P1|Month 12|Overall Study||45
2604857|NCT00177671|6393896|P2|STARTED|Overall Study||63
2604858|NCT00177671|6393897|P1|STARTED|Overall Study||67
2604859|NCT00177307|6393909|P1|NOT COMPLETED|Overall Study||1
2604860|NCT00177307|6393909|P1|COMPLETED|Overall Study||39
2604861|NCT00177307|6393909|P1|STARTED|Overall Study||40
2604862|NCT00177294|6393918|P2|NOT COMPLETED|Overall Study||5
2604863|NCT00177294|6393919|P1|NOT COMPLETED|Overall Study||7
2604864|NCT00177294|6393918|P2|COMPLETED|Overall Study||59
2604865|NCT00177294|6393919|P1|COMPLETED|Overall Study||53
2604866|NCT00177294|6393918|P2|STARTED|Overall Study||64
2604867|NCT00177294|6393919|P1|STARTED|Overall Study||60
2604868|NCT00177255|6393925|P1|NOT COMPLETED|Overall Study||0
2604869|NCT00177255|6393925|P1|COMPLETED|Overall Study||39
2604870|NCT00177255|6393925|P1|STARTED|Overall Study||39
2604871|NCT00177216|6393933|P3|NOT COMPLETED|Overall Study||1
2604872|NCT00177216|6393934|P2|NOT COMPLETED|Overall Study||3
2604873|NCT00177216|6393935|P1|NOT COMPLETED|Overall Study||6
2604874|NCT00177216|6393933|P3|COMPLETED|Overall Study||19
2604875|NCT00177216|6393934|P2|COMPLETED|Overall Study||20
2604876|NCT00177216|6393935|P1|COMPLETED|Overall Study||20
2604877|NCT00177216|6393933|P3|STARTED|Overall Study||20
2604878|NCT00177216|6393934|P2|STARTED|Overall Study||23
2604879|NCT00177216|6393935|P1|STARTED|Overall Study||26
2604880|NCT00177164|6393951|P2|NOT COMPLETED|Overall Study||16
2604881|NCT00177164|6393952|P1|NOT COMPLETED|Overall Study||9
2604882|NCT00177164|6393951|P2|COMPLETED|Overall Study||9
2604883|NCT00177164|6393952|P1|COMPLETED|Overall Study||14
2604884|NCT00177164|6393951|P2|STARTED|Overall Study||25
2604885|NCT00177164|6393952|P1|STARTED|Overall Study||23
2604886|NCT00176917|6393964|P1|NOT COMPLETED|Overall Study||0
2604887|NCT00176917|6393964|P1|COMPLETED|Overall Study||41
2604888|NCT00176917|6393964|P1|STARTED|Overall Study||41
2604889|NCT00176904|6393971|P1|NOT COMPLETED|Overall Study||0
2604890|NCT00176904|6393971|P1|COMPLETED|Overall Study||135
2604891|NCT00176904|6393971|P1|STARTED|Overall Study||135
2604892|NCT00176891|6393979|P1|NOT COMPLETED|Overall Study||3
2604893|NCT00176891|6393979|P1|COMPLETED|Overall Study||22
2604894|NCT00176891|6393979|P1|STARTED|Overall Study||25
2604895|NCT00176878|6393990|P1|NOT COMPLETED|Overall Study||0
2604896|NCT00176878|6393990|P1|COMPLETED|Overall Study||10
2604897|NCT00176878|6393990|P1|STARTED|Overall Study||10
2604898|NCT00176865|6394002|P3|NOT COMPLETED|Overall Study||0
2604899|NCT00176865|6394003|P2|NOT COMPLETED|Overall Study||0
2604900|NCT00176865|6394004|P1|NOT COMPLETED|Overall Study||0
2604901|NCT00176865|6394002|P3|COMPLETED|Overall Study||6
2604902|NCT00176865|6394003|P2|COMPLETED|Overall Study||10
2604903|NCT00176865|6394004|P1|COMPLETED|Overall Study||3
2604904|NCT00176865|6394002|P3|STARTED|Overall Study||6
2604905|NCT00176865|6394003|P2|STARTED|Overall Study||10
2604906|NCT00176865|6394004|P1|STARTED|Overall Study||3
2604916|NCT00176839|6394103|P1|NOT COMPLETED|Overall Study||0
2604917|NCT00176839|6394103|P1|COMPLETED|Overall Study||11
2604918|NCT00176839|6394103|P1|STARTED|Overall Study||11
2604919|NCT00176826|6394112|P1|NOT COMPLETED|Overall Study||0
2604920|NCT00176826|6394112|P1|COMPLETED|Overall Study||22
2604921|NCT00176826|6394112|P1|STARTED|Overall Study||22
2604922|NCT00176800|6394122|P1|NOT COMPLETED|Overall Study||0
2604923|NCT00176800|6394122|P1|COMPLETED|Overall Study||69
2604924|NCT00176800|6394122|P1|STARTED|Overall Study||69
2604925|NCT00176644|6394128|P1|NOT COMPLETED|Overall Study||1
2604926|NCT00176644|6394128|P1|COMPLETED|Overall Study||22
2604927|NCT00176644|6394128|P1|STARTED|Overall Study||23
2604928|NCT00176631|6394136|P1|NOT COMPLETED|Overall Study||0
2604929|NCT00176631|6394136|P1|COMPLETED|Overall Study||10
2604930|NCT00176631|6394136|P1|STARTED|Overall Study||10
2604931|NCT00176605|6394141|P1|NOT COMPLETED|Overall Study||2
2604932|NCT00176605|6394141|P1|COMPLETED|Overall Study||13
2604933|NCT00176605|6394141|P1|STARTED|Overall Study||15
2604934|NCT00176501|6394146|P1|NOT COMPLETED|Overall Study||0
2604935|NCT00176501|6394146|P1|COMPLETED|Overall Study||3
2604936|NCT00176501|6394146|P1|STARTED|Overall Study||3
2604937|NCT00176488|6394152|P1|NOT COMPLETED|Overall Study||1
2604938|NCT00176488|6394152|P1|COMPLETED|Overall Study||30
2604939|NCT00176488|6394152|P1|STARTED|Overall Study||31
2604940|NCT00176462|6394160|P2|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
2604941|NCT00176462|6394161|P1|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
2604942|NCT00176462|6394160|P2|COMPLETED|Continuation -up to 30mos Post Remission||26
2604943|NCT00176462|6394161|P1|COMPLETED|Continuation -up to 30mos Post Remission||19
2604944|NCT00176462|6394160|P2|STARTED|Continuation -up to 30mos Post Remission||26
2604945|NCT00176462|6394161|P1|STARTED|Continuation -up to 30mos Post Remission||19
2604946|NCT00176462|6394160|P2|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||3
2604947|NCT00176462|6394161|P1|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||1
2604948|NCT00176462|6394160|P2|COMPLETED|Intensive Continuation (8X8-week Cycles)||26
2604949|NCT00176462|6394161|P1|COMPLETED|Intensive Continuation (8X8-week Cycles)||19
2604950|NCT00176462|6394160|P2|STARTED|Intensive Continuation (8X8-week Cycles)||29
2604951|NCT00176462|6394161|P1|STARTED|Intensive Continuation (8X8-week Cycles)||20
2604952|NCT00176462|6394160|P2|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
2604953|NCT00176462|6394161|P1|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
2604954|NCT00176462|6394160|P2|COMPLETED|Delayed Intensification (8 Weeks)||29
2604955|NCT00176462|6394161|P1|COMPLETED|Delayed Intensification (8 Weeks)||20
2604956|NCT00176462|6394160|P2|STARTED|Delayed Intensification (8 Weeks)||29
2604957|NCT00176462|6394161|P1|STARTED|Delayed Intensification (8 Weeks)||20
2604958|NCT00176462|6394160|P2|NOT COMPLETED|Consolidation (12 Weeks)||5
2604959|NCT00176462|6394161|P1|NOT COMPLETED|Consolidation (12 Weeks)||0
2604960|NCT00176462|6394160|P2|COMPLETED|Consolidation (12 Weeks)||29
2604961|NCT00176462|6394161|P1|COMPLETED|Consolidation (12 Weeks)||20
2604962|NCT00176462|6394160|P2|STARTED|Consolidation (12 Weeks)||34
2604963|NCT00176462|6394161|P1|STARTED|Consolidation (12 Weeks)||20
2604964|NCT00176462|6394160|P2|NOT COMPLETED|Induction (4 Weeks)||5
2604965|NCT00176462|6394161|P1|NOT COMPLETED|Induction (4 Weeks)||1
2604966|NCT00176462|6394160|P2|COMPLETED|Induction (4 Weeks)||34
2604967|NCT00176462|6394161|P1|COMPLETED|Induction (4 Weeks)||20
2604968|NCT00176462|6394160|P2|STARTED|Induction (4 Weeks)||39
2604969|NCT00176462|6394161|P1|STARTED|Induction (4 Weeks)||21
2604970|NCT00176436|6394170|P2|NOT COMPLETED|Overall Study||5
2604971|NCT00176436|6394171|P1|NOT COMPLETED|Overall Study||6
2604972|NCT00176436|6394170|P2|COMPLETED|Overall Study||12
2604973|NCT00176436|6394171|P1|COMPLETED|Overall Study||14
2604974|NCT00176436|6394170|P2|STARTED|Overall Study||17
2604975|NCT00176436|6394171|P1|STARTED|Overall Study||20
2604976|NCT00176306|6394177|P1|NOT COMPLETED|Overall Study||0
2604977|NCT00176306|6394177|P1|COMPLETED|Overall Study||15
2604978|NCT00176306|6394177|P1|STARTED|Overall Study||15
2604979|NCT00176254|6394181|P1|NOT COMPLETED|Overall Study||1
2604980|NCT00176254|6394181|P1|COMPLETED|Overall Study|1 patient only received 1 cycle and refused further induction, another progressed in neck nodes|39
2604981|NCT00176254|6394181|P1|STARTED|Overall Study||40
2604982|NCT00176228|6394189|P1|NOT COMPLETED|Overall Study||2
2604983|NCT00176228|6394189|P1|COMPLETED|Overall Study|Study ended|46
2604984|NCT00176228|6394189|P1|STARTED|Overall Study|When study began|48
2604985|NCT00176202|6394196|P2|NOT COMPLETED|Overall Study||16
2604986|NCT00176202|6394197|P1|NOT COMPLETED|Overall Study||5
2604987|NCT00176202|6394196|P2|COMPLETED|Overall Study||17
2604988|NCT00176202|6394197|P1|COMPLETED|Overall Study||27
2604989|NCT00176202|6394196|P2|STARTED|Overall Study||33
2604990|NCT00176202|6394197|P1|STARTED|Overall Study||32
2604991|NCT00175877|6394209|P1|NOT COMPLETED|Overall Study||349
2604992|NCT00175877|6394209|P1|COMPLETED|Overall Study||497
2604993|NCT00175877|6394209|P1|STARTED|Overall Study||846
2604994|NCT00175825|6394244|P4|NOT COMPLETED|Overall Study||1
2604995|NCT00175825|6394245|P3|NOT COMPLETED|Overall Study||1
2604996|NCT00175825|6394246|P2|NOT COMPLETED|Overall Study||4
2604997|NCT00175825|6394247|P1|NOT COMPLETED|Overall Study||5
2604998|NCT00175825|6394244|P4|COMPLETED|Overall Study||51
2604999|NCT00175825|6394245|P3|COMPLETED|Overall Study||51
2605000|NCT00175825|6394246|P2|COMPLETED|Overall Study||46
2605001|NCT00175825|6394247|P1|COMPLETED|Overall Study||49
2605002|NCT00175825|6394244|P4|STARTED|Overall Study||52
2605003|NCT00175825|6394245|P3|STARTED|Overall Study||52
2605004|NCT00175825|6394246|P2|STARTED|Overall Study||50
2605005|NCT00175825|6394247|P1|STARTED|Overall Study||54
2605006|NCT00175019|6394300|P3|NOT COMPLETED|Overall Study||57
2605007|NCT00175019|6394301|P2|NOT COMPLETED|Overall Study||171
2605008|NCT00175019|6394302|P1|NOT COMPLETED|Overall Study||194
2605009|NCT00175019|6394300|P3|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|35
2605010|NCT00175019|6394301|P2|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|217
2605011|NCT00175019|6394302|P1|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|412
2605012|NCT00175019|6394300|P3|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|92
2605013|NCT00175019|6394301|P2|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|388
2605014|NCT00175019|6394302|P1|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|606
2605015|NCT00175006|6394346|P1|NOT COMPLETED|Overall Study||0
2605016|NCT00175006|6394346|P1|COMPLETED|Overall Study||13
2605017|NCT00175006|6394346|P1|STARTED|Overall Study||13
2605018|NCT00174967|6394355|P4|NOT COMPLETED|Overall Study||2
2605019|NCT00174967|6394356|P3|NOT COMPLETED|Overall Study||2
2605020|NCT00174967|6394357|P2|NOT COMPLETED|Overall Study||3
2605021|NCT00174967|6394358|P1|NOT COMPLETED|Overall Study||1
2605022|NCT00174967|6394355|P4|COMPLETED|Overall Study||36
2605023|NCT00174967|6394356|P3|COMPLETED|Overall Study||36
2605024|NCT00174967|6394357|P2|COMPLETED|Overall Study||37
2605025|NCT00174967|6394358|P1|COMPLETED|Overall Study||36
2605026|NCT00174967|6394355|P4|STARTED|Overall Study||38
2605027|NCT00174967|6394356|P3|STARTED|Overall Study||38
2605028|NCT00174967|6394357|P2|STARTED|Overall Study||40
2605029|NCT00174967|6394358|P1|STARTED|Overall Study||37
2605030|NCT00174954|6394404|P1|NOT COMPLETED|Overall Study||4
2605031|NCT00174954|6394404|P1|COMPLETED|Overall Study||28
2605032|NCT00174954|6394404|P1|STARTED|Overall Study||32
2605033|NCT00174941|6394412|P4|NOT COMPLETED|Overall Study||58
2605034|NCT00174941|6394413|P3|NOT COMPLETED|Overall Study||18
2605035|NCT00174941|6394414|P2|NOT COMPLETED|Overall Study||38
2605036|NCT00174941|6394415|P1|NOT COMPLETED|Overall Study||2
2605037|NCT00174941|6394412|P4|COMPLETED|Overall Study||58
2605038|NCT00174941|6394413|P3|COMPLETED|Overall Study||11
2605039|NCT00174941|6394414|P2|COMPLETED|Overall Study||41
2605040|NCT00174941|6394415|P1|COMPLETED|Overall Study||6
2605041|NCT00174941|6394412|P4|STARTED|Overall Study||116
2605042|NCT00174941|6394413|P3|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|29
2605043|NCT00174941|6394414|P2|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|79
2605044|NCT00174941|6394415|P1|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|8
2605045|NCT00174915|6394490|P5|NOT COMPLETED|Overall Study||33
2605046|NCT00174915|6394491|P4|NOT COMPLETED|Overall Study||57
2605047|NCT00174915|6394492|P3|NOT COMPLETED|Overall Study||48
2605048|NCT00174915|6394493|P2|NOT COMPLETED|Overall Study||69
2605049|NCT00174915|6394494|P1|NOT COMPLETED|Overall Study||93
2605050|NCT00174915|6394490|P5|COMPLETED|Overall Study||101
2605051|NCT00174915|6394491|P4|COMPLETED|Overall Study||211
2605052|NCT00174915|6394492|P3|COMPLETED|Overall Study||86
2605053|NCT00174915|6394493|P2|COMPLETED|Overall Study||200
2605054|NCT00174915|6394494|P1|COMPLETED|Overall Study||174
2605055|NCT00174915|6394490|P5|STARTED|Overall Study||134
2605056|NCT00174915|6394491|P4|STARTED|Overall Study||268
2605057|NCT00174915|6394492|P3|STARTED|Overall Study||134
2605058|NCT00174915|6394493|P2|STARTED|Overall Study||269
2605059|NCT00174915|6394494|P1|STARTED|Overall Study||267
2605060|NCT00174785|6394553|P2|NOT COMPLETED|Overall Study||716
2605061|NCT00174785|6394554|P1|NOT COMPLETED|Overall Study||696
2605062|NCT00174785|6394553|P2|COMPLETED|Overall Study|completed study drug|1611
2605063|NCT00174785|6394554|P1|COMPLETED|Overall Study|completed study drug|1605
2605064|NCT00174785|6394553|P2|STARTED|Overall Study|randomized patients; among them, 14 patients did not receive any study drug in the placebo group|2327
2605065|NCT00174785|6394554|P1|STARTED|Overall Study|randomized patients; among them, 10 patients did not receive any study drug in the dronedarone group|2301
2605066|NCT00174460|6394570|P2|NOT COMPLETED|Overall Study||1
2605067|NCT00174460|6394571|P1|NOT COMPLETED|Overall Study||0
2605068|NCT00174460|6394570|P2|COMPLETED|Overall Study||14
2605069|NCT00174460|6394571|P1|COMPLETED|Overall Study||18
2605070|NCT00174460|6394570|P2|Received Study Treatment|Overall Study||14
2605071|NCT00174460|6394571|P1|Received Study Treatment|Overall Study||18
2605072|NCT00174460|6394570|P2|STARTED|Overall Study||15
2605073|NCT00174460|6394571|P1|STARTED|Overall Study||18
2605074|NCT00174447|6394617|P1|NOT COMPLETED|Overall Study||38
2605075|NCT00174447|6394617|P1|COMPLETED|Overall Study||5
2605076|NCT00174447|6394617|P1|STARTED|Overall Study||43
2605077|NCT00174382|6394626|P1|NOT COMPLETED|Overall Study||33
2605078|NCT00174382|6394626|P1|COMPLETED|Overall Study||116
2605079|NCT00174382|6394626|P1|STARTED|Overall Study|148 are summarized below: 1 subject entered the study but was lost to follow up.|149
2605080|NCT00174291|6394645|P2|NOT COMPLETED|Overall Study||6
2605081|NCT00174291|6394646|P1|NOT COMPLETED|Overall Study||5
2605082|NCT00174291|6394645|P2|COMPLETED|Overall Study||4
2605083|NCT00174291|6394646|P1|COMPLETED|Overall Study||6
2605084|NCT00174291|6394645|P2|STARTED|Overall Study||10
2605085|NCT00174291|6394646|P1|STARTED|Overall Study||11
2605086|NCT00174265|6394676|P2|NOT COMPLETED|Overall Study||21
2605087|NCT00174265|6394677|P1|NOT COMPLETED|Overall Study||29
2605088|NCT00174265|6394676|P2|COMPLETED|Overall Study||89
2605089|NCT00174265|6394677|P1|COMPLETED|Overall Study||57
2605090|NCT00174265|6394676|P2|STARTED|Overall Study||110
2605091|NCT00174265|6394677|P1|STARTED|Overall Study|85 participants received randomized treatment assignment and at least one dose of study medication.|86
2605092|NCT00174252|6394685|P1|NOT COMPLETED|Overall Study||2
2605093|NCT00174252|6394685|P1|COMPLETED|Overall Study||55
2605094|NCT00174252|6394685|P1|STARTED|Overall Study||57
2605095|NCT00174187|6394720|P3|NOT COMPLETED|Period 2 (After 3 Years)||8
2605096|NCT00174187|6394721|P2|NOT COMPLETED|Period 2 (After 3 Years)||0
2605097|NCT00174187|6394722|P1|NOT COMPLETED|Period 2 (After 3 Years)||0
2605098|NCT00174187|6394720|P3|COMPLETED|Period 2 (After 3 Years)||13
2605099|NCT00174187|6394721|P2|COMPLETED|Period 2 (After 3 Years)||0
2605100|NCT00174187|6394722|P1|COMPLETED|Period 2 (After 3 Years)||0
2605101|NCT00174187|6394720|P3|STARTED|Period 2 (After 3 Years)||21
2605102|NCT00174187|6394721|P2|STARTED|Period 2 (After 3 Years)||0
2605103|NCT00174187|6394722|P1|STARTED|Period 2 (After 3 Years)||0
2605104|NCT00174187|6394720|P3|NOT COMPLETED|Between Period 1 and Period 2||5
2605105|NCT00174187|6394721|P2|NOT COMPLETED|Between Period 1 and Period 2||0
2605106|NCT00174187|6394722|P1|NOT COMPLETED|Between Period 1 and Period 2||0
2605107|NCT00174187|6394720|P3|COMPLETED|Between Period 1 and Period 2||21
2605108|NCT00174187|6394721|P2|COMPLETED|Between Period 1 and Period 2||0
2605109|NCT00174187|6394722|P1|COMPLETED|Between Period 1 and Period 2||0
2605110|NCT00174187|6394720|P3|Consented|Between Period 1 and Period 2||24
2605111|NCT00174187|6394721|P2|Consented|Between Period 1 and Period 2||0
2605112|NCT00174187|6394722|P1|Consented|Between Period 1 and Period 2||0
2605113|NCT00174187|6394720|P3|STARTED|Between Period 1 and Period 2||26
2605114|NCT00174187|6394721|P2|STARTED|Between Period 1 and Period 2||0
2605115|NCT00174187|6394722|P1|STARTED|Between Period 1 and Period 2||0
2605116|NCT00174187|6394720|P3|NOT COMPLETED|Period 1 (up to 3 Years)||0
2605117|NCT00174187|6394721|P2|NOT COMPLETED|Period 1 (up to 3 Years)||4
2605118|NCT00174187|6394722|P1|NOT COMPLETED|Period 1 (up to 3 Years)||0
2605119|NCT00174187|6394720|P3|COMPLETED|Period 1 (up to 3 Years)||0
2605120|NCT00174187|6394721|P2|COMPLETED|Period 1 (up to 3 Years)||11
2605121|NCT00174187|6394722|P1|COMPLETED|Period 1 (up to 3 Years)||15
2605122|NCT00174187|6394720|P3|STARTED|Period 1 (up to 3 Years)||0
2605123|NCT00174187|6394721|P2|STARTED|Period 1 (up to 3 Years)||15
2605124|NCT00174187|6394722|P1|STARTED|Period 1 (up to 3 Years)||15
2605125|NCT00172185|6394787|P4|NOT COMPLETED|Overall Study||4
2605126|NCT00172185|6394788|P3|NOT COMPLETED|Overall Study||5
2605127|NCT00172185|6394789|P2|NOT COMPLETED|Overall Study||2
2605128|NCT00172185|6394790|P1|NOT COMPLETED|Overall Study||0
2605129|NCT00172185|6394787|P4|COMPLETED|Overall Study||23
2605130|NCT00172185|6394788|P3|COMPLETED|Overall Study||20
2605131|NCT00172185|6394789|P2|COMPLETED|Overall Study||5
2605132|NCT00172185|6394790|P1|COMPLETED|Overall Study||6
2605133|NCT00172185|6394787|P4|STARTED|Overall Study||27
2605134|NCT00172185|6394788|P3|STARTED|Overall Study||25
2605135|NCT00172185|6394789|P2|STARTED|Overall Study||7
2605136|NCT00172185|6394790|P1|STARTED|Overall Study||6
2605137|NCT00172042|6394806|P2|NOT COMPLETED|Overall Study||125
2605138|NCT00172042|6394807|P1|NOT COMPLETED|Overall Study||158
2605139|NCT00172042|6394806|P2|COMPLETED|Overall Study||86
2605140|NCT00172042|6394807|P1|COMPLETED|Overall Study||68
2605141|NCT00172042|6394806|P2|STARTED|Overall Study||211
2605142|NCT00172042|6394807|P1|STARTED|Overall Study||226
2605143|NCT00171925|6394829|P2|NOT COMPLETED|Overall Study||31
2605144|NCT00171925|6394830|P1|NOT COMPLETED|Overall Study||30
2605145|NCT00171925|6394829|P2|COMPLETED|Overall Study||40
2605146|NCT00171925|6394830|P1|COMPLETED|Overall Study||42
2605147|NCT00171925|6394829|P2|STARTED|Overall Study||71
2605148|NCT00171925|6394830|P1|STARTED|Overall Study||72
2605149|NCT00171873|6394842|P2|NOT COMPLETED|Overall Study||3
2605150|NCT00171873|6394843|P1|NOT COMPLETED|Overall Study||9
2605151|NCT00171873|6394842|P2|COMPLETED|Overall Study||40
2605152|NCT00171873|6394843|P1|COMPLETED|Overall Study||33
2605153|NCT00171873|6394842|P2|STARTED|Overall Study||43
2605154|NCT00171873|6394843|P1|STARTED|Overall Study||42
2605155|NCT00171834|6394856|P7|NOT COMPLETED|Overall Study||4
2605156|NCT00171834|6394857|P6|NOT COMPLETED|Overall Study||35
2605157|NCT00171834|6394858|P5|NOT COMPLETED|Overall Study||8
2605158|NCT00171834|6394859|P4|NOT COMPLETED|Overall Study||12
2605159|NCT00171834|6394860|P3|NOT COMPLETED|Overall Study||12
2605160|NCT00171834|6394861|P2|NOT COMPLETED|Overall Study||12
2605161|NCT00171834|6394862|P1|NOT COMPLETED|Overall Study||6
2605162|NCT00171834|6394856|P7|COMPLETED|Overall Study||0
2605163|NCT00171834|6394857|P6|COMPLETED|Overall Study||0
2605164|NCT00171834|6394858|P5|COMPLETED|Overall Study||0
2605165|NCT00171834|6394859|P4|COMPLETED|Overall Study||0
2605166|NCT00171834|6394860|P3|COMPLETED|Overall Study||0
2605167|NCT00171834|6394861|P2|COMPLETED|Overall Study||0
2605168|NCT00171834|6394862|P1|COMPLETED|Overall Study||0
2605169|NCT00171834|6394856|P7|Completed 6 Cycles of Treatment|Overall Study||0
2605170|NCT00171834|6394857|P6|Completed 6 Cycles of Treatment|Overall Study||1
2605171|NCT00171834|6394858|P5|Completed 6 Cycles of Treatment|Overall Study||2
2605172|NCT00171834|6394859|P4|Completed 6 Cycles of Treatment|Overall Study||0
2605173|NCT00171834|6394860|P3|Completed 6 Cycles of Treatment|Overall Study||1
2605174|NCT00171834|6394861|P2|Completed 6 Cycles of Treatment|Overall Study||0
2605175|NCT00171834|6394862|P1|Completed 6 Cycles of Treatment|Overall Study||0
2605176|NCT00171834|6394856|P7|STARTED|Overall Study||4
2605177|NCT00171834|6394857|P6|STARTED|Overall Study||35
2605178|NCT00171834|6394858|P5|STARTED|Overall Study||8
2605179|NCT00171834|6394859|P4|STARTED|Overall Study||12
2605180|NCT00171834|6394860|P3|STARTED|Overall Study||12
2605181|NCT00171834|6394861|P2|STARTED|Overall Study||12
2605182|NCT00171834|6394862|P1|STARTED|Overall Study||6
2605183|NCT00171704|6394902|P2|NOT COMPLETED|Overall Study||49
2605184|NCT00171704|6394903|P1|NOT COMPLETED|Overall Study||44
2605185|NCT00171704|6394902|P2|COMPLETED|Overall Study||81
2605186|NCT00171704|6394903|P1|COMPLETED|Overall Study||89
2605187|NCT00171704|6394902|P2|STARTED|Overall Study||130
2605188|NCT00171704|6394903|P1|STARTED|Overall Study||133
2605189|NCT00171340|6394925|P2|NOT COMPLETED|Overall Study||135
2605190|NCT00171340|6394926|P1|NOT COMPLETED|Overall Study||124
2605191|NCT00171340|6394925|P2|COMPLETED|Overall Study||398
2605192|NCT00171340|6394926|P1|COMPLETED|Overall Study||408
2605193|NCT00171340|6394925|P2|STARTED|Overall Study||533
2605194|NCT00171340|6394926|P1|STARTED|Overall Study||532
2605195|NCT00171314|6394942|P2|NOT COMPLETED|Overall Study||78
2605196|NCT00171314|6394943|P1|NOT COMPLETED|Overall Study||91
2605197|NCT00171314|6394942|P2|COMPLETED|Overall Study||186
2605198|NCT00171314|6394943|P1|COMPLETED|Overall Study||172
2605199|NCT00171314|6394942|P2|Safety Population|Overall Study|"Treatment Actually Received = 10 from upfront Arm and 259 from delayed Arm"|269
2605200|NCT00171314|6394943|P1|Safety Population|Overall Study|"Treatment Actually Received = 251 from upfront Arm and 3 from delayed Arm"|254
2605201|NCT00171314|6394942|P2|STARTED|Overall Study||264
2605202|NCT00171314|6394943|P1|STARTED|Overall Study|2 patients in each arm were randomized but not treated.|263
2605203|NCT00171301|6394959|P2|NOT COMPLETED|Overall Study||9
2605204|NCT00171301|6394960|P1|NOT COMPLETED|Overall Study||8
2605205|NCT00171301|6394959|P2|COMPLETED|Overall Study||62
2605206|NCT00171301|6394960|P1|COMPLETED|Overall Study||154
2605207|NCT00171301|6394959|P2|Received Deferasirox|Overall Study||69
2605208|NCT00171301|6394960|P1|Received Deferasirox|Overall Study||162
2605209|NCT00171301|6394959|P2|STARTED|Overall Study|2 participants in this group never received deferasirox.|71
2605210|NCT00171301|6394960|P1|STARTED|Overall Study||162
2605211|NCT00171210|6394973|P2|NOT COMPLETED|Overall Study||115
2605212|NCT00171210|6394974|P1|NOT COMPLETED|Overall Study||69
2605213|NCT00171210|6394973|P2|COMPLETED|Overall Study||181
2605214|NCT00171210|6394974|P1|COMPLETED|Overall Study||190
2605215|NCT00171210|6394973|P2|STARTED EXTENSION STUDY|Overall Study||247
2605216|NCT00171210|6394974|P1|STARTED EXTENSION STUDY|Overall Study||259
2605217|NCT00171210|6394973|P2|STARTED|Overall Study||296
2605218|NCT00171210|6394974|P1|STARTED|Overall Study||259
2605219|NCT00171054|6395004|P2|NOT COMPLETED|Overall Study||12
2605220|NCT00171054|6395005|P1|NOT COMPLETED|Overall Study||10
2605221|NCT00171054|6395004|P2|COMPLETED|Overall Study||50
2605222|NCT00171054|6395005|P1|COMPLETED|Overall Study||53
2605223|NCT00171054|6395004|P2|STARTED|Overall Study||62
2605224|NCT00171054|6395005|P1|STARTED|Overall Study||63
2605225|NCT00170950|6395037|P2|NOT COMPLETED|Overall Study||910
2605226|NCT00170950|6395038|P1|NOT COMPLETED|Overall Study||885
2605227|NCT00170950|6395037|P2|COMPLETED|Overall Study||4852
2605228|NCT00170950|6395038|P1|COMPLETED|Overall Study||4859
2605229|NCT00170950|6395037|P2|STARTED|Overall Study||5762
2605230|NCT00170950|6395038|P1|STARTED|Overall Study||5744
2605231|NCT00170846|6395051|P3|NOT COMPLETED|Overall Study||13
2605232|NCT00170846|6395052|P2|NOT COMPLETED|Overall Study||19
2605233|NCT00170846|6395053|P1|NOT COMPLETED|Overall Study||11
2605234|NCT00170846|6395051|P3|COMPLETED|Overall Study||131
2605235|NCT00170846|6395052|P2|COMPLETED|Overall Study||108
2605236|NCT00170846|6395053|P1|COMPLETED|Overall Study||112
2605237|NCT00170846|6395051|P3|STARTED|Overall Study||144
2605238|NCT00170846|6395052|P2|STARTED|Overall Study||127
2605239|NCT00170846|6395053|P1|STARTED|Overall Study||123
2605240|NCT00170625|6395067|P1|NOT COMPLETED|Overall Study||0
2605241|NCT00170625|6395067|P1|COMPLETED|Overall Study||26
2605242|NCT00170625|6395067|P1|STARTED|Overall Study||26
2605243|NCT00170157|6395072|P2|NOT COMPLETED|Treatment Period 2 Crossover||0
2605244|NCT00170157|6395073|P1|NOT COMPLETED|Treatment Period 2 Crossover||0
2605245|NCT00170157|6395072|P2|COMPLETED|Treatment Period 2 Crossover||41
2605246|NCT00170157|6395073|P1|COMPLETED|Treatment Period 2 Crossover||0
2605247|NCT00170157|6395072|P2|STARTED|Treatment Period 2 Crossover||41
2605248|NCT00170157|6395073|P1|STARTED|Treatment Period 2 Crossover|Participants initially randomized to this arm were not eligible for crossover.|0
2605249|NCT00170157|6395072|P2|NOT COMPLETED|Washout Period of 14 Days||17
2605250|NCT00170157|6395073|P1|NOT COMPLETED|Washout Period of 14 Days||0
2605251|NCT00170157|6395072|P2|COMPLETED|Washout Period of 14 Days||41
2605252|NCT00170157|6395073|P1|COMPLETED|Washout Period of 14 Days||0
2605253|NCT00170157|6395072|P2|STARTED|Washout Period of 14 Days||58
2605254|NCT00170157|6395073|P1|STARTED|Washout Period of 14 Days|Participants initially randomized to this arm were not eligible for crossover.|0
2605255|NCT00170157|6395072|P2|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
2605256|NCT00170157|6395073|P1|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
2605257|NCT00170157|6395072|P2|COMPLETED|Treatment Period 1 Initial Randomization||58
2605258|NCT00170157|6395073|P1|COMPLETED|Treatment Period 1 Initial Randomization||54
2605259|NCT00170157|6395072|P2|STARTED|Treatment Period 1 Initial Randomization||58
2605260|NCT00170157|6395073|P1|STARTED|Treatment Period 1 Initial Randomization||54
2605261|NCT00169442|6395085|P6|NOT COMPLETED|Overall Study||2
2605262|NCT00169442|6395086|P5|NOT COMPLETED|Overall Study||1
2605263|NCT00169442|6395087|P4|NOT COMPLETED|Overall Study||0
2605264|NCT00169442|6395088|P3|NOT COMPLETED|Overall Study||1
2605265|NCT00169442|6395089|P2|NOT COMPLETED|Overall Study||1
2605266|NCT00169442|6395090|P1|NOT COMPLETED|Overall Study||0
2605267|NCT00169442|6395085|P6|COMPLETED|Overall Study||41
2605268|NCT00169442|6395086|P5|COMPLETED|Overall Study||41
2605269|NCT00169442|6395087|P4|COMPLETED|Overall Study||250
2605270|NCT00169442|6395088|P3|COMPLETED|Overall Study||166
2605271|NCT00169442|6395089|P2|COMPLETED|Overall Study||123
2605272|NCT00169442|6395090|P1|COMPLETED|Overall Study||119
2605273|NCT00169442|6395085|P6|STARTED|Overall Study||43
2605274|NCT00169442|6395086|P5|STARTED|Overall Study||42
2605275|NCT00169442|6395087|P4|STARTED|Overall Study||250
2605276|NCT00169442|6395088|P3|STARTED|Overall Study||167
2605277|NCT00169442|6395089|P2|STARTED|Overall Study||124
2605278|NCT00169442|6395090|P1|STARTED|Overall Study||119
2605279|NCT00169104|6395199|P2|NOT COMPLETED|Overall Study||2
2605280|NCT00169104|6395200|P1|NOT COMPLETED|Overall Study||2
2605281|NCT00169104|6395199|P2|COMPLETED|Overall Study||8
2605282|NCT00169104|6395200|P1|COMPLETED|Overall Study||11
2605283|NCT00169104|6395199|P2|STARTED|Overall Study||10
2605284|NCT00169104|6395200|P1|STARTED|Overall Study||13
2605285|NCT00168844|6395214|P3|NOT COMPLETED|Overall Study||91
2605286|NCT00168844|6395215|P2|NOT COMPLETED|Overall Study||55
2605287|NCT00168844|6395216|P1|NOT COMPLETED|Overall Study||55
2605288|NCT00168844|6395214|P3|COMPLETED|Overall Study||228
2605289|NCT00168844|6395215|P2|COMPLETED|Overall Study||277
2605290|NCT00168844|6395216|P1|COMPLETED|Overall Study||277
2605291|NCT00168844|6395214|P3|STARTED|Overall Study||319
2605292|NCT00168844|6395215|P2|STARTED|Overall Study||332
2605293|NCT00168844|6395216|P1|STARTED|Overall Study||332
2605294|NCT00168831|6395398|P3|NOT COMPLETED|Overall Study||114
2605295|NCT00168831|6395399|P2|NOT COMPLETED|Overall Study||81
2605296|NCT00168831|6395400|P1|NOT COMPLETED|Overall Study||60
2605297|NCT00168831|6395398|P3|COMPLETED|Overall Study||220
2605298|NCT00168831|6395399|P2|COMPLETED|Overall Study||254
2605299|NCT00168831|6395400|P1|COMPLETED|Overall Study||278
2605300|NCT00168831|6395398|P3|STARTED|Overall Study||334
2605301|NCT00168831|6395399|P2|STARTED|Overall Study||335
2605302|NCT00168831|6395400|P1|STARTED|Overall Study||338
2605303|NCT00168818|6395582|P3|NOT COMPLETED|Treatment||133
2605304|NCT00168818|6395583|P2|NOT COMPLETED|Treatment||151
2605305|NCT00168818|6395584|P1|NOT COMPLETED|Treatment||133
2605306|NCT00168818|6395582|P3|COMPLETED|Treatment||1021
2605307|NCT00168818|6395583|P2|COMPLETED|Treatment||1012
2605308|NCT00168818|6395584|P1|COMPLETED|Treatment||1013
2605309|NCT00168818|6395582|P3|STARTED|Treatment||1154
2605310|NCT00168818|6395583|P2|STARTED|Treatment||1163
2605311|NCT00168818|6395584|P1|STARTED|Treatment||1146
2605312|NCT00168818|6395582|P3|NOT COMPLETED|Overall Study||124
2605313|NCT00168818|6395583|P2|NOT COMPLETED|Overall Study||109
2605314|NCT00168818|6395584|P1|NOT COMPLETED|Overall Study||117
2605315|NCT00168818|6395582|P3|COMPLETED|Overall Study||1030
2605316|NCT00168818|6395583|P2|COMPLETED|Overall Study||1054
2605317|NCT00168818|6395584|P1|COMPLETED|Overall Study||1029
2605318|NCT00168818|6395582|P3|STARTED|Overall Study||1154
2605319|NCT00168818|6395583|P2|STARTED|Overall Study||1163
2605320|NCT00168818|6395584|P1|STARTED|Overall Study||1146
2605321|NCT00168805|6395628|P3|NOT COMPLETED|Treatment||62
2605322|NCT00168805|6395629|P2|NOT COMPLETED|Treatment||56
2605323|NCT00168805|6395630|P1|NOT COMPLETED|Treatment||49
2605324|NCT00168805|6395628|P3|COMPLETED|Treatment||632
2605325|NCT00168805|6395629|P2|COMPLETED|Treatment||647
2605326|NCT00168805|6395630|P1|COMPLETED|Treatment||630
2605327|NCT00168805|6395628|P3|STARTED|Treatment||694
2605328|NCT00168805|6395629|P2|STARTED|Treatment||703
2605329|NCT00168805|6395630|P1|STARTED|Treatment||679
2605330|NCT00168805|6395628|P3|NOT COMPLETED|Overall Study||78
2605331|NCT00168805|6395629|P2|NOT COMPLETED|Overall Study||78
2605332|NCT00168805|6395630|P1|NOT COMPLETED|Overall Study||71
2605333|NCT00168805|6395628|P3|COMPLETED|Overall Study||616
2605334|NCT00168805|6395629|P2|COMPLETED|Overall Study||625
2605335|NCT00168805|6395630|P1|COMPLETED|Overall Study||608
2605336|NCT00168805|6395628|P3|STARTED|Overall Study||694
2605337|NCT00168805|6395629|P2|STARTED|Overall Study||703
2605338|NCT00168805|6395630|P1|STARTED|Overall Study||679
2605339|NCT00168454|6395677|P6|NOT COMPLETED|Overall Study||6
2605340|NCT00168454|6395678|P5|NOT COMPLETED|Overall Study||6
2605341|NCT00168454|6395679|P4|NOT COMPLETED|Overall Study||9
2605342|NCT00168454|6395680|P3|NOT COMPLETED|Overall Study||6
2605343|NCT00168454|6395681|P2|NOT COMPLETED|Overall Study||7
2605344|NCT00168454|6395682|P1|NOT COMPLETED|Overall Study||7
2605345|NCT00168454|6395677|P6|COMPLETED|Overall Study||50
2605346|NCT00168454|6395678|P5|COMPLETED|Overall Study||47
2605347|NCT00168454|6395679|P4|COMPLETED|Overall Study||40
2605348|NCT00168454|6395680|P3|COMPLETED|Overall Study||48
2605349|NCT00168454|6395681|P2|COMPLETED|Overall Study||50
2605350|NCT00168454|6395682|P1|COMPLETED|Overall Study||37
2605351|NCT00168454|6395677|P6|STARTED|Overall Study||56
2605352|NCT00168454|6395678|P5|STARTED|Overall Study||53
2605353|NCT00168454|6395679|P4|STARTED|Overall Study||49
2605354|NCT00168454|6395680|P3|STARTED|Overall Study||54
2605355|NCT00168454|6395681|P2|STARTED|Overall Study||57
2605356|NCT00168454|6395682|P1|STARTED|Overall Study||44
2605357|NCT00168428|6395728|P2|NOT COMPLETED|Open-Label Phase (OL)||68
2605358|NCT00168428|6395729|P1|NOT COMPLETED|Open-Label Phase (OL)||44
2605359|NCT00168428|6395728|P2|COMPLETED|Open-Label Phase (OL)||261
2605360|NCT00168428|6395729|P1|COMPLETED|Open-Label Phase (OL)||261
2605361|NCT00168428|6395728|P2|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL phase|329
2605362|NCT00168428|6395729|P1|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|305
2605363|NCT00168428|6395728|P2|NOT COMPLETED|Double-Blind Phase (DB)||24
2605364|NCT00168428|6395729|P1|NOT COMPLETED|Double-Blind Phase (DB)||36
2605365|NCT00168428|6395728|P2|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|334
2605366|NCT00168428|6395729|P1|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|311
2605367|NCT00168428|6395728|P2|STARTED|Double-Blind Phase (DB)||358
2605368|NCT00168428|6395729|P1|STARTED|Double-Blind Phase (DB)||347
2605369|NCT00168389|6395748|P3|NOT COMPLETED|Overall Study||95
2605370|NCT00168389|6395749|P2|NOT COMPLETED|Overall Study||48
2605371|NCT00168389|6395750|P1|NOT COMPLETED|Overall Study||56
2605372|NCT00168389|6395748|P3|COMPLETED|Overall Study||70
2605373|NCT00168389|6395749|P2|COMPLETED|Overall Study||118
2605374|NCT00168389|6395750|P1|COMPLETED|Overall Study||107
2605375|NCT00168389|6395748|P3|STARTED|Overall Study||165
2605376|NCT00168389|6395749|P2|STARTED|Overall Study||166
2605377|NCT00168389|6395750|P1|STARTED|Overall Study||163
2605378|NCT00168337|6395779|P3|NOT COMPLETED|Overall Study||103
2605379|NCT00168337|6395780|P2|NOT COMPLETED|Overall Study||69
2605380|NCT00168337|6395781|P1|NOT COMPLETED|Overall Study||70
2605381|NCT00168337|6395779|P3|COMPLETED|Overall Study||82
2605382|NCT00168337|6395780|P2|COMPLETED|Overall Study||112
2605383|NCT00168337|6395781|P1|COMPLETED|Overall Study||118
2605384|NCT00168337|6395779|P3|STARTED|Overall Study||185
2605385|NCT00168337|6395780|P2|STARTED|Overall Study||181
2605386|NCT00168337|6395781|P1|STARTED|Overall Study||188
2605387|NCT00168324|6395810|P3|NOT COMPLETED|Open-Label Period||6
2605388|NCT00168324|6395811|P2|NOT COMPLETED|Open-Label Period||8
2605389|NCT00168324|6395812|P1|NOT COMPLETED|Open-Label Period||4
2605390|NCT00168324|6395810|P3|COMPLETED|Open-Label Period||152
2605391|NCT00168324|6395811|P2|COMPLETED|Open-Label Period||147
2605392|NCT00168324|6395812|P1|COMPLETED|Open-Label Period||160
2605393|NCT00168324|6395810|P3|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|158
2605394|NCT00168324|6395811|P2|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|155
2605395|NCT00168324|6395812|P1|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|164
2605396|NCT00168324|6395810|P3|NOT COMPLETED|Double-Blind Period||13
2605397|NCT00168324|6395811|P2|NOT COMPLETED|Double-Blind Period||7
2605398|NCT00168324|6395812|P1|NOT COMPLETED|Double-Blind Period||12
2605399|NCT00168324|6395810|P3|COMPLETED|Double-Blind Period||189
2605400|NCT00168324|6395811|P2|COMPLETED|Double-Blind Period||189
2605401|NCT00168324|6395812|P1|COMPLETED|Double-Blind Period||189
2605402|NCT00168324|6395810|P3|STARTED|Double-Blind Period||202
2605403|NCT00168324|6395811|P2|STARTED|Double-Blind Period||196
2605404|NCT00168324|6395812|P1|STARTED|Double-Blind Period||201
2605405|NCT00168311|6395834|P2|NOT COMPLETED|Overall Study||2
2605406|NCT00168311|6395835|P1|NOT COMPLETED|Overall Study||0
2605407|NCT00168311|6395834|P2|COMPLETED|Overall Study||8
2605408|NCT00168311|6395835|P1|COMPLETED|Overall Study||12
2605409|NCT00168311|6395834|P2|STARTED|Overall Study||10
2605410|NCT00168311|6395835|P1|STARTED|Overall Study||12
2605411|NCT00168298|6395844|P3|NOT COMPLETED|Open-Label Period||8
2605412|NCT00168298|6395845|P2|NOT COMPLETED|Open-Label Period||5
2605413|NCT00168298|6395846|P1|NOT COMPLETED|Open-Label Period||7
2605414|NCT00168298|6395844|P3|COMPLETED|Open-Label Period||160
2605415|NCT00168298|6395845|P2|COMPLETED|Open-Label Period||168
2605416|NCT00168298|6395846|P1|COMPLETED|Open-Label Period||172
2605417|NCT00168298|6395844|P3|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|168
2605418|NCT00168298|6395845|P2|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|173
2605419|NCT00168298|6395846|P1|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|179
2605420|NCT00168298|6395844|P3|NOT COMPLETED|Double-Blind Period||15
2605421|NCT00168298|6395845|P2|NOT COMPLETED|Double-Blind Period||12
2605422|NCT00168298|6395846|P1|NOT COMPLETED|Double-Blind Period||12
2605423|NCT00168298|6395844|P3|COMPLETED|Double-Blind Period||209
2605424|NCT00168298|6395845|P2|COMPLETED|Double-Blind Period||206
2605425|NCT00168298|6395846|P1|COMPLETED|Double-Blind Period||214
2605426|NCT00168298|6395844|P3|STARTED|Double-Blind Period||224
2605427|NCT00168298|6395845|P2|STARTED|Double-Blind Period||218
2605428|NCT00168298|6395846|P1|STARTED|Double-Blind Period||226
2605429|NCT00168103|6395866|P4|NOT COMPLETED|Overall Study||0
2605430|NCT00168103|6395867|P3|NOT COMPLETED|Overall Study||1
2605431|NCT00168103|6395868|P2|NOT COMPLETED|Overall Study||5
2605432|NCT00168103|6395869|P1|NOT COMPLETED|Overall Study||2
2605433|NCT00168103|6395866|P4|COMPLETED|Overall Study||1
2605434|NCT00168103|6395867|P3|COMPLETED|Overall Study||41
2605435|NCT00168103|6395868|P2|COMPLETED|Overall Study||38
2605436|NCT00168103|6395869|P1|COMPLETED|Overall Study|1 randomized subject received open-label rescue medication before receiving randomized treatment.|38
2605437|NCT00168103|6395866|P4|STARTED|Overall Study||1
2605438|NCT00168103|6395867|P3|STARTED|Overall Study||42
2605439|NCT00168103|6395868|P2|STARTED|Overall Study||43
2605440|NCT00168103|6395869|P1|STARTED|Overall Study||40
2605441|NCT00168064|6395891|P2|NOT COMPLETED|Overall Study||44
2605442|NCT00168064|6395892|P1|NOT COMPLETED|Overall Study||49
2605443|NCT00168064|6395891|P2|COMPLETED|Overall Study||86
2605444|NCT00168064|6395892|P1|COMPLETED|Overall Study||81
2605445|NCT00168064|6395891|P2|STARTED|Overall Study|127 participants received AP formulation|130
2605446|NCT00168064|6395892|P1|STARTED|Overall Study|128 participants received PG formulation|130
2605447|NCT00168038|6395900|P1|NOT COMPLETED|Overall Study||2
2605448|NCT00168038|6395900|P1|COMPLETED|Overall Study||55
2605449|NCT00168038|6395900|P1|STARTED|Overall Study||57
2605450|NCT00167934|6395914|P2|NOT COMPLETED|Overall Study||0
2605451|NCT00167934|6395915|P1|NOT COMPLETED|Overall Study||0
2605452|NCT00167934|6395914|P2|COMPLETED|Overall Study||82
2605453|NCT00167934|6395915|P1|COMPLETED|Overall Study||82
2605454|NCT00167934|6395914|P2|STARTED|Overall Study||82
2605455|NCT00167934|6395915|P1|STARTED|Overall Study||82
2605456|NCT00167778|6395923|P1|NOT COMPLETED|Overall Study||1
2605457|NCT00167778|6395923|P1|COMPLETED|Overall Study||10
2605458|NCT00167778|6395923|P1|STARTED|Overall Study||11
2605459|NCT00167544|6395974|P2|NOT COMPLETED|Overall Study||0
2605460|NCT00167544|6395975|P1|NOT COMPLETED|Overall Study||1
2605461|NCT00167544|6395974|P2|COMPLETED|Overall Study||33
2605462|NCT00167544|6395975|P1|COMPLETED|Overall Study||30
2605463|NCT00167544|6395974|P2|STARTED|Overall Study||33
2605464|NCT00167544|6395975|P1|STARTED|Overall Study||31
2605465|NCT00167414|6395989|P1|NOT COMPLETED|Overall Study||10
2605466|NCT00167414|6395989|P1|COMPLETED|Overall Study||39
2605467|NCT00167414|6395989|P1|STARTED|Overall Study||49
2605468|NCT00167388|6396001|P4|NOT COMPLETED|Overall Study||0
2605469|NCT00167388|6396002|P3|NOT COMPLETED|Overall Study||0
2605470|NCT00167388|6396003|P2|NOT COMPLETED|Overall Study||0
2605471|NCT00167388|6396004|P1|NOT COMPLETED|Overall Study||0
2605472|NCT00167388|6396001|P4|COMPLETED|Overall Study||6
2605473|NCT00167388|6396002|P3|COMPLETED|Overall Study||6
2605474|NCT00167388|6396003|P2|COMPLETED|Overall Study||5
2605475|NCT00167388|6396004|P1|COMPLETED|Overall Study||5
2605476|NCT00167388|6396001|P4|Completed Doppler Study|Overall Study||6
2605477|NCT00167388|6396002|P3|Completed Doppler Study|Overall Study||6
2605478|NCT00167388|6396003|P2|Completed Doppler Study|Overall Study||5
2605479|NCT00167388|6396004|P1|Completed Doppler Study|Overall Study||5
2605480|NCT00167388|6396001|P4|STARTED|Overall Study||6
2605481|NCT00167388|6396002|P3|STARTED|Overall Study||6
2605482|NCT00167388|6396003|P2|STARTED|Overall Study||5
2605483|NCT00167388|6396004|P1|STARTED|Overall Study||5
2605484|NCT00167310|6396014|P2|NOT COMPLETED|Overall Study||10
2605485|NCT00167310|6396015|P1|NOT COMPLETED|Overall Study||8
2605486|NCT00167310|6396014|P2|COMPLETED|Overall Study||18
2605487|NCT00167310|6396015|P1|COMPLETED|Overall Study||21
2605488|NCT00167310|6396014|P2|STARTED|Overall Study||28
2605489|NCT00167310|6396015|P1|STARTED|Overall Study||29
2605490|NCT00167245|6396025|P2|NOT COMPLETED|Overall Study||41
2605491|NCT00167245|6396026|P1|NOT COMPLETED|Overall Study||29
2605492|NCT00167245|6396025|P2|COMPLETED|Overall Study||46
2605493|NCT00167245|6396026|P1|COMPLETED|Overall Study||54
2605494|NCT00167245|6396025|P2|STARTED|Overall Study||87
2605495|NCT00167245|6396026|P1|STARTED|Overall Study||83
2605496|NCT00167206|6396034|P1|NOT COMPLETED|Overall Study||0
2605497|NCT00167206|6396034|P1|COMPLETED|Overall Study||16
2605498|NCT00167206|6396034|P1|STARTED|Overall Study||16
2605499|NCT00167180|6396048|P2|NOT COMPLETED|Overall Study||0
2605500|NCT00167180|6396049|P1|NOT COMPLETED|Overall Study||0
2605501|NCT00167180|6396048|P2|COMPLETED|Overall Study||57
2605502|NCT00167180|6396049|P1|COMPLETED|Overall Study||0
2605503|NCT00167180|6396048|P2|STARTED|Overall Study||57
2605504|NCT00167180|6396049|P1|STARTED|Overall Study||0
2605505|NCT00167102|6396065|P2|NOT COMPLETED|Overall Study||0
2605506|NCT00167102|6396066|P1|NOT COMPLETED|Overall Study||0
2605507|NCT00167102|6396065|P2|COMPLETED|Overall Study||22
2605508|NCT00167102|6396066|P1|COMPLETED|Overall Study||23
2605509|NCT00167102|6396065|P2|STARTED|Overall Study||22
2605510|NCT00167102|6396066|P1|STARTED|Overall Study||23
2605511|NCT00166712|6396076|P2|NOT COMPLETED|Overall Study||5
2605512|NCT00166712|6396077|P1|NOT COMPLETED|Overall Study||2
2605513|NCT00166712|6396076|P2|COMPLETED|Overall Study|Completed study participation.|11
2605514|NCT00166712|6396077|P1|COMPLETED|Overall Study|Completed study participation.|22
2605515|NCT00166712|6396076|P2|Phase 3|Overall Study|# weaned off Sirolimus at 12 months post-transplant.|0
2605516|NCT00166712|6396077|P1|Phase 3|Overall Study|Subjects from Phase 2b who were weaned off Sirolimus @ 12 months post-transplant.|0
2605517|NCT00166712|6396076|P2|Phase 2b|Overall Study|Subjects weaned off Sirolimus|0
2605518|NCT00166712|6396077|P1|Phase 2b|Overall Study|Subjects converted to Sirolimus post-transplant.|3
2605519|NCT00166712|6396076|P2|Phase 2a|Overall Study|Subject who remained on Sirolimus at 6 months post-transplant.|12
2605520|NCT00166712|6396077|P1|Phase 2a|Overall Study|Subjects who remained on Prograf at 6mo post-transplant.|19
2605521|NCT00166712|6396076|P2|Phase 1|Overall Study|Evaluated at 6 month post-transplant to potentially be weaned off Sirolimus.|12
2605522|NCT00166712|6396077|P1|Phase 1|Overall Study|Evaluated for rejection at 6months post-transplant|22
2605523|NCT00166712|6396076|P2|STARTED|Overall Study|Consented: Randomized-Group 2. Given Sirolimus & MMF prior to surgery, Alemtuzumab day of surgery.|16
2605524|NCT00166712|6396077|P1|STARTED|Overall Study|Consented:Randomized-Group 1. Given MMF prior to surgery, Alemtuzumab & TAC (Prograf) day of surgery|24
2605525|NCT00166517|6396094|P2|NOT COMPLETED|Overall Study||2
2605526|NCT00166517|6396095|P1|NOT COMPLETED|Overall Study||5
2605527|NCT00166517|6396094|P2|COMPLETED|Overall Study||61
2605528|NCT00166517|6396095|P1|COMPLETED|Overall Study||110
2605529|NCT00166517|6396094|P2|Vaccinated at Visit 3|Overall Study||61
2605530|NCT00166517|6396095|P1|Vaccinated at Visit 3|Overall Study||110
2605531|NCT00166517|6396094|P2|Vaccinated at Visit 2|Overall Study||61
2605532|NCT00166517|6396095|P1|Vaccinated at Visit 2|Overall Study||112
2605533|NCT00166517|6396094|P2|Vaccinated at Visit 1|Overall Study||63
2605534|NCT00166517|6396095|P1|Vaccinated at Visit 1|Overall Study||115
2605535|NCT00166517|6396094|P2|STARTED|Overall Study||63
2605536|NCT00166517|6396095|P1|STARTED|Overall Study||115
2605537|NCT00166504|6396105|P2|NOT COMPLETED|Overall Study||4
2605538|NCT00166504|6396106|P1|NOT COMPLETED|Overall Study||5
2605539|NCT00166504|6396105|P2|COMPLETED|Overall Study||91
2605540|NCT00166504|6396106|P1|COMPLETED|Overall Study||103
2605541|NCT00166504|6396105|P2|STARTED|Overall Study||95
2605542|NCT00166504|6396106|P1|STARTED|Overall Study||108
2605543|NCT00166439|6396112|P1|NOT COMPLETED|Overall Study||5
2605544|NCT00166439|6396112|P1|COMPLETED|Overall Study||45
2605545|NCT00166439|6396112|P1|STARTED|Overall Study||50
2605546|NCT00166361|6396120|P2|NOT COMPLETED|Overall Study||0
2605547|NCT00166361|6396121|P1|NOT COMPLETED|Overall Study||0
2605548|NCT00166361|6396120|P2|COMPLETED|Overall Study||10
2605549|NCT00166361|6396121|P1|COMPLETED|Overall Study||14
2605550|NCT00166361|6396120|P2|STARTED|Overall Study||10
2605551|NCT00166361|6396121|P1|STARTED|Overall Study||14
2605552|NCT00166296|6396129|P2|NOT COMPLETED|Overall Study||9
2605553|NCT00166296|6396130|P1|NOT COMPLETED|Overall Study||7
2605554|NCT00166296|6396129|P2|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|57
2605555|NCT00166296|6396130|P1|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|60
2605556|NCT00166296|6396129|P2|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|63
2605557|NCT00166296|6396130|P1|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|66
2605558|NCT00166296|6396129|P2|STARTED|Overall Study|Randomized patients|66
2605559|NCT00166296|6396130|P1|STARTED|Overall Study|Randomized patients|67
2605560|NCT00166205|6396142|P1|NOT COMPLETED|Overall Study||48
2605561|NCT00166205|6396142|P1|COMPLETED|Overall Study||228
2605562|NCT00166205|6396142|P1|Intervention - SAGB Surgery|Overall Study||276
2605563|NCT00166205|6396142|P1|STARTED|Overall Study||276
2605564|NCT00166166|6396158|P2|NOT COMPLETED|Overall Study||0
2605565|NCT00166166|6396159|P1|NOT COMPLETED|Overall Study||0
2605566|NCT00166166|6396158|P2|COMPLETED|Overall Study||71
2605567|NCT00166166|6396159|P1|COMPLETED|Overall Study||103
2605568|NCT00166166|6396158|P2|STARTED|Overall Study||71
2605569|NCT00166166|6396159|P1|STARTED|Overall Study||103
2605570|NCT00166114|6396182|P2|NOT COMPLETED|Overall Study||6
2605571|NCT00166114|6396183|P1|NOT COMPLETED|Overall Study||14
2605572|NCT00166114|6396182|P2|COMPLETED|Overall Study||13
2605573|NCT00166114|6396183|P1|COMPLETED|Overall Study||7
2605574|NCT00166114|6396182|P2|STARTED|Overall Study||19
2605575|NCT00166114|6396183|P1|STARTED|Overall Study||21
2605576|NCT00166036|6396191|P2|NOT COMPLETED|Overall Study||0
2605577|NCT00166036|6396192|P1|NOT COMPLETED|Overall Study||0
2605578|NCT00166036|6396191|P2|COMPLETED|Overall Study||19
2605579|NCT00166036|6396192|P1|COMPLETED|Overall Study||17
2605580|NCT00166036|6396191|P2|STARTED|Overall Study||19
2605581|NCT00166036|6396192|P1|STARTED|Overall Study||17
2605582|NCT00165984|6396200|P1|NOT COMPLETED|Overall Study||15
2605583|NCT00165984|6396200|P1|COMPLETED|Overall Study||150
2605584|NCT00165984|6396200|P1|STARTED|Overall Study||165
2605585|NCT00165958|6396209|P2|NOT COMPLETED|Overall Study||2
2605586|NCT00165958|6396210|P1|NOT COMPLETED|Overall Study||1
2605587|NCT00165958|6396209|P2|COMPLETED|Overall Study||19
2605588|NCT00165958|6396210|P1|COMPLETED|Overall Study||18
2605589|NCT00165958|6396209|P2|STARTED|Overall Study||21
2605590|NCT00165958|6396210|P1|STARTED|Overall Study||19
2605591|NCT00165841|6396218|P2|NOT COMPLETED|Overall Study||62
2605592|NCT00165841|6396219|P1|NOT COMPLETED|Overall Study||30
2605593|NCT00165841|6396218|P2|COMPLETED|Overall Study||35
2605594|NCT00165841|6396219|P1|COMPLETED|Overall Study||73
2605595|NCT00165841|6396218|P2|STARTED|Overall Study||97
2605596|NCT00165841|6396219|P1|STARTED|Overall Study||103
2605597|NCT00165789|6396229|P4|NOT COMPLETED|Overall Study||14
2605598|NCT00165789|6396230|P3|NOT COMPLETED|Overall Study||1
2605599|NCT00165789|6396231|P2|NOT COMPLETED|Overall Study||4
2605600|NCT00165789|6396232|P1|NOT COMPLETED|Overall Study||0
2605601|NCT00165789|6396229|P4|COMPLETED|Overall Study||21
2605602|NCT00165789|6396230|P3|COMPLETED|Overall Study||11
2605603|NCT00165789|6396231|P2|COMPLETED|Overall Study||16
2605604|NCT00165789|6396232|P1|COMPLETED|Overall Study||8
2605605|NCT00165789|6396229|P4|STARTED|Overall Study||35
2605606|NCT00165789|6396230|P3|STARTED|Overall Study||12
2605607|NCT00165789|6396231|P2|STARTED|Overall Study||20
2605608|NCT00165789|6396232|P1|STARTED|Overall Study||8
2605609|NCT00165776|6396286|P4|NOT COMPLETED|Overall Study||2
2605610|NCT00165776|6396287|P3|NOT COMPLETED|Overall Study||2
2605611|NCT00165776|6396288|P2|NOT COMPLETED|Overall Study||1
2605612|NCT00165776|6396289|P1|NOT COMPLETED|Overall Study||4
2605613|NCT00165776|6396286|P4|COMPLETED|Overall Study||29
2605614|NCT00165776|6396287|P3|COMPLETED|Overall Study||31
2605615|NCT00165776|6396288|P2|COMPLETED|Overall Study||33
2605616|NCT00165776|6396289|P1|COMPLETED|Overall Study||31
2605617|NCT00165776|6396286|P4|STARTED|Overall Study||31
2605618|NCT00165776|6396287|P3|STARTED|Overall Study||33
2605619|NCT00165776|6396288|P2|STARTED|Overall Study||34
2605620|NCT00165776|6396289|P1|STARTED|Overall Study||35
2605621|NCT00165698|6396325|P2|NOT COMPLETED|Overall Study||15
2605622|NCT00165698|6396326|P1|NOT COMPLETED|Overall Study||8
2605623|NCT00165698|6396325|P2|COMPLETED|Overall Study||105
2605624|NCT00165698|6396326|P1|COMPLETED|Overall Study||112
2605625|NCT00165698|6396325|P2|STARTED|Overall Study||120
2605626|NCT00165698|6396326|P1|STARTED|Overall Study||120
2605627|NCT00165672|6396352|P2|NOT COMPLETED|Overall Study||1
2605628|NCT00165672|6396353|P1|NOT COMPLETED|Overall Study||0
2605629|NCT00165672|6396352|P2|COMPLETED|Overall Study||12
2605630|NCT00165672|6396353|P1|COMPLETED|Overall Study||13
2605631|NCT00165672|6396352|P2|STARTED|Overall Study||13
2605632|NCT00165672|6396353|P1|STARTED|Overall Study||13
2605633|NCT00165646|6396362|P3|NOT COMPLETED|Overall Study||4
2605634|NCT00165646|6396363|P2|NOT COMPLETED|Overall Study||5
2605635|NCT00165646|6396364|P1|NOT COMPLETED|Overall Study||5
2605636|NCT00165646|6396362|P3|COMPLETED|Overall Study||98
2605637|NCT00165646|6396363|P2|COMPLETED|Overall Study||88
2605638|NCT00165646|6396364|P1|COMPLETED|Overall Study||88
2605639|NCT00165646|6396362|P3|STARTED|Overall Study||102
2605640|NCT00165646|6396363|P2|STARTED|Overall Study||93
2605641|NCT00165646|6396364|P1|STARTED|Overall Study||93
2605642|NCT00165503|6396372|P1|NOT COMPLETED|Overall Study||16
2605643|NCT00165503|6396372|P1|COMPLETED|Overall Study||0
2605644|NCT00165503|6396372|P1|STARTED|Overall Study||16
2605645|NCT00163657|6396379|P3|NOT COMPLETED|Overall Study||37
2605646|NCT00163657|6396380|P2|NOT COMPLETED|Overall Study||23
2605647|NCT00163657|6396381|P1|NOT COMPLETED|Overall Study||20
2605648|NCT00163657|6396379|P3|COMPLETED|Overall Study||116
2605649|NCT00163657|6396380|P2|COMPLETED|Overall Study||56
2605650|NCT00163657|6396381|P1|COMPLETED|Overall Study||60
2605651|NCT00163657|6396379|P3|STARTED|Overall Study||153
2605652|NCT00163657|6396380|P2|STARTED|Overall Study||79
2605653|NCT00163657|6396381|P1|STARTED|Overall Study||80
2605654|NCT00163293|6396395|P3|NOT COMPLETED|Overall Study||19
2605655|NCT00163293|6396396|P2|NOT COMPLETED|Overall Study||7
2605656|NCT00163293|6396397|P1|NOT COMPLETED|Overall Study||13
2605657|NCT00163293|6396395|P3|COMPLETED|Overall Study||66
2605658|NCT00163293|6396396|P2|COMPLETED|Overall Study||69
2605659|NCT00163293|6396397|P1|COMPLETED|Overall Study||66
2605660|NCT00163293|6396395|P3|STARTED|Overall Study||85
2605661|NCT00163293|6396396|P2|STARTED|Overall Study||76
2605662|NCT00163293|6396397|P1|STARTED|Overall Study||79
2605663|NCT00163215|6396471|P1|NOT COMPLETED|Overall Study||15
2605664|NCT00163215|6396471|P1|COMPLETED|Overall Study||31
2605665|NCT00163215|6396471|P1|STARTED|Overall Study||46
2605666|NCT00163189|6396491|P1|NOT COMPLETED|Overall Study||63
2605667|NCT00163189|6396491|P1|COMPLETED|Overall Study||35
2605668|NCT00163189|6396491|P1|STARTED|Overall Study||98
2605669|NCT00163020|6396515|P2|NOT COMPLETED|Overall Study||2
2605670|NCT00163020|6396516|P1|NOT COMPLETED|Overall Study||0
2605671|NCT00163020|6396515|P2|COMPLETED|Overall Study|Twins = 78 Triplets = 25|103
2605672|NCT00163020|6396516|P1|COMPLETED|Overall Study|Twins = 160 Triplets = 56|216
2605673|NCT00163020|6396515|P2|STARTED|Overall Study|Twins = 80 Triplets = 25|105
2605674|NCT00163020|6396516|P1|STARTED|Overall Study|Twins = 160 Triplets = 56|216
2605675|NCT00162981|6396556|P2|NOT COMPLETED|Overall Study||6
2605676|NCT00162981|6396557|P1|NOT COMPLETED|Overall Study||4
2605677|NCT00162981|6396556|P2|COMPLETED|Overall Study||30
2605678|NCT00162981|6396557|P1|COMPLETED|Overall Study||28
2605679|NCT00162981|6396556|P2|STARTED|Overall Study||36
2605680|NCT00162981|6396557|P1|STARTED|Overall Study||32
2605681|NCT00162942|6396573|P2|NOT COMPLETED|Overall Study||52
2605682|NCT00162942|6396574|P1|NOT COMPLETED|Overall Study||106
2605683|NCT00162942|6396573|P2|COMPLETED|Overall Study||26
2605684|NCT00162942|6396574|P1|COMPLETED|Overall Study||51
2605685|NCT00162942|6396573|P2|Week 12|Overall Study||61
2605686|NCT00162942|6396574|P1|Week 12|Overall Study||127
2605687|NCT00162942|6396573|P2|STARTED|Overall Study||78
2605688|NCT00162942|6396574|P1|STARTED|Overall Study||157
2605689|NCT00162773|6396622|P1|NOT COMPLETED|Overall Study||22
2605690|NCT00162773|6396622|P1|COMPLETED|Overall Study||7
2605691|NCT00162773|6396622|P1|STARTED|Overall Study||29
2605692|NCT00162370|6396626|P1|NOT COMPLETED|Efficacy Population||51
2605693|NCT00162370|6396626|P1|COMPLETED|Efficacy Population|Efficacy population, completed rest/stress echo with Definity & completed 2 and/or 5 year follow up|315
2605694|NCT00162370|6396626|P1|STARTED|Efficacy Population||366
2605695|NCT00162370|6396626|P1|NOT COMPLETED|Completed Echocardiography Imaging||0
2605696|NCT00162370|6396626|P1|COMPLETED|Completed Echocardiography Imaging|number of subjects who under went Definity-enhanced rest and stress echocardiogram|366
2605697|NCT00162370|6396626|P1|STARTED|Completed Echocardiography Imaging|Received at least one dose of Definity|366
2605698|NCT00162266|6396634|P4|NOT COMPLETED|Open-Label Period||137
2605699|NCT00162266|6396635|P3|NOT COMPLETED|Open-Label Period||0
2605700|NCT00162266|6396636|P2|NOT COMPLETED|Open-Label Period||0
2605701|NCT00162266|6396637|P1|NOT COMPLETED|Open-Label Period||0
2605702|NCT00162266|6396634|P4|COMPLETED|Open-Label Period||82
2605703|NCT00162266|6396635|P3|COMPLETED|Open-Label Period||0
2605704|NCT00162266|6396636|P2|COMPLETED|Open-Label Period||0
2605705|NCT00162266|6396637|P1|COMPLETED|Open-Label Period||0
2605706|NCT00162266|6396634|P4|STARTED|Open-Label Period||219
2605707|NCT00162266|6396635|P3|STARTED|Open-Label Period||0
2605708|NCT00162266|6396636|P2|STARTED|Open-Label Period||0
2605709|NCT00162266|6396637|P1|STARTED|Open-Label Period||0
2605710|NCT00162266|6396634|P4|NOT COMPLETED|Double-Blind Period||0
2605711|NCT00162266|6396635|P3|NOT COMPLETED|Double-Blind Period||48
2605712|NCT00162266|6396636|P2|NOT COMPLETED|Double-Blind Period||31
2605713|NCT00162266|6396637|P1|NOT COMPLETED|Double-Blind Period||25
2605714|NCT00162266|6396634|P4|COMPLETED|Double-Blind Period||0
2605715|NCT00162266|6396635|P3|COMPLETED|Double-Blind Period||71
2605716|NCT00162266|6396636|P2|COMPLETED|Double-Blind Period||74
2605717|NCT00162266|6396637|P1|COMPLETED|Double-Blind Period||90
2605718|NCT00162266|6396634|P4|Completed Day 1 to Day 181|Double-Blind Period||0
2605719|NCT00162266|6396635|P3|Completed Day 1 to Day 181|Double-Blind Period||78
2605720|NCT00162266|6396636|P2|Completed Day 1 to Day 181|Double-Blind Period||80
2605721|NCT00162266|6396637|P1|Completed Day 1 to Day 181|Double-Blind Period||98
2605722|NCT00162266|6396634|P4|STARTED|Double-Blind Period||0
2605723|NCT00162266|6396635|P3|STARTED|Double-Blind Period||119
2605724|NCT00162266|6396636|P2|STARTED|Double-Blind Period||105
2605725|NCT00162266|6396637|P1|STARTED|Double-Blind Period||115
2605726|NCT00162136|6396838|P1|NOT COMPLETED|Overall Study||35
2605727|NCT00162136|6396838|P1|COMPLETED|Overall Study|Number of Participants still on treatment at study termination|0
2605728|NCT00162136|6396838|P1|STARTED|Overall Study||35
2605729|NCT00162123|6396870|P8|NOT COMPLETED|Overall Study||58
2605730|NCT00162123|6396871|P7|NOT COMPLETED|Overall Study||4
2605731|NCT00162123|6396872|P6|NOT COMPLETED|Overall Study||9
2605732|NCT00162123|6396873|P5|NOT COMPLETED|Overall Study||31
2605733|NCT00162123|6396874|P4|NOT COMPLETED|Overall Study||8
2605734|NCT00162123|6396875|P3|NOT COMPLETED|Overall Study||21
2605735|NCT00162123|6396876|P2|NOT COMPLETED|Overall Study||29
2605736|NCT00162123|6396877|P1|NOT COMPLETED|Overall Study||44
2605737|NCT00162123|6396870|P8|COMPLETED|Overall Study|Still on treatment|0
2605738|NCT00162123|6396871|P7|COMPLETED|Overall Study|Still on treatment|0
2605739|NCT00162123|6396872|P6|COMPLETED|Overall Study|Still on treatment|4
2605740|NCT00162123|6396873|P5|COMPLETED|Overall Study|Still on treatment|14
2605741|NCT00162123|6396874|P4|COMPLETED|Overall Study|Still on treatment|3
2605742|NCT00162123|6396875|P3|COMPLETED|Overall Study|Still on treatment|3
2605743|NCT00162123|6396876|P2|COMPLETED|Overall Study|Still on treatment|5
2605744|NCT00162123|6396877|P1|COMPLETED|Overall Study|Still on treatment|9
2605745|NCT00162123|6396870|P8|Received Treatment|Overall Study||0
2605746|NCT00162123|6396871|P7|Received Treatment|Overall Study||4
2605747|NCT00162123|6396872|P6|Received Treatment|Overall Study||12
2605748|NCT00162123|6396873|P5|Received Treatment|Overall Study||33
2605749|NCT00162123|6396874|P4|Received Treatment|Overall Study||11
2605750|NCT00162123|6396875|P3|Received Treatment|Overall Study||24
2605751|NCT00162123|6396876|P2|Received Treatment|Overall Study||34
2605752|NCT00162123|6396877|P1|Received Treatment|Overall Study||53
2605753|NCT00162123|6396870|P8|STARTED|Overall Study|Enrolled|58
2605754|NCT00162123|6396871|P7|STARTED|Overall Study|Enrolled|4
2605755|NCT00162123|6396872|P6|STARTED|Overall Study|Enrolled|13
2605756|NCT00162123|6396873|P5|STARTED|Overall Study|Enrolled|45
2605757|NCT00162123|6396874|P4|STARTED|Overall Study|Enrolled|11
2605758|NCT00162123|6396875|P3|STARTED|Overall Study|Enrolled|24
2605759|NCT00162123|6396876|P2|STARTED|Overall Study|Enrolled|34
2605760|NCT00162123|6396877|P1|STARTED|Overall Study|Enrolled|53
2605761|NCT00162097|6396910|P4|NOT COMPLETED|Overall Study||1
2605762|NCT00162097|6396911|P3|NOT COMPLETED|Overall Study||0
2605763|NCT00162097|6396912|P2|NOT COMPLETED|Overall Study||0
2605764|NCT00162097|6396913|P1|NOT COMPLETED|Overall Study||0
2605765|NCT00162097|6396910|P4|COMPLETED|Overall Study||6
2605766|NCT00162097|6396911|P3|COMPLETED|Overall Study||1
2605767|NCT00162097|6396912|P2|COMPLETED|Overall Study||2
2605768|NCT00162097|6396913|P1|COMPLETED|Overall Study||6
2605769|NCT00162097|6396910|P4|STARTED|Overall Study|Treated on Day 1. One participant enrolled twice in the study and is hence counted twice|7
2605770|NCT00162097|6396911|P3|STARTED|Overall Study|Treated on Day 1|1
2605771|NCT00162097|6396912|P2|STARTED|Overall Study|Treated on Day 1|2
2605772|NCT00162097|6396913|P1|STARTED|Overall Study|Treated on Day 1|6
2605773|NCT00162032|6396975|P2|NOT COMPLETED|Overall Study||2
2605774|NCT00162032|6396976|P1|NOT COMPLETED|Overall Study||5
2605775|NCT00162032|6396975|P2|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|114
2605776|NCT00162032|6396976|P1|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|324
2605777|NCT00162032|6396975|P2|STARTED|Overall Study||116
2605778|NCT00162032|6396976|P1|STARTED|Overall Study||329
2605779|NCT00161616|6396997|P2|NOT COMPLETED|Overall Study||19
2605780|NCT00161616|6396998|P1|NOT COMPLETED|Overall Study||26
2605781|NCT00161616|6396997|P2|COMPLETED|Overall Study||119
2605782|NCT00161616|6396998|P1|COMPLETED|Overall Study||113
2605783|NCT00161616|6396997|P2|STARTED|Overall Study||138
2605784|NCT00161616|6396998|P1|STARTED|Overall Study||139
2605785|NCT00161473|6397008|P2|NOT COMPLETED|Overall Study||6
2605786|NCT00161473|6397009|P1|NOT COMPLETED|Overall Study||5
2605787|NCT00161473|6397008|P2|COMPLETED|Overall Study||6
2605788|NCT00161473|6397009|P1|COMPLETED|Overall Study||7
2605789|NCT00161473|6397008|P2|STARTED|Overall Study||12
2605790|NCT00161473|6397009|P1|STARTED|Overall Study||12
2605791|NCT00161382|6397023|P2|NOT COMPLETED|Overall Study||289
2605792|NCT00161382|6397024|P1|NOT COMPLETED|Overall Study||249
2605793|NCT00161382|6397023|P2|COMPLETED|Overall Study|Number of control students included in the analyzed cohort (i.e., completed 9th-grade survey)|558
2605794|NCT00161382|6397024|P1|COMPLETED|Overall Study|Number of intervention students included in the analyzed cohort (i.e., completed 9th-grade survey)|349
2605795|NCT00161382|6397023|P2|STARTED|Overall Study|Number of students allocated to comparison group|847
2605796|NCT00161382|6397024|P1|STARTED|Overall Study|Number of students allocated to intervention group|598
2605797|NCT00161213|6397030|P1|NOT COMPLETED|Overall Study||2
2605798|NCT00161213|6397030|P1|COMPLETED|Overall Study||42
2605799|NCT00161213|6397030|P1|STARTED|Overall Study||44
2605800|NCT00160706|6397037|P1|NOT COMPLETED|Overall Study||286
2605801|NCT00160706|6397037|P1|COMPLETED|Overall Study||24
2605802|NCT00160706|6397037|P1|STARTED|Overall Study||310
2605803|NCT00160693|6397049|P1|NOT COMPLETED|Overall Study||235
2605804|NCT00160693|6397049|P1|COMPLETED|Overall Study||167
2605805|NCT00160693|6397049|P1|STARTED|Overall Study||402
2605806|NCT00160680|6397068|P2|NOT COMPLETED|Overall Study||13
2605807|NCT00160680|6397069|P1|NOT COMPLETED|Overall Study||9
2605808|NCT00160680|6397068|P2|COMPLETED|Overall Study||18
2605809|NCT00160680|6397069|P1|COMPLETED|Overall Study||22
2605810|NCT00160680|6397068|P2|STARTED|Overall Study||31
2605811|NCT00160680|6397069|P1|STARTED|Overall Study||31
2605812|NCT00160667|6397104|P3|NOT COMPLETED|Overall Study||6
2605813|NCT00160667|6397105|P2|NOT COMPLETED|Overall Study||3
2605814|NCT00160667|6397106|P1|NOT COMPLETED|Overall Study||5
2605815|NCT00160667|6397104|P3|COMPLETED|Overall Study||45
2605816|NCT00160667|6397105|P2|COMPLETED|Overall Study||48
2605817|NCT00160667|6397106|P1|COMPLETED|Overall Study||45
2605818|NCT00160667|6397104|P3|STARTED|Overall Study||51
2605819|NCT00160667|6397105|P2|STARTED|Overall Study||51
2605820|NCT00160667|6397106|P1|STARTED|Overall Study||50
2605821|NCT00160641|6397153|P1|NOT COMPLETED|Overall Study||221
2605822|NCT00160641|6397153|P1|COMPLETED|Overall Study||346
2605823|NCT00160641|6397153|P1|STARTED|Overall Study||567
2605824|NCT00160615|6397186|P2|NOT COMPLETED|Overall Study||45
2605825|NCT00160615|6397187|P1|NOT COMPLETED|Overall Study||18
2605826|NCT00160615|6397186|P2|COMPLETED|Overall Study||56
2605827|NCT00160615|6397187|P1|COMPLETED|Overall Study||32
2605828|NCT00160615|6397186|P2|STARTED|Overall Study||101
2605829|NCT00160615|6397187|P1|STARTED|Overall Study||50
2605830|NCT00160563|6397210|P3|NOT COMPLETED|Overall Study||90
2605831|NCT00160563|6397211|P2|NOT COMPLETED|Overall Study||45
2605832|NCT00160563|6397212|P1|NOT COMPLETED|Overall Study||51
2605833|NCT00160563|6397210|P3|COMPLETED|Overall Study||11
2605834|NCT00160563|6397211|P2|COMPLETED|Overall Study||2
2605835|NCT00160563|6397212|P1|COMPLETED|Overall Study||8
2605836|NCT00160563|6397210|P3|STARTED|Overall Study||101
2605837|NCT00160563|6397211|P2|STARTED|Overall Study||47
2605838|NCT00160563|6397212|P1|STARTED|Overall Study||59
2605839|NCT00160524|6397224|P1|NOT COMPLETED|Overall Study||478
2605840|NCT00160524|6397224|P1|COMPLETED|Overall Study||117
2605841|NCT00160524|6397224|P1|STARTED|Overall Study|One subject was enrolled erroneously and has no data in the database.|595
2605842|NCT00160251|6397241|P8|NOT COMPLETED|Post-amendment 2||55
2605843|NCT00160251|6397242|P7|NOT COMPLETED|Post-amendment 2||0
2605844|NCT00160251|6397243|P6|NOT COMPLETED|Post-amendment 2||0
2605845|NCT00160251|6397244|P5|NOT COMPLETED|Post-amendment 2||0
2605846|NCT00160251|6397245|P4|NOT COMPLETED|Post-amendment 2||0
2605847|NCT00160251|6397246|P3|NOT COMPLETED|Post-amendment 2||0
2605848|NCT00160251|6397247|P2|NOT COMPLETED|Post-amendment 2||0
2605849|NCT00160251|6397248|P1|NOT COMPLETED|Post-amendment 2||0
2605850|NCT00160251|6397241|P8|COMPLETED|Post-amendment 2||88
2605851|NCT00160251|6397242|P7|COMPLETED|Post-amendment 2||0
2605852|NCT00160251|6397243|P6|COMPLETED|Post-amendment 2||0
2605853|NCT00160251|6397244|P5|COMPLETED|Post-amendment 2||0
2605854|NCT00160251|6397245|P4|COMPLETED|Post-amendment 2||0
2605855|NCT00160251|6397246|P3|COMPLETED|Post-amendment 2||0
2605856|NCT00160251|6397247|P2|COMPLETED|Post-amendment 2||0
2605857|NCT00160251|6397248|P1|COMPLETED|Post-amendment 2||0
2605858|NCT00160251|6397241|P8|STARTED|Post-amendment 2||143
2605859|NCT00160251|6397242|P7|STARTED|Post-amendment 2||0
2605860|NCT00160251|6397243|P6|STARTED|Post-amendment 2||0
2605861|NCT00160251|6397244|P5|STARTED|Post-amendment 2||0
2605862|NCT00160251|6397245|P4|STARTED|Post-amendment 2||0
2605863|NCT00160251|6397246|P3|STARTED|Post-amendment 2||0
2605864|NCT00160251|6397247|P2|STARTED|Post-amendment 2||0
2605865|NCT00160251|6397248|P1|STARTED|Post-amendment 2||0
2605866|NCT00160251|6397241|P8|NOT COMPLETED|Prior to Amendment 2||0
2605867|NCT00160251|6397242|P7|NOT COMPLETED|Prior to Amendment 2||4
2605868|NCT00160251|6397243|P6|NOT COMPLETED|Prior to Amendment 2||83
2605869|NCT00160251|6397244|P5|NOT COMPLETED|Prior to Amendment 2||28
2605870|NCT00160251|6397245|P4|NOT COMPLETED|Prior to Amendment 2||40
2605871|NCT00160251|6397246|P3|NOT COMPLETED|Prior to Amendment 2||44
2605872|NCT00160251|6397247|P2|NOT COMPLETED|Prior to Amendment 2||6
2605873|NCT00160251|6397248|P1|NOT COMPLETED|Prior to Amendment 2||9
2605874|NCT00160251|6397241|P8|COMPLETED|Prior to Amendment 2||0
2605875|NCT00160251|6397242|P7|COMPLETED|Prior to Amendment 2||61
2605876|NCT00160251|6397243|P6|COMPLETED|Prior to Amendment 2||14
2605877|NCT00160251|6397244|P5|COMPLETED|Prior to Amendment 2||21
2605878|NCT00160251|6397245|P4|COMPLETED|Prior to Amendment 2||9
2605879|NCT00160251|6397246|P3|COMPLETED|Prior to Amendment 2||4
2605880|NCT00160251|6397247|P2|COMPLETED|Prior to Amendment 2||28
2605881|NCT00160251|6397248|P1|COMPLETED|Prior to Amendment 2||6
2605882|NCT00160251|6397241|P8|STARTED|Prior to Amendment 2||0
2605883|NCT00160251|6397242|P7|STARTED|Prior to Amendment 2||65
2605884|NCT00160251|6397243|P6|STARTED|Prior to Amendment 2||97
2605885|NCT00160251|6397244|P5|STARTED|Prior to Amendment 2||49
2605886|NCT00160251|6397245|P4|STARTED|Prior to Amendment 2||49
2605887|NCT00160251|6397246|P3|STARTED|Prior to Amendment 2||48
2605888|NCT00160251|6397247|P2|STARTED|Prior to Amendment 2||34
2605889|NCT00160251|6397248|P1|STARTED|Prior to Amendment 2||15
2605890|NCT00160199|6397324|P2|NOT COMPLETED|Overall Study||37
2605891|NCT00160199|6397325|P1|NOT COMPLETED|Overall Study||24
2605892|NCT00160199|6397324|P2|COMPLETED|Overall Study||81
2605893|NCT00160199|6397325|P1|COMPLETED|Overall Study||98
2605894|NCT00160199|6397324|P2|STARTED|Overall Study||118
2605895|NCT00160199|6397325|P1|STARTED|Overall Study||122
2605896|NCT00159965|6397345|P2|NOT COMPLETED|Overall Study||5
2605897|NCT00159965|6397346|P1|NOT COMPLETED|Overall Study||7
2605898|NCT00159965|6397345|P2|COMPLETED|Overall Study||14
2605899|NCT00159965|6397346|P1|COMPLETED|Overall Study||12
2605900|NCT00159965|6397345|P2|STARTED|Overall Study||19
2605901|NCT00159965|6397346|P1|STARTED|Overall Study||19
2605902|NCT00159913|6397382|P4|NOT COMPLETED|Overall Study||2
2605903|NCT00159913|6397383|P3|NOT COMPLETED|Overall Study||2
2605904|NCT00159913|6397384|P2|NOT COMPLETED|Overall Study||0
2605905|NCT00159913|6397385|P1|NOT COMPLETED|Overall Study||2
2605906|NCT00159913|6397382|P4|COMPLETED|Overall Study||58
2605907|NCT00159913|6397383|P3|COMPLETED|Overall Study||75
2605908|NCT00159913|6397384|P2|COMPLETED|Overall Study||55
2605909|NCT00159913|6397385|P1|COMPLETED|Overall Study||40
2605910|NCT00159913|6397382|P4|STARTED|Overall Study||60
2605911|NCT00159913|6397383|P3|STARTED|Overall Study||77
2605912|NCT00159913|6397384|P2|STARTED|Overall Study||55
2605913|NCT00159913|6397385|P1|STARTED|Overall Study||42
2605914|NCT00159874|6397459|P7|NOT COMPLETED|Overall Study||5
2605915|NCT00159874|6397460|P6|NOT COMPLETED|Overall Study||12
2605916|NCT00159874|6397461|P5|NOT COMPLETED|Overall Study||8
2605917|NCT00159874|6397462|P4|NOT COMPLETED|Overall Study||6
2605918|NCT00159874|6397463|P3|NOT COMPLETED|Overall Study||43
2605919|NCT00159874|6397464|P2|NOT COMPLETED|Overall Study||30
2605920|NCT00159874|6397465|P1|NOT COMPLETED|Overall Study||20
2605921|NCT00159874|6397459|P7|COMPLETED|Overall Study||0
2605922|NCT00159874|6397460|P6|COMPLETED|Overall Study||11
2605923|NCT00159874|6397461|P5|COMPLETED|Overall Study||11
2605924|NCT00159874|6397462|P4|COMPLETED|Overall Study||7
2605925|NCT00159874|6397463|P3|COMPLETED|Overall Study||34
2605926|NCT00159874|6397464|P2|COMPLETED|Overall Study||25
2605927|NCT00159874|6397465|P1|COMPLETED|Overall Study||22
2605928|NCT00159874|6397459|P7|Treated|Overall Study||5
2605929|NCT00159874|6397460|P6|Treated|Overall Study||23
2605930|NCT00159874|6397461|P5|Treated|Overall Study||19
2605931|NCT00159874|6397462|P4|Treated|Overall Study||13
2605932|NCT00159874|6397463|P3|Treated|Overall Study||77
2605933|NCT00159874|6397464|P2|Treated|Overall Study||55
2605934|NCT00159874|6397465|P1|Treated|Overall Study||42
2605935|NCT00159874|6397459|P7|STARTED|Overall Study||5
2605936|NCT00159874|6397460|P6|STARTED|Overall Study||23
2605937|NCT00159874|6397461|P5|STARTED|Overall Study||19
2605938|NCT00159874|6397462|P4|STARTED|Overall Study||13
2605939|NCT00159874|6397463|P3|STARTED|Overall Study||77
2605940|NCT00159874|6397464|P2|STARTED|Overall Study||55
2605941|NCT00159874|6397465|P1|STARTED|Overall Study||42
2605942|NCT00159861|6397635|P2|NOT COMPLETED|Extension Study - up to 3 Years||71
2605943|NCT00159861|6397636|P1|NOT COMPLETED|Extension Study - up to 3 Years||62
2605944|NCT00159861|6397635|P2|COMPLETED|Extension Study - up to 3 Years||56
2605945|NCT00159861|6397636|P1|COMPLETED|Extension Study - up to 3 Years||53
2605946|NCT00159861|6397635|P2|Treated|Extension Study - up to 3 Years||127
2605947|NCT00159861|6397636|P1|Treated|Extension Study - up to 3 Years||115
2605948|NCT00159861|6397635|P2|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|127
2605949|NCT00159861|6397636|P1|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|115
2605950|NCT00159861|6397635|P2|NOT COMPLETED|Core Study - 16 Weeks||12
2605951|NCT00159861|6397636|P1|NOT COMPLETED|Core Study - 16 Weeks||25
2605952|NCT00159861|6397635|P2|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 127; Did not enter A1481153: 7|122
2605953|NCT00159861|6397636|P1|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 115; Did not enter A1481153: 16|108
2605954|NCT00159861|6397635|P2|Treated|Core Study - 16 Weeks||134
2605955|NCT00159861|6397636|P1|Treated|Core Study - 16 Weeks||131
2605956|NCT00159861|6397635|P2|STARTED|Core Study - 16 Weeks||134
2605957|NCT00159861|6397636|P1|STARTED|Core Study - 16 Weeks||133
2605958|NCT00159822|6397657|P1|NOT COMPLETED|Post-treatment Follow-up Period||3
2605959|NCT00159822|6397657|P1|COMPLETED|Post-treatment Follow-up Period||23
2605960|NCT00159822|6397657|P1|STARTED|Post-treatment Follow-up Period||26
2605961|NCT00159822|6397657|P1|NOT COMPLETED|Voriconazole Treatment Period||22
2605962|NCT00159822|6397657|P1|COMPLETED|Voriconazole Treatment Period|Number of subjects completed treatment: 36 up to month 6 (M6); 26 after M6.|26
2605963|NCT00159822|6397657|P1|STARTED|Voriconazole Treatment Period||48
2605964|NCT00159783|6397675|P3|NOT COMPLETED|Overall Study||39
2605965|NCT00159783|6397676|P2|NOT COMPLETED|Overall Study||27
2605966|NCT00159783|6397677|P1|NOT COMPLETED|Overall Study||19
2605967|NCT00159783|6397675|P3|COMPLETED|Overall Study||68
2605968|NCT00159783|6397676|P2|COMPLETED|Overall Study||52
2605969|NCT00159783|6397677|P1|COMPLETED|Overall Study||13
2605970|NCT00159783|6397675|P3|STARTED|Overall Study||107
2605971|NCT00159783|6397676|P2|STARTED|Overall Study||79
2605972|NCT00159783|6397677|P1|STARTED|Overall Study||32
2605973|NCT00159432|6397707|P1|NOT COMPLETED|Overall Study||10
2605974|NCT00159432|6397707|P1|COMPLETED|Overall Study||53
2605975|NCT00159432|6397707|P1|STARTED|Overall Study||63
2605976|NCT00159419|6397714|P2|NOT COMPLETED|Overall Study||0
2605977|NCT00159419|6397715|P1|NOT COMPLETED|Overall Study||0
2605978|NCT00159419|6397714|P2|COMPLETED|Overall Study||9
2605979|NCT00159419|6397715|P1|COMPLETED|Overall Study||9
2605980|NCT00159419|6397714|P2|STARTED|Overall Study||9
2605981|NCT00159419|6397715|P1|STARTED|Overall Study||9
2605982|NCT00159263|6397721|P6|NOT COMPLETED|Sixth Intervention||0
2605983|NCT00159263|6397722|P5|NOT COMPLETED|Sixth Intervention||0
2605984|NCT00159263|6397723|P4|NOT COMPLETED|Sixth Intervention||0
2605985|NCT00159263|6397724|P3|NOT COMPLETED|Sixth Intervention||0
2605986|NCT00159263|6397725|P2|NOT COMPLETED|Sixth Intervention||0
2605987|NCT00159263|6397726|P1|NOT COMPLETED|Sixth Intervention||0
2605988|NCT00159263|6397721|P6|COMPLETED|Sixth Intervention||2
2605989|NCT00159263|6397722|P5|COMPLETED|Sixth Intervention||2
2605990|NCT00159263|6397723|P4|COMPLETED|Sixth Intervention||2
2605991|NCT00159263|6397724|P3|COMPLETED|Sixth Intervention||2
2605992|NCT00159263|6397725|P2|COMPLETED|Sixth Intervention||1
2605993|NCT00159263|6397726|P1|COMPLETED|Sixth Intervention||1
2605994|NCT00159263|6397721|P6|STARTED|Sixth Intervention||2
2605995|NCT00159263|6397722|P5|STARTED|Sixth Intervention||2
2605996|NCT00159263|6397723|P4|STARTED|Sixth Intervention||2
2605997|NCT00159263|6397724|P3|STARTED|Sixth Intervention||2
2605998|NCT00159263|6397725|P2|STARTED|Sixth Intervention||1
2605999|NCT00159263|6397726|P1|STARTED|Sixth Intervention||1
2606000|NCT00159263|6397721|P6|NOT COMPLETED|Washout||0
2606001|NCT00159263|6397722|P5|NOT COMPLETED|Washout||0
2606002|NCT00159263|6397723|P4|NOT COMPLETED|Washout||0
2606003|NCT00159263|6397724|P3|NOT COMPLETED|Washout||0
2606004|NCT00159263|6397725|P2|NOT COMPLETED|Washout||0
2606005|NCT00159263|6397726|P1|NOT COMPLETED|Washout||0
2606006|NCT00159263|6397721|P6|COMPLETED|Washout||2
2606007|NCT00159263|6397722|P5|COMPLETED|Washout||2
2606008|NCT00159263|6397723|P4|COMPLETED|Washout||2
2606009|NCT00159263|6397724|P3|COMPLETED|Washout||2
2606010|NCT00159263|6397725|P2|COMPLETED|Washout||1
2606011|NCT00159263|6397726|P1|COMPLETED|Washout||1
2606012|NCT00159263|6397721|P6|STARTED|Washout||2
2606013|NCT00159263|6397722|P5|STARTED|Washout||2
2606014|NCT00159263|6397723|P4|STARTED|Washout||2
2606015|NCT00159263|6397724|P3|STARTED|Washout||2
2606016|NCT00159263|6397725|P2|STARTED|Washout||1
2606017|NCT00159263|6397726|P1|STARTED|Washout||1
2606018|NCT00159263|6397721|P6|NOT COMPLETED|Fifth Intervention||0
2606019|NCT00159263|6397722|P5|NOT COMPLETED|Fifth Intervention||0
2606020|NCT00159263|6397723|P4|NOT COMPLETED|Fifth Intervention||0
2606021|NCT00159263|6397724|P3|NOT COMPLETED|Fifth Intervention||0
2606022|NCT00159263|6397725|P2|NOT COMPLETED|Fifth Intervention||0
2606023|NCT00159263|6397726|P1|NOT COMPLETED|Fifth Intervention||0
2606024|NCT00159263|6397721|P6|COMPLETED|Fifth Intervention||2
2606025|NCT00159263|6397722|P5|COMPLETED|Fifth Intervention||2
2606026|NCT00159263|6397723|P4|COMPLETED|Fifth Intervention||2
2606027|NCT00159263|6397724|P3|COMPLETED|Fifth Intervention||2
2606028|NCT00159263|6397725|P2|COMPLETED|Fifth Intervention||1
2606029|NCT00159263|6397726|P1|COMPLETED|Fifth Intervention||1
2606030|NCT00159263|6397721|P6|STARTED|Fifth Intervention||2
2606031|NCT00159263|6397722|P5|STARTED|Fifth Intervention||2
2606032|NCT00159263|6397723|P4|STARTED|Fifth Intervention||2
2606033|NCT00159263|6397724|P3|STARTED|Fifth Intervention||2
2606034|NCT00159263|6397725|P2|STARTED|Fifth Intervention||1
2606035|NCT00159263|6397726|P1|STARTED|Fifth Intervention||1
2606036|NCT00159263|6397721|P6|NOT COMPLETED|Washout||0
2606037|NCT00159263|6397722|P5|NOT COMPLETED|Washout||0
2606038|NCT00159263|6397723|P4|NOT COMPLETED|Washout||0
2606039|NCT00159263|6397724|P3|NOT COMPLETED|Washout||0
2606040|NCT00159263|6397725|P2|NOT COMPLETED|Washout||0
2606041|NCT00159263|6397726|P1|NOT COMPLETED|Washout||0
2606042|NCT00159263|6397721|P6|COMPLETED|Washout||2
2606043|NCT00159263|6397722|P5|COMPLETED|Washout||2
2606044|NCT00159263|6397723|P4|COMPLETED|Washout||2
2606045|NCT00159263|6397724|P3|COMPLETED|Washout||2
2606046|NCT00159263|6397725|P2|COMPLETED|Washout||1
2606047|NCT00159263|6397726|P1|COMPLETED|Washout||1
2606048|NCT00159263|6397721|P6|STARTED|Washout||2
2606049|NCT00159263|6397722|P5|STARTED|Washout||2
2606050|NCT00159263|6397723|P4|STARTED|Washout||2
2606051|NCT00159263|6397724|P3|STARTED|Washout||2
2606052|NCT00159263|6397725|P2|STARTED|Washout||1
2606053|NCT00159263|6397726|P1|STARTED|Washout||1
2606054|NCT00159263|6397721|P6|NOT COMPLETED|Fourth Intervention||0
2606055|NCT00159263|6397722|P5|NOT COMPLETED|Fourth Intervention||0
2606056|NCT00159263|6397723|P4|NOT COMPLETED|Fourth Intervention||0
2606057|NCT00159263|6397724|P3|NOT COMPLETED|Fourth Intervention||0
2606058|NCT00159263|6397725|P2|NOT COMPLETED|Fourth Intervention||0
2606059|NCT00159263|6397726|P1|NOT COMPLETED|Fourth Intervention||0
2606060|NCT00159263|6397721|P6|COMPLETED|Fourth Intervention||2
2606061|NCT00159263|6397722|P5|COMPLETED|Fourth Intervention||2
2606062|NCT00159263|6397723|P4|COMPLETED|Fourth Intervention||2
2606063|NCT00159263|6397724|P3|COMPLETED|Fourth Intervention||2
2606064|NCT00159263|6397725|P2|COMPLETED|Fourth Intervention||1
2606065|NCT00159263|6397726|P1|COMPLETED|Fourth Intervention||1
2606066|NCT00159263|6397721|P6|STARTED|Fourth Intervention||2
2606067|NCT00159263|6397722|P5|STARTED|Fourth Intervention||2
2606068|NCT00159263|6397723|P4|STARTED|Fourth Intervention||2
2606069|NCT00159263|6397724|P3|STARTED|Fourth Intervention||2
2606070|NCT00159263|6397725|P2|STARTED|Fourth Intervention||1
2606071|NCT00159263|6397726|P1|STARTED|Fourth Intervention||1
2606072|NCT00159263|6397721|P6|NOT COMPLETED|Washout||0
2606073|NCT00159263|6397722|P5|NOT COMPLETED|Washout||0
2606074|NCT00159263|6397723|P4|NOT COMPLETED|Washout||0
2606075|NCT00159263|6397724|P3|NOT COMPLETED|Washout||0
2606076|NCT00159263|6397725|P2|NOT COMPLETED|Washout||0
2606077|NCT00159263|6397726|P1|NOT COMPLETED|Washout||0
2606078|NCT00159263|6397721|P6|COMPLETED|Washout||2
2606079|NCT00159263|6397722|P5|COMPLETED|Washout||2
2606080|NCT00159263|6397723|P4|COMPLETED|Washout||2
2606081|NCT00159263|6397724|P3|COMPLETED|Washout||2
2606082|NCT00159263|6397725|P2|COMPLETED|Washout||1
2606083|NCT00159263|6397726|P1|COMPLETED|Washout||1
2606084|NCT00159263|6397721|P6|STARTED|Washout||2
2606085|NCT00159263|6397722|P5|STARTED|Washout||2
2606086|NCT00159263|6397723|P4|STARTED|Washout||2
2606087|NCT00159263|6397724|P3|STARTED|Washout||2
2606088|NCT00159263|6397725|P2|STARTED|Washout||1
2606089|NCT00159263|6397726|P1|STARTED|Washout||1
2606090|NCT00159263|6397721|P6|NOT COMPLETED|Third Intervention||0
2606091|NCT00159263|6397722|P5|NOT COMPLETED|Third Intervention||0
2606092|NCT00159263|6397723|P4|NOT COMPLETED|Third Intervention||0
2606093|NCT00159263|6397724|P3|NOT COMPLETED|Third Intervention||0
2606094|NCT00159263|6397725|P2|NOT COMPLETED|Third Intervention||0
2606095|NCT00159263|6397726|P1|NOT COMPLETED|Third Intervention||0
2606096|NCT00159263|6397721|P6|COMPLETED|Third Intervention||2
2606097|NCT00159263|6397722|P5|COMPLETED|Third Intervention||2
2606098|NCT00159263|6397723|P4|COMPLETED|Third Intervention||2
2606099|NCT00159263|6397724|P3|COMPLETED|Third Intervention||2
2606100|NCT00159263|6397725|P2|COMPLETED|Third Intervention||1
2606101|NCT00159263|6397726|P1|COMPLETED|Third Intervention||1
2606102|NCT00159263|6397721|P6|STARTED|Third Intervention||2
2606103|NCT00159263|6397722|P5|STARTED|Third Intervention||2
2606104|NCT00159263|6397723|P4|STARTED|Third Intervention||2
2606105|NCT00159263|6397724|P3|STARTED|Third Intervention||2
2606106|NCT00159263|6397725|P2|STARTED|Third Intervention||1
2606107|NCT00159263|6397726|P1|STARTED|Third Intervention||1
2606108|NCT00159263|6397721|P6|NOT COMPLETED|Washout||0
2606109|NCT00159263|6397722|P5|NOT COMPLETED|Washout||0
2606110|NCT00159263|6397723|P4|NOT COMPLETED|Washout||0
2606111|NCT00159263|6397724|P3|NOT COMPLETED|Washout||0
2606112|NCT00159263|6397725|P2|NOT COMPLETED|Washout||0
2606113|NCT00159263|6397726|P1|NOT COMPLETED|Washout||0
2606114|NCT00159263|6397721|P6|COMPLETED|Washout||2
2606115|NCT00159263|6397722|P5|COMPLETED|Washout||2
2606116|NCT00159263|6397723|P4|COMPLETED|Washout||2
2606117|NCT00159263|6397724|P3|COMPLETED|Washout||2
2606118|NCT00159263|6397725|P2|COMPLETED|Washout||1
2606119|NCT00159263|6397726|P1|COMPLETED|Washout||1
2606120|NCT00159263|6397721|P6|STARTED|Washout||2
2606121|NCT00159263|6397722|P5|STARTED|Washout||2
2606122|NCT00159263|6397723|P4|STARTED|Washout||2
2606123|NCT00159263|6397724|P3|STARTED|Washout||2
2606124|NCT00159263|6397725|P2|STARTED|Washout||1
2606125|NCT00159263|6397726|P1|STARTED|Washout||1
2606126|NCT00159263|6397721|P6|NOT COMPLETED|Second Intervention||0
2606127|NCT00159263|6397722|P5|NOT COMPLETED|Second Intervention||0
2606128|NCT00159263|6397723|P4|NOT COMPLETED|Second Intervention||0
2606129|NCT00159263|6397724|P3|NOT COMPLETED|Second Intervention||0
2606130|NCT00159263|6397725|P2|NOT COMPLETED|Second Intervention||0
2606131|NCT00159263|6397726|P1|NOT COMPLETED|Second Intervention||0
2606132|NCT00159263|6397721|P6|COMPLETED|Second Intervention||2
2606133|NCT00159263|6397722|P5|COMPLETED|Second Intervention||2
2606134|NCT00159263|6397723|P4|COMPLETED|Second Intervention||2
2606135|NCT00159263|6397724|P3|COMPLETED|Second Intervention||2
2606136|NCT00159263|6397725|P2|COMPLETED|Second Intervention||1
2606137|NCT00159263|6397726|P1|COMPLETED|Second Intervention||1
2606138|NCT00159263|6397721|P6|STARTED|Second Intervention||2
2606139|NCT00159263|6397722|P5|STARTED|Second Intervention||2
2606140|NCT00159263|6397723|P4|STARTED|Second Intervention||2
2606141|NCT00159263|6397724|P3|STARTED|Second Intervention||2
2606142|NCT00159263|6397725|P2|STARTED|Second Intervention||1
2606143|NCT00159263|6397726|P1|STARTED|Second Intervention||1
2606144|NCT00159263|6397721|P6|NOT COMPLETED|Washout||0
2606145|NCT00159263|6397722|P5|NOT COMPLETED|Washout||0
2606146|NCT00159263|6397723|P4|NOT COMPLETED|Washout||0
2606147|NCT00159263|6397724|P3|NOT COMPLETED|Washout||0
2606148|NCT00159263|6397725|P2|NOT COMPLETED|Washout||0
2606149|NCT00159263|6397726|P1|NOT COMPLETED|Washout||0
2606150|NCT00159263|6397721|P6|COMPLETED|Washout||2
2606151|NCT00159263|6397722|P5|COMPLETED|Washout||2
2606152|NCT00159263|6397723|P4|COMPLETED|Washout||2
2606153|NCT00159263|6397724|P3|COMPLETED|Washout||2
2606154|NCT00159263|6397725|P2|COMPLETED|Washout||1
2606155|NCT00159263|6397726|P1|COMPLETED|Washout||1
2606156|NCT00159263|6397721|P6|STARTED|Washout||2
2606157|NCT00159263|6397722|P5|STARTED|Washout||2
2606158|NCT00159263|6397723|P4|STARTED|Washout||2
2606159|NCT00159263|6397724|P3|STARTED|Washout||2
2606160|NCT00159263|6397725|P2|STARTED|Washout||1
2606161|NCT00159263|6397726|P1|STARTED|Washout||1
2606162|NCT00159263|6397721|P6|NOT COMPLETED|First Intervention||0
2606163|NCT00159263|6397722|P5|NOT COMPLETED|First Intervention||0
2606164|NCT00159263|6397723|P4|NOT COMPLETED|First Intervention||0
2606165|NCT00159263|6397724|P3|NOT COMPLETED|First Intervention||0
2606166|NCT00159263|6397725|P2|NOT COMPLETED|First Intervention||0
2606167|NCT00159263|6397726|P1|NOT COMPLETED|First Intervention||0
2606168|NCT00159263|6397721|P6|COMPLETED|First Intervention||2
2606169|NCT00159263|6397722|P5|COMPLETED|First Intervention||2
2606170|NCT00159263|6397723|P4|COMPLETED|First Intervention||2
2606171|NCT00159263|6397724|P3|COMPLETED|First Intervention||2
2606172|NCT00159263|6397725|P2|COMPLETED|First Intervention||1
2606173|NCT00159263|6397726|P1|COMPLETED|First Intervention||1
2606174|NCT00159263|6397721|P6|STARTED|First Intervention||2
2606175|NCT00159263|6397722|P5|STARTED|First Intervention||2
2606176|NCT00159263|6397723|P4|STARTED|First Intervention||2
2606177|NCT00159263|6397724|P3|STARTED|First Intervention||2
2606178|NCT00159263|6397725|P2|STARTED|First Intervention||1
2606179|NCT00159263|6397726|P1|STARTED|First Intervention||1
2606180|NCT00159250|6397754|P2|NOT COMPLETED|Overall Study||0
2606181|NCT00159250|6397755|P1|NOT COMPLETED|Overall Study||0
2606182|NCT00159250|6397754|P2|COMPLETED|Overall Study||5
2606183|NCT00159250|6397755|P1|COMPLETED|Overall Study||2
2606184|NCT00159250|6397754|P2|STARTED|Overall Study||5
2606185|NCT00159250|6397755|P1|STARTED|Overall Study||2
2606186|NCT00158925|6397771|P1|NOT COMPLETED|Overall Study||12
2606187|NCT00158925|6397771|P1|COMPLETED|Overall Study||84
2606188|NCT00158925|6397771|P1|STARTED|Overall Study|96 subjects were implanted or attempted with the study lead|96
2606189|NCT00158860|6397781|P2|NOT COMPLETED|Overall Study||71
2606190|NCT00158860|6397782|P1|NOT COMPLETED|Overall Study||35
2606191|NCT00158860|6397781|P2|COMPLETED|Overall Study||184
2606192|NCT00158860|6397782|P1|COMPLETED|Overall Study||93
2606193|NCT00158860|6397781|P2|STARTED|Overall Study||255
2606194|NCT00158860|6397782|P1|STARTED|Overall Study||128
2606195|NCT00158756|6397801|P5|NOT COMPLETED|Overall Study||3
2606196|NCT00158756|6397802|P4|NOT COMPLETED|Overall Study||1
2606197|NCT00158756|6397803|P3|NOT COMPLETED|Overall Study||8
2606198|NCT00158756|6397804|P2|NOT COMPLETED|Overall Study||0
2606199|NCT00158756|6397805|P1|NOT COMPLETED|Overall Study||5
2606200|NCT00158756|6397801|P5|COMPLETED|Overall Study||96
2606201|NCT00158756|6397802|P4|COMPLETED|Overall Study||22
2606202|NCT00158756|6397803|P3|COMPLETED|Overall Study||73
2606203|NCT00158756|6397804|P2|COMPLETED|Overall Study||25
2606204|NCT00158756|6397805|P1|COMPLETED|Overall Study||75
2606205|NCT00158756|6397801|P5|STARTED|Overall Study||99
2606206|NCT00158756|6397802|P4|STARTED|Overall Study||23
2606207|NCT00158756|6397803|P3|STARTED|Overall Study||81
2606208|NCT00158756|6397804|P2|STARTED|Overall Study||25
2606209|NCT00158756|6397805|P1|STARTED|Overall Study||80
2606210|NCT00158743|6397902|P2|NOT COMPLETED|Overall Study||7
2606211|NCT00158743|6397903|P1|NOT COMPLETED|Overall Study||9
2606212|NCT00158743|6397902|P2|COMPLETED|Overall Study||20
2606213|NCT00158743|6397903|P1|COMPLETED|Overall Study||15
2606214|NCT00158743|6397902|P2|STARTED|Overall Study||27
2606215|NCT00158743|6397903|P1|STARTED|Overall Study||24
2606216|NCT00158600|6397911|P2|NOT COMPLETED|Overall Study||4
2606217|NCT00158600|6397912|P1|NOT COMPLETED|Overall Study||5
2606218|NCT00158600|6397911|P2|COMPLETED|Overall Study||26
2606219|NCT00158600|6397912|P1|COMPLETED|Overall Study||55
2606220|NCT00158600|6397911|P2|STARTED|Overall Study||30
2606221|NCT00158600|6397912|P1|STARTED|Overall Study||60
2606222|NCT00158379|6397930|P1|NOT COMPLETED|Overall Study||0
2606223|NCT00158379|6397930|P1|COMPLETED|Overall Study||105
2606224|NCT00158379|6397930|P1|STARTED|Overall Study||105
2606225|NCT00158262|6397937|P2|NOT COMPLETED|Overall Study||1
2606226|NCT00158262|6397938|P1|NOT COMPLETED|Overall Study||1
2606227|NCT00158262|6397937|P2|COMPLETED|Overall Study||21
2606228|NCT00158262|6397938|P1|COMPLETED|Overall Study||20
2606229|NCT00158262|6397937|P2|STARTED|Overall Study||22
2606230|NCT00158262|6397938|P1|STARTED|Overall Study||21
2606231|NCT00158249|6397950|P2|NOT COMPLETED|Overall Study||0
2606232|NCT00158249|6397951|P1|NOT COMPLETED|Overall Study||2
2606233|NCT00158249|6397950|P2|COMPLETED|Overall Study||10
2606234|NCT00158249|6397951|P1|COMPLETED|Overall Study||9
2606235|NCT00158249|6397950|P2|STARTED|Overall Study||10
2606236|NCT00158249|6397951|P1|STARTED|Overall Study||11
2606237|NCT00158223|6397961|P2|NOT COMPLETED|Overall Study||3
2606238|NCT00158223|6397962|P1|NOT COMPLETED|Overall Study||5
2606239|NCT00158223|6397961|P2|COMPLETED|Overall Study||22
2606240|NCT00158223|6397962|P1|COMPLETED|Overall Study||23
2606241|NCT00158223|6397961|P2|STARTED|Overall Study||25
2606242|NCT00158223|6397962|P1|STARTED|Overall Study||28
2606243|NCT00158197|6397976|P4|NOT COMPLETED|Overall Study||0
2606244|NCT00158197|6397977|P3|NOT COMPLETED|Overall Study||0
2606245|NCT00158197|6397978|P2|NOT COMPLETED|Overall Study||0
2606246|NCT00158197|6397979|P1|NOT COMPLETED|Overall Study||0
2606247|NCT00158197|6397976|P4|COMPLETED|Overall Study||29
2606248|NCT00158197|6397977|P3|COMPLETED|Overall Study||28
2606249|NCT00158197|6397978|P2|COMPLETED|Overall Study||30
2606250|NCT00158197|6397979|P1|COMPLETED|Overall Study||32
2606251|NCT00158197|6397976|P4|STARTED|Overall Study||29
2606252|NCT00158197|6397977|P3|STARTED|Overall Study||28
2606253|NCT00158197|6397978|P2|STARTED|Overall Study||30
2606254|NCT00158197|6397979|P1|STARTED|Overall Study||32
2606255|NCT00158184|6397999|P2|NOT COMPLETED|Overall Study||2
2606256|NCT00158184|6398000|P1|NOT COMPLETED|Overall Study||6
2606257|NCT00158184|6397999|P2|COMPLETED|Overall Study||9
2606258|NCT00158184|6398000|P1|COMPLETED|Overall Study||10
2606259|NCT00158184|6397999|P2|STARTED|Overall Study||11
2606260|NCT00158184|6398000|P1|STARTED|Overall Study||16
2606261|NCT00158054|6398010|P2|NOT COMPLETED|Overall Study||3
2606262|NCT00158054|6398011|P1|NOT COMPLETED|Overall Study||10
2606263|NCT00158054|6398010|P2|COMPLETED|Overall Study||74
2606264|NCT00158054|6398011|P1|COMPLETED|Overall Study||70
2606265|NCT00158054|6398010|P2|STARTED|Overall Study||77
2606266|NCT00158054|6398011|P1|STARTED|Overall Study||80
2606267|NCT00157950|6398025|P2|NOT COMPLETED|Overall Study||0
2606268|NCT00157950|6398026|P1|NOT COMPLETED|Overall Study||1
2606269|NCT00157950|6398025|P2|COMPLETED|Overall Study||59
2606270|NCT00157950|6398026|P1|COMPLETED|Overall Study||116
2606271|NCT00157950|6398025|P2|Vaccinated at Dose 3|Overall Study||59
2606272|NCT00157950|6398026|P1|Vaccinated at Dose 3|Overall Study||116
2606273|NCT00157950|6398025|P2|Vaccinated at Dose 2|Overall Study||59
2606274|NCT00157950|6398026|P1|Vaccinated at Dose 2|Overall Study||117
2606275|NCT00157950|6398025|P2|Vaccinated at Dose 1|Overall Study||59
2606276|NCT00157950|6398026|P1|Vaccinated at Dose 1|Overall Study||117
2606277|NCT00157950|6398025|P2|STARTED|Overall Study||59
2606278|NCT00157950|6398026|P1|STARTED|Overall Study||117
2606279|NCT00157820|6398043|P3|NOT COMPLETED|2nd 8 Months||14
2606280|NCT00157820|6398044|P2|NOT COMPLETED|2nd 8 Months||13
2606281|NCT00157820|6398045|P1|NOT COMPLETED|2nd 8 Months||5
2606282|NCT00157820|6398043|P3|COMPLETED|2nd 8 Months||94
2606283|NCT00157820|6398044|P2|COMPLETED|2nd 8 Months||88
2606284|NCT00157820|6398045|P1|COMPLETED|2nd 8 Months||98
2606285|NCT00157820|6398043|P3|STARTED|2nd 8 Months||108
2606286|NCT00157820|6398044|P2|STARTED|2nd 8 Months||101
2606287|NCT00157820|6398045|P1|STARTED|2nd 8 Months||103
2606288|NCT00157820|6398043|P3|NOT COMPLETED|1 Month Wash Out Period||0
2606289|NCT00157820|6398044|P2|NOT COMPLETED|1 Month Wash Out Period||0
2606290|NCT00157820|6398045|P1|NOT COMPLETED|1 Month Wash Out Period||0
2606291|NCT00157820|6398043|P3|COMPLETED|1 Month Wash Out Period||108
2606292|NCT00157820|6398044|P2|COMPLETED|1 Month Wash Out Period||101
2606293|NCT00157820|6398045|P1|COMPLETED|1 Month Wash Out Period||103
2606294|NCT00157820|6398043|P3|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in DC true period, that are now carried to SC sim period|108
2606295|NCT00157820|6398044|P2|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in SC sim period, that are now carried to DC true period|101
2606296|NCT00157820|6398045|P1|STARTED|1 Month Wash Out Period||103
2606297|NCT00157820|6398043|P3|NOT COMPLETED|1st 8 Month||6
2606298|NCT00157820|6398044|P2|NOT COMPLETED|1st 8 Month||12
2606299|NCT00157820|6398045|P1|NOT COMPLETED|1st 8 Month||8
2606300|NCT00157820|6398043|P3|COMPLETED|1st 8 Month||106
2606301|NCT00157820|6398044|P2|COMPLETED|1st 8 Month||99
2606302|NCT00157820|6398045|P1|COMPLETED|1st 8 Month||103
2606303|NCT00157820|6398043|P3|STARTED|1st 8 Month||112
2606304|NCT00157820|6398044|P2|STARTED|1st 8 Month||111
2606305|NCT00157820|6398045|P1|STARTED|1st 8 Month||111
2606306|NCT00157820|6398043|P3|NOT COMPLETED|Randomized||8
2606307|NCT00157820|6398044|P2|NOT COMPLETED|Randomized||5
2606308|NCT00157820|6398045|P1|NOT COMPLETED|Randomized||7
2606309|NCT00157820|6398043|P3|COMPLETED|Randomized||112
2606310|NCT00157820|6398044|P2|COMPLETED|Randomized||111
2606311|NCT00157820|6398045|P1|COMPLETED|Randomized||111
2606312|NCT00157820|6398043|P3|STARTED|Randomized||120
2606313|NCT00157820|6398044|P2|STARTED|Randomized||116
2606314|NCT00157820|6398045|P1|STARTED|Randomized||118
2606315|NCT00157755|6398058|P6|NOT COMPLETED|Overall Study||5
2606316|NCT00157755|6398059|P5|NOT COMPLETED|Overall Study||2
2606317|NCT00157755|6398060|P4|NOT COMPLETED|Overall Study||4
2606318|NCT00157755|6398061|P3|NOT COMPLETED|Overall Study||7
2606319|NCT00157755|6398062|P2|NOT COMPLETED|Overall Study||4
2606320|NCT00157755|6398063|P1|NOT COMPLETED|Overall Study||2
2606321|NCT00157755|6398058|P6|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|0
2606322|NCT00157755|6398059|P5|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|10
2606323|NCT00157755|6398060|P4|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|11
2606324|NCT00157755|6398061|P3|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|3
2606325|NCT00157755|6398062|P2|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|15
2606326|NCT00157755|6398063|P1|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|24
2606327|NCT00157755|6398058|P6|STARTED|Overall Study||5
2606328|NCT00157755|6398059|P5|STARTED|Overall Study||12
2606329|NCT00157755|6398060|P4|STARTED|Overall Study||15
2606330|NCT00157755|6398061|P3|STARTED|Overall Study||10
2606331|NCT00157755|6398062|P2|STARTED|Overall Study||19
2606332|NCT00157755|6398063|P1|STARTED|Overall Study||26
2606333|NCT00157573|6398085|P2|NOT COMPLETED|Overall Study||0
2606334|NCT00157573|6398086|P1|NOT COMPLETED|Overall Study||0
2606335|NCT00157573|6398085|P2|COMPLETED|Overall Study||37
2606336|NCT00157573|6398086|P1|COMPLETED|Overall Study||35
2606337|NCT00157573|6398085|P2|STARTED|Overall Study||37
2606338|NCT00157573|6398086|P1|STARTED|Overall Study||35
2606339|NCT00157248|6398099|P4|NOT COMPLETED|Overall Study||47
2606340|NCT00157248|6398100|P3|NOT COMPLETED|Overall Study||21
2606341|NCT00157248|6398101|P2|NOT COMPLETED|Overall Study||37
2606342|NCT00157248|6398102|P1|NOT COMPLETED|Overall Study||48
2606343|NCT00157248|6398099|P4|COMPLETED|Overall Study||77
2606344|NCT00157248|6398100|P3|COMPLETED|Overall Study||29
2606345|NCT00157248|6398101|P2|COMPLETED|Overall Study||52
2606346|NCT00157248|6398102|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation of study medication.|50
2606347|NCT00157248|6398099|P4|STARTED|Overall Study||124
2606348|NCT00157248|6398100|P3|STARTED|Overall Study||50
2606349|NCT00157248|6398101|P2|STARTED|Overall Study||89
2606350|NCT00157248|6398102|P1|STARTED|Overall Study|Started: Participant completed previous trial on Dabigatran and took study drug of present trial.|98
2606351|NCT00157209|6398208|P2|NOT COMPLETED|Overall Study||0
2606352|NCT00157209|6398209|P1|NOT COMPLETED|Overall Study||10
2606353|NCT00157209|6398208|P2|COMPLETED|Overall Study||83
2606354|NCT00157209|6398209|P1|COMPLETED|Overall Study||78
2606355|NCT00157209|6398208|P2|STARTED|Overall Study||83
2606356|NCT00157209|6398209|P1|STARTED|Overall Study||88
2606357|NCT00157196|6398223|P1|NOT COMPLETED|Overall Study||9
2606358|NCT00157196|6398223|P1|COMPLETED|Overall Study||13
2606359|NCT00157196|6398223|P1|STARTED|Overall Study||22
2606360|NCT00157157|6398229|P1|NOT COMPLETED|Overall Study||11
2606361|NCT00157157|6398229|P1|COMPLETED|Overall Study||44
2606362|NCT00157157|6398229|P1|STARTED|Overall Study||55
2606363|NCT00157014|6398256|P4|NOT COMPLETED|Overall Study||1
2606364|NCT00157014|6398257|P3|NOT COMPLETED|Overall Study||1
2606365|NCT00157014|6398258|P2|NOT COMPLETED|Overall Study||5
2606366|NCT00157014|6398259|P1|NOT COMPLETED|Overall Study||7
2606367|NCT00157014|6398256|P4|COMPLETED|Overall Study||5
2606368|NCT00157014|6398257|P3|COMPLETED|Overall Study||4
2606369|NCT00157014|6398258|P2|COMPLETED|Overall Study||41
2606370|NCT00157014|6398259|P1|COMPLETED|Overall Study||45
2606371|NCT00157014|6398256|P4|STARTED|Overall Study||6
2606372|NCT00157014|6398257|P3|STARTED|Overall Study||5
2606373|NCT00157014|6398258|P2|STARTED|Overall Study||46
2606374|NCT00157014|6398259|P1|STARTED|Overall Study||52
2606375|NCT00156936|6398339|P2|NOT COMPLETED|Overall Study||11
2606376|NCT00156936|6398340|P1|NOT COMPLETED|Overall Study||72
2606377|NCT00156936|6398339|P2|COMPLETED|Overall Study||5
2606378|NCT00156936|6398340|P1|COMPLETED|Overall Study||20
2606379|NCT00156936|6398339|P2|STARTED|Overall Study||16
2606380|NCT00156936|6398340|P1|STARTED|Overall Study||92
2606381|NCT00156923|6398348|P2|NOT COMPLETED|Overall Study||32
2606382|NCT00156923|6398349|P1|NOT COMPLETED|Overall Study||34
2606383|NCT00156923|6398348|P2|COMPLETED|Overall Study||20
2606384|NCT00156923|6398349|P1|COMPLETED|Overall Study||22
2606385|NCT00156923|6398348|P2|STARTED|Overall Study||52
2606386|NCT00156923|6398349|P1|STARTED|Overall Study||56
2606387|NCT00156910|6398357|P2|NOT COMPLETED|Open-Label Phase (OL)||55
2606388|NCT00156910|6398358|P1|NOT COMPLETED|Open-Label Phase (OL)||33
2606389|NCT00156910|6398357|P2|COMPLETED|Open-Label Phase (OL)||231
2606390|NCT00156910|6398358|P1|COMPLETED|Open-Label Phase (OL)||252
2606391|NCT00156910|6398357|P2|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL Phase|286
2606392|NCT00156910|6398358|P1|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|285
2606393|NCT00156910|6398357|P2|NOT COMPLETED|Double-Blind Phase (DB)||43
2606394|NCT00156910|6398358|P1|NOT COMPLETED|Double-Blind Phase (DB)||45
2606395|NCT00156910|6398357|P2|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|295
2606396|NCT00156910|6398358|P1|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|296
2606397|NCT00156910|6398357|P2|STARTED|Double-Blind Phase (DB)||338
2606398|NCT00156910|6398358|P1|STARTED|Double-Blind Phase (DB)||341
2606399|NCT00156819|6398375|P3|NOT COMPLETED|Overall Study||3
2606400|NCT00156819|6398376|P2|NOT COMPLETED|Overall Study||1
2606401|NCT00156819|6398377|P1|NOT COMPLETED|Overall Study||1
2606402|NCT00156819|6398375|P3|COMPLETED|Overall Study||162
2606403|NCT00156819|6398376|P2|COMPLETED|Overall Study||165
2606404|NCT00156819|6398377|P1|COMPLETED|Overall Study||168
2606405|NCT00156819|6398375|P3|STARTED|Overall Study||165
2606406|NCT00156819|6398376|P2|STARTED|Overall Study||166
2606407|NCT00156819|6398377|P1|STARTED|Overall Study||169
2606408|NCT00156715|6398385|P1|NOT COMPLETED|Overall Study||7
2606409|NCT00156715|6398385|P1|COMPLETED|Overall Study||16
2606410|NCT00156715|6398385|P1|STARTED|Overall Study||23
2606411|NCT00156533|6398394|P4|NOT COMPLETED|Overall Study||2
2606412|NCT00156533|6398395|P3|NOT COMPLETED|Overall Study||2
2606413|NCT00156533|6398396|P2|NOT COMPLETED|Overall Study||2
2606414|NCT00156533|6398397|P1|NOT COMPLETED|Overall Study||2
2606415|NCT00156533|6398394|P4|COMPLETED|Overall Study||3
2606416|NCT00156533|6398395|P3|COMPLETED|Overall Study||3
2606417|NCT00156533|6398396|P2|COMPLETED|Overall Study||3
2606418|NCT00156533|6398397|P1|COMPLETED|Overall Study||3
2606419|NCT00156533|6398394|P4|STARTED|Overall Study||5
2606420|NCT00156533|6398395|P3|STARTED|Overall Study||5
2606421|NCT00156533|6398396|P2|STARTED|Overall Study||5
2606422|NCT00156533|6398397|P1|STARTED|Overall Study||5
2606423|NCT00156390|6398413|P2|NOT COMPLETED|Overall Study||8
2606424|NCT00156390|6398414|P1|NOT COMPLETED|Overall Study||14
2606425|NCT00156390|6398413|P2|COMPLETED|Overall Study||69
2606426|NCT00156390|6398414|P1|COMPLETED|Overall Study||96
2606427|NCT00156390|6398413|P2|STARTED|Overall Study||77
2606428|NCT00156390|6398414|P1|STARTED|Overall Study||110
2606429|NCT00156247|6398422|P1|NOT COMPLETED|Overall Study||4
2606430|NCT00156247|6398422|P1|COMPLETED|Overall Study||5
2606431|NCT00156247|6398422|P1|STARTED|Overall Study||9
2606432|NCT00156065|6398431|P3|NOT COMPLETED|Overall Study||27
2606433|NCT00156065|6398432|P2|NOT COMPLETED|Overall Study||63
2606434|NCT00156065|6398433|P1|NOT COMPLETED|Overall Study||31
2606435|NCT00156065|6398431|P3|COMPLETED|Overall Study||16
2606436|NCT00156065|6398432|P2|COMPLETED|Overall Study||30
2606437|NCT00156065|6398433|P1|COMPLETED|Overall Study||20
2606438|NCT00156065|6398431|P3|STARTED|Overall Study||43
2606439|NCT00156065|6398432|P2|STARTED|Overall Study||93
2606440|NCT00156065|6398433|P1|STARTED|Overall Study||51
2606441|NCT00156013|6398444|P1|NOT COMPLETED|Overall Study||2
2606442|NCT00156013|6398444|P1|COMPLETED|Overall Study||31
2606443|NCT00156013|6398444|P1|STARTED|Overall Study||33
2606444|NCT00154466|6398453|P3|NOT COMPLETED|Overall Study||0
2606445|NCT00154466|6398454|P2|NOT COMPLETED|Overall Study||0
2606446|NCT00154466|6398455|P1|NOT COMPLETED|Overall Study||0
2606447|NCT00154466|6398453|P3|COMPLETED|Overall Study||19
2606448|NCT00154466|6398454|P2|COMPLETED|Overall Study||19
2606449|NCT00154466|6398455|P1|COMPLETED|Overall Study||20
2606450|NCT00154466|6398453|P3|STARTED|Overall Study|Healthy controls underwent the test of myocardial perfusion only at baseline.|19
2606451|NCT00154466|6398454|P2|STARTED|Overall Study||19
2606452|NCT00154466|6398455|P1|STARTED|Overall Study||20
2606453|NCT00154375|6398467|P2|NOT COMPLETED|Overall Study||106
2606454|NCT00154375|6398468|P1|NOT COMPLETED|Overall Study||113
2606455|NCT00154375|6398467|P2|COMPLETED|Overall Study||14
2606456|NCT00154375|6398468|P1|COMPLETED|Overall Study||7
2606457|NCT00154375|6398467|P2|Not Exposed to Study Treatment|Overall Study||2
2606458|NCT00154375|6398468|P1|Not Exposed to Study Treatment|Overall Study|4 randomized patients didn't receive study treatment were excluded from the safety analyses.|2
2606459|NCT00154375|6398467|P2|Discontinued Study Treatment|Overall Study||104
2606460|NCT00154375|6398468|P1|Discontinued Study Treatment|Overall Study||111
2606461|NCT00154375|6398467|P2|STARTED|Overall Study||120
2606462|NCT00154375|6398468|P1|STARTED|Overall Study||120
2606463|NCT00154310|6398479|P2|NOT COMPLETED|Overall Study||28
2606464|NCT00154310|6398480|P1|NOT COMPLETED|Overall Study||37
2606465|NCT00154310|6398479|P2|COMPLETED|Overall Study||117
2606466|NCT00154310|6398480|P1|COMPLETED|Overall Study||118
2606467|NCT00154310|6398479|P2|STARTED|Overall Study||145
2606468|NCT00154310|6398480|P1|STARTED|Overall Study|"Started indicates enrolled participants. Randomized participants for two arms are 154 and 146."|155
2606469|NCT00154297|6398496|P2|NOT COMPLETED|Overall Study||7
2606470|NCT00154297|6398497|P1|NOT COMPLETED|Overall Study||8
2606471|NCT00154297|6398496|P2|COMPLETED|Overall Study|Completed study by 12 month.|67
2606472|NCT00154297|6398497|P1|COMPLETED|Overall Study|Completed study by 12 month.|57
2606473|NCT00154297|6398496|P2|STARTED|Overall Study|Randomized population.|74
2606474|NCT00154297|6398497|P1|STARTED|Overall Study|Randomized population.|65
2606475|NCT00154284|6398515|P2|NOT COMPLETED|Overall Study||13
2606476|NCT00154284|6398516|P1|NOT COMPLETED|Overall Study||7
2606477|NCT00154284|6398515|P2|COMPLETED|Overall Study||42
2606478|NCT00154284|6398516|P1|COMPLETED|Overall Study|"Completed means patients completed on study medication.All patients of both arms completed study."|52
2606479|NCT00154284|6398515|P2|Intent to Treat (ITT) Population|Overall Study||53
2606480|NCT00154284|6398516|P1|Intent to Treat (ITT) Population|Overall Study||57
2606481|NCT00154284|6398515|P2|STARTED|Overall Study||55
2606482|NCT00154284|6398516|P1|STARTED|Overall Study|"Started indicates Safety Population (randomized patients and treated after randomization.)"|59
2606483|NCT00154102|6398530|P2|NOT COMPLETED|Overall Study||2
2606484|NCT00154102|6398531|P1|NOT COMPLETED|Overall Study||7
2606485|NCT00154102|6398530|P2|COMPLETED|Overall Study||597
2606486|NCT00154102|6398531|P1|COMPLETED|Overall Study||592
2606487|NCT00154102|6398530|P2|STARTED|Overall Study|Randomized and treated subjects; 3 additional subjects were treated but not randomised|599
2606488|NCT00154102|6398531|P1|STARTED|Overall Study|Randomized and treated subjects; 1 additional subject was treated but not randomised|599
2606489|NCT00154063|6398567|P2|NOT COMPLETED|Overall Study||22
2606490|NCT00154063|6398568|P1|NOT COMPLETED|Overall Study||12
2606491|NCT00154063|6398567|P2|COMPLETED|Overall Study||80
2606492|NCT00154063|6398568|P1|COMPLETED|Overall Study||92
2606493|NCT00154063|6398567|P2|STARTED|Overall Study||102
2606494|NCT00154063|6398568|P1|STARTED|Overall Study||104
2606495|NCT00153985|6398624|P1|NOT COMPLETED|Overall Study||0
2606496|NCT00153985|6398624|P1|COMPLETED|Overall Study||2
2606497|NCT00153985|6398624|P1|STARTED|Overall Study||2
2606498|NCT00153920|6398630|P1|NOT COMPLETED|Overall Study||30
2606499|NCT00153920|6398630|P1|COMPLETED|Overall Study||36
2606500|NCT00153920|6398630|P1|Eligible and Treated|Overall Study||64
2606501|NCT00153920|6398630|P1|STARTED|Overall Study||66
2606502|NCT00153842|6398641|P2|NOT COMPLETED|Overall Study||0
2606503|NCT00153842|6398642|P1|NOT COMPLETED|Overall Study||0
2606504|NCT00153842|6398641|P2|COMPLETED|Overall Study||7
2606505|NCT00153842|6398642|P1|COMPLETED|Overall Study||26
2606506|NCT00153842|6398641|P2|STARTED|Overall Study||7
2606507|NCT00153842|6398642|P1|STARTED|Overall Study||26
2606508|NCT00153816|6398656|P6|NOT COMPLETED|Overall Study||27
2606509|NCT00153816|6398657|P5|NOT COMPLETED|Overall Study||17
2606510|NCT00153816|6398658|P4|NOT COMPLETED|Overall Study||31
2606511|NCT00153816|6398659|P3|NOT COMPLETED|Overall Study||32
2606512|NCT00153816|6398660|P2|NOT COMPLETED|Overall Study||32
2606513|NCT00153816|6398661|P1|NOT COMPLETED|Overall Study||32
2606514|NCT00153816|6398656|P6|COMPLETED|Overall Study||262
2606515|NCT00153816|6398657|P5|COMPLETED|Overall Study||278
2606516|NCT00153816|6398658|P4|COMPLETED|Overall Study||390
2606517|NCT00153816|6398659|P3|COMPLETED|Overall Study||388
2606518|NCT00153816|6398660|P2|COMPLETED|Overall Study||387
2606519|NCT00153816|6398661|P1|COMPLETED|Overall Study||383
2606520|NCT00153816|6398656|P6|STARTED|Overall Study||289
2606521|NCT00153816|6398657|P5|STARTED|Overall Study||295
2606522|NCT00153816|6398658|P4|STARTED|Overall Study||421
2606523|NCT00153816|6398659|P3|STARTED|Overall Study||420
2606524|NCT00153816|6398660|P2|STARTED|Overall Study||419
2606525|NCT00153816|6398661|P1|STARTED|Overall Study||415
2606526|NCT00153803|6398683|P2|NOT COMPLETED|Investigational Drug||42
2606527|NCT00153803|6398684|P1|NOT COMPLETED|Investigational Drug||41
2606528|NCT00153803|6398683|P2|COMPLETED|Investigational Drug||75
2606529|NCT00153803|6398684|P1|COMPLETED|Investigational Drug||77
2606530|NCT00153803|6398683|P2|Investigational Drug Dispensed|Investigational Drug||75
2606531|NCT00153803|6398684|P1|Investigational Drug Dispensed|Investigational Drug||77
2606532|NCT00153803|6398683|P2|STARTED|Investigational Drug||117
2606533|NCT00153803|6398684|P1|STARTED|Investigational Drug||118
2606534|NCT00153803|6398683|P2|NOT COMPLETED|Concurrent Chemoradiation||5
2606535|NCT00153803|6398684|P1|NOT COMPLETED|Concurrent Chemoradiation||5
2606536|NCT00153803|6398683|P2|COMPLETED|Concurrent Chemoradiation||117
2606537|NCT00153803|6398684|P1|COMPLETED|Concurrent Chemoradiation||118
2606538|NCT00153803|6398683|P2|Received Chemoradiation|Concurrent Chemoradiation||117
2606539|NCT00153803|6398684|P1|Received Chemoradiation|Concurrent Chemoradiation||118
2606540|NCT00153803|6398683|P2|STARTED|Concurrent Chemoradiation||122
2606541|NCT00153803|6398684|P1|STARTED|Concurrent Chemoradiation||123
2606542|NCT00153179|6398702|P4|NOT COMPLETED|Study Visit Day 2||2
2606543|NCT00153179|6398703|P3|NOT COMPLETED|Study Visit Day 2||2
2606544|NCT00153179|6398704|P2|NOT COMPLETED|Study Visit Day 2||0
2606545|NCT00153179|6398705|P1|NOT COMPLETED|Study Visit Day 2||1
2606546|NCT00153179|6398702|P4|COMPLETED|Study Visit Day 2||7
2606547|NCT00153179|6398703|P3|COMPLETED|Study Visit Day 2||11
2606548|NCT00153179|6398704|P2|COMPLETED|Study Visit Day 2||8
2606549|NCT00153179|6398705|P1|COMPLETED|Study Visit Day 2||9
2606550|NCT00153179|6398702|P4|STARTED|Study Visit Day 2||9
2606551|NCT00153179|6398703|P3|STARTED|Study Visit Day 2||13
2606552|NCT00153179|6398704|P2|STARTED|Study Visit Day 2||8
2606553|NCT00153179|6398705|P1|STARTED|Study Visit Day 2||10
2606554|NCT00153179|6398702|P4|NOT COMPLETED|Study Visit Day 1||0
2606555|NCT00153179|6398703|P3|NOT COMPLETED|Study Visit Day 1||0
2606556|NCT00153179|6398704|P2|NOT COMPLETED|Study Visit Day 1||0
2606557|NCT00153179|6398705|P1|NOT COMPLETED|Study Visit Day 1||0
2606558|NCT00153179|6398702|P4|COMPLETED|Study Visit Day 1||9
2606559|NCT00153179|6398703|P3|COMPLETED|Study Visit Day 1||13
2606560|NCT00153179|6398704|P2|COMPLETED|Study Visit Day 1||8
2606561|NCT00153179|6398705|P1|COMPLETED|Study Visit Day 1||10
2606562|NCT00153179|6398702|P4|STARTED|Study Visit Day 1||9
2606563|NCT00153179|6398703|P3|STARTED|Study Visit Day 1||13
2606564|NCT00153179|6398704|P2|STARTED|Study Visit Day 1||8
2606565|NCT00153179|6398705|P1|STARTED|Study Visit Day 1||10
2606566|NCT00153166|6398718|P3|NOT COMPLETED|Overall Study||0
2606567|NCT00153166|6398719|P2|NOT COMPLETED|Overall Study||0
2606568|NCT00153166|6398720|P1|NOT COMPLETED|Overall Study||0
2606569|NCT00153166|6398718|P3|COMPLETED|Overall Study||28
2606570|NCT00153166|6398719|P2|COMPLETED|Overall Study||37
2606571|NCT00153166|6398720|P1|COMPLETED|Overall Study||11
2606572|NCT00153166|6398718|P3|Received Placebo and Placebo|Overall Study||7
2606573|NCT00153166|6398719|P2|Received Placebo and Placebo|Overall Study||9
2606574|NCT00153166|6398720|P1|Received Placebo and Placebo|Overall Study||3
2606575|NCT00153166|6398718|P3|Received Placebo and Pioglitazone|Overall Study||7
2606576|NCT00153166|6398719|P2|Received Placebo and Pioglitazone|Overall Study||10
2606577|NCT00153166|6398720|P1|Received Placebo and Pioglitazone|Overall Study||3
2606578|NCT00153166|6398718|P3|Received Atorvastatin and Placebo|Overall Study||7
2606579|NCT00153166|6398719|P2|Received Atorvastatin and Placebo|Overall Study||9
2606580|NCT00153166|6398720|P1|Received Atorvastatin and Placebo|Overall Study||2
2606581|NCT00153166|6398718|P3|Received Atorvastatin and Pioglitazone|Overall Study||7
2606582|NCT00153166|6398719|P2|Received Atorvastatin and Pioglitazone|Overall Study||9
2606583|NCT00153166|6398720|P1|Received Atorvastatin and Pioglitazone|Overall Study||3
2606584|NCT00153166|6398718|P3|STARTED|Overall Study||28
2606585|NCT00153166|6398719|P2|STARTED|Overall Study||37
2606586|NCT00153166|6398720|P1|STARTED|Overall Study||11
2606587|NCT00153101|6398737|P5|NOT COMPLETED|Overall Study||10
2606588|NCT00153101|6398738|P4|NOT COMPLETED|Overall Study||8
2606589|NCT00153101|6398739|P3|NOT COMPLETED|Overall Study||15
2606590|NCT00153101|6398740|P2|NOT COMPLETED|Overall Study||18
2606591|NCT00153101|6398741|P1|NOT COMPLETED|Overall Study||17
2606592|NCT00153101|6398737|P5|COMPLETED|Overall Study||2962
2606593|NCT00153101|6398738|P4|COMPLETED|Overall Study||2946
2606594|NCT00153101|6398739|P3|COMPLETED|Overall Study||8561
2606595|NCT00153101|6398740|P2|COMPLETED|Overall Study||8524
2606596|NCT00153101|6398741|P1|COMPLETED|Overall Study||8485
2606597|NCT00153101|6398737|P5|STARTED|Overall Study||2972
2606598|NCT00153101|6398738|P4|STARTED|Overall Study||2954
2606599|NCT00153101|6398739|P3|STARTED|Overall Study||8576
2606600|NCT00153101|6398740|P2|STARTED|Overall Study||8542
2606601|NCT00153101|6398741|P1|STARTED|Overall Study||8502
2606602|NCT00153062|6398849|P4|NOT COMPLETED|Overall Study||411
2606603|NCT00153062|6398850|P3|NOT COMPLETED|Overall Study||415
2606604|NCT00153062|6398851|P2|NOT COMPLETED|Overall Study||406
2606605|NCT00153062|6398852|P1|NOT COMPLETED|Overall Study||387
2606606|NCT00153062|6398849|P4|COMPLETED|Overall Study||4680
2606607|NCT00153062|6398850|P3|COMPLETED|Overall Study||4645
2606608|NCT00153062|6398851|P2|COMPLETED|Overall Study||4689
2606609|NCT00153062|6398852|P1|COMPLETED|Overall Study||4699
2606610|NCT00153062|6398849|P4|STARTED|Overall Study||5091
2606611|NCT00153062|6398850|P3|STARTED|Overall Study||5060
2606612|NCT00153062|6398851|P2|STARTED|Overall Study||5095
2606613|NCT00153062|6398852|P1|STARTED|Overall Study||5086
2606614|NCT00152971|6398871|P3|NOT COMPLETED|Treatment||80
2606615|NCT00152971|6398872|P2|NOT COMPLETED|Treatment||63
2606616|NCT00152971|6398873|P1|NOT COMPLETED|Treatment||71
2606617|NCT00152971|6398871|P3|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|788
2606618|NCT00152971|6398872|P2|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|808
2606619|NCT00152971|6398873|P1|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|786
2606620|NCT00152971|6398871|P3|STARTED|Treatment||868
2606621|NCT00152971|6398872|P2|STARTED|Treatment||871
2606622|NCT00152971|6398873|P1|STARTED|Treatment||857
2606623|NCT00152971|6398871|P3|NOT COMPLETED|Overall Study||49
2606624|NCT00152971|6398872|P2|NOT COMPLETED|Overall Study||48
2606625|NCT00152971|6398873|P1|NOT COMPLETED|Overall Study||51
2606626|NCT00152971|6398871|P3|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|819
2606627|NCT00152971|6398872|P2|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|823
2606628|NCT00152971|6398873|P1|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|806
2606629|NCT00152971|6398871|P3|STARTED|Overall Study||868
2606630|NCT00152971|6398872|P2|STARTED|Overall Study||871
2606631|NCT00152971|6398873|P1|STARTED|Overall Study||857
2606632|NCT00152763|6398909|P4|NOT COMPLETED|Overall Study||14
2606633|NCT00152763|6398910|P3|NOT COMPLETED|Overall Study||4
2606634|NCT00152763|6398911|P2|NOT COMPLETED|Overall Study||5
2606635|NCT00152763|6398912|P1|NOT COMPLETED|Overall Study||10
2606636|NCT00152763|6398909|P4|COMPLETED|Overall Study||63
2606637|NCT00152763|6398910|P3|COMPLETED|Overall Study||16
2606638|NCT00152763|6398911|P2|COMPLETED|Overall Study||14
2606639|NCT00152763|6398912|P1|COMPLETED|Overall Study||67
2606640|NCT00152763|6398909|P4|STARTED|Overall Study||77
2606641|NCT00152763|6398910|P3|STARTED|Overall Study||20
2606642|NCT00152763|6398911|P2|STARTED|Overall Study||19
2606643|NCT00152763|6398912|P1|STARTED|Overall Study||77
2606644|NCT00152516|6399028|P1|NOT COMPLETED|Overall Study||75
2606645|NCT00152516|6399028|P1|COMPLETED|Overall Study|Subjects ongoing until study close-out|180
2606646|NCT00152516|6399028|P1|STARTED|Overall Study|Subjects that were dispensed at least 1 dose of study medication|255
2606647|NCT00152464|6399054|P2|NOT COMPLETED|Overall Study||36
2606648|NCT00152464|6399055|P1|NOT COMPLETED|Overall Study||40
2606649|NCT00152464|6399054|P2|COMPLETED|Overall Study||219
2606650|NCT00152464|6399055|P1|COMPLETED|Overall Study||215
2606651|NCT00152464|6399054|P2|STARTED|Overall Study||255
2606652|NCT00152464|6399055|P1|STARTED|Overall Study||255
2606653|NCT00152009|6399083|P4|NOT COMPLETED|Overall Study||33
2606654|NCT00152009|6399084|P3|NOT COMPLETED|Overall Study||37
2606655|NCT00152009|6399085|P2|NOT COMPLETED|Overall Study||31
2606656|NCT00152009|6399086|P1|NOT COMPLETED|Overall Study||29
2606657|NCT00152009|6399083|P4|COMPLETED|Overall Study||53
2606658|NCT00152009|6399084|P3|COMPLETED|Overall Study||49
2606659|NCT00152009|6399085|P2|COMPLETED|Overall Study||55
2606660|NCT00152009|6399086|P1|COMPLETED|Overall Study||58
2606661|NCT00152009|6399083|P4|STARTED|Overall Study||86
2606662|NCT00152009|6399084|P3|STARTED|Overall Study||86
2606663|NCT00152009|6399085|P2|STARTED|Overall Study||86
2606664|NCT00152009|6399086|P1|STARTED|Overall Study||87
2606665|NCT00151996|6399118|P2|NOT COMPLETED|Overall Study||7
2606666|NCT00151996|6399119|P1|NOT COMPLETED|Overall Study||5
2606667|NCT00151996|6399118|P2|COMPLETED|Overall Study||26
2606668|NCT00151996|6399119|P1|COMPLETED|Overall Study||37
2606669|NCT00151996|6399118|P2|STARTED|Overall Study||33
2606670|NCT00151996|6399119|P1|STARTED|Overall Study||42
2606671|NCT00151892|6399135|P2|NOT COMPLETED|Overall Study||83
2606672|NCT00151892|6399136|P1|NOT COMPLETED|Overall Study||76
2606673|NCT00151892|6399135|P2|COMPLETED|Overall Study||330
2606674|NCT00151892|6399136|P1|COMPLETED|Overall Study||340
2606675|NCT00151892|6399135|P2|STARTED|Overall Study||413
2606676|NCT00151892|6399136|P1|STARTED|Overall Study||416
2606677|NCT00151814|6399153|P3|NOT COMPLETED|Overall Study||0
2606678|NCT00151814|6399154|P2|NOT COMPLETED|Overall Study||0
2606679|NCT00151814|6399155|P1|NOT COMPLETED|Overall Study||0
2606680|NCT00151814|6399153|P3|COMPLETED|Overall Study||10
2606681|NCT00151814|6399154|P2|COMPLETED|Overall Study||10
2606682|NCT00151814|6399155|P1|COMPLETED|Overall Study||4
2606683|NCT00151814|6399153|P3|STARTED|Overall Study||10
2606684|NCT00151814|6399154|P2|STARTED|Overall Study||10
2606685|NCT00151814|6399155|P1|STARTED|Overall Study||4
2606686|NCT00151775|6399181|P12|NOT COMPLETED|Period 4: Open Label||0
2606687|NCT00151775|6399182|P11|NOT COMPLETED|Period 4: Open Label||0
2606688|NCT00151775|6399183|P10|NOT COMPLETED|Period 4: Open Label||21
2606689|NCT00151775|6399184|P9|NOT COMPLETED|Period 4: Open Label||0
2606690|NCT00151775|6399185|P8|NOT COMPLETED|Period 4: Open Label||0
2606691|NCT00151775|6399186|P7|NOT COMPLETED|Period 4: Open Label||0
2606692|NCT00151775|6399187|P6|NOT COMPLETED|Period 4: Open Label||0
2606693|NCT00151775|6399188|P5|NOT COMPLETED|Period 4: Open Label||30
2606694|NCT00151775|6399189|P4|NOT COMPLETED|Period 4: Open Label||0
2606695|NCT00151775|6399190|P3|NOT COMPLETED|Period 4: Open Label||0
2606696|NCT00151775|6399191|P2|NOT COMPLETED|Period 4: Open Label||0
2606697|NCT00151775|6399192|P1|NOT COMPLETED|Period 4: Open Label||0
2606698|NCT00151775|6399181|P12|COMPLETED|Period 4: Open Label||0
2606699|NCT00151775|6399182|P11|COMPLETED|Period 4: Open Label||57
2606700|NCT00151775|6399183|P10|COMPLETED|Period 4: Open Label||83
2606701|NCT00151775|6399184|P9|COMPLETED|Period 4: Open Label||0
2606702|NCT00151775|6399185|P8|COMPLETED|Period 4: Open Label||0
2606703|NCT00151775|6399186|P7|COMPLETED|Period 4: Open Label||0
2606704|NCT00151775|6399187|P6|COMPLETED|Period 4: Open Label||0
2606705|NCT00151775|6399188|P5|COMPLETED|Period 4: Open Label||149
2606706|NCT00151775|6399189|P4|COMPLETED|Period 4: Open Label||0
2606707|NCT00151775|6399190|P3|COMPLETED|Period 4: Open Label||0
2606708|NCT00151775|6399191|P2|COMPLETED|Period 4: Open Label||0
2606709|NCT00151775|6399192|P1|COMPLETED|Period 4: Open Label||0
2606710|NCT00151775|6399181|P12|STARTED|Period 4: Open Label||0
2606711|NCT00151775|6399182|P11|STARTED|Period 4: Open Label||57
2606712|NCT00151775|6399183|P10|STARTED|Period 4: Open Label||104
2606713|NCT00151775|6399184|P9|STARTED|Period 4: Open Label||0
2606714|NCT00151775|6399185|P8|STARTED|Period 4: Open Label||0
2606715|NCT00151775|6399186|P7|STARTED|Period 4: Open Label||0
2606716|NCT00151775|6399187|P6|STARTED|Period 4: Open Label||0
2606717|NCT00151775|6399188|P5|STARTED|Period 4: Open Label||179
2606718|NCT00151775|6399189|P4|STARTED|Period 4: Open Label||0
2606719|NCT00151775|6399190|P3|STARTED|Period 4: Open Label||0
2606720|NCT00151775|6399191|P2|STARTED|Period 4: Open Label||0
2606721|NCT00151775|6399192|P1|STARTED|Period 4: Open Label||0
2606722|NCT00151775|6399181|P12|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
2606723|NCT00151775|6399182|P11|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
2606724|NCT00151775|6399183|P10|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
2606725|NCT00151775|6399184|P9|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
2606726|NCT00151775|6399185|P8|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
2606727|NCT00151775|6399186|P7|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
2606728|NCT00151775|6399187|P6|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
2606729|NCT00151775|6399188|P5|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
2606730|NCT00151775|6399189|P4|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
2606731|NCT00151775|6399190|P3|NOT COMPLETED|Period 3: Double-blind, Withdrawal||3
2606732|NCT00151775|6399191|P2|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
2606733|NCT00151775|6399192|P1|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
2606734|NCT00151775|6399181|P12|COMPLETED|Period 3: Double-blind, Withdrawal||28
2606735|NCT00151775|6399182|P11|COMPLETED|Period 3: Double-blind, Withdrawal||29
2606736|NCT00151775|6399183|P10|COMPLETED|Period 3: Double-blind, Withdrawal||0
2606737|NCT00151775|6399184|P9|COMPLETED|Period 3: Double-blind, Withdrawal||26
2606738|NCT00151775|6399185|P8|COMPLETED|Period 3: Double-blind, Withdrawal||27
2606739|NCT00151775|6399186|P7|COMPLETED|Period 3: Double-blind, Withdrawal||26
2606740|NCT00151775|6399187|P6|COMPLETED|Period 3: Double-blind, Withdrawal||25
2606741|NCT00151775|6399188|P5|COMPLETED|Period 3: Double-blind, Withdrawal||0
2606742|NCT00151775|6399189|P4|COMPLETED|Period 3: Double-blind, Withdrawal||44
2606743|NCT00151775|6399190|P3|COMPLETED|Period 3: Double-blind, Withdrawal||42
2606744|NCT00151775|6399191|P2|COMPLETED|Period 3: Double-blind, Withdrawal||45
2606745|NCT00151775|6399192|P1|COMPLETED|Period 3: Double-blind, Withdrawal||48
2606746|NCT00151775|6399181|P12|STARTED|Period 3: Double-blind, Withdrawal||29
2606747|NCT00151775|6399182|P11|STARTED|Period 3: Double-blind, Withdrawal||29
2606748|NCT00151775|6399183|P10|STARTED|Period 3: Double-blind, Withdrawal||0
2606749|NCT00151775|6399184|P9|STARTED|Period 3: Double-blind, Withdrawal||26
2606750|NCT00151775|6399185|P8|STARTED|Period 3: Double-blind, Withdrawal||28
2606751|NCT00151775|6399186|P7|STARTED|Period 3: Double-blind, Withdrawal||27
2606752|NCT00151775|6399187|P6|STARTED|Period 3: Double-blind, Withdrawal||26
2606753|NCT00151775|6399188|P5|STARTED|Period 3: Double-blind, Withdrawal||0
2606754|NCT00151775|6399189|P4|STARTED|Period 3: Double-blind, Withdrawal||44
2606755|NCT00151775|6399190|P3|STARTED|Period 3: Double-blind, Withdrawal||45
2606756|NCT00151775|6399191|P2|STARTED|Period 3: Double-blind, Withdrawal||45
2606757|NCT00151775|6399192|P1|STARTED|Period 3: Double-blind, Withdrawal||48
2606758|NCT00151775|6399181|P12|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
2606759|NCT00151775|6399182|P11|NOT COMPLETED|Period 2 - Double-Blind Dose Response||1
2606760|NCT00151775|6399183|P10|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
2606761|NCT00151775|6399184|P9|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
2606762|NCT00151775|6399185|P8|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
2606763|NCT00151775|6399186|P7|NOT COMPLETED|Period 2 - Double-Blind Dose Response||3
2606764|NCT00151775|6399187|P6|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
2606765|NCT00151775|6399188|P5|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
2606766|NCT00151775|6399189|P4|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
2606767|NCT00151775|6399190|P3|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
2606768|NCT00151775|6399191|P2|NOT COMPLETED|Period 2 - Double-Blind Dose Response||6
2606769|NCT00151775|6399192|P1|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
2606770|NCT00151775|6399181|P12|COMPLETED|Period 2 - Double-Blind Dose Response||0
2606771|NCT00151775|6399182|P11|COMPLETED|Period 2 - Double-Blind Dose Response||59
2606772|NCT00151775|6399183|P10|COMPLETED|Period 2 - Double-Blind Dose Response||0
2606773|NCT00151775|6399184|P9|COMPLETED|Period 2 - Double-Blind Dose Response||0
2606774|NCT00151775|6399185|P8|COMPLETED|Period 2 - Double-Blind Dose Response||0
2606775|NCT00151775|6399186|P7|COMPLETED|Period 2 - Double-Blind Dose Response||53
2606776|NCT00151775|6399187|P6|COMPLETED|Period 2 - Double-Blind Dose Response||54
2606777|NCT00151775|6399188|P5|COMPLETED|Period 2 - Double-Blind Dose Response||0
2606778|NCT00151775|6399189|P4|COMPLETED|Period 2 - Double-Blind Dose Response||0
2606779|NCT00151775|6399190|P3|COMPLETED|Period 2 - Double-Blind Dose Response||0
2606780|NCT00151775|6399191|P2|COMPLETED|Period 2 - Double-Blind Dose Response||89
2606781|NCT00151775|6399192|P1|COMPLETED|Period 2 - Double-Blind Dose Response||93
2606782|NCT00151775|6399181|P12|STARTED|Period 2 - Double-Blind Dose Response||0
2606783|NCT00151775|6399182|P11|STARTED|Period 2 - Double-Blind Dose Response||60
2606784|NCT00151775|6399183|P10|STARTED|Period 2 - Double-Blind Dose Response||0
2606785|NCT00151775|6399184|P9|STARTED|Period 2 - Double-Blind Dose Response||0
2606786|NCT00151775|6399185|P8|STARTED|Period 2 - Double-Blind Dose Response||0
2606787|NCT00151775|6399186|P7|STARTED|Period 2 - Double-Blind Dose Response||56
2606788|NCT00151775|6399187|P6|STARTED|Period 2 - Double-Blind Dose Response||56
2606789|NCT00151775|6399188|P5|STARTED|Period 2 - Double-Blind Dose Response||0
2606790|NCT00151775|6399189|P4|STARTED|Period 2 - Double-Blind Dose Response||0
2606791|NCT00151775|6399190|P3|STARTED|Period 2 - Double-Blind Dose Response||0
2606792|NCT00151775|6399191|P2|STARTED|Period 2 - Double-Blind Dose Response||95
2606793|NCT00151775|6399192|P1|STARTED|Period 2 - Double-Blind Dose Response||95
2606794|NCT00151476|6399236|P2|NOT COMPLETED|FAP Analyzed Subjects||3
2606795|NCT00151476|6399237|P1|NOT COMPLETED|FAP Analyzed Subjects||0
2606796|NCT00151476|6399236|P2|COMPLETED|FAP Analyzed Subjects||51
2606797|NCT00151476|6399237|P1|COMPLETED|FAP Analyzed Subjects||13
2606798|NCT00151476|6399236|P2|STARTED|FAP Analyzed Subjects||54
2606799|NCT00151476|6399237|P1|STARTED|FAP Analyzed Subjects||13
2606800|NCT00151476|6399236|P2|NOT COMPLETED|FAP Identified Subjects||1
2606801|NCT00151476|6399237|P1|NOT COMPLETED|FAP Identified Subjects||0
2606802|NCT00151476|6399236|P2|COMPLETED|FAP Identified Subjects||54
2606803|NCT00151476|6399237|P1|COMPLETED|FAP Identified Subjects||13
2606804|NCT00151476|6399236|P2|STARTED|FAP Identified Subjects||55
2606805|NCT00151476|6399237|P1|STARTED|FAP Identified Subjects||13
2606806|NCT00151411|6399294|P2|NOT COMPLETED|Overall Study||43
2606807|NCT00151411|6399295|P1|NOT COMPLETED|Overall Study||33
2606808|NCT00151411|6399294|P2|COMPLETED|Overall Study||16
2606809|NCT00151411|6399295|P1|COMPLETED|Overall Study||22
2606810|NCT00151411|6399294|P2|STARTED|Overall Study||59
2606811|NCT00151411|6399295|P1|STARTED|Overall Study||55
2606812|NCT00151372|6399307|P2|NOT COMPLETED|Overall Study||29
2606813|NCT00151372|6399308|P1|NOT COMPLETED|Overall Study||29
2606814|NCT00151372|6399307|P2|COMPLETED|Overall Study||45
2606815|NCT00151372|6399308|P1|COMPLETED|Overall Study||38
2606816|NCT00151372|6399307|P2|STARTED|Overall Study||74
2606817|NCT00151372|6399308|P1|STARTED|Overall Study||67
2606818|NCT00151320|6399318|P1|NOT COMPLETED|Overall Study||0
2606819|NCT00151320|6399318|P1|COMPLETED|Overall Study||76
2606820|NCT00151320|6399318|P1|STARTED|Overall Study||76
2606821|NCT00151281|6399323|P1|NOT COMPLETED|Overall Study||3
2606822|NCT00151281|6399323|P1|COMPLETED|Overall Study||22
2606823|NCT00151281|6399323|P1|STARTED|Overall Study||25
2606824|NCT00150969|6399332|P2|NOT COMPLETED|24-48 Month Extension||100
2606825|NCT00150969|6399333|P1|NOT COMPLETED|24-48 Month Extension||88
2606826|NCT00150969|6399332|P2|COMPLETED|24-48 Month Extension||40
2606827|NCT00150969|6399333|P1|COMPLETED|24-48 Month Extension||33
2606828|NCT00150969|6399332|P2|STARTED|24-48 Month Extension||140
2606829|NCT00150969|6399333|P1|STARTED|24-48 Month Extension||121
2606830|NCT00150969|6399332|P2|NOT COMPLETED|24 Month Main Study||21
2606831|NCT00150969|6399333|P1|NOT COMPLETED|24 Month Main Study||19
2606832|NCT00150969|6399332|P2|COMPLETED|24 Month Main Study||202
2606833|NCT00150969|6399333|P1|COMPLETED|24 Month Main Study||198
2606834|NCT00150969|6399332|P2|STARTED|24 Month Main Study||223
2606835|NCT00150969|6399333|P1|STARTED|24 Month Main Study||217
2606836|NCT00150813|6399365|P1|NOT COMPLETED|Overall Study||18
2606837|NCT00150813|6399365|P1|COMPLETED|Overall Study||48
2606838|NCT00150813|6399365|P1|STARTED|Overall Study||66
2606839|NCT00150800|6399369|P1|NOT COMPLETED|Overall Study||496
2606840|NCT00150800|6399369|P1|COMPLETED|Overall Study||171
2606841|NCT00150800|6399369|P1|STARTED|Overall Study||667
2606842|NCT00150618|6399383|P5|NOT COMPLETED|Overall Study||25
2606843|NCT00150618|6399384|P4|NOT COMPLETED|Overall Study||26
2606844|NCT00150618|6399385|P3|NOT COMPLETED|Overall Study||27
2606845|NCT00150618|6399386|P2|NOT COMPLETED|Overall Study||18
2606846|NCT00150618|6399387|P1|NOT COMPLETED|Overall Study||17
2606847|NCT00150618|6399383|P5|COMPLETED|Overall Study||41
2606848|NCT00150618|6399384|P4|COMPLETED|Overall Study||40
2606849|NCT00150618|6399385|P3|COMPLETED|Overall Study||38
2606850|NCT00150618|6399386|P2|COMPLETED|Overall Study||47
2606851|NCT00150618|6399387|P1|COMPLETED|Overall Study||45
2606852|NCT00150618|6399383|P5|STARTED|Overall Study||66
2606853|NCT00150618|6399384|P4|STARTED|Overall Study||66
2606854|NCT00150618|6399385|P3|STARTED|Overall Study||65
2606855|NCT00150618|6399386|P2|STARTED|Overall Study||65
2606856|NCT00150618|6399387|P1|STARTED|Overall Study||62
2606857|NCT00150592|6399421|P2|NOT COMPLETED|Overall Study||3
2606858|NCT00150592|6399422|P1|NOT COMPLETED|Overall Study||7
2606859|NCT00150592|6399421|P2|COMPLETED|Overall Study||54
2606860|NCT00150592|6399422|P1|COMPLETED|Overall Study||114
2606861|NCT00150592|6399421|P2|STARTED|Overall Study||57
2606862|NCT00150592|6399422|P1|STARTED|Overall Study||121
2606863|NCT00150462|6399453|P11|NOT COMPLETED|Overall Study||3
2606864|NCT00150462|6399454|P10|NOT COMPLETED|Overall Study||6
2606865|NCT00150462|6399455|P9|NOT COMPLETED|Overall Study||6
2606866|NCT00150462|6399456|P8|NOT COMPLETED|Overall Study||8
2606867|NCT00150462|6399457|P7|NOT COMPLETED|Overall Study||3
2606868|NCT00150462|6399458|P6|NOT COMPLETED|Overall Study||4
2606869|NCT00150462|6399459|P5|NOT COMPLETED|Overall Study||3
2606870|NCT00150462|6399460|P4|NOT COMPLETED|Overall Study||3
2606871|NCT00150462|6399461|P3|NOT COMPLETED|Overall Study||4
2606872|NCT00150462|6399462|P2|NOT COMPLETED|Overall Study||3
2606873|NCT00150462|6399463|P1|NOT COMPLETED|Overall Study||3
2606874|NCT00150462|6399453|P11|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
2606875|NCT00150462|6399454|P10|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
2606876|NCT00150462|6399455|P9|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
2606877|NCT00150462|6399456|P8|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
2606878|NCT00150462|6399457|P7|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
2606879|NCT00150462|6399458|P6|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
2606880|NCT00150462|6399459|P5|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
2606881|NCT00150462|6399460|P4|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
2606882|NCT00150462|6399461|P3|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
2606883|NCT00150462|6399462|P2|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
2606884|NCT00150462|6399463|P1|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
2606885|NCT00150462|6399453|P11|STARTED|Overall Study||4
2606886|NCT00150462|6399454|P10|STARTED|Overall Study||7
2606887|NCT00150462|6399455|P9|STARTED|Overall Study||6
2606888|NCT00150462|6399456|P8|STARTED|Overall Study||8
2606889|NCT00150462|6399457|P7|STARTED|Overall Study||3
2606890|NCT00150462|6399458|P6|STARTED|Overall Study||4
2606891|NCT00150462|6399459|P5|STARTED|Overall Study||3
2606892|NCT00150462|6399460|P4|STARTED|Overall Study||3
2606893|NCT00150462|6399461|P3|STARTED|Overall Study||4
2606894|NCT00150462|6399462|P2|STARTED|Overall Study||3
2606895|NCT00150462|6399463|P1|STARTED|Overall Study||3
2606896|NCT00150345|6399573|P2|NOT COMPLETED|Overall Study||32
2606897|NCT00150345|6399574|P1|NOT COMPLETED|Overall Study||34
2606898|NCT00150345|6399573|P2|COMPLETED|Overall Study||34
2606899|NCT00150345|6399574|P1|COMPLETED|Overall Study||47
2606900|NCT00150345|6399573|P2|STARTED|Overall Study||66
2606901|NCT00150345|6399574|P1|STARTED|Overall Study||81
2606902|NCT00150176|6399638|P2|NOT COMPLETED|Overall Study||120
2606903|NCT00150176|6399639|P1|NOT COMPLETED|Overall Study||59
2606904|NCT00150176|6399638|P2|COMPLETED|Overall Study||72
2606905|NCT00150176|6399639|P1|COMPLETED|Overall Study||135
2606906|NCT00150176|6399638|P2|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|192
2606907|NCT00150176|6399639|P1|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|194
2606908|NCT00149994|6399650|P2|NOT COMPLETED|Overall Study||1
2606909|NCT00149994|6399651|P1|NOT COMPLETED|Overall Study||1
2606910|NCT00149994|6399650|P2|COMPLETED|Overall Study||85
2606911|NCT00149994|6399651|P1|COMPLETED|Overall Study|"Completed indicates intention to treat (ITT) population."|84
2606912|NCT00149994|6399650|P2|STARTED|Overall Study||86
2606913|NCT00149994|6399651|P1|STARTED|Overall Study|"Started indicates Safety population."|85
2606914|NCT00149890|6399659|P2|NOT COMPLETED|Overall Study||18
2606915|NCT00149890|6399660|P1|NOT COMPLETED|Overall Study||13
2606916|NCT00149890|6399659|P2|COMPLETED|Overall Study||20
2606917|NCT00149890|6399660|P1|COMPLETED|Overall Study||26
2606918|NCT00149890|6399659|P2|STARTED|Overall Study||38
2606919|NCT00149890|6399660|P1|STARTED|Overall Study|"Started indicates all screened and treated participants."|39
2606920|NCT00149838|6399680|P4|NOT COMPLETED|Phase III||24
2606921|NCT00149838|6399681|P3|NOT COMPLETED|Phase III||0
2606922|NCT00149838|6399682|P2|NOT COMPLETED|Phase III||0
2606923|NCT00149838|6399683|P1|NOT COMPLETED|Phase III||0
2606924|NCT00149838|6399680|P4|COMPLETED|Phase III||37
2606925|NCT00149838|6399681|P3|COMPLETED|Phase III||0
2606926|NCT00149838|6399682|P2|COMPLETED|Phase III||0
2606927|NCT00149838|6399683|P1|COMPLETED|Phase III||0
2606928|NCT00149838|6399680|P4|STARTED|Phase III||61
2606929|NCT00149838|6399681|P3|STARTED|Phase III||0
2606930|NCT00149838|6399682|P2|STARTED|Phase III||0
2606931|NCT00149838|6399683|P1|STARTED|Phase III||0
2606932|NCT00149838|6399680|P4|NOT COMPLETED|Phase II||0
2606933|NCT00149838|6399681|P3|NOT COMPLETED|Phase II||0
2606934|NCT00149838|6399682|P2|NOT COMPLETED|Phase II||0
2606935|NCT00149838|6399683|P1|NOT COMPLETED|Phase II||0
2606936|NCT00149838|6399680|P4|COMPLETED|Phase II||0
2606937|NCT00149838|6399681|P3|COMPLETED|Phase II||144
2606938|NCT00149838|6399682|P2|COMPLETED|Phase II||0
2606939|NCT00149838|6399683|P1|COMPLETED|Phase II||0
2606940|NCT00149838|6399680|P4|STARTED|Phase II||0
2606941|NCT00149838|6399681|P3|STARTED|Phase II||144
2606942|NCT00149838|6399682|P2|STARTED|Phase II||0
2606943|NCT00149838|6399683|P1|STARTED|Phase II||0
2606944|NCT00149838|6399680|P4|NOT COMPLETED|Phase I||0
2606945|NCT00149838|6399681|P3|NOT COMPLETED|Phase I||0
2606946|NCT00149838|6399682|P2|NOT COMPLETED|Phase I||16
2606947|NCT00149838|6399683|P1|NOT COMPLETED|Phase I||20
2606948|NCT00149838|6399680|P4|COMPLETED|Phase I||0
2606949|NCT00149838|6399681|P3|COMPLETED|Phase I||0
2606950|NCT00149838|6399682|P2|COMPLETED|Phase I||82
2606951|NCT00149838|6399683|P1|COMPLETED|Phase I||72
2606952|NCT00149838|6399680|P4|STARTED|Phase I||0
2606953|NCT00149838|6399681|P3|STARTED|Phase I||0
2606954|NCT00149838|6399682|P2|STARTED|Phase I||98
2606955|NCT00149838|6399683|P1|STARTED|Phase I||92
2606956|NCT00149825|6399695|P2|NOT COMPLETED|Overall Study||3
2606957|NCT00149825|6399696|P1|NOT COMPLETED|Overall Study||5
2606958|NCT00149825|6399695|P2|COMPLETED|Overall Study||12
2606959|NCT00149825|6399696|P1|COMPLETED|Overall Study||10
2606960|NCT00149825|6399695|P2|STARTED|Overall Study||15
2606961|NCT00149825|6399696|P1|STARTED|Overall Study||15
2606962|NCT00149799|6399706|P3|NOT COMPLETED|Discontinuation (Phase II)||9
2606963|NCT00149799|6399707|P2|NOT COMPLETED|Discontinuation (Phase II)||3
2606964|NCT00149799|6399708|P1|NOT COMPLETED|Discontinuation (Phase II)||0
2606965|NCT00149799|6399706|P3|COMPLETED|Discontinuation (Phase II)||21
2606966|NCT00149799|6399707|P2|COMPLETED|Discontinuation (Phase II)||25
2606967|NCT00149799|6399708|P1|COMPLETED|Discontinuation (Phase II)||0
2606968|NCT00149799|6399706|P3|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|30
2606969|NCT00149799|6399707|P2|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|28
2606970|NCT00149799|6399708|P1|STARTED|Discontinuation (Phase II)||0
2606971|NCT00149799|6399706|P3|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
2606972|NCT00149799|6399707|P2|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
2606973|NCT00149799|6399708|P1|NOT COMPLETED|Open Label Escitalopram (Phase I)||26
2606974|NCT00149799|6399706|P3|COMPLETED|Open Label Escitalopram (Phase I)||0
2606975|NCT00149799|6399707|P2|COMPLETED|Open Label Escitalopram (Phase I)||0
2606976|NCT00149799|6399708|P1|COMPLETED|Open Label Escitalopram (Phase I)|14 completers were non-responders and 2 responders terminated the study after completing Phase I|74
2606977|NCT00149799|6399706|P3|STARTED|Open Label Escitalopram (Phase I)||0
2606978|NCT00149799|6399707|P2|STARTED|Open Label Escitalopram (Phase I)||0
2606979|NCT00149799|6399708|P1|STARTED|Open Label Escitalopram (Phase I)||100
2606980|NCT00149747|6399724|P2|NOT COMPLETED|Overall Study||3
2606981|NCT00149747|6399725|P1|NOT COMPLETED|Overall Study||4
2606982|NCT00149747|6399724|P2|COMPLETED|Overall Study||27
2606983|NCT00149747|6399725|P1|COMPLETED|Overall Study||32
2606984|NCT00149747|6399724|P2|STARTED|Overall Study||30
2606985|NCT00149747|6399725|P1|STARTED|Overall Study||36
2606986|NCT00149669|6399737|P2|NOT COMPLETED|Overall Study||5
2606987|NCT00149669|6399738|P1|NOT COMPLETED|Overall Study||3
2606988|NCT00149669|6399737|P2|COMPLETED|Overall Study||30
2606989|NCT00149669|6399738|P1|COMPLETED|Overall Study||29
2606990|NCT00149669|6399737|P2|STARTED|Overall Study||35
2606991|NCT00149669|6399738|P1|STARTED|Overall Study||32
2606992|NCT00149643|6399758|P2|NOT COMPLETED|Overall Study||36
2606993|NCT00149643|6399759|P1|NOT COMPLETED|Overall Study||34
2606994|NCT00149643|6399758|P2|COMPLETED|Overall Study||0
2606995|NCT00149643|6399759|P1|COMPLETED|Overall Study||0
2606996|NCT00149643|6399758|P2|STARTED|Overall Study||36
2606997|NCT00149643|6399759|P1|STARTED|Overall Study||34
2606998|NCT00149630|6399771|P2|NOT COMPLETED|Overall Study||5
2606999|NCT00149630|6399772|P1|NOT COMPLETED|Overall Study||8
2607000|NCT00149630|6399771|P2|COMPLETED|Overall Study||35
2607001|NCT00149630|6399772|P1|COMPLETED|Overall Study||26
2607002|NCT00149630|6399771|P2|STARTED|Overall Study||40
2607003|NCT00149630|6399772|P1|STARTED|Overall Study||34
2607004|NCT00149396|6399782|P1|NOT COMPLETED|Overall Study||23
2607005|NCT00149396|6399782|P1|COMPLETED|Overall Study||9
2607006|NCT00149396|6399782|P1|Completed NV1020 and Chemotherapy|Overall Study||9
2607007|NCT00149396|6399782|P1|Completed NV1020 Therapy|Overall Study||29
2607008|NCT00149396|6399782|P1|STARTED|Overall Study||32
2607009|NCT00149227|6399825|P2|NOT COMPLETED|Overall Study||0
2607010|NCT00149227|6399826|P1|NOT COMPLETED|Overall Study||0
2607011|NCT00149227|6399825|P2|COMPLETED|Overall Study||1514
2607012|NCT00149227|6399826|P1|COMPLETED|Overall Study||1517
2607013|NCT00149227|6399825|P2|STARTED|Overall Study||1514
2607014|NCT00149227|6399826|P1|STARTED|Overall Study||1517
2607015|NCT00149214|6399852|P2|NOT COMPLETED|Overall Study||17
2607016|NCT00149214|6399853|P1|NOT COMPLETED|Overall Study||26
2607017|NCT00149214|6399852|P2|COMPLETED|Overall Study||105
2607018|NCT00149214|6399853|P1|COMPLETED|Overall Study|The patient treated with Cyclophosphamide (C) was included in that arm (C) for safety analysis.|109
2607019|NCT00149214|6399852|P2|STARTED|Overall Study||122
2607020|NCT00149214|6399853|P1|STARTED|Overall Study|One patient randomized to Pemetrexed (P) was treated with Cyclophosphamide (C).|135
2607021|NCT00148954|6399869|P2|NOT COMPLETED|Overall Study||300
2607022|NCT00148954|6399870|P1|NOT COMPLETED|Overall Study||307
2607023|NCT00148954|6399869|P2|COMPLETED|Overall Study||677
2607024|NCT00148954|6399870|P1|COMPLETED|Overall Study||678
2607025|NCT00148954|6399869|P2|STARTED|Overall Study||977
2607026|NCT00148954|6399870|P1|STARTED|Overall Study||985
2607027|NCT00148941|6399880|P4|NOT COMPLETED|Overall Study||24
2607028|NCT00148941|6399881|P3|NOT COMPLETED|Overall Study||20
2607029|NCT00148941|6399882|P2|NOT COMPLETED|Overall Study||24
2607030|NCT00148941|6399883|P1|NOT COMPLETED|Overall Study||18
2607031|NCT00148941|6399880|P4|COMPLETED|Overall Study||1029
2607032|NCT00148941|6399881|P3|COMPLETED|Overall Study||1032
2607033|NCT00148941|6399882|P2|COMPLETED|Overall Study||1027
2607034|NCT00148941|6399883|P1|COMPLETED|Overall Study||1035
2607035|NCT00148941|6399880|P4|STARTED|Overall Study||1053
2607036|NCT00148941|6399881|P3|STARTED|Overall Study||1052
2607037|NCT00148941|6399882|P2|STARTED|Overall Study||1051
2607038|NCT00148941|6399883|P1|STARTED|Overall Study||1053
2607039|NCT00148798|6399975|P2|NOT COMPLETED|Overall Study||0
2607040|NCT00148798|6399976|P1|NOT COMPLETED|Overall Study||0
2607041|NCT00148798|6399975|P2|COMPLETED|Overall Study||568
2607042|NCT00148798|6399976|P1|COMPLETED|Overall Study||557
2607043|NCT00148798|6399975|P2|STARTED|Overall Study|ITT Population|568
2607044|NCT00148798|6399976|P1|STARTED|Overall Study|Intent To Treat (ITT) Population|557
2607045|NCT00148759|6399998|P2|NOT COMPLETED|Overall Study||1
2607046|NCT00148759|6399999|P1|NOT COMPLETED|Overall Study||2
2607047|NCT00148759|6399998|P2|COMPLETED|Overall Study||11
2607048|NCT00148759|6399999|P1|COMPLETED|Overall Study||9
2607049|NCT00148759|6399998|P2|24-hr PK Sampling|Overall Study||11
2607050|NCT00148759|6399999|P1|24-hr PK Sampling|Overall Study||9
2607051|NCT00148759|6399998|P2|STARTED|Overall Study||12
2607052|NCT00148759|6399999|P1|STARTED|Overall Study||11
2607053|NCT00148733|6400009|P2|NOT COMPLETED|Overall Study||15
2607054|NCT00148733|6400010|P1|NOT COMPLETED|Overall Study||14
2607055|NCT00148733|6400009|P2|COMPLETED|Overall Study||1299
2607056|NCT00148733|6400010|P1|COMPLETED|Overall Study||1300
2607057|NCT00148733|6400009|P2|STARTED|Overall Study||1314
2607058|NCT00148733|6400010|P1|STARTED|Overall Study||1314
2607059|NCT00148668|6400018|P2|NOT COMPLETED|Overall Study||0
2607060|NCT00148668|6400019|P1|NOT COMPLETED|Overall Study||0
2607061|NCT00148668|6400018|P2|COMPLETED|Overall Study||40
2607062|NCT00148668|6400019|P1|COMPLETED|Overall Study||41
2607063|NCT00148668|6400018|P2|STARTED|Overall Study||40
2607064|NCT00148668|6400019|P1|STARTED|Overall Study||41
2607065|NCT00148343|6400027|P2|NOT COMPLETED|Overall Study||11
2607066|NCT00148343|6400028|P1|NOT COMPLETED|Overall Study||15
2607067|NCT00148343|6400027|P2|COMPLETED|Overall Study||45
2607068|NCT00148343|6400028|P1|COMPLETED|Overall Study||39
2607069|NCT00148343|6400027|P2|STARTED|Overall Study||56
2607070|NCT00148343|6400028|P1|STARTED|Overall Study||54
2607071|NCT00148317|6400042|P1|NOT COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||11
2607072|NCT00148317|6400042|P1|COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||27
2607073|NCT00148317|6400042|P1|STARTED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||38
2607074|NCT00148317|6400042|P1|NOT COMPLETED|Consolidation (VEL + DEX)||0
2607075|NCT00148317|6400042|P1|COMPLETED|Consolidation (VEL + DEX)||38
2607076|NCT00148317|6400042|P1|no DOXIL Added|Consolidation (VEL + DEX)||10
2607077|NCT00148317|6400042|P1|DOXIL Added at Cycle 5|Consolidation (VEL + DEX)||12
2607078|NCT00148317|6400042|P1|DOXIL Added at Cycle 3|Consolidation (VEL + DEX)||16
2607079|NCT00148317|6400042|P1|STARTED|Consolidation (VEL + DEX)||38
2607080|NCT00148122|6400049|P1|NOT COMPLETED|Overall Study||2
2607081|NCT00148122|6400049|P1|COMPLETED|Overall Study||38
2607082|NCT00148122|6400049|P1|STARTED|Overall Study||40
2607083|NCT00148109|6400057|P2|NOT COMPLETED|Overall Study||20
2607084|NCT00148109|6400058|P1|NOT COMPLETED|Overall Study||12
2607085|NCT00148109|6400057|P2|COMPLETED|Overall Study||1
2607086|NCT00148109|6400058|P1|COMPLETED|Overall Study||3
2607087|NCT00148109|6400057|P2|STARTED|Overall Study||21
2607088|NCT00148109|6400058|P1|STARTED|Overall Study||15
2607089|NCT00147966|6400068|P1|NOT COMPLETED|Overall Study||0
2607090|NCT00147966|6400068|P1|COMPLETED|Overall Study||24
2607091|NCT00147966|6400068|P1|STARTED|Overall Study||24
2607092|NCT00147823|6400074|P2|NOT COMPLETED|Overall Study||15
2607093|NCT00147823|6400075|P1|NOT COMPLETED|Overall Study||13
2607094|NCT00147823|6400074|P2|COMPLETED|Overall Study||16
2607095|NCT00147823|6400075|P1|COMPLETED|Overall Study||19
2607096|NCT00147823|6400074|P2|Month 24 Visit|Overall Study||18
2607097|NCT00147823|6400075|P1|Month 24 Visit|Overall Study||21
2607098|NCT00147823|6400074|P2|Month 18 Visit|Overall Study||20
2607099|NCT00147823|6400075|P1|Month 18 Visit|Overall Study|As stated previously ea. subject is counted at each milestone, as data is collected at ea. timepoint|21
2607100|NCT00147823|6400074|P2|Month 12 CT Scan|Overall Study||25
2607101|NCT00147823|6400075|P1|Month 12 CT Scan|Overall Study||20
2607102|NCT00147823|6400074|P2|Month 12 Visit|Overall Study|Subjects are counted at each milestone as that is when data is collectec|25
2607103|NCT00147823|6400075|P1|Month 12 Visit|Overall Study||21
2607104|NCT00147823|6400074|P2|Month 6 Visit|Overall Study||21
2607105|NCT00147823|6400075|P1|Month 6 Visit|Overall Study||25
2607106|NCT00147823|6400074|P2|Month 3 Visit|Overall Study||24
2607107|NCT00147823|6400075|P1|Month 3 Visit|Overall Study||25
2607108|NCT00147823|6400074|P2|Week 6 Visit|Overall Study||28
2607109|NCT00147823|6400075|P1|Week 6 Visit|Overall Study||26
2607110|NCT00147823|6400074|P2|STARTED|Overall Study||31
2607111|NCT00147823|6400075|P1|STARTED|Overall Study||32
2607112|NCT00147745|6400106|P3|NOT COMPLETED|Overall Study||0
2607113|NCT00147745|6400107|P2|NOT COMPLETED|Overall Study||0
2607114|NCT00147745|6400108|P1|NOT COMPLETED|Overall Study||1
2607115|NCT00147745|6400106|P3|COMPLETED|Overall Study||6
2607116|NCT00147745|6400107|P2|COMPLETED|Overall Study||14
2607117|NCT00147745|6400108|P1|COMPLETED|Overall Study||15
2607118|NCT00147745|6400106|P3|STARTED|Overall Study||6
2607119|NCT00147745|6400107|P2|STARTED|Overall Study||14
2607120|NCT00147745|6400108|P1|STARTED|Overall Study||16
2607121|NCT00147537|6400130|P11|NOT COMPLETED|Phase 2||52
2607122|NCT00147537|6400131|P10|NOT COMPLETED|Phase 2||161
2607123|NCT00147537|6400132|P9|NOT COMPLETED|Phase 2||0
2607124|NCT00147537|6400133|P8|NOT COMPLETED|Phase 2||0
2607125|NCT00147537|6400134|P7|NOT COMPLETED|Phase 2||0
2607126|NCT00147537|6400135|P6|NOT COMPLETED|Phase 2||0
2607127|NCT00147537|6400136|P5|NOT COMPLETED|Phase 2||0
2607128|NCT00147537|6400137|P4|NOT COMPLETED|Phase 2||0
2607129|NCT00147537|6400138|P3|NOT COMPLETED|Phase 2||0
2607130|NCT00147537|6400139|P2|NOT COMPLETED|Phase 2||0
2607131|NCT00147537|6400140|P1|NOT COMPLETED|Phase 2||0
2607132|NCT00147537|6400130|P11|COMPLETED|Phase 2||3
2607133|NCT00147537|6400131|P10|COMPLETED|Phase 2||5
2607134|NCT00147537|6400132|P9|COMPLETED|Phase 2||0
2607135|NCT00147537|6400133|P8|COMPLETED|Phase 2||0
2607136|NCT00147537|6400134|P7|COMPLETED|Phase 2||0
2607137|NCT00147537|6400135|P6|COMPLETED|Phase 2||0
2607138|NCT00147537|6400136|P5|COMPLETED|Phase 2||0
2607139|NCT00147537|6400137|P4|COMPLETED|Phase 2||0
2607140|NCT00147537|6400138|P3|COMPLETED|Phase 2||0
2607141|NCT00147537|6400139|P2|COMPLETED|Phase 2||0
2607142|NCT00147537|6400140|P1|COMPLETED|Phase 2||0
2607143|NCT00147537|6400130|P11|STARTED|Phase 2|55 randomized; 56 treated-1 randomized but not treated, 2 randomized to F+P+C rec'd P+C|55
2607144|NCT00147537|6400131|P10|STARTED|Phase 2|166 particpants randomized; 163 participants treated|166
2607145|NCT00147537|6400132|P9|STARTED|Phase 2||0
2607146|NCT00147537|6400133|P8|STARTED|Phase 2||0
2607147|NCT00147537|6400134|P7|STARTED|Phase 2||0
2607148|NCT00147537|6400135|P6|STARTED|Phase 2||0
2607149|NCT00147537|6400136|P5|STARTED|Phase 2||0
2607150|NCT00147537|6400137|P4|STARTED|Phase 2||0
2607151|NCT00147537|6400138|P3|STARTED|Phase 2||0
2607152|NCT00147537|6400139|P2|STARTED|Phase 2||0
2607153|NCT00147537|6400140|P1|STARTED|Phase 2||0
2607154|NCT00147537|6400130|P11|NOT COMPLETED|Phase 1b||0
2607155|NCT00147537|6400131|P10|NOT COMPLETED|Phase 1b||0
2607156|NCT00147537|6400132|P9|NOT COMPLETED|Phase 1b||17
2607157|NCT00147537|6400133|P8|NOT COMPLETED|Phase 1b||7
2607158|NCT00147537|6400134|P7|NOT COMPLETED|Phase 1b||18
2607159|NCT00147537|6400135|P6|NOT COMPLETED|Phase 1b||3
2607160|NCT00147537|6400136|P5|NOT COMPLETED|Phase 1b||3
2607161|NCT00147537|6400137|P4|NOT COMPLETED|Phase 1b||2
2607162|NCT00147537|6400138|P3|NOT COMPLETED|Phase 1b||4
2607163|NCT00147537|6400139|P2|NOT COMPLETED|Phase 1b||2
2607164|NCT00147537|6400140|P1|NOT COMPLETED|Phase 1b||2
2607165|NCT00147537|6400130|P11|COMPLETED|Phase 1b||0
2607166|NCT00147537|6400131|P10|COMPLETED|Phase 1b||0
2607167|NCT00147537|6400132|P9|COMPLETED|Phase 1b||1
2607168|NCT00147537|6400133|P8|COMPLETED|Phase 1b||0
2607169|NCT00147537|6400134|P7|COMPLETED|Phase 1b||0
2607170|NCT00147537|6400135|P6|COMPLETED|Phase 1b||0
2607171|NCT00147537|6400136|P5|COMPLETED|Phase 1b||0
2607172|NCT00147537|6400137|P4|COMPLETED|Phase 1b||1
2607173|NCT00147537|6400138|P3|COMPLETED|Phase 1b||0
2607174|NCT00147537|6400139|P2|COMPLETED|Phase 1b||0
2607175|NCT00147537|6400140|P1|COMPLETED|Phase 1b||1
2607176|NCT00147537|6400130|P11|STARTED|Phase 1b||0
2607177|NCT00147537|6400131|P10|STARTED|Phase 1b||0
2607178|NCT00147537|6400132|P9|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
2607179|NCT00147537|6400133|P8|STARTED|Phase 1b||7
2607180|NCT00147537|6400134|P7|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
2607181|NCT00147537|6400135|P6|STARTED|Phase 1b||3
2607182|NCT00147537|6400136|P5|STARTED|Phase 1b||3
2607183|NCT00147537|6400137|P4|STARTED|Phase 1b||3
2607184|NCT00147537|6400138|P3|STARTED|Phase 1b||4
2607185|NCT00147537|6400139|P2|STARTED|Phase 1b||2
2607186|NCT00147537|6400140|P1|STARTED|Phase 1b||3
2607187|NCT00147498|6400323|P4|NOT COMPLETED|Overall Study||17
2607188|NCT00147498|6400324|P3|NOT COMPLETED|Overall Study||17
2607189|NCT00147498|6400325|P2|NOT COMPLETED|Overall Study||9
2607190|NCT00147498|6400326|P1|NOT COMPLETED|Overall Study||3
2607191|NCT00147498|6400323|P4|COMPLETED|Overall Study||48
2607192|NCT00147498|6400324|P3|COMPLETED|Overall Study||52
2607193|NCT00147498|6400325|P2|COMPLETED|Overall Study||60
2607194|NCT00147498|6400326|P1|COMPLETED|Overall Study||58
2607195|NCT00147498|6400323|P4|STARTED|Overall Study||65
2607196|NCT00147498|6400324|P3|STARTED|Overall Study||69
2607197|NCT00147498|6400325|P2|STARTED|Overall Study||69
2607198|NCT00147498|6400326|P1|STARTED|Overall Study||61
2607199|NCT00147446|6400422|P2|NOT COMPLETED|Overall Study||0
2607200|NCT00147446|6400423|P1|NOT COMPLETED|Overall Study||0
2607201|NCT00147446|6400422|P2|COMPLETED|Overall Study||61
2607202|NCT00147446|6400423|P1|COMPLETED|Overall Study||60
2607203|NCT00147446|6400422|P2|STARTED|Overall Study||61
2607204|NCT00147446|6400423|P1|STARTED|Overall Study||60
2607205|NCT00147316|6400431|P1|NOT COMPLETED|Overall Study||0
2607206|NCT00147316|6400431|P1|COMPLETED|Overall Study||103
2607207|NCT00147316|6400431|P1|STARTED|Overall Study||103
2607208|NCT00147290|6400438|P2|NOT COMPLETED|Overall Study||0
2607209|NCT00147290|6400439|P1|NOT COMPLETED|Overall Study||0
2607210|NCT00147290|6400438|P2|COMPLETED|Overall Study||260
2607211|NCT00147290|6400439|P1|COMPLETED|Overall Study||266
2607212|NCT00147290|6400438|P2|STARTED|Overall Study||260
2607213|NCT00147290|6400439|P1|STARTED|Overall Study||266
2607214|NCT00147277|6400445|P2|NOT COMPLETED|Overall Study||0
2607215|NCT00147277|6400446|P1|NOT COMPLETED|Overall Study||0
2607216|NCT00147277|6400445|P2|COMPLETED|Overall Study||450
2607217|NCT00147277|6400446|P1|COMPLETED|Overall Study||475
2607218|NCT00147277|6400445|P2|STARTED|Overall Study||450
2607219|NCT00147277|6400446|P1|STARTED|Overall Study||475
2607220|NCT00147238|6400450|P1|NOT COMPLETED|Overall Study||8
2607221|NCT00147238|6400450|P1|COMPLETED|Overall Study||2
2607222|NCT00147238|6400450|P1|STARTED|Overall Study||10
2607223|NCT00147225|6400460|P6|NOT COMPLETED|Overall Study||2
2607224|NCT00147225|6400461|P5|NOT COMPLETED|Overall Study||1
2607225|NCT00147225|6400462|P4|NOT COMPLETED|Overall Study||1
2607226|NCT00147225|6400463|P3|NOT COMPLETED|Overall Study||2
2607227|NCT00147225|6400464|P2|NOT COMPLETED|Overall Study||0
2607228|NCT00147225|6400465|P1|NOT COMPLETED|Overall Study||1
2607229|NCT00147225|6400460|P6|COMPLETED|Overall Study||10
2607230|NCT00147225|6400461|P5|COMPLETED|Overall Study||10
2607231|NCT00147225|6400462|P4|COMPLETED|Overall Study||10
2607232|NCT00147225|6400463|P3|COMPLETED|Overall Study||6
2607233|NCT00147225|6400464|P2|COMPLETED|Overall Study||6
2607234|NCT00147225|6400465|P1|COMPLETED|Overall Study||6
2607235|NCT00147225|6400460|P6|STARTED|Overall Study||12
2607236|NCT00147225|6400461|P5|STARTED|Overall Study||11
2607237|NCT00147225|6400462|P4|STARTED|Overall Study||11
2607238|NCT00147225|6400463|P3|STARTED|Overall Study||8
2607239|NCT00147225|6400464|P2|STARTED|Overall Study||6
2607240|NCT00147225|6400465|P1|STARTED|Overall Study||7
2607241|NCT00147212|6400485|P1|NOT COMPLETED|Overall Study||0
2607242|NCT00147212|6400485|P1|COMPLETED|Overall Study||50
2607243|NCT00147212|6400485|P1|STARTED|Overall Study||50
2607244|NCT00147199|6400491|P2|NOT COMPLETED|Overall Study||10
2607245|NCT00147199|6400492|P1|NOT COMPLETED|Overall Study||13
2607246|NCT00147199|6400491|P2|COMPLETED|Overall Study||110
2607247|NCT00147199|6400492|P1|COMPLETED|Overall Study||102
2607248|NCT00147199|6400491|P2|STARTED|Overall Study||120
2607249|NCT00147199|6400492|P1|STARTED|Overall Study||115
2607250|NCT00147082|6400517|P3|NOT COMPLETED|Overall Study||0
2607251|NCT00147082|6400518|P2|NOT COMPLETED|Overall Study||0
2607252|NCT00147082|6400519|P1|NOT COMPLETED|Overall Study||0
2607253|NCT00147082|6400517|P3|COMPLETED|Overall Study||30
2607254|NCT00147082|6400518|P2|COMPLETED|Overall Study||33
2607255|NCT00147082|6400519|P1|COMPLETED|Overall Study||37
2607256|NCT00147082|6400517|P3|STARTED|Overall Study||30
2607257|NCT00147082|6400518|P2|STARTED|Overall Study||33
2607258|NCT00147082|6400519|P1|STARTED|Overall Study||37
2607259|NCT00147069|6400537|P4|NOT COMPLETED|Overall Study||0
2607260|NCT00147069|6400538|P3|NOT COMPLETED|Overall Study||0
2607261|NCT00147069|6400539|P2|NOT COMPLETED|Overall Study||0
2607262|NCT00147069|6400540|P1|NOT COMPLETED|Overall Study||0
2607263|NCT00147069|6400537|P4|COMPLETED|Overall Study||15
2607264|NCT00147069|6400538|P3|COMPLETED|Overall Study||15
2607265|NCT00147069|6400539|P2|COMPLETED|Overall Study||15
2607266|NCT00147069|6400540|P1|COMPLETED|Overall Study||15
2607267|NCT00147069|6400537|P4|STARTED|Overall Study||15
2607268|NCT00147069|6400538|P3|STARTED|Overall Study||15
2607269|NCT00147069|6400539|P2|STARTED|Overall Study||15
2607270|NCT00147069|6400540|P1|STARTED|Overall Study||15
2607271|NCT00147043|6400562|P1|NOT COMPLETED|Overall Study||0
2607272|NCT00147043|6400562|P1|COMPLETED|Overall Study||5
2607273|NCT00147043|6400562|P1|STARTED|Overall Study||5
2607274|NCT00147030|6400569|P2|NOT COMPLETED|Overall Study||0
2607275|NCT00147030|6400570|P1|NOT COMPLETED|Overall Study||0
2607276|NCT00147030|6400569|P2|COMPLETED|Overall Study||162
2607277|NCT00147030|6400570|P1|COMPLETED|Overall Study||163
2607278|NCT00147030|6400569|P2|STARTED|Overall Study||162
2607279|NCT00147030|6400570|P1|STARTED|Overall Study||163
2607280|NCT00147017|6400621|P3|NOT COMPLETED|Overall Study||0
2607281|NCT00147017|6400622|P2|NOT COMPLETED|Overall Study||0
2607282|NCT00147017|6400623|P1|NOT COMPLETED|Overall Study||0
2607283|NCT00147017|6400621|P3|COMPLETED|Overall Study||4
2607284|NCT00147017|6400622|P2|COMPLETED|Overall Study||7
2607285|NCT00147017|6400623|P1|COMPLETED|Overall Study||6
2607286|NCT00147017|6400621|P3|STARTED|Overall Study||4
2607287|NCT00147017|6400622|P2|STARTED|Overall Study||7
2607288|NCT00147017|6400623|P1|STARTED|Overall Study||6
2607289|NCT00146848|6400640|P3|NOT COMPLETED|Post-randomization||39
2607290|NCT00146848|6400641|P2|NOT COMPLETED|Post-randomization||47
2607291|NCT00146848|6400642|P1|NOT COMPLETED|Post-randomization||38
2607292|NCT00146848|6400640|P3|COMPLETED|Post-randomization||431
2607293|NCT00146848|6400641|P2|COMPLETED|Post-randomization||441
2607294|NCT00146848|6400642|P1|COMPLETED|Post-randomization||437
2607295|NCT00146848|6400640|P3|STARTED|Post-randomization||470
2607296|NCT00146848|6400641|P2|STARTED|Post-randomization||488
2607297|NCT00146848|6400642|P1|STARTED|Post-randomization||475
2607298|NCT00146848|6400640|P3|NOT COMPLETED|Pre-randomization||0
2607299|NCT00146848|6400641|P2|NOT COMPLETED|Pre-randomization||0
2607300|NCT00146848|6400642|P1|NOT COMPLETED|Pre-randomization||309
2607301|NCT00146848|6400640|P3|COMPLETED|Pre-randomization||0
2607302|NCT00146848|6400641|P2|COMPLETED|Pre-randomization||0
2607303|NCT00146848|6400642|P1|COMPLETED|Pre-randomization|Reached 6-week visit and were randomized|1433
2607304|NCT00146848|6400640|P3|STARTED|Pre-randomization||0
2607305|NCT00146848|6400641|P2|STARTED|Pre-randomization||0
2607306|NCT00146848|6400642|P1|STARTED|Pre-randomization|Registered|1742
2607307|NCT00146770|6400658|P2|NOT COMPLETED|Overall Study||0
2607308|NCT00146770|6400659|P1|NOT COMPLETED|Overall Study||5
2607309|NCT00146770|6400658|P2|COMPLETED|Overall Study||22
2607310|NCT00146770|6400659|P1|COMPLETED|Overall Study||18
2607311|NCT00146770|6400658|P2|STARTED|Overall Study||22
2607312|NCT00146770|6400659|P1|STARTED|Overall Study||23
2607313|NCT00146757|6400677|P2|NOT COMPLETED|Overall Study||0
2607314|NCT00146757|6400678|P1|NOT COMPLETED|Overall Study||2
2607315|NCT00146757|6400677|P2|COMPLETED|Overall Study||4
2607316|NCT00146757|6400678|P1|COMPLETED|Overall Study||14
2607317|NCT00146757|6400677|P2|STARTED|Overall Study||4
2607318|NCT00146757|6400678|P1|STARTED|Overall Study||16
2607319|NCT00146640|6400697|P2|NOT COMPLETED|Overall Study||14
2607320|NCT00146640|6400698|P1|NOT COMPLETED|Overall Study||23
2607321|NCT00146640|6400697|P2|COMPLETED|Overall Study||130
2607322|NCT00146640|6400698|P1|COMPLETED|Overall Study||121
2607323|NCT00146640|6400697|P2|STARTED|Overall Study||144
2607324|NCT00146640|6400698|P1|STARTED|Overall Study||144
2607325|NCT00146328|6400721|P3|NOT COMPLETED|Overall Study||291
2607326|NCT00146328|6400722|P2|NOT COMPLETED|Overall Study||154
2607327|NCT00146328|6400723|P1|NOT COMPLETED|Overall Study||141
2607328|NCT00146328|6400721|P3|COMPLETED|Overall Study||158
2607329|NCT00146328|6400722|P2|COMPLETED|Overall Study||101
2607330|NCT00146328|6400723|P1|COMPLETED|Overall Study||150
2607331|NCT00146328|6400721|P3|STARTED|Overall Study||449
2607332|NCT00146328|6400722|P2|STARTED|Overall Study||255
2607333|NCT00146328|6400723|P1|STARTED|Overall Study||291
2607334|NCT00146172|6400814|P8|NOT COMPLETED|Overall Study||40
2607335|NCT00146172|6400815|P7|NOT COMPLETED|Overall Study||6
2607336|NCT00146172|6400816|P6|NOT COMPLETED|Overall Study||7
2607337|NCT00146172|6400817|P5|NOT COMPLETED|Overall Study||3
2607338|NCT00146172|6400818|P4|NOT COMPLETED|Overall Study||6
2607339|NCT00146172|6400819|P3|NOT COMPLETED|Overall Study||4
2607340|NCT00146172|6400820|P2|NOT COMPLETED|Overall Study||4
2607341|NCT00146172|6400821|P1|NOT COMPLETED|Overall Study||3
2607342|NCT00146172|6400814|P8|COMPLETED|Overall Study||0
2607343|NCT00146172|6400815|P7|COMPLETED|Overall Study||0
2607344|NCT00146172|6400816|P6|COMPLETED|Overall Study||0
2607345|NCT00146172|6400817|P5|COMPLETED|Overall Study||0
2607346|NCT00146172|6400818|P4|COMPLETED|Overall Study||0
2607347|NCT00146172|6400819|P3|COMPLETED|Overall Study||0
2607348|NCT00146172|6400820|P2|COMPLETED|Overall Study||0
2607349|NCT00146172|6400821|P1|COMPLETED|Overall Study||0
2607350|NCT00146172|6400814|P8|Received Drug|Overall Study||39
2607351|NCT00146172|6400815|P7|Received Drug|Overall Study||6
2607352|NCT00146172|6400816|P6|Received Drug|Overall Study||7
2607353|NCT00146172|6400817|P5|Received Drug|Overall Study||3
2607354|NCT00146172|6400818|P4|Received Drug|Overall Study||6
2607355|NCT00146172|6400819|P3|Received Drug|Overall Study||4
2607356|NCT00146172|6400820|P2|Received Drug|Overall Study||4
2607357|NCT00146172|6400821|P1|Received Drug|Overall Study||3
2607358|NCT00146172|6400814|P8|STARTED|Overall Study||40
2607359|NCT00146172|6400815|P7|STARTED|Overall Study||6
2607360|NCT00146172|6400816|P6|STARTED|Overall Study||7
2607361|NCT00146172|6400817|P5|STARTED|Overall Study||3
2607362|NCT00146172|6400818|P4|STARTED|Overall Study||6
2607363|NCT00146172|6400819|P3|STARTED|Overall Study||4
2607364|NCT00146172|6400820|P2|STARTED|Overall Study||4
2607365|NCT00146172|6400821|P1|STARTED|Overall Study||3
2607366|NCT00145977|6400856|P2|NOT COMPLETED|Overall Study||4
2607367|NCT00145977|6400857|P1|NOT COMPLETED|Overall Study||2
2607368|NCT00145977|6400856|P2|COMPLETED|Overall Study||13
2607369|NCT00145977|6400857|P1|COMPLETED|Overall Study||17
2607370|NCT00145977|6400856|P2|STARTED|Overall Study||17
2607371|NCT00145977|6400857|P1|STARTED|Overall Study||19
2607372|NCT00145795|6400883|P2|NOT COMPLETED|Overall Study||0
2607373|NCT00145795|6400884|P1|NOT COMPLETED|Overall Study||1
2607374|NCT00145795|6400883|P2|COMPLETED|Overall Study||10
2607375|NCT00145795|6400884|P1|COMPLETED|Overall Study|1 patient discontinued early due to grade II gastrointestinal symptoms.|9
2607376|NCT00145795|6400883|P2|STARTED|Overall Study||10
2607377|NCT00145795|6400884|P1|STARTED|Overall Study||10
2607378|NCT00145704|6400910|P2|NOT COMPLETED|Overall Study||3
2607379|NCT00145704|6400911|P1|NOT COMPLETED|Overall Study||3
2607380|NCT00145704|6400910|P2|COMPLETED|Overall Study||0
2607381|NCT00145704|6400911|P1|COMPLETED|Overall Study||0
2607382|NCT00145704|6400910|P2|STARTED|Overall Study||3
2607383|NCT00145704|6400911|P1|STARTED|Overall Study||3
2607384|NCT00145626|6400919|P1|NOT COMPLETED|Overall Study||5
2607385|NCT00145626|6400919|P1|COMPLETED|Overall Study||14
2607386|NCT00145626|6400919|P1|STARTED|Overall Study||19
2607387|NCT00145600|6400965|P4|NOT COMPLETED|Overall Study||16
2607388|NCT00145600|6400966|P3|NOT COMPLETED|Overall Study||5
2607389|NCT00145600|6400967|P2|NOT COMPLETED|Overall Study||10
2607390|NCT00145600|6400968|P1|NOT COMPLETED|Overall Study||8
2607391|NCT00145600|6400965|P4|COMPLETED|Overall Study||130
2607392|NCT00145600|6400966|P3|COMPLETED|Overall Study||8
2607393|NCT00145600|6400967|P2|COMPLETED|Overall Study||36
2607394|NCT00145600|6400968|P1|COMPLETED|Overall Study||83
2607395|NCT00145600|6400965|P4|STARTED|Overall Study||146
2607396|NCT00145600|6400966|P3|STARTED|Overall Study||13
2607397|NCT00145600|6400967|P2|STARTED|Overall Study||46
2607398|NCT00145600|6400968|P1|STARTED|Overall Study||91
2607399|NCT00145587|6401082|P2|NOT COMPLETED|Overall Study||0
2607400|NCT00145587|6401083|P1|NOT COMPLETED|Overall Study||0
2607401|NCT00145587|6401082|P2|COMPLETED|Overall Study||1
2607402|NCT00145587|6401083|P1|COMPLETED|Overall Study||5
2607403|NCT00145587|6401082|P2|STARTED|Overall Study||1
2607404|NCT00145587|6401083|P1|STARTED|Overall Study||5
2607405|NCT00145574|6401092|P3|NOT COMPLETED|Open Label Long-term Extension||11
2607406|NCT00145574|6401093|P2|NOT COMPLETED|Open Label Long-term Extension||0
2607407|NCT00145574|6401094|P1|NOT COMPLETED|Open Label Long-term Extension||0
2607408|NCT00145574|6401092|P3|COMPLETED|Open Label Long-term Extension||173
2607409|NCT00145574|6401093|P2|COMPLETED|Open Label Long-term Extension||0
2607410|NCT00145574|6401094|P1|COMPLETED|Open Label Long-term Extension||0
2607411|NCT00145574|6401092|P3|STARTED|Open Label Long-term Extension|2 participants discontinued after completing double-blind but before starting open label.|184
2607412|NCT00145574|6401093|P2|STARTED|Open Label Long-term Extension||0
2607413|NCT00145574|6401094|P1|STARTED|Open Label Long-term Extension||0
2607414|NCT00145574|6401092|P3|NOT COMPLETED|Double Blind||2
2607415|NCT00145574|6401093|P2|NOT COMPLETED|Double Blind||5
2607416|NCT00145574|6401094|P1|NOT COMPLETED|Double Blind||1
2607417|NCT00145574|6401092|P3|COMPLETED|Double Blind||62
2607418|NCT00145574|6401093|P2|COMPLETED|Double Blind||60
2607419|NCT00145574|6401094|P1|COMPLETED|Double Blind||64
2607420|NCT00145574|6401092|P3|STARTED|Double Blind||64
2607421|NCT00145574|6401093|P2|STARTED|Double Blind||65
2607422|NCT00145574|6401094|P1|STARTED|Double Blind||65
2607423|NCT00145509|6401151|P2|NOT COMPLETED|Overall Study||21
2607424|NCT00145509|6401152|P1|NOT COMPLETED|Overall Study||22
2607425|NCT00145509|6401151|P2|COMPLETED|Overall Study||15
2607426|NCT00145509|6401152|P1|COMPLETED|Overall Study||19
2607427|NCT00145509|6401151|P2|STARTED|Overall Study||36
2607428|NCT00145509|6401152|P1|STARTED|Overall Study||41
2607429|NCT00145496|6401166|P2|NOT COMPLETED|Overall Study||81
2607430|NCT00145496|6401167|P1|NOT COMPLETED|Overall Study||123
2607431|NCT00145496|6401166|P2|COMPLETED|Overall Study||143
2607432|NCT00145496|6401167|P1|COMPLETED|Overall Study||121
2607433|NCT00145496|6401166|P2|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|224
2607434|NCT00145496|6401167|P1|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|244
2607435|NCT00145470|6401179|P2|NOT COMPLETED|Overall Study||98
2607436|NCT00145470|6401180|P1|NOT COMPLETED|Overall Study||112
2607437|NCT00145470|6401179|P2|COMPLETED|Overall Study||61
2607438|NCT00145470|6401180|P1|COMPLETED|Overall Study||55
2607439|NCT00145470|6401179|P2|Treated|Overall Study||158
2607440|NCT00145470|6401180|P1|Treated|Overall Study||166
2607441|NCT00145470|6401179|P2|STARTED|Overall Study||159
2607442|NCT00145470|6401180|P1|STARTED|Overall Study||167
2607443|NCT00145418|6401240|P1|NOT COMPLETED|Overall Study||0
2607444|NCT00145418|6401240|P1|COMPLETED|Overall Study||15
2607445|NCT00145418|6401240|P1|STARTED|Overall Study||15
2607446|NCT00145327|6401250|P3|NOT COMPLETED|Overall Study||248
2607447|NCT00145327|6401251|P2|NOT COMPLETED|Overall Study||124
2607448|NCT00145327|6401252|P1|NOT COMPLETED|Overall Study||142
2607449|NCT00145327|6401250|P3|COMPLETED|Overall Study||975
2607450|NCT00145327|6401251|P2|COMPLETED|Overall Study||493
2607451|NCT00145327|6401252|P1|COMPLETED|Overall Study||474
2607452|NCT00145327|6401250|P3|STARTED|Overall Study|Group P3Z3 have non-randomized participants|1223
2607453|NCT00145327|6401251|P2|STARTED|Overall Study||617
2607454|NCT00145327|6401252|P1|STARTED|Overall Study|Group Z6 and Group Z3P3 have randomized participants.|616
2607455|NCT00145249|6401308|P3|NOT COMPLETED|Overall Study||17
2607456|NCT00145249|6401309|P2|NOT COMPLETED|Overall Study||15
2607457|NCT00145249|6401310|P1|NOT COMPLETED|Overall Study||11
2607458|NCT00145249|6401308|P3|COMPLETED|Overall Study||31
2607459|NCT00145249|6401309|P2|COMPLETED|Overall Study||33
2607460|NCT00145249|6401310|P1|COMPLETED|Overall Study||36
2607461|NCT00145249|6401308|P3|STARTED|Overall Study|48 subjects randomized; 49 treated-3 subjects randomized to AmphoB+Fluc400 rec'd AmphoB+Fluc800|48
2607462|NCT00145249|6401309|P2|STARTED|Overall Study|48 subjects randomized; 47 subjects treated-2 subjects randomized to AmphoB rec'd AmphoB+Fluc400|48
2607463|NCT00145249|6401310|P1|STARTED|Overall Study|47 subjects randomized; 45 subjects treated|47
2607464|NCT00145119|6401351|P1|NOT COMPLETED|Overall Study||45
2607465|NCT00145119|6401351|P1|COMPLETED|Overall Study||267
2607466|NCT00145119|6401351|P1|STARTED|Overall Study||312
2607467|NCT00145041|6401355|P1|NOT COMPLETED|Overall Study||0
2607468|NCT00145041|6401355|P1|COMPLETED|Overall Study||7
2607469|NCT00145041|6401355|P1|STARTED|Overall Study||7
2607470|NCT00144963|6401361|P1|NOT COMPLETED|Overall Study||0
2607471|NCT00144963|6401361|P1|COMPLETED|Overall Study||36
2607472|NCT00144963|6401361|P1|STARTED|Overall Study||36
2607473|NCT00144781|6401369|P4|NOT COMPLETED|Overall Study||0
2607474|NCT00144781|6401370|P3|NOT COMPLETED|Overall Study||0
2607475|NCT00144781|6401371|P2|NOT COMPLETED|Overall Study||2
2607476|NCT00144781|6401372|P1|NOT COMPLETED|Overall Study||0
2607477|NCT00144781|6401369|P4|COMPLETED|Overall Study||9
2607478|NCT00144781|6401370|P3|COMPLETED|Overall Study||8
2607479|NCT00144781|6401371|P2|COMPLETED|Overall Study||7
2607480|NCT00144781|6401372|P1|COMPLETED|Overall Study||8
2607481|NCT00144781|6401369|P4|STARTED|Overall Study||9
2607482|NCT00144781|6401370|P3|STARTED|Overall Study||8
2607483|NCT00144781|6401371|P2|STARTED|Overall Study||9
2607484|NCT00144781|6401372|P1|STARTED|Overall Study||8
2607485|NCT00144391|6401392|P2|NOT COMPLETED|Overall Study||0
2607486|NCT00144391|6401393|P1|NOT COMPLETED|Overall Study||0
2607487|NCT00144391|6401392|P2|COMPLETED|Overall Study||9
2607488|NCT00144391|6401393|P1|COMPLETED|Overall Study||11
2607489|NCT00144391|6401392|P2|STARTED|Overall Study||9
2607490|NCT00144391|6401393|P1|STARTED|Overall Study||11
2607491|NCT00144339|6401401|P2|NOT COMPLETED|Overall Study||1099
2607492|NCT00144339|6401402|P1|NOT COMPLETED|Overall Study||1358
2607493|NCT00144339|6401401|P2|COMPLETED|Overall Study||1887
2607494|NCT00144339|6401402|P1|COMPLETED|Overall Study||1648
2607495|NCT00144339|6401401|P2|STARTED|Overall Study||2986
2607496|NCT00144339|6401402|P1|STARTED|Overall Study||3006
2607497|NCT00144300|6401610|P2|NOT COMPLETED|Overall Study||28
2607498|NCT00144300|6401611|P1|NOT COMPLETED|Overall Study||29
2607499|NCT00144300|6401610|P2|COMPLETED|Overall Study||97
2607500|NCT00144300|6401611|P1|COMPLETED|Overall Study||92
2607501|NCT00144300|6401610|P2|STARTED|Overall Study||125
2607502|NCT00144300|6401611|P1|STARTED|Overall Study||121
2607503|NCT00144170|6401659|P2|NOT COMPLETED|Overall Study||396
2607504|NCT00144170|6401660|P1|NOT COMPLETED|Overall Study||352
2607505|NCT00144170|6401659|P2|COMPLETED|Overall Study||32
2607506|NCT00144170|6401660|P1|COMPLETED|Overall Study||86
2607507|NCT00144170|6401659|P2|STARTED|Overall Study||428
2607508|NCT00144170|6401660|P1|STARTED|Overall Study||438
2607509|NCT00144027|6401850|P2|NOT COMPLETED|Overall Study||11
2607510|NCT00144027|6401851|P1|NOT COMPLETED|Overall Study||3
2607511|NCT00144027|6401850|P2|COMPLETED|Overall Study|participants who completed 12-month follow-up|25
2607512|NCT00144027|6401851|P1|COMPLETED|Overall Study|participants who completed 12-month follow-up|36
2607513|NCT00144027|6401850|P2|Completed 6 Month Assessment|Overall Study||24
2607514|NCT00144027|6401851|P1|Completed 6 Month Assessment|Overall Study||37
2607515|NCT00144027|6401850|P2|Completed Baseline Assessment|Overall Study||29
2607516|NCT00144027|6401851|P1|Completed Baseline Assessment|Overall Study||39
2607517|NCT00144027|6401850|P2|STARTED|Overall Study|participants who consented|36
2607518|NCT00144027|6401851|P1|STARTED|Overall Study|participants who consented|39
2607519|NCT00143845|6401857|P1|NOT COMPLETED|Overall Study||0
2607520|NCT00143845|6401857|P1|COMPLETED|Overall Study||54
2607521|NCT00143845|6401857|P1|STARTED|Overall Study||54
2607522|NCT00143819|6401865|P2|NOT COMPLETED|Overall Study||3
2607523|NCT00143819|6401866|P1|NOT COMPLETED|Overall Study||2
2607524|NCT00143819|6401865|P2|COMPLETED|Overall Study||5
2607525|NCT00143819|6401866|P1|COMPLETED|Overall Study||3
2607526|NCT00143819|6401865|P2|STARTED|Overall Study||8
2607527|NCT00143819|6401866|P1|STARTED|Overall Study||5
2607528|NCT00143598|6401881|P2|NOT COMPLETED|Overall Study||94
2607529|NCT00143598|6401882|P1|NOT COMPLETED|Overall Study||92
2607530|NCT00143598|6401881|P2|COMPLETED|Overall Study||302
2607531|NCT00143598|6401882|P1|COMPLETED|Overall Study||318
2607532|NCT00143598|6401881|P2|STARTED|Overall Study||396
2607533|NCT00143598|6401882|P1|STARTED|Overall Study||410
2607534|NCT00143507|6401896|P2|NOT COMPLETED|Overall Study||652
2607535|NCT00143507|6401897|P1|NOT COMPLETED|Overall Study||687
2607536|NCT00143507|6401896|P2|COMPLETED|Overall Study||4786
2607537|NCT00143507|6401897|P1|COMPLETED|Overall Study||4792
2607538|NCT00143507|6401896|P2|STARTED|Overall Study||5438
2607539|NCT00143507|6401897|P1|STARTED|Overall Study||5479
2607540|NCT00143455|6401931|P4|NOT COMPLETED|Cohort 2||93
2607541|NCT00143455|6401932|P3|NOT COMPLETED|Cohort 2||106
2607542|NCT00143455|6401933|P2|NOT COMPLETED|Cohort 2||0
2607543|NCT00143455|6401934|P1|NOT COMPLETED|Cohort 2||0
2607544|NCT00143455|6401931|P4|COMPLETED|Cohort 2||111
2607545|NCT00143455|6401932|P3|COMPLETED|Cohort 2||97
2607546|NCT00143455|6401933|P2|COMPLETED|Cohort 2||0
2607547|NCT00143455|6401934|P1|COMPLETED|Cohort 2||0
2607548|NCT00143455|6401931|P4|Received Treatment|Cohort 2||203
2607549|NCT00143455|6401932|P3|Received Treatment|Cohort 2||202
2607550|NCT00143455|6401933|P2|Received Treatment|Cohort 2||0
2607551|NCT00143455|6401934|P1|Received Treatment|Cohort 2||0
2607552|NCT00143455|6401931|P4|STARTED|Cohort 2||204
2607553|NCT00143455|6401932|P3|STARTED|Cohort 2||203
2607554|NCT00143455|6401933|P2|STARTED|Cohort 2||0
2607555|NCT00143455|6401934|P1|STARTED|Cohort 2||0
2607556|NCT00143455|6401931|P4|NOT COMPLETED|Cohort 1||0
2607557|NCT00143455|6401932|P3|NOT COMPLETED|Cohort 1||0
2607558|NCT00143455|6401933|P2|NOT COMPLETED|Cohort 1||17
2607559|NCT00143455|6401934|P1|NOT COMPLETED|Cohort 1||14
2607560|NCT00143455|6401931|P4|COMPLETED|Cohort 1||0
2607561|NCT00143455|6401932|P3|COMPLETED|Cohort 1||0
2607562|NCT00143455|6401933|P2|COMPLETED|Cohort 1||22
2607563|NCT00143455|6401934|P1|COMPLETED|Cohort 1||25
2607564|NCT00143455|6401931|P4|Received Treatment|Cohort 1||0
2607565|NCT00143455|6401932|P3|Received Treatment|Cohort 1||0
2607566|NCT00143455|6401933|P2|Received Treatment|Cohort 1||38
2607567|NCT00143455|6401934|P1|Received Treatment|Cohort 1||39
2607568|NCT00143455|6401931|P4|STARTED|Cohort 1||0
2607569|NCT00143455|6401932|P3|STARTED|Cohort 1||0
2607570|NCT00143455|6401933|P2|STARTED|Cohort 1||39
2607571|NCT00143455|6401934|P1|STARTED|Cohort 1||39
2607572|NCT00143403|6401968|P2|NOT COMPLETED|Overall Study||46
2607573|NCT00143403|6401969|P1|NOT COMPLETED|Overall Study||35
2607574|NCT00143403|6401968|P2|COMPLETED|Overall Study|Received maximum number of cycles.|115
2607575|NCT00143403|6401969|P1|COMPLETED|Overall Study|Received maximum number of cycles.|125
2607576|NCT00143403|6401968|P2|Treated|Overall Study||153
2607577|NCT00143403|6401969|P1|Treated|Overall Study||153
2607578|NCT00143403|6401968|P2|STARTED|Overall Study||161
2607579|NCT00143403|6401969|P1|STARTED|Overall Study||160
2607580|NCT00143390|6401979|P2|NOT COMPLETED|Overall Study||149
2607581|NCT00143390|6401980|P1|NOT COMPLETED|Overall Study||149
2607582|NCT00143390|6401979|P2|COMPLETED|Overall Study||0
2607583|NCT00143390|6401980|P1|COMPLETED|Overall Study||0
2607584|NCT00143390|6401979|P2|STARTED|Overall Study||149
2607585|NCT00143390|6401980|P1|STARTED|Overall Study||149
2607586|NCT00143312|6401996|P1|NOT COMPLETED|Overall Study||16
2607587|NCT00143312|6401996|P1|COMPLETED|Overall Study||29
2607588|NCT00143312|6401996|P1|STARTED|Overall Study||45
2607589|NCT00143247|6402006|P1|NOT COMPLETED|Overall Study||156
2607590|NCT00143247|6402006|P1|COMPLETED|Overall Study||17
2607591|NCT00143247|6402006|P1|STARTED|Overall Study|173=total subjects of current + 3 previous protocols|173
2607592|NCT00142935|6402023|P3|NOT COMPLETED|Overall Study||7
2607593|NCT00142935|6402024|P2|NOT COMPLETED|Overall Study||8
2607594|NCT00142935|6402025|P1|NOT COMPLETED|Overall Study||3
2607595|NCT00142935|6402023|P3|COMPLETED|Overall Study||23
2607596|NCT00142935|6402024|P2|COMPLETED|Overall Study||20
2607597|NCT00142935|6402025|P1|COMPLETED|Overall Study||26
2607598|NCT00142935|6402023|P3|STARTED|Overall Study||30
2607599|NCT00142935|6402024|P2|STARTED|Overall Study||28
2607600|NCT00142935|6402025|P1|STARTED|Overall Study||29
2607601|NCT00142909|6402050|P2|NOT COMPLETED|Medications Begin||3
2607602|NCT00142909|6402051|P1|NOT COMPLETED|Medications Begin||9
2607603|NCT00142909|6402050|P2|COMPLETED|Medications Begin||31
2607604|NCT00142909|6402051|P1|COMPLETED|Medications Begin||26
2607605|NCT00142909|6402050|P2|STARTED|Medications Begin||34
2607606|NCT00142909|6402051|P1|STARTED|Medications Begin||35
2607607|NCT00142909|6402050|P2|NOT COMPLETED|Randomization||10
2607608|NCT00142909|6402051|P1|NOT COMPLETED|Randomization||7
2607609|NCT00142909|6402050|P2|COMPLETED|Randomization||34
2607610|NCT00142909|6402051|P1|COMPLETED|Randomization||35
2607611|NCT00142909|6402050|P2|STARTED|Randomization||44
2607612|NCT00142909|6402051|P1|STARTED|Randomization||42
2607613|NCT00142818|6402071|P4|NOT COMPLETED|Overall Study||22
2607614|NCT00142818|6402072|P3|NOT COMPLETED|Overall Study||13
2607615|NCT00142818|6402073|P2|NOT COMPLETED|Overall Study||21
2607616|NCT00142818|6402074|P1|NOT COMPLETED|Overall Study||17
2607617|NCT00142818|6402071|P4|COMPLETED|Overall Study||20
2607618|NCT00142818|6402072|P3|COMPLETED|Overall Study||24
2607619|NCT00142818|6402073|P2|COMPLETED|Overall Study||19
2607620|NCT00142818|6402074|P1|COMPLETED|Overall Study||28
2607621|NCT00142818|6402071|P4|STARTED|Overall Study||42
2607622|NCT00142818|6402072|P3|STARTED|Overall Study||37
2607623|NCT00142818|6402073|P2|STARTED|Overall Study||40
2607624|NCT00142818|6402074|P1|STARTED|Overall Study||45
2607625|NCT00142792|6402087|P3|NOT COMPLETED|Overall Study||12
2607626|NCT00142792|6402088|P2|NOT COMPLETED|Overall Study||15
2607627|NCT00142792|6402089|P1|NOT COMPLETED|Overall Study||12
2607628|NCT00142792|6402087|P3|COMPLETED|Overall Study||30
2607629|NCT00142792|6402088|P2|COMPLETED|Overall Study||26
2607630|NCT00142792|6402089|P1|COMPLETED|Overall Study||27
2607631|NCT00142792|6402087|P3|Completed Intervention|Overall Study||37
2607632|NCT00142792|6402088|P2|Completed Intervention|Overall Study||37
2607633|NCT00142792|6402089|P1|Completed Intervention|Overall Study||35
2607634|NCT00142792|6402087|P3|STARTED|Overall Study||42
2607635|NCT00142792|6402088|P2|STARTED|Overall Study||41
2607636|NCT00142792|6402089|P1|STARTED|Overall Study||39
2607637|NCT00142597|6402102|P2|NOT COMPLETED|Overall Study||1
2607638|NCT00142597|6402103|P1|NOT COMPLETED|Overall Study||3
2607639|NCT00142597|6402102|P2|COMPLETED|Overall Study|N=10 completed PET imaging|22
2607640|NCT00142597|6402103|P1|COMPLETED|Overall Study|N=10 completed PET imaging|20
2607641|NCT00142597|6402102|P2|STARTED|Overall Study|N=10 underwent PET imaging|23
2607642|NCT00142597|6402103|P1|STARTED|Overall Study|N=10 underwent PET imaging|23
2607643|NCT00142519|6402111|P2|NOT COMPLETED|Overall Study||16
2607644|NCT00142519|6402112|P1|NOT COMPLETED|Overall Study||18
2607645|NCT00142519|6402111|P2|COMPLETED|Overall Study||9
2607646|NCT00142519|6402112|P1|COMPLETED|Overall Study||7
2607647|NCT00142519|6402111|P2|STARTED|Overall Study||25
2607648|NCT00142519|6402112|P1|STARTED|Overall Study||25
2607649|NCT00142506|6402122|P2|NOT COMPLETED|Overall Study||29
2607650|NCT00142506|6402123|P1|NOT COMPLETED|Overall Study||72
2607651|NCT00142506|6402122|P2|COMPLETED|Overall Study||77
2607652|NCT00142506|6402123|P1|COMPLETED|Overall Study||112
2607653|NCT00142506|6402122|P2|STARTED|Overall Study||106
2607654|NCT00142506|6402123|P1|STARTED|Overall Study||184
2607655|NCT00142415|6402135|P6|NOT COMPLETED|Overall Study||2
2607656|NCT00142415|6402136|P5|NOT COMPLETED|Overall Study||1
2607657|NCT00142415|6402137|P4|NOT COMPLETED|Overall Study||0
2607658|NCT00142415|6402138|P3|NOT COMPLETED|Overall Study||0
2607659|NCT00142415|6402139|P2|NOT COMPLETED|Overall Study||0
2607660|NCT00142415|6402140|P1|NOT COMPLETED|Overall Study||0
2607661|NCT00142415|6402135|P6|COMPLETED|Overall Study||6
2607662|NCT00142415|6402136|P5|COMPLETED|Overall Study||2
2607663|NCT00142415|6402137|P4|COMPLETED|Overall Study||3
2607664|NCT00142415|6402138|P3|COMPLETED|Overall Study||6
2607665|NCT00142415|6402139|P2|COMPLETED|Overall Study||3
2607666|NCT00142415|6402140|P1|COMPLETED|Overall Study||3
2607667|NCT00142415|6402135|P6|STARTED|Overall Study||8
2607668|NCT00142415|6402136|P5|STARTED|Overall Study||3
2607669|NCT00142415|6402137|P4|STARTED|Overall Study||3
2607670|NCT00142415|6402138|P3|STARTED|Overall Study||6
2607671|NCT00142415|6402139|P2|STARTED|Overall Study||3
2607672|NCT00142415|6402140|P1|STARTED|Overall Study||3
2607673|NCT00142298|6402178|P10|NOT COMPLETED|Overall Study||0
2607674|NCT00142298|6402179|P9|NOT COMPLETED|Overall Study||5
2607675|NCT00142298|6402180|P8|NOT COMPLETED|Overall Study||8
2607676|NCT00142298|6402181|P7|NOT COMPLETED|Overall Study||8
2607677|NCT00142298|6402182|P6|NOT COMPLETED|Overall Study||16
2607678|NCT00142298|6402183|P5|NOT COMPLETED|Overall Study||10
2607679|NCT00142298|6402184|P4|NOT COMPLETED|Overall Study||85
2607680|NCT00142298|6402185|P3|NOT COMPLETED|Overall Study||33
2607681|NCT00142298|6402186|P2|NOT COMPLETED|Overall Study||176
2607682|NCT00142298|6402187|P1|NOT COMPLETED|Overall Study||160
2607683|NCT00142298|6402178|P10|COMPLETED|Overall Study||13
2607684|NCT00142298|6402179|P9|COMPLETED|Overall Study||52
2607685|NCT00142298|6402180|P8|COMPLETED|Overall Study||58
2607686|NCT00142298|6402181|P7|COMPLETED|Overall Study||15
2607687|NCT00142298|6402182|P6|COMPLETED|Overall Study||10
2607688|NCT00142298|6402183|P5|COMPLETED|Overall Study||46
2607689|NCT00142298|6402184|P4|COMPLETED|Overall Study||121
2607690|NCT00142298|6402185|P3|COMPLETED|Overall Study||90
2607691|NCT00142298|6402186|P2|COMPLETED|Overall Study||456
2607692|NCT00142298|6402187|P1|COMPLETED|Overall Study|Completed week 104/week 208.|507
2607693|NCT00142298|6402178|P10|Per Protocol Population|Overall Study||13
2607694|NCT00142298|6402179|P9|Per Protocol Population|Overall Study||56
2607695|NCT00142298|6402180|P8|Per Protocol Population|Overall Study||64
2607696|NCT00142298|6402181|P7|Per Protocol Population|Overall Study||19
2607697|NCT00142298|6402182|P6|Per Protocol Population|Overall Study||25
2607698|NCT00142298|6402183|P5|Per Protocol Population|Overall Study||50
2607699|NCT00142298|6402184|P4|Per Protocol Population|Overall Study||202
2607700|NCT00142298|6402185|P3|Per Protocol Population|Overall Study||120
2607701|NCT00142298|6402186|P2|Per Protocol Population|Overall Study||606
2607702|NCT00142298|6402187|P1|Per Protocol Population|Overall Study||635
2607703|NCT00142298|6402178|P10|Safety Population|Overall Study||13
2607704|NCT00142298|6402179|P9|Safety Population|Overall Study||57
2607705|NCT00142298|6402180|P8|Safety Population|Overall Study||66
2607706|NCT00142298|6402181|P7|Safety Population|Overall Study||23
2607707|NCT00142298|6402182|P6|Safety Population|Overall Study||26
2607708|NCT00142298|6402183|P5|Safety Population|Overall Study||50
2607709|NCT00142298|6402184|P4|Safety Population|Overall Study||206
2607710|NCT00142298|6402185|P3|Safety Population|Overall Study||122
2607711|NCT00142298|6402186|P2|Safety Population|Overall Study||626
2607712|NCT00142298|6402187|P1|Safety Population|Overall Study||655
2607713|NCT00142298|6402178|P10|STARTED|Overall Study||13
2607714|NCT00142298|6402179|P9|STARTED|Overall Study||57
2607715|NCT00142298|6402180|P8|STARTED|Overall Study||66
2607716|NCT00142298|6402181|P7|STARTED|Overall Study||23
2607717|NCT00142298|6402182|P6|STARTED|Overall Study||26
2607718|NCT00142298|6402183|P5|STARTED|Overall Study||56
2607719|NCT00142298|6402184|P4|STARTED|Overall Study||206
2607720|NCT00142298|6402185|P3|STARTED|Overall Study||123
2607721|NCT00142298|6402186|P2|STARTED|Overall Study||632
2607722|NCT00142298|6402187|P1|STARTED|Overall Study||667
2607723|NCT00142168|6402209|P1|NOT COMPLETED|Overall Study||0
2607724|NCT00142168|6402209|P1|COMPLETED|Overall Study||16
2607725|NCT00142168|6402209|P1|STARTED|Overall Study||16
2607726|NCT00142116|6402216|P1|NOT COMPLETED|Overall Study||0
2607727|NCT00142116|6402216|P1|COMPLETED|Overall Study||25
2607728|NCT00142116|6402216|P1|STARTED|Overall Study||25
2607729|NCT00141921|6402221|P1|NOT COMPLETED|Overall Study||141
2607730|NCT00141921|6402221|P1|COMPLETED|Overall Study||41
2607731|NCT00141921|6402221|P1|Received Treatment|Overall Study||181
2607732|NCT00141921|6402221|P1|STARTED|Overall Study||182
2607733|NCT00141817|6402247|P4|NOT COMPLETED|Overall Study||0
2607734|NCT00141817|6402248|P3|NOT COMPLETED|Overall Study||1
2607735|NCT00141817|6402249|P2|NOT COMPLETED|Overall Study||0
2607736|NCT00141817|6402250|P1|NOT COMPLETED|Overall Study||1
2607737|NCT00141817|6402247|P4|COMPLETED|Overall Study||13
2607738|NCT00141817|6402248|P3|COMPLETED|Overall Study||10
2607739|NCT00141817|6402249|P2|COMPLETED|Overall Study||10
2607740|NCT00141817|6402250|P1|COMPLETED|Overall Study||6
2607741|NCT00141817|6402247|P4|STARTED|Overall Study||13
2607742|NCT00141817|6402248|P3|STARTED|Overall Study||11
2607743|NCT00141817|6402249|P2|STARTED|Overall Study||10
2607744|NCT00141817|6402250|P1|STARTED|Overall Study||7
2607745|NCT00141778|6402291|P3|NOT COMPLETED|Started Study Medication||4
2607746|NCT00141778|6402292|P2|NOT COMPLETED|Started Study Medication||7
2607747|NCT00141778|6402293|P1|NOT COMPLETED|Started Study Medication||2
2607748|NCT00141778|6402291|P3|COMPLETED|Started Study Medication||143
2607749|NCT00141778|6402292|P2|COMPLETED|Started Study Medication||144
2607750|NCT00141778|6402293|P1|COMPLETED|Started Study Medication||145
2607751|NCT00141778|6402291|P3|STARTED|Started Study Medication||147
2607752|NCT00141778|6402292|P2|STARTED|Started Study Medication||151
2607753|NCT00141778|6402293|P1|STARTED|Started Study Medication||147
2607754|NCT00141778|6402291|P3|NOT COMPLETED|Randomization Prior to Study Med||6
2607755|NCT00141778|6402292|P2|NOT COMPLETED|Randomization Prior to Study Med||2
2607756|NCT00141778|6402293|P1|NOT COMPLETED|Randomization Prior to Study Med||5
2607757|NCT00141778|6402291|P3|COMPLETED|Randomization Prior to Study Med||147
2607758|NCT00141778|6402292|P2|COMPLETED|Randomization Prior to Study Med||151
2607759|NCT00141778|6402293|P1|COMPLETED|Randomization Prior to Study Med||147
2607760|NCT00141778|6402291|P3|STARTED|Randomization Prior to Study Med||153
2607761|NCT00141778|6402292|P2|STARTED|Randomization Prior to Study Med||153
2607762|NCT00141778|6402293|P1|STARTED|Randomization Prior to Study Med||152
2607763|NCT00141765|6402331|P1|NOT COMPLETED|Overall Study||0
2607764|NCT00141765|6402331|P1|COMPLETED|Overall Study||25
2607765|NCT00141765|6402331|P1|STARTED|Overall Study||25
2607766|NCT00141739|6402335|P1|NOT COMPLETED|Overall Study||0
2607767|NCT00141739|6402335|P1|COMPLETED|Overall Study||100
2607768|NCT00141739|6402335|P1|STARTED|Overall Study|Number of evaluable patients|100
2607769|NCT00141726|6402346|P1|NOT COMPLETED|Overall Study||3
2607770|NCT00141726|6402346|P1|COMPLETED|Overall Study||31
2607771|NCT00141726|6402346|P1|STARTED|Overall Study||34
2607772|NCT00141518|6402354|P3|NOT COMPLETED|Overall Study||6
2607773|NCT00141518|6402355|P2|NOT COMPLETED|Overall Study||6
2607774|NCT00141518|6402356|P1|NOT COMPLETED|Overall Study||16
2607775|NCT00141518|6402354|P3|COMPLETED|Overall Study||12
2607776|NCT00141518|6402355|P2|COMPLETED|Overall Study||16
2607777|NCT00141518|6402356|P1|COMPLETED|Overall Study||21
2607778|NCT00141518|6402354|P3|Full Analysis Sample|Overall Study||18
2607779|NCT00141518|6402355|P2|Full Analysis Sample|Overall Study||22
2607780|NCT00141518|6402356|P1|Full Analysis Sample|Overall Study||27
2607781|NCT00141518|6402354|P3|Safety Sample|Overall Study||18
2607782|NCT00141518|6402355|P2|Safety Sample|Overall Study||22
2607783|NCT00141518|6402356|P1|Safety Sample|Overall Study||36
2607784|NCT00141518|6402354|P3|STARTED|Overall Study||18
2607785|NCT00141518|6402355|P2|STARTED|Overall Study||22
2607786|NCT00141518|6402356|P1|STARTED|Overall Study||37
2607787|NCT00141453|6402545|P2|NOT COMPLETED|Overall Study||5
2607788|NCT00141453|6402546|P1|NOT COMPLETED|Overall Study||6
2607789|NCT00141453|6402545|P2|COMPLETED|Overall Study||284
2607790|NCT00141453|6402546|P1|COMPLETED|Overall Study||282
2607791|NCT00141453|6402545|P2|STARTED|Overall Study||289
2607792|NCT00141453|6402546|P1|STARTED|Overall Study||288
2607793|NCT00141297|6402560|P10|NOT COMPLETED|Overall Study||6
2607794|NCT00141297|6402561|P9|NOT COMPLETED|Overall Study||20
2607795|NCT00141297|6402562|P8|NOT COMPLETED|Overall Study||4
2607796|NCT00141297|6402563|P7|NOT COMPLETED|Overall Study||3
2607797|NCT00141297|6402564|P6|NOT COMPLETED|Overall Study||3
2607798|NCT00141297|6402565|P5|NOT COMPLETED|Overall Study||22
2607799|NCT00141297|6402566|P4|NOT COMPLETED|Overall Study||3
2607800|NCT00141297|6402567|P3|NOT COMPLETED|Overall Study||7
2607801|NCT00141297|6402568|P2|NOT COMPLETED|Overall Study||3
2607802|NCT00141297|6402569|P1|NOT COMPLETED|Overall Study||3
2607803|NCT00141297|6402560|P10|COMPLETED|Overall Study||0
2607804|NCT00141297|6402561|P9|COMPLETED|Overall Study||0
2607805|NCT00141297|6402562|P8|COMPLETED|Overall Study||0
2607806|NCT00141297|6402563|P7|COMPLETED|Overall Study||0
2607807|NCT00141297|6402564|P6|COMPLETED|Overall Study||0
2607808|NCT00141297|6402565|P5|COMPLETED|Overall Study||0
2607809|NCT00141297|6402566|P4|COMPLETED|Overall Study||0
2607810|NCT00141297|6402567|P3|COMPLETED|Overall Study||0
2607811|NCT00141297|6402568|P2|COMPLETED|Overall Study||0
2607812|NCT00141297|6402569|P1|COMPLETED|Overall Study||0
2607813|NCT00141297|6402560|P10|STARTED|Overall Study||6
2607814|NCT00141297|6402561|P9|STARTED|Overall Study||20
2607815|NCT00141297|6402562|P8|STARTED|Overall Study||4
2607816|NCT00141297|6402563|P7|STARTED|Overall Study||3
2607817|NCT00141297|6402564|P6|STARTED|Overall Study||3
2607818|NCT00141297|6402565|P5|STARTED|Overall Study||22
2607819|NCT00141297|6402566|P4|STARTED|Overall Study||3
2607820|NCT00141297|6402567|P3|STARTED|Overall Study||7
2607821|NCT00141297|6402568|P2|STARTED|Overall Study||3
2607822|NCT00141297|6402569|P1|STARTED|Overall Study||3
2607823|NCT00141271|6402847|P3|NOT COMPLETED|Overall Study||57
2607824|NCT00141271|6402848|P2|NOT COMPLETED|Overall Study||63
2607825|NCT00141271|6402849|P1|NOT COMPLETED|Overall Study||80
2607826|NCT00141271|6402847|P3|COMPLETED|Overall Study||111
2607827|NCT00141271|6402848|P2|COMPLETED|Overall Study||102
2607828|NCT00141271|6402849|P1|COMPLETED|Overall Study||91
2607829|NCT00141271|6402847|P3|STARTED|Overall Study||168
2607830|NCT00141271|6402848|P2|STARTED|Overall Study||165
2607831|NCT00141271|6402849|P1|STARTED|Overall Study||171
2607832|NCT00141219|6402970|P2|NOT COMPLETED|Overall Study||16
2607833|NCT00141219|6402971|P1|NOT COMPLETED|Overall Study||24
2607834|NCT00141219|6402970|P2|COMPLETED|Overall Study||62
2607835|NCT00141219|6402971|P1|COMPLETED|Overall Study||138
2607836|NCT00141219|6402970|P2|STARTED|Overall Study||78
2607837|NCT00141219|6402971|P1|STARTED|Overall Study||162
2607838|NCT00141115|6403021|P1|NOT COMPLETED|Overall Study||1
2607839|NCT00141115|6403021|P1|COMPLETED|Overall Study||2
2607840|NCT00141115|6403021|P1|STARTED|Overall Study||3
2607841|NCT00141102|6403028|P2|NOT COMPLETED|Overall Study||625
2607842|NCT00141102|6403029|P1|NOT COMPLETED|Overall Study||508
2607843|NCT00141102|6403028|P2|COMPLETED|Overall Study||1621
2607844|NCT00141102|6403029|P1|COMPLETED|Overall Study||1730
2607845|NCT00141102|6403028|P2|Received Treatment|Overall Study||2237
2607846|NCT00141102|6403029|P1|Received Treatment|Overall Study||2223
2607847|NCT00141102|6403028|P2|STARTED|Overall Study||2246
2607848|NCT00141102|6403029|P1|STARTED|Overall Study||2238
2607849|NCT00141037|6403069|P2|NOT COMPLETED|Overall Study||18
2607850|NCT00141037|6403070|P1|NOT COMPLETED|Overall Study||10
2607851|NCT00141037|6403069|P2|COMPLETED|Overall Study|8 subjects had reduced follow-up|52
2607852|NCT00141037|6403070|P1|COMPLETED|Overall Study|16 subjects had reduced follow-up|50
2607853|NCT00141037|6403069|P2|STARTED|Overall Study||70
2607854|NCT00141037|6403070|P1|STARTED|Overall Study||60
2607855|NCT00140842|6403080|P2|NOT COMPLETED|Overall Study||0
2607856|NCT00140842|6403081|P1|NOT COMPLETED|Overall Study||0
2607857|NCT00140842|6403080|P2|COMPLETED|Overall Study||15
2607858|NCT00140842|6403081|P1|COMPLETED|Overall Study||15
2607859|NCT00140842|6403080|P2|STARTED|Overall Study||15
2607860|NCT00140842|6403081|P1|STARTED|Overall Study||15
2607861|NCT00140621|6403089|P1|NOT COMPLETED|Overall Study||0
2607862|NCT00140621|6403089|P1|COMPLETED|Overall Study||6
2607863|NCT00140621|6403089|P1|STARTED|Overall Study||6
2607864|NCT00140556|6403099|P1|NOT COMPLETED|Chemoradiotherapy Period||0
2607865|NCT00140556|6403099|P1|COMPLETED|Chemoradiotherapy Period||28
2607866|NCT00140556|6403099|P1|STARTED|Chemoradiotherapy Period||28
2607867|NCT00140556|6403099|P1|NOT COMPLETED|Pre Radiation Period: Avastin / Tarceva||0
2607868|NCT00140556|6403099|P1|COMPLETED|Pre Radiation Period: Avastin / Tarceva||28
2607869|NCT00140556|6403099|P1|STARTED|Pre Radiation Period: Avastin / Tarceva||28
2607870|NCT00140426|6403105|P2|NOT COMPLETED|Overall Study||3
2607871|NCT00140426|6403106|P1|NOT COMPLETED|Overall Study||0
2607872|NCT00140426|6403105|P2|COMPLETED|Overall Study||16
2607873|NCT00140426|6403106|P1|COMPLETED|Overall Study||22
2607874|NCT00140426|6403105|P2|STARTED|Overall Study||19
2607875|NCT00140426|6403106|P1|STARTED|Overall Study||22
2607876|NCT00140413|6403139|P2|NOT COMPLETED|Overall Study||0
2607877|NCT00140413|6403140|P1|NOT COMPLETED|Overall Study||3
2607878|NCT00140413|6403139|P2|COMPLETED|Overall Study|Crossed over subjects were treated as controls for purpose of intent to treat analysis.|7
2607879|NCT00140413|6403140|P1|COMPLETED|Overall Study||10
2607880|NCT00140413|6403139|P2|Received at Least One Dose of GH|Overall Study|Controls were crossed over to GH if they met criteria for growth deceleration during the study.|3
2607881|NCT00140413|6403140|P1|Received at Least One Dose of GH|Overall Study||13
2607882|NCT00140413|6403139|P2|STARTED|Overall Study||7
2607883|NCT00140413|6403140|P1|STARTED|Overall Study||13
2607884|NCT00140244|6403147|P2|NOT COMPLETED|Intervention 2||2
2607885|NCT00140244|6403148|P1|NOT COMPLETED|Intervention 2||0
2607886|NCT00140244|6403147|P2|COMPLETED|Intervention 2||2
2607887|NCT00140244|6403148|P1|COMPLETED|Intervention 2||3
2607888|NCT00140244|6403147|P2|STARTED|Intervention 2||4
2607889|NCT00140244|6403148|P1|STARTED|Intervention 2||3
2607890|NCT00140244|6403147|P2|NOT COMPLETED|Washout||0
2607891|NCT00140244|6403148|P1|NOT COMPLETED|Washout||0
2607892|NCT00140244|6403147|P2|COMPLETED|Washout||4
2607893|NCT00140244|6403148|P1|COMPLETED|Washout||3
2607894|NCT00140244|6403147|P2|STARTED|Washout||4
2607895|NCT00140244|6403148|P1|STARTED|Washout||3
2607896|NCT00140244|6403147|P2|NOT COMPLETED|Intervention 1||0
2607897|NCT00140244|6403148|P1|NOT COMPLETED|Intervention 1||0
2607898|NCT00140244|6403147|P2|COMPLETED|Intervention 1||4
2607899|NCT00140244|6403148|P1|COMPLETED|Intervention 1||3
2607900|NCT00140244|6403147|P2|STARTED|Intervention 1||4
2607901|NCT00140244|6403148|P1|STARTED|Intervention 1||3
2607902|NCT00140231|6403180|P2|NOT COMPLETED|Fasting State With Leptin and Crossover||0
2607903|NCT00140231|6403181|P1|NOT COMPLETED|Fasting State With Leptin and Crossover||0
2607904|NCT00140231|6403180|P2|COMPLETED|Fasting State With Leptin and Crossover||6
2607905|NCT00140231|6403181|P1|COMPLETED|Fasting State With Leptin and Crossover||7
2607906|NCT00140231|6403180|P2|STARTED|Fasting State With Leptin and Crossover||6
2607907|NCT00140231|6403181|P1|STARTED|Fasting State With Leptin and Crossover||7
2607908|NCT00140231|6403180|P2|NOT COMPLETED|Washout 8 Weeks||0
2607909|NCT00140231|6403181|P1|NOT COMPLETED|Washout 8 Weeks||0
2607910|NCT00140231|6403180|P2|COMPLETED|Washout 8 Weeks||6
2607911|NCT00140231|6403181|P1|COMPLETED|Washout 8 Weeks||7
2607912|NCT00140231|6403180|P2|STARTED|Washout 8 Weeks||6
2607913|NCT00140231|6403181|P1|STARTED|Washout 8 Weeks||7
2607914|NCT00140231|6403180|P2|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
2607915|NCT00140231|6403181|P1|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
2607916|NCT00140231|6403180|P2|COMPLETED|First Fasting State 3 Days With Placebo||6
2607917|NCT00140231|6403181|P1|COMPLETED|First Fasting State 3 Days With Placebo||7
2607918|NCT00140231|6403180|P2|STARTED|First Fasting State 3 Days With Placebo||6
2607919|NCT00140231|6403181|P1|STARTED|First Fasting State 3 Days With Placebo||7
2607920|NCT00140231|6403180|P2|NOT COMPLETED|Washout 8weeks||0
2607921|NCT00140231|6403181|P1|NOT COMPLETED|Washout 8weeks||0
2607922|NCT00140231|6403180|P2|COMPLETED|Washout 8weeks||6
2607923|NCT00140231|6403181|P1|COMPLETED|Washout 8weeks||7
2607924|NCT00140231|6403180|P2|STARTED|Washout 8weeks||6
2607925|NCT00140231|6403181|P1|STARTED|Washout 8weeks||7
2607926|NCT00140231|6403180|P2|NOT COMPLETED|Fed State 1 Day- day5||0
2607927|NCT00140231|6403181|P1|NOT COMPLETED|Fed State 1 Day- day5||0
2607928|NCT00140231|6403180|P2|COMPLETED|Fed State 1 Day- day5||6
2607929|NCT00140231|6403181|P1|COMPLETED|Fed State 1 Day- day5||7
2607930|NCT00140231|6403180|P2|STARTED|Fed State 1 Day- day5||6
2607931|NCT00140231|6403181|P1|STARTED|Fed State 1 Day- day5||7
2607932|NCT00140205|6403200|P3|NOT COMPLETED|Overall Study||0
2607933|NCT00140205|6403201|P2|NOT COMPLETED|Overall Study||0
2607934|NCT00140205|6403202|P1|NOT COMPLETED|Overall Study||0
2607935|NCT00140205|6403200|P3|COMPLETED|Overall Study||5
2607936|NCT00140205|6403201|P2|COMPLETED|Overall Study||5
2607937|NCT00140205|6403202|P1|COMPLETED|Overall Study||5
2607938|NCT00140205|6403200|P3|STARTED|Overall Study||5
2607939|NCT00140205|6403201|P2|STARTED|Overall Study||5
2607940|NCT00140205|6403202|P1|STARTED|Overall Study||5
2607941|NCT00140140|6403271|P3|NOT COMPLETED|Overall Study||2
2607942|NCT00140140|6403272|P2|NOT COMPLETED|Overall Study||2
2607943|NCT00140140|6403273|P1|NOT COMPLETED|Overall Study||2
2607944|NCT00140140|6403271|P3|COMPLETED|Overall Study|Progressive disease|4
2607945|NCT00140140|6403272|P2|COMPLETED|Overall Study|Progressive disease|4
2607946|NCT00140140|6403273|P1|COMPLETED|Overall Study|Progressive disease|2
2607947|NCT00140140|6403271|P3|STARTED|Overall Study||6
2607948|NCT00140140|6403272|P2|STARTED|Overall Study||6
2607949|NCT00140140|6403273|P1|STARTED|Overall Study||4
2607950|NCT00139997|6403312|P2|NOT COMPLETED|Overall Study||2
2607951|NCT00139997|6403313|P1|NOT COMPLETED|Overall Study||1
2607952|NCT00139997|6403312|P2|COMPLETED|Overall Study||9
2607953|NCT00139997|6403313|P1|COMPLETED|Overall Study||14
2607954|NCT00139997|6403312|P2|STARTED|Overall Study||11
2607955|NCT00139997|6403313|P1|STARTED|Overall Study||15
2607956|NCT00139776|6403323|P4|NOT COMPLETED|Period III||106
2607957|NCT00139776|6403324|P3|NOT COMPLETED|Period III||76
2607958|NCT00139776|6403325|P2|NOT COMPLETED|Period III||0
2607959|NCT00139776|6403326|P1|NOT COMPLETED|Period III||0
2607960|NCT00139776|6403323|P4|COMPLETED|Period III||321
2607961|NCT00139776|6403324|P3|COMPLETED|Period III||355
2607962|NCT00139776|6403325|P2|COMPLETED|Period III||0
2607963|NCT00139776|6403326|P1|COMPLETED|Period III||0
2607964|NCT00139776|6403323|P4|STARTED|Period III|Randomized 435: 8 participants not treated|427
2607965|NCT00139776|6403324|P3|STARTED|Period III|Randomized 440: 9 participants not treated|431
2607966|NCT00139776|6403325|P2|STARTED|Period III||0
2607967|NCT00139776|6403326|P1|STARTED|Period III||0
2607968|NCT00139776|6403323|P4|NOT COMPLETED|Period II||0
2607969|NCT00139776|6403324|P3|NOT COMPLETED|Period II||0
2607970|NCT00139776|6403325|P2|NOT COMPLETED|Period II||322
2607971|NCT00139776|6403326|P1|NOT COMPLETED|Period II||0
2607972|NCT00139776|6403323|P4|COMPLETED|Period II||0
2607973|NCT00139776|6403324|P3|COMPLETED|Period II||0
2607974|NCT00139776|6403325|P2|COMPLETED|Period II||875
2607975|NCT00139776|6403326|P1|COMPLETED|Period II||0
2607976|NCT00139776|6403323|P4|STARTED|Period II||0
2607977|NCT00139776|6403324|P3|STARTED|Period II||0
2607978|NCT00139776|6403325|P2|STARTED|Period II||1197
2607979|NCT00139776|6403326|P1|STARTED|Period II||0
2607980|NCT00139776|6403323|P4|NOT COMPLETED|Period I||0
2607981|NCT00139776|6403324|P3|NOT COMPLETED|Period I||0
2607982|NCT00139776|6403325|P2|NOT COMPLETED|Period I||0
2607983|NCT00139776|6403326|P1|NOT COMPLETED|Period I||575
2607984|NCT00139776|6403323|P4|COMPLETED|Period I||0
2607985|NCT00139776|6403324|P3|COMPLETED|Period I||0
2607986|NCT00139776|6403325|P2|COMPLETED|Period I||0
2607987|NCT00139776|6403326|P1|COMPLETED|Period I||1197
2607988|NCT00139776|6403323|P4|STARTED|Period I||0
2607989|NCT00139776|6403324|P3|STARTED|Period I||0
2607990|NCT00139776|6403325|P2|STARTED|Period I||0
2607991|NCT00139776|6403326|P1|STARTED|Period I||1772
2607992|NCT00139737|6403361|P1|NOT COMPLETED|Overall Study||341
2607993|NCT00139737|6403361|P1|COMPLETED|Overall Study||3
2607994|NCT00139737|6403361|P1|Received Treatment|Overall Study||331
2607995|NCT00139737|6403361|P1|STARTED|Overall Study||344
2607996|NCT00139659|6403367|P2|NOT COMPLETED|Overall Study||18
2607997|NCT00139659|6403368|P1|NOT COMPLETED|Overall Study||40
2607998|NCT00139659|6403367|P2|COMPLETED|Overall Study||123
2607999|NCT00139659|6403368|P1|COMPLETED|Overall Study||106
2608000|NCT00139659|6403367|P2|STARTED|Overall Study|1 subject randomized DC'd before receiving subcutaneous insulin and is not included in # of subjects|141
2608001|NCT00139659|6403368|P1|STARTED|Overall Study|1 subject randomized was DC'd prior to receiving inhaled insulin but received subcutaneous insulin|146
2608002|NCT00139477|6403446|P2|NOT COMPLETED|Second Intervention -6Months to 12Months||5
2608003|NCT00139477|6403447|P1|NOT COMPLETED|Second Intervention -6Months to 12Months||5
2608004|NCT00139477|6403446|P2|COMPLETED|Second Intervention -6Months to 12Months||18
2608005|NCT00139477|6403447|P1|COMPLETED|Second Intervention -6Months to 12Months||14
2608006|NCT00139477|6403446|P2|STARTED|Second Intervention -6Months to 12Months||23
2608007|NCT00139477|6403447|P1|STARTED|Second Intervention -6Months to 12Months||19
2608008|NCT00139477|6403446|P2|NOT COMPLETED|First Intervention -Baseline to 6Months||12
2608009|NCT00139477|6403447|P1|NOT COMPLETED|First Intervention -Baseline to 6Months||12
2608010|NCT00139477|6403446|P2|COMPLETED|First Intervention -Baseline to 6Months||23
2608011|NCT00139477|6403447|P1|COMPLETED|First Intervention -Baseline to 6Months||19
2608012|NCT00139477|6403446|P2|STARTED|First Intervention -Baseline to 6Months||35
2608013|NCT00139477|6403447|P1|STARTED|First Intervention -Baseline to 6Months||31
2608014|NCT00139399|6403469|P2|NOT COMPLETED|Overall Study||23
2608015|NCT00139399|6403470|P1|NOT COMPLETED|Overall Study||16
2608016|NCT00139399|6403469|P2|COMPLETED|Overall Study||59
2608017|NCT00139399|6403470|P1|COMPLETED|Overall Study||44
2608018|NCT00139399|6403469|P2|STARTED|Overall Study||82
2608019|NCT00139399|6403470|P1|STARTED|Overall Study||60
2608020|NCT00138671|6403482|P2|NOT COMPLETED|Overall Study||16
2608021|NCT00138671|6403483|P1|NOT COMPLETED|Overall Study||13
2608022|NCT00138671|6403482|P2|COMPLETED|Overall Study||30
2608023|NCT00138671|6403483|P1|COMPLETED|Overall Study||46
2608024|NCT00138671|6403482|P2|STARTED|Overall Study||46
2608025|NCT00138671|6403483|P1|STARTED|Overall Study||59
2608026|NCT00138658|6403533|P1|NOT COMPLETED|Overall Study||61
2608027|NCT00138658|6403533|P1|COMPLETED|Overall Study||20
2608028|NCT00138658|6403533|P1|STARTED|Overall Study||81
2608029|NCT00138645|6403545|P2|NOT COMPLETED|Overall Study||7
2608030|NCT00138645|6403546|P1|NOT COMPLETED|Overall Study||6
2608031|NCT00138645|6403545|P2|COMPLETED|Overall Study||23
2608032|NCT00138645|6403546|P1|COMPLETED|Overall Study||24
2608033|NCT00138645|6403545|P2|STARTED|Overall Study||30
2608034|NCT00138645|6403546|P1|STARTED|Overall Study||30
2608035|NCT00138424|6403556|P4|NOT COMPLETED|Overall Study||0
2608036|NCT00138424|6403557|P3|NOT COMPLETED|Overall Study||0
2608037|NCT00138424|6403558|P2|NOT COMPLETED|Overall Study||1
2608038|NCT00138424|6403559|P1|NOT COMPLETED|Overall Study||0
2608039|NCT00138424|6403556|P4|COMPLETED|Overall Study||3
2608040|NCT00138424|6403557|P3|COMPLETED|Overall Study||5
2608041|NCT00138424|6403558|P2|COMPLETED|Overall Study||4
2608042|NCT00138424|6403559|P1|COMPLETED|Overall Study||9
2608043|NCT00138424|6403556|P4|STARTED|Overall Study||3
2608044|NCT00138424|6403557|P3|STARTED|Overall Study||5
2608045|NCT00138424|6403558|P2|STARTED|Overall Study||5
2608046|NCT00138424|6403559|P1|STARTED|Overall Study||9
2608047|NCT00138294|6403625|P1|NOT COMPLETED|Overall Study||0
2608048|NCT00138294|6403625|P1|COMPLETED|Overall Study||29255
2608049|NCT00138294|6403625|P1|STARTED|Overall Study||29255
2608050|NCT00138203|6403635|P1|NOT COMPLETED|Overall Study||0
2608051|NCT00138203|6403635|P1|COMPLETED|Overall Study||16
2608052|NCT00138203|6403635|P1|STARTED|Overall Study||16
2608053|NCT00138151|6403642|P1|NOT COMPLETED|Overall Study||4
2608054|NCT00138151|6403642|P1|COMPLETED|Overall Study||29
2608055|NCT00138151|6403642|P1|STARTED|Overall Study||33
2608056|NCT00138125|6403648|P1|NOT COMPLETED|Overall Study||0
2608057|NCT00138125|6403648|P1|COMPLETED|Overall Study||2
2608058|NCT00138125|6403648|P1|STARTED|Overall Study||2
2608059|NCT00138073|6403652|P1|NOT COMPLETED|Overall Study||55
2608060|NCT00138073|6403652|P1|COMPLETED|Overall Study||0
2608061|NCT00138073|6403652|P1|Pre-intervention Testing|Overall Study||55
2608062|NCT00138073|6403652|P1|STARTED|Overall Study||55
2608063|NCT00138034|6403659|P2|NOT COMPLETED|Overall Study||3
2608064|NCT00138034|6403660|P1|NOT COMPLETED|Overall Study||3
2608065|NCT00138034|6403659|P2|COMPLETED|Overall Study||20
2608066|NCT00138034|6403660|P1|COMPLETED|Overall Study||23
2608067|NCT00138034|6403659|P2|STARTED|Overall Study||23
2608068|NCT00138034|6403660|P1|STARTED|Overall Study||26
2608069|NCT00137969|6403670|P2|NOT COMPLETED|Overall Study||21
2608070|NCT00137969|6403671|P1|NOT COMPLETED|Overall Study||67
2608071|NCT00137969|6403670|P2|COMPLETED|Overall Study||67
2608072|NCT00137969|6403671|P1|COMPLETED|Overall Study||107
2608073|NCT00137969|6403670|P2|Received Study Drug|Overall Study||88
2608074|NCT00137969|6403671|P1|Received Study Drug|Overall Study||169
2608075|NCT00137969|6403670|P2|STARTED|Overall Study||88
2608076|NCT00137969|6403671|P1|STARTED|Overall Study||174
2608077|NCT00137839|6403691|P1|NOT COMPLETED|Overall Study||84
2608078|NCT00137839|6403691|P1|COMPLETED|Overall Study|Data on Reason Not Completed reflects Reason Off-Study|0
2608079|NCT00137839|6403691|P1|Treated|Overall Study||83
2608080|NCT00137839|6403691|P1|STARTED|Overall Study||84
2608081|NCT00137631|6403704|P2|NOT COMPLETED|Overall Study||41
2608082|NCT00137631|6403705|P1|NOT COMPLETED|Overall Study||37
2608083|NCT00137631|6403704|P2|COMPLETED|Overall Study||133
2608084|NCT00137631|6403705|P1|COMPLETED|Overall Study||127
2608085|NCT00137631|6403704|P2|Completed 6-month Follow-up|Overall Study|8 participants who were lost to follow-up at 3-months were retained at 6-months|133
2608086|NCT00137631|6403705|P1|Completed 6-month Follow-up|Overall Study|7 participants who were lost to follow-up at 3-months were retained at 6-months|127
2608087|NCT00137631|6403704|P2|Complete 3-month Follow-up|Overall Study||125
2608088|NCT00137631|6403705|P1|Complete 3-month Follow-up|Overall Study||120
2608089|NCT00137631|6403704|P2|STARTED|Overall Study||174
2608090|NCT00137631|6403705|P1|STARTED|Overall Study||164
2608091|NCT00137449|6403721|P2|NOT COMPLETED|Overall Study||18
2608092|NCT00137449|6403722|P1|NOT COMPLETED|Overall Study||16
2608093|NCT00137449|6403721|P2|COMPLETED|Overall Study||12
2608094|NCT00137449|6403722|P1|COMPLETED|Overall Study||14
2608095|NCT00137449|6403721|P2|STARTED|Overall Study||30
2608096|NCT00137449|6403722|P1|STARTED|Overall Study||30
2608097|NCT00137436|6403759|P1|NOT COMPLETED|Overall Study||43
2608098|NCT00137436|6403759|P1|COMPLETED|Overall Study||12
2608099|NCT00137436|6403759|P1|STARTED|Overall Study|Phase 2 did not include 38 participants from Phase 1.|55
2608100|NCT00137423|6403778|P2|NOT COMPLETED|Overall Study||44
2608101|NCT00137423|6403779|P1|NOT COMPLETED|Overall Study||39
2608102|NCT00137423|6403778|P2|COMPLETED|Overall Study||9
2608103|NCT00137423|6403779|P1|COMPLETED|Overall Study||15
2608104|NCT00137423|6403778|P2|STARTED|Overall Study||53
2608105|NCT00137423|6403779|P1|STARTED|Overall Study||54
2608106|NCT00137280|6403801|P2|NOT COMPLETED|Overall Study||55
2608107|NCT00137280|6403802|P1|NOT COMPLETED|Overall Study||84
2608108|NCT00137280|6403801|P2|COMPLETED|Overall Study||357
2608109|NCT00137280|6403802|P1|COMPLETED|Overall Study||305
2608110|NCT00137280|6403801|P2|STARTED|Overall Study||412
2608111|NCT00137280|6403802|P1|STARTED|Overall Study||389
2608112|NCT00137267|6403816|P2|NOT COMPLETED|Overall Study||21
2608113|NCT00137267|6403817|P1|NOT COMPLETED|Overall Study||15
2608114|NCT00137267|6403816|P2|COMPLETED|Overall Study||26
2608115|NCT00137267|6403817|P1|COMPLETED|Overall Study||40
2608116|NCT00137267|6403816|P2|STARTED|Overall Study||47
2608117|NCT00137267|6403817|P1|STARTED|Overall Study||55
2608118|NCT00137111|6403829|P4|NOT COMPLETED|Total Therapy||0
2608119|NCT00137111|6403830|P3|NOT COMPLETED|Total Therapy||0
2608120|NCT00137111|6403831|P2|NOT COMPLETED|Total Therapy||0
2608121|NCT00137111|6403832|P1|NOT COMPLETED|Total Therapy||40
2608122|NCT00137111|6403829|P4|COMPLETED|Total Therapy||0
2608123|NCT00137111|6403830|P3|COMPLETED|Total Therapy||0
2608124|NCT00137111|6403831|P2|COMPLETED|Total Therapy||0
2608125|NCT00137111|6403832|P1|COMPLETED|Total Therapy||458
2608126|NCT00137111|6403829|P4|STARTED|Total Therapy||0
2608127|NCT00137111|6403830|P3|STARTED|Total Therapy||0
2608128|NCT00137111|6403831|P2|STARTED|Total Therapy||0
2608129|NCT00137111|6403832|P1|STARTED|Total Therapy||498
2608130|NCT00137111|6403829|P4|NOT COMPLETED|Window Therapy||0
2608131|NCT00137111|6403830|P3|NOT COMPLETED|Window Therapy||0
2608132|NCT00137111|6403831|P2|NOT COMPLETED|Window Therapy||0
2608133|NCT00137111|6403832|P1|NOT COMPLETED|Window Therapy||0
2608134|NCT00137111|6403829|P4|COMPLETED|Window Therapy||142
2608135|NCT00137111|6403830|P3|COMPLETED|Window Therapy||180
2608136|NCT00137111|6403831|P2|COMPLETED|Window Therapy||176
2608137|NCT00137111|6403832|P1|COMPLETED|Window Therapy||0
2608138|NCT00137111|6403829|P4|STARTED|Window Therapy||142
2608139|NCT00137111|6403830|P3|STARTED|Window Therapy||180
2608140|NCT00137111|6403831|P2|STARTED|Window Therapy||176
2608141|NCT00137111|6403832|P1|STARTED|Window Therapy||0
2608142|NCT00137046|6403846|P2|NOT COMPLETED|Overall Study||93
2608143|NCT00137046|6403847|P1|NOT COMPLETED|Overall Study||99
2608144|NCT00137046|6403846|P2|COMPLETED|Overall Study||198
2608145|NCT00137046|6403847|P1|COMPLETED|Overall Study|Completed subjects were those subjects who did not discontinue while on active drug.|192
2608146|NCT00137046|6403846|P2|Received Study Treatment|Overall Study||290
2608147|NCT00137046|6403847|P1|Received Study Treatment|Overall Study||290
2608148|NCT00137046|6403846|P2|STARTED|Overall Study|One subject was randomized to subcutaneous insulin but never received treatment.|291
2608149|NCT00137046|6403847|P1|STARTED|Overall Study|One subject was randomized to inhaled insulin but never received treatment.|291
2608150|NCT00136955|6403895|P1|NOT COMPLETED|Overall Study||23
2608151|NCT00136955|6403895|P1|COMPLETED|Overall Study||18
2608152|NCT00136955|6403895|P1|STARTED|Overall Study||41
2608153|NCT00136916|6403904|P2|NOT COMPLETED|Overall Study||104
2608154|NCT00136916|6403905|P1|NOT COMPLETED|Overall Study||125
2608155|NCT00136916|6403904|P2|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|212
2608156|NCT00136916|6403905|P1|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|194
2608157|NCT00136916|6403904|P2|Received Treatment|Overall Study||311
2608158|NCT00136916|6403905|P1|Received Treatment|Overall Study||316
2608159|NCT00136916|6403904|P2|STARTED|Overall Study||316
2608160|NCT00136916|6403905|P1|STARTED|Overall Study||319
2608161|NCT00136838|6403959|P2|NOT COMPLETED|Second Intervention ( 5 Days)||0
2608162|NCT00136838|6403960|P1|NOT COMPLETED|Second Intervention ( 5 Days)||0
2608163|NCT00136838|6403959|P2|COMPLETED|Second Intervention ( 5 Days)||6
2608164|NCT00136838|6403960|P1|COMPLETED|Second Intervention ( 5 Days)||6
2608165|NCT00136838|6403959|P2|STARTED|Second Intervention ( 5 Days)||6
2608166|NCT00136838|6403960|P1|STARTED|Second Intervention ( 5 Days)||6
2608167|NCT00136838|6403959|P2|NOT COMPLETED|First Intervention ( 5 Days)||0
2608168|NCT00136838|6403960|P1|NOT COMPLETED|First Intervention ( 5 Days)||0
2608169|NCT00136838|6403959|P2|COMPLETED|First Intervention ( 5 Days)||6
2608170|NCT00136838|6403960|P1|COMPLETED|First Intervention ( 5 Days)||6
2608171|NCT00136838|6403959|P2|STARTED|First Intervention ( 5 Days)||6
2608172|NCT00136838|6403960|P1|STARTED|First Intervention ( 5 Days)||6
2608173|NCT00136812|6403970|P2|NOT COMPLETED|Overall Study||0
2608174|NCT00136812|6403971|P1|NOT COMPLETED|Overall Study||0
2608175|NCT00136812|6403970|P2|COMPLETED|Overall Study||113
2608176|NCT00136812|6403971|P1|COMPLETED|Overall Study||111
2608177|NCT00136812|6403970|P2|STARTED|Overall Study||113
2608178|NCT00136812|6403971|P1|STARTED|Overall Study||111
2608179|NCT00136760|6403981|P4|NOT COMPLETED|Overall Study||0
2608180|NCT00136760|6403982|P3|NOT COMPLETED|Overall Study||0
2608181|NCT00136760|6403983|P2|NOT COMPLETED|Overall Study||0
2608182|NCT00136760|6403984|P1|NOT COMPLETED|Overall Study||0
2608183|NCT00136760|6403981|P4|COMPLETED|Overall Study||13
2608184|NCT00136760|6403982|P3|COMPLETED|Overall Study||11
2608185|NCT00136760|6403983|P2|COMPLETED|Overall Study||16
2608186|NCT00136760|6403984|P1|COMPLETED|Overall Study||12
2608187|NCT00136760|6403981|P4|STARTED|Overall Study||13
2608188|NCT00136760|6403982|P3|STARTED|Overall Study||11
2608189|NCT00136760|6403983|P2|STARTED|Overall Study||16
2608190|NCT00136760|6403984|P1|STARTED|Overall Study||12
2608191|NCT00136695|6404000|P2|NOT COMPLETED|Overall Study||8
2608192|NCT00136695|6404001|P1|NOT COMPLETED|Overall Study||11
2608193|NCT00136695|6404000|P2|COMPLETED|Overall Study||35
2608194|NCT00136695|6404001|P1|COMPLETED|Overall Study||34
2608195|NCT00136695|6404000|P2|STARTED|Overall Study||43
2608196|NCT00136695|6404001|P1|STARTED|Overall Study||45
2608212|NCT00136357|6404124|P2|NOT COMPLETED|Overall Study||2
2608213|NCT00136357|6404125|P1|NOT COMPLETED|Overall Study||3
2608214|NCT00136357|6404124|P2|COMPLETED|Overall Study||39
2608215|NCT00136357|6404125|P1|COMPLETED|Overall Study||38
2608216|NCT00136357|6404124|P2|STARTED|Overall Study||41
2608217|NCT00136357|6404125|P1|STARTED|Overall Study||41
2608218|NCT00136318|6404133|P2|NOT COMPLETED|Overall Study||7
2608219|NCT00136318|6404134|P1|NOT COMPLETED|Overall Study||7
2608220|NCT00136318|6404133|P2|COMPLETED|Overall Study||84
2608221|NCT00136318|6404134|P1|COMPLETED|Overall Study|reached end-point of antiviral treatment|83
2608222|NCT00136318|6404133|P2|STARTED|Overall Study|Took first dose of study medication|91
2608223|NCT00136318|6404134|P1|STARTED|Overall Study|Took first dose of study medication|90
2608224|NCT00136214|6404150|P2|NOT COMPLETED|Overall Study||0
2608225|NCT00136214|6404151|P1|NOT COMPLETED|Overall Study||0
2608226|NCT00136214|6404150|P2|COMPLETED|Overall Study||7
2608227|NCT00136214|6404151|P1|COMPLETED|Overall Study||15
2608228|NCT00136214|6404150|P2|STARTED|Overall Study||7
2608229|NCT00136214|6404151|P1|STARTED|Overall Study||15
2608230|NCT00136084|6404161|P2|NOT COMPLETED|Overall Study||42
2608231|NCT00136084|6404162|P1|NOT COMPLETED|Overall Study||48
2608232|NCT00136084|6404161|P2|COMPLETED|Overall Study||72
2608233|NCT00136084|6404162|P1|COMPLETED|Overall Study||61
2608234|NCT00136084|6404161|P2|STARTED|Overall Study||114
2608235|NCT00136084|6404162|P1|STARTED|Overall Study||109
2608236|NCT00135798|6404178|P3|NOT COMPLETED|Overall Study||0
2608237|NCT00135798|6404179|P2|NOT COMPLETED|Overall Study||0
2608238|NCT00135798|6404180|P1|NOT COMPLETED|Overall Study||0
2608239|NCT00135798|6404178|P3|COMPLETED|Overall Study||32
2608240|NCT00135798|6404179|P2|COMPLETED|Overall Study||31
2608241|NCT00135798|6404180|P1|COMPLETED|Overall Study||16
2608242|NCT00135798|6404178|P3|STARTED|Overall Study||32
2608243|NCT00135798|6404179|P2|STARTED|Overall Study||31
2608244|NCT00135798|6404180|P1|STARTED|Overall Study||16
2608245|NCT00135707|6404198|P2|NOT COMPLETED|Overall Study||90
2608246|NCT00135707|6404199|P1|NOT COMPLETED|Overall Study||95
2608247|NCT00135707|6404198|P2|COMPLETED|Overall Study||4976
2608248|NCT00135707|6404199|P1|COMPLETED|Overall Study||4993
2608249|NCT00135707|6404198|P2|STARTED|Overall Study||5066
2608250|NCT00135707|6404199|P1|STARTED|Overall Study||5088
2608251|NCT00135694|6404282|P3|NOT COMPLETED|Overall Study||7
2608252|NCT00135694|6404283|P2|NOT COMPLETED|Overall Study||21
2608253|NCT00135694|6404284|P1|NOT COMPLETED|Overall Study||180
2608254|NCT00135694|6404282|P3|COMPLETED|Overall Study||11
2608255|NCT00135694|6404283|P2|COMPLETED|Overall Study||56
2608256|NCT00135694|6404284|P1|COMPLETED|Overall Study|Subjects were assessed as ineligible for random assignment and subsequently terminated per protocol.|0
2608257|NCT00135694|6404282|P3|STARTED|Overall Study||18
2608258|NCT00135694|6404283|P2|STARTED|Overall Study||77
2608259|NCT00135694|6404284|P1|STARTED|Overall Study||180
2608260|NCT00135512|6404302|P1|NOT COMPLETED|Overall Study||123
2608261|NCT00135512|6404302|P1|COMPLETED|Overall Study||111
2608262|NCT00135512|6404302|P1|STARTED|Overall Study||234
2608263|NCT00135356|6404314|P2|NOT COMPLETED|Overall Study||9
2608264|NCT00135356|6404315|P1|NOT COMPLETED|Overall Study||17
2608265|NCT00135356|6404314|P2|COMPLETED|Overall Study||60
2608266|NCT00135356|6404315|P1|COMPLETED|Overall Study||114
2608267|NCT00135356|6404314|P2|Discontinued on or After Week 96 Visit|Overall Study||0
2608268|NCT00135356|6404315|P1|Discontinued on or After Week 96 Visit|Overall Study||1
2608269|NCT00135356|6404314|P2|Discontinued Prior to Week 96 Visit|Overall Study||9
2608270|NCT00135356|6404315|P1|Discontinued Prior to Week 96 Visit|Overall Study||16
2608271|NCT00135356|6404314|P2|STARTED|Overall Study|Number randomized and treated(1 randomized and never treated subject not included in this number.)|69
2608272|NCT00135356|6404315|P1|STARTED|Overall Study|Number randomized and treated|131
2608273|NCT00135330|6404358|P3|NOT COMPLETED|Overall Study||11
2608274|NCT00135330|6404359|P2|NOT COMPLETED|Overall Study||13
2608275|NCT00135330|6404360|P1|NOT COMPLETED|Overall Study||12
2608276|NCT00135330|6404358|P3|COMPLETED|Overall Study||34
2608277|NCT00135330|6404359|P2|COMPLETED|Overall Study||34
2608278|NCT00135330|6404360|P1|COMPLETED|Overall Study||33
2608279|NCT00135330|6404358|P3|STARTED|Overall Study||45
2608280|NCT00135330|6404359|P2|STARTED|Overall Study||47
2608281|NCT00135330|6404360|P1|STARTED|Overall Study||45
2608282|NCT00135226|6404456|P4|NOT COMPLETED|Overall Study||36
2608283|NCT00135226|6404457|P3|NOT COMPLETED|Overall Study||34
2608284|NCT00135226|6404458|P2|NOT COMPLETED|Overall Study||35
2608285|NCT00135226|6404459|P1|NOT COMPLETED|Overall Study||34
2608286|NCT00135226|6404456|P4|COMPLETED|Overall Study||3834
2608287|NCT00135226|6404457|P3|COMPLETED|Overall Study||3836
2608288|NCT00135226|6404458|P2|COMPLETED|Overall Study||3835
2608289|NCT00135226|6404459|P1|COMPLETED|Overall Study||3836
2608290|NCT00135226|6404456|P4|STARTED|Overall Study||3870
2608291|NCT00135226|6404457|P3|STARTED|Overall Study||3870
2608292|NCT00135226|6404458|P2|STARTED|Overall Study||3870
2608293|NCT00135226|6404459|P1|STARTED|Overall Study||3870
2608294|NCT00135200|6404551|P1|NOT COMPLETED|Overall Study||0
2608295|NCT00135200|6404551|P1|COMPLETED|Overall Study||16
2608296|NCT00135200|6404551|P1|STARTED|Overall Study||16
2608297|NCT00134901|6404558|P2|NOT COMPLETED|Overall Study||15
2608298|NCT00134901|6404559|P1|NOT COMPLETED|Overall Study||17
2608299|NCT00134901|6404558|P2|COMPLETED|Overall Study||27
2608300|NCT00134901|6404559|P1|COMPLETED|Overall Study||22
2608301|NCT00134901|6404558|P2|STARTED|Overall Study||42
2608302|NCT00134901|6404559|P1|STARTED|Overall Study||39
2608303|NCT00134784|6404571|P4|NOT COMPLETED|Overall Study||1
2608304|NCT00134784|6404572|P3|NOT COMPLETED|Overall Study||2
2608305|NCT00134784|6404573|P2|NOT COMPLETED|Overall Study||2
2608306|NCT00134784|6404574|P1|NOT COMPLETED|Overall Study||2
2608307|NCT00134784|6404571|P4|COMPLETED|Overall Study||37
2608308|NCT00134784|6404572|P3|COMPLETED|Overall Study||35
2608309|NCT00134784|6404573|P2|COMPLETED|Overall Study||36
2608310|NCT00134784|6404574|P1|COMPLETED|Overall Study||27
2608311|NCT00134784|6404571|P4|STARTED|Overall Study||38
2608312|NCT00134784|6404572|P3|STARTED|Overall Study||37
2608313|NCT00134784|6404573|P2|STARTED|Overall Study||38
2608314|NCT00134784|6404574|P1|STARTED|Overall Study||29
2608315|NCT00134719|6404584|P3|NOT COMPLETED|Fourth Dose Vaccination Phase||1
2608316|NCT00134719|6404585|P2|NOT COMPLETED|Fourth Dose Vaccination Phase||3
2608317|NCT00134719|6404586|P1|NOT COMPLETED|Fourth Dose Vaccination Phase||2
2608318|NCT00134719|6404584|P3|COMPLETED|Fourth Dose Vaccination Phase||203
2608319|NCT00134719|6404585|P2|COMPLETED|Fourth Dose Vaccination Phase||203
2608320|NCT00134719|6404586|P1|COMPLETED|Fourth Dose Vaccination Phase||623
2608321|NCT00134719|6404584|P3|STARTED|Fourth Dose Vaccination Phase||204
2608322|NCT00134719|6404585|P2|STARTED|Fourth Dose Vaccination Phase||206
2608323|NCT00134719|6404586|P1|STARTED|Fourth Dose Vaccination Phase||625
2608324|NCT00134719|6404584|P3|NOT COMPLETED|Primary Vaccination Phase||5
2608325|NCT00134719|6404585|P2|NOT COMPLETED|Primary Vaccination Phase||6
2608326|NCT00134719|6404586|P1|NOT COMPLETED|Primary Vaccination Phase||14
2608327|NCT00134719|6404584|P3|COMPLETED|Primary Vaccination Phase||216
2608328|NCT00134719|6404585|P2|COMPLETED|Primary Vaccination Phase||215
2608329|NCT00134719|6404586|P1|COMPLETED|Primary Vaccination Phase||647
2608330|NCT00134719|6404584|P3|STARTED|Primary Vaccination Phase||221
2608331|NCT00134719|6404585|P2|STARTED|Primary Vaccination Phase||221
2608332|NCT00134719|6404586|P1|STARTED|Primary Vaccination Phase||661
2608333|NCT00134563|6404717|P3|NOT COMPLETED|Overall Study||96
2608334|NCT00134563|6404718|P2|NOT COMPLETED|Overall Study||92
2608335|NCT00134563|6404719|P1|NOT COMPLETED|Overall Study||104
2608336|NCT00134563|6404717|P3|COMPLETED|Overall Study|completed treatment period|263
2608337|NCT00134563|6404718|P2|COMPLETED|Overall Study|completed treatment period|274
2608338|NCT00134563|6404719|P1|COMPLETED|Overall Study|completed treatment period|259
2608339|NCT00134563|6404717|P3|Treated|Overall Study|one participant received doses of Teriflunomide 7 mg|358
2608340|NCT00134563|6404718|P2|Treated|Overall Study||365
2608341|NCT00134563|6404719|P1|Treated|Overall Study|Two participants received doses of Teriflunomide 7 mg, one participant doses of Teriflunomide 14 mg|363
2608342|NCT00134563|6404717|P3|STARTED|Overall Study|Randomized|359
2608343|NCT00134563|6404718|P2|STARTED|Overall Study|Randomized|366
2608344|NCT00134563|6404719|P1|STARTED|Overall Study|Randomized|363
2608345|NCT00134381|6404742|P6|NOT COMPLETED|Overall Study||2
2608346|NCT00134381|6404743|P5|NOT COMPLETED|Overall Study||0
2608347|NCT00134381|6404744|P4|NOT COMPLETED|Overall Study||0
2608348|NCT00134381|6404745|P3|NOT COMPLETED|Overall Study||0
2608349|NCT00134381|6404746|P2|NOT COMPLETED|Overall Study||0
2608350|NCT00134381|6404747|P1|NOT COMPLETED|Overall Study||0
2608351|NCT00134381|6404742|P6|COMPLETED|Overall Study||29
2608352|NCT00134381|6404743|P5|COMPLETED|Overall Study||31
2608353|NCT00134381|6404744|P4|COMPLETED|Overall Study||2
2608354|NCT00134381|6404745|P3|COMPLETED|Overall Study||1
2608355|NCT00134381|6404746|P2|COMPLETED|Overall Study||2
2608356|NCT00134381|6404747|P1|COMPLETED|Overall Study||1
2608357|NCT00134381|6404742|P6|STARTED|Overall Study||31
2608358|NCT00134381|6404743|P5|STARTED|Overall Study||31
2608359|NCT00134381|6404744|P4|STARTED|Overall Study||2
2608360|NCT00134381|6404745|P3|STARTED|Overall Study||1
2608361|NCT00134381|6404746|P2|STARTED|Overall Study||2
2608362|NCT00134381|6404747|P1|STARTED|Overall Study||1
2608363|NCT00134082|6404780|P1|NOT COMPLETED|Overall Study||3
2608364|NCT00134082|6404780|P1|COMPLETED|Overall Study||27
2608365|NCT00134082|6404780|P1|STARTED|Overall Study||30
2608366|NCT00134056|6404789|P2|NOT COMPLETED|Eligible for Protocol Assigned Treatment||315
2608367|NCT00134056|6404790|P1|NOT COMPLETED|Eligible for Protocol Assigned Treatment||327
2608368|NCT00134056|6404789|P2|COMPLETED|Eligible for Protocol Assigned Treatment||185
2608369|NCT00134056|6404790|P1|COMPLETED|Eligible for Protocol Assigned Treatment||169
2608370|NCT00134056|6404789|P2|STARTED|Eligible for Protocol Assigned Treatment||500
2608371|NCT00134056|6404790|P1|STARTED|Eligible for Protocol Assigned Treatment||496
2608372|NCT00134056|6404789|P2|NOT COMPLETED|Randomization||20
2608373|NCT00134056|6404790|P1|NOT COMPLETED|Randomization||22
2608374|NCT00134056|6404789|P2|COMPLETED|Randomization||500
2608375|NCT00134056|6404790|P1|COMPLETED|Randomization||496
2608376|NCT00134056|6404789|P2|STARTED|Randomization||520
2608377|NCT00134056|6404790|P1|STARTED|Randomization||518
2608378|NCT00134043|6404812|P2|NOT COMPLETED|Overall Study||0
2608379|NCT00134043|6404813|P1|NOT COMPLETED|Overall Study||0
2608380|NCT00134043|6404812|P2|COMPLETED|Overall Study||3
2608381|NCT00134043|6404813|P1|COMPLETED|Overall Study||16
2608382|NCT00134043|6404812|P2|STARTED|Overall Study||3
2608383|NCT00134043|6404813|P1|STARTED|Overall Study||16
2608384|NCT00134017|6404818|P1|NOT COMPLETED|Overall Study||0
2608385|NCT00134017|6404818|P1|COMPLETED|Overall Study||142
2608386|NCT00134017|6404818|P1|STARTED|Overall Study||142
2608387|NCT00134004|6404826|P1|NOT COMPLETED|Overall Study||0
2608388|NCT00134004|6404826|P1|COMPLETED|Overall Study||210
2608389|NCT00134004|6404826|P1|STARTED|Overall Study||210
2608390|NCT00133991|6404834|P1|NOT COMPLETED|Overall Study||4
2608391|NCT00133991|6404834|P1|COMPLETED|Overall Study||17
2608392|NCT00133991|6404834|P1|STARTED|Overall Study||21
2608393|NCT00133978|6404846|P4|NOT COMPLETED|Overall Study||2
2608394|NCT00133978|6404847|P3|NOT COMPLETED|Overall Study||0
2608395|NCT00133978|6404848|P2|NOT COMPLETED|Overall Study||1
2608396|NCT00133978|6404849|P1|NOT COMPLETED|Overall Study||2
2608397|NCT00133978|6404846|P4|COMPLETED|Overall Study||300
2608398|NCT00133978|6404847|P3|COMPLETED|Overall Study||310
2608399|NCT00133978|6404848|P2|COMPLETED|Overall Study||307
2608400|NCT00133978|6404849|P1|COMPLETED|Overall Study||301
2608401|NCT00133978|6404846|P4|STARTED|Overall Study||302
2608402|NCT00133978|6404847|P3|STARTED|Overall Study||310
2608403|NCT00133978|6404848|P2|STARTED|Overall Study||308
2608404|NCT00133978|6404849|P1|STARTED|Overall Study||303
2608405|NCT00133952|6404873|P2|NOT COMPLETED|Overall Study||28
2608406|NCT00133952|6404874|P1|NOT COMPLETED|Overall Study||42
2608407|NCT00133952|6404873|P2|COMPLETED|Overall Study||124
2608408|NCT00133952|6404874|P1|COMPLETED|Overall Study||115
2608409|NCT00133952|6404873|P2|Received at Least One Dose of Study Drug|Overall Study||149
2608410|NCT00133952|6404874|P1|Received at Least One Dose of Study Drug|Overall Study||153
2608411|NCT00133952|6404873|P2|STARTED|Overall Study||152
2608412|NCT00133952|6404874|P1|STARTED|Overall Study||157
2608413|NCT00133809|6404896|P1|NOT COMPLETED|Overall Study||0
2608414|NCT00133809|6404896|P1|COMPLETED|Overall Study||8
2608415|NCT00133809|6404896|P1|STARTED|Overall Study||8
2608416|NCT00133705|6404905|P2|NOT COMPLETED|Overall Study||3
2608417|NCT00133705|6404906|P1|NOT COMPLETED|Overall Study||2
2608418|NCT00133705|6404905|P2|COMPLETED|Overall Study||17
2608419|NCT00133705|6404906|P1|COMPLETED|Overall Study||20
2608420|NCT00133705|6404905|P2|STARTED|Overall Study||20
2608421|NCT00133705|6404906|P1|STARTED|Overall Study||22
2608422|NCT00133575|6404919|P7|NOT COMPLETED|Overall Study||3
2608423|NCT00133575|6404920|P6|NOT COMPLETED|Overall Study||1
2608424|NCT00133575|6404921|P5|NOT COMPLETED|Overall Study||4
2608425|NCT00133575|6404922|P4|NOT COMPLETED|Overall Study||1
2608426|NCT00133575|6404923|P3|NOT COMPLETED|Overall Study||2
2608427|NCT00133575|6404924|P2|NOT COMPLETED|Overall Study||0
2608428|NCT00133575|6404925|P1|NOT COMPLETED|Overall Study||0
2608429|NCT00133575|6404919|P7|COMPLETED|Overall Study||9
2608430|NCT00133575|6404920|P6|COMPLETED|Overall Study||9
2608431|NCT00133575|6404921|P5|COMPLETED|Overall Study||6
2608432|NCT00133575|6404922|P4|COMPLETED|Overall Study||9
2608433|NCT00133575|6404923|P3|COMPLETED|Overall Study||8
2608434|NCT00133575|6404924|P2|COMPLETED|Overall Study||10
2608435|NCT00133575|6404925|P1|COMPLETED|Overall Study||10
2608436|NCT00133575|6404919|P7|STARTED|Overall Study||12
2608437|NCT00133575|6404920|P6|STARTED|Overall Study||10
2608438|NCT00133575|6404921|P5|STARTED|Overall Study||10
2608439|NCT00133575|6404922|P4|STARTED|Overall Study||10
2608440|NCT00133575|6404923|P3|STARTED|Overall Study||10
2608441|NCT00133575|6404924|P2|STARTED|Overall Study||10
2608442|NCT00133575|6404925|P1|STARTED|Overall Study||10
2608443|NCT00132964|6405034|P2|NOT COMPLETED|Overall Study||3
2608444|NCT00132964|6405035|P1|NOT COMPLETED|Overall Study||4
2608445|NCT00132964|6405034|P2|COMPLETED|Overall Study||54
2608446|NCT00132964|6405035|P1|COMPLETED|Overall Study||50
2608447|NCT00132964|6405034|P2|STARTED|Overall Study||57
2608448|NCT00132964|6405035|P1|STARTED|Overall Study||54
2608449|NCT00132873|6405041|P1|NOT COMPLETED|Overall Study||9
2608450|NCT00132873|6405041|P1|COMPLETED|Overall Study||50
2608451|NCT00132873|6405041|P1|STARTED|Overall Study||59
2608452|NCT00132808|6405049|P3|NOT COMPLETED|Stratum II||9
2608453|NCT00132808|6405050|P2|NOT COMPLETED|Stratum II||15
2608454|NCT00132808|6405051|P1|NOT COMPLETED|Stratum II||8
2608455|NCT00132808|6405049|P3|COMPLETED|Stratum II||116
2608456|NCT00132808|6405050|P2|COMPLETED|Stratum II||96
2608457|NCT00132808|6405051|P1|COMPLETED|Stratum II||113
2608458|NCT00132808|6405049|P3|STARTED|Stratum II||125
2608459|NCT00132808|6405050|P2|STARTED|Stratum II||111
2608460|NCT00132808|6405051|P1|STARTED|Stratum II||121
2608461|NCT00132808|6405049|P3|NOT COMPLETED|Stratum I||5
2608462|NCT00132808|6405050|P2|NOT COMPLETED|Stratum I||12
2608463|NCT00132808|6405051|P1|NOT COMPLETED|Stratum I||9
2608464|NCT00132808|6405049|P3|COMPLETED|Stratum I||72
2608465|NCT00132808|6405050|P2|COMPLETED|Stratum I||58
2608466|NCT00132808|6405051|P1|COMPLETED|Stratum I||68
2608467|NCT00132808|6405049|P3|STARTED|Stratum I||77
2608468|NCT00132808|6405050|P2|STARTED|Stratum I||70
2608469|NCT00132808|6405051|P1|STARTED|Stratum I||77
2608470|NCT00132769|6405076|P2|NOT COMPLETED|Overall Study||11
2608471|NCT00132769|6405077|P1|NOT COMPLETED|Overall Study||11
2608472|NCT00132769|6405076|P2|COMPLETED|Overall Study||42
2608473|NCT00132769|6405077|P1|COMPLETED|Overall Study||42
2608474|NCT00132769|6405076|P2|STARTED|Overall Study||53
2608475|NCT00132769|6405077|P1|STARTED|Overall Study||53
2608476|NCT00132730|6405103|P6|NOT COMPLETED|Period V - Open-label Extension (EXT2)||2
2608477|NCT00132730|6405104|P5|NOT COMPLETED|Period V - Open-label Extension (EXT2)||7
2608478|NCT00132730|6405105|P4|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
2608479|NCT00132730|6405106|P3|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
2608480|NCT00132730|6405107|P2|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
2608481|NCT00132730|6405108|P1|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
2608482|NCT00132730|6405103|P6|COMPLETED|Period V - Open-label Extension (EXT2)||0
2608483|NCT00132730|6405104|P5|COMPLETED|Period V - Open-label Extension (EXT2)||0
2608484|NCT00132730|6405105|P4|COMPLETED|Period V - Open-label Extension (EXT2)||0
2608485|NCT00132730|6405106|P3|COMPLETED|Period V - Open-label Extension (EXT2)||0
2608486|NCT00132730|6405107|P2|COMPLETED|Period V - Open-label Extension (EXT2)||0
2608487|NCT00132730|6405108|P1|COMPLETED|Period V - Open-label Extension (EXT2)||0
2608488|NCT00132730|6405103|P6|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|2
2608489|NCT00132730|6405104|P5|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|7
2608490|NCT00132730|6405105|P4|STARTED|Period V - Open-label Extension (EXT2)||0
2608491|NCT00132730|6405106|P3|STARTED|Period V - Open-label Extension (EXT2)||0
2608492|NCT00132730|6405107|P2|STARTED|Period V - Open-label Extension (EXT2)||0
2608493|NCT00132730|6405108|P1|STARTED|Period V - Open-label Extension (EXT2)||0
2608494|NCT00132730|6405103|P6|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||68
2608495|NCT00132730|6405104|P5|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||179
2608496|NCT00132730|6405105|P4|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
2608497|NCT00132730|6405106|P3|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
2608498|NCT00132730|6405107|P2|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
2608499|NCT00132730|6405108|P1|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
2608500|NCT00132730|6405103|P6|COMPLETED|Period IV - Open-label Extension (EXT2)||3
2608501|NCT00132730|6405104|P5|COMPLETED|Period IV - Open-label Extension (EXT2)||8
2608502|NCT00132730|6405105|P4|COMPLETED|Period IV - Open-label Extension (EXT2)||0
2608503|NCT00132730|6405106|P3|COMPLETED|Period IV - Open-label Extension (EXT2)||0
2608504|NCT00132730|6405107|P2|COMPLETED|Period IV - Open-label Extension (EXT2)||0
2608505|NCT00132730|6405108|P1|COMPLETED|Period IV - Open-label Extension (EXT2)||0
2608506|NCT00132730|6405103|P6|STARTED|Period IV - Open-label Extension (EXT2)|Includes paricipants from Period III. Not all eligible participants entered EXT2|71
2608507|NCT00132730|6405104|P5|STARTED|Period IV - Open-label Extension (EXT2)|Includes participants from Period III. Not all eligible participants entered EXT2|187
2608508|NCT00132730|6405105|P4|STARTED|Period IV - Open-label Extension (EXT2)||0
2608509|NCT00132730|6405106|P3|STARTED|Period IV - Open-label Extension (EXT2)||0
2608510|NCT00132730|6405107|P2|STARTED|Period IV - Open-label Extension (EXT2)||0
2608511|NCT00132730|6405108|P1|STARTED|Period IV - Open-label Extension (EXT2)||0
2608512|NCT00132730|6405103|P6|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
2608513|NCT00132730|6405104|P5|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
2608514|NCT00132730|6405105|P4|NOT COMPLETED|Period III - Blinded Extension (EXT1)||25
2608515|NCT00132730|6405106|P3|NOT COMPLETED|Period III - Blinded Extension (EXT1)||82
2608516|NCT00132730|6405107|P2|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
2608517|NCT00132730|6405108|P1|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
2608518|NCT00132730|6405103|P6|COMPLETED|Period III - Blinded Extension (EXT1)||0
2608519|NCT00132730|6405104|P5|COMPLETED|Period III - Blinded Extension (EXT1)||0
2608520|NCT00132730|6405105|P4|COMPLETED|Period III - Blinded Extension (EXT1)||82
2608521|NCT00132730|6405106|P3|COMPLETED|Period III - Blinded Extension (EXT1)||235
2608522|NCT00132730|6405107|P2|COMPLETED|Period III - Blinded Extension (EXT1)||0
2608523|NCT00132730|6405108|P1|COMPLETED|Period III - Blinded Extension (EXT1)||0
2608524|NCT00132730|6405103|P6|STARTED|Period III - Blinded Extension (EXT1)||0
2608525|NCT00132730|6405104|P5|STARTED|Period III - Blinded Extension (EXT1)||0
2608526|NCT00132730|6405105|P4|STARTED|Period III - Blinded Extension (EXT1)|Not all eligible participants entered EXT1|107
2608527|NCT00132730|6405106|P3|STARTED|Period III - Blinded Extension (EXT1)|Includes all MK-0873 participants from Period II. Not all eligible participants entered EXT1|317
2608528|NCT00132730|6405107|P2|STARTED|Period III - Blinded Extension (EXT1)||0
2608529|NCT00132730|6405108|P1|STARTED|Period III - Blinded Extension (EXT1)||0
2608530|NCT00132730|6405103|P6|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
2608531|NCT00132730|6405104|P5|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
2608532|NCT00132730|6405105|P4|NOT COMPLETED|Period II - 12-week Treatment (Base)||22
2608533|NCT00132730|6405106|P3|NOT COMPLETED|Period II - 12-week Treatment (Base)||18
2608534|NCT00132730|6405107|P2|NOT COMPLETED|Period II - 12-week Treatment (Base)||15
2608535|NCT00132730|6405108|P1|NOT COMPLETED|Period II - 12-week Treatment (Base)||23
2608536|NCT00132730|6405103|P6|COMPLETED|Period II - 12-week Treatment (Base)||0
2608537|NCT00132730|6405104|P5|COMPLETED|Period II - 12-week Treatment (Base)||0
2608538|NCT00132730|6405105|P4|COMPLETED|Period II - 12-week Treatment (Base)||131
2608539|NCT00132730|6405106|P3|COMPLETED|Period II - 12-week Treatment (Base)||135
2608540|NCT00132730|6405107|P2|COMPLETED|Period II - 12-week Treatment (Base)||133
2608541|NCT00132730|6405108|P1|COMPLETED|Period II - 12-week Treatment (Base)||127
2608542|NCT00132730|6405103|P6|STARTED|Period II - 12-week Treatment (Base)||0
2608543|NCT00132730|6405104|P5|STARTED|Period II - 12-week Treatment (Base)||0
2608544|NCT00132730|6405105|P4|STARTED|Period II - 12-week Treatment (Base)||153
2608545|NCT00132730|6405106|P3|STARTED|Period II - 12-week Treatment (Base)||153
2608546|NCT00132730|6405107|P2|STARTED|Period II - 12-week Treatment (Base)||148
2608547|NCT00132730|6405108|P1|STARTED|Period II - 12-week Treatment (Base)||150
2608548|NCT00132730|6405103|P6|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
2608549|NCT00132730|6405104|P5|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
2608550|NCT00132730|6405105|P4|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
2608551|NCT00132730|6405106|P3|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
2608552|NCT00132730|6405107|P2|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
2608553|NCT00132730|6405108|P1|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
2608554|NCT00132730|6405103|P6|COMPLETED|Period I - Placebo Run-in (Base)||0
2608555|NCT00132730|6405104|P5|COMPLETED|Period I - Placebo Run-in (Base)||0
2608556|NCT00132730|6405105|P4|COMPLETED|Period I - Placebo Run-in (Base)||153
2608557|NCT00132730|6405106|P3|COMPLETED|Period I - Placebo Run-in (Base)||153
2608558|NCT00132730|6405107|P2|COMPLETED|Period I - Placebo Run-in (Base)||148
2608559|NCT00132730|6405108|P1|COMPLETED|Period I - Placebo Run-in (Base)||150
2608560|NCT00132730|6405103|P6|STARTED|Period I - Placebo Run-in (Base)||0
2608561|NCT00132730|6405104|P5|STARTED|Period I - Placebo Run-in (Base)||0
2608562|NCT00132730|6405105|P4|STARTED|Period I - Placebo Run-in (Base)||153
2608563|NCT00132730|6405106|P3|STARTED|Period I - Placebo Run-in (Base)||153
2608564|NCT00132730|6405107|P2|STARTED|Period I - Placebo Run-in (Base)||148
2608565|NCT00132730|6405108|P1|STARTED|Period I - Placebo Run-in (Base)||150
2608566|NCT00132691|6405152|P2|NOT COMPLETED|Overall Study||12
2608567|NCT00132691|6405153|P1|NOT COMPLETED|Overall Study||11
2608568|NCT00132691|6405152|P2|COMPLETED|Overall Study|114 participants completed the 2-year anniversary visit|114
2608569|NCT00132691|6405153|P1|COMPLETED|Overall Study|118 participants completed the 2-year anniversary visit|118
2608570|NCT00132691|6405152|P2|STARTED|Overall Study|126 participants were assigned to systemic treatment; 121 received systemic therapy|126
2608571|NCT00132691|6405153|P1|STARTED|Overall Study|129 participants were assigned to implant; 122 received implant|129
2608572|NCT00132678|6405193|P3|NOT COMPLETED|Period IV (Double-Blind Treatment)||0
2608573|NCT00132678|6405194|P2|NOT COMPLETED|Period IV (Double-Blind Treatment)||40
2608574|NCT00132678|6405195|P1|NOT COMPLETED|Period IV (Double-Blind Treatment)||37
2608575|NCT00132678|6405193|P3|COMPLETED|Period IV (Double-Blind Treatment)||0
2608576|NCT00132678|6405194|P2|COMPLETED|Period IV (Double-Blind Treatment)||109
2608577|NCT00132678|6405195|P1|COMPLETED|Period IV (Double-Blind Treatment)||117
2608578|NCT00132678|6405193|P3|STARTED|Period IV (Double-Blind Treatment)||0
2608579|NCT00132678|6405194|P2|STARTED|Period IV (Double-Blind Treatment)||149
2608580|NCT00132678|6405195|P1|STARTED|Period IV (Double-Blind Treatment)||154
2608581|NCT00132678|6405193|P3|NOT COMPLETED|Period III (Open-Label Stabilization)||0
2608582|NCT00132678|6405194|P2|NOT COMPLETED|Period III (Open-Label Stabilization)||0
2608583|NCT00132678|6405195|P1|NOT COMPLETED|Period III (Open-Label Stabilization)||198
2608584|NCT00132678|6405193|P3|COMPLETED|Period III (Open-Label Stabilization)||0
2608585|NCT00132678|6405194|P2|COMPLETED|Period III (Open-Label Stabilization)||0
2608586|NCT00132678|6405195|P1|COMPLETED|Period III (Open-Label Stabilization)||303
2608587|NCT00132678|6405193|P3|STARTED|Period III (Open-Label Stabilization)||0
2608588|NCT00132678|6405194|P2|STARTED|Period III (Open-Label Stabilization)||0
2608589|NCT00132678|6405195|P1|STARTED|Period III (Open-Label Stabilization)||501
2608590|NCT00132678|6405193|P3|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||58
2608591|NCT00132678|6405194|P2|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
2608592|NCT00132678|6405195|P1|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
2608593|NCT00132678|6405193|P3|COMPLETED|Period II (Open-Label Oral Risperidone)||382
2608594|NCT00132678|6405194|P2|COMPLETED|Period II (Open-Label Oral Risperidone)||0
2608595|NCT00132678|6405195|P1|COMPLETED|Period II (Open-Label Oral Risperidone)||0
2608596|NCT00132678|6405193|P3|STARTED|Period II (Open-Label Oral Risperidone)||440
2608597|NCT00132678|6405194|P2|STARTED|Period II (Open-Label Oral Risperidone)||0
2608598|NCT00132678|6405195|P1|STARTED|Period II (Open-Label Oral Risperidone)||0
2608599|NCT00132496|6405209|P2|NOT COMPLETED|Overall Study||2
2608600|NCT00132496|6405210|P1|NOT COMPLETED|Overall Study||2
2608601|NCT00132496|6405209|P2|COMPLETED|Overall Study||55
2608602|NCT00132496|6405210|P1|COMPLETED|Overall Study||52
2608603|NCT00132496|6405209|P2|STARTED|Overall Study||57
2608604|NCT00132496|6405210|P1|STARTED|Overall Study||54
2608605|NCT00132314|6405218|P2|NOT COMPLETED|Overall Study||72
2608606|NCT00132314|6405219|P1|NOT COMPLETED|Overall Study||73
2608607|NCT00132314|6405218|P2|COMPLETED|Overall Study||120
2608608|NCT00132314|6405219|P1|COMPLETED|Overall Study||117
2608609|NCT00132314|6405218|P2|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort.|182
2608610|NCT00132314|6405219|P1|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort|187
2608611|NCT00132314|6405218|P2|Received Treatment|Overall Study||185
2608612|NCT00132314|6405219|P1|Received Treatment|Overall Study||188
2608613|NCT00132314|6405218|P2|STARTED|Overall Study||192
2608614|NCT00132314|6405219|P1|STARTED|Overall Study||190
2608615|NCT00132301|6405229|P2|NOT COMPLETED|Overall Study||13
2608616|NCT00132301|6405230|P1|NOT COMPLETED|Overall Study||20
2608617|NCT00132301|6405229|P2|COMPLETED|Overall Study||144
2608618|NCT00132301|6405230|P1|COMPLETED|Overall Study||121
2608619|NCT00132301|6405229|P2|STARTED|Overall Study||157
2608620|NCT00132301|6405230|P1|STARTED|Overall Study||141
2608621|NCT00132132|6405238|P2|NOT COMPLETED|Overall Study||2
2608622|NCT00132132|6405239|P1|NOT COMPLETED|Overall Study||7
2608623|NCT00132132|6405238|P2|COMPLETED|Overall Study||13
2608624|NCT00132132|6405239|P1|COMPLETED|Overall Study||8
2608625|NCT00132132|6405238|P2|STARTED|Overall Study||15
2608626|NCT00132132|6405239|P1|STARTED|Overall Study||15
2608627|NCT00132028|6405247|P1|NOT COMPLETED|Overall Study||27
2608628|NCT00132028|6405247|P1|COMPLETED|Overall Study|"Since there was no maximum number of cycles, patients could not complete treatment."|0
2608629|NCT00132028|6405247|P1|Eligible and Began Protocol Therapy|Overall Study||25
2608630|NCT00132028|6405247|P1|Eligible|Overall Study||25
2608631|NCT00132028|6405247|P1|STARTED|Overall Study||27
2608632|NCT00132002|6405253|P1|NOT COMPLETED|Overall Study||0
2608633|NCT00132002|6405253|P1|COMPLETED|Overall Study||14
2608634|NCT00132002|6405253|P1|STARTED|Overall Study||14
2608635|NCT00131937|6405259|P1|NOT COMPLETED|Overall Study||14
2608636|NCT00131937|6405259|P1|COMPLETED|Overall Study||0
2608637|NCT00131937|6405259|P1|STARTED|Overall Study||14
2608638|NCT00131911|6405267|P2|NOT COMPLETED|Overall Study||0
2608639|NCT00131911|6405268|P1|NOT COMPLETED|Overall Study||1
2608640|NCT00131911|6405267|P2|COMPLETED|Overall Study||42
2608641|NCT00131911|6405268|P1|COMPLETED|Overall Study||50
2608642|NCT00131911|6405267|P2|STARTED|Overall Study||42
2608643|NCT00131911|6405268|P1|STARTED|Overall Study||51
2608644|NCT00131885|6405285|P4|NOT COMPLETED|Time 2: Second Intervention||0
2608645|NCT00131885|6405286|P3|NOT COMPLETED|Time 2: Second Intervention||0
2608646|NCT00131885|6405287|P2|NOT COMPLETED|Time 2: Second Intervention||0
2608647|NCT00131885|6405288|P1|NOT COMPLETED|Time 2: Second Intervention||0
2608648|NCT00131885|6405285|P4|COMPLETED|Time 2: Second Intervention||9
2608649|NCT00131885|6405286|P3|COMPLETED|Time 2: Second Intervention||9
2608650|NCT00131885|6405287|P2|COMPLETED|Time 2: Second Intervention||9
2608651|NCT00131885|6405288|P1|COMPLETED|Time 2: Second Intervention||9
2608652|NCT00131885|6405285|P4|STARTED|Time 2: Second Intervention||9
2608653|NCT00131885|6405286|P3|STARTED|Time 2: Second Intervention||9
2608654|NCT00131885|6405287|P2|STARTED|Time 2: Second Intervention||9
2608655|NCT00131885|6405288|P1|STARTED|Time 2: Second Intervention||9
2608656|NCT00131885|6405285|P4|NOT COMPLETED|Time 1: First Intervention||0
2608657|NCT00131885|6405286|P3|NOT COMPLETED|Time 1: First Intervention||0
2608658|NCT00131885|6405287|P2|NOT COMPLETED|Time 1: First Intervention||0
2608659|NCT00131885|6405288|P1|NOT COMPLETED|Time 1: First Intervention||0
2608660|NCT00131885|6405285|P4|COMPLETED|Time 1: First Intervention||9
2608661|NCT00131885|6405286|P3|COMPLETED|Time 1: First Intervention||9
2608662|NCT00131885|6405287|P2|COMPLETED|Time 1: First Intervention||9
2608663|NCT00131885|6405288|P1|COMPLETED|Time 1: First Intervention||9
2608664|NCT00131885|6405285|P4|STARTED|Time 1: First Intervention||9
2608665|NCT00131885|6405286|P3|STARTED|Time 1: First Intervention||9
2608666|NCT00131885|6405287|P2|STARTED|Time 1: First Intervention||9
2608667|NCT00131885|6405288|P1|STARTED|Time 1: First Intervention||9
2608668|NCT00131677|6405320|P2|NOT COMPLETED|Overall Study||39
2608669|NCT00131677|6405321|P1|NOT COMPLETED|Overall Study||30
2608670|NCT00131677|6405320|P2|COMPLETED|Overall Study||160
2608671|NCT00131677|6405321|P1|COMPLETED|Overall Study||171
2608672|NCT00131677|6405320|P2|STARTED|Overall Study|199 randomized to placebo; 99 to start immediately and 100 after a 9 month delay.|199
2608673|NCT00131677|6405321|P1|STARTED|Overall Study|201 randomized to active drug; 101 to start immediately and 100 after a 9 month delay.|201
2608674|NCT00131664|6405338|P6|NOT COMPLETED|Second Period (Additional Drug Added)||3
2608675|NCT00131664|6405339|P5|NOT COMPLETED|Second Period (Additional Drug Added)||1
2608676|NCT00131664|6405340|P4|NOT COMPLETED|Second Period (Additional Drug Added)||2
2608677|NCT00131664|6405341|P3|NOT COMPLETED|Second Period (Additional Drug Added)||3
2608678|NCT00131664|6405342|P2|NOT COMPLETED|Second Period (Additional Drug Added)||4
2608679|NCT00131664|6405343|P1|NOT COMPLETED|Second Period (Additional Drug Added)||9
2608680|NCT00131664|6405338|P6|COMPLETED|Second Period (Additional Drug Added)||22
2608681|NCT00131664|6405339|P5|COMPLETED|Second Period (Additional Drug Added)||15
2608682|NCT00131664|6405340|P4|COMPLETED|Second Period (Additional Drug Added)||19
2608683|NCT00131664|6405341|P3|COMPLETED|Second Period (Additional Drug Added)||76
2608684|NCT00131664|6405342|P2|COMPLETED|Second Period (Additional Drug Added)||97
2608685|NCT00131664|6405343|P1|COMPLETED|Second Period (Additional Drug Added)||81
2608686|NCT00131664|6405338|P6|STARTED|Second Period (Additional Drug Added)||25
2608687|NCT00131664|6405339|P5|STARTED|Second Period (Additional Drug Added)||16
2608688|NCT00131664|6405340|P4|STARTED|Second Period (Additional Drug Added)||21
2608689|NCT00131664|6405341|P3|STARTED|Second Period (Additional Drug Added)|25 had added Amaryl at Month 6|79
2608690|NCT00131664|6405342|P2|STARTED|Second Period (Additional Drug Added)|16 had added Amaryl at Month 6|101
2608691|NCT00131664|6405343|P1|STARTED|Second Period (Additional Drug Added)|21 had added Metformin at Month 6|90
2608692|NCT00131664|6405338|P6|NOT COMPLETED|First Period (First 6 Months)||0
2608693|NCT00131664|6405339|P5|NOT COMPLETED|First Period (First 6 Months)||0
2608694|NCT00131664|6405340|P4|NOT COMPLETED|First Period (First 6 Months)||0
2608695|NCT00131664|6405341|P3|NOT COMPLETED|First Period (First 6 Months)||16
2608696|NCT00131664|6405342|P2|NOT COMPLETED|First Period (First 6 Months)||18
2608697|NCT00131664|6405343|P1|NOT COMPLETED|First Period (First 6 Months)||25
2608698|NCT00131664|6405338|P6|COMPLETED|First Period (First 6 Months)||0
2608699|NCT00131664|6405339|P5|COMPLETED|First Period (First 6 Months)||0
2608700|NCT00131664|6405340|P4|COMPLETED|First Period (First 6 Months)||0
2608701|NCT00131664|6405341|P3|COMPLETED|First Period (First 6 Months)||104
2608702|NCT00131664|6405342|P2|COMPLETED|First Period (First 6 Months)||117
2608703|NCT00131664|6405343|P1|COMPLETED|First Period (First 6 Months)||111
2608704|NCT00131664|6405338|P6|STARTED|First Period (First 6 Months)||0
2608705|NCT00131664|6405339|P5|STARTED|First Period (First 6 Months)||0
2608706|NCT00131664|6405340|P4|STARTED|First Period (First 6 Months)||0
2608707|NCT00131664|6405341|P3|STARTED|First Period (First 6 Months)||120
2608708|NCT00131664|6405342|P2|STARTED|First Period (First 6 Months)||135
2608709|NCT00131664|6405343|P1|STARTED|First Period (First 6 Months)||136
2608710|NCT00131573|6405404|P2|NOT COMPLETED|Overall Study||26
2608711|NCT00131573|6405405|P1|NOT COMPLETED|Overall Study||33
2608712|NCT00131573|6405404|P2|COMPLETED|Overall Study||13
2608713|NCT00131573|6405405|P1|COMPLETED|Overall Study||13
2608714|NCT00131573|6405404|P2|STARTED|Overall Study||39
2608715|NCT00131573|6405405|P1|STARTED|Overall Study||46
2608716|NCT00131508|6405415|P2|NOT COMPLETED|Overall Study||8
2608717|NCT00131508|6405416|P1|NOT COMPLETED|Overall Study||3
2608718|NCT00131508|6405415|P2|COMPLETED|Overall Study||5
2608719|NCT00131508|6405416|P1|COMPLETED|Overall Study||9
2608720|NCT00131508|6405415|P2|STARTED|Overall Study||13
2608721|NCT00131508|6405416|P1|STARTED|Overall Study||12
2608722|NCT00131469|6405440|P2|NOT COMPLETED|Overall Study||13
2608723|NCT00131469|6405441|P1|NOT COMPLETED|Overall Study||9
2608724|NCT00131469|6405440|P2|COMPLETED|Overall Study||27
2608725|NCT00131469|6405441|P1|COMPLETED|Overall Study||29
2608726|NCT00131469|6405440|P2|STARTED|Overall Study||40
2608727|NCT00131469|6405441|P1|STARTED|Overall Study||38
2608728|NCT00131456|6405451|P2|NOT COMPLETED|Overall Study||20
2608729|NCT00131456|6405452|P1|NOT COMPLETED|Overall Study||19
2608730|NCT00131456|6405451|P2|COMPLETED|Overall Study||31
2608731|NCT00131456|6405452|P1|COMPLETED|Overall Study||33
2608732|NCT00131456|6405451|P2|STARTED|Overall Study||51
2608733|NCT00131456|6405452|P1|STARTED|Overall Study||52
2608734|NCT00131378|6405462|P4|NOT COMPLETED|Overall Study||9
2608735|NCT00131378|6405463|P3|NOT COMPLETED|Overall Study||10
2608736|NCT00131378|6405464|P2|NOT COMPLETED|Overall Study||18
2608737|NCT00131378|6405465|P1|NOT COMPLETED|Overall Study||11
2608738|NCT00131378|6405462|P4|COMPLETED|Overall Study||21
2608739|NCT00131378|6405463|P3|COMPLETED|Overall Study||22
2608740|NCT00131378|6405464|P2|COMPLETED|Overall Study||22
2608741|NCT00131378|6405465|P1|COMPLETED|Overall Study||29
2608742|NCT00131378|6405462|P4|STARTED|Overall Study||30
2608743|NCT00131378|6405463|P3|STARTED|Overall Study||32
2608744|NCT00131378|6405464|P2|STARTED|Overall Study||40
2608745|NCT00131378|6405465|P1|STARTED|Overall Study||40
2608746|NCT00131365|6405487|P1|NOT COMPLETED|Overall Study||4
2608747|NCT00131365|6405487|P1|COMPLETED|Overall Study||5
2608748|NCT00131365|6405487|P1|STARTED|Overall Study|Only safety data was reported due to early closure of the study due to device obsolescence.|9
2608749|NCT00131352|6405494|P2|NOT COMPLETED|Repeat Treatment Period||0
2608750|NCT00131352|6405495|P1|NOT COMPLETED|Repeat Treatment Period||2
2608751|NCT00131352|6405494|P2|COMPLETED|Repeat Treatment Period||0
2608752|NCT00131352|6405495|P1|COMPLETED|Repeat Treatment Period||158
2608753|NCT00131352|6405494|P2|STARTED|Repeat Treatment Period||0
2608754|NCT00131352|6405495|P1|STARTED|Repeat Treatment Period|Safety population: 77 Synvisc + 83 Saline Control participants from the Initial Treatment period.|160
2608755|NCT00131352|6405494|P2|NOT COMPLETED|Initial Treatment Period||12
2608756|NCT00131352|6405495|P1|NOT COMPLETED|Initial Treatment Period||9
2608757|NCT00131352|6405494|P2|COMPLETED|Initial Treatment Period||118
2608758|NCT00131352|6405495|P1|COMPLETED|Initial Treatment Period||114
2608759|NCT00131352|6405494|P2|Intent to Treat Population|Initial Treatment Period||129
2608760|NCT00131352|6405495|P1|Intent to Treat Population|Initial Treatment Period||124
2608761|NCT00131352|6405494|P2|STARTED|Initial Treatment Period|Safety population|130
2608762|NCT00131352|6405495|P1|STARTED|Initial Treatment Period|Safety population|123
2608763|NCT00131248|6405517|P2|NOT COMPLETED|Intervention 3 (4-day Course)||0
2608764|NCT00131248|6405518|P1|NOT COMPLETED|Intervention 3 (4-day Course)||0
2608765|NCT00131248|6405517|P2|COMPLETED|Intervention 3 (4-day Course)||9
2608766|NCT00131248|6405518|P1|COMPLETED|Intervention 3 (4-day Course)||8
2608767|NCT00131248|6405517|P2|STARTED|Intervention 3 (4-day Course)||9
2608768|NCT00131248|6405518|P1|STARTED|Intervention 3 (4-day Course)||8
2608769|NCT00131248|6405517|P2|NOT COMPLETED|Washout 2 (24 Hours)||0
2608770|NCT00131248|6405518|P1|NOT COMPLETED|Washout 2 (24 Hours)||0
2608771|NCT00131248|6405517|P2|COMPLETED|Washout 2 (24 Hours)||9
2608772|NCT00131248|6405518|P1|COMPLETED|Washout 2 (24 Hours)||8
2608773|NCT00131248|6405517|P2|STARTED|Washout 2 (24 Hours)||9
2608774|NCT00131248|6405518|P1|STARTED|Washout 2 (24 Hours)||8
2608775|NCT00131248|6405517|P2|NOT COMPLETED|Intervention 2 (7-day Course)||0
2608776|NCT00131248|6405518|P1|NOT COMPLETED|Intervention 2 (7-day Course)||0
2608777|NCT00131248|6405517|P2|COMPLETED|Intervention 2 (7-day Course)||9
2608778|NCT00131248|6405518|P1|COMPLETED|Intervention 2 (7-day Course)||8
2608779|NCT00131248|6405517|P2|STARTED|Intervention 2 (7-day Course)||9
2608780|NCT00131248|6405518|P1|STARTED|Intervention 2 (7-day Course)||8
2608781|NCT00131248|6405517|P2|NOT COMPLETED|Washout (24 Hour)||0
2608782|NCT00131248|6405518|P1|NOT COMPLETED|Washout (24 Hour)||0
2608783|NCT00131248|6405517|P2|COMPLETED|Washout (24 Hour)||9
2608784|NCT00131248|6405518|P1|COMPLETED|Washout (24 Hour)||8
2608785|NCT00131248|6405517|P2|STARTED|Washout (24 Hour)||9
2608786|NCT00131248|6405518|P1|STARTED|Washout (24 Hour)||8
2608787|NCT00131248|6405517|P2|NOT COMPLETED|Intervention 1 (3-day Course)||0
2608788|NCT00131248|6405518|P1|NOT COMPLETED|Intervention 1 (3-day Course)||1
2608789|NCT00131248|6405517|P2|COMPLETED|Intervention 1 (3-day Course)||9
2608790|NCT00131248|6405518|P1|COMPLETED|Intervention 1 (3-day Course)||8
2608791|NCT00131248|6405517|P2|STARTED|Intervention 1 (3-day Course)||9
2608792|NCT00131248|6405518|P1|STARTED|Intervention 1 (3-day Course)||9
2608793|NCT00130923|6405526|P2|NOT COMPLETED|Overall Study||14
2608794|NCT00130923|6405527|P1|NOT COMPLETED|Overall Study||13
2608795|NCT00130923|6405526|P2|COMPLETED|Overall Study||32
2608796|NCT00130923|6405527|P1|COMPLETED|Overall Study||36
2608797|NCT00130923|6405526|P2|STARTED|Overall Study||46
2608798|NCT00130923|6405527|P1|STARTED|Overall Study||49
2608799|NCT00130832|6405545|P2|NOT COMPLETED|Overall Study||17
2608800|NCT00130832|6405546|P1|NOT COMPLETED|Overall Study||16
2608801|NCT00130832|6405545|P2|COMPLETED|Overall Study|Those who received all 3 doses; last 2 blood draws ~42 days postdose 3 of RotaTeq™ and postdose OPV|346
2608802|NCT00130832|6405546|P1|COMPLETED|Overall Study|Those who received all 3 doses of concomitant RotaTeq™/ OPV with blood draw ~42 days postdose 3|356
2608803|NCT00130832|6405545|P2|STARTED|Overall Study||363
2608804|NCT00130832|6405546|P1|STARTED|Overall Study||372
2608805|NCT00130793|6405558|P2|NOT COMPLETED|Overall Study||4
2608806|NCT00130793|6405559|P1|NOT COMPLETED|Overall Study||3
2608807|NCT00130793|6405558|P2|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned VRC at Week 4|181
2608808|NCT00130793|6405559|P1|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned vaccination report card (VRC) at Week 4|180
2608809|NCT00130793|6405558|P2|Vaccinated|Overall Study||185
2608810|NCT00130793|6405559|P1|Vaccinated|Overall Study|One subject was allocated but not vaccinated.|182
2608811|NCT00130793|6405558|P2|STARTED|Overall Study||185
2608812|NCT00130793|6405559|P1|STARTED|Overall Study||183
2608813|NCT00130780|6405571|P2|NOT COMPLETED|Overall Study||0
2608814|NCT00130780|6405572|P1|NOT COMPLETED|Overall Study||0
2608815|NCT00130780|6405571|P2|COMPLETED|Overall Study||20
2608816|NCT00130780|6405572|P1|COMPLETED|Overall Study||51
2608817|NCT00130780|6405571|P2|STARTED|Overall Study||20
2608818|NCT00130780|6405572|P1|STARTED|Overall Study||51
2608819|NCT00130728|6405580|P2|NOT COMPLETED|Overall Study||213
2608820|NCT00130728|6405581|P1|NOT COMPLETED|Overall Study||211
2608821|NCT00130728|6405580|P2|COMPLETED|Overall Study||104
2608822|NCT00130728|6405581|P1|COMPLETED|Overall Study||108
2608823|NCT00130728|6405580|P2|Received Study Drug (Safety Population)|Overall Study||313
2608824|NCT00130728|6405581|P1|Received Study Drug (Safety Population)|Overall Study||313
2608825|NCT00130728|6405580|P2|STARTED|Overall Study||317
2608826|NCT00130728|6405581|P1|STARTED|Overall Study||319
2608827|NCT00130689|6405593|P1|NOT COMPLETED|Overall Study||43
2608828|NCT00130689|6405593|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
2608829|NCT00130689|6405593|P1|Treated|Overall Study||35
2608830|NCT00130689|6405593|P1|Eligible|Overall Study||37
2608831|NCT00130689|6405593|P1|STARTED|Overall Study||43
2608832|NCT00130637|6405597|P1|NOT COMPLETED|Overall Study||3
2608833|NCT00130637|6405597|P1|COMPLETED|Overall Study||3
2608834|NCT00130637|6405597|P1|STARTED|Overall Study||6
2608835|NCT00130533|6405604|P2|NOT COMPLETED|Overall Study||30
2608836|NCT00130533|6405605|P1|NOT COMPLETED|Overall Study||111
2608837|NCT00130533|6405604|P2|COMPLETED|Overall Study||398
2608838|NCT00130533|6405605|P1|COMPLETED|Overall Study||337
2608839|NCT00130533|6405604|P2|STARTED|Overall Study||428
2608840|NCT00130533|6405605|P1|STARTED|Overall Study||448
2608841|NCT00130520|6405617|P1|NOT COMPLETED|Overall Study||39
2608842|NCT00130520|6405617|P1|COMPLETED|Overall Study||1
2608843|NCT00130520|6405617|P1|Completion of at Least One Cycle|Overall Study||39
2608844|NCT00130520|6405617|P1|STARTED|Overall Study|85 women were screened for eligibility, 56 consented, 40 treated.|40
2608845|NCT00130286|6405627|P4|NOT COMPLETED|Overall Study||2
2608846|NCT00130286|6405628|P3|NOT COMPLETED|Overall Study||4
2608847|NCT00130286|6405629|P2|NOT COMPLETED|Overall Study||3
2608848|NCT00130286|6405630|P1|NOT COMPLETED|Overall Study||0
2608849|NCT00130286|6405627|P4|COMPLETED|Overall Study||17
2608850|NCT00130286|6405628|P3|COMPLETED|Overall Study||13
2608851|NCT00130286|6405629|P2|COMPLETED|Overall Study||16
2608852|NCT00130286|6405630|P1|COMPLETED|Overall Study||22
2608853|NCT00130286|6405627|P4|STARTED|Overall Study||19
2608854|NCT00130286|6405628|P3|STARTED|Overall Study||17
2608855|NCT00130286|6405629|P2|STARTED|Overall Study||19
2608856|NCT00130286|6405630|P1|STARTED|Overall Study||22
2608857|NCT00130247|6405650|P2|NOT COMPLETED|Overall Study||4
2608858|NCT00130247|6405651|P1|NOT COMPLETED|Overall Study||2
2608859|NCT00130247|6405650|P2|COMPLETED|Overall Study||194
2608860|NCT00130247|6405651|P1|COMPLETED|Overall Study||194
2608861|NCT00130247|6405650|P2|STARTED|Overall Study||198
2608862|NCT00130247|6405651|P1|STARTED|Overall Study||196
2608863|NCT00130208|6405669|P2|NOT COMPLETED|Washout Period (8 Weeks)||12
2608864|NCT00130208|6405670|P1|NOT COMPLETED|Washout Period (8 Weeks)||6
2608865|NCT00130208|6405669|P2|COMPLETED|Washout Period (8 Weeks)||490
2608866|NCT00130208|6405670|P1|COMPLETED|Washout Period (8 Weeks)||494
2608867|NCT00130208|6405669|P2|STARTED|Washout Period (8 Weeks)||502
2608868|NCT00130208|6405670|P1|STARTED|Washout Period (8 Weeks)||500
2608869|NCT00130208|6405669|P2|NOT COMPLETED|Maintenance Period (26 Weeks)||30
2608870|NCT00130208|6405670|P1|NOT COMPLETED|Maintenance Period (26 Weeks)||24
2608871|NCT00130208|6405669|P2|COMPLETED|Maintenance Period (26 Weeks)||502
2608872|NCT00130208|6405670|P1|COMPLETED|Maintenance Period (26 Weeks)||500
2608873|NCT00130208|6405669|P2|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||494
2608874|NCT00130208|6405670|P1|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||492
2608875|NCT00130208|6405669|P2|STARTED|Maintenance Period (26 Weeks)||532
2608876|NCT00130208|6405670|P1|STARTED|Maintenance Period (26 Weeks)||524
2608877|NCT00130117|6405682|P2|NOT COMPLETED|Overall Study||3
2608878|NCT00130117|6405683|P1|NOT COMPLETED|Overall Study||4
2608879|NCT00130117|6405682|P2|COMPLETED|Overall Study||6
2608880|NCT00130117|6405683|P1|COMPLETED|Overall Study||7
2608881|NCT00130117|6405682|P2|STARTED|Overall Study||9
2608882|NCT00130117|6405683|P1|STARTED|Overall Study||11
2608883|NCT00130039|6405706|P2|NOT COMPLETED|Overall Study||18
2608884|NCT00130039|6405707|P1|NOT COMPLETED|Overall Study||30
2608885|NCT00130039|6405706|P2|COMPLETED|Overall Study|full analysis set|207
2608886|NCT00130039|6405707|P1|COMPLETED|Overall Study|full analysis set|202
2608887|NCT00130039|6405706|P2|STARTED|Overall Study||225
2608888|NCT00130039|6405707|P1|STARTED|Overall Study||232
2608889|NCT00129987|6405725|P2|NOT COMPLETED|1 Year||21
2608890|NCT00129987|6405726|P1|NOT COMPLETED|1 Year||32
2608891|NCT00129987|6405725|P2|COMPLETED|1 Year||150
2608892|NCT00129987|6405726|P1|COMPLETED|1 Year||114
2608893|NCT00129987|6405725|P2|STARTED|1 Year||171
2608894|NCT00129987|6405726|P1|STARTED|1 Year||146
2608895|NCT00129987|6405725|P2|NOT COMPLETED|1st Educational Session||109
2608896|NCT00129987|6405726|P1|NOT COMPLETED|1st Educational Session||141
2608897|NCT00129987|6405725|P2|COMPLETED|1st Educational Session||171
2608898|NCT00129987|6405726|P1|COMPLETED|1st Educational Session||146
2608899|NCT00129987|6405725|P2|STARTED|1st Educational Session||280
2608900|NCT00129987|6405726|P1|STARTED|1st Educational Session||287
2608901|NCT00129974|6405738|P1|NOT COMPLETED|Overall Study||1
2608902|NCT00129974|6405738|P1|COMPLETED|Overall Study||0
2608903|NCT00129974|6405738|P1|STARTED|Overall Study||1
2608904|NCT00129961|6405745|P2|NOT COMPLETED|Overall Study||23
2608905|NCT00129961|6405746|P1|NOT COMPLETED|Overall Study||19
2608906|NCT00129961|6405745|P2|COMPLETED|Overall Study||24
2608907|NCT00129961|6405746|P1|COMPLETED|Overall Study||20
2608908|NCT00129961|6405745|P2|STARTED|Overall Study||47
2608909|NCT00129961|6405746|P1|STARTED|Overall Study||39
2608910|NCT00129935|6405782|P2|NOT COMPLETED|Overall Study||92
2608911|NCT00129935|6405783|P1|NOT COMPLETED|Overall Study||36
2608912|NCT00129935|6405782|P2|COMPLETED|Overall Study|1 patient crossed from arm B to A by error.|623
2608913|NCT00129935|6405783|P1|COMPLETED|Overall Study|2 patients crossed from arm A to B by error, and 1 patient received other treatment by error.|633
2608914|NCT00129935|6405782|P2|STARTED|Overall Study||715
2608915|NCT00129935|6405783|P1|STARTED|Overall Study||669
2608916|NCT00129766|6405801|P2|NOT COMPLETED|Overall Study||59
2608917|NCT00129766|6405802|P1|NOT COMPLETED|Overall Study||60
2608918|NCT00129766|6405801|P2|COMPLETED|Overall Study||3270
2608919|NCT00129766|6405802|P1|COMPLETED|Overall Study||3246
2608920|NCT00129766|6405801|P2|STARTED|Overall Study||3329
2608921|NCT00129766|6405802|P1|STARTED|Overall Study||3306
2608922|NCT00129740|6405840|P1|NOT COMPLETED|Overall Study||0
2608923|NCT00129740|6405840|P1|COMPLETED|Overall Study||148
2608924|NCT00129740|6405840|P1|STARTED|Overall Study||148
2608925|NCT00129727|6405845|P1|NOT COMPLETED|Overall Study||5
2608926|NCT00129727|6405845|P1|COMPLETED|Overall Study||57
2608927|NCT00129727|6405845|P1|STARTED|Overall Study||62
2608928|NCT00129701|6405851|P1|NOT COMPLETED|Overall Study||33
2608929|NCT00129701|6405851|P1|COMPLETED|Overall Study||71
2608930|NCT00129701|6405851|P1|STARTED|Overall Study||104
2608931|NCT00129649|6405860|P2|NOT COMPLETED|Overall Study||65
2608932|NCT00129649|6405861|P1|NOT COMPLETED|Overall Study||76
2608933|NCT00129649|6405860|P2|COMPLETED|Overall Study||181
2608934|NCT00129649|6405861|P1|COMPLETED|Overall Study||182
2608935|NCT00129649|6405860|P2|STARTED|Overall Study||246
2608936|NCT00129649|6405861|P1|STARTED|Overall Study||258
2608937|NCT00129623|6405869|P2|NOT COMPLETED|Overall Study||12
2608938|NCT00129623|6405870|P1|NOT COMPLETED|Overall Study||10
2608939|NCT00129623|6405869|P2|COMPLETED|Overall Study||65
2608940|NCT00129623|6405870|P1|COMPLETED|Overall Study||73
2608941|NCT00129623|6405869|P2|Intent-to-treat (ITT)/ Safety Population|Overall Study||77
2608942|NCT00129623|6405870|P1|Intent-to-treat (ITT)/ Safety Population|Overall Study||83
2608943|NCT00129623|6405869|P2|STARTED|Overall Study||77
2608944|NCT00129623|6405870|P1|STARTED|Overall Study||83
2608945|NCT00129545|6405895|P3|NOT COMPLETED|Overall Study||111
2608946|NCT00129545|6405896|P2|NOT COMPLETED|Overall Study||164
2608947|NCT00129545|6405897|P1|NOT COMPLETED|Overall Study||26
2608948|NCT00129545|6405895|P3|COMPLETED|Overall Study||133
2608949|NCT00129545|6405896|P2|COMPLETED|Overall Study||299
2608950|NCT00129545|6405897|P1|COMPLETED|Overall Study||67
2608951|NCT00129545|6405895|P3|STARTED|Overall Study||244
2608952|NCT00129545|6405896|P2|STARTED|Overall Study|2:1 randomization WATCHMAN to warfarin|463
2608953|NCT00129545|6405897|P1|STARTED|Overall Study||93
2608954|NCT00129480|6405909|P2|NOT COMPLETED|Overall Study||0
2608955|NCT00129480|6405910|P1|NOT COMPLETED|Overall Study||0
2608956|NCT00129480|6405909|P2|COMPLETED|Overall Study||214
2608957|NCT00129480|6405910|P1|COMPLETED|Overall Study||187
2608958|NCT00129480|6405909|P2|STARTED|Overall Study||214
2608959|NCT00129480|6405910|P1|STARTED|Overall Study||187
2608960|NCT00129467|6405926|P2|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
2608961|NCT00129467|6405927|P1|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
2608962|NCT00129467|6405926|P2|COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
2608963|NCT00129467|6405927|P1|COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
2608964|NCT00129467|6405926|P2|STARTED|Open Label for SSRI+Methylphenidate Arm||0
2609037|NCT00129402|6405959|P6|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
2608965|NCT00129467|6405927|P1|STARTED|Open Label for SSRI+Methylphenidate Arm|Eligible if in methylphenidate arm & had 50% reduction in Montgomery-Asberg Depression Rating score|4
2608966|NCT00129467|6405926|P2|NOT COMPLETED|Received Intervention||4
2608967|NCT00129467|6405927|P1|NOT COMPLETED|Received Intervention||6
2608968|NCT00129467|6405926|P2|COMPLETED|Received Intervention||13
2608969|NCT00129467|6405927|P1|COMPLETED|Received Intervention||9
2608970|NCT00129467|6405926|P2|STARTED|Received Intervention||17
2608971|NCT00129467|6405927|P1|STARTED|Received Intervention||15
2608972|NCT00129441|6405935|P2|NOT COMPLETED|Overall Study||0
2608973|NCT00129441|6405936|P1|NOT COMPLETED|Overall Study||0
2608974|NCT00129441|6405935|P2|COMPLETED|Overall Study||6
2608975|NCT00129441|6405936|P1|COMPLETED|Overall Study||9
2608976|NCT00129441|6405935|P2|Year 1, Visit 8|Overall Study||6
2608977|NCT00129441|6405936|P1|Year 1, Visit 8|Overall Study||9
2608978|NCT00129441|6405935|P2|Week 26, Visit 7|Overall Study||6
2608979|NCT00129441|6405936|P1|Week 26, Visit 7|Overall Study||9
2608980|NCT00129441|6405935|P2|Week 5, Visit 6|Overall Study||6
2608981|NCT00129441|6405936|P1|Week 5, Visit 6|Overall Study||9
2608982|NCT00129441|6405935|P2|Week 4, Visit 5|Overall Study||6
2608983|NCT00129441|6405936|P1|Week 4, Visit 5|Overall Study||9
2608984|NCT00129441|6405935|P2|Week 3, Visit 4|Overall Study||6
2608985|NCT00129441|6405936|P1|Week 3, Visit 4|Overall Study||9
2608986|NCT00129441|6405935|P2|Week 2, Visit 3|Overall Study||6
2608987|NCT00129441|6405936|P1|Week 2, Visit 3|Overall Study||9
2608988|NCT00129441|6405935|P2|Week 1, Visit 2|Overall Study||6
2608989|NCT00129441|6405936|P1|Week 1, Visit 2|Overall Study||9
2608990|NCT00129441|6405935|P2|Baseline, Visit 1|Overall Study||6
2608991|NCT00129441|6405936|P1|Baseline, Visit 1|Overall Study|Baseline # only includes those who completed 4-week trial (one L-830982 subject did not complete).|9
2608992|NCT00129441|6405935|P2|STARTED|Overall Study||6
2608993|NCT00129441|6405936|P1|STARTED|Overall Study||9
2608994|NCT00129402|6405958|P7|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||6
2608995|NCT00129402|6405959|P6|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
2608996|NCT00129402|6405960|P5|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
2608997|NCT00129402|6405961|P4|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
2608998|NCT00129402|6405962|P3|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
2608999|NCT00129402|6405963|P2|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
2609000|NCT00129402|6405964|P1|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
2609001|NCT00129402|6405958|P7|COMPLETED|Start Period3 to End Period3(Week 34-53)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|222
2609002|NCT00129402|6405959|P6|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
2609003|NCT00129402|6405960|P5|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
2609004|NCT00129402|6405961|P4|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
2609005|NCT00129402|6405962|P3|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
2609006|NCT00129402|6405963|P2|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
2609007|NCT00129402|6405964|P1|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
2609008|NCT00129402|6405958|P7|STARTED|Start Period3 to End Period3(Week 34-53)|In Period 3, all subjects from Period 1 and Period 2 were combined into one treatment group.|228
2609009|NCT00129402|6405959|P6|STARTED|Start Period3 to End Period3(Week 34-53)||0
2609010|NCT00129402|6405960|P5|STARTED|Start Period3 to End Period3(Week 34-53)||0
2609011|NCT00129402|6405961|P4|STARTED|Start Period3 to End Period3(Week 34-53)||0
2609012|NCT00129402|6405962|P3|STARTED|Start Period3 to End Period3(Week 34-53)||0
2609013|NCT00129402|6405963|P2|STARTED|Start Period3 to End Period3(Week 34-53)||0
2609014|NCT00129402|6405964|P1|STARTED|Start Period3 to End Period3(Week 34-53)||0
2609015|NCT00129402|6405958|P7|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
2609016|NCT00129402|6405959|P6|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||5
2609017|NCT00129402|6405960|P5|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
2609018|NCT00129402|6405961|P4|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
2609019|NCT00129402|6405962|P3|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||8
2609020|NCT00129402|6405963|P2|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
2609021|NCT00129402|6405964|P1|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
2609022|NCT00129402|6405958|P7|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
2609023|NCT00129402|6405959|P6|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|113
2609024|NCT00129402|6405960|P5|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
2609025|NCT00129402|6405961|P4|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
2609026|NCT00129402|6405962|P3|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|114
2609027|NCT00129402|6405963|P2|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
2609028|NCT00129402|6405964|P1|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
2609029|NCT00129402|6405958|P7|STARTED|Start Period2 to End Period2 (Week 7-33)||0
2609030|NCT00129402|6405959|P6|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received simvastatin monotherapy|118
2609031|NCT00129402|6405960|P5|STARTED|Start Period2 to End Period2 (Week 7-33)||0
2609032|NCT00129402|6405961|P4|STARTED|Start Period2 to End Period2 (Week 7-33)||0
2609033|NCT00129402|6405962|P3|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received ezetimibe with simvastatin|122
2609034|NCT00129402|6405963|P2|STARTED|Start Period2 to End Period2 (Week 7-33)||0
2609035|NCT00129402|6405964|P1|STARTED|Start Period2 to End Period2 (Week 7-33)||0
2609036|NCT00129402|6405958|P7|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
2609038|NCT00129402|6405960|P5|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
2609039|NCT00129402|6405961|P4|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
2609040|NCT00129402|6405962|P3|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
2609041|NCT00129402|6405963|P2|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
2609042|NCT00129402|6405964|P1|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
2609043|NCT00129402|6405958|P7|COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
2609044|NCT00129402|6405959|P6|COMPLETED|Start Period1 to End Period1 (Week 1-6)||40
2609045|NCT00129402|6405960|P5|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
2609046|NCT00129402|6405961|P4|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
2609047|NCT00129402|6405962|P3|COMPLETED|Start Period1 to End Period1 (Week 1-6)||41
2609048|NCT00129402|6405963|P2|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
2609049|NCT00129402|6405964|P1|COMPLETED|Start Period1 to End Period1 (Week 1-6)||43
2609050|NCT00129402|6405958|P7|STARTED|Start Period1 to End Period1 (Week 1-6)||0
2609051|NCT00129402|6405959|P6|STARTED|Start Period1 to End Period1 (Week 1-6)||42
2609052|NCT00129402|6405960|P5|STARTED|Start Period1 to End Period1 (Week 1-6)||40
2609053|NCT00129402|6405961|P4|STARTED|Start Period1 to End Period1 (Week 1-6)||40
2609054|NCT00129402|6405962|P3|STARTED|Start Period1 to End Period1 (Week 1-6)||43
2609055|NCT00129402|6405963|P2|STARTED|Start Period1 to End Period1 (Week 1-6)||40
2609056|NCT00129402|6405964|P1|STARTED|Start Period1 to End Period1 (Week 1-6)||43
2609057|NCT00129389|6405983|P2|NOT COMPLETED|Overall Study||140
2609058|NCT00129389|6405984|P1|NOT COMPLETED|Overall Study||33
2609059|NCT00129389|6405983|P2|COMPLETED|Overall Study|16 patients were crossed from arm B to A by error. 1 patient was crossed from arm A to B by error.|811
2609060|NCT00129389|6405984|P1|COMPLETED|Overall Study|1 patient was crossed from arm A to B by error. 16 patients were crossed from arm B, to A by error.|941
2609061|NCT00129389|6405983|P2|STARTED|Overall Study||951
2609062|NCT00129389|6405984|P1|STARTED|Overall Study||974
2609063|NCT00129376|6405992|P1|NOT COMPLETED|Overall Study||2
2609064|NCT00129376|6405992|P1|COMPLETED|Overall Study||61
2609065|NCT00129376|6405992|P1|STARTED|Overall Study||63
2609066|NCT00129311|6406002|P2|NOT COMPLETED|Overall Study||19
2609067|NCT00129311|6406003|P1|NOT COMPLETED|Overall Study||12
2609068|NCT00129311|6406002|P2|COMPLETED|Overall Study||31
2609069|NCT00129311|6406003|P1|COMPLETED|Overall Study||39
2609070|NCT00129311|6406002|P2|STARTED|Overall Study||50
2609071|NCT00129311|6406003|P1|STARTED|Overall Study||51
2609072|NCT00129285|6406014|P3|NOT COMPLETED|Overall Study||38
2609073|NCT00129285|6406015|P2|NOT COMPLETED|Overall Study||27
2609074|NCT00129285|6406016|P1|NOT COMPLETED|Overall Study||25
2609075|NCT00129285|6406014|P3|COMPLETED|Overall Study||37
2609076|NCT00129285|6406015|P2|COMPLETED|Overall Study||43
2609077|NCT00129285|6406016|P1|COMPLETED|Overall Study||40
2609078|NCT00129285|6406014|P3|STARTED|Overall Study||75
2609079|NCT00129285|6406015|P2|STARTED|Overall Study||70
2609080|NCT00129285|6406016|P1|STARTED|Overall Study||65
2609081|NCT00129272|6406032|P2|NOT COMPLETED|Overall Study||22
2609082|NCT00129272|6406033|P1|NOT COMPLETED|Overall Study||17
2609083|NCT00129272|6406032|P2|COMPLETED|Overall Study||51
2609084|NCT00129272|6406033|P1|COMPLETED|Overall Study||54
2609085|NCT00129272|6406032|P2|STARTED|Overall Study||73
2609086|NCT00129272|6406033|P1|STARTED|Overall Study||71
2609087|NCT00129259|6406043|P2|NOT COMPLETED|Overall Study||3
2609088|NCT00129259|6406044|P1|NOT COMPLETED|Overall Study||3
2609089|NCT00129259|6406043|P2|COMPLETED|Overall Study||22
2609090|NCT00129259|6406044|P1|COMPLETED|Overall Study||49
2609091|NCT00129259|6406043|P2|Received All or Part of Cycle 2|Overall Study||0
2609092|NCT00129259|6406044|P1|Received All or Part of Cycle 2|Overall Study||40
2609093|NCT00129259|6406043|P2|Received All or Part of Cycle 1|Overall Study||0
2609094|NCT00129259|6406044|P1|Received All or Part of Cycle 1|Overall Study||52
2609095|NCT00129259|6406043|P2|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|25
2609096|NCT00129259|6406044|P1|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|52
2609097|NCT00129246|6406056|P2|NOT COMPLETED|Overall Study||0
2609098|NCT00129246|6406057|P1|NOT COMPLETED|Overall Study||0
2609099|NCT00129246|6406056|P2|COMPLETED|Overall Study||20
2609100|NCT00129246|6406057|P1|COMPLETED|Overall Study||20
2609101|NCT00129246|6406056|P2|STARTED|Overall Study||20
2609102|NCT00129246|6406057|P1|STARTED|Overall Study||20
2609103|NCT00129220|6406072|P3|NOT COMPLETED|Study Period III||10
2609104|NCT00129220|6406073|P2|NOT COMPLETED|Study Period III||1
2609105|NCT00129220|6406074|P1|NOT COMPLETED|Study Period III||13
2609106|NCT00129220|6406072|P3|COMPLETED|Study Period III||42
2609107|NCT00129220|6406073|P2|COMPLETED|Study Period III||7
2609108|NCT00129220|6406074|P1|COMPLETED|Study Period III||59
2609109|NCT00129220|6406072|P3|STARTED|Study Period III||52
2609110|NCT00129220|6406073|P2|STARTED|Study Period III||8
2609111|NCT00129220|6406074|P1|STARTED|Study Period III||72
2609112|NCT00129220|6406072|P3|NOT COMPLETED|Study Period II||47
2609113|NCT00129220|6406073|P2|NOT COMPLETED|Study Period II||12
2609114|NCT00129220|6406074|P1|NOT COMPLETED|Study Period II||33
2609115|NCT00129220|6406072|P3|COMPLETED|Study Period II||52
2609116|NCT00129220|6406073|P2|COMPLETED|Study Period II||8
2609117|NCT00129220|6406074|P1|COMPLETED|Study Period II||72
2609118|NCT00129220|6406072|P3|Received at Least One Dose of Study Drug|Study Period II||97
2609119|NCT00129220|6406073|P2|Received at Least One Dose of Study Drug|Study Period II||20
2609120|NCT00129220|6406074|P1|Received at Least One Dose of Study Drug|Study Period II||104
2609121|NCT00129220|6406072|P3|STARTED|Study Period II||99
2609122|NCT00129220|6406073|P2|STARTED|Study Period II||20
2609123|NCT00129220|6406074|P1|STARTED|Study Period II||105
2609124|NCT00129129|6406114|P5|NOT COMPLETED|Fourth Dose Phase||6
2609125|NCT00129129|6406115|P4|NOT COMPLETED|Fourth Dose Phase||4
2609126|NCT00129129|6406116|P3|NOT COMPLETED|Fourth Dose Phase||0
2609127|NCT00129129|6406117|P2|NOT COMPLETED|Fourth Dose Phase||0
2609128|NCT00129129|6406118|P1|NOT COMPLETED|Fourth Dose Phase||4
2609129|NCT00129129|6406114|P5|COMPLETED|Fourth Dose Phase||124
2609130|NCT00129129|6406115|P4|COMPLETED|Fourth Dose Phase||128
2609131|NCT00129129|6406116|P3|COMPLETED|Fourth Dose Phase||0
2609132|NCT00129129|6406117|P2|COMPLETED|Fourth Dose Phase||0
2609133|NCT00129129|6406118|P1|COMPLETED|Fourth Dose Phase||232
2609134|NCT00129129|6406114|P5|STARTED|Fourth Dose Phase||130
2609135|NCT00129129|6406115|P4|STARTED|Fourth Dose Phase||132
2609136|NCT00129129|6406116|P3|STARTED|Fourth Dose Phase||0
2609137|NCT00129129|6406117|P2|STARTED|Fourth Dose Phase||0
2609138|NCT00129129|6406118|P1|STARTED|Fourth Dose Phase||236
2609139|NCT00129129|6406114|P5|NOT COMPLETED|Primary Phase||0
2609140|NCT00129129|6406115|P4|NOT COMPLETED|Primary Phase||0
2609141|NCT00129129|6406116|P3|NOT COMPLETED|Primary Phase||0
2609142|NCT00129129|6406117|P2|NOT COMPLETED|Primary Phase||25
2609143|NCT00129129|6406118|P1|NOT COMPLETED|Primary Phase||25
2609144|NCT00129129|6406114|P5|COMPLETED|Primary Phase||0
2609145|NCT00129129|6406115|P4|COMPLETED|Primary Phase||0
2609146|NCT00129129|6406116|P3|COMPLETED|Primary Phase||150
2609147|NCT00129129|6406117|P2|COMPLETED|Primary Phase||294
2609148|NCT00129129|6406118|P1|COMPLETED|Primary Phase||262
2609149|NCT00129129|6406114|P5|STARTED|Primary Phase||0
2609150|NCT00129129|6406115|P4|STARTED|Primary Phase||0
2609151|NCT00129129|6406116|P3|STARTED|Primary Phase||150
2609152|NCT00129129|6406117|P2|STARTED|Primary Phase||319
2609153|NCT00129129|6406118|P1|STARTED|Primary Phase||287
2609154|NCT00129116|6406325|P5|NOT COMPLETED|Booster Phase||1
2609155|NCT00129116|6406326|P4|NOT COMPLETED|Booster Phase||0
2609156|NCT00129116|6406327|P3|NOT COMPLETED|Booster Phase||0
2609157|NCT00129116|6406328|P2|NOT COMPLETED|Booster Phase||0
2609158|NCT00129116|6406329|P1|NOT COMPLETED|Booster Phase||2
2609159|NCT00129116|6406325|P5|COMPLETED|Booster Phase||43
2609160|NCT00129116|6406326|P4|COMPLETED|Booster Phase||44
2609161|NCT00129116|6406327|P3|COMPLETED|Booster Phase||44
2609162|NCT00129116|6406328|P2|COMPLETED|Booster Phase||42
2609163|NCT00129116|6406329|P1|COMPLETED|Booster Phase||45
2609164|NCT00129116|6406325|P5|STARTED|Booster Phase||44
2609165|NCT00129116|6406326|P4|STARTED|Booster Phase||44
2609166|NCT00129116|6406327|P3|STARTED|Booster Phase||44
2609167|NCT00129116|6406328|P2|STARTED|Booster Phase||42
2609168|NCT00129116|6406329|P1|STARTED|Booster Phase||47
2609169|NCT00129116|6406325|P5|NOT COMPLETED|Primary Phase||1
2609170|NCT00129116|6406326|P4|NOT COMPLETED|Primary Phase||1
2609171|NCT00129116|6406327|P3|NOT COMPLETED|Primary Phase||1
2609172|NCT00129116|6406328|P2|NOT COMPLETED|Primary Phase||4
2609173|NCT00129116|6406329|P1|NOT COMPLETED|Primary Phase||2
2609174|NCT00129116|6406325|P5|COMPLETED|Primary Phase||76
2609175|NCT00129116|6406326|P4|COMPLETED|Primary Phase||77
2609176|NCT00129116|6406327|P3|COMPLETED|Primary Phase||77
2609177|NCT00129116|6406328|P2|COMPLETED|Primary Phase||73
2609178|NCT00129116|6406329|P1|COMPLETED|Primary Phase||76
2609179|NCT00129116|6406325|P5|STARTED|Primary Phase||77
2609180|NCT00129116|6406326|P4|STARTED|Primary Phase||78
2609181|NCT00129116|6406327|P3|STARTED|Primary Phase||78
2609182|NCT00129116|6406328|P2|STARTED|Primary Phase||77
2609183|NCT00129116|6406329|P1|STARTED|Primary Phase||78
2609184|NCT00128921|6406594|P3|NOT COMPLETED|Overall Study||0
2609185|NCT00128921|6406595|P2|NOT COMPLETED|Overall Study||5
2609186|NCT00128921|6406596|P1|NOT COMPLETED|Overall Study||5
2609187|NCT00128921|6406594|P3|COMPLETED|Overall Study||0
2609188|NCT00128921|6406595|P2|COMPLETED|Overall Study||3
2609189|NCT00128921|6406596|P1|COMPLETED|Overall Study||5
2609190|NCT00128921|6406594|P3|Received Bortezomib|Overall Study||0
2609191|NCT00128921|6406595|P2|Received Bortezomib|Overall Study||6
2609192|NCT00128921|6406596|P1|Received Bortezomib|Overall Study||10
2609193|NCT00128921|6406594|P3|STARTED|Overall Study||0
2609194|NCT00128921|6406595|P2|STARTED|Overall Study||8
2609195|NCT00128921|6406596|P1|STARTED|Overall Study||10
2609196|NCT00128830|6406613|P1|NOT COMPLETED|Overall Study||72
2609197|NCT00128830|6406613|P1|COMPLETED|Overall Study||139
2609198|NCT00128830|6406613|P1|STARTED|Overall Study||211
2609199|NCT00128713|6406631|P3|NOT COMPLETED|Overall Study||0
2609200|NCT00128713|6406632|P2|NOT COMPLETED|Overall Study||0
2609201|NCT00128713|6406633|P1|NOT COMPLETED|Overall Study||0
2609202|NCT00128713|6406631|P3|COMPLETED|Overall Study||449
2609203|NCT00128713|6406632|P2|COMPLETED|Overall Study||449
2609204|NCT00128713|6406633|P1|COMPLETED|Overall Study||453
2609205|NCT00128713|6406631|P3|STARTED|Overall Study||449
2609206|NCT00128713|6406632|P2|STARTED|Overall Study||449
2609207|NCT00128713|6406633|P1|STARTED|Overall Study||453
2609208|NCT00128661|6406655|P2|NOT COMPLETED|Overall Study||258
2609209|NCT00128661|6406656|P1|NOT COMPLETED|Overall Study||274
2609210|NCT00128661|6406655|P2|COMPLETED|Overall Study||3481
2609211|NCT00128661|6406656|P1|COMPLETED|Overall Study||3453
2609212|NCT00128661|6406655|P2|STARTED|Overall Study||3739
2609213|NCT00128661|6406656|P1|STARTED|Overall Study||3727
2609214|NCT00128492|6406702|P2|NOT COMPLETED|Overall Study||59
2609215|NCT00128492|6406703|P1|NOT COMPLETED|Overall Study||20
2609216|NCT00128492|6406702|P2|COMPLETED|Overall Study||130
2609217|NCT00128492|6406703|P1|COMPLETED|Overall Study||65
2609218|NCT00128492|6406702|P2|STARTED|Overall Study||189
2609219|NCT00128492|6406703|P1|STARTED|Overall Study||85
2609220|NCT00128401|6406763|P2|NOT COMPLETED|Overall Study||4
2609221|NCT00128401|6406764|P1|NOT COMPLETED|Overall Study||6
2609222|NCT00128401|6406763|P2|COMPLETED|Overall Study||15
2609223|NCT00128401|6406764|P1|COMPLETED|Overall Study||14
2609224|NCT00128401|6406763|P2|STARTED|Overall Study||19
2609225|NCT00128401|6406764|P1|STARTED|Overall Study||20
2609226|NCT00128219|6406775|P2|NOT COMPLETED|Overall Study||71
2609227|NCT00128219|6406776|P1|NOT COMPLETED|Overall Study||69
2609228|NCT00128219|6406775|P2|COMPLETED|Overall Study||263
2609229|NCT00128219|6406776|P1|COMPLETED|Overall Study||264
2609230|NCT00128219|6406775|P2|STARTED|Overall Study||334
2609231|NCT00128219|6406776|P1|STARTED|Overall Study||333
2609232|NCT00128206|6406860|P2|NOT COMPLETED|Overall Study||120
2609233|NCT00128206|6406861|P1|NOT COMPLETED|Overall Study||137
2609234|NCT00128206|6406860|P2|COMPLETED|Overall Study||60
2609235|NCT00128206|6406861|P1|COMPLETED|Overall Study||47
2609236|NCT00128206|6406860|P2|STARTED|Overall Study||180
2609237|NCT00128206|6406861|P1|STARTED|Overall Study||184
2609238|NCT00128193|6406879|P12|NOT COMPLETED|Overall Study||2
2609239|NCT00128193|6406880|P11|NOT COMPLETED|Overall Study||3
2609240|NCT00128193|6406881|P10|NOT COMPLETED|Overall Study||2
2609241|NCT00128193|6406882|P9|NOT COMPLETED|Overall Study||2
2609242|NCT00128193|6406883|P8|NOT COMPLETED|Overall Study||0
2609243|NCT00128193|6406884|P7|NOT COMPLETED|Overall Study||4
2609244|NCT00128193|6406885|P6|NOT COMPLETED|Overall Study||3
2609245|NCT00128193|6406886|P5|NOT COMPLETED|Overall Study||2
2609246|NCT00128193|6406887|P4|NOT COMPLETED|Overall Study||1
2609247|NCT00128193|6406888|P3|NOT COMPLETED|Overall Study||3
2609248|NCT00128193|6406889|P2|NOT COMPLETED|Overall Study||0
2609249|NCT00128193|6406890|P1|NOT COMPLETED|Overall Study||0
2609250|NCT00128193|6406879|P12|COMPLETED|Overall Study||18
2609251|NCT00128193|6406880|P11|COMPLETED|Overall Study||17
2609252|NCT00128193|6406881|P10|COMPLETED|Overall Study||18
2609253|NCT00128193|6406882|P9|COMPLETED|Overall Study||18
2609254|NCT00128193|6406883|P8|COMPLETED|Overall Study||20
2609255|NCT00128193|6406884|P7|COMPLETED|Overall Study||16
2609256|NCT00128193|6406885|P6|COMPLETED|Overall Study||17
2609257|NCT00128193|6406886|P5|COMPLETED|Overall Study||18
2609258|NCT00128193|6406887|P4|COMPLETED|Overall Study||44
2609259|NCT00128193|6406888|P3|COMPLETED|Overall Study||42
2609260|NCT00128193|6406889|P2|COMPLETED|Overall Study||5
2609261|NCT00128193|6406890|P1|COMPLETED|Overall Study||5
2609262|NCT00128193|6406879|P12|STARTED|Overall Study||20
2609263|NCT00128193|6406880|P11|STARTED|Overall Study||20
2609264|NCT00128193|6406881|P10|STARTED|Overall Study||20
2609265|NCT00128193|6406882|P9|STARTED|Overall Study||20
2609266|NCT00128193|6406883|P8|STARTED|Overall Study||20
2609267|NCT00128193|6406884|P7|STARTED|Overall Study||20
2609268|NCT00128193|6406885|P6|STARTED|Overall Study||20
2609269|NCT00128193|6406886|P5|STARTED|Overall Study||20
2609270|NCT00128193|6406887|P4|STARTED|Overall Study||45
2609271|NCT00128193|6406888|P3|STARTED|Overall Study||45
2609272|NCT00128193|6406889|P2|STARTED|Overall Study||5
2609273|NCT00128193|6406890|P1|STARTED|Overall Study||5
2609274|NCT00128180|6407126|P2|NOT COMPLETED|Overall Study||0
2609275|NCT00128180|6407127|P1|NOT COMPLETED|Overall Study||0
2609276|NCT00128180|6407126|P2|COMPLETED|Overall Study||34
2609277|NCT00128180|6407127|P1|COMPLETED|Overall Study||32
2609278|NCT00128180|6407126|P2|STARTED|Overall Study||34
2609279|NCT00128180|6407127|P1|STARTED|Overall Study||32
2609280|NCT00127933|6407153|P2|NOT COMPLETED|Overall Study||0
2609281|NCT00127933|6407154|P1|NOT COMPLETED|Overall Study||1
2609282|NCT00127933|6407153|P2|COMPLETED|Overall Study||34
2609283|NCT00127933|6407154|P1|COMPLETED|Overall Study||122
2609284|NCT00127933|6407153|P2|Postoperative|Overall Study||27
2609285|NCT00127933|6407154|P1|Postoperative|Overall Study||98
2609286|NCT00127933|6407153|P2|Quality of Life Population|Overall Study||33
2609287|NCT00127933|6407154|P1|Quality of Life Population|Overall Study||118
2609288|NCT00127933|6407153|P2|Safety Population|Overall Study||34
2609289|NCT00127933|6407154|P1|Safety Population|Overall Study||122
2609290|NCT00127933|6407153|P2|Clinical Response|Overall Study||34
2609291|NCT00127933|6407154|P1|Clinical Response|Overall Study||122
2609292|NCT00127933|6407153|P2|Pathological Response|Overall Study||28
2609293|NCT00127933|6407154|P1|Pathological Response|Overall Study||101
2609294|NCT00127933|6407153|P2|STARTED|Overall Study||34
2609295|NCT00127933|6407154|P1|STARTED|Overall Study||123
2609296|NCT00127855|6407175|P5|NOT COMPLETED|Polysaccharide Challenge Dose||0
2609297|NCT00127855|6407176|P4|NOT COMPLETED|Polysaccharide Challenge Dose||0
2609298|NCT00127855|6407177|P3|NOT COMPLETED|Polysaccharide Challenge Dose||0
2609299|NCT00127855|6407178|P2|NOT COMPLETED|Polysaccharide Challenge Dose||0
2609300|NCT00127855|6407179|P1|NOT COMPLETED|Polysaccharide Challenge Dose||0
2609301|NCT00127855|6407175|P5|COMPLETED|Polysaccharide Challenge Dose||77
2609302|NCT00127855|6407176|P4|COMPLETED|Polysaccharide Challenge Dose||81
2609303|NCT00127855|6407177|P3|COMPLETED|Polysaccharide Challenge Dose||77
2609304|NCT00127855|6407178|P2|COMPLETED|Polysaccharide Challenge Dose||79
2609305|NCT00127855|6407179|P1|COMPLETED|Polysaccharide Challenge Dose||80
2609306|NCT00127855|6407175|P5|STARTED|Polysaccharide Challenge Dose||77
2609307|NCT00127855|6407176|P4|STARTED|Polysaccharide Challenge Dose||81
2609308|NCT00127855|6407177|P3|STARTED|Polysaccharide Challenge Dose||77
2609309|NCT00127855|6407178|P2|STARTED|Polysaccharide Challenge Dose||79
2609310|NCT00127855|6407179|P1|STARTED|Polysaccharide Challenge Dose||80
2609311|NCT00127855|6407175|P5|NOT COMPLETED|Primary Vaccination Course||4
2609312|NCT00127855|6407176|P4|NOT COMPLETED|Primary Vaccination Course||0
2609313|NCT00127855|6407177|P3|NOT COMPLETED|Primary Vaccination Course||2
2609314|NCT00127855|6407178|P2|NOT COMPLETED|Primary Vaccination Course||1
2609315|NCT00127855|6407179|P1|NOT COMPLETED|Primary Vaccination Course||2
2609316|NCT00127855|6407175|P5|COMPLETED|Primary Vaccination Course||78
2609317|NCT00127855|6407176|P4|COMPLETED|Primary Vaccination Course||81
2609318|NCT00127855|6407177|P3|COMPLETED|Primary Vaccination Course||78
2609319|NCT00127855|6407178|P2|COMPLETED|Primary Vaccination Course||81
2609320|NCT00127855|6407179|P1|COMPLETED|Primary Vaccination Course||80
2609321|NCT00127855|6407175|P5|STARTED|Primary Vaccination Course||82
2609322|NCT00127855|6407176|P4|STARTED|Primary Vaccination Course||81
2609323|NCT00127855|6407177|P3|STARTED|Primary Vaccination Course||80
2609324|NCT00127855|6407178|P2|STARTED|Primary Vaccination Course||82
2609325|NCT00127855|6407179|P1|STARTED|Primary Vaccination Course||82
2609326|NCT00127842|6407361|P1|NOT COMPLETED|Overall Study||39
2609327|NCT00127842|6407361|P1|COMPLETED|Overall Study||71
2609328|NCT00127842|6407361|P1|STARTED|Overall Study||110
2609329|NCT00127803|6407379|P4|NOT COMPLETED|Overall Study||1
2609330|NCT00127803|6407380|P3|NOT COMPLETED|Overall Study||0
2609331|NCT00127803|6407381|P2|NOT COMPLETED|Overall Study||0
2609332|NCT00127803|6407382|P1|NOT COMPLETED|Overall Study||3
2609333|NCT00127803|6407379|P4|COMPLETED|Overall Study||11
2609334|NCT00127803|6407380|P3|COMPLETED|Overall Study||12
2609335|NCT00127803|6407381|P2|COMPLETED|Overall Study||13
2609336|NCT00127803|6407382|P1|COMPLETED|Overall Study||10
2609337|NCT00127803|6407379|P4|STARTED|Overall Study||12
2609338|NCT00127803|6407380|P3|STARTED|Overall Study||12
2609339|NCT00127803|6407381|P2|STARTED|Overall Study||13
2609340|NCT00127803|6407382|P1|STARTED|Overall Study||13
2609341|NCT00127790|6407404|P4|NOT COMPLETED|Post-Treatment||0
2609342|NCT00127790|6407405|P3|NOT COMPLETED|Post-Treatment||0
2609343|NCT00127790|6407406|P2|NOT COMPLETED|Post-Treatment||0
2609344|NCT00127790|6407407|P1|NOT COMPLETED|Post-Treatment||0
2609345|NCT00127790|6407404|P4|COMPLETED|Post-Treatment||4
2609346|NCT00127790|6407405|P3|COMPLETED|Post-Treatment||6
2609347|NCT00127790|6407406|P2|COMPLETED|Post-Treatment||5
2609348|NCT00127790|6407407|P1|COMPLETED|Post-Treatment||6
2609349|NCT00127790|6407404|P4|STARTED|Post-Treatment||4
2609350|NCT00127790|6407405|P3|STARTED|Post-Treatment||6
2609351|NCT00127790|6407406|P2|STARTED|Post-Treatment||5
2609352|NCT00127790|6407407|P1|STARTED|Post-Treatment||6
2609353|NCT00127790|6407404|P4|NOT COMPLETED|Pre-Treatment||0
2609354|NCT00127790|6407405|P3|NOT COMPLETED|Pre-Treatment||0
2609355|NCT00127790|6407406|P2|NOT COMPLETED|Pre-Treatment||0
2609356|NCT00127790|6407407|P1|NOT COMPLETED|Pre-Treatment||0
2609357|NCT00127790|6407404|P4|COMPLETED|Pre-Treatment||4
2609358|NCT00127790|6407405|P3|COMPLETED|Pre-Treatment||6
2609359|NCT00127790|6407406|P2|COMPLETED|Pre-Treatment||5
2609360|NCT00127790|6407407|P1|COMPLETED|Pre-Treatment||6
2609361|NCT00127790|6407404|P4|STARTED|Pre-Treatment||4
2609362|NCT00127790|6407405|P3|STARTED|Pre-Treatment||6
2609363|NCT00127790|6407406|P2|STARTED|Pre-Treatment||5
2609364|NCT00127790|6407407|P1|STARTED|Pre-Treatment|7 enrolled subjects were withdrawn prior to randomization; 21 of 28 enrolled were randomized.|6
2609365|NCT00127712|6407431|P2|NOT COMPLETED|Overall Study||0
2609366|NCT00127712|6407432|P1|NOT COMPLETED|Overall Study||5
2609367|NCT00127712|6407431|P2|COMPLETED|Overall Study||65
2609368|NCT00127712|6407432|P1|COMPLETED|Overall Study||60
2609369|NCT00127712|6407431|P2|STARTED|Overall Study||65
2609370|NCT00127712|6407432|P1|STARTED|Overall Study||65
2609371|NCT00127660|6407448|P4|NOT COMPLETED|Overall Study||0
2609372|NCT00127660|6407449|P3|NOT COMPLETED|Overall Study||5
2609373|NCT00127660|6407450|P2|NOT COMPLETED|Overall Study||3
2609374|NCT00127660|6407451|P1|NOT COMPLETED|Overall Study||3
2609375|NCT00127660|6407448|P4|COMPLETED|Overall Study||150
2609376|NCT00127660|6407449|P3|COMPLETED|Overall Study||143
2609377|NCT00127660|6407450|P2|COMPLETED|Overall Study||151
2609378|NCT00127660|6407451|P1|COMPLETED|Overall Study||150
2609379|NCT00127660|6407448|P4|STARTED|Overall Study||150
2609380|NCT00127660|6407449|P3|STARTED|Overall Study||148
2609381|NCT00127660|6407450|P2|STARTED|Overall Study||154
2609382|NCT00127660|6407451|P1|STARTED|Overall Study||153
2609383|NCT00127608|6407461|P1|NOT COMPLETED|Overall Study||1
2609384|NCT00127608|6407461|P1|COMPLETED|Overall Study||35
2609385|NCT00127608|6407461|P1|STARTED|Overall Study||36
2609386|NCT00127530|6407469|P2|NOT COMPLETED|Overall Study||21
2609387|NCT00127530|6407470|P1|NOT COMPLETED|Overall Study||1
2609388|NCT00127530|6407469|P2|COMPLETED|Overall Study||207
2609389|NCT00127530|6407470|P1|COMPLETED|Overall Study||71
2609390|NCT00127530|6407469|P2|STARTED|Overall Study||228
2609391|NCT00127530|6407470|P1|STARTED|Overall Study||72
2609392|NCT00127439|6407478|P2|NOT COMPLETED|Overall Study||0
2609393|NCT00127439|6407479|P1|NOT COMPLETED|Overall Study||0
2609394|NCT00127439|6407478|P2|COMPLETED|Overall Study||10
2609395|NCT00127439|6407479|P1|COMPLETED|Overall Study||9
2609396|NCT00127439|6407478|P2|STARTED|Overall Study||10
2609397|NCT00127439|6407479|P1|STARTED|Overall Study||9
2609398|NCT00127413|6407505|P4|NOT COMPLETED|Overall Study||2
2609399|NCT00127413|6407506|P3|NOT COMPLETED|Overall Study||8
2609400|NCT00127413|6407507|P2|NOT COMPLETED|Overall Study||4
2609401|NCT00127413|6407508|P1|NOT COMPLETED|Overall Study||6
2609402|NCT00127413|6407505|P4|COMPLETED|Overall Study||5
2609403|NCT00127413|6407506|P3|COMPLETED|Overall Study||5
2609404|NCT00127413|6407507|P2|COMPLETED|Overall Study||6
2609405|NCT00127413|6407508|P1|COMPLETED|Overall Study||6
2609406|NCT00127413|6407505|P4|STARTED|Overall Study||7
2609407|NCT00127413|6407506|P3|STARTED|Overall Study||13
2609408|NCT00127413|6407507|P2|STARTED|Overall Study||10
2609409|NCT00127413|6407508|P1|STARTED|Overall Study||12
2609410|NCT00127231|6407520|P2|NOT COMPLETED|Overall Study||6
2609411|NCT00127231|6407521|P1|NOT COMPLETED|Overall Study||6
2609412|NCT00127231|6407520|P2|COMPLETED|Overall Study||68
2609413|NCT00127231|6407521|P1|COMPLETED|Overall Study||68
2609414|NCT00127231|6407520|P2|STARTED|Overall Study||74
2609415|NCT00127231|6407521|P1|STARTED|Overall Study||74
2609416|NCT00127218|6407537|P2|NOT COMPLETED|Overall Study||15
2609417|NCT00127218|6407538|P1|NOT COMPLETED|Overall Study||13
2609418|NCT00127218|6407537|P2|COMPLETED|Overall Study||58
2609419|NCT00127218|6407538|P1|COMPLETED|Overall Study||59
2609420|NCT00127218|6407537|P2|STARTED|Overall Study||73
2609421|NCT00127218|6407538|P1|STARTED|Overall Study||72
2609422|NCT00127205|6407549|P3|NOT COMPLETED|Overall Study||617
2609423|NCT00127205|6407550|P2|NOT COMPLETED|Overall Study||980
2609424|NCT00127205|6407551|P1|NOT COMPLETED|Overall Study||835
2609425|NCT00127205|6407549|P3|COMPLETED|Overall Study||950
2609426|NCT00127205|6407550|P2|COMPLETED|Overall Study||1288
2609427|NCT00127205|6407551|P1|COMPLETED|Overall Study||1427
2609428|NCT00127205|6407549|P3|STARTED|Overall Study||1567
2609429|NCT00127205|6407550|P2|STARTED|Overall Study||2268
2609430|NCT00127205|6407551|P1|STARTED|Overall Study||2262
2609431|NCT00127192|6407573|P5|NOT COMPLETED|Overall Study||5
2609432|NCT00127192|6407574|P4|NOT COMPLETED|Overall Study||1
2609433|NCT00127192|6407575|P3|NOT COMPLETED|Overall Study||2
2609434|NCT00127192|6407576|P2|NOT COMPLETED|Overall Study||1
2609435|NCT00127192|6407577|P1|NOT COMPLETED|Overall Study||3
2609436|NCT00127192|6407573|P5|COMPLETED|Overall Study||68
2609437|NCT00127192|6407574|P4|COMPLETED|Overall Study||67
2609438|NCT00127192|6407575|P3|COMPLETED|Overall Study||68
2609439|NCT00127192|6407576|P2|COMPLETED|Overall Study||71
2609440|NCT00127192|6407577|P1|COMPLETED|Overall Study||77
2609441|NCT00127192|6407573|P5|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|73
2609442|NCT00127192|6407574|P4|STARTED|Overall Study|Study enrolled slightly less than the target of N=70|68
2609443|NCT00127192|6407575|P3|STARTED|Overall Study|Study enrolled as per the target of N=70|70
2609444|NCT00127192|6407576|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|72
2609445|NCT00127192|6407577|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|80
2609446|NCT00127166|6407601|P2|NOT COMPLETED|Period II||0
2609447|NCT00127166|6407602|P1|NOT COMPLETED|Period II||3
2609448|NCT00127166|6407601|P2|COMPLETED|Period II||73
2609449|NCT00127166|6407602|P1|COMPLETED|Period II||72
2609450|NCT00127166|6407601|P2|STARTED|Period II||73
2609451|NCT00127166|6407602|P1|STARTED|Period II||75
2609452|NCT00127166|6407601|P2|NOT COMPLETED|Washout Period||1
2609453|NCT00127166|6407602|P1|NOT COMPLETED|Washout Period||0
2609454|NCT00127166|6407601|P2|COMPLETED|Washout Period||73
2609455|NCT00127166|6407602|P1|COMPLETED|Washout Period||75
2609456|NCT00127166|6407601|P2|STARTED|Washout Period||74
2609457|NCT00127166|6407602|P1|STARTED|Washout Period||75
2609458|NCT00127166|6407601|P2|NOT COMPLETED|Period I||2
2609459|NCT00127166|6407602|P1|NOT COMPLETED|Period I||3
2609460|NCT00127166|6407601|P2|COMPLETED|Period I||74
2609461|NCT00127166|6407602|P1|COMPLETED|Period I||75
2609462|NCT00127166|6407601|P2|STARTED|Period I||76
2609463|NCT00127166|6407602|P1|STARTED|Period I||78
2609464|NCT00127101|6407622|P6|NOT COMPLETED|Continuation Phase||3
2609465|NCT00127101|6407623|P5|NOT COMPLETED|Continuation Phase||3
2609466|NCT00127101|6407624|P4|NOT COMPLETED|Continuation Phase||0
2609467|NCT00127101|6407625|P3|NOT COMPLETED|Continuation Phase||1
2609468|NCT00127101|6407626|P2|NOT COMPLETED|Continuation Phase||0
2609469|NCT00127101|6407627|P1|NOT COMPLETED|Continuation Phase||0
2609470|NCT00127101|6407622|P6|COMPLETED|Continuation Phase||0
2609471|NCT00127101|6407623|P5|COMPLETED|Continuation Phase||0
2609472|NCT00127101|6407624|P4|COMPLETED|Continuation Phase||0
2609473|NCT00127101|6407625|P3|COMPLETED|Continuation Phase||0
2609474|NCT00127101|6407626|P2|COMPLETED|Continuation Phase||0
2609475|NCT00127101|6407627|P1|COMPLETED|Continuation Phase||0
2609476|NCT00127101|6407622|P6|STARTED|Continuation Phase||3
2609477|NCT00127101|6407623|P5|STARTED|Continuation Phase||3
2609478|NCT00127101|6407624|P4|STARTED|Continuation Phase|No patients from the 2b Cohort entered into the extension phase|0
2609479|NCT00127101|6407625|P3|STARTED|Continuation Phase||1
2609480|NCT00127101|6407626|P2|STARTED|Continuation Phase||0
2609481|NCT00127101|6407627|P1|STARTED|Continuation Phase||0
2609482|NCT00127101|6407622|P6|NOT COMPLETED|Base Protocol||1
2609483|NCT00127101|6407623|P5|NOT COMPLETED|Base Protocol||2
2609484|NCT00127101|6407624|P4|NOT COMPLETED|Base Protocol||0
2609485|NCT00127101|6407625|P3|NOT COMPLETED|Base Protocol||2
2609486|NCT00127101|6407626|P2|NOT COMPLETED|Base Protocol||4
2609487|NCT00127101|6407627|P1|NOT COMPLETED|Base Protocol||2
2609488|NCT00127101|6407622|P6|COMPLETED|Base Protocol||3
2609489|NCT00127101|6407623|P5|COMPLETED|Base Protocol||3
2609490|NCT00127101|6407624|P4|COMPLETED|Base Protocol||3
2609491|NCT00127101|6407625|P3|COMPLETED|Base Protocol||1
2609492|NCT00127101|6407626|P2|COMPLETED|Base Protocol||1
2609493|NCT00127101|6407627|P1|COMPLETED|Base Protocol||1
2609494|NCT00127101|6407622|P6|STARTED|Base Protocol||4
2609495|NCT00127101|6407623|P5|STARTED|Base Protocol||5
2609496|NCT00127101|6407624|P4|STARTED|Base Protocol||3
2609497|NCT00127101|6407625|P3|STARTED|Base Protocol||3
2609498|NCT00127101|6407626|P2|STARTED|Base Protocol||5
2609499|NCT00127101|6407627|P1|STARTED|Base Protocol||3
2609500|NCT00127062|6407649|P2|NOT COMPLETED|Second intervention_Hyde Park||0
2609501|NCT00127062|6407650|P1|NOT COMPLETED|Second intervention_Hyde Park||0
2609502|NCT00127062|6407649|P2|COMPLETED|Second intervention_Hyde Park||29
2609503|NCT00127062|6407650|P1|COMPLETED|Second intervention_Hyde Park||31
2609504|NCT00127062|6407649|P2|STARTED|Second intervention_Hyde Park||29
2609505|NCT00127062|6407650|P1|STARTED|Second intervention_Hyde Park||31
2609506|NCT00127062|6407649|P2|NOT COMPLETED|First intervention_Oxford Street||0
2609507|NCT00127062|6407650|P1|NOT COMPLETED|First intervention_Oxford Street||0
2609508|NCT00127062|6407649|P2|COMPLETED|First intervention_Oxford Street||29
2609509|NCT00127062|6407650|P1|COMPLETED|First intervention_Oxford Street||31
2609510|NCT00127062|6407649|P2|STARTED|First intervention_Oxford Street||29
2609511|NCT00127062|6407650|P1|STARTED|First intervention_Oxford Street||31
2609512|NCT00127036|6407662|P2|NOT COMPLETED|Overall Study||11
2609513|NCT00127036|6407663|P1|NOT COMPLETED|Overall Study||8
2609514|NCT00127036|6407662|P2|COMPLETED|Overall Study|20 Participants were evaluable.|20
2609515|NCT00127036|6407663|P1|COMPLETED|Overall Study|26 Participants were evaluable.|26
2609516|NCT00127036|6407662|P2|STARTED|Overall Study||31
2609517|NCT00127036|6407663|P1|STARTED|Overall Study||34
2609518|NCT00126776|6407675|P2|NOT COMPLETED|Overall Study||0
2609519|NCT00126776|6407676|P1|NOT COMPLETED|Overall Study||0
2609520|NCT00126776|6407675|P2|COMPLETED|Overall Study||371
2609521|NCT00126776|6407676|P1|COMPLETED|Overall Study||372
2609522|NCT00126776|6407675|P2|STARTED|Overall Study||371
2609523|NCT00126776|6407676|P1|STARTED|Overall Study||372
2609524|NCT00126750|6407682|P2|NOT COMPLETED|Overall Study||266
2609525|NCT00126750|6407683|P1|NOT COMPLETED|Overall Study||180
2609526|NCT00126750|6407682|P2|COMPLETED|Overall Study|Total providers at clinic locations were given the option to 'enroll'.|196
2609527|NCT00126750|6407683|P1|COMPLETED|Overall Study|Total providers at participating clinic locations were given the option to 'enroll'.|205
2609528|NCT00126750|6407682|P2|STARTED|Overall Study|Number of providers from 84 clinics|462
2609529|NCT00126750|6407683|P1|STARTED|Overall Study|Number of providers from 84 clinics|385
2609530|NCT00126737|6407693|P4|NOT COMPLETED|Overall Study||7
2609531|NCT00126737|6407694|P3|NOT COMPLETED|Overall Study||6
2609532|NCT00126737|6407695|P2|NOT COMPLETED|Overall Study||3
2609533|NCT00126737|6407696|P1|NOT COMPLETED|Overall Study||6
2609534|NCT00126737|6407693|P4|COMPLETED|Overall Study||18
2609535|NCT00126737|6407694|P3|COMPLETED|Overall Study||24
2609536|NCT00126737|6407695|P2|COMPLETED|Overall Study||24
2609537|NCT00126737|6407696|P1|COMPLETED|Overall Study||22
2609538|NCT00126737|6407693|P4|STARTED|Overall Study||25
2609539|NCT00126737|6407694|P3|STARTED|Overall Study||30
2609540|NCT00126737|6407695|P2|STARTED|Overall Study||27
2609541|NCT00126737|6407696|P1|STARTED|Overall Study||28
2609542|NCT00126659|6407725|P3|NOT COMPLETED|Overall Study||2
2609543|NCT00126659|6407726|P2|NOT COMPLETED|Overall Study||0
2609544|NCT00126659|6407727|P1|NOT COMPLETED|Overall Study||0
2609545|NCT00126659|6407725|P3|COMPLETED|Overall Study||2
2609546|NCT00126659|6407726|P2|COMPLETED|Overall Study||3
2609547|NCT00126659|6407727|P1|COMPLETED|Overall Study||3
2609548|NCT00126659|6407725|P3|STARTED|Overall Study||4
2609549|NCT00126659|6407726|P2|STARTED|Overall Study||3
2609550|NCT00126659|6407727|P1|STARTED|Overall Study||3
2609551|NCT00126594|6407735|P2|NOT COMPLETED|Overall Study||37
2609552|NCT00126594|6407736|P1|NOT COMPLETED|Overall Study||39
2609553|NCT00126594|6407735|P2|COMPLETED|Overall Study||3
2609554|NCT00126594|6407736|P1|COMPLETED|Overall Study||1
2609555|NCT00126594|6407735|P2|STARTED|Overall Study||40
2609556|NCT00126594|6407736|P1|STARTED|Overall Study||40
2609557|NCT00126581|6407753|P2|NOT COMPLETED|Overall Study||20
2609558|NCT00126581|6407754|P1|NOT COMPLETED|Overall Study||13
2609559|NCT00126581|6407753|P2|COMPLETED|Overall Study||80
2609560|NCT00126581|6407754|P1|COMPLETED|Overall Study||68
2609561|NCT00126581|6407753|P2|STARTED|Overall Study||100
2609562|NCT00126581|6407754|P1|STARTED|Overall Study||81
2609563|NCT00126568|6407774|P1|NOT COMPLETED|Overall Study||2
2609564|NCT00126568|6407774|P1|COMPLETED|Overall Study|Disease progression at beginning of study, not evaluable|18
2609565|NCT00126568|6407774|P1|STARTED|Overall Study||20
2609566|NCT00126555|6407781|P1|NOT COMPLETED|Overall Study||6
2609567|NCT00126555|6407781|P1|COMPLETED|Overall Study||17
2609568|NCT00126555|6407781|P1|Stratum 2- Unresectable|Overall Study||4
2609569|NCT00126555|6407781|P1|Stratum 1- Resectable|Overall Study|1 participant did not participate|18
2609570|NCT00126555|6407781|P1|STARTED|Overall Study||23
2609571|NCT00126503|6407803|P2|NOT COMPLETED|Overall Study||21
2609572|NCT00126503|6407804|P1|NOT COMPLETED|Overall Study||47
2609573|NCT00126503|6407803|P2|COMPLETED|Overall Study||0
2609574|NCT00126503|6407804|P1|COMPLETED|Overall Study||1
2609575|NCT00126503|6407803|P2|STARTED|Overall Study||21
2609576|NCT00126503|6407804|P1|STARTED|Overall Study||48
2609577|NCT00126490|6407816|P1|NOT COMPLETED|Overall Study||1
2609578|NCT00126490|6407816|P1|COMPLETED|Overall Study||18
2609579|NCT00126490|6407816|P1|STARTED|Overall Study||19
2609580|NCT00126438|6407826|P2|NOT COMPLETED|Overall Study||10
2609581|NCT00126438|6407827|P1|NOT COMPLETED|Overall Study||34
2609582|NCT00126438|6407826|P2|COMPLETED|Overall Study||52
2609583|NCT00126438|6407827|P1|COMPLETED|Overall Study||419
2609584|NCT00126438|6407826|P2|STARTED|Overall Study||62
2609585|NCT00126438|6407827|P1|STARTED|Overall Study||453
2609586|NCT00126425|6407835|P2|NOT COMPLETED|Overall Study||11
2609587|NCT00126425|6407836|P1|NOT COMPLETED|Overall Study||41
2609588|NCT00126425|6407835|P2|COMPLETED|Overall Study||37
2609589|NCT00126425|6407836|P1|COMPLETED|Overall Study||498
2609590|NCT00126425|6407835|P2|STARTED|Overall Study||48
2609591|NCT00126425|6407836|P1|STARTED|Overall Study||539
2609592|NCT00126191|6407844|P2|NOT COMPLETED|Overall Study||2
2609593|NCT00126191|6407845|P1|NOT COMPLETED|Overall Study||0
2609594|NCT00126191|6407844|P2|COMPLETED|Overall Study|1 pt off study during cycle 1 due to toxicity|6
2609595|NCT00126191|6407845|P1|COMPLETED|Overall Study||2
2609596|NCT00126191|6407844|P2|STARTED|Overall Study||8
2609597|NCT00126191|6407845|P1|STARTED|Overall Study||2
2609598|NCT00126126|6407855|P2|NOT COMPLETED|Overall Study||2
2609599|NCT00126126|6407856|P1|NOT COMPLETED|Overall Study||0
2609600|NCT00126126|6407855|P2|COMPLETED|Overall Study||7
2609601|NCT00126126|6407856|P1|COMPLETED|Overall Study||9
2609602|NCT00126126|6407855|P2|STARTED|Overall Study||9
2609603|NCT00126126|6407856|P1|STARTED|Overall Study||9
2609604|NCT00126113|6407866|P2|NOT COMPLETED|Overall Study||2
2609605|NCT00126113|6407867|P1|NOT COMPLETED|Overall Study||3
2609606|NCT00126113|6407866|P2|COMPLETED|Overall Study||35
2609607|NCT00126113|6407867|P1|COMPLETED|Overall Study||34
2609608|NCT00126113|6407866|P2|STARTED|Overall Study||37
2609609|NCT00126113|6407867|P1|STARTED|Overall Study||37
2609610|NCT00125957|6407881|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
2609611|NCT00125957|6407882|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
2609612|NCT00125957|6407881|P2|COMPLETED|Second Intervention (3 Weeks)||17
2609613|NCT00125957|6407882|P1|COMPLETED|Second Intervention (3 Weeks)||15
2609614|NCT00125957|6407881|P2|STARTED|Second Intervention (3 Weeks)||17
2609615|NCT00125957|6407882|P1|STARTED|Second Intervention (3 Weeks)||15
2609616|NCT00125957|6407881|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
2609617|NCT00125957|6407882|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
2609618|NCT00125957|6407881|P2|COMPLETED|First Intervention (3 Weeks)||17
2609619|NCT00125957|6407882|P1|COMPLETED|First Intervention (3 Weeks)||15
2609620|NCT00125957|6407881|P2|STARTED|First Intervention (3 Weeks)||17
2609621|NCT00125957|6407882|P1|STARTED|First Intervention (3 Weeks)||15
2609622|NCT00125931|6407890|P1|NOT COMPLETED|Overall Study||0
2609623|NCT00125931|6407890|P1|COMPLETED|Overall Study||10
2609624|NCT00125931|6407890|P1|STARTED|Overall Study||10
2609625|NCT00125853|6407895|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
2609626|NCT00125853|6407896|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
2609627|NCT00125853|6407895|P2|COMPLETED|Second Intervention (8 Weeks)||20
2609628|NCT00125853|6407896|P1|COMPLETED|Second Intervention (8 Weeks)||24
2609629|NCT00125853|6407895|P2|STARTED|Second Intervention (8 Weeks)||20
2609630|NCT00125853|6407896|P1|STARTED|Second Intervention (8 Weeks)||24
2609631|NCT00125853|6407895|P2|NOT COMPLETED|Wash-out (4 Weeks)||7
2609632|NCT00125853|6407896|P1|NOT COMPLETED|Wash-out (4 Weeks)||3
2609633|NCT00125853|6407895|P2|COMPLETED|Wash-out (4 Weeks)||20
2609634|NCT00125853|6407896|P1|COMPLETED|Wash-out (4 Weeks)||24
2609635|NCT00125853|6407895|P2|STARTED|Wash-out (4 Weeks)||27
2609636|NCT00125853|6407896|P1|STARTED|Wash-out (4 Weeks)||27
2609637|NCT00125853|6407895|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
2609638|NCT00125853|6407896|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
2609639|NCT00125853|6407895|P2|COMPLETED|First Intervention (8 Weeks)||27
2609640|NCT00125853|6407896|P1|COMPLETED|First Intervention (8 Weeks)||27
2609641|NCT00125853|6407895|P2|STARTED|First Intervention (8 Weeks)||27
2609642|NCT00125853|6407896|P1|STARTED|First Intervention (8 Weeks)||27
2609643|NCT00125853|6407895|P2|NOT COMPLETED|Wash-out (4 Weeks)||0
2609644|NCT00125853|6407896|P1|NOT COMPLETED|Wash-out (4 Weeks)||0
2609645|NCT00125853|6407895|P2|COMPLETED|Wash-out (4 Weeks)||27
2609646|NCT00125853|6407896|P1|COMPLETED|Wash-out (4 Weeks)||27
2609647|NCT00125853|6407895|P2|STARTED|Wash-out (4 Weeks)||27
2609648|NCT00125853|6407896|P1|STARTED|Wash-out (4 Weeks)||27
2609649|NCT00125762|6407910|P1|NOT COMPLETED|Overall Study||159
2609650|NCT00125762|6407910|P1|COMPLETED|Overall Study||748
2609651|NCT00125762|6407910|P1|STARTED|Overall Study||907
2609652|NCT00125658|6407917|P2|NOT COMPLETED|Overall Study||0
2609653|NCT00125658|6407918|P1|NOT COMPLETED|Overall Study||0
2609654|NCT00125658|6407917|P2|COMPLETED|Overall Study||6
2609655|NCT00125658|6407918|P1|COMPLETED|Overall Study||8
2609656|NCT00125658|6407917|P2|STARTED|Overall Study||6
2609657|NCT00125658|6407918|P1|STARTED|Overall Study||8
2609658|NCT00125619|6407938|P2|NOT COMPLETED|Overall Study||0
2609659|NCT00125619|6407939|P1|NOT COMPLETED|Overall Study||0
2609660|NCT00125619|6407938|P2|COMPLETED|Overall Study||8
2609661|NCT00125619|6407939|P1|COMPLETED|Overall Study||8
2609662|NCT00125619|6407938|P2|STARTED|Overall Study||8
2609663|NCT00125619|6407939|P1|STARTED|Overall Study||8
2609664|NCT00125593|6407959|P2|NOT COMPLETED|Overall Study||103
2609665|NCT00125593|6407960|P1|NOT COMPLETED|Overall Study||101
2609666|NCT00125593|6407959|P2|COMPLETED|Overall Study||4517
2609667|NCT00125593|6407960|P1|COMPLETED|Overall Study||4549
2609668|NCT00125593|6407959|P2|STARTED|Overall Study||4620
2609669|NCT00125593|6407960|P1|STARTED|Overall Study||4650
2609670|NCT00125528|6407980|P2|NOT COMPLETED|Overall Study||1
2609671|NCT00125528|6407981|P1|NOT COMPLETED|Overall Study||2
2609672|NCT00125528|6407980|P2|COMPLETED|Overall Study||20
2609673|NCT00125528|6407981|P1|COMPLETED|Overall Study||18
2609674|NCT00125528|6407980|P2|STARTED|Overall Study||21
2609675|NCT00125528|6407981|P1|STARTED|Overall Study||20
2609676|NCT00125515|6407992|P3|NOT COMPLETED|Overall Study||21
2609677|NCT00125515|6407993|P2|NOT COMPLETED|Overall Study||20
2609678|NCT00125515|6407994|P1|NOT COMPLETED|Overall Study||20
2609679|NCT00125515|6407992|P3|COMPLETED|Overall Study||6
2609680|NCT00125515|6407993|P2|COMPLETED|Overall Study||7
2609681|NCT00125515|6407994|P1|COMPLETED|Overall Study||7
2609682|NCT00125515|6407992|P3|STARTED|Overall Study||27
2609683|NCT00125515|6407993|P2|STARTED|Overall Study||27
2609684|NCT00125515|6407994|P1|STARTED|Overall Study||27
2609685|NCT00125372|6408002|P1|NOT COMPLETED|Overall Study||2
2609686|NCT00125372|6408002|P1|COMPLETED|Overall Study||10
2609687|NCT00125372|6408002|P1|STARTED|Overall Study||12
2609688|NCT00125359|6408010|P1|NOT COMPLETED|Overall Study||23
2609689|NCT00125359|6408010|P1|COMPLETED|Overall Study||19
2609690|NCT00125359|6408010|P1|STARTED|Overall Study||42
2609691|NCT00125268|6408019|P2|NOT COMPLETED|Overall Study||1
2609692|NCT00125268|6408020|P1|NOT COMPLETED|Overall Study||1
2609693|NCT00125268|6408019|P2|COMPLETED|Overall Study||13
2609694|NCT00125268|6408020|P1|COMPLETED|Overall Study||15
2609695|NCT00125268|6408019|P2|STARTED|Overall Study||14
2609696|NCT00125268|6408020|P1|STARTED|Overall Study||16
2609697|NCT00125242|6408032|P2|NOT COMPLETED|Overall Study||2
2609698|NCT00125242|6408033|P1|NOT COMPLETED|Overall Study||7
2609699|NCT00125242|6408032|P2|COMPLETED|Overall Study||14
2609700|NCT00125242|6408033|P1|COMPLETED|Overall Study||87
2609701|NCT00125242|6408032|P2|STARTED|Overall Study||16
2609702|NCT00125242|6408033|P1|STARTED|Overall Study||94
2609703|NCT00125190|6408038|P1|NOT COMPLETED|Overall Study||15
2609704|NCT00125190|6408038|P1|COMPLETED|Overall Study||30
2609705|NCT00125190|6408038|P1|STARTED|Overall Study||45
2609706|NCT00125164|6408056|P4|NOT COMPLETED|Overall Study||6
2609707|NCT00125164|6408057|P3|NOT COMPLETED|Overall Study||4
2609708|NCT00125164|6408058|P2|NOT COMPLETED|Overall Study||0
2609709|NCT00125164|6408059|P1|NOT COMPLETED|Overall Study||2
2609710|NCT00125164|6408056|P4|COMPLETED|Overall Study||45
2609711|NCT00125164|6408057|P3|COMPLETED|Overall Study||40
2609712|NCT00125164|6408058|P2|COMPLETED|Overall Study||16
2609713|NCT00125164|6408059|P1|COMPLETED|Overall Study||23
2609714|NCT00125164|6408056|P4|STARTED|Overall Study||51
2609715|NCT00125164|6408057|P3|STARTED|Overall Study||44
2609716|NCT00125164|6408058|P2|STARTED|Overall Study||16
2609717|NCT00125164|6408059|P1|STARTED|Overall Study||25
2609718|NCT00125138|6408113|P4|NOT COMPLETED|Overall Study||5
2609719|NCT00125138|6408114|P3|NOT COMPLETED|Overall Study||4
2609720|NCT00125138|6408115|P2|NOT COMPLETED|Overall Study||3
2609721|NCT00125138|6408116|P1|NOT COMPLETED|Overall Study||3
2609722|NCT00125138|6408113|P4|COMPLETED|Overall Study||25
2609723|NCT00125138|6408114|P3|COMPLETED|Overall Study||21
2609724|NCT00125138|6408115|P2|COMPLETED|Overall Study||17
2609725|NCT00125138|6408116|P1|COMPLETED|Overall Study||12
2609726|NCT00125138|6408113|P4|STARTED|Overall Study||30
2609727|NCT00125138|6408114|P3|STARTED|Overall Study||25
2609728|NCT00125138|6408115|P2|STARTED|Overall Study|One subject requested withdrawal prior to treatment; data for the subject are excluded from results.|20
2609729|NCT00125138|6408116|P1|STARTED|Overall Study||15
2609730|NCT00125034|6408132|P2|NOT COMPLETED|Overall Study||0
2609731|NCT00125034|6408133|P1|NOT COMPLETED|Overall Study||0
2609732|NCT00125034|6408132|P2|COMPLETED|Overall Study||168
2609733|NCT00125034|6408133|P1|COMPLETED|Overall Study||170
2609734|NCT00125034|6408132|P2|STARTED|Overall Study|Randomized & treated|168
2609735|NCT00125034|6408133|P1|STARTED|Overall Study|Randomized & treated. 1 subject was not randomized correctly and was excluded in the ITT population.|170
2609736|NCT00124982|6408165|P3|NOT COMPLETED|Long-term Period||89
2609737|NCT00124982|6408166|P2|NOT COMPLETED|Long-term Period||0
2609738|NCT00124982|6408167|P1|NOT COMPLETED|Long-term Period||0
2609739|NCT00124982|6408165|P3|COMPLETED|Long-term Period||441
2609740|NCT00124982|6408166|P2|COMPLETED|Long-term Period||0
2609741|NCT00124982|6408167|P1|COMPLETED|Long-term Period||0
2609742|NCT00124982|6408165|P3|STARTED|Long-term Period|A large number did not continue due to a rollover from study drug to commercially available drug.|530
2609743|NCT00124982|6408166|P2|STARTED|Long-term Period||0
2609744|NCT00124982|6408167|P1|STARTED|Long-term Period||0
2609745|NCT00124982|6408165|P3|NOT COMPLETED|Short-term Period||0
2609746|NCT00124982|6408166|P2|NOT COMPLETED|Short-term Period||114
2609747|NCT00124982|6408167|P1|NOT COMPLETED|Short-term Period||72
2609748|NCT00124982|6408165|P3|COMPLETED|Short-term Period||0
2609749|NCT00124982|6408166|P2|COMPLETED|Short-term Period||483
2609750|NCT00124982|6408167|P1|COMPLETED|Short-term Period||377
2609751|NCT00124982|6408165|P3|STARTED|Short-term Period||0
2609752|NCT00124982|6408166|P2|STARTED|Short-term Period||597
2609753|NCT00124982|6408167|P1|STARTED|Short-term Period||449
2609754|NCT00124943|6408249|P4|NOT COMPLETED|Phase II||5
2609755|NCT00124943|6408250|P3|NOT COMPLETED|Phase II||0
2609756|NCT00124943|6408251|P2|NOT COMPLETED|Phase II||2
2609757|NCT00124943|6408252|P1|NOT COMPLETED|Phase II||0
2609758|NCT00124943|6408249|P4|COMPLETED|Phase II||50
2609759|NCT00124943|6408250|P3|COMPLETED|Phase II||3
2609760|NCT00124943|6408251|P2|COMPLETED|Phase II||49
2609761|NCT00124943|6408252|P1|COMPLETED|Phase II||3
2609762|NCT00124943|6408249|P4|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|55
2609763|NCT00124943|6408250|P3|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
2609764|NCT00124943|6408251|P2|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|51
2609765|NCT00124943|6408252|P1|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
2609766|NCT00124943|6408249|P4|NOT COMPLETED|Phase I||0
2609767|NCT00124943|6408250|P3|NOT COMPLETED|Phase I||0
2609768|NCT00124943|6408251|P2|NOT COMPLETED|Phase I||0
2609769|NCT00124943|6408252|P1|NOT COMPLETED|Phase I||0
2609770|NCT00124943|6408249|P4|COMPLETED|Phase I||3
2609771|NCT00124943|6408250|P3|COMPLETED|Phase I||3
2609772|NCT00124943|6408251|P2|COMPLETED|Phase I||3
2609773|NCT00124943|6408252|P1|COMPLETED|Phase I||3
2609774|NCT00124943|6408249|P4|STARTED|Phase I||3
2609775|NCT00124943|6408250|P3|STARTED|Phase I||3
2609776|NCT00124943|6408251|P2|STARTED|Phase I||3
2609777|NCT00124943|6408252|P1|STARTED|Phase I||3
2609778|NCT00124917|6408290|P1|NOT COMPLETED|Overall Study||3
2609779|NCT00124917|6408290|P1|COMPLETED|Overall Study||3
2609780|NCT00124917|6408290|P1|STARTED|Overall Study||6
2609781|NCT00124748|6408300|P2|NOT COMPLETED|Overall Study||284
2609782|NCT00124748|6408301|P1|NOT COMPLETED|Overall Study||143
2609783|NCT00124748|6408300|P2|COMPLETED|Overall Study||35
2609784|NCT00124748|6408301|P1|COMPLETED|Overall Study||14
2609785|NCT00124748|6408300|P2|Safety Population|Overall Study||316
2609786|NCT00124748|6408301|P1|Safety Population|Overall Study||157
2609787|NCT00124748|6408300|P2|STARTED|Overall Study||319
2609788|NCT00124748|6408301|P1|STARTED|Overall Study||157
2609789|NCT00124735|6408353|P10|NOT COMPLETED|Overall Study||2
2609790|NCT00124735|6408354|P9|NOT COMPLETED|Overall Study||3
2609791|NCT00124735|6408355|P8|NOT COMPLETED|Overall Study||1
2609792|NCT00124735|6408356|P7|NOT COMPLETED|Overall Study||0
2609793|NCT00124735|6408357|P6|NOT COMPLETED|Overall Study||2
2609794|NCT00124735|6408358|P5|NOT COMPLETED|Overall Study||2
2609795|NCT00124735|6408359|P4|NOT COMPLETED|Overall Study||3
2609796|NCT00124735|6408360|P3|NOT COMPLETED|Overall Study||0
2609797|NCT00124735|6408361|P2|NOT COMPLETED|Overall Study||2
2609798|NCT00124735|6408362|P1|NOT COMPLETED|Overall Study||1
2609799|NCT00124735|6408353|P10|COMPLETED|Overall Study||18
2609800|NCT00124735|6408354|P9|COMPLETED|Overall Study||22
2609801|NCT00124735|6408355|P8|COMPLETED|Overall Study||19
2609802|NCT00124735|6408356|P7|COMPLETED|Overall Study||6
2609803|NCT00124735|6408357|P6|COMPLETED|Overall Study||5
2609804|NCT00124735|6408358|P5|COMPLETED|Overall Study||17
2609805|NCT00124735|6408359|P4|COMPLETED|Overall Study||18
2609806|NCT00124735|6408360|P3|COMPLETED|Overall Study||18
2609807|NCT00124735|6408361|P2|COMPLETED|Overall Study||6
2609808|NCT00124735|6408362|P1|COMPLETED|Overall Study||4
2609809|NCT00124735|6408353|P10|STARTED|Overall Study||20
2609810|NCT00124735|6408354|P9|STARTED|Overall Study||25
2609811|NCT00124735|6408355|P8|STARTED|Overall Study||20
2609812|NCT00124735|6408356|P7|STARTED|Overall Study||6
2609813|NCT00124735|6408357|P6|STARTED|Overall Study||7
2609814|NCT00124735|6408358|P5|STARTED|Overall Study||19
2609815|NCT00124735|6408359|P4|STARTED|Overall Study||21
2609816|NCT00124735|6408360|P3|STARTED|Overall Study||18
2609817|NCT00124735|6408361|P2|STARTED|Overall Study||8
2609818|NCT00124735|6408362|P1|STARTED|Overall Study||5
2609819|NCT00124709|6408408|P2|NOT COMPLETED|Overall Study||272
2609820|NCT00124709|6408409|P1|NOT COMPLETED|Overall Study||255
2609821|NCT00124709|6408408|P2|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|273
2609822|NCT00124709|6408409|P1|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|291
2609823|NCT00124709|6408408|P2|Patients Who Received Study Medication|Overall Study||544
2609824|NCT00124709|6408409|P1|Patients Who Received Study Medication|Overall Study||543
2609825|NCT00124709|6408408|P2|STARTED|Overall Study||545
2609826|NCT00124709|6408409|P1|STARTED|Overall Study||546
2609827|NCT00124657|6408426|P3|NOT COMPLETED|Overall Study||32
2609828|NCT00124657|6408427|P2|NOT COMPLETED|Overall Study||5
2609829|NCT00124657|6408428|P1|NOT COMPLETED|Overall Study||16
2609830|NCT00124657|6408426|P3|COMPLETED|Overall Study||7
2609831|NCT00124657|6408427|P2|COMPLETED|Overall Study||0
2609832|NCT00124657|6408428|P1|COMPLETED|Overall Study||2
2609833|NCT00124657|6408426|P3|STARTED|Overall Study||39
2609834|NCT00124657|6408427|P2|STARTED|Overall Study||5
2609835|NCT00124657|6408428|P1|STARTED|Overall Study||18
2609836|NCT00124618|6408463|P1|NOT COMPLETED|Overall Study||1
2609837|NCT00124618|6408463|P1|COMPLETED|Overall Study||57
2609838|NCT00124618|6408463|P1|STARTED|Overall Study||58
2609839|NCT00124579|6408470|P1|NOT COMPLETED|Maintenance||2
2609840|NCT00124579|6408470|P1|COMPLETED|Maintenance||0
2609841|NCT00124579|6408470|P1|STARTED|Maintenance||2
2609842|NCT00124579|6408470|P1|NOT COMPLETED|Induction||5
2609843|NCT00124579|6408470|P1|COMPLETED|Induction||2
2609844|NCT00124579|6408470|P1|STARTED|Induction||7
2609845|NCT00124462|6408478|P2|NOT COMPLETED|Overall Study||13
2609846|NCT00124462|6408479|P1|NOT COMPLETED|Overall Study||11
2609847|NCT00124462|6408478|P2|COMPLETED|Overall Study||27
2609848|NCT00124462|6408479|P1|COMPLETED|Overall Study||29
2609849|NCT00124462|6408478|P2|STARTED|Overall Study||40
2609850|NCT00124462|6408479|P1|STARTED|Overall Study||40
2609851|NCT00124449|6408489|P2|NOT COMPLETED|18-Month Untreated Observation Period||13
2609852|NCT00124449|6408490|P1|NOT COMPLETED|18-Month Untreated Observation Period||15
2609853|NCT00124449|6408489|P2|COMPLETED|18-Month Untreated Observation Period||4
2609854|NCT00124449|6408490|P1|COMPLETED|18-Month Untreated Observation Period||7
2609855|NCT00124449|6408489|P2|Completed Year 1 of Study|18-Month Untreated Observation Period||9
2609856|NCT00124449|6408490|P1|Completed Year 1 of Study|18-Month Untreated Observation Period||14
2609857|NCT00124449|6408489|P2|STARTED|18-Month Untreated Observation Period||17
2609858|NCT00124449|6408490|P1|STARTED|18-Month Untreated Observation Period||22
2609859|NCT00124449|6408489|P2|NOT COMPLETED|6-month Double-Blind Treatment Period||11
2609860|NCT00124449|6408490|P1|NOT COMPLETED|6-month Double-Blind Treatment Period||6
2609861|NCT00124449|6408489|P2|COMPLETED|6-month Double-Blind Treatment Period||17
2609862|NCT00124449|6408490|P1|COMPLETED|6-month Double-Blind Treatment Period||22
2609863|NCT00124449|6408489|P2|STARTED|6-month Double-Blind Treatment Period||28
2609864|NCT00124449|6408490|P1|STARTED|6-month Double-Blind Treatment Period||28
2609865|NCT00124176|6408525|P2|NOT COMPLETED|Overall Study||0
2609866|NCT00124176|6408526|P1|NOT COMPLETED|Overall Study||0
2609867|NCT00124176|6408525|P2|COMPLETED|Overall Study||41
2609868|NCT00124176|6408526|P1|COMPLETED|Overall Study||40
2609869|NCT00124176|6408525|P2|Received Study Drug|Overall Study||41
2609870|NCT00124176|6408526|P1|Received Study Drug|Overall Study|3 never started on drug due to improvement but were kept in the study by intention to treat.|37
2609871|NCT00124176|6408525|P2|STARTED|Overall Study||41
2609872|NCT00124176|6408526|P1|STARTED|Overall Study||40
2609873|NCT00124072|6408544|P4|NOT COMPLETED|Overall Study||500
2609874|NCT00124072|6408545|P3|NOT COMPLETED|Overall Study||492
2609875|NCT00124072|6408546|P2|NOT COMPLETED|Overall Study||512
2609876|NCT00124072|6408547|P1|NOT COMPLETED|Overall Study||514
2609877|NCT00124072|6408544|P4|COMPLETED|Overall Study||2515
2609878|NCT00124072|6408545|P3|COMPLETED|Overall Study||2524
2609879|NCT00124072|6408546|P2|COMPLETED|Overall Study||2504
2609880|NCT00124072|6408547|P1|COMPLETED|Overall Study||2503
2609881|NCT00124072|6408544|P4|STARTED|Overall Study||3015
2609882|NCT00124072|6408545|P3|STARTED|Overall Study||3016
2609883|NCT00124072|6408546|P2|STARTED|Overall Study||3016
2609884|NCT00124072|6408547|P1|STARTED|Overall Study||3017
2609885|NCT00124020|6408559|P2|NOT COMPLETED|Overall Study||91
2609886|NCT00124020|6408560|P1|NOT COMPLETED|Overall Study||88
2609887|NCT00124020|6408559|P2|COMPLETED|Overall Study||289
2609888|NCT00124020|6408560|P1|COMPLETED|Overall Study||289
2609889|NCT00124020|6408559|P2|STARTED|Overall Study||380
2609890|NCT00124020|6408560|P1|STARTED|Overall Study||377
2609891|NCT00123955|6408568|P2|NOT COMPLETED|Overall Study||4
2609892|NCT00123955|6408569|P1|NOT COMPLETED|Overall Study||5
2609893|NCT00123955|6408568|P2|COMPLETED|Overall Study||34
2609894|NCT00123955|6408569|P1|COMPLETED|Overall Study||37
2609895|NCT00123955|6408568|P2|STARTED|Overall Study||38
2609896|NCT00123955|6408569|P1|STARTED|Overall Study||42
2609897|NCT00123734|6408581|P1|NOT COMPLETED|Overall Study||8
2609898|NCT00123734|6408581|P1|COMPLETED|Overall Study||74
2609899|NCT00123734|6408581|P1|STARTED|Overall Study||82
2609900|NCT00123682|6408616|P4|NOT COMPLETED|Overall Study||95
2609901|NCT00123682|6408617|P3|NOT COMPLETED|Overall Study||154
2609902|NCT00123682|6408618|P2|NOT COMPLETED|Overall Study||203
2609903|NCT00123682|6408619|P1|NOT COMPLETED|Overall Study||320
2609904|NCT00123682|6408616|P4|COMPLETED|Overall Study||430
2609905|NCT00123682|6408617|P3|COMPLETED|Overall Study||438
2609906|NCT00123682|6408618|P2|COMPLETED|Overall Study||731
2609907|NCT00123682|6408619|P1|COMPLETED|Overall Study||749
2609908|NCT00123682|6408616|P4|STARTED|Overall Study||525
2609909|NCT00123682|6408617|P3|STARTED|Overall Study||592
2609910|NCT00123682|6408618|P2|STARTED|Overall Study||934
2609911|NCT00123682|6408619|P1|STARTED|Overall Study||1069
2609912|NCT00123643|6408639|P2|NOT COMPLETED|Overall Study||0
2609913|NCT00123643|6408640|P1|NOT COMPLETED|Overall Study||0
2609914|NCT00123643|6408639|P2|COMPLETED|Overall Study||16
2609915|NCT00123643|6408640|P1|COMPLETED|Overall Study||20
2609916|NCT00123643|6408639|P2|STARTED|Overall Study||16
2609917|NCT00123643|6408640|P1|STARTED|Overall Study||20
2609918|NCT00123630|6408648|P2|NOT COMPLETED|Overall Study||0
2609919|NCT00123630|6408649|P1|NOT COMPLETED|Overall Study||0
2609920|NCT00123630|6408648|P2|COMPLETED|Overall Study||15
2609921|NCT00123630|6408649|P1|COMPLETED|Overall Study||15
2609922|NCT00123630|6408648|P2|STARTED|Overall Study||15
2609923|NCT00123630|6408649|P1|STARTED|Overall Study||15
2609924|NCT00123604|6408657|P2|NOT COMPLETED|Overall Study||1
2609925|NCT00123604|6408658|P1|NOT COMPLETED|Overall Study||1
2609926|NCT00123604|6408657|P2|COMPLETED|Overall Study||16
2609927|NCT00123604|6408658|P1|COMPLETED|Overall Study||18
2609928|NCT00123604|6408657|P2|STARTED|Overall Study||17
2609929|NCT00123604|6408658|P1|STARTED|Overall Study||19
2609930|NCT00123487|6408666|P2|NOT COMPLETED|Treated With Study Drug||305
2609931|NCT00123487|6408667|P1|NOT COMPLETED|Treated With Study Drug||304
2609932|NCT00123487|6408666|P2|COMPLETED|Treated With Study Drug||0
2609933|NCT00123487|6408667|P1|COMPLETED|Treated With Study Drug||0
2609934|NCT00123487|6408666|P2|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 305 represents actual BID treatment.|305
2609935|NCT00123487|6408667|P1|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 304 represents actual QD treatment.|304
2609936|NCT00123487|6408666|P2|NOT COMPLETED|Randomized||1
2609937|NCT00123487|6408667|P1|NOT COMPLETED|Randomized||1
2609938|NCT00123487|6408666|P2|COMPLETED|Randomized||304
2609939|NCT00123487|6408667|P1|COMPLETED|Randomized||305
2609940|NCT00123487|6408666|P2|STARTED|Randomized||305
2609941|NCT00123487|6408667|P1|STARTED|Randomized||306
2609942|NCT00123474|6408711|P4|NOT COMPLETED|As Treated at Study Closure||167
2609943|NCT00123474|6408712|P3|NOT COMPLETED|As Treated at Study Closure||167
2609944|NCT00123474|6408713|P2|NOT COMPLETED|As Treated at Study Closure||163
2609945|NCT00123474|6408714|P1|NOT COMPLETED|As Treated at Study Closure||165
2609946|NCT00123474|6408711|P4|COMPLETED|As Treated at Study Closure||0
2609947|NCT00123474|6408712|P3|COMPLETED|As Treated at Study Closure|Randomized to 100 mg QD but received 50 mg BID.|0
2609948|NCT00123474|6408713|P2|COMPLETED|As Treated at Study Closure||0
2609949|NCT00123474|6408714|P1|COMPLETED|As Treated at Study Closure||0
2609950|NCT00123474|6408711|P4|STARTED|As Treated at Study Closure||167
2609951|NCT00123474|6408712|P3|STARTED|As Treated at Study Closure||167
2609952|NCT00123474|6408713|P2|STARTED|As Treated at Study Closure||163
2609953|NCT00123474|6408714|P1|STARTED|As Treated at Study Closure|Randomized to 50 mg BID but received 100 mg QD.|165
2609954|NCT00123474|6408711|P4|NOT COMPLETED|Randomized to Treatment||1
2609955|NCT00123474|6408712|P3|NOT COMPLETED|Randomized to Treatment||2
2609956|NCT00123474|6408713|P2|NOT COMPLETED|Randomized to Treatment||4
2609957|NCT00123474|6408714|P1|NOT COMPLETED|Randomized to Treatment||1
2609958|NCT00123474|6408711|P4|COMPLETED|Randomized to Treatment||167
2609959|NCT00123474|6408712|P3|COMPLETED|Randomized to Treatment||166
2609960|NCT00123474|6408713|P2|COMPLETED|Randomized to Treatment||163
2609961|NCT00123474|6408714|P1|COMPLETED|Randomized to Treatment||166
2609962|NCT00123474|6408711|P4|STARTED|Randomized to Treatment||168
2609963|NCT00123474|6408712|P3|STARTED|Randomized to Treatment||168
2609964|NCT00123474|6408713|P2|STARTED|Randomized to Treatment||167
2609965|NCT00123474|6408714|P1|STARTED|Randomized to Treatment||167
2609966|NCT00123422|6408808|P3|NOT COMPLETED|Overall Study||10
2609967|NCT00123422|6408809|P2|NOT COMPLETED|Overall Study||6
2609968|NCT00123422|6408810|P1|NOT COMPLETED|Overall Study||4
2609969|NCT00123422|6408808|P3|COMPLETED|Overall Study||25
2609970|NCT00123422|6408809|P2|COMPLETED|Overall Study||27
2609971|NCT00123422|6408810|P1|COMPLETED|Overall Study||31
2609972|NCT00123422|6408808|P3|8-week Testing|Overall Study||27
2609973|NCT00123422|6408809|P2|8-week Testing|Overall Study||30
2609974|NCT00123422|6408810|P1|8-week Testing|Overall Study||32
2609975|NCT00123422|6408808|P3|STARTED|Overall Study||35
2609976|NCT00123422|6408809|P2|STARTED|Overall Study||33
2609977|NCT00123422|6408810|P1|STARTED|Overall Study||35
2609978|NCT00123409|6408823|P2|NOT COMPLETED|Overall Study||3
2609979|NCT00123409|6408824|P1|NOT COMPLETED|Overall Study||4
2609980|NCT00123409|6408823|P2|COMPLETED|Overall Study||71
2609981|NCT00123409|6408824|P1|COMPLETED|Overall Study||68
2609982|NCT00123409|6408823|P2|STARTED|Overall Study||74
2609983|NCT00123409|6408824|P1|STARTED|Overall Study||72
2609984|NCT00123162|6408834|P2|NOT COMPLETED|Overall Study||0
2609985|NCT00123162|6408835|P1|NOT COMPLETED|Overall Study||0
2609986|NCT00123162|6408834|P2|COMPLETED|Overall Study||12
2609987|NCT00123162|6408835|P1|COMPLETED|Overall Study||13
2609988|NCT00123162|6408834|P2|STARTED|Overall Study||12
2609989|NCT00123162|6408835|P1|STARTED|Overall Study||13
2609990|NCT00123123|6408846|P3|NOT COMPLETED|Overall Study||0
2609991|NCT00123123|6408847|P2|NOT COMPLETED|Overall Study||0
2609992|NCT00123123|6408848|P1|NOT COMPLETED|Overall Study||0
2609993|NCT00123123|6408846|P3|COMPLETED|Overall Study||58
2609994|NCT00123123|6408847|P2|COMPLETED|Overall Study||58
2609995|NCT00123123|6408848|P1|COMPLETED|Overall Study||59
2609996|NCT00123123|6408846|P3|STARTED|Overall Study||58
2609997|NCT00123123|6408847|P2|STARTED|Overall Study||58
2609998|NCT00123123|6408848|P1|STARTED|Overall Study||59
2609999|NCT00123110|6408862|P3|NOT COMPLETED|Overall Study||0
2610000|NCT00123110|6408863|P2|NOT COMPLETED|Overall Study||0
2610001|NCT00123110|6408864|P1|NOT COMPLETED|Overall Study||0
2610002|NCT00123110|6408862|P3|COMPLETED|Overall Study||11
2610003|NCT00123110|6408863|P2|COMPLETED|Overall Study||12
2610004|NCT00123110|6408864|P1|COMPLETED|Overall Study||12
2610005|NCT00123110|6408862|P3|STARTED|Overall Study||11
2610006|NCT00123110|6408863|P2|STARTED|Overall Study||12
2610007|NCT00123110|6408864|P1|STARTED|Overall Study||12
2610008|NCT00122980|6408898|P2|NOT COMPLETED|Overall Study||40
2610009|NCT00122980|6408899|P1|NOT COMPLETED|Overall Study||43
2610010|NCT00122980|6408898|P2|COMPLETED|Overall Study|Study terminated early|26
2610011|NCT00122980|6408899|P1|COMPLETED|Overall Study|Study terminated early|24
2610012|NCT00122980|6408898|P2|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 66|66
2610013|NCT00122980|6408899|P1|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 67|67
2610014|NCT00122954|6408923|P2|NOT COMPLETED|Overall Study||3
2610015|NCT00122954|6408924|P1|NOT COMPLETED|Overall Study||2
2610016|NCT00122954|6408923|P2|COMPLETED|Overall Study||18
2610017|NCT00122954|6408924|P1|COMPLETED|Overall Study||16
2610018|NCT00122954|6408923|P2|STARTED|Overall Study||21
2610019|NCT00122954|6408924|P1|STARTED|Overall Study||18
2610020|NCT00122681|6408934|P2|NOT COMPLETED|Overall Study||1521
2610021|NCT00122681|6408935|P1|NOT COMPLETED|Overall Study||1514
2610022|NCT00122681|6408934|P2|COMPLETED|Overall Study||7798
2610023|NCT00122681|6408935|P1|COMPLETED|Overall Study||7811
2610024|NCT00122681|6408934|P2|STARTED|Overall Study||9319
2610025|NCT00122681|6408935|P1|STARTED|Overall Study||9325
2610026|NCT00122460|6409009|P2|NOT COMPLETED|Overall Study||1
2610027|NCT00122460|6409010|P1|NOT COMPLETED|Overall Study||7
2610028|NCT00122460|6409009|P2|COMPLETED|Overall Study||219
2610029|NCT00122460|6409010|P1|COMPLETED|Overall Study||215
2610030|NCT00122460|6409009|P2|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|220
2610031|NCT00122460|6409010|P1|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|222
2610032|NCT00122447|6409036|P4|NOT COMPLETED|Overall Study||3
2610033|NCT00122447|6409037|P3|NOT COMPLETED|Overall Study||1
2610034|NCT00122447|6409038|P2|NOT COMPLETED|Overall Study||5
2610035|NCT00122447|6409039|P1|NOT COMPLETED|Overall Study||1
2610036|NCT00122447|6409036|P4|COMPLETED|Overall Study||14
2610037|NCT00122447|6409037|P3|COMPLETED|Overall Study||16
2610038|NCT00122447|6409038|P2|COMPLETED|Overall Study||13
2610039|NCT00122447|6409039|P1|COMPLETED|Overall Study||17
2610040|NCT00122447|6409036|P4|STARTED|Overall Study||17
2610041|NCT00122447|6409037|P3|STARTED|Overall Study||17
2610042|NCT00122447|6409038|P2|STARTED|Overall Study||18
2610043|NCT00122447|6409039|P1|STARTED|Overall Study||18
2610044|NCT00122382|6409059|P3|NOT COMPLETED|Open-Label Study||26
2610045|NCT00122382|6409060|P2|NOT COMPLETED|Open-Label Study||0
2610046|NCT00122382|6409061|P1|NOT COMPLETED|Open-Label Study||0
2610047|NCT00122382|6409059|P3|COMPLETED|Open-Label Study||433
2610048|NCT00122382|6409060|P2|COMPLETED|Open-Label Study||0
2610049|NCT00122382|6409061|P1|COMPLETED|Open-Label Study||0
2610050|NCT00122382|6409059|P3|STARTED|Open-Label Study||459
2610051|NCT00122382|6409060|P2|STARTED|Open-Label Study||0
2610052|NCT00122382|6409061|P1|STARTED|Open-Label Study||0
2610053|NCT00122382|6409059|P3|NOT COMPLETED|Double-Blind Study||0
2610054|NCT00122382|6409060|P2|NOT COMPLETED|Double-Blind Study||28
2610055|NCT00122382|6409061|P1|NOT COMPLETED|Double-Blind Study||24
2610056|NCT00122382|6409059|P3|COMPLETED|Double-Blind Study||0
2610057|NCT00122382|6409060|P2|COMPLETED|Double-Blind Study||227
2610058|NCT00122382|6409061|P1|COMPLETED|Double-Blind Study||232
2610059|NCT00122382|6409059|P3|Treated|Double-Blind Study||0
2610060|NCT00122382|6409060|P2|Treated|Double-Blind Study||253
2610061|NCT00122382|6409061|P1|Treated|Double-Blind Study||256
2610062|NCT00122382|6409059|P3|STARTED|Double-Blind Study||0
2610063|NCT00122382|6409060|P2|STARTED|Double-Blind Study|participants randomized|255
2610064|NCT00122382|6409061|P1|STARTED|Double-Blind Study|participants randomized|256
2610065|NCT00122369|6409114|P3|NOT COMPLETED|Overall Study||0
2610066|NCT00122369|6409115|P2|NOT COMPLETED|Overall Study||0
2610067|NCT00122369|6409116|P1|NOT COMPLETED|Overall Study||0
2610068|NCT00122369|6409114|P3|COMPLETED|Overall Study||78
2610069|NCT00122369|6409115|P2|COMPLETED|Overall Study||82
2610070|NCT00122369|6409116|P1|COMPLETED|Overall Study||76
2610071|NCT00122369|6409114|P3|STARTED|Overall Study||78
2610072|NCT00122369|6409115|P2|STARTED|Overall Study||82
2610073|NCT00122369|6409116|P1|STARTED|Overall Study||76
2610074|NCT00122317|6409205|P1|NOT COMPLETED|Overall Study||11
2610075|NCT00122317|6409205|P1|COMPLETED|Overall Study||176
2610076|NCT00122317|6409205|P1|STARTED|Overall Study||187
2610077|NCT00122278|6409214|P2|NOT COMPLETED|Overall Study||0
2610078|NCT00122278|6409215|P1|NOT COMPLETED|Overall Study||2
2610079|NCT00122278|6409214|P2|COMPLETED|Overall Study||99
2610080|NCT00122278|6409215|P1|COMPLETED|Overall Study||104
2610081|NCT00122278|6409214|P2|STARTED|Overall Study||99
2610082|NCT00122278|6409215|P1|STARTED|Overall Study||106
2610083|NCT00122187|6409225|P2|NOT COMPLETED|Overall Study||2
2610084|NCT00122187|6409226|P1|NOT COMPLETED|Overall Study||2
2610085|NCT00122187|6409225|P2|COMPLETED|Overall Study||2
2610086|NCT00122187|6409226|P1|COMPLETED|Overall Study||2
2610087|NCT00122187|6409225|P2|Post-intervention Data Collection|Overall Study||2
2610088|NCT00122187|6409226|P1|Post-intervention Data Collection|Overall Study||2
2610089|NCT00122187|6409225|P2|Intervention Implemented|Overall Study||4
2610090|NCT00122187|6409226|P1|Intervention Implemented|Overall Study||3
2610091|NCT00122187|6409225|P2|Randomized to Intervention or Usual Care|Overall Study||4
2610092|NCT00122187|6409226|P1|Randomized to Intervention or Usual Care|Overall Study||4
2610093|NCT00122187|6409225|P2|Matched by Colonoscopy Volume|Overall Study||4
2610094|NCT00122187|6409226|P1|Matched by Colonoscopy Volume|Overall Study||4
2610095|NCT00122187|6409225|P2|STARTED|Overall Study||4
2610096|NCT00122187|6409226|P1|STARTED|Overall Study||4
2610097|NCT00122135|6409240|P2|NOT COMPLETED|Overall Study||0
2610098|NCT00122135|6409241|P1|NOT COMPLETED|Overall Study||3
2610099|NCT00122135|6409240|P2|COMPLETED|Overall Study||60
2610100|NCT00122135|6409241|P1|COMPLETED|Overall Study||57
2610101|NCT00122135|6409240|P2|STARTED|Overall Study||60
2610102|NCT00122135|6409241|P1|STARTED|Overall Study||60
2610103|NCT00122109|6409249|P2|NOT COMPLETED|Overall Study||7
2610104|NCT00122109|6409250|P1|NOT COMPLETED|Overall Study||6
2610105|NCT00122109|6409249|P2|COMPLETED|Overall Study||57
2610106|NCT00122109|6409250|P1|COMPLETED|Overall Study||55
2610107|NCT00122109|6409249|P2|STARTED|Overall Study|ITT|64
2610108|NCT00122109|6409250|P1|STARTED|Overall Study|ITT|61
2610109|NCT00121836|6409274|P1|NOT COMPLETED|Overall Study||55
2610110|NCT00121836|6409274|P1|COMPLETED|Overall Study||54
2610111|NCT00121836|6409274|P1|STARTED|Overall Study||109
2610112|NCT00121810|6409285|P2|NOT COMPLETED|Overall Study||39
2610113|NCT00121810|6409286|P1|NOT COMPLETED|Overall Study||30
2610114|NCT00121810|6409285|P2|COMPLETED|Overall Study||115
2610115|NCT00121810|6409286|P1|COMPLETED|Overall Study||121
2610116|NCT00121810|6409285|P2|Intent-to-Treat (ITT) Population|Overall Study||151
2610117|NCT00121810|6409286|P1|Intent-to-Treat (ITT) Population|Overall Study||148
2610118|NCT00121810|6409285|P2|Safety Population|Overall Study||153
2610119|NCT00121810|6409286|P1|Safety Population|Overall Study||148
2610120|NCT00121810|6409285|P2|STARTED|Overall Study||154
2610121|NCT00121810|6409286|P1|STARTED|Overall Study||151
2610122|NCT00121719|6409312|P14|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2610123|NCT00121719|6409313|P13|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2610124|NCT00121719|6409314|P12|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||5
2610125|NCT00121719|6409315|P11|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||6
2610126|NCT00121719|6409316|P10|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2610127|NCT00121719|6409317|P9|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2610128|NCT00121719|6409318|P8|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2610129|NCT00121719|6409319|P7|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2610130|NCT00121719|6409320|P6|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2610131|NCT00121719|6409321|P5|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2610132|NCT00121719|6409322|P4|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2610133|NCT00121719|6409323|P3|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2610134|NCT00121719|6409324|P2|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2610135|NCT00121719|6409325|P1|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2610136|NCT00121719|6409312|P14|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2610137|NCT00121719|6409313|P13|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2610138|NCT00121719|6409314|P12|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2610139|NCT00121719|6409315|P11|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2610140|NCT00121719|6409316|P10|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2610141|NCT00121719|6409317|P9|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2610142|NCT00121719|6409318|P8|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2610143|NCT00121719|6409319|P7|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2610144|NCT00121719|6409320|P6|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2610145|NCT00121719|6409321|P5|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2610146|NCT00121719|6409322|P4|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2610147|NCT00121719|6409323|P3|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2610148|NCT00121719|6409324|P2|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2610149|NCT00121719|6409325|P1|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
2610150|NCT00121719|6409312|P14|STARTED|Food-Effect Pilot Study (4 Weeks)||0
2610151|NCT00121719|6409313|P13|STARTED|Food-Effect Pilot Study (4 Weeks)||0
2610152|NCT00121719|6409314|P12|STARTED|Food-Effect Pilot Study (4 Weeks)|Participants in the Pilot Food Effect Study were also in the Dose Escalation Study.|5
2610153|NCT00121719|6409315|P11|STARTED|Food-Effect Pilot Study (4 Weeks)|Participants in the Pilot Food Effect Study were also in the Dose Escalation Study.|6
2610154|NCT00121719|6409316|P10|STARTED|Food-Effect Pilot Study (4 Weeks)||0
2610155|NCT00121719|6409317|P9|STARTED|Food-Effect Pilot Study (4 Weeks)||0
2610156|NCT00121719|6409318|P8|STARTED|Food-Effect Pilot Study (4 Weeks)||0
2610157|NCT00121719|6409319|P7|STARTED|Food-Effect Pilot Study (4 Weeks)||0
2610158|NCT00121719|6409320|P6|STARTED|Food-Effect Pilot Study (4 Weeks)||0
2610159|NCT00121719|6409321|P5|STARTED|Food-Effect Pilot Study (4 Weeks)||0
2610160|NCT00121719|6409322|P4|STARTED|Food-Effect Pilot Study (4 Weeks)||0
2610161|NCT00121719|6409323|P3|STARTED|Food-Effect Pilot Study (4 Weeks)||0
2610162|NCT00121719|6409324|P2|STARTED|Food-Effect Pilot Study (4 Weeks)||0
2610163|NCT00121719|6409325|P1|STARTED|Food-Effect Pilot Study (4 Weeks)||0
2610164|NCT00121719|6409312|P14|NOT COMPLETED|Dose Escalation (4 Weeks)||7
2610165|NCT00121719|6409313|P13|NOT COMPLETED|Dose Escalation (4 Weeks)||24
2610166|NCT00121719|6409314|P12|NOT COMPLETED|Dose Escalation (4 Weeks)||0
2610167|NCT00121719|6409315|P11|NOT COMPLETED|Dose Escalation (4 Weeks)||0
2610168|NCT00121719|6409316|P10|NOT COMPLETED|Dose Escalation (4 Weeks)||3
2610169|NCT00121719|6409317|P9|NOT COMPLETED|Dose Escalation (4 Weeks)||6
2610170|NCT00121719|6409318|P8|NOT COMPLETED|Dose Escalation (4 Weeks)||9
2610171|NCT00121719|6409319|P7|NOT COMPLETED|Dose Escalation (4 Weeks)||12
2610172|NCT00121719|6409320|P6|NOT COMPLETED|Dose Escalation (4 Weeks)||3
2610173|NCT00121719|6409321|P5|NOT COMPLETED|Dose Escalation (4 Weeks)||3
2610174|NCT00121719|6409322|P4|NOT COMPLETED|Dose Escalation (4 Weeks)||3
2610175|NCT00121719|6409323|P3|NOT COMPLETED|Dose Escalation (4 Weeks)||4
2610176|NCT00121719|6409324|P2|NOT COMPLETED|Dose Escalation (4 Weeks)||4
2610177|NCT00121719|6409325|P1|NOT COMPLETED|Dose Escalation (4 Weeks)||4
2610178|NCT00121719|6409312|P14|COMPLETED|Dose Escalation (4 Weeks)||0
2610179|NCT00121719|6409313|P13|COMPLETED|Dose Escalation (4 Weeks)||0
2610180|NCT00121719|6409314|P12|COMPLETED|Dose Escalation (4 Weeks)||0
2610181|NCT00121719|6409315|P11|COMPLETED|Dose Escalation (4 Weeks)||0
2610182|NCT00121719|6409316|P10|COMPLETED|Dose Escalation (4 Weeks)||0
2610183|NCT00121719|6409317|P9|COMPLETED|Dose Escalation (4 Weeks)||0
2610184|NCT00121719|6409318|P8|COMPLETED|Dose Escalation (4 Weeks)||0
2610185|NCT00121719|6409319|P7|COMPLETED|Dose Escalation (4 Weeks)||0
2610186|NCT00121719|6409320|P6|COMPLETED|Dose Escalation (4 Weeks)||0
2610187|NCT00121719|6409321|P5|COMPLETED|Dose Escalation (4 Weeks)||0
2610188|NCT00121719|6409322|P4|COMPLETED|Dose Escalation (4 Weeks)||0
2610189|NCT00121719|6409323|P3|COMPLETED|Dose Escalation (4 Weeks)||0
2610190|NCT00121719|6409324|P2|COMPLETED|Dose Escalation (4 Weeks)||0
2610191|NCT00121719|6409325|P1|COMPLETED|Dose Escalation (4 Weeks)||0
2610192|NCT00121719|6409312|P14|STARTED|Dose Escalation (4 Weeks)||7
2610193|NCT00121719|6409313|P13|STARTED|Dose Escalation (4 Weeks)||24
2610194|NCT00121719|6409314|P12|STARTED|Dose Escalation (4 Weeks)||0
2610195|NCT00121719|6409315|P11|STARTED|Dose Escalation (4 Weeks)||0
2610196|NCT00121719|6409316|P10|STARTED|Dose Escalation (4 Weeks)||3
2610197|NCT00121719|6409317|P9|STARTED|Dose Escalation (4 Weeks)||6
2610198|NCT00121719|6409318|P8|STARTED|Dose Escalation (4 Weeks)||9
2610199|NCT00121719|6409319|P7|STARTED|Dose Escalation (4 Weeks)||12
2610200|NCT00121719|6409320|P6|STARTED|Dose Escalation (4 Weeks)||3
2610201|NCT00121719|6409321|P5|STARTED|Dose Escalation (4 Weeks)||3
2610202|NCT00121719|6409322|P4|STARTED|Dose Escalation (4 Weeks)||3
2610203|NCT00121719|6409323|P3|STARTED|Dose Escalation (4 Weeks)||4
2610204|NCT00121719|6409324|P2|STARTED|Dose Escalation (4 Weeks)||4
2610205|NCT00121719|6409325|P1|STARTED|Dose Escalation (4 Weeks)||4
2610206|NCT00121667|6409502|P4|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||140
2610207|NCT00121667|6409503|P3|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||113
2610208|NCT00121667|6409504|P2|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||133
2610209|NCT00121667|6409505|P1|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||128
2610210|NCT00121667|6409502|P4|COMPLETED|Short Term (ST) + Long Term (LT) Period||39
2610211|NCT00121667|6409503|P3|COMPLETED|Short Term (ST) + Long Term (LT) Period||68
2610212|NCT00121667|6409504|P2|COMPLETED|Short Term (ST) + Long Term (LT) Period||58
2610213|NCT00121667|6409505|P1|COMPLETED|Short Term (ST) + Long Term (LT) Period||64
2610214|NCT00121667|6409502|P4|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||7
2610215|NCT00121667|6409503|P3|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||23
2610216|NCT00121667|6409504|P2|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||18
2610217|NCT00121667|6409505|P1|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||14
2610218|NCT00121667|6409502|P4|STARTED|Short Term (ST) + Long Term (LT) Period||179
2610219|NCT00121667|6409503|P3|STARTED|Short Term (ST) + Long Term (LT) Period||181
2610220|NCT00121667|6409504|P2|STARTED|Short Term (ST) + Long Term (LT) Period||191
2610221|NCT00121667|6409505|P1|STARTED|Short Term (ST) + Long Term (LT) Period||192
2610222|NCT00121667|6409502|P4|NOT COMPLETED|Short Term (ST) Period||67
2610223|NCT00121667|6409503|P3|NOT COMPLETED|Short Term (ST) Period||41
2610224|NCT00121667|6409504|P2|NOT COMPLETED|Short Term (ST) Period||48
2610225|NCT00121667|6409505|P1|NOT COMPLETED|Short Term (ST) Period||44
2610226|NCT00121667|6409502|P4|COMPLETED|Short Term (ST) Period||112
2610227|NCT00121667|6409503|P3|COMPLETED|Short Term (ST) Period||140
2610228|NCT00121667|6409504|P2|COMPLETED|Short Term (ST) Period||143
2610229|NCT00121667|6409505|P1|COMPLETED|Short Term (ST) Period||148
2610230|NCT00121667|6409502|P4|STARTED|Short Term (ST) Period||179
2610231|NCT00121667|6409503|P3|STARTED|Short Term (ST) Period||181
2610232|NCT00121667|6409504|P2|STARTED|Short Term (ST) Period||191
2610233|NCT00121667|6409505|P1|STARTED|Short Term (ST) Period||192
2610234|NCT00121641|6409603|P5|NOT COMPLETED|48-month Short Term + Long Term Period||58
2610235|NCT00121641|6409604|P4|NOT COMPLETED|48-month Short Term + Long Term Period||71
2610236|NCT00121641|6409605|P3|NOT COMPLETED|48-month Short Term + Long Term Period||70
2610237|NCT00121641|6409606|P2|NOT COMPLETED|48-month Short Term + Long Term Period||82
2610238|NCT00121641|6409607|P1|NOT COMPLETED|48-month Short Term + Long Term Period||79
2610239|NCT00121641|6409603|P5|COMPLETED|48-month Short Term + Long Term Period||8
2610240|NCT00121641|6409604|P4|COMPLETED|48-month Short Term + Long Term Period||24
2610241|NCT00121641|6409605|P3|COMPLETED|48-month Short Term + Long Term Period||28
2610242|NCT00121641|6409606|P2|COMPLETED|48-month Short Term + Long Term Period||24
2610243|NCT00121641|6409607|P1|COMPLETED|48-month Short Term + Long Term Period||23
2610244|NCT00121641|6409603|P5|STARTED|48-month Short Term + Long Term Period||66
2610245|NCT00121641|6409604|P4|STARTED|48-month Short Term + Long Term Period||95
2610246|NCT00121641|6409605|P3|STARTED|48-month Short Term + Long Term Period||98
2610247|NCT00121641|6409606|P2|STARTED|48-month Short Term + Long Term Period||106
2610248|NCT00121641|6409607|P1|STARTED|48-month Short Term + Long Term Period||102
2610249|NCT00121641|6409603|P5|NOT COMPLETED|24-week Short-term Treatment Period||41
2610250|NCT00121641|6409604|P4|NOT COMPLETED|24-week Short-term Treatment Period||40
2610251|NCT00121641|6409605|P3|NOT COMPLETED|24-week Short-term Treatment Period||29
2610252|NCT00121641|6409606|P2|NOT COMPLETED|24-week Short-term Treatment Period||38
2610253|NCT00121641|6409607|P1|NOT COMPLETED|24-week Short-term Treatment Period||29
2610254|NCT00121641|6409603|P5|COMPLETED|24-week Short-term Treatment Period||25
2610255|NCT00121641|6409604|P4|COMPLETED|24-week Short-term Treatment Period||55
2610256|NCT00121641|6409605|P3|COMPLETED|24-week Short-term Treatment Period||69
2610257|NCT00121641|6409606|P2|COMPLETED|24-week Short-term Treatment Period||68
2610258|NCT00121641|6409607|P1|COMPLETED|24-week Short-term Treatment Period||73
2610259|NCT00121641|6409603|P5|STARTED|24-week Short-term Treatment Period||66
2610260|NCT00121641|6409604|P4|STARTED|24-week Short-term Treatment Period||95
2610261|NCT00121641|6409605|P3|STARTED|24-week Short-term Treatment Period||98
2610262|NCT00121641|6409606|P2|STARTED|24-week Short-term Treatment Period||106
2610263|NCT00121641|6409607|P1|STARTED|24-week Short-term Treatment Period||102
2610264|NCT00121485|6409720|P2|NOT COMPLETED|Overall Study||7
2610265|NCT00121485|6409721|P1|NOT COMPLETED|Overall Study||1
2610266|NCT00121485|6409720|P2|COMPLETED|Overall Study||59
2610267|NCT00121485|6409721|P1|COMPLETED|Overall Study||133
2610268|NCT00121485|6409720|P2|STARTED|Overall Study||66
2610269|NCT00121485|6409721|P1|STARTED|Overall Study||134
2610270|NCT00121472|6409755|P1|NOT COMPLETED|Overall Study||0
2610271|NCT00121472|6409755|P1|COMPLETED|Overall Study|Followed for at least 1 year after implantation of HM II LVAS.|194
2610272|NCT00121472|6409755|P1|STARTED|Overall Study||194
2610273|NCT00121238|6409766|P1|NOT COMPLETED|Overall Study||3
2610274|NCT00121238|6409766|P1|COMPLETED|Overall Study|2 were later deemed ineligible (PSA rise), censored from efficacy but included for toxicity analysis|13
2610275|NCT00121238|6409766|P1|STARTED|Overall Study||16
2610276|NCT00121225|6409774|P1|NOT COMPLETED|Overall Study||0
2610277|NCT00121225|6409774|P1|COMPLETED|Overall Study||32
2610278|NCT00121225|6409774|P1|STARTED|Overall Study||32
2610279|NCT00121199|6409782|P1|NOT COMPLETED|Overall Study||28
2610280|NCT00121199|6409782|P1|COMPLETED|Overall Study||45
2610281|NCT00121199|6409782|P1|Eligible and Began Protocol Therapy|Overall Study||64
2610282|NCT00121199|6409782|P1|Eligible|Overall Study||64
2610283|NCT00121199|6409782|P1|STARTED|Overall Study||73
2610284|NCT00121186|6409789|P1|NOT COMPLETED|Overall Study||0
2610285|NCT00121186|6409789|P1|COMPLETED|Overall Study||1
2610286|NCT00121186|6409789|P1|STARTED|Overall Study||1
2610287|NCT00121173|6409797|P3|NOT COMPLETED|Overall Study||0
2610288|NCT00121173|6409798|P2|NOT COMPLETED|Overall Study||0
2610289|NCT00121173|6409799|P1|NOT COMPLETED|Overall Study||1
2610290|NCT00121173|6409797|P3|COMPLETED|Overall Study||9
2610291|NCT00121173|6409798|P2|COMPLETED|Overall Study||3
2610292|NCT00121173|6409799|P1|COMPLETED|Overall Study||3
2610293|NCT00121173|6409797|P3|STARTED|Overall Study||9
2610294|NCT00121173|6409798|P2|STARTED|Overall Study||3
2610295|NCT00121173|6409799|P1|STARTED|Overall Study||4
2610296|NCT00121134|6409826|P4|NOT COMPLETED|Overall Study||9
2610297|NCT00121134|6409827|P3|NOT COMPLETED|Overall Study||21
2610298|NCT00121134|6409828|P2|NOT COMPLETED|Overall Study||15
2610299|NCT00121134|6409829|P1|NOT COMPLETED|Overall Study||16
2610300|NCT00121134|6409826|P4|COMPLETED|Overall Study||31
2610301|NCT00121134|6409827|P3|COMPLETED|Overall Study||20
2610302|NCT00121134|6409828|P2|COMPLETED|Overall Study||26
2610303|NCT00121134|6409829|P1|COMPLETED|Overall Study||24
2610304|NCT00121134|6409826|P4|STARTED|Overall Study||40
2610305|NCT00121134|6409827|P3|STARTED|Overall Study||41
2610306|NCT00121134|6409828|P2|STARTED|Overall Study||41
2610307|NCT00121134|6409829|P1|STARTED|Overall Study||40
2610308|NCT00120874|6409841|P2|NOT COMPLETED|Overall Study||1
2610309|NCT00120874|6409842|P1|NOT COMPLETED|Overall Study||0
2610310|NCT00120874|6409841|P2|COMPLETED|Overall Study||9
2610311|NCT00120874|6409842|P1|COMPLETED|Overall Study||10
2610312|NCT00120874|6409841|P2|Completed Study; Started Extension Study|Overall Study||10
2610313|NCT00120874|6409842|P1|Completed Study; Started Extension Study|Overall Study||10
2610314|NCT00120874|6409841|P2|STARTED|Overall Study||10
2610315|NCT00120874|6409842|P1|STARTED|Overall Study||10
2610316|NCT00120627|6409880|P2|NOT COMPLETED|Overall Study||5
2610317|NCT00120627|6409881|P1|NOT COMPLETED|Overall Study||5
2610318|NCT00120627|6409880|P2|COMPLETED|Overall Study|Three people refused the post-assessments CAPS interview only.|70
2610319|NCT00120627|6409881|P1|COMPLETED|Overall Study||66
2610320|NCT00120627|6409880|P2|Did Not Complete Post-tx Assessments|Overall Study|Three people dropped out but no reason given.|3
2610321|NCT00120627|6409881|P1|Did Not Complete Post-tx Assessments|Overall Study|One person had a scheduling conflict and two people were incarcerated.|3
2610322|NCT00120627|6409880|P2|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and an unknown reason.|73
2610323|NCT00120627|6409881|P1|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and illness.|69
2610324|NCT00120627|6409880|P2|STARTED|Overall Study|This was the number that enrolled and was randomly assigned to receive the control condition.|75
2610325|NCT00120627|6409881|P1|STARTED|Overall Study|This is the number who enrolled and was randomly assigned to receive the Mantram Repetition Program.|71
2610326|NCT00120523|6409907|P2|NOT COMPLETED|Follow-Up Period||24
2610327|NCT00120523|6409908|P1|NOT COMPLETED|Follow-Up Period||30
2610328|NCT00120523|6409907|P2|COMPLETED|Follow-Up Period||46
2610329|NCT00120523|6409908|P1|COMPLETED|Follow-Up Period||90
2610330|NCT00120523|6409907|P2|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|70
2610331|NCT00120523|6409908|P1|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|120
2610332|NCT00120523|6409907|P2|NOT COMPLETED|Treatment Period||339
2610333|NCT00120523|6409908|P1|NOT COMPLETED|Treatment Period||369
2610334|NCT00120523|6409907|P2|COMPLETED|Treatment Period||874
2610335|NCT00120523|6409908|P1|COMPLETED|Treatment Period||836
2610336|NCT00120523|6409907|P2|STARTED|Treatment Period||1213
2610337|NCT00120523|6409908|P1|STARTED|Treatment Period||1205
2610338|NCT00120406|6409932|P2|NOT COMPLETED|Overall Study||16
2610339|NCT00120406|6409933|P1|NOT COMPLETED|Overall Study||19
2610340|NCT00120406|6409932|P2|COMPLETED|Overall Study||222
2610341|NCT00120406|6409933|P1|COMPLETED|Overall Study||217
2610342|NCT00120406|6409932|P2|STARTED|Overall Study||238
2610343|NCT00120406|6409933|P1|STARTED|Overall Study||236
2610344|NCT00120289|6409943|P2|NOT COMPLETED|Overall Study||109
2610345|NCT00120289|6409944|P1|NOT COMPLETED|Overall Study||121
2610346|NCT00120289|6409943|P2|COMPLETED|Overall Study||1587
2610347|NCT00120289|6409944|P1|COMPLETED|Overall Study||1597
2610348|NCT00120289|6409943|P2|STARTED|Overall Study||1696
2610349|NCT00120289|6409944|P1|STARTED|Overall Study||1718
2610350|NCT00120250|6409956|P2|NOT COMPLETED|Overall Study||2
2610351|NCT00120250|6409957|P1|NOT COMPLETED|Overall Study||1
2610352|NCT00120250|6409956|P2|COMPLETED|Overall Study||12
2610353|NCT00120250|6409957|P1|COMPLETED|Overall Study||12
2610354|NCT00120250|6409956|P2|STARTED|Overall Study||14
2610355|NCT00120250|6409957|P1|STARTED|Overall Study||13
2610356|NCT00120042|6409973|P3|NOT COMPLETED|Overall Study||0
2610357|NCT00120042|6409974|P2|NOT COMPLETED|Overall Study||0
2610358|NCT00120042|6409975|P1|NOT COMPLETED|Overall Study||0
2610359|NCT00120042|6409973|P3|COMPLETED|Overall Study||83
2610360|NCT00120042|6409974|P2|COMPLETED|Overall Study||83
2610361|NCT00120042|6409975|P1|COMPLETED|Overall Study||85
2610362|NCT00120042|6409973|P3|STARTED|Overall Study||83
2610363|NCT00120042|6409974|P2|STARTED|Overall Study||83
2610364|NCT00120042|6409975|P1|STARTED|Overall Study||85
2610365|NCT00119847|6409985|P2|NOT COMPLETED|Overall Study||32
2610366|NCT00119847|6409986|P1|NOT COMPLETED|Overall Study||31
2610367|NCT00119847|6409985|P2|COMPLETED|Overall Study||119
2610368|NCT00119847|6409986|P1|COMPLETED|Overall Study||118
2610369|NCT00119847|6409985|P2|STARTED|Overall Study||151
2610370|NCT00119847|6409986|P1|STARTED|Overall Study||149
2610371|NCT00119678|6409998|P2|NOT COMPLETED|Open-label Treatment Period||0
2610372|NCT00119678|6409999|P1|NOT COMPLETED|Open-label Treatment Period||110
2610373|NCT00119678|6409998|P2|COMPLETED|Open-label Treatment Period||0
2610374|NCT00119678|6409999|P1|COMPLETED|Open-label Treatment Period||0
2610375|NCT00119678|6409998|P2|STARTED|Open-label Treatment Period||0
2610376|NCT00119678|6409999|P1|STARTED|Open-label Treatment Period|Number of participants treated|110
2610377|NCT00119678|6409998|P2|NOT COMPLETED|Double-blind Treatment Period||26
2610378|NCT00119678|6409999|P1|NOT COMPLETED|Double-blind Treatment Period||41
2610379|NCT00119678|6409998|P2|COMPLETED|Double-blind Treatment Period||35
2610380|NCT00119678|6409999|P1|COMPLETED|Double-blind Treatment Period||81
2610381|NCT00119678|6409998|P2|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||57
2610382|NCT00119678|6409999|P1|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||118
2610383|NCT00119678|6409998|P2|RANDOMIZED AND TREATED|Double-blind Treatment Period||59
2610384|NCT00119678|6409999|P1|RANDOMIZED AND TREATED|Double-blind Treatment Period||121
2610385|NCT00119678|6409998|P2|STARTED|Double-blind Treatment Period||61
2610386|NCT00119678|6409999|P1|STARTED|Double-blind Treatment Period||122
2610387|NCT00119405|6410045|P1|NOT COMPLETED|Overall Study||1
2610388|NCT00119405|6410045|P1|COMPLETED|Overall Study||17
2610389|NCT00119405|6410045|P1|STARTED|Overall Study||18
2610390|NCT00119392|6410049|P1|NOT COMPLETED|Overall Study||5
2610391|NCT00119392|6410049|P1|COMPLETED|Overall Study||40
2610392|NCT00119392|6410049|P1|STARTED|Overall Study||45
2610393|NCT00119379|6410059|P2|NOT COMPLETED|Overall Study||1
2610394|NCT00119379|6410060|P1|NOT COMPLETED|Overall Study||4
2610395|NCT00119379|6410059|P2|COMPLETED|Overall Study||23
2610396|NCT00119379|6410060|P1|COMPLETED|Overall Study||22
2610397|NCT00119379|6410059|P2|STARTED|Overall Study||24
2610398|NCT00119379|6410060|P1|STARTED|Overall Study||26
2610399|NCT00119262|6410078|P2|NOT COMPLETED|Overall Study||58
2610400|NCT00119262|6410079|P1|NOT COMPLETED|Overall Study||46
2610401|NCT00119262|6410078|P2|COMPLETED|Overall Study||64
2610402|NCT00119262|6410079|P1|COMPLETED|Overall Study||58
2610403|NCT00119262|6410078|P2|Eligible and Treated|Overall Study||119
2610404|NCT00119262|6410079|P1|Eligible and Treated|Overall Study||102
2610405|NCT00119262|6410078|P2|Treated|Overall Study||120
2610406|NCT00119262|6410079|P1|Treated|Overall Study||103
2610407|NCT00119262|6410078|P2|Eligible|Overall Study||120
2610408|NCT00119262|6410079|P1|Eligible|Overall Study||103
2610409|NCT00119262|6410078|P2|STARTED|Overall Study||122
2610410|NCT00119262|6410079|P1|STARTED|Overall Study||104
2610411|NCT00119158|6410091|P2|NOT COMPLETED|Placebo Treatment||0
2610412|NCT00119158|6410092|P1|NOT COMPLETED|Placebo Treatment||0
2610413|NCT00119158|6410091|P2|COMPLETED|Placebo Treatment||45
2610414|NCT00119158|6410092|P1|COMPLETED|Placebo Treatment||45
2610415|NCT00119158|6410091|P2|STARTED|Placebo Treatment||45
2610416|NCT00119158|6410092|P1|STARTED|Placebo Treatment||45
2610417|NCT00119158|6410091|P2|NOT COMPLETED|Active Treatment||0
2610418|NCT00119158|6410092|P1|NOT COMPLETED|Active Treatment||0
2610419|NCT00119158|6410091|P2|COMPLETED|Active Treatment||45
2610420|NCT00119158|6410092|P1|COMPLETED|Active Treatment||45
2610421|NCT00119158|6410091|P2|STARTED|Active Treatment||45
2610422|NCT00119158|6410092|P1|STARTED|Active Treatment|patients are self controls|45
2610423|NCT00119041|6410103|P3|NOT COMPLETED|Overall Study||0
2610424|NCT00119041|6410104|P2|NOT COMPLETED|Overall Study||0
2610425|NCT00119041|6410105|P1|NOT COMPLETED|Overall Study||0
2610426|NCT00119041|6410103|P3|COMPLETED|Overall Study||22
2610427|NCT00119041|6410104|P2|COMPLETED|Overall Study||83
2610428|NCT00119041|6410105|P1|COMPLETED|Overall Study||199
2610429|NCT00119041|6410103|P3|STARTED|Overall Study||22
2610430|NCT00119041|6410104|P2|STARTED|Overall Study||83
2610431|NCT00119041|6410105|P1|STARTED|Overall Study||199
2610432|NCT00119015|6410116|P3|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
2610433|NCT00119015|6410117|P2|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
2610434|NCT00119015|6410118|P1|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
2610435|NCT00119015|6410116|P3|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||26
2610436|NCT00119015|6410117|P2|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||28
2610437|NCT00119015|6410118|P1|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
2610438|NCT00119015|6410116|P3|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|26
2610439|NCT00119015|6410117|P2|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|28
2610440|NCT00119015|6410118|P1|STARTED|Double-Blind, Randomized Phase (2 Weeks)||0
2610441|NCT00119015|6410116|P3|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
2610442|NCT00119015|6410117|P2|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
2610443|NCT00119015|6410118|P1|NOT COMPLETED|Open-Label Phase (2 Weeks)||48
2610444|NCT00119015|6410116|P3|COMPLETED|Open-Label Phase (2 Weeks)||0
2610445|NCT00119015|6410117|P2|COMPLETED|Open-Label Phase (2 Weeks)||0
2610446|NCT00119015|6410118|P1|COMPLETED|Open-Label Phase (2 Weeks)||54
2610447|NCT00119015|6410116|P3|STARTED|Open-Label Phase (2 Weeks)||0
2610448|NCT00119015|6410117|P2|STARTED|Open-Label Phase (2 Weeks)||0
2610449|NCT00119015|6410118|P1|STARTED|Open-Label Phase (2 Weeks)||102
2610450|NCT00118911|6410134|P2|NOT COMPLETED|Overall Study||5
2610451|NCT00118911|6410135|P1|NOT COMPLETED|Overall Study||2
2610452|NCT00118911|6410134|P2|COMPLETED|Overall Study||38
2610453|NCT00118911|6410135|P1|COMPLETED|Overall Study||41
2610454|NCT00118911|6410134|P2|12 Month Follow-up|Overall Study|2 participants did not complete the 6 month follow-up but did complete the 12 month follow-up|32
2610455|NCT00118911|6410135|P1|12 Month Follow-up|Overall Study|1 participant did not complete the 6 month follow-up but did complete the 12 month follow-up|38
2610456|NCT00118911|6410134|P2|6 Month Follow-up|Overall Study||30
2610457|NCT00118911|6410135|P1|6 Month Follow-up|Overall Study||37
2610458|NCT00118911|6410134|P2|Completed Post-Treatment Assessment|Overall Study||37
2610459|NCT00118911|6410135|P1|Completed Post-Treatment Assessment|Overall Study||41
2610460|NCT00118911|6410134|P2|Received Intervention as Assigned|Overall Study||38
2610461|NCT00118911|6410135|P1|Received Intervention as Assigned|Overall Study||41
2610462|NCT00118911|6410134|P2|STARTED|Overall Study||43
2610463|NCT00118911|6410135|P1|STARTED|Overall Study||43
2610464|NCT00118898|6410147|P4|NOT COMPLETED|Overall Study||141
2610465|NCT00118898|6410148|P3|NOT COMPLETED|Overall Study||123
2610466|NCT00118898|6410149|P2|NOT COMPLETED|Overall Study||141
2610467|NCT00118898|6410150|P1|NOT COMPLETED|Overall Study||121
2610468|NCT00118898|6410147|P4|COMPLETED|Overall Study||322
2610469|NCT00118898|6410148|P3|COMPLETED|Overall Study||342
2610470|NCT00118898|6410149|P2|COMPLETED|Overall Study||324
2610471|NCT00118898|6410150|P1|COMPLETED|Overall Study||343
2610472|NCT00118898|6410147|P4|Initiated Treatment|Overall Study||462
2610473|NCT00118898|6410148|P3|Initiated Treatment|Overall Study||464
2610474|NCT00118898|6410149|P2|Initiated Treatment|Overall Study||461
2610475|NCT00118898|6410150|P1|Initiated Treatment|Overall Study||461
2610476|NCT00118898|6410147|P4|STARTED|Overall Study||463
2610477|NCT00118898|6410148|P3|STARTED|Overall Study||465
2610478|NCT00118898|6410149|P2|STARTED|Overall Study||465
2610479|NCT00118898|6410150|P1|STARTED|Overall Study||464
2610480|NCT00118755|6410246|P2|NOT COMPLETED|Overall Study||215
2610481|NCT00118755|6410247|P1|NOT COMPLETED|Overall Study||210
2610482|NCT00118755|6410246|P2|COMPLETED|Overall Study||3
2610483|NCT00118755|6410247|P1|COMPLETED|Overall Study||7
2610484|NCT00118755|6410246|P2|Safety Population|Overall Study||211
2610485|NCT00118755|6410247|P1|Safety Population|Overall Study||208
2610486|NCT00118755|6410246|P2|STARTED|Overall Study||218
2610487|NCT00118755|6410247|P1|STARTED|Overall Study||217
2610488|NCT00118742|6410261|P2|NOT COMPLETED|Overall Study||66
2610489|NCT00118742|6410262|P1|NOT COMPLETED|Overall Study||49
2610490|NCT00118742|6410261|P2|COMPLETED|Overall Study||82
2610491|NCT00118742|6410262|P1|COMPLETED|Overall Study||96
2610492|NCT00118742|6410261|P2|STARTED|Overall Study||148
2610493|NCT00118742|6410262|P1|STARTED|Overall Study||145
2610494|NCT00118716|6410276|P2|NOT COMPLETED|Overall Study||22
2610495|NCT00118716|6410277|P1|NOT COMPLETED|Overall Study||13
2610496|NCT00118716|6410276|P2|COMPLETED|Overall Study||102
2610497|NCT00118716|6410277|P1|COMPLETED|Overall Study||111
2610498|NCT00118716|6410276|P2|STARTED|Overall Study||124
2610499|NCT00118716|6410277|P1|STARTED|Overall Study||124
2610500|NCT00118703|6410297|P2|NOT COMPLETED|Overall Study||9
2610501|NCT00118703|6410298|P1|NOT COMPLETED|Overall Study||5
2610502|NCT00118703|6410297|P2|COMPLETED|Overall Study||165
2610503|NCT00118703|6410298|P1|COMPLETED|Overall Study||168
2610504|NCT00118703|6410297|P2|STARTED|Overall Study||174
2610505|NCT00118703|6410298|P1|STARTED|Overall Study||173
2610506|NCT00118534|6410310|P2|NOT COMPLETED|Overall Study||0
2610507|NCT00118534|6410311|P1|NOT COMPLETED|Overall Study||0
2610508|NCT00118534|6410310|P2|COMPLETED|Overall Study||471
2610509|NCT00118534|6410311|P1|COMPLETED|Overall Study||472
2610510|NCT00118534|6410310|P2|STARTED|Overall Study||471
2610511|NCT00118534|6410311|P1|STARTED|Overall Study||472
2610512|NCT00118482|6410395|P2|NOT COMPLETED|Overall Study||29
2610513|NCT00118482|6410396|P1|NOT COMPLETED|Overall Study||30
2610514|NCT00118482|6410395|P2|COMPLETED|Overall Study||76
2610515|NCT00118482|6410396|P1|COMPLETED|Overall Study|210 in the Intention To Treat analysis|75
2610516|NCT00118482|6410395|P2|STARTED|Overall Study||105
2610517|NCT00118482|6410396|P1|STARTED|Overall Study|3 patients signed the consent but did not take the study medication.|105
2610518|NCT00118430|6410411|P3|NOT COMPLETED|Overall Study||28
2610519|NCT00118430|6410412|P2|NOT COMPLETED|Overall Study||24
2610520|NCT00118430|6410413|P1|NOT COMPLETED|Overall Study||21
2610521|NCT00118430|6410411|P3|COMPLETED|Overall Study||222
2610522|NCT00118430|6410412|P2|COMPLETED|Overall Study|127 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|103
2610523|NCT00118430|6410413|P1|COMPLETED|Overall Study|123 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|102
2610524|NCT00118430|6410411|P3|STARTED|Overall Study||250
2610525|NCT00118430|6410412|P2|STARTED|Overall Study||127
2610526|NCT00118430|6410413|P1|STARTED|Overall Study||123
2610527|NCT00118417|6410428|P2|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
2610528|NCT00118417|6410429|P1|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
2610529|NCT00118417|6410428|P2|COMPLETED|Phase III (Weeks 12 to 24)||9
2610530|NCT00118417|6410429|P1|COMPLETED|Phase III (Weeks 12 to 24)||8
2610531|NCT00118417|6410428|P2|STARTED|Phase III (Weeks 12 to 24)||10
2610532|NCT00118417|6410429|P1|STARTED|Phase III (Weeks 12 to 24)||9
2610533|NCT00118417|6410428|P2|NOT COMPLETED|Phase II (Weeks 6 to 12)||3
2610534|NCT00118417|6410429|P1|NOT COMPLETED|Phase II (Weeks 6 to 12)||2
2610535|NCT00118417|6410428|P2|COMPLETED|Phase II (Weeks 6 to 12)||10
2610536|NCT00118417|6410429|P1|COMPLETED|Phase II (Weeks 6 to 12)||9
2610537|NCT00118417|6410428|P2|STARTED|Phase II (Weeks 6 to 12)||13
2610538|NCT00118417|6410429|P1|STARTED|Phase II (Weeks 6 to 12)|Three new participants on Phase 1 endpoint doses of SSRIs entered at Phase 2.|11
2610539|NCT00118417|6410428|P2|NOT COMPLETED|Phase I (Weeks 0 to 6)||0
2610540|NCT00118417|6410429|P1|NOT COMPLETED|Phase I (Weeks 0 to 6)||18
2610541|NCT00118417|6410428|P2|COMPLETED|Phase I (Weeks 0 to 6)||0
2610542|NCT00118417|6410429|P1|COMPLETED|Phase I (Weeks 0 to 6)||21
2610543|NCT00118417|6410428|P2|STARTED|Phase I (Weeks 0 to 6)|In Phase 1, all participants received open label SSRI - no second treatment arm.|0
2610544|NCT00118417|6410429|P1|STARTED|Phase I (Weeks 0 to 6)||39
2610545|NCT00118404|6410442|P3|NOT COMPLETED|Overall Study||20
2610546|NCT00118404|6410443|P2|NOT COMPLETED|Overall Study||16
2610547|NCT00118404|6410444|P1|NOT COMPLETED|Overall Study||24
2610548|NCT00118404|6410442|P3|COMPLETED|Overall Study||49
2610549|NCT00118404|6410443|P2|COMPLETED|Overall Study||70
2610550|NCT00118404|6410444|P1|COMPLETED|Overall Study||62
2610551|NCT00118404|6410442|P3|STARTED|Overall Study||69
2610552|NCT00118404|6410443|P2|STARTED|Overall Study||86
2610553|NCT00118404|6410444|P1|STARTED|Overall Study||86
2610554|NCT00118378|6410460|P2|NOT COMPLETED|Overall Study||8
2610555|NCT00118378|6410461|P1|NOT COMPLETED|Overall Study||2
2610556|NCT00118378|6410460|P2|COMPLETED|Overall Study||45
2610557|NCT00118378|6410461|P1|COMPLETED|Overall Study||60
2610558|NCT00118378|6410460|P2|STARTED|Overall Study||53
2610559|NCT00118378|6410461|P1|STARTED|Overall Study||62
2610560|NCT00118365|6410475|P2|NOT COMPLETED|Overall Study||60
2610561|NCT00118365|6410476|P1|NOT COMPLETED|Overall Study||59
2610562|NCT00118365|6410475|P2|COMPLETED|Overall Study||124
2610563|NCT00118365|6410476|P1|COMPLETED|Overall Study||132
2610564|NCT00118365|6410475|P2|STARTED|Overall Study||184
2610565|NCT00118365|6410476|P1|STARTED|Overall Study||191
2610566|NCT00118352|6410545|P3|NOT COMPLETED|Overall Study||0
2610567|NCT00118352|6410546|P2|NOT COMPLETED|Overall Study||0
2610568|NCT00118352|6410547|P1|NOT COMPLETED|Overall Study||0
2610569|NCT00118352|6410545|P3|COMPLETED|Overall Study||0
2610570|NCT00118352|6410546|P2|COMPLETED|Overall Study||0
2610571|NCT00118352|6410547|P1|COMPLETED|Overall Study||12
2610572|NCT00118352|6410545|P3|STARTED|Overall Study||0
2610573|NCT00118352|6410546|P2|STARTED|Overall Study||0
2610574|NCT00118352|6410547|P1|STARTED|Overall Study||12
2610575|NCT00118287|6410573|P1|NOT COMPLETED|Overall Study||2
2610576|NCT00118287|6410573|P1|COMPLETED|Overall Study||30
2610577|NCT00118287|6410573|P1|STARTED|Overall Study||32
2610578|NCT00118248|6410579|P2|NOT COMPLETED|Overall Study||0
2610579|NCT00118248|6410580|P1|NOT COMPLETED|Overall Study||0
2610580|NCT00118248|6410579|P2|COMPLETED|Overall Study||24
2610581|NCT00118248|6410580|P1|COMPLETED|Overall Study||17
2610582|NCT00118248|6410579|P2|STARTED|Overall Study||24
2610583|NCT00118248|6410580|P1|STARTED|Overall Study||17
2610584|NCT00118157|6410593|P1|NOT COMPLETED|Overall Study||12
2610585|NCT00118157|6410593|P1|COMPLETED|Overall Study||7
2610586|NCT00118157|6410593|P1|STARTED|Overall Study||19
2610587|NCT00118144|6410598|P1|NOT COMPLETED|Overall Study||1
2610588|NCT00118144|6410598|P1|COMPLETED|Overall Study||41
2610589|NCT00118144|6410598|P1|STARTED|Overall Study||42
2610590|NCT00118131|6410604|P1|NOT COMPLETED|Overall Study||0
2610591|NCT00118131|6410604|P1|COMPLETED|Overall Study||49
2610592|NCT00118131|6410604|P1|STARTED|Overall Study||49
2610593|NCT00118092|6410611|P1|NOT COMPLETED|Overall Study||2
2610594|NCT00118092|6410611|P1|COMPLETED|Overall Study||15
2610595|NCT00118092|6410611|P1|STARTED|Overall Study||17
2610596|NCT00118053|6410619|P1|NOT COMPLETED|Overall Study||0
2610597|NCT00118053|6410619|P1|COMPLETED|Overall Study||5
2610598|NCT00118053|6410619|P1|STARTED|Overall Study||5
2610599|NCT00118040|6410629|P3|NOT COMPLETED|Overall Study||6
2610600|NCT00118040|6410630|P2|NOT COMPLETED|Overall Study||2
2610601|NCT00118040|6410631|P1|NOT COMPLETED|Overall Study||1
2610602|NCT00118040|6410629|P3|COMPLETED|Overall Study||14
2610603|NCT00118040|6410630|P2|COMPLETED|Overall Study||18
2610604|NCT00118040|6410631|P1|COMPLETED|Overall Study||19
2610605|NCT00118040|6410629|P3|STARTED|Overall Study||20
2610606|NCT00118040|6410630|P2|STARTED|Overall Study||20
2610607|NCT00118040|6410631|P1|STARTED|Overall Study||20
2610608|NCT00117988|6410692|P1|NOT COMPLETED|Overall Study||4
2610609|NCT00117988|6410692|P1|COMPLETED|Overall Study||18
2610610|NCT00117988|6410692|P1|STARTED|Overall Study||22
2610611|NCT00117962|6410698|P2|NOT COMPLETED|Overall Study||25
2610612|NCT00117962|6410699|P1|NOT COMPLETED|Overall Study||22
2610613|NCT00117962|6410698|P2|COMPLETED|Overall Study||28
2610614|NCT00117962|6410699|P1|COMPLETED|Overall Study||26
2610615|NCT00117962|6410698|P2|STARTED|Overall Study||53
2610616|NCT00117962|6410699|P1|STARTED|Overall Study||48
2610617|NCT00117949|6410715|P4|NOT COMPLETED|Overall Study||24
2610618|NCT00117949|6410716|P3|NOT COMPLETED|Overall Study||24
2610619|NCT00117949|6410717|P2|NOT COMPLETED|Overall Study||24
2610620|NCT00117949|6410718|P1|NOT COMPLETED|Overall Study||10
2610621|NCT00117949|6410715|P4|COMPLETED|Overall Study||0
2610622|NCT00117949|6410716|P3|COMPLETED|Overall Study||0
2610623|NCT00117949|6410717|P2|COMPLETED|Overall Study||0
2610624|NCT00117949|6410718|P1|COMPLETED|Overall Study||0
2610625|NCT00117949|6410715|P4|STARTED|Overall Study||24
2610626|NCT00117949|6410716|P3|STARTED|Overall Study||24
2610627|NCT00117949|6410717|P2|STARTED|Overall Study||24
2610628|NCT00117949|6410718|P1|STARTED|Overall Study|Dose level terminated prematurely due to inadequate testosterone response|10
2610629|NCT00117845|6410752|P1|NOT COMPLETED|Overall Study||1
2610630|NCT00117845|6410752|P1|COMPLETED|Overall Study||16
2610631|NCT00117845|6410752|P1|STARTED|Overall Study||17
2610632|NCT00117806|6410759|P2|NOT COMPLETED|Overall Study||16
2610633|NCT00117806|6410760|P1|NOT COMPLETED|Overall Study||38
2610634|NCT00117806|6410759|P2|COMPLETED|Overall Study||60
2610635|NCT00117806|6410760|P1|COMPLETED|Overall Study||43
2610636|NCT00117806|6410759|P2|STARTED|Overall Study||76
2610637|NCT00117806|6410760|P1|STARTED|Overall Study||81
2610638|NCT00117793|6410770|P1|NOT COMPLETED|Overall Study||12
2610639|NCT00117793|6410770|P1|COMPLETED|Overall Study||5
2610640|NCT00117793|6410770|P1|STARTED|Overall Study||17
2610641|NCT00117715|6410785|P1|NOT COMPLETED|Overall Study||72
2610642|NCT00117715|6410785|P1|COMPLETED|Overall Study||49
2610643|NCT00117715|6410785|P1|5 Year|Overall Study||49
2610644|NCT00117715|6410785|P1|4.5 Year|Overall Study||55
2610645|NCT00117715|6410785|P1|4 Year|Overall Study||58
2610646|NCT00117715|6410785|P1|3.5 Year|Overall Study||60
2610647|NCT00117715|6410785|P1|3 Year|Overall Study||61
2610648|NCT00117715|6410785|P1|2.5 Year|Overall Study||70
2610649|NCT00117715|6410785|P1|2 Year|Overall Study||76
2610650|NCT00117715|6410785|P1|1.5 Year|Overall Study||85
2610651|NCT00117715|6410785|P1|1 Year|Overall Study||88
2610652|NCT00117715|6410785|P1|STARTED|Overall Study||121
2610653|NCT00117676|6410793|P2|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
2610654|NCT00117676|6410794|P1|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
2610655|NCT00117676|6410793|P2|COMPLETED|Open-label Period: Weeks 433 - 480||41
2610656|NCT00117676|6410794|P1|COMPLETED|Open-label Period: Weeks 433 - 480||80
2610657|NCT00117676|6410793|P2|STARTED|Open-label Period: Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|43
2610658|NCT00117676|6410794|P1|STARTED|Open-label Period: Weeks 433 - 480||82
2610659|NCT00117676|6410793|P2|NOT COMPLETED|Open-label Period: Weeks 385 - 432||2
2610660|NCT00117676|6410794|P1|NOT COMPLETED|Open-label Period: Weeks 385 - 432||0
2610661|NCT00117676|6410793|P2|COMPLETED|Open-label Period: Weeks 385 - 432||44
2610662|NCT00117676|6410794|P1|COMPLETED|Open-label Period: Weeks 385 - 432||82
2610663|NCT00117676|6410793|P2|STARTED|Open-label Period: Weeks 385 - 432|44 participants completed 384 weeks but did not continue on study.|46
2610664|NCT00117676|6410794|P1|STARTED|Open-label Period: Weeks 385 - 432|94 participants completed 384 weeks but did not continue on study.|82
2610665|NCT00117676|6410793|P2|NOT COMPLETED|Open-label Period: Weeks 337 - 384||3
2610666|NCT00117676|6410794|P1|NOT COMPLETED|Open-label Period: Weeks 337 - 384||7
2610667|NCT00117676|6410793|P2|COMPLETED|Open-label Period: Weeks 337 - 384||90
2610668|NCT00117676|6410794|P1|COMPLETED|Open-label Period: Weeks 337 - 384||176
2610669|NCT00117676|6410793|P2|STARTED|Open-label Period: Weeks 337 - 384||93
2610670|NCT00117676|6410794|P1|STARTED|Open-label Period: Weeks 337 - 384||183
2610671|NCT00117676|6410793|P2|NOT COMPLETED|Open-label Period: Weeks 289 - 336||7
2610672|NCT00117676|6410794|P1|NOT COMPLETED|Open-label Period: Weeks 289 - 336||9
2610673|NCT00117676|6410793|P2|COMPLETED|Open-label Period: Weeks 289 - 336||93
2610674|NCT00117676|6410794|P1|COMPLETED|Open-label Period: Weeks 289 - 336||183
2610675|NCT00117676|6410793|P2|STARTED|Open-label Period: Weeks 289 - 336||100
2610676|NCT00117676|6410794|P1|STARTED|Open-label Period: Weeks 289 - 336||192
2610677|NCT00117676|6410793|P2|NOT COMPLETED|Open-label Period: Weeks 241 - 288||3
2610678|NCT00117676|6410794|P1|NOT COMPLETED|Open-label Period: Weeks 241 - 288||10
2610679|NCT00117676|6410793|P2|COMPLETED|Open-label Period: Weeks 241 - 288||100
2610680|NCT00117676|6410794|P1|COMPLETED|Open-label Period: Weeks 241 - 288||192
2610681|NCT00117676|6410793|P2|STARTED|Open-label Period: Weeks 241 - 288||103
2610682|NCT00117676|6410794|P1|STARTED|Open-label Period: Weeks 241 - 288||202
2610683|NCT00117676|6410793|P2|NOT COMPLETED|Open-label Period: Weeks 193 - 240||3
2610684|NCT00117676|6410794|P1|NOT COMPLETED|Open-label Period: Weeks 193 - 240||7
2610685|NCT00117676|6410793|P2|COMPLETED|Open-label Period: Weeks 193 - 240||103
2610686|NCT00117676|6410794|P1|COMPLETED|Open-label Period: Weeks 193 - 240||202
2610687|NCT00117676|6410793|P2|STARTED|Open-label Period: Weeks 193 - 240||106
2610688|NCT00117676|6410794|P1|STARTED|Open-label Period: Weeks 193 - 240||209
2610689|NCT00117676|6410793|P2|NOT COMPLETED|Open-label Period: Weeks 145 - 192||3
2610690|NCT00117676|6410794|P1|NOT COMPLETED|Open-label Period: Weeks 145 - 192||10
2610691|NCT00117676|6410793|P2|COMPLETED|Open-label Period: Weeks 145 - 192||106
2610692|NCT00117676|6410794|P1|COMPLETED|Open-label Period: Weeks 145 - 192||209
2610693|NCT00117676|6410793|P2|STARTED|Open-label Period: Weeks 145 - 192||109
2610694|NCT00117676|6410794|P1|STARTED|Open-label Period: Weeks 145 - 192||219
2610695|NCT00117676|6410793|P2|NOT COMPLETED|Open-label Period: Weeks 97 - 144||1
2610696|NCT00117676|6410794|P1|NOT COMPLETED|Open-label Period: Weeks 97 - 144||6
2610697|NCT00117676|6410793|P2|COMPLETED|Open-label Period: Weeks 97 - 144||109
2610698|NCT00117676|6410794|P1|COMPLETED|Open-label Period: Weeks 97 - 144||219
2610699|NCT00117676|6410793|P2|STARTED|Open-label Period: Weeks 97 - 144||110
2610700|NCT00117676|6410794|P1|STARTED|Open-label Period: Weeks 97 - 144||225
2610701|NCT00117676|6410793|P2|NOT COMPLETED|Open-label Period: Weeks 49 - 96||2
2610702|NCT00117676|6410794|P1|NOT COMPLETED|Open-label Period: Weeks 49 - 96||10
2610703|NCT00117676|6410793|P2|COMPLETED|Open-label Period: Weeks 49 - 96||110
2610704|NCT00117676|6410794|P1|COMPLETED|Open-label Period: Weeks 49 - 96||225
2610705|NCT00117676|6410793|P2|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|112
2610706|NCT00117676|6410794|P1|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|235
2610707|NCT00117676|6410793|P2|NOT COMPLETED|Double-blind Period Through Week 48||7
2610708|NCT00117676|6410794|P1|NOT COMPLETED|Double-blind Period Through Week 48||10
2610709|NCT00117676|6410793|P2|COMPLETED|Double-blind Period Through Week 48||121
2610710|NCT00117676|6410794|P1|COMPLETED|Double-blind Period Through Week 48||244
2610711|NCT00117676|6410793|P2|STARTED|Double-blind Period Through Week 48||128
2610712|NCT00117676|6410794|P1|STARTED|Double-blind Period Through Week 48||254
2610713|NCT00117637|6410883|P2|NOT COMPLETED|Second Intervention (Period 2)||22
2610714|NCT00117637|6410884|P1|NOT COMPLETED|Second Intervention (Period 2)||10
2610715|NCT00117637|6410883|P2|COMPLETED|Second Intervention (Period 2)||39
2610716|NCT00117637|6410884|P1|COMPLETED|Second Intervention (Period 2)||39
2610717|NCT00117637|6410883|P2|Subjects Received Treatment|Second Intervention (Period 2)||61
2610718|NCT00117637|6410884|P1|Subjects Received Treatment|Second Intervention (Period 2)||49
2610719|NCT00117637|6410883|P2|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|61
2610720|NCT00117637|6410884|P1|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|49
2610721|NCT00117637|6410883|P2|NOT COMPLETED|First Intervention (Period 1)||25
2610722|NCT00117637|6410884|P1|NOT COMPLETED|First Intervention (Period 1)||18
2610723|NCT00117637|6410883|P2|COMPLETED|First Intervention (Period 1)||67
2610724|NCT00117637|6410884|P1|COMPLETED|First Intervention (Period 1)||79
2610725|NCT00117637|6410883|P2|Subjects Received Treatment|First Intervention (Period 1)||90
2610726|NCT00117637|6410884|P1|Subjects Received Treatment|First Intervention (Period 1)||97
2610727|NCT00117637|6410883|P2|STARTED|First Intervention (Period 1)||92
2610728|NCT00117637|6410884|P1|STARTED|First Intervention (Period 1)||97
2610729|NCT00117598|6410959|P5|NOT COMPLETED|After Treament Cross Over||4
2610730|NCT00117598|6410960|P4|NOT COMPLETED|After Treament Cross Over||3
2610731|NCT00117598|6410961|P3|NOT COMPLETED|After Treament Cross Over||0
2610732|NCT00117598|6410962|P2|NOT COMPLETED|After Treament Cross Over||0
2610733|NCT00117598|6410963|P1|NOT COMPLETED|After Treament Cross Over||0
2610734|NCT00117598|6410959|P5|COMPLETED|After Treament Cross Over||0
2610735|NCT00117598|6410960|P4|COMPLETED|After Treament Cross Over||0
2610736|NCT00117598|6410961|P3|COMPLETED|After Treament Cross Over||0
2610737|NCT00117598|6410962|P2|COMPLETED|After Treament Cross Over||0
2610738|NCT00117598|6410963|P1|COMPLETED|After Treament Cross Over||0
2610739|NCT00117598|6410959|P5|STARTED|After Treament Cross Over||4
2610740|NCT00117598|6410960|P4|STARTED|After Treament Cross Over||3
2610741|NCT00117598|6410961|P3|STARTED|After Treament Cross Over||0
2610742|NCT00117598|6410962|P2|STARTED|After Treament Cross Over||0
2610743|NCT00117598|6410963|P1|STARTED|After Treament Cross Over||0
2610744|NCT00117598|6410959|P5|NOT COMPLETED|Prior to Treatment Cross Over||0
2610745|NCT00117598|6410960|P4|NOT COMPLETED|Prior to Treatment Cross Over||0
2610746|NCT00117598|6410961|P3|NOT COMPLETED|Prior to Treatment Cross Over||52
2610747|NCT00117598|6410962|P2|NOT COMPLETED|Prior to Treatment Cross Over||53
2610748|NCT00117598|6410963|P1|NOT COMPLETED|Prior to Treatment Cross Over||57
2610749|NCT00117598|6410959|P5|COMPLETED|Prior to Treatment Cross Over||0
2610750|NCT00117598|6410960|P4|COMPLETED|Prior to Treatment Cross Over||0
2610751|NCT00117598|6410961|P3|COMPLETED|Prior to Treatment Cross Over||4
2610752|NCT00117598|6410962|P2|COMPLETED|Prior to Treatment Cross Over||3
2610753|NCT00117598|6410963|P1|COMPLETED|Prior to Treatment Cross Over||0
2610754|NCT00117598|6410959|P5|STARTED|Prior to Treatment Cross Over||0
2610755|NCT00117598|6410960|P4|STARTED|Prior to Treatment Cross Over||0
2610756|NCT00117598|6410961|P3|STARTED|Prior to Treatment Cross Over||56
2610757|NCT00117598|6410962|P2|STARTED|Prior to Treatment Cross Over||56
2610758|NCT00117598|6410963|P1|STARTED|Prior to Treatment Cross Over||57
2610759|NCT00117585|6410991|P1|NOT COMPLETED|Overall Study||0
2610760|NCT00117585|6410991|P1|COMPLETED|Overall Study||341
2610761|NCT00117585|6410991|P1|STARTED|Overall Study||341
2610762|NCT00117572|6410997|P2|NOT COMPLETED|Overall Study||6
2610763|NCT00117572|6410998|P1|NOT COMPLETED|Overall Study||6
2610764|NCT00117572|6410997|P2|COMPLETED|Overall Study||135
2610765|NCT00117572|6410998|P1|COMPLETED|Overall Study||138
2610766|NCT00117572|6410997|P2|STARTED|Overall Study||141
2610767|NCT00117572|6410998|P1|STARTED|Overall Study||144
2610768|NCT00117559|6411030|P2|NOT COMPLETED|Overall Study||1
2610769|NCT00117559|6411031|P1|NOT COMPLETED|Overall Study||1
2610770|NCT00117559|6411030|P2|COMPLETED|Overall Study||9
2610771|NCT00117559|6411031|P1|COMPLETED|Overall Study||8
2610772|NCT00117559|6411030|P2|STARTED|Overall Study||10
2610773|NCT00117559|6411031|P1|STARTED|Overall Study||9
2610774|NCT00117338|6411039|P2|NOT COMPLETED|Overall Study||4
2610775|NCT00117338|6411040|P1|NOT COMPLETED|Overall Study||5
2610776|NCT00117338|6411039|P2|COMPLETED|Overall Study||127
2610777|NCT00117338|6411040|P1|COMPLETED|Overall Study||140
2610778|NCT00117338|6411039|P2|STARTED|Overall Study||131
2610779|NCT00117338|6411040|P1|STARTED|Overall Study||145
2610780|NCT00117325|6411060|P2|NOT COMPLETED|Overall Study||12
2610781|NCT00117325|6411061|P1|NOT COMPLETED|Overall Study||13
2610782|NCT00117325|6411060|P2|COMPLETED|Overall Study||167
2610783|NCT00117325|6411061|P1|COMPLETED|Overall Study||160
2610784|NCT00117325|6411060|P2|STARTED|Overall Study||179
2610785|NCT00117325|6411061|P1|STARTED|Overall Study||173
2610786|NCT00117312|6411093|P4|NOT COMPLETED|Overall Study||21
2610787|NCT00117312|6411094|P3|NOT COMPLETED|Overall Study||24
2610788|NCT00117312|6411095|P2|NOT COMPLETED|Overall Study||20
2610789|NCT00117312|6411096|P1|NOT COMPLETED|Overall Study||10
2610790|NCT00117312|6411093|P4|COMPLETED|Overall Study||3
2610791|NCT00117312|6411094|P3|COMPLETED|Overall Study||0
2610792|NCT00117312|6411095|P2|COMPLETED|Overall Study|Defined as those patients ongoing when the extension study was terminated|4
2610793|NCT00117312|6411096|P1|COMPLETED|Overall Study||0
2610794|NCT00117312|6411093|P4|Started FE200486 CS06A|Overall Study||9
2610795|NCT00117312|6411094|P3|Started FE200486 CS06A|Overall Study||16
2610796|NCT00117312|6411095|P2|Started FE200486 CS06A|Overall Study||11
2610797|NCT00117312|6411096|P1|Started FE200486 CS06A|Overall Study||1
2610798|NCT00117312|6411093|P4|STARTED|Overall Study||24
2610799|NCT00117312|6411094|P3|STARTED|Overall Study||24
2610800|NCT00117312|6411095|P2|STARTED|Overall Study||24
2610801|NCT00117312|6411096|P1|STARTED|Overall Study||10
2610802|NCT00117286|6411112|P2|NOT COMPLETED|Overall Study||21
2610803|NCT00117286|6411113|P1|NOT COMPLETED|Overall Study||28
2610804|NCT00117286|6411112|P2|COMPLETED|Overall Study||6
2610805|NCT00117286|6411113|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|2
2610806|NCT00117286|6411112|P2|Switched to Higher Dose|Overall Study||17
2610807|NCT00117286|6411113|P1|Switched to Higher Dose|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL)|17
2610808|NCT00117286|6411112|P2|STARTED|Overall Study||27
2610809|NCT00117286|6411113|P1|STARTED|Overall Study|Safety analysis set|30
2610810|NCT00117156|6411121|P1|NOT COMPLETED|Overall Study||11
2610811|NCT00117156|6411121|P1|COMPLETED|Overall Study||15
2610812|NCT00117156|6411121|P1|STARTED|Overall Study||26
2610813|NCT00117143|6411133|P4|NOT COMPLETED|Overall Study||0
2610814|NCT00117143|6411134|P3|NOT COMPLETED|Overall Study||0
2610815|NCT00117143|6411135|P2|NOT COMPLETED|Overall Study||0
2610816|NCT00117143|6411136|P1|NOT COMPLETED|Overall Study||0
2610817|NCT00117143|6411133|P4|COMPLETED|Overall Study||1
2610818|NCT00117143|6411134|P3|COMPLETED|Overall Study||7
2610819|NCT00117143|6411135|P2|COMPLETED|Overall Study||4
2610820|NCT00117143|6411136|P1|COMPLETED|Overall Study||4
2610821|NCT00117143|6411133|P4|Received Second Dose|Overall Study||0
2610822|NCT00117143|6411134|P3|Received Second Dose|Overall Study||6
2610823|NCT00117143|6411135|P2|Received Second Dose|Overall Study||4
2610824|NCT00117143|6411136|P1|Received Second Dose|Overall Study||4
2610825|NCT00117143|6411133|P4|Received First Dose|Overall Study||1
2610826|NCT00117143|6411134|P3|Received First Dose|Overall Study||7
2610827|NCT00117143|6411135|P2|Received First Dose|Overall Study||4
2610828|NCT00117143|6411136|P1|Received First Dose|Overall Study||4
2610829|NCT00117143|6411133|P4|STARTED|Overall Study||1
2610830|NCT00117143|6411134|P3|STARTED|Overall Study||7
2610831|NCT00117143|6411135|P2|STARTED|Overall Study||4
2610832|NCT00117143|6411136|P1|STARTED|Overall Study||4
2610833|NCT00116857|6411180|P2|NOT COMPLETED|Overall Study||4
2610834|NCT00116857|6411181|P1|NOT COMPLETED|Overall Study||3
2610835|NCT00116857|6411180|P2|COMPLETED|Overall Study||56
2610836|NCT00116857|6411181|P1|COMPLETED|Overall Study||59
2610837|NCT00116857|6411180|P2|STARTED|Overall Study||60
2610838|NCT00116857|6411181|P1|STARTED|Overall Study||62
2610839|NCT00116844|6411189|P2|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||5
2610840|NCT00116844|6411190|P1|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||4
2610841|NCT00116844|6411189|P2|COMPLETED|Period 1: Treatment Period 2 (60 Days)||28
2610842|NCT00116844|6411190|P1|COMPLETED|Period 1: Treatment Period 2 (60 Days)||24
2610843|NCT00116844|6411189|P2|STARTED|Period 1: Treatment Period 2 (60 Days)||33
2610844|NCT00116844|6411190|P1|STARTED|Period 1: Treatment Period 2 (60 Days)||28
2610845|NCT00116844|6411189|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
2610846|NCT00116844|6411190|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
2610847|NCT00116844|6411189|P2|COMPLETED|Period 2: Washout Period (7 Days)||33
2610848|NCT00116844|6411190|P1|COMPLETED|Period 2: Washout Period (7 Days)||28
2610849|NCT00116844|6411189|P2|STARTED|Period 2: Washout Period (7 Days)||33
2610850|NCT00116844|6411190|P1|STARTED|Period 2: Washout Period (7 Days)||28
2610851|NCT00116844|6411189|P2|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||3
2610852|NCT00116844|6411190|P1|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||7
2610853|NCT00116844|6411189|P2|COMPLETED|Period 1: Treatment Period 1 (60 Days)||33
2610854|NCT00116844|6411190|P1|COMPLETED|Period 1: Treatment Period 1 (60 Days)||28
2610855|NCT00116844|6411189|P2|STARTED|Period 1: Treatment Period 1 (60 Days)||36
2610856|NCT00116844|6411190|P1|STARTED|Period 1: Treatment Period 1 (60 Days)||35
2610857|NCT00116831|6411208|P2|NOT COMPLETED|Overall Study||72
2610858|NCT00116831|6411209|P1|NOT COMPLETED|Overall Study||73
2610859|NCT00116831|6411208|P2|COMPLETED|Overall Study||259
2610860|NCT00116831|6411209|P1|COMPLETED|Overall Study||264
2610861|NCT00116831|6411208|P2|STARTED|Overall Study||331
2610862|NCT00116831|6411209|P1|STARTED|Overall Study||337
2610863|NCT00116805|6411287|P2|NOT COMPLETED|Open-label Period Weeks 433 - 480||0
2610864|NCT00116805|6411288|P1|NOT COMPLETED|Open-label Period Weeks 433 - 480||4
2610865|NCT00116805|6411287|P2|COMPLETED|Open-label Period Weeks 433 - 480||29
2610866|NCT00116805|6411288|P1|COMPLETED|Open-label Period Weeks 433 - 480||53
2610867|NCT00116805|6411287|P2|STARTED|Open-label Period Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|29
2610868|NCT00116805|6411288|P1|STARTED|Open-label Period Weeks 433 - 480||57
2610869|NCT00116805|6411287|P2|NOT COMPLETED|Open-label Period Weeks 385 - 432||0
2610870|NCT00116805|6411288|P1|NOT COMPLETED|Open-label Period Weeks 385 - 432||2
2610871|NCT00116805|6411287|P2|COMPLETED|Open-label Period Weeks 385 - 432||30
2610872|NCT00116805|6411288|P1|COMPLETED|Open-label Period Weeks 385 - 432||57
2610873|NCT00116805|6411287|P2|STARTED|Open-label Period Weeks 385 - 432|26 participants completed 384 weeks but did not continue on study.|30
2610874|NCT00116805|6411288|P1|STARTED|Open-label Period Weeks 385 - 432|31 participants completed 384 weeks but did not continue on study.|59
2610875|NCT00116805|6411287|P2|NOT COMPLETED|Open-label Period Weeks 337 - 384||1
2610876|NCT00116805|6411288|P1|NOT COMPLETED|Open-label Period Weeks 337 - 384||8
2610877|NCT00116805|6411287|P2|COMPLETED|Open-label Period Weeks 337 - 384||56
2610878|NCT00116805|6411288|P1|COMPLETED|Open-label Period Weeks 337 - 384||90
2610879|NCT00116805|6411287|P2|STARTED|Open-label Period Weeks 337 - 384||57
2610880|NCT00116805|6411288|P1|STARTED|Open-label Period Weeks 337 - 384||98
2610881|NCT00116805|6411287|P2|NOT COMPLETED|Open-label Period Weeks 289 - 336||7
2610882|NCT00116805|6411288|P1|NOT COMPLETED|Open-label Period Weeks 289 - 336||6
2610883|NCT00116805|6411287|P2|COMPLETED|Open-label Period Weeks 289 - 336||57
2610884|NCT00116805|6411288|P1|COMPLETED|Open-label Period Weeks 289 - 336||98
2610885|NCT00116805|6411287|P2|STARTED|Open-label Period Weeks 289 - 336||64
2610886|NCT00116805|6411288|P1|STARTED|Open-label Period Weeks 289 - 336||104
2610887|NCT00116805|6411287|P2|NOT COMPLETED|Open-label Period Weeks 241 - 288||0
2610888|NCT00116805|6411288|P1|NOT COMPLETED|Open-label Period Weeks 241 - 288||6
2610889|NCT00116805|6411287|P2|COMPLETED|Open-label Period Weeks 241 - 288||64
2610890|NCT00116805|6411288|P1|COMPLETED|Open-label Period Weeks 241 - 288||104
2610891|NCT00116805|6411287|P2|STARTED|Open-label Period Weeks 241 - 288||64
2610892|NCT00116805|6411288|P1|STARTED|Open-label Period Weeks 241 - 288||110
2610893|NCT00116805|6411287|P2|NOT COMPLETED|Open-label Period Weeks 193 - 240||4
2610894|NCT00116805|6411288|P1|NOT COMPLETED|Open-label Period Weeks 193 - 240||13
2610895|NCT00116805|6411287|P2|COMPLETED|Open-label Period Weeks 193 - 240||64
2610896|NCT00116805|6411288|P1|COMPLETED|Open-label Period Weeks 193 - 240||110
2610897|NCT00116805|6411287|P2|STARTED|Open-label Period Weeks 193 - 240||68
2610898|NCT00116805|6411288|P1|STARTED|Open-label Period Weeks 193 - 240||123
2610899|NCT00116805|6411287|P2|NOT COMPLETED|Open-label Period Weeks 145 - 192||6
2610900|NCT00116805|6411288|P1|NOT COMPLETED|Open-label Period Weeks 145 - 192||10
2610901|NCT00116805|6411287|P2|COMPLETED|Open-label Period Weeks 145 - 192||68
2610902|NCT00116805|6411288|P1|COMPLETED|Open-label Period Weeks 145 - 192||123
2610903|NCT00116805|6411287|P2|STARTED|Open-label Period Weeks 145 - 192||74
2610904|NCT00116805|6411288|P1|STARTED|Open-label Period Weeks 145 - 192||133
2610905|NCT00116805|6411287|P2|NOT COMPLETED|Open-label Period Weeks 97 - 144||9
2610906|NCT00116805|6411288|P1|NOT COMPLETED|Open-label Period Weeks 97 - 144||11
2610907|NCT00116805|6411287|P2|COMPLETED|Open-label Period Weeks 97 - 144||74
2610908|NCT00116805|6411288|P1|COMPLETED|Open-label Period Weeks 97 - 144||133
2610909|NCT00116805|6411287|P2|STARTED|Open-label Period Weeks 97 - 144||83
2610910|NCT00116805|6411288|P1|STARTED|Open-label Period Weeks 97 - 144||144
2610911|NCT00116805|6411287|P2|NOT COMPLETED|Open-label Period Weeks 49 - 96||1
2610912|NCT00116805|6411288|P1|NOT COMPLETED|Open-label Period Weeks 49 - 96||10
2610913|NCT00116805|6411287|P2|COMPLETED|Open-label Period Weeks 49 - 96||83
2610914|NCT00116805|6411288|P1|COMPLETED|Open-label Period Weeks 49 - 96||144
2610915|NCT00116805|6411287|P2|STARTED|Open-label Period Weeks 49 - 96|1 participant completed 48 weeks but did not continue on study.|84
2610916|NCT00116805|6411288|P1|STARTED|Open-label Period Weeks 49 - 96|11 participants completed 48 weeks but did not continue on study.|154
2610917|NCT00116805|6411287|P2|NOT COMPLETED|Double-blind Period Through Week 48||5
2610918|NCT00116805|6411288|P1|NOT COMPLETED|Double-blind Period Through Week 48||11
2610919|NCT00116805|6411287|P2|COMPLETED|Double-blind Period Through Week 48||85
2610920|NCT00116805|6411288|P1|COMPLETED|Double-blind Period Through Week 48||165
2610921|NCT00116805|6411287|P2|STARTED|Double-blind Period Through Week 48||90
2610922|NCT00116805|6411288|P1|STARTED|Double-blind Period Through Week 48||176
2610923|NCT00116779|6411381|P2|NOT COMPLETED|Overall Study||19
2610924|NCT00116779|6411382|P1|NOT COMPLETED|Overall Study||21
2610925|NCT00116779|6411381|P2|COMPLETED|Overall Study||45
2610926|NCT00116779|6411382|P1|COMPLETED|Overall Study||42
2610927|NCT00116779|6411381|P2|STARTED|Overall Study|Randomized and treated; intent-to-treat population|64
2610928|NCT00116779|6411382|P1|STARTED|Overall Study|Randomized and treated; Intent-to-treat population|63
2610929|NCT00116753|6411415|P3|NOT COMPLETED|Overall Study||24
2610930|NCT00116753|6411416|P2|NOT COMPLETED|Overall Study||30
2610931|NCT00116753|6411417|P1|NOT COMPLETED|Overall Study||32
2610932|NCT00116753|6411415|P3|COMPLETED|Overall Study||128
2610933|NCT00116753|6411416|P2|COMPLETED|Overall Study||125
2610934|NCT00116753|6411417|P1|COMPLETED|Overall Study||121
2610935|NCT00116753|6411415|P3|ITT Population|Overall Study||147
2610936|NCT00116753|6411416|P2|ITT Population|Overall Study||150
2610937|NCT00116753|6411417|P1|ITT Population|Overall Study||150
2610938|NCT00116753|6411415|P3|STARTED|Overall Study||152
2610939|NCT00116753|6411416|P2|STARTED|Overall Study||155
2610940|NCT00116753|6411417|P1|STARTED|Overall Study|Randomised.|153
2610941|NCT00116688|6411439|P2|NOT COMPLETED|Overall Study||4
2610942|NCT00116688|6411440|P1|NOT COMPLETED|Overall Study||92
2610943|NCT00116688|6411439|P2|COMPLETED|Overall Study||17
2610944|NCT00116688|6411440|P1|COMPLETED|Overall Study||200
2610945|NCT00116688|6411439|P2|Received Study Medication|Overall Study||20
2610946|NCT00116688|6411440|P1|Received Study Medication|Overall Study||291
2610947|NCT00116688|6411439|P2|STARTED|Overall Study||21
2610948|NCT00116688|6411440|P1|STARTED|Overall Study||292
2610949|NCT00116649|6411455|P1|NOT COMPLETED|Overall Study||155
2610950|NCT00116649|6411455|P1|COMPLETED|Overall Study||396
2610951|NCT00116649|6411455|P1|STARTED|Overall Study|586 screened (34 not eligible) 552 enrolled 551 study population (1 subject not treated)|551
2610952|NCT00116558|6411463|P3|NOT COMPLETED|Overall Study||33
2610953|NCT00116558|6411464|P2|NOT COMPLETED|Overall Study||15
2610954|NCT00116558|6411465|P1|NOT COMPLETED|Overall Study||31
2610955|NCT00116558|6411463|P3|COMPLETED|Overall Study||14
2610956|NCT00116558|6411464|P2|COMPLETED|Overall Study||11
2610957|NCT00116558|6411465|P1|COMPLETED|Overall Study||49
2610958|NCT00116558|6411463|P3|STARTED|Overall Study||47
2610959|NCT00116558|6411464|P2|STARTED|Overall Study||26
2610960|NCT00116558|6411465|P1|STARTED|Overall Study||80
2610961|NCT00116428|6411476|P2|NOT COMPLETED|Overall Study||5
2610962|NCT00116428|6411477|P1|NOT COMPLETED|Overall Study||3
2610963|NCT00116428|6411476|P2|COMPLETED|Overall Study||56
2610964|NCT00116428|6411477|P1|COMPLETED|Overall Study||103
2610965|NCT00116428|6411476|P2|Underwent Study Ablation Procedure|Overall Study||36
2610966|NCT00116428|6411477|P1|Underwent Study Ablation Procedure|Overall Study||103
2610967|NCT00116428|6411476|P2|STARTED|Overall Study||61
2610968|NCT00116428|6411477|P1|STARTED|Overall Study||106
2610969|NCT00116272|6411495|P2|NOT COMPLETED|Overall Study||6
2610970|NCT00116272|6411496|P1|NOT COMPLETED|Overall Study||11
2610971|NCT00116272|6411495|P2|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|158
2610972|NCT00116272|6411496|P1|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|359
2610973|NCT00116272|6411495|P2|STARTED|Overall Study||164
2610974|NCT00116272|6411496|P1|STARTED|Overall Study||370
2610975|NCT00116207|6411548|P2|NOT COMPLETED|Overall Study||4
2610976|NCT00116207|6411549|P1|NOT COMPLETED|Overall Study||9
2610977|NCT00116207|6411548|P2|COMPLETED|Overall Study||18
2610978|NCT00116207|6411549|P1|COMPLETED|Overall Study||13
2610979|NCT00116207|6411548|P2|STARTED|Overall Study||22
2610980|NCT00116207|6411549|P1|STARTED|Overall Study||22
2610981|NCT00116168|6411565|P4|NOT COMPLETED|Overall Study||0
2610982|NCT00116168|6411566|P3|NOT COMPLETED|Overall Study||0
2610983|NCT00116168|6411567|P2|NOT COMPLETED|Overall Study||5
2610984|NCT00116168|6411568|P1|NOT COMPLETED|Overall Study||6
2610985|NCT00116168|6411565|P4|COMPLETED|Overall Study||6
2610986|NCT00116168|6411566|P3|COMPLETED|Overall Study||6
2610987|NCT00116168|6411567|P2|COMPLETED|Overall Study||6
2610988|NCT00116168|6411568|P1|COMPLETED|Overall Study||0
2610989|NCT00116168|6411565|P4|STARTED|Overall Study||6
2610990|NCT00116168|6411566|P3|STARTED|Overall Study||6
2610991|NCT00116168|6411567|P2|STARTED|Overall Study||11
2610992|NCT00116168|6411568|P1|STARTED|Overall Study||6
2610993|NCT00115934|6411632|P2|NOT COMPLETED|Overall Study||2
2610994|NCT00115934|6411633|P1|NOT COMPLETED|Overall Study||4
2610995|NCT00115934|6411632|P2|COMPLETED|Overall Study||274
2610996|NCT00115934|6411633|P1|COMPLETED|Overall Study||275
2610997|NCT00115934|6411632|P2|STARTED|Overall Study|276 randomized to RVPAS, but 2 did not have a Norwood surgery and were excluded from analyses.|276
2610998|NCT00115934|6411633|P1|STARTED|Overall Study|279 randomized to MBTS, but 3 did not have a Norwood surgery; one was withdrawn-with limited data.|279
2610999|NCT00115869|6411673|P2|NOT COMPLETED|Overall Study||296
2611000|NCT00115869|6411674|P1|NOT COMPLETED|Overall Study||317
2611001|NCT00115869|6411673|P2|COMPLETED|Overall Study|Follow-up at two years post high school.|3881
2611002|NCT00115869|6411674|P1|COMPLETED|Overall Study||3894
2611003|NCT00115869|6411673|P2|Completed Data Collection at 12th Grade|Overall Study||3847
2611004|NCT00115869|6411674|P1|Completed Data Collection at 12th Grade|Overall Study||3876
2611005|NCT00115869|6411673|P2|STARTED|Overall Study||4177
2611006|NCT00115869|6411674|P1|STARTED|Overall Study||4211
2611007|NCT00115804|6411682|P1|NOT COMPLETED|Overall Study||2
2611008|NCT00115804|6411682|P1|COMPLETED|Overall Study||4
2611009|NCT00115804|6411682|P1|STARTED|Overall Study||6
2611010|NCT00115778|6411693|P2|NOT COMPLETED|Overall Study||1
2611011|NCT00115778|6411694|P1|NOT COMPLETED|Overall Study||0
2611012|NCT00115778|6411693|P2|COMPLETED|Overall Study||4
2611013|NCT00115778|6411694|P1|COMPLETED|Overall Study||6
2611014|NCT00115778|6411693|P2|STARTED|Overall Study||5
2611015|NCT00115778|6411694|P1|STARTED|Overall Study||6
2611016|NCT00115765|6411714|P4|NOT COMPLETED|Overall Study||31
2611017|NCT00115765|6411715|P3|NOT COMPLETED|Overall Study||121
2611018|NCT00115765|6411716|P2|NOT COMPLETED|Overall Study||100
2611019|NCT00115765|6411717|P1|NOT COMPLETED|Overall Study||35
2611020|NCT00115765|6411714|P4|COMPLETED|Overall Study|Participants who were on study at closure or died|84
2611021|NCT00115765|6411715|P3|COMPLETED|Overall Study|Participants who were on study at closure or died|289
2611022|NCT00115765|6411716|P2|COMPLETED|Overall Study|Participants who were on study at closure or died|313
2611023|NCT00115765|6411717|P1|COMPLETED|Overall Study|Participants who were on study at closure or died|80
2611024|NCT00115765|6411714|P4|STARTED|Overall Study||115
2611025|NCT00115765|6411715|P3|STARTED|Overall Study||410
2611026|NCT00115765|6411716|P2|STARTED|Overall Study||413
2611027|NCT00115765|6411717|P1|STARTED|Overall Study||115
2611028|NCT00115739|6411755|P1|NOT COMPLETED|Overall Study||3
2611029|NCT00115739|6411755|P1|COMPLETED|Overall Study||8
2611030|NCT00115739|6411755|P1|STARTED|Overall Study||11
2611031|NCT00115349|6411764|P2|NOT COMPLETED|Overall Study||9
2611032|NCT00115349|6411765|P1|NOT COMPLETED|Overall Study||11
2611033|NCT00115349|6411764|P2|COMPLETED|Overall Study|study closed due to low enrollment.|0
2611034|NCT00115349|6411765|P1|COMPLETED|Overall Study|Study closed due to low enrollment.|0
2611035|NCT00115349|6411764|P2|STARTED|Overall Study|Target was 43 subjects in this arm.|9
2611036|NCT00115349|6411765|P1|STARTED|Overall Study|Target was 43 subjects in this arm.|11
2611037|NCT00115297|6411773|P2|NOT COMPLETED|Overall Study||0
2611038|NCT00115297|6411774|P1|NOT COMPLETED|Overall Study||0
2611039|NCT00115297|6411773|P2|COMPLETED|Overall Study||32
2611040|NCT00115297|6411774|P1|COMPLETED|Overall Study||30
2611041|NCT00115297|6411773|P2|STARTED|Overall Study||32
2611042|NCT00115297|6411774|P1|STARTED|Overall Study||30
2611043|NCT00115063|6411786|P2|NOT COMPLETED|Overall Study||104
2611044|NCT00115063|6411787|P1|NOT COMPLETED|Overall Study||99
2611045|NCT00115063|6411786|P2|COMPLETED|Overall Study||86
2611046|NCT00115063|6411787|P1|COMPLETED|Overall Study||101
2611047|NCT00115063|6411786|P2|STARTED|Overall Study||190
2611048|NCT00115063|6411787|P1|STARTED|Overall Study||200
2611049|NCT00115037|6411805|P6|NOT COMPLETED|Phase2||12
2611050|NCT00115037|6411806|P5|NOT COMPLETED|Phase2||6
2611051|NCT00115037|6411807|P4|NOT COMPLETED|Phase2||15
2611052|NCT00115037|6411808|P3|NOT COMPLETED|Phase2||15
2611053|NCT00115037|6411809|P2|NOT COMPLETED|Phase2||0
2611054|NCT00115037|6411810|P1|NOT COMPLETED|Phase2||0
2611055|NCT00115037|6411805|P6|COMPLETED|Phase2||21
2611056|NCT00115037|6411806|P5|COMPLETED|Phase2||28
2611057|NCT00115037|6411807|P4|COMPLETED|Phase2||77
2611058|NCT00115037|6411808|P3|COMPLETED|Phase2||76
2611059|NCT00115037|6411809|P2|COMPLETED|Phase2||0
2611060|NCT00115037|6411810|P1|COMPLETED|Phase2||0
2611061|NCT00115037|6411805|P6|STARTED|Phase2||33
2611062|NCT00115037|6411806|P5|STARTED|Phase2||34
2611063|NCT00115037|6411807|P4|STARTED|Phase2||92
2611064|NCT00115037|6411808|P3|STARTED|Phase2||91
2611065|NCT00115037|6411809|P2|STARTED|Phase2||0
2611066|NCT00115037|6411810|P1|STARTED|Phase2||0
2611067|NCT00115037|6411805|P6|NOT COMPLETED|Phase1||0
2611068|NCT00115037|6411806|P5|NOT COMPLETED|Phase1||0
2611069|NCT00115037|6411807|P4|NOT COMPLETED|Phase1||0
2611070|NCT00115037|6411808|P3|NOT COMPLETED|Phase1||0
2611071|NCT00115037|6411809|P2|NOT COMPLETED|Phase1||27
2611072|NCT00115037|6411810|P1|NOT COMPLETED|Phase1||25
2611073|NCT00115037|6411805|P6|COMPLETED|Phase1||0
2611074|NCT00115037|6411806|P5|COMPLETED|Phase1||0
2611075|NCT00115037|6411807|P4|COMPLETED|Phase1||0
2611076|NCT00115037|6411808|P3|COMPLETED|Phase1||0
2611077|NCT00115037|6411809|P2|COMPLETED|Phase1||123
2611078|NCT00115037|6411810|P1|COMPLETED|Phase1||127
2611079|NCT00115037|6411805|P6|STARTED|Phase1||0
2611080|NCT00115037|6411806|P5|STARTED|Phase1||0
2611081|NCT00115037|6411807|P4|STARTED|Phase1||0
2611082|NCT00115037|6411808|P3|STARTED|Phase1||0
2611083|NCT00115037|6411809|P2|STARTED|Phase1||150
2611084|NCT00115037|6411810|P1|STARTED|Phase1||152
2611085|NCT00114972|6411826|P2|NOT COMPLETED|Overall Study||12
2611086|NCT00114972|6411827|P1|NOT COMPLETED|Overall Study||48
2611087|NCT00114972|6411826|P2|COMPLETED|Overall Study||891
2611088|NCT00114972|6411827|P1|COMPLETED|Overall Study||849
2611089|NCT00114972|6411826|P2|STARTED|Overall Study||903
2611090|NCT00114972|6411827|P1|STARTED|Overall Study||897
2611091|NCT00114959|6411847|P1|NOT COMPLETED|Overall Study||8
2611092|NCT00114959|6411847|P1|COMPLETED|Overall Study|protocol definition of completed study is having received >= 4 cycles of treatment|7
2611093|NCT00114959|6411847|P1|STARTED|Overall Study||15
2611094|NCT00114777|6411857|P3|NOT COMPLETED|Long-Term Extension to Month 84||30
2611095|NCT00114777|6411858|P2|NOT COMPLETED|Long-Term Extension to Month 84||29
2611096|NCT00114777|6411859|P1|NOT COMPLETED|Long-Term Extension to Month 84||30
2611097|NCT00114777|6411857|P3|COMPLETED|Long-Term Extension to Month 84||57
2611098|NCT00114777|6411858|P2|COMPLETED|Long-Term Extension to Month 84||84
2611099|NCT00114777|6411859|P1|COMPLETED|Long-Term Extension to Month 84||74
2611100|NCT00114777|6411857|P3|STARTED|Long-Term Extension to Month 84||87
2611101|NCT00114777|6411858|P2|STARTED|Long-Term Extension to Month 84||113
2611102|NCT00114777|6411859|P1|STARTED|Long-Term Extension to Month 84||104
2611103|NCT00114777|6411857|P3|NOT COMPLETED|Randomization to Month 36||84
2611104|NCT00114777|6411858|P2|NOT COMPLETED|Randomization to Month 36||61
2611105|NCT00114777|6411859|P1|NOT COMPLETED|Randomization to Month 36||75
2611106|NCT00114777|6411857|P3|COMPLETED|Randomization to Month 36||100
2611107|NCT00114777|6411858|P2|COMPLETED|Randomization to Month 36||114
2611108|NCT00114777|6411859|P1|COMPLETED|Randomization to Month 36||109
2611109|NCT00114777|6411857|P3|STARTED|Randomization to Month 36||184
2611110|NCT00114777|6411858|P2|STARTED|Randomization to Month 36||175
2611111|NCT00114777|6411859|P1|STARTED|Randomization to Month 36||184
2611112|NCT00114738|6411933|P3|NOT COMPLETED|Randomization||0
2611113|NCT00114738|6411934|P2|NOT COMPLETED|Randomization||0
2611114|NCT00114738|6411935|P1|NOT COMPLETED|Randomization||0
2611115|NCT00114738|6411933|P3|COMPLETED|Randomization||16
2611116|NCT00114738|6411934|P2|COMPLETED|Randomization||14
2611117|NCT00114738|6411935|P1|COMPLETED|Randomization||0
2611118|NCT00114738|6411933|P3|STARTED|Randomization||16
2611119|NCT00114738|6411934|P2|STARTED|Randomization||14
2611120|NCT00114738|6411935|P1|STARTED|Randomization||0
2611121|NCT00114738|6411933|P3|NOT COMPLETED|Screening for Randomization||0
2611122|NCT00114738|6411934|P2|NOT COMPLETED|Screening for Randomization||0
2611123|NCT00114738|6411935|P1|NOT COMPLETED|Screening for Randomization||21
2611124|NCT00114738|6411933|P3|COMPLETED|Screening for Randomization||0
2611125|NCT00114738|6411934|P2|COMPLETED|Screening for Randomization||0
2611126|NCT00114738|6411935|P1|COMPLETED|Screening for Randomization||30
2611127|NCT00114738|6411933|P3|STARTED|Screening for Randomization||0
2611128|NCT00114738|6411934|P2|STARTED|Screening for Randomization||0
2611129|NCT00114738|6411935|P1|STARTED|Screening for Randomization||51
2611130|NCT00114738|6411933|P3|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||0
2611131|NCT00114738|6411934|P2|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||0
2611132|NCT00114738|6411935|P1|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||2
2611133|NCT00114738|6411933|P3|COMPLETED|Bortezomib Then Bortezomib + Induction||0
2611134|NCT00114738|6411934|P2|COMPLETED|Bortezomib Then Bortezomib + Induction||0
2611135|NCT00114738|6411935|P1|COMPLETED|Bortezomib Then Bortezomib + Induction||51
2611136|NCT00114738|6411933|P3|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
2611137|NCT00114738|6411934|P2|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
2611138|NCT00114738|6411935|P1|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||6
2611139|NCT00114738|6411933|P3|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
2611140|NCT00114738|6411934|P2|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
2611141|NCT00114738|6411935|P1|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||47
2611142|NCT00114738|6411933|P3|STARTED|Bortezomib Then Bortezomib + Induction||0
2611143|NCT00114738|6411934|P2|STARTED|Bortezomib Then Bortezomib + Induction||0
2611144|NCT00114738|6411935|P1|STARTED|Bortezomib Then Bortezomib + Induction||53
2611145|NCT00114634|6411948|P1|NOT COMPLETED|Overall Study||3
2611146|NCT00114634|6411948|P1|COMPLETED|Overall Study|Assessment forms lost by one failure to complete and return forms by two|10
2611147|NCT00114634|6411948|P1|STARTED|Overall Study||13
2611148|NCT00114530|6411964|P2|NOT COMPLETED|Overall Study||20
2611149|NCT00114530|6411965|P1|NOT COMPLETED|Overall Study||9
2611150|NCT00114530|6411964|P2|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient’s 54 mo visit)|19
2611151|NCT00114530|6411965|P1|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient’s 54 mo visit)|27
2611152|NCT00114530|6411964|P2|STARTED|Overall Study||39
2611153|NCT00114530|6411965|P1|STARTED|Overall Study||36
2611154|NCT00114517|6412074|P4|NOT COMPLETED|Overall Study||10
2611155|NCT00114517|6412075|P3|NOT COMPLETED|Overall Study||14
2611156|NCT00114517|6412076|P2|NOT COMPLETED|Overall Study||11
2611157|NCT00114517|6412077|P1|NOT COMPLETED|Overall Study||12
2611158|NCT00114517|6412074|P4|COMPLETED|Overall Study||176
2611159|NCT00114517|6412075|P3|COMPLETED|Overall Study||172
2611160|NCT00114517|6412076|P2|COMPLETED|Overall Study||123
2611161|NCT00114517|6412077|P1|COMPLETED|Overall Study||125
2611162|NCT00114517|6412074|P4|STARTED|Overall Study||186
2611163|NCT00114517|6412075|P3|STARTED|Overall Study||186
2611164|NCT00114517|6412076|P2|STARTED|Overall Study||134
2611165|NCT00114517|6412077|P1|STARTED|Overall Study||137
2611166|NCT00114504|6412089|P2|NOT COMPLETED|Overall Study||0
2611167|NCT00114504|6412090|P1|NOT COMPLETED|Overall Study||0
2611168|NCT00114504|6412089|P2|COMPLETED|Overall Study||22
2611169|NCT00114504|6412090|P1|COMPLETED|Overall Study||21
2611170|NCT00114504|6412089|P2|STARTED|Overall Study||22
2611171|NCT00114504|6412090|P1|STARTED|Overall Study||21
2611172|NCT00114244|6412102|P2|NOT COMPLETED|Overall Study||7
2611173|NCT00114244|6412103|P1|NOT COMPLETED|Overall Study||2
2611174|NCT00114244|6412102|P2|COMPLETED|Overall Study||30
2611175|NCT00114244|6412103|P1|COMPLETED|Overall Study||13
2611176|NCT00114244|6412102|P2|STARTED|Overall Study||37
2611177|NCT00114244|6412103|P1|STARTED|Overall Study||15
2611178|NCT00114231|6412115|P2|NOT COMPLETED|Overall Study||2
2611179|NCT00114231|6412116|P1|NOT COMPLETED|Overall Study||9
2611180|NCT00114231|6412115|P2|COMPLETED|Overall Study||26
2611181|NCT00114231|6412116|P1|COMPLETED|Overall Study||53
2611182|NCT00114231|6412115|P2|STARTED|Overall Study||28
2611183|NCT00114231|6412116|P1|STARTED|Overall Study||62
2611184|NCT00114218|6412125|P1|NOT COMPLETED|Overall Study||4
2611185|NCT00114218|6412125|P1|COMPLETED|Overall Study||24
2611186|NCT00114218|6412125|P1|STARTED|Overall Study||28
2611187|NCT00114166|6412132|P2|NOT COMPLETED|Overall Study||1
2611188|NCT00114166|6412133|P1|NOT COMPLETED|Overall Study||0
2611189|NCT00114166|6412132|P2|COMPLETED|Overall Study||65
2611190|NCT00114166|6412133|P1|COMPLETED|Overall Study||15
2611191|NCT00114166|6412132|P2|STARTED|Overall Study||66
2611192|NCT00114166|6412133|P1|STARTED|Overall Study||15
2611193|NCT00114140|6412143|P1|NOT COMPLETED|Overall Study||7
2611194|NCT00114140|6412143|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|129
2611195|NCT00114140|6412143|P1|STARTED|Overall Study||136
2611196|NCT00114127|6412157|P2|NOT COMPLETED|Overall Study||4
2611197|NCT00114127|6412158|P1|NOT COMPLETED|Overall Study||4
2611198|NCT00114127|6412157|P2|COMPLETED|Overall Study||11
2611199|NCT00114127|6412158|P1|COMPLETED|Overall Study||9
2611200|NCT00114127|6412157|P2|STARTED|Overall Study||15
2611201|NCT00114127|6412158|P1|STARTED|Overall Study||13
2611202|NCT00114114|6412172|P6|NOT COMPLETED|Overall Study||1
2611203|NCT00114114|6412173|P5|NOT COMPLETED|Overall Study||2
2611204|NCT00114114|6412174|P4|NOT COMPLETED|Overall Study||4
2611205|NCT00114114|6412175|P3|NOT COMPLETED|Overall Study||1
2611206|NCT00114114|6412176|P2|NOT COMPLETED|Overall Study||1
2611207|NCT00114114|6412177|P1|NOT COMPLETED|Overall Study||5
2611208|NCT00114114|6412172|P6|COMPLETED|Overall Study||30
2611209|NCT00114114|6412173|P5|COMPLETED|Overall Study||27
2611210|NCT00114114|6412174|P4|COMPLETED|Overall Study||31
2611211|NCT00114114|6412175|P3|COMPLETED|Overall Study||30
2611212|NCT00114114|6412176|P2|COMPLETED|Overall Study||24
2611213|NCT00114114|6412177|P1|COMPLETED|Overall Study||21
2611214|NCT00114114|6412172|P6|STARTED|Overall Study||31
2611215|NCT00114114|6412173|P5|STARTED|Overall Study||29
2611216|NCT00114114|6412174|P4|STARTED|Overall Study||35
2611217|NCT00114114|6412175|P3|STARTED|Overall Study||31
2611218|NCT00114114|6412176|P2|STARTED|Overall Study||25
2611219|NCT00114114|6412177|P1|STARTED|Overall Study||26
2611220|NCT00114101|6412217|P2|NOT COMPLETED|Overall Study||0
2611221|NCT00114101|6412218|P1|NOT COMPLETED|Overall Study||0
2611222|NCT00114101|6412217|P2|COMPLETED|Overall Study||229
2611223|NCT00114101|6412218|P1|COMPLETED|Overall Study||231
2611224|NCT00114101|6412217|P2|STARTED|Overall Study||229
2611225|NCT00114101|6412218|P1|STARTED|Overall Study||231
2611226|NCT00113919|6412230|P1|NOT COMPLETED|Overall Study||14
2611227|NCT00113919|6412230|P1|COMPLETED|Overall Study||0
2611228|NCT00113919|6412230|P1|STARTED|Overall Study||14
2611229|NCT00113880|6412237|P3|NOT COMPLETED|Overall Study||0
2611230|NCT00113880|6412238|P2|NOT COMPLETED|Overall Study||0
2611231|NCT00113880|6412239|P1|NOT COMPLETED|Overall Study||0
2611232|NCT00113880|6412237|P3|COMPLETED|Overall Study||62492
2611233|NCT00113880|6412238|P2|COMPLETED|Overall Study||71949
2611234|NCT00113880|6412239|P1|COMPLETED|Overall Study||63061
2611235|NCT00113880|6412237|P3|STARTED|Overall Study||62492
2611236|NCT00113880|6412238|P2|STARTED|Overall Study||71949
2611237|NCT00113880|6412239|P1|STARTED|Overall Study||63061
2611238|NCT00113841|6412298|P2|NOT COMPLETED|Overall Study||2
2611239|NCT00113841|6412299|P1|NOT COMPLETED|Overall Study||1
2611240|NCT00113841|6412298|P2|COMPLETED|Overall Study||15
2611241|NCT00113841|6412299|P1|COMPLETED|Overall Study||15
2611242|NCT00113841|6412298|P2|STARTED|Overall Study||17
2611243|NCT00113841|6412299|P1|STARTED|Overall Study||16
2611244|NCT00113763|6412307|P2|NOT COMPLETED|Overall Study||26
2611245|NCT00113763|6412308|P1|NOT COMPLETED|Overall Study||73
2611246|NCT00113763|6412307|P2|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|206
2611247|NCT00113763|6412308|P1|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|158
2611248|NCT00113763|6412307|P2|Received Study Drug|Overall Study||0
2611249|NCT00113763|6412308|P1|Received Study Drug|Overall Study||229
2611250|NCT00113763|6412307|P2|STARTED|Overall Study||232
2611251|NCT00113763|6412308|P1|STARTED|Overall Study||231
2611252|NCT00113607|6412334|P2|NOT COMPLETED|Overall Study||337
2611253|NCT00113607|6412335|P1|NOT COMPLETED|Overall Study||335
2611254|NCT00113607|6412334|P2|COMPLETED|Overall Study||0
2611255|NCT00113607|6412335|P1|COMPLETED|Overall Study||0
2611256|NCT00113607|6412334|P2|STARTED|Overall Study|Number of randomized participants|337
2611257|NCT00113607|6412335|P1|STARTED|Overall Study|Number of randomized participants|335
2611258|NCT00113568|6412349|P1|NOT COMPLETED|Overall Study||545
2611259|NCT00113568|6412349|P1|COMPLETED|Overall Study||239
2611260|NCT00113568|6412349|P1|Intent to Treat Population|Overall Study||723
2611261|NCT00113568|6412349|P1|STARTED|Overall Study||784
2611262|NCT00113555|6412361|P1|NOT COMPLETED|Overall Study||79
2611263|NCT00113555|6412361|P1|COMPLETED|Overall Study|All treated patients were considered in the Intent to Treat analysis.|142
2611264|NCT00113555|6412361|P1|TREATED|Overall Study|1 Additional Patient was treated on a compassionate use basis.|162
2611265|NCT00113555|6412361|P1|STARTED|Overall Study||221
2611266|NCT00113529|6412371|P1|NOT COMPLETED|Overall Study||34
2611267|NCT00113529|6412371|P1|COMPLETED|Overall Study|Subject discontinued from the study and continued treatment on commercially available sunitinib.|1
2611268|NCT00113529|6412371|P1|STARTED|Overall Study|Phase 2 included 4 subjects from Phase 1 and 31 from Phase 2, for a total of 35 subjects.|35
2611269|NCT00113516|6412404|P2|NOT COMPLETED|Part 2||66
2611270|NCT00113516|6412405|P1|NOT COMPLETED|Part 2||0
2611271|NCT00113516|6412404|P2|COMPLETED|Part 2||0
2611272|NCT00113516|6412405|P1|COMPLETED|Part 2||0
2611273|NCT00113516|6412404|P2|STARTED|Part 2||66
2611274|NCT00113516|6412405|P1|STARTED|Part 2||0
2611275|NCT00113516|6412404|P2|NOT COMPLETED|Part 1||0
2611276|NCT00113516|6412405|P1|NOT COMPLETED|Part 1||84
2611277|NCT00113516|6412404|P2|COMPLETED|Part 1||0
2611278|NCT00113516|6412405|P1|COMPLETED|Part 1|66 subjects continued into Part 2 of the study.|0
2611279|NCT00113516|6412404|P2|STARTED|Part 1||0
2611280|NCT00113516|6412405|P1|STARTED|Part 1||84
2611281|NCT00113490|6412448|P2|NOT COMPLETED|Overall Study||3
2611282|NCT00113490|6412449|P1|NOT COMPLETED|Overall Study||2
2611283|NCT00113490|6412448|P2|COMPLETED|Overall Study||67
2611284|NCT00113490|6412449|P1|COMPLETED|Overall Study||64
2611285|NCT00113490|6412448|P2|STARTED|Overall Study||70
2611286|NCT00113490|6412449|P1|STARTED|Overall Study||66
2611287|NCT00113425|6412462|P1|NOT COMPLETED|Overall Study||15
2611288|NCT00113425|6412462|P1|COMPLETED|Overall Study||29
2611289|NCT00113425|6412462|P1|STARTED|Overall Study||44
2611290|NCT00113399|6412482|P2|NOT COMPLETED|Overall Study||5
2611291|NCT00113399|6412483|P1|NOT COMPLETED|Overall Study||2
2611292|NCT00113399|6412482|P2|COMPLETED|Overall Study||3
2611293|NCT00113399|6412483|P1|COMPLETED|Overall Study||5
2611294|NCT00113399|6412482|P2|STARTED|Overall Study||8
2611295|NCT00113399|6412483|P1|STARTED|Overall Study||7
2611296|NCT00113386|6412491|P2|NOT COMPLETED|Overall Study||4
2611297|NCT00113386|6412492|P1|NOT COMPLETED|Overall Study||7
2611298|NCT00113386|6412491|P2|COMPLETED|Overall Study||5
2611299|NCT00113386|6412492|P1|COMPLETED|Overall Study||3
2611300|NCT00113386|6412491|P2|STARTED|Overall Study||9
2611301|NCT00113386|6412492|P1|STARTED|Overall Study||10
2611302|NCT00113373|6412498|P1|NOT COMPLETED|Overall Study||3
2611303|NCT00113373|6412498|P1|COMPLETED|Overall Study|Eligible and treated patients.|25
2611304|NCT00113373|6412498|P1|STARTED|Overall Study||28
2611305|NCT00113360|6412513|P1|NOT COMPLETED|Overall Study||7
2611306|NCT00113360|6412513|P1|COMPLETED|Overall Study||60
2611307|NCT00113360|6412513|P1|STARTED|Overall Study|67 participants were enrolled for screening.|67
2611308|NCT00113334|6412517|P1|NOT COMPLETED|Overall Study||0
2611309|NCT00113334|6412517|P1|COMPLETED|Overall Study||6
2611310|NCT00113334|6412517|P1|STARTED|Overall Study||6
2611311|NCT00113321|6412521|P1|NOT COMPLETED|Overall Study||0
2611312|NCT00113321|6412521|P1|COMPLETED|Overall Study||16
2611313|NCT00113321|6412521|P1|STARTED|Overall Study||16
2611314|NCT00113295|6412527|P2|NOT COMPLETED|Overall Study||1
2611315|NCT00113295|6412528|P1|NOT COMPLETED|Overall Study||5
2611316|NCT00113295|6412527|P2|COMPLETED|Overall Study||10
2611317|NCT00113295|6412528|P1|COMPLETED|Overall Study||6
2611318|NCT00113295|6412527|P2|STARTED|Overall Study||11
2611319|NCT00113295|6412528|P1|STARTED|Overall Study||11
2611320|NCT00113269|6412547|P4|NOT COMPLETED|Overall Study||40
2611321|NCT00113269|6412548|P3|NOT COMPLETED|Overall Study||41
2611322|NCT00113269|6412549|P2|NOT COMPLETED|Overall Study||22
2611323|NCT00113269|6412550|P1|NOT COMPLETED|Overall Study||25
2611324|NCT00113269|6412547|P4|COMPLETED|Overall Study||140
2611325|NCT00113269|6412548|P3|COMPLETED|Overall Study||134
2611326|NCT00113269|6412549|P2|COMPLETED|Overall Study||48
2611327|NCT00113269|6412550|P1|COMPLETED|Overall Study||51
2611328|NCT00113269|6412547|P4|Received Treatment|Overall Study||171
2611329|NCT00113269|6412548|P3|Received Treatment|Overall Study||164
2611330|NCT00113269|6412549|P2|Received Treatment|Overall Study||69
2611331|NCT00113269|6412550|P1|Received Treatment|Overall Study||70
2611332|NCT00113269|6412547|P4|STARTED|Overall Study||180
2611333|NCT00113269|6412548|P3|STARTED|Overall Study||175
2611334|NCT00113269|6412549|P2|STARTED|Overall Study||70
2611335|NCT00113269|6412550|P1|STARTED|Overall Study||76
2611336|NCT00113230|6412600|P1|NOT COMPLETED|Overall Study||0
2611337|NCT00113230|6412600|P1|COMPLETED|Overall Study||25
2611338|NCT00113230|6412600|P1|STARTED|Overall Study||25
2611339|NCT00113217|6412604|P1|NOT COMPLETED|Overall Study||0
2611340|NCT00113217|6412604|P1|COMPLETED|Overall Study||50
2611341|NCT00113217|6412604|P1|STARTED|Overall Study||50
2611342|NCT00113087|6412610|P2|NOT COMPLETED|Overall Study||21
2611343|NCT00113087|6412611|P1|NOT COMPLETED|Overall Study||24
2611344|NCT00113087|6412610|P2|COMPLETED|Overall Study||94
2611345|NCT00113087|6412611|P1|COMPLETED|Overall Study||91
2611346|NCT00113087|6412610|P2|STARTED|Overall Study||115
2611347|NCT00113087|6412611|P1|STARTED|Overall Study||115
2611348|NCT00113022|6412675|P2|NOT COMPLETED|Overall Study||2
2611349|NCT00113022|6412676|P1|NOT COMPLETED|Overall Study||3
2611350|NCT00113022|6412675|P2|COMPLETED|Overall Study||2
2611351|NCT00113022|6412676|P1|COMPLETED|Overall Study||2
2611352|NCT00113022|6412675|P2|STARTED|Overall Study||4
2611353|NCT00113022|6412676|P1|STARTED|Overall Study||5
2611354|NCT00112957|6412682|P1|NOT COMPLETED|Overall Study||19
2611355|NCT00112957|6412682|P1|COMPLETED|Overall Study||4
2611356|NCT00112957|6412682|P1|STARTED|Overall Study||23
2611357|NCT00112918|6412697|P3|NOT COMPLETED|Overall Study||299
2611358|NCT00112918|6412698|P2|NOT COMPLETED|Overall Study||345
2611359|NCT00112918|6412699|P1|NOT COMPLETED|Overall Study||297
2611360|NCT00112918|6412697|P3|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|846
2611361|NCT00112918|6412698|P2|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|810
2611362|NCT00112918|6412699|P1|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|854
2611363|NCT00112918|6412697|P3|Stage III Disease Population|Overall Study||952
2611364|NCT00112918|6412698|P2|Stage III Disease Population|Overall Study||960
2611365|NCT00112918|6412699|P1|Stage III Disease Population|Overall Study||955
2611366|NCT00112918|6412697|P3|Received Treatment|Overall Study||1135
2611367|NCT00112918|6412698|P2|Received Treatment|Overall Study|Includes two patients from FOLFOX4 who received Bv and were assigned to FOLFOX4+Bv safety analysis|1145
2611368|NCT00112918|6412699|P1|Received Treatment|Overall Study||1126
2611369|NCT00112918|6412697|P3|STARTED|Overall Study||1145
2611370|NCT00112918|6412698|P2|STARTED|Overall Study||1155
2611371|NCT00112918|6412699|P1|STARTED|Overall Study||1151
2611372|NCT00112905|6412722|P1|NOT COMPLETED|Overall Study||12
2611373|NCT00112905|6412722|P1|COMPLETED|Overall Study||15
2611374|NCT00112905|6412722|P1|Eligible and Treated|Overall Study||22
2611375|NCT00112905|6412722|P1|STARTED|Overall Study||27
2611376|NCT00112866|6412731|P2|NOT COMPLETED|Overall Study||2
2611377|NCT00112866|6412732|P1|NOT COMPLETED|Overall Study||2
2611378|NCT00112866|6412731|P2|COMPLETED|Overall Study||13
2611379|NCT00112866|6412732|P1|COMPLETED|Overall Study||13
2611380|NCT00112866|6412731|P2|STARTED|Overall Study||15
2611381|NCT00112866|6412732|P1|STARTED|Overall Study||15
2611382|NCT00112840|6412754|P3|NOT COMPLETED|Overall Study||6
2611383|NCT00112840|6412755|P2|NOT COMPLETED|Overall Study||0
2611384|NCT00112840|6412756|P1|NOT COMPLETED|Overall Study||2
2611385|NCT00112840|6412754|P3|COMPLETED|Overall Study||40
2611386|NCT00112840|6412755|P2|COMPLETED|Overall Study||6
2611387|NCT00112840|6412756|P1|COMPLETED|Overall Study||6
2611388|NCT00112840|6412754|P3|STARTED|Overall Study||46
2611389|NCT00112840|6412755|P2|STARTED|Overall Study||6
2611390|NCT00112840|6412756|P1|STARTED|Overall Study||8
2611391|NCT00112736|6412775|P2|NOT COMPLETED|Overall Study||0
2611392|NCT00112736|6412776|P1|NOT COMPLETED|Overall Study||1
2611393|NCT00112736|6412775|P2|COMPLETED|Overall Study|12 additional pts from phase 1 study were used in analysis for Phase 2 as they were treated at MTD|47
2611394|NCT00112736|6412776|P1|COMPLETED|Overall Study|12 of Phase I pts treated at MTD and hence considered part of the Phase II analysis|21
2611395|NCT00112736|6412775|P2|STARTED|Overall Study||47
2611396|NCT00112736|6412776|P1|STARTED|Overall Study||22
2611397|NCT00112723|6412789|P3|NOT COMPLETED|Overall Study||2
2611398|NCT00112723|6412790|P2|NOT COMPLETED|Overall Study||7
2611399|NCT00112723|6412791|P1|NOT COMPLETED|Overall Study||2
2611400|NCT00112723|6412789|P3|COMPLETED|Overall Study||12
2611401|NCT00112723|6412790|P2|COMPLETED|Overall Study||12
2611402|NCT00112723|6412791|P1|COMPLETED|Overall Study||11
2611403|NCT00112723|6412789|P3|Patients Evaluable for Toxicity|Overall Study||12
2611404|NCT00112723|6412790|P2|Patients Evaluable for Toxicity|Overall Study||12
2611405|NCT00112723|6412791|P1|Patients Evaluable for Toxicity|Overall Study||11
2611406|NCT00112723|6412789|P3|STARTED|Overall Study||14
2611407|NCT00112723|6412790|P2|STARTED|Overall Study||19
2611408|NCT00112723|6412791|P1|STARTED|Overall Study||13
2611409|NCT00112671|6412816|P1|NOT COMPLETED|Overall Study||0
2611410|NCT00112671|6412816|P1|COMPLETED|Overall Study||17
2611411|NCT00112671|6412816|P1|STARTED|Overall Study||17
2611412|NCT00112593|6412824|P1|NOT COMPLETED|Overall Study||0
2611413|NCT00112593|6412824|P1|COMPLETED|Overall Study||5
2611414|NCT00112593|6412824|P1|STARTED|Overall Study||5
2611415|NCT00112489|6412833|P1|NOT COMPLETED|Overall Study||40
2611416|NCT00112489|6412833|P1|COMPLETED|Overall Study|Completed regimen due to progression|15
2611417|NCT00112489|6412833|P1|STARTED|Overall Study|All patients enrolled on study|55
2611418|NCT00112463|6412843|P1|NOT COMPLETED|Overall Study||39
2611419|NCT00112463|6412843|P1|COMPLETED|Overall Study||1
2611420|NCT00112463|6412843|P1|STARTED|Overall Study||40
2611421|NCT00112437|6412855|P26|NOT COMPLETED|Years 6-10 (60-Month Extension)||5
2611422|NCT00112437|6412856|P25|NOT COMPLETED|Years 6-10 (60-Month Extension)||1
2611423|NCT00112437|6412857|P24|NOT COMPLETED|Years 6-10 (60-Month Extension)||12
2611424|NCT00112437|6412858|P23|NOT COMPLETED|Years 6-10 (60-Month Extension)||5
2611425|NCT00112437|6412859|P22|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2611426|NCT00112437|6412860|P21|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2611427|NCT00112437|6412861|P20|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2611428|NCT00112437|6412862|P19|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2611429|NCT00112437|6412863|P18|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2611430|NCT00112437|6412864|P17|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2611431|NCT00112437|6412865|P16|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2611432|NCT00112437|6412866|P15|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2611433|NCT00112437|6412867|P14|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2611434|NCT00112437|6412868|P13|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2611435|NCT00112437|6412869|P12|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2611436|NCT00112437|6412870|P11|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2611437|NCT00112437|6412871|P10|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2611438|NCT00112437|6412872|P9|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2611439|NCT00112437|6412873|P8|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2611440|NCT00112437|6412874|P7|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2611441|NCT00112437|6412875|P6|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2611442|NCT00112437|6412876|P5|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2611443|NCT00112437|6412877|P4|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2611444|NCT00112437|6412878|P3|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2611445|NCT00112437|6412879|P2|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2611446|NCT00112437|6412880|P1|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
2611447|NCT00112437|6412855|P26|COMPLETED|Years 6-10 (60-Month Extension)||27
2611448|NCT00112437|6412856|P25|COMPLETED|Years 6-10 (60-Month Extension)||22
2611449|NCT00112437|6412857|P24|COMPLETED|Years 6-10 (60-Month Extension)||22
2611450|NCT00112437|6412858|P23|COMPLETED|Years 6-10 (60-Month Extension)||23
2611451|NCT00112437|6412859|P22|COMPLETED|Years 6-10 (60-Month Extension)||0
2611452|NCT00112437|6412860|P21|COMPLETED|Years 6-10 (60-Month Extension)||0
2611453|NCT00112437|6412861|P20|COMPLETED|Years 6-10 (60-Month Extension)||0
2611454|NCT00112437|6412862|P19|COMPLETED|Years 6-10 (60-Month Extension)||0
2611455|NCT00112437|6412863|P18|COMPLETED|Years 6-10 (60-Month Extension)||0
2611456|NCT00112437|6412864|P17|COMPLETED|Years 6-10 (60-Month Extension)||0
2611457|NCT00112437|6412865|P16|COMPLETED|Years 6-10 (60-Month Extension)||0
2611458|NCT00112437|6412866|P15|COMPLETED|Years 6-10 (60-Month Extension)||0
2611459|NCT00112437|6412867|P14|COMPLETED|Years 6-10 (60-Month Extension)||0
2611460|NCT00112437|6412868|P13|COMPLETED|Years 6-10 (60-Month Extension)||0
2611461|NCT00112437|6412869|P12|COMPLETED|Years 6-10 (60-Month Extension)||0
2611462|NCT00112437|6412870|P11|COMPLETED|Years 6-10 (60-Month Extension)||0
2611463|NCT00112437|6412871|P10|COMPLETED|Years 6-10 (60-Month Extension)||0
2611464|NCT00112437|6412872|P9|COMPLETED|Years 6-10 (60-Month Extension)||0
2611465|NCT00112437|6412873|P8|COMPLETED|Years 6-10 (60-Month Extension)||0
2611466|NCT00112437|6412874|P7|COMPLETED|Years 6-10 (60-Month Extension)||0
2611467|NCT00112437|6412875|P6|COMPLETED|Years 6-10 (60-Month Extension)||0
2611468|NCT00112437|6412876|P5|COMPLETED|Years 6-10 (60-Month Extension)||0
2611469|NCT00112437|6412877|P4|COMPLETED|Years 6-10 (60-Month Extension)||0
2611470|NCT00112437|6412878|P3|COMPLETED|Years 6-10 (60-Month Extension)||0
2611471|NCT00112437|6412879|P2|COMPLETED|Years 6-10 (60-Month Extension)||0
2611472|NCT00112437|6412880|P1|COMPLETED|Years 6-10 (60-Month Extension)||0
2611473|NCT00112437|6412855|P26|STARTED|Years 6-10 (60-Month Extension)||32
2611474|NCT00112437|6412856|P25|STARTED|Years 6-10 (60-Month Extension)||23
2611475|NCT00112437|6412857|P24|STARTED|Years 6-10 (60-Month Extension)||34
2611476|NCT00112437|6412858|P23|STARTED|Years 6-10 (60-Month Extension)||28
2611477|NCT00112437|6412859|P22|STARTED|Years 6-10 (60-Month Extension)||0
2611478|NCT00112437|6412860|P21|STARTED|Years 6-10 (60-Month Extension)||0
2611479|NCT00112437|6412861|P20|STARTED|Years 6-10 (60-Month Extension)||0
2611480|NCT00112437|6412862|P19|STARTED|Years 6-10 (60-Month Extension)||0
2611481|NCT00112437|6412863|P18|STARTED|Years 6-10 (60-Month Extension)||0
2611482|NCT00112437|6412864|P17|STARTED|Years 6-10 (60-Month Extension)||0
2611483|NCT00112437|6412865|P16|STARTED|Years 6-10 (60-Month Extension)||0
2611484|NCT00112437|6412866|P15|STARTED|Years 6-10 (60-Month Extension)||0
2611485|NCT00112437|6412867|P14|STARTED|Years 6-10 (60-Month Extension)||0
2611486|NCT00112437|6412868|P13|STARTED|Years 6-10 (60-Month Extension)||0
2611487|NCT00112437|6412869|P12|STARTED|Years 6-10 (60-Month Extension)||0
2611488|NCT00112437|6412870|P11|STARTED|Years 6-10 (60-Month Extension)||0
2611489|NCT00112437|6412871|P10|STARTED|Years 6-10 (60-Month Extension)||0
2611490|NCT00112437|6412872|P9|STARTED|Years 6-10 (60-Month Extension)||0
2611491|NCT00112437|6412873|P8|STARTED|Years 6-10 (60-Month Extension)||0
2611492|NCT00112437|6412874|P7|STARTED|Years 6-10 (60-Month Extension)||0
2611493|NCT00112437|6412875|P6|STARTED|Years 6-10 (60-Month Extension)||0
2611494|NCT00112437|6412876|P5|STARTED|Years 6-10 (60-Month Extension)||0
2611495|NCT00112437|6412877|P4|STARTED|Years 6-10 (60-Month Extension)||0
2611496|NCT00112437|6412878|P3|STARTED|Years 6-10 (60-Month Extension)||0
2611497|NCT00112437|6412879|P2|STARTED|Years 6-10 (60-Month Extension)||0
2611498|NCT00112437|6412880|P1|STARTED|Years 6-10 (60-Month Extension)||0
2611499|NCT00112437|6412855|P26|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2611500|NCT00112437|6412856|P25|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2611501|NCT00112437|6412857|P24|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2611502|NCT00112437|6412858|P23|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2611503|NCT00112437|6412859|P22|NOT COMPLETED|Years 4-5 (24-Month Extension)||8
2611504|NCT00112437|6412860|P21|NOT COMPLETED|Years 4-5 (24-Month Extension)||4
2611505|NCT00112437|6412861|P20|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2611506|NCT00112437|6412862|P19|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2611507|NCT00112437|6412863|P18|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2611508|NCT00112437|6412864|P17|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2611509|NCT00112437|6412865|P16|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2611510|NCT00112437|6412866|P15|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2611511|NCT00112437|6412867|P14|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2611512|NCT00112437|6412868|P13|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2611513|NCT00112437|6412869|P12|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2611514|NCT00112437|6412870|P11|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2611515|NCT00112437|6412871|P10|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2611516|NCT00112437|6412872|P9|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2611517|NCT00112437|6412873|P8|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2611518|NCT00112437|6412874|P7|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2611519|NCT00112437|6412875|P6|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2611520|NCT00112437|6412876|P5|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2611521|NCT00112437|6412877|P4|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2611522|NCT00112437|6412878|P3|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2611523|NCT00112437|6412879|P2|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2611524|NCT00112437|6412880|P1|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
2611525|NCT00112437|6412855|P26|COMPLETED|Years 4-5 (24-Month Extension)||0
2611526|NCT00112437|6412856|P25|COMPLETED|Years 4-5 (24-Month Extension)||0
2611527|NCT00112437|6412857|P24|COMPLETED|Years 4-5 (24-Month Extension)||0
2611528|NCT00112437|6412858|P23|COMPLETED|Years 4-5 (24-Month Extension)||0
2611529|NCT00112437|6412859|P22|COMPLETED|Years 4-5 (24-Month Extension)||92
2611530|NCT00112437|6412860|P21|COMPLETED|Years 4-5 (24-Month Extension)||37
2611531|NCT00112437|6412861|P20|COMPLETED|Years 4-5 (24-Month Extension)||0
2611532|NCT00112437|6412862|P19|COMPLETED|Years 4-5 (24-Month Extension)||0
2611533|NCT00112437|6412863|P18|COMPLETED|Years 4-5 (24-Month Extension)||0
2611534|NCT00112437|6412864|P17|COMPLETED|Years 4-5 (24-Month Extension)||0
2611535|NCT00112437|6412865|P16|COMPLETED|Years 4-5 (24-Month Extension)||0
2611536|NCT00112437|6412866|P15|COMPLETED|Years 4-5 (24-Month Extension)||0
2611537|NCT00112437|6412867|P14|COMPLETED|Years 4-5 (24-Month Extension)||0
2611538|NCT00112437|6412868|P13|COMPLETED|Years 4-5 (24-Month Extension)||0
2611539|NCT00112437|6412869|P12|COMPLETED|Years 4-5 (24-Month Extension)||0
2611540|NCT00112437|6412870|P11|COMPLETED|Years 4-5 (24-Month Extension)||0
2611541|NCT00112437|6412871|P10|COMPLETED|Years 4-5 (24-Month Extension)||0
2611542|NCT00112437|6412872|P9|COMPLETED|Years 4-5 (24-Month Extension)||0
2611543|NCT00112437|6412873|P8|COMPLETED|Years 4-5 (24-Month Extension)||0
2611544|NCT00112437|6412874|P7|COMPLETED|Years 4-5 (24-Month Extension)||0
2611545|NCT00112437|6412875|P6|COMPLETED|Years 4-5 (24-Month Extension)||0
2611546|NCT00112437|6412876|P5|COMPLETED|Years 4-5 (24-Month Extension)||0
2611547|NCT00112437|6412877|P4|COMPLETED|Years 4-5 (24-Month Extension)||0
2611548|NCT00112437|6412878|P3|COMPLETED|Years 4-5 (24-Month Extension)||0
2611549|NCT00112437|6412879|P2|COMPLETED|Years 4-5 (24-Month Extension)||0
2611550|NCT00112437|6412880|P1|COMPLETED|Years 4-5 (24-Month Extension)||0
2611551|NCT00112437|6412855|P26|STARTED|Years 4-5 (24-Month Extension)||0
2611552|NCT00112437|6412856|P25|STARTED|Years 4-5 (24-Month Extension)||0
2611553|NCT00112437|6412857|P24|STARTED|Years 4-5 (24-Month Extension)||0
2611554|NCT00112437|6412858|P23|STARTED|Years 4-5 (24-Month Extension)||0
2611555|NCT00112437|6412859|P22|STARTED|Years 4-5 (24-Month Extension)||100
2611556|NCT00112437|6412860|P21|STARTED|Years 4-5 (24-Month Extension)||41
2611557|NCT00112437|6412861|P20|STARTED|Years 4-5 (24-Month Extension)||0
2611558|NCT00112437|6412862|P19|STARTED|Years 4-5 (24-Month Extension)||0
2611559|NCT00112437|6412863|P18|STARTED|Years 4-5 (24-Month Extension)||0
2611560|NCT00112437|6412864|P17|STARTED|Years 4-5 (24-Month Extension)||0
2611561|NCT00112437|6412865|P16|STARTED|Years 4-5 (24-Month Extension)||0
2611562|NCT00112437|6412866|P15|STARTED|Years 4-5 (24-Month Extension)||0
2611563|NCT00112437|6412867|P14|STARTED|Years 4-5 (24-Month Extension)||0
2611564|NCT00112437|6412868|P13|STARTED|Years 4-5 (24-Month Extension)||0
2611565|NCT00112437|6412869|P12|STARTED|Years 4-5 (24-Month Extension)||0
2611566|NCT00112437|6412870|P11|STARTED|Years 4-5 (24-Month Extension)||0
2611567|NCT00112437|6412871|P10|STARTED|Years 4-5 (24-Month Extension)||0
2611568|NCT00112437|6412872|P9|STARTED|Years 4-5 (24-Month Extension)||0
2611569|NCT00112437|6412873|P8|STARTED|Years 4-5 (24-Month Extension)||0
2611570|NCT00112437|6412874|P7|STARTED|Years 4-5 (24-Month Extension)||0
2611571|NCT00112437|6412875|P6|STARTED|Years 4-5 (24-Month Extension)||0
2611572|NCT00112437|6412876|P5|STARTED|Years 4-5 (24-Month Extension)||0
2611573|NCT00112437|6412877|P4|STARTED|Years 4-5 (24-Month Extension)||0
2611574|NCT00112437|6412878|P3|STARTED|Years 4-5 (24-Month Extension)||0
2611575|NCT00112437|6412879|P2|STARTED|Years 4-5 (24-Month Extension)||0
2611576|NCT00112437|6412880|P1|STARTED|Years 4-5 (24-Month Extension)||0
2611577|NCT00112437|6412855|P26|NOT COMPLETED|Year 3 (12-Month Extension)||0
2611578|NCT00112437|6412856|P25|NOT COMPLETED|Year 3 (12-Month Extension)||0
2611579|NCT00112437|6412857|P24|NOT COMPLETED|Year 3 (12-Month Extension)||0
2611580|NCT00112437|6412858|P23|NOT COMPLETED|Year 3 (12-Month Extension)||0
2611581|NCT00112437|6412859|P22|NOT COMPLETED|Year 3 (12-Month Extension)||0
2611582|NCT00112437|6412860|P21|NOT COMPLETED|Year 3 (12-Month Extension)||0
2611583|NCT00112437|6412861|P20|NOT COMPLETED|Year 3 (12-Month Extension)||1
2611584|NCT00112437|6412862|P19|NOT COMPLETED|Year 3 (12-Month Extension)||2
2611585|NCT00112437|6412863|P18|NOT COMPLETED|Year 3 (12-Month Extension)||1
2611586|NCT00112437|6412864|P17|NOT COMPLETED|Year 3 (12-Month Extension)||3
2611587|NCT00112437|6412865|P16|NOT COMPLETED|Year 3 (12-Month Extension)||4
2611588|NCT00112437|6412866|P15|NOT COMPLETED|Year 3 (12-Month Extension)||1
2611589|NCT00112437|6412867|P14|NOT COMPLETED|Year 3 (12-Month Extension)||1
2611590|NCT00112437|6412868|P13|NOT COMPLETED|Year 3 (12-Month Extension)||0
2611591|NCT00112437|6412869|P12|NOT COMPLETED|Year 3 (12-Month Extension)||5
2611592|NCT00112437|6412870|P11|NOT COMPLETED|Year 3 (12-Month Extension)||2
2611593|NCT00112437|6412871|P10|NOT COMPLETED|Year 3 (12-Month Extension)||0
2611594|NCT00112437|6412872|P9|NOT COMPLETED|Year 3 (12-Month Extension)||0
2611595|NCT00112437|6412873|P8|NOT COMPLETED|Year 3 (12-Month Extension)||0
2611596|NCT00112437|6412874|P7|NOT COMPLETED|Year 3 (12-Month Extension)||0
2611597|NCT00112437|6412875|P6|NOT COMPLETED|Year 3 (12-Month Extension)||0
2611598|NCT00112437|6412876|P5|NOT COMPLETED|Year 3 (12-Month Extension)||0
2611599|NCT00112437|6412877|P4|NOT COMPLETED|Year 3 (12-Month Extension)||0
2611600|NCT00112437|6412878|P3|NOT COMPLETED|Year 3 (12-Month Extension)||0
2611601|NCT00112437|6412879|P2|NOT COMPLETED|Year 3 (12-Month Extension)||0
2611602|NCT00112437|6412880|P1|NOT COMPLETED|Year 3 (12-Month Extension)||0
2611603|NCT00112437|6412855|P26|COMPLETED|Year 3 (12-Month Extension)||0
2611604|NCT00112437|6412856|P25|COMPLETED|Year 3 (12-Month Extension)||0
2611605|NCT00112437|6412857|P24|COMPLETED|Year 3 (12-Month Extension)||0
2611606|NCT00112437|6412858|P23|COMPLETED|Year 3 (12-Month Extension)||0
2611607|NCT00112437|6412859|P22|COMPLETED|Year 3 (12-Month Extension)||0
2611608|NCT00112437|6412860|P21|COMPLETED|Year 3 (12-Month Extension)||0
2611609|NCT00112437|6412861|P20|COMPLETED|Year 3 (12-Month Extension)||19
2611610|NCT00112437|6412862|P19|COMPLETED|Year 3 (12-Month Extension)||16
2611611|NCT00112437|6412863|P18|COMPLETED|Year 3 (12-Month Extension)||20
2611612|NCT00112437|6412864|P17|COMPLETED|Year 3 (12-Month Extension)||16
2611613|NCT00112437|6412865|P16|COMPLETED|Year 3 (12-Month Extension)||13
2611614|NCT00112437|6412866|P15|COMPLETED|Year 3 (12-Month Extension)||17
2611615|NCT00112437|6412867|P14|COMPLETED|Year 3 (12-Month Extension)||16
2611616|NCT00112437|6412868|P13|COMPLETED|Year 3 (12-Month Extension)||18
2611617|NCT00112437|6412869|P12|COMPLETED|Year 3 (12-Month Extension)||17
2611618|NCT00112437|6412870|P11|COMPLETED|Year 3 (12-Month Extension)||17
2611619|NCT00112437|6412871|P10|COMPLETED|Year 3 (12-Month Extension)||0
2611620|NCT00112437|6412872|P9|COMPLETED|Year 3 (12-Month Extension)||0
2611621|NCT00112437|6412873|P8|COMPLETED|Year 3 (12-Month Extension)||0
2611622|NCT00112437|6412874|P7|COMPLETED|Year 3 (12-Month Extension)||0
2611623|NCT00112437|6412875|P6|COMPLETED|Year 3 (12-Month Extension)||0
2611624|NCT00112437|6412876|P5|COMPLETED|Year 3 (12-Month Extension)||0
2611625|NCT00112437|6412877|P4|COMPLETED|Year 3 (12-Month Extension)||0
2611626|NCT00112437|6412878|P3|COMPLETED|Year 3 (12-Month Extension)||0
2611627|NCT00112437|6412879|P2|COMPLETED|Year 3 (12-Month Extension)||0
2611628|NCT00112437|6412880|P1|COMPLETED|Year 3 (12-Month Extension)||0
2611629|NCT00112437|6412855|P26|STARTED|Year 3 (12-Month Extension)||0
2611630|NCT00112437|6412856|P25|STARTED|Year 3 (12-Month Extension)||0
2611631|NCT00112437|6412857|P24|STARTED|Year 3 (12-Month Extension)||0
2611632|NCT00112437|6412858|P23|STARTED|Year 3 (12-Month Extension)||0
2611633|NCT00112437|6412859|P22|STARTED|Year 3 (12-Month Extension)||0
2611634|NCT00112437|6412860|P21|STARTED|Year 3 (12-Month Extension)||0
2611635|NCT00112437|6412861|P20|STARTED|Year 3 (12-Month Extension)||20
2611636|NCT00112437|6412862|P19|STARTED|Year 3 (12-Month Extension)||18
2611637|NCT00112437|6412863|P18|STARTED|Year 3 (12-Month Extension)||21
2611638|NCT00112437|6412864|P17|STARTED|Year 3 (12-Month Extension)||19
2611639|NCT00112437|6412865|P16|STARTED|Year 3 (12-Month Extension)||17
2611640|NCT00112437|6412866|P15|STARTED|Year 3 (12-Month Extension)||18
2611641|NCT00112437|6412867|P14|STARTED|Year 3 (12-Month Extension)||17
2611642|NCT00112437|6412868|P13|STARTED|Year 3 (12-Month Extension)||18
2611643|NCT00112437|6412869|P12|STARTED|Year 3 (12-Month Extension)||22
2611644|NCT00112437|6412870|P11|STARTED|Year 3 (12-Month Extension)||19
2611645|NCT00112437|6412871|P10|STARTED|Year 3 (12-Month Extension)||0
2611646|NCT00112437|6412872|P9|STARTED|Year 3 (12-Month Extension)||0
2611647|NCT00112437|6412873|P8|STARTED|Year 3 (12-Month Extension)||0
2611648|NCT00112437|6412874|P7|STARTED|Year 3 (12-Month Extension)||0
2611649|NCT00112437|6412875|P6|STARTED|Year 3 (12-Month Extension)||0
2611650|NCT00112437|6412876|P5|STARTED|Year 3 (12-Month Extension)||0
2611651|NCT00112437|6412877|P4|STARTED|Year 3 (12-Month Extension)||0
2611652|NCT00112437|6412878|P3|STARTED|Year 3 (12-Month Extension)||0
2611653|NCT00112437|6412879|P2|STARTED|Year 3 (12-Month Extension)||0
2611654|NCT00112437|6412880|P1|STARTED|Year 3 (12-Month Extension)||0
2611655|NCT00112437|6412855|P26|NOT COMPLETED|Year 2 (12-Month Extension)||0
2611656|NCT00112437|6412856|P25|NOT COMPLETED|Year 2 (12-Month Extension)||0
2611657|NCT00112437|6412857|P24|NOT COMPLETED|Year 2 (12-Month Extension)||0
2611658|NCT00112437|6412858|P23|NOT COMPLETED|Year 2 (12-Month Extension)||0
2611659|NCT00112437|6412859|P22|NOT COMPLETED|Year 2 (12-Month Extension)||0
2611660|NCT00112437|6412860|P21|NOT COMPLETED|Year 2 (12-Month Extension)||0
2611661|NCT00112437|6412861|P20|NOT COMPLETED|Year 2 (12-Month Extension)||0
2611662|NCT00112437|6412862|P19|NOT COMPLETED|Year 2 (12-Month Extension)||0
2611663|NCT00112437|6412863|P18|NOT COMPLETED|Year 2 (12-Month Extension)||0
2611664|NCT00112437|6412864|P17|NOT COMPLETED|Year 2 (12-Month Extension)||0
2611665|NCT00112437|6412865|P16|NOT COMPLETED|Year 2 (12-Month Extension)||0
2611666|NCT00112437|6412866|P15|NOT COMPLETED|Year 2 (12-Month Extension)||0
2611667|NCT00112437|6412867|P14|NOT COMPLETED|Year 2 (12-Month Extension)||0
2611668|NCT00112437|6412868|P13|NOT COMPLETED|Year 2 (12-Month Extension)||0
2611669|NCT00112437|6412869|P12|NOT COMPLETED|Year 2 (12-Month Extension)||0
2611670|NCT00112437|6412870|P11|NOT COMPLETED|Year 2 (12-Month Extension)||0
2611671|NCT00112437|6412871|P10|NOT COMPLETED|Year 2 (12-Month Extension)||13
2611672|NCT00112437|6412872|P9|NOT COMPLETED|Year 2 (12-Month Extension)||7
2611673|NCT00112437|6412873|P8|NOT COMPLETED|Year 2 (12-Month Extension)||8
2611674|NCT00112437|6412874|P7|NOT COMPLETED|Year 2 (12-Month Extension)||9
2611675|NCT00112437|6412875|P6|NOT COMPLETED|Year 2 (12-Month Extension)||3
2611676|NCT00112437|6412876|P5|NOT COMPLETED|Year 2 (12-Month Extension)||0
2611677|NCT00112437|6412877|P4|NOT COMPLETED|Year 2 (12-Month Extension)||0
2611678|NCT00112437|6412878|P3|NOT COMPLETED|Year 2 (12-Month Extension)||0
2611679|NCT00112437|6412879|P2|NOT COMPLETED|Year 2 (12-Month Extension)||0
2611680|NCT00112437|6412880|P1|NOT COMPLETED|Year 2 (12-Month Extension)||0
2611681|NCT00112437|6412855|P26|COMPLETED|Year 2 (12-Month Extension)||0
2611682|NCT00112437|6412856|P25|COMPLETED|Year 2 (12-Month Extension)||0
2611683|NCT00112437|6412857|P24|COMPLETED|Year 2 (12-Month Extension)||0
2611684|NCT00112437|6412858|P23|COMPLETED|Year 2 (12-Month Extension)||0
2611685|NCT00112437|6412859|P22|COMPLETED|Year 2 (12-Month Extension)||0
2611686|NCT00112437|6412860|P21|COMPLETED|Year 2 (12-Month Extension)||0
2611687|NCT00112437|6412861|P20|COMPLETED|Year 2 (12-Month Extension)||0
2611688|NCT00112437|6412862|P19|COMPLETED|Year 2 (12-Month Extension)||0
2611689|NCT00112437|6412863|P18|COMPLETED|Year 2 (12-Month Extension)||0
2611690|NCT00112437|6412864|P17|COMPLETED|Year 2 (12-Month Extension)||0
2611691|NCT00112437|6412865|P16|COMPLETED|Year 2 (12-Month Extension)||0
2611692|NCT00112437|6412866|P15|COMPLETED|Year 2 (12-Month Extension)||0
2611693|NCT00112437|6412867|P14|COMPLETED|Year 2 (12-Month Extension)||0
2611694|NCT00112437|6412868|P13|COMPLETED|Year 2 (12-Month Extension)||0
2611695|NCT00112437|6412869|P12|COMPLETED|Year 2 (12-Month Extension)||0
2611696|NCT00112437|6412870|P11|COMPLETED|Year 2 (12-Month Extension)||0
2611697|NCT00112437|6412871|P10|COMPLETED|Year 2 (12-Month Extension)||50
2611698|NCT00112437|6412872|P9|COMPLETED|Year 2 (12-Month Extension)||62
2611699|NCT00112437|6412873|P8|COMPLETED|Year 2 (12-Month Extension)||55
2611700|NCT00112437|6412874|P7|COMPLETED|Year 2 (12-Month Extension)||53
2611701|NCT00112437|6412875|P6|COMPLETED|Year 2 (12-Month Extension)||60
2611702|NCT00112437|6412876|P5|COMPLETED|Year 2 (12-Month Extension)||0
2611703|NCT00112437|6412877|P4|COMPLETED|Year 2 (12-Month Extension)||0
2611704|NCT00112437|6412878|P3|COMPLETED|Year 2 (12-Month Extension)||0
2611705|NCT00112437|6412879|P2|COMPLETED|Year 2 (12-Month Extension)||0
2611706|NCT00112437|6412880|P1|COMPLETED|Year 2 (12-Month Extension)||0
2611707|NCT00112437|6412855|P26|STARTED|Year 2 (12-Month Extension)||0
2611708|NCT00112437|6412856|P25|STARTED|Year 2 (12-Month Extension)||0
2611709|NCT00112437|6412857|P24|STARTED|Year 2 (12-Month Extension)||0
2611710|NCT00112437|6412858|P23|STARTED|Year 2 (12-Month Extension)||0
2611711|NCT00112437|6412859|P22|STARTED|Year 2 (12-Month Extension)||0
2611712|NCT00112437|6412860|P21|STARTED|Year 2 (12-Month Extension)||0
2611713|NCT00112437|6412861|P20|STARTED|Year 2 (12-Month Extension)||0
2611714|NCT00112437|6412862|P19|STARTED|Year 2 (12-Month Extension)||0
2611715|NCT00112437|6412863|P18|STARTED|Year 2 (12-Month Extension)||0
2611716|NCT00112437|6412864|P17|STARTED|Year 2 (12-Month Extension)||0
2611717|NCT00112437|6412865|P16|STARTED|Year 2 (12-Month Extension)||0
2611718|NCT00112437|6412866|P15|STARTED|Year 2 (12-Month Extension)||0
2611719|NCT00112437|6412867|P14|STARTED|Year 2 (12-Month Extension)||0
2611720|NCT00112437|6412868|P13|STARTED|Year 2 (12-Month Extension)||0
2611721|NCT00112437|6412869|P12|STARTED|Year 2 (12-Month Extension)||0
2611722|NCT00112437|6412870|P11|STARTED|Year 2 (12-Month Extension)||0
2611723|NCT00112437|6412871|P10|STARTED|Year 2 (12-Month Extension)||63
2611724|NCT00112437|6412872|P9|STARTED|Year 2 (12-Month Extension)||69
2611725|NCT00112437|6412873|P8|STARTED|Year 2 (12-Month Extension)||63
2611726|NCT00112437|6412874|P7|STARTED|Year 2 (12-Month Extension)||62
2611727|NCT00112437|6412875|P6|STARTED|Year 2 (12-Month Extension)||63
2611728|NCT00112437|6412876|P5|STARTED|Year 2 (12-Month Extension)||0
2611729|NCT00112437|6412877|P4|STARTED|Year 2 (12-Month Extension)||0
2611730|NCT00112437|6412878|P3|STARTED|Year 2 (12-Month Extension)||0
2611731|NCT00112437|6412879|P2|STARTED|Year 2 (12-Month Extension)||0
2611732|NCT00112437|6412880|P1|STARTED|Year 2 (12-Month Extension)||0
2611733|NCT00112437|6412855|P26|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2611734|NCT00112437|6412856|P25|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2611735|NCT00112437|6412857|P24|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2611736|NCT00112437|6412858|P23|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2611737|NCT00112437|6412859|P22|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2611738|NCT00112437|6412860|P21|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2611739|NCT00112437|6412861|P20|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2611740|NCT00112437|6412862|P19|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2611741|NCT00112437|6412863|P18|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2611742|NCT00112437|6412864|P17|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2611743|NCT00112437|6412865|P16|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2611744|NCT00112437|6412866|P15|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2611745|NCT00112437|6412867|P14|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2611746|NCT00112437|6412868|P13|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2611747|NCT00112437|6412869|P12|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2611748|NCT00112437|6412870|P11|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2611749|NCT00112437|6412871|P10|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2611750|NCT00112437|6412872|P9|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2611751|NCT00112437|6412873|P8|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2611752|NCT00112437|6412874|P7|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2611753|NCT00112437|6412875|P6|NOT COMPLETED|Year 1 (12-Month Base Study)||0
2611754|NCT00112437|6412876|P5|NOT COMPLETED|Year 1 (12-Month Base Study)||12
2611755|NCT00112437|6412877|P4|NOT COMPLETED|Year 1 (12-Month Base Study)||8
2611756|NCT00112437|6412878|P3|NOT COMPLETED|Year 1 (12-Month Base Study)||12
2611757|NCT00112437|6412879|P2|NOT COMPLETED|Year 1 (12-Month Base Study)||18
2611758|NCT00112437|6412880|P1|NOT COMPLETED|Year 1 (12-Month Base Study)||15
2611759|NCT00112437|6412855|P26|COMPLETED|Year 1 (12-Month Base Study)||0
2611760|NCT00112437|6412856|P25|COMPLETED|Year 1 (12-Month Base Study)||0
2611761|NCT00112437|6412857|P24|COMPLETED|Year 1 (12-Month Base Study)||0
2611762|NCT00112437|6412858|P23|COMPLETED|Year 1 (12-Month Base Study)||0
2611763|NCT00112437|6412859|P22|COMPLETED|Year 1 (12-Month Base Study)||0
2611764|NCT00112437|6412860|P21|COMPLETED|Year 1 (12-Month Base Study)||0
2611765|NCT00112437|6412861|P20|COMPLETED|Year 1 (12-Month Base Study)||0
2611766|NCT00112437|6412862|P19|COMPLETED|Year 1 (12-Month Base Study)||0
2611767|NCT00112437|6412863|P18|COMPLETED|Year 1 (12-Month Base Study)||0
2611768|NCT00112437|6412864|P17|COMPLETED|Year 1 (12-Month Base Study)||0
2611769|NCT00112437|6412865|P16|COMPLETED|Year 1 (12-Month Base Study)||0
2611770|NCT00112437|6412866|P15|COMPLETED|Year 1 (12-Month Base Study)||0
2611771|NCT00112437|6412867|P14|COMPLETED|Year 1 (12-Month Base Study)||0
2611772|NCT00112437|6412868|P13|COMPLETED|Year 1 (12-Month Base Study)||0
2611773|NCT00112437|6412869|P12|COMPLETED|Year 1 (12-Month Base Study)||0
2611774|NCT00112437|6412870|P11|COMPLETED|Year 1 (12-Month Base Study)||0
2611775|NCT00112437|6412871|P10|COMPLETED|Year 1 (12-Month Base Study)||0
2611776|NCT00112437|6412872|P9|COMPLETED|Year 1 (12-Month Base Study)||0
2611777|NCT00112437|6412873|P8|COMPLETED|Year 1 (12-Month Base Study)||0
2611778|NCT00112437|6412874|P7|COMPLETED|Year 1 (12-Month Base Study)||0
2611779|NCT00112437|6412875|P6|COMPLETED|Year 1 (12-Month Base Study)||0
2611780|NCT00112437|6412876|P5|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in the completed total.|66
2611781|NCT00112437|6412877|P4|COMPLETED|Year 1 (12-Month Base Study)||71
2611782|NCT00112437|6412878|P3|COMPLETED|Year 1 (12-Month Base Study)||65
2611783|NCT00112437|6412879|P2|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|64
2611784|NCT00112437|6412880|P1|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|68
2611785|NCT00112437|6412855|P26|STARTED|Year 1 (12-Month Base Study)||0
2611786|NCT00112437|6412856|P25|STARTED|Year 1 (12-Month Base Study)||0
2611787|NCT00112437|6412857|P24|STARTED|Year 1 (12-Month Base Study)||0
2611788|NCT00112437|6412858|P23|STARTED|Year 1 (12-Month Base Study)||0
2611789|NCT00112437|6412859|P22|STARTED|Year 1 (12-Month Base Study)||0
2611790|NCT00112437|6412860|P21|STARTED|Year 1 (12-Month Base Study)||0
2611791|NCT00112437|6412861|P20|STARTED|Year 1 (12-Month Base Study)||0
2611792|NCT00112437|6412862|P19|STARTED|Year 1 (12-Month Base Study)||0
2611793|NCT00112437|6412863|P18|STARTED|Year 1 (12-Month Base Study)||0
2611794|NCT00112437|6412864|P17|STARTED|Year 1 (12-Month Base Study)||0
2611795|NCT00112437|6412865|P16|STARTED|Year 1 (12-Month Base Study)||0
2611796|NCT00112437|6412866|P15|STARTED|Year 1 (12-Month Base Study)||0
2611797|NCT00112437|6412867|P14|STARTED|Year 1 (12-Month Base Study)||0
2611798|NCT00112437|6412868|P13|STARTED|Year 1 (12-Month Base Study)||0
2611799|NCT00112437|6412869|P12|STARTED|Year 1 (12-Month Base Study)||0
2611800|NCT00112437|6412870|P11|STARTED|Year 1 (12-Month Base Study)||0
2611801|NCT00112437|6412871|P10|STARTED|Year 1 (12-Month Base Study)||0
2611802|NCT00112437|6412872|P9|STARTED|Year 1 (12-Month Base Study)||0
2611803|NCT00112437|6412873|P8|STARTED|Year 1 (12-Month Base Study)||0
2611804|NCT00112437|6412874|P7|STARTED|Year 1 (12-Month Base Study)||0
2611805|NCT00112437|6412875|P6|STARTED|Year 1 (12-Month Base Study)||0
2611806|NCT00112437|6412876|P5|STARTED|Year 1 (12-Month Base Study)||78
2611807|NCT00112437|6412877|P4|STARTED|Year 1 (12-Month Base Study)||79
2611808|NCT00112437|6412878|P3|STARTED|Year 1 (12-Month Base Study)||77
2611809|NCT00112437|6412879|P2|STARTED|Year 1 (12-Month Base Study)||82
2611810|NCT00112437|6412880|P1|STARTED|Year 1 (12-Month Base Study)||83
2611811|NCT00112385|6413160|P2|NOT COMPLETED|Overall Study||1
2611812|NCT00112385|6413161|P1|NOT COMPLETED|Overall Study||1
2611813|NCT00112385|6413160|P2|COMPLETED|Overall Study||4
2611814|NCT00112385|6413161|P1|COMPLETED|Overall Study||10
2611815|NCT00112385|6413160|P2|STARTED|Overall Study||5
2611816|NCT00112385|6413161|P1|STARTED|Overall Study||11
2611817|NCT00112359|6413251|P2|NOT COMPLETED|Overall Study||13
2611818|NCT00112359|6413252|P1|NOT COMPLETED|Overall Study||27
2611819|NCT00112359|6413251|P2|COMPLETED|Overall Study||67
2611820|NCT00112359|6413252|P1|COMPLETED|Overall Study||57
2611821|NCT00112359|6413251|P2|STARTED|Overall Study||80
2611822|NCT00112359|6413252|P1|STARTED|Overall Study||84
2611823|NCT00112294|6413278|P2|NOT COMPLETED|Overall Study||0
2611824|NCT00112294|6413279|P1|NOT COMPLETED|Overall Study||5
2611825|NCT00112294|6413278|P2|COMPLETED|Overall Study|Off all study therapies.|320
2611826|NCT00112294|6413279|P1|COMPLETED|Overall Study|Off all study therapies.|320
2611827|NCT00112294|6413278|P2|Never Treated|Overall Study|Number by randomized group = 20, but 2 participants received C/T/C instead of T/C.|18
2611828|NCT00112294|6413279|P1|Never Treated|Overall Study|Number by randomized group = 11, but 2 participants received C/T/C instead of T/C.|13
2611829|NCT00112294|6413278|P2|STARTED|Overall Study|338 randomized and 320 treated.|320
2611830|NCT00112294|6413279|P1|STARTED|Overall Study|338 randomized and 325 treated.|325
2611831|NCT00112151|6413323|P6|NOT COMPLETED|Overall Study||3
2611832|NCT00112151|6413324|P5|NOT COMPLETED|Overall Study||6
2611833|NCT00112151|6413325|P4|NOT COMPLETED|Overall Study||3
2611834|NCT00112151|6413326|P3|NOT COMPLETED|Overall Study||3
2611835|NCT00112151|6413327|P2|NOT COMPLETED|Overall Study||5
2611836|NCT00112151|6413328|P1|NOT COMPLETED|Overall Study||4
2611837|NCT00112151|6413323|P6|COMPLETED|Overall Study||25
2611838|NCT00112151|6413324|P5|COMPLETED|Overall Study||22
2611839|NCT00112151|6413325|P4|COMPLETED|Overall Study||24
2611840|NCT00112151|6413326|P3|COMPLETED|Overall Study||25
2611841|NCT00112151|6413327|P2|COMPLETED|Overall Study||23
2611842|NCT00112151|6413328|P1|COMPLETED|Overall Study||24
2611843|NCT00112151|6413323|P6|STARTED|Overall Study||28
2611844|NCT00112151|6413324|P5|STARTED|Overall Study||28
2611845|NCT00112151|6413325|P4|STARTED|Overall Study||27
2611846|NCT00112151|6413326|P3|STARTED|Overall Study||28
2611847|NCT00112151|6413327|P2|STARTED|Overall Study||28
2611848|NCT00112151|6413328|P1|STARTED|Overall Study||28
2611849|NCT00112112|6413359|P2|NOT COMPLETED|Overall Study||0
2611850|NCT00112112|6413360|P1|NOT COMPLETED|Overall Study||0
2611851|NCT00112112|6413359|P2|COMPLETED|Overall Study||10
2611852|NCT00112112|6413360|P1|COMPLETED|Overall Study||10
2611853|NCT00112112|6413359|P2|STARTED|Overall Study||10
2611854|NCT00112112|6413360|P1|STARTED|Overall Study||10
2611855|NCT00112047|6413502|P2|NOT COMPLETED|Atripla Phase||20
2611856|NCT00112047|6413503|P1|NOT COMPLETED|Atripla Phase||18
2611857|NCT00112047|6413502|P2|COMPLETED|Atripla Phase||106
2611858|NCT00112047|6413503|P1|COMPLETED|Atripla Phase||142
2611859|NCT00112047|6413502|P2|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|126
2611860|NCT00112047|6413503|P1|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|160
2611861|NCT00112047|6413502|P2|NOT COMPLETED|Randomized Phase||88
2611862|NCT00112047|6413503|P1|NOT COMPLETED|Randomized Phase||70
2611863|NCT00112047|6413502|P2|COMPLETED|Randomized Phase||166
2611864|NCT00112047|6413503|P1|COMPLETED|Randomized Phase||187
2611865|NCT00112047|6413502|P2|STARTED|Randomized Phase|ITT analysis population|254
2611866|NCT00112047|6413503|P1|STARTED|Randomized Phase|Intention to treat (ITT) population N=255 (2 participants had received prior antiretroviral therapy)|257
2611867|NCT00111917|6413603|P2|NOT COMPLETED|Overall Study||1
2611868|NCT00111917|6413604|P1|NOT COMPLETED|Overall Study||1
2611869|NCT00111917|6413603|P2|COMPLETED|Overall Study||3
2611870|NCT00111917|6413604|P1|COMPLETED|Overall Study||8
2611871|NCT00111917|6413603|P2|STARTED|Overall Study||4
2611872|NCT00111917|6413604|P1|STARTED|Overall Study||9
2611873|NCT00111839|6413619|P3|NOT COMPLETED|Overall Study||49
2611874|NCT00111839|6413620|P2|NOT COMPLETED|Overall Study||46
2611875|NCT00111839|6413621|P1|NOT COMPLETED|Overall Study||48
2611876|NCT00111839|6413619|P3|COMPLETED|Overall Study||0
2611877|NCT00111839|6413620|P2|COMPLETED|Overall Study||5
2611878|NCT00111839|6413621|P1|COMPLETED|Overall Study||2
2611879|NCT00111839|6413619|P3|Treated|Overall Study||47
2611880|NCT00111839|6413620|P2|Treated|Overall Study||51
2611881|NCT00111839|6413621|P1|Treated|Overall Study||50
2611882|NCT00111839|6413619|P3|STARTED|Overall Study||49
2611883|NCT00111839|6413620|P2|STARTED|Overall Study||51
2611884|NCT00111839|6413621|P1|STARTED|Overall Study||50
2611885|NCT00111813|6413641|P6|NOT COMPLETED|Overall Study||6
2611886|NCT00111813|6413642|P5|NOT COMPLETED|Overall Study||6
2611887|NCT00111813|6413643|P4|NOT COMPLETED|Overall Study||5
2611888|NCT00111813|6413644|P3|NOT COMPLETED|Overall Study||10
2611889|NCT00111813|6413645|P2|NOT COMPLETED|Overall Study||3
2611890|NCT00111813|6413646|P1|NOT COMPLETED|Overall Study||3
2611891|NCT00111813|6413641|P6|COMPLETED|Overall Study||0
2611892|NCT00111813|6413642|P5|COMPLETED|Overall Study||0
2611893|NCT00111813|6413643|P4|COMPLETED|Overall Study||1
2611894|NCT00111813|6413644|P3|COMPLETED|Overall Study||0
2611895|NCT00111813|6413645|P2|COMPLETED|Overall Study||0
2611896|NCT00111813|6413646|P1|COMPLETED|Overall Study||0
2611897|NCT00111813|6413641|P6|STARTED|Overall Study||6
2611898|NCT00111813|6413642|P5|STARTED|Overall Study||6
2611899|NCT00111813|6413643|P4|STARTED|Overall Study||6
2611900|NCT00111813|6413644|P3|STARTED|Overall Study||10
2611901|NCT00111813|6413645|P2|STARTED|Overall Study||3
2611902|NCT00111813|6413646|P1|STARTED|Overall Study||3
2611903|NCT00111800|6413685|P6|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2
2611904|NCT00111800|6413686|P5|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||4
2611905|NCT00111800|6413687|P4|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||5
2611906|NCT00111800|6413688|P3|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7
2611907|NCT00111800|6413689|P2|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7
2611908|NCT00111800|6413690|P1|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2
2611909|NCT00111800|6413685|P6|COMPLETED|Period 2: Extension Phase (12 Weeks)||53
2611910|NCT00111800|6413686|P5|COMPLETED|Period 2: Extension Phase (12 Weeks)||51
2611911|NCT00111800|6413687|P4|COMPLETED|Period 2: Extension Phase (12 Weeks)||54
2611912|NCT00111800|6413688|P3|COMPLETED|Period 2: Extension Phase (12 Weeks)||47
2611913|NCT00111800|6413689|P2|COMPLETED|Period 2: Extension Phase (12 Weeks)||40
2611914|NCT00111800|6413690|P1|COMPLETED|Period 2: Extension Phase (12 Weeks)||46
2611915|NCT00111800|6413685|P6|STARTED|Period 2: Extension Phase (12 Weeks)||55
2611916|NCT00111800|6413686|P5|STARTED|Period 2: Extension Phase (12 Weeks)||55
2611917|NCT00111800|6413687|P4|STARTED|Period 2: Extension Phase (12 Weeks)||59
2611918|NCT00111800|6413688|P3|STARTED|Period 2: Extension Phase (12 Weeks)||54
2611919|NCT00111800|6413689|P2|STARTED|Period 2: Extension Phase (12 Weeks)||47
2611920|NCT00111800|6413690|P1|STARTED|Period 2: Extension Phase (12 Weeks)||48
2611921|NCT00111800|6413685|P6|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5
2611922|NCT00111800|6413686|P5|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5
2611923|NCT00111800|6413687|P4|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||6
2611924|NCT00111800|6413688|P3|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||9
2611925|NCT00111800|6413689|P2|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||14
2611926|NCT00111800|6413690|P1|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||15
2611927|NCT00111800|6413685|P6|COMPLETED|Period 1: Main Phase (12 Weeks)||56
2611928|NCT00111800|6413686|P5|COMPLETED|Period 1: Main Phase (12 Weeks)||55
2611929|NCT00111800|6413687|P4|COMPLETED|Period 1: Main Phase (12 Weeks)||60
2611930|NCT00111800|6413688|P3|COMPLETED|Period 1: Main Phase (12 Weeks)||54
2611931|NCT00111800|6413689|P2|COMPLETED|Period 1: Main Phase (12 Weeks)||47
2611932|NCT00111800|6413690|P1|COMPLETED|Period 1: Main Phase (12 Weeks)||49
2611933|NCT00111800|6413685|P6|STARTED|Period 1: Main Phase (12 Weeks)||61
2611934|NCT00111800|6413686|P5|STARTED|Period 1: Main Phase (12 Weeks)||60
2611935|NCT00111800|6413687|P4|STARTED|Period 1: Main Phase (12 Weeks)||66
2611936|NCT00111800|6413688|P3|STARTED|Period 1: Main Phase (12 Weeks)||63
2611937|NCT00111800|6413689|P2|STARTED|Period 1: Main Phase (12 Weeks)||61
2611938|NCT00111800|6413690|P1|STARTED|Period 1: Main Phase (12 Weeks)||64
2611939|NCT00111761|6413860|P2|NOT COMPLETED|Part 2||0
2611940|NCT00111761|6413861|P1|NOT COMPLETED|Part 2||8
2611941|NCT00111761|6413860|P2|COMPLETED|Part 2||0
2611942|NCT00111761|6413861|P1|COMPLETED|Part 2||16
2611943|NCT00111761|6413860|P2|STARTED|Part 2|This treatment group was used in Part 1 only|0
2611944|NCT00111761|6413861|P1|STARTED|Part 2||24
2611945|NCT00111761|6413860|P2|NOT COMPLETED|Part 1||5
2611946|NCT00111761|6413861|P1|NOT COMPLETED|Part 1||0
2611947|NCT00111761|6413860|P2|COMPLETED|Part 1|Completed through safety followup|14
2611948|NCT00111761|6413861|P1|COMPLETED|Part 1||0
2611949|NCT00111761|6413860|P2|STARTED|Part 1||19
2611950|NCT00111761|6413861|P1|STARTED|Part 1|This treatment group was not initiated until Part 2|0
2611951|NCT00111657|6413878|P1|NOT COMPLETED|Overall Study||16
2611952|NCT00111657|6413878|P1|COMPLETED|Overall Study|Completed all intended doses.|21
2611953|NCT00111657|6413878|P1|STARTED|Overall Study|37 consented. 30 initiated treatment. 29 completed at least 1 dose.|37
2611954|NCT00111475|6413898|P10|NOT COMPLETED|Overall Study||0
2611955|NCT00111475|6413899|P9|NOT COMPLETED|Overall Study||0
2611956|NCT00111475|6413900|P8|NOT COMPLETED|Overall Study||0
2611957|NCT00111475|6413901|P7|NOT COMPLETED|Overall Study||0
2611958|NCT00111475|6413902|P6|NOT COMPLETED|Overall Study||1
2611959|NCT00111475|6413903|P5|NOT COMPLETED|Overall Study||0
2611960|NCT00111475|6413904|P4|NOT COMPLETED|Overall Study||0
2611961|NCT00111475|6413905|P3|NOT COMPLETED|Overall Study||0
2611962|NCT00111475|6413906|P2|NOT COMPLETED|Overall Study||0
2611963|NCT00111475|6413907|P1|NOT COMPLETED|Overall Study||0
2611964|NCT00111475|6413898|P10|COMPLETED|Overall Study||1
2611965|NCT00111475|6413899|P9|COMPLETED|Overall Study||8
2611966|NCT00111475|6413900|P8|COMPLETED|Overall Study||8
2611967|NCT00111475|6413901|P7|COMPLETED|Overall Study||4
2611968|NCT00111475|6413902|P6|COMPLETED|Overall Study||3
2611969|NCT00111475|6413903|P5|COMPLETED|Overall Study||4
2611970|NCT00111475|6413904|P4|COMPLETED|Overall Study||4
2611971|NCT00111475|6413905|P3|COMPLETED|Overall Study||4
2611972|NCT00111475|6413906|P2|COMPLETED|Overall Study||4
2611973|NCT00111475|6413907|P1|COMPLETED|Overall Study||4
2611974|NCT00111475|6413898|P10|STARTED|Overall Study||1
2611975|NCT00111475|6413899|P9|STARTED|Overall Study||8
2611976|NCT00111475|6413900|P8|STARTED|Overall Study||8
2611977|NCT00111475|6413901|P7|STARTED|Overall Study||4
2611978|NCT00111475|6413902|P6|STARTED|Overall Study||4
2611979|NCT00111475|6413903|P5|STARTED|Overall Study||4
2611980|NCT00111475|6413904|P4|STARTED|Overall Study||4
2611981|NCT00111475|6413905|P3|STARTED|Overall Study||4
2611982|NCT00111475|6413906|P2|STARTED|Overall Study||4
2611983|NCT00111475|6413907|P1|STARTED|Overall Study||4
2611984|NCT00111241|6414025|P2|NOT COMPLETED|Overall Study||8
2611985|NCT00111241|6414026|P1|NOT COMPLETED|Overall Study||15
2611986|NCT00111241|6414025|P2|COMPLETED|Overall Study||62
2611987|NCT00111241|6414026|P1|COMPLETED|Overall Study||30
2611988|NCT00111241|6414025|P2|STARTED|Overall Study||70
2611989|NCT00111241|6414026|P1|STARTED|Overall Study||45
2611990|NCT00111228|6414037|P3|NOT COMPLETED|Overall Study||0
2611991|NCT00111228|6414038|P2|NOT COMPLETED|Overall Study||1
2611992|NCT00111228|6414039|P1|NOT COMPLETED|Overall Study||5
2611993|NCT00111228|6414037|P3|COMPLETED|Overall Study||54
2611994|NCT00111228|6414038|P2|COMPLETED|Overall Study||53
2611995|NCT00111228|6414039|P1|COMPLETED|Overall Study||49
2611996|NCT00111228|6414037|P3|STARTED|Overall Study||54
2611997|NCT00111228|6414038|P2|STARTED|Overall Study||54
2611998|NCT00111228|6414039|P1|STARTED|Overall Study||54
2611999|NCT00111007|6414052|P2|NOT COMPLETED|Long Term Follow-up||45
2612000|NCT00111007|6414053|P1|NOT COMPLETED|Long Term Follow-up||47
2612001|NCT00111007|6414052|P2|COMPLETED|Long Term Follow-up||62
2612002|NCT00111007|6414053|P1|COMPLETED|Long Term Follow-up||54
2612003|NCT00111007|6414052|P2|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|107
2612004|NCT00111007|6414053|P1|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|101
2612005|NCT00111007|6414052|P2|NOT COMPLETED|Active Follow-up||2
2612006|NCT00111007|6414053|P1|NOT COMPLETED|Active Follow-up||6
2612007|NCT00111007|6414052|P2|COMPLETED|Active Follow-up||2
2612008|NCT00111007|6414053|P1|COMPLETED|Active Follow-up||0
2612009|NCT00111007|6414052|P2|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|4
2612010|NCT00111007|6414053|P1|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|6
2612011|NCT00111007|6414052|P2|NOT COMPLETED|Double-blind (DB) Treatment||111
2612012|NCT00111007|6414053|P1|NOT COMPLETED|Double-blind (DB) Treatment||108
2612013|NCT00111007|6414052|P2|COMPLETED|Double-blind (DB) Treatment||24
2612014|NCT00111007|6414053|P1|COMPLETED|Double-blind (DB) Treatment||27
2612015|NCT00111007|6414052|P2|Received Treatment|Double-blind (DB) Treatment|Safety population|134
2612016|NCT00111007|6414053|P1|Received Treatment|Double-blind (DB) Treatment|Safety population|134
2612017|NCT00111007|6414052|P2|STARTED|Double-blind (DB) Treatment|ITT population|135
2612018|NCT00111007|6414053|P1|STARTED|Double-blind (DB) Treatment|ITT population|135
2612019|NCT00110994|6414069|P2|NOT COMPLETED|Long Term Follow-up||17
2612020|NCT00110994|6414070|P1|NOT COMPLETED|Long Term Follow-up||19
2612021|NCT00110994|6414069|P2|COMPLETED|Long Term Follow-up||30
2612022|NCT00110994|6414070|P1|COMPLETED|Long Term Follow-up||22
2612023|NCT00110994|6414069|P2|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|47
2612024|NCT00110994|6414070|P1|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|41
2612025|NCT00110994|6414069|P2|NOT COMPLETED|Active Follow-up||2
2612026|NCT00110994|6414070|P1|NOT COMPLETED|Active Follow-up||1
2612027|NCT00110994|6414069|P2|COMPLETED|Active Follow-up||0
2612028|NCT00110994|6414070|P1|COMPLETED|Active Follow-up||0
2612029|NCT00110994|6414069|P2|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|2
2612030|NCT00110994|6414070|P1|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|1
2612031|NCT00110994|6414069|P2|NOT COMPLETED|Double-blind (DB) Treatment||47
2612032|NCT00110994|6414070|P1|NOT COMPLETED|Double-blind (DB) Treatment||42
2612033|NCT00110994|6414069|P2|COMPLETED|Double-blind (DB) Treatment||3
2612034|NCT00110994|6414070|P1|COMPLETED|Double-blind (DB) Treatment||9
2612035|NCT00110994|6414069|P2|Received Treatment|Double-blind (DB) Treatment|Safety population|50
2612036|NCT00110994|6414070|P1|Received Treatment|Double-blind (DB) Treatment|Safety population|51
2612037|NCT00110994|6414069|P2|STARTED|Double-blind (DB) Treatment|ITT population|50
2612038|NCT00110994|6414070|P1|STARTED|Double-blind (DB) Treatment|ITT population|51
2612039|NCT00110890|6414096|P2|NOT COMPLETED|Overall Study||179
2612040|NCT00110890|6414097|P1|NOT COMPLETED|Overall Study||361
2612041|NCT00110890|6414096|P2|COMPLETED|Overall Study|Follow-up Phase|5
2612042|NCT00110890|6414097|P1|COMPLETED|Overall Study|Follow-up Phase|7
2612043|NCT00110890|6414096|P2|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|150
2612044|NCT00110890|6414097|P1|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|280
2612045|NCT00110890|6414096|P2|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|170
2612046|NCT00110890|6414097|P1|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|316
2612047|NCT00110890|6414096|P2|STARTED|Overall Study||184
2612048|NCT00110890|6414097|P1|STARTED|Overall Study||368
2612049|NCT00110812|6414114|P3|NOT COMPLETED|Extended Follow-up||4
2612050|NCT00110812|6414115|P2|NOT COMPLETED|Extended Follow-up||4
2612051|NCT00110812|6414116|P1|NOT COMPLETED|Extended Follow-up||2
2612052|NCT00110812|6414114|P3|COMPLETED|Extended Follow-up||69
2612053|NCT00110812|6414115|P2|COMPLETED|Extended Follow-up||65
2612054|NCT00110812|6414116|P1|COMPLETED|Extended Follow-up||78
2612055|NCT00110812|6414114|P3|STARTED|Extended Follow-up||73
2612056|NCT00110812|6414115|P2|STARTED|Extended Follow-up||69
2612057|NCT00110812|6414116|P1|STARTED|Extended Follow-up||80
2612058|NCT00110812|6414114|P3|NOT COMPLETED|Main Study||13
2612059|NCT00110812|6414115|P2|NOT COMPLETED|Main Study||11
2612060|NCT00110812|6414116|P1|NOT COMPLETED|Main Study||8
2612061|NCT00110812|6414114|P3|COMPLETED|Main Study||74
2612062|NCT00110812|6414115|P2|COMPLETED|Main Study||78
2612063|NCT00110812|6414116|P1|COMPLETED|Main Study||83
2612064|NCT00110812|6414114|P3|STARTED|Main Study||87
2612065|NCT00110812|6414115|P2|STARTED|Main Study||89
2612066|NCT00110812|6414116|P1|STARTED|Main Study||91
2612067|NCT00110617|6414161|P2|NOT COMPLETED|Overall Study||29
2612068|NCT00110617|6414162|P1|NOT COMPLETED|Overall Study||39
2612069|NCT00110617|6414161|P2|COMPLETED|Overall Study||39
2612070|NCT00110617|6414162|P1|COMPLETED|Overall Study||96
2612071|NCT00110617|6414161|P2|On Going at Week 24|Overall Study||53
2612072|NCT00110617|6414162|P1|On Going at Week 24|Overall Study||126
2612073|NCT00110617|6414161|P2|Full Analysis 2; Received ICL670|Overall Study||53
2612074|NCT00110617|6414162|P1|Full Analysis 2; Received ICL670|Overall Study||135
2612075|NCT00110617|6414161|P2|Safety Set 1; Received Study Drug|Overall Study||56
2612076|NCT00110617|6414162|P1|Safety Set 1; Received Study Drug|Overall Study||135
2612077|NCT00110617|6414161|P2|STARTED|Overall Study|Full Analysis Set 1 does not include 9 participants who were excluded due to GCP violations.|68
2612078|NCT00110617|6414162|P1|STARTED|Overall Study||135
2612079|NCT00110513|6414175|P1|NOT COMPLETED|Overall Study||0
2612080|NCT00110513|6414175|P1|COMPLETED|Overall Study||18
2612081|NCT00110513|6414175|P1|STARTED|Overall Study||18
2612082|NCT00110461|6414182|P3|NOT COMPLETED|Acute Phase||23
2612083|NCT00110461|6414183|P2|NOT COMPLETED|Acute Phase||22
2612084|NCT00110461|6414184|P1|NOT COMPLETED|Acute Phase||14
2612085|NCT00110461|6414182|P3|COMPLETED|Acute Phase||76
2612086|NCT00110461|6414183|P2|COMPLETED|Acute Phase||77
2612087|NCT00110461|6414184|P1|COMPLETED|Acute Phase||84
2612088|NCT00110461|6414182|P3|STARTED|Acute Phase||99
2612089|NCT00110461|6414183|P2|STARTED|Acute Phase||99
2612090|NCT00110461|6414184|P1|STARTED|Acute Phase||98
2612091|NCT00110461|6414182|P3|NOT COMPLETED|30-Week, Double-blind Treatment Phase||87
2612092|NCT00110461|6414183|P2|NOT COMPLETED|30-Week, Double-blind Treatment Phase||77
2612093|NCT00110461|6414184|P1|NOT COMPLETED|30-Week, Double-blind Treatment Phase||64
2612094|NCT00110461|6414182|P3|COMPLETED|30-Week, Double-blind Treatment Phase||12
2612095|NCT00110461|6414183|P2|COMPLETED|30-Week, Double-blind Treatment Phase||22
2612096|NCT00110461|6414184|P1|COMPLETED|30-Week, Double-blind Treatment Phase||34
2612097|NCT00110461|6414182|P3|STARTED|30-Week, Double-blind Treatment Phase||99
2612098|NCT00110461|6414183|P2|STARTED|30-Week, Double-blind Treatment Phase||99
2612099|NCT00110461|6414184|P1|STARTED|30-Week, Double-blind Treatment Phase||98
2612100|NCT00110396|6414279|P1|NOT COMPLETED|Overall Study||36
2612101|NCT00110396|6414279|P1|COMPLETED|Overall Study|260 participants included in the Safety Population.207 completed treatment. 224 completed the trial|224
2612102|NCT00110396|6414279|P1|STARTED|Overall Study||260
2612103|NCT00110357|6414287|P2|NOT COMPLETED|Overall Study||19
2612104|NCT00110357|6414288|P1|NOT COMPLETED|Overall Study||27
2612105|NCT00110357|6414287|P2|COMPLETED|Overall Study|Number Still on Study|0
2612106|NCT00110357|6414288|P1|COMPLETED|Overall Study|Number Still on Study|0
2612107|NCT00110357|6414287|P2|STARTED|Overall Study||19
2612108|NCT00110357|6414288|P1|STARTED|Overall Study||27
2612109|NCT00110305|6414376|P2|NOT COMPLETED|Overall Study||32
2612110|NCT00110305|6414377|P1|NOT COMPLETED|Overall Study||114
2612111|NCT00110305|6414376|P2|COMPLETED|Overall Study||57
2612112|NCT00110305|6414377|P1|COMPLETED|Overall Study||165
2612113|NCT00110305|6414376|P2|STARTED|Overall Study||89
2612114|NCT00110305|6414377|P1|STARTED|Overall Study||279
2612115|NCT00110214|6414430|P2|NOT COMPLETED|Overall Study||503
2612116|NCT00110214|6414431|P1|NOT COMPLETED|Overall Study||509
2612117|NCT00110214|6414430|P2|COMPLETED|Overall Study||21
2612118|NCT00110214|6414431|P1|COMPLETED|Overall Study||17
2612119|NCT00110214|6414430|P2|STARTED|Overall Study||524
2612120|NCT00110214|6414431|P1|STARTED|Overall Study||526
2612121|NCT00110149|6414443|P1|NOT COMPLETED|Overall Study||3
2612122|NCT00110149|6414443|P1|COMPLETED|Overall Study||9
2612123|NCT00110149|6414443|P1|Received Treatment|Overall Study|total number of patient that passed screening and received treatment.|9
2612124|NCT00110149|6414443|P1|STARTED|Overall Study|total number that signed consent to be screened.|12
2612125|NCT00110136|6414448|P1|NOT COMPLETED|Overall Study||0
2612126|NCT00110136|6414448|P1|COMPLETED|Overall Study||9
2612127|NCT00110136|6414448|P1|STARTED|Overall Study||9
2612128|NCT00110084|6414457|P1|NOT COMPLETED|Overall Study||28
2612129|NCT00110084|6414457|P1|COMPLETED|Overall Study||22
2612130|NCT00110084|6414457|P1|STARTED|Overall Study||50
2612131|NCT00110019|6414466|P2|NOT COMPLETED|Overall Study||413
2612132|NCT00110019|6414467|P1|NOT COMPLETED|Overall Study||406
2612133|NCT00110019|6414466|P2|COMPLETED|Overall Study||0
2612134|NCT00110019|6414467|P1|COMPLETED|Overall Study||4
2612135|NCT00110019|6414466|P2|Treated|Overall Study||397
2612136|NCT00110019|6414467|P1|Treated|Overall Study||393
2612137|NCT00110019|6414466|P2|Eligible|Overall Study||398
2612138|NCT00110019|6414467|P1|Eligible|Overall Study||395
2612139|NCT00110019|6414466|P2|STARTED|Overall Study||413
2612140|NCT00110019|6414467|P1|STARTED|Overall Study||410
2612141|NCT00109967|6414479|P2|NOT COMPLETED|Overall Study||6
2612142|NCT00109967|6414480|P1|NOT COMPLETED|Overall Study||20
2612143|NCT00109967|6414479|P2|COMPLETED|Overall Study||15
2612144|NCT00109967|6414480|P1|COMPLETED|Overall Study||30
2612145|NCT00109967|6414479|P2|STARTED|Overall Study||21
2612146|NCT00109967|6414480|P1|STARTED|Overall Study||50
2612147|NCT00109928|6414494|P1|NOT COMPLETED|Overall Study||13
2612148|NCT00109928|6414494|P1|COMPLETED|Overall Study||21
2612149|NCT00109928|6414494|P1|Eligible and Began Protocol Therapy|Overall Study||33
2612150|NCT00109928|6414494|P1|Eligible|Overall Study||33
2612151|NCT00109928|6414494|P1|STARTED|Overall Study||34
2612152|NCT00109876|6414501|P1|NOT COMPLETED|Overall Study||0
2612153|NCT00109876|6414501|P1|COMPLETED|Overall Study||51
2612154|NCT00109876|6414501|P1|STARTED|Overall Study||51
2612155|NCT00109850|6414511|P1|NOT COMPLETED|Overall Study||4
2612156|NCT00109850|6414511|P1|COMPLETED|Overall Study||18
2612157|NCT00109850|6414511|P1|Eligible and Began Protocol Therapy|Overall Study||21
2612158|NCT00109850|6414511|P1|Eligible|Overall Study||21
2612159|NCT00109850|6414511|P1|STARTED|Overall Study||22
2612160|NCT00109837|6414518|P1|NOT COMPLETED|Overall Study||23
2612161|NCT00109837|6414518|P1|COMPLETED|Overall Study||56
2612162|NCT00109837|6414518|P1|Eligible and Ph- and Treated|Overall Study||60
2612163|NCT00109837|6414518|P1|Eligible and Ph-|Overall Study||61
2612164|NCT00109837|6414518|P1|Eligible|Overall Study||78
2612165|NCT00109837|6414518|P1|STARTED|Overall Study||79
2612166|NCT00109772|6414528|P2|NOT COMPLETED|Open-label Extension||49
2612167|NCT00109772|6414529|P1|NOT COMPLETED|Open-label Extension||45
2612168|NCT00109772|6414528|P2|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|29
2612169|NCT00109772|6414529|P1|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|19
2612170|NCT00109772|6414528|P2|STARTED|Open-label Extension|One double-blind participant did not continue into the open-label extension|78
2612171|NCT00109772|6414529|P1|STARTED|Open-label Extension|Four double-blind participants did not continue into the open-label extension|64
2612172|NCT00109772|6414528|P2|NOT COMPLETED|Double-blind Treatment||15
2612173|NCT00109772|6414529|P1|NOT COMPLETED|Double-blind Treatment||22
2612174|NCT00109772|6414528|P2|COMPLETED|Double-blind Treatment||79
2612175|NCT00109772|6414529|P1|COMPLETED|Double-blind Treatment||68
2612176|NCT00109772|6414528|P2|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|93
2612177|NCT00109772|6414529|P1|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|87
2612178|NCT00109772|6414528|P2|STARTED|Double-blind Treatment||94
2612179|NCT00109772|6414529|P1|STARTED|Double-blind Treatment||90
2612180|NCT00109733|6414569|P2|NOT COMPLETED|Overall Study||4
2612181|NCT00109733|6414570|P1|NOT COMPLETED|Overall Study||2
2612182|NCT00109733|6414569|P2|COMPLETED|Overall Study||12
2612183|NCT00109733|6414570|P1|COMPLETED|Overall Study||13
2612184|NCT00109733|6414569|P2|STARTED|Overall Study||16
2612185|NCT00109733|6414570|P1|STARTED|Overall Study||15
2612186|NCT00109590|6414587|P3|NOT COMPLETED|Overall Study||4
2612187|NCT00109590|6414588|P2|NOT COMPLETED|Overall Study||2
2612188|NCT00109590|6414589|P1|NOT COMPLETED|Overall Study||2
2612189|NCT00109590|6414587|P3|COMPLETED|Overall Study||56
2612190|NCT00109590|6414588|P2|COMPLETED|Overall Study||56
2612191|NCT00109590|6414589|P1|COMPLETED|Overall Study||55
2612192|NCT00109590|6414587|P3|RECEIVED TREATMENT|Overall Study||57
2612193|NCT00109590|6414588|P2|RECEIVED TREATMENT|Overall Study||56
2612194|NCT00109590|6414589|P1|RECEIVED TREATMENT|Overall Study||56
2612195|NCT00109590|6414587|P3|STARTED|Overall Study||60
2612196|NCT00109590|6414588|P2|STARTED|Overall Study||58
2612197|NCT00109590|6414589|P1|STARTED|Overall Study||57
2612198|NCT00109577|6414631|P2|NOT COMPLETED|Overall Study||3
2612199|NCT00109577|6414632|P1|NOT COMPLETED|Overall Study||3
2612200|NCT00109577|6414631|P2|COMPLETED|Overall Study||17
2612201|NCT00109577|6414632|P1|COMPLETED|Overall Study||17
2612202|NCT00109577|6414631|P2|STARTED|Overall Study||20
2612203|NCT00109577|6414632|P1|STARTED|Overall Study||20
2612204|NCT00109473|6414640|P2|NOT COMPLETED|52 Week Extension Phase||5
2612205|NCT00109473|6414641|P1|NOT COMPLETED|52 Week Extension Phase||4
2612206|NCT00109473|6414640|P2|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|3
2612207|NCT00109473|6414641|P1|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|5
2612208|NCT00109473|6414640|P2|Analyzed|52 Week Extension Phase||8
2612209|NCT00109473|6414641|P1|Analyzed|52 Week Extension Phase||9
2612210|NCT00109473|6414640|P2|STARTED|52 Week Extension Phase||8
2612211|NCT00109473|6414641|P1|STARTED|52 Week Extension Phase||9
2612212|NCT00109473|6414640|P2|NOT COMPLETED|Week 12 to Week 24||0
2612213|NCT00109473|6414641|P1|NOT COMPLETED|Week 12 to Week 24||1
2612214|NCT00109473|6414640|P2|COMPLETED|Week 12 to Week 24|one subject discontinued intervention due to active disease requiring surgery|9
2612215|NCT00109473|6414641|P1|COMPLETED|Week 12 to Week 24|One subject withdrew consent|9
2612216|NCT00109473|6414640|P2|Analyzed|Week 12 to Week 24||9
2612217|NCT00109473|6414641|P1|Analyzed|Week 12 to Week 24||9
2612218|NCT00109473|6414640|P2|STARTED|Week 12 to Week 24||9
2612219|NCT00109473|6414641|P1|STARTED|Week 12 to Week 24||10
2612220|NCT00109473|6414640|P2|NOT COMPLETED|Baseline (0 Through 12 Weeks)||1
2612221|NCT00109473|6414641|P1|NOT COMPLETED|Baseline (0 Through 12 Weeks)||0
2612222|NCT00109473|6414640|P2|COMPLETED|Baseline (0 Through 12 Weeks)|One subject discontinued intervention because of active disease requiring imfliximab|9
2612223|NCT00109473|6414641|P1|COMPLETED|Baseline (0 Through 12 Weeks)||10
2612224|NCT00109473|6414640|P2|Analyzed|Baseline (0 Through 12 Weeks)||10
2612225|NCT00109473|6414641|P1|Analyzed|Baseline (0 Through 12 Weeks)||10
2612226|NCT00109473|6414640|P2|STARTED|Baseline (0 Through 12 Weeks)||10
2612227|NCT00109473|6414641|P1|STARTED|Baseline (0 Through 12 Weeks)|11 subjects allocated to Group A; one withdrew consent, only 10 receieved intervention.|10
2612228|NCT00109343|6414663|P3|NOT COMPLETED|Overall Study||30
2612229|NCT00109343|6414664|P2|NOT COMPLETED|Overall Study||37
2612230|NCT00109343|6414665|P1|NOT COMPLETED|Overall Study||64
2612231|NCT00109343|6414663|P3|COMPLETED|Overall Study||229
2612232|NCT00109343|6414664|P2|COMPLETED|Overall Study||221
2612233|NCT00109343|6414665|P1|COMPLETED|Overall Study||446
2612234|NCT00109343|6414663|P3|Vaccinated at Visit 4|Overall Study||240
2612235|NCT00109343|6414664|P2|Vaccinated at Visit 4|Overall Study||235
2612236|NCT00109343|6414665|P1|Vaccinated at Visit 4|Overall Study||466
2612237|NCT00109343|6414663|P3|Vaccinated at Visit 2|Overall Study||246
2612238|NCT00109343|6414664|P2|Vaccinated at Visit 2|Overall Study||246
2612409|NCT00107952|6415051|P2|STARTED|Overall Study||380
2612239|NCT00109343|6414665|P1|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects in Group 1 were not vaccinated at Visit 2|0
2612240|NCT00109343|6414663|P3|Vaccinated at Visit 1|Overall Study||259
2612241|NCT00109343|6414664|P2|Vaccinated at Visit 1|Overall Study||258
2612242|NCT00109343|6414665|P1|Vaccinated at Visit 1|Overall Study||510
2612243|NCT00109343|6414663|P3|STARTED|Overall Study||259
2612244|NCT00109343|6414664|P2|STARTED|Overall Study||258
2612245|NCT00109343|6414665|P1|STARTED|Overall Study||510
2612246|NCT00109031|6414710|P4|NOT COMPLETED|Overall Study||0
2612247|NCT00109031|6414711|P3|NOT COMPLETED|Overall Study||2
2612248|NCT00109031|6414712|P2|NOT COMPLETED|Overall Study||2
2612249|NCT00109031|6414713|P1|NOT COMPLETED|Overall Study||0
2612250|NCT00109031|6414710|P4|COMPLETED|Overall Study||12
2612251|NCT00109031|6414711|P3|COMPLETED|Overall Study||12
2612252|NCT00109031|6414712|P2|COMPLETED|Overall Study||8
2612253|NCT00109031|6414713|P1|COMPLETED|Overall Study||11
2612254|NCT00109031|6414710|P4|STARTED|Overall Study||12
2612255|NCT00109031|6414711|P3|STARTED|Overall Study||14
2612256|NCT00109031|6414712|P2|STARTED|Overall Study||10
2612257|NCT00109031|6414713|P1|STARTED|Overall Study||11
2612258|NCT00109005|6414749|P2|NOT COMPLETED|Overall Study||0
2612259|NCT00109005|6414750|P1|NOT COMPLETED|Overall Study||0
2612260|NCT00109005|6414749|P2|COMPLETED|Overall Study||9
2612261|NCT00109005|6414750|P1|COMPLETED|Overall Study||8
2612262|NCT00109005|6414749|P2|STARTED|Overall Study||9
2612263|NCT00109005|6414750|P1|STARTED|Overall Study||8
2612264|NCT00108953|6414764|P2|NOT COMPLETED|Follow-up||33
2612265|NCT00108953|6414765|P1|NOT COMPLETED|Follow-up||29
2612266|NCT00108953|6414764|P2|COMPLETED|Follow-up||12
2612267|NCT00108953|6414765|P1|COMPLETED|Follow-up||11
2612268|NCT00108953|6414764|P2|STARTED|Follow-up|45 out of 49 patients were followed after end of double blind treatment|45
2612269|NCT00108953|6414765|P1|STARTED|Follow-up|40 out of 47 patients were followed after end of double blind treatment|40
2612270|NCT00108953|6414764|P2|NOT COMPLETED|Treatment Period||0
2612271|NCT00108953|6414765|P1|NOT COMPLETED|Treatment Period||0
2612272|NCT00108953|6414764|P2|COMPLETED|Treatment Period|No patient under study medication anymore|49
2612273|NCT00108953|6414765|P1|COMPLETED|Treatment Period|No patient under study medication anymore|47
2612274|NCT00108953|6414764|P2|STARTED|Treatment Period|ITT population|49
2612275|NCT00108953|6414765|P1|STARTED|Treatment Period|ITT population|47
2612276|NCT00108862|6414787|P2|NOT COMPLETED|Overall Study||62
2612277|NCT00108862|6414788|P1|NOT COMPLETED|Overall Study||68
2612278|NCT00108862|6414787|P2|COMPLETED|Overall Study||339
2612279|NCT00108862|6414788|P1|COMPLETED|Overall Study||337
2612280|NCT00108862|6414787|P2|STARTED|Overall Study|Three participants who were deemed clinically ineligible and taken off study were omitted.|401
2612281|NCT00108862|6414788|P1|STARTED|Overall Study||405
2612282|NCT00108732|6414816|P1|NOT COMPLETED|Step 2 (Androgen Ablation and Vaccine)||5
2612283|NCT00108732|6414816|P1|COMPLETED|Step 2 (Androgen Ablation and Vaccine)||26
2612284|NCT00108732|6414816|P1|STARTED|Step 2 (Androgen Ablation and Vaccine)||31
2612285|NCT00108732|6414816|P1|NOT COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||14
2612286|NCT00108732|6414816|P1|COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||36
2612287|NCT00108732|6414816|P1|Eligible and Treated|Step 1 (Vaccinia/Fowlpox/GM-CSF)||40
2612288|NCT00108732|6414816|P1|STARTED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||50
2612289|NCT00108628|6414825|P2|NOT COMPLETED|Overall Study||10
2612290|NCT00108628|6414826|P1|NOT COMPLETED|Overall Study||20
2612291|NCT00108628|6414825|P2|COMPLETED|Overall Study||53
2612292|NCT00108628|6414826|P1|COMPLETED|Overall Study||41
2612293|NCT00108628|6414825|P2|Completed Treatment|Overall Study||57
2612294|NCT00108628|6414826|P1|Completed Treatment|Overall Study||42
2612295|NCT00108628|6414825|P2|Received One or More Sessions|Overall Study||58
2612296|NCT00108628|6414826|P1|Received One or More Sessions|Overall Study||53
2612297|NCT00108628|6414825|P2|STARTED|Overall Study||63
2612298|NCT00108628|6414826|P1|STARTED|Overall Study||61
2612299|NCT00108550|6414852|P2|NOT COMPLETED|Overall Study||16
2612300|NCT00108550|6414853|P1|NOT COMPLETED|Overall Study||16
2612301|NCT00108550|6414852|P2|COMPLETED|Overall Study||37
2612302|NCT00108550|6414853|P1|COMPLETED|Overall Study||39
2612303|NCT00108550|6414852|P2|STARTED|Overall Study||53
2612304|NCT00108550|6414853|P1|STARTED|Overall Study||55
2612305|NCT00108524|6414863|P2|NOT COMPLETED|Overall Study||18
2612306|NCT00108524|6414864|P1|NOT COMPLETED|Overall Study||29
2612307|NCT00108524|6414863|P2|COMPLETED|Overall Study||61
2612308|NCT00108524|6414864|P1|COMPLETED|Overall Study||52
2612309|NCT00108524|6414863|P2|STARTED|Overall Study||79
2612310|NCT00108524|6414864|P1|STARTED|Overall Study||81
2612311|NCT00108485|6414876|P2|NOT COMPLETED|Overall Study||2
2612312|NCT00108485|6414877|P1|NOT COMPLETED|Overall Study||3
2612313|NCT00108485|6414876|P2|COMPLETED|Overall Study||2
2612314|NCT00108485|6414877|P1|COMPLETED|Overall Study||2
2612315|NCT00108485|6414876|P2|STARTED|Overall Study||4
2612316|NCT00108485|6414877|P1|STARTED|Overall Study||5
2612317|NCT00108433|6414885|P2|NOT COMPLETED|Overall Study||17
2612318|NCT00108433|6414886|P1|NOT COMPLETED|Overall Study||21
2612319|NCT00108433|6414885|P2|COMPLETED|Overall Study||14
2612320|NCT00108433|6414886|P1|COMPLETED|Overall Study||9
2612321|NCT00108433|6414885|P2|STARTED|Overall Study||31
2612322|NCT00108433|6414886|P1|STARTED|Overall Study||30
2612323|NCT00108355|6414902|P2|NOT COMPLETED|Overall Study||2
2612324|NCT00108355|6414903|P1|NOT COMPLETED|Overall Study||2
2612325|NCT00108355|6414902|P2|COMPLETED|Overall Study||12
2612326|NCT00108355|6414903|P1|COMPLETED|Overall Study||13
2612410|NCT00107952|6415052|P1|STARTED|Overall Study||381
2612327|NCT00108355|6414902|P2|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis, other loculated ascites.|14
2612328|NCT00108355|6414903|P1|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis , other loculated ascites.|15
2612329|NCT00108342|6414913|P2|NOT COMPLETED|Overall Study||0
2612330|NCT00108342|6414914|P1|NOT COMPLETED|Overall Study||1
2612331|NCT00108342|6414913|P2|COMPLETED|Overall Study||9
2612332|NCT00108342|6414914|P1|COMPLETED|Overall Study||7
2612333|NCT00108342|6414913|P2|STARTED|Overall Study||9
2612334|NCT00108342|6414914|P1|STARTED|Overall Study||8
2612335|NCT00108303|6414923|P3|NOT COMPLETED|Overall Study||0
2612336|NCT00108303|6414924|P2|NOT COMPLETED|Overall Study||0
2612337|NCT00108303|6414925|P1|NOT COMPLETED|Overall Study||0
2612338|NCT00108303|6414923|P3|COMPLETED|Overall Study||180
2612339|NCT00108303|6414924|P2|COMPLETED|Overall Study||179
2612340|NCT00108303|6414925|P1|COMPLETED|Overall Study||179
2612341|NCT00108303|6414923|P3|STARTED|Overall Study||180
2612342|NCT00108303|6414924|P2|STARTED|Overall Study||179
2612343|NCT00108303|6414925|P1|STARTED|Overall Study||179
2612344|NCT00108277|6414940|P3|NOT COMPLETED|Overall Study||16
2612345|NCT00108277|6414941|P2|NOT COMPLETED|Overall Study||12
2612346|NCT00108277|6414942|P1|NOT COMPLETED|Overall Study||10
2612347|NCT00108277|6414940|P3|COMPLETED|Overall Study||19
2612348|NCT00108277|6414941|P2|COMPLETED|Overall Study||16
2612349|NCT00108277|6414942|P1|COMPLETED|Overall Study||19
2612350|NCT00108277|6414940|P3|STARTED|Overall Study||35
2612351|NCT00108277|6414941|P2|STARTED|Overall Study||28
2612352|NCT00108277|6414942|P1|STARTED|Overall Study||29
2612353|NCT00108160|6414952|P2|NOT COMPLETED|Overall Study||21
2612354|NCT00108160|6414953|P1|NOT COMPLETED|Overall Study||39
2612355|NCT00108160|6414952|P2|COMPLETED|Overall Study|Participants who completed 18 months of placebo or developed new (recurrent) S. aureus infection.|42
2612356|NCT00108160|6414953|P1|COMPLETED|Overall Study|Patients who completed 18 months of mupirocin or developed new (recurrent) S. aureus infection.|44
2612357|NCT00108160|6414952|P2|Completed Visit 7 (18 mo)|Overall Study||31
2612358|NCT00108160|6414953|P1|Completed Visit 7 (18 mo)|Overall Study||34
2612359|NCT00108160|6414952|P2|Completed Visit 6 (15 mo)|Overall Study||33
2612360|NCT00108160|6414953|P1|Completed Visit 6 (15 mo)|Overall Study||36
2612361|NCT00108160|6414952|P2|Completed Visit 5 (12 mo)|Overall Study||37
2612362|NCT00108160|6414953|P1|Completed Visit 5 (12 mo)|Overall Study||37
2612363|NCT00108160|6414952|P2|Completed Visit 4 (9 mo)|Overall Study||37
2612364|NCT00108160|6414953|P1|Completed Visit 4 (9 mo)|Overall Study||38
2612365|NCT00108160|6414952|P2|Completed Visit 3 (6 mo)|Overall Study||38
2612366|NCT00108160|6414953|P1|Completed Visit 3 (6 mo)|Overall Study||44
2612367|NCT00108160|6414952|P2|Completed Visit 2 (3 mo)|Overall Study||46
2612368|NCT00108160|6414953|P1|Completed Visit 2 (3 mo)|Overall Study||54
2612369|NCT00108160|6414952|P2|Completed Visit 1 (2 Wks)|Overall Study||54
2612370|NCT00108160|6414953|P1|Completed Visit 1 (2 Wks)|Overall Study||72
2612371|NCT00108160|6414952|P2|Completed Visit 0 (Baseline)|Overall Study|3 patients who signed a consent and were randomized did not complete the initial visit to start drug|60
2612372|NCT00108160|6414953|P1|Completed Visit 0 (Baseline)|Overall Study|4 patients who signed consent and were randomized did not complete the initial visit to start drug|79
2612373|NCT00108160|6414952|P2|STARTED|Overall Study||63
2612374|NCT00108160|6414953|P1|STARTED|Overall Study||83
2612375|NCT00108082|6414966|P3|NOT COMPLETED|Overall Study||43
2612376|NCT00108082|6414967|P2|NOT COMPLETED|Overall Study||32
2612377|NCT00108082|6414968|P1|NOT COMPLETED|Overall Study||38
2612378|NCT00108082|6414966|P3|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
2612379|NCT00108082|6414967|P2|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|68
2612380|NCT00108082|6414968|P1|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
2612381|NCT00108082|6414966|P3|STARTED|Overall Study||96
2612382|NCT00108082|6414967|P2|STARTED|Overall Study||100
2612383|NCT00108082|6414968|P1|STARTED|Overall Study||91
2612384|NCT00108069|6415017|P2|NOT COMPLETED|Overall Study||13
2612385|NCT00108069|6415018|P1|NOT COMPLETED|Overall Study||30
2612386|NCT00108069|6415017|P2|COMPLETED|Overall Study||0
2612387|NCT00108069|6415018|P1|COMPLETED|Overall Study||0
2612388|NCT00108069|6415017|P2|STARTED|Overall Study||13
2612389|NCT00108069|6415018|P1|STARTED|Overall Study||30
2612390|NCT00107991|6415032|P1|NOT COMPLETED|18-Week Post Treatment Assessment||2
2612391|NCT00107991|6415032|P1|COMPLETED|18-Week Post Treatment Assessment||8
2612392|NCT00107991|6415032|P1|STARTED|18-Week Post Treatment Assessment||10
2612393|NCT00107991|6415032|P1|NOT COMPLETED|12 Week Treatment Period||5
2612394|NCT00107991|6415032|P1|COMPLETED|12 Week Treatment Period||10
2612395|NCT00107991|6415032|P1|STARTED|12 Week Treatment Period||15
2612396|NCT00107991|6415032|P1|NOT COMPLETED|Eligibility Assessment||23
2612397|NCT00107991|6415032|P1|COMPLETED|Eligibility Assessment||15
2612398|NCT00107991|6415032|P1|STARTED|Eligibility Assessment||38
2612399|NCT00107978|6415042|P2|NOT COMPLETED|Overall Study||50
2612400|NCT00107978|6415043|P1|NOT COMPLETED|Overall Study||33
2612401|NCT00107978|6415042|P2|COMPLETED|Overall Study||431
2612402|NCT00107978|6415043|P1|COMPLETED|Overall Study||425
2612403|NCT00107978|6415042|P2|STARTED|Overall Study||481
2612404|NCT00107978|6415043|P1|STARTED|Overall Study||458
2612405|NCT00107952|6415051|P2|NOT COMPLETED|Overall Study||81
2612406|NCT00107952|6415052|P1|NOT COMPLETED|Overall Study||95
2612407|NCT00107952|6415051|P2|COMPLETED|Overall Study||299
2612408|NCT00107952|6415052|P1|COMPLETED|Overall Study||286
2612411|NCT00107900|6415064|P6|NOT COMPLETED|Overall Study||9
2612412|NCT00107900|6415065|P5|NOT COMPLETED|Overall Study||21
2612413|NCT00107900|6415066|P4|NOT COMPLETED|Overall Study||12
2612414|NCT00107900|6415067|P3|NOT COMPLETED|Overall Study||25
2612415|NCT00107900|6415068|P2|NOT COMPLETED|Overall Study||3
2612416|NCT00107900|6415069|P1|NOT COMPLETED|Overall Study||10
2612417|NCT00107900|6415064|P6|COMPLETED|Overall Study||94
2612418|NCT00107900|6415065|P5|COMPLETED|Overall Study||94
2612419|NCT00107900|6415066|P4|COMPLETED|Overall Study||87
2612420|NCT00107900|6415067|P3|COMPLETED|Overall Study||104
2612421|NCT00107900|6415068|P2|COMPLETED|Overall Study||72
2612422|NCT00107900|6415069|P1|COMPLETED|Overall Study||75
2612423|NCT00107900|6415064|P6|STARTED|Overall Study||103
2612424|NCT00107900|6415065|P5|STARTED|Overall Study||115
2612425|NCT00107900|6415066|P4|STARTED|Overall Study||99
2612426|NCT00107900|6415067|P3|STARTED|Overall Study||129
2612427|NCT00107900|6415068|P2|STARTED|Overall Study||75
2612428|NCT00107900|6415069|P1|STARTED|Overall Study||85
2612429|NCT00107783|6415103|P2|NOT COMPLETED|Overall Study||4
2612430|NCT00107783|6415104|P1|NOT COMPLETED|Overall Study||3
2612431|NCT00107783|6415103|P2|COMPLETED|Overall Study||16
2612432|NCT00107783|6415104|P1|COMPLETED|Overall Study||17
2612433|NCT00107783|6415103|P2|STARTED|Overall Study||20
2612434|NCT00107783|6415104|P1|STARTED|Overall Study||20
2612435|NCT00107744|6415121|P3|NOT COMPLETED|Intervention 3 (8 Weeks)||0
2612436|NCT00107744|6415122|P2|NOT COMPLETED|Intervention 3 (8 Weeks)||0
2612437|NCT00107744|6415123|P1|NOT COMPLETED|Intervention 3 (8 Weeks)||0
2612438|NCT00107744|6415121|P3|COMPLETED|Intervention 3 (8 Weeks)||88
2612439|NCT00107744|6415122|P2|COMPLETED|Intervention 3 (8 Weeks)||92
2612440|NCT00107744|6415123|P1|COMPLETED|Intervention 3 (8 Weeks)||93
2612441|NCT00107744|6415121|P3|STARTED|Intervention 3 (8 Weeks)||88
2612442|NCT00107744|6415122|P2|STARTED|Intervention 3 (8 Weeks)||92
2612443|NCT00107744|6415123|P1|STARTED|Intervention 3 (8 Weeks)||93
2612444|NCT00107744|6415121|P3|NOT COMPLETED|Intervention 2 (8 Weeks)||13
2612445|NCT00107744|6415122|P2|NOT COMPLETED|Intervention 2 (8 Weeks)||12
2612446|NCT00107744|6415123|P1|NOT COMPLETED|Intervention 2 (8 Weeks)||8
2612447|NCT00107744|6415121|P3|COMPLETED|Intervention 2 (8 Weeks)||88
2612448|NCT00107744|6415122|P2|COMPLETED|Intervention 2 (8 Weeks)||92
2612449|NCT00107744|6415123|P1|COMPLETED|Intervention 2 (8 Weeks)||93
2612450|NCT00107744|6415121|P3|STARTED|Intervention 2 (8 Weeks)||101
2612451|NCT00107744|6415122|P2|STARTED|Intervention 2 (8 Weeks)||104
2612452|NCT00107744|6415123|P1|STARTED|Intervention 2 (8 Weeks)||101
2612453|NCT00107744|6415121|P3|NOT COMPLETED|Intervention 1 (8 Weeks)||17
2612454|NCT00107744|6415122|P2|NOT COMPLETED|Intervention 1 (8 Weeks)||13
2612455|NCT00107744|6415123|P1|NOT COMPLETED|Intervention 1 (8 Weeks)||16
2612456|NCT00107744|6415121|P3|COMPLETED|Intervention 1 (8 Weeks)||101
2612457|NCT00107744|6415122|P2|COMPLETED|Intervention 1 (8 Weeks)||104
2612458|NCT00107744|6415123|P1|COMPLETED|Intervention 1 (8 Weeks)||101
2612459|NCT00107744|6415121|P3|STARTED|Intervention 1 (8 Weeks)||118
2612460|NCT00107744|6415122|P2|STARTED|Intervention 1 (8 Weeks)||117
2612461|NCT00107744|6415123|P1|STARTED|Intervention 1 (8 Weeks)||117
2612462|NCT00107653|6415139|P2|NOT COMPLETED|Overall Study||76
2612463|NCT00107653|6415140|P1|NOT COMPLETED|Overall Study||79
2612464|NCT00107653|6415139|P2|COMPLETED|Overall Study||224
2612465|NCT00107653|6415140|P1|COMPLETED|Overall Study||190
2612466|NCT00107653|6415139|P2|STARTED|Overall Study||300
2612467|NCT00107653|6415140|P1|STARTED|Overall Study||269
2612468|NCT00107614|6415186|P1|NOT COMPLETED|Overall Study||12
2612469|NCT00107614|6415186|P1|COMPLETED|Overall Study||0
2612470|NCT00107614|6415186|P1|STARTED|Overall Study||12
2612471|NCT00107575|6415192|P2|NOT COMPLETED|Overall Study||10
2612472|NCT00107575|6415193|P1|NOT COMPLETED|Overall Study||11
2612473|NCT00107575|6415192|P2|COMPLETED|Overall Study||107
2612474|NCT00107575|6415193|P1|COMPLETED|Overall Study||108
2612475|NCT00107575|6415192|P2|STARTED|Overall Study||117
2612476|NCT00107575|6415193|P1|STARTED|Overall Study||119
2612477|NCT00107536|6415207|P1|NOT COMPLETED|Overall Study||0
2612478|NCT00107536|6415207|P1|COMPLETED|Overall Study||26
2612479|NCT00107536|6415207|P1|STARTED|Overall Study||26
2612480|NCT00107380|6415217|P1|NOT COMPLETED|Overall Study||30
2612481|NCT00107380|6415217|P1|COMPLETED|Overall Study||56
2612482|NCT00107380|6415217|P1|Eligible|Overall Study||84
2612483|NCT00107380|6415217|P1|STARTED|Overall Study||86
2612484|NCT00107315|6415223|P1|NOT COMPLETED|Overall Study||15
2612485|NCT00107315|6415223|P1|COMPLETED|Overall Study||1
2612486|NCT00107315|6415223|P1|STARTED|Overall Study||16
2612487|NCT00107276|6415230|P1|NOT COMPLETED|Overall Study||72
2612488|NCT00107276|6415230|P1|COMPLETED|Overall Study||40
2612489|NCT00107276|6415230|P1|Eligible|Overall Study||96
2612490|NCT00107276|6415230|P1|STARTED|Overall Study||112
2612491|NCT00107198|6415236|P1|NOT COMPLETED|Overall Study||52
2612492|NCT00107198|6415236|P1|COMPLETED|Overall Study||136
2612493|NCT00107198|6415236|P1|STARTED|Overall Study||188
2612494|NCT00107172|6415246|P2|NOT COMPLETED|Overall Study||5
2612495|NCT00107172|6415247|P1|NOT COMPLETED|Overall Study||5
2612496|NCT00107172|6415246|P2|COMPLETED|Overall Study||103
2612497|NCT00107172|6415247|P1|COMPLETED|Overall Study||109
2612498|NCT00107172|6415246|P2|STARTED|Overall Study||108
2612499|NCT00107172|6415247|P1|STARTED|Overall Study||114
2612500|NCT00107120|6415277|P2|NOT COMPLETED|Overall Study||24
2612501|NCT00107120|6415278|P1|NOT COMPLETED|Overall Study||29
2612502|NCT00107120|6415277|P2|COMPLETED|Overall Study||133
2612503|NCT00107120|6415278|P1|COMPLETED|Overall Study||126
2612504|NCT00107120|6415277|P2|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|157
2612505|NCT00107120|6415278|P1|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|155
2612506|NCT00107042|6415290|P2|NOT COMPLETED|Overall Study||16
2612507|NCT00107042|6415291|P1|NOT COMPLETED|Overall Study||22
2612508|NCT00107042|6415290|P2|COMPLETED|Overall Study||47
2612509|NCT00107042|6415291|P1|COMPLETED|Overall Study||38
2612510|NCT00107042|6415290|P2|STARTED|Overall Study||63
2612511|NCT00107042|6415291|P1|STARTED|Overall Study||60
2612512|NCT00106964|6415357|P3|NOT COMPLETED|Overall Study||7
2612513|NCT00106964|6415358|P2|NOT COMPLETED|Overall Study||15
2612514|NCT00106964|6415359|P1|NOT COMPLETED|Overall Study||13
2612515|NCT00106964|6415357|P3|COMPLETED|Overall Study|The number of those who completed the vaccine series was 120.|120
2612516|NCT00106964|6415358|P2|COMPLETED|Overall Study|The number of those who completed the vaccine series was 111.|111
2612517|NCT00106964|6415359|P1|COMPLETED|Overall Study|The number of those those who completed the vaccine series was 105.|105
2612518|NCT00106964|6415357|P3|STARTED|Overall Study||127
2612519|NCT00106964|6415358|P2|STARTED|Overall Study||126
2612520|NCT00106964|6415359|P1|STARTED|Overall Study||118
2612521|NCT00106938|6415384|P2|NOT COMPLETED|Overall Study||71
2612522|NCT00106938|6415385|P1|NOT COMPLETED|Overall Study||176
2612523|NCT00106938|6415384|P2|COMPLETED|Overall Study||293
2612524|NCT00106938|6415385|P1|COMPLETED|Overall Study||913
2612525|NCT00106938|6415384|P2|STARTED|Overall Study||364
2612526|NCT00106938|6415385|P1|STARTED|Overall Study||1089
2612527|NCT00106704|6415454|P2|NOT COMPLETED|Overall Study||151
2612528|NCT00106704|6415455|P1|NOT COMPLETED|Overall Study||131
2612529|NCT00106704|6415454|P2|COMPLETED|Overall Study||68
2612530|NCT00106704|6415455|P1|COMPLETED|Overall Study||91
2612531|NCT00106704|6415454|P2|STARTED|Overall Study||219
2612532|NCT00106704|6415455|P1|STARTED|Overall Study||222
2612533|NCT00106639|6415466|P3|NOT COMPLETED|Overall Study||2
2612534|NCT00106639|6415467|P2|NOT COMPLETED|Overall Study||7
2612535|NCT00106639|6415468|P1|NOT COMPLETED|Overall Study||3
2612536|NCT00106639|6415466|P3|COMPLETED|Overall Study||19
2612537|NCT00106639|6415467|P2|COMPLETED|Overall Study||13
2612538|NCT00106639|6415468|P1|COMPLETED|Overall Study||17
2612539|NCT00106639|6415466|P3|STARTED|Overall Study||21
2612540|NCT00106639|6415467|P2|STARTED|Overall Study||20
2612541|NCT00106639|6415468|P1|STARTED|Overall Study||20
2612542|NCT00106626|6415595|P4|NOT COMPLETED|Overall Study||13
2612543|NCT00106626|6415596|P3|NOT COMPLETED|Overall Study||12
2612544|NCT00106626|6415597|P2|NOT COMPLETED|Overall Study||6
2612545|NCT00106626|6415598|P1|NOT COMPLETED|Overall Study||10
2612546|NCT00106626|6415595|P4|COMPLETED|Overall Study||3
2612547|NCT00106626|6415596|P3|COMPLETED|Overall Study||2
2612548|NCT00106626|6415597|P2|COMPLETED|Overall Study||3
2612549|NCT00106626|6415598|P1|COMPLETED|Overall Study||3
2612550|NCT00106626|6415595|P4|STARTED|Overall Study||16
2612551|NCT00106626|6415596|P3|STARTED|Overall Study||14
2612552|NCT00106626|6415597|P2|STARTED|Overall Study||9
2612553|NCT00106626|6415598|P1|STARTED|Overall Study||13
2612554|NCT00106535|6415616|P4|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||190
2612555|NCT00106535|6415617|P3|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
2612556|NCT00106535|6415618|P2|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
2612557|NCT00106535|6415619|P1|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
2612558|NCT00106535|6415616|P4|COMPLETED|Long-term Extension Period (Year 3 to 5)|Completed the study.|704
2612559|NCT00106535|6415617|P3|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
2612560|NCT00106535|6415618|P2|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
2612561|NCT00106535|6415619|P1|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
2612562|NCT00106535|6415616|P4|STARTED|Long-term Extension Period (Year 3 to 5)|Entered the Long-term Extension.|894
2612563|NCT00106535|6415617|P3|STARTED|Long-term Extension Period (Year 3 to 5)||0
2612564|NCT00106535|6415618|P2|STARTED|Long-term Extension Period (Year 3 to 5)||0
2612565|NCT00106535|6415619|P1|STARTED|Long-term Extension Period (Year 3 to 5)||0
2612566|NCT00106535|6415616|P4|NOT COMPLETED|2-year Placebo Controlled Period||0
2612567|NCT00106535|6415617|P3|NOT COMPLETED|2-year Placebo Controlled Period||91
2612568|NCT00106535|6415618|P2|NOT COMPLETED|2-year Placebo Controlled Period||92
2612569|NCT00106535|6415619|P1|NOT COMPLETED|2-year Placebo Controlled Period||107
2612570|NCT00106535|6415616|P4|COMPLETED|2-year Placebo Controlled Period||0
2612571|NCT00106535|6415617|P3|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 306 participants randomized to the TCZ 8 mg/kg arm entered the LTE period.|310
2612572|NCT00106535|6415618|P2|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 304 participants randomized to the TCZ 4 mg/kg arm entered the LTE period.|309
2612573|NCT00106535|6415619|P1|COMPLETED|2-year Placebo Controlled Period|Completed Week 104 (Year 2). 284 participants randomized to the Placebo arm entered the LTE period.|287
2612574|NCT00106535|6415616|P4|Completed Week 52|2-year Placebo Controlled Period||0
2612575|NCT00106535|6415617|P3|Completed Week 52|2-year Placebo Controlled Period||338
2612576|NCT00106535|6415618|P2|Completed Week 52|2-year Placebo Controlled Period||342
2612577|NCT00106535|6415619|P1|Completed Week 52|2-year Placebo Controlled Period||326
2612578|NCT00106535|6415616|P4|Completed Week 24|2-year Placebo Controlled Period||0
2612579|NCT00106535|6415617|P3|Completed Week 24|2-year Placebo Controlled Period||366
2612580|NCT00106535|6415618|P2|Completed Week 24|2-year Placebo Controlled Period||373
2612581|NCT00106535|6415619|P1|Completed Week 24|2-year Placebo Controlled Period||356
2612582|NCT00106535|6415616|P4|Safety: Actual Treatment Received|2-year Placebo Controlled Period||0
2612583|NCT00106535|6415617|P3|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
2612584|NCT00106535|6415618|P2|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
2612585|NCT00106535|6415619|P1|Safety: Actual Treatment Received|2-year Placebo Controlled Period||392
2612586|NCT00106535|6415616|P4|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||0
2612587|NCT00106535|6415617|P3|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||398
2612588|NCT00106535|6415618|P2|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||399
2612589|NCT00106535|6415619|P1|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||393
2612590|NCT00106535|6415616|P4|STARTED|2-year Placebo Controlled Period||0
2612591|NCT00106535|6415617|P3|STARTED|2-year Placebo Controlled Period||401
2612592|NCT00106535|6415618|P2|STARTED|2-year Placebo Controlled Period||401
2612593|NCT00106535|6415619|P1|STARTED|2-year Placebo Controlled Period||394
2612594|NCT00106431|6415912|P1|NOT COMPLETED|Overall Study||65
2612595|NCT00106431|6415912|P1|COMPLETED|Overall Study|37 represents the number of patients who reached at least 6 months treatment|37
2612596|NCT00106431|6415912|P1|STARTED|Overall Study||102
2612597|NCT00106392|6415924|P2|NOT COMPLETED|Overall Study||27
2612598|NCT00106392|6415925|P1|NOT COMPLETED|Overall Study||26
2612599|NCT00106392|6415924|P2|COMPLETED|Overall Study||42
2612600|NCT00106392|6415925|P1|COMPLETED|Overall Study||36
2612601|NCT00106392|6415924|P2|Full Analysis Set (FAS)|Overall Study||61
2612602|NCT00106392|6415925|P1|Full Analysis Set (FAS)|Overall Study||53
2612603|NCT00106392|6415924|P2|Baseline Participants|Overall Study|4 patients withdrew: all prior to surgery and study drug|65
2612604|NCT00106392|6415925|P1|Baseline Participants|Overall Study|3 patients withdrew: 2 prior to surgery and study drug; 1 took study drug but did not have surgery|59
2612605|NCT00106392|6415924|P2|STARTED|Overall Study||69
2612606|NCT00106392|6415925|P1|STARTED|Overall Study||62
2612607|NCT00106353|6415943|P7|NOT COMPLETED|Part 2||16
2612608|NCT00106353|6415944|P6|NOT COMPLETED|Part 2||18
2612609|NCT00106353|6415945|P5|NOT COMPLETED|Part 2||16
2612610|NCT00106353|6415946|P4|NOT COMPLETED|Part 2||0
2612611|NCT00106353|6415947|P3|NOT COMPLETED|Part 2||0
2612612|NCT00106353|6415948|P2|NOT COMPLETED|Part 2||0
2612613|NCT00106353|6415949|P1|NOT COMPLETED|Part 2||0
2612614|NCT00106353|6415943|P7|COMPLETED|Part 2||0
2612615|NCT00106353|6415944|P6|COMPLETED|Part 2||1
2612616|NCT00106353|6415945|P5|COMPLETED|Part 2||1
2612617|NCT00106353|6415946|P4|COMPLETED|Part 2||0
2612618|NCT00106353|6415947|P3|COMPLETED|Part 2||0
2612619|NCT00106353|6415948|P2|COMPLETED|Part 2||0
2612620|NCT00106353|6415949|P1|COMPLETED|Part 2||0
2612621|NCT00106353|6415943|P7|STARTED|Part 2||16
2612622|NCT00106353|6415944|P6|STARTED|Part 2||19
2612623|NCT00106353|6415945|P5|STARTED|Part 2||17
2612624|NCT00106353|6415946|P4|STARTED|Part 2||0
2612625|NCT00106353|6415947|P3|STARTED|Part 2||0
2612626|NCT00106353|6415948|P2|STARTED|Part 2||0
2612627|NCT00106353|6415949|P1|STARTED|Part 2||0
2612628|NCT00106353|6415943|P7|NOT COMPLETED|Part 1||0
2612629|NCT00106353|6415944|P6|NOT COMPLETED|Part 1||0
2612630|NCT00106353|6415945|P5|NOT COMPLETED|Part 1||0
2612631|NCT00106353|6415946|P4|NOT COMPLETED|Part 1||7
2612632|NCT00106353|6415947|P3|NOT COMPLETED|Part 1||3
2612633|NCT00106353|6415948|P2|NOT COMPLETED|Part 1||5
2612634|NCT00106353|6415949|P1|NOT COMPLETED|Part 1||4
2612635|NCT00106353|6415943|P7|COMPLETED|Part 1||0
2612636|NCT00106353|6415944|P6|COMPLETED|Part 1||0
2612637|NCT00106353|6415945|P5|COMPLETED|Part 1||0
2612638|NCT00106353|6415946|P4|COMPLETED|Part 1||0
2612639|NCT00106353|6415947|P3|COMPLETED|Part 1||0
2612640|NCT00106353|6415948|P2|COMPLETED|Part 1||0
2612641|NCT00106353|6415949|P1|COMPLETED|Part 1||0
2612642|NCT00106353|6415943|P7|STARTED|Part 1||0
2612643|NCT00106353|6415944|P6|STARTED|Part 1||0
2612644|NCT00106353|6415945|P5|STARTED|Part 1||0
2612645|NCT00106353|6415946|P4|STARTED|Part 1||7
2612646|NCT00106353|6415947|P3|STARTED|Part 1||3
2612647|NCT00106353|6415948|P2|STARTED|Part 1||5
2612648|NCT00106353|6415949|P1|STARTED|Part 1||4
2612649|NCT00106249|6416076|P2|NOT COMPLETED|Overall Study||2
2612650|NCT00106249|6416077|P1|NOT COMPLETED|Overall Study||3
2612651|NCT00106249|6416076|P2|COMPLETED|Overall Study||11
2612652|NCT00106249|6416077|P1|COMPLETED|Overall Study||11
2612653|NCT00106249|6416076|P2|STARTED|Overall Study||13
2612654|NCT00106249|6416077|P1|STARTED|Overall Study||14
2612655|NCT00106184|6416089|P2|NOT COMPLETED|Overall Study||2
2612656|NCT00106184|6416090|P1|NOT COMPLETED|Overall Study||3
2612657|NCT00106184|6416089|P2|COMPLETED|Overall Study||102
2612658|NCT00106184|6416090|P1|COMPLETED|Overall Study||93
2612659|NCT00106184|6416089|P2|Treated|Overall Study|104 subjects were randomized.|102
2612660|NCT00106184|6416090|P1|Treated|Overall Study|96 subjects were randomized.|93
2612661|NCT00106184|6416089|P2|STARTED|Overall Study||104
2612662|NCT00106184|6416090|P1|STARTED|Overall Study||96
2612663|NCT00106119|6416100|P2|NOT COMPLETED|Second Intervention||0
2612664|NCT00106119|6416101|P1|NOT COMPLETED|Second Intervention||0
2612665|NCT00106119|6416100|P2|COMPLETED|Second Intervention||7
2612666|NCT00106119|6416101|P1|COMPLETED|Second Intervention||7
2612667|NCT00106119|6416100|P2|STARTED|Second Intervention||7
2612668|NCT00106119|6416101|P1|STARTED|Second Intervention||7
2612669|NCT00106119|6416100|P2|NOT COMPLETED|Washout Period of 30 Days||0
2612670|NCT00106119|6416101|P1|NOT COMPLETED|Washout Period of 30 Days||0
2612671|NCT00106119|6416100|P2|COMPLETED|Washout Period of 30 Days||7
2612672|NCT00106119|6416101|P1|COMPLETED|Washout Period of 30 Days||7
2612673|NCT00106119|6416100|P2|STARTED|Washout Period of 30 Days||7
2612674|NCT00106119|6416101|P1|STARTED|Washout Period of 30 Days||7
2612675|NCT00106119|6416100|P2|NOT COMPLETED|First Intervention||0
2612676|NCT00106119|6416101|P1|NOT COMPLETED|First Intervention||0
2612677|NCT00106119|6416100|P2|COMPLETED|First Intervention||7
2612678|NCT00106119|6416101|P1|COMPLETED|First Intervention||7
2612679|NCT00106119|6416100|P2|STARTED|First Intervention||7
2612680|NCT00106119|6416101|P1|STARTED|First Intervention||7
2612681|NCT00106106|6416121|P2|NOT COMPLETED|Overall Study||4
2612682|NCT00106106|6416122|P1|NOT COMPLETED|Overall Study||4
2612683|NCT00106106|6416121|P2|COMPLETED|Overall Study|Although 19 subjects completed all other assessments for the study, only 15 completed both MRS scans|19
2612684|NCT00106106|6416122|P1|COMPLETED|Overall Study|Although 22 subjects completed all other assessments for the study, only 18 completed both MRS scans|22
2612685|NCT00106106|6416121|P2|Completed Both MRS Scans|Overall Study||15
2612686|NCT00106106|6416122|P1|Completed Both MRS Scans|Overall Study||18
2612687|NCT00106106|6416121|P2|STARTED|Overall Study||23
2612688|NCT00106106|6416122|P1|STARTED|Overall Study||26
2612689|NCT00106080|6416132|P2|NOT COMPLETED|Overall Study||27
2612690|NCT00106080|6416133|P1|NOT COMPLETED|Overall Study||43
2612691|NCT00106080|6416132|P2|COMPLETED|Overall Study||155
2612692|NCT00106080|6416133|P1|COMPLETED|Overall Study||151
2612693|NCT00106080|6416132|P2|STARTED|Overall Study||182
2612694|NCT00106080|6416133|P1|STARTED|Overall Study||194
2612695|NCT00106028|6416143|P2|NOT COMPLETED|Overall Study||12
2612696|NCT00106028|6416144|P1|NOT COMPLETED|Overall Study||6
2612697|NCT00106028|6416143|P2|COMPLETED|Overall Study|Completed Month 36|82
2612698|NCT00106028|6416144|P1|COMPLETED|Overall Study|Completed Month 36|43
2612699|NCT00106028|6416143|P2|Month 12 Completed/Started Open Label|Overall Study||87
2612700|NCT00106028|6416144|P1|Month 12 Completed/Started Open Label|Overall Study||49
2612701|NCT00106028|6416143|P2|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|94
2612702|NCT00106028|6416144|P1|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|49
2612703|NCT00106002|6416238|P1|NOT COMPLETED|Overall Study||2
2612704|NCT00106002|6416238|P1|COMPLETED|Overall Study|Completed means that the patient was evaluable for response.|35
2612705|NCT00106002|6416238|P1|STARTED|Overall Study||37
2612706|NCT00105989|6416246|P2|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||69
2612707|NCT00105989|6416247|P1|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||50
2612708|NCT00105989|6416246|P2|COMPLETED|Maintenance - Double-Blind:Week 34-86||73
2612709|NCT00105989|6416247|P1|COMPLETED|Maintenance - Double-Blind:Week 34-86||96
2612710|NCT00105989|6416246|P2|STARTED|Maintenance - Double-Blind:Week 34-86||142
2612711|NCT00105989|6416247|P1|STARTED|Maintenance - Double-Blind:Week 34-86||146
2612712|NCT00105989|6416246|P2|NOT COMPLETED|Continuation - Open Label:Week 10-34||0
2612713|NCT00105989|6416247|P1|NOT COMPLETED|Continuation - Open Label:Week 10-34||125
2612714|NCT00105989|6416246|P2|COMPLETED|Continuation - Open Label:Week 10-34||0
2612715|NCT00105989|6416247|P1|COMPLETED|Continuation - Open Label:Week 10-34||288
2612716|NCT00105989|6416246|P2|STARTED|Continuation - Open Label:Week 10-34||0
2612717|NCT00105989|6416247|P1|STARTED|Continuation - Open Label:Week 10-34||413
2612718|NCT00105989|6416246|P2|NOT COMPLETED|Acute - Open Label: Week 0-10||0
2612719|NCT00105989|6416247|P1|NOT COMPLETED|Acute - Open Label: Week 0-10||101
2612720|NCT00105989|6416246|P2|COMPLETED|Acute - Open Label: Week 0-10||0
2612721|NCT00105989|6416247|P1|COMPLETED|Acute - Open Label: Week 0-10||413
2612722|NCT00105989|6416246|P2|STARTED|Acute - Open Label: Week 0-10||0
2612723|NCT00105989|6416247|P1|STARTED|Acute - Open Label: Week 0-10||514
2612724|NCT00105586|6416363|P2|NOT COMPLETED|Overall Study||16
2612725|NCT00105586|6416364|P1|NOT COMPLETED|Overall Study||17
2612726|NCT00105586|6416363|P2|COMPLETED|Overall Study||69
2612727|NCT00105586|6416364|P1|COMPLETED|Overall Study||75
2612728|NCT00105586|6416363|P2|STARTED|Overall Study||85
2612729|NCT00105586|6416364|P1|STARTED|Overall Study||92
2612730|NCT00105560|6416372|P1|NOT COMPLETED|Overall Study||1
2612731|NCT00105560|6416372|P1|COMPLETED|Overall Study||58
2612732|NCT00105560|6416372|P1|STARTED|Overall Study||59
2612733|NCT00105534|6416394|P2|NOT COMPLETED|Overall Study||33
2612734|NCT00105534|6416395|P1|NOT COMPLETED|Overall Study||22
2612735|NCT00105534|6416394|P2|COMPLETED|Overall Study||317
2612736|NCT00105534|6416395|P1|COMPLETED|Overall Study||313
2612737|NCT00105534|6416394|P2|STARTED|Overall Study||350
2612738|NCT00105534|6416395|P1|STARTED|Overall Study||335
2612739|NCT00105521|6416407|P4|NOT COMPLETED|Overall Study||17
2612740|NCT00105521|6416408|P3|NOT COMPLETED|Overall Study||17
2612741|NCT00105521|6416409|P2|NOT COMPLETED|Overall Study||11
2612742|NCT00105521|6416410|P1|NOT COMPLETED|Overall Study||15
2612743|NCT00105521|6416407|P4|COMPLETED|Overall Study||85
2612744|NCT00105521|6416408|P3|COMPLETED|Overall Study||80
2612745|NCT00105521|6416409|P2|COMPLETED|Overall Study||90
2612746|NCT00105521|6416410|P1|COMPLETED|Overall Study||83
2612747|NCT00105521|6416407|P4|STARTED|Overall Study||102
2612748|NCT00105521|6416408|P3|STARTED|Overall Study||97
2612749|NCT00105521|6416409|P2|STARTED|Overall Study||101
2612750|NCT00105521|6416410|P1|STARTED|Overall Study||98
2612751|NCT00105508|6416434|P2|NOT COMPLETED|Overall Study||36
2612752|NCT00105508|6416435|P1|NOT COMPLETED|Overall Study||40
2612753|NCT00105508|6416434|P2|COMPLETED|Overall Study||217
2612754|NCT00105508|6416435|P1|COMPLETED|Overall Study||213
2612755|NCT00105508|6416434|P2|STARTED|Overall Study||253
2612756|NCT00105508|6416435|P1|STARTED|Overall Study||253
2612757|NCT00105482|6416449|P2|NOT COMPLETED|Overall Study||55
2612758|NCT00105482|6416450|P1|NOT COMPLETED|Overall Study||59
2612759|NCT00105482|6416449|P2|COMPLETED|Overall Study||30
2612760|NCT00105482|6416450|P1|COMPLETED|Overall Study||28
2612761|NCT00105482|6416449|P2|STARTED|Overall Study||85
2612762|NCT00105482|6416450|P1|STARTED|Overall Study||87
2612763|NCT00105469|6416466|P2|NOT COMPLETED|Overall Study||11
2612764|NCT00105469|6416467|P1|NOT COMPLETED|Overall Study||22
2612765|NCT00105469|6416466|P2|COMPLETED|Overall Study||367
2612766|NCT00105469|6416467|P1|COMPLETED|Overall Study||343
2612767|NCT00105469|6416466|P2|STARTED|Overall Study||378
2612768|NCT00105469|6416467|P1|STARTED|Overall Study||365
2612769|NCT00105443|6416477|P4|NOT COMPLETED|Follow-up and/or Open Label Nexavar||47
2612770|NCT00105443|6416478|P3|NOT COMPLETED|Follow-up and/or Open Label Nexavar||245
2612771|NCT00105443|6416479|P2|NOT COMPLETED|Follow-up and/or Open Label Nexavar||57
2612772|NCT00105443|6416480|P1|NOT COMPLETED|Follow-up and/or Open Label Nexavar||228
2612773|NCT00105443|6416477|P4|COMPLETED|Follow-up and/or Open Label Nexavar|47 participants in total (36 + 11) received Open Label Sorafenib treatment (Subjects at Risk)|0
2612774|NCT00105443|6416478|P3|COMPLETED|Follow-up and/or Open Label Nexavar||0
2612775|NCT00105443|6416479|P2|COMPLETED|Follow-up and/or Open Label Nexavar|57 participants in total (47 + 10) received Open Label Sorafenib treatment (Subjects at Risk)|0
2612776|NCT00105443|6416480|P1|COMPLETED|Follow-up and/or Open Label Nexavar||0
2612777|NCT00105443|6416477|P4|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||11
2612778|NCT00105443|6416478|P3|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
2612779|NCT00105443|6416479|P2|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||10
2612780|NCT00105443|6416480|P1|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
2612781|NCT00105443|6416477|P4|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|36
2612782|NCT00105443|6416478|P3|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
2612783|NCT00105443|6416479|P2|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|47
2612784|NCT00105443|6416480|P1|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
2612785|NCT00105443|6416477|P4|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
2612786|NCT00105443|6416478|P3|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|245
2612787|NCT00105443|6416479|P2|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
2612788|NCT00105443|6416480|P1|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|228
2612789|NCT00105443|6416477|P4|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 36 participants directly switched to Open Label (OL) Sorafenib treatment|47
2612790|NCT00105443|6416478|P3|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 245 participants directly switched to Follow-up (FU)|245
2612791|NCT00105443|6416479|P2|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 47 participants directly switched to Open Label (OL) Sorafenib treatment|57
2612792|NCT00105443|6416480|P1|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 228 participants directly switched to Follow-up (FU)|228
2612793|NCT00105443|6416477|P4|NOT COMPLETED|Double-Blind Treatment||0
2612794|NCT00105443|6416478|P3|NOT COMPLETED|Double-Blind Treatment||11
2612795|NCT00105443|6416479|P2|NOT COMPLETED|Double-Blind Treatment||0
2612796|NCT00105443|6416480|P1|NOT COMPLETED|Double-Blind Treatment||14
2612797|NCT00105443|6416477|P4|COMPLETED|Double-Blind Treatment|36 participants switched to Sorafenib Open Label (OL); 11 first to FU prior to also switch to OL|47
2612798|NCT00105443|6416478|P3|COMPLETED|Double-Blind Treatment|245 participants directly switched to the Follow-up (FU) phase|245
2612799|NCT00105443|6416479|P2|COMPLETED|Double-Blind Treatment|47 participants continued with Sorafenib Open Label (OL); 10 first to FU prior to also switch to OL|57
2612800|NCT00105443|6416480|P1|COMPLETED|Double-Blind Treatment|228 participants directly switched to the Follow-up (FU) phase only|228
2612801|NCT00105443|6416477|P4|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4 as well as RG5|47
2612802|NCT00105443|6416478|P3|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4|255
2612803|NCT00105443|6416479|P2|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3|57
2612804|NCT00105443|6416480|P1|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3 (RG = Reporting Group for Safety Data)|240
2612805|NCT00105443|6416477|P4|STARTED|Double-Blind Treatment||47
2612806|NCT00105443|6416478|P3|STARTED|Double-Blind Treatment||256
2612807|NCT00105443|6416479|P2|STARTED|Double-Blind Treatment||57
2612808|NCT00105443|6416480|P1|STARTED|Double-Blind Treatment||242
2612809|NCT00105235|6416507|P1|NOT COMPLETED|Overall Study||7
2612810|NCT00105235|6416507|P1|COMPLETED|Overall Study||20
2612811|NCT00105235|6416507|P1|STARTED|Overall Study||27
2612812|NCT00105196|6416520|P2|NOT COMPLETED|Overall Study||23
2612813|NCT00105196|6416521|P1|NOT COMPLETED|Overall Study||30
2612814|NCT00105196|6416520|P2|COMPLETED|Overall Study||149
2612815|NCT00105196|6416521|P1|COMPLETED|Overall Study||147
2612816|NCT00105196|6416520|P2|STARTED|Overall Study||172
2612817|NCT00105196|6416521|P1|STARTED|Overall Study||177
2612818|NCT00105183|6416544|P3|NOT COMPLETED|Overall Study||23
2612819|NCT00105183|6416545|P2|NOT COMPLETED|Overall Study||19
2612820|NCT00105183|6416546|P1|NOT COMPLETED|Overall Study||22
2612821|NCT00105183|6416544|P3|COMPLETED|Overall Study|Completed at least 12 months follow up|39
2612822|NCT00105183|6416545|P2|COMPLETED|Overall Study|Completed at least 12 months follow up|60
2612823|NCT00105183|6416546|P1|COMPLETED|Overall Study|Completed at least 12 months follow up|60
2612824|NCT00105183|6416544|P3|STARTED|Overall Study|Randomized|62
2612825|NCT00105183|6416545|P2|STARTED|Overall Study|Randomized|79
2612826|NCT00105183|6416546|P1|STARTED|Overall Study|Randomized|82
2612827|NCT00105157|6416582|P4|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||18
2612828|NCT00105157|6416583|P3|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
2612829|NCT00105157|6416584|P2|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
2612830|NCT00105157|6416585|P1|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||9
2612831|NCT00105157|6416582|P4|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||19
2612832|NCT00105157|6416583|P3|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||5
2612833|NCT00105157|6416584|P2|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||7
2612834|NCT00105157|6416585|P1|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||2
2612835|NCT00105157|6416582|P4|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|37
2612836|NCT00105157|6416583|P3|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
2612837|NCT00105157|6416584|P2|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|13
2612838|NCT00105157|6416585|P1|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
2612839|NCT00105157|6416582|P4|NOT COMPLETED|Open-Label Continuation of DB||1
2612840|NCT00105157|6416583|P3|NOT COMPLETED|Open-Label Continuation of DB||9
2612841|NCT00105157|6416584|P2|NOT COMPLETED|Open-Label Continuation of DB||10
2612842|NCT00105157|6416585|P1|NOT COMPLETED|Open-Label Continuation of DB||7
2612843|NCT00105157|6416582|P4|COMPLETED|Open-Label Continuation of DB||5
2612844|NCT00105157|6416583|P3|COMPLETED|Open-Label Continuation of DB||24
2612845|NCT00105157|6416584|P2|COMPLETED|Open-Label Continuation of DB||21
2612846|NCT00105157|6416585|P1|COMPLETED|Open-Label Continuation of DB||23
2612847|NCT00105157|6416582|P4|STARTED|Open-Label Continuation of DB||6
2612848|NCT00105157|6416583|P3|STARTED|Open-Label Continuation of DB||33
2612849|NCT00105157|6416584|P2|STARTED|Open-Label Continuation of DB||31
2612850|NCT00105157|6416585|P1|STARTED|Open-Label Continuation of DB||30
2612851|NCT00105157|6416582|P4|NOT COMPLETED|Double-Blind (DB)||39
2612852|NCT00105157|6416583|P3|NOT COMPLETED|Double-Blind (DB)||12
2612853|NCT00105157|6416584|P2|NOT COMPLETED|Double-Blind (DB)||14
2612854|NCT00105157|6416585|P1|NOT COMPLETED|Double-Blind (DB)||14
2612855|NCT00105157|6416582|P4|COMPLETED|Double-Blind (DB)||6
2612856|NCT00105157|6416583|P3|COMPLETED|Double-Blind (DB)||33
2612857|NCT00105157|6416584|P2|COMPLETED|Double-Blind (DB)||31
2612858|NCT00105157|6416585|P1|COMPLETED|Double-Blind (DB)||30
2612859|NCT00105157|6416582|P4|Treated|Double-Blind (DB)||45
2612860|NCT00105157|6416583|P3|Treated|Double-Blind (DB)||45
2612861|NCT00105157|6416584|P2|Treated|Double-Blind (DB)||45
2612862|NCT00105157|6416585|P1|Treated|Double-Blind (DB)||43
2612863|NCT00105157|6416582|P4|STARTED|Double-Blind (DB)||45
2612864|NCT00105157|6416583|P3|STARTED|Double-Blind (DB)||45
2612865|NCT00105157|6416584|P2|STARTED|Double-Blind (DB)||45
2612866|NCT00105157|6416585|P1|STARTED|Double-Blind (DB)||44
2612867|NCT00105079|6416779|P2|NOT COMPLETED|Overall Study||35
2612868|NCT00105079|6416780|P1|NOT COMPLETED|Overall Study||39
2612869|NCT00105079|6416779|P2|COMPLETED|Overall Study||135
2612870|NCT00105079|6416780|P1|COMPLETED|Overall Study||128
2612871|NCT00105079|6416779|P2|Safety Population|Overall Study||168
2612872|NCT00105079|6416780|P1|Safety Population|Overall Study||163
2612873|NCT00105079|6416779|P2|STARTED|Overall Study||170
2612874|NCT00105079|6416780|P1|STARTED|Overall Study||167
2612875|NCT00105066|6416798|P2|NOT COMPLETED|Overall Study||5
2612876|NCT00105066|6416799|P1|NOT COMPLETED|Overall Study||2
2612877|NCT00105066|6416798|P2|COMPLETED|Overall Study||45
2612878|NCT00105066|6416799|P1|COMPLETED|Overall Study||25
2612879|NCT00105066|6416798|P2|STARTED|Overall Study||50
2612880|NCT00105066|6416799|P1|STARTED|Overall Study||27
2612881|NCT00105027|6416815|P6|NOT COMPLETED|Overall Study||13
2612882|NCT00105027|6416816|P5|NOT COMPLETED|Overall Study||15
2612883|NCT00105027|6416817|P4|NOT COMPLETED|Overall Study||16
2612884|NCT00105027|6416818|P3|NOT COMPLETED|Overall Study||9
2612885|NCT00105027|6416819|P2|NOT COMPLETED|Overall Study||9
2612886|NCT00105027|6416820|P1|NOT COMPLETED|Overall Study||15
2612887|NCT00105027|6416815|P6|COMPLETED|Overall Study||125
2612888|NCT00105027|6416816|P5|COMPLETED|Overall Study||121
2612889|NCT00105027|6416817|P4|COMPLETED|Overall Study||121
2612890|NCT00105027|6416818|P3|COMPLETED|Overall Study||82
2612891|NCT00105027|6416819|P2|COMPLETED|Overall Study||83
2612892|NCT00105027|6416820|P1|COMPLETED|Overall Study||73
2612893|NCT00105027|6416815|P6|STARTED|Overall Study||138
2612894|NCT00105027|6416816|P5|STARTED|Overall Study||136
2612895|NCT00105027|6416817|P4|STARTED|Overall Study||137
2612896|NCT00105027|6416818|P3|STARTED|Overall Study||91
2612897|NCT00105027|6416819|P2|STARTED|Overall Study||92
2612898|NCT00105027|6416820|P1|STARTED|Overall Study||88
2612899|NCT00105001|6416855|P3|NOT COMPLETED|Overall Study||0
2612900|NCT00105001|6416856|P2|NOT COMPLETED|Overall Study||0
2612901|NCT00105001|6416857|P1|NOT COMPLETED|Overall Study||0
2612902|NCT00105001|6416855|P3|COMPLETED|Overall Study||69
2612903|NCT00105001|6416856|P2|COMPLETED|Overall Study||71
2612904|NCT00105001|6416857|P1|COMPLETED|Overall Study||70
2612905|NCT00105001|6416855|P3|STARTED|Overall Study||69
2612906|NCT00105001|6416856|P2|STARTED|Overall Study||71
2612907|NCT00105001|6416857|P1|STARTED|Overall Study||70
2612908|NCT00104884|6416877|P1|NOT COMPLETED|Overall Study||4
2612909|NCT00104884|6416877|P1|COMPLETED|Overall Study||0
2612910|NCT00104884|6416877|P1|STARTED|Overall Study||4
2612911|NCT00104871|6416881|P1|NOT COMPLETED|Overall Study||1
2612912|NCT00104871|6416881|P1|COMPLETED|Overall Study||21
2612913|NCT00104871|6416881|P1|STARTED|Overall Study||22
2612914|NCT00104858|6416887|P1|NOT COMPLETED|Overall Study||0
2612915|NCT00104858|6416887|P1|COMPLETED|Overall Study||52
2612916|NCT00104858|6416887|P1|STARTED|Overall Study||52
2612917|NCT00104728|6416902|P1|NOT COMPLETED|Overall Study||19
2612918|NCT00104728|6416902|P1|COMPLETED|Overall Study||23
2612919|NCT00104728|6416902|P1|STARTED|Overall Study|42 consented on study|42
2612920|NCT00104650|6416910|P3|NOT COMPLETED|Follow-up Period||10
2612921|NCT00104650|6416911|P2|NOT COMPLETED|Follow-up Period||13
2612922|NCT00104650|6416912|P1|NOT COMPLETED|Follow-up Period||11
2612923|NCT00104650|6416910|P3|COMPLETED|Follow-up Period||18
2612924|NCT00104650|6416911|P2|COMPLETED|Follow-up Period||12
2612925|NCT00104650|6416912|P1|COMPLETED|Follow-up Period||14
2612926|NCT00104650|6416910|P3|STARTED|Follow-up Period||28
2612927|NCT00104650|6416911|P2|STARTED|Follow-up Period||25
2612928|NCT00104650|6416912|P1|STARTED|Follow-up Period||25
2612929|NCT00104650|6416910|P3|NOT COMPLETED|Treatment Period (25 Weeks)||10
2612930|NCT00104650|6416911|P2|NOT COMPLETED|Treatment Period (25 Weeks)||11
2612931|NCT00104650|6416912|P1|NOT COMPLETED|Treatment Period (25 Weeks)||12
2612932|NCT00104650|6416910|P3|COMPLETED|Treatment Period (25 Weeks)||28
2612933|NCT00104650|6416911|P2|COMPLETED|Treatment Period (25 Weeks)||25
2612934|NCT00104650|6416912|P1|COMPLETED|Treatment Period (25 Weeks)||25
2612935|NCT00104650|6416910|P3|Received Investigational Product|Treatment Period (25 Weeks)||38
2612936|NCT00104650|6416911|P2|Received Investigational Product|Treatment Period (25 Weeks)||35
2612937|NCT00104650|6416912|P1|Received Investigational Product|Treatment Period (25 Weeks)||35
2612938|NCT00104650|6416910|P3|STARTED|Treatment Period (25 Weeks)||38
2612939|NCT00104650|6416911|P2|STARTED|Treatment Period (25 Weeks)||36
2612940|NCT00104650|6416912|P1|STARTED|Treatment Period (25 Weeks)||37
2612941|NCT00104637|6416944|P2|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
2612942|NCT00104637|6416945|P1|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
2612943|NCT00104637|6416944|P2|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||4
2612944|NCT00104637|6416945|P1|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||5
2612945|NCT00104637|6416944|P2|STARTED|Period 3 ( TREATMENT: 4 Weeks)||4
2612946|NCT00104637|6416945|P1|STARTED|Period 3 ( TREATMENT: 4 Weeks)||5
2612947|NCT00104637|6416944|P2|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
2612948|NCT00104637|6416945|P1|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
2612949|NCT00104637|6416944|P2|COMPLETED|Period 2 (WASHOUT: 1 Week)||4
2612950|NCT00104637|6416945|P1|COMPLETED|Period 2 (WASHOUT: 1 Week)||5
2612951|NCT00104637|6416944|P2|STARTED|Period 2 (WASHOUT: 1 Week)||4
2612952|NCT00104637|6416945|P1|STARTED|Period 2 (WASHOUT: 1 Week)||5
2612953|NCT00104637|6416944|P2|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||0
2612954|NCT00104637|6416945|P1|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||1
2612955|NCT00104637|6416944|P2|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||4
2612956|NCT00104637|6416945|P1|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||5
2612957|NCT00104637|6416944|P2|STARTED|Period 1: ( TREATMENT: 4 Weeks)||4
2612958|NCT00104637|6416945|P1|STARTED|Period 1: ( TREATMENT: 4 Weeks)||6
2612959|NCT00104572|6416974|P3|NOT COMPLETED|Overall Study||0
2612960|NCT00104572|6416975|P2|NOT COMPLETED|Overall Study||3
2612961|NCT00104572|6416976|P1|NOT COMPLETED|Overall Study||3
2612962|NCT00104572|6416974|P3|COMPLETED|Overall Study||9
2612963|NCT00104572|6416975|P2|COMPLETED|Overall Study||10
2612964|NCT00104572|6416976|P1|COMPLETED|Overall Study||10
2612965|NCT00104572|6416974|P3|STARTED|Overall Study|(N=11) in placebo, physician removed 2 men due to total testosterone>450 ng/DL, N=9 analysed.|9
2612966|NCT00104572|6416975|P2|STARTED|Overall Study|These are the analysed subjects|13
2612967|NCT00104572|6416976|P1|STARTED|Overall Study|These are the analysed subjects|13
2612968|NCT00104520|6416995|P2|NOT COMPLETED|Overall Study||71
2612969|NCT00104520|6416996|P1|NOT COMPLETED|Overall Study||50
2612970|NCT00104520|6416995|P2|COMPLETED|Overall Study||64
2612971|NCT00104520|6416996|P1|COMPLETED|Overall Study||26
2612972|NCT00104520|6416995|P2|STARTED|Overall Study||135
2612973|NCT00104520|6416996|P1|STARTED|Overall Study||76
2612974|NCT00104416|6417016|P5|NOT COMPLETED|Continuation Phase||5
2612975|NCT00104416|6417017|P4|NOT COMPLETED|Continuation Phase||2
2612976|NCT00104416|6417018|P3|NOT COMPLETED|Continuation Phase||6
2612977|NCT00104416|6417019|P2|NOT COMPLETED|Continuation Phase||0
2612978|NCT00104416|6417020|P1|NOT COMPLETED|Continuation Phase||0
2612979|NCT00104416|6417016|P5|COMPLETED|Continuation Phase||27
2612980|NCT00104416|6417017|P4|COMPLETED|Continuation Phase||65
2612981|NCT00104416|6417018|P3|COMPLETED|Continuation Phase||63
2612982|NCT00104416|6417019|P2|COMPLETED|Continuation Phase||0
2612983|NCT00104416|6417020|P1|COMPLETED|Continuation Phase||0
2612984|NCT00104416|6417016|P5|STARTED|Continuation Phase||32
2612985|NCT00104416|6417017|P4|STARTED|Continuation Phase|One participant did not complete the Double-Blind Phase but was enrolled in the Continuation Phase.|67
2612986|NCT00104416|6417018|P3|STARTED|Continuation Phase||69
2612987|NCT00104416|6417019|P2|STARTED|Continuation Phase||0
2612988|NCT00104416|6417020|P1|STARTED|Continuation Phase||0
2612989|NCT00104416|6417016|P5|NOT COMPLETED|Double-Blind Phase||0
2612990|NCT00104416|6417017|P4|NOT COMPLETED|Double-Blind Phase||0
2612991|NCT00104416|6417018|P3|NOT COMPLETED|Double-Blind Phase||0
2612992|NCT00104416|6417019|P2|NOT COMPLETED|Double-Blind Phase||10
2612993|NCT00104416|6417020|P1|NOT COMPLETED|Double-Blind Phase||8
2612994|NCT00104416|6417016|P5|COMPLETED|Double-Blind Phase||0
2612995|NCT00104416|6417017|P4|COMPLETED|Double-Blind Phase||0
2612996|NCT00104416|6417018|P3|COMPLETED|Double-Blind Phase||0
2612997|NCT00104416|6417019|P2|COMPLETED|Double-Blind Phase||66
2612998|NCT00104416|6417020|P1|COMPLETED|Double-Blind Phase||69
2612999|NCT00104416|6417016|P5|STARTED|Double-Blind Phase||0
2613000|NCT00104416|6417017|P4|STARTED|Double-Blind Phase||0
2613001|NCT00104416|6417018|P3|STARTED|Double-Blind Phase||0
2613002|NCT00104416|6417019|P2|STARTED|Double-Blind Phase||76
2613003|NCT00104416|6417020|P1|STARTED|Double-Blind Phase||77
2613004|NCT00104299|6417065|P2|NOT COMPLETED|Overall Study||10
2613005|NCT00104299|6417066|P1|NOT COMPLETED|Overall Study||9
2613006|NCT00104299|6417065|P2|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|88
2613007|NCT00104299|6417066|P1|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|90
2613008|NCT00104299|6417065|P2|STARTED|Overall Study||98
2613009|NCT00104299|6417066|P1|STARTED|Overall Study||99
2613010|NCT00104247|6417088|P2|NOT COMPLETED|Overall Study||1
2613011|NCT00104247|6417089|P1|NOT COMPLETED|Overall Study||1
2613012|NCT00104247|6417088|P2|COMPLETED|Overall Study|One subject withdrew at Week 4, but is included in the data analysis|46
2613013|NCT00104247|6417089|P1|COMPLETED|Overall Study|Subject withdrew prior to dosing|41
2613014|NCT00104247|6417088|P2|STARTED|Overall Study||47
2613015|NCT00104247|6417089|P1|STARTED|Overall Study||42
2613016|NCT00104234|6417097|P2|NOT COMPLETED|Overall Study||1
2613017|NCT00104234|6417098|P1|NOT COMPLETED|Overall Study||0
2613018|NCT00104234|6417097|P2|COMPLETED|Overall Study||19
2613019|NCT00104234|6417098|P1|COMPLETED|Overall Study||19
2613020|NCT00104234|6417097|P2|STARTED|Overall Study||20
2613021|NCT00104234|6417098|P1|STARTED|Overall Study||19
2613022|NCT00104104|6417108|P2|NOT COMPLETED|Overall Study||72
2613023|NCT00104104|6417109|P1|NOT COMPLETED|Overall Study||75
2613024|NCT00104104|6417108|P2|COMPLETED|Overall Study||17
2613025|NCT00104104|6417109|P1|COMPLETED|Overall Study||15
2613026|NCT00104104|6417108|P2|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 4 patients in this arm were excluded.|84
2613027|NCT00104104|6417109|P1|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 3 patients in this arm were excluded.|85
2613028|NCT00104104|6417108|P2|Safety Population (Including Site 74)|Overall Study||88
2613029|NCT00104104|6417109|P1|Safety Population (Including Site 74)|Overall Study||88
2613030|NCT00104104|6417108|P2|STARTED|Overall Study|1 Participants in the 30-minute infusion group did not receive study drug.|89
2613031|NCT00104104|6417109|P1|STARTED|Overall Study|2 Participants in the 15-minute infusion group did not receive study drug.|90
2613032|NCT00104052|6417123|P1|NOT COMPLETED|Overall Study||29
2613033|NCT00104052|6417123|P1|COMPLETED|Overall Study||78
2613034|NCT00104052|6417123|P1|STARTED|Overall Study||107
2613035|NCT00103857|6417134|P7|NOT COMPLETED|50-Week Extension Study||0
2613036|NCT00103857|6417135|P6|NOT COMPLETED|50-Week Extension Study||20
2613037|NCT00103857|6417136|P5|NOT COMPLETED|50-Week Extension Study||21
2613038|NCT00103857|6417137|P4|NOT COMPLETED|50-Week Extension Study||36
2613039|NCT00103857|6417138|P3|NOT COMPLETED|50-Week Extension Study||26
2613040|NCT00103857|6417139|P2|NOT COMPLETED|50-Week Extension Study||27
2613041|NCT00103857|6417140|P1|NOT COMPLETED|50-Week Extension Study||38
2613042|NCT00103857|6417134|P7|COMPLETED|50-Week Extension Study||0
2613043|NCT00103857|6417135|P6|COMPLETED|50-Week Extension Study||78
2613044|NCT00103857|6417136|P5|COMPLETED|50-Week Extension Study||101
2613045|NCT00103857|6417137|P4|COMPLETED|50-Week Extension Study||98
2613046|NCT00103857|6417138|P3|COMPLETED|50-Week Extension Study||95
2613047|NCT00103857|6417139|P2|COMPLETED|50-Week Extension Study||80
2613048|NCT00103857|6417140|P1|COMPLETED|50-Week Extension Study||65
2613049|NCT00103857|6417134|P7|STARTED|50-Week Extension Study||0
2613050|NCT00103857|6417135|P6|STARTED|50-Week Extension Study|17 randomized patients completed Period 1 but did not enter Period 2.|98
2613051|NCT00103857|6417136|P5|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|122
2613052|NCT00103857|6417137|P4|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|134
2613053|NCT00103857|6417138|P3|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|121
2613054|NCT00103857|6417139|P2|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|107
2613055|NCT00103857|6417140|P1|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|103
2613056|NCT00103857|6417134|P7|NOT COMPLETED|54-Week Base Study||38
2613057|NCT00103857|6417135|P6|NOT COMPLETED|54-Week Base Study||61
2613058|NCT00103857|6417136|P5|NOT COMPLETED|54-Week Base Study||41
2613059|NCT00103857|6417137|P4|NOT COMPLETED|54-Week Base Study||42
2613060|NCT00103857|6417138|P3|NOT COMPLETED|54-Week Base Study||47
2613061|NCT00103857|6417139|P2|NOT COMPLETED|54-Week Base Study||56
2613062|NCT00103857|6417140|P1|NOT COMPLETED|54-Week Base Study||57
2613063|NCT00103857|6417134|P7|COMPLETED|54-Week Base Study||79
2613064|NCT00103857|6417135|P6|COMPLETED|54-Week Base Study||115
2613065|NCT00103857|6417136|P5|COMPLETED|54-Week Base Study||141
2613066|NCT00103857|6417137|P4|COMPLETED|54-Week Base Study||148
2613067|NCT00103857|6417138|P3|COMPLETED|54-Week Base Study||135
2613068|NCT00103857|6417139|P2|COMPLETED|54-Week Base Study||126
2613069|NCT00103857|6417140|P1|COMPLETED|54-Week Base Study||122
2613070|NCT00103857|6417134|P7|STARTED|54-Week Base Study|Results for the OLC are through Week 24. Results for the 6 randomized groups are through Week 54.|117
2613071|NCT00103857|6417135|P6|STARTED|54-Week Base Study||176
2613072|NCT00103857|6417136|P5|STARTED|54-Week Base Study||182
2613073|NCT00103857|6417137|P4|STARTED|54-Week Base Study||190
2613074|NCT00103857|6417138|P3|STARTED|54-Week Base Study||182
2613075|NCT00103857|6417139|P2|STARTED|54-Week Base Study||182
2613076|NCT00103857|6417140|P1|STARTED|54-Week Base Study||179
2613077|NCT00103844|6417205|P2|NOT COMPLETED|Overall Study||0
2613078|NCT00103844|6417206|P1|NOT COMPLETED|Overall Study||0
2613079|NCT00103844|6417205|P2|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|49
2613080|NCT00103844|6417206|P1|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|101
2613081|NCT00103844|6417205|P2|Crossed Over|Overall Study|40 participants from the imatinib arm crossed over the dasatinib|40
2613082|NCT00103844|6417206|P1|Crossed Over|Overall Study|22 participants from the dasatinib arm crossed over to imatinib|22
2613083|NCT00103844|6417205|P2|STARTED|Overall Study||49
2613084|NCT00103844|6417206|P1|STARTED|Overall Study||101
2613085|NCT00103740|6417239|P2|NOT COMPLETED|Period 2 - Extended Observation Period||36
2613086|NCT00103740|6417240|P1|NOT COMPLETED|Period 2 - Extended Observation Period||69
2613087|NCT00103740|6417239|P2|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|27
2613088|NCT00103740|6417240|P1|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|9
2613089|NCT00103740|6417239|P2|STARTED|Period 2 - Extended Observation Period||63
2613090|NCT00103740|6417240|P1|STARTED|Period 2 - Extended Observation Period||78
2613091|NCT00103740|6417239|P2|NOT COMPLETED|Period 1 - Core||4
2613092|NCT00103740|6417240|P1|NOT COMPLETED|Period 1 - Core||7
2613093|NCT00103740|6417239|P2|COMPLETED|Period 1 - Core||89
2613094|NCT00103740|6417240|P1|COMPLETED|Period 1 - Core||85
2613095|NCT00103740|6417239|P2|STARTED|Period 1 - Core||93
2613096|NCT00103740|6417240|P1|STARTED|Period 1 - Core||92
2613097|NCT00103662|6417268|P2|NOT COMPLETED|Overall Study||33
2613098|NCT00103662|6417269|P1|NOT COMPLETED|Overall Study||19
2613099|NCT00103662|6417268|P2|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|121
2613100|NCT00103662|6417269|P1|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|129
2613101|NCT00103662|6417268|P2|STARTED|Overall Study||154
2613102|NCT00103662|6417269|P1|STARTED|Overall Study||148
2613103|NCT00103610|6417295|P2|NOT COMPLETED|Overall Study||80
2613104|NCT00103610|6417296|P1|NOT COMPLETED|Overall Study||38
2613105|NCT00103610|6417295|P2|COMPLETED|Overall Study||68
2613106|NCT00103610|6417296|P1|COMPLETED|Overall Study||112
2613107|NCT00103610|6417295|P2|STARTED|Overall Study||148
2613108|NCT00103610|6417296|P1|STARTED|Overall Study||150
2613109|NCT00103506|6417320|P2|NOT COMPLETED|Overall Study||324
2613110|NCT00103506|6417321|P1|NOT COMPLETED|Overall Study||322
2613111|NCT00103506|6417320|P2|COMPLETED|Overall Study||0
2613112|NCT00103506|6417321|P1|COMPLETED|Overall Study||0
2613113|NCT00103506|6417320|P2|STARTED|Overall Study||324
2613114|NCT00103506|6417321|P1|STARTED|Overall Study||322
2613115|NCT00103376|6417334|P3|NOT COMPLETED|Overall Study||0
2613116|NCT00103376|6417335|P2|NOT COMPLETED|Overall Study||0
2613117|NCT00103376|6417336|P1|NOT COMPLETED|Overall Study||0
2613118|NCT00103376|6417334|P3|COMPLETED|Overall Study||8
2613119|NCT00103376|6417335|P2|COMPLETED|Overall Study||7
2613120|NCT00103376|6417336|P1|COMPLETED|Overall Study||8
2613121|NCT00103376|6417334|P3|STARTED|Overall Study||8
2613122|NCT00103376|6417335|P2|STARTED|Overall Study||7
2613123|NCT00103376|6417336|P1|STARTED|Overall Study||8
2613124|NCT00103311|6417352|P2|NOT COMPLETED|Overall Study||1
2613125|NCT00103311|6417353|P1|NOT COMPLETED|Overall Study||4
2613126|NCT00103311|6417352|P2|COMPLETED|Overall Study||30
2613127|NCT00103311|6417353|P1|COMPLETED|Overall Study||29
2613128|NCT00103311|6417352|P2|STARTED|Overall Study||31
2613129|NCT00103311|6417353|P1|STARTED|Overall Study||33
2613130|NCT00103285|6417363|P8|NOT COMPLETED|Response Assignment||120
2613131|NCT00103285|6417364|P7|NOT COMPLETED|Response Assignment||49
2613132|NCT00103285|6417365|P6|NOT COMPLETED|Response Assignment||48
2613133|NCT00103285|6417366|P5|NOT COMPLETED|Response Assignment||84
2613134|NCT00103285|6417367|P4|NOT COMPLETED|Response Assignment||62
2613135|NCT00103285|6417368|P3|NOT COMPLETED|Response Assignment||84
2613136|NCT00103285|6417369|P2|NOT COMPLETED|Response Assignment||132
2613137|NCT00103285|6417370|P1|NOT COMPLETED|Response Assignment||0
2613138|NCT00103285|6417363|P8|COMPLETED|Response Assignment||523
2613139|NCT00103285|6417364|P7|COMPLETED|Response Assignment||199
2613140|NCT00103285|6417365|P6|COMPLETED|Response Assignment||201
2613141|NCT00103285|6417366|P5|COMPLETED|Response Assignment||425
2613142|NCT00103285|6417367|P4|COMPLETED|Response Assignment||441
2613143|NCT00103285|6417368|P3|COMPLETED|Response Assignment||853
2613144|NCT00103285|6417369|P2|COMPLETED|Response Assignment||807
2613145|NCT00103285|6417370|P1|COMPLETED|Response Assignment||0
2613146|NCT00103285|6417363|P8|STARTED|Response Assignment||643
2613147|NCT00103285|6417364|P7|STARTED|Response Assignment||248
2613148|NCT00103285|6417365|P6|STARTED|Response Assignment||249
2613149|NCT00103285|6417366|P5|STARTED|Response Assignment||509
2613150|NCT00103285|6417367|P4|STARTED|Response Assignment||503
2613151|NCT00103285|6417368|P3|STARTED|Response Assignment||937
2613152|NCT00103285|6417369|P2|STARTED|Response Assignment||939
2613153|NCT00103285|6417370|P1|STARTED|Response Assignment||0
2613154|NCT00103285|6417363|P8|NOT COMPLETED|Induction||0
2613155|NCT00103285|6417364|P7|NOT COMPLETED|Induction||0
2613156|NCT00103285|6417365|P6|NOT COMPLETED|Induction||0
2613157|NCT00103285|6417366|P5|NOT COMPLETED|Induction||0
2613158|NCT00103285|6417367|P4|NOT COMPLETED|Induction||0
2613159|NCT00103285|6417368|P3|NOT COMPLETED|Induction||0
2613160|NCT00103285|6417369|P2|NOT COMPLETED|Induction||0
2613161|NCT00103285|6417370|P1|NOT COMPLETED|Induction||1349
2613162|NCT00103285|6417363|P8|COMPLETED|Induction||0
2613163|NCT00103285|6417364|P7|COMPLETED|Induction||0
2613164|NCT00103285|6417365|P6|COMPLETED|Induction||0
2613165|NCT00103285|6417366|P5|COMPLETED|Induction||0
2613166|NCT00103285|6417367|P4|COMPLETED|Induction||0
2613167|NCT00103285|6417368|P3|COMPLETED|Induction||0
2613168|NCT00103285|6417369|P2|COMPLETED|Induction||0
2613169|NCT00103285|6417370|P1|COMPLETED|Induction||4028
2613170|NCT00103285|6417363|P8|STARTED|Induction||0
2613171|NCT00103285|6417364|P7|STARTED|Induction||0
2613172|NCT00103285|6417365|P6|STARTED|Induction||0
2613173|NCT00103285|6417366|P5|STARTED|Induction||0
2613174|NCT00103285|6417367|P4|STARTED|Induction||0
2613175|NCT00103285|6417368|P3|STARTED|Induction||0
2613176|NCT00103285|6417369|P2|STARTED|Induction||0
2613177|NCT00103285|6417370|P1|STARTED|Induction||5377
2613178|NCT00103259|6417399|P2|NOT COMPLETED|Overall Study||12
2613179|NCT00103259|6417400|P1|NOT COMPLETED|Overall Study||12
2613180|NCT00103259|6417399|P2|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.This number is for stage I.|32
2613181|NCT00103259|6417400|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|15
2613182|NCT00103259|6417399|P2|Eligible Patients Who Cross Over|Overall Study||10
2613183|NCT00103259|6417400|P1|Eligible Patients Who Cross Over|Overall Study||0
2613184|NCT00103259|6417399|P2|Cross Over to the Other Arm|Overall Study|11 patients who progressed on bortezomib crossed over to Arm I. 10 of them were eligible|11
2613185|NCT00103259|6417400|P1|Cross Over to the Other Arm|Overall Study||0
2613186|NCT00103259|6417399|P2|Eligible and Treated|Overall Study||38
2613187|NCT00103259|6417400|P1|Eligible and Treated|Overall Study||23
2613188|NCT00103259|6417399|P2|Treated|Overall Study||41
2613189|NCT00103259|6417400|P1|Treated|Overall Study||23
2613190|NCT00103259|6417399|P2|Eligible|Overall Study||41
2613191|NCT00103259|6417400|P1|Eligible|Overall Study||27
2613192|NCT00103259|6417399|P2|STARTED|Overall Study||44
2613193|NCT00103259|6417400|P1|STARTED|Overall Study||27
2613194|NCT00103207|6417412|P1|NOT COMPLETED|Overall Study||38
2613195|NCT00103207|6417412|P1|COMPLETED|Overall Study||34
2613196|NCT00103207|6417412|P1|Eligible Patients w/ Smoking Status Data|Overall Study||37
2613197|NCT00103207|6417412|P1|Eligible Patients w/ Confirmed Diagnosis|Overall Study||41
2613198|NCT00103207|6417412|P1|STARTED|Overall Study||72
2613199|NCT00103194|6417422|P1|NOT COMPLETED|Overall Study||31
2613200|NCT00103194|6417422|P1|COMPLETED|Overall Study||18
2613201|NCT00103194|6417422|P1|Eligible and Treated|Overall Study||35
2613202|NCT00103194|6417422|P1|Eligible|Overall Study||35
2613203|NCT00103194|6417422|P1|Treated|Overall Study||49
2613204|NCT00103194|6417422|P1|STARTED|Overall Study||49
2613205|NCT00103142|6417431|P2|NOT COMPLETED|Overall Study||1
2613206|NCT00103142|6417432|P1|NOT COMPLETED|Overall Study||3
2613207|NCT00103142|6417431|P2|COMPLETED|Overall Study||36
2613208|NCT00103142|6417432|P1|COMPLETED|Overall Study||33
2613209|NCT00103142|6417431|P2|STARTED|Overall Study||37
2613210|NCT00103142|6417432|P1|STARTED|Overall Study||36
2613211|NCT00103116|6417440|P1|NOT COMPLETED|Overall Study||0
2613212|NCT00103116|6417440|P1|COMPLETED|Overall Study||32
2613213|NCT00103116|6417440|P1|STARTED|Overall Study||32
2613214|NCT00103012|6417448|P3|NOT COMPLETED|Overall Study||4
2613215|NCT00103012|6417449|P2|NOT COMPLETED|Overall Study||1
2613216|NCT00103012|6417450|P1|NOT COMPLETED|Overall Study||3
2613217|NCT00103012|6417448|P3|COMPLETED|Overall Study||12
2613218|NCT00103012|6417449|P2|COMPLETED|Overall Study||13
2613219|NCT00103012|6417450|P1|COMPLETED|Overall Study||14
2613220|NCT00103012|6417448|P3|STARTED|Overall Study||16
2613221|NCT00103012|6417449|P2|STARTED|Overall Study||14
2613222|NCT00103012|6417450|P1|STARTED|Overall Study||17
2613223|NCT00102960|6417461|P3|NOT COMPLETED|Overall Study||28
2613224|NCT00102960|6417462|P2|NOT COMPLETED|Overall Study||23
2613225|NCT00102960|6417463|P1|NOT COMPLETED|Overall Study||30
2613226|NCT00102960|6417461|P3|COMPLETED|Overall Study||98
2613227|NCT00102960|6417462|P2|COMPLETED|Overall Study||103
2613228|NCT00102960|6417463|P1|COMPLETED|Overall Study||95
2613229|NCT00102960|6417461|P3|STARTED|Overall Study||126
2613230|NCT00102960|6417462|P2|STARTED|Overall Study||126
2613231|NCT00102960|6417463|P1|STARTED|Overall Study||125
2613232|NCT00102804|6417512|P2|NOT COMPLETED|Overall Study||222
2613233|NCT00102804|6417513|P1|NOT COMPLETED|Overall Study||441
2613234|NCT00102804|6417512|P2|COMPLETED|Overall Study||0
2613235|NCT00102804|6417513|P1|COMPLETED|Overall Study||0
2613236|NCT00102804|6417512|P2|Received at Least 1 Dose of Study Drug|Overall Study|Four participants randomized to placebo received pemetrexed.|222
2613237|NCT00102804|6417513|P1|Received at Least 1 Dose of Study Drug|Overall Study||434
2613238|NCT00102804|6417512|P2|STARTED|Overall Study||222
2613239|NCT00102804|6417513|P1|STARTED|Overall Study||441
2613240|NCT00102687|6417534|P5|NOT COMPLETED|Maintenance Period||13
2613241|NCT00102687|6417535|P4|NOT COMPLETED|Maintenance Period||10
2613242|NCT00102687|6417536|P3|NOT COMPLETED|Maintenance Period||6
2613243|NCT00102687|6417537|P2|NOT COMPLETED|Maintenance Period||4
2613244|NCT00102687|6417538|P1|NOT COMPLETED|Maintenance Period||7
2613245|NCT00102687|6417534|P5|COMPLETED|Maintenance Period||8
2613246|NCT00102687|6417535|P4|COMPLETED|Maintenance Period||12
2613247|NCT00102687|6417536|P3|COMPLETED|Maintenance Period||2
2613248|NCT00102687|6417537|P2|COMPLETED|Maintenance Period||2
2613249|NCT00102687|6417538|P1|COMPLETED|Maintenance Period||6
2613250|NCT00102687|6417534|P5|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|21
2613251|NCT00102687|6417535|P4|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|22
2613252|NCT00102687|6417536|P3|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|8
2613253|NCT00102687|6417537|P2|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|6
2613254|NCT00102687|6417538|P1|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|13
2613255|NCT00102687|6417534|P5|NOT COMPLETED|Initial Period||0
2613256|NCT00102687|6417535|P4|NOT COMPLETED|Initial Period||0
2613257|NCT00102687|6417536|P3|NOT COMPLETED|Initial Period||26
2613258|NCT00102687|6417537|P2|NOT COMPLETED|Initial Period||28
2613259|NCT00102687|6417538|P1|NOT COMPLETED|Initial Period||18
2613260|NCT00102687|6417534|P5|COMPLETED|Initial Period||0
2613261|NCT00102687|6417535|P4|COMPLETED|Initial Period||0
2613262|NCT00102687|6417536|P3|COMPLETED|Initial Period||25
2613263|NCT00102687|6417537|P2|COMPLETED|Initial Period||22
2613264|NCT00102687|6417538|P1|COMPLETED|Initial Period||32
2613265|NCT00102687|6417534|P5|STARTED|Initial Period||0
2613266|NCT00102687|6417535|P4|STARTED|Initial Period||0
2613267|NCT00102687|6417536|P3|STARTED|Initial Period|3 randomized participants did not receive treatment.|51
2613268|NCT00102687|6417537|P2|STARTED|Initial Period||50
2613269|NCT00102687|6417538|P1|STARTED|Initial Period||50
2613270|NCT00102596|6417602|P2|NOT COMPLETED|Part C||0
2613271|NCT00102596|6417603|P1|NOT COMPLETED|Part C||0
2613272|NCT00102596|6417602|P2|COMPLETED|Part C||2
2613273|NCT00102596|6417603|P1|COMPLETED|Part C||0
2613274|NCT00102596|6417602|P2|STARTED|Part C|Only 2 patients participated in Part C|2
2613275|NCT00102596|6417603|P1|STARTED|Part C||0
2613276|NCT00102596|6417602|P2|NOT COMPLETED|Part B||0
2613277|NCT00102596|6417603|P1|NOT COMPLETED|Part B||0
2613278|NCT00102596|6417602|P2|COMPLETED|Part B||10
2613279|NCT00102596|6417603|P1|COMPLETED|Part B||0
2613280|NCT00102596|6417602|P2|STARTED|Part B||10
2613281|NCT00102596|6417603|P1|STARTED|Part B|Participants from Part A did not continue to Part B|0
2613282|NCT00102596|6417602|P2|NOT COMPLETED|Part A||0
2613283|NCT00102596|6417603|P1|NOT COMPLETED|Part A||7
2613284|NCT00102596|6417602|P2|COMPLETED|Part A||0
2613285|NCT00102596|6417603|P1|COMPLETED|Part A||4
2613286|NCT00102596|6417602|P2|Participants Assigned Treatment|Part A||0
2613287|NCT00102596|6417603|P1|Participants Assigned Treatment|Part A||5
2613288|NCT00102596|6417602|P2|STARTED|Part A||0
2613289|NCT00102596|6417603|P1|STARTED|Part A||11
2613290|NCT00102531|6417614|P2|NOT COMPLETED|Overall Study||11
2613291|NCT00102531|6417615|P1|NOT COMPLETED|Overall Study||5
2613292|NCT00102531|6417614|P2|COMPLETED|Overall Study||1
2613293|NCT00102531|6417615|P1|COMPLETED|Overall Study||2
2613294|NCT00102531|6417614|P2|STARTED|Overall Study||12
2613295|NCT00102531|6417615|P1|STARTED|Overall Study||7
2613296|NCT00102518|6417621|P1|NOT COMPLETED|Overall Study||87
2613297|NCT00102518|6417621|P1|COMPLETED|Overall Study||238
2613298|NCT00102518|6417621|P1|STARTED|Overall Study||325
2613299|NCT00102440|6417630|P3|NOT COMPLETED|Overall Study||66
2613300|NCT00102440|6417631|P2|NOT COMPLETED|Overall Study||98
2613301|NCT00102440|6417632|P1|NOT COMPLETED|Overall Study||88
2613302|NCT00102440|6417630|P3|COMPLETED|Overall Study||187
2613303|NCT00102440|6417631|P2|COMPLETED|Overall Study||153
2613304|NCT00102440|6417632|P1|COMPLETED|Overall Study||168
2613305|NCT00102440|6417630|P3|STARTED|Overall Study||253
2613306|NCT00102440|6417631|P2|STARTED|Overall Study||251
2613307|NCT00102440|6417632|P1|STARTED|Overall Study||256
2613308|NCT00102063|6417682|P3|NOT COMPLETED|Overall Study||10
2613309|NCT00102063|6417683|P2|NOT COMPLETED|Overall Study||18
2613310|NCT00102063|6417684|P1|NOT COMPLETED|Overall Study||16
2613311|NCT00102063|6417682|P3|COMPLETED|Overall Study||90
2613312|NCT00102063|6417683|P2|COMPLETED|Overall Study||84
2613313|NCT00102063|6417684|P1|COMPLETED|Overall Study||84
2613314|NCT00102063|6417682|P3|STARTED|Overall Study||100
2613315|NCT00102063|6417683|P2|STARTED|Overall Study||102
2613316|NCT00102063|6417684|P1|STARTED|Overall Study||100
2613317|NCT00101933|6417715|P2|NOT COMPLETED|Overall Study||0
2613318|NCT00101933|6417716|P1|NOT COMPLETED|Overall Study||0
2613319|NCT00101933|6417715|P2|COMPLETED|Overall Study||55
2613320|NCT00101933|6417716|P1|COMPLETED|Overall Study||54
2613321|NCT00101933|6417715|P2|STARTED|Overall Study||55
2613322|NCT00101933|6417716|P1|STARTED|Overall Study||54
2613323|NCT00101907|6417742|P6|NOT COMPLETED|Overall Study||0
2613324|NCT00101907|6417743|P5|NOT COMPLETED|Overall Study||5
2613325|NCT00101907|6417744|P4|NOT COMPLETED|Overall Study||1
2613326|NCT00101907|6417745|P3|NOT COMPLETED|Overall Study||1
2613327|NCT00101907|6417746|P2|NOT COMPLETED|Overall Study||1
2613328|NCT00101907|6417747|P1|NOT COMPLETED|Overall Study||2
2613329|NCT00101907|6417742|P6|COMPLETED|Overall Study||2
2613330|NCT00101907|6417743|P5|COMPLETED|Overall Study||6
2613331|NCT00101907|6417744|P4|COMPLETED|Overall Study||5
2613332|NCT00101907|6417745|P3|COMPLETED|Overall Study||5
2613333|NCT00101907|6417746|P2|COMPLETED|Overall Study||7
2613334|NCT00101907|6417747|P1|COMPLETED|Overall Study||6
2613335|NCT00101907|6417742|P6|STARTED|Overall Study||2
2613336|NCT00101907|6417743|P5|STARTED|Overall Study||11
2613337|NCT00101907|6417744|P4|STARTED|Overall Study||6
2613338|NCT00101907|6417745|P3|STARTED|Overall Study||6
2613339|NCT00101907|6417746|P2|STARTED|Overall Study||8
2613340|NCT00101907|6417747|P1|STARTED|Overall Study||8
2613341|NCT00101868|6417789|P2|NOT COMPLETED|Overall Study||32
2613342|NCT00101868|6417790|P1|NOT COMPLETED|Overall Study||29
2613343|NCT00101868|6417789|P2|COMPLETED|Overall Study|zero hospital physician with zero patients lost to follow up|283
2613344|NCT00101868|6417790|P1|COMPLETED|Overall Study|1 hospital physician with zero patients lost to follow up|287
2613345|NCT00101868|6417789|P2|STARTED|Overall Study|35 hospital physicians allocated to usual care discharge|315
2613346|NCT00101868|6417790|P1|STARTED|Overall Study|35 hospital physicians allocated to discharge software|316
2613347|NCT00101816|6417802|P2|NOT COMPLETED|Overall Study||0
2613348|NCT00101816|6417803|P1|NOT COMPLETED|Overall Study||0
2613349|NCT00101816|6417802|P2|COMPLETED|Overall Study||99
2613350|NCT00101816|6417803|P1|COMPLETED|Overall Study||10
2613351|NCT00101816|6417802|P2|STARTED|Overall Study||99
2613352|NCT00101816|6417803|P1|STARTED|Overall Study||10
2613353|NCT00101686|6417860|P10|NOT COMPLETED|Overall Study||30
2613354|NCT00101686|6417861|P9|NOT COMPLETED|Overall Study||30
2613355|NCT00101686|6417862|P8|NOT COMPLETED|Overall Study||30
2613356|NCT00101686|6417863|P7|NOT COMPLETED|Overall Study||27
2613357|NCT00101686|6417864|P6|NOT COMPLETED|Overall Study||72
2613358|NCT00101686|6417865|P5|NOT COMPLETED|Overall Study||73
2613359|NCT00101686|6417866|P4|NOT COMPLETED|Overall Study||72
2613360|NCT00101686|6417867|P3|NOT COMPLETED|Overall Study||69
2613361|NCT00101686|6417868|P2|NOT COMPLETED|Overall Study||73
2613362|NCT00101686|6417869|P1|NOT COMPLETED|Overall Study||71
2613363|NCT00101686|6417860|P10|COMPLETED|Overall Study|Patients treated until disease progression.|0
2613364|NCT00101686|6417861|P9|COMPLETED|Overall Study|Patients treated until disease progression.|0
2613365|NCT00101686|6417862|P8|COMPLETED|Overall Study|Patients treated until disease progression.|0
2613366|NCT00101686|6417863|P7|COMPLETED|Overall Study|Patients treated until disease progression.|0
2613367|NCT00101686|6417864|P6|COMPLETED|Overall Study|Patients treated until disease progression.|0
2613368|NCT00101686|6417865|P5|COMPLETED|Overall Study|Patients treated until disease progression.|0
2613369|NCT00101686|6417866|P4|COMPLETED|Overall Study|Patients treated until disease progression.|0
2613370|NCT00101686|6417867|P3|COMPLETED|Overall Study|Patients treated until disease progression.|0
2613371|NCT00101686|6417868|P2|COMPLETED|Overall Study|Patients treated until disease progression.|0
2613372|NCT00101686|6417869|P1|COMPLETED|Overall Study|Patients treated until disease progression.|0
2613373|NCT00101686|6417860|P10|Received Treatment|Overall Study||29
2613374|NCT00101686|6417861|P9|Received Treatment|Overall Study||30
2613375|NCT00101686|6417862|P8|Received Treatment|Overall Study||29
2613376|NCT00101686|6417863|P7|Received Treatment|Overall Study||27
2613377|NCT00101686|6417864|P6|Received Treatment|Overall Study||70
2613378|NCT00101686|6417865|P5|Received Treatment|Overall Study||71
2613379|NCT00101686|6417866|P4|Received Treatment|Overall Study||70
2613380|NCT00101686|6417867|P3|Received Treatment|Overall Study||67
2613381|NCT00101686|6417868|P2|Received Treatment|Overall Study||67
2613382|NCT00101686|6417869|P1|Received Treatment|Overall Study||70
2613383|NCT00101686|6417860|P10|STARTED|Overall Study||30
2613384|NCT00101686|6417861|P9|STARTED|Overall Study||30
2613385|NCT00101686|6417862|P8|STARTED|Overall Study||30
2613386|NCT00101686|6417863|P7|STARTED|Overall Study||27
2613387|NCT00101686|6417864|P6|STARTED|Overall Study||72
2613388|NCT00101686|6417865|P5|STARTED|Overall Study||73
2613389|NCT00101686|6417866|P4|STARTED|Overall Study||72
2613390|NCT00101686|6417867|P3|STARTED|Overall Study||69
2613391|NCT00101686|6417868|P2|STARTED|Overall Study||73
2613392|NCT00101686|6417869|P1|STARTED|Overall Study||71
2613393|NCT00101660|6417916|P2|NOT COMPLETED|Overall Study||0
2613394|NCT00101660|6417917|P1|NOT COMPLETED|Overall Study||0
2613395|NCT00101660|6417916|P2|COMPLETED|Overall Study||288
2613396|NCT00101660|6417917|P1|COMPLETED|Overall Study||99
2613397|NCT00101660|6417916|P2|STARTED|Overall Study||288
2613398|NCT00101660|6417917|P1|STARTED|Overall Study||99
2613399|NCT00101647|6417935|P2|NOT COMPLETED|Overall Study||0
2613400|NCT00101647|6417936|P1|NOT COMPLETED|Overall Study||0
2613401|NCT00101647|6417935|P2|COMPLETED|Overall Study||161
2613402|NCT00101647|6417936|P1|COMPLETED|Overall Study||13
2613403|NCT00101647|6417935|P2|STARTED|Overall Study|Randomized|161
2613404|NCT00101647|6417936|P1|STARTED|Overall Study|Randomized|13
2613405|NCT00101582|6417986|P2|NOT COMPLETED|Overall Study||15
2613406|NCT00101582|6417987|P1|NOT COMPLETED|Overall Study||11
2613407|NCT00101582|6417986|P2|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|79
2613408|NCT00101582|6417987|P1|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|83
2613409|NCT00101582|6417986|P2|Received Study Drug|Overall Study||94
2613410|NCT00101582|6417987|P1|Received Study Drug|Overall Study||91
2613411|NCT00101582|6417986|P2|STARTED|Overall Study||94
2613412|NCT00101582|6417987|P1|STARTED|Overall Study||94
2613413|NCT00101452|6418010|P3|NOT COMPLETED|Overall Study||43
2613414|NCT00101452|6418011|P2|NOT COMPLETED|Overall Study||43
2613415|NCT00101452|6418012|P1|NOT COMPLETED|Overall Study||44
2613416|NCT00101452|6418010|P3|COMPLETED|Overall Study||22
2613417|NCT00101452|6418011|P2|COMPLETED|Overall Study||26
2613418|NCT00101452|6418012|P1|COMPLETED|Overall Study||21
2613419|NCT00101452|6418010|P3|STARTED|Overall Study||65
2613420|NCT00101452|6418011|P2|STARTED|Overall Study||69
2613421|NCT00101452|6418012|P1|STARTED|Overall Study||65
2613422|NCT00101439|6418026|P2|NOT COMPLETED|Period 2||2
2613423|NCT00101439|6418027|P1|NOT COMPLETED|Period 2||0
2613424|NCT00101439|6418026|P2|COMPLETED|Period 2||28
2613425|NCT00101439|6418027|P1|COMPLETED|Period 2||28
2613426|NCT00101439|6418026|P2|STARTED|Period 2||30
2613427|NCT00101439|6418027|P1|STARTED|Period 2||28
2613428|NCT00101439|6418026|P2|NOT COMPLETED|Period 1||0
2613429|NCT00101439|6418027|P1|NOT COMPLETED|Period 1||0
2613430|NCT00101439|6418026|P2|COMPLETED|Period 1||30
2613431|NCT00101439|6418027|P1|COMPLETED|Period 1||28
2613432|NCT00101439|6418026|P2|STARTED|Period 1||30
2613433|NCT00101439|6418027|P1|STARTED|Period 1||28
2613434|NCT00101413|6418035|P1|NOT COMPLETED|Overall Study||0
2613435|NCT00101413|6418035|P1|COMPLETED|Overall Study|Safety data collected for 4 subjects after 30 Jun 2005 until 11 Apr 2008.|52
2613436|NCT00101413|6418035|P1|STARTED|Overall Study||52
2613437|NCT00101400|6418043|P1|NOT COMPLETED|Survival Follow-Up||7
2613438|NCT00101400|6418043|P1|COMPLETED|Survival Follow-Up|44 subjects reached endpoint (death); 7 subjects were still alive|44
2613439|NCT00101400|6418043|P1|STARTED|Survival Follow-Up|3 subjects died during previous period (completion as defined in protocol)|51
2613440|NCT00101400|6418043|P1|NOT COMPLETED|Treatment||0
2613441|NCT00101400|6418043|P1|COMPLETED|Treatment|Reasons for treatment termination: 4 Adverse Events, 3 Deaths, 46 Progression, 1 Withdrawal.|54
2613442|NCT00101400|6418043|P1|STARTED|Treatment|Treated until disease progression, unacceptable sorafenib-related toxicity or withdrawal of consent.|54
2613443|NCT00101361|6418054|P2|NOT COMPLETED|Overall Study||0
2613444|NCT00101361|6418055|P1|NOT COMPLETED|Overall Study||0
2613445|NCT00101361|6418054|P2|COMPLETED|Overall Study||104
2613446|NCT00101361|6418055|P1|COMPLETED|Overall Study||108
2613447|NCT00101361|6418054|P2|STARTED|Overall Study||104
2613448|NCT00101361|6418055|P1|STARTED|Overall Study||108
2613449|NCT00101283|6418063|P2|NOT COMPLETED|Overall Study||3
2613450|NCT00101283|6418064|P1|NOT COMPLETED|Overall Study||0
2613451|NCT00101283|6418063|P2|COMPLETED|Overall Study||13
2613452|NCT00101283|6418064|P1|COMPLETED|Overall Study||16
2613453|NCT00101283|6418063|P2|Began Treatment|Overall Study||13
2613454|NCT00101283|6418064|P1|Began Treatment|Overall Study||16
2613455|NCT00101283|6418063|P2|STARTED|Overall Study||16
2613456|NCT00101283|6418064|P1|STARTED|Overall Study||16
2613457|NCT00101192|6418074|P1|NOT COMPLETED|Overall Study||7
2613458|NCT00101192|6418074|P1|COMPLETED|Overall Study||69
2613459|NCT00101192|6418074|P1|STARTED|Overall Study||76
2613460|NCT00101166|6418078|P1|NOT COMPLETED|Overall Study||10
2613461|NCT00101166|6418078|P1|COMPLETED|Overall Study||18
2613462|NCT00101166|6418078|P1|STARTED|Overall Study||28
2613463|NCT00101101|6418086|P1|NOT COMPLETED|Overall Study||20
2613464|NCT00101101|6418086|P1|COMPLETED|Overall Study|Participants who received at least one vaccine injection.|23
2613465|NCT00101101|6418086|P1|STARTED|Overall Study||43
2613466|NCT00101036|6418094|P2|NOT COMPLETED|Overall Study||0
2613467|NCT00101036|6418095|P1|NOT COMPLETED|Overall Study||0
2613468|NCT00101036|6418094|P2|COMPLETED|Overall Study||40
2613469|NCT00101036|6418095|P1|COMPLETED|Overall Study||17
2613470|NCT00101036|6418094|P2|STARTED|Overall Study||40
2613471|NCT00101036|6418095|P1|STARTED|Overall Study||17
2613472|NCT00100932|6418109|P2|NOT COMPLETED|Overall Study||27
2613473|NCT00100932|6418110|P1|NOT COMPLETED|Overall Study||73
2613474|NCT00100932|6418109|P2|COMPLETED|Overall Study||1
2613475|NCT00100932|6418110|P1|COMPLETED|Overall Study||5
2613476|NCT00100932|6418109|P2|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|28
2613477|NCT00100932|6418110|P1|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|78
2613478|NCT00100841|6418120|P1|NOT COMPLETED|Overall Study||0
2613479|NCT00100841|6418120|P1|COMPLETED|Overall Study||66
2613480|NCT00100841|6418120|P1|STARTED|Overall Study||66
2613481|NCT00100828|6418125|P1|NOT COMPLETED|Overall Study||6
2613482|NCT00100828|6418125|P1|COMPLETED|Overall Study||0
2613483|NCT00100828|6418125|P1|STARTED|Overall Study||6
2613484|NCT00100815|6418129|P1|NOT COMPLETED|Overall Study||49
2613485|NCT00100815|6418129|P1|COMPLETED|Overall Study||1
2613486|NCT00100815|6418129|P1|STARTED|Overall Study||50
2613487|NCT00100802|6418137|P1|NOT COMPLETED|Overall Study||80
2613488|NCT00100802|6418137|P1|COMPLETED|Overall Study||38
2613489|NCT00100802|6418137|P1|STARTED|Overall Study||118
2613490|NCT00100789|6418142|P1|NOT COMPLETED|Overall Study||64
2613491|NCT00100789|6418142|P1|COMPLETED|Overall Study||3
2613492|NCT00100789|6418142|P1|Eligible and Began Protocol Therapy|Overall Study||63
2613493|NCT00100789|6418142|P1|Eligible|Overall Study||64
2613494|NCT00100789|6418142|P1|STARTED|Overall Study||67
2613495|NCT00100698|6418151|P2|NOT COMPLETED|Overall Study||2
2613496|NCT00100698|6418152|P1|NOT COMPLETED|Overall Study||6
2613497|NCT00100698|6418151|P2|COMPLETED|Overall Study||27
2613498|NCT00100698|6418152|P1|COMPLETED|Overall Study||21
2613499|NCT00100698|6418151|P2|STARTED|Overall Study||29
2613500|NCT00100698|6418152|P1|STARTED|Overall Study||27
2613501|NCT00100659|6418194|P2|NOT COMPLETED|Overall Study||2
2613502|NCT00100659|6418195|P1|NOT COMPLETED|Overall Study||3
2613503|NCT00100659|6418194|P2|COMPLETED|Overall Study||57
2613504|NCT00100659|6418195|P1|COMPLETED|Overall Study||52
2613505|NCT00100659|6418194|P2|STARTED|Overall Study||59
2613506|NCT00100659|6418195|P1|STARTED|Overall Study||55
2613507|NCT00100230|6418205|P2|NOT COMPLETED|Overall Study||15
2613508|NCT00100230|6418206|P1|NOT COMPLETED|Overall Study||12
2613509|NCT00100230|6418205|P2|COMPLETED|Overall Study||22
2613510|NCT00100230|6418206|P1|COMPLETED|Overall Study||29
2613511|NCT00100230|6418205|P2|STARTED|Overall Study||37
2613512|NCT00100230|6418206|P1|STARTED|Overall Study||41
2613513|NCT00100178|6418219|P3|NOT COMPLETED|Overall Study||10
2613514|NCT00100178|6418220|P2|NOT COMPLETED|Overall Study||10
2613515|NCT00100178|6418221|P1|NOT COMPLETED|Overall Study||9
2613516|NCT00100178|6418219|P3|COMPLETED|Overall Study||32
2613517|NCT00100178|6418220|P2|COMPLETED|Overall Study||21
2613518|NCT00100178|6418221|P1|COMPLETED|Overall Study||32
2613519|NCT00100178|6418219|P3|STARTED|Overall Study||42
2613520|NCT00100178|6418220|P2|STARTED|Overall Study|12 subjects randomized to the MMF alone group were excluded from analysis due to randomization error|31
2613521|NCT00100178|6418221|P1|STARTED|Overall Study||41
2613522|NCT00100165|6418232|P3|NOT COMPLETED|Third Intervention (4 Weeks)||0
2613523|NCT00100165|6418233|P2|NOT COMPLETED|Third Intervention (4 Weeks)||0
2613524|NCT00100165|6418234|P1|NOT COMPLETED|Third Intervention (4 Weeks)||0
2613525|NCT00100165|6418232|P3|COMPLETED|Third Intervention (4 Weeks)||9
2613526|NCT00100165|6418233|P2|COMPLETED|Third Intervention (4 Weeks)||10
2613527|NCT00100165|6418234|P1|COMPLETED|Third Intervention (4 Weeks)||10
2613528|NCT00100165|6418232|P3|STARTED|Third Intervention (4 Weeks)||9
2613529|NCT00100165|6418233|P2|STARTED|Third Intervention (4 Weeks)||10
2613530|NCT00100165|6418234|P1|STARTED|Third Intervention (4 Weeks)||10
2613531|NCT00100165|6418232|P3|NOT COMPLETED|Washout (1 Week)||0
2613532|NCT00100165|6418233|P2|NOT COMPLETED|Washout (1 Week)||0
2613533|NCT00100165|6418234|P1|NOT COMPLETED|Washout (1 Week)||0
2613534|NCT00100165|6418232|P3|COMPLETED|Washout (1 Week)||9
2613535|NCT00100165|6418233|P2|COMPLETED|Washout (1 Week)||10
2613536|NCT00100165|6418234|P1|COMPLETED|Washout (1 Week)||10
2613537|NCT00100165|6418232|P3|STARTED|Washout (1 Week)||9
2613538|NCT00100165|6418233|P2|STARTED|Washout (1 Week)||10
2613539|NCT00100165|6418234|P1|STARTED|Washout (1 Week)||10
2613540|NCT00100165|6418232|P3|NOT COMPLETED|Second Intervention (4 Weeks)||0
2613541|NCT00100165|6418233|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
2613542|NCT00100165|6418234|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
2613543|NCT00100165|6418232|P3|COMPLETED|Second Intervention (4 Weeks)||9
2613544|NCT00100165|6418233|P2|COMPLETED|Second Intervention (4 Weeks)||10
2613545|NCT00100165|6418234|P1|COMPLETED|Second Intervention (4 Weeks)||10
2613546|NCT00100165|6418232|P3|STARTED|Second Intervention (4 Weeks)||9
2613547|NCT00100165|6418233|P2|STARTED|Second Intervention (4 Weeks)||10
2613548|NCT00100165|6418234|P1|STARTED|Second Intervention (4 Weeks)||10
2613549|NCT00100165|6418232|P3|NOT COMPLETED|Washout (1 Week)||0
2613550|NCT00100165|6418233|P2|NOT COMPLETED|Washout (1 Week)||0
2613551|NCT00100165|6418234|P1|NOT COMPLETED|Washout (1 Week)||0
2613552|NCT00100165|6418232|P3|COMPLETED|Washout (1 Week)||9
2613553|NCT00100165|6418233|P2|COMPLETED|Washout (1 Week)||10
2613554|NCT00100165|6418234|P1|COMPLETED|Washout (1 Week)||10
2613555|NCT00100165|6418232|P3|STARTED|Washout (1 Week)||9
2613556|NCT00100165|6418233|P2|STARTED|Washout (1 Week)||10
2613557|NCT00100165|6418234|P1|STARTED|Washout (1 Week)||10
2613558|NCT00100165|6418232|P3|NOT COMPLETED|First Intervention (4 Weeks)||0
2613559|NCT00100165|6418233|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
2613560|NCT00100165|6418234|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
2613561|NCT00100165|6418232|P3|COMPLETED|First Intervention (4 Weeks)||9
2613562|NCT00100165|6418233|P2|COMPLETED|First Intervention (4 Weeks)||10
2613563|NCT00100165|6418234|P1|COMPLETED|First Intervention (4 Weeks)||10
2613564|NCT00100165|6418232|P3|STARTED|First Intervention (4 Weeks)||9
2613565|NCT00100165|6418233|P2|STARTED|First Intervention (4 Weeks)||10
2613566|NCT00100165|6418234|P1|STARTED|First Intervention (4 Weeks)||10
2613567|NCT00100165|6418232|P3|NOT COMPLETED|Baseline||0
2613568|NCT00100165|6418233|P2|NOT COMPLETED|Baseline||0
2613569|NCT00100165|6418234|P1|NOT COMPLETED|Baseline||0
2613570|NCT00100165|6418232|P3|COMPLETED|Baseline||9
2613571|NCT00100165|6418233|P2|COMPLETED|Baseline||10
2613572|NCT00100165|6418234|P1|COMPLETED|Baseline||10
2613573|NCT00100165|6418232|P3|STARTED|Baseline||9
2613574|NCT00100165|6418233|P2|STARTED|Baseline||10
2613575|NCT00100165|6418234|P1|STARTED|Baseline||10
2613576|NCT00100048|6418250|P6|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
2613577|NCT00100048|6418251|P5|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||0
2613578|NCT00100048|6418252|P4|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||10
2613579|NCT00100048|6418253|P3|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
2613580|NCT00100048|6418254|P2|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||9
2613581|NCT00100048|6418255|P1|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||14
2613582|NCT00100048|6418250|P6|COMPLETED|Cohort I & II-Combination Therapy Phase||26
2613583|NCT00100048|6418251|P5|COMPLETED|Cohort I & II-Combination Therapy Phase||0
2613584|NCT00100048|6418252|P4|COMPLETED|Cohort I & II-Combination Therapy Phase||30
2613585|NCT00100048|6418253|P3|COMPLETED|Cohort I & II-Combination Therapy Phase||28
2613586|NCT00100048|6418254|P2|COMPLETED|Cohort I & II-Combination Therapy Phase||31
2613587|NCT00100048|6418255|P1|COMPLETED|Cohort I & II-Combination Therapy Phase||27
2613588|NCT00100048|6418250|P6|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|1
2613589|NCT00100048|6418251|P5|Never Treated|Cohort I & II-Combination Therapy Phase||0
2613590|NCT00100048|6418252|P4|Never Treated|Cohort I & II-Combination Therapy Phase||0
2613591|NCT00100048|6418253|P3|Never Treated|Cohort I & II-Combination Therapy Phase||0
2613592|NCT00100048|6418254|P2|Never Treated|Cohort I & II-Combination Therapy Phase||0
2613593|NCT00100048|6418255|P1|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|2
2613594|NCT00100048|6418250|P6|Treated|Cohort I & II-Combination Therapy Phase||38
2613595|NCT00100048|6418251|P5|Treated|Cohort I & II-Combination Therapy Phase||0
2613596|NCT00100048|6418252|P4|Treated|Cohort I & II-Combination Therapy Phase||40
2613597|NCT00100048|6418253|P3|Treated|Cohort I & II-Combination Therapy Phase||41
2613598|NCT00100048|6418254|P2|Treated|Cohort I & II-Combination Therapy Phase||40
2613599|NCT00100048|6418255|P1|Treated|Cohort I & II-Combination Therapy Phase||39
2613600|NCT00100048|6418250|P6|STARTED|Cohort I & II-Combination Therapy Phase|4 subjects from the Monotherapy Phase (Placebo)and 35 new subjects|39
2613601|NCT00100048|6418251|P5|STARTED|Cohort I & II-Combination Therapy Phase|participants only assigned Placebo in Cohort I-Monotherapy Phase.|0
2613602|NCT00100048|6418252|P4|STARTED|Cohort I & II-Combination Therapy Phase|8 subjects from the Monotherapy Phase and 32 new subjects|40
2613603|NCT00100048|6418253|P3|STARTED|Cohort I & II-Combination Therapy Phase|6 subjects from the Monotherapy Phase and 35 new subjects|41
2613604|NCT00100048|6418254|P2|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 33 new subjects|40
2613605|NCT00100048|6418255|P1|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 34 new subjects|41
2613606|NCT00100048|6418250|P6|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
2613607|NCT00100048|6418251|P5|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
2613608|NCT00100048|6418252|P4|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
2613609|NCT00100048|6418253|P3|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
2613610|NCT00100048|6418254|P2|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
2613611|NCT00100048|6418255|P1|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
2613612|NCT00100048|6418250|P6|COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
2613613|NCT00100048|6418251|P5|COMPLETED|Cohort I-Monotherapy Phase 10 Days|4 Subjects Continued to Cohort II, as part of the Efavirenz 600 mg q.d. arm|7
2613614|NCT00100048|6418252|P4|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|8
2613615|NCT00100048|6418253|P3|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|6
2613616|NCT00100048|6418254|P2|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
2613617|NCT00100048|6418255|P1|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
2613618|NCT00100048|6418250|P6|Treated|Cohort I-Monotherapy Phase 10 Days||0
2613619|NCT00100048|6418251|P5|Treated|Cohort I-Monotherapy Phase 10 Days||7
2613620|NCT00100048|6418252|P4|Treated|Cohort I-Monotherapy Phase 10 Days||8
2613621|NCT00100048|6418253|P3|Treated|Cohort I-Monotherapy Phase 10 Days||6
2613622|NCT00100048|6418254|P2|Treated|Cohort I-Monotherapy Phase 10 Days||7
2613623|NCT00100048|6418255|P1|Treated|Cohort I-Monotherapy Phase 10 Days||7
2613624|NCT00100048|6418250|P6|STARTED|Cohort I-Monotherapy Phase 10 Days|participants only assigned Efavirenz 600 mg q.h.s in Cohort II Combined-Combination Therapy Phase|0
2613625|NCT00100048|6418251|P5|STARTED|Cohort I-Monotherapy Phase 10 Days||7
2613626|NCT00100048|6418252|P4|STARTED|Cohort I-Monotherapy Phase 10 Days||8
2613627|NCT00100048|6418253|P3|STARTED|Cohort I-Monotherapy Phase 10 Days||6
2613628|NCT00100048|6418254|P2|STARTED|Cohort I-Monotherapy Phase 10 Days||7
2613629|NCT00100048|6418255|P1|STARTED|Cohort I-Monotherapy Phase 10 Days||7
2613630|NCT00099983|6418364|P2|NOT COMPLETED|Overall Study||25
2613631|NCT00099983|6418365|P1|NOT COMPLETED|Overall Study||24
2613632|NCT00099983|6418364|P2|COMPLETED|Overall Study||124
2613633|NCT00099983|6418365|P1|COMPLETED|Overall Study||123
2613634|NCT00099983|6418364|P2|STARTED|Overall Study||149
2613635|NCT00099983|6418365|P1|STARTED|Overall Study||147
2613636|NCT00099632|6418377|P6|NOT COMPLETED|Overall Study||2
2613637|NCT00099632|6418378|P5|NOT COMPLETED|Overall Study||1
2613638|NCT00099632|6418379|P4|NOT COMPLETED|Overall Study||1
2613639|NCT00099632|6418380|P3|NOT COMPLETED|Overall Study||3
2613640|NCT00099632|6418381|P2|NOT COMPLETED|Overall Study||1
2613641|NCT00099632|6418382|P1|NOT COMPLETED|Overall Study||1
2613642|NCT00099632|6418377|P6|COMPLETED|Overall Study||66
2613643|NCT00099632|6418378|P5|COMPLETED|Overall Study||70
2613644|NCT00099632|6418379|P4|COMPLETED|Overall Study||66
2613645|NCT00099632|6418380|P3|COMPLETED|Overall Study||72
2613646|NCT00099632|6418381|P2|COMPLETED|Overall Study||67
2613647|NCT00099632|6418382|P1|COMPLETED|Overall Study||72
2613648|NCT00099632|6418377|P6|STARTED|Overall Study||68
2613649|NCT00099632|6418378|P5|STARTED|Overall Study||71
2613650|NCT00099632|6418379|P4|STARTED|Overall Study||67
2613651|NCT00099632|6418380|P3|STARTED|Overall Study||75
2613652|NCT00099632|6418381|P2|STARTED|Overall Study||68
2613653|NCT00099632|6418382|P1|STARTED|Overall Study||73
2613654|NCT00099437|6418422|P2|NOT COMPLETED|Overall Study||349
2613655|NCT00099437|6418423|P1|NOT COMPLETED|Overall Study||366
2613656|NCT00099437|6418422|P2|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|13
2613657|NCT00099437|6418423|P1|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|8
2613658|NCT00099437|6418422|P2|STARTED|Overall Study|randomised patients|362
2613659|NCT00099437|6418423|P1|STARTED|Overall Study|randomised patients|374
2613660|NCT00099359|6418446|P3|NOT COMPLETED|Overall Study||68
2613661|NCT00099359|6418447|P2|NOT COMPLETED|Overall Study||65
2613662|NCT00099359|6418448|P1|NOT COMPLETED|Overall Study||54
2613663|NCT00099359|6418446|P3|COMPLETED|Overall Study||506
2613664|NCT00099359|6418447|P2|COMPLETED|Overall Study||515
2613665|NCT00099359|6418448|P1|COMPLETED|Overall Study||527
2613666|NCT00099359|6418446|P3|STARTED|Overall Study||574
2613667|NCT00099359|6418447|P2|STARTED|Overall Study||580
2613668|NCT00099359|6418448|P1|STARTED|Overall Study||581
2613669|NCT00099268|6418471|P2|NOT COMPLETED|Overall Study||82
2613670|NCT00099268|6418472|P1|NOT COMPLETED|Overall Study||92
2613671|NCT00099268|6418471|P2|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa group within 30 days of treatment discontinuation|291
2613672|NCT00099268|6418472|P1|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa/entacapone group within 30 days of treatment discontinuation|282
2613673|NCT00099268|6418471|P2|Intent-to-Treat|Overall Study||372
2613674|NCT00099268|6418472|P1|Intent-to-Treat|Overall Study|One patient from each group discontinued without receiving a single dose of study drug.|373
2613675|NCT00099268|6418471|P2|STARTED|Overall Study||373
2613676|NCT00099268|6418472|P1|STARTED|Overall Study||374
2613677|NCT00099047|6418490|P2|NOT COMPLETED|Overall Study||0
2613678|NCT00099047|6418491|P1|NOT COMPLETED|Overall Study||0
2613679|NCT00099047|6418490|P2|COMPLETED|Overall Study||12
2613680|NCT00099047|6418491|P1|COMPLETED|Overall Study||11
2613681|NCT00099047|6418490|P2|STARTED|Overall Study||12
2613682|NCT00099047|6418491|P1|STARTED|Overall Study||11
2613683|NCT00099021|6418497|P1|NOT COMPLETED|Overall Study||0
2613684|NCT00099021|6418497|P1|COMPLETED|Overall Study||21
2613685|NCT00099021|6418497|P1|STARTED|Overall Study||21
2613686|NCT00098956|6418503|P1|NOT COMPLETED|Overall Study||0
2613687|NCT00098956|6418503|P1|COMPLETED|Overall Study||19
2613688|NCT00098956|6418503|P1|STARTED|Overall Study||19
2613689|NCT00098865|6418512|P1|NOT COMPLETED|Overall Study||9
2613690|NCT00098865|6418512|P1|COMPLETED|Overall Study||6
2613691|NCT00098865|6418512|P1|STARTED|Overall Study||15
2613692|NCT00098839|6418520|P2|NOT COMPLETED|Overall Study||33
2613693|NCT00098839|6418521|P1|NOT COMPLETED|Overall Study||32
2613694|NCT00098839|6418520|P2|COMPLETED|Overall Study||27
2613695|NCT00098839|6418521|P1|COMPLETED|Overall Study||24
2613696|NCT00098839|6418520|P2|STARTED|Overall Study||60
2613697|NCT00098839|6418521|P1|STARTED|Overall Study||56
2613698|NCT00098813|6418532|P1|NOT COMPLETED|Overall Study||19
2613699|NCT00098813|6418532|P1|COMPLETED|Overall Study||1
2613700|NCT00098813|6418532|P1|STARTED|Overall Study||20
2613701|NCT00098787|6418539|P3|NOT COMPLETED|Overall Study||63
2613702|NCT00098787|6418540|P2|NOT COMPLETED|Overall Study||75
2613703|NCT00098787|6418541|P1|NOT COMPLETED|Overall Study||73
2613704|NCT00098787|6418539|P3|COMPLETED|Overall Study||0
2613705|NCT00098787|6418540|P2|COMPLETED|Overall Study||0
2613706|NCT00098787|6418541|P1|COMPLETED|Overall Study||0
2613707|NCT00098787|6418539|P3|Eligible and Treated|Overall Study||59
2613708|NCT00098787|6418540|P2|Eligible and Treated|Overall Study||66
2613709|NCT00098787|6418541|P1|Eligible and Treated|Overall Study||61
2613710|NCT00098787|6418539|P3|Treated|Overall Study||62
2613711|NCT00098787|6418540|P2|Treated|Overall Study||73
2613712|NCT00098787|6418541|P1|Treated|Overall Study||70
2613713|NCT00098787|6418539|P3|STARTED|Overall Study||63
2613714|NCT00098787|6418540|P2|STARTED|Overall Study||75
2613715|NCT00098787|6418541|P1|STARTED|Overall Study||73
2613716|NCT00098774|6418555|P1|NOT COMPLETED|Overall Study||18
2613717|NCT00098774|6418555|P1|COMPLETED|Overall Study||26
2613718|NCT00098774|6418555|P1|STARTED|Overall Study||44
2613719|NCT00098748|6418565|P3|NOT COMPLETED|Continued on Open-Label Treatment||0
2613720|NCT00098748|6418566|P2|NOT COMPLETED|Continued on Open-Label Treatment||15
2613721|NCT00098748|6418567|P1|NOT COMPLETED|Continued on Open-Label Treatment||8
2613722|NCT00098748|6418565|P3|COMPLETED|Continued on Open-Label Treatment||0
2613723|NCT00098748|6418566|P2|COMPLETED|Continued on Open-Label Treatment||10
2613724|NCT00098748|6418567|P1|COMPLETED|Continued on Open-Label Treatment||7
2613725|NCT00098748|6418565|P3|STARTED|Continued on Open-Label Treatment|Placebo group not offered open-label maraviroc due to study not reaching primary endpoint at Week 24|0
2613726|NCT00098748|6418566|P2|STARTED|Continued on Open-Label Treatment||25
2613727|NCT00098748|6418567|P1|STARTED|Continued on Open-Label Treatment||15
2613728|NCT00098748|6418565|P3|NOT COMPLETED|Received Study Treatment||44
2613729|NCT00098748|6418566|P2|NOT COMPLETED|Received Study Treatment||36
2613730|NCT00098748|6418567|P1|NOT COMPLETED|Received Study Treatment||48
2613731|NCT00098748|6418565|P3|COMPLETED|Received Study Treatment||18
2613732|NCT00098748|6418566|P2|COMPLETED|Received Study Treatment||25
2613733|NCT00098748|6418567|P1|COMPLETED|Received Study Treatment||15
2613734|NCT00098748|6418565|P3|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||58
2613735|NCT00098748|6418566|P2|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||52
2613736|NCT00098748|6418567|P1|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment|Dual-tropic: Virus capable of using both CCR5 and CXCR4 coreceptors for cell entry.|57
2613737|NCT00098748|6418565|P3|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, Placebo = 61 subjects in Adverse event tables.|62
2613738|NCT00098748|6418566|P2|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, BID = 62 subjects in Adverse event tables.|61
2613739|NCT00098748|6418567|P1|STARTED|Received Study Treatment||63
2613740|NCT00098748|6418565|P3|NOT COMPLETED|Assigned to Study Treatment||2
2613741|NCT00098748|6418566|P2|NOT COMPLETED|Assigned to Study Treatment||2
2613742|NCT00098748|6418567|P1|NOT COMPLETED|Assigned to Study Treatment||0
2613743|NCT00098748|6418565|P3|COMPLETED|Assigned to Study Treatment||62
2613744|NCT00098748|6418566|P2|COMPLETED|Assigned to Study Treatment||61
2613745|NCT00098748|6418567|P1|COMPLETED|Assigned to Study Treatment||63
2613746|NCT00098748|6418565|P3|STARTED|Assigned to Study Treatment||64
2613747|NCT00098748|6418566|P2|STARTED|Assigned to Study Treatment||63
2613748|NCT00098748|6418567|P1|STARTED|Assigned to Study Treatment||63
2613749|NCT00098722|6418623|P7|NOT COMPLETED|Observation Phase||17
2613750|NCT00098722|6418624|P6|NOT COMPLETED|Observation Phase||45
2613751|NCT00098722|6418625|P5|NOT COMPLETED|Observation Phase||0
2613752|NCT00098722|6418626|P4|NOT COMPLETED|Observation Phase||0
2613753|NCT00098722|6418627|P3|NOT COMPLETED|Observation Phase||0
2613754|NCT00098722|6418628|P2|NOT COMPLETED|Observation Phase||0
2613755|NCT00098722|6418629|P1|NOT COMPLETED|Observation Phase||0
2613756|NCT00098722|6418623|P7|COMPLETED|Observation Phase||48
2613757|NCT00098722|6418624|P6|COMPLETED|Observation Phase||160
2613758|NCT00098722|6418625|P5|COMPLETED|Observation Phase||0
2613759|NCT00098722|6418626|P4|COMPLETED|Observation Phase||0
2613760|NCT00098722|6418627|P3|COMPLETED|Observation Phase||0
2613761|NCT00098722|6418628|P2|COMPLETED|Observation Phase||0
2613762|NCT00098722|6418629|P1|COMPLETED|Observation Phase||0
2613763|NCT00098722|6418623|P7|STARTED|Observation Phase||65
2613764|NCT00098722|6418624|P6|STARTED|Observation Phase||205
2613765|NCT00098722|6418625|P5|STARTED|Observation Phase||0
2613766|NCT00098722|6418626|P4|STARTED|Observation Phase||0
2613767|NCT00098722|6418627|P3|STARTED|Observation Phase||0
2613768|NCT00098722|6418628|P2|STARTED|Observation Phase||0
2613769|NCT00098722|6418629|P1|STARTED|Observation Phase||0
2613770|NCT00098722|6418623|P7|NOT COMPLETED|Open Label Phase||0
2613771|NCT00098722|6418624|P6|NOT COMPLETED|Open Label Phase||0
2613772|NCT00098722|6418625|P5|NOT COMPLETED|Open Label Phase||50
2613773|NCT00098722|6418626|P4|NOT COMPLETED|Open Label Phase||272
2613774|NCT00098722|6418627|P3|NOT COMPLETED|Open Label Phase||0
2613775|NCT00098722|6418628|P2|NOT COMPLETED|Open Label Phase||0
2613776|NCT00098722|6418629|P1|NOT COMPLETED|Open Label Phase||0
2613777|NCT00098722|6418623|P7|COMPLETED|Open Label Phase||0
2613778|NCT00098722|6418624|P6|COMPLETED|Open Label Phase||0
2613779|NCT00098722|6418625|P5|COMPLETED|Open Label Phase||0
2613780|NCT00098722|6418626|P4|COMPLETED|Open Label Phase||0
2613781|NCT00098722|6418627|P3|COMPLETED|Open Label Phase||0
2613782|NCT00098722|6418628|P2|COMPLETED|Open Label Phase||0
2613783|NCT00098722|6418629|P1|COMPLETED|Open Label Phase||0
2613784|NCT00098722|6418623|P7|STARTED|Open Label Phase||0
2613785|NCT00098722|6418624|P6|STARTED|Open Label Phase||0
2613786|NCT00098722|6418625|P5|STARTED|Open Label Phase||50
2613787|NCT00098722|6418626|P4|STARTED|Open Label Phase||272
2613788|NCT00098722|6418627|P3|STARTED|Open Label Phase||0
2613789|NCT00098722|6418628|P2|STARTED|Open Label Phase||0
2613790|NCT00098722|6418629|P1|STARTED|Open Label Phase||0
2613791|NCT00098722|6418623|P7|NOT COMPLETED|Double Blind Phase||0
2613792|NCT00098722|6418624|P6|NOT COMPLETED|Double Blind Phase||0
2613793|NCT00098722|6418625|P5|NOT COMPLETED|Double Blind Phase||0
2613794|NCT00098722|6418626|P4|NOT COMPLETED|Double Blind Phase||0
2613795|NCT00098722|6418627|P3|NOT COMPLETED|Double Blind Phase||94
2613796|NCT00098722|6418628|P2|NOT COMPLETED|Double Blind Phase||194
2613797|NCT00098722|6418629|P1|NOT COMPLETED|Double Blind Phase||186
2613798|NCT00098722|6418623|P7|COMPLETED|Double Blind Phase||0
2613799|NCT00098722|6418624|P6|COMPLETED|Double Blind Phase||0
2613800|NCT00098722|6418625|P5|COMPLETED|Double Blind Phase||0
2613801|NCT00098722|6418626|P4|COMPLETED|Double Blind Phase||0
2613802|NCT00098722|6418627|P3|COMPLETED|Double Blind Phase||0
2613803|NCT00098722|6418628|P2|COMPLETED|Double Blind Phase||0
2613804|NCT00098722|6418629|P1|COMPLETED|Double Blind Phase||0
2613805|NCT00098722|6418623|P7|Treated|Double Blind Phase||0
2613806|NCT00098722|6418624|P6|Treated|Double Blind Phase||0
2613807|NCT00098722|6418625|P5|Treated|Double Blind Phase||0
2613808|NCT00098722|6418626|P4|Treated|Double Blind Phase||0
2613809|NCT00098722|6418627|P3|Treated|Double Blind Phase||91
2613810|NCT00098722|6418628|P2|Treated|Double Blind Phase||191
2613811|NCT00098722|6418629|P1|Treated|Double Blind Phase||182
2613812|NCT00098722|6418623|P7|STARTED|Double Blind Phase||0
2613813|NCT00098722|6418624|P6|STARTED|Double Blind Phase||0
2613814|NCT00098722|6418625|P5|STARTED|Double Blind Phase||0
2613815|NCT00098722|6418626|P4|STARTED|Double Blind Phase||0
2613816|NCT00098722|6418627|P3|STARTED|Double Blind Phase||94
2613817|NCT00098722|6418628|P2|STARTED|Double Blind Phase||194
2613818|NCT00098722|6418629|P1|STARTED|Double Blind Phase||186
2613819|NCT00098670|6418692|P1|NOT COMPLETED|Overall Study||0
2613820|NCT00098670|6418692|P1|COMPLETED|Overall Study||102
2613821|NCT00098670|6418692|P1|STARTED|Overall Study||102
2613822|NCT00098475|6418703|P4|NOT COMPLETED|Step 2||0
2613823|NCT00098475|6418704|P3|NOT COMPLETED|Step 2||0
2613824|NCT00098475|6418705|P2|NOT COMPLETED|Step 2||10
2613825|NCT00098475|6418706|P1|NOT COMPLETED|Step 2||5
2613826|NCT00098475|6418703|P4|COMPLETED|Step 2||0
2613827|NCT00098475|6418704|P3|COMPLETED|Step 2||0
2613828|NCT00098475|6418705|P2|COMPLETED|Step 2||5
2613829|NCT00098475|6418706|P1|COMPLETED|Step 2||0
2613830|NCT00098475|6418703|P4|Eligible|Step 2||0
2613831|NCT00098475|6418704|P3|Eligible|Step 2||0
2613832|NCT00098475|6418705|P2|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|9
2613833|NCT00098475|6418706|P1|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|2
2613834|NCT00098475|6418703|P4|Treated|Step 2||0
2613835|NCT00098475|6418704|P3|Treated|Step 2||0
2613836|NCT00098475|6418705|P2|Treated|Step 2||14
2613837|NCT00098475|6418706|P1|Treated|Step 2||4
2613838|NCT00098475|6418703|P4|STARTED|Step 2||0
2613839|NCT00098475|6418704|P3|STARTED|Step 2||0
2613840|NCT00098475|6418705|P2|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|15
2613841|NCT00098475|6418706|P1|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|5
2613842|NCT00098475|6418703|P4|NOT COMPLETED|Step 1||3
2613843|NCT00098475|6418704|P3|NOT COMPLETED|Step 1||4
2613844|NCT00098475|6418705|P2|NOT COMPLETED|Step 1||173
2613845|NCT00098475|6418706|P1|NOT COMPLETED|Step 1||171
2613846|NCT00098475|6418703|P4|COMPLETED|Step 1||0
2613847|NCT00098475|6418704|P3|COMPLETED|Step 1||0
2613848|NCT00098475|6418705|P2|COMPLETED|Step 1||49
2613849|NCT00098475|6418706|P1|COMPLETED|Step 1||52
2613850|NCT00098475|6418703|P4|Eligible|Step 1||3
2613851|NCT00098475|6418704|P3|Eligible|Step 1||4
2613852|NCT00098475|6418705|P2|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|208
2613853|NCT00098475|6418706|P1|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|214
2613854|NCT00098475|6418703|P4|Treated|Step 1||3
2613855|NCT00098475|6418704|P3|Treated|Step 1||4
2613856|NCT00098475|6418705|P2|Treated|Step 1||220
2613857|NCT00098475|6418706|P1|Treated|Step 1||223
2613858|NCT00098475|6418703|P4|STARTED|Step 1||3
2613859|NCT00098475|6418704|P3|STARTED|Step 1||4
2613860|NCT00098475|6418705|P2|STARTED|Step 1||222
2613861|NCT00098475|6418706|P1|STARTED|Step 1||223
2613862|NCT00098371|6418718|P1|NOT COMPLETED|Overall Study||0
2613863|NCT00098371|6418718|P1|COMPLETED|Overall Study||64
2613864|NCT00098371|6418718|P1|STARTED|Overall Study||64
2613865|NCT00098345|6418743|P1|NOT COMPLETED|Overall Study||13
2613866|NCT00098345|6418743|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|17
2613867|NCT00098345|6418743|P1|STARTED|Overall Study||30
2613868|NCT00098306|6418756|P7|NOT COMPLETED|Observational Phase||26
2613869|NCT00098306|6418757|P6|NOT COMPLETED|Observational Phase||46
2613870|NCT00098306|6418758|P5|NOT COMPLETED|Observational Phase||0
2613871|NCT00098306|6418759|P4|NOT COMPLETED|Observational Phase||0
2613872|NCT00098306|6418760|P3|NOT COMPLETED|Observational Phase||0
2613873|NCT00098306|6418761|P2|NOT COMPLETED|Observational Phase||0
2613874|NCT00098306|6418762|P1|NOT COMPLETED|Observational Phase||0
2613875|NCT00098306|6418756|P7|COMPLETED|Observational Phase||55
2613876|NCT00098306|6418757|P6|COMPLETED|Observational Phase||204
2613877|NCT00098306|6418758|P5|COMPLETED|Observational Phase||0
2613878|NCT00098306|6418759|P4|COMPLETED|Observational Phase||0
2613879|NCT00098306|6418760|P3|COMPLETED|Observational Phase||0
2613880|NCT00098306|6418761|P2|COMPLETED|Observational Phase||0
2613881|NCT00098306|6418762|P1|COMPLETED|Observational Phase||0
2613882|NCT00098306|6418756|P7|STARTED|Observational Phase||81
2613883|NCT00098306|6418757|P6|STARTED|Observational Phase||250
2613884|NCT00098306|6418758|P5|STARTED|Observational Phase||0
2613885|NCT00098306|6418759|P4|STARTED|Observational Phase||0
2613886|NCT00098306|6418760|P3|STARTED|Observational Phase||0
2613887|NCT00098306|6418761|P2|STARTED|Observational Phase||0
2613888|NCT00098306|6418762|P1|STARTED|Observational Phase||0
2613889|NCT00098306|6418756|P7|NOT COMPLETED|Open Label||0
2613890|NCT00098306|6418757|P6|NOT COMPLETED|Open Label||0
2613891|NCT00098306|6418758|P5|NOT COMPLETED|Open Label||62
2613892|NCT00098306|6418759|P4|NOT COMPLETED|Open Label||327
2613893|NCT00098306|6418760|P3|NOT COMPLETED|Open Label||0
2613894|NCT00098306|6418761|P2|NOT COMPLETED|Open Label||0
2613895|NCT00098306|6418762|P1|NOT COMPLETED|Open Label||0
2613896|NCT00098306|6418756|P7|COMPLETED|Open Label||0
2613897|NCT00098306|6418757|P6|COMPLETED|Open Label||0
2613898|NCT00098306|6418758|P5|COMPLETED|Open Label||0
2613899|NCT00098306|6418759|P4|COMPLETED|Open Label||0
2613900|NCT00098306|6418760|P3|COMPLETED|Open Label||0
2613901|NCT00098306|6418761|P2|COMPLETED|Open Label||0
2613902|NCT00098306|6418762|P1|COMPLETED|Open Label||0
2613903|NCT00098306|6418756|P7|STARTED|Open Label||0
2613904|NCT00098306|6418757|P6|STARTED|Open Label||0
2613905|NCT00098306|6418758|P5|STARTED|Open Label||62
2613906|NCT00098306|6418759|P4|STARTED|Open Label||327
2613907|NCT00098306|6418760|P3|STARTED|Open Label||0
2613908|NCT00098306|6418761|P2|STARTED|Open Label||0
2613909|NCT00098306|6418762|P1|STARTED|Open Label||0
2613910|NCT00098306|6418756|P7|NOT COMPLETED|Double Blind||0
2613911|NCT00098306|6418757|P6|NOT COMPLETED|Double Blind||0
2613912|NCT00098306|6418758|P5|NOT COMPLETED|Double Blind||0
2613913|NCT00098306|6418759|P4|NOT COMPLETED|Double Blind||0
2613914|NCT00098306|6418760|P3|NOT COMPLETED|Double Blind||120
2613915|NCT00098306|6418761|P2|NOT COMPLETED|Double Blind||240
2613916|NCT00098306|6418762|P1|NOT COMPLETED|Double Blind||241
2613917|NCT00098306|6418756|P7|COMPLETED|Double Blind||0
2613918|NCT00098306|6418757|P6|COMPLETED|Double Blind||0
2613919|NCT00098306|6418758|P5|COMPLETED|Double Blind||0
2613920|NCT00098306|6418759|P4|COMPLETED|Double Blind||0
2613921|NCT00098306|6418760|P3|COMPLETED|Double Blind||0
2613922|NCT00098306|6418761|P2|COMPLETED|Double Blind||0
2613923|NCT00098306|6418762|P1|COMPLETED|Double Blind||0
2613924|NCT00098306|6418756|P7|Treated|Double Blind||0
2613925|NCT00098306|6418757|P6|Treated|Double Blind||0
2613926|NCT00098306|6418758|P5|Treated|Double Blind||0
2613927|NCT00098306|6418759|P4|Treated|Double Blind||0
2613928|NCT00098306|6418760|P3|Treated|Double Blind||118
2613929|NCT00098306|6418761|P2|Treated|Double Blind||235
2613930|NCT00098306|6418762|P1|Treated|Double Blind||232
2613931|NCT00098306|6418756|P7|STARTED|Double Blind||0
2613932|NCT00098306|6418757|P6|STARTED|Double Blind||0
2613933|NCT00098306|6418758|P5|STARTED|Double Blind||0
2613934|NCT00098306|6418759|P4|STARTED|Double Blind||0
2613935|NCT00098306|6418760|P3|STARTED|Double Blind||120
2613936|NCT00098306|6418761|P2|STARTED|Double Blind||240
2613937|NCT00098306|6418762|P1|STARTED|Double Blind||241
2613938|NCT00098293|6418828|P5|NOT COMPLETED|Supplemental Phase (SP)||33
2613939|NCT00098293|6418829|P4|NOT COMPLETED|Supplemental Phase (SP)||0
2613940|NCT00098293|6418830|P3|NOT COMPLETED|Supplemental Phase (SP)||0
2613941|NCT00098293|6418831|P2|NOT COMPLETED|Supplemental Phase (SP)||0
2613942|NCT00098293|6418832|P1|NOT COMPLETED|Supplemental Phase (SP)||0
2613943|NCT00098293|6418828|P5|COMPLETED|Supplemental Phase (SP)||94
2613944|NCT00098293|6418829|P4|COMPLETED|Supplemental Phase (SP)||0
2613945|NCT00098293|6418830|P3|COMPLETED|Supplemental Phase (SP)||0
2613946|NCT00098293|6418831|P2|COMPLETED|Supplemental Phase (SP)||0
2613947|NCT00098293|6418832|P1|COMPLETED|Supplemental Phase (SP)||0
2613948|NCT00098293|6418828|P5|STARTED|Supplemental Phase (SP)||127
2613949|NCT00098293|6418829|P4|STARTED|Supplemental Phase (SP)||0
2613950|NCT00098293|6418830|P3|STARTED|Supplemental Phase (SP)||0
2613951|NCT00098293|6418831|P2|STARTED|Supplemental Phase (SP)||0
2613952|NCT00098293|6418832|P1|STARTED|Supplemental Phase (SP)||0
2613953|NCT00098293|6418828|P5|NOT COMPLETED|Open-label (OL) Phase||0
2613954|NCT00098293|6418829|P4|NOT COMPLETED|Open-label (OL) Phase||65
2613955|NCT00098293|6418830|P3|NOT COMPLETED|Open-label (OL) Phase||41
2613956|NCT00098293|6418831|P2|NOT COMPLETED|Open-label (OL) Phase||25
2613957|NCT00098293|6418832|P1|NOT COMPLETED|Open-label (OL) Phase||0
2613958|NCT00098293|6418828|P5|COMPLETED|Open-label (OL) Phase||0
2613959|NCT00098293|6418829|P4|COMPLETED|Open-label (OL) Phase||65
2613960|NCT00098293|6418830|P3|COMPLETED|Open-label (OL) Phase||158
2613961|NCT00098293|6418831|P2|COMPLETED|Open-label (OL) Phase||177
2613962|NCT00098293|6418832|P1|COMPLETED|Open-label (OL) Phase||0
2613963|NCT00098293|6418828|P5|STARTED|Open-label (OL) Phase||0
2613964|NCT00098293|6418829|P4|STARTED|Open-label (OL) Phase||130
2613965|NCT00098293|6418830|P3|STARTED|Open-label (OL) Phase||199
2613966|NCT00098293|6418831|P2|STARTED|Open-label (OL) Phase||202
2613967|NCT00098293|6418832|P1|STARTED|Open-label (OL) Phase||0
2613968|NCT00098293|6418828|P5|NOT COMPLETED|Between DB and OL Phase||0
2613969|NCT00098293|6418829|P4|NOT COMPLETED|Between DB and OL Phase||0
2613970|NCT00098293|6418830|P3|NOT COMPLETED|Between DB and OL Phase||3
2613971|NCT00098293|6418831|P2|NOT COMPLETED|Between DB and OL Phase||0
2613972|NCT00098293|6418832|P1|NOT COMPLETED|Between DB and OL Phase||0
2613973|NCT00098293|6418828|P5|COMPLETED|Between DB and OL Phase||0
2613974|NCT00098293|6418829|P4|COMPLETED|Between DB and OL Phase||0
2613975|NCT00098293|6418830|P3|COMPLETED|Between DB and OL Phase||199
2613976|NCT00098293|6418831|P2|COMPLETED|Between DB and OL Phase||202
2613977|NCT00098293|6418832|P1|COMPLETED|Between DB and OL Phase||0
2613978|NCT00098293|6418828|P5|STARTED|Between DB and OL Phase||0
2613979|NCT00098293|6418829|P4|STARTED|Between DB and OL Phase||0
2613980|NCT00098293|6418830|P3|STARTED|Between DB and OL Phase||202
2613981|NCT00098293|6418831|P2|STARTED|Between DB and OL Phase||202
2613982|NCT00098293|6418832|P1|STARTED|Between DB and OL Phase||0
2613983|NCT00098293|6418828|P5|NOT COMPLETED|Double-blind (DB) Phase||0
2613984|NCT00098293|6418829|P4|NOT COMPLETED|Double-blind (DB) Phase||0
2613985|NCT00098293|6418830|P3|NOT COMPLETED|Double-blind (DB) Phase||170
2613986|NCT00098293|6418831|P2|NOT COMPLETED|Double-blind (DB) Phase||166
2613987|NCT00098293|6418832|P1|NOT COMPLETED|Double-blind (DB) Phase||177
2613988|NCT00098293|6418828|P5|COMPLETED|Double-blind (DB) Phase||0
2613989|NCT00098293|6418829|P4|COMPLETED|Double-blind (DB) Phase||0
2613990|NCT00098293|6418830|P3|COMPLETED|Double-blind (DB) Phase||202
2613991|NCT00098293|6418831|P2|COMPLETED|Double-blind (DB) Phase||202
2613992|NCT00098293|6418832|P1|COMPLETED|Double-blind (DB) Phase||0
2613993|NCT00098293|6418828|P5|Treated|Double-blind (DB) Phase||0
2613994|NCT00098293|6418829|P4|Treated|Double-blind (DB) Phase||0
2613995|NCT00098293|6418830|P3|Treated|Double-blind (DB) Phase||361
2613996|NCT00098293|6418831|P2|Treated|Double-blind (DB) Phase||360
2613997|NCT00098293|6418832|P1|Treated|Double-blind (DB) Phase||174
2613998|NCT00098293|6418828|P5|STARTED|Double-blind (DB) Phase||0
2613999|NCT00098293|6418829|P4|STARTED|Double-blind (DB) Phase||0
2614000|NCT00098293|6418830|P3|STARTED|Double-blind (DB) Phase||372
2614001|NCT00098293|6418831|P2|STARTED|Double-blind (DB) Phase||368
2614002|NCT00098293|6418832|P1|STARTED|Double-blind (DB) Phase||177
2614003|NCT00098254|6418885|P1|NOT COMPLETED|Overall Study||3
2614004|NCT00098254|6418885|P1|COMPLETED|Overall Study||34
2614005|NCT00098254|6418885|P1|STARTED|Overall Study||37
2614006|NCT00098059|6418906|P2|NOT COMPLETED|Overall Study||1
2614007|NCT00098059|6418907|P1|NOT COMPLETED|Overall Study||0
2614008|NCT00098059|6418906|P2|COMPLETED|Overall Study||46
2614009|NCT00098059|6418907|P1|COMPLETED|Overall Study||27
2614010|NCT00098059|6418906|P2|STARTED|Overall Study||47
2614011|NCT00098059|6418907|P1|STARTED|Overall Study||27
2614012|NCT00098020|6418951|P1|NOT COMPLETED|Overall Study||6
2614013|NCT00098020|6418951|P1|COMPLETED|Overall Study||6
2614014|NCT00098020|6418951|P1|Started Isotretinoin|Overall Study||8
2614015|NCT00098020|6418951|P1|STARTED|Overall Study||12
2614016|NCT00097981|6418958|P2|NOT COMPLETED|Overall Study||100
2614017|NCT00097981|6418959|P1|NOT COMPLETED|Overall Study||106
2614018|NCT00097981|6418958|P2|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|12
2614019|NCT00097981|6418959|P1|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|7
2614020|NCT00097981|6418958|P2|Received Study Medication|Overall Study||106
2614021|NCT00097981|6418959|P1|Received Study Medication|Overall Study||110
2614022|NCT00097981|6418958|P2|STARTED|Overall Study|Enrollment at randomization|112
2614023|NCT00097981|6418959|P1|STARTED|Overall Study|Enrollment at randomization|113
2614024|NCT00097786|6418981|P4|NOT COMPLETED|Overall Study||310
2614025|NCT00097786|6418982|P3|NOT COMPLETED|Overall Study||313
2614026|NCT00097786|6418983|P2|NOT COMPLETED|Overall Study||292
2614027|NCT00097786|6418984|P1|NOT COMPLETED|Overall Study||296
2614028|NCT00097786|6418981|P4|COMPLETED|Overall Study||2036
2614029|NCT00097786|6418982|P3|COMPLETED|Overall Study||2016
2614030|NCT00097786|6418983|P2|COMPLETED|Overall Study||2023
2614031|NCT00097786|6418984|P1|COMPLETED|Overall Study|"Completed means completed follow up for all cause death."|2020
2614032|NCT00097786|6418981|P4|Complete Follow-up for Core CV EPs|Overall Study||1988
2614033|NCT00097786|6418982|P3|Complete Follow-up for Core CV EPs|Overall Study||1966
2614034|NCT00097786|6418983|P2|Complete Follow-up for Core CV EPs|Overall Study||1963
2614035|NCT00097786|6418984|P1|Complete Follow-up for Core CV EPs|Overall Study||1948
2614036|NCT00097786|6418981|P4|Complete Follow-up for Extended CV EPs|Overall Study||2015
2614037|NCT00097786|6418982|P3|Complete Follow-up for Extended CV EPs|Overall Study||1987
2614038|NCT00097786|6418983|P2|Complete Follow-up for Extended CV EPs|Overall Study||1985
2614039|NCT00097786|6418984|P1|Complete Follow-up for Extended CV EPs|Overall Study||1969
2614040|NCT00097786|6418981|P4|Complete FU for Progression to Diabetes|Overall Study||1762
2614041|NCT00097786|6418982|P3|Complete FU for Progression to Diabetes|Overall Study||1734
2614042|NCT00097786|6418983|P2|Complete FU for Progression to Diabetes|Overall Study||1712
2614043|NCT00097786|6418984|P1|Complete FU for Progression to Diabetes|Overall Study||1709
2614044|NCT00097786|6418981|P4|STARTED|Overall Study||2346
2614045|NCT00097786|6418982|P3|STARTED|Overall Study||2329
2614046|NCT00097786|6418983|P2|STARTED|Overall Study||2315
2614047|NCT00097786|6418984|P1|STARTED|Overall Study|"Started indicates Full Analysis Set (FAS) population. Initially enrolled 9518, 212 excluded."|2316
2614048|NCT00097773|6419006|P4|NOT COMPLETED|Overall Study||3
2614049|NCT00097773|6419007|P3|NOT COMPLETED|Overall Study||8
2614050|NCT00097773|6419008|P2|NOT COMPLETED|Overall Study||8
2614051|NCT00097773|6419009|P1|NOT COMPLETED|Overall Study||8
2614052|NCT00097773|6419006|P4|COMPLETED|Overall Study||73
2614053|NCT00097773|6419007|P3|COMPLETED|Overall Study||68
2614054|NCT00097773|6419008|P2|COMPLETED|Overall Study||68
2614055|NCT00097773|6419009|P1|COMPLETED|Overall Study||68
2614056|NCT00097773|6419006|P4|STARTED|Overall Study||76
2614057|NCT00097773|6419007|P3|STARTED|Overall Study||76
2614058|NCT00097773|6419008|P2|STARTED|Overall Study||76
2614059|NCT00097773|6419009|P1|STARTED|Overall Study||76
2614060|NCT00097721|6419029|P2|NOT COMPLETED|Overall Study||33
2614061|NCT00097721|6419030|P1|NOT COMPLETED|Overall Study||71
2614062|NCT00097721|6419029|P2|COMPLETED|Overall Study||0
2614063|NCT00097721|6419030|P1|COMPLETED|Overall Study||0
2614064|NCT00097721|6419029|P2|STARTED|Overall Study||33
2614065|NCT00097721|6419030|P1|STARTED|Overall Study|The number started is all enrolled subjects.BL Characteristics consists of Safety Population.|71
2614066|NCT00097708|6419047|P3|NOT COMPLETED|Overall Study||65
2614067|NCT00097708|6419048|P2|NOT COMPLETED|Overall Study||56
2614068|NCT00097708|6419049|P1|NOT COMPLETED|Overall Study||64
2614069|NCT00097708|6419047|P3|COMPLETED|Overall Study||97
2614070|NCT00097708|6419048|P2|COMPLETED|Overall Study||120
2614071|NCT00097708|6419049|P1|COMPLETED|Overall Study||109
2614072|NCT00097708|6419047|P3|Treated|Overall Study||160
2614073|NCT00097708|6419048|P2|Treated|Overall Study||176
2614074|NCT00097708|6419049|P1|Treated|Overall Study||171
2614075|NCT00097708|6419047|P3|Intent-to-Treat (ITT)|Overall Study||149
2614076|NCT00097708|6419048|P2|Intent-to-Treat (ITT)|Overall Study||169
2614077|NCT00097708|6419049|P1|Intent-to-Treat (ITT)|Overall Study||165
2614078|NCT00097708|6419047|P3|STARTED|Overall Study||162
2614079|NCT00097708|6419048|P2|STARTED|Overall Study||176
2614080|NCT00097708|6419049|P1|STARTED|Overall Study||173
2614081|NCT00097695|6419061|P4|NOT COMPLETED|The Open Label Extension (OLE) Phase||5
2614082|NCT00097695|6419062|P3|NOT COMPLETED|The Open Label Extension (OLE) Phase||2
2614083|NCT00097695|6419063|P2|NOT COMPLETED|The Open Label Extension (OLE) Phase||15
2614084|NCT00097695|6419064|P1|NOT COMPLETED|The Open Label Extension (OLE) Phase||13
2614085|NCT00097695|6419061|P4|COMPLETED|The Open Label Extension (OLE) Phase||15
2614086|NCT00097695|6419062|P3|COMPLETED|The Open Label Extension (OLE) Phase||1
2614087|NCT00097695|6419063|P2|COMPLETED|The Open Label Extension (OLE) Phase||11
2614088|NCT00097695|6419064|P1|COMPLETED|The Open Label Extension (OLE) Phase||10
2614089|NCT00097695|6419061|P4|STARTED|The Open Label Extension (OLE) Phase||20
2614090|NCT00097695|6419062|P3|STARTED|The Open Label Extension (OLE) Phase||3
2614091|NCT00097695|6419063|P2|STARTED|The Open Label Extension (OLE) Phase||26
2614092|NCT00097695|6419064|P1|STARTED|The Open Label Extension (OLE) Phase||23
2614093|NCT00097695|6419061|P4|NOT COMPLETED|The Controlled Phase||20
2614094|NCT00097695|6419062|P3|NOT COMPLETED|The Controlled Phase||5
2614095|NCT00097695|6419063|P2|NOT COMPLETED|The Controlled Phase||3
2614096|NCT00097695|6419064|P1|NOT COMPLETED|The Controlled Phase||4
2614097|NCT00097695|6419061|P4|COMPLETED|The Controlled Phase|Patients screened and found eligible but did not have HAE attack or attack was not severe enough|0
2614098|NCT00097695|6419062|P3|COMPLETED|The Controlled Phase||3
2614099|NCT00097695|6419063|P2|COMPLETED|The Controlled Phase||26
2614100|NCT00097695|6419064|P1|COMPLETED|The Controlled Phase||23
2614101|NCT00097695|6419061|P4|STARTED|The Controlled Phase||20
2614102|NCT00097695|6419062|P3|STARTED|The Controlled Phase||8
2614103|NCT00097695|6419063|P2|STARTED|The Controlled Phase||29
2614104|NCT00097695|6419064|P1|STARTED|The Controlled Phase||27
2614105|NCT00097591|6419080|P2|NOT COMPLETED|Overall Study||394
2614106|NCT00097591|6419081|P1|NOT COMPLETED|Overall Study||410
2614107|NCT00097591|6419080|P2|COMPLETED|Overall Study||6401
2614108|NCT00097591|6419081|P1|COMPLETED|Overall Study||6403
2614109|NCT00097591|6419080|P2|STARTED|Overall Study|4 subjects randomized but not analyzed due to an incomplete informed consent document|6795
2614110|NCT00097591|6419081|P1|STARTED|Overall Study|7 subjects randomized but not analyzed due to an incomplete informed consent document|6813
2614111|NCT00097539|6419104|P7|NOT COMPLETED|Overall Study||171
2614112|NCT00097539|6419105|P6|NOT COMPLETED|Overall Study||5892
2614113|NCT00097539|6419106|P5|NOT COMPLETED|Overall Study||1758
2614114|NCT00097539|6419107|P4|NOT COMPLETED|Overall Study||3585
2614115|NCT00097539|6419108|P3|NOT COMPLETED|Overall Study||9108
2614116|NCT00097539|6419109|P2|NOT COMPLETED|Overall Study||6531
2614117|NCT00097539|6419110|P1|NOT COMPLETED|Overall Study||19066
2614118|NCT00097539|6419104|P7|COMPLETED|Overall Study||68
2614119|NCT00097539|6419105|P6|COMPLETED|Overall Study||2118
2614120|NCT00097539|6419106|P5|COMPLETED|Overall Study||386
2614121|NCT00097539|6419107|P4|COMPLETED|Overall Study||2066
2614122|NCT00097539|6419108|P3|COMPLETED|Overall Study||3411
2614123|NCT00097539|6419109|P2|COMPLETED|Overall Study||2825
2614124|NCT00097539|6419110|P1|COMPLETED|Overall Study||8220
2614125|NCT00097539|6419104|P7|STARTED|Overall Study||239
2614126|NCT00097539|6419105|P6|STARTED|Overall Study||8010
2614127|NCT00097539|6419106|P5|STARTED|Overall Study||2144
2614128|NCT00097539|6419107|P4|STARTED|Overall Study||5651
2614129|NCT00097539|6419108|P3|STARTED|Overall Study||12519
2614130|NCT00097539|6419109|P2|STARTED|Overall Study||9356
2614131|NCT00097539|6419110|P1|STARTED|Overall Study||27286
2614132|NCT00097500|6419156|P2|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||4
2614133|NCT00097500|6419157|P1|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||5
2614134|NCT00097500|6419156|P2|COMPLETED|Off-drug Period (Week 52 to Week 64)||26
2614135|NCT00097500|6419157|P1|COMPLETED|Off-drug Period (Week 52 to Week 64)||25
2614136|NCT00097500|6419156|P2|STARTED|Off-drug Period (Week 52 to Week 64)|Insulin Glargine is discontinued, metformin is continued|30
2614137|NCT00097500|6419157|P1|STARTED|Off-drug Period (Week 52 to Week 64)|Exenatide is discontinued, metformin is continued|30
2614138|NCT00097500|6419156|P2|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||3
2614139|NCT00097500|6419157|P1|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||6
2614140|NCT00097500|6419156|P2|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
2614141|NCT00097500|6419157|P1|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
2614142|NCT00097500|6419156|P2|STARTED|On-drug Period (Week 0 to Week 52)||33
2614143|NCT00097500|6419157|P1|STARTED|On-drug Period (Week 0 to Week 52)||36
2614144|NCT00097448|6419181|P2|NOT COMPLETED|Overall Study||1
2614145|NCT00097448|6419182|P1|NOT COMPLETED|Overall Study||4
2614146|NCT00097448|6419181|P2|COMPLETED|Overall Study||129
2614147|NCT00097448|6419182|P1|COMPLETED|Overall Study||121
2614148|NCT00097448|6419181|P2|STARTED|Overall Study||130
2614149|NCT00097448|6419182|P1|STARTED|Overall Study||125
2614150|NCT00097370|6419188|P1|NOT COMPLETED|Stage 3||59
2614151|NCT00097370|6419188|P1|COMPLETED|Stage 3||0
2614152|NCT00097370|6419188|P1|STARTED|Stage 3|Participants continued from Stage 2.|59
2614153|NCT00097370|6419188|P1|NOT COMPLETED|Stage 2||13
2614154|NCT00097370|6419188|P1|COMPLETED|Stage 2||59
2614155|NCT00097370|6419188|P1|STARTED|Stage 2|41 participants entered from study MHE100185 and 31 participants continued from Stage 1.|72
2614156|NCT00097370|6419188|P1|NOT COMPLETED|Stage 1||6
2614157|NCT00097370|6419188|P1|COMPLETED|Stage 1||31
2614158|NCT00097370|6419188|P1|STARTED|Stage 1|Participants entered from study MHE100185.|37
2614159|NCT00097253|6419205|P1|NOT COMPLETED|Water (Control)||0
2614160|NCT00097253|6419205|P1|COMPLETED|Water (Control)||56
2614161|NCT00097253|6419205|P1|STARTED|Water (Control)||56
2614162|NCT00097253|6419205|P1|NOT COMPLETED|Lemon||0
2614163|NCT00097253|6419205|P1|COMPLETED|Lemon||56
2614164|NCT00097253|6419205|P1|STARTED|Lemon||56
2614165|NCT00097253|6419205|P1|NOT COMPLETED|Lavender||0
2614166|NCT00097253|6419205|P1|COMPLETED|Lavender||56
2614167|NCT00097253|6419205|P1|STARTED|Lavender||56
2614168|NCT00096993|6419222|P2|NOT COMPLETED|Overall Study||65
2614169|NCT00096993|6419223|P1|NOT COMPLETED|Overall Study||65
2614170|NCT00096993|6419222|P2|COMPLETED|Overall Study||0
2614171|NCT00096993|6419223|P1|COMPLETED|Overall Study||1
2614172|NCT00096993|6419222|P2|STARTED|Overall Study||65
2614173|NCT00096993|6419223|P1|STARTED|Overall Study||66
2614174|NCT00096954|6419239|P2|NOT COMPLETED|Overall Study||20
2614175|NCT00096954|6419240|P1|NOT COMPLETED|Overall Study||24
2614176|NCT00096954|6419239|P2|COMPLETED|Overall Study||154
2614177|NCT00096954|6419240|P1|COMPLETED|Overall Study||135
2614178|NCT00096954|6419239|P2|Received Study Drug|Overall Study||171
2614179|NCT00096954|6419240|P1|Received Study Drug|Overall Study||157
2614180|NCT00096954|6419239|P2|STARTED|Overall Study||174
2614181|NCT00096954|6419240|P1|STARTED|Overall Study||159
2614182|NCT00096941|6419252|P1|NOT COMPLETED|Overall Study||3
2614183|NCT00096941|6419252|P1|COMPLETED|Overall Study||0
2614184|NCT00096941|6419252|P1|STARTED|Overall Study||3
2614185|NCT00096785|6419259|P2|NOT COMPLETED|Overall Study||1
2614186|NCT00096785|6419260|P1|NOT COMPLETED|Overall Study||2
2614187|NCT00096785|6419259|P2|COMPLETED|Overall Study|As randomized cohort|33
2614188|NCT00096785|6419260|P1|COMPLETED|Overall Study|As randomized cohort|33
2614189|NCT00096785|6419259|P2|As-Treated Population|Overall Study||33
2614190|NCT00096785|6419260|P1|As-Treated Population|Overall Study||36
2614191|NCT00096785|6419259|P2|As-Randomized Population|Overall Study||34
2614192|NCT00096785|6419260|P1|As-Randomized Population|Overall Study||35
2614193|NCT00096785|6419259|P2|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 34; as treated=33)|34
2614194|NCT00096785|6419260|P1|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 35; as treated=36)|35
2614195|NCT00096681|6419284|P1|NOT COMPLETED|Overall Study||0
2614196|NCT00096681|6419284|P1|COMPLETED|Overall Study||762
2614197|NCT00096681|6419284|P1|STARTED|Overall Study||762
2614198|NCT00096538|6419289|P1|NOT COMPLETED|Overall Study||1
2614199|NCT00096538|6419289|P1|COMPLETED|Overall Study||5
2614200|NCT00096538|6419289|P1|STARTED|Overall Study||6
2614201|NCT00096486|6419297|P4|NOT COMPLETED|Overall Study||2
2614202|NCT00096486|6419298|P3|NOT COMPLETED|Overall Study||2
2614203|NCT00096486|6419299|P2|NOT COMPLETED|Overall Study||0
2614204|NCT00096486|6419300|P1|NOT COMPLETED|Overall Study||0
2614205|NCT00096486|6419297|P4|COMPLETED|Overall Study||36
2614206|NCT00096486|6419298|P3|COMPLETED|Overall Study||24
2614207|NCT00096486|6419299|P2|COMPLETED|Overall Study||6
2614208|NCT00096486|6419300|P1|COMPLETED|Overall Study||4
2614209|NCT00096486|6419297|P4|STARTED|Overall Study||38
2614210|NCT00096486|6419298|P3|STARTED|Overall Study||26
2614211|NCT00096486|6419299|P2|STARTED|Overall Study||6
2614212|NCT00096486|6419300|P1|STARTED|Overall Study||4
2614213|NCT00096460|6419312|P2|NOT COMPLETED|Overall Study||1
2614214|NCT00096460|6419313|P1|NOT COMPLETED|Overall Study||7
2614215|NCT00096460|6419312|P2|COMPLETED|Overall Study||7
2614216|NCT00096460|6419313|P1|COMPLETED|Overall Study||15
2614217|NCT00096460|6419312|P2|STARTED|Overall Study||8
2614218|NCT00096460|6419313|P1|STARTED|Overall Study||22
2614219|NCT00096447|6419319|P1|NOT COMPLETED|Overall Study||1
2614220|NCT00096447|6419319|P1|COMPLETED|Overall Study|Eligible and treated patients.|30
2614221|NCT00096447|6419319|P1|STARTED|Overall Study||31
2614222|NCT00096382|6419335|P2|NOT COMPLETED|Overall Study||0
2614223|NCT00096382|6419336|P1|NOT COMPLETED|Overall Study||2
2614224|NCT00096382|6419335|P2|COMPLETED|Overall Study||3
2614225|NCT00096382|6419336|P1|COMPLETED|Overall Study||21
2614226|NCT00096382|6419335|P2|STARTED|Overall Study||3
2614227|NCT00096382|6419336|P1|STARTED|Overall Study||23
2614228|NCT00096356|6419346|P2|NOT COMPLETED|Overall Study||53
2614229|NCT00096356|6419347|P1|NOT COMPLETED|Overall Study||44
2614230|NCT00096356|6419346|P2|COMPLETED|Overall Study||61
2614231|NCT00096356|6419347|P1|COMPLETED|Overall Study||78
2614232|NCT00096356|6419346|P2|STARTED|Overall Study||114
2614233|NCT00096356|6419347|P1|STARTED|Overall Study||122
2614234|NCT00096278|6419359|P2|NOT COMPLETED|Overall Study||20
2614235|NCT00096278|6419360|P1|NOT COMPLETED|Overall Study||18
2614236|NCT00096278|6419359|P2|COMPLETED|Overall Study||1334
2614237|NCT00096278|6419360|P1|COMPLETED|Overall Study||1338
2614238|NCT00096278|6419359|P2|STARTED|Overall Study||1354
2614239|NCT00096278|6419360|P1|STARTED|Overall Study||1356
2614240|NCT00096265|6419379|P3|NOT COMPLETED|Overall Study||0
2614241|NCT00096265|6419380|P2|NOT COMPLETED|Overall Study||0
2614242|NCT00096265|6419381|P1|NOT COMPLETED|Overall Study||1
2614243|NCT00096265|6419379|P3|COMPLETED|Overall Study||41
2614244|NCT00096265|6419380|P2|COMPLETED|Overall Study||40
2614245|NCT00096265|6419381|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
2614246|NCT00096265|6419379|P3|STARTED|Overall Study||41
2614247|NCT00096265|6419380|P2|STARTED|Overall Study||40
2614248|NCT00096265|6419381|P1|STARTED|Overall Study||45
2614249|NCT00096226|6419407|P1|NOT COMPLETED|Overall Study||3
2614250|NCT00096226|6419407|P1|COMPLETED|Overall Study|Subjects contributing any data to analysis are considered to have completed the study|57
2614251|NCT00096226|6419407|P1|Eligible and Underwent Surgery|Overall Study||37
2614252|NCT00096226|6419407|P1|Eligible|Overall Study||57
2614253|NCT00096226|6419407|P1|STARTED|Overall Study||60
2614254|NCT00096200|6419421|P3|NOT COMPLETED|Overall Study||0
2614255|NCT00096200|6419422|P2|NOT COMPLETED|Overall Study||7
2614256|NCT00096200|6419423|P1|NOT COMPLETED|Overall Study||1
2614257|NCT00096200|6419421|P3|COMPLETED|Overall Study||5
2614258|NCT00096200|6419422|P2|COMPLETED|Overall Study||23
2614259|NCT00096200|6419423|P1|COMPLETED|Overall Study||8
2614260|NCT00096200|6419421|P3|STARTED|Overall Study||5
2614261|NCT00096200|6419422|P2|STARTED|Overall Study||30
2614262|NCT00096200|6419423|P1|STARTED|Overall Study||9
2614263|NCT00096174|6419437|P1|NOT COMPLETED|Overall Study||62
2614264|NCT00096174|6419437|P1|COMPLETED|Overall Study||7
2614265|NCT00096174|6419437|P1|Eligible and Treated|Overall Study|6 treated patients were ineligible|60
2614266|NCT00096174|6419437|P1|Began Protocol Therapy|Overall Study|3 patients never started treatment|66
2614267|NCT00096174|6419437|P1|STARTED|Overall Study||69
2614268|NCT00096161|6419447|P4|NOT COMPLETED|Overall Study||0
2614269|NCT00096161|6419448|P3|NOT COMPLETED|Overall Study||0
2614270|NCT00096161|6419449|P2|NOT COMPLETED|Overall Study||0
2614271|NCT00096161|6419450|P1|NOT COMPLETED|Overall Study||0
2614272|NCT00096161|6419447|P4|COMPLETED|Overall Study||0
2614273|NCT00096161|6419448|P3|COMPLETED|Overall Study||6
2614274|NCT00096161|6419449|P2|COMPLETED|Overall Study||10
2614275|NCT00096161|6419450|P1|COMPLETED|Overall Study||20
2614276|NCT00096161|6419447|P4|STARTED|Overall Study||0
2614277|NCT00096161|6419448|P3|STARTED|Overall Study||6
2614278|NCT00096161|6419449|P2|STARTED|Overall Study||10
2614279|NCT00096161|6419450|P1|STARTED|Overall Study||20
2614280|NCT00096135|6419482|P2|NOT COMPLETED|Overall Study||15
2614281|NCT00096135|6419483|P1|NOT COMPLETED|Overall Study||63
2614282|NCT00096135|6419482|P2|COMPLETED|Overall Study||27
2614283|NCT00096135|6419483|P1|COMPLETED|Overall Study||63
2614284|NCT00096135|6419482|P2|STARTED|Overall Study||42
2614285|NCT00096135|6419483|P1|STARTED|Overall Study||126
2614286|NCT00096122|6419489|P1|NOT COMPLETED|Overall Study||0
2614287|NCT00096122|6419489|P1|COMPLETED|Overall Study||95
2614288|NCT00096122|6419489|P1|STARTED|Overall Study||95
2614289|NCT00096109|6419493|P1|NOT COMPLETED|Overall Study||0
2614290|NCT00096109|6419493|P1|COMPLETED|Overall Study||11
2614291|NCT00096109|6419493|P1|STARTED|Overall Study||11
2614292|NCT00096044|6419499|P1|NOT COMPLETED|Overall Study||34
2614293|NCT00096044|6419499|P1|COMPLETED|Overall Study||11
2614294|NCT00096044|6419499|P1|STARTED|Overall Study||45
2614295|NCT00096031|6419508|P1|NOT COMPLETED|Overall Study||63
2614296|NCT00096031|6419508|P1|COMPLETED|Overall Study||0
2614297|NCT00096031|6419508|P1|Eligible and Began Protocol Therapy|Overall Study||55
2614298|NCT00096031|6419508|P1|Eligible|Overall Study||57
2614299|NCT00096031|6419508|P1|STARTED|Overall Study||63
2614300|NCT00096018|6419516|P2|NOT COMPLETED|Overall Study||14
2614301|NCT00096018|6419517|P1|NOT COMPLETED|Overall Study||2
2614302|NCT00096018|6419516|P2|COMPLETED|Overall Study||16
2614303|NCT00096018|6419517|P1|COMPLETED|Overall Study||11
2614304|NCT00096018|6419516|P2|Treated With Study Therapy|Overall Study||25
2614305|NCT00096018|6419517|P1|Treated With Study Therapy|Overall Study||13
2614306|NCT00096018|6419516|P2|STARTED|Overall Study||30
2614307|NCT00096018|6419517|P1|STARTED|Overall Study||13
2614308|NCT00095979|6419525|P1|NOT COMPLETED|Overall Study||2
2614309|NCT00095979|6419525|P1|COMPLETED|Overall Study||50
2614310|NCT00095979|6419525|P1|STARTED|Overall Study||52
2614311|NCT00095940|6419543|P9|NOT COMPLETED|Lapatinib Continuation/Phase II||13
2614312|NCT00095940|6419544|P8|NOT COMPLETED|Lapatinib Continuation/Phase II||2
2614313|NCT00095940|6419545|P7|NOT COMPLETED|Lapatinib Continuation/Phase II||2
2614314|NCT00095940|6419546|P6|NOT COMPLETED|Lapatinib Continuation/Phase II||13
2614315|NCT00095940|6419547|P5|NOT COMPLETED|Lapatinib Continuation/Phase II||0
2614316|NCT00095940|6419548|P4|NOT COMPLETED|Lapatinib Continuation/Phase II||0
2614317|NCT00095940|6419549|P3|NOT COMPLETED|Lapatinib Continuation/Phase II||16
2614318|NCT00095940|6419550|P2|NOT COMPLETED|Lapatinib Continuation/Phase II||2
2614319|NCT00095940|6419551|P1|NOT COMPLETED|Lapatinib Continuation/Phase II||2
2614320|NCT00095940|6419543|P9|COMPLETED|Lapatinib Continuation/Phase II||1
2614321|NCT00095940|6419544|P8|COMPLETED|Lapatinib Continuation/Phase II||0
2614322|NCT00095940|6419545|P7|COMPLETED|Lapatinib Continuation/Phase II||0
2614323|NCT00095940|6419546|P6|COMPLETED|Lapatinib Continuation/Phase II||0
2614324|NCT00095940|6419547|P5|COMPLETED|Lapatinib Continuation/Phase II||0
2614325|NCT00095940|6419548|P4|COMPLETED|Lapatinib Continuation/Phase II||0
2614326|NCT00095940|6419549|P3|COMPLETED|Lapatinib Continuation/Phase II||1
2614327|NCT00095940|6419550|P2|COMPLETED|Lapatinib Continuation/Phase II||0
2614328|NCT00095940|6419551|P1|COMPLETED|Lapatinib Continuation/Phase II||0
2614329|NCT00095940|6419543|P9|STARTED|Lapatinib Continuation/Phase II||14
2614330|NCT00095940|6419544|P8|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
2614331|NCT00095940|6419545|P7|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
2614332|NCT00095940|6419546|P6|STARTED|Lapatinib Continuation/Phase II||13
2614333|NCT00095940|6419547|P5|STARTED|Lapatinib Continuation/Phase II||0
2614334|NCT00095940|6419548|P4|STARTED|Lapatinib Continuation/Phase II||0
2614335|NCT00095940|6419549|P3|STARTED|Lapatinib Continuation/Phase II||17
2614336|NCT00095940|6419550|P2|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
2614337|NCT00095940|6419551|P1|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
2614338|NCT00095940|6419543|P9|NOT COMPLETED|Molecular Biology Phase||0
2614339|NCT00095940|6419544|P8|NOT COMPLETED|Molecular Biology Phase||0
2614340|NCT00095940|6419545|P7|NOT COMPLETED|Molecular Biology Phase||0
2614341|NCT00095940|6419546|P6|NOT COMPLETED|Molecular Biology Phase||0
2614342|NCT00095940|6419547|P5|NOT COMPLETED|Molecular Biology Phase||0
2614343|NCT00095940|6419548|P4|NOT COMPLETED|Molecular Biology Phase||0
2614344|NCT00095940|6419549|P3|NOT COMPLETED|Molecular Biology Phase||0
2614345|NCT00095940|6419550|P2|NOT COMPLETED|Molecular Biology Phase||0
2614346|NCT00095940|6419551|P1|NOT COMPLETED|Molecular Biology Phase||0
2614347|NCT00095940|6419543|P9|COMPLETED|Molecular Biology Phase||0
2614348|NCT00095940|6419544|P8|COMPLETED|Molecular Biology Phase||2
2614349|NCT00095940|6419545|P7|COMPLETED|Molecular Biology Phase||2
2614350|NCT00095940|6419546|P6|COMPLETED|Molecular Biology Phase||0
2614351|NCT00095940|6419547|P5|COMPLETED|Molecular Biology Phase||0
2614352|NCT00095940|6419548|P4|COMPLETED|Molecular Biology Phase||0
2614353|NCT00095940|6419549|P3|COMPLETED|Molecular Biology Phase||0
2614354|NCT00095940|6419550|P2|COMPLETED|Molecular Biology Phase||2
2614355|NCT00095940|6419551|P1|COMPLETED|Molecular Biology Phase||2
2614356|NCT00095940|6419543|P9|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
2614357|NCT00095940|6419544|P8|STARTED|Molecular Biology Phase||2
2614358|NCT00095940|6419545|P7|STARTED|Molecular Biology Phase||2
2614359|NCT00095940|6419546|P6|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
2614360|NCT00095940|6419547|P5|STARTED|Molecular Biology Phase||0
2614361|NCT00095940|6419548|P4|STARTED|Molecular Biology Phase||0
2614362|NCT00095940|6419549|P3|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
2614363|NCT00095940|6419550|P2|STARTED|Molecular Biology Phase||2
2614364|NCT00095940|6419551|P1|STARTED|Molecular Biology Phase||2
2614365|NCT00095875|6419575|P2|NOT COMPLETED|Overall Study||9
2614366|NCT00095875|6419576|P1|NOT COMPLETED|Overall Study||14
2614367|NCT00095875|6419575|P2|COMPLETED|Overall Study||66
2614368|NCT00095875|6419576|P1|COMPLETED|Overall Study||56
2614369|NCT00095875|6419575|P2|STARTED|Overall Study||75
2614370|NCT00095875|6419576|P1|STARTED|Overall Study||70
2614371|NCT00095836|6419584|P1|NOT COMPLETED|Overall Study||4
2614372|NCT00095836|6419584|P1|COMPLETED|Overall Study||23
2614373|NCT00095836|6419584|P1|STARTED|Overall Study||27
2614374|NCT00095784|6419591|P1|NOT COMPLETED|Overall Study||0
2614375|NCT00095784|6419591|P1|COMPLETED|Overall Study||21
2614376|NCT00095784|6419591|P1|STARTED|Overall Study||21
2614377|NCT00095628|6419614|P1|NOT COMPLETED|Overall Study||1
2614378|NCT00095628|6419614|P1|COMPLETED|Overall Study||20
2614379|NCT00095628|6419614|P1|STARTED|Overall Study||21
2614380|NCT00095576|6419625|P2|NOT COMPLETED|Overall Study||1481
2614381|NCT00095576|6419626|P1|NOT COMPLETED|Overall Study||1475
2614382|NCT00095576|6419625|P2|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|14
2614383|NCT00095576|6419626|P1|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|9
2614384|NCT00095576|6419625|P2|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1361
2614385|NCT00095576|6419626|P1|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1328
2614386|NCT00095576|6419625|P2|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1443
2614387|NCT00095576|6419626|P1|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1426
2614388|NCT00095576|6419625|P2|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1495
2614389|NCT00095576|6419626|P1|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1484
2614390|NCT00095576|6419625|P2|STARTED|Overall Study||1495
2614391|NCT00095576|6419626|P1|STARTED|Overall Study||1484
2614392|NCT00095563|6419638|P1|NOT COMPLETED|Overall Study||0
2614393|NCT00095563|6419638|P1|COMPLETED|Overall Study||39
2614394|NCT00095563|6419638|P1|STARTED|Overall Study||39
2614395|NCT00095498|6419650|P3|NOT COMPLETED|Overall Study||39
2614396|NCT00095498|6419651|P2|NOT COMPLETED|Overall Study||35
2614397|NCT00095498|6419652|P1|NOT COMPLETED|Overall Study||37
2614398|NCT00095498|6419650|P3|COMPLETED|Overall Study||39
2614399|NCT00095498|6419651|P2|COMPLETED|Overall Study||38
2614400|NCT00095498|6419652|P1|COMPLETED|Overall Study||39
2614401|NCT00095498|6419650|P3|Received Investigational Product|Overall Study||75
2614402|NCT00095498|6419651|P2|Received Investigational Product|Overall Study||71
2614403|NCT00095498|6419652|P1|Received Investigational Product|Overall Study||72
2614404|NCT00095498|6419650|P3|STARTED|Overall Study||78
2614405|NCT00095498|6419651|P2|STARTED|Overall Study||73
2614406|NCT00095498|6419652|P1|STARTED|Overall Study||76
2614407|NCT00095303|6420079|P2|NOT COMPLETED|Follow Up Study||58
2614408|NCT00095303|6420080|P1|NOT COMPLETED|Follow Up Study||59
2614409|NCT00095303|6420079|P2|COMPLETED|Follow Up Study||121
2614410|NCT00095303|6420080|P1|COMPLETED|Follow Up Study||140
2614411|NCT00095303|6420079|P2|STARTED|Follow Up Study|179 (TAU) gave permission for future contact; not a requirement to finish Main to start Follow up|179
2614412|NCT00095303|6420080|P1|STARTED|Follow Up Study|199 (BSFT) gave permission for future contact; not a requirement to finish Main to start Follow up|199
2614413|NCT00095303|6420079|P2|NOT COMPLETED|Main Study||87
2614414|NCT00095303|6420080|P1|NOT COMPLETED|Main Study||91
2614415|NCT00095303|6420079|P2|COMPLETED|Main Study||148
2614416|NCT00095303|6420080|P1|COMPLETED|Main Study||154
2614417|NCT00095303|6420079|P2|STARTED|Main Study||235
2614418|NCT00095303|6420080|P1|STARTED|Main Study||245
2614419|NCT00095238|6420148|P2|NOT COMPLETED|Overall Study||852
2614420|NCT00095238|6420149|P1|NOT COMPLETED|Overall Study||857
2614421|NCT00095238|6420148|P2|COMPLETED|Overall Study|completed double-blind therapy|1209
2614422|NCT00095238|6420149|P1|COMPLETED|Overall Study|completed double-blind therapy|1210
2614423|NCT00095238|6420148|P2|Safety (Treated) Population|Overall Study|One participant randomized to irbesartan received placebo.|2062
2614424|NCT00095238|6420149|P1|Safety (Treated) Population|Overall Study|Two participants were randomized but not treated; 1 randomized to irbesartan received placebo|2064
2614425|NCT00095238|6420148|P2|STARTED|Overall Study|number randomized|2061
2614426|NCT00095238|6420149|P1|STARTED|Overall Study|number randomized|2067
2614427|NCT00095212|6420211|P2|NOT COMPLETED|Overall Study||3
2614428|NCT00095212|6420212|P1|NOT COMPLETED|Overall Study||1
2614429|NCT00095212|6420211|P2|COMPLETED|Overall Study||9
2614430|NCT00095212|6420212|P1|COMPLETED|Overall Study||12
2614431|NCT00095212|6420211|P2|STARTED|Overall Study||12
2614432|NCT00095212|6420212|P1|STARTED|Overall Study||13
2614433|NCT00095199|6420242|P4|NOT COMPLETED|Overall Study||143
2614434|NCT00095199|6420243|P3|NOT COMPLETED|Overall Study||160
2614435|NCT00095199|6420244|P2|NOT COMPLETED|Overall Study||242
2614436|NCT00095199|6420245|P1|NOT COMPLETED|Overall Study||296
2614437|NCT00095199|6420242|P4|COMPLETED|Overall Study||23
2614438|NCT00095199|6420243|P3|COMPLETED|Overall Study||7
2614439|NCT00095199|6420244|P2|COMPLETED|Overall Study||62
2614440|NCT00095199|6420245|P1|COMPLETED|Overall Study||6
2614441|NCT00095199|6420242|P4|STARTED|Overall Study||166
2614442|NCT00095199|6420243|P3|STARTED|Overall Study||167
2614443|NCT00095199|6420244|P2|STARTED|Overall Study||304
2614444|NCT00095199|6420245|P1|STARTED|Overall Study|1 participant has no data in database; not included in analyses. Data was lost/destroyed at site.|302
2614445|NCT00095173|6420283|P6|NOT COMPLETED|Open-Label Extension Phase (Period C)||32
2614446|NCT00095173|6420284|P5|NOT COMPLETED|Open-Label Extension Phase (Period C)||29
2614447|NCT00095173|6420285|P4|NOT COMPLETED|Open-Label Extension Phase (Period C)||23
2614448|NCT00095173|6420286|P3|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
2614449|NCT00095173|6420287|P2|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
2614450|NCT00095173|6420288|P1|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
2614451|NCT00095173|6420283|P6|COMPLETED|Open-Label Extension Phase (Period C)||27
2614452|NCT00095173|6420284|P5|COMPLETED|Open-Label Extension Phase (Period C)||29
2614453|NCT00095173|6420285|P4|COMPLETED|Open-Label Extension Phase (Period C)||13
2614454|NCT00095173|6420286|P3|COMPLETED|Open-Label Extension Phase (Period C)||0
2614455|NCT00095173|6420287|P2|COMPLETED|Open-Label Extension Phase (Period C)||0
2614456|NCT00095173|6420288|P1|COMPLETED|Open-Label Extension Phase (Period C)||0
2614457|NCT00095173|6420283|P6|STARTED|Open-Label Extension Phase (Period C)|Includes 33 who discontinued Period B due to a flare and 26 who completed Period B with no flare|59
2614458|NCT00095173|6420284|P5|STARTED|Open-Label Extension Phase (Period C)|Includes 47 who completed Period B with no flare and 11 who discontinued Period B due to a flare|58
2614459|NCT00095173|6420285|P4|STARTED|Open-Label Extension Phase (Period C)|Participants were non-responders from Period A who re-entered in Period C.|36
2614460|NCT00095173|6420286|P3|STARTED|Open-Label Extension Phase (Period C)||0
2614461|NCT00095173|6420287|P2|STARTED|Open-Label Extension Phase (Period C)||0
2614462|NCT00095173|6420288|P1|STARTED|Open-Label Extension Phase (Period C)||0
2614463|NCT00095173|6420283|P6|NOT COMPLETED|Double-Blind Phase (Period B)||0
2614464|NCT00095173|6420284|P5|NOT COMPLETED|Double-Blind Phase (Period B)||0
2614465|NCT00095173|6420285|P4|NOT COMPLETED|Double-Blind Phase (Period B)||0
2614466|NCT00095173|6420286|P3|NOT COMPLETED|Double-Blind Phase (Period B)||31
2614467|NCT00095173|6420287|P2|NOT COMPLETED|Double-Blind Phase (Period B)||11
2614468|NCT00095173|6420288|P1|NOT COMPLETED|Double-Blind Phase (Period B)||0
2614469|NCT00095173|6420283|P6|COMPLETED|Double-Blind Phase (Period B)||0
2614470|NCT00095173|6420284|P5|COMPLETED|Double-Blind Phase (Period B)||0
2614471|NCT00095173|6420285|P4|COMPLETED|Double-Blind Phase (Period B)||0
2614472|NCT00095173|6420286|P3|COMPLETED|Double-Blind Phase (Period B)||31
2614473|NCT00095173|6420287|P2|COMPLETED|Double-Blind Phase (Period B)||49
2614474|NCT00095173|6420288|P1|COMPLETED|Double-Blind Phase (Period B)||0
2614475|NCT00095173|6420283|P6|STARTED|Double-Blind Phase (Period B)||0
2614476|NCT00095173|6420284|P5|STARTED|Double-Blind Phase (Period B)||0
2614477|NCT00095173|6420285|P4|STARTED|Double-Blind Phase (Period B)||0
2614478|NCT00095173|6420286|P3|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|62
2614479|NCT00095173|6420287|P2|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|60
2614480|NCT00095173|6420288|P1|STARTED|Double-Blind Phase (Period B)|All participants did not continue; responders entered Period B; non-responders re-entered Period C.|0
2614481|NCT00095173|6420283|P6|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
2614482|NCT00095173|6420284|P5|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
2614483|NCT00095173|6420285|P4|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
2614484|NCT00095173|6420286|P3|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
2614485|NCT00095173|6420287|P2|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
2614486|NCT00095173|6420288|P1|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||20
2614487|NCT00095173|6420283|P6|COMPLETED|Open-Label Lead-In Phase (Period A)||0
2614488|NCT00095173|6420284|P5|COMPLETED|Open-Label Lead-In Phase (Period A)||0
2614489|NCT00095173|6420285|P4|COMPLETED|Open-Label Lead-In Phase (Period A)||0
2614490|NCT00095173|6420286|P3|COMPLETED|Open-Label Lead-In Phase (Period A)||0
2614491|NCT00095173|6420287|P2|COMPLETED|Open-Label Lead-In Phase (Period A)||0
2614492|NCT00095173|6420288|P1|COMPLETED|Open-Label Lead-In Phase (Period A)||170
2614493|NCT00095173|6420283|P6|STARTED|Open-Label Lead-In Phase (Period A)||0
2614494|NCT00095173|6420284|P5|STARTED|Open-Label Lead-In Phase (Period A)||0
2614495|NCT00095173|6420285|P4|STARTED|Open-Label Lead-In Phase (Period A)||0
2614496|NCT00095173|6420286|P3|STARTED|Open-Label Lead-In Phase (Period A)||0
2614497|NCT00095173|6420287|P2|STARTED|Open-Label Lead-In Phase (Period A)||0
2614498|NCT00095173|6420288|P1|STARTED|Open-Label Lead-In Phase (Period A)||190
2614499|NCT00095147|6420326|P5|NOT COMPLETED|Long-term Extension Period||45
2614500|NCT00095147|6420327|P4|NOT COMPLETED|Long-term Extension Period||0
2614501|NCT00095147|6420328|P3|NOT COMPLETED|Long-term Extension Period||0
2614502|NCT00095147|6420329|P2|NOT COMPLETED|Long-term Extension Period||0
2614503|NCT00095147|6420330|P1|NOT COMPLETED|Long-term Extension Period||0
2614504|NCT00095147|6420326|P5|COMPLETED|Long-term Extension Period||327
2614505|NCT00095147|6420327|P4|COMPLETED|Long-term Extension Period||0
2614506|NCT00095147|6420328|P3|COMPLETED|Long-term Extension Period||0
2614507|NCT00095147|6420329|P2|COMPLETED|Long-term Extension Period||0
2614508|NCT00095147|6420330|P1|COMPLETED|Long-term Extension Period||0
2614509|NCT00095147|6420326|P5|STARTED|Long-term Extension Period||372
2614510|NCT00095147|6420327|P4|STARTED|Long-term Extension Period||0
2614511|NCT00095147|6420328|P3|STARTED|Long-term Extension Period||0
2614512|NCT00095147|6420329|P2|STARTED|Long-term Extension Period||0
2614513|NCT00095147|6420330|P1|STARTED|Long-term Extension Period||0
2614514|NCT00095147|6420326|P5|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
2614515|NCT00095147|6420327|P4|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||3
2614516|NCT00095147|6420328|P3|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
2614517|NCT00095147|6420329|P2|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||11
2614518|NCT00095147|6420330|P1|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||8
2614519|NCT00095147|6420326|P5|COMPLETED|Double-blind Period 2 (Days 198-365)||0
2614520|NCT00095147|6420327|P4|COMPLETED|Double-blind Period 2 (Days 198-365)||104
2614521|NCT00095147|6420328|P3|COMPLETED|Double-blind Period 2 (Days 198-365)||0
2614522|NCT00095147|6420329|P2|COMPLETED|Double-blind Period 2 (Days 198-365)||141
2614523|NCT00095147|6420330|P1|COMPLETED|Double-blind Period 2 (Days 198-365)||139
2614524|NCT00095147|6420326|P5|STARTED|Double-blind Period 2 (Days 198-365)||0
2614525|NCT00095147|6420327|P4|STARTED|Double-blind Period 2 (Days 198-365)||107
2614526|NCT00095147|6420328|P3|STARTED|Double-blind Period 2 (Days 198-365)||0
2614527|NCT00095147|6420329|P2|STARTED|Double-blind Period 2 (Days 198-365)||152
2614528|NCT00095147|6420330|P1|STARTED|Double-blind Period 2 (Days 198-365)||147
2614529|NCT00095147|6420326|P5|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
2614530|NCT00095147|6420327|P4|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
2614531|NCT00095147|6420328|P3|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||3
2614532|NCT00095147|6420329|P2|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||13
2614533|NCT00095147|6420330|P1|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||9
2614534|NCT00095147|6420326|P5|COMPLETED|Double-blind Period 1 (Days 1-197)||0
2614535|NCT00095147|6420327|P4|COMPLETED|Double-blind Period 1 (Days 1-197)||0
2614536|NCT00095147|6420328|P3|COMPLETED|Double-blind Period 1 (Days 1-197)||107
2614537|NCT00095147|6420329|P2|COMPLETED|Double-blind Period 1 (Days 1-197)||152
2614538|NCT00095147|6420330|P1|COMPLETED|Double-blind Period 1 (Days 1-197)||147
2614539|NCT00095147|6420326|P5|STARTED|Double-blind Period 1 (Days 1-197)||0
2614540|NCT00095147|6420327|P4|STARTED|Double-blind Period 1 (Days 1-197)||0
2614541|NCT00095147|6420328|P3|STARTED|Double-blind Period 1 (Days 1-197)||110
2614542|NCT00095147|6420329|P2|STARTED|Double-blind Period 1 (Days 1-197)||165
2614543|NCT00095147|6420330|P1|STARTED|Double-blind Period 1 (Days 1-197)||156
2614544|NCT00095121|6420525|P2|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||19
2614545|NCT00095121|6420526|P1|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||62
2614546|NCT00095121|6420525|P2|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|35
2614547|NCT00095121|6420526|P1|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|46
2614548|NCT00095121|6420525|P2|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||11
2614549|NCT00095121|6420526|P1|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||21
2614550|NCT00095121|6420525|P2|STARTED|Open-Label (Study Weeks 49 Through 240)||54
2614551|NCT00095121|6420526|P1|STARTED|Open-Label (Study Weeks 49 Through 240)||108
2614552|NCT00095121|6420525|P2|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||0
2614553|NCT00095121|6420526|P1|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||3
2614554|NCT00095121|6420525|P2|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||58
2614555|NCT00095121|6420526|P1|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||112
2614556|NCT00095121|6420525|P2|STARTED|Double-Blind (Study Weeks 0 Through 48)||58
2614557|NCT00095121|6420526|P1|STARTED|Double-Blind (Study Weeks 0 Through 48)||115
2614558|NCT00095056|6420572|P2|NOT COMPLETED|Phase B (Weeks 12-54)||5
2614559|NCT00095056|6420573|P1|NOT COMPLETED|Phase B (Weeks 12-54)||10
2614560|NCT00095056|6420572|P2|COMPLETED|Phase B (Weeks 12-54)||20
2614561|NCT00095056|6420573|P1|COMPLETED|Phase B (Weeks 12-54)||46
2614562|NCT00095056|6420572|P2|STARTED|Phase B (Weeks 12-54)||25
2614563|NCT00095056|6420573|P1|STARTED|Phase B (Weeks 12-54)|2 randomized patients completed Period 1 but did not enter Period 2.|56
2614564|NCT00095056|6420572|P2|NOT COMPLETED|Phase A (Weeks 0-12)||1
2614565|NCT00095056|6420573|P1|NOT COMPLETED|Phase A (Weeks 0-12)||7
2614566|NCT00095056|6420572|P2|COMPLETED|Phase A (Weeks 0-12)||25
2614567|NCT00095056|6420573|P1|COMPLETED|Phase A (Weeks 0-12)||58
2614568|NCT00095056|6420572|P2|STARTED|Phase A (Weeks 0-12)||26
2614569|NCT00095056|6420573|P1|STARTED|Phase A (Weeks 0-12)||65
2614570|NCT00094900|6420581|P1|NOT COMPLETED|Overall Study||1
2614571|NCT00094900|6420581|P1|COMPLETED|Overall Study||10
2614572|NCT00094900|6420581|P1|STARTED|Overall Study||11
2614573|NCT00094887|6420683|P2|NOT COMPLETED|Overall Study||4
2614574|NCT00094887|6420684|P1|NOT COMPLETED|Overall Study||4
2614575|NCT00094887|6420683|P2|COMPLETED|Overall Study||71
2614576|NCT00094887|6420684|P1|COMPLETED|Overall Study||71
2614577|NCT00094887|6420683|P2|Primary Efficacy Population|Overall Study||64
2614578|NCT00094887|6420684|P1|Primary Efficacy Population|Overall Study||65
2614579|NCT00094887|6420683|P2|Per Protocol Analysis Set|Overall Study||71
2614580|NCT00094887|6420684|P1|Per Protocol Analysis Set|Overall Study||71
2614581|NCT00094887|6420683|P2|Intent to Treat Population|Overall Study||75
2614582|NCT00094887|6420684|P1|Intent to Treat Population|Overall Study||75
2614583|NCT00094887|6420683|P2|Safety Population|Overall Study||75
2614584|NCT00094887|6420684|P1|Safety Population|Overall Study||75
2614585|NCT00094887|6420683|P2|STARTED|Overall Study||75
2614586|NCT00094887|6420684|P1|STARTED|Overall Study||75
2614587|NCT00094861|6420702|P2|NOT COMPLETED|Overall Study||9
2614588|NCT00094861|6420703|P1|NOT COMPLETED|Overall Study||18
2614589|NCT00094861|6420702|P2|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|40
2614590|NCT00094861|6420703|P1|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|28
2614591|NCT00094861|6420702|P2|Participants Treated|Overall Study||48
2614592|NCT00094861|6420703|P1|Participants Treated|Overall Study||46
2614593|NCT00094861|6420702|P2|STARTED|Overall Study||49
2614594|NCT00094861|6420703|P1|STARTED|Overall Study||46
2614595|NCT00094835|6420730|P7|NOT COMPLETED|Overall Study||2
2614596|NCT00094835|6420731|P6|NOT COMPLETED|Overall Study||3
2614597|NCT00094835|6420732|P5|NOT COMPLETED|Overall Study||4
2614598|NCT00094835|6420733|P4|NOT COMPLETED|Overall Study||1
2614599|NCT00094835|6420734|P3|NOT COMPLETED|Overall Study||3
2614600|NCT00094835|6420735|P2|NOT COMPLETED|Overall Study||3
2614601|NCT00094835|6420736|P1|NOT COMPLETED|Overall Study||4
2614602|NCT00094835|6420730|P7|COMPLETED|Overall Study||4
2614603|NCT00094835|6420731|P6|COMPLETED|Overall Study||3
2614604|NCT00094835|6420732|P5|COMPLETED|Overall Study||3
2614605|NCT00094835|6420733|P4|COMPLETED|Overall Study||4
2614606|NCT00094835|6420734|P3|COMPLETED|Overall Study||4
2614607|NCT00094835|6420735|P2|COMPLETED|Overall Study||8
2614608|NCT00094835|6420736|P1|COMPLETED|Overall Study||5
2614609|NCT00094835|6420730|P7|Treated With Motesanib|Overall Study||6
2614610|NCT00094835|6420731|P6|Treated With Motesanib|Overall Study||5
2614611|NCT00094835|6420732|P5|Treated With Motesanib|Overall Study||7
2614612|NCT00094835|6420733|P4|Treated With Motesanib|Overall Study||4
2614613|NCT00094835|6420734|P3|Treated With Motesanib|Overall Study||6
2614614|NCT00094835|6420735|P2|Treated With Motesanib|Overall Study||11
2614615|NCT00094835|6420736|P1|Treated With Motesanib|Overall Study||6
2614616|NCT00094835|6420730|P7|STARTED|Overall Study||6
2614617|NCT00094835|6420731|P6|STARTED|Overall Study||6
2614618|NCT00094835|6420732|P5|STARTED|Overall Study||7
2614619|NCT00094835|6420733|P4|STARTED|Overall Study||5
2614620|NCT00094835|6420734|P3|STARTED|Overall Study||7
2614621|NCT00094835|6420735|P2|STARTED|Overall Study||11
2614622|NCT00094835|6420736|P1|STARTED|Overall Study||9
2614623|NCT00094809|6420814|P2|NOT COMPLETED|Overall Study||65
2614624|NCT00094809|6420815|P1|NOT COMPLETED|Overall Study||52
2614625|NCT00094809|6420814|P2|COMPLETED|Overall Study|Subjects who completed treatment and LTFU|61
2614626|NCT00094809|6420815|P1|COMPLETED|Overall Study|Subjects who completed treatment and Long term follow up (LTFU)|74
2614627|NCT00094809|6420814|P2|Completed All 4 Cycles of Treatment|Overall Study||90
2614628|NCT00094809|6420815|P1|Completed All 4 Cycles of Treatment|Overall Study||98
2614629|NCT00094809|6420814|P2|Properly Consented; Received Study Drug|Overall Study||118
2614630|NCT00094809|6420815|P1|Properly Consented; Received Study Drug|Overall Study||123
2614631|NCT00094809|6420814|P2|Received Study Drug|Overall Study||118
2614632|NCT00094809|6420815|P1|Received Study Drug|Overall Study||124
2614633|NCT00094809|6420814|P2|STARTED|Overall Study||126
2614634|NCT00094809|6420815|P1|STARTED|Overall Study||126
2614635|NCT00094770|6420841|P2|NOT COMPLETED|Year 2 (Week 0 to Week 104)||320
2614636|NCT00094770|6420842|P1|NOT COMPLETED|Year 2 (Week 0 to Week 104)||333
2614637|NCT00094770|6420841|P2|COMPLETED|Year 2 (Week 0 to Week 104)||264
2614638|NCT00094770|6420842|P1|COMPLETED|Year 2 (Week 0 to Week 104)||255
2614639|NCT00094770|6420841|P2|STARTED|Year 2 (Week 0 to Week 104)||584
2614640|NCT00094770|6420842|P1|STARTED|Year 2 (Week 0 to Week 104)||588
2614641|NCT00094770|6420841|P2|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||172
2614642|NCT00094770|6420842|P1|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||202
2614643|NCT00094770|6420841|P2|COMPLETED|Year 1 ( Week 0 to Week 52)|11 Participants who Completed Week 52, Did NOT Enter second year|412
2614644|NCT00094770|6420842|P1|COMPLETED|Year 1 ( Week 0 to Week 52)|4 Participants who Completed Week 52, Did NOT Enter second year|386
2614645|NCT00094770|6420841|P2|STARTED|Year 1 ( Week 0 to Week 52)||584
2614646|NCT00094770|6420842|P1|STARTED|Year 1 ( Week 0 to Week 52)||588
2614647|NCT00094757|6420873|P3|NOT COMPLETED|Overall Study||30
2614648|NCT00094757|6420874|P2|NOT COMPLETED|Overall Study||62
2614649|NCT00094757|6420875|P1|NOT COMPLETED|Overall Study||53
2614650|NCT00094757|6420873|P3|COMPLETED|Overall Study||80
2614651|NCT00094757|6420874|P2|COMPLETED|Overall Study||144
2614652|NCT00094757|6420875|P1|COMPLETED|Overall Study||152
2614653|NCT00094757|6420873|P3|STARTED|Overall Study||110
2614654|NCT00094757|6420874|P2|STARTED|Overall Study||206
2614655|NCT00094757|6420875|P1|STARTED|Overall Study||205
2614656|NCT00094653|6420895|P3|NOT COMPLETED|Overall Study||126
2614657|NCT00094653|6420896|P2|NOT COMPLETED|Overall Study||106
2614658|NCT00094653|6420897|P1|NOT COMPLETED|Overall Study||321
2614659|NCT00094653|6420895|P3|COMPLETED|Overall Study||10
2614660|NCT00094653|6420896|P2|COMPLETED|Overall Study||31
2614661|NCT00094653|6420897|P1|COMPLETED|Overall Study||82
2614662|NCT00094653|6420895|P3|Treated|Overall Study||131
2614663|NCT00094653|6420896|P2|Treated|Overall Study||131
2614664|NCT00094653|6420897|P1|Treated|Overall Study||381
2614665|NCT00094653|6420895|P3|STARTED|Overall Study||136
2614666|NCT00094653|6420896|P2|STARTED|Overall Study||137
2614667|NCT00094653|6420897|P1|STARTED|Overall Study||403
2614668|NCT00094575|6420960|P2|NOT COMPLETED|Overall Study||146
2614669|NCT00094575|6420961|P1|NOT COMPLETED|Overall Study||146
2614670|NCT00094575|6420960|P2|COMPLETED|Overall Study||291
2614671|NCT00094575|6420961|P1|COMPLETED|Overall Study||298
2614672|NCT00094575|6420960|P2|STARTED|Overall Study||437
2614673|NCT00094575|6420961|P1|STARTED|Overall Study||444
2614674|NCT00094536|6420981|P1|NOT COMPLETED|Treatment and Follow-up||31
2614675|NCT00094536|6420981|P1|COMPLETED|Treatment and Follow-up|51 subjects successfully completed the study.|51
2614676|NCT00094536|6420981|P1|36 Month Follow-up|Treatment and Follow-up||51
2614677|NCT00094536|6420981|P1|24 Month Follow-up|Treatment and Follow-up||53
2614678|NCT00094536|6420981|P1|12 Month Follow-up|Treatment and Follow-up|69 subjects were evaluated at 1-year post-treatment for the primary endpoint of success.|69
2614679|NCT00094536|6420981|P1|STARTED|Treatment and Follow-up|82 subjects qualified for and underwent the study treatment.|82
2614680|NCT00094536|6420981|P1|NOT COMPLETED|Inclusion Exclusion Evaluation||24
2614681|NCT00094536|6420981|P1|COMPLETED|Inclusion Exclusion Evaluation||82
2614682|NCT00094536|6420981|P1|STARTED|Inclusion Exclusion Evaluation||106
2614683|NCT00094497|6420987|P2|NOT COMPLETED|Overall Study||0
2614684|NCT00094497|6420988|P1|NOT COMPLETED|Overall Study||0
2614685|NCT00094497|6420987|P2|COMPLETED|Overall Study||153
2614686|NCT00094497|6420988|P1|COMPLETED|Overall Study||151
2614687|NCT00094497|6420987|P2|Received Second Line Therapy|Overall Study||101
2614688|NCT00094497|6420988|P1|Received Second Line Therapy|Overall Study||84
2614689|NCT00094497|6420987|P2|Treated|Overall Study||149
2614690|NCT00094497|6420988|P1|Treated|Overall Study||148
2614691|NCT00094497|6420987|P2|STARTED|Overall Study||153
2614692|NCT00094497|6420988|P1|STARTED|Overall Study||151
2614693|NCT00094458|6421005|P6|NOT COMPLETED|OLE: Open-Label Extension||4
2614694|NCT00094458|6421006|P5|NOT COMPLETED|OLE: Open-Label Extension||5
2614695|NCT00094458|6421007|P4|NOT COMPLETED|OLE: Open-Label Extension||1
2614696|NCT00094458|6421008|P3|NOT COMPLETED|OLE: Open-Label Extension||0
2614697|NCT00094458|6421009|P2|NOT COMPLETED|OLE: Open-Label Extension||0
2614698|NCT00094458|6421010|P1|NOT COMPLETED|OLE: Open-Label Extension||0
2614699|NCT00094458|6421005|P6|COMPLETED|OLE: Open-Label Extension||13
2614700|NCT00094458|6421006|P5|COMPLETED|OLE: Open-Label Extension||13
2614701|NCT00094458|6421007|P4|COMPLETED|OLE: Open-Label Extension||7
2614702|NCT00094458|6421008|P3|COMPLETED|OLE: Open-Label Extension||0
2614703|NCT00094458|6421009|P2|COMPLETED|OLE: Open-Label Extension||0
2614704|NCT00094458|6421010|P1|COMPLETED|OLE: Open-Label Extension||0
2614705|NCT00094458|6421005|P6|STARTED|OLE: Open-Label Extension||17
2614706|NCT00094458|6421006|P5|STARTED|OLE: Open-Label Extension||18
2614707|NCT00094458|6421007|P4|STARTED|OLE: Open-Label Extension||8
2614708|NCT00094458|6421008|P3|STARTED|OLE: Open-Label Extension||0
2614709|NCT00094458|6421009|P2|STARTED|OLE: Open-Label Extension||0
2614710|NCT00094458|6421010|P1|STARTED|OLE: Open-Label Extension||0
2614711|NCT00094458|6421005|P6|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
2614712|NCT00094458|6421006|P5|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
2614713|NCT00094458|6421007|P4|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
2614714|NCT00094458|6421008|P3|NOT COMPLETED|Study Extension: Week 30 Through Week 50||18
2614715|NCT00094458|6421009|P2|NOT COMPLETED|Study Extension: Week 30 Through Week 50||12
2614716|NCT00094458|6421010|P1|NOT COMPLETED|Study Extension: Week 30 Through Week 50||8
2614717|NCT00094458|6421005|P6|COMPLETED|Study Extension: Week 30 Through Week 50||0
2614718|NCT00094458|6421006|P5|COMPLETED|Study Extension: Week 30 Through Week 50||0
2614719|NCT00094458|6421007|P4|COMPLETED|Study Extension: Week 30 Through Week 50||0
2614720|NCT00094458|6421008|P3|COMPLETED|Study Extension: Week 30 Through Week 50||90
2614721|NCT00094458|6421009|P2|COMPLETED|Study Extension: Week 30 Through Week 50||85
2614722|NCT00094458|6421010|P1|COMPLETED|Study Extension: Week 30 Through Week 50||67
2614723|NCT00094458|6421005|P6|STARTED|Study Extension: Week 30 Through Week 50||0
2614724|NCT00094458|6421006|P5|STARTED|Study Extension: Week 30 Through Week 50||0
2614725|NCT00094458|6421007|P4|STARTED|Study Extension: Week 30 Through Week 50||0
2614726|NCT00094458|6421008|P3|STARTED|Study Extension: Week 30 Through Week 50||108
2614727|NCT00094458|6421009|P2|STARTED|Study Extension: Week 30 Through Week 50||97
2614728|NCT00094458|6421010|P1|STARTED|Study Extension: Week 30 Through Week 50||75
2614729|NCT00094458|6421005|P6|NOT COMPLETED|Main Study: Through Week 30||0
2614730|NCT00094458|6421006|P5|NOT COMPLETED|Main Study: Through Week 30||0
2614731|NCT00094458|6421007|P4|NOT COMPLETED|Main Study: Through Week 30||0
2614732|NCT00094458|6421008|P3|NOT COMPLETED|Main Study: Through Week 30||48
2614733|NCT00094458|6421009|P2|NOT COMPLETED|Main Study: Through Week 30||58
2614734|NCT00094458|6421010|P1|NOT COMPLETED|Main Study: Through Week 30||84
2614735|NCT00094458|6421005|P6|COMPLETED|Main Study: Through Week 30||0
2614736|NCT00094458|6421006|P5|COMPLETED|Main Study: Through Week 30||0
2614737|NCT00094458|6421007|P4|COMPLETED|Main Study: Through Week 30||0
2614738|NCT00094458|6421008|P3|COMPLETED|Main Study: Through Week 30||121
2614739|NCT00094458|6421009|P2|COMPLETED|Main Study: Through Week 30||111
2614740|NCT00094458|6421010|P1|COMPLETED|Main Study: Through Week 30||86
2614741|NCT00094458|6421005|P6|STARTED|Main Study: Through Week 30||0
2614742|NCT00094458|6421006|P5|STARTED|Main Study: Through Week 30||0
2614743|NCT00094458|6421007|P4|STARTED|Main Study: Through Week 30||0
2614744|NCT00094458|6421008|P3|STARTED|Main Study: Through Week 30||169
2614745|NCT00094458|6421009|P2|STARTED|Main Study: Through Week 30||169
2614746|NCT00094458|6421010|P1|STARTED|Main Study: Through Week 30||170
2614747|NCT00094328|6421048|P1|NOT COMPLETED|Overall Study||1
2614748|NCT00094328|6421048|P1|COMPLETED|Overall Study|Completed 12 months on treatment|13
2614749|NCT00094328|6421048|P1|STARTED|Overall Study|Received treatment|14
2614750|NCT00094302|6421062|P2|NOT COMPLETED|Overall Study||406
2614751|NCT00094302|6421063|P1|NOT COMPLETED|Overall Study||417
2614752|NCT00094302|6421062|P2|COMPLETED|Overall Study||1316
2614753|NCT00094302|6421063|P1|COMPLETED|Overall Study||1306
2614754|NCT00094302|6421062|P2|STARTED|Overall Study||1722
2614755|NCT00094302|6421063|P1|STARTED|Overall Study||1723
2614756|NCT00094211|6421121|P4|NOT COMPLETED|Overall Study||7
2614757|NCT00094211|6421122|P3|NOT COMPLETED|Overall Study||10
2614758|NCT00094211|6421123|P2|NOT COMPLETED|Overall Study||8
2614759|NCT00094211|6421124|P1|NOT COMPLETED|Overall Study||9
2614760|NCT00094211|6421121|P4|COMPLETED|Overall Study||179
2614761|NCT00094211|6421122|P3|COMPLETED|Overall Study||220
2614762|NCT00094211|6421123|P2|COMPLETED|Overall Study||251
2614763|NCT00094211|6421124|P1|COMPLETED|Overall Study||212
2614764|NCT00094211|6421121|P4|STARTED|Overall Study||186
2614765|NCT00094211|6421122|P3|STARTED|Overall Study||230
2614766|NCT00094211|6421123|P2|STARTED|Overall Study||259
2614767|NCT00094211|6421124|P1|STARTED|Overall Study||221
2614768|NCT00094172|6421152|P2|NOT COMPLETED|Overall Study||7
2614769|NCT00094172|6421153|P1|NOT COMPLETED|Overall Study||14
2614770|NCT00094172|6421152|P2|COMPLETED|Overall Study||25
2614771|NCT00094172|6421153|P1|COMPLETED|Overall Study||36
2614772|NCT00094172|6421152|P2|STARTED|Overall Study|Safety Sample: 32; Intent-to-Treat Sample: 32; Per Protocol Sample: 28|32
2614773|NCT00094172|6421153|P1|STARTED|Overall Study|Safety Sample: 49; Intent-to-Treat Sample: 49; Per Protocol Sample: 39|50
2614774|NCT00094107|6421163|P1|NOT COMPLETED|Overall Study||32
2614775|NCT00094107|6421163|P1|COMPLETED|Overall Study||0
2614776|NCT00094107|6421163|P1|STARTED|Overall Study||32
2614777|NCT00094094|6421172|P1|NOT COMPLETED|Overall Study||32
2614778|NCT00094094|6421172|P1|COMPLETED|Overall Study||0
2614779|NCT00094094|6421172|P1|STARTED|Overall Study||32
2614780|NCT00094055|6421181|P1|NOT COMPLETED|Overall Study||60
2614781|NCT00094055|6421181|P1|COMPLETED|Overall Study||0
2614782|NCT00094055|6421181|P1|STARTED|Overall Study||60
2614783|NCT00093964|6421192|P2|NOT COMPLETED|Overall Study||0
2614784|NCT00093964|6421193|P1|NOT COMPLETED|Overall Study||0
2614785|NCT00093964|6421192|P2|COMPLETED|Overall Study||40
2614786|NCT00093964|6421193|P1|COMPLETED|Overall Study||41
2614787|NCT00093964|6421192|P2|STARTED|Overall Study||40
2614788|NCT00093964|6421193|P1|STARTED|Overall Study||41
2614789|NCT00093847|6421229|P2|NOT COMPLETED|Overall Study||10
2614790|NCT00093847|6421230|P1|NOT COMPLETED|Overall Study||8
2614791|NCT00093847|6421229|P2|COMPLETED|Overall Study||24
2614792|NCT00093847|6421230|P1|COMPLETED|Overall Study||31
2614793|NCT00093847|6421229|P2|STARTED|Overall Study||34
2614794|NCT00093847|6421230|P1|STARTED|Overall Study||39
2614795|NCT00093808|6421238|P1|NOT COMPLETED|Overall Study||2
2614796|NCT00093808|6421238|P1|COMPLETED|Overall Study||45
2614797|NCT00093808|6421238|P1|STARTED|Overall Study||47
2614798|NCT00093795|6421248|P3|NOT COMPLETED|Overall Study||17
2614799|NCT00093795|6421249|P2|NOT COMPLETED|Overall Study||16
2614800|NCT00093795|6421250|P1|NOT COMPLETED|Overall Study||20
2614801|NCT00093795|6421248|P3|COMPLETED|Overall Study||1613
2614802|NCT00093795|6421249|P2|COMPLETED|Overall Study||1618
2614803|NCT00093795|6421250|P1|COMPLETED|Overall Study||1610
2614804|NCT00093795|6421248|P3|STARTED|Overall Study||1630
2614805|NCT00093795|6421249|P2|STARTED|Overall Study||1634
2614806|NCT00093795|6421250|P1|STARTED|Overall Study||1630
2614807|NCT00093782|6421270|P1|NOT COMPLETED|Overall Study||0
2614808|NCT00093782|6421270|P1|COMPLETED|Overall Study||36
2614809|NCT00093782|6421270|P1|STARTED|Overall Study||36
2614810|NCT00093756|6421282|P2|NOT COMPLETED|Overall Study||0
2614811|NCT00093756|6421283|P1|NOT COMPLETED|Overall Study||0
2614812|NCT00093756|6421282|P2|COMPLETED|Overall Study||21
2614813|NCT00093756|6421283|P1|COMPLETED|Overall Study||27
2614814|NCT00093756|6421282|P2|STARTED|Overall Study||21
2614815|NCT00093756|6421283|P1|STARTED|Overall Study||27
2614816|NCT00093496|6421295|P2|NOT COMPLETED|Overall Study||3
2614817|NCT00093496|6421296|P1|NOT COMPLETED|Overall Study||1
2614818|NCT00093496|6421295|P2|COMPLETED|Overall Study||11
2614819|NCT00093496|6421296|P1|COMPLETED|Overall Study||14
2614820|NCT00093496|6421295|P2|STARTED|Overall Study||14
2614821|NCT00093496|6421296|P1|STARTED|Overall Study||15
2614822|NCT00093470|6421309|P2|NOT COMPLETED|Overall Study||0
2614823|NCT00093470|6421310|P1|NOT COMPLETED|Overall Study||73
2614824|NCT00093470|6421309|P2|COMPLETED|Overall Study|Patients underwent observation only.|71
2614825|NCT00093470|6421310|P1|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
2614826|NCT00093470|6421309|P2|Patients With Toxicity Assessment|Overall Study||69
2614827|NCT00093470|6421310|P1|Patients With Toxicity Assessment|Overall Study||72
2614828|NCT00093470|6421309|P2|Treated|Overall Study||71
2614829|NCT00093470|6421310|P1|Treated|Overall Study||72
2614830|NCT00093470|6421309|P2|STARTED|Overall Study||71
2614831|NCT00093470|6421310|P1|STARTED|Overall Study||73
2614832|NCT00093379|6421318|P1|NOT COMPLETED|Overall Study||0
2614833|NCT00093379|6421318|P1|COMPLETED|Overall Study||20
2614834|NCT00093379|6421318|P1|STARTED|Overall Study||20
2614835|NCT00093145|6421324|P1|NOT COMPLETED|Overall Study||17
2614836|NCT00093145|6421324|P1|COMPLETED|Overall Study|Treatment completed upon progressive disease|15
2614837|NCT00093145|6421324|P1|At Least One Response Assessment|Overall Study||31
2614838|NCT00093145|6421324|P1|STARTED|Overall Study||32
2614839|NCT00093041|6421339|P6|NOT COMPLETED|Overall Study||3
2614840|NCT00093041|6421340|P5|NOT COMPLETED|Overall Study||1
2614841|NCT00093041|6421341|P4|NOT COMPLETED|Overall Study||1
2614842|NCT00093041|6421342|P3|NOT COMPLETED|Overall Study||2
2614843|NCT00093041|6421343|P2|NOT COMPLETED|Overall Study||3
2614844|NCT00093041|6421344|P1|NOT COMPLETED|Overall Study||2
2614845|NCT00093041|6421339|P6|COMPLETED|Overall Study|Three discontinued during multiple dose period|4
2614846|NCT00093041|6421340|P5|COMPLETED|Overall Study|One discontinued during multiple dose period|3
2614847|NCT00093041|6421341|P4|COMPLETED|Overall Study|One discontinued during single dose period|3
2614848|NCT00093041|6421342|P3|COMPLETED|Overall Study|Two discontinued during single dose period|3
2614849|NCT00093041|6421343|P2|COMPLETED|Overall Study|Three discontinued during single dose period|1
2614850|NCT00093041|6421344|P1|COMPLETED|Overall Study|One discontinued during single dose period and one during multiple dose period|2
2614851|NCT00093041|6421339|P6|STARTED|Overall Study||7
2614852|NCT00093041|6421340|P5|STARTED|Overall Study||4
2614853|NCT00093041|6421341|P4|STARTED|Overall Study||4
2614854|NCT00093041|6421342|P3|STARTED|Overall Study||5
2614855|NCT00093041|6421343|P2|STARTED|Overall Study||4
2614856|NCT00093041|6421344|P1|STARTED|Overall Study||4
2614857|NCT00093015|6421366|P2|NOT COMPLETED|Overall Study||664
2614858|NCT00093015|6421367|P1|NOT COMPLETED|Overall Study||665
2614859|NCT00093015|6421366|P2|COMPLETED|Overall Study||1348
2614860|NCT00093015|6421367|P1|COMPLETED|Overall Study||1361
2614861|NCT00093015|6421366|P2|Received Study Medication|Overall Study||2004
2614862|NCT00093015|6421367|P1|Received Study Medication|Overall Study||2019
2614863|NCT00093015|6421366|P2|STARTED|Overall Study||2012
2614864|NCT00093015|6421367|P1|STARTED|Overall Study||2026
2614865|NCT00092677|6421395|P2|NOT COMPLETED|Overall Study||11
2614866|NCT00092677|6421396|P1|NOT COMPLETED|Overall Study||5
2614867|NCT00092677|6421395|P2|COMPLETED|Overall Study|Placebo: 698 (on drug), 120 (after drug discon), 100 (at death)|918
2614868|NCT00092677|6421396|P1|COMPLETED|Overall Study|EZ/Simva: 694 (on drug), 140 (after drug discon), 105 (at death)|939
2614869|NCT00092677|6421395|P2|STARTED|Overall Study||929
2614870|NCT00092677|6421396|P1|STARTED|Overall Study||944
2614871|NCT00092547|6421440|P3|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
2614872|NCT00092547|6421441|P2|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
2614873|NCT00092547|6421442|P1|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
2614874|NCT00092547|6421440|P3|COMPLETED|Long-term Follow-up (Month 126 Visit)||211
2614875|NCT00092547|6421441|P2|COMPLETED|Long-term Follow-up (Month 126 Visit)||0
2614876|NCT00092547|6421442|P1|COMPLETED|Long-term Follow-up (Month 126 Visit)||454
2614877|NCT00092547|6421440|P3|STARTED|Long-term Follow-up (Month 126 Visit)||211
2614878|NCT00092547|6421441|P2|STARTED|Long-term Follow-up (Month 126 Visit)||0
2614879|NCT00092547|6421442|P1|STARTED|Long-term Follow-up (Month 126 Visit)||454
2614880|NCT00092547|6421440|P3|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
2614881|NCT00092547|6421441|P2|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
2614882|NCT00092547|6421442|P1|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
2614883|NCT00092547|6421440|P3|COMPLETED|Long-term Follow-up (Month 96 Visit)||267
2614884|NCT00092547|6421441|P2|COMPLETED|Long-term Follow-up (Month 96 Visit)||0
2614885|NCT00092547|6421442|P1|COMPLETED|Long-term Follow-up (Month 96 Visit)||508
2614886|NCT00092547|6421440|P3|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|267
2614887|NCT00092547|6421441|P2|STARTED|Long-term Follow-up (Month 96 Visit)||0
2614888|NCT00092547|6421442|P1|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|508
2614889|NCT00092547|6421440|P3|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
2614890|NCT00092547|6421441|P2|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
2614891|NCT00092547|6421442|P1|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
2614892|NCT00092547|6421440|P3|COMPLETED|Long-term Follow-up (Month 72 Visit)||276
2614893|NCT00092547|6421441|P2|COMPLETED|Long-term Follow-up (Month 72 Visit)||0
2614894|NCT00092547|6421442|P1|COMPLETED|Long-term Follow-up (Month 72 Visit)||550
2614895|NCT00092547|6421440|P3|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|276
2614896|NCT00092547|6421441|P2|STARTED|Long-term Follow-up (Month 72 Visit)||0
2614897|NCT00092547|6421442|P1|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|550
2614898|NCT00092547|6421440|P3|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
2614899|NCT00092547|6421441|P2|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
2614900|NCT00092547|6421442|P1|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||1
2614901|NCT00092547|6421440|P3|COMPLETED|Long-term Follow-up (Month 42 Visit)||308
2614902|NCT00092547|6421441|P2|COMPLETED|Long-term Follow-up (Month 42 Visit)||0
2614903|NCT00092547|6421442|P1|COMPLETED|Long-term Follow-up (Month 42 Visit)||611
2614904|NCT00092547|6421440|P3|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|308
2614905|NCT00092547|6421441|P2|STARTED|Long-term Follow-up (Month 42 Visit)||0
2614906|NCT00092547|6421442|P1|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|612
2614907|NCT00092547|6421440|P3|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||16
2614908|NCT00092547|6421441|P2|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
2614909|NCT00092547|6421442|P1|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||23
2614910|NCT00092547|6421440|P3|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||469
2614911|NCT00092547|6421441|P2|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
2614912|NCT00092547|6421442|P1|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||933
2614913|NCT00092547|6421440|P3|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||482
2614914|NCT00092547|6421441|P2|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
2614915|NCT00092547|6421442|P1|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
2614916|NCT00092547|6421440|P3|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|485
2614917|NCT00092547|6421441|P2|STARTED|Extension Vaccine Phase (Month 30 to 37)||0
2614918|NCT00092547|6421442|P1|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|956
2614919|NCT00092547|6421440|P3|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
2614920|NCT00092547|6421441|P2|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||5
2614921|NCT00092547|6421442|P1|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||8
2614922|NCT00092547|6421440|P3|COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
2614923|NCT00092547|6421441|P2|COMPLETED|Base Follow-up Phase (Month 18 to 30)||485
2614924|NCT00092547|6421442|P1|COMPLETED|Base Follow-up Phase (Month 18 to 30)||956
2614925|NCT00092547|6421440|P3|STARTED|Base Follow-up Phase (Month 18 to 30)||0
2614926|NCT00092547|6421441|P2|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|490
2614927|NCT00092547|6421442|P1|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|964
2614928|NCT00092547|6421440|P3|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
2614929|NCT00092547|6421441|P2|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||14
2614930|NCT00092547|6421442|P1|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||20
2614931|NCT00092547|6421440|P3|COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
2614932|NCT00092547|6421441|P2|COMPLETED|Base Follow-up Phase (Month 7 to 18)||551
2614933|NCT00092547|6421442|P1|COMPLETED|Base Follow-up Phase (Month 7 to 18)||1108
2614934|NCT00092547|6421440|P3|STARTED|Base Follow-up Phase (Month 7 to 18)||0
2614935|NCT00092547|6421441|P2|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|565
2614936|NCT00092547|6421442|P1|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|1128
2614937|NCT00092547|6421440|P3|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
2614938|NCT00092547|6421441|P2|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||36
2614939|NCT00092547|6421442|P1|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||63
2614940|NCT00092547|6421440|P3|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
2614941|NCT00092547|6421441|P2|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||561
2614942|NCT00092547|6421442|P1|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||1121
2614943|NCT00092547|6421440|P3|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||0
2614944|NCT00092547|6421441|P2|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||596
2614945|NCT00092547|6421442|P1|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||1179
2614946|NCT00092547|6421440|P3|STARTED|Base Vaccine Phase (Day 1 to Month 7)||0
2614947|NCT00092547|6421441|P2|STARTED|Base Vaccine Phase (Day 1 to Month 7)||597
2614948|NCT00092547|6421442|P1|STARTED|Base Vaccine Phase (Day 1 to Month 7)||1184
2614949|NCT00092534|6421486|P5|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
2614950|NCT00092534|6421487|P4|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||1
2614951|NCT00092534|6421488|P3|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
2614952|NCT00092534|6421489|P2|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
2614953|NCT00092534|6421490|P1|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
2614954|NCT00092534|6421486|P5|COMPLETED|Long-Term Follow-Up (LTFU) Study||2097
2614955|NCT00092534|6421487|P4|COMPLETED|Long-Term Follow-Up (LTFU) Study||2749
2614956|NCT00092534|6421488|P3|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
2614957|NCT00092534|6421489|P2|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
2614958|NCT00092534|6421490|P1|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
2614959|NCT00092534|6421486|P5|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||1888
2614960|NCT00092534|6421487|P4|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||2448
2614961|NCT00092534|6421488|P3|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
2614962|NCT00092534|6421489|P2|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
2614963|NCT00092534|6421490|P1|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
2614964|NCT00092534|6421486|P5|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||1849
2614965|NCT00092534|6421487|P4|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||2385
2614966|NCT00092534|6421488|P3|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
2614967|NCT00092534|6421489|P2|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
2614968|NCT00092534|6421490|P1|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
2614969|NCT00092534|6421486|P5|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||2050
2614970|NCT00092534|6421487|P4|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||2650
2614971|NCT00092534|6421488|P3|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
2614972|NCT00092534|6421489|P2|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
2614973|NCT00092534|6421490|P1|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
2614974|NCT00092534|6421486|P5|STARTED|Long-Term Follow-Up (LTFU) Study|Some Base Study participants did not consent for inclusion in the LTFU.|2097
2614975|NCT00092534|6421487|P4|STARTED|Long-Term Follow-Up (LTFU) Study|Some Base Study participants did not consent for inclusion in the LTFU.|2750
2614976|NCT00092534|6421488|P3|STARTED|Long-Term Follow-Up (LTFU) Study||0
2614977|NCT00092534|6421489|P2|STARTED|Long-Term Follow-Up (LTFU) Study||0
2614978|NCT00092534|6421490|P1|STARTED|Long-Term Follow-Up (LTFU) Study||0
2614979|NCT00092534|6421486|P5|NOT COMPLETED|Base Study EXT||0
2614980|NCT00092534|6421487|P4|NOT COMPLETED|Base Study EXT||0
2614981|NCT00092534|6421488|P3|NOT COMPLETED|Base Study EXT||145
2614982|NCT00092534|6421489|P2|NOT COMPLETED|Base Study EXT||0
2614983|NCT00092534|6421490|P1|NOT COMPLETED|Base Study EXT||0
2614984|NCT00092534|6421486|P5|COMPLETED|Base Study EXT||0
2614985|NCT00092534|6421487|P4|COMPLETED|Base Study EXT||0
2614986|NCT00092534|6421488|P3|COMPLETED|Base Study EXT||449
2614987|NCT00092534|6421489|P2|COMPLETED|Base Study EXT||0
2614988|NCT00092534|6421490|P1|COMPLETED|Base Study EXT||0
2614989|NCT00092534|6421486|P5|STARTED|Base Study EXT||0
2614990|NCT00092534|6421487|P4|STARTED|Base Study EXT||0
2614991|NCT00092534|6421488|P3|STARTED|Base Study EXT||594
2614992|NCT00092534|6421489|P2|STARTED|Base Study EXT||0
2614993|NCT00092534|6421490|P1|STARTED|Base Study EXT||0
2614994|NCT00092534|6421486|P5|NOT COMPLETED|Base Study Follow-Up Period||0
2614995|NCT00092534|6421487|P4|NOT COMPLETED|Base Study Follow-Up Period||0
2614996|NCT00092534|6421488|P3|NOT COMPLETED|Base Study Follow-Up Period||0
2614997|NCT00092534|6421489|P2|NOT COMPLETED|Base Study Follow-Up Period||694
2614998|NCT00092534|6421490|P1|NOT COMPLETED|Base Study Follow-Up Period||316
2614999|NCT00092534|6421486|P5|COMPLETED|Base Study Follow-Up Period||0
2615000|NCT00092534|6421487|P4|COMPLETED|Base Study Follow-Up Period||0
2615001|NCT00092534|6421488|P3|COMPLETED|Base Study Follow-Up Period||0
2615002|NCT00092534|6421489|P2|COMPLETED|Base Study Follow-Up Period||5277
2615003|NCT00092534|6421490|P1|COMPLETED|Base Study Follow-Up Period||5626
2615004|NCT00092534|6421486|P5|STARTED|Base Study Follow-Up Period||0
2615005|NCT00092534|6421487|P4|STARTED|Base Study Follow-Up Period||0
2615006|NCT00092534|6421488|P3|STARTED|Base Study Follow-Up Period||0
2615007|NCT00092534|6421489|P2|STARTED|Base Study Follow-Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5971
2615008|NCT00092534|6421490|P1|STARTED|Base Study Follow-Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5942
2615009|NCT00092534|6421486|P5|NOT COMPLETED|Base Study Vaccination Period||0
2615010|NCT00092534|6421487|P4|NOT COMPLETED|Base Study Vaccination Period||0
2615011|NCT00092534|6421488|P3|NOT COMPLETED|Base Study Vaccination Period||0
2615012|NCT00092534|6421489|P2|NOT COMPLETED|Base Study Vaccination Period||126
2615013|NCT00092534|6421490|P1|NOT COMPLETED|Base Study Vaccination Period||171
2615014|NCT00092534|6421486|P5|COMPLETED|Base Study Vaccination Period||0
2615015|NCT00092534|6421487|P4|COMPLETED|Base Study Vaccination Period||0
2615016|NCT00092534|6421488|P3|COMPLETED|Base Study Vaccination Period||0
2615017|NCT00092534|6421489|P2|COMPLETED|Base Study Vaccination Period||5954
2615018|NCT00092534|6421490|P1|COMPLETED|Base Study Vaccination Period||5916
2615019|NCT00092534|6421486|P5|STARTED|Base Study Vaccination Period||0
2615020|NCT00092534|6421487|P4|STARTED|Base Study Vaccination Period||0
2615021|NCT00092534|6421488|P3|STARTED|Base Study Vaccination Period||0
2615022|NCT00092534|6421489|P2|STARTED|Base Study Vaccination Period||6080
2615023|NCT00092534|6421490|P1|STARTED|Base Study Vaccination Period||6087
2615024|NCT00092521|6421521|P4|NOT COMPLETED|Extension Study (Group 4)||209
2615025|NCT00092521|6421522|P3|NOT COMPLETED|Extension Study (Group 4)||0
2615026|NCT00092521|6421523|P2|NOT COMPLETED|Extension Study (Group 4)||0
2615027|NCT00092521|6421524|P1|NOT COMPLETED|Extension Study (Group 4)||0
2615028|NCT00092521|6421521|P4|COMPLETED|Extension Study (Group 4)||635
2615029|NCT00092521|6421522|P3|COMPLETED|Extension Study (Group 4)||0
2615030|NCT00092521|6421523|P2|COMPLETED|Extension Study (Group 4)||0
2615031|NCT00092521|6421524|P1|COMPLETED|Extension Study (Group 4)||0
2615032|NCT00092521|6421521|P4|Received >=1 Dose in Extension Study|Extension Study (Group 4)||801
2615033|NCT00092521|6421522|P3|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
2615034|NCT00092521|6421523|P2|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
2615035|NCT00092521|6421524|P1|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
2615036|NCT00092521|6421521|P4|Initiated Extension Study|Extension Study (Group 4)||829
2615037|NCT00092521|6421522|P3|Initiated Extension Study|Extension Study (Group 4)||0
2615038|NCT00092521|6421523|P2|Initiated Extension Study|Extension Study (Group 4)||0
2615039|NCT00092521|6421524|P1|Initiated Extension Study|Extension Study (Group 4)||0
2615040|NCT00092521|6421521|P4|STARTED|Extension Study (Group 4)||844
2615041|NCT00092521|6421522|P3|STARTED|Extension Study (Group 4)||0
2615042|NCT00092521|6421523|P2|STARTED|Extension Study (Group 4)||0
2615043|NCT00092521|6421524|P1|STARTED|Extension Study (Group 4)||0
2615044|NCT00092521|6421521|P4|NOT COMPLETED|Follow-Up (After Month 7)||0
2615045|NCT00092521|6421522|P3|NOT COMPLETED|Follow-Up (After Month 7)||648
2615046|NCT00092521|6421523|P2|NOT COMPLETED|Follow-Up (After Month 7)||136
2615047|NCT00092521|6421524|P1|NOT COMPLETED|Follow-Up (After Month 7)||246
2615048|NCT00092521|6421521|P4|COMPLETED|Follow-Up (After Month 7)||0
2615049|NCT00092521|6421522|P3|COMPLETED|Follow-Up (After Month 7)||1959
2615050|NCT00092521|6421523|P2|COMPLETED|Follow-Up (After Month 7)||155
2615051|NCT00092521|6421524|P1|COMPLETED|Follow-Up (After Month 7)||2353
2615052|NCT00092521|6421521|P4|STARTED|Follow-Up (After Month 7)||0
2615053|NCT00092521|6421522|P3|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2607
2615054|NCT00092521|6421523|P2|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|291
2615055|NCT00092521|6421524|P1|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2599
2615056|NCT00092521|6421521|P4|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||0
2615057|NCT00092521|6421522|P3|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||146
2615058|NCT00092521|6421523|P2|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||14
2615059|NCT00092521|6421524|P1|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||140
2615060|NCT00092521|6421521|P4|COMPLETED|Vaccination (Day 1 Through Month 7)||0
2615061|NCT00092521|6421522|P3|COMPLETED|Vaccination (Day 1 Through Month 7)||2586
2615062|NCT00092521|6421523|P2|COMPLETED|Vaccination (Day 1 Through Month 7)||290
2615063|NCT00092521|6421524|P1|COMPLETED|Vaccination (Day 1 Through Month 7)||2583
2615064|NCT00092521|6421521|P4|STARTED|Vaccination (Day 1 Through Month 7)||0
2615065|NCT00092521|6421522|P3|STARTED|Vaccination (Day 1 Through Month 7)||2732
2615066|NCT00092521|6421523|P2|STARTED|Vaccination (Day 1 Through Month 7)||304
2615067|NCT00092521|6421524|P1|STARTED|Vaccination (Day 1 Through Month 7)||2723
2615068|NCT00092495|6421538|P5|NOT COMPLETED|Extension Study||0
2615069|NCT00092495|6421539|P4|NOT COMPLETED|Extension Study||0
2615070|NCT00092495|6421540|P3|NOT COMPLETED|Extension Study||0
2615071|NCT00092495|6421541|P2|NOT COMPLETED|Extension Study||0
2615072|NCT00092495|6421542|P1|NOT COMPLETED|Extension Study||0
2615073|NCT00092495|6421538|P5|COMPLETED|Extension Study||12
2615074|NCT00092495|6421539|P4|COMPLETED|Extension Study||0
2615075|NCT00092495|6421540|P3|COMPLETED|Extension Study||0
2615076|NCT00092495|6421541|P2|COMPLETED|Extension Study||0
2615077|NCT00092495|6421542|P1|COMPLETED|Extension Study||0
2615078|NCT00092495|6421538|P5|STARTED|Extension Study||12
2615079|NCT00092495|6421539|P4|STARTED|Extension Study||0
2615080|NCT00092495|6421540|P3|STARTED|Extension Study||0
2615081|NCT00092495|6421541|P2|STARTED|Extension Study||0
2615082|NCT00092495|6421542|P1|STARTED|Extension Study||0
2615083|NCT00092495|6421538|P5|NOT COMPLETED|Base Study Follow-up Period||0
2615084|NCT00092495|6421539|P4|NOT COMPLETED|Base Study Follow-up Period||14
2615085|NCT00092495|6421540|P3|NOT COMPLETED|Base Study Follow-up Period||4
2615086|NCT00092495|6421541|P2|NOT COMPLETED|Base Study Follow-up Period||3
2615087|NCT00092495|6421542|P1|NOT COMPLETED|Base Study Follow-up Period||3
2615088|NCT00092495|6421538|P5|COMPLETED|Base Study Follow-up Period||0
2615089|NCT00092495|6421539|P4|COMPLETED|Base Study Follow-up Period||446
2615090|NCT00092495|6421540|P3|COMPLETED|Base Study Follow-up Period||126
2615091|NCT00092495|6421541|P2|COMPLETED|Base Study Follow-up Period||122
2615092|NCT00092495|6421542|P1|COMPLETED|Base Study Follow-up Period||112
2615093|NCT00092495|6421538|P5|STARTED|Base Study Follow-up Period||0
2615094|NCT00092495|6421539|P4|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|460
2615095|NCT00092495|6421540|P3|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|130
2615096|NCT00092495|6421541|P2|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|125
2615097|NCT00092495|6421542|P1|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|115
2615098|NCT00092495|6421538|P5|NOT COMPLETED|Base Study Vaccination Period||0
2615099|NCT00092495|6421539|P4|NOT COMPLETED|Base Study Vaccination Period||88
2615100|NCT00092495|6421540|P3|NOT COMPLETED|Base Study Vaccination Period||34
2615101|NCT00092495|6421541|P2|NOT COMPLETED|Base Study Vaccination Period||22
2615102|NCT00092495|6421542|P1|NOT COMPLETED|Base Study Vaccination Period||37
2615103|NCT00092495|6421538|P5|COMPLETED|Base Study Vaccination Period||0
2615104|NCT00092495|6421539|P4|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|1441
2615105|NCT00092495|6421540|P3|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|474
2615106|NCT00092495|6421541|P2|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|492
2615107|NCT00092495|6421542|P1|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|467
2615108|NCT00092495|6421538|P5|Without Long-term Follow-up|Base Study Vaccination Period||0
2615109|NCT00092495|6421539|P4|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|73
2615110|NCT00092495|6421540|P3|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|28
2615111|NCT00092495|6421541|P2|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|20
2615112|NCT00092495|6421542|P1|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|34
2615113|NCT00092495|6421538|P5|With Long-term Follow-up *|Base Study Vaccination Period||0
2615114|NCT00092495|6421539|P4|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|10
2615115|NCT00092495|6421540|P3|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|6
2615116|NCT00092495|6421541|P2|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
2615117|NCT00092495|6421542|P1|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
2615118|NCT00092495|6421538|P5|STARTED|Base Study Vaccination Period||0
2615119|NCT00092495|6421539|P4|STARTED|Base Study Vaccination Period||1529
2615120|NCT00092495|6421540|P3|STARTED|Base Study Vaccination Period||508
2615121|NCT00092495|6421541|P2|STARTED|Base Study Vaccination Period||514
2615122|NCT00092495|6421542|P1|STARTED|Base Study Vaccination Period||504
2615123|NCT00092456|6421608|P4|NOT COMPLETED|Overall Study||16
2615124|NCT00092456|6421609|P3|NOT COMPLETED|Overall Study||29
2615125|NCT00092456|6421610|P2|NOT COMPLETED|Overall Study||17
2615126|NCT00092456|6421611|P1|NOT COMPLETED|Overall Study||25
2615127|NCT00092456|6421608|P4|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|97
2615128|NCT00092456|6421609|P3|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|200
2615129|NCT00092456|6421610|P2|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|208
2615130|NCT00092456|6421611|P1|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|201
2615131|NCT00092456|6421608|P4|Vaccinated at Visit 3|Overall Study||98
2615132|NCT00092456|6421609|P3|Vaccinated at Visit 3|Overall Study||200
2615133|NCT00092456|6421610|P2|Vaccinated at Visit 3|Overall Study||210
2615134|NCT00092456|6421611|P1|Vaccinated at Visit 3|Overall Study||202
2615135|NCT00092456|6421608|P4|Vaccinated at Visit 2|Overall Study||104
2615136|NCT00092456|6421609|P3|Vaccinated at Visit 2|Overall Study||210
2615137|NCT00092456|6421610|P2|Vaccinated at Visit 2|Overall Study||217
2615138|NCT00092456|6421611|P1|Vaccinated at Visit 2|Overall Study||208
2615139|NCT00092456|6421608|P4|Vaccinated at Visit 1|Overall Study||113
2615140|NCT00092456|6421609|P3|Vaccinated at Visit 1|Overall Study||229
2615141|NCT00092456|6421610|P2|Vaccinated at Visit 1|Overall Study||225
2615142|NCT00092456|6421611|P1|Vaccinated at Visit 1|Overall Study||226
2615143|NCT00092456|6421608|P4|STARTED|Overall Study|Subjects assigned to Placebo-matching RotaTeq™|113
2615144|NCT00092456|6421609|P3|STARTED|Overall Study|Subject assigned to ~6.91 X 10^7 IU/Dose of RotaTeq™ - Lot 3|229
2615145|NCT00092456|6421610|P2|STARTED|Overall Study|Subject assigned to ~8.01 X 10^7 IU/Dose of RotaTeq™ - Lot 2|225
2615146|NCT00092456|6421611|P1|STARTED|Overall Study|Subject assigned to ~8.81 X 10^7 IU/Dose of RotaTeq™ - Lot 1|226
2615147|NCT00092443|6421659|P2|NOT COMPLETED|Overall Study||54
2615148|NCT00092443|6421660|P1|NOT COMPLETED|Overall Study||58
2615149|NCT00092443|6421659|P2|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|607
2615150|NCT00092443|6421660|P1|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|593
2615151|NCT00092443|6421659|P2|Vaccinated at Visit 3|Overall Study||608
2615152|NCT00092443|6421660|P1|Vaccinated at Visit 3|Overall Study||593
2615153|NCT00092443|6421659|P2|Vaccinated at Visit 2|Overall Study||627
2615154|NCT00092443|6421660|P1|Vaccinated at Visit 2|Overall Study||618
2615155|NCT00092443|6421659|P2|Vaccinated at Visit 1|Overall Study||660
2615156|NCT00092443|6421660|P1|Vaccinated at Visit 1|Overall Study||650
2615157|NCT00092443|6421659|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|661
2615158|NCT00092443|6421660|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|651
2615159|NCT00092417|6421678|P2|NOT COMPLETED|Overall Study||1
2615160|NCT00092417|6421679|P1|NOT COMPLETED|Overall Study||5
2615161|NCT00092417|6421678|P2|COMPLETED|Overall Study|Received the lower potency zoster vaccine & completed 42 days of safety follow-up post vaccination|233
2615162|NCT00092417|6421679|P1|COMPLETED|Overall Study|Received the higher potency zoster vaccine & completed 42 days of safety follow-up post vaccination|459
2615163|NCT00092417|6421678|P2|Vaccinated|Overall Study||234
2615164|NCT00092417|6421679|P1|Vaccinated|Overall Study|3 participants were allocated,not vaccinated; they are not reported in the Baseline Characteristics|461
2615165|NCT00092417|6421678|P2|STARTED|Overall Study|Started Period Group 2|234
2615166|NCT00092417|6421679|P1|STARTED|Overall Study|Started Period Group 1|464
2615167|NCT00092131|6421693|P2|NOT COMPLETED|Treatment Period II||1
2615168|NCT00092131|6421694|P1|NOT COMPLETED|Treatment Period II||0
2615169|NCT00092131|6421693|P2|COMPLETED|Treatment Period II||25
2615170|NCT00092131|6421694|P1|COMPLETED|Treatment Period II||24
2615171|NCT00092131|6421693|P2|STARTED|Treatment Period II|1 patient discontinued after taking Period II study medication, due to asthma exacerbation|26
2615172|NCT00092131|6421694|P1|STARTED|Treatment Period II||24
2615173|NCT00092131|6421693|P2|NOT COMPLETED|Treatment Period I||0
2615174|NCT00092131|6421694|P1|NOT COMPLETED|Treatment Period I||1
2615175|NCT00092131|6421693|P2|COMPLETED|Treatment Period I||26
2615176|NCT00092131|6421694|P1|COMPLETED|Treatment Period I||24
2615177|NCT00092131|6421693|P2|STARTED|Treatment Period I||26
2615178|NCT00092131|6421694|P1|STARTED|Treatment Period I|1 patient discontinued due to influenza which started in washout (11 days after Period I medication)|25
2615179|NCT00092118|6421724|P2|NOT COMPLETED|Overall Study||89
2615180|NCT00092118|6421725|P1|NOT COMPLETED|Overall Study||84
2615181|NCT00092118|6421724|P2|COMPLETED|Overall Study||913
2615182|NCT00092118|6421725|P1|COMPLETED|Overall Study||906
2615183|NCT00092118|6421724|P2|STARTED|Overall Study|2 patients discontinued after randomization due to adverse experience that began pre-randomization.|1002
2615184|NCT00092118|6421725|P1|STARTED|Overall Study|1 patient discontinued after randomization due to a adverse experience that began pre-randomization.|990
2615185|NCT00091962|6421738|P3|NOT COMPLETED|Overall Study||0
2615186|NCT00091962|6421739|P2|NOT COMPLETED|Overall Study||0
2615187|NCT00091962|6421740|P1|NOT COMPLETED|Overall Study||0
2615188|NCT00091962|6421738|P3|COMPLETED|Overall Study||151
2615189|NCT00091962|6421739|P2|COMPLETED|Overall Study||152
2615190|NCT00091962|6421740|P1|COMPLETED|Overall Study||150
2615191|NCT00091962|6421738|P3|STARTED|Overall Study||151
2615192|NCT00091962|6421739|P2|STARTED|Overall Study||152
2615193|NCT00091962|6421740|P1|STARTED|Overall Study||150
2615194|NCT00091949|6421759|P2|NOT COMPLETED|Overall Study||151
2615195|NCT00091949|6421760|P1|NOT COMPLETED|Overall Study||175
2615196|NCT00091949|6421759|P2|COMPLETED|Overall Study||1786
2615197|NCT00091949|6421760|P1|COMPLETED|Overall Study||1764
2615198|NCT00091949|6421759|P2|STARTED|Overall Study||1937
2615199|NCT00091949|6421760|P1|STARTED|Overall Study||1939
2615200|NCT00091832|6421784|P6|NOT COMPLETED|Overall Study||11
2615201|NCT00091832|6421785|P5|NOT COMPLETED|Overall Study||15
2615202|NCT00091832|6421786|P4|NOT COMPLETED|Overall Study||14
2615203|NCT00091832|6421787|P3|NOT COMPLETED|Overall Study||12
2615204|NCT00091832|6421788|P2|NOT COMPLETED|Overall Study||11
2615205|NCT00091832|6421789|P1|NOT COMPLETED|Overall Study||14
2615206|NCT00091832|6421784|P6|COMPLETED|Overall Study||32
2615207|NCT00091832|6421785|P5|COMPLETED|Overall Study||27
2615208|NCT00091832|6421786|P4|COMPLETED|Overall Study||29
2615209|NCT00091832|6421787|P3|COMPLETED|Overall Study||30
2615210|NCT00091832|6421788|P2|COMPLETED|Overall Study||31
2615211|NCT00091832|6421789|P1|COMPLETED|Overall Study||29
2615212|NCT00091832|6421784|P6|Received Study Medication|Overall Study||43
2615213|NCT00091832|6421785|P5|Received Study Medication|Overall Study||42
2615214|NCT00091832|6421786|P4|Received Study Medication|Overall Study||43
2615215|NCT00091832|6421787|P3|Received Study Medication|Overall Study||41
2615216|NCT00091832|6421788|P2|Received Study Medication|Overall Study||42
2615217|NCT00091832|6421789|P1|Received Study Medication|Overall Study||43
2615218|NCT00091832|6421784|P6|STARTED|Overall Study||43
2615219|NCT00091832|6421785|P5|STARTED|Overall Study||42
2615220|NCT00091832|6421786|P4|STARTED|Overall Study||43
2615221|NCT00091832|6421787|P3|STARTED|Overall Study||42
2615222|NCT00091832|6421788|P2|STARTED|Overall Study||42
2615223|NCT00091832|6421789|P1|STARTED|Overall Study||43
2615224|NCT00091819|6421907|P2|NOT COMPLETED|Overall Study||46
2615225|NCT00091819|6421908|P1|NOT COMPLETED|Overall Study||42
2615226|NCT00091819|6421907|P2|COMPLETED|Overall Study||387
2615227|NCT00091819|6421908|P1|COMPLETED|Overall Study||387
2615228|NCT00091819|6421907|P2|STARTED|Overall Study||433
2615229|NCT00091819|6421908|P1|STARTED|Overall Study||429
2615230|NCT00091793|6421916|P2|NOT COMPLETED|Overall Study||22
2615231|NCT00091793|6421917|P1|NOT COMPLETED|Overall Study||24
2615232|NCT00091793|6421916|P2|COMPLETED|Overall Study||144
2615233|NCT00091793|6421917|P1|COMPLETED|Overall Study||142
2615234|NCT00091793|6421916|P2|STARTED|Overall Study||166
2615235|NCT00091793|6421917|P1|STARTED|Overall Study||166
2615236|NCT00091572|6421941|P2|NOT COMPLETED|Overall Study||82
2615237|NCT00091572|6421942|P1|NOT COMPLETED|Overall Study||95
2615238|NCT00091572|6421941|P2|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|348
2615239|NCT00091572|6421942|P1|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|334
2615240|NCT00091572|6421941|P2|STARTED|Overall Study|9 subjects in dacarbazine group not treated.|430
2615241|NCT00091572|6421942|P1|STARTED|Overall Study|10 subjects in temozolomide group not treated.|429
2615242|NCT00091507|6421956|P2|NOT COMPLETED|Overall Study||19
2615243|NCT00091507|6421957|P1|NOT COMPLETED|Overall Study||21
2615244|NCT00091507|6421956|P2|COMPLETED|Overall Study||460
2615245|NCT00091507|6421957|P1|COMPLETED|Overall Study||411
2615246|NCT00091507|6421956|P2|STARTED|Overall Study||479
2615247|NCT00091507|6421957|P1|STARTED|Overall Study||432
2615248|NCT00091442|6421973|P2|NOT COMPLETED|Overall Study||373
2615249|NCT00091442|6421974|P1|NOT COMPLETED|Overall Study||369
2615250|NCT00091442|6421973|P2|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|5
2615251|NCT00091442|6421974|P1|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|4
2615252|NCT00091442|6421973|P2|STARTED|Overall Study||378
2615253|NCT00091442|6421974|P1|STARTED|Overall Study||373
2615254|NCT00091390|6421984|P1|NOT COMPLETED|Overall Study||4
2615255|NCT00091390|6421984|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|125
2615256|NCT00091390|6421984|P1|STARTED|Overall Study||129
2615257|NCT00091273|6421988|P1|NOT COMPLETED|Overall Study||0
2615258|NCT00091273|6421988|P1|COMPLETED|Overall Study||9
2615259|NCT00091273|6421988|P1|STARTED|Overall Study||9
2615260|NCT00091260|6421994|P1|NOT COMPLETED|Overall Study||0
2615261|NCT00091260|6421994|P1|COMPLETED|Overall Study||82
2615262|NCT00091260|6421994|P1|STARTED|Overall Study||82
2615263|NCT00091169|6422002|P2|NOT COMPLETED|Overall Study||53
2615264|NCT00091169|6422003|P1|NOT COMPLETED|Overall Study||57
2615265|NCT00091169|6422002|P2|COMPLETED|Overall Study||134
2615266|NCT00091169|6422003|P1|COMPLETED|Overall Study||132
2615267|NCT00091169|6422002|P2|Treated|Overall Study||170
2615268|NCT00091169|6422003|P1|Treated|Overall Study||163
2615269|NCT00091169|6422002|P2|STARTED|Overall Study||187
2615270|NCT00091169|6422003|P1|STARTED|Overall Study||189
2615271|NCT00091026|6422021|P2|NOT COMPLETED|Overall Study||3
2615272|NCT00091026|6422022|P1|NOT COMPLETED|Overall Study||1
2615273|NCT00091026|6422021|P2|COMPLETED|Overall Study||68
2615274|NCT00091026|6422022|P1|COMPLETED|Overall Study||71
2615275|NCT00091026|6422021|P2|STARTED|Overall Study||71
2615276|NCT00091026|6422022|P1|STARTED|Overall Study||72
2615277|NCT00090987|6422032|P1|NOT COMPLETED|Overall Study||21
2615278|NCT00090987|6422032|P1|COMPLETED|Overall Study||9
2615279|NCT00090987|6422032|P1|STARTED|Overall Study||30
2615280|NCT00090870|6422036|P1|NOT COMPLETED|Overall Study||0
2615281|NCT00090870|6422036|P1|COMPLETED|Overall Study||10
2615282|NCT00090870|6422036|P1|STARTED|Overall Study||10
2615283|NCT00090857|6422045|P2|NOT COMPLETED|Overall Study||3
2615284|NCT00090857|6422046|P1|NOT COMPLETED|Overall Study||4
2615285|NCT00090857|6422045|P2|COMPLETED|Overall Study||13
2615286|NCT00090857|6422046|P1|COMPLETED|Overall Study||29
2615287|NCT00090857|6422045|P2|STARTED|Overall Study||16
2615288|NCT00090857|6422046|P1|STARTED|Overall Study||33
2615289|NCT00090844|6422076|P2|NOT COMPLETED|Overall Study||1
2615290|NCT00090844|6422077|P1|NOT COMPLETED|Overall Study||1
2615291|NCT00090844|6422076|P2|COMPLETED|Overall Study||21
2615292|NCT00090844|6422077|P1|COMPLETED|Overall Study||26
2615293|NCT00090844|6422076|P2|STARTED|Overall Study||22
2615294|NCT00090844|6422077|P1|STARTED|Overall Study||27
2615295|NCT00090779|6422085|P2|NOT COMPLETED|Step 3||5
2615296|NCT00090779|6422086|P1|NOT COMPLETED|Step 3||7
2615297|NCT00090779|6422085|P2|COMPLETED|Step 3||0
2615298|NCT00090779|6422086|P1|COMPLETED|Step 3||0
2615299|NCT00090779|6422085|P2|STARTED|Step 3||5
2615300|NCT00090779|6422086|P1|STARTED|Step 3||7
2615301|NCT00090779|6422085|P2|NOT COMPLETED|Step 2||18
2615302|NCT00090779|6422086|P1|NOT COMPLETED|Step 2||6
2615303|NCT00090779|6422085|P2|COMPLETED|Step 2||1
2615304|NCT00090779|6422086|P1|COMPLETED|Step 2||0
2615305|NCT00090779|6422085|P2|STARTED|Step 2|Three with two consecutive CD4<350cells/mm^3 and one with CDC category B event didn't enter step 2.|19
2615306|NCT00090779|6422086|P1|STARTED|Step 2|One subject who had two consecutive CD4<350cells/mm^3 did not enter step 2.|6
2615307|NCT00090779|6422085|P2|NOT COMPLETED|Step 1||15
2615308|NCT00090779|6422086|P1|NOT COMPLETED|Step 1||11
2615309|NCT00090779|6422085|P2|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|49
2615310|NCT00090779|6422086|P1|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|55
2615311|NCT00090779|6422085|P2|STARTED|Step 1||64
2615312|NCT00090779|6422086|P1|STARTED|Step 1||66
2615313|NCT00090766|6422110|P3|NOT COMPLETED|Overall Study||3
2615314|NCT00090766|6422111|P2|NOT COMPLETED|Overall Study||2
2615315|NCT00090766|6422112|P1|NOT COMPLETED|Overall Study||3
2615316|NCT00090766|6422110|P3|COMPLETED|Overall Study||22
2615317|NCT00090766|6422111|P2|COMPLETED|Overall Study||19
2615318|NCT00090766|6422112|P1|COMPLETED|Overall Study||14
2615319|NCT00090766|6422110|P3|STARTED|Overall Study||25
2615320|NCT00090766|6422111|P2|STARTED|Overall Study||21
2615321|NCT00090766|6422112|P1|STARTED|Overall Study||17
2615322|NCT00090753|6422154|P2|NOT COMPLETED|Extended Treatment Period||191
2615323|NCT00090753|6422155|P1|NOT COMPLETED|Extended Treatment Period||359
2615324|NCT00090753|6422154|P2|COMPLETED|Extended Treatment Period||59
2615325|NCT00090753|6422155|P1|COMPLETED|Extended Treatment Period||94
2615326|NCT00090753|6422154|P2|STARTED|Extended Treatment Period|52 patients who completed the first treatment period refused to enter the extended treatment period.|250
2615327|NCT00090753|6422155|P1|STARTED|Extended Treatment Period|39 patients who completed the first treatment period refused to enter the extended treatment period.|453
2615328|NCT00090753|6422154|P2|NOT COMPLETED|First Treatment Period||178
2615329|NCT00090753|6422155|P1|NOT COMPLETED|First Treatment Period||256
2615330|NCT00090753|6422154|P2|COMPLETED|First Treatment Period||302
2615331|NCT00090753|6422155|P1|COMPLETED|First Treatment Period||492
2615332|NCT00090753|6422154|P2|STARTED|First Treatment Period||480
2615333|NCT00090753|6422155|P1|STARTED|First Treatment Period||748
2615334|NCT00090610|6422165|P2|NOT COMPLETED|Overall Study||1
2615335|NCT00090610|6422166|P1|NOT COMPLETED|Overall Study||1
2615336|NCT00090610|6422165|P2|COMPLETED|Overall Study||74
2615337|NCT00090610|6422166|P1|COMPLETED|Overall Study||74
2615338|NCT00090610|6422165|P2|STARTED|Overall Study||75
2615339|NCT00090610|6422166|P1|STARTED|Overall Study||75
2615340|NCT00090584|6422182|P2|NOT COMPLETED|Baseline to 8 Months||41
2615341|NCT00090584|6422183|P1|NOT COMPLETED|Baseline to 8 Months||44
2615342|NCT00090584|6422182|P2|COMPLETED|Baseline to 8 Months||112
2615343|NCT00090584|6422183|P1|COMPLETED|Baseline to 8 Months||110
2615344|NCT00090584|6422182|P2|STARTED|Baseline to 8 Months||153
2615345|NCT00090584|6422183|P1|STARTED|Baseline to 8 Months||154
2615346|NCT00090584|6422182|P2|NOT COMPLETED|Baseline to 10 Weeks||12
2615347|NCT00090584|6422183|P1|NOT COMPLETED|Baseline to 10 Weeks||15
2615348|NCT00090584|6422182|P2|COMPLETED|Baseline to 10 Weeks||141
2615349|NCT00090584|6422183|P1|COMPLETED|Baseline to 10 Weeks||139
2615350|NCT00090584|6422182|P2|STARTED|Baseline to 10 Weeks||153
2615351|NCT00090584|6422183|P1|STARTED|Baseline to 10 Weeks||154
2615352|NCT00090519|6422215|P2|NOT COMPLETED|Overall Study||75
2615353|NCT00090519|6422216|P1|NOT COMPLETED|Overall Study||73
2615354|NCT00090519|6422215|P2|COMPLETED|Overall Study||285
2615355|NCT00090519|6422216|P1|COMPLETED|Overall Study||298
2615356|NCT00090519|6422215|P2|STARTED|Overall Study||360
2615357|NCT00090519|6422216|P1|STARTED|Overall Study||371
2615358|NCT00090493|6422240|P1|NOT COMPLETED|Overall Study||2
2615359|NCT00090493|6422240|P1|COMPLETED|Overall Study||2
2615360|NCT00090493|6422240|P1|STARTED|Overall Study||4
2615361|NCT00090363|6422247|P3|NOT COMPLETED|Overall Study||96
2615362|NCT00090363|6422248|P2|NOT COMPLETED|Overall Study||107
2615363|NCT00090363|6422249|P1|NOT COMPLETED|Overall Study||106
2615364|NCT00090363|6422247|P3|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|2
2615365|NCT00090363|6422248|P2|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|0
2615366|NCT00090363|6422249|P1|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|1
2615367|NCT00090363|6422247|P3|Received Study Treatment.|Overall Study||98
2615368|NCT00090363|6422248|P2|Received Study Treatment.|Overall Study||107
2615369|NCT00090363|6422249|P1|Received Study Treatment.|Overall Study||107
2615370|NCT00090363|6422247|P3|STARTED|Overall Study||98
2615371|NCT00090363|6422248|P2|STARTED|Overall Study||107
2615372|NCT00090363|6422249|P1|STARTED|Overall Study||107
2615373|NCT00090545|6422271|P2|NOT COMPLETED|Overall Study||24
2615374|NCT00090545|6422272|P1|NOT COMPLETED|Overall Study||22
2615375|NCT00090545|6422271|P2|COMPLETED|Overall Study||0
2615376|NCT00090545|6422272|P1|COMPLETED|Overall Study||0
2615377|NCT00090545|6422271|P2|STARTED|Overall Study||24
2615378|NCT00090545|6422272|P1|STARTED|Overall Study||22
2615379|NCT00090285|6422292|P6|NOT COMPLETED|Long-term Follow-up (EXT2)||203
2615380|NCT00090285|6422293|P5|NOT COMPLETED|Long-term Follow-up (EXT2)||227
2615381|NCT00090285|6422294|P4|NOT COMPLETED|Long-term Follow-up (EXT2)||0
2615382|NCT00090285|6422295|P3|NOT COMPLETED|Long-term Follow-up (EXT2)||0
2615383|NCT00090285|6422296|P2|NOT COMPLETED|Long-term Follow-up (EXT2)||0
2615384|NCT00090285|6422297|P1|NOT COMPLETED|Long-term Follow-up (EXT2)||0
2615385|NCT00090285|6422292|P6|COMPLETED|Long-term Follow-up (EXT2)||664
2615386|NCT00090285|6422293|P5|COMPLETED|Long-term Follow-up (EXT2)||709
2615387|NCT00090285|6422294|P4|COMPLETED|Long-term Follow-up (EXT2)||0
2615388|NCT00090285|6422295|P3|COMPLETED|Long-term Follow-up (EXT2)||0
2615389|NCT00090285|6422296|P2|COMPLETED|Long-term Follow-up (EXT2)||0
2615390|NCT00090285|6422297|P1|COMPLETED|Long-term Follow-up (EXT2)||0
2615391|NCT00090285|6422292|P6|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|867
2615392|NCT00090285|6422293|P5|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|936
2615393|NCT00090285|6422294|P4|STARTED|Long-term Follow-up (EXT2)||0
2615394|NCT00090285|6422295|P3|STARTED|Long-term Follow-up (EXT2)||0
2615395|NCT00090285|6422296|P2|STARTED|Long-term Follow-up (EXT2)||0
2615396|NCT00090285|6422297|P1|STARTED|Long-term Follow-up (EXT2)||0
2615397|NCT00090285|6422292|P6|NOT COMPLETED|Extension 1||0
2615398|NCT00090285|6422293|P5|NOT COMPLETED|Extension 1||0
2615399|NCT00090285|6422294|P4|NOT COMPLETED|Extension 1||1
2615400|NCT00090285|6422295|P3|NOT COMPLETED|Extension 1||57
2615401|NCT00090285|6422296|P2|NOT COMPLETED|Extension 1||0
2615402|NCT00090285|6422297|P1|NOT COMPLETED|Extension 1||0
2615403|NCT00090285|6422292|P6|COMPLETED|Extension 1||0
2615404|NCT00090285|6422293|P5|COMPLETED|Extension 1||0
2615405|NCT00090285|6422294|P4|COMPLETED|Extension 1||15
2615406|NCT00090285|6422295|P3|COMPLETED|Extension 1||1041
2615407|NCT00090285|6422296|P2|COMPLETED|Extension 1||0
2615408|NCT00090285|6422297|P1|COMPLETED|Extension 1||0
2615409|NCT00090285|6422292|P6|STARTED|Extension 1||0
2615410|NCT00090285|6422293|P5|STARTED|Extension 1||0
2615411|NCT00090285|6422294|P4|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|16
2615412|NCT00090285|6422295|P3|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1098
2615413|NCT00090285|6422296|P2|STARTED|Extension 1||0
2615414|NCT00090285|6422297|P1|STARTED|Extension 1||0
2615415|NCT00090285|6422292|P6|NOT COMPLETED|Base Study Follow-up Period||0
2615416|NCT00090285|6422293|P5|NOT COMPLETED|Base Study Follow-up Period||0
2615417|NCT00090285|6422294|P4|NOT COMPLETED|Base Study Follow-up Period||0
2615418|NCT00090285|6422295|P3|NOT COMPLETED|Base Study Follow-up Period||0
2615419|NCT00090285|6422296|P2|NOT COMPLETED|Base Study Follow-up Period||342
2615420|NCT00090285|6422297|P1|NOT COMPLETED|Base Study Follow-up Period||335
2615421|NCT00090285|6422292|P6|COMPLETED|Base Study Follow-up Period||0
2615422|NCT00090285|6422293|P5|COMPLETED|Base Study Follow-up Period||0
2615423|NCT00090285|6422294|P4|COMPLETED|Base Study Follow-up Period||0
2615424|NCT00090285|6422295|P3|COMPLETED|Base Study Follow-up Period||0
2615425|NCT00090285|6422296|P2|COMPLETED|Base Study Follow-up Period||1479
2615426|NCT00090285|6422297|P1|COMPLETED|Base Study Follow-up Period||1487
2615427|NCT00090285|6422292|P6|STARTED|Base Study Follow-up Period||0
2615428|NCT00090285|6422293|P5|STARTED|Base Study Follow-up Period||0
2615429|NCT00090285|6422294|P4|STARTED|Base Study Follow-up Period||0
2615430|NCT00090285|6422295|P3|STARTED|Base Study Follow-up Period||0
2615431|NCT00090285|6422296|P2|STARTED|Base Study Follow-up Period|7 subjects who did not receive 3 doses of placebo in base study continued into the Follow-up Period|1821
2615432|NCT00090285|6422297|P1|STARTED|Base Study Follow-up Period|4 subjects who did not receive 3 doses of vaccine in base study continued into the Follow-up Period|1822
2615433|NCT00090285|6422292|P6|NOT COMPLETED|Base Study Vaccination Period||0
2615434|NCT00090285|6422293|P5|NOT COMPLETED|Base Study Vaccination Period||0
2615435|NCT00090285|6422294|P4|NOT COMPLETED|Base Study Vaccination Period||0
2615436|NCT00090285|6422295|P3|NOT COMPLETED|Base Study Vaccination Period||0
2615437|NCT00090285|6422296|P2|NOT COMPLETED|Base Study Vaccination Period||219
2615438|NCT00090285|6422297|P1|NOT COMPLETED|Base Study Vaccination Period||214
2615439|NCT00090285|6422292|P6|COMPLETED|Base Study Vaccination Period||0
2615440|NCT00090285|6422293|P5|COMPLETED|Base Study Vaccination Period||0
2615441|NCT00090285|6422294|P4|COMPLETED|Base Study Vaccination Period||0
2615442|NCT00090285|6422295|P3|COMPLETED|Base Study Vaccination Period||0
2615443|NCT00090285|6422296|P2|COMPLETED|Base Study Vaccination Period||1814
2615444|NCT00090285|6422297|P1|COMPLETED|Base Study Vaccination Period||1818
2615445|NCT00090285|6422292|P6|Vaccinated|Base Study Vaccination Period||0
2615446|NCT00090285|6422293|P5|Vaccinated|Base Study Vaccination Period||0
2615447|NCT00090285|6422294|P4|Vaccinated|Base Study Vaccination Period||0
2615448|NCT00090285|6422295|P3|Vaccinated|Base Study Vaccination Period||0
2615449|NCT00090285|6422296|P2|Vaccinated|Base Study Vaccination Period||2030
2615450|NCT00090285|6422297|P1|Vaccinated|Base Study Vaccination Period||2025
2615451|NCT00090285|6422292|P6|STARTED|Base Study Vaccination Period||0
2615452|NCT00090285|6422293|P5|STARTED|Base Study Vaccination Period||0
2615453|NCT00090285|6422294|P4|STARTED|Base Study Vaccination Period||0
2615454|NCT00090285|6422295|P3|STARTED|Base Study Vaccination Period||0
2615455|NCT00090285|6422296|P2|STARTED|Base Study Vaccination Period||2033
2615456|NCT00090285|6422297|P1|STARTED|Base Study Vaccination Period||2032
2615457|NCT00090259|6422334|P2|NOT COMPLETED|Overall Study||48
2615458|NCT00090259|6422335|P1|NOT COMPLETED|Overall Study||62
2615459|NCT00090259|6422334|P2|COMPLETED|Overall Study|Completed follow-up: 1005 on drug, 233 off drug,& 635 at death (death was considered an endpoint)|1873
2615460|NCT00090259|6422335|P1|COMPLETED|Overall Study|Completed follow-up: 963 on drug, 223 off drug, & 665 at death (death was considered an endpoint)|1851
2615461|NCT00090259|6422334|P2|STARTED|Overall Study||1921
2615462|NCT00090259|6422335|P1|STARTED|Overall Study||1913
2615463|NCT00090233|6422351|P2|NOT COMPLETED|Overall Study||5065
2615464|NCT00090233|6422352|P1|NOT COMPLETED|Overall Study||4999
2615465|NCT00090233|6422351|P2|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29565
2615466|NCT00090233|6422352|P1|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29645
2615467|NCT00090233|6422351|P2|Vaccinated at Visit 3|Overall Study||29598
2615468|NCT00090233|6422352|P1|Vaccinated at Visit 3|Overall Study||29667
2615469|NCT00090233|6422351|P2|Vaccinated at Visit 2|Overall Study||31066
2615470|NCT00090233|6422352|P1|Vaccinated at Visit 2|Overall Study||31052
2615471|NCT00090233|6422351|P2|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 627|34003
2615472|NCT00090233|6422352|P1|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 609|34035
2615473|NCT00090233|6422351|P2|STARTED|Overall Study|Evaluated by data safety monitoring board when they recommended stopping enrollment|34630
2615474|NCT00090233|6422352|P1|STARTED|Overall Study|Evaluated by data safety monitoring board (DSMB) when they recommended stopping enrollment|34644
2615475|NCT00090220|6422376|P6|NOT COMPLETED|Long-term Follow-up (EXT2)||28
2615476|NCT00090220|6422377|P5|NOT COMPLETED|Long-term Follow-up (EXT2)||44
2615477|NCT00090220|6422378|P4|NOT COMPLETED|Long-term Follow-up (EXT2)||0
2615478|NCT00090220|6422379|P3|NOT COMPLETED|Long-term Follow-up (EXT2)||0
2615479|NCT00090220|6422380|P2|NOT COMPLETED|Long-term Follow-up (EXT2)||0
2615480|NCT00090220|6422381|P1|NOT COMPLETED|Long-term Follow-up (EXT2)||0
2615481|NCT00090220|6422376|P6|COMPLETED|Long-term Follow-up (EXT2)||623
2615482|NCT00090220|6422377|P5|COMPLETED|Long-term Follow-up (EXT2)||641
2615483|NCT00090220|6422378|P4|COMPLETED|Long-term Follow-up (EXT2)||0
2615484|NCT00090220|6422379|P3|COMPLETED|Long-term Follow-up (EXT2)||0
2615485|NCT00090220|6422380|P2|COMPLETED|Long-term Follow-up (EXT2)||0
2615486|NCT00090220|6422381|P1|COMPLETED|Long-term Follow-up (EXT2)||0
2615487|NCT00090220|6422376|P6|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|651
2615488|NCT00090220|6422377|P5|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|685
2615489|NCT00090220|6422378|P4|STARTED|Long-term Follow-up (EXT2)||0
2615490|NCT00090220|6422379|P3|STARTED|Long-term Follow-up (EXT2)||0
2615491|NCT00090220|6422380|P2|STARTED|Long-term Follow-up (EXT2)||0
2615492|NCT00090220|6422381|P1|STARTED|Long-term Follow-up (EXT2)||0
2615493|NCT00090220|6422376|P6|NOT COMPLETED|Extension 1 (EXT1)||0
2615494|NCT00090220|6422377|P5|NOT COMPLETED|Extension 1 (EXT1)||0
2615495|NCT00090220|6422378|P4|NOT COMPLETED|Extension 1 (EXT1)||2
2615496|NCT00090220|6422379|P3|NOT COMPLETED|Extension 1 (EXT1)||55
2615497|NCT00090220|6422380|P2|NOT COMPLETED|Extension 1 (EXT1)||0
2615498|NCT00090220|6422381|P1|NOT COMPLETED|Extension 1 (EXT1)||0
2615499|NCT00090220|6422376|P6|COMPLETED|Extension 1 (EXT1)||0
2615500|NCT00090220|6422377|P5|COMPLETED|Extension 1 (EXT1)||0
2615501|NCT00090220|6422378|P4|COMPLETED|Extension 1 (EXT1)||5
2615502|NCT00090220|6422379|P3|COMPLETED|Extension 1 (EXT1)||1267
2615503|NCT00090220|6422380|P2|COMPLETED|Extension 1 (EXT1)||0
2615504|NCT00090220|6422381|P1|COMPLETED|Extension 1 (EXT1)||0
2615505|NCT00090220|6422376|P6|Vaccinated|Extension 1 (EXT1)||0
2615506|NCT00090220|6422377|P5|Vaccinated|Extension 1 (EXT1)||0
2615507|NCT00090220|6422378|P4|Vaccinated|Extension 1 (EXT1)||7
2615508|NCT00090220|6422379|P3|Vaccinated|Extension 1 (EXT1)||1321
2615509|NCT00090220|6422380|P2|Vaccinated|Extension 1 (EXT1)||0
2615510|NCT00090220|6422381|P1|Vaccinated|Extension 1 (EXT1)||0
2615511|NCT00090220|6422376|P6|STARTED|Extension 1 (EXT1)||0
2615512|NCT00090220|6422377|P5|STARTED|Extension 1 (EXT1)||0
2615513|NCT00090220|6422378|P4|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|7
2615514|NCT00090220|6422379|P3|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1322
2615515|NCT00090220|6422380|P2|STARTED|Extension 1 (EXT1)||0
2615516|NCT00090220|6422381|P1|STARTED|Extension 1 (EXT1)||0
2615517|NCT00090220|6422376|P6|NOT COMPLETED|Base Study Follow-up Period||0
2615518|NCT00090220|6422377|P5|NOT COMPLETED|Base Study Follow-up Period||0
2615519|NCT00090220|6422378|P4|NOT COMPLETED|Base Study Follow-up Period||0
2615520|NCT00090220|6422379|P3|NOT COMPLETED|Base Study Follow-up Period||0
2615521|NCT00090220|6422380|P2|NOT COMPLETED|Base Study Follow-up Period||164
2615522|NCT00090220|6422381|P1|NOT COMPLETED|Base Study Follow-up Period||160
2615523|NCT00090220|6422376|P6|COMPLETED|Base Study Follow-up Period||0
2615524|NCT00090220|6422377|P5|COMPLETED|Base Study Follow-up Period||0
2615525|NCT00090220|6422378|P4|COMPLETED|Base Study Follow-up Period||0
2615526|NCT00090220|6422379|P3|COMPLETED|Base Study Follow-up Period||0
2615527|NCT00090220|6422380|P2|COMPLETED|Base Study Follow-up Period||1687
2615528|NCT00090220|6422381|P1|COMPLETED|Base Study Follow-up Period||1695
2615529|NCT00090220|6422376|P6|STARTED|Base Study Follow-up Period||0
2615530|NCT00090220|6422377|P5|STARTED|Base Study Follow-up Period||0
2615531|NCT00090220|6422378|P4|STARTED|Base Study Follow-up Period||0
2615532|NCT00090220|6422379|P3|STARTED|Base Study Follow-up Period||0
2615533|NCT00090220|6422380|P2|STARTED|Base Study Follow-up Period|5 participants did not complete the Vaccination Period but entered the Follow-up Period.|1851
2615534|NCT00090220|6422381|P1|STARTED|Base Study Follow-up Period|8 participants did not complete the Vaccination Period but entered the Follow-up Period.|1855
2615535|NCT00090220|6422376|P6|NOT COMPLETED|Base Study Vaccination Period||0
2615536|NCT00090220|6422377|P5|NOT COMPLETED|Base Study Vaccination Period||0
2615537|NCT00090220|6422378|P4|NOT COMPLETED|Base Study Vaccination Period||0
2615538|NCT00090220|6422379|P3|NOT COMPLETED|Base Study Vaccination Period||0
2615539|NCT00090220|6422380|P2|NOT COMPLETED|Base Study Vaccination Period||63
2615540|NCT00090220|6422381|P1|NOT COMPLETED|Base Study Vaccination Period||64
2615541|NCT00090220|6422376|P6|COMPLETED|Base Study Vaccination Period||0
2615542|NCT00090220|6422377|P5|COMPLETED|Base Study Vaccination Period||0
2615543|NCT00090220|6422378|P4|COMPLETED|Base Study Vaccination Period||0
2615544|NCT00090220|6422379|P3|COMPLETED|Base Study Vaccination Period||0
2615545|NCT00090220|6422380|P2|COMPLETED|Base Study Vaccination Period||1845
2615546|NCT00090220|6422381|P1|COMPLETED|Base Study Vaccination Period||1847
2615547|NCT00090220|6422376|P6|Vaccinated|Base Study Vaccination Period||0
2615548|NCT00090220|6422377|P5|Vaccinated|Base Study Vaccination Period||0
2615549|NCT00090220|6422378|P4|Vaccinated|Base Study Vaccination Period||0
2615550|NCT00090220|6422379|P3|Vaccinated|Base Study Vaccination Period||0
2615551|NCT00090220|6422380|P2|Vaccinated|Base Study Vaccination Period||1907
2615552|NCT00090220|6422381|P1|Vaccinated|Base Study Vaccination Period||1910
2615553|NCT00090220|6422376|P6|STARTED|Base Study Vaccination Period||0
2615554|NCT00090220|6422377|P5|STARTED|Base Study Vaccination Period||0
2615555|NCT00090220|6422378|P4|STARTED|Base Study Vaccination Period||0
2615556|NCT00090220|6422379|P3|STARTED|Base Study Vaccination Period||0
2615557|NCT00090220|6422380|P2|STARTED|Base Study Vaccination Period||1908
2615558|NCT00090220|6422381|P1|STARTED|Base Study Vaccination Period||1911
2615559|NCT00090402|6422476|P3|NOT COMPLETED|Overall Study||1
2615560|NCT00090402|6422477|P2|NOT COMPLETED|Overall Study||2
2615561|NCT00090402|6422478|P1|NOT COMPLETED|Overall Study||2
2615562|NCT00090402|6422476|P3|COMPLETED|Overall Study||12
2615563|NCT00090402|6422477|P2|COMPLETED|Overall Study||11
2615564|NCT00090402|6422478|P1|COMPLETED|Overall Study||11
2615565|NCT00090402|6422476|P3|STARTED|Overall Study||13
2615566|NCT00090402|6422477|P2|STARTED|Overall Study||13
2615567|NCT00090402|6422478|P1|STARTED|Overall Study||13
2615568|NCT00090142|6422492|P2|NOT COMPLETED|Treatment Period II||0
2615569|NCT00090142|6422493|P1|NOT COMPLETED|Treatment Period II||1
2615570|NCT00090142|6422492|P2|COMPLETED|Treatment Period II||28
2615571|NCT00090142|6422493|P1|COMPLETED|Treatment Period II||25
2615572|NCT00090142|6422492|P2|STARTED|Treatment Period II||28
2615573|NCT00090142|6422493|P1|STARTED|Treatment Period II||26
2615574|NCT00090142|6422492|P2|NOT COMPLETED|Treatment Period I||3
2615575|NCT00090142|6422493|P1|NOT COMPLETED|Treatment Period I||5
2615576|NCT00090142|6422492|P2|COMPLETED|Treatment Period I||28
2615577|NCT00090142|6422493|P1|COMPLETED|Treatment Period I||26
2615578|NCT00090142|6422492|P2|STARTED|Treatment Period I||31
2615579|NCT00090142|6422493|P1|STARTED|Treatment Period I|1 patient was lost to follow-up after randomization and did not receive any study drug.|31
2615580|NCT00090103|6422524|P3|NOT COMPLETED|16-Week Safety Follow-up Period||457
2615581|NCT00090103|6422525|P2|NOT COMPLETED|16-Week Safety Follow-up Period||410
2615582|NCT00090103|6422526|P1|NOT COMPLETED|16-Week Safety Follow-up Period||374
2615583|NCT00090103|6422524|P3|COMPLETED|16-Week Safety Follow-up Period||1143
2615584|NCT00090103|6422525|P2|COMPLETED|16-Week Safety Follow-up Period||1205
2615585|NCT00090103|6422526|P1|COMPLETED|16-Week Safety Follow-up Period||1224
2615586|NCT00090103|6422524|P3|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1600
2615587|NCT00090103|6422525|P2|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1615
2615588|NCT00090103|6422526|P1|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1598
2615589|NCT00090103|6422524|P3|NOT COMPLETED|Four-Year Double-Blind Treatment Period||622
2615590|NCT00090103|6422525|P2|NOT COMPLETED|Four-Year Double-Blind Treatment Period||530
2615591|NCT00090103|6422526|P1|NOT COMPLETED|Four-Year Double-Blind Treatment Period||497
2615592|NCT00090103|6422524|P3|COMPLETED|Four-Year Double-Blind Treatment Period||989
2615593|NCT00090103|6422525|P2|COMPLETED|Four-Year Double-Blind Treatment Period||1093
2615594|NCT00090103|6422526|P1|COMPLETED|Four-Year Double-Blind Treatment Period||1113
2615595|NCT00090103|6422524|P3|STARTED|Four-Year Double-Blind Treatment Period||1611
2615596|NCT00090103|6422525|P2|STARTED|Four-Year Double-Blind Treatment Period||1623
2615597|NCT00090103|6422526|P1|STARTED|Four-Year Double-Blind Treatment Period||1610
2615598|NCT00090051|6422626|P2|NOT COMPLETED|Overall Study||95
2615599|NCT00090051|6422627|P1|NOT COMPLETED|Overall Study||109
2615600|NCT00090051|6422626|P2|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|181
2615601|NCT00090051|6422627|P1|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|167
2615602|NCT00090051|6422626|P2|Safety Population; Received Study Drug|Overall Study||274
2615603|NCT00090051|6422627|P1|Safety Population; Received Study Drug|Overall Study||272
2615604|NCT00090051|6422626|P2|STARTED|Overall Study||276
2615605|NCT00090051|6422627|P1|STARTED|Overall Study||276
2615606|NCT00003224|6422667|P6|NOT COMPLETED|Overall Study||0
2615607|NCT00003224|6422668|P5|NOT COMPLETED|Overall Study||0
2615608|NCT00003224|6422669|P4|NOT COMPLETED|Overall Study||0
2615609|NCT00003224|6422670|P3|NOT COMPLETED|Overall Study||0
2615610|NCT00003224|6422671|P2|NOT COMPLETED|Overall Study||0
2615611|NCT00003224|6422672|P1|NOT COMPLETED|Overall Study||0
2615612|NCT00003224|6422667|P6|COMPLETED|Overall Study||3
2615613|NCT00003224|6422668|P5|COMPLETED|Overall Study||4
2615614|NCT00003224|6422669|P4|COMPLETED|Overall Study||2
2615615|NCT00003224|6422670|P3|COMPLETED|Overall Study||4
2615616|NCT00003224|6422671|P2|COMPLETED|Overall Study||5
2615617|NCT00003224|6422672|P1|COMPLETED|Overall Study||4
2615618|NCT00003224|6422667|P6|STARTED|Overall Study||3
2615619|NCT00003224|6422668|P5|STARTED|Overall Study||4
2615620|NCT00003224|6422669|P4|STARTED|Overall Study||2
2615621|NCT00003224|6422670|P3|STARTED|Overall Study||4
2615622|NCT00003224|6422671|P2|STARTED|Overall Study||5
2615623|NCT00003224|6422672|P1|STARTED|Overall Study||4
2615624|NCT00089999|6422692|P2|NOT COMPLETED|Overall Study||69
2615625|NCT00089999|6422693|P1|NOT COMPLETED|Overall Study||69
2615626|NCT00089999|6422692|P2|COMPLETED|Overall Study||0
2615627|NCT00089999|6422693|P1|COMPLETED|Overall Study||0
2615628|NCT00089999|6422692|P2|STARTED|Overall Study||69
2615629|NCT00089999|6422693|P1|STARTED|Overall Study||69
2615630|NCT00089986|6422716|P3|NOT COMPLETED|Overall Study||10
2615631|NCT00089986|6422717|P2|NOT COMPLETED|Overall Study||24
2615632|NCT00089986|6422718|P1|NOT COMPLETED|Overall Study||15
2615633|NCT00089986|6422716|P3|COMPLETED|Overall Study||172
2615634|NCT00089986|6422717|P2|COMPLETED|Overall Study||574
2615635|NCT00089986|6422718|P1|COMPLETED|Overall Study||584
2615636|NCT00089986|6422716|P3|STARTED|Overall Study||182
2615637|NCT00089986|6422717|P2|STARTED|Overall Study||598
2615638|NCT00089986|6422718|P1|STARTED|Overall Study||599
2615639|NCT00089973|6422735|P1|NOT COMPLETED|Overall Study||50
2615640|NCT00089973|6422735|P1|COMPLETED|Overall Study||0
2615641|NCT00089973|6422735|P1|STARTED|Overall Study||50
2615642|NCT00089895|6422750|P2|NOT COMPLETED|Overall Study||42
2615643|NCT00089895|6422751|P1|NOT COMPLETED|Overall Study||35
2615644|NCT00089895|6422750|P2|COMPLETED|Overall Study|Number of Subjects treated|4642
2615645|NCT00089895|6422751|P1|COMPLETED|Overall Study|Number of Subjects treated|4687
2615646|NCT00089895|6422750|P2|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4684
2615647|NCT00089895|6422751|P1|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4722
2615648|NCT00089843|6422763|P4|NOT COMPLETED|Overall Study||7
2615649|NCT00089843|6422764|P3|NOT COMPLETED|Overall Study||5
2615650|NCT00089843|6422765|P2|NOT COMPLETED|Overall Study||4
2615651|NCT00089843|6422766|P1|NOT COMPLETED|Overall Study||2
2615652|NCT00089843|6422763|P4|COMPLETED|Overall Study||11
2615653|NCT00089843|6422764|P3|COMPLETED|Overall Study||15
2615654|NCT00089843|6422765|P2|COMPLETED|Overall Study||16
2615655|NCT00089843|6422766|P1|COMPLETED|Overall Study||17
2615656|NCT00089843|6422763|P4|STARTED|Overall Study||18
2615657|NCT00089843|6422764|P3|STARTED|Overall Study||20
2615658|NCT00089843|6422765|P2|STARTED|Overall Study||20
2615659|NCT00089843|6422766|P1|STARTED|Overall Study||19
2615660|NCT00089791|6422778|P2|NOT COMPLETED|Overall Study||630
2615661|NCT00089791|6422779|P1|NOT COMPLETED|Overall Study||700
2615662|NCT00089791|6422778|P2|COMPLETED|Overall Study||3272
2615663|NCT00089791|6422779|P1|COMPLETED|Overall Study||3206
2615664|NCT00089791|6422778|P2|Safety Analysis Set|Overall Study||3886
2615665|NCT00089791|6422779|P1|Safety Analysis Set|Overall Study|7 participants in the placebo arm received ≥1 dose of denosumab & were analyzed in the denosumab arm|3876
2615666|NCT00089791|6422778|P2|Received Study Medication|Overall Study||3879
2615667|NCT00089791|6422779|P1|Received Study Medication|Overall Study||3883
2615668|NCT00089791|6422778|P2|STARTED|Overall Study||3902
2615669|NCT00089791|6422779|P1|STARTED|Overall Study||3906
2615670|NCT00089752|6422791|P2|NOT COMPLETED|Overall Study||22
2615671|NCT00089752|6422792|P1|NOT COMPLETED|Overall Study||20
2615672|NCT00089752|6422791|P2|COMPLETED|Overall Study||118
2615673|NCT00089752|6422792|P1|COMPLETED|Overall Study||121
2615674|NCT00089752|6422791|P2|STARTED|Overall Study||140
2615675|NCT00089752|6422792|P1|STARTED|Overall Study||141
2615676|NCT00089778|6422813|P3|NOT COMPLETED|Overall Study||1
2615677|NCT00089778|6422814|P2|NOT COMPLETED|Overall Study||0
2615678|NCT00089778|6422815|P1|NOT COMPLETED|Overall Study||0
2615679|NCT00089778|6422813|P3|COMPLETED|Overall Study||7
2615680|NCT00089778|6422814|P2|COMPLETED|Overall Study||1
2615681|NCT00089778|6422815|P1|COMPLETED|Overall Study||2
2615682|NCT00089778|6422813|P3|STARTED|Overall Study||8
2615683|NCT00089778|6422814|P2|STARTED|Overall Study||1
2615684|NCT00089778|6422815|P1|STARTED|Overall Study||2
2615685|NCT00089674|6422828|P2|NOT COMPLETED|Overall Study||267
2615686|NCT00089674|6422829|P1|NOT COMPLETED|Overall Study||289
2615687|NCT00089674|6422828|P2|COMPLETED|Overall Study||467
2615688|NCT00089674|6422829|P1|COMPLETED|Overall Study||445
2615689|NCT00089674|6422828|P2|Received Study Drug|Overall Study||726
2615690|NCT00089674|6422829|P1|Received Study Drug|Overall Study||730
2615691|NCT00089674|6422828|P2|STARTED|Overall Study||734
2615692|NCT00089674|6422829|P1|STARTED|Overall Study||734
2615693|NCT00089661|6422855|P2|NOT COMPLETED|Overall Study||26
2615694|NCT00089661|6422856|P1|NOT COMPLETED|Overall Study||21
2615695|NCT00089661|6422855|P2|COMPLETED|Overall Study||99
2615696|NCT00089661|6422856|P1|COMPLETED|Overall Study||106
2615697|NCT00089661|6422855|P2|STARTED|Overall Study||125
2615698|NCT00089661|6422856|P1|STARTED|Overall Study||127
2615699|NCT00089648|6422872|P1|NOT COMPLETED|Overall Study||41
2615700|NCT00089648|6422872|P1|COMPLETED|Overall Study||20
2615701|NCT00089648|6422872|P1|STARTED|Overall Study||61
2615702|NCT00089635|6422888|P1|NOT COMPLETED|Overall Study||43
2615703|NCT00089635|6422888|P1|COMPLETED|Overall Study||160
2615704|NCT00089635|6422888|P1|STARTED|Overall Study||203
2615705|NCT00089583|6422902|P2|NOT COMPLETED|Overall Study||38
2615706|NCT00089583|6422903|P1|NOT COMPLETED|Overall Study||7
2615707|NCT00089583|6422902|P2|COMPLETED|Overall Study||51
2615708|NCT00089583|6422903|P1|COMPLETED|Overall Study||13
2615709|NCT00089583|6422902|P2|STARTED|Overall Study||89
2615710|NCT00089583|6422903|P1|STARTED|Overall Study||20
2615711|NCT00089609|6422997|P2|NOT COMPLETED|Overall Study||1
2615712|NCT00089609|6422998|P1|NOT COMPLETED|Overall Study||3
2615713|NCT00089609|6422997|P2|COMPLETED|Overall Study||12
2615714|NCT00089609|6422998|P1|COMPLETED|Overall Study||57
2615715|NCT00089609|6422997|P2|STARTED|Overall Study||13
2615716|NCT00089609|6422998|P1|STARTED|Overall Study||60
2615717|NCT00089544|6423017|P2|NOT COMPLETED|Overall Study||0
2615718|NCT00089544|6423018|P1|NOT COMPLETED|Overall Study||1
2615719|NCT00089544|6423017|P2|COMPLETED|Overall Study||7
2615720|NCT00089544|6423018|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|15
2615721|NCT00089544|6423017|P2|STARTED|Overall Study||7
2615722|NCT00089544|6423018|P1|STARTED|Overall Study||16
2615723|NCT00089505|6423032|P4|NOT COMPLETED|Overall Study||21
2615724|NCT00089505|6423033|P3|NOT COMPLETED|Overall Study||21
2615725|NCT00089505|6423034|P2|NOT COMPLETED|Overall Study||2
2615726|NCT00089505|6423035|P1|NOT COMPLETED|Overall Study||9
2615727|NCT00089505|6423032|P4|COMPLETED|Overall Study||230
2615728|NCT00089505|6423033|P3|COMPLETED|Overall Study||228
2615729|NCT00089505|6423034|P2|COMPLETED|Overall Study|The results for NVP/LPV_r were through database cutoff for DSMB review (by 6 October 2008).|118
2615730|NCT00089505|6423035|P1|COMPLETED|Overall Study|The results for NVP/NVP were through database cutoff for DSMB review (by 6 October 2008).|112
2615731|NCT00089505|6423032|P4|STARTED|Overall Study||251
2615732|NCT00089505|6423033|P3|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|249
2615733|NCT00089505|6423034|P2|STARTED|Overall Study||120
2615734|NCT00089505|6423035|P1|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|121
2615735|NCT00089479|6423079|P2|NOT COMPLETED|Overall Study||289
2615736|NCT00089479|6423080|P1|NOT COMPLETED|Overall Study||331
2615737|NCT00089479|6423079|P2|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|1018
2615738|NCT00089479|6423080|P1|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|973
2615739|NCT00089479|6423079|P2|Received Treatment|Overall Study|Safety Population (includes 5 patients randomized to ACT, who received ACXT)|1283
2615740|NCT00089479|6423080|P1|Received Treatment|Overall Study|Safety Population (includes 19 patients randomized to ACXT, who received ACT)|1305
2615741|NCT00089479|6423079|P2|STARTED|Overall Study||1307
2615742|NCT00089479|6423080|P1|STARTED|Overall Study||1304
2615743|NCT00089414|6423107|P3|NOT COMPLETED|Overall Study||0
2615744|NCT00089414|6423108|P2|NOT COMPLETED|Overall Study||0
2615745|NCT00089414|6423109|P1|NOT COMPLETED|Overall Study||0
2615746|NCT00089414|6423107|P3|COMPLETED|Overall Study||2
2615747|NCT00089414|6423108|P2|COMPLETED|Overall Study||1
2615748|NCT00089414|6423109|P1|COMPLETED|Overall Study||2
2615749|NCT00089414|6423107|P3|STARTED|Overall Study||2
2615750|NCT00089414|6423108|P2|STARTED|Overall Study||1
2615751|NCT00089414|6423109|P1|STARTED|Overall Study||2
2615752|NCT00089297|6423123|P1|NOT COMPLETED|Overall Study||38
2615753|NCT00089297|6423123|P1|COMPLETED|Overall Study||36
2615754|NCT00089297|6423123|P1|Eligible|Overall Study||63
2615755|NCT00089297|6423123|P1|Treated|Overall Study||70
2615756|NCT00089297|6423123|P1|STARTED|Overall Study||74
2615757|NCT00089284|6423135|P7|NOT COMPLETED|Overall Study||1
2615758|NCT00089284|6423136|P6|NOT COMPLETED|Overall Study||0
2615759|NCT00089284|6423137|P5|NOT COMPLETED|Overall Study||0
2615760|NCT00089284|6423138|P4|NOT COMPLETED|Overall Study||0
2615761|NCT00089284|6423139|P3|NOT COMPLETED|Overall Study||0
2615762|NCT00089284|6423140|P2|NOT COMPLETED|Overall Study||0
2615763|NCT00089284|6423141|P1|NOT COMPLETED|Overall Study||0
2615764|NCT00089284|6423135|P7|COMPLETED|Overall Study||7
2615765|NCT00089284|6423136|P6|COMPLETED|Overall Study||0
2615766|NCT00089284|6423137|P5|COMPLETED|Overall Study||0
2615767|NCT00089284|6423138|P4|COMPLETED|Overall Study||6
2615768|NCT00089284|6423139|P3|COMPLETED|Overall Study||6
2615769|NCT00089284|6423140|P2|COMPLETED|Overall Study||3
2615770|NCT00089284|6423141|P1|COMPLETED|Overall Study||7
2615771|NCT00089284|6423135|P7|STARTED|Overall Study||8
2615772|NCT00089284|6423136|P6|STARTED|Overall Study|No patients were accrued to this cohort of 6-24% involvement due to lack of eligible patients.|0
2615773|NCT00089284|6423137|P5|STARTED|Overall Study|No patients were accrued to this cohort of 6-24% involvement due to lack of eligible patients.|0
2615774|NCT00089284|6423138|P4|STARTED|Overall Study||6
2615775|NCT00089284|6423139|P3|STARTED|Overall Study||6
2615776|NCT00089284|6423140|P2|STARTED|Overall Study||3
2615777|NCT00089284|6423141|P1|STARTED|Overall Study||7
2615778|NCT00089141|6423178|P2|NOT COMPLETED|Overall Study||24
2615779|NCT00089141|6423179|P1|NOT COMPLETED|Overall Study||18
2615780|NCT00089141|6423178|P2|COMPLETED|Overall Study||53
2615781|NCT00089141|6423179|P1|COMPLETED|Overall Study||56
2615782|NCT00089141|6423178|P2|STARTED|Overall Study||77
2615783|NCT00089141|6423179|P1|STARTED|Overall Study||74
2615784|NCT00089128|6423201|P1|NOT COMPLETED|Overall Study||0
2615785|NCT00089128|6423201|P1|COMPLETED|Overall Study||16
2615786|NCT00089128|6423201|P1|STARTED|Overall Study||16
2615787|NCT00089102|6423208|P1|NOT COMPLETED|Overall Study||0
2615788|NCT00089102|6423208|P1|COMPLETED|Overall Study||9
2615789|NCT00089102|6423208|P1|STARTED|Overall Study||9
2615790|NCT00089076|6423215|P1|NOT COMPLETED|Overall Study||10
2615791|NCT00089076|6423215|P1|COMPLETED|Overall Study||8
2615792|NCT00089076|6423215|P1|STARTED|Overall Study||18
2615793|NCT00089024|6423226|P1|NOT COMPLETED|Overall Study||5
2615794|NCT00089024|6423226|P1|COMPLETED|Overall Study||24
2615795|NCT00089024|6423226|P1|Treated Subjects|Overall Study||29
2615796|NCT00089024|6423226|P1|STARTED|Overall Study||29
2615797|NCT00089011|6423233|P2|NOT COMPLETED|Overall Study||0
2615798|NCT00089011|6423234|P1|NOT COMPLETED|Overall Study||0
2615799|NCT00089011|6423233|P2|COMPLETED|Overall Study||50
2615800|NCT00089011|6423234|P1|COMPLETED|Overall Study||100
2615801|NCT00089011|6423233|P2|STARTED|Overall Study||50
2615802|NCT00089011|6423234|P1|STARTED|Overall Study||100
2615803|NCT00088985|6423254|P1|NOT COMPLETED|Overall Study||3
2615804|NCT00088985|6423254|P1|COMPLETED|Overall Study||4
2615805|NCT00088985|6423254|P1|STARTED|Overall Study||7
2615806|NCT00088972|6423261|P2|NOT COMPLETED|Overall Study||4
2615807|NCT00088972|6423262|P1|NOT COMPLETED|Overall Study||2
2615808|NCT00088972|6423261|P2|COMPLETED|Overall Study||1
2615809|NCT00088972|6423262|P1|COMPLETED|Overall Study||1
2615810|NCT00088972|6423261|P2|STARTED|Overall Study||5
2615811|NCT00088972|6423262|P1|STARTED|Overall Study||3
2615812|NCT00088907|6423272|P2|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||0
2615813|NCT00088907|6423273|P1|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||24
2615814|NCT00088907|6423272|P2|COMPLETED|Single Gefitinib Treatment (Step 2)||0
2615815|NCT00088907|6423273|P1|COMPLETED|Single Gefitinib Treatment (Step 2)||0
2615816|NCT00088907|6423272|P2|Treated|Single Gefitinib Treatment (Step 2)||0
2615817|NCT00088907|6423273|P1|Treated|Single Gefitinib Treatment (Step 2)||19
2615818|NCT00088907|6423272|P2|STARTED|Single Gefitinib Treatment (Step 2)|Cross over to single gefitinib therapy at progression was allowed for patients on Arm I only.|0
2615908|NCT00088218|6423421|P2|COMPLETED|Overall Study||79
2615819|NCT00088907|6423273|P1|STARTED|Single Gefitinib Treatment (Step 2)|Patients on Arm I could cross over to gefitinib after disease progression on step 1.|24
2615820|NCT00088907|6423272|P2|NOT COMPLETED|Randomized Study (Step 1)||134
2615821|NCT00088907|6423273|P1|NOT COMPLETED|Randomized Study (Step 1)||136
2615822|NCT00088907|6423272|P2|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles|0
2615823|NCT00088907|6423273|P1|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles.|0
2615824|NCT00088907|6423272|P2|Eligible and Treated|Randomized Study (Step 1)||122
2615825|NCT00088907|6423273|P1|Eligible and Treated|Randomized Study (Step 1)||117
2615826|NCT00088907|6423272|P2|Eligible|Randomized Study (Step 1)||122
2615827|NCT00088907|6423273|P1|Eligible|Randomized Study (Step 1)||117
2615828|NCT00088907|6423272|P2|Treated|Randomized Study (Step 1)||124
2615829|NCT00088907|6423273|P1|Treated|Randomized Study (Step 1)||129
2615830|NCT00088907|6423272|P2|STARTED|Randomized Study (Step 1)||134
2615831|NCT00088907|6423273|P1|STARTED|Randomized Study (Step 1)||136
2615832|NCT00088881|6423284|P1|NOT COMPLETED|Step 3 - Radiation Therapy||0
2615833|NCT00088881|6423284|P1|COMPLETED|Step 3 - Radiation Therapy||1
2615834|NCT00088881|6423284|P1|STARTED|Step 3 - Radiation Therapy||1
2615835|NCT00088881|6423284|P1|NOT COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||11
2615836|NCT00088881|6423284|P1|COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||45
2615837|NCT00088881|6423284|P1|Eligible and Treated|Step 2 - Zevalin™ Radioimmunotherapy||48
2615838|NCT00088881|6423284|P1|STARTED|Step 2 - Zevalin™ Radioimmunotherapy|This includes all patients who received step 2 treatment regardless of eligibility.|56
2615839|NCT00088881|6423284|P1|NOT COMPLETED|Step 1 - R-CHOP||14
2615840|NCT00088881|6423284|P1|COMPLETED|Step 1 - R-CHOP||48
2615841|NCT00088881|6423284|P1|Eligible and Treated|Step 1 - R-CHOP||53
2615842|NCT00088881|6423284|P1|STARTED|Step 1 - R-CHOP||62
2615843|NCT00088829|6423293|P1|NOT COMPLETED|Overall Study||22
2615844|NCT00088829|6423293|P1|COMPLETED|Overall Study||0
2615845|NCT00088829|6423293|P1|STARTED|Overall Study||22
2615846|NCT00088699|6423299|P4|NOT COMPLETED|Infusion 2||1
2615847|NCT00088699|6423300|P3|NOT COMPLETED|Infusion 2||0
2615848|NCT00088699|6423301|P2|NOT COMPLETED|Infusion 2||0
2615849|NCT00088699|6423302|P1|NOT COMPLETED|Infusion 2||0
2615850|NCT00088699|6423299|P4|COMPLETED|Infusion 2||10
2615851|NCT00088699|6423300|P3|COMPLETED|Infusion 2||11
2615852|NCT00088699|6423301|P2|COMPLETED|Infusion 2||18
2615853|NCT00088699|6423302|P1|COMPLETED|Infusion 2||19
2615854|NCT00088699|6423299|P4|STARTED|Infusion 2||11
2615855|NCT00088699|6423300|P3|STARTED|Infusion 2||11
2615856|NCT00088699|6423301|P2|STARTED|Infusion 2||18
2615857|NCT00088699|6423302|P1|STARTED|Infusion 2||19
2615858|NCT00088699|6423299|P4|NOT COMPLETED|Infusion 1||2
2615859|NCT00088699|6423300|P3|NOT COMPLETED|Infusion 1||1
2615860|NCT00088699|6423301|P2|NOT COMPLETED|Infusion 1||0
2615861|NCT00088699|6423302|P1|NOT COMPLETED|Infusion 1||1
2615862|NCT00088699|6423299|P4|COMPLETED|Infusion 1||10
2615863|NCT00088699|6423300|P3|COMPLETED|Infusion 1||12
2615864|NCT00088699|6423301|P2|COMPLETED|Infusion 1||19
2615865|NCT00088699|6423302|P1|COMPLETED|Infusion 1||22
2615866|NCT00088699|6423299|P4|STARTED|Infusion 1||12
2615867|NCT00088699|6423300|P3|STARTED|Infusion 1||13
2615868|NCT00088699|6423301|P2|STARTED|Infusion 1||19
2615869|NCT00088699|6423302|P1|STARTED|Infusion 1||23
2615870|NCT00088634|6423318|P2|NOT COMPLETED|Overall Study||43
2615871|NCT00088634|6423319|P1|NOT COMPLETED|Overall Study||38
2615872|NCT00088634|6423318|P2|COMPLETED|Overall Study||47
2615873|NCT00088634|6423319|P1|COMPLETED|Overall Study||52
2615874|NCT00088634|6423318|P2|STARTED|Overall Study||90
2615875|NCT00088634|6423319|P1|STARTED|Overall Study||90
2615876|NCT00088621|6423331|P1|NOT COMPLETED|Overall Study||54
2615877|NCT00088621|6423331|P1|COMPLETED|Overall Study||7
2615878|NCT00088621|6423331|P1|STARTED|Overall Study||61
2615879|NCT00088595|6423335|P1|NOT COMPLETED|Overall Study||28
2615880|NCT00088595|6423335|P1|COMPLETED|Overall Study||17
2615881|NCT00088595|6423335|P1|STARTED|Overall Study||45
2615882|NCT00088530|6423353|P2|NOT COMPLETED|Overall Study||54
2615883|NCT00088530|6423354|P1|NOT COMPLETED|Overall Study||50
2615884|NCT00088530|6423353|P2|COMPLETED|Overall Study||16
2615885|NCT00088530|6423354|P1|COMPLETED|Overall Study||20
2615886|NCT00088530|6423353|P2|STARTED|Overall Study||70
2615887|NCT00088530|6423354|P1|STARTED|Overall Study||70
2615888|NCT00088465|6423366|P1|NOT COMPLETED|Overall Study||561
2615889|NCT00088465|6423366|P1|COMPLETED|Overall Study||370
2615890|NCT00088465|6423366|P1|STARTED|Overall Study||931
2615891|NCT00088413|6423393|P4|NOT COMPLETED|Overall Study||14
2615892|NCT00088413|6423394|P3|NOT COMPLETED|Overall Study||12
2615893|NCT00088413|6423395|P2|NOT COMPLETED|Overall Study||15
2615894|NCT00088413|6423396|P1|NOT COMPLETED|Overall Study||10
2615895|NCT00088413|6423393|P4|COMPLETED|Overall Study||0
2615896|NCT00088413|6423394|P3|COMPLETED|Overall Study||0
2615897|NCT00088413|6423395|P2|COMPLETED|Overall Study||0
2615898|NCT00088413|6423396|P1|COMPLETED|Overall Study||0
2615899|NCT00088413|6423393|P4|STARTED|Overall Study||14
2615900|NCT00088413|6423394|P3|STARTED|Overall Study||12
2615901|NCT00088413|6423395|P2|STARTED|Overall Study||15
2615902|NCT00088413|6423396|P1|STARTED|Overall Study||10
2615903|NCT00088374|6423410|P1|NOT COMPLETED|Overall Study||2
2615904|NCT00088374|6423410|P1|COMPLETED|Overall Study||7
2615905|NCT00088374|6423410|P1|STARTED|Overall Study||9
2615906|NCT00088218|6423421|P2|NOT COMPLETED|Overall Study||0
2615907|NCT00088218|6423422|P1|NOT COMPLETED|Overall Study||0
2615909|NCT00088218|6423422|P1|COMPLETED|Overall Study||16
2615910|NCT00088218|6423421|P2|STARTED|Overall Study||79
2615911|NCT00088218|6423422|P1|STARTED|Overall Study||16
2615912|NCT00088166|6423430|P2|NOT COMPLETED|Overall Study||61
2615913|NCT00088166|6423431|P1|NOT COMPLETED|Overall Study||53
2615914|NCT00088166|6423430|P2|COMPLETED|Overall Study||39
2615915|NCT00088166|6423431|P1|COMPLETED|Overall Study||47
2615916|NCT00088166|6423430|P2|STARTED|Overall Study||100
2615917|NCT00088166|6423431|P1|STARTED|Overall Study||100
2615918|NCT00088153|6423455|P2|NOT COMPLETED|Overall Study||25
2615919|NCT00088153|6423456|P1|NOT COMPLETED|Overall Study||24
2615920|NCT00088153|6423455|P2|COMPLETED|Overall Study||30
2615921|NCT00088153|6423456|P1|COMPLETED|Overall Study||31
2615922|NCT00088153|6423455|P2|STARTED|Overall Study||55
2615923|NCT00088153|6423456|P1|STARTED|Overall Study||55
2615924|NCT00087698|6423466|P1|NOT COMPLETED|Overall Study||36
2615925|NCT00087698|6423466|P1|COMPLETED|Overall Study||41
2615926|NCT00087698|6423466|P1|STARTED|Overall Study||77
2615927|NCT00087685|6423475|P1|NOT COMPLETED|Overall Study||14
2615928|NCT00087685|6423475|P1|COMPLETED|Overall Study||21
2615929|NCT00087685|6423475|P1|STARTED|Overall Study||35
2615930|NCT00087672|6423480|P1|NOT COMPLETED|Overall Study||0
2615931|NCT00087672|6423480|P1|COMPLETED|Overall Study||41
2615932|NCT00087672|6423480|P1|STARTED|Overall Study||41
2615933|NCT00087646|6423488|P4|NOT COMPLETED|Overall Study||84
2615934|NCT00087646|6423489|P3|NOT COMPLETED|Overall Study||65
2615935|NCT00087646|6423490|P2|NOT COMPLETED|Overall Study||42
2615936|NCT00087646|6423491|P1|NOT COMPLETED|Overall Study||135
2615937|NCT00087646|6423488|P4|COMPLETED|Overall Study||229
2615938|NCT00087646|6423489|P3|COMPLETED|Overall Study||91
2615939|NCT00087646|6423490|P2|COMPLETED|Overall Study||114
2615940|NCT00087646|6423491|P1|COMPLETED|Overall Study||182
2615941|NCT00087646|6423488|P4|STARTED|Overall Study||313
2615942|NCT00087646|6423489|P3|STARTED|Overall Study||156
2615943|NCT00087646|6423490|P2|STARTED|Overall Study||156
2615944|NCT00087646|6423491|P1|STARTED|Overall Study||317
2615945|NCT00087633|6423519|P2|NOT COMPLETED|Overall Study||17
2615946|NCT00087633|6423520|P1|NOT COMPLETED|Overall Study||24
2615947|NCT00087633|6423519|P2|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|43
2615948|NCT00087633|6423520|P1|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|31
2615949|NCT00087633|6423519|P2|STARTED|Overall Study|Randomized|60
2615950|NCT00087633|6423520|P1|STARTED|Overall Study|Randomized|55
2615951|NCT00087607|6423530|P2|NOT COMPLETED|Overall Study||122
2615952|NCT00087607|6423531|P1|NOT COMPLETED|Overall Study||122
2615953|NCT00087607|6423530|P2|COMPLETED|Overall Study||71
2615954|NCT00087607|6423531|P1|COMPLETED|Overall Study||70
2615955|NCT00087607|6423530|P2|STARTED|Overall Study||193
2615956|NCT00087607|6423531|P1|STARTED|Overall Study||192
2615957|NCT00087594|6423571|P2|NOT COMPLETED|Overall Study||12
2615958|NCT00087594|6423572|P1|NOT COMPLETED|Overall Study||8
2615959|NCT00087594|6423571|P2|COMPLETED|Overall Study||12
2615960|NCT00087594|6423572|P1|COMPLETED|Overall Study||16
2615961|NCT00087594|6423571|P2|STARTED|Overall Study||24
2615962|NCT00087594|6423572|P1|STARTED|Overall Study||24
2615963|NCT00087568|6423606|P2|NOT COMPLETED|Overall Study||2
2615964|NCT00087568|6423607|P1|NOT COMPLETED|Overall Study||30
2615965|NCT00087568|6423606|P2|COMPLETED|Overall Study||23
2615966|NCT00087568|6423607|P1|COMPLETED|Overall Study||2
2615967|NCT00087568|6423606|P2|STARTED|Overall Study||25
2615968|NCT00087568|6423607|P1|STARTED|Overall Study||32
2615969|NCT00087555|6423634|P3|NOT COMPLETED|Overall Study||21
2615970|NCT00087555|6423635|P2|NOT COMPLETED|Overall Study||11
2615971|NCT00087555|6423636|P1|NOT COMPLETED|Overall Study||12
2615972|NCT00087555|6423634|P3|COMPLETED|Overall Study||46
2615973|NCT00087555|6423635|P2|COMPLETED|Overall Study||51
2615974|NCT00087555|6423636|P1|COMPLETED|Overall Study||54
2615975|NCT00087555|6423634|P3|Treated|Overall Study||67
2615976|NCT00087555|6423635|P2|Treated|Overall Study||60
2615977|NCT00087555|6423636|P1|Treated|Overall Study||65
2615978|NCT00087555|6423634|P3|STARTED|Overall Study||67
2615979|NCT00087555|6423635|P2|STARTED|Overall Study||62
2615980|NCT00087555|6423636|P1|STARTED|Overall Study||66
2615981|NCT00087529|6423646|P2|NOT COMPLETED|Overall Study||68
2615982|NCT00087529|6423647|P1|NOT COMPLETED|Overall Study||31
2615983|NCT00087529|6423646|P2|COMPLETED|Overall Study||224
2615984|NCT00087529|6423647|P1|COMPLETED|Overall Study||116
2615985|NCT00087529|6423646|P2|STARTED|Overall Study||292
2615986|NCT00087529|6423647|P1|STARTED|Overall Study||147
2615987|NCT00087516|6423662|P4|NOT COMPLETED|Overall Study||85
2615988|NCT00087516|6423663|P3|NOT COMPLETED|Overall Study||97
2615989|NCT00087516|6423664|P2|NOT COMPLETED|Overall Study||169
2615990|NCT00087516|6423665|P1|NOT COMPLETED|Overall Study||161
2615991|NCT00087516|6423662|P4|COMPLETED|Overall Study||38
2615992|NCT00087516|6423663|P3|COMPLETED|Overall Study||33
2615993|NCT00087516|6423664|P2|COMPLETED|Overall Study||81
2615994|NCT00087516|6423665|P1|COMPLETED|Overall Study||77
2615995|NCT00087516|6423662|P4|STARTED|Overall Study||123
2615996|NCT00087516|6423663|P3|STARTED|Overall Study||130
2615997|NCT00087516|6423664|P2|STARTED|Overall Study||250
2615998|NCT00087516|6423665|P1|STARTED|Overall Study||238
2615999|NCT00087490|6423694|P2|NOT COMPLETED|Overall Study||269
2616000|NCT00087490|6423695|P1|NOT COMPLETED|Overall Study||258
2616001|NCT00087490|6423694|P2|COMPLETED|Overall Study||264
2616002|NCT00087490|6423695|P1|COMPLETED|Overall Study||286
2616003|NCT00087490|6423694|P2|Treated|Overall Study||515
2616004|NCT00087490|6423695|P1|Treated|Overall Study||537
2616005|NCT00087490|6423694|P2|STARTED|Overall Study||533
2616006|NCT00087490|6423695|P1|STARTED|Overall Study||544
2616007|NCT00087438|6423729|P1|NOT COMPLETED|Overall Study||4
2616008|NCT00087438|6423729|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|55
2616009|NCT00087438|6423729|P1|STARTED|Overall Study||59
2616010|NCT00087152|6423739|P1|NOT COMPLETED|Overall Study||6
2616011|NCT00087152|6423739|P1|COMPLETED|Overall Study||21
2616012|NCT00087152|6423739|P1|STARTED|Overall Study||27
2616013|NCT00087139|6423748|P3|NOT COMPLETED|Overall Study||36
2616014|NCT00087139|6423749|P2|NOT COMPLETED|Overall Study||49
2616015|NCT00087139|6423750|P1|NOT COMPLETED|Overall Study||39
2616016|NCT00087139|6423748|P3|COMPLETED|Overall Study||0
2616017|NCT00087139|6423749|P2|COMPLETED|Overall Study||0
2616018|NCT00087139|6423750|P1|COMPLETED|Overall Study||0
2616019|NCT00087139|6423748|P3|Patients w/ Measurable Disease Response|Overall Study||0
2616020|NCT00087139|6423749|P2|Patients w/ Measurable Disease Response|Overall Study||2
2616021|NCT00087139|6423750|P1|Patients w/ Measurable Disease Response|Overall Study||5
2616022|NCT00087139|6423748|P3|Patients With PSA Response|Overall Study||4
2616023|NCT00087139|6423749|P2|Patients With PSA Response|Overall Study||8
2616024|NCT00087139|6423750|P1|Patients With PSA Response|Overall Study||10
2616025|NCT00087139|6423748|P3|Patients With Measurable Disease|Overall Study||24
2616026|NCT00087139|6423749|P2|Patients With Measurable Disease|Overall Study||25
2616027|NCT00087139|6423750|P1|Patients With Measurable Disease|Overall Study||22
2616028|NCT00087139|6423748|P3|Patients for the Analysis of PSA Respons|Overall Study||22
2616029|NCT00087139|6423749|P2|Patients for the Analysis of PSA Respons|Overall Study||34
2616030|NCT00087139|6423750|P1|Patients for the Analysis of PSA Respons|Overall Study||30
2616031|NCT00087139|6423748|P3|Eligible and Treated|Overall Study||32
2616032|NCT00087139|6423749|P2|Eligible and Treated|Overall Study||42
2616033|NCT00087139|6423750|P1|Eligible and Treated|Overall Study||35
2616034|NCT00087139|6423748|P3|Treated|Overall Study||36
2616035|NCT00087139|6423749|P2|Treated|Overall Study||48
2616036|NCT00087139|6423750|P1|Treated|Overall Study||39
2616037|NCT00087139|6423748|P3|STARTED|Overall Study||36
2616038|NCT00087139|6423749|P2|STARTED|Overall Study||49
2616039|NCT00087139|6423750|P1|STARTED|Overall Study||39
2616040|NCT00087126|6423765|P1|NOT COMPLETED|Overall Study||2
2616041|NCT00087126|6423765|P1|COMPLETED|Overall Study||25
2616042|NCT00087126|6423765|P1|STARTED|Overall Study||27
2616043|NCT00087022|6423776|P2|NOT COMPLETED|Overall Study||55
2616044|NCT00087022|6423777|P1|NOT COMPLETED|Overall Study||54
2616045|NCT00087022|6423776|P2|COMPLETED|Overall Study||376
2616046|NCT00087022|6423777|P1|COMPLETED|Overall Study||379
2616047|NCT00087022|6423776|P2|Treated (Safety Population)|Overall Study||424
2616048|NCT00087022|6423777|P1|Treated (Safety Population)|Overall Study||431
2616049|NCT00087022|6423776|P2|STARTED|Overall Study||431
2616050|NCT00087022|6423777|P1|STARTED|Overall Study||433
2616051|NCT00086996|6423790|P1|NOT COMPLETED|Overall Study||64
2616052|NCT00086996|6423790|P1|COMPLETED|Overall Study||34
2616053|NCT00086996|6423790|P1|Eligible and Began Protocol Therapy|Overall Study||93
2616054|NCT00086996|6423790|P1|Eligible|Overall Study||93
2616055|NCT00086996|6423790|P1|STARTED|Overall Study||98
2616056|NCT00086957|6423797|P3|NOT COMPLETED|Overall Study||0
2616057|NCT00086957|6423798|P2|NOT COMPLETED|Overall Study||0
2616058|NCT00086957|6423799|P1|NOT COMPLETED|Overall Study||0
2616059|NCT00086957|6423797|P3|COMPLETED|Overall Study||22
2616060|NCT00086957|6423798|P2|COMPLETED|Overall Study||7
2616061|NCT00086957|6423799|P1|COMPLETED|Overall Study||2
2616062|NCT00086957|6423797|P3|STARTED|Overall Study||22
2616063|NCT00086957|6423798|P2|STARTED|Overall Study||7
2616064|NCT00086957|6423799|P1|STARTED|Overall Study||2
2616065|NCT00086684|6423812|P3|NOT COMPLETED|Overall Study||53
2616066|NCT00086684|6423813|P2|NOT COMPLETED|Overall Study||55
2616067|NCT00086684|6423814|P1|NOT COMPLETED|Overall Study||55
2616068|NCT00086684|6423812|P3|COMPLETED|Overall Study||69
2616069|NCT00086684|6423813|P2|COMPLETED|Overall Study||74
2616070|NCT00086684|6423814|P1|COMPLETED|Overall Study||63
2616071|NCT00086684|6423812|P3|STARTED|Overall Study||122
2616072|NCT00086684|6423813|P2|STARTED|Overall Study||129
2616073|NCT00086684|6423814|P1|STARTED|Overall Study||118
2616074|NCT00086619|6423827|P2|NOT COMPLETED|Overall Study||17
2616075|NCT00086619|6423828|P1|NOT COMPLETED|Overall Study||15
2616076|NCT00086619|6423827|P2|COMPLETED|Overall Study||23
2616077|NCT00086619|6423828|P1|COMPLETED|Overall Study||25
2616078|NCT00086619|6423827|P2|Completed 12 Month Visit|Overall Study||26
2616079|NCT00086619|6423828|P1|Completed 12 Month Visit|Overall Study||26
2616080|NCT00086619|6423827|P2|Completed Baseline Visit|Overall Study||36
2616081|NCT00086619|6423828|P1|Completed Baseline Visit|Overall Study||34
2616082|NCT00086619|6423827|P2|STARTED|Overall Study||40
2616083|NCT00086619|6423828|P1|STARTED|Overall Study||40
2616084|NCT00086580|6423838|P2|NOT COMPLETED|Observation Period||65
2616085|NCT00086580|6423839|P1|NOT COMPLETED|Observation Period||46
2616086|NCT00086580|6423838|P2|COMPLETED|Observation Period||56
2616087|NCT00086580|6423839|P1|COMPLETED|Observation Period||49
2616088|NCT00086580|6423838|P2|STARTED|Observation Period||121
2616089|NCT00086580|6423839|P1|STARTED|Observation Period||95
2616090|NCT00086580|6423838|P2|NOT COMPLETED|Follow-up Period||119
2616091|NCT00086580|6423839|P1|NOT COMPLETED|Follow-up Period||104
2616092|NCT00086580|6423838|P2|COMPLETED|Follow-up Period||18
2616093|NCT00086580|6423839|P1|COMPLETED|Follow-up Period||37
2616094|NCT00086580|6423838|P2|STARTED|Follow-up Period||137
2616095|NCT00086580|6423839|P1|STARTED|Follow-up Period||141
2616096|NCT00086580|6423838|P2|NOT COMPLETED|Treatment Period||60
2616097|NCT00086580|6423839|P1|NOT COMPLETED|Treatment Period||65
2616098|NCT00086580|6423838|P2|COMPLETED|Treatment Period|Finished 6 cycles of study drug|107
2616099|NCT00086580|6423839|P1|COMPLETED|Treatment Period|Finished 6 cycles of study drugs|103
2616100|NCT00086580|6423838|P2|Safety Population|Treatment Period|Two participants did not receive treatment|165
2616101|NCT00086580|6423839|P1|Safety Population|Treatment Period|Four participants did not receive treatment|164
2616102|NCT00086580|6423838|P2|STARTED|Treatment Period||167
2616103|NCT00086580|6423839|P1|STARTED|Treatment Period||168
2616104|NCT00086411|6423887|P4|NOT COMPLETED|Overall Study||12
2616105|NCT00086411|6423888|P3|NOT COMPLETED|Overall Study||13
2616106|NCT00086411|6423889|P2|NOT COMPLETED|Overall Study||11
2616107|NCT00086411|6423890|P1|NOT COMPLETED|Overall Study||11
2616108|NCT00086411|6423887|P4|COMPLETED|Overall Study||53
2616109|NCT00086411|6423888|P3|COMPLETED|Overall Study||49
2616110|NCT00086411|6423889|P2|COMPLETED|Overall Study||52
2616111|NCT00086411|6423890|P1|COMPLETED|Overall Study||59
2616112|NCT00086411|6423887|P4|STARTED|Overall Study||65
2616113|NCT00086411|6423888|P3|STARTED|Overall Study||62
2616114|NCT00086411|6423889|P2|STARTED|Overall Study||63
2616115|NCT00086411|6423890|P1|STARTED|Overall Study||70
2616116|NCT00086385|6423908|P4|NOT COMPLETED|Overall Study||1
2616117|NCT00086385|6423909|P3|NOT COMPLETED|Overall Study||1
2616118|NCT00086385|6423910|P2|NOT COMPLETED|Overall Study||2
2616119|NCT00086385|6423911|P1|NOT COMPLETED|Overall Study||2
2616120|NCT00086385|6423908|P4|COMPLETED|Overall Study||98
2616121|NCT00086385|6423909|P3|COMPLETED|Overall Study||103
2616122|NCT00086385|6423910|P2|COMPLETED|Overall Study||97
2616123|NCT00086385|6423911|P1|COMPLETED|Overall Study||98
2616124|NCT00086385|6423908|P4|STARTED|Overall Study||99
2616125|NCT00086385|6423909|P3|STARTED|Overall Study||104
2616126|NCT00086385|6423910|P2|STARTED|Overall Study||99
2616127|NCT00086385|6423911|P1|STARTED|Overall Study||100
2616128|NCT00086515|6423923|P2|NOT COMPLETED|Phase B (Weeks 24-104)||55
2616129|NCT00086515|6423924|P1|NOT COMPLETED|Phase B (Weeks 24-104)||190
2616130|NCT00086515|6423923|P2|COMPLETED|Phase B (Weeks 24-104)||109
2616131|NCT00086515|6423924|P1|COMPLETED|Phase B (Weeks 24-104)||201
2616132|NCT00086515|6423923|P2|STARTED|Phase B (Weeks 24-104)||164
2616133|NCT00086515|6423924|P1|STARTED|Phase B (Weeks 24-104)||391
2616134|NCT00086515|6423923|P2|NOT COMPLETED|Phase A to Phase B Transition Period||28
2616135|NCT00086515|6423924|P1|NOT COMPLETED|Phase A to Phase B Transition Period||24
2616136|NCT00086515|6423923|P2|COMPLETED|Phase A to Phase B Transition Period||164
2616137|NCT00086515|6423924|P1|COMPLETED|Phase A to Phase B Transition Period||391
2616138|NCT00086515|6423923|P2|STARTED|Phase A to Phase B Transition Period||192
2616139|NCT00086515|6423924|P1|STARTED|Phase A to Phase B Transition Period||415
2616140|NCT00086515|6423923|P2|NOT COMPLETED|Phase A (Weeks 0-24)||45
2616141|NCT00086515|6423924|P1|NOT COMPLETED|Phase A (Weeks 0-24)||49
2616142|NCT00086515|6423923|P2|COMPLETED|Phase A (Weeks 0-24)||192
2616143|NCT00086515|6423924|P1|COMPLETED|Phase A (Weeks 0-24)||415
2616144|NCT00086515|6423923|P2|STARTED|Phase A (Weeks 0-24)||237
2616145|NCT00086515|6423924|P1|STARTED|Phase A (Weeks 0-24)||464
2616146|NCT00086502|6423936|P2|NOT COMPLETED|Overall Study||20
2616147|NCT00086502|6423937|P1|NOT COMPLETED|Overall Study||26
2616148|NCT00086502|6423936|P2|COMPLETED|Overall Study||158
2616149|NCT00086502|6423937|P1|COMPLETED|Overall Study||149
2616150|NCT00086502|6423936|P2|STARTED|Overall Study||178
2616151|NCT00086502|6423937|P1|STARTED|Overall Study||175
2616152|NCT00086450|6423947|P2|NOT COMPLETED|Overall Study||0
2616153|NCT00086450|6423948|P1|NOT COMPLETED|Overall Study||0
2616154|NCT00086450|6423947|P2|COMPLETED|Overall Study||947
2616155|NCT00086450|6423948|P1|COMPLETED|Overall Study||953
2616156|NCT00086450|6423947|P2|STARTED|Overall Study||947
2616157|NCT00086450|6423948|P1|STARTED|Overall Study||953
2616158|NCT00086346|6423962|P2|NOT COMPLETED|Patients Dosed With Test Article||23
2616159|NCT00086346|6423963|P1|NOT COMPLETED|Patients Dosed With Test Article||140
2616160|NCT00086346|6423962|P2|COMPLETED|Patients Dosed With Test Article||187
2616161|NCT00086346|6423963|P1|COMPLETED|Patients Dosed With Test Article||249
2616162|NCT00086346|6423962|P2|STARTED|Patients Dosed With Test Article||210
2616163|NCT00086346|6423963|P1|STARTED|Patients Dosed With Test Article||389
2616164|NCT00086346|6423962|P2|NOT COMPLETED|Randomization||4
2616165|NCT00086346|6423963|P1|NOT COMPLETED|Randomization||4
2616166|NCT00086346|6423962|P2|COMPLETED|Randomization||210
2616167|NCT00086346|6423963|P1|COMPLETED|Randomization||389
2616168|NCT00086346|6423962|P2|STARTED|Randomization||214
2616169|NCT00086346|6423963|P1|STARTED|Randomization||393
2616170|NCT00086281|6423990|P15|NOT COMPLETED|Phase 2||0
2616171|NCT00086281|6423991|P14|NOT COMPLETED|Phase 2||1
2616172|NCT00086281|6423992|P13|NOT COMPLETED|Phase 2||1
2616173|NCT00086281|6423993|P12|NOT COMPLETED|Phase 2||0
2616174|NCT00086281|6423994|P11|NOT COMPLETED|Phase 2||0
2616175|NCT00086281|6423995|P10|NOT COMPLETED|Phase 2||0
2616176|NCT00086281|6423996|P9|NOT COMPLETED|Phase 2||0
2616177|NCT00086281|6423997|P8|NOT COMPLETED|Phase 2||0
2616178|NCT00086281|6423998|P7|NOT COMPLETED|Phase 2||0
2616179|NCT00086281|6423999|P6|NOT COMPLETED|Phase 2||0
2616180|NCT00086281|6424000|P5|NOT COMPLETED|Phase 2||0
2616181|NCT00086281|6424001|P4|NOT COMPLETED|Phase 2||0
2616182|NCT00086281|6424002|P3|NOT COMPLETED|Phase 2||0
2616183|NCT00086281|6424003|P2|NOT COMPLETED|Phase 2||0
2616184|NCT00086281|6424004|P1|NOT COMPLETED|Phase 2||0
2616185|NCT00086281|6423990|P15|COMPLETED|Phase 2||0
2616186|NCT00086281|6423991|P14|COMPLETED|Phase 2||26
2616187|NCT00086281|6423992|P13|COMPLETED|Phase 2||22
2616188|NCT00086281|6423993|P12|COMPLETED|Phase 2||0
2616189|NCT00086281|6423994|P11|COMPLETED|Phase 2||0
2616190|NCT00086281|6423995|P10|COMPLETED|Phase 2||0
2616191|NCT00086281|6423996|P9|COMPLETED|Phase 2||0
2616192|NCT00086281|6423997|P8|COMPLETED|Phase 2||0
2616193|NCT00086281|6423998|P7|COMPLETED|Phase 2||0
2616194|NCT00086281|6423999|P6|COMPLETED|Phase 2||0
2616195|NCT00086281|6424000|P5|COMPLETED|Phase 2||0
2616196|NCT00086281|6424001|P4|COMPLETED|Phase 2||0
2616197|NCT00086281|6424002|P3|COMPLETED|Phase 2||0
2616198|NCT00086281|6424003|P2|COMPLETED|Phase 2||0
2616199|NCT00086281|6424004|P1|COMPLETED|Phase 2||0
2616200|NCT00086281|6423990|P15|STARTED|Phase 2||0
2616201|NCT00086281|6423991|P14|STARTED|Phase 2||27
2616202|NCT00086281|6423992|P13|STARTED|Phase 2||23
2616203|NCT00086281|6423993|P12|STARTED|Phase 2||0
2616204|NCT00086281|6423994|P11|STARTED|Phase 2||0
2616205|NCT00086281|6423995|P10|STARTED|Phase 2||0
2616206|NCT00086281|6423996|P9|STARTED|Phase 2||0
2616207|NCT00086281|6423997|P8|STARTED|Phase 2||0
2616208|NCT00086281|6423998|P7|STARTED|Phase 2||0
2616209|NCT00086281|6423999|P6|STARTED|Phase 2||0
2616210|NCT00086281|6424000|P5|STARTED|Phase 2||0
2616211|NCT00086281|6424001|P4|STARTED|Phase 2||0
2616212|NCT00086281|6424002|P3|STARTED|Phase 2||0
2616213|NCT00086281|6424003|P2|STARTED|Phase 2||0
2616214|NCT00086281|6424004|P1|STARTED|Phase 2||0
2616215|NCT00086281|6423990|P15|NOT COMPLETED|Phase 1||3
2616216|NCT00086281|6423991|P14|NOT COMPLETED|Phase 1||1
2616217|NCT00086281|6423992|P13|NOT COMPLETED|Phase 1||1
2616218|NCT00086281|6423993|P12|NOT COMPLETED|Phase 1||1
2616219|NCT00086281|6423994|P11|NOT COMPLETED|Phase 1||3
2616220|NCT00086281|6423995|P10|NOT COMPLETED|Phase 1||1
2616221|NCT00086281|6423996|P9|NOT COMPLETED|Phase 1||0
2616222|NCT00086281|6423997|P8|NOT COMPLETED|Phase 1||0
2616223|NCT00086281|6423998|P7|NOT COMPLETED|Phase 1||0
2616224|NCT00086281|6423999|P6|NOT COMPLETED|Phase 1||0
2616225|NCT00086281|6424000|P5|NOT COMPLETED|Phase 1||0
2616226|NCT00086281|6424001|P4|NOT COMPLETED|Phase 1||0
2616227|NCT00086281|6424002|P3|NOT COMPLETED|Phase 1||0
2616228|NCT00086281|6424003|P2|NOT COMPLETED|Phase 1||0
2616229|NCT00086281|6424004|P1|NOT COMPLETED|Phase 1||0
2616230|NCT00086281|6423990|P15|COMPLETED|Phase 1||0
2616231|NCT00086281|6423991|P14|COMPLETED|Phase 1||0
2616232|NCT00086281|6423992|P13|COMPLETED|Phase 1||0
2616233|NCT00086281|6423993|P12|COMPLETED|Phase 1||0
2616234|NCT00086281|6423994|P11|COMPLETED|Phase 1||0
2616235|NCT00086281|6423995|P10|COMPLETED|Phase 1||0
2616236|NCT00086281|6423996|P9|COMPLETED|Phase 1||2
2616237|NCT00086281|6423997|P8|COMPLETED|Phase 1||1
2616238|NCT00086281|6423998|P7|COMPLETED|Phase 1||1
2616239|NCT00086281|6423999|P6|COMPLETED|Phase 1||3
2616240|NCT00086281|6424000|P5|COMPLETED|Phase 1||1
2616241|NCT00086281|6424001|P4|COMPLETED|Phase 1||11
2616242|NCT00086281|6424002|P3|COMPLETED|Phase 1||8
2616243|NCT00086281|6424003|P2|COMPLETED|Phase 1||12
2616244|NCT00086281|6424004|P1|COMPLETED|Phase 1||11
2616245|NCT00086281|6423990|P15|STARTED|Phase 1||3
2616246|NCT00086281|6423991|P14|STARTED|Phase 1||1
2616247|NCT00086281|6423992|P13|STARTED|Phase 1||1
2616248|NCT00086281|6423993|P12|STARTED|Phase 1||1
2616249|NCT00086281|6423994|P11|STARTED|Phase 1||3
2616250|NCT00086281|6423995|P10|STARTED|Phase 1||1
2616251|NCT00086281|6423996|P9|STARTED|Phase 1||2
2616252|NCT00086281|6423997|P8|STARTED|Phase 1||1
2616253|NCT00086281|6423998|P7|STARTED|Phase 1||1
2616254|NCT00086281|6423999|P6|STARTED|Phase 1||3
2616255|NCT00086281|6424000|P5|STARTED|Phase 1||1
2616256|NCT00086281|6424001|P4|STARTED|Phase 1||11
2616257|NCT00086281|6424002|P3|STARTED|Phase 1||8
2616258|NCT00086281|6424003|P2|STARTED|Phase 1||12
2616259|NCT00086281|6424004|P1|STARTED|Phase 1||11
2616260|NCT00086307|6424017|P3|NOT COMPLETED|Overall Study||8
2616261|NCT00086307|6424018|P2|NOT COMPLETED|Overall Study||1
2616262|NCT00086307|6424019|P1|NOT COMPLETED|Overall Study||2
2616263|NCT00086307|6424017|P3|COMPLETED|Overall Study||5
2616264|NCT00086307|6424018|P2|COMPLETED|Overall Study||12
2616265|NCT00086307|6424019|P1|COMPLETED|Overall Study||11
2616266|NCT00086307|6424017|P3|STARTED|Overall Study||13
2616267|NCT00086307|6424018|P2|STARTED|Overall Study||13
2616268|NCT00086307|6424019|P1|STARTED|Overall Study||13
2616269|NCT00086190|6424030|P3|NOT COMPLETED|Overall Study||6
2616270|NCT00086190|6424031|P2|NOT COMPLETED|Overall Study||4
2616271|NCT00086190|6424032|P1|NOT COMPLETED|Overall Study||8
2616272|NCT00086190|6424030|P3|COMPLETED|Overall Study||33
2616273|NCT00086190|6424031|P2|COMPLETED|Overall Study||30
2616274|NCT00086190|6424032|P1|COMPLETED|Overall Study||34
2616275|NCT00086190|6424030|P3|STARTED|Overall Study||39
2616276|NCT00086190|6424031|P2|STARTED|Overall Study||34
2616277|NCT00086190|6424032|P1|STARTED|Overall Study||42
2616278|NCT00086138|6424090|P2|NOT COMPLETED|Overall Study||3
2616279|NCT00086138|6424091|P1|NOT COMPLETED|Overall Study||4
2616280|NCT00086138|6424090|P2|COMPLETED|Overall Study||64
2616281|NCT00086138|6424091|P1|COMPLETED|Overall Study||60
2616282|NCT00086138|6424090|P2|STARTED|Overall Study||67
2616283|NCT00086138|6424091|P1|STARTED|Overall Study||64
2616284|NCT00086047|6424101|P2|NOT COMPLETED|Overall Study||7
2616285|NCT00086047|6424102|P1|NOT COMPLETED|Overall Study||7
2616286|NCT00086047|6424101|P2|COMPLETED|Overall Study||50
2616287|NCT00086047|6424102|P1|COMPLETED|Overall Study||50
2616288|NCT00086047|6424101|P2|STARTED|Overall Study||57
2616289|NCT00086047|6424102|P1|STARTED|Overall Study||57
2616290|NCT00085917|6424110|P2|NOT COMPLETED|Overall Study||3
2616291|NCT00085917|6424111|P1|NOT COMPLETED|Overall Study||4
2616292|NCT00085917|6424110|P2|COMPLETED|Overall Study||11
2616293|NCT00085917|6424111|P1|COMPLETED|Overall Study||11
2616294|NCT00085917|6424110|P2|STARTED|Overall Study||14
2616295|NCT00085917|6424111|P1|STARTED|Overall Study||15
2616296|NCT00085839|6424123|P2|NOT COMPLETED|Overall Study||0
2616297|NCT00085839|6424124|P1|NOT COMPLETED|Overall Study||0
2616298|NCT00085839|6424123|P2|COMPLETED|Overall Study||51
2616299|NCT00085839|6424124|P1|COMPLETED|Overall Study||52
2616300|NCT00085839|6424123|P2|STARTED|Overall Study||51
2616301|NCT00085839|6424124|P1|STARTED|Overall Study||52
2616302|NCT00085735|6424140|P6|NOT COMPLETED|Overall Study||31
2616303|NCT00085735|6424141|P5|NOT COMPLETED|Overall Study||42
2616304|NCT00085735|6424142|P4|NOT COMPLETED|Overall Study||19
2616305|NCT00085735|6424143|P3|NOT COMPLETED|Overall Study||17
2616306|NCT00085735|6424144|P2|NOT COMPLETED|Overall Study||10
2616307|NCT00085735|6424145|P1|NOT COMPLETED|Overall Study||12
2616308|NCT00085735|6424140|P6|COMPLETED|Overall Study||115
2616309|NCT00085735|6424141|P5|COMPLETED|Overall Study||105
2616310|NCT00085735|6424142|P4|COMPLETED|Overall Study||46
2616311|NCT00085735|6424143|P3|COMPLETED|Overall Study||46
2616312|NCT00085735|6424144|P2|COMPLETED|Overall Study||54
2616313|NCT00085735|6424145|P1|COMPLETED|Overall Study||52
2616314|NCT00085735|6424140|P6|STARTED|Overall Study||146
2616315|NCT00085735|6424141|P5|STARTED|Overall Study||147
2616316|NCT00085735|6424142|P4|STARTED|Overall Study||65
2616317|NCT00085735|6424143|P3|STARTED|Overall Study||63
2616318|NCT00085735|6424144|P2|STARTED|Overall Study||64
2616319|NCT00085735|6424145|P1|STARTED|Overall Study||64
2616320|NCT00085709|6424200|P2|NOT COMPLETED|Overall Study||50
2616321|NCT00085709|6424201|P1|NOT COMPLETED|Overall Study||53
2616322|NCT00085709|6424200|P2|COMPLETED|Overall Study||270
2616323|NCT00085709|6424201|P1|COMPLETED|Overall Study||264
2616324|NCT00085709|6424200|P2|Eligible and Did Not Withdraw Consent|Overall Study||300
2616325|NCT00085709|6424201|P1|Eligible and Did Not Withdraw Consent|Overall Study||296
2616326|NCT00085709|6424200|P2|Eligible|Overall Study||301
2616327|NCT00085709|6424201|P1|Eligible|Overall Study||298
2616328|NCT00085709|6424200|P2|STARTED|Overall Study||320
2616329|NCT00085709|6424201|P1|STARTED|Overall Study||317
2616330|NCT00085644|6424217|P3|NOT COMPLETED|Open-Label Period||109
2616331|NCT00085644|6424218|P2|NOT COMPLETED|Open-Label Period||0
2616332|NCT00085644|6424219|P1|NOT COMPLETED|Open-Label Period||0
2616333|NCT00085644|6424217|P3|COMPLETED|Open-Label Period||202
2616334|NCT00085644|6424218|P2|COMPLETED|Open-Label Period||0
2616335|NCT00085644|6424219|P1|COMPLETED|Open-Label Period||0
2616336|NCT00085644|6424217|P3|STARTED|Open-Label Period|1 subject who discontinued for personal reasons subsequently died 450 days after last dose.|311
2616337|NCT00085644|6424218|P2|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
2616338|NCT00085644|6424219|P1|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
2616339|NCT00085644|6424217|P3|NOT COMPLETED|Double-Blind Period||0
2616340|NCT00085644|6424218|P2|NOT COMPLETED|Double-Blind Period||6
2616341|NCT00085644|6424219|P1|NOT COMPLETED|Double-Blind Period||13
2616342|NCT00085644|6424217|P3|COMPLETED|Double-Blind Period||0
2616343|NCT00085644|6424218|P2|COMPLETED|Double-Blind Period||101
2616344|NCT00085644|6424219|P1|COMPLETED|Double-Blind Period||195
2616345|NCT00085644|6424217|P3|STARTED|Double-Blind Period|This treatment group is not applicable to the Double-Blind Period.|0
2616346|NCT00085644|6424218|P2|STARTED|Double-Blind Period||107
2616347|NCT00085644|6424219|P1|STARTED|Double-Blind Period||208
2616348|NCT00085631|6424260|P3|NOT COMPLETED|Overall Study||7
2616349|NCT00085631|6424261|P2|NOT COMPLETED|Overall Study||11
2616350|NCT00085631|6424262|P1|NOT COMPLETED|Overall Study||4
2616351|NCT00085631|6424260|P3|COMPLETED|Overall Study||32
2616352|NCT00085631|6424261|P2|COMPLETED|Overall Study||38
2616353|NCT00085631|6424262|P1|COMPLETED|Overall Study||9
2616354|NCT00085631|6424260|P3|STARTED|Overall Study||39
2616355|NCT00085631|6424261|P2|STARTED|Overall Study||49
2616356|NCT00085631|6424262|P1|STARTED|Overall Study||13
2616357|NCT00085566|6424272|P3|NOT COMPLETED|Overall Study||14
2616358|NCT00085566|6424273|P2|NOT COMPLETED|Overall Study||0
2616359|NCT00085566|6424274|P1|NOT COMPLETED|Overall Study||0
2616360|NCT00085566|6424272|P3|COMPLETED|Overall Study||43
2616361|NCT00085566|6424273|P2|COMPLETED|Overall Study||3
2616362|NCT00085566|6424274|P1|COMPLETED|Overall Study||3
2616363|NCT00085566|6424272|P3|STARTED|Overall Study||57
2616364|NCT00085566|6424273|P2|STARTED|Overall Study||3
2616365|NCT00085566|6424274|P1|STARTED|Overall Study||3
2616366|NCT00085540|6424284|P2|NOT COMPLETED|Overall Study||2
2616367|NCT00085540|6424285|P1|NOT COMPLETED|Overall Study||0
2616368|NCT00085540|6424284|P2|COMPLETED|Overall Study||40
2616369|NCT00085540|6424285|P1|COMPLETED|Overall Study||8
2616370|NCT00085540|6424284|P2|STARTED|Overall Study||42
2616371|NCT00085540|6424285|P1|STARTED|Overall Study||8
2616372|NCT00085436|6424292|P1|NOT COMPLETED|Overall Study||0
2616373|NCT00085436|6424292|P1|COMPLETED|Overall Study||18
2616374|NCT00085436|6424292|P1|STARTED|Overall Study||18
2616375|NCT00085423|6424297|P1|NOT COMPLETED|Overall Study||2
2616376|NCT00085423|6424297|P1|COMPLETED|Overall Study||18
2616377|NCT00085423|6424297|P1|STARTED|Overall Study||20
2616378|NCT00085410|6424303|P1|NOT COMPLETED|Overall Study||0
2616379|NCT00085410|6424303|P1|COMPLETED|Overall Study||20
2616380|NCT00085410|6424303|P1|STARTED|Overall Study||20
2616381|NCT00085293|6424317|P1|NOT COMPLETED|Overall Study||0
2616382|NCT00085293|6424317|P1|COMPLETED|Overall Study||12
2616383|NCT00085293|6424317|P1|STARTED|Overall Study||12
2616384|NCT00085254|6424330|P3|NOT COMPLETED|Overall Study||0
2616385|NCT00085254|6424331|P2|NOT COMPLETED|Overall Study||0
2616386|NCT00085254|6424332|P1|NOT COMPLETED|Overall Study||0
2616387|NCT00085254|6424330|P3|COMPLETED|Overall Study||48
2616388|NCT00085254|6424331|P2|COMPLETED|Overall Study||46
2616389|NCT00085254|6424332|P1|COMPLETED|Overall Study||18
2616390|NCT00085254|6424330|P3|STARTED|Overall Study||48
2616391|NCT00085254|6424331|P2|STARTED|Overall Study||46
2616392|NCT00085254|6424332|P1|STARTED|Overall Study||18
2616393|NCT00085202|6424348|P2|NOT COMPLETED|Overall Study||24
2616394|NCT00085202|6424349|P1|NOT COMPLETED|Overall Study||18
2616395|NCT00085202|6424348|P2|COMPLETED|Overall Study||120
2616396|NCT00085202|6424349|P1|COMPLETED|Overall Study||251
2616397|NCT00085202|6424348|P2|STARTED|Overall Study||144
2616398|NCT00085202|6424349|P1|STARTED|Overall Study||269
2616399|NCT00085098|6424370|P2|NOT COMPLETED|Overall Study||2
2616400|NCT00085098|6424371|P1|NOT COMPLETED|Overall Study||1
2616401|NCT00085098|6424370|P2|COMPLETED|Overall Study||11
2616402|NCT00085098|6424371|P1|COMPLETED|Overall Study||10
2616403|NCT00085098|6424370|P2|STARTED|Overall Study||13
2616404|NCT00085098|6424371|P1|STARTED|Overall Study||11
2616405|NCT00084864|6424385|P4|NOT COMPLETED|Overall Study||0
2616406|NCT00084864|6424386|P3|NOT COMPLETED|Overall Study||0
2616407|NCT00084864|6424387|P2|NOT COMPLETED|Overall Study||0
2616408|NCT00084864|6424388|P1|NOT COMPLETED|Overall Study||1
2616409|NCT00084864|6424385|P4|COMPLETED|Overall Study||4
2616410|NCT00084864|6424386|P3|COMPLETED|Overall Study||4
2616411|NCT00084864|6424387|P2|COMPLETED|Overall Study||7
2616412|NCT00084864|6424388|P1|COMPLETED|Overall Study||9
2616413|NCT00084864|6424385|P4|STARTED|Overall Study||4
2616414|NCT00084864|6424386|P3|STARTED|Overall Study||4
2616415|NCT00084864|6424387|P2|STARTED|Overall Study||7
2616416|NCT00084864|6424388|P1|STARTED|Overall Study||10
2616417|NCT00084838|6424414|P1|NOT COMPLETED|Overall Study||13
2616418|NCT00084838|6424414|P1|COMPLETED|Overall Study||12
2616419|NCT00084838|6424414|P1|Eligible and Treated|Overall Study|4 ineligible pts upon central path review (n=3) and per DFCI IRB (n=1); 1 pt withdrew before rcv trt|20
2616420|NCT00084838|6424414|P1|STARTED|Overall Study||25
2616421|NCT00084747|6424436|P1|NOT COMPLETED|Overall Study||13
2616422|NCT00084747|6424436|P1|COMPLETED|Overall Study||17
2616423|NCT00084747|6424436|P1|STARTED|Overall Study||30
2616424|NCT00084682|6424441|P1|NOT COMPLETED|Overall Study||1
2616425|NCT00084682|6424441|P1|COMPLETED|Overall Study||13
2616426|NCT00084682|6424441|P1|STARTED|Overall Study||14
2616427|NCT00084617|6424445|P1|NOT COMPLETED|Overall Study||9
2616428|NCT00084617|6424445|P1|COMPLETED|Overall Study||30
2616429|NCT00084617|6424445|P1|STARTED|Overall Study||39
2616430|NCT00084487|6424451|P1|NOT COMPLETED|Overall Study||1
2616431|NCT00084487|6424451|P1|COMPLETED|Overall Study||20
2616432|NCT00084487|6424451|P1|STARTED|Overall Study||21
2616433|NCT00084409|6424461|P2|NOT COMPLETED|Overall Study||12
2616434|NCT00084409|6424462|P1|NOT COMPLETED|Overall Study||15
2616435|NCT00084409|6424461|P2|COMPLETED|Overall Study|4 Current, 8 former|65
2616436|NCT00084409|6424462|P1|COMPLETED|Overall Study|9 current, 6 former|60
2616437|NCT00084409|6424461|P2|STARTED|Overall Study|41 current, 36 former|77
2616438|NCT00084409|6424462|P1|STARTED|Overall Study|40 Current, 35 former|75
2616439|NCT00084383|6424488|P1|NOT COMPLETED|Overall Study||47
2616440|NCT00084383|6424488|P1|COMPLETED|Overall Study||13
2616441|NCT00084383|6424488|P1|STARTED|Overall Study||60
2616442|NCT00084318|6424495|P2|NOT COMPLETED|Overall Study||13
2616443|NCT00084318|6424496|P1|NOT COMPLETED|Overall Study||22
2616444|NCT00084318|6424495|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|106
2616445|NCT00084318|6424496|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|97
2616446|NCT00084318|6424495|P2|STARTED|Overall Study||119
2616447|NCT00084318|6424496|P1|STARTED|Overall Study||119
2616448|NCT00084266|6424516|P2|NOT COMPLETED|Overall Study||423
2616449|NCT00084266|6424517|P1|NOT COMPLETED|Overall Study||441
2616450|NCT00084266|6424516|P2|COMPLETED|Overall Study||184
2616451|NCT00084266|6424517|P1|COMPLETED|Overall Study||177
2616452|NCT00084266|6424516|P2|Treated|Overall Study||587
2616453|NCT00084266|6424517|P1|Treated|Overall Study||597
2616454|NCT00084266|6424516|P2|STARTED|Overall Study||607
2616455|NCT00084266|6424517|P1|STARTED|Overall Study||618
2616456|NCT00084149|6424553|P2|NOT COMPLETED|Overall Study||5
2616457|NCT00084149|6424554|P1|NOT COMPLETED|Overall Study||8
2616458|NCT00084149|6424553|P2|COMPLETED|Overall Study||13
2616459|NCT00084149|6424554|P1|COMPLETED|Overall Study||28
2616460|NCT00084149|6424553|P2|STARTED|Overall Study||18
2616461|NCT00084149|6424554|P1|STARTED|Overall Study||36
2616462|NCT00084136|6424575|P3|NOT COMPLETED|NRTI Comparison||82
2616463|NCT00084136|6424576|P2|NOT COMPLETED|NRTI Comparison||0
2616464|NCT00084136|6424577|P1|NOT COMPLETED|NRTI Comparison||101
2616465|NCT00084136|6424575|P3|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|444
2616466|NCT00084136|6424576|P2|COMPLETED|NRTI Comparison||0
2616467|NCT00084136|6424577|P1|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|418
2616468|NCT00084136|6424575|P3|STARTED|NRTI Comparison||526
2616469|NCT00084136|6424576|P2|STARTED|NRTI Comparison||0
2616470|NCT00084136|6424577|P1|STARTED|NRTI Comparison||519
2616471|NCT00084136|6424575|P3|NOT COMPLETED|PI Comparison||0
2616472|NCT00084136|6424576|P2|NOT COMPLETED|PI Comparison||47
2616473|NCT00084136|6424577|P1|NOT COMPLETED|PI Comparison||55
2616474|NCT00084136|6424575|P3|COMPLETED|PI Comparison||0
2616475|NCT00084136|6424576|P2|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|479
2616476|NCT00084136|6424577|P1|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|464
2616477|NCT00084136|6424575|P3|STARTED|PI Comparison||0
2616478|NCT00084136|6424576|P2|STARTED|PI Comparison||526
2616479|NCT00084136|6424577|P1|STARTED|PI Comparison||519
2616480|NCT00084084|6424636|P1|NOT COMPLETED|Phase 2 (Transition to Replagal AF)||1
2616481|NCT00084084|6424636|P1|COMPLETED|Phase 2 (Transition to Replagal AF)||10
2616482|NCT00084084|6424636|P1|STARTED|Phase 2 (Transition to Replagal AF)|The 11 patients remaining in TKT029 at the time Replagal AF was made available continued to Phase 2.|11
2616483|NCT00084084|6424636|P1|NOT COMPLETED|Phase 1 (Treatment With Replagal RB)||1
2616484|NCT00084084|6424636|P1|COMPLETED|Phase 1 (Treatment With Replagal RB)||16
2616485|NCT00084084|6424636|P1|STARTED|Phase 1 (Treatment With Replagal RB)||17
2616486|NCT00083915|6424646|P2|NOT COMPLETED|Overall Study||37
2616487|NCT00083915|6424647|P1|NOT COMPLETED|Overall Study||50
2616488|NCT00083915|6424646|P2|COMPLETED|Overall Study||8
2616489|NCT00083915|6424647|P1|COMPLETED|Overall Study||2
2616490|NCT00083915|6424646|P2|STARTED|Overall Study||45
2616491|NCT00083915|6424647|P1|STARTED|Overall Study||52
2616492|NCT00083889|6424655|P2|NOT COMPLETED|Overall Study||375
2616493|NCT00083889|6424656|P1|NOT COMPLETED|Overall Study||375
2616494|NCT00083889|6424655|P2|COMPLETED|Overall Study|Discontinuation crossover subjects: AEs 5,consent withdrawn 2, lack efficacy 13, sponsor decision 5.|0
2616495|NCT00083889|6424656|P1|COMPLETED|Overall Study||0
2616496|NCT00083889|6424655|P2|Received Treatment|Overall Study|15 subjects randomized to IFN-α discontinued before receiving their first dose of study medication.|360
2616497|NCT00083889|6424656|P1|Received Treatment|Overall Study||375
2616498|NCT00083889|6424655|P2|STARTED|Overall Study||375
2616499|NCT00083889|6424656|P1|STARTED|Overall Study||375
2616500|NCT00004146|6424705|P1|NOT COMPLETED|Overall Study||0
2616501|NCT00004146|6424705|P1|COMPLETED|Overall Study||55
2616502|NCT00004146|6424705|P1|STARTED|Overall Study||55
2616503|NCT00083759|6424714|P2|NOT COMPLETED|Overall Study||83
2616504|NCT00083759|6424715|P1|NOT COMPLETED|Overall Study||84
2616505|NCT00083759|6424714|P2|COMPLETED|Overall Study||66
2616506|NCT00083759|6424715|P1|COMPLETED|Overall Study||66
2616507|NCT00083759|6424714|P2|STARTED|Overall Study|149 subjects enrolled, 136 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|149
2616508|NCT00083759|6424715|P1|STARTED|Overall Study|150 subjects enrolled, 137 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|150
2616509|NCT00083720|6424723|P1|NOT COMPLETED|Overall Study||0
2616510|NCT00083720|6424723|P1|COMPLETED|Overall Study|Two patients died prior to receiving cetuximab.|85
2616511|NCT00083720|6424723|P1|STARTED|Overall Study|Patients analyzed for efficacy who met the epidermal growth factor receptor (EGFR) negative criteria|85
2616512|NCT00083616|6424733|P1|NOT COMPLETED|Overall Study||31
2616513|NCT00083616|6424733|P1|COMPLETED|Overall Study|Completed safety followup or died on study as of the data cut-off date of 22 December 2006|154
2616514|NCT00083616|6424733|P1|Received Study Medication|Overall Study||182
2616515|NCT00083616|6424733|P1|STARTED|Overall Study||185
2616516|NCT00083551|6424747|P2|NOT COMPLETED|Overall Study||0
2616517|NCT00083551|6424748|P1|NOT COMPLETED|Overall Study||0
2616518|NCT00083551|6424747|P2|COMPLETED|Overall Study||345
2616519|NCT00083551|6424748|P1|COMPLETED|Overall Study||323
2616520|NCT00083551|6424747|P2|STARTED|Overall Study||345
2616521|NCT00083551|6424748|P1|STARTED|Overall Study||323
2616522|NCT00083382|6424754|P1|NOT COMPLETED|Overall Study||0
2616523|NCT00083382|6424754|P1|COMPLETED|Overall Study||83
2616524|NCT00083382|6424754|P1|STARTED|Overall Study||83
2616525|NCT00082888|6424758|P1|NOT COMPLETED|Overall Study||22
2616526|NCT00082888|6424758|P1|COMPLETED|Overall Study||71
2616527|NCT00082888|6424758|P1|STARTED|Overall Study||93
2616528|NCT00082810|6424762|P1|NOT COMPLETED|Overall Study||31
2616529|NCT00082810|6424762|P1|COMPLETED|Overall Study||2
2616530|NCT00082810|6424762|P1|STARTED|Overall Study||33
2616531|NCT00082758|6424773|P3|NOT COMPLETED|Overall Study||0
2616532|NCT00082758|6424774|P2|NOT COMPLETED|Overall Study||17
2616533|NCT00082758|6424775|P1|NOT COMPLETED|Overall Study||15
2616534|NCT00082758|6424773|P3|COMPLETED|Overall Study||0
2616535|NCT00082758|6424774|P2|COMPLETED|Overall Study||7
2616536|NCT00082758|6424775|P1|COMPLETED|Overall Study||0
2616537|NCT00082758|6424773|P3|STARTED|Overall Study||0
2616538|NCT00082758|6424774|P2|STARTED|Overall Study||24
2616539|NCT00082758|6424775|P1|STARTED|Overall Study||15
2616540|NCT00082641|6424785|P2|NOT COMPLETED|Overall Study||0
2616541|NCT00082641|6424786|P1|NOT COMPLETED|Overall Study||0
2616542|NCT00082641|6424785|P2|COMPLETED|Overall Study||12
2616543|NCT00082641|6424786|P1|COMPLETED|Overall Study||11
2616544|NCT00082641|6424785|P2|STARTED|Overall Study||12
2616545|NCT00082641|6424786|P1|STARTED|Overall Study||11
2616546|NCT00083226|6424795|P1|NOT COMPLETED|Overall Study||42
2616547|NCT00083226|6424795|P1|COMPLETED|Overall Study||0
2616548|NCT00083226|6424795|P1|STARTED|Overall Study||42
2616549|NCT00083174|6424803|P3|NOT COMPLETED|Open-label Extension||0
2616550|NCT00083174|6424804|P2|NOT COMPLETED|Open-label Extension||0
2616551|NCT00083174|6424805|P1|NOT COMPLETED|Open-label Extension||0
2616552|NCT00083174|6424803|P3|COMPLETED|Open-label Extension||2831
2616553|NCT00083174|6424804|P2|COMPLETED|Open-label Extension||0
2616554|NCT00083174|6424805|P1|COMPLETED|Open-label Extension||0
2616555|NCT00083174|6424803|P3|STARTED|Open-label Extension||2831
2616556|NCT00083174|6424804|P2|STARTED|Open-label Extension||0
2616557|NCT00083174|6424805|P1|STARTED|Open-label Extension||0
2616558|NCT00083174|6424803|P3|NOT COMPLETED|Randomization Period||0
2616559|NCT00083174|6424804|P2|NOT COMPLETED|Randomization Period||0
2616560|NCT00083174|6424805|P1|NOT COMPLETED|Randomization Period||0
2616561|NCT00083174|6424803|P3|COMPLETED|Randomization Period||0
2616562|NCT00083174|6424804|P2|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2275
2616563|NCT00083174|6424805|P1|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2285
2616564|NCT00083174|6424803|P3|STARTED|Randomization Period||0
2616565|NCT00083174|6424804|P2|STARTED|Randomization Period||2275
2616566|NCT00083174|6424805|P1|STARTED|Randomization Period||2285
2616567|NCT00083122|6424827|P2|NOT COMPLETED|Overall Study||0
2616568|NCT00083122|6424828|P1|NOT COMPLETED|Overall Study||0
2616569|NCT00083122|6424827|P2|COMPLETED|Overall Study||5
2616570|NCT00083122|6424828|P1|COMPLETED|Overall Study||40
2616571|NCT00083122|6424827|P2|STARTED|Overall Study||5
2616572|NCT00083122|6424828|P1|STARTED|Overall Study||40
2616573|NCT00082628|6424839|P5|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||18
2616574|NCT00082628|6424840|P4|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||16
2616575|NCT00082628|6424841|P3|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||15
2616576|NCT00082628|6424842|P2|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||0
2616577|NCT00082628|6424843|P1|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||0
2616578|NCT00082628|6424839|P5|COMPLETED|Treatment Period II: Week 12 to Week 36||55
2616579|NCT00082628|6424840|P4|COMPLETED|Treatment Period II: Week 12 to Week 36||76
2616580|NCT00082628|6424841|P3|COMPLETED|Treatment Period II: Week 12 to Week 36||78
2616581|NCT00082628|6424842|P2|COMPLETED|Treatment Period II: Week 12 to Week 36||0
2616582|NCT00082628|6424843|P1|COMPLETED|Treatment Period II: Week 12 to Week 36||0
2616583|NCT00082628|6424839|P5|STARTED|Treatment Period II: Week 12 to Week 36||73
2616584|NCT00082628|6424840|P4|STARTED|Treatment Period II: Week 12 to Week 36||92
2616585|NCT00082628|6424841|P3|STARTED|Treatment Period II: Week 12 to Week 36||93
2616586|NCT00082628|6424842|P2|STARTED|Treatment Period II: Week 12 to Week 36||0
2616587|NCT00082628|6424843|P1|STARTED|Treatment Period II: Week 12 to Week 36||0
2616588|NCT00082628|6424839|P5|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
2616589|NCT00082628|6424840|P4|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
2616590|NCT00082628|6424841|P3|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
2616591|NCT00082628|6424842|P2|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||60
2616592|NCT00082628|6424843|P1|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||8
2616593|NCT00082628|6424839|P5|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
2616594|NCT00082628|6424840|P4|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
2616595|NCT00082628|6424841|P3|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
2616596|NCT00082628|6424842|P2|COMPLETED|Treatment Period I (Week 1 to Week 12)||185
2616597|NCT00082628|6424843|P1|COMPLETED|Treatment Period I (Week 1 to Week 12)||73
2616598|NCT00082628|6424839|P5|STARTED|Treatment Period I (Week 1 to Week 12)||0
2616599|NCT00082628|6424840|P4|STARTED|Treatment Period I (Week 1 to Week 12)||0
2616600|NCT00082628|6424841|P3|STARTED|Treatment Period I (Week 1 to Week 12)||0
2616601|NCT00082628|6424842|P2|STARTED|Treatment Period I (Week 1 to Week 12)||245
2616602|NCT00082628|6424843|P1|STARTED|Treatment Period I (Week 1 to Week 12)||81
2616603|NCT00082433|6424863|P2|NOT COMPLETED|Overall Study||597
2616604|NCT00082433|6424864|P1|NOT COMPLETED|Overall Study||594
2616605|NCT00082433|6424863|P2|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
2616606|NCT00082433|6424864|P1|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
2616607|NCT00082433|6424863|P2|STARTED|Overall Study||612
2616608|NCT00082433|6424864|P1|STARTED|Overall Study||609
2616609|NCT00082381|6424884|P2|NOT COMPLETED|Overall Study||26
2616610|NCT00082381|6424885|P1|NOT COMPLETED|Overall Study||55
2616611|NCT00082381|6424884|P2|COMPLETED|Overall Study||242
2616612|NCT00082381|6424885|P1|COMPLETED|Overall Study||228
2616613|NCT00082381|6424884|P2|Received Treatment (Intent to Treat)|Overall Study||267
2616614|NCT00082381|6424885|P1|Received Treatment (Intent to Treat)|Overall Study||282
2616615|NCT00082381|6424884|P2|STARTED|Overall Study||268
2616616|NCT00082381|6424885|P1|STARTED|Overall Study||283
2616617|NCT00082407|6424905|P2|NOT COMPLETED|Overall Study||27
2616618|NCT00082407|6424906|P1|NOT COMPLETED|Overall Study||56
2616619|NCT00082407|6424905|P2|COMPLETED|Overall Study||223
2616620|NCT00082407|6424906|P1|COMPLETED|Overall Study||199
2616621|NCT00082407|6424905|P2|Received Treatment (Intent to Treat)|Overall Study||248
2616622|NCT00082407|6424906|P1|Received Treatment (Intent to Treat)|Overall Study||253
2616623|NCT00082407|6424905|P2|STARTED|Overall Study||250
2616624|NCT00082407|6424906|P1|STARTED|Overall Study||255
2616625|NCT00082368|6424924|P1|NOT COMPLETED|Overall Study||1
2616626|NCT00082368|6424924|P1|COMPLETED|Overall Study||11
2616627|NCT00082368|6424924|P1|STARTED|Overall Study||12
2616628|NCT00082355|6424929|P1|NOT COMPLETED|5 Year Recurrent Thromboembolism Rate||28
2616629|NCT00082355|6424929|P1|COMPLETED|5 Year Recurrent Thromboembolism Rate|data will not be complied until 2014|0
2616630|NCT00082355|6424929|P1|STARTED|5 Year Recurrent Thromboembolism Rate||28
2616631|NCT00082355|6424929|P1|NOT COMPLETED|Initial Results of Thrombolytic Therapy||2
2616808|NCT00080119|6425315|P3|STARTED|Overall Study||273
2616632|NCT00082355|6424929|P1|COMPLETED|Initial Results of Thrombolytic Therapy||28
2616633|NCT00082355|6424929|P1|STARTED|Initial Results of Thrombolytic Therapy||30
2616634|NCT00082342|6424936|P2|NOT COMPLETED|Overall Study||0
2616635|NCT00082342|6424937|P1|NOT COMPLETED|Overall Study||0
2616636|NCT00082342|6424936|P2|COMPLETED|Overall Study||12
2616637|NCT00082342|6424937|P1|COMPLETED|Overall Study||13
2616638|NCT00082342|6424936|P2|STARTED|Overall Study||12
2616639|NCT00082342|6424937|P1|STARTED|Overall Study||13
2616640|NCT00082329|6424957|P1|NOT COMPLETED|Overall Study||0
2616641|NCT00082329|6424957|P1|COMPLETED|Overall Study||9
2616642|NCT00082329|6424957|P1|STARTED|Overall Study||9
2616643|NCT00082173|6424963|P2|NOT COMPLETED|Overall Study||11
2616644|NCT00082173|6424964|P1|NOT COMPLETED|Overall Study||10
2616645|NCT00082173|6424963|P2|COMPLETED|Overall Study||61
2616646|NCT00082173|6424964|P1|COMPLETED|Overall Study||64
2616647|NCT00082173|6424963|P2|STARTED|Overall Study||72
2616648|NCT00082173|6424964|P1|STARTED|Overall Study||74
2616649|NCT00003726|6424972|P1|NOT COMPLETED|Overall Study||1
2616650|NCT00003726|6424972|P1|COMPLETED|Overall Study|Funding was pulled on the trial and therefore no other participants were enrolled|0
2616651|NCT00003726|6424972|P1|STARTED|Overall Study||1
2616652|NCT00081939|6424976|P1|NOT COMPLETED|Overall Study||0
2616653|NCT00081939|6424976|P1|COMPLETED|Overall Study||303
2616654|NCT00081939|6424976|P1|STARTED|Overall Study||303
2616655|NCT00082017|6424980|P2|NOT COMPLETED|Overall Study||0
2616656|NCT00082017|6424981|P1|NOT COMPLETED|Overall Study||0
2616657|NCT00082017|6424980|P2|COMPLETED|Overall Study||9
2616658|NCT00082017|6424981|P1|COMPLETED|Overall Study||11
2616659|NCT00082017|6424980|P2|STARTED|Overall Study||9
2616660|NCT00082017|6424981|P1|STARTED|Overall Study||11
2616661|NCT00081861|6424997|P1|NOT COMPLETED|Overall Study||0
2616662|NCT00081861|6424997|P1|COMPLETED|Overall Study||13
2616663|NCT00081861|6424997|P1|STARTED|Overall Study||13
2616664|NCT00003270|6425001|P1|NOT COMPLETED|Overall Study||0
2616665|NCT00003270|6425001|P1|COMPLETED|Overall Study||20
2616666|NCT00003270|6425001|P1|STARTED|Overall Study||20
2616667|NCT00081770|6425009|P3|NOT COMPLETED|Overall Study||456
2616668|NCT00081770|6425010|P2|NOT COMPLETED|Overall Study||546
2616669|NCT00081770|6425011|P1|NOT COMPLETED|Overall Study||502
2616670|NCT00081770|6425009|P3|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|579
2616671|NCT00081770|6425010|P2|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|470
2616672|NCT00081770|6425011|P1|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|517
2616673|NCT00081770|6425009|P3|STARTED|Overall Study||1035
2616674|NCT00081770|6425010|P2|STARTED|Overall Study||1016
2616675|NCT00081770|6425011|P1|STARTED|Overall Study||1019
2616676|NCT00081731|6425030|P2|NOT COMPLETED|Overall Study||8
2616677|NCT00081731|6425031|P1|NOT COMPLETED|Overall Study||8
2616678|NCT00081731|6425030|P2|COMPLETED|Overall Study||459
2616679|NCT00081731|6425031|P1|COMPLETED|Overall Study||472
2616680|NCT00081731|6425030|P2|STARTED|Overall Study||467
2616681|NCT00081731|6425031|P1|STARTED|Overall Study||480
2616682|NCT00081653|6425051|P2|NOT COMPLETED|Overall Study||37
2616683|NCT00081653|6425052|P1|NOT COMPLETED|Overall Study||47
2616684|NCT00081653|6425051|P2|COMPLETED|Overall Study|Completed 3 years of treatment|324
2616685|NCT00081653|6425052|P1|COMPLETED|Overall Study|Completed 3 years of treatment|311
2616686|NCT00081653|6425051|P2|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|361
2616687|NCT00081653|6425052|P1|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|358
2616688|NCT00081497|6425070|P2|NOT COMPLETED|Overall Study||2
2616689|NCT00081497|6425071|P1|NOT COMPLETED|Overall Study||3
2616690|NCT00081497|6425070|P2|COMPLETED|Overall Study||37
2616691|NCT00081497|6425071|P1|COMPLETED|Overall Study||25
2616692|NCT00081497|6425070|P2|STARTED|Overall Study|Patients who were randomized to Fabrazyme in AGAL-008-00 (NCT00074984).|39
2616693|NCT00081497|6425071|P1|STARTED|Overall Study|Patients who were randomized to placebo in AGAL-008-00 (NCT00074984).|28
2616694|NCT00081458|6425089|P3|NOT COMPLETED|Overall Study||4
2616695|NCT00081458|6425090|P2|NOT COMPLETED|Overall Study||8
2616696|NCT00081458|6425091|P1|NOT COMPLETED|Overall Study||1
2616697|NCT00081458|6425089|P3|COMPLETED|Overall Study||29
2616698|NCT00081458|6425090|P2|COMPLETED|Overall Study||27
2616699|NCT00081458|6425091|P1|COMPLETED|Overall Study||15
2616700|NCT00081458|6425089|P3|Received Treatment|Overall Study|1 subject was randomized but did not receive the study drug|32
2616701|NCT00081458|6425090|P2|Received Treatment|Overall Study||35
2616702|NCT00081458|6425091|P1|Received Treatment|Overall Study||16
2616703|NCT00081458|6425089|P3|STARTED|Overall Study||33
2616704|NCT00081458|6425090|P2|STARTED|Overall Study||35
2616705|NCT00081458|6425091|P1|STARTED|Overall Study||16
2616706|NCT00081328|6425105|P3|NOT COMPLETED|Overall Study||0
2616707|NCT00081328|6425106|P2|NOT COMPLETED|Overall Study||0
2616708|NCT00081328|6425107|P1|NOT COMPLETED|Overall Study||0
2616709|NCT00081328|6425105|P3|COMPLETED|Overall Study||234
2616710|NCT00081328|6425106|P2|COMPLETED|Overall Study||233
2616711|NCT00081328|6425107|P1|COMPLETED|Overall Study||232
2616712|NCT00081328|6425105|P3|STARTED|Overall Study||234
2616713|NCT00081328|6425106|P2|STARTED|Overall Study||233
2616714|NCT00081328|6425107|P1|STARTED|Overall Study||232
2616809|NCT00080119|6425316|P2|STARTED|Overall Study||401
2616810|NCT00080119|6425317|P1|STARTED|Overall Study||403
2616721|NCT00081263|6425156|P2|NOT COMPLETED|Overall Study||22
2616722|NCT00081263|6425157|P1|NOT COMPLETED|Overall Study||17
2616723|NCT00081263|6425156|P2|COMPLETED|Overall Study||41
2616724|NCT00081263|6425157|P1|COMPLETED|Overall Study||50
2616725|NCT00081263|6425156|P2|STARTED|Overall Study||63
2616726|NCT00081263|6425157|P1|STARTED|Overall Study||67
2616727|NCT00081159|6425167|P2|NOT COMPLETED|Overall Study||5
2616728|NCT00081159|6425168|P1|NOT COMPLETED|Overall Study||2
2616729|NCT00081159|6425167|P2|COMPLETED|Overall Study||35
2616730|NCT00081159|6425168|P1|COMPLETED|Overall Study||37
2616731|NCT00081159|6425167|P2|STARTED|Overall Study||40
2616732|NCT00081159|6425168|P1|STARTED|Overall Study||39
2616733|NCT00080938|6425178|P1|NOT COMPLETED|Overall Study||24
2616734|NCT00080938|6425178|P1|COMPLETED|Overall Study||2
2616735|NCT00080938|6425178|P1|Eligible and Treated|Overall Study||21
2616736|NCT00080938|6425178|P1|Began Protocol Therapy|Overall Study||25
2616737|NCT00080938|6425178|P1|STARTED|Overall Study||26
2616738|NCT00080912|6425187|P2|NOT COMPLETED|Overall Study||0
2616739|NCT00080912|6425188|P1|NOT COMPLETED|Overall Study||0
2616740|NCT00080912|6425187|P2|COMPLETED|Overall Study||425
2616741|NCT00080912|6425188|P1|COMPLETED|Overall Study||425
2616742|NCT00080912|6425187|P2|STARTED|Overall Study||425
2616743|NCT00080912|6425188|P1|STARTED|Overall Study||425
2616744|NCT00080899|6425194|P1|NOT COMPLETED|Overall Study||1
2616745|NCT00080899|6425194|P1|COMPLETED|Overall Study||22
2616746|NCT00080899|6425194|P1|STARTED|Overall Study||23
2616747|NCT00080535|6425199|P1|NOT COMPLETED|Overall Study||0
2616748|NCT00080535|6425199|P1|COMPLETED|Overall Study||10
2616749|NCT00080535|6425199|P1|STARTED|Overall Study||10
2616750|NCT00080483|6425206|P2|NOT COMPLETED|Overall Study||2
2616751|NCT00080483|6425207|P1|NOT COMPLETED|Overall Study||2
2616752|NCT00080483|6425206|P2|COMPLETED|Overall Study||16
2616753|NCT00080483|6425207|P1|COMPLETED|Overall Study||15
2616754|NCT00080483|6425206|P2|STARTED|Overall Study||18
2616755|NCT00080483|6425207|P1|STARTED|Overall Study||17
2616756|NCT00002525|6425215|P2|NOT COMPLETED|Overall Study||0
2616757|NCT00002525|6425216|P1|NOT COMPLETED|Overall Study||186
2616758|NCT00002525|6425215|P2|COMPLETED|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|428
2616759|NCT00002525|6425216|P1|COMPLETED|Overall Study||241
2616760|NCT00002525|6425215|P2|Dukes' B2 Stage|Overall Study||139
2616761|NCT00002525|6425216|P1|Dukes' B2 Stage|Overall Study||150
2616762|NCT00002525|6425215|P2|Dukes' B3 or C Stage|Overall Study||158
2616763|NCT00002525|6425216|P1|Dukes' B3 or C Stage|Overall Study|"Primary population: pts with Duke's B3, C disease. 158 such pts on No perioperative 5-FU arm"|156
2616764|NCT00002525|6425215|P2|Treated|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|0
2616765|NCT00002525|6425216|P1|Treated|Overall Study||419
2616766|NCT00002525|6425215|P2|STARTED|Overall Study||428
2616767|NCT00002525|6425216|P1|STARTED|Overall Study|859 patients were enrolled to the study, but 4 patients were not randomized to any treatment arm|427
2616768|NCT00080470|6425232|P2|NOT COMPLETED|Overall Study||28
2616769|NCT00080470|6425233|P1|NOT COMPLETED|Overall Study||34
2616770|NCT00080470|6425232|P2|COMPLETED|Overall Study||14
2616771|NCT00080470|6425233|P1|COMPLETED|Overall Study||11
2616772|NCT00080470|6425232|P2|STARTED|Overall Study||42
2616773|NCT00080470|6425233|P1|STARTED|Overall Study||45
2616774|NCT00080301|6425243|P2|NOT COMPLETED|Overall Study||11
2616775|NCT00080301|6425244|P1|NOT COMPLETED|Overall Study||5
2616776|NCT00080301|6425243|P2|COMPLETED|Overall Study|Participants who are off treatment|366
2616777|NCT00080301|6425244|P1|COMPLETED|Overall Study|Participants who are off treatment|370
2616778|NCT00080301|6425243|P2|Still on Treatment|Overall Study||1
2616779|NCT00080301|6425244|P1|Still on Treatment|Overall Study||0
2616780|NCT00080301|6425243|P2|Never Treated|Overall Study||10
2616781|NCT00080301|6425244|P1|Never Treated|Overall Study||5
2616782|NCT00080301|6425243|P2|STARTED|Overall Study||377
2616783|NCT00080301|6425244|P1|STARTED|Overall Study||375
2616784|NCT00080288|6425264|P2|NOT COMPLETED|Overall Study||38
2616785|NCT00080288|6425265|P1|NOT COMPLETED|Overall Study||30
2616786|NCT00080288|6425264|P2|COMPLETED|Overall Study||89
2616787|NCT00080288|6425265|P1|COMPLETED|Overall Study||97
2616788|NCT00080288|6425264|P2|STARTED|Overall Study||127
2616789|NCT00080288|6425265|P1|STARTED|Overall Study||127
2616790|NCT00080223|6425273|P1|NOT COMPLETED|Overall Study||76
2616791|NCT00080223|6425273|P1|COMPLETED|Overall Study||7
2616792|NCT00080223|6425273|P1|STARTED|Overall Study||83
2616793|NCT00002540|6425283|P2|NOT COMPLETED|Overall Study||2464
2616794|NCT00002540|6425284|P1|NOT COMPLETED|Overall Study||801
2616795|NCT00002540|6425283|P2|COMPLETED|Overall Study||35876
2616796|NCT00002540|6425284|P1|COMPLETED|Overall Study||37544
2616797|NCT00002540|6425283|P2|STARTED|Overall Study||38340
2616798|NCT00002540|6425284|P1|STARTED|Overall Study||38345
2616799|NCT00080119|6425314|P4|NOT COMPLETED|Overall Study||163
2616800|NCT00080119|6425315|P3|NOT COMPLETED|Overall Study||165
2616801|NCT00080119|6425316|P2|NOT COMPLETED|Overall Study||62
2616802|NCT00080119|6425317|P1|NOT COMPLETED|Overall Study||56
2616803|NCT00080119|6425314|P4|COMPLETED|Overall Study||111
2616804|NCT00080119|6425315|P3|COMPLETED|Overall Study||108
2616805|NCT00080119|6425316|P2|COMPLETED|Overall Study||339
2616806|NCT00080119|6425317|P1|COMPLETED|Overall Study||347
2616807|NCT00080119|6425314|P4|STARTED|Overall Study||274
2616811|NCT00079937|6425351|P2|NOT COMPLETED|Overall Study||32
2616812|NCT00079937|6425352|P1|NOT COMPLETED|Overall Study||69
2616813|NCT00079937|6425351|P2|COMPLETED|Overall Study||175
2616814|NCT00079937|6425352|P1|COMPLETED|Overall Study||352
2616815|NCT00079937|6425351|P2|STARTED|Overall Study||207
2616816|NCT00079937|6425352|P1|STARTED|Overall Study||421
2616817|NCT00009737|6425370|P2|NOT COMPLETED|Overall Study||123
2616818|NCT00009737|6425371|P1|NOT COMPLETED|Overall Study||170
2616819|NCT00009737|6425370|P2|COMPLETED|Overall Study||860
2616820|NCT00009737|6425371|P1|COMPLETED|Overall Study||834
2616821|NCT00009737|6425370|P2|STARTED|Overall Study||983
2616822|NCT00009737|6425371|P1|STARTED|Overall Study||1004
2616823|NCT00079781|6425390|P3|NOT COMPLETED|Follow-up Period||2
2616824|NCT00079781|6425391|P2|NOT COMPLETED|Follow-up Period||0
2616825|NCT00079781|6425392|P1|NOT COMPLETED|Follow-up Period||4
2616826|NCT00079781|6425390|P3|COMPLETED|Follow-up Period||12
2616827|NCT00079781|6425391|P2|COMPLETED|Follow-up Period||9
2616828|NCT00079781|6425392|P1|COMPLETED|Follow-up Period||38
2616829|NCT00079781|6425390|P3|STARTED|Follow-up Period||14
2616830|NCT00079781|6425391|P2|STARTED|Follow-up Period||9
2616831|NCT00079781|6425392|P1|STARTED|Follow-up Period||42
2616832|NCT00079781|6425390|P3|NOT COMPLETED|Evaluation Period||0
2616833|NCT00079781|6425391|P2|NOT COMPLETED|Evaluation Period||0
2616834|NCT00079781|6425392|P1|NOT COMPLETED|Evaluation Period||0
2616835|NCT00079781|6425390|P3|COMPLETED|Evaluation Period||14
2616836|NCT00079781|6425391|P2|COMPLETED|Evaluation Period||9
2616837|NCT00079781|6425392|P1|COMPLETED|Evaluation Period||42
2616838|NCT00079781|6425390|P3|STARTED|Evaluation Period||14
2616839|NCT00079781|6425391|P2|STARTED|Evaluation Period||9
2616840|NCT00079781|6425392|P1|STARTED|Evaluation Period||42
2616841|NCT00079781|6425390|P3|NOT COMPLETED|Pre-implant Period||1
2616842|NCT00079781|6425391|P2|NOT COMPLETED|Pre-implant Period||1
2616843|NCT00079781|6425392|P1|NOT COMPLETED|Pre-implant Period||3
2616844|NCT00079781|6425390|P3|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|14
2616845|NCT00079781|6425391|P2|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|9
2616846|NCT00079781|6425392|P1|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|42
2616847|NCT00079781|6425390|P3|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|15
2616848|NCT00079781|6425391|P2|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|10
2616849|NCT00079781|6425392|P1|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|45
2616850|NCT00079677|6425401|P2|NOT COMPLETED|Overall Study||14
2616851|NCT00079677|6425402|P1|NOT COMPLETED|Overall Study||20
2616852|NCT00079677|6425401|P2|COMPLETED|Overall Study||118
2616853|NCT00079677|6425402|P1|COMPLETED|Overall Study||111
2616854|NCT00079677|6425401|P2|STARTED|Overall Study||132
2616855|NCT00079677|6425402|P1|STARTED|Overall Study||131
2616856|NCT00002601|6425410|P1|NOT COMPLETED|Overall Study||0
2616857|NCT00002601|6425410|P1|COMPLETED|Overall Study||13
2616858|NCT00002601|6425410|P1|STARTED|Overall Study||13
2616859|NCT00079417|6425418|P1|NOT COMPLETED|Overall Study||9
2616860|NCT00079417|6425418|P1|COMPLETED|Overall Study||19
2616861|NCT00079417|6425418|P1|STARTED|Overall Study||28
2616862|NCT00079391|6425426|P1|NOT COMPLETED|Overall Study||1
2616863|NCT00079391|6425426|P1|COMPLETED|Overall Study||49
2616864|NCT00079391|6425426|P1|STARTED|Overall Study|1 of these withdrew after consent.|50
2616865|NCT00079339|6425438|P3|NOT COMPLETED|Overall Study||6
2616866|NCT00079339|6425439|P2|NOT COMPLETED|Overall Study||39
2616867|NCT00079339|6425440|P1|NOT COMPLETED|Overall Study||5
2616868|NCT00079339|6425438|P3|COMPLETED|Overall Study||0
2616869|NCT00079339|6425439|P2|COMPLETED|Overall Study||1
2616870|NCT00079339|6425440|P1|COMPLETED|Overall Study||0
2616871|NCT00079339|6425438|P3|Enrolled in Phase II|Overall Study|Participants treated at the 150 mg/m2 dose level did not participate in the phase II part.|0
2616872|NCT00079339|6425439|P2|Enrolled in Phase II|Overall Study|This number includes the 6 patients enrolled on the phase I part.|40
2616873|NCT00079339|6425440|P1|Enrolled in Phase II|Overall Study|Participants treated at the 100 mg/m2 dose level did not participate in the phase II part.|0
2616874|NCT00079339|6425438|P3|Maximum Tolerated Dose (MTD) Estimation|Overall Study|One participant enrolled in the phase I part did not complete the 8 week MTD estimation period.|5
2616875|NCT00079339|6425439|P2|Maximum Tolerated Dose (MTD) Estimation|Overall Study||6
2616876|NCT00079339|6425440|P1|Maximum Tolerated Dose (MTD) Estimation|Overall Study|2 participants enrolled in the phase I part did not complete the 8 week MTD estimation period.|3
2616877|NCT00079339|6425438|P3|Enrolled in Phase I|Overall Study||6
2616878|NCT00079339|6425439|P2|Enrolled in Phase I|Overall Study||6
2616879|NCT00079339|6425440|P1|Enrolled in Phase I|Overall Study||5
2616880|NCT00079339|6425438|P3|STARTED|Overall Study||6
2616881|NCT00079339|6425439|P2|STARTED|Overall Study||40
2616882|NCT00079339|6425440|P1|STARTED|Overall Study||5
2616883|NCT00079326|6425456|P2|NOT COMPLETED|Overall Study||0
2616884|NCT00079326|6425457|P1|NOT COMPLETED|Overall Study||0
2616885|NCT00079326|6425456|P2|COMPLETED|Overall Study||24
2616886|NCT00079326|6425457|P1|COMPLETED|Overall Study||15
2616887|NCT00079326|6425456|P2|STARTED|Overall Study||24
2616888|NCT00079326|6425457|P1|STARTED|Overall Study||15
2616889|NCT00079274|6425471|P7|NOT COMPLETED|Overall Study||0
2616890|NCT00079274|6425472|P6|NOT COMPLETED|Overall Study||20
2616891|NCT00079274|6425473|P5|NOT COMPLETED|Overall Study||15
2616892|NCT00079274|6425474|P4|NOT COMPLETED|Overall Study||444
2616893|NCT00079274|6425475|P3|NOT COMPLETED|Overall Study||27
2616894|NCT00079274|6425476|P2|NOT COMPLETED|Overall Study||27
2616895|NCT00079274|6425477|P1|NOT COMPLETED|Overall Study||321
2616896|NCT00079274|6425471|P7|COMPLETED|Overall Study||332
2616897|NCT00079274|6425472|P6|COMPLETED|Overall Study||26
2616898|NCT00079274|6425473|P5|COMPLETED|Overall Study||30
2616899|NCT00079274|6425474|P4|COMPLETED|Overall Study||906
2616900|NCT00079274|6425475|P3|COMPLETED|Overall Study||84
2616901|NCT00079274|6425476|P2|COMPLETED|Overall Study||84
2616902|NCT00079274|6425477|P1|COMPLETED|Overall Study||1081
2616903|NCT00079274|6425471|P7|STARTED|Overall Study||332
2616904|NCT00079274|6425472|P6|STARTED|Overall Study||46
2616905|NCT00079274|6425473|P5|STARTED|Overall Study||45
2616906|NCT00079274|6425474|P4|STARTED|Overall Study||1350
2616907|NCT00079274|6425475|P3|STARTED|Overall Study||111
2616908|NCT00079274|6425476|P2|STARTED|Overall Study||111
2616909|NCT00079274|6425477|P1|STARTED|Overall Study||1402
2616910|NCT00079183|6425498|P1|NOT COMPLETED|Overall Study||7
2616911|NCT00079183|6425498|P1|COMPLETED|Overall Study||37
2616912|NCT00079183|6425498|P1|Drop Outs|Overall Study||7
2616913|NCT00079183|6425498|P1|STARTED|Overall Study||44
2616914|NCT00079040|6425513|P1|NOT COMPLETED|Overall Study||2
2616915|NCT00079040|6425513|P1|COMPLETED|Overall Study||63
2616916|NCT00079040|6425513|P1|STARTED|Overall Study||65
2616917|NCT00079001|6425521|P2|NOT COMPLETED|Overall Study||0
2616918|NCT00079001|6425522|P1|NOT COMPLETED|Overall Study||0
2616919|NCT00079001|6425521|P2|COMPLETED|Overall Study||322
2616920|NCT00079001|6425522|P1|COMPLETED|Overall Study||323
2616921|NCT00079001|6425521|P2|STARTED|Overall Study||322
2616922|NCT00079001|6425522|P1|STARTED|Overall Study||323
2616935|NCT00078897|6425557|P2|NOT COMPLETED|Overall Study||123
2616936|NCT00078897|6425558|P1|NOT COMPLETED|Overall Study||124
2616937|NCT00078897|6425557|P2|COMPLETED|Overall Study||689
2616938|NCT00078897|6425558|P1|COMPLETED|Overall Study||685
2616939|NCT00078897|6425557|P2|STARTED|Overall Study||812
2616940|NCT00078897|6425558|P1|STARTED|Overall Study||809
2616941|NCT00078819|6425568|P4|NOT COMPLETED|Re-treatment Period||0
2616942|NCT00078819|6425569|P3|NOT COMPLETED|Re-treatment Period||0
2616943|NCT00078819|6425570|P2|NOT COMPLETED|Re-treatment Period||0
2616944|NCT00078819|6425571|P1|NOT COMPLETED|Re-treatment Period||0
2616945|NCT00078819|6425568|P4|COMPLETED|Re-treatment Period||13
2616946|NCT00078819|6425569|P3|COMPLETED|Re-treatment Period||29
2616947|NCT00078819|6425570|P2|COMPLETED|Re-treatment Period||0
2616948|NCT00078819|6425571|P1|COMPLETED|Re-treatment Period||0
2616949|NCT00078819|6425568|P4|Received Study Drug|Re-treatment Period||12
2616950|NCT00078819|6425569|P3|Received Study Drug|Re-treatment Period|One additional participant received re-treatment without having disease relapse|30
2616951|NCT00078819|6425570|P2|Received Study Drug|Re-treatment Period||0
2616952|NCT00078819|6425571|P1|Received Study Drug|Re-treatment Period||0
2616953|NCT00078819|6425568|P4|STARTED|Re-treatment Period||13
2616954|NCT00078819|6425569|P3|STARTED|Re-treatment Period||29
2616955|NCT00078819|6425570|P2|STARTED|Re-treatment Period||0
2616956|NCT00078819|6425571|P1|STARTED|Re-treatment Period||0
2616957|NCT00078819|6425568|P4|NOT COMPLETED|Withdrawal Period: Weeks 37-48||14
2616958|NCT00078819|6425569|P3|NOT COMPLETED|Withdrawal Period: Weeks 37-48||29
2616959|NCT00078819|6425570|P2|NOT COMPLETED|Withdrawal Period: Weeks 37-48||0
2616960|NCT00078819|6425571|P1|NOT COMPLETED|Withdrawal Period: Weeks 37-48||0
2616961|NCT00078819|6425568|P4|COMPLETED|Withdrawal Period: Weeks 37-48|Defined as continuing to receive blinded study drug through week 48|55
2616962|NCT00078819|6425569|P3|COMPLETED|Withdrawal Period: Weeks 37-48|Defined as continuing to receive blinded study drug through week 48|40
2616963|NCT00078819|6425570|P2|COMPLETED|Withdrawal Period: Weeks 37-48||0
2616964|NCT00078819|6425571|P1|COMPLETED|Withdrawal Period: Weeks 37-48||0
2616965|NCT00078819|6425568|P4|Received Study Drug|Withdrawal Period: Weeks 37-48||68
2616966|NCT00078819|6425569|P3|Received Study Drug|Withdrawal Period: Weeks 37-48||69
2616967|NCT00078819|6425570|P2|Received Study Drug|Withdrawal Period: Weeks 37-48||0
2616968|NCT00078819|6425571|P1|Received Study Drug|Withdrawal Period: Weeks 37-48||0
2616969|NCT00078819|6425568|P4|STARTED|Withdrawal Period: Weeks 37-48|Participants who completed week 36 with a PASI response|69
2616970|NCT00078819|6425569|P3|STARTED|Withdrawal Period: Weeks 37-48|Participants who completed week 36 with a PASI response|69
2616971|NCT00078819|6425570|P2|STARTED|Withdrawal Period: Weeks 37-48||0
2616972|NCT00078819|6425571|P1|STARTED|Withdrawal Period: Weeks 37-48||0
2616973|NCT00078819|6425568|P4|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||0
2616974|NCT00078819|6425569|P3|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||0
2616975|NCT00078819|6425570|P2|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||30
2616976|NCT00078819|6425571|P1|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||40
2616977|NCT00078819|6425568|P4|COMPLETED|Open-label Treatment Period: Weeks 13-36||0
2616978|NCT00078819|6425569|P3|COMPLETED|Open-label Treatment Period: Weeks 13-36||0
2616979|NCT00078819|6425570|P2|COMPLETED|Open-label Treatment Period: Weeks 13-36||75
2616980|NCT00078819|6425571|P1|COMPLETED|Open-label Treatment Period: Weeks 13-36||63
2616981|NCT00078819|6425568|P4|STARTED|Open-label Treatment Period: Weeks 13-36||0
2616982|NCT00078819|6425569|P3|STARTED|Open-label Treatment Period: Weeks 13-36||0
2616983|NCT00078819|6425570|P2|STARTED|Open-label Treatment Period: Weeks 13-36||105
2616984|NCT00078819|6425571|P1|STARTED|Open-label Treatment Period: Weeks 13-36|One participant discontinued before starting the open-label period|103
2616985|NCT00078819|6425568|P4|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||0
2616986|NCT00078819|6425569|P3|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||0
2616987|NCT00078819|6425570|P2|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||1
2616988|NCT00078819|6425571|P1|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||1
2616989|NCT00078819|6425568|P4|COMPLETED|Double-blind Treatment Period: Week 1-12||0
2616990|NCT00078819|6425569|P3|COMPLETED|Double-blind Treatment Period: Week 1-12||0
2616991|NCT00078819|6425570|P2|COMPLETED|Double-blind Treatment Period: Week 1-12||105
2616992|NCT00078819|6425571|P1|COMPLETED|Double-blind Treatment Period: Week 1-12||104
2616993|NCT00078819|6425568|P4|Entered Escape|Double-blind Treatment Period: Week 1-12||0
2616994|NCT00078819|6425569|P3|Entered Escape|Double-blind Treatment Period: Week 1-12||0
2616995|NCT00078819|6425570|P2|Entered Escape|Double-blind Treatment Period: Week 1-12||5
2616996|NCT00078819|6425571|P1|Entered Escape|Double-blind Treatment Period: Week 1-12||27
2616997|NCT00078819|6425568|P4|STARTED|Double-blind Treatment Period: Week 1-12||0
2616998|NCT00078819|6425569|P3|STARTED|Double-blind Treatment Period: Week 1-12||0
2616999|NCT00078819|6425570|P2|STARTED|Double-blind Treatment Period: Week 1-12||106
2617000|NCT00078819|6425571|P1|STARTED|Double-blind Treatment Period: Week 1-12||105
2617001|NCT00078806|6425596|P4|NOT COMPLETED|Part 3||0
2617002|NCT00078806|6425597|P3|NOT COMPLETED|Part 3||0
2617003|NCT00078806|6425598|P2|NOT COMPLETED|Part 3||0
2617004|NCT00078806|6425599|P1|NOT COMPLETED|Part 3||0
2617005|NCT00078806|6425596|P4|COMPLETED|Part 3||9
2617006|NCT00078806|6425597|P3|COMPLETED|Part 3||0
2617007|NCT00078806|6425598|P2|COMPLETED|Part 3||0
2617008|NCT00078806|6425599|P1|COMPLETED|Part 3||0
2617009|NCT00078806|6425596|P4|STARTED|Part 3||9
2617010|NCT00078806|6425597|P3|STARTED|Part 3||0
2617011|NCT00078806|6425598|P2|STARTED|Part 3||0
2617012|NCT00078806|6425599|P1|STARTED|Part 3||0
2617013|NCT00078806|6425596|P4|NOT COMPLETED|Part 2||0
2617014|NCT00078806|6425597|P3|NOT COMPLETED|Part 2||0
2617015|NCT00078806|6425598|P2|NOT COMPLETED|Part 2||1
2617016|NCT00078806|6425599|P1|NOT COMPLETED|Part 2||0
2617017|NCT00078806|6425596|P4|COMPLETED|Part 2||0
2617018|NCT00078806|6425597|P3|COMPLETED|Part 2||4
2617019|NCT00078806|6425598|P2|COMPLETED|Part 2||5
2617020|NCT00078806|6425599|P1|COMPLETED|Part 2||0
2617021|NCT00078806|6425596|P4|Received Study Drug|Part 2||0
2617022|NCT00078806|6425597|P3|Received Study Drug|Part 2||4
2617023|NCT00078806|6425598|P2|Received Study Drug|Part 2||5
2617024|NCT00078806|6425599|P1|Received Study Drug|Part 2||0
2617025|NCT00078806|6425596|P4|STARTED|Part 2||0
2617026|NCT00078806|6425597|P3|STARTED|Part 2||4
2617027|NCT00078806|6425598|P2|STARTED|Part 2||6
2617028|NCT00078806|6425599|P1|STARTED|Part 2||0
2617029|NCT00078806|6425596|P4|NOT COMPLETED|Part 1B||0
2617030|NCT00078806|6425597|P3|NOT COMPLETED|Part 1B||0
2617031|NCT00078806|6425598|P2|NOT COMPLETED|Part 1B||0
2617032|NCT00078806|6425599|P1|NOT COMPLETED|Part 1B||8
2617033|NCT00078806|6425596|P4|COMPLETED|Part 1B||0
2617034|NCT00078806|6425597|P3|COMPLETED|Part 1B||0
2617035|NCT00078806|6425598|P2|COMPLETED|Part 1B||0
2617036|NCT00078806|6425599|P1|COMPLETED|Part 1B||2
2617037|NCT00078806|6425596|P4|STARTED|Part 1B||0
2617038|NCT00078806|6425597|P3|STARTED|Part 1B||0
2617039|NCT00078806|6425598|P2|STARTED|Part 1B||0
2617040|NCT00078806|6425599|P1|STARTED|Part 1B||10
2617041|NCT00078806|6425596|P4|NOT COMPLETED|Part 1A||0
2617042|NCT00078806|6425597|P3|NOT COMPLETED|Part 1A||0
2617043|NCT00078806|6425598|P2|NOT COMPLETED|Part 1A||0
2617044|NCT00078806|6425599|P1|NOT COMPLETED|Part 1A||10
2617045|NCT00078806|6425596|P4|COMPLETED|Part 1A||0
2617046|NCT00078806|6425597|P3|COMPLETED|Part 1A||0
2617047|NCT00078806|6425598|P2|COMPLETED|Part 1A||0
2617048|NCT00078806|6425599|P1|COMPLETED|Part 1A||9
2617049|NCT00078806|6425596|P4|STARTED|Part 1A||0
2617050|NCT00078806|6425597|P3|STARTED|Part 1A||0
2617051|NCT00078806|6425598|P2|STARTED|Part 1A||0
2617052|NCT00078806|6425599|P1|STARTED|Part 1A||19
2617053|NCT00078767|6425635|P2|NOT COMPLETED|Overall Study||1
2617054|NCT00078767|6425636|P1|NOT COMPLETED|Overall Study||1
2617055|NCT00078767|6425635|P2|COMPLETED|Overall Study||11
2617056|NCT00078767|6425636|P1|COMPLETED|Overall Study||11
2617057|NCT00078767|6425635|P2|STARTED|Overall Study||12
2617058|NCT00078767|6425636|P1|STARTED|Overall Study||12
2617059|NCT00078754|6425653|P3|NOT COMPLETED|Overall Study||15
2617060|NCT00078754|6425654|P2|NOT COMPLETED|Overall Study||19
2617061|NCT00078754|6425655|P1|NOT COMPLETED|Overall Study||15
2617062|NCT00078754|6425653|P3|COMPLETED|Overall Study||16
2617063|NCT00078754|6425654|P2|COMPLETED|Overall Study||11
2617064|NCT00078754|6425655|P1|COMPLETED|Overall Study||14
2617065|NCT00078754|6425653|P3|STARTED|Overall Study||31
2617066|NCT00078754|6425654|P2|STARTED|Overall Study||30
2617067|NCT00078754|6425655|P1|STARTED|Overall Study||29
2617068|NCT00078728|6425665|P2|NOT COMPLETED|Overall Study||3
2617069|NCT00078728|6425666|P1|NOT COMPLETED|Overall Study||4
2617070|NCT00078728|6425665|P2|COMPLETED|Overall Study||17
2617071|NCT00078728|6425666|P1|COMPLETED|Overall Study||16
2617072|NCT00078728|6425665|P2|STARTED|Overall Study||20
2617073|NCT00078728|6425666|P1|STARTED|Overall Study||20
2617074|NCT00078715|6425674|P2|NOT COMPLETED|Second Intervention||0
2617075|NCT00078715|6425675|P1|NOT COMPLETED|Second Intervention||0
2617076|NCT00078715|6425674|P2|COMPLETED|Second Intervention||4
2617077|NCT00078715|6425675|P1|COMPLETED|Second Intervention||2
2617078|NCT00078715|6425674|P2|STARTED|Second Intervention||4
2617079|NCT00078715|6425675|P1|STARTED|Second Intervention||2
2617080|NCT00078715|6425674|P2|NOT COMPLETED|First Intervention||0
2617081|NCT00078715|6425675|P1|NOT COMPLETED|First Intervention||0
2617082|NCT00078715|6425674|P2|COMPLETED|First Intervention||4
2617083|NCT00078715|6425675|P1|COMPLETED|First Intervention||2
2617084|NCT00078715|6425674|P2|STARTED|First Intervention||4
2617085|NCT00078715|6425675|P1|STARTED|First Intervention||2
2617086|NCT00005947|6425683|P2|NOT COMPLETED|Overall Study||41
2617087|NCT00005947|6425684|P1|NOT COMPLETED|Overall Study||57
2617088|NCT00005947|6425683|P2|COMPLETED|Overall Study||4
2617089|NCT00005947|6425684|P1|COMPLETED|Overall Study||25
2617090|NCT00005947|6425683|P2|STARTED|Overall Study||45
2617091|NCT00005947|6425684|P1|STARTED|Overall Study||82
2617092|NCT00078559|6425692|P1|NOT COMPLETED|Overall Study||0
2617093|NCT00078559|6425692|P1|COMPLETED|Overall Study|1 subject stopped study drug due to a severe but non-serious AE, and completed the trial|10
2617094|NCT00078559|6425692|P1|STARTED|Overall Study||10
2617095|NCT00002597|6425720|P2|NOT COMPLETED|Overall Study||23
2617096|NCT00002597|6425721|P1|NOT COMPLETED|Overall Study||26
2617097|NCT00002597|6425720|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|992
2617098|NCT00002597|6425721|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|987
2617099|NCT00002597|6425720|P2|STARTED|Overall Study||1015
2617100|NCT00002597|6425721|P1|STARTED|Overall Study||1013
2617101|NCT00078377|6425746|P3|NOT COMPLETED|Overall Study||9
2617102|NCT00078377|6425747|P2|NOT COMPLETED|Overall Study||16
2617103|NCT00078377|6425748|P1|NOT COMPLETED|Overall Study||11
2617104|NCT00078377|6425746|P3|COMPLETED|Overall Study||55
2617105|NCT00078377|6425747|P2|COMPLETED|Overall Study||49
2617106|NCT00078377|6425748|P1|COMPLETED|Overall Study||56
2617107|NCT00078377|6425746|P3|STARTED|Overall Study||64
2617108|NCT00078377|6425747|P2|STARTED|Overall Study||65
2617109|NCT00078377|6425748|P1|STARTED|Overall Study||67
2617110|NCT00078338|6425763|P2|NOT COMPLETED|Overall Study||54
2617111|NCT00078338|6425764|P1|NOT COMPLETED|Overall Study||85
2617112|NCT00078338|6425763|P2|COMPLETED|Overall Study||324
2617113|NCT00078338|6425764|P1|COMPLETED|Overall Study||301
2617114|NCT00078338|6425763|P2|Safety Population|Overall Study|Safety population=subjects who received at least 1 dose of treatment and had followup safety data.|375
2617115|NCT00078338|6425764|P1|Safety Population|Overall Study|Safety population=subjects who received at least 1 dose of treatment and had followup safety data.|381
2617116|NCT00078338|6425763|P2|STARTED|Overall Study||378
2617117|NCT00078338|6425764|P1|STARTED|Overall Study||386
2617118|NCT00076687|6425773|P3|NOT COMPLETED|Overall Study||4
2617119|NCT00076687|6425774|P2|NOT COMPLETED|Overall Study||5
2617120|NCT00076687|6425775|P1|NOT COMPLETED|Overall Study||6
2617121|NCT00076687|6425773|P3|COMPLETED|Overall Study||51
2617122|NCT00076687|6425774|P2|COMPLETED|Overall Study||47
2617123|NCT00076687|6425775|P1|COMPLETED|Overall Study||42
2617124|NCT00076687|6425773|P3|STARTED|Overall Study||55
2617125|NCT00076687|6425774|P2|STARTED|Overall Study||52
2617126|NCT00076687|6425775|P1|STARTED|Overall Study||48
2617127|NCT00078403|6425795|P3|NOT COMPLETED|Overall Study||28
2617128|NCT00078403|6425796|P2|NOT COMPLETED|Overall Study||16
2617129|NCT00078403|6425797|P1|NOT COMPLETED|Overall Study||18
2617130|NCT00078403|6425795|P3|COMPLETED|Overall Study||141
2617131|NCT00078403|6425796|P2|COMPLETED|Overall Study||26
2617132|NCT00078403|6425797|P1|COMPLETED|Overall Study||26
2617133|NCT00078403|6425795|P3|STARTED|Overall Study||169
2617134|NCT00078403|6425796|P2|STARTED|Overall Study|Eligible at pre-assignment (40), direct (1), Arm C week 36 non-response (1).|42
2617135|NCT00078403|6425797|P1|STARTED|Overall Study|Eligible at pre-assignment (40), direct (2), Arm C week 36 non-response (1), EVR inadvertently (1).|44
2617136|NCT00078325|6425857|P3|NOT COMPLETED|Overall Study||11
2617137|NCT00078325|6425858|P2|NOT COMPLETED|Overall Study||19
2617138|NCT00078325|6425859|P1|NOT COMPLETED|Overall Study||21
2617139|NCT00078325|6425857|P3|COMPLETED|Overall Study||120
2617140|NCT00078325|6425858|P2|COMPLETED|Overall Study||114
2617141|NCT00078325|6425859|P1|COMPLETED|Overall Study||110
2617142|NCT00078325|6425857|P3|STARTED|Overall Study||131
2617143|NCT00078325|6425858|P2|STARTED|Overall Study||133
2617144|NCT00078325|6425859|P1|STARTED|Overall Study||131
2617145|NCT00078312|6425870|P1|NOT COMPLETED|Overall Study||177
2617146|NCT00078312|6425870|P1|COMPLETED|Overall Study||151
2617147|NCT00078312|6425870|P1|STARTED|Overall Study||328
2617148|NCT00078286|6425876|P2|NOT COMPLETED|Overall Study||83
2617149|NCT00078286|6425877|P1|NOT COMPLETED|Overall Study||96
2617150|NCT00078286|6425876|P2|COMPLETED|Overall Study||152
2617151|NCT00078286|6425877|P1|COMPLETED|Overall Study||138
2617152|NCT00078286|6425876|P2|STARTED|Overall Study||235
2617153|NCT00078286|6425877|P1|STARTED|Overall Study||234
2617154|NCT00077974|6425885|P1|NOT COMPLETED|Overall Study||104
2617155|NCT00077974|6425885|P1|COMPLETED|Overall Study||2
2617156|NCT00077974|6425885|P1|STARTED|Overall Study||106
2617157|NCT00077857|6425902|P2|NOT COMPLETED|Overall Study||204
2617158|NCT00077857|6425903|P1|NOT COMPLETED|Overall Study||201
2617159|NCT00077857|6425902|P2|COMPLETED|Overall Study||31
2617160|NCT00077857|6425903|P1|COMPLETED|Overall Study||34
2617161|NCT00077857|6425902|P2|Safety Population: Actual Dose Received|Overall Study||248
2617162|NCT00077857|6425903|P1|Safety Population: Actual Dose Received|Overall Study|14 patients in the 1250 dose arm received a lower dose and were included in the 825 arm for Safety.|217
2617163|NCT00077857|6425902|P2|Received Study Drug|Overall Study||234
2617164|NCT00077857|6425903|P1|Received Study Drug|Overall Study||231
2617165|NCT00077857|6425902|P2|STARTED|Overall Study||235
2617166|NCT00077857|6425903|P1|STARTED|Overall Study||235
2617167|NCT00077766|6425923|P2|NOT COMPLETED|Overall Study||25
2617168|NCT00077766|6425924|P1|NOT COMPLETED|Overall Study||39
2617169|NCT00077766|6425923|P2|COMPLETED|Overall Study||131
2617170|NCT00077766|6425924|P1|COMPLETED|Overall Study||118
2617171|NCT00077766|6425923|P2|STARTED|Overall Study||156
2617172|NCT00077766|6425924|P1|STARTED|Overall Study||157
2617173|NCT00077922|6425942|P1|NOT COMPLETED|Overall Study||0
2617174|NCT00077922|6425942|P1|COMPLETED|Overall Study||15
2617175|NCT00077922|6425942|P1|STARTED|Overall Study||15
2617176|NCT00077675|6425949|P2|NOT COMPLETED|Overall Study||9
2617177|NCT00077675|6425950|P1|NOT COMPLETED|Overall Study||11
2617178|NCT00077675|6425949|P2|COMPLETED|Overall Study||89
2617179|NCT00077675|6425950|P1|COMPLETED|Overall Study||92
2617180|NCT00077675|6425949|P2|STARTED|Overall Study||98
2617181|NCT00077675|6425950|P1|STARTED|Overall Study||103
2617182|NCT00077649|6425960|P4|NOT COMPLETED|Overall Study||17
2617183|NCT00077649|6425961|P3|NOT COMPLETED|Overall Study||15
2617184|NCT00077649|6425962|P2|NOT COMPLETED|Overall Study||9
2617185|NCT00077649|6425963|P1|NOT COMPLETED|Overall Study||14
2617186|NCT00077649|6425960|P4|COMPLETED|Overall Study||30
2617187|NCT00077649|6425961|P3|COMPLETED|Overall Study||32
2617188|NCT00077649|6425962|P2|COMPLETED|Overall Study||38
2617189|NCT00077649|6425963|P1|COMPLETED|Overall Study||33
2617190|NCT00077649|6425960|P4|Completed 24 Weeks of Follow-up|Overall Study||31
2617191|NCT00077649|6425961|P3|Completed 24 Weeks of Follow-up|Overall Study||36
2617192|NCT00077649|6425962|P2|Completed 24 Weeks of Follow-up|Overall Study||40
2617193|NCT00077649|6425963|P1|Completed 24 Weeks of Follow-up|Overall Study||36
2617194|NCT00077649|6425960|P4|STARTED|Overall Study||47
2617195|NCT00077649|6425961|P3|STARTED|Overall Study||47
2617196|NCT00077649|6425962|P2|STARTED|Overall Study||47
2617197|NCT00077649|6425963|P1|STARTED|Overall Study||47
2617198|NCT00077636|6426011|P2|NOT COMPLETED|Overall Study||92
2617199|NCT00077636|6426012|P1|NOT COMPLETED|Overall Study||44
2617200|NCT00077636|6426011|P2|COMPLETED|Overall Study||641
2617201|NCT00077636|6426012|P1|COMPLETED|Overall Study||692
2617202|NCT00077636|6426011|P2|STARTED|Overall Study||733
2617203|NCT00077636|6426012|P1|STARTED|Overall Study||736
2617204|NCT00077623|6426033|P3|NOT COMPLETED|Overall Study||32
2617205|NCT00077623|6426034|P2|NOT COMPLETED|Overall Study||43
2617206|NCT00077623|6426035|P1|NOT COMPLETED|Overall Study||36
2617207|NCT00077623|6426033|P3|COMPLETED|Overall Study||159
2617208|NCT00077623|6426034|P2|COMPLETED|Overall Study||148
2617209|NCT00077623|6426035|P1|COMPLETED|Overall Study||154
2617210|NCT00077623|6426033|P3|STARTED|Overall Study||191
2617211|NCT00077623|6426034|P2|STARTED|Overall Study||191
2617212|NCT00077623|6426035|P1|STARTED|Overall Study||190
2617213|NCT00077610|6426070|P3|NOT COMPLETED|Overall Study||46
2617214|NCT00077610|6426071|P2|NOT COMPLETED|Overall Study||56
2617215|NCT00077610|6426072|P1|NOT COMPLETED|Overall Study||54
2617216|NCT00077610|6426070|P3|COMPLETED|Overall Study||180
2617217|NCT00077610|6426071|P2|COMPLETED|Overall Study||168
2617218|NCT00077610|6426072|P1|COMPLETED|Overall Study||169
2617219|NCT00077610|6426070|P3|Started Treatment|Overall Study||225
2617220|NCT00077610|6426071|P2|Started Treatment|Overall Study||220
2617221|NCT00077610|6426072|P1|Started Treatment|Overall Study||221
2617222|NCT00077610|6426070|P3|STARTED|Overall Study||226
2617223|NCT00077610|6426071|P2|STARTED|Overall Study||224
2617224|NCT00077610|6426072|P1|STARTED|Overall Study||223
2617225|NCT00077376|6426101|P1|NOT COMPLETED|Overall Study||22
2617226|NCT00077376|6426101|P1|COMPLETED|Overall Study||39
2617227|NCT00077376|6426101|P1|HER2+ in Central Testing|Overall Study||39
2617228|NCT00077376|6426101|P1|Treated|Overall Study||59
2617229|NCT00077376|6426101|P1|STARTED|Overall Study||61
2617230|NCT00077207|6426112|P1|NOT COMPLETED|Overall Study||30
2617231|NCT00077207|6426112|P1|COMPLETED|Overall Study||36
2617232|NCT00077207|6426112|P1|STARTED|Overall Study||66
2617233|NCT00077064|6426124|P2|NOT COMPLETED|Overall Study||6
2617234|NCT00077064|6426125|P1|NOT COMPLETED|Overall Study||0
2617235|NCT00077064|6426124|P2|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|10
2617236|NCT00077064|6426125|P1|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|17
2617237|NCT00077064|6426124|P2|STARTED|Overall Study||16
2617238|NCT00077064|6426125|P1|STARTED|Overall Study||17
2617239|NCT00076999|6426141|P5|NOT COMPLETED|Overall Study||25
2617240|NCT00076999|6426142|P4|NOT COMPLETED|Overall Study||1
2617241|NCT00076999|6426143|P3|NOT COMPLETED|Overall Study||17
2617242|NCT00076999|6426144|P2|NOT COMPLETED|Overall Study||24
2617243|NCT00076999|6426145|P1|NOT COMPLETED|Overall Study||12
2617244|NCT00076999|6426141|P5|COMPLETED|Overall Study||9
2617245|NCT00076999|6426142|P4|COMPLETED|Overall Study||5
2617246|NCT00076999|6426143|P3|COMPLETED|Overall Study||2
2617247|NCT00076999|6426144|P2|COMPLETED|Overall Study||7
2617248|NCT00076999|6426145|P1|COMPLETED|Overall Study||13
2617249|NCT00076999|6426141|P5|STARTED|Overall Study||34
2617250|NCT00076999|6426142|P4|STARTED|Overall Study||6
2617251|NCT00076999|6426143|P3|STARTED|Overall Study||19
2617252|NCT00076999|6426144|P2|STARTED|Overall Study||31
2617253|NCT00076999|6426145|P1|STARTED|Overall Study||25
2617254|NCT00003222|6426264|P2|NOT COMPLETED|Overall Study||1
2617255|NCT00003222|6426265|P1|NOT COMPLETED|Overall Study||0
2617256|NCT00003222|6426264|P2|COMPLETED|Overall Study|Decline in performance status between enrollment and initiation of therapy.|27
2617257|NCT00003222|6426265|P1|COMPLETED|Overall Study||13
2617258|NCT00003222|6426264|P2|STARTED|Overall Study||28
2617259|NCT00003222|6426265|P1|STARTED|Overall Study||13
2617260|NCT00076804|6426277|P2|NOT COMPLETED|Overall Study||69
2617261|NCT00076804|6426278|P1|NOT COMPLETED|Overall Study||60
2617262|NCT00076804|6426277|P2|COMPLETED|Overall Study|102 completed week 48, 68 completed week 96|68
2617263|NCT00076804|6426278|P1|COMPLETED|Overall Study|111 completed week 48, 77 completed week 96.|77
2617264|NCT00076804|6426277|P2|STARTED|Overall Study||137
2617265|NCT00076804|6426278|P1|STARTED|Overall Study||137
2617266|NCT00076752|6426290|P1|NOT COMPLETED|Overall Study||3
2617267|NCT00076752|6426290|P1|COMPLETED|Overall Study||6
2617268|NCT00076752|6426290|P1|STARTED|Overall Study||9
2617269|NCT00076622|6426313|P4|NOT COMPLETED|Overall Study||0
2617270|NCT00076622|6426314|P3|NOT COMPLETED|Overall Study||0
2617271|NCT00076622|6426315|P2|NOT COMPLETED|Overall Study||0
2617272|NCT00076622|6426316|P1|NOT COMPLETED|Overall Study||0
2617273|NCT00076622|6426313|P4|COMPLETED|Overall Study||18
2617274|NCT00076622|6426314|P3|COMPLETED|Overall Study||40
2617275|NCT00076622|6426315|P2|COMPLETED|Overall Study||13
2617276|NCT00076622|6426316|P1|COMPLETED|Overall Study||23
2617277|NCT00076622|6426313|P4|STARTED|Overall Study||18
2617278|NCT00076622|6426314|P3|STARTED|Overall Study||40
2617279|NCT00076622|6426315|P2|STARTED|Overall Study||13
2617280|NCT00076622|6426316|P1|STARTED|Overall Study||23
2617281|NCT00076570|6426336|P2|NOT COMPLETED|Overall Study||8
2617282|NCT00076570|6426337|P1|NOT COMPLETED|Overall Study||8
2617283|NCT00076570|6426336|P2|COMPLETED|Overall Study||8
2617284|NCT00076570|6426337|P1|COMPLETED|Overall Study||7
2617285|NCT00076570|6426336|P2|STARTED|Overall Study||16
2617286|NCT00076570|6426337|P1|STARTED|Overall Study||15
2617287|NCT00003298|6426345|P1|NOT COMPLETED|Step 2 (Adjuvant Therapy)||6
2617288|NCT00003298|6426345|P1|COMPLETED|Step 2 (Adjuvant Therapy)||4
2617289|NCT00003298|6426345|P1|Eligible and Treated on Step 2|Step 2 (Adjuvant Therapy)||7
2617290|NCT00003298|6426345|P1|STARTED|Step 2 (Adjuvant Therapy)||10
2617291|NCT00003298|6426345|P1|NOT COMPLETED|Re-register to Step 2 After Surgery||18
2617292|NCT00003298|6426345|P1|COMPLETED|Re-register to Step 2 After Surgery||10
2617293|NCT00003298|6426345|P1|STARTED|Re-register to Step 2 After Surgery||28
2617294|NCT00003298|6426345|P1|NOT COMPLETED|Surgery||7
2617295|NCT00003298|6426345|P1|COMPLETED|Surgery|1 patient did not complete neoadjuvant therapy but went to surgery anyway, not included here.|28
2617296|NCT00003298|6426345|P1|STARTED|Surgery||35
2617297|NCT00003298|6426345|P1|NOT COMPLETED|Step 1 (Neoadjuvant Therapy)||4
2617298|NCT00003298|6426345|P1|COMPLETED|Step 1 (Neoadjuvant Therapy)||35
2617299|NCT00003298|6426345|P1|Complete 3 Cycles of Neoadjuvant Therapy|Step 1 (Neoadjuvant Therapy)||35
2617300|NCT00003298|6426345|P1|Eligible and Treated|Step 1 (Neoadjuvant Therapy)||38
2617301|NCT00003298|6426345|P1|STARTED|Step 1 (Neoadjuvant Therapy)||39
2617302|NCT00076336|6426355|P2|NOT COMPLETED|Overall Study||56
2617303|NCT00076336|6426356|P1|NOT COMPLETED|Overall Study||52
2617304|NCT00076336|6426355|P2|COMPLETED|Overall Study||60
2617305|NCT00076336|6426356|P1|COMPLETED|Overall Study||64
2617306|NCT00076336|6426355|P2|Completed Week 104|Overall Study||62
2617307|NCT00076336|6426356|P1|Completed Week 104|Overall Study||70
2617308|NCT00076336|6426355|P2|Completed Week 52|Overall Study||94
2617309|NCT00076336|6426356|P1|Completed Week 52|Overall Study||97
2617310|NCT00076336|6426355|P2|Intent to Treat (ITT) Population|Overall Study|2 patients had no HBV DNA assessments after baseline and were excluded from ITT population.|114
2617311|NCT00076336|6426356|P1|Intent to Treat (ITT) Population|Overall Study|1 patient had no HBV DNA assessments after baseline and was excluded from ITT population.|114
2617312|NCT00076336|6426355|P2|Safety Population|Overall Study||116
2617313|NCT00076336|6426356|P1|Safety Population|Overall Study|1 patient was randomized but never received study drug and not included in safety population.|115
2617314|NCT00076336|6426355|P2|STARTED|Overall Study||116
2617315|NCT00076336|6426356|P1|STARTED|Overall Study||116
2617316|NCT00076258|6426372|P2|NOT COMPLETED|Overall Study||3
2617317|NCT00076258|6426373|P1|NOT COMPLETED|Overall Study||1
2617318|NCT00076258|6426372|P2|COMPLETED|Overall Study||61
2617319|NCT00076258|6426373|P1|COMPLETED|Overall Study||61
2617320|NCT00076258|6426372|P2|STARTED|Overall Study||64
2617321|NCT00076258|6426373|P1|STARTED|Overall Study||62
2617322|NCT00076245|6426383|P4|NOT COMPLETED|Overall Study||1
2617323|NCT00076245|6426384|P3|NOT COMPLETED|Overall Study||0
2617324|NCT00076245|6426385|P2|NOT COMPLETED|Overall Study||0
2617325|NCT00076245|6426386|P1|NOT COMPLETED|Overall Study||0
2617326|NCT00076245|6426383|P4|COMPLETED|Overall Study||14
2617327|NCT00076245|6426384|P3|COMPLETED|Overall Study||15
2617328|NCT00076245|6426385|P2|COMPLETED|Overall Study||15
2617329|NCT00076245|6426386|P1|COMPLETED|Overall Study||16
2617330|NCT00076245|6426383|P4|STARTED|Overall Study||15
2617331|NCT00076245|6426384|P3|STARTED|Overall Study||15
2617332|NCT00076245|6426385|P2|STARTED|Overall Study||15
2617333|NCT00076245|6426386|P1|STARTED|Overall Study||16
2617334|NCT00076219|6426402|P2|NOT COMPLETED|Overall Study||11
2617335|NCT00076219|6426403|P1|NOT COMPLETED|Overall Study||18
2617336|NCT00076219|6426402|P2|COMPLETED|Overall Study||550
2617337|NCT00076219|6426403|P1|COMPLETED|Overall Study||545
2617338|NCT00076219|6426402|P2|STARTED|Overall Study||561
2617339|NCT00076219|6426403|P1|STARTED|Overall Study||563
2617340|NCT00076102|6426409|P1|NOT COMPLETED|Overall Study||5
2617341|NCT00076102|6426409|P1|COMPLETED|Overall Study||31
2617342|NCT00076102|6426409|P1|STARTED|Overall Study||36
2617343|NCT00076050|6426423|P2|NOT COMPLETED|Overall Study||43
2617344|NCT00076050|6426424|P1|NOT COMPLETED|Overall Study||23
2617345|NCT00076050|6426423|P2|COMPLETED|Overall Study||83
2617346|NCT00076050|6426424|P1|COMPLETED|Overall Study||99
2617347|NCT00076050|6426423|P2|STARTED|Overall Study||126
2617348|NCT00076050|6426424|P1|STARTED|Overall Study||122
2617349|NCT00076024|6426437|P4|NOT COMPLETED|Phase 2, Open-label||16
2617350|NCT00076024|6426438|P3|NOT COMPLETED|Phase 2, Open-label||0
2617351|NCT00076024|6426439|P2|NOT COMPLETED|Phase 2, Open-label||0
2617352|NCT00076024|6426440|P1|NOT COMPLETED|Phase 2, Open-label||0
2617353|NCT00076024|6426437|P4|COMPLETED|Phase 2, Open-label||0
2617354|NCT00076024|6426438|P3|COMPLETED|Phase 2, Open-label||0
2617355|NCT00076024|6426439|P2|COMPLETED|Phase 2, Open-label||0
2617356|NCT00076024|6426440|P1|COMPLETED|Phase 2, Open-label||0
2617357|NCT00076024|6426437|P4|STARTED|Phase 2, Open-label||16
2617358|NCT00076024|6426438|P3|STARTED|Phase 2, Open-label||0
2617359|NCT00076024|6426439|P2|STARTED|Phase 2, Open-label||0
2617360|NCT00076024|6426440|P1|STARTED|Phase 2, Open-label||0
2617361|NCT00076024|6426437|P4|NOT COMPLETED|Phase 2, Double-blind||0
2617362|NCT00076024|6426438|P3|NOT COMPLETED|Phase 2, Double-blind||56
2617363|NCT00076024|6426439|P2|NOT COMPLETED|Phase 2, Double-blind||112
2617364|NCT00076024|6426440|P1|NOT COMPLETED|Phase 2, Double-blind||0
2617365|NCT00076024|6426437|P4|COMPLETED|Phase 2, Double-blind||0
2617366|NCT00076024|6426438|P3|COMPLETED|Phase 2, Double-blind||0
2617367|NCT00076024|6426439|P2|COMPLETED|Phase 2, Double-blind||0
2617368|NCT00076024|6426440|P1|COMPLETED|Phase 2, Double-blind||0
2617369|NCT00076024|6426437|P4|Treated|Phase 2, Double-blind||0
2617370|NCT00076024|6426438|P3|Treated|Phase 2, Double-blind||56
2617371|NCT00076024|6426439|P2|Treated|Phase 2, Double-blind||111
2617372|NCT00076024|6426440|P1|Treated|Phase 2, Double-blind||0
2617373|NCT00076024|6426437|P4|STARTED|Phase 2, Double-blind||0
2617374|NCT00076024|6426438|P3|STARTED|Phase 2, Double-blind||56
2617375|NCT00076024|6426439|P2|STARTED|Phase 2, Double-blind||112
2617376|NCT00076024|6426440|P1|STARTED|Phase 2, Double-blind||0
2617377|NCT00076024|6426437|P4|NOT COMPLETED|Phase 1, Lead-in||0
2617378|NCT00076024|6426438|P3|NOT COMPLETED|Phase 1, Lead-in||0
2617379|NCT00076024|6426439|P2|NOT COMPLETED|Phase 1, Lead-in||0
2617380|NCT00076024|6426440|P1|NOT COMPLETED|Phase 1, Lead-in||6
2617381|NCT00076024|6426437|P4|COMPLETED|Phase 1, Lead-in||0
2617382|NCT00076024|6426438|P3|COMPLETED|Phase 1, Lead-in||0
2617383|NCT00076024|6426439|P2|COMPLETED|Phase 1, Lead-in||0
2617384|NCT00076024|6426440|P1|COMPLETED|Phase 1, Lead-in||0
2617385|NCT00076024|6426437|P4|STARTED|Phase 1, Lead-in||0
2617386|NCT00076024|6426438|P3|STARTED|Phase 1, Lead-in||0
2617387|NCT00076024|6426439|P2|STARTED|Phase 1, Lead-in||0
2617388|NCT00076024|6426440|P1|STARTED|Phase 1, Lead-in||6
2617389|NCT00076011|6426454|P1|NOT COMPLETED|Overall Study||52
2617390|NCT00076011|6426454|P1|COMPLETED|Overall Study||0
2617391|NCT00076011|6426454|P1|STARTED|Overall Study||52
2617392|NCT00075946|6426466|P5|NOT COMPLETED|Overall Study||188
2617393|NCT00075946|6426467|P4|NOT COMPLETED|Overall Study||30
2617394|NCT00075946|6426468|P3|NOT COMPLETED|Overall Study||28
2617395|NCT00075946|6426469|P2|NOT COMPLETED|Overall Study||151
2617396|NCT00075946|6426470|P1|NOT COMPLETED|Overall Study||148
2617397|NCT00075946|6426466|P5|COMPLETED|Overall Study||0
2617398|NCT00075946|6426467|P4|COMPLETED|Overall Study||0
2617399|NCT00075946|6426468|P3|COMPLETED|Overall Study||0
2617400|NCT00075946|6426469|P2|COMPLETED|Overall Study||0
2617401|NCT00075946|6426470|P1|COMPLETED|Overall Study||0
2617402|NCT00075946|6426466|P5|Included in Primary Analysis|Overall Study||0
2617403|NCT00075946|6426467|P4|Included in Primary Analysis|Overall Study||29
2617404|NCT00075946|6426468|P3|Included in Primary Analysis|Overall Study||23
2617405|NCT00075946|6426469|P2|Included in Primary Analysis|Overall Study||146
2617406|NCT00075946|6426470|P1|Included in Primary Analysis|Overall Study||143
2617407|NCT00075946|6426466|P5|Treated and With Toxicity Data Available|Overall Study||154
2617408|NCT00075946|6426467|P4|Treated and With Toxicity Data Available|Overall Study||29
2617409|NCT00075946|6426468|P3|Treated and With Toxicity Data Available|Overall Study||27
2617410|NCT00075946|6426469|P2|Treated and With Toxicity Data Available|Overall Study||148
2617411|NCT00075946|6426470|P1|Treated and With Toxicity Data Available|Overall Study||142
2617412|NCT00075946|6426466|P5|STARTED|Overall Study||188
2617413|NCT00075946|6426467|P4|STARTED|Overall Study||30
2617414|NCT00075946|6426468|P3|STARTED|Overall Study||28
2617415|NCT00075946|6426469|P2|STARTED|Overall Study||151
2617416|NCT00075946|6426470|P1|STARTED|Overall Study||148
2617417|NCT00075881|6426485|P1|NOT COMPLETED|Overall Study||43
2617418|NCT00075881|6426485|P1|COMPLETED|Overall Study||1
2617419|NCT00075881|6426485|P1|Reinduction Treatment|Overall Study||7
2617420|NCT00075881|6426485|P1|Maintenance Treatment|Overall Study||15
2617421|NCT00075881|6426485|P1|Induction Treatment|Overall Study||42
2617422|NCT00075881|6426485|P1|Treated|Overall Study||42
2617423|NCT00075881|6426485|P1|Eligible|Overall Study||43
2617424|NCT00075881|6426485|P1|STARTED|Overall Study||44
2617425|NCT00075829|6426496|P4|NOT COMPLETED|Overall Study||24
2617426|NCT00075829|6426497|P3|NOT COMPLETED|Overall Study||34
2617427|NCT00075829|6426498|P2|NOT COMPLETED|Overall Study||118
2617428|NCT00075829|6426499|P1|NOT COMPLETED|Overall Study||258
2617429|NCT00075829|6426496|P4|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|13
2617430|NCT00075829|6426497|P3|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|14
2617431|NCT00075829|6426498|P2|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|71
2617432|NCT00075829|6426499|P1|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|178
2617433|NCT00075829|6426496|P4|STARTED|Overall Study||37
2617434|NCT00075829|6426497|P3|STARTED|Overall Study||48
2617435|NCT00075829|6426498|P2|STARTED|Overall Study||189
2617436|NCT00075829|6426499|P1|STARTED|Overall Study||436
2617437|NCT00075816|6426529|P2|NOT COMPLETED|Overall Study||11
2617438|NCT00075816|6426530|P1|NOT COMPLETED|Overall Study||14
2617439|NCT00075816|6426529|P2|COMPLETED|Overall Study||262
2617440|NCT00075816|6426530|P1|COMPLETED|Overall Study||264
2617441|NCT00075816|6426529|P2|STARTED|Overall Study||273
2617442|NCT00075816|6426530|P1|STARTED|Overall Study||278
2617443|NCT00075803|6426570|P2|NOT COMPLETED|Overall Study||0
2617444|NCT00075803|6426571|P1|NOT COMPLETED|Overall Study||0
2617445|NCT00075803|6426570|P2|COMPLETED|Overall Study||305
2617446|NCT00075803|6426571|P1|COMPLETED|Overall Study||295
2617447|NCT00075803|6426570|P2|STARTED|Overall Study||305
2617448|NCT00075803|6426571|P1|STARTED|Overall Study||295
2617449|NCT00075764|6426599|P2|NOT COMPLETED|Overall Study||349
2617450|NCT00075764|6426600|P1|NOT COMPLETED|Overall Study||345
2617451|NCT00075764|6426599|P2|COMPLETED|Overall Study||0
2617452|NCT00075764|6426600|P1|COMPLETED|Overall Study||0
2617453|NCT00075764|6426599|P2|STARTED|Overall Study||349
2617454|NCT00075764|6426600|P1|STARTED|Overall Study||345
2617455|NCT00075725|6426624|P12|NOT COMPLETED|Overall Study||18
2617456|NCT00075725|6426625|P11|NOT COMPLETED|Overall Study||9
2617457|NCT00075725|6426626|P10|NOT COMPLETED|Overall Study||18
2617458|NCT00075725|6426627|P9|NOT COMPLETED|Overall Study||117
2617459|NCT00075725|6426628|P8|NOT COMPLETED|Overall Study||295
2617460|NCT00075725|6426629|P7|NOT COMPLETED|Overall Study||75
2617461|NCT00075725|6426630|P6|NOT COMPLETED|Overall Study||313
2617462|NCT00075725|6426631|P5|NOT COMPLETED|Overall Study||66
2617463|NCT00075725|6426632|P4|NOT COMPLETED|Overall Study||78
2617464|NCT00075725|6426633|P3|NOT COMPLETED|Overall Study||121
2617465|NCT00075725|6426634|P2|NOT COMPLETED|Overall Study||49
2617466|NCT00075725|6426635|P1|NOT COMPLETED|Overall Study||74
2617467|NCT00075725|6426624|P12|COMPLETED|Overall Study||10
2617468|NCT00075725|6426625|P11|COMPLETED|Overall Study||3
2617469|NCT00075725|6426626|P10|COMPLETED|Overall Study||16
2617470|NCT00075725|6426627|P9|COMPLETED|Overall Study||185
2617471|NCT00075725|6426628|P8|COMPLETED|Overall Study||401
2617472|NCT00075725|6426629|P7|COMPLETED|Overall Study||171
2617473|NCT00075725|6426630|P6|COMPLETED|Overall Study||397
2617474|NCT00075725|6426631|P5|COMPLETED|Overall Study||166
2617475|NCT00075725|6426632|P4|COMPLETED|Overall Study||168
2617476|NCT00075725|6426633|P3|COMPLETED|Overall Study||175
2617477|NCT00075725|6426634|P2|COMPLETED|Overall Study||57
2617478|NCT00075725|6426635|P1|COMPLETED|Overall Study||172
2617479|NCT00075725|6426624|P12|STARTED|Overall Study||28
2617480|NCT00075725|6426625|P11|STARTED|Overall Study||12
2617481|NCT00075725|6426626|P10|STARTED|Overall Study||34
2617482|NCT00075725|6426627|P9|STARTED|Overall Study||302
2617483|NCT00075725|6426628|P8|STARTED|Overall Study||696
2617484|NCT00075725|6426629|P7|STARTED|Overall Study||246
2617485|NCT00075725|6426630|P6|STARTED|Overall Study||710
2617486|NCT00075725|6426631|P5|STARTED|Overall Study||232
2617487|NCT00075725|6426632|P4|STARTED|Overall Study||246
2617488|NCT00075725|6426633|P3|STARTED|Overall Study||296
2617489|NCT00075725|6426634|P2|STARTED|Overall Study||106
2617490|NCT00075725|6426635|P1|STARTED|Overall Study||246
2617491|NCT00075608|6426724|P1|NOT COMPLETED|Overall Study||0
2617492|NCT00075608|6426724|P1|COMPLETED|Overall Study||12
2617493|NCT00075608|6426724|P1|STARTED|Overall Study||12
2617494|NCT00075582|6426732|P2|NOT COMPLETED|Overall Study||35
2617495|NCT00075582|6426733|P1|NOT COMPLETED|Overall Study||50
2617496|NCT00075582|6426732|P2|COMPLETED|Overall Study||50
2617497|NCT00075582|6426733|P1|COMPLETED|Overall Study||255
2617498|NCT00075582|6426732|P2|STARTED|Overall Study||85
2617499|NCT00075582|6426733|P1|STARTED|Overall Study||305
2617500|NCT00075504|6426747|P2|NOT COMPLETED|Overall Study||7
2617501|NCT00075504|6426748|P1|NOT COMPLETED|Overall Study||9
2617502|NCT00075504|6426747|P2|COMPLETED|Overall Study||3
2617503|NCT00075504|6426748|P1|COMPLETED|Overall Study||14
2617504|NCT00075504|6426747|P2|STARTED|Overall Study||10
2617505|NCT00075504|6426748|P1|STARTED|Overall Study||23
2617506|NCT00075478|6426760|P2|NOT COMPLETED|Overall Study||1
2617507|NCT00075478|6426761|P1|NOT COMPLETED|Overall Study||1
2617508|NCT00075478|6426760|P2|COMPLETED|Overall Study||44
2617509|NCT00075478|6426761|P1|COMPLETED|Overall Study||41
2617510|NCT00075478|6426760|P2|STARTED|Overall Study||45
2617511|NCT00075478|6426761|P1|STARTED|Overall Study||42
2617512|NCT00075400|6426781|P1|NOT COMPLETED|Overall Study||3
2617513|NCT00075400|6426781|P1|COMPLETED|Overall Study|Eligible and treated patients.|23
2617514|NCT00075400|6426781|P1|STARTED|Overall Study||26
2617515|NCT00075335|6426795|P1|NOT COMPLETED|Overall Study||0
2617516|NCT00075335|6426795|P1|COMPLETED|Overall Study||8
2617517|NCT00075335|6426795|P1|STARTED|Overall Study||8
2617518|NCT00075270|6426802|P2|NOT COMPLETED|Overall Study||284
2617519|NCT00075270|6426803|P1|NOT COMPLETED|Overall Study||286
2617520|NCT00075270|6426802|P2|COMPLETED|Overall Study||4
2617521|NCT00075270|6426803|P1|COMPLETED|Overall Study||5
2617522|NCT00075270|6426802|P2|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|13
2617523|NCT00075270|6426803|P1|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|26
2617524|NCT00075270|6426802|P2|STARTED|Overall Study||288
2617525|NCT00075270|6426803|P1|STARTED|Overall Study||291
2617526|NCT00075218|6426849|P3|NOT COMPLETED|Open-Label Treatment||255
2617527|NCT00075218|6426850|P2|NOT COMPLETED|Open-Label Treatment||0
2617528|NCT00075218|6426851|P1|NOT COMPLETED|Open-Label Treatment||0
2617529|NCT00075218|6426849|P3|COMPLETED|Open-Label Treatment||0
2617530|NCT00075218|6426850|P2|COMPLETED|Open-Label Treatment||0
2617531|NCT00075218|6426851|P1|COMPLETED|Open-Label Treatment||0
2617532|NCT00075218|6426849|P3|STARTED|Open-Label Treatment||255
2617533|NCT00075218|6426850|P2|STARTED|Open-Label Treatment||0
2617534|NCT00075218|6426851|P1|STARTED|Open-Label Treatment||0
2617535|NCT00075218|6426849|P3|NOT COMPLETED|Double-Blind Treatment||0
2617536|NCT00075218|6426850|P2|NOT COMPLETED|Double-Blind Treatment||15
2617537|NCT00075218|6426851|P1|NOT COMPLETED|Double-Blind Treatment||91
2617538|NCT00075218|6426849|P3|COMPLETED|Double-Blind Treatment||0
2617539|NCT00075218|6426850|P2|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|103
2617540|NCT00075218|6426851|P1|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|152
2617541|NCT00075218|6426849|P3|Crossed Over to Open-Label Treatment|Double-Blind Treatment||0
2617542|NCT00075218|6426850|P2|Crossed Over to Open-Label Treatment|Double-Blind Treatment||103
2617543|NCT00075218|6426851|P1|Crossed Over to Open-Label Treatment|Double-Blind Treatment||152
2617544|NCT00075218|6426849|P3|Received Double-Blind Treatment|Double-Blind Treatment||0
2617545|NCT00075218|6426850|P2|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|114
2617546|NCT00075218|6426851|P1|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|228
2617547|NCT00075218|6426849|P3|STARTED|Double-Blind Treatment||0
2617548|NCT00075218|6426850|P2|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|118
2617549|NCT00075218|6426851|P1|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|243
2617550|NCT00075088|6426886|P2|NOT COMPLETED|Overall Study||0
2617551|NCT00075088|6426887|P1|NOT COMPLETED|Overall Study||0
2617552|NCT00075088|6426886|P2|COMPLETED|Overall Study||391
2617553|NCT00075088|6426887|P1|COMPLETED|Overall Study||403
2617554|NCT00075088|6426886|P2|STARTED|Overall Study||391
2617555|NCT00075088|6426887|P1|STARTED|Overall Study||403
2617556|NCT00075023|6426900|P2|NOT COMPLETED|Part Two||0
2617557|NCT00075023|6426901|P1|NOT COMPLETED|Part Two||0
2617558|NCT00075023|6426900|P2|COMPLETED|Part Two||0
2617559|NCT00075023|6426901|P1|COMPLETED|Part Two||0
2617560|NCT00075023|6426900|P2|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
2617561|NCT00075023|6426901|P1|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
2617562|NCT00075023|6426900|P2|NOT COMPLETED|Pilot Study||2
2617563|NCT00075023|6426901|P1|NOT COMPLETED|Pilot Study||2
2617564|NCT00075023|6426900|P2|COMPLETED|Pilot Study||3
2617565|NCT00075023|6426901|P1|COMPLETED|Pilot Study||3
2617566|NCT00075023|6426900|P2|STARTED|Pilot Study||5
2617567|NCT00075023|6426901|P1|STARTED|Pilot Study||5
2617568|NCT00074984|6426910|P2|NOT COMPLETED|Overall Study||8
2617569|NCT00074984|6426911|P1|NOT COMPLETED|Overall Study||3
2617570|NCT00074984|6426910|P2|COMPLETED|Overall Study||43
2617571|NCT00074984|6426911|P1|COMPLETED|Overall Study||28
2617572|NCT00074984|6426910|P2|STARTED|Overall Study||51
2617573|NCT00074984|6426911|P1|STARTED|Overall Study||31
2617574|NCT00074958|6426926|P1|NOT COMPLETED|Overall Study||1
2617575|NCT00074958|6426926|P1|COMPLETED|Overall Study||15
2617576|NCT00074958|6426926|P1|STARTED|Overall Study||16
2617577|NCT00074815|6426934|P3|NOT COMPLETED|Overall Study||12
2617578|NCT00074815|6426935|P2|NOT COMPLETED|Overall Study||6
2617579|NCT00074815|6426936|P1|NOT COMPLETED|Overall Study||5
2617580|NCT00074815|6426934|P3|COMPLETED|Overall Study||30
2617581|NCT00074815|6426935|P2|COMPLETED|Overall Study||34
2617582|NCT00074815|6426936|P1|COMPLETED|Overall Study||37
2617583|NCT00074815|6426934|P3|STARTED|Overall Study||42
2617584|NCT00074815|6426935|P2|STARTED|Overall Study||40
2617585|NCT00074815|6426936|P1|STARTED|Overall Study||42
2617586|NCT00074802|6426946|P2|NOT COMPLETED|Overall Study||7
2617587|NCT00074802|6426947|P1|NOT COMPLETED|Overall Study||9
2617588|NCT00074802|6426946|P2|COMPLETED|Overall Study||25
2617589|NCT00074802|6426947|P1|COMPLETED|Overall Study||20
2617590|NCT00074802|6426946|P2|STARTED|Overall Study||32
2617591|NCT00074802|6426947|P1|STARTED|Overall Study||29
2617592|NCT00074711|6426967|P2|NOT COMPLETED|Overall Study||15
2617593|NCT00074711|6426968|P1|NOT COMPLETED|Overall Study||15
2617594|NCT00074711|6426967|P2|COMPLETED|Overall Study||106
2617595|NCT00074711|6426968|P1|COMPLETED|Overall Study||105
2617596|NCT00074711|6426967|P2|STARTED|Overall Study||121
2617597|NCT00074711|6426968|P1|STARTED|Overall Study||120
2617598|NCT00074581|6426986|P2|NOT COMPLETED|Overall Study||226
2617599|NCT00074581|6426987|P1|NOT COMPLETED|Overall Study||244
2617600|NCT00074581|6426986|P2|COMPLETED|Overall Study||1541
2617601|NCT00074581|6426987|P1|COMPLETED|Overall Study||1545
2617602|NCT00074581|6426986|P2|STARTED|Overall Study|877 HIV-infected index cases and 890 HIV-uninfected partners|1767
2617603|NCT00074581|6426987|P1|STARTED|Overall Study|886 HIV-infected index cases and 903 HIV-uninfected partners|1789
2617604|NCT00074490|6427000|P6|NOT COMPLETED|Overall Study||0
2617605|NCT00074490|6427001|P5|NOT COMPLETED|Overall Study||3
2617606|NCT00074490|6427002|P4|NOT COMPLETED|Overall Study||0
2617607|NCT00074490|6427003|P3|NOT COMPLETED|Overall Study||0
2617608|NCT00074490|6427004|P2|NOT COMPLETED|Overall Study||7
2617609|NCT00074490|6427005|P1|NOT COMPLETED|Overall Study||0
2617610|NCT00074490|6427000|P6|COMPLETED|Overall Study||221
2617611|NCT00074490|6427001|P5|COMPLETED|Overall Study||42
2617612|NCT00074490|6427002|P4|COMPLETED|Overall Study||44
2617613|NCT00074490|6427003|P3|COMPLETED|Overall Study||40
2617614|NCT00074490|6427004|P2|COMPLETED|Overall Study||27
2617615|NCT00074490|6427005|P1|COMPLETED|Overall Study||1
2617616|NCT00074490|6427000|P6|STARTED|Overall Study||221
2617617|NCT00074490|6427001|P5|STARTED|Overall Study||45
2617618|NCT00074490|6427002|P4|STARTED|Overall Study||44
2617619|NCT00074490|6427003|P3|STARTED|Overall Study||40
2617620|NCT00074490|6427004|P2|STARTED|Overall Study||34
2617621|NCT00074490|6427005|P1|STARTED|Overall Study||1
2617622|NCT00074412|6427039|P2|NOT COMPLETED|Overall Study||84
2617623|NCT00074412|6427040|P1|NOT COMPLETED|Overall Study||82
2617624|NCT00074412|6427039|P2|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|675
2617625|NCT00074412|6427040|P1|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|681
2617626|NCT00074412|6427039|P2|Month 12 Visit|Overall Study||735
2617627|NCT00074412|6427040|P1|Month 12 Visit|Overall Study||733
2617628|NCT00074412|6427039|P2|Month 9 Visit|Overall Study||741
2617629|NCT00074412|6427040|P1|Month 9 Visit|Overall Study||741
2617630|NCT00074412|6427039|P2|Month 6 Visit|Overall Study||748
2617631|NCT00074412|6427040|P1|Month 6 Visit|Overall Study||748
2617632|NCT00074412|6427039|P2|Month 5 Visit|Overall Study||750
2617633|NCT00074412|6427040|P1|Month 5 Visit|Overall Study||756
2617634|NCT00074412|6427039|P2|Month 4 Visit|Overall Study||752
2617635|NCT00074412|6427040|P1|Month 4 Visit|Overall Study||758
2617636|NCT00074412|6427039|P2|Month 3 Visit|Overall Study||755
2617637|NCT00074412|6427040|P1|Month 3 Visit|Overall Study||759
2617638|NCT00074412|6427039|P2|Week 8 Visit|Overall Study||759
2617639|NCT00074412|6427040|P1|Week 8 Visit|Overall Study||759
2617640|NCT00074412|6427039|P2|STARTED|Overall Study|Number of infants randomized at 6 weeks.|759
2617641|NCT00074412|6427040|P1|STARTED|Overall Study|Number of infants randomized at 6 weeks.|763
2617642|NCT00074308|6427056|P5|NOT COMPLETED|Overall Study||0
2617643|NCT00074308|6427057|P4|NOT COMPLETED|Overall Study||0
2617644|NCT00074308|6427058|P3|NOT COMPLETED|Overall Study||0
2617645|NCT00074308|6427059|P2|NOT COMPLETED|Overall Study||0
2617646|NCT00074308|6427060|P1|NOT COMPLETED|Overall Study||0
2617647|NCT00074308|6427056|P5|COMPLETED|Overall Study||23
2617648|NCT00074308|6427057|P4|COMPLETED|Overall Study||8
2617649|NCT00074308|6427058|P3|COMPLETED|Overall Study||3
2617650|NCT00074308|6427059|P2|COMPLETED|Overall Study||3
2617651|NCT00074308|6427060|P1|COMPLETED|Overall Study||3
2617652|NCT00074308|6427056|P5|STARTED|Overall Study||23
2617653|NCT00074308|6427057|P4|STARTED|Overall Study||8
2617654|NCT00074308|6427058|P3|STARTED|Overall Study||3
2617655|NCT00074308|6427059|P2|STARTED|Overall Study||3
2617656|NCT00074308|6427060|P1|STARTED|Overall Study||3
2617657|NCT00074282|6427071|P3|NOT COMPLETED|Step 2||24
2617658|NCT00074282|6427072|P2|NOT COMPLETED|Step 2||2
2617659|NCT00074282|6427073|P1|NOT COMPLETED|Step 2||0
2617660|NCT00074282|6427071|P3|COMPLETED|Step 2||7
2617661|NCT00074282|6427072|P2|COMPLETED|Step 2||7
2617662|NCT00074282|6427073|P1|COMPLETED|Step 2||0
2617663|NCT00074282|6427071|P3|STARTED|Step 2||31
2617664|NCT00074282|6427072|P2|STARTED|Step 2||9
2617665|NCT00074282|6427073|P1|STARTED|Step 2||0
2617666|NCT00074282|6427071|P3|NOT COMPLETED|Step 1||0
2617667|NCT00074282|6427072|P2|NOT COMPLETED|Step 1||0
2617668|NCT00074282|6427073|P1|NOT COMPLETED|Step 1||58
2617669|NCT00074282|6427071|P3|COMPLETED|Step 1||0
2617670|NCT00074282|6427072|P2|COMPLETED|Step 1||0
2617671|NCT00074282|6427073|P1|COMPLETED|Step 1||44
2617672|NCT00074282|6427071|P3|Started Treatment|Step 1||0
2617673|NCT00074282|6427072|P2|Started Treatment|Step 1||0
2617674|NCT00074282|6427073|P1|Started Treatment|Step 1||96
2617675|NCT00074282|6427071|P3|Eligible|Step 1||0
2617676|NCT00074282|6427072|P2|Eligible|Step 1||0
2617677|NCT00074282|6427073|P1|Eligible|Step 1||98
2617678|NCT00074282|6427071|P3|STARTED|Step 1||0
2617679|NCT00074282|6427072|P2|STARTED|Step 1||0
2617680|NCT00074282|6427073|P1|STARTED|Step 1||102
2617681|NCT00074269|6427082|P1|NOT COMPLETED|Overall Study||0
2617682|NCT00074269|6427082|P1|COMPLETED|Overall Study||5
2617683|NCT00074269|6427082|P1|STARTED|Overall Study||5
2617684|NCT00074165|6427092|P1|NOT COMPLETED|Overall Study||0
2617685|NCT00074165|6427092|P1|COMPLETED|Overall Study||17
2617686|NCT00074165|6427092|P1|STARTED|Overall Study||17
2617687|NCT00074152|6427099|P2|NOT COMPLETED|Overall Study||33
2617688|NCT00074152|6427100|P1|NOT COMPLETED|Overall Study||55
2617689|NCT00074152|6427099|P2|COMPLETED|Overall Study||52
2617690|NCT00074152|6427100|P1|COMPLETED|Overall Study||22
2617691|NCT00074152|6427099|P2|STARTED|Overall Study||85
2617692|NCT00074152|6427100|P1|STARTED|Overall Study||77
2617693|NCT00074035|6427110|P1|NOT COMPLETED|Overall Study||0
2617694|NCT00074035|6427110|P1|COMPLETED|Overall Study||38
2617695|NCT00074035|6427110|P1|STARTED|Overall Study||38
2617696|NCT00073983|6427117|P1|NOT COMPLETED|Overall Study||1
2617697|NCT00073983|6427117|P1|COMPLETED|Overall Study|One patient in the chondrosarcoma subtype was not evaluable.|53
2617698|NCT00073983|6427117|P1|STARTED|Overall Study||54
2617699|NCT00073957|6427132|P1|NOT COMPLETED|Overall Study||0
2617700|NCT00073957|6427132|P1|COMPLETED|Overall Study||25
2617701|NCT00073957|6427132|P1|STARTED|Overall Study||25
2617702|NCT00073918|6427138|P1|NOT COMPLETED|Overall Study||4
2617703|NCT00073918|6427138|P1|COMPLETED|Overall Study||107
2617704|NCT00073918|6427138|P1|STARTED|Overall Study||111
2617705|NCT00073749|6427152|P7|NOT COMPLETED|Overall Study||40
2617706|NCT00073749|6427153|P6|NOT COMPLETED|Overall Study||6
2617707|NCT00073749|6427154|P5|NOT COMPLETED|Overall Study||6
2617708|NCT00073749|6427155|P4|NOT COMPLETED|Overall Study||6
2617709|NCT00073749|6427156|P3|NOT COMPLETED|Overall Study||11
2617710|NCT00073749|6427157|P2|NOT COMPLETED|Overall Study||5
2617711|NCT00073749|6427158|P1|NOT COMPLETED|Overall Study||2
2617712|NCT00073749|6427152|P7|COMPLETED|Overall Study||3
2617713|NCT00073749|6427153|P6|COMPLETED|Overall Study||0
2617714|NCT00073749|6427154|P5|COMPLETED|Overall Study||0
2617715|NCT00073749|6427155|P4|COMPLETED|Overall Study||0
2617716|NCT00073749|6427156|P3|COMPLETED|Overall Study||0
2617717|NCT00073749|6427157|P2|COMPLETED|Overall Study||0
2617718|NCT00073749|6427158|P1|COMPLETED|Overall Study||0
2617719|NCT00073749|6427152|P7|STARTED|Overall Study||43
2617720|NCT00073749|6427153|P6|STARTED|Overall Study||6
2617721|NCT00073749|6427154|P5|STARTED|Overall Study||6
2617722|NCT00073749|6427155|P4|STARTED|Overall Study||6
2617723|NCT00073749|6427156|P3|STARTED|Overall Study||11
2617724|NCT00073749|6427157|P2|STARTED|Overall Study||5
2617725|NCT00073749|6427158|P1|STARTED|Overall Study||2
2617726|NCT00073528|6427189|P2|NOT COMPLETED|Overall Study||642
2617727|NCT00073528|6427190|P1|NOT COMPLETED|Overall Study||644
2617728|NCT00073528|6427189|P2|COMPLETED|Overall Study||0
2617729|NCT00073528|6427190|P1|COMPLETED|Overall Study||0
2617730|NCT00073528|6427189|P2|Ongoing|Overall Study|These participants are still on study and do not yet have end of study data available.|344
2617731|NCT00073528|6427190|P1|Ongoing|Overall Study|These participants are still on study and do not yet have end of study data available.|349
2617732|NCT00073528|6427189|P2|STARTED|Overall Study||642
2617733|NCT00073528|6427190|P1|STARTED|Overall Study||644
2617734|NCT00073333|6427267|P3|NOT COMPLETED|Overall Study||0
2617735|NCT00073333|6427268|P2|NOT COMPLETED|Overall Study||14
2617736|NCT00073333|6427269|P1|NOT COMPLETED|Overall Study||14
2617737|NCT00073333|6427267|P3|COMPLETED|Overall Study||19
2617738|NCT00073333|6427268|P2|COMPLETED|Overall Study||27
2617739|NCT00073333|6427269|P1|COMPLETED|Overall Study||32
2617740|NCT00073333|6427267|P3|STARTED|Overall Study||19
2617741|NCT00073333|6427268|P2|STARTED|Overall Study||41
2617742|NCT00073333|6427269|P1|STARTED|Overall Study||46
2617743|NCT00073307|6427279|P3|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||156
2617744|NCT00073307|6427280|P2|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
2617745|NCT00073307|6427281|P1|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||134
2617746|NCT00073307|6427279|P3|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||143
2617747|NCT00073307|6427280|P2|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
2617748|NCT00073307|6427281|P1|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||120
2617749|NCT00073307|6427279|P3|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||216
2617750|NCT00073307|6427280|P2|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||0
2617751|NCT00073307|6427281|P1|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||219
2617752|NCT00073307|6427279|P3|STARTED|Open Label-Sorafenib Only [30Jun2008]||299
2617753|NCT00073307|6427280|P2|STARTED|Open Label-Sorafenib Only [30Jun2008]|Placebo treatment ended ~ 31May2005. Those who continued, switched to receive Sorafenib.|0
2617754|NCT00073307|6427281|P1|STARTED|Open Label-Sorafenib Only [30Jun2008]||254
2617755|NCT00073307|6427279|P3|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||0
2617756|NCT00073307|6427280|P2|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||153
2617757|NCT00073307|6427281|P1|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||197
2617758|NCT00073307|6427279|P3|COMPLETED|Double-Blind (DB, as of ~31May2005)||0
2617759|NCT00073307|6427280|P2|COMPLETED|Double-Blind (DB, as of ~31May2005)||299
2617760|NCT00073307|6427281|P1|COMPLETED|Double-Blind (DB, as of ~31May2005)||254
2617761|NCT00073307|6427279|P3|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||0
2617762|NCT00073307|6427280|P2|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
2617763|NCT00073307|6427281|P1|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
2617764|NCT00073307|6427279|P3|STARTED|Double-Blind (DB, as of ~31May2005)||0
2617765|NCT00073307|6427280|P2|STARTED|Double-Blind (DB, as of ~31May2005)||452
2617766|NCT00073307|6427281|P1|STARTED|Double-Blind (DB, as of ~31May2005)||451
2617767|NCT00073073|6427299|P1|NOT COMPLETED|Overall Study||4
2617768|NCT00073073|6427299|P1|COMPLETED|Overall Study||42
2617769|NCT00073073|6427299|P1|STARTED|Overall Study||46
2617770|NCT00073021|6427312|P2|NOT COMPLETED|Overall Study||16
2617771|NCT00073021|6427313|P1|NOT COMPLETED|Overall Study||26
2617772|NCT00073021|6427312|P2|COMPLETED|Overall Study||113
2617773|NCT00073021|6427313|P1|COMPLETED|Overall Study||113
2617774|NCT00073021|6427312|P2|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|129
2617775|NCT00073021|6427313|P1|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|139
2617776|NCT00073008|6427343|P2|NOT COMPLETED|Overall Study||63
2617777|NCT00073008|6427344|P1|NOT COMPLETED|Overall Study||62
2617778|NCT00073008|6427343|P2|COMPLETED|Overall Study||3
2617779|NCT00073008|6427344|P1|COMPLETED|Overall Study||3
2617780|NCT00073008|6427343|P2|STARTED|Overall Study||66
2617781|NCT00073008|6427344|P1|STARTED|Overall Study||65
2617782|NCT00072761|6427376|P2|NOT COMPLETED|Overall Study||2
2617783|NCT00072761|6427377|P1|NOT COMPLETED|Overall Study||9
2617784|NCT00072761|6427376|P2|COMPLETED|Overall Study||95
2617785|NCT00072761|6427377|P1|COMPLETED|Overall Study||90
2617786|NCT00072761|6427376|P2|STARTED|Overall Study||97
2617787|NCT00072761|6427377|P1|STARTED|Overall Study||99
2617788|NCT00072475|6427383|P1|NOT COMPLETED|Overall Study||97
2617789|NCT00072475|6427383|P1|COMPLETED|Overall Study||45
2617790|NCT00072475|6427383|P1|STARTED|Overall Study||142
2617791|NCT00072449|6427391|P1|NOT COMPLETED|Overall Study||0
2617792|NCT00072449|6427391|P1|COMPLETED|Overall Study||12
2617793|NCT00072449|6427391|P1|STARTED|Overall Study||12
2617794|NCT00072384|6427398|P1|NOT COMPLETED|Overall Study||9
2617795|NCT00072384|6427398|P1|COMPLETED|Overall Study||21
2617796|NCT00072384|6427398|P1|STARTED|Overall Study||30
2617797|NCT00072293|6427411|P2|NOT COMPLETED|Overall Study||2
2617798|NCT00072293|6427412|P1|NOT COMPLETED|Overall Study||1
2617799|NCT00072293|6427411|P2|COMPLETED|Overall Study||467
2617800|NCT00072293|6427412|P1|COMPLETED|Overall Study||464
2617801|NCT00072293|6427411|P2|STARTED|Overall Study||469
2617802|NCT00072293|6427412|P1|STARTED|Overall Study||465
2617803|NCT00072280|6427424|P2|NOT COMPLETED|Follow-up||2
2617804|NCT00072280|6427425|P1|NOT COMPLETED|Follow-up||2
2617805|NCT00072280|6427424|P2|COMPLETED|Follow-up||0
2617806|NCT00072280|6427425|P1|COMPLETED|Follow-up||0
2617807|NCT00072280|6427424|P2|STARTED|Follow-up||2
2617808|NCT00072280|6427425|P1|STARTED|Follow-up||2
2617809|NCT00072280|6427424|P2|NOT COMPLETED|Treatment||2
2617810|NCT00072280|6427425|P1|NOT COMPLETED|Treatment||1
2617811|NCT00072280|6427424|P2|COMPLETED|Treatment||2
2617812|NCT00072280|6427425|P1|COMPLETED|Treatment||2
2617813|NCT00072280|6427424|P2|STARTED|Treatment||4
2617814|NCT00072280|6427425|P1|STARTED|Treatment||3
2617815|NCT00072189|6427430|P1|NOT COMPLETED|Overall Study||1
2617816|NCT00072189|6427430|P1|COMPLETED|Overall Study||16
2617817|NCT00072189|6427430|P1|STARTED|Overall Study||17
2617818|NCT00072176|6427438|P2|NOT COMPLETED|Overall Study||1
2617819|NCT00072176|6427439|P1|NOT COMPLETED|Overall Study||1
2617820|NCT00072176|6427438|P2|COMPLETED|Overall Study||27
2617821|NCT00072176|6427439|P1|COMPLETED|Overall Study||33
2617822|NCT00072176|6427438|P2|STARTED|Overall Study||28
2617823|NCT00072176|6427439|P1|STARTED|Overall Study||34
2617824|NCT00071981|6427451|P4|NOT COMPLETED|Overall Study||45
2617825|NCT00071981|6427452|P3|NOT COMPLETED|Overall Study||37
2617826|NCT00071981|6427453|P2|NOT COMPLETED|Overall Study||41
2617827|NCT00071981|6427454|P1|NOT COMPLETED|Overall Study||46
2617828|NCT00071981|6427451|P4|COMPLETED|Overall Study||3
2617829|NCT00071981|6427452|P3|COMPLETED|Overall Study||0
2617830|NCT00071981|6427453|P2|COMPLETED|Overall Study||2
2617831|NCT00071981|6427454|P1|COMPLETED|Overall Study||1
2617832|NCT00071981|6427451|P4|Have Helper T Cell Response Data|Overall Study||39
2617833|NCT00071981|6427452|P3|Have Helper T Cell Response Data|Overall Study||25
2617834|NCT00071981|6427453|P2|Have Helper T Cell Response Data|Overall Study||27
2617835|NCT00071981|6427454|P1|Have Helper T Cell Response Data|Overall Study||37
2617836|NCT00071981|6427451|P4|Have CTL Response Data|Overall Study||41
2617837|NCT00071981|6427452|P3|Have CTL Response Data|Overall Study||29
2617838|NCT00071981|6427453|P2|Have CTL Response Data|Overall Study||30
2617839|NCT00071981|6427454|P1|Have CTL Response Data|Overall Study||40
2617840|NCT00071981|6427451|P4|Eligible and Treated|Overall Study||42
2617841|NCT00071981|6427452|P3|Eligible and Treated|Overall Study||32
2617842|NCT00071981|6427453|P2|Eligible and Treated|Overall Study||33
2617843|NCT00071981|6427454|P1|Eligible and Treated|Overall Study||41
2617844|NCT00071981|6427451|P4|Treated|Overall Study||48
2617845|NCT00071981|6427452|P3|Treated|Overall Study||36
2617846|NCT00071981|6427453|P2|Treated|Overall Study||38
2617847|NCT00071981|6427454|P1|Treated|Overall Study||45
2617848|NCT00071981|6427451|P4|Eligible|Overall Study||42
2617849|NCT00071981|6427452|P3|Eligible|Overall Study||33
2617850|NCT00071981|6427453|P2|Eligible|Overall Study||36
2617851|NCT00071981|6427454|P1|Eligible|Overall Study||43
2617852|NCT00071981|6427451|P4|STARTED|Overall Study||48
2617853|NCT00071981|6427452|P3|STARTED|Overall Study||37
2617854|NCT00071981|6427453|P2|STARTED|Overall Study||43
2617855|NCT00071981|6427454|P1|STARTED|Overall Study||47
2617856|NCT00072566|6427480|P1|NOT COMPLETED|Overall Study||0
2617857|NCT00072566|6427480|P1|COMPLETED|Overall Study||70
2617858|NCT00072566|6427480|P1|STARTED|Overall Study||70
2617859|NCT00072514|6427486|P1|NOT COMPLETED|Overall Study||4
2617860|NCT00072514|6427486|P1|COMPLETED|Overall Study||51
2617861|NCT00072514|6427486|P1|STARTED|Overall Study||55
2617862|NCT00071812|6427497|P4|NOT COMPLETED|24-Week Open-Label Extension Period||40
2617863|NCT00071812|6427498|P3|NOT COMPLETED|24-Week Open-Label Extension Period||1
2617864|NCT00071812|6427499|P2|NOT COMPLETED|24-Week Open-Label Extension Period||0
2617865|NCT00071812|6427500|P1|NOT COMPLETED|24-Week Open-Label Extension Period||0
2617866|NCT00071812|6427497|P4|COMPLETED|24-Week Open-Label Extension Period||178
2617867|NCT00071812|6427498|P3|COMPLETED|24-Week Open-Label Extension Period||7
2617868|NCT00071812|6427499|P2|COMPLETED|24-Week Open-Label Extension Period||11
2617869|NCT00071812|6427500|P1|COMPLETED|24-Week Open-Label Extension Period||0
2617870|NCT00071812|6427497|P4|STARTED|24-Week Open-Label Extension Period|Of 60: 56 continued with 10 mg/kg; 4 elected not to continue in the open-label extension.|218
2617871|NCT00071812|6427498|P3|STARTED|24-Week Open-Label Extension Period|Of 63: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|8
2617948|NCT00071110|6427743|P1|NOT COMPLETED|Overall Study||0
2617872|NCT00071812|6427499|P2|STARTED|24-Week Open-Label Extension Period|Of 66: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|11
2617873|NCT00071812|6427500|P1|STARTED|24-Week Open-Label Extension Period|Of 59: 56 switched to 10 mg/kg; 3 elected not to continue in the open-label extension.|0
2617874|NCT00071812|6427497|P4|NOT COMPLETED|24-Week Double-Blind Period||11
2617875|NCT00071812|6427498|P3|NOT COMPLETED|24-Week Double-Blind Period||8
2617876|NCT00071812|6427499|P2|NOT COMPLETED|24-Week Double-Blind Period||6
2617877|NCT00071812|6427500|P1|NOT COMPLETED|24-Week Double-Blind Period||10
2617878|NCT00071812|6427497|P4|COMPLETED|24-Week Double-Blind Period||60
2617879|NCT00071812|6427498|P3|COMPLETED|24-Week Double-Blind Period||63
2617880|NCT00071812|6427499|P2|COMPLETED|24-Week Double-Blind Period||66
2617881|NCT00071812|6427500|P1|COMPLETED|24-Week Double-Blind Period||59
2617882|NCT00071812|6427497|P4|STARTED|24-Week Double-Blind Period||71
2617883|NCT00071812|6427498|P3|STARTED|24-Week Double-Blind Period||71
2617884|NCT00071812|6427499|P2|STARTED|24-Week Double-Blind Period||72
2617885|NCT00071812|6427500|P1|STARTED|24-Week Double-Blind Period||69
2617886|NCT00071799|6427542|P2|NOT COMPLETED|Overall Study||98
2617887|NCT00071799|6427543|P1|NOT COMPLETED|Overall Study||70
2617888|NCT00071799|6427542|P2|COMPLETED|Overall Study|Includes patients who died or transformed to AML during treatment, or were still receiving drug.|81
2617889|NCT00071799|6427543|P1|COMPLETED|Overall Study|Includes those who died or transformed to AML, or receiving drug + eligible for extension period.|109
2617890|NCT00071799|6427542|P2|STARTED|Overall Study|Best supportive care: 105, Low-dose cytarabine: 49, Standard chemotherapy: 25 patients|179
2617891|NCT00071799|6427543|P1|STARTED|Overall Study||179
2617892|NCT00071890|6427585|P2|NOT COMPLETED|Overall Study||0
2617893|NCT00071890|6427586|P1|NOT COMPLETED|Overall Study||0
2617894|NCT00071890|6427585|P2|COMPLETED|Overall Study|"1 withdrawal~1 lost of follow-up~1 death 67 patients analysed"|67
2617895|NCT00071890|6427586|P1|COMPLETED|Overall Study|"1 withdrawal~1 death 81 patients analysed"|81
2617896|NCT00071890|6427585|P2|STARTED|Overall Study|1 patients stopped HAART at week 0|67
2617897|NCT00071890|6427586|P1|STARTED|Overall Study|3 patients did not received Interleukin-2|81
2617898|NCT00071760|6427596|P1|NOT COMPLETED|Overall Study||54
2617899|NCT00071760|6427596|P1|COMPLETED|Overall Study||0
2617900|NCT00071760|6427596|P1|Ongoing|Overall Study||25
2617901|NCT00071760|6427596|P1|STARTED|Overall Study||54
2617902|NCT00071721|6427657|P2|NOT COMPLETED|Overall Study||91
2617903|NCT00071721|6427658|P1|NOT COMPLETED|Overall Study||72
2617904|NCT00071721|6427657|P2|COMPLETED|Overall Study||69
2617905|NCT00071721|6427658|P1|COMPLETED|Overall Study||81
2617906|NCT00071721|6427657|P2|STARTED|Overall Study||160
2617907|NCT00071721|6427658|P1|STARTED|Overall Study||153
2617908|NCT00071513|6427676|P2|NOT COMPLETED|Follow-up Assessment||6
2617909|NCT00071513|6427677|P1|NOT COMPLETED|Follow-up Assessment||6
2617910|NCT00071513|6427676|P2|COMPLETED|Follow-up Assessment||247
2617911|NCT00071513|6427677|P1|COMPLETED|Follow-up Assessment||233
2617912|NCT00071513|6427676|P2|STARTED|Follow-up Assessment||253
2617913|NCT00071513|6427677|P1|STARTED|Follow-up Assessment||239
2617914|NCT00071513|6427676|P2|NOT COMPLETED|Intervention Component||3
2617915|NCT00071513|6427677|P1|NOT COMPLETED|Intervention Component||2
2617916|NCT00071513|6427676|P2|COMPLETED|Intervention Component||253
2617917|NCT00071513|6427677|P1|COMPLETED|Intervention Component||239
2617918|NCT00071513|6427676|P2|STARTED|Intervention Component||256
2617919|NCT00071513|6427677|P1|STARTED|Intervention Component||241
2617920|NCT00071487|6427689|P4|NOT COMPLETED|24-Week Open-Label Extension Period||23
2617921|NCT00071487|6427690|P3|NOT COMPLETED|24-Week Open-Label Extension Period||1
2617922|NCT00071487|6427691|P2|NOT COMPLETED|24-Week Open-Label Extension Period||0
2617923|NCT00071487|6427692|P1|NOT COMPLETED|24-Week Open-Label Extension Period||0
2617924|NCT00071487|6427689|P4|COMPLETED|24-Week Open-Label Extension Period||279
2617925|NCT00071487|6427690|P3|COMPLETED|24-Week Open-Label Extension Period||23
2617926|NCT00071487|6427691|P2|COMPLETED|24-Week Open-Label Extension Period||19
2617927|NCT00071487|6427692|P1|COMPLETED|24-Week Open-Label Extension Period||0
2617928|NCT00071487|6427689|P4|STARTED|24-Week Open-Label Extension Period|Of 90: 85 continued with 10 mg/kg; 5 elected not to continue in the open-label extension period.|302
2617929|NCT00071487|6427690|P3|STARTED|24-Week Open-Label Extension Period|Of 94: 64 switched to 10 mg/kg; 6 elected not to continue in the open-label extension period.|24
2617930|NCT00071487|6427691|P2|STARTED|24-Week Open-Label Extension Period|Of 87: 65 switched to 10 mg/kg; 3 elected not to continue in the open-label extension period.|19
2617931|NCT00071487|6427692|P1|STARTED|24-Week Open-Label Extension Period|Of 93: 88 switched to 10 mg/kg; 5 elected not to continue in the open-label extension period.|0
2617932|NCT00071487|6427689|P4|NOT COMPLETED|52-Week Double-Blind Period||21
2617933|NCT00071487|6427690|P3|NOT COMPLETED|52-Week Double-Blind Period||17
2617934|NCT00071487|6427691|P2|NOT COMPLETED|52-Week Double-Blind Period||27
2617935|NCT00071487|6427692|P1|NOT COMPLETED|52-Week Double-Blind Period||20
2617936|NCT00071487|6427689|P4|COMPLETED|52-Week Double-Blind Period||90
2617937|NCT00071487|6427690|P3|COMPLETED|52-Week Double-Blind Period||94
2617938|NCT00071487|6427691|P2|COMPLETED|52-Week Double-Blind Period||87
2617939|NCT00071487|6427692|P1|COMPLETED|52-Week Double-Blind Period||93
2617940|NCT00071487|6427689|P4|STARTED|52-Week Double-Blind Period||111
2617941|NCT00071487|6427690|P3|STARTED|52-Week Double-Blind Period||111
2617942|NCT00071487|6427691|P2|STARTED|52-Week Double-Blind Period||114
2617943|NCT00071487|6427692|P1|STARTED|52-Week Double-Blind Period||113
2617944|NCT00071396|6427736|P1|NOT COMPLETED|Overall Study||3
2617945|NCT00071396|6427736|P1|COMPLETED|Overall Study|Evaluable for response.|41
2617946|NCT00071396|6427736|P1|STARTED|Overall Study||44
2617947|NCT00071110|6427742|P2|NOT COMPLETED|Overall Study||4
2617949|NCT00071110|6427742|P2|COMPLETED|Overall Study||25
2617950|NCT00071110|6427743|P1|COMPLETED|Overall Study||28
2617951|NCT00071110|6427742|P2|STARTED|Overall Study||29
2617952|NCT00071110|6427743|P1|STARTED|Overall Study||28
2617953|NCT00071032|6427757|P2|NOT COMPLETED|Overall Study||8
2617954|NCT00071032|6427758|P1|NOT COMPLETED|Overall Study||9
2617955|NCT00071032|6427757|P2|COMPLETED|Overall Study||1001
2617956|NCT00071032|6427758|P1|COMPLETED|Overall Study||998
2617957|NCT00071032|6427757|P2|STARTED|Overall Study||1009
2617958|NCT00071032|6427758|P1|STARTED|Overall Study||1007
2617959|NCT00071006|6427766|P1|NOT COMPLETED|Overall Study||12
2617960|NCT00071006|6427766|P1|COMPLETED|Overall Study||0
2617961|NCT00071006|6427766|P1|STARTED|Overall Study||12
2617962|NCT00070941|6427779|P3|NOT COMPLETED|Overall Study||4
2617963|NCT00070941|6427780|P2|NOT COMPLETED|Overall Study||8
2617964|NCT00070941|6427781|P1|NOT COMPLETED|Overall Study||10
2617965|NCT00070941|6427779|P3|COMPLETED|Overall Study||2
2617966|NCT00070941|6427780|P2|COMPLETED|Overall Study||3
2617967|NCT00070941|6427781|P1|COMPLETED|Overall Study||2
2617968|NCT00070941|6427779|P3|STARTED|Overall Study||6
2617969|NCT00070941|6427780|P2|STARTED|Overall Study||11
2617970|NCT00070941|6427781|P1|STARTED|Overall Study||12
2617971|NCT00071058|6427789|P1|NOT COMPLETED|Overall Study||1
2617972|NCT00071058|6427789|P1|COMPLETED|Overall Study||49
2617973|NCT00071058|6427789|P1|STARTED|Overall Study||50
2617974|NCT00070707|6427796|P2|NOT COMPLETED|Overall Study||7
2617975|NCT00070707|6427797|P1|NOT COMPLETED|Overall Study||14
2617976|NCT00070707|6427796|P2|COMPLETED|Overall Study||68
2617977|NCT00070707|6427797|P1|COMPLETED|Overall Study||99
2617978|NCT00070707|6427796|P2|STARTED|Overall Study||75
2617979|NCT00070707|6427797|P1|STARTED|Overall Study||113
2617980|NCT00003907|6427845|P2|NOT COMPLETED|Overall Study||23
2617981|NCT00003907|6427846|P1|NOT COMPLETED|Overall Study||13
2617982|NCT00003907|6427845|P2|COMPLETED|Overall Study||8
2617983|NCT00003907|6427846|P1|COMPLETED|Overall Study||6
2617984|NCT00003907|6427845|P2|Eligible and Treated|Overall Study||29
2617985|NCT00003907|6427846|P1|Eligible and Treated|Overall Study||17
2617986|NCT00003907|6427845|P2|Received Protocol Therapy (Treated)|Overall Study||31
2617987|NCT00003907|6427846|P1|Received Protocol Therapy (Treated)|Overall Study||18
2617988|NCT00003907|6427845|P2|Eligible|Overall Study||29
2617989|NCT00003907|6427846|P1|Eligible|Overall Study||18
2617990|NCT00003907|6427845|P2|STARTED|Overall Study||31
2617991|NCT00003907|6427846|P1|STARTED|Overall Study||19
2617992|NCT00070564|6427862|P6|NOT COMPLETED|Overall Study||52
2617993|NCT00070564|6427863|P5|NOT COMPLETED|Overall Study||79
2617994|NCT00070564|6427864|P4|NOT COMPLETED|Overall Study||167
2617995|NCT00070564|6427865|P3|NOT COMPLETED|Overall Study||171
2617996|NCT00070564|6427866|P2|NOT COMPLETED|Overall Study||203
2617997|NCT00070564|6427867|P1|NOT COMPLETED|Overall Study||200
2617998|NCT00070564|6427862|P6|COMPLETED|Overall Study||244
2617999|NCT00070564|6427863|P5|COMPLETED|Overall Study||203
2618000|NCT00070564|6427864|P4|COMPLETED|Overall Study||481
2618001|NCT00070564|6427865|P3|COMPLETED|Overall Study||526
2618002|NCT00070564|6427866|P2|COMPLETED|Overall Study||490
2618003|NCT00070564|6427867|P1|COMPLETED|Overall Study||478
2618004|NCT00070564|6427862|P6|STARTED|Overall Study||296
2618005|NCT00070564|6427863|P5|STARTED|Overall Study||282
2618006|NCT00070564|6427864|P4|STARTED|Overall Study||648
2618007|NCT00070564|6427865|P3|STARTED|Overall Study||697
2618008|NCT00070564|6427866|P2|STARTED|Overall Study||693
2618009|NCT00070564|6427867|P1|STARTED|Overall Study||678
2618010|NCT00070499|6427921|P4|NOT COMPLETED|Overall Study||110
2618011|NCT00070499|6427922|P3|NOT COMPLETED|Overall Study||120
2618012|NCT00070499|6427923|P2|NOT COMPLETED|Overall Study||26
2618013|NCT00070499|6427924|P1|NOT COMPLETED|Overall Study||38
2618014|NCT00070499|6427921|P4|COMPLETED|Overall Study||17
2618015|NCT00070499|6427922|P3|COMPLETED|Overall Study||6
2618016|NCT00070499|6427923|P2|COMPLETED|Overall Study||52
2618017|NCT00070499|6427924|P1|COMPLETED|Overall Study||37
2618018|NCT00070499|6427921|P4|Eligible and Treated|Overall Study||123
2618019|NCT00070499|6427922|P3|Eligible and Treated|Overall Study||123
2618020|NCT00070499|6427923|P2|Eligible and Treated|Overall Study||73
2618021|NCT00070499|6427924|P1|Eligible and Treated|Overall Study||72
2618022|NCT00070499|6427921|P4|Eligible|Overall Study||125
2618023|NCT00070499|6427922|P3|Eligible|Overall Study||123
2618024|NCT00070499|6427923|P2|Eligible|Overall Study||73
2618025|NCT00070499|6427924|P1|Eligible|Overall Study||73
2618026|NCT00070499|6427921|P4|STARTED|Overall Study||127
2618027|NCT00070499|6427922|P3|STARTED|Overall Study||126
2618028|NCT00070499|6427923|P2|STARTED|Overall Study||78
2618029|NCT00070499|6427924|P1|STARTED|Overall Study||75
2618030|NCT00070317|6427950|P1|NOT COMPLETED|Overall Study||13
2618031|NCT00070317|6427950|P1|COMPLETED|Overall Study||89
2618032|NCT00070317|6427950|P1|STARTED|Overall Study||102
2618033|NCT00070291|6427955|P1|NOT COMPLETED|Step 2||1
2618034|NCT00070291|6427955|P1|COMPLETED|Step 2||0
2618035|NCT00070291|6427955|P1|STARTED|Step 2|One patient completed step 1, but opted to get alternative therapy. One patient entered step 2.|1
2618036|NCT00070291|6427955|P1|NOT COMPLETED|Step 1||2
2618037|NCT00070291|6427955|P1|COMPLETED|Step 1||2
2618038|NCT00070291|6427955|P1|Treated|Step 1||3
2618039|NCT00070291|6427955|P1|STARTED|Step 1||4
2618040|NCT00070135|6427960|P1|NOT COMPLETED|Overall Study||0
2618041|NCT00070135|6427960|P1|COMPLETED|Overall Study||114
2618042|NCT00070135|6427960|P1|STARTED|Overall Study||114
2618043|NCT00070109|6427971|P5|NOT COMPLETED|Overall Study||8
2618044|NCT00070109|6427972|P4|NOT COMPLETED|Overall Study||20
2618045|NCT00070109|6427973|P3|NOT COMPLETED|Overall Study||8
2618046|NCT00070109|6427974|P2|NOT COMPLETED|Overall Study||6
2618047|NCT00070109|6427975|P1|NOT COMPLETED|Overall Study||8
2618048|NCT00070109|6427971|P5|COMPLETED|Overall Study||0
2618049|NCT00070109|6427972|P4|COMPLETED|Overall Study||0
2618050|NCT00070109|6427973|P3|COMPLETED|Overall Study||0
2618051|NCT00070109|6427974|P2|COMPLETED|Overall Study||0
2618052|NCT00070109|6427975|P1|COMPLETED|Overall Study||0
2618053|NCT00070109|6427971|P5|STARTED|Overall Study||8
2618054|NCT00070109|6427972|P4|STARTED|Overall Study||20
2618055|NCT00070109|6427973|P3|STARTED|Overall Study||8
2618056|NCT00070109|6427974|P2|STARTED|Overall Study||6
2618057|NCT00070109|6427975|P1|STARTED|Overall Study||8
2618058|NCT00070018|6428003|P1|NOT COMPLETED|Overall Study||4
2618059|NCT00070018|6428003|P1|COMPLETED|Overall Study||42
2618060|NCT00070018|6428003|P1|Eligible and Began Protocol Therapy|Overall Study||46
2618061|NCT00070018|6428003|P1|Eligible|Overall Study||46
2618062|NCT00070018|6428003|P1|STARTED|Overall Study||46
2618063|NCT00069953|6428007|P1|NOT COMPLETED|Overall Study||2
2618064|NCT00069953|6428007|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study|41
2618065|NCT00069953|6428007|P1|STARTED|Overall Study||43
2618066|NCT00069784|6428013|P2|NOT COMPLETED|Overall Study||0
2618067|NCT00069784|6428014|P1|NOT COMPLETED|Overall Study||1212
2618068|NCT00069784|6428013|P2|COMPLETED|Overall Study|not applicable (no treatment)|6273
2618069|NCT00069784|6428014|P1|COMPLETED|Overall Study|completed study treatment|5052
2618070|NCT00069784|6428013|P2|Safety Population (Treated)|Overall Study|patients randomized to standard care arm|6273
2618071|NCT00069784|6428014|P1|Safety Population (Treated)|Overall Study|randomized patients who received at least one dose of insulin glargine|6231
2618072|NCT00069784|6428013|P2|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6273
2618073|NCT00069784|6428014|P1|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6264
2618074|NCT00069823|6428034|P2|NOT COMPLETED|Overall Study||3
2618075|NCT00069823|6428035|P1|NOT COMPLETED|Overall Study||6
2618076|NCT00069823|6428034|P2|COMPLETED|Overall Study||200
2618077|NCT00069823|6428035|P1|COMPLETED|Overall Study||193
2618078|NCT00069823|6428034|P2|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|203
2618079|NCT00069823|6428035|P1|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|199
2618080|NCT00069641|6428078|P3|NOT COMPLETED|Overall Study||1
2618081|NCT00069641|6428079|P2|NOT COMPLETED|Overall Study||0
2618082|NCT00069641|6428080|P1|NOT COMPLETED|Overall Study||1
2618083|NCT00069641|6428078|P3|COMPLETED|Overall Study||31
2618084|NCT00069641|6428079|P2|COMPLETED|Overall Study||32
2618085|NCT00069641|6428080|P1|COMPLETED|Overall Study||31
2618086|NCT00069641|6428078|P3|STARTED|Overall Study||32
2618087|NCT00069641|6428079|P2|STARTED|Overall Study||32
2618088|NCT00069641|6428080|P1|STARTED|Overall Study||32
2618089|NCT00069576|6428107|P2|NOT COMPLETED|Follow-up Study at 5-10 Years||204
2618090|NCT00069576|6428108|P1|NOT COMPLETED|Follow-up Study at 5-10 Years||196
2618091|NCT00069576|6428107|P2|COMPLETED|Follow-up Study at 5-10 Years||236
2618092|NCT00069576|6428108|P1|COMPLETED|Follow-up Study at 5-10 Years||264
2618093|NCT00069576|6428107|P2|STARTED|Follow-up Study at 5-10 Years||440
2618094|NCT00069576|6428108|P1|STARTED|Follow-up Study at 5-10 Years||460
2618095|NCT00069576|6428107|P2|NOT COMPLETED|Original Trial||33
2618096|NCT00069576|6428108|P1|NOT COMPLETED|Original Trial||25
2618097|NCT00069576|6428107|P2|COMPLETED|Original Trial||440
2618098|NCT00069576|6428108|P1|COMPLETED|Original Trial||460
2618099|NCT00069576|6428107|P2|STARTED|Original Trial||473
2618100|NCT00069576|6428108|P1|STARTED|Original Trial||485
2618101|NCT00069277|6428158|P1|NOT COMPLETED|Overall Study||21
2618102|NCT00069277|6428158|P1|COMPLETED|Overall Study||0
2618103|NCT00069277|6428158|P1|STARTED|Overall Study||21
2618104|NCT00069264|6428162|P1|NOT COMPLETED|Overall Study||32
2618105|NCT00069264|6428162|P1|COMPLETED|Overall Study||0
2618106|NCT00069264|6428162|P1|STARTED|Overall Study||32
2618107|NCT00069329|6428166|P1|NOT COMPLETED|Overall Study||2
2618108|NCT00069329|6428166|P1|COMPLETED|Overall Study||41
2618109|NCT00069329|6428166|P1|STARTED|Overall Study||43
2618110|NCT00069238|6428190|P3|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||2
2618111|NCT00069238|6428191|P2|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
2618112|NCT00069238|6428192|P1|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
2618113|NCT00069238|6428190|P3|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||1
2618114|NCT00069238|6428191|P2|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
2618115|NCT00069238|6428192|P1|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
2618116|NCT00069238|6428190|P3|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||3
2618117|NCT00069238|6428191|P2|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
2618118|NCT00069238|6428192|P1|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
2618119|NCT00069238|6428190|P3|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
2618120|NCT00069238|6428191|P2|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||2
2618121|NCT00069238|6428192|P1|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
2618122|NCT00069238|6428190|P3|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
2618123|NCT00069238|6428191|P2|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||1
2618124|NCT00069238|6428192|P1|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
2618125|NCT00069238|6428190|P3|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
2618126|NCT00069238|6428191|P2|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||3
2618127|NCT00069238|6428192|P1|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
2618128|NCT00069238|6428190|P3|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
2618129|NCT00069238|6428191|P2|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
2618130|NCT00069238|6428192|P1|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||9
2618131|NCT00069238|6428190|P3|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
2618132|NCT00069238|6428191|P2|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
2618133|NCT00069238|6428192|P1|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||16
2618134|NCT00069238|6428190|P3|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
2618135|NCT00069238|6428191|P2|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
2618136|NCT00069238|6428192|P1|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||25
2618137|NCT00069121|6428200|P2|NOT COMPLETED|Overall Study||276
2618138|NCT00069121|6428201|P1|NOT COMPLETED|Overall Study||302
2618139|NCT00069121|6428200|P2|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|668
2618140|NCT00069121|6428201|P1|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|640
2618141|NCT00069121|6428200|P2|Received Treatment|Overall Study|Safety Population|938
2618142|NCT00069121|6428201|P1|Received Treatment|Overall Study|Safety Population|926
2618143|NCT00069121|6428200|P2|STARTED|Overall Study||944
2618144|NCT00069121|6428201|P1|STARTED|Overall Study||942
2618145|NCT00069108|6428223|P2|NOT COMPLETED|Overall Study||219
2618146|NCT00069108|6428224|P1|NOT COMPLETED|Overall Study||213
2618147|NCT00069108|6428223|P2|COMPLETED|Overall Study||95
2618148|NCT00069108|6428224|P1|COMPLETED|Overall Study||100
2618149|NCT00069108|6428223|P2|STARTED|Overall Study||314
2618150|NCT00069108|6428224|P1|STARTED|Overall Study||313
2618151|NCT00069095|6428256|P6|NOT COMPLETED|Follow-up Phase||101
2618152|NCT00069095|6428257|P5|NOT COMPLETED|Follow-up Phase||92
2618153|NCT00069095|6428258|P4|NOT COMPLETED|Follow-up Phase||112
2618154|NCT00069095|6428259|P3|NOT COMPLETED|Follow-up Phase||120
2618155|NCT00069095|6428260|P2|NOT COMPLETED|Follow-up Phase||206
2618156|NCT00069095|6428261|P1|NOT COMPLETED|Follow-up Phase||174
2618157|NCT00069095|6428256|P6|COMPLETED|Follow-up Phase||171
2618158|NCT00069095|6428257|P5|COMPLETED|Follow-up Phase||186
2618159|NCT00069095|6428258|P4|COMPLETED|Follow-up Phase||187
2618160|NCT00069095|6428259|P3|COMPLETED|Follow-up Phase||178
2618161|NCT00069095|6428260|P2|COMPLETED|Follow-up Phase||93
2618162|NCT00069095|6428261|P1|COMPLETED|Follow-up Phase||110
2618163|NCT00069095|6428256|P6|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|272
2618164|NCT00069095|6428257|P5|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|278
2618165|NCT00069095|6428258|P4|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
2618166|NCT00069095|6428259|P3|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|298
2618167|NCT00069095|6428260|P2|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
2618168|NCT00069095|6428261|P1|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|284
2618169|NCT00069095|6428256|P6|NOT COMPLETED|Post-study Treatment Phase||29
2618170|NCT00069095|6428257|P5|NOT COMPLETED|Post-study Treatment Phase||36
2618171|NCT00069095|6428258|P4|NOT COMPLETED|Post-study Treatment Phase||17
2618172|NCT00069095|6428259|P3|NOT COMPLETED|Post-study Treatment Phase||21
2618173|NCT00069095|6428260|P2|NOT COMPLETED|Post-study Treatment Phase||13
2618174|NCT00069095|6428261|P1|NOT COMPLETED|Post-study Treatment Phase||8
2618175|NCT00069095|6428256|P6|COMPLETED|Post-study Treatment Phase||0
2618176|NCT00069095|6428257|P5|COMPLETED|Post-study Treatment Phase||0
2618177|NCT00069095|6428258|P4|COMPLETED|Post-study Treatment Phase||0
2618178|NCT00069095|6428259|P3|COMPLETED|Post-study Treatment Phase||0
2618179|NCT00069095|6428260|P2|COMPLETED|Post-study Treatment Phase||0
2618180|NCT00069095|6428261|P1|COMPLETED|Post-study Treatment Phase||0
2618181|NCT00069095|6428256|P6|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|29
2618182|NCT00069095|6428257|P5|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|36
2618183|NCT00069095|6428258|P4|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|17
2618184|NCT00069095|6428259|P3|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|21
2618185|NCT00069095|6428260|P2|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|13
2618186|NCT00069095|6428261|P1|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|8
2618187|NCT00069095|6428256|P6|NOT COMPLETED|Primary Treatment Phase||301
2618188|NCT00069095|6428257|P5|NOT COMPLETED|Primary Treatment Phase||302
2618189|NCT00069095|6428258|P4|NOT COMPLETED|Primary Treatment Phase||320
2618190|NCT00069095|6428259|P3|NOT COMPLETED|Primary Treatment Phase||314
2618191|NCT00069095|6428260|P2|NOT COMPLETED|Primary Treatment Phase||302
2618192|NCT00069095|6428261|P1|NOT COMPLETED|Primary Treatment Phase||295
2618193|NCT00069095|6428256|P6|COMPLETED|Primary Treatment Phase||48
2618194|NCT00069095|6428257|P5|COMPLETED|Primary Treatment Phase||48
2618195|NCT00069095|6428258|P4|COMPLETED|Primary Treatment Phase||31
2618196|NCT00069095|6428259|P3|COMPLETED|Primary Treatment Phase||36
2618197|NCT00069095|6428260|P2|COMPLETED|Primary Treatment Phase||15
2618198|NCT00069095|6428261|P1|COMPLETED|Primary Treatment Phase||22
2618199|NCT00069095|6428256|P6|STARTED|Primary Treatment Phase||349
2618200|NCT00069095|6428257|P5|STARTED|Primary Treatment Phase||350
2618201|NCT00069095|6428258|P4|STARTED|Primary Treatment Phase||351
2618202|NCT00069095|6428259|P3|STARTED|Primary Treatment Phase||350
2618203|NCT00069095|6428260|P2|STARTED|Primary Treatment Phase||317
2618204|NCT00069095|6428261|P1|STARTED|Primary Treatment Phase||317
2618205|NCT00069160|6428315|P2|NOT COMPLETED|Overall Study||0
2618206|NCT00069160|6428316|P1|NOT COMPLETED|Overall Study||0
2618207|NCT00069160|6428315|P2|COMPLETED|Overall Study||25
2618208|NCT00069160|6428316|P1|COMPLETED|Overall Study||23
2618209|NCT00069160|6428315|P2|STARTED|Overall Study||25
2618210|NCT00069160|6428316|P1|STARTED|Overall Study||23
2618211|NCT00068822|6428331|P2|NOT COMPLETED|Optional Crossover Intervention||0
2618212|NCT00068822|6428332|P1|NOT COMPLETED|Optional Crossover Intervention||0
2618213|NCT00068822|6428331|P2|COMPLETED|Optional Crossover Intervention||29
2618214|NCT00068822|6428332|P1|COMPLETED|Optional Crossover Intervention||9
2618215|NCT00068822|6428331|P2|Crossover at Month 3|Optional Crossover Intervention||27
2618216|NCT00068822|6428332|P1|Crossover at Month 3|Optional Crossover Intervention||8
2618217|NCT00068822|6428331|P2|Crossover at Month 1|Optional Crossover Intervention||2
2618218|NCT00068822|6428332|P1|Crossover at Month 1|Optional Crossover Intervention||1
2618219|NCT00068822|6428331|P2|STARTED|Optional Crossover Intervention||29
2618220|NCT00068822|6428332|P1|STARTED|Optional Crossover Intervention||9
2618221|NCT00068822|6428331|P2|NOT COMPLETED|First Randomized Intervention||2
2618222|NCT00068822|6428332|P1|NOT COMPLETED|First Randomized Intervention||1
2618223|NCT00068822|6428331|P2|COMPLETED|First Randomized Intervention||61
2618224|NCT00068822|6428332|P1|COMPLETED|First Randomized Intervention||67
2618225|NCT00068822|6428331|P2|STARTED|First Randomized Intervention||63
2618226|NCT00068822|6428332|P1|STARTED|First Randomized Intervention||68
2618227|NCT00068770|6428344|P2|NOT COMPLETED|Overall Study||0
2618228|NCT00068770|6428345|P1|NOT COMPLETED|Overall Study||0
2618229|NCT00068770|6428344|P2|COMPLETED|Overall Study||22
2618230|NCT00068770|6428345|P1|COMPLETED|Overall Study||13
2618231|NCT00068770|6428344|P2|STARTED|Overall Study||22
2618232|NCT00068770|6428345|P1|STARTED|Overall Study||13
2618233|NCT00068718|6428353|P1|NOT COMPLETED|Overall Study||0
2618234|NCT00068718|6428353|P1|COMPLETED|Overall Study||35
2618235|NCT00068718|6428353|P1|STARTED|Overall Study||35
2618236|NCT00068692|6428366|P8|NOT COMPLETED|Step 2: Randomization||8
2618237|NCT00068692|6428367|P7|NOT COMPLETED|Step 2: Randomization||4
2618238|NCT00068692|6428368|P6|NOT COMPLETED|Step 2: Randomization||6
2618239|NCT00068692|6428369|P5|NOT COMPLETED|Step 2: Randomization||9
2618240|NCT00068692|6428370|P4|NOT COMPLETED|Step 2: Randomization||12
2618241|NCT00068692|6428371|P3|NOT COMPLETED|Step 2: Randomization||10
2618242|NCT00068692|6428372|P2|NOT COMPLETED|Step 2: Randomization||0
2618243|NCT00068692|6428373|P1|NOT COMPLETED|Step 2: Randomization||0
2618244|NCT00068692|6428366|P8|COMPLETED|Step 2: Randomization||24
2618245|NCT00068692|6428367|P7|COMPLETED|Step 2: Randomization||29
2618246|NCT00068692|6428368|P6|COMPLETED|Step 2: Randomization||25
2618247|NCT00068692|6428369|P5|COMPLETED|Step 2: Randomization||21
2618248|NCT00068692|6428370|P4|COMPLETED|Step 2: Randomization||13
2618249|NCT00068692|6428371|P3|COMPLETED|Step 2: Randomization||18
2618250|NCT00068692|6428372|P2|COMPLETED|Step 2: Randomization||0
2618251|NCT00068692|6428373|P1|COMPLETED|Step 2: Randomization||0
2618252|NCT00068692|6428366|P8|Reported AE Data|Step 2: Randomization||32
2618253|NCT00068692|6428367|P7|Reported AE Data|Step 2: Randomization||33
2618254|NCT00068692|6428368|P6|Reported AE Data|Step 2: Randomization||31
2618255|NCT00068692|6428369|P5|Reported AE Data|Step 2: Randomization||28
2618256|NCT00068692|6428370|P4|Reported AE Data|Step 2: Randomization||22
2618257|NCT00068692|6428371|P3|Reported AE Data|Step 2: Randomization||27
2618258|NCT00068692|6428372|P2|Reported AE Data|Step 2: Randomization||0
2618259|NCT00068692|6428373|P1|Reported AE Data|Step 2: Randomization||0
2618260|NCT00068692|6428366|P8|Had Sphincter Preservation|Step 2: Randomization||30
2618261|NCT00068692|6428367|P7|Had Sphincter Preservation|Step 2: Randomization||33
2618262|NCT00068692|6428368|P6|Had Sphincter Preservation|Step 2: Randomization||31
2618263|NCT00068692|6428369|P5|Had Sphincter Preservation|Step 2: Randomization||28
2618264|NCT00068692|6428370|P4|Had Sphincter Preservation|Step 2: Randomization||25
2618265|NCT00068692|6428371|P3|Had Sphincter Preservation|Step 2: Randomization||28
2618266|NCT00068692|6428372|P2|Had Sphincter Preservation|Step 2: Randomization||0
2618267|NCT00068692|6428373|P1|Had Sphincter Preservation|Step 2: Randomization||0
2618268|NCT00068692|6428366|P8|Treated|Step 2: Randomization||32
2618269|NCT00068692|6428367|P7|Treated|Step 2: Randomization||33
2618270|NCT00068692|6428368|P6|Treated|Step 2: Randomization||31
2618271|NCT00068692|6428369|P5|Treated|Step 2: Randomization||29
2618272|NCT00068692|6428370|P4|Treated|Step 2: Randomization||25
2618273|NCT00068692|6428371|P3|Treated|Step 2: Randomization||27
2618274|NCT00068692|6428372|P2|Treated|Step 2: Randomization||0
2618275|NCT00068692|6428373|P1|Treated|Step 2: Randomization||0
2618276|NCT00068692|6428366|P8|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|32
2618277|NCT00068692|6428367|P7|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|33
2618278|NCT00068692|6428368|P6|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|31
2618279|NCT00068692|6428369|P5|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|30
2618359|NCT00068406|6428462|P1|STARTED|Overall Study||61
2618280|NCT00068692|6428370|P4|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|25
2618281|NCT00068692|6428371|P3|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|28
2618282|NCT00068692|6428372|P2|STARTED|Step 2: Randomization|Group II patients were registered and randomized at the same time, reported as arms I,II,III here.|0
2618283|NCT00068692|6428373|P1|STARTED|Step 2: Randomization|Patients on arm S completing step 1 treatment were randomized to step 2 (Arms I-III).|0
2618284|NCT00068692|6428366|P8|NOT COMPLETED|Step 1: Registration||0
2618285|NCT00068692|6428367|P7|NOT COMPLETED|Step 1: Registration||0
2618286|NCT00068692|6428368|P6|NOT COMPLETED|Step 1: Registration||0
2618287|NCT00068692|6428369|P5|NOT COMPLETED|Step 1: Registration||0
2618288|NCT00068692|6428370|P4|NOT COMPLETED|Step 1: Registration||0
2618289|NCT00068692|6428371|P3|NOT COMPLETED|Step 1: Registration||0
2618290|NCT00068692|6428372|P2|NOT COMPLETED|Step 1: Registration||1
2618291|NCT00068692|6428373|P1|NOT COMPLETED|Step 1: Registration||40
2618292|NCT00068692|6428366|P8|COMPLETED|Step 1: Registration||0
2618293|NCT00068692|6428367|P7|COMPLETED|Step 1: Registration||0
2618294|NCT00068692|6428368|P6|COMPLETED|Step 1: Registration||0
2618295|NCT00068692|6428369|P5|COMPLETED|Step 1: Registration||0
2618296|NCT00068692|6428370|P4|COMPLETED|Step 1: Registration||0
2618297|NCT00068692|6428371|P3|COMPLETED|Step 1: Registration||0
2618298|NCT00068692|6428372|P2|COMPLETED|Step 1: Registration|Case 32191 entered the study as Group II patient but was never randomized.|96
2618299|NCT00068692|6428373|P1|COMPLETED|Step 1: Registration||88
2618300|NCT00068692|6428366|P8|Reported AE Data|Step 1: Registration||0
2618301|NCT00068692|6428367|P7|Reported AE Data|Step 1: Registration||0
2618302|NCT00068692|6428368|P6|Reported AE Data|Step 1: Registration||0
2618303|NCT00068692|6428369|P5|Reported AE Data|Step 1: Registration||0
2618304|NCT00068692|6428370|P4|Reported AE Data|Step 1: Registration||0
2618305|NCT00068692|6428371|P3|Reported AE Data|Step 1: Registration||0
2618306|NCT00068692|6428372|P2|Reported AE Data|Step 1: Registration||0
2618307|NCT00068692|6428373|P1|Reported AE Data|Step 1: Registration||123
2618308|NCT00068692|6428366|P8|Started Concurrent Chemo/Radiation|Step 1: Registration||0
2618309|NCT00068692|6428367|P7|Started Concurrent Chemo/Radiation|Step 1: Registration||0
2618310|NCT00068692|6428368|P6|Started Concurrent Chemo/Radiation|Step 1: Registration||0
2618311|NCT00068692|6428369|P5|Started Concurrent Chemo/Radiation|Step 1: Registration||0
2618312|NCT00068692|6428370|P4|Started Concurrent Chemo/Radiation|Step 1: Registration||0
2618313|NCT00068692|6428371|P3|Started Concurrent Chemo/Radiation|Step 1: Registration||0
2618314|NCT00068692|6428372|P2|Started Concurrent Chemo/Radiation|Step 1: Registration|Group II patients receive protocol therapy in Step 2 after randomization|0
2618315|NCT00068692|6428373|P1|Started Concurrent Chemo/Radiation|Step 1: Registration||125
2618316|NCT00068692|6428366|P8|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
2618317|NCT00068692|6428367|P7|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
2618318|NCT00068692|6428368|P6|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
2618319|NCT00068692|6428369|P5|STARTED|Step 1: Registration||0
2618320|NCT00068692|6428370|P4|STARTED|Step 1: Registration||0
2618321|NCT00068692|6428371|P3|STARTED|Step 1: Registration||0
2618322|NCT00068692|6428372|P2|STARTED|Step 1: Registration|Group II patients were registered and randomized at the same time, and were reported in Step 2.|97
2618323|NCT00068692|6428373|P1|STARTED|Step 1: Registration||128
2618324|NCT00068601|6428396|P2|NOT COMPLETED|Overall Study||60
2618325|NCT00068601|6428397|P1|NOT COMPLETED|Overall Study||62
2618326|NCT00068601|6428396|P2|COMPLETED|Overall Study||66
2618327|NCT00068601|6428397|P1|COMPLETED|Overall Study||69
2618328|NCT00068601|6428396|P2|STARTED|Overall Study||126
2618329|NCT00068601|6428397|P1|STARTED|Overall Study||131
2618330|NCT00068588|6428410|P3|NOT COMPLETED|Overall Study||4
2618331|NCT00068588|6428411|P2|NOT COMPLETED|Overall Study||0
2618332|NCT00068588|6428412|P1|NOT COMPLETED|Overall Study||0
2618333|NCT00068588|6428410|P3|COMPLETED|Overall Study||17
2618334|NCT00068588|6428411|P2|COMPLETED|Overall Study||3
2618335|NCT00068588|6428412|P1|COMPLETED|Overall Study||0
2618336|NCT00068588|6428410|P3|STARTED|Overall Study||21
2618337|NCT00068588|6428411|P2|STARTED|Overall Study||3
2618338|NCT00068588|6428412|P1|STARTED|Overall Study||0
2618339|NCT00068575|6428422|P1|NOT COMPLETED|Overall Study||0
2618340|NCT00068575|6428422|P1|COMPLETED|Overall Study||28
2618341|NCT00068575|6428422|P1|STARTED|Overall Study||28
2618342|NCT00068445|6428428|P2|NOT COMPLETED|Treatment||16
2618343|NCT00068445|6428429|P1|NOT COMPLETED|Treatment||29
2618344|NCT00068445|6428428|P2|COMPLETED|Treatment||46
2618345|NCT00068445|6428429|P1|COMPLETED|Treatment||34
2618346|NCT00068445|6428428|P2|STARTED|Treatment||62
2618347|NCT00068445|6428429|P1|STARTED|Treatment||63
2618348|NCT00068445|6428428|P2|NOT COMPLETED|Randomization||4
2618349|NCT00068445|6428429|P1|NOT COMPLETED|Randomization||2
2618350|NCT00068445|6428428|P2|COMPLETED|Randomization||62
2618351|NCT00068445|6428429|P1|COMPLETED|Randomization||63
2618352|NCT00068445|6428428|P2|STARTED|Randomization||66
2618353|NCT00068445|6428429|P1|STARTED|Randomization||65
2618357|NCT00068406|6428462|P1|NOT COMPLETED|Overall Study||3
2618358|NCT00068406|6428462|P1|COMPLETED|Overall Study||58
2618360|NCT00068393|6428467|P1|NOT COMPLETED|Overall Study||10
2618361|NCT00068393|6428467|P1|COMPLETED|Overall Study||29
2618362|NCT00068393|6428467|P1|Eligible and Treated|Overall Study||38
2618363|NCT00068393|6428467|P1|STARTED|Overall Study||39
2618364|NCT00068380|6428473|P1|NOT COMPLETED|Overall Study||5
2618365|NCT00068380|6428473|P1|COMPLETED|Overall Study||12
2618366|NCT00068380|6428473|P1|STARTED|Overall Study||17
2618367|NCT00068367|6428482|P1|NOT COMPLETED|Overall Study||0
2618368|NCT00068367|6428482|P1|COMPLETED|Overall Study||20
2618369|NCT00068367|6428482|P1|STARTED|Overall Study||20
2618370|NCT00068341|6428491|P3|NOT COMPLETED|Overall Study||0
2618371|NCT00068341|6428492|P2|NOT COMPLETED|Overall Study||0
2618372|NCT00068341|6428493|P1|NOT COMPLETED|Overall Study||0
2618373|NCT00068341|6428491|P3|COMPLETED|Overall Study||44
2618374|NCT00068341|6428492|P2|COMPLETED|Overall Study||15
2618375|NCT00068341|6428493|P1|COMPLETED|Overall Study||15
2618376|NCT00068341|6428491|P3|STARTED|Overall Study||44
2618377|NCT00068341|6428492|P2|STARTED|Overall Study||15
2618378|NCT00068341|6428493|P1|STARTED|Overall Study||15
2618379|NCT00068250|6428517|P4|NOT COMPLETED|Phase II: Dose Level 2||0
2618380|NCT00068250|6428518|P3|NOT COMPLETED|Phase II: Dose Level 2||0
2618381|NCT00068250|6428519|P2|NOT COMPLETED|Phase II: Dose Level 2||0
2618382|NCT00068250|6428520|P1|NOT COMPLETED|Phase II: Dose Level 2||0
2618383|NCT00068250|6428517|P4|COMPLETED|Phase II: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|47
2618384|NCT00068250|6428518|P3|COMPLETED|Phase II: Dose Level 2||0
2618385|NCT00068250|6428519|P2|COMPLETED|Phase II: Dose Level 2||0
2618386|NCT00068250|6428520|P1|COMPLETED|Phase II: Dose Level 2||0
2618387|NCT00068250|6428517|P4|STARTED|Phase II: Dose Level 2||47
2618388|NCT00068250|6428518|P3|STARTED|Phase II: Dose Level 2||0
2618389|NCT00068250|6428519|P2|STARTED|Phase II: Dose Level 2||0
2618390|NCT00068250|6428520|P1|STARTED|Phase II: Dose Level 2||0
2618391|NCT00068250|6428517|P4|NOT COMPLETED|Phase I: Dose Level 2||0
2618392|NCT00068250|6428518|P3|NOT COMPLETED|Phase I: Dose Level 2||0
2618393|NCT00068250|6428519|P2|NOT COMPLETED|Phase I: Dose Level 2||1
2618394|NCT00068250|6428520|P1|NOT COMPLETED|Phase I: Dose Level 2||0
2618395|NCT00068250|6428517|P4|COMPLETED|Phase I: Dose Level 2||0
2618396|NCT00068250|6428518|P3|COMPLETED|Phase I: Dose Level 2||0
2618397|NCT00068250|6428519|P2|COMPLETED|Phase I: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|6
2618398|NCT00068250|6428520|P1|COMPLETED|Phase I: Dose Level 2||0
2618399|NCT00068250|6428517|P4|STARTED|Phase I: Dose Level 2||0
2618400|NCT00068250|6428518|P3|STARTED|Phase I: Dose Level 2||0
2618401|NCT00068250|6428519|P2|STARTED|Phase I: Dose Level 2||7
2618402|NCT00068250|6428520|P1|STARTED|Phase I: Dose Level 2||0
2618403|NCT00068250|6428517|P4|NOT COMPLETED|Phase I: Dose Level 1||0
2618404|NCT00068250|6428518|P3|NOT COMPLETED|Phase I: Dose Level 1||0
2618405|NCT00068250|6428519|P2|NOT COMPLETED|Phase I: Dose Level 1||0
2618406|NCT00068250|6428520|P1|NOT COMPLETED|Phase I: Dose Level 1||0
2618407|NCT00068250|6428517|P4|COMPLETED|Phase I: Dose Level 1||0
2618408|NCT00068250|6428518|P3|COMPLETED|Phase I: Dose Level 1||0
2618409|NCT00068250|6428519|P2|COMPLETED|Phase I: Dose Level 1||0
2618410|NCT00068250|6428520|P1|COMPLETED|Phase I: Dose Level 1|Subjects with data available for the primary analysis are considered to have completed the study.|6
2618411|NCT00068250|6428517|P4|STARTED|Phase I: Dose Level 1||0
2618412|NCT00068250|6428518|P3|STARTED|Phase I: Dose Level 1||0
2618413|NCT00068250|6428519|P2|STARTED|Phase I: Dose Level 1||0
2618414|NCT00068250|6428520|P1|STARTED|Phase I: Dose Level 1||6
2618415|NCT00068237|6428530|P1|NOT COMPLETED|Overall Study||5
2618416|NCT00068237|6428530|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
2618417|NCT00068237|6428530|P1|STARTED|Overall Study||49
2618418|NCT00068107|6428542|P1|NOT COMPLETED|Overall Study||9
2618419|NCT00068107|6428542|P1|COMPLETED|Overall Study||3
2618420|NCT00068107|6428542|P1|STARTED|Overall Study||12
2618421|NCT00067990|6428555|P2|NOT COMPLETED|Overall Study||22
2618422|NCT00067990|6428556|P1|NOT COMPLETED|Overall Study||10
2618423|NCT00067990|6428555|P2|COMPLETED|Overall Study||54
2618424|NCT00067990|6428556|P1|COMPLETED|Overall Study||67
2618425|NCT00067990|6428555|P2|STARTED|Overall Study||76
2618426|NCT00067990|6428556|P1|STARTED|Overall Study||77
2618427|NCT00067808|6428567|P3|NOT COMPLETED|Overall Study||0
2618428|NCT00067808|6428568|P2|NOT COMPLETED|Overall Study||0
2618429|NCT00067808|6428569|P1|NOT COMPLETED|Overall Study||0
2618430|NCT00067808|6428567|P3|COMPLETED|Overall Study||14
2618431|NCT00067808|6428568|P2|COMPLETED|Overall Study||93
2618432|NCT00067808|6428569|P1|COMPLETED|Overall Study||17
2618433|NCT00067808|6428567|P3|STARTED|Overall Study||14
2618434|NCT00067808|6428568|P2|STARTED|Overall Study||93
2618435|NCT00067808|6428569|P1|STARTED|Overall Study||17
2618436|NCT00067470|6428579|P2|NOT COMPLETED|Overall Study||1
2618437|NCT00067470|6428580|P1|NOT COMPLETED|Overall Study||0
2618438|NCT00067470|6428579|P2|COMPLETED|Overall Study||19
2618439|NCT00067470|6428580|P1|COMPLETED|Overall Study||19
2618440|NCT00067470|6428579|P2|STARTED|Overall Study||20
2618441|NCT00067470|6428580|P1|STARTED|Overall Study||19
2618442|NCT00067236|6428592|P2|NOT COMPLETED|Overall Study||26
2618443|NCT00067236|6428593|P1|NOT COMPLETED|Overall Study||20
2618444|NCT00067236|6428592|P2|COMPLETED|Overall Study||99
2618445|NCT00067236|6428593|P1|COMPLETED|Overall Study||108
2618446|NCT00067236|6428592|P2|STARTED|Overall Study||125
2618447|NCT00067236|6428593|P1|STARTED|Overall Study||128
2618448|NCT00067002|6428601|P2|NOT COMPLETED|Overall Study||9
2618449|NCT00067002|6428602|P1|NOT COMPLETED|Overall Study||7
2618450|NCT00067002|6428601|P2|COMPLETED|Overall Study||44
2618451|NCT00067002|6428602|P1|COMPLETED|Overall Study||45
2618452|NCT00067002|6428601|P2|STARTED|Overall Study||53
2618453|NCT00067002|6428602|P1|STARTED|Overall Study||52
2618454|NCT00066963|6428619|P3|NOT COMPLETED|Overall Study||39
2618455|NCT00066963|6428620|P2|NOT COMPLETED|Overall Study||31
2618456|NCT00066963|6428621|P1|NOT COMPLETED|Overall Study||26
2618457|NCT00066963|6428619|P3|COMPLETED|Overall Study||87
2618458|NCT00066963|6428620|P2|COMPLETED|Overall Study||93
2618459|NCT00066963|6428621|P1|COMPLETED|Overall Study|any follow-up|100
2618460|NCT00066963|6428619|P3|STARTED|Overall Study||126
2618461|NCT00066963|6428620|P2|STARTED|Overall Study||124
2618462|NCT00066963|6428621|P1|STARTED|Overall Study||126
2618463|NCT00066937|6428633|P4|NOT COMPLETED|6 Month Follow-up||1
2618464|NCT00066937|6428634|P3|NOT COMPLETED|6 Month Follow-up||3
2618465|NCT00066937|6428635|P2|NOT COMPLETED|6 Month Follow-up||3
2618466|NCT00066937|6428636|P1|NOT COMPLETED|6 Month Follow-up||7
2618467|NCT00066937|6428633|P4|COMPLETED|6 Month Follow-up||14
2618468|NCT00066937|6428634|P3|COMPLETED|6 Month Follow-up||22
2618469|NCT00066937|6428635|P2|COMPLETED|6 Month Follow-up||29
2618470|NCT00066937|6428636|P1|COMPLETED|6 Month Follow-up||26
2618471|NCT00066937|6428633|P4|STARTED|6 Month Follow-up||15
2618472|NCT00066937|6428634|P3|STARTED|6 Month Follow-up||25
2618473|NCT00066937|6428635|P2|STARTED|6 Month Follow-up||32
2618474|NCT00066937|6428636|P1|STARTED|6 Month Follow-up||33
2618475|NCT00066937|6428633|P4|NOT COMPLETED|3 Month Follow-up||4
2618476|NCT00066937|6428634|P3|NOT COMPLETED|3 Month Follow-up||1
2618477|NCT00066937|6428635|P2|NOT COMPLETED|3 Month Follow-up||1
2618478|NCT00066937|6428636|P1|NOT COMPLETED|3 Month Follow-up||5
2618479|NCT00066937|6428633|P4|COMPLETED|3 Month Follow-up||15
2618480|NCT00066937|6428634|P3|COMPLETED|3 Month Follow-up||25
2618481|NCT00066937|6428635|P2|COMPLETED|3 Month Follow-up||32
2618482|NCT00066937|6428636|P1|COMPLETED|3 Month Follow-up||33
2618483|NCT00066937|6428633|P4|STARTED|3 Month Follow-up||19
2618484|NCT00066937|6428634|P3|STARTED|3 Month Follow-up||26
2618485|NCT00066937|6428635|P2|STARTED|3 Month Follow-up||33
2618486|NCT00066937|6428636|P1|STARTED|3 Month Follow-up||38
2618487|NCT00066937|6428633|P4|NOT COMPLETED|Treatment Phase||5
2618488|NCT00066937|6428634|P3|NOT COMPLETED|Treatment Phase||11
2618489|NCT00066937|6428635|P2|NOT COMPLETED|Treatment Phase||5
2618490|NCT00066937|6428636|P1|NOT COMPLETED|Treatment Phase||3
2618491|NCT00066937|6428633|P4|COMPLETED|Treatment Phase||19
2618492|NCT00066937|6428634|P3|COMPLETED|Treatment Phase||26
2618493|NCT00066937|6428635|P2|COMPLETED|Treatment Phase||33
2618494|NCT00066937|6428636|P1|COMPLETED|Treatment Phase||38
2618495|NCT00066937|6428633|P4|STARTED|Treatment Phase||24
2618496|NCT00066937|6428634|P3|STARTED|Treatment Phase||37
2618497|NCT00066937|6428635|P2|STARTED|Treatment Phase||38
2618498|NCT00066937|6428636|P1|STARTED|Treatment Phase||41
2618499|NCT00066807|6428660|P2|NOT COMPLETED|Overall Study||15
2618500|NCT00066807|6428661|P1|NOT COMPLETED|Overall Study||14
2618501|NCT00066807|6428660|P2|COMPLETED|Overall Study||0
2618502|NCT00066807|6428661|P1|COMPLETED|Overall Study||0
2618503|NCT00066807|6428660|P2|STARTED|Overall Study||15
2618504|NCT00066807|6428661|P1|STARTED|Overall Study||14
2618505|NCT00066781|6428675|P2|NOT COMPLETED|Overall Study||0
2618506|NCT00066781|6428676|P1|NOT COMPLETED|Overall Study||0
2618507|NCT00066781|6428675|P2|COMPLETED|Overall Study||17
2618508|NCT00066781|6428676|P1|COMPLETED|Overall Study||14
2618509|NCT00066781|6428675|P2|STARTED|Overall Study||17
2618510|NCT00066781|6428676|P1|STARTED|Overall Study||14
2618511|NCT00066742|6428686|P1|NOT COMPLETED|Consolidation Chemotherapy||3
2618512|NCT00066742|6428686|P1|COMPLETED|Consolidation Chemotherapy||39
2618513|NCT00066742|6428686|P1|Eligible|Consolidation Chemotherapy||40
2618514|NCT00066742|6428686|P1|STARTED|Consolidation Chemotherapy||42
2618515|NCT00066742|6428686|P1|NOT COMPLETED|Induction Chemoradiotherapy||29
2618516|NCT00066742|6428686|P1|COMPLETED|Induction Chemoradiotherapy||43
2618517|NCT00066742|6428686|P1|Began Protocol Treatment|Induction Chemoradiotherapy||68
2618518|NCT00066742|6428686|P1|Eligible|Induction Chemoradiotherapy||69
2618519|NCT00066742|6428686|P1|STARTED|Induction Chemoradiotherapy||72
2618520|NCT00066703|6428695|P2|NOT COMPLETED|Overall Study||582
2618521|NCT00066703|6428696|P1|NOT COMPLETED|Overall Study||612
2618522|NCT00066703|6428695|P2|COMPLETED|Overall Study||756
2618523|NCT00066703|6428696|P1|COMPLETED|Overall Study||722
2618524|NCT00066703|6428695|P2|STARTED|Overall Study||1338
2618525|NCT00066703|6428696|P1|STARTED|Overall Study||1334
2618526|NCT00066690|6428711|P3|NOT COMPLETED|Overall Study||564
2618527|NCT00066690|6428712|P2|NOT COMPLETED|Overall Study||522
2618528|NCT00066690|6428713|P1|NOT COMPLETED|Overall Study||598
2618529|NCT00066690|6428711|P3|COMPLETED|Overall Study||457
2618530|NCT00066690|6428712|P2|COMPLETED|Overall Study||502
2618531|NCT00066690|6428713|P1|COMPLETED|Overall Study||423
2618532|NCT00066690|6428711|P3|STARTED|Overall Study||1021
2618533|NCT00066690|6428712|P2|STARTED|Overall Study||1024
2618534|NCT00066690|6428713|P1|STARTED|Overall Study||1021
2618535|NCT00066573|6428732|P2|NOT COMPLETED|Overall Study||28
2618536|NCT00066573|6428733|P1|NOT COMPLETED|Overall Study||28
2618537|NCT00066573|6428732|P2|COMPLETED|Overall Study||3759
2618538|NCT00066573|6428733|P1|COMPLETED|Overall Study||3761
2618539|NCT00066573|6428732|P2|STARTED|Overall Study||3787
2618540|NCT00066573|6428733|P1|STARTED|Overall Study||3789
2618541|NCT00066469|6428745|P1|NOT COMPLETED|Overall Study||16
2618542|NCT00066469|6428745|P1|COMPLETED|Overall Study||39
2618543|NCT00066469|6428745|P1|STARTED|Overall Study||55
2618544|NCT00066365|6428751|P2|NOT COMPLETED|Overall Study||14
2618545|NCT00066365|6428752|P1|NOT COMPLETED|Overall Study||23
2618546|NCT00066365|6428751|P2|COMPLETED|Overall Study||4
2618547|NCT00066365|6428752|P1|COMPLETED|Overall Study||8
2618548|NCT00066365|6428751|P2|STARTED|Overall Study||18
2618549|NCT00066365|6428752|P1|STARTED|Overall Study||31
2618550|NCT00066222|6428780|P1|NOT COMPLETED|Overall Study||1
2618551|NCT00066222|6428780|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|71
2618552|NCT00066222|6428780|P1|STARTED|Overall Study||72
2618553|NCT00066170|6428793|P4|NOT COMPLETED|Overall Study||9
2618554|NCT00066170|6428794|P3|NOT COMPLETED|Overall Study||4
2618555|NCT00066170|6428795|P2|NOT COMPLETED|Overall Study||10
2618556|NCT00066170|6428796|P1|NOT COMPLETED|Overall Study||7
2618557|NCT00066170|6428793|P4|COMPLETED|Overall Study||48
2618558|NCT00066170|6428794|P3|COMPLETED|Overall Study||59
2618559|NCT00066170|6428795|P2|COMPLETED|Overall Study||45
2618560|NCT00066170|6428796|P1|COMPLETED|Overall Study||49
2618561|NCT00066170|6428793|P4|Intent to Treat|Overall Study||54
2618562|NCT00066170|6428794|P3|Intent to Treat|Overall Study||63
2618563|NCT00066170|6428795|P2|Intent to Treat|Overall Study||50
2618564|NCT00066170|6428796|P1|Intent to Treat|Overall Study||55
2618565|NCT00066170|6428793|P4|STARTED|Overall Study||57
2618566|NCT00066170|6428794|P3|STARTED|Overall Study||63
2618567|NCT00066170|6428795|P2|STARTED|Overall Study||55
2618568|NCT00066170|6428796|P1|STARTED|Overall Study||56
2618569|NCT00066066|6428809|P6|NOT COMPLETED|Overall Study||5
2618570|NCT00066066|6428810|P5|NOT COMPLETED|Overall Study||3
2618571|NCT00066066|6428811|P4|NOT COMPLETED|Overall Study||4
2618572|NCT00066066|6428812|P3|NOT COMPLETED|Overall Study||7
2618573|NCT00066066|6428813|P2|NOT COMPLETED|Overall Study||4
2618574|NCT00066066|6428814|P1|NOT COMPLETED|Overall Study||6
2618575|NCT00066066|6428809|P6|COMPLETED|Overall Study|20 enrolled, 15 analyzed,9 subjects had complete data,6 subjects had data carried forward.|15
2618576|NCT00066066|6428810|P5|COMPLETED|Overall Study|27 enrolled, 24 analyzed,19 subjects had complete data,5 subjects had data carried forward.|24
2618577|NCT00066066|6428811|P4|COMPLETED|Overall Study|20 enrolled, 16 analyzed,11 subjects had complete data,5 subjects had data carried forward.|16
2618578|NCT00066066|6428812|P3|COMPLETED|Overall Study|30 enrolled, 23 analyzed,21 subjects had complete data,2 subjects had data carried forward.|23
2618579|NCT00066066|6428813|P2|COMPLETED|Overall Study|22 enrolled, 18 analyzed,11 subjects had complete data,7 subjects had data carried forward.|18
2618580|NCT00066066|6428814|P1|COMPLETED|Overall Study|27 enrolled, 21 analyzed,18 subjects had complete data,3 subjects had data carried forward.|21
2618581|NCT00066066|6428809|P6|12 Month|Overall Study||9
2618582|NCT00066066|6428810|P5|12 Month|Overall Study||19
2618583|NCT00066066|6428811|P4|12 Month|Overall Study||11
2618584|NCT00066066|6428812|P3|12 Month|Overall Study||21
2618585|NCT00066066|6428813|P2|12 Month|Overall Study||11
2618586|NCT00066066|6428814|P1|12 Month|Overall Study||18
2618587|NCT00066066|6428809|P6|6 Month|Overall Study||14
2618588|NCT00066066|6428810|P5|6 Month|Overall Study||21
2618589|NCT00066066|6428811|P4|6 Month|Overall Study||13
2618590|NCT00066066|6428812|P3|6 Month|Overall Study||23
2618591|NCT00066066|6428813|P2|6 Month|Overall Study||13
2618592|NCT00066066|6428814|P1|6 Month|Overall Study||19
2618593|NCT00066066|6428809|P6|3 Month|Overall Study||15
2618594|NCT00066066|6428810|P5|3 Month|Overall Study||22
2618595|NCT00066066|6428811|P4|3 Month|Overall Study||16
2618596|NCT00066066|6428812|P3|3 Month|Overall Study||23
2618597|NCT00066066|6428813|P2|3 Month|Overall Study||17
2618598|NCT00066066|6428814|P1|3 Month|Overall Study||21
2618599|NCT00066066|6428809|P6|Baseline|Overall Study||20
2618600|NCT00066066|6428810|P5|Baseline|Overall Study||27
2618601|NCT00066066|6428811|P4|Baseline|Overall Study||20
2618602|NCT00066066|6428812|P3|Baseline|Overall Study||30
2618603|NCT00066066|6428813|P2|Baseline|Overall Study||22
2618604|NCT00066066|6428814|P1|Baseline|Overall Study||27
2618605|NCT00066066|6428809|P6|STARTED|Overall Study||20
2618606|NCT00066066|6428810|P5|STARTED|Overall Study||27
2618607|NCT00066066|6428811|P4|STARTED|Overall Study||20
2618608|NCT00066066|6428812|P3|STARTED|Overall Study||30
2618609|NCT00066066|6428813|P2|STARTED|Overall Study||22
2618610|NCT00066066|6428814|P1|STARTED|Overall Study||27
2618611|NCT00065806|6428830|P2|NOT COMPLETED|Overall Study||19
2618612|NCT00065806|6428831|P1|NOT COMPLETED|Overall Study||20
2618613|NCT00065806|6428830|P2|COMPLETED|Overall Study||89
2618614|NCT00065806|6428831|P1|COMPLETED|Overall Study||93
2618615|NCT00065806|6428830|P2|STARTED|Overall Study||108
2618616|NCT00065806|6428831|P1|STARTED|Overall Study||113
2618617|NCT00014560|6428873|P1|NOT COMPLETED|Overall Study||3
2618618|NCT00014560|6428873|P1|COMPLETED|Overall Study||0
2618619|NCT00014560|6428873|P1|STARTED|Overall Study||3
2618620|NCT00065611|6428879|P2|NOT COMPLETED|Overall Study||1
2618621|NCT00065611|6428880|P1|NOT COMPLETED|Overall Study||0
2618622|NCT00065611|6428879|P2|COMPLETED|Overall Study||3
2618623|NCT00065611|6428880|P1|COMPLETED|Overall Study||4
2618624|NCT00065611|6428879|P2|STARTED|Overall Study||4
2618625|NCT00065611|6428880|P1|STARTED|Overall Study||4
2618626|NCT00065507|6428892|P2|NOT COMPLETED|Overall Study||29
2618627|NCT00065507|6428893|P1|NOT COMPLETED|Overall Study||29
2618628|NCT00065507|6428892|P2|COMPLETED|Overall Study|Completed first 48 weeks of treatment|62
2618629|NCT00065507|6428893|P1|COMPLETED|Overall Study|Completed first 48 weeks of treatment|71
2618630|NCT00065507|6428892|P2|Treated, 24-Week Follow-Up Population|Overall Study||28
2618631|NCT00065507|6428893|P1|Treated, 24-Week Follow-Up Population|Overall Study||25
2618632|NCT00065507|6428892|P2|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
2618633|NCT00065507|6428893|P1|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
2618634|NCT00065507|6428892|P2|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
2618635|NCT00065507|6428893|P1|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
2618636|NCT00065507|6428892|P2|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|91
2618637|NCT00065507|6428893|P1|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|100
2618638|NCT00065507|6428892|P2|STARTED|Overall Study|94 participants were randomized; 3 never treated.|91
2618639|NCT00065507|6428893|P1|STARTED|Overall Study|101 participants were randomized; 1 never treated.|100
2618640|NCT00065468|6428958|P3|NOT COMPLETED|Overall Study||210
2618641|NCT00065468|6428959|P2|NOT COMPLETED|Overall Study||209
2618642|NCT00065468|6428960|P1|NOT COMPLETED|Overall Study||207
2618643|NCT00065468|6428958|P3|COMPLETED|Overall Study||0
2618644|NCT00065468|6428959|P2|COMPLETED|Overall Study||0
2618645|NCT00065468|6428960|P1|COMPLETED|Overall Study||0
2618646|NCT00065468|6428958|P3|Received Treatment|Overall Study||208
2618647|NCT00065468|6428959|P2|Received Treatment|Overall Study||208
2618648|NCT00065468|6428960|P1|Received Treatment|Overall Study||200
2618649|NCT00065468|6428958|P3|STARTED|Overall Study||210
2618650|NCT00065468|6428959|P2|STARTED|Overall Study||209
2618651|NCT00065468|6428960|P1|STARTED|Overall Study||207
2618652|NCT00065442|6428991|P2|NOT COMPLETED|Overall Study||220
2618653|NCT00065442|6428992|P1|NOT COMPLETED|Overall Study||125
2618654|NCT00065442|6428991|P2|COMPLETED|Overall Study||121
2618655|NCT00065442|6428992|P1|COMPLETED|Overall Study||46
2618656|NCT00065442|6428991|P2|STARTED|Overall Study||341
2618657|NCT00065442|6428992|P1|STARTED|Overall Study||171
2618658|NCT00065429|6429007|P7|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
2618659|NCT00065429|6429008|P6|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
2618660|NCT00065429|6429009|P5|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||6
2618661|NCT00065429|6429010|P4|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
2618662|NCT00065429|6429011|P3|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
2618663|NCT00065429|6429012|P2|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
2618664|NCT00065429|6429013|P1|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
2618665|NCT00065429|6429007|P7|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
2618666|NCT00065429|6429008|P6|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
2618667|NCT00065429|6429009|P5|COMPLETED|Phase II - Apr 2003 - Aug 2008||26
2618668|NCT00065429|6429010|P4|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
2618669|NCT00065429|6429011|P3|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
2618670|NCT00065429|6429012|P2|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
2618671|NCT00065429|6429013|P1|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
2618672|NCT00065429|6429007|P7|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
2618673|NCT00065429|6429008|P6|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
2618674|NCT00065429|6429009|P5|STARTED|Phase II - Apr 2003 - Aug 2008|All 32 patients enrolled in Phase 2 were at 60 mg/m2.|32
2618675|NCT00065429|6429010|P4|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
2618676|NCT00065429|6429011|P3|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
2618677|NCT00065429|6429012|P2|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
2618678|NCT00065429|6429013|P1|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
2618679|NCT00065429|6429007|P7|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
2618680|NCT00065429|6429008|P6|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
2618681|NCT00065429|6429009|P5|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
2618682|NCT00065429|6429010|P4|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
2618683|NCT00065429|6429011|P3|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
2618684|NCT00065429|6429012|P2|NOT COMPLETED|Phase I - May 2001 - Oct 2002||0
2618685|NCT00065429|6429013|P1|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
2618686|NCT00065429|6429007|P7|COMPLETED|Phase I - May 2001 - Oct 2002||2
2618687|NCT00065429|6429008|P6|COMPLETED|Phase I - May 2001 - Oct 2002||2
2618688|NCT00065429|6429009|P5|COMPLETED|Phase I - May 2001 - Oct 2002||8
2618689|NCT00065429|6429010|P4|COMPLETED|Phase I - May 2001 - Oct 2002||3
2618690|NCT00065429|6429011|P3|COMPLETED|Phase I - May 2001 - Oct 2002||3
2618691|NCT00065429|6429012|P2|COMPLETED|Phase I - May 2001 - Oct 2002||3
2618692|NCT00065429|6429013|P1|COMPLETED|Phase I - May 2001 - Oct 2002||3
2618693|NCT00065429|6429007|P7|STARTED|Phase I - May 2001 - Oct 2002||4
2618694|NCT00065429|6429008|P6|STARTED|Phase I - May 2001 - Oct 2002||4
2618695|NCT00065429|6429009|P5|STARTED|Phase I - May 2001 - Oct 2002||9
2618696|NCT00065429|6429010|P4|STARTED|Phase I - May 2001 - Oct 2002||4
2618697|NCT00065429|6429011|P3|STARTED|Phase I - May 2001 - Oct 2002||4
2618698|NCT00065429|6429012|P2|STARTED|Phase I - May 2001 - Oct 2002||3
2618699|NCT00065429|6429013|P1|STARTED|Phase I - May 2001 - Oct 2002||4
2618700|NCT00065260|6429027|P2|NOT COMPLETED|Overall Study||1
2618701|NCT00065260|6429028|P1|NOT COMPLETED|Overall Study||0
2618702|NCT00065260|6429027|P2|COMPLETED|Overall Study||26
2618703|NCT00065260|6429028|P1|COMPLETED|Overall Study||27
2618704|NCT00065260|6429027|P2|STARTED|Overall Study||27
2618705|NCT00065260|6429028|P1|STARTED|Overall Study||27
2618706|NCT00065182|6429036|P2|NOT COMPLETED|Overall Study||37
2618707|NCT00065182|6429037|P1|NOT COMPLETED|Overall Study||48
2618708|NCT00065182|6429036|P2|COMPLETED|Overall Study||160
2618709|NCT00065182|6429037|P1|COMPLETED|Overall Study||154
2618710|NCT00065182|6429036|P2|STARTED|Overall Study||197
2618711|NCT00065182|6429037|P1|STARTED|Overall Study||202
2618712|NCT00065156|6429063|P1|NOT COMPLETED|Overall Study||124
2618713|NCT00065156|6429063|P1|COMPLETED|Overall Study|24 patients rolled over to free drug due to sponsor closure of study.|24
2618714|NCT00065156|6429063|P1|Modified Intent to Treat Population|Overall Study||94
2618715|NCT00065156|6429063|P1|STARTED|Overall Study||148
2618716|NCT00065065|6429080|P2|NOT COMPLETED|Overall Study||20
2618717|NCT00065065|6429081|P1|NOT COMPLETED|Overall Study||10
2618718|NCT00065065|6429080|P2|COMPLETED|Overall Study||33
2618719|NCT00065065|6429081|P1|COMPLETED|Overall Study||42
2618720|NCT00065065|6429080|P2|STARTED|Overall Study||53
2618721|NCT00065065|6429081|P1|STARTED|Overall Study||52
2618722|NCT00003895|6429093|P2|NOT COMPLETED|Overall Study||4
2618723|NCT00003895|6429094|P1|NOT COMPLETED|Overall Study||7
2618724|NCT00003895|6429093|P2|COMPLETED|Overall Study||14
2618725|NCT00003895|6429094|P1|COMPLETED|Overall Study||11
2618726|NCT00003895|6429093|P2|STARTED|Overall Study||18
2618727|NCT00003895|6429094|P1|STARTED|Overall Study||18
2618728|NCT00064987|6429102|P2|NOT COMPLETED|Overall Study||0
2618729|NCT00064987|6429103|P1|NOT COMPLETED|Overall Study||3
2618730|NCT00064987|6429102|P2|COMPLETED|Overall Study||6
2618731|NCT00064987|6429103|P1|COMPLETED|Overall Study||7
2618732|NCT00064987|6429102|P2|STARTED|Overall Study||6
2618733|NCT00064987|6429103|P1|STARTED|Overall Study||10
2618734|NCT00064844|6429123|P2|NOT COMPLETED|Overall Study||19
2618735|NCT00064844|6429124|P1|NOT COMPLETED|Overall Study||8
2618736|NCT00064844|6429123|P2|COMPLETED|Overall Study||32
2618737|NCT00064844|6429124|P1|COMPLETED|Overall Study||37
2618738|NCT00064844|6429123|P2|12 Month Follow-up|Overall Study||32
2618739|NCT00064844|6429124|P1|12 Month Follow-up|Overall Study||37
2618740|NCT00064844|6429123|P2|6 Month Follow-up|Overall Study||40
2618741|NCT00064844|6429124|P1|6 Month Follow-up|Overall Study||39
2618742|NCT00064844|6429123|P2|3 Month Follow-up|Overall Study||47
2618743|NCT00064844|6429124|P1|3 Month Follow-up|Overall Study||40
2618744|NCT00064844|6429123|P2|2 Week Follow-up|Overall Study||51
2618745|NCT00064844|6429124|P1|2 Week Follow-up|Overall Study||45
2618746|NCT00064844|6429123|P2|STARTED|Overall Study||51
2618747|NCT00064844|6429124|P1|STARTED|Overall Study||45
2618748|NCT00064753|6429134|P2|NOT COMPLETED|Overall Study||648
2618749|NCT00064753|6429135|P1|NOT COMPLETED|Overall Study||674
2618750|NCT00064753|6429134|P2|COMPLETED|Overall Study||1406
2618751|NCT00064753|6429135|P1|COMPLETED|Overall Study||1382
2618752|NCT00064753|6429134|P2|STARTED|Overall Study||2054
2618753|NCT00064753|6429135|P1|STARTED|Overall Study||2056
2618754|NCT00064792|6429165|P2|NOT COMPLETED|Overall Study||0
2618755|NCT00064792|6429166|P1|NOT COMPLETED|Overall Study||5
2618756|NCT00064792|6429165|P2|COMPLETED|Overall Study||10
2618757|NCT00064792|6429166|P1|COMPLETED|Overall Study||8
2618758|NCT00064792|6429165|P2|STARTED|Overall Study||10
2618759|NCT00064792|6429166|P1|STARTED|Overall Study||13
2618760|NCT00064701|6429177|P3|NOT COMPLETED|Clinical Continuation Phase||140
2618761|NCT00064701|6429178|P2|NOT COMPLETED|Clinical Continuation Phase||178
2618762|NCT00064701|6429179|P1|NOT COMPLETED|Clinical Continuation Phase||170
2618763|NCT00064701|6429177|P3|COMPLETED|Clinical Continuation Phase||11
2618764|NCT00064701|6429178|P2|COMPLETED|Clinical Continuation Phase||4
2618765|NCT00064701|6429179|P1|COMPLETED|Clinical Continuation Phase||9
2618766|NCT00064701|6429177|P3|STARTED|Clinical Continuation Phase||151
2618767|NCT00064701|6429178|P2|STARTED|Clinical Continuation Phase|One participant did not enter the Clinical Continuation phase|182
2618768|NCT00064701|6429179|P1|STARTED|Clinical Continuation Phase||179
2618769|NCT00064701|6429177|P3|NOT COMPLETED|One Year Post-transplant||72
2618770|NCT00064701|6429178|P2|NOT COMPLETED|One Year Post-transplant||43
2618771|NCT00064701|6429179|P1|NOT COMPLETED|One Year Post-transplant||40
2618772|NCT00064701|6429177|P3|COMPLETED|One Year Post-transplant||151
2618773|NCT00064701|6429178|P2|COMPLETED|One Year Post-transplant||183
2618774|NCT00064701|6429179|P1|COMPLETED|One Year Post-transplant||179
2618775|NCT00064701|6429177|P3|Received Study Drug|One Year Post-transplant||212
2618776|NCT00064701|6429178|P2|Received Study Drug|One Year Post-transplant||214
2618777|NCT00064701|6429179|P1|Received Study Drug|One Year Post-transplant||212
2618778|NCT00064701|6429177|P3|STARTED|One Year Post-transplant||223
2618779|NCT00064701|6429178|P2|STARTED|One Year Post-transplant||226
2618780|NCT00064701|6429179|P1|STARTED|One Year Post-transplant||219
2618781|NCT00064662|6429231|P2|NOT COMPLETED|Overall Study||61
2618782|NCT00064662|6429232|P1|NOT COMPLETED|Overall Study||74
2618783|NCT00064662|6429231|P2|COMPLETED|Overall Study||265
2618784|NCT00064662|6429232|P1|COMPLETED|Overall Study||255
2618785|NCT00064662|6429231|P2|STARTED|Overall Study||326
2618786|NCT00064662|6429232|P1|STARTED|Overall Study||329
2618787|NCT00064350|6429243|P3|NOT COMPLETED|Cross-Over||0
2618788|NCT00064350|6429244|P2|NOT COMPLETED|Cross-Over||14
2618789|NCT00064350|6429245|P1|NOT COMPLETED|Cross-Over||6
2618790|NCT00064350|6429243|P3|COMPLETED|Cross-Over||0
2618791|NCT00064350|6429244|P2|COMPLETED|Cross-Over||13
2618792|NCT00064350|6429245|P1|COMPLETED|Cross-Over||4
2618793|NCT00064350|6429243|P3|Eligible and Treated|Cross-Over||0
2618794|NCT00064350|6429244|P2|Eligible and Treated|Cross-Over||21
2618795|NCT00064350|6429245|P1|Eligible and Treated|Cross-Over||7
2618796|NCT00064350|6429243|P3|Treated|Cross-Over||0
2618797|NCT00064350|6429244|P2|Treated|Cross-Over||26
2618798|NCT00064350|6429245|P1|Treated|Cross-Over||9
2618799|NCT00064350|6429243|P3|STARTED|Cross-Over||0
2618800|NCT00064350|6429244|P2|STARTED|Cross-Over||27
2618801|NCT00064350|6429245|P1|STARTED|Cross-Over||10
2618802|NCT00064350|6429243|P3|NOT COMPLETED|Randomization||0
2618803|NCT00064350|6429244|P2|NOT COMPLETED|Randomization||18
2618804|NCT00064350|6429245|P1|NOT COMPLETED|Randomization||26
2618805|NCT00064350|6429243|P3|COMPLETED|Randomization||0
2618806|NCT00064350|6429244|P2|COMPLETED|Randomization||28
2618807|NCT00064350|6429245|P1|COMPLETED|Randomization||33
2618808|NCT00064350|6429243|P3|Eligible and Treated|Randomization||0
2618809|NCT00064350|6429244|P2|Eligible and Treated|Randomization||31
2618810|NCT00064350|6429245|P1|Eligible and Treated|Randomization||50
2618811|NCT00064350|6429243|P3|Treated|Randomization||0
2618812|NCT00064350|6429244|P2|Treated|Randomization||40
2618813|NCT00064350|6429245|P1|Treated|Randomization||55
2618814|NCT00064350|6429243|P3|STARTED|Randomization||0
2618815|NCT00064350|6429244|P2|STARTED|Randomization||46
2618816|NCT00064350|6429245|P1|STARTED|Randomization||59
2618817|NCT00064350|6429243|P3|NOT COMPLETED|Induction Treatment||236
2618818|NCT00064350|6429244|P2|NOT COMPLETED|Induction Treatment||9
2618819|NCT00064350|6429245|P1|NOT COMPLETED|Induction Treatment||8
2618820|NCT00064350|6429243|P3|COMPLETED|Induction Treatment||1
2618821|NCT00064350|6429244|P2|COMPLETED|Induction Treatment||37
2618822|NCT00064350|6429245|P1|COMPLETED|Induction Treatment||51
2618823|NCT00064350|6429243|P3|Eligible and Treated|Induction Treatment||194
2618824|NCT00064350|6429244|P2|Eligible and Treated|Induction Treatment||46
2618825|NCT00064350|6429245|P1|Eligible and Treated|Induction Treatment||59
2618826|NCT00064350|6429243|P3|Treated|Induction Treatment||228
2618827|NCT00064350|6429244|P2|Treated|Induction Treatment||46
2618828|NCT00064350|6429245|P1|Treated|Induction Treatment||59
2618829|NCT00064350|6429243|P3|STARTED|Induction Treatment||237
2618830|NCT00064350|6429244|P2|STARTED|Induction Treatment||46
2618831|NCT00064350|6429245|P1|STARTED|Induction Treatment||59
2618832|NCT00064337|6429260|P1|NOT COMPLETED|Maintenance||10
2618833|NCT00064337|6429260|P1|COMPLETED|Maintenance||3
2618834|NCT00064337|6429260|P1|STARTED|Maintenance|Only patients with High Risk MM or AL + MM were allowed to enroll to Maintenance treatment.|13
2618835|NCT00064337|6429260|P1|NOT COMPLETED|Transplant||21
2618836|NCT00064337|6429260|P1|COMPLETED|Transplant||46
2618837|NCT00064337|6429260|P1|STARTED|Transplant|6 patients who completed PBSCC or Induction/PBSCC did not begin Transplant|67
2618838|NCT00064337|6429260|P1|NOT COMPLETED|PBSCC or Induction/PBSCC||20
2618839|NCT00064337|6429260|P1|COMPLETED|PBSCC or Induction/PBSCC||73
2618840|NCT00064337|6429260|P1|STARTED|PBSCC or Induction/PBSCC|104 patients were registered, 93 of whom were eligible and analyzable.|93
2618841|NCT00064298|6429269|P2|NOT COMPLETED|Overall Study||5
2618842|NCT00064298|6429270|P1|NOT COMPLETED|Overall Study||6
2618843|NCT00064298|6429269|P2|COMPLETED|Overall Study||57
2618844|NCT00064298|6429270|P1|COMPLETED|Overall Study||66
2618845|NCT00064298|6429269|P2|STARTED|Overall Study||62
2618846|NCT00064298|6429270|P1|STARTED|Overall Study||72
2618847|NCT00064259|6429278|P4|NOT COMPLETED|Overall Study||1
2618848|NCT00064259|6429279|P3|NOT COMPLETED|Overall Study||0
2618849|NCT00064259|6429280|P2|NOT COMPLETED|Overall Study||0
2618850|NCT00064259|6429281|P1|NOT COMPLETED|Overall Study||1
2618851|NCT00064259|6429278|P4|COMPLETED|Overall Study||0
2618852|NCT00064259|6429279|P3|COMPLETED|Overall Study||6
2618853|NCT00064259|6429280|P2|COMPLETED|Overall Study||4
2618854|NCT00064259|6429281|P1|COMPLETED|Overall Study||3
2618855|NCT00064259|6429278|P4|STARTED|Overall Study||1
2618856|NCT00064259|6429279|P3|STARTED|Overall Study||6
2618857|NCT00064259|6429280|P2|STARTED|Overall Study||4
2618858|NCT00064259|6429281|P1|STARTED|Overall Study||4
2618859|NCT00064077|6429289|P4|NOT COMPLETED|Overall Study||7
2618860|NCT00064077|6429290|P3|NOT COMPLETED|Overall Study||7
2618861|NCT00064077|6429291|P2|NOT COMPLETED|Overall Study||9
2618862|NCT00064077|6429292|P1|NOT COMPLETED|Overall Study||15
2618863|NCT00064077|6429289|P4|COMPLETED|Overall Study|Evaluable (treatment)|111
2618864|NCT00064077|6429290|P3|COMPLETED|Overall Study|Evaluable (treatment)|112
2618865|NCT00064077|6429291|P2|COMPLETED|Overall Study|Evaluable (treatment)|108
2618866|NCT00064077|6429292|P1|COMPLETED|Overall Study|Evaluable (treatment)|103
2618867|NCT00064077|6429289|P4|STARTED|Overall Study||118
2618868|NCT00064077|6429290|P3|STARTED|Overall Study||119
2618869|NCT00064077|6429291|P2|STARTED|Overall Study||117
2618870|NCT00064077|6429292|P1|STARTED|Overall Study||118
2618871|NCT00064038|6429324|P3|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||2
2618872|NCT00064038|6429325|P2|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
2618873|NCT00064038|6429326|P1|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
2618874|NCT00064038|6429324|P3|COMPLETED|Crossover to Lenalidomide+Dexamethasone||40
2618875|NCT00064038|6429325|P2|COMPLETED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
2618876|NCT00064038|6429326|P1|COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
2618877|NCT00064038|6429324|P3|Safety Population|Crossover to Lenalidomide+Dexamethasone||40
2618878|NCT00064038|6429325|P2|Safety Population|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
2618879|NCT00064038|6429326|P1|Safety Population|Crossover to Lenalidomide+Dexamethasone||0
2618880|NCT00064038|6429324|P3|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||40
2618881|NCT00064038|6429325|P2|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
2618882|NCT00064038|6429326|P1|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||0
2618883|NCT00064038|6429324|P3|STARTED|Crossover to Lenalidomide+Dexamethasone||42
2618884|NCT00064038|6429325|P2|STARTED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
2618885|NCT00064038|6429326|P1|STARTED|Crossover to Lenalidomide+Dexamethasone||0
2618886|NCT00064038|6429324|P3|NOT COMPLETED|Initial Randomization||0
2618887|NCT00064038|6429325|P2|NOT COMPLETED|Initial Randomization||98
2618888|NCT00064038|6429326|P1|NOT COMPLETED|Initial Randomization||100
2618889|NCT00064038|6429324|P3|COMPLETED|Initial Randomization||0
2618890|NCT00064038|6429325|P2|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
2618891|NCT00064038|6429326|P1|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
2618892|NCT00064038|6429324|P3|Safety Population|Initial Randomization||0
2618893|NCT00064038|6429325|P2|Safety Population|Initial Randomization||94
2618894|NCT00064038|6429326|P1|Safety Population|Initial Randomization||96
2618895|NCT00064038|6429324|P3|Eligible and Analyzable|Initial Randomization||0
2618896|NCT00064038|6429325|P2|Eligible and Analyzable|Initial Randomization||95
2618897|NCT00064038|6429326|P1|Eligible and Analyzable|Initial Randomization||97
2618898|NCT00064038|6429324|P3|STARTED|Initial Randomization||0
2618899|NCT00064038|6429325|P2|STARTED|Initial Randomization||98
2618900|NCT00064038|6429326|P1|STARTED|Initial Randomization||100
2618901|NCT00064025|6429336|P1|NOT COMPLETED|Overall Study||7
2618902|NCT00064025|6429336|P1|COMPLETED|Overall Study||68
2618903|NCT00064025|6429336|P1|STARTED|Overall Study||75
2618904|NCT00063999|6429345|P2|NOT COMPLETED|Overall Study||24
2618905|NCT00063999|6429346|P1|NOT COMPLETED|Overall Study||45
2618906|NCT00063999|6429345|P2|COMPLETED|Overall Study||665
2618907|NCT00063999|6429346|P1|COMPLETED|Overall Study||647
2618908|NCT00063999|6429345|P2|STARTED|Overall Study||689
2618909|NCT00063999|6429346|P1|STARTED|Overall Study||692
2618910|NCT00063986|6429362|P1|NOT COMPLETED|Overall Study||6
2618911|NCT00063986|6429362|P1|COMPLETED|Overall Study||104
2618912|NCT00063986|6429362|P1|Eligible and Treated|Overall Study||104
2618913|NCT00063986|6429362|P1|Treated|Overall Study||105
2618914|NCT00063986|6429362|P1|STARTED|Overall Study||110
2618915|NCT00063934|6429374|P1|NOT COMPLETED|Overall Study||1
2618916|NCT00063934|6429374|P1|COMPLETED|Overall Study||30
2618917|NCT00063934|6429374|P1|STARTED|Overall Study||31
2618918|NCT00063882|6429383|P2|NOT COMPLETED|Overall Study||4
2618919|NCT00063882|6429384|P1|NOT COMPLETED|Overall Study||5
2618920|NCT00063882|6429383|P2|COMPLETED|Overall Study||292
2618921|NCT00063882|6429384|P1|COMPLETED|Overall Study||287
2618922|NCT00063882|6429383|P2|Eligible Patients|Overall Study||292
2618923|NCT00063882|6429384|P1|Eligible Patients|Overall Study||287
2618924|NCT00063882|6429383|P2|Has Baseline/24-month EPIC Data|Overall Study||219
2618925|NCT00063882|6429384|P1|Has Baseline/24-month EPIC Data|Overall Study||201
2618926|NCT00063882|6429383|P2|Has Baseline/4-month EPIC Data|Overall Study||241
2618927|NCT00063882|6429384|P1|Has Baseline/4-month EPIC Data|Overall Study||222
2618928|NCT00063882|6429383|P2|Has Late Adverse Event Data|Overall Study||287
2618929|NCT00063882|6429384|P1|Has Late Adverse Event Data|Overall Study||282
2618930|NCT00063882|6429383|P2|Has Acute Adverse Event Data|Overall Study||288
2618931|NCT00063882|6429384|P1|Has Acute Adverse Event Data|Overall Study||282
2618932|NCT00063882|6429383|P2|STARTED|Overall Study||296
2618933|NCT00063882|6429384|P1|STARTED|Overall Study||292
2618934|NCT00063635|6429415|P3|NOT COMPLETED|Overall Study||9
2618935|NCT00063635|6429416|P2|NOT COMPLETED|Overall Study||8
2618936|NCT00063635|6429417|P1|NOT COMPLETED|Overall Study||6
2618937|NCT00063635|6429415|P3|COMPLETED|Overall Study||49
2618938|NCT00063635|6429416|P2|COMPLETED|Overall Study||50
2618939|NCT00063635|6429417|P1|COMPLETED|Overall Study||51
2618940|NCT00063635|6429415|P3|STARTED|Overall Study||58
2618941|NCT00063635|6429416|P2|STARTED|Overall Study||58
2618942|NCT00063635|6429417|P1|STARTED|Overall Study||57
2618943|NCT00063622|6429458|P3|NOT COMPLETED|Overall Study||11
2618944|NCT00063622|6429459|P2|NOT COMPLETED|Overall Study||4
2618945|NCT00063622|6429460|P1|NOT COMPLETED|Overall Study||10
2618946|NCT00063622|6429458|P3|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|72
2618947|NCT00063622|6429459|P2|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|80
2618948|NCT00063622|6429460|P1|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|70
2618949|NCT00063622|6429458|P3|STARTED|Overall Study||83
2618950|NCT00063622|6429459|P2|STARTED|Overall Study||84
2618951|NCT00063622|6429460|P1|STARTED|Overall Study||80
2618952|NCT00063570|6429485|P2|NOT COMPLETED|Overall Study||0
2618953|NCT00063570|6429486|P1|NOT COMPLETED|Overall Study||0
2618954|NCT00063570|6429485|P2|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|21
2618955|NCT00063570|6429486|P1|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|52
2618956|NCT00063570|6429485|P2|STARTED|Overall Study||21
2618957|NCT00063570|6429486|P1|STARTED|Overall Study||52
2618958|NCT00063362|6429502|P2|NOT COMPLETED|Overall Study||4
2618959|NCT00063362|6429503|P1|NOT COMPLETED|Overall Study||4
2618960|NCT00063362|6429502|P2|COMPLETED|Overall Study||22
2618961|NCT00063362|6429503|P1|COMPLETED|Overall Study||19
2618962|NCT00063362|6429502|P2|STARTED|Overall Study||26
2618963|NCT00063362|6429503|P1|STARTED|Overall Study||23
2618964|NCT00063258|6429511|P2|NOT COMPLETED|Overall Study||0
2618965|NCT00063258|6429512|P1|NOT COMPLETED|Overall Study||4
2618966|NCT00063258|6429511|P2|COMPLETED|Overall Study||0
2618967|NCT00063258|6429512|P1|COMPLETED|Overall Study||1
2618968|NCT00063258|6429511|P2|STARTED|Overall Study||0
2618969|NCT00063258|6429512|P1|STARTED|Overall Study||5
2618970|NCT00063154|6429518|P1|NOT COMPLETED|Overall Study||51
2618971|NCT00063154|6429518|P1|COMPLETED|Overall Study||0
2618972|NCT00063154|6429518|P1|STARTED|Overall Study||51
2618973|NCT00063232|6429525|P1|NOT COMPLETED|Overall Study||0
2618974|NCT00063232|6429525|P1|COMPLETED|Overall Study||26
2618975|NCT00063232|6429525|P1|STARTED|Overall Study||26
2618976|NCT00062868|6429552|P21|NOT COMPLETED|Dose Level 3||0
2618977|NCT00062868|6429553|P20|NOT COMPLETED|Dose Level 3||0
2618978|NCT00062868|6429554|P19|NOT COMPLETED|Dose Level 3||0
2618979|NCT00062868|6429555|P18|NOT COMPLETED|Dose Level 3||1
2618980|NCT00062868|6429556|P17|NOT COMPLETED|Dose Level 3||0
2618981|NCT00062868|6429557|P16|NOT COMPLETED|Dose Level 3||0
2618982|NCT00062868|6429558|P15|NOT COMPLETED|Dose Level 3||1
2618983|NCT00062868|6429559|P14|NOT COMPLETED|Dose Level 3||0
2618984|NCT00062868|6429560|P13|NOT COMPLETED|Dose Level 3||0
2618985|NCT00062868|6429561|P12|NOT COMPLETED|Dose Level 3||1
2618986|NCT00062868|6429562|P11|NOT COMPLETED|Dose Level 3||0
2618987|NCT00062868|6429563|P10|NOT COMPLETED|Dose Level 3||0
2618988|NCT00062868|6429564|P9|NOT COMPLETED|Dose Level 3||0
2618989|NCT00062868|6429565|P8|NOT COMPLETED|Dose Level 3||0
2618990|NCT00062868|6429566|P7|NOT COMPLETED|Dose Level 3||0
2618991|NCT00062868|6429567|P6|NOT COMPLETED|Dose Level 3||0
2618992|NCT00062868|6429568|P5|NOT COMPLETED|Dose Level 3||0
2618993|NCT00062868|6429569|P4|NOT COMPLETED|Dose Level 3||0
2618994|NCT00062868|6429570|P3|NOT COMPLETED|Dose Level 3||2
2618995|NCT00062868|6429571|P2|NOT COMPLETED|Dose Level 3||0
2618996|NCT00062868|6429572|P1|NOT COMPLETED|Dose Level 3||0
2618997|NCT00062868|6429552|P21|COMPLETED|Dose Level 3||0
2618998|NCT00062868|6429553|P20|COMPLETED|Dose Level 3||0
2618999|NCT00062868|6429554|P19|COMPLETED|Dose Level 3||0
2619000|NCT00062868|6429555|P18|COMPLETED|Dose Level 3||3
2619001|NCT00062868|6429556|P17|COMPLETED|Dose Level 3||0
2619002|NCT00062868|6429557|P16|COMPLETED|Dose Level 3||0
2619003|NCT00062868|6429558|P15|COMPLETED|Dose Level 3||2
2619004|NCT00062868|6429559|P14|COMPLETED|Dose Level 3||0
2619005|NCT00062868|6429560|P13|COMPLETED|Dose Level 3||0
2619006|NCT00062868|6429561|P12|COMPLETED|Dose Level 3||4
2619007|NCT00062868|6429562|P11|COMPLETED|Dose Level 3||0
2619008|NCT00062868|6429563|P10|COMPLETED|Dose Level 3||0
2619009|NCT00062868|6429564|P9|COMPLETED|Dose Level 3||0
2619010|NCT00062868|6429565|P8|COMPLETED|Dose Level 3||0
2619011|NCT00062868|6429566|P7|COMPLETED|Dose Level 3||0
2619012|NCT00062868|6429567|P6|COMPLETED|Dose Level 3||0
2619013|NCT00062868|6429568|P5|COMPLETED|Dose Level 3||0
2619014|NCT00062868|6429569|P4|COMPLETED|Dose Level 3||0
2619015|NCT00062868|6429570|P3|COMPLETED|Dose Level 3||1
2619016|NCT00062868|6429571|P2|COMPLETED|Dose Level 3||0
2619017|NCT00062868|6429572|P1|COMPLETED|Dose Level 3||0
2619018|NCT00062868|6429552|P21|STARTED|Dose Level 3||0
2619019|NCT00062868|6429553|P20|STARTED|Dose Level 3||0
2619020|NCT00062868|6429554|P19|STARTED|Dose Level 3||0
2619021|NCT00062868|6429555|P18|STARTED|Dose Level 3||4
2619022|NCT00062868|6429556|P17|STARTED|Dose Level 3||0
2619023|NCT00062868|6429557|P16|STARTED|Dose Level 3||0
2619024|NCT00062868|6429558|P15|STARTED|Dose Level 3||3
2619025|NCT00062868|6429559|P14|STARTED|Dose Level 3||0
2619026|NCT00062868|6429560|P13|STARTED|Dose Level 3||0
2619027|NCT00062868|6429561|P12|STARTED|Dose Level 3||5
2619028|NCT00062868|6429562|P11|STARTED|Dose Level 3||0
2619029|NCT00062868|6429563|P10|STARTED|Dose Level 3||0
2619030|NCT00062868|6429564|P9|STARTED|Dose Level 3||0
2619031|NCT00062868|6429565|P8|STARTED|Dose Level 3||0
2619032|NCT00062868|6429566|P7|STARTED|Dose Level 3||0
2619033|NCT00062868|6429567|P6|STARTED|Dose Level 3||0
2619034|NCT00062868|6429568|P5|STARTED|Dose Level 3||0
2619035|NCT00062868|6429569|P4|STARTED|Dose Level 3||0
2619036|NCT00062868|6429570|P3|STARTED|Dose Level 3||3
2619037|NCT00062868|6429571|P2|STARTED|Dose Level 3||0
2619038|NCT00062868|6429572|P1|STARTED|Dose Level 3||0
2619039|NCT00062868|6429552|P21|NOT COMPLETED|Dose Level 2||0
2619040|NCT00062868|6429553|P20|NOT COMPLETED|Dose Level 2||0
2619041|NCT00062868|6429554|P19|NOT COMPLETED|Dose Level 2||0
2619042|NCT00062868|6429555|P18|NOT COMPLETED|Dose Level 2||0
2619043|NCT00062868|6429556|P17|NOT COMPLETED|Dose Level 2||3
2619044|NCT00062868|6429557|P16|NOT COMPLETED|Dose Level 2||0
2619045|NCT00062868|6429558|P15|NOT COMPLETED|Dose Level 2||0
2619046|NCT00062868|6429559|P14|NOT COMPLETED|Dose Level 2||1
2619047|NCT00062868|6429560|P13|NOT COMPLETED|Dose Level 2||0
2619048|NCT00062868|6429561|P12|NOT COMPLETED|Dose Level 2||0
2619049|NCT00062868|6429562|P11|NOT COMPLETED|Dose Level 2||1
2619050|NCT00062868|6429563|P10|NOT COMPLETED|Dose Level 2||0
2619051|NCT00062868|6429564|P9|NOT COMPLETED|Dose Level 2||0
2619052|NCT00062868|6429565|P8|NOT COMPLETED|Dose Level 2||0
2619053|NCT00062868|6429566|P7|NOT COMPLETED|Dose Level 2||0
2619054|NCT00062868|6429567|P6|NOT COMPLETED|Dose Level 2||0
2619055|NCT00062868|6429568|P5|NOT COMPLETED|Dose Level 2||2
2619056|NCT00062868|6429569|P4|NOT COMPLETED|Dose Level 2||0
2619057|NCT00062868|6429570|P3|NOT COMPLETED|Dose Level 2||0
2619058|NCT00062868|6429571|P2|NOT COMPLETED|Dose Level 2||3
2619059|NCT00062868|6429572|P1|NOT COMPLETED|Dose Level 2||0
2619060|NCT00062868|6429552|P21|COMPLETED|Dose Level 2||0
2619061|NCT00062868|6429553|P20|COMPLETED|Dose Level 2||0
2619062|NCT00062868|6429554|P19|COMPLETED|Dose Level 2||0
2619063|NCT00062868|6429555|P18|COMPLETED|Dose Level 2||0
2619064|NCT00062868|6429556|P17|COMPLETED|Dose Level 2||0
2619065|NCT00062868|6429557|P16|COMPLETED|Dose Level 2||0
2619066|NCT00062868|6429558|P15|COMPLETED|Dose Level 2||0
2619067|NCT00062868|6429559|P14|COMPLETED|Dose Level 2||2
2619068|NCT00062868|6429560|P13|COMPLETED|Dose Level 2||0
2619069|NCT00062868|6429561|P12|COMPLETED|Dose Level 2||0
2619070|NCT00062868|6429562|P11|COMPLETED|Dose Level 2||3
2619071|NCT00062868|6429563|P10|COMPLETED|Dose Level 2||0
2619072|NCT00062868|6429564|P9|COMPLETED|Dose Level 2||0
2619073|NCT00062868|6429565|P8|COMPLETED|Dose Level 2||0
2619074|NCT00062868|6429566|P7|COMPLETED|Dose Level 2||0
2619075|NCT00062868|6429567|P6|COMPLETED|Dose Level 2||0
2619076|NCT00062868|6429568|P5|COMPLETED|Dose Level 2||1
2619077|NCT00062868|6429569|P4|COMPLETED|Dose Level 2||0
2619078|NCT00062868|6429570|P3|COMPLETED|Dose Level 2||0
2619079|NCT00062868|6429571|P2|COMPLETED|Dose Level 2||3
2619080|NCT00062868|6429572|P1|COMPLETED|Dose Level 2||0
2619081|NCT00062868|6429552|P21|STARTED|Dose Level 2||0
2619082|NCT00062868|6429553|P20|STARTED|Dose Level 2||0
2619083|NCT00062868|6429554|P19|STARTED|Dose Level 2||0
2619084|NCT00062868|6429555|P18|STARTED|Dose Level 2||0
2619085|NCT00062868|6429556|P17|STARTED|Dose Level 2||3
2619086|NCT00062868|6429557|P16|STARTED|Dose Level 2||0
2619087|NCT00062868|6429558|P15|STARTED|Dose Level 2||0
2619088|NCT00062868|6429559|P14|STARTED|Dose Level 2||3
2619089|NCT00062868|6429560|P13|STARTED|Dose Level 2||0
2619090|NCT00062868|6429561|P12|STARTED|Dose Level 2||0
2619091|NCT00062868|6429562|P11|STARTED|Dose Level 2||4
2619092|NCT00062868|6429563|P10|STARTED|Dose Level 2||0
2619093|NCT00062868|6429564|P9|STARTED|Dose Level 2||0
2619094|NCT00062868|6429565|P8|STARTED|Dose Level 2||0
2619095|NCT00062868|6429566|P7|STARTED|Dose Level 2||0
2619096|NCT00062868|6429567|P6|STARTED|Dose Level 2||0
2619097|NCT00062868|6429568|P5|STARTED|Dose Level 2||3
2619098|NCT00062868|6429569|P4|STARTED|Dose Level 2||0
2619099|NCT00062868|6429570|P3|STARTED|Dose Level 2||0
2619100|NCT00062868|6429571|P2|STARTED|Dose Level 2||6
2619101|NCT00062868|6429572|P1|STARTED|Dose Level 2||0
2619102|NCT00062868|6429552|P21|NOT COMPLETED|Dose Level 1||2
2619103|NCT00062868|6429553|P20|NOT COMPLETED|Dose Level 1||0
2619104|NCT00062868|6429554|P19|NOT COMPLETED|Dose Level 1||9
2619105|NCT00062868|6429555|P18|NOT COMPLETED|Dose Level 1||0
2619106|NCT00062868|6429556|P17|NOT COMPLETED|Dose Level 1||0
2619107|NCT00062868|6429557|P16|NOT COMPLETED|Dose Level 1||0
2619108|NCT00062868|6429558|P15|NOT COMPLETED|Dose Level 1||0
2619109|NCT00062868|6429559|P14|NOT COMPLETED|Dose Level 1||0
2619110|NCT00062868|6429560|P13|NOT COMPLETED|Dose Level 1||1
2619111|NCT00062868|6429561|P12|NOT COMPLETED|Dose Level 1||0
2619112|NCT00062868|6429562|P11|NOT COMPLETED|Dose Level 1||0
2619113|NCT00062868|6429563|P10|NOT COMPLETED|Dose Level 1||0
2619114|NCT00062868|6429564|P9|NOT COMPLETED|Dose Level 1||0
2619115|NCT00062868|6429565|P8|NOT COMPLETED|Dose Level 1||0
2619116|NCT00062868|6429566|P7|NOT COMPLETED|Dose Level 1||3
2619117|NCT00062868|6429567|P6|NOT COMPLETED|Dose Level 1||0
2619118|NCT00062868|6429568|P5|NOT COMPLETED|Dose Level 1||0
2619119|NCT00062868|6429569|P4|NOT COMPLETED|Dose Level 1||2
2619120|NCT00062868|6429570|P3|NOT COMPLETED|Dose Level 1||0
2619121|NCT00062868|6429571|P2|NOT COMPLETED|Dose Level 1||0
2619122|NCT00062868|6429572|P1|NOT COMPLETED|Dose Level 1||2
2619123|NCT00062868|6429552|P21|COMPLETED|Dose Level 1||1
2619124|NCT00062868|6429553|P20|COMPLETED|Dose Level 1||2
2619125|NCT00062868|6429554|P19|COMPLETED|Dose Level 1||7
2619126|NCT00062868|6429555|P18|COMPLETED|Dose Level 1||0
2619127|NCT00062868|6429556|P17|COMPLETED|Dose Level 1||0
2619128|NCT00062868|6429557|P16|COMPLETED|Dose Level 1||3
2619129|NCT00062868|6429558|P15|COMPLETED|Dose Level 1||0
2619130|NCT00062868|6429559|P14|COMPLETED|Dose Level 1||0
2619131|NCT00062868|6429560|P13|COMPLETED|Dose Level 1||2
2619132|NCT00062868|6429561|P12|COMPLETED|Dose Level 1||0
2619133|NCT00062868|6429562|P11|COMPLETED|Dose Level 1||0
2619134|NCT00062868|6429563|P10|COMPLETED|Dose Level 1||3
2619135|NCT00062868|6429564|P9|COMPLETED|Dose Level 1||0
2619136|NCT00062868|6429565|P8|COMPLETED|Dose Level 1||0
2619137|NCT00062868|6429566|P7|COMPLETED|Dose Level 1||1
2619138|NCT00062868|6429567|P6|COMPLETED|Dose Level 1||0
2619139|NCT00062868|6429568|P5|COMPLETED|Dose Level 1||0
2619140|NCT00062868|6429569|P4|COMPLETED|Dose Level 1||1
2619141|NCT00062868|6429570|P3|COMPLETED|Dose Level 1||0
2619142|NCT00062868|6429571|P2|COMPLETED|Dose Level 1||0
2619143|NCT00062868|6429572|P1|COMPLETED|Dose Level 1||1
2619144|NCT00062868|6429552|P21|STARTED|Dose Level 1||3
2619145|NCT00062868|6429553|P20|STARTED|Dose Level 1||2
2619146|NCT00062868|6429554|P19|STARTED|Dose Level 1||16
2619147|NCT00062868|6429555|P18|STARTED|Dose Level 1||0
2619148|NCT00062868|6429556|P17|STARTED|Dose Level 1||0
2619149|NCT00062868|6429557|P16|STARTED|Dose Level 1||3
2619150|NCT00062868|6429558|P15|STARTED|Dose Level 1||0
2619151|NCT00062868|6429559|P14|STARTED|Dose Level 1||0
2619152|NCT00062868|6429560|P13|STARTED|Dose Level 1||3
2619153|NCT00062868|6429561|P12|STARTED|Dose Level 1||0
2619154|NCT00062868|6429562|P11|STARTED|Dose Level 1||0
2619155|NCT00062868|6429563|P10|STARTED|Dose Level 1||3
2619156|NCT00062868|6429564|P9|STARTED|Dose Level 1||0
2619157|NCT00062868|6429565|P8|STARTED|Dose Level 1||0
2619158|NCT00062868|6429566|P7|STARTED|Dose Level 1||4
2619159|NCT00062868|6429567|P6|STARTED|Dose Level 1||0
2619160|NCT00062868|6429568|P5|STARTED|Dose Level 1||0
2619161|NCT00062868|6429569|P4|STARTED|Dose Level 1||3
2619162|NCT00062868|6429570|P3|STARTED|Dose Level 1||0
2619163|NCT00062868|6429571|P2|STARTED|Dose Level 1||0
2619164|NCT00062868|6429572|P1|STARTED|Dose Level 1||3
2619165|NCT00062764|6429658|P1|NOT COMPLETED|Overall Study||0
2619166|NCT00062764|6429658|P1|COMPLETED|Overall Study||18
2619167|NCT00062764|6429658|P1|STARTED|Overall Study||18
2619168|NCT00062751|6429671|P5|NOT COMPLETED|Overall Study||6
2619169|NCT00062751|6429672|P4|NOT COMPLETED|Overall Study||5
2619170|NCT00062751|6429673|P3|NOT COMPLETED|Overall Study||30
2619171|NCT00062751|6429674|P2|NOT COMPLETED|Overall Study||30
2619172|NCT00062751|6429675|P1|NOT COMPLETED|Overall Study||33
2619173|NCT00062751|6429671|P5|COMPLETED|Overall Study||0
2619174|NCT00062751|6429672|P4|COMPLETED|Overall Study||1
2619175|NCT00062751|6429673|P3|COMPLETED|Overall Study||3
2619176|NCT00062751|6429674|P2|COMPLETED|Overall Study||0
2619177|NCT00062751|6429675|P1|COMPLETED|Overall Study||0
2619178|NCT00062751|6429671|P5|STARTED|Overall Study||6
2619179|NCT00062751|6429672|P4|STARTED|Overall Study||6
2619180|NCT00062751|6429673|P3|STARTED|Overall Study||33
2619181|NCT00062751|6429674|P2|STARTED|Overall Study||30
2619182|NCT00062751|6429675|P1|STARTED|Overall Study||33
2619183|NCT00062738|6429746|P3|NOT COMPLETED|Overall Study||0
2619184|NCT00062738|6429747|P2|NOT COMPLETED|Overall Study||0
2619185|NCT00062738|6429748|P1|NOT COMPLETED|Overall Study||0
2619186|NCT00062738|6429746|P3|COMPLETED|Overall Study||17
2619187|NCT00062738|6429747|P2|COMPLETED|Overall Study||18
2619188|NCT00062738|6429748|P1|COMPLETED|Overall Study||17
2619189|NCT00062738|6429746|P3|STARTED|Overall Study||17
2619190|NCT00062738|6429747|P2|STARTED|Overall Study||18
2619191|NCT00062738|6429748|P1|STARTED|Overall Study||17
2619192|NCT00062647|6429761|P2|NOT COMPLETED|Overall Study||13
2619193|NCT00062647|6429762|P1|NOT COMPLETED|Overall Study||16
2619194|NCT00062647|6429761|P2|COMPLETED|Overall Study||17
2619195|NCT00062647|6429762|P1|COMPLETED|Overall Study||14
2619196|NCT00062647|6429761|P2|STARTED|Overall Study||30
2619197|NCT00062647|6429762|P1|STARTED|Overall Study||30
2619198|NCT00062439|6429768|P1|NOT COMPLETED|Consolidation Chemotherapy||2
2619199|NCT00062439|6429768|P1|COMPLETED|Consolidation Chemotherapy||20
2619200|NCT00062439|6429768|P1|STARTED|Consolidation Chemotherapy||22
2619201|NCT00062439|6429768|P1|NOT COMPLETED|Surgery||7
2619202|NCT00062439|6429768|P1|COMPLETED|Surgery||22
2619203|NCT00062439|6429768|P1|STARTED|Surgery||29
2619204|NCT00062439|6429768|P1|NOT COMPLETED|Post Chemoradiation Assessment||9
2619205|NCT00062439|6429768|P1|COMPLETED|Post Chemoradiation Assessment||29
2619206|NCT00062439|6429768|P1|STARTED|Post Chemoradiation Assessment||38
2619207|NCT00062439|6429768|P1|NOT COMPLETED|Induction Chemotherapy + Radiotherapy||8
2619208|NCT00062439|6429768|P1|COMPLETED|Induction Chemotherapy + Radiotherapy||38
2619209|NCT00062439|6429768|P1|STARTED|Induction Chemotherapy + Radiotherapy||46
2619210|NCT00062374|6429780|P1|NOT COMPLETED|Overall Study||12
2619211|NCT00062374|6429780|P1|COMPLETED|Overall Study||43
2619212|NCT00062374|6429780|P1|STARTED|Overall Study||55
2619213|NCT00062166|6429785|P1|NOT COMPLETED|Overall Study||6
2619214|NCT00062166|6429785|P1|COMPLETED|Overall Study||334
2619215|NCT00062166|6429785|P1|STARTED|Overall Study||340
2619216|NCT00062010|6429793|P1|NOT COMPLETED|Overall Study||3
2619217|NCT00062010|6429793|P1|COMPLETED|Overall Study||34
2619218|NCT00062010|6429793|P1|Eligible and Treated|Overall Study||34
2619219|NCT00062010|6429793|P1|STARTED|Overall Study||37
2619220|NCT00061945|6429801|P2|NOT COMPLETED|Course IV: Alemtuzumab||16
2619221|NCT00061945|6429802|P1|NOT COMPLETED|Course IV: Alemtuzumab||7
2619222|NCT00061945|6429801|P2|COMPLETED|Course IV: Alemtuzumab||50
2619223|NCT00061945|6429802|P1|COMPLETED|Course IV: Alemtuzumab||18
2619224|NCT00061945|6429801|P2|STARTED|Course IV: Alemtuzumab||66
2619225|NCT00061945|6429802|P1|STARTED|Course IV: Alemtuzumab||25
2619226|NCT00061945|6429801|P2|NOT COMPLETED|Registration Through Course 3||115
2619227|NCT00061945|6429802|P1|NOT COMPLETED|Registration Through Course 3||94
2619228|NCT00061945|6429801|P2|COMPLETED|Registration Through Course 3||66
2619229|NCT00061945|6429802|P1|COMPLETED|Registration Through Course 3||25
2619230|NCT00061945|6429801|P2|STARTED|Registration Through Course 3||181
2619231|NCT00061945|6429802|P1|STARTED|Registration Through Course 3||119
2619232|NCT00061932|6429812|P2|NOT COMPLETED|Overall Study||4
2619233|NCT00061932|6429813|P1|NOT COMPLETED|Overall Study||13
2619234|NCT00061932|6429812|P2|COMPLETED|Overall Study||8
2619235|NCT00061932|6429813|P1|COMPLETED|Overall Study||16
2619236|NCT00061932|6429812|P2|STARTED|Overall Study||12
2619237|NCT00061932|6429813|P1|STARTED|Overall Study||29
2619238|NCT00061893|6429819|P1|NOT COMPLETED|Overall Study||18
2619239|NCT00061893|6429819|P1|COMPLETED|Overall Study||20
2619240|NCT00061893|6429819|P1|STARTED|Overall Study||38
2619241|NCT00061633|6429826|P2|NOT COMPLETED|Overall Study||11
2619242|NCT00061633|6429827|P1|NOT COMPLETED|Overall Study||5
2619243|NCT00061633|6429826|P2|COMPLETED|Overall Study||74
2619244|NCT00061633|6429827|P1|COMPLETED|Overall Study||79
2619245|NCT00061633|6429826|P2|STARTED|Overall Study||85
2619246|NCT00061633|6429827|P1|STARTED|Overall Study||84
2619247|NCT00061373|6429835|P2|NOT COMPLETED|Overall Study||0
2619248|NCT00061373|6429836|P1|NOT COMPLETED|Overall Study||0
2619249|NCT00061373|6429835|P2|COMPLETED|Overall Study||3
2619250|NCT00061373|6429836|P1|COMPLETED|Overall Study||15
2619251|NCT00061373|6429835|P2|Aspirin and Tinzaparin|Overall Study||3
2619252|NCT00061373|6429836|P1|Aspirin and Tinzaparin|Overall Study||15
2619253|NCT00061373|6429835|P2|STARTED|Overall Study||3
2619254|NCT00061373|6429836|P1|STARTED|Overall Study||15
2619255|NCT00061048|6429852|P1|NOT COMPLETED|Overall Study||22
2619256|NCT00061048|6429852|P1|COMPLETED|Overall Study|Began protocol specified follow-up period.|7
2619257|NCT00061048|6429852|P1|STARTED|Overall Study||29
2619258|NCT00060944|6429862|P2|NOT COMPLETED|Overall Study||134
2619259|NCT00060944|6429863|P1|NOT COMPLETED|Overall Study||136
2619260|NCT00060944|6429862|P2|COMPLETED|Overall Study||0
2619261|NCT00060944|6429863|P1|COMPLETED|Overall Study||0
2619262|NCT00060944|6429862|P2|Treated|Overall Study||130
2619263|NCT00060944|6429863|P1|Treated|Overall Study||130
2619264|NCT00060944|6429862|P2|STARTED|Overall Study||134
2619265|NCT00060944|6429863|P1|STARTED|Overall Study||136
2619266|NCT00060840|6429879|P2|NOT COMPLETED|Overall Study||9
2619267|NCT00060840|6429880|P1|NOT COMPLETED|Overall Study||4
2619268|NCT00060840|6429879|P2|COMPLETED|Overall Study||68
2619269|NCT00060840|6429880|P1|COMPLETED|Overall Study||69
2619270|NCT00060840|6429879|P2|STARTED|Overall Study||77
2619271|NCT00060840|6429880|P1|STARTED|Overall Study||73
2619272|NCT00060528|6429886|P4|NOT COMPLETED|Overall Study||0
2619273|NCT00060528|6429887|P3|NOT COMPLETED|Overall Study||0
2619274|NCT00060528|6429888|P2|NOT COMPLETED|Overall Study||0
2619275|NCT00060528|6429889|P1|NOT COMPLETED|Overall Study||0
2619276|NCT00060528|6429886|P4|COMPLETED|Overall Study||8
2619277|NCT00060528|6429887|P3|COMPLETED|Overall Study||7
2619278|NCT00060528|6429888|P2|COMPLETED|Overall Study||9
2619279|NCT00060528|6429889|P1|COMPLETED|Overall Study||8
2619280|NCT00060528|6429886|P4|STARTED|Overall Study||8
2619281|NCT00060528|6429887|P3|STARTED|Overall Study||7
2619282|NCT00060528|6429888|P2|STARTED|Overall Study||9
2619283|NCT00060528|6429889|P1|STARTED|Overall Study|32 participants are reported for the phase II portion.|8
2619284|NCT00060424|6429903|P1|NOT COMPLETED|Overall Study||0
2619285|NCT00060424|6429903|P1|COMPLETED|Overall Study||21
2619286|NCT00060424|6429903|P1|STARTED|Overall Study||21
2619287|NCT00060346|6429911|P1|NOT COMPLETED|Overall Study||0
2619288|NCT00060346|6429911|P1|COMPLETED|Overall Study||16
2619289|NCT00060346|6429911|P1|Eligible and Treated|Overall Study||16
2619290|NCT00060346|6429911|P1|STARTED|Overall Study||16
2619291|NCT00060333|6429915|P1|NOT COMPLETED|Overall Study||0
2619292|NCT00060333|6429915|P1|COMPLETED|Overall Study||20
2619293|NCT00060333|6429915|P1|STARTED|Overall Study||20
2619294|NCT00060008|6429926|P1|NOT COMPLETED|Overall Study||0
2619295|NCT00060008|6429926|P1|COMPLETED|Overall Study||18
2619296|NCT00060008|6429926|P1|STARTED|Overall Study||18
2619297|NCT00059839|6429933|P2|NOT COMPLETED|Overall Study||17
2619298|NCT00059839|6429934|P1|NOT COMPLETED|Overall Study||12
2619299|NCT00059839|6429933|P2|COMPLETED|Overall Study||47
2619300|NCT00059839|6429934|P1|COMPLETED|Overall Study||53
2619301|NCT00059839|6429933|P2|STARTED|Overall Study||64
2619302|NCT00059839|6429934|P1|STARTED|Overall Study||65
2619303|NCT00059787|6429940|P1|NOT COMPLETED|Overall Study||20
2619304|NCT00059787|6429940|P1|COMPLETED|Overall Study||36
2619305|NCT00059787|6429940|P1|STARTED|Overall Study||56
2619306|NCT00059475|6429956|P8|NOT COMPLETED|Overall Study||0
2619307|NCT00059475|6429957|P7|NOT COMPLETED|Overall Study||0
2619308|NCT00059475|6429958|P6|NOT COMPLETED|Overall Study||0
2619309|NCT00059475|6429959|P5|NOT COMPLETED|Overall Study||0
2619310|NCT00059475|6429960|P4|NOT COMPLETED|Overall Study||0
2619311|NCT00059475|6429961|P3|NOT COMPLETED|Overall Study||0
2619312|NCT00059475|6429962|P2|NOT COMPLETED|Overall Study||0
2619313|NCT00059475|6429963|P1|NOT COMPLETED|Overall Study||0
2619314|NCT00059475|6429956|P8|COMPLETED|Overall Study||7
2619315|NCT00059475|6429957|P7|COMPLETED|Overall Study||34
2619316|NCT00059475|6429958|P6|COMPLETED|Overall Study||2
2619317|NCT00059475|6429959|P5|COMPLETED|Overall Study||33
2619318|NCT00059475|6429960|P4|COMPLETED|Overall Study||3
2619319|NCT00059475|6429961|P3|COMPLETED|Overall Study||24
2619320|NCT00059475|6429962|P2|COMPLETED|Overall Study||2
2619321|NCT00059475|6429963|P1|COMPLETED|Overall Study||33
2619322|NCT00059475|6429956|P8|STARTED|Overall Study||7
2619323|NCT00059475|6429957|P7|STARTED|Overall Study||34
2619324|NCT00059475|6429958|P6|STARTED|Overall Study||2
2619325|NCT00059475|6429959|P5|STARTED|Overall Study||33
2619326|NCT00059475|6429960|P4|STARTED|Overall Study||3
2619327|NCT00059475|6429961|P3|STARTED|Overall Study||24
2619328|NCT00059475|6429962|P2|STARTED|Overall Study||2
2619329|NCT00059475|6429963|P1|STARTED|Overall Study||33
2619330|NCT00059332|6429991|P2|NOT COMPLETED|Overall Study||2
2619331|NCT00059332|6429992|P1|NOT COMPLETED|Overall Study||3
2619332|NCT00059332|6429991|P2|COMPLETED|Overall Study||855
2619333|NCT00059332|6429992|P1|COMPLETED|Overall Study||840
2619334|NCT00059332|6429991|P2|STARTED|Overall Study||857
2619335|NCT00059332|6429992|P1|STARTED|Overall Study||843
2619336|NCT00059215|6430018|P4|NOT COMPLETED|Overall Study||15
2619337|NCT00059215|6430019|P3|NOT COMPLETED|Overall Study||15
2619338|NCT00059215|6430020|P2|NOT COMPLETED|Overall Study||14
2619339|NCT00059215|6430021|P1|NOT COMPLETED|Overall Study||13
2619340|NCT00059215|6430018|P4|COMPLETED|Overall Study||239
2619341|NCT00059215|6430019|P3|COMPLETED|Overall Study||236
2619342|NCT00059215|6430020|P2|COMPLETED|Overall Study||186
2619343|NCT00059215|6430021|P1|COMPLETED|Overall Study|One subject discontinued before receiving treatment and is not included in the evaluable set.|187
2619344|NCT00059215|6430018|P4|STARTED|Overall Study||254
2619345|NCT00059215|6430019|P3|STARTED|Overall Study||251
2619346|NCT00059215|6430020|P2|STARTED|Overall Study||200
2619347|NCT00059215|6430021|P1|STARTED|Overall Study||200
2619348|NCT00059228|6430049|P2|NOT COMPLETED|Overall Study||1
2619349|NCT00059228|6430050|P1|NOT COMPLETED|Overall Study||0
2619350|NCT00059228|6430049|P2|COMPLETED|Overall Study||5
2619351|NCT00059228|6430050|P1|COMPLETED|Overall Study||6
2619352|NCT00059228|6430049|P2|STARTED|Overall Study||6
2619353|NCT00059228|6430050|P1|STARTED|Overall Study||6
2619354|NCT00058825|6430058|P1|NOT COMPLETED|Overall Study||22
2619355|NCT00058825|6430058|P1|COMPLETED|Overall Study||5
2619356|NCT00058825|6430058|P1|STARTED|Overall Study||27
2619357|NCT00058552|6430074|P2|NOT COMPLETED|Overall Study||62
2619358|NCT00058552|6430075|P1|NOT COMPLETED|Overall Study||65
2619359|NCT00058552|6430074|P2|COMPLETED|Overall Study||2
2619360|NCT00058552|6430075|P1|COMPLETED|Overall Study||0
2619361|NCT00058552|6430074|P2|STARTED|Overall Study||64
2619362|NCT00058552|6430075|P1|STARTED|Overall Study||65
2619363|NCT00058539|6430093|P1|NOT COMPLETED|Overall Study||42
2619364|NCT00058539|6430093|P1|COMPLETED|Overall Study||0
2619365|NCT00058539|6430093|P1|STARTED|Overall Study||42
2619366|NCT00058240|6430107|P4|NOT COMPLETED|Second Dose Level||0
2619367|NCT00058240|6430108|P3|NOT COMPLETED|Second Dose Level||0
2619368|NCT00058240|6430109|P2|NOT COMPLETED|Second Dose Level||0
2619369|NCT00058240|6430110|P1|NOT COMPLETED|Second Dose Level||0
2619370|NCT00058240|6430107|P4|COMPLETED|Second Dose Level||4
2619371|NCT00058240|6430108|P3|COMPLETED|Second Dose Level||2
2619372|NCT00058240|6430109|P2|COMPLETED|Second Dose Level||0
2619373|NCT00058240|6430110|P1|COMPLETED|Second Dose Level||0
2619374|NCT00058240|6430107|P4|STARTED|Second Dose Level|4 patients previously relapsed on a different Dose level and were retreated at Dose level 4.|4
2619375|NCT00058240|6430108|P3|STARTED|Second Dose Level|2 patients were previously treated at Dose level 1, relapsed, and retreated at Dose level 3.|2
2619376|NCT00058240|6430109|P2|STARTED|Second Dose Level||0
2619377|NCT00058240|6430110|P1|STARTED|Second Dose Level||0
2619378|NCT00058240|6430107|P4|NOT COMPLETED|First Dose Level||0
2619379|NCT00058240|6430108|P3|NOT COMPLETED|First Dose Level||0
2619380|NCT00058240|6430109|P2|NOT COMPLETED|First Dose Level||0
2619381|NCT00058240|6430110|P1|NOT COMPLETED|First Dose Level||0
2619382|NCT00058240|6430107|P4|COMPLETED|First Dose Level||12
2619383|NCT00058240|6430108|P3|COMPLETED|First Dose Level||17
2619384|NCT00058240|6430109|P2|COMPLETED|First Dose Level||3
2619385|NCT00058240|6430110|P1|COMPLETED|First Dose Level||20
2619386|NCT00058240|6430107|P4|Treated|First Dose Level||12
2619387|NCT00058240|6430108|P3|Treated|First Dose Level||17
2619388|NCT00058240|6430109|P2|Treated|First Dose Level||3
2619389|NCT00058240|6430110|P1|Treated|First Dose Level||20
2619390|NCT00058240|6430107|P4|STARTED|First Dose Level||12
2619391|NCT00058240|6430108|P3|STARTED|First Dose Level||17
2619392|NCT00058240|6430109|P2|STARTED|First Dose Level||3
2619393|NCT00058240|6430110|P1|STARTED|First Dose Level||20
2619394|NCT00058214|6430120|P1|NOT COMPLETED|Overall Study||1
2619395|NCT00058214|6430120|P1|COMPLETED|Overall Study||24
2619396|NCT00058214|6430120|P1|STARTED|Overall Study||25
2619397|NCT00058123|6430125|P1|NOT COMPLETED|Overall Study||10
2619398|NCT00058123|6430125|P1|COMPLETED|Overall Study||45
2619399|NCT00058123|6430125|P1|STARTED|Overall Study||55
2619400|NCT00058058|6430132|P1|NOT COMPLETED|Overall Study||38
2619401|NCT00058058|6430132|P1|COMPLETED|Overall Study||969
2619402|NCT00058058|6430132|P1|STARTED|Overall Study||1007
2619403|NCT00058019|6430143|P2|NOT COMPLETED|Overall Study||0
2619404|NCT00058019|6430144|P1|NOT COMPLETED|Overall Study||0
2619405|NCT00058019|6430143|P2|COMPLETED|Overall Study||12
2619406|NCT00058019|6430144|P1|COMPLETED|Overall Study||39
2619407|NCT00058019|6430143|P2|STARTED|Overall Study||12
2619408|NCT00058019|6430144|P1|STARTED|Overall Study||39
2619409|NCT00057954|6430157|P1|NOT COMPLETED|Overall Study||2
2619410|NCT00057954|6430157|P1|COMPLETED|Overall Study||4
2619411|NCT00057954|6430157|P1|STARTED|Overall Study||6
2619412|NCT00057941|6430165|P2|NOT COMPLETED|Overall Study||74
2619413|NCT00057941|6430166|P1|NOT COMPLETED|Overall Study||74
2619414|NCT00057941|6430165|P2|COMPLETED|Overall Study||0
2619415|NCT00057941|6430166|P1|COMPLETED|Overall Study||0
2619416|NCT00057941|6430165|P2|Eligible|Overall Study||69
2619417|NCT00057941|6430166|P1|Eligible|Overall Study||72
2619418|NCT00057941|6430165|P2|Treated|Overall Study||74
2619419|NCT00057941|6430166|P1|Treated|Overall Study||74
2619420|NCT00057941|6430165|P2|STARTED|Overall Study||74
2619421|NCT00057941|6430166|P1|STARTED|Overall Study||74
2619422|NCT00057876|6430174|P2|NOT COMPLETED|Overall Study||27
2619423|NCT00057876|6430175|P1|NOT COMPLETED|Overall Study||29
2619424|NCT00057876|6430174|P2|COMPLETED|Overall Study||9
2619425|NCT00057876|6430175|P1|COMPLETED|Overall Study||9
2619426|NCT00057876|6430174|P2|Eligible and Treated|Overall Study||34
2619427|NCT00057876|6430175|P1|Eligible and Treated|Overall Study||34
2619428|NCT00057876|6430174|P2|Began Protocol Therapy|Overall Study||34
2619429|NCT00057876|6430175|P1|Began Protocol Therapy|Overall Study||35
2619430|NCT00057876|6430174|P2|Eligible|Overall Study||34
2619431|NCT00057876|6430175|P1|Eligible|Overall Study||37
2619432|NCT00057876|6430174|P2|STARTED|Overall Study||36
2619433|NCT00057876|6430175|P1|STARTED|Overall Study||38
2619434|NCT00057863|6430185|P1|NOT COMPLETED|Overall Study||3
2619435|NCT00057863|6430185|P1|COMPLETED|Overall Study||32
2619436|NCT00057863|6430185|P1|STARTED|Overall Study||35
2619437|NCT00057837|6430194|P2|NOT COMPLETED|Overall Study||39
2619438|NCT00057837|6430195|P1|NOT COMPLETED|Overall Study||31
2619439|NCT00057837|6430194|P2|COMPLETED|Overall Study||31
2619440|NCT00057837|6430195|P1|COMPLETED|Overall Study||39
2619441|NCT00057837|6430194|P2|Patients With Response|Overall Study||38
2619442|NCT00057837|6430195|P1|Patients With Response|Overall Study||46
2619443|NCT00057837|6430194|P2|Eligible and Treated|Overall Study||66
2619444|NCT00057837|6430195|P1|Eligible and Treated|Overall Study||66
2619445|NCT00057837|6430194|P2|Treated|Overall Study||68
2619446|NCT00057837|6430195|P1|Treated|Overall Study||69
2619447|NCT00057837|6430194|P2|STARTED|Overall Study||70
2619448|NCT00057837|6430195|P1|STARTED|Overall Study||70
2619449|NCT00057811|6430207|P2|NOT COMPLETED|Overall Study||12
2619450|NCT00057811|6430208|P1|NOT COMPLETED|Overall Study||10
2619451|NCT00057811|6430207|P2|COMPLETED|Overall Study||34
2619452|NCT00057811|6430208|P1|COMPLETED|Overall Study||41
2619453|NCT00057811|6430207|P2|STARTED|Overall Study||46
2619454|NCT00057811|6430208|P1|STARTED|Overall Study||51
2619455|NCT00057785|6430220|P1|NOT COMPLETED|Overall Study||0
2619456|NCT00057785|6430220|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|68
2619457|NCT00057785|6430220|P1|STARTED|Overall Study||68
2619458|NCT00057746|6430227|P3|NOT COMPLETED|Overall Study||1
2619459|NCT00057746|6430228|P2|NOT COMPLETED|Overall Study||0
2619460|NCT00057746|6430229|P1|NOT COMPLETED|Overall Study||0
2619461|NCT00057746|6430227|P3|COMPLETED|Overall Study||66
2619462|NCT00057746|6430228|P2|COMPLETED|Overall Study||67
2619463|NCT00057746|6430229|P1|COMPLETED|Overall Study||131
2619464|NCT00057746|6430227|P3|STARTED|Overall Study||67
2619465|NCT00057746|6430228|P2|STARTED|Overall Study||67
2619466|NCT00057746|6430229|P1|STARTED|Overall Study||131
2619467|NCT00023673|6430240|P4|NOT COMPLETED|Overall Study||2
2619468|NCT00023673|6430241|P3|NOT COMPLETED|Overall Study||0
2619469|NCT00023673|6430242|P2|NOT COMPLETED|Overall Study||0
2619470|NCT00023673|6430243|P1|NOT COMPLETED|Overall Study||0
2619471|NCT00023673|6430240|P4|COMPLETED|Overall Study|Phase II subjects contributing data to primary analysis are considered to have completed the study.|44
2619472|NCT00023673|6430241|P3|COMPLETED|Overall Study|This arm was not used since further de-escalation was not required.|0
2619473|NCT00023673|6430242|P2|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|9
2619474|NCT00023673|6430243|P1|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|8
2619475|NCT00023673|6430240|P4|STARTED|Overall Study||46
2619476|NCT00023673|6430241|P3|STARTED|Overall Study||0
2619477|NCT00023673|6430242|P2|STARTED|Overall Study||9
2619478|NCT00023673|6430243|P1|STARTED|Overall Study||8
2619479|NCT00057681|6430259|P3|NOT COMPLETED|Overall Study||34
2619480|NCT00057681|6430260|P2|NOT COMPLETED|Overall Study||72
2619481|NCT00057681|6430261|P1|NOT COMPLETED|Overall Study||65
2619482|NCT00057681|6430259|P3|COMPLETED|Overall Study||69
2619483|NCT00057681|6430260|P2|COMPLETED|Overall Study||67
2619484|NCT00057681|6430261|P1|COMPLETED|Overall Study||72
2619485|NCT00057681|6430259|P3|STARTED|Overall Study||103
2619486|NCT00057681|6430260|P2|STARTED|Overall Study||139
2619487|NCT00057681|6430261|P1|STARTED|Overall Study||137
2619488|NCT00057577|6430277|P2|NOT COMPLETED|Overall Study||0
2619489|NCT00057577|6430278|P1|NOT COMPLETED|Overall Study||0
2619490|NCT00057577|6430277|P2|COMPLETED|Overall Study||225
2619491|NCT00057577|6430278|P1|COMPLETED|Overall Study||227
2619492|NCT00057577|6430277|P2|STARTED|Overall Study||225
2619493|NCT00057577|6430278|P1|STARTED|Overall Study||227
2619494|NCT00057551|6430295|P3|NOT COMPLETED|Overall Study||16
2619495|NCT00057551|6430296|P2|NOT COMPLETED|Overall Study||27
2619496|NCT00057551|6430297|P1|NOT COMPLETED|Overall Study||25
2619497|NCT00057551|6430295|P3|COMPLETED|Overall Study||80
2619498|NCT00057551|6430296|P2|COMPLETED|Overall Study||168
2619499|NCT00057551|6430297|P1|COMPLETED|Overall Study||175
2619500|NCT00057551|6430295|P3|STARTED|Overall Study||96
2619501|NCT00057551|6430296|P2|STARTED|Overall Study||195
2619502|NCT00057551|6430297|P1|STARTED|Overall Study||200
2619503|NCT00057330|6430307|P2|NOT COMPLETED|Overall Study||920
2619504|NCT00057330|6430308|P1|NOT COMPLETED|Overall Study||1132
2619505|NCT00057330|6430307|P2|COMPLETED|Overall Study||2826
2619506|NCT00057330|6430308|P1|COMPLETED|Overall Study||3445
2619507|NCT00057330|6430307|P2|STARTED|Overall Study||3746
2619508|NCT00057330|6430308|P1|STARTED|Overall Study||4577
2619509|NCT00056862|6430338|P2|NOT COMPLETED|Overall Study||0
2619510|NCT00056862|6430339|P1|NOT COMPLETED|Overall Study||1
2619511|NCT00056862|6430338|P2|COMPLETED|Overall Study||27
2619512|NCT00056862|6430339|P1|COMPLETED|Overall Study||30
2619513|NCT00056862|6430338|P2|STARTED|Overall Study||27
2619514|NCT00056862|6430339|P1|STARTED|Overall Study||31
2619515|NCT00056563|6430355|P2|NOT COMPLETED|Overall Study||0
2619516|NCT00056563|6430356|P1|NOT COMPLETED|Overall Study||0
2619517|NCT00056563|6430355|P2|COMPLETED|Overall Study||134
2619518|NCT00056563|6430356|P1|COMPLETED|Overall Study||121
2619519|NCT00056563|6430355|P2|STARTED|Overall Study||134
2619520|NCT00056563|6430356|P1|STARTED|Overall Study||121
2619521|NCT00056550|6430364|P1|NOT COMPLETED|Overall Study||0
2619522|NCT00056550|6430364|P1|COMPLETED|Overall Study||14
2619523|NCT00056550|6430364|P1|STARTED|Overall Study||14
2619524|NCT00056498|6430371|P2|NOT COMPLETED|Overall Study||7
2619525|NCT00056498|6430372|P1|NOT COMPLETED|Overall Study||5
2619526|NCT00056498|6430371|P2|COMPLETED|Overall Study||28
2619527|NCT00056498|6430372|P1|COMPLETED|Overall Study||25
2619528|NCT00056498|6430371|P2|STARTED|Overall Study||35
2619529|NCT00056498|6430372|P1|STARTED|Overall Study||30
2619530|NCT00056472|6430384|P2|NOT COMPLETED|Overall Study||69
2619531|NCT00056472|6430385|P1|NOT COMPLETED|Overall Study||48
2619532|NCT00056472|6430384|P2|COMPLETED|Overall Study||61
2619533|NCT00056472|6430385|P1|COMPLETED|Overall Study||81
2619534|NCT00056472|6430384|P2|STARTED|Overall Study||130
2619535|NCT00056472|6430385|P1|STARTED|Overall Study||129
2619536|NCT00056407|6430397|P2|NOT COMPLETED|Overall Study||1193
2619537|NCT00056407|6430398|P1|NOT COMPLETED|Overall Study||1211
2619538|NCT00056407|6430397|P2|COMPLETED|Overall Study||2912
2619539|NCT00056407|6430398|P1|COMPLETED|Overall Study||2915
2619540|NCT00056407|6430397|P2|STARTED|Overall Study||4105
2619541|NCT00056407|6430398|P1|STARTED|Overall Study||4126
2619542|NCT00056316|6430456|P2|NOT COMPLETED|Overall Study||3
2619543|NCT00056316|6430457|P1|NOT COMPLETED|Overall Study||3
2619544|NCT00056316|6430456|P2|COMPLETED|Overall Study||38
2619545|NCT00056316|6430457|P1|COMPLETED|Overall Study||30
2619546|NCT00056316|6430456|P2|STARTED|Overall Study|over-enrolled due to potential higher rates of drop-out.|41
2619547|NCT00056316|6430457|P1|STARTED|Overall Study||33
2619548|NCT00056160|6430471|P2|NOT COMPLETED|Final Follow-up||0
2619549|NCT00056160|6430472|P1|NOT COMPLETED|Final Follow-up||6
2619550|NCT00056160|6430471|P2|COMPLETED|Final Follow-up||0
2619551|NCT00056160|6430472|P1|COMPLETED|Final Follow-up||0
2619552|NCT00056160|6430471|P2|STARTED|Final Follow-up||0
2619553|NCT00056160|6430472|P1|STARTED|Final Follow-up||6
2619554|NCT00056160|6430471|P2|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
2619555|NCT00056160|6430472|P1|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||171
2619556|NCT00056160|6430471|P2|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
2619557|NCT00056160|6430472|P1|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||6
2619558|NCT00056160|6430471|P2|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||0
2619559|NCT00056160|6430472|P1|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||177
2619560|NCT00056160|6430471|P2|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||163
2619561|NCT00056160|6430472|P1|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||113
2619562|NCT00056160|6430471|P2|COMPLETED|Up to Unblinding (07 Jun 2005)||13
2619563|NCT00056160|6430472|P1|COMPLETED|Up to Unblinding (07 Jun 2005)||64
2619564|NCT00056160|6430471|P2|STARTED|Up to Unblinding (07 Jun 2005)||176
2619565|NCT00056160|6430472|P1|STARTED|Up to Unblinding (07 Jun 2005)||177
2619566|NCT00055692|6430484|P1|NOT COMPLETED|Overall Study||0
2619567|NCT00055692|6430484|P1|COMPLETED|Overall Study||46
2619568|NCT00055692|6430484|P1|STARTED|Overall Study||46
2619569|NCT00055601|6430495|P2|NOT COMPLETED|Overall Study||2
2619570|NCT00055601|6430496|P1|NOT COMPLETED|Overall Study||2
2619571|NCT00055601|6430495|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
2619572|NCT00055601|6430496|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|46
2619573|NCT00055601|6430495|P2|STARTED|Overall Study||49
2619574|NCT00055601|6430496|P1|STARTED|Overall Study||48
2619575|NCT00055497|6430510|P4|NOT COMPLETED|Overall Study||90
2619576|NCT00055497|6430511|P3|NOT COMPLETED|Overall Study||2
2619577|NCT00055497|6430512|P2|NOT COMPLETED|Overall Study||3
2619578|NCT00055497|6430513|P1|NOT COMPLETED|Overall Study||5
2619579|NCT00055497|6430510|P4|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|131
2619580|NCT00055497|6430511|P3|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
2619581|NCT00055497|6430512|P2|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
2619582|NCT00055497|6430513|P1|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|13
2619583|NCT00055497|6430510|P4|STARTED|Overall Study|17 participants who discontinued at/before Week 4 are counted here because they were not randomized.|221
2619584|NCT00055497|6430511|P3|STARTED|Overall Study||18
2619585|NCT00055497|6430512|P2|STARTED|Overall Study||19
2619586|NCT00055497|6430513|P1|STARTED|Overall Study||18
2619587|NCT00055471|6430558|P3|NOT COMPLETED|Period 2: Extension Period||0
2619588|NCT00055471|6430559|P2|NOT COMPLETED|Period 2: Extension Period||0
2619589|NCT00055471|6430560|P1|NOT COMPLETED|Period 2: Extension Period||0
2619590|NCT00055471|6430558|P3|COMPLETED|Period 2: Extension Period||0
2619591|NCT00055471|6430559|P2|COMPLETED|Period 2: Extension Period||6
2619592|NCT00055471|6430560|P1|COMPLETED|Period 2: Extension Period||3
2619593|NCT00055471|6430558|P3|STARTED|Period 2: Extension Period||0
2619594|NCT00055471|6430559|P2|STARTED|Period 2: Extension Period|2 pts discontinued after completion of Period1,therefore 9 pts proceeded to participate in Period2|6
2619595|NCT00055471|6430560|P1|STARTED|Period 2: Extension Period|Period 2 - attend Pts who,in the opinion of the Investigator,show benefit from treatment with ZD4054|3
2619596|NCT00055471|6430558|P3|NOT COMPLETED|Period 1: Dose Escalation Period||3
2619597|NCT00055471|6430559|P2|NOT COMPLETED|Period 1: Dose Escalation Period||2
2619598|NCT00055471|6430560|P1|NOT COMPLETED|Period 1: Dose Escalation Period||0
2619599|NCT00055471|6430558|P3|COMPLETED|Period 1: Dose Escalation Period||0
2619600|NCT00055471|6430559|P2|COMPLETED|Period 1: Dose Escalation Period||8
2619601|NCT00055471|6430560|P1|COMPLETED|Period 1: Dose Escalation Period||3
2619602|NCT00055471|6430558|P3|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|3
2619603|NCT00055471|6430559|P2|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|10
2619604|NCT00055471|6430560|P1|STARTED|Period 1: Dose Escalation Period||3
2619605|NCT00055237|6430588|P2|NOT COMPLETED|Overall Study||0
2619606|NCT00055237|6430589|P1|NOT COMPLETED|Overall Study||0
2619607|NCT00055237|6430588|P2|COMPLETED|Overall Study||2
2619608|NCT00055237|6430589|P1|COMPLETED|Overall Study||17
2619609|NCT00055237|6430588|P2|STARTED|Overall Study||2
2619610|NCT00055237|6430589|P1|STARTED|Overall Study||17
2619611|NCT00054847|6430596|P2|NOT COMPLETED|Overall Study||100
2619612|NCT00054847|6430597|P1|NOT COMPLETED|Overall Study||98
2619613|NCT00054847|6430596|P2|COMPLETED|Overall Study||266
2619614|NCT00054847|6430597|P1|COMPLETED|Overall Study||269
2619615|NCT00054847|6430596|P2|STARTED|Overall Study||366
2619616|NCT00054847|6430597|P1|STARTED|Overall Study||367
2619617|NCT00054756|6430609|P1|NOT COMPLETED|Overall Study||2
2619618|NCT00054756|6430609|P1|COMPLETED|Overall Study||94
2619619|NCT00054756|6430609|P1|STARTED|Overall Study||96
2619620|NCT00054717|6430615|P2|NOT COMPLETED|Overall Study||299
2619621|NCT00054717|6430616|P1|NOT COMPLETED|Overall Study||262
2619622|NCT00054717|6430615|P2|COMPLETED|Overall Study||18
2619623|NCT00054717|6430616|P1|COMPLETED|Overall Study||51
2619624|NCT00054717|6430615|P2|STARTED|Overall Study||317
2619625|NCT00054717|6430616|P1|STARTED|Overall Study||313
2619626|NCT00054704|6430804|P2|NOT COMPLETED|Overall Study||5
2619627|NCT00054704|6430805|P1|NOT COMPLETED|Overall Study||5
2619628|NCT00054704|6430804|P2|COMPLETED|Overall Study||6
2619629|NCT00054704|6430805|P1|COMPLETED|Overall Study||3
2619630|NCT00054704|6430804|P2|STARTED|Overall Study||11
2619631|NCT00054704|6430805|P1|STARTED|Overall Study||8
2619632|NCT00054691|6430811|P1|NOT COMPLETED|Overall Study||3
2619633|NCT00054691|6430811|P1|COMPLETED|Overall Study||37
2619634|NCT00054691|6430811|P1|STARTED|Overall Study||40
2619635|NCT00054665|6430816|P2|NOT COMPLETED|Part B||0
2619636|NCT00054665|6430817|P1|NOT COMPLETED|Part B||0
2619637|NCT00054665|6430816|P2|COMPLETED|Part B||44
2619638|NCT00054665|6430817|P1|COMPLETED|Part B||0
2619639|NCT00054665|6430816|P2|STARTED|Part B|26 participants received only Part B|44
2619640|NCT00054665|6430817|P1|STARTED|Part B||0
2619641|NCT00054665|6430816|P2|NOT COMPLETED|Part A||0
2619642|NCT00054665|6430817|P1|NOT COMPLETED|Part A||0
2619643|NCT00054665|6430816|P2|COMPLETED|Part A||0
2619644|NCT00054665|6430817|P1|COMPLETED|Part A||23
2619645|NCT00054665|6430816|P2|STARTED|Part A||0
2619646|NCT00054665|6430817|P1|STARTED|Part A|5 participants only received Part A and 18 participants received Part B after Part A.|23
2619647|NCT00054639|6430825|P1|NOT COMPLETED|Overall Study||2
2619648|NCT00054639|6430825|P1|COMPLETED|Overall Study||46
2619649|NCT00054639|6430825|P1|STARTED|Overall Study||48
2619650|NCT00054353|6430831|P2|NOT COMPLETED|Overall Study||0
2619651|NCT00054353|6430832|P1|NOT COMPLETED|Overall Study||0
2619652|NCT00054353|6430831|P2|COMPLETED|Overall Study||4
2619653|NCT00054353|6430832|P1|COMPLETED|Overall Study||12
2619654|NCT00054353|6430831|P2|STARTED|Overall Study||4
2619655|NCT00054353|6430832|P1|STARTED|Overall Study||12
2619656|NCT00054327|6430858|P6|NOT COMPLETED|Overall Study||0
2619657|NCT00054327|6430859|P5|NOT COMPLETED|Overall Study||0
2619658|NCT00054327|6430860|P4|NOT COMPLETED|Overall Study||0
2619659|NCT00054327|6430861|P3|NOT COMPLETED|Overall Study||0
2619660|NCT00054327|6430862|P2|NOT COMPLETED|Overall Study||0
2619661|NCT00054327|6430863|P1|NOT COMPLETED|Overall Study||1
2619662|NCT00054327|6430858|P6|COMPLETED|Overall Study||2
2619663|NCT00054327|6430859|P5|COMPLETED|Overall Study||10
2619664|NCT00054327|6430860|P4|COMPLETED|Overall Study||4
2619665|NCT00054327|6430861|P3|COMPLETED|Overall Study||3
2619666|NCT00054327|6430862|P2|COMPLETED|Overall Study||4
2619667|NCT00054327|6430863|P1|COMPLETED|Overall Study||10
2619668|NCT00054327|6430858|P6|STARTED|Overall Study||2
2619669|NCT00054327|6430859|P5|STARTED|Overall Study||10
2619670|NCT00054327|6430860|P4|STARTED|Overall Study||4
2619671|NCT00054327|6430861|P3|STARTED|Overall Study||3
2619672|NCT00054327|6430862|P2|STARTED|Overall Study||4
2619673|NCT00054327|6430863|P1|STARTED|Overall Study||11
2619674|NCT00054275|6430901|P1|NOT COMPLETED|Overall Study||11
2619675|NCT00054275|6430901|P1|COMPLETED|Overall Study||28
2619676|NCT00054275|6430901|P1|STARTED|Overall Study||39
2619677|NCT00054132|6430907|P1|NOT COMPLETED|Overall Study||1
2619678|NCT00054132|6430907|P1|COMPLETED|Overall Study||37
2619679|NCT00054132|6430907|P1|STARTED|Overall Study||38
2619680|NCT00054028|6430918|P1|NOT COMPLETED|Overall Study||0
2619681|NCT00054028|6430918|P1|COMPLETED|Overall Study||31
2619682|NCT00054028|6430918|P1|Phase II|Overall Study||22
2619683|NCT00054028|6430918|P1|Phase I|Overall Study||9
2619684|NCT00054028|6430918|P1|STARTED|Overall Study||31
2619685|NCT00053989|6430924|P1|NOT COMPLETED|Overall Study||0
2619686|NCT00053989|6430924|P1|COMPLETED|Overall Study||41
2619687|NCT00053989|6430924|P1|STARTED|Overall Study||41
2619688|NCT00053898|6430934|P2|NOT COMPLETED|Overall Study||13
2619689|NCT00053898|6430935|P1|NOT COMPLETED|Overall Study||14
2619690|NCT00053898|6430934|P2|COMPLETED|Overall Study||1539
2619691|NCT00053898|6430935|P1|COMPLETED|Overall Study||1538
2619692|NCT00053898|6430934|P2|STARTED|Overall Study||1552
2619693|NCT00053898|6430935|P1|STARTED|Overall Study||1552
2619694|NCT00053846|6430961|P2|NOT COMPLETED|Overall Study||27
2619695|NCT00053846|6430962|P1|NOT COMPLETED|Overall Study||26
2619696|NCT00053846|6430961|P2|COMPLETED|Overall Study||192
2619697|NCT00053846|6430962|P1|COMPLETED|Overall Study||187
2619698|NCT00053846|6430961|P2|STARTED|Overall Study||219
2619699|NCT00053846|6430962|P1|STARTED|Overall Study||213
2619700|NCT00053703|6430971|P3|NOT COMPLETED|Overall Study||15
2619701|NCT00053703|6430972|P2|NOT COMPLETED|Overall Study||13
2619702|NCT00053703|6430973|P1|NOT COMPLETED|Overall Study||18
2619703|NCT00053703|6430971|P3|COMPLETED|Overall Study||25
2619704|NCT00053703|6430972|P2|COMPLETED|Overall Study||28
2619705|NCT00053703|6430973|P1|COMPLETED|Overall Study||17
2619706|NCT00053703|6430971|P3|STARTED|Overall Study||40
2619707|NCT00053703|6430972|P2|STARTED|Overall Study||41
2619708|NCT00053703|6430973|P1|STARTED|Overall Study||35
2619709|NCT00053677|6430998|P2|NOT COMPLETED|Overall Study||6
2619710|NCT00053677|6430999|P1|NOT COMPLETED|Overall Study||22
2619711|NCT00053677|6430998|P2|COMPLETED|Overall Study||13
2619712|NCT00053677|6430999|P1|COMPLETED|Overall Study||36
2619713|NCT00053677|6430998|P2|STARTED|Overall Study||19
2619714|NCT00053677|6430999|P1|STARTED|Overall Study||58
2619715|NCT00053495|6431010|P5|NOT COMPLETED|Overall Study||0
2619716|NCT00053495|6431011|P4|NOT COMPLETED|Overall Study||0
2619717|NCT00053495|6431012|P3|NOT COMPLETED|Overall Study||0
2619718|NCT00053495|6431013|P2|NOT COMPLETED|Overall Study||0
2619719|NCT00053495|6431014|P1|NOT COMPLETED|Overall Study||0
2619720|NCT00053495|6431010|P5|COMPLETED|Overall Study||49
2619721|NCT00053495|6431011|P4|COMPLETED|Overall Study||51
2619722|NCT00053495|6431012|P3|COMPLETED|Overall Study||101
2619723|NCT00053495|6431013|P2|COMPLETED|Overall Study||101
2619724|NCT00053495|6431014|P1|COMPLETED|Overall Study||51
2619725|NCT00053495|6431010|P5|STARTED|Overall Study||49
2619726|NCT00053495|6431011|P4|STARTED|Overall Study||51
2619727|NCT00053495|6431012|P3|STARTED|Overall Study||101
2619728|NCT00053495|6431013|P2|STARTED|Overall Study||101
2619729|NCT00053495|6431014|P1|STARTED|Overall Study||51
2619730|NCT00053482|6431066|P5|NOT COMPLETED|Overall Study||0
2619731|NCT00053482|6431067|P4|NOT COMPLETED|Overall Study||0
2619732|NCT00053482|6431068|P3|NOT COMPLETED|Overall Study||0
2619733|NCT00053482|6431069|P2|NOT COMPLETED|Overall Study||0
2619734|NCT00053482|6431070|P1|NOT COMPLETED|Overall Study||0
2619735|NCT00053482|6431066|P5|COMPLETED|Overall Study||52
2619736|NCT00053482|6431067|P4|COMPLETED|Overall Study||50
2619737|NCT00053482|6431068|P3|COMPLETED|Overall Study||102
2619738|NCT00053482|6431069|P2|COMPLETED|Overall Study||102
2619739|NCT00053482|6431070|P1|COMPLETED|Overall Study||51
2619740|NCT00053482|6431066|P5|STARTED|Overall Study||52
2619741|NCT00053482|6431067|P4|STARTED|Overall Study||50
2619742|NCT00053482|6431068|P3|STARTED|Overall Study||102
2619743|NCT00053482|6431069|P2|STARTED|Overall Study||102
2619744|NCT00053482|6431070|P1|STARTED|Overall Study||51
2619745|NCT00053417|6431121|P4|NOT COMPLETED|Overall Study||6
2619746|NCT00053417|6431122|P3|NOT COMPLETED|Overall Study||1
2619747|NCT00053417|6431123|P2|NOT COMPLETED|Overall Study||2
2619748|NCT00053417|6431124|P1|NOT COMPLETED|Overall Study||2
2619749|NCT00053417|6431121|P4|COMPLETED|Overall Study||51
2619750|NCT00053417|6431122|P3|COMPLETED|Overall Study||49
2619751|NCT00053417|6431123|P2|COMPLETED|Overall Study||50
2619752|NCT00053417|6431124|P1|COMPLETED|Overall Study||45
2619753|NCT00053417|6431121|P4|STARTED|Overall Study||57
2619754|NCT00053417|6431122|P3|STARTED|Overall Study||50
2619755|NCT00053417|6431123|P2|STARTED|Overall Study||52
2619756|NCT00053417|6431124|P1|STARTED|Overall Study||47
2619757|NCT00053365|6431134|P1|NOT COMPLETED|Overall Study||6
2619758|NCT00053365|6431134|P1|COMPLETED|Overall Study||55
2619759|NCT00053365|6431134|P1|STARTED|Overall Study||61
2619760|NCT00053352|6431143|P2|NOT COMPLETED|Overall Study||10
2619761|NCT00053352|6431144|P1|NOT COMPLETED|Overall Study||21
2619762|NCT00053352|6431143|P2|COMPLETED|Overall Study||102
2619763|NCT00053352|6431144|P1|COMPLETED|Overall Study||169
2619764|NCT00053352|6431143|P2|STARTED|Overall Study||112
2619765|NCT00053352|6431144|P1|STARTED|Overall Study||190
2619766|NCT00053014|6431153|P1|NOT COMPLETED|Overall Study||0
2619767|NCT00053014|6431153|P1|COMPLETED|Overall Study||5
2619768|NCT00053014|6431153|P1|STARTED|Overall Study||5
2619769|NCT00003830|6431160|P2|NOT COMPLETED|Overall Study||793
2619770|NCT00003830|6431161|P1|NOT COMPLETED|Overall Study||832
2619771|NCT00003830|6431160|P2|COMPLETED|Overall Study||2011
2619772|NCT00003830|6431161|P1|COMPLETED|Overall Study||1975
2619773|NCT00003830|6431160|P2|STARTED|Overall Study||2804
2619774|NCT00003830|6431161|P1|STARTED|Overall Study||2807
2619775|NCT00052962|6431187|P2|NOT COMPLETED|Overall Study||2
2619776|NCT00052962|6431188|P1|NOT COMPLETED|Overall Study||1
2619777|NCT00052962|6431187|P2|COMPLETED|Overall Study||15
2619778|NCT00052962|6431188|P1|COMPLETED|Overall Study||12
2619779|NCT00052962|6431187|P2|STARTED|Overall Study||17
2619780|NCT00052962|6431188|P1|STARTED|Overall Study||13
2619781|NCT00052910|6431198|P2|NOT COMPLETED|Overall Study||0
2619782|NCT00052910|6431199|P1|NOT COMPLETED|Overall Study||0
2619783|NCT00052910|6431198|P2|COMPLETED|Overall Study||266
2619784|NCT00052910|6431199|P1|COMPLETED|Overall Study||280
2619785|NCT00052910|6431198|P2|STARTED|Overall Study||266
2619786|NCT00052910|6431199|P1|STARTED|Overall Study||280
2619787|NCT00052715|6431207|P1|NOT COMPLETED|Overall Study||1
2619788|NCT00052715|6431207|P1|COMPLETED|Overall Study||30
2619789|NCT00052715|6431207|P1|STARTED|Overall Study||31
2619790|NCT00052429|6431216|P1|NOT COMPLETED|Overall Study||0
2619791|NCT00052429|6431216|P1|COMPLETED|Overall Study||25
2619792|NCT00052429|6431216|P1|STARTED|Overall Study||25
2619793|NCT00049543|6431223|P2|NOT COMPLETED|Overall Study||9
2619794|NCT00049543|6431224|P1|NOT COMPLETED|Overall Study||2
2619795|NCT00049543|6431223|P2|COMPLETED|Overall Study||243
2619796|NCT00049543|6431224|P1|COMPLETED|Overall Study||249
2619797|NCT00049543|6431223|P2|STARTED|Overall Study||252
2619798|NCT00049543|6431224|P1|STARTED|Overall Study||251
2619799|NCT00049530|6431234|P1|NOT COMPLETED|Overall Study||32
2619800|NCT00049530|6431234|P1|COMPLETED|Overall Study||0
2619801|NCT00049530|6431234|P1|Eligible and Treated|Overall Study||29
2619802|NCT00049530|6431234|P1|STARTED|Overall Study||32
2619803|NCT00049517|6431243|P6|NOT COMPLETED|Conditioning/Transplant||6
2619804|NCT00049517|6431244|P5|NOT COMPLETED|Conditioning/Transplant||6
2619805|NCT00049517|6431245|P4|NOT COMPLETED|Conditioning/Transplant||43
2619806|NCT00049517|6431246|P3|NOT COMPLETED|Conditioning/Transplant||38
2619807|NCT00049517|6431247|P2|NOT COMPLETED|Conditioning/Transplant||50
2619808|NCT00049517|6431248|P1|NOT COMPLETED|Conditioning/Transplant||52
2619809|NCT00049517|6431243|P6|COMPLETED|Conditioning/Transplant||18
2619810|NCT00049517|6431244|P5|COMPLETED|Conditioning/Transplant||15
2619811|NCT00049517|6431245|P4|COMPLETED|Conditioning/Transplant||32
2619812|NCT00049517|6431246|P3|COMPLETED|Conditioning/Transplant||25
2619813|NCT00049517|6431247|P2|COMPLETED|Conditioning/Transplant||40
2619814|NCT00049517|6431248|P1|COMPLETED|Conditioning/Transplant||27
2619815|NCT00049517|6431243|P6|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 24 patients received Allogeneic HCT without randomization.|0
2619816|NCT00049517|6431244|P5|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 21 patients received Allogeneic HCT without randomization.|0
2619817|NCT00049517|6431245|P4|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||75
2619818|NCT00049517|6431246|P3|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||63
2619819|NCT00049517|6431247|P2|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 17 patients received Autologous HCT without randomization.|73
2619820|NCT00049517|6431248|P1|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 20 patients received Autologous HCT without randomization.|59
2619821|NCT00049517|6431243|P6|STARTED|Conditioning/Transplant||24
2619822|NCT00049517|6431244|P5|STARTED|Conditioning/Transplant||21
2619823|NCT00049517|6431245|P4|STARTED|Conditioning/Transplant||75
2619824|NCT00049517|6431246|P3|STARTED|Conditioning/Transplant||63
2619825|NCT00049517|6431247|P2|STARTED|Conditioning/Transplant||90
2619826|NCT00049517|6431248|P1|STARTED|Conditioning/Transplant||79
2619827|NCT00049517|6431243|P6|NOT COMPLETED|Induction||54
2619828|NCT00049517|6431244|P5|NOT COMPLETED|Induction||60
2619829|NCT00049517|6431245|P4|NOT COMPLETED|Induction||0
2619830|NCT00049517|6431246|P3|NOT COMPLETED|Induction||0
2619831|NCT00049517|6431247|P2|NOT COMPLETED|Induction||0
2619832|NCT00049517|6431248|P1|NOT COMPLETED|Induction||0
2619833|NCT00049517|6431243|P6|COMPLETED|Induction||108
2619834|NCT00049517|6431244|P5|COMPLETED|Induction||128
2619835|NCT00049517|6431245|P4|COMPLETED|Induction||75
2619836|NCT00049517|6431246|P3|COMPLETED|Induction||63
2619837|NCT00049517|6431247|P2|COMPLETED|Induction||90
2619838|NCT00049517|6431248|P1|COMPLETED|Induction||79
2619839|NCT00049517|6431243|P6|Treated|Induction||160
2619840|NCT00049517|6431244|P5|Treated|Induction||186
2619841|NCT00049517|6431245|P4|Treated|Induction||75
2619842|NCT00049517|6431246|P3|Treated|Induction||63
2619843|NCT00049517|6431247|P2|Treated|Induction||90
2619844|NCT00049517|6431248|P1|Treated|Induction||79
2619845|NCT00049517|6431243|P6|STARTED|Induction||162
2619846|NCT00049517|6431244|P5|STARTED|Induction||188
2619847|NCT00049517|6431245|P4|STARTED|Induction||75
2619848|NCT00049517|6431246|P3|STARTED|Induction||63
2619849|NCT00049517|6431247|P2|STARTED|Induction||90
2619850|NCT00049517|6431248|P1|STARTED|Induction||79
2619851|NCT00049504|6431258|P1|NOT COMPLETED|Overall Study||0
2619852|NCT00049504|6431258|P1|COMPLETED|Overall Study||55
2619853|NCT00049504|6431258|P1|STARTED|Overall Study||55
2619854|NCT00049322|6431266|P2|NOT COMPLETED|Overall Study||6
2619855|NCT00049322|6431267|P1|NOT COMPLETED|Overall Study||1
2619856|NCT00049322|6431266|P2|COMPLETED|Overall Study||9
2619857|NCT00049322|6431267|P1|COMPLETED|Overall Study||14
2619858|NCT00049322|6431266|P2|STARTED|Overall Study||15
2619859|NCT00049322|6431267|P1|STARTED|Overall Study||15
2619860|NCT00049257|6431279|P1|NOT COMPLETED|Follow-up Period for Survival Status||4
2619861|NCT00049257|6431279|P1|COMPLETED|Follow-up Period for Survival Status||41
2619862|NCT00049257|6431279|P1|STARTED|Follow-up Period for Survival Status||45
2619863|NCT00049257|6431279|P1|NOT COMPLETED|Carboplatin, Paclitaxel||13
2619864|NCT00049257|6431279|P1|COMPLETED|Carboplatin, Paclitaxel|13 participants did not complete treatment|45
2619865|NCT00049257|6431279|P1|STARTED|Carboplatin, Paclitaxel||58
2619866|NCT00049127|6431291|P5|NOT COMPLETED|Overall Study||0
2619867|NCT00049127|6431292|P4|NOT COMPLETED|Overall Study||0
2619868|NCT00049127|6431293|P3|NOT COMPLETED|Overall Study||1
2619869|NCT00049127|6431294|P2|NOT COMPLETED|Overall Study||0
2619870|NCT00049127|6431295|P1|NOT COMPLETED|Overall Study||0
2619871|NCT00049127|6431291|P5|COMPLETED|Overall Study||12
2619872|NCT00049127|6431292|P4|COMPLETED|Overall Study||0
2619873|NCT00049127|6431293|P3|COMPLETED|Overall Study||39
2619874|NCT00049127|6431294|P2|COMPLETED|Overall Study||0
2619875|NCT00049127|6431295|P1|COMPLETED|Overall Study||12
2619876|NCT00049127|6431291|P5|STARTED|Overall Study||12
2619877|NCT00049127|6431292|P4|STARTED|Overall Study||0
2619878|NCT00049127|6431293|P3|STARTED|Overall Study||40
2619879|NCT00049127|6431294|P2|STARTED|Overall Study||0
2619880|NCT00049127|6431295|P1|STARTED|Overall Study||12
2619881|NCT00049036|6431324|P2|NOT COMPLETED|Overall Study||0
2619882|NCT00049036|6431325|P1|NOT COMPLETED|Overall Study||0
2619883|NCT00049036|6431324|P2|COMPLETED|Overall Study||55
2619884|NCT00049036|6431325|P1|COMPLETED|Overall Study||51
2619885|NCT00049036|6431324|P2|STARTED|Overall Study||55
2619886|NCT00049036|6431325|P1|STARTED|Overall Study||51
2619887|NCT00048997|6431333|P2|NOT COMPLETED|Overall Study||3
2619888|NCT00048997|6431334|P1|NOT COMPLETED|Overall Study||13
2619889|NCT00048997|6431333|P2|COMPLETED|Overall Study||177
2619890|NCT00048997|6431334|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|163
2619891|NCT00048997|6431333|P2|STARTED|Overall Study||180
2619892|NCT00048997|6431334|P1|STARTED|Overall Study||176
2619893|NCT00047385|6431357|P2|NOT COMPLETED|Overall Study||500
2619894|NCT00047385|6431358|P1|NOT COMPLETED|Overall Study||267
2619895|NCT00047385|6431357|P2|COMPLETED|Overall Study||26232
2619896|NCT00047385|6431358|P1|COMPLETED|Overall Study|Had at least one screening exam.|26455
2619897|NCT00047385|6431357|P2|STARTED|Overall Study||26732
2619898|NCT00047385|6431358|P1|STARTED|Overall Study||26722
2619899|NCT00047320|6431376|P1|NOT COMPLETED|Overall Study||28
2619900|NCT00047320|6431376|P1|COMPLETED|Overall Study||76
2619901|NCT00047320|6431376|P1|STARTED|Overall Study||104
2619905|NCT00047008|6431391|P2|NOT COMPLETED|Overall Study||11
2619906|NCT00047008|6431392|P1|NOT COMPLETED|Overall Study||11
2619907|NCT00047008|6431391|P2|COMPLETED|Overall Study||360
2619908|NCT00047008|6431392|P1|COMPLETED|Overall Study||361
2619909|NCT00047008|6431391|P2|STARTED|Overall Study||371
2619910|NCT00047008|6431392|P1|STARTED|Overall Study||372
2619911|NCT00046930|6431400|P2|NOT COMPLETED|Overall Study||4
2619912|NCT00046930|6431401|P1|NOT COMPLETED|Overall Study||12
2619913|NCT00046930|6431400|P2|COMPLETED|Overall Study||221
2619914|NCT00046930|6431401|P1|COMPLETED|Overall Study||212
2619915|NCT00046930|6431400|P2|STARTED|Overall Study||225
2619916|NCT00046930|6431401|P1|STARTED|Overall Study||224
2619917|NCT00046891|6431416|P2|NOT COMPLETED|Overall Study||30
2619918|NCT00046891|6431417|P1|NOT COMPLETED|Overall Study||29
2619919|NCT00046891|6431416|P2|COMPLETED|Overall Study||83
2619920|NCT00046891|6431417|P1|COMPLETED|Overall Study||84
2619921|NCT00046891|6431416|P2|STARTED|Overall Study||113
2619922|NCT00046891|6431417|P1|STARTED|Overall Study||113
2619923|NCT00046839|6431437|P2|NOT COMPLETED|Overall Study||2
2619924|NCT00046839|6431438|P1|NOT COMPLETED|Overall Study||1
2619925|NCT00046839|6431437|P2|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|11
2619926|NCT00046839|6431438|P1|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|7
2619927|NCT00046839|6431437|P2|STARTED|Overall Study||13
2619928|NCT00046839|6431438|P1|STARTED|Overall Study||8
2619929|NCT00045734|6431445|P1|NOT COMPLETED|Overall Study||1
2619930|NCT00045734|6431445|P1|COMPLETED|Overall Study||22
2619931|NCT00045734|6431445|P1|STARTED|Overall Study||23
2619932|NCT00045708|6431460|P3|NOT COMPLETED|Phase 2||0
2619933|NCT00045708|6431461|P2|NOT COMPLETED|Phase 2||0
2619934|NCT00045708|6431462|P1|NOT COMPLETED|Phase 2||0
2619935|NCT00045708|6431460|P3|COMPLETED|Phase 2||19
2619936|NCT00045708|6431461|P2|COMPLETED|Phase 2||0
2619937|NCT00045708|6431462|P1|COMPLETED|Phase 2||0
2619938|NCT00045708|6431460|P3|STARTED|Phase 2||19
2619939|NCT00045708|6431461|P2|STARTED|Phase 2||0
2619940|NCT00045708|6431462|P1|STARTED|Phase 2||0
2619941|NCT00045708|6431460|P3|NOT COMPLETED|Phase 1||0
2619942|NCT00045708|6431461|P2|NOT COMPLETED|Phase 1||1
2619943|NCT00045708|6431462|P1|NOT COMPLETED|Phase 1||0
2619944|NCT00045708|6431460|P3|COMPLETED|Phase 1||0
2619945|NCT00045708|6431461|P2|COMPLETED|Phase 1||16
2619946|NCT00045708|6431462|P1|COMPLETED|Phase 1||21
2619947|NCT00045708|6431460|P3|STARTED|Phase 1||0
2619948|NCT00045708|6431461|P2|STARTED|Phase 1||17
2619949|NCT00045708|6431462|P1|STARTED|Phase 1||21
2619950|NCT00045630|6431487|P1|NOT COMPLETED|Overall Study||6
2619951|NCT00045630|6431487|P1|COMPLETED|Overall Study||71
2619952|NCT00045630|6431487|P1|Eligible and Began Protocol Therapy|Overall Study||74
2619953|NCT00045630|6431487|P1|Eligible|Overall Study||75
2619954|NCT00045630|6431487|P1|STARTED|Overall Study||77
2619955|NCT00045487|6431493|P1|NOT COMPLETED|Overall Study||11
2619956|NCT00045487|6431493|P1|COMPLETED|Overall Study||30
2619957|NCT00045487|6431493|P1|STARTED|Overall Study||41
2619958|NCT00045435|6431497|P1|NOT COMPLETED|Overall Study||0
2619959|NCT00045435|6431497|P1|COMPLETED|Overall Study||17
2619960|NCT00045435|6431497|P1|STARTED|Overall Study||17
2619961|NCT00045305|6431506|P1|NOT COMPLETED|Overall Study||14
2619962|NCT00045305|6431506|P1|COMPLETED|Overall Study||3
2619963|NCT00045305|6431506|P1|Eligible and Treated|Overall Study||17
2619964|NCT00045305|6431506|P1|STARTED|Overall Study||17
2619965|NCT00045162|6431517|P2|NOT COMPLETED|Overall Study||118
2619966|NCT00045162|6431518|P1|NOT COMPLETED|Overall Study||142
2619967|NCT00045162|6431517|P2|COMPLETED|Overall Study||217
2619968|NCT00045162|6431518|P1|COMPLETED|Overall Study||194
2619969|NCT00045162|6431517|P2|STARTED|Overall Study||335
2619970|NCT00045162|6431518|P1|STARTED|Overall Study||336
2619971|NCT00045110|6431533|P3|NOT COMPLETED|775mg Dose Escalation||0
2619972|NCT00045110|6431534|P2|NOT COMPLETED|775mg Dose Escalation||0
2619973|NCT00045110|6431535|P1|NOT COMPLETED|775mg Dose Escalation||0
2619974|NCT00045110|6431533|P3|COMPLETED|775mg Dose Escalation||0
2619975|NCT00045110|6431534|P2|COMPLETED|775mg Dose Escalation||0
2619976|NCT00045110|6431535|P1|COMPLETED|775mg Dose Escalation||7
2619977|NCT00045110|6431533|P3|STARTED|775mg Dose Escalation||0
2619978|NCT00045110|6431534|P2|STARTED|775mg Dose Escalation||0
2619979|NCT00045110|6431535|P1|STARTED|775mg Dose Escalation||7
2619980|NCT00045110|6431533|P3|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
2619981|NCT00045110|6431534|P2|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
2619982|NCT00045110|6431535|P1|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
2619983|NCT00045110|6431533|P3|COMPLETED|650mg Phase 1 Dose Escalation||0
2619984|NCT00045110|6431534|P2|COMPLETED|650mg Phase 1 Dose Escalation||0
2619985|NCT00045110|6431535|P1|COMPLETED|650mg Phase 1 Dose Escalation||6
2619986|NCT00045110|6431533|P3|STARTED|650mg Phase 1 Dose Escalation||0
2619987|NCT00045110|6431534|P2|STARTED|650mg Phase 1 Dose Escalation||0
2619988|NCT00045110|6431535|P1|STARTED|650mg Phase 1 Dose Escalation||6
2619989|NCT00045110|6431533|P3|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
2619990|NCT00045110|6431534|P2|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
2619991|NCT00045110|6431535|P1|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
2619992|NCT00045110|6431533|P3|COMPLETED|525mg Phase 1 Dose Escalation||0
2619993|NCT00045110|6431534|P2|COMPLETED|525mg Phase 1 Dose Escalation||0
2619994|NCT00045110|6431535|P1|COMPLETED|525mg Phase 1 Dose Escalation||3
2619995|NCT00045110|6431533|P3|STARTED|525mg Phase 1 Dose Escalation||0
2619996|NCT00045110|6431534|P2|STARTED|525mg Phase 1 Dose Escalation||0
2619997|NCT00045110|6431535|P1|STARTED|525mg Phase 1 Dose Escalation||3
2619998|NCT00045110|6431533|P3|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
2619999|NCT00045110|6431534|P2|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
2620000|NCT00045110|6431535|P1|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
2620001|NCT00045110|6431533|P3|COMPLETED|400mg Phase 1 Dose Escalation||0
2620002|NCT00045110|6431534|P2|COMPLETED|400mg Phase 1 Dose Escalation||0
2620003|NCT00045110|6431535|P1|COMPLETED|400mg Phase 1 Dose Escalation||3
2620004|NCT00045110|6431533|P3|STARTED|400mg Phase 1 Dose Escalation||0
2620005|NCT00045110|6431534|P2|STARTED|400mg Phase 1 Dose Escalation||0
2620006|NCT00045110|6431535|P1|STARTED|400mg Phase 1 Dose Escalation||3
2620007|NCT00045110|6431533|P3|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
2620008|NCT00045110|6431534|P2|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
2620009|NCT00045110|6431535|P1|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
2620010|NCT00045110|6431533|P3|COMPLETED|275mg Phase 1 Dose Escalation||0
2620011|NCT00045110|6431534|P2|COMPLETED|275mg Phase 1 Dose Escalation||0
2620012|NCT00045110|6431535|P1|COMPLETED|275mg Phase 1 Dose Escalation||3
2620013|NCT00045110|6431533|P3|STARTED|275mg Phase 1 Dose Escalation||0
2620014|NCT00045110|6431534|P2|STARTED|275mg Phase 1 Dose Escalation||0
2620015|NCT00045110|6431535|P1|STARTED|275mg Phase 1 Dose Escalation||3
2620016|NCT00045110|6431533|P3|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
2620017|NCT00045110|6431534|P2|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
2620018|NCT00045110|6431535|P1|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
2620019|NCT00045110|6431533|P3|COMPLETED|200mg Phase 1 Dose Escalation||0
2620020|NCT00045110|6431534|P2|COMPLETED|200mg Phase 1 Dose Escalation||0
2620021|NCT00045110|6431535|P1|COMPLETED|200mg Phase 1 Dose Escalation||4
2620022|NCT00045110|6431533|P3|STARTED|200mg Phase 1 Dose Escalation||0
2620023|NCT00045110|6431534|P2|STARTED|200mg Phase 1 Dose Escalation||0
2620024|NCT00045110|6431535|P1|STARTED|200mg Phase 1 Dose Escalation||4
2620025|NCT00045110|6431533|P3|NOT COMPLETED|100mg Phase 1 Dose Escalalation||2
2620026|NCT00045110|6431534|P2|NOT COMPLETED|100mg Phase 1 Dose Escalalation||6
2620027|NCT00045110|6431535|P1|NOT COMPLETED|100mg Phase 1 Dose Escalalation||0
2620028|NCT00045110|6431533|P3|COMPLETED|100mg Phase 1 Dose Escalalation||43
2620029|NCT00045110|6431534|P2|COMPLETED|100mg Phase 1 Dose Escalalation||53
2620030|NCT00045110|6431535|P1|COMPLETED|100mg Phase 1 Dose Escalalation||6
2620031|NCT00045110|6431533|P3|STARTED|100mg Phase 1 Dose Escalalation||45
2620032|NCT00045110|6431534|P2|STARTED|100mg Phase 1 Dose Escalalation||59
2620033|NCT00045110|6431535|P1|STARTED|100mg Phase 1 Dose Escalalation||6
2620034|NCT00045032|6431584|P3|NOT COMPLETED|Overall Study||726
2620035|NCT00045032|6431585|P2|NOT COMPLETED|Overall Study||708
2620036|NCT00045032|6431586|P1|NOT COMPLETED|Overall Study||863
2620037|NCT00045032|6431584|P3|COMPLETED|Overall Study||974
2620038|NCT00045032|6431585|P2|COMPLETED|Overall Study||994
2620039|NCT00045032|6431586|P1|COMPLETED|Overall Study||834
2620040|NCT00045032|6431584|P3|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
2620041|NCT00045032|6431585|P2|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
2620042|NCT00045032|6431586|P1|Crossover to Adjuvant Herceptin|Overall Study||888
2620043|NCT00045032|6431584|P3|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1700
2620044|NCT00045032|6431585|P2|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1702
2620045|NCT00045032|6431586|P1|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1697
2620046|NCT00042991|6431720|P7|NOT COMPLETED|Overall Study||2
2620047|NCT00042991|6431721|P6|NOT COMPLETED|Overall Study||5
2620048|NCT00042991|6431722|P5|NOT COMPLETED|Overall Study||3
2620049|NCT00042991|6431723|P4|NOT COMPLETED|Overall Study||2
2620050|NCT00042991|6431724|P3|NOT COMPLETED|Overall Study||6
2620051|NCT00042991|6431725|P2|NOT COMPLETED|Overall Study||40
2620052|NCT00042991|6431726|P1|NOT COMPLETED|Overall Study||6
2620053|NCT00042991|6431720|P7|COMPLETED|Overall Study||1
2620054|NCT00042991|6431721|P6|COMPLETED|Overall Study||0
2620055|NCT00042991|6431722|P5|COMPLETED|Overall Study||0
2620056|NCT00042991|6431723|P4|COMPLETED|Overall Study||0
2620057|NCT00042991|6431724|P3|COMPLETED|Overall Study||1
2620058|NCT00042991|6431725|P2|COMPLETED|Overall Study||3
2620059|NCT00042991|6431726|P1|COMPLETED|Overall Study||0
2620060|NCT00042991|6431720|P7|Phase-II Trial|Overall Study||0
2620061|NCT00042991|6431721|P6|Phase-II Trial|Overall Study||0
2620062|NCT00042991|6431722|P5|Phase-II Trial|Overall Study||0
2620063|NCT00042991|6431723|P4|Phase-II Trial|Overall Study||0
2620064|NCT00042991|6431724|P3|Phase-II Trial|Overall Study||0
2620065|NCT00042991|6431725|P2|Phase-II Trial|Overall Study||36
2620066|NCT00042991|6431726|P1|Phase-II Trial|Overall Study||0
2620067|NCT00042991|6431720|P7|Phase-I Trial|Overall Study||3
2620068|NCT00042991|6431721|P6|Phase-I Trial|Overall Study||5
2620069|NCT00042991|6431722|P5|Phase-I Trial|Overall Study||3
2620070|NCT00042991|6431723|P4|Phase-I Trial|Overall Study||2
2620071|NCT00042991|6431724|P3|Phase-I Trial|Overall Study||7
2620072|NCT00042991|6431725|P2|Phase-I Trial|Overall Study|These seven patients contributed to both Phase-I and Phase-II objectives.|7
2620073|NCT00042991|6431726|P1|Phase-I Trial|Overall Study||6
2620074|NCT00042991|6431720|P7|STARTED|Overall Study||3
2620075|NCT00042991|6431721|P6|STARTED|Overall Study||5
2620076|NCT00042991|6431722|P5|STARTED|Overall Study||3
2620077|NCT00042991|6431723|P4|STARTED|Overall Study||2
2620078|NCT00042991|6431724|P3|STARTED|Overall Study||7
2620079|NCT00042991|6431725|P2|STARTED|Overall Study|These 43 patients form the Phase-II cohort, seven contributing from the Phase-I trial.|43
2620080|NCT00042991|6431726|P1|STARTED|Overall Study||6
2620081|NCT00042939|6431769|P2|NOT COMPLETED|Overall Study||21
2620082|NCT00042939|6431770|P1|NOT COMPLETED|Overall Study||24
2620083|NCT00042939|6431769|P2|COMPLETED|Overall Study||25
2620084|NCT00042939|6431770|P1|COMPLETED|Overall Study||24
2620085|NCT00042939|6431769|P2|Patients With EGFR Results Available|Overall Study||31
2620086|NCT00042939|6431770|P1|Patients With EGFR Results Available|Overall Study||30
2620087|NCT00042939|6431769|P2|Eligible and Began Protocol Therapy|Overall Study||43
2620088|NCT00042939|6431770|P1|Eligible and Began Protocol Therapy|Overall Study||44
2620089|NCT00042939|6431769|P2|Treated|Overall Study||45
2620090|NCT00042939|6431770|P1|Treated|Overall Study||46
2620091|NCT00042939|6431769|P2|STARTED|Overall Study||46
2620092|NCT00042939|6431770|P1|STARTED|Overall Study||48
2620093|NCT00041132|6431784|P1|NOT COMPLETED|Overall Study||30
2620094|NCT00041132|6431784|P1|COMPLETED|Overall Study||26
2620095|NCT00041132|6431784|P1|Eligible and Began Protocol Therapy|Overall Study||49
2620096|NCT00041132|6431784|P1|Eligible|Overall Study||49
2620097|NCT00041132|6431784|P1|STARTED|Overall Study||56
2620098|NCT00041119|6431794|P4|NOT COMPLETED|Overall Study||0
2620099|NCT00041119|6431795|P3|NOT COMPLETED|Overall Study||0
2620100|NCT00041119|6431796|P2|NOT COMPLETED|Overall Study||0
2620101|NCT00041119|6431797|P1|NOT COMPLETED|Overall Study||0
2620102|NCT00041119|6431794|P4|COMPLETED|Overall Study||789
2620103|NCT00041119|6431795|P3|COMPLETED|Overall Study||1151
2620104|NCT00041119|6431796|P2|COMPLETED|Overall Study||789
2620105|NCT00041119|6431797|P1|COMPLETED|Overall Study||1142
2620106|NCT00041119|6431794|P4|STARTED|Overall Study||789
2620107|NCT00041119|6431795|P3|STARTED|Overall Study||1151
2620108|NCT00041119|6431796|P2|STARTED|Overall Study||789
2620109|NCT00041119|6431797|P1|STARTED|Overall Study||1142
2620110|NCT00041080|6431819|P2|NOT COMPLETED|Overall Study||10
2620111|NCT00041080|6431820|P1|NOT COMPLETED|Overall Study||30
2620112|NCT00041080|6431819|P2|COMPLETED|Overall Study||60
2620113|NCT00041080|6431820|P1|COMPLETED|Overall Study||39
2620114|NCT00041080|6431819|P2|STARTED|Overall Study|number patients enrolled on study|70
2620115|NCT00041080|6431820|P1|STARTED|Overall Study|number patients enrolled on study|69
2620116|NCT00041067|6431826|P1|NOT COMPLETED|Overall Study||76
2620117|NCT00041067|6431826|P1|COMPLETED|Overall Study||0
2620118|NCT00041067|6431826|P1|Eligible|Overall Study||74
2620119|NCT00041067|6431826|P1|STARTED|Overall Study||76
2620120|NCT00040937|6431833|P1|NOT COMPLETED|Maintenance||0
2620121|NCT00040937|6431833|P1|COMPLETED|Maintenance|Patients remained on protocol therapy until progression.|76
2620122|NCT00040937|6431833|P1|STARTED|Maintenance||76
2620123|NCT00040937|6431833|P1|NOT COMPLETED|Autologous PBSCT||31
2620124|NCT00040937|6431833|P1|COMPLETED|Autologous PBSCT||77
2620125|NCT00040937|6431833|P1|STARTED|Autologous PBSCT|108 registered to this period; 105 were eligible and analyzable; 105 were assessable for toxicity.|108
2620126|NCT00040937|6431833|P1|NOT COMPLETED|Induction/PBSC Mobilization||37
2620127|NCT00040937|6431833|P1|COMPLETED|Induction/PBSC Mobilization||110
2620128|NCT00040937|6431833|P1|STARTED|Induction/PBSC Mobilization|147 registered to this period; 142 were eligible and analyzable; 140 were assessable for toxicity.|147
2620129|NCT00040846|6431846|P6|NOT COMPLETED|Overall Study||0
2620130|NCT00040846|6431847|P5|NOT COMPLETED|Overall Study||0
2620131|NCT00040846|6431848|P4|NOT COMPLETED|Overall Study||0
2620132|NCT00040846|6431849|P3|NOT COMPLETED|Overall Study||0
2620133|NCT00040846|6431850|P2|NOT COMPLETED|Overall Study||0
2620134|NCT00040846|6431851|P1|NOT COMPLETED|Overall Study||0
2620135|NCT00040846|6431846|P6|COMPLETED|Overall Study||0
2620136|NCT00040846|6431847|P5|COMPLETED|Overall Study||0
2620137|NCT00040846|6431848|P4|COMPLETED|Overall Study||0
2620138|NCT00040846|6431849|P3|COMPLETED|Overall Study||0
2620139|NCT00040846|6431850|P2|COMPLETED|Overall Study||0
2620140|NCT00040846|6431851|P1|COMPLETED|Overall Study||60
2620141|NCT00040846|6431846|P6|STARTED|Overall Study||0
2620142|NCT00040846|6431847|P5|STARTED|Overall Study||0
2620143|NCT00040846|6431848|P4|STARTED|Overall Study||0
2620144|NCT00040846|6431849|P3|STARTED|Overall Study||0
2620145|NCT00040846|6431850|P2|STARTED|Overall Study||0
2620146|NCT00040846|6431851|P1|STARTED|Overall Study||60
2620147|NCT00040742|6431893|P4|NOT COMPLETED|Overall Study||34
2620148|NCT00040742|6431894|P3|NOT COMPLETED|Overall Study||46
2620149|NCT00040742|6431895|P2|NOT COMPLETED|Overall Study||49
2620150|NCT00040742|6431896|P1|NOT COMPLETED|Overall Study||39
2620151|NCT00040742|6431893|P4|COMPLETED|Overall Study||152
2620152|NCT00040742|6431894|P3|COMPLETED|Overall Study||141
2620153|NCT00040742|6431895|P2|COMPLETED|Overall Study||134
2620154|NCT00040742|6431896|P1|COMPLETED|Overall Study||149
2620155|NCT00040742|6431893|P4|STARTED|Overall Study|One subject found to be ineligible after randomization. No baseline data collected.|186
2620156|NCT00040742|6431894|P3|STARTED|Overall Study||187
2620157|NCT00040742|6431895|P2|STARTED|Overall Study||183
2620158|NCT00040742|6431896|P1|STARTED|Overall Study||188
2620159|NCT00039377|6431910|P4|NOT COMPLETED|Course 5 (Transplant Assignments)||0
2620160|NCT00039377|6431911|P3|NOT COMPLETED|Course 5 (Transplant Assignments)||0
2620161|NCT00039377|6431912|P2|NOT COMPLETED|Course 5 (Transplant Assignments)||0
2620162|NCT00039377|6431913|P1|NOT COMPLETED|Course 5 (Transplant Assignments)||0
2620163|NCT00039377|6431910|P4|COMPLETED|Course 5 (Transplant Assignments)||1
2620164|NCT00039377|6431911|P3|COMPLETED|Course 5 (Transplant Assignments)||19
2620165|NCT00039377|6431912|P2|COMPLETED|Course 5 (Transplant Assignments)||15
2620166|NCT00039377|6431913|P1|COMPLETED|Course 5 (Transplant Assignments)||0
2620167|NCT00039377|6431910|P4|STARTED|Course 5 (Transplant Assignments)||1
2620168|NCT00039377|6431911|P3|STARTED|Course 5 (Transplant Assignments)||19
2620169|NCT00039377|6431912|P2|STARTED|Course 5 (Transplant Assignments)||15
2620170|NCT00039377|6431913|P1|STARTED|Course 5 (Transplant Assignments)|After Course I-IV, participants were grouped into autologous, allogeneic or no transplant arms.|0
2620171|NCT00039377|6431910|P4|NOT COMPLETED|Initial Registration||0
2620172|NCT00039377|6431911|P3|NOT COMPLETED|Initial Registration||0
2620173|NCT00039377|6431912|P2|NOT COMPLETED|Initial Registration||0
2620174|NCT00039377|6431913|P1|NOT COMPLETED|Initial Registration||22
2620175|NCT00039377|6431910|P4|COMPLETED|Initial Registration||0
2620176|NCT00039377|6431911|P3|COMPLETED|Initial Registration||0
2620177|NCT00039377|6431912|P2|COMPLETED|Initial Registration||0
2620178|NCT00039377|6431913|P1|COMPLETED|Initial Registration||35
2620179|NCT00039377|6431910|P4|STARTED|Initial Registration||0
2620180|NCT00039377|6431911|P3|STARTED|Initial Registration||0
2620181|NCT00039377|6431912|P2|STARTED|Initial Registration||0
2620182|NCT00039377|6431913|P1|STARTED|Initial Registration||57
2620183|NCT00039195|6431925|P1|NOT COMPLETED|Overall Study||0
2620184|NCT00039195|6431925|P1|COMPLETED|Overall Study||98
2620185|NCT00039195|6431925|P1|STARTED|Overall Study||98
2620186|NCT00039130|6431929|P1|NOT COMPLETED|Overall Study||30
2620187|NCT00039130|6431929|P1|COMPLETED|Overall Study||75
2620188|NCT00039130|6431929|P1|STARTED|Overall Study||105
2620189|NCT00036738|6431935|P1|NOT COMPLETED|Overall Study||0
2620190|NCT00036738|6431935|P1|COMPLETED|Overall Study||28
2620191|NCT00036738|6431935|P1|STARTED|Overall Study||28
2620192|NCT00033657|6431945|P2|NOT COMPLETED|Adjuvant Chemotherapy||17
2620193|NCT00033657|6431946|P1|NOT COMPLETED|Adjuvant Chemotherapy||18
2620194|NCT00033657|6431945|P2|COMPLETED|Adjuvant Chemotherapy||16
2620195|NCT00033657|6431946|P1|COMPLETED|Adjuvant Chemotherapy||18
2620196|NCT00033657|6431945|P2|STARTED|Adjuvant Chemotherapy||33
2620197|NCT00033657|6431946|P1|STARTED|Adjuvant Chemotherapy||36
2620198|NCT00033657|6431945|P2|NOT COMPLETED|Surgical Resection||3
2620199|NCT00033657|6431946|P1|NOT COMPLETED|Surgical Resection||0
2620200|NCT00033657|6431945|P2|COMPLETED|Surgical Resection||33
2620201|NCT00033657|6431946|P1|COMPLETED|Surgical Resection||36
2620202|NCT00033657|6431945|P2|STARTED|Surgical Resection||36
2620203|NCT00033657|6431946|P1|STARTED|Surgical Resection||36
2620204|NCT00033657|6431945|P2|NOT COMPLETED|Neoadjuvant Chemotherapy||11
2620205|NCT00033657|6431946|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||14
2620206|NCT00033657|6431945|P2|COMPLETED|Neoadjuvant Chemotherapy||36
2620207|NCT00033657|6431946|P1|COMPLETED|Neoadjuvant Chemotherapy||36
2620208|NCT00033657|6431945|P2|Eligible and Treated|Neoadjuvant Chemotherapy||42
2620209|NCT00033657|6431946|P1|Eligible and Treated|Neoadjuvant Chemotherapy||39
2620210|NCT00033657|6431945|P2|Eligible|Neoadjuvant Chemotherapy||43
2620211|NCT00033657|6431946|P1|Eligible|Neoadjuvant Chemotherapy||42
2620212|NCT00033657|6431945|P2|STARTED|Neoadjuvant Chemotherapy||47
2620213|NCT00033657|6431946|P1|STARTED|Neoadjuvant Chemotherapy||50
2620214|NCT00033631|6431960|P2|NOT COMPLETED|Overall Study||15
2620215|NCT00033631|6431961|P1|NOT COMPLETED|Overall Study||18
2620216|NCT00033631|6431960|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|748
2620217|NCT00033631|6431961|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|751
2620218|NCT00033631|6431960|P2|STARTED|Overall Study||763
2620219|NCT00033631|6431961|P1|STARTED|Overall Study||769
2620220|NCT00033540|6431979|P1|NOT COMPLETED|Overall Study||57
2620221|NCT00033540|6431979|P1|COMPLETED|Overall Study||0
2620222|NCT00033540|6431979|P1|Eligible and Began Protocol Therapy|Overall Study|One patient went off study prior to any toxicity assessments and is not evaluable for toxicities.|52
2620223|NCT00033540|6431979|P1|Eligible|Overall Study||54
2620224|NCT00033540|6431979|P1|STARTED|Overall Study||57
2620225|NCT00033514|6431989|P2|NOT COMPLETED|Overall Study||4
2620226|NCT00033514|6431990|P1|NOT COMPLETED|Overall Study||1
2620227|NCT00033514|6431989|P2|COMPLETED|Overall Study||7
2620228|NCT00033514|6431990|P1|COMPLETED|Overall Study||15
2620229|NCT00033514|6431989|P2|STARTED|Overall Study||11
2620230|NCT00033514|6431990|P1|STARTED|Overall Study||16
2620231|NCT00033371|6432000|P2|NOT COMPLETED|Overall Study||10
2620232|NCT00033371|6432001|P1|NOT COMPLETED|Overall Study||6
2620233|NCT00033371|6432000|P2|COMPLETED|Overall Study||47
2620234|NCT00033371|6432001|P1|COMPLETED|Overall Study||49
2620235|NCT00033371|6432000|P2|STARTED|Overall Study||57
2620236|NCT00033371|6432001|P1|STARTED|Overall Study||55
2620237|NCT00033293|6432009|P2|NOT COMPLETED|Overall Study||18
2620238|NCT00033293|6432010|P1|NOT COMPLETED|Overall Study||10
2620239|NCT00033293|6432009|P2|COMPLETED|Overall Study||9
2620240|NCT00033293|6432010|P1|COMPLETED|Overall Study||16
2620241|NCT00033293|6432009|P2|STARTED|Overall Study||27
2620242|NCT00033293|6432010|P1|STARTED|Overall Study||26
2620243|NCT00031694|6432028|P1|NOT COMPLETED|Overall Study||19
2620244|NCT00031694|6432028|P1|COMPLETED|Overall Study||0
2620245|NCT00031694|6432028|P1|STARTED|Overall Study||19
2620246|NCT00031590|6432032|P1|NOT COMPLETED|Overall Study||3
2620247|NCT00031590|6432032|P1|COMPLETED|Overall Study||25
2620248|NCT00031590|6432032|P1|STARTED|Overall Study||28
2620249|NCT00030901|6432039|P3|NOT COMPLETED|Randomization||88
2620250|NCT00030901|6432040|P2|NOT COMPLETED|Randomization||101
2620251|NCT00030901|6432041|P1|NOT COMPLETED|Randomization||0
2620252|NCT00030901|6432039|P3|COMPLETED|Randomization||137
2620253|NCT00030901|6432040|P2|COMPLETED|Randomization||126
2620254|NCT00030901|6432041|P1|COMPLETED|Randomization||0
2620255|NCT00030901|6432039|P3|Eligible|Randomization||211
2620256|NCT00030901|6432040|P2|Eligible|Randomization||212
2620257|NCT00030901|6432041|P1|Eligible|Randomization||0
2620258|NCT00030901|6432039|P3|STARTED|Randomization||225
2620259|NCT00030901|6432040|P2|STARTED|Randomization||227
2620260|NCT00030901|6432041|P1|STARTED|Randomization||0
2620261|NCT00030901|6432039|P3|NOT COMPLETED|Initial Registration||0
2620262|NCT00030901|6432040|P2|NOT COMPLETED|Initial Registration||0
2620263|NCT00030901|6432041|P1|NOT COMPLETED|Initial Registration||167
2620264|NCT00030901|6432039|P3|COMPLETED|Initial Registration||0
2620265|NCT00030901|6432040|P2|COMPLETED|Initial Registration||0
2620266|NCT00030901|6432041|P1|COMPLETED|Initial Registration||452
2620267|NCT00030901|6432039|P3|STARTED|Initial Registration||0
2620268|NCT00030901|6432040|P2|STARTED|Initial Registration||0
2620269|NCT00030901|6432041|P1|STARTED|Initial Registration||619
2620270|NCT00030823|6432049|P1|NOT COMPLETED|Overall Study||1
2620271|NCT00030823|6432049|P1|COMPLETED|Overall Study||13
2620272|NCT00030823|6432049|P1|STARTED|Overall Study||14
2620273|NCT00030264|6432053|P1|NOT COMPLETED|Overall Study||0
2620274|NCT00030264|6432053|P1|COMPLETED|Overall Study||23
2620275|NCT00030264|6432053|P1|STARTED|Overall Study||23
2620276|NCT00028769|6432057|P1|NOT COMPLETED|Overall Study||41
2620277|NCT00028769|6432057|P1|COMPLETED|Overall Study|Patients receive protocol treatments until evidence of disease progression|0
2620278|NCT00028769|6432057|P1|Eligible and Began Protocol Therapy|Overall Study|One patient refused all protocol treatment and was not evaluable for the present analysis|35
2620279|NCT00028769|6432057|P1|Eligible|Overall Study||36
2620280|NCT00028769|6432057|P1|STARTED|Overall Study||41
2620281|NCT00028002|6432063|P1|NOT COMPLETED|Overall Study||11
2620282|NCT00028002|6432063|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
2620283|NCT00028002|6432063|P1|STARTED|Overall Study||63
2620284|NCT00027846|6432073|P3|NOT COMPLETED|Overall Study||37
2620285|NCT00027846|6432074|P2|NOT COMPLETED|Overall Study||68
2620286|NCT00027846|6432075|P1|NOT COMPLETED|Overall Study||2
2620287|NCT00027846|6432073|P3|COMPLETED|Overall Study||41
2620288|NCT00027846|6432074|P2|COMPLETED|Overall Study||219
2620289|NCT00027846|6432075|P1|COMPLETED|Overall Study||11
2620290|NCT00027846|6432073|P3|STARTED|Overall Study||78
2620291|NCT00027846|6432074|P2|STARTED|Overall Study||287
2620292|NCT00027846|6432075|P1|STARTED|Overall Study||13
2620293|NCT00027560|6432093|P1|NOT COMPLETED|Overall Study||1
2620294|NCT00027560|6432093|P1|COMPLETED|Overall Study||50
2620295|NCT00027560|6432093|P1|STARTED|Overall Study||51
2620296|NCT00026494|6432106|P4|NOT COMPLETED|Overall Study||0
2620297|NCT00026494|6432107|P3|NOT COMPLETED|Overall Study||6
2620298|NCT00026494|6432108|P2|NOT COMPLETED|Overall Study||0
2620299|NCT00026494|6432109|P1|NOT COMPLETED|Overall Study||2
2620300|NCT00026494|6432106|P4|COMPLETED|Overall Study||16
2620301|NCT00026494|6432107|P3|COMPLETED|Overall Study||16
2620302|NCT00026494|6432108|P2|COMPLETED|Overall Study||4
2620303|NCT00026494|6432109|P1|COMPLETED|Overall Study||5
2620304|NCT00026494|6432106|P4|STARTED|Overall Study||16
2620305|NCT00026494|6432107|P3|STARTED|Overall Study||22
2620306|NCT00026494|6432108|P2|STARTED|Overall Study||4
2620307|NCT00026494|6432109|P1|STARTED|Overall Study||7
2620308|NCT00026312|6432121|P2|NOT COMPLETED|Overall Study||269
2620309|NCT00026312|6432122|P1|NOT COMPLETED|Overall Study||34
2620310|NCT00026312|6432121|P2|COMPLETED|Overall Study||1064
2620311|NCT00026312|6432122|P1|COMPLETED|Overall Study||82
2620312|NCT00026312|6432121|P2|STARTED|Overall Study||1333
2620313|NCT00026312|6432122|P1|STARTED|Overall Study||116
2620314|NCT00026221|6432140|P3|NOT COMPLETED|Overall Study||0
2620315|NCT00026221|6432141|P2|NOT COMPLETED|Overall Study||0
2620316|NCT00026221|6432142|P1|NOT COMPLETED|Overall Study||0
2620317|NCT00026221|6432140|P3|COMPLETED|Overall Study||25
2620318|NCT00026221|6432141|P2|COMPLETED|Overall Study||16
2620319|NCT00026221|6432142|P1|COMPLETED|Overall Study||16
2620320|NCT00026221|6432140|P3|STARTED|Overall Study||25
2620321|NCT00026221|6432141|P2|STARTED|Overall Study||16
2620322|NCT00026221|6432142|P1|STARTED|Overall Study||16
2620323|NCT00026208|6432161|P2|NOT COMPLETED|Overall Study||0
2620324|NCT00026208|6432162|P1|NOT COMPLETED|Overall Study||1
2620325|NCT00026208|6432161|P2|COMPLETED|Overall Study||4
2620326|NCT00026208|6432162|P1|COMPLETED|Overall Study||71
2620327|NCT00026208|6432161|P2|STARTED|Overall Study||4
2620328|NCT00026208|6432162|P1|STARTED|Overall Study||72
2620329|NCT00025662|6432180|P1|NOT COMPLETED|Overall Study||3
2620330|NCT00025662|6432180|P1|COMPLETED|Overall Study|One patient who received a transplant did not meet eligibility and was a special exemption.|22
2620331|NCT00025662|6432180|P1|STARTED|Overall Study||25
2620332|NCT00025506|6432188|P1|NOT COMPLETED|Overall Study||10
2620333|NCT00025506|6432188|P1|COMPLETED|Overall Study|Eligible and treated patients.|45
2620334|NCT00025506|6432188|P1|STARTED|Overall Study||55
2620335|NCT00025259|6432209|P7|NOT COMPLETED|Overall Study||51
2620336|NCT00025259|6432210|P6|NOT COMPLETED|Overall Study||52
2620337|NCT00025259|6432211|P5|NOT COMPLETED|Overall Study||36
2620338|NCT00025259|6432212|P4|NOT COMPLETED|Overall Study||114
2620339|NCT00025259|6432213|P3|NOT COMPLETED|Overall Study||81
2620340|NCT00025259|6432214|P2|NOT COMPLETED|Overall Study||89
2620341|NCT00025259|6432215|P1|NOT COMPLETED|Overall Study||45
2620342|NCT00025259|6432209|P7|COMPLETED|Overall Study||102
2620343|NCT00025259|6432210|P6|COMPLETED|Overall Study||101
2620344|NCT00025259|6432211|P5|COMPLETED|Overall Study||6
2620345|NCT00025259|6432212|P4|COMPLETED|Overall Study||457
2620346|NCT00025259|6432213|P3|COMPLETED|Overall Study||301
2620347|NCT00025259|6432214|P2|COMPLETED|Overall Study||292
2620348|NCT00025259|6432215|P1|COMPLETED|Overall Study||7
2620349|NCT00025259|6432209|P7|STARTED|Overall Study||153
2620350|NCT00025259|6432210|P6|STARTED|Overall Study||153
2620351|NCT00025259|6432211|P5|STARTED|Overall Study||42
2620352|NCT00025259|6432212|P4|STARTED|Overall Study||571
2620353|NCT00025259|6432213|P3|STARTED|Overall Study||382
2620354|NCT00025259|6432214|P2|STARTED|Overall Study||381
2620355|NCT00025259|6432215|P1|STARTED|Overall Study||52
2620356|NCT00025233|6432251|P1|NOT COMPLETED|Overall Study||4
2620357|NCT00025233|6432251|P1|COMPLETED|Overall Study||46
2620358|NCT00025233|6432251|P1|STARTED|Overall Study||50
2620359|NCT00025155|6432266|P1|NOT COMPLETED|Overall Study||2
2620360|NCT00025155|6432266|P1|COMPLETED|Overall Study|Patients who were eligible and received any study treatment.|49
2620361|NCT00025155|6432266|P1|STARTED|Overall Study||51
2620362|NCT00024258|6432277|P1|NOT COMPLETED|Overall Study||9
2620363|NCT00024258|6432277|P1|COMPLETED|Overall Study||13
2620364|NCT00024258|6432277|P1|STARTED|Overall Study||22
2620365|NCT00024167|6432284|P2|NOT COMPLETED|Overall Study||47
2620366|NCT00024167|6432285|P1|NOT COMPLETED|Overall Study||53
2620367|NCT00024167|6432284|P2|COMPLETED|Overall Study||15
2620368|NCT00024167|6432285|P1|COMPLETED|Overall Study||12
2620369|NCT00024167|6432284|P2|Induction Treatment Option 2 Completed|Overall Study||41
2620370|NCT00024167|6432285|P1|Induction Treatment Option 2 Completed|Overall Study||43
2620371|NCT00024167|6432284|P2|Induction Treatment Option 1 Completed|Overall Study||21
2620372|NCT00024167|6432285|P1|Induction Treatment Option 1 Completed|Overall Study||22
2620373|NCT00024167|6432284|P2|STARTED|Overall Study||62
2620374|NCT00024167|6432285|P1|STARTED|Overall Study||65
2620375|NCT00024102|6432296|P2|NOT COMPLETED|Overall Study||0
2620376|NCT00024102|6432297|P1|NOT COMPLETED|Overall Study||0
2620377|NCT00024102|6432296|P2|COMPLETED|Overall Study||307
2620378|NCT00024102|6432297|P1|COMPLETED|Overall Study||326
2620379|NCT00024102|6432296|P2|STARTED|Overall Study||307
2620380|NCT00024102|6432297|P1|STARTED|Overall Study||326
2620381|NCT00023764|6432309|P1|NOT COMPLETED|Overall Study||14
2620382|NCT00023764|6432309|P1|COMPLETED|Overall Study||89
2620383|NCT00023764|6432309|P1|STARTED|Overall Study||103
2620384|NCT00023712|6432316|P2|NOT COMPLETED|Overall Study||1
2620385|NCT00023712|6432317|P1|NOT COMPLETED|Overall Study||2
2620386|NCT00023712|6432316|P2|COMPLETED|Overall Study|total number of participants eligible and evaluable|29
2620387|NCT00023712|6432317|P1|COMPLETED|Overall Study|total number of participants eligible and evaluable|26
2620388|NCT00023712|6432316|P2|STARTED|Overall Study|total number of participants enrolled on study|30
2620389|NCT00023712|6432317|P1|STARTED|Overall Study|total number of participants enrolled on study|28
2620390|NCT00022698|6432341|P2|NOT COMPLETED|Overall Study||35
2620391|NCT00022698|6432342|P1|NOT COMPLETED|Overall Study||8
2620392|NCT00022698|6432341|P2|COMPLETED|Overall Study||17
2620393|NCT00022698|6432342|P1|COMPLETED|Overall Study||7
2620394|NCT00022698|6432341|P2|STARTED|Overall Study||52
2620395|NCT00022698|6432342|P1|STARTED|Overall Study||15
2620396|NCT00022672|6432367|P2|NOT COMPLETED|Extension Phase||51
2620397|NCT00022672|6432368|P1|NOT COMPLETED|Extension Phase||3
2620398|NCT00022672|6432367|P2|COMPLETED|Extension Phase||7
2620399|NCT00022672|6432368|P1|COMPLETED|Extension Phase||11
2620400|NCT00022672|6432367|P2|Safety Set: Received Study Drug|Extension Phase||58
2620401|NCT00022672|6432368|P1|Safety Set: Received Study Drug|Extension Phase||14
2620402|NCT00022672|6432367|P2|STARTED|Extension Phase||58
2620403|NCT00022672|6432368|P1|STARTED|Extension Phase|2 patients completed Main Phase; but did not enter Extension (1-did not cooperate and 1-withdrew).|14
2620404|NCT00022672|6432367|P2|NOT COMPLETED|Main Phase: 24 Months||100
2620405|NCT00022672|6432368|P1|NOT COMPLETED|Main Phase: 24 Months||87
2620406|NCT00022672|6432367|P2|COMPLETED|Main Phase: 24 Months||4
2620407|NCT00022672|6432368|P1|COMPLETED|Main Phase: 24 Months||16
2620408|NCT00022672|6432367|P2|Safety Set: Received Study Drug|Main Phase: 24 Months||104
2620409|NCT00022672|6432368|P1|Safety Set: Received Study Drug|Main Phase: 24 Months||103
2620410|NCT00022672|6432367|P2|STARTED|Main Phase: 24 Months||104
2620411|NCT00022672|6432368|P1|STARTED|Main Phase: 24 Months||103
2620412|NCT00022659|6432401|P1|NOT COMPLETED|Overall Study||2
2620413|NCT00022659|6432401|P1|COMPLETED|Overall Study|Eligible and treated patients.|62
2620414|NCT00022659|6432401|P1|STARTED|Overall Study||64
2620415|NCT00022633|6432414|P2|NOT COMPLETED|Overall Study||5
2620416|NCT00022633|6432415|P1|NOT COMPLETED|Overall Study||32
2620417|NCT00022633|6432414|P2|COMPLETED|Overall Study||5
2620418|NCT00022633|6432415|P1|COMPLETED|Overall Study||23
2620419|NCT00022633|6432414|P2|Eligible|Overall Study||10
2620420|NCT00022633|6432415|P1|Eligible|Overall Study||51
2620421|NCT00022633|6432414|P2|STARTED|Overall Study||10
2620422|NCT00022633|6432415|P1|STARTED|Overall Study||55
2620423|NCT00022516|6432428|P2|NOT COMPLETED|Overall Study||230
2620424|NCT00022516|6432429|P1|NOT COMPLETED|Overall Study||3
2620425|NCT00022516|6432428|P2|COMPLETED|Overall Study||314
2620426|NCT00022516|6432429|P1|COMPLETED|Overall Study||539
2620427|NCT00022516|6432428|P2|STARTED|Overall Study||544
2620428|NCT00022516|6432429|P1|STARTED|Overall Study||542
2620429|NCT00022490|6432441|P1|NOT COMPLETED|Overall Study||0
2620430|NCT00022490|6432441|P1|COMPLETED|Overall Study||24
2620431|NCT00022490|6432441|P1|STARTED|Overall Study||24
2620432|NCT00021255|6432448|P3|NOT COMPLETED|Overall Study||149
2620433|NCT00021255|6432449|P2|NOT COMPLETED|Overall Study||270
2620434|NCT00021255|6432450|P1|NOT COMPLETED|Overall Study||121
2620435|NCT00021255|6432448|P3|COMPLETED|Overall Study||926
2620436|NCT00021255|6432449|P2|COMPLETED|Overall Study||804
2620437|NCT00021255|6432450|P1|COMPLETED|Overall Study||952
2620438|NCT00021255|6432448|P3|Safety Population|Overall Study|1056 participants received TCH.|1056
2620439|NCT00021255|6432449|P2|Safety Population|Overall Study|1100 participants received AC-TH (1066 from AC-TH arm, 33 from AC-T arm and 1 from TCH arm).|1100
2620440|NCT00021255|6432450|P1|Safety Population|Overall Study|1018 participants received AC-T (1012 from AC-T arm, 6 from AC-TH arm).|1018
2620441|NCT00021255|6432448|P3|Treated|Overall Study||1057
2620442|NCT00021255|6432449|P2|Treated|Overall Study||1072
2620443|NCT00021255|6432450|P1|Treated|Overall Study||1045
2620444|NCT00021255|6432448|P3|STARTED|Overall Study|Randomized|1075
2620445|NCT00021255|6432449|P2|STARTED|Overall Study|Randomized|1074
2620446|NCT00021255|6432450|P1|STARTED|Overall Study|Randomized|1073
2620447|NCT00021229|6432467|P3|NOT COMPLETED|Overall Study||16
2620448|NCT00021229|6432468|P2|NOT COMPLETED|Overall Study||33
2620449|NCT00021229|6432469|P1|NOT COMPLETED|Overall Study||35
2620450|NCT00021229|6432467|P3|COMPLETED|Overall Study||0
2620451|NCT00021229|6432468|P2|COMPLETED|Overall Study||0
2620452|NCT00021229|6432469|P1|COMPLETED|Overall Study|1 participant completed 13 courses of therapy|1
2620453|NCT00021229|6432467|P3|Enrolled in Phase II|Overall Study|Participants from stratum IIB did not participate in the phase II part of the study.|0
2620454|NCT00021229|6432468|P2|Enrolled in Phase II|Overall Study|Participants from stratum IIA did not participate in the phase II part of the study.|0
2620455|NCT00021229|6432469|P1|Enrolled in Phase II|Overall Study|Thirteen participants treated at the MTD in the phase I were also part of the phase II.|14
2620456|NCT00021229|6432467|P3|Maximum Tolerated Dose (MTD) Estimation|Overall Study|4 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|12
2620457|NCT00021229|6432468|P2|Maximum Tolerated Dose (MTD) Estimation|Overall Study|13 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|20
2620458|NCT00021229|6432469|P1|Maximum Tolerated Dose (MTD) Estimation|Overall Study|12 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|23
2620459|NCT00021229|6432467|P3|Enrolled in Phase I|Overall Study||16
2620460|NCT00021229|6432468|P2|Enrolled in Phase I|Overall Study||33
2620461|NCT00021229|6432469|P1|Enrolled in Phase I|Overall Study||35
2620462|NCT00021229|6432467|P3|STARTED|Overall Study||16
2620463|NCT00021229|6432468|P2|STARTED|Overall Study||33
2620464|NCT00021229|6432469|P1|STARTED|Overall Study||36
2620465|NCT00020722|6432495|P1|NOT COMPLETED|Overall Study||0
2620466|NCT00020722|6432495|P1|COMPLETED|Overall Study||7
2620467|NCT00020722|6432495|P1|STARTED|Overall Study||7
2620468|NCT00019747|6432502|P2|NOT COMPLETED|Overall Study||0
2620469|NCT00019747|6432503|P1|NOT COMPLETED|Overall Study||0
2620470|NCT00019747|6432502|P2|COMPLETED|Overall Study||16
2620471|NCT00019747|6432503|P1|COMPLETED|Overall Study||23
2620472|NCT00019747|6432502|P2|STARTED|Overall Study||16
2620473|NCT00019747|6432503|P1|STARTED|Overall Study||23
2620474|NCT00019682|6432511|P2|NOT COMPLETED|Overall Study||6
2620475|NCT00019682|6432512|P1|NOT COMPLETED|Overall Study||1
2620476|NCT00019682|6432511|P2|COMPLETED|Overall Study||85
2620477|NCT00019682|6432512|P1|COMPLETED|Overall Study||93
2620478|NCT00019682|6432511|P2|STARTED|Overall Study||91
2620479|NCT00019682|6432512|P1|STARTED|Overall Study||94
2620480|NCT00019604|6432524|P1|NOT COMPLETED|Overall Study||39
2620481|NCT00019604|6432524|P1|COMPLETED|Overall Study||5
2620482|NCT00019604|6432524|P1|STARTED|Overall Study||44
2620483|NCT00017563|6432537|P1|NOT COMPLETED|Overall Study||1
2620484|NCT00017563|6432537|P1|COMPLETED|Overall Study||56
2620485|NCT00017563|6432537|P1|STARTED|Overall Study||57
2620486|NCT00016913|6432541|P1|NOT COMPLETED|Overall Study||0
2620487|NCT00016913|6432541|P1|COMPLETED|Overall Study||27
2620488|NCT00016913|6432541|P1|STARTED|Overall Study||27
2620489|NCT00016354|6432547|P8|NOT COMPLETED|Overall Study||1
2620490|NCT00016354|6432548|P7|NOT COMPLETED|Overall Study||0
2620491|NCT00016354|6432549|P6|NOT COMPLETED|Overall Study||0
2620492|NCT00016354|6432550|P5|NOT COMPLETED|Overall Study||0
2620493|NCT00016354|6432551|P4|NOT COMPLETED|Overall Study||0
2620494|NCT00016354|6432552|P3|NOT COMPLETED|Overall Study||0
2620495|NCT00016354|6432553|P2|NOT COMPLETED|Overall Study||0
2620496|NCT00016354|6432554|P1|NOT COMPLETED|Overall Study||0
2620497|NCT00016354|6432547|P8|COMPLETED|Overall Study||6
2620498|NCT00016354|6432548|P7|COMPLETED|Overall Study||6
2620499|NCT00016354|6432549|P6|COMPLETED|Overall Study||1
2620500|NCT00016354|6432550|P5|COMPLETED|Overall Study||1
2620501|NCT00016354|6432551|P4|COMPLETED|Overall Study||1
2620502|NCT00016354|6432552|P3|COMPLETED|Overall Study||1
2620503|NCT00016354|6432553|P2|COMPLETED|Overall Study||1
2620504|NCT00016354|6432554|P1|COMPLETED|Overall Study||1
2620505|NCT00016354|6432547|P8|STARTED|Overall Study||7
2620506|NCT00016354|6432548|P7|STARTED|Overall Study||6
2620507|NCT00016354|6432549|P6|STARTED|Overall Study||1
2620508|NCT00016354|6432550|P5|STARTED|Overall Study||1
2620509|NCT00016354|6432551|P4|STARTED|Overall Study||1
2620510|NCT00016354|6432552|P3|STARTED|Overall Study||1
2620511|NCT00016354|6432553|P2|STARTED|Overall Study||1
2620512|NCT00016354|6432554|P1|STARTED|Overall Study||1
2620513|NCT00015847|6432558|P1|NOT COMPLETED|Overall Study||0
2620514|NCT00015847|6432558|P1|COMPLETED|Overall Study||25
2620515|NCT00015847|6432558|P1|STARTED|Overall Study||25
2620516|NCT00014495|6432568|P4|NOT COMPLETED|Overall Study||1
2620517|NCT00014495|6432569|P3|NOT COMPLETED|Overall Study||1
2620518|NCT00014495|6432570|P2|NOT COMPLETED|Overall Study||0
2620519|NCT00014495|6432571|P1|NOT COMPLETED|Overall Study||0
2620520|NCT00014495|6432568|P4|COMPLETED|Overall Study||5
2620521|NCT00014495|6432569|P3|COMPLETED|Overall Study||19
2620522|NCT00014495|6432570|P2|COMPLETED|Overall Study||3
2620523|NCT00014495|6432571|P1|COMPLETED|Overall Study||3
2620524|NCT00014495|6432568|P4|STARTED|Overall Study||6
2620525|NCT00014495|6432569|P3|STARTED|Overall Study||20
2620526|NCT00014495|6432570|P2|STARTED|Overall Study||3
2620527|NCT00014495|6432571|P1|STARTED|Overall Study||3
2620528|NCT00012298|6432585|P7|NOT COMPLETED|Overall Study||0
2620529|NCT00012298|6432586|P6|NOT COMPLETED|Overall Study||0
2620530|NCT00012298|6432587|P5|NOT COMPLETED|Overall Study||0
2620531|NCT00012298|6432588|P4|NOT COMPLETED|Overall Study||0
2620532|NCT00012298|6432589|P3|NOT COMPLETED|Overall Study||0
2620533|NCT00012298|6432590|P2|NOT COMPLETED|Overall Study||0
2620534|NCT00012298|6432591|P1|NOT COMPLETED|Overall Study||0
2620535|NCT00012298|6432585|P7|COMPLETED|Overall Study||39
2620536|NCT00012298|6432586|P6|COMPLETED|Overall Study||6
2620537|NCT00012298|6432587|P5|COMPLETED|Overall Study||5
2620538|NCT00012298|6432588|P4|COMPLETED|Overall Study||4
2620539|NCT00012298|6432589|P3|COMPLETED|Overall Study||9
2620540|NCT00012298|6432590|P2|COMPLETED|Overall Study||7
2620541|NCT00012298|6432591|P1|COMPLETED|Overall Study||11
2620542|NCT00012298|6432585|P7|STARTED|Overall Study||39
2620543|NCT00012298|6432586|P6|STARTED|Overall Study||6
2620544|NCT00012298|6432587|P5|STARTED|Overall Study||5
2620545|NCT00012298|6432588|P4|STARTED|Overall Study||4
2620546|NCT00012298|6432589|P3|STARTED|Overall Study||9
2620547|NCT00012298|6432590|P2|STARTED|Overall Study||7
2620548|NCT00012298|6432591|P1|STARTED|Overall Study||11
2620549|NCT00012012|6432621|P2|NOT COMPLETED|Overall Study||3
2620550|NCT00012012|6432622|P1|NOT COMPLETED|Overall Study||1
2620551|NCT00012012|6432621|P2|COMPLETED|Overall Study||15
2620552|NCT00012012|6432622|P1|COMPLETED|Overall Study||26
2620553|NCT00012012|6432621|P2|STARTED|Overall Study||18
2620554|NCT00012012|6432622|P1|STARTED|Overall Study||27
2620555|NCT00011986|6432633|P5|NOT COMPLETED|Overall Study||0
2620556|NCT00011986|6432634|P4|NOT COMPLETED|Overall Study||0
2620557|NCT00011986|6432635|P3|NOT COMPLETED|Overall Study||0
2620558|NCT00011986|6432636|P2|NOT COMPLETED|Overall Study||0
2620559|NCT00011986|6432637|P1|NOT COMPLETED|Overall Study||0
2620560|NCT00011986|6432633|P5|COMPLETED|Overall Study||861
2620561|NCT00011986|6432634|P4|COMPLETED|Overall Study||861
2620562|NCT00011986|6432635|P3|COMPLETED|Overall Study||862
2620563|NCT00011986|6432636|P2|COMPLETED|Overall Study||864
2620564|NCT00011986|6432637|P1|COMPLETED|Overall Study||864
2620565|NCT00011986|6432633|P5|Initiated Treatment|Overall Study||851
2620566|NCT00011986|6432634|P4|Initiated Treatment|Overall Study||846
2620567|NCT00011986|6432635|P3|Initiated Treatment|Overall Study||854
2620568|NCT00011986|6432636|P2|Initiated Treatment|Overall Study||860
2620569|NCT00011986|6432637|P1|Initiated Treatment|Overall Study||862
2620570|NCT00011986|6432633|P5|STARTED|Overall Study||861
2620571|NCT00011986|6432634|P4|STARTED|Overall Study||861
2620572|NCT00011986|6432635|P3|STARTED|Overall Study||862
2620573|NCT00011986|6432636|P2|STARTED|Overall Study||864
2620574|NCT00011986|6432637|P1|STARTED|Overall Study||864
2620575|NCT00010257|6432661|P2|NOT COMPLETED|Overall Study||0
2620576|NCT00010257|6432662|P1|NOT COMPLETED|Overall Study||1
2620577|NCT00010257|6432661|P2|COMPLETED|Overall Study||21
2620578|NCT00010257|6432662|P1|COMPLETED|Overall Study||24
2620579|NCT00010257|6432661|P2|STARTED|Overall Study||21
2620580|NCT00010257|6432662|P1|STARTED|Overall Study||25
2620581|NCT00009945|6432672|P2|NOT COMPLETED|Overall Study||5
2620582|NCT00009945|6432673|P1|NOT COMPLETED|Overall Study||7
2620583|NCT00009945|6432672|P2|COMPLETED|Overall Study||1656
2620584|NCT00009945|6432673|P1|COMPLETED|Overall Study||1655
2620585|NCT00009945|6432672|P2|STARTED|Overall Study||1661
2620586|NCT00009945|6432673|P1|STARTED|Overall Study||1662
2620587|NCT00008385|6432689|P2|NOT COMPLETED|Overall Study||802
2620588|NCT00008385|6432690|P1|NOT COMPLETED|Overall Study||387
2620589|NCT00008385|6432689|P2|COMPLETED|Overall Study||238
2620590|NCT00008385|6432690|P1|COMPLETED|Overall Study||134
2620591|NCT00008385|6432689|P2|Off Treatment Reasons Reported|Overall Study||795
2620592|NCT00008385|6432690|P1|Off Treatment Reasons Reported|Overall Study||398
2620593|NCT00008385|6432689|P2|Treated|Overall Study||865
2620594|NCT00008385|6432690|P1|Treated|Overall Study||477
2620595|NCT00008385|6432689|P2|STARTED|Overall Study||1040
2620596|NCT00008385|6432690|P1|STARTED|Overall Study||521
2620597|NCT00008138|6432700|P1|NOT COMPLETED|Post-Cytoreduction Chemotherapy||8
2620598|NCT00008138|6432700|P1|COMPLETED|Post-Cytoreduction Chemotherapy||18
2620599|NCT00008138|6432700|P1|STARTED|Post-Cytoreduction Chemotherapy|Among 36 patients from previous period, 5 patients rejected and 5 patients are ineligible.|26
2620600|NCT00008138|6432700|P1|NOT COMPLETED|Interval Debulking||2
2620601|NCT00008138|6432700|P1|COMPLETED|Interval Debulking||36
2620602|NCT00008138|6432700|P1|Received Protocol Surgery|Interval Debulking||36
2620603|NCT00008138|6432700|P1|STARTED|Interval Debulking||38
2620604|NCT00008138|6432700|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||20
2620605|NCT00008138|6432700|P1|COMPLETED|Neoadjuvant Chemotherapy||38
2620606|NCT00008138|6432700|P1|Eligible|Neoadjuvant Chemotherapy||58
2620607|NCT00008138|6432700|P1|STARTED|Neoadjuvant Chemotherapy||58
2620608|NCT00006916|6432706|P1|NOT COMPLETED|Overall Study||5
2620609|NCT00006916|6432706|P1|COMPLETED|Overall Study|Subjects with survival data for the primary analysis are considered to have completed the study.|14
2620610|NCT00006916|6432706|P1|STARTED|Overall Study||19
2620611|NCT00006903|6432712|P3|NOT COMPLETED|Overall Study||6
2620612|NCT00006903|6432713|P2|NOT COMPLETED|Overall Study||4
2620613|NCT00006903|6432714|P1|NOT COMPLETED|Overall Study||10
2620614|NCT00006903|6432712|P3|COMPLETED|Overall Study||27
2620615|NCT00006903|6432713|P2|COMPLETED|Overall Study||20
2620616|NCT00006903|6432714|P1|COMPLETED|Overall Study||0
2620617|NCT00006903|6432712|P3|STARTED|Overall Study||33
2620618|NCT00006903|6432713|P2|STARTED|Overall Study||24
2620619|NCT00006903|6432714|P1|STARTED|Overall Study||10
2620620|NCT00006721|6432727|P3|NOT COMPLETED|Overall Study||33
2620621|NCT00006721|6432728|P2|NOT COMPLETED|Overall Study||25
2620622|NCT00006721|6432729|P1|NOT COMPLETED|Overall Study||4
2620623|NCT00006721|6432727|P3|COMPLETED|Overall Study||242
2620624|NCT00006721|6432728|P2|COMPLETED|Overall Study||254
2620625|NCT00006721|6432729|P1|COMPLETED|Overall Study||13
2620626|NCT00006721|6432727|P3|Eligible and Began Protocol Therapy|Overall Study||265
2620627|NCT00006721|6432728|P2|Eligible and Began Protocol Therapy|Overall Study||267
2620628|NCT00006721|6432729|P1|Eligible and Began Protocol Therapy|Overall Study||14
2620629|NCT00006721|6432727|P3|Eligible|Overall Study||265
2620630|NCT00006721|6432728|P2|Eligible|Overall Study||267
2620631|NCT00006721|6432729|P1|Eligible|Overall Study||15
2620632|NCT00006721|6432727|P3|STARTED|Overall Study||275
2620633|NCT00006721|6432728|P2|STARTED|Overall Study||279
2620634|NCT00006721|6432729|P1|STARTED|Overall Study||17
2620635|NCT00006478|6432747|P1|NOT COMPLETED|Overall Study||7
2620636|NCT00006478|6432747|P1|COMPLETED|Overall Study||12
2620637|NCT00006478|6432747|P1|STARTED|Overall Study||19
2620638|NCT00006392|6432758|P4|NOT COMPLETED|Overall Study||160
2620639|NCT00006392|6432759|P3|NOT COMPLETED|Overall Study||160
2620640|NCT00006392|6432760|P2|NOT COMPLETED|Overall Study||158
2620641|NCT00006392|6432761|P1|NOT COMPLETED|Overall Study||167
2620642|NCT00006392|6432758|P4|COMPLETED|Overall Study||8696
2620643|NCT00006392|6432759|P3|COMPLETED|Overall Study||8703
2620644|NCT00006392|6432760|P2|COMPLETED|Overall Study||8752
2620645|NCT00006392|6432761|P1|COMPLETED|Overall Study||8737
2620646|NCT00006392|6432758|P4|STARTED|Overall Study||8856
2620647|NCT00006392|6432759|P3|STARTED|Overall Study||8863
2620648|NCT00006392|6432760|P2|STARTED|Overall Study||8910
2620649|NCT00006392|6432761|P1|STARTED|Overall Study||8904
2620650|NCT00006389|6432791|P1|NOT COMPLETED|Overall Study||1
2620651|NCT00006389|6432791|P1|COMPLETED|Overall Study||11
2620652|NCT00006389|6432791|P1|STARTED|Overall Study||12
2620653|NCT00006244|6432797|P1|NOT COMPLETED|Overall Study||0
2620654|NCT00006244|6432797|P1|COMPLETED|Overall Study||36
2620655|NCT00006244|6432797|P1|STARTED|Overall Study||36
2620656|NCT00006237|6432808|P2|NOT COMPLETED|Overall Study||61
2620657|NCT00006237|6432809|P1|NOT COMPLETED|Overall Study||125
2620658|NCT00006237|6432808|P2|COMPLETED|Overall Study||159
2620659|NCT00006237|6432809|P1|COMPLETED|Overall Study||87
2620660|NCT00006237|6432808|P2|Eligible and Treated|Overall Study||199
2620661|NCT00006237|6432809|P1|Eligible and Treated|Overall Study||203
2620662|NCT00006237|6432808|P2|Eligible|Overall Study||200
2620663|NCT00006237|6432809|P1|Eligible|Overall Study||203
2620664|NCT00006237|6432808|P2|STARTED|Overall Study||220
2620665|NCT00006237|6432809|P1|STARTED|Overall Study||212
2620666|NCT00006110|6432821|P2|NOT COMPLETED|Overall Study||0
2620667|NCT00006110|6432822|P1|NOT COMPLETED|Overall Study||0
2620668|NCT00006110|6432821|P2|COMPLETED|Overall Study||30
2620669|NCT00006110|6432822|P1|COMPLETED|Overall Study||52
2620670|NCT00006110|6432821|P2|STARTED|Overall Study||30
2620671|NCT00006110|6432822|P1|STARTED|Overall Study||52
2620672|NCT00006101|6432836|P2|NOT COMPLETED|Overall Study||5
2620673|NCT00006101|6432837|P1|NOT COMPLETED|Overall Study||5
2620674|NCT00006101|6432836|P2|COMPLETED|Overall Study||33
2620675|NCT00006101|6432837|P1|COMPLETED|Overall Study||33
2620676|NCT00006101|6432836|P2|STARTED|Overall Study||38
2620677|NCT00006101|6432837|P1|STARTED|Overall Study||38
2620678|NCT00006011|6432846|P3|NOT COMPLETED|Overall Study||73
2620679|NCT00006011|6432847|P2|NOT COMPLETED|Overall Study||77
2620680|NCT00006011|6432848|P1|NOT COMPLETED|Overall Study||65
2620681|NCT00006011|6432846|P3|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|0
2620682|NCT00006011|6432847|P2|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|221
2620683|NCT00006011|6432848|P1|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|223
2620684|NCT00006011|6432846|P3|STARTED|Overall Study|total number of participants enrolled, that only received radiation treatment.|73
2620775|NCT00004124|6433034|P1|NOT COMPLETED|Overall Study||12
2620685|NCT00006011|6432847|P2|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 2 of study.|298
2620686|NCT00006011|6432848|P1|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 1 of study.|288
2620687|NCT00005957|6432856|P2|NOT COMPLETED|Overall Study||28
2620688|NCT00005957|6432857|P1|NOT COMPLETED|Overall Study||8
2620689|NCT00005957|6432856|P2|COMPLETED|Overall Study||888
2620690|NCT00005957|6432857|P1|COMPLETED|Overall Study||908
2620691|NCT00005957|6432856|P2|STARTED|Overall Study||916
2620692|NCT00005957|6432857|P1|STARTED|Overall Study||916
2620693|NCT00005879|6432867|P2|NOT COMPLETED|Overall Study||10
2620694|NCT00005879|6432868|P1|NOT COMPLETED|Overall Study||8
2620695|NCT00005879|6432867|P2|COMPLETED|Overall Study||88
2620696|NCT00005879|6432868|P1|COMPLETED|Overall Study||93
2620697|NCT00005879|6432867|P2|STARTED|Overall Study||98
2620698|NCT00005879|6432868|P1|STARTED|Overall Study||101
2620699|NCT00005803|6432876|P1|NOT COMPLETED|Overall Study||22
2620700|NCT00005803|6432876|P1|COMPLETED|Overall Study||54
2620701|NCT00005803|6432876|P1|STARTED|Overall Study||76
2620702|NCT00005047|6432891|P4|NOT COMPLETED|Overall Study||0
2620703|NCT00005047|6432892|P3|NOT COMPLETED|Overall Study||0
2620704|NCT00005047|6432893|P2|NOT COMPLETED|Overall Study||0
2620705|NCT00005047|6432894|P1|NOT COMPLETED|Overall Study||19
2620706|NCT00005047|6432891|P4|COMPLETED|Overall Study||158
2620707|NCT00005047|6432892|P3|COMPLETED|Overall Study||227
2620708|NCT00005047|6432893|P2|COMPLETED|Overall Study||56
2620709|NCT00005047|6432894|P1|COMPLETED|Overall Study||39
2620710|NCT00005047|6432891|P4|STARTED|Overall Study||158
2620711|NCT00005047|6432892|P3|STARTED|Overall Study||227
2620712|NCT00005047|6432893|P2|STARTED|Overall Study||56
2620713|NCT00005047|6432894|P1|STARTED|Overall Study||58
2620714|NCT00005044|6432910|P2|NOT COMPLETED|Overall Study||52
2620715|NCT00005044|6432911|P1|NOT COMPLETED|Overall Study||38
2620716|NCT00005044|6432910|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|737
2620717|NCT00005044|6432911|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|752
2620718|NCT00005044|6432910|P2|STARTED|Overall Study||789
2620719|NCT00005044|6432911|P1|STARTED|Overall Study||790
2620720|NCT00004888|6432931|P2|NOT COMPLETED|Overall Study||24
2620721|NCT00004888|6432932|P1|NOT COMPLETED|Overall Study||11
2620722|NCT00004888|6432931|P2|COMPLETED|Overall Study||22
2620723|NCT00004888|6432932|P1|COMPLETED|Overall Study||27
2620724|NCT00004888|6432931|P2|STARTED|Overall Study|Of the 48 pts, 2 were ineligible.|46
2620725|NCT00004888|6432932|P1|STARTED|Overall Study|Of the 41 pts, 3 were ineligible.|38
2620726|NCT00004859|6432950|P2|NOT COMPLETED|Overall Study||282
2620727|NCT00004859|6432951|P1|NOT COMPLETED|Overall Study||118
2620728|NCT00004859|6432950|P2|COMPLETED|Overall Study||12
2620729|NCT00004859|6432951|P1|COMPLETED|Overall Study||177
2620730|NCT00004859|6432950|P2|Treated and Having Toxicity Data|Overall Study|1 patient had missing record for toxicity|288
2620731|NCT00004859|6432951|P1|Treated and Having Toxicity Data|Overall Study||289
2620732|NCT00004859|6432950|P2|Treated|Overall Study||289
2620733|NCT00004859|6432951|P1|Treated|Overall Study||289
2620734|NCT00004859|6432950|P2|Eligible|Overall Study||271
2620735|NCT00004859|6432951|P1|Eligible|Overall Study||275
2620736|NCT00004859|6432950|P2|STARTED|Overall Study||294
2620737|NCT00004859|6432951|P1|STARTED|Overall Study||295
2620738|NCT00004259|6432965|P4|NOT COMPLETED|Overall Study||0
2620739|NCT00004259|6432966|P3|NOT COMPLETED|Overall Study||0
2620740|NCT00004259|6432967|P2|NOT COMPLETED|Overall Study||4
2620741|NCT00004259|6432968|P1|NOT COMPLETED|Overall Study||1
2620742|NCT00004259|6432965|P4|COMPLETED|Overall Study||14
2620743|NCT00004259|6432966|P3|COMPLETED|Overall Study||15
2620744|NCT00004259|6432967|P2|COMPLETED|Overall Study||99
2620745|NCT00004259|6432968|P1|COMPLETED|Overall Study||97
2620746|NCT00004259|6432965|P4|STARTED|Overall Study||14
2620747|NCT00004259|6432966|P3|STARTED|Overall Study||15
2620748|NCT00004259|6432967|P2|STARTED|Overall Study||103
2620749|NCT00004259|6432968|P1|STARTED|Overall Study||98
2620750|NCT00004228|6432993|P7|NOT COMPLETED|Overall Study||12
2620751|NCT00004228|6432994|P6|NOT COMPLETED|Overall Study||14
2620752|NCT00004228|6432995|P5|NOT COMPLETED|Overall Study||16
2620753|NCT00004228|6432996|P4|NOT COMPLETED|Overall Study||7
2620754|NCT00004228|6432997|P3|NOT COMPLETED|Overall Study||19
2620755|NCT00004228|6432998|P2|NOT COMPLETED|Overall Study||15
2620756|NCT00004228|6432999|P1|NOT COMPLETED|Overall Study||9
2620757|NCT00004228|6432993|P7|COMPLETED|Overall Study||45
2620758|NCT00004228|6432994|P6|COMPLETED|Overall Study||51
2620759|NCT00004228|6432995|P5|COMPLETED|Overall Study||51
2620760|NCT00004228|6432996|P4|COMPLETED|Overall Study||6
2620761|NCT00004228|6432997|P3|COMPLETED|Overall Study||46
2620762|NCT00004228|6432998|P2|COMPLETED|Overall Study||51
2620763|NCT00004228|6432999|P1|COMPLETED|Overall Study||51
2620764|NCT00004228|6432993|P7|STARTED|Overall Study||57
2620765|NCT00004228|6432994|P6|STARTED|Overall Study||65
2620766|NCT00004228|6432995|P5|STARTED|Overall Study||67
2620767|NCT00004228|6432996|P4|STARTED|Overall Study||13
2620768|NCT00004228|6432997|P3|STARTED|Overall Study||65
2620769|NCT00004228|6432998|P2|STARTED|Overall Study||66
2620770|NCT00004228|6432999|P1|STARTED|Overall Study||60
2620771|NCT00004143|6433022|P1|NOT COMPLETED|Overall Study||0
2620772|NCT00004143|6433022|P1|COMPLETED|Overall Study||2
2620773|NCT00004143|6433022|P1|STARTED|Overall Study||2
2620774|NCT00004124|6433033|P2|NOT COMPLETED|Overall Study||20
2620776|NCT00004124|6433033|P2|COMPLETED|Overall Study||460
2620777|NCT00004124|6433034|P1|COMPLETED|Overall Study||469
2620778|NCT00004124|6433033|P2|STARTED|Overall Study||480
2620779|NCT00004124|6433034|P1|STARTED|Overall Study||481
2620780|NCT00004092|6433050|P2|NOT COMPLETED|Overall Study||0
2620781|NCT00004092|6433051|P1|NOT COMPLETED|Overall Study||0
2620782|NCT00004092|6433050|P2|COMPLETED|Overall Study||51
2620783|NCT00004092|6433051|P1|COMPLETED|Overall Study||21
2620784|NCT00004092|6433050|P2|STARTED|Overall Study||51
2620785|NCT00004092|6433051|P1|STARTED|Overall Study||21
2620786|NCT00004088|6433059|P1|NOT COMPLETED|Overall Study||9
2620787|NCT00004088|6433059|P1|COMPLETED|Overall Study||68
2620788|NCT00004088|6433059|P1|STARTED|Overall Study||77
2620789|NCT00004054|6433070|P2|NOT COMPLETED|Overall Study||0
2620790|NCT00004054|6433071|P1|NOT COMPLETED|Overall Study||0
2620791|NCT00004054|6433070|P2|COMPLETED|Overall Study||200
2620792|NCT00004054|6433071|P1|COMPLETED|Overall Study||197
2620793|NCT00004054|6433070|P2|STARTED|Overall Study||200
2620794|NCT00004054|6433071|P1|STARTED|Overall Study||197
2620795|NCT00003910|6433085|P2|NOT COMPLETED|Step 2||0
2620796|NCT00003910|6433086|P1|NOT COMPLETED|Step 2||0
2620797|NCT00003910|6433085|P2|COMPLETED|Step 2||16
2620798|NCT00003910|6433086|P1|COMPLETED|Step 2||0
2620799|NCT00003910|6433085|P2|STARTED|Step 2|The 16 includes 2 ineligible pts.|16
2620800|NCT00003910|6433086|P1|STARTED|Step 2||0
2620801|NCT00003910|6433085|P2|NOT COMPLETED|Step 1||0
2620802|NCT00003910|6433086|P1|NOT COMPLETED|Step 1||0
2620803|NCT00003910|6433085|P2|COMPLETED|Step 1||0
2620804|NCT00003910|6433086|P1|COMPLETED|Step 1||55
2620805|NCT00003910|6433085|P2|STARTED|Step 1||0
2620806|NCT00003910|6433086|P1|STARTED|Step 1|Of 59 (step 1), 4 pts were ineligible.|55
2620807|NCT00003901|6433092|P1|NOT COMPLETED|Overall Study||17
2620808|NCT00003901|6433092|P1|COMPLETED|Overall Study||1030
2620809|NCT00003901|6433092|P1|STARTED|Overall Study||1047
2620810|NCT00003896|6433103|P1|NOT COMPLETED|Overall Study||29
2620811|NCT00003896|6433103|P1|COMPLETED|Overall Study||39
2620812|NCT00003896|6433103|P1|Eligible|Overall Study|2 eligible patients did not have any toxicity assessments reported.|63
2620813|NCT00003896|6433103|P1|STARTED|Overall Study||68
2620814|NCT00003875|6433109|P1|NOT COMPLETED|Overall Study||1
2620815|NCT00003875|6433109|P1|COMPLETED|Overall Study||29
2620816|NCT00003875|6433109|P1|STARTED|Overall Study||30
2620817|NCT00003869|6433118|P2|NOT COMPLETED|Overall Study||12
2620818|NCT00003869|6433119|P1|NOT COMPLETED|Overall Study||41
2620819|NCT00003869|6433118|P2|COMPLETED|Overall Study||80
2620820|NCT00003869|6433119|P1|COMPLETED|Overall Study||53
2620821|NCT00003869|6433118|P2|STARTED|Overall Study||92
2620822|NCT00003869|6433119|P1|STARTED|Overall Study||94
2620823|NCT00003820|6433135|P2|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
2620824|NCT00003820|6433136|P1|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
2620825|NCT00003820|6433135|P2|COMPLETED|Cycle 4 (Maintenance Treatment)|Patients with treatment assessment at 24 months|16
2620826|NCT00003820|6433136|P1|COMPLETED|Cycle 4 (Maintenance Treatment)||0
2620827|NCT00003820|6433135|P2|STARTED|Cycle 4 (Maintenance Treatment)|Patients with treatment response/stable disease at 18 months|16
2620828|NCT00003820|6433136|P1|STARTED|Cycle 4 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
2620829|NCT00003820|6433135|P2|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
2620830|NCT00003820|6433136|P1|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
2620831|NCT00003820|6433135|P2|COMPLETED|Cycle 3 (Maintenance Treatment)|Patients with treatment assessment at 18 months|16
2620832|NCT00003820|6433136|P1|COMPLETED|Cycle 3 (Maintenance Treatment)||0
2620833|NCT00003820|6433135|P2|STARTED|Cycle 3 (Maintenance Treatment)|Patients with treatment response/stable disease at 12 months|16
2620834|NCT00003820|6433136|P1|STARTED|Cycle 3 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
2620835|NCT00003820|6433135|P2|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
2620836|NCT00003820|6433136|P1|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
2620837|NCT00003820|6433135|P2|COMPLETED|Cycle 2 (Maintenance Treatment)|Patients with treatment assessment at 12 months|16
2620838|NCT00003820|6433136|P1|COMPLETED|Cycle 2 (Maintenance Treatment)||0
2620839|NCT00003820|6433135|P2|STARTED|Cycle 2 (Maintenance Treatment)|Pts with treatment response/stable disease at 6 mos, & eligible to continue.|16
2620840|NCT00003820|6433136|P1|STARTED|Cycle 2 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
2620841|NCT00003820|6433135|P2|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
2620842|NCT00003820|6433136|P1|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
2620843|NCT00003820|6433135|P2|COMPLETED|Cycle 1 (Initial Treatment)||16
2620844|NCT00003820|6433136|P1|COMPLETED|Cycle 1 (Initial Treatment)||23
2620845|NCT00003820|6433135|P2|STARTED|Cycle 1 (Initial Treatment)||16
2620846|NCT00003820|6433136|P1|STARTED|Cycle 1 (Initial Treatment)||23
2620847|NCT00003782|6433145|P3|NOT COMPLETED|Overall Study||26
2620848|NCT00003782|6433146|P2|NOT COMPLETED|Overall Study||31
2620849|NCT00003782|6433147|P1|NOT COMPLETED|Overall Study||30
2620850|NCT00003782|6433145|P3|COMPLETED|Overall Study||1758
2620851|NCT00003782|6433146|P2|COMPLETED|Overall Study||1753
2620852|NCT00003782|6433147|P1|COMPLETED|Overall Study||1753
2620853|NCT00003782|6433145|P3|STARTED|Overall Study||1784
2620854|NCT00003782|6433146|P2|STARTED|Overall Study||1784
2620855|NCT00003782|6433147|P1|STARTED|Overall Study||1783
2620856|NCT00003702|6433157|P2|NOT COMPLETED|Overall Study||11
2620857|NCT00003702|6433158|P1|NOT COMPLETED|Overall Study||13
2620858|NCT00003702|6433157|P2|COMPLETED|Overall Study||109
2620859|NCT00003702|6433158|P1|COMPLETED|Overall Study||107
2620860|NCT00003702|6433157|P2|STARTED|Overall Study||120
2620861|NCT00003702|6433158|P1|STARTED|Overall Study||120
2620862|NCT00003659|6433167|P1|NOT COMPLETED|Overall Study||3
2620863|NCT00003659|6433167|P1|COMPLETED|Overall Study||36
2620864|NCT00003659|6433167|P1|STARTED|Overall Study||39
2620865|NCT00003644|6433175|P2|NOT COMPLETED|Overall Study||14
2620866|NCT00003644|6433176|P1|NOT COMPLETED|Overall Study||15
2620867|NCT00003644|6433175|P2|COMPLETED|Overall Study||268
2620868|NCT00003644|6433176|P1|COMPLETED|Overall Study||274
2620869|NCT00003644|6433175|P2|STARTED|Overall Study||282
2620870|NCT00003644|6433176|P1|STARTED|Overall Study||289
2620871|NCT00003641|6433188|P2|NOT COMPLETED|Overall Study||174
2620872|NCT00003641|6433189|P1|NOT COMPLETED|Overall Study||569
2620873|NCT00003641|6433188|P2|COMPLETED|Overall Study||407
2620874|NCT00003641|6433189|P1|COMPLETED|Overall Study||0
2620875|NCT00003641|6433188|P2|Toxicity Assessed|Overall Study||568
2620876|NCT00003641|6433189|P1|Toxicity Assessed|Overall Study|439 patients on arm I had their toxicity assessed even though they did not receive any treatment|439
2620877|NCT00003641|6433188|P2|Treated|Overall Study||569
2620878|NCT00003641|6433189|P1|Treated|Overall Study|Patients on arm I should undergo observation, but 2 patients received interferon therapy|2
2620879|NCT00003641|6433188|P2|STARTED|Overall Study||581
2620880|NCT00003641|6433189|P1|STARTED|Overall Study||569
2620881|NCT00003631|6433200|P3|NOT COMPLETED|Overall Study||9
2620882|NCT00003631|6433201|P2|NOT COMPLETED|Overall Study||1
2620883|NCT00003631|6433202|P1|NOT COMPLETED|Overall Study||3
2620884|NCT00003631|6433200|P3|COMPLETED|Overall Study||15
2620885|NCT00003631|6433201|P2|COMPLETED|Overall Study||43
2620886|NCT00003631|6433202|P1|COMPLETED|Overall Study||47
2620887|NCT00003631|6433200|P3|STARTED|Overall Study||24
2620888|NCT00003631|6433201|P2|STARTED|Overall Study||44
2620889|NCT00003631|6433202|P1|STARTED|Overall Study||50
2620890|NCT00003590|6433210|P1|NOT COMPLETED|Overall Study||22
2620891|NCT00003590|6433210|P1|COMPLETED|Overall Study|Patients were to receive Hydroxyurea up to 2 years in absence of progressive disease.|7
2620892|NCT00003590|6433210|P1|Eligible and Began Protocol Therapy|Overall Study||28
2620893|NCT00003590|6433210|P1|Eligible|Overall Study||28
2620894|NCT00003590|6433210|P1|STARTED|Overall Study||29
2620895|NCT00003537|6433215|P1|NOT COMPLETED|Overall Study||1
2620896|NCT00003537|6433215|P1|COMPLETED|Overall Study||18
2620897|NCT00003537|6433215|P1|STARTED|Overall Study||19
2620898|NCT00003535|6433220|P1|NOT COMPLETED|Overall Study||5
2620899|NCT00003535|6433220|P1|COMPLETED|Overall Study||4
2620900|NCT00003535|6433220|P1|STARTED|Overall Study||9
2620901|NCT00003499|6433225|P1|NOT COMPLETED|Overall Study||8
2620902|NCT00003499|6433225|P1|COMPLETED|Overall Study||23
2620903|NCT00003499|6433225|P1|STARTED|Overall Study||31
2620904|NCT00003483|6433230|P1|NOT COMPLETED|Overall Study||1
2620905|NCT00003483|6433230|P1|COMPLETED|Overall Study||2
2620906|NCT00003483|6433230|P1|STARTED|Overall Study||3
2620907|NCT00003479|6433235|P1|NOT COMPLETED|Overall Study||3
2620908|NCT00003479|6433235|P1|COMPLETED|Overall Study||6
2620909|NCT00003479|6433235|P1|STARTED|Overall Study||9
2620910|NCT00003477|6433240|P1|NOT COMPLETED|Overall Study||4
2620911|NCT00003477|6433240|P1|COMPLETED|Overall Study||8
2620912|NCT00003477|6433240|P1|STARTED|Overall Study||12
2620913|NCT00003476|6433245|P1|NOT COMPLETED|Overall Study||1
2620914|NCT00003476|6433245|P1|COMPLETED|Overall Study||7
2620915|NCT00003476|6433245|P1|STARTED|Overall Study||8
2620916|NCT00003475|6433250|P1|NOT COMPLETED|Overall Study||13
2620917|NCT00003475|6433250|P1|COMPLETED|Overall Study||27
2620918|NCT00003475|6433250|P1|STARTED|Overall Study||40
2620919|NCT00003474|6433255|P1|NOT COMPLETED|Overall Study||14
2620920|NCT00003474|6433255|P1|COMPLETED|Overall Study||26
2620921|NCT00003474|6433255|P1|STARTED|Overall Study||40
2620922|NCT00003473|6433260|P1|NOT COMPLETED|Overall Study||3
2620923|NCT00003473|6433260|P1|COMPLETED|Overall Study||17
2620924|NCT00003473|6433260|P1|STARTED|Overall Study||20
2620925|NCT00003472|6433265|P1|NOT COMPLETED|Overall Study||3
2620926|NCT00003472|6433265|P1|COMPLETED|Overall Study||10
2620927|NCT00003472|6433265|P1|STARTED|Overall Study||13
2620928|NCT00003471|6433270|P1|NOT COMPLETED|Overall Study||4
2620929|NCT00003471|6433270|P1|COMPLETED|Overall Study||3
2620930|NCT00003471|6433270|P1|STARTED|Overall Study||7
2620931|NCT00003470|6433275|P1|NOT COMPLETED|Overall Study||6
2620932|NCT00003470|6433275|P1|COMPLETED|Overall Study||21
2620933|NCT00003470|6433275|P1|STARTED|Overall Study||27
2620934|NCT00003469|6433280|P1|NOT COMPLETED|Overall Study||0
2620935|NCT00003469|6433280|P1|COMPLETED|Overall Study||4
2620936|NCT00003469|6433280|P1|STARTED|Overall Study||4
2620937|NCT00003468|6433285|P1|NOT COMPLETED|Overall Study||2
2620938|NCT00003468|6433285|P1|COMPLETED|Overall Study|Two patients were not evaluable.|9
2620939|NCT00003468|6433285|P1|STARTED|Overall Study||11
2620940|NCT00003460|6433290|P1|NOT COMPLETED|Overall Study||1
2620941|NCT00003460|6433290|P1|COMPLETED|Overall Study|One patient was not evaluable.|12
2620942|NCT00003460|6433290|P1|STARTED|Overall Study||13
2620943|NCT00003459|6433295|P1|NOT COMPLETED|Overall Study||9
2620944|NCT00003459|6433295|P1|COMPLETED|Overall Study|Nine patients were not evaluable.|31
2620945|NCT00003459|6433295|P1|STARTED|Overall Study||40
2620946|NCT00003458|6433300|P1|NOT COMPLETED|Overall Study||4
2620947|NCT00003458|6433300|P1|COMPLETED|Overall Study||30
2620948|NCT00003458|6433300|P1|STARTED|Overall Study||34
2620949|NCT00003457|6433305|P1|NOT COMPLETED|Overall Study||9
2620950|NCT00003457|6433305|P1|COMPLETED|Overall Study||31
2620951|NCT00003457|6433305|P1|STARTED|Overall Study||40
2620952|NCT00003456|6433310|P1|NOT COMPLETED|Overall Study||8
2620953|NCT00003456|6433310|P1|COMPLETED|Overall Study||32
2620954|NCT00003456|6433310|P1|STARTED|Overall Study||40
2620955|NCT00003453|6433315|P1|NOT COMPLETED|Overall Study||1
2620956|NCT00003453|6433315|P1|COMPLETED|Overall Study|One patient was not evaluable|5
2620957|NCT00003453|6433315|P1|STARTED|Overall Study||6
2620958|NCT00003404|6433320|P1|NOT COMPLETED|Overall Study||0
2620959|NCT00003404|6433320|P1|COMPLETED|Overall Study||46
2620960|NCT00003404|6433320|P1|STARTED|Overall Study||46
2620961|NCT00003389|6433327|P2|NOT COMPLETED|Overall Study||60
2620962|NCT00003389|6433328|P1|NOT COMPLETED|Overall Study||98
2620963|NCT00003389|6433327|P2|COMPLETED|Overall Study||366
2620964|NCT00003389|6433328|P1|COMPLETED|Overall Study||330
2620965|NCT00003389|6433327|P2|Eligible Patients|Overall Study||399
2620966|NCT00003389|6433328|P1|Eligible Patients|Overall Study||395
2620967|NCT00003389|6433327|P2|Treated Pts w/ Toxicity Data Available|Overall Study||422
2620968|NCT00003389|6433328|P1|Treated Pts w/ Toxicity Data Available|Overall Study||414
2620969|NCT00003389|6433327|P2|STARTED|Overall Study||426
2620970|NCT00003389|6433328|P1|STARTED|Overall Study||428
2620971|NCT00003377|6433343|P5|NOT COMPLETED|Period II||1
2620972|NCT00003377|6433344|P4|NOT COMPLETED|Period II||0
2620973|NCT00003377|6433345|P3|NOT COMPLETED|Period II||0
2620974|NCT00003377|6433346|P2|NOT COMPLETED|Period II||0
2620975|NCT00003377|6433347|P1|NOT COMPLETED|Period II||0
2620976|NCT00003377|6433343|P5|COMPLETED|Period II||16
2620977|NCT00003377|6433344|P4|COMPLETED|Period II||0
2620978|NCT00003377|6433345|P3|COMPLETED|Period II||0
2620979|NCT00003377|6433346|P2|COMPLETED|Period II||0
2620980|NCT00003377|6433347|P1|COMPLETED|Period II||0
2620981|NCT00003377|6433343|P5|STARTED|Period II|All pts enrolled on Per II received cisplatin 40 mg/m2 & paclitaxel 40 mg/m2 concurrent w/ radiation|17
2620982|NCT00003377|6433344|P4|STARTED|Period II|Patients participated at this dose level only in Period I.|0
2620983|NCT00003377|6433345|P3|STARTED|Period II|Patients participated at this dose level only in Period I.|0
2620984|NCT00003377|6433346|P2|STARTED|Period II|Patients participated at this dose level only in Period I.|0
2620985|NCT00003377|6433347|P1|STARTED|Period II|Patients participated at this dose level only in Period I.|0
2620986|NCT00003377|6433343|P5|NOT COMPLETED|Period I||0
2620987|NCT00003377|6433344|P4|NOT COMPLETED|Period I||1
2620988|NCT00003377|6433345|P3|NOT COMPLETED|Period I||1
2620989|NCT00003377|6433346|P2|NOT COMPLETED|Period I||0
2620990|NCT00003377|6433347|P1|NOT COMPLETED|Period I||0
2620991|NCT00003377|6433343|P5|COMPLETED|Period I||0
2620992|NCT00003377|6433344|P4|COMPLETED|Period I||2
2620993|NCT00003377|6433345|P3|COMPLETED|Period I||2
2620994|NCT00003377|6433346|P2|COMPLETED|Period I||3
2620995|NCT00003377|6433347|P1|COMPLETED|Period I||3
2620996|NCT00003377|6433343|P5|STARTED|Period I||0
2620997|NCT00003377|6433344|P4|STARTED|Period I||3
2620998|NCT00003377|6433345|P3|STARTED|Period I||3
2620999|NCT00003377|6433346|P2|STARTED|Period I||3
2621000|NCT00003377|6433347|P1|STARTED|Period I||3
2621001|NCT00003199|6433361|P1|NOT COMPLETED|Overall Study||22
2621002|NCT00003199|6433361|P1|COMPLETED|Overall Study||28
2621003|NCT00003199|6433361|P1|STARTED|Overall Study||50
2621004|NCT00003138|6433369|P2|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||7
2621005|NCT00003138|6433370|P1|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||6
2621006|NCT00003138|6433369|P2|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
2621007|NCT00003138|6433370|P1|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
2621008|NCT00003138|6433369|P2|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||7
2621009|NCT00003138|6433370|P1|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||6
2621010|NCT00003138|6433369|P2|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||20
2621011|NCT00003138|6433370|P1|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||12
2621012|NCT00003138|6433369|P2|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
2621013|NCT00003138|6433370|P1|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
2621014|NCT00003138|6433369|P2|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||19
2621015|NCT00003138|6433370|P1|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||12
2621016|NCT00003138|6433369|P2|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||20
2621017|NCT00003138|6433370|P1|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||12
2621018|NCT00003138|6433369|P2|NOT COMPLETED|Step 2 (Cross Over)||0
2621019|NCT00003138|6433370|P1|NOT COMPLETED|Step 2 (Cross Over)||26
2621020|NCT00003138|6433369|P2|COMPLETED|Step 2 (Cross Over)||0
2621021|NCT00003138|6433370|P1|COMPLETED|Step 2 (Cross Over)||0
2621022|NCT00003138|6433369|P2|STARTED|Step 2 (Cross Over)|Only patients in the supportive care arm are eligible to cross over to the Erythropoietin arm.|0
2621023|NCT00003138|6433370|P1|STARTED|Step 2 (Cross Over)||26
2621024|NCT00003138|6433369|P2|NOT COMPLETED|Step 1||57
2621025|NCT00003138|6433370|P1|NOT COMPLETED|Step 1||61
2621026|NCT00003138|6433369|P2|COMPLETED|Step 1||0
2621027|NCT00003138|6433370|P1|COMPLETED|Step 1||0
2621028|NCT00003138|6433369|P2|Patients With Transfusion Data|Step 1||42
2621029|NCT00003138|6433370|P1|Patients With Transfusion Data|Step 1||37
2621030|NCT00003138|6433369|P2|Patients With QOL Data at 4 Months|Step 1||42
2621031|NCT00003138|6433370|P1|Patients With QOL Data at 4 Months|Step 1||42
2621032|NCT00003138|6433369|P2|Eligible and Treated|Step 1||50
2621033|NCT00003138|6433370|P1|Eligible and Treated|Step 1||52
2621034|NCT00003138|6433369|P2|Treated|Step 1||53
2621035|NCT00003138|6433370|P1|Treated|Step 1||56
2621036|NCT00003138|6433369|P2|Patients With Complete Data|Step 1||53
2621037|NCT00003138|6433370|P1|Patients With Complete Data|Step 1||57
2621038|NCT00003138|6433369|P2|STARTED|Step 1||57
2621039|NCT00003138|6433370|P1|STARTED|Step 1||61
2621040|NCT00002975|6433383|P1|NOT COMPLETED|Overall Study||5
2621041|NCT00002975|6433383|P1|COMPLETED|Overall Study||175
2621042|NCT00002975|6433383|P1|Treated With Study Therapy|Overall Study||175
2621043|NCT00002975|6433383|P1|STARTED|Overall Study||180
2621044|NCT00002931|6433387|P1|NOT COMPLETED|Overall Study||2
2621045|NCT00002931|6433387|P1|COMPLETED|Overall Study||46
2621046|NCT00002931|6433387|P1|STARTED|Overall Study||48
2621047|NCT00002874|6433395|P2|NOT COMPLETED|Overall Study||35
2621048|NCT00002874|6433396|P1|NOT COMPLETED|Overall Study||45
2621049|NCT00002874|6433395|P2|COMPLETED|Overall Study||384
2621050|NCT00002874|6433396|P1|COMPLETED|Overall Study||376
2621051|NCT00002874|6433395|P2|STARTED|Overall Study||419
2621052|NCT00002874|6433396|P1|STARTED|Overall Study||421
2621053|NCT00002850|6433421|P3|NOT COMPLETED|Overall Study||4
2621054|NCT00002850|6433422|P2|NOT COMPLETED|Overall Study||2
2621055|NCT00002850|6433423|P1|NOT COMPLETED|Overall Study||5
2621056|NCT00002850|6433421|P3|COMPLETED|Overall Study||63
2621057|NCT00002850|6433422|P2|COMPLETED|Overall Study||74
2621058|NCT00002850|6433423|P1|COMPLETED|Overall Study||64
2621059|NCT00002850|6433421|P3|STARTED|Overall Study||67
2621060|NCT00002850|6433422|P2|STARTED|Overall Study||76
2621061|NCT00002850|6433423|P1|STARTED|Overall Study||69
2621062|NCT00002842|6433431|P1|NOT COMPLETED|Overall Study||27
2621063|NCT00002842|6433431|P1|COMPLETED|Overall Study||22
2621064|NCT00002842|6433431|P1|STARTED|Overall Study||49
2621065|NCT00002766|6433437|P2|NOT COMPLETED|Overall Study||4
2621066|NCT00002766|6433438|P1|NOT COMPLETED|Overall Study||3
2621067|NCT00002766|6433437|P2|COMPLETED|Overall Study||85
2621068|NCT00002766|6433438|P1|COMPLETED|Overall Study||78
2621069|NCT00002766|6433437|P2|STARTED|Overall Study||89
2621070|NCT00002766|6433438|P1|STARTED|Overall Study||81
2621071|NCT00002651|6433446|P3|NOT COMPLETED|Consolidation and Randomization||860
2621072|NCT00002651|6433447|P2|NOT COMPLETED|Consolidation and Randomization||838
2621073|NCT00002651|6433448|P1|NOT COMPLETED|Consolidation and Randomization||0
2621074|NCT00002651|6433446|P3|COMPLETED|Consolidation and Randomization||22
2621075|NCT00002651|6433447|P2|COMPLETED|Consolidation and Randomization||29
2621076|NCT00002651|6433448|P1|COMPLETED|Consolidation and Randomization||0
2621077|NCT00002651|6433446|P3|Assessable for Toxicity|Consolidation and Randomization||702
2621078|NCT00002651|6433447|P2|Assessable for Toxicity|Consolidation and Randomization||732
2621079|NCT00002651|6433448|P1|Assessable for Toxicity|Consolidation and Randomization||0
2621080|NCT00002651|6433446|P3|Eligible|Consolidation and Randomization||770
2621081|NCT00002651|6433447|P2|Eligible|Consolidation and Randomization||765
2621082|NCT00002651|6433448|P1|Eligible|Consolidation and Randomization||0
2621083|NCT00002651|6433446|P3|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|882
2621084|NCT00002651|6433447|P2|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|867
2621085|NCT00002651|6433448|P1|STARTED|Consolidation and Randomization||0
2621086|NCT00002651|6433446|P3|NOT COMPLETED|Induction||0
2621087|NCT00002651|6433447|P2|NOT COMPLETED|Induction||0
2621088|NCT00002651|6433448|P1|NOT COMPLETED|Induction||1343
2621089|NCT00002651|6433446|P3|COMPLETED|Induction||0
2621090|NCT00002651|6433447|P2|COMPLETED|Induction||0
2621091|NCT00002651|6433448|P1|COMPLETED|Induction||1697
2621092|NCT00002651|6433446|P3|Eligible and Began Protocol Therapy|Induction||0
2621093|NCT00002651|6433447|P2|Eligible and Began Protocol Therapy|Induction||0
2621094|NCT00002651|6433448|P1|Eligible and Began Protocol Therapy|Induction||2950
2621095|NCT00002651|6433446|P3|Eligible|Induction||0
2621096|NCT00002651|6433447|P2|Eligible|Induction||0
2621097|NCT00002651|6433448|P1|Eligible|Induction||2950
2621098|NCT00002651|6433446|P3|STARTED|Induction||0
2621099|NCT00002651|6433447|P2|STARTED|Induction||0
2621100|NCT00002651|6433448|P1|STARTED|Induction||3040
2621101|NCT00002558|6433466|P2|NOT COMPLETED|Overall Study||1
2621102|NCT00002558|6433467|P1|NOT COMPLETED|Overall Study||0
2621103|NCT00002558|6433466|P2|COMPLETED|Overall Study||15
2621104|NCT00002558|6433467|P1|COMPLETED|Overall Study||92
2621105|NCT00002558|6433466|P2|STARTED|Overall Study||16
2621106|NCT00002558|6433467|P1|STARTED|Overall Study||92
2621107|NCT00052078|6433477|P4|NOT COMPLETED|Overall Study||15
2621108|NCT00052078|6433478|P3|NOT COMPLETED|Overall Study||13
2621109|NCT00052078|6433479|P2|NOT COMPLETED|Overall Study||6
2621110|NCT00052078|6433480|P1|NOT COMPLETED|Overall Study||23
2621111|NCT00052078|6433477|P4|COMPLETED|Overall Study||61
2621112|NCT00052078|6433478|P3|COMPLETED|Overall Study||127
2621113|NCT00052078|6433479|P2|COMPLETED|Overall Study||133
2621114|NCT00052078|6433480|P1|COMPLETED|Overall Study||110
2621115|NCT00052078|6433477|P4|STARTED|Overall Study||76
2621116|NCT00052078|6433478|P3|STARTED|Overall Study||140
2621117|NCT00052078|6433479|P2|STARTED|Overall Study||139
2621118|NCT00052078|6433480|P1|STARTED|Overall Study||133
2621119|NCT00051636|6433492|P2|NOT COMPLETED|Period 2- Extended Observation Period||30
2621120|NCT00051636|6433493|P1|NOT COMPLETED|Period 2- Extended Observation Period||70
2621121|NCT00051636|6433492|P2|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease|22
2621122|NCT00051636|6433493|P1|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|5
2621123|NCT00051636|6433492|P2|STARTED|Period 2- Extended Observation Period||52
2621124|NCT00051636|6433493|P1|STARTED|Period 2- Extended Observation Period||75
2621125|NCT00051636|6433492|P2|NOT COMPLETED|Period 1 - Core||6
2621126|NCT00051636|6433493|P1|NOT COMPLETED|Period 1 - Core||4
2621127|NCT00051636|6433492|P2|COMPLETED|Period 1 - Core||76
2621128|NCT00051636|6433493|P1|COMPLETED|Period 1 - Core||86
2621129|NCT00051636|6433492|P2|STARTED|Period 1 - Core||82
2621130|NCT00051636|6433493|P1|STARTED|Period 1 - Core||90
2621131|NCT00051558|6433521|P2|NOT COMPLETED|Overall Study||96
2621132|NCT00051558|6433522|P1|NOT COMPLETED|Overall Study||91
2621133|NCT00051558|6433521|P2|COMPLETED|Overall Study||118
2621134|NCT00051558|6433522|P1|COMPLETED|Overall Study||123
2621135|NCT00051558|6433521|P2|STARTED|Overall Study||214
2621136|NCT00051558|6433522|P1|STARTED|Overall Study||214
2621137|NCT00051363|6433558|P2|NOT COMPLETED|Overall Study||144
2621138|NCT00051363|6433559|P1|NOT COMPLETED|Overall Study||115
2621139|NCT00051363|6433558|P2|COMPLETED|Overall Study||403
2621140|NCT00051363|6433559|P1|COMPLETED|Overall Study||443
2621141|NCT00051363|6433558|P2|Completed 6M Vist On-Study|Overall Study||403
2621142|NCT00051363|6433559|P1|Completed 6M Vist On-Study|Overall Study||443
2621143|NCT00051363|6433558|P2|Completed 6M Visit On-Treatment|Overall Study||372
2621144|NCT00051363|6433559|P1|Completed 6M Visit On-Treatment|Overall Study||427
2621145|NCT00051363|6433558|P2|Completed 2M Visit On-Study|Overall Study||432
2621146|NCT00051363|6433559|P1|Completed 2M Visit On-Study|Overall Study||468
2621147|NCT00051363|6433558|P2|Completed 2M Visit On-Treatment|Overall Study||417
2621148|NCT00051363|6433559|P1|Completed 2M Visit On-Treatment|Overall Study||456
2621149|NCT00051363|6433558|P2|Randomized & Analyzed|Overall Study||542
2621150|NCT00051363|6433559|P1|Randomized & Analyzed|Overall Study||556
2621151|NCT00051363|6433558|P2|STARTED|Overall Study||547
2621152|NCT00051363|6433559|P1|STARTED|Overall Study||558
2621153|NCT00051168|6433593|P1|NOT COMPLETED|Overall Study||135
2621154|NCT00051168|6433593|P1|COMPLETED|Overall Study||367
2621155|NCT00051168|6433593|P1|STARTED|Overall Study||502
2621156|NCT00051025|6433599|P2|NOT COMPLETED|Overall Study||4
2621157|NCT00051025|6433600|P1|NOT COMPLETED|Overall Study||2
2621158|NCT00051025|6433599|P2|COMPLETED|Overall Study||0
2621159|NCT00051025|6433600|P1|COMPLETED|Overall Study||3
2621160|NCT00051025|6433599|P2|STARTED|Overall Study||4
2621161|NCT00051025|6433600|P1|STARTED|Overall Study||5
2621162|NCT00050986|6433608|P1|NOT COMPLETED|Overall Study||2
2621163|NCT00050986|6433608|P1|COMPLETED|Overall Study|Two participants had withdrawn consents before the study treatment was initiated.|53
2621164|NCT00050986|6433608|P1|STARTED|Overall Study||55
2621165|NCT00050960|6433614|P2|NOT COMPLETED|Overall Study||304
2621166|NCT00050960|6433615|P1|NOT COMPLETED|Overall Study||302
2621167|NCT00050960|6433614|P2|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|2
2621168|NCT00050960|6433615|P1|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|4
2621169|NCT00050960|6433614|P2|STARTED|Overall Study||306
2621170|NCT00050960|6433615|P1|STARTED|Overall Study||306
2621171|NCT00050778|6433624|P3|NOT COMPLETED|Overall Study||18
2621172|NCT00050778|6433625|P2|NOT COMPLETED|Overall Study||21
2621173|NCT00050778|6433626|P1|NOT COMPLETED|Overall Study||45
2621174|NCT00050778|6433624|P3|COMPLETED|Overall Study||92
2621175|NCT00050778|6433625|P2|COMPLETED|Overall Study||92
2621176|NCT00050778|6433626|P1|COMPLETED|Overall Study||66
2621177|NCT00050778|6433624|P3|Treated|Overall Study||108
2621178|NCT00050778|6433625|P2|Treated|Overall Study||108
2621179|NCT00050778|6433626|P1|Treated|Overall Study||107
2621180|NCT00050778|6433624|P3|STARTED|Overall Study||110
2621181|NCT00050778|6433625|P2|STARTED|Overall Study||113
2621182|NCT00050778|6433626|P1|STARTED|Overall Study|Randomized.|111
2621183|NCT00050622|6433652|P1|NOT COMPLETED|Overall Study||1
2621184|NCT00050622|6433652|P1|COMPLETED|Overall Study||153
2621185|NCT00050622|6433652|P1|STARTED|Overall Study||154
2621186|NCT00050167|6433690|P2|NOT COMPLETED|Overall Study||1
2621187|NCT00050167|6433691|P1|NOT COMPLETED|Overall Study||1
2621188|NCT00050167|6433690|P2|COMPLETED|Overall Study||300
2621189|NCT00050167|6433691|P1|COMPLETED|Overall Study||301
2621190|NCT00050167|6433690|P2|STARTED|Overall Study||301
2621191|NCT00050167|6433691|P1|STARTED|Overall Study||302
2621192|NCT00050089|6433701|P4|NOT COMPLETED|Overall Study||0
2621193|NCT00050089|6433702|P3|NOT COMPLETED|Overall Study||0
2621194|NCT00050089|6433703|P2|NOT COMPLETED|Overall Study||0
2621195|NCT00050089|6433704|P1|NOT COMPLETED|Overall Study||0
2621196|NCT00050089|6433701|P4|COMPLETED|Overall Study|For primary outcome assessment|78
2621197|NCT00050089|6433702|P3|COMPLETED|Overall Study|For primary outcome assessment|86
2621198|NCT00050089|6433703|P2|COMPLETED|Overall Study|For primary outcome assessment|98
2621199|NCT00050089|6433704|P1|COMPLETED|Overall Study|For primary outcome assessment|106
2621200|NCT00050089|6433701|P4|Baseline|Overall Study||78
2621201|NCT00050089|6433702|P3|Baseline|Overall Study||86
2621202|NCT00050089|6433703|P2|Baseline|Overall Study|14 participants randomized in the UK Option scheme (not shown in 2X2 baseline data)|84
2621203|NCT00050089|6433704|P1|Baseline|Overall Study|15 participants randomized in the UK Option scheme (not displayed in the 2X2 baseline data)|91
2621204|NCT00050089|6433701|P4|STARTED|Overall Study||78
2621205|NCT00050089|6433702|P3|STARTED|Overall Study||86
2621206|NCT00050089|6433703|P2|STARTED|Overall Study||98
2621207|NCT00050089|6433704|P1|STARTED|Overall Study||106
2621208|NCT00050011|6433724|P2|NOT COMPLETED|Overall Study||126
2621209|NCT00050011|6433725|P1|NOT COMPLETED|Overall Study||121
2621210|NCT00050011|6433724|P2|COMPLETED|Overall Study||175
2621211|NCT00050011|6433725|P1|COMPLETED|Overall Study||180
2621212|NCT00050011|6433724|P2|Intent-to-treat Population|Overall Study||300
2621213|NCT00050011|6433725|P1|Intent-to-treat Population|Overall Study||300
2621214|NCT00050011|6433724|P2|STARTED|Overall Study||301
2621215|NCT00050011|6433725|P1|STARTED|Overall Study||301
2621216|NCT00049842|6433747|P2|NOT COMPLETED|Follow-up Phase||5
2621217|NCT00049842|6433748|P1|NOT COMPLETED|Follow-up Phase||7
2621218|NCT00049842|6433747|P2|COMPLETED|Follow-up Phase||189
2621219|NCT00049842|6433748|P1|COMPLETED|Follow-up Phase||211
2621220|NCT00049842|6433747|P2|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|194
2621221|NCT00049842|6433748|P1|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|218
2621222|NCT00049842|6433747|P2|NOT COMPLETED|Treatment Phase||78
2621223|NCT00049842|6433748|P1|NOT COMPLETED|Treatment Phase||93
2621224|NCT00049842|6433747|P2|COMPLETED|Treatment Phase||192
2621225|NCT00049842|6433748|P1|COMPLETED|Treatment Phase||177
2621226|NCT00049842|6433747|P2|STARTED|Treatment Phase||270
2621227|NCT00049842|6433748|P1|STARTED|Treatment Phase||270
2621228|NCT00048932|6433766|P3|NOT COMPLETED|Open Label Period (OL)||441
2621229|NCT00048932|6433767|P2|NOT COMPLETED|Open Label Period (OL)||0
2621230|NCT00048932|6433768|P1|NOT COMPLETED|Open Label Period (OL)||0
2621231|NCT00048932|6433766|P3|COMPLETED|Open Label Period (OL)||743
2621232|NCT00048932|6433767|P2|COMPLETED|Open Label Period (OL)||0
2621233|NCT00048932|6433768|P1|COMPLETED|Open Label Period (OL)||0
2621234|NCT00048932|6433766|P3|STARTED|Open Label Period (OL)|47 participants who completed the double-blind did not enter the open-label|1184
2621235|NCT00048932|6433767|P2|STARTED|Open Label Period (OL)||0
2621236|NCT00048932|6433768|P1|STARTED|Open Label Period (OL)||0
2621237|NCT00048932|6433766|P3|NOT COMPLETED|Double Blind Period (DB)||0
2621238|NCT00048932|6433767|P2|NOT COMPLETED|Double Blind Period (DB)||87
2621239|NCT00048932|6433768|P1|NOT COMPLETED|Double Blind Period (DB)||123
2621240|NCT00048932|6433766|P3|COMPLETED|Double Blind Period (DB)||0
2621241|NCT00048932|6433767|P2|COMPLETED|Double Blind Period (DB)||395
2621242|NCT00048932|6433768|P1|COMPLETED|Double Blind Period (DB)||836
2621243|NCT00048932|6433766|P3|STARTED|Double Blind Period (DB)||0
2621244|NCT00048932|6433767|P2|STARTED|Double Blind Period (DB)|Number Treated|482
2621245|NCT00048932|6433768|P1|STARTED|Double Blind Period (DB)|Number Treated|959
2621246|NCT00048815|6433795|P3|NOT COMPLETED|Overall Study||4
2621247|NCT00048815|6433796|P2|NOT COMPLETED|Overall Study||4
2621248|NCT00048815|6433797|P1|NOT COMPLETED|Overall Study||6
2621249|NCT00048815|6433795|P3|COMPLETED|Overall Study||19
2621250|NCT00048815|6433796|P2|COMPLETED|Overall Study||22
2621251|NCT00048815|6433797|P1|COMPLETED|Overall Study||18
2621252|NCT00048815|6433795|P3|STARTED|Overall Study||23
2621253|NCT00048815|6433796|P2|STARTED|Overall Study||26
2621254|NCT00048815|6433797|P1|STARTED|Overall Study||24
2621255|NCT00048581|6433810|P3|NOT COMPLETED|Open-Label Period||167
2621256|NCT00048581|6433811|P2|NOT COMPLETED|Open-Label Period||0
2621257|NCT00048581|6433812|P1|NOT COMPLETED|Open-Label Period||0
2621258|NCT00048581|6433810|P3|COMPLETED|Open-Label Period||150
2621259|NCT00048581|6433811|P2|COMPLETED|Open-Label Period||0
2621260|NCT00048581|6433812|P1|COMPLETED|Open-Label Period||0
2621261|NCT00048581|6433810|P3|STARTED|Open-Label Period||317
2621262|NCT00048581|6433811|P2|STARTED|Open-Label Period||0
2621263|NCT00048581|6433812|P1|STARTED|Open-Label Period||0
2621264|NCT00048581|6433810|P3|NOT COMPLETED|Double-Blind Period||0
2621265|NCT00048581|6433811|P2|NOT COMPLETED|Double-Blind Period||34
2621266|NCT00048581|6433812|P1|NOT COMPLETED|Double-Blind Period||35
2621267|NCT00048581|6433810|P3|COMPLETED|Double-Blind Period||0
2621268|NCT00048581|6433811|P2|COMPLETED|Double-Blind Period||99
2621269|NCT00048581|6433812|P1|COMPLETED|Double-Blind Period||223
2621270|NCT00048581|6433810|P3|STARTED|Double-Blind Period||0
2621271|NCT00048581|6433811|P2|STARTED|Double-Blind Period||133
2621272|NCT00048581|6433812|P1|STARTED|Double-Blind Period||258
2621273|NCT00048568|6433979|P3|NOT COMPLETED|Open-Label Period||160
2621274|NCT00048568|6433980|P2|NOT COMPLETED|Open-Label Period||0
2621275|NCT00048568|6433981|P1|NOT COMPLETED|Open-Label Period||0
2621276|NCT00048568|6433979|P3|COMPLETED|Open-Label Period||379
2621277|NCT00048568|6433980|P2|COMPLETED|Open-Label Period||0
2621278|NCT00048568|6433981|P1|COMPLETED|Open-Label Period||0
2621279|NCT00048568|6433979|P3|STARTED|Open-Label Period||539
2621280|NCT00048568|6433980|P2|STARTED|Open-Label Period||0
2621281|NCT00048568|6433981|P1|STARTED|Open-Label Period||0
2621282|NCT00048568|6433979|P3|NOT COMPLETED|Double-Blind Period Days 170 to 365||0
2621283|NCT00048568|6433980|P2|NOT COMPLETED|Double-Blind Period Days 170 to 365||12
2621284|NCT00048568|6433981|P1|NOT COMPLETED|Double-Blind Period Days 170 to 365||16
2621285|NCT00048568|6433979|P3|COMPLETED|Double-Blind Period Days 170 to 365||0
2621286|NCT00048568|6433980|P2|COMPLETED|Double-Blind Period Days 170 to 365||162
2621287|NCT00048568|6433981|P1|COMPLETED|Double-Blind Period Days 170 to 365||385
2621288|NCT00048568|6433979|P3|STARTED|Double-Blind Period Days 170 to 365||0
2621289|NCT00048568|6433980|P2|STARTED|Double-Blind Period Days 170 to 365||174
2621290|NCT00048568|6433981|P1|STARTED|Double-Blind Period Days 170 to 365||401
2621291|NCT00048568|6433979|P3|NOT COMPLETED|Double-Blind Period Days 1 to 169||0
2621292|NCT00048568|6433980|P2|NOT COMPLETED|Double-Blind Period Days 1 to 169||45
2621293|NCT00048568|6433981|P1|NOT COMPLETED|Double-Blind Period Days 1 to 169||32
2621294|NCT00048568|6433979|P3|COMPLETED|Double-Blind Period Days 1 to 169||0
2621295|NCT00048568|6433980|P2|COMPLETED|Double-Blind Period Days 1 to 169||174
2621296|NCT00048568|6433981|P1|COMPLETED|Double-Blind Period Days 1 to 169||401
2621297|NCT00048568|6433979|P3|STARTED|Double-Blind Period Days 1 to 169||0
2621298|NCT00048568|6433980|P2|STARTED|Double-Blind Period Days 1 to 169||219
2621299|NCT00048568|6433981|P1|STARTED|Double-Blind Period Days 1 to 169||433
2621300|NCT00048893|6434269|P1|NOT COMPLETED|Overall Study||0
2621301|NCT00048893|6434269|P1|COMPLETED|Overall Study||37
2621302|NCT00048893|6434269|P1|STARTED|Overall Study||37
2621303|NCT00048737|6434280|P1|NOT COMPLETED|Overall Study||0
2621304|NCT00048737|6434280|P1|COMPLETED|Overall Study||70
2621305|NCT00048737|6434280|P1|STARTED|Overall Study||70
2621306|NCT00048724|6434286|P2|NOT COMPLETED|Overall Study||118
2621307|NCT00048724|6434287|P1|NOT COMPLETED|Overall Study||116
2621308|NCT00048724|6434286|P2|COMPLETED|Overall Study||197
2621309|NCT00048724|6434287|P1|COMPLETED|Overall Study||195
2621310|NCT00048724|6434286|P2|STARTED|Overall Study||315
2621311|NCT00048724|6434287|P1|STARTED|Overall Study||311
2621312|NCT00048542|6434299|P8|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
2621313|NCT00048542|6434300|P7|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
2621314|NCT00048542|6434301|P6|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
2621315|NCT00048542|6434302|P5|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
2621316|NCT00048542|6434303|P4|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
2621317|NCT00048542|6434304|P3|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
2621318|NCT00048542|6434305|P2|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
2621319|NCT00048542|6434306|P1|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
2621320|NCT00048542|6434299|P8|COMPLETED|Open-Label Extension Fixed Dose Phase||25
2621321|NCT00048542|6434300|P7|COMPLETED|Open-Label Extension Fixed Dose Phase||37
2621322|NCT00048542|6434301|P6|COMPLETED|Open-Label Extension Fixed Dose Phase||0
2621323|NCT00048542|6434302|P5|COMPLETED|Open-Label Extension Fixed Dose Phase||0
2621324|NCT00048542|6434303|P4|COMPLETED|Open-Label Extension Fixed Dose Phase||0
2621325|NCT00048542|6434304|P3|COMPLETED|Open-Label Extension Fixed Dose Phase||0
2621326|NCT00048542|6434305|P2|COMPLETED|Open-Label Extension Fixed Dose Phase||0
2621327|NCT00048542|6434306|P1|COMPLETED|Open-Label Extension Fixed Dose Phase||0
2621328|NCT00048542|6434299|P8|STARTED|Open-Label Extension Fixed Dose Phase||47
2621329|NCT00048542|6434300|P7|STARTED|Open-Label Extension Fixed Dose Phase||59
2621330|NCT00048542|6434301|P6|STARTED|Open-Label Extension Fixed Dose Phase||0
2621331|NCT00048542|6434302|P5|STARTED|Open-Label Extension Fixed Dose Phase||0
2621332|NCT00048542|6434303|P4|STARTED|Open-Label Extension Fixed Dose Phase||0
2621333|NCT00048542|6434304|P3|STARTED|Open-Label Extension Fixed Dose Phase||0
2621334|NCT00048542|6434305|P2|STARTED|Open-Label Extension Fixed Dose Phase||0
2621335|NCT00048542|6434306|P1|STARTED|Open-Label Extension Fixed Dose Phase||0
2621336|NCT00048542|6434299|P8|NOT COMPLETED|Open-Label Extension BSA Phase||0
2621337|NCT00048542|6434300|P7|NOT COMPLETED|Open-Label Extension BSA Phase||0
2621338|NCT00048542|6434301|P6|NOT COMPLETED|Open-Label Extension BSA Phase||10
2621339|NCT00048542|6434302|P5|NOT COMPLETED|Open-Label Extension BSA Phase||12
2621340|NCT00048542|6434303|P4|NOT COMPLETED|Open-Label Extension BSA Phase||0
2621341|NCT00048542|6434304|P3|NOT COMPLETED|Open-Label Extension BSA Phase||0
2621342|NCT00048542|6434305|P2|NOT COMPLETED|Open-Label Extension BSA Phase||0
2621343|NCT00048542|6434306|P1|NOT COMPLETED|Open-Label Extension BSA Phase||0
2621344|NCT00048542|6434299|P8|COMPLETED|Open-Label Extension BSA Phase||0
2621345|NCT00048542|6434300|P7|COMPLETED|Open-Label Extension BSA Phase||0
2621346|NCT00048542|6434301|P6|COMPLETED|Open-Label Extension BSA Phase||47
2621347|NCT00048542|6434302|P5|COMPLETED|Open-Label Extension BSA Phase||59
2621348|NCT00048542|6434303|P4|COMPLETED|Open-Label Extension BSA Phase||0
2621349|NCT00048542|6434304|P3|COMPLETED|Open-Label Extension BSA Phase||0
2621350|NCT00048542|6434305|P2|COMPLETED|Open-Label Extension BSA Phase||0
2621351|NCT00048542|6434306|P1|COMPLETED|Open-Label Extension BSA Phase||0
2621352|NCT00048542|6434299|P8|STARTED|Open-Label Extension BSA Phase||0
2621353|NCT00048542|6434300|P7|STARTED|Open-Label Extension BSA Phase||0
2621354|NCT00048542|6434301|P6|STARTED|Open-Label Extension BSA Phase||57
2621355|NCT00048542|6434302|P5|STARTED|Open-Label Extension BSA Phase||71
2621356|NCT00048542|6434303|P4|STARTED|Open-Label Extension BSA Phase||0
2621357|NCT00048542|6434304|P3|STARTED|Open-Label Extension BSA Phase||0
2621358|NCT00048542|6434305|P2|STARTED|Open-Label Extension BSA Phase||0
2621359|NCT00048542|6434306|P1|STARTED|Open-Label Extension BSA Phase||0
2621360|NCT00048542|6434299|P8|NOT COMPLETED|Double-Blind Phase||0
2621361|NCT00048542|6434300|P7|NOT COMPLETED|Double-Blind Phase||0
2621362|NCT00048542|6434301|P6|NOT COMPLETED|Double-Blind Phase||0
2621363|NCT00048542|6434302|P5|NOT COMPLETED|Double-Blind Phase||0
2621364|NCT00048542|6434303|P4|NOT COMPLETED|Double-Blind Phase||0
2621365|NCT00048542|6434304|P3|NOT COMPLETED|Double-Blind Phase||1
2621366|NCT00048542|6434305|P2|NOT COMPLETED|Double-Blind Phase||1
2621367|NCT00048542|6434306|P1|NOT COMPLETED|Double-Blind Phase||3
2621368|NCT00048542|6434299|P8|COMPLETED|Double-Blind Phase||0
2621369|NCT00048542|6434300|P7|COMPLETED|Double-Blind Phase||0
2621370|NCT00048542|6434301|P6|COMPLETED|Double-Blind Phase||0
2621371|NCT00048542|6434302|P5|COMPLETED|Double-Blind Phase||0
2621372|NCT00048542|6434303|P4|COMPLETED|Double-Blind Phase||28
2621373|NCT00048542|6434304|P3|COMPLETED|Double-Blind Phase||29
2621374|NCT00048542|6434305|P2|COMPLETED|Double-Blind Phase||36
2621375|NCT00048542|6434306|P1|COMPLETED|Double-Blind Phase||35
2621376|NCT00048542|6434299|P8|STARTED|Double-Blind Phase||0
2621377|NCT00048542|6434300|P7|STARTED|Double-Blind Phase||0
2621378|NCT00048542|6434301|P6|STARTED|Double-Blind Phase||0
2621379|NCT00048542|6434302|P5|STARTED|Double-Blind Phase||0
2621380|NCT00048542|6434303|P4|STARTED|Double-Blind Phase||28
2621381|NCT00048542|6434304|P3|STARTED|Double-Blind Phase||30
2621382|NCT00048542|6434305|P2|STARTED|Double-Blind Phase||37
2621471|NCT00048048|6434558|P9|COMPLETED|Extension Year 1||0
2621383|NCT00048542|6434306|P1|STARTED|Double-Blind Phase|For all groups, started indicates when the subjects entered the double-blind treatment phase.|38
2621384|NCT00048347|6434372|P1|NOT COMPLETED|Overall Study||2
2621385|NCT00048347|6434372|P1|COMPLETED|Overall Study||16
2621386|NCT00048347|6434372|P1|STARTED|Overall Study||18
2621387|NCT00048165|6434378|P2|NOT COMPLETED|Completed 12 Months Study||3
2621388|NCT00048165|6434379|P1|NOT COMPLETED|Completed 12 Months Study||3
2621389|NCT00048165|6434378|P2|COMPLETED|Completed 12 Months Study||167
2621390|NCT00048165|6434379|P1|COMPLETED|Completed 12 Months Study||162
2621391|NCT00048165|6434378|P2|STARTED|Completed 12 Months Study||170
2621392|NCT00048165|6434379|P1|STARTED|Completed 12 Months Study||165
2621393|NCT00048165|6434378|P2|NOT COMPLETED|Completed 6 Months Study||48
2621394|NCT00048165|6434379|P1|NOT COMPLETED|Completed 6 Months Study||51
2621395|NCT00048165|6434378|P2|COMPLETED|Completed 6 Months Study||170
2621396|NCT00048165|6434379|P1|COMPLETED|Completed 6 Months Study||165
2621397|NCT00048165|6434378|P2|STARTED|Completed 6 Months Study||218
2621398|NCT00048165|6434379|P1|STARTED|Completed 6 Months Study||216
2621399|NCT00048074|6434414|P3|NOT COMPLETED|Overall Study||97
2621400|NCT00048074|6434415|P2|NOT COMPLETED|Overall Study||87
2621401|NCT00048074|6434416|P1|NOT COMPLETED|Overall Study||81
2621402|NCT00048074|6434414|P3|COMPLETED|Overall Study||372
2621403|NCT00048074|6434415|P2|COMPLETED|Overall Study||361
2621404|NCT00048074|6434416|P1|COMPLETED|Overall Study||384
2621405|NCT00048074|6434414|P3|STARTED|Overall Study||469
2621406|NCT00048074|6434415|P2|STARTED|Overall Study||448
2621407|NCT00048074|6434416|P1|STARTED|Overall Study||465
2621408|NCT00048061|6434473|P4|NOT COMPLETED|Overall Study||79
2621409|NCT00048061|6434474|P3|NOT COMPLETED|Overall Study||84
2621410|NCT00048061|6434475|P2|NOT COMPLETED|Overall Study||73
2621411|NCT00048061|6434476|P1|NOT COMPLETED|Overall Study||75
2621412|NCT00048061|6434473|P4|COMPLETED|Overall Study||322
2621413|NCT00048061|6434474|P3|COMPLETED|Overall Study||316
2621414|NCT00048061|6434475|P2|COMPLETED|Overall Study||328
2621415|NCT00048061|6434476|P1|COMPLETED|Overall Study||325
2621416|NCT00048061|6434473|P4|STARTED|Overall Study||401
2621417|NCT00048061|6434474|P3|STARTED|Overall Study||400
2621418|NCT00048061|6434475|P2|STARTED|Overall Study||401
2621419|NCT00048061|6434476|P1|STARTED|Overall Study||400
2621420|NCT00048048|6434555|P12|NOT COMPLETED|Extension Year 2||2
2621421|NCT00048048|6434556|P11|NOT COMPLETED|Extension Year 2||4
2621422|NCT00048048|6434557|P10|NOT COMPLETED|Extension Year 2||0
2621423|NCT00048048|6434558|P9|NOT COMPLETED|Extension Year 2||0
2621424|NCT00048048|6434559|P8|NOT COMPLETED|Extension Year 2||0
2621425|NCT00048048|6434560|P7|NOT COMPLETED|Extension Year 2||0
2621426|NCT00048048|6434561|P6|NOT COMPLETED|Extension Year 2||0
2621427|NCT00048048|6434562|P5|NOT COMPLETED|Extension Year 2||0
2621428|NCT00048048|6434563|P4|NOT COMPLETED|Extension Year 2||0
2621429|NCT00048048|6434564|P3|NOT COMPLETED|Extension Year 2||0
2621430|NCT00048048|6434565|P2|NOT COMPLETED|Extension Year 2||0
2621431|NCT00048048|6434566|P1|NOT COMPLETED|Extension Year 2||0
2621432|NCT00048048|6434555|P12|COMPLETED|Extension Year 2||13
2621433|NCT00048048|6434556|P11|COMPLETED|Extension Year 2||19
2621434|NCT00048048|6434557|P10|COMPLETED|Extension Year 2||2
2621435|NCT00048048|6434558|P9|COMPLETED|Extension Year 2||0
2621436|NCT00048048|6434559|P8|COMPLETED|Extension Year 2||0
2621437|NCT00048048|6434560|P7|COMPLETED|Extension Year 2||0
2621438|NCT00048048|6434561|P6|COMPLETED|Extension Year 2||0
2621439|NCT00048048|6434562|P5|COMPLETED|Extension Year 2||0
2621440|NCT00048048|6434563|P4|COMPLETED|Extension Year 2||0
2621441|NCT00048048|6434564|P3|COMPLETED|Extension Year 2||0
2621442|NCT00048048|6434565|P2|COMPLETED|Extension Year 2||0
2621443|NCT00048048|6434566|P1|COMPLETED|Extension Year 2||0
2621444|NCT00048048|6434555|P12|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|15
2621445|NCT00048048|6434556|P11|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1 + 12 participants from RO0503821 (1X/Week).|23
2621446|NCT00048048|6434557|P10|STARTED|Extension Year 2|Twelve participants who completed Extension Year 1 were switched to RO0503821 (1x/2Week).|2
2621447|NCT00048048|6434558|P9|STARTED|Extension Year 2||0
2621448|NCT00048048|6434559|P8|STARTED|Extension Year 2||0
2621449|NCT00048048|6434560|P7|STARTED|Extension Year 2||0
2621450|NCT00048048|6434561|P6|STARTED|Extension Year 2||0
2621451|NCT00048048|6434562|P5|STARTED|Extension Year 2||0
2621452|NCT00048048|6434563|P4|STARTED|Extension Year 2||0
2621453|NCT00048048|6434564|P3|STARTED|Extension Year 2||0
2621454|NCT00048048|6434565|P2|STARTED|Extension Year 2||0
2621455|NCT00048048|6434566|P1|STARTED|Extension Year 2||0
2621456|NCT00048048|6434555|P12|NOT COMPLETED|Extension Year 1||4
2621457|NCT00048048|6434556|P11|NOT COMPLETED|Extension Year 1||2
2621458|NCT00048048|6434557|P10|NOT COMPLETED|Extension Year 1||2
2621459|NCT00048048|6434558|P9|NOT COMPLETED|Extension Year 1||0
2621460|NCT00048048|6434559|P8|NOT COMPLETED|Extension Year 1||0
2621461|NCT00048048|6434560|P7|NOT COMPLETED|Extension Year 1||0
2621462|NCT00048048|6434561|P6|NOT COMPLETED|Extension Year 1||0
2621463|NCT00048048|6434562|P5|NOT COMPLETED|Extension Year 1||0
2621464|NCT00048048|6434563|P4|NOT COMPLETED|Extension Year 1||0
2621465|NCT00048048|6434564|P3|NOT COMPLETED|Extension Year 1||0
2621466|NCT00048048|6434565|P2|NOT COMPLETED|Extension Year 1||0
2621467|NCT00048048|6434566|P1|NOT COMPLETED|Extension Year 1||0
2621468|NCT00048048|6434555|P12|COMPLETED|Extension Year 1||15
2621469|NCT00048048|6434556|P11|COMPLETED|Extension Year 1||14
2621470|NCT00048048|6434557|P10|COMPLETED|Extension Year 1||14
2621472|NCT00048048|6434559|P8|COMPLETED|Extension Year 1||0
2621473|NCT00048048|6434560|P7|COMPLETED|Extension Year 1||0
2621474|NCT00048048|6434561|P6|COMPLETED|Extension Year 1||0
2621475|NCT00048048|6434562|P5|COMPLETED|Extension Year 1||0
2621476|NCT00048048|6434563|P4|COMPLETED|Extension Year 1||0
2621477|NCT00048048|6434564|P3|COMPLETED|Extension Year 1||0
2621478|NCT00048048|6434565|P2|COMPLETED|Extension Year 1||0
2621479|NCT00048048|6434566|P1|COMPLETED|Extension Year 1||0
2621480|NCT00048048|6434555|P12|STARTED|Extension Year 1|Participants (Cohorts 7, 8, and 9) who completed core, entered extension period (entry optional).|19
2621481|NCT00048048|6434556|P11|STARTED|Extension Year 1|Participants (Cohorts 4, 5, and 6) who completed core, entered extension period (entry optional).|16
2621482|NCT00048048|6434557|P10|STARTED|Extension Year 1|Participants (Cohorts 1, 2, and 3) who completed core, entered extension period (entry optional).|16
2621483|NCT00048048|6434558|P9|STARTED|Extension Year 1||0
2621484|NCT00048048|6434559|P8|STARTED|Extension Year 1||0
2621485|NCT00048048|6434560|P7|STARTED|Extension Year 1||0
2621486|NCT00048048|6434561|P6|STARTED|Extension Year 1||0
2621487|NCT00048048|6434562|P5|STARTED|Extension Year 1||0
2621488|NCT00048048|6434563|P4|STARTED|Extension Year 1||0
2621489|NCT00048048|6434564|P3|STARTED|Extension Year 1||0
2621490|NCT00048048|6434565|P2|STARTED|Extension Year 1||0
2621491|NCT00048048|6434566|P1|STARTED|Extension Year 1||0
2621492|NCT00048048|6434555|P12|NOT COMPLETED|Core Treatment||0
2621493|NCT00048048|6434556|P11|NOT COMPLETED|Core Treatment||0
2621494|NCT00048048|6434557|P10|NOT COMPLETED|Core Treatment||0
2621495|NCT00048048|6434558|P9|NOT COMPLETED|Core Treatment||0
2621496|NCT00048048|6434559|P8|NOT COMPLETED|Core Treatment||1
2621497|NCT00048048|6434560|P7|NOT COMPLETED|Core Treatment||0
2621498|NCT00048048|6434561|P6|NOT COMPLETED|Core Treatment||0
2621499|NCT00048048|6434562|P5|NOT COMPLETED|Core Treatment||0
2621500|NCT00048048|6434563|P4|NOT COMPLETED|Core Treatment||0
2621501|NCT00048048|6434564|P3|NOT COMPLETED|Core Treatment||1
2621502|NCT00048048|6434565|P2|NOT COMPLETED|Core Treatment||0
2621503|NCT00048048|6434566|P1|NOT COMPLETED|Core Treatment||0
2621504|NCT00048048|6434555|P12|COMPLETED|Core Treatment||0
2621505|NCT00048048|6434556|P11|COMPLETED|Core Treatment||0
2621506|NCT00048048|6434557|P10|COMPLETED|Core Treatment||0
2621507|NCT00048048|6434558|P9|COMPLETED|Core Treatment||10
2621508|NCT00048048|6434559|P8|COMPLETED|Core Treatment||5
2621509|NCT00048048|6434560|P7|COMPLETED|Core Treatment||6
2621510|NCT00048048|6434561|P6|COMPLETED|Core Treatment||9
2621511|NCT00048048|6434562|P5|COMPLETED|Core Treatment||6
2621512|NCT00048048|6434563|P4|COMPLETED|Core Treatment||6
2621513|NCT00048048|6434564|P3|COMPLETED|Core Treatment||9
2621514|NCT00048048|6434565|P2|COMPLETED|Core Treatment||6
2621515|NCT00048048|6434566|P1|COMPLETED|Core Treatment||6
2621516|NCT00048048|6434555|P12|STARTED|Core Treatment||0
2621517|NCT00048048|6434556|P11|STARTED|Core Treatment||0
2621518|NCT00048048|6434557|P10|STARTED|Core Treatment||0
2621519|NCT00048048|6434558|P9|STARTED|Core Treatment||10
2621520|NCT00048048|6434559|P8|STARTED|Core Treatment||6
2621521|NCT00048048|6434560|P7|STARTED|Core Treatment||6
2621522|NCT00048048|6434561|P6|STARTED|Core Treatment||9
2621523|NCT00048048|6434562|P5|STARTED|Core Treatment||6
2621524|NCT00048048|6434563|P4|STARTED|Core Treatment||6
2621525|NCT00048048|6434564|P3|STARTED|Core Treatment||10
2621526|NCT00048048|6434565|P2|STARTED|Core Treatment||6
2621527|NCT00048048|6434566|P1|STARTED|Core Treatment||6
2621528|NCT00048035|6434622|P8|NOT COMPLETED|Extension Year 2||3
2621529|NCT00048035|6434623|P7|NOT COMPLETED|Extension Year 2||3
2621530|NCT00048035|6434624|P6|NOT COMPLETED|Extension Year 2||0
2621531|NCT00048035|6434625|P5|NOT COMPLETED|Extension Year 2||0
2621532|NCT00048035|6434626|P4|NOT COMPLETED|Extension Year 2||0
2621533|NCT00048035|6434627|P3|NOT COMPLETED|Extension Year 2||0
2621534|NCT00048035|6434628|P2|NOT COMPLETED|Extension Year 2||0
2621535|NCT00048035|6434629|P1|NOT COMPLETED|Extension Year 2||0
2621536|NCT00048035|6434622|P8|COMPLETED|Extension Year 2||10
2621537|NCT00048035|6434623|P7|COMPLETED|Extension Year 2||11
2621538|NCT00048035|6434624|P6|COMPLETED|Extension Year 2||0
2621539|NCT00048035|6434625|P5|COMPLETED|Extension Year 2||0
2621540|NCT00048035|6434626|P4|COMPLETED|Extension Year 2||0
2621541|NCT00048035|6434627|P3|COMPLETED|Extension Year 2||0
2621542|NCT00048035|6434628|P2|COMPLETED|Extension Year 2||0
2621543|NCT00048035|6434629|P1|COMPLETED|Extension Year 2||0
2621544|NCT00048035|6434622|P8|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|13
2621545|NCT00048035|6434623|P7|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
2621546|NCT00048035|6434624|P6|STARTED|Extension Year 2||0
2621547|NCT00048035|6434625|P5|STARTED|Extension Year 2||0
2621548|NCT00048035|6434626|P4|STARTED|Extension Year 2||0
2621549|NCT00048035|6434627|P3|STARTED|Extension Year 2||0
2621550|NCT00048035|6434628|P2|STARTED|Extension Year 2||0
2621551|NCT00048035|6434629|P1|STARTED|Extension Year 2||0
2621552|NCT00048035|6434622|P8|NOT COMPLETED|Extension Year 1||11
2621553|NCT00048035|6434623|P7|NOT COMPLETED|Extension Year 1||11
2621554|NCT00048035|6434624|P6|NOT COMPLETED|Extension Year 1||0
2621555|NCT00048035|6434625|P5|NOT COMPLETED|Extension Year 1||0
2621556|NCT00048035|6434626|P4|NOT COMPLETED|Extension Year 1||0
2621557|NCT00048035|6434627|P3|NOT COMPLETED|Extension Year 1||0
2621558|NCT00048035|6434628|P2|NOT COMPLETED|Extension Year 1||0
2621559|NCT00048035|6434629|P1|NOT COMPLETED|Extension Year 1||0
2621560|NCT00048035|6434622|P8|COMPLETED|Extension Year 1||15
2621561|NCT00048035|6434623|P7|COMPLETED|Extension Year 1||16
2621562|NCT00048035|6434624|P6|COMPLETED|Extension Year 1||0
2621563|NCT00048035|6434625|P5|COMPLETED|Extension Year 1||0
2621564|NCT00048035|6434626|P4|COMPLETED|Extension Year 1||0
2621565|NCT00048035|6434627|P3|COMPLETED|Extension Year 1||0
2621566|NCT00048035|6434628|P2|COMPLETED|Extension Year 1||0
2621567|NCT00048035|6434629|P1|COMPLETED|Extension Year 1||0
2621568|NCT00048035|6434622|P8|STARTED|Extension Year 1|Participants (Cohorts 2, 4 and 6) who completed core, entered extension period (entry optional).|26
2621569|NCT00048035|6434623|P7|STARTED|Extension Year 1|Participants (Cohorts 1, 3, and 5) who completed core, entered extension period (entry optional).|27
2621570|NCT00048035|6434624|P6|STARTED|Extension Year 1||0
2621571|NCT00048035|6434625|P5|STARTED|Extension Year 1||0
2621572|NCT00048035|6434626|P4|STARTED|Extension Year 1||0
2621573|NCT00048035|6434627|P3|STARTED|Extension Year 1||0
2621574|NCT00048035|6434628|P2|STARTED|Extension Year 1||0
2621575|NCT00048035|6434629|P1|STARTED|Extension Year 1||0
2621576|NCT00048035|6434622|P8|NOT COMPLETED|Core Period||0
2621577|NCT00048035|6434623|P7|NOT COMPLETED|Core Period||0
2621578|NCT00048035|6434624|P6|NOT COMPLETED|Core Period||1
2621579|NCT00048035|6434625|P5|NOT COMPLETED|Core Period||1
2621580|NCT00048035|6434626|P4|NOT COMPLETED|Core Period||1
2621581|NCT00048035|6434627|P3|NOT COMPLETED|Core Period||1
2621582|NCT00048035|6434628|P2|NOT COMPLETED|Core Period||2
2621583|NCT00048035|6434629|P1|NOT COMPLETED|Core Period||4
2621584|NCT00048035|6434622|P8|COMPLETED|Core Period||0
2621585|NCT00048035|6434623|P7|COMPLETED|Core Period||0
2621586|NCT00048035|6434624|P6|COMPLETED|Core Period||14
2621587|NCT00048035|6434625|P5|COMPLETED|Core Period||15
2621588|NCT00048035|6434626|P4|COMPLETED|Core Period||14
2621589|NCT00048035|6434627|P3|COMPLETED|Core Period||14
2621590|NCT00048035|6434628|P2|COMPLETED|Core Period||13
2621591|NCT00048035|6434629|P1|COMPLETED|Core Period||11
2621592|NCT00048035|6434622|P8|STARTED|Core Period||0
2621593|NCT00048035|6434623|P7|STARTED|Core Period||0
2621594|NCT00048035|6434624|P6|STARTED|Core Period||15
2621595|NCT00048035|6434625|P5|STARTED|Core Period||16
2621596|NCT00048035|6434626|P4|STARTED|Core Period||15
2621597|NCT00048035|6434627|P3|STARTED|Core Period||15
2621598|NCT00048035|6434628|P2|STARTED|Core Period||15
2621599|NCT00048035|6434629|P1|STARTED|Core Period||15
2621600|NCT00047879|6434667|P2|NOT COMPLETED|Overall Study||3
2621601|NCT00047879|6434668|P1|NOT COMPLETED|Overall Study||4
2621602|NCT00047879|6434667|P2|COMPLETED|Overall Study||0
2621603|NCT00047879|6434668|P1|COMPLETED|Overall Study||0
2621604|NCT00047879|6434667|P2|STARTED|Overall Study||3
2621605|NCT00047879|6434668|P1|STARTED|Overall Study||4
2621606|NCT00047697|6434680|P2|NOT COMPLETED|Overall Study||2
2621607|NCT00047697|6434681|P1|NOT COMPLETED|Overall Study||0
2621608|NCT00047697|6434680|P2|COMPLETED|Overall Study||14
2621609|NCT00047697|6434681|P1|COMPLETED|Overall Study||18
2621610|NCT00047697|6434680|P2|STARTED|Overall Study||16
2621611|NCT00047697|6434681|P1|STARTED|Overall Study||18
2621612|NCT00047619|6434693|P2|NOT COMPLETED|Overall Study||0
2621613|NCT00047619|6434694|P1|NOT COMPLETED|Overall Study||0
2621614|NCT00047619|6434693|P2|COMPLETED|Overall Study||14
2621615|NCT00047619|6434694|P1|COMPLETED|Overall Study||14
2621616|NCT00047619|6434693|P2|STARTED|Overall Study||14
2621617|NCT00047619|6434694|P1|STARTED|Overall Study||14
2621618|NCT00047463|6434704|P2|NOT COMPLETED|Overall Study||3
2621619|NCT00047463|6434705|P1|NOT COMPLETED|Overall Study||0
2621620|NCT00047463|6434704|P2|COMPLETED|Overall Study||19
2621621|NCT00047463|6434705|P1|COMPLETED|Overall Study||13
2621622|NCT00047463|6434704|P2|STARTED|Overall Study||22
2621623|NCT00047463|6434705|P1|STARTED|Overall Study||13
2621624|NCT00046475|6434716|P3|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
2621625|NCT00046475|6434717|P2|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||1
2621626|NCT00046475|6434718|P1|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
2621627|NCT00046475|6434716|P3|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||59
2621628|NCT00046475|6434717|P2|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||44
2621629|NCT00046475|6434718|P1|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
2621630|NCT00046475|6434716|P3|STARTED|Treatment Period 2 (Up to 2 Weeks)||59
2621631|NCT00046475|6434717|P2|STARTED|Treatment Period 2 (Up to 2 Weeks)||45
2621632|NCT00046475|6434718|P1|STARTED|Treatment Period 2 (Up to 2 Weeks)||0
2621633|NCT00046475|6434716|P3|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||1
2621634|NCT00046475|6434717|P2|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
2621635|NCT00046475|6434718|P1|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
2621636|NCT00046475|6434716|P3|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||59
2621637|NCT00046475|6434717|P2|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||45
2621638|NCT00046475|6434718|P1|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
2621639|NCT00046475|6434716|P3|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|60
2621640|NCT00046475|6434717|P2|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|45
2621641|NCT00046475|6434718|P1|STARTED|Treatment Period 1 (Up to 2 Weeks)||0
2621642|NCT00046475|6434716|P3|NOT COMPLETED|Titration (1 Week)||0
2621643|NCT00046475|6434717|P2|NOT COMPLETED|Titration (1 Week)||0
2621644|NCT00046475|6434718|P1|NOT COMPLETED|Titration (1 Week)||0
2621645|NCT00046475|6434716|P3|COMPLETED|Titration (1 Week)||0
2621646|NCT00046475|6434717|P2|COMPLETED|Titration (1 Week)||0
2621647|NCT00046475|6434718|P1|COMPLETED|Titration (1 Week)||136
2621648|NCT00046475|6434716|P3|STARTED|Titration (1 Week)||0
2621649|NCT00046475|6434717|P2|STARTED|Titration (1 Week)||0
2621650|NCT00046475|6434718|P1|STARTED|Titration (1 Week)||136
2621651|NCT00046475|6434716|P3|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
2621652|NCT00046475|6434717|P2|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
2621653|NCT00046475|6434718|P1|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||4
2621654|NCT00046475|6434716|P3|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
2621655|NCT00046475|6434717|P2|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
2621656|NCT00046475|6434718|P1|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||136
2621657|NCT00046475|6434716|P3|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
2621658|NCT00046475|6434717|P2|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
2621659|NCT00046475|6434718|P1|STARTED|Screening/Washout Period (Up to 2 Weeks)||140
2621660|NCT00046566|6434757|P3|NOT COMPLETED|Intervention 3 (8 Weeks)||0
2621661|NCT00046566|6434758|P2|NOT COMPLETED|Intervention 3 (8 Weeks)||0
2621662|NCT00046566|6434759|P1|NOT COMPLETED|Intervention 3 (8 Weeks)||0
2621663|NCT00046566|6434757|P3|COMPLETED|Intervention 3 (8 Weeks)||88
2621664|NCT00046566|6434758|P2|COMPLETED|Intervention 3 (8 Weeks)||92
2621665|NCT00046566|6434759|P1|COMPLETED|Intervention 3 (8 Weeks)||93
2621666|NCT00046566|6434757|P3|STARTED|Intervention 3 (8 Weeks)||88
2621667|NCT00046566|6434758|P2|STARTED|Intervention 3 (8 Weeks)||92
2621668|NCT00046566|6434759|P1|STARTED|Intervention 3 (8 Weeks)||93
2621669|NCT00046566|6434757|P3|NOT COMPLETED|Intervention 2 (8 Weeks)||13
2621670|NCT00046566|6434758|P2|NOT COMPLETED|Intervention 2 (8 Weeks)||12
2621671|NCT00046566|6434759|P1|NOT COMPLETED|Intervention 2 (8 Weeks)||8
2621672|NCT00046566|6434757|P3|COMPLETED|Intervention 2 (8 Weeks)||88
2621673|NCT00046566|6434758|P2|COMPLETED|Intervention 2 (8 Weeks)||92
2621674|NCT00046566|6434759|P1|COMPLETED|Intervention 2 (8 Weeks)||93
2621675|NCT00046566|6434757|P3|STARTED|Intervention 2 (8 Weeks)|Soy protein 8 weeks|101
2621676|NCT00046566|6434758|P2|STARTED|Intervention 2 (8 Weeks)|Carbohydrate 8 weeks|104
2621677|NCT00046566|6434759|P1|STARTED|Intervention 2 (8 Weeks)|Milk protein 8 weeks|101
2621678|NCT00046566|6434757|P3|NOT COMPLETED|Intervention 1 (8 Weeks)||17
2621679|NCT00046566|6434758|P2|NOT COMPLETED|Intervention 1 (8 Weeks)||13
2621680|NCT00046566|6434759|P1|NOT COMPLETED|Intervention 1 (8 Weeks)||16
2621681|NCT00046566|6434757|P3|COMPLETED|Intervention 1 (8 Weeks)||101
2621682|NCT00046566|6434758|P2|COMPLETED|Intervention 1 (8 Weeks)||104
2621683|NCT00046566|6434759|P1|COMPLETED|Intervention 1 (8 Weeks)||101
2621684|NCT00046566|6434757|P3|STARTED|Intervention 1 (8 Weeks)|Carbohydrate 8 weeks|118
2621685|NCT00046566|6434758|P2|STARTED|Intervention 1 (8 Weeks)|Milk protein 8 weeks|117
2621686|NCT00046566|6434759|P1|STARTED|Intervention 1 (8 Weeks)|Soy protein 8 weeks|117
2621687|NCT00046228|6434776|P3|NOT COMPLETED|1 Year||12
2621688|NCT00046228|6434777|P2|NOT COMPLETED|1 Year||14
2621689|NCT00046228|6434778|P1|NOT COMPLETED|1 Year||19
2621690|NCT00046228|6434776|P3|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window|816
2621691|NCT00046228|6434777|P2|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|804
2621692|NCT00046228|6434778|P1|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|787
2621693|NCT00046228|6434776|P3|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|828
2621694|NCT00046228|6434777|P2|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|818
2621695|NCT00046228|6434778|P1|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|806
2621696|NCT00046228|6434776|P3|NOT COMPLETED|90 Days||15
2621697|NCT00046228|6434777|P2|NOT COMPLETED|90 Days||8
2621698|NCT00046228|6434778|P1|NOT COMPLETED|90 Days||13
2621699|NCT00046228|6434776|P3|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|813
2621700|NCT00046228|6434777|P2|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|810
2621701|NCT00046228|6434778|P1|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|793
2621702|NCT00046228|6434776|P3|STARTED|90 Days||828
2621703|NCT00046228|6434777|P2|STARTED|90 Days||818
2621704|NCT00046228|6434778|P1|STARTED|90 Days||806
2621705|NCT00045942|6434822|P9|NOT COMPLETED|PKC412A2104E2||6
2621706|NCT00045942|6434823|P8|NOT COMPLETED|PKC412A2104E2||7
2621707|NCT00045942|6434824|P7|NOT COMPLETED|PKC412A2104E2||7
2621708|NCT00045942|6434825|P6|NOT COMPLETED|PKC412A2104E2||9
2621709|NCT00045942|6434826|P5|NOT COMPLETED|PKC412A2104E2||0
2621710|NCT00045942|6434827|P4|NOT COMPLETED|PKC412A2104E2||0
2621711|NCT00045942|6434828|P3|NOT COMPLETED|PKC412A2104E2||0
2621712|NCT00045942|6434829|P2|NOT COMPLETED|PKC412A2104E2||0
2621713|NCT00045942|6434830|P1|NOT COMPLETED|PKC412A2104E2||0
2621714|NCT00045942|6434822|P9|COMPLETED|PKC412A2104E2||0
2621715|NCT00045942|6434823|P8|COMPLETED|PKC412A2104E2||0
2621716|NCT00045942|6434824|P7|COMPLETED|PKC412A2104E2||0
2621717|NCT00045942|6434825|P6|COMPLETED|PKC412A2104E2||0
2621718|NCT00045942|6434826|P5|COMPLETED|PKC412A2104E2||0
2621719|NCT00045942|6434827|P4|COMPLETED|PKC412A2104E2||0
2621720|NCT00045942|6434828|P3|COMPLETED|PKC412A2104E2||0
2621721|NCT00045942|6434829|P2|COMPLETED|PKC412A2104E2||0
2621722|NCT00045942|6434830|P1|COMPLETED|PKC412A2104E2||0
2621723|NCT00045942|6434822|P9|Primary Efficacy|PKC412A2104E2||6
2621724|NCT00045942|6434823|P8|Primary Efficacy|PKC412A2104E2||7
2621725|NCT00045942|6434824|P7|Primary Efficacy|PKC412A2104E2||7
2621726|NCT00045942|6434825|P6|Primary Efficacy|PKC412A2104E2||9
2621727|NCT00045942|6434826|P5|Primary Efficacy|PKC412A2104E2||0
2621728|NCT00045942|6434827|P4|Primary Efficacy|PKC412A2104E2||0
2621729|NCT00045942|6434828|P3|Primary Efficacy|PKC412A2104E2||0
2621730|NCT00045942|6434829|P2|Primary Efficacy|PKC412A2104E2||0
2621731|NCT00045942|6434830|P1|Primary Efficacy|PKC412A2104E2||0
2621732|NCT00045942|6434822|P9|STARTED|PKC412A2104E2||6
2621733|NCT00045942|6434823|P8|STARTED|PKC412A2104E2||7
2621734|NCT00045942|6434824|P7|STARTED|PKC412A2104E2||7
2621735|NCT00045942|6434825|P6|STARTED|PKC412A2104E2||9
2621736|NCT00045942|6434826|P5|STARTED|PKC412A2104E2||0
2621737|NCT00045942|6434827|P4|STARTED|PKC412A2104E2||0
2621738|NCT00045942|6434828|P3|STARTED|PKC412A2104E2||0
2621739|NCT00045942|6434829|P2|STARTED|PKC412A2104E2||0
2621740|NCT00045942|6434830|P1|STARTED|PKC412A2104E2||0
2621741|NCT00045942|6434822|P9|NOT COMPLETED|PKC412A2104E1||0
2621742|NCT00045942|6434823|P8|NOT COMPLETED|PKC412A2104E1||0
2621743|NCT00045942|6434824|P7|NOT COMPLETED|PKC412A2104E1||0
2621744|NCT00045942|6434825|P6|NOT COMPLETED|PKC412A2104E1||0
2621745|NCT00045942|6434826|P5|NOT COMPLETED|PKC412A2104E1||27
2621746|NCT00045942|6434827|P4|NOT COMPLETED|PKC412A2104E1||33
2621747|NCT00045942|6434828|P3|NOT COMPLETED|PKC412A2104E1||17
2621748|NCT00045942|6434829|P2|NOT COMPLETED|PKC412A2104E1||18
2621749|NCT00045942|6434830|P1|NOT COMPLETED|PKC412A2104E1||0
2621750|NCT00045942|6434822|P9|COMPLETED|PKC412A2104E1||0
2621751|NCT00045942|6434823|P8|COMPLETED|PKC412A2104E1||0
2621752|NCT00045942|6434824|P7|COMPLETED|PKC412A2104E1||0
2621753|NCT00045942|6434825|P6|COMPLETED|PKC412A2104E1||0
2621754|NCT00045942|6434826|P5|COMPLETED|PKC412A2104E1||0
2621755|NCT00045942|6434827|P4|COMPLETED|PKC412A2104E1||0
2621756|NCT00045942|6434828|P3|COMPLETED|PKC412A2104E1||0
2621757|NCT00045942|6434829|P2|COMPLETED|PKC412A2104E1||0
2621758|NCT00045942|6434830|P1|COMPLETED|PKC412A2104E1||0
2621759|NCT00045942|6434822|P9|Primary Efficacy|PKC412A2104E1||0
2621760|NCT00045942|6434823|P8|Primary Efficacy|PKC412A2104E1||0
2621761|NCT00045942|6434824|P7|Primary Efficacy|PKC412A2104E1||0
2621762|NCT00045942|6434825|P6|Primary Efficacy|PKC412A2104E1||0
2621763|NCT00045942|6434826|P5|Primary Efficacy|PKC412A2104E1||25
2621764|NCT00045942|6434827|P4|Primary Efficacy|PKC412A2104E1||32
2621765|NCT00045942|6434828|P3|Primary Efficacy|PKC412A2104E1||17
2621766|NCT00045942|6434829|P2|Primary Efficacy|PKC412A2104E1||18
2621767|NCT00045942|6434830|P1|Primary Efficacy|PKC412A2104E1||0
2621768|NCT00045942|6434822|P9|STARTED|PKC412A2104E1||0
2621769|NCT00045942|6434823|P8|STARTED|PKC412A2104E1||0
2621770|NCT00045942|6434824|P7|STARTED|PKC412A2104E1||0
2621771|NCT00045942|6434825|P6|STARTED|PKC412A2104E1||0
2621772|NCT00045942|6434826|P5|STARTED|PKC412A2104E1||27
2621773|NCT00045942|6434827|P4|STARTED|PKC412A2104E1||33
2621774|NCT00045942|6434828|P3|STARTED|PKC412A2104E1||17
2621775|NCT00045942|6434829|P2|STARTED|PKC412A2104E1||18
2621776|NCT00045942|6434830|P1|STARTED|PKC412A2104E1||0
2621777|NCT00045942|6434822|P9|NOT COMPLETED|PKC412A2104 (Core)||0
2621778|NCT00045942|6434823|P8|NOT COMPLETED|PKC412A2104 (Core)||0
2621779|NCT00045942|6434824|P7|NOT COMPLETED|PKC412A2104 (Core)||0
2621780|NCT00045942|6434825|P6|NOT COMPLETED|PKC412A2104 (Core)||0
2621781|NCT00045942|6434826|P5|NOT COMPLETED|PKC412A2104 (Core)||0
2621782|NCT00045942|6434827|P4|NOT COMPLETED|PKC412A2104 (Core)||0
2621783|NCT00045942|6434828|P3|NOT COMPLETED|PKC412A2104 (Core)||0
2621784|NCT00045942|6434829|P2|NOT COMPLETED|PKC412A2104 (Core)||0
2621785|NCT00045942|6434830|P1|NOT COMPLETED|PKC412A2104 (Core)||20
2621786|NCT00045942|6434822|P9|COMPLETED|PKC412A2104 (Core)||0
2621787|NCT00045942|6434823|P8|COMPLETED|PKC412A2104 (Core)||0
2621788|NCT00045942|6434824|P7|COMPLETED|PKC412A2104 (Core)||0
2621789|NCT00045942|6434825|P6|COMPLETED|PKC412A2104 (Core)||0
2621790|NCT00045942|6434826|P5|COMPLETED|PKC412A2104 (Core)||0
2621791|NCT00045942|6434827|P4|COMPLETED|PKC412A2104 (Core)||0
2621792|NCT00045942|6434828|P3|COMPLETED|PKC412A2104 (Core)||0
2621793|NCT00045942|6434829|P2|COMPLETED|PKC412A2104 (Core)||0
2621794|NCT00045942|6434830|P1|COMPLETED|PKC412A2104 (Core)||0
2621795|NCT00045942|6434822|P9|Core Primary Efficacy|PKC412A2104 (Core)||0
2621796|NCT00045942|6434823|P8|Core Primary Efficacy|PKC412A2104 (Core)||0
2621797|NCT00045942|6434824|P7|Core Primary Efficacy|PKC412A2104 (Core)||0
2621798|NCT00045942|6434825|P6|Core Primary Efficacy|PKC412A2104 (Core)||0
2621799|NCT00045942|6434826|P5|Core Primary Efficacy|PKC412A2104 (Core)||0
2621800|NCT00045942|6434827|P4|Core Primary Efficacy|PKC412A2104 (Core)||0
2621801|NCT00045942|6434828|P3|Core Primary Efficacy|PKC412A2104 (Core)||0
2621802|NCT00045942|6434829|P2|Core Primary Efficacy|PKC412A2104 (Core)||0
2621803|NCT00045942|6434830|P1|Core Primary Efficacy|PKC412A2104 (Core)||20
2621804|NCT00045942|6434822|P9|STARTED|PKC412A2104 (Core)||0
2621805|NCT00045942|6434823|P8|STARTED|PKC412A2104 (Core)||0
2621806|NCT00045942|6434824|P7|STARTED|PKC412A2104 (Core)||0
2621807|NCT00045942|6434825|P6|STARTED|PKC412A2104 (Core)||0
2621808|NCT00045942|6434826|P5|STARTED|PKC412A2104 (Core)||0
2621809|NCT00045942|6434827|P4|STARTED|PKC412A2104 (Core)||0
2621810|NCT00045942|6434828|P3|STARTED|PKC412A2104 (Core)||0
2621811|NCT00045942|6434829|P2|STARTED|PKC412A2104 (Core)||0
2621812|NCT00045942|6434830|P1|STARTED|PKC412A2104 (Core)||20
2621813|NCT00044655|6434912|P2|NOT COMPLETED|Overall Study||38
2621814|NCT00044655|6434913|P1|NOT COMPLETED|Overall Study||20
2621815|NCT00044655|6434912|P2|COMPLETED|Overall Study||79
2621816|NCT00044655|6434913|P1|COMPLETED|Overall Study||82
2621817|NCT00044655|6434912|P2|STARTED|Overall Study||117
2621818|NCT00044655|6434913|P1|STARTED|Overall Study||102
2621819|NCT00044512|6434919|P1|NOT COMPLETED|Follow Up||2
2621820|NCT00044512|6434919|P1|COMPLETED|Follow Up||135
2621821|NCT00044512|6434919|P1|STARTED|Follow Up||137
2621822|NCT00044512|6434919|P1|NOT COMPLETED|Treatment||0
2621823|NCT00044512|6434919|P1|COMPLETED|Treatment||137
2621824|NCT00044512|6434919|P1|STARTED|Treatment||137
2621825|NCT00044213|6434934|P4|NOT COMPLETED|Overall Study||136
2621826|NCT00044213|6434935|P3|NOT COMPLETED|Overall Study||138
2621827|NCT00044213|6434936|P2|NOT COMPLETED|Overall Study||112
2621828|NCT00044213|6434937|P1|NOT COMPLETED|Overall Study||100
2621829|NCT00044213|6434934|P4|COMPLETED|Overall Study||301
2621830|NCT00044213|6434935|P3|COMPLETED|Overall Study||294
2621831|NCT00044213|6434936|P2|COMPLETED|Overall Study||306
2621832|NCT00044213|6434937|P1|COMPLETED|Overall Study||321
2621833|NCT00044213|6434934|P4|STARTED|Overall Study||437
2621834|NCT00044213|6434935|P3|STARTED|Overall Study||432
2621835|NCT00044213|6434936|P2|STARTED|Overall Study||418
2621836|NCT00044213|6434937|P1|STARTED|Overall Study||421
2621837|NCT00044044|6434956|P5|NOT COMPLETED|Overall Study||36
2621838|NCT00044044|6434957|P4|NOT COMPLETED|Overall Study||44
2621839|NCT00044044|6434958|P3|NOT COMPLETED|Overall Study||40
2621840|NCT00044044|6434959|P2|NOT COMPLETED|Overall Study||41
2621841|NCT00044044|6434960|P1|NOT COMPLETED|Overall Study||44
2621842|NCT00044044|6434956|P5|COMPLETED|Overall Study||36
2621843|NCT00044044|6434957|P4|COMPLETED|Overall Study||29
2621844|NCT00044044|6434958|P3|COMPLETED|Overall Study||31
2621845|NCT00044044|6434959|P2|COMPLETED|Overall Study||28
2621846|NCT00044044|6434960|P1|COMPLETED|Overall Study||27
2621847|NCT00044044|6434956|P5|STARTED|Overall Study||72
2621848|NCT00044044|6434957|P4|STARTED|Overall Study||73
2621849|NCT00044044|6434958|P3|STARTED|Overall Study||71
2621850|NCT00044044|6434959|P2|STARTED|Overall Study||69
2621851|NCT00044044|6434960|P1|STARTED|Overall Study||71
2621852|NCT00044005|6434990|P3|NOT COMPLETED|Overall Study||22
2621853|NCT00044005|6434991|P2|NOT COMPLETED|Overall Study||14
2621854|NCT00044005|6434992|P1|NOT COMPLETED|Overall Study||19
2621855|NCT00044005|6434990|P3|COMPLETED|Overall Study||11
2621856|NCT00044005|6434991|P2|COMPLETED|Overall Study||19
2621857|NCT00044005|6434992|P1|COMPLETED|Overall Study||13
2621858|NCT00044005|6434990|P3|STARTED|Overall Study||33
2621859|NCT00044005|6434991|P2|STARTED|Overall Study||33
2621860|NCT00044005|6434992|P1|STARTED|Overall Study||32
2621861|NCT00044083|6435002|P2|NOT COMPLETED|Second Intervention (One Week) Patients||1
2621862|NCT00044083|6435003|P1|NOT COMPLETED|Second Intervention (One Week) Patients||0
2621863|NCT00044083|6435002|P2|COMPLETED|Second Intervention (One Week) Patients||29
2621864|NCT00044083|6435003|P1|COMPLETED|Second Intervention (One Week) Patients||30
2621865|NCT00044083|6435002|P2|STARTED|Second Intervention (One Week) Patients||30
2621866|NCT00044083|6435003|P1|STARTED|Second Intervention (One Week) Patients||30
2621867|NCT00044083|6435002|P2|NOT COMPLETED|First Intervention (One Week) Patients||2
2621868|NCT00044083|6435003|P1|NOT COMPLETED|First Intervention (One Week) Patients||1
2621869|NCT00044083|6435002|P2|COMPLETED|First Intervention (One Week) Patients||30
2621870|NCT00044083|6435003|P1|COMPLETED|First Intervention (One Week) Patients||30
2621871|NCT00044083|6435002|P2|STARTED|First Intervention (One Week) Patients||32
2621872|NCT00044083|6435003|P1|STARTED|First Intervention (One Week) Patients||31
2621873|NCT00044083|6435002|P2|NOT COMPLETED|Second Intervention (One Week) HV's||0
2621874|NCT00044083|6435003|P1|NOT COMPLETED|Second Intervention (One Week) HV's||0
2621875|NCT00044083|6435002|P2|COMPLETED|Second Intervention (One Week) HV's||66
2621876|NCT00044083|6435003|P1|COMPLETED|Second Intervention (One Week) HV's||64
2621877|NCT00044083|6435002|P2|STARTED|Second Intervention (One Week) HV's||66
2621878|NCT00044083|6435003|P1|STARTED|Second Intervention (One Week) HV's||64
2621879|NCT00044083|6435002|P2|NOT COMPLETED|First Intervention (One Week)- HV's||7
2621880|NCT00044083|6435003|P1|NOT COMPLETED|First Intervention (One Week)- HV's||10
2621881|NCT00044083|6435002|P2|COMPLETED|First Intervention (One Week)- HV's||66
2621882|NCT00044083|6435003|P1|COMPLETED|First Intervention (One Week)- HV's||64
2621883|NCT00044083|6435002|P2|STARTED|First Intervention (One Week)- HV's||73
2621884|NCT00044083|6435003|P1|STARTED|First Intervention (One Week)- HV's||74
2621885|NCT00043979|6435041|P3|NOT COMPLETED|Period 2||0
2621886|NCT00043979|6435042|P2|NOT COMPLETED|Period 2||0
2621887|NCT00043979|6435043|P1|NOT COMPLETED|Period 2||0
2621888|NCT00043979|6435041|P3|COMPLETED|Period 2||10
2621889|NCT00043979|6435042|P2|COMPLETED|Period 2||13
2621890|NCT00043979|6435043|P1|COMPLETED|Period 2||0
2621891|NCT00043979|6435041|P3|STARTED|Period 2||10
2621892|NCT00043979|6435042|P2|STARTED|Period 2||13
2621893|NCT00043979|6435043|P1|STARTED|Period 2||0
2621894|NCT00043979|6435041|P3|NOT COMPLETED|Period 1||3
2621895|NCT00043979|6435042|P2|NOT COMPLETED|Period 1||4
2621896|NCT00043979|6435043|P1|NOT COMPLETED|Period 1||7
2621897|NCT00043979|6435041|P3|COMPLETED|Period 1||10
2621898|NCT00043979|6435042|P2|COMPLETED|Period 1||13
2621899|NCT00043979|6435043|P1|COMPLETED|Period 1||23
2621900|NCT00043979|6435041|P3|STARTED|Period 1||13
2621901|NCT00043979|6435042|P2|STARTED|Period 1||17
2621902|NCT00043979|6435043|P1|STARTED|Period 1||30
2621903|NCT00043550|6435064|P3|NOT COMPLETED|Overall Study||20
2621904|NCT00043550|6435065|P2|NOT COMPLETED|Overall Study||12
2621905|NCT00043550|6435066|P1|NOT COMPLETED|Overall Study||22
2621906|NCT00043550|6435064|P3|COMPLETED|Overall Study||30
2621907|NCT00043550|6435065|P2|COMPLETED|Overall Study||39
2621908|NCT00043550|6435066|P1|COMPLETED|Overall Study||33
2621909|NCT00043550|6435064|P3|Week 8 Completed|Overall Study||35
2621910|NCT00043550|6435065|P2|Week 8 Completed|Overall Study||40
2621911|NCT00043550|6435066|P1|Week 8 Completed|Overall Study||35
2621912|NCT00043550|6435064|P3|STARTED|Overall Study||50
2621913|NCT00043550|6435065|P2|STARTED|Overall Study||51
2621914|NCT00043550|6435066|P1|STARTED|Overall Study||55
2621915|NCT00043186|6435083|P9|NOT COMPLETED|Overall Study||17
2621916|NCT00043186|6435084|P8|NOT COMPLETED|Overall Study||16
2621917|NCT00043186|6435085|P7|NOT COMPLETED|Overall Study||17
2621918|NCT00043186|6435086|P6|NOT COMPLETED|Overall Study||8
2621919|NCT00043186|6435087|P5|NOT COMPLETED|Overall Study||18
2621920|NCT00043186|6435088|P4|NOT COMPLETED|Overall Study||22
2621921|NCT00043186|6435089|P3|NOT COMPLETED|Overall Study||20
2621922|NCT00043186|6435090|P2|NOT COMPLETED|Overall Study||15
2621923|NCT00043186|6435091|P1|NOT COMPLETED|Overall Study||17
2621924|NCT00043186|6435083|P9|COMPLETED|Overall Study||30
2621925|NCT00043186|6435084|P8|COMPLETED|Overall Study||31
2621926|NCT00043186|6435085|P7|COMPLETED|Overall Study||25
2621927|NCT00043186|6435086|P6|COMPLETED|Overall Study||39
2621928|NCT00043186|6435087|P5|COMPLETED|Overall Study||36
2621929|NCT00043186|6435088|P4|COMPLETED|Overall Study||19
2621930|NCT00043186|6435089|P3|COMPLETED|Overall Study||24
2621931|NCT00043186|6435090|P2|COMPLETED|Overall Study||29
2621932|NCT00043186|6435091|P1|COMPLETED|Overall Study||29
2621933|NCT00043186|6435083|P9|STARTED|Overall Study||47
2621934|NCT00043186|6435084|P8|STARTED|Overall Study||47
2621935|NCT00043186|6435085|P7|STARTED|Overall Study||42
2621936|NCT00043186|6435086|P6|STARTED|Overall Study||47
2621937|NCT00043186|6435087|P5|STARTED|Overall Study||54
2621938|NCT00043186|6435088|P4|STARTED|Overall Study||41
2621939|NCT00043186|6435089|P3|STARTED|Overall Study||44
2621940|NCT00043186|6435090|P2|STARTED|Overall Study||44
2621941|NCT00043186|6435091|P1|STARTED|Overall Study||46
2621942|NCT00042432|6435419|P2|NOT COMPLETED|Overall Study||7
2621943|NCT00042432|6435420|P1|NOT COMPLETED|Overall Study||9
2621944|NCT00042432|6435419|P2|COMPLETED|Overall Study||20
2621945|NCT00042432|6435420|P1|COMPLETED|Overall Study||18
2621946|NCT00042432|6435419|P2|STARTED|Overall Study||27
2621947|NCT00042432|6435420|P1|STARTED|Overall Study||27
2621948|NCT00042224|6435430|P2|NOT COMPLETED|Overall Study||3
2621949|NCT00042224|6435431|P1|NOT COMPLETED|Overall Study||3
2621950|NCT00042224|6435430|P2|COMPLETED|Overall Study||16
2621951|NCT00042224|6435431|P1|COMPLETED|Overall Study||17
2621952|NCT00042224|6435430|P2|STARTED|Overall Study||19
2621953|NCT00042224|6435431|P1|STARTED|Overall Study||20
2621954|NCT00041938|6435439|P2|NOT COMPLETED|Overall Study||31
2621955|NCT00041938|6435440|P1|NOT COMPLETED|Overall Study||38
2621956|NCT00041938|6435439|P2|COMPLETED|Overall Study||1111
2621957|NCT00041938|6435440|P1|COMPLETED|Overall Study||1125
2621958|NCT00041938|6435439|P2|Withdrew Consent|Overall Study||14
2621959|NCT00041938|6435440|P1|Withdrew Consent|Overall Study||20
2621960|NCT00041938|6435439|P2|Lost to Follow-up|Overall Study||17
2621961|NCT00041938|6435440|P1|Lost to Follow-up|Overall Study||18
2621962|NCT00041938|6435439|P2|Only Vital Status Known|Overall Study||46
2621963|NCT00041938|6435440|P1|Only Vital Status Known|Overall Study||44
2621964|NCT00041938|6435439|P2|Primary Endpoint|Overall Study||302
2621965|NCT00041938|6435440|P1|Primary Endpoint|Overall Study||320
2621966|NCT00041938|6435439|P2|Completed Follow-up|Overall Study||745
2621967|NCT00041938|6435440|P1|Completed Follow-up|Overall Study||761
2621968|NCT00041938|6435439|P2|STARTED|Overall Study||1142
2621969|NCT00041938|6435440|P1|STARTED|Overall Study||1163
2621970|NCT00041756|6435473|P5|NOT COMPLETED|Overall Study||60
2621971|NCT00041756|6435474|P4|NOT COMPLETED|Overall Study||16
2621972|NCT00041756|6435475|P3|NOT COMPLETED|Overall Study||13
2621973|NCT00041756|6435476|P2|NOT COMPLETED|Overall Study||15
2621974|NCT00041756|6435477|P1|NOT COMPLETED|Overall Study||8
2621975|NCT00041756|6435473|P5|COMPLETED|Overall Study||19
2621976|NCT00041756|6435474|P4|COMPLETED|Overall Study||64
2621977|NCT00041756|6435475|P3|COMPLETED|Overall Study||66
2621978|NCT00041756|6435476|P2|COMPLETED|Overall Study||65
2621979|NCT00041756|6435477|P1|COMPLETED|Overall Study||69
2621980|NCT00041756|6435473|P5|STARTED|Overall Study||79
2621981|NCT00041756|6435474|P4|STARTED|Overall Study||80
2621982|NCT00041756|6435475|P3|STARTED|Overall Study||79
2621983|NCT00041756|6435476|P2|STARTED|Overall Study||80
2621984|NCT00041756|6435477|P1|STARTED|Overall Study||77
2621985|NCT00041717|6435496|P2|NOT COMPLETED|Overall Study||12
2621986|NCT00041717|6435497|P1|NOT COMPLETED|Overall Study||33
2621987|NCT00041717|6435496|P2|COMPLETED|Overall Study||86
2621988|NCT00041717|6435497|P1|COMPLETED|Overall Study||81
2621989|NCT00041717|6435496|P2|STARTED|Overall Study||98
2621990|NCT00041717|6435497|P1|STARTED|Overall Study||114
2621991|NCT00041470|6435505|P1|NOT COMPLETED|Overall Study||38
2621992|NCT00041470|6435505|P1|COMPLETED|Overall Study||0
2621993|NCT00041470|6435505|P1|STARTED|Overall Study||38
2621994|NCT00040664|6435510|P4|NOT COMPLETED|Overall Study||27
2621995|NCT00040664|6435511|P3|NOT COMPLETED|Overall Study||13
2621996|NCT00040664|6435512|P2|NOT COMPLETED|Overall Study||13
2621997|NCT00040664|6435513|P1|NOT COMPLETED|Overall Study||53
2621998|NCT00040664|6435510|P4|COMPLETED|Overall Study||8
2621999|NCT00040664|6435511|P3|COMPLETED|Overall Study||4
2622000|NCT00040664|6435512|P2|COMPLETED|Overall Study||4
2622001|NCT00040664|6435513|P1|COMPLETED|Overall Study||16
2622002|NCT00040664|6435510|P4|STARTED|Overall Study||35
2622003|NCT00040664|6435511|P3|STARTED|Overall Study||17
2622004|NCT00040664|6435512|P2|STARTED|Overall Study||17
2622090|NCT00038142|6435758|P1|STARTED|Overall Study||32
2622091|NCT00038103|6435766|P2|NOT COMPLETED|Overall Study||56
2622005|NCT00040664|6435513|P1|STARTED|Overall Study|All (69) enrolled on QD; 10 switched to twice daily. Participant flow not collected for this group.|69
2622006|NCT00041392|6435563|P2|NOT COMPLETED|Overall Study||0
2622007|NCT00041392|6435564|P1|NOT COMPLETED|Overall Study||0
2622008|NCT00041392|6435563|P2|COMPLETED|Overall Study||191
2622009|NCT00041392|6435564|P1|COMPLETED|Overall Study||198
2622010|NCT00041392|6435563|P2|STARTED|Overall Study||191
2622011|NCT00041392|6435564|P1|STARTED|Overall Study||198
2622012|NCT00040443|6435572|P2|NOT COMPLETED|Overall Study||0
2622013|NCT00040443|6435573|P1|NOT COMPLETED|Overall Study||0
2622014|NCT00040443|6435572|P2|COMPLETED|Overall Study||91
2622015|NCT00040443|6435573|P1|COMPLETED|Overall Study||84
2622016|NCT00040443|6435572|P2|STARTED|Overall Study||91
2622017|NCT00040443|6435573|P1|STARTED|Overall Study||84
2622018|NCT00040365|6435579|P1|NOT COMPLETED|Overall Study||11
2622019|NCT00040365|6435579|P1|COMPLETED|Overall Study||19
2622020|NCT00040365|6435579|P1|Completed Follow Up Phase|Overall Study||19
2622021|NCT00040365|6435579|P1|STARTED|Overall Study||30
2622022|NCT00039871|6435588|P1|NOT COMPLETED|Overall Study||1384
2622023|NCT00039871|6435588|P1|COMPLETED|Overall Study||928
2622024|NCT00039871|6435588|P1|STARTED|Overall Study|Enrolled 2333; 21 subjects excluded due to GCP non-compliance|2312
2622025|NCT00039741|6435598|P4|NOT COMPLETED|Overall Study||14
2622026|NCT00039741|6435599|P3|NOT COMPLETED|Overall Study||11
2622027|NCT00039741|6435600|P2|NOT COMPLETED|Overall Study||12
2622028|NCT00039741|6435601|P1|NOT COMPLETED|Overall Study||15
2622029|NCT00039741|6435598|P4|COMPLETED|Overall Study||50
2622030|NCT00039741|6435599|P3|COMPLETED|Overall Study||54
2622031|NCT00039741|6435600|P2|COMPLETED|Overall Study||56
2622032|NCT00039741|6435601|P1|COMPLETED|Overall Study||51
2622033|NCT00039741|6435598|P4|Death|Overall Study||0
2622034|NCT00039741|6435599|P3|Death|Overall Study||0
2622035|NCT00039741|6435600|P2|Death|Overall Study||1
2622036|NCT00039741|6435601|P1|Death|Overall Study||0
2622037|NCT00039741|6435598|P4|STARTED|Overall Study||64
2622038|NCT00039741|6435599|P3|STARTED|Overall Study||65
2622039|NCT00039741|6435600|P2|STARTED|Overall Study||68
2622040|NCT00039741|6435601|P1|STARTED|Overall Study||66
2622041|NCT00038948|6435645|P2|NOT COMPLETED|Overall Study||77
2622042|NCT00038948|6435646|P1|NOT COMPLETED|Overall Study||169
2622043|NCT00038948|6435645|P2|COMPLETED|Overall Study||198
2622044|NCT00038948|6435646|P1|COMPLETED|Overall Study||386
2622045|NCT00038948|6435645|P2|STARTED|Overall Study||275
2622046|NCT00038948|6435646|P1|STARTED|Overall Study||555
2622047|NCT00038857|6435658|P1|NOT COMPLETED|Overall Study||1
2622048|NCT00038857|6435658|P1|COMPLETED|Overall Study||28
2622049|NCT00038857|6435658|P1|STARTED|Overall Study||29
2622050|NCT00038727|6435665|P3|NOT COMPLETED|Overall Study||0
2622051|NCT00038727|6435666|P2|NOT COMPLETED|Overall Study||0
2622052|NCT00038727|6435667|P1|NOT COMPLETED|Overall Study||0
2622053|NCT00038727|6435665|P3|COMPLETED|Overall Study||936
2622054|NCT00038727|6435666|P2|COMPLETED|Overall Study||927
2622055|NCT00038727|6435667|P1|COMPLETED|Overall Study||916
2622056|NCT00038727|6435665|P3|DPPOS Phase 3 Enrolled|Overall Study||936
2622057|NCT00038727|6435666|P2|DPPOS Phase 3 Enrolled|Overall Study||927
2622058|NCT00038727|6435667|P1|DPPOS Phase 3 Enrolled|Overall Study||916
2622059|NCT00038727|6435665|P3|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|780
2622060|NCT00038727|6435666|P2|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|772
2622061|NCT00038727|6435667|P1|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|751
2622062|NCT00038727|6435665|P3|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|935
2622063|NCT00038727|6435666|P2|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|926
2622064|NCT00038727|6435667|P1|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|915
2622065|NCT00038727|6435665|P3|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|932
2622066|NCT00038727|6435666|P2|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|924
2622067|NCT00038727|6435667|P1|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|910
2622068|NCT00038727|6435665|P3|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|936
2622069|NCT00038727|6435666|P2|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|927
2622070|NCT00038727|6435667|P1|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|916
2622071|NCT00038649|6435681|P1|NOT COMPLETED|Overall Study||9
2622072|NCT00038649|6435681|P1|COMPLETED|Overall Study||105
2622073|NCT00038649|6435681|P1|STARTED|Overall Study||114
2622074|NCT00038610|6435686|P1|NOT COMPLETED|Overall Study||0
2622075|NCT00038610|6435686|P1|COMPLETED|Overall Study||54
2622076|NCT00038610|6435686|P1|STARTED|Overall Study||54
2622077|NCT00038467|6435694|P2|NOT COMPLETED|Overall Study||542
2622078|NCT00038467|6435695|P1|NOT COMPLETED|Overall Study||542
2622079|NCT00038467|6435694|P2|COMPLETED|Overall Study||1830
2622080|NCT00038467|6435695|P1|COMPLETED|Overall Study||1810
2622081|NCT00038467|6435694|P2|Treated|Overall Study|7 participants randomized to receive tamoxifen, received exemestane. Reported as per randomization.|2337
2622082|NCT00038467|6435695|P1|Treated|Overall Study|8 participants randomized to receive exemestane, received tamoxifen. Reported as per randomization.|2321
2622083|NCT00038467|6435694|P2|STARTED|Overall Study||2372
2622084|NCT00038467|6435695|P1|STARTED|Overall Study||2352
2622085|NCT00038142|6435757|P2|NOT COMPLETED|Overall Study||7
2622086|NCT00038142|6435758|P1|NOT COMPLETED|Overall Study||22
2622087|NCT00038142|6435757|P2|COMPLETED|Overall Study||7
2622088|NCT00038142|6435758|P1|COMPLETED|Overall Study||10
2622089|NCT00038142|6435757|P2|STARTED|Overall Study||14
2622092|NCT00038103|6435767|P1|NOT COMPLETED|Overall Study||55
2622093|NCT00038103|6435766|P2|COMPLETED|Overall Study||0
2622094|NCT00038103|6435767|P1|COMPLETED|Overall Study||0
2622095|NCT00038103|6435766|P2|End of Treatment|Overall Study|patients remained on treatment until discontinued|56
2622096|NCT00038103|6435767|P1|End of Treatment|Overall Study|patients remained on treatment until discontinued|53
2622097|NCT00038103|6435766|P2|STARTED|Overall Study||56
2622098|NCT00038103|6435767|P1|STARTED|Overall Study||55
2622099|NCT00037830|6435790|P3|NOT COMPLETED|Overall Study||1
2622100|NCT00037830|6435791|P2|NOT COMPLETED|Overall Study||7
2622101|NCT00037830|6435792|P1|NOT COMPLETED|Overall Study||10
2622102|NCT00037830|6435790|P3|COMPLETED|Overall Study||16
2622103|NCT00037830|6435791|P2|COMPLETED|Overall Study||31
2622104|NCT00037830|6435792|P1|COMPLETED|Overall Study||29
2622105|NCT00037830|6435790|P3|STARTED|Overall Study||17
2622106|NCT00037830|6435791|P2|STARTED|Overall Study||38
2622107|NCT00037830|6435792|P1|STARTED|Overall Study||39
2622108|NCT00036569|6435813|P1|NOT COMPLETED|Overall Study||0
2622109|NCT00036569|6435813|P1|COMPLETED|Overall Study||32
2622110|NCT00036569|6435813|P1|STARTED|Overall Study||32
2622111|NCT00036270|6435824|P2|NOT COMPLETED|Study Treatment to 5 Year Report||3488
2622112|NCT00036270|6435825|P1|NOT COMPLETED|Study Treatment to 5 Year Report||2565
2622113|NCT00036270|6435824|P2|COMPLETED|Study Treatment to 5 Year Report||1380
2622114|NCT00036270|6435825|P1|COMPLETED|Study Treatment to 5 Year Report||2333
2622115|NCT00036270|6435824|P2|Treated|Study Treatment to 5 Year Report||4814
2622116|NCT00036270|6435825|P1|Treated|Study Treatment to 5 Year Report||4852
2622117|NCT00036270|6435824|P2|STARTED|Study Treatment to 5 Year Report||4868
2622118|NCT00036270|6435825|P1|STARTED|Study Treatment to 5 Year Report||4898
2622119|NCT00036270|6435824|P2|NOT COMPLETED|Randomized to Study Treatment||7
2622120|NCT00036270|6435825|P1|NOT COMPLETED|Randomized to Study Treatment||6
2622121|NCT00036270|6435824|P2|COMPLETED|Randomized to Study Treatment||4868
2622122|NCT00036270|6435825|P1|COMPLETED|Randomized to Study Treatment||4898
2622123|NCT00036270|6435824|P2|STARTED|Randomized to Study Treatment||4875
2622124|NCT00036270|6435825|P1|STARTED|Randomized to Study Treatment||4904
2622125|NCT00035932|6435844|P3|NOT COMPLETED|Overall Study||49
2622126|NCT00035932|6435845|P2|NOT COMPLETED|Overall Study||60
2622127|NCT00035932|6435846|P1|NOT COMPLETED|Overall Study||56
2622128|NCT00035932|6435844|P3|COMPLETED|Overall Study|59 remained on treatment, 10 completed at Week 96|69
2622129|NCT00035932|6435845|P2|COMPLETED|Overall Study|50 remained on treatment, 0 completed at Week 96|50
2622130|NCT00035932|6435846|P1|COMPLETED|Overall Study|63 remained on treatment, 0 completed at Week 96|63
2622131|NCT00035932|6435844|P3|Discontinued on or After Week 96|Overall Study||6
2622132|NCT00035932|6435845|P2|Discontinued on or After Week 96|Overall Study||4
2622133|NCT00035932|6435846|P1|Discontinued on or After Week 96|Overall Study||4
2622134|NCT00035932|6435844|P3|Discontinued Between Weeks 48 and 96|Overall Study||30
2622135|NCT00035932|6435845|P2|Discontinued Between Weeks 48 and 96|Overall Study||27
2622136|NCT00035932|6435846|P1|Discontinued Between Weeks 48 and 96|Overall Study||26
2622137|NCT00035932|6435844|P3|Discontinued Prior to Week 48 Visit|Overall Study||13
2622138|NCT00035932|6435845|P2|Discontinued Prior to Week 48 Visit|Overall Study||29
2622139|NCT00035932|6435846|P1|Discontinued Prior to Week 48 Visit|Overall Study||26
2622140|NCT00035932|6435844|P3|STARTED|Overall Study|123 randomized, 118 treated|118
2622141|NCT00035932|6435845|P2|STARTED|Overall Study|115 randomized, 110 treated|110
2622142|NCT00035932|6435846|P1|STARTED|Overall Study|120 randomized, 119 treated|119
2622143|NCT00035815|6435972|P2|NOT COMPLETED|Overall Study||11
2622144|NCT00035815|6435973|P1|NOT COMPLETED|Overall Study||17
2622145|NCT00035815|6435972|P2|COMPLETED|Overall Study||152
2622146|NCT00035815|6435973|P1|COMPLETED|Overall Study||150
2622147|NCT00035815|6435972|P2|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|163
2622148|NCT00035815|6435973|P1|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|167
2622149|NCT00035555|6435986|P3|NOT COMPLETED|Overall Study||22
2622150|NCT00035555|6435987|P2|NOT COMPLETED|Overall Study||16
2622151|NCT00035555|6435988|P1|NOT COMPLETED|Overall Study||16
2622152|NCT00035555|6435986|P3|COMPLETED|Overall Study||51
2622153|NCT00035555|6435987|P2|COMPLETED|Overall Study||55
2622154|NCT00035555|6435988|P1|COMPLETED|Overall Study||58
2622155|NCT00035555|6435986|P3|Number Who Received Study Drug|Overall Study||71
2622156|NCT00035555|6435987|P2|Number Who Received Study Drug|Overall Study||71
2622157|NCT00035555|6435988|P1|Number Who Received Study Drug|Overall Study||74
2622158|NCT00035555|6435986|P3|Number Who Had Undergone Transplantation|Overall Study||73
2622159|NCT00035555|6435987|P2|Number Who Had Undergone Transplantation|Overall Study||71
2622160|NCT00035555|6435988|P1|Number Who Had Undergone Transplantation|Overall Study||74
2622161|NCT00035555|6435986|P3|STARTED|Overall Study|Randomized patients|73
2622162|NCT00035555|6435987|P2|STARTED|Overall Study|Randomized patients|71
2622163|NCT00035555|6435988|P1|STARTED|Overall Study|Randomized patients|74
2622164|NCT00033917|6436031|P2|NOT COMPLETED|Overall Study||0
2622165|NCT00033917|6436032|P1|NOT COMPLETED|Overall Study||0
2622166|NCT00033917|6436031|P2|COMPLETED|Overall Study||222
2622167|NCT00033917|6436032|P1|COMPLETED|Overall Study||209
2622168|NCT00033917|6436031|P2|STARTED|Overall Study||222
2622169|NCT00033917|6436032|P1|STARTED|Overall Study||209
2622170|NCT00032630|6436044|P2|NOT COMPLETED|Overall Study||43
2622171|NCT00032630|6436045|P1|NOT COMPLETED|Overall Study||49
2622172|NCT00032630|6436044|P2|COMPLETED|Overall Study||1061
2622173|NCT00032630|6436045|P1|COMPLETED|Overall Study||1050
2622174|NCT00032630|6436044|P2|STARTED|Overall Study||1104
2622175|NCT00032630|6436045|P1|STARTED|Overall Study||1099
2622176|NCT00032591|6436055|P2|NOT COMPLETED|Follow-up||5
2622177|NCT00032591|6436056|P1|NOT COMPLETED|Follow-up||2
2622178|NCT00032591|6436055|P2|COMPLETED|Follow-up|1452 were included in analysis with greater than 1 day of follow-up|1452
2622179|NCT00032591|6436056|P1|COMPLETED|Follow-up|1463 were included in analysis with greater than 1 day of follow-up|1463
2622180|NCT00032591|6436055|P2|STARTED|Follow-up|5 were lost to follow-up, all with Atrial Fibrillation, no Mechanical Heart Valves|1457
2622181|NCT00032591|6436056|P1|STARTED|Follow-up|2 were lost to follow-up, both with Atrial Fibrillation, no Mechanical Heart Valves|1465
2622182|NCT00032591|6436055|P2|NOT COMPLETED|Randomization||0
2622183|NCT00032591|6436056|P1|NOT COMPLETED|Randomization||0
2622184|NCT00032591|6436055|P2|COMPLETED|Randomization|1457 were assigned to clinic testing|1457
2622185|NCT00032591|6436056|P1|COMPLETED|Randomization|1465 were assigned to self-testing|1465
2622186|NCT00032591|6436055|P2|STARTED|Randomization||1457
2622187|NCT00032591|6436056|P1|STARTED|Randomization|2922 underwent randomization|1465
2622188|NCT00032591|6436055|P2|NOT COMPLETED|Screening||415
2622189|NCT00032591|6436056|P1|NOT COMPLETED|Screening||408
2622190|NCT00032591|6436055|P2|COMPLETED|Screening||1457
2622191|NCT00032591|6436056|P1|COMPLETED|Screening|823 were excluded from the study|1465
2622192|NCT00032591|6436055|P2|STARTED|Screening|Treatment assigned at randomization; screening counts by arm represent half of the total screened.|1872
2622193|NCT00032591|6436056|P1|STARTED|Screening|3745 patients provided informed consent and were screened for participation.|1873
2622194|NCT00032487|6436072|P2|NOT COMPLETED|Overall Study||120
2622195|NCT00032487|6436073|P1|NOT COMPLETED|Overall Study||139
2622196|NCT00032487|6436072|P2|COMPLETED|Overall Study||772
2622197|NCT00032487|6436073|P1|COMPLETED|Overall Study||760
2622198|NCT00032487|6436072|P2|STARTED|Overall Study||892
2622199|NCT00032487|6436073|P1|STARTED|Overall Study||899
2622200|NCT00031551|6436083|P2|NOT COMPLETED|Overall Study||0
2622201|NCT00031551|6436084|P1|NOT COMPLETED|Overall Study||2
2622202|NCT00031551|6436083|P2|COMPLETED|Overall Study||25
2622203|NCT00031551|6436084|P1|COMPLETED|Overall Study||0
2622204|NCT00031551|6436083|P2|STARTED|Overall Study||25
2622205|NCT00031551|6436084|P1|STARTED|Overall Study||2
2622206|NCT00031486|6436096|P2|NOT COMPLETED|Overall Study||12
2622207|NCT00031486|6436097|P1|NOT COMPLETED|Overall Study||7
2622208|NCT00031486|6436096|P2|COMPLETED|Overall Study||35
2622209|NCT00031486|6436097|P1|COMPLETED|Overall Study||33
2622210|NCT00031486|6436096|P2|STARTED|Overall Study||47
2622211|NCT00031486|6436097|P1|STARTED|Overall Study||40
2622212|NCT00031460|6436123|P2|NOT COMPLETED|Overall Study||14
2622213|NCT00031460|6436124|P1|NOT COMPLETED|Overall Study||9
2622214|NCT00031460|6436123|P2|COMPLETED|Overall Study||8
2622215|NCT00031460|6436124|P1|COMPLETED|Overall Study||15
2622216|NCT00031460|6436123|P2|STARTED|Overall Study||22
2622217|NCT00031460|6436124|P1|STARTED|Overall Study||24
2622218|NCT00031447|6436138|P2|NOT COMPLETED|Overall Study||7
2622219|NCT00031447|6436139|P1|NOT COMPLETED|Overall Study||10
2622220|NCT00031447|6436138|P2|COMPLETED|Overall Study||8
2622221|NCT00031447|6436139|P1|COMPLETED|Overall Study||4
2622222|NCT00031447|6436138|P2|STARTED|Overall Study||15
2622223|NCT00031447|6436139|P1|STARTED|Overall Study||14
2622224|NCT00030992|6436151|P1|NOT COMPLETED|Overall Study||0
2622225|NCT00030992|6436151|P1|COMPLETED|Overall Study||102
2622226|NCT00030992|6436151|P1|STARTED|Overall Study||102
2622227|NCT00030147|6436160|P4|NOT COMPLETED|Overall Study||0
2622228|NCT00030147|6436161|P3|NOT COMPLETED|Overall Study||0
2622229|NCT00030147|6436162|P2|NOT COMPLETED|Overall Study||1
2622230|NCT00030147|6436163|P1|NOT COMPLETED|Overall Study||0
2622231|NCT00030147|6436160|P4|COMPLETED|Overall Study||11
2622232|NCT00030147|6436161|P3|COMPLETED|Overall Study||16
2622233|NCT00030147|6436162|P2|COMPLETED|Overall Study||18
2622234|NCT00030147|6436163|P1|COMPLETED|Overall Study||17
2622235|NCT00030147|6436160|P4|STARTED|Overall Study||11
2622236|NCT00030147|6436161|P3|STARTED|Overall Study||16
2622237|NCT00030147|6436162|P2|STARTED|Overall Study||19
2622238|NCT00030147|6436163|P1|STARTED|Overall Study||17
2622239|NCT00029536|6436181|P4|NOT COMPLETED|Overall Study||0
2622240|NCT00029536|6436182|P3|NOT COMPLETED|Overall Study||0
2622241|NCT00029536|6436183|P2|NOT COMPLETED|Overall Study||0
2622242|NCT00029536|6436184|P1|NOT COMPLETED|Overall Study||0
2622243|NCT00029536|6436181|P4|COMPLETED|Overall Study||59
2622244|NCT00029536|6436182|P3|COMPLETED|Overall Study||105
2622245|NCT00029536|6436183|P2|COMPLETED|Overall Study||45
2622246|NCT00029536|6436184|P1|COMPLETED|Overall Study||85
2622247|NCT00029536|6436181|P4|STARTED|Overall Study||59
2622248|NCT00029536|6436182|P3|STARTED|Overall Study||105
2622249|NCT00029536|6436183|P2|STARTED|Overall Study||45
2622250|NCT00029536|6436184|P1|STARTED|Overall Study||85
2622251|NCT00029172|6436208|P1|NOT COMPLETED|Overall Study||6
2622252|NCT00029172|6436208|P1|COMPLETED|Overall Study||182
2622253|NCT00029172|6436208|P1|STARTED|Overall Study||188
2622254|NCT00029146|6436214|P2|NOT COMPLETED|Overall Study||1
2622255|NCT00029146|6436215|P1|NOT COMPLETED|Overall Study||2
2622256|NCT00029146|6436214|P2|COMPLETED|Overall Study||97
2622257|NCT00029146|6436215|P1|COMPLETED|Overall Study||95
2622258|NCT00029146|6436214|P2|STARTED|Overall Study||98
2622259|NCT00029146|6436215|P1|STARTED|Overall Study||97
2622260|NCT00029107|6436244|P2|NOT COMPLETED|Overall Study||0
2622261|NCT00029107|6436245|P1|NOT COMPLETED|Overall Study||0
2622262|NCT00029107|6436244|P2|COMPLETED|Overall Study||12
2622263|NCT00029107|6436245|P1|COMPLETED|Overall Study||12
2622264|NCT00029107|6436244|P2|STARTED|Overall Study||12
2622265|NCT00029107|6436245|P1|STARTED|Overall Study||12
2622266|NCT00028262|6436251|P1|NOT COMPLETED|Overall Study||1
2622267|NCT00028262|6436251|P1|COMPLETED|Overall Study||9
2622268|NCT00028262|6436251|P1|STARTED|Overall Study||10
2622269|NCT00028093|6436257|P2|NOT COMPLETED|Overall Study||0
2622270|NCT00028093|6436258|P1|NOT COMPLETED|Overall Study||0
2622271|NCT00028093|6436257|P2|COMPLETED|Overall Study||25
2622272|NCT00028093|6436258|P1|COMPLETED|Overall Study||25
2622273|NCT00028093|6436257|P2|STARTED|Overall Study||25
2622274|NCT00028093|6436258|P1|STARTED|Overall Study||25
2622275|NCT00027378|6436266|P2|NOT COMPLETED|Overall Study||3
2622276|NCT00027378|6436267|P1|NOT COMPLETED|Overall Study||0
2622277|NCT00027378|6436266|P2|COMPLETED|Overall Study||23
2622278|NCT00027378|6436267|P1|COMPLETED|Overall Study||24
2622279|NCT00027378|6436266|P2|STARTED|Overall Study||26
2622280|NCT00027378|6436267|P1|STARTED|Overall Study||24
2622281|NCT00027027|6436280|P5|NOT COMPLETED|Overall Study||8
2622282|NCT00027027|6436281|P4|NOT COMPLETED|Overall Study||3
2622283|NCT00027027|6436282|P3|NOT COMPLETED|Overall Study||4
2622284|NCT00027027|6436283|P2|NOT COMPLETED|Overall Study||3
2622285|NCT00027027|6436284|P1|NOT COMPLETED|Overall Study||3
2622286|NCT00027027|6436280|P5|COMPLETED|Overall Study||0
2622287|NCT00027027|6436281|P4|COMPLETED|Overall Study||0
2622288|NCT00027027|6436282|P3|COMPLETED|Overall Study||0
2622289|NCT00027027|6436283|P2|COMPLETED|Overall Study||0
2622290|NCT00027027|6436284|P1|COMPLETED|Overall Study||0
2622291|NCT00027027|6436280|P5|Treated Beyond Cycle 2|Overall Study||4
2622292|NCT00027027|6436281|P4|Treated Beyond Cycle 2|Overall Study||2
2622293|NCT00027027|6436282|P3|Treated Beyond Cycle 2|Overall Study||2
2622294|NCT00027027|6436283|P2|Treated Beyond Cycle 2|Overall Study||1
2622295|NCT00027027|6436284|P1|Treated Beyond Cycle 2|Overall Study||1
2622296|NCT00027027|6436280|P5|Discontinued at Cycle 2|Overall Study||3
2622297|NCT00027027|6436281|P4|Discontinued at Cycle 2|Overall Study||1
2622298|NCT00027027|6436282|P3|Discontinued at Cycle 2|Overall Study||1
2622299|NCT00027027|6436283|P2|Discontinued at Cycle 2|Overall Study||2
2622300|NCT00027027|6436284|P1|Discontinued at Cycle 2|Overall Study||2
2622301|NCT00027027|6436280|P5|Completed 2 Cycles of Treatment|Overall Study||7
2622302|NCT00027027|6436281|P4|Completed 2 Cycles of Treatment|Overall Study||3
2622303|NCT00027027|6436282|P3|Completed 2 Cycles of Treatment|Overall Study||3
2622304|NCT00027027|6436283|P2|Completed 2 Cycles of Treatment|Overall Study||3
2622305|NCT00027027|6436284|P1|Completed 2 Cycles of Treatment|Overall Study||3
2622306|NCT00027027|6436280|P5|Discontinued Before 2 Treatment Cycles|Overall Study||1
2622307|NCT00027027|6436281|P4|Discontinued Before 2 Treatment Cycles|Overall Study||0
2622308|NCT00027027|6436282|P3|Discontinued Before 2 Treatment Cycles|Overall Study||1
2622309|NCT00027027|6436283|P2|Discontinued Before 2 Treatment Cycles|Overall Study||0
2622310|NCT00027027|6436284|P1|Discontinued Before 2 Treatment Cycles|Overall Study||0
2622311|NCT00027027|6436280|P5|STARTED|Overall Study||8
2622312|NCT00027027|6436281|P4|STARTED|Overall Study||3
2622313|NCT00027027|6436282|P3|STARTED|Overall Study||4
2622314|NCT00027027|6436283|P2|STARTED|Overall Study||3
2622315|NCT00027027|6436284|P1|STARTED|Overall Study||3
2622316|NCT00025883|6436331|P1|NOT COMPLETED|Overall Study||17
2622317|NCT00025883|6436331|P1|COMPLETED|Overall Study||86
2622318|NCT00025883|6436331|P1|Partial Lipodystrophy|Overall Study||40
2622319|NCT00025883|6436331|P1|Generalized Lipodystrophy|Overall Study||63
2622320|NCT00025883|6436331|P1|STARTED|Overall Study||103
2622321|NCT00023595|6436343|P5|NOT COMPLETED|10 Year Follow up||0
2622322|NCT00023595|6436344|P4|NOT COMPLETED|10 Year Follow up||0
2622323|NCT00023595|6436345|P3|NOT COMPLETED|10 Year Follow up||3
2622324|NCT00023595|6436346|P2|NOT COMPLETED|10 Year Follow up||10
2622325|NCT00023595|6436347|P1|NOT COMPLETED|10 Year Follow up||12
2622326|NCT00023595|6436343|P5|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
2622327|NCT00023595|6436344|P4|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
2622328|NCT00023595|6436345|P3|COMPLETED|10 Year Follow up||73
2622329|NCT00023595|6436346|P2|COMPLETED|10 Year Follow up||524
2622330|NCT00023595|6436347|P1|COMPLETED|10 Year Follow up||590
2622331|NCT00023595|6436343|P5|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
2622332|NCT00023595|6436344|P4|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
2622333|NCT00023595|6436345|P3|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|76
2622334|NCT00023595|6436346|P2|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|534
2622335|NCT00023595|6436347|P1|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|602
2622336|NCT00023595|6436343|P5|NOT COMPLETED|5 Year Follow up||3
2622337|NCT00023595|6436344|P4|NOT COMPLETED|5 Year Follow up||7
2622338|NCT00023595|6436345|P3|NOT COMPLETED|5 Year Follow up||1
2622339|NCT00023595|6436346|P2|NOT COMPLETED|5 Year Follow up||2
2622340|NCT00023595|6436347|P1|NOT COMPLETED|5 Year Follow up||2
2622341|NCT00023595|6436343|P5|COMPLETED|5 Year Follow up||498
2622342|NCT00023595|6436344|P4|COMPLETED|5 Year Follow up||416
2622343|NCT00023595|6436345|P3|COMPLETED|5 Year Follow up||75
2622344|NCT00023595|6436346|P2|COMPLETED|5 Year Follow up||532
2622345|NCT00023595|6436347|P1|COMPLETED|5 Year Follow up||600
2622346|NCT00023595|6436343|P5|STARTED|5 Year Follow up||501
2622347|NCT00023595|6436344|P4|STARTED|5 Year Follow up|76 of stratum B pts who were randomized to med therapy + CABG group belong to both H01 and H02.|423
2622348|NCT00023595|6436345|P3|STARTED|5 Year Follow up||76
2622349|NCT00023595|6436346|P2|STARTED|5 Year Follow up||534
2622350|NCT00023595|6436347|P1|STARTED|5 Year Follow up||602
2622351|NCT00023452|6436558|P2|NOT COMPLETED|Overall Study||872
2622352|NCT00023452|6436559|P1|NOT COMPLETED|Overall Study||1323
2622353|NCT00023452|6436558|P2|COMPLETED|Overall Study||3273
2622354|NCT00023452|6436559|P1|COMPLETED|Overall Study||2585
2622355|NCT00023452|6436558|P2|Completed Study|Overall Study||3475
2622356|NCT00023452|6436559|P1|Completed Study|Overall Study||3174
2622357|NCT00023452|6436558|P2|Not Treated|Overall Study||105
2622358|NCT00023452|6436559|P1|Not Treated|Overall Study||149
2622359|NCT00023452|6436558|P2|Completed Treatment|Overall Study||3273
2622360|NCT00023452|6436559|P1|Completed Treatment|Overall Study||2585
2622361|NCT00023452|6436558|P2|Enrolled as Part of a Cluster|Overall Study||971
2622362|NCT00023452|6436559|P1|Enrolled as Part of a Cluster|Overall Study||718
2622363|NCT00023452|6436558|P2|Randomized|Overall Study||3174
2622364|NCT00023452|6436559|P1|Randomized|Overall Study||3190
2622365|NCT00023452|6436558|P2|STARTED|Overall Study||4145
2622366|NCT00023452|6436559|P1|STARTED|Overall Study||3908
2622367|NCT00023322|6436583|P1|NOT COMPLETED|Overall Study||1
2622368|NCT00023322|6436583|P1|COMPLETED|Overall Study||12
2622369|NCT00023322|6436583|P1|STARTED|Overall Study||13
2622370|NCT00023309|6436590|P2|NOT COMPLETED|Overall Study||0
2622371|NCT00023309|6436591|P1|NOT COMPLETED|Overall Study||0
2622372|NCT00023309|6436590|P2|COMPLETED|Overall Study||19
2622373|NCT00023309|6436591|P1|COMPLETED|Overall Study||22
2622374|NCT00023309|6436590|P2|STARTED|Overall Study||19
2622375|NCT00023309|6436591|P1|STARTED|Overall Study||22
2622376|NCT00022763|6436607|P2|NOT COMPLETED|Overall Study||17
2622377|NCT00022763|6436608|P1|NOT COMPLETED|Overall Study||9
2622378|NCT00022763|6436607|P2|COMPLETED|Overall Study||11
2622379|NCT00022763|6436608|P1|COMPLETED|Overall Study||15
2622380|NCT00022763|6436607|P2|STARTED|Overall Study||28
2622381|NCT00022763|6436608|P1|STARTED|Overall Study||24
2622382|NCT00016718|6436634|P3|NOT COMPLETED|Overall Study||0
2622383|NCT00016718|6436635|P2|NOT COMPLETED|Overall Study||0
2622384|NCT00016718|6436636|P1|NOT COMPLETED|Overall Study||0
2622385|NCT00016718|6436634|P3|COMPLETED|Overall Study||16
2622386|NCT00016718|6436635|P2|COMPLETED|Overall Study||21
2622387|NCT00016718|6436636|P1|COMPLETED|Overall Study||6
2622388|NCT00016718|6436634|P3|STARTED|Overall Study||16
2622389|NCT00016718|6436635|P2|STARTED|Overall Study||21
2622390|NCT00016718|6436636|P1|STARTED|Overall Study||6
2622391|NCT00014911|6436650|P1|NOT COMPLETED|Overall Study||11
2622392|NCT00014911|6436650|P1|COMPLETED|Overall Study|One subject experienced pneumonia, myocardial infarction, and acute renal failure|25
2622393|NCT00014911|6436650|P1|STARTED|Overall Study||36
2622394|NCT00006604|6436666|P17|NOT COMPLETED|Overall Study||9
2622395|NCT00006604|6436667|P16|NOT COMPLETED|Overall Study||5
2622396|NCT00006604|6436668|P15|NOT COMPLETED|Overall Study||10
2622397|NCT00006604|6436669|P14|NOT COMPLETED|Overall Study||6
2622398|NCT00006604|6436670|P13|NOT COMPLETED|Overall Study||4
2622399|NCT00006604|6436671|P12|NOT COMPLETED|Overall Study||6
2622400|NCT00006604|6436672|P11|NOT COMPLETED|Overall Study||8
2622401|NCT00006604|6436673|P10|NOT COMPLETED|Overall Study||19
2622402|NCT00006604|6436674|P9|NOT COMPLETED|Overall Study||1
2622403|NCT00006604|6436675|P8|NOT COMPLETED|Overall Study||3
2622404|NCT00006604|6436676|P7|NOT COMPLETED|Overall Study||9
2622405|NCT00006604|6436677|P6|NOT COMPLETED|Overall Study||3
2622406|NCT00006604|6436678|P5|NOT COMPLETED|Overall Study||2
2622407|NCT00006604|6436679|P4|NOT COMPLETED|Overall Study||5
2622408|NCT00006604|6436680|P3|NOT COMPLETED|Overall Study||4
2622409|NCT00006604|6436681|P2|NOT COMPLETED|Overall Study||0
2622410|NCT00006604|6436682|P1|NOT COMPLETED|Overall Study||2
2622411|NCT00006604|6436666|P17|COMPLETED|Overall Study||6
2622412|NCT00006604|6436667|P16|COMPLETED|Overall Study||1
2622413|NCT00006604|6436668|P15|COMPLETED|Overall Study||14
2622414|NCT00006604|6436669|P14|COMPLETED|Overall Study||0
2622415|NCT00006604|6436670|P13|COMPLETED|Overall Study||22
2622416|NCT00006604|6436671|P12|COMPLETED|Overall Study||6
2622417|NCT00006604|6436672|P11|COMPLETED|Overall Study||13
2622418|NCT00006604|6436673|P10|COMPLETED|Overall Study||6
2622419|NCT00006604|6436674|P9|COMPLETED|Overall Study||4
2622420|NCT00006604|6436675|P8|COMPLETED|Overall Study||2
2622421|NCT00006604|6436676|P7|COMPLETED|Overall Study||12
2622422|NCT00006604|6436677|P6|COMPLETED|Overall Study||2
2622423|NCT00006604|6436678|P5|COMPLETED|Overall Study||3
2622424|NCT00006604|6436679|P4|COMPLETED|Overall Study||1
2622425|NCT00006604|6436680|P3|COMPLETED|Overall Study||1
2622426|NCT00006604|6436681|P2|COMPLETED|Overall Study||2
2622427|NCT00006604|6436682|P1|COMPLETED|Overall Study||4
2622428|NCT00006604|6436666|P17|STARTED|Overall Study||15
2622429|NCT00006604|6436667|P16|STARTED|Overall Study||6
2622430|NCT00006604|6436668|P15|STARTED|Overall Study||24
2622431|NCT00006604|6436669|P14|STARTED|Overall Study||6
2622432|NCT00006604|6436670|P13|STARTED|Overall Study||26
2622433|NCT00006604|6436671|P12|STARTED|Overall Study||12
2622434|NCT00006604|6436672|P11|STARTED|Overall Study||21
2622435|NCT00006604|6436673|P10|STARTED|Overall Study||25
2622436|NCT00006604|6436674|P9|STARTED|Overall Study||5
2622437|NCT00006604|6436675|P8|STARTED|Overall Study||5
2622438|NCT00006604|6436676|P7|STARTED|Overall Study||21
2622439|NCT00006604|6436677|P6|STARTED|Overall Study||5
2622440|NCT00006604|6436678|P5|STARTED|Overall Study||5
2622441|NCT00006604|6436679|P4|STARTED|Overall Study||6
2622442|NCT00006604|6436680|P3|STARTED|Overall Study||5
2622443|NCT00006604|6436681|P2|STARTED|Overall Study||2
2622444|NCT00006604|6436682|P1|STARTED|Overall Study||6
2622445|NCT00004978|6436798|P2|NOT COMPLETED|Overall Study||270
2622446|NCT00004978|6436799|P1|NOT COMPLETED|Overall Study||244
2622447|NCT00004978|6436798|P2|COMPLETED|Overall Study||1790
2622448|NCT00004978|6436799|P1|COMPLETED|Overall Study||1846
2622449|NCT00004978|6436798|P2|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2060
2622450|NCT00004978|6436799|P1|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2090
2622451|NCT00021541|6436825|P2|NOT COMPLETED|Period 2-crossover||11
2622452|NCT00021541|6436826|P1|NOT COMPLETED|Period 2-crossover||10
2622453|NCT00021541|6436825|P2|COMPLETED|Period 2-crossover||12
2622454|NCT00021541|6436826|P1|COMPLETED|Period 2-crossover||10
2622455|NCT00021541|6436825|P2|STARTED|Period 2-crossover||23
2622456|NCT00021541|6436826|P1|STARTED|Period 2-crossover||20
2622457|NCT00021541|6436825|P2|NOT COMPLETED|Period 1-First Treatment||8
2622458|NCT00021541|6436826|P1|NOT COMPLETED|Period 1-First Treatment||11
2622459|NCT00021541|6436825|P2|COMPLETED|Period 1-First Treatment||23
2622460|NCT00021541|6436826|P1|COMPLETED|Period 1-First Treatment||20
2622461|NCT00021541|6436825|P2|Ineligible Patients|Period 1-First Treatment||2
2622462|NCT00021541|6436826|P1|Ineligible Patients|Period 1-First Treatment||0
2622463|NCT00021541|6436825|P2|Pts Who Progressed to Second Treatment|Period 1-First Treatment||23
2622464|NCT00021541|6436826|P1|Pts Who Progressed to Second Treatment|Period 1-First Treatment||20
2622465|NCT00021541|6436825|P2|STARTED|Period 1-First Treatment|These are the patients randomized to receive placebo. Two of these patients were deemed ineligible.|31
2622466|NCT00021541|6436826|P1|STARTED|Period 1-First Treatment||31
2622467|NCT00018031|6436836|P1|NOT COMPLETED|Overall Study||0
2622468|NCT00018031|6436836|P1|COMPLETED|Overall Study||36
2622469|NCT00018031|6436836|P1|STARTED|Overall Study||36
2622470|NCT00015457|6436840|P2|NOT COMPLETED|Second Intervention||0
2622471|NCT00015457|6436841|P1|NOT COMPLETED|Second Intervention||1
2622472|NCT00015457|6436840|P2|COMPLETED|Second Intervention||5
2622473|NCT00015457|6436841|P1|COMPLETED|Second Intervention||7
2622474|NCT00015457|6436840|P2|STARTED|Second Intervention||5
2622475|NCT00015457|6436841|P1|STARTED|Second Intervention||8
2622476|NCT00015457|6436840|P2|NOT COMPLETED|First Intervention||3
2622477|NCT00015457|6436841|P1|NOT COMPLETED|First Intervention||0
2622478|NCT00015457|6436840|P2|COMPLETED|First Intervention||5
2622479|NCT00015457|6436841|P1|COMPLETED|First Intervention||8
2622480|NCT00015457|6436840|P2|STARTED|First Intervention||8
2622481|NCT00015457|6436841|P1|STARTED|First Intervention||8
2622482|NCT00013611|6436851|P2|NOT COMPLETED|Overall Study||100
2622483|NCT00013611|6436852|P1|NOT COMPLETED|Overall Study||91
2622484|NCT00013611|6436851|P2|COMPLETED|Overall Study||746
2622485|NCT00013611|6436852|P1|COMPLETED|Overall Study||758
2622486|NCT00013611|6436851|P2|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|846
2622487|NCT00013611|6436852|P1|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|849
2622488|NCT00010803|6436870|P2|NOT COMPLETED|Overall Study||98
2622489|NCT00010803|6436871|P1|NOT COMPLETED|Overall Study||97
2622490|NCT00010803|6436870|P2|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1426
2622491|NCT00010803|6436871|P1|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1448
2622492|NCT00010803|6436870|P2|STARTED|Overall Study|Randomized|1524
2622493|NCT00010803|6436871|P1|STARTED|Overall Study|Randomized|1545
2622494|NCT00010439|6436881|P1|NOT COMPLETED|Overall Study||0
2622495|NCT00010439|6436881|P1|COMPLETED|Overall Study||10
2622496|NCT00010439|6436881|P1|6 Months|Overall Study||10
2622497|NCT00010439|6436881|P1|STARTED|Overall Study||10
2622504|NCT00007475|6436898|P4|NOT COMPLETED|Overall Study||0
2622505|NCT00007475|6436899|P3|NOT COMPLETED|Overall Study||0
2622506|NCT00007475|6436900|P2|NOT COMPLETED|Overall Study||0
2622507|NCT00007475|6436901|P1|NOT COMPLETED|Overall Study||4
2622508|NCT00007475|6436898|P4|COMPLETED|Overall Study||0
2622509|NCT00007475|6436899|P3|COMPLETED|Overall Study||2
2622510|NCT00007475|6436900|P2|COMPLETED|Overall Study||1
2622511|NCT00007475|6436901|P1|COMPLETED|Overall Study||8
2622512|NCT00007475|6436898|P4|Initiate Cyclophosphamide|Overall Study||0
2622513|NCT00007475|6436899|P3|Initiate Cyclophosphamide|Overall Study||2
2622514|NCT00007475|6436900|P2|Initiate Cyclophosphamide|Overall Study||1
2622515|NCT00007475|6436901|P1|Initiate Cyclophosphamide|Overall Study||12
2622516|NCT00007475|6436898|P4|Initial Plasma Exchange|Overall Study||0
2622517|NCT00007475|6436899|P3|Initial Plasma Exchange|Overall Study||2
2622518|NCT00007475|6436900|P2|Initial Plasma Exchange|Overall Study||1
2622519|NCT00007475|6436901|P1|Initial Plasma Exchange|Overall Study||12
2622520|NCT00007475|6436898|P4|Post-initial Transplant Proteinuria|Overall Study||0
2622521|NCT00007475|6436899|P3|Post-initial Transplant Proteinuria|Overall Study||2
2622522|NCT00007475|6436900|P2|Post-initial Transplant Proteinuria|Overall Study||1
2622523|NCT00007475|6436901|P1|Post-initial Transplant Proteinuria|Overall Study||12
2622524|NCT00007475|6436898|P4|Initial Transplant|Overall Study||0
2622525|NCT00007475|6436899|P3|Initial Transplant|Overall Study||2
2622526|NCT00007475|6436900|P2|Initial Transplant|Overall Study||1
2622527|NCT00007475|6436901|P1|Initial Transplant|Overall Study||12
2622528|NCT00007475|6436898|P4|FSGS Permeability Factor (FPF) Assayed|Overall Study||0
2622529|NCT00007475|6436899|P3|FSGS Permeability Factor (FPF) Assayed|Overall Study||2
2622530|NCT00007475|6436900|P2|FSGS Permeability Factor (FPF) Assayed|Overall Study||1
2622531|NCT00007475|6436901|P1|FSGS Permeability Factor (FPF) Assayed|Overall Study|FSGS Permeability Factor's provisional assay only applied to minority of early enrollees, by design.|0
2622532|NCT00007475|6436898|P4|STARTED|Overall Study||0
2622533|NCT00007475|6436899|P3|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|2
2622534|NCT00007475|6436900|P2|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|1
2622535|NCT00007475|6436901|P1|STARTED|Overall Study|[ arm reflects un-assayed participants' disposition ]|12
2622536|NCT00007345|6436923|P2|NOT COMPLETED|Overall Study||11
2622537|NCT00007345|6436924|P1|NOT COMPLETED|Overall Study||2
2622538|NCT00007345|6436923|P2|COMPLETED|Overall Study||73
2622539|NCT00007345|6436924|P1|COMPLETED|Overall Study||45
2622540|NCT00007345|6436923|P2|STARTED|Overall Study||84
2622541|NCT00007345|6436924|P1|STARTED|Overall Study||47
2622542|NCT00006489|6436946|P4|NOT COMPLETED|Overall Study||11
2622543|NCT00006489|6436947|P3|NOT COMPLETED|Overall Study||15
2622544|NCT00006489|6436948|P2|NOT COMPLETED|Overall Study||14
2622545|NCT00006489|6436949|P1|NOT COMPLETED|Overall Study||13
2622546|NCT00006489|6436946|P4|COMPLETED|Overall Study||32
2622547|NCT00006489|6436947|P3|COMPLETED|Overall Study||25
2622548|NCT00006489|6436948|P2|COMPLETED|Overall Study||26
2622549|NCT00006489|6436949|P1|COMPLETED|Overall Study||29
2622550|NCT00006489|6436946|P4|STARTED|Overall Study||43
2622551|NCT00006489|6436947|P3|STARTED|Overall Study||40
2622552|NCT00006489|6436948|P2|STARTED|Overall Study||40
2622553|NCT00006489|6436949|P1|STARTED|Overall Study||42
2622560|NCT00006409|6436984|P6|NOT COMPLETED|Post-3 Year Intervention||62
2622561|NCT00006409|6436985|P5|NOT COMPLETED|Post-3 Year Intervention||62
2622562|NCT00006409|6436986|P4|NOT COMPLETED|Post-3 Year Intervention||0
2622563|NCT00006409|6436987|P3|NOT COMPLETED|Post-3 Year Intervention||0
2622564|NCT00006409|6436988|P2|NOT COMPLETED|Post-3 Year Intervention||0
2622565|NCT00006409|6436989|P1|NOT COMPLETED|Post-3 Year Intervention||0
2622566|NCT00006409|6436984|P6|COMPLETED|Post-3 Year Intervention||1714
2622567|NCT00006409|6436985|P5|COMPLETED|Post-3 Year Intervention||1664
2622568|NCT00006409|6436986|P4|COMPLETED|Post-3 Year Intervention||0
2622569|NCT00006409|6436987|P3|COMPLETED|Post-3 Year Intervention||0
2622570|NCT00006409|6436988|P2|COMPLETED|Post-3 Year Intervention||0
2622571|NCT00006409|6436989|P1|COMPLETED|Post-3 Year Intervention||0
2622572|NCT00006409|6436984|P6|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1776
2622573|NCT00006409|6436985|P5|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1726
2622574|NCT00006409|6436986|P4|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
2622575|NCT00006409|6436987|P3|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
2622576|NCT00006409|6436988|P2|STARTED|Post-3 Year Intervention||0
2622577|NCT00006409|6436989|P1|STARTED|Post-3 Year Intervention||0
2622578|NCT00006409|6436984|P6|NOT COMPLETED|Post-2 Year Intervention||0
2622579|NCT00006409|6436985|P5|NOT COMPLETED|Post-2 Year Intervention||0
2622580|NCT00006409|6436986|P4|NOT COMPLETED|Post-2 Year Intervention||168
2622581|NCT00006409|6436987|P3|NOT COMPLETED|Post-2 Year Intervention||251
2622582|NCT00006409|6436988|P2|NOT COMPLETED|Post-2 Year Intervention||0
2622583|NCT00006409|6436989|P1|NOT COMPLETED|Post-2 Year Intervention||0
2622584|NCT00006409|6436984|P6|COMPLETED|Post-2 Year Intervention||0
2622585|NCT00006409|6436985|P5|COMPLETED|Post-2 Year Intervention||0
2622586|NCT00006409|6436986|P4|COMPLETED|Post-2 Year Intervention||1545
2622587|NCT00006409|6436987|P3|COMPLETED|Post-2 Year Intervention||1540
2622588|NCT00006409|6436988|P2|COMPLETED|Post-2 Year Intervention||0
2622589|NCT00006409|6436989|P1|COMPLETED|Post-2 Year Intervention||0
2622590|NCT00006409|6436984|P6|STARTED|Post-2 Year Intervention||0
2622591|NCT00006409|6436985|P5|STARTED|Post-2 Year Intervention||0
2622592|NCT00006409|6436986|P4|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1713
2622593|NCT00006409|6436987|P3|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1791
2622594|NCT00006409|6436988|P2|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
2622595|NCT00006409|6436989|P1|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
2622596|NCT00006409|6436984|P6|NOT COMPLETED|Baseline||0
2622597|NCT00006409|6436985|P5|NOT COMPLETED|Baseline||0
2622598|NCT00006409|6436986|P4|NOT COMPLETED|Baseline||0
2622599|NCT00006409|6436987|P3|NOT COMPLETED|Baseline||0
2622600|NCT00006409|6436988|P2|NOT COMPLETED|Baseline||70
2622601|NCT00006409|6436989|P1|NOT COMPLETED|Baseline||48
2622602|NCT00006409|6436984|P6|COMPLETED|Baseline||0
2622603|NCT00006409|6436985|P5|COMPLETED|Baseline||0
2622604|NCT00006409|6436986|P4|COMPLETED|Baseline||0
2622605|NCT00006409|6436987|P3|COMPLETED|Baseline||0
2622606|NCT00006409|6436988|P2|COMPLETED|Baseline||786
2622607|NCT00006409|6436989|P1|COMPLETED|Baseline||817
2622608|NCT00006409|6436984|P6|STARTED|Baseline||0
2622609|NCT00006409|6436985|P5|STARTED|Baseline||0
2622610|NCT00006409|6436986|P4|STARTED|Baseline||0
2622611|NCT00006409|6436987|P3|STARTED|Baseline||0
2622612|NCT00006409|6436988|P2|STARTED|Baseline||856
2622613|NCT00006409|6436989|P1|STARTED|Baseline||865
2622614|NCT00006305|6437013|P4|NOT COMPLETED|Overall Study||14
2622615|NCT00006305|6437014|P3|NOT COMPLETED|Overall Study||15
2622616|NCT00006305|6437015|P2|NOT COMPLETED|Overall Study||10
2622617|NCT00006305|6437016|P1|NOT COMPLETED|Overall Study||17
2622618|NCT00006305|6437013|P4|COMPLETED|Overall Study||585
2622619|NCT00006305|6437014|P3|COMPLETED|Overall Study||578
2622620|NCT00006305|6437015|P2|COMPLETED|Overall Study||574
2622621|NCT00006305|6437016|P1|COMPLETED|Overall Study||575
2622622|NCT00006305|6437013|P4|STARTED|Overall Study||599
2622623|NCT00006305|6437014|P3|STARTED|Overall Study||593
2622624|NCT00006305|6437015|P2|STARTED|Overall Study||584
2622625|NCT00006305|6437016|P1|STARTED|Overall Study||592
2622626|NCT00006289|6437032|P2|NOT COMPLETED|Second Intervention (5 Weeks)||1
2622627|NCT00006289|6437033|P1|NOT COMPLETED|Second Intervention (5 Weeks)||1
2622628|NCT00006289|6437032|P2|COMPLETED|Second Intervention (5 Weeks)||9
2622629|NCT00006289|6437033|P1|COMPLETED|Second Intervention (5 Weeks)||9
2622630|NCT00006289|6437032|P2|STARTED|Second Intervention (5 Weeks)||10
2622631|NCT00006289|6437033|P1|STARTED|Second Intervention (5 Weeks)||10
2622632|NCT00006289|6437032|P2|NOT COMPLETED|Washout (>= 1 Week)||0
2622633|NCT00006289|6437033|P1|NOT COMPLETED|Washout (>= 1 Week)||0
2622634|NCT00006289|6437032|P2|COMPLETED|Washout (>= 1 Week)||10
2622635|NCT00006289|6437033|P1|COMPLETED|Washout (>= 1 Week)||10
2622636|NCT00006289|6437032|P2|STARTED|Washout (>= 1 Week)||10
2622637|NCT00006289|6437033|P1|STARTED|Washout (>= 1 Week)||10
2622638|NCT00006289|6437032|P2|NOT COMPLETED|First Intervention (5 Weeks)||0
2622639|NCT00006289|6437033|P1|NOT COMPLETED|First Intervention (5 Weeks)||1
2622640|NCT00006289|6437032|P2|COMPLETED|First Intervention (5 Weeks)||10
2622641|NCT00006289|6437033|P1|COMPLETED|First Intervention (5 Weeks)||10
2622642|NCT00006289|6437032|P2|STARTED|First Intervention (5 Weeks)||10
2622643|NCT00006289|6437033|P1|STARTED|First Intervention (5 Weeks)||11
2622644|NCT00006184|6437051|P2|NOT COMPLETED|Overall Study||0
2622645|NCT00006184|6437052|P1|NOT COMPLETED|Overall Study||1
2622646|NCT00006184|6437051|P2|COMPLETED|Overall Study||10
2622647|NCT00006184|6437052|P1|COMPLETED|Overall Study||9
2622648|NCT00006184|6437051|P2|STARTED|Overall Study||10
2622649|NCT00006184|6437052|P1|STARTED|Overall Study||10
2622650|NCT00006178|6437059|P1|NOT COMPLETED|Overall Study||0
2622651|NCT00006178|6437059|P1|COMPLETED|Overall Study||12
2622652|NCT00006178|6437059|P1|STARTED|Overall Study||12
2622653|NCT00006170|6437070|P4|NOT COMPLETED|Overall Study||39
2622654|NCT00006170|6437071|P3|NOT COMPLETED|Overall Study||43
2622655|NCT00006170|6437072|P2|NOT COMPLETED|Overall Study||50
2622656|NCT00006170|6437073|P1|NOT COMPLETED|Overall Study||49
2622657|NCT00006170|6437070|P4|COMPLETED|Overall Study||28
2622658|NCT00006170|6437071|P3|COMPLETED|Overall Study||46
2622659|NCT00006170|6437072|P2|COMPLETED|Overall Study||37
2622660|NCT00006170|6437073|P1|COMPLETED|Overall Study||57
2622661|NCT00006170|6437070|P4|STARTED|Overall Study||67
2622662|NCT00006170|6437071|P3|STARTED|Overall Study||89
2622663|NCT00006170|6437072|P2|STARTED|Overall Study||87
2622664|NCT00006170|6437073|P1|STARTED|Overall Study||106
2622665|NCT00006156|6437093|P2|NOT COMPLETED|Overall Study||0
2622666|NCT00006156|6437094|P1|NOT COMPLETED|Overall Study||0
2622667|NCT00006156|6437093|P2|COMPLETED|Overall Study||7
2622668|NCT00006156|6437094|P1|COMPLETED|Overall Study||42
2622669|NCT00006156|6437093|P2|STARTED|Overall Study||7
2622670|NCT00006156|6437094|P1|STARTED|Overall Study||42
2622671|NCT00006164|6437103|P2|NOT COMPLETED|Overall Study||81
2622672|NCT00006164|6437104|P1|NOT COMPLETED|Overall Study||70
2622673|NCT00006164|6437103|P2|COMPLETED|Overall Study|81 Withdrew or were lost to followup; 9 took peginterferon outside of protocol|452
2622674|NCT00006164|6437104|P1|COMPLETED|Overall Study|70 Withdrew or were lost to followup; 158 Discontinued peginterferon but were followed|447
2622675|NCT00006164|6437103|P2|STARTED|Overall Study||533
2622676|NCT00006164|6437104|P1|STARTED|Overall Study||517
2622677|NCT00006151|6437140|P2|NOT COMPLETED|Overall Study||14
2622678|NCT00006151|6437141|P1|NOT COMPLETED|Overall Study||13
2622679|NCT00006151|6437140|P2|COMPLETED|Overall Study||16
2622680|NCT00006151|6437141|P1|COMPLETED|Overall Study||17
2622681|NCT00006151|6437140|P2|STARTED|Overall Study||30
2622682|NCT00006151|6437141|P1|STARTED|Overall Study||30
2622683|NCT00005937|6437147|P1|NOT COMPLETED|Overall Study||5
2622684|NCT00005937|6437147|P1|COMPLETED|Overall Study||37
2622685|NCT00005937|6437147|P1|STARTED|Overall Study||42
2622686|NCT00005908|6437151|P2|NOT COMPLETED|Overall Study||0
2622687|NCT00005908|6437152|P1|NOT COMPLETED|Overall Study||1
2622688|NCT00005908|6437151|P2|COMPLETED|Overall Study||20
2622689|NCT00005908|6437152|P1|COMPLETED|Overall Study||9
2622690|NCT00005908|6437151|P2|STARTED|Overall Study||20
2622691|NCT00005908|6437152|P1|STARTED|Overall Study||10
2622692|NCT00005906|6437161|P1|NOT COMPLETED|Overall Study||3
2622693|NCT00005906|6437161|P1|COMPLETED|Overall Study||1
2622694|NCT00005906|6437161|P1|STARTED|Overall Study||4
2622695|NCT00005901|6437169|P2|NOT COMPLETED|Overall Study||0
2622696|NCT00005901|6437170|P1|NOT COMPLETED|Overall Study||0
2622697|NCT00005901|6437169|P2|COMPLETED|Overall Study||15
2622698|NCT00005901|6437170|P1|COMPLETED|Overall Study||19
2622699|NCT00005901|6437169|P2|STARTED|Overall Study||15
2622700|NCT00005901|6437170|P1|STARTED|Overall Study||19
2622701|NCT00005669|6437188|P2|NOT COMPLETED|Overall Study||7
2622702|NCT00005669|6437189|P1|NOT COMPLETED|Overall Study||8
2622703|NCT00005669|6437188|P2|COMPLETED|Overall Study||40
2622704|NCT00005669|6437189|P1|COMPLETED|Overall Study||45
2622705|NCT00005669|6437188|P2|STARTED|Overall Study||47
2622706|NCT00005669|6437189|P1|STARTED|Overall Study||53
2622707|NCT00004980|6437205|P2|NOT COMPLETED|Overall Study||2
2622708|NCT00004980|6437206|P1|NOT COMPLETED|Overall Study||2
2622709|NCT00004980|6437205|P2|COMPLETED|Overall Study||21
2622710|NCT00004980|6437206|P1|COMPLETED|Overall Study||25
2622711|NCT00004980|6437205|P2|STARTED|Overall Study||23
2622712|NCT00004980|6437206|P1|STARTED|Overall Study||27
2622713|NCT00004732|6437220|P2|NOT COMPLETED|Overall Study||111
2622714|NCT00004732|6437221|P1|NOT COMPLETED|Overall Study||69
2622715|NCT00004732|6437220|P2|COMPLETED|Overall Study||1129
2622716|NCT00004732|6437221|P1|COMPLETED|Overall Study||1193
2622717|NCT00004732|6437220|P2|STARTED|Overall Study||1240
2622718|NCT00004732|6437221|P1|STARTED|Overall Study||1262
2622719|NCT00004635|6437231|P2|NOT COMPLETED|Period Two||9
2622720|NCT00004635|6437232|P1|NOT COMPLETED|Period Two||6
2622721|NCT00004635|6437231|P2|COMPLETED|Period Two||50
2622722|NCT00004635|6437232|P1|COMPLETED|Period Two||38
2622723|NCT00004635|6437231|P2|STARTED|Period Two||59
2622724|NCT00004635|6437232|P1|STARTED|Period Two||44
2622725|NCT00004635|6437231|P2|NOT COMPLETED|Period One||6
2622726|NCT00004635|6437232|P1|NOT COMPLETED|Period One||6
2622727|NCT00004635|6437231|P2|COMPLETED|Period One||74
2622728|NCT00004635|6437232|P1|COMPLETED|Period One||73
2622729|NCT00004635|6437231|P2|Received Treatment|Period One||75
2622730|NCT00004635|6437232|P1|Received Treatment|Period One||73
2622731|NCT00004635|6437231|P2|STARTED|Period One||80
2622732|NCT00004635|6437232|P1|STARTED|Period One||79
2622733|NCT00004563|6437244|P2|NOT COMPLETED|Overall Study||24
2622734|NCT00004563|6437245|P1|NOT COMPLETED|Overall Study||25
2622735|NCT00004563|6437244|P2|COMPLETED|Overall Study||55
2622736|NCT00004563|6437245|P1|COMPLETED|Overall Study||54
2622737|NCT00004563|6437244|P2|STARTED|Overall Study||79
2622738|NCT00004563|6437245|P1|STARTED|Overall Study||79
2622739|NCT00004562|6437257|P2|NOT COMPLETED|Overall Study||91
2622740|NCT00004562|6437258|P1|NOT COMPLETED|Overall Study||102
2622741|NCT00004562|6437257|P2|COMPLETED|Overall Study||1009
2622742|NCT00004562|6437258|P1|COMPLETED|Overall Study||999
2622743|NCT00004562|6437257|P2|STARTED|Overall Study||1100
2622744|NCT00004562|6437258|P1|STARTED|Overall Study||1101
2622745|NCT00004547|6437269|P3|NOT COMPLETED|Overall Study||22
2622746|NCT00004547|6437270|P2|NOT COMPLETED|Overall Study||9
2622747|NCT00004547|6437271|P1|NOT COMPLETED|Overall Study||22
2622748|NCT00004547|6437269|P3|COMPLETED|Overall Study||35
2622749|NCT00004547|6437270|P2|COMPLETED|Overall Study||39
2622750|NCT00004547|6437271|P1|COMPLETED|Overall Study||61
2622751|NCT00004547|6437269|P3|Not Evaluable|Overall Study||23
2622752|NCT00004547|6437270|P2|Not Evaluable|Overall Study||9
2622753|NCT00004547|6437271|P1|Not Evaluable|Overall Study||21
2622754|NCT00004547|6437269|P3|STARTED|Overall Study||57
2622755|NCT00004547|6437270|P2|STARTED|Overall Study||48
2622756|NCT00004547|6437271|P1|STARTED|Overall Study||83
2622757|NCT00001984|6437289|P1|NOT COMPLETED|Overall Study||0
2622758|NCT00001984|6437289|P1|COMPLETED|Overall Study||5
2622759|NCT00001984|6437289|P1|STARTED|Overall Study||5
2622760|NCT00001962|6437299|P1|NOT COMPLETED|Overall Study||28
2622761|NCT00001962|6437299|P1|COMPLETED|Overall Study||72
2622762|NCT00001962|6437299|P1|STARTED|Overall Study||100
2622763|NCT00001959|6437303|P1|NOT COMPLETED|Overall Study||3
2622764|NCT00001959|6437303|P1|COMPLETED|Overall Study||18
2622765|NCT00001959|6437303|P1|STARTED|Overall Study||21
2622766|NCT00001941|6437309|P5|NOT COMPLETED|Overall Study||1
2622767|NCT00001941|6437310|P4|NOT COMPLETED|Overall Study||0
2622768|NCT00001941|6437311|P3|NOT COMPLETED|Overall Study||0
2622769|NCT00001941|6437312|P2|NOT COMPLETED|Overall Study||0
2622770|NCT00001941|6437313|P1|NOT COMPLETED|Overall Study||0
2622771|NCT00001941|6437309|P5|COMPLETED|Overall Study||19
2622772|NCT00001941|6437310|P4|COMPLETED|Overall Study||3
2622773|NCT00001941|6437311|P3|COMPLETED|Overall Study||3
2622774|NCT00001941|6437312|P2|COMPLETED|Overall Study||5
2622775|NCT00001941|6437313|P1|COMPLETED|Overall Study||3
2622776|NCT00001941|6437309|P5|STARTED|Overall Study||20
2622777|NCT00001941|6437310|P4|STARTED|Overall Study||3
2622778|NCT00001941|6437311|P3|STARTED|Overall Study||3
2622779|NCT00001941|6437312|P2|STARTED|Overall Study||5
2622780|NCT00001941|6437313|P1|STARTED|Overall Study||3
2622781|NCT00000392|6437322|P2|NOT COMPLETED|Overall Study||32
2622782|NCT00000392|6437323|P1|NOT COMPLETED|Overall Study||40
2622783|NCT00000392|6437322|P2|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|77
2622784|NCT00000392|6437323|P1|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|66
2622785|NCT00000392|6437322|P2|STARTED|Overall Study||109
2622786|NCT00000392|6437323|P1|STARTED|Overall Study||106
2622787|NCT00001832|6437345|P15|NOT COMPLETED|Treatment Period||0
2622788|NCT00001832|6437346|P14|NOT COMPLETED|Treatment Period||0
2622789|NCT00001832|6437347|P13|NOT COMPLETED|Treatment Period||0
2622790|NCT00001832|6437348|P12|NOT COMPLETED|Treatment Period||0
2622791|NCT00001832|6437349|P11|NOT COMPLETED|Treatment Period||0
2622792|NCT00001832|6437350|P10|NOT COMPLETED|Treatment Period||0
2622793|NCT00001832|6437351|P9|NOT COMPLETED|Treatment Period||0
2622794|NCT00001832|6437352|P8|NOT COMPLETED|Treatment Period||1
2622795|NCT00001832|6437353|P7|NOT COMPLETED|Treatment Period||0
2622796|NCT00001832|6437354|P6|NOT COMPLETED|Treatment Period||1
2622797|NCT00001832|6437355|P5|NOT COMPLETED|Treatment Period||0
2622798|NCT00001832|6437356|P4|NOT COMPLETED|Treatment Period||0
2622799|NCT00001832|6437357|P3|NOT COMPLETED|Treatment Period||0
2622800|NCT00001832|6437358|P2|NOT COMPLETED|Treatment Period||0
2622801|NCT00001832|6437359|P1|NOT COMPLETED|Treatment Period||0
2622802|NCT00001832|6437345|P15|COMPLETED|Treatment Period||2
2622803|NCT00001832|6437346|P14|COMPLETED|Treatment Period||3
2622804|NCT00001832|6437347|P13|COMPLETED|Treatment Period||6
2622805|NCT00001832|6437348|P12|COMPLETED|Treatment Period||7
2622806|NCT00001832|6437349|P11|COMPLETED|Treatment Period||1
2622807|NCT00001832|6437350|P10|COMPLETED|Treatment Period||6
2622808|NCT00001832|6437351|P9|COMPLETED|Treatment Period||8
2622809|NCT00001832|6437352|P8|COMPLETED|Treatment Period||6
2622810|NCT00001832|6437353|P7|COMPLETED|Treatment Period||4
2622811|NCT00001832|6437354|P6|COMPLETED|Treatment Period||50
2622812|NCT00001832|6437355|P5|COMPLETED|Treatment Period||6
2622813|NCT00001832|6437356|P4|COMPLETED|Treatment Period||3
2622814|NCT00001832|6437357|P3|COMPLETED|Treatment Period||3
2622815|NCT00001832|6437358|P2|COMPLETED|Treatment Period||3
2622816|NCT00001832|6437359|P1|COMPLETED|Treatment Period||0
2622817|NCT00001832|6437345|P15|STARTED|Treatment Period||2
2622818|NCT00001832|6437346|P14|STARTED|Treatment Period||3
2622819|NCT00001832|6437347|P13|STARTED|Treatment Period||6
2622820|NCT00001832|6437348|P12|STARTED|Treatment Period||7
2622821|NCT00001832|6437349|P11|STARTED|Treatment Period||1
2622822|NCT00001832|6437350|P10|STARTED|Treatment Period||6
2622823|NCT00001832|6437351|P9|STARTED|Treatment Period||8
2622824|NCT00001832|6437352|P8|STARTED|Treatment Period||7
2622825|NCT00001832|6437353|P7|STARTED|Treatment Period||4
2622826|NCT00001832|6437354|P6|STARTED|Treatment Period||51
2622827|NCT00001832|6437355|P5|STARTED|Treatment Period||6
2622828|NCT00001832|6437356|P4|STARTED|Treatment Period||3
2622829|NCT00001832|6437357|P3|STARTED|Treatment Period||3
2622830|NCT00001832|6437358|P2|STARTED|Treatment Period||3
2622831|NCT00001832|6437359|P1|STARTED|Treatment Period||0
2622832|NCT00001832|6437345|P15|NOT COMPLETED|Apheresis Period||0
2622833|NCT00001832|6437346|P14|NOT COMPLETED|Apheresis Period||0
2622834|NCT00001832|6437347|P13|NOT COMPLETED|Apheresis Period||0
2622835|NCT00001832|6437348|P12|NOT COMPLETED|Apheresis Period||0
2622836|NCT00001832|6437349|P11|NOT COMPLETED|Apheresis Period||0
2622837|NCT00001832|6437350|P10|NOT COMPLETED|Apheresis Period||0
2622838|NCT00001832|6437351|P9|NOT COMPLETED|Apheresis Period||0
2622839|NCT00001832|6437352|P8|NOT COMPLETED|Apheresis Period||0
2622840|NCT00001832|6437353|P7|NOT COMPLETED|Apheresis Period||0
2622841|NCT00001832|6437354|P6|NOT COMPLETED|Apheresis Period||0
2622842|NCT00001832|6437355|P5|NOT COMPLETED|Apheresis Period||0
2622843|NCT00001832|6437356|P4|NOT COMPLETED|Apheresis Period||0
2622844|NCT00001832|6437357|P3|NOT COMPLETED|Apheresis Period||0
2622845|NCT00001832|6437358|P2|NOT COMPLETED|Apheresis Period||0
2622846|NCT00001832|6437359|P1|NOT COMPLETED|Apheresis Period||60
2622847|NCT00001832|6437345|P15|COMPLETED|Apheresis Period||0
2622848|NCT00001832|6437346|P14|COMPLETED|Apheresis Period||0
2622849|NCT00001832|6437347|P13|COMPLETED|Apheresis Period||0
2622850|NCT00001832|6437348|P12|COMPLETED|Apheresis Period||0
2622851|NCT00001832|6437349|P11|COMPLETED|Apheresis Period||0
2622852|NCT00001832|6437350|P10|COMPLETED|Apheresis Period||0
2622853|NCT00001832|6437351|P9|COMPLETED|Apheresis Period||0
2622854|NCT00001832|6437352|P8|COMPLETED|Apheresis Period||0
2622855|NCT00001832|6437353|P7|COMPLETED|Apheresis Period||0
2622856|NCT00001832|6437354|P6|COMPLETED|Apheresis Period||0
2622857|NCT00001832|6437355|P5|COMPLETED|Apheresis Period||0
2622858|NCT00001832|6437356|P4|COMPLETED|Apheresis Period||0
2622859|NCT00001832|6437357|P3|COMPLETED|Apheresis Period||0
2622860|NCT00001832|6437358|P2|COMPLETED|Apheresis Period||0
2622861|NCT00001832|6437359|P1|COMPLETED|Apheresis Period||110
2622862|NCT00001832|6437345|P15|STARTED|Apheresis Period||0
2622863|NCT00001832|6437346|P14|STARTED|Apheresis Period||0
2622864|NCT00001832|6437347|P13|STARTED|Apheresis Period||0
2622865|NCT00001832|6437348|P12|STARTED|Apheresis Period||0
2622866|NCT00001832|6437349|P11|STARTED|Apheresis Period||0
2622867|NCT00001832|6437350|P10|STARTED|Apheresis Period||0
2622868|NCT00001832|6437351|P9|STARTED|Apheresis Period||0
2622869|NCT00001832|6437352|P8|STARTED|Apheresis Period||0
2622870|NCT00001832|6437353|P7|STARTED|Apheresis Period||0
2622871|NCT00001832|6437354|P6|STARTED|Apheresis Period||0
2622872|NCT00001832|6437355|P5|STARTED|Apheresis Period||0
2622873|NCT00001832|6437356|P4|STARTED|Apheresis Period||0
2622874|NCT00001832|6437357|P3|STARTED|Apheresis Period||0
2622875|NCT00001832|6437358|P2|STARTED|Apheresis Period||0
2622876|NCT00001832|6437359|P1|STARTED|Apheresis Period||170
2622877|NCT00001723|6437405|P2|NOT COMPLETED|Overall Study||16
2622878|NCT00001723|6437406|P1|NOT COMPLETED|Overall Study||13
2622879|NCT00001723|6437405|P2|COMPLETED|Overall Study||84
2622880|NCT00001723|6437406|P1|COMPLETED|Overall Study||87
2622881|NCT00001723|6437405|P2|STARTED|Overall Study||100
2622882|NCT00001723|6437406|P1|STARTED|Overall Study||100
2622883|NCT00001703|6437422|P1|NOT COMPLETED|Overall Study||5
2622884|NCT00001703|6437422|P1|COMPLETED|Overall Study||1
2622885|NCT00001703|6437422|P1|Peptide Stock Completed|Overall Study|off therapy reason for 3 patients|3
2622886|NCT00001703|6437422|P1|STARTED|Overall Study||6
2622887|NCT00001656|6437429|P2|NOT COMPLETED|Overall Study||0
2622888|NCT00001656|6437430|P1|NOT COMPLETED|Overall Study||1
2622889|NCT00001656|6437429|P2|COMPLETED|Overall Study||12
2622890|NCT00001656|6437430|P1|COMPLETED|Overall Study||12
2622891|NCT00001656|6437429|P2|STARTED|Overall Study||12
2622892|NCT00001656|6437430|P1|STARTED|Overall Study||13
2622893|NCT00001596|6437460|P2|NOT COMPLETED|Overall Study||10
2622894|NCT00001596|6437461|P1|NOT COMPLETED|Overall Study||17
2622895|NCT00001596|6437460|P2|COMPLETED|Overall Study||2
2622896|NCT00001596|6437461|P1|COMPLETED|Overall Study||6
2622897|NCT00001596|6437460|P2|STARTED|Overall Study||12
2622898|NCT00001596|6437461|P1|STARTED|Overall Study||23
2622899|NCT00001586|6437483|P2|NOT COMPLETED|Overall Study||0
2622900|NCT00001586|6437484|P1|NOT COMPLETED|Overall Study||0
2622901|NCT00001586|6437483|P2|COMPLETED|Overall Study||56
2622902|NCT00001586|6437484|P1|COMPLETED|Overall Study||49
2622903|NCT00001586|6437483|P2|STARTED|Overall Study||56
2622904|NCT00001586|6437484|P1|STARTED|Overall Study||49
2622905|NCT00001575|6437492|P1|NOT COMPLETED|Overall Study||45
2622906|NCT00001575|6437492|P1|COMPLETED|Overall Study||42
2622907|NCT00001575|6437492|P1|Treated|Overall Study||65
2622908|NCT00001575|6437492|P1|STARTED|Overall Study||87
2622909|NCT00001566|6437498|P1|NOT COMPLETED|Overall Study||19
2622910|NCT00001566|6437498|P1|COMPLETED|Overall Study||23
2622911|NCT00001566|6437498|P1|Completed Immunotherapy|Overall Study||23
2622912|NCT00001566|6437498|P1|STARTED|Overall Study||42
2622913|NCT00001305|6437510|P1|NOT COMPLETED|Overall Study||0
2622914|NCT00001305|6437510|P1|COMPLETED|Overall Study||42
2622915|NCT00001305|6437510|P1|STARTED|Overall Study||42
2622916|NCT00001304|6437516|P2|NOT COMPLETED|Overall Study||0
2622917|NCT00001304|6437517|P1|NOT COMPLETED|Overall Study||0
2622918|NCT00001304|6437516|P2|COMPLETED|Overall Study||14
2622919|NCT00001304|6437517|P1|COMPLETED|Overall Study||13
2622920|NCT00001304|6437516|P2|STARTED|Overall Study||14
2622921|NCT00001304|6437517|P1|STARTED|Overall Study||13
2622922|NCT00001262|6437538|P3|NOT COMPLETED|Overall Study||0
2622923|NCT00001262|6437539|P2|NOT COMPLETED|Overall Study||14
2622924|NCT00001262|6437540|P1|NOT COMPLETED|Overall Study||10
2622925|NCT00001262|6437538|P3|COMPLETED|Overall Study||3
2622926|NCT00001262|6437539|P2|COMPLETED|Overall Study||8
2622927|NCT00001262|6437540|P1|COMPLETED|Overall Study||25
2622928|NCT00001262|6437538|P3|STARTED|Overall Study||3
2622929|NCT00001262|6437539|P2|STARTED|Overall Study||22
2622930|NCT00001262|6437540|P1|STARTED|Overall Study||35
2622931|NCT00001213|6437566|P1|NOT COMPLETED|Overall Study||18
2622932|NCT00001213|6437566|P1|COMPLETED|Overall Study||310
2622933|NCT00001213|6437566|P1|STARTED|Overall Study||328
2622934|NCT00001151|6437571|P1|NOT COMPLETED|Overall Study||5
2622935|NCT00001151|6437571|P1|COMPLETED|Overall Study||1
2622936|NCT00001151|6437571|P1|STARTED|Overall Study||6
2622937|NCT00000378|6437577|P2|NOT COMPLETED|Overall Study||14
2622938|NCT00000378|6437578|P1|NOT COMPLETED|Overall Study||16
2622939|NCT00000378|6437577|P2|COMPLETED|Overall Study||38
2622940|NCT00000378|6437578|P1|COMPLETED|Overall Study||42
2622941|NCT00000378|6437577|P2|STARTED|Overall Study||52
2622942|NCT00000378|6437578|P1|STARTED|Overall Study||58
2622943|NCT00000371|6437586|P2|NOT COMPLETED|Overall Study||16
2622944|NCT00000371|6437587|P1|NOT COMPLETED|Overall Study||13
2622945|NCT00000371|6437586|P2|COMPLETED|Overall Study||12
2622946|NCT00000371|6437587|P1|COMPLETED|Overall Study||14
2622947|NCT00000371|6437586|P2|STARTED|Overall Study||28
2622948|NCT00000371|6437587|P1|STARTED|Overall Study||27
2622949|NCT00000620|6437595|P8|NOT COMPLETED|Overall Study||146
2622950|NCT00000620|6437596|P7|NOT COMPLETED|Overall Study||149
2622951|NCT00000620|6437597|P6|NOT COMPLETED|Overall Study||152
2622952|NCT00000620|6437598|P5|NOT COMPLETED|Overall Study||135
2622953|NCT00000620|6437599|P4|NOT COMPLETED|Overall Study||178
2622954|NCT00000620|6437600|P3|NOT COMPLETED|Overall Study||170
2622955|NCT00000620|6437601|P2|NOT COMPLETED|Overall Study||136
2622956|NCT00000620|6437602|P1|NOT COMPLETED|Overall Study||162
2622957|NCT00000620|6437595|P8|COMPLETED|Overall Study||1224
2622958|NCT00000620|6437596|P7|COMPLETED|Overall Study||1242
2622959|NCT00000620|6437597|P6|COMPLETED|Overall Study||1026
2622960|NCT00000620|6437598|P5|COMPLETED|Overall Study||1049
2622961|NCT00000620|6437599|P4|COMPLETED|Overall Study||1205
2622962|NCT00000620|6437600|P3|COMPLETED|Overall Study||1204
2622963|NCT00000620|6437601|P2|COMPLETED|Overall Study||1057
2622964|NCT00000620|6437602|P1|COMPLETED|Overall Study||1016
2622965|NCT00000620|6437595|P8|STARTED|Overall Study||1370
2622966|NCT00000620|6437596|P7|STARTED|Overall Study||1391
2622967|NCT00000620|6437597|P6|STARTED|Overall Study||1178
2622968|NCT00000620|6437598|P5|STARTED|Overall Study||1184
2622969|NCT00000620|6437599|P4|STARTED|Overall Study||1383
2622970|NCT00000620|6437600|P3|STARTED|Overall Study||1374
2622971|NCT00000620|6437601|P2|STARTED|Overall Study||1193
2622972|NCT00000620|6437602|P1|STARTED|Overall Study||1178
2622973|NCT00000575|6437621|P3|NOT COMPLETED|Overall Study||0
2622974|NCT00000575|6437622|P2|NOT COMPLETED|Overall Study||0
2622975|NCT00000575|6437623|P1|NOT COMPLETED|Overall Study||0
2622976|NCT00000575|6437621|P3|COMPLETED|Overall Study||418
2622977|NCT00000575|6437622|P2|COMPLETED|Overall Study||312
2622978|NCT00000575|6437623|P1|COMPLETED|Overall Study||311
2622979|NCT00000575|6437621|P3|STARTED|Overall Study||418
2622980|NCT00000575|6437622|P2|STARTED|Overall Study||312
2622981|NCT00000575|6437623|P1|STARTED|Overall Study||311
2622982|NCT00000479|6437653|P4|NOT COMPLETED|Overall Study||0
2622983|NCT00000479|6437654|P3|NOT COMPLETED|Overall Study||0
2622984|NCT00000479|6437655|P2|NOT COMPLETED|Overall Study||0
2622985|NCT00000479|6437656|P1|NOT COMPLETED|Overall Study||0
2622986|NCT00000479|6437653|P4|COMPLETED|Overall Study||9971
2622987|NCT00000479|6437654|P3|COMPLETED|Overall Study||9966
2622988|NCT00000479|6437655|P2|COMPLETED|Overall Study||9971
2622989|NCT00000479|6437656|P1|COMPLETED|Overall Study||9968
2622990|NCT00000479|6437653|P4|STARTED|Overall Study||9971
2622991|NCT00000479|6437654|P3|STARTED|Overall Study||9966
2622992|NCT00000479|6437655|P2|STARTED|Overall Study||9971
2622993|NCT00000479|6437656|P1|STARTED|Overall Study||9968
2622994|NCT00004500|6437672|P2|NOT COMPLETED|Overall Study||0
2622995|NCT00004500|6437673|P1|NOT COMPLETED|Overall Study||0
2622996|NCT00004500|6437672|P2|COMPLETED|Overall Study||31
2622997|NCT00004500|6437673|P1|COMPLETED|Overall Study||38
2622998|NCT00004500|6437672|P2|1 Year Follow-Up|Overall Study||24
2622999|NCT00004500|6437673|P1|1 Year Follow-Up|Overall Study||24
2623000|NCT00004500|6437672|P2|STARTED|Overall Study||31
2623001|NCT00004500|6437673|P1|STARTED|Overall Study||38
2623002|NCT00004445|6437683|P1|NOT COMPLETED|Overall Study||3
2623003|NCT00004445|6437683|P1|COMPLETED|Overall Study||15
2623004|NCT00004445|6437683|P1|STARTED|Overall Study||18
2623005|NCT00004412|6437691|P3|NOT COMPLETED|Crossover Period||0
2623006|NCT00004412|6437692|P2|NOT COMPLETED|Crossover Period||0
2623007|NCT00004412|6437693|P1|NOT COMPLETED|Crossover Period||0
2623008|NCT00004412|6437691|P3|COMPLETED|Crossover Period|Three subjects, from Arm I, who crossed- over to Arm II completed the study.|3
2623009|NCT00004412|6437692|P2|COMPLETED|Crossover Period|Twelve subjects in this arm completed the study.|12
2623010|NCT00004412|6437693|P1|COMPLETED|Crossover Period|Eight subjects in this arm completed study without crossing over.|8
2623011|NCT00004412|6437691|P3|STARTED|Crossover Period|Three of Randomized Period's Arm I elected to move to Crossover Period's Crossover Arm.|3
2623012|NCT00004412|6437692|P2|STARTED|Crossover Period|Twelve patients were randomized to the Arginine Butyrate plus Standard local care dressing Arm|12
2623013|NCT00004412|6437693|P1|STARTED|Crossover Period|Eight subjects were randomized to Standard of Care dressing Arm|8
2623014|NCT00004412|6437691|P3|NOT COMPLETED|Randomized Period||0
2623015|NCT00004412|6437692|P2|NOT COMPLETED|Randomized Period||0
2623016|NCT00004412|6437693|P1|NOT COMPLETED|Randomized Period||3
2623017|NCT00004412|6437691|P3|COMPLETED|Randomized Period||0
2623018|NCT00004412|6437692|P2|COMPLETED|Randomized Period||12
2623019|NCT00004412|6437693|P1|COMPLETED|Randomized Period||8
2623020|NCT00004412|6437691|P3|STARTED|Randomized Period||0
2623021|NCT00004412|6437692|P2|STARTED|Randomized Period||12
2623022|NCT00004412|6437693|P1|STARTED|Randomized Period||11
2623023|NCT00000143|6437703|P2|NOT COMPLETED|Overall Study||0
2623024|NCT00000143|6437704|P1|NOT COMPLETED|Overall Study||0
2623025|NCT00000143|6437703|P2|COMPLETED|Overall Study||30
2623026|NCT00000143|6437704|P1|COMPLETED|Overall Study||31
2623027|NCT00000143|6437703|P2|STARTED|Overall Study||30
2623028|NCT00000143|6437704|P1|STARTED|Overall Study||31
2623029|NCT00000142|6437713|P3|NOT COMPLETED|Overall Study||0
2623030|NCT00000142|6437714|P2|NOT COMPLETED|Overall Study||0
2623031|NCT00000142|6437715|P1|NOT COMPLETED|Overall Study||0
2623032|NCT00000142|6437713|P3|COMPLETED|Overall Study||12
2623033|NCT00000142|6437714|P2|COMPLETED|Overall Study||26
2623034|NCT00000142|6437715|P1|COMPLETED|Overall Study||26
2623035|NCT00000142|6437713|P3|STARTED|Overall Study||12
2623036|NCT00000142|6437714|P2|STARTED|Overall Study||26
2623037|NCT00000142|6437715|P1|STARTED|Overall Study||26
2623038|NCT00000136|6437725|P2|NOT COMPLETED|Overall Study||0
2623039|NCT00000136|6437726|P1|NOT COMPLETED|Overall Study||0
2623040|NCT00000136|6437725|P2|COMPLETED|Overall Study||127
2623041|NCT00000136|6437726|P1|COMPLETED|Overall Study||107
2623042|NCT00000136|6437725|P2|STARTED|Overall Study||127
2623043|NCT00000136|6437726|P1|STARTED|Overall Study||107
2623044|NCT00000135|6437734|P2|NOT COMPLETED|Overall Study||14
2623045|NCT00000135|6437735|P1|NOT COMPLETED|Overall Study||27
2623046|NCT00000135|6437734|P2|COMPLETED|Overall Study||91
2623047|NCT00000135|6437735|P1|COMPLETED|Overall Study||77
2623048|NCT00000135|6437734|P2|STARTED|Overall Study||105
2623049|NCT00000135|6437735|P1|STARTED|Overall Study||104
2623050|NCT00000134|6437744|P3|NOT COMPLETED|Overall Study||0
2623051|NCT00000134|6437745|P2|NOT COMPLETED|Overall Study||0
2623052|NCT00000134|6437746|P1|NOT COMPLETED|Overall Study||0
2623053|NCT00000134|6437744|P3|COMPLETED|Overall Study||96
2623054|NCT00000134|6437745|P2|COMPLETED|Overall Study||94
2623055|NCT00000134|6437746|P1|COMPLETED|Overall Study||89
2623056|NCT00000134|6437744|P3|STARTED|Overall Study||96
2623057|NCT00000134|6437745|P2|STARTED|Overall Study||94
2623058|NCT00000134|6437746|P1|STARTED|Overall Study||89
2623059|NCT00000125|6437756|P2|NOT COMPLETED|Overall Study||238
2623060|NCT00000125|6437757|P1|NOT COMPLETED|Overall Study||239
2623061|NCT00000125|6437756|P2|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|579
2623062|NCT00000125|6437757|P1|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|580
2623063|NCT00000125|6437756|P2|Completed OHTS Phase I, June 2002|Overall Study||702
2623064|NCT00000125|6437757|P1|Completed OHTS Phase I, June 2002|Overall Study||706
2623065|NCT00000125|6437756|P2|STARTED|Overall Study||817
2623066|NCT00000125|6437757|P1|STARTED|Overall Study||819
2623145|NCT03700671|6438034|P2|NOT COMPLETED|Overall Study||2
2623146|NCT03700671|6438035|P1|NOT COMPLETED|Overall Study||1
2623147|NCT03700671|6438034|P2|COMPLETED|Overall Study||19
2623148|NCT03700671|6438035|P1|COMPLETED|Overall Study||20
2623149|NCT03700671|6438034|P2|STARTED|Overall Study||21
2623150|NCT03700671|6438035|P1|STARTED|Overall Study||21
2626266|NCT03678870|6446916|P2|NOT COMPLETED|Overall Study||8
2626267|NCT03678870|6446917|P1|NOT COMPLETED|Overall Study||13
2626268|NCT03678870|6446916|P2|COMPLETED|Overall Study||91
2626269|NCT03678870|6446917|P1|COMPLETED|Overall Study||84
2626270|NCT03678870|6446916|P2|STARTED|Overall Study||99
2626271|NCT03678870|6446917|P1|STARTED|Overall Study||97
2626291|NCT03630185|6446957|P2|NOT COMPLETED|Overall Study||4
2626292|NCT03630185|6446958|P1|NOT COMPLETED|Overall Study||4
2626293|NCT03630185|6446957|P2|COMPLETED|Overall Study||0
2626294|NCT03630185|6446958|P1|COMPLETED|Overall Study||0
2626295|NCT03630185|6446957|P2|6 Month Follow up|Overall Study||0
2626296|NCT03630185|6446958|P1|6 Month Follow up|Overall Study||0
2626297|NCT03630185|6446957|P2|90 Day Follow up|Overall Study||1
2626298|NCT03630185|6446958|P1|90 Day Follow up|Overall Study||0
2626299|NCT03630185|6446957|P2|30 Day Follow up|Overall Study||1
2626300|NCT03630185|6446958|P1|30 Day Follow up|Overall Study||1
2626301|NCT03630185|6446957|P2|STARTED|Overall Study||4
2626302|NCT03630185|6446958|P1|STARTED|Overall Study||4
2626323|NCT03585296|6447029|P1|NOT COMPLETED|Overall Study||5
2626324|NCT03585296|6447029|P1|COMPLETED|Overall Study||17
2626325|NCT03585296|6447029|P1|STARTED|Overall Study||22
2626369|NCT03473236|6447153|P10|NOT COMPLETED|Overall Study||0
2626370|NCT03473236|6447154|P9|NOT COMPLETED|Overall Study||1
2626371|NCT03473236|6447155|P8|NOT COMPLETED|Overall Study||0
2626372|NCT03473236|6447156|P7|NOT COMPLETED|Overall Study||0
2626373|NCT03473236|6447157|P6|NOT COMPLETED|Overall Study||1
2626374|NCT03473236|6447158|P5|NOT COMPLETED|Overall Study||0
2626375|NCT03473236|6447159|P4|NOT COMPLETED|Overall Study||0
2626376|NCT03473236|6447160|P3|NOT COMPLETED|Overall Study||0
2626377|NCT03473236|6447161|P2|NOT COMPLETED|Overall Study||0
2626378|NCT03473236|6447162|P1|NOT COMPLETED|Overall Study||0
2626379|NCT03473236|6447153|P10|COMPLETED|Overall Study||6
2626380|NCT03473236|6447154|P9|COMPLETED|Overall Study||6
2626381|NCT03473236|6447155|P8|COMPLETED|Overall Study||6
2626382|NCT03473236|6447156|P7|COMPLETED|Overall Study||6
2626383|NCT03473236|6447157|P6|COMPLETED|Overall Study||6
2626384|NCT03473236|6447158|P5|COMPLETED|Overall Study||6
2626385|NCT03473236|6447159|P4|COMPLETED|Overall Study||6
2626386|NCT03473236|6447160|P3|COMPLETED|Overall Study||6
2626387|NCT03473236|6447161|P2|COMPLETED|Overall Study||6
2626388|NCT03473236|6447162|P1|COMPLETED|Overall Study||10
2626389|NCT03473236|6447153|P10|STARTED|Overall Study||6
2626390|NCT03473236|6447154|P9|STARTED|Overall Study||7
2626391|NCT03473236|6447155|P8|STARTED|Overall Study||6
2626392|NCT03473236|6447156|P7|STARTED|Overall Study||6
2626393|NCT03473236|6447157|P6|STARTED|Overall Study||7
2626394|NCT03473236|6447158|P5|STARTED|Overall Study||6
2626395|NCT03473236|6447159|P4|STARTED|Overall Study||6
2626396|NCT03473236|6447160|P3|STARTED|Overall Study||6
2626397|NCT03473236|6447161|P2|STARTED|Overall Study||6
2626398|NCT03473236|6447162|P1|STARTED|Overall Study||10
2626399|NCT03471871|6447284|P5|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||1
2626400|NCT03471871|6447285|P4|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||1
2626401|NCT03471871|6447286|P3|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
2626402|NCT03471871|6447287|P2|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
2626403|NCT03471871|6447288|P1|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
2626404|NCT03471871|6447284|P5|COMPLETED|Follow Up (14 Days for Both HV and OSA)||17
2626405|NCT03471871|6447285|P4|COMPLETED|Follow Up (14 Days for Both HV and OSA)||17
2626406|NCT03471871|6447286|P3|COMPLETED|Follow Up (14 Days for Both HV and OSA)||5
2626407|NCT03471871|6447287|P2|COMPLETED|Follow Up (14 Days for Both HV and OSA)||5
2626408|NCT03471871|6447288|P1|COMPLETED|Follow Up (14 Days for Both HV and OSA)||6
2626409|NCT03471871|6447284|P5|STARTED|Follow Up (14 Days for Both HV and OSA)|OSA cohort was treated till Treatment Period 2 only and then entered in follow up period.|18
2626410|NCT03471871|6447285|P4|STARTED|Follow Up (14 Days for Both HV and OSA)|OSA cohort was treated till Treatment Period 2 only and then entered in follow up period.|18
2626411|NCT03471871|6447286|P3|STARTED|Follow Up (14 Days for Both HV and OSA)||5
2626412|NCT03471871|6447287|P2|STARTED|Follow Up (14 Days for Both HV and OSA)||5
2626413|NCT03471871|6447288|P1|STARTED|Follow Up (14 Days for Both HV and OSA)||6
2626414|NCT03471871|6447284|P5|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
2626415|NCT03471871|6447285|P4|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
2626416|NCT03471871|6447286|P3|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
2626417|NCT03471871|6447287|P2|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
2626418|NCT03471871|6447288|P1|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
2626419|NCT03471871|6447284|P5|COMPLETED|Treatment Period 3: ( HV:1 Day)||0
2626420|NCT03471871|6447285|P4|COMPLETED|Treatment Period 3: ( HV:1 Day)||0
2626421|NCT03471871|6447286|P3|COMPLETED|Treatment Period 3: ( HV:1 Day)||5
2626422|NCT03471871|6447287|P2|COMPLETED|Treatment Period 3: ( HV:1 Day)||5
2626423|NCT03471871|6447288|P1|COMPLETED|Treatment Period 3: ( HV:1 Day)||6
2626424|NCT03471871|6447284|P5|STARTED|Treatment Period 3: ( HV:1 Day)||0
2626425|NCT03471871|6447285|P4|STARTED|Treatment Period 3: ( HV:1 Day)||0
2626426|NCT03471871|6447286|P3|STARTED|Treatment Period 3: ( HV:1 Day)||5
2626427|NCT03471871|6447287|P2|STARTED|Treatment Period 3: ( HV:1 Day)||5
2626428|NCT03471871|6447288|P1|STARTED|Treatment Period 3: ( HV:1 Day)||6
2626429|NCT03471871|6447284|P5|NOT COMPLETED|Washout Period 2 (14 Days)||0
2626430|NCT03471871|6447285|P4|NOT COMPLETED|Washout Period 2 (14 Days)||0
2626431|NCT03471871|6447286|P3|NOT COMPLETED|Washout Period 2 (14 Days)||0
2626432|NCT03471871|6447287|P2|NOT COMPLETED|Washout Period 2 (14 Days)||0
2626433|NCT03471871|6447288|P1|NOT COMPLETED|Washout Period 2 (14 Days)||0
2626434|NCT03471871|6447284|P5|COMPLETED|Washout Period 2 (14 Days)||0
2626435|NCT03471871|6447285|P4|COMPLETED|Washout Period 2 (14 Days)||0
2626436|NCT03471871|6447286|P3|COMPLETED|Washout Period 2 (14 Days)||5
2626437|NCT03471871|6447287|P2|COMPLETED|Washout Period 2 (14 Days)||5
2626438|NCT03471871|6447288|P1|COMPLETED|Washout Period 2 (14 Days)||6
2626439|NCT03471871|6447284|P5|STARTED|Washout Period 2 (14 Days)|0=not applicable, as OSA cohort was treated till Treatment Period 2, then directly followed up.|0
2626440|NCT03471871|6447285|P4|STARTED|Washout Period 2 (14 Days)|0=not applicable, as OSA cohort was treated till Treatment Period 2, then directly followed up.|0
2626441|NCT03471871|6447286|P3|STARTED|Washout Period 2 (14 Days)||5
2626442|NCT03471871|6447287|P2|STARTED|Washout Period 2 (14 Days)||5
2626443|NCT03471871|6447288|P1|STARTED|Washout Period 2 (14 Days)||6
2626444|NCT03471871|6447284|P5|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||1
2626445|NCT03471871|6447285|P4|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
2626446|NCT03471871|6447286|P3|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
2626447|NCT03471871|6447287|P2|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
2626448|NCT03471871|6447288|P1|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
2626449|NCT03471871|6447284|P5|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
2626450|NCT03471871|6447285|P4|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
2626451|NCT03471871|6447286|P3|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
2626452|NCT03471871|6447287|P2|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
2626453|NCT03471871|6447288|P1|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||6
2626454|NCT03471871|6447284|P5|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||19
2626455|NCT03471871|6447285|P4|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
2626456|NCT03471871|6447286|P3|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
2626457|NCT03471871|6447287|P2|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
2626458|NCT03471871|6447288|P1|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||6
2626459|NCT03471871|6447284|P5|NOT COMPLETED|Washout Period 1 (14 Days)||0
2626460|NCT03471871|6447285|P4|NOT COMPLETED|Washout Period 1 (14 Days)||0
2626461|NCT03471871|6447286|P3|NOT COMPLETED|Washout Period 1 (14 Days)||0
2626462|NCT03471871|6447287|P2|NOT COMPLETED|Washout Period 1 (14 Days)||0
2626463|NCT03471871|6447288|P1|NOT COMPLETED|Washout Period 1 (14 Days)||0
2626464|NCT03471871|6447284|P5|COMPLETED|Washout Period 1 (14 Days)||19
2626465|NCT03471871|6447285|P4|COMPLETED|Washout Period 1 (14 Days)||18
2626466|NCT03471871|6447286|P3|COMPLETED|Washout Period 1 (14 Days)||5
2626467|NCT03471871|6447287|P2|COMPLETED|Washout Period 1 (14 Days)||5
2626468|NCT03471871|6447288|P1|COMPLETED|Washout Period 1 (14 Days)||6
2626469|NCT03471871|6447284|P5|STARTED|Washout Period 1 (14 Days)||19
2626470|NCT03471871|6447285|P4|STARTED|Washout Period 1 (14 Days)||18
2626471|NCT03471871|6447286|P3|STARTED|Washout Period 1 (14 Days)||5
2626472|NCT03471871|6447287|P2|STARTED|Washout Period 1 (14 Days)||5
2626473|NCT03471871|6447288|P1|STARTED|Washout Period 1 (14 Days)||6
2626474|NCT03471871|6447284|P5|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
2626475|NCT03471871|6447285|P4|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
2626476|NCT03471871|6447286|P3|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
2626477|NCT03471871|6447287|P2|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||0
2626478|NCT03471871|6447288|P1|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||0
2626479|NCT03471871|6447284|P5|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||19
2626480|NCT03471871|6447285|P4|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||18
2626481|NCT03471871|6447286|P3|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
2626482|NCT03471871|6447287|P2|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
2626483|NCT03471871|6447288|P1|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
2626484|NCT03471871|6447284|P5|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||20
2626485|NCT03471871|6447285|P4|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||18
2626486|NCT03471871|6447286|P3|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
2626487|NCT03471871|6447287|P2|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
2626488|NCT03471871|6447288|P1|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
2626489|NCT03471871|6447284|P5|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||20
2626490|NCT03471871|6447285|P4|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||19
2626491|NCT03471871|6447286|P3|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
2626492|NCT03471871|6447287|P2|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
2626493|NCT03471871|6447288|P1|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
2626506|NCT03439072|6447349|P2|NOT COMPLETED|Overall Study||4
2626507|NCT03439072|6447350|P1|NOT COMPLETED|Overall Study||2
2626508|NCT03439072|6447349|P2|COMPLETED|Overall Study|1 subject dropped before Lilly Glucagon; 3 others after Lilly Glucagon (N=39 Lilly; N=36 G-Pen)|36
2626509|NCT03439072|6447350|P1|COMPLETED|Overall Study|1 subject dropped before G-Pen; another after G-Pen (n=40 G-Pen; N=39 Lilly Glucagon)|39
2626510|NCT03439072|6447349|P2|STARTED|Overall Study||40
2626511|NCT03439072|6447350|P1|STARTED|Overall Study||41
2626624|NCT03248492|6447682|P5|NOT COMPLETED|Overall Study||4
2626625|NCT03248492|6447683|P4|NOT COMPLETED|Overall Study||130
2626626|NCT03248492|6447684|P3|NOT COMPLETED|Overall Study||21
2626627|NCT03248492|6447685|P2|NOT COMPLETED|Overall Study||48
2626628|NCT03248492|6447686|P1|NOT COMPLETED|Overall Study||50
2626629|NCT03248492|6447682|P5|COMPLETED|Overall Study||0
2626630|NCT03248492|6447683|P4|COMPLETED|Overall Study||0
2626631|NCT03248492|6447684|P3|COMPLETED|Overall Study||0
2626632|NCT03248492|6447685|P2|COMPLETED|Overall Study||0
2626633|NCT03248492|6447686|P1|COMPLETED|Overall Study||0
2626634|NCT03248492|6447682|P5|STARTED|Overall Study||4
2626635|NCT03248492|6447683|P4|STARTED|Overall Study||130
2626636|NCT03248492|6447684|P3|STARTED|Overall Study||21
2626637|NCT03248492|6447685|P2|STARTED|Overall Study||48
2626638|NCT03248492|6447686|P1|STARTED|Overall Study||50
2626829|NCT03099187|6448053|P2|NOT COMPLETED|Overall Study||34
2626830|NCT03099187|6448054|P1|NOT COMPLETED|Overall Study||43
2626831|NCT03099187|6448053|P2|COMPLETED|Overall Study||92
2626832|NCT03099187|6448054|P1|COMPLETED|Overall Study||84
2626833|NCT03099187|6448053|P2|STARTED|Overall Study||126
2626834|NCT03099187|6448054|P1|STARTED|Overall Study||127
2626871|NCT03058991|6448222|P3|NOT COMPLETED|Overall Study||12
2626872|NCT03058991|6448223|P2|NOT COMPLETED|Overall Study||12
2626873|NCT03058991|6448224|P1|NOT COMPLETED|Overall Study||18
2626874|NCT03058991|6448222|P3|COMPLETED|Overall Study||25
2626875|NCT03058991|6448223|P2|COMPLETED|Overall Study||20
2626876|NCT03058991|6448224|P1|COMPLETED|Overall Study||21
2626877|NCT03058991|6448222|P3|1-Week Follow Up|Overall Study||28
2626878|NCT03058991|6448223|P2|1-Week Follow Up|Overall Study||27
2626879|NCT03058991|6448224|P1|1-Week Follow Up|Overall Study||23
2626880|NCT03058991|6448222|P3|STARTED|Overall Study||37
2626881|NCT03058991|6448223|P2|STARTED|Overall Study||32
2626882|NCT03058991|6448224|P1|STARTED|Overall Study||39
2626978|NCT03001557|6448588|P5|NOT COMPLETED|Overall Study||0
2626979|NCT03001557|6448589|P4|NOT COMPLETED|Overall Study||0
2626980|NCT03001557|6448590|P3|NOT COMPLETED|Overall Study||1
2626981|NCT03001557|6448591|P2|NOT COMPLETED|Overall Study||0
2626982|NCT03001557|6448592|P1|NOT COMPLETED|Overall Study||0
2626983|NCT03001557|6448588|P5|COMPLETED|Overall Study||12
2626984|NCT03001557|6448589|P4|COMPLETED|Overall Study||13
2626985|NCT03001557|6448590|P3|COMPLETED|Overall Study||13
2626986|NCT03001557|6448591|P2|COMPLETED|Overall Study||12
2626987|NCT03001557|6448592|P1|COMPLETED|Overall Study||12
2626988|NCT03001557|6448588|P5|Treated|Overall Study||12
2626989|NCT03001557|6448589|P4|Treated|Overall Study||13
2626990|NCT03001557|6448590|P3|Treated|Overall Study||13
2626991|NCT03001557|6448591|P2|Treated|Overall Study||12
2626992|NCT03001557|6448592|P1|Treated|Overall Study||12
2626993|NCT03001557|6448588|P5|STARTED|Overall Study||12
2626994|NCT03001557|6448589|P4|STARTED|Overall Study||13
2626995|NCT03001557|6448590|P3|STARTED|Overall Study||14
2626996|NCT03001557|6448591|P2|STARTED|Overall Study||12
2626997|NCT03001557|6448592|P1|STARTED|Overall Study||12
2627016|NCT02984995|6449013|P2|NOT COMPLETED|Overall Study||3
2627017|NCT02984995|6449014|P1|NOT COMPLETED|Overall Study||25
2627018|NCT02984995|6449013|P2|COMPLETED|Overall Study||0
2627019|NCT02984995|6449014|P1|COMPLETED|Overall Study||9
2627020|NCT02984995|6449013|P2|STARTED|Overall Study||3
2627021|NCT02984995|6449014|P1|STARTED|Overall Study||34
2627068|NCT02933034|6449188|P1|NOT COMPLETED|Overall Study||9
2627069|NCT02933034|6449188|P1|COMPLETED|Overall Study||24
2627070|NCT02933034|6449188|P1|Received Both MEMRI and DEMRI Scans|Overall Study||24
2627071|NCT02933034|6449188|P1|STARTED|Overall Study||33
2627118|NCT02906930|6449415|P4|NOT COMPLETED|Overall Study||8
2627119|NCT02906930|6449416|P3|NOT COMPLETED|Overall Study||12
2627120|NCT02906930|6449417|P2|NOT COMPLETED|Overall Study||14
2627121|NCT02906930|6449418|P1|NOT COMPLETED|Overall Study||6
2627122|NCT02906930|6449415|P4|COMPLETED|Overall Study||170
2627123|NCT02906930|6449416|P3|COMPLETED|Overall Study||163
2627124|NCT02906930|6449417|P2|COMPLETED|Overall Study||161
2627125|NCT02906930|6449418|P1|COMPLETED|Overall Study||169
2627126|NCT02906930|6449415|P4|Safety Analysis Set (SAS)|Overall Study||178
2627127|NCT02906930|6449416|P3|Safety Analysis Set (SAS)|Overall Study||175
2627128|NCT02906930|6449417|P2|Safety Analysis Set (SAS)|Overall Study||175
2627129|NCT02906930|6449418|P1|Safety Analysis Set (SAS)|Overall Study||175
2627130|NCT02906930|6449415|P4|Full Analysis Set (FAS)|Overall Study||178
2627131|NCT02906930|6449416|P3|Full Analysis Set (FAS)|Overall Study||175
2627132|NCT02906930|6449417|P2|Full Analysis Set (FAS)|Overall Study||175
2627133|NCT02906930|6449418|P1|Full Analysis Set (FAS)|Overall Study||175
2627134|NCT02906930|6449415|P4|STARTED|Overall Study||178
2627135|NCT02906930|6449416|P3|STARTED|Overall Study||175
2627136|NCT02906930|6449417|P2|STARTED|Overall Study||175
2627137|NCT02906930|6449418|P1|STARTED|Overall Study||175
2627168|NCT02849080|6450054|P2|NOT COMPLETED|Overall Study||7
2627169|NCT02849080|6450055|P1|NOT COMPLETED|Overall Study||12
2627170|NCT02849080|6450054|P2|COMPLETED|Overall Study||244
2627171|NCT02849080|6450055|P1|COMPLETED|Overall Study||241
2627172|NCT02849080|6450054|P2|Safety Analysis Set (SAS)|Overall Study||250
2627173|NCT02849080|6450055|P1|Safety Analysis Set (SAS)|Overall Study||253
2627174|NCT02849080|6450054|P2|Full Analysis Set (FAS)|Overall Study||251
2627175|NCT02849080|6450055|P1|Full Analysis Set (FAS)|Overall Study||253
2627176|NCT02849080|6450054|P2|Exposed|Overall Study||250
2627177|NCT02849080|6450055|P1|Exposed|Overall Study||253
2627178|NCT02849080|6450054|P2|STARTED|Overall Study||251
2627179|NCT02849080|6450055|P1|STARTED|Overall Study||253
2627209|NCT02836249|6450180|P2|NOT COMPLETED|Overall Study||58
2627210|NCT02836249|6450181|P1|NOT COMPLETED|Overall Study||123
2627211|NCT02836249|6450180|P2|COMPLETED|Overall Study||0
2627212|NCT02836249|6450181|P1|COMPLETED|Overall Study||0
2627213|NCT02836249|6450180|P2|STARTED|Overall Study||58
2627214|NCT02836249|6450181|P1|STARTED|Overall Study||123
2627215|NCT02833922|6450197|P1|NOT COMPLETED|Overall Study||382
2627216|NCT02833922|6450197|P1|COMPLETED|Overall Study||336
2627217|NCT02833922|6450197|P1|STARTED|Overall Study||718
2627218|NCT02827708|6450207|P2|NOT COMPLETED|Overall Study||5
2627219|NCT02827708|6450208|P1|NOT COMPLETED|Overall Study||5
2627220|NCT02827708|6450207|P2|COMPLETED|Overall Study||156
2627221|NCT02827708|6450208|P1|COMPLETED|Overall Study||158
2627222|NCT02827708|6450207|P2|Safety Analysis Set (SAS)|Overall Study||161
2627223|NCT02827708|6450208|P1|Safety Analysis Set (SAS)|Overall Study||163
2627224|NCT02827708|6450207|P2|Full Analysis Set (FAS)|Overall Study||161
2627225|NCT02827708|6450208|P1|Full Analysis Set (FAS)|Overall Study||163
2627226|NCT02827708|6450207|P2|STARTED|Overall Study||161
2627227|NCT02827708|6450208|P1|STARTED|Overall Study||163
2627258|NCT02819726|6450417|P4|NOT COMPLETED|Part B (All Participants)||2
2627259|NCT02819726|6450418|P3|NOT COMPLETED|Part B (All Participants)||4
2627260|NCT02819726|6450419|P2|NOT COMPLETED|Part B (All Participants)||2
2627261|NCT02819726|6450420|P1|NOT COMPLETED|Part B (All Participants)||3
2627262|NCT02819726|6450417|P4|COMPLETED|Part B (All Participants)||36
2627263|NCT02819726|6450418|P3|COMPLETED|Part B (All Participants)||35
2627264|NCT02819726|6450419|P2|COMPLETED|Part B (All Participants)||68
2627265|NCT02819726|6450420|P1|COMPLETED|Part B (All Participants)||70
2627266|NCT02819726|6450417|P4|STARTED|Part B (All Participants)|5 participants completing Part A were ineligible for Part B.|38
2627267|NCT02819726|6450418|P3|STARTED|Part B (All Participants)|5 participants completing Part A were ineligible for Part B.|39
2627268|NCT02819726|6450419|P2|STARTED|Part B (All Participants)|18 participants completing Part A were not eligible for Part B|70
2627269|NCT02819726|6450420|P1|STARTED|Part B (All Participants)|19 participants who completed Part A were not eligible for Part B|73
2627270|NCT02819726|6450417|P4|NOT COMPLETED|Part A (All Participants)||0
2627271|NCT02819726|6450418|P3|NOT COMPLETED|Part A (All Participants)||11
2627272|NCT02819726|6450419|P2|NOT COMPLETED|Part A (All Participants)||10
2627273|NCT02819726|6450420|P1|NOT COMPLETED|Part A (All Participants)||6
2627274|NCT02819726|6450417|P4|COMPLETED|Part A (All Participants)||0
2627275|NCT02819726|6450418|P3|COMPLETED|Part A (All Participants)||87
2627276|NCT02819726|6450419|P2|COMPLETED|Part A (All Participants)||88
2627277|NCT02819726|6450420|P1|COMPLETED|Part A (All Participants)||92
2627278|NCT02819726|6450417|P4|STARTED|Part A (All Participants)||0
2627279|NCT02819726|6450418|P3|STARTED|Part A (All Participants)||98
2627280|NCT02819726|6450419|P2|STARTED|Part A (All Participants)||98
2627281|NCT02819726|6450420|P1|STARTED|Part A (All Participants)||98
2627293|NCT02800356|6450547|P1|NOT COMPLETED|Overall Study||0
2627294|NCT02800356|6450547|P1|COMPLETED|Overall Study||20
2627295|NCT02800356|6450547|P1|STARTED|Overall Study||20
2627296|NCT02788656|6450558|P2|NOT COMPLETED|Overall Study||0
2627297|NCT02788656|6450559|P1|NOT COMPLETED|Overall Study||1
2627298|NCT02788656|6450558|P2|COMPLETED|Overall Study||2
2627299|NCT02788656|6450559|P1|COMPLETED|Overall Study||1
2627300|NCT02788656|6450558|P2|STARTED|Overall Study||2
2627301|NCT02788656|6450559|P1|STARTED|Overall Study||2
2627361|NCT02775435|6450685|P2|NOT COMPLETED|Overall Study||281
2627362|NCT02775435|6450686|P1|NOT COMPLETED|Overall Study||278
2627363|NCT02775435|6450685|P2|COMPLETED|Overall Study||0
2627364|NCT02775435|6450686|P1|COMPLETED|Overall Study||0
2627365|NCT02775435|6450685|P2|Switched to Pembrolizumab+Chemotherapy|Overall Study||75
2627366|NCT02775435|6450686|P1|Switched to Pembrolizumab+Chemotherapy|Overall Study||0
2627367|NCT02775435|6450685|P2|Treated|Overall Study||280
2627368|NCT02775435|6450686|P1|Treated|Overall Study||278
2627369|NCT02775435|6450685|P2|STARTED|Overall Study||281
2627370|NCT02775435|6450686|P1|STARTED|Overall Study||278
2627515|NCT02702401|6451086|P2|NOT COMPLETED|Overall Study||135
2627516|NCT02702401|6451087|P1|NOT COMPLETED|Overall Study||278
2627517|NCT02702401|6451086|P2|COMPLETED|Overall Study||0
2627518|NCT02702401|6451087|P1|COMPLETED|Overall Study||0
2627519|NCT02702401|6451086|P2|Treated|Overall Study||135
2627520|NCT02702401|6451087|P1|Treated|Overall Study||278
2627521|NCT02702401|6451086|P2|STARTED|Overall Study||135
2627522|NCT02702401|6451087|P1|STARTED|Overall Study||278
2627611|NCT02613208|6451548|P1|NOT COMPLETED|Overall Study||47
2627612|NCT02613208|6451548|P1|COMPLETED|Overall Study||64
2627613|NCT02613208|6451548|P1|STARTED|Overall Study||111
2627683|NCT02562482|6452031|P2|NOT COMPLETED|Overall Study||16
2627684|NCT02562482|6452032|P1|NOT COMPLETED|Overall Study||21
2627685|NCT02562482|6452031|P2|COMPLETED|Overall Study||183
2627686|NCT02562482|6452032|P1|COMPLETED|Overall Study||180
2627687|NCT02562482|6452031|P2|Received 2nd Injection|Overall Study||192
2627688|NCT02562482|6452032|P1|Received 2nd Injection|Overall Study||192
2627689|NCT02562482|6452031|P2|Received 1st Injection|Overall Study||199
2627690|NCT02562482|6452032|P1|Received 1st Injection|Overall Study||197
2627691|NCT02562482|6452031|P2|STARTED|Overall Study||199
2627692|NCT02562482|6452032|P1|STARTED|Overall Study||201
2627708|NCT02547766|6452139|P1|NOT COMPLETED|Overall Study||1
2627709|NCT02547766|6452139|P1|COMPLETED|Overall Study||9
2627710|NCT02547766|6452139|P1|STARTED|Overall Study||10
2627747|NCT02540291|6452278|P4|NOT COMPLETED|Overall Study||7
2627748|NCT02540291|6452279|P3|NOT COMPLETED|Overall Study||7
2627749|NCT02540291|6452280|P2|NOT COMPLETED|Overall Study||8
2627750|NCT02540291|6452281|P1|NOT COMPLETED|Overall Study||8
2627751|NCT02540291|6452278|P4|COMPLETED|Overall Study||0
2627752|NCT02540291|6452279|P3|COMPLETED|Overall Study||0
2627753|NCT02540291|6452280|P2|COMPLETED|Overall Study||0
2627754|NCT02540291|6452281|P1|COMPLETED|Overall Study||0
2627755|NCT02540291|6452278|P4|STARTED|Overall Study||7
2627756|NCT02540291|6452279|P3|STARTED|Overall Study||7
2627757|NCT02540291|6452280|P2|STARTED|Overall Study||8
2627758|NCT02540291|6452281|P1|STARTED|Overall Study||8
2627853|NCT02515669|6452788|P4|NOT COMPLETED|48 Week Open-Label Phase||0
2627854|NCT02515669|6452789|P3|NOT COMPLETED|48 Week Open-Label Phase||1
2627855|NCT02515669|6452790|P2|NOT COMPLETED|48 Week Open-Label Phase||0
2627856|NCT02515669|6452791|P1|NOT COMPLETED|48 Week Open-Label Phase||0
2627857|NCT02515669|6452788|P4|COMPLETED|48 Week Open-Label Phase||26
2627858|NCT02515669|6452789|P3|COMPLETED|48 Week Open-Label Phase||7
2627859|NCT02515669|6452790|P2|COMPLETED|48 Week Open-Label Phase||9
2627860|NCT02515669|6452791|P1|COMPLETED|48 Week Open-Label Phase||0
2627861|NCT02515669|6452788|P4|STARTED|48 Week Open-Label Phase|7 DB placebo participants switched to the Panel 3/Expansion RO cohort for the open-label phase.|26
2627862|NCT02515669|6452789|P3|STARTED|48 Week Open-Label Phase|2 DB placebo participants switched to the Panel 2 RO cohort for the open-label phase.|8
2627863|NCT02515669|6452790|P2|STARTED|48 Week Open-Label Phase|2 DB placebo participants switched to the Panel 1 RO cohort for the open-label phase.|9
2627864|NCT02515669|6452791|P1|STARTED|48 Week Open-Label Phase|Double-blind (DB) placebo participants switched to RO7239361 (RO) for the open label phase.|0
2627865|NCT02515669|6452788|P4|NOT COMPLETED|24 Week Double-Blind Phase||0
2627866|NCT02515669|6452789|P3|NOT COMPLETED|24 Week Double-Blind Phase||0
2627867|NCT02515669|6452790|P2|NOT COMPLETED|24 Week Double-Blind Phase||0
2627868|NCT02515669|6452791|P1|NOT COMPLETED|24 Week Double-Blind Phase||0
2627869|NCT02515669|6452788|P4|COMPLETED|24 Week Double-Blind Phase||19
2627870|NCT02515669|6452789|P3|COMPLETED|24 Week Double-Blind Phase||6
2627871|NCT02515669|6452790|P2|COMPLETED|24 Week Double-Blind Phase||7
2627872|NCT02515669|6452791|P1|COMPLETED|24 Week Double-Blind Phase||11
2627873|NCT02515669|6452788|P4|STARTED|24 Week Double-Blind Phase||19
2627874|NCT02515669|6452789|P3|STARTED|24 Week Double-Blind Phase||6
2627875|NCT02515669|6452790|P2|STARTED|24 Week Double-Blind Phase||7
2627876|NCT02515669|6452791|P1|STARTED|24 Week Double-Blind Phase||11
2627937|NCT02469701|6453043|P1|NOT COMPLETED|Overall Study||0
2627938|NCT02469701|6453043|P1|COMPLETED|Overall Study||10
2627939|NCT02469701|6453043|P1|STARTED|Overall Study||10
2627940|NCT02464540|6453047|P2|NOT COMPLETED|Overall Study||0
2627941|NCT02464540|6453048|P1|NOT COMPLETED|Overall Study||0
2627942|NCT02464540|6453047|P2|COMPLETED|Overall Study||11
2627943|NCT02464540|6453048|P1|COMPLETED|Overall Study||11
2627944|NCT02464540|6453047|P2|STARTED|Overall Study||11
2627945|NCT02464540|6453048|P1|STARTED|Overall Study||11
2627964|NCT02422797|6453109|P2|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||18
2627965|NCT02422797|6453110|P1|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||23
2627966|NCT02422797|6453109|P2|COMPLETED|Late Switch Phase (Week 52 to Week 148)||221
2627967|NCT02422797|6453110|P1|COMPLETED|Late Switch Phase (Week 52 to Week 148)||222
2627968|NCT02422797|6453109|P2|STARTED|Late Switch Phase (Week 52 to Week 148)||239
2627969|NCT02422797|6453110|P1|STARTED|Late Switch Phase (Week 52 to Week 148)||245
2627970|NCT02422797|6453109|P2|NOT COMPLETED|Early Switch Phase (Up to Week 52)||16
2627971|NCT02422797|6453110|P1|NOT COMPLETED|Early Switch Phase (Up to Week 52)||16
2627972|NCT02422797|6453109|P2|COMPLETED|Early Switch Phase (Up to Week 52)||239
2627973|NCT02422797|6453110|P1|COMPLETED|Early Switch Phase (Up to Week 52)||245
2627974|NCT02422797|6453109|P2|STARTED|Early Switch Phase (Up to Week 52)||255
2627975|NCT02422797|6453110|P1|STARTED|Early Switch Phase (Up to Week 52)||261
2628076|NCT02401542|6453475|P3|NOT COMPLETED|Overall Study||0
2628077|NCT02401542|6453476|P2|NOT COMPLETED|Overall Study||0
2628078|NCT02401542|6453477|P1|NOT COMPLETED|Overall Study||1
2628079|NCT02401542|6453475|P3|COMPLETED|Overall Study||0
2628080|NCT02401542|6453476|P2|COMPLETED|Overall Study||30
2628081|NCT02401542|6453477|P1|COMPLETED|Overall Study||40
2628082|NCT02401542|6453475|P3|STARTED|Overall Study||0
2628083|NCT02401542|6453476|P2|STARTED|Overall Study||30
2628084|NCT02401542|6453477|P1|STARTED|Overall Study||41
2628109|NCT02371668|6453602|P2|NOT COMPLETED|Overall Study||0
2628110|NCT02371668|6453603|P1|NOT COMPLETED|Overall Study||0
2628111|NCT02371668|6453602|P2|COMPLETED|Overall Study||42
2628112|NCT02371668|6453603|P1|COMPLETED|Overall Study||49
2628113|NCT02371668|6453602|P2|STARTED|Overall Study||42
2628114|NCT02371668|6453603|P1|STARTED|Overall Study||49
2628115|NCT02362503|6453628|P3|NOT COMPLETED|Open Label Period-Up to Atleast 96 Weeks||99
2628116|NCT02362503|6453629|P2|NOT COMPLETED|Open Label Period-Up to Atleast 96 Weeks||198
2628117|NCT02362503|6453630|P1|NOT COMPLETED|Open Label Period-Up to Atleast 96 Weeks||68
2628118|NCT02362503|6453628|P3|COMPLETED|Open Label Period-Up to Atleast 96 Weeks||0
2628119|NCT02362503|6453629|P2|COMPLETED|Open Label Period-Up to Atleast 96 Weeks||0
2628120|NCT02362503|6453630|P1|COMPLETED|Open Label Period-Up to Atleast 96 Weeks||0
2628121|NCT02362503|6453628|P3|STARTED|Open Label Period-Up to Atleast 96 Weeks||99
2628122|NCT02362503|6453629|P2|STARTED|Open Label Period-Up to Atleast 96 Weeks|Subject withdrawn due to progression of disease died during study due to squamous cell carcinoma.|198
2628123|NCT02362503|6453630|P1|STARTED|Open Label Period-Up to Atleast 96 Weeks||68
2628124|NCT02362503|6453628|P3|NOT COMPLETED|Double-blind Period-Up to 8 Days||0
2628125|NCT02362503|6453629|P2|NOT COMPLETED|Double-blind Period-Up to 8 Days||5
2628126|NCT02362503|6453630|P1|NOT COMPLETED|Double-blind Period-Up to 8 Days||1
2628127|NCT02362503|6453628|P3|COMPLETED|Double-blind Period-Up to 8 Days||0
2628128|NCT02362503|6453629|P2|COMPLETED|Double-blind Period-Up to 8 Days||198
2628129|NCT02362503|6453630|P1|COMPLETED|Double-blind Period-Up to 8 Days||68
2628130|NCT02362503|6453628|P3|STARTED|Double-blind Period-Up to 8 Days||0
2628131|NCT02362503|6453629|P2|STARTED|Double-blind Period-Up to 8 Days||203
2628132|NCT02362503|6453630|P1|STARTED|Double-blind Period-Up to 8 Days||69
2628133|NCT02358031|6453658|P3|NOT COMPLETED|Overall Study||300
2628134|NCT02358031|6453659|P2|NOT COMPLETED|Overall Study||281
2628135|NCT02358031|6453660|P1|NOT COMPLETED|Overall Study||301
2628136|NCT02358031|6453658|P3|COMPLETED|Overall Study||0
2628137|NCT02358031|6453659|P2|COMPLETED|Overall Study||0
2628138|NCT02358031|6453660|P1|COMPLETED|Overall Study||0
2628139|NCT02358031|6453658|P3|Pembro Combo v Control Efficacy Analyses|Overall Study||278
2628140|NCT02358031|6453659|P2|Pembro Combo v Control Efficacy Analyses|Overall Study||281
2628141|NCT02358031|6453660|P1|Pembro Combo v Control Efficacy Analyses|Overall Study||0
2628142|NCT02358031|6453658|P3|Pembro Mono v Control Efficacy Analyses|Overall Study||300
2628143|NCT02358031|6453659|P2|Pembro Mono v Control Efficacy Analyses|Overall Study||0
2628144|NCT02358031|6453660|P1|Pembro Mono v Control Efficacy Analyses|Overall Study||301
2628145|NCT02358031|6453658|P3|Treated|Overall Study||287
2628146|NCT02358031|6453659|P2|Treated|Overall Study||276
2628147|NCT02358031|6453660|P1|Treated|Overall Study||300
2628148|NCT02358031|6453658|P3|STARTED|Overall Study||300
2628149|NCT02358031|6453659|P2|STARTED|Overall Study||281
2628150|NCT02358031|6453660|P1|STARTED|Overall Study||301
2628229|NCT02319044|6454262|P3|NOT COMPLETED|Overall Study||67
2628230|NCT02319044|6454263|P2|NOT COMPLETED|Overall Study||60
2628231|NCT02319044|6454264|P1|NOT COMPLETED|Overall Study||122
2628232|NCT02319044|6454262|P3|COMPLETED|Overall Study||0
2628233|NCT02319044|6454263|P2|COMPLETED|Overall Study||7
2628234|NCT02319044|6454264|P1|COMPLETED|Overall Study||11
2628235|NCT02319044|6454262|P3|STARTED|Overall Study||67
2628236|NCT02319044|6454263|P2|STARTED|Overall Study||67
2628237|NCT02319044|6454264|P1|STARTED|Overall Study||133
2628283|NCT02291913|6454557|P1|NOT COMPLETED|Overall Study||48
2628284|NCT02291913|6454557|P1|COMPLETED|Overall Study||0
2628285|NCT02291913|6454557|P1|STARTED|Overall Study||48
2628303|NCT02238847|6454646|P2|NOT COMPLETED|Overall Study||24
2628304|NCT02238847|6454647|P1|NOT COMPLETED|Overall Study||22
2628305|NCT02238847|6454646|P2|COMPLETED|Overall Study||36
2628306|NCT02238847|6454647|P1|COMPLETED|Overall Study||37
2628307|NCT02238847|6454646|P2|STARTED|Overall Study||60
2628308|NCT02238847|6454647|P1|STARTED|Overall Study||59
2628338|NCT02208063|6454735|P2|NOT COMPLETED|Overall Study||11
2628339|NCT02208063|6454736|P1|NOT COMPLETED|Overall Study||12
2628340|NCT02208063|6454735|P2|COMPLETED|Overall Study||50
2628341|NCT02208063|6454736|P1|COMPLETED|Overall Study||48
2628342|NCT02208063|6454735|P2|Microbiological All Treated|Overall Study||52
2628343|NCT02208063|6454736|P1|Microbiological All Treated|Overall Study||47
2628344|NCT02208063|6454735|P2|Randomized and Treated|Overall Study||60
2628345|NCT02208063|6454736|P1|Randomized and Treated|Overall Study||58
2628346|NCT02208063|6454735|P2|STARTED|Overall Study||61
2628347|NCT02208063|6454736|P1|STARTED|Overall Study||60
2628348|NCT02207530|6454748|P1|NOT COMPLETED|Overall Study||91
2628349|NCT02207530|6454748|P1|COMPLETED|Overall Study||21
2628350|NCT02207530|6454748|P1|STARTED|Overall Study||112
2628379|NCT02189473|6454851|P2|NOT COMPLETED|Overall Study||25
2628380|NCT02189473|6454852|P1|NOT COMPLETED|Overall Study||23
2628381|NCT02189473|6454851|P2|COMPLETED|Overall Study||77
2628382|NCT02189473|6454852|P1|COMPLETED|Overall Study||78
2628383|NCT02189473|6454851|P2|STARTED|Overall Study||102
2628384|NCT02189473|6454852|P1|STARTED|Overall Study||101
2628391|NCT02178709|6454898|P1|NOT COMPLETED|Overall Study||16
2628392|NCT02178709|6454898|P1|COMPLETED|Overall Study||32
2628393|NCT02178709|6454898|P1|STARTED|Overall Study||48
2628394|NCT02163902|6454911|P2|NOT COMPLETED|Overall Study||13
2628395|NCT02163902|6454912|P1|NOT COMPLETED|Overall Study||11
2628396|NCT02163902|6454911|P2|COMPLETED|Overall Study||98
2628397|NCT02163902|6454912|P1|COMPLETED|Overall Study||102
2628398|NCT02163902|6454911|P2|STARTED|Overall Study||111
2628399|NCT02163902|6454912|P1|STARTED|Overall Study||113
2628400|NCT02161406|6454930|P2|NOT COMPLETED|Overall Study||9
2628401|NCT02161406|6454931|P1|NOT COMPLETED|Overall Study||10
2628402|NCT02161406|6454930|P2|COMPLETED|Overall Study||35
2628403|NCT02161406|6454931|P1|COMPLETED|Overall Study||34
2628404|NCT02161406|6454930|P2|STARTED|Overall Study||44
2628405|NCT02161406|6454931|P1|STARTED|Overall Study||44
2628406|NCT02159729|6455007|P2|NOT COMPLETED|Overall Study||21
2628407|NCT02159729|6455008|P1|NOT COMPLETED|Overall Study||42
2628408|NCT02159729|6455007|P2|COMPLETED|Overall Study||44
2628409|NCT02159729|6455008|P1|COMPLETED|Overall Study||98
2628410|NCT02159729|6455007|P2|STARTED|Overall Study||65
2628411|NCT02159729|6455008|P1|STARTED|Overall Study||140
2628455|NCT02146365|6455102|P8|NOT COMPLETED|Overall Study||1
2628456|NCT02146365|6455103|P7|NOT COMPLETED|Overall Study||0
2628457|NCT02146365|6455104|P6|NOT COMPLETED|Overall Study||1
2628458|NCT02146365|6455105|P5|NOT COMPLETED|Overall Study||2
2628459|NCT02146365|6455106|P4|NOT COMPLETED|Overall Study||9
2628460|NCT02146365|6455107|P3|NOT COMPLETED|Overall Study||7
2628461|NCT02146365|6455108|P2|NOT COMPLETED|Overall Study||4
2628462|NCT02146365|6455109|P1|NOT COMPLETED|Overall Study||4
2628463|NCT02146365|6455102|P8|COMPLETED|Overall Study||24
2628464|NCT02146365|6455103|P7|COMPLETED|Overall Study||25
2628465|NCT02146365|6455104|P6|COMPLETED|Overall Study||24
2628466|NCT02146365|6455105|P5|COMPLETED|Overall Study||22
2628467|NCT02146365|6455106|P4|COMPLETED|Overall Study||41
2628468|NCT02146365|6455107|P3|COMPLETED|Overall Study||43
2628469|NCT02146365|6455108|P2|COMPLETED|Overall Study||45
2628470|NCT02146365|6455109|P1|COMPLETED|Overall Study||45
2628471|NCT02146365|6455102|P8|STARTED|Overall Study||25
2628472|NCT02146365|6455103|P7|STARTED|Overall Study||25
2628473|NCT02146365|6455104|P6|STARTED|Overall Study||25
2628474|NCT02146365|6455105|P5|STARTED|Overall Study||24
2628475|NCT02146365|6455106|P4|STARTED|Overall Study||50
2628476|NCT02146365|6455107|P3|STARTED|Overall Study||50
2628477|NCT02146365|6455108|P2|STARTED|Overall Study||49
2628478|NCT02146365|6455109|P1|STARTED|Overall Study||49
2628542|NCT02123134|6455404|P2|NOT COMPLETED|Overall Study||3
2628543|NCT02123134|6455405|P1|NOT COMPLETED|Overall Study||3
2628544|NCT02123134|6455404|P2|COMPLETED|Overall Study||24
2628545|NCT02123134|6455405|P1|COMPLETED|Overall Study||25
2628546|NCT02123134|6455404|P2|STARTED|Overall Study||27
2628547|NCT02123134|6455405|P1|STARTED|Overall Study||28
2628635|NCT02037230|6455722|P4|NOT COMPLETED|Overall Study||6
2628636|NCT02037230|6455723|P3|NOT COMPLETED|Overall Study||6
2628637|NCT02037230|6455724|P2|NOT COMPLETED|Overall Study||6
2628638|NCT02037230|6455725|P1|NOT COMPLETED|Overall Study||1
2628639|NCT02037230|6455722|P4|COMPLETED|Overall Study||5
2628640|NCT02037230|6455723|P3|COMPLETED|Overall Study||3
2628641|NCT02037230|6455724|P2|COMPLETED|Overall Study||7
2628642|NCT02037230|6455725|P1|COMPLETED|Overall Study||0
2628643|NCT02037230|6455722|P4|Completed 4 Cycles of Treatment|Overall Study||9
2628644|NCT02037230|6455723|P3|Completed 4 Cycles of Treatment|Overall Study||7
2628645|NCT02037230|6455724|P2|Completed 4 Cycles of Treatment|Overall Study||9
2628646|NCT02037230|6455725|P1|Completed 4 Cycles of Treatment|Overall Study||1
2628647|NCT02037230|6455722|P4|STARTED|Overall Study||11
2628648|NCT02037230|6455723|P3|STARTED|Overall Study||9
2628649|NCT02037230|6455724|P2|STARTED|Overall Study||13
2628650|NCT02037230|6455725|P1|STARTED|Overall Study||1
2628651|NCT02035267|6455748|P4|NOT COMPLETED|Overall Study||1
2628652|NCT02035267|6455749|P3|NOT COMPLETED|Overall Study||2
2628653|NCT02035267|6455750|P2|NOT COMPLETED|Overall Study||1
2628654|NCT02035267|6455751|P1|NOT COMPLETED|Overall Study||0
2628655|NCT02035267|6455748|P4|COMPLETED|Overall Study||15
2628656|NCT02035267|6455749|P3|COMPLETED|Overall Study||28
2628657|NCT02035267|6455750|P2|COMPLETED|Overall Study||15
2628658|NCT02035267|6455751|P1|COMPLETED|Overall Study||31
2628659|NCT02035267|6455748|P4|STARTED|Overall Study||16
2628660|NCT02035267|6455749|P3|STARTED|Overall Study||30
2628661|NCT02035267|6455750|P2|STARTED|Overall Study||16
2628662|NCT02035267|6455751|P1|STARTED|Overall Study||31
2628699|NCT02011945|6455852|P3|NOT COMPLETED|Overall Study||10
2628700|NCT02011945|6455853|P2|NOT COMPLETED|Overall Study||10
2628701|NCT02011945|6455854|P1|NOT COMPLETED|Overall Study||2
2628702|NCT02011945|6455852|P3|COMPLETED|Overall Study||6
2628703|NCT02011945|6455853|P2|COMPLETED|Overall Study||3
2628704|NCT02011945|6455854|P1|COMPLETED|Overall Study||0
2628705|NCT02011945|6455852|P3|STARTED|Overall Study||16
2628706|NCT02011945|6455853|P2|STARTED|Overall Study||13
2628707|NCT02011945|6455854|P1|STARTED|Overall Study||2
2628708|NCT02010203|6455936|P5|NOT COMPLETED|Overall Study||13
2628709|NCT02010203|6455937|P4|NOT COMPLETED|Overall Study||3
2628710|NCT02010203|6455938|P3|NOT COMPLETED|Overall Study||10
2628711|NCT02010203|6455939|P2|NOT COMPLETED|Overall Study||9
2628712|NCT02010203|6455940|P1|NOT COMPLETED|Overall Study||0
2628713|NCT02010203|6455936|P5|COMPLETED|Overall Study||3
2628714|NCT02010203|6455937|P4|COMPLETED|Overall Study||23
2628715|NCT02010203|6455938|P3|COMPLETED|Overall Study||16
2628716|NCT02010203|6455939|P2|COMPLETED|Overall Study||17
2628717|NCT02010203|6455940|P1|COMPLETED|Overall Study||10
2628718|NCT02010203|6455936|P5|STARTED|Overall Study||16
2628719|NCT02010203|6455937|P4|STARTED|Overall Study||26
2628720|NCT02010203|6455938|P3|STARTED|Overall Study||26
2628721|NCT02010203|6455939|P2|STARTED|Overall Study||26
2628722|NCT02010203|6455940|P1|STARTED|Overall Study||10
2628856|NCT01921179|6456334|P2|NOT COMPLETED|Long Term Follow-up After GOALS Training||0
2628857|NCT01921179|6456335|P1|NOT COMPLETED|Long Term Follow-up After GOALS Training||2
2628858|NCT01921179|6456334|P2|COMPLETED|Long Term Follow-up After GOALS Training||0
2628859|NCT01921179|6456335|P1|COMPLETED|Long Term Follow-up After GOALS Training||32
2628860|NCT01921179|6456334|P2|STARTED|Long Term Follow-up After GOALS Training|13 out of 19 participants who completed EDU, also completed GOALS training|0
2628861|NCT01921179|6456335|P1|STARTED|Long Term Follow-up After GOALS Training||34
2628862|NCT01921179|6456334|P2|NOT COMPLETED|5 Week Randomized GOALS vs EDU Training||3
2628863|NCT01921179|6456335|P1|NOT COMPLETED|5 Week Randomized GOALS vs EDU Training||3
2628864|NCT01921179|6456334|P2|COMPLETED|5 Week Randomized GOALS vs EDU Training||19
2628865|NCT01921179|6456335|P1|COMPLETED|5 Week Randomized GOALS vs EDU Training||21
2628866|NCT01921179|6456334|P2|STARTED|5 Week Randomized GOALS vs EDU Training||22
2628867|NCT01921179|6456335|P1|STARTED|5 Week Randomized GOALS vs EDU Training||24
2628922|NCT01890226|6456433|P2|NOT COMPLETED|Overall Study||0
2628923|NCT01890226|6456434|P1|NOT COMPLETED|Overall Study||0
2628924|NCT01890226|6456433|P2|COMPLETED|Overall Study||156
2628925|NCT01890226|6456434|P1|COMPLETED|Overall Study||155
2628926|NCT01890226|6456433|P2|STARTED|Overall Study||156
2628927|NCT01890226|6456434|P1|STARTED|Overall Study||155
2628946|NCT01883492|6456486|P2|NOT COMPLETED|Overall Study||11
2628947|NCT01883492|6456487|P1|NOT COMPLETED|Overall Study||13
2628948|NCT01883492|6456486|P2|COMPLETED|Overall Study||67
2628949|NCT01883492|6456487|P1|COMPLETED|Overall Study||62
2628950|NCT01883492|6456486|P2|STARTED|Overall Study||78
2628951|NCT01883492|6456487|P1|STARTED|Overall Study||75
2628984|NCT01822457|6456572|P2|NOT COMPLETED|Overall Study||5
2628985|NCT01822457|6456573|P1|NOT COMPLETED|Overall Study||4
2628986|NCT01822457|6456572|P2|COMPLETED|Overall Study||12
2628987|NCT01822457|6456573|P1|COMPLETED|Overall Study||16
2628988|NCT01822457|6456572|P2|STARTED|Overall Study||17
2628989|NCT01822457|6456573|P1|STARTED|Overall Study||20
2628990|NCT01817959|6456587|P2|NOT COMPLETED|Overall Study||3
2628991|NCT01817959|6456588|P1|NOT COMPLETED|Overall Study||4
2628992|NCT01817959|6456587|P2|COMPLETED|Overall Study||16
2628993|NCT01817959|6456588|P1|COMPLETED|Overall Study||25
2628994|NCT01817959|6456587|P2|STARTED|Overall Study||19
2628995|NCT01817959|6456588|P1|STARTED|Overall Study||29
2629034|NCT01759277|6456709|P2|NOT COMPLETED|Overall Study||0
2629035|NCT01759277|6456710|P1|NOT COMPLETED|Overall Study||0
2629036|NCT01759277|6456709|P2|COMPLETED|Overall Study||39
2629037|NCT01759277|6456710|P1|COMPLETED|Overall Study||41
2629038|NCT01759277|6456709|P2|STARTED|Overall Study||39
2629039|NCT01759277|6456710|P1|STARTED|Overall Study||41
2629046|NCT01744353|6456730|P3|NOT COMPLETED|Overall Study||0
2629047|NCT01744353|6456731|P2|NOT COMPLETED|Overall Study||0
2629048|NCT01744353|6456732|P1|NOT COMPLETED|Overall Study||0
2629049|NCT01744353|6456730|P3|COMPLETED|Overall Study||3
2629050|NCT01744353|6456731|P2|COMPLETED|Overall Study||26
2629051|NCT01744353|6456732|P1|COMPLETED|Overall Study||6
2629052|NCT01744353|6456730|P3|STARTED|Overall Study||3
2629053|NCT01744353|6456731|P2|STARTED|Overall Study||26
2629054|NCT01744353|6456732|P1|STARTED|Overall Study||6
2629055|NCT01744340|6456743|P2|NOT COMPLETED|Overall Study||0
2629056|NCT01744340|6456744|P1|NOT COMPLETED|Overall Study||0
2629057|NCT01744340|6456743|P2|COMPLETED|Overall Study||15
2629058|NCT01744340|6456744|P1|COMPLETED|Overall Study||8
2629059|NCT01744340|6456743|P2|STARTED|Overall Study||15
2629060|NCT01744340|6456744|P1|STARTED|Overall Study||8
2629127|NCT01705288|6456883|P2|NOT COMPLETED|Overall Study||0
2629128|NCT01705288|6456884|P1|NOT COMPLETED|Overall Study||0
2629129|NCT01705288|6456883|P2|COMPLETED|Overall Study||51
2629130|NCT01705288|6456884|P1|COMPLETED|Overall Study||52
2629131|NCT01705288|6456883|P2|STARTED|Overall Study||51
2629132|NCT01705288|6456884|P1|STARTED|Overall Study||52
2629166|NCT01671488|6457083|P1|NOT COMPLETED|Overall Study||1
2629167|NCT01671488|6457083|P1|COMPLETED|Overall Study||10
2629168|NCT01671488|6457083|P1|STARTED|Overall Study||11
2629169|NCT01669720|6457091|P2|NOT COMPLETED|Overall Study||0
2629170|NCT01669720|6457092|P1|NOT COMPLETED|Overall Study||0
2629171|NCT01669720|6457091|P2|COMPLETED|Overall Study||3
2629172|NCT01669720|6457092|P1|COMPLETED|Overall Study||7
2629173|NCT01669720|6457091|P2|STARTED|Overall Study||3
2629174|NCT01669720|6457092|P1|STARTED|Overall Study||7
2629221|NCT01570348|6457208|P1|NOT COMPLETED|Overall Study||0
2629222|NCT01570348|6457208|P1|COMPLETED|Overall Study||2
2629223|NCT01570348|6457208|P1|STARTED|Overall Study||2
2629245|NCT01490892|6457355|P1|NOT COMPLETED|Overall Study||0
2629246|NCT01490892|6457355|P1|COMPLETED|Overall Study||219
2629247|NCT01490892|6457355|P1|STARTED|Overall Study||219
2629248|NCT01475162|6457360|P1|NOT COMPLETED|Overall Study||14
2629249|NCT01475162|6457360|P1|COMPLETED|Overall Study||0
2629250|NCT01475162|6457360|P1|STARTED|Overall Study||14
2629285|NCT01445171|6457512|P1|NOT COMPLETED|Overall Study||95
2629286|NCT01445171|6457512|P1|COMPLETED|Overall Study||200
2629287|NCT01445171|6457512|P1|Implanted With Study Device|Overall Study||287
2629288|NCT01445171|6457512|P1|STARTED|Overall Study||295
2629331|NCT01402063|6457602|P2|NOT COMPLETED|Overall Study||3
2629332|NCT01402063|6457603|P1|NOT COMPLETED|Overall Study||3
2629333|NCT01402063|6457602|P2|COMPLETED|Overall Study||18
2629334|NCT01402063|6457603|P1|COMPLETED|Overall Study||39
2629335|NCT01402063|6457602|P2|STARTED|Overall Study||21
2629336|NCT01402063|6457603|P1|STARTED|Overall Study||42
2629409|NCT01264419|6457777|P1|NOT COMPLETED|Overall Study||3
2629410|NCT01264419|6457777|P1|COMPLETED|Overall Study||72
2629411|NCT01264419|6457777|P1|STARTED|Overall Study||75
2629537|NCT01057277|6458143|P1|NOT COMPLETED|Overall Study||0
2629538|NCT01057277|6458143|P1|COMPLETED|Overall Study||3
2629539|NCT01057277|6458143|P1|STARTED|Overall Study||3
2629540|NCT01057017|6458147|P1|NOT COMPLETED|Overall Study||0
2629541|NCT01057017|6458147|P1|COMPLETED|Overall Study||5
2629542|NCT01057017|6458147|P1|STARTED|Overall Study||5
2629626|NCT00942331|6458309|P2|NOT COMPLETED|Overall Study||22
2629627|NCT00942331|6458310|P1|NOT COMPLETED|Overall Study||15
2629628|NCT00942331|6458309|P2|COMPLETED|Overall Study||232
2629629|NCT00942331|6458310|P1|COMPLETED|Overall Study||237
2629630|NCT00942331|6458309|P2|Reported Adverse Events|Overall Study||233
2629631|NCT00942331|6458310|P1|Reported Adverse Events|Overall Study||234
2629632|NCT00942331|6458309|P2|STARTED|Overall Study||254
2629633|NCT00942331|6458310|P1|STARTED|Overall Study||252
2629677|NCT00831766|6458405|P2|NOT COMPLETED|Overall Study||0
2629678|NCT00831766|6458406|P1|NOT COMPLETED|Overall Study||0
2629679|NCT00831766|6458405|P2|COMPLETED|Overall Study||28
2629680|NCT00831766|6458406|P1|COMPLETED|Overall Study||23
2629681|NCT00831766|6458405|P2|STARTED|Overall Study||28
2629682|NCT00831766|6458406|P1|STARTED|Overall Study||23
2629683|NCT00812838|6458417|P2|NOT COMPLETED|Optional Crossover of 16 Weeks||0
2629684|NCT00812838|6458418|P1|NOT COMPLETED|Optional Crossover of 16 Weeks||0
2629685|NCT00812838|6458417|P2|COMPLETED|Optional Crossover of 16 Weeks||4
2629686|NCT00812838|6458418|P1|COMPLETED|Optional Crossover of 16 Weeks||0
2629687|NCT00812838|6458417|P2|STARTED|Optional Crossover of 16 Weeks||4
2629688|NCT00812838|6458418|P1|STARTED|Optional Crossover of 16 Weeks||0
2629689|NCT00812838|6458417|P2|NOT COMPLETED|Treatment Period of 16 Weeks||0
2629690|NCT00812838|6458418|P1|NOT COMPLETED|Treatment Period of 16 Weeks||0
2629691|NCT00812838|6458417|P2|COMPLETED|Treatment Period of 16 Weeks||6
2629692|NCT00812838|6458418|P1|COMPLETED|Treatment Period of 16 Weeks||6
2629693|NCT00812838|6458417|P2|STARTED|Treatment Period of 16 Weeks||6
2629694|NCT00812838|6458418|P1|STARTED|Treatment Period of 16 Weeks||6
2629707|NCT00763750|6458466|P1|NOT COMPLETED|Overall Study||0
2629708|NCT00763750|6458466|P1|COMPLETED|Overall Study||25
2629709|NCT00763750|6458466|P1|STARTED|Overall Study||25
2629733|NCT00720941|6458559|P2|NOT COMPLETED|Overall Study||415
2629734|NCT00720941|6458560|P1|NOT COMPLETED|Overall Study||413
2629735|NCT00720941|6458559|P2|COMPLETED|Overall Study||138
2629736|NCT00720941|6458560|P1|COMPLETED|Overall Study||144
2629737|NCT00720941|6458559|P2|Ongoing|Overall Study||23
2629738|NCT00720941|6458560|P1|Ongoing|Overall Study||34
2629739|NCT00720941|6458559|P2|STARTED|Overall Study||553
2629740|NCT00720941|6458560|P1|STARTED|Overall Study||557
2629741|NCT00717756|6458600|P1|NOT COMPLETED|Overall Study||1
2629742|NCT00717756|6458600|P1|COMPLETED|Overall Study||40
2629743|NCT00717756|6458600|P1|STARTED|Overall Study||41
2629750|NCT00698997|6458610|P2|NOT COMPLETED|Overall Study||27
2629751|NCT00698997|6458611|P1|NOT COMPLETED|Overall Study||10
2629752|NCT00698997|6458610|P2|COMPLETED|Overall Study|36 - final assessment completed|36
2629753|NCT00698997|6458611|P1|COMPLETED|Overall Study|45 - final participant assessment completed|45
2629754|NCT00698997|6458610|P2|STARTED|Overall Study|1 enrollment|63
2629755|NCT00698997|6458611|P1|STARTED|Overall Study|1 enrollment|55
2629867|NCT00579527|6458823|P1|NOT COMPLETED|Overall Study||4
2629868|NCT00579527|6458823|P1|COMPLETED|Overall Study||10
2629869|NCT00579527|6458823|P1|STARTED|Overall Study||14
2629870|NCT00576836|6458835|P2|NOT COMPLETED|Overall Study||2
2629871|NCT00576836|6458836|P1|NOT COMPLETED|Overall Study||0
2629872|NCT00576836|6458835|P2|COMPLETED|Overall Study||5
2629873|NCT00576836|6458836|P1|COMPLETED|Overall Study||0
2629874|NCT00576836|6458835|P2|STARTED|Overall Study||7
2629875|NCT00576836|6458836|P1|STARTED|Overall Study||0
2629876|NCT00576407|6458848|P1|NOT COMPLETED|Overall Study||8
2629877|NCT00576407|6458848|P1|COMPLETED|Overall Study||18
2629878|NCT00576407|6458848|P1|STARTED|Overall Study||26
2629879|NCT00553098|6458860|P1|NOT COMPLETED|Overall Study||1
2629880|NCT00553098|6458860|P1|COMPLETED|Overall Study||28
2629881|NCT00553098|6458860|P1|STARTED|Overall Study||29
2629891|NCT00522795|6458899|P1|NOT COMPLETED|Overall Study||0
2629892|NCT00522795|6458899|P1|COMPLETED|Overall Study||40
2629893|NCT00522795|6458899|P1|STARTED|Overall Study||40
2629894|NCT00504829|6458906|P3|NOT COMPLETED|Overall Study||10
2629895|NCT00504829|6458907|P2|NOT COMPLETED|Overall Study||4
2629896|NCT00504829|6458908|P1|NOT COMPLETED|Overall Study||6
2629897|NCT00504829|6458906|P3|COMPLETED|Overall Study||63
2629898|NCT00504829|6458907|P2|COMPLETED|Overall Study||70
2629899|NCT00504829|6458908|P1|COMPLETED|Overall Study||67
2629900|NCT00504829|6458906|P3|STARTED|Overall Study||73
2629901|NCT00504829|6458907|P2|STARTED|Overall Study||74
2629902|NCT00504829|6458908|P1|STARTED|Overall Study||73
2629903|NCT00478426|6458917|P1|NOT COMPLETED|Overall Study||1
2629904|NCT00478426|6458917|P1|COMPLETED|Overall Study||33
2629905|NCT00478426|6458917|P1|STARTED|Overall Study||34
2629930|NCT00439608|6458976|P1|NOT COMPLETED|Overall Study||0
2629931|NCT00439608|6458976|P1|COMPLETED|Overall Study||60
2629932|NCT00439608|6458976|P1|STARTED|Overall Study||60
2629933|NCT00439179|6458985|P4|NOT COMPLETED|Overall Study||0
2629934|NCT00439179|6458986|P3|NOT COMPLETED|Overall Study||0
2629935|NCT00439179|6458987|P2|NOT COMPLETED|Overall Study||2
2629936|NCT00439179|6458988|P1|NOT COMPLETED|Overall Study||0
2629937|NCT00439179|6458985|P4|COMPLETED|Overall Study||5
2629938|NCT00439179|6458986|P3|COMPLETED|Overall Study||6
2629939|NCT00439179|6458987|P2|COMPLETED|Overall Study||11
2629940|NCT00439179|6458988|P1|COMPLETED|Overall Study||3
2629941|NCT00439179|6458985|P4|STARTED|Overall Study|2 with biliry|5
2629942|NCT00439179|6458986|P3|STARTED|Overall Study|2 with biliary|6
2629943|NCT00439179|6458987|P2|STARTED|Overall Study|2 with biliary|13
2629944|NCT00439179|6458988|P1|STARTED|Overall Study|1 with biliary|3
2630005|NCT00357214|6459082|P4|NOT COMPLETED|Overall Study||1
2630006|NCT00357214|6459083|P3|NOT COMPLETED|Overall Study||0
2630007|NCT00357214|6459084|P2|NOT COMPLETED|Overall Study||4
2630008|NCT00357214|6459085|P1|NOT COMPLETED|Overall Study||4
2630009|NCT00357214|6459082|P4|COMPLETED|Overall Study||42
2630010|NCT00357214|6459083|P3|COMPLETED|Overall Study||42
2630011|NCT00357214|6459084|P2|COMPLETED|Overall Study||39
2630012|NCT00357214|6459085|P1|COMPLETED|Overall Study||39
2630013|NCT00357214|6459082|P4|STARTED|Overall Study||43
2630014|NCT00357214|6459083|P3|STARTED|Overall Study||42
2630015|NCT00357214|6459084|P2|STARTED|Overall Study||43
2630016|NCT00357214|6459085|P1|STARTED|Overall Study||43
2630110|NCT00203021|6459255|P2|NOT COMPLETED|Overall Study||77
2630111|NCT00203021|6459256|P1|NOT COMPLETED|Overall Study||79
2630112|NCT00203021|6459255|P2|COMPLETED|Overall Study||24
2630113|NCT00203021|6459256|P1|COMPLETED|Overall Study||28
2630114|NCT00203021|6459255|P2|Received at Least 1 Dose of Study Drug|Overall Study||101
2630115|NCT00203021|6459256|P1|Received at Least 1 Dose of Study Drug|Overall Study||107
2630116|NCT00203021|6459255|P2|STARTED|Overall Study||101
2630117|NCT00203021|6459256|P1|STARTED|Overall Study||107
2633076|NCT03694821|6468074|P3|NOT COMPLETED|Overall Study||4
2633077|NCT03694821|6468075|P2|NOT COMPLETED|Overall Study||8
2633078|NCT03694821|6468076|P1|NOT COMPLETED|Overall Study||4
2633079|NCT03694821|6468074|P3|COMPLETED|Overall Study||2
2633080|NCT03694821|6468075|P2|COMPLETED|Overall Study||0
2633081|NCT03694821|6468076|P1|COMPLETED|Overall Study||0
2633082|NCT03694821|6468074|P3|STARTED|Overall Study||6
2633083|NCT03694821|6468075|P2|STARTED|Overall Study||8
2633084|NCT03694821|6468076|P1|STARTED|Overall Study||4
2633106|NCT03639675|6468147|P1|NOT COMPLETED|Overall Study||1
2633107|NCT03639675|6468147|P1|COMPLETED|Overall Study||15
2633108|NCT03639675|6468147|P1|Received Treatment|Overall Study||16
2633109|NCT03639675|6468147|P1|STARTED|Overall Study||16
2633142|NCT03574818|6468224|P1|NOT COMPLETED|Overall Study||0
2633143|NCT03574818|6468224|P1|COMPLETED|Overall Study||1
2633144|NCT03574818|6468224|P1|STARTED|Overall Study||1
2633145|NCT03571607|6468230|P2|NOT COMPLETED|Overall Study||0
2633146|NCT03571607|6468231|P1|NOT COMPLETED|Overall Study||0
2633147|NCT03571607|6468230|P2|COMPLETED|Overall Study||153
2633148|NCT03571607|6468231|P1|COMPLETED|Overall Study||53
2633149|NCT03571607|6468230|P2|Vaccinated|Overall Study||153
2633150|NCT03571607|6468231|P1|Vaccinated|Overall Study||53
2633151|NCT03571607|6468230|P2|STARTED|Overall Study||153
2633152|NCT03571607|6468231|P1|STARTED|Overall Study||53
2633192|NCT03504189|6468348|P1|NOT COMPLETED|Overall Study||4
2633193|NCT03504189|6468348|P1|COMPLETED|Overall Study||147
2633194|NCT03504189|6468348|P1|STARTED|Overall Study||151
2633212|NCT03447821|6468398|P3|NOT COMPLETED|Overall Study||1
2633213|NCT03447821|6468399|P2|NOT COMPLETED|Overall Study||1
2633214|NCT03447821|6468400|P1|NOT COMPLETED|Overall Study||1
2633215|NCT03447821|6468398|P3|COMPLETED|Overall Study||12
2633216|NCT03447821|6468399|P2|COMPLETED|Overall Study||12
2633217|NCT03447821|6468400|P1|COMPLETED|Overall Study||13
2633218|NCT03447821|6468398|P3|STARTED|Overall Study||13
2633219|NCT03447821|6468399|P2|STARTED|Overall Study||13
2633220|NCT03447821|6468400|P1|STARTED|Overall Study||14
2633321|NCT03285373|6468688|P4|NOT COMPLETED|Overall Study||0
2633322|NCT03285373|6468689|P3|NOT COMPLETED|Overall Study||0
2633323|NCT03285373|6468690|P2|NOT COMPLETED|Overall Study||0
2633324|NCT03285373|6468691|P1|NOT COMPLETED|Overall Study||0
2633325|NCT03285373|6468688|P4|COMPLETED|Overall Study||130
2633326|NCT03285373|6468689|P3|COMPLETED|Overall Study||266
2633327|NCT03285373|6468690|P2|COMPLETED|Overall Study||253
2633328|NCT03285373|6468691|P1|COMPLETED|Overall Study||314
2633329|NCT03285373|6468688|P4|STARTED|Overall Study||130
2633330|NCT03285373|6468689|P3|STARTED|Overall Study||266
2633331|NCT03285373|6468690|P2|STARTED|Overall Study||253
2633332|NCT03285373|6468691|P1|STARTED|Overall Study||314
2633438|NCT03152526|6469033|P2|NOT COMPLETED|Overall Study||1
2633439|NCT03152526|6469034|P1|NOT COMPLETED|Overall Study||0
2633440|NCT03152526|6469033|P2|COMPLETED|Overall Study|The one participant enrolled on this arm withdrew from the study early.|0
2633441|NCT03152526|6469034|P1|COMPLETED|Overall Study|No participants were enrolled on this arm.|0
2633442|NCT03152526|6469033|P2|STARTED|Overall Study|One participant was enrolled on this arm.|1
2633443|NCT03152526|6469034|P1|STARTED|Overall Study|No participants were enrolled on this arm.|0
2633570|NCT03101371|6469164|P2|NOT COMPLETED|Overall Study||6
2633571|NCT03101371|6469165|P1|NOT COMPLETED|Overall Study||3
2633572|NCT03101371|6469164|P2|COMPLETED|Overall Study||45
2633573|NCT03101371|6469165|P1|COMPLETED|Overall Study||45
2633574|NCT03101371|6469164|P2|STARTED|Overall Study||51
2633575|NCT03101371|6469165|P1|STARTED|Overall Study||48
2633659|NCT03034928|6469589|P4|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
2633660|NCT03034928|6469590|P3|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
2633661|NCT03034928|6469591|P2|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
2633662|NCT03034928|6469592|P1|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
2633663|NCT03034928|6469589|P4|COMPLETED|Period 2, Second 2 Hours of Wear||8
2633664|NCT03034928|6469590|P3|COMPLETED|Period 2, Second 2 Hours of Wear||9
2633665|NCT03034928|6469591|P2|COMPLETED|Period 2, Second 2 Hours of Wear||8
2633666|NCT03034928|6469592|P1|COMPLETED|Period 2, Second 2 Hours of Wear||8
2633667|NCT03034928|6469589|P4|STARTED|Period 2, Second 2 Hours of Wear||8
2633668|NCT03034928|6469590|P3|STARTED|Period 2, Second 2 Hours of Wear||9
2633669|NCT03034928|6469591|P2|STARTED|Period 2, Second 2 Hours of Wear||8
2633670|NCT03034928|6469592|P1|STARTED|Period 2, Second 2 Hours of Wear||8
2633671|NCT03034928|6469589|P4|NOT COMPLETED|Washout Period Between Lens Wear||0
2633672|NCT03034928|6469590|P3|NOT COMPLETED|Washout Period Between Lens Wear||0
2633673|NCT03034928|6469591|P2|NOT COMPLETED|Washout Period Between Lens Wear||0
2633674|NCT03034928|6469592|P1|NOT COMPLETED|Washout Period Between Lens Wear||0
2633675|NCT03034928|6469589|P4|COMPLETED|Washout Period Between Lens Wear||8
2633676|NCT03034928|6469590|P3|COMPLETED|Washout Period Between Lens Wear||9
2633677|NCT03034928|6469591|P2|COMPLETED|Washout Period Between Lens Wear||8
2633678|NCT03034928|6469592|P1|COMPLETED|Washout Period Between Lens Wear||8
2633679|NCT03034928|6469589|P4|STARTED|Washout Period Between Lens Wear||8
2633680|NCT03034928|6469590|P3|STARTED|Washout Period Between Lens Wear||9
2633681|NCT03034928|6469591|P2|STARTED|Washout Period Between Lens Wear||8
2633682|NCT03034928|6469592|P1|STARTED|Washout Period Between Lens Wear||8
2633683|NCT03034928|6469589|P4|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
2633684|NCT03034928|6469590|P3|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
2633685|NCT03034928|6469591|P2|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
2633686|NCT03034928|6469592|P1|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
2633687|NCT03034928|6469589|P4|COMPLETED|Period 1, First 2 Hours of Wear||8
2633688|NCT03034928|6469590|P3|COMPLETED|Period 1, First 2 Hours of Wear||9
2633689|NCT03034928|6469591|P2|COMPLETED|Period 1, First 2 Hours of Wear||8
2633690|NCT03034928|6469592|P1|COMPLETED|Period 1, First 2 Hours of Wear||8
2633691|NCT03034928|6469589|P4|STARTED|Period 1, First 2 Hours of Wear||8
2633692|NCT03034928|6469590|P3|STARTED|Period 1, First 2 Hours of Wear||9
2633693|NCT03034928|6469591|P2|STARTED|Period 1, First 2 Hours of Wear||8
2633694|NCT03034928|6469592|P1|STARTED|Period 1, First 2 Hours of Wear||8
2633985|NCT02844946|6471099|P2|NOT COMPLETED|Overall Study||0
2633986|NCT02844946|6471100|P1|NOT COMPLETED|Overall Study||7
2633987|NCT02844946|6471099|P2|COMPLETED|Overall Study||12
2633988|NCT02844946|6471100|P1|COMPLETED|Overall Study||20
2633989|NCT02844946|6471099|P2|STARTED|Overall Study||12
2633990|NCT02844946|6471100|P1|STARTED|Overall Study||27
2633991|NCT02842866|6471120|P2|NOT COMPLETED|Overall Study||3
2633992|NCT02842866|6471121|P1|NOT COMPLETED|Overall Study||7
2633993|NCT02842866|6471120|P2|COMPLETED|Overall Study||452
2633994|NCT02842866|6471121|P1|COMPLETED|Overall Study||444
2633995|NCT02842866|6471120|P2|Vaccinated|Overall Study||453
2633996|NCT02842866|6471121|P1|Vaccinated|Overall Study||448
2633997|NCT02842866|6471120|P2|STARTED|Overall Study||455
2633998|NCT02842866|6471121|P1|STARTED|Overall Study||451
2634041|NCT02818920|6471305|P1|NOT COMPLETED|Overall Study||18
2634042|NCT02818920|6471305|P1|COMPLETED|Overall Study||12
2634043|NCT02818920|6471305|P1|Received Adjuvant Therapy|Overall Study||17
2634044|NCT02818920|6471305|P1|Completed Surgery|Overall Study||25
2634045|NCT02818920|6471305|P1|STARTED|Overall Study||30
2634046|NCT02804594|6471311|P2|NOT COMPLETED|Overall Study||0
2634047|NCT02804594|6471312|P1|NOT COMPLETED|Overall Study||0
2634048|NCT02804594|6471311|P2|COMPLETED|Overall Study||5
2634049|NCT02804594|6471312|P1|COMPLETED|Overall Study||10
2634050|NCT02804594|6471311|P2|STARTED|Overall Study||5
2634051|NCT02804594|6471312|P1|STARTED|Overall Study||10
2634105|NCT02785913|6471415|P1|NOT COMPLETED|Overall Study||31
2634106|NCT02785913|6471415|P1|COMPLETED|Overall Study||0
2634107|NCT02785913|6471415|P1|Eligible and Began Protocol Therapy|Overall Study||26
2634108|NCT02785913|6471415|P1|Eligible|Overall Study||27
2634109|NCT02785913|6471415|P1|STARTED|Overall Study||31
2634142|NCT02767427|6471477|P2|NOT COMPLETED|Overall Study||0
2634143|NCT02767427|6471478|P1|NOT COMPLETED|Overall Study||0
2634144|NCT02767427|6471477|P2|COMPLETED|Overall Study||19
2634145|NCT02767427|6471478|P1|COMPLETED|Overall Study||21
2634146|NCT02767427|6471477|P2|STARTED|Overall Study||19
2634147|NCT02767427|6471478|P1|STARTED|Overall Study||21
2634160|NCT02743949|6471528|P3|NOT COMPLETED|Overall Study||3
2634161|NCT02743949|6471529|P2|NOT COMPLETED|Overall Study||1
2634162|NCT02743949|6471530|P1|NOT COMPLETED|Overall Study||4
2634163|NCT02743949|6471528|P3|COMPLETED|Overall Study||82
2634164|NCT02743949|6471529|P2|COMPLETED|Overall Study||84
2634165|NCT02743949|6471530|P1|COMPLETED|Overall Study||82
2634166|NCT02743949|6471528|P3|STARTED|Overall Study||85
2634167|NCT02743949|6471529|P2|STARTED|Overall Study||85
2634168|NCT02743949|6471530|P1|STARTED|Overall Study||86
2634169|NCT02738086|6471543|P2|NOT COMPLETED|Overall Study||2
2634170|NCT02738086|6471544|P1|NOT COMPLETED|Overall Study||2
2634171|NCT02738086|6471543|P2|COMPLETED|Overall Study||13
2634172|NCT02738086|6471544|P1|COMPLETED|Overall Study||14
2634173|NCT02738086|6471543|P2|STARTED|Overall Study||15
2634174|NCT02738086|6471544|P1|STARTED|Overall Study||16
2634530|NCT02559687|6473159|P1|NOT COMPLETED|Overall Study||121
2634531|NCT02559687|6473159|P1|COMPLETED|Overall Study||0
2634532|NCT02559687|6473159|P1|STARTED|Overall Study||121
2634642|NCT02527434|6473747|P3|NOT COMPLETED|Overall Study||20
2634643|NCT02527434|6473748|P2|NOT COMPLETED|Overall Study||11
2634644|NCT02527434|6473749|P1|NOT COMPLETED|Overall Study||28
2634645|NCT02527434|6473747|P3|COMPLETED|Overall Study||0
2634646|NCT02527434|6473748|P2|COMPLETED|Overall Study||1
2634647|NCT02527434|6473749|P1|COMPLETED|Overall Study||4
2634648|NCT02527434|6473747|P3|Started Retreatment Phase (MEDI)|Overall Study||1
2634649|NCT02527434|6473748|P2|Started Retreatment Phase (MEDI)|Overall Study||0
2634650|NCT02527434|6473749|P1|Started Retreatment Phase (MEDI)|Overall Study||4
2634651|NCT02527434|6473747|P3|Started Retreatment Phase (COMBO)|Overall Study||4
2634652|NCT02527434|6473748|P2|Started Retreatment Phase (COMBO)|Overall Study||5
2634653|NCT02527434|6473749|P1|Started Retreatment Phase (COMBO)|Overall Study||7
2634654|NCT02527434|6473747|P3|STARTED|Overall Study||20
2634655|NCT02527434|6473748|P2|STARTED|Overall Study||12
2634656|NCT02527434|6473749|P1|STARTED|Overall Study||32
2634657|NCT02526277|6473811|P4|NOT COMPLETED|Overall Study||0
2634658|NCT02526277|6473812|P3|NOT COMPLETED|Overall Study||0
2634659|NCT02526277|6473813|P2|NOT COMPLETED|Overall Study||0
2634660|NCT02526277|6473814|P1|NOT COMPLETED|Overall Study||0
2634661|NCT02526277|6473811|P4|COMPLETED|Overall Study||7
2634662|NCT02526277|6473812|P3|COMPLETED|Overall Study||7
2634663|NCT02526277|6473813|P2|COMPLETED|Overall Study||6
2634664|NCT02526277|6473814|P1|COMPLETED|Overall Study||8
2634665|NCT02526277|6473811|P4|STARTED|Overall Study||7
2634666|NCT02526277|6473812|P3|STARTED|Overall Study||7
2634667|NCT02526277|6473813|P2|STARTED|Overall Study||6
2634668|NCT02526277|6473814|P1|STARTED|Overall Study||8
2634684|NCT02506309|6473879|P2|NOT COMPLETED|Overall Study||20
2634685|NCT02506309|6473880|P1|NOT COMPLETED|Overall Study||18
2634686|NCT02506309|6473879|P2|COMPLETED|Overall Study||64
2634687|NCT02506309|6473880|P1|COMPLETED|Overall Study||66
2634688|NCT02506309|6473879|P2|STARTED|Overall Study||84
2634689|NCT02506309|6473880|P1|STARTED|Overall Study||84
2634759|NCT02418182|6474100|P2|NOT COMPLETED|Overall Study||17
2634760|NCT02418182|6474101|P1|NOT COMPLETED|Overall Study||18
2634761|NCT02418182|6474100|P2|COMPLETED|Overall Study||33
2634762|NCT02418182|6474101|P1|COMPLETED|Overall Study||31
2634763|NCT02418182|6474100|P2|STARTED|Overall Study||50
2634764|NCT02418182|6474101|P1|STARTED|Overall Study||49
2634789|NCT02408198|6474194|P2|NOT COMPLETED|Overall Study||0
2634790|NCT02408198|6474195|P1|NOT COMPLETED|Overall Study||3
2634791|NCT02408198|6474194|P2|COMPLETED|Overall Study||5
2634792|NCT02408198|6474195|P1|COMPLETED|Overall Study||10
2634793|NCT02408198|6474194|P2|STARTED|Overall Study||5
2634794|NCT02408198|6474195|P1|STARTED|Overall Study||13
2634907|NCT02387970|6474574|P2|NOT COMPLETED|Overall Study||2
2634908|NCT02387970|6474575|P1|NOT COMPLETED|Overall Study||1
2634909|NCT02387970|6474574|P2|COMPLETED|Overall Study||23
2634910|NCT02387970|6474575|P1|COMPLETED|Overall Study||26
2634911|NCT02387970|6474574|P2|STARTED|Overall Study||25
2634912|NCT02387970|6474575|P1|STARTED|Overall Study||27
2635003|NCT02324504|6475117|P1|NOT COMPLETED|Overall Study||0
2635004|NCT02324504|6475117|P1|COMPLETED|Overall Study||60
2635005|NCT02324504|6475117|P1|STARTED|Overall Study||60
2635039|NCT02296125|6475308|P4|NOT COMPLETED|Overall Study||44
2635040|NCT02296125|6475309|P3|NOT COMPLETED|Overall Study||38
2635041|NCT02296125|6475310|P2|NOT COMPLETED|Overall Study||213
2635042|NCT02296125|6475311|P1|NOT COMPLETED|Overall Study||138
2635043|NCT02296125|6475308|P4|COMPLETED|Overall Study||21
2635044|NCT02296125|6475309|P3|COMPLETED|Overall Study||33
2635045|NCT02296125|6475310|P2|COMPLETED|Overall Study||64
2635046|NCT02296125|6475311|P1|COMPLETED|Overall Study||141
2635047|NCT02296125|6475308|P4|STARTED|Overall Study|There were 7 participants who were in both the Global and China Extension SoC EGFR-TKI Arm.|65
2635048|NCT02296125|6475309|P3|STARTED|Overall Study||71
2635049|NCT02296125|6475310|P2|STARTED|Overall Study|183 participant received gefitinib and 93 participants received erlotinib.|277
2635050|NCT02296125|6475311|P1|STARTED|Overall Study|There were 12 participants who were in both the Global and China Extension Osimertinib Arm.|279
2635060|NCT02269917|6475401|P2|NOT COMPLETED|Overall Study||383
2635061|NCT02269917|6475402|P1|NOT COMPLETED|Overall Study||766
2635062|NCT02269917|6475401|P2|COMPLETED|Overall Study||0
2635063|NCT02269917|6475402|P1|COMPLETED|Overall Study||0
2635064|NCT02269917|6475401|P2|Treated|Overall Study||378
2635065|NCT02269917|6475402|P1|Treated|Overall Study||763
2635066|NCT02269917|6475401|P2|STARTED|Overall Study||383
2635067|NCT02269917|6475402|P1|STARTED|Overall Study||766
2635068|NCT02241512|6475455|P2|NOT COMPLETED|Overall Study||0
2635069|NCT02241512|6475456|P1|NOT COMPLETED|Overall Study||1
2635070|NCT02241512|6475455|P2|COMPLETED|Overall Study||29
2635071|NCT02241512|6475456|P1|COMPLETED|Overall Study||29
2635072|NCT02241512|6475455|P2|STARTED|Overall Study||29
2635073|NCT02241512|6475456|P1|STARTED|Overall Study||30
2635164|NCT02159521|6475711|P1|NOT COMPLETED|Overall Study||18
2635165|NCT02159521|6475711|P1|COMPLETED|Overall Study||63
2635166|NCT02159521|6475711|P1|Received EkoSonic® Treatment|Overall Study||78
2635167|NCT02159521|6475711|P1|STARTED|Overall Study|4 participants had both limbs treated.|81
2635171|NCT02151981|6475742|P2|NOT COMPLETED|Overall Study||140
2635172|NCT02151981|6475743|P1|NOT COMPLETED|Overall Study||279
2635173|NCT02151981|6475742|P2|COMPLETED|Overall Study||0
2635174|NCT02151981|6475743|P1|COMPLETED|Overall Study||0
2635175|NCT02151981|6475742|P2|Crossed Over AZD9291|Overall Study|Patients randomised to chemotherapy were allowed to crossover to AZD9291 after progression|82
2635176|NCT02151981|6475743|P1|Crossed Over AZD9291|Overall Study||0
2635177|NCT02151981|6475742|P2|Did Not Receive Treatment|Overall Study||4
2635178|NCT02151981|6475743|P1|Did Not Receive Treatment|Overall Study||0
2635179|NCT02151981|6475742|P2|Received Randomised Treatment Only|Overall Study||54
2635180|NCT02151981|6475743|P1|Received Randomised Treatment Only|Overall Study||279
2635181|NCT02151981|6475742|P2|STARTED|Overall Study||140
2635182|NCT02151981|6475743|P1|STARTED|Overall Study||279
2635342|NCT02082340|6476248|P2|NOT COMPLETED|Overall Study||1
2635343|NCT02082340|6476249|P1|NOT COMPLETED|Overall Study||1
2635344|NCT02082340|6476248|P2|COMPLETED|Overall Study||197
2635345|NCT02082340|6476249|P1|COMPLETED|Overall Study||193
2635346|NCT02082340|6476248|P2|STARTED|Overall Study||198
2635347|NCT02082340|6476249|P1|STARTED|Overall Study||194
2635396|NCT02018445|6476298|P1|NOT COMPLETED|Overall Study||7
2635397|NCT02018445|6476298|P1|COMPLETED|Overall Study||29
2635398|NCT02018445|6476298|P1|STARTED|Overall Study||36
2635511|NCT01953081|6476660|P2|NOT COMPLETED|Overall Study||3
2635512|NCT01953081|6476661|P1|NOT COMPLETED|Overall Study||2
2635513|NCT01953081|6476660|P2|COMPLETED|Overall Study||3
2635514|NCT01953081|6476661|P1|COMPLETED|Overall Study||5
2635515|NCT01953081|6476660|P2|STARTED|Overall Study||6
2635516|NCT01953081|6476661|P1|STARTED|Overall Study||7
2635621|NCT01893372|6476880|P2|NOT COMPLETED|Overall Study||0
2635622|NCT01893372|6476881|P1|NOT COMPLETED|Overall Study||0
2635623|NCT01893372|6476880|P2|COMPLETED|Overall Study||22
2635624|NCT01893372|6476881|P1|COMPLETED|Overall Study||7
2635625|NCT01893372|6476880|P2|STARTED|Overall Study||22
2635626|NCT01893372|6476881|P1|STARTED|Overall Study||7
2635654|NCT01878084|6476953|P1|NOT COMPLETED|Overall Study||2
2635655|NCT01878084|6476953|P1|COMPLETED|Overall Study||7
2635656|NCT01878084|6476953|P1|Control (Sockets Were Left Empty)|Overall Study||7
2635657|NCT01878084|6476953|P1|Test(Received TAMP Bioglass) s|Overall Study||7
2635658|NCT01878084|6476953|P1|STARTED|Overall Study||9
2635718|NCT01828073|6477023|P2|NOT COMPLETED|Overall Study||2
2635719|NCT01828073|6477024|P1|NOT COMPLETED|Overall Study||1
2635720|NCT01828073|6477023|P2|COMPLETED|Overall Study||16
2635721|NCT01828073|6477024|P1|COMPLETED|Overall Study||21
2635722|NCT01828073|6477023|P2|STARTED|Overall Study||18
2635723|NCT01828073|6477024|P1|STARTED|Overall Study||22
2635876|NCT01705509|6477325|P1|NOT COMPLETED|CPET w/ Ranexa||2
2635877|NCT01705509|6477325|P1|COMPLETED|CPET w/ Ranexa||5
2635878|NCT01705509|6477325|P1|STARTED|CPET w/ Ranexa||7
2635879|NCT01705509|6477325|P1|NOT COMPLETED|Inclusion CPET||7
2635880|NCT01705509|6477325|P1|COMPLETED|Inclusion CPET||7
2635881|NCT01705509|6477325|P1|STARTED|Inclusion CPET||14
2636033|NCT01524679|6477974|P2|NOT COMPLETED|Overall Study||9
2636034|NCT01524679|6477975|P1|NOT COMPLETED|Overall Study||23
2636035|NCT01524679|6477974|P2|COMPLETED|Overall Study||49
2636036|NCT01524679|6477975|P1|COMPLETED|Overall Study||89
2636037|NCT01524679|6477974|P2|STARTED|Overall Study||58
2636038|NCT01524679|6477975|P1|STARTED|Overall Study||112
2636072|NCT01460160|6478114|P2|NOT COMPLETED|Follow-up||2
2636073|NCT01460160|6478115|P1|NOT COMPLETED|Follow-up||11
2636074|NCT01460160|6478114|P2|COMPLETED|Follow-up||20
2636075|NCT01460160|6478115|P1|COMPLETED|Follow-up||67
2636076|NCT01460160|6478114|P2|STARTED|Follow-up||22
2636077|NCT01460160|6478115|P1|STARTED|Follow-up||78
2636078|NCT01460160|6478114|P2|NOT COMPLETED|Treatment||5
2636079|NCT01460160|6478115|P1|NOT COMPLETED|Treatment||23
2636080|NCT01460160|6478114|P2|COMPLETED|Treatment||19
2636081|NCT01460160|6478115|P1|COMPLETED|Treatment||59
2636082|NCT01460160|6478114|P2|STARTED|Treatment||24
2636083|NCT01460160|6478115|P1|STARTED|Treatment||82
2636132|NCT01383018|6478234|P1|NOT COMPLETED|Overall Study||375
2636133|NCT01383018|6478234|P1|COMPLETED|Overall Study||1082
2636134|NCT01383018|6478234|P1|STARTED|Overall Study||1457
2636184|NCT01338415|6478426|P2|NOT COMPLETED|Overall Study||9
2636185|NCT01338415|6478427|P1|NOT COMPLETED|Overall Study||10
2636186|NCT01338415|6478426|P2|COMPLETED|Overall Study||22
2636187|NCT01338415|6478427|P1|COMPLETED|Overall Study||23
2636188|NCT01338415|6478426|P2|Enrolled in FUTURE 3 Extension|Overall Study||27
2636189|NCT01338415|6478427|P1|Enrolled in FUTURE 3 Extension|Overall Study||31
2636190|NCT01338415|6478426|P2|STARTED|Overall Study||31
2636191|NCT01338415|6478427|P1|STARTED|Overall Study||33
2636238|NCT01243333|6478532|P1|NOT COMPLETED|Overall Study||8
2636239|NCT01243333|6478532|P1|COMPLETED|Overall Study||18
2636240|NCT01243333|6478532|P1|STARTED|Overall Study||26
2636410|NCT01005745|6478991|P1|NOT COMPLETED|Overall Study||6
2636411|NCT01005745|6478991|P1|COMPLETED|Overall Study||13
2636412|NCT01005745|6478991|P1|STARTED|Overall Study||19
2636416|NCT00972478|6479006|P2|NOT COMPLETED|Overall Study||38
2636417|NCT00972478|6479007|P1|NOT COMPLETED|Overall Study||7
2636418|NCT00972478|6479006|P2|COMPLETED|Overall Study||34
2636419|NCT00972478|6479007|P1|COMPLETED|Overall Study||4
2636420|NCT00972478|6479006|P2|Eligible and Began Protocol Therapy|Overall Study||63
2636421|NCT00972478|6479007|P1|Eligible and Began Protocol Therapy|Overall Study||9
2636422|NCT00972478|6479006|P2|STARTED|Overall Study||72
2636423|NCT00972478|6479007|P1|STARTED|Overall Study||11
2636536|NCT00736944|6479256|P1|NOT COMPLETED|Definitive Treatment||1
2636537|NCT00736944|6479256|P1|COMPLETED|Definitive Treatment||28
2636538|NCT00736944|6479256|P1|STARTED|Definitive Treatment||29
2636539|NCT00736944|6479256|P1|NOT COMPLETED|Induction||1
2636540|NCT00736944|6479256|P1|COMPLETED|Induction||29
2636541|NCT00736944|6479256|P1|STARTED|Induction||30
2636571|NCT00674479|6479353|P1|NOT COMPLETED|Overall Study||0
2636572|NCT00674479|6479353|P1|COMPLETED|Overall Study||51
2636573|NCT00674479|6479353|P1|STARTED|Overall Study||51
2636583|NCT00667368|6479376|P2|NOT COMPLETED|Overall Study||172
2636584|NCT00667368|6479377|P1|NOT COMPLETED|Overall Study||200
2636585|NCT00667368|6479376|P2|COMPLETED|Overall Study||511
2636586|NCT00667368|6479377|P1|COMPLETED|Overall Study||482
2636587|NCT00667368|6479376|P2|STARTED|Overall Study||683
2636588|NCT00667368|6479377|P1|STARTED|Overall Study||682
2636639|NCT00634283|6479449|P1|NOT COMPLETED|Overall Study||0
2636640|NCT00634283|6479449|P1|COMPLETED|Overall Study||6
2636641|NCT00634283|6479449|P1|STARTED|Overall Study||6
2636682|NCT00539656|6479556|P1|NOT COMPLETED|Overall Study||0
2636683|NCT00539656|6479556|P1|COMPLETED|Overall Study||3
2636684|NCT00539656|6479556|P1|STARTED|Overall Study||3
2636697|NCT00443599|6479598|P2|NOT COMPLETED|Overall Study||3
2636698|NCT00443599|6479599|P1|NOT COMPLETED|Overall Study||6
2636699|NCT00443599|6479598|P2|COMPLETED|Overall Study|Included in per-protocol analysis|490
2636700|NCT00443599|6479599|P1|COMPLETED|Overall Study|Included in per-protocol analysis|490
2636701|NCT00443599|6479598|P2|STARTED|Overall Study|Randomly Assigned to Standard Care|493
2636702|NCT00443599|6479599|P1|STARTED|Overall Study|Randomly Assigned to Tight Glycemic Control|496
2636748|NCT00419562|6479668|P2|NOT COMPLETED|Overall Study||31
2636749|NCT00419562|6479669|P1|NOT COMPLETED|Overall Study||33
2636750|NCT00419562|6479668|P2|COMPLETED|Overall Study||246
2636751|NCT00419562|6479669|P1|COMPLETED|Overall Study||250
2636752|NCT00419562|6479668|P2|STARTED|Overall Study||277
2636753|NCT00419562|6479669|P1|STARTED|Overall Study||283
2636829|NCT04002648|6479909|P2|NOT COMPLETED|Overall Study||0
2636830|NCT04002648|6479910|P1|NOT COMPLETED|Overall Study||2
2636831|NCT04002648|6479909|P2|COMPLETED|Overall Study||104
2636832|NCT04002648|6479910|P1|COMPLETED|Overall Study||102
2636833|NCT04002648|6479909|P2|STARTED|Overall Study||104
2636834|NCT04002648|6479910|P1|STARTED|Overall Study||104
2636835|NCT03965403|6479918|P1|NOT COMPLETED|Overall Study||1
2636836|NCT03965403|6479918|P1|COMPLETED|Overall Study||6
2636837|NCT03965403|6479918|P1|STARTED|Overall Study||7
2636907|NCT03679494|6480174|P2|NOT COMPLETED|Overall Study||0
2636908|NCT03679494|6480175|P1|NOT COMPLETED|Overall Study||0
2636909|NCT03679494|6480174|P2|COMPLETED|Overall Study||63
2636910|NCT03679494|6480175|P1|COMPLETED|Overall Study||67
2636911|NCT03679494|6480174|P2|STARTED|Overall Study||63
2636912|NCT03679494|6480175|P1|STARTED|Overall Study||67
2637016|NCT03426631|6480427|P2|NOT COMPLETED|Overall Study||1
2637017|NCT03426631|6480428|P1|NOT COMPLETED|Overall Study||0
2637018|NCT03426631|6480427|P2|COMPLETED|Overall Study||5
2637019|NCT03426631|6480428|P1|COMPLETED|Overall Study||7
2637020|NCT03426631|6480427|P2|STARTED|Overall Study||6
2637021|NCT03426631|6480428|P1|STARTED|Overall Study||7
2637046|NCT03400163|6480518|P2|NOT COMPLETED|Follow-up Period||0
2637047|NCT03400163|6480519|P1|NOT COMPLETED|Follow-up Period||0
2637048|NCT03400163|6480518|P2|COMPLETED|Follow-up Period||2
2637049|NCT03400163|6480519|P1|COMPLETED|Follow-up Period||1
2637050|NCT03400163|6480518|P2|STARTED|Follow-up Period||2
2637051|NCT03400163|6480519|P1|STARTED|Follow-up Period||1
2637052|NCT03400163|6480518|P2|NOT COMPLETED|Treatment Period||0
2637053|NCT03400163|6480519|P1|NOT COMPLETED|Treatment Period||0
2637054|NCT03400163|6480518|P2|COMPLETED|Treatment Period||2
2637055|NCT03400163|6480519|P1|COMPLETED|Treatment Period||1
2637056|NCT03400163|6480518|P2|STARTED|Treatment Period||2
2637057|NCT03400163|6480519|P1|STARTED|Treatment Period||1
2637058|NCT03387462|6480551|P1|NOT COMPLETED|Overall Study||1
2637059|NCT03387462|6480551|P1|COMPLETED|Overall Study||19
2637060|NCT03387462|6480551|P1|8 Weeks|Overall Study||19
2637061|NCT03387462|6480551|P1|4 Weeks|Overall Study||20
2637062|NCT03387462|6480551|P1|STARTED|Overall Study||20
2637069|NCT03374995|6480569|P2|NOT COMPLETED|Overall Study||1
2637070|NCT03374995|6480570|P1|NOT COMPLETED|Overall Study||0
2637071|NCT03374995|6480569|P2|COMPLETED|Overall Study||11
2637072|NCT03374995|6480570|P1|COMPLETED|Overall Study||13
2637073|NCT03374995|6480569|P2|STARTED|Overall Study||12
2637074|NCT03374995|6480570|P1|STARTED|Overall Study||13
2637075|NCT03331835|6480584|P2|NOT COMPLETED|Overall Study||47
2637076|NCT03331835|6480585|P1|NOT COMPLETED|Overall Study||14
2637077|NCT03331835|6480584|P2|COMPLETED|Overall Study||58
2637078|NCT03331835|6480585|P1|COMPLETED|Overall Study||91
2637079|NCT03331835|6480584|P2|STARTED|Overall Study||105
2637080|NCT03331835|6480585|P1|STARTED|Overall Study||105
2637081|NCT03305731|6480617|P1|NOT COMPLETED|Overall Study||1
2637082|NCT03305731|6480617|P1|COMPLETED|Overall Study||20
2637083|NCT03305731|6480617|P1|Week 11|Overall Study||20
2637084|NCT03305731|6480617|P1|Week 6|Overall Study||20
2637085|NCT03305731|6480617|P1|STARTED|Overall Study||21
2637177|NCT03200860|6480873|P2|NOT COMPLETED|Overall Study||0
2637178|NCT03200860|6480874|P1|NOT COMPLETED|Overall Study||1
2637179|NCT03200860|6480873|P2|COMPLETED|Overall Study||39
2637180|NCT03200860|6480874|P1|COMPLETED|Overall Study||40
2637181|NCT03200860|6480873|P2|STARTED|Overall Study||39
2637182|NCT03200860|6480874|P1|STARTED|Overall Study||41
2637195|NCT03181503|6480912|P2|NOT COMPLETED|Overall Study||3
2637196|NCT03181503|6480913|P1|NOT COMPLETED|Overall Study||7
2637197|NCT03181503|6480912|P2|COMPLETED|Overall Study||31
2637198|NCT03181503|6480913|P1|COMPLETED|Overall Study||29
2637199|NCT03181503|6480912|P2|Treated|Overall Study||34
2637200|NCT03181503|6480913|P1|Treated|Overall Study||36
2637201|NCT03181503|6480912|P2|STARTED|Overall Study||34
2637202|NCT03181503|6480913|P1|STARTED|Overall Study||36
2637203|NCT03168308|6480951|P2|NOT COMPLETED|Overall Study||0
2637204|NCT03168308|6480952|P1|NOT COMPLETED|Overall Study||0
2637205|NCT03168308|6480951|P2|COMPLETED|Overall Study||44
2637206|NCT03168308|6480952|P1|COMPLETED|Overall Study||48
2637207|NCT03168308|6480951|P2|STARTED|Overall Study||44
2637208|NCT03168308|6480952|P1|STARTED|Overall Study||48
2637230|NCT03136861|6481024|P7|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||1
2637231|NCT03136861|6481025|P6|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
2637232|NCT03136861|6481026|P5|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||2
2637233|NCT03136861|6481027|P4|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||1
2637234|NCT03136861|6481028|P3|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||2
2637235|NCT03136861|6481029|P2|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
2637236|NCT03136861|6481030|P1|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
2637237|NCT03136861|6481024|P7|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||43
2637238|NCT03136861|6481025|P6|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||45
2637239|NCT03136861|6481026|P5|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||92
2637240|NCT03136861|6481027|P4|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||93
2637241|NCT03136861|6481028|P3|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||88
2637242|NCT03136861|6481029|P2|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
2637243|NCT03136861|6481030|P1|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
2637244|NCT03136861|6481024|P7|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||44
2637245|NCT03136861|6481025|P6|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||45
2637246|NCT03136861|6481026|P5|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||94
2637247|NCT03136861|6481027|P4|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||94
2637248|NCT03136861|6481028|P3|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||90
2637249|NCT03136861|6481029|P2|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
2637250|NCT03136861|6481030|P1|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
2637251|NCT03136861|6481024|P7|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
2637252|NCT03136861|6481025|P6|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
2637253|NCT03136861|6481026|P5|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
2637254|NCT03136861|6481027|P4|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
2637255|NCT03136861|6481028|P3|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
2637256|NCT03136861|6481029|P2|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||6
2637257|NCT03136861|6481030|P1|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||7
2637258|NCT03136861|6481024|P7|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
2637259|NCT03136861|6481025|P6|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
2637260|NCT03136861|6481026|P5|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
2637261|NCT03136861|6481027|P4|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
2637262|NCT03136861|6481028|P3|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
2637263|NCT03136861|6481029|P2|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||89
2637264|NCT03136861|6481030|P1|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||278
2637265|NCT03136861|6481024|P7|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
2637266|NCT03136861|6481025|P6|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
2637267|NCT03136861|6481026|P5|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
2637268|NCT03136861|6481027|P4|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
2637269|NCT03136861|6481028|P3|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
2637270|NCT03136861|6481029|P2|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||95
2637271|NCT03136861|6481030|P1|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||285
2637657|NCT02921490|6482430|P1|NOT COMPLETED|Overall Study||0
2637658|NCT02921490|6482430|P1|COMPLETED|Overall Study||10
2637659|NCT02921490|6482430|P1|STARTED|Overall Study||10
2637687|NCT02859246|6482567|P1|NOT COMPLETED|Overall Study||5
2637688|NCT02859246|6482567|P1|COMPLETED|Overall Study|10 subjects completed the study|10
2637689|NCT02859246|6482567|P1|STARTED|Overall Study|15 subjects were enrolled into study|15
2637711|NCT02845375|6482996|P3|NOT COMPLETED|Overall Study||1
2637712|NCT02845375|6482997|P2|NOT COMPLETED|Overall Study||2
2637713|NCT02845375|6482998|P1|NOT COMPLETED|Overall Study||1
2637714|NCT02845375|6482996|P3|COMPLETED|Overall Study||12
2637715|NCT02845375|6482997|P2|COMPLETED|Overall Study||12
2637716|NCT02845375|6482998|P1|COMPLETED|Overall Study||12
2637717|NCT02845375|6482996|P3|STARTED|Overall Study||13
2637718|NCT02845375|6482997|P2|STARTED|Overall Study||14
2637719|NCT02845375|6482998|P1|STARTED|Overall Study||13
2637833|NCT02773576|6483301|P2|NOT COMPLETED|Overall Study||0
2637834|NCT02773576|6483302|P1|NOT COMPLETED|Overall Study||0
2637835|NCT02773576|6483301|P2|COMPLETED|Overall Study||0
2637836|NCT02773576|6483302|P1|COMPLETED|Overall Study||0
2637837|NCT02773576|6483301|P2|STARTED|Overall Study||0
2637838|NCT02773576|6483302|P1|STARTED|Overall Study||0
2637859|NCT02736825|6483374|P2|NOT COMPLETED|Overall Study||12
2637860|NCT02736825|6483375|P1|NOT COMPLETED|Overall Study||10
2637861|NCT02736825|6483374|P2|COMPLETED|Overall Study||123
2637862|NCT02736825|6483375|P1|COMPLETED|Overall Study||117
2637863|NCT02736825|6483374|P2|STARTED|Overall Study||135
2637864|NCT02736825|6483375|P1|STARTED|Overall Study||127
2637877|NCT02706951|6483435|P3|NOT COMPLETED|Overall Study||10
2637878|NCT02706951|6483436|P2|NOT COMPLETED|Overall Study||16
2637879|NCT02706951|6483437|P1|NOT COMPLETED|Overall Study||14
2637880|NCT02706951|6483435|P3|COMPLETED|Overall Study||205
2637881|NCT02706951|6483436|P2|COMPLETED|Overall Study||201
2637882|NCT02706951|6483437|P1|COMPLETED|Overall Study||202
2637883|NCT02706951|6483435|P3|STARTED|Overall Study||215
2637884|NCT02706951|6483436|P2|STARTED|Overall Study||217
2637885|NCT02706951|6483437|P1|STARTED|Overall Study||216
2638000|NCT02680834|6483925|P2|NOT COMPLETED|Overall Study||3
2638001|NCT02680834|6483926|P1|NOT COMPLETED|Overall Study||11
2638002|NCT02680834|6483925|P2|COMPLETED|Overall Study||27
2638003|NCT02680834|6483926|P1|COMPLETED|Overall Study||15
2638004|NCT02680834|6483925|P2|STARTED|Overall Study||30
2638005|NCT02680834|6483926|P1|STARTED|Overall Study||26
2638020|NCT02677896|6483992|P2|NOT COMPLETED|Overall Study||244
2638021|NCT02677896|6483993|P1|NOT COMPLETED|Overall Study||137
2638022|NCT02677896|6483992|P2|COMPLETED|Overall Study||332
2638023|NCT02677896|6483993|P1|COMPLETED|Overall Study||437
2638024|NCT02677896|6483992|P2|Treated|Overall Study||574
2638025|NCT02677896|6483993|P1|Treated|Overall Study||572
2638026|NCT02677896|6483992|P2|STARTED|Overall Study||576
2638027|NCT02677896|6483993|P1|STARTED|Overall Study||574
2638028|NCT02675426|6484022|P3|NOT COMPLETED|Overall Study||18
2638029|NCT02675426|6484023|P2|NOT COMPLETED|Overall Study||8
2638030|NCT02675426|6484024|P1|NOT COMPLETED|Overall Study||13
2638031|NCT02675426|6484022|P3|COMPLETED|Overall Study||201
2638032|NCT02675426|6484023|P2|COMPLETED|Overall Study||213
2638033|NCT02675426|6484024|P1|COMPLETED|Overall Study||208
2638034|NCT02675426|6484022|P3|Treated|Overall Study||219
2638035|NCT02675426|6484023|P2|Treated|Overall Study||221
2638036|NCT02675426|6484024|P1|Treated|Overall Study||221
2638037|NCT02675426|6484022|P3|STARTED|Overall Study||219
2638038|NCT02675426|6484023|P2|STARTED|Overall Study||221
2638039|NCT02675426|6484024|P1|STARTED|Overall Study||221
2638043|NCT02658357|6484077|P2|NOT COMPLETED|Overall Study||0
2638044|NCT02658357|6484078|P1|NOT COMPLETED|Overall Study||0
2638045|NCT02658357|6484077|P2|COMPLETED|Overall Study||0
2638046|NCT02658357|6484078|P1|COMPLETED|Overall Study||0
2638047|NCT02658357|6484077|P2|STARTED|Overall Study||0
2638048|NCT02658357|6484078|P1|STARTED|Overall Study||0
2638187|NCT02585830|6484866|P1|NOT COMPLETED|Overall Study||3
2638188|NCT02585830|6484866|P1|COMPLETED|Overall Study||22
2638189|NCT02585830|6484866|P1|STARTED|Overall Study||25
2638211|NCT02564432|6484957|P1|NOT COMPLETED|Overall Study||2
2638212|NCT02564432|6484957|P1|COMPLETED|Overall Study|1 patient suffered periprosthetic fracture at 8 months; 1 failed to osseointegrate|8
2638213|NCT02564432|6484957|P1|STARTED|Overall Study||10
2638350|NCT02478359|6485610|P2|NOT COMPLETED|Overall Study||65
2638351|NCT02478359|6485611|P1|NOT COMPLETED|Overall Study||106
2638352|NCT02478359|6485610|P2|COMPLETED|Overall Study||1293
2638353|NCT02478359|6485611|P1|COMPLETED|Overall Study||1243
2638354|NCT02478359|6485610|P2|Intention-to-treat Population Month 12|Overall Study|Disenrolled from health plan: 65|1293
2638355|NCT02478359|6485611|P1|Intention-to-treat Population Month 12|Overall Study|Disenrolled from health plan: 106|1243
2638356|NCT02478359|6485610|P2|STARTED|Overall Study||1358
2638357|NCT02478359|6485611|P1|STARTED|Overall Study||1349
2638564|NCT02344004|6486335|P2|NOT COMPLETED|Overall Study||14
2638565|NCT02344004|6486336|P1|NOT COMPLETED|Overall Study||61
2638566|NCT02344004|6486335|P2|COMPLETED|Overall Study||98
2638567|NCT02344004|6486336|P1|COMPLETED|Overall Study||163
2638568|NCT02344004|6486335|P2|STARTED|Overall Study||112
2638569|NCT02344004|6486336|P1|STARTED|Overall Study||224
2638792|NCT02141451|6487265|P4|NOT COMPLETED|Overall Study||9
2638793|NCT02141451|6487266|P3|NOT COMPLETED|Overall Study||5
2638794|NCT02141451|6487267|P2|NOT COMPLETED|Overall Study||2
2638795|NCT02141451|6487268|P1|NOT COMPLETED|Overall Study||0
2638796|NCT02141451|6487265|P4|COMPLETED|Overall Study||7
2638797|NCT02141451|6487266|P3|COMPLETED|Overall Study||2
2638798|NCT02141451|6487267|P2|COMPLETED|Overall Study||2
2638799|NCT02141451|6487268|P1|COMPLETED|Overall Study||3
2638800|NCT02141451|6487265|P4|STARTED|Overall Study||16
2638801|NCT02141451|6487266|P3|STARTED|Overall Study||7
2638802|NCT02141451|6487267|P2|STARTED|Overall Study||4
2638803|NCT02141451|6487268|P1|STARTED|Overall Study||3
2638998|NCT01990820|6487884|P2|NOT COMPLETED|Overall Study||0
2638999|NCT01990820|6487885|P1|NOT COMPLETED|Overall Study||0
2639000|NCT01990820|6487884|P2|COMPLETED|Overall Study||12
2639001|NCT01990820|6487885|P1|COMPLETED|Overall Study||13
2639002|NCT01990820|6487884|P2|STARTED|Overall Study||12
2639003|NCT01990820|6487885|P1|STARTED|Overall Study||13
2639283|NCT01808794|6488443|P2|NOT COMPLETED|Overall Study||0
2639284|NCT01808794|6488444|P1|NOT COMPLETED|Overall Study||0
2639285|NCT01808794|6488443|P2|COMPLETED|Overall Study||0
2639286|NCT01808794|6488444|P1|COMPLETED|Overall Study||0
2639287|NCT01808794|6488443|P2|STARTED|Overall Study||0
2639288|NCT01808794|6488444|P1|STARTED|Overall Study||0
2639375|NCT01736085|6488622|P6|NOT COMPLETED|Overall Study||0
2639376|NCT01736085|6488623|P5|NOT COMPLETED|Overall Study||0
2639377|NCT01736085|6488624|P4|NOT COMPLETED|Overall Study||0
2639378|NCT01736085|6488625|P3|NOT COMPLETED|Overall Study||0
2639379|NCT01736085|6488626|P2|NOT COMPLETED|Overall Study||0
2639380|NCT01736085|6488627|P1|NOT COMPLETED|Overall Study||0
2639381|NCT01736085|6488622|P6|COMPLETED|Overall Study||794
2639382|NCT01736085|6488623|P5|COMPLETED|Overall Study||530
2639383|NCT01736085|6488624|P4|COMPLETED|Overall Study||530
2639384|NCT01736085|6488625|P3|COMPLETED|Overall Study||793
2639385|NCT01736085|6488626|P2|COMPLETED|Overall Study||530
2639386|NCT01736085|6488627|P1|COMPLETED|Overall Study||529
2639387|NCT01736085|6488622|P6|STARTED|Overall Study||794
2639388|NCT01736085|6488623|P5|STARTED|Overall Study||530
2639389|NCT01736085|6488624|P4|STARTED|Overall Study||530
2639390|NCT01736085|6488625|P3|STARTED|Overall Study||793
2639391|NCT01736085|6488626|P2|STARTED|Overall Study||530
2639392|NCT01736085|6488627|P1|STARTED|Overall Study||529
2639435|NCT01693523|6488723|P3|NOT COMPLETED|Overall Study||8
2639436|NCT01693523|6488724|P2|NOT COMPLETED|Overall Study||8
2639437|NCT01693523|6488725|P1|NOT COMPLETED|Overall Study||5
2639438|NCT01693523|6488723|P3|COMPLETED|Overall Study||27
2639439|NCT01693523|6488724|P2|COMPLETED|Overall Study||13
2639440|NCT01693523|6488725|P1|COMPLETED|Overall Study||18
2639441|NCT01693523|6488723|P3|STARTED|Overall Study||35
2639442|NCT01693523|6488724|P2|STARTED|Overall Study||21
2639443|NCT01693523|6488725|P1|STARTED|Overall Study||23
2639474|NCT01665768|6488932|P1|NOT COMPLETED|Overall Study||23
2639475|NCT01665768|6488932|P1|COMPLETED|Overall Study||26
2639476|NCT01665768|6488932|P1|STARTED|Overall Study||49
2639610|NCT01461005|6489472|P1|NOT COMPLETED|Overall Study||1
2639611|NCT01461005|6489472|P1|COMPLETED|Overall Study||0
2639612|NCT01461005|6489472|P1|STARTED|Overall Study||1
2639616|NCT01420926|6489490|P2|NOT COMPLETED|Overall Study||65
2639617|NCT01420926|6489491|P1|NOT COMPLETED|Overall Study||60
2639618|NCT01420926|6489490|P2|COMPLETED|Overall Study||16
2639619|NCT01420926|6489491|P1|COMPLETED|Overall Study||22
2639620|NCT01420926|6489490|P2|STARTED|Overall Study||81
2639621|NCT01420926|6489491|P1|STARTED|Overall Study||82
2639622|NCT01413191|6489505|P1|NOT COMPLETED|Overall Study||11
2639623|NCT01413191|6489505|P1|COMPLETED|Overall Study||7
2639624|NCT01413191|6489505|P1|STARTED|Overall Study||18
2639661|NCT01380535|6489565|P2|NOT COMPLETED|Overall Study||15
2639662|NCT01380535|6489566|P1|NOT COMPLETED|Overall Study||7
2639663|NCT01380535|6489565|P2|COMPLETED|Overall Study||16
2639664|NCT01380535|6489566|P1|COMPLETED|Overall Study||22
2639665|NCT01380535|6489565|P2|Intent-to-treat Population|Overall Study||24
2639666|NCT01380535|6489566|P1|Intent-to-treat Population|Overall Study||29
2639667|NCT01380535|6489565|P2|Safety Population|Overall Study||28
2639668|NCT01380535|6489566|P1|Safety Population|Overall Study||28
2639669|NCT01380535|6489565|P2|Baseline Population|Overall Study||31
2639670|NCT01380535|6489566|P1|Baseline Population|Overall Study||29
2639671|NCT01380535|6489565|P2|STARTED|Overall Study||31
2639672|NCT01380535|6489566|P1|STARTED|Overall Study||29
2639707|NCT01346410|6489708|P1|NOT COMPLETED|Overall Study||1
2639708|NCT01346410|6489708|P1|COMPLETED|Overall Study||0
2639709|NCT01346410|6489708|P1|STARTED|Overall Study||1
2639742|NCT01266603|6489783|P1|NOT COMPLETED|Overall Study||42
2639743|NCT01266603|6489783|P1|COMPLETED|Overall Study||2
2639744|NCT01266603|6489783|P1|Maintenance Completion|Overall Study||2
2639745|NCT01266603|6489783|P1|Continued to Maintenance- MAGE-A3|Overall Study||4
2639746|NCT01266603|6489783|P1|Patients Evaluable for Response|Overall Study||16
2639747|NCT01266603|6489783|P1|Patients Evaluable for Safety|Overall Study||17
2639748|NCT01266603|6489783|P1|MAGE-A3 Positive Tumor|Overall Study||18
2639749|NCT01266603|6489783|P1|STARTED|Overall Study||44
2639765|NCT01129440|6489832|P2|NOT COMPLETED|Overall Study||42
2639766|NCT01129440|6489833|P1|NOT COMPLETED|Overall Study||51
2639767|NCT01129440|6489832|P2|COMPLETED|Overall Study||258
2639768|NCT01129440|6489833|P1|COMPLETED|Overall Study||246
2639769|NCT01129440|6489832|P2|24 Month Follow-up|Overall Study||258
2639770|NCT01129440|6489833|P1|24 Month Follow-up|Overall Study||239
2639771|NCT01129440|6489832|P2|12 Month Follow-up|Overall Study||256
2639772|NCT01129440|6489833|P1|12 Month Follow-up|Overall Study||249
2639773|NCT01129440|6489832|P2|STARTED|Overall Study||300
2639774|NCT01129440|6489833|P1|STARTED|Overall Study||297
2639848|NCT01064648|6490136|P4|NOT COMPLETED|Phase II||48
2639849|NCT01064648|6490137|P3|NOT COMPLETED|Phase II||49
2639850|NCT01064648|6490138|P2|NOT COMPLETED|Phase II||0
2639851|NCT01064648|6490139|P1|NOT COMPLETED|Phase II||0
2639852|NCT01064648|6490136|P4|COMPLETED|Phase II||0
2639853|NCT01064648|6490137|P3|COMPLETED|Phase II||0
2639854|NCT01064648|6490138|P2|COMPLETED|Phase II||0
2639855|NCT01064648|6490139|P1|COMPLETED|Phase II||0
2639856|NCT01064648|6490136|P4|STARTED|Phase II||48
2639857|NCT01064648|6490137|P3|STARTED|Phase II||49
2639858|NCT01064648|6490138|P2|STARTED|Phase II||0
2639859|NCT01064648|6490139|P1|STARTED|Phase II||0
2639860|NCT01064648|6490136|P4|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
2639861|NCT01064648|6490137|P3|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
2639862|NCT01064648|6490138|P2|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||13
2639863|NCT01064648|6490139|P1|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
2639864|NCT01064648|6490136|P4|COMPLETED|Phase I Cohort 2: Dose Level 2||0
2639865|NCT01064648|6490137|P3|COMPLETED|Phase I Cohort 2: Dose Level 2||0
2639866|NCT01064648|6490138|P2|COMPLETED|Phase I Cohort 2: Dose Level 2||0
2639867|NCT01064648|6490139|P1|COMPLETED|Phase I Cohort 2: Dose Level 2||0
2639868|NCT01064648|6490136|P4|STARTED|Phase I Cohort 2: Dose Level 2||0
2639869|NCT01064648|6490137|P3|STARTED|Phase I Cohort 2: Dose Level 2||0
2639870|NCT01064648|6490138|P2|STARTED|Phase I Cohort 2: Dose Level 2||13
2639871|NCT01064648|6490139|P1|STARTED|Phase I Cohort 2: Dose Level 2||0
2639872|NCT01064648|6490136|P4|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
2639873|NCT01064648|6490137|P3|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
2639874|NCT01064648|6490138|P2|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
2639875|NCT01064648|6490139|P1|NOT COMPLETED|Phase I Cohort1: Dose Level 1||7
2639876|NCT01064648|6490136|P4|COMPLETED|Phase I Cohort1: Dose Level 1||0
2639877|NCT01064648|6490137|P3|COMPLETED|Phase I Cohort1: Dose Level 1||0
2639878|NCT01064648|6490138|P2|COMPLETED|Phase I Cohort1: Dose Level 1||0
2639879|NCT01064648|6490139|P1|COMPLETED|Phase I Cohort1: Dose Level 1||0
2639880|NCT01064648|6490136|P4|STARTED|Phase I Cohort1: Dose Level 1||0
2639881|NCT01064648|6490137|P3|STARTED|Phase I Cohort1: Dose Level 1||0
2639882|NCT01064648|6490138|P2|STARTED|Phase I Cohort1: Dose Level 1||0
2639883|NCT01064648|6490139|P1|STARTED|Phase I Cohort1: Dose Level 1||7
2639898|NCT01014390|6490220|P1|NOT COMPLETED|Overall Study||10
2639899|NCT01014390|6490220|P1|COMPLETED|Overall Study||177
2639900|NCT01014390|6490220|P1|STARTED|Overall Study||187
2639925|NCT00979992|6490251|P1|NOT COMPLETED|Overall Study||5
2639926|NCT00979992|6490251|P1|COMPLETED|Overall Study||30
2639927|NCT00979992|6490251|P1|STARTED|Overall Study||35
2639973|NCT00939653|6490354|P1|NOT COMPLETED|Treatment Course 4||0
2639974|NCT00939653|6490354|P1|COMPLETED|Treatment Course 4||0
2639975|NCT00939653|6490354|P1|STARTED|Treatment Course 4||0
2639976|NCT00939653|6490354|P1|NOT COMPLETED|Treatment Course 3||0
2639977|NCT00939653|6490354|P1|COMPLETED|Treatment Course 3||0
2639978|NCT00939653|6490354|P1|STARTED|Treatment Course 3||0
2639979|NCT00939653|6490354|P1|NOT COMPLETED|Treatment Course 2||0
2639980|NCT00939653|6490354|P1|COMPLETED|Treatment Course 2||2
2639981|NCT00939653|6490354|P1|STARTED|Treatment Course 2||2
2639982|NCT00939653|6490354|P1|NOT COMPLETED|Treatment Course 1||0
2639983|NCT00939653|6490354|P1|COMPLETED|Treatment Course 1||6
2639984|NCT00939653|6490354|P1|STARTED|Treatment Course 1||6
2640040|NCT00732212|6490502|P2|NOT COMPLETED|Overall Study||0
2640041|NCT00732212|6490503|P1|NOT COMPLETED|Overall Study||0
2640042|NCT00732212|6490502|P2|COMPLETED|Overall Study||123
2640043|NCT00732212|6490503|P1|COMPLETED|Overall Study||112
2640044|NCT00732212|6490502|P2|Temporarily Suspended|Overall Study||50
2640045|NCT00732212|6490503|P1|Temporarily Suspended|Overall Study|Study was suspended for a 9 month period by the VA DMC because of slow enrollment, then restarted.|50
2640046|NCT00732212|6490502|P2|STARTED|Overall Study||123
2640047|NCT00732212|6490503|P1|STARTED|Overall Study||112
2640149|NCT00602043|6490706|P1|NOT COMPLETED|Overall Study||5
2640150|NCT00602043|6490706|P1|COMPLETED|Overall Study||15
2640151|NCT00602043|6490706|P1|STARTED|Overall Study||20
2640180|NCT00440726|6490783|P3|NOT COMPLETED|Phase 2||2
2640181|NCT00440726|6490784|P2|NOT COMPLETED|Phase 2||0
2640182|NCT00440726|6490785|P1|NOT COMPLETED|Phase 2||0
2640183|NCT00440726|6490783|P3|COMPLETED|Phase 2||20
2640184|NCT00440726|6490784|P2|COMPLETED|Phase 2||0
2640185|NCT00440726|6490785|P1|COMPLETED|Phase 2||0
2640186|NCT00440726|6490783|P3|STARTED|Phase 2||22
2640187|NCT00440726|6490784|P2|STARTED|Phase 2||0
2640188|NCT00440726|6490785|P1|STARTED|Phase 2||0
2640189|NCT00440726|6490783|P3|NOT COMPLETED|Phase 1||0
2640190|NCT00440726|6490784|P2|NOT COMPLETED|Phase 1||1
2640191|NCT00440726|6490785|P1|NOT COMPLETED|Phase 1||1
2640192|NCT00440726|6490783|P3|COMPLETED|Phase 1||0
2640193|NCT00440726|6490784|P2|COMPLETED|Phase 1||5
2640194|NCT00440726|6490785|P1|COMPLETED|Phase 1||3
2640195|NCT00440726|6490783|P3|STARTED|Phase 1||0
2640196|NCT00440726|6490784|P2|STARTED|Phase 1||6
2640197|NCT00440726|6490785|P1|STARTED|Phase 1||4
2640225|NCT00390325|6490817|P2|NOT COMPLETED|Overall Study||0
2640226|NCT00390325|6490818|P1|NOT COMPLETED|Overall Study||0
2640227|NCT00390325|6490817|P2|COMPLETED|Overall Study||16
2640228|NCT00390325|6490818|P1|COMPLETED|Overall Study||5
2640229|NCT00390325|6490817|P2|STARTED|Overall Study||16
2640230|NCT00390325|6490818|P1|STARTED|Overall Study||5
2640252|NCT00310180|6490863|P4|NOT COMPLETED|Overall Study||348
2640253|NCT00310180|6490864|P3|NOT COMPLETED|Overall Study||137
2640254|NCT00310180|6490865|P2|NOT COMPLETED|Overall Study||59
2640255|NCT00310180|6490866|P1|NOT COMPLETED|Overall Study||10
2640256|NCT00310180|6490863|P4|COMPLETED|Overall Study||1389
2640257|NCT00310180|6490864|P3|COMPLETED|Overall Study||3312
2640258|NCT00310180|6490865|P2|COMPLETED|Overall Study||3399
2640259|NCT00310180|6490866|P1|COMPLETED|Overall Study||1619
2640260|NCT00310180|6490863|P4|No Follow-up Data|Overall Study||245
2640261|NCT00310180|6490864|P3|No Follow-up Data|Overall Study||131
2640262|NCT00310180|6490865|P2|No Follow-up Data|Overall Study||55
2640263|NCT00310180|6490866|P1|No Follow-up Data|Overall Study||7
2640264|NCT00310180|6490863|P4|Ineligible|Overall Study||7
2640265|NCT00310180|6490864|P3|Ineligible|Overall Study||6
2640266|NCT00310180|6490865|P2|Ineligible|Overall Study||4
2640267|NCT00310180|6490866|P1|Ineligible|Overall Study||3
2640268|NCT00310180|6490863|P4|No On-study Data|Overall Study||172
2640269|NCT00310180|6490864|P3|No On-study Data|Overall Study||10
2640270|NCT00310180|6490865|P2|No On-study Data|Overall Study||2
2640271|NCT00310180|6490866|P1|No On-study Data|Overall Study||0
2640272|NCT00310180|6490863|P4|STARTED|Overall Study||1737
2640273|NCT00310180|6490864|P3|STARTED|Overall Study||3449
2640274|NCT00310180|6490865|P2|STARTED|Overall Study||3458
2640275|NCT00310180|6490866|P1|STARTED|Overall Study||1629
2640276|NCT00305760|6490896|P1|NOT COMPLETED|Overall Study||47
2640277|NCT00305760|6490896|P1|COMPLETED|Overall Study||13
2640278|NCT00305760|6490896|P1|STARTED|Overall Study||60
2640302|NCT00278109|6490914|P1|NOT COMPLETED|Overall Study||4
2640303|NCT00278109|6490914|P1|COMPLETED|Overall Study||21
2640304|NCT00278109|6490914|P1|Completed 3 Cycles of Chemotherapy|Overall Study||25
2640305|NCT00278109|6490914|P1|STARTED|Overall Study||25
2640306|NCT00262834|6490920|P2|NOT COMPLETED|Overall Study||4
2640307|NCT00262834|6490921|P1|NOT COMPLETED|Overall Study||1
2640308|NCT00262834|6490920|P2|COMPLETED|Overall Study||25
2640309|NCT00262834|6490921|P1|COMPLETED|Overall Study||24
2640310|NCT00262834|6490920|P2|STARTED|Overall Study||29
2640311|NCT00262834|6490921|P1|STARTED|Overall Study||25
2640312|NCT00248287|6490934|P2|NOT COMPLETED|Overall Study||19
2640313|NCT00248287|6490935|P1|NOT COMPLETED|Overall Study||24
2640314|NCT00248287|6490934|P2|COMPLETED|Overall Study||60
2640315|NCT00248287|6490935|P1|COMPLETED|Overall Study||51
2640316|NCT00248287|6490934|P2|STARTED|Overall Study||79
2640317|NCT00248287|6490935|P1|STARTED|Overall Study||75
2640416|NCT00068419|6491265|P1|NOT COMPLETED|Overall Study||60
2640417|NCT00068419|6491265|P1|COMPLETED|Overall Study|Participant flow data reported here are for the period of protocol therapy.|10
2640418|NCT00068419|6491265|P1|STARTED|Overall Study||70
2640434|NCT04272775|6491300|P2|NOT COMPLETED|Overall Study||7
2640435|NCT04272775|6491301|P1|NOT COMPLETED|Overall Study||7
2640436|NCT04272775|6491300|P2|COMPLETED|Overall Study||0
2640437|NCT04272775|6491301|P1|COMPLETED|Overall Study||0
2640438|NCT04272775|6491300|P2|STARTED|Overall Study||7
2640439|NCT04272775|6491301|P1|STARTED|Overall Study||7
2640440|NCT04241146|6491323|P2|NOT COMPLETED|Overall Study||0
2640441|NCT04241146|6491324|P1|NOT COMPLETED|Overall Study||0
2640442|NCT04241146|6491323|P2|COMPLETED|Overall Study||28
2640443|NCT04241146|6491324|P1|COMPLETED|Overall Study||24
2640444|NCT04241146|6491323|P2|STARTED|Overall Study||28
2640445|NCT04241146|6491324|P1|STARTED|Overall Study||24
2640446|NCT04150224|6491338|P6|NOT COMPLETED|Overall Study||0
2640447|NCT04150224|6491339|P5|NOT COMPLETED|Overall Study||0
2640448|NCT04150224|6491340|P4|NOT COMPLETED|Overall Study||0
2640449|NCT04150224|6491341|P3|NOT COMPLETED|Overall Study||0
2640450|NCT04150224|6491342|P2|NOT COMPLETED|Overall Study||0
2640451|NCT04150224|6491343|P1|NOT COMPLETED|Overall Study||0
2640452|NCT04150224|6491338|P6|COMPLETED|Overall Study|Period 2: Multple Dosing|10
2640453|NCT04150224|6491339|P5|COMPLETED|Overall Study||10
2640454|NCT04150224|6491340|P4|COMPLETED|Overall Study||10
2640455|NCT04150224|6491341|P3|COMPLETED|Overall Study||10
2640456|NCT04150224|6491342|P2|COMPLETED|Overall Study||10
2640457|NCT04150224|6491343|P1|COMPLETED|Overall Study||10
2640458|NCT04150224|6491338|P6|STARTED|Overall Study|Period 2: Multple Dosing|10
2640459|NCT04150224|6491339|P5|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
2640460|NCT04150224|6491340|P4|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
2640461|NCT04150224|6491341|P3|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
2640462|NCT04150224|6491342|P2|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
2640463|NCT04150224|6491343|P1|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
2640464|NCT04080297|6491444|P2|NOT COMPLETED|Overall Study||3
2640465|NCT04080297|6491445|P1|NOT COMPLETED|Overall Study||2
2640466|NCT04080297|6491444|P2|COMPLETED|Overall Study||8
2640467|NCT04080297|6491445|P1|COMPLETED|Overall Study||8
2640468|NCT04080297|6491444|P2|STARTED|Overall Study||11
2640469|NCT04080297|6491445|P1|STARTED|Overall Study||10
2640470|NCT04053465|6491465|P2|NOT COMPLETED|Overall Study||4
2640471|NCT04053465|6491466|P1|NOT COMPLETED|Overall Study||4
2640472|NCT04053465|6491465|P2|COMPLETED|Overall Study||8
2640473|NCT04053465|6491466|P1|COMPLETED|Overall Study||18
2640474|NCT04053465|6491465|P2|STARTED|Overall Study||12
2640475|NCT04053465|6491466|P1|STARTED|Overall Study||22
2640476|NCT04019990|6491474|P2|NOT COMPLETED|Overall Study||3
2640477|NCT04019990|6491475|P1|NOT COMPLETED|Overall Study||1
2640478|NCT04019990|6491474|P2|COMPLETED|Overall Study||12
2640479|NCT04019990|6491475|P1|COMPLETED|Overall Study||12
2640480|NCT04019990|6491474|P2|STARTED|Overall Study||15
2640481|NCT04019990|6491475|P1|STARTED|Overall Study||13
2640482|NCT03933449|6491484|P2|NOT COMPLETED|Overall Study||61
2640483|NCT03933449|6491485|P1|NOT COMPLETED|Overall Study||62
2640484|NCT03933449|6491484|P2|COMPLETED|Overall Study||0
2640485|NCT03933449|6491485|P1|COMPLETED|Overall Study||0
2640486|NCT03933449|6491484|P2|Treated|Overall Study||59
2640487|NCT03933449|6491485|P1|Treated|Overall Study||62
2640488|NCT03933449|6491484|P2|STARTED|Overall Study||61
2640489|NCT03933449|6491485|P1|STARTED|Overall Study||62
2640490|NCT03881670|6491509|P2|NOT COMPLETED|Overall Study||0
2640491|NCT03881670|6491510|P1|NOT COMPLETED|Overall Study||0
2640492|NCT03881670|6491509|P2|COMPLETED|Overall Study||12
2640493|NCT03881670|6491510|P1|COMPLETED|Overall Study||12
2640494|NCT03881670|6491509|P2|Completed Second Intervetion|Overall Study||12
2640495|NCT03881670|6491510|P1|Completed Second Intervetion|Overall Study||12
2640496|NCT03881670|6491509|P2|Completed First Intervention|Overall Study||12
2640497|NCT03881670|6491510|P1|Completed First Intervention|Overall Study||12
2640498|NCT03881670|6491509|P2|STARTED|Overall Study||12
2640499|NCT03881670|6491510|P1|STARTED|Overall Study||12
2640500|NCT03868631|6491522|P2|NOT COMPLETED|Week 6 to Week 12 (Study Completion)||1
2640501|NCT03868631|6491523|P1|NOT COMPLETED|Week 6 to Week 12 (Study Completion)||4
2640502|NCT03868631|6491522|P2|COMPLETED|Week 6 to Week 12 (Study Completion)||26
2640503|NCT03868631|6491523|P1|COMPLETED|Week 6 to Week 12 (Study Completion)||22
2640504|NCT03868631|6491522|P2|STARTED|Week 6 to Week 12 (Study Completion)||27
2640505|NCT03868631|6491523|P1|STARTED|Week 6 to Week 12 (Study Completion)||26
2640506|NCT03868631|6491522|P2|NOT COMPLETED|Baseline to Week 6||4
2640507|NCT03868631|6491523|P1|NOT COMPLETED|Baseline to Week 6||4
2640508|NCT03868631|6491522|P2|COMPLETED|Baseline to Week 6||27
2640509|NCT03868631|6491523|P1|COMPLETED|Baseline to Week 6||26
2640510|NCT03868631|6491522|P2|STARTED|Baseline to Week 6||31
2640511|NCT03868631|6491523|P1|STARTED|Baseline to Week 6||30
2640512|NCT03831282|6491535|P1|NOT COMPLETED|Overall Study||1
2640513|NCT03831282|6491535|P1|COMPLETED|Overall Study||11
2640514|NCT03831282|6491535|P1|STARTED|Overall Study||12
2640515|NCT03796260|6491541|P2|NOT COMPLETED|Period 2||0
2640516|NCT03796260|6491542|P1|NOT COMPLETED|Period 2||0
2640517|NCT03796260|6491541|P2|COMPLETED|Period 2||7
2640518|NCT03796260|6491542|P1|COMPLETED|Period 2||7
2640519|NCT03796260|6491541|P2|STARTED|Period 2||7
2640520|NCT03796260|6491542|P1|STARTED|Period 2||7
2640521|NCT03796260|6491541|P2|NOT COMPLETED|Period 1||0
2640522|NCT03796260|6491542|P1|NOT COMPLETED|Period 1||0
2640523|NCT03796260|6491541|P2|COMPLETED|Period 1||7
2640524|NCT03796260|6491542|P1|COMPLETED|Period 1||7
2640525|NCT03796260|6491541|P2|STARTED|Period 1||7
2640526|NCT03796260|6491542|P1|STARTED|Period 1||7
2640527|NCT03764449|6491556|P2|NOT COMPLETED|Overall Study||0
2640528|NCT03764449|6491557|P1|NOT COMPLETED|Overall Study||0
2640529|NCT03764449|6491556|P2|COMPLETED|Overall Study||8
2640530|NCT03764449|6491557|P1|COMPLETED|Overall Study||8
2640531|NCT03764449|6491556|P2|STARTED|Overall Study||8
2640532|NCT03764449|6491557|P1|STARTED|Overall Study||8
2640533|NCT03756038|6491649|P2|NOT COMPLETED|Overall Study||0
2640534|NCT03756038|6491650|P1|NOT COMPLETED|Overall Study||0
2640535|NCT03756038|6491649|P2|COMPLETED|Overall Study||0
2640536|NCT03756038|6491650|P1|COMPLETED|Overall Study||1
2640537|NCT03756038|6491649|P2|STARTED|Overall Study||0
2640538|NCT03756038|6491650|P1|STARTED|Overall Study||1
2640539|NCT03748758|6491661|P3|NOT COMPLETED|Overall Study||1
2640540|NCT03748758|6491662|P2|NOT COMPLETED|Overall Study||0
2640541|NCT03748758|6491663|P1|NOT COMPLETED|Overall Study||0
2640542|NCT03748758|6491661|P3|COMPLETED|Overall Study||5
2640543|NCT03748758|6491662|P2|COMPLETED|Overall Study||12
2640544|NCT03748758|6491663|P1|COMPLETED|Overall Study||12
2640545|NCT03748758|6491661|P3|STARTED|Overall Study||6
2640546|NCT03748758|6491662|P2|STARTED|Overall Study||12
2640547|NCT03748758|6491663|P1|STARTED|Overall Study||12
2640548|NCT03722264|6491715|P1|NOT COMPLETED|Overall Study||3
2640549|NCT03722264|6491715|P1|COMPLETED|Overall Study||9
2640550|NCT03722264|6491715|P1|STARTED|Overall Study||12
2640551|NCT03640052|6491725|P5|NOT COMPLETED|Overall Study||0
2640552|NCT03640052|6491726|P4|NOT COMPLETED|Overall Study||0
2640553|NCT03640052|6491727|P3|NOT COMPLETED|Overall Study||0
2640554|NCT03640052|6491728|P2|NOT COMPLETED|Overall Study||1
2640555|NCT03640052|6491729|P1|NOT COMPLETED|Overall Study||0
2640556|NCT03640052|6491725|P5|COMPLETED|Overall Study||1
2640557|NCT03640052|6491726|P4|COMPLETED|Overall Study||1
2640558|NCT03640052|6491727|P3|COMPLETED|Overall Study||1
2640559|NCT03640052|6491728|P2|COMPLETED|Overall Study|the patient performed 4 out of 5 nights|0
2640560|NCT03640052|6491729|P1|COMPLETED|Overall Study||2
2640561|NCT03640052|6491725|P5|STARTED|Overall Study||1
2640562|NCT03640052|6491726|P4|STARTED|Overall Study||1
2640563|NCT03640052|6491727|P3|STARTED|Overall Study||1
2640564|NCT03640052|6491728|P2|STARTED|Overall Study||1
2640565|NCT03640052|6491729|P1|STARTED|Overall Study||2
2640566|NCT03629054|6491748|P2|NOT COMPLETED|Period 2 (4 Days)||1
2640567|NCT03629054|6491749|P1|NOT COMPLETED|Period 2 (4 Days)||0
2640568|NCT03629054|6491748|P2|COMPLETED|Period 2 (4 Days)||14
2640569|NCT03629054|6491749|P1|COMPLETED|Period 2 (4 Days)||15
2640570|NCT03629054|6491748|P2|Treated|Period 2 (4 Days)||14
2640571|NCT03629054|6491749|P1|Treated|Period 2 (4 Days)||15
2640572|NCT03629054|6491748|P2|STARTED|Period 2 (4 Days)|Started this period|15
2640573|NCT03629054|6491749|P1|STARTED|Period 2 (4 Days)|Started this period|15
2640574|NCT03629054|6491748|P2|NOT COMPLETED|Wasout Period (35 Days)||0
2640575|NCT03629054|6491749|P1|NOT COMPLETED|Wasout Period (35 Days)||0
2640576|NCT03629054|6491748|P2|COMPLETED|Wasout Period (35 Days)||15
2640577|NCT03629054|6491749|P1|COMPLETED|Wasout Period (35 Days)||15
2640578|NCT03629054|6491748|P2|STARTED|Wasout Period (35 Days)|Started this period|15
2640579|NCT03629054|6491749|P1|STARTED|Wasout Period (35 Days)|Started this period|15
2640580|NCT03629054|6491748|P2|NOT COMPLETED|Period 1 (4 Days)||0
2640581|NCT03629054|6491749|P1|NOT COMPLETED|Period 1 (4 Days)||0
2640582|NCT03629054|6491748|P2|COMPLETED|Period 1 (4 Days)||15
2640583|NCT03629054|6491749|P1|COMPLETED|Period 1 (4 Days)||15
2640584|NCT03629054|6491748|P2|STARTED|Period 1 (4 Days)|Started this period|15
2640585|NCT03629054|6491749|P1|STARTED|Period 1 (4 Days)|Started this period|15
2640586|NCT03608488|6491777|P4|NOT COMPLETED|Overall Study||5
2640587|NCT03608488|6491778|P3|NOT COMPLETED|Overall Study||2
2640588|NCT03608488|6491779|P2|NOT COMPLETED|Overall Study||3
2640589|NCT03608488|6491780|P1|NOT COMPLETED|Overall Study||1
2640590|NCT03608488|6491777|P4|COMPLETED|Overall Study||40
2640591|NCT03608488|6491778|P3|COMPLETED|Overall Study||20
2640592|NCT03608488|6491779|P2|COMPLETED|Overall Study||18
2640593|NCT03608488|6491780|P1|COMPLETED|Overall Study||21
2640594|NCT03608488|6491777|P4|STARTED|Overall Study||45
2640595|NCT03608488|6491778|P3|STARTED|Overall Study||22
2640596|NCT03608488|6491779|P2|STARTED|Overall Study||21
2640597|NCT03608488|6491780|P1|STARTED|Overall Study||22
2640598|NCT03570658|6491822|P4|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
2640599|NCT03570658|6491823|P3|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
2640600|NCT03570658|6491824|P2|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
2640601|NCT03570658|6491825|P1|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
2640602|NCT03570658|6491822|P4|COMPLETED|Multiple Ascending Dose (MAD)||10
2640603|NCT03570658|6491823|P3|COMPLETED|Multiple Ascending Dose (MAD)||10
2640604|NCT03570658|6491824|P2|COMPLETED|Multiple Ascending Dose (MAD)||0
2640605|NCT03570658|6491825|P1|COMPLETED|Multiple Ascending Dose (MAD)||4
2640606|NCT03570658|6491822|P4|STARTED|Multiple Ascending Dose (MAD)||10
2640607|NCT03570658|6491823|P3|STARTED|Multiple Ascending Dose (MAD)||10
2640608|NCT03570658|6491824|P2|STARTED|Multiple Ascending Dose (MAD)||0
2640609|NCT03570658|6491825|P1|STARTED|Multiple Ascending Dose (MAD)||4
2640610|NCT03570658|6491822|P4|NOT COMPLETED|Single Ascending Dose (SAD)||0
2640611|NCT03570658|6491823|P3|NOT COMPLETED|Single Ascending Dose (SAD)||0
2640612|NCT03570658|6491824|P2|NOT COMPLETED|Single Ascending Dose (SAD)||0
2640613|NCT03570658|6491825|P1|NOT COMPLETED|Single Ascending Dose (SAD)||0
2640614|NCT03570658|6491822|P4|COMPLETED|Single Ascending Dose (SAD)||10
2640615|NCT03570658|6491823|P3|COMPLETED|Single Ascending Dose (SAD)||10
2640616|NCT03570658|6491824|P2|COMPLETED|Single Ascending Dose (SAD)||2
2640617|NCT03570658|6491825|P1|COMPLETED|Single Ascending Dose (SAD)||6
2640618|NCT03570658|6491822|P4|STARTED|Single Ascending Dose (SAD)||10
2640619|NCT03570658|6491823|P3|STARTED|Single Ascending Dose (SAD)||10
2640620|NCT03570658|6491824|P2|STARTED|Single Ascending Dose (SAD)||2
2640621|NCT03570658|6491825|P1|STARTED|Single Ascending Dose (SAD)||6
2640622|NCT03570255|6491875|P1|NOT COMPLETED|Overall Study||0
2640623|NCT03570255|6491875|P1|COMPLETED|Overall Study||28
2640624|NCT03570255|6491875|P1|STARTED|Overall Study||28
2640625|NCT03546842|6491879|P1|NOT COMPLETED|Overall Study||3
2640626|NCT03546842|6491879|P1|COMPLETED|Overall Study||198
2640627|NCT03546842|6491879|P1|Vaccination 3|Overall Study||198
2640628|NCT03546842|6491879|P1|Vaccination 2|Overall Study||200
2640629|NCT03546842|6491879|P1|Vaccination 1|Overall Study||200
2640630|NCT03546842|6491879|P1|STARTED|Overall Study||201
2640631|NCT03513757|6491890|P2|NOT COMPLETED|Overall Study||0
2640632|NCT03513757|6491891|P1|NOT COMPLETED|Overall Study||0
2640633|NCT03513757|6491890|P2|COMPLETED|Overall Study||18
2640634|NCT03513757|6491891|P1|COMPLETED|Overall Study||22
2640635|NCT03513757|6491890|P2|STARTED|Overall Study||18
2640636|NCT03513757|6491891|P1|STARTED|Overall Study||22
2640637|NCT03497039|6491923|P2|NOT COMPLETED|Overall Study||1
2640638|NCT03497039|6491924|P1|NOT COMPLETED|Overall Study||1
2640639|NCT03497039|6491923|P2|COMPLETED|Overall Study||16
2640640|NCT03497039|6491924|P1|COMPLETED|Overall Study||29
2640641|NCT03497039|6491923|P2|Treated|Overall Study||17
2640642|NCT03497039|6491924|P1|Treated|Overall Study||29
2640643|NCT03497039|6491923|P2|STARTED|Overall Study||17
2640644|NCT03497039|6491924|P1|STARTED|Overall Study||30
2640645|NCT03474172|6491938|P2|NOT COMPLETED|Overall Study||0
2640646|NCT03474172|6491939|P1|NOT COMPLETED|Overall Study||0
2640647|NCT03474172|6491938|P2|COMPLETED|Overall Study||30
2640648|NCT03474172|6491939|P1|COMPLETED|Overall Study||30
2640649|NCT03474172|6491938|P2|STARTED|Overall Study||30
2640650|NCT03474172|6491939|P1|STARTED|Overall Study||30
2640651|NCT03456245|6491955|P1|NOT COMPLETED|Overall Study||15
2640652|NCT03456245|6491955|P1|COMPLETED|Overall Study||190
2640653|NCT03456245|6491955|P1|STARTED|Overall Study||205
2640654|NCT03408392|6491959|P2|NOT COMPLETED|Treatment Period 2 (16 Days)||0
2640655|NCT03408392|6491960|P1|NOT COMPLETED|Treatment Period 2 (16 Days)||0
2640656|NCT03408392|6491959|P2|COMPLETED|Treatment Period 2 (16 Days)||14
2640657|NCT03408392|6491960|P1|COMPLETED|Treatment Period 2 (16 Days)||14
2640658|NCT03408392|6491959|P2|STARTED|Treatment Period 2 (16 Days)||14
2640659|NCT03408392|6491960|P1|STARTED|Treatment Period 2 (16 Days)||14
2640660|NCT03408392|6491959|P2|NOT COMPLETED|Wash-out Period (14 Days)||0
2640661|NCT03408392|6491960|P1|NOT COMPLETED|Wash-out Period (14 Days)||0
2640662|NCT03408392|6491959|P2|COMPLETED|Wash-out Period (14 Days)||14
2640663|NCT03408392|6491960|P1|COMPLETED|Wash-out Period (14 Days)||14
2640664|NCT03408392|6491959|P2|STARTED|Wash-out Period (14 Days)||14
2640665|NCT03408392|6491960|P1|STARTED|Wash-out Period (14 Days)||14
2640666|NCT03408392|6491959|P2|NOT COMPLETED|Treatment Period 1 (16 Days)||0
2640667|NCT03408392|6491960|P1|NOT COMPLETED|Treatment Period 1 (16 Days)||0
2640668|NCT03408392|6491959|P2|COMPLETED|Treatment Period 1 (16 Days)||14
2640669|NCT03408392|6491960|P1|COMPLETED|Treatment Period 1 (16 Days)||14
2640670|NCT03408392|6491959|P2|STARTED|Treatment Period 1 (16 Days)||14
2640671|NCT03408392|6491960|P1|STARTED|Treatment Period 1 (16 Days)||14
2640672|NCT03404843|6492014|P2|NOT COMPLETED|Overall Study||1
2640673|NCT03404843|6492015|P1|NOT COMPLETED|Overall Study||4
2640674|NCT03404843|6492014|P2|COMPLETED|Overall Study||13
2640675|NCT03404843|6492015|P1|COMPLETED|Overall Study||13
2640676|NCT03404843|6492014|P2|STARTED|Overall Study||14
2640677|NCT03404843|6492015|P1|STARTED|Overall Study||17
2640678|NCT03383887|6492041|P2|NOT COMPLETED|Overall Study||1
2640679|NCT03383887|6492042|P1|NOT COMPLETED|Overall Study||0
2640680|NCT03383887|6492041|P2|COMPLETED|Overall Study||5
2640681|NCT03383887|6492042|P1|COMPLETED|Overall Study||5
2640682|NCT03383887|6492041|P2|STARTED|Overall Study||6
2640683|NCT03383887|6492042|P1|STARTED|Overall Study||5
2640684|NCT03303521|6492052|P2|NOT COMPLETED|Overall Study||3
2640685|NCT03303521|6492053|P1|NOT COMPLETED|Overall Study||5
2640686|NCT03303521|6492052|P2|COMPLETED|Overall Study||96
2640687|NCT03303521|6492053|P1|COMPLETED|Overall Study||92
2640688|NCT03303521|6492052|P2|STARTED|Overall Study||99
2640689|NCT03303521|6492053|P1|STARTED|Overall Study||97
2640690|NCT03289858|6492065|P2|NOT COMPLETED|Overall Study||0
2640691|NCT03289858|6492066|P1|NOT COMPLETED|Overall Study||2
2640692|NCT03289858|6492065|P2|COMPLETED|Overall Study||28
2640693|NCT03289858|6492066|P1|COMPLETED|Overall Study||25
2640694|NCT03289858|6492065|P2|STARTED|Overall Study||28
2640695|NCT03289858|6492066|P1|STARTED|Overall Study||27
2640696|NCT03289234|6492075|P3|NOT COMPLETED|Overall Study||0
2640697|NCT03289234|6492076|P2|NOT COMPLETED|Overall Study||0
2640698|NCT03289234|6492077|P1|NOT COMPLETED|Overall Study||0
2640699|NCT03289234|6492075|P3|COMPLETED|Overall Study||8
2640700|NCT03289234|6492076|P2|COMPLETED|Overall Study||6
2640701|NCT03289234|6492077|P1|COMPLETED|Overall Study||8
2640702|NCT03289234|6492075|P3|STARTED|Overall Study||8
2640703|NCT03289234|6492076|P2|STARTED|Overall Study||6
2640704|NCT03289234|6492077|P1|STARTED|Overall Study||8
2640705|NCT03289208|6492097|P3|NOT COMPLETED|Overall Study||0
2640706|NCT03289208|6492098|P2|NOT COMPLETED|Overall Study||0
2640707|NCT03289208|6492099|P1|NOT COMPLETED|Overall Study||1
2640708|NCT03289208|6492097|P3|COMPLETED|Overall Study||11
2640709|NCT03289208|6492098|P2|COMPLETED|Overall Study||8
2640710|NCT03289208|6492099|P1|COMPLETED|Overall Study||10
2640711|NCT03289208|6492097|P3|STARTED|Overall Study||11
2640712|NCT03289208|6492098|P2|STARTED|Overall Study||8
2640713|NCT03289208|6492099|P1|STARTED|Overall Study||11
2640714|NCT03282591|6492118|P2|NOT COMPLETED|Overall Study||4
2640715|NCT03282591|6492119|P1|NOT COMPLETED|Overall Study||4
2640716|NCT03282591|6492118|P2|COMPLETED|Overall Study||89
2640717|NCT03282591|6492119|P1|COMPLETED|Overall Study||88
2640718|NCT03282591|6492118|P2|STARTED|Overall Study||93
2640719|NCT03282591|6492119|P1|STARTED|Overall Study||92
2640720|NCT03271021|6492135|P2|NOT COMPLETED|Overall Study||106
2640721|NCT03271021|6492136|P1|NOT COMPLETED|Overall Study||89
2640722|NCT03271021|6492135|P2|COMPLETED|Overall Study||644
2640723|NCT03271021|6492136|P1|COMPLETED|Overall Study||649
2640724|NCT03271021|6492135|P2|STARTED|Overall Study||750
2640725|NCT03271021|6492136|P1|STARTED|Overall Study||738
2640726|NCT03264157|6492146|P2|NOT COMPLETED|Overall Study||7
2640727|NCT03264157|6492147|P1|NOT COMPLETED|Overall Study||13
2640728|NCT03264157|6492146|P2|COMPLETED|Overall Study||74
2640729|NCT03264157|6492147|P1|COMPLETED|Overall Study||68
2640730|NCT03264157|6492146|P2|STARTED|Overall Study||81
2640731|NCT03264157|6492147|P1|STARTED|Overall Study||81
2640732|NCT03259490|6492165|P2|NOT COMPLETED|Period 2||0
2640733|NCT03259490|6492166|P1|NOT COMPLETED|Period 2||1
2640734|NCT03259490|6492165|P2|COMPLETED|Period 2||14
2640735|NCT03259490|6492166|P1|COMPLETED|Period 2||14
2640736|NCT03259490|6492165|P2|STARTED|Period 2||14
2640737|NCT03259490|6492166|P1|STARTED|Period 2||15
2640738|NCT03259490|6492165|P2|NOT COMPLETED|Period 1||1
2640739|NCT03259490|6492166|P1|NOT COMPLETED|Period 1||0
2640740|NCT03259490|6492165|P2|COMPLETED|Period 1||14
2640741|NCT03259490|6492166|P1|COMPLETED|Period 1||15
2640742|NCT03259490|6492165|P2|STARTED|Period 1||15
2640743|NCT03259490|6492166|P1|STARTED|Period 1||15
2640744|NCT03238911|6492190|P2|NOT COMPLETED|Overall Study||3
2640745|NCT03238911|6492191|P1|NOT COMPLETED|Overall Study||3
2640746|NCT03238911|6492190|P2|COMPLETED|Overall Study||58
2640747|NCT03238911|6492191|P1|COMPLETED|Overall Study||59
2640748|NCT03238911|6492190|P2|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|60
2640749|NCT03238911|6492191|P1|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|63
2640750|NCT03238911|6492190|P2|STARTED|Overall Study||61
2640751|NCT03238911|6492191|P1|STARTED|Overall Study||62
2640752|NCT03237065|6492233|P2|NOT COMPLETED|Overall Study||4
2640753|NCT03237065|6492234|P1|NOT COMPLETED|Overall Study||4
2640754|NCT03237065|6492233|P2|COMPLETED|Overall Study||57
2640755|NCT03237065|6492234|P1|COMPLETED|Overall Study||57
2640756|NCT03237065|6492233|P2|Safety Analysis Set|Overall Study||57
2640757|NCT03237065|6492234|P1|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|62
2640758|NCT03237065|6492233|P2|STARTED|Overall Study||61
2640759|NCT03237065|6492234|P1|STARTED|Overall Study||61
2640760|NCT03226392|6492276|P2|NOT COMPLETED|Overall Study||8
2640761|NCT03226392|6492277|P1|NOT COMPLETED|Overall Study||11
2640762|NCT03226392|6492276|P2|COMPLETED|Overall Study||344
2640763|NCT03226392|6492277|P1|COMPLETED|Overall Study||341
2640764|NCT03226392|6492276|P2|FAS|Overall Study|2 patients in the placebo were mis-randomized, not treated, not included due to “technical problems|350
2640765|NCT03226392|6492277|P1|FAS|Overall Study||352
2640766|NCT03226392|6492276|P2|STARTED|Overall Study||352
2640767|NCT03226392|6492277|P1|STARTED|Overall Study||352
2640768|NCT03201900|6492289|P1|NOT COMPLETED|Extension Phase (Up to 124 Weeks)||46
2640769|NCT03201900|6492289|P1|COMPLETED|Extension Phase (Up to 124 Weeks)||0
2640770|NCT03201900|6492289|P1|STARTED|Extension Phase (Up to 124 Weeks)|Eligible participants who completed Treatment Phase and agreed to continue in the Extension Phase.|46
2640771|NCT03201900|6492289|P1|NOT COMPLETED|Treatment Phase (Up to 62 Weeks)||37
2640772|NCT03201900|6492289|P1|COMPLETED|Treatment Phase (Up to 62 Weeks)||54
2640773|NCT03201900|6492289|P1|Treated|Treatment Phase (Up to 62 Weeks)||89
2640774|NCT03201900|6492289|P1|STARTED|Treatment Phase (Up to 62 Weeks)||91
2640775|NCT03187197|6492298|P3|NOT COMPLETED|Overall Study||23
2640776|NCT03187197|6492299|P2|NOT COMPLETED|Overall Study||393
2640777|NCT03187197|6492300|P1|NOT COMPLETED|Overall Study||46
2640778|NCT03187197|6492298|P3|COMPLETED|Overall Study||32
2640779|NCT03187197|6492299|P2|COMPLETED|Overall Study||704
2640780|NCT03187197|6492300|P1|COMPLETED|Overall Study||107
2640781|NCT03187197|6492298|P3|Started (Eligible Participants as FAS)|Overall Study||54
2640782|NCT03187197|6492299|P2|Started (Eligible Participants as FAS)|Overall Study||1052
2640783|NCT03187197|6492300|P1|Started (Eligible Participants as FAS)|Overall Study||139
2640784|NCT03187197|6492298|P3|STARTED|Overall Study||55
2640785|NCT03187197|6492299|P2|STARTED|Overall Study||1097
2640786|NCT03187197|6492300|P1|STARTED|Overall Study||153
2640787|NCT03155178|6492315|P4|NOT COMPLETED|Overall Study||7
2640788|NCT03155178|6492316|P3|NOT COMPLETED|Overall Study||7
2640789|NCT03155178|6492317|P2|NOT COMPLETED|Overall Study||7
2640790|NCT03155178|6492318|P1|NOT COMPLETED|Overall Study||7
2640791|NCT03155178|6492315|P4|COMPLETED|Overall Study||62
2640792|NCT03155178|6492316|P3|COMPLETED|Overall Study||62
2640793|NCT03155178|6492317|P2|COMPLETED|Overall Study||62
2640794|NCT03155178|6492318|P1|COMPLETED|Overall Study||62
2640795|NCT03155178|6492315|P4|STARTED|Overall Study||69
2640796|NCT03155178|6492316|P3|STARTED|Overall Study||69
2640797|NCT03155178|6492317|P2|STARTED|Overall Study||69
2640798|NCT03155178|6492318|P1|STARTED|Overall Study||69
2640799|NCT03146741|6492336|P1|NOT COMPLETED|Overall Study||10
2640800|NCT03146741|6492336|P1|COMPLETED|Overall Study||10
2640801|NCT03146741|6492336|P1|STARTED|Overall Study||20
2640802|NCT03143569|6492343|P2|NOT COMPLETED|Overall Study||2
2640803|NCT03143569|6492344|P1|NOT COMPLETED|Overall Study||0
2640804|NCT03143569|6492343|P2|COMPLETED|Overall Study||8
2640805|NCT03143569|6492344|P1|COMPLETED|Overall Study||10
2640806|NCT03143569|6492343|P2|STARTED|Overall Study||10
2640807|NCT03143569|6492344|P1|STARTED|Overall Study||10
2640808|NCT03135535|6492366|P1|NOT COMPLETED|Overall Study||0
2640809|NCT03135535|6492366|P1|COMPLETED|Overall Study||30
2640810|NCT03135535|6492366|P1|STARTED|Overall Study||30
2640811|NCT03128008|6492374|P1|NOT COMPLETED|Overall Study||9
2640812|NCT03128008|6492374|P1|COMPLETED|Overall Study|9 participants are in follow up|1
2640813|NCT03128008|6492374|P1|STARTED|Overall Study||10
2640814|NCT03126539|6492381|P5|NOT COMPLETED|Overall Study||0
2640815|NCT03126539|6492382|P4|NOT COMPLETED|Overall Study||0
2640816|NCT03126539|6492383|P3|NOT COMPLETED|Overall Study||1
2640817|NCT03126539|6492384|P2|NOT COMPLETED|Overall Study||1
2640818|NCT03126539|6492385|P1|NOT COMPLETED|Overall Study||1
2640819|NCT03126539|6492381|P5|COMPLETED|Overall Study||0
2640820|NCT03126539|6492382|P4|COMPLETED|Overall Study||0
2640821|NCT03126539|6492383|P3|COMPLETED|Overall Study||8
2640822|NCT03126539|6492384|P2|COMPLETED|Overall Study||8
2640823|NCT03126539|6492385|P1|COMPLETED|Overall Study||8
2640824|NCT03126539|6492381|P5|STARTED|Overall Study||0
2640825|NCT03126539|6492382|P4|STARTED|Overall Study|Group B was not done|0
2640826|NCT03126539|6492383|P3|STARTED|Overall Study||9
2640827|NCT03126539|6492384|P2|STARTED|Overall Study||9
2640828|NCT03126539|6492385|P1|STARTED|Overall Study||9
2640829|NCT03125915|6492402|P4|NOT COMPLETED|6 Month Follow-up||3
2640830|NCT03125915|6492403|P3|NOT COMPLETED|6 Month Follow-up||6
2640831|NCT03125915|6492404|P2|NOT COMPLETED|6 Month Follow-up||3
2640832|NCT03125915|6492405|P1|NOT COMPLETED|6 Month Follow-up||7
2640833|NCT03125915|6492402|P4|COMPLETED|6 Month Follow-up||31
2640834|NCT03125915|6492403|P3|COMPLETED|6 Month Follow-up||28
2640835|NCT03125915|6492404|P2|COMPLETED|6 Month Follow-up||37
2640836|NCT03125915|6492405|P1|COMPLETED|6 Month Follow-up||25
2640837|NCT03125915|6492402|P4|STARTED|6 Month Follow-up||34
2640838|NCT03125915|6492403|P3|STARTED|6 Month Follow-up||34
2640839|NCT03125915|6492404|P2|STARTED|6 Month Follow-up||40
2640840|NCT03125915|6492405|P1|STARTED|6 Month Follow-up||32
2640841|NCT03125915|6492402|P4|NOT COMPLETED|3 Month Follow-up||2
2640842|NCT03125915|6492403|P3|NOT COMPLETED|3 Month Follow-up||4
2640843|NCT03125915|6492404|P2|NOT COMPLETED|3 Month Follow-up||4
2640844|NCT03125915|6492405|P1|NOT COMPLETED|3 Month Follow-up||6
2640845|NCT03125915|6492402|P4|COMPLETED|3 Month Follow-up||32
2640846|NCT03125915|6492403|P3|COMPLETED|3 Month Follow-up||30
2640847|NCT03125915|6492404|P2|COMPLETED|3 Month Follow-up||36
2640848|NCT03125915|6492405|P1|COMPLETED|3 Month Follow-up||26
2640849|NCT03125915|6492402|P4|STARTED|3 Month Follow-up||34
2640850|NCT03125915|6492403|P3|STARTED|3 Month Follow-up||34
2640851|NCT03125915|6492404|P2|STARTED|3 Month Follow-up||40
2640852|NCT03125915|6492405|P1|STARTED|3 Month Follow-up||32
2640853|NCT03125915|6492402|P4|NOT COMPLETED|1 Month Follow up||3
2640854|NCT03125915|6492403|P3|NOT COMPLETED|1 Month Follow up||2
2640855|NCT03125915|6492404|P2|NOT COMPLETED|1 Month Follow up||3
2640856|NCT03125915|6492405|P1|NOT COMPLETED|1 Month Follow up||3
2640857|NCT03125915|6492402|P4|COMPLETED|1 Month Follow up||31
2640858|NCT03125915|6492403|P3|COMPLETED|1 Month Follow up||32
2640859|NCT03125915|6492404|P2|COMPLETED|1 Month Follow up||37
2640860|NCT03125915|6492405|P1|COMPLETED|1 Month Follow up||29
2640861|NCT03125915|6492402|P4|STARTED|1 Month Follow up||34
2640862|NCT03125915|6492403|P3|STARTED|1 Month Follow up||34
2640863|NCT03125915|6492404|P2|STARTED|1 Month Follow up||40
2640864|NCT03125915|6492405|P1|STARTED|1 Month Follow up||32
2640865|NCT03125915|6492402|P4|NOT COMPLETED|Baseline and Intervention||0
2640866|NCT03125915|6492403|P3|NOT COMPLETED|Baseline and Intervention||0
2640867|NCT03125915|6492404|P2|NOT COMPLETED|Baseline and Intervention||0
2640868|NCT03125915|6492405|P1|NOT COMPLETED|Baseline and Intervention||0
2640869|NCT03125915|6492402|P4|COMPLETED|Baseline and Intervention||34
2640870|NCT03125915|6492403|P3|COMPLETED|Baseline and Intervention||34
2640871|NCT03125915|6492404|P2|COMPLETED|Baseline and Intervention||40
2640872|NCT03125915|6492405|P1|COMPLETED|Baseline and Intervention||32
2640873|NCT03125915|6492402|P4|STARTED|Baseline and Intervention||34
2640874|NCT03125915|6492403|P3|STARTED|Baseline and Intervention||34
2640875|NCT03125915|6492404|P2|STARTED|Baseline and Intervention||40
2640876|NCT03125915|6492405|P1|STARTED|Baseline and Intervention||32
2640877|NCT03105362|6492423|P1|NOT COMPLETED|Overall Study||2
2640878|NCT03105362|6492423|P1|COMPLETED|Overall Study||2
2640879|NCT03105362|6492423|P1|Completed 2 Week Questionaire|Overall Study||2
2640880|NCT03105362|6492423|P1|Completed 2 Weeks of Study|Overall Study||3
2640881|NCT03105362|6492423|P1|Completed 1 Week of Study|Overall Study||4
2640882|NCT03105362|6492423|P1|STARTED|Overall Study||4
2640883|NCT03093181|6492433|P3|NOT COMPLETED|Overall Study||3
2640884|NCT03093181|6492434|P2|NOT COMPLETED|Overall Study||2
2640885|NCT03093181|6492435|P1|NOT COMPLETED|Overall Study||3
2640886|NCT03093181|6492433|P3|COMPLETED|Overall Study||41
2640887|NCT03093181|6492434|P2|COMPLETED|Overall Study||42
2640888|NCT03093181|6492435|P1|COMPLETED|Overall Study||41
2640889|NCT03093181|6492433|P3|STARTED|Overall Study||44
2640890|NCT03093181|6492434|P2|STARTED|Overall Study||44
2640891|NCT03093181|6492435|P1|STARTED|Overall Study||44
2640892|NCT03092375|6492465|P4|NOT COMPLETED|Overall Study||0
2640893|NCT03092375|6492466|P3|NOT COMPLETED|Overall Study||1
2640894|NCT03092375|6492467|P2|NOT COMPLETED|Overall Study||1
2640895|NCT03092375|6492468|P1|NOT COMPLETED|Overall Study||0
2640896|NCT03092375|6492465|P4|COMPLETED|Overall Study||29
2640897|NCT03092375|6492466|P3|COMPLETED|Overall Study||20
2640898|NCT03092375|6492467|P2|COMPLETED|Overall Study||48
2640899|NCT03092375|6492468|P1|COMPLETED|Overall Study||78
2640900|NCT03092375|6492465|P4|STARTED|Overall Study||29
2640901|NCT03092375|6492466|P3|STARTED|Overall Study||21
2640902|NCT03092375|6492467|P2|STARTED|Overall Study||49
2640903|NCT03092375|6492468|P1|STARTED|Overall Study||78
2640904|NCT03078595|6492496|P2|NOT COMPLETED|Overall Study||0
2640905|NCT03078595|6492497|P1|NOT COMPLETED|Overall Study||0
2640906|NCT03078595|6492496|P2|COMPLETED|Overall Study||24
2640907|NCT03078595|6492497|P1|COMPLETED|Overall Study||24
2640908|NCT03078595|6492496|P2|STARTED|Overall Study||24
2640909|NCT03078595|6492497|P1|STARTED|Overall Study||24
2640910|NCT03073876|6492507|P2|NOT COMPLETED|Overall Study||0
2640911|NCT03073876|6492508|P1|NOT COMPLETED|Overall Study||0
2640912|NCT03073876|6492507|P2|COMPLETED|Overall Study||11
2640913|NCT03073876|6492508|P1|COMPLETED|Overall Study||12
2640914|NCT03073876|6492507|P2|STARTED|Overall Study||11
2640915|NCT03073876|6492508|P1|STARTED|Overall Study||12
2640916|NCT03069352|6492549|P2|NOT COMPLETED|Overall Study||40
2640917|NCT03069352|6492550|P1|NOT COMPLETED|Overall Study||12
2640918|NCT03069352|6492549|P2|COMPLETED|Overall Study||103
2640919|NCT03069352|6492550|P1|COMPLETED|Overall Study||56
2640920|NCT03069352|6492549|P2|Received Treatment|Overall Study||142
2640921|NCT03069352|6492550|P1|Received Treatment|Overall Study||68
2640922|NCT03069352|6492549|P2|STARTED|Overall Study||143
2640923|NCT03069352|6492550|P1|STARTED|Overall Study||68
2640924|NCT03068312|6492594|P2|NOT COMPLETED|Overall Study||0
2640925|NCT03068312|6492595|P1|NOT COMPLETED|Overall Study||0
2640926|NCT03068312|6492594|P2|COMPLETED|Overall Study||19
2640927|NCT03068312|6492595|P1|COMPLETED|Overall Study||19
2640928|NCT03068312|6492594|P2|STARTED|Overall Study||19
2640929|NCT03068312|6492595|P1|STARTED|Overall Study||19
2640930|NCT03066193|6492601|P1|NOT COMPLETED|Overall Study||1
2640931|NCT03066193|6492601|P1|COMPLETED|Overall Study||16
2640932|NCT03066193|6492601|P1|STARTED|Overall Study||17
2640933|NCT03055260|6492607|P2|NOT COMPLETED|Overall Study||0
2640934|NCT03055260|6492608|P1|NOT COMPLETED|Overall Study||1
2640935|NCT03055260|6492607|P2|COMPLETED|Overall Study||0
2640936|NCT03055260|6492608|P1|COMPLETED|Overall Study||7
2640937|NCT03055260|6492607|P2|STARTED|Overall Study||0
2640938|NCT03055260|6492608|P1|STARTED|Overall Study||8
2640939|NCT03055195|6492618|P2|NOT COMPLETED|Overall Study||14
2640940|NCT03055195|6492619|P1|NOT COMPLETED|Overall Study||12
2640941|NCT03055195|6492618|P2|COMPLETED|Overall Study||4
2640942|NCT03055195|6492619|P1|COMPLETED|Overall Study||4
2640943|NCT03055195|6492618|P2|STARTED|Overall Study||18
2640944|NCT03055195|6492619|P1|STARTED|Overall Study||16
2640945|NCT03049852|6492674|P3|NOT COMPLETED|Overall Study||0
2640946|NCT03049852|6492675|P2|NOT COMPLETED|Overall Study||1
2640947|NCT03049852|6492676|P1|NOT COMPLETED|Overall Study||0
2640948|NCT03049852|6492674|P3|COMPLETED|Overall Study||26
2640949|NCT03049852|6492675|P2|COMPLETED|Overall Study||24
2640950|NCT03049852|6492676|P1|COMPLETED|Overall Study||24
2640951|NCT03049852|6492674|P3|STARTED|Overall Study||26
2640952|NCT03049852|6492675|P2|STARTED|Overall Study||25
2640953|NCT03049852|6492676|P1|STARTED|Overall Study||24
2640954|NCT03041467|6492688|P2|NOT COMPLETED|Overall Study||160
2640955|NCT03041467|6492689|P1|NOT COMPLETED|Overall Study||170
2640956|NCT03041467|6492688|P2|COMPLETED|Overall Study||0
2640957|NCT03041467|6492689|P1|COMPLETED|Overall Study||0
2640958|NCT03041467|6492688|P2|STARTED|Overall Study||160
2640959|NCT03041467|6492689|P1|STARTED|Overall Study||170
2640960|NCT03038867|6492721|P2|NOT COMPLETED|Overall Study||0
2640961|NCT03038867|6492722|P1|NOT COMPLETED|Overall Study||0
2640962|NCT03038867|6492721|P2|COMPLETED|Overall Study||32
2640963|NCT03038867|6492722|P1|COMPLETED|Overall Study||37
2640964|NCT03038867|6492721|P2|STARTED|Overall Study||32
2640965|NCT03038867|6492722|P1|STARTED|Overall Study||37
2640966|NCT03030183|6492836|P1|NOT COMPLETED|Overall Study||0
2640967|NCT03030183|6492836|P1|COMPLETED|Overall Study||3
2640968|NCT03030183|6492836|P1|STARTED|Overall Study||3
2640969|NCT03015181|6492853|P7|NOT COMPLETED|Overall Study||1
2640970|NCT03015181|6492854|P6|NOT COMPLETED|Overall Study||1
2640971|NCT03015181|6492855|P5|NOT COMPLETED|Overall Study||0
2640972|NCT03015181|6492856|P4|NOT COMPLETED|Overall Study||0
2640973|NCT03015181|6492857|P3|NOT COMPLETED|Overall Study||0
2640974|NCT03015181|6492858|P2|NOT COMPLETED|Overall Study||0
2640975|NCT03015181|6492859|P1|NOT COMPLETED|Overall Study||1
2640976|NCT03015181|6492853|P7|COMPLETED|Overall Study|Group 7 subject who received only 1 dose was withdrawn after unrelated intercurrent illness resolved|4
2640977|NCT03015181|6492854|P6|COMPLETED|Overall Study|Group 6 subject who received only 1 dose chose to withdraw from study after the first administration|4
2640978|NCT03015181|6492855|P5|COMPLETED|Overall Study||3
2640979|NCT03015181|6492856|P4|COMPLETED|Overall Study||3
2640980|NCT03015181|6492857|P3|COMPLETED|Overall Study||3
2640981|NCT03015181|6492858|P2|COMPLETED|Overall Study||3
2640982|NCT03015181|6492859|P1|COMPLETED|Overall Study||3
2640983|NCT03015181|6492853|P7|Discontinued VRC07-523LS Administrations|Overall Study|One Group 7 subject received only 1 of 3 scheduled doses due to an unrelated intercurrent illness|1
2641071|NCT02959177|6493378|P1|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|52
2640984|NCT03015181|6492854|P6|Discontinued VRC07-523LS Administrations|Overall Study|One Group 6 subject received only 1 of 3 scheduled doses prior to withdrawing from the study|1
2640985|NCT03015181|6492855|P5|Discontinued VRC07-523LS Administrations|Overall Study||0
2640986|NCT03015181|6492856|P4|Discontinued VRC07-523LS Administrations|Overall Study||0
2640987|NCT03015181|6492857|P3|Discontinued VRC07-523LS Administrations|Overall Study||0
2640988|NCT03015181|6492858|P2|Discontinued VRC07-523LS Administrations|Overall Study||0
2640989|NCT03015181|6492859|P1|Discontinued VRC07-523LS Administrations|Overall Study|One Group 1 subject decided not to receive the VRC07-523LS infusion|1
2640990|NCT03015181|6492853|P7|Received VRC07-523LS Per Protocol|Overall Study||4
2640991|NCT03015181|6492854|P6|Received VRC07-523LS Per Protocol|Overall Study||4
2640992|NCT03015181|6492855|P5|Received VRC07-523LS Per Protocol|Overall Study||3
2640993|NCT03015181|6492856|P4|Received VRC07-523LS Per Protocol|Overall Study||3
2640994|NCT03015181|6492857|P3|Received VRC07-523LS Per Protocol|Overall Study||3
2640995|NCT03015181|6492858|P2|Received VRC07-523LS Per Protocol|Overall Study||3
2640996|NCT03015181|6492859|P1|Received VRC07-523LS Per Protocol|Overall Study||3
2640997|NCT03015181|6492853|P7|STARTED|Overall Study||5
2640998|NCT03015181|6492854|P6|STARTED|Overall Study||5
2640999|NCT03015181|6492855|P5|STARTED|Overall Study||3
2641000|NCT03015181|6492856|P4|STARTED|Overall Study||3
2641001|NCT03015181|6492857|P3|STARTED|Overall Study||3
2641002|NCT03015181|6492858|P2|STARTED|Overall Study||3
2641003|NCT03015181|6492859|P1|STARTED|Overall Study||4
2641004|NCT03006562|6492972|P2|NOT COMPLETED|Overall Study||1
2641005|NCT03006562|6492973|P1|NOT COMPLETED|Overall Study||0
2641006|NCT03006562|6492972|P2|COMPLETED|Overall Study||249
2641007|NCT03006562|6492973|P1|COMPLETED|Overall Study||251
2641008|NCT03006562|6492972|P2|Voluntary Ultrasound at 30 Days|Overall Study||137
2641009|NCT03006562|6492973|P1|Voluntary Ultrasound at 30 Days|Overall Study||141
2641010|NCT03006562|6492972|P2|STARTED|Overall Study||250
2641011|NCT03006562|6492973|P1|STARTED|Overall Study||251
2641012|NCT02997163|6492995|P4|NOT COMPLETED|Overall Study||1
2641013|NCT02997163|6492996|P3|NOT COMPLETED|Overall Study||0
2641014|NCT02997163|6492997|P2|NOT COMPLETED|Overall Study||0
2641015|NCT02997163|6492998|P1|NOT COMPLETED|Overall Study||1
2641016|NCT02997163|6492995|P4|COMPLETED|Overall Study||7
2641017|NCT02997163|6492996|P3|COMPLETED|Overall Study||8
2641018|NCT02997163|6492997|P2|COMPLETED|Overall Study||9
2641019|NCT02997163|6492998|P1|COMPLETED|Overall Study||8
2641020|NCT02997163|6492995|P4|STARTED|Overall Study||8
2641021|NCT02997163|6492996|P3|STARTED|Overall Study||8
2641022|NCT02997163|6492997|P2|STARTED|Overall Study||9
2641023|NCT02997163|6492998|P1|STARTED|Overall Study||9
2641024|NCT02996500|6493134|P6|NOT COMPLETED|Overall Study||4
2641025|NCT02996500|6493135|P5|NOT COMPLETED|Overall Study||5
2641026|NCT02996500|6493136|P4|NOT COMPLETED|Overall Study||4
2641027|NCT02996500|6493137|P3|NOT COMPLETED|Overall Study||10
2641028|NCT02996500|6493138|P2|NOT COMPLETED|Overall Study||1
2641029|NCT02996500|6493139|P1|NOT COMPLETED|Overall Study||8
2641030|NCT02996500|6493134|P6|COMPLETED|Overall Study||44
2641031|NCT02996500|6493135|P5|COMPLETED|Overall Study||45
2641032|NCT02996500|6493136|P4|COMPLETED|Overall Study||46
2641033|NCT02996500|6493137|P3|COMPLETED|Overall Study||29
2641034|NCT02996500|6493138|P2|COMPLETED|Overall Study||42
2641035|NCT02996500|6493139|P1|COMPLETED|Overall Study||31
2641036|NCT02996500|6493134|P6|STARTED|Overall Study||48
2641037|NCT02996500|6493135|P5|STARTED|Overall Study||50
2641038|NCT02996500|6493136|P4|STARTED|Overall Study||50
2641039|NCT02996500|6493137|P3|STARTED|Overall Study||39
2641040|NCT02996500|6493138|P2|STARTED|Overall Study||43
2641041|NCT02996500|6493139|P1|STARTED|Overall Study||39
2641042|NCT02993302|6493324|P2|NOT COMPLETED|Overall Study||0
2641043|NCT02993302|6493325|P1|NOT COMPLETED|Overall Study||0
2641044|NCT02993302|6493324|P2|COMPLETED|Overall Study||12
2641045|NCT02993302|6493325|P1|COMPLETED|Overall Study||13
2641046|NCT02993302|6493324|P2|STARTED|Overall Study||12
2641047|NCT02993302|6493325|P1|STARTED|Overall Study||13
2641048|NCT02983617|6493339|P2|NOT COMPLETED|Overall Study||30
2641049|NCT02983617|6493340|P1|NOT COMPLETED|Overall Study||6
2641050|NCT02983617|6493339|P2|COMPLETED|Overall Study||0
2641051|NCT02983617|6493340|P1|COMPLETED|Overall Study||0
2641052|NCT02983617|6493339|P2|STARTED|Overall Study||30
2641053|NCT02983617|6493340|P1|STARTED|Overall Study||6
2641054|NCT02975206|6493357|P3|NOT COMPLETED|Overall Study||17
2641055|NCT02975206|6493358|P2|NOT COMPLETED|Overall Study||17
2641056|NCT02975206|6493359|P1|NOT COMPLETED|Overall Study||27
2641057|NCT02975206|6493357|P3|COMPLETED|Overall Study||145
2641058|NCT02975206|6493358|P2|COMPLETED|Overall Study||144
2641059|NCT02975206|6493359|P1|COMPLETED|Overall Study||134
2641060|NCT02975206|6493357|P3|STARTED|Overall Study||162
2641061|NCT02975206|6493358|P2|STARTED|Overall Study||161
2641062|NCT02975206|6493359|P1|STARTED|Overall Study||161
2641063|NCT02959177|6493376|P3|NOT COMPLETED|Follow-up Post Treatment Phase||2
2641064|NCT02959177|6493377|P2|NOT COMPLETED|Follow-up Post Treatment Phase||1
2641065|NCT02959177|6493378|P1|NOT COMPLETED|Follow-up Post Treatment Phase||1
2641066|NCT02959177|6493376|P3|COMPLETED|Follow-up Post Treatment Phase||98
2641067|NCT02959177|6493377|P2|COMPLETED|Follow-up Post Treatment Phase||51
2641068|NCT02959177|6493378|P1|COMPLETED|Follow-up Post Treatment Phase||51
2641069|NCT02959177|6493376|P3|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|100
2641070|NCT02959177|6493377|P2|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|52
2641072|NCT02959177|6493376|P3|NOT COMPLETED|Double-Blind Treatment Phase||5
2641073|NCT02959177|6493377|P2|NOT COMPLETED|Double-Blind Treatment Phase||3
2641074|NCT02959177|6493378|P1|NOT COMPLETED|Double-Blind Treatment Phase||11
2641075|NCT02959177|6493376|P3|COMPLETED|Double-Blind Treatment Phase||225
2641076|NCT02959177|6493377|P2|COMPLETED|Double-Blind Treatment Phase||111
2641077|NCT02959177|6493378|P1|COMPLETED|Double-Blind Treatment Phase||104
2641078|NCT02959177|6493376|P3|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||230
2641079|NCT02959177|6493377|P2|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||114
2641080|NCT02959177|6493378|P1|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||115
2641081|NCT02959177|6493376|P3|STARTED|Double-Blind Treatment Phase||230
2641082|NCT02959177|6493377|P2|STARTED|Double-Blind Treatment Phase||114
2641083|NCT02959177|6493378|P1|STARTED|Double-Blind Treatment Phase||115
2641084|NCT02953938|6493432|P2|NOT COMPLETED|Overall Study||2
2641085|NCT02953938|6493433|P1|NOT COMPLETED|Overall Study||1
2641086|NCT02953938|6493432|P2|COMPLETED|Overall Study||28
2641087|NCT02953938|6493433|P1|COMPLETED|Overall Study||28
2641088|NCT02953938|6493432|P2|STARTED|Overall Study||30
2641089|NCT02953938|6493433|P1|STARTED|Overall Study||29
2641090|NCT02951819|6493450|P2|NOT COMPLETED|Overall Study||14
2641091|NCT02951819|6493451|P1|NOT COMPLETED|Overall Study||87
2641092|NCT02951819|6493450|P2|COMPLETED|Overall Study||0
2641093|NCT02951819|6493451|P1|COMPLETED|Overall Study||0
2641094|NCT02951819|6493450|P2|Treated|Overall Study||14
2641095|NCT02951819|6493451|P1|Treated|Overall Study||86
2641096|NCT02951819|6493450|P2|STARTED|Overall Study||14
2641097|NCT02951819|6493451|P1|STARTED|Overall Study||87
2641098|NCT02951533|6493475|P3|NOT COMPLETED|Part III (Week 64 Through Week 100)||2
2641099|NCT02951533|6493476|P2|NOT COMPLETED|Part III (Week 64 Through Week 100)||0
2641100|NCT02951533|6493477|P1|NOT COMPLETED|Part III (Week 64 Through Week 100)||4
2641101|NCT02951533|6493475|P3|COMPLETED|Part III (Week 64 Through Week 100)||10
2641102|NCT02951533|6493476|P2|COMPLETED|Part III (Week 64 Through Week 100)||0
2641103|NCT02951533|6493477|P1|COMPLETED|Part III (Week 64 Through Week 100)||32
2641104|NCT02951533|6493475|P3|STARTED|Part III (Week 64 Through Week 100)|8 participants were not eligible to enter Part III.|12
2641105|NCT02951533|6493476|P2|STARTED|Part III (Week 64 Through Week 100)|10 participants in the FAE group were not eligible to enter Part III.|0
2641106|NCT02951533|6493477|P1|STARTED|Part III (Week 64 Through Week 100)|18 participants were not eligible to enter Part III.|36
2641107|NCT02951533|6493475|P3|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||0
2641108|NCT02951533|6493476|P2|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||4
2641109|NCT02951533|6493477|P1|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||1
2641110|NCT02951533|6493475|P3|COMPLETED|Part IIb (Week 32 Through Week 56)||20
2641111|NCT02951533|6493476|P2|COMPLETED|Part IIb (Week 32 Through Week 56)||10
2641112|NCT02951533|6493477|P1|COMPLETED|Part IIb (Week 32 Through Week 56)||54
2641113|NCT02951533|6493475|P3|STARTED|Part IIb (Week 32 Through Week 56)|Out of 34 participants in FAE group, 20 PASI 75 non-responders switched to GUS group.|20
2641114|NCT02951533|6493476|P2|STARTED|Part IIb (Week 32 Through Week 56)|Out of 34 participants in the FAE group, 14 PASI 75 responders remained on FAE treatment.|14
2641115|NCT02951533|6493477|P1|STARTED|Part IIb (Week 32 Through Week 56)||55
2641116|NCT02951533|6493475|P3|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||0
2641117|NCT02951533|6493476|P2|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||1
2641118|NCT02951533|6493477|P1|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||1
2641119|NCT02951533|6493475|P3|COMPLETED|Part IIa (Week 24 Through Week 32)||0
2641120|NCT02951533|6493476|P2|COMPLETED|Part IIa (Week 24 Through Week 32)||34
2641121|NCT02951533|6493477|P1|COMPLETED|Part IIa (Week 24 Through Week 32)||55
2641122|NCT02951533|6493475|P3|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||0
2641123|NCT02951533|6493476|P2|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||20
2641124|NCT02951533|6493477|P1|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||1
2641125|NCT02951533|6493475|P3|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||0
2641126|NCT02951533|6493476|P2|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||14
2641127|NCT02951533|6493477|P1|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||54
2641128|NCT02951533|6493475|P3|STARTED|Part IIa (Week 24 Through Week 32)||0
2641129|NCT02951533|6493476|P2|STARTED|Part IIa (Week 24 Through Week 32)|1 participant did not sign informed consent form (ICF) for Study Part II but completed Study Part I.|35
2641130|NCT02951533|6493477|P1|STARTED|Part IIa (Week 24 Through Week 32)||56
2641131|NCT02951533|6493475|P3|NOT COMPLETED|Part I (Week 0 Through Week 24)||0
2641132|NCT02951533|6493476|P2|NOT COMPLETED|Part I (Week 0 Through Week 24)||23
2641133|NCT02951533|6493477|P1|NOT COMPLETED|Part I (Week 0 Through Week 24)||4
2641134|NCT02951533|6493475|P3|COMPLETED|Part I (Week 0 Through Week 24)||0
2641135|NCT02951533|6493476|P2|COMPLETED|Part I (Week 0 Through Week 24)||36
2641136|NCT02951533|6493477|P1|COMPLETED|Part I (Week 0 Through Week 24)||56
2641137|NCT02951533|6493475|P3|Treated|Part I (Week 0 Through Week 24)||0
2641138|NCT02951533|6493476|P2|Treated|Part I (Week 0 Through Week 24)||58
2641139|NCT02951533|6493477|P1|Treated|Part I (Week 0 Through Week 24)||60
2641140|NCT02951533|6493475|P3|STARTED|Part I (Week 0 Through Week 24)||0
2641141|NCT02951533|6493476|P2|STARTED|Part I (Week 0 Through Week 24)||59
2641142|NCT02951533|6493477|P1|STARTED|Part I (Week 0 Through Week 24)||60
2641143|NCT02945150|6493574|P1|NOT COMPLETED|Overall Study||0
2641144|NCT02945150|6493574|P1|COMPLETED|Overall Study||8
2641145|NCT02945150|6493574|P1|SVR12|Overall Study||8
2641146|NCT02945150|6493574|P1|STARTED|Overall Study||8
2641147|NCT02939599|6493581|P2|NOT COMPLETED|Overall Study||2
2641148|NCT02939599|6493582|P1|NOT COMPLETED|Overall Study||3
2641149|NCT02939599|6493581|P2|COMPLETED|Overall Study||0
2641150|NCT02939599|6493582|P1|COMPLETED|Overall Study||0
2641151|NCT02939599|6493581|P2|STARTED|Overall Study||2
2641152|NCT02939599|6493582|P1|STARTED|Overall Study||3
2641153|NCT02939014|6493598|P2|NOT COMPLETED|Overall Study||9
2641154|NCT02939014|6493599|P1|NOT COMPLETED|Overall Study||30
2641155|NCT02939014|6493598|P2|COMPLETED|Overall Study||0
2641156|NCT02939014|6493599|P1|COMPLETED|Overall Study||0
2641157|NCT02939014|6493598|P2|STARTED|Overall Study||9
2641158|NCT02939014|6493599|P1|STARTED|Overall Study||30
2641159|NCT02928029|6493628|P2|NOT COMPLETED|Overall Study||4
2641160|NCT02928029|6493629|P1|NOT COMPLETED|Overall Study||3
2641161|NCT02928029|6493628|P2|COMPLETED|Overall Study||0
2641162|NCT02928029|6493629|P1|COMPLETED|Overall Study||0
2641163|NCT02928029|6493628|P2|STARTED|Overall Study||4
2641164|NCT02928029|6493629|P1|STARTED|Overall Study||3
2641165|NCT02927366|6493641|P2|NOT COMPLETED|Overall Study||0
2641166|NCT02927366|6493642|P1|NOT COMPLETED|Overall Study||2
2641167|NCT02927366|6493641|P2|COMPLETED|Overall Study||2
2641168|NCT02927366|6493642|P1|COMPLETED|Overall Study||4
2641169|NCT02927366|6493641|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||0
2641170|NCT02927366|6493642|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||4
2641171|NCT02927366|6493641|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||2
2641172|NCT02927366|6493642|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||6
2641173|NCT02927366|6493641|P2|STARTED|Overall Study||2
2641174|NCT02927366|6493642|P1|STARTED|Overall Study||6
2641175|NCT02924688|6493680|P6|NOT COMPLETED|Overall Study||24
2641176|NCT02924688|6493681|P5|NOT COMPLETED|Overall Study||23
2641177|NCT02924688|6493682|P4|NOT COMPLETED|Overall Study||28
2641178|NCT02924688|6493683|P3|NOT COMPLETED|Overall Study||23
2641179|NCT02924688|6493684|P2|NOT COMPLETED|Overall Study||31
2641180|NCT02924688|6493685|P1|NOT COMPLETED|Overall Study||33
2641181|NCT02924688|6493680|P6|COMPLETED|Overall Study||384
2641182|NCT02924688|6493681|P5|COMPLETED|Overall Study||381
2641183|NCT02924688|6493682|P4|COMPLETED|Overall Study||378
2641184|NCT02924688|6493683|P3|COMPLETED|Overall Study||383
2641185|NCT02924688|6493684|P2|COMPLETED|Overall Study||374
2641186|NCT02924688|6493685|P1|COMPLETED|Overall Study||374
2641187|NCT02924688|6493680|P6|STARTED|Overall Study||408
2641188|NCT02924688|6493681|P5|STARTED|Overall Study||404
2641189|NCT02924688|6493682|P4|STARTED|Overall Study||406
2641190|NCT02924688|6493683|P3|STARTED|Overall Study||406
2641191|NCT02924688|6493684|P2|STARTED|Overall Study||405
2641192|NCT02924688|6493685|P1|STARTED|Overall Study||407
2641193|NCT02918669|6493753|P1|NOT COMPLETED|Overall Study||4
2641194|NCT02918669|6493753|P1|COMPLETED|Overall Study||8
2641195|NCT02918669|6493753|P1|STARTED|Overall Study||12
2641196|NCT02911948|6493762|P2|NOT COMPLETED|Overall Study||7
2641197|NCT02911948|6493763|P1|NOT COMPLETED|Overall Study||0
2641198|NCT02911948|6493762|P2|COMPLETED|Overall Study||98
2641199|NCT02911948|6493763|P1|COMPLETED|Overall Study||105
2641200|NCT02911948|6493762|P2|STARTED|Overall Study||105
2641201|NCT02911948|6493763|P1|STARTED|Overall Study||105
2641202|NCT02911324|6493825|P2|NOT COMPLETED|Overall Study||1
2641203|NCT02911324|6493826|P1|NOT COMPLETED|Overall Study||3
2641204|NCT02911324|6493825|P2|COMPLETED|Overall Study||6
2641205|NCT02911324|6493826|P1|COMPLETED|Overall Study||6
2641206|NCT02911324|6493825|P2|STARTED|Overall Study||7
2641207|NCT02911324|6493826|P1|STARTED|Overall Study||9
2641208|NCT02891200|6493835|P2|NOT COMPLETED|Overall Study||49
2641209|NCT02891200|6493836|P1|NOT COMPLETED|Overall Study||42
2641210|NCT02891200|6493835|P2|COMPLETED|Overall Study||98
2641211|NCT02891200|6493836|P1|COMPLETED|Overall Study||103
2641212|NCT02891200|6493835|P2|STARTED|Overall Study||147
2641213|NCT02891200|6493836|P1|STARTED|Overall Study||145
2641214|NCT02874404|6493862|P1|NOT COMPLETED|Overall Study||0
2641215|NCT02874404|6493862|P1|COMPLETED|Overall Study||13
2641216|NCT02874404|6493862|P1|STARTED|Overall Study||13
2641217|NCT02859454|6493868|P1|NOT COMPLETED|Overall Study||1
2641218|NCT02859454|6493868|P1|COMPLETED|Overall Study||12
2641219|NCT02859454|6493868|P1|STARTED|Overall Study||13
2641220|NCT02858401|6493886|P7|NOT COMPLETED|Overall Study||0
2641221|NCT02858401|6493887|P6|NOT COMPLETED|Overall Study||1
2641222|NCT02858401|6493888|P5|NOT COMPLETED|Overall Study||0
2641223|NCT02858401|6493889|P4|NOT COMPLETED|Overall Study||0
2641224|NCT02858401|6493890|P3|NOT COMPLETED|Overall Study||0
2641225|NCT02858401|6493891|P2|NOT COMPLETED|Overall Study||1
2641226|NCT02858401|6493892|P1|NOT COMPLETED|Overall Study||0
2641227|NCT02858401|6493886|P7|COMPLETED|Overall Study||12
2641228|NCT02858401|6493887|P6|COMPLETED|Overall Study||5
2641229|NCT02858401|6493888|P5|COMPLETED|Overall Study||6
2641230|NCT02858401|6493889|P4|COMPLETED|Overall Study||6
2641231|NCT02858401|6493890|P3|COMPLETED|Overall Study||6
2641232|NCT02858401|6493891|P2|COMPLETED|Overall Study||5
2641233|NCT02858401|6493892|P1|COMPLETED|Overall Study||6
2641234|NCT02858401|6493886|P7|STARTED|Overall Study||12
2641235|NCT02858401|6493887|P6|STARTED|Overall Study||6
2641236|NCT02858401|6493888|P5|STARTED|Overall Study||6
2641237|NCT02858401|6493889|P4|STARTED|Overall Study||6
2641238|NCT02858401|6493890|P3|STARTED|Overall Study||6
2641239|NCT02858401|6493891|P2|STARTED|Overall Study||6
2641240|NCT02858401|6493892|P1|STARTED|Overall Study||6
2641241|NCT02836496|6494302|P2|NOT COMPLETED|Overall Study||2
2641242|NCT02836496|6494303|P1|NOT COMPLETED|Overall Study||2
2641243|NCT02836496|6494302|P2|COMPLETED|Overall Study||52
2641244|NCT02836496|6494303|P1|COMPLETED|Overall Study||52
2641245|NCT02836496|6494302|P2|STARTED|Overall Study||54
2641246|NCT02836496|6494303|P1|STARTED|Overall Study||54
2641247|NCT02822235|6494319|P2|NOT COMPLETED|Prospective Phase (Day 1 up to Month 12)||2
2641248|NCT02822235|6494320|P1|NOT COMPLETED|Prospective Phase (Day 1 up to Month 12)||11
2641249|NCT02822235|6494319|P2|COMPLETED|Prospective Phase (Day 1 up to Month 12)||34
2641250|NCT02822235|6494320|P1|COMPLETED|Prospective Phase (Day 1 up to Month 12)||107
2641251|NCT02822235|6494319|P2|STARTED|Prospective Phase (Day 1 up to Month 12)||36
2641252|NCT02822235|6494320|P1|STARTED|Prospective Phase (Day 1 up to Month 12)||118
2641253|NCT02822235|6494319|P2|NOT COMPLETED|Cross-sectional Phase (Day 1)||107
2641254|NCT02822235|6494320|P1|NOT COMPLETED|Cross-sectional Phase (Day 1)||146
2641255|NCT02822235|6494319|P2|COMPLETED|Cross-sectional Phase (Day 1)||36
2641256|NCT02822235|6494320|P1|COMPLETED|Cross-sectional Phase (Day 1)||118
2641257|NCT02822235|6494319|P2|STARTED|Cross-sectional Phase (Day 1)||143
2641258|NCT02822235|6494320|P1|STARTED|Cross-sectional Phase (Day 1)||264
2641259|NCT02821910|6494379|P6|NOT COMPLETED|Overall Study||1
2641260|NCT02821910|6494380|P5|NOT COMPLETED|Overall Study||0
2641261|NCT02821910|6494381|P4|NOT COMPLETED|Overall Study||0
2641262|NCT02821910|6494382|P3|NOT COMPLETED|Overall Study||2
2641263|NCT02821910|6494383|P2|NOT COMPLETED|Overall Study||0
2641264|NCT02821910|6494384|P1|NOT COMPLETED|Overall Study||1
2641265|NCT02821910|6494379|P6|COMPLETED|Overall Study||7
2641266|NCT02821910|6494380|P5|COMPLETED|Overall Study||7
2641267|NCT02821910|6494381|P4|COMPLETED|Overall Study||10
2641268|NCT02821910|6494382|P3|COMPLETED|Overall Study||8
2641269|NCT02821910|6494383|P2|COMPLETED|Overall Study||8
2641270|NCT02821910|6494384|P1|COMPLETED|Overall Study||6
2641271|NCT02821910|6494379|P6|STARTED|Overall Study||8
2641272|NCT02821910|6494380|P5|STARTED|Overall Study||7
2641273|NCT02821910|6494381|P4|STARTED|Overall Study||10
2641274|NCT02821910|6494382|P3|STARTED|Overall Study||10
2641275|NCT02821910|6494383|P2|STARTED|Overall Study||8
2641276|NCT02821910|6494384|P1|STARTED|Overall Study||7
2641277|NCT02819011|6494448|P2|NOT COMPLETED|Overall Study||5
2641278|NCT02819011|6494449|P1|NOT COMPLETED|Overall Study||7
2641279|NCT02819011|6494448|P2|COMPLETED|Overall Study||17
2641280|NCT02819011|6494449|P1|COMPLETED|Overall Study||15
2641281|NCT02819011|6494448|P2|STARTED|Overall Study||22
2641282|NCT02819011|6494449|P1|STARTED|Overall Study||22
2641283|NCT02801578|6494476|P1|NOT COMPLETED|Overall Study||2
2641284|NCT02801578|6494476|P1|COMPLETED|Overall Study||9
2641285|NCT02801578|6494476|P1|STARTED|Overall Study||11
2641286|NCT02797613|6494482|P2|NOT COMPLETED|Overall Study||0
2641287|NCT02797613|6494483|P1|NOT COMPLETED|Overall Study||0
2641288|NCT02797613|6494482|P2|COMPLETED|Overall Study||55
2641289|NCT02797613|6494483|P1|COMPLETED|Overall Study||55
2641290|NCT02797613|6494482|P2|STARTED|Overall Study||55
2641291|NCT02797613|6494483|P1|STARTED|Overall Study||55
2641292|NCT02788175|6494489|P1|NOT COMPLETED|Overall Study||13
2641293|NCT02788175|6494489|P1|COMPLETED|Overall Study||13
2641294|NCT02788175|6494489|P1|Received Study Agent|Overall Study||20
2641295|NCT02788175|6494489|P1|STARTED|Overall Study||26
2641296|NCT02787863|6494502|P8|NOT COMPLETED|Overall Study||0
2641297|NCT02787863|6494503|P7|NOT COMPLETED|Overall Study||0
2641298|NCT02787863|6494504|P6|NOT COMPLETED|Overall Study||0
2641299|NCT02787863|6494505|P5|NOT COMPLETED|Overall Study||0
2641300|NCT02787863|6494506|P4|NOT COMPLETED|Overall Study||0
2641301|NCT02787863|6494507|P3|NOT COMPLETED|Overall Study||2
2641302|NCT02787863|6494508|P2|NOT COMPLETED|Overall Study||1
2641303|NCT02787863|6494509|P1|NOT COMPLETED|Overall Study||1
2641304|NCT02787863|6494502|P8|COMPLETED|Overall Study||27
2641305|NCT02787863|6494503|P7|COMPLETED|Overall Study||25
2641306|NCT02787863|6494504|P6|COMPLETED|Overall Study||18
2641307|NCT02787863|6494505|P5|COMPLETED|Overall Study||32
2641308|NCT02787863|6494506|P4|COMPLETED|Overall Study||25
2641309|NCT02787863|6494507|P3|COMPLETED|Overall Study||23
2641310|NCT02787863|6494508|P2|COMPLETED|Overall Study||33
2641311|NCT02787863|6494509|P1|COMPLETED|Overall Study||32
2641312|NCT02787863|6494502|P8|4 Years After Vaccination|Overall Study||27
2641313|NCT02787863|6494503|P7|4 Years After Vaccination|Overall Study||25
2641314|NCT02787863|6494504|P6|4 Years After Vaccination|Overall Study||18
2641315|NCT02787863|6494505|P5|4 Years After Vaccination|Overall Study||32
2641316|NCT02787863|6494506|P4|4 Years After Vaccination|Overall Study||25
2641317|NCT02787863|6494507|P3|4 Years After Vaccination|Overall Study||23
2641318|NCT02787863|6494508|P2|4 Years After Vaccination|Overall Study||33
2641319|NCT02787863|6494509|P1|4 Years After Vaccination|Overall Study||32
2641320|NCT02787863|6494502|P8|1 Year After Vaccination|Overall Study||27
2641321|NCT02787863|6494503|P7|1 Year After Vaccination|Overall Study||25
2641322|NCT02787863|6494504|P6|1 Year After Vaccination|Overall Study||18
2641323|NCT02787863|6494505|P5|1 Year After Vaccination|Overall Study||32
2641324|NCT02787863|6494506|P4|1 Year After Vaccination|Overall Study||25
2641325|NCT02787863|6494507|P3|1 Year After Vaccination|Overall Study||23
2641326|NCT02787863|6494508|P2|1 Year After Vaccination|Overall Study||33
2641327|NCT02787863|6494509|P1|1 Year After Vaccination|Overall Study||32
2641328|NCT02787863|6494502|P8|STARTED|Overall Study||27
2641329|NCT02787863|6494503|P7|STARTED|Overall Study||25
2641330|NCT02787863|6494504|P6|STARTED|Overall Study||18
2641331|NCT02787863|6494505|P5|STARTED|Overall Study||32
2641332|NCT02787863|6494506|P4|STARTED|Overall Study||25
2641333|NCT02787863|6494507|P3|STARTED|Overall Study||25
2641334|NCT02787863|6494508|P2|STARTED|Overall Study||34
2641335|NCT02787863|6494509|P1|STARTED|Overall Study||33
2641336|NCT02776904|6494571|P2|NOT COMPLETED|Overall Study||0
2641337|NCT02776904|6494572|P1|NOT COMPLETED|Overall Study||0
2641338|NCT02776904|6494571|P2|COMPLETED|Overall Study||46
2641339|NCT02776904|6494572|P1|COMPLETED|Overall Study||281
2641340|NCT02776904|6494571|P2|ImPACT|Overall Study|ImPACT testing for the concussed subjects was completed for the clinical assessment (not research).|46
2641341|NCT02776904|6494572|P1|ImPACT|Overall Study||21
2641342|NCT02776904|6494571|P2|Gait Assessment|Overall Study||32
2641343|NCT02776904|6494572|P1|Gait Assessment|Overall Study||178
2641344|NCT02776904|6494571|P2|STARTED|Overall Study||46
2641345|NCT02776904|6494572|P1|STARTED|Overall Study||281
2641346|NCT02774681|6494586|P1|NOT COMPLETED|Follow-Up for 3 Years||12
2641347|NCT02774681|6494586|P1|COMPLETED|Follow-Up for 3 Years||0
2641348|NCT02774681|6494586|P1|STARTED|Follow-Up for 3 Years||12
2641349|NCT02774681|6494586|P1|NOT COMPLETED|Treatment on Study||7
2641350|NCT02774681|6494586|P1|COMPLETED|Treatment on Study||5
2641351|NCT02774681|6494586|P1|Went on to Start Cycle 3|Treatment on Study||5
2641352|NCT02774681|6494586|P1|Reached 1st Response/2 Cycles|Treatment on Study||10
2641353|NCT02774681|6494586|P1|STARTED|Treatment on Study||12
2641354|NCT02768558|6494592|P2|NOT COMPLETED|Overall Study||0
2641355|NCT02768558|6494593|P1|NOT COMPLETED|Overall Study||0
2641356|NCT02768558|6494592|P2|COMPLETED|Overall Study||5
2641357|NCT02768558|6494593|P1|COMPLETED|Overall Study||3
2641358|NCT02768558|6494592|P2|Eligible|Overall Study||5
2641359|NCT02768558|6494593|P1|Eligible|Overall Study||3
2641360|NCT02768558|6494592|P2|STARTED|Overall Study||5
2641361|NCT02768558|6494593|P1|STARTED|Overall Study||3
2641362|NCT02755818|6494613|P4|NOT COMPLETED|Overall Study||3
2641363|NCT02755818|6494614|P3|NOT COMPLETED|Overall Study||1
2641364|NCT02755818|6494615|P2|NOT COMPLETED|Overall Study||0
2641365|NCT02755818|6494616|P1|NOT COMPLETED|Overall Study||0
2641366|NCT02755818|6494613|P4|COMPLETED|Overall Study||14
2641367|NCT02755818|6494614|P3|COMPLETED|Overall Study||1
2641368|NCT02755818|6494615|P2|COMPLETED|Overall Study||2
2641369|NCT02755818|6494616|P1|COMPLETED|Overall Study||30
2641370|NCT02755818|6494613|P4|STARTED|Overall Study||17
2641371|NCT02755818|6494614|P3|STARTED|Overall Study||2
2641372|NCT02755818|6494615|P2|STARTED|Overall Study||2
2641373|NCT02755818|6494616|P1|STARTED|Overall Study||30
2641374|NCT02725671|6494650|P1|NOT COMPLETED|Overall Study||1
2641375|NCT02725671|6494650|P1|COMPLETED|Overall Study||1
2641376|NCT02725671|6494650|P1|STARTED|Overall Study||2
2641377|NCT02709538|6494657|P3|NOT COMPLETED|Overall Study||20
2641378|NCT02709538|6494658|P2|NOT COMPLETED|Overall Study||28
2641379|NCT02709538|6494659|P1|NOT COMPLETED|Overall Study||113
2641380|NCT02709538|6494657|P3|COMPLETED|Overall Study||81
2641381|NCT02709538|6494658|P2|COMPLETED|Overall Study||72
2641382|NCT02709538|6494659|P1|COMPLETED|Overall Study||287
2641383|NCT02709538|6494657|P3|STARTED|Overall Study||101
2641384|NCT02709538|6494658|P2|STARTED|Overall Study||100
2641385|NCT02709538|6494659|P1|STARTED|Overall Study||400
2641386|NCT02706873|6494671|P4|NOT COMPLETED|Overall Study||33
2641387|NCT02706873|6494672|P3|NOT COMPLETED|Overall Study||27
2641388|NCT02706873|6494673|P2|NOT COMPLETED|Overall Study||4
2641389|NCT02706873|6494674|P1|NOT COMPLETED|Overall Study||47
2641390|NCT02706873|6494671|P4|COMPLETED|Overall Study||282
2641391|NCT02706873|6494672|P3|COMPLETED|Overall Study||290
2641392|NCT02706873|6494673|P2|COMPLETED|Overall Study||51
2641393|NCT02706873|6494674|P1|COMPLETED|Overall Study||268
2641394|NCT02706873|6494671|P4|Japan Sub-study|Overall Study||28
2641395|NCT02706873|6494672|P3|Japan Sub-study|Overall Study||27
2641396|NCT02706873|6494673|P2|Japan Sub-study|Overall Study||55
2641397|NCT02706873|6494674|P1|Japan Sub-study|Overall Study||28
2641398|NCT02706873|6494671|P4|Global Analysis Population|Overall Study|Includes 28 participants in the Japan sub-study|314
2641399|NCT02706873|6494672|P3|Global Analysis Population|Overall Study|Includes 27 participants in the Japan sub-study|317
2641400|NCT02706873|6494673|P2|Global Analysis Population|Overall Study||0
2641401|NCT02706873|6494674|P1|Global Analysis Population|Overall Study|Includes 28 participants in the Japan sub-study|314
2641402|NCT02706873|6494671|P4|Received Study Drug|Overall Study||314
2641403|NCT02706873|6494672|P3|Received Study Drug|Overall Study||317
2641404|NCT02706873|6494673|P2|Received Study Drug|Overall Study||55
2641405|NCT02706873|6494674|P1|Received Study Drug|Overall Study||314
2641406|NCT02706873|6494671|P4|STARTED|Overall Study||315
2641407|NCT02706873|6494672|P3|STARTED|Overall Study||317
2641408|NCT02706873|6494673|P2|STARTED|Overall Study||55
2641409|NCT02706873|6494674|P1|STARTED|Overall Study||315
2641410|NCT02706847|6494774|P4|NOT COMPLETED|Week 12 to Week 24||14
2641411|NCT02706847|6494775|P3|NOT COMPLETED|Week 12 to Week 24||4
2641412|NCT02706847|6494776|P2|NOT COMPLETED|Week 12 to Week 24||2
2641413|NCT02706847|6494777|P1|NOT COMPLETED|Week 12 to Week 24||3
2641414|NCT02706847|6494774|P4|COMPLETED|Week 12 to Week 24||135
2641415|NCT02706847|6494775|P3|COMPLETED|Week 12 to Week 24||153
2641416|NCT02706847|6494776|P2|COMPLETED|Week 12 to Week 24||74
2641417|NCT02706847|6494777|P1|COMPLETED|Week 12 to Week 24||72
2641418|NCT02706847|6494774|P4|Received Study Treatment|Week 12 to Week 24||148
2641419|NCT02706847|6494775|P3|Received Study Treatment|Week 12 to Week 24||156
2641420|NCT02706847|6494776|P2|Received Study Treatment|Week 12 to Week 24||75
2641421|NCT02706847|6494777|P1|Received Study Treatment|Week 12 to Week 24||72
2641422|NCT02706847|6494774|P4|STARTED|Week 12 to Week 24||149
2641423|NCT02706847|6494775|P3|STARTED|Week 12 to Week 24||157
2641424|NCT02706847|6494776|P2|STARTED|Week 12 to Week 24||76
2641425|NCT02706847|6494777|P1|STARTED|Week 12 to Week 24||75
2641426|NCT02706847|6494774|P4|NOT COMPLETED|Day 1 to Week 12||16
2641427|NCT02706847|6494775|P3|NOT COMPLETED|Day 1 to Week 12||8
2641428|NCT02706847|6494776|P2|NOT COMPLETED|Day 1 to Week 12||8
2641429|NCT02706847|6494777|P1|NOT COMPLETED|Day 1 to Week 12||10
2641430|NCT02706847|6494774|P4|COMPLETED|Day 1 to Week 12||149
2641431|NCT02706847|6494775|P3|COMPLETED|Day 1 to Week 12||157
2641432|NCT02706847|6494776|P2|COMPLETED|Day 1 to Week 12||76
2641433|NCT02706847|6494777|P1|COMPLETED|Day 1 to Week 12||75
2641434|NCT02706847|6494774|P4|Received Study Treatment|Day 1 to Week 12||165
2641435|NCT02706847|6494775|P3|Received Study Treatment|Day 1 to Week 12||164
2641436|NCT02706847|6494776|P2|Received Study Treatment|Day 1 to Week 12||84
2641437|NCT02706847|6494777|P1|Received Study Treatment|Day 1 to Week 12||85
2641438|NCT02706847|6494774|P4|STARTED|Day 1 to Week 12||165
2641439|NCT02706847|6494775|P3|STARTED|Day 1 to Week 12||165
2641440|NCT02706847|6494776|P2|STARTED|Day 1 to Week 12||84
2641441|NCT02706847|6494777|P1|STARTED|Day 1 to Week 12||85
2641442|NCT02705352|6494810|P2|NOT COMPLETED|Overall Study||0
2641443|NCT02705352|6494811|P1|NOT COMPLETED|Overall Study||0
2641444|NCT02705352|6494810|P2|COMPLETED|Overall Study||0
2641445|NCT02705352|6494811|P1|COMPLETED|Overall Study||1
2641446|NCT02705352|6494810|P2|STARTED|Overall Study||0
2641447|NCT02705352|6494811|P1|STARTED|Overall Study||1
2641448|NCT02693834|6494823|P2|NOT COMPLETED|Week 2 Practice||1
2641449|NCT02693834|6494824|P1|NOT COMPLETED|Week 2 Practice||0
2641450|NCT02693834|6494823|P2|COMPLETED|Week 2 Practice||10
2641451|NCT02693834|6494824|P1|COMPLETED|Week 2 Practice||10
2641452|NCT02693834|6494823|P2|STARTED|Week 2 Practice||11
2641453|NCT02693834|6494824|P1|STARTED|Week 2 Practice||10
2641454|NCT02693834|6494823|P2|NOT COMPLETED|Week 1 Practice||0
2641455|NCT02693834|6494824|P1|NOT COMPLETED|Week 1 Practice||0
2641456|NCT02693834|6494823|P2|COMPLETED|Week 1 Practice||11
2641457|NCT02693834|6494824|P1|COMPLETED|Week 1 Practice||10
2641458|NCT02693834|6494823|P2|STARTED|Week 1 Practice|During the first week of practice, 11 participants were assigned to DAAFO group|11
2641459|NCT02693834|6494824|P1|STARTED|Week 1 Practice|During the first week of practice, 10 participants were assigned to PLS AFO group|10
2641460|NCT02693834|6494823|P2|NOT COMPLETED|Baseline Measurement||0
2641461|NCT02693834|6494824|P1|NOT COMPLETED|Baseline Measurement||2
2641462|NCT02693834|6494823|P2|COMPLETED|Baseline Measurement|10 particiapnts completed wearing DA AFO during the first week and 10 the second week (1 was lost)|11
2641463|NCT02693834|6494824|P1|COMPLETED|Baseline Measurement|10 particiapnts completed wearing PLS AFO during the first week and 10 during the second week|10
2641464|NCT02693834|6494823|P2|STARTED|Baseline Measurement|11 participants were assigned to DA AFO first group|11
2641465|NCT02693834|6494824|P1|STARTED|Baseline Measurement|10 were randomized to PLS AFO first week group (2 dropped out at baseline)|12
2641466|NCT02692716|6494834|P2|NOT COMPLETED|Overall Study||6
2641467|NCT02692716|6494835|P1|NOT COMPLETED|Overall Study||5
2641468|NCT02692716|6494834|P2|COMPLETED|Overall Study||1586
2641469|NCT02692716|6494835|P1|COMPLETED|Overall Study||1586
2641470|NCT02692716|6494834|P2|Exposed|Overall Study||1591
2641471|NCT02692716|6494835|P1|Exposed|Overall Study||1591
2641472|NCT02692716|6494834|P2|Full Analysis Set (FAS)|Overall Study||1592
2641473|NCT02692716|6494835|P1|Full Analysis Set (FAS)|Overall Study||1591
2641474|NCT02692716|6494834|P2|STARTED|Overall Study||1592
2641475|NCT02692716|6494835|P1|STARTED|Overall Study||1591
2641476|NCT02689206|6494880|P5|NOT COMPLETED|Overall Study||8
2641477|NCT02689206|6494881|P4|NOT COMPLETED|Overall Study||4
2641478|NCT02689206|6494882|P3|NOT COMPLETED|Overall Study||4
2641479|NCT02689206|6494883|P2|NOT COMPLETED|Overall Study||1
2641480|NCT02689206|6494884|P1|NOT COMPLETED|Overall Study||3
2641481|NCT02689206|6494880|P5|COMPLETED|Overall Study||14
2641482|NCT02689206|6494881|P4|COMPLETED|Overall Study||17
2641483|NCT02689206|6494882|P3|COMPLETED|Overall Study||16
2641484|NCT02689206|6494883|P2|COMPLETED|Overall Study||19
2641485|NCT02689206|6494884|P1|COMPLETED|Overall Study||17
2641486|NCT02689206|6494880|P5|STARTED|Overall Study||22
2641487|NCT02689206|6494881|P4|STARTED|Overall Study||21
2641488|NCT02689206|6494882|P3|STARTED|Overall Study||20
2641489|NCT02689206|6494883|P2|STARTED|Overall Study||20
2641490|NCT02689206|6494884|P1|STARTED|Overall Study||20
2641491|NCT02688868|6495088|P1|NOT COMPLETED|Overall Study||4
2641492|NCT02688868|6495088|P1|COMPLETED|Overall Study||34
2641493|NCT02688868|6495088|P1|STARTED|Overall Study||38
2641494|NCT02688842|6495100|P1|NOT COMPLETED|Overall Study||0
2641495|NCT02688842|6495100|P1|COMPLETED|Overall Study||38
2641496|NCT02688842|6495100|P1|STARTED|Overall Study||38
2641497|NCT02682069|6495117|P1|NOT COMPLETED|Overall Study||0
2641498|NCT02682069|6495117|P1|COMPLETED|Overall Study||30
2641499|NCT02682069|6495117|P1|STARTED|Overall Study||30
2641500|NCT02680756|6495123|P2|NOT COMPLETED|Overall Study||19
2641501|NCT02680756|6495124|P1|NOT COMPLETED|Overall Study||32
2641502|NCT02680756|6495123|P2|COMPLETED|Overall Study||106
2641503|NCT02680756|6495124|P1|COMPLETED|Overall Study||93
2641504|NCT02680756|6495123|P2|Recieved Treatment|Overall Study||120
2641505|NCT02680756|6495124|P1|Recieved Treatment|Overall Study||127
2641506|NCT02680756|6495123|P2|STARTED|Overall Study||125
2641507|NCT02680756|6495124|P1|STARTED|Overall Study||125
2641508|NCT02679573|6495158|P2|NOT COMPLETED|Overall Study||39
2641509|NCT02679573|6495159|P1|NOT COMPLETED|Overall Study||37
2641510|NCT02679573|6495158|P2|COMPLETED|Overall Study||389
2641511|NCT02679573|6495159|P1|COMPLETED|Overall Study||394
2641512|NCT02679573|6495158|P2|STARTED|Overall Study||428
2641513|NCT02679573|6495159|P1|STARTED|Overall Study||431
2641514|NCT02672033|6495175|P1|NOT COMPLETED|Overall Study||0
2641515|NCT02672033|6495175|P1|COMPLETED|Overall Study||2
2641516|NCT02672033|6495175|P1|STARTED|Overall Study||2
2641517|NCT02650856|6495187|P2|NOT COMPLETED|Overall Study||0
2641518|NCT02650856|6495188|P1|NOT COMPLETED|Overall Study||0
2641519|NCT02650856|6495187|P2|COMPLETED|Overall Study||21
2641520|NCT02650856|6495188|P1|COMPLETED|Overall Study||19
2641521|NCT02650856|6495187|P2|72 Hours|Overall Study||21
2641522|NCT02650856|6495188|P1|72 Hours|Overall Study||19
2641523|NCT02650856|6495187|P2|48 Hours|Overall Study||21
2641524|NCT02650856|6495188|P1|48 Hours|Overall Study||19
2641525|NCT02650856|6495187|P2|24 Hours|Overall Study||21
2641526|NCT02650856|6495188|P1|24 Hours|Overall Study||19
2641527|NCT02650856|6495187|P2|Baseline|Overall Study||21
2641528|NCT02650856|6495188|P1|Baseline|Overall Study||19
2641529|NCT02650856|6495187|P2|STARTED|Overall Study||21
2641530|NCT02650856|6495188|P1|STARTED|Overall Study||19
2641531|NCT02647346|6495198|P1|NOT COMPLETED|Overall Study||3
2641532|NCT02647346|6495198|P1|COMPLETED|Overall Study||129
2641533|NCT02647346|6495198|P1|STARTED|Overall Study||132
2641534|NCT02645409|6495207|P2|NOT COMPLETED|Overall Study||0
2641535|NCT02645409|6495208|P1|NOT COMPLETED|Overall Study||4
2641536|NCT02645409|6495207|P2|COMPLETED|Overall Study||0
2641537|NCT02645409|6495208|P1|COMPLETED|Overall Study||10
2641538|NCT02645409|6495207|P2|STARTED|Overall Study|It was decided to not continue with the Radical Nephrectomy arm of the study.|0
2641539|NCT02645409|6495208|P1|STARTED|Overall Study||14
2641540|NCT02638103|6495217|P4|NOT COMPLETED|Overall Study||142
2641541|NCT02638103|6495218|P3|NOT COMPLETED|Overall Study||85
2641542|NCT02638103|6495219|P2|NOT COMPLETED|Overall Study||118
2641543|NCT02638103|6495220|P1|NOT COMPLETED|Overall Study||106
2641544|NCT02638103|6495217|P4|COMPLETED|Overall Study||383
2641545|NCT02638103|6495218|P3|COMPLETED|Overall Study||335
2641546|NCT02638103|6495219|P2|COMPLETED|Overall Study||408
2641547|NCT02638103|6495220|P1|COMPLETED|Overall Study||313
2641548|NCT02638103|6495217|P4|Full Analysis Set (FAS)|Overall Study||523
2641549|NCT02638103|6495218|P3|Full Analysis Set (FAS)|Overall Study||419
2641550|NCT02638103|6495219|P2|Full Analysis Set (FAS)|Overall Study||520
2641551|NCT02638103|6495220|P1|Full Analysis Set (FAS)|Overall Study||416
2641552|NCT02638103|6495217|P4|Safety Analysis Set|Overall Study||525
2641553|NCT02638103|6495218|P3|Safety Analysis Set|Overall Study||419
2641554|NCT02638103|6495219|P2|Safety Analysis Set|Overall Study||526
2641555|NCT02638103|6495220|P1|Safety Analysis Set|Overall Study||418
2641556|NCT02638103|6495217|P4|STARTED|Overall Study||525
2641557|NCT02638103|6495218|P3|STARTED|Overall Study||420
2641558|NCT02638103|6495219|P2|STARTED|Overall Study||526
2641559|NCT02638103|6495220|P1|STARTED|Overall Study||419
2641560|NCT02628964|6495296|P2|NOT COMPLETED|Overall Study||1
2641561|NCT02628964|6495297|P1|NOT COMPLETED|Overall Study||0
2641562|NCT02628964|6495296|P2|COMPLETED|Overall Study||49
2641563|NCT02628964|6495297|P1|COMPLETED|Overall Study||50
2641564|NCT02628964|6495296|P2|STARTED|Overall Study||50
2641565|NCT02628964|6495297|P1|STARTED|Overall Study||50
2641566|NCT02627963|6495317|P2|NOT COMPLETED|Overall Study||14
2641567|NCT02627963|6495318|P1|NOT COMPLETED|Overall Study||36
2641568|NCT02627963|6495317|P2|COMPLETED|Overall Study||161
2641569|NCT02627963|6495318|P1|COMPLETED|Overall Study||139
2641570|NCT02627963|6495317|P2|STARTED|Overall Study||175
2641571|NCT02627963|6495318|P1|STARTED|Overall Study||175
2641572|NCT02607865|6495332|P4|NOT COMPLETED|Overall Study||16
2641573|NCT02607865|6495333|P3|NOT COMPLETED|Overall Study||27
2641574|NCT02607865|6495334|P2|NOT COMPLETED|Overall Study||30
2641575|NCT02607865|6495335|P1|NOT COMPLETED|Overall Study||33
2641576|NCT02607865|6495332|P4|COMPLETED|Overall Study||451
2641577|NCT02607865|6495333|P3|COMPLETED|Overall Study||438
2641578|NCT02607865|6495334|P2|COMPLETED|Overall Study||436
2641579|NCT02607865|6495335|P1|COMPLETED|Overall Study||433
2641580|NCT02607865|6495332|P4|Safety Analysis Set (SAS)|Overall Study||466
2641581|NCT02607865|6495333|P3|Safety Analysis Set (SAS)|Overall Study||465
2641582|NCT02607865|6495334|P2|Safety Analysis Set (SAS)|Overall Study||464
2641583|NCT02607865|6495335|P1|Safety Analysis Set (SAS)|Overall Study||466
2641584|NCT02607865|6495332|P4|Full Analysis Set (FAS)|Overall Study||467
2641585|NCT02607865|6495333|P3|Full Analysis Set (FAS)|Overall Study||465
2641586|NCT02607865|6495334|P2|Full Analysis Set (FAS)|Overall Study||465
2641587|NCT02607865|6495335|P1|Full Analysis Set (FAS)|Overall Study||466
2641588|NCT02607865|6495332|P4|STARTED|Overall Study||467
2641589|NCT02607865|6495333|P3|STARTED|Overall Study||465
2641590|NCT02607865|6495334|P2|STARTED|Overall Study||466
2641591|NCT02607865|6495335|P1|STARTED|Overall Study||466
2641592|NCT02607306|6495510|P3|NOT COMPLETED|Overall Study||10
2641593|NCT02607306|6495511|P2|NOT COMPLETED|Overall Study||23
2641594|NCT02607306|6495512|P1|NOT COMPLETED|Overall Study||21
2641595|NCT02607306|6495510|P3|COMPLETED|Overall Study||263
2641596|NCT02607306|6495511|P2|COMPLETED|Overall Study||248
2641597|NCT02607306|6495512|P1|COMPLETED|Overall Study||254
2641598|NCT02607306|6495510|P3|STARTED|Overall Study||273
2641599|NCT02607306|6495511|P2|STARTED|Overall Study||271
2641600|NCT02607306|6495512|P1|STARTED|Overall Study||275
2641601|NCT02592434|6495632|P3|NOT COMPLETED|Double Blind Phase (26 Weeks)||47
2641602|NCT02592434|6495633|P2|NOT COMPLETED|Double Blind Phase (26 Weeks)||27
2641603|NCT02592434|6495634|P1|NOT COMPLETED|Double Blind Phase (26 Weeks)||0
2641604|NCT02592434|6495632|P3|COMPLETED|Double Blind Phase (26 Weeks)||38
2641605|NCT02592434|6495633|P2|COMPLETED|Double Blind Phase (26 Weeks)||61
2641606|NCT02592434|6495634|P1|COMPLETED|Double Blind Phase (26 Weeks)||0
2641607|NCT02592434|6495632|P3|Treated|Double Blind Phase (26 Weeks)||85
2641608|NCT02592434|6495633|P2|Treated|Double Blind Phase (26 Weeks)||88
2641609|NCT02592434|6495634|P1|Treated|Double Blind Phase (26 Weeks)||0
2641610|NCT02592434|6495632|P3|STARTED|Double Blind Phase (26 Weeks)|Only those participants who completed OL phase,achieved at least a JIA ACR 30 response in OL phase.|85
2641611|NCT02592434|6495633|P2|STARTED|Double Blind Phase (26 Weeks)|Only those participants who completed OL phase, achieved at least a JIA ACR 30 response in OL phase.|88
2641612|NCT02592434|6495634|P1|STARTED|Double Blind Phase (26 Weeks)||0
2641613|NCT02592434|6495632|P3|NOT COMPLETED|Open-Label Phase (18 Weeks)||0
2641614|NCT02592434|6495633|P2|NOT COMPLETED|Open-Label Phase (18 Weeks)||0
2641615|NCT02592434|6495634|P1|NOT COMPLETED|Open-Label Phase (18 Weeks)||40
2641616|NCT02592434|6495632|P3|COMPLETED|Open-Label Phase (18 Weeks)||0
2641617|NCT02592434|6495633|P2|COMPLETED|Open-Label Phase (18 Weeks)||0
2641618|NCT02592434|6495634|P1|COMPLETED|Open-Label Phase (18 Weeks)||185
2641619|NCT02592434|6495632|P3|Treated|Open-Label Phase (18 Weeks)||0
2641620|NCT02592434|6495633|P2|Treated|Open-Label Phase (18 Weeks)||0
2641621|NCT02592434|6495634|P1|Treated|Open-Label Phase (18 Weeks)||225
2641622|NCT02592434|6495632|P3|STARTED|Open-Label Phase (18 Weeks)||0
2641623|NCT02592434|6495633|P2|STARTED|Open-Label Phase (18 Weeks)||0
2641624|NCT02592434|6495634|P1|STARTED|Open-Label Phase (18 Weeks)||225
2641625|NCT02588092|6495760|P10|NOT COMPLETED|Overall Study||3
2641626|NCT02588092|6495761|P9|NOT COMPLETED|Overall Study||6
2641627|NCT02588092|6495762|P8|NOT COMPLETED|Overall Study||4
2641628|NCT02588092|6495763|P7|NOT COMPLETED|Overall Study||3
2641629|NCT02588092|6495764|P6|NOT COMPLETED|Overall Study||3
2641630|NCT02588092|6495765|P5|NOT COMPLETED|Overall Study||3
2641631|NCT02588092|6495766|P4|NOT COMPLETED|Overall Study||3
2641632|NCT02588092|6495767|P3|NOT COMPLETED|Overall Study||3
2641633|NCT02588092|6495768|P2|NOT COMPLETED|Overall Study||3
2641634|NCT02588092|6495769|P1|NOT COMPLETED|Overall Study||4
2641635|NCT02588092|6495760|P10|COMPLETED|Overall Study||0
2641636|NCT02588092|6495761|P9|COMPLETED|Overall Study||0
2641637|NCT02588092|6495762|P8|COMPLETED|Overall Study||0
2641638|NCT02588092|6495763|P7|COMPLETED|Overall Study||0
2641639|NCT02588092|6495764|P6|COMPLETED|Overall Study||0
2641640|NCT02588092|6495765|P5|COMPLETED|Overall Study||0
2641641|NCT02588092|6495766|P4|COMPLETED|Overall Study||0
2641642|NCT02588092|6495767|P3|COMPLETED|Overall Study||0
2641643|NCT02588092|6495768|P2|COMPLETED|Overall Study||0
2641644|NCT02588092|6495769|P1|COMPLETED|Overall Study||0
2641645|NCT02588092|6495760|P10|STARTED|Overall Study||3
2641646|NCT02588092|6495761|P9|STARTED|Overall Study||6
2641647|NCT02588092|6495762|P8|STARTED|Overall Study||4
2641648|NCT02588092|6495763|P7|STARTED|Overall Study||3
2641649|NCT02588092|6495764|P6|STARTED|Overall Study||3
2641650|NCT02588092|6495765|P5|STARTED|Overall Study||3
2641651|NCT02588092|6495766|P4|STARTED|Overall Study||3
2641652|NCT02588092|6495767|P3|STARTED|Overall Study||3
2641653|NCT02588092|6495768|P2|STARTED|Overall Study||3
2641654|NCT02588092|6495769|P1|STARTED|Overall Study||4
2641655|NCT02579759|6495966|P3|NOT COMPLETED|Overall Study||21
2641656|NCT02579759|6495967|P2|NOT COMPLETED|Overall Study||64
2641657|NCT02579759|6495968|P1|NOT COMPLETED|Overall Study||24
2641658|NCT02579759|6495966|P3|COMPLETED|Overall Study||80
2641659|NCT02579759|6495967|P2|COMPLETED|Overall Study||49
2641660|NCT02579759|6495968|P1|COMPLETED|Overall Study||85
2641661|NCT02579759|6495966|P3|STARTED|Overall Study||101
2641662|NCT02579759|6495967|P2|STARTED|Overall Study||113
2641663|NCT02579759|6495968|P1|STARTED|Overall Study||109
2641664|NCT02576678|6496015|P3|NOT COMPLETED|Overall Study||5
2641665|NCT02576678|6496016|P2|NOT COMPLETED|Overall Study||1
2641666|NCT02576678|6496017|P1|NOT COMPLETED|Overall Study||5
2641667|NCT02576678|6496015|P3|COMPLETED|Overall Study||16
2641668|NCT02576678|6496016|P2|COMPLETED|Overall Study||7
2641669|NCT02576678|6496017|P1|COMPLETED|Overall Study||8
2641670|NCT02576678|6496015|P3|Pharmacokinetic (PK) Population|Overall Study||18
2641671|NCT02576678|6496016|P2|Pharmacokinetic (PK) Population|Overall Study||8
2641672|NCT02576678|6496017|P1|Pharmacokinetic (PK) Population|Overall Study||12
2641673|NCT02576678|6496015|P3|STARTED|Overall Study||21
2641674|NCT02576678|6496016|P2|STARTED|Overall Study||8
2641675|NCT02576678|6496017|P1|STARTED|Overall Study||13
2641676|NCT02552966|6496049|P1|NOT COMPLETED|Overall Study||5
2641677|NCT02552966|6496049|P1|COMPLETED|Overall Study||15
2641678|NCT02552966|6496049|P1|STARTED|Overall Study||20
2641679|NCT02550652|6496058|P2|NOT COMPLETED|Overall Study||62
2641680|NCT02550652|6496059|P1|NOT COMPLETED|Overall Study||63
2641681|NCT02550652|6496058|P2|COMPLETED|Overall Study||0
2641682|NCT02550652|6496059|P1|COMPLETED|Overall Study||0
2641683|NCT02550652|6496058|P2|STARTED|Overall Study||62
2641684|NCT02550652|6496059|P1|STARTED|Overall Study||63
2641685|NCT02550106|6496101|P1|NOT COMPLETED|Overall Study||12
2641686|NCT02550106|6496101|P1|COMPLETED|Overall Study||124
2641687|NCT02550106|6496101|P1|STARTED|Overall Study||136
2641688|NCT02541604|6496137|P12|NOT COMPLETED|Overall Study||3
2641689|NCT02541604|6496138|P11|NOT COMPLETED|Overall Study||2
2641690|NCT02541604|6496139|P10|NOT COMPLETED|Overall Study||4
2641691|NCT02541604|6496140|P9|NOT COMPLETED|Overall Study||4
2641692|NCT02541604|6496141|P8|NOT COMPLETED|Overall Study||10
2641693|NCT02541604|6496142|P7|NOT COMPLETED|Overall Study||10
2641694|NCT02541604|6496143|P6|NOT COMPLETED|Overall Study||10
2641695|NCT02541604|6496144|P5|NOT COMPLETED|Overall Study||10
2641696|NCT02541604|6496145|P4|NOT COMPLETED|Overall Study||3
2641697|NCT02541604|6496146|P3|NOT COMPLETED|Overall Study||11
2641698|NCT02541604|6496147|P2|NOT COMPLETED|Overall Study||9
2641699|NCT02541604|6496148|P1|NOT COMPLETED|Overall Study||11
2641700|NCT02541604|6496137|P12|COMPLETED|Overall Study||0
2641701|NCT02541604|6496138|P11|COMPLETED|Overall Study||0
2641702|NCT02541604|6496139|P10|COMPLETED|Overall Study||0
2641703|NCT02541604|6496140|P9|COMPLETED|Overall Study||0
2641704|NCT02541604|6496141|P8|COMPLETED|Overall Study||0
2641705|NCT02541604|6496142|P7|COMPLETED|Overall Study||0
2641706|NCT02541604|6496143|P6|COMPLETED|Overall Study||0
2641707|NCT02541604|6496144|P5|COMPLETED|Overall Study||0
2641708|NCT02541604|6496145|P4|COMPLETED|Overall Study||0
2641709|NCT02541604|6496146|P3|COMPLETED|Overall Study||0
2641710|NCT02541604|6496147|P2|COMPLETED|Overall Study||0
2641711|NCT02541604|6496148|P1|COMPLETED|Overall Study||0
2641712|NCT02541604|6496137|P12|STARTED|Overall Study||3
2641713|NCT02541604|6496138|P11|STARTED|Overall Study||2
2641714|NCT02541604|6496139|P10|STARTED|Overall Study||4
2641715|NCT02541604|6496140|P9|STARTED|Overall Study||4
2641716|NCT02541604|6496141|P8|STARTED|Overall Study||10
2641717|NCT02541604|6496142|P7|STARTED|Overall Study||10
2641718|NCT02541604|6496143|P6|STARTED|Overall Study||10
2641719|NCT02541604|6496144|P5|STARTED|Overall Study||10
2641720|NCT02541604|6496145|P4|STARTED|Overall Study||3
2641721|NCT02541604|6496146|P3|STARTED|Overall Study||11
2641722|NCT02541604|6496147|P2|STARTED|Overall Study||9
2641723|NCT02541604|6496148|P1|STARTED|Overall Study||11
2641724|NCT02539225|6496255|P2|NOT COMPLETED|Part B||16
2641725|NCT02539225|6496256|P1|NOT COMPLETED|Part B||4
2641726|NCT02539225|6496255|P2|COMPLETED|Part B||48
2641727|NCT02539225|6496256|P1|COMPLETED|Part B||54
2641728|NCT02539225|6496255|P2|STARTED|Part B||64
2641729|NCT02539225|6496256|P1|STARTED|Part B||58
2641730|NCT02539225|6496255|P2|NOT COMPLETED|Pre Treatment for Part B||2
2641731|NCT02539225|6496256|P1|NOT COMPLETED|Pre Treatment for Part B||5
2641732|NCT02539225|6496255|P2|COMPLETED|Pre Treatment for Part B||64
2641733|NCT02539225|6496256|P1|COMPLETED|Pre Treatment for Part B||58
2641734|NCT02539225|6496255|P2|STARTED|Pre Treatment for Part B|Participants who met initiation criteria of Part B were allowed to pretreatment for part B.|66
2641735|NCT02539225|6496256|P1|STARTED|Pre Treatment for Part B|Participants who met initiation criteria of Part B were allowed to pretreatment for part B.|63
2641736|NCT02539225|6496255|P2|NOT COMPLETED|Part A||16
2641737|NCT02539225|6496256|P1|NOT COMPLETED|Part A||20
2641738|NCT02539225|6496255|P2|COMPLETED|Part A||78
2641739|NCT02539225|6496256|P1|COMPLETED|Part A||77
2641740|NCT02539225|6496255|P2|Received Any Quantity of Study Drug|Part A||93
2641741|NCT02539225|6496256|P1|Received Any Quantity of Study Drug|Part A||96
2641742|NCT02539225|6496255|P2|STARTED|Part A||94
2641743|NCT02539225|6496256|P1|STARTED|Part A||97
2641744|NCT02538666|6496280|P3|NOT COMPLETED|Overall Study||1
2641745|NCT02538666|6496281|P2|NOT COMPLETED|Overall Study||1
2641746|NCT02538666|6496282|P1|NOT COMPLETED|Overall Study||2
2641747|NCT02538666|6496280|P3|COMPLETED|Overall Study||278
2641748|NCT02538666|6496281|P2|COMPLETED|Overall Study||279
2641749|NCT02538666|6496282|P1|COMPLETED|Overall Study||273
2641750|NCT02538666|6496280|P3|STARTED|Overall Study||279
2641751|NCT02538666|6496281|P2|STARTED|Overall Study||280
2641752|NCT02538666|6496282|P1|STARTED|Overall Study||275
2641753|NCT02532374|6496301|P1|NOT COMPLETED|Overall Study||2
2641754|NCT02532374|6496301|P1|COMPLETED|Overall Study||14
2641755|NCT02532374|6496301|P1|P3L150 μg/Puff (Visit 6)|Overall Study||14
2641756|NCT02532374|6496301|P1|P3L 80 μg/Puff (Visit 5)|Overall Study||14
2641757|NCT02532374|6496301|P1|P3L 50 μg/Puff (Visit 4)|Overall Study||15
2641758|NCT02532374|6496301|P1|Nicorette Inhalator (Visit 3)|Overall Study||15
2641759|NCT02532374|6496301|P1|STARTED|Overall Study||16
2641760|NCT02528253|6496330|P5|NOT COMPLETED|Overall Study||223
2641761|NCT02528253|6496331|P4|NOT COMPLETED|Overall Study||136
2641762|NCT02528253|6496332|P3|NOT COMPLETED|Overall Study||140
2641763|NCT02528253|6496333|P2|NOT COMPLETED|Overall Study||70
2641764|NCT02528253|6496334|P1|NOT COMPLETED|Overall Study||75
2641765|NCT02528253|6496330|P5|COMPLETED|Overall Study||379
2641766|NCT02528253|6496331|P4|COMPLETED|Overall Study||271
2641767|NCT02528253|6496332|P3|COMPLETED|Overall Study||267
2641768|NCT02528253|6496333|P2|COMPLETED|Overall Study||134
2641769|NCT02528253|6496334|P1|COMPLETED|Overall Study||130
2641770|NCT02528253|6496330|P5|Treated at Week 16|Overall Study||307
2641771|NCT02528253|6496331|P4|Treated at Week 16|Overall Study||242
2641772|NCT02528253|6496332|P3|Treated at Week 16|Overall Study||236
2641773|NCT02528253|6496333|P2|Treated at Week 16|Overall Study||95
2641774|NCT02528253|6496334|P1|Treated at Week 16|Overall Study||99
2641775|NCT02528253|6496330|P5|Intent to Treat Population|Overall Study|3 participants randomized to placebo arm received tramadol during the course of study|605
2641776|NCT02528253|6496331|P4|Intent to Treat Population|Overall Study||407
2641777|NCT02528253|6496332|P3|Intent to Treat Population|Overall Study||407
2641778|NCT02528253|6496333|P2|Intent to Treat Population|Overall Study||204
2641779|NCT02528253|6496334|P1|Intent to Treat Population|Overall Study||202
2641780|NCT02528253|6496330|P5|STARTED|Overall Study||602
2641781|NCT02528253|6496331|P4|STARTED|Overall Study||407
2641782|NCT02528253|6496332|P3|STARTED|Overall Study||407
2641783|NCT02528253|6496333|P2|STARTED|Overall Study||204
2641784|NCT02528253|6496334|P1|STARTED|Overall Study||205
2641785|NCT02525523|6496627|P2|NOT COMPLETED|Overall Study||25
2641786|NCT02525523|6496628|P1|NOT COMPLETED|Overall Study||23
2641787|NCT02525523|6496627|P2|COMPLETED|Overall Study||44
2641788|NCT02525523|6496628|P1|COMPLETED|Overall Study||46
2641789|NCT02525523|6496627|P2|STARTED|Overall Study||69
2641790|NCT02525523|6496628|P1|STARTED|Overall Study||69
2641791|NCT02510664|6496639|P3|NOT COMPLETED|Overall Study||0
2641792|NCT02510664|6496640|P2|NOT COMPLETED|Overall Study||20
2641793|NCT02510664|6496641|P1|NOT COMPLETED|Overall Study||20
2641794|NCT02510664|6496639|P3|COMPLETED|Overall Study||4
2641795|NCT02510664|6496640|P2|COMPLETED|Overall Study||64
2641796|NCT02510664|6496641|P1|COMPLETED|Overall Study||64
2641797|NCT02510664|6496639|P3|STARTED|Overall Study||4
2641798|NCT02510664|6496640|P2|STARTED|Overall Study||84
2641799|NCT02510664|6496641|P1|STARTED|Overall Study||84
2641800|NCT02493608|6496672|P2|NOT COMPLETED|Overall Study||0
2641801|NCT02493608|6496673|P1|NOT COMPLETED|Overall Study||0
2641802|NCT02493608|6496672|P2|COMPLETED|Overall Study||48
2641803|NCT02493608|6496673|P1|COMPLETED|Overall Study||48
2641804|NCT02493608|6496672|P2|STARTED|Overall Study||48
2641805|NCT02493608|6496673|P1|STARTED|Overall Study||48
2641806|NCT02490631|6496685|P2|NOT COMPLETED|Overall Study||0
2641807|NCT02490631|6496686|P1|NOT COMPLETED|Overall Study||0
2641808|NCT02490631|6496685|P2|COMPLETED|Overall Study||75
2641809|NCT02490631|6496686|P1|COMPLETED|Overall Study||76
2641810|NCT02490631|6496685|P2|STARTED|Overall Study||75
2641811|NCT02490631|6496686|P1|STARTED|Overall Study||76
2641812|NCT02473965|6496696|P2|NOT COMPLETED|Overall Study||10
2641813|NCT02473965|6496697|P1|NOT COMPLETED|Overall Study||12
2641814|NCT02473965|6496696|P2|COMPLETED|Overall Study||20
2641815|NCT02473965|6496697|P1|COMPLETED|Overall Study||18
2641816|NCT02473965|6496696|P2|STARTED|Overall Study||30
2641817|NCT02473965|6496697|P1|STARTED|Overall Study||30
2641818|NCT02472795|6496712|P5|NOT COMPLETED|Overall Study||3
2641819|NCT02472795|6496713|P4|NOT COMPLETED|Overall Study||0
2641820|NCT02472795|6496714|P3|NOT COMPLETED|Overall Study||0
2641821|NCT02472795|6496715|P2|NOT COMPLETED|Overall Study||1
2641822|NCT02472795|6496716|P1|NOT COMPLETED|Overall Study||0
2641823|NCT02472795|6496712|P5|COMPLETED|Overall Study||14
2641824|NCT02472795|6496713|P4|COMPLETED|Overall Study||13
2641825|NCT02472795|6496714|P3|COMPLETED|Overall Study||13
2641826|NCT02472795|6496715|P2|COMPLETED|Overall Study||11
2641827|NCT02472795|6496716|P1|COMPLETED|Overall Study||12
2641828|NCT02472795|6496712|P5|Modified Pharmacodynamic Analysis Set|Overall Study||16
2641829|NCT02472795|6496713|P4|Modified Pharmacodynamic Analysis Set|Overall Study||9
2641830|NCT02472795|6496714|P3|Modified Pharmacodynamic Analysis Set|Overall Study||13
2641831|NCT02472795|6496715|P2|Modified Pharmacodynamic Analysis Set|Overall Study||10
2641832|NCT02472795|6496716|P1|Modified Pharmacodynamic Analysis Set|Overall Study||12
2641833|NCT02472795|6496712|P5|Pharmacodynamic Set|Overall Study||16
2641834|NCT02472795|6496713|P4|Pharmacodynamic Set|Overall Study||13
2641835|NCT02472795|6496714|P3|Pharmacodynamic Set|Overall Study||13
2641836|NCT02472795|6496715|P2|Pharmacodynamic Set|Overall Study||10
2641837|NCT02472795|6496716|P1|Pharmacodynamic Set|Overall Study||12
2641838|NCT02472795|6496712|P5|STARTED|Overall Study||17
2641839|NCT02472795|6496713|P4|STARTED|Overall Study||13
2641840|NCT02472795|6496714|P3|STARTED|Overall Study||13
2641841|NCT02472795|6496715|P2|STARTED|Overall Study||12
2641842|NCT02472795|6496716|P1|STARTED|Overall Study||12
2641843|NCT02438384|6496751|P3|NOT COMPLETED|Overall Study||4
2641844|NCT02438384|6496752|P2|NOT COMPLETED|Overall Study||6
2641845|NCT02438384|6496753|P1|NOT COMPLETED|Overall Study||8
2641846|NCT02438384|6496751|P3|COMPLETED|Overall Study||21
2641847|NCT02438384|6496752|P2|COMPLETED|Overall Study||19
2641848|NCT02438384|6496753|P1|COMPLETED|Overall Study||17
2641849|NCT02438384|6496751|P3|STARTED|Overall Study||25
2641850|NCT02438384|6496752|P2|STARTED|Overall Study||25
2641851|NCT02438384|6496753|P1|STARTED|Overall Study||25
2641852|NCT02431494|6496773|P3|NOT COMPLETED|Overall Study||0
2641853|NCT02431494|6496774|P2|NOT COMPLETED|Overall Study||0
2641854|NCT02431494|6496775|P1|NOT COMPLETED|Overall Study||0
2641855|NCT02431494|6496773|P3|COMPLETED|Overall Study||0
2641856|NCT02431494|6496774|P2|COMPLETED|Overall Study||0
2641857|NCT02431494|6496775|P1|COMPLETED|Overall Study||0
2641858|NCT02431494|6496773|P3|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
2641859|NCT02431494|6496774|P2|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
2641860|NCT02431494|6496775|P1|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
2641861|NCT02412722|6496807|P6|NOT COMPLETED|Overall Study||13
2641862|NCT02412722|6496808|P5|NOT COMPLETED|Overall Study||7
2641863|NCT02412722|6496809|P4|NOT COMPLETED|Overall Study||15
2641864|NCT02412722|6496810|P3|NOT COMPLETED|Overall Study||7
2641865|NCT02412722|6496811|P2|NOT COMPLETED|Overall Study||8
2641866|NCT02412722|6496812|P1|NOT COMPLETED|Overall Study||11
2641867|NCT02412722|6496807|P6|COMPLETED|Overall Study||0
2641868|NCT02412722|6496808|P5|COMPLETED|Overall Study||0
2641869|NCT02412722|6496809|P4|COMPLETED|Overall Study||0
2641870|NCT02412722|6496810|P3|COMPLETED|Overall Study||0
2641871|NCT02412722|6496811|P2|COMPLETED|Overall Study||0
2641872|NCT02412722|6496812|P1|COMPLETED|Overall Study||0
2641873|NCT02412722|6496807|P6|Safety Population|Overall Study||13
2641874|NCT02412722|6496808|P5|Safety Population|Overall Study||7
2641875|NCT02412722|6496809|P4|Safety Population|Overall Study||15
2641876|NCT02412722|6496810|P3|Safety Population|Overall Study||7
2641877|NCT02412722|6496811|P2|Safety Population|Overall Study||6
2641878|NCT02412722|6496812|P1|Safety Population|Overall Study||11
2641879|NCT02412722|6496807|P6|STARTED|Overall Study||13
2641880|NCT02412722|6496808|P5|STARTED|Overall Study||7
2641881|NCT02412722|6496809|P4|STARTED|Overall Study||15
2641882|NCT02412722|6496810|P3|STARTED|Overall Study||7
2641883|NCT02412722|6496811|P2|STARTED|Overall Study||8
2641884|NCT02412722|6496812|P1|STARTED|Overall Study||11
2641885|NCT02407236|6496888|P8|NOT COMPLETED|Maintenance Study (44 Weeks)||8
2641886|NCT02407236|6496889|P7|NOT COMPLETED|Maintenance Study (44 Weeks)||9
2641887|NCT02407236|6496890|P6|NOT COMPLETED|Maintenance Study (44 Weeks)||8
2641888|NCT02407236|6496891|P5|NOT COMPLETED|Maintenance Study (44 Weeks)||11
2641889|NCT02407236|6496892|P4|NOT COMPLETED|Maintenance Study (44 Weeks)||10
2641890|NCT02407236|6496893|P3|NOT COMPLETED|Maintenance Study (44 Weeks)||0
2641891|NCT02407236|6496894|P2|NOT COMPLETED|Maintenance Study (44 Weeks)||0
2641892|NCT02407236|6496895|P1|NOT COMPLETED|Maintenance Study (44 Weeks)||0
2641893|NCT02407236|6496888|P8|COMPLETED|Maintenance Study (44 Weeks)||149
2641894|NCT02407236|6496889|P7|COMPLETED|Maintenance Study (44 Weeks)||94
2641895|NCT02407236|6496890|P6|COMPLETED|Maintenance Study (44 Weeks)||168
2641896|NCT02407236|6496891|P5|COMPLETED|Maintenance Study (44 Weeks)||161
2641897|NCT02407236|6496892|P4|COMPLETED|Maintenance Study (44 Weeks)||165
2641898|NCT02407236|6496893|P3|COMPLETED|Maintenance Study (44 Weeks)||0
2641899|NCT02407236|6496894|P2|COMPLETED|Maintenance Study (44 Weeks)||0
2641900|NCT02407236|6496895|P1|COMPLETED|Maintenance Study (44 Weeks)||0
2641901|NCT02407236|6496888|P8|STARTED|Maintenance Study (44 Weeks)||157
2641902|NCT02407236|6496889|P7|STARTED|Maintenance Study (44 Weeks)||103
2641903|NCT02407236|6496890|P6|STARTED|Maintenance Study (44 Weeks)||176
2641904|NCT02407236|6496891|P5|STARTED|Maintenance Study (44 Weeks)||172
2641905|NCT02407236|6496892|P4|STARTED|Maintenance Study (44 Weeks)||175
2641906|NCT02407236|6496893|P3|STARTED|Maintenance Study (44 Weeks)||0
2641907|NCT02407236|6496894|P2|STARTED|Maintenance Study (44 Weeks)||0
2641908|NCT02407236|6496895|P1|STARTED|Maintenance Study (44 Weeks)||0
2641909|NCT02407236|6496888|P8|NOT COMPLETED|Induction Study (8 Weeks)||0
2641910|NCT02407236|6496889|P7|NOT COMPLETED|Induction Study (8 Weeks)||0
2641911|NCT02407236|6496890|P6|NOT COMPLETED|Induction Study (8 Weeks)||0
2641912|NCT02407236|6496891|P5|NOT COMPLETED|Induction Study (8 Weeks)||0
2641913|NCT02407236|6496892|P4|NOT COMPLETED|Induction Study (8 Weeks)||0
2641914|NCT02407236|6496893|P3|NOT COMPLETED|Induction Study (8 Weeks)||15
2641915|NCT02407236|6496894|P2|NOT COMPLETED|Induction Study (8 Weeks)||11
2641916|NCT02407236|6496895|P1|NOT COMPLETED|Induction Study (8 Weeks)||23
2641917|NCT02407236|6496888|P8|COMPLETED|Induction Study (8 Weeks)||0
2641918|NCT02407236|6496889|P7|COMPLETED|Induction Study (8 Weeks)||0
2641919|NCT02407236|6496890|P6|COMPLETED|Induction Study (8 Weeks)||0
2641920|NCT02407236|6496891|P5|COMPLETED|Induction Study (8 Weeks)||0
2641921|NCT02407236|6496892|P4|COMPLETED|Induction Study (8 Weeks)||0
2641922|NCT02407236|6496893|P3|COMPLETED|Induction Study (8 Weeks)||307
2641923|NCT02407236|6496894|P2|COMPLETED|Induction Study (8 Weeks)||309
2641924|NCT02407236|6496895|P1|COMPLETED|Induction Study (8 Weeks)||296
2641925|NCT02407236|6496888|P8|Non-responders at Week 8|Induction Study (8 Weeks)||0
2641926|NCT02407236|6496889|P7|Non-responders at Week 8|Induction Study (8 Weeks)||0
2641927|NCT02407236|6496890|P6|Non-responders at Week 8|Induction Study (8 Weeks)||0
2641928|NCT02407236|6496891|P5|Non-responders at Week 8|Induction Study (8 Weeks)||0
2641929|NCT02407236|6496892|P4|Non-responders at Week 8|Induction Study (8 Weeks)||0
2641930|NCT02407236|6496893|P3|Non-responders at Week 8|Induction Study (8 Weeks)||101
2641931|NCT02407236|6496894|P2|Non-responders at Week 8|Induction Study (8 Weeks)||132
2641932|NCT02407236|6496895|P1|Non-responders at Week 8|Induction Study (8 Weeks)||184
2641933|NCT02407236|6496888|P8|Safety Analysis Set|Induction Study (8 Weeks)||0
2641934|NCT02407236|6496889|P7|Safety Analysis Set|Induction Study (8 Weeks)||0
2641935|NCT02407236|6496890|P6|Safety Analysis Set|Induction Study (8 Weeks)||0
2641936|NCT02407236|6496891|P5|Safety Analysis Set|Induction Study (8 Weeks)||0
2641937|NCT02407236|6496892|P4|Safety Analysis Set|Induction Study (8 Weeks)||0
2641938|NCT02407236|6496893|P3|Safety Analysis Set|Induction Study (8 Weeks)||320
2641939|NCT02407236|6496894|P2|Safety Analysis Set|Induction Study (8 Weeks)|1 participant of ustekinumab 130mg never had drug, 2 participants planned to 6 mg/kg but had 130mg.|321
2641940|NCT02407236|6496895|P1|Safety Analysis Set|Induction Study (8 Weeks)||319
2641941|NCT02407236|6496888|P8|Completed Safety Follow-up|Induction Study (8 Weeks)||0
2641942|NCT02407236|6496889|P7|Completed Safety Follow-up|Induction Study (8 Weeks)||0
2641943|NCT02407236|6496890|P6|Completed Safety Follow-up|Induction Study (8 Weeks)||0
2641944|NCT02407236|6496891|P5|Completed Safety Follow-up|Induction Study (8 Weeks)||0
2641945|NCT02407236|6496892|P4|Completed Safety Follow-up|Induction Study (8 Weeks)||0
2641946|NCT02407236|6496893|P3|Completed Safety Follow-up|Induction Study (8 Weeks)|10 participants from IW- 8 and 22 from IW- 16.|32
2641947|NCT02407236|6496894|P2|Completed Safety Follow-up|Induction Study (8 Weeks)|10 participants from IW- 8 and 37 from IW- 16.|47
2641948|NCT02407236|6496895|P1|Completed Safety Follow-up|Induction Study (8 Weeks)|17 participants from Induction Week (IW)- 8 and 33 participants from IW- 16.|50
2641949|NCT02407236|6496888|P8|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
2641950|NCT02407236|6496889|P7|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
2641951|NCT02407236|6496890|P6|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
2641952|NCT02407236|6496891|P5|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
2641953|NCT02407236|6496892|P4|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
2641954|NCT02407236|6496893|P3|Clinical Response at IS Week 16|Induction Study (8 Weeks)||67
2641955|NCT02407236|6496894|P2|Clinical Response at IS Week 16|Induction Study (8 Weeks)||90
2641956|NCT02407236|6496895|P1|Clinical Response at IS Week 16|Induction Study (8 Weeks)||143
2641957|NCT02407236|6496888|P8|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
2641958|NCT02407236|6496889|P7|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
2641959|NCT02407236|6496890|P6|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
2641960|NCT02407236|6496891|P5|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
2641961|NCT02407236|6496892|P4|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
2641962|NCT02407236|6496893|P3|Clinical Response at IS Week 8|Induction Study (8 Weeks)||208
2641963|NCT02407236|6496894|P2|Clinical Response at IS Week 8|Induction Study (8 Weeks)||172
2641964|NCT02407236|6496895|P1|Clinical Response at IS Week 8|Induction Study (8 Weeks)||103
2641965|NCT02407236|6496888|P8|STARTED|Induction Study (8 Weeks)||0
2641966|NCT02407236|6496889|P7|STARTED|Induction Study (8 Weeks)||0
2641967|NCT02407236|6496890|P6|STARTED|Induction Study (8 Weeks)||0
2641968|NCT02407236|6496891|P5|STARTED|Induction Study (8 Weeks)||0
2641969|NCT02407236|6496892|P4|STARTED|Induction Study (8 Weeks)||0
2641970|NCT02407236|6496893|P3|STARTED|Induction Study (8 Weeks)||322
2641971|NCT02407236|6496894|P2|STARTED|Induction Study (8 Weeks)||320
2641972|NCT02407236|6496895|P1|STARTED|Induction Study (8 Weeks)||319
2641973|NCT02397837|6497134|P2|NOT COMPLETED|Overall Study||6
2641974|NCT02397837|6497135|P1|NOT COMPLETED|Overall Study||7
2641975|NCT02397837|6497134|P2|COMPLETED|Overall Study||24
2641976|NCT02397837|6497135|P1|COMPLETED|Overall Study||26
2641977|NCT02397837|6497134|P2|STARTED|Overall Study||30
2641978|NCT02397837|6497135|P1|STARTED|Overall Study||33
2641979|NCT02394548|6497159|P1|NOT COMPLETED|Overall Study||1
2641980|NCT02394548|6497159|P1|COMPLETED|Overall Study||25
2641981|NCT02394548|6497159|P1|STARTED|Overall Study||26
2641982|NCT02392351|6497167|P2|NOT COMPLETED|Overall Study||17
2641983|NCT02392351|6497168|P1|NOT COMPLETED|Overall Study||34
2641984|NCT02392351|6497167|P2|COMPLETED|Overall Study|Primary endpoint: only observational results available.|0
2641985|NCT02392351|6497168|P1|COMPLETED|Overall Study|Primary endpoint: only observational results available.|0
2641986|NCT02392351|6497167|P2|STARTED|Overall Study||17
2641987|NCT02392351|6497168|P1|STARTED|Overall Study||34
2641988|NCT02388737|6497217|P3|NOT COMPLETED|Overall Study||62
2641989|NCT02388737|6497218|P2|NOT COMPLETED|Overall Study||60
2641990|NCT02388737|6497219|P1|NOT COMPLETED|Overall Study||54
2641991|NCT02388737|6497217|P3|COMPLETED|Overall Study||180
2641992|NCT02388737|6497218|P2|COMPLETED|Overall Study||166
2641993|NCT02388737|6497219|P1|COMPLETED|Overall Study||181
2641994|NCT02388737|6497217|P3|STARTED|Overall Study||242
2641995|NCT02388737|6497218|P2|STARTED|Overall Study||226
2641996|NCT02388737|6497219|P1|STARTED|Overall Study||235
2641997|NCT02379052|6497253|P2|NOT COMPLETED|Overall Study||5
2641998|NCT02379052|6497254|P1|NOT COMPLETED|Overall Study||6
2641999|NCT02379052|6497253|P2|COMPLETED|Overall Study||18
2642000|NCT02379052|6497254|P1|COMPLETED|Overall Study||18
2642001|NCT02379052|6497253|P2|STARTED|Overall Study||23
2642002|NCT02379052|6497254|P1|STARTED|Overall Study||24
2642003|NCT02360488|6497294|P2|NOT COMPLETED|Overall Study||7
2642004|NCT02360488|6497295|P1|NOT COMPLETED|Overall Study||3
2642005|NCT02360488|6497294|P2|COMPLETED|Overall Study||55
2642006|NCT02360488|6497295|P1|COMPLETED|Overall Study||59
2642007|NCT02360488|6497294|P2|STARTED|Overall Study||62
2642008|NCT02360488|6497295|P1|STARTED|Overall Study||62
2642009|NCT02354690|6497301|P1|NOT COMPLETED|Overall Study||1
2642010|NCT02354690|6497301|P1|COMPLETED|Overall Study||12
2642011|NCT02354690|6497301|P1|STARTED|Overall Study||13
2642012|NCT02346136|6497311|P2|NOT COMPLETED|Overall Study||23
2642013|NCT02346136|6497312|P1|NOT COMPLETED|Overall Study||22
2642014|NCT02346136|6497311|P2|COMPLETED|Overall Study||64
2642015|NCT02346136|6497312|P1|COMPLETED|Overall Study||71
2642016|NCT02346136|6497311|P2|STARTED|Overall Study||87
2642017|NCT02346136|6497312|P1|STARTED|Overall Study||93
2642018|NCT02341495|6497344|P1|NOT COMPLETED|Overall Study||0
2642019|NCT02341495|6497344|P1|COMPLETED|Overall Study||4
2642020|NCT02341495|6497344|P1|STARTED|Overall Study||4
2642021|NCT02336451|6497356|P5|NOT COMPLETED|Overall Study||18
2642022|NCT02336451|6497357|P4|NOT COMPLETED|Overall Study||44
2642023|NCT02336451|6497358|P3|NOT COMPLETED|Overall Study||12
2642024|NCT02336451|6497359|P2|NOT COMPLETED|Overall Study||40
2642025|NCT02336451|6497360|P1|NOT COMPLETED|Overall Study||42
2642026|NCT02336451|6497356|P5|COMPLETED|Overall Study||0
2642027|NCT02336451|6497357|P4|COMPLETED|Overall Study||0
2642028|NCT02336451|6497358|P3|COMPLETED|Overall Study||0
2642029|NCT02336451|6497359|P2|COMPLETED|Overall Study||0
2642030|NCT02336451|6497360|P1|COMPLETED|Overall Study||0
2642031|NCT02336451|6497356|P5|STARTED|Overall Study||18
2642032|NCT02336451|6497357|P4|STARTED|Overall Study||44
2642033|NCT02336451|6497358|P3|STARTED|Overall Study||12
2642034|NCT02336451|6497359|P2|STARTED|Overall Study||40
2642035|NCT02336451|6497360|P1|STARTED|Overall Study||42
2642036|NCT02327169|6497519|P15|NOT COMPLETED|Overall Study||10
2642037|NCT02327169|6497520|P14|NOT COMPLETED|Overall Study||7
2642038|NCT02327169|6497521|P13|NOT COMPLETED|Overall Study||1
2642039|NCT02327169|6497522|P12|NOT COMPLETED|Overall Study||7
2642040|NCT02327169|6497523|P11|NOT COMPLETED|Overall Study||6
2642041|NCT02327169|6497524|P10|NOT COMPLETED|Overall Study||8
2642042|NCT02327169|6497525|P9|NOT COMPLETED|Overall Study||6
2642043|NCT02327169|6497526|P8|NOT COMPLETED|Overall Study||4
2642044|NCT02327169|6497527|P7|NOT COMPLETED|Overall Study||3
2642045|NCT02327169|6497528|P6|NOT COMPLETED|Overall Study||4
2642046|NCT02327169|6497529|P5|NOT COMPLETED|Overall Study||8
2642047|NCT02327169|6497530|P4|NOT COMPLETED|Overall Study||3
2642048|NCT02327169|6497531|P3|NOT COMPLETED|Overall Study||7
2642049|NCT02327169|6497532|P2|NOT COMPLETED|Overall Study||3
2642050|NCT02327169|6497533|P1|NOT COMPLETED|Overall Study||4
2642051|NCT02327169|6497519|P15|COMPLETED|Overall Study||0
2642052|NCT02327169|6497520|P14|COMPLETED|Overall Study||0
2642053|NCT02327169|6497521|P13|COMPLETED|Overall Study||0
2642054|NCT02327169|6497522|P12|COMPLETED|Overall Study||0
2642055|NCT02327169|6497523|P11|COMPLETED|Overall Study||0
2642056|NCT02327169|6497524|P10|COMPLETED|Overall Study||0
2642057|NCT02327169|6497525|P9|COMPLETED|Overall Study||0
2642058|NCT02327169|6497526|P8|COMPLETED|Overall Study||0
2642059|NCT02327169|6497527|P7|COMPLETED|Overall Study||0
2642060|NCT02327169|6497528|P6|COMPLETED|Overall Study||0
2642061|NCT02327169|6497529|P5|COMPLETED|Overall Study||0
2642062|NCT02327169|6497530|P4|COMPLETED|Overall Study||0
2642063|NCT02327169|6497531|P3|COMPLETED|Overall Study||0
2642064|NCT02327169|6497532|P2|COMPLETED|Overall Study||0
2642065|NCT02327169|6497533|P1|COMPLETED|Overall Study||0
2642066|NCT02327169|6497519|P15|STARTED|Overall Study||10
2642067|NCT02327169|6497520|P14|STARTED|Overall Study||7
2642068|NCT02327169|6497521|P13|STARTED|Overall Study||1
2642069|NCT02327169|6497522|P12|STARTED|Overall Study||7
2642070|NCT02327169|6497523|P11|STARTED|Overall Study||6
2642071|NCT02327169|6497524|P10|STARTED|Overall Study||8
2642072|NCT02327169|6497525|P9|STARTED|Overall Study||6
2642073|NCT02327169|6497526|P8|STARTED|Overall Study||4
2642074|NCT02327169|6497527|P7|STARTED|Overall Study||3
2642075|NCT02327169|6497528|P6|STARTED|Overall Study||4
2642076|NCT02327169|6497529|P5|STARTED|Overall Study||8
2642077|NCT02327169|6497530|P4|STARTED|Overall Study||3
2642078|NCT02327169|6497531|P3|STARTED|Overall Study||7
2642079|NCT02327169|6497532|P2|STARTED|Overall Study||3
2642080|NCT02327169|6497533|P1|STARTED|Overall Study||4
2642081|NCT02316717|6497757|P3|NOT COMPLETED|Overall Study||3
2642082|NCT02316717|6497758|P2|NOT COMPLETED|Overall Study||7
2642083|NCT02316717|6497759|P1|NOT COMPLETED|Overall Study||11
2642084|NCT02316717|6497757|P3|COMPLETED|Overall Study||41
2642085|NCT02316717|6497758|P2|COMPLETED|Overall Study||39
2642086|NCT02316717|6497759|P1|COMPLETED|Overall Study||32
2642087|NCT02316717|6497757|P3|STARTED|Overall Study||44
2642088|NCT02316717|6497758|P2|STARTED|Overall Study||46
2642089|NCT02316717|6497759|P1|STARTED|Overall Study||43
2642090|NCT02302066|6497891|P4|NOT COMPLETED|Overall Study||41
2642091|NCT02302066|6497892|P3|NOT COMPLETED|Overall Study||172
2642092|NCT02302066|6497893|P2|NOT COMPLETED|Overall Study||75
2642093|NCT02302066|6497894|P1|NOT COMPLETED|Overall Study||33
2642094|NCT02302066|6497891|P4|COMPLETED|Overall Study||158
2642095|NCT02302066|6497892|P3|COMPLETED|Overall Study||830
2642096|NCT02302066|6497893|P2|COMPLETED|Overall Study||323
2642097|NCT02302066|6497894|P1|COMPLETED|Overall Study||168
2642098|NCT02302066|6497891|P4|Per-Protocol Set (PPS)|Overall Study||81
2642099|NCT02302066|6497892|P3|Per-Protocol Set (PPS)|Overall Study||174
2642100|NCT02302066|6497893|P2|Per-Protocol Set (PPS)|Overall Study||171
2642101|NCT02302066|6497894|P1|Per-Protocol Set (PPS)|Overall Study||83
2642102|NCT02302066|6497891|P4|Immunogenicity Subset|Overall Study||94
2642103|NCT02302066|6497892|P3|Immunogenicity Subset|Overall Study||192
2642104|NCT02302066|6497893|P2|Immunogenicity Subset|Overall Study||187
2642105|NCT02302066|6497894|P1|Immunogenicity Subset|Overall Study||92
2642106|NCT02302066|6497891|P4|Safety Analysis Set|Overall Study||198
2642107|NCT02302066|6497892|P3|Safety Analysis Set|Overall Study||998
2642108|NCT02302066|6497893|P2|Safety Analysis Set|Overall Study||398
2642109|NCT02302066|6497894|P1|Safety Analysis Set|Overall Study||200
2642110|NCT02302066|6497891|P4|STARTED|Overall Study||199
2642111|NCT02302066|6497892|P3|STARTED|Overall Study||1002
2642112|NCT02302066|6497893|P2|STARTED|Overall Study||398
2642113|NCT02302066|6497894|P1|STARTED|Overall Study||201
2642114|NCT02292758|6497938|P2|NOT COMPLETED|Overall Study||0
2642115|NCT02292758|6497939|P1|NOT COMPLETED|Overall Study||0
2642116|NCT02292758|6497938|P2|COMPLETED|Overall Study||17
2642117|NCT02292758|6497939|P1|COMPLETED|Overall Study||19
2642118|NCT02292758|6497938|P2|STARTED|Overall Study||17
2642119|NCT02292758|6497939|P1|STARTED|Overall Study||19
2642120|NCT02287636|6497963|P1|NOT COMPLETED|Overall Study||0
2642121|NCT02287636|6497963|P1|COMPLETED|Overall Study||13
2642122|NCT02287636|6497963|P1|STARTED|Overall Study||13
2642123|NCT02231892|6497975|P3|NOT COMPLETED|Overall Study||45
2642124|NCT02231892|6497976|P2|NOT COMPLETED|Overall Study||12
2642125|NCT02231892|6497977|P1|NOT COMPLETED|Overall Study||11
2642126|NCT02231892|6497975|P3|COMPLETED|Overall Study|3 participants completed this phase and Hi Frequency Beh phase, but are only counted in Hi Freq MRI.|25
2642127|NCT02231892|6497976|P2|COMPLETED|Overall Study|3 participants completed this phase and Hi Frequency MRI phase, but are only counted in Hi Freq MRI.|5
2642128|NCT02231892|6497977|P1|COMPLETED|Overall Study||6
2642129|NCT02231892|6497975|P3|110% MT|Overall Study||27
2642130|NCT02231892|6497976|P2|110% MT|Overall Study||5
2642131|NCT02231892|6497977|P1|110% MT|Overall Study||7
2642132|NCT02231892|6497975|P3|100% MT|Overall Study||25
2642133|NCT02231892|6497976|P2|100% MT|Overall Study||6
2642134|NCT02231892|6497977|P1|100% MT|Overall Study||7
2642135|NCT02231892|6497975|P3|Sham|Overall Study||26
2642136|NCT02231892|6497976|P2|Sham|Overall Study||5
2642137|NCT02231892|6497977|P1|Sham|Overall Study||8
2642138|NCT02231892|6497975|P3|STARTED|Overall Study||70
2642139|NCT02231892|6497976|P2|STARTED|Overall Study||17
2642140|NCT02231892|6497977|P1|STARTED|Overall Study||17
2642141|NCT02225925|6497994|P1|NOT COMPLETED|Overall Study||0
2642142|NCT02225925|6497994|P1|COMPLETED|Overall Study||45
2642143|NCT02225925|6497994|P1|STARTED|Overall Study||45
2642144|NCT02220894|6498007|P2|NOT COMPLETED|Overall Study||637
2642145|NCT02220894|6498008|P1|NOT COMPLETED|Overall Study||637
2642146|NCT02220894|6498007|P2|COMPLETED|Overall Study||0
2642147|NCT02220894|6498008|P1|COMPLETED|Overall Study||0
2642148|NCT02220894|6498007|P2|Treated|Overall Study||615
2642149|NCT02220894|6498008|P1|Treated|Overall Study||636
2642150|NCT02220894|6498007|P2|STARTED|Overall Study||637
2642151|NCT02220894|6498008|P1|STARTED|Overall Study|1 additional participant was randomized in error|637
2642152|NCT02200614|6498036|P2|NOT COMPLETED|Follow-up Period||163
2642153|NCT02200614|6498037|P1|NOT COMPLETED|Follow-up Period||174
2642154|NCT02200614|6498036|P2|COMPLETED|Follow-up Period||169
2642155|NCT02200614|6498037|P1|COMPLETED|Follow-up Period||117
2642156|NCT02200614|6498036|P2|STARTED|Follow-up Period|Not all participants from treatment period entered follow-up|332
2642157|NCT02200614|6498037|P1|STARTED|Follow-up Period|Not all participants from treatment period entered follow-up|291
2642158|NCT02200614|6498036|P2|NOT COMPLETED|Treatment Period to Primary Completion||354
2642159|NCT02200614|6498037|P1|NOT COMPLETED|Treatment Period to Primary Completion||340
2642160|NCT02200614|6498036|P2|COMPLETED|Treatment Period to Primary Completion||200
2642161|NCT02200614|6498037|P1|COMPLETED|Treatment Period to Primary Completion||615
2642162|NCT02200614|6498036|P2|Treated|Treatment Period to Primary Completion|Safety population|554
2642163|NCT02200614|6498037|P1|Treated|Treatment Period to Primary Completion|Safety population|954
2642164|NCT02200614|6498036|P2|Ongoing|Treatment Period to Primary Completion||200
2642165|NCT02200614|6498037|P1|Ongoing|Treatment Period to Primary Completion||615
2642166|NCT02200614|6498036|P2|STARTED|Treatment Period to Primary Completion||554
2642167|NCT02200614|6498037|P1|STARTED|Treatment Period to Primary Completion||955
2642168|NCT02199964|6498053|P2|NOT COMPLETED|Overall Study||0
2642169|NCT02199964|6498054|P1|NOT COMPLETED|Overall Study||0
2642170|NCT02199964|6498053|P2|COMPLETED|Overall Study||2
2642171|NCT02199964|6498054|P1|COMPLETED|Overall Study||2
2642172|NCT02199964|6498053|P2|STARTED|Overall Study||2
2642173|NCT02199964|6498054|P1|STARTED|Overall Study||2
2642174|NCT02191397|6498064|P2|NOT COMPLETED|Overall Study||70
2642175|NCT02191397|6498065|P1|NOT COMPLETED|Overall Study||83
2642176|NCT02191397|6498064|P2|COMPLETED|Overall Study||198
2642177|NCT02191397|6498065|P1|COMPLETED|Overall Study||183
2642178|NCT02191397|6498064|P2|STARTED|Overall Study||268
2642179|NCT02191397|6498065|P1|STARTED|Overall Study||266
2642180|NCT02179047|6498125|P2|NOT COMPLETED|Overall Study||0
2642181|NCT02179047|6498126|P1|NOT COMPLETED|Overall Study||7
2642182|NCT02179047|6498125|P2|COMPLETED|Overall Study||20
2642183|NCT02179047|6498126|P1|COMPLETED|Overall Study||187
2642184|NCT02179047|6498125|P2|STARTED|Overall Study||20
2642185|NCT02179047|6498126|P1|STARTED|Overall Study||194
2642186|NCT02176005|6498153|P4|NOT COMPLETED|Overall Study||0
2642187|NCT02176005|6498154|P3|NOT COMPLETED|Overall Study||0
2642188|NCT02176005|6498155|P2|NOT COMPLETED|Overall Study||0
2642189|NCT02176005|6498156|P1|NOT COMPLETED|Overall Study||0
2642190|NCT02176005|6498153|P4|COMPLETED|Overall Study||8
2642191|NCT02176005|6498154|P3|COMPLETED|Overall Study||8
2642192|NCT02176005|6498155|P2|COMPLETED|Overall Study||14
2642193|NCT02176005|6498156|P1|COMPLETED|Overall Study||14
2642194|NCT02176005|6498153|P4|STARTED|Overall Study||8
2642195|NCT02176005|6498154|P3|STARTED|Overall Study||8
2642196|NCT02176005|6498155|P2|STARTED|Overall Study||14
2642197|NCT02176005|6498156|P1|STARTED|Overall Study||14
2642198|NCT02168101|6498185|P3|NOT COMPLETED|Overall Study||1
2642199|NCT02168101|6498186|P2|NOT COMPLETED|Overall Study||2
2642200|NCT02168101|6498187|P1|NOT COMPLETED|Overall Study||2
2642201|NCT02168101|6498185|P3|COMPLETED|Overall Study||2
2642202|NCT02168101|6498186|P2|COMPLETED|Overall Study||1
2642203|NCT02168101|6498187|P1|COMPLETED|Overall Study||1
2642204|NCT02168101|6498185|P3|STARTED|Overall Study||3
2642205|NCT02168101|6498186|P2|STARTED|Overall Study||3
2642206|NCT02168101|6498187|P1|STARTED|Overall Study||3
2642207|NCT02161705|6498208|P2|NOT COMPLETED|Overall Study||0
2642208|NCT02161705|6498209|P1|NOT COMPLETED|Overall Study||0
2642209|NCT02161705|6498208|P2|COMPLETED|Overall Study||9
2642210|NCT02161705|6498209|P1|COMPLETED|Overall Study||9
2642211|NCT02161705|6498208|P2|STARTED|Overall Study||9
2642212|NCT02161705|6498209|P1|STARTED|Overall Study||9
2642213|NCT02156804|6498215|P1|NOT COMPLETED|Overall Study||1
2642214|NCT02156804|6498215|P1|COMPLETED|Overall Study||1008
2642215|NCT02156804|6498215|P1|STARTED|Overall Study||1009
2642216|NCT02151591|6498225|P2|NOT COMPLETED|Overall Study||3
2642217|NCT02151591|6498226|P1|NOT COMPLETED|Overall Study||6
2642218|NCT02151591|6498225|P2|COMPLETED|Overall Study||10
2642219|NCT02151591|6498226|P1|COMPLETED|Overall Study||7
2642220|NCT02151591|6498225|P2|STARTED|Overall Study||13
2642221|NCT02151591|6498226|P1|STARTED|Overall Study||13
2642222|NCT02148250|6498236|P2|NOT COMPLETED|Period 2||0
2642223|NCT02148250|6498237|P1|NOT COMPLETED|Period 2||0
2642224|NCT02148250|6498236|P2|COMPLETED|Period 2||6
2642225|NCT02148250|6498237|P1|COMPLETED|Period 2||6
2642226|NCT02148250|6498236|P2|STARTED|Period 2||6
2642227|NCT02148250|6498237|P1|STARTED|Period 2||6
2642228|NCT02148250|6498236|P2|NOT COMPLETED|Period 1||0
2642229|NCT02148250|6498237|P1|NOT COMPLETED|Period 1||0
2642230|NCT02148250|6498236|P2|COMPLETED|Period 1||6
2642231|NCT02148250|6498237|P1|COMPLETED|Period 1||6
2642232|NCT02148250|6498236|P2|STARTED|Period 1||6
2642233|NCT02148250|6498237|P1|STARTED|Period 1||6
2642234|NCT02148250|6498236|P2|NOT COMPLETED|Screening||0
2642235|NCT02148250|6498237|P1|NOT COMPLETED|Screening||5
2642236|NCT02148250|6498236|P2|COMPLETED|Screening||0
2642237|NCT02148250|6498237|P1|COMPLETED|Screening||12
2642238|NCT02148250|6498236|P2|STARTED|Screening||0
2642239|NCT02148250|6498237|P1|STARTED|Screening||17
2642240|NCT02138747|6498255|P4|NOT COMPLETED|Treatment Period 2||3
2642241|NCT02138747|6498256|P3|NOT COMPLETED|Treatment Period 2||2
2642242|NCT02138747|6498257|P2|NOT COMPLETED|Treatment Period 2||7
2642243|NCT02138747|6498258|P1|NOT COMPLETED|Treatment Period 2||17
2642244|NCT02138747|6498255|P4|COMPLETED|Treatment Period 2||24
2642245|NCT02138747|6498256|P3|COMPLETED|Treatment Period 2||24
2642246|NCT02138747|6498257|P2|COMPLETED|Treatment Period 2||125
2642247|NCT02138747|6498258|P1|COMPLETED|Treatment Period 2||121
2642248|NCT02138747|6498255|P4|STARTED|Treatment Period 2|One participant completed treatment in period 1.|27
2642249|NCT02138747|6498256|P3|STARTED|Treatment Period 2|One participant completed treatment in period 1.|26
2642250|NCT02138747|6498257|P2|STARTED|Treatment Period 2||132
2642251|NCT02138747|6498258|P1|STARTED|Treatment Period 2|Two participants who discontinued treatment in period 1 entered period 2.|138
2642252|NCT02138747|6498255|P4|NOT COMPLETED|Treatment Period 1||4
2642253|NCT02138747|6498256|P3|NOT COMPLETED|Treatment Period 1||4
2642254|NCT02138747|6498257|P2|NOT COMPLETED|Treatment Period 1||25
2642255|NCT02138747|6498258|P1|NOT COMPLETED|Treatment Period 1||20
2642256|NCT02138747|6498255|P4|COMPLETED|Treatment Period 1||28
2642257|NCT02138747|6498256|P3|COMPLETED|Treatment Period 1||27
2642258|NCT02138747|6498257|P2|COMPLETED|Treatment Period 1||132
2642259|NCT02138747|6498258|P1|COMPLETED|Treatment Period 1||136
2642260|NCT02138747|6498255|P4|STARTED|Treatment Period 1||32
2642261|NCT02138747|6498256|P3|STARTED|Treatment Period 1||31
2642262|NCT02138747|6498257|P2|STARTED|Treatment Period 1||157
2642263|NCT02138747|6498258|P1|STARTED|Treatment Period 1||156
2642264|NCT02134912|6498292|P2|NOT COMPLETED|Overall Study||0
2642265|NCT02134912|6498293|P1|NOT COMPLETED|Overall Study||0
2642266|NCT02134912|6498292|P2|COMPLETED|Overall Study||0
2642267|NCT02134912|6498293|P1|COMPLETED|Overall Study||0
2642268|NCT02134912|6498292|P2|STARTED|Overall Study||0
2642269|NCT02134912|6498293|P1|STARTED|Overall Study||0
2642270|NCT02133742|6498309|P1|NOT COMPLETED|Period 2:Dose Expansion Phase (903 Days)||52
2642271|NCT02133742|6498309|P1|COMPLETED|Period 2:Dose Expansion Phase (903 Days)||0
2642272|NCT02133742|6498309|P1|STARTED|Period 2:Dose Expansion Phase (903 Days)|Participants participated in dose finding phase continued treatment in dose expansion phase.|52
2642273|NCT02133742|6498309|P1|NOT COMPLETED|Period 1: Dose Finding Phase (6 Months)||0
2642274|NCT02133742|6498309|P1|COMPLETED|Period 1: Dose Finding Phase (6 Months)||11
2642275|NCT02133742|6498309|P1|STARTED|Period 1: Dose Finding Phase (6 Months)||11
2642276|NCT02132533|6498328|P2|NOT COMPLETED|Overall Study||0
2642277|NCT02132533|6498329|P1|NOT COMPLETED|Overall Study||0
2642278|NCT02132533|6498328|P2|COMPLETED|Overall Study||42
2642279|NCT02132533|6498329|P1|COMPLETED|Overall Study||46
2642280|NCT02132533|6498328|P2|STARTED|Overall Study||42
2642281|NCT02132533|6498329|P1|STARTED|Overall Study||46
2642282|NCT02127710|6498344|P3|NOT COMPLETED|Overall Study||0
2642283|NCT02127710|6498345|P2|NOT COMPLETED|Overall Study||0
2642284|NCT02127710|6498346|P1|NOT COMPLETED|Overall Study||0
2642285|NCT02127710|6498344|P3|COMPLETED|Overall Study||19
2642286|NCT02127710|6498345|P2|COMPLETED|Overall Study||46
2642287|NCT02127710|6498346|P1|COMPLETED|Overall Study||44
2642288|NCT02127710|6498344|P3|STARTED|Overall Study||19
2642289|NCT02127710|6498345|P2|STARTED|Overall Study||46
2642290|NCT02127710|6498346|P1|STARTED|Overall Study||44
2642291|NCT02100930|6498386|P1|NOT COMPLETED|Overall Study||0
2642292|NCT02100930|6498386|P1|COMPLETED|Overall Study||69
2642293|NCT02100930|6498386|P1|STARTED|Overall Study||69
2642294|NCT02095340|6498394|P3|NOT COMPLETED|Overall Study||0
2642295|NCT02095340|6498395|P2|NOT COMPLETED|Overall Study||0
2642296|NCT02095340|6498396|P1|NOT COMPLETED|Overall Study||0
2642297|NCT02095340|6498394|P3|COMPLETED|Overall Study||105
2642298|NCT02095340|6498395|P2|COMPLETED|Overall Study||54
2642299|NCT02095340|6498396|P1|COMPLETED|Overall Study||51
2642300|NCT02095340|6498394|P3|STARTED|Overall Study||105
2642301|NCT02095340|6498395|P2|STARTED|Overall Study|Mother (not the child) received the training.|54
2642302|NCT02095340|6498396|P1|STARTED|Overall Study|Mother (not the child) received the training.|51
2642303|NCT02082977|6498417|P10|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
2642304|NCT02082977|6498418|P9|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
2642305|NCT02082977|6498419|P8|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
2642306|NCT02082977|6498420|P7|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
2642307|NCT02082977|6498421|P6|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
2642308|NCT02082977|6498422|P5|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
2642309|NCT02082977|6498423|P4|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
2642310|NCT02082977|6498424|P3|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
2642311|NCT02082977|6498425|P2|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
2642312|NCT02082977|6498426|P1|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
2642313|NCT02082977|6498417|P10|COMPLETED|Part 2 (Up to 3.2 Years)||0
2642314|NCT02082977|6498418|P9|COMPLETED|Part 2 (Up to 3.2 Years)||0
2642315|NCT02082977|6498419|P8|COMPLETED|Part 2 (Up to 3.2 Years)||0
2642316|NCT02082977|6498420|P7|COMPLETED|Part 2 (Up to 3.2 Years)||0
2642317|NCT02082977|6498421|P6|COMPLETED|Part 2 (Up to 3.2 Years)||0
2642318|NCT02082977|6498422|P5|COMPLETED|Part 2 (Up to 3.2 Years)||0
2642319|NCT02082977|6498423|P4|COMPLETED|Part 2 (Up to 3.2 Years)||0
2642320|NCT02082977|6498424|P3|COMPLETED|Part 2 (Up to 3.2 Years)||0
2642321|NCT02082977|6498425|P2|COMPLETED|Part 2 (Up to 3.2 Years)||0
2642322|NCT02082977|6498426|P1|COMPLETED|Part 2 (Up to 3.2 Years)||0
2642323|NCT02082977|6498417|P10|STARTED|Part 2 (Up to 3.2 Years)||0
2642324|NCT02082977|6498418|P9|STARTED|Part 2 (Up to 3.2 Years)||0
2642325|NCT02082977|6498419|P8|STARTED|Part 2 (Up to 3.2 Years)||0
2642326|NCT02082977|6498420|P7|STARTED|Part 2 (Up to 3.2 Years)||0
2642327|NCT02082977|6498421|P6|STARTED|Part 2 (Up to 3.2 Years)||0
2642328|NCT02082977|6498422|P5|STARTED|Part 2 (Up to 3.2 Years)||0
2642329|NCT02082977|6498423|P4|STARTED|Part 2 (Up to 3.2 Years)||0
2642330|NCT02082977|6498424|P3|STARTED|Part 2 (Up to 3.2 Years)||0
2642331|NCT02082977|6498425|P2|STARTED|Part 2 (Up to 3.2 Years)||0
2642332|NCT02082977|6498426|P1|STARTED|Part 2 (Up to 3.2 Years)||0
2642333|NCT02082977|6498417|P10|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
2642334|NCT02082977|6498418|P9|NOT COMPLETED|Part 1 (Up to 3.2 Years)||3
2642335|NCT02082977|6498419|P8|NOT COMPLETED|Part 1 (Up to 3.2 Years)||5
2642336|NCT02082977|6498420|P7|NOT COMPLETED|Part 1 (Up to 3.2 Years)||6
2642337|NCT02082977|6498421|P6|NOT COMPLETED|Part 1 (Up to 3.2 Years)||3
2642338|NCT02082977|6498422|P5|NOT COMPLETED|Part 1 (Up to 3.2 Years)||1
2642339|NCT02082977|6498423|P4|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
2642340|NCT02082977|6498424|P3|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
2642341|NCT02082977|6498425|P2|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
2642342|NCT02082977|6498426|P1|NOT COMPLETED|Part 1 (Up to 3.2 Years)||1
2642343|NCT02082977|6498417|P10|COMPLETED|Part 1 (Up to 3.2 Years)||0
2642344|NCT02082977|6498418|P9|COMPLETED|Part 1 (Up to 3.2 Years)||4
2642345|NCT02082977|6498419|P8|COMPLETED|Part 1 (Up to 3.2 Years)||7
2642346|NCT02082977|6498420|P7|COMPLETED|Part 1 (Up to 3.2 Years)||4
2642347|NCT02082977|6498421|P6|COMPLETED|Part 1 (Up to 3.2 Years)||1
2642348|NCT02082977|6498422|P5|COMPLETED|Part 1 (Up to 3.2 Years)||2
2642349|NCT02082977|6498423|P4|COMPLETED|Part 1 (Up to 3.2 Years)||1
2642350|NCT02082977|6498424|P3|COMPLETED|Part 1 (Up to 3.2 Years)||1
2642351|NCT02082977|6498425|P2|COMPLETED|Part 1 (Up to 3.2 Years)||1
2642352|NCT02082977|6498426|P1|COMPLETED|Part 1 (Up to 3.2 Years)||1
2642353|NCT02082977|6498417|P10|STARTED|Part 1 (Up to 3.2 Years)||0
2642354|NCT02082977|6498418|P9|STARTED|Part 1 (Up to 3.2 Years)||7
2642355|NCT02082977|6498419|P8|STARTED|Part 1 (Up to 3.2 Years)||12
2642356|NCT02082977|6498420|P7|STARTED|Part 1 (Up to 3.2 Years)||10
2642357|NCT02082977|6498421|P6|STARTED|Part 1 (Up to 3.2 Years)||4
2642358|NCT02082977|6498422|P5|STARTED|Part 1 (Up to 3.2 Years)||3
2642359|NCT02082977|6498423|P4|STARTED|Part 1 (Up to 3.2 Years)||1
2642360|NCT02082977|6498424|P3|STARTED|Part 1 (Up to 3.2 Years)||1
2642361|NCT02082977|6498425|P2|STARTED|Part 1 (Up to 3.2 Years)||1
2642362|NCT02082977|6498426|P1|STARTED|Part 1 (Up to 3.2 Years)||2
2642363|NCT02066311|6498678|P1|NOT COMPLETED|Overall Study||5
2642364|NCT02066311|6498678|P1|COMPLETED|Overall Study|Stage 1 terminated 6/1/18 prior to completion of Stage 1 due to low enrollment and efficacy.|10
2642365|NCT02066311|6498678|P1|STARTED|Overall Study||15
2642366|NCT02060370|6498682|P1|NOT COMPLETED|Overall Study||1
2642367|NCT02060370|6498682|P1|COMPLETED|Overall Study||59
2642368|NCT02060370|6498682|P1|STARTED|Overall Study||60
2642369|NCT02038179|6498691|P2|NOT COMPLETED|Phase 2 (4 Weeks)||2
2642370|NCT02038179|6498692|P1|NOT COMPLETED|Phase 2 (4 Weeks)||2
2642371|NCT02038179|6498691|P2|COMPLETED|Phase 2 (4 Weeks)||38
2642372|NCT02038179|6498692|P1|COMPLETED|Phase 2 (4 Weeks)||44
2642373|NCT02038179|6498691|P2|STARTED|Phase 2 (4 Weeks)||40
2642374|NCT02038179|6498692|P1|STARTED|Phase 2 (4 Weeks)||46
2642375|NCT02038179|6498691|P2|NOT COMPLETED|Washout (2-4 Weeks)||2
2642376|NCT02038179|6498692|P1|NOT COMPLETED|Washout (2-4 Weeks)||2
2642377|NCT02038179|6498691|P2|COMPLETED|Washout (2-4 Weeks)||40
2642378|NCT02038179|6498692|P1|COMPLETED|Washout (2-4 Weeks)||46
2642379|NCT02038179|6498691|P2|STARTED|Washout (2-4 Weeks)||42
2642380|NCT02038179|6498692|P1|STARTED|Washout (2-4 Weeks)||48
2642381|NCT02038179|6498691|P2|NOT COMPLETED|Phase 1 (4 Weeks)||5
2642382|NCT02038179|6498692|P1|NOT COMPLETED|Phase 1 (4 Weeks)||4
2642383|NCT02038179|6498691|P2|COMPLETED|Phase 1 (4 Weeks)||42
2642384|NCT02038179|6498692|P1|COMPLETED|Phase 1 (4 Weeks)||48
2642385|NCT02038179|6498691|P2|STARTED|Phase 1 (4 Weeks)||47
2642386|NCT02038179|6498692|P1|STARTED|Phase 1 (4 Weeks)||52
2642387|NCT02019667|6498702|P2|NOT COMPLETED|Washout Period (9 Weeks)||0
2642388|NCT02019667|6498703|P1|NOT COMPLETED|Washout Period (9 Weeks)||0
2642389|NCT02019667|6498702|P2|COMPLETED|Washout Period (9 Weeks)||6
2642390|NCT02019667|6498703|P1|COMPLETED|Washout Period (9 Weeks)||10
2642391|NCT02019667|6498702|P2|STARTED|Washout Period (9 Weeks)||6
2642392|NCT02019667|6498703|P1|STARTED|Washout Period (9 Weeks)||10
2642393|NCT02019667|6498702|P2|NOT COMPLETED|2nd Intervention (6 Months)||2
2642394|NCT02019667|6498703|P1|NOT COMPLETED|2nd Intervention (6 Months)||0
2642395|NCT02019667|6498702|P2|COMPLETED|2nd Intervention (6 Months)||6
2642396|NCT02019667|6498703|P1|COMPLETED|2nd Intervention (6 Months)||10
2642397|NCT02019667|6498702|P2|STARTED|2nd Intervention (6 Months)||8
2642398|NCT02019667|6498703|P1|STARTED|2nd Intervention (6 Months)||10
2642399|NCT02019667|6498702|P2|NOT COMPLETED|Washout Period (9 Weeks)||0
2642400|NCT02019667|6498703|P1|NOT COMPLETED|Washout Period (9 Weeks)||0
2642401|NCT02019667|6498702|P2|COMPLETED|Washout Period (9 Weeks)||8
2642402|NCT02019667|6498703|P1|COMPLETED|Washout Period (9 Weeks)||10
2642403|NCT02019667|6498702|P2|STARTED|Washout Period (9 Weeks)||8
2642404|NCT02019667|6498703|P1|STARTED|Washout Period (9 Weeks)||10
2642405|NCT02019667|6498702|P2|NOT COMPLETED|First Intervention (6 Months)||1
2642406|NCT02019667|6498703|P1|NOT COMPLETED|First Intervention (6 Months)||0
2642407|NCT02019667|6498702|P2|COMPLETED|First Intervention (6 Months)||8
2642408|NCT02019667|6498703|P1|COMPLETED|First Intervention (6 Months)||10
2642409|NCT02019667|6498702|P2|STARTED|First Intervention (6 Months)||9
2642410|NCT02019667|6498703|P1|STARTED|First Intervention (6 Months)||10
2642411|NCT02017210|6498724|P3|NOT COMPLETED|Overall Study||0
2642412|NCT02017210|6498725|P2|NOT COMPLETED|Overall Study||0
2642413|NCT02017210|6498726|P1|NOT COMPLETED|Overall Study||0
2642414|NCT02017210|6498724|P3|COMPLETED|Overall Study||20
2642415|NCT02017210|6498725|P2|COMPLETED|Overall Study||20
2642416|NCT02017210|6498726|P1|COMPLETED|Overall Study||17
2642417|NCT02017210|6498724|P3|STARTED|Overall Study||20
2642418|NCT02017210|6498725|P2|STARTED|Overall Study||20
2642419|NCT02017210|6498726|P1|STARTED|Overall Study||17
2642420|NCT02005471|6498763|P2|NOT COMPLETED|Overall Study||194
2642421|NCT02005471|6498764|P1|NOT COMPLETED|Overall Study||195
2642422|NCT02005471|6498763|P2|COMPLETED|Overall Study||0
2642423|NCT02005471|6498764|P1|COMPLETED|Overall Study||0
2642424|NCT02005471|6498763|P2|Treated|Overall Study||194
2642425|NCT02005471|6498764|P1|Treated|Overall Study||188
2642426|NCT02005471|6498763|P2|STARTED|Overall Study||194
2642427|NCT02005471|6498764|P1|STARTED|Overall Study||195
2642428|NCT02000622|6498819|P2|NOT COMPLETED|Overall Study||53
2642429|NCT02000622|6498820|P1|NOT COMPLETED|Overall Study||101
2642430|NCT02000622|6498819|P2|COMPLETED|Overall Study|Patients were ongoing on the study at the data cut-off.|44
2642431|NCT02000622|6498820|P1|COMPLETED|Overall Study|Patients were ongoing on the study at the data cut-off.|104
2642432|NCT02000622|6498819|P2|STARTED|Overall Study||97
2642433|NCT02000622|6498820|P1|STARTED|Overall Study||205
2642434|NCT01979523|6498842|P2|NOT COMPLETED|Overall Study||0
2642435|NCT01979523|6498843|P1|NOT COMPLETED|Overall Study||1
2642436|NCT01979523|6498842|P2|COMPLETED|Overall Study||21
2642437|NCT01979523|6498843|P1|COMPLETED|Overall Study||20
2642438|NCT01979523|6498842|P2|STARTED|Overall Study||21
2642439|NCT01979523|6498843|P1|STARTED|Overall Study||21
2642440|NCT01979445|6498866|P4|NOT COMPLETED|Overall Study||0
2642441|NCT01979445|6498867|P3|NOT COMPLETED|Overall Study||0
2642442|NCT01979445|6498868|P2|NOT COMPLETED|Overall Study||0
2642443|NCT01979445|6498869|P1|NOT COMPLETED|Overall Study||0
2642444|NCT01979445|6498866|P4|COMPLETED|Overall Study||3
2642445|NCT01979445|6498867|P3|COMPLETED|Overall Study||6
2642446|NCT01979445|6498868|P2|COMPLETED|Overall Study||3
2642447|NCT01979445|6498869|P1|COMPLETED|Overall Study||3
2642448|NCT01979445|6498866|P4|ITT Population|Overall Study||3
2642449|NCT01979445|6498867|P3|ITT Population|Overall Study||6
2642450|NCT01979445|6498868|P2|ITT Population|Overall Study||3
2642451|NCT01979445|6498869|P1|ITT Population|Overall Study||3
2642452|NCT01979445|6498866|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
2642453|NCT01979445|6498867|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
2642454|NCT01979445|6498868|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
2642455|NCT01979445|6498869|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
2642456|NCT01979445|6498866|P4|STARTED|Overall Study||3
2642457|NCT01979445|6498867|P3|STARTED|Overall Study||6
2642458|NCT01979445|6498868|P2|STARTED|Overall Study||3
2642459|NCT01979445|6498869|P1|STARTED|Overall Study||3
2642460|NCT01972061|6498898|P3|NOT COMPLETED|Overall Study||0
2642461|NCT01972061|6498899|P2|NOT COMPLETED|Overall Study||0
2642462|NCT01972061|6498900|P1|NOT COMPLETED|Overall Study||0
2642463|NCT01972061|6498898|P3|COMPLETED|Overall Study||20
2642464|NCT01972061|6498899|P2|COMPLETED|Overall Study||23
2642465|NCT01972061|6498900|P1|COMPLETED|Overall Study||1
2642466|NCT01972061|6498898|P3|STARTED|Overall Study||20
2642467|NCT01972061|6498899|P2|STARTED|Overall Study||23
2642468|NCT01972061|6498900|P1|STARTED|Overall Study||1
2642469|NCT01968213|6498914|P2|NOT COMPLETED|Overall Study||9
2642470|NCT01968213|6498915|P1|NOT COMPLETED|Overall Study||90
2642471|NCT01968213|6498914|P2|COMPLETED|Overall Study||180
2642472|NCT01968213|6498915|P1|COMPLETED|Overall Study||285
2642473|NCT01968213|6498914|P2|STARTED|Overall Study||189
2642474|NCT01968213|6498915|P1|STARTED|Overall Study||375
2642475|NCT01964378|6498926|P2|NOT COMPLETED|Overall Study||21
2642476|NCT01964378|6498927|P1|NOT COMPLETED|Overall Study||25
2642477|NCT01964378|6498926|P2|COMPLETED|Overall Study||45
2642478|NCT01964378|6498927|P1|COMPLETED|Overall Study||41
2642479|NCT01964378|6498926|P2|Participants Treated (Safety Set)|Overall Study|"4 Participants died during treatment, hereof 2 with withdrawal... as primary reason for discont."|61
2642480|NCT01964378|6498927|P1|Participants Treated (Safety Set)|Overall Study||65
2642481|NCT01964378|6498926|P2|STARTED|Overall Study||66
2642482|NCT01964378|6498927|P1|STARTED|Overall Study||66
2642483|NCT01964300|6498961|P2|NOT COMPLETED|Overall Study||11
2642484|NCT01964300|6498962|P1|NOT COMPLETED|Overall Study||6
2642485|NCT01964300|6498961|P2|COMPLETED|Overall Study||1
2642486|NCT01964300|6498962|P1|COMPLETED|Overall Study||1
2642487|NCT01964300|6498961|P2|STARTED|Overall Study||12
2642488|NCT01964300|6498962|P1|STARTED|Overall Study||7
2642489|NCT01962714|6498976|P2|NOT COMPLETED|Overall Study||33
2642490|NCT01962714|6498977|P1|NOT COMPLETED|Overall Study||30
2642491|NCT01962714|6498976|P2|COMPLETED|Overall Study||60
2642492|NCT01962714|6498977|P1|COMPLETED|Overall Study||61
2642493|NCT01962714|6498976|P2|3-month Follow-up|Overall Study||56
2642494|NCT01962714|6498977|P1|3-month Follow-up|Overall Study||58
2642495|NCT01962714|6498976|P2|Immediate Post-treatment Assessment|Overall Study||57
2642496|NCT01962714|6498977|P1|Immediate Post-treatment Assessment|Overall Study||63
2642497|NCT01962714|6498976|P2|STARTED|Overall Study||93
2642498|NCT01962714|6498977|P1|STARTED|Overall Study||91
2642499|NCT01961362|6498985|P1|NOT COMPLETED|Overall Study||0
2642500|NCT01961362|6498985|P1|COMPLETED|Overall Study||19
2642501|NCT01961362|6498985|P1|STARTED|Overall Study||19
2642502|NCT01960075|6498994|P3|NOT COMPLETED|Overall Study||7
2642503|NCT01960075|6498995|P2|NOT COMPLETED|Overall Study||3
2642504|NCT01960075|6498996|P1|NOT COMPLETED|Overall Study||8
2642505|NCT01960075|6498994|P3|COMPLETED|Overall Study||173
2642506|NCT01960075|6498995|P2|COMPLETED|Overall Study||146
2642507|NCT01960075|6498996|P1|COMPLETED|Overall Study||141
2642508|NCT01960075|6498994|P3|STARTED|Overall Study||180
2642509|NCT01960075|6498995|P2|STARTED|Overall Study||149
2642510|NCT01960075|6498996|P1|STARTED|Overall Study||149
2642511|NCT01953432|6499054|P2|NOT COMPLETED|Overall Study||15
2642512|NCT01953432|6499055|P1|NOT COMPLETED|Overall Study||14
2642513|NCT01953432|6499054|P2|COMPLETED|Overall Study||6
2642514|NCT01953432|6499055|P1|COMPLETED|Overall Study||8
2642515|NCT01953432|6499054|P2|STARTED|Overall Study||21
2642516|NCT01953432|6499055|P1|STARTED|Overall Study||22
2642517|NCT01933984|6499063|P2|NOT COMPLETED|Overall Study||0
2642518|NCT01933984|6499064|P1|NOT COMPLETED|Overall Study||0
2642519|NCT01933984|6499063|P2|COMPLETED|Overall Study||25
2642520|NCT01933984|6499064|P1|COMPLETED|Overall Study||26
2642521|NCT01933984|6499063|P2|STARTED|Overall Study||25
2642522|NCT01933984|6499064|P1|STARTED|Overall Study||26
2642523|NCT01924806|6499086|P2|NOT COMPLETED|Overall Study||1
2642524|NCT01924806|6499087|P1|NOT COMPLETED|Overall Study||2
2642525|NCT01924806|6499086|P2|COMPLETED|Overall Study||3
2642526|NCT01924806|6499087|P1|COMPLETED|Overall Study||3
2642527|NCT01924806|6499086|P2|STARTED|Overall Study||4
2642528|NCT01924806|6499087|P1|STARTED|Overall Study||5
2642529|NCT01923181|6499108|P9|NOT COMPLETED|Overall Study||3
2642530|NCT01923181|6499109|P8|NOT COMPLETED|Overall Study||8
2642531|NCT01923181|6499110|P7|NOT COMPLETED|Overall Study||8
2642532|NCT01923181|6499111|P6|NOT COMPLETED|Overall Study||4
2642533|NCT01923181|6499112|P5|NOT COMPLETED|Overall Study||8
2642534|NCT01923181|6499113|P4|NOT COMPLETED|Overall Study||5
2642535|NCT01923181|6499114|P3|NOT COMPLETED|Overall Study||2
2642536|NCT01923181|6499115|P2|NOT COMPLETED|Overall Study||6
2642537|NCT01923181|6499116|P1|NOT COMPLETED|Overall Study||3
2642538|NCT01923181|6499108|P9|COMPLETED|Overall Study||68
2642539|NCT01923181|6499109|P8|COMPLETED|Overall Study||61
2642540|NCT01923181|6499110|P7|COMPLETED|Overall Study||62
2642541|NCT01923181|6499111|P6|COMPLETED|Overall Study||66
2642542|NCT01923181|6499112|P5|COMPLETED|Overall Study||63
2642543|NCT01923181|6499113|P4|COMPLETED|Overall Study||65
2642544|NCT01923181|6499114|P3|COMPLETED|Overall Study||67
2642545|NCT01923181|6499115|P2|COMPLETED|Overall Study||64
2642546|NCT01923181|6499116|P1|COMPLETED|Overall Study||67
2642547|NCT01923181|6499108|P9|Safety Analysis Set (SAS)|Overall Study||71
2642548|NCT01923181|6499109|P8|Safety Analysis Set (SAS)|Overall Study||69
2642549|NCT01923181|6499110|P7|Safety Analysis Set (SAS)|Overall Study||70
2642550|NCT01923181|6499111|P6|Safety Analysis Set (SAS)|Overall Study||70
2642551|NCT01923181|6499112|P5|Safety Analysis Set (SAS)|Overall Study||71
2642552|NCT01923181|6499113|P4|Safety Analysis Set (SAS)|Overall Study||70
2642553|NCT01923181|6499114|P3|Safety Analysis Set (SAS)|Overall Study||69
2642554|NCT01923181|6499115|P2|Safety Analysis Set (SAS)|Overall Study||70
2642555|NCT01923181|6499116|P1|Safety Analysis Set (SAS)|Overall Study||70
2642556|NCT01923181|6499108|P9|Full Analysis Set (FAS)|Overall Study||71
2642557|NCT01923181|6499109|P8|Full Analysis Set (FAS)|Overall Study||69
2642558|NCT01923181|6499110|P7|Full Analysis Set (FAS)|Overall Study||70
2642559|NCT01923181|6499111|P6|Full Analysis Set (FAS)|Overall Study||70
2642560|NCT01923181|6499112|P5|Full Analysis Set (FAS)|Overall Study||71
2642561|NCT01923181|6499113|P4|Full Analysis Set (FAS)|Overall Study||70
2642562|NCT01923181|6499114|P3|Full Analysis Set (FAS)|Overall Study||69
2642563|NCT01923181|6499115|P2|Full Analysis Set (FAS)|Overall Study||70
2642564|NCT01923181|6499116|P1|Full Analysis Set (FAS)|Overall Study||70
2642565|NCT01923181|6499108|P9|STARTED|Overall Study||71
2642566|NCT01923181|6499109|P8|STARTED|Overall Study||69
2642567|NCT01923181|6499110|P7|STARTED|Overall Study||70
2642568|NCT01923181|6499111|P6|STARTED|Overall Study||70
2642569|NCT01923181|6499112|P5|STARTED|Overall Study||71
2642570|NCT01923181|6499113|P4|STARTED|Overall Study||70
2642571|NCT01923181|6499114|P3|STARTED|Overall Study||69
2642572|NCT01923181|6499115|P2|STARTED|Overall Study||70
2642573|NCT01923181|6499116|P1|STARTED|Overall Study||70
2642574|NCT01919411|6499193|P2|NOT COMPLETED|Overall Study||5
2642575|NCT01919411|6499194|P1|NOT COMPLETED|Overall Study||5
2642576|NCT01919411|6499193|P2|COMPLETED|Overall Study||41
2642577|NCT01919411|6499194|P1|COMPLETED|Overall Study||38
2642578|NCT01919411|6499193|P2|STARTED|Overall Study||46
2642579|NCT01919411|6499194|P1|STARTED|Overall Study||43
2642580|NCT01912339|6499212|P3|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||53
2642581|NCT01912339|6499213|P2|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
2642582|NCT01912339|6499214|P1|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||133
2642583|NCT01912339|6499212|P3|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
2642584|NCT01912339|6499213|P2|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
2642585|NCT01912339|6499214|P1|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
2642586|NCT01912339|6499212|P3|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|Control subjects that have crossed over.|53
2642587|NCT01912339|6499213|P2|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|All subjects for the control group either completed study or crossed over.|0
2642588|NCT01912339|6499214|P1|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)||133
2642589|NCT01912339|6499212|P3|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
2642590|NCT01912339|6499213|P2|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
2642591|NCT01912339|6499214|P1|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||1
2642592|NCT01912339|6499212|P3|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|0
2642593|NCT01912339|6499213|P2|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Of the 61 subjects, there were 53 crossover subjects and 8 that completed their study participation.|61
2642594|NCT01912339|6499214|P1|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|133
2642595|NCT01912339|6499212|P3|STARTED|Unblinded (3 to 6 Months/Crossover)||0
2642596|NCT01912339|6499213|P2|STARTED|Unblinded (3 to 6 Months/Crossover)||61
2642597|NCT01912339|6499214|P1|STARTED|Unblinded (3 to 6 Months/Crossover)||134
2642598|NCT01912339|6499212|P3|NOT COMPLETED|Blinded (0 to 3 Months)||0
2642599|NCT01912339|6499213|P2|NOT COMPLETED|Blinded (0 to 3 Months)||0
2642600|NCT01912339|6499214|P1|NOT COMPLETED|Blinded (0 to 3 Months)||2
2642601|NCT01912339|6499212|P3|COMPLETED|Blinded (0 to 3 Months)||0
2642602|NCT01912339|6499213|P2|COMPLETED|Blinded (0 to 3 Months)||61
2642603|NCT01912339|6499214|P1|COMPLETED|Blinded (0 to 3 Months)||134
2642604|NCT01912339|6499212|P3|STARTED|Blinded (0 to 3 Months)||0
2642605|NCT01912339|6499213|P2|STARTED|Blinded (0 to 3 Months)||61
2642606|NCT01912339|6499214|P1|STARTED|Blinded (0 to 3 Months)||136
2642607|NCT01908699|6499230|P2|NOT COMPLETED|Overall Study||78
2642608|NCT01908699|6499231|P1|NOT COMPLETED|Overall Study||75
2642609|NCT01908699|6499230|P2|COMPLETED|Overall Study||58
2642610|NCT01908699|6499231|P1|COMPLETED|Overall Study||62
2642611|NCT01908699|6499230|P2|Received at Least 1 Dose of Study Drug|Overall Study||135
2642612|NCT01908699|6499231|P1|Received at Least 1 Dose of Study Drug|Overall Study||136
2642613|NCT01908699|6499230|P2|STARTED|Overall Study||136
2642614|NCT01908699|6499231|P1|STARTED|Overall Study||137
2642615|NCT01900730|6499249|P2|NOT COMPLETED|Overall Study||0
2642616|NCT01900730|6499250|P1|NOT COMPLETED|Overall Study||2
2642617|NCT01900730|6499249|P2|COMPLETED|Overall Study||0
2642618|NCT01900730|6499250|P1|COMPLETED|Overall Study||1
2642619|NCT01900730|6499249|P2|STARTED|Overall Study||0
2642620|NCT01900730|6499250|P1|STARTED|Overall Study||3
2642621|NCT01892540|6499259|P3|NOT COMPLETED|Overall Study||3
2642622|NCT01892540|6499260|P2|NOT COMPLETED|Overall Study||0
2642623|NCT01892540|6499261|P1|NOT COMPLETED|Overall Study||0
2642624|NCT01892540|6499259|P3|COMPLETED|Overall Study||25
2642625|NCT01892540|6499260|P2|COMPLETED|Overall Study||0
2642626|NCT01892540|6499261|P1|COMPLETED|Overall Study||15
2642627|NCT01892540|6499259|P3|STARTED|Overall Study||28
2642628|NCT01892540|6499260|P2|STARTED|Overall Study||0
2642629|NCT01892540|6499261|P1|STARTED|Overall Study||15
2642630|NCT01886872|6499281|P3|NOT COMPLETED|Overall Study||12
2642631|NCT01886872|6499282|P2|NOT COMPLETED|Overall Study||4
2642632|NCT01886872|6499283|P1|NOT COMPLETED|Overall Study||7
2642633|NCT01886872|6499281|P3|COMPLETED|Overall Study||170
2642634|NCT01886872|6499282|P2|COMPLETED|Overall Study||178
2642635|NCT01886872|6499283|P1|COMPLETED|Overall Study||176
2642636|NCT01886872|6499281|P3|Crossover Cohort|Overall Study||0
2642637|NCT01886872|6499282|P2|Crossover Cohort|Overall Study||0
2642638|NCT01886872|6499283|P1|Crossover Cohort|Overall Study||30
2642639|NCT01886872|6499281|P3|Evaluable for Adverse Events|Overall Study||181
2642640|NCT01886872|6499282|P2|Evaluable for Adverse Events|Overall Study||180
2642641|NCT01886872|6499283|P1|Evaluable for Adverse Events|Overall Study||176
2642642|NCT01886872|6499281|P3|Evaluable for Secondary Endpoints|Overall Study||182
2642643|NCT01886872|6499282|P2|Evaluable for Secondary Endpoints|Overall Study||182
2642644|NCT01886872|6499283|P1|Evaluable for Secondary Endpoints|Overall Study||183
2642645|NCT01886872|6499281|P3|STARTED|Overall Study||182
2642646|NCT01886872|6499282|P2|STARTED|Overall Study||182
2642647|NCT01886872|6499283|P1|STARTED|Overall Study||183
2642648|NCT01868139|6499316|P1|NOT COMPLETED|Overall Study||1
2642649|NCT01868139|6499316|P1|COMPLETED|Overall Study||0
2642650|NCT01868139|6499316|P1|STARTED|Overall Study||1
2642651|NCT01866826|6499326|P2|NOT COMPLETED|Second Intervention - 4 Weeks||0
2642652|NCT01866826|6499327|P1|NOT COMPLETED|Second Intervention - 4 Weeks||0
2642653|NCT01866826|6499326|P2|COMPLETED|Second Intervention - 4 Weeks||20
2642654|NCT01866826|6499327|P1|COMPLETED|Second Intervention - 4 Weeks||22
2642655|NCT01866826|6499326|P2|STARTED|Second Intervention - 4 Weeks||20
2642656|NCT01866826|6499327|P1|STARTED|Second Intervention - 4 Weeks||22
2642657|NCT01866826|6499326|P2|NOT COMPLETED|Wash-Out Period - 4 -6 Weeks||3
2642658|NCT01866826|6499327|P1|NOT COMPLETED|Wash-Out Period - 4 -6 Weeks||0
2642659|NCT01866826|6499326|P2|COMPLETED|Wash-Out Period - 4 -6 Weeks||20
2642660|NCT01866826|6499327|P1|COMPLETED|Wash-Out Period - 4 -6 Weeks||22
2642661|NCT01866826|6499326|P2|STARTED|Wash-Out Period - 4 -6 Weeks||23
2642662|NCT01866826|6499327|P1|STARTED|Wash-Out Period - 4 -6 Weeks||22
2642663|NCT01866826|6499326|P2|NOT COMPLETED|Phase I -Initial Randomization - 4 Weeks||0
2642664|NCT01866826|6499327|P1|NOT COMPLETED|Phase I -Initial Randomization - 4 Weeks||1
2642665|NCT01866826|6499326|P2|COMPLETED|Phase I -Initial Randomization - 4 Weeks||23
2642666|NCT01866826|6499327|P1|COMPLETED|Phase I -Initial Randomization - 4 Weeks||22
2642667|NCT01866826|6499326|P2|STARTED|Phase I -Initial Randomization - 4 Weeks||23
2642668|NCT01866826|6499327|P1|STARTED|Phase I -Initial Randomization - 4 Weeks||23
2642669|NCT01853644|6499341|P1|NOT COMPLETED|Follow up for 3 Years or Until Death||3
2642670|NCT01853644|6499341|P1|COMPLETED|Follow up for 3 Years or Until Death||26
2642671|NCT01853644|6499341|P1|STARTED|Follow up for 3 Years or Until Death|All patients that are treated on the study go into the follow up period|29
2642672|NCT01853644|6499341|P1|NOT COMPLETED|Continued Treatment After First Response||12
2642673|NCT01853644|6499341|P1|COMPLETED|Continued Treatment After First Response||12
2642674|NCT01853644|6499341|P1|STARTED|Continued Treatment After First Response||24
2642675|NCT01853644|6499341|P1|NOT COMPLETED|Reached First Response/Complete 2 Cycles||6
2642676|NCT01853644|6499341|P1|COMPLETED|Reached First Response/Complete 2 Cycles||24
2642677|NCT01853644|6499341|P1|STARTED|Reached First Response/Complete 2 Cycles||30
2642678|NCT01853644|6499341|P1|NOT COMPLETED|Registration and Treatment Start||1
2642679|NCT01853644|6499341|P1|COMPLETED|Registration and Treatment Start||30
2642680|NCT01853644|6499341|P1|Started Treatment|Registration and Treatment Start||30
2642681|NCT01853644|6499341|P1|Registered|Registration and Treatment Start||31
2642682|NCT01853644|6499341|P1|STARTED|Registration and Treatment Start||31
2642683|NCT01832961|6499350|P2|NOT COMPLETED|Third Intervention||0
2642684|NCT01832961|6499351|P1|NOT COMPLETED|Third Intervention||0
2642685|NCT01832961|6499350|P2|COMPLETED|Third Intervention||7
2642686|NCT01832961|6499351|P1|COMPLETED|Third Intervention||8
2642687|NCT01832961|6499350|P2|STARTED|Third Intervention||7
2642688|NCT01832961|6499351|P1|STARTED|Third Intervention||8
2642689|NCT01832961|6499350|P2|NOT COMPLETED|Second Intervention||0
2642690|NCT01832961|6499351|P1|NOT COMPLETED|Second Intervention||0
2642691|NCT01832961|6499350|P2|COMPLETED|Second Intervention||7
2642692|NCT01832961|6499351|P1|COMPLETED|Second Intervention||8
2642693|NCT01832961|6499350|P2|STARTED|Second Intervention||7
2642694|NCT01832961|6499351|P1|STARTED|Second Intervention||8
2642695|NCT01832961|6499350|P2|NOT COMPLETED|Washout||0
2642696|NCT01832961|6499351|P1|NOT COMPLETED|Washout||0
2642697|NCT01832961|6499350|P2|COMPLETED|Washout||7
2642698|NCT01832961|6499351|P1|COMPLETED|Washout||8
2642699|NCT01832961|6499350|P2|STARTED|Washout||7
2642700|NCT01832961|6499351|P1|STARTED|Washout||8
2642701|NCT01832961|6499350|P2|NOT COMPLETED|First Intervention||0
2642702|NCT01832961|6499351|P1|NOT COMPLETED|First Intervention||0
2642703|NCT01832961|6499350|P2|COMPLETED|First Intervention||7
2642704|NCT01832961|6499351|P1|COMPLETED|First Intervention||8
2642705|NCT01832961|6499350|P2|STARTED|First Intervention||7
2642706|NCT01832961|6499351|P1|STARTED|First Intervention||8
2642707|NCT01811654|6499381|P2|NOT COMPLETED|Overall Study||0
2642708|NCT01811654|6499382|P1|NOT COMPLETED|Overall Study||0
2642709|NCT01811654|6499381|P2|COMPLETED|Overall Study||16
2642710|NCT01811654|6499382|P1|COMPLETED|Overall Study||14
2642711|NCT01811654|6499381|P2|STARTED|Overall Study||16
2642712|NCT01811654|6499382|P1|STARTED|Overall Study||14
2642713|NCT01807299|6499394|P4|NOT COMPLETED|Overall Study||2
2642714|NCT01807299|6499395|P3|NOT COMPLETED|Overall Study||0
2642715|NCT01807299|6499396|P2|NOT COMPLETED|Overall Study||1
2642716|NCT01807299|6499397|P1|NOT COMPLETED|Overall Study||3
2642717|NCT01807299|6499394|P4|COMPLETED|Overall Study||11
2642718|NCT01807299|6499395|P3|COMPLETED|Overall Study||12
2642719|NCT01807299|6499396|P2|COMPLETED|Overall Study||13
2642720|NCT01807299|6499397|P1|COMPLETED|Overall Study||11
2642721|NCT01807299|6499394|P4|STARTED|Overall Study||13
2642722|NCT01807299|6499395|P3|STARTED|Overall Study||12
2642723|NCT01807299|6499396|P2|STARTED|Overall Study||14
2642724|NCT01807299|6499397|P1|STARTED|Overall Study||14
2642725|NCT01797263|6499409|P2|NOT COMPLETED|Overall Study||40
2642726|NCT01797263|6499410|P1|NOT COMPLETED|Overall Study||37
2642727|NCT01797263|6499409|P2|COMPLETED|Overall Study||87
2642728|NCT01797263|6499410|P1|COMPLETED|Overall Study||92
2642729|NCT01797263|6499409|P2|9 Month|Overall Study||87
2642730|NCT01797263|6499410|P1|9 Month|Overall Study||92
2642731|NCT01797263|6499409|P2|6 Month|Overall Study||85
2642732|NCT01797263|6499410|P1|6 Month|Overall Study||90
2642733|NCT01797263|6499409|P2|3 Month|Overall Study||84
2642734|NCT01797263|6499410|P1|3 Month|Overall Study||87
2642735|NCT01797263|6499409|P2|1 Month|Overall Study||87
2642736|NCT01797263|6499410|P1|1 Month|Overall Study||96
2642737|NCT01797263|6499409|P2|STARTED|Overall Study||127
2642738|NCT01797263|6499410|P1|STARTED|Overall Study||129
2642739|NCT01787292|6499442|P2|NOT COMPLETED|Home Based Exercise Program||1
2642740|NCT01787292|6499443|P1|NOT COMPLETED|Home Based Exercise Program||3
2642741|NCT01787292|6499442|P2|COMPLETED|Home Based Exercise Program||13
2642742|NCT01787292|6499443|P1|COMPLETED|Home Based Exercise Program||12
2642743|NCT01787292|6499442|P2|STARTED|Home Based Exercise Program||14
2642744|NCT01787292|6499443|P1|STARTED|Home Based Exercise Program||15
2642745|NCT01787292|6499442|P2|NOT COMPLETED|Crossover Exercise Interventions||2
2642746|NCT01787292|6499443|P1|NOT COMPLETED|Crossover Exercise Interventions||2
2642747|NCT01787292|6499442|P2|COMPLETED|Crossover Exercise Interventions|These participants completed the 12-week in-house program and cross-over into the balance program.|14
2642748|NCT01787292|6499443|P1|COMPLETED|Crossover Exercise Interventions|Participants completed the 12-week in-house program and cross-over into the balance program.|15
2642749|NCT01787292|6499442|P2|STARTED|Crossover Exercise Interventions|Participants in this group performed balance training prior to cross-over to aerobic training.|16
2642750|NCT01787292|6499443|P1|STARTED|Crossover Exercise Interventions|Participants in this group performed aerobic training prior to cross-over to balance training.|17
2642751|NCT01753401|6499462|P4|NOT COMPLETED|Open Label Period (44 Weeks)||9
2642752|NCT01753401|6499463|P3|NOT COMPLETED|Open Label Period (44 Weeks)||4
2642753|NCT01753401|6499464|P2|NOT COMPLETED|Open Label Period (44 Weeks)||0
2642754|NCT01753401|6499465|P1|NOT COMPLETED|Open Label Period (44 Weeks)||0
2642755|NCT01753401|6499462|P4|COMPLETED|Open Label Period (44 Weeks)||13
2642756|NCT01753401|6499463|P3|COMPLETED|Open Label Period (44 Weeks)||7
2642757|NCT01753401|6499464|P2|COMPLETED|Open Label Period (44 Weeks)||0
2642758|NCT01753401|6499465|P1|COMPLETED|Open Label Period (44 Weeks)||0
2642759|NCT01753401|6499462|P4|Safety Analysis Set|Open Label Period (44 Weeks)||22
2642760|NCT01753401|6499463|P3|Safety Analysis Set|Open Label Period (44 Weeks)||11
2642761|NCT01753401|6499464|P2|Safety Analysis Set|Open Label Period (44 Weeks)||0
2642762|NCT01753401|6499465|P1|Safety Analysis Set|Open Label Period (44 Weeks)||0
2642763|NCT01753401|6499462|P4|mITT|Open Label Period (44 Weeks)||22
2642764|NCT01753401|6499463|P3|mITT|Open Label Period (44 Weeks)||11
2642765|NCT01753401|6499464|P2|mITT|Open Label Period (44 Weeks)||0
2642766|NCT01753401|6499465|P1|mITT|Open Label Period (44 Weeks)||0
2642767|NCT01753401|6499462|P4|STARTED|Open Label Period (44 Weeks)||22
2642768|NCT01753401|6499463|P3|STARTED|Open Label Period (44 Weeks)||11
2642769|NCT01753401|6499464|P2|STARTED|Open Label Period (44 Weeks)|This arm was not included in the open label period|0
2642770|NCT01753401|6499465|P1|STARTED|Open Label Period (44 Weeks)|This arm was not included in the open label period|0
2642771|NCT01753401|6499462|P4|NOT COMPLETED|Double-blind Period (8 Weeks)||0
2642772|NCT01753401|6499463|P3|NOT COMPLETED|Double-blind Period (8 Weeks)||0
2642773|NCT01753401|6499464|P2|NOT COMPLETED|Double-blind Period (8 Weeks)||4
2642774|NCT01753401|6499465|P1|NOT COMPLETED|Double-blind Period (8 Weeks)||1
2642775|NCT01753401|6499462|P4|COMPLETED|Double-blind Period (8 Weeks)||0
2642776|NCT01753401|6499463|P3|COMPLETED|Double-blind Period (8 Weeks)||0
2642777|NCT01753401|6499464|P2|COMPLETED|Double-blind Period (8 Weeks)||22
2642778|NCT01753401|6499465|P1|COMPLETED|Double-blind Period (8 Weeks)||11
2642779|NCT01753401|6499462|P4|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||0
2642780|NCT01753401|6499463|P3|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||0
2642781|NCT01753401|6499464|P2|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||25
2642782|NCT01753401|6499465|P1|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||11
2642783|NCT01753401|6499462|P4|STARTED|Double-blind Period (8 Weeks)|This arm was not included in the double-blind period|0
2642784|NCT01753401|6499463|P3|STARTED|Double-blind Period (8 Weeks)|This arm was not included in the double-blind period|0
2642785|NCT01753401|6499464|P2|STARTED|Double-blind Period (8 Weeks)||26
2642786|NCT01753401|6499465|P1|STARTED|Double-blind Period (8 Weeks)||12
2642787|NCT01752426|6499513|P1|NOT COMPLETED|Overall Study||0
2642788|NCT01752426|6499513|P1|COMPLETED|Overall Study||30
2642789|NCT01752426|6499513|P1|STARTED|Overall Study||30
2642790|NCT01749293|6499518|P1|NOT COMPLETED|Overall Study||0
2642791|NCT01749293|6499518|P1|COMPLETED|Overall Study||3
2642792|NCT01749293|6499518|P1|STARTED|Overall Study||3
2642793|NCT01740427|6499526|P2|NOT COMPLETED|Overall Study||222
2642794|NCT01740427|6499527|P1|NOT COMPLETED|Overall Study||444
2642795|NCT01740427|6499526|P2|COMPLETED|Overall Study||0
2642796|NCT01740427|6499527|P1|COMPLETED|Overall Study||0
2642797|NCT01740427|6499526|P2|STARTED|Overall Study||222
2642798|NCT01740427|6499527|P1|STARTED|Overall Study||444
2642799|NCT01729208|6499556|P2|NOT COMPLETED|36 Months Follow-up||4
2642800|NCT01729208|6499557|P1|NOT COMPLETED|36 Months Follow-up||3
2642801|NCT01729208|6499556|P2|COMPLETED|36 Months Follow-up||56
2642802|NCT01729208|6499557|P1|COMPLETED|36 Months Follow-up||52
2642803|NCT01729208|6499556|P2|STARTED|36 Months Follow-up||60
2642804|NCT01729208|6499557|P1|STARTED|36 Months Follow-up||55
2642805|NCT01729208|6499556|P2|NOT COMPLETED|24 Months Follow-up||0
2642806|NCT01729208|6499557|P1|NOT COMPLETED|24 Months Follow-up||3
2642807|NCT01729208|6499556|P2|COMPLETED|24 Months Follow-up||60
2642808|NCT01729208|6499557|P1|COMPLETED|24 Months Follow-up||55
2642809|NCT01729208|6499556|P2|STARTED|24 Months Follow-up||60
2642810|NCT01729208|6499557|P1|STARTED|24 Months Follow-up||58
2642811|NCT01729208|6499556|P2|NOT COMPLETED|12 Months Follow-up||10
2642812|NCT01729208|6499557|P1|NOT COMPLETED|12 Months Follow-up||7
2642813|NCT01729208|6499556|P2|COMPLETED|12 Months Follow-up||60
2642814|NCT01729208|6499557|P1|COMPLETED|12 Months Follow-up||58
2642815|NCT01729208|6499556|P2|STARTED|12 Months Follow-up||70
2642816|NCT01729208|6499557|P1|STARTED|12 Months Follow-up||65
2642817|NCT01729208|6499556|P2|NOT COMPLETED|Baseline||4
2642818|NCT01729208|6499557|P1|NOT COMPLETED|Baseline||5
2642819|NCT01729208|6499556|P2|COMPLETED|Baseline||70
2642820|NCT01729208|6499557|P1|COMPLETED|Baseline||65
2642821|NCT01729208|6499556|P2|STARTED|Baseline||74
2642822|NCT01729208|6499557|P1|STARTED|Baseline||70
2642823|NCT01723826|6499591|P4|NOT COMPLETED|Overall Study||90
2642824|NCT01723826|6499592|P3|NOT COMPLETED|Overall Study||57
2642825|NCT01723826|6499593|P2|NOT COMPLETED|Overall Study||36
2642826|NCT01723826|6499594|P1|NOT COMPLETED|Overall Study||27
2642827|NCT01723826|6499591|P4|COMPLETED|Overall Study||59
2642828|NCT01723826|6499592|P3|COMPLETED|Overall Study||44
2642829|NCT01723826|6499593|P2|COMPLETED|Overall Study||27
2642830|NCT01723826|6499594|P1|COMPLETED|Overall Study||20
2642831|NCT01723826|6499591|P4|STARTED|Overall Study||149
2642832|NCT01723826|6499592|P3|STARTED|Overall Study||101
2642833|NCT01723826|6499593|P2|STARTED|Overall Study||63
2642834|NCT01723826|6499594|P1|STARTED|Overall Study||47
2642835|NCT01697800|6499626|P2|NOT COMPLETED|Overall Study||1
2642836|NCT01697800|6499627|P1|NOT COMPLETED|Overall Study||0
2642837|NCT01697800|6499626|P2|COMPLETED|Overall Study||24
2642838|NCT01697800|6499627|P1|COMPLETED|Overall Study||15
2642839|NCT01697800|6499626|P2|STARTED|Overall Study||25
2642840|NCT01697800|6499627|P1|STARTED|Overall Study||15
2642841|NCT01691950|6499635|P2|NOT COMPLETED|Overall Study||0
2642842|NCT01691950|6499636|P1|NOT COMPLETED|Overall Study||10
2642843|NCT01691950|6499635|P2|COMPLETED|Overall Study||10
2642844|NCT01691950|6499636|P1|COMPLETED|Overall Study||10
2642845|NCT01691950|6499635|P2|STARTED|Overall Study||10
2642846|NCT01691950|6499636|P1|STARTED|Overall Study||20
2642847|NCT01691898|6499648|P6|NOT COMPLETED|Overall Study||35
2642848|NCT01691898|6499649|P5|NOT COMPLETED|Overall Study||14
2642849|NCT01691898|6499650|P4|NOT COMPLETED|Overall Study||5
2642850|NCT01691898|6499651|P3|NOT COMPLETED|Overall Study||9
2642851|NCT01691898|6499652|P2|NOT COMPLETED|Overall Study||44
2642852|NCT01691898|6499653|P1|NOT COMPLETED|Overall Study||47
2642853|NCT01691898|6499648|P6|COMPLETED|Overall Study||5
2642854|NCT01691898|6499649|P5|COMPLETED|Overall Study||26
2642855|NCT01691898|6499650|P4|COMPLETED|Overall Study||4
2642856|NCT01691898|6499651|P3|COMPLETED|Overall Study||11
2642857|NCT01691898|6499652|P2|COMPLETED|Overall Study||15
2642858|NCT01691898|6499653|P1|COMPLETED|Overall Study||16
2642859|NCT01691898|6499648|P6|STARTED|Overall Study||40
2642860|NCT01691898|6499649|P5|STARTED|Overall Study||40
2642861|NCT01691898|6499650|P4|STARTED|Overall Study||9
2642862|NCT01691898|6499651|P3|STARTED|Overall Study||20
2642863|NCT01691898|6499652|P2|STARTED|Overall Study||59
2642864|NCT01691898|6499653|P1|STARTED|Overall Study||63
2642865|NCT01668355|6499809|P2|NOT COMPLETED|Overall Study||2
2642866|NCT01668355|6499810|P1|NOT COMPLETED|Overall Study||9
2642867|NCT01668355|6499809|P2|COMPLETED|Overall Study||165
2642868|NCT01668355|6499810|P1|COMPLETED|Overall Study||155
2642869|NCT01668355|6499809|P2|STARTED|Overall Study||167
2642870|NCT01668355|6499810|P1|STARTED|Overall Study||164
2642871|NCT01665144|6499832|P2|NOT COMPLETED|Overall Study||122
2642872|NCT01665144|6499833|P1|NOT COMPLETED|Overall Study||202
2642873|NCT01665144|6499832|P2|COMPLETED|Overall Study||424
2642874|NCT01665144|6499833|P1|COMPLETED|Overall Study||903
2642875|NCT01665144|6499832|P2|Full Analysis Set|Overall Study||546
2642876|NCT01665144|6499833|P1|Full Analysis Set|Overall Study||1099
2642877|NCT01665144|6499832|P2|Safety Set|Overall Study||546
2642878|NCT01665144|6499833|P1|Safety Set|Overall Study||1099
2642879|NCT01665144|6499832|P2|STARTED|Overall Study||546
2642880|NCT01665144|6499833|P1|STARTED|Overall Study||1105
2642881|NCT01649765|6499841|P2|NOT COMPLETED|Overall Study||8
2642882|NCT01649765|6499842|P1|NOT COMPLETED|Overall Study||9
2642883|NCT01649765|6499841|P2|COMPLETED|Overall Study||45
2642884|NCT01649765|6499842|P1|COMPLETED|Overall Study||31
2642885|NCT01649765|6499841|P2|STARTED|Overall Study||53
2642886|NCT01649765|6499842|P1|STARTED|Overall Study||40
2642887|NCT01648296|6499870|P2|NOT COMPLETED|Overall Study||0
2642888|NCT01648296|6499871|P1|NOT COMPLETED|Overall Study||0
2642889|NCT01648296|6499870|P2|COMPLETED|Overall Study||17
2642890|NCT01648296|6499871|P1|COMPLETED|Overall Study||11
2642891|NCT01648296|6499870|P2|STARTED|Overall Study||17
2642892|NCT01648296|6499871|P1|STARTED|Overall Study||11
2642893|NCT01643850|6499888|P9|NOT COMPLETED|Overall Study||1
2642894|NCT01643850|6499889|P8|NOT COMPLETED|Overall Study||0
2642895|NCT01643850|6499890|P7|NOT COMPLETED|Overall Study||1
2642896|NCT01643850|6499891|P6|NOT COMPLETED|Overall Study||0
2642897|NCT01643850|6499892|P5|NOT COMPLETED|Overall Study||3
2642898|NCT01643850|6499893|P4|NOT COMPLETED|Overall Study||0
2642899|NCT01643850|6499894|P3|NOT COMPLETED|Overall Study||1
2642900|NCT01643850|6499895|P2|NOT COMPLETED|Overall Study||0
2642901|NCT01643850|6499896|P1|NOT COMPLETED|Overall Study||0
2642902|NCT01643850|6499888|P9|COMPLETED|Overall Study||3
2642903|NCT01643850|6499889|P8|COMPLETED|Overall Study||4
2642904|NCT01643850|6499890|P7|COMPLETED|Overall Study||3
2642905|NCT01643850|6499891|P6|COMPLETED|Overall Study||3
2642906|NCT01643850|6499892|P5|COMPLETED|Overall Study||0
2642907|NCT01643850|6499893|P4|COMPLETED|Overall Study||3
2642908|NCT01643850|6499894|P3|COMPLETED|Overall Study||7
2642909|NCT01643850|6499895|P2|COMPLETED|Overall Study||2
2642910|NCT01643850|6499896|P1|COMPLETED|Overall Study||5
2642911|NCT01643850|6499888|P9|STARTED|Overall Study||4
2642912|NCT01643850|6499889|P8|STARTED|Overall Study||4
2642913|NCT01643850|6499890|P7|STARTED|Overall Study||4
2642914|NCT01643850|6499891|P6|STARTED|Overall Study||3
2642915|NCT01643850|6499892|P5|STARTED|Overall Study||3
2642916|NCT01643850|6499893|P4|STARTED|Overall Study||3
2642917|NCT01643850|6499894|P3|STARTED|Overall Study||8
2642918|NCT01643850|6499895|P2|STARTED|Overall Study||2
2642919|NCT01643850|6499896|P1|STARTED|Overall Study||5
2642920|NCT01640366|6500035|P1|NOT COMPLETED|Overall Study||22
2642921|NCT01640366|6500035|P1|COMPLETED|Overall Study||178
2642922|NCT01640366|6500035|P1|Day 90 Follow-up|Overall Study||178
2642923|NCT01640366|6500035|P1|Day 42 Follow-up|Overall Study||177
2642924|NCT01640366|6500035|P1|Day 21 Follow-up|Overall Study||185
2642925|NCT01640366|6500035|P1|STARTED|Overall Study||200
2642926|NCT01629511|6500052|P4|NOT COMPLETED|Overall Study||0
2642927|NCT01629511|6500053|P3|NOT COMPLETED|Overall Study||0
2642928|NCT01629511|6500054|P2|NOT COMPLETED|Overall Study||0
2642929|NCT01629511|6500055|P1|NOT COMPLETED|Overall Study||0
2642930|NCT01629511|6500052|P4|COMPLETED|Overall Study||3
2642931|NCT01629511|6500053|P3|COMPLETED|Overall Study||8
2642932|NCT01629511|6500054|P2|COMPLETED|Overall Study||0
2642933|NCT01629511|6500055|P1|COMPLETED|Overall Study||4
2642934|NCT01629511|6500052|P4|STARTED|Overall Study||3
2642935|NCT01629511|6500053|P3|STARTED|Overall Study||8
2642936|NCT01629511|6500054|P2|STARTED|Overall Study||0
2642937|NCT01629511|6500055|P1|STARTED|Overall Study||4
2642938|NCT01619085|6500085|P1|NOT COMPLETED|Overall Study||369
2642939|NCT01619085|6500085|P1|COMPLETED|Overall Study|Total 341 patients did not complete the trial.|366
2642940|NCT01619085|6500085|P1|STARTED|Overall Study|27 patients were ongoing on trial at database lock. 1 patient was not treated with trial drugs.|735
2642941|NCT01615029|6500094|P5|NOT COMPLETED|Overall Study||32
2642942|NCT01615029|6500095|P4|NOT COMPLETED|Overall Study||3
2642943|NCT01615029|6500096|P3|NOT COMPLETED|Overall Study||4
2642944|NCT01615029|6500097|P2|NOT COMPLETED|Overall Study||3
2642945|NCT01615029|6500098|P1|NOT COMPLETED|Overall Study||3
2642946|NCT01615029|6500094|P5|COMPLETED|Overall Study||0
2642947|NCT01615029|6500095|P4|COMPLETED|Overall Study||0
2642948|NCT01615029|6500096|P3|COMPLETED|Overall Study||0
2642949|NCT01615029|6500097|P2|COMPLETED|Overall Study||0
2642950|NCT01615029|6500098|P1|COMPLETED|Overall Study||0
2642951|NCT01615029|6500094|P5|STARTED|Overall Study||32
2642952|NCT01615029|6500095|P4|STARTED|Overall Study||3
2642953|NCT01615029|6500096|P3|STARTED|Overall Study||4
2642954|NCT01615029|6500097|P2|STARTED|Overall Study||3
2642955|NCT01615029|6500098|P1|STARTED|Overall Study||3
2642956|NCT01596699|6500121|P2|NOT COMPLETED|Overall Study||0
2642957|NCT01596699|6500122|P1|NOT COMPLETED|Overall Study||0
2642958|NCT01596699|6500121|P2|COMPLETED|Overall Study||6
2642959|NCT01596699|6500122|P1|COMPLETED|Overall Study||10
2642960|NCT01596699|6500121|P2|STARTED|Overall Study||6
2642961|NCT01596699|6500122|P1|STARTED|Overall Study||10
2642962|NCT01569594|6500132|P1|NOT COMPLETED|Overall Study||67
2642963|NCT01569594|6500132|P1|COMPLETED|Overall Study||163
2642964|NCT01569594|6500132|P1|STARTED|Overall Study||230
2642965|NCT01566695|6500138|P2|NOT COMPLETED|Overall Study||99
2642966|NCT01566695|6500139|P1|NOT COMPLETED|Overall Study||95
2642967|NCT01566695|6500138|P2|COMPLETED|Overall Study||10
2642968|NCT01566695|6500139|P1|COMPLETED|Overall Study||12
2642969|NCT01566695|6500138|P2|STARTED|Overall Study||109
2642970|NCT01566695|6500139|P1|STARTED|Overall Study||107
2642971|NCT01557881|6500241|P1|NOT COMPLETED|Overall Study||0
2642972|NCT01557881|6500241|P1|COMPLETED|Overall Study||98
2642973|NCT01557881|6500241|P1|STARTED|Overall Study||98
2642974|NCT01497756|6500247|P1|NOT COMPLETED|Overall Study||0
2642975|NCT01497756|6500247|P1|COMPLETED|Overall Study||10
2642976|NCT01497756|6500247|P1|STARTED|Overall Study||10
2642977|NCT01470781|6500254|P2|NOT COMPLETED|Overall Study||12
2642978|NCT01470781|6500255|P1|NOT COMPLETED|Overall Study||18
2642979|NCT01470781|6500254|P2|COMPLETED|Overall Study||21
2642980|NCT01470781|6500255|P1|COMPLETED|Overall Study||21
2642981|NCT01470781|6500254|P2|Post-Treatment Assessment|Overall Study||23
2642982|NCT01470781|6500255|P1|Post-Treatment Assessment|Overall Study||22
2642983|NCT01470781|6500254|P2|Midpoint Assessment|Overall Study||30
2642984|NCT01470781|6500255|P1|Midpoint Assessment|Overall Study||30
2642985|NCT01470781|6500254|P2|STARTED|Overall Study||33
2642986|NCT01470781|6500255|P1|STARTED|Overall Study||39
2642987|NCT01467427|6500273|P2|NOT COMPLETED|Overall Study||13
2642988|NCT01467427|6500274|P1|NOT COMPLETED|Overall Study||12
2642989|NCT01467427|6500273|P2|COMPLETED|Overall Study||0
2642990|NCT01467427|6500274|P1|COMPLETED|Overall Study||0
2642991|NCT01467427|6500273|P2|Completed Main Phase|Overall Study||13
2642992|NCT01467427|6500274|P1|Completed Main Phase|Overall Study||11
2642993|NCT01467427|6500273|P2|STARTED|Overall Study||13
2642994|NCT01467427|6500274|P1|STARTED|Overall Study||12
2642995|NCT01463306|6500295|P3|NOT COMPLETED|Overall Study||5
2642996|NCT01463306|6500296|P2|NOT COMPLETED|Overall Study||52
2642997|NCT01463306|6500297|P1|NOT COMPLETED|Overall Study||86
2642998|NCT01463306|6500295|P3|COMPLETED|Overall Study||6
2642999|NCT01463306|6500296|P2|COMPLETED|Overall Study||158
2643000|NCT01463306|6500297|P1|COMPLETED|Overall Study||298
2643001|NCT01463306|6500295|P3|STARTED|Overall Study||11
2643002|NCT01463306|6500296|P2|STARTED|Overall Study||210
2643003|NCT01463306|6500297|P1|STARTED|Overall Study||384
2643004|NCT01438177|6500365|P1|NOT COMPLETED|Overall Study||2
2643005|NCT01438177|6500365|P1|COMPLETED|Overall Study|Patients who were off due to disease progression|9
2643006|NCT01438177|6500365|P1|STARTED|Overall Study||11
2643007|NCT01411267|6500378|P10|NOT COMPLETED|Overall Study||0
2643008|NCT01411267|6500379|P9|NOT COMPLETED|Overall Study||0
2643009|NCT01411267|6500380|P8|NOT COMPLETED|Overall Study||0
2643010|NCT01411267|6500381|P7|NOT COMPLETED|Overall Study||0
2643011|NCT01411267|6500382|P6|NOT COMPLETED|Overall Study||2
2643012|NCT01411267|6500383|P5|NOT COMPLETED|Overall Study||2
2643013|NCT01411267|6500384|P4|NOT COMPLETED|Overall Study||1
2643014|NCT01411267|6500385|P3|NOT COMPLETED|Overall Study||0
2643015|NCT01411267|6500386|P2|NOT COMPLETED|Overall Study||0
2643016|NCT01411267|6500387|P1|NOT COMPLETED|Overall Study||0
2643017|NCT01411267|6500378|P10|COMPLETED|Overall Study||0
2643018|NCT01411267|6500379|P9|COMPLETED|Overall Study||0
2643019|NCT01411267|6500380|P8|COMPLETED|Overall Study||0
2643020|NCT01411267|6500381|P7|COMPLETED|Overall Study||0
2643021|NCT01411267|6500382|P6|COMPLETED|Overall Study||10
2643022|NCT01411267|6500383|P5|COMPLETED|Overall Study||0
2643023|NCT01411267|6500384|P4|COMPLETED|Overall Study||4
2643024|NCT01411267|6500385|P3|COMPLETED|Overall Study||2
2643025|NCT01411267|6500386|P2|COMPLETED|Overall Study||3
2643026|NCT01411267|6500387|P1|COMPLETED|Overall Study||0
2643027|NCT01411267|6500378|P10|STARTED|Overall Study||0
2643028|NCT01411267|6500379|P9|STARTED|Overall Study||0
2643029|NCT01411267|6500380|P8|STARTED|Overall Study||0
2643030|NCT01411267|6500381|P7|STARTED|Overall Study||0
2643031|NCT01411267|6500382|P6|STARTED|Overall Study||12
2643032|NCT01411267|6500383|P5|STARTED|Overall Study||2
2643033|NCT01411267|6500384|P4|STARTED|Overall Study||5
2643034|NCT01411267|6500385|P3|STARTED|Overall Study||2
2643035|NCT01411267|6500386|P2|STARTED|Overall Study||3
2643036|NCT01411267|6500387|P1|STARTED|Overall Study||0
2643037|NCT01393821|6500407|P2|NOT COMPLETED|Overall Study||3
2643038|NCT01393821|6500408|P1|NOT COMPLETED|Overall Study||5
2643039|NCT01393821|6500407|P2|COMPLETED|Overall Study||10
2643040|NCT01393821|6500408|P1|COMPLETED|Overall Study||9
2643041|NCT01393821|6500407|P2|STARTED|Overall Study||13
2643042|NCT01393821|6500408|P1|STARTED|Overall Study||14
2643043|NCT01371305|6500426|P6|NOT COMPLETED|Overall Study||2
2643044|NCT01371305|6500427|P5|NOT COMPLETED|Overall Study||4
2643045|NCT01371305|6500428|P4|NOT COMPLETED|Overall Study||2
2643046|NCT01371305|6500429|P3|NOT COMPLETED|Overall Study||0
2643047|NCT01371305|6500430|P2|NOT COMPLETED|Overall Study||0
2643048|NCT01371305|6500431|P1|NOT COMPLETED|Overall Study||0
2643049|NCT01371305|6500426|P6|COMPLETED|Overall Study||8
2643050|NCT01371305|6500427|P5|COMPLETED|Overall Study||2
2643051|NCT01371305|6500428|P4|COMPLETED|Overall Study||5
2643052|NCT01371305|6500429|P3|COMPLETED|Overall Study||6
2643053|NCT01371305|6500430|P2|COMPLETED|Overall Study||6
2643054|NCT01371305|6500431|P1|COMPLETED|Overall Study||6
2643055|NCT01371305|6500426|P6|STARTED|Overall Study||10
2643056|NCT01371305|6500427|P5|STARTED|Overall Study||6
2643057|NCT01371305|6500428|P4|STARTED|Overall Study||7
2643058|NCT01371305|6500429|P3|STARTED|Overall Study||6
2643059|NCT01371305|6500430|P2|STARTED|Overall Study||6
2643060|NCT01371305|6500431|P1|STARTED|Overall Study||6
2643061|NCT01369199|6500502|P1|NOT COMPLETED|Overall Study||3
2643062|NCT01369199|6500502|P1|COMPLETED|Overall Study||25
2643063|NCT01369199|6500502|P1|End of Treatment (EOT)|Overall Study|1 withdrew consent before treatment,1 missed end of treatment (EOT) visit but completed follow-up.|26
2643064|NCT01369199|6500502|P1|STARTED|Overall Study||28
2643065|NCT01362127|6500526|P2|NOT COMPLETED|Overall Study||0
2643066|NCT01362127|6500527|P1|NOT COMPLETED|Overall Study||0
2643067|NCT01362127|6500526|P2|COMPLETED|Overall Study||91
2643068|NCT01362127|6500527|P1|COMPLETED|Overall Study||90
2643069|NCT01362127|6500526|P2|STARTED|Overall Study||91
2643070|NCT01362127|6500527|P1|STARTED|Overall Study||90
2643071|NCT01348542|6500539|P2|NOT COMPLETED|Overall Study||0
2643072|NCT01348542|6500540|P1|NOT COMPLETED|Overall Study||3
2643073|NCT01348542|6500539|P2|COMPLETED|Overall Study||11
2643074|NCT01348542|6500540|P1|COMPLETED|Overall Study||10
2643075|NCT01348542|6500539|P2|STARTED|Overall Study||11
2643076|NCT01348542|6500540|P1|STARTED|Overall Study||13
2643077|NCT01337700|6500558|P2|NOT COMPLETED|Overall Study||0
2643078|NCT01337700|6500559|P1|NOT COMPLETED|Overall Study||0
2643079|NCT01337700|6500558|P2|COMPLETED|Overall Study||5
2643080|NCT01337700|6500559|P1|COMPLETED|Overall Study||5
2643081|NCT01337700|6500558|P2|STARTED|Overall Study||5
2643082|NCT01337700|6500559|P1|STARTED|Overall Study||5
2643083|NCT01337687|6500575|P2|NOT COMPLETED|Overall Study||0
2643084|NCT01337687|6500576|P1|NOT COMPLETED|Overall Study||0
2643085|NCT01337687|6500575|P2|COMPLETED|Overall Study||9
2643086|NCT01337687|6500576|P1|COMPLETED|Overall Study||10
2643087|NCT01337687|6500575|P2|STARTED|Overall Study||9
2643088|NCT01337687|6500576|P1|STARTED|Overall Study||10
2643089|NCT01317160|6500590|P2|NOT COMPLETED|Overall Study||6
2643090|NCT01317160|6500591|P1|NOT COMPLETED|Overall Study||4
2643091|NCT01317160|6500590|P2|COMPLETED|Overall Study||69
2643092|NCT01317160|6500591|P1|COMPLETED|Overall Study||71
2643093|NCT01317160|6500590|P2|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
2643094|NCT01317160|6500591|P1|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
2643095|NCT01317160|6500590|P2|STARTED|Overall Study||75
2643096|NCT01317160|6500591|P1|STARTED|Overall Study||75
2643097|NCT01293682|6500599|P1|NOT COMPLETED|Overall Study||0
2643098|NCT01293682|6500599|P1|COMPLETED|Overall Study||12
2643099|NCT01293682|6500599|P1|STARTED|Overall Study||12
2643100|NCT01289457|6500607|P3|NOT COMPLETED|Overall Study||0
2643101|NCT01289457|6500608|P2|NOT COMPLETED|Overall Study||0
2643102|NCT01289457|6500609|P1|NOT COMPLETED|Overall Study||0
2643103|NCT01289457|6500607|P3|COMPLETED|Overall Study||113
2643104|NCT01289457|6500608|P2|COMPLETED|Overall Study||157
2643105|NCT01289457|6500609|P1|COMPLETED|Overall Study||12
2643106|NCT01289457|6500607|P3|STARTED|Overall Study||113
2643107|NCT01289457|6500608|P2|STARTED|Overall Study||157
2643108|NCT01289457|6500609|P1|STARTED|Overall Study||12
2643109|NCT01251393|6500628|P2|NOT COMPLETED|Overall Study||44
2643110|NCT01251393|6500629|P1|NOT COMPLETED|Overall Study||32
2643111|NCT01251393|6500628|P2|COMPLETED|Overall Study||11
2643112|NCT01251393|6500629|P1|COMPLETED|Overall Study||24
2643113|NCT01251393|6500628|P2|STARTED|Overall Study||55
2643114|NCT01251393|6500629|P1|STARTED|Overall Study||56
2643115|NCT01202409|6500635|P1|NOT COMPLETED|Overall Study||8
2643116|NCT01202409|6500635|P1|COMPLETED|Overall Study||11
2643117|NCT01202409|6500635|P1|STARTED|Overall Study||19
2643118|NCT01149096|6500642|P2|NOT COMPLETED|Overall Study||1
2643119|NCT01149096|6500643|P1|NOT COMPLETED|Overall Study||0
2643120|NCT01149096|6500642|P2|COMPLETED|Overall Study||6
2643121|NCT01149096|6500643|P1|COMPLETED|Overall Study||6
2643122|NCT01149096|6500642|P2|STARTED|Overall Study||7
2643123|NCT01149096|6500643|P1|STARTED|Overall Study||6
2643124|NCT01114971|6500670|P3|NOT COMPLETED|Overall Study||0
2643125|NCT01114971|6500671|P2|NOT COMPLETED|Overall Study||0
2643126|NCT01114971|6500672|P1|NOT COMPLETED|Overall Study||0
2643127|NCT01114971|6500670|P3|COMPLETED|Overall Study||25
2643128|NCT01114971|6500671|P2|COMPLETED|Overall Study||25
2643129|NCT01114971|6500672|P1|COMPLETED|Overall Study||25
2643130|NCT01114971|6500670|P3|STARTED|Overall Study||25
2643131|NCT01114971|6500671|P2|STARTED|Overall Study||25
2643132|NCT01114971|6500672|P1|STARTED|Overall Study||25
2643133|NCT01098006|6500699|P4|NOT COMPLETED|Overall Study||0
2643134|NCT01098006|6500700|P3|NOT COMPLETED|Overall Study||0
2643135|NCT01098006|6500701|P2|NOT COMPLETED|Overall Study||0
2643136|NCT01098006|6500702|P1|NOT COMPLETED|Overall Study||0
2643137|NCT01098006|6500699|P4|COMPLETED|Overall Study||21
2643138|NCT01098006|6500700|P3|COMPLETED|Overall Study||60
2643139|NCT01098006|6500701|P2|COMPLETED|Overall Study||11
2643140|NCT01098006|6500702|P1|COMPLETED|Overall Study||7
2643141|NCT01098006|6500699|P4|STARTED|Overall Study||21
2643142|NCT01098006|6500700|P3|STARTED|Overall Study||60
2643143|NCT01098006|6500701|P2|STARTED|Overall Study||11
2643144|NCT01098006|6500702|P1|STARTED|Overall Study||7
2643145|NCT01096550|6500778|P2|NOT COMPLETED|Overall Study||29
2643146|NCT01096550|6500779|P1|NOT COMPLETED|Overall Study||37
2643147|NCT01096550|6500778|P2|COMPLETED|Overall Study||146
2643148|NCT01096550|6500779|P1|COMPLETED|Overall Study||133
2643149|NCT01096550|6500778|P2|STARTED|Overall Study||175
2643150|NCT01096550|6500779|P1|STARTED|Overall Study||170
2643151|NCT01094782|6500791|P6|NOT COMPLETED|Overall Study||8
2643152|NCT01094782|6500792|P5|NOT COMPLETED|Overall Study||11
2643153|NCT01094782|6500793|P4|NOT COMPLETED|Overall Study||11
2643154|NCT01094782|6500794|P3|NOT COMPLETED|Overall Study||3
2643155|NCT01094782|6500795|P2|NOT COMPLETED|Overall Study||10
2643156|NCT01094782|6500796|P1|NOT COMPLETED|Overall Study||8
2643157|NCT01094782|6500791|P6|COMPLETED|Overall Study||30
2643158|NCT01094782|6500792|P5|COMPLETED|Overall Study||31
2643159|NCT01094782|6500793|P4|COMPLETED|Overall Study||45
2643160|NCT01094782|6500794|P3|COMPLETED|Overall Study||31
2643161|NCT01094782|6500795|P2|COMPLETED|Overall Study||29
2643162|NCT01094782|6500796|P1|COMPLETED|Overall Study||31
2643163|NCT01094782|6500791|P6|STARTED|Overall Study||38
2643164|NCT01094782|6500792|P5|STARTED|Overall Study||42
2643165|NCT01094782|6500793|P4|STARTED|Overall Study||56
2643166|NCT01094782|6500794|P3|STARTED|Overall Study||34
2643167|NCT01094782|6500795|P2|STARTED|Overall Study||39
2643168|NCT01094782|6500796|P1|STARTED|Overall Study||39
2643169|NCT01065454|6500844|P4|NOT COMPLETED|Follow up||44
2643170|NCT01065454|6500845|P3|NOT COMPLETED|Follow up||17
2643171|NCT01065454|6500846|P2|NOT COMPLETED|Follow up||24
2643172|NCT01065454|6500847|P1|NOT COMPLETED|Follow up||39
2643173|NCT01065454|6500844|P4|COMPLETED|Follow up||13
2643174|NCT01065454|6500845|P3|COMPLETED|Follow up||6
2643175|NCT01065454|6500846|P2|COMPLETED|Follow up||4
2643176|NCT01065454|6500847|P1|COMPLETED|Follow up||15
2643177|NCT01065454|6500844|P4|Entering Follow-up|Follow up||51
2643178|NCT01065454|6500845|P3|Entering Follow-up|Follow up||23
2643179|NCT01065454|6500846|P2|Entering Follow-up|Follow up||27
2643180|NCT01065454|6500847|P1|Entering Follow-up|Follow up||49
2643181|NCT01065454|6500844|P4|STARTED|Follow up||57
2643182|NCT01065454|6500845|P3|STARTED|Follow up||23
2643183|NCT01065454|6500846|P2|STARTED|Follow up||28
2643184|NCT01065454|6500847|P1|STARTED|Follow up||54
2643185|NCT01065454|6500844|P4|NOT COMPLETED|Treatment||12
2643186|NCT01065454|6500845|P3|NOT COMPLETED|Treatment||9
2643187|NCT01065454|6500846|P2|NOT COMPLETED|Treatment||5
2643188|NCT01065454|6500847|P1|NOT COMPLETED|Treatment||13
2643189|NCT01065454|6500844|P4|COMPLETED|Treatment||57
2643190|NCT01065454|6500845|P3|COMPLETED|Treatment||23
2643191|NCT01065454|6500846|P2|COMPLETED|Treatment||28
2643192|NCT01065454|6500847|P1|COMPLETED|Treatment||54
2643193|NCT01065454|6500844|P4|STARTED|Treatment||69
2643194|NCT01065454|6500845|P3|STARTED|Treatment||32
2643195|NCT01065454|6500846|P2|STARTED|Treatment||33
2643196|NCT01065454|6500847|P1|STARTED|Treatment||67
2643197|NCT01063517|6500959|P2|NOT COMPLETED|Overall Study||60
2643198|NCT01063517|6500960|P1|NOT COMPLETED|Overall Study||58
2643199|NCT01063517|6500959|P2|COMPLETED|Overall Study||2
2643200|NCT01063517|6500960|P1|COMPLETED|Overall Study||4
2643201|NCT01063517|6500959|P2|Received Randomised Treatment|Overall Study||62
2643202|NCT01063517|6500960|P1|Received Randomised Treatment|Overall Study||61
2643203|NCT01063517|6500959|P2|STARTED|Overall Study||62
2643204|NCT01063517|6500960|P1|STARTED|Overall Study||62
2643205|NCT01015833|6501000|P2|NOT COMPLETED|Overall Study||5
2643206|NCT01015833|6501001|P1|NOT COMPLETED|Overall Study||13
2643207|NCT01015833|6501000|P2|COMPLETED|Overall Study||171
2643208|NCT01015833|6501001|P1|COMPLETED|Overall Study||167
2643209|NCT01015833|6501000|P2|STARTED|Overall Study||176
2643210|NCT01015833|6501001|P1|STARTED|Overall Study||180
2643211|NCT01011413|6501017|P2|NOT COMPLETED|Overall Study||25
2643212|NCT01011413|6501018|P1|NOT COMPLETED|Overall Study||26
2643213|NCT01011413|6501017|P2|COMPLETED|Overall Study||299
2643214|NCT01011413|6501018|P1|COMPLETED|Overall Study||286
2643215|NCT01011413|6501017|P2|Lost to Follow-up Between Week 48 and 96|Overall Study||4
2643216|NCT01011413|6501018|P1|Lost to Follow-up Between Week 48 and 96|Overall Study||10
2643217|NCT01011413|6501017|P2|Withdrew Consent Between Week 48 and 96|Overall Study||6
2643218|NCT01011413|6501018|P1|Withdrew Consent Between Week 48 and 96|Overall Study||2
2643219|NCT01011413|6501017|P2|Died Between Week 48 and 96|Overall Study||3
2643220|NCT01011413|6501018|P1|Died Between Week 48 and 96|Overall Study||2
2643221|NCT01011413|6501017|P2|Attended w48 Visit|Overall Study||311
2643222|NCT01011413|6501018|P1|Attended w48 Visit|Overall Study||295
2643223|NCT01011413|6501017|P2|Withdrew Consent Before w48|Overall Study||3
2643224|NCT01011413|6501018|P1|Withdrew Consent Before w48|Overall Study||3
2643225|NCT01011413|6501017|P2|Lost to Follow up Before w48|Overall Study||4
2643226|NCT01011413|6501018|P1|Lost to Follow up Before w48|Overall Study||3
2643227|NCT01011413|6501017|P2|Died Before Week 48|Overall Study||2
2643228|NCT01011413|6501018|P1|Died Before Week 48|Overall Study||3
2643229|NCT01011413|6501017|P2|In Modified ITT|Overall Study||321
2643230|NCT01011413|6501018|P1|In Modified ITT|Overall Study||309
2643231|NCT01011413|6501017|P2|Did Not Start Study Drug|Overall Study||3
2643232|NCT01011413|6501018|P1|Did Not Start Study Drug|Overall Study||3
2643233|NCT01011413|6501017|P2|STARTED|Overall Study|324 randomised|324
2643234|NCT01011413|6501018|P1|STARTED|Overall Study|312 randomised|312
2643235|NCT00969332|6501042|P1|NOT COMPLETED|Overall Study||11
2643236|NCT00969332|6501042|P1|COMPLETED|Overall Study||51
2643237|NCT00969332|6501042|P1|STARTED|Overall Study||62
2643238|NCT00967941|6501059|P3|NOT COMPLETED|Overall Study||4
2643239|NCT00967941|6501060|P2|NOT COMPLETED|Overall Study||3
2643240|NCT00967941|6501061|P1|NOT COMPLETED|Overall Study||5
2643241|NCT00967941|6501059|P3|COMPLETED|Overall Study||56
2643242|NCT00967941|6501060|P2|COMPLETED|Overall Study||51
2643243|NCT00967941|6501061|P1|COMPLETED|Overall Study||62
2643244|NCT00967941|6501059|P3|STARTED|Overall Study||60
2643245|NCT00967941|6501060|P2|STARTED|Overall Study||54
2643246|NCT00967941|6501061|P1|STARTED|Overall Study||67
2643247|NCT00952588|6501071|P2|NOT COMPLETED|Overall Study||24
2643248|NCT00952588|6501072|P1|NOT COMPLETED|Overall Study||36
2643249|NCT00952588|6501071|P2|COMPLETED|Overall Study||2
2643250|NCT00952588|6501072|P1|COMPLETED|Overall Study||12
2643251|NCT00952588|6501071|P2|STARTED|Overall Study||26
2643252|NCT00952588|6501072|P1|STARTED|Overall Study||48
2643253|NCT00951496|6501093|P3|NOT COMPLETED|Overall Study||13
2643254|NCT00951496|6501094|P2|NOT COMPLETED|Overall Study||8
2643255|NCT00951496|6501095|P1|NOT COMPLETED|Overall Study||10
2643256|NCT00951496|6501093|P3|COMPLETED|Overall Study||508
2643257|NCT00951496|6501094|P2|COMPLETED|Overall Study||510
2643258|NCT00951496|6501095|P1|COMPLETED|Overall Study||511
2643259|NCT00951496|6501093|P3|STARTED|Overall Study||521
2643260|NCT00951496|6501094|P2|STARTED|Overall Study||518
2643261|NCT00951496|6501095|P1|STARTED|Overall Study||521
2643262|NCT00948064|6501124|P3|NOT COMPLETED|Phase II||1
2643263|NCT00948064|6501125|P2|NOT COMPLETED|Phase II||1
2643264|NCT00948064|6501126|P1|NOT COMPLETED|Phase II||0
2643265|NCT00948064|6501124|P3|COMPLETED|Phase II||26
2643266|NCT00948064|6501125|P2|COMPLETED|Phase II||51
2643267|NCT00948064|6501126|P1|COMPLETED|Phase II||0
2643268|NCT00948064|6501124|P3|STARTED|Phase II||27
2643269|NCT00948064|6501125|P2|STARTED|Phase II||52
2643270|NCT00948064|6501126|P1|STARTED|Phase II||0
2643271|NCT00948064|6501124|P3|NOT COMPLETED|Phase I||0
2643272|NCT00948064|6501125|P2|NOT COMPLETED|Phase I||0
2643273|NCT00948064|6501126|P1|NOT COMPLETED|Phase I||1
2643274|NCT00948064|6501124|P3|COMPLETED|Phase I||0
2643275|NCT00948064|6501125|P2|COMPLETED|Phase I||0
2643276|NCT00948064|6501126|P1|COMPLETED|Phase I||30
2643277|NCT00948064|6501124|P3|STARTED|Phase I||0
2643278|NCT00948064|6501125|P2|STARTED|Phase I||0
2643279|NCT00948064|6501126|P1|STARTED|Phase I||31
2643280|NCT00918723|6501137|P1|NOT COMPLETED|Overall Study||0
2643281|NCT00918723|6501137|P1|COMPLETED|Overall Study||40
2643282|NCT00918723|6501137|P1|STARTED|Overall Study||40
2643283|NCT00918333|6501148|P2|NOT COMPLETED|Overall Study||5
2643284|NCT00918333|6501149|P1|NOT COMPLETED|Overall Study||3
2643285|NCT00918333|6501148|P2|COMPLETED|Overall Study||93
2643286|NCT00918333|6501149|P1|COMPLETED|Overall Study||23
2643287|NCT00918333|6501148|P2|STARTED|Overall Study||98
2643288|NCT00918333|6501149|P1|STARTED|Overall Study||26
2643289|NCT00874614|6501169|P1|NOT COMPLETED|Overall Study||58
2643290|NCT00874614|6501169|P1|COMPLETED|Overall Study|As of December 2017|16
2643291|NCT00874614|6501169|P1|Received Two Therapeutic Doses|Overall Study||50
2643292|NCT00874614|6501169|P1|Received at Least One Therapeutic Dose|Overall Study||68
2643293|NCT00874614|6501169|P1|STARTED|Overall Study||74
2643294|NCT00868166|6501179|P2|NOT COMPLETED|Overall Study||114
2643295|NCT00868166|6501180|P1|NOT COMPLETED|Overall Study||112
2643296|NCT00868166|6501179|P2|COMPLETED|Overall Study||139
2643297|NCT00868166|6501180|P1|COMPLETED|Overall Study||147
2643298|NCT00868166|6501179|P2|STARTED|Overall Study||253
2643299|NCT00868166|6501180|P1|STARTED|Overall Study||259
2643300|NCT00846742|6501200|P1|NOT COMPLETED|Overall Study||1
2643301|NCT00846742|6501200|P1|COMPLETED|Overall Study||84
2643302|NCT00846742|6501200|P1|Without Radiation Therapy (RT)|Overall Study||68
2643303|NCT00846742|6501200|P1|With Radiation Therapy (RT)|Overall Study||17
2643304|NCT00846742|6501200|P1|STARTED|Overall Study||85
2643305|NCT00836407|6501208|P2|NOT COMPLETED|Overall Study||8
2643306|NCT00836407|6501209|P1|NOT COMPLETED|Overall Study||11
2643307|NCT00836407|6501208|P2|COMPLETED|Overall Study||7
2643308|NCT00836407|6501209|P1|COMPLETED|Overall Study||4
2643309|NCT00836407|6501208|P2|STARTED|Overall Study||15
2643310|NCT00836407|6501209|P1|STARTED|Overall Study||15
2643311|NCT00792948|6501217|P1|NOT COMPLETED|Overall Study||28
2643312|NCT00792948|6501217|P1|COMPLETED|Overall Study|Patients who completed induction/consolidation step|69
2643313|NCT00792948|6501217|P1|STARTED|Overall Study|Patients registered to induction/consolidation step|97
2643314|NCT00787722|6501226|P1|NOT COMPLETED|Overall Study||1
2643315|NCT00787722|6501226|P1|COMPLETED|Overall Study||12
2643316|NCT00787722|6501226|P1|STARTED|Overall Study||13
2643317|NCT00785291|6501238|P3|NOT COMPLETED|Overall Study||106
2643318|NCT00785291|6501239|P2|NOT COMPLETED|Overall Study||149
2643319|NCT00785291|6501240|P1|NOT COMPLETED|Overall Study||136
2643320|NCT00785291|6501238|P3|COMPLETED|Overall Study||139
2643321|NCT00785291|6501239|P2|COMPLETED|Overall Study||122
2643322|NCT00785291|6501240|P1|COMPLETED|Overall Study||147
2643323|NCT00785291|6501238|P3|STARTED|Overall Study||245
2643324|NCT00785291|6501239|P2|STARTED|Overall Study||271
2643325|NCT00785291|6501240|P1|STARTED|Overall Study||283
2643326|NCT00753948|6501263|P3|NOT COMPLETED|Overall Study||0
2643327|NCT00753948|6501264|P2|NOT COMPLETED|Overall Study||0
2643328|NCT00753948|6501265|P1|NOT COMPLETED|Overall Study||0
2643329|NCT00753948|6501263|P3|COMPLETED|Overall Study||7
2643330|NCT00753948|6501264|P2|COMPLETED|Overall Study||7
2643331|NCT00753948|6501265|P1|COMPLETED|Overall Study||9
2643332|NCT00753948|6501263|P3|STARTED|Overall Study||7
2643333|NCT00753948|6501264|P2|STARTED|Overall Study||7
2643334|NCT00753948|6501265|P1|STARTED|Overall Study||9
2643335|NCT00727441|6501279|P3|NOT COMPLETED|Overall Study||25
2643336|NCT00727441|6501280|P2|NOT COMPLETED|Overall Study||22
2643337|NCT00727441|6501281|P1|NOT COMPLETED|Overall Study||18
2643338|NCT00727441|6501279|P3|COMPLETED|Overall Study||5
2643339|NCT00727441|6501280|P2|COMPLETED|Overall Study||6
2643340|NCT00727441|6501281|P1|COMPLETED|Overall Study||11
2643341|NCT00727441|6501279|P3|STARTED|Overall Study||30
2643342|NCT00727441|6501280|P2|STARTED|Overall Study||28
2643343|NCT00727441|6501281|P1|STARTED|Overall Study||29
2643344|NCT00700882|6501301|P1|NOT COMPLETED|Overall Study||59
2643345|NCT00700882|6501301|P1|COMPLETED|Overall Study||22
2643346|NCT00700882|6501301|P1|Eligible, Treated and KIT+ Patients|Overall Study||22
2643347|NCT00700882|6501301|P1|Eligible and Treated Patients|Overall Study||73
2643348|NCT00700882|6501301|P1|Received Protocol Therapy|Overall Study||75
2643349|NCT00700882|6501301|P1|STARTED|Overall Study||81
2643350|NCT00676689|6501305|P1|NOT COMPLETED|Overall Study||61
2643351|NCT00676689|6501305|P1|COMPLETED|Overall Study||20
2643352|NCT00676689|6501305|P1|1 Year Follow-up|Overall Study||64
2643353|NCT00676689|6501305|P1|30 Day Follow-up|Overall Study||78
2643354|NCT00676689|6501305|P1|Procedure|Overall Study|Two enrolled patients did not meet eligibility criteria and did not undergo the study procedure.|79
2643355|NCT00676689|6501305|P1|STARTED|Overall Study||81
2643356|NCT00673790|6501314|P3|NOT COMPLETED|Overall Study||12
2643357|NCT00673790|6501315|P2|NOT COMPLETED|Overall Study||38
2643358|NCT00673790|6501316|P1|NOT COMPLETED|Overall Study||45
2643359|NCT00673790|6501314|P3|COMPLETED|Overall Study||90
2643360|NCT00673790|6501315|P2|COMPLETED|Overall Study||174
2643361|NCT00673790|6501316|P1|COMPLETED|Overall Study||178
2643362|NCT00673790|6501314|P3|STARTED|Overall Study||102
2643363|NCT00673790|6501315|P2|STARTED|Overall Study||212
2643364|NCT00673790|6501316|P1|STARTED|Overall Study||223
2643365|NCT00667251|6501328|P2|NOT COMPLETED|Overall Study||95
2643366|NCT00667251|6501329|P1|NOT COMPLETED|Overall Study||70
2643367|NCT00667251|6501328|P2|COMPLETED|Overall Study||231
2643368|NCT00667251|6501329|P1|COMPLETED|Overall Study||256
2643369|NCT00667251|6501328|P2|Not Started|Overall Study||1
2643370|NCT00667251|6501329|P1|Not Started|Overall Study||4
2643371|NCT00667251|6501328|P2|Monotherapy|Overall Study||232
2643372|NCT00667251|6501329|P1|Monotherapy|Overall Study||225
2643373|NCT00667251|6501328|P2|Combination Rx|Overall Study||325
2643374|NCT00667251|6501329|P1|Combination Rx|Overall Study||322
2643375|NCT00667251|6501328|P2|STARTED|Overall Study||326
2643376|NCT00667251|6501329|P1|STARTED|Overall Study||326
2643377|NCT00661193|6501355|P2|NOT COMPLETED|Overall Study||26
2643378|NCT00661193|6501356|P1|NOT COMPLETED|Overall Study||33
2643379|NCT00661193|6501355|P2|COMPLETED|Overall Study||0
2643380|NCT00661193|6501356|P1|COMPLETED|Overall Study||0
2643381|NCT00661193|6501355|P2|STARTED|Overall Study||26
2643382|NCT00661193|6501356|P1|STARTED|Overall Study||33
2643383|NCT00658814|6501366|P2|NOT COMPLETED|Maintenance Therapy||1
2643384|NCT00658814|6501367|P1|NOT COMPLETED|Maintenance Therapy||3
2643385|NCT00658814|6501366|P2|COMPLETED|Maintenance Therapy||7
2643386|NCT00658814|6501367|P1|COMPLETED|Maintenance Therapy||17
2643387|NCT00658814|6501366|P2|Eligible|Maintenance Therapy||8
2643388|NCT00658814|6501367|P1|Eligible|Maintenance Therapy||19
2643389|NCT00658814|6501366|P2|STARTED|Maintenance Therapy||8
2643390|NCT00658814|6501367|P1|STARTED|Maintenance Therapy||20
2643391|NCT00658814|6501366|P2|NOT COMPLETED|Consolidation Therapy||3
2643392|NCT00658814|6501367|P1|NOT COMPLETED|Consolidation Therapy||2
2643393|NCT00658814|6501366|P2|COMPLETED|Consolidation Therapy||10
2643394|NCT00658814|6501367|P1|COMPLETED|Consolidation Therapy||22
2643395|NCT00658814|6501366|P2|Eligible|Consolidation Therapy||11
2643396|NCT00658814|6501367|P1|Eligible|Consolidation Therapy||22
2643397|NCT00658814|6501366|P2|STARTED|Consolidation Therapy||13
2643398|NCT00658814|6501367|P1|STARTED|Consolidation Therapy||24
2643399|NCT00658814|6501366|P2|NOT COMPLETED|Remission Induction Chemotherapy||18
2643400|NCT00658814|6501367|P1|NOT COMPLETED|Remission Induction Chemotherapy||8
2643401|NCT00658814|6501366|P2|COMPLETED|Remission Induction Chemotherapy||41
2643402|NCT00658814|6501367|P1|COMPLETED|Remission Induction Chemotherapy||75
2643403|NCT00658814|6501366|P2|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||54
2643404|NCT00658814|6501367|P1|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||79
2643405|NCT00658814|6501366|P2|Eligible|Remission Induction Chemotherapy||57
2643406|NCT00658814|6501367|P1|Eligible|Remission Induction Chemotherapy||82
2643407|NCT00658814|6501366|P2|STARTED|Remission Induction Chemotherapy||59
2643408|NCT00658814|6501367|P1|STARTED|Remission Induction Chemotherapy||83
2643409|NCT00654732|6501383|P2|NOT COMPLETED|Overall Study||6
2643410|NCT00654732|6501384|P1|NOT COMPLETED|Overall Study||4
2643411|NCT00654732|6501383|P2|COMPLETED|Overall Study||26
2643412|NCT00654732|6501384|P1|COMPLETED|Overall Study||22
2643413|NCT00654732|6501383|P2|STARTED|Overall Study||32
2643414|NCT00654732|6501384|P1|STARTED|Overall Study||26
2643415|NCT00625846|6501394|P4|NOT COMPLETED|Overall Study||2
2643416|NCT00625846|6501395|P3|NOT COMPLETED|Overall Study||1
2643417|NCT00625846|6501396|P2|NOT COMPLETED|Overall Study||0
2643418|NCT00625846|6501397|P1|NOT COMPLETED|Overall Study||2
2643419|NCT00625846|6501394|P4|COMPLETED|Overall Study||60
2643420|NCT00625846|6501395|P3|COMPLETED|Overall Study||15
2643421|NCT00625846|6501396|P2|COMPLETED|Overall Study||35
2643422|NCT00625846|6501397|P1|COMPLETED|Overall Study||37
2643423|NCT00625846|6501394|P4|STARTED|Overall Study||62
2643424|NCT00625846|6501395|P3|STARTED|Overall Study||16
2643425|NCT00625846|6501396|P2|STARTED|Overall Study||35
2643426|NCT00625846|6501397|P1|STARTED|Overall Study||39
2643427|NCT00616967|6501425|P3|NOT COMPLETED|Overall Study||1
2643428|NCT00616967|6501426|P2|NOT COMPLETED|Overall Study||0
2643429|NCT00616967|6501427|P1|NOT COMPLETED|Overall Study||0
2643430|NCT00616967|6501425|P3|COMPLETED|Overall Study||30
2643431|NCT00616967|6501426|P2|COMPLETED|Overall Study||31
2643432|NCT00616967|6501427|P1|COMPLETED|Overall Study||6
2643433|NCT00616967|6501425|P3|STARTED|Overall Study||31
2643434|NCT00616967|6501426|P2|STARTED|Overall Study||31
2643435|NCT00616967|6501427|P1|STARTED|Overall Study||6
2643436|NCT00601900|6501451|P2|NOT COMPLETED|Overall Study||3
2643437|NCT00601900|6501452|P1|NOT COMPLETED|Overall Study||0
2643438|NCT00601900|6501451|P2|COMPLETED|Overall Study||196
2643439|NCT00601900|6501452|P1|COMPLETED|Overall Study||195
2643440|NCT00601900|6501451|P2|STARTED|Overall Study||199
2643441|NCT00601900|6501452|P1|STARTED|Overall Study||195
2643442|NCT00588770|6501468|P2|NOT COMPLETED|Overall Study||200
2643443|NCT00588770|6501469|P1|NOT COMPLETED|Overall Study||159
2643444|NCT00588770|6501468|P2|COMPLETED|Overall Study||3
2643445|NCT00588770|6501469|P1|COMPLETED|Overall Study||41
2643446|NCT00588770|6501468|P2|Start Protocol Therapy|Overall Study||194
2643447|NCT00588770|6501469|P1|Start Protocol Therapy|Overall Study||200
2643448|NCT00588770|6501468|P2|Eligible|Overall Study||183
2643449|NCT00588770|6501469|P1|Eligible|Overall Study||188
2643450|NCT00588770|6501468|P2|STARTED|Overall Study||203
2643451|NCT00588770|6501469|P1|STARTED|Overall Study||200
2643452|NCT00534703|6501481|P2|NOT COMPLETED|Overall Study||0
2643453|NCT00534703|6501482|P1|NOT COMPLETED|Overall Study||0
2643454|NCT00534703|6501481|P2|COMPLETED|Overall Study||1
2643455|NCT00534703|6501482|P1|COMPLETED|Overall Study||4
2643456|NCT00534703|6501481|P2|STARTED|Overall Study||1
2643457|NCT00534703|6501482|P1|STARTED|Overall Study||4
2643458|NCT00500890|6501500|P2|NOT COMPLETED|Overall Study||0
2643459|NCT00500890|6501501|P1|NOT COMPLETED|Overall Study||0
2643460|NCT00500890|6501500|P2|COMPLETED|Overall Study||1
2643461|NCT00500890|6501501|P1|COMPLETED|Overall Study||1
2643462|NCT00500890|6501500|P2|STARTED|Overall Study||1
2643463|NCT00500890|6501501|P1|STARTED|Overall Study||1
2643464|NCT00433511|6501516|P3|NOT COMPLETED|Step 2 (Arm D)||491
2643465|NCT00433511|6501517|P2|NOT COMPLETED|Step 2 (Arm D)||0
2643466|NCT00433511|6501518|P1|NOT COMPLETED|Step 2 (Arm D)||0
2643467|NCT00433511|6501516|P3|COMPLETED|Step 2 (Arm D)||825
2643468|NCT00433511|6501517|P2|COMPLETED|Step 2 (Arm D)||0
2643469|NCT00433511|6501518|P1|COMPLETED|Step 2 (Arm D)||0
2643470|NCT00433511|6501516|P3|Patients Who Received Treatment|Step 2 (Arm D)||1168
2643471|NCT00433511|6501517|P2|Patients Who Received Treatment|Step 2 (Arm D)||0
2643472|NCT00433511|6501518|P1|Patients Who Received Treatment|Step 2 (Arm D)||0
2643473|NCT00433511|6501516|P3|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|1316
2643474|NCT00433511|6501517|P2|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|0
2643475|NCT00433511|6501518|P1|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|0
2643476|NCT00433511|6501516|P3|NOT COMPLETED|Step 1||390
2643477|NCT00433511|6501517|P2|NOT COMPLETED|Step 1||385
2643478|NCT00433511|6501518|P1|NOT COMPLETED|Step 1||136
2643479|NCT00433511|6501516|P3|COMPLETED|Step 1||1618
2643480|NCT00433511|6501517|P2|COMPLETED|Step 1||1601
2643481|NCT00433511|6501518|P1|COMPLETED|Step 1||864
2643482|NCT00433511|6501516|P3|Patients in Genetic Ancestry Analysis|Step 1||1158
2643483|NCT00433511|6501517|P2|Patients in Genetic Ancestry Analysis|Step 1||1126
2643484|NCT00433511|6501518|P1|Patients in Genetic Ancestry Analysis|Step 1||575
2643485|NCT00433511|6501516|P3|Patients Who Received Treatment|Step 1||1942
2643486|NCT00433511|6501517|P2|Patients Who Received Treatment|Step 1||1922
2643487|NCT00433511|6501518|P1|Patients Who Received Treatment|Step 1||972
2643488|NCT00433511|6501516|P3|STARTED|Step 1||2008
2643489|NCT00433511|6501517|P2|STARTED|Step 1||1986
2643490|NCT00433511|6501518|P1|STARTED|Step 1||1000
2643491|NCT00376688|6501532|P1|NOT COMPLETED|Overall Study||4
2643492|NCT00376688|6501532|P1|COMPLETED|Overall Study||27
2643493|NCT00376688|6501532|P1|STARTED|Overall Study||31
2643494|NCT00367458|6501538|P2|NOT COMPLETED|Second Intervention - 8 Weeks||0
2643495|NCT00367458|6501539|P1|NOT COMPLETED|Second Intervention - 8 Weeks||0
2643496|NCT00367458|6501538|P2|COMPLETED|Second Intervention - 8 Weeks||12
2643497|NCT00367458|6501539|P1|COMPLETED|Second Intervention - 8 Weeks||10
2643498|NCT00367458|6501538|P2|STARTED|Second Intervention - 8 Weeks||12
2643499|NCT00367458|6501539|P1|STARTED|Second Intervention - 8 Weeks||10
2643500|NCT00367458|6501538|P2|NOT COMPLETED|Washout Period - 4-6 Weeks||0
2643501|NCT00367458|6501539|P1|NOT COMPLETED|Washout Period - 4-6 Weeks||0
2643502|NCT00367458|6501538|P2|COMPLETED|Washout Period - 4-6 Weeks||12
2643503|NCT00367458|6501539|P1|COMPLETED|Washout Period - 4-6 Weeks||10
2643504|NCT00367458|6501538|P2|STARTED|Washout Period - 4-6 Weeks||12
2643505|NCT00367458|6501539|P1|STARTED|Washout Period - 4-6 Weeks||10
2643506|NCT00367458|6501538|P2|NOT COMPLETED|First Intervention - 8 Weeks||0
2643507|NCT00367458|6501539|P1|NOT COMPLETED|First Intervention - 8 Weeks||2
2643508|NCT00367458|6501538|P2|COMPLETED|First Intervention - 8 Weeks||12
2643509|NCT00367458|6501539|P1|COMPLETED|First Intervention - 8 Weeks||10
2643510|NCT00367458|6501538|P2|STARTED|First Intervention - 8 Weeks||12
2643511|NCT00367458|6501539|P1|STARTED|First Intervention - 8 Weeks||12
2643512|NCT00294632|6501555|P2|NOT COMPLETED|Phase II: 20 mg Lenalidomide||0
2643513|NCT00294632|6501556|P1|NOT COMPLETED|Phase II: 20 mg Lenalidomide||0
2643514|NCT00294632|6501555|P2|COMPLETED|Phase II: 20 mg Lenalidomide||38
2643515|NCT00294632|6501556|P1|COMPLETED|Phase II: 20 mg Lenalidomide||6
2643516|NCT00294632|6501555|P2|STARTED|Phase II: 20 mg Lenalidomide||38
2643517|NCT00294632|6501556|P1|STARTED|Phase II: 20 mg Lenalidomide||6
2643518|NCT00294632|6501555|P2|NOT COMPLETED|Phase I Dose Escalation Period||0
2643519|NCT00294632|6501556|P1|NOT COMPLETED|Phase I Dose Escalation Period||0
2643520|NCT00294632|6501555|P2|COMPLETED|Phase I Dose Escalation Period||0
2643521|NCT00294632|6501556|P1|COMPLETED|Phase I Dose Escalation Period||14
2643522|NCT00294632|6501555|P2|Cohort 4: 25 mg|Phase I Dose Escalation Period||0
2643523|NCT00294632|6501556|P1|Cohort 4: 25 mg|Phase I Dose Escalation Period||2
2643524|NCT00294632|6501555|P2|Cohort 3: 20 mg|Phase I Dose Escalation Period||0
2643525|NCT00294632|6501556|P1|Cohort 3: 20 mg|Phase I Dose Escalation Period||6
2643526|NCT00294632|6501555|P2|Cohort 2: 15 mg|Phase I Dose Escalation Period||0
2643527|NCT00294632|6501556|P1|Cohort 2: 15 mg|Phase I Dose Escalation Period||3
2643528|NCT00294632|6501555|P2|Cohort 1: 10 mg|Phase I Dose Escalation Period||0
2643529|NCT00294632|6501556|P1|Cohort 1: 10 mg|Phase I Dose Escalation Period||3
2643530|NCT00294632|6501555|P2|STARTED|Phase I Dose Escalation Period||0
2643531|NCT00294632|6501556|P1|STARTED|Phase I Dose Escalation Period||14
2643532|NCT00278538|6501563|P1|NOT COMPLETED|Overall Study||2
2643533|NCT00278538|6501563|P1|COMPLETED|Overall Study||30
2643534|NCT00278538|6501563|P1|STARTED|Overall Study||32
2643535|NCT00238420|6501569|P2|NOT COMPLETED|Overall Study||1
2643536|NCT00238420|6501570|P1|NOT COMPLETED|Overall Study||1
2643537|NCT00238420|6501569|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
2643538|NCT00238420|6501570|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|21
2643539|NCT00238420|6501569|P2|STARTED|Overall Study||48
2643540|NCT00238420|6501570|P1|STARTED|Overall Study||22
2643541|NCT00228917|6501588|P8|NOT COMPLETED|Overall Study||0
2643542|NCT00228917|6501589|P7|NOT COMPLETED|Overall Study||0
2643543|NCT00228917|6501590|P6|NOT COMPLETED|Overall Study||2
2643544|NCT00228917|6501591|P5|NOT COMPLETED|Overall Study||0
2643545|NCT00228917|6501592|P4|NOT COMPLETED|Overall Study||0
2643546|NCT00228917|6501593|P3|NOT COMPLETED|Overall Study||0
2643547|NCT00228917|6501594|P2|NOT COMPLETED|Overall Study||0
2643548|NCT00228917|6501595|P1|NOT COMPLETED|Overall Study||0
2643549|NCT00228917|6501588|P8|COMPLETED|Overall Study||33
2643550|NCT00228917|6501589|P7|COMPLETED|Overall Study||69
2643551|NCT00228917|6501590|P6|COMPLETED|Overall Study||102
2643552|NCT00228917|6501591|P5|COMPLETED|Overall Study||205
2643553|NCT00228917|6501592|P4|COMPLETED|Overall Study||33
2643554|NCT00228917|6501593|P3|COMPLETED|Overall Study||65
2643555|NCT00228917|6501594|P2|COMPLETED|Overall Study||96
2643556|NCT00228917|6501595|P1|COMPLETED|Overall Study||193
2643557|NCT00228917|6501588|P8|STARTED|Overall Study||33
2643558|NCT00228917|6501589|P7|STARTED|Overall Study||69
2643559|NCT00228917|6501590|P6|STARTED|Overall Study||104
2643560|NCT00228917|6501591|P5|STARTED|Overall Study||205
2643561|NCT00228917|6501592|P4|STARTED|Overall Study||33
2643562|NCT00228917|6501593|P3|STARTED|Overall Study||65
2643563|NCT00228917|6501594|P2|STARTED|Overall Study||96
2643564|NCT00228917|6501595|P1|STARTED|Overall Study||193
2643565|NCT00176852|6501644|P3|NOT COMPLETED|Overall Study||0
2643566|NCT00176852|6501645|P2|NOT COMPLETED|Overall Study||0
2643567|NCT00176852|6501646|P1|NOT COMPLETED|Overall Study||0
2643568|NCT00176852|6501644|P3|COMPLETED|Overall Study||14
2643569|NCT00176852|6501645|P2|COMPLETED|Overall Study||5
2643570|NCT00176852|6501646|P1|COMPLETED|Overall Study||3
2643571|NCT00176852|6501644|P3|STARTED|Overall Study||14
2643572|NCT00176852|6501645|P2|STARTED|Overall Study||5
2643573|NCT00176852|6501646|P1|STARTED|Overall Study||3
2643574|NCT00136604|6501707|P5|NOT COMPLETED|Overall Study||1
2643575|NCT00136604|6501708|P4|NOT COMPLETED|Overall Study||0
2643576|NCT00136604|6501709|P3|NOT COMPLETED|Overall Study||0
2643577|NCT00136604|6501710|P2|NOT COMPLETED|Overall Study||1
2643578|NCT00136604|6501711|P1|NOT COMPLETED|Overall Study||1
2643579|NCT00136604|6501707|P5|COMPLETED|Overall Study||124
2643580|NCT00136604|6501708|P4|COMPLETED|Overall Study||41
2643581|NCT00136604|6501709|P3|COMPLETED|Overall Study||79
2643582|NCT00136604|6501710|P2|COMPLETED|Overall Study||122
2643583|NCT00136604|6501711|P1|COMPLETED|Overall Study||248
2643584|NCT00136604|6501707|P5|STARTED|Overall Study||125
2643585|NCT00136604|6501708|P4|STARTED|Overall Study||41
2643586|NCT00136604|6501709|P3|STARTED|Overall Study||79
2643587|NCT00136604|6501710|P2|STARTED|Overall Study||123
2643588|NCT00136604|6501711|P1|STARTED|Overall Study||249
2643589|NCT00081289|6501819|P2|NOT COMPLETED|Overall Study||21
2643590|NCT00081289|6501820|P1|NOT COMPLETED|Overall Study||21
2643591|NCT00081289|6501819|P2|COMPLETED|Overall Study||52
2643592|NCT00081289|6501820|P1|COMPLETED|Overall Study||52
2643593|NCT00081289|6501819|P2|Defecation Symptom Score at Two Years|Overall Study||15
2643594|NCT00081289|6501820|P1|Defecation Symptom Score at Two Years|Overall Study||13
2643595|NCT00081289|6501819|P2|DS Score at End of Post-op CT|Overall Study||14
2643596|NCT00081289|6501820|P1|DS Score at End of Post-op CT|Overall Study||12
2643597|NCT00081289|6501819|P2|Defecation Symptom Score at End of CR|Overall Study||32
2643598|NCT00081289|6501820|P1|Defecation Symptom Score at End of CR|Overall Study||32
2643599|NCT00081289|6501819|P2|GI Symptom Score at Two Years|Overall Study||20
2643600|NCT00081289|6501820|P1|GI Symptom Score at Two Years|Overall Study||21
2643601|NCT00081289|6501819|P2|GI Symptom Score at End of Post-op CT|Overall Study||27
2643602|NCT00081289|6501820|P1|GI Symptom Score at End of Post-op CT|Overall Study||22
2643603|NCT00081289|6501819|P2|GI Symptom Score at End of CR|Overall Study||33
2643604|NCT00081289|6501820|P1|GI Symptom Score at End of CR|Overall Study||34
2643605|NCT00081289|6501819|P2|GHS at Two Years|Overall Study||20
2643606|NCT00081289|6501820|P1|GHS at Two Years|Overall Study||21
2643607|NCT00081289|6501819|P2|GHS at End of Post-op CT|Overall Study||28
2643608|NCT00081289|6501820|P1|GHS at End of Post-op CT|Overall Study||20
2643609|NCT00081289|6501819|P2|Global Health Status Score at End of CR|Overall Study||32
2643610|NCT00081289|6501820|P1|Global Health Status Score at End of CR|Overall Study|European Organization for Research & Treatment of Cancer Quality of Life Questionnaire [EORTC QLQ]|34
2643611|NCT00081289|6501819|P2|Surgery|Overall Study||51
2643612|NCT00081289|6501820|P1|Surgery|Overall Study||47
2643613|NCT00081289|6501819|P2|Full AE Population|Overall Study||68
2643614|NCT00081289|6501820|P1|Full AE Population|Overall Study||70
2643615|NCT00081289|6501819|P2|General Analysis Population|Overall Study||52
2643616|NCT00081289|6501820|P1|General Analysis Population|Overall Study||52
2643617|NCT00081289|6501819|P2|Primary Endpoint Population|Overall Study||48
2643618|NCT00081289|6501820|P1|Primary Endpoint Population|Overall Study||48
2643619|NCT00081289|6501819|P2|STARTED|Overall Study||73
2643620|NCT00081289|6501820|P1|STARTED|Overall Study||73
2643621|NCT00078949|6501866|P4|NOT COMPLETED|Overall Study||3
2643622|NCT00078949|6501867|P3|NOT COMPLETED|Overall Study||3
2643623|NCT00078949|6501868|P2|NOT COMPLETED|Overall Study||5
2643624|NCT00078949|6501869|P1|NOT COMPLETED|Overall Study||4
2643625|NCT00078949|6501866|P4|COMPLETED|Overall Study||112
2643626|NCT00078949|6501867|P3|COMPLETED|Overall Study||112
2643627|NCT00078949|6501868|P2|COMPLETED|Overall Study||304
2643628|NCT00078949|6501869|P1|COMPLETED|Overall Study||306
2643629|NCT00078949|6501866|P4|STARTED|Overall Study||115
2643630|NCT00078949|6501867|P3|STARTED|Overall Study||115
2643631|NCT00078949|6501868|P2|STARTED|Overall Study||309
2643632|NCT00078949|6501869|P1|STARTED|Overall Study||310
2643633|NCT00047060|6501885|P1|NOT COMPLETED|Overall Study||2
2643634|NCT00047060|6501885|P1|COMPLETED|Overall Study||3
2643635|NCT00047060|6501885|P1|STARTED|Overall Study||5
2643636|NCT00007644|6501891|P2|NOT COMPLETED|Overall Study||0
2643637|NCT00007644|6501892|P1|NOT COMPLETED|Overall Study||0
2643638|NCT00007644|6501891|P2|COMPLETED|Overall Study||367
2643639|NCT00007644|6501892|P1|COMPLETED|Overall Study||364
2643640|NCT00007644|6501891|P2|STARTED|Overall Study||367
2643641|NCT00007644|6501892|P1|STARTED|Overall Study||364
2643642|NCT00006411|6501900|P2|NOT COMPLETED|Overall Study||0
2643643|NCT00006411|6501901|P1|NOT COMPLETED|Overall Study||0
2643644|NCT00006411|6501900|P2|COMPLETED|Overall Study||383
2643645|NCT00006411|6501901|P1|COMPLETED|Overall Study||707
2643646|NCT00006411|6501900|P2|STARTED|Overall Study||383
2643647|NCT00006411|6501901|P1|STARTED|Overall Study||707
